id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
44261369|NCT02569710|79141238|FG000|Overall Study|Adverse Event|1|||
44261370|NCT02569710|79141239|FG001|Overall Study|Adverse Event|0|||
44261371|NCT02569710|79141240|FG002|Overall Study|Adverse Event|0|||
44261372|NCT02569710|79141241|FG003|Overall Study|Adverse Event|0|||
44261373|NCT02569710|79141242|FG004|Overall Study|Adverse Event|0|||
44261374|NCT02569710|79141243|FG005|Overall Study|Adverse Event|0|||
44261375|NCT02569710|79141244|FG006|Overall Study|Adverse Event|0|||
44261376|NCT02569710|79141245|FG007|Overall Study|Adverse Event|0|||
44261377|NCT02569710|79141246|FG008|Overall Study|Adverse Event|0|||
44261378|NCT02569710|79141247|FG009|Overall Study|Adverse Event|0|||
44261379|NCT02569710|79141238|FG000|Overall Study|Lost to Follow-up|0|||
44261380|NCT02569710|79141239|FG001|Overall Study|Lost to Follow-up|0|||
44261381|NCT02569710|79141240|FG002|Overall Study|Lost to Follow-up|0|||
44261382|NCT02569710|79141241|FG003|Overall Study|Lost to Follow-up|0|||
44261383|NCT02569710|79141242|FG004|Overall Study|Lost to Follow-up|0|||
44261384|NCT02569710|79141243|FG005|Overall Study|Lost to Follow-up|0|||
44261385|NCT02569710|79141244|FG006|Overall Study|Lost to Follow-up|1|||
44261386|NCT02569710|79141245|FG007|Overall Study|Lost to Follow-up|0|||
44261387|NCT02569710|79141246|FG008|Overall Study|Lost to Follow-up|1|||
44261388|NCT02569710|79141247|FG009|Overall Study|Lost to Follow-up|0|||
44261389|NCT02569710|79141238|FG000|Overall Study|Virologic failure|0|||
44261390|NCT02569710|79141239|FG001|Overall Study|Virologic failure|0|||
44261391|NCT02569710|79141240|FG002|Overall Study|Virologic failure|0|||
44261392|NCT02569710|79141241|FG003|Overall Study|Virologic failure|0|||
44261393|NCT02569710|79141242|FG004|Overall Study|Virologic failure|1|||
44261394|NCT02569710|79141243|FG005|Overall Study|Virologic failure|0|||
44261395|NCT02569710|79141244|FG006|Overall Study|Virologic failure|1|||
44541904|NCT03282357|79554641|FG000|Overall Study|Lost to Follow-up|3|||
44541905|NCT03282357|79554641|FG000|Overall Study|Withdrawal by Subject|4|||
44541906|NCT03282357|79554641|FG000|Overall Study|Adverse Event|1|||
44541907|NCT03282357|79554641|FG000|Overall Study|Other|9|||
44541908|NCT04272775|79554648|FG000|Overall Study|Study Terminated by Sponsor|1|||
44541909|NCT04272775|79554649|FG001|Overall Study|Study Terminated by Sponsor|0|||
44541910|NCT04272775|79554648|FG000|Overall Study|Protocol Violation|0|||
44541911|NCT04272775|79554649|FG001|Overall Study|Protocol Violation|1|||
44261396|NCT02569710|79141245|FG007|Overall Study|Virologic failure|0|||
44261397|NCT02569710|79141246|FG008|Overall Study|Virologic failure|0|||
44261398|NCT02569710|79141247|FG009|Overall Study|Virologic failure|0|||
44261399|NCT02569710|79141238|FG000|Overall Study|Withdrawal by Subject|0|||
44261400|NCT02569710|79141239|FG001|Overall Study|Withdrawal by Subject|0|||
44261401|NCT02569710|79141240|FG002|Overall Study|Withdrawal by Subject|0|||
44261402|NCT02569710|79141241|FG003|Overall Study|Withdrawal by Subject|0|||
44541912|NCT04272775|79554648|FG000|Overall Study|Symptomatic Deterioration|1|||
44541913|NCT04272775|79554649|FG001|Overall Study|Symptomatic Deterioration|1|||
44541914|NCT04272775|79554648|FG000|Overall Study|Withdrawal by Subject|1|||
44541915|NCT04272775|79554649|FG001|Overall Study|Withdrawal by Subject|2|||
44261403|NCT02569710|79141242|FG004|Overall Study|Withdrawal by Subject|0|||
44261404|NCT02569710|79141243|FG005|Overall Study|Withdrawal by Subject|1|||
44261405|NCT02569710|79141244|FG006|Overall Study|Withdrawal by Subject|0|||
44541916|NCT04272775|79554648|FG000|Overall Study|Adverse Event|1|||
44541917|NCT04272775|79554649|FG001|Overall Study|Adverse Event|2|||
44541918|NCT04272775|79554648|FG000|Overall Study|Progressive Disease|3|||
44541919|NCT04272775|79554649|FG001|Overall Study|Progressive Disease|1|||
44541920|NCT03232983|79554655|FG000|Period 1|Physician Decision|0|||
44541921|NCT03232983|79554656|FG001|Period 1|Physician Decision|0|||
44541922|NCT03232983|79554657|FG002|Period 1|Physician Decision|1|||
44541923|NCT03232983|79554658|FG003|Period 1|Physician Decision|0|||
44541924|NCT03232983|79554655|FG000|Washout Period 2|Physician Decision|0|||
44541925|NCT03232983|79554656|FG001|Washout Period 2|Physician Decision|0|||
44541926|NCT03232983|79554657|FG002|Washout Period 2|Physician Decision|1|||
44261406|NCT02569710|79141245|FG007|Overall Study|Withdrawal by Subject|0|||
44261407|NCT02569710|79141246|FG008|Overall Study|Withdrawal by Subject|0|||
44261408|NCT02569710|79141247|FG009|Overall Study|Withdrawal by Subject|0|||
44261409|NCT02569476|79141349|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
44261410|NCT02569476|79141349|FG000|Overall Study|Death|33|||
44261411|NCT02569476|79141349|FG000|Overall Study|Withdrawal by Subject|9|||
44261412|NCT02569476|79141349|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
44261413|NCT02569476|79141349|FG000|Overall Study|Palliative care|1|||
44261414|NCT02569476|79141349|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
44261415|NCT02569476|79141349|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
44261416|NCT02565576|79141421|FG000|Overall Study|abnormal lab value|2|||
44261417|NCT02565576|79141422|FG001|Overall Study|abnormal lab value|0|||
44261418|NCT02565576|79141421|FG000|Overall Study|subject / guardian decision|1|||
44261419|NCT02565576|79141422|FG001|Overall Study|subject / guardian decision|3|||
44448449|NCT00561470|79457151|FG000|Overall Study|Adverse Event|74|||
44261420|NCT02565576|79141421|FG000|Overall Study|Lost to Follow-up|1|||
44261421|NCT02565576|79141422|FG001|Overall Study|Lost to Follow-up|0|||
44541927|NCT03232983|79554658|FG003|Washout Period 2|Physician Decision|0|||
44261422|NCT02565576|79141421|FG000|Overall Study|Death|0|||
44261423|NCT02565576|79141422|FG001|Overall Study|Death|2|||
44261424|NCT02565576|79141421|FG000|Overall Study|Adverse Event|1|||
44261425|NCT02565576|79141422|FG001|Overall Study|Adverse Event|0|||
44261426|NCT02569398|79141453|FG000|Overall Study|Adverse Event|0|||
44261427|NCT02569398|79141454|FG001|Overall Study|Adverse Event|1|||
44261428|NCT02569398|79141455|FG002|Overall Study|Adverse Event|6|||
44261429|NCT02569398|79141453|FG000|Overall Study|Withdrawal by Subject|43|||
44261430|NCT02569398|79141454|FG001|Overall Study|Withdrawal by Subject|43|||
44261431|NCT02569398|79141455|FG002|Overall Study|Withdrawal by Subject|30|||
44261432|NCT02569398|79141453|FG000|Overall Study|Study terminated by sponsor|130|||
44261433|NCT02569398|79141454|FG001|Overall Study|Study terminated by sponsor|131|||
44261434|NCT02569398|79141455|FG002|Overall Study|Study terminated by sponsor|134|||
44261435|NCT02569398|79141453|FG000|Overall Study|Other|12|||
44261436|NCT02569398|79141454|FG001|Overall Study|Other|14|||
44261437|NCT02569398|79141455|FG002|Overall Study|Other|13|||
44261438|NCT02569242|79141499|FG000|Overall Study|Death|1|||
44261439|NCT02569242|79141500|FG001|Overall Study|Death|0|||
44261440|NCT02569242|79141499|FG000|Overall Study|Withdrawal by Subject|0|||
44261441|NCT02569242|79141500|FG001|Overall Study|Withdrawal by Subject|1|||
44261442|NCT01663740|79141568|FG000|Overall Study|Lost to Follow-up|1|||
44261443|NCT01663740|79141569|FG001|Overall Study|Lost to Follow-up|4|||
44261444|NCT01663740|79141568|FG000|Overall Study|Other|9|||
44261445|NCT01663740|79141569|FG001|Overall Study|Other|2|||
44261446|NCT01663740|79141568|FG000|Overall Study|Inclusion/Exclusion not met|1|||
44261447|NCT01663740|79141569|FG001|Overall Study|Inclusion/Exclusion not met|0|||
44261448|NCT01663740|79141568|FG000|Overall Study|Death|0|||
44261449|NCT01663740|79141569|FG001|Overall Study|Death|1|||
44261450|NCT01663740|79141568|FG000|Overall Study|Withdrawal by Subject|2|||
44261451|NCT01663740|79141569|FG001|Overall Study|Withdrawal by Subject|1|||
44261452|NCT01663740|79141568|FG000|Overall Study|No end of study status|3|||
44261453|NCT01663740|79141569|FG001|Overall Study|No end of study status|0|||
44261454|NCT01663506|79141685|FG000|Overall Study|Lack of Efficacy|3|||
44261455|NCT01663506|79141685|FG000|Overall Study|Consent Withdrawal by Subject|1|||
44261456|NCT01663506|79141685|FG000|Overall Study|Lost to Follow-up|1|||
44261457|NCT01663506|79141685|FG000|Overall Study|Adverse Event|1|||
44261458|NCT01663506|79141685|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
44261459|NCT02568384|79141689|FG000|Overall Study|Mobile devices incompatible with App|2|||
44261460|NCT02965976|79141796|FG000|Overall Study|Withdrawal by Subject|2|||
44261461|NCT02965976|79141797|FG001|Overall Study|Withdrawal by Subject|0|||
44261462|NCT04125680|79141815|FG000|Overall Study|Lost to Follow-up|15|||
44261463|NCT02565186|79141839|FG000|Overall Study|Adverse Event|113|||
44261464|NCT02565186|79141840|FG001|Overall Study|Adverse Event|148|||
44261465|NCT02565186|79141839|FG000|Overall Study|Lost to Follow-up|102|||
44261466|NCT02565186|79141840|FG001|Overall Study|Lost to Follow-up|93|||
44261467|NCT02565186|79141839|FG000|Overall Study|Non-Compliance|57|||
44261468|NCT02565186|79141840|FG001|Overall Study|Non-Compliance|55|||
44261469|NCT02565186|79141839|FG000|Overall Study|Withdrawal by Subject|229|||
44261470|NCT02565186|79141840|FG001|Overall Study|Withdrawal by Subject|214|||
44541928|NCT03232983|79554655|FG000|Washout Period 2|Withdrawal by Subject|0|||
44541929|NCT03232983|79554656|FG001|Washout Period 2|Withdrawal by Subject|0|||
44541930|NCT03232983|79554657|FG002|Washout Period 2|Withdrawal by Subject|0|||
44541931|NCT03232983|79554658|FG003|Washout Period 2|Withdrawal by Subject|1|||
44541932|NCT03232983|79554655|FG000|Period 4|Withdrawal by Subject|1|||
44541933|NCT03232983|79554656|FG001|Period 4|Withdrawal by Subject|0|||
44541934|NCT03232983|79554657|FG002|Period 4|Withdrawal by Subject|0|||
44541935|NCT03232983|79554658|FG003|Period 4|Withdrawal by Subject|0|||
44541936|NCT04102345|79554672|FG000|Overall Study|Withdrawal by Subject|1|||
44541937|NCT04102345|79554673|FG001|Overall Study|Withdrawal by Subject|0|||
44541938|NCT04271605|79554679|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
44541939|NCT03299244|79554685|FG000|Overall Study|Withdrawal by Subject|34|||
44541940|NCT03299244|79554686|FG001|Overall Study|Withdrawal by Subject|29|||
44261471|NCT02565186|79141839|FG000|Overall Study|Physician Decision|18|||
44261472|NCT02565186|79141840|FG001|Overall Study|Physician Decision|16|||
44261473|NCT02565186|79141839|FG000|Overall Study|Sponsor Request|5|||
44261474|NCT02565186|79141840|FG001|Overall Study|Sponsor Request|9|||
44261475|NCT02565186|79141839|FG000|Overall Study|Missing|1|||
44261476|NCT02565186|79141840|FG001|Overall Study|Missing|0|||
44541941|NCT03299244|79554685|FG000|Overall Study|Decision by Sponsor|4|||
44143663|NCT00271817|78932989|FG001|Part 1|Patient Moved|1|||
44261477|NCT02565186|79141839|FG000|Overall Study|Did Not Receive Study Drug|55|||
44261478|NCT02565186|79141840|FG001|Overall Study|Did Not Receive Study Drug|86|||
44261479|NCT02568072|79141846|FG000|Overall Study|Unavailable for appointment|23|||
44261480|NCT02568072|79141846|FG000|Overall Study|Unable to contact|3|||
44261481|NCT02568072|79141846|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
44261482|NCT02568072|79141846|FG000|Overall Study|Withdrawal by Subject|1|||
44261483|NCT02568072|79141846|FG000|Overall Study|Sustained injury, marathon not run|24|||
44261484|NCT02565108|79141853|FG000|Overall Study|Adverse Event|1|||
44261485|NCT02565108|79141854|FG001|Overall Study|Adverse Event|0|||
44261486|NCT02565108|79141853|FG000|Overall Study|Withdrew Consent|1|||
44261487|NCT02565108|79141854|FG001|Overall Study|Withdrew Consent|0|||
44261488|NCT02564952|79141860|FG000|Overall Study|Adverse Event|6|||
44261489|NCT02564952|79141860|FG000|Overall Study|Lost to Follow-up|1|||
44261490|NCT02564952|79141860|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
44261491|NCT02564952|79141860|FG000|Overall Study|Withdrawal by Subject|1|||
44261492|NCT02564952|79141860|FG000|Overall Study|Low Efficacy|1|||
44261493|NCT02564952|79141860|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
44261494|NCT02566902|79141866|FG000|Overall Study|Protocol Violation|2|||
44261495|NCT02566902|79141867|FG001|Overall Study|Protocol Violation|1|||
44261496|NCT02564796|79141875|FG000|Overall Study|Physician Decision|2|||
44261497|NCT02564796|79141876|FG001|Overall Study|Physician Decision|2|||
44261498|NCT02564718|79141884|FG000|Overall Study|Withdrew from treatment|0|||
44261499|NCT02564718|79141885|FG001|Overall Study|Withdrew from treatment|1|||
44261500|NCT01453946|79141891|FG000|Overall Study|Did not receive drug for the taper phase|1|||
44261501|NCT01453946|79141891|FG000|Overall Study|Protocol Violation|2|||
44261502|NCT01453946|79141891|FG000|Overall Study|Lack of Efficacy|3|||
44261503|NCT01453946|79141891|FG000|Overall Study|Adverse Event|3|||
44261504|NCT02563548|79142013|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
44261505|NCT02563548|79142014|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
44261506|NCT02563548|79142015|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
44261507|NCT02563548|79142016|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
44261508|NCT02563548|79142017|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
44261509|NCT02563548|79142018|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
44261510|NCT02563548|79142013|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
44261511|NCT02563548|79142014|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
44541942|NCT03299244|79554686|FG001|Overall Study|Decision by Sponsor|5|||
44541943|NCT03299244|79554685|FG000|Overall Study|Death|9|||
44541944|NCT03299244|79554686|FG001|Overall Study|Death|4|||
44541945|NCT03757715|79554695|FG000|Overall Study|Lost to Follow-up|4|||
44541946|NCT03757715|79554696|FG001|Overall Study|Lost to Follow-up|9|||
44541947|NCT03757715|79554695|FG000|Overall Study|Withdrawal by Subject|1|||
44541948|NCT03757715|79554696|FG001|Overall Study|Withdrawal by Subject|1|||
44541949|NCT03281577|79554706|FG000|Overall Study|Adverse Event|0|||
44541950|NCT03281577|79554707|FG001|Overall Study|Adverse Event|0|||
44541951|NCT03281577|79554708|FG002|Overall Study|Adverse Event|0|||
44541952|NCT03281577|79554709|FG003|Overall Study|Adverse Event|1|||
44541953|NCT03281577|79554706|FG000|Overall Study|Withdrawal by Subject|1|||
44541954|NCT03281577|79554707|FG001|Overall Study|Withdrawal by Subject|0|||
44541955|NCT03281577|79554708|FG002|Overall Study|Withdrawal by Subject|0|||
44541956|NCT03281577|79554709|FG003|Overall Study|Withdrawal by Subject|0|||
44143664|NCT00271817|78932990|FG002|Part 1|Patient Moved|5|||
44261512|NCT02563548|79142015|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
44261513|NCT02563548|79142016|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
44261514|NCT02563548|79142017|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
44261515|NCT02563548|79142018|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
44261516|NCT02563548|79142013|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
44261517|NCT02563548|79142014|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
44261518|NCT02563548|79142015|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
44261519|NCT02563548|79142016|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
44261520|NCT02563548|79142017|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
44261521|NCT02563548|79142018|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
44261522|NCT02563548|79142013|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
44261523|NCT02563548|79142014|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
44261524|NCT02563548|79142015|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
44261525|NCT02563548|79142016|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
44261526|NCT02563548|79142017|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
44261527|NCT02563548|79142018|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
44261528|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
44261529|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
44261530|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
44261531|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
44261532|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
44261533|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
44261534|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
44261535|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
44261536|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
44261537|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
44354913|NCT00938860|79359339|FG000|Overall Study|Adverse Event|2|||
44354914|NCT00938860|79359340|FG001|Overall Study|Adverse Event|1|||
44448450|NCT00561470|79457152|FG001|Overall Study|Adverse Event|163|||
44541957|NCT04098367|79554725|FG000|Overall Study|Adverse Event|0|||
44261538|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
44261539|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
44261540|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
44261541|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
44261542|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
44261543|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
44261544|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
44261545|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
44261546|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
44261547|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
44261548|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
44261549|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
44261550|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
44261551|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
44261552|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
44261553|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
44261554|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
44261555|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
44261556|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
44261557|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
44261558|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
44261559|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
44261560|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
44261561|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
44261562|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
44261563|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
44261564|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
44261565|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
44261566|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
44261567|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
44261568|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
44261569|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
44261570|NCT02563548|79142013|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
44261571|NCT02563548|79142014|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
44261572|NCT02563548|79142015|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
44261573|NCT02563548|79142016|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
44261574|NCT02563548|79142017|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
44261575|NCT02563548|79142018|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
44261576|NCT02559570|79142099|FG000|Overall Study|Adverse Event|0|||
44261577|NCT02559570|79142100|FG001|Overall Study|Adverse Event|2|||
44261578|NCT02559570|79142101|FG002|Overall Study|Adverse Event|0|||
44261579|NCT02559570|79142102|FG003|Overall Study|Adverse Event|1|||
44261580|NCT02559570|79142103|FG004|Overall Study|Adverse Event|0|||
44261581|NCT02559570|79142099|FG000|Overall Study|Withdrawal of Consent|0|||
44261582|NCT02559570|79142100|FG001|Overall Study|Withdrawal of Consent|0|||
44261583|NCT02559570|79142101|FG002|Overall Study|Withdrawal of Consent|1|||
44261584|NCT02559570|79142102|FG003|Overall Study|Withdrawal of Consent|2|||
44261585|NCT02559570|79142103|FG004|Overall Study|Withdrawal of Consent|1|||
44261586|NCT02559570|79142099|FG000|Overall Study|Lost to Follow-up|1|||
44261587|NCT02559570|79142100|FG001|Overall Study|Lost to Follow-up|0|||
44261588|NCT02559570|79142101|FG002|Overall Study|Lost to Follow-up|0|||
44261589|NCT02559570|79142102|FG003|Overall Study|Lost to Follow-up|0|||
44261590|NCT02559570|79142103|FG004|Overall Study|Lost to Follow-up|0|||
44261591|NCT02559570|79142099|FG000|Overall Study|Protocol Violation|1|||
44261592|NCT02559570|79142100|FG001|Overall Study|Protocol Violation|0|||
44261593|NCT02559570|79142101|FG002|Overall Study|Protocol Violation|0|||
44261594|NCT02559570|79142102|FG003|Overall Study|Protocol Violation|0|||
44261595|NCT02559570|79142103|FG004|Overall Study|Protocol Violation|1|||
44261596|NCT02559570|79142099|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44261597|NCT02559570|79142100|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44261598|NCT02559570|79142101|FG002|Overall Study|Other Miscellaneous Reasons|1|||
44261599|NCT02559570|79142102|FG003|Overall Study|Other Miscellaneous Reasons|0|||
44541958|NCT04098367|79554726|FG001|Overall Study|Adverse Event|0|||
44541959|NCT04098367|79554727|FG002|Overall Study|Adverse Event|1|||
44261600|NCT02559570|79142103|FG004|Overall Study|Other Miscellaneous Reasons|0|||
44261601|NCT02559414|79142458|FG000|Overall Study|Lost to Follow-up|0|||
44261602|NCT02559414|79142459|FG001|Overall Study|Lost to Follow-up|1|||
44261603|NCT02559414|79142460|FG002|Overall Study|Lost to Follow-up|0|||
44261604|NCT02559414|79142458|FG000|Overall Study|Withdrawal by Subject|1|||
44261605|NCT02559414|79142459|FG001|Overall Study|Withdrawal by Subject|0|||
44541960|NCT04098367|79554725|FG000|Overall Study|Lost to Follow-up|1|||
44261606|NCT02559414|79142460|FG002|Overall Study|Withdrawal by Subject|1|||
44261607|NCT02559414|79142458|FG000|Overall Study|Other|0|||
44261608|NCT02559414|79142459|FG001|Overall Study|Other|1|||
44261609|NCT02559414|79142460|FG002|Overall Study|Other|1|||
44261610|NCT02558790|79142535|FG000|Overall Study|Lost to Follow-up|2|||
44261611|NCT02558790|79142535|FG000|Overall Study|Physician Decision|1|||
44541961|NCT04098367|79554726|FG001|Overall Study|Lost to Follow-up|5|||
44541962|NCT04098367|79554727|FG002|Overall Study|Lost to Follow-up|2|||
44541963|NCT04098367|79554725|FG000|Overall Study|Withdrawal by Subject|0|||
44541964|NCT04098367|79554726|FG001|Overall Study|Withdrawal by Subject|0|||
44541965|NCT04098367|79554727|FG002|Overall Study|Withdrawal by Subject|1|||
44541966|NCT04098367|79554725|FG000|Overall Study|Sick . Could not attend visit|1|||
44541967|NCT04098367|79554726|FG001|Overall Study|Sick . Could not attend visit|0|||
44541968|NCT04098367|79554727|FG002|Overall Study|Sick . Could not attend visit|0|||
44541969|NCT04091659|79554744|FG000|Overall Study|Protocol Violation|3|||
44541970|NCT04091659|79554745|FG001|Overall Study|Protocol Violation|0|||
44541971|NCT04091659|79554744|FG000|Overall Study|Lost to Follow-up|0|||
44541972|NCT04091659|79554745|FG001|Overall Study|Lost to Follow-up|1|||
44541973|NCT04256785|79554782|FG000|Overall Study|Adverse Event|8|||
44541974|NCT04256785|79554783|FG001|Overall Study|Adverse Event|6|||
44541975|NCT04256785|79554782|FG000|Overall Study|Lack of Efficacy|3|||
44541976|NCT04256785|79554783|FG001|Overall Study|Lack of Efficacy|4|||
44261612|NCT02558790|79142535|FG000|Overall Study|Withdrawal by Subject|1|||
44261613|NCT02558790|79142535|FG000|Overall Study|Screen Fail|3|||
44261614|NCT02556138|79142561|FG000|Overall Study|Withdrawal by Subject|1|||
44261615|NCT02558400|79142644|FG000|Overall Study|Adverse Event|47|||
44261616|NCT02558400|79142645|FG001|Overall Study|Adverse Event|53|||
44261617|NCT02558400|79142646|FG002|Overall Study|Adverse Event|4|||
44261618|NCT02558400|79142644|FG000|Overall Study|Withdrawal by Subject|13|||
44261619|NCT02558400|79142645|FG001|Overall Study|Withdrawal by Subject|9|||
44261620|NCT02558400|79142646|FG002|Overall Study|Withdrawal by Subject|8|||
44261621|NCT02558400|79142644|FG000|Overall Study|Non-Compliant|0|||
44541977|NCT04256785|79554782|FG000|Overall Study|Lost to Follow-up|7|||
44541978|NCT04256785|79554783|FG001|Overall Study|Lost to Follow-up|7|||
44541979|NCT04256785|79554782|FG000|Overall Study|Protocol Violation|1|||
44541980|NCT04256785|79554783|FG001|Overall Study|Protocol Violation|0|||
44541981|NCT04256785|79554782|FG000|Overall Study|Withdrawal by Subject|4|||
44541982|NCT04256785|79554783|FG001|Overall Study|Withdrawal by Subject|1|||
44541983|NCT04256785|79554782|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
44541984|NCT04256785|79554783|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
44541985|NCT02959918|79554805|FG000|Overall Study|Adverse Event|1|||
44541986|NCT02959918|79554806|FG001|Overall Study|Adverse Event|1|||
44541987|NCT02959918|79554807|FG002|Overall Study|Adverse Event|2|||
44541988|NCT02959918|79554808|FG003|Overall Study|Adverse Event|0|||
44541989|NCT02959918|79554809|FG004|Overall Study|Adverse Event|0|||
44541990|NCT02959918|79554810|FG005|Overall Study|Adverse Event|2|||
44541991|NCT02959918|79554811|FG006|Overall Study|Adverse Event|2|||
44261622|NCT02558400|79142645|FG001|Overall Study|Non-Compliant|1|||
44261623|NCT02558400|79142646|FG002|Overall Study|Non-Compliant|3|||
44261624|NCT02558400|79142644|FG000|Overall Study|Lost to Follow-up|5|||
44261625|NCT02558400|79142645|FG001|Overall Study|Lost to Follow-up|5|||
44261626|NCT02558400|79142646|FG002|Overall Study|Lost to Follow-up|4|||
44261627|NCT02558400|79142644|FG000|Overall Study|Lack of Efficacy|0|||
44261628|NCT02558400|79142645|FG001|Overall Study|Lack of Efficacy|13|||
44261629|NCT02558400|79142646|FG002|Overall Study|Lack of Efficacy|1|||
44261630|NCT02558400|79142644|FG000|Overall Study|Disallowed Concurrent Medication|6|||
44261631|NCT02558400|79142645|FG001|Overall Study|Disallowed Concurrent Medication|7|||
44541992|NCT02959918|79554812|FG007|Overall Study|Adverse Event|1|||
44541993|NCT02959918|79554813|FG008|Overall Study|Adverse Event|2|||
44261632|NCT02558400|79142646|FG002|Overall Study|Disallowed Concurrent Medication|5|||
44261633|NCT02558400|79142644|FG000|Overall Study|Physician Decision|2|||
44261634|NCT02558400|79142645|FG001|Overall Study|Physician Decision|2|||
44261635|NCT02558400|79142646|FG002|Overall Study|Physician Decision|0|||
44261636|NCT02558400|79142644|FG000|Overall Study|Protocol Violation|6|||
44541994|NCT02959918|79554814|FG009|Overall Study|Adverse Event|1|||
44541995|NCT02959918|79554815|FG010|Overall Study|Adverse Event|1|||
44541996|NCT02959918|79554816|FG011|Overall Study|Adverse Event|3|||
44541997|NCT02959918|79554817|FG012|Overall Study|Adverse Event|2|||
44541998|NCT02959918|79554818|FG013|Overall Study|Adverse Event|4|||
44541999|NCT02959918|79554805|FG000|Overall Study|Lost to Follow-up|0|||
44542000|NCT02959918|79554806|FG001|Overall Study|Lost to Follow-up|0|||
44542001|NCT02959918|79554807|FG002|Overall Study|Lost to Follow-up|0|||
44542002|NCT02959918|79554808|FG003|Overall Study|Lost to Follow-up|0|||
44354915|NCT00938860|79359339|FG000|Overall Study|Abnormal laboratory values|2|||
44354916|NCT00938860|79359340|FG001|Overall Study|Abnormal laboratory values|2|||
44354917|NCT00938860|79359339|FG000|Overall Study|Withdrawal by Subject|11|||
44354918|NCT00938860|79359340|FG001|Overall Study|Withdrawal by Subject|8|||
44542003|NCT02959918|79554809|FG004|Overall Study|Lost to Follow-up|0|||
44542004|NCT02959918|79554810|FG005|Overall Study|Lost to Follow-up|0|||
44542005|NCT02959918|79554811|FG006|Overall Study|Lost to Follow-up|0|||
44542006|NCT02959918|79554812|FG007|Overall Study|Lost to Follow-up|0|||
44542007|NCT02959918|79554813|FG008|Overall Study|Lost to Follow-up|0|||
44542008|NCT02959918|79554814|FG009|Overall Study|Lost to Follow-up|1|||
44542009|NCT02959918|79554815|FG010|Overall Study|Lost to Follow-up|0|||
44542010|NCT02959918|79554816|FG011|Overall Study|Lost to Follow-up|0|||
44542011|NCT02959918|79554817|FG012|Overall Study|Lost to Follow-up|1|||
44542012|NCT02959918|79554818|FG013|Overall Study|Lost to Follow-up|0|||
44542013|NCT02959918|79554805|FG000|Overall Study|Withdrawal by Subject|0|||
44542014|NCT02959918|79554806|FG001|Overall Study|Withdrawal by Subject|0|||
44542015|NCT02959918|79554807|FG002|Overall Study|Withdrawal by Subject|1|||
44542016|NCT02959918|79554808|FG003|Overall Study|Withdrawal by Subject|2|||
44542017|NCT02959918|79554809|FG004|Overall Study|Withdrawal by Subject|0|||
44542018|NCT02959918|79554810|FG005|Overall Study|Withdrawal by Subject|0|||
44542019|NCT02959918|79554811|FG006|Overall Study|Withdrawal by Subject|1|||
44542020|NCT02959918|79554812|FG007|Overall Study|Withdrawal by Subject|0|||
44542021|NCT02959918|79554813|FG008|Overall Study|Withdrawal by Subject|1|||
44542022|NCT02959918|79554814|FG009|Overall Study|Withdrawal by Subject|1|||
44542023|NCT02959918|79554815|FG010|Overall Study|Withdrawal by Subject|2|||
44542024|NCT02959918|79554816|FG011|Overall Study|Withdrawal by Subject|3|||
44542025|NCT02959918|79554817|FG012|Overall Study|Withdrawal by Subject|1|||
44542026|NCT02959918|79554818|FG013|Overall Study|Withdrawal by Subject|1|||
44542027|NCT02959918|79554805|FG000|Overall Study|Protocol Violation|0|||
44542028|NCT02959918|79554806|FG001|Overall Study|Protocol Violation|0|||
44542029|NCT02959918|79554807|FG002|Overall Study|Protocol Violation|1|||
44542030|NCT02959918|79554808|FG003|Overall Study|Protocol Violation|0|||
44542031|NCT02959918|79554809|FG004|Overall Study|Protocol Violation|0|||
44542032|NCT02959918|79554810|FG005|Overall Study|Protocol Violation|1|||
44542033|NCT02959918|79554811|FG006|Overall Study|Protocol Violation|0|||
44542034|NCT02959918|79554812|FG007|Overall Study|Protocol Violation|0|||
44542035|NCT02959918|79554813|FG008|Overall Study|Protocol Violation|2|||
44542036|NCT02959918|79554814|FG009|Overall Study|Protocol Violation|1|||
44542037|NCT02959918|79554815|FG010|Overall Study|Protocol Violation|0|||
44542038|NCT02959918|79554816|FG011|Overall Study|Protocol Violation|1|||
44261637|NCT02558400|79142645|FG001|Overall Study|Protocol Violation|3|||
44261638|NCT02558400|79142646|FG002|Overall Study|Protocol Violation|8|||
44261639|NCT02558400|79142644|FG000|Overall Study|Death|0|||
44261640|NCT02558400|79142645|FG001|Overall Study|Death|1|||
44261641|NCT02558400|79142646|FG002|Overall Study|Death|0|||
44261642|NCT02558400|79142644|FG000|Overall Study|Ineligible for the study|0|||
44261643|NCT02558400|79142645|FG001|Overall Study|Ineligible for the study|2|||
44261644|NCT02558400|79142646|FG002|Overall Study|Ineligible for the study|0|||
44261645|NCT01662648|79142778|FG000|Overall Study|Death|1|||
44261646|NCT01662648|79142779|FG001|Overall Study|Death|3|||
44261647|NCT01662648|79142778|FG000|Overall Study|Adverse Event|40|||
44261648|NCT01662648|79142779|FG001|Overall Study|Adverse Event|37|||
44261649|NCT01662648|79142778|FG000|Overall Study|Lack of Efficacy|17|||
44261650|NCT01662648|79142779|FG001|Overall Study|Lack of Efficacy|16|||
44261651|NCT01662648|79142778|FG000|Overall Study|Participant ineligible to continue trial|1|||
44261652|NCT01662648|79142779|FG001|Overall Study|Participant ineligible to continue trial|1|||
44261653|NCT01662648|79142778|FG000|Overall Study|Lost to Follow-up|24|||
44261654|NCT01662648|79142779|FG001|Overall Study|Lost to Follow-up|36|||
44261655|NCT01662648|79142778|FG000|Overall Study|Withdrawal by Subject|36|||
44261656|NCT01662648|79142779|FG001|Overall Study|Withdrawal by Subject|53|||
44261657|NCT01662648|79142778|FG000|Overall Study|Participant non-compliant|16|||
44261658|NCT01662648|79142779|FG001|Overall Study|Participant non-compliant|20|||
44261659|NCT01662648|79142778|FG000|Overall Study|Other|8|||
44261660|NCT01662648|79142779|FG001|Overall Study|Other|11|||
44261661|NCT01662648|79142778|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
44261662|NCT01662648|79142779|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
44261663|NCT01662648|79142778|FG000|Overall Study|LOE and other reason unspecified|1|||
44261664|NCT01662648|79142779|FG001|Overall Study|LOE and other reason unspecified|0|||
44261665|NCT01662648|79142778|FG000|Overall Study|LOE and Participant non-compliant|0|||
44261666|NCT01662648|79142779|FG001|Overall Study|LOE and Participant non-compliant|1|||
44261667|NCT02556918|79142844|FG000|Overall Study|Protocol Violation|5|||
44261668|NCT02556918|79142845|FG001|Overall Study|Protocol Violation|6|||
44261669|NCT02556918|79142844|FG000|Overall Study|Withdrawal by Subject|4|||
44261670|NCT02556918|79142845|FG001|Overall Study|Withdrawal by Subject|4|||
44261671|NCT01662492|79142961|FG000|Overall Study|Other miscellaneous reasons.|1|||
44261672|NCT01662492|79142962|FG001|Overall Study|Other miscellaneous reasons.|0|||
44261673|NCT01662492|79142963|FG002|Overall Study|Other miscellaneous reasons.|1|||
44261674|NCT01662492|79142961|FG000|Overall Study|Withdrawal by Subject|0|||
44261675|NCT01662492|79142962|FG001|Overall Study|Withdrawal by Subject|0|||
44261676|NCT01662492|79142963|FG002|Overall Study|Withdrawal by Subject|1|||
44542039|NCT02959918|79554817|FG012|Overall Study|Protocol Violation|1|||
44542040|NCT02959918|79554818|FG013|Overall Study|Protocol Violation|0|||
44542041|NCT02959918|79554805|FG000|Overall Study|Stopping Rule Met|1|||
44542042|NCT02959918|79554806|FG001|Overall Study|Stopping Rule Met|0|||
44261677|NCT01662492|79142961|FG000|Overall Study|Protocol Violation|1|||
44261678|NCT01662492|79142962|FG001|Overall Study|Protocol Violation|0|||
44261679|NCT01662492|79142963|FG002|Overall Study|Protocol Violation|0|||
44261680|NCT01662492|79142961|FG000|Overall Study|Lost to Follow-up|0|||
44261681|NCT01662492|79142962|FG001|Overall Study|Lost to Follow-up|0|||
44261682|NCT01662492|79142963|FG002|Overall Study|Lost to Follow-up|2|||
44261683|NCT01662492|79142961|FG000|Overall Study|Lack of Efficacy|1|||
44261684|NCT01662492|79142962|FG001|Overall Study|Lack of Efficacy|1|||
44261685|NCT01662492|79142963|FG002|Overall Study|Lack of Efficacy|2|||
44261686|NCT02552238|79143133|FG000|Overall Study|Withdrawal by Subject|2|||
44261687|NCT02552238|79143133|FG000|Overall Study|Adverse Event|2|||
44261688|NCT01662102|79143346|FG000|Overall Study|Sponsor's decision|1|||
44261689|NCT01662102|79143347|FG001|Overall Study|Sponsor's decision|0|||
44261690|NCT02554656|79143387|FG000|Overall Study|Protocol Violation|3|||
44261691|NCT04053868|79143435|FG000|Overall Study|Withdrawal by Subject|1|||
44261692|NCT04053868|79143436|FG001|Overall Study|Withdrawal by Subject|0|||
44261693|NCT02551692|79143611|FG000|Overall Study|Lost to Follow-up|0|||
44261694|NCT02551692|79143612|FG001|Overall Study|Lost to Follow-up|1|||
44261695|NCT02551692|79143613|FG002|Overall Study|Lost to Follow-up|4|||
44261696|NCT02551692|79143611|FG000|Overall Study|Withdrawal by Subject|1|||
44261697|NCT02551692|79143612|FG001|Overall Study|Withdrawal by Subject|0|||
44261698|NCT02551692|79143613|FG002|Overall Study|Withdrawal by Subject|1|||
44261699|NCT02553330|79143700|FG000|Overall Study|Study Terminated by Sponsor|2|||
44261700|NCT02553330|79143701|FG001|Overall Study|Study Terminated by Sponsor|13|||
44261701|NCT02553330|79143702|FG002|Overall Study|Study Terminated by Sponsor|12|||
44261702|NCT02553330|79143700|FG000|Overall Study|Withdrawal by Subject|3|||
44261703|NCT02553330|79143701|FG001|Overall Study|Withdrawal by Subject|19|||
44261704|NCT02553330|79143702|FG002|Overall Study|Withdrawal by Subject|21|||
44261705|NCT02553330|79143700|FG000|Overall Study|Other|0|||
44261706|NCT02553330|79143701|FG001|Overall Study|Other|1|||
44261707|NCT02553330|79143702|FG002|Overall Study|Other|0|||
44261708|NCT02553330|79143700|FG000|Overall Study|Non compliance to study treatment|0|||
44261709|NCT02553330|79143701|FG001|Overall Study|Non compliance to study treatment|1|||
44261710|NCT02553330|79143702|FG002|Overall Study|Non compliance to study treatment|0|||
44261711|NCT02553330|79143700|FG000|Overall Study|Adverse Event|0|||
44261712|NCT02553330|79143701|FG001|Overall Study|Adverse Event|1|||
44261713|NCT02553330|79143702|FG002|Overall Study|Adverse Event|0|||
44261714|NCT02553330|79143700|FG000|Overall Study|Lost to Follow-up|0|||
44261715|NCT02553330|79143701|FG001|Overall Study|Lost to Follow-up|4|||
44261716|NCT02553330|79143702|FG002|Overall Study|Lost to Follow-up|4|||
44261717|NCT02550288|79143744|FG000|Overall Study|Adverse Event|0|||
44261718|NCT02550288|79143745|FG001|Overall Study|Adverse Event|1|||
44261719|NCT02550288|79143746|FG002|Overall Study|Adverse Event|0|||
44261720|NCT02550288|79143747|FG003|Overall Study|Adverse Event|0|||
44261721|NCT02550288|79143748|FG004|Overall Study|Adverse Event|0|||
44261722|NCT02550288|79143744|FG000|Overall Study|Physician Decision|0|||
44261723|NCT02550288|79143745|FG001|Overall Study|Physician Decision|0|||
44261724|NCT02550288|79143746|FG002|Overall Study|Physician Decision|0|||
44261725|NCT02550288|79143747|FG003|Overall Study|Physician Decision|1|||
44261726|NCT02550288|79143748|FG004|Overall Study|Physician Decision|0|||
44354919|NCT00938860|79359339|FG000|Overall Study|Lost to Follow-up|4|||
44354920|NCT00938860|79359340|FG001|Overall Study|Lost to Follow-up|4|||
44354921|NCT00938860|79359339|FG000|Overall Study|Administration problems|2|||
44354922|NCT00938860|79359340|FG001|Overall Study|Administration problems|0|||
44354923|NCT00938860|79359339|FG000|Overall Study|Death|1|||
44354924|NCT00938860|79359340|FG001|Overall Study|Death|1|||
44354925|NCT00938860|79359339|FG000|Overall Study|Protocol Violation|3|||
44354926|NCT00938860|79359340|FG001|Overall Study|Protocol Violation|1|||
44354927|NCT00938470|79359348|FG000|Overall Study|Disease Progression|3|||
44354928|NCT00938470|79359349|FG001|Overall Study|Disease Progression|0|||
44354929|NCT00938470|79359348|FG000|Overall Study|Alternate Treatment|1|||
44354930|NCT00938470|79359349|FG001|Overall Study|Alternate Treatment|0|||
44261727|NCT02550288|79143744|FG000|Overall Study|Protocol Violation|2|||
44261728|NCT02550288|79143745|FG001|Overall Study|Protocol Violation|2|||
44261729|NCT02550288|79143746|FG002|Overall Study|Protocol Violation|1|||
44261730|NCT02550288|79143747|FG003|Overall Study|Protocol Violation|0|||
44261731|NCT02550288|79143748|FG004|Overall Study|Protocol Violation|3|||
44261732|NCT02550288|79143744|FG000|Overall Study|Participant moved|0|||
44261733|NCT02550288|79143745|FG001|Overall Study|Participant moved|0|||
44261734|NCT02550288|79143746|FG002|Overall Study|Participant moved|0|||
44261735|NCT02550288|79143747|FG003|Overall Study|Participant moved|1|||
44261736|NCT02550288|79143748|FG004|Overall Study|Participant moved|0|||
44354931|NCT00938470|79359348|FG000|Overall Study|Death|3|||
44261737|NCT02550288|79143744|FG000|Overall Study|Withdrawal by Subject|0|||
44261738|NCT02550288|79143745|FG001|Overall Study|Withdrawal by Subject|0|||
44261739|NCT02550288|79143746|FG002|Overall Study|Withdrawal by Subject|0|||
44261740|NCT02550288|79143747|FG003|Overall Study|Withdrawal by Subject|1|||
44261741|NCT02550288|79143748|FG004|Overall Study|Withdrawal by Subject|0|||
44261742|NCT01662336|79143809|FG000|Overall Study|Adverse Event|1|||
44261743|NCT01662336|79143809|FG000|Overall Study|No longer on LPV/r|30|||
44261744|NCT01662336|79143809|FG000|Overall Study|Other|29|||
44261745|NCT01662336|79143809|FG000|Overall Study|Withdrawal by Subject|6|||
44261746|NCT02549352|79143828|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
44261747|NCT02549352|79143829|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
44261748|NCT02549352|79143828|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
44261749|NCT02549352|79143829|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
44261750|NCT02549352|79143828|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
44261751|NCT02549352|79143829|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
44261752|NCT02549352|79143828|FG000|12-month Follow-up|Withdrawal by Subject|4|||
44261753|NCT02549352|79143829|FG001|12-month Follow-up|Withdrawal by Subject|5|||
44261754|NCT02549352|79143828|FG000|12-month Follow-up|Lost to Follow-up|3|||
44261755|NCT02549352|79143829|FG001|12-month Follow-up|Lost to Follow-up|2|||
44261756|NCT02549352|79143828|FG000|12-month Follow-up|Death|0|||
44261757|NCT02549352|79143829|FG001|12-month Follow-up|Death|1|||
44261758|NCT02549352|79143828|FG000|12-month Follow-up|Protocol Violation|0|||
44261759|NCT02549352|79143829|FG001|12-month Follow-up|Protocol Violation|1|||
44261760|NCT02549352|79143828|FG000|12-month Follow-up|Other|1|||
44261761|NCT02549352|79143829|FG001|12-month Follow-up|Other|3|||
44261762|NCT02554890|79144006|FG000|Double-blind|Adverse Event|45|||
44261763|NCT02554890|79144007|FG001|Double-blind|Adverse Event|51|||
44261764|NCT02554890|79144006|FG000|Double-blind|Death|6|||
44261765|NCT02554890|79144007|FG001|Double-blind|Death|4|||
44261766|NCT02554890|79144006|FG000|Double-blind|Protocol Violation|1|||
44261767|NCT02554890|79144007|FG001|Double-blind|Protocol Violation|1|||
44261768|NCT02554890|79144006|FG000|Double-blind|Physician Decision|4|||
44261769|NCT02554890|79144007|FG001|Double-blind|Physician Decision|3|||
44261770|NCT02554890|79144006|FG000|Double-blind|Subject/Guardian decision|21|||
44261771|NCT02554890|79144007|FG001|Double-blind|Subject/Guardian decision|16|||
44261772|NCT02554890|79144006|FG000|Double-blind|Lost to Follow-up|7|||
44261773|NCT02554890|79144007|FG001|Double-blind|Lost to Follow-up|5|||
44261774|NCT02554890|79144006|FG000|Double-blind|Technical problems|1|||
44261775|NCT02554890|79144007|FG001|Double-blind|Technical problems|0|||
44261776|NCT02554890|79144006|FG000|Double-blind|Withdrawal by Subject|5|||
44354932|NCT00938470|79359349|FG001|Overall Study|Death|2|||
44354933|NCT00938470|79359348|FG000|Overall Study|Other Reason|0|||
44261777|NCT02554890|79144007|FG001|Double-blind|Withdrawal by Subject|6|||
44261778|NCT02554890|79144006|FG000|Double-blind|Noncompliance with study treatment|6|||
44261779|NCT02554890|79144007|FG001|Double-blind|Noncompliance with study treatment|5|||
44261780|NCT02554890|79144006|FG000|Open-label|Adverse Event|0|||
44261781|NCT02554890|79144007|FG001|Open-label|Adverse Event|30|||
44261782|NCT02554890|79144006|FG000|Open-label|Death|0|||
44261783|NCT02554890|79144007|FG001|Open-label|Death|1|||
44354934|NCT00938470|79359349|FG001|Overall Study|Other Reason|1|||
44354935|NCT00938392|79359357|FG000|Overall Study|Adverse Event|0|||
44354936|NCT00938392|79359358|FG001|Overall Study|Adverse Event|1|||
44354937|NCT00938392|79359357|FG000|Overall Study|Withdrawal by Subject|0|||
44354938|NCT00938392|79359358|FG001|Overall Study|Withdrawal by Subject|1|||
44448451|NCT00561470|79457151|FG000|Overall Study|Disease progression|437|||
44448452|NCT00561470|79457152|FG001|Overall Study|Disease progression|305|||
44448453|NCT00561470|79457151|FG000|Overall Study|poor compliance to protocol|4|||
44448454|NCT00561470|79457152|FG001|Overall Study|poor compliance to protocol|4|||
44448455|NCT00561470|79457151|FG000|Overall Study|Lost to Follow-up|2|||
44448456|NCT00561470|79457152|FG001|Overall Study|Lost to Follow-up|0|||
44448457|NCT00561470|79457151|FG000|Overall Study|Physician Decision|21|||
44448458|NCT00561470|79457152|FG001|Overall Study|Physician Decision|20|||
44448459|NCT00561470|79457151|FG000|Overall Study|Consent Withdrawn|2|||
44448460|NCT00561470|79457152|FG001|Overall Study|Consent Withdrawn|6|||
44261784|NCT02554890|79144006|FG000|Open-label|Physician Decision|0|||
44261785|NCT02554890|79144007|FG001|Open-label|Physician Decision|1|||
44261786|NCT02554890|79144006|FG000|Open-label|Subject/Guardian decision|0|||
44261787|NCT02554890|79144007|FG001|Open-label|Subject/Guardian decision|11|||
44261788|NCT02554890|79144006|FG000|Open-label|Lost to Follow-up|0|||
44261789|NCT02554890|79144007|FG001|Open-label|Lost to Follow-up|7|||
44261790|NCT02554890|79144006|FG000|Open-label|Technical problems|0|||
44261791|NCT02554890|79144007|FG001|Open-label|Technical problems|1|||
44261792|NCT02554890|79144006|FG000|Open-label|Withdrawal by Subject|0|||
44261793|NCT02554890|79144007|FG001|Open-label|Withdrawal by Subject|1|||
44261794|NCT02552316|79144024|FG000|Overall Study|Withdrawal by Subject|1|||
44261795|NCT02552316|79144024|FG000|Overall Study|Withdrawal due to non-compliance|1|||
44261796|NCT02543346|79144072|FG000|Second Priming Visit|Withdrawal by Subject|0|||
44261797|NCT02543346|79144073|FG001|Second Priming Visit|Withdrawal by Subject|2|||
44354939|NCT00938392|79359357|FG000|Overall Study|Lost to Follow-up|2|||
44354940|NCT00938392|79359358|FG001|Overall Study|Lost to Follow-up|2|||
44261798|NCT02543346|79144074|FG002|Second Priming Visit|Withdrawal by Subject|2|||
44261799|NCT02543346|79144075|FG003|Second Priming Visit|Withdrawal by Subject|2|||
44448461|NCT00561470|79457151|FG000|Overall Study|Subject request|43|||
44448462|NCT00561470|79457152|FG001|Overall Study|Subject request|77|||
44261800|NCT02543346|79144072|FG000|Second Priming Visit|Adverse Event|1|||
44448463|NCT00561470|79457151|FG000|Overall Study|Metastatic surgery|10|||
44448464|NCT00561470|79457152|FG001|Overall Study|Metastatic surgery|12|||
44448465|NCT00561470|79457151|FG000|Overall Study|Unauthorized procedure|3|||
44448466|NCT00561470|79457152|FG001|Overall Study|Unauthorized procedure|1|||
44448467|NCT00561470|79457151|FG000|Overall Study|Randomized but not treated|5|||
44448468|NCT00561470|79457152|FG001|Overall Study|Randomized but not treated|5|||
44448469|NCT00561470|79457151|FG000|Overall Study|Missed visit window|1|||
44448470|NCT00561470|79457152|FG001|Overall Study|Missed visit window|4|||
44448471|NCT00561470|79457151|FG000|Overall Study|Planning surgery|1|||
44448472|NCT00561470|79457152|FG001|Overall Study|Planning surgery|1|||
44448473|NCT00561470|79457151|FG000|Overall Study|Ongoing Treatment|11|||
44448474|NCT00561470|79457152|FG001|Overall Study|Ongoing Treatment|14|||
44448475|NCT00443872|79457160|FG000|Overall Study|Protocol Violation|7|||
44448476|NCT00443872|79457160|FG000|Overall Study|Lost to Follow-up|2|||
44448477|NCT00443872|79457160|FG000|Overall Study|Adverse Event|8|||
44448478|NCT00441064|79457175|FG000|Overall Study|Adverse Event|1|||
44448479|NCT00441064|79457176|FG001|Overall Study|Adverse Event|0|||
44448480|NCT00441064|79457175|FG000|Overall Study|Abnormal laboratory values|0|||
44448481|NCT00441064|79457176|FG001|Overall Study|Abnormal laboratory values|2|||
44448482|NCT00441064|79457175|FG000|Overall Study|Abnormal test procedure results|0|||
44448483|NCT00441064|79457176|FG001|Overall Study|Abnormal test procedure results|1|||
44448484|NCT00441064|79457175|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44448485|NCT00441064|79457176|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44448486|NCT00441064|79457175|FG000|Overall Study|Protocol Deviation|3|||
44448487|NCT00441064|79457176|FG001|Overall Study|Protocol Deviation|2|||
44448488|NCT00441064|79457175|FG000|Overall Study|Patient withdrew consent|5|||
44448489|NCT00441064|79457176|FG001|Overall Study|Patient withdrew consent|2|||
44448490|NCT03962738|79457186|FG000|Overall Study|Protocol Deviation|3|||
44448491|NCT03962738|79457187|FG001|Overall Study|Protocol Deviation|0|||
44448492|NCT03962738|79457188|FG002|Overall Study|Protocol Deviation|1|||
44448493|NCT03962738|79457189|FG003|Overall Study|Protocol Deviation|1|||
44448494|NCT03962738|79457186|FG000|Overall Study|Withdrawal by Subject|4|||
44448495|NCT03962738|79457187|FG001|Overall Study|Withdrawal by Subject|0|||
44448496|NCT03962738|79457188|FG002|Overall Study|Withdrawal by Subject|0|||
44448497|NCT03962738|79457189|FG003|Overall Study|Withdrawal by Subject|0|||
44448498|NCT03962738|79457186|FG000|Overall Study|Lost to Follow-up|0|||
44448499|NCT03962738|79457187|FG001|Overall Study|Lost to Follow-up|0|||
44448500|NCT03962738|79457188|FG002|Overall Study|Lost to Follow-up|1|||
44448501|NCT03962738|79457189|FG003|Overall Study|Lost to Follow-up|0|||
44448502|NCT00561392|79457207|FG000|Overall Study|Adverse Event|38|||
44448503|NCT00561392|79457207|FG000|Overall Study|Lack of Efficacy|2|||
44448504|NCT00561392|79457207|FG000|Overall Study|Protocol Violation|1|||
44448505|NCT00561392|79457207|FG000|Overall Study|Withdrawal by Subject|8|||
44448506|NCT00561392|79457207|FG000|Overall Study|Administrative problems|4|||
44448507|NCT00694109|79457211|FG000|Overall Study|Physician Decision|3|||
44448508|NCT00694109|79457211|FG000|Overall Study|Adverse Event|74|||
44448509|NCT00694109|79457211|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
44448510|NCT00694109|79457211|FG000|Overall Study|Lack of Efficacy|2|||
44448511|NCT00694109|79457211|FG000|Overall Study|Withdrawal by Subject|13|||
44448512|NCT00694109|79457211|FG000|Overall Study|Pregnancy|1|||
44448513|NCT00694109|79457211|FG000|Overall Study|Enrolled but not treated|1|||
44448514|NCT00694109|79457211|FG000|Overall Study|Other|2|||
44448515|NCT00694109|79457211|FG000|Overall Study|Consented but no additional treatment|3|||
44448516|NCT00562484|79457222|FG000|Overall Study|Adverse Event|6|||
44448517|NCT00562484|79457223|FG001|Overall Study|Adverse Event|1|||
44448518|NCT00562484|79457222|FG000|Overall Study|Protocol Violation|11|||
44448519|NCT00562484|79457223|FG001|Overall Study|Protocol Violation|2|||
44448520|NCT00562484|79457222|FG000|Overall Study|Withdrawal by Subject|12|||
44448521|NCT00562484|79457223|FG001|Overall Study|Withdrawal by Subject|9|||
44448522|NCT00562484|79457222|FG000|Overall Study|Moved away from the study area|20|||
44448523|NCT00562484|79457223|FG001|Overall Study|Moved away from the study area|9|||
44448524|NCT00562484|79457222|FG000|Overall Study|Lost to Follow-up|132|||
44448525|NCT00562484|79457223|FG001|Overall Study|Lost to Follow-up|71|||
44448526|NCT00562484|79457222|FG000|Overall Study|Reason not provided or not specified|25|||
44448527|NCT00562484|79457223|FG001|Overall Study|Reason not provided or not specified|12|||
44448528|NCT00561080|79457232|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
44448529|NCT00561080|79457233|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
44448530|NCT00561080|79457234|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
44448531|NCT00561080|79457232|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
44448532|NCT00561080|79457233|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
44448533|NCT00561080|79457234|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
44448534|NCT00561080|79457232|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
44448535|NCT00561080|79457233|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
44448536|NCT00561080|79457234|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
44448537|NCT00561080|79457232|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
44542043|NCT02959918|79554807|FG002|Overall Study|Stopping Rule Met|3|||
44448538|NCT00561080|79457233|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
44448539|NCT00561080|79457234|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
44448540|NCT00561080|79457232|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
44448541|NCT00561080|79457233|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
44448542|NCT00561080|79457234|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
44448543|NCT00561080|79457232|FG000|Vaccination Period (up to Month 4)|Other|0|||
44448544|NCT00561080|79457233|FG001|Vaccination Period (up to Month 4)|Other|2|||
44448545|NCT00561080|79457234|FG002|Vaccination Period (up to Month 4)|Other|1|||
44448546|NCT00561080|79457232|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
44448547|NCT00561080|79457233|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
44448548|NCT00561080|79457234|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
44448549|NCT00561080|79457232|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
44448550|NCT00561080|79457233|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
44448551|NCT00561080|79457234|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
44448552|NCT00561080|79457232|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
44448553|NCT00561080|79457233|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
44448554|NCT00561080|79457234|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
44448555|NCT00561080|79457232|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
44448556|NCT00561080|79457233|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
44448557|NCT00561080|79457234|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
44448558|NCT00562094|79457244|FG000|Overall Study|Lost to Follow-up|62|||
44448559|NCT03817853|79457252|FG000|Induction Phase|Adverse Event|5|||
44448560|NCT03817853|79457253|FG001|Induction Phase|Adverse Event|0|||
44448561|NCT03817853|79457254|FG002|Induction Phase|Adverse Event|0|||
44448562|NCT03817853|79457252|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
44448563|NCT03817853|79457253|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
44448564|NCT03817853|79457254|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
44448565|NCT03817853|79457252|FG000|Induction Phase|Physician Decision|2|||
44448566|NCT03817853|79457253|FG001|Induction Phase|Physician Decision|0|||
44448567|NCT03817853|79457254|FG002|Induction Phase|Physician Decision|0|||
44448568|NCT03817853|79457252|FG000|Induction Phase|Progressive Disease|4|||
44448569|NCT03817853|79457253|FG001|Induction Phase|Progressive Disease|0|||
44448570|NCT03817853|79457254|FG002|Induction Phase|Progressive Disease|0|||
44448571|NCT03817853|79457252|FG000|Induction Phase|Withdrawal by Subject|3|||
44448572|NCT03817853|79457253|FG001|Induction Phase|Withdrawal by Subject|0|||
44448573|NCT03817853|79457254|FG002|Induction Phase|Withdrawal by Subject|0|||
44448574|NCT03817853|79457252|FG000|Induction Phase|Continuing on Study|34|||
44448575|NCT03817853|79457253|FG001|Induction Phase|Continuing on Study|0|||
44448576|NCT03817853|79457254|FG002|Induction Phase|Continuing on Study|0|||
44448577|NCT03817853|79457252|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
44448578|NCT03817853|79457253|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
44448579|NCT03817853|79457254|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
44448580|NCT03817853|79457252|FG000|Maintenance/ Follow-up Phase|Death|0|||
44448581|NCT03817853|79457253|FG001|Maintenance/ Follow-up Phase|Death|1|||
44167937|NCT02440789|78961155|FG000|Overall Study|Withdrawal by Subject|3|||
44167938|NCT02440789|78961155|FG000|Overall Study|Not willing to adhere to reqs|1|||
44167939|NCT02462083|78961159|FG000|Overall Study|Sponsor request|39|||
44167940|NCT02462083|78961159|FG000|Overall Study|Withdrawal by Subject|87|||
44167941|NCT02462083|78961159|FG000|Overall Study|Lost to Follow-up|41|||
44167942|NCT02462083|78961159|FG000|Overall Study|Lack of Efficacy|151|||
44167943|NCT02462083|78961159|FG000|Overall Study|Pregnancy|1|||
44167944|NCT02462083|78961159|FG000|Overall Study|Protocol Violation|6|||
44167945|NCT02462083|78961159|FG000|Overall Study|Adverse Event|33|||
44167946|NCT02462083|78961159|FG000|Overall Study|Worsening condition|16|||
44167947|NCT02462083|78961159|FG000|Overall Study|Other than specified|45|||
44167948|NCT02538341|78961165|FG000|Overall Study|Lost to Follow-up|51|||
44448582|NCT03817853|79457254|FG002|Maintenance/ Follow-up Phase|Death|1|||
44448583|NCT03817853|79457252|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
44448584|NCT03817853|79457253|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
44448585|NCT03817853|79457254|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
44448586|NCT03817853|79457252|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
44448587|NCT03817853|79457253|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
44448588|NCT03817853|79457254|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
44448589|NCT03817853|79457252|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
44448590|NCT03817853|79457253|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
44448591|NCT03817853|79457254|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
44448592|NCT00439270|79457267|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
44448593|NCT00439270|79457268|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
44448594|NCT00439270|79457269|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
44167949|NCT02538341|78961166|FG001|Overall Study|Lost to Follow-up|46|||
44448595|NCT00439270|79457270|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
44448596|NCT00439270|79457271|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
44448597|NCT00439270|79457267|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
44448598|NCT00439270|79457268|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
44448599|NCT00439270|79457269|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
44448600|NCT00439270|79457270|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
44448601|NCT00439270|79457271|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
44448602|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
44448603|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
44448604|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
44448605|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
44448606|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
44448607|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
44448608|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
44448609|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
44448610|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
44448611|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
44448612|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
44448613|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
44448614|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
44448615|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
44448616|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
44448617|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
44448618|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
44448619|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
44448620|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
44448621|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
44448622|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
44448623|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
44448624|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
44448625|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
44448626|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
44448627|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
44448628|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
44448629|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
44448630|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
44448631|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
44448632|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
44448633|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
44448634|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
44448635|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
44448636|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
44448637|NCT00439270|79457267|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
44448638|NCT00439270|79457268|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
44448639|NCT00439270|79457269|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
44448640|NCT00439270|79457270|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
44448641|NCT00439270|79457271|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
44448642|NCT00553280|79457290|FG000|Overall Study|Adverse Event|19|||
44448643|NCT00553280|79457290|FG000|Overall Study|Lack of Efficacy|3|||
44448644|NCT00553280|79457290|FG000|Overall Study|Withdrawal by Subject|3|||
44448645|NCT00553280|79457290|FG000|Overall Study|Physician Decision|1|||
44448646|NCT00440518|79457297|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
44448647|NCT00440518|79457298|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
44448648|NCT00440518|79457299|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
44448649|NCT00440518|79457297|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
44448650|NCT00440518|79457298|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
44448651|NCT00440518|79457299|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
44448652|NCT00440518|79457297|FG000|Randomized /Titration Period|Protocol Deviation|1|||
44448653|NCT00440518|79457298|FG001|Randomized /Titration Period|Protocol Deviation|0|||
44448654|NCT00440518|79457299|FG002|Randomized /Titration Period|Protocol Deviation|0|||
44448655|NCT00440518|79457297|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
44448656|NCT00440518|79457298|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
44448657|NCT00440518|79457299|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
44448658|NCT00440518|79457297|FG000|Randomized /Titration Period|Other|1|||
44448659|NCT00440518|79457298|FG001|Randomized /Titration Period|Other|0|||
44448660|NCT00440518|79457299|FG002|Randomized /Titration Period|Other|0|||
44448661|NCT00440518|79457297|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
44448662|NCT00440518|79457298|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
44448663|NCT00440518|79457299|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
44448664|NCT00440518|79457297|FG000|Randomized /Titration Period|Adverse Event|2|||
44448665|NCT00440518|79457298|FG001|Randomized /Titration Period|Adverse Event|3|||
44448666|NCT00440518|79457299|FG002|Randomized /Titration Period|Adverse Event|0|||
44448667|NCT00440518|79457297|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
44448668|NCT00440518|79457298|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
44448669|NCT00440518|79457299|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
44448670|NCT00440518|79457297|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
44448671|NCT00440518|79457298|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
44448672|NCT00440518|79457299|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
44448673|NCT00440518|79457297|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
44448674|NCT00440518|79457298|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
44448675|NCT00440518|79457299|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
44448676|NCT00440518|79457297|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
44448677|NCT00440518|79457298|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
44448678|NCT00440518|79457299|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
44448679|NCT00440518|79457297|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
44448680|NCT00440518|79457298|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
44448681|NCT00440518|79457299|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
44448682|NCT00440518|79457297|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
44448683|NCT00440518|79457298|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
44448684|NCT00440518|79457299|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
44448685|NCT00438256|79457307|FG000|Overall Study|Ineligible for Resection|2|||
44448686|NCT00438256|79457308|FG001|Overall Study|Ineligible for Resection|1|||
44448687|NCT00438256|79457309|FG002|Overall Study|Ineligible for Resection|1|||
44448688|NCT00438256|79457310|FG003|Overall Study|Ineligible for Resection|7|||
44448689|NCT00438256|79457307|FG000|Overall Study|Excluded final Diagnosis|0|||
44448690|NCT00438256|79457308|FG001|Overall Study|Excluded final Diagnosis|0|||
44448691|NCT00438256|79457309|FG002|Overall Study|Excluded final Diagnosis|0|||
44448692|NCT00438256|79457310|FG003|Overall Study|Excluded final Diagnosis|2|||
44448693|NCT00436852|79457329|FG000|Overall Study|Death|23|||
44448694|NCT00436852|79457330|FG001|Overall Study|Death|34|||
44448695|NCT00436852|79457329|FG000|Overall Study|Lack of Efficacy|9|||
44448696|NCT00436852|79457330|FG001|Overall Study|Lack of Efficacy|7|||
44448697|NCT00436852|79457329|FG000|Overall Study|Withdrawal by Subject|2|||
44448698|NCT00436852|79457330|FG001|Overall Study|Withdrawal by Subject|4|||
44448699|NCT00436852|79457329|FG000|Overall Study|Ineligible|1|||
44448700|NCT00436852|79457330|FG001|Overall Study|Ineligible|0|||
44448701|NCT00120289|79457341|FG000|Overall Study|Death|96|||
44448702|NCT00120289|79457342|FG001|Overall Study|Death|82|||
44448703|NCT00120289|79457341|FG000|Overall Study|Lost to Follow-up|11|||
44448704|NCT00120289|79457342|FG001|Overall Study|Lost to Follow-up|14|||
44448705|NCT00120289|79457341|FG000|Overall Study|Withdrawal by Subject|14|||
44542044|NCT02959918|79554808|FG003|Overall Study|Stopping Rule Met|4|||
44542045|NCT02959918|79554809|FG004|Overall Study|Stopping Rule Met|5|||
44542046|NCT02959918|79554810|FG005|Overall Study|Stopping Rule Met|3|||
44542047|NCT02959918|79554811|FG006|Overall Study|Stopping Rule Met|2|||
44542048|NCT02959918|79554812|FG007|Overall Study|Stopping Rule Met|4|||
44542049|NCT02959918|79554813|FG008|Overall Study|Stopping Rule Met|1|||
44542050|NCT02959918|79554814|FG009|Overall Study|Stopping Rule Met|1|||
44542051|NCT02959918|79554815|FG010|Overall Study|Stopping Rule Met|3|||
44542052|NCT02959918|79554816|FG011|Overall Study|Stopping Rule Met|5|||
44542053|NCT02959918|79554817|FG012|Overall Study|Stopping Rule Met|2|||
44542054|NCT02959918|79554818|FG013|Overall Study|Stopping Rule Met|1|||
44542055|NCT02959918|79554805|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
44542056|NCT02959918|79554806|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
44542057|NCT02959918|79554807|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
44542058|NCT02959918|79554808|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
44542059|NCT02959918|79554809|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542060|NCT02959918|79554810|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542061|NCT02959918|79554811|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542062|NCT02959918|79554812|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542063|NCT02959918|79554813|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542064|NCT02959918|79554814|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542065|NCT02959918|79554815|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542066|NCT02959918|79554816|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542067|NCT02959918|79554817|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542068|NCT02959918|79554818|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
44542069|NCT02959918|79554805|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542070|NCT02959918|79554806|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542071|NCT02959918|79554807|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542072|NCT02959918|79554808|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542073|NCT02959918|79554809|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542074|NCT02959918|79554810|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542075|NCT02959918|79554811|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542076|NCT02959918|79554812|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
44542077|NCT02959918|79554813|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542078|NCT02959918|79554814|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542079|NCT02959918|79554815|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542080|NCT02959918|79554816|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542081|NCT02959918|79554817|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542082|NCT02959918|79554818|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
44542083|NCT02959918|79554805|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542084|NCT02959918|79554806|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542085|NCT02959918|79554807|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542086|NCT02959918|79554808|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542087|NCT02959918|79554809|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542088|NCT02959918|79554810|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542089|NCT02959918|79554811|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542090|NCT02959918|79554812|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542091|NCT02959918|79554813|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
44542092|NCT02959918|79554814|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542093|NCT02959918|79554815|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542094|NCT02959918|79554816|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542095|NCT02959918|79554817|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542096|NCT02959918|79554818|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
44542097|NCT02959918|79554805|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542098|NCT02959918|79554806|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542099|NCT02959918|79554807|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542100|NCT02959918|79554808|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542101|NCT02959918|79554809|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542102|NCT02959918|79554810|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542103|NCT02959918|79554811|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542104|NCT02959918|79554812|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542105|NCT02959918|79554813|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542106|NCT02959918|79554814|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
44542107|NCT02959918|79554815|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542108|NCT02959918|79554816|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542109|NCT02959918|79554817|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542110|NCT02959918|79554818|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
44542111|NCT03263442|79554853|FG000|Inpatient Phase|Death|1|||
44542112|NCT03263442|79554854|FG001|Inpatient Phase|Death|0|||
44542113|NCT03263442|79554853|FG000|Inpatient Phase|Withdrawal by Subject|1|||
44542114|NCT03263442|79554854|FG001|Inpatient Phase|Withdrawal by Subject|0|||
44542115|NCT03263442|79554853|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
44542116|NCT03263442|79554854|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
44542117|NCT03263442|79554853|FG000|1-month Follow-Up|Lost to Follow-up|1|||
44542118|NCT03263442|79554854|FG001|1-month Follow-Up|Lost to Follow-up|0|||
44542119|NCT03263442|79554853|FG000|3-month Follow-Up|Lost to Follow-up|1|||
44542120|NCT03263442|79554854|FG001|3-month Follow-Up|Lost to Follow-up|3|||
44542121|NCT03263442|79554853|FG000|6-month Follow-Up|Lost to Follow-up|2|||
44542122|NCT03263442|79554854|FG001|6-month Follow-Up|Lost to Follow-up|2|||
44542123|NCT04245709|79554862|FG000|Overall Study|Adverse Event|13|||
44542124|NCT04245709|79554862|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
44542125|NCT04091581|79554868|FG000|Overall Study|Lost to Follow-up|0|||
44542126|NCT04091581|79554869|FG001|Overall Study|Lost to Follow-up|1|||
44542127|NCT02940522|79554877|FG000|Overall Study|Lost to Follow-up|1|||
44542128|NCT02940522|79554878|FG001|Overall Study|Lost to Follow-up|2|||
44542129|NCT02940522|79554877|FG000|Overall Study|Withdrawal by Subject|1|||
44542130|NCT02940522|79554878|FG001|Overall Study|Withdrawal by Subject|0|||
44542131|NCT03262038|79554886|FG000|Overall Study|Withdrawal by Subject|0|||
44542132|NCT03262038|79554887|FG001|Overall Study|Withdrawal by Subject|1|||
44542133|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
44542134|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
44542135|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|disease progression|58|||
44542136|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|disease progression|47|||
44542137|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|Death|3|||
44542138|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|Death|6|||
44542139|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
44542140|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
44542141|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
44542142|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
44542143|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
44542144|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
44542145|NCT02472964|79554895|FG000|Part 1 (up to Week 24)|Other|2|||
44542146|NCT02472964|79554896|FG001|Part 1 (up to Week 24)|Other|1|||
44542147|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
44542148|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
44542149|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
44542150|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
44542151|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Death|0|||
44542152|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Death|1|||
44542153|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
44542154|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
44542155|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
44542156|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
44542157|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
44542158|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
44542159|NCT02472964|79554895|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
44542160|NCT02472964|79554896|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
44542161|NCT04079803|79554909|FG000|Overall Study|Withdrawal by Subject|0|||
44542162|NCT04079803|79554910|FG001|Overall Study|Withdrawal by Subject|0|||
44542163|NCT04079803|79554911|FG002|Overall Study|Withdrawal by Subject|1|||
44542164|NCT03278613|79554939|FG000|Overall Study|Lost to Follow-up|3|||
44542165|NCT03278613|79554940|FG001|Overall Study|Lost to Follow-up|1|||
44542166|NCT03761147|79554948|FG000|Overall Study|Withdrawal by Subject|6|||
44542167|NCT03761147|79554949|FG001|Overall Study|Withdrawal by Subject|1|||
44542168|NCT03761147|79554948|FG000|Overall Study|Adverse Event|1|||
44542169|NCT03761147|79554949|FG001|Overall Study|Adverse Event|3|||
44542170|NCT04076917|79554955|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
44542171|NCT04076917|79554955|FG000|Overall Study|Study closure|13|||
44542172|NCT04076917|79554955|FG000|Overall Study|Physician Decision|3|||
44542173|NCT04076917|79554955|FG000|Overall Study|Death|1|||
44542174|NCT04076917|79554955|FG000|Overall Study|Lost to Follow-up|1|||
44542175|NCT04076917|79554955|FG000|Overall Study|Withdrawal by Subject|1|||
44542176|NCT04076917|79554955|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
44542177|NCT04222699|79554959|FG000|Overall Study|Lost to Follow-up|2|||
44542178|NCT02731690|79554972|FG000|Overall Study|Adverse Event|1|||
44542179|NCT02731690|79554972|FG000|Overall Study|Withdrawal by Subject|3|||
44542180|NCT02731690|79554972|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
44542181|NCT04075513|79554978|FG000|Overall Study|Withdrawal by Subject|2|||
44542182|NCT04075513|79554979|FG001|Overall Study|Withdrawal by Subject|2|||
44542183|NCT04075513|79554978|FG000|Overall Study|Lack of Efficacy|1|||
44542184|NCT04075513|79554979|FG001|Overall Study|Lack of Efficacy|0|||
44542185|NCT04075513|79554978|FG000|Overall Study|Lost to Follow-up|4|||
44542186|NCT04075513|79554979|FG001|Overall Study|Lost to Follow-up|2|||
44542187|NCT04075513|79554978|FG000|Overall Study|Switch to insulin pump|1|||
44542188|NCT04075513|79554979|FG001|Overall Study|Switch to insulin pump|0|||
44542189|NCT04073407|79554987|FG000|Part 1|Withdrawal by Subject|1|||
44542190|NCT04073407|79554988|FG001|Part 1|Withdrawal by Subject|0|||
44542191|NCT04073407|79554987|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
44542192|NCT04073407|79554988|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
44542193|NCT04073407|79554987|FG000|Part 2|Withdrawal by Subject|0|||
44542194|NCT04073407|79554988|FG001|Part 2|Withdrawal by Subject|1|||
44542195|NCT02778204|79554998|FG000|Overall Study|Adverse Event|1|||
44542196|NCT02778204|79554999|FG001|Overall Study|Adverse Event|0|||
44542197|NCT02778204|79555000|FG002|Overall Study|Adverse Event|0|||
44542198|NCT02778204|79555001|FG003|Overall Study|Adverse Event|0|||
44542199|NCT02778204|79554998|FG000|Overall Study|Withdrawal by Subject|0|||
44542200|NCT02778204|79554999|FG001|Overall Study|Withdrawal by Subject|0|||
44542201|NCT02778204|79555000|FG002|Overall Study|Withdrawal by Subject|1|||
44542202|NCT02778204|79555001|FG003|Overall Study|Withdrawal by Subject|2|||
44542203|NCT02778204|79554998|FG000|Overall Study|Lost to Follow-up|1|||
44542204|NCT02778204|79554999|FG001|Overall Study|Lost to Follow-up|0|||
44542205|NCT02778204|79555000|FG002|Overall Study|Lost to Follow-up|2|||
44542206|NCT02778204|79555001|FG003|Overall Study|Lost to Follow-up|1|||
44542207|NCT02778204|79554998|FG000|Overall Study|Protocol Violation|0|||
44542208|NCT02778204|79554999|FG001|Overall Study|Protocol Violation|0|||
44542209|NCT02778204|79555000|FG002|Overall Study|Protocol Violation|1|||
44542210|NCT02778204|79555001|FG003|Overall Study|Protocol Violation|0|||
44542211|NCT02778204|79554998|FG000|Overall Study|Eligibility Violation|0|||
44542212|NCT02778204|79554999|FG001|Overall Study|Eligibility Violation|0|||
44542213|NCT02778204|79555000|FG002|Overall Study|Eligibility Violation|0|||
44542214|NCT02778204|79555001|FG003|Overall Study|Eligibility Violation|1|||
44542215|NCT04072159|79555015|FG000|Overall Study|Lost to Follow-up|6|||
44542216|NCT04072159|79555016|FG001|Overall Study|Lost to Follow-up|6|||
44542217|NCT04072159|79555015|FG000|Overall Study|Withdrawal by Subject|2|||
44542218|NCT04072159|79555016|FG001|Overall Study|Withdrawal by Subject|0|||
44542219|NCT03232281|79555025|FG000|Overall Study|Adverse Event|1|||
44542220|NCT03232281|79555026|FG001|Overall Study|Adverse Event|1|||
44542221|NCT03232281|79555025|FG000|Overall Study|Withdrawal by Subject|5|||
44542222|NCT03232281|79555026|FG001|Overall Study|Withdrawal by Subject|4|||
44542223|NCT03232281|79555025|FG000|Overall Study|Protocol Deviation|1|||
44542224|NCT03232281|79555026|FG001|Overall Study|Protocol Deviation|1|||
44542225|NCT04071301|79555032|FG000|Overall Study|Withdrawal by Subject|6|||
44542226|NCT04071301|79555032|FG000|Overall Study|Death|1|||
44542227|NCT03261336|79555036|FG000|Overall Study|Adverse Event|1|||
44542228|NCT00462748|79555043|FG000|Overall Study|Adverse Event|7|||
44542229|NCT00462748|79555044|FG001|Overall Study|Adverse Event|5|||
44542230|NCT00462748|79555045|FG002|Overall Study|Adverse Event|9|||
44542231|NCT00462748|79555043|FG000|Overall Study|Protocol Violation|0|||
44542232|NCT00462748|79555044|FG001|Overall Study|Protocol Violation|2|||
44542233|NCT00462748|79555045|FG002|Overall Study|Protocol Violation|1|||
44542234|NCT00462748|79555043|FG000|Overall Study|Withdrew consent|3|||
44542235|NCT00462748|79555044|FG001|Overall Study|Withdrew consent|3|||
44542236|NCT00462748|79555045|FG002|Overall Study|Withdrew consent|0|||
44542237|NCT00462748|79555043|FG000|Overall Study|Lost to Follow-up|1|||
44542238|NCT00462748|79555044|FG001|Overall Study|Lost to Follow-up|1|||
44542239|NCT00462748|79555045|FG002|Overall Study|Lost to Follow-up|1|||
44542240|NCT00462748|79555043|FG000|Overall Study|Discontinued after 41 days Rx|1|||
44542241|NCT00462748|79555044|FG001|Overall Study|Discontinued after 41 days Rx|0|||
44542242|NCT00462748|79555045|FG002|Overall Study|Discontinued after 41 days Rx|0|||
44542243|NCT04206085|79555056|FG000|Overall Study|Lost to Follow-up|0|||
44542244|NCT04206085|79555057|FG001|Overall Study|Lost to Follow-up|1|||
44542245|NCT04206085|79555058|FG002|Overall Study|Lost to Follow-up|0|||
44542246|NCT04206085|79555056|FG000|Overall Study|Lost to Follow-up|0|||
44542247|NCT04206085|79555057|FG001|Overall Study|Lost to Follow-up|0|||
44542248|NCT04206085|79555058|FG002|Overall Study|Lost to Follow-up|1|||
44542249|NCT04202497|79555066|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
44542250|NCT04202497|79555067|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
44542251|NCT04202497|79555068|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
44542252|NCT04202497|79555069|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
44542253|NCT03297294|79555085|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
44542254|NCT03297294|79555086|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
44542255|NCT03297294|79555087|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44542256|NCT03297294|79555088|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44542257|NCT03297294|79555089|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44542258|NCT03297294|79555085|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
44542259|NCT03297294|79555086|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
44542260|NCT03297294|79555087|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44542261|NCT03297294|79555088|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44542262|NCT03297294|79555089|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44542263|NCT03297294|79555085|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
44542264|NCT03297294|79555086|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
44542265|NCT03297294|79555087|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44542266|NCT03297294|79555088|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44542267|NCT03297294|79555089|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44542268|NCT03297294|79555085|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
44542269|NCT03297294|79555086|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
44542270|NCT03297294|79555087|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44542271|NCT03297294|79555088|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44542272|NCT03297294|79555089|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44542273|NCT03297294|79555085|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
44542274|NCT03297294|79555086|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
44542275|NCT03297294|79555087|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
44542276|NCT03297294|79555088|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
44542277|NCT03297294|79555089|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
44542278|NCT03238911|79555103|FG000|Overall Study|Withdrawal by Subject|1|||
44542279|NCT03238911|79555104|FG001|Overall Study|Withdrawal by Subject|2|||
44542280|NCT03238911|79555103|FG000|Overall Study|Lost to Follow-up|2|||
44542281|NCT03238911|79555104|FG001|Overall Study|Lost to Follow-up|1|||
44542282|NCT00418834|79555113|FG000|Overall Study|Adverse Event|16|||
44542283|NCT00418834|79555114|FG001|Overall Study|Adverse Event|9|||
44143665|NCT00271817|78932988|FG000|Part 1|Withdrawal by Subject|23|||
44542284|NCT00418834|79555113|FG000|Overall Study|Lost to Follow-up|0|||
44542285|NCT00418834|79555114|FG001|Overall Study|Lost to Follow-up|1|||
44542286|NCT00418834|79555113|FG000|Overall Study|Protocol Violation|4|||
44542287|NCT00418834|79555114|FG001|Overall Study|Protocol Violation|3|||
44542288|NCT00418834|79555113|FG000|Overall Study|Withdrawal by Subject|3|||
44542289|NCT00418834|79555114|FG001|Overall Study|Withdrawal by Subject|7|||
44542290|NCT03276975|79555122|FG000|Overall Study|Withdrawal by Subject|1|||
44542291|NCT03276975|79555123|FG001|Overall Study|Withdrawal by Subject|0|||
44542292|NCT03297216|79555131|FG000|Overall Study|Death|0|||
44542293|NCT03297216|79555132|FG001|Overall Study|Death|1|||
44542294|NCT03297216|79555131|FG000|Overall Study|Miscarriage|0|||
44542295|NCT03297216|79555132|FG001|Overall Study|Miscarriage|2|||
44542296|NCT03297216|79555131|FG000|Overall Study|Lost to Follow-up|3|||
44542297|NCT03297216|79555132|FG001|Overall Study|Lost to Follow-up|2|||
44542298|NCT03260868|79555147|FG000|Overall Study|Poor Compliance to Protocol|0|||
44542299|NCT03260868|79555148|FG001|Overall Study|Poor Compliance to Protocol|2|||
44542300|NCT03260868|79555147|FG000|Overall Study|Study Terminated By Sponsor|2|||
44542301|NCT03260868|79555148|FG001|Overall Study|Study Terminated By Sponsor|1|||
44542302|NCT03260868|79555147|FG000|Overall Study|Other than specified above|1|||
44542303|NCT03260868|79555148|FG001|Overall Study|Other than specified above|0|||
44542304|NCT03293394|79555156|FG000|Follow-up (6 Months)|Adverse Event|4|||
44542305|NCT03293394|79555157|FG001|Follow-up (6 Months)|Adverse Event|2|||
44542306|NCT03259308|79555166|FG000|Overall Study|Adverse Event|5|||
44542307|NCT03259308|79555167|FG001|Overall Study|Adverse Event|4|||
44542308|NCT03259308|79555168|FG002|Overall Study|Adverse Event|1|||
44542309|NCT03259308|79555166|FG000|Overall Study|Withdrawal by Subject|2|||
44542310|NCT03259308|79555167|FG001|Overall Study|Withdrawal by Subject|1|||
44542311|NCT03259308|79555168|FG002|Overall Study|Withdrawal by Subject|3|||
44542312|NCT03259308|79555166|FG000|Overall Study|Lost to Follow-up|0|||
44542313|NCT03259308|79555167|FG001|Overall Study|Lost to Follow-up|0|||
44542314|NCT03259308|79555168|FG002|Overall Study|Lost to Follow-up|1|||
44542315|NCT03259308|79555166|FG000|Overall Study|Pregnancy|0|||
44542316|NCT03259308|79555167|FG001|Overall Study|Pregnancy|0|||
44542317|NCT03259308|79555168|FG002|Overall Study|Pregnancy|1|||
44542318|NCT03259308|79555166|FG000|Overall Study|Protocol Deviation|0|||
44542319|NCT03259308|79555167|FG001|Overall Study|Protocol Deviation|3|||
44542320|NCT03259308|79555168|FG002|Overall Study|Protocol Deviation|0|||
44542321|NCT03259308|79555166|FG000|Overall Study|Lack of Efficacy|0|||
44542322|NCT03259308|79555167|FG001|Overall Study|Lack of Efficacy|0|||
44542323|NCT03259308|79555168|FG002|Overall Study|Lack of Efficacy|1|||
44542324|NCT03258762|79555178|FG000|Overall Study|Lost to Follow-up|0|||
44542325|NCT03258762|79555179|FG001|Overall Study|Lost to Follow-up|1|||
44542326|NCT04502589|79555188|FG000|Overall Study|Physician Decision|1|||
44542327|NCT04502589|79555189|FG001|Overall Study|Physician Decision|0|||
44542328|NCT03291288|79555195|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
44542329|NCT03291288|79555196|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
44542330|NCT03291288|79555195|FG000|Drug-drug Interaction Phase|Disease progression|1|||
44542331|NCT03291288|79555196|FG001|Drug-drug Interaction Phase|Disease progression|0|||
44542332|NCT03291288|79555195|FG000|Drug-drug Interaction Phase|Other|3|||
44542333|NCT03291288|79555196|FG001|Drug-drug Interaction Phase|Other|0|||
44542334|NCT03291288|79555195|FG000|Pexidartinib Only|Ongoing|0|||
44542335|NCT03291288|79555196|FG001|Pexidartinib Only|Ongoing|2|||
44542336|NCT03257358|79555221|FG000|Overall Study|Adverse Event|25|||
44542337|NCT03257358|79555222|FG001|Overall Study|Adverse Event|12|||
44542338|NCT03257358|79555221|FG000|Overall Study|Lack of Efficacy|1|||
44542339|NCT03257358|79555222|FG001|Overall Study|Lack of Efficacy|1|||
44542340|NCT03257358|79555221|FG000|Overall Study|Lost to Follow-up|12|||
44542341|NCT03257358|79555222|FG001|Overall Study|Lost to Follow-up|4|||
44542342|NCT03257358|79555221|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
44542343|NCT03257358|79555222|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
44542344|NCT03257358|79555221|FG000|Overall Study|Physician Decision|2|||
44542345|NCT03257358|79555222|FG001|Overall Study|Physician Decision|2|||
44542346|NCT03257358|79555221|FG000|Overall Study|Protocol Violation|5|||
44542347|NCT03257358|79555222|FG001|Overall Study|Protocol Violation|3|||
44542348|NCT03257358|79555221|FG000|Overall Study|Technical problems|4|||
44542349|NCT03257358|79555222|FG001|Overall Study|Technical problems|1|||
44261801|NCT02543346|79144073|FG001|Second Priming Visit|Adverse Event|0|||
44261802|NCT02543346|79144074|FG002|Second Priming Visit|Adverse Event|0|||
44542350|NCT03257358|79555221|FG000|Overall Study|Withdrawal by Subject|8|||
44542351|NCT03257358|79555222|FG001|Overall Study|Withdrawal by Subject|3|||
44542352|NCT03257358|79555221|FG000|Overall Study|Withdrawal of informed consent|9|||
44542353|NCT03257358|79555222|FG001|Overall Study|Withdrawal of informed consent|5|||
44542354|NCT03257358|79555221|FG000|Overall Study|New therapy for study indication|1|||
44542355|NCT03257358|79555222|FG001|Overall Study|New therapy for study indication|0|||
44542356|NCT03257358|79555221|FG000|Overall Study|No longer requires treatment|0|||
44542357|NCT03257358|79555222|FG001|Overall Study|No longer requires treatment|1|||
44542358|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
44542359|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
44542360|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
44542361|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
44542362|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
44542363|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
44542364|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Death|0|||
44542365|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Death|1|||
44542366|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Adverse Event|11|||
44542367|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Adverse Event|11|||
44542368|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
44542369|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
44542370|NCT02936037|79555230|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44542371|NCT02936037|79555231|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
44542372|NCT02936037|79555230|FG000|Open Label Extension|Adverse Event|0|||
44542373|NCT02936037|79555231|FG001|Open Label Extension|Adverse Event|3|||
44542374|NCT02936037|79555230|FG000|Open Label Extension|Other|0|||
44542375|NCT02936037|79555231|FG001|Open Label Extension|Other|3|||
44354941|NCT01022853|79359369|FG000|Overall Study|Progressive disease|2|||
44354942|NCT01022853|79359370|FG001|Overall Study|Progressive disease|3|||
44354943|NCT01022853|79359371|FG002|Overall Study|Progressive disease|11|||
44542376|NCT02936037|79555230|FG000|Open Label Extension|Withdrawal by Subject|0|||
44542377|NCT02936037|79555231|FG001|Open Label Extension|Withdrawal by Subject|4|||
44542378|NCT03288714|79555239|FG000|Overall Study|Lost to Follow-up|2|||
44542379|NCT03288714|79555240|FG001|Overall Study|Lost to Follow-up|1|||
44542380|NCT03288714|79555239|FG000|Overall Study|Non-compliance with study schedule|2|||
44542381|NCT03288714|79555240|FG001|Overall Study|Non-compliance with study schedule|0|||
44542382|NCT03288714|79555239|FG000|Overall Study|Withdrawal by Subject|3|||
44542383|NCT03288714|79555240|FG001|Overall Study|Withdrawal by Subject|1|||
44542384|NCT03288714|79555239|FG000|Overall Study|Clinical Worsening|2|||
44542385|NCT03288714|79555240|FG001|Overall Study|Clinical Worsening|1|||
44542386|NCT03288714|79555239|FG000|Overall Study|Adverse Event|1|||
44261803|NCT02543346|79144075|FG003|Second Priming Visit|Adverse Event|0|||
44261804|NCT02549196|79144089|FG000|Overall Study|Protocol Violation|0|||
44261805|NCT02549196|79144090|FG001|Overall Study|Protocol Violation|0|||
44261806|NCT02549196|79144091|FG002|Overall Study|Protocol Violation|0|||
44261807|NCT02549196|79144092|FG003|Overall Study|Protocol Violation|1|||
44261808|NCT02549196|79144089|FG000|Overall Study|Withdrawal by Subject|1|||
44261809|NCT02549196|79144090|FG001|Overall Study|Withdrawal by Subject|0|||
44261810|NCT02549196|79144091|FG002|Overall Study|Withdrawal by Subject|1|||
44261811|NCT02549196|79144092|FG003|Overall Study|Withdrawal by Subject|0|||
44261812|NCT02904954|79144104|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
44261813|NCT02904954|79144105|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
44261814|NCT02904954|79144104|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
44261815|NCT02904954|79144105|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
44261816|NCT02904954|79144104|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
44542387|NCT03288714|79555240|FG001|Overall Study|Adverse Event|0|||
44542388|NCT03256578|79555250|FG000|Overall Study|Excluded Post Randomization|66|||
44542389|NCT03256578|79555251|FG001|Overall Study|Excluded Post Randomization|56|||
44542390|NCT03227445|79555257|FG000|Period 1 (28 Days)|Adverse Event|1|||
44542391|NCT03227445|79555258|FG001|Period 1 (28 Days)|Adverse Event|2|||
44542392|NCT03227445|79555259|FG002|Period 1 (28 Days)|Adverse Event|0|||
44542393|NCT03227445|79555260|FG003|Period 1 (28 Days)|Adverse Event|1|||
44542394|NCT03227445|79555257|FG000|Period 1 (28 Days)|Protocol Violation|1|||
44542395|NCT03227445|79555258|FG001|Period 1 (28 Days)|Protocol Violation|0|||
44542396|NCT03227445|79555259|FG002|Period 1 (28 Days)|Protocol Violation|0|||
44542397|NCT03227445|79555260|FG003|Period 1 (28 Days)|Protocol Violation|0|||
44542398|NCT03227445|79555257|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
44542399|NCT03227445|79555258|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
44542400|NCT03227445|79555259|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
44542401|NCT03227445|79555260|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
44542402|NCT03227445|79555257|FG000|Period 2 (28 Days)|Adverse Event|1|||
44542403|NCT03227445|79555258|FG001|Period 2 (28 Days)|Adverse Event|0|||
44542404|NCT03227445|79555259|FG002|Period 2 (28 Days)|Adverse Event|2|||
44542405|NCT03227445|79555260|FG003|Period 2 (28 Days)|Adverse Event|1|||
44542406|NCT03227445|79555257|FG000|Period 2 (28 Days)|Protocol Violation|0|||
44542407|NCT03227445|79555258|FG001|Period 2 (28 Days)|Protocol Violation|0|||
44542408|NCT03227445|79555259|FG002|Period 2 (28 Days)|Protocol Violation|0|||
44261817|NCT02904954|79144105|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
44261818|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Recurrence|2|||
44542409|NCT03227445|79555260|FG003|Period 2 (28 Days)|Protocol Violation|1|||
44542410|NCT03227445|79555257|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
44542411|NCT03227445|79555258|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
44261819|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Recurrence|0|||
44542412|NCT03227445|79555259|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
44542413|NCT03227445|79555260|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
44542414|NCT04067401|79555271|FG000|Overall Study|Withdrawal by Subject|7|||
44542415|NCT04067401|79555272|FG001|Overall Study|Withdrawal by Subject|0|||
44542416|NCT04067401|79555271|FG000|Overall Study|no data provided|1|||
44542417|NCT04067401|79555272|FG001|Overall Study|no data provided|0|||
44542418|NCT04194151|79555284|FG000|Overall Study|Physician Decision|1|||
44542419|NCT04194151|79555285|FG001|Overall Study|Physician Decision|1|||
44542420|NCT04194151|79555286|FG002|Overall Study|Physician Decision|1|||
44542421|NCT04194151|79555287|FG003|Overall Study|Physician Decision|1|||
44542422|NCT04194151|79555288|FG004|Overall Study|Physician Decision|0|||
44542423|NCT04194151|79555289|FG005|Overall Study|Physician Decision|1|||
44542424|NCT04194151|79555284|FG000|Overall Study|Monitorization problem|0|||
44542425|NCT04194151|79555285|FG001|Overall Study|Monitorization problem|1|||
44542426|NCT04194151|79555286|FG002|Overall Study|Monitorization problem|0|||
44542427|NCT04194151|79555287|FG003|Overall Study|Monitorization problem|0|||
44542428|NCT04194151|79555288|FG004|Overall Study|Monitorization problem|0|||
44542429|NCT04194151|79555289|FG005|Overall Study|Monitorization problem|0|||
44542430|NCT03820323|79555305|FG000|Overall Study|Lost to Follow-up|2|||
44542431|NCT03820323|79555306|FG001|Overall Study|Lost to Follow-up|1|||
44542432|NCT03820323|79555305|FG000|Overall Study|Missed 12-month visit|22|||
44542433|NCT03820323|79555306|FG001|Overall Study|Missed 12-month visit|14|||
44542434|NCT03820323|79555305|FG000|Overall Study|Death|2|||
44542435|NCT03820323|79555306|FG001|Overall Study|Death|1|||
44542436|NCT03820323|79555305|FG000|Overall Study|Transferred out|13|||
44542437|NCT03820323|79555306|FG001|Overall Study|Transferred out|11|||
44542438|NCT03820323|79555305|FG000|Overall Study|Terminated|0|||
44542439|NCT03820323|79555306|FG001|Overall Study|Terminated|3|||
44542440|NCT03820323|79555305|FG000|Overall Study|Withdrawal by Subject|1|||
44542441|NCT03820323|79555306|FG001|Overall Study|Withdrawal by Subject|6|||
44542442|NCT03287622|79555321|FG000|Overall Study|Withdrawal by Subject|1|||
44542443|NCT03287622|79555322|FG001|Overall Study|Withdrawal by Subject|0|||
44542444|NCT03287622|79555321|FG000|Overall Study|Lost to Follow-up|27|||
44542445|NCT03287622|79555322|FG001|Overall Study|Lost to Follow-up|15|||
44542446|NCT03287622|79555321|FG000|Overall Study|No prescripion after surgery|28|||
44542447|NCT03287622|79555322|FG001|Overall Study|No prescripion after surgery|31|||
44542448|NCT03287622|79555321|FG000|Overall Study|prolonged Length of stay|2|||
44542449|NCT03287622|79555322|FG001|Overall Study|prolonged Length of stay|0|||
44542450|NCT03287622|79555321|FG000|Overall Study|surgery related|0|||
44542451|NCT03287622|79555322|FG001|Overall Study|surgery related|2|||
44542452|NCT04063657|79555337|FG000|Overall Study|Lost to Follow-up|1|||
44542453|NCT04063657|79555338|FG001|Overall Study|Lost to Follow-up|0|||
44542454|NCT04058353|79555355|FG000|Overall Study|Adverse Event|2|||
44542455|NCT04058353|79555356|FG001|Overall Study|Adverse Event|1|||
44542456|NCT04058353|79555355|FG000|Overall Study|Physician Decision|1|||
44542457|NCT04058353|79555356|FG001|Overall Study|Physician Decision|0|||
44542458|NCT04058353|79555355|FG000|Overall Study|Other|1|||
44542459|NCT04058353|79555356|FG001|Overall Study|Other|0|||
44542460|NCT03226353|79555363|FG000|Overall Study|Withdrawal by Subject|1|||
44542461|NCT03226353|79555363|FG000|Overall Study|Screen Failure|5|||
44542462|NCT02730598|79555372|FG000|Overall Study|Withdrawal by Subject|3|||
44542463|NCT02730598|79555373|FG001|Overall Study|Withdrawal by Subject|3|||
44542464|NCT02730598|79555372|FG000|Overall Study|Protocol Violation|0|||
44542465|NCT02730598|79555373|FG001|Overall Study|Protocol Violation|1|||
44542466|NCT02730598|79555372|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
44542467|NCT02730598|79555373|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
44542468|NCT03226275|79555383|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
44542469|NCT03226275|79555384|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
44542470|NCT03226275|79555385|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
44542471|NCT03226275|79555386|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
44167950|NCT02538341|78961165|FG000|Overall Study|Withdrawal by Subject|3|||
44167951|NCT02538341|78961166|FG001|Overall Study|Withdrawal by Subject|1|||
44167952|NCT02538341|78961165|FG000|Overall Study|Death|2|||
44167953|NCT02538341|78961166|FG001|Overall Study|Death|0|||
44167954|NCT02538107|78961172|FG000|Overall Study|Did not receive any Mircera dose|11|||
44167955|NCT02538107|78961172|FG000|Overall Study|Missing|5|||
44167956|NCT02538107|78961172|FG000|Overall Study|Necessity of dialysis|20|||
44167957|NCT02538107|78961172|FG000|Overall Study|Administration of other ESA|11|||
44167958|NCT02538107|78961172|FG000|Overall Study|No further treatment necessary|18|||
44167959|NCT02538107|78961172|FG000|Overall Study|Withdrawal by Subject|17|||
44167960|NCT02538107|78961172|FG000|Overall Study|Death|4|||
44167961|NCT02538107|78961172|FG000|Overall Study|Administrative reason|5|||
44167962|NCT02538107|78961172|FG000|Overall Study|Adverse Event|4|||
44167963|NCT02538107|78961172|FG000|Overall Study|Surgery|1|||
44167964|NCT02538107|78961172|FG000|Overall Study|Other|7|||
44167965|NCT02538107|78961172|FG000|Overall Study|Not recorded|7|||
44167966|NCT02538029|78961189|FG000|Overall Study|unable to complete cognitive assessments|1|||
44249597|NCT02649894|79083538|FG000|Overall Study|Lost to Follow-up|2|||
44542472|NCT03226275|79555383|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
44542473|NCT03226275|79555384|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
44261820|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Adverse Event|2|||
44261821|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Adverse Event|6|||
44261822|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Participant wishes|12|||
44261823|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Participant wishes|7|||
44261824|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Physician Decision|2|||
44261825|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Physician Decision|1|||
44261826|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
44261827|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
44261828|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Death|0|||
44261829|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Death|1|||
44261830|NCT02904954|79144104|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
44261831|NCT02904954|79144105|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
44261832|NCT02548962|79144221|FG000|Overall Study|Withdrawal by Subject|1|||
44261833|NCT02548962|79144222|FG001|Overall Study|Withdrawal by Subject|0|||
44261834|NCT02548650|79144249|FG000|Triple Therapy|Adverse Event|1|||
44261835|NCT02548650|79144250|FG001|Triple Therapy|Adverse Event|0|||
44261836|NCT02548650|79144249|FG000|Triple Therapy|Withdrawal by Subject|0|||
44261837|NCT02548650|79144250|FG001|Triple Therapy|Withdrawal by Subject|4|||
44261838|NCT02548650|79144249|FG000|Double Therapy|Adverse Event|1|||
44261839|NCT02548650|79144250|FG001|Double Therapy|Adverse Event|1|||
44261840|NCT02548650|79144249|FG000|Double Therapy|Withdrawal by Subject|0|||
44261841|NCT02548650|79144250|FG001|Double Therapy|Withdrawal by Subject|1|||
44261842|NCT02535000|79144316|FG000|Overall Study|Cancellation of surgery.|1|||
44261843|NCT02535000|79144317|FG001|Overall Study|Cancellation of surgery.|2|||
44261844|NCT03110562|79144446|FG000|Overall Study|Withdrawal by Subject|37|||
44261845|NCT03110562|79144447|FG001|Overall Study|Withdrawal by Subject|35|||
44261846|NCT03110562|79144446|FG000|Overall Study|Death|47|||
44261847|NCT03110562|79144447|FG001|Overall Study|Death|61|||
44261848|NCT03110562|79144446|FG000|Overall Study|Lost to Follow-up|7|||
44261849|NCT03110562|79144447|FG001|Overall Study|Lost to Follow-up|6|||
44261850|NCT03110562|79144446|FG000|Overall Study|Other|2|||
44261851|NCT03110562|79144447|FG001|Overall Study|Other|1|||
44261852|NCT03110562|79144446|FG000|Overall Study|Randomized but never treated|0|||
44261853|NCT03110562|79144447|FG001|Overall Study|Randomized but never treated|3|||
44261854|NCT03110562|79144446|FG000|Overall Study|Ongoing|102|||
44261855|NCT03110562|79144447|FG001|Overall Study|Ongoing|101|||
44261856|NCT02546856|79144490|FG000|4 Months Evaluation|Death|2|||
44261857|NCT02546856|79144491|FG001|4 Months Evaluation|Death|3|||
44261858|NCT02546856|79144490|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
44261859|NCT02546856|79144491|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
44261860|NCT02546856|79144490|FG000|4 Months Evaluation|Lost to Follow-up|3|||
44261861|NCT02546856|79144491|FG001|4 Months Evaluation|Lost to Follow-up|3|||
44261862|NCT02546856|79144490|FG000|4 Months Evaluation|Physician Decision|3|||
44261863|NCT02546856|79144491|FG001|4 Months Evaluation|Physician Decision|0|||
44261864|NCT02546856|79144490|FG000|4 Months Evaluation|Working or living abroad|5|||
44261865|NCT02546856|79144491|FG001|4 Months Evaluation|Working or living abroad|1|||
44261866|NCT02546856|79144490|FG000|4 Months Evaluation|reasons not due to titration|4|||
44261867|NCT02546856|79144491|FG001|4 Months Evaluation|reasons not due to titration|1|||
44261868|NCT02546856|79144490|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
44261869|NCT02546856|79144491|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
44261870|NCT02546856|79144490|FG000|6 Months Evaluation|Death|1|||
44261871|NCT02546856|79144491|FG001|6 Months Evaluation|Death|1|||
44261872|NCT02546856|79144490|FG000|6 Months Evaluation|Lost to Follow-up|1|||
44261873|NCT02546856|79144491|FG001|6 Months Evaluation|Lost to Follow-up|1|||
44261874|NCT02546856|79144490|FG000|6 Months Evaluation|Working or living abroad|6|||
44261875|NCT02546856|79144491|FG001|6 Months Evaluation|Working or living abroad|4|||
44261876|NCT02546856|79144490|FG000|6 Months Evaluation|reasons not due to titration|0|||
44261877|NCT02546856|79144491|FG001|6 Months Evaluation|reasons not due to titration|1|||
44261878|NCT02696616|79144616|FG000|Overall Study|Adverse Event|0|||
44261879|NCT02696616|79144617|FG001|Overall Study|Adverse Event|1|||
44261880|NCT02696616|79144618|FG002|Overall Study|Adverse Event|0|||
44261881|NCT02696616|79144619|FG003|Overall Study|Adverse Event|0|||
44261882|NCT02696616|79144620|FG004|Overall Study|Adverse Event|0|||
44261883|NCT02696616|79144621|FG005|Overall Study|Adverse Event|0|||
44261884|NCT02696616|79144622|FG006|Overall Study|Adverse Event|0|||
44261885|NCT01661790|79144665|FG000|Overall Study|Lost to Follow-up|0|||
44261886|NCT01661790|79144666|FG001|Overall Study|Lost to Follow-up|2|||
44261887|NCT02546544|79144686|FG000|Overall Study|Disease Progression|14|||
44261888|NCT02546544|79144686|FG000|Overall Study|Adverse Event|1|||
44261889|NCT02546544|79144686|FG000|Overall Study|Withdrawal by Subject|1|||
44261890|NCT05593211|79144977|FG000|Overall Study|Withdrawal by Subject|1|||
44261891|NCT02533674|79145316|FG000|Dose Level I|Progressive disease|1|||
44261892|NCT02533674|79145317|FG001|Dose Level I|Progressive disease|0|||
44261893|NCT02533674|79145318|FG002|Dose Level I|Progressive disease|0|||
44261894|NCT02533674|79145319|FG003|Dose Level I|Progressive disease|0|||
44261895|NCT02533674|79145320|FG004|Dose Level I|Progressive disease|0|||
44261896|NCT02533674|79145321|FG005|Dose Level I|Progressive disease|0|||
44261897|NCT02533674|79145322|FG006|Dose Level I|Progressive disease|0|||
44261898|NCT02533674|79145323|FG007|Dose Level I|Progressive disease|0|||
44261899|NCT02533674|79145316|FG000|Dose Level I|Withdrawal by Subject|1|||
44261900|NCT02533674|79145317|FG001|Dose Level I|Withdrawal by Subject|0|||
44261901|NCT02533674|79145318|FG002|Dose Level I|Withdrawal by Subject|0|||
44261902|NCT02533674|79145319|FG003|Dose Level I|Withdrawal by Subject|0|||
44261903|NCT02533674|79145320|FG004|Dose Level I|Withdrawal by Subject|0|||
44261904|NCT02533674|79145321|FG005|Dose Level I|Withdrawal by Subject|0|||
44261905|NCT02533674|79145322|FG006|Dose Level I|Withdrawal by Subject|0|||
44261906|NCT02533674|79145323|FG007|Dose Level I|Withdrawal by Subject|0|||
44261907|NCT02533674|79145316|FG000|Dose Level I|Physician Decision|1|||
44261908|NCT02533674|79145317|FG001|Dose Level I|Physician Decision|0|||
44261909|NCT02533674|79145318|FG002|Dose Level I|Physician Decision|0|||
44261910|NCT02533674|79145319|FG003|Dose Level I|Physician Decision|0|||
44261911|NCT02533674|79145320|FG004|Dose Level I|Physician Decision|0|||
44261912|NCT02533674|79145321|FG005|Dose Level I|Physician Decision|0|||
44261913|NCT02533674|79145322|FG006|Dose Level I|Physician Decision|0|||
44261914|NCT02533674|79145323|FG007|Dose Level I|Physician Decision|0|||
44261915|NCT02533674|79145316|FG000|Dose Level I|Death|1|||
44261916|NCT02533674|79145317|FG001|Dose Level I|Death|0|||
44261917|NCT02533674|79145318|FG002|Dose Level I|Death|0|||
44261918|NCT02533674|79145319|FG003|Dose Level I|Death|0|||
44261919|NCT02533674|79145320|FG004|Dose Level I|Death|0|||
44261920|NCT02533674|79145321|FG005|Dose Level I|Death|0|||
44261921|NCT02533674|79145322|FG006|Dose Level I|Death|0|||
44261922|NCT02533674|79145323|FG007|Dose Level I|Death|0|||
44261923|NCT02533674|79145316|FG000|Dose Level I|Never Treated|1|||
44261924|NCT02533674|79145317|FG001|Dose Level I|Never Treated|0|||
44261925|NCT02533674|79145318|FG002|Dose Level I|Never Treated|0|||
44261926|NCT02533674|79145319|FG003|Dose Level I|Never Treated|0|||
44261927|NCT02533674|79145320|FG004|Dose Level I|Never Treated|0|||
44261928|NCT02533674|79145321|FG005|Dose Level I|Never Treated|0|||
44261929|NCT02533674|79145322|FG006|Dose Level I|Never Treated|0|||
44261930|NCT02533674|79145323|FG007|Dose Level I|Never Treated|0|||
44261931|NCT02533674|79145316|FG000|Dose Level II|Progressive disease|0|||
44261932|NCT02533674|79145317|FG001|Dose Level II|Progressive disease|3|||
44261933|NCT02533674|79145318|FG002|Dose Level II|Progressive disease|0|||
44261934|NCT02533674|79145319|FG003|Dose Level II|Progressive disease|0|||
44261935|NCT02533674|79145320|FG004|Dose Level II|Progressive disease|0|||
44261936|NCT02533674|79145321|FG005|Dose Level II|Progressive disease|0|||
44261937|NCT02533674|79145322|FG006|Dose Level II|Progressive disease|0|||
44261938|NCT02533674|79145323|FG007|Dose Level II|Progressive disease|0|||
44261939|NCT02533674|79145316|FG000|Dose Level II|Withdrawal by Subject|0|||
44261940|NCT02533674|79145317|FG001|Dose Level II|Withdrawal by Subject|1|||
44261941|NCT02533674|79145318|FG002|Dose Level II|Withdrawal by Subject|0|||
44261942|NCT02533674|79145319|FG003|Dose Level II|Withdrawal by Subject|0|||
44261943|NCT02533674|79145320|FG004|Dose Level II|Withdrawal by Subject|0|||
44261944|NCT02533674|79145321|FG005|Dose Level II|Withdrawal by Subject|0|||
44261945|NCT02533674|79145322|FG006|Dose Level II|Withdrawal by Subject|0|||
44261946|NCT02533674|79145323|FG007|Dose Level II|Withdrawal by Subject|0|||
44261947|NCT02533674|79145316|FG000|Dose Level II|Treatment-related AE|0|||
44261948|NCT02533674|79145317|FG001|Dose Level II|Treatment-related AE|1|||
44261949|NCT02533674|79145318|FG002|Dose Level II|Treatment-related AE|0|||
44261950|NCT02533674|79145319|FG003|Dose Level II|Treatment-related AE|0|||
44261951|NCT02533674|79145320|FG004|Dose Level II|Treatment-related AE|0|||
44261952|NCT02533674|79145321|FG005|Dose Level II|Treatment-related AE|0|||
44261953|NCT02533674|79145322|FG006|Dose Level II|Treatment-related AE|0|||
44261954|NCT02533674|79145323|FG007|Dose Level II|Treatment-related AE|0|||
44261955|NCT02533674|79145316|FG000|Dose Level II|Physician Decision|0|||
44261956|NCT02533674|79145317|FG001|Dose Level II|Physician Decision|1|||
44261957|NCT02533674|79145318|FG002|Dose Level II|Physician Decision|0|||
44261958|NCT02533674|79145319|FG003|Dose Level II|Physician Decision|0|||
44261959|NCT02533674|79145320|FG004|Dose Level II|Physician Decision|0|||
44261960|NCT02533674|79145321|FG005|Dose Level II|Physician Decision|0|||
44261961|NCT02533674|79145322|FG006|Dose Level II|Physician Decision|0|||
44261962|NCT02533674|79145323|FG007|Dose Level II|Physician Decision|0|||
44261963|NCT02533674|79145316|FG000|Dose Level II|Non-treatment-related AE|0|||
44261964|NCT02533674|79145317|FG001|Dose Level II|Non-treatment-related AE|1|||
44261965|NCT02533674|79145318|FG002|Dose Level II|Non-treatment-related AE|0|||
44261966|NCT02533674|79145319|FG003|Dose Level II|Non-treatment-related AE|0|||
44261967|NCT02533674|79145320|FG004|Dose Level II|Non-treatment-related AE|0|||
44261968|NCT02533674|79145321|FG005|Dose Level II|Non-treatment-related AE|0|||
44261969|NCT02533674|79145322|FG006|Dose Level II|Non-treatment-related AE|0|||
44261970|NCT02533674|79145323|FG007|Dose Level II|Non-treatment-related AE|0|||
44261971|NCT02533674|79145316|FG000|Dose Level III|Progressive disease|0|||
44261972|NCT02533674|79145317|FG001|Dose Level III|Progressive disease|0|||
44261973|NCT02533674|79145318|FG002|Dose Level III|Progressive disease|2|||
44261974|NCT02533674|79145319|FG003|Dose Level III|Progressive disease|0|||
44261975|NCT02533674|79145320|FG004|Dose Level III|Progressive disease|0|||
44261976|NCT02533674|79145321|FG005|Dose Level III|Progressive disease|0|||
44261977|NCT02533674|79145322|FG006|Dose Level III|Progressive disease|0|||
44261978|NCT02533674|79145323|FG007|Dose Level III|Progressive disease|0|||
44261979|NCT02533674|79145316|FG000|Dose Level III|Withdrawal by Subject|0|||
44261980|NCT02533674|79145317|FG001|Dose Level III|Withdrawal by Subject|0|||
44261981|NCT02533674|79145318|FG002|Dose Level III|Withdrawal by Subject|1|||
44261982|NCT02533674|79145319|FG003|Dose Level III|Withdrawal by Subject|0|||
44261983|NCT02533674|79145320|FG004|Dose Level III|Withdrawal by Subject|0|||
44261984|NCT02533674|79145321|FG005|Dose Level III|Withdrawal by Subject|0|||
44261985|NCT02533674|79145322|FG006|Dose Level III|Withdrawal by Subject|0|||
44261986|NCT02533674|79145323|FG007|Dose Level III|Withdrawal by Subject|0|||
44261987|NCT02533674|79145316|FG000|Dose Level III|Treatment-related AE|0|||
44261988|NCT02533674|79145317|FG001|Dose Level III|Treatment-related AE|0|||
44261989|NCT02533674|79145318|FG002|Dose Level III|Treatment-related AE|1|||
44261990|NCT02533674|79145319|FG003|Dose Level III|Treatment-related AE|0|||
44261991|NCT02533674|79145320|FG004|Dose Level III|Treatment-related AE|0|||
44261992|NCT02533674|79145321|FG005|Dose Level III|Treatment-related AE|0|||
44261993|NCT02533674|79145322|FG006|Dose Level III|Treatment-related AE|0|||
44261994|NCT02533674|79145323|FG007|Dose Level III|Treatment-related AE|0|||
44261995|NCT02533674|79145316|FG000|Dose Level IV|Progressive disease|0|||
44261996|NCT02533674|79145317|FG001|Dose Level IV|Progressive disease|0|||
44261997|NCT02533674|79145318|FG002|Dose Level IV|Progressive disease|0|||
44261998|NCT02533674|79145319|FG003|Dose Level IV|Progressive disease|3|||
44261999|NCT02533674|79145320|FG004|Dose Level IV|Progressive disease|0|||
44262000|NCT02533674|79145321|FG005|Dose Level IV|Progressive disease|0|||
44262001|NCT02533674|79145322|FG006|Dose Level IV|Progressive disease|0|||
44262002|NCT02533674|79145323|FG007|Dose Level IV|Progressive disease|0|||
44262003|NCT02533674|79145316|FG000|Dose Level IV|Withdrawal by Subject|0|||
44262004|NCT02533674|79145317|FG001|Dose Level IV|Withdrawal by Subject|0|||
44262005|NCT02533674|79145318|FG002|Dose Level IV|Withdrawal by Subject|0|||
44262006|NCT02533674|79145319|FG003|Dose Level IV|Withdrawal by Subject|1|||
44262007|NCT02533674|79145320|FG004|Dose Level IV|Withdrawal by Subject|0|||
44262008|NCT02533674|79145321|FG005|Dose Level IV|Withdrawal by Subject|0|||
44262009|NCT02533674|79145322|FG006|Dose Level IV|Withdrawal by Subject|0|||
44262010|NCT02533674|79145323|FG007|Dose Level IV|Withdrawal by Subject|0|||
44262011|NCT02533674|79145316|FG000|Dose Level IV|Physician Decision|0|||
44262012|NCT02533674|79145317|FG001|Dose Level IV|Physician Decision|0|||
44262013|NCT02533674|79145318|FG002|Dose Level IV|Physician Decision|0|||
44262014|NCT02533674|79145319|FG003|Dose Level IV|Physician Decision|1|||
44262015|NCT02533674|79145320|FG004|Dose Level IV|Physician Decision|0|||
44262016|NCT02533674|79145321|FG005|Dose Level IV|Physician Decision|0|||
44262017|NCT02533674|79145322|FG006|Dose Level IV|Physician Decision|0|||
44262018|NCT02533674|79145323|FG007|Dose Level IV|Physician Decision|0|||
44262019|NCT02533674|79145316|FG000|Dose Level V|Progressive disease|0|||
44262020|NCT02533674|79145317|FG001|Dose Level V|Progressive disease|0|||
44262021|NCT02533674|79145318|FG002|Dose Level V|Progressive disease|0|||
44262022|NCT02533674|79145319|FG003|Dose Level V|Progressive disease|0|||
44262023|NCT02533674|79145320|FG004|Dose Level V|Progressive disease|3|||
44262024|NCT02533674|79145321|FG005|Dose Level V|Progressive disease|0|||
44262025|NCT02533674|79145322|FG006|Dose Level V|Progressive disease|0|||
44262026|NCT02533674|79145323|FG007|Dose Level V|Progressive disease|0|||
44262027|NCT02533674|79145316|FG000|Dose Level V|Withdrawal by Subject|0|||
44262028|NCT02533674|79145317|FG001|Dose Level V|Withdrawal by Subject|0|||
44262029|NCT02533674|79145318|FG002|Dose Level V|Withdrawal by Subject|0|||
44262030|NCT02533674|79145319|FG003|Dose Level V|Withdrawal by Subject|0|||
44262031|NCT02533674|79145320|FG004|Dose Level V|Withdrawal by Subject|1|||
44262032|NCT02533674|79145321|FG005|Dose Level V|Withdrawal by Subject|0|||
44262033|NCT02533674|79145322|FG006|Dose Level V|Withdrawal by Subject|0|||
44262034|NCT02533674|79145323|FG007|Dose Level V|Withdrawal by Subject|0|||
44262035|NCT02533674|79145316|FG000|Dose Level V|Physician Decision|0|||
44262036|NCT02533674|79145317|FG001|Dose Level V|Physician Decision|0|||
44262037|NCT02533674|79145318|FG002|Dose Level V|Physician Decision|0|||
44262038|NCT02533674|79145319|FG003|Dose Level V|Physician Decision|0|||
44262039|NCT02533674|79145320|FG004|Dose Level V|Physician Decision|1|||
44262040|NCT02533674|79145321|FG005|Dose Level V|Physician Decision|0|||
44262041|NCT02533674|79145322|FG006|Dose Level V|Physician Decision|0|||
44262042|NCT02533674|79145323|FG007|Dose Level V|Physician Decision|0|||
44262043|NCT02533674|79145316|FG000|Dose Level VI|Progressive disease|0|||
44262044|NCT02533674|79145317|FG001|Dose Level VI|Progressive disease|0|||
44262045|NCT02533674|79145318|FG002|Dose Level VI|Progressive disease|0|||
44262046|NCT02533674|79145319|FG003|Dose Level VI|Progressive disease|0|||
44262047|NCT02533674|79145320|FG004|Dose Level VI|Progressive disease|0|||
44262048|NCT02533674|79145321|FG005|Dose Level VI|Progressive disease|7|||
44262049|NCT02533674|79145322|FG006|Dose Level VI|Progressive disease|0|||
44262050|NCT02533674|79145323|FG007|Dose Level VI|Progressive disease|0|||
44262051|NCT02533674|79145316|FG000|Dose Level VI|Withdrawal by Subject|0|||
44262052|NCT02533674|79145317|FG001|Dose Level VI|Withdrawal by Subject|0|||
44262053|NCT02533674|79145318|FG002|Dose Level VI|Withdrawal by Subject|0|||
44262054|NCT02533674|79145319|FG003|Dose Level VI|Withdrawal by Subject|0|||
44262055|NCT02533674|79145320|FG004|Dose Level VI|Withdrawal by Subject|0|||
44262056|NCT02533674|79145321|FG005|Dose Level VI|Withdrawal by Subject|1|||
44262057|NCT02533674|79145322|FG006|Dose Level VI|Withdrawal by Subject|0|||
44262058|NCT02533674|79145323|FG007|Dose Level VI|Withdrawal by Subject|0|||
44262059|NCT02533674|79145316|FG000|Dose Level VI|Treatment-related AE|0|||
44262060|NCT02533674|79145317|FG001|Dose Level VI|Treatment-related AE|0|||
44262061|NCT02533674|79145318|FG002|Dose Level VI|Treatment-related AE|0|||
44262062|NCT02533674|79145319|FG003|Dose Level VI|Treatment-related AE|0|||
44262063|NCT02533674|79145320|FG004|Dose Level VI|Treatment-related AE|0|||
44262064|NCT02533674|79145321|FG005|Dose Level VI|Treatment-related AE|1|||
44262065|NCT02533674|79145322|FG006|Dose Level VI|Treatment-related AE|0|||
44262066|NCT02533674|79145323|FG007|Dose Level VI|Treatment-related AE|0|||
44262067|NCT02533674|79145316|FG000|Dose Level VII|Progressive disease|0|||
44262068|NCT02533674|79145317|FG001|Dose Level VII|Progressive disease|0|||
44262069|NCT02533674|79145318|FG002|Dose Level VII|Progressive disease|0|||
44262070|NCT02533674|79145319|FG003|Dose Level VII|Progressive disease|0|||
44262071|NCT02533674|79145320|FG004|Dose Level VII|Progressive disease|0|||
44262072|NCT02533674|79145321|FG005|Dose Level VII|Progressive disease|0|||
44262073|NCT02533674|79145322|FG006|Dose Level VII|Progressive disease|10|||
44262074|NCT02533674|79145323|FG007|Dose Level VII|Progressive disease|0|||
44262075|NCT02533674|79145316|FG000|Dose Level VII|Withdrawal by Subject|0|||
44262076|NCT02533674|79145317|FG001|Dose Level VII|Withdrawal by Subject|0|||
44262077|NCT02533674|79145318|FG002|Dose Level VII|Withdrawal by Subject|0|||
44262078|NCT02533674|79145319|FG003|Dose Level VII|Withdrawal by Subject|0|||
44262079|NCT02533674|79145320|FG004|Dose Level VII|Withdrawal by Subject|0|||
44262080|NCT02533674|79145321|FG005|Dose Level VII|Withdrawal by Subject|0|||
44262081|NCT02533674|79145322|FG006|Dose Level VII|Withdrawal by Subject|3|||
44262082|NCT02533674|79145323|FG007|Dose Level VII|Withdrawal by Subject|0|||
44262083|NCT02533674|79145316|FG000|Dose Level VII|Treatment-related AE|0|||
44262084|NCT02533674|79145317|FG001|Dose Level VII|Treatment-related AE|0|||
44262085|NCT02533674|79145318|FG002|Dose Level VII|Treatment-related AE|0|||
44262086|NCT02533674|79145319|FG003|Dose Level VII|Treatment-related AE|0|||
44262087|NCT02533674|79145320|FG004|Dose Level VII|Treatment-related AE|0|||
44262088|NCT02533674|79145321|FG005|Dose Level VII|Treatment-related AE|0|||
44262089|NCT02533674|79145322|FG006|Dose Level VII|Treatment-related AE|1|||
44262090|NCT02533674|79145323|FG007|Dose Level VII|Treatment-related AE|0|||
44262091|NCT02533674|79145316|FG000|Dose Level VII|Death|0|||
44262092|NCT02533674|79145317|FG001|Dose Level VII|Death|0|||
44262093|NCT02533674|79145318|FG002|Dose Level VII|Death|0|||
44262094|NCT02533674|79145319|FG003|Dose Level VII|Death|0|||
44262095|NCT02533674|79145320|FG004|Dose Level VII|Death|0|||
44262096|NCT02533674|79145321|FG005|Dose Level VII|Death|0|||
44262097|NCT02533674|79145322|FG006|Dose Level VII|Death|2|||
44262098|NCT02533674|79145323|FG007|Dose Level VII|Death|0|||
44262099|NCT02533674|79145316|FG000|Dose Level VIII|Progressive disease|0|||
44262100|NCT02533674|79145317|FG001|Dose Level VIII|Progressive disease|0|||
44262101|NCT02533674|79145318|FG002|Dose Level VIII|Progressive disease|0|||
44262102|NCT02533674|79145319|FG003|Dose Level VIII|Progressive disease|0|||
44262103|NCT02533674|79145320|FG004|Dose Level VIII|Progressive disease|0|||
44262104|NCT02533674|79145321|FG005|Dose Level VIII|Progressive disease|0|||
44262105|NCT02533674|79145322|FG006|Dose Level VIII|Progressive disease|0|||
44262106|NCT02533674|79145323|FG007|Dose Level VIII|Progressive disease|3|||
44262107|NCT02533674|79145316|FG000|Dose Level VIII|Withdrawal by Subject|0|||
44262108|NCT02533674|79145317|FG001|Dose Level VIII|Withdrawal by Subject|0|||
44262109|NCT02533674|79145318|FG002|Dose Level VIII|Withdrawal by Subject|0|||
44262110|NCT02533674|79145319|FG003|Dose Level VIII|Withdrawal by Subject|0|||
44262111|NCT02533674|79145320|FG004|Dose Level VIII|Withdrawal by Subject|0|||
44262112|NCT02533674|79145321|FG005|Dose Level VIII|Withdrawal by Subject|0|||
44262113|NCT02533674|79145322|FG006|Dose Level VIII|Withdrawal by Subject|0|||
44262114|NCT02533674|79145323|FG007|Dose Level VIII|Withdrawal by Subject|1|||
44262115|NCT02533674|79145316|FG000|Dose Level VIII|Treatment-related AE|0|||
44262116|NCT02533674|79145317|FG001|Dose Level VIII|Treatment-related AE|0|||
44262117|NCT02533674|79145318|FG002|Dose Level VIII|Treatment-related AE|0|||
44262118|NCT02533674|79145319|FG003|Dose Level VIII|Treatment-related AE|0|||
44262119|NCT02533674|79145320|FG004|Dose Level VIII|Treatment-related AE|0|||
44262120|NCT02533674|79145321|FG005|Dose Level VIII|Treatment-related AE|0|||
44262121|NCT02533674|79145322|FG006|Dose Level VIII|Treatment-related AE|0|||
44262122|NCT02533674|79145323|FG007|Dose Level VIII|Treatment-related AE|1|||
44262123|NCT02533674|79145316|FG000|Dose Level VIII|Never treated|0|||
44262124|NCT02533674|79145317|FG001|Dose Level VIII|Never treated|0|||
44262125|NCT02533674|79145318|FG002|Dose Level VIII|Never treated|0|||
44262126|NCT02533674|79145319|FG003|Dose Level VIII|Never treated|0|||
44262127|NCT02533674|79145320|FG004|Dose Level VIII|Never treated|0|||
44262128|NCT02533674|79145321|FG005|Dose Level VIII|Never treated|0|||
44262129|NCT02533674|79145322|FG006|Dose Level VIII|Never treated|0|||
44262130|NCT02533674|79145323|FG007|Dose Level VIII|Never treated|1|||
44262131|NCT02540850|79145344|FG000|Overall Study|Lost to Follow-up|69|||
44262132|NCT02540850|79145345|FG001|Overall Study|Lost to Follow-up|66|||
44262133|NCT02540850|79145346|FG002|Overall Study|Lost to Follow-up|34|||
44262134|NCT01662024|79145354|FG000|Overall Study|Pregnancy|2|||
44262135|NCT01662024|79145354|FG000|Overall Study|Withdrawal by Subject|3|||
44262136|NCT02544750|79145423|FG000|Overall Study|Physician Decision|3|||
44262137|NCT02544750|79145424|FG001|Overall Study|Physician Decision|1|||
44262138|NCT02544750|79145423|FG000|Overall Study|Other reasons|69|||
44262139|NCT02544750|79145424|FG001|Overall Study|Other reasons|39|||
44262140|NCT02544750|79145423|FG000|Overall Study|Met withdrawal criteria|2|||
44262141|NCT02544750|79145424|FG001|Overall Study|Met withdrawal criteria|2|||
44262142|NCT02544750|79145423|FG000|Overall Study|Transition To Commercial Product|1|||
44262143|NCT02544750|79145424|FG001|Overall Study|Transition To Commercial Product|0|||
44262144|NCT02544750|79145423|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
44262145|NCT02544750|79145424|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
44262146|NCT02544750|79145423|FG000|Overall Study|Adverse Event|8|||
44262147|NCT02544750|79145424|FG001|Overall Study|Adverse Event|10|||
44262148|NCT02544750|79145423|FG000|Overall Study|Withdrawal by Subject|10|||
44262149|NCT02544750|79145424|FG001|Overall Study|Withdrawal by Subject|4|||
44262150|NCT02544750|79145423|FG000|Overall Study|Lost to Follow-up|1|||
44262151|NCT02544750|79145424|FG001|Overall Study|Lost to Follow-up|0|||
44262152|NCT02540538|79145470|FG000|Overall Study|Pregnancy|0|||
44262153|NCT02540538|79145471|FG001|Overall Study|Pregnancy|1|||
44262154|NCT02540538|79145472|FG002|Overall Study|Pregnancy|0|||
44262155|NCT04697056|79145505|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
44262156|NCT04697056|79145506|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
44262157|NCT02532972|79145644|FG000|Overall Study|Withdrawal by Subject|1|||
44262158|NCT03187834|79145697|FG000|Overall Study|Lost to Follow-up|0|||
44262159|NCT03187834|79145698|FG001|Overall Study|Lost to Follow-up|1|||
44262160|NCT03187834|79145699|FG002|Overall Study|Lost to Follow-up|2|||
44262161|NCT03187834|79145700|FG003|Overall Study|Lost to Follow-up|2|||
44262162|NCT03187834|79145697|FG000|Overall Study|Had invalid anthropometric measurements|5|||
44262163|NCT03187834|79145698|FG001|Overall Study|Had invalid anthropometric measurements|3|||
44262164|NCT03187834|79145699|FG002|Overall Study|Had invalid anthropometric measurements|4|||
44262165|NCT03187834|79145700|FG003|Overall Study|Had invalid anthropometric measurements|2|||
44262166|NCT03713944|79145853|FG000|Study Treatment|Patient non-compliance|1|||
44262167|NCT03713944|79145853|FG000|Study Treatment|Alternative Cancer Therapy|3|||
44262168|NCT03713944|79145853|FG000|Study Treatment|Disease Progression|18|||
44262169|NCT03713944|79145853|FG000|Study Treatment|AE/Side Effects/Complications|2|||
44262170|NCT03713944|79145853|FG000|Study Treatment|Death|2|||
44262171|NCT03713944|79145853|FG000|Study Treatment|Withdrawal by Subject|1|||
44262172|NCT03713944|79145853|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
44262173|NCT03713944|79145853|FG000|Study Treatment|Symptomatic Deterioration|2|||
44262174|NCT03713944|79145853|FG000|Follow up|Withdrawal by Subject|2|||
44262175|NCT03713944|79145853|FG000|Follow up|Death|11|||
44262176|NCT03713944|79145853|FG000|Follow up|Study Terminated|3|||
44262177|NCT01572662|79145931|FG000|Overall Study|Withdrawal by Subject|1|||
44262178|NCT01572662|79145932|FG001|Overall Study|Withdrawal by Subject|0|||
44262179|NCT01572662|79145931|FG000|Overall Study|Physician Decision|0|||
44262180|NCT01572662|79145932|FG001|Overall Study|Physician Decision|1|||
44262181|NCT02325154|79145962|FG000|Overall Study|Physician Decision|1|||
44262182|NCT00493870|79146089|FG000|Overall Study|Lost to Follow-up|12|||
44262183|NCT00493870|79146090|FG001|Overall Study|Lost to Follow-up|15|||
44262184|NCT03951753|79146359|FG000|Overall Study|Adverse Event|1|||
44262185|NCT03951753|79146360|FG001|Overall Study|Adverse Event|0|||
44262186|NCT03951753|79146361|FG002|Overall Study|Adverse Event|3|||
44262187|NCT03951753|79146359|FG000|Overall Study|Withdrawal by Subject|3|||
44262188|NCT03951753|79146360|FG001|Overall Study|Withdrawal by Subject|1|||
44262189|NCT03951753|79146361|FG002|Overall Study|Withdrawal by Subject|0|||
44262190|NCT03951753|79146359|FG000|Overall Study|Lost to Follow-up|0|||
44262191|NCT03951753|79146360|FG001|Overall Study|Lost to Follow-up|0|||
44262192|NCT03951753|79146361|FG002|Overall Study|Lost to Follow-up|1|||
44262193|NCT03941964|79146371|FG000|Overall Study|Adverse Event|1|||
44262194|NCT03941964|79146372|FG001|Overall Study|Adverse Event|8|||
44262195|NCT03941964|79146371|FG000|Overall Study|Progressive disease|7|||
44262196|NCT03941964|79146372|FG001|Overall Study|Progressive disease|3|||
44262197|NCT03941964|79146371|FG000|Overall Study|Lack of Efficacy|0|||
44262198|NCT03941964|79146372|FG001|Overall Study|Lack of Efficacy|1|||
44262199|NCT03941964|79146371|FG000|Overall Study|Death|3|||
44262200|NCT03941964|79146372|FG001|Overall Study|Death|1|||
44262201|NCT03941964|79146371|FG000|Overall Study|Withdrew consent|1|||
44262202|NCT03941964|79146372|FG001|Overall Study|Withdrew consent|3|||
44262203|NCT03941964|79146371|FG000|Overall Study|Physician Decision|9|||
44262204|NCT03941964|79146372|FG001|Overall Study|Physician Decision|2|||
44262205|NCT03941964|79146371|FG000|Overall Study|Other, not specified|2|||
44262206|NCT03941964|79146372|FG001|Overall Study|Other, not specified|1|||
44262207|NCT03837509|79146393|FG000|Phase 1|Death|5|||
44262208|NCT03837509|79146394|FG001|Phase 1|Death|2|||
44262209|NCT03837509|79146395|FG002|Phase 1|Death|0|||
44262210|NCT03837509|79146396|FG003|Phase 1|Death|0|||
44262211|NCT03837509|79146397|FG004|Phase 1|Death|0|||
44262212|NCT03837509|79146393|FG000|Phase 2|Death|0|||
44262213|NCT03837509|79146394|FG001|Phase 2|Death|0|||
44262214|NCT03837509|79146395|FG002|Phase 2|Death|0|||
44262215|NCT03837509|79146396|FG003|Phase 2|Death|1|||
44262216|NCT03837509|79146397|FG004|Phase 2|Death|1|||
44262217|NCT03822117|79146417|FG000|Overall Study|Death|18|||
44262218|NCT03822117|79146418|FG001|Overall Study|Death|17|||
44262219|NCT03822117|79146419|FG002|Overall Study|Death|12|||
44262220|NCT03822117|79146420|FG003|Overall Study|Death|4|||
44262221|NCT03822117|79146417|FG000|Overall Study|Lost to Follow-up|1|||
44262222|NCT03822117|79146418|FG001|Overall Study|Lost to Follow-up|2|||
44262223|NCT03822117|79146419|FG002|Overall Study|Lost to Follow-up|3|||
44262224|NCT03822117|79146420|FG003|Overall Study|Lost to Follow-up|0|||
44262225|NCT03822117|79146417|FG000|Overall Study|Study Terminated by Sponsor|25|||
44262226|NCT03822117|79146418|FG001|Overall Study|Study Terminated by Sponsor|11|||
44262227|NCT03822117|79146419|FG002|Overall Study|Study Terminated by Sponsor|6|||
44262228|NCT03822117|79146420|FG003|Overall Study|Study Terminated by Sponsor|0|||
44262229|NCT03822117|79146417|FG000|Overall Study|Withdrawal by Subject|4|||
44262230|NCT03822117|79146418|FG001|Overall Study|Withdrawal by Subject|0|||
44262231|NCT03822117|79146419|FG002|Overall Study|Withdrawal by Subject|3|||
44262232|NCT03822117|79146420|FG003|Overall Study|Withdrawal by Subject|0|||
44262233|NCT03822117|79146417|FG000|Overall Study|Disease Progression|1|||
44262234|NCT03822117|79146418|FG001|Overall Study|Disease Progression|2|||
44262235|NCT03822117|79146419|FG002|Overall Study|Disease Progression|1|||
44262236|NCT03822117|79146420|FG003|Overall Study|Disease Progression|0|||
44262237|NCT03822117|79146417|FG000|Overall Study|Never Returned to Hospital|0|||
44262238|NCT03822117|79146418|FG001|Overall Study|Never Returned to Hospital|0|||
44262239|NCT03822117|79146419|FG002|Overall Study|Never Returned to Hospital|1|||
44262240|NCT03822117|79146420|FG003|Overall Study|Never Returned to Hospital|0|||
44262241|NCT03497897|79146434|FG000|Overall Study|Adverse Event|1|||
44262242|NCT03497897|79146435|FG001|Overall Study|Adverse Event|1|||
44262243|NCT03497897|79146436|FG002|Overall Study|Adverse Event|1|||
44262244|NCT03497897|79146434|FG000|Overall Study|Lost to Follow-up|2|||
44262245|NCT03497897|79146435|FG001|Overall Study|Lost to Follow-up|0|||
44262246|NCT03497897|79146436|FG002|Overall Study|Lost to Follow-up|2|||
44262247|NCT03497897|79146434|FG000|Overall Study|Physician Decision|1|||
44262248|NCT03497897|79146435|FG001|Overall Study|Physician Decision|0|||
44262249|NCT03497897|79146436|FG002|Overall Study|Physician Decision|0|||
44262250|NCT03497897|79146434|FG000|Overall Study|Subject/Guardian Decision|2|||
44262251|NCT03497897|79146435|FG001|Overall Study|Subject/Guardian Decision|1|||
44262252|NCT03497897|79146436|FG002|Overall Study|Subject/Guardian Decision|3|||
44262253|NCT03428217|79146447|FG000|Overall Study|Death|89|||
44262254|NCT03428217|79146448|FG001|Overall Study|Death|93|||
44262255|NCT03428217|79146447|FG000|Overall Study|Withdrawal by Subject|8|||
44262256|NCT03428217|79146448|FG001|Overall Study|Withdrawal by Subject|7|||
44262257|NCT03428217|79146447|FG000|Overall Study|Lost to Follow-up|1|||
44262258|NCT03428217|79146448|FG001|Overall Study|Lost to Follow-up|3|||
44262259|NCT03428217|79146447|FG000|Overall Study|Study terminated by sponsor|124|||
44262260|NCT03428217|79146448|FG001|Overall Study|Study terminated by sponsor|118|||
44262261|NCT03428217|79146447|FG000|Overall Study|Other, Not Specified|1|||
44262262|NCT03428217|79146448|FG001|Overall Study|Other, Not Specified|0|||
44262263|NCT03189719|79146458|FG000|Overall Study|Death|260|||
44262264|NCT03189719|79146459|FG001|Overall Study|Death|308|||
44262265|NCT03189719|79146458|FG000|Overall Study|Withdrawal by Subject|5|||
44262266|NCT03189719|79146459|FG001|Overall Study|Withdrawal by Subject|3|||
44262267|NCT03189719|79146458|FG000|Overall Study|Ongoing in Study|108|||
44262268|NCT03189719|79146459|FG001|Overall Study|Ongoing in Study|65|||
44262269|NCT02969525|79146470|FG000|Double-Blind Period|Adverse Event|0|||
44262270|NCT02969525|79146471|FG001|Double-Blind Period|Adverse Event|0|||
44262271|NCT02969525|79146472|FG002|Double-Blind Period|Adverse Event|1|||
44262272|NCT02969525|79146473|FG003|Double-Blind Period|Adverse Event|1|||
44262273|NCT02969525|79146474|FG004|Double-Blind Period|Adverse Event|0|||
44262274|NCT02969525|79146475|FG005|Double-Blind Period|Adverse Event|0|||
44262275|NCT02969525|79146476|FG006|Double-Blind Period|Adverse Event|0|||
44262276|NCT02969525|79146477|FG007|Double-Blind Period|Adverse Event|0|||
44262277|NCT02969525|79146478|FG008|Double-Blind Period|Adverse Event|0|||
44262278|NCT02969525|79146479|FG009|Double-Blind Period|Adverse Event|0|||
44262279|NCT02969525|79146480|FG010|Double-Blind Period|Adverse Event|0|||
44262280|NCT02969525|79146481|FG011|Double-Blind Period|Adverse Event|0|||
44262281|NCT02969525|79146470|FG000|Double-Blind Period|LOW EGFR|0|||
44262282|NCT02969525|79146471|FG001|Double-Blind Period|LOW EGFR|0|||
44262283|NCT02969525|79146472|FG002|Double-Blind Period|LOW EGFR|0|||
44262284|NCT02969525|79146473|FG003|Double-Blind Period|LOW EGFR|1|||
44262285|NCT02969525|79146474|FG004|Double-Blind Period|LOW EGFR|0|||
44262286|NCT02969525|79146475|FG005|Double-Blind Period|LOW EGFR|0|||
44262287|NCT02969525|79146476|FG006|Double-Blind Period|LOW EGFR|0|||
44262288|NCT02969525|79146477|FG007|Double-Blind Period|LOW EGFR|0|||
44262289|NCT02969525|79146478|FG008|Double-Blind Period|LOW EGFR|0|||
44262290|NCT02969525|79146479|FG009|Double-Blind Period|LOW EGFR|0|||
44262291|NCT02969525|79146480|FG010|Double-Blind Period|LOW EGFR|0|||
44262292|NCT02969525|79146481|FG011|Double-Blind Period|LOW EGFR|0|||
44262293|NCT02969525|79146470|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
44262294|NCT02969525|79146471|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262295|NCT02969525|79146472|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262296|NCT02969525|79146473|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
44262297|NCT02969525|79146474|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262298|NCT02969525|79146475|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262299|NCT02969525|79146476|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262300|NCT02969525|79146477|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262301|NCT02969525|79146478|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262302|NCT02969525|79146479|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262303|NCT02969525|79146480|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262304|NCT02969525|79146481|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
44262305|NCT02969525|79146470|FG000|Dose-Blind Period|Adverse Event|0|||
44262306|NCT02969525|79146471|FG001|Dose-Blind Period|Adverse Event|0|||
44262307|NCT02969525|79146472|FG002|Dose-Blind Period|Adverse Event|0|||
44262308|NCT02969525|79146473|FG003|Dose-Blind Period|Adverse Event|0|||
44262309|NCT02969525|79146474|FG004|Dose-Blind Period|Adverse Event|0|||
44262310|NCT02969525|79146475|FG005|Dose-Blind Period|Adverse Event|0|||
44262311|NCT02969525|79146476|FG006|Dose-Blind Period|Adverse Event|0|||
44262312|NCT02969525|79146477|FG007|Dose-Blind Period|Adverse Event|0|||
44262313|NCT02969525|79146478|FG008|Dose-Blind Period|Adverse Event|0|||
44262314|NCT02969525|79146479|FG009|Dose-Blind Period|Adverse Event|1|||
44262315|NCT02969525|79146480|FG010|Dose-Blind Period|Adverse Event|1|||
44262316|NCT02969525|79146481|FG011|Dose-Blind Period|Adverse Event|1|||
44262317|NCT02969525|79146470|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
44262318|NCT02969525|79146471|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
44262319|NCT02969525|79146472|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
44262320|NCT02969525|79146473|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
44262321|NCT02969525|79146474|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
44262322|NCT02969525|79146475|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
44262323|NCT02969525|79146476|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
44262324|NCT02969525|79146477|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
44262325|NCT02969525|79146478|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
44262326|NCT02969525|79146479|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
44262327|NCT02969525|79146480|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
44262328|NCT02969525|79146481|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
44262329|NCT02969525|79146470|FG000|Dose-Blind Period|Non-cooperating patient|0|||
44262330|NCT02969525|79146471|FG001|Dose-Blind Period|Non-cooperating patient|0|||
44262331|NCT02969525|79146472|FG002|Dose-Blind Period|Non-cooperating patient|0|||
44262332|NCT02969525|79146473|FG003|Dose-Blind Period|Non-cooperating patient|0|||
44262333|NCT02969525|79146474|FG004|Dose-Blind Period|Non-cooperating patient|0|||
44262334|NCT02969525|79146475|FG005|Dose-Blind Period|Non-cooperating patient|0|||
44262335|NCT02969525|79146476|FG006|Dose-Blind Period|Non-cooperating patient|0|||
44262336|NCT02969525|79146477|FG007|Dose-Blind Period|Non-cooperating patient|0|||
44262337|NCT02969525|79146478|FG008|Dose-Blind Period|Non-cooperating patient|0|||
44262338|NCT02969525|79146479|FG009|Dose-Blind Period|Non-cooperating patient|0|||
44262339|NCT02969525|79146480|FG010|Dose-Blind Period|Non-cooperating patient|0|||
44262340|NCT02969525|79146481|FG011|Dose-Blind Period|Non-cooperating patient|1|||
44262341|NCT02969525|79146470|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262342|NCT02969525|79146471|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262343|NCT02969525|79146472|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262344|NCT02969525|79146473|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262345|NCT02969525|79146474|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262346|NCT02969525|79146475|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262347|NCT02969525|79146476|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262348|NCT02969525|79146477|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262349|NCT02969525|79146478|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262350|NCT02969525|79146479|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262351|NCT02969525|79146480|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
44262352|NCT02969525|79146481|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
44262353|NCT04232215|79146512|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
44262354|NCT04232215|79146513|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
44262355|NCT02399813|79146528|FG000|Overall Study|Progressive Disease-Radiographic|2|||
44262356|NCT02399813|79146528|FG000|Overall Study|Death|20|||
44262357|NCT02399813|79146528|FG000|Overall Study|Withdrawal by Subject|3|||
44262358|NCT02399813|79146528|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
44262359|NCT02399813|79146528|FG000|Overall Study|Lost to Follow-up|2|||
44262360|NCT02399813|79146528|FG000|Overall Study|Other than specified|5|||
44262361|NCT02291055|79146537|FG000|Overall Study|Death|2|||
44354944|NCT01022853|79359372|FG003|Overall Study|Progressive disease|7|||
44262362|NCT02291055|79146538|FG001|Overall Study|Death|2|||
44262363|NCT02291055|79146539|FG002|Overall Study|Death|5|||
44262364|NCT02291055|79146540|FG003|Overall Study|Death|8|||
44262365|NCT02291055|79146541|FG004|Overall Study|Death|12|||
44262366|NCT02291055|79146537|FG000|Overall Study|Lost to Follow-up|0|||
44262367|NCT02291055|79146538|FG001|Overall Study|Lost to Follow-up|0|||
44262368|NCT02291055|79146539|FG002|Overall Study|Lost to Follow-up|0|||
44262369|NCT02291055|79146540|FG003|Overall Study|Lost to Follow-up|1|||
44262370|NCT02291055|79146541|FG004|Overall Study|Lost to Follow-up|2|||
44262371|NCT02291055|79146537|FG000|Overall Study|Withdrawal by Subject|3|||
44262372|NCT02291055|79146538|FG001|Overall Study|Withdrawal by Subject|1|||
44262373|NCT02291055|79146539|FG002|Overall Study|Withdrawal by Subject|1|||
44262374|NCT02291055|79146540|FG003|Overall Study|Withdrawal by Subject|5|||
44542474|NCT03226275|79555385|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
44542475|NCT03226275|79555386|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
44542476|NCT04189081|79555399|FG000|Overall Study|Lost to Follow-up|1|||
44542477|NCT04189081|79555400|FG001|Overall Study|Lost to Follow-up|0|||
44542478|NCT04189081|79555401|FG002|Overall Study|Lost to Follow-up|0|||
44542479|NCT04189081|79555399|FG000|Overall Study|Withdrawal by Subject|0|||
44542480|NCT04189081|79555400|FG001|Overall Study|Withdrawal by Subject|0|||
44542481|NCT04189081|79555401|FG002|Overall Study|Withdrawal by Subject|1|||
44542482|NCT04187989|79555411|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
44542483|NCT04187989|79555412|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
44542484|NCT04187989|79555411|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
44542485|NCT04187989|79555412|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
44542486|NCT01150890|79555422|FG000|Overall Study|Other|0|||
44542487|NCT01150890|79555423|FG001|Overall Study|Other|1|||
44542488|NCT01150890|79555424|FG002|Overall Study|Other|0|||
44542489|NCT01150890|79555425|FG003|Overall Study|Other|2|||
44542490|NCT01150890|79555422|FG000|Overall Study|Pregnancy|0|||
44542491|NCT01150890|79555423|FG001|Overall Study|Pregnancy|0|||
44542492|NCT01150890|79555424|FG002|Overall Study|Pregnancy|0|||
44542493|NCT01150890|79555425|FG003|Overall Study|Pregnancy|1|||
44542494|NCT01150890|79555422|FG000|Overall Study|Administrative Decision|4|||
44542495|NCT01150890|79555423|FG001|Overall Study|Administrative Decision|4|||
44542496|NCT01150890|79555424|FG002|Overall Study|Administrative Decision|5|||
44542497|NCT01150890|79555425|FG003|Overall Study|Administrative Decision|6|||
44542498|NCT01150890|79555422|FG000|Overall Study|Ineligibility determined|0|||
44542499|NCT01150890|79555423|FG001|Overall Study|Ineligibility determined|1|||
44542500|NCT01150890|79555424|FG002|Overall Study|Ineligibility determined|0|||
44542501|NCT01150890|79555425|FG003|Overall Study|Ineligibility determined|0|||
44542502|NCT01150890|79555422|FG000|Overall Study|Adverse Event|0|||
44542503|NCT01150890|79555423|FG001|Overall Study|Adverse Event|0|||
44542504|NCT01150890|79555424|FG002|Overall Study|Adverse Event|2|||
44542505|NCT01150890|79555425|FG003|Overall Study|Adverse Event|0|||
44542506|NCT01150890|79555422|FG000|Overall Study|Withdrawal by Subject|0|||
44542507|NCT01150890|79555423|FG001|Overall Study|Withdrawal by Subject|0|||
44542508|NCT01150890|79555424|FG002|Overall Study|Withdrawal by Subject|2|||
44542509|NCT01150890|79555425|FG003|Overall Study|Withdrawal by Subject|1|||
44542510|NCT01150890|79555422|FG000|Overall Study|Disease progression|0|||
44542511|NCT01150890|79555423|FG001|Overall Study|Disease progression|7|||
44542512|NCT01150890|79555424|FG002|Overall Study|Disease progression|3|||
44542513|NCT01150890|79555425|FG003|Overall Study|Disease progression|7|||
44542514|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Adverse Event|2|||
44262375|NCT02291055|79146541|FG004|Overall Study|Withdrawal by Subject|10|||
44262376|NCT02291055|79146537|FG000|Overall Study|Progressive Disease|0|||
44542515|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Adverse Event|0|||
44542516|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Adverse Event|0|||
44354945|NCT01022853|79359373|FG004|Overall Study|Progressive disease|1|||
44167967|NCT02538029|78961190|FG001|Overall Study|unable to complete cognitive assessments|0|||
44167968|NCT02538029|78961191|FG002|Overall Study|unable to complete cognitive assessments|1|||
44167969|NCT02272413|78961203|FG000|Randomized Through Treatment Start|Not treated|3|||
44167970|NCT02272413|78961204|FG001|Randomized Through Treatment Start|Not treated|5|||
44167971|NCT02272413|78961203|FG000|Pre-switch Period|Adverse Event|38|||
44262377|NCT02291055|79146538|FG001|Overall Study|Progressive Disease|0|||
44262378|NCT02291055|79146539|FG002|Overall Study|Progressive Disease|1|||
44262379|NCT02291055|79146540|FG003|Overall Study|Progressive Disease|4|||
44262380|NCT02291055|79146541|FG004|Overall Study|Progressive Disease|2|||
44262381|NCT02291055|79146537|FG000|Overall Study|Study Terminated by Sponsor|0|||
44262382|NCT02291055|79146538|FG001|Overall Study|Study Terminated by Sponsor|0|||
44262383|NCT02291055|79146539|FG002|Overall Study|Study Terminated by Sponsor|0|||
44262384|NCT02291055|79146540|FG003|Overall Study|Study Terminated by Sponsor|5|||
44262385|NCT02291055|79146541|FG004|Overall Study|Study Terminated by Sponsor|1|||
44262386|NCT02291055|79146537|FG000|Overall Study|Other|0|||
44262387|NCT02291055|79146538|FG001|Overall Study|Other|2|||
44262388|NCT02291055|79146539|FG002|Overall Study|Other|1|||
44262389|NCT02291055|79146540|FG003|Overall Study|Other|4|||
44262390|NCT02291055|79146541|FG004|Overall Study|Other|0|||
44262391|NCT00723697|79146557|FG000|Overall Study|Physician questionnaires not received|2|||
44262392|NCT00723697|79146557|FG000|Overall Study|Missing Informed Consent Form|10|||
44262393|NCT00723697|79146557|FG000|Overall Study|Other exclusion criteria applied|6|||
44262394|NCT00684073|79146564|FG000|Selection|Selection/non-selection criteria|3|||
44262395|NCT00684073|79146564|FG000|Selection|Death|1|||
44262396|NCT00684073|79146564|FG000|Selection|noncompliance|1|||
44262397|NCT00684073|79146564|FG000|Selection|Lost to Follow-up|1|||
44262398|NCT00684073|79146564|FG000|Selection|request of the sponsor|1|||
44262399|NCT00684073|79146564|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
44262400|NCT02539368|79148505|FG000|Overall Study|Death|4|||
44262401|NCT02539368|79148506|FG001|Overall Study|Death|2|||
44262402|NCT02539368|79148507|FG002|Overall Study|Death|1|||
44262403|NCT02539368|79148508|FG003|Overall Study|Death|0|||
44262404|NCT02539368|79148509|FG004|Overall Study|Death|0|||
44262405|NCT02539368|79148505|FG000|Overall Study|Withdrawal by Subject|44|||
44262406|NCT02539368|79148506|FG001|Overall Study|Withdrawal by Subject|35|||
44262407|NCT02539368|79148507|FG002|Overall Study|Withdrawal by Subject|9|||
44262408|NCT02539368|79148508|FG003|Overall Study|Withdrawal by Subject|1|||
44262409|NCT02539368|79148509|FG004|Overall Study|Withdrawal by Subject|3|||
44262410|NCT02539368|79148505|FG000|Overall Study|Physician Decision|49|||
44262411|NCT02539368|79148506|FG001|Overall Study|Physician Decision|15|||
44262412|NCT02539368|79148507|FG002|Overall Study|Physician Decision|7|||
44262413|NCT02539368|79148508|FG003|Overall Study|Physician Decision|0|||
44262414|NCT02539368|79148509|FG004|Overall Study|Physician Decision|2|||
44262415|NCT02539368|79148505|FG000|Overall Study|Lost to Follow-up|96|||
44262416|NCT02539368|79148506|FG001|Overall Study|Lost to Follow-up|21|||
44262417|NCT02539368|79148507|FG002|Overall Study|Lost to Follow-up|16|||
44262418|NCT02539368|79148508|FG003|Overall Study|Lost to Follow-up|4|||
44262419|NCT02539368|79148509|FG004|Overall Study|Lost to Follow-up|3|||
44262420|NCT02539368|79148505|FG000|Overall Study|Adverse Event|44|||
44262421|NCT02539368|79148506|FG001|Overall Study|Adverse Event|5|||
44262422|NCT02539368|79148507|FG002|Overall Study|Adverse Event|9|||
44262423|NCT02539368|79148508|FG003|Overall Study|Adverse Event|0|||
44262424|NCT02539368|79148509|FG004|Overall Study|Adverse Event|3|||
44262425|NCT02539368|79148505|FG000|Overall Study|Participant Non-compliant|13|||
44262426|NCT02539368|79148506|FG001|Overall Study|Participant Non-compliant|2|||
44262427|NCT02539368|79148507|FG002|Overall Study|Participant Non-compliant|1|||
44262428|NCT02539368|79148508|FG003|Overall Study|Participant Non-compliant|1|||
44262429|NCT02539368|79148509|FG004|Overall Study|Participant Non-compliant|0|||
44262430|NCT02539368|79148505|FG000|Overall Study|Other|145|||
44262431|NCT02539368|79148506|FG001|Overall Study|Other|18|||
44262432|NCT02539368|79148507|FG002|Overall Study|Other|24|||
44262433|NCT02539368|79148508|FG003|Overall Study|Other|1|||
44262434|NCT02539368|79148509|FG004|Overall Study|Other|3|||
44262435|NCT02539368|79148505|FG000|Overall Study|Missing|10|||
44262436|NCT02539368|79148506|FG001|Overall Study|Missing|3|||
44262437|NCT02539368|79148507|FG002|Overall Study|Missing|0|||
44262438|NCT02539368|79148508|FG003|Overall Study|Missing|0|||
44262439|NCT02539368|79148509|FG004|Overall Study|Missing|0|||
44262440|NCT02539134|79148662|FG000|Overall Study|Lost to Follow-up|1|||
44262441|NCT02539134|79148663|FG001|Overall Study|Lost to Follow-up|0|||
44262442|NCT02539134|79148664|FG002|Overall Study|Lost to Follow-up|0|||
44262443|NCT02539134|79148665|FG003|Overall Study|Lost to Follow-up|0|||
44262444|NCT02539134|79148666|FG004|Overall Study|Lost to Follow-up|0|||
44262445|NCT02539134|79148667|FG005|Overall Study|Lost to Follow-up|0|||
44262446|NCT02538900|79148771|FG000|Overall Study|Death|2|||
44262447|NCT02538900|79148772|FG001|Overall Study|Death|2|||
44262448|NCT02538900|79148773|FG002|Overall Study|Death|2|||
44262449|NCT02538900|79148771|FG000|Overall Study|Withdrawal by Subject|18|||
44262450|NCT02538900|79148772|FG001|Overall Study|Withdrawal by Subject|16|||
44262451|NCT02538900|79148773|FG002|Overall Study|Withdrawal by Subject|15|||
44262452|NCT01986348|79149253|FG000|Overall Study|Death|8|||
44262453|NCT01986348|79149254|FG001|Overall Study|Death|22|||
44262454|NCT01986348|79149255|FG002|Overall Study|Death|10|||
44262455|NCT01986348|79149256|FG003|Overall Study|Death|21|||
44262456|NCT01986348|79149253|FG000|Overall Study|Lost to Follow-up|0|||
44262457|NCT01986348|79149254|FG001|Overall Study|Lost to Follow-up|0|||
44262458|NCT01986348|79149255|FG002|Overall Study|Lost to Follow-up|0|||
44262459|NCT01986348|79149256|FG003|Overall Study|Lost to Follow-up|2|||
44262460|NCT01986348|79149253|FG000|Overall Study|Physician Decision|0|||
44262461|NCT01986348|79149254|FG001|Overall Study|Physician Decision|0|||
44262462|NCT01986348|79149255|FG002|Overall Study|Physician Decision|0|||
44262463|NCT01986348|79149256|FG003|Overall Study|Physician Decision|1|||
44262464|NCT01986348|79149253|FG000|Overall Study|Progressive Disease|0|||
44262465|NCT01986348|79149254|FG001|Overall Study|Progressive Disease|0|||
44262466|NCT01986348|79149255|FG002|Overall Study|Progressive Disease|2|||
44262467|NCT01986348|79149256|FG003|Overall Study|Progressive Disease|0|||
44262468|NCT01986348|79149253|FG000|Overall Study|Withdrawal by Participant|0|||
44262469|NCT01986348|79149254|FG001|Overall Study|Withdrawal by Participant|1|||
44262470|NCT01986348|79149255|FG002|Overall Study|Withdrawal by Participant|2|||
44262471|NCT01986348|79149256|FG003|Overall Study|Withdrawal by Participant|1|||
44262472|NCT01986348|79149253|FG000|Overall Study|Study Terminated by Sponsor|0|||
44262473|NCT01986348|79149254|FG001|Overall Study|Study Terminated by Sponsor|0|||
44262474|NCT01986348|79149255|FG002|Overall Study|Study Terminated by Sponsor|0|||
44262475|NCT01986348|79149256|FG003|Overall Study|Study Terminated by Sponsor|3|||
44262476|NCT01986348|79149253|FG000|Overall Study|Other-unspecified|0|||
44262477|NCT01986348|79149254|FG001|Overall Study|Other-unspecified|1|||
44262478|NCT01986348|79149255|FG002|Overall Study|Other-unspecified|0|||
44262479|NCT01986348|79149256|FG003|Overall Study|Other-unspecified|2|||
44262480|NCT02543892|79149829|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
44262481|NCT02543892|79149830|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
44262482|NCT02543892|79149831|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
44262483|NCT02543892|79149832|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
44262484|NCT02543892|79149833|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
44262485|NCT02543892|79149834|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
44262486|NCT02543892|79149835|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
44262487|NCT02543892|79149836|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
44262488|NCT02543892|79149829|FG000|Received Vaccination 2|Physician Decision|0|||
44262489|NCT02543892|79149830|FG001|Received Vaccination 2|Physician Decision|0|||
44262490|NCT02543892|79149831|FG002|Received Vaccination 2|Physician Decision|0|||
44262491|NCT02543892|79149832|FG003|Received Vaccination 2|Physician Decision|0|||
44262492|NCT02543892|79149833|FG004|Received Vaccination 2|Physician Decision|0|||
44262493|NCT02543892|79149834|FG005|Received Vaccination 2|Physician Decision|1|||
44262494|NCT02543892|79149835|FG006|Received Vaccination 2|Physician Decision|0|||
44262495|NCT02543892|79149836|FG007|Received Vaccination 2|Physician Decision|0|||
44262496|NCT02543892|79149829|FG000|Received Vaccination 2|Adverse Event|0|||
44262497|NCT02543892|79149830|FG001|Received Vaccination 2|Adverse Event|1|||
44262498|NCT02543892|79149831|FG002|Received Vaccination 2|Adverse Event|0|||
44262499|NCT02543892|79149832|FG003|Received Vaccination 2|Adverse Event|0|||
44262500|NCT02543892|79149833|FG004|Received Vaccination 2|Adverse Event|0|||
44262501|NCT02543892|79149834|FG005|Received Vaccination 2|Adverse Event|0|||
44262502|NCT02543892|79149835|FG006|Received Vaccination 2|Adverse Event|0|||
44262503|NCT02543892|79149836|FG007|Received Vaccination 2|Adverse Event|0|||
44262504|NCT02543892|79149829|FG000|Had Immunology Data|Withdrawal by Subject|0|||
44262505|NCT02543892|79149830|FG001|Had Immunology Data|Withdrawal by Subject|0|||
44262506|NCT02543892|79149831|FG002|Had Immunology Data|Withdrawal by Subject|0|||
44262507|NCT02543892|79149832|FG003|Had Immunology Data|Withdrawal by Subject|0|||
44262508|NCT02543892|79149833|FG004|Had Immunology Data|Withdrawal by Subject|0|||
44262509|NCT02543892|79149834|FG005|Had Immunology Data|Withdrawal by Subject|0|||
44262510|NCT02543892|79149835|FG006|Had Immunology Data|Withdrawal by Subject|1|||
44262511|NCT02543892|79149836|FG007|Had Immunology Data|Withdrawal by Subject|0|||
44262512|NCT02543658|79149917|FG000|Overall Study|Lack of Efficacy|0|||
44262513|NCT02543658|79149918|FG001|Overall Study|Lack of Efficacy|4|||
44262514|NCT01607892|79150673|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
44262515|NCT01607892|79150674|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
44262516|NCT01607892|79150675|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
44262517|NCT01607892|79150676|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
44262518|NCT01607892|79150677|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
44262519|NCT01607892|79150673|FG000|Overall Study|Death|4|||
44262520|NCT01607892|79150674|FG001|Overall Study|Death|2|||
44262521|NCT01607892|79150675|FG002|Overall Study|Death|8|||
44262522|NCT01607892|79150676|FG003|Overall Study|Death|10|||
44262523|NCT01607892|79150677|FG004|Overall Study|Death|3|||
44262524|NCT01607892|79150673|FG000|Overall Study|Investigator discretion|2|||
44262525|NCT01607892|79150674|FG001|Overall Study|Investigator discretion|4|||
44262526|NCT01607892|79150675|FG002|Overall Study|Investigator discretion|4|||
44262527|NCT01607892|79150676|FG003|Overall Study|Investigator discretion|8|||
44262528|NCT01607892|79150677|FG004|Overall Study|Investigator discretion|0|||
44262529|NCT01607892|79150673|FG000|Overall Study|Other treatments became available|1|||
44262530|NCT01607892|79150674|FG001|Overall Study|Other treatments became available|1|||
44262531|NCT01607892|79150675|FG002|Overall Study|Other treatments became available|0|||
44262532|NCT01607892|79150676|FG003|Overall Study|Other treatments became available|0|||
44262533|NCT01607892|79150677|FG004|Overall Study|Other treatments became available|2|||
44262534|NCT01607892|79150673|FG000|Overall Study|Intercurrent illness|1|||
44262535|NCT01607892|79150674|FG001|Overall Study|Intercurrent illness|0|||
44262536|NCT01607892|79150675|FG002|Overall Study|Intercurrent illness|0|||
44262537|NCT01607892|79150676|FG003|Overall Study|Intercurrent illness|3|||
44262538|NCT01607892|79150677|FG004|Overall Study|Intercurrent illness|0|||
44262539|NCT01607892|79150673|FG000|Overall Study|Non-Compliance with study procedures|0|||
44262540|NCT01607892|79150674|FG001|Overall Study|Non-Compliance with study procedures|0|||
44262541|NCT01607892|79150675|FG002|Overall Study|Non-Compliance with study procedures|1|||
44262542|NCT01607892|79150676|FG003|Overall Study|Non-Compliance with study procedures|0|||
44262543|NCT01607892|79150677|FG004|Overall Study|Non-Compliance with study procedures|0|||
44262544|NCT01607892|79150673|FG000|Overall Study|Consent withdrawn by participant|9|||
44262545|NCT01607892|79150674|FG001|Overall Study|Consent withdrawn by participant|4|||
44262546|NCT01607892|79150675|FG002|Overall Study|Consent withdrawn by participant|24|||
44262547|NCT01607892|79150676|FG003|Overall Study|Consent withdrawn by participant|14|||
44262548|NCT01607892|79150677|FG004|Overall Study|Consent withdrawn by participant|4|||
44262549|NCT01607892|79150673|FG000|Overall Study|Disease progression|38|||
44262550|NCT01607892|79150674|FG001|Overall Study|Disease progression|13|||
44262551|NCT01607892|79150675|FG002|Overall Study|Disease progression|37|||
44262552|NCT01607892|79150676|FG003|Overall Study|Disease progression|57|||
44262553|NCT01607892|79150677|FG004|Overall Study|Disease progression|9|||
44262554|NCT01607892|79150673|FG000|Overall Study|Incidence or severity of Adverse events|3|||
44262555|NCT01607892|79150674|FG001|Overall Study|Incidence or severity of Adverse events|3|||
44262556|NCT01607892|79150675|FG002|Overall Study|Incidence or severity of Adverse events|7|||
44262557|NCT01607892|79150676|FG003|Overall Study|Incidence or severity of Adverse events|2|||
44262558|NCT01607892|79150677|FG004|Overall Study|Incidence or severity of Adverse events|6|||
44262559|NCT02530242|79150723|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
44262560|NCT02530242|79150724|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
44262561|NCT02537574|79150748|FG000|Overall Study|Adverse Event|1|||
44262562|NCT02537574|79150749|FG001|Overall Study|Adverse Event|3|||
44262563|NCT02537574|79150750|FG002|Overall Study|Adverse Event|2|||
44262564|NCT02537574|79150748|FG000|Overall Study|Lost to Follow-up|40|||
44262565|NCT02537574|79150749|FG001|Overall Study|Lost to Follow-up|51|||
44262566|NCT02537574|79150750|FG002|Overall Study|Lost to Follow-up|55|||
44262567|NCT02537574|79150748|FG000|Overall Study|Noncompliance with study drug|0|||
44262568|NCT02537574|79150749|FG001|Overall Study|Noncompliance with study drug|1|||
44262569|NCT02537574|79150750|FG002|Overall Study|Noncompliance with study drug|1|||
44262570|NCT02537574|79150748|FG000|Overall Study|Physician Decision|2|||
44262571|NCT02537574|79150749|FG001|Overall Study|Physician Decision|0|||
44262572|NCT02537574|79150750|FG002|Overall Study|Physician Decision|0|||
44262573|NCT02537574|79150748|FG000|Overall Study|Protocol Violation|4|||
44262574|NCT02537574|79150749|FG001|Overall Study|Protocol Violation|2|||
44262575|NCT02537574|79150750|FG002|Overall Study|Protocol Violation|3|||
44262576|NCT02537574|79150748|FG000|Overall Study|Withdrawal by Subject|37|||
44262577|NCT02537574|79150749|FG001|Overall Study|Withdrawal by Subject|27|||
44262578|NCT02537574|79150750|FG002|Overall Study|Withdrawal by Subject|29|||
44262579|NCT02537574|79150748|FG000|Overall Study|Lack of Efficacy|14|||
44143666|NCT00271817|78932989|FG001|Part 1|Withdrawal by Subject|17|||
44262580|NCT02537574|79150749|FG001|Overall Study|Lack of Efficacy|16|||
44262581|NCT02537574|79150750|FG002|Overall Study|Lack of Efficacy|15|||
44262582|NCT02537574|79150748|FG000|Overall Study|Duplicate Patient|1|||
44262583|NCT02537574|79150749|FG001|Overall Study|Duplicate Patient|0|||
44262584|NCT02537574|79150750|FG002|Overall Study|Duplicate Patient|0|||
44262585|NCT02537574|79150748|FG000|Overall Study|Patient not Stable|0|||
44262586|NCT02537574|79150749|FG001|Overall Study|Patient not Stable|1|||
44262587|NCT02537574|79150750|FG002|Overall Study|Patient not Stable|0|||
44262588|NCT02537574|79150748|FG000|Overall Study|Incarceration|0|||
44262589|NCT02537574|79150749|FG001|Overall Study|Incarceration|1|||
44262590|NCT02537574|79150750|FG002|Overall Study|Incarceration|0|||
44262591|NCT02537574|79150748|FG000|Overall Study|Failed Naloxone Challenge|0|||
44262592|NCT02537574|79150749|FG001|Overall Study|Failed Naloxone Challenge|1|||
44262593|NCT02537574|79150750|FG002|Overall Study|Failed Naloxone Challenge|0|||
44262594|NCT02537574|79150748|FG000|Overall Study|Transportation Issues|0|||
44262595|NCT02537574|79150749|FG001|Overall Study|Transportation Issues|0|||
44262596|NCT02537574|79150750|FG002|Overall Study|Transportation Issues|1|||
44262597|NCT02537574|79150748|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
44262598|NCT02537574|79150749|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
44262599|NCT02537574|79150750|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
44262600|NCT02537574|79150748|FG000|Overall Study|Noncompliance with Protocol|0|||
44262601|NCT02537574|79150749|FG001|Overall Study|Noncompliance with Protocol|0|||
44262602|NCT02537574|79150750|FG002|Overall Study|Noncompliance with Protocol|1|||
44262603|NCT02531802|79151402|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
44262604|NCT02531802|79151403|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
44262605|NCT02531802|79151404|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
44262606|NCT02531802|79151405|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
44262607|NCT02531802|79151406|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
44262608|NCT02531802|79151407|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
44262609|NCT02531802|79151408|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
44262610|NCT02531802|79151409|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
44262611|NCT02531802|79151410|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
44262612|NCT02531802|79151411|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
44262613|NCT02531802|79151412|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
44262614|NCT02531802|79151413|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
44262615|NCT02531802|79151414|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
44262616|NCT02531802|79151415|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
44262617|NCT02531802|79151416|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
44262618|NCT02531802|79151417|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
44262619|NCT02531802|79151418|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
44262620|NCT02531802|79151419|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
44262621|NCT02531802|79151420|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
44262622|NCT02531802|79151421|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
44262623|NCT02531802|79151422|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
44262624|NCT02531802|79151402|FG000|Received Vaccination 2|Physician Decision|0|||
44262625|NCT02531802|79151403|FG001|Received Vaccination 2|Physician Decision|0|||
44262626|NCT02531802|79151404|FG002|Received Vaccination 2|Physician Decision|0|||
44262627|NCT02531802|79151405|FG003|Received Vaccination 2|Physician Decision|0|||
44262628|NCT02531802|79151406|FG004|Received Vaccination 2|Physician Decision|0|||
44262629|NCT02531802|79151407|FG005|Received Vaccination 2|Physician Decision|1|||
44262630|NCT02531802|79151408|FG006|Received Vaccination 2|Physician Decision|0|||
44262631|NCT02531802|79151409|FG007|Received Vaccination 2|Physician Decision|0|||
44262632|NCT02531802|79151410|FG008|Received Vaccination 2|Physician Decision|0|||
44262633|NCT02531802|79151411|FG009|Received Vaccination 2|Physician Decision|2|||
44262634|NCT02531802|79151412|FG010|Received Vaccination 2|Physician Decision|0|||
44262635|NCT02531802|79151413|FG011|Received Vaccination 2|Physician Decision|0|||
44262636|NCT02531802|79151414|FG012|Received Vaccination 2|Physician Decision|0|||
44262637|NCT02531802|79151415|FG013|Received Vaccination 2|Physician Decision|1|||
44262638|NCT02531802|79151416|FG014|Received Vaccination 2|Physician Decision|0|||
44262639|NCT02531802|79151417|FG015|Received Vaccination 2|Physician Decision|0|||
44262640|NCT02531802|79151418|FG016|Received Vaccination 2|Physician Decision|0|||
44262641|NCT02531802|79151419|FG017|Received Vaccination 2|Physician Decision|1|||
44262642|NCT02531802|79151420|FG018|Received Vaccination 2|Physician Decision|0|||
44262643|NCT02531802|79151421|FG019|Received Vaccination 2|Physician Decision|0|||
44262644|NCT02531802|79151422|FG020|Received Vaccination 2|Physician Decision|0|||
44262645|NCT02531802|79151402|FG000|Received Vaccination 2|Adverse Event|0|||
44262646|NCT02531802|79151403|FG001|Received Vaccination 2|Adverse Event|0|||
44262647|NCT02531802|79151404|FG002|Received Vaccination 2|Adverse Event|0|||
44262648|NCT02531802|79151405|FG003|Received Vaccination 2|Adverse Event|0|||
44262649|NCT02531802|79151406|FG004|Received Vaccination 2|Adverse Event|0|||
44262650|NCT02531802|79151407|FG005|Received Vaccination 2|Adverse Event|2|||
44262651|NCT02531802|79151408|FG006|Received Vaccination 2|Adverse Event|0|||
44262652|NCT02531802|79151409|FG007|Received Vaccination 2|Adverse Event|0|||
44262653|NCT02531802|79151410|FG008|Received Vaccination 2|Adverse Event|0|||
44262654|NCT02531802|79151411|FG009|Received Vaccination 2|Adverse Event|0|||
44262655|NCT02531802|79151412|FG010|Received Vaccination 2|Adverse Event|0|||
44262656|NCT02531802|79151413|FG011|Received Vaccination 2|Adverse Event|0|||
44262657|NCT02531802|79151414|FG012|Received Vaccination 2|Adverse Event|0|||
44262658|NCT02531802|79151415|FG013|Received Vaccination 2|Adverse Event|0|||
44262659|NCT02531802|79151416|FG014|Received Vaccination 2|Adverse Event|0|||
44262660|NCT02531802|79151417|FG015|Received Vaccination 2|Adverse Event|0|||
44262661|NCT02531802|79151418|FG016|Received Vaccination 2|Adverse Event|0|||
44262662|NCT02531802|79151419|FG017|Received Vaccination 2|Adverse Event|2|||
44262663|NCT02531802|79151420|FG018|Received Vaccination 2|Adverse Event|1|||
44262664|NCT02531802|79151421|FG019|Received Vaccination 2|Adverse Event|0|||
44262665|NCT02531802|79151422|FG020|Received Vaccination 2|Adverse Event|1|||
44262666|NCT02531802|79151402|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
44262667|NCT02531802|79151403|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
44262668|NCT02531802|79151404|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
44262669|NCT02531802|79151405|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
44262670|NCT02531802|79151406|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
44262671|NCT02531802|79151407|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
44262672|NCT02531802|79151408|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
44262673|NCT02531802|79151409|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
44262674|NCT02531802|79151410|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
44262675|NCT02531802|79151411|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
44262676|NCT02531802|79151412|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
44262677|NCT02531802|79151413|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
44262678|NCT02531802|79151414|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
44262679|NCT02531802|79151415|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
44262680|NCT02531802|79151416|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
44262681|NCT02531802|79151417|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
44262682|NCT02531802|79151418|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
44262683|NCT02531802|79151419|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
44262684|NCT02531802|79151420|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
44262685|NCT02531802|79151421|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
44262686|NCT02531802|79151422|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
44262687|NCT02531646|79151526|FG000|Overall Study|equip. image processing issue|5|||
44262688|NCT02531646|79151527|FG001|Overall Study|equip. image processing issue|1|||
44262689|NCT02531646|79151528|FG002|Overall Study|equip. image processing issue|0|||
44262690|NCT02536404|79151593|FG000|Overall Study|Adverse Event|5|||
44262691|NCT02536404|79151594|FG001|Overall Study|Adverse Event|0|||
44262692|NCT02536404|79151593|FG000|Overall Study|Withdrawal by Subject|4|||
44262693|NCT02536404|79151594|FG001|Overall Study|Withdrawal by Subject|1|||
44262694|NCT02536404|79151593|FG000|Overall Study|Physician Decision|10|||
44262695|NCT02536404|79151594|FG001|Overall Study|Physician Decision|0|||
44262696|NCT02536404|79151593|FG000|Overall Study|Sponsor decision|1|||
44262697|NCT02536404|79151594|FG001|Overall Study|Sponsor decision|0|||
44262698|NCT01659996|79152554|FG000|Overall Study|Protocol Violation|3|||
44262699|NCT01659996|79152555|FG001|Overall Study|Protocol Violation|3|||
44262700|NCT01659996|79152556|FG002|Overall Study|Protocol Violation|3|||
44262701|NCT01659996|79152554|FG000|Overall Study|Lost to Follow-up|1|||
44262702|NCT01659996|79152555|FG001|Overall Study|Lost to Follow-up|3|||
44262703|NCT01659996|79152556|FG002|Overall Study|Lost to Follow-up|2|||
44262704|NCT01659996|79152554|FG000|Overall Study|Adverse Event|0|||
44262705|NCT01659996|79152555|FG001|Overall Study|Adverse Event|0|||
44262706|NCT01659996|79152556|FG002|Overall Study|Adverse Event|1|||
44262707|NCT01659996|79152554|FG000|Overall Study|Withdrawal by Subject|4|||
44262708|NCT01659996|79152555|FG001|Overall Study|Withdrawal by Subject|1|||
44262709|NCT01659996|79152556|FG002|Overall Study|Withdrawal by Subject|5|||
44262710|NCT02525874|79152915|FG000|Overall Study|Other|1|||
44262711|NCT02525874|79152915|FG000|Overall Study|Investigator Decision|1|||
44262712|NCT02525874|79152915|FG000|Overall Study|Consent withdrawn|22|||
44262713|NCT02525874|79152915|FG000|Overall Study|Non-compliance with study drug|3|||
44262714|NCT02525874|79152915|FG000|Overall Study|Adverse Event|17|||
44262715|NCT02525874|79152915|FG000|Overall Study|Lost to Follow-up|7|||
44262716|NCT02525874|79152915|FG000|Overall Study|Disease progression, defined by protocol|2|||
44262717|NCT02525874|79152915|FG000|Overall Study|Disease relapse|4|||
44262718|NCT02525874|79152915|FG000|Overall Study|Alternative Treatment for MS|2|||
44262719|NCT02525874|79152915|FG000|Overall Study|New lesions in Brain|1|||
44262720|NCT02528214|79152925|FG000|Overall Study|Protocol Violation|0|||
44262721|NCT02528214|79152926|FG001|Overall Study|Protocol Violation|1|||
44262722|NCT02528214|79152925|FG000|Overall Study|Adverse Event|0|||
44262723|NCT02528214|79152926|FG001|Overall Study|Adverse Event|1|||
44262724|NCT02528214|79152925|FG000|Overall Study|Other than specified above|0|||
44262725|NCT02528214|79152926|FG001|Overall Study|Other than specified above|1|||
44262726|NCT05348681|79152970|FG000|Overall Study|Study terminated by Sponsor|8|||
44262727|NCT05348681|79152971|FG001|Overall Study|Study terminated by Sponsor|3|||
44262728|NCT05348681|79152970|FG000|Overall Study|Withdrawal by Subject|1|||
44262729|NCT05348681|79152971|FG001|Overall Study|Withdrawal by Subject|1|||
44262730|NCT05348681|79152970|FG000|Overall Study|Lost to Follow-up|1|||
44262731|NCT05348681|79152971|FG001|Overall Study|Lost to Follow-up|1|||
44262732|NCT05348681|79152970|FG000|Overall Study|Adverse Event|1|||
44262733|NCT05348681|79152971|FG001|Overall Study|Adverse Event|0|||
44262734|NCT05348681|79152970|FG000|Overall Study|Other|2|||
44262735|NCT05348681|79152971|FG001|Overall Study|Other|1|||
44262736|NCT04423757|79152997|FG000|Overall Study|Adverse Event|2|||
44262737|NCT04423757|79152998|FG001|Overall Study|Adverse Event|0|||
44262738|NCT04423757|79152997|FG000|Overall Study|Not treated|1|||
44262739|NCT04423757|79152998|FG001|Overall Study|Not treated|1|||
44262740|NCT04379713|79153006|FG000|Overall Study|Adverse Event|2|||
44262741|NCT04379713|79153007|FG001|Overall Study|Adverse Event|0|||
44262742|NCT04379713|79153006|FG000|Overall Study|Physician Decision|2|||
44262743|NCT04379713|79153007|FG001|Overall Study|Physician Decision|1|||
44262744|NCT04379713|79153006|FG000|Overall Study|Protocol Violation|11|||
44262745|NCT04379713|79153007|FG001|Overall Study|Protocol Violation|6|||
44262746|NCT04379713|79153006|FG000|Overall Study|No longer met eligibility criteria|14|||
44262747|NCT04379713|79153007|FG001|Overall Study|No longer met eligibility criteria|11|||
44262748|NCT04379713|79153006|FG000|Overall Study|Withdrawal by parent/guardian|36|||
44262749|NCT04379713|79153007|FG001|Overall Study|Withdrawal by parent/guardian|15|||
44262750|NCT04379713|79153006|FG000|Overall Study|Lost to Follow-up|31|||
44262751|NCT04379713|79153007|FG001|Overall Study|Lost to Follow-up|21|||
44262752|NCT04085328|79153015|FG000|Overall Study|Witihdrew Consent|16|||
44262753|NCT04085328|79153016|FG001|Overall Study|Witihdrew Consent|16|||
44262754|NCT04085328|79153015|FG000|Overall Study|Adverse Event|8|||
44262755|NCT04085328|79153016|FG001|Overall Study|Adverse Event|7|||
44262756|NCT04085328|79153015|FG000|Overall Study|Lost to Follow-up|7|||
44262757|NCT04085328|79153016|FG001|Overall Study|Lost to Follow-up|2|||
44262758|NCT04085328|79153015|FG000|Overall Study|Physician Decision|0|||
44262759|NCT04085328|79153016|FG001|Overall Study|Physician Decision|1|||
44262760|NCT04085328|79153015|FG000|Overall Study|Pregnancy|0|||
44262761|NCT04085328|79153016|FG001|Overall Study|Pregnancy|1|||
44262762|NCT04085328|79153015|FG000|Overall Study|Reasons Related to COVID-19|5|||
44262763|NCT04085328|79153016|FG001|Overall Study|Reasons Related to COVID-19|8|||
44262764|NCT04085328|79153015|FG000|Overall Study|Did not meet inclusion criteria|1|||
44262765|NCT04085328|79153016|FG001|Overall Study|Did not meet inclusion criteria|1|||
44262766|NCT04085328|79153015|FG000|Overall Study|Early termination|1|||
44262767|NCT04085328|79153016|FG001|Overall Study|Early termination|0|||
44262768|NCT03074474|79153047|FG000|Overall Study|Lost to Follow-up|10|||
44262769|NCT03074474|79153047|FG000|Overall Study|Withdrawal by Subject|10|||
44262770|NCT03074474|79153047|FG000|Overall Study|Death|4|||
44262771|NCT03074474|79153047|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
44262772|NCT02744391|79153056|FG000|Overall Study|Lost to Follow-up|9|||
44262773|NCT02744391|79153056|FG000|Overall Study|Physician Decision|2|||
44262774|NCT02744391|79153056|FG000|Overall Study|Withdrawal by Subject|3|||
44262775|NCT02462837|79153062|FG000|Overall Study|pt developed hives|1|||
44262776|NCT02462837|79153063|FG001|Overall Study|pt developed hives|0|||
44262777|NCT02462837|79153062|FG000|Overall Study|Withdrawal by Subject|1|||
44262778|NCT02462837|79153063|FG001|Overall Study|Withdrawal by Subject|0|||
44262779|NCT02346201|79153071|FG000|Overall Study|Adverse Event|3|||
44262780|NCT02346201|79153072|FG001|Overall Study|Adverse Event|2|||
44262781|NCT02346201|79153071|FG000|Overall Study|Lost to Follow-up|1|||
44262782|NCT02346201|79153072|FG001|Overall Study|Lost to Follow-up|0|||
44262783|NCT02346201|79153071|FG000|Overall Study|Withdrawal by Subject|6|||
44262784|NCT02346201|79153072|FG001|Overall Study|Withdrawal by Subject|3|||
44262785|NCT02346201|79153071|FG000|Overall Study|Unavailable for future follow-up|0|||
44262786|NCT02346201|79153072|FG001|Overall Study|Unavailable for future follow-up|1|||
44262787|NCT02346201|79153071|FG000|Overall Study|Physician Decision|0|||
44262788|NCT02346201|79153072|FG001|Overall Study|Physician Decision|1|||
44262789|NCT02346201|79153071|FG000|Overall Study|Missed final visit|0|||
44262790|NCT02346201|79153072|FG001|Overall Study|Missed final visit|2|||
44262791|NCT01866930|79153092|FG000|Treatment Period|Other|1|||
44262792|NCT01866930|79153093|FG001|Treatment Period|Other|0|||
44262793|NCT01866930|79153092|FG000|Treatment Period|Death|0|||
44262794|NCT01866930|79153093|FG001|Treatment Period|Death|2|||
44262795|NCT01866930|79153092|FG000|Treatment Period|Poor/non compliance|0|||
44262796|NCT01866930|79153093|FG001|Treatment Period|Poor/non compliance|2|||
44262797|NCT01866930|79153092|FG000|Treatment Period|No longer meets study criteria|0|||
44262798|NCT01866930|79153093|FG001|Treatment Period|No longer meets study criteria|1|||
44262799|NCT01866930|79153092|FG000|Treatment Period|Withdrawal by Subject|2|||
44262800|NCT01866930|79153093|FG001|Treatment Period|Withdrawal by Subject|8|||
44262801|NCT01866930|79153092|FG000|Treatment Period|Lack of Efficacy|1|||
44262802|NCT01866930|79153093|FG001|Treatment Period|Lack of Efficacy|9|||
44262803|NCT01866930|79153092|FG000|Treatment Period|Adverse Event|4|||
44262804|NCT01866930|79153093|FG001|Treatment Period|Adverse Event|12|||
44262805|NCT01866930|79153092|FG000|Treatment Period|Lost to Follow-up|1|||
44262806|NCT01866930|79153093|FG001|Treatment Period|Lost to Follow-up|1|||
44262807|NCT01866930|79153092|FG000|Follow-up Period|Lost to Follow-up|1|||
44262808|NCT01866930|79153093|FG001|Follow-up Period|Lost to Follow-up|1|||
44262809|NCT01866930|79153092|FG000|Follow-up Period|Other|1|||
44262810|NCT01866930|79153093|FG001|Follow-up Period|Other|5|||
44262811|NCT01866930|79153092|FG000|Follow-up Period|No longer required per protocol|1|||
44262812|NCT01866930|79153093|FG001|Follow-up Period|No longer required per protocol|0|||
44262813|NCT01866930|79153092|FG000|Follow-up Period|Withdrawal by Subject|3|||
44262814|NCT01866930|79153093|FG001|Follow-up Period|Withdrawal by Subject|3|||
44262815|NCT01621568|79153101|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
44262816|NCT01621568|79153102|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
44262817|NCT01621568|79153101|FG000|Week 5-6 No Treatment|Death|1|||
44262818|NCT01621568|79153102|FG001|Week 5-6 No Treatment|Death|0|||
44262819|NCT00813293|79153122|FG000|Overall Study|Intercurrent illness|1|||
44262820|NCT00813293|79153123|FG001|Overall Study|Intercurrent illness|0|||
44262821|NCT00813293|79153122|FG000|Overall Study|Adverse Event|0|||
44262822|NCT00813293|79153123|FG001|Overall Study|Adverse Event|1|||
44262823|NCT00481091|79153139|FG000|Overall Study|Withdrawal by Subject|0|||
44262824|NCT00481091|79153140|FG001|Overall Study|Withdrawal by Subject|1|||
44262825|NCT00481091|79153141|FG002|Overall Study|Withdrawal by Subject|1|||
44262826|NCT00481091|79153142|FG003|Overall Study|Withdrawal by Subject|0|||
44262827|NCT00481091|79153143|FG004|Overall Study|Withdrawal by Subject|0|||
44262828|NCT00481091|79153144|FG005|Overall Study|Withdrawal by Subject|0|||
44262829|NCT00481091|79153145|FG006|Overall Study|Withdrawal by Subject|0|||
44262830|NCT00481091|79153146|FG007|Overall Study|Withdrawal by Subject|0|||
44262831|NCT00481091|79153147|FG008|Overall Study|Withdrawal by Subject|1|||
44262832|NCT00481091|79153148|FG009|Overall Study|Withdrawal by Subject|6|||
44262833|NCT00481091|79153139|FG000|Overall Study|Other, Not Specified|0|||
44262834|NCT00481091|79153140|FG001|Overall Study|Other, Not Specified|1|||
44262835|NCT00481091|79153141|FG002|Overall Study|Other, Not Specified|1|||
44262836|NCT00481091|79153142|FG003|Overall Study|Other, Not Specified|0|||
44262837|NCT00481091|79153143|FG004|Overall Study|Other, Not Specified|0|||
44262838|NCT00481091|79153144|FG005|Overall Study|Other, Not Specified|1|||
44262839|NCT00481091|79153145|FG006|Overall Study|Other, Not Specified|0|||
44262840|NCT00481091|79153146|FG007|Overall Study|Other, Not Specified|0|||
44262841|NCT00481091|79153147|FG008|Overall Study|Other, Not Specified|0|||
44262842|NCT00481091|79153148|FG009|Overall Study|Other, Not Specified|4|||
44262843|NCT00481091|79153139|FG000|Overall Study|Adverse Event|1|||
44262844|NCT00481091|79153140|FG001|Overall Study|Adverse Event|2|||
44262845|NCT00481091|79153141|FG002|Overall Study|Adverse Event|0|||
44262846|NCT00481091|79153142|FG003|Overall Study|Adverse Event|1|||
44262847|NCT00481091|79153143|FG004|Overall Study|Adverse Event|1|||
44262848|NCT00481091|79153144|FG005|Overall Study|Adverse Event|1|||
44262849|NCT00481091|79153145|FG006|Overall Study|Adverse Event|2|||
44262850|NCT00481091|79153146|FG007|Overall Study|Adverse Event|1|||
44262851|NCT00481091|79153147|FG008|Overall Study|Adverse Event|1|||
44262852|NCT00481091|79153148|FG009|Overall Study|Adverse Event|6|||
44262853|NCT00481091|79153139|FG000|Overall Study|Progressive disease clinical|0|||
44262854|NCT00481091|79153140|FG001|Overall Study|Progressive disease clinical|0|||
44262855|NCT00481091|79153141|FG002|Overall Study|Progressive disease clinical|0|||
44262856|NCT00481091|79153142|FG003|Overall Study|Progressive disease clinical|0|||
44262857|NCT00481091|79153143|FG004|Overall Study|Progressive disease clinical|0|||
44262858|NCT00481091|79153144|FG005|Overall Study|Progressive disease clinical|0|||
44262859|NCT00481091|79153145|FG006|Overall Study|Progressive disease clinical|0|||
44262860|NCT00481091|79153146|FG007|Overall Study|Progressive disease clinical|0|||
44262861|NCT00481091|79153147|FG008|Overall Study|Progressive disease clinical|1|||
44262862|NCT00481091|79153148|FG009|Overall Study|Progressive disease clinical|7|||
44262863|NCT00481091|79153139|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
44262864|NCT00481091|79153140|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
44262865|NCT00481091|79153141|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262866|NCT00481091|79153142|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262867|NCT00481091|79153143|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262868|NCT00481091|79153144|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
44262869|NCT00481091|79153145|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262870|NCT00481091|79153146|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262871|NCT00481091|79153147|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262872|NCT00481091|79153148|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
44262873|NCT00481091|79153139|FG000|Overall Study|Progressive disease other|1|||
44262874|NCT00481091|79153140|FG001|Overall Study|Progressive disease other|1|||
44262875|NCT00481091|79153141|FG002|Overall Study|Progressive disease other|0|||
44262876|NCT00481091|79153142|FG003|Overall Study|Progressive disease other|1|||
44262877|NCT00481091|79153143|FG004|Overall Study|Progressive disease other|1|||
44262878|NCT00481091|79153144|FG005|Overall Study|Progressive disease other|1|||
44262879|NCT00481091|79153145|FG006|Overall Study|Progressive disease other|0|||
44262880|NCT00481091|79153146|FG007|Overall Study|Progressive disease other|2|||
44262881|NCT00481091|79153147|FG008|Overall Study|Progressive disease other|0|||
44262882|NCT00481091|79153148|FG009|Overall Study|Progressive disease other|0|||
44262883|NCT00481091|79153139|FG000|Overall Study|No reason given|0|||
44262884|NCT00481091|79153140|FG001|Overall Study|No reason given|0|||
44262885|NCT00481091|79153141|FG002|Overall Study|No reason given|1|||
44262886|NCT00481091|79153142|FG003|Overall Study|No reason given|1|||
44262887|NCT00481091|79153143|FG004|Overall Study|No reason given|1|||
44262888|NCT00481091|79153144|FG005|Overall Study|No reason given|0|||
44262889|NCT00481091|79153145|FG006|Overall Study|No reason given|1|||
44262890|NCT00481091|79153146|FG007|Overall Study|No reason given|1|||
44262891|NCT00481091|79153147|FG008|Overall Study|No reason given|1|||
44262892|NCT00481091|79153148|FG009|Overall Study|No reason given|4|||
44262893|NCT00003641|79153179|FG000|Overall Study|Withdrawal by Subject|0|||
44262894|NCT00003641|79153180|FG001|Overall Study|Withdrawal by Subject|100|||
44262895|NCT00003641|79153179|FG000|Overall Study|Adverse Event|0|||
44262896|NCT00003641|79153180|FG001|Overall Study|Adverse Event|38|||
44262897|NCT00003641|79153179|FG000|Overall Study|Disease progression|0|||
44262898|NCT00003641|79153180|FG001|Overall Study|Disease progression|2|||
44262899|NCT00003641|79153179|FG000|Overall Study|Unknown/missing|0|||
44262900|NCT00003641|79153180|FG001|Overall Study|Unknown/missing|22|||
44262901|NCT00003641|79153179|FG000|Overall Study|Should not receive interferon therapy|2|||
44262902|NCT00003641|79153180|FG001|Overall Study|Should not receive interferon therapy|0|||
44262903|NCT00003641|79153179|FG000|Overall Study|Never started interferon|567|||
44262904|NCT00003641|79153180|FG001|Overall Study|Never started interferon|12|||
44262905|NCT02524158|79153210|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
44262906|NCT02524158|79153211|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
44262907|NCT02524158|79153210|FG000|12-weeks Assessment|Lost to Follow-up|18|||
44262908|NCT02524158|79153211|FG001|12-weeks Assessment|Lost to Follow-up|12|||
44262909|NCT02524158|79153210|FG000|6-month Assessment|Withdrawal by Subject|1|||
44262910|NCT02524158|79153211|FG001|6-month Assessment|Withdrawal by Subject|1|||
44262911|NCT02524158|79153210|FG000|6-month Assessment|Lost to Follow-up|21|||
44262912|NCT02524158|79153211|FG001|6-month Assessment|Lost to Follow-up|20|||
44262913|NCT02525094|79153231|FG000|Overall Study|Lost to Follow-up|2|||
44262914|NCT02525094|79153232|FG001|Overall Study|Lost to Follow-up|1|||
44262915|NCT02525094|79153231|FG000|Overall Study|Withdrawal by Subject|5|||
44262916|NCT02525094|79153232|FG001|Overall Study|Withdrawal by Subject|6|||
44262917|NCT02525094|79153231|FG000|Overall Study|Not Treated|1|||
44262918|NCT02525094|79153232|FG001|Overall Study|Not Treated|1|||
44262919|NCT01657266|79153389|FG000|Overall Study|Lost to Follow-up|2|||
44262920|NCT01657266|79153390|FG001|Overall Study|Lost to Follow-up|2|||
44262921|NCT01657266|79153389|FG000|Overall Study|Adverse Event|2|||
44262922|NCT01657266|79153390|FG001|Overall Study|Adverse Event|3|||
44262923|NCT01657032|79153444|FG000|Overall Study|Lost to Follow-up|0|||
44262924|NCT01657032|79153445|FG001|Overall Study|Lost to Follow-up|7|||
44262925|NCT01657500|79153548|FG000|Overall Study|set impropperly matched|3|||
44262926|NCT01657500|79153549|FG001|Overall Study|set impropperly matched|3|||
44262927|NCT01657500|79153548|FG000|Overall Study|Lost to Follow-up|2|||
44262928|NCT01657500|79153549|FG001|Overall Study|Lost to Follow-up|2|||
44262929|NCT01658904|79153562|FG000|Overall Study|Principal Investigator discretion|2|||
44262930|NCT01658904|79153563|FG001|Overall Study|Principal Investigator discretion|0|||
44262931|NCT01658904|79153564|FG002|Overall Study|Principal Investigator discretion|0|||
44262932|NCT01658514|79153748|FG000|Overall Study|Protocol Violation|1|||
44262933|NCT01658514|79153749|FG001|Overall Study|Protocol Violation|0|||
44262934|NCT01658514|79153750|FG002|Overall Study|Protocol Violation|2|||
44262935|NCT01658436|79153771|FG000|Overall Study|Adverse Event|6|||
44262936|NCT01658436|79153772|FG001|Overall Study|Adverse Event|5|||
44262937|NCT01658436|79153771|FG000|Overall Study|Physician Decision|1|||
44262938|NCT01658436|79153772|FG001|Overall Study|Physician Decision|0|||
44262939|NCT01658436|79153771|FG000|Overall Study|Progressive disease|12|||
44262940|NCT01658436|79153772|FG001|Overall Study|Progressive disease|4|||
44262941|NCT01658436|79153771|FG000|Overall Study|Study terminated by sponsor|0|||
44262942|NCT01658436|79153772|FG001|Overall Study|Study terminated by sponsor|1|||
44262943|NCT01658436|79153771|FG000|Overall Study|Subject/guardian decision|0|||
44262944|NCT01658436|79153772|FG001|Overall Study|Subject/guardian decision|1|||
44262945|NCT01658436|79153771|FG000|Overall Study|Death|1|||
44262946|NCT01658436|79153772|FG001|Overall Study|Death|0|||
44262947|NCT00550862|79154254|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
44262948|NCT00550862|79154255|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
44262949|NCT00550862|79154256|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
44262950|NCT00550862|79154257|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
44262951|NCT00550862|79154258|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
44262952|NCT00550862|79154254|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
44262953|NCT00550862|79154255|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
44262954|NCT00550862|79154256|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
44262955|NCT00550862|79154257|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
44262956|NCT00550862|79154258|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
44262957|NCT00550862|79154254|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
44262958|NCT00550862|79154255|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
44262959|NCT00550862|79154256|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
44262960|NCT00550862|79154257|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
44262961|NCT00550862|79154258|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
44262962|NCT00550862|79154254|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
44262963|NCT00550862|79154255|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
44262964|NCT00550862|79154256|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
44262965|NCT00550862|79154257|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
44262966|NCT00550862|79154258|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
44262967|NCT00550862|79154254|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
44262968|NCT00550862|79154255|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
44262969|NCT00550862|79154256|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
44262970|NCT00550862|79154257|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
44262971|NCT00550862|79154258|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
44262972|NCT00550862|79154254|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
44262973|NCT00550862|79154255|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
44262974|NCT00550862|79154256|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
44262975|NCT00550862|79154257|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
44262976|NCT00550862|79154258|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
44262977|NCT00550862|79154254|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
44262978|NCT00550862|79154255|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
44262979|NCT00550862|79154256|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
44262980|NCT00550862|79154257|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
44262981|NCT00550862|79154258|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
44262982|NCT00550862|79154254|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
44262983|NCT00550862|79154255|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
44262984|NCT00550862|79154256|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
44262985|NCT00550862|79154257|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
44262986|NCT00550862|79154258|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
44262987|NCT00550862|79154254|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
44262988|NCT00550862|79154255|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
44262989|NCT00550862|79154256|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
44262990|NCT00550862|79154257|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
44262991|NCT00550862|79154258|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
44262992|NCT00550862|79154254|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
44262993|NCT00550862|79154255|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
44262994|NCT00550862|79154256|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
44262995|NCT00550862|79154257|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
44262996|NCT00550862|79154258|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
44262997|NCT01656408|79154320|FG000|Overall Study|Adverse Event|0|||
44262998|NCT01656408|79154321|FG001|Overall Study|Adverse Event|0|||
44262999|NCT01656408|79154322|FG002|Overall Study|Adverse Event|1|||
44263000|NCT01656408|79154323|FG003|Overall Study|Adverse Event|0|||
44263001|NCT01656408|79154324|FG004|Overall Study|Adverse Event|0|||
44263002|NCT01656408|79154325|FG005|Overall Study|Adverse Event|1|||
44263003|NCT01656408|79154326|FG006|Overall Study|Adverse Event|1|||
44263004|NCT01656408|79154327|FG007|Overall Study|Adverse Event|0|||
44263005|NCT01656408|79154328|FG008|Overall Study|Adverse Event|1|||
44263006|NCT01656408|79154329|FG009|Overall Study|Adverse Event|0|||
44263007|NCT01656408|79154320|FG000|Overall Study|Physician Decision|1|||
44263008|NCT01656408|79154321|FG001|Overall Study|Physician Decision|0|||
44263009|NCT01656408|79154322|FG002|Overall Study|Physician Decision|1|||
44263010|NCT01656408|79154323|FG003|Overall Study|Physician Decision|0|||
44263011|NCT01656408|79154324|FG004|Overall Study|Physician Decision|1|||
44263012|NCT01656408|79154325|FG005|Overall Study|Physician Decision|1|||
44263013|NCT01656408|79154326|FG006|Overall Study|Physician Decision|0|||
44263014|NCT01656408|79154327|FG007|Overall Study|Physician Decision|1|||
44263015|NCT01656408|79154328|FG008|Overall Study|Physician Decision|1|||
44263016|NCT01656408|79154329|FG009|Overall Study|Physician Decision|3|||
44263017|NCT01364298|79154777|FG000|Overall Study|Adverse Event|3|||
44263018|NCT01364298|79154778|FG001|Overall Study|Adverse Event|4|||
44263019|NCT01364298|79154777|FG000|Overall Study|Lack of adherence to treatment|1|||
44263020|NCT01364298|79154778|FG001|Overall Study|Lack of adherence to treatment|3|||
44263021|NCT01364298|79154777|FG000|Overall Study|Lack of Efficacy|1|||
44263022|NCT01364298|79154778|FG001|Overall Study|Lack of Efficacy|0|||
44263023|NCT01364298|79154777|FG000|Overall Study|Lost to Follow-up|5|||
44263024|NCT01364298|79154778|FG001|Overall Study|Lost to Follow-up|10|||
44263025|NCT01364298|79154777|FG000|Overall Study|Withdrawal by Subject|3|||
44263026|NCT01364298|79154778|FG001|Overall Study|Withdrawal by Subject|3|||
44263027|NCT01364298|79154777|FG000|Overall Study|Other|1|||
44263028|NCT01364298|79154778|FG001|Overall Study|Other|3|||
44263029|NCT01364922|79154837|FG000|Open-label (OL) Period|Adverse Event|7|||
44263030|NCT01364922|79154838|FG001|Open-label (OL) Period|Adverse Event|0|||
44263031|NCT01364922|79154839|FG002|Open-label (OL) Period|Adverse Event|0|||
44263032|NCT01364922|79154837|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
44263033|NCT01364922|79154838|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
44263034|NCT01364922|79154839|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
44263035|NCT01364922|79154837|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
44263036|NCT01364922|79154838|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
44263037|NCT01364922|79154839|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
44263038|NCT01364922|79154837|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
44263039|NCT01364922|79154838|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
44263040|NCT01364922|79154839|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
44263041|NCT01364922|79154837|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
44263042|NCT01364922|79154838|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
44263043|NCT01364922|79154839|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
44263044|NCT01364922|79154837|FG000|Open-label (OL) Period|Other, Unspecified|1|||
44263045|NCT01364922|79154838|FG001|Open-label (OL) Period|Other, Unspecified|0|||
44263046|NCT01364922|79154839|FG002|Open-label (OL) Period|Other, Unspecified|0|||
44263047|NCT01364922|79154837|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
44263048|NCT01364922|79154838|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
44263049|NCT01364922|79154839|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
44263050|NCT01364922|79154837|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
44263051|NCT01364922|79154838|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
44263052|NCT01364922|79154839|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
44263053|NCT01364922|79154837|FG000|Double-Blind (DB) Period|Adverse Event|0|||
44263054|NCT01364922|79154838|FG001|Double-Blind (DB) Period|Adverse Event|0|||
44263055|NCT01364922|79154839|FG002|Double-Blind (DB) Period|Adverse Event|1|||
44263056|NCT01364922|79154837|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
44263057|NCT01364922|79154838|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
44263058|NCT01364922|79154839|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
44263059|NCT02522286|79155013|FG000|Overall Study|Withdrawal by Subject|3|||
44263060|NCT02522286|79155014|FG001|Overall Study|Withdrawal by Subject|0|||
44263061|NCT02522286|79155015|FG002|Overall Study|Withdrawal by Subject|0|||
44263062|NCT02522286|79155016|FG003|Overall Study|Withdrawal by Subject|3|||
44263063|NCT02520726|79155037|FG000|Overall Study|Lost to Follow-up|3|||
44263064|NCT02520726|79155038|FG001|Overall Study|Lost to Follow-up|2|||
44263065|NCT02519712|79155061|FG000|Overall Study|Disease Relapse|1|||
44263066|NCT02519712|79155061|FG000|Overall Study|Disease Progression|1|||
44263067|NCT02519712|79155061|FG000|Overall Study|Accruals are donors|2|||
44263068|NCT02516202|79155304|FG000|Overall Study|Withdrawal by Subject|1|||
44263069|NCT02516202|79155305|FG001|Overall Study|Withdrawal by Subject|0|||
44263070|NCT02516202|79155306|FG002|Overall Study|Withdrawal by Subject|1|||
44263071|NCT02516202|79155304|FG000|Overall Study|Lost to Follow-up|1|||
44263072|NCT02516202|79155305|FG001|Overall Study|Lost to Follow-up|1|||
44263073|NCT02516202|79155306|FG002|Overall Study|Lost to Follow-up|1|||
44263074|NCT02516202|79155304|FG000|Overall Study|Stopped Follow-up|0|||
44263075|NCT02516202|79155305|FG001|Overall Study|Stopped Follow-up|0|||
44263076|NCT02516202|79155306|FG002|Overall Study|Stopped Follow-up|1|||
44263077|NCT02518620|79155503|FG000|Overall Study|Adverse Event|23|||
44263078|NCT02518620|79155504|FG001|Overall Study|Adverse Event|11|||
44263079|NCT02518620|79155503|FG000|Overall Study|Lack of Efficacy|2|||
44263080|NCT02518620|79155504|FG001|Overall Study|Lack of Efficacy|0|||
44263081|NCT02518620|79155503|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44263082|NCT02518620|79155504|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44263083|NCT02518620|79155503|FG000|Overall Study|Physician Decision|1|||
44263084|NCT02518620|79155504|FG001|Overall Study|Physician Decision|1|||
44263085|NCT02518620|79155503|FG000|Overall Study|Sponsor's Decision|0|||
44263086|NCT02518620|79155504|FG001|Overall Study|Sponsor's Decision|3|||
44263087|NCT02518620|79155503|FG000|Overall Study|Lost to Follow-up|1|||
44263088|NCT02518620|79155504|FG001|Overall Study|Lost to Follow-up|1|||
44263089|NCT02518620|79155503|FG000|Overall Study|Withdrawal by Subject|17|||
44263090|NCT02518620|79155504|FG001|Overall Study|Withdrawal by Subject|9|||
44263091|NCT02518620|79155503|FG000|Overall Study|Death|1|||
44263092|NCT02518620|79155504|FG001|Overall Study|Death|0|||
44263093|NCT02518620|79155503|FG000|Overall Study|Pregnancy Wish|3|||
44263094|NCT02518620|79155504|FG001|Overall Study|Pregnancy Wish|0|||
44263095|NCT02518620|79155503|FG000|Overall Study|Pregnancy|1|||
44263096|NCT02518620|79155504|FG001|Overall Study|Pregnancy|0|||
44263097|NCT02518620|79155503|FG000|Overall Study|Relocation|2|||
44263098|NCT02518620|79155504|FG001|Overall Study|Relocation|1|||
44263099|NCT01653912|79155683|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
44263100|NCT01653912|79155684|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
44263101|NCT01653912|79155685|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
44263102|NCT01653912|79155686|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
44263103|NCT01653912|79155687|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
44263104|NCT01653912|79155688|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
44263105|NCT01653912|79155683|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
44263106|NCT01653912|79155684|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
44263107|NCT01653912|79155685|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
44263108|NCT01653912|79155686|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
44263109|NCT01653912|79155687|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
44263110|NCT01653912|79155688|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
44263111|NCT01653912|79155683|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
44263112|NCT01653912|79155684|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
44263113|NCT01653912|79155685|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
44263114|NCT01653912|79155686|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
44263115|NCT01653912|79155687|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
44263116|NCT01653912|79155688|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
44263117|NCT01653912|79155683|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263118|NCT01653912|79155684|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263119|NCT01653912|79155685|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263120|NCT01653912|79155686|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
44263121|NCT01653912|79155687|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263122|NCT01653912|79155688|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263123|NCT01653912|79155683|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
44263124|NCT01653912|79155684|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
44263125|NCT01653912|79155685|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
44263126|NCT01653912|79155686|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
44263127|NCT01653912|79155687|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
44263128|NCT01653912|79155688|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
44263129|NCT01653912|79155683|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
44263130|NCT01653912|79155684|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
44263131|NCT01653912|79155685|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
44263132|NCT01653912|79155686|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
44263133|NCT01653912|79155687|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
44263134|NCT01653912|79155688|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
44263135|NCT01653912|79155683|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263136|NCT01653912|79155684|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263137|NCT01653912|79155685|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263138|NCT01653912|79155686|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263139|NCT01653912|79155687|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
44263140|NCT01653912|79155688|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
44263141|NCT02483520|79155714|FG000|Overall Study|Lost to Follow-up|3|||
44263142|NCT02483520|79155715|FG001|Overall Study|Lost to Follow-up|4|||
44263143|NCT02483520|79155714|FG000|Overall Study|Withdrawal by Subject|4|||
44263144|NCT02483520|79155715|FG001|Overall Study|Withdrawal by Subject|14|||
44263145|NCT02483520|79155714|FG000|Overall Study|Hospitalized|2|||
44263146|NCT02483520|79155715|FG001|Overall Study|Hospitalized|3|||
44263147|NCT02483520|79155714|FG000|Overall Study|Moved to LTC|2|||
44263148|NCT02483520|79155715|FG001|Overall Study|Moved to LTC|3|||
44263149|NCT02514174|79155721|FG000|Overall Study|Patient refused to continue medication|1|||
44263150|NCT02514174|79155721|FG000|Overall Study|Adverse Event|2|||
44263151|NCT02514174|79155721|FG000|Overall Study|Study closed by sponsor|9|||
44263152|NCT02514174|79155721|FG000|Overall Study|Progressive disease|11|||
44263153|NCT02514174|79155721|FG000|Overall Study|Treatment change|1|||
44263154|NCT02514174|79155721|FG000|Overall Study|Treated off study with Afatinib.|1|||
44263155|NCT02482428|79155781|FG000|Overall Study|Lost to Follow-up|4|||
44263156|NCT02482428|79155782|FG001|Overall Study|Lost to Follow-up|9|||
44263157|NCT02482428|79155783|FG002|Overall Study|Lost to Follow-up|1|||
44263158|NCT02482428|79155784|FG003|Overall Study|Lost to Follow-up|2|||
44263159|NCT02482428|79155785|FG004|Overall Study|Lost to Follow-up|4|||
44263160|NCT02482428|79155781|FG000|Overall Study|Physician Decision|0|||
44263161|NCT02482428|79155782|FG001|Overall Study|Physician Decision|0|||
44263162|NCT02482428|79155783|FG002|Overall Study|Physician Decision|0|||
44263163|NCT02482428|79155784|FG003|Overall Study|Physician Decision|0|||
44263164|NCT02482428|79155785|FG004|Overall Study|Physician Decision|1|||
44263165|NCT02482428|79155781|FG000|Overall Study|protocol deviation|1|||
44263166|NCT02482428|79155782|FG001|Overall Study|protocol deviation|1|||
44263167|NCT02482428|79155783|FG002|Overall Study|protocol deviation|0|||
44263168|NCT02482428|79155784|FG003|Overall Study|protocol deviation|0|||
44263169|NCT02482428|79155785|FG004|Overall Study|protocol deviation|0|||
44263170|NCT02482428|79155781|FG000|Overall Study|subject/guardian decision|4|||
44263171|NCT02482428|79155782|FG001|Overall Study|subject/guardian decision|2|||
44263172|NCT02482428|79155783|FG002|Overall Study|subject/guardian decision|0|||
44263173|NCT02482428|79155784|FG003|Overall Study|subject/guardian decision|0|||
44263174|NCT02482428|79155785|FG004|Overall Study|subject/guardian decision|2|||
44263175|NCT02480712|79155824|FG000|Overall Study|Enrolled but Never Treated|1|||
44263176|NCT02480712|79155824|FG000|Overall Study|Lost to Follow-up|5|||
44263177|NCT02480712|79155824|FG000|Overall Study|Withdrew Consent|3|||
44263178|NCT02480712|79155824|FG000|Overall Study|Death|1|||
44263179|NCT02480712|79155824|FG000|Overall Study|Lack of Efficacy|1|||
44263180|NCT02513550|79157093|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
44263181|NCT02513550|79157094|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
44263182|NCT02513550|79157095|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
44263183|NCT02513550|79157096|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
44263184|NCT02513550|79157097|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
44263185|NCT02513550|79157098|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
44263186|NCT02513550|79157093|FG000|Double Blind Treatment Period|Adverse Event|5|||
44263187|NCT02513550|79157094|FG001|Double Blind Treatment Period|Adverse Event|13|||
44263188|NCT02513550|79157095|FG002|Double Blind Treatment Period|Adverse Event|17|||
44263189|NCT02513550|79157096|FG003|Double Blind Treatment Period|Adverse Event|0|||
44263190|NCT02513550|79157097|FG004|Double Blind Treatment Period|Adverse Event|1|||
44263191|NCT02513550|79157098|FG005|Double Blind Treatment Period|Adverse Event|0|||
44263192|NCT02513550|79157093|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
44263193|NCT02513550|79157094|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
44263194|NCT02513550|79157095|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
44263195|NCT02513550|79157096|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
44263196|NCT02513550|79157097|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
44263197|NCT02513550|79157098|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
44263198|NCT02513550|79157093|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
44263199|NCT02513550|79157094|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
44263200|NCT02513550|79157095|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
44263201|NCT02513550|79157096|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
44263202|NCT02513550|79157097|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
44263203|NCT02513550|79157098|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
44263204|NCT02513550|79157093|FG000|Double Blind Treatment Period|Protocol Violation|1|||
44263205|NCT02513550|79157094|FG001|Double Blind Treatment Period|Protocol Violation|1|||
44263206|NCT02513550|79157095|FG002|Double Blind Treatment Period|Protocol Violation|4|||
44263207|NCT02513550|79157096|FG003|Double Blind Treatment Period|Protocol Violation|0|||
44263208|NCT02513550|79157097|FG004|Double Blind Treatment Period|Protocol Violation|0|||
44263209|NCT02513550|79157098|FG005|Double Blind Treatment Period|Protocol Violation|0|||
44263210|NCT02513550|79157093|FG000|Double Blind Treatment Period|Physician Decision|2|||
44263211|NCT02513550|79157094|FG001|Double Blind Treatment Period|Physician Decision|0|||
44263212|NCT02513550|79157095|FG002|Double Blind Treatment Period|Physician Decision|4|||
44263213|NCT02513550|79157096|FG003|Double Blind Treatment Period|Physician Decision|0|||
44263214|NCT02513550|79157097|FG004|Double Blind Treatment Period|Physician Decision|0|||
44263215|NCT02513550|79157098|FG005|Double Blind Treatment Period|Physician Decision|0|||
44263216|NCT02513550|79157093|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
44263217|NCT02513550|79157094|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
44263218|NCT02513550|79157095|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
44263219|NCT02513550|79157096|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
44263220|NCT02513550|79157097|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
44263221|NCT02513550|79157098|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
44263222|NCT02513550|79157093|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
44263223|NCT02513550|79157094|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
44263224|NCT02513550|79157095|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
44263225|NCT02513550|79157096|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
44263226|NCT02513550|79157097|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
44263227|NCT02513550|79157098|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
44263228|NCT02513550|79157093|FG000|Double Blind Treatment Period|Due to personal business|2|||
44263229|NCT02513550|79157094|FG001|Double Blind Treatment Period|Due to personal business|0|||
44263230|NCT02513550|79157095|FG002|Double Blind Treatment Period|Due to personal business|1|||
44263231|NCT02513550|79157096|FG003|Double Blind Treatment Period|Due to personal business|0|||
44263232|NCT02513550|79157097|FG004|Double Blind Treatment Period|Due to personal business|0|||
44263233|NCT02513550|79157098|FG005|Double Blind Treatment Period|Due to personal business|0|||
44263234|NCT02513550|79157093|FG000|Double Blind Treatment Period|Death|1|||
44263235|NCT02513550|79157094|FG001|Double Blind Treatment Period|Death|0|||
44263236|NCT02513550|79157095|FG002|Double Blind Treatment Period|Death|2|||
44263237|NCT02513550|79157096|FG003|Double Blind Treatment Period|Death|0|||
44263238|NCT02513550|79157097|FG004|Double Blind Treatment Period|Death|0|||
44263239|NCT02513550|79157098|FG005|Double Blind Treatment Period|Death|0|||
44263240|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
44263241|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
44263242|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
44263243|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44263244|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44263245|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44263246|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
44263247|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
44263248|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
44263249|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
44263250|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
44263251|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
44263252|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
44263253|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
44263254|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
44263255|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44263256|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44263257|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44263258|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
44263259|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
44263260|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
44263261|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
44263262|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
44263263|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
44263264|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
44263265|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
44263266|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
44263267|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
44263268|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
44263269|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
44263270|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Death|0|||
44263271|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Death|0|||
44263272|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Death|1|||
44263273|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Death|0|||
44263274|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Death|0|||
44263275|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Death|0|||
44263276|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
44263277|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
44263278|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
44263279|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
44263280|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
44263281|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
44263282|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
44263283|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
44263284|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
44263285|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
44263286|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
44263287|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
44263288|NCT02513550|79157093|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
44263289|NCT02513550|79157094|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
44263290|NCT02513550|79157095|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
44263291|NCT02513550|79157096|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
44263292|NCT02513550|79157097|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
44263293|NCT02513550|79157098|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
44263294|NCT02513472|79157432|FG000|Overall Study|Radiological Disease Progression|45|||
44263295|NCT02513472|79157433|FG001|Overall Study|Radiological Disease Progression|57|||
44263296|NCT02513472|79157432|FG000|Overall Study|Clinical Disease Progression|5|||
44263297|NCT02513472|79157433|FG001|Overall Study|Clinical Disease Progression|13|||
44263298|NCT02513472|79157432|FG000|Overall Study|Adverse Event|8|||
44263299|NCT02513472|79157433|FG001|Overall Study|Adverse Event|11|||
44263300|NCT02513472|79157432|FG000|Overall Study|Withdrawal by Subject|0|||
44263301|NCT02513472|79157433|FG001|Overall Study|Withdrawal by Subject|4|||
44263302|NCT02513472|79157432|FG000|Overall Study|Subject Choice|2|||
44263303|NCT02513472|79157433|FG001|Overall Study|Subject Choice|7|||
44263304|NCT02513472|79157432|FG000|Overall Study|Treatment Completed as per Protocol|3|||
44263305|NCT02513472|79157433|FG001|Overall Study|Treatment Completed as per Protocol|3|||
44263306|NCT02513472|79157432|FG000|Overall Study|Other|3|||
44263307|NCT02513472|79157433|FG001|Overall Study|Other|6|||
44263308|NCT04490395|79157653|FG000|Overall Study|Lost to Follow-up|0|||
44263309|NCT04490395|79157654|FG001|Overall Study|Lost to Follow-up|1|||
44263310|NCT03843541|79158097|FG000|Overall Study|Adverse Event|4|||
44263311|NCT03843541|79158098|FG001|Overall Study|Adverse Event|2|||
44263312|NCT03843541|79158099|FG002|Overall Study|Adverse Event|3|||
44263313|NCT03843541|79158097|FG000|Overall Study|Death|1|||
44263314|NCT03843541|79158098|FG001|Overall Study|Death|0|||
44263315|NCT03843541|79158099|FG002|Overall Study|Death|0|||
44263316|NCT03843541|79158097|FG000|Overall Study|Lack of adherence to study medication|0|||
44263317|NCT03843541|79158098|FG001|Overall Study|Lack of adherence to study medication|0|||
44263318|NCT03843541|79158099|FG002|Overall Study|Lack of adherence to study medication|1|||
44263319|NCT03843541|79158097|FG000|Overall Study|Physician Decision|1|||
44263320|NCT03843541|79158098|FG001|Overall Study|Physician Decision|2|||
44263321|NCT03843541|79158099|FG002|Overall Study|Physician Decision|2|||
44263322|NCT03843541|79158097|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
44263323|NCT03843541|79158098|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
44263324|NCT03843541|79158099|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
44263325|NCT03843541|79158097|FG000|Overall Study|Withdrawal by Subject|6|||
44263326|NCT03843541|79158098|FG001|Overall Study|Withdrawal by Subject|9|||
44263327|NCT03843541|79158099|FG002|Overall Study|Withdrawal by Subject|7|||
44263328|NCT03843541|79158097|FG000|Overall Study|Administration of rescue mucolytic|0|||
44263329|NCT03843541|79158098|FG001|Overall Study|Administration of rescue mucolytic|0|||
44263330|NCT03843541|79158099|FG002|Overall Study|Administration of rescue mucolytic|1|||
44263331|NCT03843541|79158097|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
44263332|NCT03843541|79158098|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
44263333|NCT03843541|79158099|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
44263334|NCT02992418|79159362|FG000|Overall Study|Withdrawal by Subject|11|||
44263335|NCT02992418|79159363|FG001|Overall Study|Withdrawal by Subject|12|||
44263336|NCT02992418|79159362|FG000|Overall Study|Non-compliance with the protocol|308|||
44263337|NCT02992418|79159363|FG001|Overall Study|Non-compliance with the protocol|308|||
44263338|NCT02992418|79159362|FG000|Overall Study|Lost to Follow-up|27|||
44263339|NCT02992418|79159363|FG001|Overall Study|Lost to Follow-up|22|||
44263340|NCT01276106|79159605|FG000|Overall Study|Adverse Event|3|||
44263341|NCT01276106|79159606|FG001|Overall Study|Adverse Event|3|||
44263342|NCT01276106|79159607|FG002|Overall Study|Adverse Event|11|||
44263343|NCT01276106|79159608|FG003|Overall Study|Adverse Event|3|||
44263344|NCT01276106|79159605|FG000|Overall Study|Withdrawal by Subject|6|||
44263345|NCT01276106|79159606|FG001|Overall Study|Withdrawal by Subject|3|||
44263346|NCT01276106|79159607|FG002|Overall Study|Withdrawal by Subject|1|||
44263347|NCT01276106|79159608|FG003|Overall Study|Withdrawal by Subject|6|||
44263348|NCT01276106|79159605|FG000|Overall Study|Lack of Efficacy|0|||
44263349|NCT01276106|79159606|FG001|Overall Study|Lack of Efficacy|1|||
44263350|NCT01276106|79159607|FG002|Overall Study|Lack of Efficacy|0|||
44263351|NCT01276106|79159608|FG003|Overall Study|Lack of Efficacy|1|||
44263352|NCT01276106|79159605|FG000|Overall Study|Lost to Follow-up|2|||
44263353|NCT01276106|79159606|FG001|Overall Study|Lost to Follow-up|1|||
44263354|NCT01276106|79159607|FG002|Overall Study|Lost to Follow-up|1|||
44263355|NCT01276106|79159608|FG003|Overall Study|Lost to Follow-up|0|||
44263356|NCT01276106|79159605|FG000|Overall Study|Physician Decision|0|||
44263357|NCT01276106|79159606|FG001|Overall Study|Physician Decision|0|||
44263358|NCT01276106|79159607|FG002|Overall Study|Physician Decision|1|||
44263359|NCT01276106|79159608|FG003|Overall Study|Physician Decision|1|||
44263360|NCT01276106|79159605|FG000|Overall Study|Protocol Violation|1|||
44263361|NCT01276106|79159606|FG001|Overall Study|Protocol Violation|1|||
44263362|NCT01276106|79159607|FG002|Overall Study|Protocol Violation|0|||
44263363|NCT01276106|79159608|FG003|Overall Study|Protocol Violation|2|||
44263364|NCT01276106|79159605|FG000|Overall Study|Insufficient therapeutic effects|0|||
44263365|NCT01276106|79159606|FG001|Overall Study|Insufficient therapeutic effects|0|||
44263366|NCT01276106|79159607|FG002|Overall Study|Insufficient therapeutic effects|2|||
44263367|NCT01276106|79159608|FG003|Overall Study|Insufficient therapeutic effects|0|||
44263368|NCT01275170|79159626|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
44263369|NCT01275170|79159627|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263370|NCT01275170|79159628|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263371|NCT01275170|79159629|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263372|NCT01275170|79159630|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263373|NCT01275170|79159631|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263374|NCT01275170|79159632|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263375|NCT01275170|79159633|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
44263376|NCT01273064|79159680|FG000|Overall Study|Adverse Event|5|||
44263377|NCT01273064|79159681|FG001|Overall Study|Adverse Event|1|||
44263378|NCT01273064|79159682|FG002|Overall Study|Adverse Event|3|||
44263379|NCT01273064|79159683|FG003|Overall Study|Adverse Event|2|||
44263380|NCT01273064|79159684|FG004|Overall Study|Adverse Event|1|||
44263381|NCT01273064|79159680|FG000|Overall Study|Withdrawal by Subject|4|||
44263382|NCT01273064|79159681|FG001|Overall Study|Withdrawal by Subject|2|||
44263383|NCT01273064|79159682|FG002|Overall Study|Withdrawal by Subject|2|||
44263384|NCT01273064|79159683|FG003|Overall Study|Withdrawal by Subject|2|||
44263385|NCT01273064|79159684|FG004|Overall Study|Withdrawal by Subject|0|||
44263386|NCT01273064|79159680|FG000|Overall Study|Study Termination|13|||
44263387|NCT01273064|79159681|FG001|Overall Study|Study Termination|27|||
44263388|NCT01273064|79159682|FG002|Overall Study|Study Termination|26|||
44263389|NCT01273064|79159683|FG003|Overall Study|Study Termination|16|||
44263390|NCT01273064|79159684|FG004|Overall Study|Study Termination|8|||
44263391|NCT01273064|79159680|FG000|Overall Study|Lost to Follow-up|1|||
44263392|NCT01273064|79159681|FG001|Overall Study|Lost to Follow-up|0|||
44263393|NCT01273064|79159682|FG002|Overall Study|Lost to Follow-up|0|||
44263394|NCT01273064|79159683|FG003|Overall Study|Lost to Follow-up|0|||
44263395|NCT01273064|79159684|FG004|Overall Study|Lost to Follow-up|0|||
44263396|NCT01273064|79159680|FG000|Overall Study|Physician Decision|0|||
44263397|NCT01273064|79159681|FG001|Overall Study|Physician Decision|0|||
44263398|NCT01273064|79159682|FG002|Overall Study|Physician Decision|0|||
44263399|NCT01273064|79159683|FG003|Overall Study|Physician Decision|0|||
44263400|NCT01273064|79159684|FG004|Overall Study|Physician Decision|1|||
44263401|NCT01272908|79159696|FG000|Initial Treatment Period|Adverse Event|1|||
44263402|NCT01272908|79159696|FG000|Initial Treatment Period|Lack of Efficacy|5|||
44263403|NCT01272908|79159696|FG000|Initial Treatment Period|Protocol Violation|1|||
44263404|NCT01272908|79159696|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
44263405|NCT01272908|79159696|FG000|Re-Treatment Period|Adverse Event|2|||
44263406|NCT01272908|79159696|FG000|Re-Treatment Period|Lack of Efficacy|3|||
44263407|NCT01272908|79159696|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
44263408|NCT01271504|79159706|FG000|Overall Study|Death|7|||
44263409|NCT01271504|79159707|FG001|Overall Study|Death|6|||
44263410|NCT01271504|79159708|FG002|Overall Study|Death|32|||
44263411|NCT01271504|79159709|FG003|Overall Study|Death|32|||
44263412|NCT01271504|79159706|FG000|Overall Study|Lost to Follow-up|0|||
44263413|NCT01271504|79159707|FG001|Overall Study|Lost to Follow-up|1|||
44263414|NCT01271504|79159708|FG002|Overall Study|Lost to Follow-up|3|||
44263415|NCT01271504|79159709|FG003|Overall Study|Lost to Follow-up|1|||
44263416|NCT01271504|79159706|FG000|Overall Study|Protocol Violation|0|||
44263417|NCT01271504|79159707|FG001|Overall Study|Protocol Violation|0|||
44263418|NCT01271504|79159708|FG002|Overall Study|Protocol Violation|0|||
44263419|NCT01271504|79159709|FG003|Overall Study|Protocol Violation|2|||
44263420|NCT01271504|79159706|FG000|Overall Study|Administrative Reasons|0|||
44263421|NCT01271504|79159707|FG001|Overall Study|Administrative Reasons|0|||
44263422|NCT01271504|79159708|FG002|Overall Study|Administrative Reasons|6|||
44263423|NCT01271504|79159709|FG003|Overall Study|Administrative Reasons|5|||
44263424|NCT01271504|79159706|FG000|Overall Study|Withdrawal by Subject|0|||
44263425|NCT01271504|79159707|FG001|Overall Study|Withdrawal by Subject|0|||
44263426|NCT01271504|79159708|FG002|Overall Study|Withdrawal by Subject|1|||
44263427|NCT01271504|79159709|FG003|Overall Study|Withdrawal by Subject|3|||
44263428|NCT01271504|79159706|FG000|Overall Study|Other|0|||
44263429|NCT01271504|79159707|FG001|Overall Study|Other|1|||
44263430|NCT01271504|79159708|FG002|Overall Study|Other|2|||
44263431|NCT01271504|79159709|FG003|Overall Study|Other|0|||
44263432|NCT01270958|79159752|FG000|Overall Study|Lost to Follow-up|2|||
44263433|NCT01270958|79159752|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
44263434|NCT01270880|79159756|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
44263435|NCT01270802|79159762|FG000|Overall Study|Withdrawal by Subject|1|||
44263436|NCT01270802|79159763|FG001|Overall Study|Withdrawal by Subject|0|||
44263437|NCT01270802|79159762|FG000|Overall Study|Adverse Event|1|||
44263438|NCT01270802|79159763|FG001|Overall Study|Adverse Event|0|||
44263439|NCT01270802|79159762|FG000|Overall Study|Lost to Follow-up|0|||
44263440|NCT01270802|79159763|FG001|Overall Study|Lost to Follow-up|1|||
44263441|NCT01270256|79159772|FG000|Overall Study|Withdrawal by Subject|1|||
44263442|NCT01270256|79159773|FG001|Overall Study|Withdrawal by Subject|0|||
44263443|NCT01279616|79159843|FG000|Overall Study|donor could not be located|5|||
44263444|NCT01279616|79159843|FG000|Overall Study|no signs of sickle cell disease|2|||
44263445|NCT01279070|79159854|FG000|Overall Study|Withdrawal by Subject|2|||
44263446|NCT01279070|79159855|FG001|Overall Study|Withdrawal by Subject|3|||
44263447|NCT01279070|79159854|FG000|Overall Study|Acute exacerbation|3|||
44263448|NCT01279070|79159855|FG001|Overall Study|Acute exacerbation|1|||
44263449|NCT01277744|79159865|FG000|Overall Study|Physician Decision|2|||
44263450|NCT01277822|79159871|FG000|Overall Study|Adverse Event|2|||
44263451|NCT01277822|79159872|FG001|Overall Study|Adverse Event|1|||
44263452|NCT01277822|79159871|FG000|Overall Study|Withdrawal by Subject|6|||
44263453|NCT01277822|79159872|FG001|Overall Study|Withdrawal by Subject|7|||
44263454|NCT01277822|79159871|FG000|Overall Study|Physician Decision|1|||
44263455|NCT01277822|79159872|FG001|Overall Study|Physician Decision|1|||
44263456|NCT01277822|79159871|FG000|Overall Study|Protocol Violation|1|||
44263457|NCT01277822|79159872|FG001|Overall Study|Protocol Violation|0|||
44263458|NCT01277822|79159871|FG000|Overall Study|Lost to Follow-up|2|||
44263459|NCT01277822|79159872|FG001|Overall Study|Lost to Follow-up|1|||
44263460|NCT01277822|79159871|FG000|Overall Study|Contraindicated medication used|2|||
44263461|NCT01277822|79159872|FG001|Overall Study|Contraindicated medication used|1|||
44263462|NCT01277822|79159871|FG000|Overall Study|Participant moved|1|||
44263463|NCT01277822|79159872|FG001|Overall Study|Participant moved|0|||
44263464|NCT01277666|79159881|FG000|Overall Study|Adverse Event|26|||
44263465|NCT01277666|79159882|FG001|Overall Study|Adverse Event|25|||
44263466|NCT01277666|79159883|FG002|Overall Study|Adverse Event|20|||
44263467|NCT01277666|79159881|FG000|Overall Study|Lack of Efficacy|8|||
44263468|NCT01277666|79159882|FG001|Overall Study|Lack of Efficacy|20|||
44263469|NCT01277666|79159883|FG002|Overall Study|Lack of Efficacy|12|||
44263470|NCT01277666|79159881|FG000|Overall Study|Protocol Violation|2|||
44263471|NCT01277666|79159882|FG001|Overall Study|Protocol Violation|3|||
44263472|NCT01277666|79159883|FG002|Overall Study|Protocol Violation|2|||
44263473|NCT01277666|79159881|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
44263474|NCT01277666|79159882|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
44263475|NCT01277666|79159883|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
44263476|NCT01277666|79159881|FG000|Overall Study|Lost to Follow-up|1|||
44263477|NCT01277666|79159882|FG001|Overall Study|Lost to Follow-up|1|||
44263478|NCT01277666|79159883|FG002|Overall Study|Lost to Follow-up|2|||
44263479|NCT01277666|79159881|FG000|Overall Study|Withdrawal by Subject|7|||
44263480|NCT01277666|79159882|FG001|Overall Study|Withdrawal by Subject|8|||
44263481|NCT01277666|79159883|FG002|Overall Study|Withdrawal by Subject|6|||
44263482|NCT01277666|79159881|FG000|Overall Study|Death|0|||
44263483|NCT01277666|79159882|FG001|Overall Study|Death|0|||
44263484|NCT01277666|79159883|FG002|Overall Study|Death|1|||
44263485|NCT00249002|79159891|FG000|Overall Study|Adverse Event|2|||
44263486|NCT00249002|79159891|FG000|Overall Study|Study cancellation|3|||
44263487|NCT00249002|79159891|FG000|Overall Study|Other|2|||
44263488|NCT01277042|79159897|FG000|Overall Study|Adverse Event|4|||
44263489|NCT01277042|79159898|FG001|Overall Study|Adverse Event|3|||
44263490|NCT01277042|79159897|FG000|Overall Study|Lost to Follow-up|2|||
44263491|NCT01277042|79159898|FG001|Overall Study|Lost to Follow-up|2|||
44263492|NCT01277042|79159897|FG000|Overall Study|Withdrawal by Subject|2|||
44263493|NCT01277042|79159898|FG001|Overall Study|Withdrawal by Subject|0|||
44263494|NCT00246740|79159938|FG000|Initial Enrollment|Death|1|||
44263495|NCT00246740|79159939|FG001|Initial Enrollment|Death|0|||
44263496|NCT00246740|79159938|FG000|Initial Enrollment|Additional surgery scheduled|0|||
44263497|NCT00246740|79159939|FG001|Initial Enrollment|Additional surgery scheduled|2|||
44263498|NCT00246740|79159938|FG000|Initial Enrollment|Surgery schedule change|4|||
44263499|NCT00246740|79159939|FG001|Initial Enrollment|Surgery schedule change|4|||
44263500|NCT00246740|79159938|FG000|Initial Enrollment|Other|1|||
44263501|NCT00246740|79159939|FG001|Initial Enrollment|Other|2|||
44263502|NCT00245102|79159984|FG000|Overall Study|Not Treated|1|||
44263503|NCT00245102|79159985|FG001|Overall Study|Not Treated|0|||
44263504|NCT00245102|79159986|FG002|Overall Study|Not Treated|1|||
44263505|NCT00245102|79159987|FG003|Overall Study|Not Treated|0|||
44263506|NCT00245102|79159988|FG004|Overall Study|Not Treated|0|||
44263507|NCT00245102|79159989|FG005|Overall Study|Not Treated|0|||
44263508|NCT00245102|79159984|FG000|Overall Study|Protocol Violation|1|||
44263509|NCT00245102|79159985|FG001|Overall Study|Protocol Violation|0|||
44263510|NCT00245102|79159986|FG002|Overall Study|Protocol Violation|0|||
44263511|NCT00245102|79159987|FG003|Overall Study|Protocol Violation|0|||
44263512|NCT00245102|79159988|FG004|Overall Study|Protocol Violation|0|||
44263513|NCT00245102|79159989|FG005|Overall Study|Protocol Violation|0|||
44263514|NCT00245102|79159984|FG000|Overall Study|Death|0|||
44263515|NCT00245102|79159985|FG001|Overall Study|Death|0|||
44263516|NCT00245102|79159986|FG002|Overall Study|Death|0|||
44263517|NCT00245102|79159987|FG003|Overall Study|Death|1|||
44263518|NCT00245102|79159988|FG004|Overall Study|Death|0|||
44263519|NCT00245102|79159989|FG005|Overall Study|Death|0|||
44263520|NCT00245102|79159984|FG000|Overall Study|Adverse Event|4|||
44263521|NCT00245102|79159985|FG001|Overall Study|Adverse Event|2|||
44263522|NCT00245102|79159986|FG002|Overall Study|Adverse Event|5|||
44263523|NCT00245102|79159987|FG003|Overall Study|Adverse Event|1|||
44263524|NCT00245102|79159988|FG004|Overall Study|Adverse Event|0|||
44263525|NCT00245102|79159989|FG005|Overall Study|Adverse Event|2|||
44263526|NCT00245102|79159984|FG000|Overall Study|Decline in performance|0|||
44263527|NCT00245102|79159985|FG001|Overall Study|Decline in performance|2|||
44263528|NCT00245102|79159986|FG002|Overall Study|Decline in performance|0|||
44263529|NCT00245102|79159987|FG003|Overall Study|Decline in performance|1|||
44263530|NCT00245102|79159988|FG004|Overall Study|Decline in performance|0|||
44263531|NCT00245102|79159989|FG005|Overall Study|Decline in performance|2|||
44263532|NCT00245102|79159984|FG000|Overall Study|Participant needed surgery|0|||
44263533|NCT00245102|79159985|FG001|Overall Study|Participant needed surgery|0|||
44263534|NCT00245102|79159986|FG002|Overall Study|Participant needed surgery|1|||
44263535|NCT00245102|79159987|FG003|Overall Study|Participant needed surgery|0|||
44263536|NCT00245102|79159988|FG004|Overall Study|Participant needed surgery|0|||
44263537|NCT00245102|79159989|FG005|Overall Study|Participant needed surgery|0|||
44263538|NCT00245102|79159984|FG000|Overall Study|Clinical progression|1|||
44263539|NCT00245102|79159985|FG001|Overall Study|Clinical progression|0|||
44263540|NCT00245102|79159986|FG002|Overall Study|Clinical progression|0|||
44263541|NCT00245102|79159987|FG003|Overall Study|Clinical progression|0|||
44263542|NCT00245102|79159988|FG004|Overall Study|Clinical progression|0|||
44263543|NCT00245102|79159989|FG005|Overall Study|Clinical progression|0|||
44263544|NCT00244712|79160034|FG000|Overall Study|Adverse Event|20|||
44263545|NCT00244712|79160035|FG001|Overall Study|Adverse Event|21|||
44263546|NCT00244712|79160034|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
44263547|NCT00244712|79160035|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
44263548|NCT00244712|79160034|FG000|Overall Study|Lack of Compliance|10|||
44263549|NCT00244712|79160035|FG001|Overall Study|Lack of Compliance|11|||
44263550|NCT00244712|79160034|FG000|Overall Study|Lost to Follow-up|45|||
44263551|NCT00244712|79160035|FG001|Overall Study|Lost to Follow-up|52|||
44263552|NCT00244712|79160034|FG000|Overall Study|Withdrawal by Subject|13|||
44263553|NCT00244712|79160035|FG001|Overall Study|Withdrawal by Subject|23|||
44263554|NCT00244712|79160034|FG000|Overall Study|Protocol Violation, disease progression|13|||
44263555|NCT00244712|79160035|FG001|Overall Study|Protocol Violation, disease progression|11|||
44263556|NCT00243932|79160053|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
44263557|NCT00243932|79160054|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
44263558|NCT00243932|79160055|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
44263559|NCT00243386|79160063|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
44263560|NCT00243386|79160064|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
44263561|NCT00243386|79160065|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
44263562|NCT00243386|79160063|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
44263563|NCT00243386|79160064|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
44263564|NCT00243386|79160065|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
44263565|NCT00243386|79160063|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
44263566|NCT00243386|79160064|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
44263567|NCT00243386|79160065|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
44263568|NCT00243386|79160063|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
44263569|NCT00243386|79160064|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
44263570|NCT00243386|79160065|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
44263571|NCT00243386|79160063|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
44263572|NCT00243386|79160064|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
44263573|NCT00243386|79160065|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
44263574|NCT00243386|79160063|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
44263575|NCT00243386|79160064|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
44263576|NCT00243386|79160065|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
44263577|NCT00243386|79160063|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
44263578|NCT00243386|79160064|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
44263579|NCT00243386|79160065|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
44263580|NCT00243386|79160063|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
44263581|NCT00243386|79160064|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
44263582|NCT00243386|79160065|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
44263583|NCT00243230|79160124|FG000|Double-Blind Period|Adverse Event|0|||
44263584|NCT00243230|79160125|FG001|Double-Blind Period|Adverse Event|2|||
44263585|NCT00243230|79160126|FG002|Double-Blind Period|Adverse Event|2|||
44263586|NCT00243230|79160127|FG003|Double-Blind Period|Adverse Event|0|||
44263587|NCT00243230|79160124|FG000|Double-Blind Period|Withdrawal by Subject|1|||
44263588|NCT00243230|79160125|FG001|Double-Blind Period|Withdrawal by Subject|0|||
44263589|NCT00243230|79160126|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44263590|NCT00243230|79160127|FG003|Double-Blind Period|Withdrawal by Subject|0|||
44263591|NCT00243230|79160124|FG000|Double-Blind Period|Protocol Violation|0|||
44263592|NCT00243230|79160125|FG001|Double-Blind Period|Protocol Violation|0|||
44263593|NCT00243230|79160126|FG002|Double-Blind Period|Protocol Violation|1|||
44263594|NCT00243230|79160127|FG003|Double-Blind Period|Protocol Violation|0|||
44263595|NCT00243230|79160124|FG000|Double-Blind Period|Randomized but Not Treated|0|||
44263596|NCT00243230|79160125|FG001|Double-Blind Period|Randomized but Not Treated|0|||
44263597|NCT00243230|79160126|FG002|Double-Blind Period|Randomized but Not Treated|2|||
44263598|NCT00243230|79160127|FG003|Double-Blind Period|Randomized but Not Treated|0|||
44263599|NCT00243230|79160124|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
44263600|NCT00243230|79160125|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
44263601|NCT00243230|79160126|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
44263602|NCT00243230|79160127|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
44263603|NCT00243230|79160124|FG000|Open Label Period|Adverse Event|0|||
44263604|NCT00243230|79160125|FG001|Open Label Period|Adverse Event|0|||
44263605|NCT00243230|79160126|FG002|Open Label Period|Adverse Event|0|||
44263606|NCT00243230|79160127|FG003|Open Label Period|Adverse Event|2|||
44263607|NCT00243230|79160124|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
44263608|NCT00243230|79160125|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
44263609|NCT00243230|79160126|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
44263610|NCT00243230|79160127|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
44263611|NCT00243230|79160124|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
44263612|NCT00243230|79160125|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
44263613|NCT00243230|79160126|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
44263614|NCT00243230|79160127|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
44263615|NCT00243230|79160124|FG000|Open Label Period|Lost to Follow-up|0|||
44263616|NCT00243230|79160125|FG001|Open Label Period|Lost to Follow-up|0|||
44263617|NCT00243230|79160126|FG002|Open Label Period|Lost to Follow-up|0|||
44263618|NCT00243230|79160127|FG003|Open Label Period|Lost to Follow-up|2|||
44263619|NCT00243230|79160124|FG000|Open Label Period|Withdrawal by Subject|0|||
44263620|NCT00243230|79160125|FG001|Open Label Period|Withdrawal by Subject|0|||
44263621|NCT00243230|79160126|FG002|Open Label Period|Withdrawal by Subject|0|||
44263622|NCT00243230|79160127|FG003|Open Label Period|Withdrawal by Subject|2|||
44263623|NCT00243230|79160124|FG000|Open Label Period|Protocol Violation|0|||
44263624|NCT00243230|79160125|FG001|Open Label Period|Protocol Violation|0|||
44263625|NCT00243230|79160126|FG002|Open Label Period|Protocol Violation|0|||
44263626|NCT00243230|79160127|FG003|Open Label Period|Protocol Violation|2|||
44263627|NCT00243230|79160124|FG000|Open Label Period|Administrative Reason|0|||
44263628|NCT00243230|79160125|FG001|Open Label Period|Administrative Reason|0|||
44263629|NCT00243230|79160126|FG002|Open Label Period|Administrative Reason|0|||
44263630|NCT00243230|79160127|FG003|Open Label Period|Administrative Reason|63|||
44263631|NCT00243074|79160137|FG000|Overall Study|Ineligible|6|||
44263632|NCT00243074|79160137|FG000|Overall Study|Adverse Event|6|||
44263633|NCT00243074|79160137|FG000|Overall Study|Withdrawal by Subject|2|||
44263634|NCT00243074|79160137|FG000|Overall Study|Lack of Efficacy|36|||
44263635|NCT00243074|79160137|FG000|Overall Study|Death|2|||
44263636|NCT00243074|79160137|FG000|Overall Study|not protocol specified|1|||
44263637|NCT00243074|79160137|FG000|Overall Study|Did not receive any treatment|1|||
44263638|NCT00241358|79160145|FG000|Overall Study|Determined to be not ineligible|0|||
44263639|NCT00241358|79160146|FG001|Overall Study|Determined to be not ineligible|1|||
44263640|NCT00241358|79160147|FG002|Overall Study|Determined to be not ineligible|1|||
44263641|NCT00241280|79160156|FG000|Overall Study|Adverse Event|2|||
44263642|NCT00241280|79160157|FG001|Overall Study|Adverse Event|6|||
44263643|NCT00241280|79160156|FG000|Overall Study|Discomfort|11|||
44263644|NCT00241280|79160157|FG001|Overall Study|Discomfort|16|||
44263645|NCT00241280|79160156|FG000|Overall Study|Pregnancy|1|||
44263646|NCT00241280|79160157|FG001|Overall Study|Pregnancy|5|||
44263647|NCT00241280|79160156|FG000|Overall Study|Lost to Follow-up|5|||
44263648|NCT00241280|79160157|FG001|Overall Study|Lost to Follow-up|8|||
44263649|NCT00241280|79160156|FG000|Overall Study|Withdrawal by Subject|7|||
44263650|NCT00241280|79160157|FG001|Overall Study|Withdrawal by Subject|4|||
44263651|NCT00241280|79160156|FG000|Overall Study|Protocol Violation|4|||
44263652|NCT00241280|79160157|FG001|Overall Study|Protocol Violation|10|||
44263653|NCT00241280|79160156|FG000|Overall Study|Relocation|4|||
44263654|NCT00241280|79160157|FG001|Overall Study|Relocation|4|||
44263655|NCT00241280|79160156|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
44263656|NCT00241280|79160157|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
44263657|NCT00241280|79160156|FG000|Overall Study|Unsatisfactory Visual Response|1|||
44263658|NCT00241280|79160157|FG001|Overall Study|Unsatisfactory Visual Response|1|||
44263659|NCT00241280|79160156|FG000|Overall Study|Diabetic|1|||
44263660|NCT00241280|79160157|FG001|Overall Study|Diabetic|0|||
44263661|NCT00241280|79160156|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
44263662|NCT00241280|79160157|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
44263663|NCT00241280|79160156|FG000|Overall Study|Dispensed incorrect test article|1|||
44263664|NCT00241280|79160157|FG001|Overall Study|Dispensed incorrect test article|2|||
44263665|NCT00241280|79160156|FG000|Overall Study|Unacceptable Fit|0|||
44263666|NCT00241280|79160157|FG001|Overall Study|Unacceptable Fit|1|||
44263667|NCT00241280|79160156|FG000|Overall Study|Scheduling Conflict|0|||
44263668|NCT00241280|79160157|FG001|Overall Study|Scheduling Conflict|2|||
44263669|NCT00241280|79160156|FG000|Overall Study|History of Ocular Surgery|0|||
44263670|NCT00241280|79160157|FG001|Overall Study|History of Ocular Surgery|1|||
44263671|NCT00241280|79160156|FG000|Overall Study|Coating on Lens|1|||
44263672|NCT00241280|79160157|FG001|Overall Study|Coating on Lens|0|||
44263673|NCT00241280|79160156|FG000|Overall Study|Excessive Dryness|0|||
44263674|NCT00241280|79160157|FG001|Overall Study|Excessive Dryness|1|||
44263675|NCT04278872|79160725|FG000|Overall Study|Adverse Event|1|||
44263676|NCT04278872|79160726|FG001|Overall Study|Adverse Event|0|||
44263677|NCT04278872|79160725|FG000|Overall Study|Protocol Violation|0|||
44263678|NCT04278872|79160726|FG001|Overall Study|Protocol Violation|1|||
44263679|NCT04278872|79160725|FG000|Overall Study|Study Termination|2|||
44263680|NCT04278872|79160726|FG001|Overall Study|Study Termination|0|||
44263681|NCT05497557|79161433|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
44263682|NCT05497557|79161434|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
44263683|NCT05497557|79161435|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
44263684|NCT05024032|79161447|FG000|Overall Study|Withdrawal by Subject|0|||
44263685|NCT05024032|79161448|FG001|Overall Study|Withdrawal by Subject|3|||
44263686|NCT05024032|79161449|FG002|Overall Study|Withdrawal by Subject|4|||
44263687|NCT05024032|79161447|FG000|Overall Study|Adverse Event|0|||
44263688|NCT05024032|79161448|FG001|Overall Study|Adverse Event|1|||
44263689|NCT05024032|79161449|FG002|Overall Study|Adverse Event|0|||
44263690|NCT05024032|79161447|FG000|Overall Study|Protocol Deviation|1|||
44263691|NCT05024032|79161448|FG001|Overall Study|Protocol Deviation|0|||
44263692|NCT05024032|79161449|FG002|Overall Study|Protocol Deviation|0|||
44263693|NCT04696055|79161461|FG000|Overall Study|Adverse Event|10|||
44263694|NCT04696055|79161462|FG001|Overall Study|Adverse Event|0|||
44263695|NCT04696055|79161461|FG000|Overall Study|Death|2|||
44263696|NCT04696055|79161462|FG001|Overall Study|Death|1|||
44263697|NCT04696055|79161461|FG000|Overall Study|Other|4|||
44263698|NCT04696055|79161462|FG001|Overall Study|Other|0|||
44263699|NCT04696055|79161461|FG000|Overall Study|Physician Decision|1|||
44263700|NCT04696055|79161462|FG001|Overall Study|Physician Decision|0|||
44263701|NCT04696055|79161461|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
44263702|NCT04696055|79161462|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
44263703|NCT04696055|79161461|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
44263704|NCT04696055|79161462|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
44263705|NCT04696055|79161461|FG000|Overall Study|Subject Decision|1|||
44263706|NCT04696055|79161462|FG001|Overall Study|Subject Decision|2|||
44263707|NCT04696055|79161461|FG000|Overall Study|Ongoing with study treatment|13|||
44263708|NCT04696055|79161462|FG001|Overall Study|Ongoing with study treatment|10|||
44263709|NCT04432376|79161471|FG000|Double-blind Treatment Period|Adverse Event|2|||
44263710|NCT04432376|79161472|FG001|Double-blind Treatment Period|Adverse Event|6|||
44263711|NCT04432376|79161473|FG002|Double-blind Treatment Period|Adverse Event|0|||
44263712|NCT04432376|79161471|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
44263713|NCT04432376|79161472|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
44263714|NCT04432376|79161473|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
44263715|NCT04432376|79161471|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
44263716|NCT04432376|79161472|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
44263717|NCT04432376|79161473|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44263718|NCT04432376|79161471|FG000|Double-blind Treatment Period|Protocol Violation|0|||
44263719|NCT04432376|79161472|FG001|Double-blind Treatment Period|Protocol Violation|1|||
44263720|NCT04432376|79161473|FG002|Double-blind Treatment Period|Protocol Violation|0|||
44263721|NCT04432376|79161471|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
44263722|NCT04432376|79161472|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
44263723|NCT04432376|79161473|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
44263724|NCT04409834|79161482|FG000|Overall Study|Death|55|||
44263725|NCT04409834|79161483|FG001|Overall Study|Death|62|||
44263726|NCT04320849|79161495|FG000|Overall Study|Withdrawal by Subject|4|||
44263727|NCT04320849|79161495|FG000|Overall Study|Imaging data unavailable|2|||
44263728|NCT04320849|79161495|FG000|Overall Study|Incomplete imaging|2|||
44263729|NCT03750838|79161516|FG000|Overall Study|Lost to Follow-up|10|||
44263730|NCT03750838|79161517|FG001|Overall Study|Lost to Follow-up|6|||
44263731|NCT02726386|79161588|FG000|Overall Study|Adverse Event|17|||
44263732|NCT02726386|79161589|FG001|Overall Study|Adverse Event|20|||
44263733|NCT02726386|79161588|FG000|Overall Study|Withdrawal by Subject|14|||
44263734|NCT02726386|79161589|FG001|Overall Study|Withdrawal by Subject|28|||
44263735|NCT02726386|79161588|FG000|Overall Study|Other reasons|7|||
44263736|NCT02726386|79161589|FG001|Overall Study|Other reasons|8|||
44263737|NCT02711553|79161599|FG000|Overall Study|Withdrawal by Subject|2|||
44263738|NCT02711553|79161600|FG001|Overall Study|Withdrawal by Subject|1|||
44263739|NCT02711553|79161601|FG002|Overall Study|Withdrawal by Subject|1|||
44263740|NCT02711553|79161602|FG003|Overall Study|Withdrawal by Subject|0|||
44263741|NCT02711553|79161599|FG000|Overall Study|Lost to Follow-up|3|||
44263742|NCT02711553|79161600|FG001|Overall Study|Lost to Follow-up|3|||
44263743|NCT02711553|79161601|FG002|Overall Study|Lost to Follow-up|6|||
44263744|NCT02711553|79161602|FG003|Overall Study|Lost to Follow-up|3|||
44263745|NCT02711553|79161599|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
44263746|NCT02711553|79161600|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
44263747|NCT02711553|79161601|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
44263748|NCT02711553|79161602|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
44263749|NCT02667587|79161616|FG000|Pre-Treatment|Not reported|1|||
44263750|NCT02667587|79161617|FG001|Pre-Treatment|Not reported|0|||
44263751|NCT02667587|79161616|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
44263752|NCT02667587|79161617|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
44263753|NCT02667587|79161616|FG000|Pre-Treatment|Participant withdrew consent|0|||
44263754|NCT02667587|79161617|FG001|Pre-Treatment|Participant withdrew consent|1|||
44263755|NCT02667587|79161616|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
44263756|NCT02667587|79161617|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
44263757|NCT02667587|79161616|FG000|End of Treatment|Other reasons|11|||
44263758|NCT02667587|79161617|FG001|End of Treatment|Other reasons|8|||
44263759|NCT02667587|79161616|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
44263760|NCT02667587|79161617|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
44263761|NCT02667587|79161616|FG000|End of Treatment|Poor/Non-Compliance|0|||
44263762|NCT02667587|79161617|FG001|End of Treatment|Poor/Non-Compliance|1|||
44263763|NCT02667587|79161616|FG000|End of Treatment|Maximum Clinical Benefit|3|||
44263764|NCT02667587|79161617|FG001|End of Treatment|Maximum Clinical Benefit|3|||
44263765|NCT02667587|79161616|FG000|End of Treatment|Participant Withdrew Consent|5|||
44263766|NCT02667587|79161617|FG001|End of Treatment|Participant Withdrew Consent|6|||
44263767|NCT02667587|79161616|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
44263768|NCT02667587|79161617|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
44263769|NCT02667587|79161616|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
44263770|NCT02667587|79161617|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
44263771|NCT02667587|79161616|FG000|End of Treatment|Death|2|||
44263772|NCT02667587|79161617|FG001|End of Treatment|Death|1|||
44263773|NCT02667587|79161616|FG000|End of Treatment|Study Drug Toxicity|74|||
44263774|NCT02667587|79161617|FG001|End of Treatment|Study Drug Toxicity|18|||
44263775|NCT02667587|79161616|FG000|End of Treatment|Disease progression|177|||
44263776|NCT02667587|79161617|FG001|End of Treatment|Disease progression|222|||
44263777|NCT02667587|79161616|FG000|End of Treatment|Lost to Follow-up|1|||
44263778|NCT02667587|79161617|FG001|End of Treatment|Lost to Follow-up|3|||
44263779|NCT02576509|79161625|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
44263780|NCT02576509|79161626|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
44263781|NCT02576509|79161625|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
44263782|NCT02576509|79161626|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
44263783|NCT02576509|79161625|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
44263784|NCT02576509|79161626|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
44263785|NCT02576509|79161625|FG000|Treatment Period|Disease progression|245|||
44263786|NCT02576509|79161626|FG001|Treatment Period|Disease progression|240|||
44263787|NCT02576509|79161625|FG000|Treatment Period|Study drug toxicity|32|||
44263788|NCT02576509|79161626|FG001|Treatment Period|Study drug toxicity|41|||
44263789|NCT02576509|79161625|FG000|Treatment Period|Death|1|||
44263790|NCT02576509|79161626|FG001|Treatment Period|Death|1|||
44263791|NCT02576509|79161625|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
44263792|NCT02576509|79161626|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
44263793|NCT02576509|79161625|FG000|Treatment Period|Participant request to stop treatment|8|||
44263794|NCT02576509|79161626|FG001|Treatment Period|Participant request to stop treatment|17|||
44263795|NCT02576509|79161625|FG000|Treatment Period|Participant withdrew consent|2|||
44263796|NCT02576509|79161626|FG001|Treatment Period|Participant withdrew consent|7|||
44263797|NCT02576509|79161625|FG000|Treatment Period|Lost to Follow-up|0|||
44263798|NCT02576509|79161626|FG001|Treatment Period|Lost to Follow-up|1|||
44263799|NCT02576509|79161625|FG000|Treatment Period|Maximum clinical benefit|1|||
44263800|NCT02576509|79161626|FG001|Treatment Period|Maximum clinical benefit|0|||
44263801|NCT02576509|79161625|FG000|Treatment Period|Poor/non-compliance|0|||
44263802|NCT02576509|79161626|FG001|Treatment Period|Poor/non-compliance|1|||
44263803|NCT02576509|79161625|FG000|Treatment Period|Participant no longer meets criteria|1|||
44263804|NCT02576509|79161626|FG001|Treatment Period|Participant no longer meets criteria|0|||
44263805|NCT02576509|79161625|FG000|Treatment Period|Other reason|2|||
44263806|NCT02576509|79161626|FG001|Treatment Period|Other reason|7|||
44263807|NCT02576509|79161625|FG000|Follow-up Period|Death|41|||
44263808|NCT02576509|79161626|FG001|Follow-up Period|Death|35|||
44263809|NCT02576509|79161625|FG000|Follow-up Period|Participant withdrew consent|7|||
44263810|NCT02576509|79161626|FG001|Follow-up Period|Participant withdrew consent|14|||
44263811|NCT02576509|79161625|FG000|Follow-up Period|Lost to Follow-up|0|||
44263812|NCT02576509|79161626|FG001|Follow-up Period|Lost to Follow-up|1|||
44263813|NCT02576509|79161625|FG000|Follow-up Period|Other reason|1|||
44263814|NCT02576509|79161626|FG001|Follow-up Period|Other reason|2|||
44263815|NCT02203799|79161632|FG000|Overall Study|Withdrawal by Subject|3|||
44263816|NCT02180724|79161639|FG000|Overall Study|Death|26|||
44263817|NCT02180724|79161640|FG001|Overall Study|Death|1|||
44263818|NCT02180724|79161639|FG000|Overall Study|Lost to Follow-up|3|||
44263819|NCT02180724|79161640|FG001|Overall Study|Lost to Follow-up|1|||
44263820|NCT02180724|79161639|FG000|Overall Study|Withdrawal by Subject|4|||
44263821|NCT02180724|79161640|FG001|Overall Study|Withdrawal by Subject|2|||
44263822|NCT02180724|79161639|FG000|Overall Study|PI Decision|5|||
44263823|NCT02180724|79161640|FG001|Overall Study|PI Decision|2|||
44263824|NCT02180724|79161639|FG000|Overall Study|Study terminated by sponsor|54|||
44263825|NCT02180724|79161640|FG001|Overall Study|Study terminated by sponsor|8|||
44448706|NCT00120289|79457342|FG001|Overall Study|Withdrawal by Subject|13|||
44448707|NCT00550446|79457355|FG000|Up To Week 12|Adverse Event|2|||
44448708|NCT00550446|79457356|FG001|Up To Week 12|Adverse Event|2|||
44448709|NCT00550446|79457357|FG002|Up To Week 12|Adverse Event|0|||
44448710|NCT00550446|79457358|FG003|Up To Week 12|Adverse Event|0|||
44448711|NCT00550446|79457359|FG004|Up To Week 12|Adverse Event|2|||
44448712|NCT00550446|79457360|FG005|Up To Week 12|Adverse Event|2|||
44448713|NCT00550446|79457361|FG006|Up To Week 12|Adverse Event|1|||
44448714|NCT00550446|79457362|FG007|Up To Week 12|Adverse Event|0|||
44448715|NCT00550446|79457363|FG008|Up To Week 12|Adverse Event|0|||
44448716|NCT00550446|79457364|FG009|Up To Week 12|Adverse Event|0|||
44448717|NCT00550446|79457365|FG010|Up To Week 12|Adverse Event|0|||
44448718|NCT00550446|79457355|FG000|Up To Week 12|Lack of Efficacy|3|||
44448719|NCT00550446|79457356|FG001|Up To Week 12|Lack of Efficacy|1|||
44448720|NCT00550446|79457357|FG002|Up To Week 12|Lack of Efficacy|0|||
44448721|NCT00550446|79457358|FG003|Up To Week 12|Lack of Efficacy|1|||
44448722|NCT00550446|79457359|FG004|Up To Week 12|Lack of Efficacy|0|||
44448723|NCT00550446|79457360|FG005|Up To Week 12|Lack of Efficacy|3|||
44448724|NCT00550446|79457361|FG006|Up To Week 12|Lack of Efficacy|3|||
44448725|NCT00550446|79457362|FG007|Up To Week 12|Lack of Efficacy|0|||
44263846|NCT01853748|79161672|FG000|Allocation|Withdrawal by Subject|1|||
44263847|NCT01853748|79161673|FG001|Allocation|Withdrawal by Subject|13|||
44263848|NCT01853748|79161672|FG000|Allocation|not sufficient to receive intervention|0|||
44263849|NCT01853748|79161673|FG001|Allocation|not sufficient to receive intervention|1|||
44263850|NCT01853748|79161672|FG000|Follow-Up|Withdrawal by Subject|7|||
44263851|NCT01853748|79161673|FG001|Follow-Up|Withdrawal by Subject|6|||
44263852|NCT01853748|79161672|FG000|Follow-Up|Adverse Event|67|||
44263853|NCT01853748|79161673|FG001|Follow-Up|Adverse Event|7|||
44263854|NCT01853748|79161672|FG000|Follow-Up|not available for data collection|16|||
44263855|NCT01853748|79161673|FG001|Follow-Up|not available for data collection|4|||
44263856|NCT01843374|79161690|FG000|Overall Study|Death|155|||
44263857|NCT01843374|79161691|FG001|Overall Study|Death|313|||
44263858|NCT01843374|79161690|FG000|Overall Study|Withdrawal by Subject|14|||
44263859|NCT01843374|79161691|FG001|Overall Study|Withdrawal by Subject|20|||
44263860|NCT01843374|79161690|FG000|Overall Study|Withdrawing due to Other reason|20|||
44263861|NCT01843374|79161691|FG001|Overall Study|Withdrawing due to Other reason|46|||
44263862|NCT01773733|79161702|FG000|Overall Study|Adverse Event|3286|||
44263863|NCT01773733|79161703|FG001|Overall Study|Adverse Event|540|||
44263864|NCT01773733|79161702|FG000|Overall Study|Pregnancy|28|||
44263865|NCT01773733|79161703|FG001|Overall Study|Pregnancy|0|||
44263866|NCT01773733|79161702|FG000|Overall Study|Other different categories of not compl|55415|||
44263867|NCT01773733|79161703|FG001|Overall Study|Other different categories of not compl|7781|||
44263868|NCT01757535|79161713|FG000|Overall Study|Disease Relapse|143|||
44263869|NCT01757535|79161714|FG001|Overall Study|Disease Relapse|180|||
44263870|NCT01757535|79161713|FG000|Overall Study|Adverse Event|29|||
44263871|NCT01757535|79161714|FG001|Overall Study|Adverse Event|11|||
44263872|NCT01757535|79161713|FG000|Overall Study|Withdrawal by Subject|9|||
44263873|NCT01757535|79161714|FG001|Overall Study|Withdrawal by Subject|13|||
44263874|NCT01757535|79161713|FG000|Overall Study|Miscellaneous|5|||
44263875|NCT01757535|79161714|FG001|Overall Study|Miscellaneous|2|||
44263876|NCT01757535|79161713|FG000|Overall Study|Physician Decision|6|||
44263877|NCT01757535|79161714|FG001|Overall Study|Physician Decision|0|||
44263878|NCT01757535|79161713|FG000|Overall Study|Death|1|||
44263879|NCT01757535|79161714|FG001|Overall Study|Death|2|||
44263880|NCT01110005|79161742|FG000|Overall Study|ineligible|1|||
44263881|NCT01110005|79161743|FG001|Overall Study|ineligible|2|||
44263882|NCT01110005|79161742|FG000|Overall Study|missing consent|3|||
44263883|NCT01110005|79161743|FG001|Overall Study|missing consent|2|||
44263884|NCT01110005|79161742|FG000|Overall Study|Withdrawal by Subject|0|||
44263885|NCT01110005|79161743|FG001|Overall Study|Withdrawal by Subject|1|||
44263886|NCT00840801|79161751|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
44263887|NCT00840801|79161752|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
44263888|NCT00840801|79161753|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
44263889|NCT00840801|79161751|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
44263890|NCT00840801|79161752|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
44263891|NCT00840801|79161753|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
44263892|NCT00840801|79161751|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
44263893|NCT00840801|79161752|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
44263894|NCT00840801|79161753|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
44263895|NCT00840801|79161751|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
44263896|NCT00840801|79161752|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
44448726|NCT00550446|79457363|FG008|Up To Week 12|Lack of Efficacy|0|||
44263897|NCT00840801|79161753|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
44263898|NCT00494234|79161787|FG000|Overall Study|Withdrawal by Subject|1|||
44263899|NCT00494234|79161788|FG001|Overall Study|Withdrawal by Subject|0|||
44263900|NCT00494234|79161787|FG000|Overall Study|Disease progression|11|||
44263901|NCT00494234|79161788|FG001|Overall Study|Disease progression|8|||
44263902|NCT00494234|79161787|FG000|Overall Study|Death|2|||
44263903|NCT00494234|79161788|FG001|Overall Study|Death|1|||
44263904|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
44448727|NCT00550446|79457364|FG009|Up To Week 12|Lack of Efficacy|0|||
44263905|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
44263906|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
44263907|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
44263908|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
44263909|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
44263910|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
44263911|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
44263912|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
44263913|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
44263914|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
44263915|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
44263916|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
44263917|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
44263918|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
44263919|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
44263920|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
44263921|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
44263922|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
44263923|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
44263924|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
44263925|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
44263926|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
44263927|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
44263928|NCT02513160|79163563|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
44263929|NCT02513160|79163564|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
44263930|NCT02513160|79163565|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
44263931|NCT02513160|79163566|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
44263932|NCT02513160|79163563|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
44263933|NCT02513160|79163564|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
44263934|NCT02513160|79163565|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
44263935|NCT02513160|79163566|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
44263936|NCT02513160|79163563|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
44263937|NCT02513160|79163564|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
44263938|NCT02513160|79163565|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
44263939|NCT02513160|79163566|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
44263940|NCT02513160|79163563|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
44263941|NCT02513160|79163564|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
44263942|NCT02513160|79163565|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
44263943|NCT02513160|79163566|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
44263944|NCT02513160|79163563|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
44263945|NCT02513160|79163564|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
44263946|NCT02513160|79163565|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
44263947|NCT02513160|79163566|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
44263948|NCT02513160|79163563|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
44263949|NCT02513160|79163564|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
44263950|NCT02513160|79163565|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
44263951|NCT02513160|79163566|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
44263952|NCT02480010|79163601|FG000|Overall Study|Adverse Event|3|||
44263953|NCT02480010|79163602|FG001|Overall Study|Adverse Event|1|||
44263954|NCT02480010|79163601|FG000|Overall Study|Death|1|||
44263955|NCT02480010|79163602|FG001|Overall Study|Death|0|||
44263956|NCT02480010|79163601|FG000|Overall Study|Insufficient therapeutic response|31|||
44263957|NCT02480010|79163602|FG001|Overall Study|Insufficient therapeutic response|29|||
44263958|NCT02480010|79163601|FG000|Overall Study|Refused Treatment|0|||
44263959|NCT02480010|79163602|FG001|Overall Study|Refused Treatment|3|||
44263960|NCT02512302|79163630|FG000|Period 1|Adverse Event|0|||
44263961|NCT02512302|79163631|FG001|Period 1|Adverse Event|1|||
44263962|NCT02512302|79163632|FG002|Period 1|Adverse Event|0|||
44263963|NCT02512302|79163633|FG003|Period 1|Adverse Event|0|||
44263964|NCT02512302|79163634|FG004|Period 1|Adverse Event|0|||
44263965|NCT02512302|79163635|FG005|Period 1|Adverse Event|0|||
44263966|NCT02512302|79163636|FG006|Period 1|Adverse Event|0|||
44263967|NCT02512302|79163637|FG007|Period 1|Adverse Event|0|||
44263968|NCT02512302|79163638|FG008|Period 1|Adverse Event|0|||
44263969|NCT02512302|79163639|FG009|Period 1|Adverse Event|0|||
44263970|NCT02512302|79163630|FG000|Period 2|Adverse Event|0|||
44263971|NCT02512302|79163631|FG001|Period 2|Adverse Event|0|||
44263972|NCT02512302|79163632|FG002|Period 2|Adverse Event|0|||
44263973|NCT02512302|79163633|FG003|Period 2|Adverse Event|0|||
44263974|NCT02512302|79163634|FG004|Period 2|Adverse Event|0|||
44263975|NCT02512302|79163635|FG005|Period 2|Adverse Event|0|||
44263976|NCT02512302|79163636|FG006|Period 2|Adverse Event|0|||
44263977|NCT02512302|79163637|FG007|Period 2|Adverse Event|0|||
44263978|NCT02512302|79163638|FG008|Period 2|Adverse Event|0|||
44263979|NCT02512302|79163639|FG009|Period 2|Adverse Event|1|||
44263980|NCT02512302|79163630|FG000|Period 3|Lost to Follow-up|0|||
44263981|NCT02512302|79163631|FG001|Period 3|Lost to Follow-up|0|||
44263982|NCT02512302|79163632|FG002|Period 3|Lost to Follow-up|1|||
44263983|NCT02512302|79163633|FG003|Period 3|Lost to Follow-up|0|||
44263984|NCT02512302|79163634|FG004|Period 3|Lost to Follow-up|0|||
44263985|NCT02512302|79163635|FG005|Period 3|Lost to Follow-up|0|||
44263986|NCT02512302|79163636|FG006|Period 3|Lost to Follow-up|0|||
44263987|NCT02512302|79163637|FG007|Period 3|Lost to Follow-up|0|||
44263988|NCT02512302|79163638|FG008|Period 3|Lost to Follow-up|0|||
44263989|NCT02512302|79163639|FG009|Period 3|Lost to Follow-up|0|||
44263990|NCT02512302|79163630|FG000|Period 4|Adverse Event|0|||
44263991|NCT02512302|79163631|FG001|Period 4|Adverse Event|0|||
44263992|NCT02512302|79163632|FG002|Period 4|Adverse Event|0|||
44263993|NCT02512302|79163633|FG003|Period 4|Adverse Event|0|||
44263994|NCT02512302|79163634|FG004|Period 4|Adverse Event|0|||
44263995|NCT02512302|79163635|FG005|Period 4|Adverse Event|0|||
44263996|NCT02512302|79163636|FG006|Period 4|Adverse Event|1|||
44263997|NCT02512302|79163637|FG007|Period 4|Adverse Event|0|||
44263998|NCT02512302|79163638|FG008|Period 4|Adverse Event|0|||
44263999|NCT02512302|79163639|FG009|Period 4|Adverse Event|0|||
44264000|NCT02511678|79163754|FG000|Overall Study|Withdrawal by Subject|2|||
44264001|NCT02511678|79163754|FG000|Overall Study|Lost to Follow-up|4|||
44264002|NCT02511678|79163754|FG000|Overall Study|Death|19|||
44264003|NCT02511678|79163754|FG000|Overall Study|Adverse Event|1|||
44264004|NCT02511678|79163754|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
44264005|NCT02511678|79163754|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
44264006|NCT02511678|79163754|FG000|Overall Study|Required Radiofrequency Ablation|1|||
44264007|NCT02511678|79163754|FG000|Overall Study|Biopsy was Negative|1|||
44264008|NCT02511678|79163754|FG000|Overall Study|Protocol Violation|1|||
44264009|NCT02511678|79163754|FG000|Overall Study|Received Radiation Treatment|1|||
44264010|NCT02518464|79163781|FG000|Overall Study|Adverse Event|2|||
44264011|NCT02510820|79163785|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
44264012|NCT02510820|79163786|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
44264013|NCT02510820|79163785|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44264014|NCT02510820|79163786|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
44264015|NCT02510664|79163796|FG000|Overall Study|Transferred Care|9|||
44264016|NCT02510664|79163797|FG001|Overall Study|Transferred Care|9|||
44264017|NCT02510664|79163798|FG002|Overall Study|Transferred Care|0|||
44264018|NCT02510664|79163796|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
44264019|NCT02510664|79163797|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
44264020|NCT02510664|79163798|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
44264021|NCT02510664|79163796|FG000|Overall Study|Time Constraints|1|||
44264022|NCT02510664|79163797|FG001|Overall Study|Time Constraints|1|||
44264023|NCT02510664|79163798|FG002|Overall Study|Time Constraints|0|||
44264024|NCT01363986|79163829|FG000|Overall Study|Disease progression|1|||
44264025|NCT02478372|79163863|FG000|Overall Study|Protocol Violation|12|||
44264026|NCT02478372|79163864|FG001|Overall Study|Protocol Violation|8|||
44264027|NCT02478372|79163863|FG000|Overall Study|Lost to Follow-up|1|||
44264028|NCT02478372|79163864|FG001|Overall Study|Lost to Follow-up|4|||
44264029|NCT02478372|79163863|FG000|Overall Study|Death|0|||
44354946|NCT01022853|79359369|FG000|Overall Study|Dose-limiting toxicity|0|||
44448728|NCT00550446|79457365|FG010|Up To Week 12|Lack of Efficacy|0|||
44264030|NCT02478372|79163864|FG001|Overall Study|Death|2|||
44264031|NCT01654536|79163876|FG000|Overall Study|Lost to Follow-up|5|||
44264032|NCT01654536|79163877|FG001|Overall Study|Lost to Follow-up|5|||
44264033|NCT01654536|79163876|FG000|Overall Study|Physician Decision|12|||
44264034|NCT01654536|79163877|FG001|Overall Study|Physician Decision|8|||
44264035|NCT01654536|79163876|FG000|Overall Study|Withdrawal by Subject|27|||
44264036|NCT01654536|79163877|FG001|Overall Study|Withdrawal by Subject|25|||
44264037|NCT01654380|79163886|FG000|Part B, Period 1|Physician Decision|0|||
44264038|NCT01654380|79163887|FG001|Part B, Period 1|Physician Decision|0|||
44264039|NCT01654380|79163888|FG002|Part B, Period 1|Physician Decision|1|||
44264040|NCT01654380|79163889|FG003|Part B, Period 1|Physician Decision|0|||
44264041|NCT02477670|79163908|FG000|Stage 1|Adverse Event|2|||
44264042|NCT02477670|79163909|FG001|Stage 1|Adverse Event|7|||
44264043|NCT02477670|79163910|FG002|Stage 1|Adverse Event|0|||
44264044|NCT02477670|79163911|FG003|Stage 1|Adverse Event|0|||
44264045|NCT02477670|79163912|FG004|Stage 1|Adverse Event|0|||
44264046|NCT02477670|79163913|FG005|Stage 1|Adverse Event|0|||
44264047|NCT02477670|79163914|FG006|Stage 1|Adverse Event|0|||
44264048|NCT02477670|79163908|FG000|Stage 1|Lost to Follow-up|0|||
44264049|NCT02477670|79163909|FG001|Stage 1|Lost to Follow-up|2|||
44264050|NCT02477670|79163910|FG002|Stage 1|Lost to Follow-up|0|||
44264051|NCT02477670|79163911|FG003|Stage 1|Lost to Follow-up|0|||
44264052|NCT02477670|79163912|FG004|Stage 1|Lost to Follow-up|0|||
44264053|NCT02477670|79163913|FG005|Stage 1|Lost to Follow-up|0|||
44264054|NCT02477670|79163914|FG006|Stage 1|Lost to Follow-up|0|||
44264055|NCT02477670|79163908|FG000|Stage 1|Withdrawal by Subject|1|||
44264056|NCT02477670|79163909|FG001|Stage 1|Withdrawal by Subject|2|||
44264057|NCT02477670|79163910|FG002|Stage 1|Withdrawal by Subject|0|||
44264058|NCT02477670|79163911|FG003|Stage 1|Withdrawal by Subject|0|||
44264059|NCT02477670|79163912|FG004|Stage 1|Withdrawal by Subject|0|||
44264060|NCT02477670|79163913|FG005|Stage 1|Withdrawal by Subject|0|||
44264061|NCT02477670|79163914|FG006|Stage 1|Withdrawal by Subject|0|||
44264062|NCT02477670|79163908|FG000|Stage 1|Non-compliance with Study Drug|1|||
44264063|NCT02477670|79163909|FG001|Stage 1|Non-compliance with Study Drug|2|||
44264064|NCT02477670|79163910|FG002|Stage 1|Non-compliance with Study Drug|0|||
44264065|NCT02477670|79163911|FG003|Stage 1|Non-compliance with Study Drug|0|||
44264066|NCT02477670|79163912|FG004|Stage 1|Non-compliance with Study Drug|0|||
44264067|NCT02477670|79163913|FG005|Stage 1|Non-compliance with Study Drug|0|||
44264068|NCT02477670|79163914|FG006|Stage 1|Non-compliance with Study Drug|0|||
44264069|NCT02477670|79163908|FG000|Stage 2|Adverse Event|0|||
44264070|NCT02477670|79163909|FG001|Stage 2|Adverse Event|0|||
44264071|NCT02477670|79163910|FG002|Stage 2|Adverse Event|1|||
44264072|NCT02477670|79163911|FG003|Stage 2|Adverse Event|0|||
44264073|NCT02477670|79163912|FG004|Stage 2|Adverse Event|0|||
44264074|NCT02477670|79163913|FG005|Stage 2|Adverse Event|0|||
44264075|NCT02477670|79163914|FG006|Stage 2|Adverse Event|0|||
44264076|NCT02477670|79163908|FG000|Stage 2|Antipsychotic Medication Changed|0|||
44264077|NCT02477670|79163909|FG001|Stage 2|Antipsychotic Medication Changed|0|||
44264078|NCT02477670|79163910|FG002|Stage 2|Antipsychotic Medication Changed|1|||
44264079|NCT02477670|79163911|FG003|Stage 2|Antipsychotic Medication Changed|0|||
44264080|NCT02477670|79163912|FG004|Stage 2|Antipsychotic Medication Changed|0|||
44264081|NCT02477670|79163913|FG005|Stage 2|Antipsychotic Medication Changed|0|||
44264082|NCT02477670|79163914|FG006|Stage 2|Antipsychotic Medication Changed|0|||
44264083|NCT02477670|79163908|FG000|Stage 2|Withdrawal by Subject|0|||
44264084|NCT02477670|79163909|FG001|Stage 2|Withdrawal by Subject|0|||
44264085|NCT02477670|79163910|FG002|Stage 2|Withdrawal by Subject|0|||
44264086|NCT02477670|79163911|FG003|Stage 2|Withdrawal by Subject|1|||
44264087|NCT02477670|79163912|FG004|Stage 2|Withdrawal by Subject|0|||
44264088|NCT02477670|79163913|FG005|Stage 2|Withdrawal by Subject|0|||
44264089|NCT02477670|79163914|FG006|Stage 2|Withdrawal by Subject|0|||
44264090|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
44264091|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
44264092|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
44264093|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
44264094|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Other|2|||
44264095|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
44264096|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
44264097|NCT02509026|79163925|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
44264098|NCT02509026|79163925|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
44264099|NCT02509026|79163925|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
44264100|NCT02509026|79163925|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
44264101|NCT02509026|79163925|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
44264102|NCT02509026|79163925|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
44264103|NCT02476968|79164299|FG000|Overall Study|Other|0|||
44264104|NCT02476968|79164300|FG001|Overall Study|Other|2|||
44264105|NCT02476968|79164301|FG002|Overall Study|Other|0|||
44264106|NCT02476968|79164299|FG000|Overall Study|Lost to Follow-up|10|||
44264107|NCT02476968|79164300|FG001|Overall Study|Lost to Follow-up|0|||
44264108|NCT02476968|79164301|FG002|Overall Study|Lost to Follow-up|1|||
44264109|NCT02476968|79164299|FG000|Overall Study|Death|48|||
44264110|NCT02476968|79164300|FG001|Overall Study|Death|8|||
44264111|NCT02476968|79164301|FG002|Overall Study|Death|1|||
44264112|NCT02476968|79164299|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44264113|NCT02476968|79164300|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44264114|NCT02476968|79164301|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
44264115|NCT02476968|79164299|FG000|Overall Study|Patient decision|37|||
44264116|NCT02476968|79164300|FG001|Overall Study|Patient decision|8|||
44264117|NCT02476968|79164301|FG002|Overall Study|Patient decision|0|||
44264118|NCT02476578|79164322|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
44264119|NCT02476578|79164323|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
44264120|NCT02476578|79164322|FG000|Overall Study|Lost to Follow-up|6|||
44264121|NCT02476578|79164323|FG001|Overall Study|Lost to Follow-up|13|||
44264122|NCT02504892|79164341|FG000|Overall Study|Adverse event-pneumonitis|2|||
44264123|NCT02504502|79164347|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
44264124|NCT02504502|79164348|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
44264125|NCT02504502|79164347|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
44264126|NCT02504502|79164348|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
44264127|NCT04184622|79164371|FG000|Overall Study|Adverse Event|7|||
44264128|NCT04184622|79164372|FG001|Overall Study|Adverse Event|7|||
44264129|NCT04184622|79164373|FG002|Overall Study|Adverse Event|11|||
44264130|NCT04184622|79164374|FG003|Overall Study|Adverse Event|8|||
44264131|NCT04184622|79164371|FG000|Overall Study|Death|4|||
44264132|NCT04184622|79164372|FG001|Overall Study|Death|4|||
44264133|NCT04184622|79164373|FG002|Overall Study|Death|2|||
44264134|NCT04184622|79164374|FG003|Overall Study|Death|1|||
44264135|NCT04184622|79164371|FG000|Overall Study|Lost to Follow-up|41|||
44264136|NCT04184622|79164372|FG001|Overall Study|Lost to Follow-up|19|||
44264137|NCT04184622|79164373|FG002|Overall Study|Lost to Follow-up|20|||
44264138|NCT04184622|79164374|FG003|Overall Study|Lost to Follow-up|15|||
44264139|NCT04184622|79164371|FG000|Overall Study|Missing Weight at Week 72|1|||
44264140|NCT04184622|79164372|FG001|Overall Study|Missing Weight at Week 72|0|||
44264141|NCT04184622|79164373|FG002|Overall Study|Missing Weight at Week 72|1|||
44264142|NCT04184622|79164374|FG003|Overall Study|Missing Weight at Week 72|0|||
44264143|NCT04184622|79164371|FG000|Overall Study|Other - as reported by the investigator|22|||
44264144|NCT04184622|79164372|FG001|Overall Study|Other - as reported by the investigator|7|||
44264145|NCT04184622|79164373|FG002|Overall Study|Other - as reported by the investigator|5|||
44264146|NCT04184622|79164374|FG003|Overall Study|Other - as reported by the investigator|12|||
44264147|NCT04184622|79164371|FG000|Overall Study|Physician Decision|0|||
44264148|NCT04184622|79164372|FG001|Overall Study|Physician Decision|0|||
44264149|NCT04184622|79164373|FG002|Overall Study|Physician Decision|3|||
44264150|NCT04184622|79164374|FG003|Overall Study|Physician Decision|1|||
44264151|NCT04184622|79164371|FG000|Overall Study|Pregnancy|4|||
44264152|NCT04184622|79164372|FG001|Overall Study|Pregnancy|4|||
44264153|NCT04184622|79164373|FG002|Overall Study|Pregnancy|3|||
44264154|NCT04184622|79164374|FG003|Overall Study|Pregnancy|5|||
44264155|NCT04184622|79164371|FG000|Overall Study|Protocol Deviation|1|||
44354947|NCT01022853|79359370|FG001|Overall Study|Dose-limiting toxicity|0|||
44354948|NCT01022853|79359371|FG002|Overall Study|Dose-limiting toxicity|0|||
44354949|NCT01022853|79359372|FG003|Overall Study|Dose-limiting toxicity|0|||
44354950|NCT01022853|79359373|FG004|Overall Study|Dose-limiting toxicity|1|||
44354951|NCT01022853|79359369|FG000|Overall Study|Withdrawal by Subject|0|||
44354952|NCT01022853|79359370|FG001|Overall Study|Withdrawal by Subject|1|||
44354953|NCT01022853|79359371|FG002|Overall Study|Withdrawal by Subject|1|||
44354954|NCT01022853|79359372|FG003|Overall Study|Withdrawal by Subject|1|||
44354955|NCT01022853|79359373|FG004|Overall Study|Withdrawal by Subject|0|||
44354956|NCT01022853|79359369|FG000|Overall Study|Other not stated above|1|||
44354957|NCT01022853|79359370|FG001|Overall Study|Other not stated above|0|||
44354958|NCT01022853|79359371|FG002|Overall Study|Other not stated above|1|||
44354959|NCT01022853|79359372|FG003|Overall Study|Other not stated above|0|||
44354960|NCT01022853|79359373|FG004|Overall Study|Other not stated above|0|||
44354961|NCT01034709|79359390|FG000|Overall Study|Protocol Violation|9|||
44354962|NCT01034709|79359391|FG001|Overall Study|Protocol Violation|16|||
44354963|NCT00937768|79359399|FG000|Overall Study|Refused Further Treatment|3|||
44354964|NCT00937768|79359400|FG001|Overall Study|Refused Further Treatment|2|||
44354965|NCT00937768|79359399|FG000|Overall Study|Disease Progression|1|||
44354966|NCT00937768|79359400|FG001|Overall Study|Disease Progression|1|||
44354967|NCT00937768|79359399|FG000|Overall Study|Alternate Treatment|0|||
44354968|NCT00937768|79359400|FG001|Overall Study|Alternate Treatment|1|||
44354969|NCT00937768|79359399|FG000|Overall Study|No Further Funding|4|||
44354970|NCT00937768|79359400|FG001|Overall Study|No Further Funding|4|||
44354971|NCT00940888|79359406|FG000|Overall Study|Unsuccessful Implant|4|||
44354972|NCT00940888|79359406|FG000|Overall Study|Death|461|||
44354973|NCT00940888|79359406|FG000|Overall Study|Withdrawn - Non-Death|364|||
44354974|NCT00940888|79359406|FG000|Overall Study|Lost to Follow-up|6|||
44354975|NCT01189266|79359413|FG000|Overall Study|Adverse Event|1|||
44354976|NCT01189266|79359414|FG001|Overall Study|Adverse Event|0|||
44354977|NCT01189266|79359415|FG002|Overall Study|Adverse Event|5|||
44354978|NCT01189266|79359413|FG000|Overall Study|Death|0|||
44354979|NCT01189266|79359414|FG001|Overall Study|Death|0|||
44354980|NCT01189266|79359415|FG002|Overall Study|Death|5|||
44354981|NCT01189266|79359413|FG000|Overall Study|Lack of Efficacy|4|||
44354982|NCT01189266|79359414|FG001|Overall Study|Lack of Efficacy|5|||
44354983|NCT01189266|79359415|FG002|Overall Study|Lack of Efficacy|44|||
44354984|NCT01189266|79359413|FG000|Overall Study|Physician Decision|0|||
44354985|NCT01189266|79359414|FG001|Overall Study|Physician Decision|0|||
44354986|NCT01189266|79359415|FG002|Overall Study|Physician Decision|1|||
44354987|NCT01189266|79359413|FG000|Overall Study|Protocol Violation|0|||
44354988|NCT01189266|79359414|FG001|Overall Study|Protocol Violation|1|||
44354989|NCT01189266|79359415|FG002|Overall Study|Protocol Violation|1|||
44354990|NCT01189266|79359413|FG000|Overall Study|Withdrawal by Subject|0|||
44354991|NCT01189266|79359414|FG001|Overall Study|Withdrawal by Subject|0|||
44354992|NCT01189266|79359415|FG002|Overall Study|Withdrawal by Subject|1|||
44354993|NCT01189266|79359413|FG000|Overall Study|Patient refuses further therapy|1|||
44354994|NCT01189266|79359414|FG001|Overall Study|Patient refuses further therapy|0|||
44354995|NCT01189266|79359415|FG002|Overall Study|Patient refuses further therapy|7|||
44354996|NCT01189266|79359413|FG000|Overall Study|No treatment|0|||
44264156|NCT04184622|79164372|FG001|Overall Study|Protocol Deviation|0|||
44354997|NCT01189266|79359414|FG001|Overall Study|No treatment|0|||
44354998|NCT01189266|79359415|FG002|Overall Study|No treatment|1|||
44354999|NCT01189032|79359427|FG000|Overall Study|Adverse Event|1|||
44355000|NCT01189032|79359428|FG001|Overall Study|Adverse Event|3|||
44355001|NCT01189032|79359429|FG002|Overall Study|Adverse Event|4|||
44355002|NCT01189032|79359427|FG000|Overall Study|Lack of Efficacy|2|||
44355003|NCT01189032|79359428|FG001|Overall Study|Lack of Efficacy|3|||
44355004|NCT01189032|79359429|FG002|Overall Study|Lack of Efficacy|0|||
44355005|NCT01189032|79359427|FG000|Overall Study|Withdrawal by Subject|1|||
44355006|NCT01189032|79359428|FG001|Overall Study|Withdrawal by Subject|0|||
44355007|NCT01189032|79359429|FG002|Overall Study|Withdrawal by Subject|1|||
44355008|NCT01189032|79359427|FG000|Overall Study|Protocol Violation|1|||
44355009|NCT01189032|79359428|FG001|Overall Study|Protocol Violation|1|||
44355010|NCT01189032|79359429|FG002|Overall Study|Protocol Violation|1|||
44355011|NCT01188798|79359439|FG000|Overall Study|Death|0|||
44355012|NCT01188798|79359440|FG001|Overall Study|Death|1|||
44355013|NCT01188798|79359439|FG000|Overall Study|Required additional transplant|1|||
44355014|NCT01188798|79359440|FG001|Overall Study|Required additional transplant|1|||
44355015|NCT01188798|79359439|FG000|Overall Study|Protocol closure|1|||
44355016|NCT01188798|79359440|FG001|Overall Study|Protocol closure|1|||
44355017|NCT01183104|79359449|FG000|Overall Study|Adverse Event|8|||
44355018|NCT01183104|79359450|FG001|Overall Study|Adverse Event|6|||
44355019|NCT01183104|79359449|FG000|Overall Study|Death|0|||
44355020|NCT01183104|79359450|FG001|Overall Study|Death|1|||
44355021|NCT01183104|79359449|FG000|Overall Study|Lost to Follow-up|14|||
44355022|NCT01183104|79359450|FG001|Overall Study|Lost to Follow-up|7|||
44355023|NCT01183104|79359449|FG000|Overall Study|Physician Decision|5|||
44355024|NCT01183104|79359450|FG001|Overall Study|Physician Decision|8|||
44355025|NCT01183104|79359449|FG000|Overall Study|Withdrawal by Subject|6|||
44355026|NCT01183104|79359450|FG001|Overall Study|Withdrawal by Subject|11|||
44355027|NCT01183104|79359449|FG000|Overall Study|Nonparticipation in Extension Study|39|||
44355028|NCT01183104|79359450|FG001|Overall Study|Nonparticipation in Extension Study|50|||
44355029|NCT01183104|79359449|FG000|Overall Study|Did not receive study drug|5|||
44355030|NCT01183104|79359450|FG001|Overall Study|Did not receive study drug|9|||
44355031|NCT01163292|79359458|FG000|Overall Study|Lack of Efficacy|9|||
44355032|NCT01163292|79359459|FG001|Overall Study|Lack of Efficacy|0|||
44355033|NCT01163292|79359458|FG000|Overall Study|Adverse Event|6|||
44355034|NCT01163292|79359459|FG001|Overall Study|Adverse Event|0|||
44355035|NCT01163292|79359458|FG000|Overall Study|Initiation of biological therapy|0|||
44355036|NCT01163292|79359459|FG001|Overall Study|Initiation of biological therapy|15|||
44355037|NCT01163292|79359458|FG000|Overall Study|Sufficient response to adalimumab|8|||
44355038|NCT01163292|79359459|FG001|Overall Study|Sufficient response to adalimumab|0|||
44355039|NCT01163292|79359458|FG000|Overall Study|Refusal to receive adalimumab|7|||
44355040|NCT01163292|79359459|FG001|Overall Study|Refusal to receive adalimumab|0|||
44355041|NCT01163292|79359458|FG000|Overall Study|Economic reasons|6|||
44355042|NCT01163292|79359459|FG001|Overall Study|Economic reasons|0|||
44355043|NCT01163292|79359458|FG000|Overall Study|No further visits|5|||
44355044|NCT01163292|79359459|FG001|Overall Study|No further visits|7|||
44355045|NCT00950248|79359467|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
44355046|NCT00950248|79359468|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
44355047|NCT00950248|79359469|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
44355048|NCT00950248|79359467|FG000|Year 1: Baseline|worsening of symptoms|2|||
44355049|NCT00950248|79359468|FG001|Year 1: Baseline|worsening of symptoms|0|||
44355050|NCT00950248|79359469|FG002|Year 1: Baseline|worsening of symptoms|0|||
44355051|NCT00950248|79359467|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
44355052|NCT00950248|79359468|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
44355053|NCT00950248|79359469|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
44355054|NCT00950248|79359467|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
44355055|NCT00950248|79359468|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
44355056|NCT00950248|79359469|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
44355057|NCT00950248|79359467|FG000|Year 2&3 Treatment Randomization|Death|0|||
44355058|NCT00950248|79359468|FG001|Year 2&3 Treatment Randomization|Death|0|||
44355059|NCT00950248|79359469|FG002|Year 2&3 Treatment Randomization|Death|1|||
44355060|NCT00950248|79359467|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
44355061|NCT00950248|79359468|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
44355062|NCT00950248|79359469|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
44355063|NCT00950170|79359476|FG000|Overall Study|Parent/Legal Guardian Request|1|||
44355064|NCT00950170|79359476|FG000|Overall Study|Adverse Event|2|||
44355065|NCT00950170|79359476|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
44355066|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
44355067|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
44355068|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
44355069|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
44355070|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
44355071|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
44448729|NCT00550446|79457355|FG000|Up To Week 12|Lost to Follow-up|0|||
44355072|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
44355073|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
44355074|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
44355075|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
44355076|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
44355077|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
44355078|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
44355079|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
44355080|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
44355081|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
44355082|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
44355083|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
44355084|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
44355085|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
44355086|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
44355087|NCT01227824|79359500|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
44355088|NCT01227824|79359501|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
44355089|NCT01227824|79359502|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
44355090|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
44355091|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
44355092|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
44355093|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
44355094|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
44355095|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
44355096|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
44355097|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
44355098|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
44355099|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
44355100|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
44355101|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
44355102|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
44355103|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
44355104|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
44355105|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
44355106|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
44355107|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
44355108|NCT01227824|79359500|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
44355109|NCT01227824|79359501|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
44355110|NCT01227824|79359502|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
44355111|NCT00949702|79359509|FG000|Overall Study|Death|40|||
44355112|NCT00949702|79359509|FG000|Overall Study|Disease progression|7|||
44355113|NCT00949702|79359509|FG000|Overall Study|Withdrawal of consent|1|||
44355114|NCT01034631|79359516|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
44355115|NCT01034631|79359517|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
44355116|NCT01034631|79359518|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
44355117|NCT01034631|79359516|FG000|Phase II|Not Evaluable per protocol|0|||
44355118|NCT01034631|79359517|FG001|Phase II|Not Evaluable per protocol|0|||
44355119|NCT01034631|79359518|FG002|Phase II|Not Evaluable per protocol|2|||
44355120|NCT01034631|79359516|FG000|Phase II|Determined Ineligible per protocol|0|||
44355121|NCT01034631|79359517|FG001|Phase II|Determined Ineligible per protocol|1|||
44355122|NCT01034631|79359518|FG002|Phase II|Determined Ineligible per protocol|0|||
44355123|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
44355124|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
44355125|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
44355126|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
44355127|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
44355128|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
44355129|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
44355130|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
44355131|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
44355132|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
44355133|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
44355134|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
44355135|NCT01227668|79359530|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
44355136|NCT01227668|79359531|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
44355137|NCT01227668|79359530|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
44355138|NCT01227668|79359531|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
44355139|NCT01227668|79359530|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
44355140|NCT01227668|79359531|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
44355141|NCT01227668|79359530|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
44355142|NCT01227668|79359531|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
44355143|NCT01227668|79359530|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
44355144|NCT01227668|79359531|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
44355145|NCT01227668|79359530|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
44355146|NCT01227668|79359531|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
44355147|NCT01227512|79359543|FG000|Overall Study|Physician Decision|6|||
44355148|NCT01227512|79359544|FG001|Overall Study|Physician Decision|6|||
44355149|NCT01227512|79359543|FG000|Overall Study|Adverse Event|4|||
44355150|NCT01227512|79359544|FG001|Overall Study|Adverse Event|3|||
44355151|NCT01227512|79359543|FG000|Overall Study|Withdrawal by Subject|3|||
44355152|NCT01227512|79359544|FG001|Overall Study|Withdrawal by Subject|0|||
44355153|NCT01227512|79359543|FG000|Overall Study|Participant met withdrawal criteria|0|||
44355154|NCT01227512|79359544|FG001|Overall Study|Participant met withdrawal criteria|1|||
44355155|NCT01227278|79359554|FG000|Overall Study|Withdrawal by Subject|4|||
44355156|NCT01227278|79359555|FG001|Overall Study|Withdrawal by Subject|4|||
44355157|NCT01227278|79359554|FG000|Overall Study|Death|0|||
44355158|NCT01227278|79359555|FG001|Overall Study|Death|2|||
44355159|NCT01227278|79359554|FG000|Overall Study|Other|1|||
44355160|NCT01227278|79359555|FG001|Overall Study|Other|2|||
44355161|NCT01034397|79359563|FG000|Overall Study|Lack of compliance|0|||
44355162|NCT01034397|79359564|FG001|Overall Study|Lack of compliance|1|||
44355163|NCT01034397|79359563|FG000|Overall Study|Lack of Efficacy|3|||
44355164|NCT01034397|79359564|FG001|Overall Study|Lack of Efficacy|0|||
44355165|NCT01034397|79359563|FG000|Overall Study|Adverse Event|4|||
44355166|NCT01034397|79359564|FG001|Overall Study|Adverse Event|0|||
44355167|NCT01034397|79359563|FG000|Overall Study|Other|0|||
44355168|NCT01034397|79359564|FG001|Overall Study|Other|1|||
44355169|NCT01227044|79359581|FG000|Overall Study|Lost to Follow-up|5|||
44355170|NCT01227044|79359582|FG001|Overall Study|Lost to Follow-up|7|||
44355171|NCT01227044|79359581|FG000|Overall Study|Discontinued Intervention|1|||
44355172|NCT01227044|79359582|FG001|Overall Study|Discontinued Intervention|2|||
44355173|NCT01225952|79359591|FG000|Overall Study|Lost to Follow-up|1|||
44355174|NCT01225952|79359592|FG001|Overall Study|Lost to Follow-up|0|||
44355175|NCT01225952|79359593|FG002|Overall Study|Lost to Follow-up|0|||
44355176|NCT01225952|79359591|FG000|Overall Study|Study Eye Explanted|0|||
44355177|NCT01225952|79359592|FG001|Overall Study|Study Eye Explanted|0|||
44355178|NCT01225952|79359593|FG002|Overall Study|Study Eye Explanted|1|||
44355179|NCT01225952|79359591|FG000|Overall Study|Withdrawal by Subject|4|||
44355180|NCT01225952|79359592|FG001|Overall Study|Withdrawal by Subject|4|||
44355181|NCT01225952|79359593|FG002|Overall Study|Withdrawal by Subject|5|||
44355182|NCT01225952|79359591|FG000|Overall Study|Surgical complications|1|||
44355183|NCT01225952|79359592|FG001|Overall Study|Surgical complications|0|||
44355184|NCT01225952|79359593|FG002|Overall Study|Surgical complications|0|||
44355185|NCT01034163|79359603|FG000|Overall Study|Treatment completed as per protocol|8|||
44355186|NCT01034163|79359604|FG001|Overall Study|Treatment completed as per protocol|7|||
44355187|NCT01034163|79359603|FG000|Overall Study|Withdrawal by Subject|8|||
44355188|NCT01034163|79359604|FG001|Overall Study|Withdrawal by Subject|2|||
44355189|NCT01034163|79359603|FG000|Overall Study|Protocol deviation|1|||
44355190|NCT01034163|79359604|FG001|Overall Study|Protocol deviation|0|||
44355191|NCT01034163|79359603|FG000|Overall Study|Disease progression|3|||
44355192|NCT01034163|79359604|FG001|Overall Study|Disease progression|4|||
44355193|NCT01034163|79359603|FG000|Overall Study|Adverse Event|6|||
44355194|NCT01034163|79359604|FG001|Overall Study|Adverse Event|0|||
44355195|NCT01034163|79359603|FG000|Overall Study|Administrative problems|0|||
44355196|NCT01034163|79359604|FG001|Overall Study|Administrative problems|1|||
44355197|NCT01034163|79359603|FG000|Overall Study|Abnormal laboratory value|1|||
44355198|NCT01034163|79359604|FG001|Overall Study|Abnormal laboratory value|0|||
44355199|NCT01033851|79359612|FG000|Overall Study|Withdrawal by Subject|3|||
44355200|NCT01033851|79359613|FG001|Overall Study|Withdrawal by Subject|7|||
44355201|NCT01162122|79359621|FG000|Overall Study|Withdrawal by Subject|52|||
44355202|NCT01162122|79359622|FG001|Overall Study|Withdrawal by Subject|43|||
44355203|NCT01162122|79359621|FG000|Overall Study|Lost to Follow-up|73|||
44355204|NCT01162122|79359622|FG001|Overall Study|Lost to Follow-up|91|||
44355205|NCT01162122|79359621|FG000|Overall Study|Adverse Event|3|||
44355206|NCT01162122|79359622|FG001|Overall Study|Adverse Event|2|||
44355207|NCT01162122|79359621|FG000|Overall Study|Death|51|||
44355208|NCT01162122|79359622|FG001|Overall Study|Death|46|||
44355209|NCT01162122|79359621|FG000|Overall Study|Protocol Violation|2|||
44355210|NCT01162122|79359622|FG001|Overall Study|Protocol Violation|2|||
44355211|NCT01162122|79359621|FG000|Overall Study|Inappropriate enrollment|5|||
44355212|NCT01162122|79359622|FG001|Overall Study|Inappropriate enrollment|4|||
44355213|NCT01162122|79359621|FG000|Overall Study|Administrative reason|1|||
44355214|NCT01162122|79359622|FG001|Overall Study|Administrative reason|1|||
44355215|NCT01162122|79359621|FG000|Overall Study|Unable to classify|3|||
44355216|NCT01162122|79359622|FG001|Overall Study|Unable to classify|7|||
44355217|NCT01162122|79359621|FG000|Overall Study|Missing primary reason|1|||
44355218|NCT01162122|79359622|FG001|Overall Study|Missing primary reason|0|||
44355219|NCT01033071|79359634|FG000|Overall Study|Adverse Event|28|||
44355220|NCT01033071|79359635|FG001|Overall Study|Adverse Event|51|||
44355221|NCT01033071|79359636|FG002|Overall Study|Adverse Event|26|||
44355222|NCT01033071|79359634|FG000|Overall Study|Protocol Violation|0|||
44355223|NCT01033071|79359635|FG001|Overall Study|Protocol Violation|2|||
44355224|NCT01033071|79359636|FG002|Overall Study|Protocol Violation|1|||
44355225|NCT01033071|79359634|FG000|Overall Study|Lost to Follow-up|4|||
44355226|NCT01033071|79359635|FG001|Overall Study|Lost to Follow-up|5|||
44355227|NCT01033071|79359636|FG002|Overall Study|Lost to Follow-up|5|||
44355228|NCT01033071|79359634|FG000|Overall Study|Withdrawal by Subject|17|||
44355229|NCT01033071|79359635|FG001|Overall Study|Withdrawal by Subject|14|||
44355230|NCT01033071|79359636|FG002|Overall Study|Withdrawal by Subject|11|||
44355231|NCT01033071|79359634|FG000|Overall Study|Lack of Efficacy|0|||
44355232|NCT01033071|79359635|FG001|Overall Study|Lack of Efficacy|1|||
44355233|NCT01033071|79359636|FG002|Overall Study|Lack of Efficacy|1|||
44355234|NCT01033071|79359634|FG000|Overall Study|Other|6|||
44355235|NCT01033071|79359635|FG001|Overall Study|Other|4|||
44355236|NCT01033071|79359636|FG002|Overall Study|Other|3|||
44355237|NCT01032915|79359648|FG000|Overall Study|Adverse Event|2|||
44355238|NCT01032915|79359649|FG001|Overall Study|Adverse Event|2|||
44355239|NCT01032915|79359650|FG002|Overall Study|Adverse Event|1|||
44355240|NCT01032915|79359651|FG003|Overall Study|Adverse Event|1|||
44355241|NCT01032915|79359648|FG000|Overall Study|Abnormal test procedure result|0|||
44355242|NCT01032915|79359649|FG001|Overall Study|Abnormal test procedure result|0|||
44355243|NCT01032915|79359650|FG002|Overall Study|Abnormal test procedure result|1|||
44355244|NCT01032915|79359651|FG003|Overall Study|Abnormal test procedure result|0|||
44355245|NCT01032915|79359648|FG000|Overall Study|Withdrawal by Subject|0|||
44355246|NCT01032915|79359649|FG001|Overall Study|Withdrawal by Subject|3|||
44355247|NCT01032915|79359650|FG002|Overall Study|Withdrawal by Subject|1|||
44355248|NCT01032915|79359651|FG003|Overall Study|Withdrawal by Subject|1|||
44355249|NCT01032915|79359648|FG000|Overall Study|Administrative reasons|5|||
44355250|NCT01032915|79359649|FG001|Overall Study|Administrative reasons|6|||
44355251|NCT01032915|79359650|FG002|Overall Study|Administrative reasons|4|||
44355252|NCT01032915|79359651|FG003|Overall Study|Administrative reasons|4|||
44355253|NCT01032915|79359648|FG000|Overall Study|Protocol Violation|1|||
44355254|NCT01032915|79359649|FG001|Overall Study|Protocol Violation|0|||
44355255|NCT01032915|79359650|FG002|Overall Study|Protocol Violation|0|||
44355256|NCT01032915|79359651|FG003|Overall Study|Protocol Violation|1|||
44355257|NCT01161498|79359663|FG000|Overall Study|Disease Progression|0|||
44355258|NCT01161498|79359664|FG001|Overall Study|Disease Progression|1|||
44355259|NCT01180998|79359673|FG000|Overall Study|Poor Vision|0|||
44355260|NCT01180998|79359674|FG001|Overall Study|Poor Vision|2|||
44355261|NCT01180998|79359675|FG002|Overall Study|Poor Vision|2|||
44355262|NCT01180998|79359673|FG000|Overall Study|Lost to Follow-up|0|||
44355263|NCT01180998|79359674|FG001|Overall Study|Lost to Follow-up|0|||
44355264|NCT01180998|79359675|FG002|Overall Study|Lost to Follow-up|1|||
44355265|NCT01180998|79359673|FG000|Overall Study|Protocol Violation|1|||
44355266|NCT01180998|79359674|FG001|Overall Study|Protocol Violation|2|||
44355267|NCT01180998|79359675|FG002|Overall Study|Protocol Violation|0|||
44355268|NCT01180998|79359673|FG000|Overall Study|Withdrawal by Subject|0|||
44355269|NCT01180998|79359674|FG001|Overall Study|Withdrawal by Subject|0|||
44355270|NCT01180998|79359675|FG002|Overall Study|Withdrawal by Subject|1|||
44355271|NCT01180998|79359673|FG000|Overall Study|Poor comfort|3|||
44355272|NCT01180998|79359674|FG001|Overall Study|Poor comfort|0|||
44355273|NCT01180998|79359675|FG002|Overall Study|Poor comfort|4|||
44355274|NCT01180998|79359673|FG000|Overall Study|Poor lens handling|0|||
44355275|NCT01180998|79359674|FG001|Overall Study|Poor lens handling|0|||
44355276|NCT01180998|79359675|FG002|Overall Study|Poor lens handling|2|||
44355277|NCT01029795|79359686|FG000|Overall Study|Entry Criteria Not Met|2|||
44355278|NCT01029795|79359687|FG001|Overall Study|Entry Criteria Not Met|1|||
44355279|NCT01029795|79359686|FG000|Overall Study|Physician Decision|2|||
44355280|NCT01029795|79359687|FG001|Overall Study|Physician Decision|1|||
44355281|NCT01029795|79359686|FG000|Overall Study|Sponsor Decision|11|||
44355282|NCT01029795|79359687|FG001|Overall Study|Sponsor Decision|17|||
44355283|NCT01029795|79359686|FG000|Overall Study|Withdrawal by Subject|1|||
44355284|NCT01029795|79359687|FG001|Overall Study|Withdrawal by Subject|3|||
44355285|NCT01032837|79359697|FG000|Overall Study|Adverse event/internal illness|0|||
44355286|NCT01032837|79359698|FG001|Overall Study|Adverse event/internal illness|1|||
44355287|NCT01032837|79359699|FG002|Overall Study|Adverse event/internal illness|0|||
44355288|NCT01032837|79359700|FG003|Overall Study|Adverse event/internal illness|1|||
44355289|NCT01032837|79359697|FG000|Overall Study|Withdrew consent|0|||
44355290|NCT01032837|79359698|FG001|Overall Study|Withdrew consent|2|||
44355291|NCT01032837|79359699|FG002|Overall Study|Withdrew consent|0|||
44355292|NCT01032837|79359700|FG003|Overall Study|Withdrew consent|1|||
44355293|NCT01032837|79359697|FG000|Overall Study|Failed to return|0|||
44355294|NCT01032837|79359698|FG001|Overall Study|Failed to return|0|||
44355295|NCT01032837|79359699|FG002|Overall Study|Failed to return|1|||
44355296|NCT01032837|79359700|FG003|Overall Study|Failed to return|0|||
44355297|NCT01032837|79359697|FG000|Overall Study|Refused treatment|0|||
44355298|NCT01032837|79359698|FG001|Overall Study|Refused treatment|0|||
44355299|NCT01032837|79359699|FG002|Overall Study|Refused treatment|0|||
44355300|NCT01032837|79359700|FG003|Overall Study|Refused treatment|1|||
44355301|NCT01180296|79359712|FG000|Overall Study|Protocol Violation|1|||
44355302|NCT01180296|79359713|FG001|Overall Study|Protocol Violation|2|||
44355303|NCT01160640|79359723|FG000|Overall Study|Physician Decision|3|||
44355304|NCT01160640|79359724|FG001|Overall Study|Physician Decision|3|||
44355305|NCT01160640|79359723|FG000|Overall Study|Incarceration|1|||
44355306|NCT01160640|79359724|FG001|Overall Study|Incarceration|0|||
44355307|NCT01160640|79359723|FG000|Overall Study|Withdrawal by Subject|0|||
44355308|NCT01160640|79359724|FG001|Overall Study|Withdrawal by Subject|3|||
44355309|NCT01160484|79359732|FG000|Overall Study|Lack of Efficacy|9|||
44355310|NCT01160484|79359732|FG000|Overall Study|Adverse Event|6|||
44355311|NCT01160484|79359732|FG000|Overall Study|Withdrawal by Subject|2|||
44355312|NCT01160484|79359732|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
44355313|NCT01032291|79359739|FG000|Safety Lead-in|Adverse Event|1|||
44355314|NCT01032291|79359740|FG001|Safety Lead-in|Adverse Event|0|||
44355315|NCT01032291|79359741|FG002|Safety Lead-in|Adverse Event|0|||
44355316|NCT01032291|79359739|FG000|Safety Lead-in|Death|1|||
44355317|NCT01032291|79359740|FG001|Safety Lead-in|Death|0|||
44355318|NCT01032291|79359741|FG002|Safety Lead-in|Death|0|||
44355319|NCT01032291|79359739|FG000|Proof of Concept|Adverse Event|0|||
44355320|NCT01032291|79359740|FG001|Proof of Concept|Adverse Event|5|||
44355321|NCT01032291|79359741|FG002|Proof of Concept|Adverse Event|1|||
44355322|NCT01032291|79359739|FG000|Proof of Concept|Death|0|||
44355323|NCT01032291|79359740|FG001|Proof of Concept|Death|1|||
44355324|NCT01032291|79359741|FG002|Proof of Concept|Death|2|||
44355325|NCT01032291|79359739|FG000|Proof of Concept|Lack of Efficacy|0|||
44355326|NCT01032291|79359740|FG001|Proof of Concept|Lack of Efficacy|1|||
44355327|NCT01032291|79359741|FG002|Proof of Concept|Lack of Efficacy|0|||
44355328|NCT01032291|79359739|FG000|Proof of Concept|Never Received Study Drug|0|||
44355329|NCT01032291|79359740|FG001|Proof of Concept|Never Received Study Drug|1|||
44355330|NCT01032291|79359741|FG002|Proof of Concept|Never Received Study Drug|0|||
44355331|NCT01159938|79359755|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
44355332|NCT01159938|79359756|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
44355333|NCT01159938|79359757|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
44355334|NCT01159938|79359758|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
44355335|NCT01159938|79359759|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
44355336|NCT01029405|79359784|FG000|Overall Study|Withdrawal by Subject|0|||
44355337|NCT01029405|79359785|FG001|Overall Study|Withdrawal by Subject|1|||
44355338|NCT01029405|79359786|FG002|Overall Study|Withdrawal by Subject|2|||
44355339|NCT01029405|79359787|FG003|Overall Study|Withdrawal by Subject|0|||
44355340|NCT01029405|79359784|FG000|Overall Study|Protocol Violation|0|||
44355341|NCT01029405|79359785|FG001|Overall Study|Protocol Violation|0|||
44355342|NCT01029405|79359786|FG002|Overall Study|Protocol Violation|0|||
44355343|NCT01029405|79359787|FG003|Overall Study|Protocol Violation|1|||
44355344|NCT01029405|79359784|FG000|Overall Study|Adverse Event|0|||
44355345|NCT01029405|79359785|FG001|Overall Study|Adverse Event|0|||
44355346|NCT01029405|79359786|FG002|Overall Study|Adverse Event|1|||
44355347|NCT01029405|79359787|FG003|Overall Study|Adverse Event|1|||
44355348|NCT01029405|79359784|FG000|Overall Study|Lost to Follow-up|2|||
44355349|NCT01029405|79359785|FG001|Overall Study|Lost to Follow-up|1|||
44355350|NCT01029405|79359786|FG002|Overall Study|Lost to Follow-up|1|||
44355351|NCT01029405|79359787|FG003|Overall Study|Lost to Follow-up|2|||
44355352|NCT01029405|79359784|FG000|Overall Study|Other|0|||
44355353|NCT01029405|79359785|FG001|Overall Study|Other|1|||
44355354|NCT01029405|79359786|FG002|Overall Study|Other|0|||
44355355|NCT01029405|79359787|FG003|Overall Study|Other|1|||
44355356|NCT01021683|79359797|FG000|Overall Study|Lack of Efficacy|12|||
44355357|NCT01021683|79359797|FG000|Overall Study|Recovery of neutrophil count|51|||
44355358|NCT01021683|79359797|FG000|Overall Study|Other|8|||
44355359|NCT01021293|79359803|FG000|Overall Study|Serious Adverse Event|2|||
44355360|NCT01021293|79359804|FG001|Overall Study|Serious Adverse Event|1|||
44355361|NCT01021293|79359803|FG000|Overall Study|Adverse Event|2|||
44355362|NCT01021293|79359804|FG001|Overall Study|Adverse Event|1|||
44355363|NCT01021293|79359803|FG000|Overall Study|Withdrawal by Subject|1|||
44355364|NCT01021293|79359804|FG001|Overall Study|Withdrawal by Subject|3|||
44355365|NCT01021293|79359803|FG000|Overall Study|Migrated/moved from study area|6|||
44355366|NCT01021293|79359804|FG001|Overall Study|Migrated/moved from study area|18|||
44355367|NCT01021293|79359803|FG000|Overall Study|Lost to Follow-up|1|||
44355368|NCT01021293|79359804|FG001|Overall Study|Lost to Follow-up|1|||
44355369|NCT04625725|79359813|FG000|Overall Study|Death|4|||
44355370|NCT04625725|79359814|FG001|Overall Study|Death|4|||
44355371|NCT04625725|79359813|FG000|Overall Study|Lost to Follow-up|11|||
44355372|NCT04625725|79359814|FG001|Overall Study|Lost to Follow-up|8|||
44355373|NCT04625725|79359813|FG000|Overall Study|Physician Decision|1|||
44355374|NCT04625725|79359814|FG001|Overall Study|Physician Decision|0|||
44355375|NCT04625725|79359813|FG000|Overall Study|Withdrawal by Subject|56|||
44355376|NCT04625725|79359814|FG001|Overall Study|Withdrawal by Subject|32|||
44355377|NCT04625725|79359813|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
44355378|NCT04625725|79359814|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
44355379|NCT04625725|79359813|FG000|Overall Study|Ongoing in study|3409|||
44355380|NCT04625725|79359814|FG001|Overall Study|Ongoing in study|1700|||
44355381|NCT04625725|79359813|FG000|Overall Study|Protocol Deviation|1|||
44355382|NCT04625725|79359814|FG001|Overall Study|Protocol Deviation|0|||
44355383|NCT01021215|79359822|FG000|Overall Study|Lost to Follow-up|3|||
44355384|NCT01021215|79359823|FG001|Overall Study|Lost to Follow-up|0|||
44355385|NCT01021137|79359833|FG000|Overall Study|Lost to Follow-up|9|||
44355386|NCT01021137|79359834|FG001|Overall Study|Lost to Follow-up|4|||
44355387|NCT01021137|79359835|FG002|Overall Study|Lost to Follow-up|2|||
44355388|NCT01021137|79359836|FG003|Overall Study|Lost to Follow-up|6|||
44355389|NCT01021137|79359833|FG000|Overall Study|Withdrawal by Subject|1|||
44355390|NCT01021137|79359834|FG001|Overall Study|Withdrawal by Subject|0|||
44355391|NCT01021137|79359835|FG002|Overall Study|Withdrawal by Subject|0|||
44355392|NCT01021137|79359836|FG003|Overall Study|Withdrawal by Subject|3|||
44355393|NCT01020981|79359849|FG000|Overall Study|Did not return mailed survey|74|||
44355394|NCT01020981|79359850|FG001|Overall Study|Did not return mailed survey|58|||
44355395|NCT01020981|79359849|FG000|Overall Study|Survey returned undeliverable|8|||
44355396|NCT01020981|79359850|FG001|Overall Study|Survey returned undeliverable|32|||
44355397|NCT01020981|79359849|FG000|Overall Study|Participant declined to complete survey|2|||
44355398|NCT01020981|79359850|FG001|Overall Study|Participant declined to complete survey|0|||
44355399|NCT01020747|79359858|FG000|Overall Study|Withdrawal by Subject|1|||
44355400|NCT01020435|79359865|FG000|Overall Study|Lost to Follow-up|0|||
44355401|NCT01020435|79359866|FG001|Overall Study|Lost to Follow-up|1|||
44355402|NCT01031979|79359875|FG000|Overall Study|Lost to Follow-up|5|||
44355403|NCT01031979|79359876|FG001|Overall Study|Lost to Follow-up|4|||
44355404|NCT01020123|79359889|FG000|Main Period|Withdrawal by Subject|6|||
44355405|NCT01020123|79359890|FG001|Main Period|Withdrawal by Subject|5|||
44355406|NCT01020123|79359891|FG002|Main Period|Withdrawal by Subject|3|||
44355407|NCT01020123|79359892|FG003|Main Period|Withdrawal by Subject|1|||
44355408|NCT01020123|79359893|FG004|Main Period|Withdrawal by Subject|6|||
44355409|NCT01020123|79359894|FG005|Main Period|Withdrawal by Subject|3|||
44355410|NCT01020123|79359895|FG006|Main Period|Withdrawal by Subject|2|||
44355411|NCT01020123|79359889|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
44355412|NCT01020123|79359890|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
44355413|NCT01020123|79359891|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
44355414|NCT01020123|79359892|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
44355415|NCT01020123|79359893|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
44355416|NCT01020123|79359894|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
44355417|NCT01020123|79359895|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
44355418|NCT01020123|79359889|FG000|Main Period|Adverse Event|5|||
44355419|NCT01020123|79359890|FG001|Main Period|Adverse Event|2|||
44355420|NCT01020123|79359891|FG002|Main Period|Adverse Event|2|||
44355421|NCT01020123|79359892|FG003|Main Period|Adverse Event|1|||
44355422|NCT01020123|79359893|FG004|Main Period|Adverse Event|1|||
44355423|NCT01020123|79359894|FG005|Main Period|Adverse Event|2|||
44355424|NCT01020123|79359895|FG006|Main Period|Adverse Event|1|||
44355425|NCT01020123|79359889|FG000|Main Period|Protocol Violation|4|||
44355426|NCT01020123|79359890|FG001|Main Period|Protocol Violation|4|||
44355427|NCT01020123|79359891|FG002|Main Period|Protocol Violation|2|||
44355428|NCT01020123|79359892|FG003|Main Period|Protocol Violation|5|||
44355429|NCT01020123|79359893|FG004|Main Period|Protocol Violation|2|||
44355430|NCT01020123|79359894|FG005|Main Period|Protocol Violation|3|||
44355431|NCT01020123|79359895|FG006|Main Period|Protocol Violation|2|||
44355432|NCT01020123|79359889|FG000|Main Period|Lost to Follow-up|0|||
44355433|NCT01020123|79359890|FG001|Main Period|Lost to Follow-up|2|||
44355434|NCT01020123|79359891|FG002|Main Period|Lost to Follow-up|0|||
44355435|NCT01020123|79359892|FG003|Main Period|Lost to Follow-up|0|||
44355436|NCT01020123|79359893|FG004|Main Period|Lost to Follow-up|0|||
44355437|NCT01020123|79359894|FG005|Main Period|Lost to Follow-up|0|||
44355438|NCT01020123|79359895|FG006|Main Period|Lost to Follow-up|0|||
44355439|NCT01020123|79359889|FG000|Main Period|Unclasified|2|||
44355440|NCT01020123|79359890|FG001|Main Period|Unclasified|0|||
44355441|NCT01020123|79359891|FG002|Main Period|Unclasified|1|||
44355442|NCT01020123|79359892|FG003|Main Period|Unclasified|0|||
44355443|NCT01020123|79359893|FG004|Main Period|Unclasified|1|||
44355444|NCT01020123|79359894|FG005|Main Period|Unclasified|3|||
44355445|NCT01020123|79359895|FG006|Main Period|Unclasified|6|||
44355446|NCT01020123|79359889|FG000|Extention Period|Withdrawal by Subject|2|||
44355447|NCT01020123|79359890|FG001|Extention Period|Withdrawal by Subject|1|||
44355448|NCT01020123|79359891|FG002|Extention Period|Withdrawal by Subject|1|||
44355449|NCT01020123|79359892|FG003|Extention Period|Withdrawal by Subject|0|||
44355450|NCT01020123|79359893|FG004|Extention Period|Withdrawal by Subject|0|||
44355451|NCT01020123|79359894|FG005|Extention Period|Withdrawal by Subject|0|||
44355452|NCT01020123|79359895|FG006|Extention Period|Withdrawal by Subject|0|||
44355453|NCT01020123|79359889|FG000|Extention Period|Adverse Event|0|||
44355454|NCT01020123|79359890|FG001|Extention Period|Adverse Event|0|||
44355455|NCT01020123|79359891|FG002|Extention Period|Adverse Event|0|||
44355456|NCT01020123|79359892|FG003|Extention Period|Adverse Event|1|||
44355457|NCT01020123|79359893|FG004|Extention Period|Adverse Event|0|||
44355458|NCT01020123|79359894|FG005|Extention Period|Adverse Event|0|||
44355459|NCT01020123|79359895|FG006|Extention Period|Adverse Event|0|||
44355460|NCT01020123|79359889|FG000|Extention Period|Protocol Violation|1|||
44355461|NCT01020123|79359890|FG001|Extention Period|Protocol Violation|1|||
44355462|NCT01020123|79359891|FG002|Extention Period|Protocol Violation|1|||
44355463|NCT01020123|79359892|FG003|Extention Period|Protocol Violation|0|||
44355464|NCT01020123|79359893|FG004|Extention Period|Protocol Violation|0|||
44355465|NCT01020123|79359894|FG005|Extention Period|Protocol Violation|0|||
44355466|NCT01020123|79359895|FG006|Extention Period|Protocol Violation|1|||
44355467|NCT01020123|79359889|FG000|Extention Period|Lost to Follow-up|0|||
44355468|NCT01020123|79359890|FG001|Extention Period|Lost to Follow-up|0|||
44355469|NCT01020123|79359891|FG002|Extention Period|Lost to Follow-up|0|||
44355470|NCT01020123|79359892|FG003|Extention Period|Lost to Follow-up|0|||
44355471|NCT01020123|79359893|FG004|Extention Period|Lost to Follow-up|0|||
44355472|NCT01020123|79359894|FG005|Extention Period|Lost to Follow-up|2|||
44355473|NCT01020123|79359895|FG006|Extention Period|Lost to Follow-up|0|||
44355474|NCT01028391|79359936|FG000|Overall Study|Adverse Event|4|||
44355475|NCT01028391|79359937|FG001|Overall Study|Adverse Event|0|||
44355476|NCT01028391|79359936|FG000|Overall Study|Lack of Efficacy|0|||
44355477|NCT01028391|79359937|FG001|Overall Study|Lack of Efficacy|2|||
44355478|NCT01028391|79359936|FG000|Overall Study|Lost to Follow-up|3|||
44355479|NCT01028391|79359937|FG001|Overall Study|Lost to Follow-up|4|||
44355480|NCT01028391|79359936|FG000|Overall Study|Physician Decision|0|||
44355481|NCT01028391|79359937|FG001|Overall Study|Physician Decision|1|||
44355482|NCT01028391|79359936|FG000|Overall Study|Withdrawal by Subject|6|||
44355483|NCT01028391|79359937|FG001|Overall Study|Withdrawal by Subject|3|||
44355484|NCT01028391|79359936|FG000|Overall Study|Needed excluded medication|1|||
44355485|NCT01028391|79359937|FG001|Overall Study|Needed excluded medication|1|||
44355486|NCT01179672|79359945|FG000|Overall Study|Adverse Event|17|||
44355487|NCT01179672|79359946|FG001|Overall Study|Adverse Event|8|||
44355488|NCT01179672|79359945|FG000|Overall Study|Withdrawal by Subject|10|||
44355489|NCT01179672|79359946|FG001|Overall Study|Withdrawal by Subject|12|||
44355490|NCT01179672|79359945|FG000|Overall Study|Entry Criteria Not Met|0|||
44355491|NCT01179672|79359946|FG001|Overall Study|Entry Criteria Not Met|2|||
44355492|NCT01179672|79359945|FG000|Overall Study|Lost to Follow-up|0|||
44355493|NCT01179672|79359946|FG001|Overall Study|Lost to Follow-up|1|||
44355494|NCT01179672|79359945|FG000|Overall Study|Protocol Violation|2|||
44355495|NCT01179672|79359946|FG001|Overall Study|Protocol Violation|2|||
44355496|NCT01179672|79359945|FG000|Overall Study|Physician Decision|1|||
44355497|NCT01179672|79359946|FG001|Overall Study|Physician Decision|1|||
44355498|NCT01030965|79359960|FG000|Overall Study|Lack of Efficacy|3|||
44355499|NCT01030965|79359961|FG001|Overall Study|Lack of Efficacy|2|||
44355500|NCT01030965|79359962|FG002|Overall Study|Lack of Efficacy|0|||
44355501|NCT01030965|79359963|FG003|Overall Study|Lack of Efficacy|3|||
44355502|NCT01030965|79359960|FG000|Overall Study|Protocol Violation|1|||
44355503|NCT01030965|79359961|FG001|Overall Study|Protocol Violation|1|||
44355504|NCT01030965|79359962|FG002|Overall Study|Protocol Violation|1|||
44355505|NCT01030965|79359963|FG003|Overall Study|Protocol Violation|1|||
44355506|NCT01030965|79359960|FG000|Overall Study|Adverse Event|0|||
44355507|NCT01030965|79359961|FG001|Overall Study|Adverse Event|1|||
44355508|NCT01030965|79359962|FG002|Overall Study|Adverse Event|2|||
44355509|NCT01030965|79359963|FG003|Overall Study|Adverse Event|1|||
44355510|NCT01030965|79359960|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
44355511|NCT01030965|79359961|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
44355512|NCT01030965|79359962|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
44355513|NCT01030965|79359963|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
44355514|NCT01030965|79359960|FG000|Overall Study|Withdrawal by Subject|0|||
44355515|NCT01030965|79359961|FG001|Overall Study|Withdrawal by Subject|1|||
44355516|NCT01030965|79359962|FG002|Overall Study|Withdrawal by Subject|0|||
44355517|NCT01030965|79359963|FG003|Overall Study|Withdrawal by Subject|2|||
44355518|NCT01179516|79359976|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
44355519|NCT01179516|79359977|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
44355520|NCT01179516|79359978|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
44355521|NCT01179516|79359976|FG000|Overall Study|Lack of Efficacy|4|||
44355522|NCT01179516|79359977|FG001|Overall Study|Lack of Efficacy|2|||
44355523|NCT01179516|79359978|FG002|Overall Study|Lack of Efficacy|0|||
44355524|NCT01179516|79359976|FG000|Overall Study|Noncompliance with Study Drug|2|||
44355525|NCT01179516|79359977|FG001|Overall Study|Noncompliance with Study Drug|0|||
44355526|NCT01179516|79359978|FG002|Overall Study|Noncompliance with Study Drug|1|||
44355527|NCT01179516|79359976|FG000|Overall Study|Protocol Deviations|4|||
44355528|NCT01179516|79359977|FG001|Overall Study|Protocol Deviations|3|||
44355529|NCT01179516|79359978|FG002|Overall Study|Protocol Deviations|3|||
44355530|NCT01179516|79359976|FG000|Overall Study|Withdrawal of Consent|2|||
44355531|NCT01179516|79359977|FG001|Overall Study|Withdrawal of Consent|6|||
44355532|NCT01179516|79359978|FG002|Overall Study|Withdrawal of Consent|10|||
44355533|NCT01179516|79359976|FG000|Overall Study|Lost to Follow-up|7|||
44355534|NCT01179516|79359977|FG001|Overall Study|Lost to Follow-up|7|||
44355535|NCT01179516|79359978|FG002|Overall Study|Lost to Follow-up|3|||
44355536|NCT01179516|79359976|FG000|Overall Study|Other|2|||
44355537|NCT01179516|79359977|FG001|Overall Study|Other|0|||
44355538|NCT01179516|79359978|FG002|Overall Study|Other|2|||
44355539|NCT01018953|79359986|FG000|Overall Study|Adverse Event|2|||
44355540|NCT01018953|79359986|FG000|Overall Study|Withdrawal by Subject|1|||
44355541|NCT01018953|79359986|FG000|Overall Study|Study termination by sponsor|5|||
44355542|NCT01158924|79359993|FG000|Overall Study|Withdrawal by Subject|1|||
44355543|NCT01158924|79359994|FG001|Overall Study|Withdrawal by Subject|2|||
44355544|NCT01158924|79359993|FG000|Overall Study|Lost to Follow-up|0|||
44355545|NCT01158924|79359994|FG001|Overall Study|Lost to Follow-up|1|||
44355546|NCT01027845|79360002|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
44355547|NCT01027845|79360003|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
44355548|NCT01027845|79360004|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
44355549|NCT01027845|79360005|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
44355550|NCT01027845|79360002|FG000|Primary Vaccination Phase|Adverse Event|1|||
44355551|NCT01027845|79360003|FG001|Primary Vaccination Phase|Adverse Event|0|||
44355552|NCT01027845|79360004|FG002|Primary Vaccination Phase|Adverse Event|0|||
44355553|NCT01027845|79360005|FG003|Primary Vaccination Phase|Adverse Event|0|||
44355554|NCT01027845|79360002|FG000|Primary Vaccination Phase|Protocol Violation|1|||
44355555|NCT01027845|79360003|FG001|Primary Vaccination Phase|Protocol Violation|0|||
44355556|NCT01027845|79360004|FG002|Primary Vaccination Phase|Protocol Violation|0|||
44355557|NCT01027845|79360005|FG003|Primary Vaccination Phase|Protocol Violation|0|||
44355558|NCT01027845|79360002|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
44355559|NCT01027845|79360003|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
44355560|NCT01027845|79360004|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
44355561|NCT01027845|79360005|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
44355562|NCT01027845|79360002|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
44355563|NCT01027845|79360003|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
44355564|NCT01027845|79360004|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
44355565|NCT01027845|79360005|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
44355566|NCT01027845|79360002|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
44355567|NCT01027845|79360003|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
44355568|NCT01027845|79360004|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
44355569|NCT01027845|79360005|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
44355570|NCT01017549|79360014|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
44355571|NCT01017549|79360014|FG000|One-year Follow-up|Lost to Follow-up|2|||
44355572|NCT01017549|79360014|FG000|One-year Follow-up|Withdrawal by Subject|5|||
44355573|NCT01017549|79360014|FG000|5 Year Follow-up|Lost to Follow-up|9|||
44355574|NCT01017549|79360014|FG000|5 Year Follow-up|Mastectomy|3|||
44355575|NCT01030341|79360018|FG000|Overall Study|Withdrawal by Subject|1|||
44355576|NCT01030341|79360018|FG000|Overall Study|Lost to Follow-up|2|||
44355577|NCT01026831|79360024|FG000|Overall Study|Adverse Event|4|||
44355578|NCT01026831|79360025|FG001|Overall Study|Adverse Event|3|||
44355579|NCT01026831|79360024|FG000|Overall Study|Lost to Follow-up|2|||
44355580|NCT01026831|79360025|FG001|Overall Study|Lost to Follow-up|0|||
44355581|NCT01026831|79360024|FG000|Overall Study|Physician Decision|1|||
44355582|NCT01026831|79360025|FG001|Overall Study|Physician Decision|1|||
44355583|NCT01026831|79360024|FG000|Overall Study|Protocol Violation|0|||
44355584|NCT01026831|79360025|FG001|Overall Study|Protocol Violation|2|||
44355585|NCT01026831|79360024|FG000|Overall Study|Withdrawal by Subject|7|||
44355586|NCT01026831|79360025|FG001|Overall Study|Withdrawal by Subject|5|||
44355587|NCT01016067|79360033|FG000|Overall Study|Lost to Follow-up|1|||
44355588|NCT01016067|79360034|FG001|Overall Study|Lost to Follow-up|2|||
44355589|NCT01016067|79360033|FG000|Overall Study|Physician Decision|1|||
44355590|NCT01016067|79360034|FG001|Overall Study|Physician Decision|1|||
44355591|NCT01016067|79360033|FG000|Overall Study|Withdrew due to Relocation|0|||
44355592|NCT01016067|79360034|FG001|Overall Study|Withdrew due to Relocation|1|||
44355593|NCT01015833|79360042|FG000|Overall Study|Death|1|||
44355594|NCT01015833|79360043|FG001|Overall Study|Death|0|||
44355595|NCT01015833|79360042|FG000|Overall Study|Withdrawal by Subject|3|||
44355596|NCT01015833|79360043|FG001|Overall Study|Withdrawal by Subject|2|||
44355597|NCT01015833|79360042|FG000|Overall Study|Adverse Event|0|||
44355598|NCT01015833|79360043|FG001|Overall Study|Adverse Event|1|||
44355599|NCT01015833|79360042|FG000|Overall Study|Physician Decision|2|||
44355600|NCT01015833|79360043|FG001|Overall Study|Physician Decision|0|||
44355601|NCT01015833|79360042|FG000|Overall Study|Symptomatic deterioration|0|||
44355602|NCT01015833|79360043|FG001|Overall Study|Symptomatic deterioration|1|||
44355603|NCT01015833|79360042|FG000|Overall Study|Other|5|||
44355604|NCT01015833|79360043|FG001|Overall Study|Other|1|||
44355605|NCT01015833|79360042|FG000|Overall Study|Motor Vehicle Accidents|1|||
44355606|NCT01015833|79360043|FG001|Overall Study|Motor Vehicle Accidents|0|||
44355607|NCT01015833|79360042|FG000|Overall Study|Did not start treatment|1|||
44355608|NCT01015833|79360043|FG001|Overall Study|Did not start treatment|0|||
44355609|NCT01015677|79360061|FG000|Overall Study|Adverse Event|0|||
44355610|NCT01015677|79360062|FG001|Overall Study|Adverse Event|1|||
44355611|NCT01015677|79360063|FG002|Overall Study|Adverse Event|0|||
44355612|NCT01015677|79360061|FG000|Overall Study|Lack of Efficacy|0|||
44355613|NCT01015677|79360062|FG001|Overall Study|Lack of Efficacy|1|||
44355614|NCT01015677|79360063|FG002|Overall Study|Lack of Efficacy|0|||
44355615|NCT01015677|79360061|FG000|Overall Study|Protocol Violation|0|||
44355616|NCT01015677|79360062|FG001|Overall Study|Protocol Violation|1|||
44355617|NCT01015677|79360063|FG002|Overall Study|Protocol Violation|0|||
44355618|NCT01015677|79360061|FG000|Overall Study|Withdrawal by Subject|1|||
44355619|NCT01015677|79360062|FG001|Overall Study|Withdrawal by Subject|1|||
44355620|NCT01015677|79360063|FG002|Overall Study|Withdrawal by Subject|0|||
44355621|NCT01225211|79360103|FG000|Overall Study|Adverse Event|0|||
44355622|NCT01225211|79360104|FG001|Overall Study|Adverse Event|0|||
44355623|NCT01225211|79360105|FG002|Overall Study|Adverse Event|1|||
44355624|NCT01225211|79360106|FG003|Overall Study|Adverse Event|0|||
44355625|NCT01225211|79360107|FG004|Overall Study|Adverse Event|0|||
44355626|NCT01225211|79360108|FG005|Overall Study|Adverse Event|0|||
44355627|NCT01225211|79360109|FG006|Overall Study|Adverse Event|0|||
44355628|NCT01225211|79360110|FG007|Overall Study|Adverse Event|0|||
44355629|NCT01225211|79360111|FG008|Overall Study|Adverse Event|0|||
44355630|NCT01225211|79360112|FG009|Overall Study|Adverse Event|1|||
44355631|NCT01225211|79360103|FG000|Overall Study|Withdrawal by Subject|0|||
44355632|NCT01225211|79360104|FG001|Overall Study|Withdrawal by Subject|0|||
44355633|NCT01225211|79360105|FG002|Overall Study|Withdrawal by Subject|0|||
44355634|NCT01225211|79360106|FG003|Overall Study|Withdrawal by Subject|0|||
44355635|NCT01225211|79360107|FG004|Overall Study|Withdrawal by Subject|0|||
44355636|NCT01225211|79360108|FG005|Overall Study|Withdrawal by Subject|0|||
44355637|NCT01225211|79360109|FG006|Overall Study|Withdrawal by Subject|1|||
44355638|NCT01225211|79360110|FG007|Overall Study|Withdrawal by Subject|0|||
44355639|NCT01225211|79360111|FG008|Overall Study|Withdrawal by Subject|1|||
44355640|NCT01225211|79360112|FG009|Overall Study|Withdrawal by Subject|3|||
44355641|NCT01225211|79360103|FG000|Overall Study|Other|0|||
44355642|NCT01225211|79360104|FG001|Overall Study|Other|0|||
44355643|NCT01225211|79360105|FG002|Overall Study|Other|0|||
44355644|NCT01225211|79360106|FG003|Overall Study|Other|0|||
44355645|NCT01225211|79360107|FG004|Overall Study|Other|0|||
44355646|NCT01225211|79360108|FG005|Overall Study|Other|0|||
44355647|NCT01225211|79360109|FG006|Overall Study|Other|0|||
44355648|NCT01225211|79360110|FG007|Overall Study|Other|0|||
44355649|NCT01225211|79360111|FG008|Overall Study|Other|0|||
44355650|NCT01225211|79360112|FG009|Overall Study|Other|1|||
44355651|NCT01224821|79360195|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
44355652|NCT01224821|79360195|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
44355653|NCT01224821|79360195|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
44355654|NCT01224821|79360195|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
44355655|NCT01224821|79360195|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
44355656|NCT01224821|79360195|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
44355657|NCT01224821|79360195|FG000|Long-Term Follow-Up|Death|2|||
44355658|NCT01224821|79360195|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
44355659|NCT01224431|79360212|FG000|Overall Study|not randomized|0|||
44355660|NCT01224431|79360213|FG001|Overall Study|not randomized|4|||
44355661|NCT01224431|79360212|FG000|Overall Study|no video record|0|||
44355662|NCT01224431|79360213|FG001|Overall Study|no video record|1|||
44355663|NCT01223183|79360223|FG000|Imaging Day 1|Physician Decision|0|||
44355664|NCT01223183|79360224|FG001|Imaging Day 1|Physician Decision|1|||
44355665|NCT01223183|79360223|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
44355666|NCT01223183|79360224|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
44355667|NCT01223183|79360223|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
44355668|NCT01223183|79360224|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
44355669|NCT01223027|79360233|FG000|Overall Study|Adverse Event|20|||
44355670|NCT01223027|79360234|FG001|Overall Study|Adverse Event|10|||
44355671|NCT01223027|79360233|FG000|Overall Study|Death|42|||
44355672|NCT01223027|79360234|FG001|Overall Study|Death|42|||
44355673|NCT01223027|79360233|FG000|Overall Study|Lost to Follow-up|2|||
44355674|NCT01223027|79360234|FG001|Overall Study|Lost to Follow-up|1|||
44355675|NCT01223027|79360233|FG000|Overall Study|Physician Decision|4|||
44355676|NCT01223027|79360234|FG001|Overall Study|Physician Decision|8|||
44355677|NCT01223027|79360233|FG000|Overall Study|Progressive Disease|167|||
44355678|NCT01223027|79360234|FG001|Overall Study|Progressive Disease|183|||
44355679|NCT01223027|79360233|FG000|Overall Study|Protocol Violation|2|||
44355680|NCT01223027|79360234|FG001|Overall Study|Protocol Violation|1|||
44355681|NCT01223027|79360233|FG000|Overall Study|Subject/guardian decicion|18|||
44355682|NCT01223027|79360234|FG001|Overall Study|Subject/guardian decicion|16|||
44355683|NCT01223027|79360233|FG000|Overall Study|New therapy for study indication|17|||
44355684|NCT01223027|79360234|FG001|Overall Study|New therapy for study indication|8|||
44355685|NCT01223027|79360233|FG000|Overall Study|Study terminated by sponsor|2|||
44355686|NCT01223027|79360234|FG001|Overall Study|Study terminated by sponsor|8|||
44355687|NCT01015287|79360242|FG000|Overall Study|Death|21|||
44355688|NCT01015287|79360243|FG001|Overall Study|Death|16|||
44355689|NCT01015287|79360242|FG000|Overall Study|Adverse Event|1|||
44355690|NCT01015287|79360243|FG001|Overall Study|Adverse Event|0|||
44355691|NCT01015287|79360242|FG000|Overall Study|Sponsor Decision|3|||
44355692|NCT01015287|79360243|FG001|Overall Study|Sponsor Decision|7|||
44355693|NCT01015287|79360242|FG000|Overall Study|Physician Decision|19|||
44355694|NCT01015287|79360243|FG001|Overall Study|Physician Decision|21|||
44355695|NCT01015287|79360242|FG000|Overall Study|Withdrawal by Subject|14|||
44355696|NCT01015287|79360243|FG001|Overall Study|Withdrawal by Subject|19|||
44355697|NCT01015287|79360242|FG000|Overall Study|Entry Criteria not Met|11|||
44355698|NCT01015287|79360243|FG001|Overall Study|Entry Criteria not Met|14|||
44355699|NCT01015287|79360242|FG000|Overall Study|Lost to Follow-up|2|||
44355700|NCT01015287|79360243|FG001|Overall Study|Lost to Follow-up|1|||
44355701|NCT01015287|79360242|FG000|Overall Study|Protocol Violation|1|||
44355702|NCT01015287|79360243|FG001|Overall Study|Protocol Violation|1|||
44355703|NCT01015131|79360251|FG000|Overall Study|Physician Decision|1|||
44355704|NCT01015131|79360251|FG000|Overall Study|Protocol Violation|1|||
44355705|NCT01015131|79360251|FG000|Overall Study|Withdrawal by Subject|2|||
44355706|NCT01015131|79360251|FG000|Overall Study|Other Protocol Specified Criteria|4|||
44355707|NCT01222715|79360257|FG000|Overall Study|Adverse Event|0|||
44355708|NCT01222715|79360258|FG001|Overall Study|Adverse Event|4|||
44355709|NCT01222715|79360257|FG000|Overall Study|Death|0|||
44355710|NCT01222715|79360258|FG001|Overall Study|Death|1|||
44355711|NCT01222715|79360257|FG000|Overall Study|Lack of Efficacy|22|||
44355712|NCT01222715|79360258|FG001|Overall Study|Lack of Efficacy|14|||
44355713|NCT01222715|79360257|FG000|Overall Study|Physician Decision|12|||
44355714|NCT01222715|79360258|FG001|Overall Study|Physician Decision|2|||
44355715|NCT01222715|79360257|FG000|Overall Study|Refusal of further protocol therapy|0|||
44355716|NCT01222715|79360258|FG001|Overall Study|Refusal of further protocol therapy|4|||
44355717|NCT01222715|79360257|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
44355718|NCT01222715|79360258|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
44355719|NCT01222715|79360257|FG000|Overall Study|Ineligible|0|||
44355720|NCT01222715|79360258|FG001|Overall Study|Ineligible|1|||
44355721|NCT01222715|79360257|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
44355722|NCT01222715|79360258|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
44355723|NCT01222403|79360266|FG000|Overall Study|Inappropriate enrollment|0|||
44355724|NCT01222403|79360267|FG001|Overall Study|Inappropriate enrollment|2|||
44355725|NCT01222247|79360275|FG000|Overall Study|Lost to Follow-up|2|||
44355726|NCT01222247|79360276|FG001|Overall Study|Lost to Follow-up|2|||
44355727|NCT01014975|79360282|FG000|Overall Study|Withdrawal by Subject|1|||
44355728|NCT01014975|79360283|FG001|Overall Study|Withdrawal by Subject|0|||
44355729|NCT01014975|79360284|FG002|Overall Study|Withdrawal by Subject|1|||
44355730|NCT01014975|79360282|FG000|Overall Study|Death|3|||
44355731|NCT01014975|79360283|FG001|Overall Study|Death|3|||
44355732|NCT01014975|79360284|FG002|Overall Study|Death|4|||
44355733|NCT01014975|79360282|FG000|Overall Study|Lost to Follow-up|0|||
44355734|NCT01014975|79360283|FG001|Overall Study|Lost to Follow-up|0|||
44355735|NCT01014975|79360284|FG002|Overall Study|Lost to Follow-up|1|||
44355736|NCT01221623|79360294|FG000|Overall Study|Withdrawal by Subject|19|||
44355737|NCT01221623|79360295|FG001|Overall Study|Withdrawal by Subject|8|||
44355738|NCT01221623|79360294|FG000|Overall Study|Lost to Follow-up|7|||
44355739|NCT01221623|79360295|FG001|Overall Study|Lost to Follow-up|1|||
44355740|NCT01221623|79360294|FG000|Overall Study|Adverse Event|6|||
44355741|NCT01221623|79360295|FG001|Overall Study|Adverse Event|3|||
44355742|NCT01221623|79360294|FG000|Overall Study|Death|1|||
44355743|NCT01221623|79360295|FG001|Overall Study|Death|0|||
44355744|NCT01221623|79360294|FG000|Overall Study|Other|5|||
44355745|NCT01221623|79360295|FG001|Overall Study|Other|2|||
44355746|NCT01014585|79360305|FG000|Overall Study|Adverse Event|0|||
44355747|NCT01014585|79360306|FG001|Overall Study|Adverse Event|2|||
44355748|NCT01014585|79360307|FG002|Overall Study|Adverse Event|0|||
44355749|NCT01014585|79360308|FG003|Overall Study|Adverse Event|3|||
44355750|NCT01014585|79360305|FG000|Overall Study|Withdrawal by Subject|2|||
44355751|NCT01014585|79360306|FG001|Overall Study|Withdrawal by Subject|0|||
44355752|NCT01014585|79360307|FG002|Overall Study|Withdrawal by Subject|1|||
44355753|NCT01014585|79360308|FG003|Overall Study|Withdrawal by Subject|3|||
44355754|NCT01014585|79360305|FG000|Overall Study|Lost to Follow-up|0|||
44355755|NCT01014585|79360306|FG001|Overall Study|Lost to Follow-up|0|||
44355756|NCT01014585|79360307|FG002|Overall Study|Lost to Follow-up|0|||
44355757|NCT01014585|79360308|FG003|Overall Study|Lost to Follow-up|2|||
44355758|NCT01014585|79360305|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
44448730|NCT00550446|79457356|FG001|Up To Week 12|Lost to Follow-up|1|||
44355759|NCT01014585|79360306|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
44355760|NCT01014585|79360307|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
44355761|NCT01014585|79360308|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
44355762|NCT01221233|79360320|FG000|Overall Study|Withdrawal by Subject|3|||
44355763|NCT01221233|79360321|FG001|Overall Study|Withdrawal by Subject|1|||
44355764|NCT01220609|79360327|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
44355765|NCT01220609|79360327|FG000|Overall Study|Ineligible- Wrong cell type|1|||
44355766|NCT01220609|79360327|FG000|Overall Study|Ineligible-Never treated|1|||
44355767|NCT01220297|79360339|FG000|Overall Study|Death|2|||
44355768|NCT01220297|79360339|FG000|Overall Study|Lost to Follow-up|1|||
44355769|NCT01219985|79360345|FG000|Overall Study|Physician Decision|20|||
44355770|NCT01218659|79360353|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
44355771|NCT01218659|79360354|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
44355772|NCT01218659|79360355|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
44355773|NCT01218659|79360353|FG000|18-Month Randomized Period|Did not receive study drug|0|||
44355774|NCT01218659|79360354|FG001|18-Month Randomized Period|Did not receive study drug|3|||
44355775|NCT01218659|79360355|FG002|18-Month Randomized Period|Did not receive study drug|0|||
44355776|NCT01218659|79360353|FG000|12-Month OLE|Withdrawal by Subject|0|||
44355777|NCT01218659|79360354|FG001|12-Month OLE|Withdrawal by Subject|0|||
44355778|NCT01218659|79360355|FG002|12-Month OLE|Withdrawal by Subject|2|||
44355779|NCT01218659|79360353|FG000|12-Month OLE|Physician Decision|0|||
44355780|NCT01218659|79360354|FG001|12-Month OLE|Physician Decision|0|||
44355781|NCT01218659|79360355|FG002|12-Month OLE|Physician Decision|1|||
44355782|NCT01218659|79360353|FG000|12-Month OLE|Lost to Follow-up|0|||
44355783|NCT01218659|79360354|FG001|12-Month OLE|Lost to Follow-up|0|||
44355784|NCT01218659|79360355|FG002|12-Month OLE|Lost to Follow-up|1|||
44355785|NCT01218659|79360353|FG000|12-Month OLE|Pregnancy|0|||
44355786|NCT01218659|79360354|FG001|12-Month OLE|Pregnancy|0|||
44355787|NCT01218659|79360355|FG002|12-Month OLE|Pregnancy|1|||
44355788|NCT01218659|79360353|FG000|12-Month OLE|Lack of Efficacy|0|||
44355789|NCT01218659|79360354|FG001|12-Month OLE|Lack of Efficacy|0|||
44355790|NCT01218659|79360355|FG002|12-Month OLE|Lack of Efficacy|1|||
44355791|NCT01218659|79360353|FG000|12-Month OLE|Declined to participate in the OLE|0|||
44355792|NCT01218659|79360354|FG001|12-Month OLE|Declined to participate in the OLE|0|||
44355793|NCT01218659|79360355|FG002|12-Month OLE|Declined to participate in the OLE|4|||
44355794|NCT00940498|79360370|FG000|Overall Study|Death|2|||
44355795|NCT00940498|79360371|FG001|Overall Study|Death|0|||
44355796|NCT00940498|79360372|FG002|Overall Study|Death|0|||
44355797|NCT00940498|79360373|FG003|Overall Study|Death|1|||
44355798|NCT00940498|79360374|FG004|Overall Study|Death|5|||
44355799|NCT00940498|79360375|FG005|Overall Study|Death|0|||
44355800|NCT00940498|79360376|FG006|Overall Study|Death|1|||
44355801|NCT00940498|79360377|FG007|Overall Study|Death|0|||
44355802|NCT00940498|79360370|FG000|Overall Study|Lost to Follow-up|1|||
44355803|NCT00940498|79360371|FG001|Overall Study|Lost to Follow-up|1|||
44355804|NCT00940498|79360372|FG002|Overall Study|Lost to Follow-up|2|||
44355805|NCT00940498|79360373|FG003|Overall Study|Lost to Follow-up|0|||
44355806|NCT00940498|79360374|FG004|Overall Study|Lost to Follow-up|1|||
44355807|NCT00940498|79360375|FG005|Overall Study|Lost to Follow-up|0|||
44355808|NCT00940498|79360376|FG006|Overall Study|Lost to Follow-up|0|||
44355809|NCT00940498|79360377|FG007|Overall Study|Lost to Follow-up|1|||
44355810|NCT00940498|79360370|FG000|Overall Study|Disease Progression|0|||
44355811|NCT00940498|79360371|FG001|Overall Study|Disease Progression|0|||
44355812|NCT00940498|79360372|FG002|Overall Study|Disease Progression|1|||
44355813|NCT00940498|79360373|FG003|Overall Study|Disease Progression|1|||
44355814|NCT00940498|79360374|FG004|Overall Study|Disease Progression|0|||
44355815|NCT00940498|79360375|FG005|Overall Study|Disease Progression|1|||
44355816|NCT00940498|79360376|FG006|Overall Study|Disease Progression|0|||
44355817|NCT00940498|79360377|FG007|Overall Study|Disease Progression|0|||
44355818|NCT00940498|79360370|FG000|Overall Study|Physician Decision|0|||
44355819|NCT00940498|79360371|FG001|Overall Study|Physician Decision|0|||
44355820|NCT00940498|79360372|FG002|Overall Study|Physician Decision|0|||
44355821|NCT00940498|79360373|FG003|Overall Study|Physician Decision|0|||
44355822|NCT00940498|79360374|FG004|Overall Study|Physician Decision|2|||
44355823|NCT00940498|79360375|FG005|Overall Study|Physician Decision|0|||
44355824|NCT00940498|79360376|FG006|Overall Study|Physician Decision|0|||
44355825|NCT00940498|79360377|FG007|Overall Study|Physician Decision|0|||
44355826|NCT00940498|79360370|FG000|Overall Study|Not treated due to disease related pain|0|||
44355827|NCT00940498|79360371|FG001|Overall Study|Not treated due to disease related pain|0|||
44355828|NCT00940498|79360372|FG002|Overall Study|Not treated due to disease related pain|0|||
44355829|NCT00940498|79360373|FG003|Overall Study|Not treated due to disease related pain|0|||
44355830|NCT00940498|79360374|FG004|Overall Study|Not treated due to disease related pain|1|||
44355831|NCT00940498|79360375|FG005|Overall Study|Not treated due to disease related pain|0|||
44355832|NCT00940498|79360376|FG006|Overall Study|Not treated due to disease related pain|0|||
44355833|NCT00940498|79360377|FG007|Overall Study|Not treated due to disease related pain|0|||
44355834|NCT00940342|79360404|FG000|Overall Study|Adverse Event|0|||
44355835|NCT00940342|79360405|FG001|Overall Study|Adverse Event|2|||
44355836|NCT00940342|79360406|FG002|Overall Study|Adverse Event|1|||
44355837|NCT00936910|79360414|FG000|Overall Study|Lack of Efficacy|3|||
44355838|NCT00940108|79360423|FG000|Overall Study|Adverse Event|2|||
44355839|NCT00940108|79360424|FG001|Overall Study|Adverse Event|4|||
44355840|NCT00940108|79360425|FG002|Overall Study|Adverse Event|0|||
44355841|NCT00940108|79360426|FG003|Overall Study|Adverse Event|2|||
44355842|NCT00940108|79360423|FG000|Overall Study|Withdrew Consent|2|||
44355843|NCT00940108|79360424|FG001|Overall Study|Withdrew Consent|1|||
44355844|NCT00940108|79360425|FG002|Overall Study|Withdrew Consent|0|||
44355845|NCT00940108|79360426|FG003|Overall Study|Withdrew Consent|1|||
44355846|NCT00940108|79360423|FG000|Overall Study|Dose 2 contraindicated|1|||
44355847|NCT00940108|79360424|FG001|Overall Study|Dose 2 contraindicated|1|||
44355848|NCT00940108|79360425|FG002|Overall Study|Dose 2 contraindicated|0|||
44355849|NCT00940108|79360426|FG003|Overall Study|Dose 2 contraindicated|1|||
44355850|NCT00940108|79360423|FG000|Overall Study|Declined further vaccination|0|||
44355851|NCT00940108|79360424|FG001|Overall Study|Declined further vaccination|1|||
44355852|NCT00940108|79360425|FG002|Overall Study|Declined further vaccination|3|||
44355853|NCT00940108|79360426|FG003|Overall Study|Declined further vaccination|0|||
44355854|NCT00940108|79360423|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
44355855|NCT00940108|79360424|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
44355856|NCT00940108|79360425|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
44355857|NCT00940108|79360426|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
44355858|NCT00940108|79360423|FG000|Overall Study|Viral illness after Dose 1|0|||
44355859|NCT00940108|79360424|FG001|Overall Study|Viral illness after Dose 1|1|||
44355860|NCT00940108|79360425|FG002|Overall Study|Viral illness after Dose 1|0|||
44355861|NCT00940108|79360426|FG003|Overall Study|Viral illness after Dose 1|0|||
44355862|NCT00940108|79360423|FG000|Overall Study|Diagnosed with H1N1|0|||
44355863|NCT00940108|79360424|FG001|Overall Study|Diagnosed with H1N1|0|||
44355864|NCT00940108|79360425|FG002|Overall Study|Diagnosed with H1N1|0|||
44355865|NCT00940108|79360426|FG003|Overall Study|Diagnosed with H1N1|1|||
44355866|NCT00936598|79360438|FG000|Overall Study|Withdrawal by Subject|1|||
44355867|NCT00936598|79360439|FG001|Overall Study|Withdrawal by Subject|0|||
44355868|NCT00936598|79360438|FG000|Overall Study|Ineligible after consent|1|||
44355869|NCT00936598|79360439|FG001|Overall Study|Ineligible after consent|0|||
44355870|NCT01025817|79360447|FG000|Completed Study Medication|Adverse Event|66|||
44355871|NCT01025817|79360448|FG001|Completed Study Medication|Adverse Event|39|||
44355872|NCT01025817|79360447|FG000|Completed Study Medication|Protocol Deviation|9|||
44355873|NCT01025817|79360448|FG001|Completed Study Medication|Protocol Deviation|8|||
44355874|NCT01025817|79360447|FG000|Completed Study Medication|Withdrawal by Subject|8|||
44355875|NCT01025817|79360448|FG001|Completed Study Medication|Withdrawal by Subject|9|||
44355876|NCT01025817|79360447|FG000|Completed Study Medication|Administrative problems|7|||
44355877|NCT01025817|79360448|FG001|Completed Study Medication|Administrative problems|5|||
44355878|NCT01025817|79360447|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
44355879|NCT01025817|79360448|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
44355880|NCT01025817|79360447|FG000|Completed Study Medication|Abnormal test procedure|4|||
44355881|NCT01025817|79360448|FG001|Completed Study Medication|Abnormal test procedure|0|||
44355882|NCT01025817|79360447|FG000|Completed Study Medication|Graft loss|2|||
44355883|NCT01025817|79360448|FG001|Completed Study Medication|Graft loss|5|||
44355884|NCT01025817|79360447|FG000|Completed Study Medication|Death|2|||
44355885|NCT01025817|79360448|FG001|Completed Study Medication|Death|2|||
44355886|NCT01025817|79360447|FG000|Completed Study Medication|Abnormal lab values|0|||
44355887|NCT01025817|79360448|FG001|Completed Study Medication|Abnormal lab values|2|||
44355888|NCT01025817|79360447|FG000|Completed Study Medication|Subject no longer required study drug|0|||
44355889|NCT01025817|79360448|FG001|Completed Study Medication|Subject no longer required study drug|1|||
44355890|NCT01025817|79360447|FG000|Completed Study Medication|Lost to Follow-up|0|||
44355891|NCT01025817|79360448|FG001|Completed Study Medication|Lost to Follow-up|1|||
44355892|NCT01025817|79360447|FG000|Completed Study|Withdrawal by Subject|8|||
44355893|NCT01025817|79360448|FG001|Completed Study|Withdrawal by Subject|16|||
44355894|NCT01025817|79360447|FG000|Completed Study|Death|6|||
44355895|NCT01025817|79360448|FG001|Completed Study|Death|5|||
44355896|NCT01025817|79360447|FG000|Completed Study|Missing|2|||
44355897|NCT01025817|79360448|FG001|Completed Study|Missing|0|||
44355898|NCT01025817|79360447|FG000|Completed Study|Lost to Follow-up|0|||
44355899|NCT01025817|79360448|FG001|Completed Study|Lost to Follow-up|1|||
44355900|NCT00939640|79360454|FG000|Overall Study|Physician Decision|1|||
44355901|NCT01218113|79360466|FG000|Overall Study|Withdrawal by Subject|1|||
44355902|NCT01218113|79360467|FG001|Overall Study|Withdrawal by Subject|0|||
44355903|NCT01218113|79360468|FG002|Overall Study|Withdrawal by Subject|1|||
44355904|NCT01218113|79360466|FG000|Overall Study|Lost to Follow-up|4|||
44355905|NCT01218113|79360467|FG001|Overall Study|Lost to Follow-up|1|||
44355906|NCT01218113|79360468|FG002|Overall Study|Lost to Follow-up|4|||
44355907|NCT01218113|79360466|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
44355908|NCT01218113|79360467|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
44355909|NCT01218113|79360468|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
44355910|NCT03873493|79360483|FG000|Overall Study|Withdrawal by Subject|1|||
44355911|NCT03873493|79360483|FG000|Overall Study|Death|9|||
44355912|NCT03873493|79360483|FG000|Overall Study|Lost to Follow-up|1|||
44355913|NCT03873493|79360483|FG000|Overall Study|Study Terminated by Sponsor|1|||
44355914|NCT03873493|79360483|FG000|Overall Study|Other|2|||
44355915|NCT00939484|79360503|FG000|Overall Study|Progression/Relapse|8|||
44355916|NCT00939484|79360504|FG001|Overall Study|Progression/Relapse|20|||
44355917|NCT00939484|79360505|FG002|Overall Study|Progression/Relapse|3|||
44355918|NCT01010217|79360520|FG000|Overall Study|Lost to Follow-up|4|||
44355919|NCT01010217|79360521|FG001|Overall Study|Lost to Follow-up|5|||
44355920|NCT01010217|79360522|FG002|Overall Study|Lost to Follow-up|1|||
44355921|NCT01010217|79360523|FG003|Overall Study|Lost to Follow-up|0|||
44355922|NCT01010217|79360524|FG004|Overall Study|Lost to Follow-up|0|||
44355923|NCT01010217|79360520|FG000|Overall Study|Withdrawal by Subject|1|||
44355924|NCT01010217|79360521|FG001|Overall Study|Withdrawal by Subject|0|||
44355925|NCT01010217|79360522|FG002|Overall Study|Withdrawal by Subject|0|||
44355926|NCT01010217|79360523|FG003|Overall Study|Withdrawal by Subject|0|||
44355927|NCT01010217|79360524|FG004|Overall Study|Withdrawal by Subject|0|||
44355928|NCT01010217|79360520|FG000|Overall Study|Physician Decision|0|||
44355929|NCT01010217|79360521|FG001|Overall Study|Physician Decision|0|||
44355930|NCT01010217|79360522|FG002|Overall Study|Physician Decision|0|||
44355931|NCT01010217|79360523|FG003|Overall Study|Physician Decision|6|||
44355932|NCT01010217|79360524|FG004|Overall Study|Physician Decision|3|||
44355933|NCT01217957|79360541|FG000|Phase 1|Withdrawal by Patient|1|||
44355934|NCT01217957|79360542|FG001|Phase 1|Withdrawal by Patient|0|||
44355935|NCT01217957|79360543|FG002|Phase 1|Withdrawal by Patient|1|||
44355936|NCT01217957|79360544|FG003|Phase 1|Withdrawal by Patient|1|||
44355937|NCT01217957|79360545|FG004|Phase 1|Withdrawal by Patient|0|||
44355938|NCT01217957|79360541|FG000|Phase 2|Withdrawal by Patient|0|||
44355939|NCT01217957|79360542|FG001|Phase 2|Withdrawal by Patient|0|||
44355940|NCT01217957|79360543|FG002|Phase 2|Withdrawal by Patient|0|||
44355941|NCT01217957|79360544|FG003|Phase 2|Withdrawal by Patient|0|||
44355942|NCT01217957|79360545|FG004|Phase 2|Withdrawal by Patient|1|||
44355943|NCT00939094|79360568|FG000|Overall Study|Adverse Event|9|||
44355944|NCT00939094|79360569|FG001|Overall Study|Adverse Event|0|||
44355945|NCT00939094|79360568|FG000|Overall Study|Withdrawal by Subject|1|||
44355946|NCT00939094|79360569|FG001|Overall Study|Withdrawal by Subject|6|||
44355947|NCT00939094|79360568|FG000|Overall Study|Lost to Follow-up|1|||
44355948|NCT00939094|79360569|FG001|Overall Study|Lost to Follow-up|1|||
44355949|NCT00939094|79360568|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44355950|NCT00939094|79360569|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44355951|NCT00939094|79360568|FG000|Overall Study|Severe non-compliance to protocol|0|||
44355952|NCT00939094|79360569|FG001|Overall Study|Severe non-compliance to protocol|1|||
44355953|NCT00939094|79360568|FG000|Overall Study|Study stopped by sponsor|0|||
44355954|NCT00939094|79360569|FG001|Overall Study|Study stopped by sponsor|2|||
44355955|NCT00939094|79360568|FG000|Overall Study|Abnormal ECG findings|1|||
44355956|NCT00939094|79360569|FG001|Overall Study|Abnormal ECG findings|0|||
44355957|NCT01217801|79360577|FG000|Period 1|Protocol Violation|1|||
44355958|NCT01217801|79360578|FG001|Period 1|Protocol Violation|1|||
44355959|NCT01217801|79360577|FG000|Period 1|Withdrawal by Subject|0|||
44355960|NCT01217801|79360578|FG001|Period 1|Withdrawal by Subject|1|||
44355961|NCT00935818|79360586|FG000|Overall Study|Withdrawal by Subject|45|||
44355962|NCT00935818|79360587|FG001|Overall Study|Withdrawal by Subject|50|||
44355963|NCT00935818|79360586|FG000|Overall Study|Lost to Follow-up|40|||
44355964|NCT00935818|79360587|FG001|Overall Study|Lost to Follow-up|42|||
44355965|NCT00935818|79360586|FG000|Overall Study|Adverse Event|6|||
44355966|NCT00935818|79360587|FG001|Overall Study|Adverse Event|7|||
44355967|NCT00935818|79360586|FG000|Overall Study|Physician Decision|0|||
44355968|NCT00935818|79360587|FG001|Overall Study|Physician Decision|1|||
44355969|NCT01216319|79360593|FG000|Overall Study|Lost to Follow-up|2|||
44355970|NCT01216319|79360593|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
44355971|NCT00936208|79360599|FG000|Overall Study|Protocol Violation|37|||
44355972|NCT00936208|79360600|FG001|Overall Study|Protocol Violation|22|||
44355973|NCT01216163|79360609|FG000|Overall Study|Withdrawal by Subject|1|||
44355974|NCT01216163|79360610|FG001|Overall Study|Withdrawal by Subject|1|||
44355975|NCT01216163|79360611|FG002|Overall Study|Withdrawal by Subject|0|||
44355976|NCT00933244|79360622|FG000|Overall Study|Withdrawal by Subject|5|||
44355977|NCT00933244|79360623|FG001|Overall Study|Withdrawal by Subject|1|||
44355978|NCT00933244|79360624|FG002|Overall Study|Withdrawal by Subject|3|||
44355979|NCT00930046|79360634|FG000|Overall Study|Wound catheter malfunctioned|1|||
44355980|NCT00930046|79360635|FG001|Overall Study|Wound catheter malfunctioned|2|||
44355981|NCT00935584|79360643|FG000|Overall Study|Withdrawal by Subject|9|||
44355982|NCT00935584|79360644|FG001|Overall Study|Withdrawal by Subject|0|||
44355983|NCT00935584|79360643|FG000|Overall Study|Death|3|||
44355984|NCT00935584|79360644|FG001|Overall Study|Death|0|||
44355985|NCT00935584|79360643|FG000|Overall Study|Lost to Follow-up|8|||
44355986|NCT00935584|79360644|FG001|Overall Study|Lost to Follow-up|0|||
44355987|NCT00935584|79360643|FG000|Overall Study|No show|9|||
44355988|NCT00935584|79360644|FG001|Overall Study|No show|0|||
44355989|NCT00935584|79360643|FG000|Overall Study|Relocated|3|||
44355990|NCT00935584|79360644|FG001|Overall Study|Relocated|0|||
44355991|NCT00935584|79360643|FG000|Overall Study|Patient changed provider|3|||
44355992|NCT00935584|79360644|FG001|Overall Study|Patient changed provider|0|||
44355993|NCT00935584|79360643|FG000|Overall Study|Provider dropped out of study|14|||
44355994|NCT00935584|79360644|FG001|Overall Study|Provider dropped out of study|4|||
44355995|NCT01215851|79360654|FG000|Treatment Period|Adverse Event|1|||
44355996|NCT01215851|79360655|FG001|Treatment Period|Adverse Event|1|||
44355997|NCT01215851|79360656|FG002|Treatment Period|Adverse Event|1|||
44355998|NCT01215851|79360657|FG003|Treatment Period|Adverse Event|3|||
44355999|NCT01215851|79360658|FG004|Treatment Period|Adverse Event|0|||
44356000|NCT01215851|79360659|FG005|Treatment Period|Adverse Event|1|||
44356001|NCT01215851|79360654|FG000|Follow up Period|Lost to Follow-up|0|||
44356002|NCT01215851|79360655|FG001|Follow up Period|Lost to Follow-up|0|||
44356003|NCT01215851|79360656|FG002|Follow up Period|Lost to Follow-up|0|||
44356004|NCT01215851|79360657|FG003|Follow up Period|Lost to Follow-up|0|||
44356005|NCT01215851|79360658|FG004|Follow up Period|Lost to Follow-up|0|||
44356006|NCT01215851|79360659|FG005|Follow up Period|Lost to Follow-up|1|||
44356007|NCT00933166|79360674|FG000|Overall Study|Lost to Follow-up|4|||
44356008|NCT00933166|79360674|FG000|Overall Study|Lack of Efficacy|9|||
44356009|NCT00933166|79360674|FG000|Overall Study|Unavailable|4|||
44356010|NCT00933166|79360674|FG000|Overall Study|Withdrawal by Subject|1|||
44356011|NCT00935272|79360680|FG000|Overall Study|Lost to Follow-up|10|||
44356012|NCT00935272|79360681|FG001|Overall Study|Lost to Follow-up|3|||
44356013|NCT00935272|79360680|FG000|Overall Study|Withdrawal by Subject|8|||
44356014|NCT00935272|79360681|FG001|Overall Study|Withdrawal by Subject|2|||
44356015|NCT00935272|79360680|FG000|Overall Study|Physician Decision|1|||
44356016|NCT00935272|79360681|FG001|Overall Study|Physician Decision|0|||
44356017|NCT00935272|79360680|FG000|Overall Study|Protocol Violation|0|||
44356018|NCT00935272|79360681|FG001|Overall Study|Protocol Violation|1|||
44356019|NCT01010061|79360690|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
44356020|NCT01010061|79360691|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
44356021|NCT01010061|79360690|FG000|Overall Study|Disease Progression|2|||
44356022|NCT01010061|79360691|FG001|Overall Study|Disease Progression|8|||
44356023|NCT01010061|79360690|FG000|Overall Study|Withdrew Consent|5|||
44356024|NCT01010061|79360691|FG001|Overall Study|Withdrew Consent|1|||
44356025|NCT01010061|79360690|FG000|Overall Study|Death|3|||
44356026|NCT01010061|79360691|FG001|Overall Study|Death|6|||
44356027|NCT01010061|79360690|FG000|Overall Study|Administrative/Other|0|||
44356028|NCT01010061|79360691|FG001|Overall Study|Administrative/Other|1|||
44356029|NCT01010061|79360690|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
44356030|NCT01010061|79360691|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
44356031|NCT01010061|79360690|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44356032|NCT01010061|79360691|FG001|Overall Study|Insufficient Therapeutic Response|5|||
44356033|NCT01010061|79360690|FG000|Overall Study|Violation of Selection Criteria|0|||
44356034|NCT01010061|79360691|FG001|Overall Study|Violation of Selection Criteria|1|||
44356035|NCT01010061|79360690|FG000|Overall Study|Did Not Receive Treatment|2|||
44356036|NCT01010061|79360691|FG001|Overall Study|Did Not Receive Treatment|2|||
44356037|NCT00929734|79360711|FG000|Overall Study|Lost to Follow-up|2|||
44356038|NCT00929734|79360712|FG001|Overall Study|Lost to Follow-up|1|||
44356039|NCT00929734|79360711|FG000|Overall Study|Withdrawal by Subject|0|||
44356040|NCT00929734|79360712|FG001|Overall Study|Withdrawal by Subject|2|||
44356041|NCT01013883|79360720|FG000|Overall Study|Lost to Follow-up|2|||
44356042|NCT01013883|79360721|FG001|Overall Study|Lost to Follow-up|2|||
44356043|NCT01009983|79360727|FG000|Overall Study|necessary scans not completed|1|||
44356044|NCT01215227|79360741|FG000|Overall Study|Adverse Event|11|||
44356045|NCT01215227|79360742|FG001|Overall Study|Adverse Event|11|||
44356046|NCT01215227|79360743|FG002|Overall Study|Adverse Event|4|||
44356047|NCT01215227|79360744|FG003|Overall Study|Adverse Event|8|||
44356048|NCT01215227|79360745|FG004|Overall Study|Adverse Event|7|||
44356049|NCT01215227|79360746|FG005|Overall Study|Adverse Event|6|||
44356050|NCT01215227|79360741|FG000|Overall Study|Treatment Failure|8|||
44356051|NCT01215227|79360742|FG001|Overall Study|Treatment Failure|4|||
44356052|NCT01215227|79360743|FG002|Overall Study|Treatment Failure|1|||
44356053|NCT01215227|79360744|FG003|Overall Study|Treatment Failure|5|||
44356054|NCT01215227|79360745|FG004|Overall Study|Treatment Failure|1|||
44356055|NCT01215227|79360746|FG005|Overall Study|Treatment Failure|1|||
44356056|NCT01215227|79360741|FG000|Overall Study|Lost to Follow-up|1|||
44356057|NCT01215227|79360742|FG001|Overall Study|Lost to Follow-up|4|||
44356058|NCT01215227|79360743|FG002|Overall Study|Lost to Follow-up|1|||
44356059|NCT01215227|79360744|FG003|Overall Study|Lost to Follow-up|1|||
44356060|NCT01215227|79360745|FG004|Overall Study|Lost to Follow-up|1|||
44356061|NCT01215227|79360746|FG005|Overall Study|Lost to Follow-up|2|||
44356062|NCT01215227|79360741|FG000|Overall Study|Subject Withdrew Consent|16|||
44356063|NCT01215227|79360742|FG001|Overall Study|Subject Withdrew Consent|20|||
44356064|NCT01215227|79360743|FG002|Overall Study|Subject Withdrew Consent|7|||
44356065|NCT01215227|79360744|FG003|Overall Study|Subject Withdrew Consent|10|||
44356066|NCT01215227|79360745|FG004|Overall Study|Subject Withdrew Consent|11|||
44356067|NCT01215227|79360746|FG005|Overall Study|Subject Withdrew Consent|8|||
44356068|NCT01215227|79360741|FG000|Overall Study|Non-Compliance With Protocol|2|||
44356069|NCT01215227|79360742|FG001|Overall Study|Non-Compliance With Protocol|6|||
44356070|NCT01215227|79360743|FG002|Overall Study|Non-Compliance With Protocol|1|||
44356071|NCT01215227|79360744|FG003|Overall Study|Non-Compliance With Protocol|0|||
44356072|NCT01215227|79360745|FG004|Overall Study|Non-Compliance With Protocol|0|||
44356073|NCT01215227|79360746|FG005|Overall Study|Non-Compliance With Protocol|0|||
44356074|NCT01215227|79360741|FG000|Overall Study|Administrative|83|||
44356075|NCT01215227|79360742|FG001|Overall Study|Administrative|73|||
44356076|NCT01215227|79360743|FG002|Overall Study|Administrative|42|||
44356077|NCT01215227|79360744|FG003|Overall Study|Administrative|24|||
44356078|NCT01215227|79360745|FG004|Overall Study|Administrative|28|||
44356079|NCT01215227|79360746|FG005|Overall Study|Administrative|40|||
44356080|NCT01215227|79360741|FG000|Overall Study|Missing Status|0|||
44356081|NCT01215227|79360742|FG001|Overall Study|Missing Status|1|||
44356082|NCT01215227|79360743|FG002|Overall Study|Missing Status|0|||
44356083|NCT01215227|79360744|FG003|Overall Study|Missing Status|0|||
44356084|NCT01215227|79360745|FG004|Overall Study|Missing Status|0|||
44356085|NCT01215227|79360746|FG005|Overall Study|Missing Status|0|||
44356086|NCT01215227|79360741|FG000|Overall Study|Randomized but not treated|0|||
44356087|NCT01215227|79360742|FG001|Overall Study|Randomized but not treated|0|||
44356088|NCT01215227|79360743|FG002|Overall Study|Randomized but not treated|1|||
44356089|NCT01215227|79360744|FG003|Overall Study|Randomized but not treated|1|||
44356090|NCT01215227|79360745|FG004|Overall Study|Randomized but not treated|0|||
44356091|NCT01215227|79360746|FG005|Overall Study|Randomized but not treated|1|||
44356092|NCT01009515|79360760|FG000|Overall Study|Withdrawal by Subject|3|||
44356093|NCT01214915|79360764|FG000|Overall Study|Adverse Event|8|||
44356094|NCT01214915|79360764|FG000|Overall Study|Lack of Efficacy|3|||
44356095|NCT01009281|79360768|FG000|Overall Study|Administrative problems|7|||
44356096|NCT01009203|79360772|FG000|Overall Study|Withdrawal by Subject|1|||
44356097|NCT01009203|79360772|FG000|Overall Study|Adverse Event|5|||
44356098|NCT01009203|79360772|FG000|Overall Study|Treatment-unrelated death|1|||
44356099|NCT01009047|79360778|FG000|Overall Study|Adverse Event|5|||
44356100|NCT01009047|79360779|FG001|Overall Study|Adverse Event|0|||
44356101|NCT01009047|79360778|FG000|Overall Study|Lost to Follow-up|0|||
44356102|NCT01009047|79360779|FG001|Overall Study|Lost to Follow-up|2|||
44356103|NCT01009047|79360778|FG000|Overall Study|Lack of Efficacy|4|||
44356104|NCT01009047|79360779|FG001|Overall Study|Lack of Efficacy|11|||
44356105|NCT01009047|79360778|FG000|Overall Study|Withdrawal by consent|16|||
44356106|NCT01009047|79360779|FG001|Overall Study|Withdrawal by consent|11|||
44356107|NCT01009047|79360778|FG000|Overall Study|Other|3|||
44356108|NCT01009047|79360779|FG001|Overall Study|Other|2|||
44356109|NCT01025193|79360785|FG000|Overall Study|Protocol Violation|1|||
44356110|NCT01025193|79360785|FG000|Overall Study|Adverse Event|3|||
44356111|NCT01025037|79360793|FG000|Overall Study|Adverse Event|3|||
44356112|NCT01025037|79360793|FG000|Overall Study|Lost to Follow-up|7|||
44356113|NCT01025037|79360793|FG000|Overall Study|Withdrawal by Subject|1|||
44356114|NCT01214837|79360800|FG000|Overall Study|Death|0|||
44356115|NCT01214837|79360801|FG001|Overall Study|Death|0|||
44356116|NCT01214837|79360802|FG002|Overall Study|Death|1|||
44356117|NCT01214837|79360800|FG000|Overall Study|Adverse Event|1|||
44356118|NCT01214837|79360801|FG001|Overall Study|Adverse Event|2|||
44356119|NCT01214837|79360802|FG002|Overall Study|Adverse Event|1|||
44356120|NCT01214837|79360800|FG000|Overall Study|Withdrawal by Subject|27|||
44356121|NCT01214837|79360801|FG001|Overall Study|Withdrawal by Subject|36|||
44356122|NCT01214837|79360802|FG002|Overall Study|Withdrawal by Subject|28|||
44356123|NCT01214837|79360800|FG000|Overall Study|Lost to Follow-up|20|||
44356124|NCT01214837|79360801|FG001|Overall Study|Lost to Follow-up|15|||
44356125|NCT01214837|79360802|FG002|Overall Study|Lost to Follow-up|21|||
44356126|NCT01214837|79360800|FG000|Overall Study|Inappropriate Enrolment|0|||
44356127|NCT01214837|79360801|FG001|Overall Study|Inappropriate Enrolment|1|||
44356128|NCT01214837|79360802|FG002|Overall Study|Inappropriate Enrolment|2|||
44356129|NCT01214837|79360800|FG000|Overall Study|Administrative Reason|2|||
44356130|NCT01214837|79360801|FG001|Overall Study|Administrative Reason|6|||
44356131|NCT01214837|79360802|FG002|Overall Study|Administrative Reason|4|||
44356132|NCT01214837|79360800|FG000|Overall Study|Protocol Violation|3|||
44356133|NCT01214837|79360801|FG001|Overall Study|Protocol Violation|1|||
44356134|NCT01214837|79360802|FG002|Overall Study|Protocol Violation|5|||
44356135|NCT01214837|79360800|FG000|Overall Study|Unable to Classify|1|||
44448731|NCT00550446|79457357|FG002|Up To Week 12|Lost to Follow-up|0|||
44356136|NCT01214837|79360801|FG001|Overall Study|Unable to Classify|3|||
44356137|NCT01214837|79360802|FG002|Overall Study|Unable to Classify|0|||
44356138|NCT01024959|79360811|FG000|Overall Study|ineligible|12|||
44356139|NCT01024959|79360811|FG000|Overall Study|results not evaluable|12|||
44356140|NCT01024959|79360811|FG000|Overall Study|missing results required for analysis|17|||
44356141|NCT01008423|79360822|FG000|Overall Study|Adverse Event|13|||
44356142|NCT01008423|79360823|FG001|Overall Study|Adverse Event|6|||
44356143|NCT01008423|79360822|FG000|Overall Study|Withdrawal by Subject|4|||
44356144|NCT01008423|79360823|FG001|Overall Study|Withdrawal by Subject|7|||
44356145|NCT01008423|79360822|FG000|Overall Study|Lost to Follow-up|0|||
44356146|NCT01008423|79360823|FG001|Overall Study|Lost to Follow-up|2|||
44356147|NCT01008423|79360822|FG000|Overall Study|Low Cortisol|0|||
44356148|NCT01008423|79360823|FG001|Overall Study|Low Cortisol|1|||
44356149|NCT01008423|79360822|FG000|Overall Study|Lack of Efficacy|0|||
44356150|NCT01008423|79360823|FG001|Overall Study|Lack of Efficacy|5|||
44356151|NCT01008423|79360822|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
44356152|NCT01008423|79360823|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
44356153|NCT01008423|79360822|FG000|Overall Study|Personal Conflict|1|||
44356154|NCT01008423|79360823|FG001|Overall Study|Personal Conflict|0|||
44356155|NCT01008423|79360822|FG000|Overall Study|Other|0|||
44356156|NCT01008423|79360823|FG001|Overall Study|Other|1|||
44356157|NCT01012947|79360834|FG000|Overall Study|Lost to Follow-up|131|||
44356158|NCT01012947|79360835|FG001|Overall Study|Lost to Follow-up|135|||
44356159|NCT01012947|79360836|FG002|Overall Study|Lost to Follow-up|130|||
44356160|NCT01012947|79360837|FG003|Overall Study|Lost to Follow-up|118|||
44356161|NCT01012947|79360838|FG004|Overall Study|Lost to Follow-up|142|||
44356162|NCT01214603|79360870|FG000|Overall Study|Adverse Event|0|||
44356163|NCT01214603|79360871|FG001|Overall Study|Adverse Event|0|||
44356164|NCT01214603|79360872|FG002|Overall Study|Adverse Event|1|||
44356165|NCT01214603|79360870|FG000|Overall Study|Death|1|||
44356166|NCT01214603|79360871|FG001|Overall Study|Death|0|||
44356167|NCT01214603|79360872|FG002|Overall Study|Death|0|||
44356168|NCT01214603|79360870|FG000|Overall Study|Progressive Disease|4|||
44356169|NCT01214603|79360871|FG001|Overall Study|Progressive Disease|1|||
44356170|NCT01214603|79360872|FG002|Overall Study|Progressive Disease|3|||
44356171|NCT01212185|79360883|FG000|Overall Study|Protocol Violation|2|||
44356172|NCT01212185|79360884|FG001|Overall Study|Protocol Violation|1|||
44356173|NCT01995175|79360890|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
44356174|NCT01995175|79360890|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
44356175|NCT01995175|79360890|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
44356176|NCT01995175|79360890|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
44356177|NCT01995175|79360890|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
44356178|NCT01995175|79360890|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
44356179|NCT01995175|79360890|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
44356180|NCT01995175|79360890|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
44356181|NCT01995175|79360890|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
44356182|NCT01752907|79360979|FG000|Overall Study|Withdrawal by Subject|4|||
44356183|NCT01752907|79360980|FG001|Overall Study|Withdrawal by Subject|10|||
44356184|NCT01752907|79360979|FG000|Overall Study|Lost to Follow-up|2|||
44356185|NCT01752907|79360980|FG001|Overall Study|Lost to Follow-up|1|||
44356186|NCT01752907|79360979|FG000|Overall Study|Decision by Sponsor|6|||
44356187|NCT01752907|79360980|FG001|Overall Study|Decision by Sponsor|9|||
44356188|NCT03439189|79360986|FG000|Overall Study|Protocol Violation|19|||
44356189|NCT03439189|79360986|FG000|Overall Study|Lack of Efficacy|63|||
44356190|NCT01211483|79360995|FG000|Phase 1b|Death|6|||
44356191|NCT01211483|79360996|FG001|Phase 1b|Death|0|||
44356192|NCT01211483|79360997|FG002|Phase 1b|Death|0|||
44356193|NCT01211483|79360998|FG003|Phase 1b|Death|0|||
44356194|NCT01211483|79360995|FG000|Phase 1b|Withdrawal by Subject|1|||
44356195|NCT01211483|79360996|FG001|Phase 1b|Withdrawal by Subject|0|||
44356196|NCT01211483|79360997|FG002|Phase 1b|Withdrawal by Subject|0|||
44356197|NCT01211483|79360998|FG003|Phase 1b|Withdrawal by Subject|0|||
44356198|NCT01211483|79360995|FG000|Phase 2|Lost to Follow-up|0|||
44356199|NCT01211483|79360996|FG001|Phase 2|Lost to Follow-up|1|||
44356200|NCT01211483|79360997|FG002|Phase 2|Lost to Follow-up|1|||
44356201|NCT01211483|79360998|FG003|Phase 2|Lost to Follow-up|2|||
44356202|NCT01211483|79360995|FG000|Phase 2|Death|0|||
44356203|NCT01211483|79360996|FG001|Phase 2|Death|64|||
44356204|NCT01211483|79360997|FG002|Phase 2|Death|53|||
44356205|NCT01211483|79360998|FG003|Phase 2|Death|53|||
44356206|NCT01211483|79360995|FG000|Phase 2|Withdrawal by Subject|0|||
44356207|NCT01211483|79360996|FG001|Phase 2|Withdrawal by Subject|1|||
44356208|NCT01211483|79360997|FG002|Phase 2|Withdrawal by Subject|10|||
44356209|NCT01211483|79360998|FG003|Phase 2|Withdrawal by Subject|5|||
44356210|NCT01211483|79360995|FG000|Phase 2|Study terminated by Sponsor|0|||
44356211|NCT01211483|79360996|FG001|Phase 2|Study terminated by Sponsor|6|||
44356212|NCT01211483|79360997|FG002|Phase 2|Study terminated by Sponsor|8|||
44356213|NCT01211483|79360998|FG003|Phase 2|Study terminated by Sponsor|11|||
44356214|NCT01210001|79361015|FG000|Overall Study|Not treated|1|||
44356215|NCT01210001|79361016|FG001|Overall Study|Not treated|0|||
44356216|NCT01210001|79361017|FG002|Overall Study|Not treated|0|||
44356217|NCT01210001|79361015|FG000|Overall Study|Adverse Event|4|||
44356218|NCT01210001|79361016|FG001|Overall Study|Adverse Event|2|||
44356219|NCT01210001|79361017|FG002|Overall Study|Adverse Event|5|||
44356220|NCT01210001|79361015|FG000|Overall Study|Non compliant with protocol|2|||
44356221|NCT01210001|79361016|FG001|Overall Study|Non compliant with protocol|2|||
44356222|NCT01210001|79361017|FG002|Overall Study|Non compliant with protocol|3|||
44356223|NCT01210001|79361015|FG000|Overall Study|Lost to Follow-up|4|||
44356224|NCT01210001|79361016|FG001|Overall Study|Lost to Follow-up|3|||
44356225|NCT01210001|79361017|FG002|Overall Study|Lost to Follow-up|2|||
44356226|NCT01210001|79361015|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
44356227|NCT01210001|79361016|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
44356228|NCT01210001|79361017|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
44356229|NCT01210001|79361015|FG000|Overall Study|Other reason not defined above|2|||
44356230|NCT01210001|79361016|FG001|Overall Study|Other reason not defined above|2|||
44356231|NCT01210001|79361017|FG002|Overall Study|Other reason not defined above|1|||
44356232|NCT01209689|79361058|FG000|Overall Study|Insufficient Therapeutic Response|7|||
44356233|NCT01209689|79361059|FG001|Overall Study|Insufficient Therapeutic Response|2|||
44356234|NCT01209689|79361058|FG000|Overall Study|Refused Treatment|8|||
44356235|NCT01209689|79361059|FG001|Overall Study|Refused Treatment|3|||
44356236|NCT01209689|79361058|FG000|Overall Study|Adverse Event|4|||
44356237|NCT01209689|79361059|FG001|Overall Study|Adverse Event|0|||
44356238|NCT01209689|79361058|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
44356239|NCT01209689|79361059|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
44356240|NCT01209689|79361058|FG000|Overall Study|Failure to Return|3|||
44356241|NCT01209689|79361059|FG001|Overall Study|Failure to Return|0|||
44356242|NCT01209689|79361058|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
44356243|NCT01209689|79361059|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
44356244|NCT01209143|79361067|FG000|Overall Study|Adverse Event|2|||
44356245|NCT01209143|79361068|FG001|Overall Study|Adverse Event|1|||
44356246|NCT01209143|79361067|FG000|Overall Study|Death|0|||
44356247|NCT01209143|79361068|FG001|Overall Study|Death|1|||
44356248|NCT01209143|79361067|FG000|Overall Study|Physician Decision|3|||
44356249|NCT01209143|79361068|FG001|Overall Study|Physician Decision|1|||
44356250|NCT01209143|79361067|FG000|Overall Study|Lost to Follow-up|1|||
44356251|NCT01209143|79361068|FG001|Overall Study|Lost to Follow-up|0|||
44356252|NCT01209143|79361067|FG000|Overall Study|Withdrawal by Subject|2|||
44356253|NCT01209143|79361068|FG001|Overall Study|Withdrawal by Subject|1|||
44356254|NCT01209143|79361067|FG000|Overall Study|Disease progression|11|||
44356255|NCT01209143|79361068|FG001|Overall Study|Disease progression|16|||
44356256|NCT01023789|79361074|FG000|3 - Year Visit|Death|29|||
44356257|NCT01023789|79361074|FG000|3 - Year Visit|Withdrawal of consent|1|||
44356258|NCT01023789|79361074|FG000|3 - Year Visit|Lost to Follow-up|13|||
44356259|NCT01208207|79361081|FG000|Part I|Adverse Event|19|||
44356260|NCT01208207|79361082|FG001|Part I|Adverse Event|2|||
44356261|NCT01208207|79361083|FG002|Part I|Adverse Event|6|||
44356262|NCT01208207|79361084|FG003|Part I|Adverse Event|0|||
44356263|NCT01208207|79361085|FG004|Part I|Adverse Event|0|||
44356264|NCT01208207|79361086|FG005|Part I|Adverse Event|0|||
44356265|NCT01208207|79361087|FG006|Part I|Adverse Event|0|||
44356266|NCT01208207|79361081|FG000|Part I|Lack of Efficacy|21|||
44356267|NCT01208207|79361082|FG001|Part I|Lack of Efficacy|3|||
44356268|NCT01208207|79361083|FG002|Part I|Lack of Efficacy|2|||
44356269|NCT01208207|79361084|FG003|Part I|Lack of Efficacy|0|||
44356270|NCT01208207|79361085|FG004|Part I|Lack of Efficacy|0|||
44356271|NCT01208207|79361086|FG005|Part I|Lack of Efficacy|0|||
44356272|NCT01208207|79361087|FG006|Part I|Lack of Efficacy|0|||
44356273|NCT01208207|79361081|FG000|Part I|Lost to Follow-up|6|||
44356274|NCT01208207|79361082|FG001|Part I|Lost to Follow-up|1|||
44356275|NCT01208207|79361083|FG002|Part I|Lost to Follow-up|0|||
44356276|NCT01208207|79361084|FG003|Part I|Lost to Follow-up|0|||
44356277|NCT01208207|79361085|FG004|Part I|Lost to Follow-up|0|||
44356278|NCT01208207|79361086|FG005|Part I|Lost to Follow-up|0|||
44356279|NCT01208207|79361087|FG006|Part I|Lost to Follow-up|0|||
44356280|NCT01208207|79361081|FG000|Part I|Non-Compliance With Study Drug|1|||
44356281|NCT01208207|79361082|FG001|Part I|Non-Compliance With Study Drug|0|||
44356282|NCT01208207|79361083|FG002|Part I|Non-Compliance With Study Drug|1|||
44356283|NCT01208207|79361084|FG003|Part I|Non-Compliance With Study Drug|0|||
44356284|NCT01208207|79361085|FG004|Part I|Non-Compliance With Study Drug|0|||
44356285|NCT01208207|79361086|FG005|Part I|Non-Compliance With Study Drug|0|||
44356286|NCT01208207|79361087|FG006|Part I|Non-Compliance With Study Drug|0|||
44356287|NCT01208207|79361081|FG000|Part I|Physician Decision|0|||
44356288|NCT01208207|79361082|FG001|Part I|Physician Decision|1|||
44356289|NCT01208207|79361083|FG002|Part I|Physician Decision|0|||
44356290|NCT01208207|79361084|FG003|Part I|Physician Decision|0|||
44356291|NCT01208207|79361085|FG004|Part I|Physician Decision|0|||
44356292|NCT01208207|79361086|FG005|Part I|Physician Decision|0|||
44356293|NCT01208207|79361087|FG006|Part I|Physician Decision|0|||
44356294|NCT01208207|79361081|FG000|Part I|Progressive Disease|1|||
44356295|NCT01208207|79361082|FG001|Part I|Progressive Disease|0|||
44356296|NCT01208207|79361083|FG002|Part I|Progressive Disease|0|||
44356297|NCT01208207|79361084|FG003|Part I|Progressive Disease|0|||
44356298|NCT01208207|79361085|FG004|Part I|Progressive Disease|0|||
44356299|NCT01208207|79361086|FG005|Part I|Progressive Disease|0|||
44356300|NCT01208207|79361087|FG006|Part I|Progressive Disease|0|||
44356301|NCT01208207|79361081|FG000|Part I|Protocol Violation|8|||
44356302|NCT01208207|79361082|FG001|Part I|Protocol Violation|0|||
44356303|NCT01208207|79361083|FG002|Part I|Protocol Violation|2|||
44356304|NCT01208207|79361084|FG003|Part I|Protocol Violation|0|||
44356305|NCT01208207|79361085|FG004|Part I|Protocol Violation|0|||
44356306|NCT01208207|79361086|FG005|Part I|Protocol Violation|0|||
44356307|NCT01208207|79361087|FG006|Part I|Protocol Violation|0|||
44356308|NCT01208207|79361081|FG000|Part I|Withdrawal by Subject|14|||
44356309|NCT01208207|79361082|FG001|Part I|Withdrawal by Subject|4|||
44356310|NCT01208207|79361083|FG002|Part I|Withdrawal by Subject|4|||
44356311|NCT01208207|79361084|FG003|Part I|Withdrawal by Subject|0|||
44356312|NCT01208207|79361085|FG004|Part I|Withdrawal by Subject|0|||
44356313|NCT01208207|79361086|FG005|Part I|Withdrawal by Subject|0|||
44356314|NCT01208207|79361087|FG006|Part I|Withdrawal by Subject|0|||
44356315|NCT01208207|79361081|FG000|Part II|Withdrawal by Subject|0|||
44356316|NCT01208207|79361082|FG001|Part II|Withdrawal by Subject|0|||
44356317|NCT01208207|79361083|FG002|Part II|Withdrawal by Subject|0|||
44356318|NCT01208207|79361084|FG003|Part II|Withdrawal by Subject|10|||
44356319|NCT01208207|79361085|FG004|Part II|Withdrawal by Subject|9|||
44356320|NCT01208207|79361086|FG005|Part II|Withdrawal by Subject|3|||
44356321|NCT01208207|79361087|FG006|Part II|Withdrawal by Subject|5|||
44356322|NCT01208207|79361081|FG000|Part II|Adverse Event|0|||
44356323|NCT01208207|79361082|FG001|Part II|Adverse Event|0|||
44356324|NCT01208207|79361083|FG002|Part II|Adverse Event|0|||
44356325|NCT01208207|79361084|FG003|Part II|Adverse Event|5|||
44356326|NCT01208207|79361085|FG004|Part II|Adverse Event|9|||
44356327|NCT01208207|79361086|FG005|Part II|Adverse Event|4|||
44356328|NCT01208207|79361087|FG006|Part II|Adverse Event|2|||
44356329|NCT01208207|79361081|FG000|Part II|Lack of Efficacy|0|||
44356330|NCT01208207|79361082|FG001|Part II|Lack of Efficacy|0|||
44356331|NCT01208207|79361083|FG002|Part II|Lack of Efficacy|0|||
44356332|NCT01208207|79361084|FG003|Part II|Lack of Efficacy|6|||
44356333|NCT01208207|79361085|FG004|Part II|Lack of Efficacy|4|||
44356334|NCT01208207|79361086|FG005|Part II|Lack of Efficacy|3|||
44356335|NCT01208207|79361087|FG006|Part II|Lack of Efficacy|3|||
44356336|NCT01208207|79361081|FG000|Part II|Lost to Follow-up|0|||
44356337|NCT01208207|79361082|FG001|Part II|Lost to Follow-up|0|||
44356338|NCT01208207|79361083|FG002|Part II|Lost to Follow-up|0|||
44356339|NCT01208207|79361084|FG003|Part II|Lost to Follow-up|4|||
44356340|NCT01208207|79361085|FG004|Part II|Lost to Follow-up|0|||
44356341|NCT01208207|79361086|FG005|Part II|Lost to Follow-up|2|||
44356342|NCT01208207|79361087|FG006|Part II|Lost to Follow-up|1|||
44356343|NCT01208207|79361081|FG000|Part II|Non-Compliance With Study Drug|0|||
44356344|NCT01208207|79361082|FG001|Part II|Non-Compliance With Study Drug|0|||
44356345|NCT01208207|79361083|FG002|Part II|Non-Compliance With Study Drug|0|||
44356346|NCT01208207|79361084|FG003|Part II|Non-Compliance With Study Drug|4|||
44356347|NCT01208207|79361085|FG004|Part II|Non-Compliance With Study Drug|1|||
44356348|NCT01208207|79361086|FG005|Part II|Non-Compliance With Study Drug|1|||
44356349|NCT01208207|79361087|FG006|Part II|Non-Compliance With Study Drug|0|||
44356350|NCT01208207|79361081|FG000|Part II|Physician Decision|0|||
44356351|NCT01208207|79361082|FG001|Part II|Physician Decision|0|||
44356352|NCT01208207|79361083|FG002|Part II|Physician Decision|0|||
44356353|NCT01208207|79361084|FG003|Part II|Physician Decision|1|||
44356354|NCT01208207|79361085|FG004|Part II|Physician Decision|0|||
44356355|NCT01208207|79361086|FG005|Part II|Physician Decision|2|||
44356356|NCT01208207|79361087|FG006|Part II|Physician Decision|0|||
44356357|NCT01208207|79361081|FG000|Part II|Protocol Violation|0|||
44356358|NCT01208207|79361082|FG001|Part II|Protocol Violation|0|||
44356359|NCT01208207|79361083|FG002|Part II|Protocol Violation|0|||
44356360|NCT01208207|79361084|FG003|Part II|Protocol Violation|1|||
44356361|NCT01208207|79361085|FG004|Part II|Protocol Violation|0|||
44356362|NCT01208207|79361086|FG005|Part II|Protocol Violation|0|||
44356363|NCT01208207|79361087|FG006|Part II|Protocol Violation|0|||
44356364|NCT01208207|79361081|FG000|Part II|Technical Problems|0|||
44356365|NCT01208207|79361082|FG001|Part II|Technical Problems|0|||
44356366|NCT01208207|79361083|FG002|Part II|Technical Problems|0|||
44356367|NCT01208207|79361084|FG003|Part II|Technical Problems|1|||
44356368|NCT01208207|79361085|FG004|Part II|Technical Problems|0|||
44356369|NCT01208207|79361086|FG005|Part II|Technical Problems|1|||
44356370|NCT01208207|79361087|FG006|Part II|Technical Problems|0|||
44356371|NCT01012713|79361118|FG000|Overall Study|Lack of Efficacy|3|||
44356372|NCT01007253|79361123|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
44356373|NCT01007253|79361124|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
44356374|NCT01007253|79361125|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
44356375|NCT01007253|79361126|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
44356376|NCT01006707|79361136|FG000|Study Session 1|Lost to Follow-up|2|||
44356377|NCT01006707|79361137|FG001|Study Session 1|Lost to Follow-up|0|||
44356378|NCT01006707|79361138|FG002|Study Session 1|Lost to Follow-up|0|||
44356379|NCT01006707|79361136|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
44356380|NCT01006707|79361137|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
44356381|NCT01006707|79361138|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
44356382|NCT01006629|79361146|FG000|Overall Study|Adverse Event|1|||
44356383|NCT01006629|79361146|FG000|Overall Study|Parent refused to continue participation|1|||
44356384|NCT01006629|79361146|FG000|Overall Study|Parent unable to perform site visit|4|||
44356385|NCT01012323|79361150|FG000|Overall Study|Investigator Judgment|1|||
44356386|NCT01011933|79361154|FG000|Overall Study|Wrong cell type|1|||
44356387|NCT01011933|79361154|FG000|Overall Study|Improper pre-protocol Rx|1|||
44356388|NCT01011933|79361154|FG000|Overall Study|Inadequate pathology|1|||
44356389|NCT01011933|79361154|FG000|Overall Study|Never treated|1|||
44356390|NCT01011465|79361176|FG000|Overall Study|Withdrawal by Subject|2|||
44356391|NCT01011465|79361177|FG001|Overall Study|Withdrawal by Subject|1|||
44356392|NCT01011465|79361178|FG002|Overall Study|Withdrawal by Subject|0|||
44356393|NCT01011465|79361179|FG003|Overall Study|Withdrawal by Subject|0|||
44356394|NCT01011465|79361180|FG004|Overall Study|Withdrawal by Subject|1|||
44356395|NCT01011465|79361181|FG005|Overall Study|Withdrawal by Subject|0|||
44356396|NCT01011465|79361182|FG006|Overall Study|Withdrawal by Subject|1|||
44356397|NCT01011465|79361183|FG007|Overall Study|Withdrawal by Subject|0|||
44356398|NCT01011387|79361208|FG000|Overall Study|Withdrawal by Subject|3|||
44356399|NCT01011387|79361208|FG000|Overall Study|Adverse Event|2|||
44356400|NCT01011387|79361208|FG000|Overall Study|Protocol Violation|1|||
44356401|NCT01011309|79361215|FG000|Overall Study|Adverse Event|2|||
44356402|NCT01011309|79361216|FG001|Overall Study|Adverse Event|1|||
44356403|NCT01011309|79361217|FG002|Overall Study|Adverse Event|2|||
44356404|NCT01011309|79361215|FG000|Overall Study|Lack of Efficacy|0|||
44356405|NCT01011309|79361216|FG001|Overall Study|Lack of Efficacy|1|||
44356406|NCT01011309|79361217|FG002|Overall Study|Lack of Efficacy|0|||
44356407|NCT01011309|79361215|FG000|Overall Study|Protocol Violation|0|||
44356408|NCT01011309|79361216|FG001|Overall Study|Protocol Violation|1|||
44356409|NCT01011309|79361217|FG002|Overall Study|Protocol Violation|3|||
44356410|NCT01011153|79361228|FG000|Overall Study|Less than 78 cases completed|8|||
44356411|NCT01011153|79361229|FG001|Overall Study|Less than 78 cases completed|11|||
44356412|NCT01011153|79361230|FG002|Overall Study|Less than 78 cases completed|9|||
44356413|NCT00997893|79361262|FG000|Overall Study|Adverse Event|1|||
44356414|NCT00997893|79361263|FG001|Overall Study|Adverse Event|0|||
44356415|NCT00997893|79361264|FG002|Overall Study|Adverse Event|0|||
44356416|NCT00997893|79361262|FG000|Overall Study|Unable to meet study timelines|1|||
44356417|NCT00997893|79361263|FG001|Overall Study|Unable to meet study timelines|0|||
44356418|NCT00997893|79361264|FG002|Overall Study|Unable to meet study timelines|0|||
44356419|NCT00997893|79361262|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
44356420|NCT00997893|79361263|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
44356421|NCT00997893|79361264|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
44356422|NCT02905825|79361281|FG000|Overall Study|Protocol Violation|11|||
44356423|NCT02905825|79361281|FG000|Overall Study|Device Malfunction|1|||
44356424|NCT01208051|79361290|FG000|Total Enrollment|Withdrawal by Subject|0|||
44356425|NCT01208051|79361291|FG001|Total Enrollment|Withdrawal by Subject|1|||
44356426|NCT01208051|79361292|FG002|Total Enrollment|Withdrawal by Subject|0|||
44356427|NCT01208051|79361293|FG003|Total Enrollment|Withdrawal by Subject|0|||
44356428|NCT01208051|79361294|FG004|Total Enrollment|Withdrawal by Subject|2|||
44356429|NCT01208051|79361290|FG000|Total Enrollment|Brain metastases|0|||
44356430|NCT01208051|79361291|FG001|Total Enrollment|Brain metastases|0|||
44356431|NCT01208051|79361292|FG002|Total Enrollment|Brain metastases|1|||
44356432|NCT01208051|79361293|FG003|Total Enrollment|Brain metastases|0|||
44356433|NCT01208051|79361294|FG004|Total Enrollment|Brain metastases|0|||
44356434|NCT01207583|79361313|FG000|Overall Study|Withdrawal by Subject|0|||
44356435|NCT01207583|79361314|FG001|Overall Study|Withdrawal by Subject|3|||
44356436|NCT01207583|79361315|FG002|Overall Study|Withdrawal by Subject|1|||
44356437|NCT01207583|79361313|FG000|Overall Study|Participant failed to return|1|||
44356438|NCT01207583|79361314|FG001|Overall Study|Participant failed to return|0|||
44356439|NCT01207583|79361315|FG002|Overall Study|Participant failed to return|0|||
44356440|NCT01207583|79361313|FG000|Overall Study|Lost to Follow-up|0|||
44356441|NCT01207583|79361314|FG001|Overall Study|Lost to Follow-up|2|||
44356442|NCT01207583|79361315|FG002|Overall Study|Lost to Follow-up|0|||
44356443|NCT01207427|79361339|FG000|Double-blind Treatment Period|Adverse Event|0|||
44356444|NCT01207427|79361340|FG001|Double-blind Treatment Period|Adverse Event|1|||
44356445|NCT01207427|79361341|FG002|Double-blind Treatment Period|Adverse Event|0|||
44356446|NCT01207427|79361339|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44356447|NCT01207427|79361340|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
44356448|NCT01207427|79361341|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
44356449|NCT01207427|79361339|FG000|Double-blind Treatment Period|Protocol Violation|2|||
44356450|NCT01207427|79361340|FG001|Double-blind Treatment Period|Protocol Violation|1|||
44356451|NCT01207427|79361341|FG002|Double-blind Treatment Period|Protocol Violation|1|||
44356452|NCT01207427|79361339|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
44356453|NCT01207427|79361340|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
44356454|NCT01207427|79361341|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44356455|NCT04713553|79361354|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
44356456|NCT04713553|79361355|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
44356457|NCT04713553|79361356|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
44356458|NCT04713553|79361357|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
44356459|NCT04713553|79361358|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
44356460|NCT04713553|79361359|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
44356461|NCT04713553|79361360|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
44356462|NCT04713553|79361354|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
44356463|NCT04713553|79361355|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
44356464|NCT04713553|79361356|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
44356465|NCT04713553|79361357|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
44356466|NCT04713553|79361358|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
44356467|NCT04713553|79361359|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
44356468|NCT04713553|79361360|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
44356469|NCT04713553|79361354|FG000|Primary Study (2 Months)|Other|1|||
44356470|NCT04713553|79361355|FG001|Primary Study (2 Months)|Other|2|||
44356471|NCT04713553|79361356|FG002|Primary Study (2 Months)|Other|0|||
44356472|NCT04713553|79361357|FG003|Primary Study (2 Months)|Other|0|||
44356473|NCT04713553|79361358|FG004|Primary Study (2 Months)|Other|1|||
44356474|NCT04713553|79361359|FG005|Primary Study (2 Months)|Other|0|||
44356475|NCT04713553|79361360|FG006|Primary Study (2 Months)|Other|0|||
44356476|NCT04713553|79361354|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
44356477|NCT04713553|79361355|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
44356478|NCT04713553|79361356|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
44356479|NCT04713553|79361357|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
44356480|NCT04713553|79361358|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
44356481|NCT04713553|79361359|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
44356482|NCT04713553|79361360|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
44356483|NCT04713553|79361354|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
44356484|NCT04713553|79361355|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
44356485|NCT04713553|79361356|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
44356486|NCT04713553|79361357|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
44356487|NCT04713553|79361358|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
44356488|NCT04713553|79361359|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
44356489|NCT04713553|79361360|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
44356490|NCT01206101|79361383|FG000|Overall Study|Adverse Event|1|||
44356491|NCT01206101|79361384|FG001|Overall Study|Adverse Event|0|||
44356492|NCT01206101|79361383|FG000|Overall Study|Physician Decision|0|||
44356493|NCT01206101|79361384|FG001|Overall Study|Physician Decision|1|||
44356494|NCT01206101|79361383|FG000|Overall Study|Unclassified|1|||
44356495|NCT01206101|79361384|FG001|Overall Study|Unclassified|0|||
44356496|NCT01205165|79361390|FG000|Overall Study|Lost to Follow-up|2|||
44356497|NCT00997503|79361395|FG000|Overall Study|Death|53|||
44356498|NCT00997503|79361395|FG000|Overall Study|Withdrawal by Subject|76|||
44356499|NCT00997503|79361395|FG000|Overall Study|Lost to Follow-up|33|||
44356500|NCT00997503|79361395|FG000|Overall Study|Adverse Event|3|||
44356501|NCT00997503|79361395|FG000|Overall Study|Physician Decision|10|||
44356502|NCT00997503|79361395|FG000|Overall Study|Missed 12-month follow-up|85|||
44356503|NCT00997503|79361395|FG000|Overall Study|Other reason|13|||
44356504|NCT01204775|79361404|FG000|Overall Study|Poor/non-compliance|0|||
44356505|NCT01204775|79361405|FG001|Overall Study|Poor/non-compliance|1|||
44356506|NCT01204775|79361404|FG000|Overall Study|Withdrawal by Subject|1|||
44356507|NCT01204775|79361405|FG001|Overall Study|Withdrawal by Subject|0|||
44356508|NCT00997035|79361413|FG000|3-week Followup Visit|Lost to Follow-up|9|||
44356509|NCT00997035|79361414|FG001|3-week Followup Visit|Lost to Follow-up|6|||
44356510|NCT00997035|79361413|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
44356511|NCT00997035|79361414|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
44356512|NCT01204697|79361432|FG000|Overall Study|Death|26|||
44356513|NCT01204697|79361433|FG001|Overall Study|Death|27|||
44356514|NCT01204697|79361432|FG000|Overall Study|Lost to Follow-up|3|||
44356515|NCT01204697|79361433|FG001|Overall Study|Lost to Follow-up|4|||
44356516|NCT01204697|79361432|FG000|Overall Study|Withdrawal by Subject|2|||
44356517|NCT01204697|79361433|FG001|Overall Study|Withdrawal by Subject|4|||
44356518|NCT01204697|79361432|FG000|Overall Study|Randomized, but not treated|0|||
44356519|NCT01204697|79361433|FG001|Overall Study|Randomized, but not treated|1|||
44356520|NCT01001325|79361441|FG000|Overall Study|Lost to Follow-up|16|||
44356521|NCT01001325|79361442|FG001|Overall Study|Lost to Follow-up|10|||
44356522|NCT01001325|79361441|FG000|Overall Study|Protocol Violation|2|||
44356523|NCT01001325|79361442|FG001|Overall Study|Protocol Violation|0|||
44356524|NCT01203917|79361448|FG000|Overall Study|Death|29|||
44356525|NCT01203917|79361448|FG000|Overall Study|Lost to Follow-up|2|||
44356526|NCT01203917|79361448|FG000|Overall Study|Withdrawal by Subject|3|||
44356527|NCT01203917|79361448|FG000|Overall Study|Due to objective disease progression|1|||
44356528|NCT01203917|79361448|FG000|Overall Study|Due to EGFR M+I patient|1|||
44356529|NCT01202903|79361454|FG000|Overall Study|Administrative Probelms|1|||
44356530|NCT01202903|79361455|FG001|Overall Study|Administrative Probelms|4|||
44356531|NCT01202903|79361454|FG000|Overall Study|Protocol Violation|0|||
44448732|NCT00550446|79457358|FG003|Up To Week 12|Lost to Follow-up|0|||
44356532|NCT01202903|79361455|FG001|Overall Study|Protocol Violation|1|||
44356533|NCT01202903|79361454|FG000|Overall Study|Death|1|||
44356534|NCT01202903|79361455|FG001|Overall Study|Death|0|||
44356535|NCT01202903|79361454|FG000|Overall Study|Lost to Follow-up|1|||
44356536|NCT01202903|79361455|FG001|Overall Study|Lost to Follow-up|1|||
44356537|NCT01202903|79361454|FG000|Overall Study|Lack of Efficacy|1|||
44356538|NCT01202903|79361455|FG001|Overall Study|Lack of Efficacy|3|||
44356539|NCT01202903|79361454|FG000|Overall Study|Adverse Event|3|||
44356540|NCT01202903|79361455|FG001|Overall Study|Adverse Event|3|||
44356541|NCT01202903|79361454|FG000|Overall Study|Withdrawal by Subject|4|||
44356542|NCT01202903|79361455|FG001|Overall Study|Withdrawal by Subject|4|||
44356543|NCT01001169|79361463|FG000|Overall Study|Withdrawal by Subject|2|||
44356544|NCT01001169|79361464|FG001|Overall Study|Withdrawal by Subject|1|||
44356545|NCT01202747|79361478|FG000|Overall Study|Withdrawal by Subject|1|||
44356546|NCT00996801|79361488|FG000|Overall Study|Adverse Event|6|||
44356547|NCT00996801|79361489|FG001|Overall Study|Adverse Event|4|||
44356548|NCT00996801|79361490|FG002|Overall Study|Adverse Event|12|||
44356549|NCT00996801|79361491|FG003|Overall Study|Adverse Event|17|||
44356550|NCT00996801|79361492|FG004|Overall Study|Adverse Event|31|||
44356551|NCT00996801|79361493|FG005|Overall Study|Adverse Event|3|||
44356552|NCT00996801|79361488|FG000|Overall Study|Lack of Efficacy|3|||
44356553|NCT00996801|79361489|FG001|Overall Study|Lack of Efficacy|0|||
44356554|NCT00996801|79361490|FG002|Overall Study|Lack of Efficacy|1|||
44356555|NCT00996801|79361491|FG003|Overall Study|Lack of Efficacy|3|||
44356556|NCT00996801|79361492|FG004|Overall Study|Lack of Efficacy|0|||
44356557|NCT00996801|79361493|FG005|Overall Study|Lack of Efficacy|1|||
44356558|NCT00996801|79361488|FG000|Overall Study|Lost to Follow-up|0|||
44356559|NCT00996801|79361489|FG001|Overall Study|Lost to Follow-up|0|||
44356560|NCT00996801|79361490|FG002|Overall Study|Lost to Follow-up|0|||
44356561|NCT00996801|79361491|FG003|Overall Study|Lost to Follow-up|3|||
44356562|NCT00996801|79361492|FG004|Overall Study|Lost to Follow-up|3|||
44356563|NCT00996801|79361493|FG005|Overall Study|Lost to Follow-up|2|||
44356564|NCT00996801|79361488|FG000|Overall Study|Physician Decision|0|||
44356565|NCT00996801|79361489|FG001|Overall Study|Physician Decision|0|||
44356566|NCT00996801|79361490|FG002|Overall Study|Physician Decision|0|||
44356567|NCT00996801|79361491|FG003|Overall Study|Physician Decision|1|||
44356568|NCT00996801|79361492|FG004|Overall Study|Physician Decision|0|||
44356569|NCT00996801|79361493|FG005|Overall Study|Physician Decision|0|||
44356570|NCT00996801|79361488|FG000|Overall Study|Progressive Disease|0|||
44356571|NCT00996801|79361489|FG001|Overall Study|Progressive Disease|1|||
44356572|NCT00996801|79361490|FG002|Overall Study|Progressive Disease|0|||
44356573|NCT00996801|79361491|FG003|Overall Study|Progressive Disease|0|||
44356574|NCT00996801|79361492|FG004|Overall Study|Progressive Disease|0|||
44356575|NCT00996801|79361493|FG005|Overall Study|Progressive Disease|0|||
44356576|NCT00996801|79361488|FG000|Overall Study|Protocol Violation|3|||
44356577|NCT00996801|79361489|FG001|Overall Study|Protocol Violation|4|||
44356578|NCT00996801|79361490|FG002|Overall Study|Protocol Violation|1|||
44356579|NCT00996801|79361491|FG003|Overall Study|Protocol Violation|2|||
44356580|NCT00996801|79361492|FG004|Overall Study|Protocol Violation|3|||
44356581|NCT00996801|79361493|FG005|Overall Study|Protocol Violation|4|||
44356582|NCT00996801|79361488|FG000|Overall Study|Study Terminated by Sponsor|0|||
44356583|NCT00996801|79361489|FG001|Overall Study|Study Terminated by Sponsor|1|||
44356584|NCT00996801|79361490|FG002|Overall Study|Study Terminated by Sponsor|0|||
44356585|NCT00996801|79361491|FG003|Overall Study|Study Terminated by Sponsor|0|||
44356586|NCT00996801|79361492|FG004|Overall Study|Study Terminated by Sponsor|46|||
44356587|NCT00996801|79361493|FG005|Overall Study|Study Terminated by Sponsor|0|||
44356588|NCT00996801|79361488|FG000|Overall Study|Withdrawal by Subject|8|||
44356589|NCT00996801|79361489|FG001|Overall Study|Withdrawal by Subject|6|||
44356590|NCT00996801|79361490|FG002|Overall Study|Withdrawal by Subject|9|||
44356591|NCT00996801|79361491|FG003|Overall Study|Withdrawal by Subject|5|||
44356592|NCT00996801|79361492|FG004|Overall Study|Withdrawal by Subject|5|||
44356593|NCT00996801|79361493|FG005|Overall Study|Withdrawal by Subject|9|||
44356594|NCT00996489|79361509|FG000|Overall Study|Device failure|45|||
44356595|NCT00996489|79361509|FG000|Overall Study|Discontinued|116|||
44356596|NCT01000311|79361515|FG000|Overall Study|Adverse Event|2|||
44356597|NCT01000311|79361516|FG001|Overall Study|Adverse Event|5|||
44356598|NCT01000311|79361515|FG000|Overall Study|Withdrawal by Subject|16|||
44356599|NCT01000311|79361516|FG001|Overall Study|Withdrawal by Subject|24|||
44356600|NCT01000311|79361515|FG000|Overall Study|Lost to Follow-up|15|||
44356601|NCT01000311|79361516|FG001|Overall Study|Lost to Follow-up|24|||
44356602|NCT01000311|79361515|FG000|Overall Study|Protocol Violation|1|||
44356603|NCT01000311|79361516|FG001|Overall Study|Protocol Violation|2|||
44356604|NCT01000311|79361515|FG000|Overall Study|Inappropriate enrollment|2|||
44356605|NCT01000311|79361516|FG001|Overall Study|Inappropriate enrollment|0|||
44356606|NCT01000311|79361515|FG000|Overall Study|Administrative reason|9|||
44356607|NCT01000311|79361516|FG001|Overall Study|Administrative reason|15|||
44356608|NCT01003899|79361522|FG000|Overall Study|Other Adverse Event|8|||
44356609|NCT01003899|79361522|FG000|Overall Study|Not entered|4|||
44356610|NCT01003899|79361522|FG000|Overall Study|Not treated|1|||
44356611|NCT01003899|79361522|FG000|Overall Study|Progressive disease|34|||
44356612|NCT01000155|79361526|FG000|Overall Study|Withdrawal by Subject|1|||
44356613|NCT01000155|79361526|FG000|Overall Study|Adverse Event|1|||
44356614|NCT00999921|79361532|FG000|Overall Study|Lost to Follow-up|10|||
44356615|NCT00999921|79361533|FG001|Overall Study|Lost to Follow-up|19|||
44356616|NCT01002573|79361544|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
44356617|NCT01002573|79361545|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
44356618|NCT00999687|79361551|FG000|First Intervention|Withdrawal by Subject|1|||
44356619|NCT00999687|79361551|FG000|Second Intervention|Withdrawal by Subject|2|||
44356620|NCT00999687|79361551|FG000|Second Intervention|Lack of Efficacy|1|||
44356621|NCT00996333|79361557|FG000|Overall Study|Screen failure|1|||
44356622|NCT00996333|79361557|FG000|Overall Study|Withdrawal by Subject|1|||
44356623|NCT00996333|79361557|FG000|Overall Study|Death|4|||
44356624|NCT00996333|79361557|FG000|Overall Study|Adverse Event|1|||
44356625|NCT00996333|79361557|FG000|Overall Study|Physician Decision|1|||
44356626|NCT00996333|79361557|FG000|Overall Study|Other|5|||
44356627|NCT00995865|79361564|FG000|Overall Study|Protocol Violation|2|||
44356628|NCT00995865|79361565|FG001|Overall Study|Protocol Violation|0|||
44356629|NCT00995865|79361566|FG002|Overall Study|Protocol Violation|0|||
44356630|NCT00995865|79361564|FG000|Overall Study|Lost to Follow-up|0|||
44356631|NCT00995865|79361565|FG001|Overall Study|Lost to Follow-up|0|||
44356632|NCT00995865|79361566|FG002|Overall Study|Lost to Follow-up|1|||
44356633|NCT00995709|79361582|FG000|Overall Study|Adverse Event|4|||
44356634|NCT00995709|79361583|FG001|Overall Study|Adverse Event|2|||
44356635|NCT00995709|79361584|FG002|Overall Study|Adverse Event|0|||
44356636|NCT00995709|79361582|FG000|Overall Study|Lack of Efficacy|0|||
44356637|NCT00995709|79361583|FG001|Overall Study|Lack of Efficacy|1|||
44356638|NCT00995709|79361584|FG002|Overall Study|Lack of Efficacy|4|||
44356639|NCT00995709|79361582|FG000|Overall Study|Withdrawal by Subject|0|||
44356640|NCT00995709|79361583|FG001|Overall Study|Withdrawal by Subject|4|||
44356641|NCT00995709|79361584|FG002|Overall Study|Withdrawal by Subject|1|||
44356642|NCT00995709|79361582|FG000|Overall Study|Lost to Follow-up|1|||
44356643|NCT00995709|79361583|FG001|Overall Study|Lost to Follow-up|0|||
44356644|NCT00995709|79361584|FG002|Overall Study|Lost to Follow-up|0|||
44356645|NCT00995709|79361582|FG000|Overall Study|Death|0|||
44356646|NCT00995709|79361583|FG001|Overall Study|Death|1|||
44356647|NCT00995709|79361584|FG002|Overall Study|Death|0|||
44356648|NCT00995709|79361582|FG000|Overall Study|Protocol Violation|2|||
44356649|NCT00995709|79361583|FG001|Overall Study|Protocol Violation|1|||
44356650|NCT00995709|79361584|FG002|Overall Study|Protocol Violation|0|||
44356651|NCT00998985|79361606|FG000|Overall Study|Withdrawal by Subject|0|||
44356652|NCT00998985|79361607|FG001|Overall Study|Withdrawal by Subject|0|||
44356653|NCT00998985|79361608|FG002|Overall Study|Withdrawal by Subject|0|||
44356654|NCT00998985|79361609|FG003|Overall Study|Withdrawal by Subject|0|||
44356655|NCT00998985|79361610|FG004|Overall Study|Withdrawal by Subject|0|||
44356656|NCT00998985|79361611|FG005|Overall Study|Withdrawal by Subject|0|||
44356657|NCT00998985|79361612|FG006|Overall Study|Withdrawal by Subject|0|||
44356658|NCT00998985|79361613|FG007|Overall Study|Withdrawal by Subject|0|||
44356659|NCT00998985|79361614|FG008|Overall Study|Withdrawal by Subject|1|||
44356660|NCT00998985|79361615|FG009|Overall Study|Withdrawal by Subject|0|||
44356661|NCT00998985|79361616|FG010|Overall Study|Withdrawal by Subject|0|||
44356662|NCT00998985|79361617|FG011|Overall Study|Withdrawal by Subject|0|||
44356663|NCT00998985|79361618|FG012|Overall Study|Withdrawal by Subject|0|||
44356664|NCT00998985|79361619|FG013|Overall Study|Withdrawal by Subject|0|||
44356665|NCT00998985|79361606|FG000|Overall Study|Protocol Violation|0|||
44356666|NCT00998985|79361607|FG001|Overall Study|Protocol Violation|0|||
44356667|NCT00998985|79361608|FG002|Overall Study|Protocol Violation|0|||
44356668|NCT00998985|79361609|FG003|Overall Study|Protocol Violation|0|||
44356669|NCT00998985|79361610|FG004|Overall Study|Protocol Violation|0|||
44356670|NCT00998985|79361611|FG005|Overall Study|Protocol Violation|1|||
44356671|NCT00998985|79361612|FG006|Overall Study|Protocol Violation|0|||
44356672|NCT00998985|79361613|FG007|Overall Study|Protocol Violation|0|||
44356673|NCT00998985|79361614|FG008|Overall Study|Protocol Violation|0|||
44356674|NCT00998985|79361615|FG009|Overall Study|Protocol Violation|0|||
44356675|NCT00998985|79361616|FG010|Overall Study|Protocol Violation|0|||
44356676|NCT00998985|79361617|FG011|Overall Study|Protocol Violation|0|||
44356677|NCT00998985|79361618|FG012|Overall Study|Protocol Violation|0|||
44356678|NCT00998985|79361619|FG013|Overall Study|Protocol Violation|0|||
44356679|NCT00995553|79361666|FG000|Overall Study|Withdrawal by Subject|2|||
44356680|NCT00995553|79361667|FG001|Overall Study|Withdrawal by Subject|6|||
44356681|NCT00991887|79361675|FG000|Overall Study|Lost to Follow-up|2|||
44356682|NCT00991887|79361676|FG001|Overall Study|Lost to Follow-up|1|||
44356683|NCT01002339|79361685|FG000|Overall Study|Withdrawal by Subject|0|||
44356684|NCT01002339|79361686|FG001|Overall Study|Withdrawal by Subject|1|||
44356685|NCT01002339|79361687|FG002|Overall Study|Withdrawal by Subject|0|||
44356686|NCT01002339|79361685|FG000|Overall Study|Incorrect treatment assignment|0|||
44356687|NCT01002339|79361686|FG001|Overall Study|Incorrect treatment assignment|0|||
44356688|NCT01002339|79361687|FG002|Overall Study|Incorrect treatment assignment|1|||
44356689|NCT01002339|79361685|FG000|Overall Study|Protocol Violation|0|||
44356690|NCT01002339|79361686|FG001|Overall Study|Protocol Violation|0|||
44356691|NCT01002339|79361687|FG002|Overall Study|Protocol Violation|2|||
44448733|NCT00550446|79457359|FG004|Up To Week 12|Lost to Follow-up|1|||
44356692|NCT01002339|79361685|FG000|Overall Study|Lung cancer detected before transplant|0|||
44356693|NCT01002339|79361686|FG001|Overall Study|Lung cancer detected before transplant|0|||
44356694|NCT01002339|79361687|FG002|Overall Study|Lung cancer detected before transplant|1|||
44356695|NCT01002339|79361685|FG000|Overall Study|Randomized. Not transplanted|0|||
44356696|NCT01002339|79361686|FG001|Overall Study|Randomized. Not transplanted|0|||
44356697|NCT01002339|79361687|FG002|Overall Study|Randomized. Not transplanted|1|||
44356698|NCT01002105|79361697|FG000|Overall Study|Lost to Follow-up|10|||
44356699|NCT01002105|79361698|FG001|Overall Study|Lost to Follow-up|16|||
44356700|NCT01002105|79361697|FG000|Overall Study|non compliance|5|||
44356701|NCT01002105|79361698|FG001|Overall Study|non compliance|3|||
44356702|NCT01002105|79361697|FG000|Overall Study|condition worsened|4|||
44356703|NCT01002105|79361698|FG001|Overall Study|condition worsened|2|||
44356704|NCT02605993|79361711|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
44356705|NCT02605993|79361712|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
44356706|NCT02605993|79361713|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
44356707|NCT02605993|79361714|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
44356708|NCT00995085|79361724|FG000|Overall Study|Withdrawal by Subject|5|||
44356709|NCT00603733|79361730|FG000|Active Phase ITT|Adverse Event|8|||
44356710|NCT00603733|79361731|FG001|Active Phase ITT|Adverse Event|7|||
44356711|NCT00603733|79361730|FG000|Active Phase ITT|Withdrawal by Subject|0|||
44356712|NCT00603733|79361731|FG001|Active Phase ITT|Withdrawal by Subject|3|||
44356713|NCT00603733|79361730|FG000|Active Phase ITT|Lost to Follow-up|0|||
44356714|NCT00603733|79361731|FG001|Active Phase ITT|Lost to Follow-up|1|||
44356715|NCT00603733|79361730|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
44356716|NCT00603733|79361731|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
44356717|NCT00603733|79361730|FG000|Active Phase ITT|Lack of Efficacy|1|||
44356718|NCT00603733|79361731|FG001|Active Phase ITT|Lack of Efficacy|2|||
44356719|NCT00603733|79361730|FG000|Active Phase ITT|Subject moved, site closed|1|||
44356720|NCT00603733|79361731|FG001|Active Phase ITT|Subject moved, site closed|1|||
44356721|NCT00603733|79361730|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
44356722|NCT00603733|79361731|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
44356723|NCT00603733|79361730|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
44356724|NCT00603733|79361731|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
44356725|NCT00603733|79361730|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
44356726|NCT00603733|79361731|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
44356727|NCT00603733|79361730|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
44356728|NCT00603733|79361731|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
44356729|NCT00603733|79361730|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
44356730|NCT00603733|79361731|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
44356731|NCT00603733|79361730|FG000|Maintenance Phase ITT|Adverse Event|3|||
44356732|NCT00603733|79361731|FG001|Maintenance Phase ITT|Adverse Event|6|||
44356733|NCT00603733|79361730|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
44356734|NCT00603733|79361731|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
44356735|NCT00603733|79361730|FG000|Maintenance Phase ITT|Protocol Violation|1|||
44356736|NCT00603733|79361731|FG001|Maintenance Phase ITT|Protocol Violation|1|||
44356737|NCT00603733|79361730|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
44356738|NCT00603733|79361731|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
44356739|NCT00603733|79361730|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
44356740|NCT00603733|79361731|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
44356741|NCT00603733|79361730|FG000|Maintenance Phase ITT|Physician Decision|0|||
44356742|NCT00603733|79361731|FG001|Maintenance Phase ITT|Physician Decision|1|||
44356743|NCT00603733|79361730|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
44356744|NCT00603733|79361731|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
44356745|NCT04631107|79361737|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
44356746|NCT04631107|79361737|FG000|Second Intervention (1 Night)|Adverse Event|1|||
44356747|NCT04631107|79361737|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
44356748|NCT04631107|79361737|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
44356749|NCT00995007|79361747|FG000|Overall Study|Withdrew consent|1|||
44356750|NCT00995007|79361748|FG001|Overall Study|Withdrew consent|0|||
44356751|NCT00995007|79361747|FG000|Overall Study|Refused further treatment|8|||
44356752|NCT00995007|79361748|FG001|Overall Study|Refused further treatment|2|||
44356753|NCT00995007|79361747|FG000|Overall Study|Toxicity|8|||
44356754|NCT00995007|79361748|FG001|Overall Study|Toxicity|0|||
44356755|NCT00994461|79361766|FG000|Overall Study|Adverse Event|2|||
44356756|NCT00994461|79361767|FG001|Overall Study|Adverse Event|1|||
44356757|NCT00994461|79361768|FG002|Overall Study|Adverse Event|0|||
44356758|NCT00993915|79361776|FG000|Overall Study|Insufficient clinical response|3|||
44356759|NCT00993915|79361776|FG000|Overall Study|Withdrawal by Subject|2|||
44356760|NCT00993915|79361776|FG000|Overall Study|Other|1|||
44356761|NCT00993915|79361776|FG000|Overall Study|Ongoing|3|||
44356762|NCT01202591|79361786|FG000|Overall Study|Adverse Event|2|||
44356763|NCT01202591|79361787|FG001|Overall Study|Adverse Event|1|||
44356764|NCT01202591|79361788|FG002|Overall Study|Adverse Event|4|||
44356765|NCT01202591|79361789|FG003|Overall Study|Adverse Event|4|||
44356766|NCT01202591|79361790|FG004|Overall Study|Adverse Event|0|||
44356767|NCT01202591|79361791|FG005|Overall Study|Adverse Event|0|||
44356768|NCT01202591|79361786|FG000|Overall Study|Other reason as per investigator|3|||
44356769|NCT01202591|79361787|FG001|Overall Study|Other reason as per investigator|4|||
44356770|NCT01202591|79361788|FG002|Overall Study|Other reason as per investigator|7|||
44356771|NCT01202591|79361789|FG003|Overall Study|Other reason as per investigator|3|||
44356772|NCT01202591|79361790|FG004|Overall Study|Other reason as per investigator|1|||
44356773|NCT01202591|79361791|FG005|Overall Study|Other reason as per investigator|3|||
44356774|NCT01202591|79361786|FG000|Overall Study|Withdrawal by Subject|0|||
44356775|NCT01202591|79361787|FG001|Overall Study|Withdrawal by Subject|0|||
44356776|NCT01202591|79361788|FG002|Overall Study|Withdrawal by Subject|0|||
44356777|NCT01202591|79361789|FG003|Overall Study|Withdrawal by Subject|0|||
44356778|NCT01202591|79361790|FG004|Overall Study|Withdrawal by Subject|2|||
44356779|NCT01202591|79361791|FG005|Overall Study|Withdrawal by Subject|1|||
44356780|NCT01202591|79361786|FG000|Overall Study|Objective Disease Progression|0|||
44356781|NCT01202591|79361787|FG001|Overall Study|Objective Disease Progression|0|||
44356782|NCT01202591|79361788|FG002|Overall Study|Objective Disease Progression|0|||
44356783|NCT01202591|79361789|FG003|Overall Study|Objective Disease Progression|0|||
44356784|NCT01202591|79361790|FG004|Overall Study|Objective Disease Progression|2|||
44356785|NCT01202591|79361791|FG005|Overall Study|Objective Disease Progression|0|||
44356786|NCT01202279|79361807|FG000|Overall Study|Adverse Event|8|||
44356787|NCT01202279|79361808|FG001|Overall Study|Adverse Event|6|||
44356788|NCT01202279|79361807|FG000|Overall Study|Withdrawal by Subject|13|||
44356789|NCT01202279|79361808|FG001|Overall Study|Withdrawal by Subject|10|||
44356790|NCT01202279|79361807|FG000|Overall Study|Physician Decision|0|||
44356791|NCT01202279|79361808|FG001|Overall Study|Physician Decision|1|||
44356792|NCT01202279|79361807|FG000|Overall Study|Lost to Follow-up|10|||
44356793|NCT01202279|79361808|FG001|Overall Study|Lost to Follow-up|7|||
44356794|NCT01202279|79361807|FG000|Overall Study|Protocol Violation|1|||
44356795|NCT01202279|79361808|FG001|Overall Study|Protocol Violation|1|||
44356796|NCT01202279|79361807|FG000|Overall Study|study compliance|5|||
44356797|NCT01202279|79361808|FG001|Overall Study|study compliance|2|||
44356798|NCT01201967|79361816|FG000|Overall Study|Lost to Follow-up|6|||
44356799|NCT01201967|79361817|FG001|Overall Study|Lost to Follow-up|5|||
44356800|NCT01201811|79361833|FG000|Overall Study|Adverse Event|6|||
44356801|NCT01201811|79361833|FG000|Overall Study|Disease progression|3|||
44356802|NCT01201811|79361833|FG000|Overall Study|Withdrawal by Subject|3|||
44356803|NCT01201811|79361833|FG000|Overall Study|Death|4|||
44356804|NCT01201811|79361833|FG000|Overall Study|Treatment Failure|2|||
44356805|NCT01201811|79361833|FG000|Overall Study|Physician Decision|1|||
44356806|NCT01201343|79361837|FG000|Overall Study|Adverse Event|6|||
44356807|NCT01201343|79361837|FG000|Overall Study|Withdrawal by Subject|5|||
44356808|NCT01201343|79361837|FG000|Overall Study|Lost to Follow-up|2|||
44356809|NCT01201343|79361837|FG000|Overall Study|Lack of Efficacy|2|||
44356810|NCT01201343|79361837|FG000|Overall Study|Participant wrongly included in trial|1|||
44356811|NCT01201343|79361837|FG000|Overall Study|Randomized, not treated|3|||
44356812|NCT01201265|79361841|FG000|Overall Study|Death|14|||
44356813|NCT01201265|79361841|FG000|Overall Study|Insufficient Therapeutic Response|3|||
44356814|NCT01201265|79361841|FG000|Overall Study|Lost to Follow-up|10|||
44356815|NCT01201265|79361841|FG000|Overall Study|Withdrawal by Subject|7|||
44356816|NCT01201265|79361841|FG000|Overall Study|Disease Progression|4|||
44356817|NCT04246801|79361847|FG000|Overall Study|Adverse Event|1|||
44356818|NCT04246801|79361848|FG001|Overall Study|Adverse Event|1|||
44356819|NCT04246801|79361847|FG000|Overall Study|Protocol Violation|1|||
44356820|NCT04246801|79361848|FG001|Overall Study|Protocol Violation|1|||
44356821|NCT04246801|79361847|FG000|Overall Study|Lack of Efficacy|0|||
44356822|NCT04246801|79361848|FG001|Overall Study|Lack of Efficacy|2|||
44356823|NCT04246801|79361847|FG000|Overall Study|Lost to Follow-up|1|||
44356824|NCT04246801|79361848|FG001|Overall Study|Lost to Follow-up|1|||
44356825|NCT04246801|79361847|FG000|Overall Study|Withdrawal by Subject|2|||
44356826|NCT04246801|79361848|FG001|Overall Study|Withdrawal by Subject|1|||
44356827|NCT01200797|79361854|FG000|Overall Study|symptomatic deterioration|2|||
44356828|NCT01200797|79361854|FG000|Overall Study|Adverse Event|4|||
44356829|NCT01200797|79361854|FG000|Overall Study|Disease Progression|13|||
44356830|NCT01200485|79361859|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
44356831|NCT01200485|79361860|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
44356832|NCT01200485|79361861|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
44356833|NCT01200485|79361859|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
44356834|NCT01200485|79361860|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
44356835|NCT01200485|79361861|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
44356836|NCT01200407|79361868|FG000|Overall Study|Lost to Follow-up|56|||
44356837|NCT01200407|79361868|FG000|Overall Study|Adverse Event|3|||
44356838|NCT01200407|79361868|FG000|Overall Study|Withdrawal by Subject|4|||
44356839|NCT01200407|79361868|FG000|Overall Study|Other|19|||
44356840|NCT01200329|79361872|FG000|Overall Study|Lack of financial coverage|2|||
44356841|NCT01200329|79361872|FG000|Overall Study|Progressive disease|1|||
44356842|NCT01199939|79361876|FG000|Overall Study|Adverse Event|4|||
44356843|NCT01199939|79361876|FG000|Overall Study|Protocol Violation|3|||
44356844|NCT01199939|79361876|FG000|Overall Study|Lost to Follow-up|2|||
44356845|NCT01199939|79361876|FG000|Overall Study|Reached a virologic endpoint|4|||
44356846|NCT01199861|79361882|FG000|Overall Study|Administrative problems|1|||
44356847|NCT01199861|79361883|FG001|Overall Study|Administrative problems|0|||
44356848|NCT01199861|79361882|FG000|Overall Study|Adverse Event|1|||
44356849|NCT01199861|79361883|FG001|Overall Study|Adverse Event|0|||
44356850|NCT01199705|79361903|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
44356851|NCT01199471|79361918|FG000|Overall Study|Protocol Violation|4|||
44356852|NCT01199471|79361918|FG000|Overall Study|Withdrawal by Subject|1|||
44356853|NCT01199471|79361918|FG000|Overall Study|Physician Decision|1|||
44356854|NCT01198145|79361925|FG000|Overall Study|Withdrawal by Subject|1|||
44356855|NCT01198145|79361926|FG001|Overall Study|Withdrawal by Subject|1|||
44356856|NCT01197911|79361936|FG000|Overall Study|Adverse Event|0|||
44356857|NCT01197911|79361937|FG001|Overall Study|Adverse Event|0|||
44356858|NCT01197911|79361938|FG002|Overall Study|Adverse Event|1|||
44356859|NCT01197755|79361950|FG000|Overall Study|Adverse Event|8|||
44356860|NCT01197755|79361951|FG001|Overall Study|Adverse Event|10|||
44356861|NCT01197755|79361952|FG002|Overall Study|Adverse Event|10|||
44356862|NCT01197755|79361950|FG000|Overall Study|Study-specific discontinuation criteria|2|||
44356863|NCT01197755|79361951|FG001|Overall Study|Study-specific discontinuation criteria|1|||
44356864|NCT01197755|79361952|FG002|Overall Study|Study-specific discontinuation criteria|0|||
44356865|NCT01197755|79361950|FG000|Overall Study|Entered the long-term extension study|18|||
44356866|NCT01197755|79361951|FG001|Overall Study|Entered the long-term extension study|21|||
44356867|NCT01197755|79361952|FG002|Overall Study|Entered the long-term extension study|35|||
44356868|NCT01197755|79361950|FG000|Overall Study|Lack of therapeutic response|0|||
44356869|NCT01197755|79361951|FG001|Overall Study|Lack of therapeutic response|7|||
44356870|NCT01197755|79361952|FG002|Overall Study|Lack of therapeutic response|4|||
44356871|NCT01197755|79361950|FG000|Overall Study|Severe non-compliance to the protocol|2|||
44356872|NCT01197755|79361951|FG001|Overall Study|Severe non-compliance to the protocol|1|||
44356873|NCT01197755|79361952|FG002|Overall Study|Severe non-compliance to the protocol|2|||
44356874|NCT01197755|79361950|FG000|Overall Study|Withdrawal by Subject|1|||
44356875|NCT01197755|79361951|FG001|Overall Study|Withdrawal by Subject|0|||
44356876|NCT01197755|79361952|FG002|Overall Study|Withdrawal by Subject|0|||
44356877|NCT01197755|79361950|FG000|Overall Study|Lost to Follow-up|0|||
44356878|NCT01197755|79361951|FG001|Overall Study|Lost to Follow-up|0|||
44356879|NCT01197755|79361952|FG002|Overall Study|Lost to Follow-up|1|||
44356880|NCT01197755|79361950|FG000|Overall Study|eg, change in circumstances|7|||
44356881|NCT01197755|79361951|FG001|Overall Study|eg, change in circumstances|3|||
44356882|NCT01197755|79361952|FG002|Overall Study|eg, change in circumstances|2|||
44356883|NCT01179048|79361964|FG000|Overall Study|Withdrawn - does not allow contact|4|||
44356884|NCT01179048|79361965|FG001|Overall Study|Withdrawn - does not allow contact|8|||
44356885|NCT01179048|79361964|FG000|Overall Study|Lost to Follow-up|8|||
44356886|NCT01179048|79361965|FG001|Overall Study|Lost to Follow-up|9|||
44356887|NCT01179048|79361964|FG000|Overall Study|Alive|127|||
44356888|NCT01179048|79361965|FG001|Overall Study|Alive|142|||
44356889|NCT00603265|79361974|FG000|Overall Study|Adverse Event|2|||
44356890|NCT00603265|79361975|FG001|Overall Study|Adverse Event|11|||
44356891|NCT00603265|79361976|FG002|Overall Study|Adverse Event|1|||
44356892|NCT00603265|79361974|FG000|Overall Study|Withdrawal by Subject|1|||
44356893|NCT00603265|79361975|FG001|Overall Study|Withdrawal by Subject|2|||
44356894|NCT00603265|79361976|FG002|Overall Study|Withdrawal by Subject|1|||
44356895|NCT00603265|79361974|FG000|Overall Study|Lack of Efficacy|3|||
44356896|NCT00603265|79361975|FG001|Overall Study|Lack of Efficacy|0|||
44356897|NCT00603265|79361976|FG002|Overall Study|Lack of Efficacy|3|||
44356898|NCT00603265|79361974|FG000|Overall Study|Lost to Follow-up|0|||
44356899|NCT00603265|79361975|FG001|Overall Study|Lost to Follow-up|1|||
44356900|NCT00603265|79361976|FG002|Overall Study|Lost to Follow-up|0|||
44356901|NCT00603265|79361974|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
44356902|NCT00603265|79361975|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
44356903|NCT00603265|79361976|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
44356904|NCT00603265|79361974|FG000|Overall Study|Participant Left Country, No Responses|0|||
44356905|NCT00603265|79361975|FG001|Overall Study|Participant Left Country, No Responses|1|||
44356906|NCT00603265|79361976|FG002|Overall Study|Participant Left Country, No Responses|0|||
44356907|NCT00603265|79361974|FG000|Overall Study|Protocol Violation|1|||
44356908|NCT00603265|79361975|FG001|Overall Study|Protocol Violation|0|||
44356909|NCT00603265|79361976|FG002|Overall Study|Protocol Violation|0|||
44356910|NCT04010227|79361986|FG000|Overall Study|Death|1|||
44356911|NCT04010227|79361987|FG001|Overall Study|Death|2|||
44356912|NCT04010227|79361986|FG000|Overall Study|Medical Reasons|4|||
44356913|NCT04010227|79361987|FG001|Overall Study|Medical Reasons|3|||
44356914|NCT04010227|79361986|FG000|Overall Study|Withdrawal by Subject|2|||
44356915|NCT04010227|79361987|FG001|Overall Study|Withdrawal by Subject|0|||
44356916|NCT04010227|79361986|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
44356917|NCT04010227|79361987|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
44356918|NCT01158534|79361994|FG000|Overall Study|Withdrawal by Subject|1|||
44356919|NCT01158534|79361994|FG000|Overall Study|Death|1|||
44356920|NCT01158534|79361994|FG000|Overall Study|Other|1|||
44356921|NCT01158378|79362000|FG000|Overall Study|Death|4|||
44356922|NCT01158378|79362001|FG001|Overall Study|Death|5|||
44356923|NCT01158378|79362000|FG000|Overall Study|Lost to Follow-up|2|||
44356924|NCT01158378|79362001|FG001|Overall Study|Lost to Follow-up|4|||
44356925|NCT01158378|79362000|FG000|Overall Study|Withdrawal by Subject|4|||
44356926|NCT01158378|79362001|FG001|Overall Study|Withdrawal by Subject|0|||
44356927|NCT01158222|79362008|FG000|Overall Study|Not eligible for intermediate phase|17|||
44356928|NCT01197521|79362015|FG000|Overall Study|Not reported|24|||
44356929|NCT01197521|79362016|FG001|Overall Study|Not reported|25|||
44356930|NCT01197521|79362017|FG002|Overall Study|Not reported|21|||
44356931|NCT01197521|79362015|FG000|Overall Study|Enrolment in long term extension|42|||
44356932|NCT01197521|79362016|FG001|Overall Study|Enrolment in long term extension|36|||
44356933|NCT01197521|79362017|FG002|Overall Study|Enrolment in long term extension|87|||
44356934|NCT01197521|79362015|FG000|Overall Study|Severe non-compliance to protocol|1|||
44356935|NCT01197521|79362016|FG001|Overall Study|Severe non-compliance to protocol|3|||
44356936|NCT01197521|79362017|FG002|Overall Study|Severe non-compliance to protocol|3|||
44356937|NCT01197521|79362015|FG000|Overall Study|Lack of therapeutic response|2|||
44356938|NCT01197521|79362016|FG001|Overall Study|Lack of therapeutic response|3|||
44356939|NCT01197521|79362017|FG002|Overall Study|Lack of therapeutic response|4|||
44356940|NCT01197521|79362015|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
44356941|NCT01197521|79362016|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
44356942|NCT01197521|79362017|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
44356943|NCT01197521|79362015|FG000|Overall Study|Lost to Follow-up|3|||
44356944|NCT01197521|79362016|FG001|Overall Study|Lost to Follow-up|2|||
44356945|NCT01197521|79362017|FG002|Overall Study|Lost to Follow-up|2|||
44356946|NCT01197521|79362015|FG000|Overall Study|Adverse Event|25|||
44356947|NCT01197521|79362016|FG001|Overall Study|Adverse Event|28|||
44356948|NCT01197521|79362017|FG002|Overall Study|Adverse Event|24|||
44356949|NCT01157676|79362030|FG000|Randomization|Death|1|||
44356950|NCT01157676|79362031|FG001|Randomization|Death|1|||
44356951|NCT01157676|79362030|FG000|Randomization|unresectable|2|||
44356952|NCT01157676|79362031|FG001|Randomization|unresectable|3|||
44356953|NCT01157676|79362030|FG000|Randomization|Withdrawal by Subject|17|||
44356954|NCT01157676|79362031|FG001|Randomization|Withdrawal by Subject|13|||
44356955|NCT01157676|79362030|FG000|Randomization|Physician Decision|1|||
44356956|NCT01157676|79362031|FG001|Randomization|Physician Decision|0|||
44356957|NCT01157676|79362030|FG000|Surgery|underwent open cystectomy|0|||
44356958|NCT01157676|79362031|FG001|Surgery|underwent open cystectomy|4|||
44356959|NCT01157676|79362030|FG000|Surgery|converted to open procedure|0|||
44356960|NCT01157676|79362031|FG001|Surgery|converted to open procedure|5|||
44356961|NCT01157676|79362030|FG000|Surgery|underwent robotic cystectomy|1|||
44356962|NCT01157676|79362031|FG001|Surgery|underwent robotic cystectomy|0|||
44356963|NCT00991341|79362045|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
44356964|NCT00991341|79362046|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
44356965|NCT00991341|79362045|FG000|Overall Study|Death|3|||
44356966|NCT00991341|79362046|FG001|Overall Study|Death|0|||
44356967|NCT00991341|79362045|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
44356968|NCT00991341|79362046|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
44356969|NCT00991341|79362045|FG000|Overall Study|Physician Decision|1|||
44356970|NCT00991341|79362046|FG001|Overall Study|Physician Decision|2|||
44356971|NCT00991341|79362045|FG000|Overall Study|Withdrawal by Subject|3|||
44356972|NCT00991341|79362046|FG001|Overall Study|Withdrawal by Subject|4|||
44356973|NCT00990249|79362052|FG000|Overall Study|Disease Progression|8|||
44356974|NCT00990249|79362052|FG000|Overall Study|Non-Compliance|1|||
44356975|NCT00990249|79362052|FG000|Overall Study|Death|2|||
44356976|NCT00990249|79362052|FG000|Overall Study|Not treated|2|||
44356977|NCT02846545|79362058|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
44356978|NCT02846545|79362059|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
44356979|NCT02846545|79362058|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
44356980|NCT02846545|79362059|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
44356981|NCT02846545|79362058|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
44356982|NCT02846545|79362059|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
44356983|NCT02846545|79362058|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
44356984|NCT02846545|79362059|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
44356985|NCT02846545|79362058|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
44356986|NCT02846545|79362059|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
44356987|NCT00990093|79362069|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
44356988|NCT00990093|79362070|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
44356989|NCT00990093|79362069|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
44356990|NCT00990093|79362070|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
44356991|NCT00990093|79362069|FG000|Test Period 1 (1-14 Days)|Other|1|||
44356992|NCT00990093|79362070|FG001|Test Period 1 (1-14 Days)|Other|0|||
44356993|NCT00990093|79362069|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
44356994|NCT00990093|79362070|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
44356995|NCT00990093|79362069|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
44356996|NCT00990093|79362070|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
44356997|NCT00990093|79362069|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
44356998|NCT00990093|79362070|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
44356999|NCT00990093|79362069|FG000|Test Period 2 (15-28 Days)|Other|0|||
44357000|NCT00990093|79362070|FG001|Test Period 2 (15-28 Days)|Other|1|||
44357001|NCT00984165|79362080|FG000|Overall Study|Death on study|2|||
44357002|NCT00984165|79362081|FG001|Overall Study|Death on study|0|||
44357003|NCT00984165|79362082|FG002|Overall Study|Death on study|0|||
44357004|NCT00984165|79362083|FG003|Overall Study|Death on study|0|||
44357005|NCT00984165|79362080|FG000|Overall Study|Disease progression on study|5|||
44357006|NCT00984165|79362081|FG001|Overall Study|Disease progression on study|1|||
44357007|NCT00984165|79362082|FG002|Overall Study|Disease progression on study|0|||
44357008|NCT00984165|79362083|FG003|Overall Study|Disease progression on study|0|||
44357009|NCT00984165|79362080|FG000|Overall Study|Death of recipient|0|||
44357010|NCT00984165|79362081|FG001|Overall Study|Death of recipient|0|||
44357011|NCT00984165|79362082|FG002|Overall Study|Death of recipient|0|||
44357012|NCT00984165|79362083|FG003|Overall Study|Death of recipient|1|||
44357013|NCT00984165|79362080|FG000|Overall Study|New protocol|0|||
44357014|NCT00984165|79362081|FG001|Overall Study|New protocol|0|||
44357015|NCT00984165|79362082|FG002|Overall Study|New protocol|0|||
44357016|NCT00984165|79362083|FG003|Overall Study|New protocol|1|||
44357017|NCT00984165|79362080|FG000|Overall Study|P+/donor pair removed from protocol|0|||
44357018|NCT00984165|79362081|FG001|Overall Study|P+/donor pair removed from protocol|0|||
44357019|NCT00984165|79362082|FG002|Overall Study|P+/donor pair removed from protocol|0|||
44357020|NCT00984165|79362083|FG003|Overall Study|P+/donor pair removed from protocol|1|||
44357021|NCT00984165|79362080|FG000|Overall Study|removed with a pair recipient|0|||
44357022|NCT00984165|79362081|FG001|Overall Study|removed with a pair recipient|0|||
44357023|NCT00984165|79362082|FG002|Overall Study|removed with a pair recipient|0|||
44357024|NCT00984165|79362083|FG003|Overall Study|removed with a pair recipient|1|||
44357025|NCT00993291|79362094|FG000|Overall Study|Withdrawal by Subject|1|||
44357026|NCT01196975|79362103|FG000|Overall Study|Adverse Event|2|||
44357027|NCT01196975|79362104|FG001|Overall Study|Adverse Event|2|||
44357028|NCT01196975|79362105|FG002|Overall Study|Adverse Event|0|||
44357029|NCT01196975|79362106|FG003|Overall Study|Adverse Event|0|||
44357030|NCT01196975|79362107|FG004|Overall Study|Adverse Event|2|||
44357031|NCT01196975|79362103|FG000|Overall Study|Withdrawal by Subject|2|||
44357032|NCT01196975|79362104|FG001|Overall Study|Withdrawal by Subject|1|||
44357033|NCT01196975|79362105|FG002|Overall Study|Withdrawal by Subject|0|||
44357034|NCT01196975|79362106|FG003|Overall Study|Withdrawal by Subject|1|||
44357035|NCT01196975|79362107|FG004|Overall Study|Withdrawal by Subject|0|||
44357036|NCT01196975|79362103|FG000|Overall Study|Lost to Follow-up|11|||
44357037|NCT01196975|79362104|FG001|Overall Study|Lost to Follow-up|6|||
44357038|NCT01196975|79362105|FG002|Overall Study|Lost to Follow-up|5|||
44357039|NCT01196975|79362106|FG003|Overall Study|Lost to Follow-up|5|||
44357040|NCT01196975|79362107|FG004|Overall Study|Lost to Follow-up|11|||
44357041|NCT00992589|79362142|FG000|Open-Label Phase|Adverse Event|4|||
44357042|NCT00992589|79362143|FG001|Open-Label Phase|Adverse Event|0|||
44357043|NCT00992589|79362144|FG002|Open-Label Phase|Adverse Event|0|||
44357044|NCT00992589|79362145|FG003|Open-Label Phase|Adverse Event|0|||
44357045|NCT00992589|79362142|FG000|Open-Label Phase|Withdrawal by Subject|20|||
44357046|NCT00992589|79362143|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44357047|NCT00992589|79362144|FG002|Open-Label Phase|Withdrawal by Subject|0|||
44357048|NCT00992589|79362145|FG003|Open-Label Phase|Withdrawal by Subject|0|||
44357049|NCT00992589|79362142|FG000|Open-Label Phase|Lost to Follow-up|1|||
44357050|NCT00992589|79362143|FG001|Open-Label Phase|Lost to Follow-up|0|||
44357051|NCT00992589|79362144|FG002|Open-Label Phase|Lost to Follow-up|0|||
44357052|NCT00992589|79362145|FG003|Open-Label Phase|Lost to Follow-up|0|||
44357053|NCT00992589|79362142|FG000|Open-Label Phase|Protocol Violation|3|||
44357054|NCT00992589|79362143|FG001|Open-Label Phase|Protocol Violation|0|||
44357055|NCT00992589|79362144|FG002|Open-Label Phase|Protocol Violation|0|||
44357056|NCT00992589|79362145|FG003|Open-Label Phase|Protocol Violation|0|||
44357057|NCT00992589|79362142|FG000|Open-Label Phase|Physician Decision|4|||
44357058|NCT00992589|79362143|FG001|Open-Label Phase|Physician Decision|0|||
44357059|NCT00992589|79362144|FG002|Open-Label Phase|Physician Decision|0|||
44357060|NCT00992589|79362145|FG003|Open-Label Phase|Physician Decision|0|||
44357061|NCT00992589|79362142|FG000|Open-Label Phase|Other|45|||
44357062|NCT00992589|79362143|FG001|Open-Label Phase|Other|0|||
44357063|NCT00992589|79362144|FG002|Open-Label Phase|Other|0|||
44357064|NCT00992589|79362145|FG003|Open-Label Phase|Other|0|||
44357065|NCT00992589|79362142|FG000|Double-Blind Phase|Adverse Event|0|||
44357066|NCT00992589|79362143|FG001|Double-Blind Phase|Adverse Event|6|||
44357067|NCT00992589|79362144|FG002|Double-Blind Phase|Adverse Event|2|||
44357068|NCT00992589|79362145|FG003|Double-Blind Phase|Adverse Event|3|||
44357069|NCT00992589|79362142|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
44357070|NCT00992589|79362143|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
44357071|NCT00992589|79362144|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
44357072|NCT00992589|79362145|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
44357073|NCT00992589|79362142|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44357074|NCT00992589|79362143|FG001|Double-Blind Phase|Lost to Follow-up|0|||
44357075|NCT00992589|79362144|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44357076|NCT00992589|79362145|FG003|Double-Blind Phase|Lost to Follow-up|2|||
44357077|NCT00992589|79362142|FG000|Double-Blind Phase|Other|0|||
44357078|NCT00992589|79362143|FG001|Double-Blind Phase|Other|1|||
44357079|NCT00992589|79362144|FG002|Double-Blind Phase|Other|6|||
44357080|NCT00992589|79362145|FG003|Double-Blind Phase|Other|3|||
44357081|NCT01196741|79362165|FG000|Overall Study|Disease progression|34|||
44357082|NCT01196741|79362166|FG001|Overall Study|Disease progression|14|||
44357083|NCT01196741|79362165|FG000|Overall Study|Adverse Event|10|||
44357084|NCT01196741|79362166|FG001|Overall Study|Adverse Event|6|||
44357085|NCT01196741|79362165|FG000|Overall Study|Serious Adverse Event|3|||
44357086|NCT01196741|79362166|FG001|Overall Study|Serious Adverse Event|1|||
44357087|NCT01196741|79362165|FG000|Overall Study|Dose limiting Adverse Event|2|||
44357088|NCT01196741|79362166|FG001|Overall Study|Dose limiting Adverse Event|1|||
44357089|NCT01196741|79362165|FG000|Overall Study|Withdrawal by Subject|3|||
44357090|NCT01196741|79362166|FG001|Overall Study|Withdrawal by Subject|0|||
44357091|NCT01196741|79362165|FG000|Overall Study|Other reason|3|||
44357092|NCT01196741|79362166|FG001|Overall Study|Other reason|3|||
44357093|NCT01196741|79362165|FG000|Overall Study|Other|3|||
44357094|NCT01196741|79362166|FG001|Overall Study|Other|2|||
44357095|NCT01196741|79362165|FG000|Overall Study|Protocol Violation|2|||
44357096|NCT01196741|79362166|FG001|Overall Study|Protocol Violation|1|||
44357097|NCT00983385|79362172|FG000|Observation Period|Not eligible to be dosed|20|||
44357098|NCT00983385|79362172|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
44357099|NCT00992511|79362195|FG000|Overall Study|Migrated/moved from study area|1|||
44357100|NCT00992511|79362196|FG001|Overall Study|Migrated/moved from study area|0|||
44357101|NCT00992511|79362197|FG002|Overall Study|Migrated/moved from study area|1|||
44357102|NCT00992511|79362198|FG003|Overall Study|Migrated/moved from study area|2|||
44357103|NCT00992511|79362195|FG000|Overall Study|Lost to Follow-up|1|||
44357104|NCT00992511|79362196|FG001|Overall Study|Lost to Follow-up|0|||
44357105|NCT00992511|79362197|FG002|Overall Study|Lost to Follow-up|0|||
44357106|NCT00992511|79362198|FG003|Overall Study|Lost to Follow-up|2|||
44357107|NCT00992511|79362195|FG000|Overall Study|Withdrawal by Subject|0|||
44357108|NCT00992511|79362196|FG001|Overall Study|Withdrawal by Subject|0|||
44357109|NCT00992511|79362197|FG002|Overall Study|Withdrawal by Subject|1|||
44357110|NCT00992511|79362198|FG003|Overall Study|Withdrawal by Subject|1|||
44357111|NCT01196429|79362210|FG000|Overall Study|Ineligible - inadequate pathology|1|||
44357112|NCT01196429|79362211|FG001|Overall Study|Ineligible - inadequate pathology|0|||
44357113|NCT01196429|79362210|FG000|Overall Study|Ineligible - wrong cell type|1|||
44357114|NCT01196429|79362211|FG001|Overall Study|Ineligible - wrong cell type|0|||
44357115|NCT01196429|79362210|FG000|Overall Study|Refused - Never Treated|1|||
44357116|NCT01196429|79362211|FG001|Overall Study|Refused - Never Treated|0|||
44357117|NCT01157364|79362225|FG000|Overall Study|Other Reasons|1|||
44357118|NCT01157364|79362226|FG001|Overall Study|Other Reasons|1|||
44357119|NCT01157364|79362227|FG002|Overall Study|Other Reasons|2|||
44357120|NCT01157364|79362228|FG003|Overall Study|Other Reasons|1|||
44357121|NCT01157364|79362229|FG004|Overall Study|Other Reasons|0|||
44357122|NCT01157364|79362230|FG005|Overall Study|Other Reasons|0|||
44357123|NCT01157364|79362225|FG000|Overall Study|Personal Reasons|0|||
44357124|NCT01157364|79362226|FG001|Overall Study|Personal Reasons|2|||
44357125|NCT01157364|79362227|FG002|Overall Study|Personal Reasons|0|||
44357126|NCT01157364|79362228|FG003|Overall Study|Personal Reasons|0|||
44357127|NCT01157364|79362229|FG004|Overall Study|Personal Reasons|1|||
44357128|NCT01157364|79362230|FG005|Overall Study|Personal Reasons|1|||
44357129|NCT01157364|79362225|FG000|Overall Study|Lost to Follow-up|1|||
44357130|NCT01157364|79362226|FG001|Overall Study|Lost to Follow-up|0|||
44357131|NCT01157364|79362227|FG002|Overall Study|Lost to Follow-up|1|||
44357132|NCT01157364|79362228|FG003|Overall Study|Lost to Follow-up|0|||
44357133|NCT01157364|79362229|FG004|Overall Study|Lost to Follow-up|0|||
44357134|NCT01157364|79362230|FG005|Overall Study|Lost to Follow-up|0|||
44357135|NCT01157364|79362225|FG000|Overall Study|Lack of Efficacy|0|||
44357136|NCT01157364|79362226|FG001|Overall Study|Lack of Efficacy|0|||
44357137|NCT01157364|79362227|FG002|Overall Study|Lack of Efficacy|0|||
44357138|NCT01157364|79362228|FG003|Overall Study|Lack of Efficacy|1|||
44357139|NCT01157364|79362229|FG004|Overall Study|Lack of Efficacy|0|||
44357140|NCT01157364|79362230|FG005|Overall Study|Lack of Efficacy|0|||
44357141|NCT01157364|79362225|FG000|Overall Study|Adverse Event|0|||
44357142|NCT01157364|79362226|FG001|Overall Study|Adverse Event|1|||
44357143|NCT01157364|79362227|FG002|Overall Study|Adverse Event|1|||
44357144|NCT01157364|79362228|FG003|Overall Study|Adverse Event|0|||
44357145|NCT01157364|79362229|FG004|Overall Study|Adverse Event|1|||
44357146|NCT01157364|79362230|FG005|Overall Study|Adverse Event|0|||
44357147|NCT01195415|79362244|FG000|Overall Study|No repeat biopsy due to progression|2|||
44357148|NCT01195103|79362251|FG000|Overall Study|Withdrawal by Subject|1|||
44357149|NCT01195103|79362252|FG001|Overall Study|Withdrawal by Subject|0|||
44357150|NCT01195103|79362253|FG002|Overall Study|Withdrawal by Subject|0|||
44357151|NCT01194869|79362261|FG000|Overall Study|Disease Progression|2|||
44357152|NCT01194869|79362261|FG000|Overall Study|Toxicity|2|||
44357153|NCT01177800|79362267|FG000|Overall Study|Adverse Event|9|||
44357154|NCT01177800|79362268|FG001|Overall Study|Adverse Event|3|||
44357155|NCT01177800|79362267|FG000|Overall Study|Protocol Violation|0|||
44357156|NCT01177800|79362268|FG001|Overall Study|Protocol Violation|1|||
44357157|NCT01177800|79362267|FG000|Overall Study|Physician Decision|1|||
44357158|NCT01177800|79362268|FG001|Overall Study|Physician Decision|0|||
44357159|NCT01177800|79362267|FG000|Overall Study|Withdrawal of informed consent|0|||
44357160|NCT01177800|79362268|FG001|Overall Study|Withdrawal of informed consent|1|||
44357161|NCT01177722|79362278|FG000|Overall Study|Serious Adverse Event|0|||
44357162|NCT01177722|79362279|FG001|Overall Study|Serious Adverse Event|0|||
44357163|NCT01177722|79362280|FG002|Overall Study|Serious Adverse Event|1|||
44357164|NCT01177722|79362281|FG003|Overall Study|Serious Adverse Event|0|||
44357165|NCT01177722|79362278|FG000|Overall Study|Protocol Violation|0|||
44357166|NCT01177722|79362279|FG001|Overall Study|Protocol Violation|0|||
44357167|NCT01177722|79362280|FG002|Overall Study|Protocol Violation|1|||
44357168|NCT01177722|79362281|FG003|Overall Study|Protocol Violation|0|||
44357169|NCT01177722|79362278|FG000|Overall Study|Lost to Follow-up|3|||
44357170|NCT01177722|79362279|FG001|Overall Study|Lost to Follow-up|4|||
44357171|NCT01177722|79362280|FG002|Overall Study|Lost to Follow-up|3|||
44357172|NCT01177722|79362281|FG003|Overall Study|Lost to Follow-up|1|||
44357173|NCT01177722|79362278|FG000|Overall Study|Withdrawal by Subject|10|||
44357174|NCT01177722|79362279|FG001|Overall Study|Withdrawal by Subject|6|||
44357175|NCT01177722|79362280|FG002|Overall Study|Withdrawal by Subject|4|||
44357176|NCT01177722|79362281|FG003|Overall Study|Withdrawal by Subject|6|||
44357177|NCT01177410|79362295|FG000|Overall Study|Adverse Event|0|||
44357178|NCT01177410|79362296|FG001|Overall Study|Adverse Event|2|||
44357179|NCT01177410|79362297|FG002|Overall Study|Adverse Event|2|||
44357180|NCT01177410|79362295|FG000|Overall Study|Withdrawal by Subject|1|||
44357181|NCT01177410|79362296|FG001|Overall Study|Withdrawal by Subject|4|||
44357182|NCT01177410|79362297|FG002|Overall Study|Withdrawal by Subject|3|||
44357183|NCT01177410|79362295|FG000|Overall Study|Lost to Follow-up|0|||
44357184|NCT01177410|79362296|FG001|Overall Study|Lost to Follow-up|1|||
44357185|NCT01177410|79362297|FG002|Overall Study|Lost to Follow-up|0|||
44357186|NCT01156116|79362307|FG000|Overall Study|Withdrawal by Subject|3|||
44357187|NCT01156116|79362308|FG001|Overall Study|Withdrawal by Subject|1|||
44357188|NCT01156116|79362307|FG000|Overall Study|CPAP intolerance|2|||
44357189|NCT01156116|79362308|FG001|Overall Study|CPAP intolerance|0|||
44357190|NCT01155726|79362314|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
44357191|NCT01155726|79362315|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
44357192|NCT01155726|79362316|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
44357193|NCT01155726|79362317|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
44357194|NCT01155570|79362339|FG000|Overall Study|Adverse Event|39|||
44357195|NCT01155570|79362339|FG000|Overall Study|Lack of Efficacy|46|||
44357196|NCT01155570|79362339|FG000|Overall Study|Participant's Economic Reasons|17|||
44357197|NCT01155570|79362339|FG000|Overall Study|No Hospital Visits|7|||
44357198|NCT01155570|79362339|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
44357199|NCT01155570|79362339|FG000|Overall Study|Adverse Event + Other Reasons|7|||
44357200|NCT01155570|79362339|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
44357201|NCT01155570|79362339|FG000|Overall Study|Other Reasons|23|||
44357202|NCT01155024|79362345|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
44357203|NCT01155024|79362346|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
44357204|NCT01155024|79362345|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
44357205|NCT01155024|79362346|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
44357206|NCT01155024|79362345|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
44357207|NCT01155024|79362346|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
44357208|NCT01176240|79362357|FG000|Study 306A|Lack of Efficacy|2|||
44357209|NCT01176240|79362358|FG001|Study 306A|Lack of Efficacy|1|||
44357210|NCT01176240|79362357|FG000|Study 306A|Protocol Violation|0|||
44357211|NCT01176240|79362358|FG001|Study 306A|Protocol Violation|1|||
44357212|NCT01176240|79362357|FG000|Study 306A|Withdrawal by Subject|0|||
44357213|NCT01176240|79362358|FG001|Study 306A|Withdrawal by Subject|1|||
44357214|NCT01176240|79362357|FG000|Study 306A|Stop due to diverse problems|1|||
44357215|NCT01176240|79362358|FG001|Study 306A|Stop due to diverse problems|0|||
44357216|NCT01176240|79362357|FG000|Study 306B|Lack of Efficacy|5|||
44357217|NCT01176240|79362358|FG001|Study 306B|Lack of Efficacy|3|||
44357218|NCT01176240|79362357|FG000|Study 306B|Adverse Event|10|||
44357219|NCT01176240|79362358|FG001|Study 306B|Adverse Event|5|||
44357220|NCT01176240|79362357|FG000|Study 306B|Protocol Violation|2|||
44357221|NCT01176240|79362358|FG001|Study 306B|Protocol Violation|3|||
44357222|NCT01176240|79362357|FG000|Study 306B|Withdrawal by Subject|4|||
44357223|NCT01176240|79362358|FG001|Study 306B|Withdrawal by Subject|1|||
44357224|NCT01176240|79362357|FG000|Study 306B|Physician Decision|2|||
44357225|NCT01176240|79362358|FG001|Study 306B|Physician Decision|1|||
44357226|NCT01176240|79362357|FG000|Study 306B|Supine Hypertension|1|||
44357227|NCT01176240|79362358|FG001|Study 306B|Supine Hypertension|2|||
44357228|NCT01176240|79362357|FG000|Study 306B|Lost to Follow-up|0|||
44357229|NCT01176240|79362358|FG001|Study 306B|Lost to Follow-up|1|||
44357230|NCT01176240|79362357|FG000|Study 306B|withdrew prior to dosing|2|||
44357231|NCT01176240|79362358|FG001|Study 306B|withdrew prior to dosing|1|||
44357232|NCT00988221|79362367|FG000|Part I|Adverse Event|0|||
44357233|NCT00988221|79362368|FG001|Part I|Adverse Event|1|||
44357234|NCT00988221|79362369|FG002|Part I|Adverse Event|2|||
44357235|NCT00988221|79362370|FG003|Part I|Adverse Event|0|||
44357236|NCT00988221|79362367|FG000|Part I|Insufficient Therapeutic Response|4|||
44357237|NCT00988221|79362368|FG001|Part I|Insufficient Therapeutic Response|6|||
44357238|NCT00988221|79362369|FG002|Part I|Insufficient Therapeutic Response|5|||
44357239|NCT00988221|79362370|FG003|Part I|Insufficient Therapeutic Response|0|||
44357240|NCT00988221|79362367|FG000|Part I|Refused Treatment|0|||
44357241|NCT00988221|79362368|FG001|Part I|Refused Treatment|2|||
44357242|NCT00988221|79362369|FG002|Part I|Refused Treatment|1|||
44357243|NCT00988221|79362370|FG003|Part I|Refused Treatment|0|||
44357244|NCT00988221|79362367|FG000|Part I|Lost to Follow-up|0|||
44357245|NCT00988221|79362368|FG001|Part I|Lost to Follow-up|1|||
44357246|NCT00988221|79362369|FG002|Part I|Lost to Follow-up|0|||
44357247|NCT00988221|79362370|FG003|Part I|Lost to Follow-up|0|||
44357248|NCT00988221|79362367|FG000|Part II|Adverse Event|1|||
44357249|NCT00988221|79362368|FG001|Part II|Adverse Event|0|||
44357250|NCT00988221|79362369|FG002|Part II|Adverse Event|0|||
44357251|NCT00988221|79362370|FG003|Part II|Adverse Event|1|||
44357252|NCT00988221|79362367|FG000|Part II|Withdrawal by Subject|0|||
44357253|NCT00988221|79362368|FG001|Part II|Withdrawal by Subject|0|||
44357254|NCT00988221|79362369|FG002|Part II|Withdrawal by Subject|2|||
44357255|NCT00988221|79362370|FG003|Part II|Withdrawal by Subject|2|||
44357256|NCT00988221|79362367|FG000|Part II|Reason not Specified|0|||
44357257|NCT00988221|79362368|FG001|Part II|Reason not Specified|0|||
44357258|NCT00988221|79362369|FG002|Part II|Reason not Specified|1|||
44357259|NCT00988221|79362370|FG003|Part II|Reason not Specified|0|||
44357260|NCT00988221|79362367|FG000|Part III|Adverse Event|1|||
44357261|NCT00988221|79362368|FG001|Part III|Adverse Event|0|||
44357262|NCT00988221|79362369|FG002|Part III|Adverse Event|1|||
44357263|NCT00988221|79362370|FG003|Part III|Adverse Event|0|||
44357264|NCT00988221|79362367|FG000|Part III|Insufficient Therapeutic Response|0|||
44357265|NCT00988221|79362368|FG001|Part III|Insufficient Therapeutic Response|1|||
44357266|NCT00988221|79362369|FG002|Part III|Insufficient Therapeutic Response|1|||
44357267|NCT00988221|79362370|FG003|Part III|Insufficient Therapeutic Response|0|||
44357268|NCT00988221|79362367|FG000|Part III|Refused Treatment|0|||
44357269|NCT00988221|79362368|FG001|Part III|Refused Treatment|0|||
44357270|NCT00988221|79362369|FG002|Part III|Refused Treatment|1|||
44357271|NCT00988221|79362370|FG003|Part III|Refused Treatment|0|||
44357272|NCT01149096|79362391|FG000|Overall Study|Lost to Follow-up|0|||
44357273|NCT01149096|79362392|FG001|Overall Study|Lost to Follow-up|1|||
44357274|NCT01175382|79362402|FG000|Overall Study|Lost to Follow-up|4|||
44357275|NCT01175382|79362403|FG001|Overall Study|Lost to Follow-up|3|||
44357276|NCT01175382|79362404|FG002|Overall Study|Lost to Follow-up|1|||
44357277|NCT01175382|79362402|FG000|Overall Study|Physician Decision|0|||
44357278|NCT01175382|79362403|FG001|Overall Study|Physician Decision|1|||
44357279|NCT01175382|79362404|FG002|Overall Study|Physician Decision|0|||
44357280|NCT01175382|79362402|FG000|Overall Study|Withdrawal by Subject|0|||
44357281|NCT01175382|79362403|FG001|Overall Study|Withdrawal by Subject|0|||
44357282|NCT01175382|79362404|FG002|Overall Study|Withdrawal by Subject|1|||
44357283|NCT01175382|79362402|FG000|Overall Study|No longer having problem|1|||
44357284|NCT01175382|79362403|FG001|Overall Study|No longer having problem|0|||
44357285|NCT01175382|79362404|FG002|Overall Study|No longer having problem|1|||
44357286|NCT01175382|79362402|FG000|Overall Study|Unable/unwilling to attend visits|3|||
44357287|NCT01175382|79362403|FG001|Overall Study|Unable/unwilling to attend visits|1|||
44357288|NCT01175382|79362404|FG002|Overall Study|Unable/unwilling to attend visits|2|||
44357289|NCT01175382|79362402|FG000|Overall Study|Unwilling to follow protocol|0|||
44357290|NCT01175382|79362403|FG001|Overall Study|Unwilling to follow protocol|1|||
44357291|NCT01175382|79362404|FG002|Overall Study|Unwilling to follow protocol|0|||
44357292|NCT01175382|79362402|FG000|Overall Study|Unable to tolerate study meds|0|||
44357293|NCT01175382|79362403|FG001|Overall Study|Unable to tolerate study meds|1|||
44357294|NCT01175382|79362404|FG002|Overall Study|Unable to tolerate study meds|1|||
44357295|NCT01194245|79362417|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
44357296|NCT01194245|79362418|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
44357297|NCT01194245|79362419|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
44357298|NCT01194245|79362420|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
44357299|NCT01194245|79362421|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
44357300|NCT01194245|79362417|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
44357301|NCT01194245|79362418|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
44357302|NCT01194245|79362419|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
44357303|NCT01194245|79362420|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
44357304|NCT01194245|79362421|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
44357305|NCT01194245|79362417|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
44357306|NCT01194245|79362418|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
44357307|NCT01194245|79362419|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
44357308|NCT01194245|79362420|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
44357309|NCT01194245|79362421|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
44357310|NCT01194245|79362417|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
44357311|NCT01194245|79362418|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
44357312|NCT01194245|79362419|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
44357313|NCT01194245|79362420|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
44357314|NCT01194245|79362421|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
44357315|NCT01194245|79362417|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44357316|NCT01194245|79362418|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44357317|NCT01194245|79362419|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44357318|NCT01194245|79362420|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44357319|NCT01194245|79362421|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
44357320|NCT01194245|79362417|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44357321|NCT01194245|79362418|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44357322|NCT01194245|79362419|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
44357323|NCT01194245|79362420|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
44357324|NCT01194245|79362421|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
44357325|NCT00979407|79362432|FG000|Overall Study|Withdrawal by Subject|3|||
44357326|NCT00979407|79362433|FG001|Overall Study|Withdrawal by Subject|4|||
44357327|NCT00979407|79362432|FG000|Overall Study|Lost to Follow-up|3|||
44357328|NCT00979407|79362433|FG001|Overall Study|Lost to Follow-up|3|||
44357329|NCT01148862|79362441|FG000|Second Intervention|Withdrawal by Subject|0|||
44357330|NCT01148862|79362442|FG001|Second Intervention|Withdrawal by Subject|2|||
44357331|NCT00975975|79362448|FG000|Overall Study|Death|6|||
44357332|NCT01193153|79362452|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
44357333|NCT01193153|79362453|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
44357334|NCT01193153|79362452|FG000|Open-label Lead in Period|Pregnancy|1|||
44357335|NCT01193153|79362453|FG001|Open-label Lead in Period|Pregnancy|0|||
44357336|NCT01193153|79362452|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
44357337|NCT01193153|79362453|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
44357338|NCT01193153|79362452|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
44357339|NCT01193153|79362453|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
44357340|NCT01193153|79362452|FG000|Open-label Lead in Period|Other|14|||
44357341|NCT01193153|79362453|FG001|Open-label Lead in Period|Other|0|||
44357342|NCT01193153|79362452|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
44357343|NCT01193153|79362453|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
44357344|NCT01193153|79362452|FG000|Open-label Lead in Period|Adverse Event|41|||
44357345|NCT01193153|79362453|FG001|Open-label Lead in Period|Adverse Event|0|||
44357346|NCT01193153|79362452|FG000|Open-label Lead in Period|Death|1|||
44357347|NCT01193153|79362453|FG001|Open-label Lead in Period|Death|0|||
44357348|NCT01193153|79362452|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
44357349|NCT01193153|79362453|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
44357350|NCT01193153|79362452|FG000|Open-label Stabilization Period|Adverse Event|9|||
44357351|NCT01193153|79362453|FG001|Open-label Stabilization Period|Adverse Event|0|||
44357352|NCT01193153|79362452|FG000|Open-label Stabilization Period|Death|2|||
44357353|NCT01193153|79362453|FG001|Open-label Stabilization Period|Death|0|||
44357354|NCT01193153|79362452|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
44357355|NCT01193153|79362453|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
44357356|NCT01193153|79362452|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
44357357|NCT01193153|79362453|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
44357358|NCT01193153|79362452|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
44357359|NCT01193153|79362453|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
44357360|NCT01193153|79362452|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
44357361|NCT01193153|79362453|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
44357362|NCT01193153|79362452|FG000|Open-label Stabilization Period|Other|8|||
44357363|NCT01193153|79362453|FG001|Open-label Stabilization Period|Other|0|||
44357364|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Other|2|||
44357365|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Other|3|||
44357366|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
44357367|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
44357368|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Death|2|||
44357369|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Death|0|||
44357370|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
44357371|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
44357372|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
44357373|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
44357374|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
44357375|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
44357376|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
44357377|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
44357378|NCT01193153|79362452|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
44357379|NCT01193153|79362453|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
44357380|NCT01192295|79362464|FG000|Overall Study|Adverse Event|3|||
44357381|NCT01192295|79362465|FG001|Overall Study|Adverse Event|7|||
44357382|NCT01192295|79362464|FG000|Overall Study|Withdrawal by Subject|3|||
44357383|NCT01192295|79362465|FG001|Overall Study|Withdrawal by Subject|4|||
44357384|NCT01192295|79362464|FG000|Overall Study|Lost to Follow-up|0|||
44357385|NCT01192295|79362465|FG001|Overall Study|Lost to Follow-up|1|||
44357386|NCT01192295|79362464|FG000|Overall Study|Lack of Efficacy|0|||
44357387|NCT01192295|79362465|FG001|Overall Study|Lack of Efficacy|5|||
44357388|NCT01192295|79362464|FG000|Overall Study|Administrative|4|||
44357389|NCT01192295|79362465|FG001|Overall Study|Administrative|6|||
44357390|NCT01154166|79362475|FG000|Overall Study|Adverse Event|14|||
44357391|NCT01154166|79362476|FG001|Overall Study|Adverse Event|9|||
44357392|NCT01154166|79362475|FG000|Overall Study|Lost to Follow-up|1|||
44357393|NCT01154166|79362476|FG001|Overall Study|Lost to Follow-up|1|||
44357394|NCT01154166|79362475|FG000|Overall Study|Protocol Violation|4|||
44357395|NCT01154166|79362476|FG001|Overall Study|Protocol Violation|1|||
44357396|NCT01154166|79362475|FG000|Overall Study|Withdrawal by Subject|10|||
44357397|NCT01154166|79362476|FG001|Overall Study|Withdrawal by Subject|1|||
44357398|NCT01154166|79362475|FG000|Overall Study|Lack of Efficacy|3|||
44357399|NCT01154166|79362476|FG001|Overall Study|Lack of Efficacy|0|||
44357400|NCT01154166|79362475|FG000|Overall Study|Disease Progression|1|||
44357401|NCT01154166|79362476|FG001|Overall Study|Disease Progression|0|||
44357402|NCT01154166|79362475|FG000|Overall Study|Poor Compliance|1|||
44357403|NCT01154166|79362476|FG001|Overall Study|Poor Compliance|0|||
44357404|NCT00975585|79362484|FG000|Overall Study|Adverse Event|0|||
44357405|NCT00975585|79362485|FG001|Overall Study|Adverse Event|4|||
44357406|NCT00975585|79362484|FG000|Overall Study|Lost to Follow-up|3|||
44357407|NCT00975585|79362485|FG001|Overall Study|Lost to Follow-up|5|||
44357408|NCT00975585|79362484|FG000|Overall Study|Withdrawal by Subject|2|||
44357409|NCT00975585|79362485|FG001|Overall Study|Withdrawal by Subject|1|||
44357410|NCT00975585|79362484|FG000|Overall Study|Lens issue|2|||
44357411|NCT00975585|79362485|FG001|Overall Study|Lens issue|2|||
44357412|NCT01181921|79362493|FG000|Overall Study|Lost to Follow-up|1|||
44357413|NCT01174446|79362497|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
44357414|NCT01174446|79362498|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
44357415|NCT01174446|79362499|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
44357416|NCT01174446|79362500|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
44357417|NCT01174446|79362497|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
44357418|NCT01174446|79362498|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
44357419|NCT01174446|79362499|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
44357420|NCT01174446|79362500|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
44357421|NCT01174446|79362497|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
44357422|NCT01174446|79362498|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
44357423|NCT01174446|79362499|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
44357424|NCT01174446|79362500|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
44357425|NCT01174446|79362497|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
44357426|NCT01174446|79362498|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
44357427|NCT01174446|79362499|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
44357428|NCT01174446|79362500|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
44357429|NCT00932698|79362558|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
44357430|NCT00932698|79362559|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
44357431|NCT00932698|79362560|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
44357432|NCT00932698|79362561|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
44357433|NCT00932698|79362562|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
44357434|NCT00932698|79362563|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
44357435|NCT00932698|79362564|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
44357436|NCT00932698|79362565|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
44357437|NCT00932698|79362566|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
44357438|NCT00932698|79362567|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
44357439|NCT00932698|79362568|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
44357440|NCT00932698|79362558|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357441|NCT00932698|79362559|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
44357442|NCT00932698|79362560|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357443|NCT00932698|79362561|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
44357444|NCT00932698|79362562|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357445|NCT00932698|79362563|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
44357446|NCT00932698|79362564|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
44357447|NCT00932698|79362565|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357448|NCT00932698|79362566|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357449|NCT00932698|79362567|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357450|NCT00932698|79362568|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
44357451|NCT00932698|79362558|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
44357452|NCT00932698|79362559|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
44357453|NCT00932698|79362560|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
44357454|NCT00932698|79362561|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
44357455|NCT00932698|79362562|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
44357456|NCT00932698|79362563|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
44357457|NCT00932698|79362564|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
44357458|NCT00932698|79362565|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
44357459|NCT00932698|79362566|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
44357460|NCT00932698|79362567|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
44357461|NCT00932698|79362568|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
44357462|NCT00932698|79362558|FG000|Part 1 (Dose Escalation)|Other|0|||
44357463|NCT00932698|79362559|FG001|Part 1 (Dose Escalation)|Other|0|||
44357464|NCT00932698|79362560|FG002|Part 1 (Dose Escalation)|Other|1|||
44357465|NCT00932698|79362561|FG003|Part 1 (Dose Escalation)|Other|0|||
44357466|NCT00932698|79362562|FG004|Part 1 (Dose Escalation)|Other|0|||
44357467|NCT00932698|79362563|FG005|Part 1 (Dose Escalation)|Other|0|||
44357468|NCT00932698|79362564|FG006|Part 1 (Dose Escalation)|Other|1|||
44357469|NCT00932698|79362565|FG007|Part 1 (Dose Escalation)|Other|0|||
44357470|NCT00932698|79362566|FG008|Part 1 (Dose Escalation)|Other|0|||
44357471|NCT00932698|79362567|FG009|Part 1 (Dose Escalation)|Other|0|||
44357472|NCT00932698|79362568|FG010|Part 1 (Dose Escalation)|Other|0|||
44357473|NCT00932698|79362558|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357474|NCT00932698|79362559|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357475|NCT00932698|79362560|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357476|NCT00932698|79362561|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357477|NCT00932698|79362562|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357478|NCT00932698|79362563|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357479|NCT00932698|79362564|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
44357480|NCT00932698|79362565|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
44357481|NCT00932698|79362566|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
44357482|NCT00932698|79362567|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
44357483|NCT00932698|79362568|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
44357484|NCT00932698|79362558|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357485|NCT00932698|79362559|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357486|NCT00932698|79362560|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357487|NCT00932698|79362561|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357488|NCT00932698|79362562|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357489|NCT00932698|79362563|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357490|NCT00932698|79362564|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357491|NCT00932698|79362565|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
44357492|NCT00932698|79362566|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
44357493|NCT00932698|79362567|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
44357494|NCT00932698|79362568|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
44357495|NCT00932698|79362558|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
44357496|NCT00932698|79362559|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
44357497|NCT00932698|79362560|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
44357498|NCT00932698|79362561|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
44357499|NCT00932698|79362562|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
44357500|NCT00932698|79362563|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
44357501|NCT00932698|79362564|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
44357502|NCT00932698|79362565|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
44357503|NCT00932698|79362566|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
44357504|NCT00932698|79362567|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
44357505|NCT00932698|79362568|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
44357506|NCT00978627|79362596|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
44357507|NCT00978627|79362597|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
44357508|NCT00978627|79362596|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
44357509|NCT00978627|79362597|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
44357510|NCT00978627|79362596|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
44357511|NCT00978627|79362597|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
44357512|NCT00978627|79362596|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
44357513|NCT00978627|79362597|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
44357514|NCT00978627|79362596|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
44357515|NCT00978627|79362597|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
44357516|NCT00978627|79362596|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
44357517|NCT00978627|79362597|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
44357518|NCT00978627|79362596|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
44357519|NCT00978627|79362597|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
44357520|NCT00978627|79362596|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
44357521|NCT00978627|79362597|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
44357522|NCT00978627|79362596|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
44357523|NCT00978627|79362597|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
44357524|NCT01181609|79362603|FG000|Overall Study|Adverse Event|1|||
44357525|NCT01181609|79362603|FG000|Overall Study|Withdrawal by Subject|1|||
44357526|NCT01181609|79362603|FG000|Overall Study|Lost to Follow-up|1|||
44357527|NCT01181609|79362603|FG000|Overall Study|Death|50|||
44357528|NCT01154010|79362609|FG000|Overall Study|Lost to Follow-up|0|||
44357529|NCT01154010|79362610|FG001|Overall Study|Lost to Follow-up|1|||
44357530|NCT01174368|79362616|FG000|Overall Study|Withdrawal by Subject|1|||
44357531|NCT01147926|79362622|FG000|Overall Study|Subject Withdrew Consent|9|||
44357532|NCT01147926|79362623|FG001|Overall Study|Subject Withdrew Consent|10|||
44357533|NCT01147926|79362622|FG000|Overall Study|Adverse Event|7|||
44357534|NCT01147926|79362623|FG001|Overall Study|Adverse Event|6|||
44357535|NCT01147926|79362622|FG000|Overall Study|Subject Non-Compliant|5|||
44357536|NCT01147926|79362623|FG001|Overall Study|Subject Non-Compliant|4|||
44357537|NCT01147926|79362622|FG000|Overall Study|Principal investigator left hospital|1|||
44357538|NCT01147926|79362623|FG001|Overall Study|Principal investigator left hospital|3|||
44357539|NCT01147926|79362622|FG000|Overall Study|Selection criteria not met|3|||
44357540|NCT01147926|79362623|FG001|Overall Study|Selection criteria not met|1|||
44357541|NCT01147926|79362622|FG000|Overall Study|Lost to Follow-up|0|||
44357542|NCT01147926|79362623|FG001|Overall Study|Lost to Follow-up|2|||
44357543|NCT01147926|79362622|FG000|Overall Study|Sponsor's Decision|0|||
44357544|NCT01147926|79362623|FG001|Overall Study|Sponsor's Decision|1|||
44357545|NCT01147926|79362622|FG000|Overall Study|Lack of Efficacy|1|||
44357546|NCT01147926|79362623|FG001|Overall Study|Lack of Efficacy|0|||
44357547|NCT01147926|79362622|FG000|Overall Study|Too busy, no time for study|1|||
44357548|NCT01147926|79362623|FG001|Overall Study|Too busy, no time for study|0|||
44357549|NCT01147926|79362622|FG000|Overall Study|Went on holiday|0|||
44357550|NCT01147926|79362623|FG001|Overall Study|Went on holiday|1|||
44357551|NCT01147926|79362622|FG000|Overall Study|Colonoscopy result|0|||
44357552|NCT01147926|79362623|FG001|Overall Study|Colonoscopy result|1|||
44357553|NCT00975507|79362631|FG000|Overall Study|Adverse Event|1|||
44357554|NCT00975507|79362632|FG001|Overall Study|Adverse Event|0|||
44357555|NCT00975507|79362631|FG000|Overall Study|Lost to Follow-up|7|||
44357556|NCT00975507|79362632|FG001|Overall Study|Lost to Follow-up|1|||
44357557|NCT00975507|79362631|FG000|Overall Study|Protocol Violation|2|||
44357558|NCT00975507|79362632|FG001|Overall Study|Protocol Violation|0|||
44357559|NCT00975507|79362631|FG000|Overall Study|Withdrawal by Subject|10|||
44357560|NCT00975507|79362632|FG001|Overall Study|Withdrawal by Subject|3|||
44357561|NCT01147848|79362642|FG000|Run-in Period|Screen Failure|623|||
44357562|NCT01147848|79362643|FG001|Run-in Period|Screen Failure|0|||
44357563|NCT01147848|79362644|FG002|Run-in Period|Screen Failure|0|||
44357564|NCT01147848|79362642|FG000|Run-in Period|Run-in Failure|135|||
44357565|NCT01147848|79362643|FG001|Run-in Period|Run-in Failure|0|||
44357566|NCT01147848|79362644|FG002|Run-in Period|Run-in Failure|0|||
44357567|NCT01147848|79362642|FG000|Randomized Phase|Adverse Event|0|||
44357568|NCT01147848|79362643|FG001|Randomized Phase|Adverse Event|6|||
44357569|NCT01147848|79362644|FG002|Randomized Phase|Adverse Event|8|||
44357570|NCT01147848|79362642|FG000|Randomized Phase|Lack of Efficacy|0|||
44357571|NCT01147848|79362643|FG001|Randomized Phase|Lack of Efficacy|20|||
44357572|NCT01147848|79362644|FG002|Randomized Phase|Lack of Efficacy|11|||
44357573|NCT01147848|79362642|FG000|Randomized Phase|Protocol Violation|0|||
44357574|NCT01147848|79362643|FG001|Randomized Phase|Protocol Violation|7|||
44357575|NCT01147848|79362644|FG002|Randomized Phase|Protocol Violation|10|||
44357576|NCT01147848|79362642|FG000|Randomized Phase|Lost to Follow-up|0|||
44357577|NCT01147848|79362643|FG001|Randomized Phase|Lost to Follow-up|5|||
44357578|NCT01147848|79362644|FG002|Randomized Phase|Lost to Follow-up|7|||
44357579|NCT01147848|79362642|FG000|Randomized Phase|Physician Decision|0|||
44357580|NCT01147848|79362643|FG001|Randomized Phase|Physician Decision|0|||
44357581|NCT01147848|79362644|FG002|Randomized Phase|Physician Decision|1|||
44357582|NCT01147848|79362642|FG000|Randomized Phase|Withdrawal by Subject|0|||
44357583|NCT01147848|79362643|FG001|Randomized Phase|Withdrawal by Subject|7|||
44357584|NCT01147848|79362644|FG002|Randomized Phase|Withdrawal by Subject|9|||
44357585|NCT00929656|79362653|FG000|Overall Study|Lost to Follow-up|0|||
44357586|NCT00929656|79362654|FG001|Overall Study|Lost to Follow-up|1|||
44357587|NCT00977613|79362660|FG000|Overall Study|Lost to Follow-up|16|||
44357588|NCT01152996|79362664|FG000|Overall Study|Withdrawal by Subject|142|||
44357589|NCT01152996|79362664|FG000|Overall Study|Adverse Event|115|||
44357590|NCT01152996|79362664|FG000|Overall Study|Lost to Follow-up|112|||
44357591|NCT01152996|79362664|FG000|Overall Study|Lack of Efficacy|68|||
44357592|NCT01152996|79362664|FG000|Overall Study|Noncompliance|41|||
44357593|NCT01152996|79362664|FG000|Overall Study|Other|36|||
44357594|NCT01152996|79362664|FG000|Overall Study|Protocol Violation|22|||
44357595|NCT01152996|79362664|FG000|Overall Study|Elevated liver enzymes|1|||
44357596|NCT00979953|79362672|FG000|Overall Study|Adverse Event|5|||
44357597|NCT00979953|79362673|FG001|Overall Study|Adverse Event|2|||
44357598|NCT00979953|79362674|FG002|Overall Study|Adverse Event|17|||
44357599|NCT00979953|79362675|FG003|Overall Study|Adverse Event|4|||
44357600|NCT00979953|79362672|FG000|Overall Study|Lack of Efficacy|1|||
44357601|NCT00979953|79362673|FG001|Overall Study|Lack of Efficacy|2|||
44357602|NCT00979953|79362674|FG002|Overall Study|Lack of Efficacy|0|||
44357603|NCT00979953|79362675|FG003|Overall Study|Lack of Efficacy|0|||
44357604|NCT00979953|79362672|FG000|Overall Study|Lost to Follow-up|1|||
44357605|NCT00979953|79362673|FG001|Overall Study|Lost to Follow-up|1|||
44357606|NCT00979953|79362674|FG002|Overall Study|Lost to Follow-up|1|||
44357607|NCT00979953|79362675|FG003|Overall Study|Lost to Follow-up|0|||
44357608|NCT00979953|79362672|FG000|Overall Study|Withdrawal by Subject|0|||
44357609|NCT00979953|79362673|FG001|Overall Study|Withdrawal by Subject|0|||
44357610|NCT00979953|79362674|FG002|Overall Study|Withdrawal by Subject|2|||
44357611|NCT00979953|79362675|FG003|Overall Study|Withdrawal by Subject|1|||
44357612|NCT00979953|79362672|FG000|Overall Study|Protocol Violation|1|||
44357613|NCT00979953|79362673|FG001|Overall Study|Protocol Violation|0|||
44357614|NCT00979953|79362674|FG002|Overall Study|Protocol Violation|2|||
44357615|NCT00979953|79362675|FG003|Overall Study|Protocol Violation|2|||
44357616|NCT01181531|79362687|FG000|Overall Study|Other|17|||
44357617|NCT01181531|79362688|FG001|Overall Study|Other|12|||
44357618|NCT01181531|79362687|FG000|Overall Study|Partial consent by subject withdrawn|0|||
44357619|NCT01181531|79362688|FG001|Overall Study|Partial consent by subject withdrawn|1|||
44357620|NCT01181531|79362687|FG000|Overall Study|Physician Decision|3|||
44357621|NCT01181531|79362688|FG001|Overall Study|Physician Decision|1|||
44357622|NCT01181531|79362687|FG000|Overall Study|Noncompliance|2|||
44357623|NCT01181531|79362688|FG001|Overall Study|Noncompliance|2|||
44357624|NCT01181531|79362687|FG000|Overall Study|Ineligibility determined|1|||
44357625|NCT01181531|79362688|FG001|Overall Study|Ineligibility determined|2|||
44357626|NCT01181531|79362687|FG000|Overall Study|Protocol Specified Criteria|15|||
44357627|NCT01181531|79362688|FG001|Overall Study|Protocol Specified Criteria|8|||
44357628|NCT01181531|79362687|FG000|Overall Study|Pregnancy|0|||
44357629|NCT01181531|79362688|FG001|Overall Study|Pregnancy|1|||
44357630|NCT01181531|79362687|FG000|Overall Study|Withdrawal by Subject|8|||
44357631|NCT01181531|79362688|FG001|Overall Study|Withdrawal by Subject|7|||
44357632|NCT01181531|79362687|FG000|Overall Study|Protocol Violation|6|||
44357633|NCT01181531|79362688|FG001|Overall Study|Protocol Violation|6|||
44357634|NCT01181531|79362687|FG000|Overall Study|Death|9|||
44357635|NCT01181531|79362688|FG001|Overall Study|Death|12|||
44357636|NCT01181531|79362687|FG000|Overall Study|Adverse Event|0|||
44357637|NCT01181531|79362688|FG001|Overall Study|Adverse Event|1|||
44357638|NCT01152450|79362694|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
44357639|NCT01152450|79362695|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
44357640|NCT01152450|79362696|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
44357641|NCT01152450|79362697|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
44357642|NCT01152450|79362698|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
44357643|NCT01152450|79362699|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
44357644|NCT01152450|79362694|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
44357645|NCT01152450|79362695|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
44357646|NCT01152450|79362696|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
44357647|NCT01152450|79362697|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
44357648|NCT01152450|79362698|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
44357649|NCT01152450|79362699|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
44357650|NCT01152450|79362694|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44357651|NCT01152450|79362695|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
44357652|NCT01152450|79362696|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
44357653|NCT01152450|79362697|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44357654|NCT01152450|79362698|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44357655|NCT01152450|79362699|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44357656|NCT01181141|79362709|FG000|Overall Study|Adverse Event|2|||
44357657|NCT01181141|79362710|FG001|Overall Study|Adverse Event|1|||
44357658|NCT01181141|79362709|FG000|Overall Study|Lack of Efficacy|1|||
44357659|NCT01181141|79362710|FG001|Overall Study|Lack of Efficacy|0|||
44357660|NCT01181141|79362709|FG000|Overall Study|Lost to Follow-up|1|||
44357661|NCT01181141|79362710|FG001|Overall Study|Lost to Follow-up|1|||
44357662|NCT01181141|79362709|FG000|Overall Study|Physician Decision|2|||
44357663|NCT01181141|79362710|FG001|Overall Study|Physician Decision|0|||
44357664|NCT01181141|79362709|FG000|Overall Study|Protocol Violation|3|||
44357665|NCT01181141|79362710|FG001|Overall Study|Protocol Violation|1|||
44357666|NCT01181141|79362709|FG000|Overall Study|Withdrawal by Subject|3|||
44357667|NCT01181141|79362710|FG001|Overall Study|Withdrawal by Subject|1|||
44357668|NCT01173120|79362716|FG000|Overall Study|Lack of Efficacy|2|||
44357669|NCT01173120|79362716|FG000|Overall Study|Lost to Follow-up|1|||
44357670|NCT01173120|79362716|FG000|Overall Study|Participant Decision|2|||
44357671|NCT01173120|79362716|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
44357672|NCT01173120|79362716|FG000|Overall Study|Switch-Participant Decision|12|||
44357673|NCT01173120|79362716|FG000|Overall Study|Switch-Difficulty With Device|12|||
44357674|NCT00977379|79362724|FG000|Overall Study|Withdrawal by Subject|1|||
44357675|NCT00977379|79362725|FG001|Overall Study|Withdrawal by Subject|1|||
44357676|NCT00977379|79362724|FG000|Overall Study|Death|7|||
44357677|NCT00977379|79362725|FG001|Overall Study|Death|9|||
44357678|NCT00977379|79362724|FG000|Overall Study|Premature Study Termination|4|||
44357679|NCT00977379|79362725|FG001|Overall Study|Premature Study Termination|0|||
44357680|NCT00977379|79362724|FG000|Overall Study|Participant Moving House|0|||
44357681|NCT00977379|79362725|FG001|Overall Study|Participant Moving House|1|||
44357682|NCT00977379|79362724|FG000|Overall Study|Randomization Error|0|||
44357683|NCT00977379|79362725|FG001|Overall Study|Randomization Error|1|||
44357684|NCT01180985|79362731|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
44357685|NCT01180985|79362732|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
44357686|NCT01147536|79362739|FG000|Overall Study|Administrative study close|2|||
44357687|NCT01147536|79362739|FG000|Overall Study|Death|1|||
44357688|NCT01154088|79362746|FG000|Overall Study|Lost to Follow-up|4|||
44357689|NCT01154088|79362747|FG001|Overall Study|Lost to Follow-up|6|||
44357690|NCT01154088|79362748|FG002|Overall Study|Lost to Follow-up|7|||
44357691|NCT01180049|79362759|FG000|Overall Study|Other|9|||
44357692|NCT01180049|79362760|FG001|Overall Study|Other|7|||
44357693|NCT01180049|79362759|FG000|Overall Study|Lost to Follow-up|8|||
44357694|NCT01180049|79362760|FG001|Overall Study|Lost to Follow-up|6|||
44357695|NCT01180049|79362759|FG000|Overall Study|Death|36|||
44357696|NCT01180049|79362760|FG001|Overall Study|Death|35|||
44357697|NCT01147458|79362766|FG000|First Intervention|Study terminated by sponsor|8|||
44357698|NCT01147458|79362767|FG001|First Intervention|Study terminated by sponsor|8|||
44357699|NCT01147458|79362768|FG002|First Intervention|Study terminated by sponsor|7|||
44357700|NCT01147458|79362769|FG003|First Intervention|Study terminated by sponsor|8|||
44357701|NCT01147458|79362766|FG000|First Intervention|Protocol Violation|2|||
44357702|NCT01147458|79362767|FG001|First Intervention|Protocol Violation|3|||
44357703|NCT01147458|79362768|FG002|First Intervention|Protocol Violation|2|||
44357704|NCT01147458|79362769|FG003|First Intervention|Protocol Violation|3|||
44357705|NCT01147458|79362766|FG000|First Intervention|Withdrawal by Subject|3|||
44357706|NCT01147458|79362767|FG001|First Intervention|Withdrawal by Subject|0|||
44357707|NCT01147458|79362768|FG002|First Intervention|Withdrawal by Subject|1|||
44357708|NCT01147458|79362769|FG003|First Intervention|Withdrawal by Subject|0|||
44357709|NCT01147458|79362766|FG000|First Intervention|Adverse Event|0|||
44357710|NCT01147458|79362767|FG001|First Intervention|Adverse Event|3|||
44357711|NCT01147458|79362768|FG002|First Intervention|Adverse Event|2|||
44357712|NCT01147458|79362769|FG003|First Intervention|Adverse Event|3|||
44357713|NCT01147458|79362766|FG000|First Intervention|Other|1|||
44357714|NCT01147458|79362767|FG001|First Intervention|Other|2|||
44357715|NCT01147458|79362768|FG002|First Intervention|Other|0|||
44357716|NCT01147458|79362769|FG003|First Intervention|Other|0|||
44357717|NCT01147458|79362766|FG000|Second Intervention|Study terminated by sponsor|7|||
44357718|NCT01147458|79362767|FG001|Second Intervention|Study terminated by sponsor|5|||
44357719|NCT01147458|79362768|FG002|Second Intervention|Study terminated by sponsor|5|||
44357720|NCT01147458|79362769|FG003|Second Intervention|Study terminated by sponsor|3|||
44357721|NCT01147458|79362766|FG000|Second Intervention|Protocol Violation|0|||
44357722|NCT01147458|79362767|FG001|Second Intervention|Protocol Violation|1|||
44357723|NCT01147458|79362768|FG002|Second Intervention|Protocol Violation|1|||
44357724|NCT01147458|79362769|FG003|Second Intervention|Protocol Violation|0|||
44357725|NCT01147458|79362766|FG000|Second Intervention|Withdrawal by Subject|0|||
44357726|NCT01147458|79362767|FG001|Second Intervention|Withdrawal by Subject|1|||
44357727|NCT01147458|79362768|FG002|Second Intervention|Withdrawal by Subject|0|||
44357728|NCT01147458|79362769|FG003|Second Intervention|Withdrawal by Subject|0|||
44357729|NCT01147458|79362766|FG000|Second Intervention|Adverse Event|2|||
44357730|NCT01147458|79362767|FG001|Second Intervention|Adverse Event|0|||
44357731|NCT01147458|79362768|FG002|Second Intervention|Adverse Event|1|||
44357732|NCT01147458|79362769|FG003|Second Intervention|Adverse Event|1|||
44357733|NCT01147458|79362766|FG000|Second Intervention|Other|0|||
44357734|NCT01147458|79362767|FG001|Second Intervention|Other|0|||
44357735|NCT01147458|79362768|FG002|Second Intervention|Other|1|||
44357736|NCT01147458|79362769|FG003|Second Intervention|Other|0|||
44357737|NCT01172808|79362785|FG000|Overall Study|Adverse Event|8|||
44357738|NCT01172808|79362786|FG001|Overall Study|Adverse Event|4|||
44357739|NCT01172808|79362787|FG002|Overall Study|Adverse Event|8|||
44357740|NCT01172808|79362788|FG003|Overall Study|Adverse Event|3|||
44357741|NCT01172808|79362785|FG000|Overall Study|Lack of Efficacy|1|||
44357742|NCT01172808|79362786|FG001|Overall Study|Lack of Efficacy|0|||
44357743|NCT01172808|79362787|FG002|Overall Study|Lack of Efficacy|0|||
44357744|NCT01172808|79362788|FG003|Overall Study|Lack of Efficacy|0|||
44357745|NCT01172808|79362785|FG000|Overall Study|Protocol Violation|2|||
44357746|NCT01172808|79362786|FG001|Overall Study|Protocol Violation|2|||
44357747|NCT01172808|79362787|FG002|Overall Study|Protocol Violation|2|||
44357748|NCT01172808|79362788|FG003|Overall Study|Protocol Violation|0|||
44357749|NCT01172808|79362785|FG000|Overall Study|Lost to Follow-up|0|||
44357750|NCT01172808|79362786|FG001|Overall Study|Lost to Follow-up|1|||
44357751|NCT01172808|79362787|FG002|Overall Study|Lost to Follow-up|1|||
44357752|NCT01172808|79362788|FG003|Overall Study|Lost to Follow-up|3|||
44357753|NCT01172808|79362785|FG000|Overall Study|Withdrawal by Subject|4|||
44357754|NCT01172808|79362786|FG001|Overall Study|Withdrawal by Subject|1|||
44357755|NCT01172808|79362787|FG002|Overall Study|Withdrawal by Subject|3|||
44357756|NCT01172808|79362788|FG003|Overall Study|Withdrawal by Subject|2|||
44357757|NCT01172808|79362785|FG000|Overall Study|Other|6|||
44357758|NCT01172808|79362786|FG001|Overall Study|Other|5|||
44357759|NCT01172808|79362787|FG002|Overall Study|Other|9|||
44357760|NCT01172808|79362788|FG003|Overall Study|Other|7|||
44357761|NCT01151280|79362798|FG000|Overall Study|Adverse Event|1|||
44357762|NCT01151280|79362798|FG000|Overall Study|Lack of Efficacy|3|||
44357763|NCT01149486|79362804|FG000|First Intervention|Adverse Event|0|||
44357764|NCT01149486|79362805|FG001|First Intervention|Adverse Event|1|||
44357765|NCT00601705|79362811|FG000|Overall Study|Withdrawal by Subject|1|||
44357766|NCT01179737|79362820|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
44357767|NCT01179737|79362821|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
44357768|NCT01179737|79362822|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
44357769|NCT01179737|79362823|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
44357770|NCT01179737|79362820|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
44357771|NCT01179737|79362821|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
44357772|NCT01179737|79362822|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
44357773|NCT01179737|79362823|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
44357774|NCT01179737|79362820|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
44357775|NCT01179737|79362821|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
44357776|NCT01179737|79362822|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
44357777|NCT01179737|79362823|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
44357778|NCT01179737|79362820|FG000|Cohort 1 & Cohort 2|Death|0|||
44357779|NCT01179737|79362821|FG001|Cohort 1 & Cohort 2|Death|0|||
44357780|NCT01179737|79362822|FG002|Cohort 1 & Cohort 2|Death|1|||
44357781|NCT01179737|79362823|FG003|Cohort 1 & Cohort 2|Death|0|||
44357782|NCT01179737|79362820|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
44357783|NCT01179737|79362821|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
44357784|NCT01179737|79362822|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
44357785|NCT01179737|79362823|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
44357786|NCT01179737|79362820|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
44357787|NCT01179737|79362821|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
44357788|NCT01179737|79362822|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
44357789|NCT01179737|79362823|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
44357790|NCT01179737|79362820|FG000|Extension|The study was terminated|3|||
44357791|NCT01179737|79362821|FG001|Extension|The study was terminated|0|||
44357792|NCT01179737|79362822|FG002|Extension|The study was terminated|0|||
44357793|NCT01179737|79362823|FG003|Extension|The study was terminated|0|||
44357794|NCT00929110|79362835|FG000|Overall Study|Adverse Event|40|||
44357795|NCT00929110|79362836|FG001|Overall Study|Adverse Event|29|||
44357796|NCT00929110|79362837|FG002|Overall Study|Adverse Event|18|||
44357797|NCT00929110|79362835|FG000|Overall Study|Subject withdrew consent|40|||
44357798|NCT00929110|79362836|FG001|Overall Study|Subject withdrew consent|23|||
44357799|NCT00929110|79362837|FG002|Overall Study|Subject withdrew consent|26|||
44357800|NCT00929110|79362835|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
44357801|NCT00929110|79362836|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
44357802|NCT00929110|79362837|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
44357803|NCT00929110|79362835|FG000|Overall Study|Lost to Follow-up|7|||
44357804|NCT00929110|79362836|FG001|Overall Study|Lost to Follow-up|7|||
44357805|NCT00929110|79362837|FG002|Overall Study|Lost to Follow-up|3|||
44357806|NCT00929110|79362835|FG000|Overall Study|Protocol deviation|5|||
44357807|NCT00929110|79362836|FG001|Overall Study|Protocol deviation|2|||
44357808|NCT00929110|79362837|FG002|Overall Study|Protocol deviation|4|||
44357809|NCT00929110|79362835|FG000|Overall Study|Administrative problems|4|||
44357810|NCT00929110|79362836|FG001|Overall Study|Administrative problems|1|||
44357811|NCT00929110|79362837|FG002|Overall Study|Administrative problems|2|||
44357812|NCT00929110|79362835|FG000|Overall Study|Death|2|||
44357813|NCT00929110|79362836|FG001|Overall Study|Death|2|||
44357814|NCT00929110|79362837|FG002|Overall Study|Death|2|||
44357815|NCT00929110|79362835|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44357816|NCT00929110|79362836|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44357817|NCT00929110|79362837|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44357818|NCT00929110|79362835|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44357819|NCT00929110|79362836|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44357820|NCT00929110|79362837|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44357821|NCT00929110|79362835|FG000|Overall Study|Patient inability to use the device|0|||
44357822|NCT00929110|79362836|FG001|Overall Study|Patient inability to use the device|1|||
44357823|NCT00929110|79362837|FG002|Overall Study|Patient inability to use the device|0|||
44357824|NCT01147068|79362852|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
44357825|NCT01147068|79362853|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
44357826|NCT01147068|79362854|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
44357827|NCT01147068|79362855|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
44357828|NCT01147068|79362856|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
44357829|NCT01147068|79362857|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
44357830|NCT01147068|79362858|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
44357831|NCT01147068|79362852|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
44357832|NCT01147068|79362853|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
44357833|NCT01147068|79362854|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
44357834|NCT01147068|79362855|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
44357835|NCT01147068|79362856|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
44357836|NCT01147068|79362857|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
44357837|NCT01147068|79362858|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
44357838|NCT01147068|79362852|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
44357839|NCT01147068|79362853|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
44357840|NCT01147068|79362854|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
44357841|NCT01147068|79362855|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
44357842|NCT01147068|79362856|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
44357843|NCT01147068|79362857|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
44357844|NCT01147068|79362858|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
44357845|NCT01147068|79362852|FG000|Subjects That Received 2nd Dose|Other|0|||
44357846|NCT01147068|79362853|FG001|Subjects That Received 2nd Dose|Other|3|||
44357847|NCT01147068|79362854|FG002|Subjects That Received 2nd Dose|Other|3|||
44357848|NCT01147068|79362855|FG003|Subjects That Received 2nd Dose|Other|0|||
44357849|NCT01147068|79362856|FG004|Subjects That Received 2nd Dose|Other|1|||
44357850|NCT01147068|79362857|FG005|Subjects That Received 2nd Dose|Other|0|||
44357851|NCT01147068|79362858|FG006|Subjects That Received 2nd Dose|Other|0|||
44357852|NCT01147068|79362852|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
44357853|NCT01147068|79362853|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
44357854|NCT01147068|79362854|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
44357855|NCT01147068|79362855|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
44357856|NCT01147068|79362856|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
44357857|NCT01147068|79362857|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
44357858|NCT01147068|79362858|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
44357859|NCT01147068|79362852|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
44357860|NCT01147068|79362853|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
44357861|NCT01147068|79362854|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
44357862|NCT01147068|79362855|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
44357863|NCT01147068|79362856|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
44357864|NCT01147068|79362857|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
44357865|NCT01147068|79362858|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
44357866|NCT01147068|79362852|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
44357867|NCT01147068|79362853|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
44357868|NCT01147068|79362854|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
44357869|NCT01147068|79362855|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
44357870|NCT01147068|79362856|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
44357871|NCT01147068|79362857|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
44357872|NCT01147068|79362858|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
44357873|NCT01146912|79362881|FG000|Overall Study|Already received influenza vaccination|817|||
44357874|NCT01146912|79362882|FG001|Overall Study|Already received influenza vaccination|822|||
44357875|NCT01146912|79362883|FG002|Overall Study|Already received influenza vaccination|13|||
44357876|NCT01146912|79362884|FG003|Overall Study|Already received influenza vaccination|15|||
44357877|NCT01146912|79362885|FG004|Overall Study|Already received influenza vaccination|41|||
44357878|NCT01146912|79362886|FG005|Overall Study|Already received influenza vaccination|61|||
44357879|NCT01146912|79362887|FG006|Overall Study|Already received influenza vaccination|56|||
44357880|NCT01146912|79362888|FG007|Overall Study|Already received influenza vaccination|0|||
44357881|NCT01146912|79362881|FG000|Overall Study|< 14 weeks gestational age|0|||
44357882|NCT01146912|79362882|FG001|Overall Study|< 14 weeks gestational age|0|||
44357883|NCT01146912|79362883|FG002|Overall Study|< 14 weeks gestational age|3|||
44357884|NCT01146912|79362884|FG003|Overall Study|< 14 weeks gestational age|2|||
44357885|NCT01146912|79362885|FG004|Overall Study|< 14 weeks gestational age|0|||
44357886|NCT01146912|79362886|FG005|Overall Study|< 14 weeks gestational age|0|||
44357887|NCT01146912|79362887|FG006|Overall Study|< 14 weeks gestational age|0|||
44357888|NCT01146912|79362888|FG007|Overall Study|< 14 weeks gestational age|0|||
44357889|NCT01146912|79362881|FG000|Overall Study|Duplicate patient|0|||
44357890|NCT01146912|79362882|FG001|Overall Study|Duplicate patient|0|||
44357891|NCT01146912|79362883|FG002|Overall Study|Duplicate patient|1|||
44357892|NCT01146912|79362884|FG003|Overall Study|Duplicate patient|0|||
44357893|NCT01146912|79362885|FG004|Overall Study|Duplicate patient|0|||
44357894|NCT01146912|79362886|FG005|Overall Study|Duplicate patient|0|||
44357895|NCT01146912|79362887|FG006|Overall Study|Duplicate patient|0|||
44357896|NCT01146912|79362888|FG007|Overall Study|Duplicate patient|0|||
44357897|NCT01134042|79362910|FG000|Overall Study|Adverse Event|3|||
44357898|NCT01134042|79362911|FG001|Overall Study|Adverse Event|7|||
44357899|NCT01134042|79362912|FG002|Overall Study|Adverse Event|2|||
44357900|NCT01134042|79362910|FG000|Overall Study|Lack of Efficacy|21|||
44357901|NCT01134042|79362911|FG001|Overall Study|Lack of Efficacy|6|||
44357902|NCT01134042|79362912|FG002|Overall Study|Lack of Efficacy|18|||
44357903|NCT01134042|79362910|FG000|Overall Study|Protocol Violation|5|||
44357904|NCT01134042|79362911|FG001|Overall Study|Protocol Violation|3|||
44357905|NCT01134042|79362912|FG002|Overall Study|Protocol Violation|5|||
44357906|NCT01134042|79362910|FG000|Overall Study|Lost to Follow-up|2|||
44357907|NCT01134042|79362911|FG001|Overall Study|Lost to Follow-up|0|||
44357908|NCT01134042|79362912|FG002|Overall Study|Lost to Follow-up|1|||
44357909|NCT01134042|79362910|FG000|Overall Study|Physician Decision|4|||
44357910|NCT01134042|79362911|FG001|Overall Study|Physician Decision|8|||
44357911|NCT01134042|79362912|FG002|Overall Study|Physician Decision|1|||
44357912|NCT01134042|79362910|FG000|Overall Study|Withdrawal by Subject|13|||
44357913|NCT01134042|79362911|FG001|Overall Study|Withdrawal by Subject|4|||
44357914|NCT01134042|79362912|FG002|Overall Study|Withdrawal by Subject|7|||
44357915|NCT01179347|79362923|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
44357916|NCT01179347|79362924|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
44357917|NCT01179347|79362923|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
44357918|NCT01179347|79362924|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
44357919|NCT01179347|79362923|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
44357920|NCT01179347|79362924|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
44357921|NCT01179347|79362923|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
44357922|NCT01179347|79362924|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
44357923|NCT01179347|79362923|FG000|Double-blind Period (12 Weeks)|Other|2|||
44357924|NCT01179347|79362924|FG001|Double-blind Period (12 Weeks)|Other|4|||
44357925|NCT01179347|79362923|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
44357926|NCT01179347|79362924|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
44357927|NCT01179347|79362923|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
44357928|NCT01179347|79362924|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
44357929|NCT01179347|79362923|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
44357930|NCT01179347|79362924|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
44357931|NCT01179347|79362923|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
44357932|NCT01179347|79362924|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
44357933|NCT01179347|79362923|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
44357934|NCT01179347|79362924|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
44357935|NCT01179347|79362923|FG000|Open-label Period (12 Weeks)|Other|7|||
44357936|NCT01179347|79362924|FG001|Open-label Period (12 Weeks)|Other|4|||
44357937|NCT01146288|79362934|FG000|First Intervention(1 Day)|Adverse Event|0|||
44357938|NCT01146288|79362935|FG001|First Intervention(1 Day)|Adverse Event|1|||
44357939|NCT01146054|79362942|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
44357940|NCT01146054|79362942|FG000|Overall Study|Rapid tumor progression|2|||
44357941|NCT01146054|79362942|FG000|Overall Study|Other illness precluded treatment|2|||
44357942|NCT01146054|79362942|FG000|Overall Study|Lost to Follow-up|1|||
44357943|NCT01145898|79362948|FG000|3-year Treatment|medication change by treating physician|3|||
44357944|NCT01145898|79362949|FG001|3-year Treatment|medication change by treating physician|16|||
44357945|NCT01133418|79362956|FG000|Overall Study|Lost to Follow-up|5|||
44357946|NCT01133418|79362957|FG001|Overall Study|Lost to Follow-up|6|||
44357947|NCT00931918|79362965|FG000|Overall Study|Adverse Event|4|||
44357948|NCT00931918|79362966|FG001|Overall Study|Adverse Event|6|||
44357949|NCT00931918|79362965|FG000|Overall Study|Progressive Disease|2|||
44357950|NCT00931918|79362966|FG001|Overall Study|Progressive Disease|1|||
44357951|NCT00931918|79362965|FG000|Overall Study|Symptomatic Deterioration|1|||
44357952|NCT00931918|79362966|FG001|Overall Study|Symptomatic Deterioration|0|||
44357953|NCT00931918|79362965|FG000|Overall Study|Withdrawal by Patient|3|||
44357954|NCT00931918|79362966|FG001|Overall Study|Withdrawal by Patient|4|||
44357955|NCT00931918|79362965|FG000|Overall Study|Other Reason not Specified|4|||
44357956|NCT00931918|79362966|FG001|Overall Study|Other Reason not Specified|4|||
44357957|NCT00931918|79362965|FG000|Overall Study|Did not receive study drug|3|||
44357958|NCT00931918|79362966|FG001|Overall Study|Did not receive study drug|2|||
44357959|NCT01179191|79362972|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
44357960|NCT01179191|79362972|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
44357961|NCT01179191|79362972|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
44357962|NCT01179191|79362972|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
44381497|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
44357963|NCT01179191|79362972|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
44357964|NCT01179191|79362972|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
44357965|NCT01179191|79362972|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
44357966|NCT01179191|79362972|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
44357967|NCT01179191|79362972|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
44357968|NCT01179191|79362972|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
44357969|NCT01179191|79362972|FG000|Maintenance Phase (8 Weeks)|Other|66|||
44357970|NCT01169844|79362978|FG000|Overall Study|Adverse Event|0|||
44357971|NCT01169844|79362979|FG001|Overall Study|Adverse Event|1|||
44357972|NCT01169844|79362978|FG000|Overall Study|Patient withdrew consent|4|||
44357973|NCT01169844|79362979|FG001|Overall Study|Patient withdrew consent|0|||
44357974|NCT01169844|79362978|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44357975|NCT01169844|79362979|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44357976|NCT01132482|79362987|FG000|Overall Study|Adverse Event|1|||
44357977|NCT01132482|79362988|FG001|Overall Study|Adverse Event|0|||
44357978|NCT00931762|79362994|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
44357979|NCT00931762|79362994|FG000|Overall Study|Administrative Problems|5|||
44357980|NCT00931762|79362994|FG000|Overall Study|Death|1|||
44357981|NCT00931762|79362994|FG000|Overall Study|Disease Progression|3|||
44357982|NCT00931762|79362994|FG000|Overall Study|Adverse Event (s)|11|||
44357983|NCT00931762|79362994|FG000|Overall Study|Subject withdrew consent|13|||
44357984|NCT01178411|79362998|FG000|Overall Study|Adverse Event|5|||
44357985|NCT01178411|79362998|FG000|Overall Study|Withdrawal by Subject|4|||
44357986|NCT01178411|79362998|FG000|Overall Study|Protocol Violation|1|||
44357987|NCT01178411|79362998|FG000|Overall Study|Progressive disease per RECIST|32|||
44357988|NCT01178411|79362998|FG000|Overall Study|Progressive disease per clinician|9|||
44357989|NCT01178411|79362998|FG000|Overall Study|Physician Decision|6|||
44357990|NCT01178411|79362998|FG000|Overall Study|Death|1|||
44357991|NCT01178411|79362998|FG000|Overall Study|No reason provided|1|||
44357992|NCT01178411|79362998|FG000|Overall Study|Drug manufacturing ended|1|||
44357993|NCT01145508|79363004|FG000|Overall Study|Adverse Event|1|||
44357994|NCT01145508|79363005|FG001|Overall Study|Adverse Event|0|||
44357995|NCT01145508|79363004|FG000|Overall Study|Death|1|||
44357996|NCT01145508|79363005|FG001|Overall Study|Death|0|||
44357997|NCT01145508|79363004|FG000|Overall Study|Physician Decision|2|||
44357998|NCT01145508|79363005|FG001|Overall Study|Physician Decision|1|||
44357999|NCT01145508|79363004|FG000|Overall Study|Never started treatment|1|||
44358000|NCT01145508|79363005|FG001|Overall Study|Never started treatment|1|||
44358001|NCT00931528|79363013|FG000|Overall Study|Protocol Violation|9|||
44358002|NCT00931528|79363014|FG001|Overall Study|Protocol Violation|12|||
44358003|NCT00931528|79363013|FG000|Overall Study|Withdrawal by Subject|4|||
44358004|NCT00931528|79363014|FG001|Overall Study|Withdrawal by Subject|12|||
44358005|NCT00931528|79363013|FG000|Overall Study|Lost to Follow-up|6|||
44358006|NCT00931528|79363014|FG001|Overall Study|Lost to Follow-up|13|||
44358007|NCT00931528|79363013|FG000|Overall Study|Assessment outside of Time Frame|22|||
44358008|NCT00931528|79363014|FG001|Overall Study|Assessment outside of Time Frame|23|||
44358009|NCT00975195|79363023|FG000|Overall Study|Adverse Event|108|||
44358010|NCT00975195|79363024|FG001|Overall Study|Adverse Event|101|||
44358011|NCT00975195|79363023|FG000|Overall Study|Lack of Efficacy|6|||
44358012|NCT00975195|79363024|FG001|Overall Study|Lack of Efficacy|6|||
44358013|NCT00975195|79363023|FG000|Overall Study|Protocol Violation|27|||
44358014|NCT00975195|79363024|FG001|Overall Study|Protocol Violation|23|||
44358015|NCT00975195|79363023|FG000|Overall Study|Lost to Follow-up|9|||
44358016|NCT00975195|79363024|FG001|Overall Study|Lost to Follow-up|7|||
44358017|NCT00975195|79363023|FG000|Overall Study|Withdrawal by Subject|48|||
44358018|NCT00975195|79363024|FG001|Overall Study|Withdrawal by Subject|61|||
44358019|NCT00975195|79363023|FG000|Overall Study|Other reason not defined above|29|||
44358020|NCT00975195|79363024|FG001|Overall Study|Other reason not defined above|33|||
44358021|NCT00975195|79363023|FG000|Overall Study|Not treated|1|||
44358022|NCT00975195|79363024|FG001|Overall Study|Not treated|2|||
44358023|NCT01145352|79363030|FG000|Overall Study|Found to have been registered twice|6|||
44358024|NCT01145352|79363030|FG000|Overall Study|Treated before marketing approval|4|||
44358025|NCT01145352|79363030|FG000|Overall Study|Syringe formulation was used|1|||
44358026|NCT01178099|79363038|FG000|Overall Study|Physician Decision|0|||
44358027|NCT01178099|79363039|FG001|Overall Study|Physician Decision|1|||
44358028|NCT01169532|79363049|FG000|Overall Study|Withdrawal by Subject|1|||
44358029|NCT00928564|79363055|FG000|Overall Study|Lost to Follow-up|6|||
44358030|NCT00928564|79363056|FG001|Overall Study|Lost to Follow-up|0|||
44264157|NCT04184622|79164373|FG002|Overall Study|Protocol Deviation|0|||
44358031|NCT01177943|79363064|FG000|First Intervention|Withdrawal by Subject|2|||
44358032|NCT01177943|79363065|FG001|First Intervention|Withdrawal by Subject|0|||
44358033|NCT01131312|79363074|FG000|Overall Study|Lost to Follow-up|425|||
44358034|NCT01131312|79363075|FG001|Overall Study|Lost to Follow-up|229|||
44358035|NCT01131312|79363076|FG002|Overall Study|Lost to Follow-up|351|||
44358036|NCT01177787|79363084|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
44358037|NCT01177787|79363084|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
44358038|NCT01177787|79363084|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
44358039|NCT00928486|79363096|FG000|Overall Study|Adverse Event|2|||
44358040|NCT00928486|79363096|FG000|Overall Study|Disease Progression|7|||
44358041|NCT00928486|79363096|FG000|Overall Study|Withdrawal by Subject|1|||
44358042|NCT01168596|79363102|FG000|Overall Study|Withdrawal by Subject|3|||
44358043|NCT01168596|79363103|FG001|Overall Study|Withdrawal by Subject|1|||
44358044|NCT01177553|79363111|FG000|Overall Study|babies not yet 6 months of age|1|||
44358045|NCT01177553|79363112|FG001|Overall Study|babies not yet 6 months of age|0|||
44358046|NCT00928408|79363118|FG000|Overall Study|Other|2|||
44358047|NCT00928408|79363118|FG000|Overall Study|Withdrawal by Subject|4|||
44358048|NCT00928408|79363118|FG000|Overall Study|Death|5|||
44358049|NCT00928408|79363118|FG000|Overall Study|Lost to Follow-up|12|||
44358050|NCT00928252|79363122|FG000|Overall Study|Physician Decision|3|||
44358051|NCT01177007|79363128|FG000|Overall Study|Lost to Follow-up|2|||
44358052|NCT01177007|79363128|FG000|Overall Study|Death|4|||
44358053|NCT01177007|79363128|FG000|Overall Study|Entered hospice care|5|||
44358054|NCT01177007|79363128|FG000|Overall Study|Required additional Y90 treatment|6|||
44358055|NCT01177007|79363128|FG000|Overall Study|Change in treatment modality|21|||
44358056|NCT00930982|79363136|FG000|Overall Study|Adverse Event|19|||
44358057|NCT00930982|79363137|FG001|Overall Study|Adverse Event|23|||
44358058|NCT00930982|79363136|FG000|Overall Study|Protocol Violation|1|||
44358059|NCT00930982|79363137|FG001|Overall Study|Protocol Violation|5|||
44358060|NCT00930982|79363136|FG000|Overall Study|Withdrawal by Subject|1|||
44358061|NCT00930982|79363137|FG001|Overall Study|Withdrawal by Subject|1|||
44358062|NCT01176773|79363143|FG000|Overall Study|Screen Failure|2|||
44358063|NCT01176773|79363143|FG000|Overall Study|Withdrew consent|1|||
44358064|NCT00928018|79363150|FG000|Overall Study|Withdrawal by Subject|1|||
44358065|NCT00928018|79363151|FG001|Overall Study|Withdrawal by Subject|0|||
44358066|NCT00927940|79363161|FG000|Overall Study|Death|1|||
44358067|NCT00927862|79363168|FG000|Overall Study|Missing data needed for endpt analyses|27|||
44358068|NCT00927862|79363169|FG001|Overall Study|Missing data needed for endpt analyses|45|||
44358069|NCT00976989|79363180|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
44358070|NCT00976989|79363181|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
44358071|NCT00976989|79363182|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
44358072|NCT00976989|79363180|FG000|Overall Study|Death|5|||
44358073|NCT00976989|79363181|FG001|Overall Study|Death|7|||
44358074|NCT00976989|79363182|FG002|Overall Study|Death|10|||
44358075|NCT00976989|79363180|FG000|Overall Study|Refused Treatment|4|||
44358076|NCT00976989|79363181|FG001|Overall Study|Refused Treatment|3|||
44358077|NCT00976989|79363182|FG002|Overall Study|Refused Treatment|5|||
44358078|NCT00976989|79363180|FG000|Overall Study|Failure to Return|2|||
44358079|NCT00976989|79363181|FG001|Overall Study|Failure to Return|1|||
44358080|NCT00976989|79363182|FG002|Overall Study|Failure to Return|0|||
44358081|NCT00976989|79363180|FG000|Overall Study|Recurrence of Disease|0|||
44358082|NCT00976989|79363181|FG001|Overall Study|Recurrence of Disease|1|||
44358083|NCT00976989|79363182|FG002|Overall Study|Recurrence of Disease|0|||
44358084|NCT00976989|79363180|FG000|Overall Study|Other|1|||
44358085|NCT00976989|79363181|FG001|Overall Study|Other|0|||
44358086|NCT00976989|79363182|FG002|Overall Study|Other|1|||
44358087|NCT00927784|79363192|FG000|Overall Study|Death|1|||
44358088|NCT00927784|79363193|FG001|Overall Study|Death|0|||
44358089|NCT00927784|79363192|FG000|Overall Study|Withdrawal by Subject|1|||
44358090|NCT00927784|79363193|FG001|Overall Study|Withdrawal by Subject|0|||
44358091|NCT05056987|79363210|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
44358092|NCT05056987|79363211|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
44358093|NCT05056987|79363210|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
44358094|NCT05056987|79363211|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
44358095|NCT03439852|79363231|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
44358096|NCT03439852|79363232|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
44358097|NCT03439852|79363231|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
44358098|NCT03439852|79363232|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
44358099|NCT03439852|79363231|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
44358100|NCT03439852|79363232|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
44358101|NCT03355300|79363243|FG000|Overall Study|Physician Decision|0|||
44358102|NCT03355300|79363244|FG001|Overall Study|Physician Decision|1|||
44358103|NCT03355300|79363243|FG000|Overall Study|Lack of Efficacy|2|||
44358104|NCT03355300|79363244|FG001|Overall Study|Lack of Efficacy|1|||
44358105|NCT03355300|79363243|FG000|Overall Study|Other reason|1|||
44358106|NCT03355300|79363244|FG001|Overall Study|Other reason|0|||
44358107|NCT03332056|79363252|FG000|Overall Study|Incomplete questionnaires|8|||
44358108|NCT03332056|79363253|FG001|Overall Study|Incomplete questionnaires|9|||
44358109|NCT03332056|79363252|FG000|Overall Study|Passed stone prior to surgery date|1|||
44358110|NCT03332056|79363253|FG001|Overall Study|Passed stone prior to surgery date|0|||
44358111|NCT03332056|79363252|FG000|Overall Study|Did not require a ureteral stent|0|||
44358112|NCT03332056|79363253|FG001|Overall Study|Did not require a ureteral stent|1|||
44358113|NCT03093350|79363259|FG000|Overall Study|Death|1|||
44358114|NCT03093350|79363259|FG000|Overall Study|Signed consent, never began treartment|1|||
44358115|NCT02901041|79363265|FG000|Overall Study|Withdrawal by PI|4|||
44358116|NCT02901041|79363266|FG001|Overall Study|Withdrawal by PI|8|||
44358117|NCT02901041|79363265|FG000|Overall Study|Withdrawal by Subject|7|||
44358118|NCT02901041|79363266|FG001|Overall Study|Withdrawal by Subject|3|||
44358119|NCT02547987|79363300|FG000|Overall Study|Withdrawal by Subject|1|||
44358120|NCT02547987|79363300|FG000|Overall Study|Adverse Event|2|||
44358121|NCT02513199|79363304|FG000|Treatment|Death|1|||
44358122|NCT02513199|79363304|FG000|Treatment|Lost to Follow-up|1|||
44358123|NCT02513199|79363304|FG000|Follow-Up|Death|11|||
44358124|NCT00999804|79363321|FG000|Overall Study|Lack of Efficacy|9|||
44358125|NCT00999804|79363322|FG001|Overall Study|Lack of Efficacy|2|||
44358126|NCT00999804|79363321|FG000|Overall Study|Adverse Event|4|||
44358127|NCT00999804|79363322|FG001|Overall Study|Adverse Event|3|||
44358128|NCT00999804|79363321|FG000|Overall Study|Withdrawal by Subject|4|||
44358129|NCT00999804|79363322|FG001|Overall Study|Withdrawal by Subject|0|||
44358130|NCT00999804|79363321|FG000|Overall Study|Death|1|||
44358131|NCT00999804|79363322|FG001|Overall Study|Death|0|||
44358132|NCT00999804|79363321|FG000|Overall Study|Ineligible|3|||
44358133|NCT00999804|79363322|FG001|Overall Study|Ineligible|0|||
44358134|NCT00927472|79363330|FG000|Overall Study|Withdrawal by Subject|10|||
44358135|NCT00927472|79363331|FG001|Overall Study|Withdrawal by Subject|11|||
44358136|NCT00927472|79363330|FG000|Overall Study|Lost to Follow-up|1|||
44358137|NCT00927472|79363331|FG001|Overall Study|Lost to Follow-up|6|||
44358138|NCT00927472|79363330|FG000|Overall Study|Protocol Violation|0|||
44358139|NCT00927472|79363331|FG001|Overall Study|Protocol Violation|1|||
44358140|NCT00927472|79363330|FG000|Overall Study|Post treatment Assessment out of window|0|||
44358141|NCT00927472|79363331|FG001|Overall Study|Post treatment Assessment out of window|4|||
44358142|NCT00927394|79363339|FG000|Overall Study|Adverse Event|14|||
44358143|NCT00927394|79363340|FG001|Overall Study|Adverse Event|9|||
44358144|NCT00927394|79363339|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
44358145|NCT00927394|79363340|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
44358146|NCT00927394|79363339|FG000|Overall Study|Withdrawal by Subject|20|||
44358147|NCT00927394|79363340|FG001|Overall Study|Withdrawal by Subject|24|||
44358148|NCT00927394|79363339|FG000|Overall Study|Lost to Follow-up|8|||
44358149|NCT00927394|79363340|FG001|Overall Study|Lost to Follow-up|14|||
44358150|NCT00927394|79363339|FG000|Overall Study|Administrative Problem|1|||
44358151|NCT00927394|79363340|FG001|Overall Study|Administrative Problem|0|||
44358152|NCT00927394|79363339|FG000|Overall Study|Death|1|||
44358153|NCT00927394|79363340|FG001|Overall Study|Death|1|||
44358154|NCT00927394|79363339|FG000|Overall Study|Protocol deviation|16|||
44358155|NCT00927394|79363340|FG001|Overall Study|Protocol deviation|13|||
44358156|NCT00927394|79363339|FG000|Overall Study|Randomized in error|0|||
44358157|NCT00927394|79363340|FG001|Overall Study|Randomized in error|1|||
44358158|NCT00976911|79363349|FG000|Overall Study|Withdrawal by Subject|4|||
44358159|NCT00976911|79363350|FG001|Overall Study|Withdrawal by Subject|6|||
44358160|NCT00976911|79363349|FG000|Overall Study|Death|138|||
44358161|NCT00976911|79363350|FG001|Overall Study|Death|126|||
44358162|NCT00976911|79363349|FG000|Overall Study|Adverse Event|0|||
44358163|NCT00976911|79363350|FG001|Overall Study|Adverse Event|1|||
44358164|NCT00976911|79363349|FG000|Overall Study|Protocol Violation|2|||
44358165|NCT00976911|79363350|FG001|Overall Study|Protocol Violation|0|||
44358166|NCT00976911|79363349|FG000|Overall Study|Other|8|||
44358167|NCT00976911|79363350|FG001|Overall Study|Other|9|||
44358168|NCT00976911|79363349|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
44358169|NCT00976911|79363350|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
44358170|NCT00934648|79363356|FG000|Overall Study|Failure to return|8|||
44358171|NCT00934648|79363356|FG000|Overall Study|Withdrawal by Subject|1|||
44358172|NCT01175213|79363364|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
44358173|NCT01175213|79363365|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
44358174|NCT01175213|79363364|FG000|IGSC, 10%/rHuPH20|Death|1|||
44358175|NCT01175213|79363365|FG001|IGSC, 10%/rHuPH20|Death|0|||
44358176|NCT01175213|79363364|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
44358177|NCT01175213|79363365|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
44358178|NCT01175213|79363364|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
44358179|NCT01175213|79363365|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
44358180|NCT01175213|79363364|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
44358181|NCT01175213|79363365|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
44358182|NCT01175213|79363364|FG000|Safety Follow-up|Adverse Event|1|||
44358183|NCT01175213|79363365|FG001|Safety Follow-up|Adverse Event|0|||
44358184|NCT00974259|79363376|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
44358185|NCT00974259|79363377|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
44358186|NCT00927082|79363387|FG000|Overall Study|Lost to Follow-up|9|||
44358187|NCT00927082|79363388|FG001|Overall Study|Lost to Follow-up|8|||
44358188|NCT00927082|79363389|FG002|Overall Study|Lost to Follow-up|12|||
44358189|NCT00927082|79363390|FG003|Overall Study|Lost to Follow-up|16|||
44358190|NCT00927082|79363387|FG000|Overall Study|Withdrawal by Subject|3|||
44358191|NCT00927082|79363388|FG001|Overall Study|Withdrawal by Subject|2|||
44358192|NCT00927082|79363389|FG002|Overall Study|Withdrawal by Subject|7|||
44448734|NCT00550446|79457360|FG005|Up To Week 12|Lost to Follow-up|1|||
44358193|NCT00927082|79363390|FG003|Overall Study|Withdrawal by Subject|2|||
44358194|NCT00927082|79363387|FG000|Overall Study|Death|0|||
44358195|NCT00927082|79363388|FG001|Overall Study|Death|0|||
44358196|NCT00927082|79363389|FG002|Overall Study|Death|1|||
44358197|NCT00927082|79363390|FG003|Overall Study|Death|0|||
44358198|NCT00927082|79363387|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
44358199|NCT00927082|79363388|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
44358200|NCT00927082|79363389|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
44358201|NCT00927082|79363390|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
44358202|NCT00976677|79363406|FG000|Overall Study|Adverse Event|1|||
44358203|NCT00976677|79363407|FG001|Overall Study|Adverse Event|0|||
44358204|NCT00976677|79363406|FG000|Overall Study|Withdrawal by Subject|0|||
44358205|NCT00976677|79363407|FG001|Overall Study|Withdrawal by Subject|2|||
44358206|NCT00976677|79363406|FG000|Overall Study|Disease progression|1|||
44358207|NCT00976677|79363407|FG001|Overall Study|Disease progression|1|||
44358208|NCT00976677|79363406|FG000|Overall Study|Trial unblinded|2|||
44358209|NCT00976677|79363407|FG001|Overall Study|Trial unblinded|2|||
44358210|NCT00976677|79363406|FG000|Overall Study|Unknown/Missing|1|||
44358211|NCT00976677|79363407|FG001|Overall Study|Unknown/Missing|0|||
44358212|NCT00926536|79363415|FG000|Overall Study|Physician Decision|1|||
44358213|NCT00926536|79363416|FG001|Overall Study|Physician Decision|2|||
44358214|NCT00923260|79363424|FG000|Overall Study|Lost to Follow-up|1|||
44358215|NCT00923260|79363425|FG001|Overall Study|Lost to Follow-up|1|||
44358216|NCT00934102|79363431|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
44358217|NCT00934102|79363432|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
44358218|NCT00934102|79363433|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
44358219|NCT00970281|79363452|FG000|Overall Study|Lack of Efficacy|1|||
44358220|NCT00970281|79363453|FG001|Overall Study|Lack of Efficacy|14|||
44358221|NCT00970281|79363452|FG000|Overall Study|Withdrawal by Subject|0|||
44358222|NCT00970281|79363453|FG001|Overall Study|Withdrawal by Subject|1|||
44358223|NCT00970281|79363452|FG000|Overall Study|Physician Decision|1|||
44358224|NCT00970281|79363453|FG001|Overall Study|Physician Decision|1|||
44358225|NCT00976209|79363461|FG000|Treatment Period 1|Protocol Violation|1|||
44358226|NCT00976209|79363462|FG001|Treatment Period 1|Protocol Violation|0|||
44358227|NCT00976209|79363461|FG000|Treatment Period 1|Lost to Follow-up|2|||
44358228|NCT00976209|79363462|FG001|Treatment Period 1|Lost to Follow-up|0|||
44358229|NCT00976209|79363461|FG000|Treatment Period 1|Other|0|||
44358230|NCT00976209|79363462|FG001|Treatment Period 1|Other|1|||
44358231|NCT00976209|79363461|FG000|Wash-out Period|Adverse Event|1|||
44358232|NCT00976209|79363462|FG001|Wash-out Period|Adverse Event|2|||
44358233|NCT00976209|79363461|FG000|Wash-out Period|Lost to Follow-up|1|||
44358234|NCT00976209|79363462|FG001|Wash-out Period|Lost to Follow-up|0|||
44358235|NCT00976209|79363461|FG000|Wash-out Period|Protocol Violation|1|||
44358236|NCT00976209|79363462|FG001|Wash-out Period|Protocol Violation|0|||
44358237|NCT00976209|79363461|FG000|Wash-out Period|Other|1|||
44358238|NCT00976209|79363462|FG001|Wash-out Period|Other|0|||
44358239|NCT00976209|79363461|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44358240|NCT00976209|79363462|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44358241|NCT00976209|79363461|FG000|Treatment Period 2|Lost to Follow-up|0|||
44358242|NCT00976209|79363462|FG001|Treatment Period 2|Lost to Follow-up|1|||
44358243|NCT00925990|79363469|FG000|Overall Study|Adverse Event|1|||
44358244|NCT00925990|79363470|FG001|Overall Study|Adverse Event|3|||
44358245|NCT00925990|79363469|FG000|Overall Study|Withdrawal by Subject|2|||
44358246|NCT00925990|79363470|FG001|Overall Study|Withdrawal by Subject|2|||
44358247|NCT00925990|79363469|FG000|Overall Study|Lost to Follow-up|1|||
44358248|NCT00925990|79363470|FG001|Overall Study|Lost to Follow-up|3|||
44358249|NCT00925990|79363469|FG000|Overall Study|Physician Decision|1|||
44358250|NCT00925990|79363470|FG001|Overall Study|Physician Decision|1|||
44358251|NCT00925990|79363469|FG000|Overall Study|moved out of state, missed medication|0|||
44358252|NCT00925990|79363470|FG001|Overall Study|moved out of state, missed medication|2|||
44358253|NCT01131078|79363479|FG000|Overall Study|Adverse Event|22|||
44358254|NCT01131078|79363480|FG001|Overall Study|Adverse Event|12|||
44358255|NCT01131078|79363481|FG002|Overall Study|Adverse Event|17|||
44358256|NCT01131078|79363479|FG000|Overall Study|Progressive Disease|58|||
44358257|NCT01131078|79363480|FG001|Overall Study|Progressive Disease|77|||
44358258|NCT01131078|79363481|FG002|Overall Study|Progressive Disease|71|||
44358259|NCT01131078|79363479|FG000|Overall Study|Protocol Violation|1|||
44358260|NCT01131078|79363480|FG001|Overall Study|Protocol Violation|0|||
44358261|NCT01131078|79363481|FG002|Overall Study|Protocol Violation|0|||
44358262|NCT01131078|79363479|FG000|Overall Study|Lost to Follow-up|1|||
44358263|NCT01131078|79363480|FG001|Overall Study|Lost to Follow-up|1|||
44358264|NCT01131078|79363481|FG002|Overall Study|Lost to Follow-up|1|||
44358265|NCT01131078|79363479|FG000|Overall Study|Withdrawal by Subject|2|||
44358266|NCT01131078|79363480|FG001|Overall Study|Withdrawal by Subject|4|||
44358267|NCT01131078|79363481|FG002|Overall Study|Withdrawal by Subject|3|||
44358268|NCT01131078|79363479|FG000|Overall Study|Non-compliance|3|||
44358269|NCT01131078|79363480|FG001|Overall Study|Non-compliance|0|||
44358270|NCT01131078|79363481|FG002|Overall Study|Non-compliance|0|||
44358271|NCT01131078|79363479|FG000|Overall Study|Physician Decision|10|||
44358272|NCT01131078|79363480|FG001|Overall Study|Physician Decision|6|||
44358273|NCT01131078|79363481|FG002|Overall Study|Physician Decision|8|||
44358274|NCT01131078|79363479|FG000|Overall Study|Death|4|||
44358275|NCT01131078|79363480|FG001|Overall Study|Death|0|||
44358276|NCT01131078|79363481|FG002|Overall Study|Death|2|||
44358277|NCT01131078|79363479|FG000|Overall Study|Other|0|||
44358278|NCT01131078|79363480|FG001|Overall Study|Other|1|||
44358279|NCT01131078|79363481|FG002|Overall Study|Other|0|||
44358280|NCT01167582|79363493|FG000|Overall Study|Lost to Follow-up|0|||
44358281|NCT01167582|79363494|FG001|Overall Study|Lost to Follow-up|1|||
44358282|NCT01167426|79363500|FG000|Overall Study|Lost to Follow-up|6|||
44358283|NCT01167426|79363500|FG000|Overall Study|Protocol Violation|1|||
44358284|NCT01167426|79363500|FG000|Overall Study|Withdrawal by Subject|2|||
44358285|NCT01167426|79363500|FG000|Overall Study|Sponsor Decision|1|||
44358286|NCT00922636|79363510|FG000|Overall Study|Adverse Event|3|||
44358287|NCT00922636|79363511|FG001|Overall Study|Adverse Event|3|||
44358288|NCT00922636|79363512|FG002|Overall Study|Adverse Event|2|||
44358289|NCT00922636|79363513|FG003|Overall Study|Adverse Event|3|||
44358290|NCT00922636|79363514|FG004|Overall Study|Adverse Event|2|||
44358291|NCT00922636|79363510|FG000|Overall Study|Lack of Efficacy|1|||
44358292|NCT00922636|79363511|FG001|Overall Study|Lack of Efficacy|7|||
44358293|NCT00922636|79363512|FG002|Overall Study|Lack of Efficacy|3|||
44358294|NCT00922636|79363513|FG003|Overall Study|Lack of Efficacy|2|||
44358295|NCT00922636|79363514|FG004|Overall Study|Lack of Efficacy|4|||
44358296|NCT00922636|79363510|FG000|Overall Study|Sponsor Decision|0|||
44358297|NCT00922636|79363511|FG001|Overall Study|Sponsor Decision|0|||
44358298|NCT00922636|79363512|FG002|Overall Study|Sponsor Decision|2|||
44358299|NCT00922636|79363513|FG003|Overall Study|Sponsor Decision|0|||
44358300|NCT00922636|79363514|FG004|Overall Study|Sponsor Decision|0|||
44358301|NCT00922636|79363510|FG000|Overall Study|Withdrawal by Subject|0|||
44358302|NCT00922636|79363511|FG001|Overall Study|Withdrawal by Subject|0|||
44358303|NCT00922636|79363512|FG002|Overall Study|Withdrawal by Subject|5|||
44358304|NCT00922636|79363513|FG003|Overall Study|Withdrawal by Subject|2|||
44358305|NCT00922636|79363514|FG004|Overall Study|Withdrawal by Subject|4|||
44358306|NCT00922636|79363510|FG000|Overall Study|Protocol Violation|0|||
44358307|NCT00922636|79363511|FG001|Overall Study|Protocol Violation|0|||
44358308|NCT00922636|79363512|FG002|Overall Study|Protocol Violation|2|||
44358309|NCT00922636|79363513|FG003|Overall Study|Protocol Violation|2|||
44358310|NCT00922636|79363514|FG004|Overall Study|Protocol Violation|0|||
44358311|NCT00922636|79363510|FG000|Overall Study|Entry Criteria Not Met|0|||
44358312|NCT00922636|79363511|FG001|Overall Study|Entry Criteria Not Met|0|||
44358313|NCT00922636|79363512|FG002|Overall Study|Entry Criteria Not Met|1|||
44358314|NCT00922636|79363513|FG003|Overall Study|Entry Criteria Not Met|1|||
44358315|NCT00922636|79363514|FG004|Overall Study|Entry Criteria Not Met|0|||
44358316|NCT00922636|79363510|FG000|Overall Study|Parent/Caregiver Decision|2|||
44358317|NCT00922636|79363511|FG001|Overall Study|Parent/Caregiver Decision|4|||
44358318|NCT00922636|79363512|FG002|Overall Study|Parent/Caregiver Decision|3|||
44358319|NCT00922636|79363513|FG003|Overall Study|Parent/Caregiver Decision|5|||
44358320|NCT00922636|79363514|FG004|Overall Study|Parent/Caregiver Decision|2|||
44358321|NCT00922636|79363510|FG000|Overall Study|Lost to Follow-up|1|||
44358322|NCT00922636|79363511|FG001|Overall Study|Lost to Follow-up|2|||
44358323|NCT00922636|79363512|FG002|Overall Study|Lost to Follow-up|2|||
44358324|NCT00922636|79363513|FG003|Overall Study|Lost to Follow-up|2|||
44358325|NCT00922636|79363514|FG004|Overall Study|Lost to Follow-up|4|||
44358326|NCT01175135|79363535|FG000|Overall Study|Adverse Event|2|||
44358327|NCT01175135|79363536|FG001|Overall Study|Adverse Event|5|||
44358328|NCT01175135|79363537|FG002|Overall Study|Adverse Event|3|||
44358329|NCT01175135|79363538|FG003|Overall Study|Adverse Event|4|||
44358330|NCT01175135|79363535|FG000|Overall Study|Death|1|||
44358331|NCT01175135|79363536|FG001|Overall Study|Death|0|||
44358332|NCT01175135|79363537|FG002|Overall Study|Death|0|||
44358333|NCT01175135|79363538|FG003|Overall Study|Death|0|||
44358334|NCT01175135|79363535|FG000|Overall Study|Lack of Efficacy|4|||
44358335|NCT01175135|79363536|FG001|Overall Study|Lack of Efficacy|5|||
44358336|NCT01175135|79363537|FG002|Overall Study|Lack of Efficacy|0|||
44358337|NCT01175135|79363538|FG003|Overall Study|Lack of Efficacy|5|||
44358338|NCT01175135|79363535|FG000|Overall Study|Lost to Follow-up|1|||
44358339|NCT01175135|79363536|FG001|Overall Study|Lost to Follow-up|2|||
44358340|NCT01175135|79363537|FG002|Overall Study|Lost to Follow-up|0|||
44358341|NCT01175135|79363538|FG003|Overall Study|Lost to Follow-up|0|||
44358342|NCT01175135|79363535|FG000|Overall Study|Protocol Violation|1|||
44358343|NCT01175135|79363536|FG001|Overall Study|Protocol Violation|1|||
44358344|NCT01175135|79363537|FG002|Overall Study|Protocol Violation|0|||
44358345|NCT01175135|79363538|FG003|Overall Study|Protocol Violation|0|||
44358346|NCT01175135|79363535|FG000|Overall Study|Withdrawal by Subject|4|||
44358347|NCT01175135|79363536|FG001|Overall Study|Withdrawal by Subject|8|||
44358348|NCT01175135|79363537|FG002|Overall Study|Withdrawal by Subject|5|||
44358349|NCT01175135|79363538|FG003|Overall Study|Withdrawal by Subject|5|||
44358350|NCT01175135|79363535|FG000|Overall Study|Other|3|||
44358351|NCT01175135|79363536|FG001|Overall Study|Other|1|||
44358352|NCT01175135|79363537|FG002|Overall Study|Other|3|||
44358353|NCT01175135|79363538|FG003|Overall Study|Other|0|||
44358354|NCT01175135|79363535|FG000|Overall Study|Randomized But Not Treated|0|||
44358355|NCT01175135|79363536|FG001|Overall Study|Randomized But Not Treated|0|||
44358356|NCT01175135|79363537|FG002|Overall Study|Randomized But Not Treated|1|||
44358357|NCT01175135|79363538|FG003|Overall Study|Randomized But Not Treated|0|||
44358358|NCT00922480|79363550|FG000|Main Study|Protocol Violation|3|||
44358359|NCT00922480|79363551|FG001|Main Study|Protocol Violation|6|||
44358360|NCT00922480|79363550|FG000|Main Study|Adverse Event|6|||
44358361|NCT00922480|79363551|FG001|Main Study|Adverse Event|7|||
44358362|NCT00922480|79363550|FG000|Main Study|Lack of Efficacy|3|||
44358363|NCT00922480|79363551|FG001|Main Study|Lack of Efficacy|0|||
44358364|NCT00922480|79363550|FG000|Main Study|Withdrawal by Subject|20|||
44358365|NCT00922480|79363551|FG001|Main Study|Withdrawal by Subject|15|||
44358366|NCT00922480|79363550|FG000|Main Study|Lost to Follow-up|5|||
44358367|NCT00922480|79363551|FG001|Main Study|Lost to Follow-up|0|||
44358368|NCT00922480|79363550|FG000|Main Study|Physician Decision|0|||
44358369|NCT00922480|79363551|FG001|Main Study|Physician Decision|1|||
44358370|NCT00922480|79363550|FG000|Extension Study|Protocol Violation|3|||
44358371|NCT00922480|79363551|FG001|Extension Study|Protocol Violation|0|||
44358372|NCT00922480|79363550|FG000|Extension Study|Adverse Event|1|||
44358373|NCT00922480|79363551|FG001|Extension Study|Adverse Event|1|||
44358374|NCT00922480|79363550|FG000|Extension Study|Withdrawal by Subject|1|||
44358375|NCT00922480|79363551|FG001|Extension Study|Withdrawal by Subject|1|||
44358376|NCT00922480|79363550|FG000|Extension Study|Others|0|||
44358377|NCT00922480|79363551|FG001|Extension Study|Others|1|||
44358378|NCT00973479|79363561|FG000|Overall Study|Lost to Follow-up|0|||
44358379|NCT00973479|79363562|FG001|Overall Study|Lost to Follow-up|3|||
44358380|NCT00973479|79363561|FG000|Overall Study|Death|2|||
44358381|NCT00973479|79363562|FG001|Overall Study|Death|2|||
44358382|NCT00973479|79363561|FG000|Overall Study|Withdrawal by Subject|15|||
44358383|NCT00973479|79363562|FG001|Overall Study|Withdrawal by Subject|16|||
44358384|NCT00973479|79363561|FG000|Overall Study|Lack of Efficacy|5|||
44358385|NCT00973479|79363562|FG001|Overall Study|Lack of Efficacy|7|||
44358386|NCT00973479|79363561|FG000|Overall Study|Adverse Event|12|||
44358387|NCT00973479|79363562|FG001|Overall Study|Adverse Event|32|||
44358388|NCT00973479|79363561|FG000|Overall Study|Protocol Violation|2|||
44358389|NCT00973479|79363562|FG001|Overall Study|Protocol Violation|2|||
44358390|NCT00973479|79363561|FG000|Overall Study|Other|1|||
44358391|NCT00973479|79363562|FG001|Overall Study|Other|7|||
44358392|NCT01173653|79363572|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
44358393|NCT01173653|79363573|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
44358394|NCT01172873|79363581|FG000|Overall Study|Withdrawal by Subject|3|||
44358395|NCT01172873|79363582|FG001|Overall Study|Withdrawal by Subject|2|||
44358396|NCT00925600|79363594|FG000|Overall Study|Withdrawal by Subject|16|||
44358397|NCT00925600|79363595|FG001|Overall Study|Withdrawal by Subject|14|||
44358398|NCT00925600|79363594|FG000|Overall Study|Death|4|||
44358399|NCT00925600|79363595|FG001|Overall Study|Death|3|||
44358400|NCT00925600|79363594|FG000|Overall Study|Lost to Follow-up|2|||
44358401|NCT00925600|79363595|FG001|Overall Study|Lost to Follow-up|2|||
44358402|NCT00925600|79363594|FG000|Overall Study|Disease Progression|1|||
44358403|NCT00925600|79363595|FG001|Overall Study|Disease Progression|3|||
44358404|NCT00925600|79363594|FG000|Overall Study|Administrative Decision|1|||
44358405|NCT00925600|79363595|FG001|Overall Study|Administrative Decision|1|||
44358406|NCT00925600|79363594|FG000|Overall Study|Noncompliance|2|||
44358407|NCT00925600|79363595|FG001|Overall Study|Noncompliance|0|||
44358408|NCT00925600|79363594|FG000|Overall Study|Ineligibility Determined|2|||
44358409|NCT00925600|79363595|FG001|Overall Study|Ineligibility Determined|0|||
44358410|NCT00925600|79363594|FG000|Overall Study|Protocol Deviation|0|||
44358411|NCT00925600|79363595|FG001|Overall Study|Protocol Deviation|1|||
44358412|NCT00925600|79363594|FG000|Overall Study|Requirement for Alternative Therapy|0|||
44358413|NCT00925600|79363595|FG001|Overall Study|Requirement for Alternative Therapy|1|||
44358414|NCT00925600|79363594|FG000|Overall Study|Other|3|||
44358415|NCT00925600|79363595|FG001|Overall Study|Other|1|||
44358416|NCT00925600|79363594|FG000|Overall Study|Adverse Event|1|||
44358417|NCT00925600|79363595|FG001|Overall Study|Adverse Event|2|||
44358418|NCT00968253|79363608|FG000|Overall Study|Death|0|||
44358419|NCT00968253|79363609|FG001|Overall Study|Death|0|||
44358420|NCT00968253|79363610|FG002|Overall Study|Death|2|||
44358421|NCT00968253|79363608|FG000|Overall Study|Withdrawal by Subject|0|||
44358422|NCT00968253|79363609|FG001|Overall Study|Withdrawal by Subject|0|||
44358423|NCT00968253|79363610|FG002|Overall Study|Withdrawal by Subject|1|||
44358424|NCT00968253|79363608|FG000|Overall Study|Disease Progression|0|||
44358425|NCT00968253|79363609|FG001|Overall Study|Disease Progression|3|||
44358426|NCT00968253|79363610|FG002|Overall Study|Disease Progression|3|||
44358427|NCT00968253|79363608|FG000|Overall Study|Adverse Event|0|||
44358428|NCT00968253|79363609|FG001|Overall Study|Adverse Event|0|||
44358429|NCT00968253|79363610|FG002|Overall Study|Adverse Event|1|||
44358430|NCT00964743|79363619|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
44358431|NCT00925522|79363623|FG000|Overall Study|study closed -- business decision|20|||
44358432|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
44358433|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
44358434|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
44358435|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
44358436|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
44358437|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
44358438|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
44358439|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
44358440|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
44358441|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
44358442|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
44358443|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
44358444|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
44358445|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
44358446|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
44358447|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
44358448|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
44358449|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
44358450|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
44358451|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
44358452|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
44358453|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
44358454|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
44358455|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
44358456|NCT01130532|79363630|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
44358457|NCT01130532|79363631|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
44358458|NCT01130532|79363632|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
44358459|NCT01130532|79363633|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
44358460|NCT01130532|79363630|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
44358461|NCT01130532|79363631|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
44358462|NCT01130532|79363632|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
44358463|NCT01130532|79363633|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
44358464|NCT01130532|79363630|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
44358465|NCT01130532|79363631|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
44358466|NCT01130532|79363632|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
44358467|NCT01130532|79363633|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
44358468|NCT01130532|79363630|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
44358469|NCT01130532|79363631|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
44358470|NCT01130532|79363632|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
44358471|NCT01130532|79363633|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
44358472|NCT01130532|79363630|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
44358473|NCT01130532|79363631|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
44358474|NCT01130532|79363632|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
44358475|NCT01130532|79363633|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
44358476|NCT00972777|79363647|FG000|Overall Study|Adverse Event|3|||
44358477|NCT00972777|79363648|FG001|Overall Study|Adverse Event|2|||
44358478|NCT00972777|79363647|FG000|Overall Study|Lost to Follow-up|0|||
44358479|NCT00972777|79363648|FG001|Overall Study|Lost to Follow-up|4|||
44358480|NCT00972777|79363647|FG000|Overall Study|Withdrawal by Subject|4|||
44358481|NCT00972777|79363648|FG001|Overall Study|Withdrawal by Subject|5|||
44358482|NCT00972777|79363647|FG000|Overall Study|Physician Decision|4|||
44358483|NCT00972777|79363648|FG001|Overall Study|Physician Decision|0|||
44358484|NCT00972777|79363647|FG000|Overall Study|Protocol Violation|0|||
44358485|NCT00972777|79363648|FG001|Overall Study|Protocol Violation|2|||
44358486|NCT00972777|79363647|FG000|Overall Study|Screening Failure|2|||
44264158|NCT04184622|79164374|FG003|Overall Study|Protocol Deviation|0|||
44264159|NCT04184622|79164371|FG000|Overall Study|Withdrawal by Subject|68|||
44264160|NCT04184622|79164372|FG001|Overall Study|Withdrawal by Subject|28|||
44264161|NCT04184622|79164373|FG002|Overall Study|Withdrawal by Subject|29|||
44264162|NCT04184622|79164374|FG003|Overall Study|Withdrawal by Subject|22|||
44264163|NCT03772717|79164407|FG000|Overall Study|Withdrawal by Subject|2|||
44264164|NCT03770403|79164411|FG000|Overall Study|Adverse Event|8|||
44264165|NCT03770403|79164411|FG000|Overall Study|Death|5|||
44264166|NCT03770403|79164411|FG000|Overall Study|Physician Decision|1|||
44264167|NCT03770403|79164411|FG000|Overall Study|Sponsor decision|1|||
44264168|NCT03770403|79164411|FG000|Overall Study|Study terminated by Sponsor|1|||
44264169|NCT03770403|79164411|FG000|Overall Study|Withdrawal by Subject|13|||
44264170|NCT03770403|79164411|FG000|Overall Study|Other|88|||
44264171|NCT03740100|79164415|FG000|Overall Study|Adverse Event|1|||
44264172|NCT03740100|79164415|FG000|Overall Study|Death|1|||
44264173|NCT03499795|79164419|FG000|Overall Study|Adverse Event|1|||
44264174|NCT03499795|79164419|FG000|Overall Study|Lost to Follow-up|1|||
44264175|NCT03456700|79164436|FG000|Overall Study|Withdrawal by Subject|1|||
44264176|NCT03401450|79164442|FG000|Overall Study|Lost to Follow-up|4|||
44264177|NCT03401450|79164443|FG001|Overall Study|Lost to Follow-up|6|||
44358487|NCT00972777|79363648|FG001|Overall Study|Screening Failure|1|||
44358488|NCT00972777|79363647|FG000|Overall Study|Missed visit|1|||
44358489|NCT00972777|79363648|FG001|Overall Study|Missed visit|0|||
44358490|NCT00918736|79363654|FG000|Overall Study|Withdrawal by Subject|4|||
44358491|NCT01172639|79363663|FG000|Overall Study|Death|1|||
44358492|NCT01172639|79363664|FG001|Overall Study|Death|1|||
44358493|NCT01172639|79363665|FG002|Overall Study|Death|0|||
44358494|NCT01172639|79363666|FG003|Overall Study|Death|0|||
44358495|NCT01172639|79363667|FG004|Overall Study|Death|0|||
44358496|NCT01172639|79363663|FG000|Overall Study|Lost to Follow-up|9|||
44358497|NCT01172639|79363664|FG001|Overall Study|Lost to Follow-up|7|||
44358498|NCT01172639|79363665|FG002|Overall Study|Lost to Follow-up|11|||
44358499|NCT01172639|79363666|FG003|Overall Study|Lost to Follow-up|6|||
44358500|NCT01172639|79363667|FG004|Overall Study|Lost to Follow-up|6|||
44358501|NCT01172639|79363663|FG000|Overall Study|Withdrawal by Subject|3|||
44358502|NCT01172639|79363664|FG001|Overall Study|Withdrawal by Subject|3|||
44358503|NCT01172639|79363665|FG002|Overall Study|Withdrawal by Subject|5|||
44358504|NCT01172639|79363666|FG003|Overall Study|Withdrawal by Subject|5|||
44358505|NCT01172639|79363667|FG004|Overall Study|Withdrawal by Subject|0|||
44358506|NCT01144182|79363681|FG000|Overall Study|Death|5|||
44358507|NCT01144182|79363682|FG001|Overall Study|Death|6|||
44358508|NCT01144182|79363681|FG000|Overall Study|Withdrawal by Subject|3|||
44358509|NCT01144182|79363682|FG001|Overall Study|Withdrawal by Subject|6|||
44358510|NCT01144182|79363681|FG000|Overall Study|Lost to Follow-up|9|||
44358511|NCT01144182|79363682|FG001|Overall Study|Lost to Follow-up|9|||
44358512|NCT01225562|79363692|FG000|Overall Study|Withdrawal by Subject|52|||
44358513|NCT01225562|79363693|FG001|Overall Study|Withdrawal by Subject|50|||
44358514|NCT01225562|79363694|FG002|Overall Study|Withdrawal by Subject|52|||
44358515|NCT01225562|79363692|FG000|Overall Study|Lost to Follow-up|3|||
44358516|NCT01225562|79363693|FG001|Overall Study|Lost to Follow-up|6|||
44358517|NCT01225562|79363694|FG002|Overall Study|Lost to Follow-up|1|||
44358518|NCT00925288|79363704|FG000|Overall Study|Lost to Follow-up|9|||
44358519|NCT00925288|79363705|FG001|Overall Study|Lost to Follow-up|7|||
44358520|NCT01143714|79363715|FG000|Overall Study|Adverse Event|4|||
44358521|NCT01143714|79363716|FG001|Overall Study|Adverse Event|2|||
44358522|NCT01143714|79363715|FG000|Overall Study|Withdrawal by Subject|1|||
44358523|NCT01143714|79363716|FG001|Overall Study|Withdrawal by Subject|0|||
44358524|NCT01143714|79363715|FG000|Overall Study|Subject non-compliance|0|||
44358525|NCT01143714|79363716|FG001|Overall Study|Subject non-compliance|1|||
44358526|NCT01143714|79363715|FG000|Overall Study|wound closed = deemed healed|1|||
44358527|NCT01143714|79363716|FG001|Overall Study|wound closed = deemed healed|0|||
44358528|NCT01143714|79363715|FG000|Overall Study|wound size increased|1|||
44358529|NCT01143714|79363716|FG001|Overall Study|wound size increased|0|||
44358530|NCT00972543|79363737|FG000|Overall Study|Adverse Event|1|||
44358531|NCT00972543|79363738|FG001|Overall Study|Adverse Event|0|||
44358532|NCT00972543|79363737|FG000|Overall Study|Early study termination by sponsor|4|||
44358533|NCT00972543|79363738|FG001|Overall Study|Early study termination by sponsor|1|||
44358534|NCT00925132|79363744|FG000|Overall Study|Withdrawal by Subject|2|||
44358535|NCT00925132|79363745|FG001|Overall Study|Withdrawal by Subject|0|||
44358536|NCT00925132|79363746|FG002|Overall Study|Withdrawal by Subject|0|||
44358537|NCT00925132|79363747|FG003|Overall Study|Withdrawal by Subject|0|||
44358538|NCT00925132|79363748|FG004|Overall Study|Withdrawal by Subject|1|||
44358539|NCT00925132|79363744|FG000|Overall Study|Removed due to disease progression|0|||
44358540|NCT00925132|79363745|FG001|Overall Study|Removed due to disease progression|0|||
44358541|NCT00925132|79363746|FG002|Overall Study|Removed due to disease progression|0|||
44358542|NCT00925132|79363747|FG003|Overall Study|Removed due to disease progression|0|||
44358543|NCT00925132|79363748|FG004|Overall Study|Removed due to disease progression|4|||
44358544|NCT01143402|79363757|FG000|Overall Study|Rapid clinical decline|1|||
44358545|NCT01143402|79363758|FG001|Overall Study|Rapid clinical decline|1|||
44358546|NCT01143402|79363759|FG002|Overall Study|Rapid clinical decline|0|||
44358547|NCT01143402|79363757|FG000|Overall Study|Not Treated|0|||
44358548|NCT01143402|79363758|FG001|Overall Study|Not Treated|0|||
44358549|NCT01143402|79363759|FG002|Overall Study|Not Treated|1|||
44358550|NCT01171625|79363766|FG000|Overall Study|On-Protocol|67|||
44358551|NCT01171625|79363766|FG000|Overall Study|Death|38|||
44358552|NCT01171625|79363766|FG000|Overall Study|Withdrawal by Subject|31|||
44358553|NCT01171625|79363766|FG000|Overall Study|Explanted|10|||
44358554|NCT01171625|79363766|FG000|Overall Study|Lost to Follow-up|5|||
44358555|NCT01171625|79363766|FG000|Overall Study|Patient received valve-in-valve|3|||
44358556|NCT01171625|79363766|FG000|Overall Study|Other|1|||
44358557|NCT01171625|79363766|FG000|Overall Study|Consented but did not receive device|25|||
44358558|NCT00924898|79363778|FG000|Overall Study|Withdrawal by Subject|2|||
44358559|NCT01167192|79363787|FG000|Overall Study|Adverse Event|1|||
44358560|NCT01167192|79363787|FG000|Overall Study|Death|1|||
44358561|NCT01167192|79363787|FG000|Overall Study|Withdrawal by Subject|1|||
44358562|NCT01167192|79363787|FG000|Overall Study|Insurance denial|1|||
44358563|NCT01166958|79363793|FG000|Overall Study|Withdrawal by Subject|1|||
44358564|NCT01166958|79363794|FG001|Overall Study|Withdrawal by Subject|0|||
44358565|NCT01170221|79363802|FG000|Overall Study|Lost to Follow-up|22|||
44358566|NCT01170221|79363803|FG001|Overall Study|Lost to Follow-up|21|||
44358567|NCT01170221|79363802|FG000|Overall Study|Withdrawal by Subject|9|||
44358568|NCT01170221|79363803|FG001|Overall Study|Withdrawal by Subject|7|||
44358569|NCT01170221|79363802|FG000|Overall Study|Subject completed only screening and LFU|1|||
44358570|NCT01170221|79363803|FG001|Overall Study|Subject completed only screening and LFU|0|||
44358571|NCT01170221|79363802|FG000|Overall Study|Randomized but not treated|1|||
44358572|NCT01170221|79363803|FG001|Overall Study|Randomized but not treated|0|||
44358573|NCT01166646|79363811|FG000|Overall Study|Protocol Violation|0|||
44358574|NCT01166646|79363812|FG001|Overall Study|Protocol Violation|1|||
44358575|NCT01166646|79363811|FG000|Overall Study|Adverse Event|1|||
44358576|NCT01166646|79363812|FG001|Overall Study|Adverse Event|0|||
44358577|NCT01129284|79363821|FG000|Overall Study|Adverse Event|2|||
44358578|NCT01129284|79363822|FG001|Overall Study|Adverse Event|0|||
44358579|NCT01129284|79363823|FG002|Overall Study|Adverse Event|1|||
44358580|NCT01166568|79363834|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
44358581|NCT01166568|79363835|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
44358582|NCT01166568|79363836|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
44358583|NCT01166568|79363834|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
44358584|NCT01166568|79363835|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
44358585|NCT01166568|79363836|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
44358586|NCT01166568|79363834|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
44358587|NCT01166568|79363835|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
44358588|NCT01166568|79363836|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
44358589|NCT01166178|79363844|FG000|Overall Study|Withdrawal by Subject|1|||
44358590|NCT01166178|79363845|FG001|Overall Study|Withdrawal by Subject|0|||
44358591|NCT01166178|79363844|FG000|Overall Study|Study was terminated|20|||
44358592|NCT01166178|79363845|FG001|Overall Study|Study was terminated|8|||
44358593|NCT00924820|79363851|FG000|Overall Study|Death|2|||
44358594|NCT00924820|79363851|FG000|Overall Study|Ineligible, Screen Failure|5|||
44358595|NCT01225172|79363857|FG000|Overall Study|Subject decision to stop|1|||
44358596|NCT01225172|79363858|FG001|Overall Study|Subject decision to stop|0|||
44358597|NCT01225172|79363857|FG000|Overall Study|Subject request to discontinue treatment|3|||
44358598|NCT01225172|79363858|FG001|Overall Study|Subject request to discontinue treatment|1|||
44358599|NCT01225172|79363857|FG000|Overall Study|Subject no longer meets study criteria|1|||
44358600|NCT01225172|79363858|FG001|Overall Study|Subject no longer meets study criteria|0|||
44358601|NCT01225172|79363857|FG000|Overall Study|Withdrawal by Subject|1|||
44358602|NCT01225172|79363858|FG001|Overall Study|Withdrawal by Subject|0|||
44358603|NCT01143324|79363864|FG000|Overall Study|Lost to Follow-up|11|||
44358604|NCT01143324|79363864|FG000|Overall Study|Withdrawal by Subject|4|||
44358605|NCT01143324|79363864|FG000|Overall Study|Explant of the device|4|||
44358606|NCT01224782|79363868|FG000|Overall Study|Lost to Follow-up|177|||
44358607|NCT01224782|79363868|FG000|Overall Study|Withdrawal by Subject|16|||
44358608|NCT01224782|79363868|FG000|Overall Study|Death|14|||
44358609|NCT01224782|79363868|FG000|Overall Study|Improvement|13|||
44358610|NCT01224782|79363868|FG000|Overall Study|Adverse Event|12|||
44358611|NCT01224782|79363868|FG000|Overall Study|Adverse Reaction|11|||
44358612|NCT01224782|79363868|FG000|Overall Study|Noncompliance|10|||
44358613|NCT01224782|79363868|FG000|Overall Study|Other|4|||
44358614|NCT01224782|79363868|FG000|Overall Study|Start of Dialysis|3|||
44358615|NCT01224782|79363868|FG000|Overall Study|Change of Treatment|1|||
44358616|NCT01224782|79363868|FG000|Overall Study|Financial Reasons|1|||
44358617|NCT01224782|79363868|FG000|Overall Study|Deterioration|1|||
44358618|NCT01224782|79363868|FG000|Overall Study|Transplantation|1|||
44358619|NCT01224158|79363874|FG000|Overall Study|Withdrawal by Subject|1|||
44358620|NCT01224158|79363875|FG001|Overall Study|Withdrawal by Subject|0|||
44358621|NCT01129128|79363884|FG000|Overall Study|Lost to Follow-up|2|||
44358622|NCT01129128|79363885|FG001|Overall Study|Lost to Follow-up|2|||
44358623|NCT01129128|79363886|FG002|Overall Study|Lost to Follow-up|1|||
44358624|NCT01129128|79363884|FG000|Overall Study|Protocol Violation|0|||
44358625|NCT01129128|79363885|FG001|Overall Study|Protocol Violation|1|||
44358626|NCT01129128|79363886|FG002|Overall Study|Protocol Violation|0|||
44358627|NCT01129128|79363884|FG000|Overall Study|Withdrawal by Subject|0|||
44358628|NCT01129128|79363885|FG001|Overall Study|Withdrawal by Subject|1|||
44358629|NCT01129128|79363886|FG002|Overall Study|Withdrawal by Subject|3|||
44358630|NCT01129128|79363884|FG000|Overall Study|Physician Decision|1|||
44358631|NCT01129128|79363885|FG001|Overall Study|Physician Decision|0|||
44358632|NCT01129128|79363886|FG002|Overall Study|Physician Decision|0|||
44358633|NCT01222520|79363896|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
44358634|NCT01222520|79363897|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
44448735|NCT00550446|79457361|FG006|Up To Week 12|Lost to Follow-up|2|||
44358635|NCT01222520|79363896|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
44358636|NCT01222520|79363897|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
44358637|NCT01222520|79363896|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
44448736|NCT00550446|79457362|FG007|Up To Week 12|Lost to Follow-up|0|||
44358638|NCT01222520|79363897|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
44358639|NCT01222520|79363896|FG000|Double-blind Period|Adverse Event|0|||
44358640|NCT01222520|79363897|FG001|Double-blind Period|Adverse Event|1|||
44358641|NCT01222520|79363896|FG000|Double-blind Period|Lack of Efficacy|0|||
44358642|NCT01222520|79363897|FG001|Double-blind Period|Lack of Efficacy|1|||
44358643|NCT01222520|79363896|FG000|Double-blind Period|Study medication stolen|1|||
44358644|NCT01222520|79363897|FG001|Double-blind Period|Study medication stolen|0|||
44358645|NCT01221350|79363905|FG000|Overall Study|Discontinued intervention (GERD)|1|||
44358646|NCT01221350|79363906|FG001|Overall Study|Discontinued intervention (GERD)|0|||
44358647|NCT01221350|79363905|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
44358648|NCT01221350|79363906|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
44358649|NCT01221350|79363905|FG000|Overall Study|Withdrawal by Subject|4|||
44358650|NCT01221350|79363906|FG001|Overall Study|Withdrawal by Subject|2|||
44358651|NCT01221272|79363914|FG000|Period 1|Adverse Event|2|||
44358652|NCT01221272|79363915|FG001|Period 1|Adverse Event|0|||
44358653|NCT01221272|79363914|FG000|Period 1|Consent Withdrawal|0|||
44358654|NCT01221272|79363915|FG001|Period 1|Consent Withdrawal|1|||
44358655|NCT01221272|79363914|FG000|Period 1|Significant Dosing Noncompliance|0|||
44358656|NCT01221272|79363915|FG001|Period 1|Significant Dosing Noncompliance|1|||
44358657|NCT01221272|79363914|FG000|Period 2|Adverse Event|0|||
44358658|NCT01221272|79363915|FG001|Period 2|Adverse Event|2|||
44358659|NCT01220414|79363926|FG000|Overall Study|Withdrawal by Subject|1|||
44358660|NCT01220414|79363927|FG001|Overall Study|Withdrawal by Subject|0|||
44358661|NCT01220414|79363928|FG002|Overall Study|Withdrawal by Subject|0|||
44358662|NCT01220414|79363929|FG003|Overall Study|Withdrawal by Subject|1|||
44358663|NCT01128894|79363938|FG000|Overall Study|Adverse Event|31|||
44358664|NCT01128894|79363939|FG001|Overall Study|Adverse Event|41|||
44358665|NCT01128894|79363938|FG000|Overall Study|Protocol Violation|2|||
44358666|NCT01128894|79363939|FG001|Overall Study|Protocol Violation|1|||
44358667|NCT01128894|79363938|FG000|Overall Study|Noncompliance|4|||
44358668|NCT01128894|79363939|FG001|Overall Study|Noncompliance|5|||
44358669|NCT01128894|79363938|FG000|Overall Study|Lost to Follow-up|8|||
44358670|NCT01128894|79363939|FG001|Overall Study|Lost to Follow-up|8|||
44358671|NCT01128894|79363938|FG000|Overall Study|Withdrawal by Subject|10|||
44358672|NCT01128894|79363939|FG001|Overall Study|Withdrawal by Subject|12|||
44358673|NCT01128894|79363938|FG000|Overall Study|Physician Decision|2|||
44358674|NCT01128894|79363939|FG001|Overall Study|Physician Decision|1|||
44358675|NCT01128894|79363938|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
44358676|NCT01128894|79363939|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
44358677|NCT01220180|79363948|FG000|Overall Study|Lost to Follow-up|76|||
44358678|NCT01220180|79363948|FG000|Overall Study|Other|72|||
44358679|NCT01220180|79363948|FG000|Overall Study|Adverse Event|35|||
44358680|NCT01220180|79363948|FG000|Overall Study|Lack of Efficacy|22|||
44358681|NCT01220180|79363948|FG000|Overall Study|Death|1|||
44358682|NCT01220180|79363948|FG000|Overall Study|Randomized but not treated|1|||
44358683|NCT01220024|79363954|FG000|Overall Study|Lost to Follow-up|1|||
44358684|NCT01220024|79363955|FG001|Overall Study|Lost to Follow-up|1|||
44358685|NCT01128738|79363963|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
44358686|NCT01128738|79363964|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
44358687|NCT01128738|79363963|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
44358688|NCT01128738|79363964|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
44358689|NCT01128738|79363963|FG000|Second TP|Lost to Follow-up|0|||
44358690|NCT01128738|79363964|FG001|Second TP|Lost to Follow-up|1|||
44358691|NCT01128738|79363963|FG000|Second TP|Withdrawal by Subject|0|||
44358692|NCT01128738|79363964|FG001|Second TP|Withdrawal by Subject|2|||
44358693|NCT01143090|79363971|FG000|Overall Study|Lack of Efficacy|2|||
44358694|NCT01143090|79363971|FG000|Overall Study|Adverse Event|17|||
44358695|NCT01143090|79363971|FG000|Overall Study|Lost to Follow-up|9|||
44358696|NCT01143090|79363971|FG000|Overall Study|Protocol Violation|2|||
44358697|NCT01143090|79363971|FG000|Overall Study|Withdrawal by Subject|18|||
44358698|NCT01143090|79363971|FG000|Overall Study|Non-compliance with study drug|1|||
44358699|NCT01143090|79363971|FG000|Overall Study|Failure to meet eligibility criteria|1|||
44358700|NCT01143090|79363971|FG000|Overall Study|Administrative|1|||
44358701|NCT01165554|79363975|FG000|Overall Study|Withdrawal by Subject|23|||
44358702|NCT01218308|79363984|FG000|Overall Study|Adverse Event|1|||
44358703|NCT01218308|79363985|FG001|Overall Study|Adverse Event|2|||
44358704|NCT01218308|79363984|FG000|Overall Study|Protocol Violation|0|||
44358705|NCT01218308|79363985|FG001|Overall Study|Protocol Violation|2|||
44358706|NCT01218308|79363984|FG000|Overall Study|Withdrawal by Subject|61|||
44358707|NCT01218308|79363985|FG001|Overall Study|Withdrawal by Subject|64|||
44358708|NCT01218308|79363984|FG000|Overall Study|Lost to Follow-up|27|||
44358709|NCT01218308|79363985|FG001|Overall Study|Lost to Follow-up|31|||
44358710|NCT01218308|79363984|FG000|Overall Study|Other|14|||
44358711|NCT01218308|79363985|FG001|Overall Study|Other|21|||
44358712|NCT01165320|79363993|FG000|Overall Study|Clinical adverse experience|2|||
44358713|NCT01165320|79363994|FG001|Overall Study|Clinical adverse experience|1|||
44358714|NCT01165320|79363995|FG002|Overall Study|Clinical adverse experience|0|||
44358715|NCT01165320|79363993|FG000|Overall Study|Laboratory adverse experience|1|||
44358716|NCT01165320|79363994|FG001|Overall Study|Laboratory adverse experience|0|||
44358717|NCT01165320|79363995|FG002|Overall Study|Laboratory adverse experience|0|||
44358718|NCT01165320|79363993|FG000|Overall Study|Lack of Efficacy|0|||
44358719|NCT01165320|79363994|FG001|Overall Study|Lack of Efficacy|2|||
44358720|NCT01165320|79363995|FG002|Overall Study|Lack of Efficacy|0|||
44358721|NCT01165320|79363993|FG000|Overall Study|Reason unknown|0|||
44358722|NCT01165320|79363994|FG001|Overall Study|Reason unknown|1|||
44358723|NCT01165320|79363995|FG002|Overall Study|Reason unknown|0|||
44358724|NCT01217606|79364003|FG000|Initial Treatment Phase|Other Reasons|0|||
44358725|NCT01217606|79364004|FG001|Initial Treatment Phase|Other Reasons|2|||
44358726|NCT01217606|79364003|FG000|Initial Treatment Phase|Protocol Violation|3|||
44358727|NCT01217606|79364004|FG001|Initial Treatment Phase|Protocol Violation|2|||
44358728|NCT01217606|79364003|FG000|Initial Treatment Phase|Personal Reasons|0|||
44358729|NCT01217606|79364004|FG001|Initial Treatment Phase|Personal Reasons|2|||
44358730|NCT01217606|79364003|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
44358731|NCT01217606|79364004|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
44358732|NCT01217606|79364003|FG000|Initial Treatment Phase|Adverse Event|10|||
44358733|NCT01217606|79364004|FG001|Initial Treatment Phase|Adverse Event|6|||
44358734|NCT01217606|79364003|FG000|9-Month Masked Extension|Adverse Event|3|||
44358735|NCT01217606|79364004|FG001|9-Month Masked Extension|Adverse Event|6|||
44358736|NCT01217606|79364003|FG000|9-Month Masked Extension|Other Reasons|4|||
44358737|NCT01217606|79364004|FG001|9-Month Masked Extension|Other Reasons|4|||
44358738|NCT01217606|79364003|FG000|9-Month Masked Extension|Personal Reasons|2|||
44358739|NCT01217606|79364004|FG001|9-Month Masked Extension|Personal Reasons|1|||
44358740|NCT01217606|79364003|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
44358741|NCT01217606|79364004|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
44358742|NCT01217606|79364003|FG000|9-Month Masked Extension|Pregnancy|1|||
44358743|NCT01217606|79364004|FG001|9-Month Masked Extension|Pregnancy|0|||
44358744|NCT01217606|79364003|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
44358745|NCT01217606|79364004|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
44358746|NCT01128114|79364010|FG000|Overall Study|Treatment Withdrawn|6|||
44358747|NCT01128114|79364010|FG000|Overall Study|Screening Failed|2|||
44358748|NCT01217060|79364014|FG000|Overall Study|Withdrawal by Subject|1|||
44358749|NCT04816669|79364022|FG000|Part 1|Adverse Event|1|||
44358750|NCT04816669|79364023|FG001|Part 1|Adverse Event|1|||
44358751|NCT04816669|79364024|FG002|Part 1|Adverse Event|0|||
44358752|NCT04816669|79364025|FG003|Part 1|Adverse Event|0|||
44358753|NCT04816669|79364022|FG000|Part 1|Lost to Follow-up|2|||
44358754|NCT04816669|79364023|FG001|Part 1|Lost to Follow-up|2|||
44358755|NCT04816669|79364024|FG002|Part 1|Lost to Follow-up|0|||
44358756|NCT04816669|79364025|FG003|Part 1|Lost to Follow-up|0|||
44358757|NCT04816669|79364022|FG000|Part 1|Protocol Violation|0|||
44358758|NCT04816669|79364023|FG001|Part 1|Protocol Violation|1|||
44358759|NCT04816669|79364024|FG002|Part 1|Protocol Violation|0|||
44358760|NCT04816669|79364025|FG003|Part 1|Protocol Violation|0|||
44358761|NCT04816669|79364022|FG000|Part 1|Withdrawal by Subject|1|||
44358762|NCT04816669|79364023|FG001|Part 1|Withdrawal by Subject|2|||
44358763|NCT04816669|79364024|FG002|Part 1|Withdrawal by Subject|0|||
44358764|NCT04816669|79364025|FG003|Part 1|Withdrawal by Subject|0|||
44358765|NCT04816669|79364022|FG000|Part 2|Other|0|||
44358766|NCT04816669|79364023|FG001|Part 2|Other|0|||
44358767|NCT04816669|79364024|FG002|Part 2|Other|1|||
44358768|NCT04816669|79364025|FG003|Part 2|Other|0|||
44358769|NCT04816669|79364022|FG000|Part 2|Withdrawal by Subject|0|||
44358770|NCT04816669|79364023|FG001|Part 2|Withdrawal by Subject|0|||
44358771|NCT04816669|79364024|FG002|Part 2|Withdrawal by Subject|0|||
44358772|NCT04816669|79364025|FG003|Part 2|Withdrawal by Subject|1|||
44358773|NCT04816669|79364022|FG000|Part 2|Lost to Follow-up|0|||
44358774|NCT04816669|79364023|FG001|Part 2|Lost to Follow-up|0|||
44358775|NCT04816669|79364024|FG002|Part 2|Lost to Follow-up|1|||
44358776|NCT04816669|79364025|FG003|Part 2|Lost to Follow-up|0|||
44358777|NCT01165242|79364042|FG000|Overall Study|Unreachable Subjects|1|||
44358778|NCT01165242|79364043|FG001|Overall Study|Unreachable Subjects|0|||
44143667|NCT00271817|78932990|FG002|Part 1|Withdrawal by Subject|45|||
44358779|NCT01165242|79364044|FG002|Overall Study|Unreachable Subjects|0|||
44358780|NCT01165242|79364042|FG000|Overall Study|Incarcerated Subjects|0|||
44358781|NCT01165242|79364043|FG001|Overall Study|Incarcerated Subjects|1|||
44358782|NCT01165242|79364044|FG002|Overall Study|Incarcerated Subjects|0|||
44358783|NCT01165242|79364042|FG000|Overall Study|Visit 2 Declined by Subject|0|||
44358784|NCT01165242|79364043|FG001|Overall Study|Visit 2 Declined by Subject|0|||
44358785|NCT01165242|79364044|FG002|Overall Study|Visit 2 Declined by Subject|1|||
44358786|NCT01165242|79364042|FG000|Overall Study|Withdrawal by Subject|0|||
44358787|NCT01165242|79364043|FG001|Overall Study|Withdrawal by Subject|2|||
44358788|NCT01165242|79364044|FG002|Overall Study|Withdrawal by Subject|2|||
44358789|NCT01165242|79364042|FG000|Overall Study|Extended Holiday|0|||
44358790|NCT01165242|79364043|FG001|Overall Study|Extended Holiday|0|||
44358791|NCT01165242|79364044|FG002|Overall Study|Extended Holiday|1|||
44358792|NCT01165242|79364042|FG000|Overall Study|Lost to Follow-up|9|||
44358793|NCT01165242|79364043|FG001|Overall Study|Lost to Follow-up|7|||
44358794|NCT01165242|79364044|FG002|Overall Study|Lost to Follow-up|10|||
44358795|NCT01170065|79364057|FG000|Overall Study|Adverse Event|17|||
44358796|NCT01170065|79364058|FG001|Overall Study|Adverse Event|50|||
44358797|NCT01170065|79364059|FG002|Overall Study|Adverse Event|10|||
44358798|NCT01170065|79364057|FG000|Overall Study|Lost to Follow-up|1|||
44358799|NCT01170065|79364058|FG001|Overall Study|Lost to Follow-up|4|||
44358800|NCT01170065|79364059|FG002|Overall Study|Lost to Follow-up|1|||
44358801|NCT01170065|79364057|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
44358802|NCT01170065|79364058|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
44358803|NCT01170065|79364059|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
44358804|NCT01170065|79364057|FG000|Overall Study|Reason other than specified|3|||
44358805|NCT01170065|79364058|FG001|Overall Study|Reason other than specified|8|||
44358806|NCT01170065|79364059|FG002|Overall Study|Reason other than specified|3|||
44358807|NCT01170065|79364057|FG000|Overall Study|Ongoing after planned observation time|5|||
44358808|NCT01170065|79364058|FG001|Overall Study|Ongoing after planned observation time|26|||
44358809|NCT01170065|79364059|FG002|Overall Study|Ongoing after planned observation time|10|||
44358810|NCT00966693|79364071|FG000|Overall Study|Adverse Event|0|||
44358811|NCT00966693|79364072|FG001|Overall Study|Adverse Event|0|||
44358812|NCT00966693|79364073|FG002|Overall Study|Adverse Event|1|||
44358813|NCT00966693|79364074|FG003|Overall Study|Adverse Event|2|||
44358814|NCT00966693|79364071|FG000|Overall Study|Death|0|||
44358815|NCT00966693|79364072|FG001|Overall Study|Death|0|||
44358816|NCT00966693|79364073|FG002|Overall Study|Death|1|||
44358817|NCT00966693|79364074|FG003|Overall Study|Death|0|||
44358818|NCT00966693|79364071|FG000|Overall Study|Withdrawal by Subject|1|||
44358819|NCT00966693|79364072|FG001|Overall Study|Withdrawal by Subject|0|||
44358820|NCT00966693|79364073|FG002|Overall Study|Withdrawal by Subject|0|||
44358821|NCT00966693|79364074|FG003|Overall Study|Withdrawal by Subject|5|||
44358822|NCT00966693|79364071|FG000|Overall Study|Disease Progression|0|||
44358823|NCT00966693|79364072|FG001|Overall Study|Disease Progression|0|||
44358824|NCT00966693|79364073|FG002|Overall Study|Disease Progression|1|||
44358825|NCT00966693|79364074|FG003|Overall Study|Disease Progression|16|||
44358826|NCT01215968|79364086|FG000|Overall Study|Adverse Event|0|||
44358827|NCT01215968|79364087|FG001|Overall Study|Adverse Event|2|||
44358828|NCT01215968|79364086|FG000|Overall Study|Protocol Violation|2|||
44358829|NCT01215968|79364087|FG001|Overall Study|Protocol Violation|4|||
44358830|NCT01215968|79364086|FG000|Overall Study|Not received study drug|0|||
44358831|NCT01215968|79364087|FG001|Overall Study|Not received study drug|1|||
44358832|NCT00963807|79364096|FG000|Overall Study|Physician Decision|2|||
44358833|NCT00963807|79364096|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
44358834|NCT00963807|79364096|FG000|Overall Study|Disease progression|15|||
44358835|NCT01142466|79364104|FG000|Overall Study|Adverse Event|2|||
44358836|NCT01142466|79364105|FG001|Overall Study|Adverse Event|1|||
44358837|NCT01142466|79364104|FG000|Overall Study|Withdrawal by Subject|1|||
44358838|NCT01142466|79364105|FG001|Overall Study|Withdrawal by Subject|1|||
44358839|NCT01215734|79364113|FG000|Overall Study|Death|0|||
44358840|NCT01215734|79364114|FG001|Overall Study|Death|1|||
44358841|NCT01169987|79364120|FG000|Overall Study|Withdrawal by Subject|3|||
44358842|NCT01169987|79364120|FG000|Overall Study|Lost to Follow-up|24|||
44358843|NCT01169987|79364120|FG000|Overall Study|Other|4|||
44358844|NCT01215422|79364134|FG000|Overall Study|Relocation|1|||
44358845|NCT01215422|79364135|FG001|Overall Study|Relocation|0|||
44358846|NCT01215422|79364136|FG002|Overall Study|Relocation|0|||
44358847|NCT01215422|79364137|FG003|Overall Study|Relocation|0|||
44358848|NCT01215422|79364134|FG000|Overall Study|Failed intubations|0|||
44358849|NCT01215422|79364135|FG001|Overall Study|Failed intubations|0|||
44358850|NCT01215422|79364136|FG002|Overall Study|Failed intubations|3|||
44358851|NCT01215422|79364137|FG003|Overall Study|Failed intubations|8|||
44358852|NCT01215422|79364134|FG000|Overall Study|Did not complete all intubations|7|||
44358853|NCT01215422|79364135|FG001|Overall Study|Did not complete all intubations|0|||
44358854|NCT01215422|79364136|FG002|Overall Study|Did not complete all intubations|0|||
44358855|NCT01215422|79364137|FG003|Overall Study|Did not complete all intubations|0|||
44358856|NCT00972153|79364162|FG000|Overall Study|Equipment malfunction during case|0|||
44358857|NCT00972153|79364163|FG001|Overall Study|Equipment malfunction during case|1|||
44358858|NCT00972153|79364164|FG002|Overall Study|Equipment malfunction during case|0|||
44358859|NCT00971997|79364172|FG000|Overall Study|Adverse Event|2|||
44358860|NCT00971997|79364172|FG000|Overall Study|Death|1|||
44358861|NCT00971997|79364172|FG000|Overall Study|Protocol Violation|4|||
44358862|NCT00971997|79364172|FG000|Overall Study|Withdrawal by Subject|5|||
44358863|NCT00971997|79364172|FG000|Overall Study|Physician Decision|7|||
44358864|NCT01127646|79364181|FG000|Overall Study|Entry Criteria Not Met|1|||
44358865|NCT01127646|79364182|FG001|Overall Study|Entry Criteria Not Met|0|||
44358866|NCT01127646|79364181|FG000|Overall Study|Protocol Violation|0|||
44358867|NCT01127646|79364182|FG001|Overall Study|Protocol Violation|1|||
44358868|NCT01215188|79364193|FG000|Overall Study|Lost to Follow-up|22|||
44358869|NCT01215188|79364194|FG001|Overall Study|Lost to Follow-up|22|||
44358870|NCT01215188|79364195|FG002|Overall Study|Lost to Follow-up|16|||
44358871|NCT01215188|79364193|FG000|Overall Study|Adverse Event|1|||
44358872|NCT01215188|79364194|FG001|Overall Study|Adverse Event|1|||
44358873|NCT01215188|79364195|FG002|Overall Study|Adverse Event|3|||
44358874|NCT01215188|79364193|FG000|Overall Study|Physician Decision|2|||
44358875|NCT01215188|79364194|FG001|Overall Study|Physician Decision|1|||
44358876|NCT01215188|79364195|FG002|Overall Study|Physician Decision|0|||
44358877|NCT01215188|79364193|FG000|Overall Study|Lack of Efficacy|0|||
44358878|NCT01215188|79364194|FG001|Overall Study|Lack of Efficacy|0|||
44358879|NCT01215188|79364195|FG002|Overall Study|Lack of Efficacy|1|||
44358880|NCT01215188|79364193|FG000|Overall Study|Protocol Violation|1|||
44358881|NCT01215188|79364194|FG001|Overall Study|Protocol Violation|1|||
44358882|NCT01215188|79364195|FG002|Overall Study|Protocol Violation|1|||
44358883|NCT01215188|79364193|FG000|Overall Study|Withdrawal by Subject|32|||
44358884|NCT01215188|79364194|FG001|Overall Study|Withdrawal by Subject|34|||
44358885|NCT01215188|79364195|FG002|Overall Study|Withdrawal by Subject|31|||
44358886|NCT01215032|79364203|FG000|Overall Study|Adverse Event|3|||
44358887|NCT01215032|79364203|FG000|Overall Study|Lack of Efficacy|17|||
44358888|NCT00962247|79364209|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
44358889|NCT00962247|79364209|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
44358890|NCT00918580|79364215|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
44358891|NCT00918580|79364215|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
44358892|NCT00918580|79364215|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
44358893|NCT00918580|79364215|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
44358894|NCT00918580|79364215|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
44358895|NCT00918580|79364215|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
44358896|NCT00918580|79364215|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
44358897|NCT00920686|79364225|FG000|Overall Study|Lost to Follow-up|2|||
44358898|NCT00920686|79364226|FG001|Overall Study|Lost to Follow-up|3|||
44358899|NCT00920686|79364227|FG002|Overall Study|Lost to Follow-up|1|||
44358900|NCT00920686|79364225|FG000|Overall Study|Study drug dosing criteria not met|17|||
44358901|NCT00920686|79364226|FG001|Overall Study|Study drug dosing criteria not met|19|||
44358902|NCT00920686|79364227|FG002|Overall Study|Study drug dosing criteria not met|12|||
44358903|NCT01214720|79364241|FG000|Overall Study|Alive and still on treatment|34|||
44358904|NCT01214720|79364242|FG001|Overall Study|Alive and still on treatment|18|||
44358905|NCT01214720|79364241|FG000|Overall Study|Alive and in follow-up|45|||
44358906|NCT01214720|79364242|FG001|Overall Study|Alive and in follow-up|48|||
44358907|NCT01214720|79364241|FG000|Overall Study|Lost to Follow-up|6|||
44358908|NCT01214720|79364242|FG001|Overall Study|Lost to Follow-up|2|||
44358909|NCT01142232|79364253|FG000|Overall Study|Adverse Event|1|||
44358910|NCT01142232|79364254|FG001|Overall Study|Adverse Event|2|||
44358911|NCT01142232|79364255|FG002|Overall Study|Adverse Event|1|||
44358912|NCT01142232|79364256|FG003|Overall Study|Adverse Event|0|||
44358913|NCT01142232|79364257|FG004|Overall Study|Adverse Event|4|||
44358914|NCT01142232|79364253|FG000|Overall Study|Death|0|||
44358915|NCT01142232|79364254|FG001|Overall Study|Death|0|||
44358916|NCT01142232|79364255|FG002|Overall Study|Death|0|||
44358917|NCT01142232|79364256|FG003|Overall Study|Death|0|||
44358918|NCT01142232|79364257|FG004|Overall Study|Death|1|||
44358919|NCT01142232|79364253|FG000|Overall Study|Disease Progression|2|||
44358920|NCT01142232|79364254|FG001|Overall Study|Disease Progression|0|||
44358921|NCT01142232|79364255|FG002|Overall Study|Disease Progression|1|||
44358922|NCT01142232|79364256|FG003|Overall Study|Disease Progression|2|||
44358923|NCT01142232|79364257|FG004|Overall Study|Disease Progression|12|||
44358924|NCT01142232|79364253|FG000|Overall Study|Withdrawal by Subject|0|||
44358925|NCT01142232|79364254|FG001|Overall Study|Withdrawal by Subject|0|||
44358926|NCT01142232|79364255|FG002|Overall Study|Withdrawal by Subject|0|||
44358927|NCT01142232|79364256|FG003|Overall Study|Withdrawal by Subject|1|||
44358928|NCT01142232|79364257|FG004|Overall Study|Withdrawal by Subject|3|||
44358929|NCT01142232|79364253|FG000|Overall Study|Physician Decision|0|||
44358930|NCT01142232|79364254|FG001|Overall Study|Physician Decision|1|||
44358931|NCT01142232|79364255|FG002|Overall Study|Physician Decision|0|||
44358932|NCT01142232|79364256|FG003|Overall Study|Physician Decision|2|||
44358933|NCT01142232|79364257|FG004|Overall Study|Physician Decision|10|||
44358934|NCT01142232|79364253|FG000|Overall Study|Alternative Therapy|0|||
44358935|NCT01142232|79364254|FG001|Overall Study|Alternative Therapy|1|||
44358936|NCT01142232|79364255|FG002|Overall Study|Alternative Therapy|1|||
44358937|NCT01142232|79364256|FG003|Overall Study|Alternative Therapy|0|||
44358938|NCT01142232|79364257|FG004|Overall Study|Alternative Therapy|1|||
44358939|NCT01142232|79364253|FG000|Overall Study|Off Trt for other complicating disease|0|||
44358940|NCT01142232|79364254|FG001|Overall Study|Off Trt for other complicating disease|0|||
44358941|NCT01142232|79364255|FG002|Overall Study|Off Trt for other complicating disease|0|||
44358942|NCT01142232|79364256|FG003|Overall Study|Off Trt for other complicating disease|0|||
44358943|NCT01142232|79364257|FG004|Overall Study|Off Trt for other complicating disease|1|||
44358944|NCT01142232|79364253|FG000|Overall Study|Noncompliance|0|||
44358945|NCT01142232|79364254|FG001|Overall Study|Noncompliance|0|||
44358946|NCT01142232|79364255|FG002|Overall Study|Noncompliance|0|||
44358947|NCT01142232|79364256|FG003|Overall Study|Noncompliance|0|||
44358948|NCT01142232|79364257|FG004|Overall Study|Noncompliance|2|||
44358949|NCT01140906|79364273|FG000|Overall Study|Adverse Event|7|||
44358950|NCT01140906|79364274|FG001|Overall Study|Adverse Event|10|||
44358951|NCT01140906|79364275|FG002|Overall Study|Adverse Event|17|||
44358952|NCT01140906|79364276|FG003|Overall Study|Adverse Event|7|||
44358953|NCT01140906|79364273|FG000|Overall Study|Lack of Efficacy|6|||
44358954|NCT01140906|79364274|FG001|Overall Study|Lack of Efficacy|8|||
44358955|NCT01140906|79364275|FG002|Overall Study|Lack of Efficacy|2|||
44358956|NCT01140906|79364276|FG003|Overall Study|Lack of Efficacy|1|||
44358957|NCT01140906|79364273|FG000|Overall Study|Non-compliance|0|||
44358958|NCT01140906|79364274|FG001|Overall Study|Non-compliance|1|||
44358959|NCT01140906|79364275|FG002|Overall Study|Non-compliance|0|||
44358960|NCT01140906|79364276|FG003|Overall Study|Non-compliance|1|||
44358961|NCT01140906|79364273|FG000|Overall Study|Protocol Violation|5|||
44358962|NCT01140906|79364274|FG001|Overall Study|Protocol Violation|3|||
44358963|NCT01140906|79364275|FG002|Overall Study|Protocol Violation|2|||
44358964|NCT01140906|79364276|FG003|Overall Study|Protocol Violation|1|||
44358965|NCT01140906|79364273|FG000|Overall Study|Withdrawal of consent|6|||
44358966|NCT01140906|79364274|FG001|Overall Study|Withdrawal of consent|6|||
44358967|NCT01140906|79364275|FG002|Overall Study|Withdrawal of consent|2|||
44358968|NCT01140906|79364276|FG003|Overall Study|Withdrawal of consent|2|||
44358969|NCT01140906|79364273|FG000|Overall Study|Lost to Follow-up|1|||
44358970|NCT01140906|79364274|FG001|Overall Study|Lost to Follow-up|1|||
44358971|NCT01140906|79364275|FG002|Overall Study|Lost to Follow-up|0|||
44358972|NCT01140906|79364276|FG003|Overall Study|Lost to Follow-up|2|||
44358973|NCT01140906|79364273|FG000|Overall Study|Administrative or other reason|0|||
44358974|NCT01140906|79364274|FG001|Overall Study|Administrative or other reason|5|||
44358975|NCT01140906|79364275|FG002|Overall Study|Administrative or other reason|3|||
44358976|NCT01140906|79364276|FG003|Overall Study|Administrative or other reason|2|||
44358977|NCT00962091|79364293|FG000|Overall Study|Withdrawal by Subject|1|||
44358978|NCT00962091|79364294|FG001|Overall Study|Withdrawal by Subject|2|||
44358979|NCT00962091|79364295|FG002|Overall Study|Withdrawal by Subject|1|||
44358980|NCT00962091|79364296|FG003|Overall Study|Withdrawal by Subject|1|||
44358981|NCT00962091|79364297|FG004|Overall Study|Withdrawal by Subject|0|||
44358982|NCT00962091|79364298|FG005|Overall Study|Withdrawal by Subject|1|||
44358983|NCT00962091|79364299|FG006|Overall Study|Withdrawal by Subject|0|||
44358984|NCT00962091|79364293|FG000|Overall Study|Adverse Event|0|||
44358985|NCT00962091|79364294|FG001|Overall Study|Adverse Event|0|||
44358986|NCT00962091|79364295|FG002|Overall Study|Adverse Event|0|||
44358987|NCT00962091|79364296|FG003|Overall Study|Adverse Event|0|||
44358988|NCT00962091|79364297|FG004|Overall Study|Adverse Event|0|||
44358989|NCT00962091|79364298|FG005|Overall Study|Adverse Event|0|||
44358990|NCT00962091|79364299|FG006|Overall Study|Adverse Event|1|||
44358991|NCT01163916|79364326|FG000|Overall Study|Withdrawal by Subject|2|||
44358992|NCT01163916|79364327|FG001|Overall Study|Withdrawal by Subject|0|||
44358993|NCT01163916|79364328|FG002|Overall Study|Withdrawal by Subject|2|||
44358994|NCT01163916|79364326|FG000|Overall Study|Adverse Event|2|||
44358995|NCT01163916|79364327|FG001|Overall Study|Adverse Event|0|||
44358996|NCT01163916|79364328|FG002|Overall Study|Adverse Event|1|||
44358997|NCT01163916|79364326|FG000|Overall Study|Lack of Efficacy|2|||
44358998|NCT01163916|79364327|FG001|Overall Study|Lack of Efficacy|0|||
44358999|NCT01163916|79364328|FG002|Overall Study|Lack of Efficacy|1|||
44359000|NCT01163916|79364326|FG000|Overall Study|Other|24|||
44359001|NCT01163916|79364327|FG001|Overall Study|Other|4|||
44359002|NCT01163916|79364328|FG002|Overall Study|Other|16|||
44359003|NCT01122576|79364344|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
44359004|NCT01122576|79364345|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
44359005|NCT01122576|79364346|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
44359006|NCT01122576|79364344|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
44359007|NCT01122576|79364345|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
44359008|NCT01122576|79364346|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
44359009|NCT01122576|79364344|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
44359010|NCT01122576|79364345|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
44359011|NCT01122576|79364346|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
44359012|NCT00965523|79364357|FG000|Study 221|Progressive Disease|4|||
44359013|NCT00965523|79364357|FG000|Study 221|Physician Decision|3|||
44359014|NCT00965523|79364357|FG000|Study 224|Progressive Disease|5|||
44359015|NCT00965523|79364357|FG000|Study 224|Physician Decision|1|||
44359016|NCT01122264|79364364|FG000|Overall Study|Adverse Event|6|||
44359017|NCT01122264|79364365|FG001|Overall Study|Adverse Event|5|||
44359018|NCT01122264|79364366|FG002|Overall Study|Adverse Event|7|||
44359019|NCT01122264|79364364|FG000|Overall Study|Death|1|||
44359020|NCT01122264|79364365|FG001|Overall Study|Death|0|||
44359021|NCT01122264|79364366|FG002|Overall Study|Death|0|||
44359022|NCT01122264|79364364|FG000|Overall Study|Lost to Follow-up|5|||
44359023|NCT01122264|79364365|FG001|Overall Study|Lost to Follow-up|9|||
44359024|NCT01122264|79364366|FG002|Overall Study|Lost to Follow-up|13|||
44359025|NCT01122264|79364364|FG000|Overall Study|Entry Criteria Not Met|1|||
44359026|NCT01122264|79364365|FG001|Overall Study|Entry Criteria Not Met|0|||
44359027|NCT01122264|79364366|FG002|Overall Study|Entry Criteria Not Met|0|||
44359028|NCT01122264|79364364|FG000|Overall Study|Protocol Violation|7|||
44359029|NCT01122264|79364365|FG001|Overall Study|Protocol Violation|7|||
44359030|NCT01122264|79364366|FG002|Overall Study|Protocol Violation|9|||
44359031|NCT01122264|79364364|FG000|Overall Study|Withdrawal by Subject|6|||
44359032|NCT01122264|79364365|FG001|Overall Study|Withdrawal by Subject|6|||
44359033|NCT01122264|79364366|FG002|Overall Study|Withdrawal by Subject|16|||
44359034|NCT01122264|79364364|FG000|Overall Study|Physician Decision|3|||
44359035|NCT01122264|79364365|FG001|Overall Study|Physician Decision|1|||
44359036|NCT01122264|79364366|FG002|Overall Study|Physician Decision|1|||
44359037|NCT01122264|79364364|FG000|Overall Study|Lack of Efficacy|3|||
44359038|NCT01122264|79364365|FG001|Overall Study|Lack of Efficacy|1|||
44359039|NCT01122264|79364366|FG002|Overall Study|Lack of Efficacy|1|||
44359040|NCT00920218|79364382|FG000|Overall Study|Serious Adverse Event|2|||
44359041|NCT00920218|79364383|FG001|Overall Study|Serious Adverse Event|0|||
44359042|NCT00920218|79364384|FG002|Overall Study|Serious Adverse Event|2|||
44359043|NCT00920218|79364385|FG003|Overall Study|Serious Adverse Event|1|||
44359044|NCT00920218|79364382|FG000|Overall Study|Withdrawal by Subject|0|||
44359045|NCT00920218|79364383|FG001|Overall Study|Withdrawal by Subject|3|||
44359046|NCT00920218|79364384|FG002|Overall Study|Withdrawal by Subject|2|||
44359047|NCT00920218|79364385|FG003|Overall Study|Withdrawal by Subject|0|||
44359048|NCT00920218|79364382|FG000|Overall Study|Migrated/moved from study area|0|||
44359049|NCT00920218|79364383|FG001|Overall Study|Migrated/moved from study area|0|||
44359050|NCT00920218|79364384|FG002|Overall Study|Migrated/moved from study area|1|||
44359051|NCT00920218|79364385|FG003|Overall Study|Migrated/moved from study area|0|||
44359052|NCT00920218|79364382|FG000|Overall Study|Lost to Follow-up|0|||
44359053|NCT00920218|79364383|FG001|Overall Study|Lost to Follow-up|1|||
44359054|NCT00920218|79364384|FG002|Overall Study|Lost to Follow-up|0|||
44359055|NCT00920218|79364385|FG003|Overall Study|Lost to Follow-up|3|||
44359056|NCT00920218|79364382|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
44359057|NCT00920218|79364383|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
44359058|NCT00920218|79364384|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
44359059|NCT00920218|79364385|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
44359060|NCT00920218|79364382|FG000|Overall Study|Other|0|||
44359061|NCT00920218|79364383|FG001|Overall Study|Other|0|||
44359062|NCT00920218|79364384|FG002|Overall Study|Other|1|||
44359063|NCT00920218|79364385|FG003|Overall Study|Other|0|||
44359064|NCT01121562|79364399|FG000|Overall Study|Objective progression or relapse|8|||
44359065|NCT01121562|79364399|FG000|Overall Study|Withdrawal by Subject|1|||
44359066|NCT01121562|79364399|FG000|Overall Study|Adverse Event|1|||
44359067|NCT01121562|79364399|FG000|Overall Study|Sponsor Decision|1|||
44359068|NCT01121562|79364399|FG000|Overall Study|Met study discontinuation criteria|1|||
44359069|NCT01121484|79364405|FG000|Overall Study|Adverse Event|12|||
44359070|NCT01121484|79364406|FG001|Overall Study|Adverse Event|5|||
44359071|NCT01121484|79364405|FG000|Overall Study|Lack of Efficacy|3|||
44359072|NCT01121484|79364406|FG001|Overall Study|Lack of Efficacy|11|||
44359073|NCT01121484|79364405|FG000|Overall Study|Lost to Follow-up|5|||
44359074|NCT01121484|79364406|FG001|Overall Study|Lost to Follow-up|9|||
44359075|NCT01121484|79364405|FG000|Overall Study|Physician Decision|0|||
44359076|NCT01121484|79364406|FG001|Overall Study|Physician Decision|3|||
44359077|NCT01121484|79364405|FG000|Overall Study|Protocol Violation|1|||
44359078|NCT01121484|79364406|FG001|Overall Study|Protocol Violation|0|||
44359079|NCT01121484|79364405|FG000|Overall Study|Withdrawal by Subject|8|||
44359080|NCT01121484|79364406|FG001|Overall Study|Withdrawal by Subject|7|||
44359081|NCT01121484|79364405|FG000|Overall Study|Discontinuation of study by sponsor|0|||
44359082|NCT01121484|79364406|FG001|Overall Study|Discontinuation of study by sponsor|1|||
44359083|NCT01121484|79364405|FG000|Overall Study|Other|3|||
44359084|NCT01121484|79364406|FG001|Overall Study|Other|3|||
44359085|NCT01121484|79364405|FG000|Overall Study|Randomized, not treated|1|||
44359086|NCT01121484|79364406|FG001|Overall Study|Randomized, not treated|4|||
44359087|NCT01169675|79364417|FG000|Overall Study|Progressive disease|13|||
44359088|NCT01169675|79364418|FG001|Overall Study|Progressive disease|2|||
44359089|NCT01169675|79364419|FG002|Overall Study|Progressive disease|5|||
44359090|NCT01169675|79364420|FG003|Overall Study|Progressive disease|15|||
44359091|NCT01169675|79364421|FG004|Overall Study|Progressive disease|1|||
44359092|NCT01169675|79364417|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44359093|NCT01169675|79364418|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44359094|NCT01169675|79364419|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44359095|NCT01169675|79364420|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44359096|NCT01169675|79364421|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
44359097|NCT01169675|79364417|FG000|Overall Study|Adverse Event|5|||
44359098|NCT01169675|79364418|FG001|Overall Study|Adverse Event|1|||
44359099|NCT01169675|79364419|FG002|Overall Study|Adverse Event|2|||
44359100|NCT01169675|79364420|FG003|Overall Study|Adverse Event|0|||
44359101|NCT01169675|79364421|FG004|Overall Study|Adverse Event|0|||
44359102|NCT01169675|79364417|FG000|Overall Study|Withdrawal by Subject|1|||
44359103|NCT01169675|79364418|FG001|Overall Study|Withdrawal by Subject|0|||
44359104|NCT01169675|79364419|FG002|Overall Study|Withdrawal by Subject|0|||
44359105|NCT01169675|79364420|FG003|Overall Study|Withdrawal by Subject|1|||
44359106|NCT01169675|79364421|FG004|Overall Study|Withdrawal by Subject|2|||
44359107|NCT01169675|79364417|FG000|Overall Study|Other Reason Not Defined Above|0|||
44359108|NCT01169675|79364418|FG001|Overall Study|Other Reason Not Defined Above|0|||
44359109|NCT01169675|79364419|FG002|Overall Study|Other Reason Not Defined Above|0|||
44359110|NCT01169675|79364420|FG003|Overall Study|Other Reason Not Defined Above|1|||
44359111|NCT01169675|79364421|FG004|Overall Study|Other Reason Not Defined Above|1|||
44359112|NCT00924664|79364435|FG000|Overall Study|Adverse Event|23|||
44359113|NCT00924664|79364436|FG001|Overall Study|Adverse Event|39|||
44359114|NCT00924664|79364435|FG000|Overall Study|Lack of Efficacy|10|||
44359115|NCT00924664|79364436|FG001|Overall Study|Lack of Efficacy|15|||
44359116|NCT00924664|79364435|FG000|Overall Study|Lost to Follow-up|10|||
44359117|NCT00924664|79364436|FG001|Overall Study|Lost to Follow-up|12|||
44359118|NCT00924664|79364435|FG000|Overall Study|Withdrawal by Subject|47|||
44359119|NCT00924664|79364436|FG001|Overall Study|Withdrawal by Subject|71|||
44359120|NCT00924664|79364435|FG000|Overall Study|Protocol Violation|2|||
44359121|NCT00924664|79364436|FG001|Overall Study|Protocol Violation|5|||
44359122|NCT00924664|79364435|FG000|Overall Study|Pregnancy|1|||
44359123|NCT00924664|79364436|FG001|Overall Study|Pregnancy|1|||
44359124|NCT00924664|79364435|FG000|Overall Study|Death|0|||
44359125|NCT00924664|79364436|FG001|Overall Study|Death|2|||
44359126|NCT00924664|79364435|FG000|Overall Study|Study terminated by sponsor|199|||
44359127|NCT00924664|79364436|FG001|Overall Study|Study terminated by sponsor|330|||
44359128|NCT00924664|79364435|FG000|Overall Study|Other|29|||
44359129|NCT00924664|79364436|FG001|Overall Study|Other|52|||
44359130|NCT00924664|79364435|FG000|Overall Study|Randomized but not Treated|1|||
44359131|NCT00924664|79364436|FG001|Overall Study|Randomized but not Treated|0|||
44359132|NCT00600067|79364444|FG000|Overall Study|Adverse Event|0|||
44359133|NCT00600067|79364445|FG001|Overall Study|Adverse Event|1|||
44359134|NCT00600067|79364444|FG000|Overall Study|Lost to Follow-up|2|||
44359135|NCT00600067|79364445|FG001|Overall Study|Lost to Follow-up|3|||
44359136|NCT00600067|79364444|FG000|Overall Study|protocol non-compliance|0|||
44359137|NCT00600067|79364445|FG001|Overall Study|protocol non-compliance|3|||
44359138|NCT00600067|79364444|FG000|Overall Study|Lack of Efficacy|1|||
44359139|NCT00600067|79364445|FG001|Overall Study|Lack of Efficacy|0|||
44359140|NCT00970593|79364459|FG000|Overall Study|Adverse Event|1|||
44359141|NCT00970593|79364460|FG001|Overall Study|Adverse Event|1|||
44359142|NCT00970593|79364461|FG002|Overall Study|Adverse Event|0|||
44359143|NCT00970593|79364462|FG003|Overall Study|Adverse Event|0|||
44359144|NCT00970593|79364463|FG004|Overall Study|Adverse Event|0|||
44359145|NCT00970593|79364464|FG005|Overall Study|Adverse Event|0|||
44359146|NCT00970593|79364465|FG006|Overall Study|Adverse Event|0|||
44359147|NCT00970593|79364459|FG000|Overall Study|Discontinuation of study by sponsor|0|||
44359148|NCT00970593|79364460|FG001|Overall Study|Discontinuation of study by sponsor|0|||
44359149|NCT00970593|79364461|FG002|Overall Study|Discontinuation of study by sponsor|5|||
44359150|NCT00970593|79364462|FG003|Overall Study|Discontinuation of study by sponsor|0|||
44359151|NCT00970593|79364463|FG004|Overall Study|Discontinuation of study by sponsor|0|||
44359152|NCT00970593|79364464|FG005|Overall Study|Discontinuation of study by sponsor|0|||
44359153|NCT00970593|79364465|FG006|Overall Study|Discontinuation of study by sponsor|2|||
44359154|NCT00970593|79364459|FG000|Overall Study|Withdrawal by Subject|0|||
44359155|NCT00970593|79364460|FG001|Overall Study|Withdrawal by Subject|0|||
44359156|NCT00970593|79364461|FG002|Overall Study|Withdrawal by Subject|1|||
44359157|NCT00970593|79364462|FG003|Overall Study|Withdrawal by Subject|0|||
44359158|NCT00970593|79364463|FG004|Overall Study|Withdrawal by Subject|0|||
44359159|NCT00970593|79364464|FG005|Overall Study|Withdrawal by Subject|0|||
44359160|NCT00970593|79364465|FG006|Overall Study|Withdrawal by Subject|0|||
44359161|NCT00962013|79364485|FG000|Overall Study|Did not have surgery|1|||
44359162|NCT00962013|79364485|FG000|Overall Study|Death|8|||
44359163|NCT00962013|79364485|FG000|Overall Study|Lost to Follow-up|12|||
44359164|NCT00962013|79364485|FG000|Overall Study|Unable/Unwilling to return|6|||
44359165|NCT00962013|79364485|FG000|Overall Study|Withdrawal by Subject|8|||
44359166|NCT00962013|79364485|FG000|Overall Study|Removal of study device|3|||
44359167|NCT00962013|79364485|FG000|Overall Study|Site Termination|24|||
44359168|NCT00962013|79364485|FG000|Overall Study|No 5 year evaluation|6|||
44359169|NCT00970359|79364489|FG000|Overall Study|Not Treated|4|||
44359170|NCT01121406|79364495|FG000|Overall Study|Progressive disease RECIST|44|||
44359171|NCT01121406|79364496|FG001|Overall Study|Progressive disease RECIST|28|||
44359172|NCT01121406|79364495|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
44359173|NCT01121406|79364496|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
44359174|NCT01121406|79364495|FG000|Overall Study|Other AE|3|||
44359175|NCT01121406|79364496|FG001|Overall Study|Other AE|10|||
44359176|NCT01121406|79364495|FG000|Overall Study|Non-compliant with protocol|0|||
44359177|NCT01121406|79364496|FG001|Overall Study|Non-compliant with protocol|2|||
44359178|NCT01121406|79364495|FG000|Overall Study|Lost to Follow-up|0|||
44359179|NCT01121406|79364496|FG001|Overall Study|Lost to Follow-up|1|||
44359180|NCT01121406|79364495|FG000|Overall Study|Refused continuation of study med.|1|||
44359181|NCT01121406|79364496|FG001|Overall Study|Refused continuation of study med.|2|||
44359182|NCT01121406|79364495|FG000|Overall Study|Reason other than specified above|2|||
44359183|NCT01121406|79364496|FG001|Overall Study|Reason other than specified above|6|||
44359184|NCT01121406|79364495|FG000|Overall Study|Not treated|1|||
44359185|NCT01121406|79364496|FG001|Overall Study|Not treated|0|||
44359186|NCT00960687|79364505|FG000|Washout Period of 7 Days|Adverse Event|3|||
44359187|NCT00960687|79364506|FG001|Washout Period of 7 Days|Adverse Event|2|||
44359188|NCT00960687|79364505|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
44359189|NCT00960687|79364506|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44359190|NCT00920140|79364517|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
44359191|NCT00920140|79364518|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
44359192|NCT00920140|79364519|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
44359193|NCT00920140|79364520|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
44359194|NCT00920140|79364521|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
44359195|NCT00920140|79364517|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
44359196|NCT00920140|79364518|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
44359197|NCT00920140|79364519|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
44359198|NCT00920140|79364520|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
44359199|NCT00920140|79364521|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
44359200|NCT00920140|79364517|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
44359201|NCT00920140|79364518|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
44359202|NCT00920140|79364519|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
44359203|NCT00920140|79364520|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
44359204|NCT00920140|79364521|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
44359205|NCT00920140|79364517|FG000|Phase 2|Adverse Event|0|||
44359206|NCT00920140|79364518|FG001|Phase 2|Adverse Event|0|||
44359207|NCT00920140|79364519|FG002|Phase 2|Adverse Event|14|||
44359208|NCT00920140|79364520|FG003|Phase 2|Adverse Event|2|||
44359209|NCT00920140|79364521|FG004|Phase 2|Adverse Event|3|||
44359210|NCT00920140|79364517|FG000|Phase 2|Lack of Efficacy|0|||
44359211|NCT00920140|79364518|FG001|Phase 2|Lack of Efficacy|0|||
44359212|NCT00920140|79364519|FG002|Phase 2|Lack of Efficacy|29|||
44359213|NCT00920140|79364520|FG003|Phase 2|Lack of Efficacy|14|||
44359214|NCT00920140|79364521|FG004|Phase 2|Lack of Efficacy|5|||
44359215|NCT00920140|79364517|FG000|Phase 2|Lost to Follow-up|0|||
44359216|NCT00920140|79364518|FG001|Phase 2|Lost to Follow-up|0|||
44359217|NCT00920140|79364519|FG002|Phase 2|Lost to Follow-up|0|||
44359218|NCT00920140|79364520|FG003|Phase 2|Lost to Follow-up|1|||
44359219|NCT00920140|79364521|FG004|Phase 2|Lost to Follow-up|0|||
44359220|NCT00920140|79364517|FG000|Phase 2|Physician Decision|0|||
44359221|NCT00920140|79364518|FG001|Phase 2|Physician Decision|0|||
44359222|NCT00920140|79364519|FG002|Phase 2|Physician Decision|3|||
44359223|NCT00920140|79364520|FG003|Phase 2|Physician Decision|3|||
44359224|NCT00920140|79364521|FG004|Phase 2|Physician Decision|2|||
44359225|NCT00920140|79364517|FG000|Phase 2|Withdrawal by Subject|0|||
44359226|NCT00920140|79364518|FG001|Phase 2|Withdrawal by Subject|0|||
44359227|NCT00920140|79364519|FG002|Phase 2|Withdrawal by Subject|4|||
44359228|NCT00920140|79364520|FG003|Phase 2|Withdrawal by Subject|2|||
44359229|NCT00920140|79364521|FG004|Phase 2|Withdrawal by Subject|1|||
44359230|NCT01120782|79364534|FG000|Overall Study|Test article shipping error|11|||
44359231|NCT01120626|79364540|FG000|Overall Study|Withdrawal by Subject|1|||
44359232|NCT01120626|79364541|FG001|Overall Study|Withdrawal by Subject|0|||
44359233|NCT00924508|79364547|FG000|Overall Study|Withdrawal by Subject|3|||
44359234|NCT01139658|79364556|FG000|Overall Study|Adverse Event|10|||
44359235|NCT01139658|79364557|FG001|Overall Study|Adverse Event|27|||
44359236|NCT01139658|79364556|FG000|Overall Study|Lack of Efficacy|15|||
44359237|NCT01139658|79364557|FG001|Overall Study|Lack of Efficacy|7|||
44359238|NCT01139658|79364556|FG000|Overall Study|Withdrawal by Subject|2|||
44359239|NCT01139658|79364557|FG001|Overall Study|Withdrawal by Subject|4|||
44359240|NCT01139658|79364556|FG000|Overall Study|No documentation of treatment|1|||
44359241|NCT01139658|79364557|FG001|Overall Study|No documentation of treatment|0|||
44359242|NCT01139658|79364556|FG000|Overall Study|Other|28|||
44359243|NCT01139658|79364557|FG001|Overall Study|Other|75|||
44359244|NCT01139580|79364565|FG000|Overall Study|Adverse Event|5|||
44359245|NCT01139580|79364566|FG001|Overall Study|Adverse Event|4|||
44359246|NCT01139580|79364565|FG000|Overall Study|Lost to Follow-up|9|||
44359247|NCT01139580|79364566|FG001|Overall Study|Lost to Follow-up|1|||
44359248|NCT01139580|79364565|FG000|Overall Study|Lack of Efficacy|0|||
44359249|NCT01139580|79364566|FG001|Overall Study|Lack of Efficacy|2|||
44359250|NCT01139580|79364565|FG000|Overall Study|Withdrawal by Subject|6|||
44359251|NCT01139580|79364566|FG001|Overall Study|Withdrawal by Subject|9|||
44359252|NCT01139580|79364565|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
44359253|NCT01139580|79364566|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
44359254|NCT01139580|79364565|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
44359255|NCT01139580|79364566|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
44359256|NCT01139580|79364565|FG000|Overall Study|Misrandomized|1|||
44359257|NCT01139580|79364566|FG001|Overall Study|Misrandomized|0|||
44359258|NCT01139580|79364565|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
44359259|NCT01139580|79364566|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
44359260|NCT01139580|79364565|FG000|Overall Study|Participant Randomization in Error|0|||
44359261|NCT01139580|79364566|FG001|Overall Study|Participant Randomization in Error|1|||
44359262|NCT00917644|79364572|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
44359263|NCT00917644|79364573|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
44359264|NCT00917644|79364572|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
44359265|NCT00917644|79364573|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
44359266|NCT00917644|79364572|FG000|Period 2: Second Intervention|family emergency|1|||
44359267|NCT00917644|79364573|FG001|Period 2: Second Intervention|family emergency|0|||
44359268|NCT01137786|79364581|FG000|Overall Study|Lost to Follow-up|0|||
44359269|NCT01137786|79364582|FG001|Overall Study|Lost to Follow-up|2|||
44359270|NCT01137786|79364581|FG000|Overall Study|Withdrawal by Subject|1|||
44359271|NCT01137786|79364582|FG001|Overall Study|Withdrawal by Subject|1|||
44359272|NCT00599755|79364590|FG000|Overall Study|Adverse Event|11|||
44359273|NCT00599755|79364590|FG000|Overall Study|Withdrawal by Subject|2|||
44359274|NCT00599755|79364590|FG000|Overall Study|Progression of Disease|3|||
44359275|NCT00599755|79364590|FG000|Overall Study|Other Reason|2|||
44359276|NCT00599755|79364590|FG000|Overall Study|No data available|1|||
44359277|NCT00600613|79364594|FG000|Overall Study|Protocol Deviation|1|||
44359278|NCT01125930|79364600|FG000|Overall Study|Adverse Event|0|||
44359279|NCT01125930|79364601|FG001|Overall Study|Adverse Event|1|||
44359280|NCT01125930|79364600|FG000|Overall Study|Withdrawal by Subject|1|||
44359281|NCT01125930|79364601|FG001|Overall Study|Withdrawal by Subject|6|||
44359282|NCT01125930|79364600|FG000|Overall Study|Protocol Violation|0|||
44359283|NCT01125930|79364601|FG001|Overall Study|Protocol Violation|1|||
44359284|NCT01125930|79364600|FG000|Overall Study|Lost to Follow-up|0|||
44359285|NCT01125930|79364601|FG001|Overall Study|Lost to Follow-up|2|||
44359286|NCT00918346|79364632|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
44359287|NCT00918346|79364633|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
44359288|NCT00913978|79364644|FG000|Overall Study|Surgeon choice|1|||
44359289|NCT00913978|79364645|FG001|Overall Study|Surgeon choice|3|||
44359290|NCT01137474|79364655|FG000|Overall Study|Adverse Event|3|||
44359291|NCT01137474|79364656|FG001|Overall Study|Adverse Event|5|||
44359292|NCT01137474|79364657|FG002|Overall Study|Adverse Event|1|||
44359293|NCT01137474|79364658|FG003|Overall Study|Adverse Event|3|||
44359294|NCT01137474|79364655|FG000|Overall Study|Withdrawal by Subject|7|||
44359295|NCT01137474|79364656|FG001|Overall Study|Withdrawal by Subject|2|||
44359296|NCT01137474|79364657|FG002|Overall Study|Withdrawal by Subject|6|||
44359297|NCT01137474|79364658|FG003|Overall Study|Withdrawal by Subject|9|||
44359298|NCT01137474|79364655|FG000|Overall Study|No longer met study criteria|6|||
44359299|NCT01137474|79364656|FG001|Overall Study|No longer met study criteria|1|||
44359300|NCT01137474|79364657|FG002|Overall Study|No longer met study criteria|0|||
44359301|NCT01137474|79364658|FG003|Overall Study|No longer met study criteria|5|||
44359302|NCT01137474|79364655|FG000|Overall Study|Lost to Follow-up|5|||
44359303|NCT01137474|79364656|FG001|Overall Study|Lost to Follow-up|1|||
44359304|NCT01137474|79364657|FG002|Overall Study|Lost to Follow-up|0|||
44359305|NCT01137474|79364658|FG003|Overall Study|Lost to Follow-up|2|||
44359306|NCT01137474|79364655|FG000|Overall Study|Lack of Efficacy|0|||
44359307|NCT01137474|79364656|FG001|Overall Study|Lack of Efficacy|0|||
44359308|NCT01137474|79364657|FG002|Overall Study|Lack of Efficacy|0|||
44359309|NCT01137474|79364658|FG003|Overall Study|Lack of Efficacy|2|||
44359310|NCT01137474|79364655|FG000|Overall Study|Other|3|||
44359311|NCT01137474|79364656|FG001|Overall Study|Other|1|||
44359312|NCT01137474|79364657|FG002|Overall Study|Other|0|||
44359313|NCT01137474|79364658|FG003|Overall Study|Other|0|||
44359314|NCT01137474|79364655|FG000|Overall Study|Pregnancy|0|||
44359315|NCT01137474|79364656|FG001|Overall Study|Pregnancy|1|||
44359316|NCT01137474|79364657|FG002|Overall Study|Pregnancy|0|||
44359317|NCT01137474|79364658|FG003|Overall Study|Pregnancy|0|||
44359318|NCT01137474|79364655|FG000|Overall Study|Administrative reason by sponsor|0|||
44359319|NCT01137474|79364656|FG001|Overall Study|Administrative reason by sponsor|1|||
44359320|NCT01137474|79364657|FG002|Overall Study|Administrative reason by sponsor|0|||
44359321|NCT01137474|79364658|FG003|Overall Study|Administrative reason by sponsor|0|||
44359322|NCT01168973|79364670|FG000|Overall Study|Progressive Disease|341|||
44359323|NCT01168973|79364671|FG001|Overall Study|Progressive Disease|429|||
44359324|NCT01168973|79364670|FG000|Overall Study|Adverse Event|94|||
44359325|NCT01168973|79364671|FG001|Overall Study|Adverse Event|55|||
44359326|NCT01168973|79364670|FG000|Overall Study|Withdrawal by Subject|90|||
44359327|NCT01168973|79364671|FG001|Overall Study|Withdrawal by Subject|53|||
44359328|NCT01168973|79364670|FG000|Overall Study|Death|42|||
44359329|NCT01168973|79364671|FG001|Overall Study|Death|45|||
44359330|NCT01168973|79364670|FG000|Overall Study|Physician Decision|37|||
44359331|NCT01168973|79364671|FG001|Overall Study|Physician Decision|19|||
44359332|NCT01168973|79364670|FG000|Overall Study|Sponsor Decision|2|||
44359333|NCT01168973|79364671|FG001|Overall Study|Sponsor Decision|1|||
44359334|NCT01168973|79364670|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
44359335|NCT01168973|79364671|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
44359336|NCT03918109|79364681|FG000|Overall Study|Withdrawal by Subject|0|||
44359337|NCT03918109|79364682|FG001|Overall Study|Withdrawal by Subject|0|||
44359338|NCT03918109|79364683|FG002|Overall Study|Withdrawal by Subject|2|||
44359339|NCT03918109|79364684|FG003|Overall Study|Withdrawal by Subject|1|||
44359340|NCT03918109|79364681|FG000|Overall Study|Lost to Follow-up|0|||
44359341|NCT03918109|79364682|FG001|Overall Study|Lost to Follow-up|0|||
44359342|NCT03918109|79364683|FG002|Overall Study|Lost to Follow-up|0|||
44359343|NCT03918109|79364684|FG003|Overall Study|Lost to Follow-up|1|||
44359344|NCT01168427|79364694|FG000|Overall Study|Patient exited prior to implant|1|||
44359345|NCT01124916|79364700|FG000|Overall Study|Lost to Follow-up|3|||
44359346|NCT01124916|79364701|FG001|Overall Study|Lost to Follow-up|2|||
44359347|NCT00916006|79364709|FG000|Overall Study|Adverse Event|1|||
44359348|NCT00916006|79364710|FG001|Overall Study|Adverse Event|1|||
44359349|NCT00916006|79364709|FG000|Overall Study|Withdrawal by Subject|2|||
44359350|NCT00916006|79364710|FG001|Overall Study|Withdrawal by Subject|5|||
44359351|NCT00916006|79364709|FG000|Overall Study|Protocol Violation|0|||
44359352|NCT00916006|79364710|FG001|Overall Study|Protocol Violation|1|||
44359353|NCT01168349|79364727|FG000|Overall Study|Death|157|||
44359354|NCT01168349|79364727|FG000|Overall Study|Lost to Follow-up|34|||
44359355|NCT01168349|79364727|FG000|Overall Study|Withdrawal by Subject|9|||
44359356|NCT01168349|79364727|FG000|Overall Study|Kidney transplantation|3|||
44359357|NCT01168349|79364727|FG000|Overall Study|Other|22|||
44359358|NCT01168349|79364727|FG000|Overall Study|Protocol Violation|76|||
44359359|NCT00915772|79364750|FG000|Overall Study|Adverse Event|12|||
44359360|NCT00915772|79364751|FG001|Overall Study|Adverse Event|13|||
44359361|NCT00915772|79364752|FG002|Overall Study|Adverse Event|11|||
44359362|NCT00915772|79364750|FG000|Overall Study|Protocol Violation|4|||
44359363|NCT00915772|79364751|FG001|Overall Study|Protocol Violation|1|||
44359364|NCT00915772|79364752|FG002|Overall Study|Protocol Violation|2|||
44359365|NCT00915772|79364750|FG000|Overall Study|Lost to Follow-up|1|||
44359366|NCT00915772|79364751|FG001|Overall Study|Lost to Follow-up|2|||
44359367|NCT00915772|79364752|FG002|Overall Study|Lost to Follow-up|2|||
44359368|NCT00915772|79364750|FG000|Overall Study|Lack of Efficacy|9|||
44359369|NCT00915772|79364751|FG001|Overall Study|Lack of Efficacy|15|||
44359370|NCT00915772|79364752|FG002|Overall Study|Lack of Efficacy|3|||
44359371|NCT00915772|79364750|FG000|Overall Study|Refused to continue trial medication|6|||
44359372|NCT00915772|79364751|FG001|Overall Study|Refused to continue trial medication|8|||
44359373|NCT00915772|79364752|FG002|Overall Study|Refused to continue trial medication|4|||
44359374|NCT00915772|79364750|FG000|Overall Study|Any other reason|4|||
44359375|NCT00915772|79364751|FG001|Overall Study|Any other reason|7|||
44359376|NCT00915772|79364752|FG002|Overall Study|Any other reason|7|||
44359377|NCT00912964|79364764|FG000|Overall Study|Eligibility criterion not met|1|||
44359378|NCT00912964|79364765|FG001|Overall Study|Eligibility criterion not met|1|||
44359379|NCT00912964|79364766|FG002|Overall Study|Eligibility criterion not met|0|||
44359380|NCT00912964|79364764|FG000|Overall Study|Adverse Event|15|||
44359381|NCT00912964|79364765|FG001|Overall Study|Adverse Event|18|||
44359382|NCT00912964|79364766|FG002|Overall Study|Adverse Event|12|||
44359383|NCT00912964|79364764|FG000|Overall Study|Lack of Efficacy|11|||
44359384|NCT00912964|79364765|FG001|Overall Study|Lack of Efficacy|4|||
44359385|NCT00912964|79364766|FG002|Overall Study|Lack of Efficacy|3|||
44359386|NCT00912964|79364764|FG000|Overall Study|Withdrawal by Subject|20|||
44359387|NCT00912964|79364765|FG001|Overall Study|Withdrawal by Subject|12|||
44359388|NCT00912964|79364766|FG002|Overall Study|Withdrawal by Subject|18|||
44359389|NCT00912964|79364764|FG000|Overall Study|Lost to Follow-up|4|||
44359390|NCT00912964|79364765|FG001|Overall Study|Lost to Follow-up|3|||
44359391|NCT00912964|79364766|FG002|Overall Study|Lost to Follow-up|3|||
44359392|NCT00912964|79364764|FG000|Overall Study|Protocol Violation|5|||
44359393|NCT00912964|79364765|FG001|Overall Study|Protocol Violation|3|||
44359394|NCT00912964|79364766|FG002|Overall Study|Protocol Violation|8|||
44359395|NCT00912964|79364764|FG000|Overall Study|Taking exclusionary medications|7|||
44359396|NCT00912964|79364765|FG001|Overall Study|Taking exclusionary medications|4|||
44359397|NCT00912964|79364766|FG002|Overall Study|Taking exclusionary medications|8|||
44359398|NCT00912964|79364764|FG000|Overall Study|Medical History|1|||
44359399|NCT00912964|79364765|FG001|Overall Study|Medical History|0|||
44359400|NCT00912964|79364766|FG002|Overall Study|Medical History|0|||
44359401|NCT00912964|79364764|FG000|Overall Study|Non-compliance with study procedures|2|||
44359402|NCT00912964|79364765|FG001|Overall Study|Non-compliance with study procedures|0|||
44359403|NCT00912964|79364766|FG002|Overall Study|Non-compliance with study procedures|0|||
44359404|NCT00912964|79364764|FG000|Overall Study|Violation of exclusion criterion|0|||
44359405|NCT00912964|79364765|FG001|Overall Study|Violation of exclusion criterion|0|||
44359406|NCT00912964|79364766|FG002|Overall Study|Violation of exclusion criterion|2|||
44359407|NCT00912964|79364764|FG000|Overall Study|Randomized but never received study drug|0|||
44359408|NCT00912964|79364765|FG001|Overall Study|Randomized but never received study drug|1|||
44359409|NCT00912964|79364766|FG002|Overall Study|Randomized but never received study drug|0|||
44359410|NCT00913744|79364776|FG000|Overall Study|Adverse Event|2|||
44359411|NCT00913744|79364777|FG001|Overall Study|Adverse Event|0|||
44359412|NCT00913744|79364776|FG000|Overall Study|Withdrawal by Subject|2|||
44359413|NCT00913744|79364777|FG001|Overall Study|Withdrawal by Subject|1|||
44359414|NCT00913744|79364776|FG000|Overall Study|Death|1|||
44359415|NCT00913744|79364777|FG001|Overall Study|Death|0|||
44359416|NCT00912808|79364785|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
44359417|NCT00912808|79364786|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
44359418|NCT00912808|79364785|FG000|Washout|Withdrawal by Subject|0|||
44359419|NCT00912808|79364786|FG001|Washout|Withdrawal by Subject|1|||
44359420|NCT00912808|79364785|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
44359421|NCT00912808|79364786|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
44359422|NCT00912808|79364785|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
44359423|NCT00912808|79364786|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
44359424|NCT00960531|79364803|FG000|Overall Study|Lack of Efficacy|1|||
44359425|NCT00960531|79364804|FG001|Overall Study|Lack of Efficacy|0|||
44359426|NCT00960531|79364805|FG002|Overall Study|Lack of Efficacy|0|||
44359427|NCT00960531|79364806|FG003|Overall Study|Lack of Efficacy|0|||
44359428|NCT00960531|79364807|FG004|Overall Study|Lack of Efficacy|0|||
44359429|NCT00960531|79364808|FG005|Overall Study|Lack of Efficacy|0|||
44359430|NCT00960531|79364809|FG006|Overall Study|Lack of Efficacy|0|||
44359431|NCT00960531|79364810|FG007|Overall Study|Lack of Efficacy|0|||
44359432|NCT00960531|79364811|FG008|Overall Study|Lack of Efficacy|0|||
44359433|NCT00960531|79364812|FG009|Overall Study|Lack of Efficacy|0|||
44359434|NCT00960531|79364803|FG000|Overall Study|Withdrawal by Subject|1|||
44359435|NCT00960531|79364804|FG001|Overall Study|Withdrawal by Subject|0|||
44359436|NCT00960531|79364805|FG002|Overall Study|Withdrawal by Subject|5|||
44359437|NCT00960531|79364806|FG003|Overall Study|Withdrawal by Subject|2|||
44359438|NCT00960531|79364807|FG004|Overall Study|Withdrawal by Subject|0|||
44359439|NCT00960531|79364808|FG005|Overall Study|Withdrawal by Subject|0|||
44359440|NCT00960531|79364809|FG006|Overall Study|Withdrawal by Subject|2|||
44359441|NCT00960531|79364810|FG007|Overall Study|Withdrawal by Subject|0|||
44359442|NCT00960531|79364811|FG008|Overall Study|Withdrawal by Subject|1|||
44359443|NCT00960531|79364812|FG009|Overall Study|Withdrawal by Subject|0|||
44359444|NCT00960531|79364803|FG000|Overall Study|Caregiver Request|2|||
44359445|NCT00960531|79364804|FG001|Overall Study|Caregiver Request|0|||
44359446|NCT00960531|79364805|FG002|Overall Study|Caregiver Request|6|||
44359447|NCT00960531|79364806|FG003|Overall Study|Caregiver Request|5|||
44359448|NCT00960531|79364807|FG004|Overall Study|Caregiver Request|0|||
44359449|NCT00960531|79364808|FG005|Overall Study|Caregiver Request|2|||
44359450|NCT00960531|79364809|FG006|Overall Study|Caregiver Request|3|||
44359451|NCT00960531|79364810|FG007|Overall Study|Caregiver Request|1|||
44359452|NCT00960531|79364811|FG008|Overall Study|Caregiver Request|3|||
44359453|NCT00960531|79364812|FG009|Overall Study|Caregiver Request|0|||
44359454|NCT00960531|79364803|FG000|Overall Study|Investigator Request|0|||
44359455|NCT00960531|79364804|FG001|Overall Study|Investigator Request|0|||
44359456|NCT00960531|79364805|FG002|Overall Study|Investigator Request|1|||
44359457|NCT00960531|79364806|FG003|Overall Study|Investigator Request|0|||
44359458|NCT00960531|79364807|FG004|Overall Study|Investigator Request|0|||
44359459|NCT00960531|79364808|FG005|Overall Study|Investigator Request|0|||
44359460|NCT00960531|79364809|FG006|Overall Study|Investigator Request|0|||
44359461|NCT00960531|79364810|FG007|Overall Study|Investigator Request|0|||
44359462|NCT00960531|79364811|FG008|Overall Study|Investigator Request|0|||
44359463|NCT00960531|79364812|FG009|Overall Study|Investigator Request|0|||
44359464|NCT00960531|79364803|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
44359465|NCT00960531|79364804|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
44359466|NCT00960531|79364805|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
44359467|NCT00960531|79364806|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
44359468|NCT00960531|79364807|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
44359469|NCT00960531|79364808|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
44359470|NCT00960531|79364809|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
44359471|NCT00960531|79364810|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
44359472|NCT00960531|79364811|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
44359473|NCT00960531|79364812|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
44359474|NCT00960531|79364803|FG000|Overall Study|Lost to Follow-up|0|||
44359475|NCT00960531|79364804|FG001|Overall Study|Lost to Follow-up|0|||
44359476|NCT00960531|79364805|FG002|Overall Study|Lost to Follow-up|1|||
44359477|NCT00960531|79364806|FG003|Overall Study|Lost to Follow-up|0|||
44359478|NCT00960531|79364807|FG004|Overall Study|Lost to Follow-up|0|||
44359479|NCT00960531|79364808|FG005|Overall Study|Lost to Follow-up|0|||
44359480|NCT00960531|79364809|FG006|Overall Study|Lost to Follow-up|1|||
44359481|NCT00960531|79364810|FG007|Overall Study|Lost to Follow-up|0|||
44143668|NCT00271817|78932988|FG000|Part 1|LDL < 50 mg/dL|1|||
44359482|NCT00960531|79364811|FG008|Overall Study|Lost to Follow-up|0|||
44359483|NCT00960531|79364812|FG009|Overall Study|Lost to Follow-up|0|||
44359484|NCT00960531|79364803|FG000|Overall Study|Failed to Return|2|||
44359485|NCT00960531|79364804|FG001|Overall Study|Failed to Return|0|||
44359486|NCT00960531|79364805|FG002|Overall Study|Failed to Return|0|||
44359487|NCT00960531|79364806|FG003|Overall Study|Failed to Return|0|||
44359488|NCT00960531|79364807|FG004|Overall Study|Failed to Return|0|||
44359489|NCT00960531|79364808|FG005|Overall Study|Failed to Return|0|||
44359490|NCT00960531|79364809|FG006|Overall Study|Failed to Return|0|||
44359491|NCT00960531|79364810|FG007|Overall Study|Failed to Return|2|||
44359492|NCT00960531|79364811|FG008|Overall Study|Failed to Return|0|||
44359493|NCT00960531|79364812|FG009|Overall Study|Failed to Return|0|||
44359494|NCT00960531|79364803|FG000|Overall Study|Adverse Event (AE)|2|||
44359495|NCT00960531|79364804|FG001|Overall Study|Adverse Event (AE)|0|||
44359496|NCT00960531|79364805|FG002|Overall Study|Adverse Event (AE)|0|||
44359497|NCT00960531|79364806|FG003|Overall Study|Adverse Event (AE)|0|||
44359498|NCT00960531|79364807|FG004|Overall Study|Adverse Event (AE)|0|||
44359499|NCT00960531|79364808|FG005|Overall Study|Adverse Event (AE)|1|||
44359500|NCT00960531|79364809|FG006|Overall Study|Adverse Event (AE)|2|||
44359501|NCT00960531|79364810|FG007|Overall Study|Adverse Event (AE)|0|||
44359502|NCT00960531|79364811|FG008|Overall Study|Adverse Event (AE)|2|||
44359503|NCT00960531|79364812|FG009|Overall Study|Adverse Event (AE)|0|||
44359504|NCT00960531|79364803|FG000|Overall Study|Reason not Specified|2|||
44359505|NCT00960531|79364804|FG001|Overall Study|Reason not Specified|1|||
44359506|NCT00960531|79364805|FG002|Overall Study|Reason not Specified|13|||
44359507|NCT00960531|79364806|FG003|Overall Study|Reason not Specified|1|||
44359508|NCT00960531|79364807|FG004|Overall Study|Reason not Specified|2|||
44359509|NCT00960531|79364808|FG005|Overall Study|Reason not Specified|0|||
44359510|NCT00960531|79364809|FG006|Overall Study|Reason not Specified|16|||
44359511|NCT00960531|79364810|FG007|Overall Study|Reason not Specified|0|||
44359512|NCT00960531|79364811|FG008|Overall Study|Reason not Specified|8|||
44359513|NCT00960531|79364812|FG009|Overall Study|Reason not Specified|1|||
44359514|NCT00960375|79364840|FG000|Overall Study|Lost to Follow-up|20|||
44359515|NCT00960375|79364841|FG001|Overall Study|Lost to Follow-up|22|||
44359516|NCT00957801|79364860|FG000|Overall Study|Withdrawal by Subject|0|||
44359517|NCT00957801|79364861|FG001|Overall Study|Withdrawal by Subject|0|||
44359518|NCT00957801|79364862|FG002|Overall Study|Withdrawal by Subject|0|||
44359519|NCT00957801|79364863|FG003|Overall Study|Withdrawal by Subject|1|||
44359520|NCT00957723|79364873|FG000|Overall Study|Death|3|||
44359521|NCT00957723|79364873|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
44359522|NCT00957723|79364873|FG000|Overall Study|Lost to Follow-up|8|||
44359523|NCT00957723|79364873|FG000|Overall Study|Withdrawal by Subject|24|||
44359524|NCT00957723|79364873|FG000|Overall Study|Investigative Site Terminated|61|||
44359525|NCT00957723|79364873|FG000|Overall Study|Intercurrent Illness|2|||
44359526|NCT00957723|79364873|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
44359527|NCT03778021|79364881|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
44359528|NCT03778021|79364882|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
44359529|NCT00911170|79364891|FG000|Treatment Period|Randomized in error|1|||
44359530|NCT00911170|79364892|FG001|Treatment Period|Randomized in error|1|||
44359531|NCT00911170|79364891|FG000|Treatment Period|Ineligibility determined|1|||
44359532|NCT00911170|79364892|FG001|Treatment Period|Ineligibility determined|3|||
44359533|NCT00911170|79364891|FG000|Treatment Period|Protocol deviation|1|||
44359534|NCT00911170|79364892|FG001|Treatment Period|Protocol deviation|2|||
44359535|NCT00911170|79364891|FG000|Treatment Period|Adverse Event|9|||
44359536|NCT00911170|79364892|FG001|Treatment Period|Adverse Event|10|||
44359537|NCT00911170|79364891|FG000|Treatment Period|Withdrawal by Subject|4|||
44359538|NCT00911170|79364892|FG001|Treatment Period|Withdrawal by Subject|4|||
44359539|NCT00911170|79364891|FG000|Treatment Period|Disease progression|0|||
44359540|NCT00911170|79364892|FG001|Treatment Period|Disease progression|2|||
44359541|NCT00911170|79364891|FG000|Treatment Period|Physician Decision|5|||
44359542|NCT00911170|79364892|FG001|Treatment Period|Physician Decision|5|||
44359543|NCT00911170|79364891|FG000|Treatment Period|Lost to Follow-up|0|||
44359544|NCT00911170|79364892|FG001|Treatment Period|Lost to Follow-up|1|||
44359545|NCT00911170|79364891|FG000|Treatment Period|Death|6|||
44359546|NCT00911170|79364892|FG001|Treatment Period|Death|9|||
44359547|NCT00911170|79364891|FG000|Long Term Follow-Up|Continuing in study|274|||
44359548|NCT00911170|79364892|FG001|Long Term Follow-Up|Continuing in study|269|||
44359549|NCT00911170|79364891|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
44359550|NCT00911170|79364892|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
44359551|NCT00911170|79364891|FG000|Long Term Follow-Up|Physician Decision|5|||
44359552|NCT00911170|79364892|FG001|Long Term Follow-Up|Physician Decision|4|||
44359553|NCT00911170|79364891|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
44359554|NCT00911170|79364892|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
44359555|NCT00911170|79364891|FG000|Long Term Follow-Up|Death|116|||
44359556|NCT00911170|79364892|FG001|Long Term Follow-Up|Death|121|||
44359557|NCT01167881|79364900|FG000|Overall Study|Adverse Event|47|||
44359558|NCT01167881|79364901|FG001|Overall Study|Adverse Event|51|||
44359559|NCT01167881|79364900|FG000|Overall Study|Lack of Efficacy|4|||
44359560|NCT01167881|79364901|FG001|Overall Study|Lack of Efficacy|7|||
44359561|NCT01167881|79364900|FG000|Overall Study|Non compliant with protocol|9|||
44359562|NCT01167881|79364901|FG001|Overall Study|Non compliant with protocol|18|||
44359563|NCT01167881|79364900|FG000|Overall Study|Lost to Follow-up|19|||
44359564|NCT01167881|79364901|FG001|Overall Study|Lost to Follow-up|20|||
44359565|NCT01167881|79364900|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
44359566|NCT01167881|79364901|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
44359567|NCT01167881|79364900|FG000|Overall Study|Not treated|4|||
44359568|NCT01167881|79364901|FG001|Overall Study|Not treated|0|||
44359569|NCT01167881|79364900|FG000|Overall Study|Other not defined above|31|||
44359570|NCT01167881|79364901|FG001|Overall Study|Other not defined above|55|||
44359571|NCT00960063|79364910|FG000|Overall Study|Adverse Event|1|||
44359572|NCT00960063|79364911|FG001|Overall Study|Adverse Event|0|||
44359573|NCT00960063|79364912|FG002|Overall Study|Adverse Event|0|||
44359574|NCT00960063|79364910|FG000|Overall Study|Progression of Disease|0|||
44359575|NCT00960063|79364911|FG001|Overall Study|Progression of Disease|0|||
44359576|NCT00960063|79364912|FG002|Overall Study|Progression of Disease|3|||
44359577|NCT00959907|79364922|FG000|Overall Study|Protocol Violation|0|||
44359578|NCT00959907|79364923|FG001|Overall Study|Protocol Violation|1|||
44359579|NCT00959907|79364922|FG000|Overall Study|Adverse Event|1|||
44359580|NCT00959907|79364923|FG001|Overall Study|Adverse Event|0|||
44359581|NCT00959907|79364922|FG000|Overall Study|Withdrawal by Subject|2|||
44359582|NCT00959907|79364923|FG001|Overall Study|Withdrawal by Subject|0|||
44359583|NCT00912340|79364932|FG000|Overall Study|Adverse Event|2|||
44359584|NCT00912340|79364933|FG001|Overall Study|Adverse Event|4|||
44359585|NCT00912340|79364934|FG002|Overall Study|Adverse Event|0|||
44359586|NCT00912340|79364932|FG000|Overall Study|Protocol revised to remove arm|0|||
44359587|NCT00912340|79364933|FG001|Overall Study|Protocol revised to remove arm|0|||
44359588|NCT00912340|79364934|FG002|Overall Study|Protocol revised to remove arm|4|||
44359589|NCT01167257|79364944|FG000|Overall Study|Lost to Follow-up|2|||
44359590|NCT01167257|79364945|FG001|Overall Study|Lost to Follow-up|2|||
44359591|NCT01167257|79364944|FG000|Overall Study|Withdrew consent|1|||
44359592|NCT01167257|79364945|FG001|Overall Study|Withdrew consent|1|||
44359593|NCT01119846|79364958|FG000|Overall Study|Adverse Event|1|||
44359594|NCT01119846|79364959|FG001|Overall Study|Adverse Event|0|||
44359595|NCT01119846|79364960|FG002|Overall Study|Adverse Event|6|||
44359596|NCT01119846|79364958|FG000|Overall Study|Physician Decision|1|||
44359597|NCT01119846|79364959|FG001|Overall Study|Physician Decision|0|||
44359598|NCT01119846|79364960|FG002|Overall Study|Physician Decision|0|||
44359599|NCT01119846|79364958|FG000|Overall Study|Protocol Violation|0|||
44359600|NCT01119846|79364959|FG001|Overall Study|Protocol Violation|0|||
44359601|NCT01119846|79364960|FG002|Overall Study|Protocol Violation|1|||
44359602|NCT01119846|79364958|FG000|Overall Study|Withdrawal by Subject|0|||
44359603|NCT01119846|79364959|FG001|Overall Study|Withdrawal by Subject|0|||
44359604|NCT01119846|79364960|FG002|Overall Study|Withdrawal by Subject|4|||
44359605|NCT01167179|79364997|FG000|Overall Study|disease recurrence|4|||
44359606|NCT01167179|79364998|FG001|Overall Study|disease recurrence|4|||
44359607|NCT01167179|79364997|FG000|Overall Study|Death|4|||
44359608|NCT01167179|79364998|FG001|Overall Study|Death|10|||
44359609|NCT01167179|79364997|FG000|Overall Study|Withdrawal by Subject|1|||
44359610|NCT01167179|79364998|FG001|Overall Study|Withdrawal by Subject|2|||
44359611|NCT01167179|79364997|FG000|Overall Study|diverse|6|||
44359612|NCT01167179|79364998|FG001|Overall Study|diverse|5|||
44359613|NCT01167023|79365071|FG000|Overall Study|Lost to Follow-up|0|||
44359614|NCT01167023|79365072|FG001|Overall Study|Lost to Follow-up|1|||
44359615|NCT01167023|79365073|FG002|Overall Study|Lost to Follow-up|1|||
44359616|NCT01167023|79365071|FG000|Overall Study|Screen Failure|0|||
44359617|NCT01167023|79365072|FG001|Overall Study|Screen Failure|1|||
44359618|NCT01167023|79365073|FG002|Overall Study|Screen Failure|0|||
44359619|NCT01167023|79365071|FG000|Overall Study|Sponsor Decision|0|||
44359620|NCT01167023|79365072|FG001|Overall Study|Sponsor Decision|1|||
44359621|NCT01167023|79365073|FG002|Overall Study|Sponsor Decision|0|||
44359622|NCT01167023|79365071|FG000|Overall Study|Withdrawal by Subject|0|||
44359623|NCT01167023|79365072|FG001|Overall Study|Withdrawal by Subject|0|||
44359624|NCT01167023|79365073|FG002|Overall Study|Withdrawal by Subject|1|||
44359625|NCT03484117|79365081|FG000|Overall Study|Lost to Follow-up|1|||
44359626|NCT03484117|79365082|FG001|Overall Study|Lost to Follow-up|3|||
44359627|NCT03484117|79365081|FG000|Overall Study|Declined participation in exit assess|1|||
44359628|NCT03484117|79365082|FG001|Overall Study|Declined participation in exit assess|1|||
44359629|NCT01166945|79365090|FG000|Randomized|diagnosed with Group A strep|4|||
44359630|NCT01166945|79365091|FG001|Randomized|diagnosed with Group A strep|4|||
44359631|NCT01166945|79365090|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
44359632|NCT01166945|79365091|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
44359633|NCT01166945|79365090|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
44359634|NCT01166945|79365091|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
44359635|NCT01166945|79365090|FG000|Day 30|Lost to Follow-up|4|||
44359636|NCT01166945|79365091|FG001|Day 30|Lost to Follow-up|3|||
44359637|NCT00910000|79365105|FG000|Overall Study|Adverse Event|0|||
44359638|NCT00910000|79365106|FG001|Overall Study|Adverse Event|3|||
44359639|NCT00910000|79365107|FG002|Overall Study|Adverse Event|2|||
44359640|NCT00910000|79365108|FG003|Overall Study|Adverse Event|2|||
44359641|NCT00910000|79365109|FG004|Overall Study|Adverse Event|0|||
44359642|NCT00910000|79365110|FG005|Overall Study|Adverse Event|1|||
44448737|NCT00550446|79457363|FG008|Up To Week 12|Lost to Follow-up|0|||
44359643|NCT00910000|79365105|FG000|Overall Study|Withdrawal by Subject|0|||
44359644|NCT00910000|79365106|FG001|Overall Study|Withdrawal by Subject|0|||
44359645|NCT00910000|79365107|FG002|Overall Study|Withdrawal by Subject|1|||
44359646|NCT00910000|79365108|FG003|Overall Study|Withdrawal by Subject|0|||
44359647|NCT00910000|79365109|FG004|Overall Study|Withdrawal by Subject|1|||
44359648|NCT00910000|79365110|FG005|Overall Study|Withdrawal by Subject|0|||
44359649|NCT01119768|79365131|FG000|Treatment Period|Lack of Efficacy|18|||
44359650|NCT01119768|79365132|FG001|Treatment Period|Lack of Efficacy|25|||
44359651|NCT01165307|79365140|FG000|Overall Study|Lost to Follow-up|11|||
44359652|NCT01165307|79365141|FG001|Overall Study|Lost to Follow-up|3|||
44359653|NCT01165307|79365140|FG000|Overall Study|Withdrawal by Subject|2|||
44359654|NCT01165307|79365141|FG001|Overall Study|Withdrawal by Subject|0|||
44359655|NCT01165307|79365140|FG000|Overall Study|Subject not available for contact|1|||
44359656|NCT01165307|79365141|FG001|Overall Study|Subject not available for contact|0|||
44359657|NCT00960999|79365149|FG000|Overall Study|Withdrawal by Subject|1|||
44359658|NCT00960999|79365150|FG001|Overall Study|Withdrawal by Subject|0|||
44359659|NCT00960999|79365149|FG000|Overall Study|Protocol Violation|5|||
44359660|NCT00960999|79365150|FG001|Overall Study|Protocol Violation|2|||
44359661|NCT00960999|79365149|FG000|Overall Study|RT dose constraints not met|2|||
44359662|NCT00960999|79365150|FG001|Overall Study|RT dose constraints not met|0|||
44359663|NCT01124838|79365158|FG000|Overall Study|Miscellaneous|4|||
44359664|NCT01124838|79365159|FG001|Overall Study|Miscellaneous|2|||
44359665|NCT01124838|79365158|FG000|Overall Study|Adverse Event|7|||
44359666|NCT01124838|79365159|FG001|Overall Study|Adverse Event|11|||
44359667|NCT01124838|79365158|FG000|Overall Study|Lack of Efficacy|2|||
44359668|NCT01124838|79365159|FG001|Overall Study|Lack of Efficacy|0|||
44359669|NCT01124838|79365158|FG000|Overall Study|Withdrawal by Subject|3|||
44359670|NCT01124838|79365159|FG001|Overall Study|Withdrawal by Subject|2|||
44359671|NCT01124838|79365158|FG000|Overall Study|Lost to Follow-up|2|||
44359672|NCT01124838|79365159|FG001|Overall Study|Lost to Follow-up|0|||
44359673|NCT00959751|79365169|FG000|Overall Study|Lost to Follow-up|2|||
44359674|NCT00959751|79365170|FG001|Overall Study|Lost to Follow-up|3|||
44359675|NCT00959751|79365169|FG000|Overall Study|Consent Withdrawn|0|||
44359676|NCT00959751|79365170|FG001|Overall Study|Consent Withdrawn|1|||
44359677|NCT00959751|79365169|FG000|Overall Study|Non-compliance to Study Procedures|0|||
44359678|NCT00959751|79365170|FG001|Overall Study|Non-compliance to Study Procedures|1|||
44359679|NCT00959751|79365169|FG000|Overall Study|No migraine headache without aura|7|||
44359680|NCT00959751|79365170|FG001|Overall Study|No migraine headache without aura|7|||
44359681|NCT00910858|79365179|FG000|Pharmacokinetic Phase|Adverse Event|1|||
44359682|NCT00910858|79365180|FG001|Pharmacokinetic Phase|Adverse Event|0|||
44359683|NCT00910858|79365181|FG002|Pharmacokinetic Phase|Adverse Event|0|||
44359684|NCT00910858|79365179|FG000|Monotherapy Phase|Adverse Event|3|||
44359685|NCT00910858|79365180|FG001|Monotherapy Phase|Adverse Event|2|||
44359686|NCT00910858|79365181|FG002|Monotherapy Phase|Adverse Event|0|||
44359687|NCT00910858|79365179|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
44359688|NCT00910858|79365180|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
44359689|NCT00910858|79365181|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
44359690|NCT00910858|79365179|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
44359691|NCT00910858|79365180|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
44359692|NCT00910858|79365181|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
44359693|NCT00910858|79365179|FG000|Monotherapy Phase|Protocol Violation|1|||
44359694|NCT00910858|79365180|FG001|Monotherapy Phase|Protocol Violation|0|||
44359695|NCT00910858|79365181|FG002|Monotherapy Phase|Protocol Violation|0|||
44359696|NCT00910858|79365179|FG000|Monotherapy Phase|Other|3|||
44359697|NCT00910858|79365180|FG001|Monotherapy Phase|Other|4|||
44359698|NCT00910858|79365181|FG002|Monotherapy Phase|Other|2|||
44359699|NCT00910858|79365179|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
44359700|NCT00910858|79365180|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
44359701|NCT00910858|79365181|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
44359702|NCT00910858|79365179|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
44359703|NCT00910858|79365180|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
44359704|NCT00910858|79365181|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
44359705|NCT00910858|79365179|FG000|Combined Treatment Phase|Protocol Violation|1|||
44359706|NCT00910858|79365180|FG001|Combined Treatment Phase|Protocol Violation|0|||
44359707|NCT00910858|79365181|FG002|Combined Treatment Phase|Protocol Violation|0|||
44359708|NCT00910858|79365179|FG000|Combined Treatment Phase|Other|0|||
44359709|NCT00910858|79365180|FG001|Combined Treatment Phase|Other|2|||
44359710|NCT00910858|79365181|FG002|Combined Treatment Phase|Other|1|||
44359711|NCT00598975|79365199|FG000|Overall Study|Adverse Event|1|||
44359712|NCT00598975|79365200|FG001|Overall Study|Adverse Event|1|||
44359713|NCT00598975|79365199|FG000|Overall Study|Brain metastases|1|||
44359714|NCT00598975|79365200|FG001|Overall Study|Brain metastases|0|||
44359715|NCT00598975|79365199|FG000|Overall Study|Withdrawal by Subject|1|||
44359716|NCT00598975|79365200|FG001|Overall Study|Withdrawal by Subject|1|||
44359717|NCT00598975|79365199|FG000|Overall Study|Withdrawal of consent|0|||
44359718|NCT00598975|79365200|FG001|Overall Study|Withdrawal of consent|1|||
44359719|NCT00598975|79365199|FG000|Overall Study|Disease progression|8|||
44359720|NCT00598975|79365200|FG001|Overall Study|Disease progression|3|||
44359721|NCT00598975|79365199|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
44359722|NCT00598975|79365200|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
44359723|NCT00957021|79365208|FG000|Overall Study|Death|5|||
44359724|NCT00957021|79365208|FG000|Overall Study|Lost to Follow-up|8|||
44359725|NCT00957021|79365208|FG000|Overall Study|Withdrawal by Subject|34|||
44359726|NCT00957021|79365208|FG000|Overall Study|No 2 yr ROM data|35|||
44359727|NCT00957021|79365208|FG000|Overall Study|Revised study component by 2 yr visit|8|||
44359728|NCT00957021|79365208|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
44359729|NCT00957021|79365208|FG000|Overall Study|Surgery Cancelled|9|||
44359730|NCT00957021|79365208|FG000|Overall Study|Termination due to language issue|2|||
44359731|NCT01124604|79365215|FG000|Overall Study|Adverse Event|10|||
44359732|NCT01124604|79365216|FG001|Overall Study|Adverse Event|1|||
44359733|NCT01124604|79365215|FG000|Overall Study|Lack of Efficacy|1|||
44359734|NCT01124604|79365216|FG001|Overall Study|Lack of Efficacy|0|||
44359735|NCT01124604|79365215|FG000|Overall Study|Withdrawal by Subject|4|||
44359736|NCT01124604|79365216|FG001|Overall Study|Withdrawal by Subject|0|||
44359737|NCT01124604|79365215|FG000|Overall Study|Disease Progression|0|||
44359738|NCT01124604|79365216|FG001|Overall Study|Disease Progression|1|||
44359739|NCT00909844|79365222|FG000|Overall Study|Adverse Event|1|||
44359740|NCT00909844|79365222|FG000|Overall Study|Withdrawal by Subject|1|||
44359741|NCT00909844|79365222|FG000|Overall Study|Lost to Follow-up|2|||
44359742|NCT01124448|79365229|FG000|Overall Study|Lost to Follow-up|0|||
44359743|NCT01124448|79365230|FG001|Overall Study|Lost to Follow-up|3|||
44359744|NCT01124448|79365229|FG000|Overall Study|Protocol Violation|2|||
44359745|NCT01124448|79365230|FG001|Overall Study|Protocol Violation|0|||
44359746|NCT01124292|79365239|FG000|Overall Study|Lost to Follow-up|2|||
44359747|NCT01124292|79365240|FG001|Overall Study|Lost to Follow-up|4|||
44359748|NCT01124292|79365241|FG002|Overall Study|Lost to Follow-up|3|||
44359749|NCT01124292|79365239|FG000|Overall Study|Physician Decision|0|||
44359750|NCT01124292|79365240|FG001|Overall Study|Physician Decision|3|||
44359751|NCT01124292|79365241|FG002|Overall Study|Physician Decision|2|||
44359752|NCT01124292|79365239|FG000|Overall Study|Withdrawal by Subject|0|||
44359753|NCT01124292|79365240|FG001|Overall Study|Withdrawal by Subject|6|||
44359754|NCT01124292|79365241|FG002|Overall Study|Withdrawal by Subject|2|||
44359755|NCT01124292|79365239|FG000|Overall Study|medical issue unrelated to the study|0|||
44359756|NCT01124292|79365240|FG001|Overall Study|medical issue unrelated to the study|0|||
44359757|NCT01124292|79365241|FG002|Overall Study|medical issue unrelated to the study|2|||
44359758|NCT01124292|79365239|FG000|Overall Study|piercing track closed|0|||
44359759|NCT01124292|79365240|FG001|Overall Study|piercing track closed|2|||
44359760|NCT01124292|79365241|FG002|Overall Study|piercing track closed|1|||
44359761|NCT01136772|79365254|FG000|Overall Study|Adverse Event|15|||
44359762|NCT01136772|79365255|FG001|Overall Study|Adverse Event|14|||
44359763|NCT01136772|79365254|FG000|Overall Study|Lack of Efficacy|42|||
44359764|NCT01136772|79365255|FG001|Overall Study|Lack of Efficacy|39|||
44359765|NCT01136772|79365254|FG000|Overall Study|Administrative|14|||
44359766|NCT01136772|79365255|FG001|Overall Study|Administrative|12|||
44359767|NCT01136772|79365254|FG000|Overall Study|Withdrawal by Subject|33|||
44359768|NCT01136772|79365255|FG001|Overall Study|Withdrawal by Subject|36|||
44359769|NCT01136772|79365254|FG000|Overall Study|Did not receive injection|10|||
44359770|NCT01136772|79365255|FG001|Overall Study|Did not receive injection|7|||
44359771|NCT01136772|79365254|FG000|Overall Study|Did not follow up after first injection|2|||
44359772|NCT01136772|79365255|FG001|Overall Study|Did not follow up after first injection|2|||
44359773|NCT00909532|79365263|FG000|Overall Study|Adverse Event|4|||
44359774|NCT00909532|79365264|FG001|Overall Study|Adverse Event|1|||
44359775|NCT00909532|79365263|FG000|Overall Study|Pregnancy|0|||
44359776|NCT00909532|79365264|FG001|Overall Study|Pregnancy|1|||
44359777|NCT00909532|79365263|FG000|Overall Study|Prohibited Medication|2|||
44359778|NCT00909532|79365264|FG001|Overall Study|Prohibited Medication|1|||
44359779|NCT00909532|79365263|FG000|Overall Study|Withdrawal of Consent|1|||
44359780|NCT00909532|79365264|FG001|Overall Study|Withdrawal of Consent|1|||
44359781|NCT00909532|79365263|FG000|Overall Study|Noncompliance with Study Requirements|0|||
44359782|NCT00909532|79365264|FG001|Overall Study|Noncompliance with Study Requirements|2|||
44359783|NCT00909532|79365263|FG000|Overall Study|Physician Decision|1|||
44359784|NCT00909532|79365264|FG001|Overall Study|Physician Decision|0|||
44359785|NCT00909532|79365263|FG000|Overall Study|Wrong Genotype|1|||
44359786|NCT00909532|79365264|FG001|Overall Study|Wrong Genotype|0|||
44359787|NCT00909532|79365263|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
44359788|NCT00909532|79365264|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
44359789|NCT01136382|79365273|FG000|Overall Study|Other|8|||
44359790|NCT01136382|79365274|FG001|Overall Study|Other|3|||
44359791|NCT01136382|79365273|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
44359792|NCT01136382|79365274|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
44359793|NCT01136382|79365273|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
44359794|NCT01136382|79365274|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
44359795|NCT01136382|79365273|FG000|Overall Study|Withdrawal by Subject|4|||
44359796|NCT01136382|79365274|FG001|Overall Study|Withdrawal by Subject|1|||
44359797|NCT00912028|79365283|FG000|Overall Study|Lost to Follow-up|2|||
44359798|NCT00912028|79365284|FG001|Overall Study|Lost to Follow-up|3|||
44359799|NCT00912028|79365285|FG002|Overall Study|Lost to Follow-up|0|||
44359800|NCT00912028|79365286|FG003|Overall Study|Lost to Follow-up|1|||
44359801|NCT00912028|79365287|FG004|Overall Study|Lost to Follow-up|3|||
44359802|NCT00912028|79365283|FG000|Overall Study|Withdrawal by Subject|3|||
44359803|NCT00912028|79365284|FG001|Overall Study|Withdrawal by Subject|0|||
44359804|NCT00912028|79365285|FG002|Overall Study|Withdrawal by Subject|0|||
44359805|NCT00912028|79365286|FG003|Overall Study|Withdrawal by Subject|0|||
44359806|NCT00912028|79365287|FG004|Overall Study|Withdrawal by Subject|0|||
44359807|NCT02731729|79365299|FG000|Overall Study|Death|2|||
44359808|NCT02731729|79365300|FG001|Overall Study|Death|2|||
44359809|NCT02731729|79365299|FG000|Overall Study|Study terminated by Sponsor|6|||
44359810|NCT02731729|79365300|FG001|Overall Study|Study terminated by Sponsor|6|||
44359811|NCT02731729|79365299|FG000|Overall Study|Withdrawal by Subject|1|||
44359812|NCT02731729|79365300|FG001|Overall Study|Withdrawal by Subject|0|||
44359813|NCT01119066|79365310|FG000|Overall Study|Withdrawal by Subject|4|||
44359814|NCT01119066|79365311|FG001|Overall Study|Withdrawal by Subject|6|||
44359815|NCT01119066|79365312|FG002|Overall Study|Withdrawal by Subject|0|||
44359816|NCT01119066|79365313|FG003|Overall Study|Withdrawal by Subject|0|||
44359817|NCT01119066|79365310|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
44359818|NCT01119066|79365311|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
44359819|NCT01119066|79365312|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
44359820|NCT01119066|79365313|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
44359821|NCT01119066|79365310|FG000|Overall Study|Relapse identified before transplant|1|||
44359822|NCT01119066|79365311|FG001|Overall Study|Relapse identified before transplant|0|||
44359823|NCT01119066|79365312|FG002|Overall Study|Relapse identified before transplant|0|||
44359824|NCT01119066|79365313|FG003|Overall Study|Relapse identified before transplant|0|||
44359825|NCT01119066|79365310|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
44359826|NCT01119066|79365311|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
44359827|NCT01119066|79365312|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
44359828|NCT01119066|79365313|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
44359829|NCT01119066|79365310|FG000|Overall Study|Relapse identified before transplant|0|||
44359830|NCT01119066|79365311|FG001|Overall Study|Relapse identified before transplant|4|||
44359831|NCT01119066|79365312|FG002|Overall Study|Relapse identified before transplant|0|||
44359832|NCT01119066|79365313|FG003|Overall Study|Relapse identified before transplant|0|||
44359833|NCT00910624|79365327|FG000|Treatment Phase|Adverse Event|2|||
44359834|NCT00910624|79365328|FG001|Treatment Phase|Adverse Event|6|||
44359835|NCT00910624|79365329|FG002|Treatment Phase|Adverse Event|6|||
44359836|NCT00910624|79365330|FG003|Treatment Phase|Adverse Event|0|||
44359837|NCT00910624|79365327|FG000|Treatment Phase|Treatment Failure|23|||
44359838|NCT00910624|79365328|FG001|Treatment Phase|Treatment Failure|10|||
44359839|NCT00910624|79365329|FG002|Treatment Phase|Treatment Failure|0|||
44359840|NCT00910624|79365330|FG003|Treatment Phase|Treatment Failure|0|||
44359841|NCT00910624|79365327|FG000|Treatment Phase|Lost to Follow-up|0|||
44359842|NCT00910624|79365328|FG001|Treatment Phase|Lost to Follow-up|0|||
44359843|NCT00910624|79365329|FG002|Treatment Phase|Lost to Follow-up|1|||
44359844|NCT00910624|79365330|FG003|Treatment Phase|Lost to Follow-up|0|||
44359845|NCT00910624|79365327|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
44359846|NCT00910624|79365328|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
44359847|NCT00910624|79365329|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
44359848|NCT00910624|79365330|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
44359849|NCT00910624|79365327|FG000|Treatment Phase|Withdrawal by Subject|2|||
44359850|NCT00910624|79365328|FG001|Treatment Phase|Withdrawal by Subject|1|||
44359851|NCT00910624|79365329|FG002|Treatment Phase|Withdrawal by Subject|0|||
44359852|NCT00910624|79365330|FG003|Treatment Phase|Withdrawal by Subject|0|||
44359853|NCT00910624|79365327|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
44359854|NCT00910624|79365328|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
44359855|NCT00910624|79365329|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
44359856|NCT00910624|79365330|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
44359857|NCT00910624|79365327|FG000|Follow-Up Phase|Adverse Event|0|||
44359858|NCT00910624|79365328|FG001|Follow-Up Phase|Adverse Event|0|||
44359859|NCT00910624|79365329|FG002|Follow-Up Phase|Adverse Event|1|||
44359860|NCT00910624|79365330|FG003|Follow-Up Phase|Adverse Event|0|||
44359861|NCT00910624|79365327|FG000|Follow-Up Phase|Lost to Follow-up|3|||
44359862|NCT00910624|79365328|FG001|Follow-Up Phase|Lost to Follow-up|1|||
44359863|NCT00910624|79365329|FG002|Follow-Up Phase|Lost to Follow-up|2|||
44359864|NCT00910624|79365330|FG003|Follow-Up Phase|Lost to Follow-up|0|||
44359865|NCT00910624|79365327|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
44359866|NCT00910624|79365328|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
44359867|NCT00910624|79365329|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
44359868|NCT00910624|79365330|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
44359869|NCT00910624|79365327|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
44359870|NCT00910624|79365328|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
44359871|NCT00910624|79365329|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
44359872|NCT00910624|79365330|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
44359873|NCT00910624|79365327|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
44359874|NCT00910624|79365328|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
44359875|NCT00910624|79365329|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
44359876|NCT00910624|79365330|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
44359877|NCT00910624|79365327|FG000|Follow-Up Phase|Administrative|0|||
44359878|NCT00910624|79365328|FG001|Follow-Up Phase|Administrative|1|||
44359879|NCT00910624|79365329|FG002|Follow-Up Phase|Administrative|1|||
44359880|NCT00910624|79365330|FG003|Follow-Up Phase|Administrative|0|||
44359881|NCT01123980|79365344|FG000|Overall Study|Adverse Event|1|||
44359882|NCT01123980|79365345|FG001|Overall Study|Adverse Event|1|||
44359883|NCT01123980|79365344|FG000|Overall Study|Lack of Efficacy|1|||
44359884|NCT01123980|79365345|FG001|Overall Study|Lack of Efficacy|0|||
44359885|NCT01123980|79365344|FG000|Overall Study|Physician Decision|0|||
44359886|NCT01123980|79365345|FG001|Overall Study|Physician Decision|1|||
44359887|NCT01123980|79365344|FG000|Overall Study|Lost to Follow-up|0|||
44359888|NCT01123980|79365345|FG001|Overall Study|Lost to Follow-up|6|||
44359889|NCT01123980|79365344|FG000|Overall Study|Protocol Violation|6|||
44359890|NCT01123980|79365345|FG001|Overall Study|Protocol Violation|6|||
44359891|NCT01123980|79365344|FG000|Overall Study|Withdrawal by Subject|5|||
44359892|NCT01123980|79365345|FG001|Overall Study|Withdrawal by Subject|3|||
44359893|NCT01123980|79365344|FG000|Overall Study|Unclassified|6|||
44359894|NCT01123980|79365345|FG001|Overall Study|Unclassified|7|||
44359895|NCT01118520|79365354|FG000|Overall Study|AAA repair|9|||
44359896|NCT01118520|79365355|FG001|Overall Study|AAA repair|7|||
44359897|NCT01118520|79365356|FG002|Overall Study|AAA repair|9|||
44359898|NCT01118520|79365354|FG000|Overall Study|Adverse Event|3|||
44359899|NCT01118520|79365355|FG001|Overall Study|Adverse Event|3|||
44359900|NCT01118520|79365356|FG002|Overall Study|Adverse Event|3|||
44359901|NCT01118520|79365354|FG000|Overall Study|Withdrawal by Subject|8|||
44359902|NCT01118520|79365355|FG001|Overall Study|Withdrawal by Subject|13|||
44359903|NCT01118520|79365356|FG002|Overall Study|Withdrawal by Subject|8|||
44359904|NCT01135992|79365364|FG000|Overall Study|Adverse Event|1|||
44359905|NCT01135992|79365364|FG000|Overall Study|Lack of Efficacy|1|||
44359906|NCT01135992|79365364|FG000|Overall Study|Protocol Violation|2|||
44359907|NCT01135992|79365364|FG000|Overall Study|Withdrawal criteria|10|||
44359908|NCT01135992|79365364|FG000|Overall Study|Unclassified|7|||
44359909|NCT00959049|79365374|FG000|Overall Study|Adverse Event|1|||
44359910|NCT00959049|79365375|FG001|Overall Study|Adverse Event|0|||
44359911|NCT00959049|79365376|FG002|Overall Study|Adverse Event|0|||
44359912|NCT00959049|79365377|FG003|Overall Study|Adverse Event|0|||
44359913|NCT00959049|79365378|FG004|Overall Study|Adverse Event|0|||
44359914|NCT00959049|79365379|FG005|Overall Study|Adverse Event|0|||
44359915|NCT00959049|79365374|FG000|Overall Study|Lost to Follow-up|17|||
44359916|NCT00959049|79365375|FG001|Overall Study|Lost to Follow-up|5|||
44359917|NCT00959049|79365376|FG002|Overall Study|Lost to Follow-up|1|||
44359918|NCT00959049|79365377|FG003|Overall Study|Lost to Follow-up|10|||
44359919|NCT00959049|79365378|FG004|Overall Study|Lost to Follow-up|9|||
44359920|NCT00959049|79365379|FG005|Overall Study|Lost to Follow-up|1|||
44359921|NCT00959049|79365374|FG000|Overall Study|Contraindicated medication|0|||
44359922|NCT00959049|79365375|FG001|Overall Study|Contraindicated medication|0|||
44359923|NCT00959049|79365376|FG002|Overall Study|Contraindicated medication|0|||
44359924|NCT00959049|79365377|FG003|Overall Study|Contraindicated medication|1|||
44359925|NCT00959049|79365378|FG004|Overall Study|Contraindicated medication|0|||
44359926|NCT00959049|79365379|FG005|Overall Study|Contraindicated medication|0|||
44359927|NCT00959049|79365374|FG000|Overall Study|Withdrawal by Subject|0|||
44359928|NCT00959049|79365375|FG001|Overall Study|Withdrawal by Subject|2|||
44359929|NCT00959049|79365376|FG002|Overall Study|Withdrawal by Subject|0|||
44359930|NCT00959049|79365377|FG003|Overall Study|Withdrawal by Subject|0|||
44359931|NCT00959049|79365378|FG004|Overall Study|Withdrawal by Subject|0|||
44359932|NCT00959049|79365379|FG005|Overall Study|Withdrawal by Subject|0|||
44359933|NCT00956943|79365406|FG000|Overall Study|Lost to Follow-up|9|||
44359934|NCT00956943|79365407|FG001|Overall Study|Lost to Follow-up|10|||
44359935|NCT00958893|79365413|FG000|Overall Study|Study prematurely terminated|4|||
44359936|NCT01135914|79365420|FG000|Overall Study|Withdrawal by Subject|1|||
44359937|NCT01135914|79365421|FG001|Overall Study|Withdrawal by Subject|3|||
44359938|NCT01135914|79365422|FG002|Overall Study|Withdrawal by Subject|6|||
44359939|NCT01135914|79365420|FG000|Overall Study|Lost to Follow-up|1|||
44359940|NCT01135914|79365421|FG001|Overall Study|Lost to Follow-up|0|||
44359941|NCT01135914|79365422|FG002|Overall Study|Lost to Follow-up|1|||
44359942|NCT01135914|79365420|FG000|Overall Study|Protocol Violation|0|||
44359943|NCT01135914|79365421|FG001|Overall Study|Protocol Violation|0|||
44359944|NCT01135914|79365422|FG002|Overall Study|Protocol Violation|3|||
44359945|NCT01135914|79365420|FG000|Overall Study|Lack of Efficacy|2|||
44359946|NCT01135914|79365421|FG001|Overall Study|Lack of Efficacy|1|||
44359947|NCT01135914|79365422|FG002|Overall Study|Lack of Efficacy|10|||
44359948|NCT01135914|79365420|FG000|Overall Study|Adverse Event|0|||
44359949|NCT01135914|79365421|FG001|Overall Study|Adverse Event|1|||
44359950|NCT01135914|79365422|FG002|Overall Study|Adverse Event|2|||
44359951|NCT00907738|79365435|FG000|Overall Study|Adverse Event|2|||
44359952|NCT00907738|79365436|FG001|Overall Study|Adverse Event|0|||
44359953|NCT00907738|79365437|FG002|Overall Study|Adverse Event|1|||
44359954|NCT00907738|79365438|FG003|Overall Study|Adverse Event|0|||
44359955|NCT00907738|79365439|FG004|Overall Study|Adverse Event|0|||
44359956|NCT00907738|79365435|FG000|Overall Study|not specified or withdrew consent|3|||
44359957|NCT00907738|79365436|FG001|Overall Study|not specified or withdrew consent|0|||
44359958|NCT00907738|79365437|FG002|Overall Study|not specified or withdrew consent|0|||
44359959|NCT00907738|79365438|FG003|Overall Study|not specified or withdrew consent|0|||
44359960|NCT00907738|79365439|FG004|Overall Study|not specified or withdrew consent|0|||
44359961|NCT00907738|79365435|FG000|Overall Study|Disease progression|8|||
44359962|NCT00907738|79365436|FG001|Overall Study|Disease progression|1|||
44359963|NCT00907738|79365437|FG002|Overall Study|Disease progression|6|||
44359964|NCT00907738|79365438|FG003|Overall Study|Disease progression|4|||
44359965|NCT00907738|79365439|FG004|Overall Study|Disease progression|2|||
44359966|NCT01123356|79365455|FG000|Overall Study|Adverse Event|2|||
44359967|NCT01123356|79365455|FG000|Overall Study|Lack of Efficacy|4|||
44359968|NCT01123356|79365455|FG000|Overall Study|Withdrawal by Subject|1|||
44359969|NCT00908596|79365464|FG000|Overall Study|Other reasons|46|||
44359970|NCT00908596|79365465|FG001|Overall Study|Other reasons|6|||
44359971|NCT00908596|79365466|FG002|Overall Study|Other reasons|2|||
44359972|NCT00908596|79365467|FG003|Overall Study|Other reasons|0|||
44359973|NCT00908596|79365464|FG000|Overall Study|Lost to Follow-up|0|||
44359974|NCT00908596|79365465|FG001|Overall Study|Lost to Follow-up|1|||
44359975|NCT00908596|79365466|FG002|Overall Study|Lost to Follow-up|12|||
44359976|NCT00908596|79365467|FG003|Overall Study|Lost to Follow-up|4|||
44359977|NCT00908596|79365464|FG000|Overall Study|Death|0|||
44359978|NCT00908596|79365465|FG001|Overall Study|Death|5|||
44359979|NCT00908596|79365466|FG002|Overall Study|Death|57|||
44359980|NCT00908596|79365467|FG003|Overall Study|Death|32|||
44359981|NCT00908596|79365464|FG000|Overall Study|Protocol Violation|1|||
44359982|NCT00908596|79365465|FG001|Overall Study|Protocol Violation|0|||
44359983|NCT00908596|79365466|FG002|Overall Study|Protocol Violation|0|||
44359984|NCT00908596|79365467|FG003|Overall Study|Protocol Violation|0|||
44359985|NCT00908596|79365464|FG000|Overall Study|Withdrawal by Subject|0|||
44359986|NCT00908596|79365465|FG001|Overall Study|Withdrawal by Subject|1|||
44359987|NCT00908596|79365466|FG002|Overall Study|Withdrawal by Subject|3|||
44359988|NCT00908596|79365467|FG003|Overall Study|Withdrawal by Subject|1|||
44359989|NCT01118052|79365477|FG000|Overall Study|Never treated|2|||
44359990|NCT01123200|79365487|FG000|Overall Study|Withdrawal by Subject|1|||
44359991|NCT00955617|79365491|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
44359992|NCT00955617|79365492|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
44359993|NCT00955617|79365491|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
44359994|NCT00955617|79365492|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
44359995|NCT00955617|79365491|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
44359996|NCT00955617|79365492|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
44359997|NCT00955617|79365491|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
44359998|NCT00955617|79365492|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
44359999|NCT00958347|79365498|FG000|Overall Study|Death|43|||
44360000|NCT00958347|79365498|FG000|Overall Study|Withdrawal by Subject|23|||
44360001|NCT00958347|79365498|FG000|Overall Study|Lost to Follow-up|15|||
44360002|NCT00958347|79365498|FG000|Overall Study|revision/removal|10|||
44360003|NCT00958347|79365498|FG000|Overall Study|study termination|135|||
44360004|NCT00958191|79365502|FG000|Overall Study|Death|4|||
44360005|NCT00958191|79365502|FG000|Overall Study|Lost to Follow-up|5|||
44360006|NCT00958191|79365502|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
44360007|NCT00958191|79365502|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
44360008|NCT00958191|79365502|FG000|Overall Study|Revision of study device|4|||
44360009|NCT00958191|79365502|FG000|Overall Study|Site termination|11|||
44360010|NCT00958191|79365502|FG000|Overall Study|No 5 yr x-rays|56|||
44360011|NCT00960843|79365510|FG000|Overall Study|Lost to Follow-up|2|||
44360012|NCT00960843|79365511|FG001|Overall Study|Lost to Follow-up|0|||
44360013|NCT00960843|79365510|FG000|Overall Study|Protocol Violation|0|||
44360014|NCT00960843|79365511|FG001|Overall Study|Protocol Violation|4|||
44360015|NCT00960843|79365510|FG000|Overall Study|Repeated needle dislodgment|0|||
44360016|NCT00960843|79365511|FG001|Overall Study|Repeated needle dislodgment|1|||
44360017|NCT01605253|79365519|FG000|Overall Study|Physician Decision|3|||
44360018|NCT01605253|79365520|FG001|Overall Study|Physician Decision|2|||
44360019|NCT01605253|79365519|FG000|Overall Study|Lost to Follow-up|3|||
44360020|NCT01605253|79365520|FG001|Overall Study|Lost to Follow-up|1|||
44360021|NCT00955305|79365530|FG000|Overall Study|Disease progression|39|||
44360022|NCT00955305|79365531|FG001|Overall Study|Disease progression|41|||
44360023|NCT00955305|79365530|FG000|Overall Study|Adverse Event|22|||
44360024|NCT00955305|79365531|FG001|Overall Study|Adverse Event|22|||
44360025|NCT00955305|79365530|FG000|Overall Study|Death|2|||
44360026|NCT00955305|79365531|FG001|Overall Study|Death|1|||
44360027|NCT00955305|79365530|FG000|Overall Study|Withdrawal by Subject|5|||
44360028|NCT00955305|79365531|FG001|Overall Study|Withdrawal by Subject|4|||
44360029|NCT00955305|79365530|FG000|Overall Study|Alternative therapy|4|||
44360030|NCT00955305|79365531|FG001|Overall Study|Alternative therapy|0|||
44360031|NCT00955305|79365530|FG000|Overall Study|Other complicating disease|2|||
44360032|NCT00955305|79365531|FG001|Overall Study|Other complicating disease|4|||
44360033|NCT00955305|79365530|FG000|Overall Study|Physician Decision|1|||
44360034|NCT00955305|79365531|FG001|Overall Study|Physician Decision|0|||
44360035|NCT00955305|79365530|FG000|Overall Study|Continued presence of residual disease|0|||
44360036|NCT00955305|79365531|FG001|Overall Study|Continued presence of residual disease|1|||
44360037|NCT00955305|79365530|FG000|Overall Study|Functional decline|2|||
44360038|NCT00955305|79365531|FG001|Overall Study|Functional decline|0|||
44360039|NCT00955305|79365530|FG000|Overall Study|Maximum response achieved|0|||
44360040|NCT00955305|79365531|FG001|Overall Study|Maximum response achieved|1|||
44360041|NCT00955305|79365530|FG000|Overall Study|Lost to Follow-up|0|||
44360042|NCT00955305|79365531|FG001|Overall Study|Lost to Follow-up|1|||
44360043|NCT00955305|79365530|FG000|Overall Study|No off-treatment reason submitted|1|||
44360044|NCT00955305|79365531|FG001|Overall Study|No off-treatment reason submitted|0|||
44360045|NCT00955305|79365530|FG000|Overall Study|Never started protocol treatment|5|||
44360046|NCT00955305|79365531|FG001|Overall Study|Never started protocol treatment|5|||
44360047|NCT00955305|79365530|FG000|Overall Study|Ineligible|5|||
44360048|NCT00955305|79365531|FG001|Overall Study|Ineligible|7|||
44360049|NCT00598585|79365539|FG000|Overall Study|Lost to Follow-up|1|||
44360050|NCT00598585|79365540|FG001|Overall Study|Lost to Follow-up|0|||
44360051|NCT00953667|79365546|FG000|Overall Study|Lost to Follow-up|11|||
44360052|NCT00953667|79365546|FG000|Overall Study|Physician Decision|35|||
44360053|NCT00953667|79365546|FG000|Overall Study|Withdrawal by Subject|63|||
44360054|NCT00953667|79365546|FG000|Overall Study|Adverse Event|10|||
44360055|NCT00953667|79365546|FG000|Overall Study|poor venous access,unable to draw blood|4|||
44360056|NCT00883129|79365552|FG000|Overall Study|Adverse Event|7|||
44360057|NCT00883129|79365553|FG001|Overall Study|Adverse Event|15|||
44360058|NCT00883129|79365552|FG000|Overall Study|Withdrawal by Subject|8|||
44360059|NCT00883129|79365553|FG001|Overall Study|Withdrawal by Subject|9|||
44360060|NCT00883129|79365552|FG000|Overall Study|Non-compliance|3|||
44360061|NCT00883129|79365553|FG001|Overall Study|Non-compliance|6|||
44360062|NCT00883129|79365552|FG000|Overall Study|Lost to Follow-up|1|||
44360063|NCT00883129|79365553|FG001|Overall Study|Lost to Follow-up|2|||
44360064|NCT00883129|79365552|FG000|Overall Study|Death|1|||
44360065|NCT00883129|79365553|FG001|Overall Study|Death|2|||
44360066|NCT00883129|79365552|FG000|Overall Study|Defined Treatment Failure|0|||
44360067|NCT00883129|79365553|FG001|Overall Study|Defined Treatment Failure|2|||
44360068|NCT00905632|79365584|FG000|Overall Study|Adverse Event|0|||
44360069|NCT00905632|79365585|FG001|Overall Study|Adverse Event|0|||
44360070|NCT00905632|79365586|FG002|Overall Study|Adverse Event|0|||
44360071|NCT00905632|79365587|FG003|Overall Study|Adverse Event|0|||
44360072|NCT00905632|79365588|FG004|Overall Study|Adverse Event|0|||
44360073|NCT00905632|79365589|FG005|Overall Study|Adverse Event|1|||
44360074|NCT00905632|79365590|FG006|Overall Study|Adverse Event|4|||
44360075|NCT00954447|79365615|FG000|Overall Study|Adverse Event|33|||
44360076|NCT00954447|79365616|FG001|Overall Study|Adverse Event|25|||
44360077|NCT00954447|79365615|FG000|Overall Study|Lack of Efficacy|17|||
44360078|NCT00954447|79365616|FG001|Overall Study|Lack of Efficacy|3|||
44360079|NCT00954447|79365615|FG000|Overall Study|Protocol Violation|5|||
44360080|NCT00954447|79365616|FG001|Overall Study|Protocol Violation|7|||
44360081|NCT00954447|79365615|FG000|Overall Study|Lost to Follow-up|8|||
44360082|NCT00954447|79365616|FG001|Overall Study|Lost to Follow-up|14|||
44360083|NCT00954447|79365615|FG000|Overall Study|Withdrawal by Subject|26|||
44360084|NCT00954447|79365616|FG001|Overall Study|Withdrawal by Subject|21|||
44360085|NCT00954447|79365615|FG000|Overall Study|Other|21|||
44360086|NCT00954447|79365616|FG001|Overall Study|Other|18|||
44360087|NCT00904150|79365624|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
44360088|NCT00904150|79365625|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
44360089|NCT00904150|79365624|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
44360090|NCT00904150|79365625|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
44360091|NCT00903760|79365633|FG000|Overall Study|Disease Progression/Death|8|||
44360092|NCT00903760|79365634|FG001|Overall Study|Disease Progression/Death|6|||
44360093|NCT00903760|79365633|FG000|Overall Study|Stem Cell Transplant|8|||
44360094|NCT00903760|79365634|FG001|Overall Study|Stem Cell Transplant|4|||
44360095|NCT00903760|79365633|FG000|Overall Study|Physician Decision|1|||
44360096|NCT00903760|79365634|FG001|Overall Study|Physician Decision|2|||
44360097|NCT00903760|79365633|FG000|Overall Study|Death|0|||
44360098|NCT00903760|79365634|FG001|Overall Study|Death|1|||
44360099|NCT00903760|79365633|FG000|Overall Study|Lost to Follow-up|1|||
44360100|NCT00903760|79365634|FG001|Overall Study|Lost to Follow-up|0|||
44360101|NCT00903760|79365633|FG000|Overall Study|Withdrawal by Subject|1|||
44360102|NCT00903760|79365634|FG001|Overall Study|Withdrawal by Subject|2|||
44360103|NCT00903760|79365633|FG000|Overall Study|Off treatment for long period|0|||
44360104|NCT00903760|79365634|FG001|Overall Study|Off treatment for long period|1|||
44360105|NCT00883051|79365645|FG000|Overall Study|Lost to Follow-up|0|||
44360106|NCT00883051|79365646|FG001|Overall Study|Lost to Follow-up|0|||
44360107|NCT00883051|79365647|FG002|Overall Study|Lost to Follow-up|0|||
44360108|NCT00883051|79365648|FG003|Overall Study|Lost to Follow-up|0|||
44360109|NCT00883051|79365649|FG004|Overall Study|Lost to Follow-up|1|||
44360110|NCT00883051|79365645|FG000|Overall Study|Did not use study medication|24|||
44360111|NCT00883051|79365646|FG001|Overall Study|Did not use study medication|22|||
44360112|NCT00883051|79365647|FG002|Overall Study|Did not use study medication|29|||
44360113|NCT00883051|79365648|FG003|Overall Study|Did not use study medication|29|||
44360114|NCT00883051|79365649|FG004|Overall Study|Did not use study medication|17|||
44360115|NCT00903682|79365663|FG000|Overall Study|Adverse Event|6|||
44360116|NCT00903682|79365664|FG001|Overall Study|Adverse Event|13|||
44360117|NCT00903682|79365663|FG000|Overall Study|Lost to Follow-up|1|||
44360118|NCT00903682|79365664|FG001|Overall Study|Lost to Follow-up|0|||
44360119|NCT00903682|79365663|FG000|Overall Study|Withdrawal by Subject|5|||
44360120|NCT00903682|79365664|FG001|Overall Study|Withdrawal by Subject|0|||
44360121|NCT00903682|79365663|FG000|Overall Study|Pregnancy|0|||
44360122|NCT00903682|79365664|FG001|Overall Study|Pregnancy|1|||
44360123|NCT00903682|79365663|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
44360124|NCT00903682|79365664|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
44360125|NCT00903682|79365663|FG000|Overall Study|Subject Non-Compliant|1|||
44360126|NCT00903682|79365664|FG001|Overall Study|Subject Non-Compliant|0|||
44360127|NCT00903682|79365663|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
44360128|NCT00903682|79365664|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
44360129|NCT00903682|79365663|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
44360130|NCT00903682|79365664|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
44360131|NCT01117428|79365676|FG000|Overall Study|Lack of Efficacy|1|||
44360132|NCT01117428|79365677|FG001|Overall Study|Lack of Efficacy|0|||
44360133|NCT01117428|79365678|FG002|Overall Study|Lack of Efficacy|0|||
44360134|NCT01117428|79365679|FG003|Overall Study|Lack of Efficacy|0|||
44360135|NCT01117428|79365680|FG004|Overall Study|Lack of Efficacy|0|||
44360136|NCT01117428|79365681|FG005|Overall Study|Lack of Efficacy|0|||
44360137|NCT01117428|79365676|FG000|Overall Study|Adverse Event|4|||
44360138|NCT01117428|79365677|FG001|Overall Study|Adverse Event|0|||
44360139|NCT01117428|79365678|FG002|Overall Study|Adverse Event|0|||
44360140|NCT01117428|79365679|FG003|Overall Study|Adverse Event|0|||
44360141|NCT01117428|79365680|FG004|Overall Study|Adverse Event|1|||
44360142|NCT01117428|79365681|FG005|Overall Study|Adverse Event|2|||
44360143|NCT01117428|79365676|FG000|Overall Study|Death|0|||
44360144|NCT01117428|79365677|FG001|Overall Study|Death|1|||
44360145|NCT01117428|79365678|FG002|Overall Study|Death|2|||
44360146|NCT01117428|79365679|FG003|Overall Study|Death|0|||
44360147|NCT01117428|79365680|FG004|Overall Study|Death|0|||
44360148|NCT01117428|79365681|FG005|Overall Study|Death|1|||
44360149|NCT01117428|79365676|FG000|Overall Study|Physician Decision|0|||
44360150|NCT01117428|79365677|FG001|Overall Study|Physician Decision|1|||
44360151|NCT01117428|79365678|FG002|Overall Study|Physician Decision|0|||
44360152|NCT01117428|79365679|FG003|Overall Study|Physician Decision|0|||
44360153|NCT01117428|79365680|FG004|Overall Study|Physician Decision|0|||
44360154|NCT01117428|79365681|FG005|Overall Study|Physician Decision|0|||
44360155|NCT01117428|79365676|FG000|Overall Study|Withdrawal by Subject|0|||
44360156|NCT01117428|79365677|FG001|Overall Study|Withdrawal by Subject|0|||
44360157|NCT01117428|79365678|FG002|Overall Study|Withdrawal by Subject|1|||
44360158|NCT01117428|79365679|FG003|Overall Study|Withdrawal by Subject|0|||
44360159|NCT01117428|79365680|FG004|Overall Study|Withdrawal by Subject|0|||
44360160|NCT01117428|79365681|FG005|Overall Study|Withdrawal by Subject|0|||
44360161|NCT01117428|79365676|FG000|Overall Study|Progressive disease|15|||
44360162|NCT01117428|79365677|FG001|Overall Study|Progressive disease|27|||
44360163|NCT01117428|79365678|FG002|Overall Study|Progressive disease|10|||
44360164|NCT01117428|79365679|FG003|Overall Study|Progressive disease|12|||
44360165|NCT01117428|79365680|FG004|Overall Study|Progressive disease|16|||
44360166|NCT01117428|79365681|FG005|Overall Study|Progressive disease|17|||
44360167|NCT00655681|79365699|FG000|Overall Study|Lost to Follow-up|1|||
44360168|NCT00655681|79365700|FG001|Overall Study|Lost to Follow-up|1|||
44360169|NCT01135524|79365719|FG000|Overall Study|Withdrawal by Subject|14|||
44360170|NCT01135524|79365719|FG000|Overall Study|Adverse Event|20|||
44360171|NCT01135524|79365719|FG000|Overall Study|Lost to Follow-up|3|||
44360172|NCT01135524|79365719|FG000|Overall Study|Administrative|151|||
44360173|NCT01135524|79365719|FG000|Overall Study|Lack of Efficacy|8|||
44360174|NCT00948675|79365725|FG000|Overall Study|Lost to Follow-up|1|||
44360175|NCT00948675|79365726|FG001|Overall Study|Lost to Follow-up|0|||
44360176|NCT00903370|79365734|FG000|Overall Study|Death|13|||
44360177|NCT00903370|79365735|FG001|Overall Study|Death|10|||
44360178|NCT00903370|79365734|FG000|Overall Study|Withdrawal by Subject|9|||
44360179|NCT00903370|79365735|FG001|Overall Study|Withdrawal by Subject|6|||
44360180|NCT00903370|79365734|FG000|Overall Study|Lost to Follow-up|6|||
44360181|NCT00903370|79365735|FG001|Overall Study|Lost to Follow-up|8|||
44360182|NCT01110408|79365743|FG000|Overall Study|Protocol Violation|1|||
44360183|NCT01110408|79365744|FG001|Overall Study|Protocol Violation|0|||
44360184|NCT00953043|79365752|FG000|Overall Study|Withdrawal by Subject|4|||
44360185|NCT00953043|79365753|FG001|Overall Study|Withdrawal by Subject|0|||
44360186|NCT00953043|79365752|FG000|Overall Study|Physician Decision|0|||
44360187|NCT00953043|79365753|FG001|Overall Study|Physician Decision|2|||
44360188|NCT01135134|79365761|FG000|Overall Study|Adverse Event|1|||
44360189|NCT01135134|79365762|FG001|Overall Study|Adverse Event|1|||
44360190|NCT01135134|79365761|FG000|Overall Study|Did not meet protocol eligibility|1|||
44360191|NCT01135134|79365762|FG001|Overall Study|Did not meet protocol eligibility|0|||
44360192|NCT00948441|79365770|FG000|Overall Study|no longer meet inclusion criteria|1|||
44360193|NCT00948441|79365771|FG001|Overall Study|no longer meet inclusion criteria|4|||
44360194|NCT01117350|79365781|FG000|Comparative Period|Not Treated|5|||
44360195|NCT01117350|79365782|FG001|Comparative Period|Not Treated|8|||
44360196|NCT01117350|79365781|FG000|Comparative Period|Adverse Event|6|||
44360197|NCT01117350|79365782|FG001|Comparative Period|Adverse Event|33|||
44360198|NCT01117350|79365781|FG000|Comparative Period|Lost to Follow-up|11|||
44360199|NCT01117350|79365782|FG001|Comparative Period|Lost to Follow-up|7|||
44360200|NCT01117350|79365781|FG000|Comparative Period|Withdrawal by Subject|9|||
44360201|NCT01117350|79365782|FG001|Comparative Period|Withdrawal by Subject|13|||
44360202|NCT01117350|79365781|FG000|Comparative Period|Protocol Violation|8|||
44360203|NCT01117350|79365782|FG001|Comparative Period|Protocol Violation|12|||
44360204|NCT01117350|79365781|FG000|Comparative Period|Lack of Efficacy|1|||
44360205|NCT01117350|79365782|FG001|Comparative Period|Lack of Efficacy|0|||
44360206|NCT01117350|79365781|FG000|Comparative Period|Physician Decision|0|||
44360207|NCT01117350|79365782|FG001|Comparative Period|Physician Decision|1|||
44360208|NCT01117350|79365781|FG000|Comparative Period|Move to another city/country|2|||
44360209|NCT01117350|79365782|FG001|Comparative Period|Move to another city/country|1|||
44360210|NCT01117350|79365781|FG000|Extension Period|Not included in extension, not treated|0|||
44360211|NCT01117350|79365782|FG001|Extension Period|Not included in extension, not treated|50|||
44360212|NCT01117350|79365781|FG000|Extension Period|Adverse Event|0|||
44360213|NCT01117350|79365782|FG001|Extension Period|Adverse Event|2|||
44360214|NCT01117350|79365781|FG000|Extension Period|Protocol Violation|0|||
44360215|NCT01117350|79365782|FG001|Extension Period|Protocol Violation|2|||
44360216|NCT01117350|79365781|FG000|Extension Period|Lost to Follow-up|0|||
44360217|NCT01117350|79365782|FG001|Extension Period|Lost to Follow-up|2|||
44360218|NCT01117350|79365781|FG000|Extension Period|Withdrawal by Subject|0|||
44360219|NCT01117350|79365782|FG001|Extension Period|Withdrawal by Subject|3|||
44360220|NCT01117350|79365781|FG000|Extension Period|Lack of Efficacy|0|||
44360221|NCT01117350|79365782|FG001|Extension Period|Lack of Efficacy|2|||
44360222|NCT01117350|79365781|FG000|Extension Period|Inclusion criteria not respected|0|||
44360223|NCT01117350|79365782|FG001|Extension Period|Inclusion criteria not respected|1|||
44360224|NCT01117350|79365781|FG000|Extension Period|Prohibited medication|0|||
44360225|NCT01117350|79365782|FG001|Extension Period|Prohibited medication|1|||
44360226|NCT00952731|79365793|FG000|Overall Study|Drug supply expired|1|||
44360227|NCT00952731|79365794|FG001|Overall Study|Drug supply expired|0|||
44360228|NCT00947427|79365802|FG000|Overall Study|Withdrawal by Subject|1|||
44360229|NCT00947427|79365803|FG001|Overall Study|Withdrawal by Subject|3|||
44360230|NCT00947427|79365802|FG000|Overall Study|Protocol Violation|0|||
44360231|NCT00947427|79365803|FG001|Overall Study|Protocol Violation|1|||
44360232|NCT01116882|79365811|FG000|30-day|Lost to Follow-up|50|||
44360233|NCT01116882|79365812|FG001|30-day|Lost to Follow-up|21|||
44360234|NCT01116882|79365811|FG000|30-day|Withdrawal by Subject|2|||
44360235|NCT01116882|79365812|FG001|30-day|Withdrawal by Subject|4|||
44360236|NCT01116882|79365811|FG000|30-day|Other Reasons|16|||
44360237|NCT01116882|79365812|FG001|30-day|Other Reasons|6|||
44360238|NCT01116882|79365811|FG000|12-month|Lost to Follow-up|111|||
44143669|NCT00271817|78932989|FG001|Part 1|LDL < 50 mg/dL|4|||
44264178|NCT03401450|79164442|FG000|Overall Study|Anesthesia plan changed|2|||
44360239|NCT01116882|79365812|FG001|12-month|Lost to Follow-up|42|||
44360240|NCT01116882|79365811|FG000|12-month|Other Reasons|151|||
44360241|NCT01116882|79365812|FG001|12-month|Other Reasons|49|||
44360242|NCT01116882|79365811|FG000|12-month|Withdrawal by Subject|5|||
44360243|NCT01116882|79365812|FG001|12-month|Withdrawal by Subject|8|||
44360244|NCT00953745|79365823|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
44360245|NCT00953745|79365824|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
44360246|NCT00953745|79365823|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
44360247|NCT00953745|79365824|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
44360248|NCT00953745|79365823|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
44360249|NCT00953745|79365824|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
44360250|NCT00953745|79365823|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
44360251|NCT00953745|79365824|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
44360252|NCT00953745|79365823|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
44360253|NCT00953745|79365824|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
44360254|NCT00953745|79365823|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
44360255|NCT00953745|79365824|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
44360256|NCT00902746|79365841|FG000|Overall Study|Protocol Violation|7|||
44360257|NCT00902746|79365841|FG000|Overall Study|Withdrawal by Subject|16|||
44360258|NCT00902746|79365841|FG000|Overall Study|Adverse Event|8|||
44360259|NCT00902746|79365841|FG000|Overall Study|Lost to Follow-up|3|||
44360260|NCT00902746|79365841|FG000|Overall Study|Physician Decision|2|||
44360261|NCT00902668|79365854|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
44360262|NCT00947349|79365862|FG000|Triple Treatment Combination Period|Adverse Event|0|||
44360263|NCT00947349|79365863|FG001|Triple Treatment Combination Period|Adverse Event|1|||
44360264|NCT00947349|79365864|FG002|Triple Treatment Combination Period|Adverse Event|0|||
44360265|NCT00947349|79365865|FG003|Triple Treatment Combination Period|Adverse Event|0|||
44360266|NCT00947349|79365862|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
44360267|NCT00947349|79365863|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
44360268|NCT00947349|79365864|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
44360269|NCT00947349|79365865|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
44360270|NCT00947349|79365862|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
44360271|NCT00947349|79365863|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
44360272|NCT00947349|79365864|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
44360273|NCT00947349|79365865|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
44360274|NCT00947349|79365862|FG000|Overall Study Standard of Care|Other|0|||
44360275|NCT00947349|79365863|FG001|Overall Study Standard of Care|Other|0|||
44360276|NCT00947349|79365864|FG002|Overall Study Standard of Care|Other|0|||
44360277|NCT00947349|79365865|FG003|Overall Study Standard of Care|Other|1|||
44360278|NCT00947193|79365893|FG000|Overall Study|Lost to Follow-up|1|||
44360279|NCT00947193|79365894|FG001|Overall Study|Lost to Follow-up|0|||
44360280|NCT00947193|79365893|FG000|Overall Study|Withdrawal by Subject|1|||
44360281|NCT00947193|79365894|FG001|Overall Study|Withdrawal by Subject|0|||
44360282|NCT00947193|79365893|FG000|Overall Study|Factor VIII >1%|1|||
44360283|NCT00947193|79365894|FG001|Overall Study|Factor VIII >1%|0|||
44360284|NCT00947115|79365902|FG000|Overall Study|Missed reporting interval|3|||
44360285|NCT00947115|79365903|FG001|Overall Study|Missed reporting interval|4|||
44360286|NCT00947115|79365904|FG002|Overall Study|Missed reporting interval|2|||
44360287|NCT00947115|79365902|FG000|Overall Study|Physician Decision|0|||
44360288|NCT00947115|79365903|FG001|Overall Study|Physician Decision|2|||
44360289|NCT00947115|79365904|FG002|Overall Study|Physician Decision|0|||
44360290|NCT00947115|79365902|FG000|Overall Study|Death|0|||
44360291|NCT00947115|79365903|FG001|Overall Study|Death|1|||
44360292|NCT00947115|79365904|FG002|Overall Study|Death|1|||
44360293|NCT00947115|79365902|FG000|Overall Study|Migrated from study area|2|||
44360294|NCT00947115|79365903|FG001|Overall Study|Migrated from study area|0|||
44360295|NCT00947115|79365904|FG002|Overall Study|Migrated from study area|0|||
44360296|NCT00947115|79365902|FG000|Overall Study|Withdrawal by Subject|1|||
44360297|NCT00947115|79365903|FG001|Overall Study|Withdrawal by Subject|3|||
44360298|NCT00947115|79365904|FG002|Overall Study|Withdrawal by Subject|4|||
44360299|NCT00947115|79365902|FG000|Overall Study|Lost to Follow-up|11|||
44360300|NCT00947115|79365903|FG001|Overall Study|Lost to Follow-up|12|||
44360301|NCT00947115|79365904|FG002|Overall Study|Lost to Follow-up|8|||
44360302|NCT00952419|79365915|FG000|Overall Study|Adverse Event|2|||
44360303|NCT00952419|79365916|FG001|Overall Study|Adverse Event|0|||
44360304|NCT00952419|79365917|FG002|Overall Study|Adverse Event|0|||
44360305|NCT00952419|79365915|FG000|Overall Study|Protocol Violation|3|||
44360306|NCT00952419|79365916|FG001|Overall Study|Protocol Violation|7|||
44360307|NCT00952419|79365917|FG002|Overall Study|Protocol Violation|0|||
44360308|NCT00952419|79365915|FG000|Overall Study|Withdrawal by Subject|1|||
44360309|NCT00952419|79365916|FG001|Overall Study|Withdrawal by Subject|3|||
44360310|NCT00952419|79365917|FG002|Overall Study|Withdrawal by Subject|0|||
44360311|NCT00902278|79365930|FG000|Overall Study|Physician Decision|1|||
44360312|NCT00902278|79365931|FG001|Overall Study|Physician Decision|0|||
44360313|NCT00902278|79365932|FG002|Overall Study|Physician Decision|2|||
44360314|NCT00902278|79365933|FG003|Overall Study|Physician Decision|0|||
44360315|NCT00902278|79365934|FG004|Overall Study|Physician Decision|1|||
44360316|NCT00902278|79365930|FG000|Overall Study|Lost to Follow-up|3|||
44360317|NCT00902278|79365931|FG001|Overall Study|Lost to Follow-up|2|||
44360318|NCT00902278|79365932|FG002|Overall Study|Lost to Follow-up|3|||
44360319|NCT00902278|79365933|FG003|Overall Study|Lost to Follow-up|0|||
44360320|NCT00902278|79365934|FG004|Overall Study|Lost to Follow-up|1|||
44360321|NCT01998633|79365948|FG000|Overall Study|Death|1|||
44360322|NCT00952341|79365958|FG000|Cycle 1|Adverse Event|4|||
44360323|NCT00952341|79365959|FG001|Cycle 1|Adverse Event|1|||
44360324|NCT00952341|79365958|FG000|Cycle 1|Withdrawal by Subject|3|||
44360325|NCT00952341|79365959|FG001|Cycle 1|Withdrawal by Subject|8|||
44360326|NCT00952341|79365958|FG000|Cycle 1|Protocol Violation|2|||
44360327|NCT00952341|79365959|FG001|Cycle 1|Protocol Violation|1|||
44360328|NCT00952341|79365958|FG000|Cycle 1|Lost to Follow-up|11|||
44360329|NCT00952341|79365959|FG001|Cycle 1|Lost to Follow-up|2|||
44360330|NCT00952341|79365958|FG000|Cycle 1|Physician Decision|0|||
44360331|NCT00952341|79365959|FG001|Cycle 1|Physician Decision|1|||
44360332|NCT00952341|79365958|FG000|Cycle 2|Withdrawal by Subject|1|||
44360333|NCT00952341|79365959|FG001|Cycle 2|Withdrawal by Subject|1|||
44360334|NCT00952341|79365958|FG000|Cycle 2|Protocol Violation|1|||
44360335|NCT00952341|79365959|FG001|Cycle 2|Protocol Violation|0|||
44360336|NCT00952341|79365958|FG000|Cycle 2|Lost to Follow-up|6|||
44360337|NCT00952341|79365959|FG001|Cycle 2|Lost to Follow-up|9|||
44360338|NCT00952341|79365958|FG000|Cycle 2|Physician Decision|1|||
44360339|NCT00952341|79365959|FG001|Cycle 2|Physician Decision|1|||
44360340|NCT00952341|79365958|FG000|Cycle 2|Progressive Disease|0|||
44360341|NCT00952341|79365959|FG001|Cycle 2|Progressive Disease|1|||
44360342|NCT01214642|79365977|FG000|Overall Study|Progressive Disease|3|||
44360343|NCT01214642|79365978|FG001|Overall Study|Progressive Disease|2|||
44360344|NCT01214642|79365979|FG002|Overall Study|Progressive Disease|3|||
44360345|NCT01214642|79365980|FG003|Overall Study|Progressive Disease|5|||
44360346|NCT01214642|79365981|FG004|Overall Study|Progressive Disease|5|||
44360347|NCT01214642|79365982|FG005|Overall Study|Progressive Disease|3|||
44360348|NCT01214642|79365983|FG006|Overall Study|Progressive Disease|5|||
44360349|NCT01214642|79365984|FG007|Overall Study|Progressive Disease|3|||
44360350|NCT01214642|79365985|FG008|Overall Study|Progressive Disease|10|||
44360351|NCT01214642|79365986|FG009|Overall Study|Progressive Disease|2|||
44360352|NCT01214642|79365987|FG010|Overall Study|Progressive Disease|1|||
44360353|NCT01214642|79365988|FG011|Overall Study|Progressive Disease|4|||
44360354|NCT01214642|79365977|FG000|Overall Study|Adverse Event|0|||
44360355|NCT01214642|79365978|FG001|Overall Study|Adverse Event|1|||
44360356|NCT01214642|79365979|FG002|Overall Study|Adverse Event|0|||
44360357|NCT01214642|79365980|FG003|Overall Study|Adverse Event|0|||
44360358|NCT01214642|79365981|FG004|Overall Study|Adverse Event|0|||
44360359|NCT01214642|79365982|FG005|Overall Study|Adverse Event|0|||
44360360|NCT01214642|79365983|FG006|Overall Study|Adverse Event|1|||
44360361|NCT01214642|79365984|FG007|Overall Study|Adverse Event|0|||
44360362|NCT01214642|79365985|FG008|Overall Study|Adverse Event|0|||
44360363|NCT01214642|79365986|FG009|Overall Study|Adverse Event|1|||
44360364|NCT01214642|79365987|FG010|Overall Study|Adverse Event|1|||
44360365|NCT01214642|79365988|FG011|Overall Study|Adverse Event|0|||
44360366|NCT01214642|79365977|FG000|Overall Study|Death|0|||
44360367|NCT01214642|79365978|FG001|Overall Study|Death|0|||
44360368|NCT01214642|79365979|FG002|Overall Study|Death|1|||
44360369|NCT01214642|79365980|FG003|Overall Study|Death|0|||
44360370|NCT01214642|79365981|FG004|Overall Study|Death|0|||
44360371|NCT01214642|79365982|FG005|Overall Study|Death|0|||
44360372|NCT01214642|79365983|FG006|Overall Study|Death|0|||
44360373|NCT01214642|79365984|FG007|Overall Study|Death|0|||
44360374|NCT01214642|79365985|FG008|Overall Study|Death|0|||
44360375|NCT01214642|79365986|FG009|Overall Study|Death|0|||
44360376|NCT01214642|79365987|FG010|Overall Study|Death|1|||
44360377|NCT01214642|79365988|FG011|Overall Study|Death|0|||
44360378|NCT01214642|79365977|FG000|Overall Study|Withdrawal by Subject|0|||
44360379|NCT01214642|79365978|FG001|Overall Study|Withdrawal by Subject|0|||
44360380|NCT01214642|79365979|FG002|Overall Study|Withdrawal by Subject|1|||
44360381|NCT01214642|79365980|FG003|Overall Study|Withdrawal by Subject|0|||
44360382|NCT01214642|79365981|FG004|Overall Study|Withdrawal by Subject|0|||
44360383|NCT01214642|79365982|FG005|Overall Study|Withdrawal by Subject|0|||
44360384|NCT01214642|79365983|FG006|Overall Study|Withdrawal by Subject|0|||
44360385|NCT01214642|79365984|FG007|Overall Study|Withdrawal by Subject|0|||
44360386|NCT01214642|79365985|FG008|Overall Study|Withdrawal by Subject|3|||
44360387|NCT01214642|79365986|FG009|Overall Study|Withdrawal by Subject|1|||
44360388|NCT01214642|79365987|FG010|Overall Study|Withdrawal by Subject|1|||
44360389|NCT01214642|79365988|FG011|Overall Study|Withdrawal by Subject|0|||
44360390|NCT01214642|79365977|FG000|Overall Study|Physician Decision|0|||
44360391|NCT01214642|79365978|FG001|Overall Study|Physician Decision|0|||
44360392|NCT01214642|79365979|FG002|Overall Study|Physician Decision|1|||
44360393|NCT01214642|79365980|FG003|Overall Study|Physician Decision|1|||
44360394|NCT01214642|79365981|FG004|Overall Study|Physician Decision|1|||
44360395|NCT01214642|79365982|FG005|Overall Study|Physician Decision|0|||
44360396|NCT01214642|79365983|FG006|Overall Study|Physician Decision|0|||
44360397|NCT01214642|79365984|FG007|Overall Study|Physician Decision|0|||
44360398|NCT01214642|79365985|FG008|Overall Study|Physician Decision|0|||
44360399|NCT01214642|79365986|FG009|Overall Study|Physician Decision|0|||
44360400|NCT01214642|79365987|FG010|Overall Study|Physician Decision|0|||
44360401|NCT01214642|79365988|FG011|Overall Study|Physician Decision|2|||
44143670|NCT00271817|78932990|FG002|Part 1|LDL < 50 mg/dL|48|||
44360402|NCT01214252|79366031|FG000|Overall Study|Not eligible per protocol|82|||
44360403|NCT01214174|79366039|FG000|Overall Study|Withdrawal by Subject|0|||
44360404|NCT01214174|79366040|FG001|Overall Study|Withdrawal by Subject|0|||
44360405|NCT01214174|79366041|FG002|Overall Study|Withdrawal by Subject|1|||
44360406|NCT00901342|79366049|FG000|Overall Study|Adverse Event|1|||
44360407|NCT00901342|79366049|FG000|Overall Study|Death|4|||
44360408|NCT00901342|79366049|FG000|Overall Study|Disease progression|1|||
44360409|NCT00901342|79366049|FG000|Overall Study|Withdrawal by Subject|9|||
44360410|NCT00901186|79366055|FG000|Overall Study|Lack of Efficacy|0|||
44360411|NCT00901186|79366056|FG001|Overall Study|Lack of Efficacy|1|||
44360412|NCT00901186|79366055|FG000|Overall Study|Abnormal laboratory values|0|||
44360413|NCT00901186|79366056|FG001|Overall Study|Abnormal laboratory values|1|||
44360414|NCT00901186|79366055|FG000|Overall Study|Lost to Follow-up|2|||
44360415|NCT00901186|79366056|FG001|Overall Study|Lost to Follow-up|0|||
44360416|NCT00901186|79366055|FG000|Overall Study|Adverse Event|2|||
44360417|NCT00901186|79366056|FG001|Overall Study|Adverse Event|4|||
44360418|NCT00901186|79366055|FG000|Overall Study|Administration problems|0|||
44360419|NCT00901186|79366056|FG001|Overall Study|Administration problems|1|||
44360420|NCT00901186|79366055|FG000|Overall Study|Protocol deviations|5|||
44360421|NCT00901186|79366056|FG001|Overall Study|Protocol deviations|4|||
44360422|NCT01213472|79366062|FG000|Overall Study|Recurrence/Progressive disease|25|||
44360423|NCT01213472|79366062|FG000|Overall Study|Withdrawal by Subject|1|||
44360424|NCT01213472|79366062|FG000|Overall Study|Physician Decision|1|||
44360425|NCT00900796|79366066|FG000|Phase 1|Lacked sufficient information|4|||
44360426|NCT00900796|79366066|FG000|Phase 1|Missing information at Week 16|7|||
44360427|NCT00900796|79366066|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
44360428|NCT00900796|79366066|FG000|Phase 2|Lost to Follow-up|5|||
44360429|NCT01213082|79366074|FG000|Overall Study|Lost to Follow-up|6|||
44360430|NCT01213082|79366075|FG001|Overall Study|Lost to Follow-up|7|||
44360431|NCT01213082|79366076|FG002|Overall Study|Lost to Follow-up|4|||
44360432|NCT01213082|79366074|FG000|Overall Study|Physician Decision|0|||
44360433|NCT01213082|79366075|FG001|Overall Study|Physician Decision|0|||
44360434|NCT01213082|79366076|FG002|Overall Study|Physician Decision|1|||
44360435|NCT00885703|79366091|FG000|Overall Study|Death|9|||
44360436|NCT00885703|79366092|FG001|Overall Study|Death|7|||
44360437|NCT00885703|79366093|FG002|Overall Study|Death|8|||
44360438|NCT00885703|79366094|FG003|Overall Study|Death|7|||
44360439|NCT00885703|79366095|FG004|Overall Study|Death|7|||
44360440|NCT00885703|79366096|FG005|Overall Study|Death|8|||
44360441|NCT00885703|79366097|FG006|Overall Study|Death|4|||
44360442|NCT00885703|79366091|FG000|Overall Study|Lost to Follow-up|0|||
44360443|NCT00885703|79366092|FG001|Overall Study|Lost to Follow-up|0|||
44360444|NCT00885703|79366093|FG002|Overall Study|Lost to Follow-up|1|||
44360445|NCT00885703|79366094|FG003|Overall Study|Lost to Follow-up|0|||
44360446|NCT00885703|79366095|FG004|Overall Study|Lost to Follow-up|0|||
44360447|NCT00885703|79366096|FG005|Overall Study|Lost to Follow-up|1|||
44360448|NCT00885703|79366097|FG006|Overall Study|Lost to Follow-up|0|||
44360449|NCT00885703|79366091|FG000|Overall Study|Withdrawal by Subject|0|||
44360450|NCT00885703|79366092|FG001|Overall Study|Withdrawal by Subject|0|||
44360451|NCT00885703|79366093|FG002|Overall Study|Withdrawal by Subject|0|||
44360452|NCT00885703|79366094|FG003|Overall Study|Withdrawal by Subject|1|||
44360453|NCT00885703|79366095|FG004|Overall Study|Withdrawal by Subject|3|||
44360454|NCT00885703|79366096|FG005|Overall Study|Withdrawal by Subject|1|||
44360455|NCT00885703|79366097|FG006|Overall Study|Withdrawal by Subject|1|||
44360456|NCT00885703|79366091|FG000|Overall Study|Ineligible (no CM)|1|||
44360457|NCT00885703|79366092|FG001|Overall Study|Ineligible (no CM)|3|||
44360458|NCT00885703|79366093|FG002|Overall Study|Ineligible (no CM)|2|||
44360459|NCT00885703|79366094|FG003|Overall Study|Ineligible (no CM)|1|||
44360460|NCT00885703|79366095|FG004|Overall Study|Ineligible (no CM)|2|||
44360461|NCT00885703|79366096|FG005|Overall Study|Ineligible (no CM)|3|||
44360462|NCT00885703|79366097|FG006|Overall Study|Ineligible (no CM)|1|||
44360463|NCT00901576|79366123|FG000|Second Intervention|Withdrawal by Subject|0|||
44360464|NCT00901576|79366124|FG001|Second Intervention|Withdrawal by Subject|0|||
44360465|NCT00901576|79366125|FG002|Second Intervention|Withdrawal by Subject|0|||
44360466|NCT00901576|79366126|FG003|Second Intervention|Withdrawal by Subject|1|||
44360467|NCT00901576|79366127|FG004|Second Intervention|Withdrawal by Subject|0|||
44360468|NCT00901576|79366128|FG005|Second Intervention|Withdrawal by Subject|1|||
44360469|NCT00901576|79366123|FG000|Second Intervention|Physician Decision|1|||
44360470|NCT00901576|79366124|FG001|Second Intervention|Physician Decision|0|||
44360471|NCT00901576|79366125|FG002|Second Intervention|Physician Decision|0|||
44360472|NCT00901576|79366126|FG003|Second Intervention|Physician Decision|0|||
44264179|NCT03401450|79164443|FG001|Overall Study|Anesthesia plan changed|2|||
44360473|NCT00901576|79366127|FG004|Second Intervention|Physician Decision|0|||
44360474|NCT00901576|79366128|FG005|Second Intervention|Physician Decision|0|||
44360475|NCT00882583|79366138|FG000|Overall Study|Physician Decision|1|||
44360476|NCT00882583|79366139|FG001|Overall Study|Physician Decision|0|||
44360477|NCT00882583|79366138|FG000|Overall Study|Adverse Event|0|||
44360478|NCT00882583|79366139|FG001|Overall Study|Adverse Event|1|||
44360479|NCT00900562|79366147|FG000|Overall Study|Progressive disease|9|||
44360480|NCT00900562|79366148|FG001|Overall Study|Progressive disease|5|||
44360481|NCT00900562|79366147|FG000|Overall Study|Toxicity|1|||
44360482|NCT00900562|79366148|FG001|Overall Study|Toxicity|0|||
44360483|NCT00900562|79366147|FG000|Overall Study|Death|1|||
44360484|NCT00900562|79366148|FG001|Overall Study|Death|1|||
44360485|NCT00900562|79366147|FG000|Overall Study|Withdrawal by Subject|0|||
44360486|NCT00900562|79366148|FG001|Overall Study|Withdrawal by Subject|1|||
44360487|NCT00900562|79366147|FG000|Overall Study|Unrelated adverse event|1|||
44360488|NCT00900562|79366148|FG001|Overall Study|Unrelated adverse event|0|||
44360489|NCT00599521|79366157|FG000|Overall Study|Lack of Efficacy|4|||
44360490|NCT00599521|79366158|FG001|Overall Study|Lack of Efficacy|8|||
44360491|NCT00599521|79366157|FG000|Overall Study|Adverse Event|4|||
44360492|NCT00599521|79366158|FG001|Overall Study|Adverse Event|1|||
44360493|NCT00599521|79366157|FG000|Overall Study|Withdrawal by Subject|28|||
44360494|NCT00599521|79366158|FG001|Overall Study|Withdrawal by Subject|34|||
44360495|NCT00599521|79366157|FG000|Overall Study|Protocol Violation|1|||
44360496|NCT00599521|79366158|FG001|Overall Study|Protocol Violation|1|||
44360497|NCT00599521|79366157|FG000|Overall Study|Lost to Follow-up|23|||
44360498|NCT00599521|79366158|FG001|Overall Study|Lost to Follow-up|23|||
44360499|NCT00599521|79366157|FG000|Overall Study|Pregnancy|0|||
44360500|NCT00599521|79366158|FG001|Overall Study|Pregnancy|2|||
44360501|NCT00882115|79366164|FG000|Overall Study|Withdrawal by Subject|3|||
44360502|NCT00882115|79366164|FG000|Overall Study|did not respond to DEP challe|6|||
44360503|NCT00881959|79366170|FG000|Overall Study|Lost to Follow-up|2|||
44360504|NCT00881959|79366171|FG001|Overall Study|Lost to Follow-up|4|||
44360505|NCT00884377|79366179|FG000|Overall Study|Withdrawal by Subject|1|||
44360506|NCT00884377|79366180|FG001|Overall Study|Withdrawal by Subject|0|||
44360507|NCT00884377|79366179|FG000|Overall Study|Could not confirm diagnosis|1|||
44360508|NCT00884377|79366180|FG001|Overall Study|Could not confirm diagnosis|0|||
44360509|NCT00884377|79366179|FG000|Overall Study|Physician Decision|0|||
44360510|NCT00884377|79366180|FG001|Overall Study|Physician Decision|1|||
44360511|NCT00884221|79366194|FG000|Overall Study|Withdrawal by Subject|0|||
44360512|NCT00884221|79366195|FG001|Overall Study|Withdrawal by Subject|3|||
44360513|NCT00884221|79366194|FG000|Overall Study|Adverse Event|6|||
44360514|NCT00884221|79366195|FG001|Overall Study|Adverse Event|3|||
44360515|NCT00884221|79366194|FG000|Overall Study|Protocol Violation|16|||
44360516|NCT00884221|79366195|FG001|Overall Study|Protocol Violation|13|||
44360517|NCT00884221|79366194|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
44360518|NCT00884221|79366195|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
44360519|NCT00899548|79366216|FG000|Overall Study|Physician Decision|3|||
44360520|NCT00899392|79366226|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
44360521|NCT00899392|79366227|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
44360522|NCT00690898|79366233|FG000|SCREENING|Screen failure|18|||
44360523|NCT00690898|79366233|FG000|TREATMENT|Adverse Event|3|||
44360524|NCT00690898|79366233|FG000|TREATMENT|Lack of Efficacy|18|||
44360525|NCT00690898|79366233|FG000|TREATMENT|Withdrawal by Subject|4|||
44360526|NCT00690898|79366233|FG000|TREATMENT|Other (not otherwise specified)|1|||
44360527|NCT00895414|79366237|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
44360528|NCT00895414|79366238|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
44360529|NCT00895414|79366237|FG000|First Intervention (14 Days)|Physician Decision|0|||
44360530|NCT00895414|79366238|FG001|First Intervention (14 Days)|Physician Decision|1|||
44360531|NCT01212770|79366247|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
44360532|NCT01212770|79366248|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
44360533|NCT01212770|79366249|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
44360534|NCT01212770|79366250|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44360535|NCT01212770|79366251|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44360536|NCT01212770|79366252|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44360537|NCT01212770|79366253|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44360538|NCT01212770|79366254|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44360539|NCT01212770|79366255|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44360540|NCT01212770|79366247|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
44360541|NCT01212770|79366248|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
44360542|NCT01212770|79366249|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
44360543|NCT01212770|79366250|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44360544|NCT01212770|79366251|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44360545|NCT01212770|79366252|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44360546|NCT01212770|79366253|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44360547|NCT01212770|79366254|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44360548|NCT01212770|79366255|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44360549|NCT01212770|79366247|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
44360550|NCT01212770|79366248|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
44360551|NCT01212770|79366249|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
44360552|NCT01212770|79366250|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44360553|NCT01212770|79366251|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44360554|NCT01212770|79366252|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44360555|NCT01212770|79366253|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44360556|NCT01212770|79366254|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44360557|NCT01212770|79366255|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44360558|NCT01212770|79366247|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
44360559|NCT01212770|79366248|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360560|NCT01212770|79366249|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
44360561|NCT01212770|79366250|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360562|NCT01212770|79366251|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360563|NCT01212770|79366252|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360564|NCT01212770|79366253|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360565|NCT01212770|79366254|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360566|NCT01212770|79366255|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44360567|NCT01212770|79366247|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360568|NCT01212770|79366248|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360569|NCT01212770|79366249|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
44360570|NCT01212770|79366250|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360571|NCT01212770|79366251|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360572|NCT01212770|79366252|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360573|NCT01212770|79366253|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360574|NCT01212770|79366254|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360575|NCT01212770|79366255|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44360576|NCT01212770|79366247|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
44360577|NCT01212770|79366248|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
44360578|NCT01212770|79366249|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
44360579|NCT01212770|79366250|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
44360580|NCT01212770|79366251|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
44360581|NCT01212770|79366252|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
44360582|NCT01212770|79366253|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
44360583|NCT01212770|79366254|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
44360584|NCT01212770|79366255|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
44360585|NCT01212770|79366247|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
44360586|NCT01212770|79366248|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
44360587|NCT01212770|79366249|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
44360588|NCT01212770|79366250|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
44360589|NCT01212770|79366251|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
44360590|NCT01212770|79366252|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
44360591|NCT01212770|79366253|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
44360592|NCT01212770|79366254|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
44360593|NCT01212770|79366255|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
44360594|NCT01212770|79366247|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
44360595|NCT01212770|79366248|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
44360596|NCT01212770|79366249|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
44360597|NCT01212770|79366250|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
44360598|NCT01212770|79366251|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
44360599|NCT01212770|79366252|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
44360600|NCT01212770|79366253|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
44360601|NCT01212770|79366254|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
44360602|NCT01212770|79366255|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
44360603|NCT01212770|79366247|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
44360604|NCT01212770|79366248|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
44360605|NCT01212770|79366249|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
44360606|NCT01212770|79366250|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
44360607|NCT01212770|79366251|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
44360608|NCT01212770|79366252|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
44360609|NCT01212770|79366253|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
44360610|NCT01212770|79366254|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
44360611|NCT01212770|79366255|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
44360612|NCT01212770|79366247|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360613|NCT01212770|79366248|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360614|NCT01212770|79366249|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
44360615|NCT01212770|79366250|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360616|NCT01212770|79366251|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360617|NCT01212770|79366252|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360618|NCT01212770|79366253|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360619|NCT01212770|79366254|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360620|NCT01212770|79366255|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
44360621|NCT01212770|79366247|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360622|NCT01212770|79366248|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360623|NCT01212770|79366249|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360624|NCT01212770|79366250|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
44360625|NCT01212770|79366251|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360626|NCT01212770|79366252|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360627|NCT01212770|79366253|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360628|NCT01212770|79366254|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360629|NCT01212770|79366255|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
44360630|NCT01212770|79366247|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360631|NCT01212770|79366248|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360632|NCT01212770|79366249|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
44360633|NCT01212770|79366250|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
44360634|NCT01212770|79366251|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360635|NCT01212770|79366252|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360636|NCT01212770|79366253|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360637|NCT01212770|79366254|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360638|NCT01212770|79366255|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
44360639|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44360640|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
44360641|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
44360642|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44360643|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44360644|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44360645|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44360646|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44360647|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
44360648|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44360649|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
44360650|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
44360651|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44360652|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44360653|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44360654|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44360655|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
44360656|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
44360657|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360658|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
44360659|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360660|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360661|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360662|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360663|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360664|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360665|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
44360666|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44360667|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
44360668|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
44360669|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44360670|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44360671|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44360672|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44360673|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
44360674|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
44360675|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
44360676|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
44360677|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
44360678|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
44360679|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
44360680|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
44360681|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
44360682|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
44360683|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
44360684|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44360685|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
44360686|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
44360687|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44264180|NCT03401450|79164442|FG000|Overall Study|Did not complete medication diary|4|||
44264181|NCT03401450|79164443|FG001|Overall Study|Did not complete medication diary|2|||
44264182|NCT03401450|79164442|FG000|Overall Study|post surgery medication change|2|||
44360688|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44360689|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44360690|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44360691|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44360692|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
44360693|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44360694|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
44360695|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
44360696|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44360697|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44360698|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44360699|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44360700|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
44360701|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
44360702|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44360703|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
44360704|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
44360705|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44360706|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44360707|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44360708|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44360709|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
44360710|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
44360711|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44360712|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
44360713|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
44360714|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44360715|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44360716|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44360717|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44360718|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
44360719|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
44360720|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360721|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
44360722|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360723|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360724|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360725|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360726|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360727|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360728|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44360729|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360730|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360731|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360732|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360733|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360734|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360735|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360736|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
44360737|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
44360738|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44360739|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
44360740|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
44360741|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44360742|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44360743|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44360744|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44360745|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
44360746|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
44360747|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44360748|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
44360749|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
44360750|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44360751|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44360752|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44360753|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44360754|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44360755|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
44360756|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44360757|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
44360758|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
44360759|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44360760|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44360761|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44448738|NCT00550446|79457364|FG009|Up To Week 12|Lost to Follow-up|0|||
44448739|NCT00550446|79457365|FG010|Up To Week 12|Lost to Follow-up|0|||
44448740|NCT00550446|79457355|FG000|Up To Week 12|Withdrawal by Subject|2|||
44448741|NCT00550446|79457356|FG001|Up To Week 12|Withdrawal by Subject|0|||
44448742|NCT00550446|79457357|FG002|Up To Week 12|Withdrawal by Subject|3|||
44448743|NCT00550446|79457358|FG003|Up To Week 12|Withdrawal by Subject|2|||
44448744|NCT00550446|79457359|FG004|Up To Week 12|Withdrawal by Subject|0|||
44448745|NCT00550446|79457360|FG005|Up To Week 12|Withdrawal by Subject|1|||
44448746|NCT00550446|79457361|FG006|Up To Week 12|Withdrawal by Subject|3|||
44448747|NCT00550446|79457362|FG007|Up To Week 12|Withdrawal by Subject|0|||
44448748|NCT00550446|79457363|FG008|Up To Week 12|Withdrawal by Subject|0|||
44448749|NCT00550446|79457364|FG009|Up To Week 12|Withdrawal by Subject|0|||
44448750|NCT00550446|79457365|FG010|Up To Week 12|Withdrawal by Subject|0|||
44448751|NCT00550446|79457355|FG000|Up To Week 12|Other|3|||
44448752|NCT00550446|79457356|FG001|Up To Week 12|Other|0|||
44448753|NCT00550446|79457357|FG002|Up To Week 12|Other|0|||
44448754|NCT00550446|79457358|FG003|Up To Week 12|Other|0|||
44448755|NCT00550446|79457359|FG004|Up To Week 12|Other|0|||
44448756|NCT00550446|79457360|FG005|Up To Week 12|Other|1|||
44448757|NCT00550446|79457361|FG006|Up To Week 12|Other|4|||
44448758|NCT00550446|79457362|FG007|Up To Week 12|Other|0|||
44448759|NCT00550446|79457363|FG008|Up To Week 12|Other|0|||
44448760|NCT00550446|79457364|FG009|Up To Week 12|Other|0|||
44448761|NCT00550446|79457365|FG010|Up To Week 12|Other|0|||
44448762|NCT00550446|79457355|FG000|Up To Week 12|Randomized not treated|0|||
44448763|NCT00550446|79457356|FG001|Up To Week 12|Randomized not treated|1|||
44448764|NCT00550446|79457357|FG002|Up To Week 12|Randomized not treated|1|||
44448765|NCT00550446|79457358|FG003|Up To Week 12|Randomized not treated|0|||
44448766|NCT00550446|79457359|FG004|Up To Week 12|Randomized not treated|0|||
44448767|NCT00550446|79457360|FG005|Up To Week 12|Randomized not treated|0|||
44448768|NCT00550446|79457361|FG006|Up To Week 12|Randomized not treated|0|||
44448769|NCT00550446|79457362|FG007|Up To Week 12|Randomized not treated|0|||
44448770|NCT00550446|79457363|FG008|Up To Week 12|Randomized not treated|0|||
44448771|NCT00550446|79457364|FG009|Up To Week 12|Randomized not treated|0|||
44448772|NCT00550446|79457365|FG010|Up To Week 12|Randomized not treated|0|||
44448773|NCT00550446|79457355|FG000|Post Week 12|Adverse Event|2|||
44448774|NCT00550446|79457356|FG001|Post Week 12|Adverse Event|1|||
44448775|NCT00550446|79457357|FG002|Post Week 12|Adverse Event|1|||
44448776|NCT00550446|79457358|FG003|Post Week 12|Adverse Event|1|||
44448777|NCT00550446|79457359|FG004|Post Week 12|Adverse Event|1|||
44448778|NCT00550446|79457360|FG005|Post Week 12|Adverse Event|1|||
44448779|NCT00550446|79457361|FG006|Post Week 12|Adverse Event|0|||
44448780|NCT00550446|79457362|FG007|Post Week 12|Adverse Event|0|||
44448781|NCT00550446|79457363|FG008|Post Week 12|Adverse Event|0|||
44448782|NCT00550446|79457364|FG009|Post Week 12|Adverse Event|4|||
44448783|NCT00550446|79457365|FG010|Post Week 12|Adverse Event|0|||
44448784|NCT00550446|79457355|FG000|Post Week 12|Lack of Efficacy|0|||
44448785|NCT00550446|79457356|FG001|Post Week 12|Lack of Efficacy|0|||
44448786|NCT00550446|79457357|FG002|Post Week 12|Lack of Efficacy|1|||
44448787|NCT00550446|79457358|FG003|Post Week 12|Lack of Efficacy|0|||
44448788|NCT00550446|79457359|FG004|Post Week 12|Lack of Efficacy|0|||
44448789|NCT00550446|79457360|FG005|Post Week 12|Lack of Efficacy|0|||
44448790|NCT00550446|79457361|FG006|Post Week 12|Lack of Efficacy|0|||
44448791|NCT00550446|79457362|FG007|Post Week 12|Lack of Efficacy|1|||
44448792|NCT00550446|79457363|FG008|Post Week 12|Lack of Efficacy|1|||
44448793|NCT00550446|79457364|FG009|Post Week 12|Lack of Efficacy|2|||
44448794|NCT00550446|79457365|FG010|Post Week 12|Lack of Efficacy|1|||
44448795|NCT00550446|79457355|FG000|Post Week 12|Lost to Follow-up|0|||
44448796|NCT00550446|79457356|FG001|Post Week 12|Lost to Follow-up|0|||
44448797|NCT00550446|79457357|FG002|Post Week 12|Lost to Follow-up|1|||
44448798|NCT00550446|79457358|FG003|Post Week 12|Lost to Follow-up|1|||
44360762|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44448799|NCT00550446|79457359|FG004|Post Week 12|Lost to Follow-up|0|||
44448800|NCT00550446|79457360|FG005|Post Week 12|Lost to Follow-up|0|||
44448801|NCT00550446|79457361|FG006|Post Week 12|Lost to Follow-up|1|||
44448802|NCT00550446|79457362|FG007|Post Week 12|Lost to Follow-up|0|||
44448803|NCT00550446|79457363|FG008|Post Week 12|Lost to Follow-up|0|||
44448804|NCT00550446|79457364|FG009|Post Week 12|Lost to Follow-up|0|||
44448805|NCT00550446|79457365|FG010|Post Week 12|Lost to Follow-up|0|||
44448806|NCT00550446|79457355|FG000|Post Week 12|Withdrawal by Subject|0|||
44448807|NCT00550446|79457356|FG001|Post Week 12|Withdrawal by Subject|0|||
44448808|NCT00550446|79457357|FG002|Post Week 12|Withdrawal by Subject|0|||
44448809|NCT00550446|79457358|FG003|Post Week 12|Withdrawal by Subject|0|||
44360763|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
44448810|NCT00550446|79457359|FG004|Post Week 12|Withdrawal by Subject|1|||
44448811|NCT00550446|79457360|FG005|Post Week 12|Withdrawal by Subject|0|||
44448812|NCT00550446|79457361|FG006|Post Week 12|Withdrawal by Subject|0|||
44448813|NCT00550446|79457362|FG007|Post Week 12|Withdrawal by Subject|0|||
44448814|NCT00550446|79457363|FG008|Post Week 12|Withdrawal by Subject|0|||
44448815|NCT00550446|79457364|FG009|Post Week 12|Withdrawal by Subject|0|||
44448816|NCT00550446|79457365|FG010|Post Week 12|Withdrawal by Subject|0|||
44448817|NCT00550446|79457355|FG000|Post Week 12|Other|1|||
44448818|NCT00550446|79457356|FG001|Post Week 12|Other|1|||
44448819|NCT00550446|79457357|FG002|Post Week 12|Other|0|||
44448820|NCT00550446|79457358|FG003|Post Week 12|Other|1|||
44448821|NCT00550446|79457359|FG004|Post Week 12|Other|0|||
44448822|NCT00550446|79457360|FG005|Post Week 12|Other|0|||
44448823|NCT00550446|79457361|FG006|Post Week 12|Other|1|||
44448824|NCT00550446|79457362|FG007|Post Week 12|Other|0|||
44448825|NCT00550446|79457363|FG008|Post Week 12|Other|1|||
44448826|NCT00550446|79457364|FG009|Post Week 12|Other|1|||
44448827|NCT00550446|79457365|FG010|Post Week 12|Other|0|||
44448828|NCT00436618|79457406|FG000|Overall Study|Withdrawal by Subject|5|||
44448829|NCT00436618|79457407|FG001|Overall Study|Withdrawal by Subject|8|||
44448830|NCT00436618|79457408|FG002|Overall Study|Withdrawal by Subject|11|||
44448831|NCT00436618|79457406|FG000|Overall Study|Adverse Event|8|||
44448832|NCT00436618|79457407|FG001|Overall Study|Adverse Event|8|||
44448833|NCT00436618|79457408|FG002|Overall Study|Adverse Event|9|||
44448834|NCT00436618|79457406|FG000|Overall Study|Alternate Treatment|3|||
44448835|NCT00436618|79457407|FG001|Overall Study|Alternate Treatment|4|||
44448836|NCT00436618|79457408|FG002|Overall Study|Alternate Treatment|12|||
44448837|NCT00436618|79457406|FG000|Overall Study|Other Medical Problems|3|||
44448838|NCT00436618|79457407|FG001|Overall Study|Other Medical Problems|1|||
44448839|NCT00436618|79457408|FG002|Overall Study|Other Medical Problems|7|||
44448840|NCT00436618|79457406|FG000|Overall Study|Death|4|||
44448841|NCT00436618|79457407|FG001|Overall Study|Death|2|||
44448842|NCT00436618|79457408|FG002|Overall Study|Death|3|||
44448843|NCT00436618|79457406|FG000|Overall Study|New Primary or Other Reasons|6|||
44448844|NCT00436618|79457407|FG001|Overall Study|New Primary or Other Reasons|2|||
44448845|NCT00436618|79457408|FG002|Overall Study|New Primary or Other Reasons|12|||
44448846|NCT00436618|79457406|FG000|Overall Study|Still on treatment|1|||
44448847|NCT00436618|79457407|FG001|Overall Study|Still on treatment|2|||
44448848|NCT00436618|79457408|FG002|Overall Study|Still on treatment|7|||
44448849|NCT00548808|79457445|FG000|Overall Study|Lost to Follow-up|9|||
44448850|NCT00548808|79457446|FG001|Overall Study|Lost to Follow-up|3|||
44448851|NCT00548808|79457445|FG000|Overall Study|Protocol Violation|8|||
44448852|NCT00548808|79457446|FG001|Overall Study|Protocol Violation|8|||
44448853|NCT00548808|79457445|FG000|Overall Study|Withdrawal by Subject|8|||
44448854|NCT00548808|79457446|FG001|Overall Study|Withdrawal by Subject|4|||
44448855|NCT00548808|79457445|FG000|Overall Study|Physician Decision|6|||
44448856|NCT00548808|79457446|FG001|Overall Study|Physician Decision|3|||
44448857|NCT00548808|79457445|FG000|Overall Study|Adverse Event|4|||
44448858|NCT00548808|79457446|FG001|Overall Study|Adverse Event|5|||
44448859|NCT00548808|79457445|FG000|Overall Study|Death|2|||
44448860|NCT00548808|79457446|FG001|Overall Study|Death|0|||
44448861|NCT00548808|79457445|FG000|Overall Study|Entry Criteria Not Met|2|||
44448862|NCT00548808|79457446|FG001|Overall Study|Entry Criteria Not Met|2|||
44448863|NCT00548808|79457445|FG000|Overall Study|Lack of Efficacy|2|||
44448864|NCT00548808|79457446|FG001|Overall Study|Lack of Efficacy|0|||
44448865|NCT00548808|79457445|FG000|Overall Study|Sponsor Decision|1|||
44448866|NCT00548808|79457446|FG001|Overall Study|Sponsor Decision|1|||
44448867|NCT00110617|79457454|FG000|Overall Study|Adverse Event|2|||
44448868|NCT00110617|79457455|FG001|Overall Study|Adverse Event|4|||
44448869|NCT00110617|79457454|FG000|Overall Study|Abnormal Laboratory Value|4|||
44448870|NCT00110617|79457455|FG001|Overall Study|Abnormal Laboratory Value|2|||
44448871|NCT00110617|79457454|FG000|Overall Study|Lack of Efficacy|1|||
44448872|NCT00110617|79457455|FG001|Overall Study|Lack of Efficacy|0|||
44448873|NCT00110617|79457454|FG000|Overall Study|Patient no longer requires study drug|1|||
44448874|NCT00110617|79457455|FG001|Overall Study|Patient no longer requires study drug|0|||
44448875|NCT00110617|79457454|FG000|Overall Study|Protocol Violation|5|||
44448876|NCT00110617|79457455|FG001|Overall Study|Protocol Violation|0|||
44448877|NCT00110617|79457454|FG000|Overall Study|Withdrawal by Subject|10|||
44448878|NCT00110617|79457455|FG001|Overall Study|Withdrawal by Subject|4|||
44448879|NCT00110617|79457454|FG000|Overall Study|Lost to Follow-up|9|||
44448880|NCT00110617|79457455|FG001|Overall Study|Lost to Follow-up|1|||
44448881|NCT00110617|79457454|FG000|Overall Study|Administrative problems|6|||
44448882|NCT00110617|79457455|FG001|Overall Study|Administrative problems|5|||
44448883|NCT00110617|79457454|FG000|Overall Study|Death|1|||
44448884|NCT00110617|79457455|FG001|Overall Study|Death|1|||
44448885|NCT00110617|79457454|FG000|Overall Study|Did not receive study drug|0|||
44448886|NCT00110617|79457455|FG001|Overall Study|Did not receive study drug|12|||
44448887|NCT03956862|79457465|FG000|Overall Study|Lost to Follow-up|1|||
44448888|NCT03956862|79457466|FG001|Overall Study|Lost to Follow-up|1|||
44448889|NCT03956862|79457465|FG000|Overall Study|Withdrawal by Subject|1|||
44448890|NCT03956862|79457466|FG001|Overall Study|Withdrawal by Subject|1|||
44448891|NCT00550238|79457472|FG000|Overall Study|Adverse Event|88|||
44448892|NCT00550238|79457472|FG000|Overall Study|Death|34|||
44448893|NCT00550238|79457472|FG000|Overall Study|Disease progression|46|||
44448894|NCT00550238|79457472|FG000|Overall Study|Withdrawal by Subject|167|||
44448895|NCT00550238|79457472|FG000|Overall Study|Physician Decision|31|||
44448896|NCT00550238|79457472|FG000|Overall Study|Patient noncompliance|25|||
44448897|NCT00550238|79457472|FG000|Overall Study|Lost to Follow-up|13|||
44448898|NCT00550238|79457472|FG000|Overall Study|Sponsor decision|55|||
44448899|NCT03956550|79457479|FG000|Overall Study|Sponsor decision|65|||
44448900|NCT03956550|79457480|FG001|Overall Study|Sponsor decision|66|||
44448901|NCT03956550|79457481|FG002|Overall Study|Sponsor decision|64|||
44448902|NCT03956550|79457479|FG000|Overall Study|Adverse Event|0|||
44448903|NCT03956550|79457480|FG001|Overall Study|Adverse Event|1|||
44448904|NCT03956550|79457481|FG002|Overall Study|Adverse Event|0|||
44448905|NCT03956550|79457479|FG000|Overall Study|Withdrawal by Subject|5|||
44448906|NCT03956550|79457480|FG001|Overall Study|Withdrawal by Subject|5|||
44448907|NCT03956550|79457481|FG002|Overall Study|Withdrawal by Subject|6|||
44448908|NCT00110305|79457493|FG000|Overall Study|Adverse Event|46|||
44448909|NCT00110305|79457494|FG001|Overall Study|Adverse Event|13|||
44448910|NCT00110305|79457493|FG000|Overall Study|Sponsors Decision|1|||
44448911|NCT00110305|79457494|FG001|Overall Study|Sponsors Decision|0|||
44448912|NCT00110305|79457493|FG000|Overall Study|Subject Non-Compliant|9|||
44448913|NCT00110305|79457494|FG001|Overall Study|Subject Non-Compliant|2|||
44448914|NCT00110305|79457493|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
44448915|NCT00110305|79457494|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
44448916|NCT00110305|79457493|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
44448917|NCT00110305|79457494|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
44448918|NCT00110305|79457493|FG000|Overall Study|Protocol Violation|0|||
44448919|NCT00110305|79457494|FG001|Overall Study|Protocol Violation|1|||
44448920|NCT00110305|79457493|FG000|Overall Study|Withdrawal by Subject|7|||
44448921|NCT00110305|79457494|FG001|Overall Study|Withdrawal by Subject|7|||
44448922|NCT00110305|79457493|FG000|Overall Study|Lost to Follow-up|20|||
44448923|NCT00110305|79457494|FG001|Overall Study|Lost to Follow-up|3|||
44448924|NCT00110305|79457493|FG000|Overall Study|Other|8|||
44448925|NCT00110305|79457494|FG001|Overall Study|Other|2|||
44448926|NCT00428116|79457513|FG000|Overall Study|Death|1|||
44448927|NCT00428116|79457514|FG001|Overall Study|Death|0|||
44448928|NCT00428116|79457513|FG000|Overall Study|Withdrawal by Subject|1|||
44448929|NCT00428116|79457514|FG001|Overall Study|Withdrawal by Subject|0|||
44448930|NCT00428116|79457513|FG000|Overall Study|Lost to Follow-up|1|||
44448931|NCT00428116|79457514|FG001|Overall Study|Lost to Follow-up|0|||
44448932|NCT00560066|79457523|FG000|Overall Study|Death|2|||
44448933|NCT00560066|79457524|FG001|Overall Study|Death|1|||
44448934|NCT00560066|79457523|FG000|Overall Study|Withdrawal by Subject|0|||
44448935|NCT00560066|79457524|FG001|Overall Study|Withdrawal by Subject|3|||
44448936|NCT00560066|79457523|FG000|Overall Study|Lost to Follow-up|4|||
44448937|NCT00560066|79457524|FG001|Overall Study|Lost to Follow-up|10|||
44448938|NCT00560066|79457523|FG000|Overall Study|Protocol Violation|0|||
44448939|NCT00560066|79457524|FG001|Overall Study|Protocol Violation|1|||
44448940|NCT00560066|79457523|FG000|Overall Study|Administrative reason|0|||
44448941|NCT00560066|79457524|FG001|Overall Study|Administrative reason|5|||
44448942|NCT00560066|79457523|FG000|Overall Study|Missing primary reason|0|||
44448943|NCT00560066|79457524|FG001|Overall Study|Missing primary reason|2|||
44448944|NCT00549900|79457535|FG000|Overall Study|Adverse Event|1|||
44448945|NCT00435994|79457542|FG000|Overall Study|Lost to Follow-up|7|||
44448946|NCT00435994|79457543|FG001|Overall Study|Lost to Follow-up|0|||
44448947|NCT00435994|79457544|FG002|Overall Study|Lost to Follow-up|0|||
44448948|NCT00435370|79457555|FG000|Overall Study|Adverse Event|8|||
44448949|NCT00435370|79457556|FG001|Overall Study|Adverse Event|8|||
44448950|NCT00435370|79457555|FG000|Overall Study|Withdrawal by Subject|10|||
44448951|NCT00435370|79457556|FG001|Overall Study|Withdrawal by Subject|10|||
44448952|NCT00435370|79457555|FG000|Overall Study|Antipsychotic medication changed|4|||
44448953|NCT00435370|79457556|FG001|Overall Study|Antipsychotic medication changed|2|||
44448954|NCT00096031|79457562|FG000|Overall Study|Adverse Event|3|||
44143671|NCT00271817|78932988|FG000|Part 2|Adverse Event|0|||
44448955|NCT00096031|79457562|FG000|Overall Study|Lack of Efficacy|42|||
44448956|NCT00096031|79457562|FG000|Overall Study|Death|4|||
44448957|NCT00096031|79457562|FG000|Overall Study|Withdrawal by Subject|1|||
44448958|NCT00096031|79457562|FG000|Overall Study|Ineligible|8|||
44448959|NCT00096031|79457562|FG000|Overall Study|Not protocol specified|5|||
44448960|NCT00118417|79457566|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
44448961|NCT00118417|79457567|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
44448962|NCT00118417|79457566|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
44448963|NCT00118417|79457567|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
44448964|NCT00118417|79457566|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
44448965|NCT00118417|79457567|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
44448966|NCT00118417|79457566|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
44448967|NCT00118417|79457567|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
44448968|NCT00118417|79457566|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
44448969|NCT00118417|79457567|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
44448970|NCT00549848|79457580|FG000|Overall Study|Death|1|||
44448971|NCT00549848|79457581|FG001|Overall Study|Death|4|||
44448972|NCT00549848|79457582|FG002|Overall Study|Death|13|||
44448973|NCT00549848|79457580|FG000|Overall Study|Physician Decision|0|||
44448974|NCT00549848|79457581|FG001|Overall Study|Physician Decision|0|||
44448975|NCT00549848|79457582|FG002|Overall Study|Physician Decision|4|||
44448976|NCT00549848|79457580|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
44448977|NCT00549848|79457581|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
44448978|NCT00549848|79457582|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
44448979|NCT00549848|79457580|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
44448980|NCT00549848|79457581|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
44448981|NCT00549848|79457582|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
44448982|NCT00549848|79457580|FG000|Overall Study|Participant/Family Withdraw|2|||
44448983|NCT00549848|79457581|FG001|Overall Study|Participant/Family Withdraw|3|||
44448984|NCT00549848|79457582|FG002|Overall Study|Participant/Family Withdraw|5|||
44448985|NCT00549848|79457580|FG000|Overall Study|Second Malignancy|1|||
44448986|NCT00549848|79457581|FG001|Overall Study|Second Malignancy|0|||
44448987|NCT00549848|79457582|FG002|Overall Study|Second Malignancy|0|||
44448988|NCT00549848|79457580|FG000|Overall Study|Transplant|3|||
44448989|NCT00549848|79457581|FG001|Overall Study|Transplant|3|||
44448990|NCT00549848|79457582|FG002|Overall Study|Transplant|18|||
44448991|NCT00549848|79457580|FG000|Overall Study|Unacceptable Toxicity|1|||
44448992|NCT00549848|79457581|FG001|Overall Study|Unacceptable Toxicity|6|||
44448993|NCT00549848|79457582|FG002|Overall Study|Unacceptable Toxicity|6|||
44448994|NCT00549770|79457606|FG000|Overall Study|Protocol deviation|1|||
44448995|NCT00549770|79457607|FG001|Overall Study|Protocol deviation|1|||
44448996|NCT00549770|79457608|FG002|Overall Study|Protocol deviation|1|||
44448997|NCT00549770|79457609|FG003|Overall Study|Protocol deviation|2|||
44448998|NCT00549770|79457610|FG004|Overall Study|Protocol deviation|2|||
44448999|NCT00549770|79457611|FG005|Overall Study|Protocol deviation|2|||
44449000|NCT00549770|79457612|FG006|Overall Study|Protocol deviation|1|||
44449001|NCT00549770|79457613|FG007|Overall Study|Protocol deviation|2|||
44449002|NCT00549770|79457606|FG000|Overall Study|Administrative problems|0|||
44449003|NCT00549770|79457607|FG001|Overall Study|Administrative problems|1|||
44449004|NCT00549770|79457608|FG002|Overall Study|Administrative problems|0|||
44449005|NCT00549770|79457609|FG003|Overall Study|Administrative problems|0|||
44449006|NCT00549770|79457610|FG004|Overall Study|Administrative problems|0|||
44449007|NCT00549770|79457611|FG005|Overall Study|Administrative problems|0|||
44449008|NCT00549770|79457612|FG006|Overall Study|Administrative problems|0|||
44449009|NCT00549770|79457613|FG007|Overall Study|Administrative problems|1|||
44449010|NCT00549770|79457606|FG000|Overall Study|Lost to Follow-up|0|||
44449011|NCT00549770|79457607|FG001|Overall Study|Lost to Follow-up|0|||
44449012|NCT00549770|79457608|FG002|Overall Study|Lost to Follow-up|2|||
44449013|NCT00549770|79457609|FG003|Overall Study|Lost to Follow-up|2|||
44449014|NCT00549770|79457610|FG004|Overall Study|Lost to Follow-up|3|||
44449015|NCT00549770|79457611|FG005|Overall Study|Lost to Follow-up|2|||
44449016|NCT00549770|79457612|FG006|Overall Study|Lost to Follow-up|0|||
44449017|NCT00549770|79457613|FG007|Overall Study|Lost to Follow-up|0|||
44449018|NCT00549770|79457606|FG000|Overall Study|Withdrawal by Subject|4|||
44449019|NCT00549770|79457607|FG001|Overall Study|Withdrawal by Subject|6|||
44449020|NCT00549770|79457608|FG002|Overall Study|Withdrawal by Subject|4|||
44449021|NCT00549770|79457609|FG003|Overall Study|Withdrawal by Subject|5|||
44449022|NCT00549770|79457610|FG004|Overall Study|Withdrawal by Subject|6|||
44449023|NCT00549770|79457611|FG005|Overall Study|Withdrawal by Subject|6|||
44449024|NCT00549770|79457612|FG006|Overall Study|Withdrawal by Subject|4|||
44449025|NCT00549770|79457613|FG007|Overall Study|Withdrawal by Subject|9|||
44449026|NCT00549770|79457606|FG000|Overall Study|Lack of Efficacy|1|||
44449027|NCT00549770|79457607|FG001|Overall Study|Lack of Efficacy|0|||
44449028|NCT00549770|79457608|FG002|Overall Study|Lack of Efficacy|2|||
44449029|NCT00549770|79457609|FG003|Overall Study|Lack of Efficacy|3|||
44449030|NCT00549770|79457610|FG004|Overall Study|Lack of Efficacy|5|||
44449031|NCT00549770|79457611|FG005|Overall Study|Lack of Efficacy|1|||
44449032|NCT00549770|79457612|FG006|Overall Study|Lack of Efficacy|3|||
44449033|NCT00549770|79457613|FG007|Overall Study|Lack of Efficacy|8|||
44449034|NCT00549770|79457606|FG000|Overall Study|Abnormal test procedure results|0|||
44449035|NCT00549770|79457607|FG001|Overall Study|Abnormal test procedure results|0|||
44449036|NCT00549770|79457608|FG002|Overall Study|Abnormal test procedure results|0|||
44449037|NCT00549770|79457609|FG003|Overall Study|Abnormal test procedure results|2|||
44449038|NCT00549770|79457610|FG004|Overall Study|Abnormal test procedure results|0|||
44449039|NCT00549770|79457611|FG005|Overall Study|Abnormal test procedure results|1|||
44449040|NCT00549770|79457612|FG006|Overall Study|Abnormal test procedure results|1|||
44449041|NCT00549770|79457613|FG007|Overall Study|Abnormal test procedure results|1|||
44449042|NCT00549770|79457606|FG000|Overall Study|Abnormal laboratory values|0|||
44449043|NCT00549770|79457607|FG001|Overall Study|Abnormal laboratory values|0|||
44449044|NCT00549770|79457608|FG002|Overall Study|Abnormal laboratory values|0|||
44449045|NCT00549770|79457609|FG003|Overall Study|Abnormal laboratory values|0|||
44449046|NCT00549770|79457610|FG004|Overall Study|Abnormal laboratory values|0|||
44449047|NCT00549770|79457611|FG005|Overall Study|Abnormal laboratory values|1|||
44449048|NCT00549770|79457612|FG006|Overall Study|Abnormal laboratory values|0|||
44449049|NCT00549770|79457613|FG007|Overall Study|Abnormal laboratory values|0|||
44449050|NCT00549770|79457606|FG000|Overall Study|Adverse Event|1|||
44449051|NCT00549770|79457607|FG001|Overall Study|Adverse Event|3|||
44449052|NCT00549770|79457608|FG002|Overall Study|Adverse Event|1|||
44449053|NCT00549770|79457609|FG003|Overall Study|Adverse Event|2|||
44449054|NCT00549770|79457610|FG004|Overall Study|Adverse Event|1|||
44449055|NCT00549770|79457611|FG005|Overall Study|Adverse Event|0|||
44449056|NCT00549770|79457612|FG006|Overall Study|Adverse Event|5|||
44449057|NCT00549770|79457613|FG007|Overall Study|Adverse Event|4|||
44449058|NCT00548184|79457631|FG000|Overall Study|Adverse Event|3|||
44449059|NCT00548184|79457631|FG000|Overall Study|took other drug|1|||
44449060|NCT00548184|79457631|FG000|Overall Study|Found Her2 negative|1|||
44449061|NCT00454636|79457639|FG000|Overall Study|Adverse Event|10|||
44449062|NCT00454636|79457640|FG001|Overall Study|Adverse Event|6|||
44449063|NCT00454636|79457641|FG002|Overall Study|Adverse Event|9|||
44449064|NCT00454636|79457642|FG003|Overall Study|Adverse Event|15|||
44449065|NCT00454636|79457639|FG000|Overall Study|Disease Progression|11|||
44449066|NCT00454636|79457640|FG001|Overall Study|Disease Progression|12|||
44449067|NCT00454636|79457641|FG002|Overall Study|Disease Progression|4|||
44449068|NCT00454636|79457642|FG003|Overall Study|Disease Progression|11|||
44449069|NCT00454636|79457639|FG000|Overall Study|Protocol Violation|3|||
44449070|NCT00454636|79457640|FG001|Overall Study|Protocol Violation|2|||
44449071|NCT00454636|79457641|FG002|Overall Study|Protocol Violation|3|||
44449072|NCT00454636|79457642|FG003|Overall Study|Protocol Violation|3|||
44449073|NCT00454636|79457639|FG000|Overall Study|Death|6|||
44449074|NCT00454636|79457640|FG001|Overall Study|Death|1|||
44449075|NCT00454636|79457641|FG002|Overall Study|Death|1|||
44449076|NCT00454636|79457642|FG003|Overall Study|Death|1|||
44449077|NCT00454636|79457639|FG000|Overall Study|Patient refusal|1|||
44449078|NCT00454636|79457640|FG001|Overall Study|Patient refusal|1|||
44449079|NCT00454636|79457641|FG002|Overall Study|Patient refusal|3|||
44449080|NCT00454636|79457642|FG003|Overall Study|Patient refusal|2|||
44449081|NCT00454636|79457639|FG000|Overall Study|Lost to Follow-up|0|||
44449082|NCT00454636|79457640|FG001|Overall Study|Lost to Follow-up|1|||
44449083|NCT00454636|79457641|FG002|Overall Study|Lost to Follow-up|0|||
44449084|NCT00454636|79457642|FG003|Overall Study|Lost to Follow-up|0|||
44449085|NCT00427960|79457654|FG000|Overall Study|Adverse Event|2|||
44449086|NCT00427960|79457655|FG001|Overall Study|Adverse Event|0|||
44449087|NCT00427960|79457654|FG000|Overall Study|Withdrawal by Subject|0|||
44449088|NCT00427960|79457655|FG001|Overall Study|Withdrawal by Subject|3|||
44449089|NCT00427960|79457654|FG000|Overall Study|Other|0|||
44143672|NCT00271817|78932989|FG001|Part 2|Adverse Event|17|||
44143673|NCT00271817|78932990|FG002|Part 2|Adverse Event|33|||
44143674|NCT00271817|78932988|FG000|Part 2|Lack of Efficacy|0|||
44143675|NCT00271817|78932989|FG001|Part 2|Lack of Efficacy|1|||
44143676|NCT00271817|78932990|FG002|Part 2|Lack of Efficacy|6|||
44143677|NCT00271817|78932988|FG000|Part 2|Lost to Follow-up|0|||
44143678|NCT00271817|78932989|FG001|Part 2|Lost to Follow-up|6|||
44143679|NCT00271817|78932990|FG002|Part 2|Lost to Follow-up|18|||
44143680|NCT00271817|78932988|FG000|Part 2|Protocol Violation|0|||
44143681|NCT00271817|78932989|FG001|Part 2|Protocol Violation|3|||
44143682|NCT00271817|78932990|FG002|Part 2|Protocol Violation|5|||
44143683|NCT00271817|78932988|FG000|Part 2|Patient Moved|0|||
44143684|NCT00271817|78932989|FG001|Part 2|Patient Moved|0|||
44143685|NCT00271817|78932990|FG002|Part 2|Patient Moved|5|||
44143686|NCT00271817|78932988|FG000|Part 2|Withdrawal by Subject|0|||
44143687|NCT00271817|78932989|FG001|Part 2|Withdrawal by Subject|2|||
44143688|NCT00271817|78932990|FG002|Part 2|Withdrawal by Subject|13|||
44143689|NCT00271817|78932988|FG000|Part 2|LDL < 50 mg/dL|0|||
44143690|NCT00271817|78932989|FG001|Part 2|LDL < 50 mg/dL|3|||
44143691|NCT00271817|78932990|FG002|Part 2|LDL < 50 mg/dL|4|||
44143692|NCT02731157|78933002|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
44143693|NCT03268811|78933010|FG000|Overall Study|Adverse Event|0|||
44143694|NCT03268811|78933011|FG001|Overall Study|Adverse Event|1|||
44143695|NCT02732015|78933020|FG000|Overall Study|Lost to Follow-up|0|||
44143696|NCT02732015|78933021|FG001|Overall Study|Lost to Follow-up|1|||
44143697|NCT01441115|78933041|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
44143698|NCT02006147|78933052|FG000|Overall Study|Protocol Violation|1|||
44143699|NCT02006147|78933053|FG001|Overall Study|Protocol Violation|1|||
44143700|NCT02006147|78933054|FG002|Overall Study|Protocol Violation|0|||
44143701|NCT02006147|78933055|FG003|Overall Study|Protocol Violation|0|||
44143702|NCT02006147|78933052|FG000|Overall Study|Withdrawal by Subject|0|||
44143703|NCT02006147|78933053|FG001|Overall Study|Withdrawal by Subject|1|||
44143704|NCT02006147|78933054|FG002|Overall Study|Withdrawal by Subject|0|||
44143705|NCT02006147|78933055|FG003|Overall Study|Withdrawal by Subject|0|||
44167972|NCT02272413|78961204|FG001|Pre-switch Period|Adverse Event|37|||
44167973|NCT02272413|78961203|FG000|Pre-switch Period|Death|26|||
44167974|NCT02272413|78961204|FG001|Pre-switch Period|Death|26|||
44167975|NCT02272413|78961203|FG000|Pre-switch Period|Withdrawal by Subject|27|||
44167976|NCT02272413|78961204|FG001|Pre-switch Period|Withdrawal by Subject|15|||
44167977|NCT02272413|78961203|FG000|Pre-switch Period|Physician Decision|6|||
44167978|NCT02272413|78961204|FG001|Pre-switch Period|Physician Decision|18|||
44167979|NCT02272413|78961203|FG000|Pre-switch Period|Progressive disease|185|||
44167980|NCT02272413|78961204|FG001|Pre-switch Period|Progressive disease|173|||
44167981|NCT02272413|78961203|FG000|Pre-switch Period|Lost to Follow-up|0|||
44167982|NCT02272413|78961204|FG001|Pre-switch Period|Lost to Follow-up|2|||
44167983|NCT02272413|78961203|FG000|Pre-switch Period|Protocol Violation|1|||
44167984|NCT02272413|78961204|FG001|Pre-switch Period|Protocol Violation|0|||
44167985|NCT02272413|78961203|FG000|Pre-switch Period|Other than listed|10|||
44167986|NCT02272413|78961204|FG001|Pre-switch Period|Other than listed|11|||
44167987|NCT02272413|78961203|FG000|Post-switch Period|Adverse Event|4|||
44167988|NCT02272413|78961204|FG001|Post-switch Period|Adverse Event|4|||
44167989|NCT02272413|78961203|FG000|Post-switch Period|Death|3|||
44167990|NCT02272413|78961204|FG001|Post-switch Period|Death|2|||
44167991|NCT02272413|78961203|FG000|Post-switch Period|Withdrawal by Subject|1|||
44167992|NCT02272413|78961204|FG001|Post-switch Period|Withdrawal by Subject|2|||
44167993|NCT02272413|78961203|FG000|Post-switch Period|Physician Decision|1|||
44167994|NCT02272413|78961204|FG001|Post-switch Period|Physician Decision|1|||
44167995|NCT02272413|78961203|FG000|Post-switch Period|Progressive disease|21|||
44167996|NCT02272413|78961204|FG001|Post-switch Period|Progressive disease|21|||
44167997|NCT02272413|78961203|FG000|Post-switch Period|Study terminated by sponsor|8|||
44167998|NCT02272413|78961204|FG001|Post-switch Period|Study terminated by sponsor|11|||
44167999|NCT02272413|78961203|FG000|Post-switch Period|Other than listed|4|||
44168000|NCT02272413|78961204|FG001|Post-switch Period|Other than listed|5|||
44168001|NCT02396381|78961216|FG000|Overall Study|Adverse Event|3|||
44168002|NCT02396381|78961217|FG001|Overall Study|Adverse Event|2|||
44168003|NCT02396381|78961216|FG000|Overall Study|Withdrawal by Subject|33|||
44168004|NCT02396381|78961217|FG001|Overall Study|Withdrawal by Subject|24|||
44168005|NCT02396381|78961216|FG000|Overall Study|Lost to Follow-up|49|||
44168006|NCT02396381|78961217|FG001|Overall Study|Lost to Follow-up|31|||
44168007|NCT02396381|78961216|FG000|Overall Study|Protocol Violation|1|||
44168008|NCT02396381|78961217|FG001|Overall Study|Protocol Violation|0|||
44168009|NCT02396381|78961216|FG000|Overall Study|Site terminated by sponsor|7|||
44168010|NCT02396381|78961217|FG001|Overall Study|Site terminated by sponsor|8|||
44168011|NCT02396381|78961216|FG000|Overall Study|Physician Decision|5|||
44168012|NCT02396381|78961217|FG001|Overall Study|Physician Decision|5|||
44168013|NCT02396381|78961216|FG000|Overall Study|Pregnancy|2|||
44168014|NCT02396381|78961217|FG001|Overall Study|Pregnancy|0|||
44168015|NCT02396381|78961216|FG000|Overall Study|Non-compliance with study procedures|1|||
44168016|NCT02396381|78961217|FG001|Overall Study|Non-compliance with study procedures|0|||
44168017|NCT02396381|78961216|FG000|Overall Study|Moved out of town/state|1|||
44168018|NCT02396381|78961217|FG001|Overall Study|Moved out of town/state|3|||
44168019|NCT02396381|78961216|FG000|Overall Study|Could not complete visit|1|||
44168020|NCT02396381|78961217|FG001|Overall Study|Could not complete visit|0|||
44168021|NCT02396381|78961216|FG000|Overall Study|Possible conflict of interest|1|||
44168022|NCT02396381|78961217|FG001|Overall Study|Possible conflict of interest|0|||
44168023|NCT02396381|78961216|FG000|Overall Study|Randomization/Screening Error|3|||
44168024|NCT02396381|78961217|FG001|Overall Study|Randomization/Screening Error|1|||
44168025|NCT02532647|78961229|FG000|Overall Study|Did not receive trial medication|1|||
44168026|NCT02532647|78961230|FG001|Overall Study|Did not receive trial medication|0|||
44168027|NCT02532647|78961231|FG002|Overall Study|Did not receive trial medication|1|||
44168028|NCT02537015|78961239|FG000|Overall Study|Adverse Event|3|||
44168029|NCT02537015|78961239|FG000|Overall Study|Withdrawal by Subject|2|||
44168030|NCT02537015|78961239|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44168031|NCT02271945|78961245|FG000|Overall Study|Death|3|||
44168032|NCT02271945|78961246|FG001|Overall Study|Death|3|||
44168033|NCT02271945|78961245|FG000|Overall Study|Withdrawal by Subject|1|||
44168034|NCT02271945|78961246|FG001|Overall Study|Withdrawal by Subject|1|||
44168035|NCT02271945|78961245|FG000|Overall Study|Other|1|||
44168036|NCT02271945|78961246|FG001|Overall Study|Other|1|||
44168037|NCT01660763|78961254|FG000|Overall Study|Lack of Efficacy|45|||
44168038|NCT01660763|78961255|FG001|Overall Study|Lack of Efficacy|50|||
44168039|NCT01660763|78961254|FG000|Overall Study|Adverse Event|22|||
44168040|NCT01660763|78961255|FG001|Overall Study|Adverse Event|7|||
44168041|NCT01660763|78961254|FG000|Overall Study|Protocol Violation|1|||
44168042|NCT01660763|78961255|FG001|Overall Study|Protocol Violation|0|||
44168043|NCT01660763|78961254|FG000|Overall Study|Withdrawal by Subject|4|||
44168044|NCT01660763|78961255|FG001|Overall Study|Withdrawal by Subject|0|||
44168045|NCT01660763|78961254|FG000|Overall Study|Patient ready for early discharge|28|||
44168046|NCT01660763|78961255|FG001|Overall Study|Patient ready for early discharge|4|||
44168047|NCT02268045|78961263|FG000|Overall Study|Death|4|||
44168048|NCT02268045|78961264|FG001|Overall Study|Death|4|||
44168049|NCT02268045|78961263|FG000|Overall Study|Disease Progression|2|||
44168050|NCT02268045|78961264|FG001|Overall Study|Disease Progression|1|||
44168051|NCT02268045|78961263|FG000|Overall Study|Adverse Event|7|||
44168052|NCT02268045|78961264|FG001|Overall Study|Adverse Event|7|||
44168053|NCT02268045|78961263|FG000|Overall Study|Withdrawal by Subject|2|||
44168054|NCT02268045|78961264|FG001|Overall Study|Withdrawal by Subject|6|||
44168055|NCT02268045|78961263|FG000|Overall Study|Physician Decision|0|||
44168056|NCT02268045|78961264|FG001|Overall Study|Physician Decision|1|||
44168057|NCT02268045|78961263|FG000|Overall Study|Protocol Violation|1|||
44168058|NCT02268045|78961264|FG001|Overall Study|Protocol Violation|1|||
44168059|NCT02536781|78961274|FG000|Overall Study|Lost to Follow-up|2|||
44168060|NCT02536781|78961275|FG001|Overall Study|Lost to Follow-up|0|||
44168061|NCT02267187|78961281|FG000|Overall Study|Physician Decision|2|||
44168062|NCT02267187|78961281|FG000|Overall Study|Screen fail|3|||
44168063|NCT02532179|78961285|FG000|Overall Study|Lost to Follow-up|1|||
44168064|NCT02532179|78961285|FG000|Overall Study|Pregnancy|1|||
44168065|NCT02532179|78961285|FG000|Overall Study|Subject received depot steroid injection|1|||
44168066|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
44168067|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
44168068|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
44168069|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
44168070|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
44168071|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
44168072|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
44168073|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
44168074|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
44168075|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
44168076|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
44168077|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
44168078|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
44168079|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
44168080|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
44168081|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
44168082|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
44168083|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
44168084|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
44168085|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
44168086|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
44168087|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
44168088|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
44168089|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
44168090|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
44168091|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
44168092|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
44168093|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
44168094|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
44168095|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
44449090|NCT00427960|79457655|FG001|Overall Study|Other|1|||
44449091|NCT00548340|79457664|FG000|Overall Study|Protocol Violation|2|||
44449092|NCT00548340|79457665|FG001|Overall Study|Protocol Violation|3|||
44449093|NCT00548340|79457666|FG002|Overall Study|Protocol Violation|3|||
44449094|NCT00548340|79457664|FG000|Overall Study|Adverse Event|2|||
44449095|NCT00548340|79457665|FG001|Overall Study|Adverse Event|2|||
44449096|NCT00548340|79457666|FG002|Overall Study|Adverse Event|2|||
44449097|NCT00548340|79457664|FG000|Overall Study|Lost to Follow-up|1|||
44449098|NCT00548340|79457665|FG001|Overall Study|Lost to Follow-up|1|||
44449099|NCT00548340|79457666|FG002|Overall Study|Lost to Follow-up|0|||
44449100|NCT00548340|79457664|FG000|Overall Study|Withdrawal by Subject|2|||
44449101|NCT00548340|79457665|FG001|Overall Study|Withdrawal by Subject|4|||
44449102|NCT00548340|79457666|FG002|Overall Study|Withdrawal by Subject|3|||
44449103|NCT00548340|79457664|FG000|Overall Study|Other|1|||
44449104|NCT00548340|79457665|FG001|Overall Study|Other|1|||
44449105|NCT00548340|79457666|FG002|Overall Study|Other|1|||
44449106|NCT00454246|79457677|FG000|Overall Study|Adverse Event|2|||
44449107|NCT00454246|79457678|FG001|Overall Study|Adverse Event|2|||
44449108|NCT00454246|79457679|FG002|Overall Study|Adverse Event|0|||
44449109|NCT00454246|79457677|FG000|Overall Study|Violation of selection criteria at entry|6|||
44449110|NCT00454246|79457678|FG001|Overall Study|Violation of selection criteria at entry|0|||
44449111|NCT00454246|79457679|FG002|Overall Study|Violation of selection criteria at entry|0|||
44449112|NCT00454246|79457677|FG000|Overall Study|Protocol Violation|1|||
44168096|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
44168097|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
44168098|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
44168099|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
44168100|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
44168101|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
44168102|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
44168103|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
44168104|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
44168105|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
44168106|NCT02409667|78961289|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
44168107|NCT02409667|78961290|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
44168108|NCT02409667|78961291|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
44168109|NCT02409667|78961292|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
44168110|NCT02409667|78961293|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
44168111|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
44168112|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
44168113|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
44168114|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
44168115|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
44168116|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
44168117|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
44168118|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
44168119|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
44168120|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
44168121|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
44168122|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
44168123|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
44168124|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
44168125|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
44168126|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
44168127|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
44168128|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
44168129|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
44168130|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
44168131|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
44168132|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
44168133|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
44168134|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
44168135|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
44168136|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
44168137|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
44168138|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
44168139|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
44168140|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
44168141|NCT02409667|78961289|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
44168142|NCT02409667|78961290|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
44168143|NCT02409667|78961291|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
44168144|NCT02409667|78961292|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
44168145|NCT02409667|78961293|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
44168146|NCT01641939|78961307|FG000|Overall Study|Death|90|||
44168147|NCT01641939|78961308|FG001|Overall Study|Death|187|||
44168148|NCT01641939|78961309|FG002|Overall Study|Death|61|||
44168149|NCT01641939|78961307|FG000|Overall Study|Lost to Follow-up|3|||
44168150|NCT01641939|78961308|FG001|Overall Study|Lost to Follow-up|2|||
44168151|NCT01641939|78961309|FG002|Overall Study|Lost to Follow-up|1|||
44168152|NCT01641939|78961307|FG000|Overall Study|Withdrawal by Subject|14|||
44168153|NCT01641939|78961308|FG001|Overall Study|Withdrawal by Subject|11|||
44168154|NCT01641939|78961309|FG002|Overall Study|Withdrawal by Subject|5|||
44168155|NCT01641939|78961307|FG000|Overall Study|Study Terminated by Sponsor|10|||
44168156|NCT01641939|78961308|FG001|Overall Study|Study Terminated by Sponsor|28|||
44168157|NCT01641939|78961309|FG002|Overall Study|Study Terminated by Sponsor|3|||
44168158|NCT01641861|78961321|FG000|Overall Study|Lost to Follow-up|21|||
44168159|NCT01641861|78961322|FG001|Overall Study|Lost to Follow-up|16|||
44168160|NCT01641861|78961321|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
44168161|NCT01641861|78961322|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
44168162|NCT01641861|78961321|FG000|Overall Study|Died due to drowning|0|||
44449113|NCT00454246|79457678|FG001|Overall Study|Protocol Violation|0|||
44449114|NCT00454246|79457679|FG002|Overall Study|Protocol Violation|0|||
44449115|NCT00454246|79457677|FG000|Overall Study|Refused Treatment|1|||
44449116|NCT00454246|79457678|FG001|Overall Study|Refused Treatment|1|||
44449117|NCT00454246|79457679|FG002|Overall Study|Refused Treatment|0|||
44449118|NCT00454246|79457677|FG000|Overall Study|Failure to return|1|||
44449119|NCT00454246|79457678|FG001|Overall Study|Failure to return|0|||
44449120|NCT00454246|79457679|FG002|Overall Study|Failure to return|0|||
44449121|NCT00454246|79457677|FG000|Overall Study|Early termination of study|62|||
44449122|NCT00454246|79457678|FG001|Overall Study|Early termination of study|26|||
44449123|NCT00454246|79457679|FG002|Overall Study|Early termination of study|9|||
44449124|NCT00434590|79457689|FG000|Overall Study|Administrative problems|5|||
44449125|NCT00434590|79457690|FG001|Overall Study|Administrative problems|5|||
44449126|NCT02891837|79457698|FG000|Overall Study|Lost to Follow-up|2|||
44449127|NCT02891837|79457699|FG001|Overall Study|Lost to Follow-up|0|||
44449128|NCT02891837|79457698|FG000|Overall Study|Withdrawal by Subject|1|||
44449129|NCT02891837|79457699|FG001|Overall Study|Withdrawal by Subject|0|||
44449130|NCT00695903|79457723|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
44449131|NCT00695903|79457724|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
44449132|NCT00695903|79457723|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
44449133|NCT00695903|79457724|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
44449134|NCT00695903|79457723|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
44449135|NCT00695903|79457724|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
44449136|NCT00695903|79457723|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
44449137|NCT00695903|79457724|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
44449138|NCT00695903|79457723|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
44449139|NCT00695903|79457724|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
44449140|NCT00695903|79457723|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
44449141|NCT00695903|79457724|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
44449142|NCT00695903|79457723|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
44449143|NCT00695903|79457724|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
44449144|NCT00695903|79457723|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
44449145|NCT00695903|79457724|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
44449146|NCT00695903|79457723|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
44360764|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44360765|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
44360766|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
44360767|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
44360768|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
44360769|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
44360770|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
44360771|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
44360772|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
44360773|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
44360774|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360775|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
44360776|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
44360777|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360778|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360779|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360780|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360781|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360782|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44360783|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360784|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360785|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
44360786|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360787|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360788|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360789|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360790|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44449147|NCT00695903|79457724|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
44449148|NCT00548262|79457730|FG000|Overall Study|Death|21|||
44449149|NCT00548262|79457730|FG000|Overall Study|Adverse Event|2|||
44449150|NCT00548262|79457730|FG000|Overall Study|Lack of Efficacy|4|||
44449151|NCT00548262|79457730|FG000|Overall Study|Lost to Follow-up|1|||
44449152|NCT00548262|79457730|FG000|Overall Study|Other|3|||
44449153|NCT00548262|79457730|FG000|Overall Study|Withdrawal by Subject|1|||
44168163|NCT01641861|78961322|FG001|Overall Study|Died due to drowning|1|||
44168164|NCT02409355|78961330|FG000|Overall Study|Withdrawal by Subject|1|||
44168165|NCT02409355|78961331|FG001|Overall Study|Withdrawal by Subject|0|||
44168166|NCT02409355|78961330|FG000|Overall Study|Death|1|||
44168167|NCT02409355|78961331|FG001|Overall Study|Death|1|||
44168168|NCT02409355|78961330|FG000|Overall Study|Study terminated by Sponsor|2|||
44168169|NCT02409355|78961331|FG001|Overall Study|Study terminated by Sponsor|3|||
44168170|NCT02408887|78961339|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
44168171|NCT02408887|78961340|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
44168172|NCT02408887|78961339|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
44168173|NCT02408887|78961340|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
44168174|NCT02266875|78961348|FG000|Overall Study|Withdrawal by Subject|9|||
44168175|NCT02266875|78961349|FG001|Overall Study|Withdrawal by Subject|0|||
44168176|NCT02266875|78961348|FG000|Overall Study|Lost to Follow-up|2|||
44168177|NCT02266875|78961349|FG001|Overall Study|Lost to Follow-up|0|||
44168178|NCT02438371|78961357|FG000|Overall Study|Lost to Follow-up|3|||
44168179|NCT02438371|78961358|FG001|Overall Study|Lost to Follow-up|2|||
44168180|NCT02438371|78961357|FG000|Overall Study|Withdrawal by Subject|1|||
44168181|NCT02438371|78961358|FG001|Overall Study|Withdrawal by Subject|1|||
44168182|NCT02438137|78961366|FG000|Overall Study|Lost to Follow-up|3|||
44168183|NCT02438137|78961367|FG001|Overall Study|Lost to Follow-up|2|||
44168184|NCT02438137|78961366|FG000|Overall Study|Adverse Event|1|||
44168185|NCT02438137|78961367|FG001|Overall Study|Adverse Event|0|||
44168186|NCT02438137|78961366|FG000|Overall Study|Withdrawal by Subject|4|||
44168187|NCT02438137|78961367|FG001|Overall Study|Withdrawal by Subject|3|||
44168188|NCT02438137|78961366|FG000|Overall Study|Physician Decision|0|||
44168189|NCT02438137|78961367|FG001|Overall Study|Physician Decision|1|||
44168190|NCT02437903|78961375|FG000|Overall Study|Adverse Event|1|||
44168191|NCT02437903|78961375|FG000|Overall Study|Withdrawal by Subject|1|||
44168192|NCT02437903|78961375|FG000|Overall Study|Lost to Follow-up|3|||
44168193|NCT02437513|78961380|FG000|Overall Study|Withdrawal by Subject|2|||
44168194|NCT02460991|78961386|FG000|Overall Study|Withdrawal by Subject|0|||
44168195|NCT02460991|78961387|FG001|Overall Study|Withdrawal by Subject|2|||
44168196|NCT02407249|78961398|FG000|Overall Study|Did not complete 12-month follow-up|13|||
44168197|NCT02407249|78961398|FG000|Overall Study|Not treated|13|||
44168198|NCT02460679|78961402|FG000|Overall Study|Investigator Decision|1|||
44168199|NCT02460679|78961402|FG000|Overall Study|Withdrawal by Subject|4|||
44168200|NCT02459899|78961410|FG000|Overall Study|Adverse Event|1|||
44168201|NCT02459899|78961411|FG001|Overall Study|Adverse Event|1|||
44168202|NCT02459899|78961412|FG002|Overall Study|Adverse Event|0|||
44168203|NCT02459899|78961413|FG003|Overall Study|Adverse Event|0|||
44168204|NCT02459899|78961410|FG000|Overall Study|Lost to Follow-up|1|||
44168205|NCT02459899|78961411|FG001|Overall Study|Lost to Follow-up|2|||
44168206|NCT02459899|78961412|FG002|Overall Study|Lost to Follow-up|0|||
44168207|NCT02459899|78961413|FG003|Overall Study|Lost to Follow-up|1|||
44168208|NCT02459899|78961410|FG000|Overall Study|Non-compliance with the treatment|0|||
44168209|NCT02459899|78961411|FG001|Overall Study|Non-compliance with the treatment|0|||
44168210|NCT02459899|78961412|FG002|Overall Study|Non-compliance with the treatment|0|||
44168211|NCT02459899|78961413|FG003|Overall Study|Non-compliance with the treatment|1|||
44168212|NCT02459899|78961410|FG000|Overall Study|Withdrawal by Subject|1|||
44168213|NCT02459899|78961411|FG001|Overall Study|Withdrawal by Subject|3|||
44168214|NCT02459899|78961412|FG002|Overall Study|Withdrawal by Subject|0|||
44168215|NCT02459899|78961413|FG003|Overall Study|Withdrawal by Subject|0|||
44168216|NCT02436889|78961425|FG000|Overall Study|No improvement in symptoms|1|||
44449154|NCT00095173|79457734|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
44449155|NCT00095173|79457735|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
44449156|NCT00095173|79457736|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
44449157|NCT00095173|79457737|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
44449158|NCT00095173|79457738|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
44449159|NCT00095173|79457739|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
44449160|NCT00095173|79457734|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
44449161|NCT00095173|79457735|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
44168217|NCT02436889|78961426|FG001|Overall Study|No improvement in symptoms|0|||
44168218|NCT02436889|78961425|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
44168219|NCT02436889|78961426|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
44168220|NCT02436811|78961435|FG000|Overall Study|Lost to Follow-up|2|||
44168221|NCT02436811|78961436|FG001|Overall Study|Lost to Follow-up|9|||
44168222|NCT02436811|78961437|FG002|Overall Study|Lost to Follow-up|7|||
44168223|NCT02436577|78961451|FG000|Overall Study|Protocol Deviation|0|||
44168224|NCT02436577|78961452|FG001|Overall Study|Protocol Deviation|1|||
44168225|NCT02436577|78961453|FG002|Overall Study|Protocol Deviation|0|||
44449162|NCT00095173|79457736|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
44449163|NCT00095173|79457737|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
44449164|NCT00095173|79457738|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
44168226|NCT02436577|78961454|FG003|Overall Study|Protocol Deviation|0|||
44168227|NCT02436577|78961455|FG004|Overall Study|Protocol Deviation|0|||
44168228|NCT02436577|78961456|FG005|Overall Study|Protocol Deviation|0|||
44168229|NCT02265705|78961466|FG000|Treatment Period Week 0-24|Adverse Event|3|||
44168230|NCT02265705|78961467|FG001|Treatment Period Week 0-24|Adverse Event|2|||
44168231|NCT02265705|78961468|FG002|Treatment Period Week 0-24|Adverse Event|0|||
44168232|NCT02265705|78961469|FG003|Treatment Period Week 0-24|Adverse Event|0|||
44168233|NCT02265705|78961470|FG004|Treatment Period Week 0-24|Adverse Event|0|||
44168234|NCT02265705|78961471|FG005|Treatment Period Week 0-24|Adverse Event|0|||
44168235|NCT02265705|78961472|FG006|Treatment Period Week 0-24|Adverse Event|0|||
44168236|NCT02265705|78961466|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
44168237|NCT02265705|78961467|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
44168238|NCT02265705|78961468|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
44168239|NCT02265705|78961469|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
44168240|NCT02265705|78961470|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
44168241|NCT02265705|78961471|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
44168242|NCT02265705|78961472|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
44168243|NCT02265705|78961466|FG000|Treatment Period Week 0-24|Physician Decision|1|||
44168244|NCT02265705|78961467|FG001|Treatment Period Week 0-24|Physician Decision|0|||
44168245|NCT02265705|78961468|FG002|Treatment Period Week 0-24|Physician Decision|0|||
44168246|NCT02265705|78961469|FG003|Treatment Period Week 0-24|Physician Decision|0|||
44168247|NCT02265705|78961470|FG004|Treatment Period Week 0-24|Physician Decision|0|||
44168248|NCT02265705|78961471|FG005|Treatment Period Week 0-24|Physician Decision|0|||
44168249|NCT02265705|78961472|FG006|Treatment Period Week 0-24|Physician Decision|0|||
44168250|NCT02265705|78961466|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
44168251|NCT02265705|78961467|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
44168252|NCT02265705|78961468|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
44168253|NCT02265705|78961469|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
44168254|NCT02265705|78961470|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
44168255|NCT02265705|78961471|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
44168256|NCT02265705|78961472|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
44168257|NCT02265705|78961466|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
44168258|NCT02265705|78961467|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
44168259|NCT02265705|78961468|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
44168260|NCT02265705|78961469|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
44168261|NCT02265705|78961470|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
44168262|NCT02265705|78961471|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
44168263|NCT02265705|78961472|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
44168264|NCT02265705|78961466|FG000|Rescue Period|Withdrawal by Subject|0|||
44168265|NCT02265705|78961467|FG001|Rescue Period|Withdrawal by Subject|0|||
44168266|NCT02265705|78961468|FG002|Rescue Period|Withdrawal by Subject|1|||
44168267|NCT02265705|78961469|FG003|Rescue Period|Withdrawal by Subject|0|||
44168268|NCT02265705|78961470|FG004|Rescue Period|Withdrawal by Subject|0|||
44168269|NCT02265705|78961471|FG005|Rescue Period|Withdrawal by Subject|0|||
44168270|NCT02265705|78961472|FG006|Rescue Period|Withdrawal by Subject|0|||
44168271|NCT02265705|78961466|FG000|Rescue Period|Death|0|||
44168272|NCT02265705|78961467|FG001|Rescue Period|Death|0|||
44168273|NCT02265705|78961468|FG002|Rescue Period|Death|1|||
44168274|NCT02265705|78961469|FG003|Rescue Period|Death|0|||
44168275|NCT02265705|78961470|FG004|Rescue Period|Death|0|||
44168276|NCT02265705|78961471|FG005|Rescue Period|Death|0|||
44168277|NCT02265705|78961472|FG006|Rescue Period|Death|0|||
44168278|NCT02265705|78961466|FG000|Rescue Period|Lack of Efficacy|0|||
44168279|NCT02265705|78961467|FG001|Rescue Period|Lack of Efficacy|0|||
44168280|NCT02265705|78961468|FG002|Rescue Period|Lack of Efficacy|1|||
44168281|NCT02265705|78961469|FG003|Rescue Period|Lack of Efficacy|0|||
44168282|NCT02265705|78961470|FG004|Rescue Period|Lack of Efficacy|0|||
44168283|NCT02265705|78961471|FG005|Rescue Period|Lack of Efficacy|0|||
44168284|NCT02265705|78961472|FG006|Rescue Period|Lack of Efficacy|0|||
44168285|NCT02265705|78961466|FG000|Open Label Period|Adverse Event|0|||
44168286|NCT02265705|78961467|FG001|Open Label Period|Adverse Event|0|||
44168287|NCT02265705|78961468|FG002|Open Label Period|Adverse Event|0|||
44168288|NCT02265705|78961469|FG003|Open Label Period|Adverse Event|2|||
44168289|NCT02265705|78961470|FG004|Open Label Period|Adverse Event|2|||
44168290|NCT02265705|78961471|FG005|Open Label Period|Adverse Event|0|||
44168291|NCT02265705|78961472|FG006|Open Label Period|Adverse Event|0|||
44168292|NCT02265705|78961466|FG000|Open Label Period|Physician Decision|0|||
44168293|NCT02265705|78961467|FG001|Open Label Period|Physician Decision|0|||
44168294|NCT02265705|78961468|FG002|Open Label Period|Physician Decision|0|||
44168295|NCT02265705|78961469|FG003|Open Label Period|Physician Decision|0|||
44168296|NCT02265705|78961470|FG004|Open Label Period|Physician Decision|1|||
44168297|NCT02265705|78961471|FG005|Open Label Period|Physician Decision|0|||
44168298|NCT02265705|78961472|FG006|Open Label Period|Physician Decision|0|||
44168299|NCT02265705|78961466|FG000|Open Label Period|Withdrawal by Subject|0|||
44168300|NCT02265705|78961467|FG001|Open Label Period|Withdrawal by Subject|0|||
44168301|NCT02265705|78961468|FG002|Open Label Period|Withdrawal by Subject|0|||
44168302|NCT02265705|78961469|FG003|Open Label Period|Withdrawal by Subject|0|||
44168303|NCT02265705|78961470|FG004|Open Label Period|Withdrawal by Subject|2|||
44168304|NCT02265705|78961471|FG005|Open Label Period|Withdrawal by Subject|0|||
44168305|NCT02265705|78961472|FG006|Open Label Period|Withdrawal by Subject|0|||
44168306|NCT02265705|78961466|FG000|Follow-up Period|Sponsor Decision|0|||
44168307|NCT02265705|78961467|FG001|Follow-up Period|Sponsor Decision|0|||
44168308|NCT02265705|78961468|FG002|Follow-up Period|Sponsor Decision|0|||
44168309|NCT02265705|78961469|FG003|Follow-up Period|Sponsor Decision|0|||
44168310|NCT02265705|78961470|FG004|Follow-up Period|Sponsor Decision|0|||
44168311|NCT02265705|78961471|FG005|Follow-up Period|Sponsor Decision|1|||
44168312|NCT02265705|78961472|FG006|Follow-up Period|Sponsor Decision|6|||
44168313|NCT02265705|78961466|FG000|Follow-up Period|Adverse Event|0|||
44168314|NCT02265705|78961467|FG001|Follow-up Period|Adverse Event|0|||
44168315|NCT02265705|78961468|FG002|Follow-up Period|Adverse Event|0|||
44168316|NCT02265705|78961469|FG003|Follow-up Period|Adverse Event|0|||
44168317|NCT02265705|78961470|FG004|Follow-up Period|Adverse Event|0|||
44168318|NCT02265705|78961471|FG005|Follow-up Period|Adverse Event|0|||
44168319|NCT02265705|78961472|FG006|Follow-up Period|Adverse Event|3|||
44168320|NCT02265705|78961466|FG000|Follow-up Period|Physician Decision|0|||
44168321|NCT02265705|78961467|FG001|Follow-up Period|Physician Decision|0|||
44168322|NCT02265705|78961468|FG002|Follow-up Period|Physician Decision|0|||
44168323|NCT02265705|78961469|FG003|Follow-up Period|Physician Decision|0|||
44168324|NCT02265705|78961470|FG004|Follow-up Period|Physician Decision|0|||
44168325|NCT02265705|78961471|FG005|Follow-up Period|Physician Decision|0|||
44168326|NCT02265705|78961472|FG006|Follow-up Period|Physician Decision|1|||
44168327|NCT02265705|78961466|FG000|Follow-up Period|Withdrawal by Subject|0|||
44168328|NCT02265705|78961467|FG001|Follow-up Period|Withdrawal by Subject|0|||
44168329|NCT02265705|78961468|FG002|Follow-up Period|Withdrawal by Subject|0|||
44168330|NCT02265705|78961469|FG003|Follow-up Period|Withdrawal by Subject|0|||
44168331|NCT02265705|78961470|FG004|Follow-up Period|Withdrawal by Subject|0|||
44168332|NCT02265705|78961471|FG005|Follow-up Period|Withdrawal by Subject|0|||
44168333|NCT02265705|78961472|FG006|Follow-up Period|Withdrawal by Subject|1|||
44168334|NCT02459665|78961487|FG000|Overall Study|Withdrawal by Subject|0|||
44168335|NCT02459665|78961488|FG001|Overall Study|Withdrawal by Subject|1|||
44168336|NCT02459665|78961489|FG002|Overall Study|Withdrawal by Subject|1|||
44168337|NCT02459665|78961490|FG003|Overall Study|Withdrawal by Subject|2|||
44168338|NCT02265237|78961511|FG000|As Treated (Overall Study)|Adverse Event|1|||
44168339|NCT02265237|78961512|FG001|As Treated (Overall Study)|Adverse Event|1|||
44168340|NCT02265237|78961513|FG002|As Treated (Overall Study)|Adverse Event|0|||
44168341|NCT02265237|78961514|FG003|As Treated (Overall Study)|Adverse Event|0|||
44168342|NCT02265237|78961511|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
44449165|NCT00095173|79457739|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
44449166|NCT00095173|79457734|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
44449167|NCT00095173|79457735|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
44449168|NCT00095173|79457736|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
44449169|NCT00095173|79457737|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
44449170|NCT00095173|79457738|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
44449171|NCT00095173|79457739|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
44449172|NCT00095173|79457734|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
44449173|NCT00095173|79457735|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
44449174|NCT00095173|79457736|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
44449175|NCT00095173|79457737|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
44449176|NCT00095173|79457738|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
44449177|NCT00095173|79457739|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
44449178|NCT00095173|79457734|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
44449179|NCT00095173|79457735|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
44449180|NCT00095173|79457736|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
44449181|NCT00095173|79457737|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
44449182|NCT00095173|79457738|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
44449183|NCT00095173|79457739|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
44449184|NCT00095173|79457734|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
44449185|NCT00095173|79457735|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
44168343|NCT02265237|78961512|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
44168344|NCT02265237|78961513|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
44168345|NCT02265237|78961514|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
44168346|NCT02265237|78961511|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
44449186|NCT00095173|79457736|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
44449187|NCT00095173|79457737|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
44168347|NCT02265237|78961512|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
44168348|NCT02265237|78961513|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
44168349|NCT02265237|78961514|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
44168350|NCT02265237|78961511|FG000|As Treated (Overall Study)|Other|2|||
44168351|NCT02265237|78961512|FG001|As Treated (Overall Study)|Other|0|||
44168352|NCT02265237|78961513|FG002|As Treated (Overall Study)|Other|3|||
44168353|NCT02265237|78961514|FG003|As Treated (Overall Study)|Other|1|||
44168354|NCT02263365|78961527|FG000|Overall Study|Physician Decision|22|||
44168355|NCT02263365|78961528|FG001|Overall Study|Physician Decision|18|||
44168356|NCT02261493|78961538|FG000|Overall Study|Noncompliance|0|||
44168357|NCT02261493|78961539|FG001|Overall Study|Noncompliance|0|||
44168358|NCT02261493|78961540|FG002|Overall Study|Noncompliance|2|||
44168359|NCT02261493|78961538|FG000|Overall Study|Physician Decision|0|||
44168360|NCT02261493|78961539|FG001|Overall Study|Physician Decision|1|||
44168361|NCT02261493|78961540|FG002|Overall Study|Physician Decision|0|||
44168362|NCT02261493|78961538|FG000|Overall Study|Undisclosed alcohol abuse|0|||
44168363|NCT02261493|78961539|FG001|Overall Study|Undisclosed alcohol abuse|1|||
44168364|NCT02261493|78961540|FG002|Overall Study|Undisclosed alcohol abuse|0|||
44168365|NCT02261493|78961538|FG000|Overall Study|Protocol Violation|1|||
44168366|NCT02261493|78961539|FG001|Overall Study|Protocol Violation|0|||
44168367|NCT02261493|78961540|FG002|Overall Study|Protocol Violation|0|||
44168368|NCT02261493|78961538|FG000|Overall Study|Personal Reasons|14|||
44168369|NCT02261493|78961539|FG001|Overall Study|Personal Reasons|14|||
44168370|NCT02261493|78961540|FG002|Overall Study|Personal Reasons|16|||
44168371|NCT02261493|78961538|FG000|Overall Study|Lost to Follow-up|14|||
44168372|NCT02261493|78961539|FG001|Overall Study|Lost to Follow-up|27|||
44168373|NCT02261493|78961540|FG002|Overall Study|Lost to Follow-up|8|||
44168374|NCT02261493|78961538|FG000|Overall Study|Pregnancy|1|||
44168375|NCT02261493|78961539|FG001|Overall Study|Pregnancy|2|||
44168376|NCT02261493|78961540|FG002|Overall Study|Pregnancy|0|||
44168377|NCT02261493|78961538|FG000|Overall Study|Lack of Efficacy|0|||
44168378|NCT02261493|78961539|FG001|Overall Study|Lack of Efficacy|1|||
44168379|NCT02261493|78961540|FG002|Overall Study|Lack of Efficacy|0|||
44168380|NCT02261493|78961538|FG000|Overall Study|Adverse Event|0|||
44168381|NCT02261493|78961539|FG001|Overall Study|Adverse Event|1|||
44168382|NCT02261493|78961540|FG002|Overall Study|Adverse Event|0|||
44168383|NCT02260791|78961550|FG000|Overall Study|Lost to Follow-up|4|||
44168384|NCT02260791|78961551|FG001|Overall Study|Lost to Follow-up|4|||
44168385|NCT02260791|78961550|FG000|Overall Study|Lack of Efficacy|2|||
44168386|NCT02260791|78961551|FG001|Overall Study|Lack of Efficacy|1|||
44168387|NCT02260791|78961550|FG000|Overall Study|Adverse Event|13|||
44168388|NCT02260791|78961551|FG001|Overall Study|Adverse Event|9|||
44168389|NCT02260791|78961550|FG000|Overall Study|Death|1|||
44168390|NCT02260791|78961551|FG001|Overall Study|Death|0|||
44168391|NCT02260791|78961550|FG000|Overall Study|Withdrawal by Subject|11|||
44168392|NCT02260791|78961551|FG001|Overall Study|Withdrawal by Subject|16|||
44168393|NCT02260791|78961550|FG000|Overall Study|Screen failure|0|||
44168394|NCT02260791|78961551|FG001|Overall Study|Screen failure|1|||
44168395|NCT02260791|78961550|FG000|Overall Study|Protocol deviation|2|||
44168396|NCT02260791|78961551|FG001|Overall Study|Protocol deviation|3|||
44168397|NCT02260635|78961559|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
44168398|NCT02260635|78961560|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
44168399|NCT02260635|78961559|FG000|Open-Label Extension|Study Termination|25|||
44168400|NCT02260635|78961560|FG001|Open-Label Extension|Study Termination|25|||
44168401|NCT02260635|78961559|FG000|Open-Label Extension|Withdrawal by Subject|1|||
44168402|NCT02260635|78961560|FG001|Open-Label Extension|Withdrawal by Subject|0|||
44264183|NCT03401450|79164443|FG001|Overall Study|post surgery medication change|1|||
44264184|NCT03401450|79164442|FG000|Overall Study|Cancelled surgery|0|||
44449188|NCT00095173|79457738|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
44449189|NCT00095173|79457739|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
44449190|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Death|0|||
44449191|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Death|0|||
44449192|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Death|0|||
44449193|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Death|0|||
44449194|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Death|0|||
44449195|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Death|1|||
44449196|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
44449197|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
44449198|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
44449199|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
44449200|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
44168403|NCT02258529|78961568|FG000|Overall Study|Study Terminated by Sponsor|9|||
44168404|NCT02258529|78961568|FG000|Overall Study|Adverse Event|1|||
44168405|NCT02256969|78961575|FG000|Overall Study|Screenfailed or withdrew|2|||
44168406|NCT02256969|78961576|FG001|Overall Study|Screenfailed or withdrew|1|||
44168407|NCT02256969|78961577|FG002|Overall Study|Screenfailed or withdrew|1|||
44449201|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
44168408|NCT02256891|78961587|FG000|Overall Study|Death|0|||
44168409|NCT02256891|78961588|FG001|Overall Study|Death|2|||
44168410|NCT02256891|78961587|FG000|Overall Study|Lost to Follow-up|0|||
44264185|NCT03401450|79164443|FG001|Overall Study|Cancelled surgery|2|||
44264186|NCT03326063|79164451|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
44264187|NCT03326063|79164452|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
44360791|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44360792|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44360793|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
44360794|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44449202|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
44449203|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
44449204|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
44449205|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
44449206|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
44449207|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
44449208|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
44449209|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
44449210|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
44449211|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
44449212|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
44449213|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
44449214|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
44449215|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
44449216|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
44449217|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
44449218|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
44449219|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
44449220|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
44449221|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
44449222|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
44449223|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
44449224|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
44449225|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
44449226|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
44449227|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
44449228|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
44449229|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
44449230|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
44449231|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
44449232|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
44449233|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
44449234|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
44449235|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
44449236|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
44449237|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
44449238|NCT00095173|79457734|FG000|Open-Label Extension Phase (Period C)|Other|0|||
44449239|NCT00095173|79457735|FG001|Open-Label Extension Phase (Period C)|Other|0|||
44168411|NCT02256891|78961588|FG001|Overall Study|Lost to Follow-up|3|||
44168412|NCT02256891|78961587|FG000|Overall Study|Physician Decision|7|||
44168413|NCT02256891|78961588|FG001|Overall Study|Physician Decision|3|||
44168414|NCT02256891|78961587|FG000|Overall Study|Screen Fail|5|||
44168415|NCT02256891|78961588|FG001|Overall Study|Screen Fail|4|||
44168416|NCT02256891|78961587|FG000|Overall Study|Equipment Malfunction|0|||
44168417|NCT02256891|78961588|FG001|Overall Study|Equipment Malfunction|1|||
44360795|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44360796|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44360797|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44360798|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44360799|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44360800|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
44360801|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
44360802|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
44360803|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
44360804|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
44360805|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
44449240|NCT00095173|79457736|FG002|Open-Label Extension Phase (Period C)|Other|0|||
44449241|NCT00095173|79457737|FG003|Open-Label Extension Phase (Period C)|Other|4|||
44449242|NCT00095173|79457738|FG004|Open-Label Extension Phase (Period C)|Other|6|||
44249598|NCT02649894|79083539|FG001|Overall Study|Lost to Follow-up|1|||
44249599|NCT02649894|79083538|FG000|Overall Study|Death|30|||
44168418|NCT02256267|78961596|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
44168419|NCT02256267|78961596|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
44168420|NCT01641471|78961605|FG000|Overall Study|Withdrawal by Subject|19|||
44168421|NCT01641471|78961606|FG001|Overall Study|Withdrawal by Subject|19|||
44168422|NCT01641471|78961605|FG000|Overall Study|Lost to Follow-up|2|||
44449243|NCT00095173|79457739|FG005|Open-Label Extension Phase (Period C)|Other|8|||
44449244|NCT00690443|79457755|FG000|Overall Study|Adverse Event|1|||
44168423|NCT01641471|78961606|FG001|Overall Study|Lost to Follow-up|4|||
44449245|NCT00690443|79457756|FG001|Overall Study|Adverse Event|2|||
44449246|NCT03954834|79457766|FG000|Overall Study|Adverse Event|1|||
44449247|NCT03954834|79457767|FG001|Overall Study|Adverse Event|3|||
44449248|NCT03954834|79457768|FG002|Overall Study|Adverse Event|1|||
44449249|NCT03954834|79457769|FG003|Overall Study|Adverse Event|1|||
44449250|NCT03954834|79457766|FG000|Overall Study|Death|0|||
44449251|NCT03954834|79457767|FG001|Overall Study|Death|0|||
44168424|NCT01641471|78961605|FG000|Overall Study|Protocol Violation|2|||
44168425|NCT01641471|78961606|FG001|Overall Study|Protocol Violation|4|||
44168426|NCT02255565|78961615|FG000|Overall Study|Withdrawal by Subject|0|||
44168427|NCT02255565|78961616|FG001|Overall Study|Withdrawal by Subject|1|||
44168428|NCT02255565|78961617|FG002|Overall Study|Withdrawal by Subject|0|||
44168429|NCT01640301|78961660|FG000|Overall Study|Death|0|||
44168430|NCT01640301|78961661|FG001|Overall Study|Death|8|||
44168431|NCT01642407|78961669|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
44168432|NCT01642407|78961669|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
44168433|NCT01642407|78961669|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
44168434|NCT02255097|78961673|FG000|Overall Study|Death|151|||
44168435|NCT02255097|78961673|FG000|Overall Study|Lost to Follow-up|5|||
44168436|NCT02255097|78961673|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
44168437|NCT02255097|78961673|FG000|Overall Study|Withdrawal by Subject|7|||
44168438|NCT02255097|78961673|FG000|Overall Study|Allocated but not treated|1|||
44168439|NCT02254551|78961678|FG000|Dose Escalation|Physician Decision|1|||
44168440|NCT02254551|78961678|FG000|Dose Escalation|Dose-limiting toxicity|2|||
44168441|NCT01641237|78961685|FG000|Period II|Withdrawal by Subject|1|||
44168442|NCT01641237|78961686|FG001|Period II|Withdrawal by Subject|0|||
44168443|NCT01641237|78961687|FG002|Period II|Withdrawal by Subject|0|||
44168444|NCT01641237|78961688|FG003|Period II|Withdrawal by Subject|0|||
44168445|NCT01641237|78961685|FG000|Period III|Lost to Follow-up|1|||
44168446|NCT01641237|78961686|FG001|Period III|Lost to Follow-up|0|||
44168447|NCT01641237|78961687|FG002|Period III|Lost to Follow-up|0|||
44168448|NCT01641237|78961688|FG003|Period III|Lost to Follow-up|0|||
44168449|NCT01639833|78961700|FG000|Overall Study|Death|4|||
44168450|NCT01639833|78961701|FG001|Overall Study|Death|2|||
44168451|NCT01639833|78961700|FG000|Overall Study|Withdrawal by Subject|2|||
44168452|NCT01639833|78961701|FG001|Overall Study|Withdrawal by Subject|2|||
44168453|NCT01639131|78961707|FG000|Overall Study|Disease Progression|6|||
44168454|NCT01641159|78961713|FG000|Overall Study|Lost to Follow-up|2|||
44168455|NCT01641159|78961714|FG001|Overall Study|Lost to Follow-up|1|||
44168456|NCT01641159|78961713|FG000|Overall Study|Withdrawal by Subject|0|||
44168457|NCT01641159|78961714|FG001|Overall Study|Withdrawal by Subject|1|||
44168458|NCT01641081|78961720|FG000|Period 1|Sponsor request (potential unblinding)|0|||
44168459|NCT01641081|78961721|FG001|Period 1|Sponsor request (potential unblinding)|0|||
44168460|NCT01641081|78961722|FG002|Period 1|Sponsor request (potential unblinding)|0|||
44168461|NCT01641081|78961723|FG003|Period 1|Sponsor request (potential unblinding)|0|||
44168462|NCT01641081|78961724|FG004|Period 1|Sponsor request (potential unblinding)|0|||
44168463|NCT01641081|78961725|FG005|Period 1|Sponsor request (potential unblinding)|0|||
44168464|NCT01641081|78961726|FG006|Period 1|Sponsor request (potential unblinding)|1|||
44168465|NCT01641081|78961727|FG007|Period 1|Sponsor request (potential unblinding)|0|||
44168466|NCT01641081|78961728|FG008|Period 1|Sponsor request (potential unblinding)|0|||
44168467|NCT01641081|78961729|FG009|Period 1|Sponsor request (potential unblinding)|0|||
44168468|NCT01641081|78961720|FG000|Period 1|Protocol Violation|0|||
44168469|NCT01641081|78961721|FG001|Period 1|Protocol Violation|0|||
44168470|NCT01641081|78961722|FG002|Period 1|Protocol Violation|0|||
44168471|NCT01641081|78961723|FG003|Period 1|Protocol Violation|0|||
44168472|NCT01641081|78961724|FG004|Period 1|Protocol Violation|1|||
44449252|NCT03954834|79457768|FG002|Overall Study|Death|0|||
44168473|NCT01641081|78961725|FG005|Period 1|Protocol Violation|0|||
44360806|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
44360807|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
44360808|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
44360809|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
44360810|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44449253|NCT03954834|79457769|FG003|Overall Study|Death|1|||
44449254|NCT03954834|79457766|FG000|Overall Study|Physician Decision|0|||
44168474|NCT01641081|78961726|FG006|Period 1|Protocol Violation|0|||
44168475|NCT01641081|78961727|FG007|Period 1|Protocol Violation|1|||
44168476|NCT01641081|78961728|FG008|Period 1|Protocol Violation|0|||
44168477|NCT01641081|78961729|FG009|Period 1|Protocol Violation|0|||
44449255|NCT03954834|79457767|FG001|Overall Study|Physician Decision|1|||
44449256|NCT03954834|79457768|FG002|Overall Study|Physician Decision|0|||
44449257|NCT03954834|79457769|FG003|Overall Study|Physician Decision|2|||
44449258|NCT03954834|79457766|FG000|Overall Study|Protocol Violation|1|||
44449259|NCT03954834|79457767|FG001|Overall Study|Protocol Violation|0|||
44449260|NCT03954834|79457768|FG002|Overall Study|Protocol Violation|0|||
44449261|NCT03954834|79457769|FG003|Overall Study|Protocol Violation|1|||
44449262|NCT03954834|79457766|FG000|Overall Study|Withdrawal by Subject|2|||
44449263|NCT03954834|79457767|FG001|Overall Study|Withdrawal by Subject|3|||
44449264|NCT03954834|79457768|FG002|Overall Study|Withdrawal by Subject|13|||
44449265|NCT03954834|79457769|FG003|Overall Study|Withdrawal by Subject|6|||
44449266|NCT03954834|79457766|FG000|Overall Study|Participant left the country|0|||
44449267|NCT03954834|79457767|FG001|Overall Study|Participant left the country|0|||
44449268|NCT03954834|79457768|FG002|Overall Study|Participant left the country|1|||
44449269|NCT03954834|79457769|FG003|Overall Study|Participant left the country|0|||
44449270|NCT03954834|79457766|FG000|Overall Study|Lost to Follow-up|3|||
44449271|NCT03954834|79457767|FG001|Overall Study|Lost to Follow-up|2|||
44449272|NCT03954834|79457768|FG002|Overall Study|Lost to Follow-up|3|||
44449273|NCT03954834|79457769|FG003|Overall Study|Lost to Follow-up|5|||
44449274|NCT00693017|79457781|FG000|Overall Study|Sponsor Decision|2|||
44449275|NCT00693017|79457782|FG001|Overall Study|Sponsor Decision|1|||
44449276|NCT00693017|79457781|FG000|Overall Study|Death|0|||
44449277|NCT00693017|79457782|FG001|Overall Study|Death|1|||
44449278|NCT00692237|79457790|FG000|Overall Study|Withdrawal by Subject|1|||
44449279|NCT00692237|79457791|FG001|Overall Study|Withdrawal by Subject|3|||
44449280|NCT00692237|79457790|FG000|Overall Study|Adverse Event|0|||
44449281|NCT00692237|79457791|FG001|Overall Study|Adverse Event|1|||
44449282|NCT00110149|79457797|FG000|Overall Study|Physician Decision|3|||
44449283|NCT03954444|79457805|FG000|Overall Study|Withdrawal by Subject|5|||
44449284|NCT03954444|79457806|FG001|Overall Study|Withdrawal by Subject|5|||
44449285|NCT03954444|79457807|FG002|Overall Study|Withdrawal by Subject|5|||
44449286|NCT03954444|79457805|FG000|Overall Study|Adverse Event|1|||
44449287|NCT03954444|79457806|FG001|Overall Study|Adverse Event|3|||
44449288|NCT03954444|79457807|FG002|Overall Study|Adverse Event|2|||
44449289|NCT03954444|79457805|FG000|Overall Study|Protocol Violation|0|||
44449290|NCT03954444|79457806|FG001|Overall Study|Protocol Violation|3|||
44449291|NCT03954444|79457807|FG002|Overall Study|Protocol Violation|5|||
44449292|NCT03954444|79457805|FG000|Overall Study|Use of prohibited therapy|1|||
44449293|NCT03954444|79457806|FG001|Overall Study|Use of prohibited therapy|1|||
44449294|NCT03954444|79457807|FG002|Overall Study|Use of prohibited therapy|2|||
44449295|NCT03954444|79457805|FG000|Overall Study|Lost to Follow-up|1|||
44449296|NCT03954444|79457806|FG001|Overall Study|Lost to Follow-up|0|||
44449297|NCT03954444|79457807|FG002|Overall Study|Lost to Follow-up|1|||
44449298|NCT03954444|79457805|FG000|Overall Study|Non-compliant with study drug application|2|||
44449299|NCT03954444|79457806|FG001|Overall Study|Non-compliant with study drug application|2|||
44449300|NCT03954444|79457807|FG002|Overall Study|Non-compliant with study drug application|0|||
44449301|NCT03954444|79457805|FG000|Overall Study|Administrative reasons|0|||
44449302|NCT03954444|79457806|FG001|Overall Study|Administrative reasons|0|||
44449303|NCT03954444|79457807|FG002|Overall Study|Administrative reasons|1|||
44449304|NCT03954444|79457805|FG000|Overall Study|Miscellaneous|3|||
44449305|NCT03954444|79457806|FG001|Overall Study|Miscellaneous|2|||
44449306|NCT03954444|79457807|FG002|Overall Study|Miscellaneous|1|||
44449307|NCT03953820|79457815|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
44449308|NCT03953820|79457816|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
44449309|NCT03953820|79457817|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
44449310|NCT03953820|79457815|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
44449311|NCT03953820|79457816|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
44449312|NCT03953820|79457817|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
44449313|NCT00117949|79457834|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
44449314|NCT00117949|79457835|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
44449315|NCT00117949|79457836|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
44449316|NCT00117949|79457837|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
44449317|NCT00117949|79457834|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
44449318|NCT00117949|79457835|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
44449319|NCT00117949|79457836|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
44449320|NCT00117949|79457837|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
44449321|NCT00117949|79457834|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
44449322|NCT00117949|79457835|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
44449323|NCT00117949|79457836|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
44449324|NCT00117949|79457837|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
44449325|NCT00117949|79457834|FG000|Overall Study|PSA increase >=10ng/mL|0|||
44449326|NCT00117949|79457835|FG001|Overall Study|PSA increase >=10ng/mL|1|||
44449327|NCT00117949|79457836|FG002|Overall Study|PSA increase >=10ng/mL|1|||
44449328|NCT00117949|79457837|FG003|Overall Study|PSA increase >=10ng/mL|0|||
44449329|NCT00117949|79457834|FG000|Overall Study|PSA reduction <=50%|0|||
44168478|NCT01641081|78961720|FG000|Period 1|Adverse Event|1|||
44168479|NCT01641081|78961721|FG001|Period 1|Adverse Event|0|||
44168480|NCT01641081|78961722|FG002|Period 1|Adverse Event|0|||
44168481|NCT01641081|78961723|FG003|Period 1|Adverse Event|0|||
44168482|NCT01641081|78961724|FG004|Period 1|Adverse Event|0|||
44168483|NCT01641081|78961725|FG005|Period 1|Adverse Event|0|||
44168484|NCT01641081|78961726|FG006|Period 1|Adverse Event|0|||
44168485|NCT01641081|78961727|FG007|Period 1|Adverse Event|2|||
44168486|NCT01641081|78961728|FG008|Period 1|Adverse Event|0|||
44168487|NCT01641081|78961729|FG009|Period 1|Adverse Event|0|||
44168488|NCT01641081|78961720|FG000|Period 2|Adverse Event|0|||
44168489|NCT01641081|78961721|FG001|Period 2|Adverse Event|0|||
44168490|NCT01641081|78961722|FG002|Period 2|Adverse Event|0|||
44168491|NCT01641081|78961723|FG003|Period 2|Adverse Event|0|||
44168492|NCT01641081|78961724|FG004|Period 2|Adverse Event|0|||
44168493|NCT01641081|78961725|FG005|Period 2|Adverse Event|1|||
44168494|NCT01641081|78961726|FG006|Period 2|Adverse Event|0|||
44168495|NCT01641081|78961727|FG007|Period 2|Adverse Event|0|||
44168496|NCT01641081|78961728|FG008|Period 2|Adverse Event|0|||
44168497|NCT01641081|78961729|FG009|Period 2|Adverse Event|0|||
44168498|NCT01641081|78961720|FG000|Period 2|Withdrawal by Subject|0|||
44168499|NCT01641081|78961721|FG001|Period 2|Withdrawal by Subject|0|||
44168500|NCT01641081|78961722|FG002|Period 2|Withdrawal by Subject|0|||
44168501|NCT01641081|78961723|FG003|Period 2|Withdrawal by Subject|1|||
44168502|NCT01641081|78961724|FG004|Period 2|Withdrawal by Subject|0|||
44168503|NCT01641081|78961725|FG005|Period 2|Withdrawal by Subject|0|||
44168504|NCT01641081|78961726|FG006|Period 2|Withdrawal by Subject|2|||
44168505|NCT01641081|78961727|FG007|Period 2|Withdrawal by Subject|0|||
44168506|NCT01641081|78961728|FG008|Period 2|Withdrawal by Subject|0|||
44168507|NCT01641081|78961729|FG009|Period 2|Withdrawal by Subject|0|||
44168508|NCT01641081|78961720|FG000|Period 2|Protocol Violation|1|||
44168509|NCT01641081|78961721|FG001|Period 2|Protocol Violation|0|||
44168510|NCT01641081|78961722|FG002|Period 2|Protocol Violation|0|||
44168511|NCT01641081|78961723|FG003|Period 2|Protocol Violation|0|||
44168512|NCT01641081|78961724|FG004|Period 2|Protocol Violation|0|||
44168513|NCT01641081|78961725|FG005|Period 2|Protocol Violation|0|||
44168514|NCT01641081|78961726|FG006|Period 2|Protocol Violation|0|||
44168515|NCT01641081|78961727|FG007|Period 2|Protocol Violation|0|||
44168516|NCT01641081|78961728|FG008|Period 2|Protocol Violation|0|||
44168517|NCT01641081|78961729|FG009|Period 2|Protocol Violation|0|||
44168518|NCT01641081|78961720|FG000|Period 3|Adverse Event|0|||
44168519|NCT01641081|78961721|FG001|Period 3|Adverse Event|0|||
44168520|NCT01641081|78961722|FG002|Period 3|Adverse Event|1|||
44168521|NCT01641081|78961723|FG003|Period 3|Adverse Event|0|||
44168522|NCT01641081|78961724|FG004|Period 3|Adverse Event|0|||
44168523|NCT01641081|78961725|FG005|Period 3|Adverse Event|0|||
44168524|NCT01641081|78961726|FG006|Period 3|Adverse Event|0|||
44168525|NCT01641081|78961727|FG007|Period 3|Adverse Event|0|||
44168526|NCT01641081|78961728|FG008|Period 3|Adverse Event|0|||
44168527|NCT01641081|78961729|FG009|Period 3|Adverse Event|0|||
44168528|NCT01641081|78961720|FG000|Period 3|Withdrawal by Subject|0|||
44168529|NCT01641081|78961721|FG001|Period 3|Withdrawal by Subject|0|||
44168530|NCT01641081|78961722|FG002|Period 3|Withdrawal by Subject|0|||
44168531|NCT01641081|78961723|FG003|Period 3|Withdrawal by Subject|0|||
44168532|NCT01641081|78961724|FG004|Period 3|Withdrawal by Subject|0|||
44168533|NCT01641081|78961725|FG005|Period 3|Withdrawal by Subject|0|||
44168534|NCT01641081|78961726|FG006|Period 3|Withdrawal by Subject|0|||
44168535|NCT01641081|78961727|FG007|Period 3|Withdrawal by Subject|0|||
44168536|NCT01641081|78961728|FG008|Period 3|Withdrawal by Subject|1|||
44168537|NCT01641081|78961729|FG009|Period 3|Withdrawal by Subject|0|||
44168538|NCT01641081|78961720|FG000|Period 4|Adverse Event|0|||
44168539|NCT01641081|78961721|FG001|Period 4|Adverse Event|1|||
44168540|NCT01641081|78961722|FG002|Period 4|Adverse Event|0|||
44168541|NCT01641081|78961723|FG003|Period 4|Adverse Event|1|||
44168542|NCT01641081|78961724|FG004|Period 4|Adverse Event|0|||
44168543|NCT01641081|78961725|FG005|Period 4|Adverse Event|0|||
44168544|NCT01641081|78961726|FG006|Period 4|Adverse Event|0|||
44168545|NCT01641081|78961727|FG007|Period 4|Adverse Event|0|||
44168546|NCT01641081|78961728|FG008|Period 4|Adverse Event|0|||
44168547|NCT01641081|78961729|FG009|Period 4|Adverse Event|0|||
44168548|NCT01641081|78961720|FG000|Period 5|Adverse Event|0|||
44168549|NCT01641081|78961721|FG001|Period 5|Adverse Event|0|||
44168550|NCT01641081|78961722|FG002|Period 5|Adverse Event|2|||
44168551|NCT01641081|78961723|FG003|Period 5|Adverse Event|0|||
44168552|NCT01641081|78961724|FG004|Period 5|Adverse Event|0|||
44168553|NCT01641081|78961725|FG005|Period 5|Adverse Event|0|||
44168554|NCT01641081|78961726|FG006|Period 5|Adverse Event|0|||
44168555|NCT01641081|78961727|FG007|Period 5|Adverse Event|0|||
44168556|NCT01641081|78961728|FG008|Period 5|Adverse Event|0|||
44168557|NCT01641081|78961729|FG009|Period 5|Adverse Event|0|||
44168558|NCT01640925|78961743|FG000|Overall Study|Withdrawal by Subject|1|||
44168559|NCT01640925|78961744|FG001|Overall Study|Withdrawal by Subject|0|||
44168560|NCT01640925|78961743|FG000|Overall Study|Previously enrolled in this trial|13|||
44168561|NCT01640925|78961744|FG001|Overall Study|Previously enrolled in this trial|11|||
44168562|NCT01638429|78961750|FG000|Overall Study|Withdrawal by Subject|1|||
44168563|NCT01639755|78961758|FG000|Overall Study|Study Ongoing|15|||
44168564|NCT01639755|78961758|FG000|Overall Study|Patient had device explantation|4|||
44168565|NCT01601535|78961768|FG000|Phase 1|Adverse Event|1|||
44168566|NCT01601535|78961769|FG001|Phase 1|Adverse Event|0|||
44168567|NCT01601535|78961770|FG002|Phase 1|Adverse Event|2|||
44168568|NCT01601535|78961771|FG003|Phase 1|Adverse Event|1|||
44168569|NCT01601535|78961772|FG004|Phase 1|Adverse Event|0|||
44168570|NCT01601535|78961773|FG005|Phase 1|Adverse Event|0|||
44168571|NCT01601535|78961768|FG000|Phase 1|Withdrawal by Subject|2|||
44168572|NCT01601535|78961769|FG001|Phase 1|Withdrawal by Subject|1|||
44168573|NCT01601535|78961770|FG002|Phase 1|Withdrawal by Subject|1|||
44168574|NCT01601535|78961771|FG003|Phase 1|Withdrawal by Subject|2|||
44168575|NCT01601535|78961772|FG004|Phase 1|Withdrawal by Subject|0|||
44168576|NCT01601535|78961773|FG005|Phase 1|Withdrawal by Subject|0|||
44168577|NCT01601535|78961768|FG000|Phase 1|Progressive Disease|2|||
44168578|NCT01601535|78961769|FG001|Phase 1|Progressive Disease|3|||
44168579|NCT01601535|78961770|FG002|Phase 1|Progressive Disease|2|||
44168580|NCT01601535|78961771|FG003|Phase 1|Progressive Disease|1|||
44168581|NCT01601535|78961772|FG004|Phase 1|Progressive Disease|0|||
44168582|NCT01601535|78961773|FG005|Phase 1|Progressive Disease|0|||
44168583|NCT01601535|78961768|FG000|Phase 1|Started Another Treatment|1|||
44168584|NCT01601535|78961769|FG001|Phase 1|Started Another Treatment|2|||
44168585|NCT01601535|78961770|FG002|Phase 1|Started Another Treatment|0|||
44168586|NCT01601535|78961771|FG003|Phase 1|Started Another Treatment|0|||
44168587|NCT01601535|78961772|FG004|Phase 1|Started Another Treatment|0|||
44168588|NCT01601535|78961773|FG005|Phase 1|Started Another Treatment|0|||
44168589|NCT01601535|78961768|FG000|Phase 2|Adverse Event|0|||
44168590|NCT01601535|78961769|FG001|Phase 2|Adverse Event|0|||
44168591|NCT01601535|78961770|FG002|Phase 2|Adverse Event|0|||
44168592|NCT01601535|78961771|FG003|Phase 2|Adverse Event|0|||
44168593|NCT01601535|78961772|FG004|Phase 2|Adverse Event|5|||
44168594|NCT01601535|78961773|FG005|Phase 2|Adverse Event|1|||
44168595|NCT01601535|78961768|FG000|Phase 2|Withdrawal by Subject|0|||
44168596|NCT01601535|78961769|FG001|Phase 2|Withdrawal by Subject|0|||
44168597|NCT01601535|78961770|FG002|Phase 2|Withdrawal by Subject|0|||
44168598|NCT01601535|78961771|FG003|Phase 2|Withdrawal by Subject|0|||
44168599|NCT01601535|78961772|FG004|Phase 2|Withdrawal by Subject|8|||
44168600|NCT01601535|78961773|FG005|Phase 2|Withdrawal by Subject|2|||
44168601|NCT01601535|78961768|FG000|Phase 2|Progressive Disease|0|||
44168602|NCT01601535|78961769|FG001|Phase 2|Progressive Disease|0|||
44168603|NCT01601535|78961770|FG002|Phase 2|Progressive Disease|0|||
44168604|NCT01601535|78961771|FG003|Phase 2|Progressive Disease|0|||
44168605|NCT01601535|78961772|FG004|Phase 2|Progressive Disease|5|||
44168606|NCT01601535|78961773|FG005|Phase 2|Progressive Disease|7|||
44168607|NCT01601535|78961768|FG000|Phase 2|Started Another Treatment|0|||
44168608|NCT01601535|78961769|FG001|Phase 2|Started Another Treatment|0|||
44168609|NCT01601535|78961770|FG002|Phase 2|Started Another Treatment|0|||
44168610|NCT01601535|78961771|FG003|Phase 2|Started Another Treatment|0|||
44168611|NCT01601535|78961772|FG004|Phase 2|Started Another Treatment|1|||
44168612|NCT01601535|78961773|FG005|Phase 2|Started Another Treatment|2|||
44168613|NCT01638819|78961798|FG000|Overall Study|Lost to Follow-up|1|||
44168614|NCT01638819|78961799|FG001|Overall Study|Lost to Follow-up|0|||
44168615|NCT01363713|78961804|FG000|Overall Study|Adverse Event|1|||
44168616|NCT01363713|78961804|FG000|Overall Study|Protocol Violation|3|||
44168617|NCT01363713|78961804|FG000|Overall Study|Withdrawal by Subject|2|||
44168618|NCT01637961|78961808|FG000|Overall Study|Ineligible: wrong primary|1|||
44168619|NCT01637961|78961808|FG000|Overall Study|Ineligible: inadequate pathology|1|||
44168620|NCT04183335|78961820|FG000|Overall Study|Adverse Event|1|||
44168621|NCT04183335|78961821|FG001|Overall Study|Adverse Event|0|||
44168622|NCT04183335|78961820|FG000|Overall Study|Withdrawal by Subject|12|||
44168623|NCT04183335|78961821|FG001|Overall Study|Withdrawal by Subject|3|||
44168624|NCT04199793|78961829|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
44168625|NCT04199793|78961830|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
44168626|NCT04199793|78961829|FG000|Overall Study|Withdrawal by Subject|1|||
44168627|NCT04199793|78961830|FG001|Overall Study|Withdrawal by Subject|1|||
44168628|NCT01636947|78961838|FG000|Overall Study|Not Treated|2|||
44168629|NCT01636947|78961839|FG001|Overall Study|Not Treated|2|||
44168630|NCT01636947|78961838|FG000|Overall Study|Lost to Follow-up|4|||
44168631|NCT01636947|78961839|FG001|Overall Study|Lost to Follow-up|0|||
44168632|NCT01636947|78961838|FG000|Overall Study|Protocol Violation|1|||
44168633|NCT01636947|78961839|FG001|Overall Study|Protocol Violation|1|||
44168634|NCT01636947|78961838|FG000|Overall Study|Withdrawal by Subject|3|||
44168635|NCT01636947|78961839|FG001|Overall Study|Withdrawal by Subject|3|||
44168636|NCT01636947|78961838|FG000|Overall Study|Adverse Event|1|||
44168637|NCT01636947|78961839|FG001|Overall Study|Adverse Event|1|||
44168638|NCT01636947|78961838|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
44168639|NCT01636947|78961839|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
44168640|NCT01635933|78961847|FG000|Overall Study|Adverse Event|1|||
44168641|NCT01635933|78961848|FG001|Overall Study|Adverse Event|0|||
44168642|NCT01635933|78961847|FG000|Overall Study|Lost to Follow-up|0|||
44168643|NCT01635933|78961848|FG001|Overall Study|Lost to Follow-up|5|||
44168644|NCT01635933|78961847|FG000|Overall Study|Subject decision|1|||
44168645|NCT01635933|78961848|FG001|Overall Study|Subject decision|1|||
44168646|NCT01635933|78961847|FG000|Overall Study|Noncompliance|0|||
44168647|NCT01635933|78961848|FG001|Overall Study|Noncompliance|1|||
44168648|NCT01635933|78961847|FG000|Overall Study|No longer had transportation|0|||
44168649|NCT01635933|78961848|FG001|Overall Study|No longer had transportation|1|||
44168650|NCT01635855|78961854|FG000|Overall Study|Withdrawal by Subject|4|||
44168651|NCT03052725|78961860|FG000|Overall Study|Adverse Event|2|||
44168652|NCT03052725|78961861|FG001|Overall Study|Adverse Event|0|||
44168653|NCT03052725|78961860|FG000|Overall Study|Withdrawal by Subject|3|||
44168654|NCT03052725|78961861|FG001|Overall Study|Withdrawal by Subject|4|||
44168655|NCT03052725|78961860|FG000|Overall Study|Pregnancy|0|||
44168656|NCT03052725|78961861|FG001|Overall Study|Pregnancy|1|||
44168657|NCT03052725|78961860|FG000|Overall Study|Site closure|0|||
44168658|NCT03052725|78961861|FG001|Overall Study|Site closure|1|||
44168659|NCT03052725|78961860|FG000|Overall Study|Study terminated by sponsor|143|||
44168660|NCT03052725|78961861|FG001|Overall Study|Study terminated by sponsor|144|||
44168661|NCT01635153|78961885|FG000|Overall Study|Lost to Follow-up|40|||
44168662|NCT01635153|78961886|FG001|Overall Study|Lost to Follow-up|43|||
44168663|NCT01636713|78961895|FG000|Overall Study|Adverse Event|16|||
44449330|NCT00117949|79457835|FG001|Overall Study|PSA reduction <=50%|2|||
44168664|NCT01636713|78961896|FG001|Overall Study|Adverse Event|16|||
44168665|NCT01636713|78961897|FG002|Overall Study|Adverse Event|7|||
44168666|NCT01636713|78961895|FG000|Overall Study|Lack of Efficacy|6|||
44168667|NCT01636713|78961896|FG001|Overall Study|Lack of Efficacy|6|||
44168668|NCT01636713|78961897|FG002|Overall Study|Lack of Efficacy|2|||
44168669|NCT01636713|78961895|FG000|Overall Study|Protocol Violation|3|||
44168670|NCT01636713|78961896|FG001|Overall Study|Protocol Violation|0|||
44168671|NCT01636713|78961897|FG002|Overall Study|Protocol Violation|1|||
44168672|NCT01636713|78961895|FG000|Overall Study|Lost to Follow-up|0|||
44168673|NCT01636713|78961896|FG001|Overall Study|Lost to Follow-up|0|||
44168674|NCT01636713|78961897|FG002|Overall Study|Lost to Follow-up|1|||
44168675|NCT01636713|78961895|FG000|Overall Study|Withdrawal by Subject|5|||
44168676|NCT01636713|78961896|FG001|Overall Study|Withdrawal by Subject|4|||
44168677|NCT01636713|78961897|FG002|Overall Study|Withdrawal by Subject|8|||
44168678|NCT01636713|78961895|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
44168679|NCT01636713|78961896|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
44168680|NCT01636713|78961897|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
44168681|NCT01600053|78961905|FG000|Overall Study|Adverse Event|2|||
44168682|NCT01600053|78961905|FG000|Overall Study|trial will not meet the interim endpoint|9|||
44168683|NCT01068249|78961909|FG000|Overall Study|Death|1|||
44168684|NCT01068249|78961909|FG000|Overall Study|Withdrawal by Subject|3|||
44168685|NCT02246673|78961928|FG000|Overall Study|Sponsor Decision|1|||
44168686|NCT02246673|78961929|FG001|Overall Study|Sponsor Decision|0|||
44168687|NCT02246673|78961930|FG002|Overall Study|Sponsor Decision|0|||
44168688|NCT02246673|78961931|FG003|Overall Study|Sponsor Decision|0|||
44168689|NCT02246673|78961932|FG004|Overall Study|Sponsor Decision|0|||
44168690|NCT02246673|78961928|FG000|Overall Study|Withdrawal by Subject|0|||
44168691|NCT02246673|78961929|FG001|Overall Study|Withdrawal by Subject|0|||
44168692|NCT02246673|78961930|FG002|Overall Study|Withdrawal by Subject|0|||
44168693|NCT02246673|78961931|FG003|Overall Study|Withdrawal by Subject|0|||
44168694|NCT02246673|78961932|FG004|Overall Study|Withdrawal by Subject|1|||
44168695|NCT02246673|78961928|FG000|Overall Study|Lost to Follow-up|0|||
44449331|NCT00117949|79457836|FG002|Overall Study|PSA reduction <=50%|2|||
44449332|NCT00117949|79457837|FG003|Overall Study|PSA reduction <=50%|4|||
44449333|NCT00117949|79457834|FG000|Overall Study|Hepatic abnormalities|0|||
44449334|NCT00117949|79457835|FG001|Overall Study|Hepatic abnormalities|1|||
44449335|NCT00117949|79457836|FG002|Overall Study|Hepatic abnormalities|0|||
44449336|NCT00117949|79457837|FG003|Overall Study|Hepatic abnormalities|1|||
44449337|NCT00117793|79457847|FG000|Overall Study|Withdrawal by Subject|12|||
44449338|NCT00695669|79457856|FG000|Overall Study|Adverse Event|0|||
44449339|NCT00695669|79457857|FG001|Overall Study|Adverse Event|0|||
44449340|NCT00695669|79457858|FG002|Overall Study|Adverse Event|2|||
44449341|NCT00695669|79457859|FG003|Overall Study|Adverse Event|0|||
44449342|NCT00695669|79457856|FG000|Overall Study|Lost to Follow-up|4|||
44449343|NCT00695669|79457857|FG001|Overall Study|Lost to Follow-up|4|||
44449344|NCT00695669|79457858|FG002|Overall Study|Lost to Follow-up|1|||
44449345|NCT00695669|79457859|FG003|Overall Study|Lost to Follow-up|4|||
44168696|NCT02246673|78961929|FG001|Overall Study|Lost to Follow-up|0|||
44168697|NCT02246673|78961930|FG002|Overall Study|Lost to Follow-up|0|||
44168698|NCT02246673|78961931|FG003|Overall Study|Lost to Follow-up|1|||
44168699|NCT02246673|78961932|FG004|Overall Study|Lost to Follow-up|0|||
44168700|NCT02246673|78961928|FG000|Overall Study|Protocol Violation|0|||
44168701|NCT02246673|78961929|FG001|Overall Study|Protocol Violation|0|||
44168702|NCT02246673|78961930|FG002|Overall Study|Protocol Violation|0|||
44168703|NCT02246673|78961931|FG003|Overall Study|Protocol Violation|1|||
44168704|NCT02246673|78961932|FG004|Overall Study|Protocol Violation|0|||
44449346|NCT03671369|79457872|FG000|Overall Study|Other|1|||
44168705|NCT02246439|78961994|FG000|Overall Study|Adverse Event|3|||
44168706|NCT02246439|78961995|FG001|Overall Study|Adverse Event|0|||
44168707|NCT02246439|78961994|FG000|Overall Study|Lost to Follow-up|7|||
44168708|NCT02246439|78961995|FG001|Overall Study|Lost to Follow-up|5|||
44168709|NCT02246439|78961994|FG000|Overall Study|Protocol Violation|0|||
44168710|NCT02246439|78961995|FG001|Overall Study|Protocol Violation|2|||
44168711|NCT02246439|78961994|FG000|Overall Study|Physician Decision|0|||
44168712|NCT02246439|78961995|FG001|Overall Study|Physician Decision|1|||
44168713|NCT02246439|78961994|FG000|Overall Study|Unkonwn|1|||
44168714|NCT02246439|78961995|FG001|Overall Study|Unkonwn|3|||
44168715|NCT02246439|78961994|FG000|Overall Study|Withdrawal by Subject|1|||
44168716|NCT02246439|78961995|FG001|Overall Study|Withdrawal by Subject|0|||
44168717|NCT02245737|78962004|FG000|Overall Study|Adverse Event|23|||
44168718|NCT02245737|78962005|FG001|Overall Study|Adverse Event|26|||
44168719|NCT02245737|78962006|FG002|Overall Study|Adverse Event|33|||
44168720|NCT02245737|78962004|FG000|Overall Study|Condition Worsened|9|||
44168721|NCT02245737|78962005|FG001|Overall Study|Condition Worsened|10|||
44168722|NCT02245737|78962006|FG002|Overall Study|Condition Worsened|9|||
44168723|NCT02245737|78962004|FG000|Overall Study|Death|2|||
44168724|NCT02245737|78962005|FG001|Overall Study|Death|4|||
44168725|NCT02245737|78962006|FG002|Overall Study|Death|4|||
44168726|NCT02245737|78962004|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
44168727|NCT02245737|78962005|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
44168728|NCT02245737|78962006|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
44168729|NCT02245737|78962004|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
44168730|NCT02245737|78962005|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
44168731|NCT02245737|78962006|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
44168732|NCT02245737|78962004|FG000|Overall Study|Lost to Follow-up|2|||
44168733|NCT02245737|78962005|FG001|Overall Study|Lost to Follow-up|5|||
44168734|NCT02245737|78962006|FG002|Overall Study|Lost to Follow-up|4|||
44168735|NCT02245737|78962004|FG000|Overall Study|Other-determined by Investigator|9|||
44168736|NCT02245737|78962005|FG001|Overall Study|Other-determined by Investigator|10|||
44168737|NCT02245737|78962006|FG002|Overall Study|Other-determined by Investigator|10|||
44168738|NCT02245737|78962004|FG000|Overall Study|Physician Decision|6|||
44168739|NCT02245737|78962005|FG001|Overall Study|Physician Decision|3|||
44168740|NCT02245737|78962006|FG002|Overall Study|Physician Decision|6|||
44168741|NCT02245737|78962004|FG000|Overall Study|Protocol Violation|3|||
44168742|NCT02245737|78962005|FG001|Overall Study|Protocol Violation|2|||
44168743|NCT02245737|78962006|FG002|Overall Study|Protocol Violation|3|||
44168744|NCT02245737|78962004|FG000|Overall Study|Withdrawal by Subject|40|||
44168745|NCT02245737|78962005|FG001|Overall Study|Withdrawal by Subject|41|||
44168746|NCT02245737|78962006|FG002|Overall Study|Withdrawal by Subject|44|||
44168747|NCT02245737|78962004|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
44168748|NCT02245737|78962005|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
44168749|NCT02245737|78962006|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
44168750|NCT02245737|78962004|FG000|Overall Study|Sponsor Decision|445|||
44168751|NCT02245737|78962005|FG001|Overall Study|Sponsor Decision|430|||
44168752|NCT02245737|78962006|FG002|Overall Study|Sponsor Decision|432|||
44168753|NCT02244957|78962018|FG000|Overall Study|Lack of Efficacy|1|||
44168754|NCT02244957|78962019|FG001|Overall Study|Lack of Efficacy|0|||
44168755|NCT02243865|78962029|FG000|Overall Study|Protocol Violation|1|||
44168756|NCT02243865|78962030|FG001|Overall Study|Protocol Violation|3|||
44168757|NCT02243865|78962029|FG000|Overall Study|Lost to Follow-up|1|||
44168758|NCT02243865|78962030|FG001|Overall Study|Lost to Follow-up|1|||
44168759|NCT02243865|78962029|FG000|Overall Study|Withdrawal by Subject|1|||
44168760|NCT02243865|78962030|FG001|Overall Study|Withdrawal by Subject|0|||
44168761|NCT02243865|78962029|FG000|Overall Study|Adverse Event|1|||
44168762|NCT02243865|78962030|FG001|Overall Study|Adverse Event|1|||
44168763|NCT02243631|78962040|FG000|Overall Study|no synovial fluid on second aspirate|0|||
44168764|NCT02243631|78962041|FG001|Overall Study|no synovial fluid on second aspirate|1|||
44168765|NCT02242305|78962049|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
44168766|NCT02242305|78962050|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
44168767|NCT02242305|78962049|FG000|Overall Study|Adverse Event|1|||
44168768|NCT02242305|78962050|FG001|Overall Study|Adverse Event|0|||
44168769|NCT02242305|78962049|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
44168770|NCT02242305|78962050|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
44168771|NCT02242305|78962049|FG000|Overall Study|Subject withdraws inform consent|0|||
44168772|NCT02242305|78962050|FG001|Overall Study|Subject withdraws inform consent|4|||
44168773|NCT02242305|78962049|FG000|Overall Study|Lost to Follow-up|2|||
44168774|NCT02242305|78962050|FG001|Overall Study|Lost to Follow-up|0|||
44168775|NCT02240121|78962058|FG000|Overall Study|Protocol Violation|1|||
44168776|NCT02240121|78962059|FG001|Overall Study|Protocol Violation|2|||
44168777|NCT02240121|78962058|FG000|Overall Study|Physician Decision|0|||
44168778|NCT02240121|78962059|FG001|Overall Study|Physician Decision|1|||
44168779|NCT02240121|78962058|FG000|Overall Study|Change in protocol interpretation|1|||
44168780|NCT02240121|78962059|FG001|Overall Study|Change in protocol interpretation|0|||
44168781|NCT02240121|78962058|FG000|Overall Study|Lack of Efficacy|2|||
44168782|NCT02240121|78962059|FG001|Overall Study|Lack of Efficacy|3|||
44168783|NCT02240121|78962058|FG000|Overall Study|Site closed|1|||
44168784|NCT02240121|78962059|FG001|Overall Study|Site closed|1|||
44168785|NCT02240121|78962058|FG000|Overall Study|Pregnancy|1|||
44168786|NCT02240121|78962059|FG001|Overall Study|Pregnancy|0|||
44168787|NCT02240121|78962058|FG000|Overall Study|Adverse Event|2|||
44168788|NCT02240121|78962059|FG001|Overall Study|Adverse Event|4|||
44168789|NCT02240121|78962058|FG000|Overall Study|Withdrawal by Subject|6|||
44168790|NCT02240121|78962059|FG001|Overall Study|Withdrawal by Subject|2|||
44168791|NCT02240121|78962058|FG000|Overall Study|Lost to Follow-up|3|||
44168792|NCT02240121|78962059|FG001|Overall Study|Lost to Follow-up|4|||
44168793|NCT02240121|78962058|FG000|Overall Study|Other than specified|1|||
44168794|NCT02240121|78962059|FG001|Overall Study|Other than specified|3|||
44168795|NCT02239263|78962065|FG000|Overall Study|Protocol Violation|6|||
44168796|NCT02238483|78962073|FG000|Overall Study|Withdrawal by Subject|2|||
44168797|NCT02238483|78962074|FG001|Overall Study|Withdrawal by Subject|7|||
44168798|NCT02238483|78962073|FG000|Overall Study|Lost to Follow-up|1|||
44168799|NCT02238483|78962074|FG001|Overall Study|Lost to Follow-up|1|||
44168800|NCT02238483|78962073|FG000|Overall Study|Protocol Violation|1|||
44168801|NCT02238483|78962074|FG001|Overall Study|Protocol Violation|2|||
44168802|NCT02238483|78962073|FG000|Overall Study|Death|1|||
44168803|NCT02238483|78962074|FG001|Overall Study|Death|0|||
44168804|NCT02238483|78962073|FG000|Overall Study|Adverse Event|7|||
44168805|NCT02238483|78962074|FG001|Overall Study|Adverse Event|3|||
44168806|NCT02238483|78962073|FG000|Overall Study|Withdrawn due to physician decision|1|||
44168807|NCT02238483|78962074|FG001|Overall Study|Withdrawn due to physician decision|0|||
44168808|NCT02238483|78962073|FG000|Overall Study|Completion status not recorded|1|||
44168809|NCT02238483|78962074|FG001|Overall Study|Completion status not recorded|1|||
44168810|NCT02238483|78962073|FG000|Overall Study|Illness in family member|1|||
44168811|NCT02238483|78962074|FG001|Overall Study|Illness in family member|0|||
44168812|NCT01632891|78962082|FG000|Overall Study|Lost to Follow-up|0|||
44168813|NCT01632891|78962083|FG001|Overall Study|Lost to Follow-up|1|||
44168814|NCT01632891|78962082|FG000|Overall Study|Withdrawal by Subject|1|||
44168815|NCT01632891|78962083|FG001|Overall Study|Withdrawal by Subject|0|||
44168816|NCT02208999|78962095|FG000|Overall Study|Lost to Follow-up|1|||
44168817|NCT02208843|78962114|FG000|Overall Study|Clinical symptoms of progression|2|||
44168818|NCT02208843|78962114|FG000|Overall Study|Progression disease according to RECIST|24|||
44168819|NCT02208843|78962114|FG000|Overall Study|Adverse Event|12|||
44168820|NCT02208843|78962114|FG000|Overall Study|Protocol Violation|1|||
44168821|NCT02208843|78962114|FG000|Overall Study|Withdrawal by Subject|1|||
44168822|NCT02208843|78962114|FG000|Overall Study|Switched to commercial afatinib|20|||
44168823|NCT02208063|78962120|FG000|Overall Study|Death|3|||
44168824|NCT02208063|78962121|FG001|Overall Study|Death|5|||
44168825|NCT02208063|78962120|FG000|Overall Study|Not Specified in report|3|||
44168826|NCT02208063|78962121|FG001|Overall Study|Not Specified in report|4|||
44168827|NCT02208063|78962120|FG000|Overall Study|Withdrawal by Subject|5|||
44168828|NCT02208063|78962121|FG001|Overall Study|Withdrawal by Subject|2|||
44168829|NCT02208063|78962120|FG000|Overall Study|Lost to Follow-up|1|||
44168830|NCT02208063|78962121|FG001|Overall Study|Lost to Follow-up|0|||
44168831|NCT02207907|78962129|FG000|Overall Study|Lost to Follow-up|3|||
44168832|NCT02207907|78962130|FG001|Overall Study|Lost to Follow-up|1|||
44168833|NCT02207907|78962129|FG000|Overall Study|Withdrawal by Subject|5|||
44168834|NCT02207907|78962130|FG001|Overall Study|Withdrawal by Subject|6|||
44168835|NCT02207907|78962129|FG000|Overall Study|Did not meet study criteria|3|||
44168836|NCT02207907|78962130|FG001|Overall Study|Did not meet study criteria|0|||
44168837|NCT02207907|78962129|FG000|Overall Study|Pregnancy|0|||
44168838|NCT02207907|78962130|FG001|Overall Study|Pregnancy|1|||
44168839|NCT02207829|78962139|FG000|Overall Study|Adverse Event|10|||
44168840|NCT02207829|78962140|FG001|Overall Study|Adverse Event|9|||
44168841|NCT02207829|78962139|FG000|Overall Study|Lack of Efficacy|7|||
44168842|NCT02207829|78962140|FG001|Overall Study|Lack of Efficacy|5|||
44168843|NCT02207829|78962139|FG000|Overall Study|Lost to Follow-up|2|||
44168844|NCT02207829|78962140|FG001|Overall Study|Lost to Follow-up|2|||
44168845|NCT02207829|78962139|FG000|Overall Study|Protocol deviation|5|||
44168846|NCT02207829|78962140|FG001|Overall Study|Protocol deviation|4|||
44168847|NCT02207829|78962139|FG000|Overall Study|Withdrew consent|18|||
44168848|NCT02207829|78962140|FG001|Overall Study|Withdrew consent|14|||
44168849|NCT02237157|78962146|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
44168850|NCT02237157|78962147|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
44168851|NCT02237157|78962148|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
44168852|NCT02237157|78962149|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
44168853|NCT02237157|78962146|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
44168854|NCT02237157|78962147|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
44168855|NCT02237157|78962148|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
44168856|NCT02237157|78962149|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
44168857|NCT02237001|78962156|FG000|Overall Study|Lost to Follow-up|2|||
44168858|NCT02237001|78962156|FG000|Overall Study|Withdrawal by Subject|1|||
44168859|NCT02237001|78962156|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
44168860|NCT02237001|78962156|FG000|Overall Study|Re-operation|4|||
44168861|NCT02237001|78962156|FG000|Overall Study|Incarceration|1|||
44168862|NCT02236611|78962162|FG000|Overall Study|Adverse Event|10|||
44168863|NCT02236611|78962163|FG001|Overall Study|Adverse Event|16|||
44168864|NCT02236611|78962162|FG000|Overall Study|Lack of Efficacy|4|||
44168865|NCT02236611|78962163|FG001|Overall Study|Lack of Efficacy|7|||
44168866|NCT02236611|78962162|FG000|Overall Study|Lost to Follow-up|0|||
44168867|NCT02236611|78962163|FG001|Overall Study|Lost to Follow-up|2|||
44168868|NCT02236611|78962162|FG000|Overall Study|Protocol deviation|3|||
44168869|NCT02236611|78962163|FG001|Overall Study|Protocol deviation|5|||
44168870|NCT02236611|78962162|FG000|Overall Study|Withdrew consent|9|||
44168871|NCT02236611|78962163|FG001|Overall Study|Withdrew consent|4|||
44168872|NCT02234583|78962171|FG000|Overall Study|Adverse Event|172|||
44168873|NCT02234583|78962172|FG001|Overall Study|Adverse Event|156|||
44168874|NCT02234583|78962171|FG000|Overall Study|Withdrawal by Subject|109|||
44168875|NCT02234583|78962172|FG001|Overall Study|Withdrawal by Subject|157|||
44168876|NCT02234583|78962171|FG000|Overall Study|Lost to Follow-up|0|||
44168877|NCT02234583|78962172|FG001|Overall Study|Lost to Follow-up|1|||
44168878|NCT02234583|78962171|FG000|Overall Study|Lack of Efficacy|58|||
44168879|NCT02234583|78962172|FG001|Overall Study|Lack of Efficacy|103|||
44168880|NCT02234583|78962171|FG000|Overall Study|Protocol Violation|35|||
44168881|NCT02234583|78962172|FG001|Overall Study|Protocol Violation|42|||
44168882|NCT02234583|78962171|FG000|Overall Study|Other|39|||
44168883|NCT02234583|78962172|FG001|Overall Study|Other|97|||
44168884|NCT03686397|78962186|FG000|Overall Study|Lack of Efficacy|3|||
44168885|NCT03686397|78962187|FG001|Overall Study|Lack of Efficacy|5|||
44168886|NCT03686397|78962186|FG000|Overall Study|Adverse Event|0|||
44168887|NCT03686397|78962187|FG001|Overall Study|Adverse Event|1|||
44168888|NCT03686397|78962186|FG000|Overall Study|Protocol Violation|0|||
44168889|NCT03686397|78962187|FG001|Overall Study|Protocol Violation|1|||
44168890|NCT03686397|78962186|FG000|Overall Study|Withdrawal by Subject|0|||
44168891|NCT03686397|78962187|FG001|Overall Study|Withdrawal by Subject|1|||
44168892|NCT03686397|78962186|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
44168893|NCT03686397|78962187|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
44168894|NCT02233803|78962193|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
44168895|NCT02233803|78962194|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
44168896|NCT02233803|78962193|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
44168897|NCT02233803|78962194|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
44168898|NCT02233803|78962193|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
44168899|NCT02233803|78962194|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
44168900|NCT02233803|78962193|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
44168901|NCT02233803|78962194|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
44168902|NCT02233803|78962193|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
44168903|NCT02233803|78962194|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
44168904|NCT02233803|78962193|FG000|Washout Period (4-Wks)|Physician Decision|1|||
44168905|NCT02233803|78962194|FG001|Washout Period (4-Wks)|Physician Decision|0|||
44168906|NCT02233803|78962193|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
44168907|NCT02233803|78962194|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
44168908|NCT02233803|78962193|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
44168909|NCT02233803|78962194|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
44168910|NCT02233803|78962193|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
44168911|NCT02233803|78962194|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
44168912|NCT02233647|78962202|FG000|Overall Study|Adverse Event|1|||
44168913|NCT02233413|78962208|FG000|Overall Study|Lost to Follow-up|7|||
44168914|NCT02233413|78962209|FG001|Overall Study|Lost to Follow-up|9|||
44168915|NCT02233413|78962208|FG000|Overall Study|Withdrawal by Subject|4|||
44168916|NCT02233413|78962209|FG001|Overall Study|Withdrawal by Subject|5|||
44168917|NCT01632579|78962215|FG000|Washout Period|Adverse Event|1|||
44168918|NCT01632579|78962216|FG001|Washout Period|Adverse Event|0|||
44168919|NCT01632579|78962217|FG002|Washout Period|Adverse Event|0|||
44168920|NCT01632579|78962218|FG003|Washout Period|Adverse Event|0|||
44168921|NCT01632579|78962219|FG004|Washout Period|Adverse Event|0|||
44168922|NCT01632579|78962220|FG005|Washout Period|Adverse Event|0|||
44168923|NCT01632579|78962221|FG006|Washout Period|Adverse Event|0|||
44168924|NCT01632579|78962222|FG007|Washout Period|Adverse Event|0|||
44168925|NCT01632579|78962223|FG008|Washout Period|Adverse Event|0|||
44168926|NCT01632579|78962215|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
44168927|NCT01632579|78962216|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
44168928|NCT01632579|78962217|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
44168929|NCT01632579|78962218|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
44168930|NCT01632579|78962219|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
44168931|NCT01632579|78962220|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
44168932|NCT01632579|78962221|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
44168933|NCT01632579|78962222|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
44168934|NCT01632579|78962223|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
44168935|NCT01632345|78962252|FG000|Treatment: Part I|Adverse Event|1|||
44168936|NCT01632345|78962253|FG001|Treatment: Part I|Adverse Event|4|||
44168937|NCT01632345|78962254|FG002|Treatment: Part I|Adverse Event|2|||
44168938|NCT01632345|78962255|FG003|Treatment: Part I|Adverse Event|1|||
44168939|NCT01632345|78962256|FG004|Treatment: Part I|Adverse Event|3|||
44168940|NCT01632345|78962257|FG005|Treatment: Part I|Adverse Event|0|||
44168941|NCT01632345|78962258|FG006|Treatment: Part I|Adverse Event|0|||
44168942|NCT01632345|78962252|FG000|Treatment: Part I|Lack of Efficacy|0|||
44168943|NCT01632345|78962253|FG001|Treatment: Part I|Lack of Efficacy|1|||
44168944|NCT01632345|78962254|FG002|Treatment: Part I|Lack of Efficacy|0|||
44168945|NCT01632345|78962255|FG003|Treatment: Part I|Lack of Efficacy|1|||
44168946|NCT01632345|78962256|FG004|Treatment: Part I|Lack of Efficacy|1|||
44168947|NCT01632345|78962257|FG005|Treatment: Part I|Lack of Efficacy|0|||
44168948|NCT01632345|78962258|FG006|Treatment: Part I|Lack of Efficacy|0|||
44168949|NCT01632345|78962252|FG000|Treatment: Part I|Lost to Follow-up|3|||
44168950|NCT01632345|78962253|FG001|Treatment: Part I|Lost to Follow-up|2|||
44168951|NCT01632345|78962254|FG002|Treatment: Part I|Lost to Follow-up|1|||
44168952|NCT01632345|78962255|FG003|Treatment: Part I|Lost to Follow-up|3|||
44168953|NCT01632345|78962256|FG004|Treatment: Part I|Lost to Follow-up|4|||
44168954|NCT01632345|78962257|FG005|Treatment: Part I|Lost to Follow-up|0|||
44168955|NCT01632345|78962258|FG006|Treatment: Part I|Lost to Follow-up|0|||
44168956|NCT01632345|78962252|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
44168957|NCT01632345|78962253|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
44168958|NCT01632345|78962254|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
44168959|NCT01632345|78962255|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
44449347|NCT03671369|79457872|FG000|Overall Study|Withdrawal by Subject|289|||
44449348|NCT03671369|79457872|FG000|Overall Study|Not willing to be vaccinated|1|||
44449349|NCT00692003|79457878|FG000|Overall Study|Sponsor Decision|5|||
44449350|NCT00692003|79457879|FG001|Overall Study|Sponsor Decision|1|||
44449351|NCT00434512|79457891|FG000|Overall Study|Migrated/moved from study area|0|||
44449352|NCT00434512|79457892|FG001|Overall Study|Migrated/moved from study area|0|||
44449353|NCT00434512|79457893|FG002|Overall Study|Migrated/moved from study area|0|||
44449354|NCT00434512|79457894|FG003|Overall Study|Migrated/moved from study area|1|||
44449355|NCT00434512|79457895|FG004|Overall Study|Migrated/moved from study area|1|||
44449356|NCT00434512|79457896|FG005|Overall Study|Migrated/moved from study area|1|||
44449357|NCT00434512|79457891|FG000|Overall Study|Other|0|||
44449358|NCT00434512|79457892|FG001|Overall Study|Other|1|||
44449359|NCT00434512|79457893|FG002|Overall Study|Other|0|||
44449360|NCT00434512|79457894|FG003|Overall Study|Other|0|||
44449361|NCT00434512|79457895|FG004|Overall Study|Other|0|||
44449362|NCT00434512|79457896|FG005|Overall Study|Other|0|||
44449363|NCT00427648|79457916|FG000|Overall Study|Protocol Violation|1|||
44449364|NCT00427648|79457917|FG001|Overall Study|Protocol Violation|2|||
44449365|NCT00427648|79457916|FG000|Overall Study|Adverse Event|0|||
44449366|NCT00427648|79457917|FG001|Overall Study|Adverse Event|1|||
44449367|NCT00416884|79457925|FG000|Overall Study|Study terminated due to low accrual|1|||
44449368|NCT00434122|79457931|FG000|Overall Study|Non-compliance with protocol|0|||
44449369|NCT00434122|79457932|FG001|Overall Study|Non-compliance with protocol|1|||
44449370|NCT00434122|79457931|FG000|Overall Study|loss of subject contact|1|||
44449371|NCT00434122|79457932|FG001|Overall Study|loss of subject contact|1|||
44449372|NCT00434122|79457931|FG000|Overall Study|Personal reasons|1|||
44449373|NCT00434122|79457932|FG001|Overall Study|Personal reasons|1|||
44449374|NCT00434122|79457931|FG000|Overall Study|Large follicle size|2|||
44449375|NCT00434122|79457932|FG001|Overall Study|Large follicle size|2|||
44449376|NCT00434122|79457931|FG000|Overall Study|Low follicular response.|1|||
44449377|NCT00434122|79457932|FG001|Overall Study|Low follicular response.|2|||
44449378|NCT00434122|79457931|FG000|Overall Study|Travelling of subject.|1|||
44449379|NCT00434122|79457932|FG001|Overall Study|Travelling of subject.|0|||
44449380|NCT00555620|79457946|FG000|Overall Study|Death|0|||
44449381|NCT00555620|79457947|FG001|Overall Study|Death|1|||
44449382|NCT00555620|79457948|FG002|Overall Study|Death|0|||
44449383|NCT00555620|79457949|FG003|Overall Study|Death|0|||
44449384|NCT00555620|79457950|FG004|Overall Study|Death|0|||
44449385|NCT00555620|79457951|FG005|Overall Study|Death|1|||
44449386|NCT00555620|79457946|FG000|Overall Study|Study terminated by sponsor|0|||
44449387|NCT00555620|79457947|FG001|Overall Study|Study terminated by sponsor|0|||
44449388|NCT00555620|79457948|FG002|Overall Study|Study terminated by sponsor|1|||
44168960|NCT01632345|78962256|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
44168961|NCT01632345|78962257|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
44168962|NCT01632345|78962258|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
44168963|NCT01632345|78962252|FG000|Treatment: Part I|Physician Decision|2|||
44168964|NCT01632345|78962253|FG001|Treatment: Part I|Physician Decision|1|||
44449389|NCT00555620|79457949|FG003|Overall Study|Study terminated by sponsor|0|||
44449390|NCT00555620|79457950|FG004|Overall Study|Study terminated by sponsor|0|||
44449391|NCT00555620|79457951|FG005|Overall Study|Study terminated by sponsor|0|||
44449392|NCT00555620|79457946|FG000|Overall Study|Adverse Event|0|||
44449393|NCT00555620|79457947|FG001|Overall Study|Adverse Event|0|||
44449394|NCT00555620|79457948|FG002|Overall Study|Adverse Event|1|||
44449395|NCT00555620|79457949|FG003|Overall Study|Adverse Event|5|||
44449396|NCT00555620|79457950|FG004|Overall Study|Adverse Event|0|||
44449397|NCT00555620|79457951|FG005|Overall Study|Adverse Event|1|||
44449398|NCT00555620|79457946|FG000|Overall Study|Objective progression or relapse|6|||
44449399|NCT00555620|79457947|FG001|Overall Study|Objective progression or relapse|5|||
44449400|NCT00555620|79457948|FG002|Overall Study|Objective progression or relapse|12|||
44449401|NCT00555620|79457949|FG003|Overall Study|Objective progression or relapse|17|||
44449402|NCT00555620|79457950|FG004|Overall Study|Objective progression or relapse|3|||
44449403|NCT00555620|79457951|FG005|Overall Study|Objective progression or relapse|16|||
44449404|NCT00555620|79457946|FG000|Overall Study|Participant refused treatment|0|||
44449405|NCT00555620|79457947|FG001|Overall Study|Participant refused treatment|1|||
44449406|NCT00555620|79457948|FG002|Overall Study|Participant refused treatment|1|||
44449407|NCT00555620|79457949|FG003|Overall Study|Participant refused treatment|0|||
44449408|NCT00555620|79457950|FG004|Overall Study|Participant refused treatment|0|||
44449409|NCT00555620|79457951|FG005|Overall Study|Participant refused treatment|1|||
44449410|NCT00555620|79457946|FG000|Overall Study|Other|0|||
44449411|NCT00555620|79457947|FG001|Overall Study|Other|0|||
44449412|NCT00555620|79457948|FG002|Overall Study|Other|0|||
44449413|NCT00555620|79457949|FG003|Overall Study|Other|1|||
44449414|NCT00555620|79457950|FG004|Overall Study|Other|0|||
44449415|NCT00555620|79457951|FG005|Overall Study|Other|3|||
44449416|NCT00433966|79457971|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
44449417|NCT00433966|79457972|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
44449418|NCT00433966|79457973|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
44449419|NCT00433966|79457974|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
44449420|NCT00433966|79457971|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
44449421|NCT00433966|79457972|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
44449422|NCT00433966|79457973|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
44449423|NCT00433966|79457974|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
44449424|NCT00433966|79457971|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
44449425|NCT00433966|79457972|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
44449426|NCT00433966|79457973|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
44449427|NCT00433966|79457974|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
44449428|NCT00433966|79457971|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
44449429|NCT00433966|79457972|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
44449430|NCT00433966|79457973|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
44449431|NCT00433966|79457974|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
44449432|NCT00433966|79457971|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
44449433|NCT00433966|79457972|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
44449434|NCT00433966|79457973|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
44449435|NCT00433966|79457974|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
44449436|NCT03952650|79457991|FG000|Overall Study|TRAVEL|0|||
44449437|NCT03952650|79457992|FG001|Overall Study|TRAVEL|4|||
44449438|NCT03952650|79457993|FG002|Overall Study|TRAVEL|0|||
44449439|NCT03952650|79457994|FG003|Overall Study|TRAVEL|4|||
44449440|NCT03952650|79457995|FG004|Overall Study|TRAVEL|0|||
44449441|NCT03952650|79457996|FG005|Overall Study|TRAVEL|3|||
44449442|NCT03952650|79457997|FG006|Overall Study|TRAVEL|2|||
44449443|NCT03952650|79457991|FG000|Overall Study|Withdrawal by Subject|0|||
44449444|NCT03952650|79457992|FG001|Overall Study|Withdrawal by Subject|2|||
44449445|NCT03952650|79457993|FG002|Overall Study|Withdrawal by Subject|0|||
44449446|NCT03952650|79457994|FG003|Overall Study|Withdrawal by Subject|3|||
44449447|NCT03952650|79457995|FG004|Overall Study|Withdrawal by Subject|0|||
44449448|NCT03952650|79457996|FG005|Overall Study|Withdrawal by Subject|1|||
44449449|NCT03952650|79457997|FG006|Overall Study|Withdrawal by Subject|1|||
44449450|NCT03952650|79457991|FG000|Overall Study|Lost to Follow-up|0|||
44449451|NCT03952650|79457992|FG001|Overall Study|Lost to Follow-up|1|||
44449452|NCT03952650|79457993|FG002|Overall Study|Lost to Follow-up|0|||
44449453|NCT03952650|79457994|FG003|Overall Study|Lost to Follow-up|0|||
44449454|NCT03952650|79457995|FG004|Overall Study|Lost to Follow-up|0|||
44449455|NCT03952650|79457996|FG005|Overall Study|Lost to Follow-up|1|||
44449456|NCT03952650|79457997|FG006|Overall Study|Lost to Follow-up|1|||
44449457|NCT03952650|79457991|FG000|Overall Study|Received wrong vaccine and travelled|0|||
44449458|NCT03952650|79457992|FG001|Overall Study|Received wrong vaccine and travelled|0|||
44449459|NCT03952650|79457993|FG002|Overall Study|Received wrong vaccine and travelled|0|||
44449460|NCT03952650|79457994|FG003|Overall Study|Received wrong vaccine and travelled|0|||
44449461|NCT03952650|79457995|FG004|Overall Study|Received wrong vaccine and travelled|0|||
44449462|NCT03952650|79457996|FG005|Overall Study|Received wrong vaccine and travelled|1|||
44449463|NCT03952650|79457997|FG006|Overall Study|Received wrong vaccine and travelled|0|||
44449464|NCT03952650|79457991|FG000|Overall Study|Unable to make study visit|0|||
44449465|NCT03952650|79457992|FG001|Overall Study|Unable to make study visit|0|||
44168965|NCT01632345|78962254|FG002|Treatment: Part I|Physician Decision|0|||
44168966|NCT01632345|78962255|FG003|Treatment: Part I|Physician Decision|0|||
44168967|NCT01632345|78962256|FG004|Treatment: Part I|Physician Decision|1|||
44168968|NCT01632345|78962257|FG005|Treatment: Part I|Physician Decision|0|||
44168969|NCT01632345|78962258|FG006|Treatment: Part I|Physician Decision|0|||
44168970|NCT01632345|78962252|FG000|Treatment: Part I|Pregnancy|0|||
44168971|NCT01632345|78962253|FG001|Treatment: Part I|Pregnancy|1|||
44168972|NCT01632345|78962254|FG002|Treatment: Part I|Pregnancy|0|||
44168973|NCT01632345|78962255|FG003|Treatment: Part I|Pregnancy|0|||
44168974|NCT01632345|78962256|FG004|Treatment: Part I|Pregnancy|0|||
44168975|NCT01632345|78962257|FG005|Treatment: Part I|Pregnancy|0|||
44168976|NCT01632345|78962258|FG006|Treatment: Part I|Pregnancy|0|||
44168977|NCT01632345|78962252|FG000|Treatment: Part I|Protocol Deviation|0|||
44168978|NCT01632345|78962253|FG001|Treatment: Part I|Protocol Deviation|0|||
44168979|NCT01632345|78962254|FG002|Treatment: Part I|Protocol Deviation|1|||
44168980|NCT01632345|78962255|FG003|Treatment: Part I|Protocol Deviation|1|||
44168981|NCT01632345|78962256|FG004|Treatment: Part I|Protocol Deviation|0|||
44168982|NCT01632345|78962257|FG005|Treatment: Part I|Protocol Deviation|0|||
44168983|NCT01632345|78962258|FG006|Treatment: Part I|Protocol Deviation|0|||
44168984|NCT01632345|78962252|FG000|Treatment: Part I|Withdrawal by Subject|3|||
44168985|NCT01632345|78962253|FG001|Treatment: Part I|Withdrawal by Subject|4|||
44168986|NCT01632345|78962254|FG002|Treatment: Part I|Withdrawal by Subject|4|||
44168987|NCT01632345|78962255|FG003|Treatment: Part I|Withdrawal by Subject|1|||
44168988|NCT01632345|78962256|FG004|Treatment: Part I|Withdrawal by Subject|4|||
44168989|NCT01632345|78962257|FG005|Treatment: Part I|Withdrawal by Subject|0|||
44168990|NCT01632345|78962258|FG006|Treatment: Part I|Withdrawal by Subject|0|||
44168991|NCT01632345|78962252|FG000|Treatment: Part II|Adverse Event|0|||
44168992|NCT01632345|78962253|FG001|Treatment: Part II|Adverse Event|0|||
44168993|NCT01632345|78962254|FG002|Treatment: Part II|Adverse Event|0|||
44168994|NCT01632345|78962255|FG003|Treatment: Part II|Adverse Event|0|||
44168995|NCT01632345|78962256|FG004|Treatment: Part II|Adverse Event|0|||
44168996|NCT01632345|78962257|FG005|Treatment: Part II|Adverse Event|3|||
44168997|NCT01632345|78962258|FG006|Treatment: Part II|Adverse Event|8|||
44168998|NCT01632345|78962252|FG000|Treatment: Part II|Lost to Follow-up|0|||
44168999|NCT01632345|78962253|FG001|Treatment: Part II|Lost to Follow-up|0|||
44169000|NCT01632345|78962254|FG002|Treatment: Part II|Lost to Follow-up|0|||
44169001|NCT01632345|78962255|FG003|Treatment: Part II|Lost to Follow-up|0|||
44169002|NCT01632345|78962256|FG004|Treatment: Part II|Lost to Follow-up|0|||
44169003|NCT01632345|78962257|FG005|Treatment: Part II|Lost to Follow-up|3|||
44169004|NCT01632345|78962258|FG006|Treatment: Part II|Lost to Follow-up|1|||
44169005|NCT01632345|78962252|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
44169006|NCT01632345|78962253|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
44169007|NCT01632345|78962254|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
44169008|NCT01632345|78962255|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
44169009|NCT01632345|78962256|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
44169010|NCT01632345|78962257|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
44169011|NCT01632345|78962258|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
44169012|NCT01632345|78962252|FG000|Treatment: Part II|Withdrawal by Subject|0|||
44169013|NCT01632345|78962253|FG001|Treatment: Part II|Withdrawal by Subject|0|||
44169014|NCT01632345|78962254|FG002|Treatment: Part II|Withdrawal by Subject|0|||
44169015|NCT01632345|78962255|FG003|Treatment: Part II|Withdrawal by Subject|0|||
44169016|NCT01632345|78962256|FG004|Treatment: Part II|Withdrawal by Subject|0|||
44169017|NCT01632345|78962257|FG005|Treatment: Part II|Withdrawal by Subject|2|||
44169018|NCT01632345|78962258|FG006|Treatment: Part II|Withdrawal by Subject|2|||
44169019|NCT02232243|78962276|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
44169020|NCT02232243|78962277|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
44169021|NCT02232243|78962278|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
44169022|NCT02205333|78962296|FG000|Overall Study|Death|5|||
44169023|NCT02205333|78962297|FG001|Overall Study|Death|6|||
44169024|NCT02205333|78962298|FG002|Overall Study|Death|2|||
44169025|NCT02205333|78962299|FG003|Overall Study|Death|6|||
44169026|NCT02205333|78962300|FG004|Overall Study|Death|5|||
44169027|NCT02205333|78962301|FG005|Overall Study|Death|3|||
44169028|NCT02205333|78962302|FG006|Overall Study|Death|3|||
44169029|NCT02205333|78962303|FG007|Overall Study|Death|2|||
44169030|NCT02205333|78962304|FG008|Overall Study|Death|0|||
44169031|NCT02205333|78962296|FG000|Overall Study|Withdrawal by Subject|1|||
44360811|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44169032|NCT02205333|78962297|FG001|Overall Study|Withdrawal by Subject|0|||
44169033|NCT02205333|78962298|FG002|Overall Study|Withdrawal by Subject|0|||
44169034|NCT02205333|78962299|FG003|Overall Study|Withdrawal by Subject|1|||
44169035|NCT02205333|78962300|FG004|Overall Study|Withdrawal by Subject|0|||
44169036|NCT02205333|78962301|FG005|Overall Study|Withdrawal by Subject|0|||
44169037|NCT02205333|78962302|FG006|Overall Study|Withdrawal by Subject|2|||
44169038|NCT02205333|78962303|FG007|Overall Study|Withdrawal by Subject|0|||
44169039|NCT02205333|78962304|FG008|Overall Study|Withdrawal by Subject|0|||
44169040|NCT02230683|78962324|FG000|Overall Study|Adverse Event|1|||
44169041|NCT02230527|78962336|FG000|Overall Study|Withdrawal by Subject|1|||
44169042|NCT02230527|78962337|FG001|Overall Study|Withdrawal by Subject|1|||
44169043|NCT02230527|78962336|FG000|Overall Study|Death|1|||
44169044|NCT02230527|78962337|FG001|Overall Study|Death|0|||
44169045|NCT02230527|78962336|FG000|Overall Study|Lost to Follow-up|2|||
44169046|NCT02230527|78962337|FG001|Overall Study|Lost to Follow-up|1|||
44169047|NCT02230527|78962336|FG000|Overall Study|Other|1|||
44169048|NCT02230527|78962337|FG001|Overall Study|Other|0|||
44169049|NCT02204319|78962343|FG000|Overall Study|Pregnancy|1|||
44169050|NCT02204319|78962343|FG000|Overall Study|Withdrawal by Subject|2|||
44169051|NCT02204007|78962350|FG000|Overall Study|Surgery Canceled|1|||
44169052|NCT02204007|78962351|FG001|Overall Study|Surgery Canceled|1|||
44169053|NCT02203851|78962357|FG000|Overall Study|Lost to Follow-up|4|||
44169054|NCT02203851|78962357|FG000|Overall Study|Withdrawal by Subject|6|||
44169055|NCT02203851|78962357|FG000|Overall Study|Other|1|||
44169056|NCT02228967|78962370|FG000|Overall Study|Lost to Follow-up|146|||
44169057|NCT02228967|78962371|FG001|Overall Study|Lost to Follow-up|142|||
44169058|NCT02228967|78962370|FG000|Overall Study|Withdrawal by Subject|13|||
44169059|NCT02228967|78962371|FG001|Overall Study|Withdrawal by Subject|18|||
44169060|NCT02227875|78962379|FG000|Overall Study|Protocol Violation|10|||
44169061|NCT02227875|78962380|FG001|Overall Study|Protocol Violation|7|||
44169062|NCT02227875|78962379|FG000|Overall Study|Other|1|||
44169063|NCT02227875|78962380|FG001|Overall Study|Other|3|||
44169064|NCT02227875|78962379|FG000|Overall Study|Physician Decision|1|||
44169065|NCT02227875|78962380|FG001|Overall Study|Physician Decision|0|||
44169066|NCT02227875|78962379|FG000|Overall Study|Adverse Event|3|||
44169067|NCT02227875|78962380|FG001|Overall Study|Adverse Event|0|||
44169068|NCT02227875|78962379|FG000|Overall Study|Withdrawal by Subject|12|||
44169069|NCT02227875|78962380|FG001|Overall Study|Withdrawal by Subject|13|||
44169070|NCT02227875|78962379|FG000|Overall Study|Lost to Follow-up|10|||
44169071|NCT02227875|78962380|FG001|Overall Study|Lost to Follow-up|10|||
44169072|NCT02203149|78962391|FG000|Part 1|Adverse Event|0|||
44169073|NCT02203149|78962392|FG001|Part 1|Adverse Event|1|||
44169074|NCT02203149|78962393|FG002|Part 1|Adverse Event|0|||
44169075|NCT02203149|78962394|FG003|Part 1|Adverse Event|0|||
44169076|NCT02203149|78962395|FG004|Part 1|Adverse Event|0|||
44169077|NCT02203149|78962391|FG000|Part 2|Death|0|||
44169078|NCT02203149|78962392|FG001|Part 2|Death|0|||
44169079|NCT02203149|78962393|FG002|Part 2|Death|1|||
44169080|NCT02203149|78962394|FG003|Part 2|Death|1|||
44169081|NCT02203149|78962395|FG004|Part 2|Death|0|||
44169082|NCT02203149|78962391|FG000|Part 2|Withdrawal by Subject|0|||
44169083|NCT02203149|78962392|FG001|Part 2|Withdrawal by Subject|0|||
44169084|NCT02203149|78962393|FG002|Part 2|Withdrawal by Subject|0|||
44169085|NCT02203149|78962394|FG003|Part 2|Withdrawal by Subject|1|||
44169086|NCT02203149|78962395|FG004|Part 2|Withdrawal by Subject|0|||
44169087|NCT02203149|78962391|FG000|Part 2|Adverse Event|0|||
44169088|NCT02203149|78962392|FG001|Part 2|Adverse Event|0|||
44169089|NCT02203149|78962393|FG002|Part 2|Adverse Event|0|||
44169090|NCT02203149|78962394|FG003|Part 2|Adverse Event|1|||
44169091|NCT02203149|78962395|FG004|Part 2|Adverse Event|1|||
44169092|NCT02203071|78962419|FG000|Overall Study|Lost to Follow-up|3|||
44169093|NCT02203071|78962420|FG001|Overall Study|Lost to Follow-up|1|||
44169094|NCT02202837|78962428|FG000|Overall Study|Enbrel treatment discontinued|36|||
44169095|NCT02202837|78962429|FG001|Overall Study|Enbrel treatment discontinued|4|||
44169096|NCT02202837|78962428|FG000|Overall Study|Other|10|||
44169097|NCT02202837|78962429|FG001|Overall Study|Other|0|||
44169098|NCT02202837|78962428|FG000|Overall Study|Lost to Follow-up|7|||
44169099|NCT02202837|78962429|FG001|Overall Study|Lost to Follow-up|1|||
44169100|NCT02202759|78962438|FG000|Overall Study|Study Terminated by Sponsor|3|||
44169101|NCT02202759|78962439|FG001|Overall Study|Study Terminated by Sponsor|3|||
44169102|NCT02202759|78962440|FG002|Overall Study|Study Terminated by Sponsor|3|||
44169103|NCT02202759|78962438|FG000|Overall Study|Withdrawal by Subject|2|||
44169104|NCT02202759|78962439|FG001|Overall Study|Withdrawal by Subject|1|||
44169105|NCT02202759|78962440|FG002|Overall Study|Withdrawal by Subject|1|||
44169106|NCT02202759|78962438|FG000|Overall Study|Reason not Specified|4|||
44169107|NCT02202759|78962439|FG001|Overall Study|Reason not Specified|11|||
44360812|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
44169108|NCT02202759|78962440|FG002|Overall Study|Reason not Specified|10|||
44169109|NCT02226549|78962449|FG000|Overall Study|Randomized but Never Treated|1|||
44169110|NCT02226549|78962450|FG001|Overall Study|Randomized but Never Treated|0|||
44169111|NCT02226549|78962449|FG000|Overall Study|Lost to Follow-up|0|||
44169112|NCT02226549|78962450|FG001|Overall Study|Lost to Follow-up|1|||
44169113|NCT02226003|78962459|FG000|Overall Study|Lost to Follow-up|2|||
44169114|NCT02226003|78962460|FG001|Overall Study|Lost to Follow-up|1|||
44169115|NCT02226003|78962461|FG002|Overall Study|Lost to Follow-up|3|||
44169116|NCT02226003|78962459|FG000|Overall Study|Withdrawal by Subject|0|||
44169117|NCT02226003|78962460|FG001|Overall Study|Withdrawal by Subject|0|||
44169118|NCT02226003|78962461|FG002|Overall Study|Withdrawal by Subject|3|||
44169119|NCT02225223|78962471|FG000|Overall Study|Death|10|||
44169120|NCT02225223|78962472|FG001|Overall Study|Death|1|||
44169121|NCT02225223|78962471|FG000|Overall Study|Lost to Follow-up|5|||
44169122|NCT02225223|78962472|FG001|Overall Study|Lost to Follow-up|0|||
44169123|NCT02225223|78962471|FG000|Overall Study|Other|1|||
44169124|NCT02225223|78962472|FG001|Overall Study|Other|2|||
44169125|NCT02225223|78962471|FG000|Overall Study|Physician Decision|1|||
44169126|NCT02225223|78962472|FG001|Overall Study|Physician Decision|0|||
44169127|NCT02225223|78962471|FG000|Overall Study|Withdrawal by Subject|2|||
44169128|NCT02225223|78962472|FG001|Overall Study|Withdrawal by Subject|2|||
44169129|NCT01634139|78962481|FG000|Overall Study|Non compliant with protocol|1|||
44169130|NCT01634139|78962482|FG001|Overall Study|Non compliant with protocol|0|||
44169131|NCT01634139|78962483|FG002|Overall Study|Non compliant with protocol|0|||
44169132|NCT01634139|78962481|FG000|Overall Study|Consent withdrawn not due to AE|4|||
44169133|NCT01634139|78962482|FG001|Overall Study|Consent withdrawn not due to AE|3|||
44169134|NCT01634139|78962483|FG002|Overall Study|Consent withdrawn not due to AE|2|||
44169135|NCT01634139|78962481|FG000|Overall Study|Other|4|||
44169136|NCT01634139|78962482|FG001|Overall Study|Other|0|||
44169137|NCT01634139|78962483|FG002|Overall Study|Other|3|||
44169138|NCT01634139|78962481|FG000|Overall Study|Lost to Follow-up|0|||
44169139|NCT01634139|78962482|FG001|Overall Study|Lost to Follow-up|2|||
44169140|NCT01634139|78962483|FG002|Overall Study|Lost to Follow-up|0|||
44169141|NCT01634139|78962481|FG000|Overall Study|Not treated|1|||
44169142|NCT01634139|78962482|FG001|Overall Study|Not treated|1|||
44169143|NCT01634139|78962483|FG002|Overall Study|Not treated|0|||
44169144|NCT02224755|78962493|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
44169145|NCT02224755|78962494|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
44169146|NCT02224755|78962493|FG000|Two Year Follow up Post-implant|Death|103|||
44169147|NCT02224755|78962494|FG001|Two Year Follow up Post-implant|Death|98|||
44169148|NCT02224755|78962493|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
44169149|NCT02224755|78962494|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
44169150|NCT02224755|78962493|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
44169151|NCT02224755|78962494|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
44169152|NCT02224755|78962493|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
44169153|NCT02224755|78962494|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
44169154|NCT02404441|78962514|FG000|Phase 1 Part|Adverse Event|1|||
44169155|NCT02404441|78962515|FG001|Phase 1 Part|Adverse Event|0|||
44169156|NCT02404441|78962516|FG002|Phase 1 Part|Adverse Event|0|||
44169157|NCT02404441|78962517|FG003|Phase 1 Part|Adverse Event|0|||
44169158|NCT02404441|78962518|FG004|Phase 1 Part|Adverse Event|0|||
44169159|NCT02404441|78962519|FG005|Phase 1 Part|Adverse Event|0|||
44169160|NCT02404441|78962520|FG006|Phase 1 Part|Adverse Event|0|||
44169161|NCT02404441|78962521|FG007|Phase 1 Part|Adverse Event|0|||
44169162|NCT02404441|78962522|FG008|Phase 1 Part|Adverse Event|0|||
44169163|NCT02404441|78962523|FG009|Phase 1 Part|Adverse Event|0|||
44169164|NCT02404441|78962514|FG000|Phase 1 Part|Physician Decision|0|||
44169165|NCT02404441|78962515|FG001|Phase 1 Part|Physician Decision|1|||
44169166|NCT02404441|78962516|FG002|Phase 1 Part|Physician Decision|0|||
44169167|NCT02404441|78962517|FG003|Phase 1 Part|Physician Decision|0|||
44169168|NCT02404441|78962518|FG004|Phase 1 Part|Physician Decision|0|||
44169169|NCT02404441|78962519|FG005|Phase 1 Part|Physician Decision|0|||
44169170|NCT02404441|78962520|FG006|Phase 1 Part|Physician Decision|0|||
44169171|NCT02404441|78962521|FG007|Phase 1 Part|Physician Decision|0|||
44169172|NCT02404441|78962522|FG008|Phase 1 Part|Physician Decision|0|||
44169173|NCT02404441|78962523|FG009|Phase 1 Part|Physician Decision|0|||
44169174|NCT02404441|78962514|FG000|Phase 1 Part|Progressive Disease|14|||
44169175|NCT02404441|78962515|FG001|Phase 1 Part|Progressive Disease|11|||
44169176|NCT02404441|78962516|FG002|Phase 1 Part|Progressive Disease|7|||
44169177|NCT02404441|78962517|FG003|Phase 1 Part|Progressive Disease|6|||
44169178|NCT02404441|78962518|FG004|Phase 1 Part|Progressive Disease|9|||
44449466|NCT03952650|79457993|FG002|Overall Study|Unable to make study visit|0|||
44449467|NCT03952650|79457994|FG003|Overall Study|Unable to make study visit|0|||
44449468|NCT03952650|79457995|FG004|Overall Study|Unable to make study visit|0|||
44449469|NCT03952650|79457996|FG005|Overall Study|Unable to make study visit|1|||
44449470|NCT03952650|79457997|FG006|Overall Study|Unable to make study visit|0|||
44449471|NCT00691301|79458013|FG000|Overall Study|Adverse Event|10|||
44449472|NCT00691301|79458013|FG000|Overall Study|Death|2|||
44449473|NCT00691301|79458013|FG000|Overall Study|Lack of Efficacy|32|||
44449474|NCT00691301|79458013|FG000|Overall Study|Withdrawal by Subject|4|||
44449475|NCT00691301|79458013|FG000|Overall Study|Concurrent illness|2|||
44449476|NCT00691301|79458013|FG000|Overall Study|other reason|3|||
44449477|NCT00691301|79458013|FG000|Overall Study|Did not initiate study treatment|1|||
44449478|NCT00927563|79458023|FG000|Overall Study|Lost to Follow-up|1|||
44169179|NCT02404441|78962519|FG005|Phase 1 Part|Progressive Disease|0|||
44169180|NCT02404441|78962520|FG006|Phase 1 Part|Progressive Disease|0|||
44169181|NCT02404441|78962521|FG007|Phase 1 Part|Progressive Disease|0|||
44169182|NCT02404441|78962522|FG008|Phase 1 Part|Progressive Disease|0|||
44169183|NCT02404441|78962523|FG009|Phase 1 Part|Progressive Disease|0|||
44449479|NCT00927563|79458023|FG000|Overall Study|Withdrawal by Subject|1|||
44169184|NCT02404441|78962514|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
44169185|NCT02404441|78962515|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
44169186|NCT02404441|78962516|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
44169187|NCT02404441|78962517|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
44169188|NCT02404441|78962518|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
44169189|NCT02404441|78962519|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
44169190|NCT02404441|78962520|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
44169191|NCT02404441|78962521|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
44169192|NCT02404441|78962522|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
44169193|NCT02404441|78962523|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
44169194|NCT02404441|78962514|FG000|Phase 1 Part|Death|1|||
44169195|NCT02404441|78962515|FG001|Phase 1 Part|Death|1|||
44169196|NCT02404441|78962516|FG002|Phase 1 Part|Death|1|||
44169197|NCT02404441|78962517|FG003|Phase 1 Part|Death|0|||
44169198|NCT02404441|78962518|FG004|Phase 1 Part|Death|1|||
44169199|NCT02404441|78962519|FG005|Phase 1 Part|Death|0|||
44169200|NCT02404441|78962520|FG006|Phase 1 Part|Death|0|||
44169201|NCT02404441|78962521|FG007|Phase 1 Part|Death|0|||
44169202|NCT02404441|78962522|FG008|Phase 1 Part|Death|0|||
44169203|NCT02404441|78962523|FG009|Phase 1 Part|Death|0|||
44169204|NCT02404441|78962514|FG000|Phase 2 Part|Adverse Event|0|||
44169205|NCT02404441|78962515|FG001|Phase 2 Part|Adverse Event|0|||
44169206|NCT02404441|78962516|FG002|Phase 2 Part|Adverse Event|0|||
44169207|NCT02404441|78962517|FG003|Phase 2 Part|Adverse Event|0|||
44169208|NCT02404441|78962518|FG004|Phase 2 Part|Adverse Event|0|||
44169209|NCT02404441|78962519|FG005|Phase 2 Part|Adverse Event|2|||
44169210|NCT02404441|78962520|FG006|Phase 2 Part|Adverse Event|3|||
44169211|NCT02404441|78962521|FG007|Phase 2 Part|Adverse Event|3|||
44169212|NCT02404441|78962522|FG008|Phase 2 Part|Adverse Event|6|||
44169213|NCT02404441|78962523|FG009|Phase 2 Part|Adverse Event|1|||
44169214|NCT02404441|78962514|FG000|Phase 2 Part|Physician Decision|0|||
44169215|NCT02404441|78962515|FG001|Phase 2 Part|Physician Decision|0|||
44169216|NCT02404441|78962516|FG002|Phase 2 Part|Physician Decision|0|||
44169217|NCT02404441|78962517|FG003|Phase 2 Part|Physician Decision|0|||
44169218|NCT02404441|78962518|FG004|Phase 2 Part|Physician Decision|0|||
44169219|NCT02404441|78962519|FG005|Phase 2 Part|Physician Decision|7|||
44169220|NCT02404441|78962520|FG006|Phase 2 Part|Physician Decision|9|||
44169221|NCT02404441|78962521|FG007|Phase 2 Part|Physician Decision|2|||
44169222|NCT02404441|78962522|FG008|Phase 2 Part|Physician Decision|1|||
44169223|NCT02404441|78962523|FG009|Phase 2 Part|Physician Decision|3|||
44169224|NCT02404441|78962514|FG000|Phase 2 Part|Progressive disease|0|||
44169225|NCT02404441|78962515|FG001|Phase 2 Part|Progressive disease|0|||
44169226|NCT02404441|78962516|FG002|Phase 2 Part|Progressive disease|0|||
44169227|NCT02404441|78962517|FG003|Phase 2 Part|Progressive disease|0|||
44169228|NCT02404441|78962518|FG004|Phase 2 Part|Progressive disease|0|||
44169229|NCT02404441|78962519|FG005|Phase 2 Part|Progressive disease|43|||
44169230|NCT02404441|78962520|FG006|Phase 2 Part|Progressive disease|32|||
44169231|NCT02404441|78962521|FG007|Phase 2 Part|Progressive disease|31|||
44169232|NCT02404441|78962522|FG008|Phase 2 Part|Progressive disease|39|||
44169233|NCT02404441|78962523|FG009|Phase 2 Part|Progressive disease|27|||
44169234|NCT02404441|78962514|FG000|Phase 2 Part|Subject/guardian decision|0|||
44169235|NCT02404441|78962515|FG001|Phase 2 Part|Subject/guardian decision|0|||
44169236|NCT02404441|78962516|FG002|Phase 2 Part|Subject/guardian decision|0|||
44169237|NCT02404441|78962517|FG003|Phase 2 Part|Subject/guardian decision|0|||
44169238|NCT02404441|78962518|FG004|Phase 2 Part|Subject/guardian decision|0|||
44169239|NCT02404441|78962519|FG005|Phase 2 Part|Subject/guardian decision|3|||
44169240|NCT02404441|78962520|FG006|Phase 2 Part|Subject/guardian decision|9|||
44449480|NCT00653159|79458038|FG000|Overall Study|Adverse Event|4|||
44449481|NCT00653159|79458039|FG001|Overall Study|Adverse Event|1|||
44449482|NCT00653159|79458038|FG000|Overall Study|Lost to Follow-up|1|||
44449483|NCT00653159|79458039|FG001|Overall Study|Lost to Follow-up|2|||
44449484|NCT00117637|79458047|FG000|First Intervention (Period 1)|Adverse Event|11|||
44449485|NCT00117637|79458048|FG001|First Intervention (Period 1)|Adverse Event|16|||
44449486|NCT00117637|79458047|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
44449487|NCT00117637|79458048|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
44449488|NCT00117637|79458047|FG000|First Intervention (Period 1)|Protocol Violation|1|||
44449489|NCT00117637|79458048|FG001|First Intervention (Period 1)|Protocol Violation|0|||
44449490|NCT00117637|79458047|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
44169241|NCT02404441|78962521|FG007|Phase 2 Part|Subject/guardian decision|0|||
44449491|NCT00117637|79458048|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
44169242|NCT02404441|78962522|FG008|Phase 2 Part|Subject/guardian decision|3|||
44169243|NCT02404441|78962523|FG009|Phase 2 Part|Subject/guardian decision|2|||
44169244|NCT02404441|78962514|FG000|Phase 2 Part|Death|0|||
44169245|NCT02404441|78962515|FG001|Phase 2 Part|Death|0|||
44169246|NCT02404441|78962516|FG002|Phase 2 Part|Death|0|||
44169247|NCT02404441|78962517|FG003|Phase 2 Part|Death|0|||
44169248|NCT02404441|78962518|FG004|Phase 2 Part|Death|0|||
44169249|NCT02404441|78962519|FG005|Phase 2 Part|Death|4|||
44169250|NCT02404441|78962520|FG006|Phase 2 Part|Death|8|||
44169251|NCT02404441|78962521|FG007|Phase 2 Part|Death|4|||
44169252|NCT02404441|78962522|FG008|Phase 2 Part|Death|10|||
44169253|NCT02404441|78962523|FG009|Phase 2 Part|Death|9|||
44169254|NCT02101281|78962569|FG000|Overall Study|Adverse Event|0|||
44169255|NCT02101281|78962570|FG001|Overall Study|Adverse Event|1|||
44169256|NCT02224599|78962582|FG000|Overall Study|Physician Decision|1|||
44169257|NCT02224599|78962582|FG000|Overall Study|Progression of Disease|1|||
44169258|NCT02201901|78962589|FG000|Overall Study|Randomized but never treated|0|||
44169259|NCT02201901|78962590|FG001|Overall Study|Randomized but never treated|1|||
44169260|NCT02201901|78962591|FG002|Overall Study|Randomized but never treated|0|||
44169261|NCT02201901|78962589|FG000|Overall Study|Lack of Efficacy|7|||
44169262|NCT02201901|78962590|FG001|Overall Study|Lack of Efficacy|1|||
44169263|NCT02201901|78962591|FG002|Overall Study|Lack of Efficacy|6|||
44169264|NCT02201901|78962589|FG000|Overall Study|Death|3|||
44169265|NCT02201901|78962590|FG001|Overall Study|Death|3|||
44169266|NCT02201901|78962591|FG002|Overall Study|Death|3|||
44169267|NCT02201901|78962589|FG000|Overall Study|Lost to Follow-up|2|||
44169268|NCT02201901|78962590|FG001|Overall Study|Lost to Follow-up|3|||
44169269|NCT02201901|78962591|FG002|Overall Study|Lost to Follow-up|2|||
44169270|NCT02201901|78962589|FG000|Overall Study|Withdrew Consent|2|||
44169271|NCT02201901|78962590|FG001|Overall Study|Withdrew Consent|0|||
44169272|NCT02201901|78962591|FG002|Overall Study|Withdrew Consent|2|||
44169273|NCT02201901|78962589|FG000|Overall Study|Adverse Event|1|||
44169274|NCT02201901|78962590|FG001|Overall Study|Adverse Event|1|||
44169275|NCT02201901|78962591|FG002|Overall Study|Adverse Event|0|||
44169276|NCT02201277|78962602|FG000|Overall Study|Death|3|||
44169277|NCT02201277|78962603|FG001|Overall Study|Death|4|||
44169278|NCT02201277|78962602|FG000|Overall Study|Lost to Follow-up|2|||
44169279|NCT02201277|78962603|FG001|Overall Study|Lost to Follow-up|1|||
44169280|NCT02201277|78962602|FG000|Overall Study|Failed retrieval|1|||
44169281|NCT02201277|78962603|FG001|Overall Study|Failed retrieval|0|||
44169282|NCT02201277|78962602|FG000|Overall Study|Physician Decision|1|||
44169283|NCT02201277|78962603|FG001|Overall Study|Physician Decision|0|||
44169284|NCT02224053|78962613|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
44169285|NCT02224053|78962613|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
44169286|NCT02224053|78962613|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
44169287|NCT02224053|78962613|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
44169288|NCT02224053|78962613|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
44169289|NCT02457793|78962625|FG000|Overall Study|Reason not specified|0|||
44169290|NCT02457793|78962626|FG001|Overall Study|Reason not specified|0|||
44169291|NCT02457793|78962627|FG002|Overall Study|Reason not specified|0|||
44169292|NCT02457793|78962628|FG003|Overall Study|Reason not specified|1|||
44169293|NCT02457793|78962629|FG004|Overall Study|Reason not specified|1|||
44169294|NCT02457793|78962630|FG005|Overall Study|Reason not specified|1|||
44169295|NCT02457793|78962625|FG000|Overall Study|Withdrawal by Subject|0|||
44169296|NCT02457793|78962626|FG001|Overall Study|Withdrawal by Subject|4|||
44169297|NCT02457793|78962627|FG002|Overall Study|Withdrawal by Subject|2|||
44169298|NCT02457793|78962628|FG003|Overall Study|Withdrawal by Subject|2|||
44169299|NCT02457793|78962629|FG004|Overall Study|Withdrawal by Subject|2|||
44169300|NCT02457793|78962630|FG005|Overall Study|Withdrawal by Subject|2|||
44169301|NCT02457793|78962625|FG000|Overall Study|Adverse Event|0|||
44169302|NCT02457793|78962626|FG001|Overall Study|Adverse Event|0|||
44169303|NCT02457793|78962627|FG002|Overall Study|Adverse Event|0|||
44169304|NCT02457793|78962628|FG003|Overall Study|Adverse Event|1|||
44169305|NCT02457793|78962629|FG004|Overall Study|Adverse Event|0|||
44169306|NCT02457793|78962630|FG005|Overall Study|Adverse Event|0|||
44169307|NCT02457793|78962625|FG000|Overall Study|Physician Decision|1|||
44169308|NCT02457793|78962626|FG001|Overall Study|Physician Decision|0|||
44169309|NCT02457793|78962627|FG002|Overall Study|Physician Decision|1|||
44169310|NCT02457793|78962628|FG003|Overall Study|Physician Decision|1|||
44169311|NCT02457793|78962629|FG004|Overall Study|Physician Decision|1|||
44449492|NCT00117637|79458047|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
44169312|NCT02457793|78962630|FG005|Overall Study|Physician Decision|3|||
44169313|NCT01650259|78962647|FG000|Overall Study|Improvement|105|||
44169314|NCT01650259|78962648|FG001|Overall Study|Improvement|0|||
44169315|NCT01650259|78962647|FG000|Overall Study|Adverse Event|127|||
44169316|NCT01650259|78962648|FG001|Overall Study|Adverse Event|0|||
44169317|NCT01650259|78962647|FG000|Overall Study|Lack of Efficacy|143|||
44169318|NCT01650259|78962648|FG001|Overall Study|Lack of Efficacy|0|||
44169319|NCT01650259|78962647|FG000|Overall Study|Lost to Follow-up|435|||
44169320|NCT01650259|78962648|FG001|Overall Study|Lost to Follow-up|0|||
44169321|NCT01650259|78962647|FG000|Overall Study|Patients had no visit after entry|70|||
44169322|NCT01650259|78962648|FG001|Overall Study|Patients had no visit after entry|0|||
44169323|NCT01650259|78962647|FG000|Overall Study|CRF not collected|98|||
44169324|NCT01650259|78962648|FG001|Overall Study|CRF not collected|82|||
44169325|NCT01650259|78962647|FG000|Overall Study|Not treated|1|||
44169326|NCT01650259|78962648|FG001|Overall Study|Not treated|7|||
44169327|NCT01650259|78962647|FG000|Overall Study|Other than listed|64|||
44169328|NCT01650259|78962648|FG001|Overall Study|Other than listed|146|||
44169329|NCT02434939|78962654|FG000|Overall Study|Lack of Efficacy|34|||
44169330|NCT02434939|78962655|FG001|Overall Study|Lack of Efficacy|48|||
44169331|NCT02434939|78962654|FG000|Overall Study|Withdrawal by Subject|3|||
44169332|NCT02434939|78962655|FG001|Overall Study|Withdrawal by Subject|0|||
44169333|NCT02434939|78962654|FG000|Overall Study|Adverse Event|0|||
44169334|NCT02434939|78962655|FG001|Overall Study|Adverse Event|1|||
44169335|NCT02434471|78962662|FG000|Overall Study|Physician Decision|9|||
44169336|NCT02457637|78962667|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
44169337|NCT02457325|78962674|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
44169338|NCT02457325|78962675|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
44169339|NCT02434081|78962681|FG000|Overall Study|Death (never started treatment)|2|||
44169340|NCT02434081|78962681|FG000|Overall Study|Death|2|||
44169341|NCT02434081|78962681|FG000|Overall Study|Progression|20|||
44169342|NCT02434081|78962681|FG000|Overall Study|Adverse Event|20|||
44169343|NCT02434081|78962681|FG000|Overall Study|Physician Decision|2|||
44169344|NCT02434081|78962681|FG000|Overall Study|Withdrawal by Subject|1|||
44169345|NCT02434081|78962681|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
44169346|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
44169347|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
44169348|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
44169349|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
44169350|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
44169351|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
44169352|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
44169353|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
44169354|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
44169355|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
44169356|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
44169357|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
44169358|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
44169359|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
44169360|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
44169361|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
44169362|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
44169363|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
44169364|NCT02222493|78962687|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
44169365|NCT02222493|78962688|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
44169366|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
44169367|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
44169368|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
44169369|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
44169370|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
44169371|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
44169372|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
44169373|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
44169374|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
44169375|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
44169376|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
44169377|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
44169378|NCT02222493|78962687|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
44169379|NCT02222493|78962688|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
44169380|NCT02222493|78962687|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
44169381|NCT02222493|78962688|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
44169382|NCT02222493|78962687|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
44169383|NCT02222493|78962688|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
44169384|NCT02222493|78962687|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
44169385|NCT02222493|78962688|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
44169386|NCT02222493|78962687|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
44169387|NCT02222493|78962688|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
44169388|NCT02222493|78962687|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
44169389|NCT02222493|78962688|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
44169390|NCT02433379|78962707|FG000|Overall Study|Screen Failures|55|||
44169391|NCT02433379|78962707|FG000|Overall Study|Death|57|||
44169392|NCT02433379|78962707|FG000|Overall Study|Total Withdrawals|209|||
44169393|NCT02199795|78962715|FG000|Overall Study|no longer met inclusion criteria|1|||
44169394|NCT02199795|78962716|FG001|Overall Study|no longer met inclusion criteria|0|||
44169395|NCT02199795|78962715|FG000|Overall Study|withdrew due to shoulder pain|1|||
44169396|NCT02199795|78962716|FG001|Overall Study|withdrew due to shoulder pain|0|||
44169397|NCT02403817|78962724|FG000|Overall Study|Withdrawal by Subject|5|||
44169398|NCT02403817|78962725|FG001|Overall Study|Withdrawal by Subject|0|||
44169399|NCT02403271|78962731|FG000|Period 1|Other varied reasons|1|||
44169400|NCT02403271|78962732|FG001|Period 1|Other varied reasons|0|||
44169401|NCT02403271|78962731|FG000|Period 2|Withdrawal by Subject|0|||
44169402|NCT02403271|78962732|FG001|Period 2|Withdrawal by Subject|14|||
44169403|NCT02403271|78962731|FG000|Period 2|Death|0|||
44169404|NCT02403271|78962732|FG001|Period 2|Death|84|||
44169405|NCT02403271|78962731|FG000|Period 2|Lost to Follow-up|0|||
44169406|NCT02403271|78962732|FG001|Period 2|Lost to Follow-up|2|||
44169407|NCT02403271|78962731|FG000|Period 2|Study Terminated by Sponsor|0|||
44169408|NCT02403271|78962732|FG001|Period 2|Study Terminated by Sponsor|14|||
44169409|NCT02403271|78962731|FG000|Period 2|Other varied reasons|0|||
44169410|NCT02403271|78962732|FG001|Period 2|Other varied reasons|10|||
44169411|NCT02219685|78962740|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
44169412|NCT02219685|78962741|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
44169413|NCT02219685|78962740|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
44169414|NCT02219685|78962741|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
44169415|NCT02457247|78962753|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
44169416|NCT02457247|78962754|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
44169417|NCT02457247|78962755|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
44169418|NCT02457247|78962756|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
44169419|NCT02457247|78962753|FG000|Period 1|Significant Protocol Deviation|1|||
44169420|NCT02457247|78962754|FG001|Period 1|Significant Protocol Deviation|1|||
44169421|NCT02457247|78962755|FG002|Period 1|Significant Protocol Deviation|0|||
44169422|NCT02457247|78962756|FG003|Period 1|Significant Protocol Deviation|0|||
44169423|NCT02457247|78962753|FG000|Period 1|Voluntary Withdrawal|1|||
44169424|NCT02457247|78962754|FG001|Period 1|Voluntary Withdrawal|0|||
44169425|NCT02457247|78962755|FG002|Period 1|Voluntary Withdrawal|0|||
44169426|NCT02457247|78962756|FG003|Period 1|Voluntary Withdrawal|0|||
44169427|NCT02457247|78962753|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
44169428|NCT02457247|78962754|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
44169429|NCT02457247|78962755|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
44169430|NCT02457247|78962756|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
44169431|NCT02457247|78962753|FG000|Period 2|Significant Protocol Deviation|1|||
44169432|NCT02457247|78962754|FG001|Period 2|Significant Protocol Deviation|0|||
44169433|NCT02457247|78962755|FG002|Period 2|Significant Protocol Deviation|0|||
44169434|NCT02457247|78962756|FG003|Period 2|Significant Protocol Deviation|0|||
44169435|NCT02457247|78962753|FG000|Period 2|Lost to Follow-up|0|||
44169436|NCT02457247|78962754|FG001|Period 2|Lost to Follow-up|1|||
44449493|NCT00117637|79458048|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
44449494|NCT00117637|79458047|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
44449495|NCT00117637|79458048|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
44449496|NCT00117637|79458047|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
44449497|NCT00117637|79458048|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
44449498|NCT00117637|79458047|FG000|First Intervention (Period 1)|reason not reported|0|||
44449499|NCT00117637|79458048|FG001|First Intervention (Period 1)|reason not reported|1|||
44449500|NCT00117637|79458047|FG000|Second Intervention (Period 2)|Adverse Event|0|||
44449501|NCT00117637|79458048|FG001|Second Intervention (Period 2)|Adverse Event|9|||
44449502|NCT00117637|79458047|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
44449503|NCT00117637|79458048|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
44449504|NCT00117637|79458047|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
44169437|NCT02457247|78962755|FG002|Period 2|Lost to Follow-up|0|||
44169438|NCT02457247|78962756|FG003|Period 2|Lost to Follow-up|0|||
44169439|NCT02457247|78962753|FG000|Period 2|Voluntary Withdrawal|1|||
44169440|NCT02457247|78962754|FG001|Period 2|Voluntary Withdrawal|1|||
44169441|NCT02457247|78962755|FG002|Period 2|Voluntary Withdrawal|0|||
44169442|NCT02457247|78962756|FG003|Period 2|Voluntary Withdrawal|0|||
44169443|NCT02401867|78962772|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
44169444|NCT02401867|78962772|FG000|Analysis|Cervical assay could not be conducted|9|||
44169445|NCT02198235|78962780|FG000|Overall Study|Lost to Follow-up|3|||
44169446|NCT02198235|78962781|FG001|Overall Study|Lost to Follow-up|2|||
44169447|NCT02198235|78962782|FG002|Overall Study|Lost to Follow-up|2|||
44169448|NCT02253147|78962790|FG000|Overall Study|Protocol Violation|30|||
44169449|NCT02253147|78962790|FG000|Overall Study|Did not consent to study extension|9|||
44169450|NCT02253147|78962790|FG000|Overall Study|Conditional re-treatment at W52|5|||
44449505|NCT00117637|79458048|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
44449506|NCT00117637|79458047|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
44169451|NCT02253147|78962790|FG000|Overall Study|Lost to Follow-up|2|||
44169452|NCT02253147|78962790|FG000|Overall Study|Withdrawal by Subject|1|||
44169453|NCT02217501|78962798|FG000|Overall Study|Death|3|||
44169454|NCT02217501|78962799|FG001|Overall Study|Death|4|||
44169455|NCT01649869|78962807|FG000|Overall Study|Family member illness|1|||
44169456|NCT01649869|78962808|FG001|Overall Study|Family member illness|0|||
44169457|NCT01649869|78962807|FG000|Overall Study|Required treatment outside protocol|1|||
44169458|NCT01649869|78962808|FG001|Overall Study|Required treatment outside protocol|0|||
44169459|NCT01649869|78962807|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
44169460|NCT01649869|78962808|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
44169461|NCT02197377|78962818|FG000|Overall Study|Insertion Failure|0|||
44169462|NCT02197377|78962819|FG001|Overall Study|Insertion Failure|3|||
44169463|NCT02400307|78962827|FG000|Overall Study|Enrolled and Never Dosed|1|||
44169464|NCT02400307|78962828|FG001|Overall Study|Enrolled and Never Dosed|0|||
44169465|NCT02196675|78962837|FG000|Overall Study|Withdrawal by Subject|1|||
44169466|NCT02196675|78962838|FG001|Overall Study|Withdrawal by Subject|0|||
44169467|NCT02196675|78962839|FG002|Overall Study|Withdrawal by Subject|0|||
44169468|NCT02196675|78962837|FG000|Overall Study|Intra-operative surgical exclusion|1|||
44169469|NCT02196675|78962838|FG001|Overall Study|Intra-operative surgical exclusion|1|||
44169470|NCT02196675|78962839|FG002|Overall Study|Intra-operative surgical exclusion|0|||
44169471|NCT02196675|78962837|FG000|Overall Study|Protocol Violation|0|||
44169472|NCT02196675|78962838|FG001|Overall Study|Protocol Violation|1|||
44169473|NCT02196675|78962839|FG002|Overall Study|Protocol Violation|0|||
44169474|NCT02196675|78962837|FG000|Overall Study|Death|0|||
44169475|NCT02196675|78962838|FG001|Overall Study|Death|0|||
44169476|NCT02196675|78962839|FG002|Overall Study|Death|1|||
44169477|NCT02399449|78962849|FG000|Overall Study|Withdrawal by Subject|3|||
44169478|NCT02399449|78962850|FG001|Overall Study|Withdrawal by Subject|9|||
44169479|NCT02399449|78962849|FG000|Overall Study|Physician Decision|0|||
44169480|NCT02399449|78962850|FG001|Overall Study|Physician Decision|1|||
44169481|NCT02217345|78962858|FG000|Overall Study|Lost to Follow-up|2|||
44169482|NCT02217345|78962859|FG001|Overall Study|Lost to Follow-up|1|||
44169483|NCT02217345|78962858|FG000|Overall Study|Withdrawal by Subject|3|||
44169484|NCT02217345|78962859|FG001|Overall Study|Withdrawal by Subject|2|||
44169485|NCT02217345|78962858|FG000|Overall Study|Adverse Event|2|||
44169486|NCT02217345|78962859|FG001|Overall Study|Adverse Event|1|||
44169487|NCT02217345|78962858|FG000|Overall Study|Physician Decision|0|||
44169488|NCT02217345|78962859|FG001|Overall Study|Physician Decision|1|||
44169489|NCT01652287|78962867|FG000|Overall Study|Withdrawal by Subject|2|||
44169490|NCT01652287|78962868|FG001|Overall Study|Withdrawal by Subject|0|||
44169491|NCT02251743|78962876|FG000|Overall Study|Withdrawal by Subject|1|||
44169492|NCT02251743|78962877|FG001|Overall Study|Withdrawal by Subject|1|||
44169493|NCT02428855|78962883|FG000|Overall Study|Withdrawal by Subject|2|||
44169494|NCT02428699|78962887|FG000|Washout Period 1|Screen Failure|1|||
44169495|NCT02428699|78962888|FG001|Washout Period 1|Screen Failure|2|||
44169496|NCT02428231|78962901|FG000|Overall Study|Other|10|||
44169497|NCT02428231|78962902|FG001|Overall Study|Other|16|||
44169498|NCT02428231|78962901|FG000|Overall Study|Required Symptomatic Therapy|0|||
44169499|NCT02428231|78962902|FG001|Overall Study|Required Symptomatic Therapy|1|||
44169500|NCT02428231|78962901|FG000|Overall Study|Adverse Event|3|||
44169501|NCT02428231|78962902|FG001|Overall Study|Adverse Event|0|||
44169502|NCT02397889|78962910|FG000|Overall Study|Physician Decision|1|||
44169503|NCT02397889|78962911|FG001|Overall Study|Physician Decision|0|||
44169504|NCT02397655|78962917|FG000|Overall Study|data not completed|1301|||
44169505|NCT02396953|78962924|FG000|Overall Study|Withdrawal by Subject|0|||
44169506|NCT02396953|78962925|FG001|Overall Study|Withdrawal by Subject|0|||
44169507|NCT02396953|78962926|FG002|Overall Study|Withdrawal by Subject|1|||
44169508|NCT02396953|78962924|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
44169509|NCT02396953|78962925|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
44169510|NCT02396953|78962926|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
44169511|NCT02396953|78962924|FG000|Overall Study|Personal Reasons|1|||
44169512|NCT02396953|78962925|FG001|Overall Study|Personal Reasons|1|||
44169513|NCT02396953|78962926|FG002|Overall Study|Personal Reasons|0|||
44169514|NCT02387983|78962941|FG000|Overall Study|Adverse Event|4|||
44169515|NCT02387983|78962941|FG000|Overall Study|Protocol Violation|1|||
44169516|NCT02387983|78962941|FG000|Overall Study|Withdrawal by Subject|2|||
44169517|NCT02395627|78962948|FG000|Overall Study|Withdrawal by Subject|0|||
44169518|NCT02395627|78962949|FG001|Overall Study|Withdrawal by Subject|2|||
44169519|NCT02395627|78962950|FG002|Overall Study|Withdrawal by Subject|0|||
44169520|NCT02395627|78962948|FG000|Overall Study|Did not receive pembrolizumab|3|||
44169521|NCT02395627|78962949|FG001|Overall Study|Did not receive pembrolizumab|1|||
44169522|NCT02395627|78962950|FG002|Overall Study|Did not receive pembrolizumab|0|||
44169523|NCT02395471|78962962|FG000|Overall Study|Lost to Follow-up|2|||
44169524|NCT02395471|78962963|FG001|Overall Study|Lost to Follow-up|0|||
44169525|NCT02395471|78962962|FG000|Overall Study|Withdrawal by Subject|2|||
44169526|NCT02395471|78962963|FG001|Overall Study|Withdrawal by Subject|1|||
44169527|NCT02395471|78962962|FG000|Overall Study|Physician Decision|1|||
44169528|NCT02395471|78962963|FG001|Overall Study|Physician Decision|0|||
44169529|NCT02395471|78962962|FG000|Overall Study|Protocol Violation|0|||
44169530|NCT02395471|78962963|FG001|Overall Study|Protocol Violation|1|||
44169531|NCT02395471|78962962|FG000|Overall Study|Failure to swollow sponge twice|1|||
44169532|NCT02395471|78962963|FG001|Overall Study|Failure to swollow sponge twice|0|||
44249600|NCT02649894|79083539|FG001|Overall Study|Death|7|||
44169533|NCT02395471|78962962|FG000|Overall Study|Patient did not return for procedure|0|||
44169534|NCT02395471|78962963|FG001|Overall Study|Patient did not return for procedure|1|||
44169535|NCT02395471|78962962|FG000|Overall Study|Subject not eligible|1|||
44169536|NCT02395471|78962963|FG001|Overall Study|Subject not eligible|0|||
44169537|NCT02395081|78962981|FG000|Overall Study|Withdrawal by Subject|1|||
44169538|NCT02395081|78962982|FG001|Overall Study|Withdrawal by Subject|1|||
44169539|NCT02395081|78962983|FG002|Overall Study|Withdrawal by Subject|0|||
44169540|NCT02395081|78962981|FG000|Overall Study|Moved where blood couldn't be collected|4|||
44169541|NCT02395081|78962982|FG001|Overall Study|Moved where blood couldn't be collected|1|||
44169542|NCT02395081|78962983|FG002|Overall Study|Moved where blood couldn't be collected|3|||
44169543|NCT02395081|78962981|FG000|Overall Study|Fetal Loss|2|||
44169544|NCT02395081|78962982|FG001|Overall Study|Fetal Loss|3|||
44169545|NCT02395081|78962983|FG002|Overall Study|Fetal Loss|1|||
44169546|NCT02394925|78962994|FG000|Overall Study|Adverse Event|1|||
44169547|NCT02394925|78962994|FG000|Overall Study|Lens Discomfort|3|||
44169548|NCT02394925|78962994|FG000|Overall Study|Lens handling difficulities|5|||
44169549|NCT02394925|78962994|FG000|Overall Study|Lost to Follow-up|9|||
44169550|NCT02394925|78962994|FG000|Overall Study|Protocol Violation|5|||
44169551|NCT02394925|78962994|FG000|Overall Study|No longer meet eligibility criteria|1|||
44169552|NCT02394925|78962994|FG000|Overall Study|Unsatisfactory Visual Response|5|||
44169553|NCT02427607|78962998|FG000|Overall Study|Withdrawal by Subject|1|||
44169554|NCT02425111|78963002|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
44169555|NCT02425111|78963002|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
44169556|NCT02425111|78963002|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
44169557|NCT02425111|78963002|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
44169558|NCT02425111|78963002|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
44169559|NCT02425111|78963002|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
44169560|NCT02424565|78963007|FG000|Period 1 (D0)|Protocol Violation|0|||
44169561|NCT02424565|78963008|FG001|Period 1 (D0)|Protocol Violation|1|||
44169562|NCT02424253|78963016|FG000|Overall Study|Other, unspecified|1|||
44169563|NCT02424253|78963017|FG001|Overall Study|Other, unspecified|0|||
44169564|NCT02424253|78963016|FG000|Overall Study|Compliance problems|1|||
44169565|NCT02424253|78963017|FG001|Overall Study|Compliance problems|0|||
44169566|NCT02424253|78963016|FG000|Overall Study|Physician Decision|2|||
44169567|NCT02424253|78963017|FG001|Overall Study|Physician Decision|0|||
44169568|NCT02424253|78963016|FG000|Overall Study|Lack of Efficacy|0|||
44169569|NCT02424253|78963017|FG001|Overall Study|Lack of Efficacy|7|||
44169570|NCT02424253|78963016|FG000|Overall Study|Adverse Event|2|||
44169571|NCT02424253|78963017|FG001|Overall Study|Adverse Event|0|||
44169572|NCT02424253|78963016|FG000|Overall Study|Consent withdrawn by subject|4|||
44169573|NCT02424253|78963017|FG001|Overall Study|Consent withdrawn by subject|1|||
44169574|NCT02424253|78963016|FG000|Overall Study|Lost to Follow-up|1|||
44169575|NCT02424253|78963017|FG001|Overall Study|Lost to Follow-up|1|||
44169576|NCT02393755|78963025|FG000|Overall Study|Withdrawal by Subject|0|||
44169577|NCT02393755|78963026|FG001|Overall Study|Withdrawal by Subject|3|||
44169578|NCT02393755|78963025|FG000|Overall Study|Adverse Event|0|||
44169579|NCT02393755|78963026|FG001|Overall Study|Adverse Event|2|||
44169580|NCT02393755|78963025|FG000|Overall Study|Physician Decision|0|||
44169581|NCT02393755|78963026|FG001|Overall Study|Physician Decision|2|||
44169582|NCT02393209|78963033|FG000|Overall Study|Study Terminated by Sponsor|1|||
44169583|NCT02393209|78963034|FG001|Overall Study|Study Terminated by Sponsor|1|||
44169584|NCT02393209|78963035|FG002|Overall Study|Study Terminated by Sponsor|0|||
44169585|NCT02393209|78963036|FG003|Overall Study|Study Terminated by Sponsor|0|||
44169586|NCT02393209|78963033|FG000|Overall Study|Withdrawal by Patient|1|||
44169587|NCT02393209|78963034|FG001|Overall Study|Withdrawal by Patient|0|||
44169588|NCT02393209|78963035|FG002|Overall Study|Withdrawal by Patient|0|||
44169589|NCT02393209|78963036|FG003|Overall Study|Withdrawal by Patient|0|||
44169590|NCT02393209|78963033|FG000|Overall Study|Death|2|||
44169591|NCT02393209|78963034|FG001|Overall Study|Death|2|||
44169592|NCT02393209|78963035|FG002|Overall Study|Death|0|||
44169593|NCT02393209|78963036|FG003|Overall Study|Death|0|||
44169594|NCT02393209|78963033|FG000|Overall Study|Death due to Disease Progression|2|||
44169595|NCT02393209|78963034|FG001|Overall Study|Death due to Disease Progression|2|||
44169596|NCT02393209|78963035|FG002|Overall Study|Death due to Disease Progression|0|||
44169597|NCT02393209|78963036|FG003|Overall Study|Death due to Disease Progression|0|||
44169598|NCT02393209|78963033|FG000|Overall Study|Death from Legionella Infection|0|||
44169599|NCT02393209|78963034|FG001|Overall Study|Death from Legionella Infection|1|||
44169600|NCT02393209|78963035|FG002|Overall Study|Death from Legionella Infection|0|||
44169601|NCT02393209|78963036|FG003|Overall Study|Death from Legionella Infection|0|||
44169602|NCT02393209|78963033|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
44169603|NCT02393209|78963034|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
44169604|NCT02393209|78963035|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
44169605|NCT02393209|78963036|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
44169606|NCT02393209|78963033|FG000|Overall Study|Lost to Follow-up|0|||
44169607|NCT02393209|78963034|FG001|Overall Study|Lost to Follow-up|1|||
44169608|NCT02393209|78963035|FG002|Overall Study|Lost to Follow-up|0|||
44169609|NCT02393209|78963036|FG003|Overall Study|Lost to Follow-up|0|||
44169610|NCT02424097|78963047|FG000|Overall Study|Lost to Follow-up|1|||
44169611|NCT02424097|78963048|FG001|Overall Study|Lost to Follow-up|2|||
44169612|NCT02392507|78963054|FG000|Induction Regimen|Death|3|||
44169613|NCT02392507|78963054|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
44169614|NCT02392507|78963054|FG000|Induction Regimen|Physician Decision|1|||
44169615|NCT02392507|78963054|FG000|Induction Regimen|Withdrawal by Subject|2|||
44169616|NCT02392507|78963054|FG000|Maintenance Regimen|Death|1|||
44169617|NCT02392507|78963054|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
44169618|NCT02386345|78963063|FG000|Overall Study|Not treated|14|||
44169619|NCT02386345|78963063|FG000|Overall Study|Lost to Follow-up|1|||
44169620|NCT02386345|78963063|FG000|Overall Study|Adverse Event|5|||
44169621|NCT02386345|78963063|FG000|Overall Study|Repeat Procedure|10|||
44169622|NCT02386345|78963063|FG000|Overall Study|Did not complete 12-month follow-up|72|||
44169623|NCT01651117|78963071|FG000|Overall Study|Death|2|||
44169624|NCT01651117|78963072|FG001|Overall Study|Death|3|||
44169625|NCT01651117|78963073|FG002|Overall Study|Death|2|||
44169626|NCT01651117|78963074|FG003|Overall Study|Death|2|||
44169627|NCT02386189|78963089|FG000|Overall Study|Lost to Follow-up|2|||
44169628|NCT02386189|78963090|FG001|Overall Study|Lost to Follow-up|3|||
44169629|NCT02386189|78963089|FG000|Overall Study|Withdrawal by Subject|1|||
44169630|NCT02386189|78963090|FG001|Overall Study|Withdrawal by Subject|0|||
44169631|NCT02386189|78963089|FG000|Overall Study|Death|1|||
44169632|NCT02386189|78963090|FG001|Overall Study|Death|0|||
44169633|NCT02385799|78963098|FG000|Overall Study|Lost to Follow-up|1|||
44169634|NCT02385799|78963099|FG001|Overall Study|Lost to Follow-up|2|||
44169635|NCT02385799|78963098|FG000|Overall Study|Adverse Event|4|||
44169636|NCT02385799|78963099|FG001|Overall Study|Adverse Event|2|||
44169637|NCT02385799|78963098|FG000|Overall Study|Withdrawal by Subject|0|||
44169638|NCT02385799|78963099|FG001|Overall Study|Withdrawal by Subject|4|||
44169639|NCT02422303|78963107|FG000|Overall Study|Lost to Follow-up|1|||
44169640|NCT02422303|78963108|FG001|Overall Study|Lost to Follow-up|1|||
44169641|NCT02392195|78963114|FG000|Overall Study|Lost to Follow-up|4|||
44169642|NCT02392195|78963114|FG000|Overall Study|Withdrawal by Subject|4|||
44169643|NCT02391961|78963120|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
44169644|NCT02391961|78963121|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
44169645|NCT02391961|78963120|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
44169646|NCT02391961|78963121|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
44169647|NCT02391961|78963120|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44169648|NCT02391961|78963121|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44169649|NCT02384941|78963130|FG000|Overall Study|Adverse Event|11|||
44169650|NCT02384941|78963131|FG001|Overall Study|Adverse Event|13|||
44169651|NCT02384941|78963132|FG002|Overall Study|Adverse Event|17|||
44169652|NCT02384941|78963130|FG000|Overall Study|Lost to Follow-up|3|||
44169653|NCT02384941|78963131|FG001|Overall Study|Lost to Follow-up|2|||
44169654|NCT02384941|78963132|FG002|Overall Study|Lost to Follow-up|1|||
44169655|NCT02384941|78963130|FG000|Overall Study|Non-Compliance With Study Drug|2|||
44169656|NCT02384941|78963131|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44169657|NCT02384941|78963132|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44169658|NCT02384941|78963130|FG000|Overall Study|Physician Decision|1|||
44169659|NCT02384941|78963131|FG001|Overall Study|Physician Decision|1|||
44169660|NCT02384941|78963132|FG002|Overall Study|Physician Decision|0|||
44169661|NCT02384941|78963130|FG000|Overall Study|Protocol Violation|3|||
44169662|NCT02384941|78963131|FG001|Overall Study|Protocol Violation|0|||
44449507|NCT00117637|79458048|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
44449508|NCT00117637|79458047|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
44449509|NCT00117637|79458048|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
44449510|NCT00117637|79458047|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
44449511|NCT00117637|79458048|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
44449512|NCT00117637|79458047|FG000|Second Intervention (Period 2)|reason not reported|1|||
44449513|NCT00117637|79458048|FG001|Second Intervention (Period 2)|reason not reported|0|||
44169663|NCT02384941|78963132|FG002|Overall Study|Protocol Violation|0|||
44169664|NCT02384941|78963130|FG000|Overall Study|Withdrawal by Subject|26|||
44169665|NCT02384941|78963131|FG001|Overall Study|Withdrawal by Subject|19|||
44169666|NCT02384941|78963132|FG002|Overall Study|Withdrawal by Subject|20|||
44169667|NCT02384941|78963130|FG000|Overall Study|Pregnancy|0|||
44449514|NCT00690755|79458068|FG000|Overall Study|Physician Decision|2|||
44169668|NCT02384941|78963131|FG001|Overall Study|Pregnancy|0|||
44169669|NCT02384941|78963132|FG002|Overall Study|Pregnancy|1|||
44169670|NCT02384941|78963130|FG000|Overall Study|Other than specified above|4|||
44169671|NCT02384941|78963131|FG001|Overall Study|Other than specified above|0|||
44169672|NCT02384941|78963132|FG002|Overall Study|Other than specified above|1|||
44169673|NCT02384395|78963141|FG000|Overall Study|Physician Decision|4|||
44169674|NCT02384395|78963141|FG000|Overall Study|Withdrawal by Subject|3|||
44449515|NCT00690755|79458069|FG001|Overall Study|Physician Decision|0|||
44169675|NCT02384395|78963141|FG000|Overall Study|Lost to Follow-up|3|||
44169676|NCT02420353|78963147|FG000|Overall Study|Withdrawal by Subject|0|||
44169677|NCT02420353|78963148|FG001|Overall Study|Withdrawal by Subject|1|||
44169678|NCT02391337|78963156|FG000|6 Months Follow-up|Death|5|||
44169679|NCT02391337|78963157|FG001|6 Months Follow-up|Death|4|||
44169680|NCT02391337|78963156|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
44169681|NCT02391337|78963157|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
44169682|NCT02391337|78963156|FG000|12 Months Follow-up|Death|2|||
44169683|NCT02391337|78963157|FG001|12 Months Follow-up|Death|0|||
44169684|NCT02391337|78963156|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
44169685|NCT02391337|78963157|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
44169686|NCT02391337|78963156|FG000|12 Months Follow-up|Lost to Follow-up|0|||
44169687|NCT02391337|78963157|FG001|12 Months Follow-up|Lost to Follow-up|2|||
44169688|NCT02382991|78963165|FG000|Overall Study|Adverse Event|1|||
44169689|NCT02382991|78963166|FG001|Overall Study|Adverse Event|2|||
44169690|NCT02382991|78963165|FG000|Overall Study|Lost to Follow-up|1|||
44169691|NCT02382991|78963166|FG001|Overall Study|Lost to Follow-up|0|||
44169692|NCT02382991|78963165|FG000|Overall Study|Withdrawal by Subject|0|||
44169693|NCT02382991|78963166|FG001|Overall Study|Withdrawal by Subject|1|||
44169694|NCT02390557|78963174|FG000|Wave 2|Survey non-respondent|72|||
44169695|NCT02390557|78963175|FG001|Wave 2|Survey non-respondent|41|||
44169696|NCT02390557|78963176|FG002|Wave 2|Survey non-respondent|23|||
44169697|NCT01649791|78963184|FG000|Overall Study|Disease Progression|2|||
44169698|NCT01649791|78963184|FG000|Overall Study|Adverse Event|1|||
44169699|NCT01649557|78963191|FG000|Overall Study|Lost to Follow-up|5|||
44169700|NCT01649557|78963192|FG001|Overall Study|Lost to Follow-up|0|||
44169701|NCT01649557|78963193|FG002|Overall Study|Lost to Follow-up|3|||
44169702|NCT01649557|78963191|FG000|Overall Study|Adverse Event|7|||
44169703|NCT01649557|78963192|FG001|Overall Study|Adverse Event|5|||
44169704|NCT01649557|78963193|FG002|Overall Study|Adverse Event|1|||
44169705|NCT01649557|78963191|FG000|Overall Study|Met withdrawal criteria|4|||
44169706|NCT01649557|78963192|FG001|Overall Study|Met withdrawal criteria|0|||
44169707|NCT01649557|78963193|FG002|Overall Study|Met withdrawal criteria|0|||
44169708|NCT01649557|78963191|FG000|Overall Study|Physician Decision|8|||
44169709|NCT01649557|78963192|FG001|Overall Study|Physician Decision|2|||
44169710|NCT01649557|78963193|FG002|Overall Study|Physician Decision|1|||
44169711|NCT01649557|78963191|FG000|Overall Study|Withdrawal by Subject|15|||
44169712|NCT01649557|78963192|FG001|Overall Study|Withdrawal by Subject|5|||
44169713|NCT01649557|78963193|FG002|Overall Study|Withdrawal by Subject|4|||
44169714|NCT01649557|78963191|FG000|Overall Study|Protocol deviation|0|||
44449516|NCT00690755|79458070|FG002|Overall Study|Physician Decision|46|||
44449517|NCT00690755|79458071|FG003|Overall Study|Physician Decision|5|||
44449518|NCT00690755|79458072|FG004|Overall Study|Physician Decision|0|||
44449519|NCT00690755|79458073|FG005|Overall Study|Physician Decision|4|||
44449520|NCT00690755|79458074|FG006|Overall Study|Physician Decision|0|||
44449521|NCT00549302|79458092|FG000|Double-Blind|Death|2|||
44449522|NCT00549302|79458093|FG001|Double-Blind|Death|9|||
44449523|NCT00549302|79458094|FG002|Double-Blind|Death|0|||
44449524|NCT00549302|79458092|FG000|Double-Blind|Adverse Event|3|||
44449525|NCT00549302|79458093|FG001|Double-Blind|Adverse Event|16|||
44449526|NCT00549302|79458094|FG002|Double-Blind|Adverse Event|0|||
44449527|NCT00549302|79458092|FG000|Double-Blind|Withdrawal by Subject|3|||
44449528|NCT00549302|79458093|FG001|Double-Blind|Withdrawal by Subject|8|||
44449529|NCT00549302|79458094|FG002|Double-Blind|Withdrawal by Subject|0|||
44449530|NCT00549302|79458092|FG000|Double-Blind|Investigator Decision|1|||
44449531|NCT00549302|79458093|FG001|Double-Blind|Investigator Decision|5|||
44449532|NCT00549302|79458094|FG002|Double-Blind|Investigator Decision|0|||
44449533|NCT00549302|79458092|FG000|Double-Blind|Sponsor Decision|0|||
44449534|NCT00549302|79458093|FG001|Double-Blind|Sponsor Decision|1|||
44449535|NCT00549302|79458094|FG002|Double-Blind|Sponsor Decision|0|||
44449536|NCT00549302|79458092|FG000|Double-Blind|Lost to Follow-up|1|||
44449537|NCT00549302|79458093|FG001|Double-Blind|Lost to Follow-up|2|||
44449538|NCT00549302|79458094|FG002|Double-Blind|Lost to Follow-up|0|||
44449539|NCT00549302|79458092|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
44449540|NCT00549302|79458093|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
44169715|NCT01649557|78963192|FG001|Overall Study|Protocol deviation|2|||
44169716|NCT01649557|78963193|FG002|Overall Study|Protocol deviation|0|||
44169717|NCT01649557|78963191|FG000|Overall Study|Lack of Efficacy|5|||
44169718|NCT01649557|78963192|FG001|Overall Study|Lack of Efficacy|0|||
44169719|NCT01649557|78963193|FG002|Overall Study|Lack of Efficacy|0|||
44169720|NCT02390245|78963201|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
44169721|NCT02390245|78963202|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
44449541|NCT00549302|79458094|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
44449542|NCT00549302|79458092|FG000|Double-Blind|New condition or starts new therapy|0|||
44449543|NCT00549302|79458093|FG001|Double-Blind|New condition or starts new therapy|2|||
44449544|NCT00549302|79458094|FG002|Double-Blind|New condition or starts new therapy|0|||
44449545|NCT00549302|79458092|FG000|Open-Label|Adverse Event|0|||
44169722|NCT02390245|78963203|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
44169723|NCT02390245|78963201|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
44449546|NCT00549302|79458093|FG001|Open-Label|Adverse Event|0|||
44449547|NCT00549302|79458094|FG002|Open-Label|Adverse Event|11|||
44169724|NCT02390245|78963202|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
44169725|NCT02390245|78963203|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
44169726|NCT02390167|78963212|FG000|Overall Study|Lost to Follow-up|1|||
44169727|NCT02347657|78963222|FG000|Overall Study|Physician Decision|0|||
44169728|NCT02347657|78963223|FG001|Overall Study|Physician Decision|1|||
44169729|NCT02347657|78963222|FG000|Overall Study|Adverse Event|8|||
44169730|NCT02347657|78963223|FG001|Overall Study|Adverse Event|4|||
44169731|NCT02347657|78963222|FG000|Overall Study|Withdrawal by Subject|6|||
44169732|NCT02347657|78963223|FG001|Overall Study|Withdrawal by Subject|7|||
44169733|NCT02347657|78963222|FG000|Overall Study|Randomized but not treated|1|||
44169734|NCT02347657|78963223|FG001|Overall Study|Randomized but not treated|0|||
44169735|NCT02347657|78963222|FG000|Overall Study|Other|3|||
44169736|NCT02347657|78963223|FG001|Overall Study|Other|3|||
44169737|NCT02347189|78963230|FG000|Overall Study|No implant attempted of study device|9|||
44169738|NCT02347189|78963230|FG000|Overall Study|No primary outcome data available|2|||
44169739|NCT02382133|78963245|FG000|Overall Study|Death|22|||
44169740|NCT02382133|78963245|FG000|Overall Study|transfer out of ICU|4|||
44169741|NCT02382133|78963245|FG000|Overall Study|Physician Decision|2|||
44169742|NCT02382133|78963245|FG000|Overall Study|arterial catheter loss|4|||
44169743|NCT02382133|78963245|FG000|Overall Study|pressure injury both sites|1|||
44169744|NCT02346877|78963251|FG000|Overall Study|Adverse Event|1|||
44169745|NCT02346877|78963252|FG001|Overall Study|Adverse Event|0|||
44169746|NCT02346877|78963251|FG000|Overall Study|Administrative Decision|1|||
44169747|NCT02346877|78963252|FG001|Overall Study|Administrative Decision|0|||
44169748|NCT02346877|78963251|FG000|Overall Study|Sponsor Decision|12|||
44169749|NCT02346877|78963252|FG001|Overall Study|Sponsor Decision|0|||
44169750|NCT02346877|78963251|FG000|Overall Study|Missing|5|||
44169751|NCT02346877|78963252|FG001|Overall Study|Missing|0|||
44169752|NCT02346721|78963258|FG000|Overall Study|Withdrew Consent|3|||
44169753|NCT02346721|78963258|FG000|Overall Study|Lack of Efficacy|1|||
44169754|NCT02389621|78963266|FG000|Treatment Period|Withdrawal by Subject|1|||
44169755|NCT02389621|78963267|FG001|Treatment Period|Withdrawal by Subject|1|||
44169756|NCT02389621|78963266|FG000|Posttreatment Period|Adverse Event|3|||
44169757|NCT02389621|78963267|FG001|Posttreatment Period|Adverse Event|1|||
44169758|NCT02389621|78963266|FG000|Posttreatment Period|Withdrawal by Subject|3|||
44169759|NCT02389621|78963267|FG001|Posttreatment Period|Withdrawal by Subject|2|||
44169760|NCT02389621|78963266|FG000|Posttreatment Period|Lost to Follow-up|1|||
44169761|NCT02389621|78963267|FG001|Posttreatment Period|Lost to Follow-up|1|||
44169762|NCT02389621|78963266|FG000|Posttreatment Period|Other - Miscellaneous|2|||
44169763|NCT02389621|78963267|FG001|Posttreatment Period|Other - Miscellaneous|0|||
44169764|NCT02388997|78963279|FG000|Overall Study|Adverse Event|1|||
44169765|NCT02388997|78963280|FG001|Overall Study|Adverse Event|2|||
44169766|NCT02388997|78963279|FG000|Overall Study|Withdrawal by Subject|2|||
44169767|NCT02388997|78963280|FG001|Overall Study|Withdrawal by Subject|1|||
44169768|NCT02388997|78963279|FG000|Overall Study|Lung function exclusion criteria|0|||
44169769|NCT02388997|78963280|FG001|Overall Study|Lung function exclusion criteria|2|||
44169770|NCT02388997|78963279|FG000|Overall Study|Tested positive for virus during run-in|0|||
44169771|NCT02388997|78963280|FG001|Overall Study|Tested positive for virus during run-in|1|||
44169772|NCT02388763|78963286|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
44169773|NCT02388763|78963287|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
44169774|NCT02388763|78963286|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
44169775|NCT02388763|78963287|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
44169776|NCT02388295|78963299|FG000|Dose Escalation Week 1|Adverse Event|1|||
44169777|NCT02388295|78963300|FG001|Dose Escalation Week 1|Adverse Event|2|||
44169778|NCT02388295|78963301|FG002|Dose Escalation Week 1|Adverse Event|1|||
44169779|NCT02388295|78963299|FG000|Dose Escalation Week 1|Determined not eligible|1|||
44169780|NCT02388295|78963300|FG001|Dose Escalation Week 1|Determined not eligible|1|||
44169781|NCT02388295|78963301|FG002|Dose Escalation Week 1|Determined not eligible|1|||
44169782|NCT02388295|78963299|FG000|Dose Escalation Week 2|Protocol Violation|0|||
44169783|NCT02388295|78963300|FG001|Dose Escalation Week 2|Protocol Violation|1|||
44169784|NCT02388295|78963301|FG002|Dose Escalation Week 2|Protocol Violation|0|||
44169785|NCT02388295|78963299|FG000|Dose Escalation Week 2|Determined not eligible|1|||
44169786|NCT02388295|78963300|FG001|Dose Escalation Week 2|Determined not eligible|1|||
44169787|NCT02388295|78963301|FG002|Dose Escalation Week 2|Determined not eligible|1|||
44169788|NCT02388295|78963299|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
44169789|NCT02388295|78963300|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
44169790|NCT02388295|78963301|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
44169791|NCT02345161|78963311|FG000|Overall Study|Withdrawal by Subject|25|||
44449548|NCT00549302|79458092|FG000|Open-Label|Death|0|||
44169792|NCT02345161|78963312|FG001|Overall Study|Withdrawal by Subject|33|||
44169793|NCT02345161|78963311|FG000|Overall Study|Adverse Event|16|||
44449549|NCT00549302|79458093|FG001|Open-Label|Death|0|||
44449550|NCT00549302|79458094|FG002|Open-Label|Death|40|||
44449551|NCT00549302|79458092|FG000|Open-Label|Investigator Decision|0|||
44169794|NCT02345161|78963312|FG001|Overall Study|Adverse Event|19|||
44169795|NCT02345161|78963311|FG000|Overall Study|Physician Decision|4|||
44169796|NCT02345161|78963312|FG001|Overall Study|Physician Decision|4|||
44169797|NCT02345161|78963311|FG000|Overall Study|Lost to Follow-up|0|||
44169798|NCT02345161|78963312|FG001|Overall Study|Lost to Follow-up|1|||
44169799|NCT02251275|78963328|FG000|Overall Study|Adverse Event|23|||
44169800|NCT02251275|78963329|FG001|Overall Study|Adverse Event|60|||
44169801|NCT02251275|78963330|FG002|Overall Study|Adverse Event|28|||
44169802|NCT02251275|78963331|FG003|Overall Study|Adverse Event|0|||
44169803|NCT02251275|78963332|FG004|Overall Study|Adverse Event|0|||
44169804|NCT02251275|78963328|FG000|Overall Study|Lost to Follow-up|5|||
44169805|NCT02251275|78963329|FG001|Overall Study|Lost to Follow-up|6|||
44169806|NCT02251275|78963330|FG002|Overall Study|Lost to Follow-up|4|||
44169807|NCT02251275|78963331|FG003|Overall Study|Lost to Follow-up|0|||
44169808|NCT02251275|78963332|FG004|Overall Study|Lost to Follow-up|0|||
44169809|NCT02251275|78963328|FG000|Overall Study|Physician Decision|19|||
44169810|NCT02251275|78963329|FG001|Overall Study|Physician Decision|30|||
44169811|NCT02251275|78963330|FG002|Overall Study|Physician Decision|26|||
44169812|NCT02251275|78963331|FG003|Overall Study|Physician Decision|0|||
44169813|NCT02251275|78963332|FG004|Overall Study|Physician Decision|1|||
44169814|NCT02251275|78963328|FG000|Overall Study|Protocol Deviation|0|||
44169815|NCT02251275|78963329|FG001|Overall Study|Protocol Deviation|0|||
44169816|NCT02251275|78963330|FG002|Overall Study|Protocol Deviation|1|||
44169817|NCT02251275|78963331|FG003|Overall Study|Protocol Deviation|0|||
44169818|NCT02251275|78963332|FG004|Overall Study|Protocol Deviation|0|||
44169819|NCT02251275|78963328|FG000|Overall Study|Withdrawal by Subject|25|||
44169820|NCT02251275|78963329|FG001|Overall Study|Withdrawal by Subject|51|||
44169821|NCT02251275|78963330|FG002|Overall Study|Withdrawal by Subject|35|||
44169822|NCT02251275|78963331|FG003|Overall Study|Withdrawal by Subject|1|||
44169823|NCT02251275|78963332|FG004|Overall Study|Withdrawal by Subject|0|||
44169824|NCT02379637|78963346|FG000|Overall Study|Protocol Violation|0|||
44169825|NCT02379637|78963347|FG001|Overall Study|Protocol Violation|1|||
44169826|NCT02379637|78963346|FG000|Overall Study|Adverse Event|1|||
44169827|NCT02379637|78963347|FG001|Overall Study|Adverse Event|0|||
44169828|NCT02379637|78963346|FG000|Overall Study|Withdrawal by Subject|1|||
44169829|NCT02379637|78963347|FG001|Overall Study|Withdrawal by Subject|0|||
44169830|NCT02195583|78963353|FG000|Overall Study|Lost to Follow-up|1|||
44169831|NCT02195583|78963353|FG000|Overall Study|Withdrawal by Subject|4|||
44169832|NCT02195583|78963353|FG000|Overall Study|Adverse Event|2|||
44169833|NCT02195583|78963353|FG000|Overall Study|Other Reason|2|||
44169834|NCT02379091|78963372|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44169835|NCT02379091|78963373|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
44169836|NCT02379091|78963374|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44169837|NCT02379091|78963375|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
44169838|NCT02379091|78963372|FG000|Overall Study|Principal Investigator Discretion|0|||
44169839|NCT02379091|78963373|FG001|Overall Study|Principal Investigator Discretion|1|||
44169840|NCT02379091|78963374|FG002|Overall Study|Principal Investigator Discretion|0|||
44169841|NCT02379091|78963375|FG003|Overall Study|Principal Investigator Discretion|0|||
44169842|NCT02379091|78963372|FG000|Overall Study|Lost to Follow-up|0|||
44169843|NCT02379091|78963373|FG001|Overall Study|Lost to Follow-up|0|||
44169844|NCT02379091|78963374|FG002|Overall Study|Lost to Follow-up|0|||
44169845|NCT02379091|78963375|FG003|Overall Study|Lost to Follow-up|1|||
44169846|NCT02379091|78963372|FG000|Overall Study|Voluntary Withdrawal|2|||
44169847|NCT02379091|78963373|FG001|Overall Study|Voluntary Withdrawal|5|||
44169848|NCT02379091|78963374|FG002|Overall Study|Voluntary Withdrawal|2|||
44169849|NCT02379091|78963375|FG003|Overall Study|Voluntary Withdrawal|4|||
44169850|NCT02379091|78963372|FG000|Overall Study|Study Termination|7|||
44169851|NCT02379091|78963373|FG001|Overall Study|Study Termination|2|||
44169852|NCT02379091|78963374|FG002|Overall Study|Study Termination|5|||
44169853|NCT02379091|78963375|FG003|Overall Study|Study Termination|8|||
44169854|NCT02379091|78963372|FG000|Overall Study|Lack of Efficacy|3|||
44169855|NCT02379091|78963373|FG001|Overall Study|Lack of Efficacy|0|||
44449552|NCT00549302|79458093|FG001|Open-Label|Investigator Decision|0|||
44449553|NCT00549302|79458094|FG002|Open-Label|Investigator Decision|5|||
44449554|NCT00549302|79458092|FG000|Open-Label|Lost to Follow-up|0|||
44449555|NCT00549302|79458093|FG001|Open-Label|Lost to Follow-up|0|||
44449556|NCT00549302|79458094|FG002|Open-Label|Lost to Follow-up|2|||
44169856|NCT02379091|78963374|FG002|Overall Study|Lack of Efficacy|0|||
44169857|NCT02379091|78963375|FG003|Overall Study|Lack of Efficacy|0|||
44169858|NCT02378935|78963394|FG000|Overall Study|Lack of Efficacy|10|||
44169859|NCT02378935|78963395|FG001|Overall Study|Lack of Efficacy|0|||
44169860|NCT02378935|78963396|FG002|Overall Study|Lack of Efficacy|2|||
44169861|NCT02378935|78963397|FG003|Overall Study|Lack of Efficacy|6|||
44169862|NCT02378935|78963398|FG004|Overall Study|Lack of Efficacy|0|||
44169863|NCT02378935|78963399|FG005|Overall Study|Lack of Efficacy|0|||
44169864|NCT02378935|78963400|FG006|Overall Study|Lack of Efficacy|0|||
44169865|NCT02378935|78963394|FG000|Overall Study|Death|0|||
44169866|NCT02378935|78963395|FG001|Overall Study|Death|0|||
44449557|NCT00549302|79458092|FG000|Open-Label|Other|0|||
44449558|NCT00549302|79458093|FG001|Open-Label|Other|0|||
44449559|NCT00549302|79458094|FG002|Open-Label|Other|3|||
44449560|NCT00549302|79458092|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
44449561|NCT00549302|79458093|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
44449562|NCT00549302|79458094|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
44449563|NCT00549302|79458092|FG000|Open-Label|Withdrawal by Subject|0|||
44449564|NCT00549302|79458093|FG001|Open-Label|Withdrawal by Subject|0|||
44449565|NCT00549302|79458094|FG002|Open-Label|Withdrawal by Subject|6|||
44449566|NCT00117325|79458104|FG000|Overall Study|Adverse Event|3|||
44449567|NCT00117325|79458105|FG001|Overall Study|Adverse Event|3|||
44449568|NCT00117325|79458104|FG000|Overall Study|Lost to Follow-up|1|||
44449569|NCT00117325|79458105|FG001|Overall Study|Lost to Follow-up|1|||
44449570|NCT00117325|79458104|FG000|Overall Study|Protocol Violation|2|||
44449571|NCT00117325|79458105|FG001|Overall Study|Protocol Violation|3|||
44449572|NCT00117325|79458104|FG000|Overall Study|Withdrawal by Subject|3|||
44449573|NCT00117325|79458105|FG001|Overall Study|Withdrawal by Subject|2|||
44449574|NCT00117325|79458104|FG000|Overall Study|Lack of Efficacy|1|||
44449575|NCT00117325|79458105|FG001|Overall Study|Lack of Efficacy|0|||
44449576|NCT00117325|79458104|FG000|Overall Study|Use of prohibited medicine|1|||
44449577|NCT00117325|79458105|FG001|Overall Study|Use of prohibited medicine|2|||
44449578|NCT00117325|79458104|FG000|Overall Study|Early termination|1|||
44449579|NCT00117325|79458105|FG001|Overall Study|Early termination|1|||
44449580|NCT00117325|79458104|FG000|Overall Study|Admisnitrative|1|||
44449581|NCT00117325|79458105|FG001|Overall Study|Admisnitrative|0|||
44449582|NCT00108433|79458114|FG000|Overall Study|Lack of Efficacy|1|||
44449583|NCT00108433|79458115|FG001|Overall Study|Lack of Efficacy|2|||
44449584|NCT00108433|79458114|FG000|Overall Study|Death|3|||
44449585|NCT00108433|79458115|FG001|Overall Study|Death|0|||
44449586|NCT00108433|79458114|FG000|Overall Study|Adverse Event|3|||
44449587|NCT00108433|79458115|FG001|Overall Study|Adverse Event|1|||
44449588|NCT00108433|79458114|FG000|Overall Study|Other|14|||
44449589|NCT00108433|79458115|FG001|Overall Study|Other|14|||
44449590|NCT00116779|79458123|FG000|Overall Study|Adverse Event|4|||
44449591|NCT00116779|79458124|FG001|Overall Study|Adverse Event|2|||
44449592|NCT00116779|79458123|FG000|Overall Study|Protocol Violation|1|||
44449593|NCT00116779|79458124|FG001|Overall Study|Protocol Violation|4|||
44449594|NCT00116779|79458123|FG000|Overall Study|Withdrawal by Subject|4|||
44449595|NCT00116779|79458124|FG001|Overall Study|Withdrawal by Subject|1|||
44449596|NCT00116779|79458123|FG000|Overall Study|Inadequate testosterone suppression|7|||
44449597|NCT00116779|79458124|FG001|Overall Study|Inadequate testosterone suppression|9|||
44169867|NCT02378935|78963396|FG002|Overall Study|Death|1|||
44169868|NCT02378935|78963397|FG003|Overall Study|Death|0|||
44169869|NCT02378935|78963398|FG004|Overall Study|Death|0|||
44169870|NCT02378935|78963399|FG005|Overall Study|Death|0|||
44169871|NCT02378935|78963400|FG006|Overall Study|Death|0|||
44169872|NCT02250651|78963419|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
44169873|NCT02250651|78963420|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
44169874|NCT02250651|78963421|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
44169875|NCT02250651|78963419|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
44169876|NCT02250651|78963420|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
44169877|NCT02250651|78963421|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
44169878|NCT02250651|78963419|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
44169879|NCT02250651|78963420|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
44169880|NCT02250651|78963421|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
44169881|NCT02250651|78963419|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
44169882|NCT02250651|78963420|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
44169883|NCT02250651|78963421|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
44169884|NCT02250651|78963419|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
44169885|NCT02250651|78963420|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
44169886|NCT02250651|78963421|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
44169887|NCT02250651|78963419|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
44169888|NCT02250651|78963420|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
44449598|NCT00116779|79458123|FG000|Overall Study|Physician Decision|3|||
44449599|NCT00116779|79458124|FG001|Overall Study|Physician Decision|1|||
44449600|NCT00116779|79458123|FG000|Overall Study|Elevated PSA levels|2|||
44449601|NCT00116779|79458124|FG001|Overall Study|Elevated PSA levels|2|||
44449602|NCT03943290|79458139|FG000|Overall Study|Sponsor Terminated Study|6|||
44169889|NCT02250651|78963421|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
44449603|NCT03943290|79458140|FG001|Overall Study|Sponsor Terminated Study|1|||
44449604|NCT03943290|79458141|FG002|Overall Study|Sponsor Terminated Study|11|||
44449605|NCT03943290|79458142|FG003|Overall Study|Sponsor Terminated Study|6|||
44449606|NCT03943290|79458143|FG004|Overall Study|Sponsor Terminated Study|7|||
44449607|NCT03943290|79458144|FG005|Overall Study|Sponsor Terminated Study|6|||
44449608|NCT03943290|79458145|FG006|Overall Study|Sponsor Terminated Study|6|||
44449609|NCT03943290|79458146|FG007|Overall Study|Sponsor Terminated Study|7|||
44169890|NCT02250651|78963419|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
44169891|NCT02250651|78963420|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
44169892|NCT02250651|78963421|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
44169893|NCT02250651|78963419|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
44169894|NCT02250651|78963420|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
44169895|NCT02250651|78963421|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
44169896|NCT02250651|78963419|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
44169897|NCT02250651|78963420|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
44169898|NCT02250651|78963421|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
44169899|NCT02250651|78963419|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
44169900|NCT02250651|78963420|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
44169901|NCT02250651|78963421|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
44169902|NCT02250651|78963419|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
44169903|NCT02250651|78963420|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
44169904|NCT02250651|78963421|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
44169905|NCT02250651|78963419|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
44169906|NCT02250651|78963420|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
44169907|NCT02250651|78963421|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
44169908|NCT02250651|78963419|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
44169909|NCT02250651|78963420|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
44169910|NCT02250651|78963421|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
44169911|NCT02250651|78963419|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
44169912|NCT02250651|78963420|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
44169913|NCT02250651|78963421|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
44169914|NCT02250651|78963419|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
44169915|NCT02250651|78963420|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
44169916|NCT02250651|78963421|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
44169917|NCT02377921|78963431|FG000|Overall Study|Subject non-compliance|1|||
44169918|NCT02377921|78963432|FG001|Overall Study|Subject non-compliance|1|||
44169919|NCT02311153|78963440|FG000|Overall Study|Lost to Follow-up|5|||
44169920|NCT02311153|78963441|FG001|Overall Study|Lost to Follow-up|7|||
44169921|NCT02195427|78963449|FG000|Overall Study|Did not consent to study extension|13|||
44169922|NCT02195427|78963450|FG001|Overall Study|Did not consent to study extension|9|||
44169923|NCT02195427|78963449|FG000|Overall Study|Withdrawal by Subject|4|||
44169924|NCT02195427|78963450|FG001|Overall Study|Withdrawal by Subject|2|||
44169925|NCT02195427|78963449|FG000|Overall Study|Lost to Follow-up|0|||
44169926|NCT02195427|78963450|FG001|Overall Study|Lost to Follow-up|1|||
44169927|NCT02195427|78963449|FG000|Overall Study|Protocol Violation|7|||
44169928|NCT02195427|78963450|FG001|Overall Study|Protocol Violation|14|||
44169929|NCT02195427|78963449|FG000|Overall Study|Conditional re-treatment at W52|2|||
44169930|NCT02195427|78963450|FG001|Overall Study|Conditional re-treatment at W52|1|||
44169931|NCT02214225|78963463|FG000|Overall Study|Lost to Follow-up|46|||
44169932|NCT02214225|78963464|FG001|Overall Study|Lost to Follow-up|18|||
44169933|NCT02214225|78963465|FG002|Overall Study|Lost to Follow-up|18|||
44169934|NCT02214225|78963463|FG000|Overall Study|Withdrawal by Subject|2|||
44169935|NCT02214225|78963464|FG001|Overall Study|Withdrawal by Subject|0|||
44169936|NCT02214225|78963465|FG002|Overall Study|Withdrawal by Subject|2|||
44169937|NCT02214225|78963463|FG000|Overall Study|Death|5|||
44169938|NCT02214225|78963464|FG001|Overall Study|Death|0|||
44169939|NCT02214225|78963465|FG002|Overall Study|Death|1|||
44169940|NCT02214225|78963463|FG000|Overall Study|randomized in error, not vaccinated|2|||
44169941|NCT02214225|78963464|FG001|Overall Study|randomized in error, not vaccinated|1|||
44169942|NCT02214225|78963465|FG002|Overall Study|randomized in error, not vaccinated|1|||
44169943|NCT02250183|78963496|FG000|Overall Study|Withdrawal by Subject|2|||
44169944|NCT02250183|78963496|FG000|Overall Study|Adverse Event|5|||
44169945|NCT02250183|78963496|FG000|Overall Study|Lost to Follow-up|1|||
44169946|NCT02249949|78963503|FG000|Overall Study|Cancelled prior to treatment|2|||
44449610|NCT03943290|79458147|FG008|Overall Study|Sponsor Terminated Study|8|||
44449611|NCT03943290|79458139|FG000|Overall Study|Lost to Follow-up|1|||
44449612|NCT03943290|79458140|FG001|Overall Study|Lost to Follow-up|0|||
44449613|NCT03943290|79458141|FG002|Overall Study|Lost to Follow-up|1|||
44449614|NCT03943290|79458142|FG003|Overall Study|Lost to Follow-up|0|||
44449615|NCT03943290|79458143|FG004|Overall Study|Lost to Follow-up|0|||
44449616|NCT03943290|79458144|FG005|Overall Study|Lost to Follow-up|0|||
44169947|NCT02249091|78963509|FG000|Overall Study|Lack of Efficacy|8|||
44169948|NCT02249091|78963510|FG001|Overall Study|Lack of Efficacy|3|||
44169949|NCT02249091|78963509|FG000|Overall Study|Physician Decision|4|||
44169950|NCT02249091|78963510|FG001|Overall Study|Physician Decision|1|||
44169951|NCT02249091|78963509|FG000|Overall Study|Withdrawal by Subject|2|||
44169952|NCT02249091|78963510|FG001|Overall Study|Withdrawal by Subject|2|||
44449617|NCT03943290|79458145|FG006|Overall Study|Lost to Follow-up|0|||
44449618|NCT03943290|79458146|FG007|Overall Study|Lost to Follow-up|1|||
44169953|NCT02249091|78963509|FG000|Overall Study|Death|3|||
44449619|NCT03943290|79458147|FG008|Overall Study|Lost to Follow-up|0|||
44449620|NCT03943290|79458139|FG000|Overall Study|Withdrawal by Subject|0|||
44449621|NCT03943290|79458140|FG001|Overall Study|Withdrawal by Subject|0|||
44449622|NCT03943290|79458141|FG002|Overall Study|Withdrawal by Subject|1|||
44449623|NCT03943290|79458142|FG003|Overall Study|Withdrawal by Subject|0|||
44449624|NCT03943290|79458143|FG004|Overall Study|Withdrawal by Subject|0|||
44449625|NCT03943290|79458144|FG005|Overall Study|Withdrawal by Subject|0|||
44449626|NCT03943290|79458145|FG006|Overall Study|Withdrawal by Subject|0|||
44449627|NCT03943290|79458146|FG007|Overall Study|Withdrawal by Subject|0|||
44449628|NCT03943290|79458147|FG008|Overall Study|Withdrawal by Subject|0|||
44449629|NCT00108355|79458182|FG000|Overall Study|Peritonitis at index paracentesis|1|||
44449630|NCT00108355|79458183|FG001|Overall Study|Peritonitis at index paracentesis|1|||
44449631|NCT00108355|79458182|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
44449632|NCT00108355|79458183|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
44449633|NCT00094861|79458204|FG000|Overall Study|Adverse Event|5|||
44449634|NCT00094861|79458205|FG001|Overall Study|Adverse Event|2|||
44169954|NCT02249091|78963510|FG001|Overall Study|Death|4|||
44169955|NCT02249091|78963509|FG000|Overall Study|Adverse Event|1|||
44169956|NCT02249091|78963510|FG001|Overall Study|Adverse Event|0|||
44169957|NCT02249091|78963509|FG000|Overall Study|Stable disease with following SCT|0|||
44169958|NCT02249091|78963510|FG001|Overall Study|Stable disease with following SCT|1|||
44169959|NCT02249091|78963509|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
44169960|NCT02249091|78963510|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
44169961|NCT02249091|78963509|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
44169962|NCT02249091|78963510|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
44169963|NCT02249091|78963509|FG000|Overall Study|Refractory AML|1|||
44169964|NCT02249091|78963510|FG001|Overall Study|Refractory AML|1|||
44169965|NCT02248857|78963519|FG000|3 Month|Withdrawal by Subject|9|||
44169966|NCT02248857|78963520|FG001|3 Month|Withdrawal by Subject|3|||
44169967|NCT02248857|78963521|FG002|3 Month|Withdrawal by Subject|4|||
44169968|NCT02248857|78963519|FG000|3 Month|Unable to reach for 3 month|35|||
44169969|NCT02248857|78963520|FG001|3 Month|Unable to reach for 3 month|29|||
44169970|NCT02248857|78963521|FG002|3 Month|Unable to reach for 3 month|26|||
44169971|NCT02248857|78963519|FG000|3 Month|Partially completed, unable to finish|2|||
44169972|NCT02248857|78963520|FG001|3 Month|Partially completed, unable to finish|2|||
44169973|NCT02248857|78963521|FG002|3 Month|Partially completed, unable to finish|1|||
44169974|NCT02248857|78963519|FG000|6 Month|Lost to Follow-up|27|||
44169975|NCT02248857|78963520|FG001|6 Month|Lost to Follow-up|26|||
44169976|NCT02248857|78963521|FG002|6 Month|Lost to Follow-up|15|||
44169977|NCT02248857|78963519|FG000|6 Month|Partially completed, unable to finish|0|||
44169978|NCT02248857|78963520|FG001|6 Month|Partially completed, unable to finish|1|||
44169979|NCT02248857|78963521|FG002|6 Month|Partially completed, unable to finish|0|||
44169980|NCT02248857|78963519|FG000|6 Month|Withdrawal by Subject|0|||
44169981|NCT02248857|78963520|FG001|6 Month|Withdrawal by Subject|2|||
44169982|NCT02248857|78963521|FG002|6 Month|Withdrawal by Subject|2|||
44169983|NCT02248857|78963519|FG000|6 Month|Death|1|||
44169984|NCT02248857|78963520|FG001|6 Month|Death|0|||
44169985|NCT02248857|78963521|FG002|6 Month|Death|0|||
44169986|NCT02213055|78963531|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
44169987|NCT02213055|78963532|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
44169988|NCT02213055|78963531|FG000|Overall Study|Protocol was not Followed during Study|1|||
44169989|NCT02213055|78963532|FG001|Overall Study|Protocol was not Followed during Study|0|||
44169990|NCT02213055|78963531|FG000|Overall Study|Documentation Issue at Enrollment|1|||
44449635|NCT00094861|79458204|FG000|Overall Study|Withdrawal by Subject|5|||
44449636|NCT00094861|79458205|FG001|Overall Study|Withdrawal by Subject|3|||
44449637|NCT00094861|79458204|FG000|Overall Study|Physician Decision|1|||
44449638|NCT00094861|79458205|FG001|Overall Study|Physician Decision|1|||
44449639|NCT00094861|79458204|FG000|Overall Study|Lost to Follow-up|0|||
44449640|NCT00094861|79458205|FG001|Overall Study|Lost to Follow-up|1|||
44449641|NCT00094861|79458204|FG000|Overall Study|Death|4|||
44449642|NCT00094861|79458205|FG001|Overall Study|Death|2|||
44169991|NCT02213055|78963532|FG001|Overall Study|Documentation Issue at Enrollment|0|||
44169992|NCT02213055|78963531|FG000|Overall Study|Documentation Issue during Study|10|||
44169993|NCT02213055|78963532|FG001|Overall Study|Documentation Issue during Study|0|||
44169994|NCT02213055|78963531|FG000|Overall Study|Did not have Live Lice|8|||
44169995|NCT02213055|78963532|FG001|Overall Study|Did not have Live Lice|0|||
44169996|NCT02213055|78963531|FG000|Overall Study|Had another Treatment during the Study|3|||
44169997|NCT02213055|78963532|FG001|Overall Study|Had another Treatment during the Study|0|||
44169998|NCT02213055|78963531|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
44169999|NCT02213055|78963532|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
44264188|NCT03155997|79164473|FG000|Overall Study|Withdrawal by Subject|119|||
44449643|NCT00094861|79458204|FG000|Overall Study|Other|3|||
44170000|NCT02213055|78963531|FG000|Overall Study|Did not Return to School|5|||
44264189|NCT03155997|79164474|FG001|Overall Study|Withdrawal by Subject|134|||
44170001|NCT02213055|78963532|FG001|Overall Study|Did not Return to School|0|||
44170002|NCT02310763|78963541|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
44170003|NCT02310763|78963542|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
44170004|NCT02310763|78963543|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
44170005|NCT02310763|78963541|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
44170006|NCT02310763|78963542|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
44170007|NCT02310763|78963543|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
44170008|NCT02310763|78963541|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
44170009|NCT02310763|78963542|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
44170010|NCT02310763|78963543|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
44170011|NCT02310763|78963541|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
44170012|NCT02310763|78963542|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
44170013|NCT02310763|78963543|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
44170014|NCT02310763|78963541|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
44170015|NCT02310763|78963542|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
44170016|NCT02310763|78963543|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
44170017|NCT02342743|78963569|FG000|Baseline Period|Withdrawal by Subject|3|||
44170018|NCT02342743|78963569|FG000|Baseline Period|Lost to Follow-up|2|||
44170019|NCT02342743|78963569|FG000|Baseline Period|Change in prophylactic medication|3|||
44170020|NCT02342743|78963569|FG000|Baseline Period|Screening failure regarding baseline|7|||
44170021|NCT02342743|78963569|FG000|Treatment Period|Withdrawal by Subject|2|||
44170022|NCT02342743|78963569|FG000|Treatment Period|Lost to Follow-up|8|||
44170023|NCT02342743|78963569|FG000|Treatment Period|Change in prophylactic medication|1|||
44170024|NCT02377063|78963573|FG000|Overall Study|Non-compliance|5|||
44170025|NCT02309515|78963579|FG000|Overall Study|Withdrawal by Subject|0|||
44170026|NCT02309515|78963580|FG001|Overall Study|Withdrawal by Subject|1|||
44170027|NCT02309359|78963591|FG000|Overall Study|Adverse Event|4|||
44170028|NCT02309359|78963592|FG001|Overall Study|Adverse Event|5|||
44170029|NCT02309359|78963593|FG002|Overall Study|Adverse Event|5|||
44170030|NCT02309359|78963594|FG003|Overall Study|Adverse Event|4|||
44170031|NCT02309359|78963595|FG004|Overall Study|Adverse Event|4|||
44170032|NCT02309359|78963591|FG000|Overall Study|Death|1|||
44170033|NCT02309359|78963592|FG001|Overall Study|Death|0|||
44170034|NCT02309359|78963593|FG002|Overall Study|Death|0|||
44170035|NCT02309359|78963594|FG003|Overall Study|Death|0|||
44170036|NCT02309359|78963595|FG004|Overall Study|Death|0|||
44170037|NCT02309359|78963591|FG000|Overall Study|Withdrawal by Subject|2|||
44170038|NCT02309359|78963592|FG001|Overall Study|Withdrawal by Subject|2|||
44170039|NCT02309359|78963593|FG002|Overall Study|Withdrawal by Subject|4|||
44170040|NCT02309359|78963594|FG003|Overall Study|Withdrawal by Subject|4|||
44170041|NCT02309359|78963595|FG004|Overall Study|Withdrawal by Subject|0|||
44170042|NCT02309359|78963591|FG000|Overall Study|Lack of Efficacy|3|||
44170043|NCT02309359|78963592|FG001|Overall Study|Lack of Efficacy|1|||
44170044|NCT02309359|78963593|FG002|Overall Study|Lack of Efficacy|0|||
44170045|NCT02309359|78963594|FG003|Overall Study|Lack of Efficacy|0|||
44170046|NCT02309359|78963595|FG004|Overall Study|Lack of Efficacy|3|||
44170047|NCT02309359|78963591|FG000|Overall Study|Lost to Follow-up|0|||
44170048|NCT02309359|78963592|FG001|Overall Study|Lost to Follow-up|0|||
44170049|NCT02309359|78963593|FG002|Overall Study|Lost to Follow-up|0|||
44170050|NCT02309359|78963594|FG003|Overall Study|Lost to Follow-up|1|||
44170051|NCT02309359|78963595|FG004|Overall Study|Lost to Follow-up|0|||
44170052|NCT02309359|78963591|FG000|Overall Study|Other|2|||
44170053|NCT02309359|78963592|FG001|Overall Study|Other|0|||
44170054|NCT02309359|78963593|FG002|Overall Study|Other|2|||
44170055|NCT02309359|78963594|FG003|Overall Study|Other|3|||
44170056|NCT02309359|78963595|FG004|Overall Study|Other|2|||
44170057|NCT02247531|78963611|FG000|Overall Study|Adverse Event|3|||
44170058|NCT02247531|78963612|FG001|Overall Study|Adverse Event|4|||
44170059|NCT02247531|78963613|FG002|Overall Study|Adverse Event|9|||
44170060|NCT02247531|78963611|FG000|Overall Study|Death|8|||
44170061|NCT02247531|78963612|FG001|Overall Study|Death|9|||
44170062|NCT02247531|78963613|FG002|Overall Study|Death|5|||
44170063|NCT02247531|78963611|FG000|Overall Study|Lost to Follow-up|1|||
44170064|NCT02247531|78963612|FG001|Overall Study|Lost to Follow-up|8|||
44170065|NCT02247531|78963613|FG002|Overall Study|Lost to Follow-up|3|||
44170066|NCT02247531|78963611|FG000|Overall Study|Non-compliance|2|||
44170067|NCT02247531|78963612|FG001|Overall Study|Non-compliance|2|||
44170068|NCT02247531|78963613|FG002|Overall Study|Non-compliance|0|||
44170069|NCT02247531|78963611|FG000|Overall Study|Withdrawal by Subject|26|||
44170070|NCT02247531|78963612|FG001|Overall Study|Withdrawal by Subject|31|||
44170071|NCT02247531|78963613|FG002|Overall Study|Withdrawal by Subject|25|||
44170072|NCT02247531|78963611|FG000|Overall Study|Study Terminated by Sponsor|64|||
44170073|NCT02247531|78963612|FG001|Overall Study|Study Terminated by Sponsor|66|||
44170074|NCT02247531|78963613|FG002|Overall Study|Study Terminated by Sponsor|62|||
44170075|NCT02247531|78963611|FG000|Overall Study|Physician Decision|0|||
44170076|NCT02247531|78963612|FG001|Overall Study|Physician Decision|2|||
44170077|NCT02247531|78963613|FG002|Overall Study|Physician Decision|2|||
44170078|NCT02247531|78963611|FG000|Overall Study|Unspecified Reason|2|||
44170079|NCT02247531|78963612|FG001|Overall Study|Unspecified Reason|3|||
44170080|NCT02247531|78963613|FG002|Overall Study|Unspecified Reason|4|||
44170081|NCT02375971|78963624|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
44170082|NCT02375971|78963625|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
44170083|NCT02375971|78963626|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
44170084|NCT02375971|78963624|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
44170085|NCT02375971|78963625|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
44170086|NCT02375971|78963626|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
44170087|NCT02375971|78963624|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
44170088|NCT02375971|78963625|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
44170089|NCT02375971|78963626|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
44170090|NCT02375971|78963624|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
44170091|NCT02375971|78963625|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
44170092|NCT02375971|78963626|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
44170093|NCT02375971|78963624|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
44170094|NCT02375971|78963625|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
44170095|NCT02375971|78963626|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
44170096|NCT02375971|78963624|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
44170097|NCT02375971|78963625|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
44170098|NCT02375971|78963626|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
44170099|NCT02375971|78963624|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
44170100|NCT02375971|78963625|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
44170101|NCT02375971|78963626|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
44170102|NCT02375971|78963624|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
44170103|NCT02375971|78963625|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
44170104|NCT02375971|78963626|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
44170105|NCT02308735|78963638|FG000|Overall Study|Physician Decision|2|||
44170106|NCT02308735|78963639|FG001|Overall Study|Physician Decision|0|||
44170107|NCT02308735|78963640|FG002|Overall Study|Physician Decision|0|||
44170108|NCT02308735|78963641|FG003|Overall Study|Physician Decision|2|||
44170109|NCT02212197|78963654|FG000|Overall Study|Need for radiotherapy|1|||
44170110|NCT02212197|78963655|FG001|Overall Study|Need for radiotherapy|0|||
44170111|NCT02212197|78963656|FG002|Overall Study|Need for radiotherapy|0|||
44170112|NCT02193165|78963667|FG000|4 Week Product Use|Lost to Follow-up|1|||
44170113|NCT02193165|78963668|FG001|4 Week Product Use|Lost to Follow-up|1|||
44170114|NCT02193165|78963669|FG002|4 Week Product Use|Lost to Follow-up|1|||
44170115|NCT02193165|78963667|FG000|6 Week Product Use|Lost to Follow-up|0|||
44170116|NCT02193165|78963668|FG001|6 Week Product Use|Lost to Follow-up|1|||
44170117|NCT02193165|78963669|FG002|6 Week Product Use|Lost to Follow-up|0|||
44170118|NCT01617460|78963677|FG000|Overall Study|Adverse Event|10|||
44170119|NCT01617460|78963677|FG000|Overall Study|Physician Decision|16|||
44170120|NCT01617460|78963677|FG000|Overall Study|Protocol Violation|5|||
44170121|NCT01617460|78963677|FG000|Overall Study|Withdrawal by Subject|9|||
44170122|NCT01890148|78963681|FG000|Overall Study|Adverse Event|1|||
44170123|NCT01889602|78963688|FG000|First Intervention|Adverse Event|1|||
44170124|NCT01889602|78963689|FG001|First Intervention|Adverse Event|1|||
44170125|NCT01889602|78963690|FG002|First Intervention|Adverse Event|1|||
44170126|NCT01889602|78963688|FG000|First Intervention|Protocol Violation|0|||
44170127|NCT01889602|78963689|FG001|First Intervention|Protocol Violation|1|||
44170128|NCT01889602|78963690|FG002|First Intervention|Protocol Violation|1|||
44170129|NCT01889602|78963688|FG000|First Intervention|Study ending|0|||
44170130|NCT01889602|78963689|FG001|First Intervention|Study ending|1|||
44170131|NCT01889602|78963690|FG002|First Intervention|Study ending|0|||
44170132|NCT01889602|78963688|FG000|Second Intervention|Adverse Event|0|||
44170133|NCT01889602|78963689|FG001|Second Intervention|Adverse Event|0|||
44170134|NCT01889602|78963690|FG002|Second Intervention|Adverse Event|1|||
44170135|NCT01889602|78963688|FG000|Second Intervention|Study ending|1|||
44170136|NCT01889602|78963689|FG001|Second Intervention|Study ending|0|||
44170137|NCT01889602|78963690|FG002|Second Intervention|Study ending|0|||
44170138|NCT01889602|78963688|FG000|Second Intervention|Withdrawal by Subject|0|||
44170139|NCT01889602|78963689|FG001|Second Intervention|Withdrawal by Subject|0|||
44170140|NCT01889602|78963690|FG002|Second Intervention|Withdrawal by Subject|1|||
44170141|NCT01889602|78963688|FG000|Third Intervention|Protocol Violation|1|||
44170142|NCT01889602|78963689|FG001|Third Intervention|Protocol Violation|0|||
44170143|NCT01889602|78963690|FG002|Third Intervention|Protocol Violation|0|||
44170144|NCT01889602|78963688|FG000|Third Intervention|Withdrawal by Subject|2|||
44170145|NCT01889602|78963689|FG001|Third Intervention|Withdrawal by Subject|2|||
44170146|NCT01889602|78963690|FG002|Third Intervention|Withdrawal by Subject|0|||
44170147|NCT01935700|78963708|FG000|Overall Study|Withdrawal by Subject|1|||
44170148|NCT01935700|78963709|FG001|Overall Study|Withdrawal by Subject|0|||
44449644|NCT00094861|79458205|FG001|Overall Study|Other|0|||
44170149|NCT01935700|78963708|FG000|Overall Study|Physician Decision|4|||
44170150|NCT01935700|78963709|FG001|Overall Study|Physician Decision|0|||
44170151|NCT01618162|78963719|FG000|Overall Study|Protocol Violation|13|||
44170152|NCT01618162|78963720|FG001|Overall Study|Protocol Violation|10|||
44170153|NCT01618162|78963719|FG000|Overall Study|Adverse Event|9|||
44170154|NCT01618162|78963720|FG001|Overall Study|Adverse Event|2|||
44170155|NCT01618162|78963719|FG000|Overall Study|Withdrawal Criteria|2|||
44170156|NCT01618162|78963720|FG001|Overall Study|Withdrawal Criteria|10|||
44170157|NCT01618162|78963719|FG000|Overall Study|Unclassified|14|||
44170158|NCT01618162|78963720|FG001|Overall Study|Unclassified|13|||
44170159|NCT02193087|78963730|FG000|Overall Study|Adverse Event|2|||
44170160|NCT02193087|78963731|FG001|Overall Study|Adverse Event|0|||
44170161|NCT02193087|78963732|FG002|Overall Study|Adverse Event|0|||
44170162|NCT02193087|78963733|FG003|Overall Study|Adverse Event|11|||
44170163|NCT02193087|78963730|FG000|Overall Study|Lost to Follow-up|14|||
44170164|NCT02193087|78963731|FG001|Overall Study|Lost to Follow-up|6|||
44170165|NCT02193087|78963732|FG002|Overall Study|Lost to Follow-up|4|||
44170166|NCT02193087|78963733|FG003|Overall Study|Lost to Follow-up|37|||
44170167|NCT02193087|78963730|FG000|Overall Study|Protocol Violation|2|||
44170168|NCT02193087|78963731|FG001|Overall Study|Protocol Violation|0|||
44170169|NCT02193087|78963732|FG002|Overall Study|Protocol Violation|1|||
44170170|NCT02193087|78963733|FG003|Overall Study|Protocol Violation|2|||
44170171|NCT02193087|78963730|FG000|Overall Study|Withdrawal by Subject|10|||
44170172|NCT02193087|78963731|FG001|Overall Study|Withdrawal by Subject|3|||
44170173|NCT02193087|78963732|FG002|Overall Study|Withdrawal by Subject|1|||
44170174|NCT02193087|78963733|FG003|Overall Study|Withdrawal by Subject|19|||
44170175|NCT02193087|78963730|FG000|Overall Study|Other Reason Not Specified|7|||
44170176|NCT02193087|78963731|FG001|Overall Study|Other Reason Not Specified|2|||
44170177|NCT02193087|78963732|FG002|Overall Study|Other Reason Not Specified|1|||
44170178|NCT02193087|78963733|FG003|Overall Study|Other Reason Not Specified|9|||
44170179|NCT02193087|78963730|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
44170180|NCT02193087|78963731|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
44170181|NCT02193087|78963732|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
44170182|NCT02193087|78963733|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
44170183|NCT01617070|78963750|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
44170184|NCT02341417|78963763|FG000|Overall Study|Withdrawal by Subject|0|||
44170185|NCT02341417|78963764|FG001|Overall Study|Withdrawal by Subject|2|||
44170186|NCT02341417|78963765|FG002|Overall Study|Withdrawal by Subject|0|||
44170187|NCT02341417|78963763|FG000|Overall Study|Decision by sponsor|2|||
44170188|NCT02341417|78963764|FG001|Overall Study|Decision by sponsor|0|||
44170189|NCT02341417|78963765|FG002|Overall Study|Decision by sponsor|0|||
44170190|NCT02341417|78963763|FG000|Overall Study|Death|0|||
44170191|NCT02341417|78963764|FG001|Overall Study|Death|0|||
44170192|NCT02341417|78963765|FG002|Overall Study|Death|1|||
44170193|NCT01888900|78963776|FG000|Overall Study|failed treatment|0|||
44170194|NCT01888900|78963777|FG001|Overall Study|failed treatment|2|||
44170195|NCT02340949|78963787|FG000|Overall Study|Adverse Event|4|||
44170196|NCT02340949|78963788|FG001|Overall Study|Adverse Event|2|||
44170197|NCT02340949|78963787|FG000|Overall Study|Withdrawal by Subject|2|||
44170198|NCT02340949|78963788|FG001|Overall Study|Withdrawal by Subject|0|||
44170199|NCT02340949|78963787|FG000|Overall Study|Progression disease|6|||
44170200|NCT02340949|78963788|FG001|Overall Study|Progression disease|2|||
44170201|NCT02340949|78963787|FG000|Overall Study|Death|3|||
44170202|NCT02340949|78963788|FG001|Overall Study|Death|0|||
44170203|NCT02340949|78963787|FG000|Overall Study|Physician Decision|1|||
44170204|NCT02340949|78963788|FG001|Overall Study|Physician Decision|0|||
44170205|NCT01646203|78963797|FG000|Overall Study|Adverse Event|2|||
44170206|NCT01646203|78963798|FG001|Overall Study|Adverse Event|0|||
44170207|NCT01646203|78963799|FG002|Overall Study|Adverse Event|1|||
44170208|NCT01646203|78963797|FG000|Overall Study|Withdrawal by Subject|0|||
44170209|NCT01646203|78963798|FG001|Overall Study|Withdrawal by Subject|1|||
44170210|NCT01646203|78963799|FG002|Overall Study|Withdrawal by Subject|0|||
44170211|NCT01646203|78963797|FG000|Overall Study|Physician's Decision|0|||
44170212|NCT01646203|78963798|FG001|Overall Study|Physician's Decision|1|||
44170213|NCT01646203|78963799|FG002|Overall Study|Physician's Decision|0|||
44170214|NCT02375347|78963812|FG000|Overall Study|Protocol Violation|1|||
44170215|NCT02374957|78963818|FG000|Overall Study|Patient did not complete forms correctly|1|||
44170216|NCT02374957|78963819|FG001|Overall Study|Patient did not complete forms correctly|0|||
44170217|NCT02374255|78963829|FG000|Overall Study|Withdrawal by Subject|2|||
44170218|NCT02374255|78963830|FG001|Overall Study|Withdrawal by Subject|0|||
44170219|NCT02374255|78963831|FG002|Overall Study|Withdrawal by Subject|0|||
44170220|NCT02374255|78963832|FG003|Overall Study|Withdrawal by Subject|0|||
44170221|NCT02308033|78963850|FG000|Overall Study|Normal Gram stain at Baseline|13|||
44170222|NCT02308033|78963851|FG001|Overall Study|Normal Gram stain at Baseline|10|||
44170223|NCT02308033|78963850|FG000|Overall Study|Positive for STD at Baseline|7|||
44170224|NCT02308033|78963851|FG001|Overall Study|Positive for STD at Baseline|4|||
44170225|NCT02308033|78963850|FG000|Overall Study|Lost to Follow-up|6|||
44170226|NCT02308033|78963851|FG001|Overall Study|Lost to Follow-up|5|||
44170227|NCT02339155|78963859|FG000|Overall Study|Adverse Event|0|||
44170228|NCT02339155|78963860|FG001|Overall Study|Adverse Event|6|||
44170229|NCT02339155|78963859|FG000|Overall Study|Death|1|||
44170230|NCT02339155|78963860|FG001|Overall Study|Death|1|||
44170231|NCT02339155|78963859|FG000|Overall Study|Lost to Follow-up|8|||
44170232|NCT02339155|78963860|FG001|Overall Study|Lost to Follow-up|9|||
44170233|NCT02339155|78963859|FG000|Overall Study|Physician Decision|2|||
44170234|NCT02339155|78963860|FG001|Overall Study|Physician Decision|1|||
44170235|NCT02339155|78963859|FG000|Overall Study|Withdrawal by Subject|4|||
44170236|NCT02339155|78963860|FG001|Overall Study|Withdrawal by Subject|4|||
44449645|NCT00426556|79458215|FG000|Phase I - Core Phase|Disease Progression|0|||
44449646|NCT00426556|79458216|FG001|Phase I - Core Phase|Disease Progression|6|||
44449647|NCT00426556|79458217|FG002|Phase I - Core Phase|Disease Progression|2|||
44449648|NCT00426556|79458218|FG003|Phase I - Core Phase|Disease Progression|0|||
44449649|NCT00426556|79458215|FG000|Phase I - Core Phase|Adverse Event|1|||
44170237|NCT02211261|78963879|FG000|Overall Study|Withdrawal by Subject|0|||
44170238|NCT02211261|78963880|FG001|Overall Study|Withdrawal by Subject|0|||
44170239|NCT02211261|78963881|FG002|Overall Study|Withdrawal by Subject|1|||
44170240|NCT02211261|78963882|FG003|Overall Study|Withdrawal by Subject|0|||
44170241|NCT02211261|78963883|FG004|Overall Study|Withdrawal by Subject|2|||
44170242|NCT02211261|78963884|FG005|Overall Study|Withdrawal by Subject|0|||
44170243|NCT02211261|78963885|FG006|Overall Study|Withdrawal by Subject|0|||
44170244|NCT02211261|78963886|FG007|Overall Study|Withdrawal by Subject|0|||
44170245|NCT02211261|78963887|FG008|Overall Study|Withdrawal by Subject|0|||
44170246|NCT02211261|78963888|FG009|Overall Study|Withdrawal by Subject|0|||
44170247|NCT02211261|78963889|FG010|Overall Study|Withdrawal by Subject|0|||
44170248|NCT02211261|78963879|FG000|Overall Study|Other|0|||
44170249|NCT02211261|78963880|FG001|Overall Study|Other|0|||
44170250|NCT02211261|78963881|FG002|Overall Study|Other|0|||
44170251|NCT02211261|78963882|FG003|Overall Study|Other|0|||
44170252|NCT02211261|78963883|FG004|Overall Study|Other|0|||
44170253|NCT02211261|78963884|FG005|Overall Study|Other|1|||
44170254|NCT02211261|78963885|FG006|Overall Study|Other|0|||
44170255|NCT02211261|78963886|FG007|Overall Study|Other|0|||
44170256|NCT02211261|78963887|FG008|Overall Study|Other|0|||
44170257|NCT02211261|78963888|FG009|Overall Study|Other|2|||
44170258|NCT02211261|78963889|FG010|Overall Study|Other|0|||
44170259|NCT02211261|78963879|FG000|Overall Study|Lost to Follow-up|0|||
44170260|NCT02211261|78963880|FG001|Overall Study|Lost to Follow-up|0|||
44170261|NCT02211261|78963881|FG002|Overall Study|Lost to Follow-up|0|||
44170262|NCT02211261|78963882|FG003|Overall Study|Lost to Follow-up|0|||
44170263|NCT02211261|78963883|FG004|Overall Study|Lost to Follow-up|0|||
44170264|NCT02211261|78963884|FG005|Overall Study|Lost to Follow-up|0|||
44170265|NCT02211261|78963885|FG006|Overall Study|Lost to Follow-up|0|||
44170266|NCT02211261|78963886|FG007|Overall Study|Lost to Follow-up|1|||
44170267|NCT02211261|78963887|FG008|Overall Study|Lost to Follow-up|0|||
44170268|NCT02211261|78963888|FG009|Overall Study|Lost to Follow-up|0|||
44170269|NCT02211261|78963889|FG010|Overall Study|Lost to Follow-up|0|||
44170270|NCT02170077|78963925|FG000|Overall Study|Withdrawal by Subject|3|||
44170271|NCT02170077|78963926|FG001|Overall Study|Withdrawal by Subject|4|||
44170272|NCT02170077|78963927|FG002|Overall Study|Withdrawal by Subject|2|||
44170273|NCT02170077|78963925|FG000|Overall Study|Adverse Event|4|||
44170274|NCT02170077|78963926|FG001|Overall Study|Adverse Event|4|||
44170275|NCT02170077|78963927|FG002|Overall Study|Adverse Event|4|||
44170276|NCT02170077|78963925|FG000|Overall Study|Lost to Follow-up|0|||
44170277|NCT02170077|78963926|FG001|Overall Study|Lost to Follow-up|1|||
44170278|NCT02170077|78963927|FG002|Overall Study|Lost to Follow-up|0|||
44170279|NCT02170077|78963925|FG000|Overall Study|Exclusion criteria|2|||
44170280|NCT02170077|78963926|FG001|Overall Study|Exclusion criteria|2|||
44170281|NCT02170077|78963927|FG002|Overall Study|Exclusion criteria|5|||
44170282|NCT02170077|78963925|FG000|Overall Study|Exacerbation of seizures|0|||
44170283|NCT02170077|78963926|FG001|Overall Study|Exacerbation of seizures|2|||
44170284|NCT02170077|78963927|FG002|Overall Study|Exacerbation of seizures|1|||
44170285|NCT02210091|78963937|FG000|Overall Study|Physician Decision|0|||
44170286|NCT02210091|78963938|FG001|Overall Study|Physician Decision|1|||
44170287|NCT02210091|78963937|FG000|Overall Study|Withdrawal by Sponsor|0|||
44170288|NCT02210091|78963938|FG001|Overall Study|Withdrawal by Sponsor|1|||
44170289|NCT02338999|78963962|FG000|First Intervention|Withdrawal by Subject|3|||
44170290|NCT02338999|78963963|FG001|First Intervention|Withdrawal by Subject|1|||
44170291|NCT02338999|78963962|FG000|Washout Period|Withdrawal by Subject|0|||
44170292|NCT02338999|78963963|FG001|Washout Period|Withdrawal by Subject|2|||
44170293|NCT02338999|78963962|FG000|Second Intervention|Withdrawal by Subject|0|||
44170294|NCT02338999|78963963|FG001|Second Intervention|Withdrawal by Subject|2|||
44170295|NCT02169219|78963969|FG000|Overall Study|Lack of Efficacy|6|||
44449650|NCT00426556|79458216|FG001|Phase I - Core Phase|Adverse Event|3|||
44170296|NCT02191605|78963983|FG000|Overall Study|Lost to Follow-up|9|||
44170297|NCT02191605|78963984|FG001|Overall Study|Lost to Follow-up|4|||
44170298|NCT02191605|78963985|FG002|Overall Study|Lost to Follow-up|7|||
44170299|NCT02191605|78963986|FG003|Overall Study|Lost to Follow-up|3|||
44170300|NCT02191605|78963987|FG004|Overall Study|Lost to Follow-up|4|||
44170301|NCT02191137|78963999|FG000|Treatment|Death|4|||
44170302|NCT02191137|78963999|FG000|Treatment|Withdrawal by Subject|3|||
44170303|NCT02191137|78963999|FG000|Treatment|Adverse Event|2|||
44170304|NCT02191137|78963999|FG000|Treatment|Other|1|||
44170305|NCT02191137|78963999|FG000|Follow-up|Lost to Follow-up|2|||
44170306|NCT02191137|78963999|FG000|Follow-up|Ongoing/unknown|2|||
44170307|NCT02191137|78963999|FG000|Follow-up|Adverse Event|1|||
44170308|NCT02168439|78964005|FG000|Overall Study|Protocol Violation|0|||
44170309|NCT02168439|78964006|FG001|Overall Study|Protocol Violation|2|||
44170310|NCT02190591|78964014|FG000|Overall Study|Withdrawal by Subject|1|||
44170311|NCT02190591|78964015|FG001|Overall Study|Withdrawal by Subject|8|||
44170312|NCT02190591|78964014|FG000|Overall Study|Protocol Violation|1|||
44170313|NCT02190591|78964015|FG001|Overall Study|Protocol Violation|0|||
44170314|NCT02190591|78964014|FG000|Overall Study|did not use peanut ball as instructed|0|||
44170315|NCT02190591|78964015|FG001|Overall Study|did not use peanut ball as instructed|2|||
44170316|NCT02190591|78964014|FG000|Overall Study|face presentation so she was ineligible|0|||
44170317|NCT02190591|78964015|FG001|Overall Study|face presentation so she was ineligible|1|||
44170318|NCT02190435|78964023|FG000|Overall Study|First 12 patients were lead-ins|12|||
44170319|NCT02190435|78964024|FG001|Overall Study|First 12 patients were lead-ins|0|||
44170320|NCT02190435|78964023|FG000|Overall Study|3 consented screen fails|3|||
44170321|NCT02190435|78964024|FG001|Overall Study|3 consented screen fails|0|||
44170322|NCT02338843|78964032|FG000|Overall Study|Adverse Event|2|||
44170323|NCT02338843|78964033|FG001|Overall Study|Adverse Event|1|||
44170324|NCT02338843|78964032|FG000|Overall Study|Death|40|||
44170325|NCT02338843|78964033|FG001|Overall Study|Death|53|||
44170326|NCT02338843|78964032|FG000|Overall Study|Physician Decision|1|||
44170327|NCT02338843|78964033|FG001|Overall Study|Physician Decision|0|||
44170328|NCT02338843|78964032|FG000|Overall Study|Withdrawal by Subject|0|||
44170329|NCT02338843|78964033|FG001|Overall Study|Withdrawal by Subject|2|||
44170330|NCT02338843|78964032|FG000|Overall Study|Subject Recovered|0|||
44170331|NCT02338843|78964033|FG001|Overall Study|Subject Recovered|2|||
44170332|NCT02338843|78964032|FG000|Overall Study|Discontinued prior to randomizat|1|||
44170333|NCT02338843|78964033|FG001|Overall Study|Discontinued prior to randomizat|0|||
44170334|NCT02190279|78964042|FG000|Overall Study|Withdrawal consent|1|||
44170335|NCT02190279|78964043|FG001|Overall Study|Withdrawal consent|0|||
44170336|NCT02190279|78964044|FG002|Overall Study|Withdrawal consent|1|||
44170337|NCT02190279|78964042|FG000|Overall Study|Lost to Follow-up|2|||
44170338|NCT02190279|78964043|FG001|Overall Study|Lost to Follow-up|0|||
44170339|NCT02190279|78964044|FG002|Overall Study|Lost to Follow-up|0|||
44170340|NCT02190279|78964042|FG000|Overall Study|Refused further treatment|0|||
44170341|NCT02190279|78964043|FG001|Overall Study|Refused further treatment|0|||
44170342|NCT02190279|78964044|FG002|Overall Study|Refused further treatment|1|||
44170343|NCT02190279|78964042|FG000|Overall Study|Screening failure|0|||
44170344|NCT02190279|78964043|FG001|Overall Study|Screening failure|0|||
44170345|NCT02190279|78964044|FG002|Overall Study|Screening failure|1|||
44170346|NCT02135445|78964056|FG000|Overall Study|Lost to Follow-up|1|||
44170347|NCT02135445|78964057|FG001|Overall Study|Lost to Follow-up|0|||
44170348|NCT02135445|78964056|FG000|Overall Study|Withdrawal by Subject|1|||
44170349|NCT02135445|78964057|FG001|Overall Study|Withdrawal by Subject|0|||
44170350|NCT02374099|78964065|FG000|Overall Study|Adverse Event|1|||
44170351|NCT02374099|78964066|FG001|Overall Study|Adverse Event|0|||
44170352|NCT02374099|78964065|FG000|Overall Study|Progressive Disease|35|||
44170353|NCT02374099|78964066|FG001|Overall Study|Progressive Disease|40|||
44170354|NCT02374099|78964065|FG000|Overall Study|Withdrawal by Subject|5|||
44170355|NCT02374099|78964066|FG001|Overall Study|Withdrawal by Subject|1|||
44170356|NCT02374099|78964065|FG000|Overall Study|Miscellaneous|2|||
44170357|NCT02374099|78964066|FG001|Overall Study|Miscellaneous|3|||
44170358|NCT02374099|78964065|FG000|Overall Study|Randomized, but not treated|2|||
44170359|NCT02374099|78964066|FG001|Overall Study|Randomized, but not treated|1|||
44170360|NCT02374099|78964065|FG000|Overall Study|Study Terminated by Sponsor|3|||
44170361|NCT02374099|78964066|FG001|Overall Study|Study Terminated by Sponsor|4|||
44449651|NCT00426556|79458217|FG002|Phase I - Core Phase|Adverse Event|1|||
44449652|NCT00426556|79458218|FG003|Phase I - Core Phase|Adverse Event|0|||
44170362|NCT02134977|78964072|FG000|Overall Study|Protocol Deviation|102|||
44170363|NCT02374021|78964078|FG000|Overall Study|Adverse Event|1|||
44170364|NCT02374021|78964079|FG001|Overall Study|Adverse Event|0|||
44360813|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44360814|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44360815|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44360816|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44360817|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44170365|NCT02374021|78964078|FG000|Overall Study|Lost to Follow-up|3|||
44170366|NCT02374021|78964079|FG001|Overall Study|Lost to Follow-up|2|||
44170367|NCT02374021|78964078|FG000|Overall Study|Physician Decision|0|||
44170368|NCT02374021|78964079|FG001|Overall Study|Physician Decision|3|||
44170369|NCT02374021|78964078|FG000|Overall Study|Withdrawal by Subject|6|||
44170370|NCT02374021|78964079|FG001|Overall Study|Withdrawal by Subject|5|||
44170371|NCT02374021|78964078|FG000|Overall Study|Poor Adherence|0|||
44170372|NCT02374021|78964079|FG001|Overall Study|Poor Adherence|1|||
44170373|NCT02374021|78964078|FG000|Overall Study|Scan protocol not followed|0|||
44170374|NCT02374021|78964079|FG001|Overall Study|Scan protocol not followed|1|||
44170375|NCT02374021|78964078|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
44170376|NCT02374021|78964079|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
44170377|NCT02372383|78964087|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
44170378|NCT02372383|78964088|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
44170379|NCT02372383|78964089|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
44170380|NCT01648699|78964099|FG000|Overall Study|Death|1|||
44170381|NCT01648699|78964099|FG000|Overall Study|Lost to Follow-up|2|||
44170382|NCT01648699|78964099|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
44170383|NCT02134353|78964114|FG000|Overall Study|Adverse Event|10|||
44170384|NCT02134353|78964115|FG001|Overall Study|Adverse Event|6|||
44170385|NCT02134353|78964114|FG000|Overall Study|Lost to Follow-up|1|||
44170386|NCT02134353|78964115|FG001|Overall Study|Lost to Follow-up|1|||
44170387|NCT02134353|78964114|FG000|Overall Study|Lack of Efficacy|2|||
44170388|NCT02134353|78964115|FG001|Overall Study|Lack of Efficacy|1|||
44170389|NCT02134353|78964114|FG000|Overall Study|Withdrawal by Subject|12|||
44170390|NCT02134353|78964115|FG001|Overall Study|Withdrawal by Subject|13|||
44170391|NCT02134353|78964114|FG000|Overall Study|Death|0|||
44170392|NCT02134353|78964115|FG001|Overall Study|Death|1|||
44170393|NCT02134353|78964114|FG000|Overall Study|Pregnancy|0|||
44170394|NCT02134353|78964115|FG001|Overall Study|Pregnancy|1|||
44170395|NCT02134353|78964114|FG000|Overall Study|Relocation|1|||
44170396|NCT02134353|78964115|FG001|Overall Study|Relocation|0|||
44170397|NCT02134353|78964114|FG000|Overall Study|Other - Patient's Choice|0|||
44170398|NCT02134353|78964115|FG001|Overall Study|Other - Patient's Choice|1|||
44170399|NCT01646125|78964123|FG000|Overall Study|Untreated|2|||
44170400|NCT01646125|78964124|FG001|Overall Study|Untreated|5|||
44170401|NCT01646125|78964123|FG000|Overall Study|Adverse Event|2|||
44170402|NCT01646125|78964124|FG001|Overall Study|Adverse Event|1|||
44170403|NCT01646125|78964123|FG000|Overall Study|Death|1|||
44170404|NCT01646125|78964124|FG001|Overall Study|Death|1|||
44170405|NCT01646125|78964123|FG000|Overall Study|Physician Decision|1|||
44170406|NCT01646125|78964124|FG001|Overall Study|Physician Decision|3|||
44170407|NCT01646125|78964123|FG000|Overall Study|Progressive disease|22|||
44170408|NCT01646125|78964124|FG001|Overall Study|Progressive disease|16|||
44170409|NCT01646125|78964123|FG000|Overall Study|Study terminated by sponsor|2|||
44170410|NCT01646125|78964124|FG001|Overall Study|Study terminated by sponsor|1|||
44170411|NCT01646125|78964123|FG000|Overall Study|Subject/Guardian decision|1|||
44170412|NCT01646125|78964124|FG001|Overall Study|Subject/Guardian decision|1|||
44170413|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
44170414|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
44170415|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
44170416|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
44170417|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
44170418|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
44170419|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
44170420|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
44170421|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
44170422|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
44170423|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
44170424|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
44170425|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
44170426|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
44170427|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
44170428|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
44170429|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
44170430|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
44170431|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
44170432|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
44170433|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
44170434|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
44170435|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
44170436|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
44170437|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
44170438|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
44170439|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
44170440|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
44170441|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
44170442|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
44170443|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
44170444|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
44170445|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
44170446|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
44264190|NCT03155997|79164473|FG000|Overall Study|Lost to Follow-up|12|||
44170447|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
44170448|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
44170449|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
44170450|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
44170451|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
44170452|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
44170453|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
44170454|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
44170455|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
44170456|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
44170457|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
44170458|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
44170459|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
44170460|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
44170461|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
44170462|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
44170463|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
44170464|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
44170465|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
44170466|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
44170467|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
44170468|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
44170469|NCT01362790|78964137|FG000|Pilot Phase & Phase 2|Death on study|0|||
44170470|NCT01362790|78964138|FG001|Pilot Phase & Phase 2|Death on study|0|||
44170471|NCT01362790|78964139|FG002|Pilot Phase & Phase 2|Death on study|0|||
44170472|NCT01362790|78964140|FG003|Pilot Phase & Phase 2|Death on study|1|||
44170473|NCT01362790|78964141|FG004|Pilot Phase & Phase 2|Death on study|0|||
44170474|NCT01362790|78964142|FG005|Pilot Phase & Phase 2|Death on study|0|||
44170475|NCT01362790|78964143|FG006|Pilot Phase & Phase 2|Death on study|0|||
44170476|NCT01362790|78964137|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
44170477|NCT01362790|78964138|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
44170478|NCT01362790|78964139|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
44170479|NCT01362790|78964140|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
44170480|NCT01362790|78964141|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
44170481|NCT01362790|78964142|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
44170482|NCT01362790|78964143|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
44170483|NCT01362790|78964137|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
44170484|NCT01362790|78964138|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
44170485|NCT01362790|78964139|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
44170486|NCT01362790|78964140|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
44170487|NCT01362790|78964141|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
44170488|NCT01362790|78964142|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
44170489|NCT01362790|78964143|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
44170490|NCT01362790|78964137|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
44170491|NCT01362790|78964138|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
44170492|NCT01362790|78964139|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
44170493|NCT01362790|78964140|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
44170494|NCT01362790|78964141|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
44170495|NCT01362790|78964142|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
44170496|NCT01362790|78964143|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
44170497|NCT02167893|78964163|FG000|Overall Study|Investigator transferred|85|||
44170498|NCT02167893|78964163|FG000|Overall Study|Investigator health reasons|10|||
44170499|NCT02167893|78964163|FG000|Overall Study|Case report forms not collected|68|||
44170500|NCT02167035|78964169|FG000|Overall Study|Adverse Event|2|||
44170501|NCT02167035|78964170|FG001|Overall Study|Adverse Event|2|||
44170502|NCT02167035|78964169|FG000|Overall Study|Lost to Follow-up|3|||
44170503|NCT02167035|78964170|FG001|Overall Study|Lost to Follow-up|3|||
44170504|NCT02167035|78964169|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
44170505|NCT02167035|78964170|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
44170506|NCT01615198|78964180|FG000|Overall Study|Withdrawal by Subject|5|||
44170507|NCT01615198|78964181|FG001|Overall Study|Withdrawal by Subject|5|||
44170508|NCT01615198|78964180|FG000|Overall Study|Protocol deviation|1|||
44170509|NCT01615198|78964181|FG001|Overall Study|Protocol deviation|1|||
44170510|NCT01615198|78964180|FG000|Overall Study|Physician Decision|5|||
44170511|NCT01615198|78964181|FG001|Overall Study|Physician Decision|1|||
44170512|NCT01615198|78964180|FG000|Overall Study|Lost to Follow-up|1|||
44170513|NCT01615198|78964181|FG001|Overall Study|Lost to Follow-up|1|||
44170514|NCT01615198|78964180|FG000|Overall Study|Lack of Efficacy|1|||
44170515|NCT01615198|78964181|FG001|Overall Study|Lack of Efficacy|6|||
44170516|NCT01615198|78964180|FG000|Overall Study|Adverse Event|11|||
44170517|NCT01615198|78964181|FG001|Overall Study|Adverse Event|5|||
44170518|NCT02337907|78964193|FG000|Overall Study|Other than listed|1|||
44170519|NCT02337907|78964194|FG001|Overall Study|Other than listed|0|||
44170520|NCT02337907|78964195|FG002|Overall Study|Other than listed|0|||
44170521|NCT02337907|78964196|FG003|Overall Study|Other than listed|1|||
44170522|NCT02337907|78964197|FG004|Overall Study|Other than listed|1|||
44170523|NCT02337907|78964198|FG005|Overall Study|Other than listed|0|||
44170524|NCT02337907|78964193|FG000|Overall Study|Withdrawal by Subject|2|||
44170525|NCT02337907|78964194|FG001|Overall Study|Withdrawal by Subject|3|||
44170526|NCT02337907|78964195|FG002|Overall Study|Withdrawal by Subject|0|||
44170527|NCT02337907|78964196|FG003|Overall Study|Withdrawal by Subject|2|||
44170528|NCT02337907|78964197|FG004|Overall Study|Withdrawal by Subject|5|||
44170529|NCT02337907|78964198|FG005|Overall Study|Withdrawal by Subject|0|||
44170530|NCT02337907|78964193|FG000|Overall Study|Lost to Follow-up|0|||
44170531|NCT02337907|78964194|FG001|Overall Study|Lost to Follow-up|0|||
44170532|NCT02337907|78964195|FG002|Overall Study|Lost to Follow-up|0|||
44170533|NCT02337907|78964196|FG003|Overall Study|Lost to Follow-up|0|||
44170534|NCT02337907|78964197|FG004|Overall Study|Lost to Follow-up|0|||
44170535|NCT02337907|78964198|FG005|Overall Study|Lost to Follow-up|1|||
44170536|NCT02337907|78964193|FG000|Overall Study|Adverse Event|1|||
44170537|NCT02337907|78964194|FG001|Overall Study|Adverse Event|1|||
44170538|NCT02337907|78964195|FG002|Overall Study|Adverse Event|1|||
44170539|NCT02337907|78964196|FG003|Overall Study|Adverse Event|1|||
44170540|NCT02337907|78964197|FG004|Overall Study|Adverse Event|4|||
44170541|NCT02337907|78964198|FG005|Overall Study|Adverse Event|0|||
44170542|NCT01913470|78964215|FG000|Overall Study|Lost to Follow-up|0|||
44170543|NCT01913470|78964216|FG001|Overall Study|Lost to Follow-up|1|||
44170544|NCT01913470|78964215|FG000|Overall Study|Physician Decision|0|||
44170545|NCT01913470|78964216|FG001|Overall Study|Physician Decision|1|||
44170546|NCT01913470|78964215|FG000|Overall Study|Withdrawal by Subject|0|||
44170547|NCT01913470|78964216|FG001|Overall Study|Withdrawal by Subject|1|||
44170548|NCT02372071|78964223|FG000|Overall Study|Protocol Violation|18|||
44170549|NCT02337751|78964230|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
44170550|NCT02337751|78964231|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
44170551|NCT02337751|78964230|FG000|Overall Study|Voluntary Withdrawal|6|||
44170552|NCT02337751|78964231|FG001|Overall Study|Voluntary Withdrawal|8|||
44170553|NCT02337751|78964230|FG000|Overall Study|Lack of Efficacy|2|||
44170554|NCT02337751|78964231|FG001|Overall Study|Lack of Efficacy|5|||
44170555|NCT02337751|78964230|FG000|Overall Study|Investigator's Judgement|1|||
44170556|NCT02337751|78964231|FG001|Overall Study|Investigator's Judgement|0|||
44170557|NCT02166333|78964242|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
44170558|NCT02166333|78964243|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
44170559|NCT02166333|78964244|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
44170560|NCT02166333|78964245|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
44170561|NCT02166333|78964246|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
44170562|NCT02166333|78964247|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
44170563|NCT02166333|78964242|FG000|Stage 1|Death|4|||
44170564|NCT02166333|78964243|FG001|Stage 1|Death|0|||
44170565|NCT02166333|78964244|FG002|Stage 1|Death|2|||
44170566|NCT02166333|78964245|FG003|Stage 1|Death|0|||
44170567|NCT02166333|78964246|FG004|Stage 1|Death|3|||
44170568|NCT02166333|78964247|FG005|Stage 1|Death|2|||
44170569|NCT02166333|78964242|FG000|Stage 1|Lost to Follow-up|12|||
44170570|NCT02166333|78964243|FG001|Stage 1|Lost to Follow-up|0|||
44170571|NCT02166333|78964244|FG002|Stage 1|Lost to Follow-up|6|||
44170572|NCT02166333|78964245|FG003|Stage 1|Lost to Follow-up|0|||
44170573|NCT02166333|78964246|FG004|Stage 1|Lost to Follow-up|3|||
44170574|NCT02166333|78964247|FG005|Stage 1|Lost to Follow-up|3|||
44170575|NCT02166333|78964242|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
44170576|NCT02166333|78964243|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
44170577|NCT02166333|78964244|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
44170578|NCT02166333|78964245|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
44170579|NCT02166333|78964246|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
44170580|NCT02166333|78964247|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
44170581|NCT02166333|78964242|FG000|Stage 2|Death|4|||
44170582|NCT02166333|78964243|FG001|Stage 2|Death|2|||
44170583|NCT02166333|78964244|FG002|Stage 2|Death|1|||
44170584|NCT02166333|78964245|FG003|Stage 2|Death|0|||
44170585|NCT02166333|78964246|FG004|Stage 2|Death|0|||
44170586|NCT02166333|78964247|FG005|Stage 2|Death|1|||
44170587|NCT02166333|78964242|FG000|Stage 2|Lost to Follow-up|23|||
44170588|NCT02166333|78964243|FG001|Stage 2|Lost to Follow-up|4|||
44170589|NCT02166333|78964244|FG002|Stage 2|Lost to Follow-up|11|||
44170590|NCT02166333|78964245|FG003|Stage 2|Lost to Follow-up|9|||
44170591|NCT02166333|78964246|FG004|Stage 2|Lost to Follow-up|3|||
44170592|NCT02166333|78964247|FG005|Stage 2|Lost to Follow-up|6|||
44170593|NCT02132949|78964261|FG000|Overall Study|Death|7|||
44170594|NCT02132949|78964262|FG001|Overall Study|Death|13|||
44170595|NCT02132949|78964261|FG000|Overall Study|Lost to Follow-up|14|||
44170596|NCT02132949|78964262|FG001|Overall Study|Lost to Follow-up|4|||
44170597|NCT02132949|78964261|FG000|Overall Study|Withdrawal by Subject|6|||
44170598|NCT02132949|78964262|FG001|Overall Study|Withdrawal by Subject|5|||
44170599|NCT02132949|78964261|FG000|Overall Study|Noncompliance|5|||
44170600|NCT02132949|78964262|FG001|Overall Study|Noncompliance|1|||
44170601|NCT02132949|78964261|FG000|Overall Study|Physician Decision|3|||
44170602|NCT02132949|78964262|FG001|Overall Study|Physician Decision|1|||
44170603|NCT02132949|78964261|FG000|Overall Study|Disease Progression|3|||
44170604|NCT02132949|78964262|FG001|Overall Study|Disease Progression|0|||
44170605|NCT02132949|78964261|FG000|Overall Study|Adverse Event|2|||
44170606|NCT02132949|78964262|FG001|Overall Study|Adverse Event|1|||
44170607|NCT02132949|78964261|FG000|Overall Study|Withdrew Prior to Treatment|1|||
44170608|NCT02132949|78964262|FG001|Overall Study|Withdrew Prior to Treatment|2|||
44170609|NCT02132949|78964261|FG000|Overall Study|Reason Unspecified|0|||
44170610|NCT02132949|78964262|FG001|Overall Study|Reason Unspecified|1|||
44170611|NCT02165397|78964271|FG000|Overall Study|Death|7|||
44170612|NCT02165397|78964272|FG001|Overall Study|Death|10|||
44170613|NCT02165397|78964273|FG002|Overall Study|Death|8|||
44170614|NCT02165397|78964271|FG000|Overall Study|Lost to Follow-up|1|||
44170615|NCT02165397|78964272|FG001|Overall Study|Lost to Follow-up|3|||
44170616|NCT02165397|78964273|FG002|Overall Study|Lost to Follow-up|0|||
44170617|NCT02165397|78964271|FG000|Overall Study|Withdrawal by Subject|6|||
44170618|NCT02165397|78964272|FG001|Overall Study|Withdrawal by Subject|6|||
44170619|NCT02165397|78964273|FG002|Overall Study|Withdrawal by Subject|1|||
44170620|NCT02165397|78964271|FG000|Overall Study|Other, Not Specified|0|||
44170621|NCT02165397|78964272|FG001|Overall Study|Other, Not Specified|0|||
44170622|NCT02165397|78964273|FG002|Overall Study|Other, Not Specified|1|||
44170623|NCT02132637|78964285|FG000|Study Period 1|Withdrawal by Subject|0|||
44170624|NCT02132637|78964286|FG001|Study Period 1|Withdrawal by Subject|4|||
44170625|NCT02132637|78964285|FG000|Study Period 1|Physician Decision|1|||
44170626|NCT02132637|78964286|FG001|Study Period 1|Physician Decision|0|||
44170627|NCT02132637|78964285|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
44170628|NCT02132637|78964286|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
44170629|NCT02132637|78964285|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
44170630|NCT02132637|78964286|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
44170631|NCT02164929|78964296|FG000|Overall Study|Converted to open procedure|1|||
44170632|NCT02164929|78964297|FG001|Overall Study|Converted to open procedure|0|||
44170633|NCT02164929|78964298|FG002|Overall Study|Converted to open procedure|0|||
44170634|NCT02164929|78964299|FG003|Overall Study|Converted to open procedure|2|||
44170635|NCT02164929|78964296|FG000|Overall Study|Failed regional block|0|||
44170636|NCT02164929|78964297|FG001|Overall Study|Failed regional block|0|||
44170637|NCT02164929|78964298|FG002|Overall Study|Failed regional block|1|||
44170638|NCT02164929|78964299|FG003|Overall Study|Failed regional block|0|||
44170639|NCT01888432|78964311|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
44170640|NCT01888432|78964312|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
44170641|NCT01888432|78964311|FG000|12-month Analysis (FAS)|Physician Decision|1|||
44170642|NCT01888432|78964312|FG001|12-month Analysis (FAS)|Physician Decision|1|||
44170643|NCT01888432|78964311|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
44170644|NCT01888432|78964312|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
44170645|NCT01888432|78964311|FG000|12-month Analysis (FAS)|Death|4|||
44170646|NCT01888432|78964312|FG001|12-month Analysis (FAS)|Death|3|||
44170647|NCT01888432|78964311|FG000|24-month Analysis (FAS)|Graft loss|0|||
44170648|NCT01888432|78964312|FG001|24-month Analysis (FAS)|Graft loss|1|||
44170649|NCT01888432|78964311|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
44170650|NCT01888432|78964312|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
44170651|NCT01888432|78964311|FG000|24-month Analysis (FAS)|Physician Decision|2|||
44170652|NCT01888432|78964312|FG001|24-month Analysis (FAS)|Physician Decision|4|||
44170653|NCT01888432|78964311|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
44170654|NCT01888432|78964312|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
44170655|NCT01888432|78964311|FG000|24-month Analysis (FAS)|Death|8|||
44170656|NCT01888432|78964312|FG001|24-month Analysis (FAS)|Death|4|||
44170657|NCT01888432|78964311|FG000|36-month Analysis (Extension)|Death|1|||
44170658|NCT01888432|78964312|FG001|36-month Analysis (Extension)|Death|0|||
44170659|NCT02188719|78964324|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
44170660|NCT02188719|78964325|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
44170661|NCT02188719|78964326|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
44170662|NCT02188719|78964327|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
44170663|NCT01934140|78964337|FG000|Persistence Phase (Year 6-10)|Other|24|||
44170664|NCT01934140|78964338|FG001|Persistence Phase (Year 6-10)|Other|6|||
44170665|NCT01934140|78964337|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
44170666|NCT01934140|78964338|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
44170667|NCT01934140|78964337|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
44170668|NCT01934140|78964338|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
44170669|NCT01934140|78964337|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
44170670|NCT01934140|78964338|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
44170671|NCT01934140|78964337|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
44170672|NCT01934140|78964338|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
44170673|NCT01934140|78964337|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
44170674|NCT01934140|78964338|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
44170675|NCT01934140|78964337|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
44170676|NCT01934140|78964338|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
44170677|NCT01934140|78964337|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
44170678|NCT01934140|78964338|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
44170679|NCT01933672|78964346|FG000|Metformin Run-in Period|Adverse Event|1|||
44170680|NCT01933672|78964347|FG001|Metformin Run-in Period|Adverse Event|0|||
44170681|NCT01933672|78964348|FG002|Metformin Run-in Period|Adverse Event|0|||
44170682|NCT01933672|78964349|FG003|Metformin Run-in Period|Adverse Event|0|||
44170683|NCT01933672|78964350|FG004|Metformin Run-in Period|Adverse Event|0|||
44170684|NCT01933672|78964351|FG005|Metformin Run-in Period|Adverse Event|0|||
44449653|NCT00426556|79458215|FG000|Phase I - Core Phase|Death|0|||
44449654|NCT00426556|79458216|FG001|Phase I - Core Phase|Death|1|||
44449655|NCT00426556|79458217|FG002|Phase I - Core Phase|Death|0|||
44449656|NCT00426556|79458218|FG003|Phase I - Core Phase|Death|0|||
44449657|NCT00426556|79458215|FG000|Phase I - Extension Phase|Adverse Event|0|||
44449658|NCT00426556|79458216|FG001|Phase I - Extension Phase|Adverse Event|1|||
44449659|NCT00426556|79458217|FG002|Phase I - Extension Phase|Adverse Event|1|||
44449660|NCT00426556|79458218|FG003|Phase I - Extension Phase|Adverse Event|0|||
44449661|NCT00426556|79458215|FG000|Phase I - Extension Phase|Disease Progression|5|||
44449662|NCT00426556|79458216|FG001|Phase I - Extension Phase|Disease Progression|5|||
44449663|NCT00426556|79458217|FG002|Phase I - Extension Phase|Disease Progression|6|||
44449664|NCT00426556|79458218|FG003|Phase I - Extension Phase|Disease Progression|0|||
44449665|NCT00426556|79458215|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
44449666|NCT00426556|79458216|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
44449667|NCT00426556|79458217|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
44449668|NCT00426556|79458218|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
44449669|NCT00426556|79458215|FG000|Phase II - Core Phase|Disease Progression|0|||
44170685|NCT01933672|78964352|FG006|Metformin Run-in Period|Adverse Event|0|||
44170686|NCT01933672|78964346|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
44170687|NCT01933672|78964347|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
44170688|NCT01933672|78964348|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
44170689|NCT01933672|78964349|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
44170690|NCT01933672|78964350|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
44170691|NCT01933672|78964351|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
44170692|NCT01933672|78964352|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
44170693|NCT01933672|78964346|FG000|Metformin Run-in Period|Other|5|||
44170694|NCT01933672|78964347|FG001|Metformin Run-in Period|Other|0|||
44170695|NCT01933672|78964348|FG002|Metformin Run-in Period|Other|0|||
44170696|NCT01933672|78964349|FG003|Metformin Run-in Period|Other|0|||
44170697|NCT01933672|78964350|FG004|Metformin Run-in Period|Other|0|||
44170698|NCT01933672|78964351|FG005|Metformin Run-in Period|Other|0|||
44170699|NCT01933672|78964352|FG006|Metformin Run-in Period|Other|0|||
44170700|NCT01933672|78964346|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170701|NCT01933672|78964347|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170702|NCT01933672|78964348|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170703|NCT01933672|78964349|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170704|NCT01933672|78964350|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
44170705|NCT01933672|78964351|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170706|NCT01933672|78964352|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170707|NCT01933672|78964346|FG000|First Intervention Period (12-16 Days)|Other|0|||
44170708|NCT01933672|78964347|FG001|First Intervention Period (12-16 Days)|Other|0|||
44170709|NCT01933672|78964348|FG002|First Intervention Period (12-16 Days)|Other|1|||
44170710|NCT01933672|78964349|FG003|First Intervention Period (12-16 Days)|Other|0|||
44170711|NCT01933672|78964350|FG004|First Intervention Period (12-16 Days)|Other|0|||
44170712|NCT01933672|78964351|FG005|First Intervention Period (12-16 Days)|Other|1|||
44170713|NCT01933672|78964352|FG006|First Intervention Period (12-16 Days)|Other|0|||
44170714|NCT01933672|78964346|FG000|Second Intervention Period (12-16 Days)|Other|0|||
44170715|NCT01933672|78964347|FG001|Second Intervention Period (12-16 Days)|Other|1|||
44170716|NCT01933672|78964348|FG002|Second Intervention Period (12-16 Days)|Other|1|||
44449670|NCT00426556|79458216|FG001|Phase II - Core Phase|Disease Progression|0|||
44449671|NCT00426556|79458217|FG002|Phase II - Core Phase|Disease Progression|0|||
44449672|NCT00426556|79458218|FG003|Phase II - Core Phase|Disease Progression|16|||
44170717|NCT01933672|78964349|FG003|Second Intervention Period (12-16 Days)|Other|0|||
44264191|NCT03155997|79164474|FG001|Overall Study|Lost to Follow-up|13|||
44170718|NCT01933672|78964350|FG004|Second Intervention Period (12-16 Days)|Other|0|||
44170719|NCT01933672|78964351|FG005|Second Intervention Period (12-16 Days)|Other|0|||
44170720|NCT01933672|78964352|FG006|Second Intervention Period (12-16 Days)|Other|0|||
44170721|NCT01933672|78964346|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170722|NCT01933672|78964347|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170723|NCT01933672|78964348|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170724|NCT01933672|78964349|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
44170725|NCT01933672|78964350|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170726|NCT01933672|78964351|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170727|NCT01933672|78964352|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
44170728|NCT01933672|78964346|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
44170729|NCT01933672|78964347|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
44170730|NCT01933672|78964348|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
44170731|NCT01933672|78964349|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
44170732|NCT01933672|78964350|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
44170733|NCT01933672|78964351|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
44170734|NCT01933672|78964352|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
44170735|NCT02164539|78964371|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
44170736|NCT02164539|78964372|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
44170737|NCT02164539|78964373|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
44170738|NCT02164539|78964374|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
44170739|NCT02164539|78964375|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
44170740|NCT02164539|78964376|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
44170741|NCT02164539|78964377|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
44170742|NCT02164539|78964371|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
44170743|NCT02164539|78964372|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
44170744|NCT02164539|78964373|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
44170745|NCT02164539|78964374|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
44170746|NCT02164539|78964375|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
44170747|NCT02164539|78964376|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
44170748|NCT02164539|78964377|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
44170749|NCT02164539|78964371|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
44170750|NCT02164539|78964372|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
44170751|NCT02164539|78964373|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
44170752|NCT02164539|78964374|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
44170753|NCT02164539|78964375|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
44170754|NCT02164539|78964376|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
44170755|NCT02164539|78964377|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
44170756|NCT02164539|78964371|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
44170757|NCT02164539|78964372|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
44170758|NCT02164539|78964373|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
44170759|NCT02164539|78964374|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
44170760|NCT02164539|78964375|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
44170761|NCT02164539|78964376|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
44170762|NCT02164539|78964377|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
44170763|NCT02164539|78964371|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
44170764|NCT02164539|78964372|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
44170765|NCT02164539|78964373|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
44170766|NCT02164539|78964374|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
44170767|NCT02164539|78964375|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
44170768|NCT02164539|78964376|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
44170769|NCT02164539|78964377|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
44170770|NCT02164539|78964371|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
44170771|NCT02164539|78964372|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
44170772|NCT02164539|78964373|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
44170773|NCT02164539|78964374|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
44170774|NCT02164539|78964375|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
44170775|NCT02164539|78964376|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
44170776|NCT02164539|78964377|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
44170777|NCT02188485|78964394|FG000|Overall Study|Withdrawal by Subject|2|||
44170778|NCT02188485|78964395|FG001|Overall Study|Withdrawal by Subject|1|||
44170779|NCT02188485|78964394|FG000|Overall Study|PI withdrew, lack of capacity|0|||
44170780|NCT02188485|78964395|FG001|Overall Study|PI withdrew, lack of capacity|2|||
44170781|NCT02132247|78964403|FG000|Overall Study|Protocol Violation|1|||
44170782|NCT02132247|78964404|FG001|Overall Study|Protocol Violation|0|||
44449673|NCT00426556|79458215|FG000|Phase II - Core Phase|Adverse Event|0|||
44170783|NCT01629381|78964412|FG000|Overall Study|Withdrawal by Subject|2|||
44170784|NCT01629381|78964413|FG001|Overall Study|Withdrawal by Subject|5|||
44170785|NCT02131311|78964423|FG000|Overall Study|Adverse Event|2|||
44170786|NCT02131311|78964423|FG000|Overall Study|Protocol Violation|1|||
44170787|NCT02131311|78964423|FG000|Overall Study|Lost to Follow-up|1|||
44170788|NCT01628913|78964430|FG000|Overall Study|Adverse Event|12|||
44170789|NCT01628913|78964431|FG001|Overall Study|Adverse Event|5|||
44170790|NCT01628913|78964430|FG000|Overall Study|Disease Progression|11|||
44170791|NCT01628913|78964431|FG001|Overall Study|Disease Progression|14|||
44170792|NCT01628913|78964430|FG000|Overall Study|Protocol Violation|1|||
44170793|NCT01628913|78964431|FG001|Overall Study|Protocol Violation|0|||
44170794|NCT01628913|78964430|FG000|Overall Study|Death|1|||
44170795|NCT01628913|78964431|FG001|Overall Study|Death|0|||
44170796|NCT01628913|78964430|FG000|Overall Study|study terminated by Sponsor|4|||
44170797|NCT01628913|78964431|FG001|Overall Study|study terminated by Sponsor|9|||
44170798|NCT01628913|78964430|FG000|Overall Study|Withdrawal by Subject|1|||
44170799|NCT01628913|78964431|FG001|Overall Study|Withdrawal by Subject|0|||
44170800|NCT01628913|78964430|FG000|Overall Study|Physician Decision|1|||
44170801|NCT01628913|78964431|FG001|Overall Study|Physician Decision|3|||
44170802|NCT02164383|78964439|FG000|Overall Study|Lost to Follow-up|1|||
44170803|NCT02164383|78964440|FG001|Overall Study|Lost to Follow-up|0|||
44170804|NCT02131233|78964448|FG000|Overall Study|Not Treated|2|||
44170805|NCT02131233|78964449|FG001|Overall Study|Not Treated|3|||
44170806|NCT02131233|78964448|FG000|Overall Study|Adverse Event|7|||
44170807|NCT02131233|78964449|FG001|Overall Study|Adverse Event|6|||
44170808|NCT02131233|78964448|FG000|Overall Study|Death|0|||
44170809|NCT02131233|78964449|FG001|Overall Study|Death|1|||
44170810|NCT02131233|78964448|FG000|Overall Study|Lack of Efficacy|6|||
44170811|NCT02131233|78964449|FG001|Overall Study|Lack of Efficacy|3|||
44170812|NCT02131233|78964448|FG000|Overall Study|Lost to Follow-up|14|||
44170813|NCT02131233|78964449|FG001|Overall Study|Lost to Follow-up|13|||
44170814|NCT02131233|78964448|FG000|Overall Study|Non-Compliance With Study Drug|8|||
44170815|NCT02131233|78964449|FG001|Overall Study|Non-Compliance With Study Drug|5|||
44170816|NCT02131233|78964448|FG000|Overall Study|Physician Decision|7|||
44170817|NCT02131233|78964449|FG001|Overall Study|Physician Decision|0|||
44170818|NCT02131233|78964448|FG000|Overall Study|Pregnancy|4|||
44170819|NCT02131233|78964449|FG001|Overall Study|Pregnancy|0|||
44170820|NCT02131233|78964448|FG000|Overall Study|Withdrawal by Subject|18|||
44170821|NCT02131233|78964449|FG001|Overall Study|Withdrawal by Subject|11|||
44170822|NCT02131155|78964457|FG000|Overall Study|Adverse Event|1|||
44170823|NCT02131155|78964458|FG001|Overall Study|Adverse Event|0|||
44170824|NCT02131155|78964457|FG000|Overall Study|Treatment completed|1|||
44170825|NCT02131155|78964458|FG001|Overall Study|Treatment completed|0|||
44170826|NCT02131155|78964457|FG000|Overall Study|Primary tumour recurrence|2|||
44170827|NCT02131155|78964458|FG001|Overall Study|Primary tumour recurrence|1|||
44170828|NCT02131155|78964457|FG000|Overall Study|Refused to continue study medication|1|||
44170829|NCT02131155|78964458|FG001|Overall Study|Refused to continue study medication|0|||
44170830|NCT02131155|78964457|FG000|Overall Study|Study early termination|20|||
44170831|NCT02131155|78964458|FG001|Overall Study|Study early termination|10|||
44170832|NCT01933594|78964470|FG000|Overall Study|Lost to Follow-up|1|||
44170833|NCT01933594|78964471|FG001|Overall Study|Lost to Follow-up|0|||
44170834|NCT01933594|78964472|FG002|Overall Study|Lost to Follow-up|0|||
44170835|NCT01933594|78964473|FG003|Overall Study|Lost to Follow-up|0|||
44170836|NCT01933594|78964474|FG004|Overall Study|Lost to Follow-up|1|||
44170837|NCT01933594|78964475|FG005|Overall Study|Lost to Follow-up|0|||
44170838|NCT01933594|78964470|FG000|Overall Study|Ineligible for subsequent study step|0|||
44170839|NCT01933594|78964471|FG001|Overall Study|Ineligible for subsequent study step|0|||
44170840|NCT01933594|78964472|FG002|Overall Study|Ineligible for subsequent study step|0|||
44170841|NCT01933594|78964473|FG003|Overall Study|Ineligible for subsequent study step|0|||
44170842|NCT01933594|78964474|FG004|Overall Study|Ineligible for subsequent study step|1|||
44170843|NCT01933594|78964475|FG005|Overall Study|Ineligible for subsequent study step|0|||
44170844|NCT01932970|78964493|FG000|Overall Study|Withdrawal by Subject|5|||
44170845|NCT01932970|78964493|FG000|Overall Study|Death|1|||
44170846|NCT01932970|78964493|FG000|Overall Study|Lost to Follow-up|2|||
44170847|NCT01932970|78964493|FG000|Overall Study|Protocol Specified Criteria|10|||
44170848|NCT01912768|78964499|FG000|Overall Study|Adverse Event|2|||
44449674|NCT00426556|79458216|FG001|Phase II - Core Phase|Adverse Event|0|||
44170849|NCT01912768|78964500|FG001|Overall Study|Adverse Event|0|||
44170850|NCT01912768|78964499|FG000|Overall Study|Lost to Follow-up|2|||
44170851|NCT01912768|78964500|FG001|Overall Study|Lost to Follow-up|1|||
44170852|NCT01912768|78964499|FG000|Overall Study|Withdrawal by Subject|5|||
44170853|NCT01912768|78964500|FG001|Overall Study|Withdrawal by Subject|3|||
44170854|NCT01912768|78964499|FG000|Overall Study|Randomized in error|1|||
44170855|NCT01912768|78964500|FG001|Overall Study|Randomized in error|0|||
44170856|NCT02305849|78964510|FG000|Overall Study|Adverse Event|10|||
44170857|NCT02305849|78964511|FG001|Overall Study|Adverse Event|12|||
44170858|NCT02305849|78964512|FG002|Overall Study|Adverse Event|7|||
44170859|NCT02305849|78964513|FG003|Overall Study|Adverse Event|3|||
44170860|NCT02305849|78964510|FG000|Overall Study|Lack of Efficacy|10|||
44170861|NCT02305849|78964511|FG001|Overall Study|Lack of Efficacy|6|||
44170862|NCT02305849|78964512|FG002|Overall Study|Lack of Efficacy|3|||
44170863|NCT02305849|78964513|FG003|Overall Study|Lack of Efficacy|9|||
44170864|NCT02305849|78964510|FG000|Overall Study|Withdrawal by Subject|2|||
44170865|NCT02305849|78964511|FG001|Overall Study|Withdrawal by Subject|2|||
44170866|NCT02305849|78964512|FG002|Overall Study|Withdrawal by Subject|1|||
44170867|NCT02305849|78964513|FG003|Overall Study|Withdrawal by Subject|4|||
44170868|NCT02305849|78964510|FG000|Overall Study|Lost to Follow-up|0|||
44170869|NCT02305849|78964511|FG001|Overall Study|Lost to Follow-up|2|||
44170870|NCT02305849|78964512|FG002|Overall Study|Lost to Follow-up|0|||
44170871|NCT02305849|78964513|FG003|Overall Study|Lost to Follow-up|0|||
44170872|NCT02305849|78964510|FG000|Overall Study|Protocol Violation|3|||
44170873|NCT02305849|78964511|FG001|Overall Study|Protocol Violation|2|||
44170874|NCT02305849|78964512|FG002|Overall Study|Protocol Violation|1|||
44170875|NCT02305849|78964513|FG003|Overall Study|Protocol Violation|1|||
44170876|NCT02305849|78964510|FG000|Overall Study|Lab data met discontinuation criteria|0|||
44170877|NCT02305849|78964511|FG001|Overall Study|Lab data met discontinuation criteria|1|||
44170878|NCT02305849|78964512|FG002|Overall Study|Lab data met discontinuation criteria|2|||
44170879|NCT02305849|78964513|FG003|Overall Study|Lab data met discontinuation criteria|1|||
44170880|NCT02305849|78964510|FG000|Overall Study|Miscellaneous|1|||
44170881|NCT02305849|78964511|FG001|Overall Study|Miscellaneous|2|||
44170882|NCT02305849|78964512|FG002|Overall Study|Miscellaneous|4|||
44170883|NCT02305849|78964513|FG003|Overall Study|Miscellaneous|1|||
44170884|NCT02305849|78964510|FG000|Overall Study|Not fulfill eligibility criteria|1|||
44170885|NCT02305849|78964511|FG001|Overall Study|Not fulfill eligibility criteria|1|||
44170886|NCT02305849|78964512|FG002|Overall Study|Not fulfill eligibility criteria|0|||
44170887|NCT02305849|78964513|FG003|Overall Study|Not fulfill eligibility criteria|0|||
44170888|NCT02371759|78964552|FG000|Overall Study|Protocol Violation|3|||
44170889|NCT02371759|78964553|FG001|Overall Study|Protocol Violation|1|||
44170890|NCT02371759|78964554|FG002|Overall Study|Protocol Violation|1|||
44170891|NCT02371759|78964555|FG003|Overall Study|Protocol Violation|0|||
44170892|NCT02371759|78964556|FG004|Overall Study|Protocol Violation|3|||
44170893|NCT02371759|78964557|FG005|Overall Study|Protocol Violation|1|||
44170894|NCT02371759|78964558|FG006|Overall Study|Protocol Violation|0|||
44170895|NCT02371759|78964559|FG007|Overall Study|Protocol Violation|3|||
44170896|NCT02371759|78964552|FG000|Overall Study|Withdrawal by Subject|0|||
44170897|NCT02371759|78964553|FG001|Overall Study|Withdrawal by Subject|0|||
44170898|NCT02371759|78964554|FG002|Overall Study|Withdrawal by Subject|0|||
44170899|NCT02371759|78964555|FG003|Overall Study|Withdrawal by Subject|0|||
44170900|NCT02371759|78964556|FG004|Overall Study|Withdrawal by Subject|0|||
44170901|NCT02371759|78964557|FG005|Overall Study|Withdrawal by Subject|0|||
44170902|NCT02371759|78964558|FG006|Overall Study|Withdrawal by Subject|0|||
44170903|NCT02371759|78964559|FG007|Overall Study|Withdrawal by Subject|1|||
44170904|NCT02531633|78964582|FG000|Part A (52 Weeks)|Sponsor request|24|||
44170905|NCT02531633|78964583|FG001|Part A (52 Weeks)|Sponsor request|24|||
44170906|NCT02531633|78964584|FG002|Part A (52 Weeks)|Sponsor request|18|||
44170907|NCT02531633|78964585|FG003|Part A (52 Weeks)|Sponsor request|18|||
44170908|NCT02531633|78964586|FG004|Part A (52 Weeks)|Sponsor request|19|||
44170909|NCT02531633|78964587|FG005|Part A (52 Weeks)|Sponsor request|0|||
44170910|NCT02531633|78964588|FG006|Part A (52 Weeks)|Sponsor request|0|||
44170911|NCT02531633|78964589|FG007|Part A (52 Weeks)|Sponsor request|0|||
44170912|NCT02531633|78964590|FG008|Part A (52 Weeks)|Sponsor request|0|||
44170913|NCT02531633|78964591|FG009|Part A (52 Weeks)|Sponsor request|0|||
44170914|NCT02531633|78964582|FG000|Part A (52 Weeks)|Protocol Violation|1|||
44170915|NCT02531633|78964583|FG001|Part A (52 Weeks)|Protocol Violation|0|||
44170916|NCT02531633|78964584|FG002|Part A (52 Weeks)|Protocol Violation|0|||
44170917|NCT02531633|78964585|FG003|Part A (52 Weeks)|Protocol Violation|0|||
44170918|NCT02531633|78964586|FG004|Part A (52 Weeks)|Protocol Violation|0|||
44170919|NCT02531633|78964587|FG005|Part A (52 Weeks)|Protocol Violation|0|||
44170920|NCT02531633|78964588|FG006|Part A (52 Weeks)|Protocol Violation|0|||
44170921|NCT02531633|78964589|FG007|Part A (52 Weeks)|Protocol Violation|0|||
44170922|NCT02531633|78964590|FG008|Part A (52 Weeks)|Protocol Violation|0|||
44170923|NCT02531633|78964591|FG009|Part A (52 Weeks)|Protocol Violation|0|||
44170924|NCT02531633|78964582|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
44170925|NCT02531633|78964583|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
44170926|NCT02531633|78964584|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
44170927|NCT02531633|78964585|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
44170928|NCT02531633|78964586|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
44170929|NCT02531633|78964587|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
44170930|NCT02531633|78964588|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
44170931|NCT02531633|78964589|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
44170932|NCT02531633|78964590|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
44170933|NCT02531633|78964591|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
44170934|NCT02531633|78964582|FG000|Part A (52 Weeks)|Physician Decision|1|||
44170935|NCT02531633|78964583|FG001|Part A (52 Weeks)|Physician Decision|4|||
44170936|NCT02531633|78964584|FG002|Part A (52 Weeks)|Physician Decision|3|||
44170937|NCT02531633|78964585|FG003|Part A (52 Weeks)|Physician Decision|1|||
44170938|NCT02531633|78964586|FG004|Part A (52 Weeks)|Physician Decision|0|||
44170939|NCT02531633|78964587|FG005|Part A (52 Weeks)|Physician Decision|0|||
44170940|NCT02531633|78964588|FG006|Part A (52 Weeks)|Physician Decision|0|||
44170941|NCT02531633|78964589|FG007|Part A (52 Weeks)|Physician Decision|0|||
44170942|NCT02531633|78964590|FG008|Part A (52 Weeks)|Physician Decision|0|||
44170943|NCT02531633|78964591|FG009|Part A (52 Weeks)|Physician Decision|0|||
44170944|NCT02531633|78964582|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
44170945|NCT02531633|78964583|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
44170946|NCT02531633|78964584|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
44170947|NCT02531633|78964585|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
44170948|NCT02531633|78964586|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
44170949|NCT02531633|78964587|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
44170950|NCT02531633|78964588|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
44170951|NCT02531633|78964589|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
44170952|NCT02531633|78964590|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
44170953|NCT02531633|78964591|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
44170954|NCT02531633|78964582|FG000|Part A (52 Weeks)|Other|2|||
44170955|NCT02531633|78964583|FG001|Part A (52 Weeks)|Other|0|||
44170956|NCT02531633|78964584|FG002|Part A (52 Weeks)|Other|0|||
44170957|NCT02531633|78964585|FG003|Part A (52 Weeks)|Other|0|||
44170958|NCT02531633|78964586|FG004|Part A (52 Weeks)|Other|0|||
44170959|NCT02531633|78964587|FG005|Part A (52 Weeks)|Other|0|||
44170960|NCT02531633|78964588|FG006|Part A (52 Weeks)|Other|0|||
44170961|NCT02531633|78964589|FG007|Part A (52 Weeks)|Other|0|||
44170962|NCT02531633|78964590|FG008|Part A (52 Weeks)|Other|0|||
44170963|NCT02531633|78964591|FG009|Part A (52 Weeks)|Other|0|||
44170964|NCT02531633|78964582|FG000|Part B (104 Weeks)|Sponsor request|0|||
44170965|NCT02531633|78964583|FG001|Part B (104 Weeks)|Sponsor request|0|||
44170966|NCT02531633|78964584|FG002|Part B (104 Weeks)|Sponsor request|0|||
44170967|NCT02531633|78964585|FG003|Part B (104 Weeks)|Sponsor request|0|||
44170968|NCT02531633|78964586|FG004|Part B (104 Weeks)|Sponsor request|0|||
44170969|NCT02531633|78964587|FG005|Part B (104 Weeks)|Sponsor request|8|||
44170970|NCT02531633|78964588|FG006|Part B (104 Weeks)|Sponsor request|5|||
44170971|NCT02531633|78964589|FG007|Part B (104 Weeks)|Sponsor request|3|||
44170972|NCT02531633|78964590|FG008|Part B (104 Weeks)|Sponsor request|5|||
44170973|NCT02531633|78964591|FG009|Part B (104 Weeks)|Sponsor request|4|||
44170974|NCT02531633|78964582|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
44170975|NCT02531633|78964583|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
44170976|NCT02531633|78964584|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
44170977|NCT02531633|78964585|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
44170978|NCT02531633|78964586|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
44170979|NCT02531633|78964587|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
44170980|NCT02531633|78964588|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
44170981|NCT02531633|78964589|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
44170982|NCT02531633|78964590|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
44170983|NCT02531633|78964591|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
44170984|NCT02536313|78964633|FG000|Overall Study|Lack of Efficacy|0|||
44170985|NCT02536313|78964634|FG001|Overall Study|Lack of Efficacy|1|||
44170986|NCT02187861|78964646|FG000|Overall Study|Adverse Event|2|||
44170987|NCT02187861|78964647|FG001|Overall Study|Adverse Event|1|||
44170988|NCT02187861|78964648|FG002|Overall Study|Adverse Event|2|||
44170989|NCT02187861|78964649|FG003|Overall Study|Adverse Event|1|||
44170990|NCT02187861|78964646|FG000|Overall Study|Death|0|||
44170991|NCT02187861|78964647|FG001|Overall Study|Death|3|||
44170992|NCT02187861|78964648|FG002|Overall Study|Death|1|||
44170993|NCT02187861|78964649|FG003|Overall Study|Death|2|||
44170994|NCT02187861|78964646|FG000|Overall Study|Physician Decision|0|||
44170995|NCT02187861|78964647|FG001|Overall Study|Physician Decision|1|||
44170996|NCT02187861|78964648|FG002|Overall Study|Physician Decision|0|||
44170997|NCT02187861|78964649|FG003|Overall Study|Physician Decision|3|||
44170998|NCT02187861|78964646|FG000|Overall Study|Progressive Disease|4|||
44170999|NCT02187861|78964647|FG001|Overall Study|Progressive Disease|42|||
44171000|NCT02187861|78964648|FG002|Overall Study|Progressive Disease|19|||
44171001|NCT02187861|78964649|FG003|Overall Study|Progressive Disease|22|||
44171002|NCT02187861|78964646|FG000|Overall Study|Withdrawal by Subject|0|||
44171003|NCT02187861|78964647|FG001|Overall Study|Withdrawal by Subject|0|||
44171004|NCT02187861|78964648|FG002|Overall Study|Withdrawal by Subject|3|||
44171005|NCT02187861|78964649|FG003|Overall Study|Withdrawal by Subject|3|||
44449675|NCT00426556|79458217|FG002|Phase II - Core Phase|Adverse Event|0|||
44171006|NCT02187861|78964646|FG000|Overall Study|Other|0|||
44171007|NCT02187861|78964647|FG001|Overall Study|Other|1|||
44171008|NCT02187861|78964648|FG002|Overall Study|Other|7|||
44171009|NCT02187861|78964649|FG003|Overall Study|Other|1|||
44171010|NCT02163993|78964664|FG000|Treatment Period|Adverse Event|0|||
44171011|NCT02163993|78964665|FG001|Treatment Period|Adverse Event|1|||
44171012|NCT02163993|78964666|FG002|Treatment Period|Adverse Event|0|||
44171013|NCT02163993|78964667|FG003|Treatment Period|Adverse Event|0|||
44171014|NCT02163993|78964668|FG004|Treatment Period|Adverse Event|1|||
44171015|NCT02163993|78964664|FG000|Treatment Period|Lost to Follow-up|2|||
44171016|NCT02163993|78964665|FG001|Treatment Period|Lost to Follow-up|3|||
44171017|NCT02163993|78964666|FG002|Treatment Period|Lost to Follow-up|1|||
44171018|NCT02163993|78964667|FG003|Treatment Period|Lost to Follow-up|3|||
44171019|NCT02163993|78964668|FG004|Treatment Period|Lost to Follow-up|1|||
44171020|NCT02163993|78964664|FG000|Treatment Period|Physician Decision|1|||
44171021|NCT02163993|78964665|FG001|Treatment Period|Physician Decision|0|||
44171022|NCT02163993|78964666|FG002|Treatment Period|Physician Decision|0|||
44171023|NCT02163993|78964667|FG003|Treatment Period|Physician Decision|0|||
44171024|NCT02163993|78964668|FG004|Treatment Period|Physician Decision|0|||
44171025|NCT02163993|78964664|FG000|Treatment Period|Protocol Violation|2|||
44171026|NCT02163993|78964665|FG001|Treatment Period|Protocol Violation|1|||
44171027|NCT02163993|78964666|FG002|Treatment Period|Protocol Violation|0|||
44171028|NCT02163993|78964667|FG003|Treatment Period|Protocol Violation|1|||
44171029|NCT02163993|78964668|FG004|Treatment Period|Protocol Violation|2|||
44171030|NCT02163993|78964664|FG000|Treatment Period|Withdrawal by Subject|6|||
44171031|NCT02163993|78964665|FG001|Treatment Period|Withdrawal by Subject|4|||
44171032|NCT02163993|78964666|FG002|Treatment Period|Withdrawal by Subject|1|||
44171033|NCT02163993|78964667|FG003|Treatment Period|Withdrawal by Subject|4|||
44171034|NCT02163993|78964668|FG004|Treatment Period|Withdrawal by Subject|1|||
44171035|NCT02163993|78964664|FG000|Treatment Period|Not treated|1|||
44171036|NCT02163993|78964665|FG001|Treatment Period|Not treated|0|||
44171037|NCT02163993|78964666|FG002|Treatment Period|Not treated|0|||
44171038|NCT02163993|78964667|FG003|Treatment Period|Not treated|1|||
44171039|NCT02163993|78964668|FG004|Treatment Period|Not treated|2|||
44171040|NCT02163993|78964664|FG000|Post-treatment Period|Adverse Event|0|||
44171041|NCT02163993|78964665|FG001|Post-treatment Period|Adverse Event|0|||
44171042|NCT02163993|78964666|FG002|Post-treatment Period|Adverse Event|1|||
44171043|NCT02163993|78964667|FG003|Post-treatment Period|Adverse Event|0|||
44171044|NCT02163993|78964668|FG004|Post-treatment Period|Adverse Event|0|||
44171045|NCT02163993|78964664|FG000|Post-treatment Period|Lost to Follow-up|2|||
44171046|NCT02163993|78964665|FG001|Post-treatment Period|Lost to Follow-up|2|||
44171047|NCT02163993|78964666|FG002|Post-treatment Period|Lost to Follow-up|3|||
44171048|NCT02163993|78964667|FG003|Post-treatment Period|Lost to Follow-up|1|||
44171049|NCT02163993|78964668|FG004|Post-treatment Period|Lost to Follow-up|0|||
44171050|NCT02163993|78964664|FG000|Post-treatment Period|Protocol Violation|0|||
44171051|NCT02163993|78964665|FG001|Post-treatment Period|Protocol Violation|0|||
44171052|NCT02163993|78964666|FG002|Post-treatment Period|Protocol Violation|0|||
44171053|NCT02163993|78964667|FG003|Post-treatment Period|Protocol Violation|0|||
44171054|NCT02163993|78964668|FG004|Post-treatment Period|Protocol Violation|1|||
44171055|NCT02163993|78964664|FG000|Post-treatment Period|Withdrawal by Subject|2|||
44171056|NCT02163993|78964665|FG001|Post-treatment Period|Withdrawal by Subject|4|||
44171057|NCT02163993|78964666|FG002|Post-treatment Period|Withdrawal by Subject|0|||
44171058|NCT02163993|78964667|FG003|Post-treatment Period|Withdrawal by Subject|1|||
44171059|NCT02163993|78964668|FG004|Post-treatment Period|Withdrawal by Subject|2|||
44171060|NCT02527421|78964691|FG000|Overall Study|Withdrawal by Subject|1|||
44171061|NCT02527421|78964692|FG001|Overall Study|Withdrawal by Subject|0|||
44171062|NCT02163915|78964703|FG000|Overall Study|Withdrawal by Subject|2|||
44171063|NCT02163915|78964704|FG001|Overall Study|Withdrawal by Subject|0|||
44171064|NCT02163915|78964705|FG002|Overall Study|Withdrawal by Subject|2|||
44171065|NCT02163915|78964706|FG003|Overall Study|Withdrawal by Subject|2|||
44171066|NCT02163915|78964707|FG004|Overall Study|Withdrawal by Subject|2|||
44171067|NCT02163915|78964703|FG000|Overall Study|Study termination|1|||
44171068|NCT02163915|78964704|FG001|Overall Study|Study termination|0|||
44171069|NCT02163915|78964705|FG002|Overall Study|Study termination|0|||
44171070|NCT02163915|78964706|FG003|Overall Study|Study termination|0|||
44171071|NCT02163915|78964707|FG004|Overall Study|Study termination|2|||
44171072|NCT02163915|78964703|FG000|Overall Study|Physician Decision|0|||
44171073|NCT02163915|78964704|FG001|Overall Study|Physician Decision|0|||
44171074|NCT02163915|78964705|FG002|Overall Study|Physician Decision|0|||
44449676|NCT00426556|79458218|FG003|Phase II - Core Phase|Adverse Event|8|||
44449677|NCT00426556|79458215|FG000|Phase II - Extension Phase|Disease Progression|0|||
44449678|NCT00426556|79458216|FG001|Phase II - Extension Phase|Disease Progression|0|||
44171075|NCT02163915|78964706|FG003|Overall Study|Physician Decision|1|||
44171076|NCT02163915|78964707|FG004|Overall Study|Physician Decision|0|||
44171077|NCT02163759|78964726|FG000|Overall Study|Withdrawal by Subject|1|||
44171078|NCT02163759|78964727|FG001|Overall Study|Withdrawal by Subject|5|||
44171079|NCT02163759|78964728|FG002|Overall Study|Withdrawal by Subject|1|||
44171080|NCT02163759|78964726|FG000|Overall Study|Adverse Event|0|||
44171081|NCT02163759|78964727|FG001|Overall Study|Adverse Event|0|||
44449679|NCT00426556|79458217|FG002|Phase II - Extension Phase|Disease Progression|0|||
44171082|NCT02163759|78964728|FG002|Overall Study|Adverse Event|1|||
44171083|NCT02163759|78964726|FG000|Overall Study|Death|0|||
44171084|NCT02163759|78964727|FG001|Overall Study|Death|0|||
44449680|NCT00426556|79458218|FG003|Phase II - Extension Phase|Disease Progression|21|||
44171085|NCT02163759|78964728|FG002|Overall Study|Death|1|||
44171086|NCT02371369|78964741|FG000|Part 1|Physician Decision|0|||
44171087|NCT02371369|78964742|FG001|Part 1|Physician Decision|3|||
44171088|NCT02371369|78964741|FG000|Part 1|Adverse Event|8|||
44171089|NCT02371369|78964742|FG001|Part 1|Adverse Event|0|||
44171090|NCT02371369|78964741|FG000|Part 1|Withdrawal by Subject|1|||
44171091|NCT02371369|78964742|FG001|Part 1|Withdrawal by Subject|6|||
44171092|NCT02371369|78964741|FG000|Part 1|Disease progression|0|||
44171093|NCT02371369|78964742|FG001|Part 1|Disease progression|1|||
44171094|NCT02371369|78964741|FG000|Part 1|Protocol Violation|0|||
44171095|NCT02371369|78964742|FG001|Part 1|Protocol Violation|1|||
44171096|NCT02371369|78964741|FG000|Part 2|Adverse Event|6|||
44171097|NCT02371369|78964742|FG001|Part 2|Adverse Event|5|||
44171098|NCT02371369|78964741|FG000|Part 2|Withdrawal by Subject|16|||
44171099|NCT02371369|78964742|FG001|Part 2|Withdrawal by Subject|6|||
44171100|NCT02371369|78964741|FG000|Part 2|Investigator decision|1|||
44171101|NCT02371369|78964742|FG001|Part 2|Investigator decision|2|||
44171102|NCT02371369|78964741|FG000|Part 2|Death|0|||
44171103|NCT02371369|78964742|FG001|Part 2|Death|1|||
44171104|NCT02371369|78964741|FG000|Part 2|Disease progression|1|||
44171105|NCT02371369|78964742|FG001|Part 2|Disease progression|0|||
44171106|NCT02371369|78964741|FG000|Part 2|Subject Noncompliance|1|||
44171107|NCT02371369|78964742|FG001|Part 2|Subject Noncompliance|0|||
44171108|NCT02371369|78964741|FG000|Part 2|Lost to Follow-up|1|||
44171109|NCT02371369|78964742|FG001|Part 2|Lost to Follow-up|1|||
44171110|NCT02371369|78964741|FG000|Part 2|Subject transitioned to commercial supply|6|||
44171111|NCT02371369|78964742|FG001|Part 2|Subject transitioned to commercial supply|4|||
44171112|NCT02371369|78964741|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
44171113|NCT02371369|78964742|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
44171114|NCT02371369|78964741|FG000|Part 2|Surgical resection of tumor|1|||
44171115|NCT02371369|78964742|FG001|Part 2|Surgical resection of tumor|1|||
44171116|NCT02371369|78964741|FG000|Part 2|Other|0|||
44171117|NCT02371369|78964742|FG001|Part 2|Other|1|||
44171118|NCT02187783|78964764|FG000|Overall Study|Adverse Event|8|||
44171119|NCT02187783|78964764|FG000|Overall Study|Death|3|||
44171120|NCT02187783|78964764|FG000|Overall Study|Progressive disease|80|||
44171121|NCT02187783|78964764|FG000|Overall Study|Protocol Violation|3|||
44171122|NCT02187783|78964764|FG000|Overall Study|Physician Decision|2|||
44171123|NCT02187783|78964764|FG000|Overall Study|Withdrawal by Subject|9|||
44171124|NCT02187783|78964764|FG000|Overall Study|Study terminated by sponsor|1|||
44171125|NCT02337361|78964770|FG000|3-month Follow-up|Lost to Follow-up|19|||
44171126|NCT02337361|78964771|FG001|3-month Follow-up|Lost to Follow-up|14|||
44171127|NCT02337361|78964770|FG000|6-month Follow-up|Lost to Follow-up|2|||
44171128|NCT02337361|78964771|FG001|6-month Follow-up|Lost to Follow-up|4|||
44171129|NCT02336737|78964778|FG000|Overall Study|Withdrawal by Subject|5|||
44171130|NCT02336737|78964778|FG000|Overall Study|Physician Decision|8|||
44171131|NCT02130765|78964787|FG000|Overall Study|Did not receive treatment|4|||
44171132|NCT02130765|78964788|FG001|Overall Study|Did not receive treatment|0|||
44171133|NCT02130765|78964789|FG002|Overall Study|Did not receive treatment|0|||
44171134|NCT02130765|78964790|FG003|Overall Study|Did not receive treatment|0|||
44171135|NCT02305381|78964805|FG000|Overall Study|Unclassified|5|||
44171136|NCT02305381|78964806|FG001|Overall Study|Unclassified|5|||
44171137|NCT02305381|78964807|FG002|Overall Study|Unclassified|7|||
44171138|NCT02336425|78964819|FG000|Overall Study|Study terminated.|2|||
44171139|NCT02336425|78964820|FG001|Overall Study|Study terminated.|2|||
44171140|NCT02336425|78964821|FG002|Overall Study|Study terminated.|3|||
44171141|NCT02336425|78964822|FG003|Overall Study|Study terminated.|3|||
44171142|NCT02163447|78964835|FG000|Overall Study|Withdrawal by Subject|2|||
44171143|NCT02163447|78964836|FG001|Overall Study|Withdrawal by Subject|0|||
44171144|NCT02163447|78964837|FG002|Overall Study|Withdrawal by Subject|1|||
44171145|NCT02163447|78964835|FG000|Overall Study|Lost to Follow-up|1|||
44171146|NCT02163447|78964836|FG001|Overall Study|Lost to Follow-up|3|||
44171147|NCT02163447|78964837|FG002|Overall Study|Lost to Follow-up|0|||
44171148|NCT02163447|78964835|FG000|Overall Study|Moved out of study area|2|||
44171149|NCT02163447|78964836|FG001|Overall Study|Moved out of study area|3|||
44171150|NCT02163447|78964837|FG002|Overall Study|Moved out of study area|2|||
44171151|NCT02163447|78964835|FG000|Overall Study|Became HIV infected at time of delivery|1|||
44171152|NCT02163447|78964836|FG001|Overall Study|Became HIV infected at time of delivery|0|||
44171153|NCT02163447|78964837|FG002|Overall Study|Became HIV infected at time of delivery|0|||
44171154|NCT02370667|78964858|FG000|Overall Study|Lost to Follow-up|0|||
44171155|NCT02370667|78964859|FG001|Overall Study|Lost to Follow-up|1|||
44171156|NCT02370667|78964860|FG002|Overall Study|Lost to Follow-up|0|||
44171157|NCT02130297|78964868|FG000|Overall Study|Lost to Follow-up|4|||
44171158|NCT01931956|78964876|FG000|Overall Study|Death|42|||
44171159|NCT01931956|78964877|FG001|Overall Study|Death|7|||
44171160|NCT01931956|78964878|FG002|Overall Study|Death|379|||
44171161|NCT01931956|78964879|FG003|Overall Study|Death|96|||
44171162|NCT01931956|78964876|FG000|Overall Study|Withdrawal by Subject|5|||
44171163|NCT01931956|78964877|FG001|Overall Study|Withdrawal by Subject|0|||
44171164|NCT01931956|78964878|FG002|Overall Study|Withdrawal by Subject|70|||
44171165|NCT01931956|78964879|FG003|Overall Study|Withdrawal by Subject|30|||
44171166|NCT01931956|78964876|FG000|Overall Study|Lost to Follow-up|2|||
44171167|NCT01931956|78964877|FG001|Overall Study|Lost to Follow-up|0|||
44171168|NCT01931956|78964878|FG002|Overall Study|Lost to Follow-up|11|||
44171169|NCT01931956|78964879|FG003|Overall Study|Lost to Follow-up|7|||
44171170|NCT01931956|78964876|FG000|Overall Study|Expected|2|||
44171171|NCT01931956|78964877|FG001|Overall Study|Expected|0|||
44171172|NCT01931956|78964878|FG002|Overall Study|Expected|6|||
44171173|NCT01931956|78964879|FG003|Overall Study|Expected|0|||
44171174|NCT01931956|78964876|FG000|Overall Study|Not due|0|||
44171175|NCT01931956|78964877|FG001|Overall Study|Not due|0|||
44171176|NCT01931956|78964878|FG002|Overall Study|Not due|21|||
44171177|NCT01931956|78964879|FG003|Overall Study|Not due|0|||
44171178|NCT01887418|78964905|FG000|Overall Study|Travelling difficulties|0|||
44171179|NCT01887418|78964906|FG001|Overall Study|Travelling difficulties|0|||
44171180|NCT01887418|78964907|FG002|Overall Study|Travelling difficulties|1|||
44171181|NCT01886716|78964919|FG000|Week 1|Lost to Follow-up|0|||
44171182|NCT01886716|78964920|FG001|Week 1|Lost to Follow-up|0|||
44171183|NCT01886716|78964921|FG002|Week 1|Lost to Follow-up|2|||
44171184|NCT01886716|78964922|FG003|Week 1|Lost to Follow-up|2|||
44171185|NCT01886716|78964919|FG000|Week 2|Lost to Follow-up|3|||
44171186|NCT01886716|78964920|FG001|Week 2|Lost to Follow-up|2|||
44171187|NCT01886716|78964921|FG002|Week 2|Lost to Follow-up|1|||
44171188|NCT01886716|78964922|FG003|Week 2|Lost to Follow-up|3|||
44171189|NCT01886716|78964919|FG000|Week 3|Lost to Follow-up|1|||
44171190|NCT01886716|78964920|FG001|Week 3|Lost to Follow-up|1|||
44171191|NCT01886716|78964921|FG002|Week 3|Lost to Follow-up|0|||
44171192|NCT01886716|78964922|FG003|Week 3|Lost to Follow-up|1|||
44171193|NCT01912612|78964934|FG000|Overall Study|Adverse Event|4|||
44171194|NCT01912612|78964935|FG001|Overall Study|Adverse Event|0|||
44171195|NCT01912612|78964936|FG002|Overall Study|Adverse Event|0|||
44171196|NCT01912612|78964934|FG000|Overall Study|Withdrew consent|1|||
44171197|NCT01912612|78964935|FG001|Overall Study|Withdrew consent|0|||
44171198|NCT01912612|78964936|FG002|Overall Study|Withdrew consent|0|||
44171199|NCT01912612|78964934|FG000|Overall Study|Study design change|0|||
44171200|NCT01912612|78964935|FG001|Overall Study|Study design change|0|||
44171201|NCT01912612|78964936|FG002|Overall Study|Study design change|3|||
44171202|NCT02370511|78964945|FG000|Overall Study|Death|10|||
44171203|NCT02370511|78964946|FG001|Overall Study|Death|7|||
44171204|NCT02370511|78964947|FG002|Overall Study|Death|1|||
44171205|NCT02370511|78964945|FG000|Overall Study|Withdrawal by Subject|2|||
44171206|NCT02370511|78964946|FG001|Overall Study|Withdrawal by Subject|0|||
44171207|NCT02370511|78964947|FG002|Overall Study|Withdrawal by Subject|0|||
44171208|NCT02370511|78964945|FG000|Overall Study|Lost to Follow-up|0|||
44171209|NCT02370511|78964946|FG001|Overall Study|Lost to Follow-up|4|||
44171210|NCT02370511|78964947|FG002|Overall Study|Lost to Follow-up|0|||
44171211|NCT02303041|78964957|FG000|Overall Study|Adverse Event|1|||
44171212|NCT02303041|78964958|FG001|Overall Study|Adverse Event|2|||
44171213|NCT02302807|78964966|FG000|Overall Study|Withdrawal by Subject|28|||
44171214|NCT02302807|78964967|FG001|Overall Study|Withdrawal by Subject|11|||
44171215|NCT02302807|78964966|FG000|Overall Study|Lost to Follow-up|4|||
44171216|NCT02302807|78964967|FG001|Overall Study|Lost to Follow-up|6|||
44171217|NCT02302807|78964966|FG000|Overall Study|Death|397|||
44171218|NCT02302807|78964967|FG001|Overall Study|Death|385|||
44171219|NCT02302807|78964966|FG000|Overall Study|Study Terminated By Sponsor|35|||
44171220|NCT02302807|78964967|FG001|Overall Study|Study Terminated By Sponsor|64|||
44171221|NCT02302807|78964966|FG000|Overall Study|Physician Decision|0|||
44171222|NCT02302807|78964967|FG001|Overall Study|Physician Decision|1|||
44171223|NCT02335489|78964986|FG000|Overall Study|Sponsor terminated study|4|||
44171224|NCT02335489|78964986|FG000|Overall Study|Lost to Follow-up|1|||
44171225|NCT02335489|78964986|FG000|Overall Study|Withdrawal by Subject|2|||
44171226|NCT02335489|78964986|FG000|Overall Study|Physician Decision|2|||
44171227|NCT02335489|78964986|FG000|Overall Study|Lack of Efficacy|1|||
44171228|NCT02527343|78964992|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
44171229|NCT02527343|78964993|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
44171230|NCT02527343|78964994|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
44171231|NCT02527343|78964995|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
44171232|NCT02527343|78964996|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
44171233|NCT02527343|78964997|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
44171234|NCT02527343|78964992|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
44171235|NCT02527343|78964993|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
44171236|NCT02527343|78964994|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
44171237|NCT02527343|78964995|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
44171238|NCT02527343|78964996|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
44171239|NCT02527343|78964997|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
44171240|NCT02527343|78964992|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44171241|NCT02527343|78964993|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
44171242|NCT02527343|78964994|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44171243|NCT02527343|78964995|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44171244|NCT02527343|78964996|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44171245|NCT02527343|78964997|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44171246|NCT02527343|78964992|FG000|RT Period: Weeks 1 to 52|Other|4|||
44171247|NCT02527343|78964993|FG001|RT Period: Weeks 1 to 52|Other|3|||
44171248|NCT02527343|78964994|FG002|RT Period: Weeks 1 to 52|Other|0|||
44171249|NCT02527343|78964995|FG003|RT Period: Weeks 1 to 52|Other|0|||
44171250|NCT02527343|78964996|FG004|RT Period: Weeks 1 to 52|Other|0|||
44171251|NCT02527343|78964997|FG005|RT Period: Weeks 1 to 52|Other|0|||
44171252|NCT02527343|78964992|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
44171253|NCT02527343|78964993|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
44171254|NCT02527343|78964994|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
44171255|NCT02527343|78964995|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
44171256|NCT02527343|78964996|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
44171257|NCT02527343|78964997|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
44171258|NCT02527343|78964992|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
44171259|NCT02527343|78964993|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
44171260|NCT02527343|78964994|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
44171261|NCT02527343|78964995|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
44171262|NCT02527343|78964996|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
44171263|NCT02527343|78964997|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
44171264|NCT02527343|78964992|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
44171265|NCT02527343|78964993|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
44171266|NCT02527343|78964994|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
44171267|NCT02527343|78964995|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
44171268|NCT02527343|78964996|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
44171269|NCT02527343|78964997|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
44171270|NCT02527343|78964992|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
44171271|NCT02527343|78964993|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
44171272|NCT02527343|78964994|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
44171273|NCT02527343|78964995|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
44171274|NCT02527343|78964996|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
44171275|NCT02527343|78964997|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
44171276|NCT02527343|78964992|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
44171277|NCT02527343|78964993|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
44171278|NCT02527343|78964994|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
44171279|NCT02527343|78964995|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
44171280|NCT02527343|78964996|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
44171281|NCT02527343|78964997|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
44171282|NCT02527343|78964992|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
44171283|NCT02527343|78964993|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
44171284|NCT02527343|78964994|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
44171285|NCT02527343|78964995|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
44171286|NCT02527343|78964996|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
44171287|NCT02527343|78964997|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
44171288|NCT02527343|78964992|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
44171289|NCT02527343|78964993|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
44171290|NCT02527343|78964994|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
44171291|NCT02527343|78964995|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
44171292|NCT02527343|78964996|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
44171293|NCT02527343|78964997|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
44171294|NCT02527343|78964992|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
44171295|NCT02527343|78964993|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
44171296|NCT02527343|78964994|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
44171297|NCT02527343|78964995|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
44171298|NCT02527343|78964996|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
44171299|NCT02527343|78964997|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
44171300|NCT02527343|78964992|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
44171301|NCT02527343|78964993|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
44171302|NCT02527343|78964994|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
44171303|NCT02527343|78964995|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
44171304|NCT02527343|78964996|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
44171305|NCT02527343|78964997|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
44171306|NCT01931566|78965015|FG000|Overall Study|Randomized But Not Treated|6|||
44171307|NCT01931566|78965016|FG001|Overall Study|Randomized But Not Treated|9|||
44171308|NCT01931566|78965017|FG002|Overall Study|Randomized But Not Treated|14|||
44171309|NCT01931566|78965015|FG000|Overall Study|Adverse Event|37|||
44171310|NCT01931566|78965016|FG001|Overall Study|Adverse Event|167|||
44171311|NCT01931566|78965017|FG002|Overall Study|Adverse Event|132|||
44171312|NCT01931566|78965015|FG000|Overall Study|Major Protocol Deviation|5|||
44171313|NCT01931566|78965016|FG001|Overall Study|Major Protocol Deviation|14|||
44171314|NCT01931566|78965017|FG002|Overall Study|Major Protocol Deviation|21|||
44171315|NCT01931566|78965015|FG000|Overall Study|Lost to Follow-up|3|||
44171316|NCT01931566|78965016|FG001|Overall Study|Lost to Follow-up|26|||
44171317|NCT01931566|78965017|FG002|Overall Study|Lost to Follow-up|23|||
44171318|NCT01931566|78965015|FG000|Overall Study|Voluntary Withdrawal|78|||
44171319|NCT01931566|78965016|FG001|Overall Study|Voluntary Withdrawal|245|||
44171320|NCT01931566|78965017|FG002|Overall Study|Voluntary Withdrawal|225|||
44171321|NCT01931566|78965015|FG000|Overall Study|Study Termination|289|||
44171322|NCT01931566|78965016|FG001|Overall Study|Study Termination|968|||
44171323|NCT01931566|78965017|FG002|Overall Study|Study Termination|1037|||
44171324|NCT01931566|78965015|FG000|Overall Study|Reason Not Specified|11|||
44171325|NCT01931566|78965016|FG001|Overall Study|Reason Not Specified|47|||
44171326|NCT01931566|78965017|FG002|Overall Study|Reason Not Specified|53|||
44171327|NCT01931566|78965015|FG000|Overall Study|Missing|0|||
44171328|NCT01931566|78965016|FG001|Overall Study|Missing|0|||
44171329|NCT01931566|78965017|FG002|Overall Study|Missing|1|||
44171330|NCT01912456|78965028|FG000|Period 1|Physician Decision|0|||
44171331|NCT01912456|78965029|FG001|Period 1|Physician Decision|0|||
44171332|NCT01912456|78965030|FG002|Period 1|Physician Decision|1|||
44171333|NCT01912456|78965031|FG003|Period 1|Physician Decision|0|||
44171334|NCT01912456|78965028|FG000|Period 1|non-compliance|1|||
44171335|NCT01912456|78965029|FG001|Period 1|non-compliance|0|||
44171336|NCT01912456|78965030|FG002|Period 1|non-compliance|0|||
44171337|NCT01912456|78965031|FG003|Period 1|non-compliance|1|||
44171338|NCT01912456|78965028|FG000|Period 1|Adverse Event|1|||
44171339|NCT01912456|78965029|FG001|Period 1|Adverse Event|0|||
44171340|NCT01912456|78965030|FG002|Period 1|Adverse Event|0|||
44171341|NCT01912456|78965031|FG003|Period 1|Adverse Event|1|||
44171342|NCT01912456|78965028|FG000|Period 1|Withdrawal by Subject|0|||
44171343|NCT01912456|78965029|FG001|Period 1|Withdrawal by Subject|1|||
44171344|NCT01912456|78965030|FG002|Period 1|Withdrawal by Subject|1|||
44171345|NCT01912456|78965031|FG003|Period 1|Withdrawal by Subject|1|||
44171346|NCT01912456|78965028|FG000|Period 2|Lack of Efficacy|0|||
44171347|NCT01912456|78965029|FG001|Period 2|Lack of Efficacy|2|||
44171348|NCT01912456|78965030|FG002|Period 2|Lack of Efficacy|0|||
44171349|NCT01912456|78965031|FG003|Period 2|Lack of Efficacy|0|||
44171350|NCT01912456|78965028|FG000|Period 2|Adverse Event|0|||
44171351|NCT01912456|78965029|FG001|Period 2|Adverse Event|0|||
44171352|NCT01912456|78965030|FG002|Period 2|Adverse Event|0|||
44171353|NCT01912456|78965031|FG003|Period 2|Adverse Event|1|||
44171354|NCT01885936|78965043|FG000|Overall Study|Withdrawal by Subject|1|||
44171355|NCT01885936|78965044|FG001|Overall Study|Withdrawal by Subject|0|||
44171356|NCT01912222|78965053|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
44171357|NCT01912222|78965054|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
44171358|NCT01912222|78965055|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
44171359|NCT01912222|78965053|FG000|Part B: Treatment Period|Progressive disease|10|||
44171360|NCT01912222|78965054|FG001|Part B: Treatment Period|Progressive disease|12|||
44171361|NCT01912222|78965055|FG002|Part B: Treatment Period|Progressive disease|15|||
44171362|NCT01912222|78965053|FG000|Part B: Treatment Period|Adverse Event|1|||
44171363|NCT01912222|78965054|FG001|Part B: Treatment Period|Adverse Event|2|||
44171364|NCT01912222|78965055|FG002|Part B: Treatment Period|Adverse Event|3|||
44171365|NCT01912222|78965053|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
44171366|NCT01912222|78965054|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
44171367|NCT01912222|78965055|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
44171368|NCT02525861|78965066|FG000|Overall Study|Adverse Event|1|||
44171369|NCT02525861|78965067|FG001|Overall Study|Adverse Event|0|||
44171370|NCT02525861|78965066|FG000|Overall Study|Withdrawal by Subject|0|||
44171371|NCT02525861|78965067|FG001|Overall Study|Withdrawal by Subject|1|||
44171372|NCT02525861|78965066|FG000|Overall Study|Physician Decision|0|||
44171373|NCT02525861|78965067|FG001|Overall Study|Physician Decision|1|||
44171374|NCT02524847|78965075|FG000|Overall Study|Adverse Event|4|||
44171375|NCT02524847|78965075|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
44171376|NCT02524847|78965075|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
44171377|NCT02524847|78965075|FG000|Overall Study|Death|1|||
44171378|NCT02524847|78965075|FG000|Overall Study|Reason not Specified|1|||
44171379|NCT02129205|78965090|FG000|Overall Study|Withdrawal by Subject|0|||
44171380|NCT02129205|78965091|FG001|Overall Study|Withdrawal by Subject|0|||
44171381|NCT02129205|78965092|FG002|Overall Study|Withdrawal by Subject|0|||
44171382|NCT02129205|78965093|FG003|Overall Study|Withdrawal by Subject|0|||
44171383|NCT02129205|78965094|FG004|Overall Study|Withdrawal by Subject|1|||
44171384|NCT02129205|78965095|FG005|Overall Study|Withdrawal by Subject|1|||
44171385|NCT02129205|78965096|FG006|Overall Study|Withdrawal by Subject|1|||
44449681|NCT00426556|79458215|FG000|Phase II - Extension Phase|Adverse Event|0|||
44171386|NCT02129205|78965097|FG007|Overall Study|Withdrawal by Subject|0|||
44171387|NCT02129205|78965098|FG008|Overall Study|Withdrawal by Subject|1|||
44171388|NCT02129205|78965099|FG009|Overall Study|Withdrawal by Subject|0|||
44171389|NCT02129205|78965090|FG000|Overall Study|Other|1|||
44171390|NCT02129205|78965091|FG001|Overall Study|Other|0|||
44171391|NCT02129205|78965092|FG002|Overall Study|Other|0|||
44171392|NCT02129205|78965093|FG003|Overall Study|Other|0|||
44171393|NCT02129205|78965094|FG004|Overall Study|Other|2|||
44171394|NCT02129205|78965095|FG005|Overall Study|Other|3|||
44171395|NCT02129205|78965096|FG006|Overall Study|Other|3|||
44171396|NCT02129205|78965097|FG007|Overall Study|Other|2|||
44171397|NCT02129205|78965098|FG008|Overall Study|Other|1|||
44171398|NCT02129205|78965099|FG009|Overall Study|Other|0|||
44171399|NCT02128269|78965123|FG000|Treatment Period|Adverse Event|1|||
44171400|NCT02128269|78965123|FG000|Treatment Period|Physician Decision|1|||
44171401|NCT01626885|78965127|FG000|Overall Study|Adverse Event|8|||
44171402|NCT01626885|78965127|FG000|Overall Study|Withdrawal by Subject|4|||
44171403|NCT02524379|78965131|FG000|Overall Study|Death|1|||
44171404|NCT02524145|78965138|FG000|Overall Study|Withdrawal by Subject|2|||
44171405|NCT02524145|78965139|FG001|Overall Study|Withdrawal by Subject|2|||
44171406|NCT02524145|78965140|FG002|Overall Study|Withdrawal by Subject|3|||
44171407|NCT01658813|78965148|FG000|Overall Study|Disease progression|3|||
44171408|NCT02187471|78965160|FG000|Overall Study|Protocol Violation|4|||
44171409|NCT02187471|78965161|FG001|Overall Study|Protocol Violation|5|||
44171410|NCT02187471|78965162|FG002|Overall Study|Protocol Violation|4|||
44171411|NCT02187471|78965163|FG003|Overall Study|Protocol Violation|4|||
44171412|NCT02187471|78965160|FG000|Overall Study|Missing|0|||
44171413|NCT02187471|78965161|FG001|Overall Study|Missing|0|||
44171414|NCT02187471|78965162|FG002|Overall Study|Missing|0|||
44171415|NCT02187471|78965163|FG003|Overall Study|Missing|1|||
44171416|NCT02187471|78965160|FG000|Overall Study|Lack of Efficacy|18|||
44171417|NCT02187471|78965161|FG001|Overall Study|Lack of Efficacy|9|||
44171418|NCT02187471|78965162|FG002|Overall Study|Lack of Efficacy|13|||
44171419|NCT02187471|78965163|FG003|Overall Study|Lack of Efficacy|11|||
44171420|NCT02187471|78965160|FG000|Overall Study|Adverse Event|24|||
44171421|NCT02187471|78965161|FG001|Overall Study|Adverse Event|34|||
44171422|NCT02187471|78965162|FG002|Overall Study|Adverse Event|44|||
44171423|NCT02187471|78965163|FG003|Overall Study|Adverse Event|36|||
44171424|NCT02187471|78965160|FG000|Overall Study|Withdrawal by Subject|23|||
44171425|NCT02187471|78965161|FG001|Overall Study|Withdrawal by Subject|29|||
44171426|NCT02187471|78965162|FG002|Overall Study|Withdrawal by Subject|22|||
44171427|NCT02187471|78965163|FG003|Overall Study|Withdrawal by Subject|24|||
44171428|NCT02187471|78965160|FG000|Overall Study|Other|7|||
44171429|NCT02187471|78965161|FG001|Overall Study|Other|5|||
44171430|NCT02187471|78965162|FG002|Overall Study|Other|3|||
44171431|NCT02187471|78965163|FG003|Overall Study|Other|4|||
44171432|NCT02525471|78965174|FG000|Overall Study|Screen Failure|6|||
44171433|NCT02525471|78965174|FG000|Overall Study|Withdrawal by Subject|4|||
44171434|NCT02525471|78965174|FG000|Overall Study|Death|1|||
44171435|NCT01658735|78965182|FG000|Overall Study|Lack of Efficacy|1|||
44171436|NCT01658735|78965183|FG001|Overall Study|Lack of Efficacy|0|||
44171437|NCT01658735|78965184|FG002|Overall Study|Lack of Efficacy|1|||
44171438|NCT01658735|78965182|FG000|Overall Study|Lost to Follow-up|1|||
44171439|NCT01658735|78965183|FG001|Overall Study|Lost to Follow-up|1|||
44171440|NCT01658735|78965184|FG002|Overall Study|Lost to Follow-up|0|||
44171441|NCT01658735|78965182|FG000|Overall Study|Protocol Violation|0|||
44171442|NCT01658735|78965183|FG001|Overall Study|Protocol Violation|1|||
44171443|NCT01658735|78965184|FG002|Overall Study|Protocol Violation|0|||
44171444|NCT01658735|78965182|FG000|Overall Study|Withdrawal by Subject|3|||
44171445|NCT01658735|78965183|FG001|Overall Study|Withdrawal by Subject|5|||
44171446|NCT01658735|78965184|FG002|Overall Study|Withdrawal by Subject|3|||
44171447|NCT02523599|78965194|FG000|Overall Study|Adverse Event|1|||
44171448|NCT02523599|78965195|FG001|Overall Study|Adverse Event|0|||
44171449|NCT02523599|78965194|FG000|Overall Study|Physician Decision|1|||
44171450|NCT02523599|78965195|FG001|Overall Study|Physician Decision|0|||
44171451|NCT02523599|78965194|FG000|Overall Study|Lost to Follow-up|4|||
44171452|NCT02523599|78965195|FG001|Overall Study|Lost to Follow-up|1|||
44171453|NCT02523599|78965194|FG000|Overall Study|Did not return for Day 30 visit|2|||
44171454|NCT02523599|78965195|FG001|Overall Study|Did not return for Day 30 visit|0|||
44171455|NCT02187159|78965205|FG000|Overall Study|Protocol Violation|4|||
44171456|NCT02187159|78965206|FG001|Overall Study|Protocol Violation|6|||
44171457|NCT02187159|78965207|FG002|Overall Study|Protocol Violation|3|||
44171458|NCT02187159|78965208|FG003|Overall Study|Protocol Violation|4|||
44171459|NCT02187159|78965205|FG000|Overall Study|Lack of Efficacy|10|||
44171460|NCT02187159|78965206|FG001|Overall Study|Lack of Efficacy|5|||
44171461|NCT02187159|78965207|FG002|Overall Study|Lack of Efficacy|4|||
44171462|NCT02187159|78965208|FG003|Overall Study|Lack of Efficacy|7|||
44171463|NCT02187159|78965205|FG000|Overall Study|Adverse Event|28|||
44171464|NCT02187159|78965206|FG001|Overall Study|Adverse Event|33|||
44171465|NCT02187159|78965207|FG002|Overall Study|Adverse Event|42|||
44171466|NCT02187159|78965208|FG003|Overall Study|Adverse Event|50|||
44449682|NCT00426556|79458216|FG001|Phase II - Extension Phase|Adverse Event|0|||
44171467|NCT02187159|78965205|FG000|Overall Study|Withdrawal by Subject|24|||
44171468|NCT02187159|78965206|FG001|Overall Study|Withdrawal by Subject|28|||
44171469|NCT02187159|78965207|FG002|Overall Study|Withdrawal by Subject|25|||
44171470|NCT02187159|78965208|FG003|Overall Study|Withdrawal by Subject|26|||
44171471|NCT02187159|78965205|FG000|Overall Study|Other|3|||
44171472|NCT02187159|78965206|FG001|Overall Study|Other|7|||
44171473|NCT02187159|78965207|FG002|Overall Study|Other|3|||
44171474|NCT02187159|78965208|FG003|Overall Study|Other|9|||
44171475|NCT02335411|78965221|FG000|Overall Study|Death|223|||
44171476|NCT02335411|78965222|FG001|Overall Study|Death|22|||
44171477|NCT02335411|78965223|FG002|Overall Study|Death|26|||
44171478|NCT02335411|78965221|FG000|Overall Study|Physician Decision|3|||
44171479|NCT02335411|78965222|FG001|Overall Study|Physician Decision|0|||
44171480|NCT02335411|78965223|FG002|Overall Study|Physician Decision|0|||
44171481|NCT02335411|78965221|FG000|Overall Study|Protocol Violation|1|||
44171482|NCT02335411|78965222|FG001|Overall Study|Protocol Violation|0|||
44171483|NCT02335411|78965223|FG002|Overall Study|Protocol Violation|0|||
44171484|NCT02335411|78965221|FG000|Overall Study|Withdrawal by Subject|11|||
44171485|NCT02335411|78965222|FG001|Overall Study|Withdrawal by Subject|0|||
44171486|NCT02335411|78965223|FG002|Overall Study|Withdrawal by Subject|3|||
44171487|NCT02335411|78965221|FG000|Overall Study|Sponsor Decision|12|||
44171488|NCT02335411|78965222|FG001|Overall Study|Sponsor Decision|3|||
44171489|NCT02335411|78965223|FG002|Overall Study|Sponsor Decision|2|||
44171490|NCT02335411|78965221|FG000|Overall Study|Adverse Event|9|||
44171491|NCT02335411|78965222|FG001|Overall Study|Adverse Event|0|||
44171492|NCT02335411|78965223|FG002|Overall Study|Adverse Event|0|||
44171493|NCT02186301|78965237|FG000|Overall Study|Progressive Disease|7|||
44171494|NCT02186301|78965238|FG001|Overall Study|Progressive Disease|22|||
44171495|NCT02186301|78965239|FG002|Overall Study|Progressive Disease|27|||
44171496|NCT02186301|78965237|FG000|Overall Study|Adverse Event|5|||
44171497|NCT02186301|78965238|FG001|Overall Study|Adverse Event|5|||
44171498|NCT02186301|78965239|FG002|Overall Study|Adverse Event|5|||
44171499|NCT02186301|78965237|FG000|Overall Study|Death|1|||
44171500|NCT02186301|78965238|FG001|Overall Study|Death|0|||
44171501|NCT02186301|78965239|FG002|Overall Study|Death|0|||
44171502|NCT02186301|78965237|FG000|Overall Study|Withdrawal by Subject|5|||
44171503|NCT02186301|78965238|FG001|Overall Study|Withdrawal by Subject|1|||
44171504|NCT02186301|78965239|FG002|Overall Study|Withdrawal by Subject|3|||
44449683|NCT00426556|79458217|FG002|Phase II - Extension Phase|Adverse Event|0|||
44449684|NCT00426556|79458218|FG003|Phase II - Extension Phase|Adverse Event|2|||
44449685|NCT00107653|79458230|FG000|Overall Study|Adverse Event|24|||
44449686|NCT00107653|79458231|FG001|Overall Study|Adverse Event|43|||
44449687|NCT00107653|79458230|FG000|Overall Study|Insufficient Therapeutic Response|25|||
44449688|NCT00107653|79458231|FG001|Overall Study|Insufficient Therapeutic Response|11|||
44449689|NCT00107653|79458230|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
44449690|NCT00107653|79458231|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
44449691|NCT00107653|79458230|FG000|Overall Study|Protocol Violation|1|||
44449692|NCT00107653|79458231|FG001|Overall Study|Protocol Violation|0|||
44449693|NCT00107653|79458230|FG000|Overall Study|Withdrawal by Subject|12|||
44449694|NCT00107653|79458231|FG001|Overall Study|Withdrawal by Subject|13|||
44449695|NCT00107653|79458230|FG000|Overall Study|Lost to Follow-up|13|||
44449696|NCT00107653|79458231|FG001|Overall Study|Lost to Follow-up|5|||
44449697|NCT00107653|79458230|FG000|Overall Study|Administrative Reasons|3|||
44449698|NCT00107653|79458231|FG001|Overall Study|Administrative Reasons|3|||
44449699|NCT03950856|79458241|FG000|Overall Study|Death|1|||
44449700|NCT03950856|79458242|FG001|Overall Study|Death|2|||
44449701|NCT03950856|79458243|FG002|Overall Study|Death|0|||
44449702|NCT03950856|79458244|FG003|Overall Study|Death|0|||
44449703|NCT03950856|79458241|FG000|Overall Study|Lost to Follow-up|5|||
44449704|NCT03950856|79458242|FG001|Overall Study|Lost to Follow-up|6|||
44449705|NCT03950856|79458243|FG002|Overall Study|Lost to Follow-up|8|||
44449706|NCT03950856|79458244|FG003|Overall Study|Lost to Follow-up|2|||
44449707|NCT03950856|79458241|FG000|Overall Study|Protocol Violation|2|||
44449708|NCT03950856|79458242|FG001|Overall Study|Protocol Violation|0|||
44449709|NCT03950856|79458243|FG002|Overall Study|Protocol Violation|0|||
44449710|NCT03950856|79458244|FG003|Overall Study|Protocol Violation|1|||
44171505|NCT02186301|78965237|FG000|Overall Study|Physician Decision|1|||
44171506|NCT02186301|78965238|FG001|Overall Study|Physician Decision|0|||
44171507|NCT02186301|78965239|FG002|Overall Study|Physician Decision|1|||
44171508|NCT02186301|78965237|FG000|Overall Study|Study Terminated by Sponsor|1|||
44171509|NCT02186301|78965238|FG001|Overall Study|Study Terminated by Sponsor|0|||
44171510|NCT02186301|78965239|FG002|Overall Study|Study Terminated by Sponsor|11|||
44171511|NCT02186301|78965237|FG000|Overall Study|Protocol Deviation|0|||
44171512|NCT02186301|78965238|FG001|Overall Study|Protocol Deviation|2|||
44171513|NCT02186301|78965239|FG002|Overall Study|Protocol Deviation|0|||
44171514|NCT02186301|78965237|FG000|Overall Study|Missing|0|||
44171515|NCT02186301|78965238|FG001|Overall Study|Missing|0|||
44171516|NCT02186301|78965239|FG002|Overall Study|Missing|2|||
44171517|NCT02186301|78965237|FG000|Overall Study|Other|0|||
44171518|NCT02186301|78965238|FG001|Overall Study|Other|0|||
44171519|NCT02186301|78965239|FG002|Overall Study|Other|1|||
44171520|NCT02186223|78965249|FG000|Overall Study|Not eligible for device placement|6|||
44171521|NCT02186223|78965249|FG000|Overall Study|Unable to obtain femoral access|3|||
44171522|NCT02186223|78965249|FG000|Overall Study|Death|3|||
44171523|NCT02186223|78965249|FG000|Overall Study|Device in place less than 48 hours|9|||
44171524|NCT02163057|78965256|FG000|Overall Study|Participant Refusal to Continue|2|||
44449711|NCT03950856|79458241|FG000|Overall Study|Withdrawal by Subject|4|||
44449712|NCT03950856|79458242|FG001|Overall Study|Withdrawal by Subject|1|||
44449713|NCT03950856|79458243|FG002|Overall Study|Withdrawal by Subject|3|||
44449714|NCT03950856|79458244|FG003|Overall Study|Withdrawal by Subject|1|||
44449715|NCT03950856|79458241|FG000|Overall Study|Unable to phone|7|||
44449716|NCT03950856|79458242|FG001|Overall Study|Unable to phone|6|||
44449717|NCT03950856|79458243|FG002|Overall Study|Unable to phone|7|||
44171525|NCT02163057|78965257|FG001|Overall Study|Participant Refusal to Continue|2|||
44171526|NCT02163057|78965256|FG000|Overall Study|Participant Significant Noncompliance|0|||
44171527|NCT02163057|78965257|FG001|Overall Study|Participant Significant Noncompliance|1|||
44171528|NCT02163057|78965256|FG000|Overall Study|Progression of Disease|1|||
44171529|NCT02163057|78965257|FG001|Overall Study|Progression of Disease|2|||
44171530|NCT02185521|78965265|FG000|Overall Study|Withdrawal by Subject|1|||
44171531|NCT02185521|78965265|FG000|Overall Study|Protocol Violation|1|||
44171532|NCT01599585|78965272|FG000|Overall Study|Withdrawal by Subject|16|||
44171533|NCT01599585|78965273|FG001|Overall Study|Withdrawal by Subject|9|||
44171534|NCT01599585|78965272|FG000|Overall Study|Lost to Follow-up|3|||
44171535|NCT01599585|78965273|FG001|Overall Study|Lost to Follow-up|5|||
44171536|NCT01599585|78965272|FG000|Overall Study|randomized did not start treatment|3|||
44171537|NCT01599585|78965273|FG001|Overall Study|randomized did not start treatment|3|||
44171538|NCT02185053|78965279|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
44171539|NCT02185053|78965280|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
44171540|NCT02185053|78965281|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
44171541|NCT02185053|78965279|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
44171542|NCT02185053|78965280|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
44171543|NCT02185053|78965281|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
44171544|NCT02185053|78965279|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
44171545|NCT02185053|78965280|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
44171546|NCT02185053|78965281|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
44171547|NCT02185053|78965279|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
44171548|NCT02185053|78965280|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
44171549|NCT02185053|78965281|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
44171550|NCT02185053|78965279|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
44171551|NCT02185053|78965280|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
44171552|NCT02185053|78965281|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
44171553|NCT02185053|78965279|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
44171554|NCT02185053|78965280|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
44171555|NCT02185053|78965281|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
44171556|NCT02185053|78965279|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
44171557|NCT02185053|78965280|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
44171558|NCT02185053|78965281|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
44171559|NCT02185053|78965279|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
44171560|NCT02185053|78965280|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
44171561|NCT02185053|78965281|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
44171562|NCT02161731|78965290|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
44171563|NCT02161731|78965291|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
44171564|NCT02161731|78965290|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
44171565|NCT02161731|78965291|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
44171566|NCT02124759|78965301|FG000|Overall Study|Withdrawal by Subject|3|||
44171567|NCT02124759|78965302|FG001|Overall Study|Withdrawal by Subject|1|||
44171568|NCT02124759|78965303|FG002|Overall Study|Withdrawal by Subject|1|||
44171569|NCT02124759|78965301|FG000|Overall Study|Screen Fail|2|||
44171570|NCT02124759|78965302|FG001|Overall Study|Screen Fail|2|||
44171571|NCT02124759|78965303|FG002|Overall Study|Screen Fail|3|||
44171572|NCT02302339|78965320|FG000|Overall Study|Lost to Follow-up|1|||
44171573|NCT02302339|78965321|FG001|Overall Study|Lost to Follow-up|0|||
44171574|NCT02302339|78965322|FG002|Overall Study|Lost to Follow-up|0|||
44171575|NCT02302339|78965323|FG003|Overall Study|Lost to Follow-up|0|||
44171576|NCT02302339|78965320|FG000|Overall Study|Withdrawal by Subject|0|||
44171577|NCT02302339|78965321|FG001|Overall Study|Withdrawal by Subject|2|||
44171578|NCT02302339|78965322|FG002|Overall Study|Withdrawal by Subject|1|||
44171579|NCT02302339|78965323|FG003|Overall Study|Withdrawal by Subject|0|||
44171580|NCT02161575|78965334|FG000|Overall Study|Protocol Violation|8|||
44171581|NCT02161575|78965334|FG000|Overall Study|Lack of Efficacy|1|||
44171582|NCT02161575|78965334|FG000|Overall Study|Adverse Event|2|||
44171583|NCT02370121|78965340|FG000|Overall Study|Lost to Follow-up|1|||
44171584|NCT02370121|78965341|FG001|Overall Study|Lost to Follow-up|1|||
44360818|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44171585|NCT02161185|78965347|FG000|Treatment Phase|Administrative/Other|7|||
44171586|NCT02159469|78965351|FG000|Overall Study|Missing Completion status|1|||
44171587|NCT02159469|78965351|FG000|Overall Study|Adverse Event|5|||
44171588|NCT02159469|78965351|FG000|Overall Study|Non-compliance|2|||
44171589|NCT02159469|78965351|FG000|Overall Study|Withdrawal by Subject|9|||
44360819|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44360820|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44171590|NCT02159469|78965351|FG000|Overall Study|Lost to Follow-up|1|||
44171591|NCT02159469|78965351|FG000|Overall Study|Sponsor's request|2|||
44171592|NCT02159469|78965351|FG000|Overall Study|Met Stopping Criteria|3|||
44171593|NCT02159469|78965351|FG000|Overall Study|Other|1|||
44171594|NCT02159469|78965351|FG000|Overall Study|Multiple|29|||
44171595|NCT02123511|78965358|FG000|Overall Study|Cancelled treatment|1|||
44171596|NCT02123511|78965359|FG001|Overall Study|Cancelled treatment|0|||
44171597|NCT02123511|78965358|FG000|Overall Study|Incomplete data|1|||
44171598|NCT02123511|78965359|FG001|Overall Study|Incomplete data|3|||
44171599|NCT02123511|78965358|FG000|Overall Study|Ineligible|0|||
44171600|NCT02123511|78965359|FG001|Overall Study|Ineligible|1|||
44171601|NCT02122887|78965367|FG000|Overall Study|Withdrawal by Subject|20|||
44171602|NCT02122887|78965368|FG001|Overall Study|Withdrawal by Subject|2|||
44171603|NCT02182947|78965374|FG000|Overall Study|Withdrawal by Subject|7|||
44171604|NCT02182947|78965374|FG000|Overall Study|Lost to Follow-up|3|||
44171605|NCT02182947|78965374|FG000|Overall Study|Failed screening activities|8|||
44171606|NCT02370043|78965378|FG000|Overall Study|Withdrawal by Subject|0|||
44171607|NCT02370043|78965379|FG001|Overall Study|Withdrawal by Subject|0|||
44171608|NCT02370043|78965380|FG002|Overall Study|Withdrawal by Subject|0|||
44171609|NCT02370043|78965381|FG003|Overall Study|Withdrawal by Subject|0|||
44171610|NCT02370043|78965382|FG004|Overall Study|Withdrawal by Subject|1|||
44171611|NCT02370043|78965383|FG005|Overall Study|Withdrawal by Subject|1|||
44171612|NCT02301403|78965413|FG000|Overall Study|Withdrawal by Subject|28|||
44171613|NCT02301403|78965414|FG001|Overall Study|Withdrawal by Subject|41|||
44171614|NCT02301169|78965422|FG000|Overall Study|Adverse Event|1|||
44171615|NCT02301169|78965423|FG001|Overall Study|Adverse Event|0|||
44171616|NCT02333383|78965429|FG000|Overall Study|Adalimumab discontinuation|21|||
44171617|NCT02333383|78965429|FG000|Overall Study|Lost to Follow-up|15|||
44171618|NCT02333383|78965429|FG000|Overall Study|Withdrawal by Subject|3|||
44171619|NCT02333383|78965429|FG000|Overall Study|Transfer to another hospital|2|||
44171620|NCT02332915|78965435|FG000|Overall Study|Moved out of region|3|||
44171621|NCT02332915|78965436|FG001|Overall Study|Moved out of region|0|||
44171622|NCT02332915|78965435|FG000|Overall Study|Unrelated illness|1|||
44171623|NCT02332915|78965436|FG001|Overall Study|Unrelated illness|1|||
44171624|NCT02332915|78965435|FG000|Overall Study|Travel distance prohibitive|0|||
44171625|NCT02332915|78965436|FG001|Overall Study|Travel distance prohibitive|1|||
44171626|NCT02332915|78965435|FG000|Overall Study|did not meet inclusion criteria|2|||
44171627|NCT02332915|78965436|FG001|Overall Study|did not meet inclusion criteria|4|||
44171628|NCT02369341|78965449|FG000|Overall Study|Migrated/moved from study area|1|||
44171629|NCT02369341|78965450|FG001|Overall Study|Migrated/moved from study area|0|||
44171630|NCT02121795|78965462|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
44171631|NCT02121795|78965463|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
44171632|NCT02121795|78965462|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
44171633|NCT02121795|78965463|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
44171634|NCT02121795|78965462|FG000|Double-Blind Phase|Lost to Follow-up|7|||
44171635|NCT02121795|78965463|FG001|Double-Blind Phase|Lost to Follow-up|4|||
44171636|NCT02121795|78965462|FG000|Double-Blind Phase|Physician Decision|2|||
44171637|NCT02121795|78965463|FG001|Double-Blind Phase|Physician Decision|5|||
44171638|NCT02121795|78965462|FG000|Double-Blind Phase|Adverse Event|5|||
44171639|NCT02121795|78965463|FG001|Double-Blind Phase|Adverse Event|0|||
44171640|NCT02121795|78965462|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
44171641|NCT02121795|78965463|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
44171642|NCT02121795|78965462|FG000|Double-Blind Phase|Protocol Violation|0|||
44171643|NCT02121795|78965463|FG001|Double-Blind Phase|Protocol Violation|3|||
44171644|NCT02121795|78965462|FG000|Double-Blind Phase|Death|1|||
44171645|NCT02121795|78965463|FG001|Double-Blind Phase|Death|1|||
44171646|NCT02121795|78965462|FG000|Open-Label Phase|Physician Decision|8|||
44171647|NCT02121795|78965463|FG001|Open-Label Phase|Physician Decision|8|||
44171648|NCT02121795|78965462|FG000|Open-Label Phase|Withdrawal by Subject|3|||
44171649|NCT02121795|78965463|FG001|Open-Label Phase|Withdrawal by Subject|2|||
44171650|NCT02121795|78965462|FG000|Open-Label Phase|Lost to Follow-up|1|||
44171651|NCT02121795|78965463|FG001|Open-Label Phase|Lost to Follow-up|0|||
44171652|NCT02158533|78965474|FG000|Stage 1|Adverse Event|6|||
44171653|NCT02158533|78965475|FG001|Stage 1|Adverse Event|4|||
44171654|NCT02158533|78965476|FG002|Stage 1|Adverse Event|7|||
44171655|NCT02158533|78965477|FG003|Stage 1|Adverse Event|0|||
44171656|NCT02158533|78965478|FG004|Stage 1|Adverse Event|0|||
44171657|NCT02158533|78965479|FG005|Stage 1|Adverse Event|0|||
44171658|NCT02158533|78965474|FG000|Stage 1|Withdrawal by Subject|3|||
44171659|NCT02158533|78965475|FG001|Stage 1|Withdrawal by Subject|2|||
44171660|NCT02158533|78965476|FG002|Stage 1|Withdrawal by Subject|1|||
44171661|NCT02158533|78965477|FG003|Stage 1|Withdrawal by Subject|0|||
44264192|NCT03155997|79164473|FG000|Overall Study|Missing disposition data|0|||
44171662|NCT02158533|78965478|FG004|Stage 1|Withdrawal by Subject|0|||
44171663|NCT02158533|78965479|FG005|Stage 1|Withdrawal by Subject|0|||
44171664|NCT02158533|78965474|FG000|Stage 1|Lack of Efficacy|1|||
44171665|NCT02158533|78965475|FG001|Stage 1|Lack of Efficacy|0|||
44171666|NCT02158533|78965476|FG002|Stage 1|Lack of Efficacy|0|||
44171667|NCT02158533|78965477|FG003|Stage 1|Lack of Efficacy|0|||
44171668|NCT02158533|78965478|FG004|Stage 1|Lack of Efficacy|0|||
44171669|NCT02158533|78965479|FG005|Stage 1|Lack of Efficacy|0|||
44171670|NCT02158533|78965474|FG000|Stage 1|Lost to Follow-up|3|||
44171671|NCT02158533|78965475|FG001|Stage 1|Lost to Follow-up|1|||
44171672|NCT02158533|78965476|FG002|Stage 1|Lost to Follow-up|0|||
44171673|NCT02158533|78965477|FG003|Stage 1|Lost to Follow-up|0|||
44171674|NCT02158533|78965478|FG004|Stage 1|Lost to Follow-up|0|||
44171675|NCT02158533|78965479|FG005|Stage 1|Lost to Follow-up|0|||
44171676|NCT02158533|78965474|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
44171677|NCT02158533|78965475|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
44449718|NCT03950856|79458244|FG003|Overall Study|Unable to phone|2|||
44449719|NCT00433654|79458258|FG000|Overall Study|Death|4|||
44171678|NCT02158533|78965476|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
44171679|NCT02158533|78965477|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
44171680|NCT02158533|78965478|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
44171681|NCT02158533|78965479|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
44171682|NCT02158533|78965474|FG000|Stage 1|Non-compliance with study visits|1|||
44171683|NCT02158533|78965475|FG001|Stage 1|Non-compliance with study visits|0|||
44171684|NCT02158533|78965476|FG002|Stage 1|Non-compliance with study visits|0|||
44171685|NCT02158533|78965477|FG003|Stage 1|Non-compliance with study visits|0|||
44171686|NCT02158533|78965478|FG004|Stage 1|Non-compliance with study visits|0|||
44171687|NCT02158533|78965479|FG005|Stage 1|Non-compliance with study visits|0|||
44171688|NCT02158533|78965474|FG000|Stage 2|Adverse Event|0|||
44171689|NCT02158533|78965475|FG001|Stage 2|Adverse Event|0|||
44171690|NCT02158533|78965476|FG002|Stage 2|Adverse Event|0|||
44171691|NCT02158533|78965477|FG003|Stage 2|Adverse Event|0|||
44171692|NCT02158533|78965478|FG004|Stage 2|Adverse Event|0|||
44171693|NCT02158533|78965479|FG005|Stage 2|Adverse Event|1|||
44171694|NCT02158533|78965474|FG000|Stage 2|Lack of Efficacy|0|||
44171695|NCT02158533|78965475|FG001|Stage 2|Lack of Efficacy|0|||
44171696|NCT02158533|78965476|FG002|Stage 2|Lack of Efficacy|0|||
44171697|NCT02158533|78965477|FG003|Stage 2|Lack of Efficacy|0|||
44171698|NCT02158533|78965478|FG004|Stage 2|Lack of Efficacy|1|||
44171699|NCT02158533|78965479|FG005|Stage 2|Lack of Efficacy|0|||
44171700|NCT02158533|78965474|FG000|Stage 2|Lost to Follow-up|0|||
44171701|NCT02158533|78965475|FG001|Stage 2|Lost to Follow-up|0|||
44171702|NCT02158533|78965476|FG002|Stage 2|Lost to Follow-up|0|||
44171703|NCT02158533|78965477|FG003|Stage 2|Lost to Follow-up|1|||
44171704|NCT02158533|78965478|FG004|Stage 2|Lost to Follow-up|1|||
44171705|NCT02158533|78965479|FG005|Stage 2|Lost to Follow-up|2|||
44171706|NCT02158533|78965474|FG000|Stage 2|Withdrawal by Subject|0|||
44171707|NCT02158533|78965475|FG001|Stage 2|Withdrawal by Subject|0|||
44171708|NCT02158533|78965476|FG002|Stage 2|Withdrawal by Subject|0|||
44171709|NCT02158533|78965477|FG003|Stage 2|Withdrawal by Subject|0|||
44171710|NCT02158533|78965478|FG004|Stage 2|Withdrawal by Subject|1|||
44171711|NCT02158533|78965479|FG005|Stage 2|Withdrawal by Subject|2|||
44171712|NCT02158533|78965474|FG000|Stage 2|Physician Decision|0|||
44171713|NCT02158533|78965475|FG001|Stage 2|Physician Decision|0|||
44171714|NCT02158533|78965476|FG002|Stage 2|Physician Decision|0|||
44171715|NCT02158533|78965477|FG003|Stage 2|Physician Decision|0|||
44171716|NCT02158533|78965478|FG004|Stage 2|Physician Decision|1|||
44171717|NCT02158533|78965479|FG005|Stage 2|Physician Decision|0|||
44171718|NCT02158533|78965474|FG000|Stage 2|Pregnancy|0|||
44171719|NCT02158533|78965475|FG001|Stage 2|Pregnancy|0|||
44171720|NCT02158533|78965476|FG002|Stage 2|Pregnancy|0|||
44171721|NCT02158533|78965477|FG003|Stage 2|Pregnancy|1|||
44171722|NCT02158533|78965478|FG004|Stage 2|Pregnancy|0|||
44171723|NCT02158533|78965479|FG005|Stage 2|Pregnancy|0|||
44171724|NCT02158533|78965474|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
44171725|NCT02158533|78965475|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
44171726|NCT02158533|78965476|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
44171727|NCT02158533|78965477|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
44171728|NCT02158533|78965478|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
44171729|NCT02158533|78965479|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
44171730|NCT02158533|78965474|FG000|Stage 2|Non-adherence with study visits|0|||
44171731|NCT02158533|78965475|FG001|Stage 2|Non-adherence with study visits|0|||
44171732|NCT02158533|78965476|FG002|Stage 2|Non-adherence with study visits|0|||
44449720|NCT00433654|79458259|FG001|Overall Study|Death|0|||
44171733|NCT02158533|78965477|FG003|Stage 2|Non-adherence with study visits|0|||
44171734|NCT02158533|78965478|FG004|Stage 2|Non-adherence with study visits|0|||
44171735|NCT02158533|78965479|FG005|Stage 2|Non-adherence with study visits|1|||
44171736|NCT02120781|78965495|FG000|Overall Study|Physician Decision|2|||
44171737|NCT02120781|78965496|FG001|Overall Study|Physician Decision|0|||
44171738|NCT02120781|78965495|FG000|Overall Study|Completion not documented|2|||
44171739|NCT02120781|78965496|FG001|Overall Study|Completion not documented|1|||
44171740|NCT02120625|78965502|FG000|Overall Study|Physician Decision|2|||
44171741|NCT02120469|78965509|FG000|Overall Study|HER-2/neu-amplified|1|||
44171742|NCT02120469|78965510|FG001|Overall Study|HER-2/neu-amplified|0|||
44171743|NCT02120469|78965511|FG002|Overall Study|HER-2/neu-amplified|1|||
44171744|NCT02157519|78965524|FG000|Overall Study|Death|3|||
44449721|NCT00433654|79458258|FG000|Overall Study|Missed visit|6|||
44171745|NCT02157519|78965525|FG001|Overall Study|Death|1|||
44171746|NCT02157519|78965524|FG000|Overall Study|Withdrawal by Subject|7|||
44171747|NCT02157519|78965525|FG001|Overall Study|Withdrawal by Subject|0|||
44171748|NCT02157519|78965524|FG000|Overall Study|Lost to Follow-up|1|||
44171749|NCT02157519|78965525|FG001|Overall Study|Lost to Follow-up|0|||
44171750|NCT02180061|78965533|FG000|Overall Study|Adverse Event|4|||
44360821|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
44360822|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44360823|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44360824|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44360825|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44360826|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44360827|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
44360828|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360829|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360830|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
44360831|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360832|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360833|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360834|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360835|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360836|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44360837|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44360838|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
44449722|NCT00433654|79458259|FG001|Overall Study|Missed visit|3|||
44449723|NCT00433654|79458258|FG000|Overall Study|Subject not yet due for visit|4|||
44171751|NCT02180061|78965534|FG001|Overall Study|Adverse Event|2|||
44171752|NCT02180061|78965533|FG000|Overall Study|Clinical Progression|5|||
44171753|NCT02180061|78965534|FG001|Overall Study|Clinical Progression|1|||
44171754|NCT02180061|78965533|FG000|Overall Study|Progressive Disease|15|||
44171755|NCT02180061|78965534|FG001|Overall Study|Progressive Disease|5|||
44171756|NCT02180061|78965533|FG000|Overall Study|Physician Decision|1|||
44171757|NCT02180061|78965534|FG001|Overall Study|Physician Decision|0|||
44171758|NCT02179515|78965543|FG000|Overall Study|switched to alternative treatment|0|||
44171759|NCT02179515|78965544|FG001|Overall Study|switched to alternative treatment|1|||
44171760|NCT02179515|78965545|FG002|Overall Study|switched to alternative treatment|1|||
44171761|NCT02179515|78965543|FG000|Overall Study|Death|0|||
44171762|NCT02179515|78965544|FG001|Overall Study|Death|1|||
44171763|NCT02179515|78965545|FG002|Overall Study|Death|1|||
44171764|NCT02179515|78965543|FG000|Overall Study|refused further treatment|0|||
44171765|NCT02179515|78965544|FG001|Overall Study|refused further treatment|3|||
44171766|NCT02179515|78965545|FG002|Overall Study|refused further treatment|4|||
44171767|NCT02179515|78965543|FG000|Overall Study|Disease progression on study|2|||
44171768|NCT02179515|78965544|FG001|Overall Study|Disease progression on study|11|||
44171769|NCT02179515|78965545|FG002|Overall Study|Disease progression on study|8|||
44171770|NCT02120157|78965557|FG000|Overall Study|Death|8|||
44171771|NCT02119299|78965563|FG000|Overall Study|Withdrawal by Subject|7|||
44171772|NCT02119299|78965563|FG000|Overall Study|Lack of Efficacy|1|||
44171773|NCT02119299|78965563|FG000|Overall Study|Pregnancy|1|||
44171774|NCT02156271|78965569|FG000|Overall Study|Physician Decision|4|||
44171775|NCT02156271|78965570|FG001|Overall Study|Physician Decision|3|||
44171776|NCT01365455|78965579|FG000|Induction Period|Adverse Event|5|||
44171777|NCT01365455|78965580|FG001|Induction Period|Adverse Event|3|||
44171778|NCT01365455|78965581|FG002|Induction Period|Adverse Event|4|||
44171779|NCT01365455|78965582|FG003|Induction Period|Adverse Event|0|||
44171780|NCT01365455|78965583|FG004|Induction Period|Adverse Event|0|||
44171781|NCT01365455|78965579|FG000|Induction Period|Lack of Efficacy|1|||
44171782|NCT01365455|78965580|FG001|Induction Period|Lack of Efficacy|1|||
44171783|NCT01365455|78965581|FG002|Induction Period|Lack of Efficacy|0|||
44171784|NCT01365455|78965582|FG003|Induction Period|Lack of Efficacy|0|||
44171785|NCT01365455|78965583|FG004|Induction Period|Lack of Efficacy|0|||
44171786|NCT01365455|78965579|FG000|Induction Period|Pregnancy|0|||
44171787|NCT01365455|78965580|FG001|Induction Period|Pregnancy|1|||
44171788|NCT01365455|78965581|FG002|Induction Period|Pregnancy|0|||
44171789|NCT01365455|78965582|FG003|Induction Period|Pregnancy|0|||
44171790|NCT01365455|78965583|FG004|Induction Period|Pregnancy|0|||
44171791|NCT01365455|78965579|FG000|Induction Period|Protocol deviation|0|||
44171792|NCT01365455|78965580|FG001|Induction Period|Protocol deviation|1|||
44360839|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
44360840|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44171793|NCT01365455|78965581|FG002|Induction Period|Protocol deviation|1|||
44171794|NCT01365455|78965582|FG003|Induction Period|Protocol deviation|0|||
44171795|NCT01365455|78965583|FG004|Induction Period|Protocol deviation|0|||
44171796|NCT01365455|78965579|FG000|Induction Period|Subject/guardian decision|9|||
44171797|NCT01365455|78965580|FG001|Induction Period|Subject/guardian decision|1|||
44171798|NCT01365455|78965581|FG002|Induction Period|Subject/guardian decision|8|||
44171799|NCT01365455|78965582|FG003|Induction Period|Subject/guardian decision|0|||
44171800|NCT01365455|78965583|FG004|Induction Period|Subject/guardian decision|0|||
44171801|NCT01365455|78965579|FG000|Induction Period|Lost to Follow-up|0|||
44171802|NCT01365455|78965580|FG001|Induction Period|Lost to Follow-up|0|||
44171803|NCT01365455|78965581|FG002|Induction Period|Lost to Follow-up|3|||
44171804|NCT01365455|78965582|FG003|Induction Period|Lost to Follow-up|0|||
44171805|NCT01365455|78965583|FG004|Induction Period|Lost to Follow-up|0|||
44171806|NCT01365455|78965579|FG000|Maintenance Period|Adverse Event|12|||
44171807|NCT01365455|78965580|FG001|Maintenance Period|Adverse Event|5|||
44171808|NCT01365455|78965581|FG002|Maintenance Period|Adverse Event|1|||
44171809|NCT01365455|78965582|FG003|Maintenance Period|Adverse Event|2|||
44171810|NCT01365455|78965583|FG004|Maintenance Period|Adverse Event|4|||
44171811|NCT01365455|78965579|FG000|Maintenance Period|Lack of Efficacy|10|||
44171812|NCT01365455|78965580|FG001|Maintenance Period|Lack of Efficacy|2|||
44171813|NCT01365455|78965581|FG002|Maintenance Period|Lack of Efficacy|0|||
44171814|NCT01365455|78965582|FG003|Maintenance Period|Lack of Efficacy|2|||
44171815|NCT01365455|78965583|FG004|Maintenance Period|Lack of Efficacy|2|||
44171816|NCT01365455|78965579|FG000|Maintenance Period|Lost to Follow-up|2|||
44171817|NCT01365455|78965580|FG001|Maintenance Period|Lost to Follow-up|4|||
44171818|NCT01365455|78965581|FG002|Maintenance Period|Lost to Follow-up|0|||
44449724|NCT00433654|79458259|FG001|Overall Study|Subject not yet due for visit|0|||
44449725|NCT00433654|79458258|FG000|Overall Study|Withdrawal by Subject|1|||
44449726|NCT00433654|79458259|FG001|Overall Study|Withdrawal by Subject|2|||
44449727|NCT00689351|79458273|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
44449728|NCT00689351|79458274|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
44449729|NCT00689351|79458273|FG000|Infant Series of Dosing|Adverse Event|1|||
44449730|NCT00689351|79458274|FG001|Infant Series of Dosing|Adverse Event|0|||
44171819|NCT01365455|78965582|FG003|Maintenance Period|Lost to Follow-up|0|||
44171820|NCT01365455|78965583|FG004|Maintenance Period|Lost to Follow-up|3|||
44171821|NCT01365455|78965579|FG000|Maintenance Period|Non-compliance with study treatment|0|||
44171822|NCT01365455|78965580|FG001|Maintenance Period|Non-compliance with study treatment|0|||
44171823|NCT01365455|78965581|FG002|Maintenance Period|Non-compliance with study treatment|0|||
44171824|NCT01365455|78965582|FG003|Maintenance Period|Non-compliance with study treatment|1|||
44171825|NCT01365455|78965583|FG004|Maintenance Period|Non-compliance with study treatment|0|||
44171826|NCT01365455|78965579|FG000|Maintenance Period|Physician Decision|0|||
44171827|NCT01365455|78965580|FG001|Maintenance Period|Physician Decision|1|||
44171828|NCT01365455|78965581|FG002|Maintenance Period|Physician Decision|0|||
44171829|NCT01365455|78965582|FG003|Maintenance Period|Physician Decision|0|||
44171830|NCT01365455|78965583|FG004|Maintenance Period|Physician Decision|1|||
44171831|NCT01365455|78965579|FG000|Maintenance Period|Pregnancy|0|||
44171832|NCT01365455|78965580|FG001|Maintenance Period|Pregnancy|4|||
44171833|NCT01365455|78965581|FG002|Maintenance Period|Pregnancy|0|||
44171834|NCT01365455|78965582|FG003|Maintenance Period|Pregnancy|0|||
44171835|NCT01365455|78965583|FG004|Maintenance Period|Pregnancy|2|||
44171836|NCT01365455|78965579|FG000|Maintenance Period|Protocol deviation|1|||
44171837|NCT01365455|78965580|FG001|Maintenance Period|Protocol deviation|1|||
44171838|NCT01365455|78965581|FG002|Maintenance Period|Protocol deviation|0|||
44171839|NCT01365455|78965582|FG003|Maintenance Period|Protocol deviation|0|||
44171840|NCT01365455|78965583|FG004|Maintenance Period|Protocol deviation|0|||
44171841|NCT01365455|78965579|FG000|Maintenance Period|Subject/guardian decision|4|||
44171842|NCT01365455|78965580|FG001|Maintenance Period|Subject/guardian decision|6|||
44171843|NCT01365455|78965581|FG002|Maintenance Period|Subject/guardian decision|2|||
44171844|NCT01365455|78965582|FG003|Maintenance Period|Subject/guardian decision|4|||
44171845|NCT01365455|78965583|FG004|Maintenance Period|Subject/guardian decision|1|||
44449731|NCT00689351|79458273|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
44449732|NCT00689351|79458274|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
44449733|NCT00689351|79458273|FG000|After Infant Series|Parent/legal guardian request|1|||
44449734|NCT00689351|79458274|FG001|After Infant Series|Parent/legal guardian request|0|||
44449735|NCT03950622|79458286|FG000|Overall Study|Withdrawal by Subject|1|||
44449736|NCT03950622|79458287|FG001|Overall Study|Withdrawal by Subject|0|||
44449737|NCT03950622|79458286|FG000|Overall Study|Protocol Deviation|0|||
44449738|NCT03950622|79458287|FG001|Overall Study|Protocol Deviation|1|||
44449739|NCT03950622|79458286|FG000|Overall Study|Physician Decision|1|||
44449740|NCT03950622|79458287|FG001|Overall Study|Physician Decision|0|||
44449741|NCT03950622|79458286|FG000|Overall Study|Lost to Follow-up|5|||
44171846|NCT02155881|78965603|FG000|Overall Study|Withdrawal by Subject|0|||
44171847|NCT02155881|78965604|FG001|Overall Study|Withdrawal by Subject|2|||
44171848|NCT02155881|78965603|FG000|Overall Study|Inappropriately randomized|2|||
44171849|NCT02155881|78965604|FG001|Overall Study|Inappropriately randomized|2|||
44449742|NCT03950622|79458287|FG001|Overall Study|Lost to Follow-up|5|||
44449743|NCT03950622|79458286|FG000|Overall Study|Death|1|||
44449744|NCT03950622|79458287|FG001|Overall Study|Death|1|||
44449745|NCT03937908|79458293|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
44171850|NCT01658579|78965614|FG000|Treatment Period A|Other|0|||
44171851|NCT01658579|78965615|FG001|Treatment Period A|Other|0|||
44171852|NCT01658579|78965616|FG002|Treatment Period A|Other|1|||
44171853|NCT01658579|78965617|FG003|Treatment Period A|Other|1|||
44171854|NCT01658579|78965614|FG000|Treatment Period A|Adverse Event|1|||
44171855|NCT01658579|78965615|FG001|Treatment Period A|Adverse Event|0|||
44171856|NCT01658579|78965616|FG002|Treatment Period A|Adverse Event|0|||
44171857|NCT01658579|78965617|FG003|Treatment Period A|Adverse Event|0|||
44171858|NCT01658579|78965614|FG000|Treatment Period B|Other|0|||
44171859|NCT01658579|78965615|FG001|Treatment Period B|Other|0|||
44171860|NCT01658579|78965616|FG002|Treatment Period B|Other|0|||
44171861|NCT01658579|78965617|FG003|Treatment Period B|Other|1|||
44171862|NCT02154087|78965623|FG000|Overall Study|Study Termination|1|||
44171863|NCT02118597|78965627|FG000|Overall Study|Sponsor terminated the study|14|||
44171864|NCT02118597|78965627|FG000|Overall Study|Serious Adverse Event|1|||
44171865|NCT02118597|78965627|FG000|Overall Study|Investigator's decision|1|||
44171866|NCT01659125|78965631|FG000|Overall Study|Withdrawal by Subject|2|||
44171867|NCT01659125|78965631|FG000|Overall Study|Lost to Follow-up|7|||
44171868|NCT01659125|78965631|FG000|Overall Study|Technical Problem|1|||
44171869|NCT01659125|78965631|FG000|Overall Study|Time Constraints|2|||
44171870|NCT01659125|78965631|FG000|Overall Study|Failed to Start Treatment|2|||
44171871|NCT01657253|78965637|FG000|Overall Study|Lost to Follow-up|6|||
44171872|NCT01657253|78965638|FG001|Overall Study|Lost to Follow-up|5|||
44171873|NCT01657253|78965637|FG000|Overall Study|Withdrawal by Subject|11|||
44171874|NCT01657253|78965638|FG001|Overall Study|Withdrawal by Subject|12|||
44171875|NCT01657253|78965637|FG000|Overall Study|Adverse Event|0|||
44171876|NCT01657253|78965638|FG001|Overall Study|Adverse Event|1|||
44171877|NCT02117427|78965647|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
44171878|NCT02117427|78965648|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
44171879|NCT02117427|78965649|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
44171880|NCT02117427|78965647|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
44171881|NCT02117427|78965648|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
44171882|NCT02117427|78965649|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
44171883|NCT02117427|78965647|FG000|Overall Study|Physician Decision|0|||
44171884|NCT02117427|78965648|FG001|Overall Study|Physician Decision|2|||
44171885|NCT02117427|78965649|FG002|Overall Study|Physician Decision|0|||
44171886|NCT02117427|78965647|FG000|Overall Study|No longer meets inclusion criteria|0|||
44171887|NCT02117427|78965648|FG001|Overall Study|No longer meets inclusion criteria|1|||
44171888|NCT02117427|78965649|FG002|Overall Study|No longer meets inclusion criteria|0|||
44171889|NCT02117427|78965647|FG000|Overall Study|Death|0|||
44171890|NCT02117427|78965648|FG001|Overall Study|Death|1|||
44171891|NCT02117427|78965649|FG002|Overall Study|Death|0|||
44171892|NCT02117349|78965657|FG000|Overall Study|Withdrawal by Subject|1|||
44171893|NCT02117349|78965658|FG001|Overall Study|Withdrawal by Subject|0|||
44171894|NCT02117349|78965657|FG000|Overall Study|Lost to Follow-up|1|||
44171895|NCT02117349|78965658|FG001|Overall Study|Lost to Follow-up|1|||
44171896|NCT02117349|78965657|FG000|Overall Study|Death|1|||
44171897|NCT02117349|78965658|FG001|Overall Study|Death|0|||
44171898|NCT01626495|78965664|FG000|Overall Study|Adverse Event|3|||
44171899|NCT01626495|78965664|FG000|Overall Study|Disease progression|27|||
44171900|NCT01626495|78965664|FG000|Overall Study|Withdrawal by Subject|1|||
44171901|NCT01626495|78965664|FG000|Overall Study|Administrative problem|1|||
44171902|NCT01626495|78965664|FG000|Overall Study|Death|2|||
44171903|NCT01626495|78965664|FG000|Overall Study|Physician Decision|1|||
44171904|NCT01626495|78965664|FG000|Overall Study|New cancer therapy|16|||
44171905|NCT01626495|78965664|FG000|Overall Study|Manufacturing failure|1|||
44171906|NCT02177175|78965670|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
44171907|NCT02177175|78965671|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
44171908|NCT02153073|78965677|FG000|Overall Study|Case Report Forms Uncollected|230|||
44171909|NCT02153073|78965677|FG000|Overall Study|Protocol Deviation|68|||
44171910|NCT01657877|78965681|FG000|Overall Study|Withdrawal by Subject|4|||
44171911|NCT01657877|78965681|FG000|Overall Study|Protocol Violation|6|||
44171912|NCT01657877|78965681|FG000|Overall Study|Adverse Event|2|||
44171913|NCT01657877|78965681|FG000|Overall Study|Other Reason|2|||
44171914|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
44449746|NCT03937908|79458294|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
44449747|NCT00689273|79458302|FG000|Overall Study|Adverse Event|3|||
44171915|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171916|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44264193|NCT03155997|79164474|FG001|Overall Study|Missing disposition data|1|||
44171917|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171918|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171919|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171920|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171921|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171922|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44171923|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
44171924|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171925|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171926|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171927|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171928|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171929|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171930|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171931|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44171932|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
44171933|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171934|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171935|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171936|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171937|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171938|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171939|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171940|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44171941|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
44171942|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171943|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171944|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171945|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171946|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171947|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171948|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171949|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
44171950|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
44171951|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171952|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171953|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171954|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171955|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171956|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171957|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171958|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44171959|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
44171960|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171961|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171962|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171963|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171964|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171965|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171966|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171967|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44171968|NCT02175771|78965706|FG000|Run-In Period (Pre-assignment)|Other|8|||
44171969|NCT02175771|78965707|FG001|Run-In Period (Pre-assignment)|Other|0|||
44171970|NCT02175771|78965708|FG002|Run-In Period (Pre-assignment)|Other|0|||
44171971|NCT02175771|78965709|FG003|Run-In Period (Pre-assignment)|Other|0|||
44171972|NCT02175771|78965710|FG004|Run-In Period (Pre-assignment)|Other|0|||
44171973|NCT02175771|78965711|FG005|Run-In Period (Pre-assignment)|Other|0|||
44171974|NCT02175771|78965712|FG006|Run-In Period (Pre-assignment)|Other|0|||
44171975|NCT02175771|78965713|FG007|Run-In Period (Pre-assignment)|Other|0|||
44171976|NCT02175771|78965714|FG008|Run-In Period (Pre-assignment)|Other|0|||
44171977|NCT02175771|78965706|FG000|Treatment Period|Adverse Event|0|||
44171978|NCT02175771|78965707|FG001|Treatment Period|Adverse Event|2|||
44171979|NCT02175771|78965708|FG002|Treatment Period|Adverse Event|1|||
44171980|NCT02175771|78965709|FG003|Treatment Period|Adverse Event|1|||
44171981|NCT02175771|78965710|FG004|Treatment Period|Adverse Event|1|||
44171982|NCT02175771|78965711|FG005|Treatment Period|Adverse Event|3|||
44171983|NCT02175771|78965712|FG006|Treatment Period|Adverse Event|2|||
44171984|NCT02175771|78965713|FG007|Treatment Period|Adverse Event|0|||
44171985|NCT02175771|78965714|FG008|Treatment Period|Adverse Event|1|||
44171986|NCT02175771|78965706|FG000|Treatment Period|Withdrawal by Subject|0|||
44171987|NCT02175771|78965707|FG001|Treatment Period|Withdrawal by Subject|9|||
44171988|NCT02175771|78965708|FG002|Treatment Period|Withdrawal by Subject|3|||
44171989|NCT02175771|78965709|FG003|Treatment Period|Withdrawal by Subject|6|||
44171990|NCT02175771|78965710|FG004|Treatment Period|Withdrawal by Subject|2|||
44171991|NCT02175771|78965711|FG005|Treatment Period|Withdrawal by Subject|4|||
44449748|NCT00689273|79458303|FG001|Overall Study|Adverse Event|1|||
44171992|NCT02175771|78965712|FG006|Treatment Period|Withdrawal by Subject|2|||
44171993|NCT02175771|78965713|FG007|Treatment Period|Withdrawal by Subject|9|||
44171994|NCT02175771|78965714|FG008|Treatment Period|Withdrawal by Subject|2|||
44171995|NCT02175771|78965706|FG000|Treatment Period|Noncompliance|0|||
44171996|NCT02175771|78965707|FG001|Treatment Period|Noncompliance|1|||
44171997|NCT02175771|78965708|FG002|Treatment Period|Noncompliance|2|||
44171998|NCT02175771|78965709|FG003|Treatment Period|Noncompliance|0|||
44171999|NCT02175771|78965710|FG004|Treatment Period|Noncompliance|0|||
44172000|NCT02175771|78965711|FG005|Treatment Period|Noncompliance|0|||
44172001|NCT02175771|78965712|FG006|Treatment Period|Noncompliance|0|||
44172002|NCT02175771|78965713|FG007|Treatment Period|Noncompliance|0|||
44172003|NCT02175771|78965714|FG008|Treatment Period|Noncompliance|1|||
44172004|NCT02175771|78965706|FG000|Treatment Period|Protocol Violation|0|||
44172005|NCT02175771|78965707|FG001|Treatment Period|Protocol Violation|0|||
44172006|NCT02175771|78965708|FG002|Treatment Period|Protocol Violation|0|||
44172007|NCT02175771|78965709|FG003|Treatment Period|Protocol Violation|0|||
44172008|NCT02175771|78965710|FG004|Treatment Period|Protocol Violation|0|||
44172009|NCT02175771|78965711|FG005|Treatment Period|Protocol Violation|0|||
44172010|NCT02175771|78965712|FG006|Treatment Period|Protocol Violation|0|||
44172011|NCT02175771|78965713|FG007|Treatment Period|Protocol Violation|1|||
44172012|NCT02175771|78965714|FG008|Treatment Period|Protocol Violation|0|||
44172013|NCT02175771|78965706|FG000|Treatment Period|Disease progression|0|||
44172014|NCT02175771|78965707|FG001|Treatment Period|Disease progression|0|||
44172015|NCT02175771|78965708|FG002|Treatment Period|Disease progression|0|||
44172016|NCT02175771|78965709|FG003|Treatment Period|Disease progression|0|||
44172017|NCT02175771|78965710|FG004|Treatment Period|Disease progression|0|||
44172018|NCT02175771|78965711|FG005|Treatment Period|Disease progression|0|||
44172019|NCT02175771|78965712|FG006|Treatment Period|Disease progression|0|||
44172020|NCT02175771|78965713|FG007|Treatment Period|Disease progression|2|||
44172021|NCT02175771|78965714|FG008|Treatment Period|Disease progression|0|||
44172022|NCT02175771|78965706|FG000|Treatment Period|Lost to Follow-up|0|||
44172023|NCT02175771|78965707|FG001|Treatment Period|Lost to Follow-up|3|||
44172024|NCT02175771|78965708|FG002|Treatment Period|Lost to Follow-up|1|||
44172025|NCT02175771|78965709|FG003|Treatment Period|Lost to Follow-up|3|||
44172026|NCT02175771|78965710|FG004|Treatment Period|Lost to Follow-up|1|||
44172027|NCT02175771|78965711|FG005|Treatment Period|Lost to Follow-up|2|||
44172028|NCT02175771|78965712|FG006|Treatment Period|Lost to Follow-up|1|||
44172029|NCT02175771|78965713|FG007|Treatment Period|Lost to Follow-up|2|||
44172030|NCT02175771|78965714|FG008|Treatment Period|Lost to Follow-up|2|||
44172031|NCT02175771|78965706|FG000|Treatment Period|Lack of Efficacy|0|||
44172032|NCT02175771|78965707|FG001|Treatment Period|Lack of Efficacy|0|||
44172033|NCT02175771|78965708|FG002|Treatment Period|Lack of Efficacy|0|||
44172034|NCT02175771|78965709|FG003|Treatment Period|Lack of Efficacy|0|||
44172035|NCT02175771|78965710|FG004|Treatment Period|Lack of Efficacy|0|||
44172036|NCT02175771|78965711|FG005|Treatment Period|Lack of Efficacy|1|||
44172037|NCT02175771|78965712|FG006|Treatment Period|Lack of Efficacy|0|||
44172038|NCT02175771|78965713|FG007|Treatment Period|Lack of Efficacy|1|||
44172039|NCT02175771|78965714|FG008|Treatment Period|Lack of Efficacy|0|||
44172040|NCT02175771|78965706|FG000|Treatment Period|Other|0|||
44172041|NCT02175771|78965707|FG001|Treatment Period|Other|1|||
44172042|NCT02175771|78965708|FG002|Treatment Period|Other|0|||
44172043|NCT02175771|78965709|FG003|Treatment Period|Other|3|||
44172044|NCT02175771|78965710|FG004|Treatment Period|Other|1|||
44449749|NCT00689273|79458302|FG000|Overall Study|Lack of Efficacy|3|||
44449750|NCT00689273|79458303|FG001|Overall Study|Lack of Efficacy|0|||
44449751|NCT00689273|79458302|FG000|Overall Study|Lost to Follow-up|0|||
44449752|NCT00689273|79458303|FG001|Overall Study|Lost to Follow-up|2|||
44449753|NCT00689273|79458302|FG000|Overall Study|Other|6|||
44449754|NCT00689273|79458303|FG001|Overall Study|Other|2|||
44449755|NCT00689273|79458302|FG000|Overall Study|Randomized but not Treated|1|||
44449756|NCT00689273|79458303|FG001|Overall Study|Randomized but not Treated|0|||
44449757|NCT00553358|79458312|FG000|Overall Study|Randomized but did not receive treatment|3|||
44449758|NCT00553358|79458313|FG001|Overall Study|Randomized but did not receive treatment|3|||
44449759|NCT00553358|79458314|FG002|Overall Study|Randomized but did not receive treatment|1|||
44449760|NCT00553358|79458312|FG000|Overall Study|Lost to Follow-up|22|||
44449761|NCT00553358|79458313|FG001|Overall Study|Lost to Follow-up|26|||
44449762|NCT00553358|79458314|FG002|Overall Study|Lost to Follow-up|18|||
44449763|NCT00553358|79458312|FG000|Overall Study|Withdrew completely|23|||
44449764|NCT00553358|79458313|FG001|Overall Study|Withdrew completely|33|||
44449765|NCT00553358|79458314|FG002|Overall Study|Withdrew completely|34|||
44449766|NCT00553358|79458312|FG000|Overall Study|Died during clinical follow-up|25|||
44449767|NCT00553358|79458313|FG001|Overall Study|Died during clinical follow-up|29|||
44172045|NCT02175771|78965711|FG005|Treatment Period|Other|0|||
44172046|NCT02175771|78965712|FG006|Treatment Period|Other|0|||
44172047|NCT02175771|78965713|FG007|Treatment Period|Other|2|||
44449768|NCT00553358|79458314|FG002|Overall Study|Died during clinical follow-up|32|||
44449769|NCT00553358|79458312|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
44172048|NCT02175771|78965714|FG008|Treatment Period|Other|0|||
44449770|NCT00553358|79458313|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
44449771|NCT00553358|79458314|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
44449772|NCT00553358|79458312|FG000|Overall Study|Died after clinical follow-up ended|1|||
44449773|NCT00553358|79458313|FG001|Overall Study|Died after clinical follow-up ended|2|||
44449774|NCT00553358|79458314|FG002|Overall Study|Died after clinical follow-up ended|0|||
44449775|NCT00553358|79458312|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
44449776|NCT00553358|79458313|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
44449777|NCT00553358|79458314|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
44449778|NCT00688259|79458330|FG000|Overall Study|Lost to Follow-up|2|||
44449779|NCT00688259|79458331|FG001|Overall Study|Lost to Follow-up|4|||
44449780|NCT00688259|79458330|FG000|Overall Study|Physician Decision|1|||
44449781|NCT00688259|79458331|FG001|Overall Study|Physician Decision|0|||
44449782|NCT00688259|79458330|FG000|Overall Study|Withdrawal by Subject|2|||
44449783|NCT00688259|79458331|FG001|Overall Study|Withdrawal by Subject|0|||
44449784|NCT00688259|79458330|FG000|Overall Study|Declined Interview|2|||
44449785|NCT00688259|79458331|FG001|Overall Study|Declined Interview|3|||
44449786|NCT00688259|79458330|FG000|Overall Study|Hospitalized at Follow-up|0|||
44172049|NCT01657799|78965735|FG000|Overall Study|Adverse Event Related to progression|6|||
44172050|NCT01657799|78965736|FG001|Overall Study|Adverse Event Related to progression|8|||
44172051|NCT01657799|78965737|FG002|Overall Study|Adverse Event Related to progression|12|||
44172052|NCT01657799|78965735|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
44172053|NCT01657799|78965736|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
44172054|NCT01657799|78965737|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
44172055|NCT01657799|78965735|FG000|Overall Study|Withdrawal by Subject|13|||
44172056|NCT01657799|78965736|FG001|Overall Study|Withdrawal by Subject|10|||
44172057|NCT01657799|78965737|FG002|Overall Study|Withdrawal by Subject|10|||
44172058|NCT01657799|78965735|FG000|Overall Study|Lost to Follow-up|1|||
44172059|NCT01657799|78965736|FG001|Overall Study|Lost to Follow-up|0|||
44172060|NCT01657799|78965737|FG002|Overall Study|Lost to Follow-up|1|||
44172061|NCT01657799|78965735|FG000|Overall Study|Disease Progression|2|||
44172062|NCT01657799|78965736|FG001|Overall Study|Disease Progression|4|||
44172063|NCT01657799|78965737|FG002|Overall Study|Disease Progression|4|||
44172064|NCT01657799|78965735|FG000|Overall Study|Progressive Disease Clinical|7|||
44172065|NCT01657799|78965736|FG001|Overall Study|Progressive Disease Clinical|4|||
44172066|NCT01657799|78965737|FG002|Overall Study|Progressive Disease Clinical|7|||
44172067|NCT01657799|78965735|FG000|Overall Study|Radiographic & Clinical Progression|16|||
44172068|NCT01657799|78965736|FG001|Overall Study|Radiographic & Clinical Progression|11|||
44172069|NCT01657799|78965737|FG002|Overall Study|Radiographic & Clinical Progression|15|||
44172070|NCT01657799|78965735|FG000|Overall Study|Other|52|||
44172071|NCT01657799|78965736|FG001|Overall Study|Other|62|||
44172072|NCT01657799|78965737|FG002|Overall Study|Other|49|||
44172073|NCT02116803|78965747|FG000|Overall Study|Adverse Event|2|||
44172074|NCT02116803|78965748|FG001|Overall Study|Adverse Event|1|||
44172075|NCT02116803|78965747|FG000|Overall Study|Physician Decision|1|||
44172076|NCT02116803|78965748|FG001|Overall Study|Physician Decision|0|||
44172077|NCT02116803|78965747|FG000|Overall Study|Progressive disease|4|||
44172078|NCT02116803|78965748|FG001|Overall Study|Progressive disease|0|||
44172079|NCT02116803|78965747|FG000|Overall Study|Study terminated by sponsor|2|||
44172080|NCT02116803|78965748|FG001|Overall Study|Study terminated by sponsor|1|||
44172081|NCT02116803|78965747|FG000|Overall Study|Death|1|||
44172082|NCT02116803|78965748|FG001|Overall Study|Death|0|||
44172083|NCT02115321|78965756|FG000|Overall Study|Death|1|||
44172084|NCT02115321|78965757|FG001|Overall Study|Death|0|||
44449787|NCT00688259|79458331|FG001|Overall Study|Hospitalized at Follow-up|1|||
44449788|NCT00688181|79458337|FG000|Overall Study|Lost to Follow-up|17|||
44449789|NCT00688181|79458337|FG000|Overall Study|Unknown Reason|4|||
44449790|NCT00688181|79458337|FG000|Overall Study|Non-clinical Reason|2|||
44449791|NCT00689117|79458356|FG000|Overall Study|Adverse Event|6|||
44449792|NCT00689117|79458357|FG001|Overall Study|Adverse Event|0|||
44172085|NCT02367781|78965765|FG000|Overall Study|Withdrawal by Subject|20|||
44172086|NCT02367781|78965766|FG001|Overall Study|Withdrawal by Subject|13|||
44172087|NCT02367781|78965765|FG000|Overall Study|Protocol Violation|0|||
44172088|NCT02367781|78965766|FG001|Overall Study|Protocol Violation|1|||
44172089|NCT02367781|78965765|FG000|Overall Study|Physician Decision|7|||
44172090|NCT02367781|78965766|FG001|Overall Study|Physician Decision|0|||
44172091|NCT02367781|78965765|FG000|Overall Study|Randomized in Error|5|||
44449793|NCT00689117|79458358|FG002|Overall Study|Adverse Event|5|||
44449794|NCT00689117|79458359|FG003|Overall Study|Adverse Event|0|||
44172092|NCT02367781|78965766|FG001|Overall Study|Randomized in Error|4|||
44172093|NCT02367781|78965765|FG000|Overall Study|Non-Compliance|1|||
44172094|NCT02367781|78965766|FG001|Overall Study|Non-Compliance|0|||
44172095|NCT02367781|78965765|FG000|Overall Study|Lost to Follow-up|1|||
44172096|NCT02367781|78965766|FG001|Overall Study|Lost to Follow-up|2|||
44172097|NCT02367781|78965765|FG000|Overall Study|Death|330|||
44172098|NCT02367781|78965766|FG001|Overall Study|Death|176|||
44449795|NCT00689117|79458356|FG000|Overall Study|Lost to Follow-up|26|||
44449796|NCT00689117|79458357|FG001|Overall Study|Lost to Follow-up|19|||
44449797|NCT00689117|79458358|FG002|Overall Study|Lost to Follow-up|17|||
44449798|NCT00689117|79458359|FG003|Overall Study|Lost to Follow-up|11|||
44449799|NCT00689117|79458356|FG000|Overall Study|Lack of Efficacy|1|||
44449800|NCT00689117|79458357|FG001|Overall Study|Lack of Efficacy|2|||
44449801|NCT00689117|79458358|FG002|Overall Study|Lack of Efficacy|2|||
44449802|NCT00689117|79458359|FG003|Overall Study|Lack of Efficacy|2|||
44449803|NCT00689117|79458356|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
44449804|NCT00689117|79458357|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
44449805|NCT00689117|79458358|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
44449806|NCT00689117|79458359|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
44449807|NCT00689117|79458356|FG000|Overall Study|Withdrawal by Subject|19|||
44449808|NCT00689117|79458357|FG001|Overall Study|Withdrawal by Subject|18|||
44449809|NCT00689117|79458358|FG002|Overall Study|Withdrawal by Subject|26|||
44449810|NCT00689117|79458359|FG003|Overall Study|Withdrawal by Subject|13|||
44449811|NCT00689117|79458356|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
44449812|NCT00689117|79458357|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
44449813|NCT00689117|79458358|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
44449814|NCT00689117|79458359|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
44449815|NCT00689117|79458356|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
44449816|NCT00689117|79458357|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
44449817|NCT00689117|79458358|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44449818|NCT00689117|79458359|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44449819|NCT00689117|79458356|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
44449820|NCT00689117|79458357|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
44449821|NCT00689117|79458358|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
44449822|NCT00689117|79458359|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
44449823|NCT00689117|79458356|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
44449824|NCT00689117|79458357|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
44449825|NCT00689117|79458358|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
44449826|NCT00689117|79458359|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
44449827|NCT00689117|79458356|FG000|Overall Study|Use of Prohibitive Medication|2|||
44449828|NCT00689117|79458357|FG001|Overall Study|Use of Prohibitive Medication|1|||
44449829|NCT00689117|79458358|FG002|Overall Study|Use of Prohibitive Medication|3|||
44449830|NCT00689117|79458359|FG003|Overall Study|Use of Prohibitive Medication|0|||
44449831|NCT00689117|79458356|FG000|Overall Study|Pregnancy|0|||
44449832|NCT00689117|79458357|FG001|Overall Study|Pregnancy|2|||
44449833|NCT00689117|79458358|FG002|Overall Study|Pregnancy|0|||
44449834|NCT00689117|79458359|FG003|Overall Study|Pregnancy|2|||
44449835|NCT00689117|79458356|FG000|Overall Study|Incarceration|2|||
44449836|NCT00689117|79458357|FG001|Overall Study|Incarceration|0|||
44449837|NCT00689117|79458358|FG002|Overall Study|Incarceration|0|||
44449838|NCT00689117|79458359|FG003|Overall Study|Incarceration|0|||
44449839|NCT00689117|79458356|FG000|Overall Study|Fear of Birth Defects|0|||
44449840|NCT00689117|79458357|FG001|Overall Study|Fear of Birth Defects|0|||
44449841|NCT00689117|79458358|FG002|Overall Study|Fear of Birth Defects|1|||
44449842|NCT00689117|79458359|FG003|Overall Study|Fear of Birth Defects|0|||
44449843|NCT00689117|79458356|FG000|Overall Study|Transportation|1|||
44449844|NCT00689117|79458357|FG001|Overall Study|Transportation|0|||
44449845|NCT00689117|79458358|FG002|Overall Study|Transportation|0|||
44449846|NCT00689117|79458359|FG003|Overall Study|Transportation|0|||
44449847|NCT00689117|79458356|FG000|Overall Study|Patient Withdrew from Study|0|||
44449848|NCT00689117|79458357|FG001|Overall Study|Patient Withdrew from Study|0|||
44449849|NCT00689117|79458358|FG002|Overall Study|Patient Withdrew from Study|0|||
44449850|NCT00689117|79458359|FG003|Overall Study|Patient Withdrew from Study|1|||
44449851|NCT00689117|79458356|FG000|Overall Study|Personal Reason|0|||
44449852|NCT00689117|79458357|FG001|Overall Study|Personal Reason|1|||
44449853|NCT00689117|79458358|FG002|Overall Study|Personal Reason|0|||
44449854|NCT00689117|79458359|FG003|Overall Study|Personal Reason|0|||
44449855|NCT00689117|79458356|FG000|Overall Study|Dispensing Error|0|||
44449856|NCT00689117|79458357|FG001|Overall Study|Dispensing Error|1|||
44449857|NCT00689117|79458358|FG002|Overall Study|Dispensing Error|0|||
44449858|NCT00689117|79458359|FG003|Overall Study|Dispensing Error|0|||
44449859|NCT00547248|79458373|FG000|Overall Study|Protocol Violation|0|||
44449860|NCT00547248|79458374|FG001|Overall Study|Protocol Violation|0|||
44449861|NCT00547248|79458375|FG002|Overall Study|Protocol Violation|1|||
44449862|NCT00547248|79458376|FG003|Overall Study|Protocol Violation|1|||
44449863|NCT00547248|79458373|FG000|Overall Study|Migrated/moved from study area|0|||
44449864|NCT00547248|79458374|FG001|Overall Study|Migrated/moved from study area|0|||
44449865|NCT00547248|79458375|FG002|Overall Study|Migrated/moved from study area|2|||
44449866|NCT00547248|79458376|FG003|Overall Study|Migrated/moved from study area|0|||
44449867|NCT00547248|79458373|FG000|Overall Study|Withdrawal by Subject|0|||
44449868|NCT00547248|79458374|FG001|Overall Study|Withdrawal by Subject|0|||
44449869|NCT00547248|79458375|FG002|Overall Study|Withdrawal by Subject|7|||
44449870|NCT00547248|79458376|FG003|Overall Study|Withdrawal by Subject|1|||
44449871|NCT00688103|79458391|FG000|Overall Study|Adverse Event|4|||
44449872|NCT00688103|79458392|FG001|Overall Study|Adverse Event|1|||
44449873|NCT00688103|79458391|FG000|Overall Study|Lack of Efficacy|11|||
44172099|NCT02367781|78965765|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
44449874|NCT00688103|79458392|FG001|Overall Study|Lack of Efficacy|1|||
44449875|NCT00688103|79458391|FG000|Overall Study|Withdrawal by Subject|4|||
44449876|NCT00688103|79458392|FG001|Overall Study|Withdrawal by Subject|2|||
44449877|NCT00688103|79458391|FG000|Overall Study|complex reasons|11|||
44449878|NCT00688103|79458392|FG001|Overall Study|complex reasons|9|||
44449879|NCT00686855|79458402|FG000|Overall Study|Lost to Follow-up|1|||
44449880|NCT00686855|79458403|FG001|Overall Study|Lost to Follow-up|0|||
44449881|NCT00686855|79458402|FG000|Overall Study|Progressive GVHD|0|||
44172100|NCT02367781|78965766|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
44172101|NCT02367781|78965765|FG000|Overall Study|Prolonged Hospitalization|1|||
44172102|NCT02367781|78965766|FG001|Overall Study|Prolonged Hospitalization|0|||
44172103|NCT02367781|78965765|FG000|Overall Study|Death Prior First Dose|1|||
44172104|NCT02367781|78965766|FG001|Overall Study|Death Prior First Dose|0|||
44172105|NCT02367781|78965765|FG000|Overall Study|Administrative-Change Facility|1|||
44449882|NCT00686855|79458403|FG001|Overall Study|Progressive GVHD|1|||
44449883|NCT00686777|79458409|FG000|Overall Study|Adverse Event|2|||
44449884|NCT00686777|79458409|FG000|Overall Study|Pregnancy|1|||
44449885|NCT00686777|79458409|FG000|Overall Study|Withdrawal by Subject|2|||
44449886|NCT00686777|79458409|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
44449887|NCT00686777|79458409|FG000|Overall Study|No Visit|1|||
44449888|NCT00686699|79458415|FG000|Treatment Period 1|Adverse Event|0|||
44449889|NCT00686699|79458416|FG001|Treatment Period 1|Adverse Event|2|||
44449890|NCT00106639|79458425|FG000|Overall Study|Adverse Event|3|||
44449891|NCT00106639|79458426|FG001|Overall Study|Adverse Event|4|||
44449892|NCT00106639|79458427|FG002|Overall Study|Adverse Event|1|||
44449893|NCT00106639|79458425|FG000|Overall Study|Protocol Violation|0|||
44449894|NCT00106639|79458426|FG001|Overall Study|Protocol Violation|1|||
44449895|NCT00106639|79458427|FG002|Overall Study|Protocol Violation|0|||
44449896|NCT00106639|79458425|FG000|Overall Study|Withdrawal by Subject|0|||
44449897|NCT00106639|79458426|FG001|Overall Study|Withdrawal by Subject|1|||
44449898|NCT00106639|79458427|FG002|Overall Study|Withdrawal by Subject|0|||
44449899|NCT00106639|79458425|FG000|Overall Study|Participant defaulted|0|||
44449900|NCT00106639|79458426|FG001|Overall Study|Participant defaulted|1|||
44449901|NCT00106639|79458427|FG002|Overall Study|Participant defaulted|1|||
44449902|NCT00106249|79458438|FG000|Overall Study|Lost to Follow-up|3|||
44449903|NCT00106249|79458439|FG001|Overall Study|Lost to Follow-up|2|||
44449904|NCT00105469|79458447|FG000|Overall Study|Adverse Event|9|||
44449905|NCT00105469|79458448|FG001|Overall Study|Adverse Event|8|||
44449906|NCT00105469|79458447|FG000|Overall Study|Protocol Violation|4|||
44449907|NCT00105469|79458448|FG001|Overall Study|Protocol Violation|0|||
44449908|NCT00105469|79458447|FG000|Overall Study|Withdrawal by Subject|2|||
44449909|NCT00105469|79458448|FG001|Overall Study|Withdrawal by Subject|3|||
44449910|NCT00105469|79458447|FG000|Overall Study|Lost to Follow-up|1|||
44449911|NCT00105469|79458448|FG001|Overall Study|Lost to Follow-up|0|||
44449912|NCT00105469|79458447|FG000|Overall Study|Lack of Efficacy|2|||
44449913|NCT00105469|79458448|FG001|Overall Study|Lack of Efficacy|0|||
44449914|NCT00105469|79458447|FG000|Overall Study|Other Reason|4|||
44449915|NCT00105469|79458448|FG001|Overall Study|Other Reason|0|||
44449916|NCT00105235|79458454|FG000|Overall Study|Death|4|||
44449917|NCT00105235|79458454|FG000|Overall Study|Physician Decision|1|||
44449918|NCT00105235|79458454|FG000|Overall Study|Withdrawal by Subject|2|||
44449919|NCT00547118|79458464|FG000|Overall Study|Did not qualify prior to starting drug|1|||
44449920|NCT00547118|79458465|FG001|Overall Study|Did not qualify prior to starting drug|1|||
44449921|NCT00547118|79458464|FG000|Overall Study|Study suspended|7|||
44360841|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44449922|NCT00547118|79458465|FG001|Overall Study|Study suspended|8|||
44172106|NCT02367781|78965766|FG001|Overall Study|Administrative-Change Facility|0|||
44172107|NCT02367781|78965765|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
44449923|NCT00502593|79458485|FG000|Overall Study|Withdrawn unspecified reason|1|||
44360842|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44360843|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44360844|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
44360845|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44360846|NCT01212770|79366247|FG000|Long-term Safety Phase (Year 5)|Death|0|||
44360847|NCT01212770|79366248|FG001|Long-term Safety Phase (Year 5)|Death|0|||
44449924|NCT00502593|79458486|FG001|Overall Study|Withdrawn unspecified reason|1|||
44449925|NCT00502593|79458487|FG002|Overall Study|Withdrawn unspecified reason|3|||
44449926|NCT00502593|79458488|FG003|Overall Study|Withdrawn unspecified reason|1|||
44449927|NCT00502593|79458489|FG004|Overall Study|Withdrawn unspecified reason|2|||
44449928|NCT00502593|79458490|FG005|Overall Study|Withdrawn unspecified reason|0|||
44264194|NCT03155997|79164473|FG000|Overall Study|On study treatment|2027|||
44449929|NCT00502593|79458491|FG006|Overall Study|Withdrawn unspecified reason|2|||
44449930|NCT00502593|79458492|FG007|Overall Study|Withdrawn unspecified reason|0|||
44449931|NCT00502593|79458493|FG008|Overall Study|Withdrawn unspecified reason|0|||
44449932|NCT00502593|79458494|FG009|Overall Study|Withdrawn unspecified reason|0|||
44449933|NCT00502593|79458495|FG010|Overall Study|Withdrawn unspecified reason|0|||
44449934|NCT00502593|79458496|FG011|Overall Study|Withdrawn unspecified reason|0|||
44449935|NCT00502593|79458485|FG000|Overall Study|Withdrawal by Subject|0|||
44449936|NCT00502593|79458486|FG001|Overall Study|Withdrawal by Subject|0|||
44449937|NCT00502593|79458487|FG002|Overall Study|Withdrawal by Subject|6|||
44449938|NCT00502593|79458488|FG003|Overall Study|Withdrawal by Subject|2|||
44449939|NCT00502593|79458489|FG004|Overall Study|Withdrawal by Subject|2|||
44449940|NCT00502593|79458490|FG005|Overall Study|Withdrawal by Subject|0|||
44449941|NCT00502593|79458491|FG006|Overall Study|Withdrawal by Subject|3|||
44449942|NCT00502593|79458492|FG007|Overall Study|Withdrawal by Subject|0|||
44449943|NCT00502593|79458493|FG008|Overall Study|Withdrawal by Subject|3|||
44449944|NCT00502593|79458494|FG009|Overall Study|Withdrawal by Subject|0|||
44449945|NCT00502593|79458495|FG010|Overall Study|Withdrawal by Subject|1|||
44449946|NCT00502593|79458496|FG011|Overall Study|Withdrawal by Subject|0|||
44449947|NCT00502593|79458485|FG000|Overall Study|Lost to Follow-up|2|||
44449948|NCT00502593|79458486|FG001|Overall Study|Lost to Follow-up|1|||
44449949|NCT00502593|79458487|FG002|Overall Study|Lost to Follow-up|1|||
44449950|NCT00502593|79458488|FG003|Overall Study|Lost to Follow-up|1|||
44449951|NCT00502593|79458489|FG004|Overall Study|Lost to Follow-up|0|||
44449952|NCT00502593|79458490|FG005|Overall Study|Lost to Follow-up|0|||
44449953|NCT00502593|79458491|FG006|Overall Study|Lost to Follow-up|0|||
44449954|NCT00502593|79458492|FG007|Overall Study|Lost to Follow-up|0|||
44449955|NCT00502593|79458493|FG008|Overall Study|Lost to Follow-up|3|||
44449956|NCT00502593|79458494|FG009|Overall Study|Lost to Follow-up|0|||
44449957|NCT00502593|79458495|FG010|Overall Study|Lost to Follow-up|1|||
44449958|NCT00502593|79458496|FG011|Overall Study|Lost to Follow-up|0|||
44449959|NCT00686543|79458549|FG000|Overall Study|Adverse Event|9|||
44449960|NCT00686543|79458550|FG001|Overall Study|Adverse Event|1|||
44449961|NCT00686543|79458551|FG002|Overall Study|Adverse Event|3|||
44449962|NCT00686543|79458552|FG003|Overall Study|Adverse Event|2|||
44449963|NCT00686543|79458549|FG000|Overall Study|Withdrawal by Subject|2|||
44449964|NCT00686543|79458550|FG001|Overall Study|Withdrawal by Subject|0|||
44449965|NCT00686543|79458551|FG002|Overall Study|Withdrawal by Subject|0|||
44449966|NCT00686543|79458552|FG003|Overall Study|Withdrawal by Subject|0|||
44449967|NCT00686543|79458549|FG000|Overall Study|Protocol Violation|3|||
44449968|NCT00686543|79458550|FG001|Overall Study|Protocol Violation|0|||
44449969|NCT00686543|79458551|FG002|Overall Study|Protocol Violation|2|||
44449970|NCT00686543|79458552|FG003|Overall Study|Protocol Violation|1|||
44449971|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
44449972|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
44449973|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
44449974|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
44449975|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
44449976|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
44449977|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
44449978|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
44449979|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
44172108|NCT02367781|78965766|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
44172109|NCT02367781|78965765|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
44172110|NCT02367781|78965766|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
44172111|NCT02367781|78965765|FG000|Overall Study|Study Terminated by Sponsor|3|||
44449980|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
44449981|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
44449982|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
44449983|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Death|0|||
44172112|NCT02367781|78965766|FG001|Overall Study|Study Terminated by Sponsor|1|||
44172113|NCT02367781|78965765|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
44449984|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Death|1|||
44449985|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Death|0|||
44449986|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Death|0|||
44449987|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
44449988|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
44449989|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
44449990|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
44449991|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
44449992|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
44449993|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
44449994|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
44449995|NCT00545688|79458566|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
44449996|NCT00545688|79458567|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
44449997|NCT00545688|79458568|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
44449998|NCT00545688|79458569|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
44449999|NCT00545688|79458566|FG000|Adjuvant Treatment Period|Disease Progression|3|||
44450000|NCT00545688|79458567|FG001|Adjuvant Treatment Period|Disease Progression|3|||
44450001|NCT00545688|79458568|FG002|Adjuvant Treatment Period|Disease Progression|0|||
44450002|NCT00545688|79458569|FG003|Adjuvant Treatment Period|Disease Progression|7|||
44450003|NCT00545688|79458566|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
44450004|NCT00545688|79458567|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
44450005|NCT00545688|79458568|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
44450006|NCT00545688|79458569|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
44450007|NCT00545688|79458566|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
44450008|NCT00545688|79458567|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
44450009|NCT00545688|79458568|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
44450010|NCT00545688|79458569|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
44450011|NCT00545688|79458566|FG000|Adjuvant Treatment Period|Adverse Event|0|||
44450012|NCT00545688|79458567|FG001|Adjuvant Treatment Period|Adverse Event|3|||
44450013|NCT00545688|79458568|FG002|Adjuvant Treatment Period|Adverse Event|2|||
44450014|NCT00545688|79458569|FG003|Adjuvant Treatment Period|Adverse Event|2|||
44450015|NCT00545688|79458566|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
44450016|NCT00545688|79458567|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
44172114|NCT02367781|78965766|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
44172115|NCT02367781|78965765|FG000|Overall Study|Sponsor Decision|2|||
44172116|NCT02367781|78965766|FG001|Overall Study|Sponsor Decision|0|||
44172117|NCT02367781|78965765|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
44172118|NCT02367781|78965766|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
44450017|NCT00545688|79458568|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
44172119|NCT02152761|78965778|FG000|Epoch: Treatment Epoch|Technical problems|0|||
44450018|NCT00545688|79458569|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
44450019|NCT00545688|79458566|FG000|Follow-Up Period|Death|4|||
44450020|NCT00545688|79458567|FG001|Follow-Up Period|Death|2|||
44450021|NCT00545688|79458568|FG002|Follow-Up Period|Death|2|||
44450022|NCT00545688|79458569|FG003|Follow-Up Period|Death|6|||
44450023|NCT00545688|79458566|FG000|Follow-Up Period|Disease Progression|6|||
44450024|NCT00545688|79458567|FG001|Follow-Up Period|Disease Progression|5|||
44450025|NCT00545688|79458568|FG002|Follow-Up Period|Disease Progression|9|||
44450026|NCT00545688|79458569|FG003|Follow-Up Period|Disease Progression|9|||
44450027|NCT00545688|79458566|FG000|Follow-Up Period|Refused Treatment|6|||
44450028|NCT00545688|79458567|FG001|Follow-Up Period|Refused Treatment|2|||
44450029|NCT00545688|79458568|FG002|Follow-Up Period|Refused Treatment|0|||
44450030|NCT00545688|79458569|FG003|Follow-Up Period|Refused Treatment|2|||
44450031|NCT00545688|79458566|FG000|Follow-Up Period|Lost to Follow-up|3|||
44450032|NCT00545688|79458567|FG001|Follow-Up Period|Lost to Follow-up|3|||
44450033|NCT00545688|79458568|FG002|Follow-Up Period|Lost to Follow-up|3|||
44450034|NCT00545688|79458569|FG003|Follow-Up Period|Lost to Follow-up|1|||
44450035|NCT00545688|79458566|FG000|Follow-Up Period|Unspecified Reason|2|||
44450036|NCT00545688|79458567|FG001|Follow-Up Period|Unspecified Reason|5|||
44450037|NCT00545688|79458568|FG002|Follow-Up Period|Unspecified Reason|6|||
44450038|NCT00545688|79458569|FG003|Follow-Up Period|Unspecified Reason|8|||
44450039|NCT00545688|79458566|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
44450040|NCT00545688|79458567|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
44450041|NCT00545688|79458568|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
44450042|NCT00545688|79458569|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
44450043|NCT00502203|79458582|FG000|Overall Study|Inevaluable|1|||
44450044|NCT00546078|79458588|FG000|Overall Study|Lost to Follow-up|1|||
44450045|NCT00546078|79458589|FG001|Overall Study|Lost to Follow-up|3|||
44450046|NCT00546078|79458588|FG000|Overall Study|Withdrawal by Subject|2|||
44450047|NCT00546078|79458589|FG001|Overall Study|Withdrawal by Subject|3|||
44450048|NCT00546078|79458588|FG000|Overall Study|Other reason|1|||
44450049|NCT00546078|79458589|FG001|Overall Study|Other reason|1|||
44450050|NCT00546000|79458595|FG000|Overall Study|Adverse Event|1|||
44450051|NCT00546000|79458595|FG000|Overall Study|Lost to Follow-up|1|||
44450052|NCT00546000|79458595|FG000|Overall Study|Baseline HPA Axis Supression|2|||
44450053|NCT00501969|79458599|FG000|Overall Study|Major Protocol Violation|4|||
44450054|NCT00501969|79458599|FG000|Overall Study|Lack of Efficacy|29|||
44450055|NCT00501969|79458599|FG000|Overall Study|Adverse Event|76|||
44450056|NCT00501969|79458599|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
44450057|NCT00501969|79458599|FG000|Overall Study|Subject withdrew consent|51|||
44450058|NCT00501969|79458599|FG000|Overall Study|Lost to Follow-up|4|||
44450059|NCT00501969|79458599|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
44450060|NCT00501969|79458599|FG000|Overall Study|Other: Sponsors Request|10|||
44264195|NCT03155997|79164474|FG001|Overall Study|On study treatment|2074|||
44450061|NCT00501969|79458599|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
44450062|NCT00501969|79458599|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
44450063|NCT00501969|79458599|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
44450064|NCT00501969|79458599|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
44450065|NCT00501969|79458599|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
44450066|NCT00501969|79458599|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
44450067|NCT00501969|79458599|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
44450068|NCT00501969|79458599|FG000|Overall Study|Other: As Required by Local EC|2|||
44450069|NCT00501969|79458599|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
44450070|NCT00501969|79458599|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
44450071|NCT03942042|79458605|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
44450072|NCT03942042|79458606|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
44450073|NCT03942042|79458605|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
44450074|NCT03942042|79458606|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
44450075|NCT00104299|79458618|FG000|Overall Study|Adverse Event|3|||
44450076|NCT00104299|79458619|FG001|Overall Study|Adverse Event|1|||
44450077|NCT00104299|79458618|FG000|Overall Study|Death|2|||
44450078|NCT00104299|79458619|FG001|Overall Study|Death|2|||
44450079|NCT00104299|79458618|FG000|Overall Study|Withdrawal by Subject|2|||
44450080|NCT00104299|79458619|FG001|Overall Study|Withdrawal by Subject|6|||
44450081|NCT00104299|79458618|FG000|Overall Study|Physician Decision|1|||
44450082|NCT00104299|79458619|FG001|Overall Study|Physician Decision|1|||
44450083|NCT00104299|79458618|FG000|Overall Study|To have renal transplant|1|||
44450084|NCT00104299|79458619|FG001|Overall Study|To have renal transplant|0|||
44450085|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
44450086|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
44450087|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
44450088|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
44450089|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
44450090|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
44450091|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
44450092|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
44450093|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
44450094|NCT03939312|79458625|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
44450095|NCT03939312|79458625|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
44450096|NCT03939312|79458625|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
44450097|NCT00082381|79458633|FG000|Overall Study|Adverse Event|27|||
44450098|NCT00082381|79458634|FG001|Overall Study|Adverse Event|2|||
44450099|NCT00082381|79458633|FG000|Overall Study|Lost to Follow-up|5|||
44450100|NCT00082381|79458634|FG001|Overall Study|Lost to Follow-up|7|||
44450101|NCT00082381|79458633|FG000|Overall Study|Patient Decision|8|||
44450102|NCT00082381|79458634|FG001|Overall Study|Patient Decision|4|||
44450103|NCT00082381|79458633|FG000|Overall Study|Physician Decision|1|||
44450104|NCT00082381|79458634|FG001|Overall Study|Physician Decision|2|||
44450105|NCT00082381|79458633|FG000|Overall Study|Protocol Violation|10|||
44450106|NCT00082381|79458634|FG001|Overall Study|Protocol Violation|11|||
44450107|NCT00082381|79458633|FG000|Overall Study|Loss of Glucose Control|4|||
44450108|NCT00082381|79458634|FG001|Overall Study|Loss of Glucose Control|0|||
44450109|NCT00545844|79458640|FG000|Overall Study|Lost to Follow-up|9|||
44450110|NCT00545844|79458640|FG000|Overall Study|Protocol Violation|1|||
44450111|NCT00545844|79458640|FG000|Overall Study|Withdrawal by Subject|2|||
44450112|NCT00492063|79458650|FG000|Overall Study|Death|0|||
44450113|NCT00492063|79458651|FG001|Overall Study|Death|0|||
44450114|NCT00492063|79458652|FG002|Overall Study|Death|1|||
44450115|NCT00492063|79458653|FG003|Overall Study|Death|2|||
44450116|NCT00492063|79458650|FG000|Overall Study|Withdrawal by Subject|4|||
44450117|NCT00492063|79458651|FG001|Overall Study|Withdrawal by Subject|3|||
44450118|NCT00492063|79458652|FG002|Overall Study|Withdrawal by Subject|5|||
44450119|NCT00492063|79458653|FG003|Overall Study|Withdrawal by Subject|4|||
44450120|NCT00492063|79458650|FG000|Overall Study|Lost to Follow-up|6|||
44450121|NCT00492063|79458651|FG001|Overall Study|Lost to Follow-up|11|||
44450122|NCT00492063|79458652|FG002|Overall Study|Lost to Follow-up|5|||
44172120|NCT02152761|78965779|FG001|Epoch: Treatment Epoch|Technical problems|0|||
44172121|NCT02152761|78965780|FG002|Epoch: Treatment Epoch|Technical problems|0|||
44172122|NCT02152761|78965781|FG003|Epoch: Treatment Epoch|Technical problems|1|||
44450123|NCT00492063|79458653|FG003|Overall Study|Lost to Follow-up|3|||
44450124|NCT00492063|79458650|FG000|Overall Study|Protocol Violation|0|||
44450125|NCT00492063|79458651|FG001|Overall Study|Protocol Violation|0|||
44450126|NCT00492063|79458652|FG002|Overall Study|Protocol Violation|0|||
44450127|NCT00492063|79458653|FG003|Overall Study|Protocol Violation|1|||
44172123|NCT02152761|78965778|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
44450128|NCT00093145|79458663|FG000|Overall Study|Unacceptable Toxicity Only|2|||
44450129|NCT00093145|79458663|FG000|Overall Study|Physician Decision|5|||
44450130|NCT00093145|79458663|FG000|Overall Study|Withdrawal by Subject|9|||
44450131|NCT00093145|79458663|FG000|Overall Study|Other|1|||
44450132|NCT00513357|79458669|FG000|Overall Study|did not receive allocated placebo|2|||
44172124|NCT02152761|78965779|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
44172125|NCT02152761|78965780|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
44172126|NCT02152761|78965781|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
44172127|NCT02152761|78965778|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
44172128|NCT02152761|78965779|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
44172129|NCT02152761|78965780|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
44172130|NCT02152761|78965781|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
44172131|NCT02152761|78965778|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
44172132|NCT02152761|78965779|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
44172133|NCT02152761|78965780|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
44172134|NCT02152761|78965781|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
44172135|NCT02152761|78965778|FG000|Epoch: Treatment Epoch|Death|0|||
44172136|NCT02152761|78965779|FG001|Epoch: Treatment Epoch|Death|3|||
44172137|NCT02152761|78965780|FG002|Epoch: Treatment Epoch|Death|1|||
44172138|NCT02152761|78965781|FG003|Epoch: Treatment Epoch|Death|0|||
44172139|NCT02152761|78965778|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
44172140|NCT02152761|78965779|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
44172141|NCT02152761|78965780|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
44172142|NCT02152761|78965781|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
44172143|NCT02152761|78965778|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
44172144|NCT02152761|78965779|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
44172145|NCT02152761|78965780|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
44172146|NCT02152761|78965781|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
44172147|NCT02152761|78965778|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
44450133|NCT00513357|79458670|FG001|Overall Study|did not receive allocated placebo|3|||
44450134|NCT00513357|79458669|FG000|Overall Study|Adverse Event|4|||
44450135|NCT00513357|79458670|FG001|Overall Study|Adverse Event|2|||
44450136|NCT00513357|79458669|FG000|Overall Study|Death|2|||
44450137|NCT00513357|79458670|FG001|Overall Study|Death|0|||
44450138|NCT00513357|79458669|FG000|Overall Study|Withdrawal by Subject|5|||
44450139|NCT00513357|79458670|FG001|Overall Study|Withdrawal by Subject|4|||
44450140|NCT00513357|79458669|FG000|Overall Study|Disease Progression|2|||
44450141|NCT00513357|79458670|FG001|Overall Study|Disease Progression|1|||
44450142|NCT03933462|79458676|FG000|Overall Study|Adverse Event|2|||
44450143|NCT03933462|79458677|FG001|Overall Study|Adverse Event|0|||
44450144|NCT03929562|79458685|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
44450145|NCT03929562|79458686|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
44450146|NCT03929562|79458685|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
44450147|NCT03929562|79458686|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
44450148|NCT03929562|79458685|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
44450149|NCT03929562|79458686|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
44450150|NCT00415636|79458700|FG000|Overall Study|Symptomatic deterioration|1|||
44450151|NCT00415636|79458701|FG001|Overall Study|Symptomatic deterioration|0|||
44450152|NCT00415636|79458702|FG002|Overall Study|Symptomatic deterioration|1|||
44450153|NCT00415636|79458703|FG003|Overall Study|Symptomatic deterioration|2|||
44172148|NCT02152761|78965779|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
44172149|NCT02152761|78965780|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
44172150|NCT02152761|78965781|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
44172151|NCT02152761|78965778|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
44172152|NCT02152761|78965779|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
44172153|NCT02152761|78965780|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
44172154|NCT02152761|78965781|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
44172155|NCT02152761|78965778|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
44172156|NCT02152761|78965779|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
44172157|NCT02152761|78965780|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
44172158|NCT02152761|78965781|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
44172159|NCT02152605|78965803|FG000|Overall Study|Adverse Event|6|||
44172160|NCT02152605|78965804|FG001|Overall Study|Adverse Event|8|||
44172161|NCT02152605|78965803|FG000|Overall Study|Lack of Efficacy|7|||
44450154|NCT00415636|79458704|FG004|Overall Study|Symptomatic deterioration|0|||
44450155|NCT00415636|79458705|FG005|Overall Study|Symptomatic deterioration|1|||
44172162|NCT02152605|78965804|FG001|Overall Study|Lack of Efficacy|4|||
44172163|NCT02152605|78965803|FG000|Overall Study|Protocol deviation|1|||
44450156|NCT00415636|79458700|FG000|Overall Study|Adverse Event|0|||
44450157|NCT00415636|79458701|FG001|Overall Study|Adverse Event|0|||
44450158|NCT00415636|79458702|FG002|Overall Study|Adverse Event|0|||
44172164|NCT02152605|78965804|FG001|Overall Study|Protocol deviation|4|||
44264196|NCT02764762|79164480|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
44450159|NCT00415636|79458703|FG003|Overall Study|Adverse Event|1|||
44450160|NCT00415636|79458704|FG004|Overall Study|Adverse Event|1|||
44450161|NCT00415636|79458705|FG005|Overall Study|Adverse Event|0|||
44172165|NCT02152605|78965803|FG000|Overall Study|Lost to Follow-up|1|||
44172166|NCT02152605|78965804|FG001|Overall Study|Lost to Follow-up|0|||
44172167|NCT02152605|78965803|FG000|Overall Study|Withdrew consent|4|||
44172168|NCT02152605|78965804|FG001|Overall Study|Withdrew consent|2|||
44172169|NCT02152371|78965813|FG000|Overall Study|Adverse Event|6|||
44172170|NCT02152371|78965814|FG001|Overall Study|Adverse Event|2|||
44172171|NCT02152371|78965813|FG000|Overall Study|Withdrawal by Subject|3|||
44172172|NCT02152371|78965814|FG001|Overall Study|Withdrawal by Subject|7|||
44172173|NCT02152371|78965813|FG000|Overall Study|Protocol Violation|2|||
44172174|NCT02152371|78965814|FG001|Overall Study|Protocol Violation|3|||
44172175|NCT02152371|78965813|FG000|Overall Study|Lost to Follow-up|1|||
44172176|NCT02152371|78965814|FG001|Overall Study|Lost to Follow-up|0|||
44172177|NCT02152371|78965813|FG000|Overall Study|Lack of Efficacy|0|||
44172178|NCT02152371|78965814|FG001|Overall Study|Lack of Efficacy|1|||
44172179|NCT02152371|78965813|FG000|Overall Study|Physician Decision|0|||
44172180|NCT02152371|78965814|FG001|Overall Study|Physician Decision|2|||
44172181|NCT02152371|78965813|FG000|Overall Study|Reason Not Given|0|||
44172182|NCT02152371|78965814|FG001|Overall Study|Reason Not Given|1|||
44450162|NCT00415636|79458700|FG000|Overall Study|Withdrawal by Subject|0|||
44450163|NCT00415636|79458701|FG001|Overall Study|Withdrawal by Subject|0|||
44450164|NCT00415636|79458702|FG002|Overall Study|Withdrawal by Subject|0|||
44450165|NCT00415636|79458703|FG003|Overall Study|Withdrawal by Subject|0|||
44450166|NCT00415636|79458704|FG004|Overall Study|Withdrawal by Subject|1|||
44450167|NCT00415636|79458705|FG005|Overall Study|Withdrawal by Subject|0|||
44450168|NCT00415636|79458700|FG000|Overall Study|Disease progression|0|||
44450169|NCT00415636|79458701|FG001|Overall Study|Disease progression|0|||
44450170|NCT00415636|79458702|FG002|Overall Study|Disease progression|0|||
44450171|NCT00415636|79458703|FG003|Overall Study|Disease progression|3|||
44450172|NCT00415636|79458704|FG004|Overall Study|Disease progression|0|||
44450173|NCT00415636|79458705|FG005|Overall Study|Disease progression|1|||
44450174|NCT00425854|79458729|FG000|Overall Study|Progressive Disease|19|||
44450175|NCT00425854|79458730|FG001|Overall Study|Progressive Disease|12|||
44450176|NCT00425854|79458729|FG000|Overall Study|Dose reduction toxicity AE|8|||
44450177|NCT00425854|79458730|FG001|Overall Study|Dose reduction toxicity AE|7|||
44450178|NCT00425854|79458729|FG000|Overall Study|Other Adverse Event|2|||
44450179|NCT00425854|79458730|FG001|Overall Study|Other Adverse Event|2|||
44450180|NCT00425698|79458739|FG000|Overall Study|Adverse Event|3|||
44450181|NCT00425698|79458740|FG001|Overall Study|Adverse Event|1|||
44450182|NCT00425698|79458739|FG000|Overall Study|Withdrawal by Subject|0|||
44450183|NCT00425698|79458740|FG001|Overall Study|Withdrawal by Subject|1|||
44450184|NCT00425308|79458748|FG000|Overall Study|Adverse Event|2|||
44450185|NCT00425308|79458749|FG001|Overall Study|Adverse Event|1|||
44172183|NCT02332291|78965822|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
44172184|NCT02332291|78965823|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
44172185|NCT02332291|78965822|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
44172186|NCT02332291|78965823|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
44172187|NCT02332291|78965822|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
44172188|NCT02332291|78965823|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
44172189|NCT02332291|78965822|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
44172190|NCT02332291|78965823|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
44172191|NCT02332291|78965822|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
44172192|NCT02332291|78965823|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
44172193|NCT02332291|78965822|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
44172194|NCT02332291|78965823|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
44172195|NCT01656395|78965839|FG000|Overall Study|Adverse Event|1|||
44172196|NCT01656395|78965840|FG001|Overall Study|Adverse Event|14|||
44172197|NCT01656395|78965841|FG002|Overall Study|Adverse Event|5|||
44172198|NCT01656395|78965842|FG003|Overall Study|Adverse Event|4|||
44172199|NCT01656395|78965843|FG004|Overall Study|Adverse Event|5|||
44172200|NCT01656395|78965844|FG005|Overall Study|Adverse Event|7|||
44172201|NCT01656395|78965845|FG006|Overall Study|Adverse Event|0|||
44172202|NCT01656395|78965846|FG007|Overall Study|Adverse Event|0|||
44172203|NCT01656395|78965839|FG000|Overall Study|Lack of Efficacy|1|||
44172204|NCT01656395|78965840|FG001|Overall Study|Lack of Efficacy|8|||
44360848|NCT01212770|79366249|FG002|Long-term Safety Phase (Year 5)|Death|0|||
44360849|NCT01212770|79366250|FG003|Long-term Safety Phase (Year 5)|Death|0|||
44360850|NCT01212770|79366251|FG004|Long-term Safety Phase (Year 5)|Death|0|||
44360851|NCT01212770|79366252|FG005|Long-term Safety Phase (Year 5)|Death|0|||
44360852|NCT01212770|79366253|FG006|Long-term Safety Phase (Year 5)|Death|0|||
44360853|NCT01212770|79366254|FG007|Long-term Safety Phase (Year 5)|Death|1|||
44360854|NCT01212770|79366255|FG008|Long-term Safety Phase (Year 5)|Death|0|||
44360855|NCT00598273|79366280|FG000|Overall Study|Adverse Event|4|||
44360856|NCT00598273|79366281|FG001|Overall Study|Adverse Event|5|||
44360857|NCT00598273|79366282|FG002|Overall Study|Adverse Event|2|||
44360858|NCT00598273|79366280|FG000|Overall Study|Death|6|||
44360859|NCT00598273|79366281|FG001|Overall Study|Death|12|||
44360860|NCT00598273|79366282|FG002|Overall Study|Death|8|||
44360861|NCT00598273|79366280|FG000|Overall Study|Lost to Follow-up|8|||
44450186|NCT00425308|79458748|FG000|Overall Study|Withdrawal by Subject|1|||
44450187|NCT00425308|79458749|FG001|Overall Study|Withdrawal by Subject|0|||
44450188|NCT00425308|79458748|FG000|Overall Study|Death|1|||
44450189|NCT00425308|79458749|FG001|Overall Study|Death|0|||
44450190|NCT00545064|79458755|FG000|Overall Study|Lost to Follow-up|3|||
44450191|NCT00545064|79458755|FG000|Overall Study|Withdrawal by Subject|2|||
44450192|NCT00545064|79458755|FG000|Overall Study|did not complete course of treatment|1|||
44450193|NCT00545064|79458755|FG000|Overall Study|cancel all appointments, no rebooking|1|||
44450194|NCT00545064|79458755|FG000|Overall Study|inclement weather|1|||
44450195|NCT00432562|79458763|FG000|Overall Study|Death|3|||
44450196|NCT00432562|79458764|FG001|Overall Study|Death|0|||
44172205|NCT01656395|78965841|FG002|Overall Study|Lack of Efficacy|6|||
44172206|NCT01656395|78965842|FG003|Overall Study|Lack of Efficacy|1|||
44172207|NCT01656395|78965843|FG004|Overall Study|Lack of Efficacy|1|||
44172208|NCT01656395|78965844|FG005|Overall Study|Lack of Efficacy|6|||
44172209|NCT01656395|78965845|FG006|Overall Study|Lack of Efficacy|0|||
44172210|NCT01656395|78965846|FG007|Overall Study|Lack of Efficacy|0|||
44172211|NCT01656395|78965839|FG000|Overall Study|Lost to Follow-up|1|||
44172212|NCT01656395|78965840|FG001|Overall Study|Lost to Follow-up|0|||
44172213|NCT01656395|78965841|FG002|Overall Study|Lost to Follow-up|0|||
44172214|NCT01656395|78965842|FG003|Overall Study|Lost to Follow-up|0|||
44172215|NCT01656395|78965843|FG004|Overall Study|Lost to Follow-up|0|||
44172216|NCT01656395|78965844|FG005|Overall Study|Lost to Follow-up|0|||
44172217|NCT01656395|78965845|FG006|Overall Study|Lost to Follow-up|0|||
44172218|NCT01656395|78965846|FG007|Overall Study|Lost to Follow-up|0|||
44172219|NCT01656395|78965839|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44172220|NCT01656395|78965840|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44172221|NCT01656395|78965841|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44172222|NCT01656395|78965842|FG003|Overall Study|Non-Compliance with Study Drug|0|||
44172223|NCT01656395|78965843|FG004|Overall Study|Non-Compliance with Study Drug|1|||
44172224|NCT01656395|78965844|FG005|Overall Study|Non-Compliance with Study Drug|1|||
44172225|NCT01656395|78965845|FG006|Overall Study|Non-Compliance with Study Drug|0|||
44172226|NCT01656395|78965846|FG007|Overall Study|Non-Compliance with Study Drug|0|||
44172227|NCT01656395|78965839|FG000|Overall Study|Other|0|||
44172228|NCT01656395|78965840|FG001|Overall Study|Other|0|||
44172229|NCT01656395|78965841|FG002|Overall Study|Other|1|||
44172230|NCT01656395|78965842|FG003|Overall Study|Other|0|||
44172231|NCT01656395|78965843|FG004|Overall Study|Other|0|||
44172232|NCT01656395|78965844|FG005|Overall Study|Other|1|||
44172233|NCT01656395|78965845|FG006|Overall Study|Other|0|||
44172234|NCT01656395|78965846|FG007|Overall Study|Other|0|||
44172235|NCT01656395|78965839|FG000|Overall Study|Physician Decision|2|||
44172236|NCT01656395|78965840|FG001|Overall Study|Physician Decision|3|||
44172237|NCT01656395|78965841|FG002|Overall Study|Physician Decision|3|||
44172238|NCT01656395|78965842|FG003|Overall Study|Physician Decision|2|||
44172239|NCT01656395|78965843|FG004|Overall Study|Physician Decision|3|||
44450197|NCT00432172|79458774|FG000|Overall Study|Physician Decision|0|||
44450198|NCT00432172|79458775|FG001|Overall Study|Physician Decision|0|||
44450199|NCT00432172|79458776|FG002|Overall Study|Physician Decision|2|||
44450200|NCT00432172|79458777|FG003|Overall Study|Physician Decision|0|||
44450201|NCT00432172|79458774|FG000|Overall Study|Adverse Event|4|||
44450202|NCT00432172|79458775|FG001|Overall Study|Adverse Event|2|||
44450203|NCT00432172|79458776|FG002|Overall Study|Adverse Event|4|||
44450204|NCT00432172|79458777|FG003|Overall Study|Adverse Event|3|||
44450205|NCT00432172|79458774|FG000|Overall Study|Disease progression|0|||
44450206|NCT00432172|79458775|FG001|Overall Study|Disease progression|2|||
44450207|NCT00432172|79458776|FG002|Overall Study|Disease progression|5|||
44450208|NCT00432172|79458777|FG003|Overall Study|Disease progression|1|||
44450209|NCT00432172|79458774|FG000|Overall Study|Withdrawal by Subject|0|||
44450210|NCT00432172|79458775|FG001|Overall Study|Withdrawal by Subject|1|||
44450211|NCT00432172|79458776|FG002|Overall Study|Withdrawal by Subject|0|||
44450212|NCT00432172|79458777|FG003|Overall Study|Withdrawal by Subject|2|||
44450213|NCT00432172|79458774|FG000|Overall Study|No treatment received|2|||
44450214|NCT00432172|79458775|FG001|Overall Study|No treatment received|2|||
44450215|NCT00432172|79458776|FG002|Overall Study|No treatment received|0|||
44450216|NCT00432172|79458777|FG003|Overall Study|No treatment received|1|||
44172240|NCT01656395|78965844|FG005|Overall Study|Physician Decision|3|||
44172241|NCT01656395|78965845|FG006|Overall Study|Physician Decision|0|||
44172242|NCT01656395|78965846|FG007|Overall Study|Physician Decision|0|||
44450217|NCT00415168|79458789|FG000|Overall Study|Death|26|||
44450218|NCT00415168|79458789|FG000|Overall Study|Lost to Follow-up|3|||
44450219|NCT00415168|79458789|FG000|Overall Study|Physician Decision|13|||
44450220|NCT00415168|79458789|FG000|Overall Study|Sponsor Decision|4|||
44172243|NCT01656395|78965839|FG000|Overall Study|Pregnancy|0|||
44172244|NCT01656395|78965840|FG001|Overall Study|Pregnancy|0|||
44172245|NCT01656395|78965841|FG002|Overall Study|Pregnancy|1|||
44172246|NCT01656395|78965842|FG003|Overall Study|Pregnancy|0|||
44172247|NCT01656395|78965843|FG004|Overall Study|Pregnancy|0|||
44172248|NCT01656395|78965844|FG005|Overall Study|Pregnancy|0|||
44172249|NCT01656395|78965845|FG006|Overall Study|Pregnancy|0|||
44450221|NCT00415168|79458789|FG000|Overall Study|Withdrawal by Subject|6|||
44450222|NCT00424762|79458795|FG000|Overall Study|Withdrawal by Subject|18|||
44450223|NCT00424762|79458796|FG001|Overall Study|Withdrawal by Subject|19|||
44450224|NCT00424762|79458795|FG000|Overall Study|Lost to Follow-up|2|||
44450225|NCT00424762|79458796|FG001|Overall Study|Lost to Follow-up|3|||
44450226|NCT00414544|79458802|FG000|Overall Study|Lost to Follow-up|14|||
44450227|NCT00414466|79458812|FG000|Overall Study|Adverse Event|0|||
44450228|NCT00414466|79458813|FG001|Overall Study|Adverse Event|0|||
44450229|NCT00414466|79458814|FG002|Overall Study|Adverse Event|1|||
44450230|NCT00414466|79458815|FG003|Overall Study|Adverse Event|1|||
44450231|NCT00414466|79458812|FG000|Overall Study|Lack of Efficacy|1|||
44450232|NCT00414466|79458813|FG001|Overall Study|Lack of Efficacy|0|||
44450233|NCT00414466|79458814|FG002|Overall Study|Lack of Efficacy|0|||
44450234|NCT00414466|79458815|FG003|Overall Study|Lack of Efficacy|0|||
44450235|NCT00414466|79458812|FG000|Overall Study|Withdrawn by Sponsor|1|||
44450236|NCT00414466|79458813|FG001|Overall Study|Withdrawn by Sponsor|0|||
44450237|NCT00414466|79458814|FG002|Overall Study|Withdrawn by Sponsor|0|||
44450238|NCT00414466|79458815|FG003|Overall Study|Withdrawn by Sponsor|0|||
44450239|NCT00424528|79458831|FG000|Overall Study|Adverse Event|2|||
44450240|NCT00424528|79458832|FG001|Overall Study|Adverse Event|1|||
44450241|NCT00424528|79458833|FG002|Overall Study|Adverse Event|2|||
44450242|NCT00424528|79458831|FG000|Overall Study|Protocol Violation|1|||
44450243|NCT00424528|79458832|FG001|Overall Study|Protocol Violation|1|||
44450244|NCT00424528|79458833|FG002|Overall Study|Protocol Violation|0|||
44450245|NCT00424528|79458831|FG000|Overall Study|Lost to Follow-up|0|||
44450246|NCT00424528|79458832|FG001|Overall Study|Lost to Follow-up|1|||
44172250|NCT01656395|78965846|FG007|Overall Study|Pregnancy|0|||
44172251|NCT01656395|78965839|FG000|Overall Study|Progressive Disease|0|||
44172252|NCT01656395|78965840|FG001|Overall Study|Progressive Disease|0|||
44172253|NCT01656395|78965841|FG002|Overall Study|Progressive Disease|0|||
44172254|NCT01656395|78965842|FG003|Overall Study|Progressive Disease|0|||
44172255|NCT01656395|78965843|FG004|Overall Study|Progressive Disease|0|||
44172256|NCT01656395|78965844|FG005|Overall Study|Progressive Disease|1|||
44172257|NCT01656395|78965845|FG006|Overall Study|Progressive Disease|0|||
44172258|NCT01656395|78965846|FG007|Overall Study|Progressive Disease|0|||
44172259|NCT01656395|78965839|FG000|Overall Study|Protocol Violation|6|||
44172260|NCT01656395|78965840|FG001|Overall Study|Protocol Violation|6|||
44172261|NCT01656395|78965841|FG002|Overall Study|Protocol Violation|9|||
44172262|NCT01656395|78965842|FG003|Overall Study|Protocol Violation|2|||
44172263|NCT01656395|78965843|FG004|Overall Study|Protocol Violation|4|||
44172264|NCT01656395|78965844|FG005|Overall Study|Protocol Violation|10|||
44172265|NCT01656395|78965845|FG006|Overall Study|Protocol Violation|0|||
44172266|NCT01656395|78965846|FG007|Overall Study|Protocol Violation|0|||
44172267|NCT01656395|78965839|FG000|Overall Study|Screen Failure|2|||
44172268|NCT01656395|78965840|FG001|Overall Study|Screen Failure|1|||
44172269|NCT01656395|78965841|FG002|Overall Study|Screen Failure|7|||
44172270|NCT01656395|78965842|FG003|Overall Study|Screen Failure|1|||
44172271|NCT01656395|78965843|FG004|Overall Study|Screen Failure|0|||
44172272|NCT01656395|78965844|FG005|Overall Study|Screen Failure|8|||
44172273|NCT01656395|78965845|FG006|Overall Study|Screen Failure|0|||
44172274|NCT01656395|78965846|FG007|Overall Study|Screen Failure|0|||
44172275|NCT01656395|78965839|FG000|Overall Study|Withdrawal by Subject|3|||
44264197|NCT02764762|79164480|FG000|Overall Study|Lost to Follow-up|4|||
44450247|NCT00424528|79458833|FG002|Overall Study|Lost to Follow-up|0|||
44450248|NCT00424528|79458831|FG000|Overall Study|noncompliance with study requirements|2|||
44450249|NCT00424528|79458832|FG001|Overall Study|noncompliance with study requirements|1|||
44450250|NCT00424528|79458833|FG002|Overall Study|noncompliance with study requirements|2|||
44450251|NCT00545532|79458843|FG000|Overall Study|Withdrawal by Subject|1|||
44450252|NCT00545532|79458844|FG001|Overall Study|Withdrawal by Subject|3|||
44450253|NCT00545532|79458843|FG000|Overall Study|Lost to Follow-up|5|||
44450254|NCT00545532|79458844|FG001|Overall Study|Lost to Follow-up|6|||
44450255|NCT00545532|79458843|FG000|Overall Study|Death|0|||
44450256|NCT00545532|79458844|FG001|Overall Study|Death|1|||
44450257|NCT00544440|79458852|FG000|Overall Study|Other|1|||
44450258|NCT00544440|79458852|FG000|Overall Study|Adverse Event|1|||
44450259|NCT00544440|79458852|FG000|Overall Study|Withdrawal by Subject|2|||
44450260|NCT00544440|79458852|FG000|Overall Study|Subject Non-compliance|1|||
44450261|NCT00544440|79458852|FG000|Overall Study|Progressive Disease|47|||
44450262|NCT00544440|79458852|FG000|Overall Study|Other|5|||
44450263|NCT03920670|79458858|FG000|Overall Study|Protocol Violation|2|||
44450264|NCT03920670|79458859|FG001|Overall Study|Protocol Violation|2|||
44172276|NCT01656395|78965840|FG001|Overall Study|Withdrawal by Subject|1|||
44172277|NCT01656395|78965841|FG002|Overall Study|Withdrawal by Subject|4|||
44172278|NCT01656395|78965842|FG003|Overall Study|Withdrawal by Subject|2|||
44172279|NCT01656395|78965843|FG004|Overall Study|Withdrawal by Subject|0|||
44172280|NCT01656395|78965844|FG005|Overall Study|Withdrawal by Subject|3|||
44450265|NCT03920670|79458858|FG000|Overall Study|Adverse Event|1|||
44450266|NCT03920670|79458859|FG001|Overall Study|Adverse Event|0|||
44450267|NCT00430300|79458869|FG000|Overall Study|Adverse Event|0|||
44450268|NCT00430300|79458870|FG001|Overall Study|Adverse Event|2|||
44450269|NCT00430300|79458871|FG002|Overall Study|Adverse Event|1|||
44450270|NCT00430300|79458872|FG003|Overall Study|Adverse Event|1|||
44450271|NCT00430300|79458869|FG000|Overall Study|Withdrawal by Subject|1|||
44450272|NCT00430300|79458870|FG001|Overall Study|Withdrawal by Subject|0|||
44450273|NCT00430300|79458871|FG002|Overall Study|Withdrawal by Subject|5|||
44450274|NCT00430300|79458872|FG003|Overall Study|Withdrawal by Subject|0|||
44450275|NCT00430300|79458869|FG000|Overall Study|Laboratory abnormality|1|||
44450276|NCT00430300|79458870|FG001|Overall Study|Laboratory abnormality|0|||
44450277|NCT00430300|79458871|FG002|Overall Study|Laboratory abnormality|0|||
44450278|NCT00430300|79458872|FG003|Overall Study|Laboratory abnormality|0|||
44450279|NCT00430300|79458869|FG000|Overall Study|Other|0|||
44450280|NCT00430300|79458870|FG001|Overall Study|Other|0|||
44450281|NCT00430300|79458871|FG002|Overall Study|Other|0|||
44450282|NCT00430300|79458872|FG003|Overall Study|Other|1|||
44450283|NCT03927846|79458884|FG000|Overall Study|Lost to Follow-up|10|||
44450284|NCT03927846|79458885|FG001|Overall Study|Lost to Follow-up|11|||
44450285|NCT00545298|79458894|FG000|Overall Study|Issues with Standard of Care|2|||
44450286|NCT00545298|79458895|FG001|Overall Study|Issues with Standard of Care|0|||
44450287|NCT00545298|79458896|FG002|Overall Study|Issues with Standard of Care|1|||
44450288|NCT00429364|79458909|FG000|Overall Study|Withdrawal by Subject|11|||
44450289|NCT00429364|79458910|FG001|Overall Study|Withdrawal by Subject|5|||
44450290|NCT00429364|79458909|FG000|Overall Study|Physician Decision|4|||
44450291|NCT00429364|79458910|FG001|Overall Study|Physician Decision|2|||
44450292|NCT00429364|79458909|FG000|Overall Study|Lost to Follow-up|7|||
44450293|NCT00429364|79458910|FG001|Overall Study|Lost to Follow-up|6|||
44450294|NCT00429364|79458909|FG000|Overall Study|Death|0|||
44450295|NCT00429364|79458910|FG001|Overall Study|Death|1|||
44450296|NCT00429364|79458909|FG000|Overall Study|Underwent aortic root surgery|10|||
44450297|NCT00429364|79458910|FG001|Overall Study|Underwent aortic root surgery|18|||
44450298|NCT00429364|79458909|FG000|Overall Study|Pregnancy|0|||
44450299|NCT00429364|79458910|FG001|Overall Study|Pregnancy|1|||
44450300|NCT00414388|79458916|FG000|Overall Study|Adverse Event|1|||
44450301|NCT03920280|79458923|FG000|Overall Study|Adverse Event|2|||
44450302|NCT03920280|79458924|FG001|Overall Study|Adverse Event|3|||
44450303|NCT03920280|79458923|FG000|Overall Study|Lost to Follow-up|0|||
44450304|NCT03920280|79458924|FG001|Overall Study|Lost to Follow-up|1|||
44450305|NCT03920280|79458923|FG000|Overall Study|Withdrawal by Subject|1|||
44450306|NCT03920280|79458924|FG001|Overall Study|Withdrawal by Subject|1|||
44450307|NCT03920280|79458923|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
44450308|NCT03920280|79458924|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
44450309|NCT00424372|79458933|FG000|Overall Study|Death|1|||
44450310|NCT00424372|79458933|FG000|Overall Study|Adverse Event|18|||
44450311|NCT00424372|79458933|FG000|Overall Study|Lack of Efficacy|6|||
44450312|NCT00424372|79458933|FG000|Overall Study|Withdrawal by Subject|4|||
44450313|NCT00424372|79458933|FG000|Overall Study|Protocol Violation|1|||
44450314|NCT00424372|79458933|FG000|Overall Study|Health deterioration|1|||
44450315|NCT00414310|79458939|FG000|Overall Study|Not treated|1|||
44450316|NCT00414310|79458940|FG001|Overall Study|Not treated|0|||
44450317|NCT00542880|79458950|FG000|Period 1|Eligibility criteria not fulfilled|2|||
44450318|NCT00542880|79458951|FG001|Period 1|Eligibility criteria not fulfilled|6|||
44450319|NCT00542880|79458950|FG000|Period 1|Adverse Event|2|||
44450320|NCT00542880|79458951|FG001|Period 1|Adverse Event|2|||
44450321|NCT00542880|79458950|FG000|Period 1|Development of study-specific criteria|1|||
44450322|NCT00542880|79458951|FG001|Period 1|Development of study-specific criteria|2|||
44450323|NCT00542880|79458950|FG000|Period 1|Withdrawal by Subject|1|||
44450324|NCT00542880|79458951|FG001|Period 1|Withdrawal by Subject|1|||
44450325|NCT00542880|79458950|FG000|Period 1|Protocol Violation|0|||
44450326|NCT00542880|79458951|FG001|Period 1|Protocol Violation|1|||
44450327|NCT00542880|79458950|FG000|Period 2|Adverse Event|5|||
44450328|NCT00542880|79458951|FG001|Period 2|Adverse Event|7|||
44450329|NCT00542880|79458950|FG000|Period 2|Eligibility not fulfilled|0|||
44450330|NCT00542880|79458951|FG001|Period 2|Eligibility not fulfilled|1|||
44450331|NCT00542880|79458950|FG000|Period 2|Discontinuation criteria|2|||
44450332|NCT00542880|79458951|FG001|Period 2|Discontinuation criteria|0|||
44450333|NCT00542880|79458950|FG000|Period 2|Severe non-compliance|0|||
44450334|NCT00542880|79458951|FG001|Period 2|Severe non-compliance|1|||
44450335|NCT00542880|79458950|FG000|Period 2|Other|0|||
44450336|NCT00542880|79458951|FG001|Period 2|Other|1|||
44450337|NCT00542880|79458950|FG000|Period 3|Adverse Event|0|||
44450338|NCT00542880|79458951|FG001|Period 3|Adverse Event|2|||
44450339|NCT00414076|79458960|FG000|Overall Study|Progression|1|||
44450340|NCT00414076|79458961|FG001|Overall Study|Progression|2|||
44450341|NCT00414076|79458960|FG000|Overall Study|Withdrawal by Subject|1|||
44450342|NCT00414076|79458961|FG001|Overall Study|Withdrawal by Subject|3|||
44450343|NCT00414076|79458960|FG000|Overall Study|Adverse Event|1|||
44450344|NCT00414076|79458961|FG001|Overall Study|Adverse Event|0|||
44450345|NCT00092677|79458969|FG000|Overall Study|Lost to Follow-up|0|||
44450346|NCT00092677|79458970|FG001|Overall Study|Lost to Follow-up|2|||
44450347|NCT00092677|79458969|FG000|Overall Study|Adminstrative|5|||
44450348|NCT00092677|79458970|FG001|Overall Study|Adminstrative|9|||
44450349|NCT00542178|79458982|FG000|Overall Study|did not complete year 4 follow-up|75|||
44450350|NCT00542178|79458983|FG001|Overall Study|did not complete year 4 follow-up|80|||
44450351|NCT00542178|79458984|FG002|Overall Study|did not complete year 4 follow-up|74|||
44450352|NCT00542178|79458985|FG003|Overall Study|did not complete year 4 follow-up|62|||
44450353|NCT00542178|79458986|FG004|Overall Study|did not complete year 4 follow-up|64|||
44450354|NCT00542178|79458987|FG005|Overall Study|did not complete year 4 follow-up|89|||
44450355|NCT00542178|79458988|FG006|Overall Study|did not complete year 4 follow-up|87|||
44172281|NCT01656395|78965845|FG006|Overall Study|Withdrawal by Subject|0|||
44450356|NCT00542178|79458989|FG007|Overall Study|did not complete year 4 follow-up|85|||
44450357|NCT00424294|79459005|FG000|Overall Study|Adverse Event|4|||
44450358|NCT00424294|79459006|FG001|Overall Study|Adverse Event|10|||
44450359|NCT00424294|79459005|FG000|Overall Study|Lack of Efficacy|2|||
44450360|NCT00424294|79459006|FG001|Overall Study|Lack of Efficacy|1|||
44450361|NCT00424294|79459005|FG000|Overall Study|Withdrawal by Subject|1|||
44450362|NCT00424294|79459006|FG001|Overall Study|Withdrawal by Subject|2|||
44450363|NCT00424294|79459005|FG000|Overall Study|Other|0|||
44450364|NCT00424294|79459006|FG001|Overall Study|Other|2|||
44450365|NCT00424294|79459005|FG000|Overall Study|Randomized but not Treated|1|||
44450366|NCT00424294|79459006|FG001|Overall Study|Randomized but not Treated|0|||
44450367|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
44450368|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
44450369|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
44450370|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
44450371|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
44450372|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
44450373|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
44450374|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
44450375|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
44450376|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
44450377|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
44450378|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
44450379|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
44450380|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
44450381|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
44450382|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
44450383|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
44450384|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
44450385|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
44450386|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
44450387|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
44450388|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
44450389|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
44450390|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
44450391|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
44450392|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
44450393|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
44450394|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
44450395|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
44450396|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
44450397|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
44450398|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
44450399|NCT00092521|79459015|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
44450400|NCT00092521|79459016|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
44450401|NCT00092521|79459017|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
44450402|NCT00092521|79459018|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
44450403|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
44450404|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
44450405|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
44450406|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
44450407|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
44450408|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
44450409|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
44450410|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
44450411|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
44450412|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
44450413|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
44450414|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
44450415|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Death|2|||
44450416|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Death|0|||
44450417|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Death|1|||
44450418|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Death|0|||
44450419|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
44450420|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
44450421|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
44450422|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
44450423|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
44450424|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
44450425|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
44450426|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
44450427|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
44450428|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
44450429|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
44450430|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
44450431|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Moved|32|||
44450432|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Moved|2|||
44450433|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Moved|28|||
44450434|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Moved|0|||
44450435|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
44450436|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
44450437|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
44450438|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
44450439|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Travel|2|||
44450440|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Travel|0|||
44450441|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Travel|0|||
44450442|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Travel|0|||
44450443|NCT00092521|79459015|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
44450444|NCT00092521|79459016|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
44450445|NCT00092521|79459017|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
44450446|NCT00092521|79459018|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
44450447|NCT00092521|79459015|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
44450448|NCT00092521|79459016|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
44450449|NCT00092521|79459017|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
44450450|NCT00092521|79459018|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
44450451|NCT00092521|79459015|FG000|Extension Study (Group 4)|Adverse Event|0|||
44450452|NCT00092521|79459016|FG001|Extension Study (Group 4)|Adverse Event|0|||
44450453|NCT00092521|79459017|FG002|Extension Study (Group 4)|Adverse Event|0|||
44450454|NCT00092521|79459018|FG003|Extension Study (Group 4)|Adverse Event|2|||
44450455|NCT00092521|79459015|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
44450456|NCT00092521|79459016|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
44450457|NCT00092521|79459017|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
44450458|NCT00092521|79459018|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
44450459|NCT00092521|79459015|FG000|Extension Study (Group 4)|Pregnancy|0|||
44450460|NCT00092521|79459016|FG001|Extension Study (Group 4)|Pregnancy|0|||
44450461|NCT00092521|79459017|FG002|Extension Study (Group 4)|Pregnancy|0|||
44450462|NCT00092521|79459018|FG003|Extension Study (Group 4)|Pregnancy|4|||
44450463|NCT00092521|79459015|FG000|Extension Study (Group 4)|Protocol Violation|0|||
44450464|NCT00092521|79459016|FG001|Extension Study (Group 4)|Protocol Violation|0|||
44450465|NCT00092521|79459017|FG002|Extension Study (Group 4)|Protocol Violation|0|||
44450466|NCT00092521|79459018|FG003|Extension Study (Group 4)|Protocol Violation|2|||
44450467|NCT00092521|79459015|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
44450468|NCT00092521|79459016|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
44450469|NCT00092521|79459017|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
44450470|NCT00092521|79459018|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
44450471|NCT00092521|79459015|FG000|Extension Study (Group 4)|Moved|0|||
44450472|NCT00092521|79459016|FG001|Extension Study (Group 4)|Moved|0|||
44450473|NCT00092521|79459017|FG002|Extension Study (Group 4)|Moved|0|||
44450474|NCT00092521|79459018|FG003|Extension Study (Group 4)|Moved|16|||
44450475|NCT00092521|79459015|FG000|Extension Study (Group 4)|Site Terminated|0|||
44450476|NCT00092521|79459016|FG001|Extension Study (Group 4)|Site Terminated|0|||
44450477|NCT00092521|79459017|FG002|Extension Study (Group 4)|Site Terminated|0|||
44450478|NCT00092521|79459018|FG003|Extension Study (Group 4)|Site Terminated|4|||
44450479|NCT00092521|79459015|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
44450480|NCT00092521|79459016|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
44450481|NCT00092521|79459017|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
44450482|NCT00092521|79459018|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
44450483|NCT03908970|79459028|FG000|Overall Study|Adverse Event|7|||
44450484|NCT03908970|79459029|FG001|Overall Study|Adverse Event|21|||
44450485|NCT03908970|79459028|FG000|Overall Study|Physician Decision|1|||
44450486|NCT03908970|79459029|FG001|Overall Study|Physician Decision|4|||
44450487|NCT03908970|79459028|FG000|Overall Study|Withdrawal by Subject|9|||
44450488|NCT03908970|79459029|FG001|Overall Study|Withdrawal by Subject|22|||
44450489|NCT00092443|79459037|FG000|Overall Study|Adverse Event|9|||
44450490|NCT00092443|79459038|FG001|Overall Study|Adverse Event|13|||
44450491|NCT00092443|79459037|FG000|Overall Study|Lost to Follow-up|7|||
44450492|NCT00092443|79459038|FG001|Overall Study|Lost to Follow-up|3|||
44450493|NCT00092443|79459037|FG000|Overall Study|Protocol Violation|11|||
44450494|NCT00092443|79459038|FG001|Overall Study|Protocol Violation|9|||
44450495|NCT00092443|79459037|FG000|Overall Study|Withdrawal by Subject|9|||
44450496|NCT00092443|79459038|FG001|Overall Study|Withdrawal by Subject|11|||
44450497|NCT00092443|79459037|FG000|Overall Study|Moved|5|||
44450498|NCT00092443|79459038|FG001|Overall Study|Moved|5|||
44450499|NCT00092443|79459037|FG000|Overall Study|Other|17|||
44450500|NCT00092443|79459038|FG001|Overall Study|Other|13|||
44450501|NCT00413920|79459056|FG000|Overall Study|Adverse Event|9|||
44450502|NCT00413920|79459057|FG001|Overall Study|Adverse Event|11|||
44450503|NCT00413920|79459056|FG000|Overall Study|Lack of Efficacy|11|||
44450504|NCT00413920|79459057|FG001|Overall Study|Lack of Efficacy|9|||
44450505|NCT00413920|79459056|FG000|Overall Study|Death|3|||
44450506|NCT00413920|79459057|FG001|Overall Study|Death|5|||
44450507|NCT00413920|79459056|FG000|Overall Study|Graft Loss|5|||
44450508|NCT00413920|79459057|FG001|Overall Study|Graft Loss|3|||
44450509|NCT00091819|79459065|FG000|Overall Study|Adverse Event|1|||
44450510|NCT00091819|79459066|FG001|Overall Study|Adverse Event|1|||
44450511|NCT00091819|79459065|FG000|Overall Study|Death|4|||
44450512|NCT00091819|79459066|FG001|Overall Study|Death|5|||
44450513|NCT00091819|79459065|FG000|Overall Study|Lost to Follow-up|26|||
44450514|NCT00091819|79459066|FG001|Overall Study|Lost to Follow-up|23|||
44450515|NCT00091819|79459065|FG000|Overall Study|Withdrawal by Subject|5|||
44450516|NCT00091819|79459066|FG001|Overall Study|Withdrawal by Subject|8|||
44450517|NCT00091819|79459065|FG000|Overall Study|Protocol Violation|1|||
44450518|NCT00091819|79459066|FG001|Overall Study|Protocol Violation|2|||
44450519|NCT00091819|79459065|FG000|Overall Study|Other|2|||
44450520|NCT00091819|79459066|FG001|Overall Study|Other|3|||
44450521|NCT00091819|79459065|FG000|Overall Study|Never received study treatment|3|||
44450522|NCT00091819|79459066|FG001|Overall Study|Never received study treatment|4|||
44450523|NCT00540228|79459077|FG000|Overall Study|Adverse Event|2|||
44450524|NCT00540228|79459078|FG001|Overall Study|Adverse Event|0|||
44450525|NCT00540228|79459079|FG002|Overall Study|Adverse Event|0|||
44450526|NCT00540228|79459080|FG003|Overall Study|Adverse Event|0|||
44450527|NCT00540228|79459081|FG004|Overall Study|Adverse Event|0|||
44172282|NCT01656395|78965846|FG007|Overall Study|Withdrawal by Subject|0|||
44360862|NCT00598273|79366281|FG001|Overall Study|Lost to Follow-up|3|||
44360863|NCT00598273|79366282|FG002|Overall Study|Lost to Follow-up|5|||
44360864|NCT00598273|79366280|FG000|Overall Study|Physician Decision|0|||
44360865|NCT00598273|79366281|FG001|Overall Study|Physician Decision|0|||
44360866|NCT00598273|79366282|FG002|Overall Study|Physician Decision|1|||
44360867|NCT00598273|79366280|FG000|Overall Study|Withdrawal by Subject|12|||
44360868|NCT00598273|79366281|FG001|Overall Study|Withdrawal by Subject|10|||
44360869|NCT00598273|79366282|FG002|Overall Study|Withdrawal by Subject|10|||
44360870|NCT00598273|79366280|FG000|Overall Study|Noncompliance|3|||
44360871|NCT00598273|79366281|FG001|Overall Study|Noncompliance|2|||
44360872|NCT00598273|79366282|FG002|Overall Study|Noncompliance|3|||
44360873|NCT00598273|79366280|FG000|Overall Study|Relocation|0|||
44360874|NCT00598273|79366281|FG001|Overall Study|Relocation|2|||
44360875|NCT00598273|79366282|FG002|Overall Study|Relocation|4|||
44360876|NCT00598273|79366280|FG000|Overall Study|Renal transplant|1|||
44360877|NCT00598273|79366281|FG001|Overall Study|Renal transplant|0|||
44360878|NCT00598273|79366282|FG002|Overall Study|Renal transplant|1|||
44360879|NCT00598273|79366280|FG000|Overall Study|Site elected to close|1|||
44360880|NCT00598273|79366281|FG001|Overall Study|Site elected to close|0|||
44360881|NCT00598273|79366282|FG002|Overall Study|Site elected to close|0|||
44360882|NCT00598273|79366280|FG000|Overall Study|Started dialysis|6|||
44360883|NCT00598273|79366281|FG001|Overall Study|Started dialysis|4|||
44360884|NCT00598273|79366282|FG002|Overall Study|Started dialysis|5|||
44360885|NCT01211522|79366293|FG000|Overall Study|Withdrawal by Subject|3|||
44360886|NCT01211522|79366294|FG001|Overall Study|Withdrawal by Subject|7|||
44360887|NCT01211522|79366295|FG002|Overall Study|Withdrawal by Subject|5|||
44360888|NCT01211288|79366305|FG000|Overall Study|Lost to Follow-up|1|||
44360889|NCT01211288|79366306|FG001|Overall Study|Lost to Follow-up|1|||
44360890|NCT00883753|79366314|FG000|Overall Study|Adverse Event|37|||
44360891|NCT00883753|79366314|FG000|Overall Study|Death|2|||
44360892|NCT00883753|79366314|FG000|Overall Study|Insufficient therapeutic response|16|||
44360893|NCT00883753|79366314|FG000|Overall Study|Lost to Follow-up|4|||
44360894|NCT00883753|79366314|FG000|Overall Study|Violation of selection criteria at entry|7|||
44360895|NCT00883753|79366314|FG000|Overall Study|Protocol Violation|2|||
44360896|NCT00883753|79366314|FG000|Overall Study|Refused treatment|4|||
44360897|NCT00883753|79366314|FG000|Overall Study|Withdrew consent|10|||
44360898|NCT00883753|79366314|FG000|Overall Study|Investigator's decision|17|||
44360899|NCT00883753|79366314|FG000|Overall Study|Administrative/Other|8|||
44360900|NCT01210664|79366321|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
44360901|NCT01210664|79366322|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
44360902|NCT01210664|79366323|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
44360903|NCT01210664|79366324|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
44450528|NCT00540228|79459077|FG000|Overall Study|Lost to Follow-up|1|||
44450529|NCT00540228|79459078|FG001|Overall Study|Lost to Follow-up|1|||
44450530|NCT00540228|79459079|FG002|Overall Study|Lost to Follow-up|0|||
44450531|NCT00540228|79459080|FG003|Overall Study|Lost to Follow-up|0|||
44450532|NCT00540228|79459081|FG004|Overall Study|Lost to Follow-up|0|||
44450533|NCT05013385|79459106|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
44450534|NCT04250636|79459129|FG000|Overall Study|Lost to Follow-up|2|||
44450535|NCT03989115|79459141|FG000|Overall Study|Withdrawal by Subject|2|||
44450536|NCT03989115|79459142|FG001|Overall Study|Withdrawal by Subject|1|||
44450537|NCT03989115|79459143|FG002|Overall Study|Withdrawal by Subject|3|||
44450538|NCT03989115|79459144|FG003|Overall Study|Withdrawal by Subject|0|||
44450539|NCT03989115|79459145|FG004|Overall Study|Withdrawal by Subject|17|||
44450540|NCT03989115|79459146|FG005|Overall Study|Withdrawal by Subject|1|||
44450541|NCT03989115|79459147|FG006|Overall Study|Withdrawal by Subject|0|||
44450542|NCT03989115|79459148|FG007|Overall Study|Withdrawal by Subject|0|||
44450543|NCT03989115|79459141|FG000|Overall Study|Sponsor decision to terminate the study|1|||
44450544|NCT03989115|79459142|FG001|Overall Study|Sponsor decision to terminate the study|1|||
44450545|NCT03989115|79459143|FG002|Overall Study|Sponsor decision to terminate the study|0|||
44450546|NCT03989115|79459144|FG003|Overall Study|Sponsor decision to terminate the study|1|||
44450547|NCT03989115|79459145|FG004|Overall Study|Sponsor decision to terminate the study|11|||
44450548|NCT03989115|79459146|FG005|Overall Study|Sponsor decision to terminate the study|0|||
44450549|NCT03989115|79459147|FG006|Overall Study|Sponsor decision to terminate the study|2|||
44450550|NCT03989115|79459148|FG007|Overall Study|Sponsor decision to terminate the study|1|||
44450551|NCT03989115|79459141|FG000|Overall Study|Lost to Follow-up|2|||
44450552|NCT03989115|79459142|FG001|Overall Study|Lost to Follow-up|0|||
44450553|NCT03989115|79459143|FG002|Overall Study|Lost to Follow-up|0|||
44450554|NCT03989115|79459144|FG003|Overall Study|Lost to Follow-up|0|||
44450555|NCT03989115|79459145|FG004|Overall Study|Lost to Follow-up|1|||
44450556|NCT03989115|79459146|FG005|Overall Study|Lost to Follow-up|0|||
44450557|NCT03989115|79459147|FG006|Overall Study|Lost to Follow-up|0|||
44450558|NCT03989115|79459148|FG007|Overall Study|Lost to Follow-up|0|||
44450559|NCT03989115|79459141|FG000|Overall Study|Death|2|||
44450560|NCT03989115|79459142|FG001|Overall Study|Death|2|||
44450561|NCT03989115|79459143|FG002|Overall Study|Death|9|||
44450562|NCT03989115|79459144|FG003|Overall Study|Death|6|||
44450563|NCT03989115|79459145|FG004|Overall Study|Death|31|||
44450564|NCT03989115|79459146|FG005|Overall Study|Death|6|||
44450565|NCT03989115|79459147|FG006|Overall Study|Death|2|||
44450566|NCT03989115|79459148|FG007|Overall Study|Death|3|||
44450567|NCT03989115|79459141|FG000|Overall Study|Other|1|||
44450568|NCT03989115|79459142|FG001|Overall Study|Other|2|||
44450569|NCT03989115|79459143|FG002|Overall Study|Other|0|||
44450570|NCT03989115|79459144|FG003|Overall Study|Other|0|||
44450571|NCT03989115|79459145|FG004|Overall Study|Other|5|||
44450572|NCT03989115|79459146|FG005|Overall Study|Other|0|||
44450573|NCT03989115|79459147|FG006|Overall Study|Other|0|||
44450574|NCT03989115|79459148|FG007|Overall Study|Other|0|||
44450575|NCT03971071|79459174|FG000|Overall Study|Sponsor decision|0|||
44450576|NCT03971071|79459175|FG001|Overall Study|Sponsor decision|1|||
44450577|NCT03971071|79459176|FG002|Overall Study|Sponsor decision|0|||
44450578|NCT03971071|79459174|FG000|Overall Study|Withdrawal by Subject|7|||
44450579|NCT03971071|79459175|FG001|Overall Study|Withdrawal by Subject|11|||
44450580|NCT03971071|79459176|FG002|Overall Study|Withdrawal by Subject|6|||
44450581|NCT03971071|79459174|FG000|Overall Study|Other|2|||
44450582|NCT03971071|79459175|FG001|Overall Study|Other|2|||
44450583|NCT03971071|79459176|FG002|Overall Study|Other|0|||
44450584|NCT03797898|79459190|FG000|Overall Study|Lost to Follow-up|60|||
44450585|NCT03797898|79459191|FG001|Overall Study|Lost to Follow-up|69|||
44450586|NCT03797898|79459190|FG000|Overall Study|Withdrawal by Subject|9|||
44450587|NCT03797898|79459191|FG001|Overall Study|Withdrawal by Subject|7|||
44450588|NCT03797898|79459190|FG000|Overall Study|Became ineligible|5|||
44450589|NCT03797898|79459191|FG001|Overall Study|Became ineligible|2|||
44450590|NCT03559192|79459213|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
44450591|NCT03559192|79459214|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
44450592|NCT03559192|79459215|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
44450593|NCT03559192|79459213|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
44450594|NCT03559192|79459214|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
44450595|NCT03559192|79459215|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
44450596|NCT03559192|79459213|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
44450597|NCT03559192|79459214|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
44450598|NCT03559192|79459215|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
44450599|NCT03559192|79459213|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
44450600|NCT03559192|79459214|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
44450601|NCT03559192|79459215|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
44450602|NCT03559192|79459213|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
44450603|NCT03559192|79459214|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
44450604|NCT03559192|79459215|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
44450605|NCT03559192|79459213|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
44450606|NCT03559192|79459214|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
44450607|NCT03559192|79459215|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
44450608|NCT03559192|79459213|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
44450609|NCT03559192|79459214|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
44450610|NCT03559192|79459215|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
44450611|NCT03559192|79459213|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
44450612|NCT03559192|79459214|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
44450613|NCT03559192|79459215|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
44450614|NCT03559192|79459213|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
44450615|NCT03559192|79459214|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
44450616|NCT03559192|79459215|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
44450617|NCT03523585|79459226|FG000|Overall Study|Progressive Disease|174|||
44450618|NCT03523585|79459227|FG001|Overall Study|Progressive Disease|64|||
44450619|NCT03523585|79459228|FG002|Overall Study|Progressive Disease|77|||
44450620|NCT03523585|79459226|FG000|Overall Study|Adverse Event|74|||
44450621|NCT03523585|79459227|FG001|Overall Study|Adverse Event|5|||
44450622|NCT03523585|79459228|FG002|Overall Study|Adverse Event|9|||
44450623|NCT03523585|79459226|FG000|Overall Study|Withdrawal by Subject|30|||
44450624|NCT03523585|79459227|FG001|Overall Study|Withdrawal by Subject|11|||
44450625|NCT03523585|79459228|FG002|Overall Study|Withdrawal by Subject|6|||
44450626|NCT03523585|79459226|FG000|Overall Study|Clinical Progression|23|||
44450627|NCT03523585|79459227|FG001|Overall Study|Clinical Progression|5|||
44450628|NCT03523585|79459228|FG002|Overall Study|Clinical Progression|10|||
44450629|NCT03523585|79459226|FG000|Overall Study|Death|4|||
44450630|NCT03523585|79459227|FG001|Overall Study|Death|0|||
44450631|NCT03523585|79459228|FG002|Overall Study|Death|1|||
44450632|NCT03523585|79459226|FG000|Overall Study|Physician Decision|2|||
44450633|NCT03523585|79459227|FG001|Overall Study|Physician Decision|1|||
44450634|NCT03523585|79459228|FG002|Overall Study|Physician Decision|0|||
44450635|NCT03523585|79459226|FG000|Overall Study|Lost to Follow-up|1|||
44450636|NCT03523585|79459227|FG001|Overall Study|Lost to Follow-up|0|||
44450637|NCT03523585|79459228|FG002|Overall Study|Lost to Follow-up|0|||
44450638|NCT03523585|79459226|FG000|Overall Study|Miscellaneous|1|||
44450639|NCT03523585|79459227|FG001|Overall Study|Miscellaneous|0|||
44450640|NCT03523585|79459228|FG002|Overall Study|Miscellaneous|0|||
44450641|NCT03523585|79459226|FG000|Overall Study|Protocol Deviation|1|||
44450642|NCT03523585|79459227|FG001|Overall Study|Protocol Deviation|0|||
44450643|NCT03523585|79459228|FG002|Overall Study|Protocol Deviation|1|||
44450644|NCT03523585|79459226|FG000|Overall Study|Randomized But Not Treated|2|||
44450645|NCT03523585|79459227|FG001|Overall Study|Randomized But Not Treated|4|||
44450646|NCT03523585|79459228|FG002|Overall Study|Randomized But Not Treated|3|||
44450647|NCT03485911|79459238|FG000|Part 1|Perceived lack of efficacy|1|||
44450648|NCT03485911|79459239|FG001|Part 1|Perceived lack of efficacy|1|||
44450649|NCT03485911|79459240|FG002|Part 1|Perceived lack of efficacy|2|||
44450650|NCT03485911|79459241|FG003|Part 1|Perceived lack of efficacy|0|||
44450651|NCT03485911|79459238|FG000|Part 1|Subject withdrew consent|0|||
44450652|NCT03485911|79459239|FG001|Part 1|Subject withdrew consent|1|||
44450653|NCT03485911|79459240|FG002|Part 1|Subject withdrew consent|0|||
44450654|NCT03485911|79459241|FG003|Part 1|Subject withdrew consent|1|||
44450655|NCT03485911|79459238|FG000|Part 1|Lab abnormalities/AEs|3|||
44450656|NCT03485911|79459239|FG001|Part 1|Lab abnormalities/AEs|1|||
44450657|NCT03485911|79459240|FG002|Part 1|Lab abnormalities/AEs|1|||
44450658|NCT03485911|79459241|FG003|Part 1|Lab abnormalities/AEs|0|||
44450659|NCT03485911|79459238|FG000|Part 1|Withdrew Consent prior to dosing|0|||
44450660|NCT03485911|79459239|FG001|Part 1|Withdrew Consent prior to dosing|0|||
44450661|NCT03485911|79459240|FG002|Part 1|Withdrew Consent prior to dosing|0|||
44450662|NCT03485911|79459241|FG003|Part 1|Withdrew Consent prior to dosing|1|||
44450663|NCT03485911|79459238|FG000|Part 1|Other NOS|0|||
44450664|NCT03485911|79459239|FG001|Part 1|Other NOS|0|||
44450665|NCT03485911|79459240|FG002|Part 1|Other NOS|0|||
44450666|NCT03485911|79459241|FG003|Part 1|Other NOS|1|||
44450667|NCT03485911|79459238|FG000|Part 2|Perceived lack of efficacy|5|||
44450668|NCT03485911|79459239|FG001|Part 2|Perceived lack of efficacy|3|||
44450669|NCT03485911|79459240|FG002|Part 2|Perceived lack of efficacy|0|||
44450670|NCT03485911|79459241|FG003|Part 2|Perceived lack of efficacy|2|||
44450671|NCT03485911|79459238|FG000|Part 2|Subject withdrew consent|1|||
44450672|NCT03485911|79459239|FG001|Part 2|Subject withdrew consent|0|||
44450673|NCT03485911|79459240|FG002|Part 2|Subject withdrew consent|2|||
44450674|NCT03485911|79459241|FG003|Part 2|Subject withdrew consent|1|||
44450675|NCT03485911|79459238|FG000|Part 2|Lab abnormalities/AEs|1|||
44450676|NCT03485911|79459239|FG001|Part 2|Lab abnormalities/AEs|2|||
44450677|NCT03485911|79459240|FG002|Part 2|Lab abnormalities/AEs|0|||
44450678|NCT03485911|79459241|FG003|Part 2|Lab abnormalities/AEs|0|||
44450679|NCT03485911|79459238|FG000|Part 2|Other NOS|0|||
44450680|NCT03485911|79459239|FG001|Part 2|Other NOS|1|||
44450681|NCT03485911|79459240|FG002|Part 2|Other NOS|0|||
44450682|NCT03485911|79459241|FG003|Part 2|Other NOS|0|||
44450683|NCT03485911|79459238|FG000|Part 2|Intercurrent illness/new medical condition|1|||
44450684|NCT03485911|79459239|FG001|Part 2|Intercurrent illness/new medical condition|0|||
44450685|NCT03485911|79459240|FG002|Part 2|Intercurrent illness/new medical condition|0|||
44450686|NCT03485911|79459241|FG003|Part 2|Intercurrent illness/new medical condition|0|||
44450687|NCT03485911|79459238|FG000|Part 2|Investigator judgement|1|||
44450688|NCT03485911|79459239|FG001|Part 2|Investigator judgement|0|||
44450689|NCT03485911|79459240|FG002|Part 2|Investigator judgement|0|||
44450690|NCT03485911|79459241|FG003|Part 2|Investigator judgement|0|||
44450691|NCT03485911|79459238|FG000|Part 3|Perceived lack of efficacy|2|||
44450692|NCT03485911|79459239|FG001|Part 3|Perceived lack of efficacy|2|||
44450693|NCT03485911|79459240|FG002|Part 3|Perceived lack of efficacy|2|||
44450694|NCT03485911|79459241|FG003|Part 3|Perceived lack of efficacy|0|||
44450695|NCT03485911|79459238|FG000|Part 3|Subject withdrew consent|1|||
44450696|NCT03485911|79459239|FG001|Part 3|Subject withdrew consent|4|||
44450697|NCT03485911|79459240|FG002|Part 3|Subject withdrew consent|0|||
44450698|NCT03485911|79459241|FG003|Part 3|Subject withdrew consent|1|||
44450699|NCT03485911|79459238|FG000|Part 3|Lab abnormalities/AEs|1|||
44450700|NCT03485911|79459239|FG001|Part 3|Lab abnormalities/AEs|1|||
44450701|NCT03485911|79459240|FG002|Part 3|Lab abnormalities/AEs|0|||
44450702|NCT03485911|79459241|FG003|Part 3|Lab abnormalities/AEs|2|||
44450703|NCT03485911|79459238|FG000|Part 3|Other NOS|1|||
44450704|NCT03485911|79459239|FG001|Part 3|Other NOS|1|||
44450705|NCT03485911|79459240|FG002|Part 3|Other NOS|0|||
44450706|NCT03485911|79459241|FG003|Part 3|Other NOS|0|||
44450707|NCT03485911|79459238|FG000|Part 3|Intercurrent illness/new medical condition|0|||
44450708|NCT03485911|79459239|FG001|Part 3|Intercurrent illness/new medical condition|1|||
44450709|NCT03485911|79459240|FG002|Part 3|Intercurrent illness/new medical condition|1|||
44450710|NCT03485911|79459241|FG003|Part 3|Intercurrent illness/new medical condition|0|||
44450711|NCT03485911|79459238|FG000|Part 3|Sponsor discontinuation|1|||
44450712|NCT03485911|79459239|FG001|Part 3|Sponsor discontinuation|0|||
44450713|NCT03485911|79459240|FG002|Part 3|Sponsor discontinuation|0|||
44450714|NCT03485911|79459241|FG003|Part 3|Sponsor discontinuation|0|||
44450715|NCT03485911|79459238|FG000|Part 3|Berotralstat provided by alternative means|13|||
44450716|NCT03485911|79459239|FG001|Part 3|Berotralstat provided by alternative means|13|||
44450717|NCT03485911|79459240|FG002|Part 3|Berotralstat provided by alternative means|7|||
44450718|NCT03485911|79459241|FG003|Part 3|Berotralstat provided by alternative means|7|||
44450719|NCT02886936|79459316|FG000|Overall Study|Lost to Follow-up|4|||
44450720|NCT02886936|79459317|FG001|Overall Study|Lost to Follow-up|3|||
44450721|NCT02886936|79459318|FG002|Overall Study|Lost to Follow-up|0|||
44450722|NCT02162511|79459353|FG000|Overall Study|Lack of Efficacy|0|||
44450723|NCT02162511|79459354|FG001|Overall Study|Lack of Efficacy|0|||
44450724|NCT02162511|79459355|FG002|Overall Study|Lack of Efficacy|2|||
44450725|NCT05377749|79459361|FG000|3 Weeks|Lost to Follow-up|2|||
44450726|NCT05377749|79459362|FG001|3 Weeks|Lost to Follow-up|4|||
44450727|NCT05377749|79459361|FG000|3 Weeks|Physician Decision|0|||
44450728|NCT05377749|79459362|FG001|3 Weeks|Physician Decision|1|||
44450729|NCT05216406|79459379|FG000|Overall Study|Lost to Follow-up|8|||
44450730|NCT05216406|79459380|FG001|Overall Study|Lost to Follow-up|9|||
44450731|NCT05203822|79459386|FG000|Overall Study|Adverse Event|1|||
44450732|NCT05203822|79459386|FG000|Overall Study|Withdrawal by Subject|1|||
44450733|NCT05086510|79459404|FG000|Overall Study|Lost to Follow-up|0|||
44450734|NCT05086510|79459405|FG001|Overall Study|Lost to Follow-up|2|||
44450735|NCT05086510|79459404|FG000|Overall Study|Death|0|||
44450736|NCT05086510|79459405|FG001|Overall Study|Death|2|||
44450737|NCT04995419|79459420|FG000|Overall Study|Withdrawal by Subject|3|||
44450738|NCT04995419|79459420|FG000|Overall Study|Progressive Disease|19|||
44450739|NCT04995419|79459420|FG000|Overall Study|Adverse Event|2|||
44450740|NCT04995419|79459420|FG000|Overall Study|Ongoing|16|||
44450741|NCT04718974|79459450|FG000|Overall Study|Death|0|||
44450742|NCT04718974|79459451|FG001|Overall Study|Death|2|||
44450743|NCT04718974|79459450|FG000|Overall Study|Lost to Follow-up|10|||
44450744|NCT04718974|79459451|FG001|Overall Study|Lost to Follow-up|20|||
44450745|NCT04718974|79459450|FG000|Overall Study|Transferred out|2|||
44450746|NCT04718974|79459451|FG001|Overall Study|Transferred out|4|||
44450747|NCT04681729|79459459|FG000|Overall Study|Lack of Efficacy|2|||
44450748|NCT04681729|79459460|FG001|Overall Study|Lack of Efficacy|2|||
44450749|NCT04681729|79459459|FG000|Overall Study|Withdrawal by Subject|8|||
44450750|NCT04681729|79459460|FG001|Overall Study|Withdrawal by Subject|9|||
44450751|NCT04628793|79459469|FG000|Overall Study|Study terminated by sponsor|0|||
44450752|NCT04628793|79459470|FG001|Overall Study|Study terminated by sponsor|0|||
44450753|NCT04628793|79459471|FG002|Overall Study|Study terminated by sponsor|8|||
44450754|NCT04628793|79459469|FG000|Overall Study|Withdrawal by Subject|2|||
44450755|NCT04628793|79459470|FG001|Overall Study|Withdrawal by Subject|3|||
44450756|NCT04628793|79459471|FG002|Overall Study|Withdrawal by Subject|0|||
44450757|NCT04628793|79459469|FG000|Overall Study|Lost to Follow-up|0|||
44450758|NCT04628793|79459470|FG001|Overall Study|Lost to Follow-up|1|||
44450759|NCT04628793|79459471|FG002|Overall Study|Lost to Follow-up|0|||
44450760|NCT04607733|79459504|FG000|Overall Study|Lost to Follow-up|1|||
44450761|NCT04607733|79459505|FG001|Overall Study|Lost to Follow-up|0|||
44450762|NCT04607733|79459506|FG002|Overall Study|Lost to Follow-up|0|||
44450763|NCT04607733|79459507|FG003|Overall Study|Lost to Follow-up|1|||
44450764|NCT04607733|79459508|FG004|Overall Study|Lost to Follow-up|1|||
44450765|NCT04607733|79459509|FG005|Overall Study|Lost to Follow-up|0|||
44450766|NCT04607733|79459504|FG000|Overall Study|Withdrawal by Subject|0|||
44450767|NCT04607733|79459505|FG001|Overall Study|Withdrawal by Subject|0|||
44450768|NCT04607733|79459506|FG002|Overall Study|Withdrawal by Subject|0|||
44450769|NCT04607733|79459507|FG003|Overall Study|Withdrawal by Subject|0|||
44450770|NCT04607733|79459508|FG004|Overall Study|Withdrawal by Subject|1|||
44450771|NCT04607733|79459509|FG005|Overall Study|Withdrawal by Subject|0|||
44450772|NCT04585009|79459531|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
44450773|NCT04585009|79459532|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450774|NCT04585009|79459533|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450775|NCT04585009|79459534|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450776|NCT04585009|79459535|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450777|NCT04585009|79459536|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450778|NCT04585009|79459537|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450779|NCT04585009|79459538|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450780|NCT04585009|79459539|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450781|NCT04585009|79459540|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450782|NCT04585009|79459541|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450783|NCT04585009|79459542|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
44450784|NCT04585009|79459531|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
44450785|NCT04585009|79459532|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450786|NCT04585009|79459533|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450787|NCT04585009|79459534|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450788|NCT04585009|79459535|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450789|NCT04585009|79459536|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450790|NCT04585009|79459537|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450791|NCT04585009|79459538|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450792|NCT04585009|79459539|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450793|NCT04585009|79459540|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450794|NCT04585009|79459541|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44450795|NCT04585009|79459542|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
44172283|NCT02114931|78965862|FG000|Overall Study|Withdrawal by Subject|15|||
44172284|NCT02114931|78965863|FG001|Overall Study|Withdrawal by Subject|18|||
44172285|NCT02114931|78965862|FG000|Overall Study|Adverse Event|4|||
44172286|NCT02114931|78965863|FG001|Overall Study|Adverse Event|6|||
44172287|NCT02114931|78965862|FG000|Overall Study|Lost to Follow-up|3|||
44172288|NCT02114931|78965863|FG001|Overall Study|Lost to Follow-up|3|||
44172289|NCT02114931|78965862|FG000|Overall Study|Physician Decision|1|||
44172290|NCT02114931|78965863|FG001|Overall Study|Physician Decision|2|||
44450796|NCT04585009|79459531|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450797|NCT04585009|79459532|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450798|NCT04585009|79459533|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450799|NCT04585009|79459534|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450800|NCT04585009|79459535|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450801|NCT04585009|79459536|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450802|NCT04585009|79459537|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450803|NCT04585009|79459538|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
44450804|NCT04585009|79459539|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450805|NCT04585009|79459540|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450806|NCT04585009|79459541|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450807|NCT04585009|79459542|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
44450808|NCT04585009|79459531|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450809|NCT04585009|79459532|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450810|NCT04585009|79459533|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450811|NCT04585009|79459534|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450812|NCT04585009|79459535|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
44450813|NCT04585009|79459536|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44542517|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Adverse Event|0|||
44542518|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
44542519|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
44172291|NCT02114931|78965862|FG000|Overall Study|Other|2|||
44172292|NCT02114931|78965863|FG001|Overall Study|Other|1|||
44172293|NCT01657019|78965869|FG000|Overall Study|Withdrawal by Subject|65|||
44542520|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
44542521|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
44542522|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
44542523|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
44542524|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
44542525|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
44542526|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Physician Decision|1|||
44542527|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Physician Decision|0|||
44542528|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Physician Decision|0|||
44542529|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Physician Decision|0|||
44542530|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Pregnancy|1|||
44542531|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Pregnancy|0|||
44542532|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Pregnancy|0|||
44542533|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Pregnancy|0|||
44542534|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
44542535|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
44542536|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
44542537|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
44542538|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
44542539|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
44542540|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
44542541|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
44542542|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
44542543|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
44542544|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
44542545|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
44542546|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
44542547|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
44542548|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
44542549|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
44542550|NCT04057573|79555440|FG000|24-Week Double-Blind Period|Not Treated|1|||
44542551|NCT04057573|79555441|FG001|24-Week Double-Blind Period|Not Treated|0|||
44542552|NCT04057573|79555442|FG002|24-Week Double-Blind Period|Not Treated|0|||
44542553|NCT04057573|79555443|FG003|24-Week Double-Blind Period|Not Treated|0|||
44542554|NCT04057573|79555440|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
44542555|NCT04057573|79555441|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
44542556|NCT04057573|79555442|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
44542557|NCT04057573|79555443|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
44542558|NCT04057573|79555440|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
44542559|NCT04057573|79555441|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
44542560|NCT04057573|79555442|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
44542561|NCT04057573|79555443|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
44542562|NCT04057573|79555440|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
44542563|NCT04057573|79555441|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
44542564|NCT04057573|79555442|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
44542565|NCT04057573|79555443|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
44542566|NCT04057573|79555440|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
44542567|NCT04057573|79555441|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
44542568|NCT04057573|79555442|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
44542569|NCT04057573|79555443|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
44542570|NCT04057573|79555440|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
44542571|NCT04057573|79555441|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
44542572|NCT04057573|79555442|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
44542573|NCT04057573|79555443|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
44542574|NCT04054765|79555456|FG000|Baseline|Withdrawal by Subject|5|||
44542575|NCT04054765|79555457|FG001|Baseline|Withdrawal by Subject|3|||
44542576|NCT04054765|79555456|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
44542577|NCT04054765|79555457|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
44542578|NCT04054765|79555456|FG000|3-month Follow up|Withdrawal by Subject|0|||
44542579|NCT04054765|79555457|FG001|3-month Follow up|Withdrawal by Subject|3|||
44542580|NCT04054765|79555456|FG000|6-month Follow up|Lost to Follow-up|32|||
44542581|NCT04054765|79555457|FG001|6-month Follow up|Lost to Follow-up|32|||
44542582|NCT04179721|79555465|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
44542583|NCT04179721|79555466|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
44542584|NCT04179721|79555465|FG000|Overall Study|Lost to Follow-up|0|||
44542585|NCT04179721|79555466|FG001|Overall Study|Lost to Follow-up|1|||
44542586|NCT03286218|79555472|FG000|Qualification Phase Period 1|Adverse Event|1|||
44542587|NCT03286218|79555473|FG001|Qualification Phase Period 1|Adverse Event|0|||
44542588|NCT03286218|79555474|FG002|Qualification Phase Period 1|Adverse Event|0|||
44542589|NCT03286218|79555475|FG003|Qualification Phase Period 1|Adverse Event|0|||
44542590|NCT03286218|79555476|FG004|Qualification Phase Period 1|Adverse Event|0|||
44542591|NCT03286218|79555477|FG005|Qualification Phase Period 1|Adverse Event|0|||
44542592|NCT03286218|79555478|FG006|Qualification Phase Period 1|Adverse Event|0|||
44542593|NCT03286218|79555479|FG007|Qualification Phase Period 1|Adverse Event|0|||
44542594|NCT03286218|79555480|FG008|Qualification Phase Period 1|Adverse Event|0|||
44542595|NCT03286218|79555481|FG009|Qualification Phase Period 1|Adverse Event|0|||
44542596|NCT03286218|79555482|FG010|Qualification Phase Period 1|Adverse Event|0|||
44542597|NCT03286218|79555483|FG011|Qualification Phase Period 1|Adverse Event|0|||
44542598|NCT03286218|79555472|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542599|NCT03286218|79555473|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
44542600|NCT03286218|79555474|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542601|NCT03286218|79555475|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542602|NCT03286218|79555476|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542603|NCT03286218|79555477|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542604|NCT03286218|79555478|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542605|NCT03286218|79555479|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542606|NCT03286218|79555480|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542607|NCT03286218|79555481|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542608|NCT03286218|79555482|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542609|NCT03286218|79555483|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
44542610|NCT03286218|79555472|FG000|Qualification Phase Period 2|Adverse Event|0|||
44542611|NCT03286218|79555473|FG001|Qualification Phase Period 2|Adverse Event|1|||
44542612|NCT03286218|79555474|FG002|Qualification Phase Period 2|Adverse Event|0|||
44542613|NCT03286218|79555475|FG003|Qualification Phase Period 2|Adverse Event|0|||
44542614|NCT03286218|79555476|FG004|Qualification Phase Period 2|Adverse Event|0|||
44542615|NCT03286218|79555477|FG005|Qualification Phase Period 2|Adverse Event|0|||
44542616|NCT03286218|79555478|FG006|Qualification Phase Period 2|Adverse Event|0|||
44542617|NCT03286218|79555479|FG007|Qualification Phase Period 2|Adverse Event|0|||
44542618|NCT03286218|79555480|FG008|Qualification Phase Period 2|Adverse Event|0|||
44542619|NCT03286218|79555481|FG009|Qualification Phase Period 2|Adverse Event|0|||
44542620|NCT03286218|79555482|FG010|Qualification Phase Period 2|Adverse Event|0|||
44542621|NCT03286218|79555483|FG011|Qualification Phase Period 2|Adverse Event|0|||
44542622|NCT03286218|79555472|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
44542623|NCT03286218|79555473|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
44542624|NCT03286218|79555474|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542625|NCT03286218|79555475|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542626|NCT03286218|79555476|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542627|NCT03286218|79555477|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542628|NCT03286218|79555478|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542629|NCT03286218|79555479|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542630|NCT03286218|79555480|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542631|NCT03286218|79555481|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542632|NCT03286218|79555482|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542633|NCT03286218|79555483|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
44542634|NCT03286218|79555472|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
44542635|NCT03286218|79555473|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
44542636|NCT03286218|79555474|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
44542637|NCT03286218|79555475|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
44542638|NCT03286218|79555476|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
44542639|NCT03286218|79555477|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
44542640|NCT03286218|79555478|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
44542641|NCT03286218|79555479|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
44542642|NCT03286218|79555480|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
44542643|NCT03286218|79555481|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
44542644|NCT03286218|79555482|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
44542645|NCT03286218|79555483|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
44542646|NCT03286218|79555472|FG000|Qualification Phase Period 2|Protocol Violation|2|||
44542647|NCT03286218|79555473|FG001|Qualification Phase Period 2|Protocol Violation|0|||
44542648|NCT03286218|79555474|FG002|Qualification Phase Period 2|Protocol Violation|0|||
44542649|NCT03286218|79555475|FG003|Qualification Phase Period 2|Protocol Violation|0|||
44542650|NCT03286218|79555476|FG004|Qualification Phase Period 2|Protocol Violation|0|||
44542651|NCT03286218|79555477|FG005|Qualification Phase Period 2|Protocol Violation|0|||
44542652|NCT03286218|79555478|FG006|Qualification Phase Period 2|Protocol Violation|0|||
44542653|NCT03286218|79555479|FG007|Qualification Phase Period 2|Protocol Violation|0|||
44542654|NCT03286218|79555480|FG008|Qualification Phase Period 2|Protocol Violation|0|||
44542655|NCT03286218|79555481|FG009|Qualification Phase Period 2|Protocol Violation|0|||
44542656|NCT03286218|79555482|FG010|Qualification Phase Period 2|Protocol Violation|0|||
44542657|NCT03286218|79555483|FG011|Qualification Phase Period 2|Protocol Violation|0|||
44542658|NCT03286218|79555472|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
44542659|NCT03286218|79555473|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
44542660|NCT03286218|79555474|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542661|NCT03286218|79555475|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542662|NCT03286218|79555476|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542663|NCT03286218|79555477|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542664|NCT03286218|79555478|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542665|NCT03286218|79555479|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542666|NCT03286218|79555480|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542667|NCT03286218|79555481|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542668|NCT03286218|79555482|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542669|NCT03286218|79555483|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
44542670|NCT03286218|79555472|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542671|NCT03286218|79555473|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542672|NCT03286218|79555474|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
44542673|NCT03286218|79555475|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
44542674|NCT03286218|79555476|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542675|NCT03286218|79555477|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
44542676|NCT03286218|79555478|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542677|NCT03286218|79555479|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542678|NCT03286218|79555480|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542679|NCT03286218|79555481|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542680|NCT03286218|79555482|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
44542681|NCT03286218|79555483|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
44542682|NCT03286218|79555472|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542683|NCT03286218|79555473|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542684|NCT03286218|79555474|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542685|NCT03286218|79555475|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542686|NCT03286218|79555476|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542687|NCT03286218|79555477|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542688|NCT03286218|79555478|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542689|NCT03286218|79555479|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542690|NCT03286218|79555480|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542691|NCT03286218|79555481|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542692|NCT03286218|79555482|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
44542693|NCT03286218|79555483|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
44542694|NCT03224325|79555517|FG000|Overall Study|Adverse Event|1|||
44542695|NCT03224325|79555518|FG001|Overall Study|Adverse Event|0|||
44542696|NCT03224325|79555519|FG002|Overall Study|Adverse Event|0|||
44542697|NCT03224325|79555520|FG003|Overall Study|Adverse Event|0|||
44542698|NCT03224325|79555521|FG004|Overall Study|Adverse Event|0|||
44542699|NCT03224325|79555522|FG005|Overall Study|Adverse Event|0|||
44542700|NCT03224325|79555523|FG006|Overall Study|Adverse Event|1|||
44542701|NCT03224325|79555517|FG000|Overall Study|Withdrawal by Subject|0|||
44542702|NCT03224325|79555518|FG001|Overall Study|Withdrawal by Subject|0|||
44542703|NCT03224325|79555519|FG002|Overall Study|Withdrawal by Subject|0|||
44542704|NCT03224325|79555520|FG003|Overall Study|Withdrawal by Subject|1|||
44542705|NCT03224325|79555521|FG004|Overall Study|Withdrawal by Subject|0|||
44542706|NCT03224325|79555522|FG005|Overall Study|Withdrawal by Subject|0|||
44542707|NCT03224325|79555523|FG006|Overall Study|Withdrawal by Subject|0|||
44542708|NCT04016779|79555547|FG000|Overall Study|Adverse Event|9|||
44542709|NCT04016779|79555548|FG001|Overall Study|Adverse Event|17|||
44542710|NCT04016779|79555547|FG000|Overall Study|Lack of Efficacy|4|||
44542711|NCT04016779|79555548|FG001|Overall Study|Lack of Efficacy|1|||
44542712|NCT04016779|79555547|FG000|Overall Study|Lost to Follow-up|5|||
44542713|NCT04016779|79555548|FG001|Overall Study|Lost to Follow-up|14|||
44542714|NCT04016779|79555547|FG000|Overall Study|Physician Decision|1|||
44542715|NCT04016779|79555548|FG001|Overall Study|Physician Decision|3|||
44542716|NCT04016779|79555547|FG000|Overall Study|Withdrawal by Subject|6|||
44542717|NCT04016779|79555548|FG001|Overall Study|Withdrawal by Subject|8|||
44542718|NCT04016779|79555547|FG000|Overall Study|Non-compliance with Study Drug|2|||
44542719|NCT04016779|79555548|FG001|Overall Study|Non-compliance with Study Drug|3|||
44542720|NCT04016779|79555547|FG000|Overall Study|Other, Multiple categories|17|||
44542721|NCT04016779|79555548|FG001|Overall Study|Other, Multiple categories|17|||
44542722|NCT02857426|79555558|FG000|Overall Study|Disease progression|34|||
44542723|NCT02857426|79555559|FG001|Overall Study|Disease progression|13|||
44542724|NCT02857426|79555558|FG000|Overall Study|Study drug toxicity|4|||
44542725|NCT02857426|79555559|FG001|Overall Study|Study drug toxicity|1|||
44542726|NCT02857426|79555558|FG000|Overall Study|Death|1|||
44542727|NCT02857426|79555559|FG001|Overall Study|Death|0|||
44542728|NCT02857426|79555558|FG000|Overall Study|Adverse event unrelated to study drug|6|||
44542729|NCT02857426|79555559|FG001|Overall Study|Adverse event unrelated to study drug|2|||
44542730|NCT02857426|79555558|FG000|Overall Study|Participant withdrew consent|1|||
44542731|NCT02857426|79555559|FG001|Overall Study|Participant withdrew consent|1|||
44542732|NCT02857426|79555558|FG000|Overall Study|Maximum clinical benefit|1|||
44542733|NCT02857426|79555559|FG001|Overall Study|Maximum clinical benefit|0|||
44542734|NCT02857426|79555558|FG000|Overall Study|Completed treatment|0|||
44542735|NCT02857426|79555559|FG001|Overall Study|Completed treatment|2|||
44542736|NCT01127256|79555567|FG000|Overall Study|Adverse Event|13|||
44542737|NCT01127256|79555568|FG001|Overall Study|Adverse Event|13|||
44542738|NCT01127256|79555567|FG000|Overall Study|Lack of Efficacy|4|||
44542739|NCT01127256|79555568|FG001|Overall Study|Lack of Efficacy|0|||
44542740|NCT01127256|79555567|FG000|Overall Study|Lost to Follow-up|16|||
44542741|NCT01127256|79555568|FG001|Overall Study|Lost to Follow-up|17|||
44542742|NCT01127256|79555567|FG000|Overall Study|Withdrawal by Subject|5|||
44542743|NCT01127256|79555568|FG001|Overall Study|Withdrawal by Subject|9|||
44542744|NCT01127256|79555567|FG000|Overall Study|Protocol Violation|1|||
44542745|NCT01127256|79555568|FG001|Overall Study|Protocol Violation|0|||
44542746|NCT04016311|79555576|FG000|Overall Study|Withdrawal by Subject|1|||
44542747|NCT04016311|79555577|FG001|Overall Study|Withdrawal by Subject|0|||
44542748|NCT04052425|79555587|FG000|24-Week Double-blind Period|Adverse Event|0|||
44542749|NCT04052425|79555588|FG001|24-Week Double-blind Period|Adverse Event|1|||
44542750|NCT04052425|79555589|FG002|24-Week Double-blind Period|Adverse Event|0|||
44542751|NCT04052425|79555590|FG003|24-Week Double-blind Period|Adverse Event|0|||
44542752|NCT04052425|79555587|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
44542753|NCT04052425|79555588|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
44542754|NCT04052425|79555589|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
44542755|NCT04052425|79555590|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
44542756|NCT04052425|79555587|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
44542757|NCT04052425|79555588|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
44542758|NCT04052425|79555589|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
44542759|NCT04052425|79555590|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
44542760|NCT04052425|79555587|FG000|24-Week Double-blind Period|Physician Decision|1|||
44542761|NCT04052425|79555588|FG001|24-Week Double-blind Period|Physician Decision|0|||
44542762|NCT04052425|79555589|FG002|24-Week Double-blind Period|Physician Decision|0|||
44542763|NCT04052425|79555590|FG003|24-Week Double-blind Period|Physician Decision|0|||
44542764|NCT04052425|79555587|FG000|24-Week Double-blind Period|Protocol Violation|1|||
44542765|NCT04052425|79555588|FG001|24-Week Double-blind Period|Protocol Violation|0|||
44542766|NCT04052425|79555589|FG002|24-Week Double-blind Period|Protocol Violation|0|||
44542767|NCT04052425|79555590|FG003|24-Week Double-blind Period|Protocol Violation|0|||
44542768|NCT04052425|79555587|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
44542769|NCT04052425|79555588|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
44542770|NCT04052425|79555589|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
44542771|NCT04052425|79555590|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
44542772|NCT04052425|79555587|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
44542773|NCT04052425|79555588|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
44542774|NCT04052425|79555589|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
44542775|NCT04052425|79555590|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
44542776|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
44542777|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
44542778|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
44542779|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
44542780|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
44542781|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
44542782|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
44542783|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
44542784|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
44542785|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
44542786|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
44542787|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
44542788|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
44542789|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
44542790|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
44360904|NCT01210664|79366321|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
44360905|NCT01210664|79366322|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
44360906|NCT01210664|79366323|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
44360907|NCT01210664|79366324|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
44542791|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
44542792|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
44542793|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
44542794|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
44542795|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
44542796|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
44542797|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
44542798|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
44542799|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
44542800|NCT04052425|79555587|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
44542801|NCT04052425|79555588|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
44542802|NCT04052425|79555589|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
44542803|NCT04052425|79555590|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
44542804|NCT03235089|79555600|FG000|Overall Study|Lost to Follow-up|1|||
44542805|NCT03235089|79555601|FG001|Overall Study|Lost to Follow-up|1|||
44542806|NCT03235089|79555600|FG000|Overall Study|Physician Decision|2|||
44542807|NCT03235089|79555601|FG001|Overall Study|Physician Decision|2|||
44542808|NCT04013191|79555610|FG000|Overall Study|Adverse Event|1|||
44542809|NCT04013191|79555611|FG001|Overall Study|Adverse Event|0|||
44542810|NCT03285594|79555624|FG000|Overall Study|At the Participant's Own Request|10|||
44542811|NCT03285594|79555625|FG001|Overall Study|At the Participant's Own Request|5|||
44542812|NCT03285594|79555626|FG002|Overall Study|At the Participant's Own Request|21|||
44542813|NCT03285594|79555624|FG000|Overall Study|Adverse Event|2|||
44542814|NCT03285594|79555625|FG001|Overall Study|Adverse Event|2|||
44542815|NCT03285594|79555626|FG002|Overall Study|Adverse Event|6|||
44542816|NCT03285594|79555624|FG000|Overall Study|Poor Compliance to Protocol|0|||
44542817|NCT03285594|79555625|FG001|Overall Study|Poor Compliance to Protocol|0|||
44542818|NCT03285594|79555626|FG002|Overall Study|Poor Compliance to Protocol|1|||
44542819|NCT03285594|79555624|FG000|Overall Study|Lost to Follow-up|0|||
44542820|NCT03285594|79555625|FG001|Overall Study|Lost to Follow-up|0|||
44542821|NCT03285594|79555626|FG002|Overall Study|Lost to Follow-up|1|||
44542822|NCT03285594|79555624|FG000|Overall Study|Reason Not Specified|3|||
44542823|NCT03285594|79555625|FG001|Overall Study|Reason Not Specified|4|||
44542824|NCT03285594|79555626|FG002|Overall Study|Reason Not Specified|8|||
44542825|NCT03234465|79555637|FG000|Overall Study|Adverse Event|4|||
44542826|NCT03234465|79555638|FG001|Overall Study|Adverse Event|2|||
44542827|NCT03234465|79555637|FG000|Overall Study|Death|0|||
44542828|NCT03234465|79555638|FG001|Overall Study|Death|1|||
44542829|NCT03234465|79555637|FG000|Overall Study|Lost to Follow-up|1|||
44542830|NCT03234465|79555638|FG001|Overall Study|Lost to Follow-up|1|||
44542831|NCT03234465|79555637|FG000|Overall Study|Withdrawal by Subject|12|||
44542832|NCT03234465|79555638|FG001|Overall Study|Withdrawal by Subject|27|||
44542833|NCT03234465|79555637|FG000|Overall Study|Symptomatic deterioration|0|||
44542834|NCT03234465|79555638|FG001|Overall Study|Symptomatic deterioration|1|||
44542835|NCT03234465|79555637|FG000|Overall Study|Non-compliance|2|||
44542836|NCT03234465|79555638|FG001|Overall Study|Non-compliance|0|||
44542837|NCT03234465|79555637|FG000|Overall Study|Other|14|||
44542838|NCT03234465|79555638|FG001|Overall Study|Other|8|||
44542839|NCT03290131|79555647|FG000|Overall Study|Adverse Event|22|||
44542840|NCT03290131|79555648|FG001|Overall Study|Adverse Event|57|||
44542841|NCT03290131|79555649|FG002|Overall Study|Adverse Event|11|||
44542842|NCT03290131|79555647|FG000|Overall Study|Withdrawal by Subject|18|||
44542843|NCT03290131|79555648|FG001|Overall Study|Withdrawal by Subject|13|||
44542844|NCT03290131|79555649|FG002|Overall Study|Withdrawal by Subject|8|||
44542845|NCT03290131|79555647|FG000|Overall Study|MS Relapse|2|||
44542846|NCT03290131|79555648|FG001|Overall Study|MS Relapse|1|||
44542847|NCT03290131|79555649|FG002|Overall Study|MS Relapse|0|||
44542848|NCT03290131|79555647|FG000|Overall Study|Unknown reason|0|||
44542849|NCT03290131|79555648|FG001|Overall Study|Unknown reason|1|||
44542850|NCT03290131|79555649|FG002|Overall Study|Unknown reason|0|||
44542851|NCT04050865|79555660|FG000|Overall Study|Adverse Event|1|||
44542852|NCT04050865|79555661|FG001|Overall Study|Adverse Event|0|||
44542853|NCT04050865|79555660|FG000|Overall Study|no insert|1|||
44172294|NCT01657019|78965869|FG000|Overall Study|Adverse Event|55|||
44172295|NCT01657019|78965869|FG000|Overall Study|Lost to Follow-up|48|||
44450814|NCT04585009|79459537|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44542854|NCT04050865|79555661|FG001|Overall Study|no insert|0|||
44542855|NCT04050865|79555660|FG000|Overall Study|Only 1 insert|2|||
44542856|NCT04050865|79555661|FG001|Overall Study|Only 1 insert|3|||
44542857|NCT04050865|79555660|FG000|Overall Study|Physician Decision|0|||
44542858|NCT04050865|79555661|FG001|Overall Study|Physician Decision|1|||
44542859|NCT04050865|79555660|FG000|Overall Study|Withdrawal by Subject|0|||
44542860|NCT04050865|79555661|FG001|Overall Study|Withdrawal by Subject|1|||
44542861|NCT03283566|79555669|FG000|Overall Study|Lost to Follow-up|1|||
44542862|NCT03283566|79555670|FG001|Overall Study|Lost to Follow-up|2|||
44172296|NCT01657019|78965869|FG000|Overall Study|Protocol Violation|6|||
44542863|NCT03210519|79555678|FG000|Overall Study|Adverse Event|2|||
44542864|NCT03210519|79555679|FG001|Overall Study|Adverse Event|0|||
44542865|NCT04048681|79555685|FG000|Overall Study|family emergency|0|||
44542866|NCT04048681|79555686|FG001|Overall Study|family emergency|0|||
44542867|NCT04048681|79555687|FG002|Overall Study|family emergency|0|||
44542868|NCT04048681|79555688|FG003|Overall Study|family emergency|1|||
44542869|NCT04048681|79555689|FG004|Overall Study|family emergency|0|||
44542870|NCT04007107|79555697|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
44542871|NCT04007107|79555698|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
44542872|NCT04007107|79555699|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
44542873|NCT04007107|79555700|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
44542874|NCT04046341|79555705|FG000|Overall Study|Lost to Follow-up|2|||
44542875|NCT04046341|79555705|FG000|Overall Study|Withdrawal by Subject|1|||
44542876|NCT03233529|79555709|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
44542877|NCT03233529|79555709|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
44542878|NCT04006171|79555719|FG000|Overall Study|Withdrawal by Subject|8|||
44542879|NCT04006171|79555720|FG001|Overall Study|Withdrawal by Subject|7|||
44542880|NCT04006171|79555719|FG000|Overall Study|missing serum samples|2|||
44542881|NCT04006171|79555720|FG001|Overall Study|missing serum samples|2|||
44542882|NCT04006171|79555719|FG000|Overall Study|insufficient sample volume|2|||
44542883|NCT04006171|79555720|FG001|Overall Study|insufficient sample volume|3|||
44542884|NCT04043143|79555733|FG000|Overall Study|Lost to Follow-up|5|||
44542885|NCT04043143|79555734|FG001|Overall Study|Lost to Follow-up|5|||
44542886|NCT04043143|79555733|FG000|Overall Study|screen failure|1|||
44542887|NCT04043143|79555734|FG001|Overall Study|screen failure|0|||
44542888|NCT03283098|79555742|FG000|Overall Study|Withdrawal by Subject|0|||
44542889|NCT03283098|79555743|FG001|Overall Study|Withdrawal by Subject|1|||
44542890|NCT03655951|79555751|FG000|Overall Study|Lost to Follow-up|39|||
44542891|NCT03655951|79555752|FG001|Overall Study|Lost to Follow-up|20|||
44542892|NCT03655951|79555751|FG000|Overall Study|Withdrawal by Subject|0|||
44542893|NCT03655951|79555752|FG001|Overall Study|Withdrawal by Subject|1|||
44542894|NCT02527798|79555764|FG000|Overall Study|Physician Decision|1|||
44542895|NCT02527798|79555765|FG001|Overall Study|Physician Decision|0|||
44542896|NCT02527798|79555766|FG002|Overall Study|Physician Decision|1|||
44542897|NCT02527798|79555767|FG003|Overall Study|Physician Decision|1|||
44542898|NCT02527798|79555768|FG004|Overall Study|Physician Decision|0|||
44542899|NCT02527798|79555769|FG005|Overall Study|Physician Decision|0|||
44542900|NCT02527798|79555764|FG000|Overall Study|Death|0|||
44542901|NCT02527798|79555765|FG001|Overall Study|Death|0|||
44542902|NCT02527798|79555766|FG002|Overall Study|Death|1|||
44542903|NCT02527798|79555767|FG003|Overall Study|Death|0|||
44542904|NCT02527798|79555768|FG004|Overall Study|Death|0|||
44542905|NCT02527798|79555769|FG005|Overall Study|Death|0|||
44542906|NCT02527798|79555764|FG000|Overall Study|Withdrawal by Subject|0|||
44542907|NCT02527798|79555765|FG001|Overall Study|Withdrawal by Subject|1|||
44542908|NCT02527798|79555766|FG002|Overall Study|Withdrawal by Subject|2|||
44542909|NCT02527798|79555767|FG003|Overall Study|Withdrawal by Subject|0|||
44542910|NCT02527798|79555768|FG004|Overall Study|Withdrawal by Subject|0|||
44542911|NCT02527798|79555769|FG005|Overall Study|Withdrawal by Subject|0|||
44542912|NCT02527798|79555764|FG000|Overall Study|Reason undisclosed|1|||
44542913|NCT02527798|79555765|FG001|Overall Study|Reason undisclosed|0|||
44542914|NCT02527798|79555766|FG002|Overall Study|Reason undisclosed|1|||
44542915|NCT02527798|79555767|FG003|Overall Study|Reason undisclosed|0|||
44542916|NCT02527798|79555768|FG004|Overall Study|Reason undisclosed|0|||
44542917|NCT02527798|79555769|FG005|Overall Study|Reason undisclosed|0|||
44542918|NCT02527798|79555764|FG000|Overall Study|Did not receive intervention|1|||
44542919|NCT02527798|79555765|FG001|Overall Study|Did not receive intervention|1|||
44542920|NCT02527798|79555766|FG002|Overall Study|Did not receive intervention|0|||
44542921|NCT02527798|79555767|FG003|Overall Study|Did not receive intervention|0|||
44542922|NCT02527798|79555768|FG004|Overall Study|Did not receive intervention|0|||
44542923|NCT02527798|79555769|FG005|Overall Study|Did not receive intervention|0|||
44542924|NCT03188991|79555800|FG000|Overall Study|Withdrawal by Subject|0|||
44542925|NCT03188991|79555801|FG001|Overall Study|Withdrawal by Subject|0|||
44542926|NCT03188991|79555802|FG002|Overall Study|Withdrawal by Subject|0|||
44542927|NCT03188991|79555803|FG003|Overall Study|Withdrawal by Subject|1|||
44542928|NCT03857542|79555815|FG000|Overall Study|Adverse Event|1|||
44542929|NCT03857542|79555816|FG001|Overall Study|Adverse Event|3|||
44542930|NCT03857542|79555815|FG000|Overall Study|Withdrawal by Subject|2|||
44542931|NCT03857542|79555816|FG001|Overall Study|Withdrawal by Subject|1|||
44542932|NCT03857542|79555815|FG000|Overall Study|Lost to Follow-up|2|||
44542933|NCT03857542|79555816|FG001|Overall Study|Lost to Follow-up|1|||
44542934|NCT03857542|79555815|FG000|Overall Study|Reason not Specified|1|||
44542935|NCT03857542|79555816|FG001|Overall Study|Reason not Specified|0|||
44542936|NCT03209973|79555823|FG000|Overall Study|Withdrawal by Subject|7|||
44542937|NCT03209973|79555823|FG000|Overall Study|Lost to Follow-up|2|||
44542938|NCT03209973|79555823|FG000|Overall Study|Death|8|||
44542939|NCT03209973|79555823|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
44542940|NCT03209973|79555823|FG000|Overall Study|Sponsor Decision|18|||
44542941|NCT03209973|79555823|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
44542942|NCT03209973|79555823|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
44542943|NCT03751631|79555829|FG000|Overall Study|Withdrawal by Subject|0|||
44542944|NCT03751631|79555830|FG001|Overall Study|Withdrawal by Subject|0|||
44542945|NCT03751631|79555831|FG002|Overall Study|Withdrawal by Subject|1|||
44542946|NCT03751631|79555832|FG003|Overall Study|Withdrawal by Subject|1|||
44542947|NCT03751631|79555833|FG004|Overall Study|Withdrawal by Subject|0|||
44542948|NCT03751631|79555834|FG005|Overall Study|Withdrawal by Subject|0|||
44542949|NCT03688711|79555847|FG000|Overall Study|Withdrawal by Subject|0|||
44542950|NCT03688711|79555848|FG001|Overall Study|Withdrawal by Subject|1|||
44542951|NCT03188055|79555856|FG000|Overall Study|Unavailable for training|0|||
44542952|NCT03188055|79555857|FG001|Overall Study|Unavailable for training|0|||
44542953|NCT03188055|79555858|FG002|Overall Study|Unavailable for training|19|||
44542954|NCT03188055|79555859|FG003|Overall Study|Unavailable for training|0|||
44542955|NCT03188055|79555860|FG004|Overall Study|Unavailable for training|0|||
44542956|NCT03188055|79555861|FG005|Overall Study|Unavailable for training||||
44542957|NCT03188055|79555856|FG000|Overall Study|Lost to Follow-up|0|||
44542958|NCT03188055|79555857|FG001|Overall Study|Lost to Follow-up|18|||
44542959|NCT03188055|79555858|FG002|Overall Study|Lost to Follow-up|0|||
44542960|NCT03188055|79555859|FG003|Overall Study|Lost to Follow-up|11|||
44542961|NCT03188055|79555860|FG004|Overall Study|Lost to Follow-up|0|||
44542962|NCT03188055|79555861|FG005|Overall Study|Lost to Follow-up||||
44542963|NCT03188055|79555856|FG000|Overall Study|Withdrawal by Subject|0|||
44542964|NCT03188055|79555857|FG001|Overall Study|Withdrawal by Subject|1|||
44542965|NCT03188055|79555858|FG002|Overall Study|Withdrawal by Subject|0|||
44542966|NCT03188055|79555859|FG003|Overall Study|Withdrawal by Subject|1|||
44542967|NCT03188055|79555860|FG004|Overall Study|Withdrawal by Subject|0|||
44542968|NCT03188055|79555861|FG005|Overall Study|Withdrawal by Subject||||
44542969|NCT04035577|79555872|FG000|Overall Study|Lost to Follow-up|1|||
44542970|NCT04035577|79555872|FG000|Overall Study|Withdrawal by Subject|1|||
44542971|NCT03655717|79555900|FG000|Overall Study|Withdrawal by Subject|4|||
44542972|NCT03655717|79555901|FG001|Overall Study|Withdrawal by Subject|8|||
44542973|NCT03655717|79555902|FG002|Overall Study|Withdrawal by Subject|1|||
44542974|NCT03655717|79555903|FG003|Overall Study|Withdrawal by Subject|0|||
44542975|NCT03655717|79555904|FG004|Overall Study|Withdrawal by Subject|0|||
44542976|NCT03655717|79555905|FG005|Overall Study|Withdrawal by Subject|1|||
44542977|NCT03655717|79555906|FG006|Overall Study|Withdrawal by Subject|3|||
44542978|NCT03655717|79555907|FG007|Overall Study|Withdrawal by Subject|1|||
44542979|NCT03655717|79555908|FG008|Overall Study|Withdrawal by Subject|2|||
44542980|NCT03655717|79555909|FG009|Overall Study|Withdrawal by Subject|0|||
44542981|NCT03655717|79555910|FG010|Overall Study|Withdrawal by Subject|0|||
44542982|NCT03655717|79555911|FG011|Overall Study|Withdrawal by Subject|1|||
44542983|NCT03655717|79555912|FG012|Overall Study|Withdrawal by Subject|0|||
44542984|NCT03655717|79555913|FG013|Overall Study|Withdrawal by Subject|3|||
44542985|NCT03655717|79555914|FG014|Overall Study|Withdrawal by Subject|0|||
44542986|NCT03655717|79555915|FG015|Overall Study|Withdrawal by Subject|1|||
44542987|NCT03655717|79555916|FG016|Overall Study|Withdrawal by Subject|0|||
44542988|NCT03655717|79555917|FG017|Overall Study|Withdrawal by Subject|0|||
44542989|NCT03655717|79555918|FG018|Overall Study|Withdrawal by Subject|1|||
44542990|NCT03655717|79555919|FG019|Overall Study|Withdrawal by Subject|0|||
44542991|NCT03655717|79555920|FG020|Overall Study|Withdrawal by Subject|0|||
44542992|NCT03655717|79555921|FG021|Overall Study|Withdrawal by Subject|1|||
44542993|NCT03655717|79555922|FG022|Overall Study|Withdrawal by Subject|2|||
44542994|NCT03655717|79555923|FG023|Overall Study|Withdrawal by Subject|1|||
44542995|NCT03655717|79555924|FG024|Overall Study|Withdrawal by Subject|1|||
44542996|NCT03655717|79555925|FG025|Overall Study|Withdrawal by Subject|0|||
44172297|NCT01657019|78965869|FG000|Overall Study|Lack of Efficacy|3|||
44172298|NCT01657019|78965869|FG000|Overall Study|Other|58|||
44172299|NCT02329327|78965875|FG000|Overall Study|Death|78|||
44264198|NCT02764762|79164480|FG000|Overall Study|Voluntary Withdrawal|8|||
44542997|NCT03655717|79555900|FG000|Overall Study|Physician Decision|3|||
44264199|NCT02764762|79164480|FG000|Overall Study|Site Termination|1|||
44264200|NCT02764762|79164480|FG000|Overall Study|Lack of Efficacy|16|||
44450815|NCT04585009|79459538|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450816|NCT04585009|79459539|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450817|NCT04585009|79459540|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450818|NCT04585009|79459541|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450819|NCT04585009|79459542|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
44450820|NCT04585009|79459531|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450821|NCT04585009|79459532|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450822|NCT04585009|79459533|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44542998|NCT03655717|79555901|FG001|Overall Study|Physician Decision|3|||
44172300|NCT02329327|78965876|FG001|Overall Study|Death|0|||
44542999|NCT03655717|79555902|FG002|Overall Study|Physician Decision|0|||
44543000|NCT03655717|79555903|FG003|Overall Study|Physician Decision|0|||
44543001|NCT03655717|79555904|FG004|Overall Study|Physician Decision|0|||
44543002|NCT03655717|79555905|FG005|Overall Study|Physician Decision|0|||
44543003|NCT03655717|79555906|FG006|Overall Study|Physician Decision|0|||
44543004|NCT03655717|79555907|FG007|Overall Study|Physician Decision|0|||
44543005|NCT03655717|79555908|FG008|Overall Study|Physician Decision|0|||
44543006|NCT03655717|79555909|FG009|Overall Study|Physician Decision|1|||
44543007|NCT03655717|79555910|FG010|Overall Study|Physician Decision|0|||
44543008|NCT03655717|79555911|FG011|Overall Study|Physician Decision|0|||
44543009|NCT03655717|79555912|FG012|Overall Study|Physician Decision|0|||
44543010|NCT03655717|79555913|FG013|Overall Study|Physician Decision|0|||
44543011|NCT03655717|79555914|FG014|Overall Study|Physician Decision|0|||
44172301|NCT02329327|78965875|FG000|Overall Study|Withdrawal by Subject|3|||
44172302|NCT02329327|78965876|FG001|Overall Study|Withdrawal by Subject|0|||
44172303|NCT02329327|78965875|FG000|Overall Study|Lost to Follow-up|4|||
44172304|NCT02329327|78965876|FG001|Overall Study|Lost to Follow-up|0|||
44172305|NCT02328937|78965895|FG000|Period 1|Lost to Follow-up|0|||
44172306|NCT02328937|78965896|FG001|Period 1|Lost to Follow-up|0|||
44172307|NCT02328937|78965897|FG002|Period 1|Lost to Follow-up|0|||
44172308|NCT02328937|78965898|FG003|Period 1|Lost to Follow-up|1|||
44172309|NCT02328937|78965899|FG004|Period 1|Lost to Follow-up|0|||
44172310|NCT02328937|78965900|FG005|Period 1|Lost to Follow-up|0|||
44172311|NCT02328937|78965895|FG000|Period 2|Adverse Event|0|||
44172312|NCT02328937|78965896|FG001|Period 2|Adverse Event|0|||
44172313|NCT02328937|78965897|FG002|Period 2|Adverse Event|1|||
44172314|NCT02328937|78965898|FG003|Period 2|Adverse Event|0|||
44172315|NCT02328937|78965899|FG004|Period 2|Adverse Event|0|||
44172316|NCT02328937|78965900|FG005|Period 2|Adverse Event|0|||
44172317|NCT02328547|78965910|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
44172318|NCT02328547|78965911|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
44172319|NCT02328547|78965910|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
44172320|NCT02328547|78965911|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
44172321|NCT02300311|78965925|FG000|Overall Study|Other than the reason specified|1|||
44172322|NCT02300311|78965926|FG001|Overall Study|Other than the reason specified|0|||
44172323|NCT02300311|78965925|FG000|Overall Study|Refused to continue taking medication|18|||
44172324|NCT02300311|78965926|FG001|Overall Study|Refused to continue taking medication|0|||
44172325|NCT02300233|78965939|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
44172326|NCT02300233|78965940|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
44172327|NCT02300233|78965941|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
44172328|NCT02300233|78965939|FG000|Overall Study|Withdrawal by Subject|1|||
44172329|NCT02300233|78965940|FG001|Overall Study|Withdrawal by Subject|0|||
44172330|NCT02300233|78965941|FG002|Overall Study|Withdrawal by Subject|3|||
44172331|NCT02300233|78965939|FG000|Overall Study|Investigator Judgement|0|||
44172332|NCT02300233|78965940|FG001|Overall Study|Investigator Judgement|0|||
44172333|NCT02300233|78965941|FG002|Overall Study|Investigator Judgement|1|||
44172334|NCT02300233|78965939|FG000|Overall Study|Reason Not Specified|0|||
44172335|NCT02300233|78965940|FG001|Overall Study|Reason Not Specified|0|||
44172336|NCT02300233|78965941|FG002|Overall Study|Reason Not Specified|5|||
44172337|NCT02175225|78965952|FG000|Overall Study|Withdrawal by Subject|1|||
44172338|NCT02175225|78965953|FG001|Overall Study|Withdrawal by Subject|2|||
44172339|NCT02175225|78965952|FG000|Overall Study|Lost to Follow-up|6|||
44172340|NCT02175225|78965953|FG001|Overall Study|Lost to Follow-up|7|||
44264201|NCT02764762|79164480|FG000|Overall Study|Reason not Specified|1|||
44172341|NCT02175225|78965952|FG000|Overall Study|Study drug not administered|1|||
44172342|NCT02175225|78965953|FG001|Overall Study|Study drug not administered|2|||
44172343|NCT02299375|78965961|FG000|Overall Study|Adverse Event, serious fatal|1|||
44172344|NCT02299375|78965962|FG001|Overall Study|Adverse Event, serious fatal|3|||
44172345|NCT02299375|78965961|FG000|Overall Study|Adverse Event, non-fatal|8|||
44172346|NCT02299375|78965962|FG001|Overall Study|Adverse Event, non-fatal|9|||
44172347|NCT02299375|78965961|FG000|Overall Study|Lack of Efficacy|1|||
44172348|NCT02299375|78965962|FG001|Overall Study|Lack of Efficacy|3|||
44172349|NCT02299375|78965961|FG000|Overall Study|Protocol Violation|1|||
44172350|NCT02299375|78965962|FG001|Overall Study|Protocol Violation|3|||
44172351|NCT02299375|78965961|FG000|Overall Study|Other: Met stopping criteria|1|||
44172352|NCT02299375|78965962|FG001|Overall Study|Other: Met stopping criteria|0|||
44172353|NCT02299375|78965961|FG000|Overall Study|Other: Study closed/terminated|66|||
44172354|NCT02299375|78965962|FG001|Overall Study|Other: Study closed/terminated|55|||
44172355|NCT02299375|78965961|FG000|Overall Study|Lost to Follow-up|0|||
44172356|NCT02299375|78965962|FG001|Overall Study|Lost to Follow-up|2|||
44172357|NCT02299375|78965961|FG000|Overall Study|Physician Decision|1|||
44172358|NCT02299375|78965962|FG001|Overall Study|Physician Decision|1|||
44172359|NCT02299375|78965961|FG000|Overall Study|Withdrawal by Subject|1|||
44172360|NCT02299375|78965962|FG001|Overall Study|Withdrawal by Subject|4|||
44172361|NCT02151903|78965971|FG000|Overall Study|Withdrawal by Subject|1|||
44172362|NCT02151903|78965972|FG001|Overall Study|Withdrawal by Subject|0|||
44172363|NCT02151903|78965971|FG000|Overall Study|Progressive disease|2|||
44172364|NCT02151903|78965972|FG001|Overall Study|Progressive disease|1|||
44172365|NCT02151591|78965980|FG000|Overall Study|Lost to Follow-up|6|||
44172366|NCT02151591|78965981|FG001|Overall Study|Lost to Follow-up|3|||
44172367|NCT02174523|78965989|FG000|Overall Study|Withdrawal by Subject|1|||
44172368|NCT02174523|78965990|FG001|Overall Study|Withdrawal by Subject|0|||
44450823|NCT04585009|79459534|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450824|NCT04585009|79459535|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44172369|NCT02297815|78965997|FG000|Overall Study|Lost to Follow-up|236|||
44172370|NCT02297815|78965998|FG001|Overall Study|Lost to Follow-up|140|||
44172371|NCT02114385|78966008|FG000|Overall Study|Withdrawal by Subject|3|||
44172372|NCT02114385|78966009|FG001|Overall Study|Withdrawal by Subject|2|||
44172373|NCT02114385|78966008|FG000|Overall Study|Lost to Follow-up|0|||
44172374|NCT02114385|78966009|FG001|Overall Study|Lost to Follow-up|6|||
44172375|NCT02114151|78966015|FG000|Overall Study|Death|1|||
44172376|NCT02114151|78966015|FG000|Overall Study|Lost to Follow-up|1|||
44172377|NCT02114151|78966015|FG000|Overall Study|Withdrawal by Subject|5|||
44172378|NCT02297503|78966021|FG000|Overall Study|Withdrawal by Subject|1|||
44172379|NCT02297503|78966022|FG001|Overall Study|Withdrawal by Subject|1|||
44172380|NCT02297503|78966021|FG000|Overall Study|Protocol Violation|1|||
44172381|NCT02297503|78966022|FG001|Overall Study|Protocol Violation|0|||
44172382|NCT02297503|78966021|FG000|Overall Study|Pregnancy|0|||
44450825|NCT04585009|79459536|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450826|NCT04585009|79459537|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450827|NCT04585009|79459538|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450828|NCT04585009|79459539|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450829|NCT04585009|79459540|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
44450830|NCT04585009|79459541|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450831|NCT04585009|79459542|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
44450832|NCT04585009|79459531|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450833|NCT04585009|79459532|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450834|NCT04585009|79459533|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450835|NCT04585009|79459534|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450836|NCT04585009|79459535|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450837|NCT04585009|79459536|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450838|NCT04585009|79459537|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450839|NCT04585009|79459538|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450840|NCT04585009|79459539|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450841|NCT04585009|79459540|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450842|NCT04585009|79459541|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
44450843|NCT04585009|79459542|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
44450844|NCT04439838|79459595|FG000|Overall Study|Withdrawal by Subject|0|||
44450845|NCT04439838|79459596|FG001|Overall Study|Withdrawal by Subject|0|||
44543012|NCT03655717|79555915|FG015|Overall Study|Physician Decision|0|||
44543013|NCT03655717|79555916|FG016|Overall Study|Physician Decision|0|||
44543014|NCT03655717|79555917|FG017|Overall Study|Physician Decision|0|||
44543015|NCT03655717|79555918|FG018|Overall Study|Physician Decision|0|||
44543016|NCT03655717|79555919|FG019|Overall Study|Physician Decision|1|||
44543017|NCT03655717|79555920|FG020|Overall Study|Physician Decision|0|||
44543018|NCT03655717|79555921|FG021|Overall Study|Physician Decision|0|||
44543019|NCT03655717|79555922|FG022|Overall Study|Physician Decision|0|||
44543020|NCT03655717|79555923|FG023|Overall Study|Physician Decision|1|||
44172383|NCT02297503|78966022|FG001|Overall Study|Pregnancy|1|||
44172384|NCT02297503|78966021|FG000|Overall Study|Lost to Follow-up|0|||
44172385|NCT02297503|78966022|FG001|Overall Study|Lost to Follow-up|1|||
44172386|NCT02297503|78966021|FG000|Overall Study|Medical reason|0|||
44172387|NCT02297503|78966022|FG001|Overall Study|Medical reason|1|||
44172388|NCT02113449|78966037|FG000|Overall Study|Adverse Event|4|||
44172389|NCT02366923|78966045|FG000|Overall Study|Withdrawal by Subject|1|||
44172390|NCT02366923|78966045|FG000|Overall Study|Positive Slit Lamp Findings|2|||
44172391|NCT02366923|78966045|FG000|Overall Study|High Astigmatism|3|||
44172392|NCT02326597|78966052|FG000|Overall Study|Lost to Follow-up|42|||
44172393|NCT02326597|78966053|FG001|Overall Study|Lost to Follow-up|32|||
44172394|NCT02366767|78966063|FG000|Overall Study|left for home after 1 day at camp|1|||
44172395|NCT02366767|78966064|FG001|Overall Study|left for home after 1 day at camp|0|||
44172396|NCT02150343|78966074|FG000|Overall Study|Adverse Event|2|||
44450846|NCT04439838|79459597|FG002|Overall Study|Withdrawal by Subject|0|||
44450847|NCT04439838|79459598|FG003|Overall Study|Withdrawal by Subject|0|||
44450848|NCT04439838|79459599|FG004|Overall Study|Withdrawal by Subject|0|||
44450849|NCT04439838|79459600|FG005|Overall Study|Withdrawal by Subject|0|||
44450850|NCT04439838|79459601|FG006|Overall Study|Withdrawal by Subject|0|||
44450851|NCT04439838|79459602|FG007|Overall Study|Withdrawal by Subject|0|||
44450852|NCT04439838|79459603|FG008|Overall Study|Withdrawal by Subject|1|||
44450853|NCT04096274|79459668|FG000|Phase I|Lost to Follow-up|5|||
44450854|NCT04096274|79459669|FG001|Phase I|Lost to Follow-up|5|||
44450855|NCT04096274|79459668|FG000|Phase II|Lost to Follow-up|11|||
44172397|NCT02150343|78966075|FG001|Overall Study|Adverse Event|0|||
44172398|NCT02150343|78966076|FG002|Overall Study|Adverse Event|1|||
44172399|NCT02150343|78966077|FG003|Overall Study|Adverse Event|1|||
44172400|NCT02150343|78966074|FG000|Overall Study|Withdrawal by Subject|13|||
44172401|NCT02150343|78966075|FG001|Overall Study|Withdrawal by Subject|10|||
44172402|NCT02150343|78966076|FG002|Overall Study|Withdrawal by Subject|9|||
44172403|NCT02150343|78966077|FG003|Overall Study|Withdrawal by Subject|4|||
44264202|NCT02340962|79164490|FG000|Overall Study|Lost to Follow-up|1|||
44264203|NCT02340962|79164491|FG001|Overall Study|Lost to Follow-up|0|||
44264204|NCT02272634|79164511|FG000|Overall Study|Adverse Event|1|||
44264205|NCT02272634|79164512|FG001|Overall Study|Adverse Event|0|||
44264206|NCT02272634|79164513|FG002|Overall Study|Adverse Event|0|||
44450856|NCT04096274|79459669|FG001|Phase II|Lost to Follow-up|11|||
44450857|NCT04067011|79459687|FG000|Overall Study|Not Treated|8|||
44450858|NCT04067011|79459688|FG001|Overall Study|Not Treated|7|||
44450859|NCT04067011|79459689|FG002|Overall Study|Not Treated|5|||
44450860|NCT04067011|79459687|FG000|Overall Study|Adverse Event|2|||
44450861|NCT04067011|79459688|FG001|Overall Study|Adverse Event|1|||
44450862|NCT04067011|79459689|FG002|Overall Study|Adverse Event|0|||
44450863|NCT04067011|79459687|FG000|Overall Study|Withdrawal by Subject|6|||
44450864|NCT04067011|79459688|FG001|Overall Study|Withdrawal by Subject|2|||
44450865|NCT04067011|79459689|FG002|Overall Study|Withdrawal by Subject|1|||
44172404|NCT02150343|78966074|FG000|Overall Study|Lost to Follow-up|4|||
44172405|NCT02150343|78966075|FG001|Overall Study|Lost to Follow-up|4|||
44450866|NCT04067011|79459687|FG000|Overall Study|Lost to Follow-up|0|||
44450867|NCT04067011|79459688|FG001|Overall Study|Lost to Follow-up|0|||
44172406|NCT02150343|78966076|FG002|Overall Study|Lost to Follow-up|2|||
44172407|NCT02150343|78966077|FG003|Overall Study|Lost to Follow-up|3|||
44264207|NCT02272634|79164511|FG000|Overall Study|Protocol Violation|0|||
44450868|NCT04067011|79459689|FG002|Overall Study|Lost to Follow-up|1|||
44450869|NCT04067011|79459687|FG000|Overall Study|Physician Decision|1|||
44450870|NCT04067011|79459688|FG001|Overall Study|Physician Decision|1|||
44450871|NCT04067011|79459689|FG002|Overall Study|Physician Decision|0|||
44450872|NCT04067011|79459687|FG000|Overall Study|Other Reasons|2|||
44450873|NCT04067011|79459688|FG001|Overall Study|Other Reasons|0|||
44450874|NCT04067011|79459689|FG002|Overall Study|Other Reasons|1|||
44450875|NCT04067011|79459687|FG000|Overall Study|Missing|0|||
44450876|NCT04067011|79459688|FG001|Overall Study|Missing|2|||
44450877|NCT04067011|79459689|FG002|Overall Study|Missing|0|||
44450878|NCT04007523|79459707|FG000|Overall Study|Withdrawal by Subject|0|||
44450879|NCT04007523|79459708|FG001|Overall Study|Withdrawal by Subject|1|||
44450880|NCT04007523|79459709|FG002|Overall Study|Withdrawal by Subject|1|||
44450881|NCT04007523|79459710|FG003|Overall Study|Withdrawal by Subject|0|||
44450882|NCT04007523|79459707|FG000|Overall Study|ICU Transfer|0|||
44450883|NCT04007523|79459708|FG001|Overall Study|ICU Transfer|1|||
44450884|NCT04007523|79459709|FG002|Overall Study|ICU Transfer|0|||
44450885|NCT04007523|79459710|FG003|Overall Study|ICU Transfer|0|||
44450886|NCT04007523|79459707|FG000|Overall Study|COVID hospital closure|0|||
44450887|NCT04007523|79459708|FG001|Overall Study|COVID hospital closure|0|||
44450888|NCT04007523|79459709|FG002|Overall Study|COVID hospital closure|1|||
44450889|NCT04007523|79459710|FG003|Overall Study|COVID hospital closure|2|||
44172408|NCT02150343|78966074|FG000|Overall Study|Other|2|||
44172409|NCT02150343|78966075|FG001|Overall Study|Other|6|||
44172410|NCT02150343|78966076|FG002|Overall Study|Other|0|||
44172411|NCT02150343|78966077|FG003|Overall Study|Other|2|||
44172412|NCT02149875|78966090|FG000|Overall Study|Lost to Follow-up|3|||
44172413|NCT02149875|78966091|FG001|Overall Study|Lost to Follow-up|4|||
44172414|NCT02149875|78966092|FG002|Overall Study|Lost to Follow-up|5|||
44172415|NCT02149875|78966090|FG000|Overall Study|Withdrawal by Subject|3|||
44172416|NCT02149875|78966091|FG001|Overall Study|Withdrawal by Subject|2|||
44172417|NCT02149875|78966092|FG002|Overall Study|Withdrawal by Subject|2|||
44172418|NCT02149875|78966090|FG000|Overall Study|Physician Decision|1|||
44172419|NCT02149875|78966091|FG001|Overall Study|Physician Decision|2|||
44172420|NCT02149875|78966092|FG002|Overall Study|Physician Decision|2|||
44172421|NCT02112045|78966102|FG000|Overall Study|Withdrawal by Subject|1|||
44172422|NCT02112045|78966103|FG001|Overall Study|Withdrawal by Subject|0|||
44172423|NCT01629693|78966111|FG000|Overall Study|Lost to Follow-up|2|||
44172424|NCT01629693|78966112|FG001|Overall Study|Lost to Follow-up|4|||
44172425|NCT01629693|78966111|FG000|Overall Study|Withdrawal by Subject|2|||
44172426|NCT01629693|78966112|FG001|Overall Study|Withdrawal by Subject|2|||
44172427|NCT01629693|78966111|FG000|Overall Study|Adverse Event|1|||
44172428|NCT01629693|78966112|FG001|Overall Study|Adverse Event|0|||
44172429|NCT01629693|78966111|FG000|Overall Study|Investigator decision|0|||
44172430|NCT01629693|78966112|FG001|Overall Study|Investigator decision|1|||
44172431|NCT01629693|78966111|FG000|Overall Study|Poor comfort of study lenses|0|||
44172432|NCT01629693|78966112|FG001|Overall Study|Poor comfort of study lenses|2|||
44172433|NCT01629693|78966111|FG000|Overall Study|Subject decision unrelated to AE|0|||
44172434|NCT01629693|78966112|FG001|Overall Study|Subject decision unrelated to AE|1|||
44172435|NCT02147691|78966120|FG000|Overall Study|Withdrawal by Subject|2|||
44172436|NCT02147691|78966121|FG001|Overall Study|Withdrawal by Subject|0|||
44172437|NCT02147691|78966120|FG000|Overall Study|Adverse Event|2|||
44172438|NCT02147691|78966121|FG001|Overall Study|Adverse Event|0|||
44172439|NCT02147691|78966120|FG000|Overall Study|Lost to Follow-up|0|||
44450890|NCT04007523|79459707|FG000|Overall Study|Surgery cancelled|0|||
44450891|NCT04007523|79459708|FG001|Overall Study|Surgery cancelled|0|||
44450892|NCT04007523|79459709|FG002|Overall Study|Surgery cancelled|1|||
44450893|NCT04007523|79459710|FG003|Overall Study|Surgery cancelled|1|||
44450894|NCT04002401|79459720|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
44450895|NCT04002401|79459720|FG000|Overall Study|Death|10|||
44450896|NCT04002401|79459720|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
44450897|NCT04002401|79459720|FG000|Overall Study|Enrolled but Never Treated|1|||
44450898|NCT04002401|79459720|FG000|Overall Study|Lost to Follow-up|1|||
44450899|NCT04000724|79459727|FG000|Overall Study|Withdrawal by Subject|5|||
44450900|NCT04000724|79459728|FG001|Overall Study|Withdrawal by Subject|3|||
44172440|NCT02147691|78966121|FG001|Overall Study|Lost to Follow-up|1|||
44450901|NCT04000724|79459729|FG002|Overall Study|Withdrawal by Subject|4|||
44450902|NCT04000724|79459727|FG000|Overall Study|Lost to Follow-up|11|||
44450903|NCT04000724|79459728|FG001|Overall Study|Lost to Follow-up|7|||
44450904|NCT04000724|79459729|FG002|Overall Study|Lost to Follow-up|13|||
44450905|NCT03997448|79459740|FG000|Study Treatment|Disease Progression|1|||
44450906|NCT03997448|79459740|FG000|Study Treatment|Symptomatic Deterioration|1|||
44450907|NCT03997448|79459740|FG000|Follow up|Death|2|||
44450908|NCT03997448|79459740|FG000|Follow up|study terminated|1|||
44172441|NCT02111811|78966129|FG000|Treatment Phase|Lost to Follow-up|22|||
44172442|NCT02111811|78966130|FG001|Treatment Phase|Lost to Follow-up|18|||
44172443|NCT02111811|78966129|FG000|Treatment Phase|Death|2|||
44450909|NCT03812224|79459759|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
44543021|NCT03655717|79555924|FG024|Overall Study|Physician Decision|0|||
44450910|NCT03812224|79459760|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
44450911|NCT03812224|79459759|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
44450912|NCT03812224|79459760|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
44450913|NCT03812224|79459759|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
44450914|NCT03812224|79459760|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
44450915|NCT03812224|79459759|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
44450916|NCT03812224|79459760|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
44450917|NCT03646123|79459779|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
44450918|NCT03646123|79459780|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
44450919|NCT03646123|79459781|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
44450920|NCT03646123|79459779|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
44450921|NCT03646123|79459780|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
44450922|NCT03646123|79459781|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
44450923|NCT03646123|79459779|FG000|Overall Study|Non-compliance to study protocol|1|||
44450924|NCT03646123|79459780|FG001|Overall Study|Non-compliance to study protocol|0|||
44450925|NCT03646123|79459781|FG002|Overall Study|Non-compliance to study protocol|0|||
44450926|NCT03646123|79459779|FG000|Overall Study|Ineligible due to progression during screening|0|||
44450927|NCT03646123|79459780|FG001|Overall Study|Ineligible due to progression during screening|0|||
44450928|NCT03646123|79459781|FG002|Overall Study|Ineligible due to progression during screening|1|||
44450929|NCT03646123|79459779|FG000|Overall Study|Withdrawal by Subject|2|||
44450930|NCT03646123|79459780|FG001|Overall Study|Withdrawal by Subject|1|||
44450931|NCT03646123|79459781|FG002|Overall Study|Withdrawal by Subject|3|||
44450932|NCT03646123|79459779|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
44450933|NCT03646123|79459780|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
44450934|NCT03646123|79459781|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
44450935|NCT03646123|79459779|FG000|Overall Study|Death|2|||
44172444|NCT02111811|78966130|FG001|Treatment Phase|Death|0|||
44172445|NCT02111811|78966129|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
44450936|NCT03646123|79459780|FG001|Overall Study|Death|1|||
44450937|NCT03646123|79459781|FG002|Overall Study|Death|1|||
44450938|NCT03646123|79459779|FG000|Overall Study|Lost to Follow-up|4|||
44264208|NCT02272634|79164512|FG001|Overall Study|Protocol Violation|0|||
44264209|NCT02272634|79164513|FG002|Overall Study|Protocol Violation|1|||
44450939|NCT03646123|79459780|FG001|Overall Study|Lost to Follow-up|7|||
44172446|NCT02111811|78966130|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
44172447|NCT02111811|78966129|FG000|Follow up Period (Aim 2)|Death|2|||
44264210|NCT02272634|79164511|FG000|Overall Study|Withdrawal by Subject|0|||
44264211|NCT02272634|79164512|FG001|Overall Study|Withdrawal by Subject|1|||
44264212|NCT02272634|79164513|FG002|Overall Study|Withdrawal by Subject|0|||
44264213|NCT00788125|79164524|FG000|Overall Study|Death|6|||
44264214|NCT02504424|79164537|FG000|Overall Study|Withdrawal by Subject|2|||
44264215|NCT02548832|79164863|FG000|Overall Study|Lost to Follow-up|2|||
44360908|NCT01210664|79366321|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
44360909|NCT01210664|79366322|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
44360910|NCT01210664|79366323|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
44360911|NCT01210664|79366324|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
44264216|NCT02548832|79164864|FG001|Overall Study|Lost to Follow-up|2|||
44172448|NCT02111811|78966130|FG001|Follow up Period (Aim 2)|Death|0|||
44172449|NCT01655693|78966139|FG000|Overall Study|Progression of Disease|92|||
44172450|NCT01655693|78966140|FG001|Overall Study|Progression of Disease|76|||
44172451|NCT01655693|78966141|FG002|Overall Study|Progression of Disease|58|||
44172452|NCT01655693|78966139|FG000|Overall Study|Death|8|||
44172453|NCT01655693|78966140|FG001|Overall Study|Death|9|||
44172454|NCT01655693|78966141|FG002|Overall Study|Death|12|||
44172455|NCT01655693|78966139|FG000|Overall Study|Serious Adverse Event|3|||
44172456|NCT01655693|78966140|FG001|Overall Study|Serious Adverse Event|15|||
44172457|NCT01655693|78966141|FG002|Overall Study|Serious Adverse Event|11|||
44172458|NCT01655693|78966139|FG000|Overall Study|Withdrawal by Subject|3|||
44172459|NCT01655693|78966140|FG001|Overall Study|Withdrawal by Subject|2|||
44172460|NCT01655693|78966141|FG002|Overall Study|Withdrawal by Subject|20|||
44172461|NCT01655693|78966139|FG000|Overall Study|Adverse Event|3|||
44172462|NCT01655693|78966140|FG001|Overall Study|Adverse Event|11|||
44172463|NCT01655693|78966141|FG002|Overall Study|Adverse Event|3|||
44172464|NCT01655693|78966139|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
44172465|NCT01655693|78966140|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
44172466|NCT01655693|78966141|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
44172467|NCT01655693|78966139|FG000|Overall Study|Non-Compliance|0|||
44172468|NCT01655693|78966140|FG001|Overall Study|Non-Compliance|0|||
44172469|NCT01655693|78966141|FG002|Overall Study|Non-Compliance|7|||
44172470|NCT01655693|78966139|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
44172471|NCT01655693|78966140|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
44172472|NCT01655693|78966141|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
44172473|NCT01655693|78966139|FG000|Overall Study|Protocol Violation|1|||
44172474|NCT01655693|78966140|FG001|Overall Study|Protocol Violation|0|||
44172475|NCT01655693|78966141|FG002|Overall Study|Protocol Violation|3|||
44172476|NCT01655693|78966139|FG000|Overall Study|Lost to Follow-up|1|||
44172477|NCT01655693|78966140|FG001|Overall Study|Lost to Follow-up|0|||
44172478|NCT01655693|78966141|FG002|Overall Study|Lost to Follow-up|1|||
44172479|NCT01655693|78966139|FG000|Overall Study|Screening Failure|1|||
44172480|NCT01655693|78966140|FG001|Overall Study|Screening Failure|0|||
44172481|NCT01655693|78966141|FG002|Overall Study|Screening Failure|0|||
44172482|NCT01655693|78966139|FG000|Overall Study|Other|8|||
44172483|NCT01655693|78966140|FG001|Overall Study|Other|6|||
44172484|NCT01655693|78966141|FG002|Overall Study|Other|15|||
44172485|NCT01655381|78966159|FG000|Overall Study|Investigator Decision|1|||
44172486|NCT01655381|78966159|FG000|Overall Study|Moved to Another City|1|||
44172487|NCT01655381|78966159|FG000|Overall Study|Insufficient Treatment Response|1|||
44172488|NCT01656161|78966164|FG000|Overall Study|Death|3|||
44172489|NCT01656161|78966164|FG000|Overall Study|Adverse Event|2|||
44172490|NCT01656161|78966164|FG000|Overall Study|Protocol Violation|1|||
44172491|NCT01656161|78966164|FG000|Overall Study|Withdrawal by Subject|1|||
44264217|NCT02548832|79164865|FG002|Overall Study|Lost to Follow-up|2|||
44172492|NCT02111577|78966173|FG000|Overall Study|Protocol Violation|2|||
44172493|NCT02111577|78966174|FG001|Overall Study|Protocol Violation|0|||
44360912|NCT00881569|79366336|FG000|Overall Study|Disease progression|1|||
44172494|NCT02111577|78966173|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
44172495|NCT02111577|78966174|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
44360913|NCT00881569|79366337|FG001|Overall Study|Disease progression|1|||
44172496|NCT02111577|78966173|FG000|Overall Study|Failure to produce study treatment|6|||
44264218|NCT03215264|79165054|FG000|Dose Level 2|Adverse Event|0|||
44172497|NCT02111577|78966174|FG001|Overall Study|Failure to produce study treatment|0|||
44172498|NCT02111577|78966173|FG000|Overall Study|Death|518|||
44172499|NCT02111577|78966174|FG001|Overall Study|Death|254|||
44172500|NCT02111577|78966173|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
44172501|NCT02111577|78966174|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
44172502|NCT02111577|78966173|FG000|Overall Study|Adverse Event|1|||
44172503|NCT02111577|78966174|FG001|Overall Study|Adverse Event|1|||
44172504|NCT02111577|78966173|FG000|Overall Study|Withdrawal by Subject|51|||
44172505|NCT02111577|78966174|FG001|Overall Study|Withdrawal by Subject|23|||
44172506|NCT02111577|78966173|FG000|Overall Study|Disease progression|0|||
44450940|NCT03646123|79459781|FG002|Overall Study|Lost to Follow-up|6|||
44450941|NCT03646123|79459779|FG000|Overall Study|Participants in long term follow-up|0|||
44450942|NCT03646123|79459780|FG001|Overall Study|Participants in long term follow-up|48|||
44450943|NCT03646123|79459781|FG002|Overall Study|Participants in long term follow-up|144|||
44450944|NCT03597503|79459791|FG000|Overall Study|Withdrawal by Subject|0|||
44450945|NCT03597503|79459792|FG001|Overall Study|Withdrawal by Subject|2|||
44172507|NCT02111577|78966174|FG001|Overall Study|Disease progression|1|||
44172508|NCT02111577|78966173|FG000|Overall Study|Lost to Follow-up|19|||
44450946|NCT03597503|79459791|FG000|Overall Study|Lost to Follow-up|1|||
44450947|NCT03597503|79459792|FG001|Overall Study|Lost to Follow-up|2|||
44450948|NCT03597503|79459791|FG000|Overall Study|Protocol Violation|1|||
44450949|NCT03597503|79459792|FG001|Overall Study|Protocol Violation|0|||
44450950|NCT03554317|79459798|FG000|Overall Study|Withdrawal by Subject|1|||
44450951|NCT03554317|79459798|FG000|Overall Study|PSA Progression|3|||
44450952|NCT03554317|79459798|FG000|Overall Study|Radiographic Progression|4|||
44450953|NCT03345095|79459808|FG000|Overall Study|Lack of Efficacy|184|||
44450954|NCT03345095|79459809|FG001|Overall Study|Lack of Efficacy|156|||
44450955|NCT03345095|79459808|FG000|Overall Study|Adverse Event|36|||
44450956|NCT03345095|79459809|FG001|Overall Study|Adverse Event|118|||
44450957|NCT03345095|79459808|FG000|Overall Study|Withdrawal by Subject|22|||
44450958|NCT03345095|79459809|FG001|Overall Study|Withdrawal by Subject|59|||
44450959|NCT03345095|79459808|FG000|Overall Study|Physician Decision|3|||
44450960|NCT03345095|79459809|FG001|Overall Study|Physician Decision|18|||
44450961|NCT03345095|79459808|FG000|Overall Study|Death|2|||
44450962|NCT03345095|79459809|FG001|Overall Study|Death|4|||
44450963|NCT03345095|79459808|FG000|Overall Study|Other reasons|2|||
44450964|NCT03345095|79459809|FG001|Overall Study|Other reasons|11|||
44450965|NCT03345095|79459808|FG000|Overall Study|Protocol Violation|0|||
44450966|NCT03345095|79459809|FG001|Overall Study|Protocol Violation|1|||
44450967|NCT03113500|79459824|FG000|Overall Study|Withdrawal by Subject|1|||
44450968|NCT03085758|79459831|FG000|Overall Study|Death|26|||
44450969|NCT03085758|79459832|FG001|Overall Study|Death|24|||
44450970|NCT03085758|79459833|FG002|Overall Study|Death|53|||
44450971|NCT03085758|79459831|FG000|Overall Study|Lost to Follow-up|1|||
44450972|NCT03085758|79459832|FG001|Overall Study|Lost to Follow-up|1|||
44172509|NCT02111577|78966174|FG001|Overall Study|Lost to Follow-up|10|||
44172510|NCT02170779|78966184|FG000|Overall Study|Withdrawal by Subject|1|||
44172511|NCT02170779|78966185|FG001|Overall Study|Withdrawal by Subject|0|||
44172512|NCT02170779|78966184|FG000|Overall Study|Lost to Follow-up|0|||
44172513|NCT02170779|78966185|FG001|Overall Study|Lost to Follow-up|1|||
44172514|NCT02147067|78966193|FG000|Overall Study|Withdrawal by Subject|2|||
44172515|NCT02147067|78966194|FG001|Overall Study|Withdrawal by Subject|2|||
44172516|NCT02170389|78966200|FG000|Overall Study|Study terminated prior to start of treat|1|||
44172517|NCT02146599|78966204|FG000|Overall Study|Failed to meet inclusion criteria|5|||
44172518|NCT02146365|78966214|FG000|Overall Study|Lost to Follow-up|2|||
44172519|NCT02146365|78966215|FG001|Overall Study|Lost to Follow-up|1|||
44172520|NCT02146365|78966216|FG002|Overall Study|Lost to Follow-up|3|||
44172521|NCT02146365|78966217|FG003|Overall Study|Lost to Follow-up|3|||
44172522|NCT02146365|78966218|FG004|Overall Study|Lost to Follow-up|1|||
44172523|NCT02146365|78966219|FG005|Overall Study|Lost to Follow-up|1|||
44172524|NCT02146365|78966220|FG006|Overall Study|Lost to Follow-up|0|||
44172525|NCT02146365|78966221|FG007|Overall Study|Lost to Follow-up|1|||
44172526|NCT02146365|78966214|FG000|Overall Study|Withdrawal by Subject|1|||
44172527|NCT02146365|78966215|FG001|Overall Study|Withdrawal by Subject|2|||
44172528|NCT02146365|78966216|FG002|Overall Study|Withdrawal by Subject|1|||
44172529|NCT02146365|78966217|FG003|Overall Study|Withdrawal by Subject|5|||
44172530|NCT02146365|78966218|FG004|Overall Study|Withdrawal by Subject|1|||
44450973|NCT03085758|79459833|FG002|Overall Study|Lost to Follow-up|1|||
44172531|NCT02146365|78966219|FG005|Overall Study|Withdrawal by Subject|0|||
44172532|NCT02146365|78966220|FG006|Overall Study|Withdrawal by Subject|0|||
44172533|NCT02146365|78966221|FG007|Overall Study|Withdrawal by Subject|0|||
44172534|NCT02146365|78966214|FG000|Overall Study|Unable to Comply with Protocol|0|||
44543022|NCT03655717|79555925|FG025|Overall Study|Physician Decision|0|||
44172535|NCT02146365|78966215|FG001|Overall Study|Unable to Comply with Protocol|1|||
44172536|NCT02146365|78966216|FG002|Overall Study|Unable to Comply with Protocol|1|||
44172537|NCT02146365|78966217|FG003|Overall Study|Unable to Comply with Protocol|0|||
44172538|NCT02146365|78966218|FG004|Overall Study|Unable to Comply with Protocol|0|||
44172539|NCT02146365|78966219|FG005|Overall Study|Unable to Comply with Protocol|0|||
44172540|NCT02146365|78966220|FG006|Overall Study|Unable to Comply with Protocol|0|||
44172541|NCT02146365|78966221|FG007|Overall Study|Unable to Comply with Protocol|0|||
44172542|NCT02146365|78966214|FG000|Overall Study|Other|1|||
44172543|NCT02146365|78966215|FG001|Overall Study|Other|0|||
44172544|NCT02146365|78966216|FG002|Overall Study|Other|2|||
44172545|NCT02146365|78966217|FG003|Overall Study|Other|1|||
44172546|NCT02146365|78966218|FG004|Overall Study|Other|0|||
44172547|NCT02146365|78966219|FG005|Overall Study|Other|0|||
44172548|NCT02146365|78966220|FG006|Overall Study|Other|0|||
44172549|NCT02146365|78966221|FG007|Overall Study|Other|0|||
44172550|NCT02146131|78966241|FG000|Overall Study|Physician Decision|61|||
44172551|NCT02146131|78966242|FG001|Overall Study|Physician Decision|56|||
44172552|NCT02107131|78966250|FG000|Overall Study|Lost to Follow-up|4|||
44172553|NCT02107131|78966251|FG001|Overall Study|Lost to Follow-up|4|||
44172554|NCT02107131|78966250|FG000|Overall Study|Physician Decision|1|||
44172555|NCT02107131|78966251|FG001|Overall Study|Physician Decision|0|||
44172556|NCT02107131|78966250|FG000|Overall Study|Withdrawal by Subject|2|||
44172557|NCT02107131|78966251|FG001|Overall Study|Withdrawal by Subject|0|||
44450974|NCT03085758|79459831|FG000|Overall Study|Withdrawal by Subject|2|||
44543023|NCT03655717|79555900|FG000|Overall Study|Lost to Follow-up|3|||
44172558|NCT02107131|78966250|FG000|Overall Study|mental instability|1|||
44172559|NCT02107131|78966251|FG001|Overall Study|mental instability|0|||
44172560|NCT02107131|78966250|FG000|Overall Study|Death|0|||
44172561|NCT02107131|78966251|FG001|Overall Study|Death|1|||
44172562|NCT02107131|78966250|FG000|Overall Study|Protocol Violation|0|||
44172563|NCT02107131|78966251|FG001|Overall Study|Protocol Violation|4|||
44172564|NCT02106975|78966261|FG000|Overall Study|Death|25|||
44172565|NCT02106975|78966262|FG001|Overall Study|Death|39|||
44264219|NCT03215264|79165055|FG001|Dose Level 2|Adverse Event|1|||
44264220|NCT03215264|79165056|FG002|Dose Level 2|Adverse Event|0|||
44264221|NCT03215264|79165054|FG000|Dose Level 3|Withdrawal by Subject|0|||
44264222|NCT03215264|79165055|FG001|Dose Level 3|Withdrawal by Subject|0|||
44264223|NCT03215264|79165056|FG002|Dose Level 3|Withdrawal by Subject|1|||
44450975|NCT03085758|79459832|FG001|Overall Study|Withdrawal by Subject|2|||
44172566|NCT02145429|78966270|FG000|Overall Study|Death|4|||
44172567|NCT02145429|78966271|FG001|Overall Study|Death|5|||
44172568|NCT02145429|78966270|FG000|Overall Study|Lost to Follow-up|4|||
44172569|NCT02145429|78966271|FG001|Overall Study|Lost to Follow-up|3|||
44172570|NCT02145429|78966270|FG000|Overall Study|Withdrawal by Subject|8|||
44172571|NCT02145429|78966271|FG001|Overall Study|Withdrawal by Subject|3|||
44172572|NCT02144337|78966279|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
44172573|NCT02144337|78966280|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
44172574|NCT02144337|78966279|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
44264224|NCT02504268|79165127|FG000|Overall Study|Adverse Event|18|||
44172575|NCT02144337|78966280|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
44264225|NCT02504268|79165128|FG001|Overall Study|Adverse Event|8|||
44172576|NCT02144337|78966279|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
44172577|NCT02144337|78966280|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
44172578|NCT02144337|78966279|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
44172579|NCT02144337|78966280|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
44172580|NCT02144337|78966279|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
44172581|NCT02144337|78966280|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
44172582|NCT02520011|78966290|FG000|Overall Study|Adverse Event|0|||
44172583|NCT02520011|78966291|FG001|Overall Study|Adverse Event|1|||
44172584|NCT02520011|78966292|FG002|Overall Study|Adverse Event|2|||
44172585|NCT02520011|78966290|FG000|Overall Study|Death|0|||
44172586|NCT02520011|78966291|FG001|Overall Study|Death|8|||
44172587|NCT02520011|78966292|FG002|Overall Study|Death|1|||
44172588|NCT02520011|78966290|FG000|Overall Study|Lack of Efficacy|4|||
44172589|NCT02520011|78966291|FG001|Overall Study|Lack of Efficacy|26|||
44172590|NCT02520011|78966292|FG002|Overall Study|Lack of Efficacy|4|||
44172591|NCT02520011|78966290|FG000|Overall Study|Physician Decision|0|||
44172592|NCT02520011|78966291|FG001|Overall Study|Physician Decision|2|||
44172593|NCT02520011|78966292|FG002|Overall Study|Physician Decision|0|||
44172594|NCT02520011|78966290|FG000|Overall Study|Withdrawal by Subject|1|||
44172595|NCT02520011|78966291|FG001|Overall Study|Withdrawal by Subject|3|||
44172596|NCT02520011|78966292|FG002|Overall Study|Withdrawal by Subject|0|||
44450976|NCT03085758|79459833|FG002|Overall Study|Withdrawal by Subject|1|||
44450977|NCT03085758|79459831|FG000|Overall Study|Refusal to recall it up to day 90|0|||
44450978|NCT03085758|79459832|FG001|Overall Study|Refusal to recall it up to day 90|0|||
44450979|NCT03085758|79459833|FG002|Overall Study|Refusal to recall it up to day 90|1|||
44450980|NCT03085758|79459831|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
44450981|NCT03085758|79459832|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
44450982|NCT03085758|79459833|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
44450983|NCT03053622|79459858|FG000|Overall Study|Lost to Follow-up|0|||
44450984|NCT03053622|79459859|FG001|Overall Study|Lost to Follow-up|0|||
44450985|NCT03053622|79459860|FG002|Overall Study|Lost to Follow-up|0|||
44450986|NCT03053622|79459861|FG003|Overall Study|Lost to Follow-up|1|||
44450987|NCT02979522|79459873|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
44450988|NCT02979522|79459874|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
44450989|NCT02979522|79459873|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
44450990|NCT02979522|79459874|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
44450991|NCT02971761|79459886|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
44450992|NCT02827877|79459894|FG000|Overall Study|Withdrawal by Subject|1|||
44450993|NCT02782104|79459898|FG000|Overall Study|Other|215|||
44450994|NCT02782104|79459898|FG000|Overall Study|Induction Day 28 Non Responder|9|||
44450995|NCT02782104|79459898|FG000|Overall Study|Non-Compliance with Study Drug|2|||
44450996|NCT02782104|79459898|FG000|Overall Study|Death|8|||
44450997|NCT02782104|79459898|FG000|Overall Study|Pregnancy|6|||
44450998|NCT02782104|79459898|FG000|Overall Study|Withdrawal by Subject|63|||
44450999|NCT02782104|79459898|FG000|Overall Study|Protocol Violation|7|||
44451000|NCT02782104|79459898|FG000|Overall Study|Lack of Efficacy|61|||
44451001|NCT02782104|79459898|FG000|Overall Study|Lost to Follow-up|23|||
44451002|NCT02782104|79459898|FG000|Overall Study|Adverse Event|74|||
44172597|NCT02520011|78966290|FG000|Overall Study|Protocol Deviation|0|||
44172598|NCT02520011|78966291|FG001|Overall Study|Protocol Deviation|1|||
44451003|NCT02728830|79459909|FG000|Overall Study|Exclusionary Surgery|9|||
44451004|NCT02728830|79459909|FG000|Overall Study|Exclusionary Pathology|6|||
44451005|NCT02728830|79459909|FG000|Overall Study|Physician Decision|3|||
44451006|NCT02728830|79459909|FG000|Overall Study|Withdrawal by Subject|2|||
44451007|NCT02728830|79459909|FG000|Overall Study|Lost to Follow-up|1|||
44451008|NCT02728830|79459909|FG000|Overall Study|Exclusionary Lab Values|1|||
44172599|NCT02520011|78966292|FG002|Overall Study|Protocol Deviation|0|||
44172600|NCT02520011|78966290|FG000|Overall Study|Patient went to hospice|0|||
44172601|NCT02520011|78966291|FG001|Overall Study|Patient went to hospice|1|||
44172602|NCT02520011|78966292|FG002|Overall Study|Patient went to hospice|0|||
44172603|NCT02520011|78966290|FG000|Overall Study|Progressive disease following response|0|||
44172604|NCT02520011|78966291|FG001|Overall Study|Progressive disease following response|4|||
44172605|NCT02520011|78966292|FG002|Overall Study|Progressive disease following response|2|||
44172606|NCT02519231|78966307|FG000|Overall Study|Lost to Follow-up|2|||
44172607|NCT02519231|78966308|FG001|Overall Study|Lost to Follow-up|5|||
44172608|NCT02519231|78966307|FG000|Overall Study|Withdrawal by Subject|0|||
44172609|NCT02519231|78966308|FG001|Overall Study|Withdrawal by Subject|1|||
44172610|NCT02106351|78966319|FG000|Treatment Cycle 1|Adverse Event|2|||
44172611|NCT02106351|78966320|FG001|Treatment Cycle 1|Adverse Event|0|||
44172612|NCT02106351|78966321|FG002|Treatment Cycle 1|Adverse Event|0|||
44172613|NCT02106351|78966319|FG000|Treatment Cycle 1|Consent withdrawn|1|||
44172614|NCT02106351|78966320|FG001|Treatment Cycle 1|Consent withdrawn|0|||
44172615|NCT02106351|78966321|FG002|Treatment Cycle 1|Consent withdrawn|2|||
44172616|NCT02106351|78966319|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
44172617|NCT02106351|78966320|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
44172618|NCT02106351|78966321|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
44172619|NCT02106351|78966319|FG000|Treatment Cycle 1|Other|0|||
44172620|NCT02106351|78966320|FG001|Treatment Cycle 1|Other|3|||
44172621|NCT02106351|78966321|FG002|Treatment Cycle 1|Other|1|||
44172622|NCT02106351|78966319|FG000|Treatment Cycle 1|Randomised but not treated|1|||
44172623|NCT02106351|78966320|FG001|Treatment Cycle 1|Randomised but not treated|0|||
44172624|NCT02106351|78966321|FG002|Treatment Cycle 1|Randomised but not treated|1|||
44172625|NCT02106351|78966319|FG000|Treatment Cycle 2|Adverse Event|0|||
44172626|NCT02106351|78966320|FG001|Treatment Cycle 2|Adverse Event|2|||
44172627|NCT02106351|78966321|FG002|Treatment Cycle 2|Adverse Event|0|||
44172628|NCT02106351|78966319|FG000|Treatment Cycle 2|Consent withdrawn|0|||
44172629|NCT02106351|78966320|FG001|Treatment Cycle 2|Consent withdrawn|1|||
44172630|NCT02106351|78966321|FG002|Treatment Cycle 2|Consent withdrawn|1|||
44172631|NCT02106351|78966319|FG000|Treatment Cycle 2|Other|0|||
44172632|NCT02106351|78966320|FG001|Treatment Cycle 2|Other|2|||
44172633|NCT02106351|78966321|FG002|Treatment Cycle 2|Other|2|||
44172634|NCT02106351|78966319|FG000|Treatment Cycle 3|Adverse Event|0|||
44172635|NCT02106351|78966320|FG001|Treatment Cycle 3|Adverse Event|1|||
44172636|NCT02106351|78966321|FG002|Treatment Cycle 3|Adverse Event|0|||
44172637|NCT02106351|78966319|FG000|Treatment Cycle 3|Consent withdrawn|0|||
44172638|NCT02106351|78966320|FG001|Treatment Cycle 3|Consent withdrawn|0|||
44172639|NCT02106351|78966321|FG002|Treatment Cycle 3|Consent withdrawn|2|||
44172640|NCT02106351|78966319|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
44172641|NCT02106351|78966320|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
44172642|NCT02106351|78966321|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
44172643|NCT02106351|78966319|FG000|Treatment Cycle 3|Other|0|||
44172644|NCT02106351|78966320|FG001|Treatment Cycle 3|Other|2|||
44172645|NCT02106351|78966321|FG002|Treatment Cycle 3|Other|3|||
44172646|NCT02106351|78966319|FG000|Treatment Cycle 4|Consent withdrawn|0|||
44172647|NCT02106351|78966320|FG001|Treatment Cycle 4|Consent withdrawn|0|||
44172648|NCT02106351|78966321|FG002|Treatment Cycle 4|Consent withdrawn|2|||
44172649|NCT02106351|78966319|FG000|Treatment Cycle 4|Other|0|||
44172650|NCT02106351|78966320|FG001|Treatment Cycle 4|Other|1|||
44451009|NCT02728830|79459909|FG000|Overall Study|Contraindicated Illness|1|||
44172651|NCT02106351|78966321|FG002|Treatment Cycle 4|Other|0|||
44172652|NCT02143947|78966337|FG000|Overall Study|Lost to Follow-up|4|||
44172653|NCT02143947|78966338|FG001|Overall Study|Lost to Follow-up|2|||
44172654|NCT02075073|78966349|FG000|Overall Study|Withdrawal by Subject|0|||
44172655|NCT02075073|78966350|FG001|Overall Study|Withdrawal by Subject|1|||
44172656|NCT02075073|78966351|FG002|Overall Study|Withdrawal by Subject|0|||
44172657|NCT02074059|78966365|FG000|Overall Study|Death|0|||
44172658|NCT02074059|78966366|FG001|Overall Study|Death|0|||
44451010|NCT02728830|79459909|FG000|Overall Study|Language Barrier|1|||
44172659|NCT02074059|78966367|FG002|Overall Study|Death|0|||
44172660|NCT02074059|78966368|FG003|Overall Study|Death|0|||
44172661|NCT02074059|78966369|FG004|Overall Study|Death|1|||
44451011|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Death|113|||
44172662|NCT02074059|78966370|FG005|Overall Study|Death|1|||
44264226|NCT02504268|79165129|FG002|Overall Study|Adverse Event|14|||
44451012|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Death|189|||
44172663|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
44172664|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
44172665|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
44172666|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
44172667|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Adverse Event|7|||
44172668|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Adverse Event|8|||
44172669|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Adverse Event|8|||
44172670|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Adverse Event|9|||
44264227|NCT02504268|79165130|FG003|Overall Study|Adverse Event|0|||
44172671|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
44172672|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
44264228|NCT02504268|79165131|FG004|Overall Study|Adverse Event|0|||
44172673|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
44172674|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
44172675|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
44172676|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
44172677|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
44172678|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
44172679|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Pregnancy|0|||
44172680|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Pregnancy|2|||
44172681|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Pregnancy|2|||
44172682|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Pregnancy|0|||
44172683|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Non-compliance|1|||
44172684|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Non-compliance|0|||
44172685|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Non-compliance|0|||
44172686|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Non-compliance|3|||
44172687|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Other|3|||
44172688|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Other|0|||
44172689|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Other|3|||
44172690|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Other|2|||
44172691|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
44172692|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
44172693|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
44172694|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
44172695|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
44172696|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
44172697|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
44172698|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
44172699|NCT02143713|78966389|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
44172700|NCT02143713|78966390|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
44264229|NCT02504268|79165132|FG005|Overall Study|Adverse Event|0|||
44172701|NCT02143713|78966391|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
44172702|NCT02143713|78966392|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
44172703|NCT02143713|78966389|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
44172704|NCT02143713|78966390|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
44172705|NCT02143713|78966391|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
44360914|NCT00881335|79366345|FG000|Overall Study|Lost to Follow-up|3|||
44172706|NCT02143713|78966392|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
44172707|NCT02143713|78966389|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
44360915|NCT00881335|79366346|FG001|Overall Study|Lost to Follow-up|2|||
44172708|NCT02143713|78966390|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
44172709|NCT02143713|78966391|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
44172710|NCT02143713|78966392|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
44172711|NCT02143713|78966389|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
44172712|NCT02143713|78966390|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
44172713|NCT02143713|78966391|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
44172714|NCT02143713|78966392|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
44172715|NCT02143713|78966389|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
44172716|NCT02143713|78966390|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
44172717|NCT02143713|78966391|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
44172718|NCT02143713|78966392|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
44172719|NCT02143713|78966389|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
44172720|NCT02143713|78966390|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
44172721|NCT02143713|78966391|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
44172722|NCT02143713|78966392|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
44172723|NCT02143713|78966389|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
44172724|NCT02143713|78966390|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
44172725|NCT02143713|78966391|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
44172726|NCT02143713|78966392|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
44172727|NCT02519855|78966405|FG000|Overall Study|Adverse Event|0|||
44172728|NCT02519855|78966406|FG001|Overall Study|Adverse Event|1|||
44172729|NCT02519855|78966405|FG000|Overall Study|Lost to Follow-up|3|||
44172730|NCT02519855|78966406|FG001|Overall Study|Lost to Follow-up|3|||
44172731|NCT02142387|78966414|FG000|Overall Study|<19 years old|49|||
44172732|NCT02142387|78966415|FG001|Overall Study|<19 years old|326|||
44172733|NCT02142387|78966414|FG000|Overall Study|non-cardiac etiology|504|||
44172734|NCT02142387|78966415|FG001|Overall Study|non-cardiac etiology|3431|||
44172735|NCT02142387|78966414|FG000|Overall Study|CPR not performed|74|||
44172736|NCT02142387|78966415|FG001|Overall Study|CPR not performed|473|||
44172737|NCT02142387|78966414|FG000|Overall Study|witnessed by paramedic|139|||
44172738|NCT02142387|78966415|FG001|Overall Study|witnessed by paramedic|917|||
44172739|NCT02142387|78966414|FG000|Overall Study|incomplete data|1|||
44172740|NCT02142387|78966415|FG001|Overall Study|incomplete data|9|||
44172741|NCT02142387|78966414|FG000|Overall Study|occurred not at home|298|||
44172742|NCT02142387|78966415|FG001|Overall Study|occurred not at home|2474|||
44172743|NCT02518919|78966424|FG000|Overall Study|Protocol Violation|1|||
44172744|NCT02518919|78966425|FG001|Overall Study|Protocol Violation|1|||
44172745|NCT02518919|78966426|FG002|Overall Study|Protocol Violation|2|||
44172746|NCT02518685|78966436|FG000|Overall Study|Adverse Event|29|||
44172747|NCT02518685|78966437|FG001|Overall Study|Adverse Event|1|||
44172748|NCT02518685|78966436|FG000|Overall Study|Withdrawal by Subject|10|||
44172749|NCT02518685|78966437|FG001|Overall Study|Withdrawal by Subject|3|||
44172750|NCT02518685|78966436|FG000|Overall Study|relocation, study fatigue|7|||
44172751|NCT02518685|78966437|FG001|Overall Study|relocation, study fatigue|2|||
44172752|NCT02518685|78966436|FG000|Overall Study|Pregnancy|1|||
44172753|NCT02518685|78966437|FG001|Overall Study|Pregnancy|0|||
44172754|NCT02518685|78966436|FG000|Overall Study|Physician Decision|1|||
44172755|NCT02518685|78966437|FG001|Overall Study|Physician Decision|0|||
44172756|NCT02518685|78966436|FG000|Overall Study|Lost to Follow-up|1|||
44172757|NCT02518685|78966437|FG001|Overall Study|Lost to Follow-up|4|||
44172758|NCT02520089|78966446|FG000|Overall Study|Lost to Follow-up|3|||
44172759|NCT02520089|78966447|FG001|Overall Study|Lost to Follow-up|4|||
44172760|NCT02105961|78966456|FG000|Overall Study|Adverse Event|18|||
44172761|NCT02105961|78966457|FG001|Overall Study|Adverse Event|7|||
44360916|NCT00879775|79366363|FG000|Overall Study|Lost to Follow-up|2|||
44360917|NCT00879775|79366364|FG001|Overall Study|Lost to Follow-up|1|||
44360918|NCT00894790|79366372|FG000|Overall Study|Protocol Violation|0|||
44360919|NCT00894790|79366373|FG001|Overall Study|Protocol Violation|1|||
44360920|NCT00894790|79366372|FG000|Overall Study|Lost to Follow-up|0|||
44360921|NCT00894790|79366373|FG001|Overall Study|Lost to Follow-up|1|||
44360922|NCT00894790|79366372|FG000|Overall Study|Did not meet entrance criteria|1|||
44360923|NCT00894790|79366373|FG001|Overall Study|Did not meet entrance criteria|0|||
44360924|NCT00879229|79366381|FG000|Overall Study|Study terminated by Sponsor|13|||
44360925|NCT00879229|79366382|FG001|Overall Study|Study terminated by Sponsor|12|||
44360926|NCT00879229|79366381|FG000|Overall Study|Death|4|||
44360927|NCT00879229|79366382|FG001|Overall Study|Death|2|||
44360928|NCT00879229|79366381|FG000|Overall Study|Adverse Event|2|||
44360929|NCT00879229|79366382|FG001|Overall Study|Adverse Event|0|||
44360930|NCT00879229|79366381|FG000|Overall Study|Withdrawal by Subject|1|||
44360931|NCT00879229|79366382|FG001|Overall Study|Withdrawal by Subject|0|||
44360932|NCT00879229|79366381|FG000|Overall Study|Clinical status did not improve|1|||
44360933|NCT00879229|79366382|FG001|Overall Study|Clinical status did not improve|0|||
44360934|NCT00879229|79366381|FG000|Overall Study|Other|1|||
44360935|NCT00879229|79366382|FG001|Overall Study|Other|0|||
44172762|NCT02105961|78966458|FG002|Overall Study|Adverse Event|13|||
44172763|NCT02105961|78966456|FG000|Overall Study|Lack of Efficacy|3|||
44172764|NCT02105961|78966457|FG001|Overall Study|Lack of Efficacy|0|||
44172765|NCT02105961|78966458|FG002|Overall Study|Lack of Efficacy|3|||
44172766|NCT02105961|78966456|FG000|Overall Study|Lost to Follow-up|2|||
44360936|NCT00878995|79366390|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
44360937|NCT00878995|79366391|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
44360938|NCT00879697|79366399|FG000|Overall Study|Physician Decision|2|||
44360939|NCT00879697|79366400|FG001|Overall Study|Physician Decision|2|||
44360940|NCT00894556|79366409|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
44451013|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
44451014|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
44264230|NCT02504268|79165133|FG006|Overall Study|Adverse Event|0|||
44172767|NCT02105961|78966457|FG001|Overall Study|Lost to Follow-up|0|||
44172768|NCT02105961|78966458|FG002|Overall Study|Lost to Follow-up|1|||
44172769|NCT02105961|78966456|FG000|Overall Study|Physician Decision|3|||
44172770|NCT02105961|78966457|FG001|Overall Study|Physician Decision|3|||
44172771|NCT02105961|78966458|FG002|Overall Study|Physician Decision|2|||
44172772|NCT02105961|78966456|FG000|Overall Study|Withdrawal by Subject|15|||
44172773|NCT02105961|78966457|FG001|Overall Study|Withdrawal by Subject|7|||
44172774|NCT02105961|78966458|FG002|Overall Study|Withdrawal by Subject|11|||
44172775|NCT02141997|78966471|FG000|Overall Study|Adverse Event|0|||
44172776|NCT02141997|78966472|FG001|Overall Study|Adverse Event|2|||
44172777|NCT02141997|78966473|FG002|Overall Study|Adverse Event|0|||
44172778|NCT02141997|78966474|FG003|Overall Study|Adverse Event|1|||
44172779|NCT02141997|78966471|FG000|Overall Study|Participant noncompliance|1|||
44172780|NCT02141997|78966472|FG001|Overall Study|Participant noncompliance|0|||
44172781|NCT02141997|78966473|FG002|Overall Study|Participant noncompliance|0|||
44172782|NCT02141997|78966474|FG003|Overall Study|Participant noncompliance|0|||
44172783|NCT02141997|78966471|FG000|Overall Study|Withdrew consent|1|||
44172784|NCT02141997|78966472|FG001|Overall Study|Withdrew consent|0|||
44172785|NCT02141997|78966473|FG002|Overall Study|Withdrew consent|3|||
44543024|NCT03655717|79555901|FG001|Overall Study|Lost to Follow-up|1|||
44172786|NCT02141997|78966474|FG003|Overall Study|Withdrew consent|0|||
44172787|NCT02141997|78966471|FG000|Overall Study|Other|1|||
44172788|NCT02141997|78966472|FG001|Overall Study|Other|4|||
44172789|NCT02141997|78966473|FG002|Overall Study|Other|0|||
44172790|NCT02141997|78966474|FG003|Overall Study|Other|0|||
44172791|NCT01628367|78966486|FG000|Overall Study|Adverse Event|1|||
44172792|NCT01628367|78966487|FG001|Overall Study|Adverse Event|0|||
44264231|NCT02504268|79165134|FG007|Overall Study|Adverse Event|0|||
44264232|NCT02504268|79165135|FG008|Overall Study|Adverse Event|0|||
44264233|NCT02504268|79165127|FG000|Overall Study|Withdrawal of Consent|11|||
44264234|NCT02504268|79165128|FG001|Overall Study|Withdrawal of Consent|10|||
44264235|NCT02504268|79165129|FG002|Overall Study|Withdrawal of Consent|3|||
44264236|NCT02504268|79165130|FG003|Overall Study|Withdrawal of Consent|0|||
44360941|NCT00894556|79366410|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
44264237|NCT02504268|79165131|FG004|Overall Study|Withdrawal of Consent|0|||
44172793|NCT01627899|78966493|FG000|Overall Study|Study terminated early by sponsor.|5|||
44172794|NCT02519777|78966500|FG000|Overall Study|Death|1|||
44172795|NCT02519777|78966501|FG001|Overall Study|Death|0|||
44172796|NCT02519777|78966502|FG002|Overall Study|Death|0|||
44172797|NCT02519777|78966500|FG000|Overall Study|Lost to Follow-up|0|||
44172798|NCT02519777|78966501|FG001|Overall Study|Lost to Follow-up|4|||
44172799|NCT02519777|78966502|FG002|Overall Study|Lost to Follow-up|2|||
44172800|NCT02519777|78966500|FG000|Overall Study|Withdrawal by Subject|3|||
44172801|NCT02519777|78966501|FG001|Overall Study|Withdrawal by Subject|1|||
44172802|NCT02519777|78966502|FG002|Overall Study|Withdrawal by Subject|0|||
44172803|NCT02519777|78966500|FG000|Overall Study|Severe Debilitation|1|||
44172804|NCT02519777|78966501|FG001|Overall Study|Severe Debilitation|1|||
44172805|NCT02519777|78966502|FG002|Overall Study|Severe Debilitation|1|||
44172806|NCT02519777|78966500|FG000|Overall Study|Not able to get to clinic|1|||
44172807|NCT02519777|78966501|FG001|Overall Study|Not able to get to clinic|2|||
44172808|NCT02519777|78966502|FG002|Overall Study|Not able to get to clinic|1|||
44172809|NCT02515331|78966513|FG000|Overall Study|Withdrawal by Subject|0|||
44172810|NCT02515331|78966514|FG001|Overall Study|Withdrawal by Subject|0|||
44172811|NCT02515331|78966515|FG002|Overall Study|Withdrawal by Subject|1|||
44172812|NCT02515331|78966513|FG000|Overall Study|Protocol deviation|0|||
44172813|NCT02515331|78966514|FG001|Overall Study|Protocol deviation|0|||
44172814|NCT02515331|78966515|FG002|Overall Study|Protocol deviation|3|||
44172815|NCT02515331|78966513|FG000|Overall Study|Adverse Event|2|||
44172816|NCT02515331|78966514|FG001|Overall Study|Adverse Event|0|||
44172817|NCT02515331|78966515|FG002|Overall Study|Adverse Event|0|||
44172818|NCT02515097|78966525|FG000|Overall Study|Lost to Follow-up|4|||
44172819|NCT02515097|78966526|FG001|Overall Study|Lost to Follow-up|2|||
44172820|NCT02515097|78966525|FG000|Overall Study|Withdrawal by Subject|1|||
44172821|NCT02515097|78966526|FG001|Overall Study|Withdrawal by Subject|3|||
44264238|NCT02504268|79165132|FG005|Overall Study|Withdrawal of Consent|0|||
44264239|NCT02504268|79165133|FG006|Overall Study|Withdrawal of Consent|0|||
44172822|NCT02515097|78966525|FG000|Overall Study|Adverse Event|2|||
44172823|NCT02515097|78966526|FG001|Overall Study|Adverse Event|1|||
44172824|NCT02141295|78966535|FG000|Overall Study|Adverse Event|1|||
44172825|NCT02141295|78966536|FG001|Overall Study|Adverse Event|18|||
44172826|NCT02141295|78966537|FG002|Overall Study|Adverse Event|11|||
44172827|NCT02141295|78966535|FG000|Overall Study|Physician Decision|2|||
44360942|NCT00894556|79366411|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
44360943|NCT00894556|79366412|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
44360944|NCT00894556|79366409|FG000|Treatment Phase|Lost to Follow-up|2|||
44264240|NCT02504268|79165134|FG007|Overall Study|Withdrawal of Consent|0|||
44264241|NCT02504268|79165135|FG008|Overall Study|Withdrawal of Consent|0|||
44264242|NCT02504268|79165127|FG000|Overall Study|Pregnancy|2|||
44264243|NCT02504268|79165128|FG001|Overall Study|Pregnancy|0|||
44264244|NCT02504268|79165129|FG002|Overall Study|Pregnancy|0|||
44264245|NCT02504268|79165130|FG003|Overall Study|Pregnancy|0|||
44264246|NCT02504268|79165131|FG004|Overall Study|Pregnancy|0|||
44264247|NCT02504268|79165132|FG005|Overall Study|Pregnancy|0|||
44264248|NCT02504268|79165133|FG006|Overall Study|Pregnancy|0|||
44264249|NCT02504268|79165134|FG007|Overall Study|Pregnancy|0|||
44172828|NCT02141295|78966536|FG001|Overall Study|Physician Decision|19|||
44172829|NCT02141295|78966537|FG002|Overall Study|Physician Decision|14|||
44172830|NCT02141295|78966535|FG000|Overall Study|Study terminated by sponsor|0|||
44172831|NCT02141295|78966536|FG001|Overall Study|Study terminated by sponsor|6|||
44264250|NCT02504268|79165135|FG008|Overall Study|Pregnancy|0|||
44264251|NCT02504268|79165127|FG000|Overall Study|Lost to Follow-up|3|||
44264252|NCT02504268|79165128|FG001|Overall Study|Lost to Follow-up|6|||
44172832|NCT02141295|78966537|FG002|Overall Study|Study terminated by sponsor|6|||
44172833|NCT02141295|78966535|FG000|Overall Study|Non-compliance|0|||
44172834|NCT02141295|78966536|FG001|Overall Study|Non-compliance|1|||
44172835|NCT02141295|78966537|FG002|Overall Study|Non-compliance|0|||
44172836|NCT02141295|78966535|FG000|Overall Study|Progressive disease|3|||
44172837|NCT02141295|78966536|FG001|Overall Study|Progressive disease|32|||
44172838|NCT02141295|78966537|FG002|Overall Study|Progressive disease|50|||
44172839|NCT02141295|78966535|FG000|Overall Study|Reason not specified|0|||
44172840|NCT02141295|78966536|FG001|Overall Study|Reason not specified|9|||
44172841|NCT02141295|78966537|FG002|Overall Study|Reason not specified|10|||
44172842|NCT02141295|78966535|FG000|Overall Study|Withdrawal by Subject|0|||
44172843|NCT02141295|78966536|FG001|Overall Study|Withdrawal by Subject|9|||
44172844|NCT02141295|78966537|FG002|Overall Study|Withdrawal by Subject|4|||
44172845|NCT02514551|78966549|FG000|Overall Study|Lost to Follow-up|0|||
44172846|NCT02514551|78966550|FG001|Overall Study|Lost to Follow-up|1|||
44172847|NCT02514551|78966549|FG000|Overall Study|Participant Never Treated|0|||
44172848|NCT02514551|78966550|FG001|Overall Study|Participant Never Treated|2|||
44172849|NCT02141217|78966559|FG000|Overall Study|Adverse Event|1|||
44172850|NCT02141217|78966560|FG001|Overall Study|Adverse Event|2|||
44172851|NCT02141217|78966559|FG000|Overall Study|Protocol Violation|1|||
44172852|NCT02141217|78966560|FG001|Overall Study|Protocol Violation|4|||
44172853|NCT02141217|78966559|FG000|Overall Study|Withdrawal by Subject|6|||
44172854|NCT02141217|78966560|FG001|Overall Study|Withdrawal by Subject|0|||
44172855|NCT02141217|78966559|FG000|Overall Study|Lost to Follow-up|1|||
44172856|NCT02141217|78966560|FG001|Overall Study|Lost to Follow-up|1|||
44172857|NCT02141217|78966559|FG000|Overall Study|Physician Decision|1|||
44172858|NCT02141217|78966560|FG001|Overall Study|Physician Decision|0|||
44172859|NCT02141217|78966559|FG000|Overall Study|Surgical Intervention|1|||
44172860|NCT02141217|78966560|FG001|Overall Study|Surgical Intervention|1|||
44172861|NCT02138253|78966571|FG000|Overall Study|Adverse Event|3|||
44172862|NCT02138253|78966572|FG001|Overall Study|Adverse Event|3|||
44172863|NCT02138253|78966571|FG000|Overall Study|Lost to Follow-up|2|||
44172864|NCT02138253|78966572|FG001|Overall Study|Lost to Follow-up|1|||
44172865|NCT02138253|78966571|FG000|Overall Study|Physician Decision|2|||
44172866|NCT02138253|78966572|FG001|Overall Study|Physician Decision|0|||
44172867|NCT02138253|78966571|FG000|Overall Study|Non compliance|1|||
44172868|NCT02138253|78966572|FG001|Overall Study|Non compliance|0|||
44172869|NCT02138253|78966571|FG000|Overall Study|Withdrawal by Subject|1|||
44360945|NCT00894556|79366410|FG001|Treatment Phase|Lost to Follow-up|3|||
44360946|NCT00894556|79366411|FG002|Treatment Phase|Lost to Follow-up|1|||
44360947|NCT00894556|79366412|FG003|Treatment Phase|Lost to Follow-up|0|||
44264253|NCT02504268|79165129|FG002|Overall Study|Lost to Follow-up|4|||
44172870|NCT02138253|78966572|FG001|Overall Study|Withdrawal by Subject|0|||
44172871|NCT02514473|78966580|FG000|Overall Study|Adverse Event|0|||
44172872|NCT02514473|78966581|FG001|Overall Study|Adverse Event|2|||
44360948|NCT00894556|79366409|FG000|Treatment Phase|Lack of Qualifying Event|2|||
44172873|NCT02514473|78966580|FG000|Overall Study|Withdrawal by Subject|2|||
44172874|NCT02514473|78966581|FG001|Overall Study|Withdrawal by Subject|1|||
44360949|NCT00894556|79366410|FG001|Treatment Phase|Lack of Qualifying Event|1|||
44360950|NCT00894556|79366411|FG002|Treatment Phase|Lack of Qualifying Event|0|||
44360951|NCT00894556|79366412|FG003|Treatment Phase|Lack of Qualifying Event|0|||
44172875|NCT02514473|78966580|FG000|Overall Study|Lost to Follow-up|0|||
44172876|NCT02514473|78966581|FG001|Overall Study|Lost to Follow-up|1|||
44172877|NCT02514473|78966580|FG000|Overall Study|Other|1|||
44172878|NCT02514473|78966581|FG001|Overall Study|Other|1|||
44172879|NCT02513771|78966590|FG000|Overall Study|Lost to Follow-up|1|||
44172880|NCT02513771|78966591|FG001|Overall Study|Lost to Follow-up|1|||
44172881|NCT02513771|78966590|FG000|Overall Study|Not being able to get to clinic|1|||
44172882|NCT02513771|78966591|FG001|Overall Study|Not being able to get to clinic|0|||
44172883|NCT02104947|78966599|FG000|Overall Study|Withdrawal by Subject|10|||
44172884|NCT02104947|78966600|FG001|Overall Study|Withdrawal by Subject|3|||
44172885|NCT02104947|78966599|FG000|Overall Study|Lost to Follow-up|4|||
44172886|NCT02104947|78966600|FG001|Overall Study|Lost to Follow-up|4|||
44264254|NCT02504268|79165130|FG003|Overall Study|Lost to Follow-up|0|||
44172887|NCT02104947|78966599|FG000|Overall Study|Protocol Violation|6|||
44172888|NCT02104947|78966600|FG001|Overall Study|Protocol Violation|8|||
44172889|NCT02104947|78966599|FG000|Overall Study|Adverse Event|57|||
44172890|NCT02104947|78966600|FG001|Overall Study|Adverse Event|38|||
44172891|NCT02104947|78966599|FG000|Overall Study|Other than stated above|2|||
44172892|NCT02104947|78966600|FG001|Overall Study|Other than stated above|3|||
44172893|NCT02513459|78966610|FG000|Overall Study|Adverse Event|7|||
44172894|NCT02513459|78966610|FG000|Overall Study|Withdrew consent|5|||
44172895|NCT02513459|78966610|FG000|Overall Study|Loss of efficacy|2|||
44172896|NCT02513459|78966610|FG000|Overall Study|Pregnancy|2|||
44172897|NCT02513459|78966610|FG000|Overall Study|Subject decision|2|||
44172898|NCT02513459|78966610|FG000|Overall Study|Lack of response|1|||
44172899|NCT02513459|78966610|FG000|Overall Study|Reproductive plans|1|||
44172900|NCT02513459|78966610|FG000|Overall Study|Surgery planned-- not done|1|||
44172901|NCT02104557|78966619|FG000|Overall Study|Adverse Event|24|||
44172902|NCT02104557|78966619|FG000|Overall Study|Lost to Follow-up|34|||
44172903|NCT02104557|78966619|FG000|Overall Study|Violated the usage and dosage|14|||
44172904|NCT02104557|78966619|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
44172905|NCT02104557|78966619|FG000|Overall Study|Administered Sayana prior to the contract|1|||
44172906|NCT02104557|78966619|FG000|Overall Study|Other|17|||
44172907|NCT02104557|78966619|FG000|Overall Study|Change to other contraception methods|5|||
44172908|NCT02104557|78966619|FG000|Overall Study|Discontinuation due to no pain|1|||
44172909|NCT02104557|78966619|FG000|Overall Study|Withdrawal consent|2|||
44172910|NCT02104557|78966619|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
44172911|NCT02104557|78966619|FG000|Overall Study|Discontinuation of contraception|9|||
44172912|NCT02069379|78966625|FG000|Baseline Measurements|Lost to Follow-up|1|||
44172913|NCT02069379|78966626|FG001|Baseline Measurements|Lost to Follow-up|0|||
44172914|NCT02069379|78966627|FG002|Baseline Measurements|Lost to Follow-up|0|||
44172915|NCT02069379|78966628|FG003|Baseline Measurements|Lost to Follow-up|0|||
44172916|NCT02069379|78966625|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
44172917|NCT02069379|78966626|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
44172918|NCT02069379|78966627|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
44172919|NCT02069379|78966628|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
44172920|NCT02069379|78966625|FG000|First Treatment Arm|Lost to Follow-up|0|||
44172921|NCT02069379|78966626|FG001|First Treatment Arm|Lost to Follow-up|1|||
44172922|NCT02069379|78966627|FG002|First Treatment Arm|Lost to Follow-up|1|||
44172923|NCT02069379|78966628|FG003|First Treatment Arm|Lost to Follow-up|0|||
44172924|NCT02069379|78966625|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
44172925|NCT02069379|78966626|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
44172926|NCT02069379|78966627|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
44172927|NCT02069379|78966628|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
44172928|NCT02069379|78966625|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
44172929|NCT02069379|78966626|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
44172930|NCT02069379|78966627|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
44172931|NCT02069379|78966628|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
44172932|NCT02069379|78966625|FG000|Second Treatment Arm|Lost to Follow-up|0|||
44172933|NCT02069379|78966626|FG001|Second Treatment Arm|Lost to Follow-up|0|||
44172934|NCT02069379|78966627|FG002|Second Treatment Arm|Lost to Follow-up|1|||
44172935|NCT02069379|78966628|FG003|Second Treatment Arm|Lost to Follow-up|0|||
44172936|NCT02511431|78966644|FG000|Treatment|Lost to Follow-up|0|||
44172937|NCT02511431|78966645|FG001|Treatment|Lost to Follow-up|0|||
44172938|NCT02511431|78966646|FG002|Treatment|Lost to Follow-up|1|||
44172939|NCT02511431|78966647|FG003|Treatment|Lost to Follow-up|0|||
44172940|NCT02511431|78966648|FG004|Treatment|Lost to Follow-up|0|||
44172941|NCT02511431|78966649|FG005|Treatment|Lost to Follow-up|1|||
44172942|NCT02137785|78966666|FG000|Overall Study|Lost to Follow-up|1|||
44172943|NCT02137785|78966667|FG001|Overall Study|Lost to Follow-up|0|||
44172944|NCT02137785|78966666|FG000|Overall Study|Withdrawal by Subject|1|||
44172945|NCT02137785|78966667|FG001|Overall Study|Withdrawal by Subject|4|||
44172946|NCT02137785|78966666|FG000|Overall Study|subject moved out of state|1|||
44172947|NCT02137785|78966667|FG001|Overall Study|subject moved out of state|0|||
44172948|NCT01655069|78966677|FG000|Overall Study|Physician Decision|0|||
44172949|NCT01655069|78966678|FG001|Overall Study|Physician Decision|0|||
44172950|NCT01655069|78966679|FG002|Overall Study|Physician Decision|0|||
44172951|NCT01655069|78966680|FG003|Overall Study|Physician Decision|1|||
44172952|NCT01655069|78966677|FG000|Overall Study|Adverse Event|6|||
44172953|NCT01655069|78966678|FG001|Overall Study|Adverse Event|7|||
44172954|NCT01655069|78966679|FG002|Overall Study|Adverse Event|2|||
44172955|NCT01655069|78966680|FG003|Overall Study|Adverse Event|3|||
44172956|NCT01655069|78966677|FG000|Overall Study|Lack of Efficacy|0|||
44172957|NCT01655069|78966678|FG001|Overall Study|Lack of Efficacy|1|||
44172958|NCT01655069|78966679|FG002|Overall Study|Lack of Efficacy|0|||
44172959|NCT01655069|78966680|FG003|Overall Study|Lack of Efficacy|0|||
44172960|NCT01655069|78966677|FG000|Overall Study|No Treatment Needed|0|||
44172961|NCT01655069|78966678|FG001|Overall Study|No Treatment Needed|1|||
44172962|NCT01655069|78966679|FG002|Overall Study|No Treatment Needed|0|||
44172963|NCT01655069|78966680|FG003|Overall Study|No Treatment Needed|0|||
44172964|NCT01655069|78966677|FG000|Overall Study|Withdrawal by Subject|2|||
44172965|NCT01655069|78966678|FG001|Overall Study|Withdrawal by Subject|3|||
44172966|NCT01655069|78966679|FG002|Overall Study|Withdrawal by Subject|0|||
44172967|NCT01655069|78966680|FG003|Overall Study|Withdrawal by Subject|0|||
44360952|NCT01210352|79366428|FG000|Overall Study|Adverse Event|0|||
44360953|NCT01210352|79366429|FG001|Overall Study|Adverse Event|0|||
44172968|NCT02068599|78966691|FG000|Overall Study|Adverse Event|4|||
44172969|NCT02068599|78966692|FG001|Overall Study|Adverse Event|1|||
44360954|NCT01210352|79366430|FG002|Overall Study|Adverse Event|0|||
44172970|NCT02068599|78966693|FG002|Overall Study|Adverse Event|1|||
44172971|NCT02068599|78966691|FG000|Overall Study|Withdrawal by Subject|2|||
44172972|NCT02068599|78966692|FG001|Overall Study|Withdrawal by Subject|7|||
44172973|NCT02068599|78966693|FG002|Overall Study|Withdrawal by Subject|5|||
44172974|NCT02068599|78966691|FG000|Overall Study|Protocol Violation|4|||
44172975|NCT02068599|78966692|FG001|Overall Study|Protocol Violation|2|||
44172976|NCT02068599|78966693|FG002|Overall Study|Protocol Violation|3|||
44172977|NCT02068599|78966691|FG000|Overall Study|Lost to Follow-up|1|||
44172978|NCT02068599|78966692|FG001|Overall Study|Lost to Follow-up|0|||
44172979|NCT02068599|78966693|FG002|Overall Study|Lost to Follow-up|0|||
44172980|NCT02068599|78966691|FG000|Overall Study|Lack of Efficacy|0|||
44172981|NCT02068599|78966692|FG001|Overall Study|Lack of Efficacy|0|||
44172982|NCT02068599|78966693|FG002|Overall Study|Lack of Efficacy|3|||
44172983|NCT02068599|78966691|FG000|Overall Study|Noncompliance|0|||
44172984|NCT02068599|78966692|FG001|Overall Study|Noncompliance|0|||
44172985|NCT02068599|78966693|FG002|Overall Study|Noncompliance|1|||
44172986|NCT01654601|78966703|FG000|1st Administration|Withdrawal by Subject|2|||
44172987|NCT01654601|78966704|FG001|1st Administration|Withdrawal by Subject|0|||
44172988|NCT01654601|78966703|FG000|1st Administration|Protocol Violation|0|||
44172989|NCT01654601|78966704|FG001|1st Administration|Protocol Violation|2|||
44172990|NCT01654601|78966703|FG000|2nd Administration|Adverse Event|1|||
44172991|NCT01654601|78966704|FG001|2nd Administration|Adverse Event|0|||
44172992|NCT01654601|78966703|FG000|2nd Administration|Protocol Violation|0|||
44172993|NCT01654601|78966704|FG001|2nd Administration|Protocol Violation|1|||
44172994|NCT01654523|78966710|FG000|Overall Study|Withdrawal by Subject|1|||
44172995|NCT02508935|78966714|FG000|Overall Study|Withdrawal by Subject|1|||
44172996|NCT02508935|78966714|FG000|Overall Study|Withdrawal by Caregiver|8|||
44172997|NCT02508935|78966714|FG000|Overall Study|Pain Score <4|1|||
44172998|NCT02508935|78966714|FG000|Overall Study|Emesis|3|||
44172999|NCT02508935|78966714|FG000|Overall Study|Adverse Event|3|||
44173000|NCT02508935|78966714|FG000|Overall Study|Protocol Violation|1|||
44173001|NCT02508935|78966714|FG000|Overall Study|Physician Decision|1|||
44173002|NCT02508935|78966714|FG000|Overall Study|Trial terminated by sponsor|5|||
44173003|NCT02508701|78966724|FG000|Overall Study|Lost to Follow-up|9|||
44173004|NCT02508701|78966725|FG001|Overall Study|Lost to Follow-up|5|||
44173005|NCT02508701|78966726|FG002|Overall Study|Lost to Follow-up|5|||
44173006|NCT02508701|78966727|FG003|Overall Study|Lost to Follow-up|3|||
44173007|NCT02507375|78966743|FG000|Overall Study|Progressive Disease|4|||
44173008|NCT02507375|78966744|FG001|Overall Study|Progressive Disease|5|||
44173009|NCT02507375|78966743|FG000|Overall Study|Death|0|||
44173010|NCT02507375|78966744|FG001|Overall Study|Death|1|||
44173011|NCT02507375|78966743|FG000|Overall Study|Refused treatment|0|||
44173012|NCT02507375|78966744|FG001|Overall Study|Refused treatment|1|||
44173013|NCT02507375|78966743|FG000|Overall Study|Adverse Event|0|||
44173014|NCT02507375|78966744|FG001|Overall Study|Adverse Event|1|||
44173015|NCT02507219|78966754|FG000|Overall Study|Physician Decision|1|||
44173016|NCT02507219|78966755|FG001|Overall Study|Physician Decision|0|||
44173017|NCT02507219|78966756|FG002|Overall Study|Physician Decision|0|||
44360955|NCT01210352|79366431|FG003|Overall Study|Adverse Event|0|||
44360956|NCT01210352|79366432|FG004|Overall Study|Adverse Event|0|||
44360957|NCT01210352|79366433|FG005|Overall Study|Adverse Event|0|||
44173018|NCT02507219|78966757|FG003|Overall Study|Physician Decision|0|||
44173019|NCT02507219|78966758|FG004|Overall Study|Physician Decision|0|||
44173020|NCT02507219|78966759|FG005|Overall Study|Physician Decision|0|||
44173021|NCT02507219|78966754|FG000|Overall Study|Withdrawal by Subject|0|||
44173022|NCT02507219|78966755|FG001|Overall Study|Withdrawal by Subject|0|||
44173023|NCT02507219|78966756|FG002|Overall Study|Withdrawal by Subject|0|||
44173024|NCT02507219|78966757|FG003|Overall Study|Withdrawal by Subject|0|||
44360958|NCT01210352|79366434|FG006|Overall Study|Adverse Event|0|||
44360959|NCT01210352|79366435|FG007|Overall Study|Adverse Event|2|||
44173025|NCT02507219|78966758|FG004|Overall Study|Withdrawal by Subject|1|||
44360960|NCT01210352|79366436|FG008|Overall Study|Adverse Event|1|||
44173026|NCT02507219|78966759|FG005|Overall Study|Withdrawal by Subject|0|||
44173027|NCT02483975|78966769|FG000|Overall Study|Adverse Event|0|||
44173028|NCT02483975|78966770|FG001|Overall Study|Adverse Event|1|||
44173029|NCT02483975|78966769|FG000|Overall Study|Lost to Follow-up|0|||
44173030|NCT02483975|78966770|FG001|Overall Study|Lost to Follow-up|1|||
44173031|NCT02483975|78966769|FG000|Overall Study|Physician Decision|2|||
44173032|NCT02483975|78966770|FG001|Overall Study|Physician Decision|0|||
44173033|NCT02047227|78966781|FG000|Overall Study|Adverse Event|2|||
44173034|NCT02047227|78966782|FG001|Overall Study|Adverse Event|4|||
44173035|NCT02047227|78966781|FG000|Overall Study|Lost to Follow-up|0|||
44173036|NCT02047227|78966782|FG001|Overall Study|Lost to Follow-up|3|||
44173037|NCT02047227|78966781|FG000|Overall Study|Protocol Violation|1|||
44173038|NCT02047227|78966782|FG001|Overall Study|Protocol Violation|0|||
44173039|NCT02047227|78966781|FG000|Overall Study|Spontaneous pregnancy|1|||
44173040|NCT02047227|78966782|FG001|Overall Study|Spontaneous pregnancy|0|||
44173041|NCT02047227|78966781|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
44173042|NCT02047227|78966782|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
44173043|NCT02047227|78966781|FG000|Overall Study|No oocytes retrieved|21|||
44173044|NCT02047227|78966782|FG001|Overall Study|No oocytes retrieved|20|||
44173045|NCT02047227|78966781|FG000|Overall Study|No fertilization|61|||
44173046|NCT02047227|78966782|FG001|Overall Study|No fertilization|51|||
44173047|NCT02047227|78966781|FG000|Overall Study|Intention to freeze all embryos|1|||
44173048|NCT02047227|78966782|FG001|Overall Study|Intention to freeze all embryos|0|||
44173049|NCT02047227|78966781|FG000|Overall Study|All embryos discarded|12|||
44173050|NCT02047227|78966782|FG001|Overall Study|All embryos discarded|11|||
44173051|NCT02047227|78966781|FG000|Overall Study|Other|10|||
44264255|NCT02504268|79165131|FG004|Overall Study|Lost to Follow-up|0|||
44264256|NCT02504268|79165132|FG005|Overall Study|Lost to Follow-up|0|||
44264257|NCT02504268|79165133|FG006|Overall Study|Lost to Follow-up|0|||
44264258|NCT02504268|79165134|FG007|Overall Study|Lost to Follow-up|0|||
44264259|NCT02504268|79165135|FG008|Overall Study|Lost to Follow-up|0|||
44264260|NCT02504268|79165127|FG000|Overall Study|Death|1|||
44264261|NCT02504268|79165128|FG001|Overall Study|Death|1|||
44264262|NCT02504268|79165129|FG002|Overall Study|Death|0|||
44264263|NCT02504268|79165130|FG003|Overall Study|Death|0|||
44264264|NCT02504268|79165131|FG004|Overall Study|Death|0|||
44264265|NCT02504268|79165132|FG005|Overall Study|Death|0|||
44264266|NCT02504268|79165133|FG006|Overall Study|Death|0|||
44264267|NCT02504268|79165134|FG007|Overall Study|Death|0|||
44264268|NCT02504268|79165135|FG008|Overall Study|Death|0|||
44264269|NCT02504268|79165127|FG000|Overall Study|Subject Request to Discontinue|11|||
44264270|NCT02504268|79165128|FG001|Overall Study|Subject Request to Discontinue|3|||
44264271|NCT02504268|79165129|FG002|Overall Study|Subject Request to Discontinue|6|||
44264272|NCT02504268|79165130|FG003|Overall Study|Subject Request to Discontinue|0|||
44264273|NCT02504268|79165131|FG004|Overall Study|Subject Request to Discontinue|0|||
44264274|NCT02504268|79165132|FG005|Overall Study|Subject Request to Discontinue|0|||
44264275|NCT02504268|79165133|FG006|Overall Study|Subject Request to Discontinue|0|||
44264276|NCT02504268|79165134|FG007|Overall Study|Subject Request to Discontinue|0|||
44264277|NCT02504268|79165135|FG008|Overall Study|Subject Request to Discontinue|0|||
44264278|NCT02504268|79165127|FG000|Overall Study|No Longer Meets Study Criteria|2|||
44264279|NCT02504268|79165128|FG001|Overall Study|No Longer Meets Study Criteria|3|||
44264280|NCT02504268|79165129|FG002|Overall Study|No Longer Meets Study Criteria|0|||
44173052|NCT02047227|78966782|FG001|Overall Study|Other|9|||
44173053|NCT02483585|78966790|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
44264281|NCT02504268|79165130|FG003|Overall Study|No Longer Meets Study Criteria|0|||
44264282|NCT02504268|79165131|FG004|Overall Study|No Longer Meets Study Criteria|0|||
44264283|NCT02504268|79165132|FG005|Overall Study|No Longer Meets Study Criteria|0|||
44264284|NCT02504268|79165133|FG006|Overall Study|No Longer Meets Study Criteria|0|||
44360961|NCT01210352|79366428|FG000|Overall Study|Lack of Efficacy|0|||
44173054|NCT02483585|78966791|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
44173055|NCT02483585|78966790|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
44264285|NCT02504268|79165134|FG007|Overall Study|No Longer Meets Study Criteria|0|||
44264286|NCT02504268|79165135|FG008|Overall Study|No Longer Meets Study Criteria|0|||
44264287|NCT02504268|79165127|FG000|Overall Study|Lack of Efficacy|11|||
44264288|NCT02504268|79165128|FG001|Overall Study|Lack of Efficacy|35|||
44173056|NCT02483585|78966791|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
44173057|NCT02483585|78966790|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
44173058|NCT02483585|78966791|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
44173059|NCT02483585|78966790|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
44173060|NCT02483585|78966791|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
44173061|NCT02483585|78966790|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
44173062|NCT02483585|78966791|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
44173063|NCT02483585|78966790|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
44173064|NCT02483585|78966791|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
44173065|NCT02483585|78966790|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
44173066|NCT02483585|78966791|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
44173067|NCT02046993|78966803|FG000|Overall Study|Withdrawal by Subject|2|||
44173068|NCT02046993|78966804|FG001|Overall Study|Withdrawal by Subject|10|||
44173069|NCT02046993|78966803|FG000|Overall Study|Lost to Follow-up|1|||
44173070|NCT02046993|78966804|FG001|Overall Study|Lost to Follow-up|1|||
44173071|NCT02101983|78966814|FG000|Overall Study|Physician Decision|1|||
44173072|NCT02101983|78966815|FG001|Overall Study|Physician Decision|0|||
44173073|NCT02482805|78966824|FG000|Overall Study|Lost to Follow-up|4|||
44173074|NCT02482805|78966825|FG001|Overall Study|Lost to Follow-up|4|||
44173075|NCT02482805|78966826|FG002|Overall Study|Lost to Follow-up|0|||
44173076|NCT02503865|78966837|FG000|Overall Study|Moved out of area|1|||
44173077|NCT02503865|78966838|FG001|Overall Study|Moved out of area|8|||
44173078|NCT02503865|78966839|FG002|Overall Study|Moved out of area|0|||
44173079|NCT02503865|78966837|FG000|Overall Study|Refused treatment|4|||
44173080|NCT02503865|78966838|FG001|Overall Study|Refused treatment|39|||
44173081|NCT02503865|78966839|FG002|Overall Study|Refused treatment|2|||
44173082|NCT01623531|78966850|FG000|Overall Study|Death|1|||
44173083|NCT01623531|78966851|FG001|Overall Study|Death|0|||
44173084|NCT01623531|78966850|FG000|Overall Study|Protocol Violation|2|||
44173085|NCT01623531|78966851|FG001|Overall Study|Protocol Violation|1|||
44173086|NCT01623531|78966850|FG000|Overall Study|Missing data at primary outcome time poi|1|||
44173087|NCT01623531|78966851|FG001|Overall Study|Missing data at primary outcome time poi|1|||
44173088|NCT02503787|78966860|FG000|Enrollment|Withdrawal by Subject|6|||
44173089|NCT02503787|78966860|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
44173090|NCT02503787|78966860|FG000|Enrollment|Physician Decision|2|||
44173091|NCT02503787|78966860|FG000|Enrollment|Insurance issue|2|||
44173092|NCT02503787|78966860|FG000|Enrollment|Lost to Follow-up|1|||
44173093|NCT02503787|78966860|FG000|Enrollment|Study closure|1|||
44173094|NCT02503787|78966860|FG000|Enrollment|Adverse Event|1|||
44173095|NCT02503787|78966860|FG000|Enrollment|Protocol Violation|1|||
44173096|NCT02503787|78966860|FG000|Enrollment|Inability to implant system|1|||
44173097|NCT02503787|78966860|FG000|Enrollment|Unable to be programmed|1|||
44173098|NCT02503787|78966860|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
44173099|NCT02503787|78966860|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
44173100|NCT02503787|78966860|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
44173101|NCT02503787|78966860|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
44173102|NCT02503787|78966860|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
44173103|NCT02503787|78966860|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
44173104|NCT02482571|78966864|FG000|Overall Study|Adverse Event|1|||
44173105|NCT02482571|78966864|FG000|Overall Study|Scanner or Respiract failure|3|||
44173106|NCT02482571|78966864|FG000|Overall Study|Withdrawal by Subject|4|||
44173107|NCT02481947|78966871|FG000|Overall Study|Withdrawal by Subject|24|||
44173108|NCT02481947|78966872|FG001|Overall Study|Withdrawal by Subject|10|||
44173109|NCT02481947|78966871|FG000|Overall Study|Lost to Follow-up|11|||
44173110|NCT02481947|78966872|FG001|Overall Study|Lost to Follow-up|5|||
44173111|NCT02481947|78966871|FG000|Overall Study|Adverse Event|6|||
44173112|NCT02481947|78966872|FG001|Overall Study|Adverse Event|11|||
44173113|NCT02481947|78966871|FG000|Overall Study|Physician Decision|4|||
44173114|NCT02481947|78966872|FG001|Overall Study|Physician Decision|5|||
44173115|NCT02481947|78966871|FG000|Overall Study|Protocol Violation|1|||
44173116|NCT02481947|78966872|FG001|Overall Study|Protocol Violation|5|||
44173117|NCT02503085|78966878|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
44173118|NCT02503085|78966879|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
44173119|NCT02503085|78966880|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
44173120|NCT02503085|78966881|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
44173121|NCT02481869|78966890|FG000|Overall Study|Lost to Follow-up|3|||
44173122|NCT02481869|78966891|FG001|Overall Study|Lost to Follow-up|4|||
44173123|NCT02481869|78966890|FG000|Overall Study|Withdrawal by Subject|2|||
44173124|NCT02481869|78966891|FG001|Overall Study|Withdrawal by Subject|0|||
44173125|NCT02502149|78966898|FG000|Intermediate|Discontinued prematurely|1|||
44173126|NCT02502149|78966899|FG001|Intermediate|Discontinued prematurely|0|||
44173127|NCT02502149|78966900|FG002|Intermediate|Discontinued prematurely|0|||
44173128|NCT02502149|78966901|FG003|Intermediate|Discontinued prematurely|0|||
44173129|NCT02502149|78966902|FG004|Intermediate|Discontinued prematurely|0|||
44173130|NCT02480621|78966921|FG000|Randomization|Withdrawal by Subject|1|||
44173131|NCT02480621|78966922|FG001|Randomization|Withdrawal by Subject|0|||
44173132|NCT02480621|78966921|FG000|Randomization|Surgeon did not give intervention|0|||
44173133|NCT02480621|78966922|FG001|Randomization|Surgeon did not give intervention|1|||
44173134|NCT02480621|78966921|FG000|Follow Up|Lost to Follow-up|4|||
44173135|NCT02480621|78966922|FG001|Follow Up|Lost to Follow-up|2|||
44173136|NCT02046603|78966930|FG000|Overall Study|Other|11|||
44173137|NCT02046603|78966931|FG001|Overall Study|Other|66|||
44173138|NCT02046603|78966930|FG000|Overall Study|Protocol Violation|0|||
44264289|NCT02504268|79165129|FG002|Overall Study|Lack of Efficacy|9|||
44173139|NCT02046603|78966931|FG001|Overall Study|Protocol Violation|1|||
44173140|NCT02046603|78966930|FG000|Overall Study|Participant/legal guardian decision|1|||
44264290|NCT02504268|79165130|FG003|Overall Study|Lack of Efficacy|0|||
44173141|NCT02046603|78966931|FG001|Overall Study|Participant/legal guardian decision|3|||
44173142|NCT02046603|78966930|FG000|Overall Study|Physician Decision|2|||
44173143|NCT02046603|78966931|FG001|Overall Study|Physician Decision|1|||
44360962|NCT01210352|79366429|FG001|Overall Study|Lack of Efficacy|0|||
44173144|NCT02046603|78966930|FG000|Overall Study|Lost to Follow-up|1|||
44173145|NCT02046603|78966931|FG001|Overall Study|Lost to Follow-up|2|||
44173146|NCT02046603|78966930|FG000|Overall Study|Death|0|||
44173147|NCT02046603|78966931|FG001|Overall Study|Death|1|||
44173148|NCT02046603|78966930|FG000|Overall Study|Adverse Event|0|||
44173149|NCT02046603|78966931|FG001|Overall Study|Adverse Event|1|||
44173150|NCT01885078|78966946|FG000|Treatment Period|Adverse Event|52|||
44173151|NCT01885078|78966947|FG001|Treatment Period|Adverse Event|136|||
44173152|NCT01885078|78966948|FG002|Treatment Period|Adverse Event|30|||
44173153|NCT01885078|78966949|FG003|Treatment Period|Adverse Event|73|||
44173154|NCT01885078|78966950|FG004|Treatment Period|Adverse Event|17|||
44360963|NCT01210352|79366430|FG002|Overall Study|Lack of Efficacy|0|||
44173155|NCT01885078|78966951|FG005|Treatment Period|Adverse Event|72|||
44173156|NCT01885078|78966952|FG006|Treatment Period|Adverse Event|24|||
44360964|NCT01210352|79366431|FG003|Overall Study|Lack of Efficacy|0|||
44173157|NCT01885078|78966953|FG007|Treatment Period|Adverse Event|5|||
44173158|NCT01885078|78966954|FG008|Treatment Period|Adverse Event|0|||
44173159|NCT01885078|78966955|FG009|Treatment Period|Adverse Event|0|||
44543025|NCT03655717|79555902|FG002|Overall Study|Lost to Follow-up|0|||
44173160|NCT01885078|78966946|FG000|Treatment Period|Death|13|||
44173161|NCT01885078|78966947|FG001|Treatment Period|Death|33|||
44173162|NCT01885078|78966948|FG002|Treatment Period|Death|5|||
44173163|NCT01885078|78966949|FG003|Treatment Period|Death|9|||
44173164|NCT01885078|78966950|FG004|Treatment Period|Death|2|||
44173165|NCT01885078|78966951|FG005|Treatment Period|Death|10|||
44173166|NCT01885078|78966952|FG006|Treatment Period|Death|3|||
44173167|NCT01885078|78966953|FG007|Treatment Period|Death|2|||
44173168|NCT01885078|78966954|FG008|Treatment Period|Death|0|||
44264291|NCT02504268|79165131|FG004|Overall Study|Lack of Efficacy|0|||
44264292|NCT02504268|79165132|FG005|Overall Study|Lack of Efficacy|0|||
44264293|NCT02504268|79165133|FG006|Overall Study|Lack of Efficacy|0|||
44264294|NCT02504268|79165134|FG007|Overall Study|Lack of Efficacy|0|||
44264295|NCT02504268|79165135|FG008|Overall Study|Lack of Efficacy|0|||
44264296|NCT02504268|79165127|FG000|Overall Study|Poor/Non-Compliance|3|||
44173169|NCT01885078|78966955|FG009|Treatment Period|Death|0|||
44173170|NCT01885078|78966946|FG000|Treatment Period|Lack of Efficacy|12|||
44173171|NCT01885078|78966947|FG001|Treatment Period|Lack of Efficacy|33|||
44173172|NCT01885078|78966948|FG002|Treatment Period|Lack of Efficacy|10|||
44173173|NCT01885078|78966949|FG003|Treatment Period|Lack of Efficacy|23|||
44173174|NCT01885078|78966950|FG004|Treatment Period|Lack of Efficacy|24|||
44173175|NCT01885078|78966951|FG005|Treatment Period|Lack of Efficacy|58|||
44173176|NCT01885078|78966952|FG006|Treatment Period|Lack of Efficacy|9|||
44173177|NCT01885078|78966953|FG007|Treatment Period|Lack of Efficacy|5|||
44173178|NCT01885078|78966954|FG008|Treatment Period|Lack of Efficacy|0|||
44173179|NCT01885078|78966955|FG009|Treatment Period|Lack of Efficacy|0|||
44264297|NCT02504268|79165128|FG001|Overall Study|Poor/Non-Compliance|2|||
44173180|NCT01885078|78966946|FG000|Treatment Period|Lost to Follow-up|16|||
44173181|NCT01885078|78966947|FG001|Treatment Period|Lost to Follow-up|19|||
44173182|NCT01885078|78966948|FG002|Treatment Period|Lost to Follow-up|7|||
44264298|NCT02504268|79165129|FG002|Overall Study|Poor/Non-Compliance|3|||
44173183|NCT01885078|78966949|FG003|Treatment Period|Lost to Follow-up|9|||
44173184|NCT01885078|78966950|FG004|Treatment Period|Lost to Follow-up|2|||
44173185|NCT01885078|78966951|FG005|Treatment Period|Lost to Follow-up|8|||
44173186|NCT01885078|78966952|FG006|Treatment Period|Lost to Follow-up|2|||
44173187|NCT01885078|78966953|FG007|Treatment Period|Lost to Follow-up|0|||
44173188|NCT01885078|78966954|FG008|Treatment Period|Lost to Follow-up|0|||
44173189|NCT01885078|78966955|FG009|Treatment Period|Lost to Follow-up|0|||
44173190|NCT01885078|78966946|FG000|Treatment Period|Physician Decision|19|||
44173191|NCT01885078|78966947|FG001|Treatment Period|Physician Decision|21|||
44173192|NCT01885078|78966948|FG002|Treatment Period|Physician Decision|5|||
44264299|NCT02504268|79165130|FG003|Overall Study|Poor/Non-Compliance|0|||
44451015|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
44451016|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
44451017|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
44451018|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
44451019|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
44451020|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
44451021|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
44173193|NCT01885078|78966949|FG003|Treatment Period|Physician Decision|12|||
44264300|NCT02504268|79165131|FG004|Overall Study|Poor/Non-Compliance|0|||
44264301|NCT02504268|79165132|FG005|Overall Study|Poor/Non-Compliance|0|||
44264302|NCT02504268|79165133|FG006|Overall Study|Poor/Non-Compliance|0|||
44264303|NCT02504268|79165134|FG007|Overall Study|Poor/Non-Compliance|0|||
44264304|NCT02504268|79165135|FG008|Overall Study|Poor/Non-Compliance|0|||
44264305|NCT02504268|79165127|FG000|Overall Study|Not Disclosed|1|||
44264306|NCT02504268|79165128|FG001|Overall Study|Not Disclosed|0|||
44264307|NCT02504268|79165129|FG002|Overall Study|Not Disclosed|2|||
44264308|NCT02504268|79165130|FG003|Overall Study|Not Disclosed|0|||
44173194|NCT01885078|78966950|FG004|Treatment Period|Physician Decision|9|||
44173195|NCT01885078|78966951|FG005|Treatment Period|Physician Decision|24|||
44173196|NCT01885078|78966952|FG006|Treatment Period|Physician Decision|4|||
44173197|NCT01885078|78966953|FG007|Treatment Period|Physician Decision|3|||
44173198|NCT01885078|78966954|FG008|Treatment Period|Physician Decision|0|||
44173199|NCT01885078|78966955|FG009|Treatment Period|Physician Decision|0|||
44173200|NCT01885078|78966946|FG000|Treatment Period|Protocol Violation|3|||
44173201|NCT01885078|78966947|FG001|Treatment Period|Protocol Violation|5|||
44173202|NCT01885078|78966948|FG002|Treatment Period|Protocol Violation|0|||
44173203|NCT01885078|78966949|FG003|Treatment Period|Protocol Violation|3|||
44173204|NCT01885078|78966950|FG004|Treatment Period|Protocol Violation|1|||
44173205|NCT01885078|78966951|FG005|Treatment Period|Protocol Violation|6|||
44173206|NCT01885078|78966952|FG006|Treatment Period|Protocol Violation|0|||
44173207|NCT01885078|78966953|FG007|Treatment Period|Protocol Violation|0|||
44360965|NCT01210352|79366432|FG004|Overall Study|Lack of Efficacy|0|||
44360966|NCT01210352|79366433|FG005|Overall Study|Lack of Efficacy|0|||
44360967|NCT01210352|79366434|FG006|Overall Study|Lack of Efficacy|1|||
44173208|NCT01885078|78966954|FG008|Treatment Period|Protocol Violation|0|||
44173209|NCT01885078|78966955|FG009|Treatment Period|Protocol Violation|0|||
44173210|NCT01885078|78966946|FG000|Treatment Period|Sponsor Decision|245|||
44173211|NCT01885078|78966947|FG001|Treatment Period|Sponsor Decision|648|||
44173212|NCT01885078|78966948|FG002|Treatment Period|Sponsor Decision|49|||
44360968|NCT01210352|79366435|FG007|Overall Study|Lack of Efficacy|0|||
44264309|NCT02504268|79165131|FG004|Overall Study|Not Disclosed|0|||
44264310|NCT02504268|79165132|FG005|Overall Study|Not Disclosed|0|||
44264311|NCT02504268|79165133|FG006|Overall Study|Not Disclosed|0|||
44264312|NCT02504268|79165134|FG007|Overall Study|Not Disclosed|0|||
44264313|NCT02504268|79165135|FG008|Overall Study|Not Disclosed|0|||
44264314|NCT01654302|79165179|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
44264315|NCT01654302|79165180|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
44264316|NCT02476422|79165196|FG000|Overall Study|Subject/guardian decision|0|||
44264317|NCT02476422|79165197|FG001|Overall Study|Subject/guardian decision|1|||
44264318|NCT02475564|79165227|FG000|Overall Study|Withdrawal by Subject|1|||
44264319|NCT02475564|79165228|FG001|Overall Study|Withdrawal by Subject|0|||
44264320|NCT02475564|79165227|FG000|Overall Study|Lost to Follow-up|2|||
44264321|NCT02475564|79165228|FG001|Overall Study|Lost to Follow-up|1|||
44264322|NCT02475564|79165227|FG000|Overall Study|Intense Menstrual bleeding|1|||
44264323|NCT02475564|79165228|FG001|Overall Study|Intense Menstrual bleeding|0|||
44264324|NCT02503332|79165516|FG000|Overall Study|Adverse Event|17|||
44264325|NCT02503332|79165517|FG001|Overall Study|Adverse Event|5|||
44264326|NCT02503332|79165518|FG002|Overall Study|Adverse Event|3|||
44173213|NCT01885078|78966949|FG003|Treatment Period|Sponsor Decision|90|||
44173214|NCT01885078|78966950|FG004|Treatment Period|Sponsor Decision|20|||
44173215|NCT01885078|78966951|FG005|Treatment Period|Sponsor Decision|38|||
44173216|NCT01885078|78966952|FG006|Treatment Period|Sponsor Decision|162|||
44173217|NCT01885078|78966953|FG007|Treatment Period|Sponsor Decision|3|||
44173218|NCT01885078|78966954|FG008|Treatment Period|Sponsor Decision|0|||
44173219|NCT01885078|78966955|FG009|Treatment Period|Sponsor Decision|0|||
44173220|NCT01885078|78966946|FG000|Treatment Period|Withdrawal by Subject|72|||
44173221|NCT01885078|78966947|FG001|Treatment Period|Withdrawal by Subject|132|||
44173222|NCT01885078|78966948|FG002|Treatment Period|Withdrawal by Subject|25|||
44173223|NCT01885078|78966949|FG003|Treatment Period|Withdrawal by Subject|63|||
44173224|NCT01885078|78966950|FG004|Treatment Period|Withdrawal by Subject|15|||
44173225|NCT01885078|78966951|FG005|Treatment Period|Withdrawal by Subject|34|||
44173226|NCT01885078|78966952|FG006|Treatment Period|Withdrawal by Subject|17|||
44173227|NCT01885078|78966953|FG007|Treatment Period|Withdrawal by Subject|10|||
44173228|NCT01885078|78966954|FG008|Treatment Period|Withdrawal by Subject|0|||
44173229|NCT01885078|78966955|FG009|Treatment Period|Withdrawal by Subject|0|||
44173230|NCT01885078|78966946|FG000|Treatment Period|Other|0|||
44173231|NCT01885078|78966947|FG001|Treatment Period|Other|0|||
44173232|NCT01885078|78966948|FG002|Treatment Period|Other|0|||
44173233|NCT01885078|78966949|FG003|Treatment Period|Other|1|||
44173234|NCT01885078|78966950|FG004|Treatment Period|Other|0|||
44264327|NCT02503332|79165519|FG003|Overall Study|Adverse Event|1|||
44173235|NCT01885078|78966951|FG005|Treatment Period|Other|0|||
44173236|NCT01885078|78966952|FG006|Treatment Period|Other|0|||
44173237|NCT01885078|78966953|FG007|Treatment Period|Other|0|||
44173238|NCT01885078|78966954|FG008|Treatment Period|Other|0|||
44173239|NCT01885078|78966955|FG009|Treatment Period|Other|0|||
44173240|NCT01885078|78966946|FG000|Step-down Period|Sponsor Decision|0|||
44173241|NCT01885078|78966947|FG001|Step-down Period|Sponsor Decision|0|||
44173242|NCT01885078|78966948|FG002|Step-down Period|Sponsor Decision|0|||
44173243|NCT01885078|78966949|FG003|Step-down Period|Sponsor Decision|0|||
44173244|NCT01885078|78966950|FG004|Step-down Period|Sponsor Decision|0|||
44173245|NCT01885078|78966951|FG005|Step-down Period|Sponsor Decision|0|||
44173246|NCT01885078|78966952|FG006|Step-down Period|Sponsor Decision|0|||
44173247|NCT01885078|78966953|FG007|Step-down Period|Sponsor Decision|0|||
44173248|NCT01885078|78966954|FG008|Step-down Period|Sponsor Decision|1|||
44173249|NCT01885078|78966955|FG009|Step-down Period|Sponsor Decision|1|||
44173250|NCT01885078|78966946|FG000|Step-down Period|Adverse Event|0|||
44173251|NCT01885078|78966947|FG001|Step-down Period|Adverse Event|0|||
44173252|NCT01885078|78966948|FG002|Step-down Period|Adverse Event|0|||
44173253|NCT01885078|78966949|FG003|Step-down Period|Adverse Event|0|||
44173254|NCT01885078|78966950|FG004|Step-down Period|Adverse Event|0|||
44264328|NCT02503332|79165516|FG000|Overall Study|Investigator's Decision|5|||
44360969|NCT01210352|79366436|FG008|Overall Study|Lack of Efficacy|0|||
44360970|NCT01210352|79366428|FG000|Overall Study|Physician Decision|0|||
44360971|NCT01210352|79366429|FG001|Overall Study|Physician Decision|0|||
44360972|NCT01210352|79366430|FG002|Overall Study|Physician Decision|0|||
44360973|NCT01210352|79366431|FG003|Overall Study|Physician Decision|0|||
44360974|NCT01210352|79366432|FG004|Overall Study|Physician Decision|0|||
44360975|NCT01210352|79366433|FG005|Overall Study|Physician Decision|0|||
44360976|NCT01210352|79366434|FG006|Overall Study|Physician Decision|0|||
44360977|NCT01210352|79366435|FG007|Overall Study|Physician Decision|1|||
44360978|NCT01210352|79366436|FG008|Overall Study|Physician Decision|2|||
44360979|NCT01210352|79366428|FG000|Overall Study|Withdrawal by Subject|0|||
44360980|NCT01210352|79366429|FG001|Overall Study|Withdrawal by Subject|0|||
44360981|NCT01210352|79366430|FG002|Overall Study|Withdrawal by Subject|1|||
44360982|NCT01210352|79366431|FG003|Overall Study|Withdrawal by Subject|0|||
44360983|NCT01210352|79366432|FG004|Overall Study|Withdrawal by Subject|0|||
44264329|NCT02503332|79165517|FG001|Overall Study|Investigator's Decision|1|||
44264330|NCT02503332|79165518|FG002|Overall Study|Investigator's Decision|0|||
44264331|NCT02503332|79165519|FG003|Overall Study|Investigator's Decision|0|||
44264332|NCT02503332|79165516|FG000|Overall Study|Sponsor's Decision|1|||
44264333|NCT02503332|79165517|FG001|Overall Study|Sponsor's Decision|0|||
44264334|NCT02503332|79165518|FG002|Overall Study|Sponsor's Decision|0|||
44264335|NCT02503332|79165519|FG003|Overall Study|Sponsor's Decision|1|||
44264336|NCT02503332|79165516|FG000|Overall Study|Subject Request|6|||
44264337|NCT02503332|79165517|FG001|Overall Study|Subject Request|5|||
44173255|NCT01885078|78966951|FG005|Step-down Period|Adverse Event|0|||
44173256|NCT01885078|78966952|FG006|Step-down Period|Adverse Event|0|||
44173257|NCT01885078|78966953|FG007|Step-down Period|Adverse Event|0|||
44173258|NCT01885078|78966954|FG008|Step-down Period|Adverse Event|29|||
44173259|NCT01885078|78966955|FG009|Step-down Period|Adverse Event|38|||
44173260|NCT01885078|78966946|FG000|Step-down Period|Withdrawal by Subject|0|||
44173261|NCT01885078|78966947|FG001|Step-down Period|Withdrawal by Subject|0|||
44173262|NCT01885078|78966948|FG002|Step-down Period|Withdrawal by Subject|0|||
44360984|NCT01210352|79366433|FG005|Overall Study|Withdrawal by Subject|0|||
44360985|NCT01210352|79366434|FG006|Overall Study|Withdrawal by Subject|1|||
44173263|NCT01885078|78966949|FG003|Step-down Period|Withdrawal by Subject|0|||
44173264|NCT01885078|78966950|FG004|Step-down Period|Withdrawal by Subject|0|||
44173265|NCT01885078|78966951|FG005|Step-down Period|Withdrawal by Subject|0|||
44173266|NCT01885078|78966952|FG006|Step-down Period|Withdrawal by Subject|0|||
44173267|NCT01885078|78966953|FG007|Step-down Period|Withdrawal by Subject|0|||
44173268|NCT01885078|78966954|FG008|Step-down Period|Withdrawal by Subject|25|||
44264338|NCT02503332|79165518|FG002|Overall Study|Subject Request|2|||
44360986|NCT01210352|79366435|FG007|Overall Study|Withdrawal by Subject|0|||
44451022|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
44451023|NCT02677896|79459915|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
44360987|NCT01210352|79366436|FG008|Overall Study|Withdrawal by Subject|1|||
44360988|NCT01210352|79366428|FG000|Overall Study|Patient Discharged Early|0|||
44360989|NCT01210352|79366429|FG001|Overall Study|Patient Discharged Early|0|||
44451024|NCT02677896|79459916|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
44451025|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
44451026|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
44451027|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
44451028|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
44451029|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
44360990|NCT01210352|79366430|FG002|Overall Study|Patient Discharged Early|1|||
44360991|NCT01210352|79366431|FG003|Overall Study|Patient Discharged Early|0|||
44360992|NCT01210352|79366432|FG004|Overall Study|Patient Discharged Early|0|||
44360993|NCT01210352|79366433|FG005|Overall Study|Patient Discharged Early|0|||
44360994|NCT01210352|79366434|FG006|Overall Study|Patient Discharged Early|0|||
44360995|NCT01210352|79366435|FG007|Overall Study|Patient Discharged Early|0|||
44360996|NCT01210352|79366436|FG008|Overall Study|Patient Discharged Early|0|||
44360997|NCT01210118|79366543|FG000|Overall Study|Lost to Follow-up|1|||
44360998|NCT01210118|79366544|FG001|Overall Study|Lost to Follow-up|1|||
44360999|NCT01210118|79366543|FG000|Overall Study|Protocol Violation|1|||
44361000|NCT01210118|79366544|FG001|Overall Study|Protocol Violation|1|||
44361001|NCT01210118|79366543|FG000|Overall Study|Spontaneous abortion|1|||
44361002|NCT01210118|79366544|FG001|Overall Study|Spontaneous abortion|3|||
44361003|NCT01208870|79366555|FG000|Overall Study|Lost to Follow-up|2|||
44361004|NCT01208870|79366556|FG001|Overall Study|Lost to Follow-up|8|||
44361005|NCT00880555|79366567|FG000|Overall Study|Physician Decision|0|||
44361006|NCT00880555|79366568|FG001|Overall Study|Physician Decision|8|||
44361007|NCT00880555|79366569|FG002|Overall Study|Physician Decision|0|||
44361008|NCT00880555|79366570|FG003|Overall Study|Physician Decision|2|||
44361009|NCT00880555|79366571|FG004|Overall Study|Physician Decision|1|||
44361010|NCT00880555|79366572|FG005|Overall Study|Physician Decision|0|||
44361011|NCT00880555|79366567|FG000|Overall Study|Withdrawal by Subject|1|||
44361012|NCT00880555|79366568|FG001|Overall Study|Withdrawal by Subject|1|||
44361013|NCT00880555|79366569|FG002|Overall Study|Withdrawal by Subject|0|||
44361014|NCT00880555|79366570|FG003|Overall Study|Withdrawal by Subject|0|||
44361015|NCT00880555|79366571|FG004|Overall Study|Withdrawal by Subject|0|||
44361016|NCT00880555|79366572|FG005|Overall Study|Withdrawal by Subject|0|||
44361017|NCT00880555|79366567|FG000|Overall Study|Lack of resources (hired rater)|9|||
44361018|NCT00880555|79366568|FG001|Overall Study|Lack of resources (hired rater)|7|||
44361019|NCT00880555|79366569|FG002|Overall Study|Lack of resources (hired rater)|5|||
44361020|NCT00880555|79366570|FG003|Overall Study|Lack of resources (hired rater)|0|||
44361021|NCT00880555|79366571|FG004|Overall Study|Lack of resources (hired rater)|0|||
44361022|NCT00880555|79366572|FG005|Overall Study|Lack of resources (hired rater)|0|||
44361023|NCT00880555|79366567|FG000|Overall Study|Death|0|||
44361024|NCT00880555|79366568|FG001|Overall Study|Death|0|||
44361025|NCT00880555|79366569|FG002|Overall Study|Death|0|||
44361026|NCT00880555|79366570|FG003|Overall Study|Death|0|||
44361027|NCT00880555|79366571|FG004|Overall Study|Death|0|||
44361028|NCT00880555|79366572|FG005|Overall Study|Death|1|||
44361029|NCT00880555|79366567|FG000|Overall Study|Lost to Follow-up|0|||
44361030|NCT00880555|79366568|FG001|Overall Study|Lost to Follow-up|1|||
44361031|NCT00880555|79366569|FG002|Overall Study|Lost to Follow-up|0|||
44361032|NCT00880555|79366570|FG003|Overall Study|Lost to Follow-up|0|||
44361033|NCT00880555|79366571|FG004|Overall Study|Lost to Follow-up|0|||
44361034|NCT00880555|79366572|FG005|Overall Study|Lost to Follow-up|0|||
44361035|NCT01208402|79366585|FG000|Overall Study|Withdrawal by Subject|1|||
44361036|NCT01208402|79366586|FG001|Overall Study|Withdrawal by Subject|0|||
44361037|NCT01208324|79366596|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
44361038|NCT01208324|79366597|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
44361039|NCT01208324|79366598|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
44361040|NCT01208324|79366599|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
44361041|NCT00880399|79366612|FG000|Overall Study|Adverse Event|4|||
44361042|NCT00880399|79366613|FG001|Overall Study|Adverse Event|6|||
44361043|NCT00880399|79366614|FG002|Overall Study|Adverse Event|5|||
44361044|NCT00880399|79366612|FG000|Overall Study|Lack of Efficacy|1|||
44361045|NCT00880399|79366613|FG001|Overall Study|Lack of Efficacy|4|||
44361046|NCT00880399|79366614|FG002|Overall Study|Lack of Efficacy|2|||
44361047|NCT00880399|79366612|FG000|Overall Study|Protocol Violation|4|||
44361048|NCT00880399|79366613|FG001|Overall Study|Protocol Violation|4|||
44361049|NCT00880399|79366614|FG002|Overall Study|Protocol Violation|6|||
44361050|NCT00880399|79366612|FG000|Overall Study|Study closed/terminated|3|||
44361051|NCT00880399|79366613|FG001|Overall Study|Study closed/terminated|7|||
44361052|NCT00880399|79366614|FG002|Overall Study|Study closed/terminated|4|||
44361053|NCT00880399|79366612|FG000|Overall Study|Lost to Follow-up|8|||
44173269|NCT01885078|78966955|FG009|Step-down Period|Withdrawal by Subject|15|||
44173270|NCT01885078|78966946|FG000|Step-down Period|Physician Decision|0|||
44173271|NCT01885078|78966947|FG001|Step-down Period|Physician Decision|0|||
44361054|NCT00880399|79366613|FG001|Overall Study|Lost to Follow-up|5|||
44361055|NCT00880399|79366614|FG002|Overall Study|Lost to Follow-up|3|||
44361056|NCT00880399|79366612|FG000|Overall Study|Physician Decision|5|||
44361057|NCT00880399|79366613|FG001|Overall Study|Physician Decision|0|||
44361058|NCT00880399|79366614|FG002|Overall Study|Physician Decision|3|||
44361059|NCT00880399|79366612|FG000|Overall Study|Withdrawal by Subject|6|||
44361060|NCT00880399|79366613|FG001|Overall Study|Withdrawal by Subject|3|||
44361061|NCT00880399|79366614|FG002|Overall Study|Withdrawal by Subject|3|||
44361062|NCT01207388|79366622|FG000|Overall Study|Death|67|||
44361063|NCT01207388|79366622|FG000|Overall Study|Withdrawal by Subject|1|||
44361064|NCT01206764|79366634|FG000|Overall Study|Adverse Event|20|||
44361065|NCT01206764|79366634|FG000|Overall Study|Abnormal laboratory value|2|||
44361066|NCT01206764|79366634|FG000|Overall Study|Abnormal test procedure result|1|||
44361067|NCT01206764|79366634|FG000|Overall Study|Patient withdrew consent|5|||
44361068|NCT01206764|79366634|FG000|Overall Study|Lost to Follow-up|6|||
44173272|NCT01885078|78966948|FG002|Step-down Period|Physician Decision|0|||
44361069|NCT01206764|79366634|FG000|Overall Study|Death|11|||
44361070|NCT01206764|79366634|FG000|Overall Study|New cancer therapy|2|||
44361071|NCT01206764|79366634|FG000|Overall Study|Disease progression|88|||
44361072|NCT01206764|79366634|FG000|Overall Study|Protocol deviation|3|||
44361073|NCT00894322|79366641|FG000|Overall Study|Withdrawal by Subject|1|||
44361074|NCT00894322|79366642|FG001|Overall Study|Withdrawal by Subject|0|||
44361075|NCT00894322|79366643|FG002|Overall Study|Withdrawal by Subject|0|||
44361076|NCT00596635|79366656|FG000|Overall Study|Lost to Follow-up|0|||
44361077|NCT00596635|79366657|FG001|Overall Study|Lost to Follow-up|2|||
44361078|NCT00596635|79366658|FG002|Overall Study|Lost to Follow-up|0|||
44361079|NCT00596635|79366656|FG000|Overall Study|Treatment for symptomatic UTI|4|||
44361080|NCT00596635|79366657|FG001|Overall Study|Treatment for symptomatic UTI|6|||
44361081|NCT00596635|79366658|FG002|Overall Study|Treatment for symptomatic UTI|3|||
44361082|NCT00596635|79366656|FG000|Overall Study|Hip fracture|2|||
44361083|NCT00596635|79366657|FG001|Overall Study|Hip fracture|3|||
44361084|NCT00596635|79366658|FG002|Overall Study|Hip fracture|3|||
44361085|NCT00596635|79366656|FG000|Overall Study|Could not provide urine specimen|1|||
44361086|NCT00596635|79366657|FG001|Overall Study|Could not provide urine specimen|2|||
44361087|NCT00596635|79366658|FG002|Overall Study|Could not provide urine specimen|2|||
44361088|NCT00894166|79366674|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
44361089|NCT00894166|79366675|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
44361090|NCT00894166|79366676|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
44361091|NCT00894166|79366677|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
44361092|NCT00894166|79366678|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
44361093|NCT00894166|79366679|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
44361094|NCT00894166|79366680|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
44361095|NCT00894166|79366681|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
44361096|NCT00894166|79366674|FG000|Overall Study|Death|0|||
44361097|NCT00894166|79366675|FG001|Overall Study|Death|0|||
44361098|NCT00894166|79366676|FG002|Overall Study|Death|0|||
44361099|NCT00894166|79366677|FG003|Overall Study|Death|1|||
44361100|NCT00894166|79366678|FG004|Overall Study|Death|0|||
44361101|NCT00894166|79366679|FG005|Overall Study|Death|0|||
44361102|NCT00894166|79366680|FG006|Overall Study|Death|0|||
44361103|NCT00894166|79366681|FG007|Overall Study|Death|0|||
44361104|NCT00880165|79366706|FG000|Overall Study|Withdrawal by Subject|27|||
44361105|NCT00880165|79366707|FG001|Overall Study|Withdrawal by Subject|23|||
44361106|NCT00880165|79366706|FG000|Overall Study|Not diagnosed with OSA|14|||
44361107|NCT00880165|79366707|FG001|Overall Study|Not diagnosed with OSA|8|||
44361108|NCT00880165|79366706|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
44361109|NCT00880165|79366707|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
44361110|NCT00880165|79366706|FG000|Overall Study|Lost to follow|9|||
44361111|NCT00880165|79366707|FG001|Overall Study|Lost to follow|15|||
44361112|NCT04153981|79366713|FG000|Overall Study|Death|1|||
44361113|NCT04153981|79366713|FG000|Overall Study|Withdrawal by Subject|24|||
44361114|NCT04153981|79366713|FG000|Overall Study|Lost to Follow-up|1|||
44361115|NCT04153981|79366713|FG000|Overall Study|Physician Decision|1|||
44361116|NCT04153981|79366713|FG000|Overall Study|Due to Unavailable Glucometer|1|||
44361117|NCT04153981|79366713|FG000|Overall Study|Covid 19|52|||
44361118|NCT04153981|79366713|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
44361119|NCT04153981|79366713|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
44361120|NCT01165229|79366719|FG000|Overall Study|Serious Adverse Event|456|||
44361121|NCT01165229|79366720|FG001|Overall Study|Serious Adverse Event|487|||
44361122|NCT01165229|79366719|FG000|Overall Study|Non-Serious Adverse Event|47|||
44361123|NCT01165229|79366720|FG001|Overall Study|Non-Serious Adverse Event|15|||
44361124|NCT01165229|79366719|FG000|Overall Study|Protocol Violation|6|||
44361125|NCT01165229|79366720|FG001|Overall Study|Protocol Violation|8|||
44173273|NCT01885078|78966949|FG003|Step-down Period|Physician Decision|0|||
44264339|NCT02503332|79165519|FG003|Overall Study|Subject Request|1|||
44264340|NCT02503332|79165516|FG000|Overall Study|Death|0|||
44361126|NCT01165229|79366719|FG000|Overall Study|Withdrawal by Subject|387|||
44361127|NCT01165229|79366720|FG001|Overall Study|Withdrawal by Subject|396|||
44361128|NCT01165229|79366719|FG000|Overall Study|Migrated/moved from study area|51|||
44361129|NCT01165229|79366720|FG001|Overall Study|Migrated/moved from study area|46|||
44361130|NCT01165229|79366719|FG000|Overall Study|Lost to Follow-up|123|||
44361131|NCT01165229|79366720|FG001|Overall Study|Lost to Follow-up|133|||
44173274|NCT01885078|78966950|FG004|Step-down Period|Physician Decision|0|||
44264341|NCT02503332|79165517|FG001|Overall Study|Death|2|||
44361132|NCT01165229|79366719|FG000|Overall Study|Suspected HZ Episode|2|||
44361133|NCT01165229|79366720|FG001|Overall Study|Suspected HZ Episode|2|||
44361134|NCT01165229|79366719|FG000|Overall Study|No reason from the subject|108|||
44361135|NCT01165229|79366720|FG001|Overall Study|No reason from the subject|102|||
44361136|NCT01165229|79366719|FG000|Overall Study|Unknown completion status|0|||
44361137|NCT01165229|79366720|FG001|Overall Study|Unknown completion status|1|||
44173275|NCT01885078|78966951|FG005|Step-down Period|Physician Decision|0|||
44264342|NCT02503332|79165518|FG002|Overall Study|Death|2|||
44173276|NCT01885078|78966952|FG006|Step-down Period|Physician Decision|0|||
44173277|NCT01885078|78966953|FG007|Step-down Period|Physician Decision|0|||
44173278|NCT01885078|78966954|FG008|Step-down Period|Physician Decision|7|||
44173279|NCT01885078|78966955|FG009|Step-down Period|Physician Decision|2|||
44173280|NCT01885078|78966946|FG000|Step-down Period|Death|0|||
44173281|NCT01885078|78966947|FG001|Step-down Period|Death|0|||
44173282|NCT01885078|78966948|FG002|Step-down Period|Death|0|||
44173283|NCT01885078|78966949|FG003|Step-down Period|Death|0|||
44173284|NCT01885078|78966950|FG004|Step-down Period|Death|0|||
44173285|NCT01885078|78966951|FG005|Step-down Period|Death|0|||
44173286|NCT01885078|78966952|FG006|Step-down Period|Death|0|||
44173287|NCT01885078|78966953|FG007|Step-down Period|Death|0|||
44173288|NCT01885078|78966954|FG008|Step-down Period|Death|4|||
44173289|NCT01885078|78966955|FG009|Step-down Period|Death|3|||
44451030|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
44451031|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
44451032|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
44451033|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
44451034|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
44451035|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
44451036|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
44451037|NCT02677896|79459915|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
44451038|NCT02677896|79459916|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
44451039|NCT02624869|79459926|FG000|Overall Study|Lost to Follow-up|0|||
44451040|NCT02624869|79459927|FG001|Overall Study|Lost to Follow-up|0|||
44451041|NCT02624869|79459928|FG002|Overall Study|Lost to Follow-up|1|||
44451042|NCT02624869|79459926|FG000|Overall Study|Withdrawal by Subject|1|||
44173290|NCT01885078|78966946|FG000|Step-down Period|Lost to Follow-up|0|||
44173291|NCT01885078|78966947|FG001|Step-down Period|Lost to Follow-up|0|||
44173292|NCT01885078|78966948|FG002|Step-down Period|Lost to Follow-up|0|||
44173293|NCT01885078|78966949|FG003|Step-down Period|Lost to Follow-up|0|||
44173294|NCT01885078|78966950|FG004|Step-down Period|Lost to Follow-up|0|||
44173295|NCT01885078|78966951|FG005|Step-down Period|Lost to Follow-up|0|||
44173296|NCT01885078|78966952|FG006|Step-down Period|Lost to Follow-up|0|||
44173297|NCT01885078|78966953|FG007|Step-down Period|Lost to Follow-up|0|||
44173298|NCT01885078|78966954|FG008|Step-down Period|Lost to Follow-up|1|||
44173299|NCT01885078|78966955|FG009|Step-down Period|Lost to Follow-up|1|||
44173300|NCT01885078|78966946|FG000|Step-down Period|Lack of Efficacy|0|||
44451043|NCT02624869|79459927|FG001|Overall Study|Withdrawal by Subject|3|||
44451044|NCT02624869|79459928|FG002|Overall Study|Withdrawal by Subject|1|||
44451045|NCT02393859|79459957|FG000|Overall Study|Decision by Sponsor|2|||
44451046|NCT02393859|79459958|FG001|Overall Study|Decision by Sponsor|4|||
44451047|NCT02393859|79459957|FG000|Overall Study|Withdrawal by Subject|11|||
44451048|NCT02393859|79459958|FG001|Overall Study|Withdrawal by Subject|6|||
44451049|NCT02393859|79459957|FG000|Overall Study|Death|27|||
44451050|NCT02393859|79459958|FG001|Overall Study|Death|10|||
44451051|NCT02393859|79459957|FG000|Overall Study|Lost to Follow-up|1|||
44451052|NCT02393859|79459958|FG001|Overall Study|Lost to Follow-up|1|||
44451053|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
44451054|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
44451055|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
44451056|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
44451057|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
44451058|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
44451059|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
44451060|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
44451061|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
44451062|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
44173301|NCT01885078|78966947|FG001|Step-down Period|Lack of Efficacy|0|||
44173302|NCT01885078|78966948|FG002|Step-down Period|Lack of Efficacy|0|||
44173303|NCT01885078|78966949|FG003|Step-down Period|Lack of Efficacy|0|||
44173304|NCT01885078|78966950|FG004|Step-down Period|Lack of Efficacy|0|||
44173305|NCT01885078|78966951|FG005|Step-down Period|Lack of Efficacy|0|||
44173306|NCT01885078|78966952|FG006|Step-down Period|Lack of Efficacy|0|||
44173307|NCT01885078|78966953|FG007|Step-down Period|Lack of Efficacy|0|||
44173308|NCT01885078|78966954|FG008|Step-down Period|Lack of Efficacy|1|||
44173309|NCT01885078|78966955|FG009|Step-down Period|Lack of Efficacy|0|||
44173310|NCT01885078|78966946|FG000|Step-down Period|Protocol Violation|0|||
44173311|NCT01885078|78966947|FG001|Step-down Period|Protocol Violation|0|||
44173312|NCT01885078|78966948|FG002|Step-down Period|Protocol Violation|0|||
44173313|NCT01885078|78966949|FG003|Step-down Period|Protocol Violation|0|||
44173314|NCT01885078|78966950|FG004|Step-down Period|Protocol Violation|0|||
44173315|NCT01885078|78966951|FG005|Step-down Period|Protocol Violation|0|||
44173316|NCT01885078|78966952|FG006|Step-down Period|Protocol Violation|0|||
44173317|NCT01885078|78966953|FG007|Step-down Period|Protocol Violation|0|||
44173318|NCT01885078|78966954|FG008|Step-down Period|Protocol Violation|1|||
44173319|NCT01885078|78966955|FG009|Step-down Period|Protocol Violation|1|||
44173320|NCT02046369|78966978|FG000|Overall Study|Adverse Event|3|||
44173321|NCT02046369|78966979|FG001|Overall Study|Adverse Event|3|||
44173322|NCT02046369|78966978|FG000|Overall Study|Lack of Efficacy|3|||
44173323|NCT02046369|78966979|FG001|Overall Study|Lack of Efficacy|3|||
44173324|NCT02046369|78966978|FG000|Overall Study|Lost to Follow-up|3|||
44173325|NCT02046369|78966979|FG001|Overall Study|Lost to Follow-up|3|||
44173326|NCT02046369|78966978|FG000|Overall Study|Protocol Violation|1|||
44173327|NCT02046369|78966979|FG001|Overall Study|Protocol Violation|2|||
44173328|NCT02046369|78966978|FG000|Overall Study|Withdrawal by Subject|3|||
44173329|NCT02046369|78966979|FG001|Overall Study|Withdrawal by Subject|6|||
44173330|NCT02046369|78966978|FG000|Overall Study|never received study drug|0|||
44173331|NCT02046369|78966979|FG001|Overall Study|never received study drug|1|||
44173332|NCT02046369|78966978|FG000|Overall Study|non compliance|1|||
44173333|NCT02046369|78966979|FG001|Overall Study|non compliance|0|||
44173334|NCT02101359|78966987|FG000|Overall Study|Not included|23|||
44173335|NCT02101359|78966988|FG001|Overall Study|Not included|13|||
44173336|NCT02101359|78966987|FG000|Overall Study|Withdrawal by Subject|5|||
44173337|NCT02101359|78966988|FG001|Overall Study|Withdrawal by Subject|4|||
44173338|NCT02101359|78966987|FG000|Overall Study|Lost to Follow-up|1|||
44173339|NCT02101359|78966988|FG001|Overall Study|Lost to Follow-up|0|||
44173340|NCT02101359|78966987|FG000|Overall Study|Protocol Violation|0|||
44173341|NCT02101359|78966988|FG001|Overall Study|Protocol Violation|2|||
44173342|NCT02100969|78966994|FG000|Overall Study|Did not pass screening phase|1|||
44173343|NCT01885000|78967001|FG000|Overall Study|Adverse Event|1|||
44173344|NCT01885000|78967002|FG001|Overall Study|Adverse Event|0|||
44173345|NCT01885000|78967001|FG000|Overall Study|Withdrawal by Subject|1|||
44173346|NCT01885000|78967002|FG001|Overall Study|Withdrawal by Subject|1|||
44173347|NCT01885000|78967001|FG000|Overall Study|Protocol Violation|0|||
44173348|NCT01885000|78967002|FG001|Overall Study|Protocol Violation|1|||
44173349|NCT01884688|78967008|FG000|Overall Study|Screen Failure|2|||
44173350|NCT01883362|78967014|FG000|Treatment|Adverse Event|1|||
44173351|NCT01883362|78967015|FG001|Treatment|Adverse Event|8|||
44173352|NCT01883362|78967014|FG000|Treatment|Withdrawal by Subject|6|||
44173353|NCT01883362|78967015|FG001|Treatment|Withdrawal by Subject|2|||
44173354|NCT01883362|78967014|FG000|Treatment|Administrative problems|4|||
44173355|NCT01883362|78967015|FG001|Treatment|Administrative problems|1|||
44173356|NCT01883362|78967014|FG000|Treatment|Relapse|4|||
44361138|NCT00596011|79366758|FG000|Overall Study|Withdrawal by Subject|2|||
44173357|NCT01883362|78967015|FG001|Treatment|Relapse|2|||
44173358|NCT01883362|78967014|FG000|Treatment|Randomized, not treated|1|||
44173359|NCT01883362|78967015|FG001|Treatment|Randomized, not treated|1|||
44173360|NCT01883362|78967014|FG000|Post Treatment Follow-up|Protocol Violation|0|||
44173361|NCT01883362|78967015|FG001|Post Treatment Follow-up|Protocol Violation|1|||
44173362|NCT01883362|78967014|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
44173363|NCT01883362|78967015|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
44173364|NCT01883362|78967014|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
44173365|NCT01883362|78967015|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
44173366|NCT01883362|78967014|FG000|Post Treatment Follow-up|Administrative problems|2|||
44173367|NCT01883362|78967015|FG001|Post Treatment Follow-up|Administrative problems|0|||
44173368|NCT01883362|78967014|FG000|Post Treatment Follow-up|Death|8|||
44173369|NCT01883362|78967015|FG001|Post Treatment Follow-up|Death|4|||
44173370|NCT01883362|78967014|FG000|Post Treatment Follow-up|Relapse|1|||
44173371|NCT01883362|78967015|FG001|Post Treatment Follow-up|Relapse|2|||
44173372|NCT02100813|78967033|FG000|Overall Study|Adverse Event|0|||
44173373|NCT02100813|78967034|FG001|Overall Study|Adverse Event|0|||
44173374|NCT02100813|78967035|FG002|Overall Study|Adverse Event|0|||
44173375|NCT02100813|78967036|FG003|Overall Study|Adverse Event|0|||
44173376|NCT02100813|78967037|FG004|Overall Study|Adverse Event|0|||
44173377|NCT02100813|78967038|FG005|Overall Study|Adverse Event|0|||
44173378|NCT02100813|78967039|FG006|Overall Study|Adverse Event|0|||
44173379|NCT02100813|78967040|FG007|Overall Study|Adverse Event|1|||
44173380|NCT01930162|78967062|FG000|Overall Study|Abnormal test procedure result(s)|4|||
44173381|NCT01930162|78967062|FG000|Overall Study|Death|1|||
44173382|NCT02045979|78967070|FG000|Overall Study|Informed Consent Withdrawn|2|||
44173383|NCT02045979|78967071|FG001|Overall Study|Informed Consent Withdrawn|0|||
44173384|NCT02045979|78967072|FG002|Overall Study|Informed Consent Withdrawn|1|||
44173385|NCT02045979|78967070|FG000|Overall Study|not specified above|0|||
44173386|NCT02045979|78967071|FG001|Overall Study|not specified above|1|||
44173387|NCT02045979|78967072|FG002|Overall Study|not specified above|0|||
44173388|NCT01929226|78967082|FG000|Overall Study|Lost to Follow-up|4|||
44173389|NCT01929226|78967083|FG001|Overall Study|Lost to Follow-up|0|||
44173390|NCT01929226|78967082|FG000|Overall Study|Withdrawal by Subject|1|||
44173391|NCT01929226|78967083|FG001|Overall Study|Withdrawal by Subject|1|||
44173392|NCT02045433|78967090|FG000|Overall Study|Withdrawal by Subject|1|||
44173393|NCT01911442|78967097|FG000|Overall Study|Adverse Event|2|||
44173394|NCT01911442|78967098|FG001|Overall Study|Adverse Event|2|||
44173395|NCT01911442|78967099|FG002|Overall Study|Adverse Event|4|||
44173396|NCT01911442|78967097|FG000|Overall Study|Lack of Efficacy|1|||
44173397|NCT01911442|78967098|FG001|Overall Study|Lack of Efficacy|1|||
44173398|NCT01911442|78967099|FG002|Overall Study|Lack of Efficacy|1|||
44173399|NCT01911442|78967097|FG000|Overall Study|Lost to Follow-up|2|||
44173400|NCT01911442|78967098|FG001|Overall Study|Lost to Follow-up|0|||
44173401|NCT01911442|78967099|FG002|Overall Study|Lost to Follow-up|1|||
44173402|NCT01911442|78967097|FG000|Overall Study|Withdrawal by Subject|1|||
44173403|NCT01911442|78967098|FG001|Overall Study|Withdrawal by Subject|0|||
44451063|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
44451064|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
44173404|NCT01911442|78967099|FG002|Overall Study|Withdrawal by Subject|6|||
44173405|NCT01911442|78967097|FG000|Overall Study|Mother's Work Schedule|0|||
44173406|NCT01911442|78967098|FG001|Overall Study|Mother's Work Schedule|1|||
44173407|NCT01911442|78967099|FG002|Overall Study|Mother's Work Schedule|0|||
44173408|NCT01928758|78967113|FG000|Overall Study|Lost to Follow-up|14|||
44173409|NCT01928758|78967114|FG001|Overall Study|Lost to Follow-up|9|||
44173410|NCT01928758|78967113|FG000|Overall Study|Withdrawal by Subject|5|||
44173411|NCT01928758|78967114|FG001|Overall Study|Withdrawal by Subject|2|||
44173412|NCT01928758|78967113|FG000|Overall Study|Adverse Event|3|||
44173413|NCT01928758|78967114|FG001|Overall Study|Adverse Event|5|||
44173414|NCT01928758|78967113|FG000|Overall Study|Protocol Violation|3|||
44173415|NCT01928758|78967114|FG001|Overall Study|Protocol Violation|4|||
44173416|NCT01910116|78967123|FG000|Overall Study|Adverse Event|0|||
44173417|NCT01910116|78967124|FG001|Overall Study|Adverse Event|3|||
44173418|NCT01910116|78967123|FG000|Overall Study|Lack of Efficacy|3|||
44173419|NCT01910116|78967124|FG001|Overall Study|Lack of Efficacy|4|||
44173420|NCT01910116|78967123|FG000|Overall Study|Lost to Follow-up|1|||
44173421|NCT01910116|78967124|FG001|Overall Study|Lost to Follow-up|0|||
44173422|NCT01910116|78967123|FG000|Overall Study|Protocol Violation|1|||
44173423|NCT01910116|78967124|FG001|Overall Study|Protocol Violation|2|||
44173424|NCT01910116|78967123|FG000|Overall Study|Withdrawal by Subject|8|||
44173425|NCT01910116|78967124|FG001|Overall Study|Withdrawal by Subject|3|||
44173426|NCT01910116|78967123|FG000|Overall Study|uncertain allocation|1|||
44173427|NCT01910116|78967124|FG001|Overall Study|uncertain allocation|3|||
44173428|NCT01910116|78967123|FG000|Overall Study|incomplete data|0|||
44173429|NCT01910116|78967124|FG001|Overall Study|incomplete data|1|||
44173430|NCT01614886|78967132|FG000|Overall Study|Adverse Event|15|||
44173431|NCT01614886|78967133|FG001|Overall Study|Adverse Event|20|||
44173432|NCT01614886|78967132|FG000|Overall Study|Withdrawal by Subject|4|||
44173433|NCT01614886|78967133|FG001|Overall Study|Withdrawal by Subject|4|||
44173434|NCT01614886|78967132|FG000|Overall Study|Death|1|||
44173435|NCT01614886|78967133|FG001|Overall Study|Death|0|||
44173436|NCT01614886|78967132|FG000|Overall Study|Protocol deviation|0|||
44173437|NCT01614886|78967133|FG001|Overall Study|Protocol deviation|2|||
44173438|NCT01880554|78967139|FG000|Overall Study|Protocol Violation|14|||
44173439|NCT01880554|78967139|FG000|Overall Study|Simon's design requirements|2|||
44173440|NCT02100657|78967147|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
44173441|NCT02100657|78967148|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
44173442|NCT02100657|78967149|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
44173443|NCT02100657|78967147|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
44173444|NCT02100657|78967148|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
44173445|NCT02100657|78967149|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
44173446|NCT02100657|78967147|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
44173447|NCT02100657|78967148|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
44173448|NCT02100657|78967149|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
44173449|NCT02100657|78967147|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
44173450|NCT02100657|78967148|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
44173451|NCT02100657|78967149|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
44173452|NCT02100657|78967147|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
44173453|NCT02100657|78967148|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
44173454|NCT02100657|78967149|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
44173455|NCT02100657|78967147|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
44173456|NCT02100657|78967148|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
44173457|NCT02100657|78967149|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
44173458|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
44173459|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
44173460|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
44173461|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Death|0|||
44173462|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Death|0|||
44173463|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Death|1|||
44173464|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
44173465|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
44173466|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
44173467|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
44173468|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
44173469|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
44173470|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
44173471|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
44173472|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
44173473|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
44173474|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
44173475|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
44173476|NCT02100657|78967147|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
44173477|NCT02100657|78967148|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
44173478|NCT02100657|78967149|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
44173479|NCT02067663|78967160|FG000|Overall Study|Lost to Follow-up|13|||
44173480|NCT02067663|78967161|FG001|Overall Study|Lost to Follow-up|14|||
44173481|NCT01909804|78967179|FG000|Overall Study|Randomized but Never Treated|0|||
44173482|NCT01909804|78967180|FG001|Overall Study|Randomized but Never Treated|0|||
44173483|NCT01909804|78967181|FG002|Overall Study|Randomized but Never Treated|0|||
44173484|NCT01909804|78967182|FG003|Overall Study|Randomized but Never Treated|0|||
44173485|NCT01909804|78967183|FG004|Overall Study|Randomized but Never Treated|0|||
44173486|NCT01909804|78967184|FG005|Overall Study|Randomized but Never Treated|0|||
44173487|NCT01909804|78967185|FG006|Overall Study|Randomized but Never Treated|1|||
44173488|NCT01909804|78967186|FG007|Overall Study|Randomized but Never Treated|0|||
44173489|NCT01909804|78967187|FG008|Overall Study|Randomized but Never Treated|0|||
44173490|NCT01909804|78967188|FG009|Overall Study|Randomized but Never Treated|0|||
44173491|NCT01909804|78967189|FG010|Overall Study|Randomized but Never Treated|0|||
44173492|NCT01909804|78967190|FG011|Overall Study|Randomized but Never Treated|1|||
44173493|NCT01909804|78967179|FG000|Overall Study|Death|0|||
44173494|NCT01909804|78967180|FG001|Overall Study|Death|0|||
44173495|NCT01909804|78967181|FG002|Overall Study|Death|0|||
44173496|NCT01909804|78967182|FG003|Overall Study|Death|0|||
44173497|NCT01909804|78967183|FG004|Overall Study|Death|0|||
44173498|NCT01909804|78967184|FG005|Overall Study|Death|0|||
44173499|NCT01909804|78967185|FG006|Overall Study|Death|0|||
44173500|NCT01909804|78967186|FG007|Overall Study|Death|0|||
44173501|NCT01909804|78967187|FG008|Overall Study|Death|0|||
44173502|NCT01909804|78967188|FG009|Overall Study|Death|0|||
44173503|NCT01909804|78967189|FG010|Overall Study|Death|1|||
44173504|NCT01909804|78967190|FG011|Overall Study|Death|0|||
44173505|NCT01909804|78967179|FG000|Overall Study|Lack of Efficacy|4|||
44173506|NCT01909804|78967180|FG001|Overall Study|Lack of Efficacy|1|||
44173507|NCT01909804|78967181|FG002|Overall Study|Lack of Efficacy|0|||
44173508|NCT01909804|78967182|FG003|Overall Study|Lack of Efficacy|0|||
44173509|NCT01909804|78967183|FG004|Overall Study|Lack of Efficacy|7|||
44173510|NCT01909804|78967184|FG005|Overall Study|Lack of Efficacy|3|||
44173511|NCT01909804|78967185|FG006|Overall Study|Lack of Efficacy|1|||
44173512|NCT01909804|78967186|FG007|Overall Study|Lack of Efficacy|1|||
44173513|NCT01909804|78967187|FG008|Overall Study|Lack of Efficacy|0|||
44173514|NCT01909804|78967188|FG009|Overall Study|Lack of Efficacy|1|||
44173515|NCT01909804|78967189|FG010|Overall Study|Lack of Efficacy|0|||
44173516|NCT01909804|78967190|FG011|Overall Study|Lack of Efficacy|1|||
44173517|NCT01909804|78967179|FG000|Overall Study|Withdrew Consent|0|||
44173518|NCT01909804|78967180|FG001|Overall Study|Withdrew Consent|0|||
44173519|NCT01909804|78967181|FG002|Overall Study|Withdrew Consent|0|||
44173520|NCT01909804|78967182|FG003|Overall Study|Withdrew Consent|0|||
44173521|NCT01909804|78967183|FG004|Overall Study|Withdrew Consent|1|||
44173522|NCT01909804|78967184|FG005|Overall Study|Withdrew Consent|1|||
44173523|NCT01909804|78967185|FG006|Overall Study|Withdrew Consent|0|||
44173524|NCT01909804|78967186|FG007|Overall Study|Withdrew Consent|0|||
44173525|NCT01909804|78967187|FG008|Overall Study|Withdrew Consent|0|||
44173526|NCT01909804|78967188|FG009|Overall Study|Withdrew Consent|0|||
44173527|NCT01909804|78967189|FG010|Overall Study|Withdrew Consent|0|||
44173528|NCT01909804|78967190|FG011|Overall Study|Withdrew Consent|0|||
44173529|NCT01909804|78967179|FG000|Overall Study|Protocol Violation|0|||
44173530|NCT01909804|78967180|FG001|Overall Study|Protocol Violation|0|||
44173531|NCT01909804|78967181|FG002|Overall Study|Protocol Violation|0|||
44173532|NCT01909804|78967182|FG003|Overall Study|Protocol Violation|0|||
44173533|NCT01909804|78967183|FG004|Overall Study|Protocol Violation|0|||
44173534|NCT01909804|78967184|FG005|Overall Study|Protocol Violation|0|||
44173535|NCT01909804|78967185|FG006|Overall Study|Protocol Violation|0|||
44173536|NCT01909804|78967186|FG007|Overall Study|Protocol Violation|0|||
44264343|NCT02503332|79165519|FG003|Overall Study|Death|0|||
44264344|NCT02503332|79165516|FG000|Overall Study|Other|5|||
44264345|NCT02503332|79165517|FG001|Overall Study|Other|6|||
44173537|NCT01909804|78967187|FG008|Overall Study|Protocol Violation|0|||
44173538|NCT01909804|78967188|FG009|Overall Study|Protocol Violation|0|||
44173539|NCT01909804|78967189|FG010|Overall Study|Protocol Violation|0|||
44173540|NCT01909804|78967190|FG011|Overall Study|Protocol Violation|1|||
44173541|NCT01880086|78967214|FG000|Overall Study|Lost to Follow-up|1|||
44173542|NCT01880086|78967215|FG001|Overall Study|Lost to Follow-up|1|||
44173543|NCT01879852|78967223|FG000|Overall Study|Withdrawal by Subject|2|||
44173544|NCT01879852|78967224|FG001|Overall Study|Withdrawal by Subject|0|||
44173545|NCT01879618|78967230|FG000|Overall Study|Does not meet entrance criteria|1|||
44173546|NCT01879618|78967230|FG000|Overall Study|Withdrawal by Subject|1|||
44173547|NCT01879618|78967230|FG000|Overall Study|Surgery;changed schedule; not available|8|||
44173548|NCT01879618|78967230|FG000|Overall Study|Protocol Violation|6|||
44264346|NCT02503332|79165518|FG002|Overall Study|Other|1|||
44173549|NCT01879618|78967230|FG000|Overall Study|Adverse Event|5|||
44173550|NCT01926886|78967234|FG000|Overall Study|Administrative/other|1|||
44173551|NCT01926886|78967235|FG001|Overall Study|Administrative/other|0|||
44173552|NCT01926886|78967234|FG000|Overall Study|Adverse event/intercurrent illness|4|||
44173553|NCT01926886|78967235|FG001|Overall Study|Adverse event/intercurrent illness|0|||
44173554|NCT01926886|78967234|FG000|Overall Study|Disease progression/recurrence|4|||
44173555|NCT01926886|78967235|FG001|Overall Study|Disease progression/recurrence|0|||
44173556|NCT01926886|78967234|FG000|Overall Study|Withdrawal by Subject|15|||
44173557|NCT01926886|78967235|FG001|Overall Study|Withdrawal by Subject|0|||
44173558|NCT01926886|78967234|FG000|Overall Study|Failure to return|3|||
44173559|NCT01926886|78967235|FG001|Overall Study|Failure to return|0|||
44173560|NCT01926886|78967234|FG000|Overall Study|Recurrence of disease|1|||
44173561|NCT01926886|78967235|FG001|Overall Study|Recurrence of disease|0|||
44173562|NCT01926886|78967234|FG000|Overall Study|Progression of disease|2|||
44173563|NCT01926886|78967235|FG001|Overall Study|Progression of disease|0|||
44173564|NCT01926886|78967234|FG000|Overall Study|Death|1|||
44173565|NCT01926886|78967235|FG001|Overall Study|Death|0|||
44173566|NCT01926886|78967234|FG000|Overall Study|Did not cooperate|1|||
44173567|NCT01926886|78967235|FG001|Overall Study|Did not cooperate|0|||
44173568|NCT01909336|78967244|FG000|Overall Study|Lost to Follow-up|4|||
44173569|NCT01909336|78967245|FG001|Overall Study|Lost to Follow-up|2|||
44173570|NCT01909336|78967246|FG002|Overall Study|Lost to Follow-up|2|||
44173571|NCT01909336|78967244|FG000|Overall Study|Physician Decision|0|||
44173572|NCT01909336|78967245|FG001|Overall Study|Physician Decision|1|||
44173573|NCT01909336|78967246|FG002|Overall Study|Physician Decision|1|||
44173574|NCT01926028|78967257|FG000|Overall Study|Lost to Follow-up|7|||
44173575|NCT01926028|78967258|FG001|Overall Study|Lost to Follow-up|6|||
44173576|NCT01926028|78967259|FG002|Overall Study|Lost to Follow-up|0|||
44173577|NCT01926028|78967257|FG000|Overall Study|Physician Decision|1|||
44173578|NCT01926028|78967258|FG001|Overall Study|Physician Decision|5|||
44173579|NCT01926028|78967259|FG002|Overall Study|Physician Decision|0|||
44173580|NCT01926028|78967257|FG000|Overall Study|Withdrawal by Subject|9|||
44173581|NCT01926028|78967258|FG001|Overall Study|Withdrawal by Subject|9|||
44173582|NCT01926028|78967259|FG002|Overall Study|Withdrawal by Subject|2|||
44173583|NCT01926028|78967257|FG000|Overall Study|Non compliance or other reasons|4|||
44173584|NCT01926028|78967258|FG001|Overall Study|Non compliance or other reasons|2|||
44173585|NCT01926028|78967259|FG002|Overall Study|Non compliance or other reasons|0|||
44173586|NCT01925950|78967270|FG000|Part 2|Withdrawal by Subject|1|||
44173587|NCT01925950|78967271|FG001|Part 2|Withdrawal by Subject|0|||
44173588|NCT01878292|78967280|FG000|Randomized|Protocol Violation|1|||
44173589|NCT01878292|78967281|FG001|Randomized|Protocol Violation|0|||
44173590|NCT01878292|78967282|FG002|Randomized|Protocol Violation|0|||
44173591|NCT01878292|78967280|FG000|Randomized|Lost to Follow-up|1|||
44173592|NCT01878292|78967281|FG001|Randomized|Lost to Follow-up|0|||
44173593|NCT01878292|78967282|FG002|Randomized|Lost to Follow-up|0|||
44173594|NCT01878292|78967280|FG000|Randomized|Adverse Event|1|||
44173595|NCT01878292|78967281|FG001|Randomized|Adverse Event|0|||
44173596|NCT01878292|78967282|FG002|Randomized|Adverse Event|0|||
44173597|NCT01878292|78967280|FG000|Double-blind Treatment Period|Other Reasons|2|||
44173598|NCT01878292|78967281|FG001|Double-blind Treatment Period|Other Reasons|0|||
44173599|NCT01878292|78967282|FG002|Double-blind Treatment Period|Other Reasons|0|||
44173600|NCT01878292|78967280|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
44173601|NCT01878292|78967281|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
44173602|NCT01878292|78967282|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
44173603|NCT01878292|78967280|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
44173604|NCT01878292|78967281|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
44173605|NCT01878292|78967282|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
44173606|NCT01878292|78967280|FG000|Double-blind Treatment Period|Protocol Violation|3|||
44173607|NCT01878292|78967281|FG001|Double-blind Treatment Period|Protocol Violation|4|||
44173608|NCT01878292|78967282|FG002|Double-blind Treatment Period|Protocol Violation|2|||
44173609|NCT01878292|78967280|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
44173610|NCT01878292|78967281|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
44173611|NCT01878292|78967282|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
44173612|NCT01878292|78967280|FG000|Double-blind Treatment Period|Adverse Event|4|||
44173613|NCT01878292|78967281|FG001|Double-blind Treatment Period|Adverse Event|9|||
44173614|NCT01878292|78967282|FG002|Double-blind Treatment Period|Adverse Event|8|||
44173615|NCT01878292|78967280|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
44173616|NCT01878292|78967281|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
44173617|NCT01878292|78967282|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
44173618|NCT01908634|78967290|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
44173619|NCT01908634|78967290|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
44173620|NCT01878214|78967300|FG000|Overall Study|Withdrawal by Subject|18|||
44173621|NCT01878214|78967301|FG001|Overall Study|Withdrawal by Subject|7|||
44173622|NCT01878214|78967300|FG000|Overall Study|Death|0|||
44173623|NCT01878214|78967301|FG001|Overall Study|Death|1|||
44173624|NCT01878214|78967300|FG000|Overall Study|Lost to Follow-up|35|||
44173625|NCT01878214|78967301|FG001|Overall Study|Lost to Follow-up|36|||
44173626|NCT01907854|78967309|FG000|Overall Study|Protocol Violation|1|||
44173627|NCT01907854|78967310|FG001|Overall Study|Protocol Violation|1|||
44173628|NCT01907854|78967309|FG000|Overall Study|Withdrawal by Subject|9|||
44173629|NCT01907854|78967310|FG001|Overall Study|Withdrawal by Subject|7|||
44173630|NCT01907854|78967309|FG000|Overall Study|Lost to Follow-up|2|||
44173631|NCT01907854|78967310|FG001|Overall Study|Lost to Follow-up|2|||
44173632|NCT01907854|78967309|FG000|Overall Study|Unclassified|4|||
44173633|NCT01907854|78967310|FG001|Overall Study|Unclassified|3|||
44173634|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
44173635|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
44173636|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
44173637|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
44173638|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
44173639|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
44173640|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
44173641|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
44173642|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
44173643|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
44173644|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
44173645|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
44173646|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
44173647|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
44173648|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
44173649|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
44173650|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
44173651|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
44173652|NCT02480153|78967318|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
44173653|NCT02480153|78967319|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
44173654|NCT02480153|78967320|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
44173655|NCT02480153|78967318|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
44173656|NCT02480153|78967319|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
44173657|NCT02480153|78967320|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
44173658|NCT02480153|78967318|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
44173659|NCT02480153|78967319|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
44173660|NCT02480153|78967320|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
44173661|NCT02480153|78967318|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
44173662|NCT02480153|78967319|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
44173663|NCT02480153|78967320|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
44173664|NCT02480153|78967318|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
44173665|NCT02480153|78967319|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
44173666|NCT02480153|78967320|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
44173667|NCT02480153|78967318|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
44173668|NCT02480153|78967319|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
44173669|NCT02480153|78967320|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
44173670|NCT02480153|78967318|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
44173671|NCT02480153|78967319|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
44173672|NCT02480153|78967320|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
44173673|NCT02480153|78967318|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
44173674|NCT02480153|78967319|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
44173675|NCT02480153|78967320|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
44173676|NCT02480153|78967318|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
44173677|NCT02480153|78967319|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
44173678|NCT02480153|78967320|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
44173679|NCT02480153|78967318|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
44173680|NCT02480153|78967319|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
44173681|NCT02480153|78967320|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
44173682|NCT02480153|78967318|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
44173683|NCT02480153|78967319|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
44173684|NCT02480153|78967320|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
44173685|NCT02480153|78967318|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
44173686|NCT02480153|78967319|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
44173687|NCT02480153|78967320|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
44173688|NCT02500979|78967345|FG000|Period 1|Hyperglycemia|1|||
44264347|NCT02503332|79165519|FG003|Overall Study|Other|1|||
44451065|NCT02294461|79459967|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
44173689|NCT02500979|78967346|FG001|Period 1|Hyperglycemia|0|||
44173690|NCT02500979|78967345|FG000|Period 1|Severe non-compliance to protocol|0|||
44173691|NCT02500979|78967346|FG001|Period 1|Severe non-compliance to protocol|1|||
44173692|NCT02500979|78967345|FG000|Period 1|Adverse Event|1|||
44173693|NCT02500979|78967346|FG001|Period 1|Adverse Event|0|||
44173694|NCT02500979|78967345|FG000|Period 1|Subject decision|2|||
44173695|NCT02500979|78967346|FG001|Period 1|Subject decision|0|||
44173696|NCT02500979|78967345|FG000|Period 2|Change in risk|1|||
44173697|NCT02500979|78967346|FG001|Period 2|Change in risk|0|||
44173698|NCT02500901|78967352|FG000|Overall Study|Disease ProgressionDD|2|||
44173699|NCT02479139|78967362|FG000|Overall Study|Lost to Follow-up|2|||
44173700|NCT02479139|78967363|FG001|Overall Study|Lost to Follow-up|4|||
44173701|NCT02479139|78967364|FG002|Overall Study|Lost to Follow-up|4|||
44173702|NCT02479139|78967365|FG003|Overall Study|Lost to Follow-up|2|||
44173703|NCT02479139|78967366|FG004|Overall Study|Lost to Follow-up|3|||
44173704|NCT02479139|78967367|FG005|Overall Study|Lost to Follow-up|5|||
44173705|NCT02479139|78967362|FG000|Overall Study|Withdrew Consent|5|||
44173706|NCT02479139|78967363|FG001|Overall Study|Withdrew Consent|6|||
44173707|NCT02479139|78967364|FG002|Overall Study|Withdrew Consent|1|||
44173708|NCT02479139|78967365|FG003|Overall Study|Withdrew Consent|4|||
44173709|NCT02479139|78967366|FG004|Overall Study|Withdrew Consent|1|||
44173710|NCT02479139|78967367|FG005|Overall Study|Withdrew Consent|1|||
44173711|NCT02479139|78967362|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
44173712|NCT02479139|78967363|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
44173713|NCT02479139|78967364|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
44173714|NCT02479139|78967365|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
44173715|NCT02479139|78967366|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
44173716|NCT02479139|78967367|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
44173717|NCT02479139|78967362|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44173718|NCT02479139|78967363|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44173719|NCT02479139|78967364|FG002|Overall Study|Other Miscellaneous Reasons|1|||
44173720|NCT02479139|78967365|FG003|Overall Study|Other Miscellaneous Reasons|1|||
44173721|NCT02479139|78967366|FG004|Overall Study|Other Miscellaneous Reasons|1|||
44173722|NCT02479139|78967367|FG005|Overall Study|Other Miscellaneous Reasons|0|||
44173723|NCT02478359|78967383|FG000|Overall Study|Disenrolled from health plan|106|||
44173724|NCT02478359|78967384|FG001|Overall Study|Disenrolled from health plan|65|||
44173725|NCT01877668|78967397|FG000|Overall Study|Death|0|||
44173726|NCT01877668|78967398|FG001|Overall Study|Death|0|||
44173727|NCT01877668|78967399|FG002|Overall Study|Death|0|||
44173728|NCT01877668|78967400|FG003|Overall Study|Death|1|||
44173729|NCT01877668|78967401|FG004|Overall Study|Death|0|||
44173730|NCT01877668|78967397|FG000|Overall Study|No longer met study criteria|1|||
44173731|NCT01877668|78967398|FG001|Overall Study|No longer met study criteria|0|||
44173732|NCT01877668|78967399|FG002|Overall Study|No longer met study criteria|1|||
44173733|NCT01877668|78967400|FG003|Overall Study|No longer met study criteria|0|||
44173734|NCT01877668|78967401|FG004|Overall Study|No longer met study criteria|0|||
44173735|NCT01877668|78967397|FG000|Overall Study|Insufficient clinical response|0|||
44173736|NCT01877668|78967398|FG001|Overall Study|Insufficient clinical response|1|||
44173737|NCT01877668|78967399|FG002|Overall Study|Insufficient clinical response|2|||
44173738|NCT01877668|78967400|FG003|Overall Study|Insufficient clinical response|2|||
44173739|NCT01877668|78967401|FG004|Overall Study|Insufficient clinical response|0|||
44173740|NCT01877668|78967397|FG000|Overall Study|Lost to Follow-up|0|||
44173741|NCT01877668|78967398|FG001|Overall Study|Lost to Follow-up|2|||
44173742|NCT01877668|78967399|FG002|Overall Study|Lost to Follow-up|1|||
44173743|NCT01877668|78967400|FG003|Overall Study|Lost to Follow-up|0|||
44173744|NCT01877668|78967401|FG004|Overall Study|Lost to Follow-up|0|||
44173745|NCT01877668|78967397|FG000|Overall Study|Withdrawal by Subject|2|||
44173746|NCT01877668|78967398|FG001|Overall Study|Withdrawal by Subject|0|||
44173747|NCT01877668|78967399|FG002|Overall Study|Withdrawal by Subject|3|||
44173748|NCT01877668|78967400|FG003|Overall Study|Withdrawal by Subject|2|||
44173749|NCT01877668|78967401|FG004|Overall Study|Withdrawal by Subject|2|||
44173750|NCT01877668|78967397|FG000|Overall Study|Other|1|||
44173751|NCT01877668|78967398|FG001|Overall Study|Other|1|||
44173752|NCT01877668|78967399|FG002|Overall Study|Other|1|||
44173753|NCT01877668|78967400|FG003|Overall Study|Other|1|||
44173754|NCT01877668|78967401|FG004|Overall Study|Other|3|||
44173755|NCT01877668|78967397|FG000|Overall Study|Protocol Violation|1|||
44173756|NCT01877668|78967398|FG001|Overall Study|Protocol Violation|1|||
44173757|NCT01877668|78967399|FG002|Overall Study|Protocol Violation|0|||
44173758|NCT01877668|78967400|FG003|Overall Study|Protocol Violation|0|||
44173759|NCT01877668|78967401|FG004|Overall Study|Protocol Violation|3|||
44173760|NCT01877668|78967397|FG000|Overall Study|Adverse event related to study drug|2|||
44173761|NCT01877668|78967398|FG001|Overall Study|Adverse event related to study drug|2|||
44173762|NCT01877668|78967399|FG002|Overall Study|Adverse event related to study drug|2|||
44173763|NCT01877668|78967400|FG003|Overall Study|Adverse event related to study drug|2|||
44173764|NCT01877668|78967401|FG004|Overall Study|Adverse event related to study drug|1|||
44173765|NCT01877668|78967397|FG000|Overall Study|Adverse event unrelated to study drug|4|||
44173766|NCT01877668|78967398|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44173767|NCT01877668|78967399|FG002|Overall Study|Adverse event unrelated to study drug|2|||
44173768|NCT01877668|78967400|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44173769|NCT01877668|78967401|FG004|Overall Study|Adverse event unrelated to study drug|1|||
44173770|NCT01877278|78967419|FG000|Overall Study|Lost to Follow-up|3|||
44173771|NCT01877278|78967420|FG001|Overall Study|Lost to Follow-up|3|||
44173772|NCT01906372|78967426|FG000|Overall Study|Withdrawal by Subject|2|||
44173773|NCT01925170|78967431|FG000|Overall Study|Unverified cancer status|53|||
44173774|NCT01925014|78967439|FG000|Overall Study|Inappropriate enrollment|4|||
44173775|NCT01925014|78967440|FG001|Overall Study|Inappropriate enrollment|6|||
44173776|NCT01925014|78967439|FG000|Overall Study|Withdrawal by Subject|5|||
44173777|NCT01925014|78967440|FG001|Overall Study|Withdrawal by Subject|13|||
44173778|NCT01876810|78967446|FG000|Overall Study|Physician Decision|0|||
44173779|NCT01876810|78967447|FG001|Overall Study|Physician Decision|1|||
44173780|NCT01876732|78967456|FG000|Overall Study|MMA was not over 800mg/dL|75|||
44173781|NCT01905592|78967463|FG000|Overall Study|Disease Progression|51|||
44173782|NCT01905592|78967464|FG001|Overall Study|Disease Progression|110|||
44173783|NCT01905592|78967463|FG000|Overall Study|Toxicity|1|||
44173784|NCT01905592|78967464|FG001|Overall Study|Toxicity|16|||
44173785|NCT01905592|78967463|FG000|Overall Study|Physician Decision|0|||
44173786|NCT01905592|78967464|FG001|Overall Study|Physician Decision|2|||
44173787|NCT01905592|78967463|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
44173788|NCT01905592|78967464|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
44173789|NCT01905592|78967463|FG000|Overall Study|Protocol Violation|0|||
44173790|NCT01905592|78967464|FG001|Overall Study|Protocol Violation|1|||
44173791|NCT01905592|78967463|FG000|Overall Study|Sponsor's decision|1|||
44173792|NCT01905592|78967464|FG001|Overall Study|Sponsor's decision|1|||
44173793|NCT01905592|78967463|FG000|Overall Study|Not treated|7|||
44173794|NCT01905592|78967464|FG001|Overall Study|Not treated|3|||
44173795|NCT01905592|78967463|FG000|Overall Study|Withdrawal by Subject|10|||
44173796|NCT01905592|78967464|FG001|Overall Study|Withdrawal by Subject|2|||
44173797|NCT01876420|78967470|FG000|Overall Study|Missed 30 day visit|1|||
44173798|NCT01875874|78967474|FG000|Overall Study|Death|3|||
44173799|NCT02500121|78967481|FG000|Overall Study|Lost to Follow-up|0|||
44173800|NCT02500121|78967482|FG001|Overall Study|Lost to Follow-up|1|||
44173801|NCT02500121|78967481|FG000|Overall Study|Withdrawal by Subject|1|||
44173802|NCT02500121|78967482|FG001|Overall Study|Withdrawal by Subject|1|||
44173803|NCT02500121|78967481|FG000|Overall Study|Death|26|||
44173804|NCT02500121|78967482|FG001|Overall Study|Death|24|||
44173805|NCT01875250|78967492|FG000|Overall Study|Adverse Event|2|||
44173806|NCT01875250|78967493|FG001|Overall Study|Adverse Event|0|||
44173807|NCT01904032|78967503|FG000|Overall Study|Adverse Event|3|||
44173808|NCT01904032|78967504|FG001|Overall Study|Adverse Event|1|||
44173809|NCT01904032|78967503|FG000|Overall Study|Lost to Follow-up|4|||
44173810|NCT01904032|78967504|FG001|Overall Study|Lost to Follow-up|2|||
44173811|NCT01903876|78967512|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
44173812|NCT01903876|78967513|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
44173813|NCT01903876|78967512|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
44173814|NCT01903876|78967513|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
44264348|NCT02502864|79165537|FG000|Overall Study|Withdrawal by Subject|1|||
44264349|NCT02474082|79165571|FG000|Overall Study|Adverse Event|2|||
44264350|NCT02474082|79165572|FG001|Overall Study|Adverse Event|32|||
44264351|NCT02474082|79165571|FG000|Overall Study|Withdrawal of informed consent|1|||
44173815|NCT01921348|78967521|FG000|Overall Study|Withdrawal by Subject|1|||
44173816|NCT01921348|78967522|FG001|Overall Study|Withdrawal by Subject|0|||
44264352|NCT02474082|79165572|FG001|Overall Study|Withdrawal of informed consent|11|||
44173817|NCT01921348|78967521|FG000|Overall Study|Lost to Follow-up|0|||
44173818|NCT01921348|78967522|FG001|Overall Study|Lost to Follow-up|2|||
44173819|NCT01921270|78967528|FG000|Overall Study|Withdrawal by Subject|1|||
44173820|NCT02325739|78967543|FG000|Phase I Part|Adverse Event|1|||
44173821|NCT02325739|78967544|FG001|Phase I Part|Adverse Event|0|||
44173822|NCT02325739|78967545|FG002|Phase I Part|Adverse Event|1|||
44173823|NCT02325739|78967546|FG003|Phase I Part|Adverse Event|2|||
44173824|NCT02325739|78967547|FG004|Phase I Part|Adverse Event|3|||
44173825|NCT02325739|78967548|FG005|Phase I Part|Adverse Event|1|||
44264353|NCT02474082|79165571|FG000|Overall Study|Lost to Follow-up|2|||
44361139|NCT00596011|79366759|FG001|Overall Study|Withdrawal by Subject|3|||
44173826|NCT02325739|78967549|FG006|Phase I Part|Adverse Event|0|||
44173827|NCT02325739|78967550|FG007|Phase I Part|Adverse Event|2|||
44173828|NCT02325739|78967551|FG008|Phase I Part|Adverse Event|0|||
44173829|NCT02325739|78967552|FG009|Phase I Part|Adverse Event|0|||
44173830|NCT02325739|78967553|FG010|Phase I Part|Adverse Event|0|||
44173831|NCT02325739|78967543|FG000|Phase I Part|Progressive disease|9|||
44173832|NCT02325739|78967544|FG001|Phase I Part|Progressive disease|6|||
44173833|NCT02325739|78967545|FG002|Phase I Part|Progressive disease|3|||
44173834|NCT02325739|78967546|FG003|Phase I Part|Progressive disease|23|||
44361140|NCT00596011|79366758|FG000|Overall Study|Adverse Event|11|||
44173835|NCT02325739|78967547|FG004|Phase I Part|Progressive disease|14|||
44173836|NCT02325739|78967548|FG005|Phase I Part|Progressive disease|6|||
44173837|NCT02325739|78967549|FG006|Phase I Part|Progressive disease|6|||
44173838|NCT02325739|78967550|FG007|Phase I Part|Progressive disease|3|||
44173839|NCT02325739|78967551|FG008|Phase I Part|Progressive disease|0|||
44173840|NCT02325739|78967552|FG009|Phase I Part|Progressive disease|0|||
44173841|NCT02325739|78967553|FG010|Phase I Part|Progressive disease|0|||
44173842|NCT02325739|78967543|FG000|Phase I Part|Subject/guardian decision|1|||
44173843|NCT02325739|78967544|FG001|Phase I Part|Subject/guardian decision|0|||
44173844|NCT02325739|78967545|FG002|Phase I Part|Subject/guardian decision|1|||
44173845|NCT02325739|78967546|FG003|Phase I Part|Subject/guardian decision|1|||
44173846|NCT02325739|78967547|FG004|Phase I Part|Subject/guardian decision|0|||
44173847|NCT02325739|78967548|FG005|Phase I Part|Subject/guardian decision|0|||
44173848|NCT02325739|78967549|FG006|Phase I Part|Subject/guardian decision|0|||
44173849|NCT02325739|78967550|FG007|Phase I Part|Subject/guardian decision|1|||
44173850|NCT02325739|78967551|FG008|Phase I Part|Subject/guardian decision|0|||
44173851|NCT02325739|78967552|FG009|Phase I Part|Subject/guardian decision|0|||
44173852|NCT02325739|78967553|FG010|Phase I Part|Subject/guardian decision|0|||
44173853|NCT02325739|78967543|FG000|Phase I Part|Death|0|||
44173854|NCT02325739|78967544|FG001|Phase I Part|Death|0|||
44173855|NCT02325739|78967545|FG002|Phase I Part|Death|0|||
44173856|NCT02325739|78967546|FG003|Phase I Part|Death|0|||
44173857|NCT02325739|78967547|FG004|Phase I Part|Death|2|||
44173858|NCT02325739|78967548|FG005|Phase I Part|Death|0|||
44173859|NCT02325739|78967549|FG006|Phase I Part|Death|0|||
44173860|NCT02325739|78967550|FG007|Phase I Part|Death|0|||
44173861|NCT02325739|78967551|FG008|Phase I Part|Death|0|||
44173862|NCT02325739|78967552|FG009|Phase I Part|Death|0|||
44173863|NCT02325739|78967553|FG010|Phase I Part|Death|0|||
44173864|NCT02325739|78967543|FG000|Phase II Part|Adverse Event|0|||
44173865|NCT02325739|78967544|FG001|Phase II Part|Adverse Event|0|||
44173866|NCT02325739|78967545|FG002|Phase II Part|Adverse Event|0|||
44173867|NCT02325739|78967546|FG003|Phase II Part|Adverse Event|0|||
44173868|NCT02325739|78967547|FG004|Phase II Part|Adverse Event|0|||
44173869|NCT02325739|78967548|FG005|Phase II Part|Adverse Event|0|||
44173870|NCT02325739|78967549|FG006|Phase II Part|Adverse Event|0|||
44173871|NCT02325739|78967550|FG007|Phase II Part|Adverse Event|0|||
44173872|NCT02325739|78967551|FG008|Phase II Part|Adverse Event|4|||
44173873|NCT02325739|78967552|FG009|Phase II Part|Adverse Event|5|||
44173874|NCT02325739|78967553|FG010|Phase II Part|Adverse Event|1|||
44173875|NCT02325739|78967543|FG000|Phase II Part|Physician Decision|0|||
44173876|NCT02325739|78967544|FG001|Phase II Part|Physician Decision|0|||
44173877|NCT02325739|78967545|FG002|Phase II Part|Physician Decision|0|||
44173878|NCT02325739|78967546|FG003|Phase II Part|Physician Decision|0|||
44173879|NCT02325739|78967547|FG004|Phase II Part|Physician Decision|0|||
44173880|NCT02325739|78967548|FG005|Phase II Part|Physician Decision|0|||
44173881|NCT02325739|78967549|FG006|Phase II Part|Physician Decision|0|||
44173882|NCT02325739|78967550|FG007|Phase II Part|Physician Decision|0|||
44173883|NCT02325739|78967551|FG008|Phase II Part|Physician Decision|0|||
44173884|NCT02325739|78967552|FG009|Phase II Part|Physician Decision|1|||
44173885|NCT02325739|78967553|FG010|Phase II Part|Physician Decision|0|||
44173886|NCT02325739|78967543|FG000|Phase II Part|Progressive disease|0|||
44173887|NCT02325739|78967544|FG001|Phase II Part|Progressive disease|0|||
44173888|NCT02325739|78967545|FG002|Phase II Part|Progressive disease|0|||
44173889|NCT02325739|78967546|FG003|Phase II Part|Progressive disease|0|||
44173890|NCT02325739|78967547|FG004|Phase II Part|Progressive disease|0|||
44173891|NCT02325739|78967548|FG005|Phase II Part|Progressive disease|0|||
44173892|NCT02325739|78967549|FG006|Phase II Part|Progressive disease|0|||
44173893|NCT02325739|78967550|FG007|Phase II Part|Progressive disease|0|||
44173894|NCT02325739|78967551|FG008|Phase II Part|Progressive disease|22|||
44264354|NCT02474082|79165572|FG001|Overall Study|Lost to Follow-up|2|||
44264355|NCT02474082|79165571|FG000|Overall Study|Dose tapering not achieved|0|||
44361141|NCT00596011|79366759|FG001|Overall Study|Adverse Event|7|||
44173895|NCT02325739|78967552|FG009|Phase II Part|Progressive disease|29|||
44173896|NCT02325739|78967553|FG010|Phase II Part|Progressive disease|18|||
44173897|NCT02325739|78967543|FG000|Phase II Part|Subject/guardian decision|0|||
44173898|NCT02325739|78967544|FG001|Phase II Part|Subject/guardian decision|0|||
44173899|NCT02325739|78967545|FG002|Phase II Part|Subject/guardian decision|0|||
44173900|NCT02325739|78967546|FG003|Phase II Part|Subject/guardian decision|0|||
44173901|NCT02325739|78967547|FG004|Phase II Part|Subject/guardian decision|0|||
44173902|NCT02325739|78967548|FG005|Phase II Part|Subject/guardian decision|0|||
44173903|NCT02325739|78967549|FG006|Phase II Part|Subject/guardian decision|0|||
44173904|NCT02325739|78967550|FG007|Phase II Part|Subject/guardian decision|0|||
44173905|NCT02325739|78967551|FG008|Phase II Part|Subject/guardian decision|4|||
44173906|NCT02325739|78967552|FG009|Phase II Part|Subject/guardian decision|1|||
44173907|NCT02325739|78967553|FG010|Phase II Part|Subject/guardian decision|1|||
44173908|NCT01903720|78967598|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
44173909|NCT01903720|78967598|FG000|Overall Study|Adverse Event|1|||
44173910|NCT01903720|78967598|FG000|Overall Study|Rescinding of informed consent|2|||
44173911|NCT01903720|78967598|FG000|Overall Study|Lost to Follow-up|2|||
44173912|NCT01903720|78967598|FG000|Overall Study|Treatment with alternative drug|1|||
44173913|NCT02366689|78967605|FG000|Overall Study|Withdrawal by Subject|1|||
44173914|NCT02366689|78967606|FG001|Overall Study|Withdrawal by Subject|0|||
44173915|NCT02366689|78967607|FG002|Overall Study|Withdrawal by Subject|1|||
44173916|NCT02366689|78967605|FG000|Overall Study|Lost to Follow-up|3|||
44264356|NCT02474082|79165572|FG001|Overall Study|Dose tapering not achieved|4|||
44264357|NCT02474082|79165571|FG000|Overall Study|Participant/guardian decision|1|||
44173917|NCT02366689|78967606|FG001|Overall Study|Lost to Follow-up|2|||
44264358|NCT02474082|79165572|FG001|Overall Study|Participant/guardian decision|2|||
44264359|NCT02474082|79165571|FG000|Overall Study|Non-compliance with study treatment|0|||
44264360|NCT02474082|79165572|FG001|Overall Study|Non-compliance with study treatment|2|||
44264361|NCT02474082|79165571|FG000|Overall Study|Protocol deviation|0|||
44264362|NCT02474082|79165572|FG001|Overall Study|Protocol deviation|1|||
44264363|NCT02501928|79165682|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
44264364|NCT02501928|79165683|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
44264365|NCT02501928|79165684|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
44264366|NCT02501928|79165685|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
44264367|NCT02501928|79165686|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
44264368|NCT02501928|79165687|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
44264369|NCT02473614|79165751|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
44264370|NCT02473614|79165752|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
44264371|NCT02500758|79165774|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
44264372|NCT02500758|79165775|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
44264373|NCT02500758|79165774|FG000|Washout (1 Week)|Lost to Follow-up|2|||
44264374|NCT02500758|79165775|FG001|Washout (1 Week)|Lost to Follow-up|2|||
44264375|NCT02500758|79165774|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
44264376|NCT02500758|79165775|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
44264377|NCT02500758|79165774|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
44264378|NCT02500758|79165775|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
44173918|NCT02366689|78967607|FG002|Overall Study|Lost to Follow-up|0|||
44173919|NCT02366689|78967605|FG000|Overall Study|Pregnancy|0|||
44173920|NCT02366689|78967606|FG001|Overall Study|Pregnancy|1|||
44173921|NCT02366689|78967607|FG002|Overall Study|Pregnancy|1|||
44173922|NCT01903252|78967617|FG000|Double-Blind Induction|Adverse Event|20|||
44173923|NCT01903252|78967618|FG001|Double-Blind Induction|Adverse Event|18|||
44173924|NCT01903252|78967619|FG002|Double-Blind Induction|Adverse Event|0|||
44173925|NCT01903252|78967620|FG003|Double-Blind Induction|Adverse Event|0|||
44173926|NCT01903252|78967621|FG004|Double-Blind Induction|Adverse Event|0|||
44173927|NCT01903252|78967622|FG005|Double-Blind Induction|Adverse Event|0|||
44173928|NCT01903252|78967617|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
44173929|NCT01903252|78967618|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
44173930|NCT01903252|78967619|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
44173931|NCT01903252|78967620|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
44173932|NCT01903252|78967621|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
44173933|NCT01903252|78967622|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
44173934|NCT01903252|78967617|FG000|Double-Blind Induction|Physician Decision|2|||
44173935|NCT01903252|78967618|FG001|Double-Blind Induction|Physician Decision|3|||
44173936|NCT01903252|78967619|FG002|Double-Blind Induction|Physician Decision|0|||
44173937|NCT01903252|78967620|FG003|Double-Blind Induction|Physician Decision|0|||
44173938|NCT01903252|78967621|FG004|Double-Blind Induction|Physician Decision|0|||
44173939|NCT01903252|78967622|FG005|Double-Blind Induction|Physician Decision|0|||
44173940|NCT01903252|78967617|FG000|Double-Blind Induction|non-compliance,|7|||
44173941|NCT01903252|78967618|FG001|Double-Blind Induction|non-compliance,|7|||
44173942|NCT01903252|78967619|FG002|Double-Blind Induction|non-compliance,|0|||
44173943|NCT01903252|78967620|FG003|Double-Blind Induction|non-compliance,|0|||
44173944|NCT01903252|78967621|FG004|Double-Blind Induction|non-compliance,|0|||
44173945|NCT01903252|78967622|FG005|Double-Blind Induction|non-compliance,|0|||
44173946|NCT01903252|78967617|FG000|Extended Induction, Open-Label|Adverse Event|0|||
44173947|NCT01903252|78967618|FG001|Extended Induction, Open-Label|Adverse Event|0|||
44173948|NCT01903252|78967619|FG002|Extended Induction, Open-Label|Adverse Event|17|||
44173949|NCT01903252|78967620|FG003|Extended Induction, Open-Label|Adverse Event|0|||
44173950|NCT01903252|78967621|FG004|Extended Induction, Open-Label|Adverse Event|0|||
44173951|NCT01903252|78967622|FG005|Extended Induction, Open-Label|Adverse Event|0|||
44173952|NCT01903252|78967617|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
44173953|NCT01903252|78967618|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
44173954|NCT01903252|78967619|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
44173955|NCT01903252|78967620|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
44173956|NCT01903252|78967621|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
44173957|NCT01903252|78967622|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
44173958|NCT01903252|78967617|FG000|Extended Induction, Open-Label|Physician Decision|0|||
44173959|NCT01903252|78967618|FG001|Extended Induction, Open-Label|Physician Decision|0|||
44173960|NCT01903252|78967619|FG002|Extended Induction, Open-Label|Physician Decision|1|||
44173961|NCT01903252|78967620|FG003|Extended Induction, Open-Label|Physician Decision|0|||
44173962|NCT01903252|78967621|FG004|Extended Induction, Open-Label|Physician Decision|0|||
44173963|NCT01903252|78967622|FG005|Extended Induction, Open-Label|Physician Decision|0|||
44173964|NCT01903252|78967617|FG000|Maintenance, Open-Label|Adverse Event|0|||
44264379|NCT02500758|79165774|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
44264380|NCT02500758|79165775|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
44264381|NCT02500056|79165789|FG000|Overall Study|Lost to Follow-up|3|||
44264382|NCT02500056|79165790|FG001|Overall Study|Lost to Follow-up|7|||
44173965|NCT01903252|78967618|FG001|Maintenance, Open-Label|Adverse Event|0|||
44173966|NCT01903252|78967619|FG002|Maintenance, Open-Label|Adverse Event|0|||
44173967|NCT01903252|78967620|FG003|Maintenance, Open-Label|Adverse Event|3|||
44173968|NCT01903252|78967621|FG004|Maintenance, Open-Label|Adverse Event|9|||
44173969|NCT01903252|78967622|FG005|Maintenance, Open-Label|Adverse Event|14|||
44173970|NCT01903252|78967617|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
44173971|NCT01903252|78967618|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
44173972|NCT01903252|78967619|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
44173973|NCT01903252|78967620|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
44173974|NCT01903252|78967621|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
44173975|NCT01903252|78967622|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
44173976|NCT01903252|78967617|FG000|Maintenance, Open-Label|Other|0|||
44173977|NCT01903252|78967618|FG001|Maintenance, Open-Label|Other|0|||
44173978|NCT01903252|78967619|FG002|Maintenance, Open-Label|Other|0|||
44173979|NCT01903252|78967620|FG003|Maintenance, Open-Label|Other|2|||
44173980|NCT01903252|78967621|FG004|Maintenance, Open-Label|Other|6|||
44173981|NCT01903252|78967622|FG005|Maintenance, Open-Label|Other|2|||
44173982|NCT01920958|78967640|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
44173983|NCT01613716|78967644|FG000|Overall Study|screen failures|3|||
44173984|NCT01613716|78967644|FG000|Overall Study|Lost to Follow-up|4|||
44173985|NCT01872910|78967654|FG000|Overall Study|Lost to Follow-up|2|||
44173986|NCT01872910|78967655|FG001|Overall Study|Lost to Follow-up|0|||
44173987|NCT01872910|78967656|FG002|Overall Study|Lost to Follow-up|2|||
44173988|NCT01872910|78967657|FG003|Overall Study|Lost to Follow-up|0|||
44173989|NCT01872910|78967658|FG004|Overall Study|Lost to Follow-up|0|||
44173990|NCT01872910|78967659|FG005|Overall Study|Lost to Follow-up|0|||
44173991|NCT01920568|78967674|FG000|Overall Study|Adverse Event|27|||
44173992|NCT01920568|78967675|FG001|Overall Study|Adverse Event|8|||
44173993|NCT01920568|78967674|FG000|Overall Study|Protocol Violation|5|||
44173994|NCT01920568|78967675|FG001|Overall Study|Protocol Violation|3|||
44173995|NCT01920568|78967674|FG000|Overall Study|Lost to Follow-up|2|||
44173996|NCT01920568|78967675|FG001|Overall Study|Lost to Follow-up|2|||
44173997|NCT01920568|78967674|FG000|Overall Study|Physician Decision|13|||
44173998|NCT01920568|78967675|FG001|Overall Study|Physician Decision|4|||
44173999|NCT01920568|78967674|FG000|Overall Study|Withdrawal by Subject|79|||
44174000|NCT01920568|78967675|FG001|Overall Study|Withdrawal by Subject|55|||
44174001|NCT01920568|78967674|FG000|Overall Study|Death due to disease progression|25|||
44174002|NCT01920568|78967675|FG001|Overall Study|Death due to disease progression|12|||
44174003|NCT01902628|78967682|FG000|Overall Study|Withdrawal of participant's consent|7|||
44174004|NCT01902628|78967682|FG000|Overall Study|Adverse Event|41|||
44174005|NCT01902628|78967682|FG000|Overall Study|Lost to Follow-up|35|||
44174006|NCT01920178|78967688|FG000|Overall Study|Lost to Follow-up|2|||
44174007|NCT01920178|78967689|FG001|Overall Study|Lost to Follow-up|1|||
44174008|NCT01901848|78967697|FG000|Randomized and Treated|Lost to Follow-up|3|||
44174009|NCT01901848|78967698|FG001|Randomized and Treated|Lost to Follow-up|6|||
44174010|NCT01901848|78967697|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
44174011|NCT01901848|78967698|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
44174012|NCT01901614|78967706|FG000|Overall Study|Adverse Event|0|||
44174013|NCT01901614|78967707|FG001|Overall Study|Adverse Event|1|||
44174014|NCT01901614|78967706|FG000|Overall Study|Lost to Follow-up|1|||
44174015|NCT01901614|78967707|FG001|Overall Study|Lost to Follow-up|0|||
44174016|NCT01901614|78967706|FG000|Overall Study|Screen Fail|1|||
44174017|NCT01901614|78967707|FG001|Overall Study|Screen Fail|0|||
44174018|NCT01901302|78967715|FG000|Overall Study|Adverse Event|2|||
44174019|NCT01901302|78967716|FG001|Overall Study|Adverse Event|1|||
44174020|NCT01901302|78967715|FG000|Overall Study|Lack of Efficacy|0|||
44174021|NCT01901302|78967716|FG001|Overall Study|Lack of Efficacy|2|||
44174022|NCT01901302|78967715|FG000|Overall Study|Study Terminated by Sponsor|23|||
44174023|NCT01901302|78967716|FG001|Overall Study|Study Terminated by Sponsor|20|||
44174024|NCT01901302|78967715|FG000|Overall Study|Withdrawal by Subject|2|||
44174025|NCT01901302|78967716|FG001|Overall Study|Withdrawal by Subject|0|||
44264383|NCT02500056|79165789|FG000|Overall Study|Recurrence|1|||
44174026|NCT01919398|78967725|FG000|Overall Study|Progressive Disease|0|||
44174027|NCT01919398|78967726|FG001|Overall Study|Progressive Disease|0|||
44174028|NCT01919398|78967727|FG002|Overall Study|Progressive Disease|4|||
44174029|NCT02500043|78967737|FG000|Overall Study|Randomized, but not Treated|2|||
44264384|NCT02500056|79165790|FG001|Overall Study|Recurrence|0|||
44264385|NCT02500056|79165789|FG000|Overall Study|Death|3|||
44174030|NCT02500043|78967738|FG001|Overall Study|Randomized, but not Treated|2|||
44174031|NCT02500043|78967737|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
44174032|NCT02500043|78967738|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
44174033|NCT02500043|78967737|FG000|Overall Study|Adverse Event|33|||
44174034|NCT02500043|78967738|FG001|Overall Study|Adverse Event|11|||
44174035|NCT02500043|78967737|FG000|Overall Study|Clinical Progression|54|||
44174036|NCT02500043|78967738|FG001|Overall Study|Clinical Progression|35|||
44174037|NCT02500043|78967737|FG000|Overall Study|Radiological Progression|192|||
44174038|NCT02500043|78967738|FG001|Overall Study|Radiological Progression|110|||
44264386|NCT02500056|79165790|FG001|Overall Study|Death|1|||
44174039|NCT02500043|78967737|FG000|Overall Study|Physician's Decision|11|||
44174040|NCT02500043|78967738|FG001|Overall Study|Physician's Decision|3|||
44174041|NCT02500043|78967737|FG000|Overall Study|Withdrawal by Subject|14|||
44174042|NCT02500043|78967738|FG001|Overall Study|Withdrawal by Subject|4|||
44174043|NCT02500043|78967737|FG000|Overall Study|Death|11|||
44174044|NCT02500043|78967738|FG001|Overall Study|Death|2|||
44174045|NCT02500043|78967737|FG000|Overall Study|Protocol Deviation|1|||
44174046|NCT02500043|78967738|FG001|Overall Study|Protocol Deviation|0|||
44174047|NCT02499575|78967746|FG000|Overall Study|Protocol Violation|0|||
44174048|NCT02499575|78967747|FG001|Overall Study|Protocol Violation|1|||
44174049|NCT02065791|78967755|FG000|Overall Study|Closed Site|1|||
44174050|NCT02065791|78967756|FG001|Overall Study|Closed Site|1|||
44174051|NCT02065791|78967755|FG000|Overall Study|Withdrawal by Subject|11|||
44174052|NCT02065791|78967756|FG001|Overall Study|Withdrawal by Subject|5|||
44174053|NCT02065791|78967755|FG000|Overall Study|Lost to Follow-up|13|||
44174054|NCT02065791|78967756|FG001|Overall Study|Lost to Follow-up|9|||
44174055|NCT02499263|78967762|FG000|Overall Study|Lost to Follow-up|9|||
44264387|NCT02472756|79165839|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
44264388|NCT02472756|79165839|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
44264389|NCT02472756|79165839|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
44264390|NCT02472756|79165839|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
44264391|NCT02472756|79165839|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
44264392|NCT02498652|79165849|FG000|Overall Study|Protocol Violation|0|||
44264393|NCT02498652|79165850|FG001|Overall Study|Protocol Violation|1|||
44174056|NCT02499263|78967762|FG000|Overall Study|Participant's withdrawal of consent|4|||
44174057|NCT02499263|78967762|FG000|Overall Study|Lack of Efficacy|22|||
44174058|NCT02499263|78967762|FG000|Overall Study|investigator's judgment|12|||
44174059|NCT02499263|78967762|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
44174060|NCT02499263|78967762|FG000|Overall Study|Participant's decision|3|||
44174061|NCT02499263|78967762|FG000|Overall Study|Pregnancy|1|||
44174062|NCT01654289|78967769|FG000|Overall Study|Withdrawal by Subject|10|||
44174063|NCT01654289|78967770|FG001|Overall Study|Withdrawal by Subject|8|||
44174064|NCT01654289|78967771|FG002|Overall Study|Withdrawal by Subject|5|||
44174065|NCT01654289|78967769|FG000|Overall Study|Withdrew from intervention only|17|||
44174066|NCT01654289|78967770|FG001|Overall Study|Withdrew from intervention only|20|||
44174067|NCT01654289|78967771|FG002|Overall Study|Withdrew from intervention only|0|||
44174068|NCT02499029|78967781|FG000|Overall Study|Lost to Follow-up|2|||
44174069|NCT02499029|78967782|FG001|Overall Study|Lost to Follow-up|2|||
44174070|NCT02499029|78967781|FG000|Overall Study|Physician Decision|2|||
44174071|NCT02499029|78967782|FG001|Overall Study|Physician Decision|1|||
44174072|NCT02499029|78967781|FG000|Overall Study|Death|1|||
44174073|NCT02499029|78967782|FG001|Overall Study|Death|0|||
44174074|NCT04968353|78967792|FG000|Overall Study|Non-compliance|1|||
44174075|NCT04968353|78967793|FG001|Overall Study|Non-compliance|0|||
44174076|NCT04968353|78967794|FG002|Overall Study|Non-compliance|2|||
44174077|NCT04968353|78967795|FG003|Overall Study|Non-compliance|0|||
44174078|NCT02065713|78967807|FG000|Overall Study|Adverse Event|0|||
44174079|NCT02065713|78967808|FG001|Overall Study|Adverse Event|1|||
44174080|NCT02065713|78967807|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44174081|NCT02065713|78967808|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44174082|NCT02497781|78967816|FG000|Overall Study|Withdrawal by Subject|2|||
44174083|NCT02497781|78967817|FG001|Overall Study|Withdrawal by Subject|0|||
44174084|NCT02497781|78967816|FG000|Overall Study|Lack of Efficacy|0|||
44174085|NCT02497781|78967817|FG001|Overall Study|Lack of Efficacy|1|||
44174086|NCT02497781|78967816|FG000|Overall Study|Randomised but not treated|1|||
44174087|NCT02497781|78967817|FG001|Overall Study|Randomised but not treated|1|||
44174088|NCT02497781|78967816|FG000|Overall Study|Lost to Follow-up|1|||
44174089|NCT02497781|78967817|FG001|Overall Study|Lost to Follow-up|1|||
44174090|NCT02497469|78967825|FG000|Overall Study|Randomized but not Treated|0|||
44174091|NCT02497469|78967826|FG001|Overall Study|Randomized but not Treated|2|||
44174092|NCT02497469|78967825|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
44264394|NCT03213158|79165874|FG000|Overall Study|Withdrawal by Subject|1|||
44264395|NCT03213158|79165874|FG000|Overall Study|Physician Decision|2|||
44174093|NCT02497469|78967826|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
44264396|NCT02498418|79165881|FG000|Overall Study|Lack of Efficacy|0|||
44264397|NCT02498418|79165882|FG001|Overall Study|Lack of Efficacy|0|||
44174094|NCT02497469|78967825|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
44264398|NCT02498418|79165883|FG002|Overall Study|Lack of Efficacy|1|||
44264399|NCT02498418|79165881|FG000|Overall Study|Withdrawal by Subject|2|||
44264400|NCT02498418|79165882|FG001|Overall Study|Withdrawal by Subject|0|||
44174095|NCT02497469|78967826|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
44174096|NCT02497469|78967825|FG000|Overall Study|Significant Protocol Deviation|4|||
44174097|NCT02497469|78967826|FG001|Overall Study|Significant Protocol Deviation|5|||
44174098|NCT02497469|78967825|FG000|Overall Study|Lost to Follow-up|14|||
44174099|NCT02497469|78967826|FG001|Overall Study|Lost to Follow-up|4|||
44174100|NCT02497469|78967825|FG000|Overall Study|Voluntary Withdrawal|39|||
44174101|NCT02497469|78967826|FG001|Overall Study|Voluntary Withdrawal|41|||
44174102|NCT02497469|78967825|FG000|Overall Study|Pregnancy|1|||
44174103|NCT02497469|78967826|FG001|Overall Study|Pregnancy|1|||
44174104|NCT02497469|78967825|FG000|Overall Study|Lack of Efficacy|86|||
44174105|NCT02497469|78967826|FG001|Overall Study|Lack of Efficacy|40|||
44174106|NCT02497469|78967825|FG000|Overall Study|Reason not Specified|6|||
44174107|NCT02497469|78967826|FG001|Overall Study|Reason not Specified|6|||
44174108|NCT02497391|78967832|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
44174109|NCT02497391|78967833|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
44174110|NCT02497391|78967834|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
44174111|NCT02497391|78967835|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
44174112|NCT02497391|78967836|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
44174113|NCT02497391|78967837|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
44174114|NCT02497391|78967832|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
44174115|NCT02497391|78967833|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
44174116|NCT02497391|78967834|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
44174117|NCT02497391|78967835|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
44174118|NCT02497391|78967836|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
44174119|NCT02497391|78967837|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
44174120|NCT02497391|78967832|FG000|Period 3 (14 Days)|Adverse Event|0|||
44174121|NCT02497391|78967833|FG001|Period 3 (14 Days)|Adverse Event|1|||
44174122|NCT02497391|78967834|FG002|Period 3 (14 Days)|Adverse Event|0|||
44174123|NCT02497391|78967835|FG003|Period 3 (14 Days)|Adverse Event|0|||
44174124|NCT02497391|78967836|FG004|Period 3 (14 Days)|Adverse Event|0|||
44174125|NCT02497391|78967837|FG005|Period 3 (14 Days)|Adverse Event|0|||
44174126|NCT02497391|78967832|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
44174127|NCT02497391|78967833|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
44174128|NCT02497391|78967834|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
44174129|NCT02497391|78967835|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
44174130|NCT02497391|78967836|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
44174131|NCT02497391|78967837|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
44174132|NCT02497391|78967832|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
44174133|NCT02497391|78967833|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
44174134|NCT02497391|78967834|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
44174135|NCT02497391|78967835|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
44174136|NCT02497391|78967836|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
44174137|NCT02497391|78967837|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
44174138|NCT02476175|78967845|FG000|Overall Study|Adverse Event|2|||
44174139|NCT02065557|78967852|FG000|Induction Period|Withdrawal by Subject|2|||
44174140|NCT02065557|78967853|FG001|Induction Period|Withdrawal by Subject|1|||
44174141|NCT02065557|78967854|FG002|Induction Period|Withdrawal by Subject|0|||
44174142|NCT02065557|78967855|FG003|Induction Period|Withdrawal by Subject|0|||
44174143|NCT02065557|78967856|FG004|Induction Period|Withdrawal by Subject|0|||
44174144|NCT02065557|78967857|FG005|Induction Period|Withdrawal by Subject|0|||
44174145|NCT02065557|78967852|FG000|Induction Period|Lack of Efficacy|2|||
44174146|NCT02065557|78967853|FG001|Induction Period|Lack of Efficacy|1|||
44174147|NCT02065557|78967854|FG002|Induction Period|Lack of Efficacy|1|||
44174148|NCT02065557|78967855|FG003|Induction Period|Lack of Efficacy|0|||
44174149|NCT02065557|78967856|FG004|Induction Period|Lack of Efficacy|0|||
44174150|NCT02065557|78967857|FG005|Induction Period|Lack of Efficacy|0|||
44174151|NCT02065557|78967852|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
44174152|NCT02065557|78967853|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
44174153|NCT02065557|78967854|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
44174154|NCT02065557|78967855|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
44174155|NCT02065557|78967856|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
44174156|NCT02065557|78967857|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
44174157|NCT02065557|78967852|FG000|Induction Period|Non-Responder at Week 8|4|||
44174158|NCT02065557|78967853|FG001|Induction Period|Non-Responder at Week 8|4|||
44174159|NCT02065557|78967854|FG002|Induction Period|Non-Responder at Week 8|0|||
44174160|NCT02065557|78967855|FG003|Induction Period|Non-Responder at Week 8|0|||
44264401|NCT02498418|79165883|FG002|Overall Study|Withdrawal by Subject|3|||
44264402|NCT02498418|79165881|FG000|Overall Study|Lost to Follow-up|0|||
44264403|NCT02498418|79165882|FG001|Overall Study|Lost to Follow-up|1|||
44264404|NCT02498418|79165883|FG002|Overall Study|Lost to Follow-up|1|||
44264405|NCT02498418|79165881|FG000|Overall Study|Participant taken prohibited medication|0|||
44174161|NCT02065557|78967856|FG004|Induction Period|Non-Responder at Week 8|0|||
44174162|NCT02065557|78967857|FG005|Induction Period|Non-Responder at Week 8|0|||
44174163|NCT02065557|78967852|FG000|Induction Period|Adverse Event|1|||
44174164|NCT02065557|78967853|FG001|Induction Period|Adverse Event|1|||
44174165|NCT02065557|78967854|FG002|Induction Period|Adverse Event|0|||
44174166|NCT02065557|78967855|FG003|Induction Period|Adverse Event|0|||
44174167|NCT02065557|78967856|FG004|Induction Period|Adverse Event|0|||
44174168|NCT02065557|78967857|FG005|Induction Period|Adverse Event|0|||
44174169|NCT02065557|78967852|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
44174170|NCT02065557|78967853|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
44174171|NCT02065557|78967854|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
44174172|NCT02065557|78967855|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
44174173|NCT02065557|78967856|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
44264406|NCT02498418|79165882|FG001|Overall Study|Participant taken prohibited medication|1|||
44264407|NCT02498418|79165883|FG002|Overall Study|Participant taken prohibited medication|1|||
44264408|NCT02472366|79165901|FG000|Overall Study|Lost to Follow-up|1|||
44264409|NCT02472366|79165902|FG001|Overall Study|Lost to Follow-up|0|||
44264410|NCT03219164|79165910|FG000|Overall Study|Study Terminated by Sponsor|16|||
44264411|NCT03219164|79165911|FG001|Overall Study|Study Terminated by Sponsor|12|||
44361142|NCT01163747|79366767|FG000|Overall Study|Adverse Event|0|||
44361143|NCT01163747|79366768|FG001|Overall Study|Adverse Event|5|||
44174174|NCT02065557|78967857|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
44543026|NCT03655717|79555903|FG003|Overall Study|Lost to Follow-up|1|||
44174175|NCT02065557|78967852|FG000|Maintenance Period|Withdrawal by Subject|0|||
44174176|NCT02065557|78967853|FG001|Maintenance Period|Withdrawal by Subject|0|||
44174177|NCT02065557|78967854|FG002|Maintenance Period|Withdrawal by Subject|0|||
44174178|NCT02065557|78967855|FG003|Maintenance Period|Withdrawal by Subject|0|||
44174179|NCT02065557|78967856|FG004|Maintenance Period|Withdrawal by Subject|2|||
44174180|NCT02065557|78967857|FG005|Maintenance Period|Withdrawal by Subject|1|||
44174181|NCT02065557|78967852|FG000|Maintenance Period|Lack of Efficacy|0|||
44174182|NCT02065557|78967853|FG001|Maintenance Period|Lack of Efficacy|0|||
44174183|NCT02065557|78967854|FG002|Maintenance Period|Lack of Efficacy|0|||
44174184|NCT02065557|78967855|FG003|Maintenance Period|Lack of Efficacy|0|||
44174185|NCT02065557|78967856|FG004|Maintenance Period|Lack of Efficacy|5|||
44174186|NCT02065557|78967857|FG005|Maintenance Period|Lack of Efficacy|2|||
44174187|NCT02065557|78967852|FG000|Maintenance Period|Subject Non-Compliance|0|||
44174188|NCT02065557|78967853|FG001|Maintenance Period|Subject Non-Compliance|0|||
44174189|NCT02065557|78967854|FG002|Maintenance Period|Subject Non-Compliance|0|||
44174190|NCT02065557|78967855|FG003|Maintenance Period|Subject Non-Compliance|0|||
44174191|NCT02065557|78967856|FG004|Maintenance Period|Subject Non-Compliance|0|||
44174192|NCT02065557|78967857|FG005|Maintenance Period|Subject Non-Compliance|1|||
44174193|NCT02065245|78967889|FG000|Infusion 1|Lost to Follow-up|0|||
44174194|NCT02065245|78967890|FG001|Infusion 1|Lost to Follow-up|0|||
44174195|NCT02065245|78967891|FG002|Infusion 1|Lost to Follow-up|0|||
44174196|NCT02065245|78967892|FG003|Infusion 1|Lost to Follow-up|0|||
44174197|NCT02065245|78967893|FG004|Infusion 1|Lost to Follow-up|0|||
44174198|NCT02065245|78967894|FG005|Infusion 1|Lost to Follow-up|0|||
44174199|NCT02065245|78967895|FG006|Infusion 1|Lost to Follow-up|1|||
44174200|NCT02065245|78967889|FG000|Infusion 1|Death|0|||
44174201|NCT02065245|78967890|FG001|Infusion 1|Death|0|||
44174202|NCT02065245|78967891|FG002|Infusion 1|Death|1|||
44174203|NCT02065245|78967892|FG003|Infusion 1|Death|0|||
44174204|NCT02065245|78967893|FG004|Infusion 1|Death|1|||
44174205|NCT02065245|78967894|FG005|Infusion 1|Death|0|||
44174206|NCT02065245|78967895|FG006|Infusion 1|Death|0|||
44174207|NCT02065245|78967889|FG000|Infusion 2|Death|0|||
44174208|NCT02065245|78967890|FG001|Infusion 2|Death|0|||
44174209|NCT02065245|78967891|FG002|Infusion 2|Death|0|||
44174210|NCT02065245|78967892|FG003|Infusion 2|Death|0|||
44174211|NCT02065245|78967893|FG004|Infusion 2|Death|0|||
44174212|NCT02065245|78967894|FG005|Infusion 2|Death|0|||
44174213|NCT02065245|78967895|FG006|Infusion 2|Death|1|||
44174214|NCT02065245|78967889|FG000|Infusion 3|Lost to Follow-up|1|||
44174215|NCT02065245|78967890|FG001|Infusion 3|Lost to Follow-up|1|||
44174216|NCT02065245|78967891|FG002|Infusion 3|Lost to Follow-up|0|||
44174217|NCT02065245|78967892|FG003|Infusion 3|Lost to Follow-up|0|||
44174218|NCT02065245|78967893|FG004|Infusion 3|Lost to Follow-up|0|||
44174219|NCT02065245|78967894|FG005|Infusion 3|Lost to Follow-up|0|||
44174220|NCT02065245|78967895|FG006|Infusion 3|Lost to Follow-up|0|||
44174221|NCT02043015|78967911|FG000|Overall Study|Lost to Follow-up|4|||
44174222|NCT02043015|78967911|FG000|Overall Study|Withdrawal by Subject|4|||
44174223|NCT02043015|78967911|FG000|Overall Study|Removed once target enrollment reached|15|||
44174224|NCT02043015|78967911|FG000|Overall Study|Participant moved away from study city|4|||
44174225|NCT02043015|78967911|FG000|Overall Study|Incarceration|1|||
44174226|NCT02064231|78967917|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
44174227|NCT02064231|78967918|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
44174228|NCT02064231|78967919|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
44451066|NCT02294461|79459968|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
44451067|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
44174229|NCT02064231|78967920|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
44174230|NCT02064231|78967917|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
44174231|NCT02064231|78967918|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
44174232|NCT02064231|78967919|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
44174233|NCT02064231|78967920|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
44174234|NCT02064231|78967917|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
44543027|NCT03655717|79555904|FG004|Overall Study|Lost to Follow-up|0|||
44174235|NCT02064231|78967918|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
44174236|NCT02064231|78967919|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
44174237|NCT02064231|78967920|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
44174238|NCT02064231|78967917|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
44174239|NCT02064231|78967918|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
44174240|NCT02064231|78967919|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
44174241|NCT02064231|78967920|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
44174242|NCT02063217|78967935|FG000|Overall Study|Withdrawal by Subject|1|||
44174243|NCT02063217|78967936|FG001|Overall Study|Withdrawal by Subject|0|||
44174244|NCT02063217|78967937|FG002|Overall Study|Withdrawal by Subject|0|||
44174245|NCT02497001|78967949|FG000|Overall Study|Lost to Follow-up|10|||
44174246|NCT02497001|78967950|FG001|Overall Study|Lost to Follow-up|2|||
44174247|NCT02497001|78967951|FG002|Overall Study|Lost to Follow-up|0|||
44174248|NCT02497001|78967952|FG003|Overall Study|Lost to Follow-up|2|||
44174249|NCT02497001|78967949|FG000|Overall Study|Adverse Event|28|||
44174250|NCT02497001|78967950|FG001|Overall Study|Adverse Event|30|||
44174251|NCT02497001|78967951|FG002|Overall Study|Adverse Event|11|||
44174252|NCT02497001|78967952|FG003|Overall Study|Adverse Event|11|||
44174253|NCT02497001|78967949|FG000|Overall Study|Withdrawal by Subject|14|||
44174254|NCT02497001|78967950|FG001|Overall Study|Withdrawal by Subject|37|||
44174255|NCT02497001|78967951|FG002|Overall Study|Withdrawal by Subject|19|||
44174256|NCT02497001|78967952|FG003|Overall Study|Withdrawal by Subject|15|||
44174257|NCT02497001|78967949|FG000|Overall Study|Physician Decision|5|||
44174258|NCT02497001|78967950|FG001|Overall Study|Physician Decision|11|||
44174259|NCT02497001|78967951|FG002|Overall Study|Physician Decision|5|||
44174260|NCT02497001|78967952|FG003|Overall Study|Physician Decision|1|||
44174261|NCT02497001|78967949|FG000|Overall Study|subjects that were not treated|1|||
44174262|NCT02497001|78967950|FG001|Overall Study|subjects that were not treated|2|||
44174263|NCT02497001|78967951|FG002|Overall Study|subjects that were not treated|2|||
44174264|NCT02497001|78967952|FG003|Overall Study|subjects that were not treated|1|||
44174265|NCT02497001|78967949|FG000|Overall Study|Major Protocol Deviation|3|||
44174266|NCT02497001|78967950|FG001|Overall Study|Major Protocol Deviation|4|||
44174267|NCT02497001|78967951|FG002|Overall Study|Major Protocol Deviation|4|||
44174268|NCT02497001|78967952|FG003|Overall Study|Major Protocol Deviation|4|||
44174269|NCT02497001|78967949|FG000|Overall Study|Lack of Efficacy|10|||
44174270|NCT02497001|78967950|FG001|Overall Study|Lack of Efficacy|16|||
44174271|NCT02497001|78967951|FG002|Overall Study|Lack of Efficacy|6|||
44174272|NCT02497001|78967952|FG003|Overall Study|Lack of Efficacy|6|||
44174273|NCT02497001|78967949|FG000|Overall Study|Protocol Violation|3|||
44174274|NCT02497001|78967950|FG001|Overall Study|Protocol Violation|1|||
44174275|NCT02497001|78967951|FG002|Overall Study|Protocol Violation|3|||
44174276|NCT02497001|78967952|FG003|Overall Study|Protocol Violation|1|||
44174277|NCT02366143|78967968|FG000|Overall Study|Death|307|||
44174278|NCT02366143|78967969|FG001|Overall Study|Death|278|||
44174279|NCT02366143|78967970|FG002|Overall Study|Death|280|||
44174280|NCT02366143|78967968|FG000|Overall Study|Lost to Follow-up|2|||
44174281|NCT02366143|78967969|FG001|Overall Study|Lost to Follow-up|4|||
44174282|NCT02366143|78967970|FG002|Overall Study|Lost to Follow-up|2|||
44174283|NCT02366143|78967968|FG000|Overall Study|Physician Decision|1|||
44174284|NCT02366143|78967969|FG001|Overall Study|Physician Decision|2|||
44174285|NCT02366143|78967970|FG002|Overall Study|Physician Decision|1|||
44174286|NCT02366143|78967968|FG000|Overall Study|Protocol Violation|0|||
44174287|NCT02366143|78967969|FG001|Overall Study|Protocol Violation|0|||
44174288|NCT02366143|78967970|FG002|Overall Study|Protocol Violation|2|||
44174289|NCT02366143|78967968|FG000|Overall Study|Withdrawal by Subject|16|||
44174290|NCT02366143|78967969|FG001|Overall Study|Withdrawal by Subject|17|||
44174291|NCT02366143|78967970|FG002|Overall Study|Withdrawal by Subject|22|||
44174292|NCT02366143|78967968|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
44174293|NCT02366143|78967969|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
44174294|NCT02366143|78967970|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
44264412|NCT03219164|79165910|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
44264413|NCT03219164|79165911|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
44174295|NCT02366143|78967968|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
44174296|NCT02366143|78967969|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
44174297|NCT02366143|78967970|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
44174298|NCT02366143|78967968|FG000|Overall Study|Randomization Error|1|||
44174299|NCT02366143|78967969|FG001|Overall Study|Randomization Error|0|||
44174300|NCT02366143|78967970|FG002|Overall Study|Randomization Error|0|||
44174301|NCT02366143|78967968|FG000|Overall Study|PI Move and Site Closure|1|||
44174302|NCT02366143|78967969|FG001|Overall Study|PI Move and Site Closure|0|||
44264414|NCT03219164|79165910|FG000|Overall Study|Lost to Follow-up|1|||
44174303|NCT02366143|78967970|FG002|Overall Study|PI Move and Site Closure|1|||
44174304|NCT02366143|78967968|FG000|Overall Study|Study Terminated By Sponsor|0|||
44174305|NCT02366143|78967969|FG001|Overall Study|Study Terminated By Sponsor|0|||
44174306|NCT02366143|78967970|FG002|Overall Study|Study Terminated By Sponsor|2|||
44174307|NCT02366143|78967968|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
44174308|NCT02366143|78967969|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
44174309|NCT02366143|78967970|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
44174310|NCT02366143|78967968|FG000|Overall Study|Patient moved to roll-over study|1|||
44174311|NCT02366143|78967969|FG001|Overall Study|Patient moved to roll-over study|19|||
44174312|NCT02366143|78967970|FG002|Overall Study|Patient moved to roll-over study|28|||
44174313|NCT02366143|78967968|FG000|Overall Study|Patient moved to commercial stock|0|||
44174314|NCT02366143|78967969|FG001|Overall Study|Patient moved to commercial stock|0|||
44174315|NCT02366143|78967970|FG002|Overall Study|Patient moved to commercial stock|1|||
44174316|NCT02366143|78967968|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
44174317|NCT02366143|78967969|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
44174318|NCT02366143|78967970|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
44174319|NCT02366143|78967968|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
44174320|NCT02366143|78967969|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
44174321|NCT02366143|78967970|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
44174322|NCT02366143|78967968|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
44174323|NCT02366143|78967969|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
44174324|NCT02366143|78967970|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
44174325|NCT02366143|78967968|FG000|Overall Study|Requester's instructions|1|||
44174326|NCT02366143|78967969|FG001|Overall Study|Requester's instructions|1|||
44174327|NCT02366143|78967970|FG002|Overall Study|Requester's instructions|1|||
44174328|NCT02366143|78967968|FG000|Overall Study|Uneligible|0|||
44174329|NCT02366143|78967969|FG001|Overall Study|Uneligible|1|||
44174330|NCT02366143|78967970|FG002|Overall Study|Uneligible|0|||
44174331|NCT02366143|78967968|FG000|Overall Study|Post Trial Migration|0|||
44174332|NCT02366143|78967969|FG001|Overall Study|Post Trial Migration|1|||
44174333|NCT02366143|78967970|FG002|Overall Study|Post Trial Migration|0|||
44174334|NCT02366143|78967968|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
44174335|NCT02366143|78967969|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
44174336|NCT02366143|78967970|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
44174337|NCT02366143|78967968|FG000|Overall Study|Patient switched to PTAP|0|||
44174338|NCT02366143|78967969|FG001|Overall Study|Patient switched to PTAP|1|||
44174339|NCT02366143|78967970|FG002|Overall Study|Patient switched to PTAP|0|||
44174340|NCT02366143|78967968|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
44174341|NCT02366143|78967969|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
44174342|NCT02366143|78967970|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
44174343|NCT02098395|78967986|FG000|Overall Study|Protocol Violation|2|||
44174344|NCT02098395|78967987|FG001|Overall Study|Protocol Violation|2|||
44174345|NCT02098395|78967988|FG002|Overall Study|Protocol Violation|0|||
44174346|NCT02098395|78967989|FG003|Overall Study|Protocol Violation|7|||
44174347|NCT02098395|78967986|FG000|Overall Study|Withdrawal by Subject|10|||
44174348|NCT02098395|78967987|FG001|Overall Study|Withdrawal by Subject|10|||
44174349|NCT02098395|78967988|FG002|Overall Study|Withdrawal by Subject|5|||
44174350|NCT02098395|78967989|FG003|Overall Study|Withdrawal by Subject|13|||
44174351|NCT02098395|78967986|FG000|Overall Study|Adverse Event|12|||
44174352|NCT02098395|78967987|FG001|Overall Study|Adverse Event|19|||
44174353|NCT02098395|78967988|FG002|Overall Study|Adverse Event|34|||
44174354|NCT02098395|78967989|FG003|Overall Study|Adverse Event|2|||
44174355|NCT02098395|78967986|FG000|Overall Study|Lost to Follow-up|2|||
44174356|NCT02098395|78967987|FG001|Overall Study|Lost to Follow-up|1|||
44174357|NCT02098395|78967988|FG002|Overall Study|Lost to Follow-up|0|||
44174358|NCT02098395|78967989|FG003|Overall Study|Lost to Follow-up|3|||
44174359|NCT02098395|78967986|FG000|Overall Study|Unclassified|0|||
44174360|NCT02098395|78967987|FG001|Overall Study|Unclassified|0|||
44174361|NCT02098395|78967988|FG002|Overall Study|Unclassified|3|||
44174362|NCT02098395|78967989|FG003|Overall Study|Unclassified|2|||
44174363|NCT02041923|78968001|FG000|Overall Study|Lost to Follow-up|26|||
44174364|NCT02041923|78968002|FG001|Overall Study|Lost to Follow-up|30|||
44174365|NCT02062437|78968010|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
44174366|NCT02062437|78968010|FG000|Overall Study|Patient not available for the 2y visit|18|||
44174367|NCT02062437|78968010|FG000|Overall Study|Death|2|||
44264415|NCT03219164|79165911|FG001|Overall Study|Lost to Follow-up|1|||
44264416|NCT03219164|79165910|FG000|Overall Study|Adverse Event|1|||
44264417|NCT03219164|79165911|FG001|Overall Study|Adverse Event|0|||
44174368|NCT02062437|78968010|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
44174369|NCT02365519|78968016|FG000|Randomized and Treated|Adverse Event|0|||
44174370|NCT02365519|78968017|FG001|Randomized and Treated|Adverse Event|1|||
44174371|NCT02365519|78968018|FG002|Randomized and Treated|Adverse Event|0|||
44174372|NCT02365519|78968016|FG000|Randomized and Treated|Withdrawal by Subject|0|||
44174373|NCT02365519|78968017|FG001|Randomized and Treated|Withdrawal by Subject|1|||
44174374|NCT02365519|78968018|FG002|Randomized and Treated|Withdrawal by Subject|1|||
44174375|NCT02061813|78968027|FG000|Overall Study|Withdrawal by Subject|1|||
44174376|NCT02061813|78968027|FG000|Overall Study|Protocol Violation|2|||
44174377|NCT02096835|78968037|FG000|Overall Study|Withdrawal by Subject|1|||
44174378|NCT02096835|78968038|FG001|Overall Study|Withdrawal by Subject|0|||
44174379|NCT02096835|78968039|FG002|Overall Study|Withdrawal by Subject|0|||
44174380|NCT02096835|78968037|FG000|Overall Study|converted to open procedures|1|||
44174381|NCT02096835|78968038|FG001|Overall Study|converted to open procedures|0|||
44174382|NCT02096835|78968039|FG002|Overall Study|converted to open procedures|0|||
44174383|NCT02096835|78968037|FG000|Overall Study|Lost to Follow-up|1|||
44174384|NCT02096835|78968038|FG001|Overall Study|Lost to Follow-up|0|||
44174385|NCT02096835|78968039|FG002|Overall Study|Lost to Follow-up|1|||
44174386|NCT02294773|78968049|FG000|Overall Study|Withdrawal by Subject|0|||
44174387|NCT02294773|78968050|FG001|Overall Study|Withdrawal by Subject|2|||
44174388|NCT02365285|78968060|FG000|Overall Study|Physician Decision|0|||
44174389|NCT02365285|78968061|FG001|Overall Study|Physician Decision|1|||
44174390|NCT02365285|78968062|FG002|Overall Study|Physician Decision|1|||
44174391|NCT02365285|78968063|FG003|Overall Study|Physician Decision|0|||
44174392|NCT02365285|78968060|FG000|Overall Study|Adverse Event|0|||
44174393|NCT02365285|78968061|FG001|Overall Study|Adverse Event|0|||
44174394|NCT02365285|78968062|FG002|Overall Study|Adverse Event|0|||
44174395|NCT02365285|78968063|FG003|Overall Study|Adverse Event|2|||
44174396|NCT02041299|78968077|FG000|Overall Study|Adverse Event|9|||
44174397|NCT02041299|78968078|FG001|Overall Study|Adverse Event|3|||
44174398|NCT02041299|78968077|FG000|Overall Study|Lost to Follow-up|4|||
44174399|NCT02041299|78968078|FG001|Overall Study|Lost to Follow-up|1|||
44174400|NCT02041299|78968077|FG000|Overall Study|Physician Decision|1|||
44174401|NCT02041299|78968078|FG001|Overall Study|Physician Decision|1|||
44174402|NCT02041299|78968077|FG000|Overall Study|Withdrawal by Subject|13|||
44174403|NCT02041299|78968078|FG001|Overall Study|Withdrawal by Subject|7|||
44174404|NCT02041299|78968077|FG000|Overall Study|Protocol Violation|11|||
44174405|NCT02041299|78968078|FG001|Overall Study|Protocol Violation|4|||
44174406|NCT02041299|78968077|FG000|Overall Study|Termination of the study|7|||
44174407|NCT02041299|78968078|FG001|Overall Study|Termination of the study|3|||
44174408|NCT02041299|78968077|FG000|Overall Study|Required bone marrow transplant|0|||
44174409|NCT02041299|78968078|FG001|Overall Study|Required bone marrow transplant|1|||
44174410|NCT02041299|78968077|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
44174411|NCT02041299|78968078|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
44174412|NCT01645735|78968090|FG000|Overall Study|Physician Decision|2|||
44174413|NCT01645735|78968091|FG001|Overall Study|Physician Decision|0|||
44174414|NCT01645735|78968090|FG000|Overall Study|Withdrawal by Subject|1|||
44174415|NCT01645735|78968091|FG001|Overall Study|Withdrawal by Subject|0|||
44174416|NCT01645735|78968090|FG000|Overall Study|Protocol Violation|1|||
44174417|NCT01645735|78968091|FG001|Overall Study|Protocol Violation|0|||
44174418|NCT01645735|78968090|FG000|Overall Study|Adverse Event|0|||
44174419|NCT01645735|78968091|FG001|Overall Study|Adverse Event|1|||
44174420|NCT02365207|78968098|FG000|Overall Study|Withdrawal by Subject|1|||
44174421|NCT02365207|78968098|FG000|Overall Study|Physician Decision|1|||
44174422|NCT01645111|78968102|FG000|Overall Study|Did not require Clevidipine|15|||
44174423|NCT02364037|78968108|FG000|Overall Study|Withdrawal by Subject|7|||
44174424|NCT02364037|78968109|FG001|Overall Study|Withdrawal by Subject|4|||
44174425|NCT02364037|78968108|FG000|Overall Study|Lost to Follow-up|37|||
44174426|NCT02364037|78968109|FG001|Overall Study|Lost to Follow-up|49|||
44174427|NCT01919164|78968120|FG000|Overall Study|Adverse Event|6|||
44174428|NCT01919164|78968121|FG001|Overall Study|Adverse Event|4|||
44174429|NCT01919164|78968122|FG002|Overall Study|Adverse Event|9|||
44174430|NCT01919164|78968123|FG003|Overall Study|Adverse Event|3|||
44174431|NCT01919164|78968124|FG004|Overall Study|Adverse Event|2|||
44174432|NCT01919164|78968120|FG000|Overall Study|Lost to Follow-up|2|||
44174433|NCT01919164|78968121|FG001|Overall Study|Lost to Follow-up|2|||
44174434|NCT01919164|78968122|FG002|Overall Study|Lost to Follow-up|2|||
44174435|NCT01919164|78968123|FG003|Overall Study|Lost to Follow-up|0|||
44174436|NCT01919164|78968124|FG004|Overall Study|Lost to Follow-up|4|||
44174437|NCT01919164|78968120|FG000|Overall Study|Death|1|||
44174438|NCT01919164|78968121|FG001|Overall Study|Death|0|||
44174439|NCT01919164|78968122|FG002|Overall Study|Death|0|||
44174440|NCT01919164|78968123|FG003|Overall Study|Death|0|||
44174441|NCT01919164|78968124|FG004|Overall Study|Death|0|||
44174442|NCT01919164|78968120|FG000|Overall Study|Protocol Violation|6|||
44174443|NCT01919164|78968121|FG001|Overall Study|Protocol Violation|0|||
44174444|NCT01919164|78968122|FG002|Overall Study|Protocol Violation|3|||
44174445|NCT01919164|78968123|FG003|Overall Study|Protocol Violation|2|||
44174446|NCT01919164|78968124|FG004|Overall Study|Protocol Violation|2|||
44174447|NCT01919164|78968120|FG000|Overall Study|Disease progression|2|||
44174448|NCT01919164|78968121|FG001|Overall Study|Disease progression|2|||
44174449|NCT01919164|78968122|FG002|Overall Study|Disease progression|1|||
44174450|NCT01919164|78968123|FG003|Overall Study|Disease progression|2|||
44174451|NCT01919164|78968124|FG004|Overall Study|Disease progression|1|||
44174452|NCT01919164|78968120|FG000|Overall Study|Withdrew consent|13|||
44174453|NCT01919164|78968121|FG001|Overall Study|Withdrew consent|13|||
44174454|NCT01919164|78968122|FG002|Overall Study|Withdrew consent|14|||
44174455|NCT01919164|78968123|FG003|Overall Study|Withdrew consent|14|||
44174456|NCT01919164|78968124|FG004|Overall Study|Withdrew consent|9|||
44174457|NCT01919164|78968120|FG000|Overall Study|Other Un-specified|13|||
44174458|NCT01919164|78968121|FG001|Overall Study|Other Un-specified|9|||
44174459|NCT01919164|78968122|FG002|Overall Study|Other Un-specified|8|||
44174460|NCT01919164|78968123|FG003|Overall Study|Other Un-specified|7|||
44174461|NCT01919164|78968124|FG004|Overall Study|Other Un-specified|15|||
44174462|NCT01901224|78968136|FG000|Overall Study|study was not funded and terminated|2|||
44174463|NCT01901146|78968142|FG000|Neoadjuvant Phase|Death|1|||
44174464|NCT01901146|78968143|FG001|Neoadjuvant Phase|Death|2|||
44174465|NCT01901146|78968144|FG002|Neoadjuvant Phase|Death|0|||
44174466|NCT01901146|78968145|FG003|Neoadjuvant Phase|Death|0|||
44174467|NCT01901146|78968146|FG004|Neoadjuvant Phase|Death|0|||
44174468|NCT01901146|78968142|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
44174469|NCT01901146|78968143|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
44174470|NCT01901146|78968144|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
44174471|NCT01901146|78968145|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
44174472|NCT01901146|78968146|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
44174473|NCT01901146|78968142|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
44174474|NCT01901146|78968143|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
44174475|NCT01901146|78968144|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
44174476|NCT01901146|78968145|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
44174477|NCT01901146|78968146|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
44174478|NCT01901146|78968142|FG000|Neoadjuvant Phase|Physician Decision|1|||
44174479|NCT01901146|78968143|FG001|Neoadjuvant Phase|Physician Decision|2|||
44174480|NCT01901146|78968144|FG002|Neoadjuvant Phase|Physician Decision|0|||
44174481|NCT01901146|78968145|FG003|Neoadjuvant Phase|Physician Decision|0|||
44174482|NCT01901146|78968146|FG004|Neoadjuvant Phase|Physician Decision|0|||
44174483|NCT01901146|78968142|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
44174484|NCT01901146|78968143|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
44174485|NCT01901146|78968144|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
44174486|NCT01901146|78968145|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
44174487|NCT01901146|78968146|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
44174488|NCT01901146|78968142|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
44174489|NCT01901146|78968143|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
44174490|NCT01901146|78968144|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
44174491|NCT01901146|78968145|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
44174492|NCT01901146|78968146|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
44174493|NCT01901146|78968142|FG000|Adjuvant Phase|Other|0|||
44174494|NCT01901146|78968143|FG001|Adjuvant Phase|Other|0|||
44451068|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
44174495|NCT01901146|78968144|FG002|Adjuvant Phase|Other|1|||
44174496|NCT01901146|78968145|FG003|Adjuvant Phase|Other|0|||
44174497|NCT01901146|78968146|FG004|Adjuvant Phase|Other|0|||
44174498|NCT01901146|78968142|FG000|Adjuvant Phase|Death|0|||
44174499|NCT01901146|78968143|FG001|Adjuvant Phase|Death|0|||
44174500|NCT01901146|78968144|FG002|Adjuvant Phase|Death|0|||
44174501|NCT01901146|78968145|FG003|Adjuvant Phase|Death|0|||
44174502|NCT01901146|78968146|FG004|Adjuvant Phase|Death|3|||
44174503|NCT01901146|78968142|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
44174504|NCT01901146|78968143|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
44174505|NCT01901146|78968144|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
44174506|NCT01901146|78968145|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
44174507|NCT01901146|78968146|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
44174508|NCT01901146|78968142|FG000|Adjuvant Phase|Physician Decision|0|||
44174509|NCT01901146|78968143|FG001|Adjuvant Phase|Physician Decision|0|||
44174510|NCT01901146|78968144|FG002|Adjuvant Phase|Physician Decision|9|||
44174511|NCT01901146|78968145|FG003|Adjuvant Phase|Physician Decision|2|||
44174512|NCT01901146|78968146|FG004|Adjuvant Phase|Physician Decision|4|||
44174513|NCT01901146|78968142|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
44174514|NCT01901146|78968143|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
44174515|NCT01901146|78968144|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
44174516|NCT01901146|78968145|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
44174517|NCT01901146|78968146|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
44174518|NCT01644643|78968159|FG000|Overall Study|Death|1|||
44174519|NCT01644643|78968160|FG001|Overall Study|Death|0|||
44361144|NCT01163747|79366767|FG000|Overall Study|Insufficient Therapeutic Response|0|||
44361145|NCT01163747|79366768|FG001|Overall Study|Insufficient Therapeutic Response|1|||
44174520|NCT01644643|78968161|FG002|Overall Study|Death|3|||
44174521|NCT01644643|78968162|FG003|Overall Study|Death|3|||
44174522|NCT01644643|78968159|FG000|Overall Study|Lost to Follow-up|0|||
44174523|NCT01644643|78968160|FG001|Overall Study|Lost to Follow-up|0|||
44174524|NCT01644643|78968161|FG002|Overall Study|Lost to Follow-up|0|||
44174525|NCT01644643|78968162|FG003|Overall Study|Lost to Follow-up|4|||
44174526|NCT01644643|78968159|FG000|Overall Study|Withdrawal by Subject|1|||
44174527|NCT01644643|78968160|FG001|Overall Study|Withdrawal by Subject|0|||
44174528|NCT01644643|78968161|FG002|Overall Study|Withdrawal by Subject|2|||
44174529|NCT01644643|78968162|FG003|Overall Study|Withdrawal by Subject|1|||
44174530|NCT01644643|78968159|FG000|Overall Study|Other Eligibility criteria|0|||
44174531|NCT01644643|78968160|FG001|Overall Study|Other Eligibility criteria|0|||
44174532|NCT01644643|78968161|FG002|Overall Study|Other Eligibility criteria|0|||
44174533|NCT01644643|78968162|FG003|Overall Study|Other Eligibility criteria|2|||
44174534|NCT01864564|78968180|FG000|Overall Study|Lost to Follow-up|17|||
44174535|NCT01864564|78968181|FG001|Overall Study|Lost to Follow-up|23|||
44174536|NCT01864564|78968180|FG000|Overall Study|Withdrawal by Subject|20|||
44174537|NCT01864564|78968181|FG001|Overall Study|Withdrawal by Subject|11|||
44174538|NCT01864564|78968180|FG000|Overall Study|Protocol Violation|0|||
44174539|NCT01864564|78968181|FG001|Overall Study|Protocol Violation|27|||
44174540|NCT01864564|78968180|FG000|Overall Study|not reported|0|||
44174541|NCT01864564|78968181|FG001|Overall Study|not reported|34|||
44174542|NCT01864174|78968189|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
44174543|NCT01864174|78968190|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
44174544|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
44174545|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
44174546|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
44174547|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
44174548|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
44174549|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
44174550|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Death|1|||
44174551|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Death|0|||
44174552|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
44174553|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
44174554|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
44174555|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
44174556|NCT01864174|78968189|FG000|Double Blind - Compliant Randomized|Other|6|||
44174557|NCT01864174|78968190|FG001|Double Blind - Compliant Randomized|Other|10|||
44174558|NCT01864174|78968189|FG000|Off Treatment Follow-Up|Other|2|||
44174559|NCT01864174|78968190|FG001|Off Treatment Follow-Up|Other|0|||
44174560|NCT01864174|78968189|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
44174561|NCT01864174|78968190|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
44174562|NCT01900444|78968196|FG000|Overall Study|Protocol Violation|2|||
44174563|NCT01900444|78968196|FG000|Overall Study|Lost to Follow-up|1|||
44174564|NCT02294227|78968203|FG000|Overall Study|Death|0|||
44174565|NCT02294227|78968204|FG001|Overall Study|Death|0|||
44174566|NCT02294227|78968205|FG002|Overall Study|Death|1|||
44174567|NCT02294227|78968203|FG000|Overall Study|Subject/Guardian Decision|6|||
44174568|NCT02294227|78968204|FG001|Overall Study|Subject/Guardian Decision|3|||
44174569|NCT02294227|78968205|FG002|Overall Study|Subject/Guardian Decision|7|||
44174570|NCT02294227|78968203|FG000|Overall Study|Physician Decision|1|||
44174571|NCT02294227|78968204|FG001|Overall Study|Physician Decision|2|||
44174572|NCT02294227|78968205|FG002|Overall Study|Physician Decision|1|||
44174573|NCT02294227|78968203|FG000|Overall Study|Lost to Follow-up|1|||
44174574|NCT02294227|78968204|FG001|Overall Study|Lost to Follow-up|0|||
44174575|NCT02294227|78968205|FG002|Overall Study|Lost to Follow-up|0|||
44174576|NCT02294227|78968203|FG000|Overall Study|Lack of Efficacy|11|||
44174577|NCT02294227|78968204|FG001|Overall Study|Lack of Efficacy|12|||
44174578|NCT02294227|78968205|FG002|Overall Study|Lack of Efficacy|8|||
44174579|NCT02294227|78968203|FG000|Overall Study|Adverse Event|6|||
44174580|NCT02294227|78968204|FG001|Overall Study|Adverse Event|8|||
44174581|NCT02294227|78968205|FG002|Overall Study|Adverse Event|2|||
44174582|NCT02496767|78968219|FG000|Open-label Lead-in Phase|Adverse Event|176|||
44174583|NCT02496767|78968220|FG001|Open-label Lead-in Phase|Adverse Event|0|||
44174584|NCT02496767|78968221|FG002|Open-label Lead-in Phase|Adverse Event|0|||
44174585|NCT02496767|78968222|FG003|Open-label Lead-in Phase|Adverse Event|0|||
44174586|NCT02496767|78968223|FG004|Open-label Lead-in Phase|Adverse Event|0|||
44174587|NCT02496767|78968224|FG005|Open-label Lead-in Phase|Adverse Event|0|||
44174588|NCT02496767|78968225|FG006|Open-label Lead-in Phase|Adverse Event|0|||
44174589|NCT02496767|78968226|FG007|Open-label Lead-in Phase|Adverse Event|0|||
44174590|NCT02496767|78968219|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
44174591|NCT02496767|78968220|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
44174592|NCT02496767|78968221|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
44174593|NCT02496767|78968222|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
44174594|NCT02496767|78968223|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
44174595|NCT02496767|78968224|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
44174596|NCT02496767|78968225|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
44174597|NCT02496767|78968226|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
44174598|NCT02496767|78968219|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
44174599|NCT02496767|78968220|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174600|NCT02496767|78968221|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174601|NCT02496767|78968222|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174602|NCT02496767|78968223|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174603|NCT02496767|78968224|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174604|NCT02496767|78968225|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174605|NCT02496767|78968226|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
44174606|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
44174607|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
44174608|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
44174609|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
44174610|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
44174611|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
44174612|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
44174613|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
44174614|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
44174615|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
44174616|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
44174617|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
44174618|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
44174619|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
44174620|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
44174621|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
44174622|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
44174623|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
44174624|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
44174625|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
44174626|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
44174627|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
44174628|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
44174629|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
44174630|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
44174631|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
44174632|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
44174633|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
44174634|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
44174635|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
44174636|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
44174637|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
44174638|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44174639|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
44174640|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
44174641|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
44174642|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
44174643|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44264418|NCT03219164|79165910|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44264419|NCT03219164|79165911|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44264420|NCT03219164|79165910|FG000|Overall Study|Protocol Violation|0|||
44264421|NCT03219164|79165911|FG001|Overall Study|Protocol Violation|1|||
44264422|NCT03219164|79165910|FG000|Overall Study|Withdrew Assent|1|||
44174644|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44174645|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44174646|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44174647|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
44174648|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
44174649|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44174650|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44174651|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44174652|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44174653|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44174654|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44174655|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
44174656|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44174657|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
44174658|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
44174659|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44174660|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44174661|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44174662|NCT02496767|78968219|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174663|NCT02496767|78968220|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
44174664|NCT02496767|78968221|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174665|NCT02496767|78968222|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174666|NCT02496767|78968223|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174667|NCT02496767|78968224|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174668|NCT02496767|78968225|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174669|NCT02496767|78968226|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
44174670|NCT02496767|78968219|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
44174671|NCT02496767|78968220|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
44174672|NCT02496767|78968221|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
44174673|NCT02496767|78968222|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
44174674|NCT02496767|78968223|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
44174675|NCT02496767|78968224|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
44174676|NCT02496767|78968225|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
44174677|NCT02496767|78968226|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
44174678|NCT02496767|78968219|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
44174679|NCT02496767|78968220|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
44264423|NCT03219164|79165911|FG001|Overall Study|Withdrew Assent|0|||
44264424|NCT02471586|79165929|FG000|Overall Study|Lost to Follow-up|3|||
44264425|NCT02471586|79165930|FG001|Overall Study|Lost to Follow-up|8|||
44451069|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
44174680|NCT02496767|78968221|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
44174681|NCT02496767|78968222|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
44174682|NCT02496767|78968223|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
44174683|NCT02496767|78968224|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
44174684|NCT02496767|78968225|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
44174685|NCT02496767|78968226|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
44174686|NCT02496767|78968219|FG000|Double-blind, Withdrawal Phase|Death|0|||
44174687|NCT02496767|78968220|FG001|Double-blind, Withdrawal Phase|Death|0|||
44174688|NCT02496767|78968221|FG002|Double-blind, Withdrawal Phase|Death|0|||
44174689|NCT02496767|78968222|FG003|Double-blind, Withdrawal Phase|Death|0|||
44174690|NCT02496767|78968223|FG004|Double-blind, Withdrawal Phase|Death|0|||
44174691|NCT02496767|78968224|FG005|Double-blind, Withdrawal Phase|Death|0|||
44174692|NCT02496767|78968225|FG006|Double-blind, Withdrawal Phase|Death|1|||
44174693|NCT02496767|78968226|FG007|Double-blind, Withdrawal Phase|Death|2|||
44174694|NCT02496767|78968219|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
44174695|NCT02496767|78968220|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
44174696|NCT02496767|78968221|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
44174697|NCT02496767|78968222|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
44174698|NCT02496767|78968223|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
44174699|NCT02496767|78968224|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
44174700|NCT02496767|78968225|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
44174701|NCT02496767|78968226|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
44174702|NCT02496533|78968242|FG000|Overall Study|Lack of data on outcome|3|||
44174703|NCT02496533|78968243|FG001|Overall Study|Lack of data on outcome|0|||
44174704|NCT02496533|78968242|FG000|Overall Study|Patient did not complete all measures|0|||
44174705|NCT02496533|78968243|FG001|Overall Study|Patient did not complete all measures|4|||
44174706|NCT02496533|78968242|FG000|Overall Study|Late for radiologic testing|0|||
44174707|NCT02496533|78968243|FG001|Overall Study|Late for radiologic testing|2|||
44174708|NCT02496221|78968249|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
44174709|NCT02496221|78968250|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
44174710|NCT02496221|78968249|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
44174711|NCT02496221|78968250|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
44174712|NCT02496221|78968249|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
44174713|NCT02496221|78968250|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
44174714|NCT02475629|78968258|FG000|Overall Study|Adverse Event|1|||
44174715|NCT02475629|78968258|FG000|Overall Study|Death|4|||
44174716|NCT02475629|78968258|FG000|Overall Study|Physician Decision|1|||
44174717|NCT02475629|78968258|FG000|Overall Study|Withdrawal by Subject|1|||
44174718|NCT02475629|78968258|FG000|Overall Study|Lost to Follow-up|1|||
44174719|NCT02475629|78968258|FG000|Overall Study|Subject non-compliance|1|||
44174720|NCT02475395|78968264|FG000|Overall Study|Protocol Violation|30|||
44174721|NCT02475395|78968265|FG001|Overall Study|Protocol Violation|3|||
44174722|NCT01653743|78968273|FG000|Overall Study|Withdrawal by Subject|1|||
44174723|NCT01653743|78968274|FG001|Overall Study|Withdrawal by Subject|0|||
44174724|NCT01653743|78968273|FG000|Overall Study|Investigator discretion|3|||
44174725|NCT01653743|78968274|FG001|Overall Study|Investigator discretion|0|||
44174726|NCT02293993|78968284|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
44174727|NCT02293993|78968285|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
44174728|NCT02293993|78968286|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
44174729|NCT02293993|78968287|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
44174730|NCT02293993|78968284|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
44174731|NCT02293993|78968285|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
44174732|NCT02293993|78968286|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
44174733|NCT02293993|78968287|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
44174734|NCT02293993|78968284|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
44174735|NCT02293993|78968285|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
44174736|NCT02293993|78968286|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
44174737|NCT02293993|78968287|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
44174738|NCT02293993|78968284|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
44174739|NCT02293993|78968285|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
44174740|NCT02293993|78968286|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
44174741|NCT02293993|78968287|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
44174742|NCT02293993|78968284|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
44174743|NCT02293993|78968285|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
44264426|NCT02471586|79165931|FG002|Overall Study|Lost to Follow-up|4|||
44264427|NCT02471586|79165929|FG000|Overall Study|Death|2|||
44451070|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
44451071|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
44174744|NCT02293993|78968286|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
44174745|NCT02293993|78968287|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
44174746|NCT02322775|78968307|FG000|Overall Study|Adverse Event|1|||
44174747|NCT02322775|78968308|FG001|Overall Study|Adverse Event|0|||
44174748|NCT02322775|78968307|FG000|Overall Study|Lost to Follow-up|0|||
44174749|NCT02322775|78968308|FG001|Overall Study|Lost to Follow-up|1|||
44174750|NCT02322775|78968307|FG000|Overall Study|Protocol Violation|1|||
44174751|NCT02322775|78968308|FG001|Overall Study|Protocol Violation|0|||
44174752|NCT02322775|78968307|FG000|Overall Study|Withdrawal by Subject|3|||
44174753|NCT02322775|78968308|FG001|Overall Study|Withdrawal by Subject|4|||
44174754|NCT02322775|78968307|FG000|Overall Study|Not willing to perform all FU visits|0|||
44174755|NCT02322775|78968308|FG001|Overall Study|Not willing to perform all FU visits|1|||
44174756|NCT02322229|78968314|FG000|Overall Study|Physician Decision|2|||
44174757|NCT02362789|78968321|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
44174758|NCT02362789|78968322|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
44174759|NCT02362789|78968323|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
44174760|NCT02362789|78968321|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
44174761|NCT02362789|78968322|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
44174762|NCT02362789|78968323|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
44174763|NCT02362789|78968321|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
44174764|NCT02362789|78968322|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
44174765|NCT02362789|78968323|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
44174766|NCT02362789|78968321|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
44174767|NCT02362789|78968322|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
44174768|NCT02362789|78968323|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
44174769|NCT02362789|78968321|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
44174770|NCT02362789|78968322|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
44174771|NCT02362789|78968323|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
44174772|NCT01646827|78968332|FG000|Overall Study|Lost to Follow-up|0|||
44174773|NCT01646827|78968333|FG001|Overall Study|Lost to Follow-up|3|||
44174774|NCT01646827|78968332|FG000|Overall Study|Physician Decision|1|||
44174775|NCT01646827|78968333|FG001|Overall Study|Physician Decision|2|||
44174776|NCT01646827|78968332|FG000|Overall Study|Withdrawal by Subject|1|||
44174777|NCT01646827|78968333|FG001|Overall Study|Withdrawal by Subject|0|||
44174778|NCT02293837|78968343|FG000|Overall Study|Lost to Follow-up|0|||
44174779|NCT02293837|78968344|FG001|Overall Study|Lost to Follow-up|2|||
44174780|NCT02293837|78968345|FG002|Overall Study|Lost to Follow-up|1|||
44174781|NCT02293837|78968346|FG003|Overall Study|Lost to Follow-up|0|||
44174782|NCT02293837|78968343|FG000|Overall Study|Withdrawal by Subject|2|||
44174783|NCT02293837|78968344|FG001|Overall Study|Withdrawal by Subject|1|||
44174784|NCT02293837|78968345|FG002|Overall Study|Withdrawal by Subject|2|||
44174785|NCT02293837|78968346|FG003|Overall Study|Withdrawal by Subject|1|||
44174786|NCT02293837|78968343|FG000|Overall Study|COVID-19 Related|1|||
44174787|NCT02293837|78968344|FG001|Overall Study|COVID-19 Related|1|||
44174788|NCT02293837|78968345|FG002|Overall Study|COVID-19 Related|0|||
44174789|NCT02293837|78968346|FG003|Overall Study|COVID-19 Related|0|||
44174790|NCT02293837|78968343|FG000|Overall Study|Participant ill and could not be infused|0|||
44174791|NCT02293837|78968344|FG001|Overall Study|Participant ill and could not be infused|0|||
44174792|NCT02293837|78968345|FG002|Overall Study|Participant ill and could not be infused|1|||
44174793|NCT02293837|78968346|FG003|Overall Study|Participant ill and could not be infused|0|||
44174794|NCT02361307|78968362|FG000|Overall Study|Unstable medical condition.|0|||
44174795|NCT02361307|78968363|FG001|Overall Study|Unstable medical condition.|1|||
44174796|NCT02320903|78968372|FG000|Overall Study|Withdrawal by Subject|0|||
44174797|NCT02320903|78968373|FG001|Overall Study|Withdrawal by Subject|9|||
44174798|NCT02320903|78968374|FG002|Overall Study|Withdrawal by Subject|9|||
44174799|NCT02320903|78968372|FG000|Overall Study|Exited therapy; no longer eligible|8|||
44174800|NCT02320903|78968373|FG001|Overall Study|Exited therapy; no longer eligible|2|||
44174801|NCT02320903|78968374|FG002|Overall Study|Exited therapy; no longer eligible|2|||
44174802|NCT02320903|78968372|FG000|Overall Study|Lost to Follow-up|0|||
44174803|NCT02320903|78968373|FG001|Overall Study|Lost to Follow-up|5|||
44174804|NCT02320903|78968374|FG002|Overall Study|Lost to Follow-up|5|||
44174805|NCT02320123|78968385|FG000|Overall Study|Lost to Follow-up|4|||
44174806|NCT02320123|78968386|FG001|Overall Study|Lost to Follow-up|6|||
44174807|NCT02320123|78968385|FG000|Overall Study|Death|6|||
44174808|NCT02320123|78968386|FG001|Overall Study|Death|5|||
44174809|NCT02360995|78968399|FG000|Overall Study|Lost to Follow-up|2|||
44174810|NCT02360995|78968400|FG001|Overall Study|Lost to Follow-up|0|||
44174811|NCT02360995|78968401|FG002|Overall Study|Lost to Follow-up|2|||
44174812|NCT02360995|78968399|FG000|Overall Study|Withdrawal by Subject|0|||
44174813|NCT02360995|78968400|FG001|Overall Study|Withdrawal by Subject|1|||
44174814|NCT02360995|78968401|FG002|Overall Study|Withdrawal by Subject|0|||
44174815|NCT02360605|78968411|FG000|Overall Study|Withdrawal by Subject|4|||
44174816|NCT02360605|78968412|FG001|Overall Study|Withdrawal by Subject|9|||
44174817|NCT02360605|78968411|FG000|Overall Study|Lost to Follow-up|7|||
44174818|NCT02360605|78968412|FG001|Overall Study|Lost to Follow-up|8|||
44174819|NCT02360605|78968411|FG000|Overall Study|Death|0|||
44174820|NCT02360605|78968412|FG001|Overall Study|Death|1|||
44174821|NCT02360293|78968422|FG000|Overall Study|Lost to Follow-up|73|||
44174822|NCT02360293|78968423|FG001|Overall Study|Lost to Follow-up|95|||
44174823|NCT02360293|78968422|FG000|Overall Study|Withdrawal by Subject|2|||
44174824|NCT02360293|78968423|FG001|Overall Study|Withdrawal by Subject|1|||
44174825|NCT02360293|78968422|FG000|Overall Study|Excluded|1|||
44174826|NCT02360293|78968423|FG001|Overall Study|Excluded|0|||
44174827|NCT02359903|78968431|FG000|Overall Study|Adverse Event|0|||
44174828|NCT02359903|78968432|FG001|Overall Study|Adverse Event|2|||
44174829|NCT02291419|78968440|FG000|Overall Study|Early study termination|1|||
44174830|NCT02291419|78968441|FG001|Overall Study|Early study termination|5|||
44174831|NCT02319031|78968449|FG000|Treatment Period|Death|1|||
44174832|NCT02319031|78968450|FG001|Treatment Period|Death|0|||
44174833|NCT02318797|78968458|FG000|Overall Study|Death|3|||
44174834|NCT02318797|78968459|FG001|Overall Study|Death|6|||
44174835|NCT02318797|78968458|FG000|Overall Study|Lost to Follow-up|85|||
44174836|NCT02318797|78968459|FG001|Overall Study|Lost to Follow-up|96|||
44174837|NCT02359435|78968467|FG000|Overall Study|Lost to Follow-up|4|||
44174838|NCT02359435|78968468|FG001|Overall Study|Lost to Follow-up|4|||
44174839|NCT02318719|78968478|FG000|Double-blind Phase|Adverse Event|7|||
44174840|NCT02318719|78968479|FG001|Double-blind Phase|Adverse Event|6|||
44174841|NCT02318719|78968480|FG002|Double-blind Phase|Adverse Event|12|||
44174842|NCT02318719|78968481|FG003|Double-blind Phase|Adverse Event|4|||
44174843|NCT02318719|78968482|FG004|Double-blind Phase|Adverse Event|0|||
44174844|NCT02318719|78968478|FG000|Double-blind Phase|Lack of Efficacy|5|||
44174845|NCT02318719|78968479|FG001|Double-blind Phase|Lack of Efficacy|0|||
44451072|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
44174846|NCT02318719|78968480|FG002|Double-blind Phase|Lack of Efficacy|1|||
44174847|NCT02318719|78968481|FG003|Double-blind Phase|Lack of Efficacy|1|||
44174848|NCT02318719|78968482|FG004|Double-blind Phase|Lack of Efficacy|0|||
44451073|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
44451074|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
44451075|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
44451076|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
44451077|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
44451078|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
44451079|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
44451080|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
44451081|NCT02294461|79459967|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
44451082|NCT02294461|79459968|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
44451083|NCT01921062|79460029|FG000|Overall Study|Withdrawal by Subject|0|||
44451084|NCT01921062|79460030|FG001|Overall Study|Withdrawal by Subject|7|||
44451085|NCT01921062|79460029|FG000|Overall Study|Adverse Event|5|||
44451086|NCT01921062|79460030|FG001|Overall Study|Adverse Event|6|||
44451087|NCT01921062|79460029|FG000|Overall Study|Protocol Violation|0|||
44451088|NCT01921062|79460030|FG001|Overall Study|Protocol Violation|1|||
44451089|NCT01921062|79460029|FG000|Overall Study|VMIQ score > 72|4|||
44451090|NCT01921062|79460030|FG001|Overall Study|VMIQ score > 72|1|||
44451091|NCT01921062|79460029|FG000|Overall Study|Logistic error|0|||
44451092|NCT01921062|79460030|FG001|Overall Study|Logistic error|1|||
44174849|NCT02318719|78968478|FG000|Double-blind Phase|Protocol Violation|0|||
44174850|NCT02318719|78968479|FG001|Double-blind Phase|Protocol Violation|1|||
44174851|NCT02318719|78968480|FG002|Double-blind Phase|Protocol Violation|3|||
44174852|NCT02318719|78968481|FG003|Double-blind Phase|Protocol Violation|0|||
44174853|NCT02318719|78968482|FG004|Double-blind Phase|Protocol Violation|0|||
44174854|NCT02318719|78968478|FG000|Double-blind Phase|Withdrawal by Subject|25|||
44174855|NCT02318719|78968479|FG001|Double-blind Phase|Withdrawal by Subject|7|||
44174856|NCT02318719|78968480|FG002|Double-blind Phase|Withdrawal by Subject|9|||
44174857|NCT02318719|78968481|FG003|Double-blind Phase|Withdrawal by Subject|10|||
44174858|NCT02318719|78968482|FG004|Double-blind Phase|Withdrawal by Subject|0|||
44174859|NCT02318719|78968478|FG000|Double-blind Phase|Other|1|||
44174860|NCT02318719|78968479|FG001|Double-blind Phase|Other|2|||
44174861|NCT02318719|78968480|FG002|Double-blind Phase|Other|0|||
44174862|NCT02318719|78968481|FG003|Double-blind Phase|Other|0|||
44174863|NCT02318719|78968482|FG004|Double-blind Phase|Other|0|||
44174864|NCT02318719|78968478|FG000|Open-label Extension Phase|Adverse Event|0|||
44174865|NCT02318719|78968479|FG001|Open-label Extension Phase|Adverse Event|0|||
44174866|NCT02318719|78968480|FG002|Open-label Extension Phase|Adverse Event|0|||
44174867|NCT02318719|78968481|FG003|Open-label Extension Phase|Adverse Event|0|||
44174868|NCT02318719|78968482|FG004|Open-label Extension Phase|Adverse Event|15|||
44174869|NCT02318719|78968478|FG000|Open-label Extension Phase|Death|0|||
44174870|NCT02318719|78968479|FG001|Open-label Extension Phase|Death|0|||
44174871|NCT02318719|78968480|FG002|Open-label Extension Phase|Death|0|||
44174872|NCT02318719|78968481|FG003|Open-label Extension Phase|Death|0|||
44174873|NCT02318719|78968482|FG004|Open-label Extension Phase|Death|1|||
44174874|NCT02318719|78968478|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
44174875|NCT02318719|78968479|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
44174876|NCT02318719|78968480|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
44174877|NCT02318719|78968481|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
44174878|NCT02318719|78968482|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
44174879|NCT02318719|78968478|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
44174880|NCT02318719|78968479|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
44174881|NCT02318719|78968480|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
44174882|NCT02318719|78968481|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
44174883|NCT02318719|78968482|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
44174884|NCT02318719|78968478|FG000|Open-label Extension Phase|Other|0|||
44174885|NCT02318719|78968479|FG001|Open-label Extension Phase|Other|0|||
44174886|NCT02318719|78968480|FG002|Open-label Extension Phase|Other|0|||
44174887|NCT02318719|78968481|FG003|Open-label Extension Phase|Other|0|||
44174888|NCT02318719|78968482|FG004|Open-label Extension Phase|Other|7|||
44174889|NCT01870726|78968501|FG000|Overall Study|Withdrawal of informed consent|0|||
44174890|NCT01870726|78968502|FG001|Overall Study|Withdrawal of informed consent|0|||
44174891|NCT01870726|78968503|FG002|Overall Study|Withdrawal of informed consent|0|||
44174892|NCT01870726|78968504|FG003|Overall Study|Withdrawal of informed consent|1|||
44174893|NCT01870726|78968505|FG004|Overall Study|Withdrawal of informed consent|0|||
44174894|NCT01870726|78968506|FG005|Overall Study|Withdrawal of informed consent|0|||
44174895|NCT01870726|78968507|FG006|Overall Study|Withdrawal of informed consent|0|||
44174896|NCT01870726|78968501|FG000|Overall Study|Withdrawal by Subject|0|||
44174897|NCT01870726|78968502|FG001|Overall Study|Withdrawal by Subject|1|||
44174898|NCT01870726|78968503|FG002|Overall Study|Withdrawal by Subject|0|||
44174899|NCT01870726|78968504|FG003|Overall Study|Withdrawal by Subject|0|||
44174900|NCT01870726|78968505|FG004|Overall Study|Withdrawal by Subject|0|||
44174901|NCT01870726|78968506|FG005|Overall Study|Withdrawal by Subject|0|||
44174902|NCT01870726|78968507|FG006|Overall Study|Withdrawal by Subject|0|||
44264428|NCT02471586|79165930|FG001|Overall Study|Death|2|||
44361146|NCT01163747|79366767|FG000|Overall Study|Protocol Violation|0|||
44361147|NCT01163747|79366768|FG001|Overall Study|Protocol Violation|1|||
44174903|NCT01870726|78968501|FG000|Overall Study|Adverse Event|0|||
44174904|NCT01870726|78968502|FG001|Overall Study|Adverse Event|0|||
44174905|NCT01870726|78968503|FG002|Overall Study|Adverse Event|0|||
44174906|NCT01870726|78968504|FG003|Overall Study|Adverse Event|0|||
44174907|NCT01870726|78968505|FG004|Overall Study|Adverse Event|1|||
44174908|NCT01870726|78968506|FG005|Overall Study|Adverse Event|1|||
44174909|NCT01870726|78968507|FG006|Overall Study|Adverse Event|0|||
44174910|NCT01870726|78968501|FG000|Overall Study|Progressive disease|5|||
44174911|NCT01870726|78968502|FG001|Overall Study|Progressive disease|5|||
44174912|NCT01870726|78968503|FG002|Overall Study|Progressive disease|4|||
44174913|NCT01870726|78968504|FG003|Overall Study|Progressive disease|5|||
44174914|NCT01870726|78968505|FG004|Overall Study|Progressive disease|6|||
44264429|NCT02471586|79165931|FG002|Overall Study|Death|0|||
44264430|NCT02470806|79166078|FG000|Overall Study|Lost to Follow-up|1|||
44174915|NCT01870726|78968506|FG005|Overall Study|Progressive disease|4|||
44174916|NCT01870726|78968507|FG006|Overall Study|Progressive disease|10|||
44361148|NCT01163747|79366767|FG000|Overall Study|Refused Treatment|6|||
44174917|NCT01900054|78968532|FG000|Overall Study|Physician Decision|1|||
44174918|NCT01900054|78968532|FG000|Overall Study|Withdrawal by Subject|1|||
44174919|NCT01612156|78968538|FG000|Overall Study|Protocol Violation|2|||
44174920|NCT01612156|78968539|FG001|Overall Study|Protocol Violation|0|||
44174921|NCT01899742|78968547|FG000|Overall Study|Adverse Event|5|||
44174922|NCT01899742|78968548|FG001|Overall Study|Adverse Event|4|||
44174923|NCT01899742|78968547|FG000|Overall Study|Lack of Efficacy|1|||
44174924|NCT01899742|78968548|FG001|Overall Study|Lack of Efficacy|5|||
44174925|NCT01899742|78968547|FG000|Overall Study|Protocol Violation|2|||
44174926|NCT01899742|78968548|FG001|Overall Study|Protocol Violation|2|||
44174927|NCT01899742|78968547|FG000|Overall Study|Withdrawal by Subject|9|||
44174928|NCT01899742|78968548|FG001|Overall Study|Withdrawal by Subject|5|||
44174929|NCT01615822|78968557|FG000|Period 1|Withdrawal by Subject|0|||
44174930|NCT01615822|78968558|FG001|Period 1|Withdrawal by Subject|1|||
44174931|NCT01615822|78968559|FG002|Period 1|Withdrawal by Subject|0|||
44174932|NCT01615822|78968557|FG000|Period 1|Adverse Event|1|||
44174933|NCT01615822|78968558|FG001|Period 1|Adverse Event|1|||
44174934|NCT01615822|78968559|FG002|Period 1|Adverse Event|0|||
44174935|NCT01615822|78968557|FG000|Period 2|Lost to Follow-up|0|||
44174936|NCT01615822|78968558|FG001|Period 2|Lost to Follow-up|1|||
44174937|NCT01615822|78968559|FG002|Period 2|Lost to Follow-up|2|||
44174938|NCT01898884|78968575|FG000|Multiple Dose Period|Adverse Event|0|||
44174939|NCT01898884|78968576|FG001|Multiple Dose Period|Adverse Event|0|||
44174940|NCT01898884|78968577|FG002|Multiple Dose Period|Adverse Event|0|||
44174941|NCT01898884|78968578|FG003|Multiple Dose Period|Adverse Event|0|||
44174942|NCT01898884|78968579|FG004|Multiple Dose Period|Adverse Event|0|||
44174943|NCT01898884|78968580|FG005|Multiple Dose Period|Adverse Event|0|||
44174944|NCT01898884|78968581|FG006|Multiple Dose Period|Adverse Event|1|||
44174945|NCT01898884|78968582|FG007|Multiple Dose Period|Adverse Event|0|||
44174946|NCT01898884|78968583|FG008|Multiple Dose Period|Adverse Event|0|||
44174947|NCT01898884|78968575|FG000|Multiple Dose Period|Randomized Not Treated|0|||
44174948|NCT01898884|78968576|FG001|Multiple Dose Period|Randomized Not Treated|0|||
44174949|NCT01898884|78968577|FG002|Multiple Dose Period|Randomized Not Treated|0|||
44174950|NCT01898884|78968578|FG003|Multiple Dose Period|Randomized Not Treated|0|||
44174951|NCT01898884|78968579|FG004|Multiple Dose Period|Randomized Not Treated|0|||
44174952|NCT01898884|78968580|FG005|Multiple Dose Period|Randomized Not Treated|0|||
44174953|NCT01898884|78968581|FG006|Multiple Dose Period|Randomized Not Treated|0|||
44174954|NCT01898884|78968582|FG007|Multiple Dose Period|Randomized Not Treated|0|||
44174955|NCT01898884|78968583|FG008|Multiple Dose Period|Randomized Not Treated|1|||
44174956|NCT01613326|78968621|FG000|Overall Study|Adverse Event|7|||
44174957|NCT01613326|78968622|FG001|Overall Study|Adverse Event|5|||
44174958|NCT01613326|78968621|FG000|Overall Study|Withdrawal by Subject|3|||
44174959|NCT01613326|78968622|FG001|Overall Study|Withdrawal by Subject|4|||
44174960|NCT01613326|78968621|FG000|Overall Study|Abnormal test procedure result(s)|2|||
44174961|NCT01613326|78968622|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44174962|NCT01613326|78968621|FG000|Overall Study|inability to use device|1|||
44174963|NCT01613326|78968622|FG001|Overall Study|inability to use device|0|||
44174964|NCT01613326|78968621|FG000|Overall Study|Lack of Efficacy|0|||
44174965|NCT01613326|78968622|FG001|Overall Study|Lack of Efficacy|1|||
44174966|NCT01613326|78968621|FG000|Overall Study|Lost to Follow-up|0|||
44174967|NCT01613326|78968622|FG001|Overall Study|Lost to Follow-up|1|||
44174968|NCT01613326|78968621|FG000|Overall Study|Administrative|0|||
44174969|NCT01613326|78968622|FG001|Overall Study|Administrative|2|||
44264431|NCT02470806|79166079|FG001|Overall Study|Lost to Follow-up|1|||
44361149|NCT01163747|79366768|FG001|Overall Study|Refused Treatment|4|||
44174970|NCT01613326|78968621|FG000|Overall Study|Protocol Violation|0|||
44174971|NCT01613326|78968622|FG001|Overall Study|Protocol Violation|1|||
44174972|NCT01613248|78968634|FG000|Overall Study|Adverse Event|0|||
44174973|NCT01613248|78968635|FG001|Overall Study|Adverse Event|0|||
44174974|NCT01613248|78968636|FG002|Overall Study|Adverse Event|0|||
44174975|NCT01613248|78968637|FG003|Overall Study|Adverse Event|1|||
44174976|NCT01613248|78968638|FG004|Overall Study|Adverse Event|0|||
44174977|NCT01613248|78968639|FG005|Overall Study|Adverse Event|0|||
44174978|NCT01613248|78968634|FG000|Overall Study|Withdrawal by Subject|3|||
44174979|NCT01613248|78968635|FG001|Overall Study|Withdrawal by Subject|2|||
44174980|NCT01613248|78968636|FG002|Overall Study|Withdrawal by Subject|2|||
44174981|NCT01613248|78968637|FG003|Overall Study|Withdrawal by Subject|5|||
44174982|NCT01613248|78968638|FG004|Overall Study|Withdrawal by Subject|0|||
44174983|NCT01613248|78968639|FG005|Overall Study|Withdrawal by Subject|1|||
44174984|NCT01613248|78968634|FG000|Overall Study|Lost to Follow-up|5|||
44174985|NCT01613248|78968635|FG001|Overall Study|Lost to Follow-up|7|||
44174986|NCT01613248|78968636|FG002|Overall Study|Lost to Follow-up|4|||
44174987|NCT01613248|78968637|FG003|Overall Study|Lost to Follow-up|8|||
44174988|NCT01613248|78968638|FG004|Overall Study|Lost to Follow-up|4|||
44174989|NCT01613248|78968639|FG005|Overall Study|Lost to Follow-up|2|||
44174990|NCT01613248|78968634|FG000|Overall Study|Study Terminated by Sponsor|4|||
44174991|NCT01613248|78968635|FG001|Overall Study|Study Terminated by Sponsor|6|||
44174992|NCT01613248|78968636|FG002|Overall Study|Study Terminated by Sponsor|8|||
44174993|NCT01613248|78968637|FG003|Overall Study|Study Terminated by Sponsor|8|||
44174994|NCT01613248|78968638|FG004|Overall Study|Study Terminated by Sponsor|9|||
44264432|NCT02470806|79166078|FG000|Overall Study|Adverse Event|5|||
44174995|NCT01613248|78968639|FG005|Overall Study|Study Terminated by Sponsor|11|||
44174996|NCT01613248|78968634|FG000|Overall Study|Physician Decision|8|||
44174997|NCT01613248|78968635|FG001|Overall Study|Physician Decision|8|||
44174998|NCT01613248|78968636|FG002|Overall Study|Physician Decision|9|||
44174999|NCT01613248|78968637|FG003|Overall Study|Physician Decision|4|||
44175000|NCT01613248|78968638|FG004|Overall Study|Physician Decision|7|||
44175001|NCT01613248|78968639|FG005|Overall Study|Physician Decision|6|||
44175002|NCT01613248|78968634|FG000|Overall Study|Lack of Qualifying Event|9|||
44175003|NCT01613248|78968635|FG001|Overall Study|Lack of Qualifying Event|11|||
44175004|NCT01613248|78968636|FG002|Overall Study|Lack of Qualifying Event|10|||
44175005|NCT01613248|78968637|FG003|Overall Study|Lack of Qualifying Event|11|||
44175006|NCT01613248|78968638|FG004|Overall Study|Lack of Qualifying Event|15|||
44175007|NCT01613248|78968639|FG005|Overall Study|Lack of Qualifying Event|18|||
44175008|NCT01613248|78968634|FG000|Overall Study|Pregnancy|0|||
44175009|NCT01613248|78968635|FG001|Overall Study|Pregnancy|0|||
44175010|NCT01613248|78968636|FG002|Overall Study|Pregnancy|0|||
44175011|NCT01613248|78968637|FG003|Overall Study|Pregnancy|1|||
44175012|NCT01613248|78968638|FG004|Overall Study|Pregnancy|0|||
44175013|NCT01613248|78968639|FG005|Overall Study|Pregnancy|0|||
44175014|NCT01898806|78968653|FG000|Overall Study|Withdrawal by Subject|2|||
44175015|NCT01898806|78968653|FG000|Overall Study|Physician Decision|1|||
44175016|NCT02291029|78968663|FG000|Overall Study|Withdrawal by Subject|0|||
44175017|NCT02291029|78968664|FG001|Overall Study|Withdrawal by Subject|0|||
44175018|NCT02291029|78968665|FG002|Overall Study|Withdrawal by Subject|1|||
44175019|NCT02291029|78968666|FG003|Overall Study|Withdrawal by Subject|0|||
44175020|NCT02291029|78968667|FG004|Overall Study|Withdrawal by Subject|0|||
44175021|NCT02291029|78968668|FG005|Overall Study|Withdrawal by Subject|0|||
44175022|NCT02291029|78968663|FG000|Overall Study|Adverse Event|0|||
44175023|NCT02291029|78968664|FG001|Overall Study|Adverse Event|1|||
44175024|NCT02291029|78968665|FG002|Overall Study|Adverse Event|0|||
44175025|NCT02291029|78968666|FG003|Overall Study|Adverse Event|0|||
44175026|NCT02291029|78968667|FG004|Overall Study|Adverse Event|0|||
44175027|NCT02291029|78968668|FG005|Overall Study|Adverse Event|0|||
44175028|NCT02290873|78968685|FG000|Overall Study|Withdrawal by Subject|0|||
44175029|NCT02290873|78968686|FG001|Overall Study|Withdrawal by Subject|1|||
44175030|NCT02290873|78968687|FG002|Overall Study|Withdrawal by Subject|1|||
44175031|NCT02290873|78968685|FG000|Overall Study|Nellcor device error|1|||
44175032|NCT02290873|78968686|FG001|Overall Study|Nellcor device error|0|||
44175033|NCT02290873|78968687|FG002|Overall Study|Nellcor device error|0|||
44175034|NCT02290873|78968685|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
44175035|NCT02290873|78968686|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
44175036|NCT02290873|78968687|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
44175037|NCT02290873|78968685|FG000|Overall Study|Protocol Violation|0|||
44175038|NCT02290873|78968686|FG001|Overall Study|Protocol Violation|0|||
44175039|NCT02290873|78968687|FG002|Overall Study|Protocol Violation|1|||
44175040|NCT02290405|78968698|FG000|Overall Study|Withdrawal by Subject|1|||
44175041|NCT02290405|78968699|FG001|Overall Study|Withdrawal by Subject|0|||
44175042|NCT02359045|78968707|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
44175043|NCT02359045|78968708|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44175044|NCT02359045|78968707|FG000|Overall Study|Lost to Follow-up|1|||
44264433|NCT02470806|79166079|FG001|Overall Study|Adverse Event|2|||
44264434|NCT02470806|79166078|FG000|Overall Study|Protocol Violation|4|||
44175045|NCT02359045|78968708|FG001|Overall Study|Lost to Follow-up|1|||
44175046|NCT02359045|78968707|FG000|Overall Study|Adverse Event|0|||
44175047|NCT02359045|78968708|FG001|Overall Study|Adverse Event|1|||
44175048|NCT02358343|78968729|FG000|Screening Intervention|Death|0|||
44175049|NCT02358343|78968730|FG001|Screening Intervention|Death|2|||
44175050|NCT02358343|78968731|FG002|Screening Intervention|Death|0|||
44175051|NCT02358343|78968732|FG003|Screening Intervention|Death|0|||
44175052|NCT02358343|78968733|FG004|Screening Intervention|Death|0|||
44175053|NCT02358343|78968729|FG000|Screening Intervention|Withdrawal by Subject|1|||
44175054|NCT02358343|78968730|FG001|Screening Intervention|Withdrawal by Subject|0|||
44175055|NCT02358343|78968731|FG002|Screening Intervention|Withdrawal by Subject|0|||
44175056|NCT02358343|78968732|FG003|Screening Intervention|Withdrawal by Subject|0|||
44175057|NCT02358343|78968733|FG004|Screening Intervention|Withdrawal by Subject|0|||
44175058|NCT02358343|78968729|FG000|Screening Intervention|Determined Ineligible|5|||
44175059|NCT02358343|78968730|FG001|Screening Intervention|Determined Ineligible|6|||
44175060|NCT02358343|78968731|FG002|Screening Intervention|Determined Ineligible|0|||
44175061|NCT02358343|78968732|FG003|Screening Intervention|Determined Ineligible|0|||
44175062|NCT02358343|78968733|FG004|Screening Intervention|Determined Ineligible|0|||
44175063|NCT02358343|78968729|FG000|Comparative Efficacy Trial / Observation|Death|0|||
44175064|NCT02358343|78968730|FG001|Comparative Efficacy Trial / Observation|Death|0|||
44175065|NCT02358343|78968731|FG002|Comparative Efficacy Trial / Observation|Death|2|||
44175066|NCT02358343|78968732|FG003|Comparative Efficacy Trial / Observation|Death|0|||
44175067|NCT02358343|78968733|FG004|Comparative Efficacy Trial / Observation|Death|0|||
44175068|NCT02358343|78968729|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
44175069|NCT02358343|78968730|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
44175070|NCT02358343|78968731|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
44175071|NCT02358343|78968732|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
44175072|NCT02358343|78968733|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
44175073|NCT02358343|78968729|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
44175074|NCT02358343|78968730|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
44175075|NCT02358343|78968731|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
44175076|NCT02358343|78968732|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
44175077|NCT02358343|78968733|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
44175078|NCT02356783|78968746|FG000|Overall Study|Lost to Follow-up|1|||
44175079|NCT02356783|78968747|FG001|Overall Study|Lost to Follow-up|3|||
44175080|NCT02289469|78968755|FG000|Overall Study|Unable to match a control|6|||
44175081|NCT02289469|78968756|FG001|Overall Study|Unable to match a control|0|||
44175082|NCT02318095|78968762|FG000|Overall Study|Adverse Event|1|||
44175083|NCT02317705|78968767|FG000|Overall Study|Withdrawal by Subject|3|||
44175084|NCT02317705|78968767|FG000|Overall Study|Physician Decision|1|||
44175085|NCT02317705|78968767|FG000|Overall Study|Drug not usable|1|||
44175086|NCT02474069|78968771|FG000|Selection Phase (SP)|Adverse Event|8|||
44175087|NCT02474069|78968772|FG001|Selection Phase (SP)|Adverse Event|0|||
44175088|NCT02474069|78968773|FG002|Selection Phase (SP)|Adverse Event|0|||
44175089|NCT02474069|78968771|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
44175090|NCT02474069|78968772|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
44175091|NCT02474069|78968773|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
44175092|NCT02474069|78968771|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
44264435|NCT02470806|79166079|FG001|Overall Study|Protocol Violation|11|||
44264436|NCT02470806|79166078|FG000|Overall Study|Physician Decision|0|||
44264437|NCT02470806|79166079|FG001|Overall Study|Physician Decision|3|||
44264438|NCT02470806|79166078|FG000|Overall Study|Withdrawal by Subject|3|||
44264439|NCT02470806|79166079|FG001|Overall Study|Withdrawal by Subject|10|||
44264440|NCT02470806|79166078|FG000|Overall Study|Lack of Efficacy|5|||
44264441|NCT02470806|79166079|FG001|Overall Study|Lack of Efficacy|15|||
44264442|NCT01363908|79166121|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
44264443|NCT01363908|79166122|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
44264444|NCT01363908|79166121|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
44264445|NCT01363908|79166122|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
44175093|NCT02474069|78968772|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
44175094|NCT02474069|78968773|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
44175095|NCT02474069|78968771|FG000|Selection Phase (SP)|Physician Decision|1|||
44175096|NCT02474069|78968772|FG001|Selection Phase (SP)|Physician Decision|0|||
44175097|NCT02474069|78968773|FG002|Selection Phase (SP)|Physician Decision|0|||
44175098|NCT02474069|78968771|FG000|Selection Phase (SP)|Protocol Violation|1|||
44175099|NCT02474069|78968772|FG001|Selection Phase (SP)|Protocol Violation|0|||
44175100|NCT02474069|78968773|FG002|Selection Phase (SP)|Protocol Violation|0|||
44264446|NCT01363908|79166121|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
44264447|NCT01363908|79166122|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
44264448|NCT01363908|79166121|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
44175101|NCT02474069|78968771|FG000|Selection Phase (SP)|No longer requires treatment|1|||
44175102|NCT02474069|78968772|FG001|Selection Phase (SP)|No longer requires treatment|0|||
44264449|NCT01363908|79166122|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
44264450|NCT02497404|79166160|FG000|Overall Study|Adverse Event|1|||
44264451|NCT02496702|79166193|FG000|Overall Study|Lost to Follow-up|8|||
44264452|NCT02496702|79166194|FG001|Overall Study|Lost to Follow-up|6|||
44264453|NCT02496702|79166193|FG000|Overall Study|Only partially tested|0|||
44175103|NCT02474069|78968773|FG002|Selection Phase (SP)|No longer requires treatment|0|||
44175104|NCT02474069|78968771|FG000|Selection Phase (SP)|Technical Problem|1|||
44175105|NCT02474069|78968772|FG001|Selection Phase (SP)|Technical Problem|0|||
44175106|NCT02474069|78968773|FG002|Selection Phase (SP)|Technical Problem|0|||
44175107|NCT02474069|78968771|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
44175108|NCT02474069|78968772|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
44175109|NCT02474069|78968773|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
44175110|NCT02474069|78968771|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
44175111|NCT02474069|78968772|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
44175112|NCT02474069|78968773|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
44175113|NCT02474069|78968771|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
44175114|NCT02474069|78968772|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
44175115|NCT02474069|78968773|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
44175116|NCT02474069|78968771|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
44175117|NCT02474069|78968772|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
44175118|NCT02474069|78968773|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
44175119|NCT02474069|78968771|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
44175120|NCT02474069|78968772|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
44175121|NCT02474069|78968773|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
44175122|NCT02474069|78968771|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
44451097|NCT01712490|79460047|FG000|Overall Study|Ongoing|601|||
44451098|NCT01712490|79460048|FG001|Overall Study|Ongoing|586|||
44175123|NCT02474069|78968772|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
44175124|NCT02474069|78968773|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
44175125|NCT02317627|78968786|FG000|Overall Study|Withdrawal by Subject|0|||
44175126|NCT02317627|78968787|FG001|Overall Study|Withdrawal by Subject|1|||
44175127|NCT02317627|78968788|FG002|Overall Study|Withdrawal by Subject|1|||
44175128|NCT02317627|78968786|FG000|Overall Study|Lost to Follow-up|2|||
44175129|NCT02317627|78968787|FG001|Overall Study|Lost to Follow-up|0|||
44175130|NCT02317627|78968788|FG002|Overall Study|Lost to Follow-up|0|||
44175131|NCT02317627|78968786|FG000|Overall Study|Stopped by Investigator|0|||
44175132|NCT02317627|78968787|FG001|Overall Study|Stopped by Investigator|1|||
44175133|NCT02317627|78968788|FG002|Overall Study|Stopped by Investigator|0|||
44175134|NCT02317627|78968786|FG000|Overall Study|Adverse Event|0|||
44175135|NCT02317627|78968787|FG001|Overall Study|Adverse Event|2|||
44175136|NCT02317627|78968788|FG002|Overall Study|Adverse Event|3|||
44175137|NCT02317627|78968786|FG000|Overall Study|Non-compliance with study drug|0|||
44175138|NCT02317627|78968787|FG001|Overall Study|Non-compliance with study drug|1|||
44175139|NCT02317627|78968788|FG002|Overall Study|Non-compliance with study drug|0|||
44175140|NCT02517905|78968804|FG000|Overall Study|Lost to Follow-up|4|||
44175141|NCT02517905|78968805|FG001|Overall Study|Lost to Follow-up|0|||
44175142|NCT02517905|78968804|FG000|Overall Study|Withdrawal by Subject|4|||
44175143|NCT02517905|78968805|FG001|Overall Study|Withdrawal by Subject|0|||
44175144|NCT02517905|78968804|FG000|Overall Study|Screen failure|2|||
44175145|NCT02517905|78968805|FG001|Overall Study|Screen failure|2|||
44175146|NCT02473913|78968813|FG000|Overall Study|Lost to Follow-up|3|||
44175147|NCT02473913|78968814|FG001|Overall Study|Lost to Follow-up|3|||
44264454|NCT02496702|79166194|FG001|Overall Study|Only partially tested|2|||
44264455|NCT02469246|79166270|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
44264456|NCT02469246|79166271|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
44264457|NCT02469246|79166270|FG000|Double-Blind Phase|Adverse Event|12|||
44264458|NCT02469246|79166271|FG001|Double-Blind Phase|Adverse Event|9|||
44264459|NCT02469246|79166270|FG000|Double-Blind Phase|Death|2|||
44264460|NCT02469246|79166271|FG001|Double-Blind Phase|Death|0|||
44264461|NCT02469246|79166270|FG000|Double-Blind Phase|Lack of Efficacy|2|||
44264462|NCT02469246|79166271|FG001|Double-Blind Phase|Lack of Efficacy|1|||
44264463|NCT02469246|79166270|FG000|Double-Blind Phase|Investigator's Discretion|8|||
44264464|NCT02469246|79166271|FG001|Double-Blind Phase|Investigator's Discretion|8|||
44264465|NCT02469246|79166270|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
44361150|NCT01163279|79366776|FG000|Overall Study|Withdrawal by Subject|2|||
44361151|NCT01163279|79366777|FG001|Overall Study|Withdrawal by Subject|0|||
44361152|NCT01162499|79366784|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
44264466|NCT02469246|79166271|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
44264467|NCT02469246|79166270|FG000|Double-Blind Phase|Protocol Violation|1|||
44361153|NCT01162499|79366785|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
44361154|NCT01206140|79366795|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
44361155|NCT01206140|79366796|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
44361156|NCT01162421|79366804|FG000|Overall Study|Did not receive study drug|2|||
44451099|NCT01712490|79460047|FG000|Overall Study|Other|11|||
44175148|NCT02316847|78968822|FG000|Overall Study|Adverse Event|0|||
44175149|NCT02316847|78968823|FG001|Overall Study|Adverse Event|3|||
44451100|NCT01712490|79460048|FG001|Overall Study|Other|11|||
44175150|NCT02316847|78968822|FG000|Overall Study|Lost to Follow-up|0|||
44175151|NCT02316847|78968823|FG001|Overall Study|Lost to Follow-up|2|||
44175152|NCT02316847|78968822|FG000|Overall Study|Physician Decision|0|||
44175153|NCT02316847|78968823|FG001|Overall Study|Physician Decision|1|||
44175154|NCT02316847|78968822|FG000|Overall Study|Pregnancy|0|||
44175155|NCT02316847|78968823|FG001|Overall Study|Pregnancy|1|||
44175156|NCT02316847|78968822|FG000|Overall Study|Withdrawal by Subject|2|||
44175157|NCT02316847|78968823|FG001|Overall Study|Withdrawal by Subject|9|||
44175158|NCT02316847|78968822|FG000|Overall Study|Noncompliance with study drug|0|||
44175159|NCT02316847|78968823|FG001|Overall Study|Noncompliance with study drug|3|||
44175160|NCT02316847|78968822|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
44175161|NCT02316847|78968823|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
44175162|NCT02473523|78968831|FG000|Overall Study|Death|1|||
44175163|NCT02473523|78968831|FG000|Overall Study|Lost to Follow-up|1|||
44175164|NCT02316769|78968837|FG000|Overall Study|Physician Decision|1|||
44175165|NCT02316769|78968838|FG001|Overall Study|Physician Decision|0|||
44175166|NCT02316769|78968837|FG000|Overall Study|Withdrawal by Subject|1|||
44175167|NCT02316769|78968838|FG001|Overall Study|Withdrawal by Subject|0|||
44175168|NCT02473445|78968844|FG000|Overall Study|Withdrawal by Subject|2|||
44175169|NCT02473445|78968844|FG000|Overall Study|Sponsor Decision|20|||
44175170|NCT02473367|78968848|FG000|Wait 1|Withdrawal by Subject|1|||
44175171|NCT02473367|78968848|FG000|Period 4|Lost to Follow-up|1|||
44175172|NCT02316613|78968858|FG000|Overall Study|Death|63|||
44175173|NCT02316613|78968858|FG000|Overall Study|Lost to Follow-up|9|||
44175174|NCT02316613|78968858|FG000|Overall Study|Lymphoma transformation|2|||
44175175|NCT02316613|78968858|FG000|Overall Study|Participant moved/changed medical team|11|||
44175176|NCT02316613|78968858|FG000|Overall Study|No data and duplicate cases|5|||
44175177|NCT02316613|78968858|FG000|Overall Study|Did not met selection criteria|14|||
44175178|NCT02492165|78968877|FG000|Overall Study|Withdrawal by Subject|0|||
44175179|NCT02492165|78968878|FG001|Overall Study|Withdrawal by Subject|1|||
44175180|NCT02492165|78968879|FG002|Overall Study|Withdrawal by Subject|0|||
44175181|NCT02492165|78968880|FG003|Overall Study|Withdrawal by Subject|0|||
44175182|NCT02355691|78968892|FG000|Overall Study|Loss of Research Personnel|7|||
44175183|NCT02355691|78968893|FG001|Overall Study|Loss of Research Personnel|9|||
44175184|NCT02473289|78968901|FG000|Overall Study|Adverse Event|2|||
44175185|NCT02473289|78968902|FG001|Overall Study|Adverse Event|3|||
44175186|NCT02473289|78968901|FG000|Overall Study|Lost to Follow-up|1|||
44175187|NCT02473289|78968902|FG001|Overall Study|Lost to Follow-up|1|||
44175188|NCT02473289|78968901|FG000|Overall Study|Protocol Violation|0|||
44175189|NCT02473289|78968902|FG001|Overall Study|Protocol Violation|1|||
44175190|NCT02473289|78968901|FG000|Overall Study|Withdrawal of consent|6|||
44175191|NCT02473289|78968902|FG001|Overall Study|Withdrawal of consent|7|||
44175192|NCT02473289|78968901|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
44175193|NCT02473289|78968902|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
44175194|NCT02473289|78968901|FG000|Overall Study|Other|2|||
44175195|NCT02473289|78968902|FG001|Overall Study|Other|0|||
44175196|NCT02354599|78968914|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44175197|NCT02354599|78968915|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
44175198|NCT02354599|78968916|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44175199|NCT02354599|78968917|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
44175200|NCT02354599|78968918|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
44175201|NCT02354599|78968919|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
44175202|NCT02354599|78968914|FG000|Overall Study|Withdrawal by Subject|1|||
44175203|NCT02354599|78968915|FG001|Overall Study|Withdrawal by Subject|1|||
44175204|NCT02354599|78968916|FG002|Overall Study|Withdrawal by Subject|0|||
44175205|NCT02354599|78968917|FG003|Overall Study|Withdrawal by Subject|0|||
44175206|NCT02354599|78968918|FG004|Overall Study|Withdrawal by Subject|0|||
44175207|NCT02354599|78968919|FG005|Overall Study|Withdrawal by Subject|0|||
44175208|NCT02316223|78968942|FG000|Overall Study|Lack of Efficacy|0|||
44175209|NCT02316223|78968943|FG001|Overall Study|Lack of Efficacy|1|||
44175210|NCT02316223|78968944|FG002|Overall Study|Lack of Efficacy|1|||
44175211|NCT02316223|78968942|FG000|Overall Study|Lost to Follow-up|27|||
44175212|NCT02316223|78968943|FG001|Overall Study|Lost to Follow-up|34|||
44175213|NCT02316223|78968944|FG002|Overall Study|Lost to Follow-up|36|||
44175214|NCT02316223|78968942|FG000|Overall Study|COPD Diagnosis|3|||
44175215|NCT02316223|78968943|FG001|Overall Study|COPD Diagnosis|2|||
44175216|NCT02316223|78968944|FG002|Overall Study|COPD Diagnosis|3|||
44175217|NCT02316223|78968942|FG000|Overall Study|Reside outside study area|1|||
44175218|NCT02316223|78968943|FG001|Overall Study|Reside outside study area|1|||
44175219|NCT02316223|78968944|FG002|Overall Study|Reside outside study area|1|||
44175220|NCT02316223|78968942|FG000|Overall Study|No asthma|2|||
44175221|NCT02316223|78968943|FG001|Overall Study|No asthma|0|||
44175222|NCT02316223|78968944|FG002|Overall Study|No asthma|0|||
44175223|NCT02316223|78968942|FG000|Overall Study|Discontinued by PI|11|||
44175224|NCT02316223|78968943|FG001|Overall Study|Discontinued by PI|19|||
44175225|NCT02316223|78968944|FG002|Overall Study|Discontinued by PI|3|||
44175226|NCT02286895|78968954|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
44175227|NCT02286895|78968955|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
44175228|NCT02286895|78968954|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
44175229|NCT02286895|78968955|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
44175230|NCT02286895|78968954|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
44175231|NCT02286895|78968955|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
44175232|NCT02472977|78968964|FG000|Overall Study|Disease progression|4|||
44175233|NCT02472977|78968965|FG001|Overall Study|Disease progression|25|||
44175234|NCT02472977|78968966|FG002|Overall Study|Disease progression|6|||
44175235|NCT02472977|78968964|FG000|Overall Study|Withdrawal by Subject|0|||
44175236|NCT02472977|78968965|FG001|Overall Study|Withdrawal by Subject|1|||
44175237|NCT02472977|78968966|FG002|Overall Study|Withdrawal by Subject|0|||
44175238|NCT02472977|78968964|FG000|Overall Study|Study drug toxicity|2|||
44175239|NCT02472977|78968965|FG001|Overall Study|Study drug toxicity|0|||
44175240|NCT02472977|78968966|FG002|Overall Study|Study drug toxicity|2|||
44175241|NCT02472977|78968964|FG000|Overall Study|Subject request to discontinue treatment|0|||
44175242|NCT02472977|78968965|FG001|Overall Study|Subject request to discontinue treatment|1|||
44175243|NCT02472977|78968966|FG002|Overall Study|Subject request to discontinue treatment|0|||
44175244|NCT02060487|78968977|FG000|Overall Study|Other|1|||
44175245|NCT02060487|78968978|FG001|Overall Study|Other|2|||
44175246|NCT02060487|78968979|FG002|Overall Study|Other|1|||
44175247|NCT02060487|78968977|FG000|Overall Study|Lack of Efficacy|0|||
44175248|NCT02060487|78968978|FG001|Overall Study|Lack of Efficacy|1|||
44175249|NCT02060487|78968979|FG002|Overall Study|Lack of Efficacy|0|||
44175250|NCT02060487|78968977|FG000|Overall Study|Withdrawal by Subject|3|||
44175251|NCT02060487|78968978|FG001|Overall Study|Withdrawal by Subject|10|||
44175252|NCT02060487|78968979|FG002|Overall Study|Withdrawal by Subject|4|||
44175253|NCT02060487|78968977|FG000|Overall Study|Study Terminated By Sponsor|87|||
44175254|NCT02060487|78968978|FG001|Overall Study|Study Terminated By Sponsor|89|||
44175255|NCT02060487|78968979|FG002|Overall Study|Study Terminated By Sponsor|100|||
44175256|NCT02060487|78968977|FG000|Overall Study|Randomized in error|1|||
44175257|NCT02060487|78968978|FG001|Overall Study|Randomized in error|0|||
44175258|NCT02060487|78968979|FG002|Overall Study|Randomized in error|0|||
44175259|NCT02060487|78968977|FG000|Overall Study|Protocol Violation|0|||
44175260|NCT02060487|78968978|FG001|Overall Study|Protocol Violation|1|||
44175261|NCT02060487|78968979|FG002|Overall Study|Protocol Violation|1|||
44175262|NCT02060487|78968977|FG000|Overall Study|Lost to Follow-up|3|||
44175263|NCT02060487|78968978|FG001|Overall Study|Lost to Follow-up|0|||
44175264|NCT02060487|78968979|FG002|Overall Study|Lost to Follow-up|2|||
44175265|NCT02060487|78968977|FG000|Overall Study|Death|34|||
44175266|NCT02060487|78968978|FG001|Overall Study|Death|25|||
44175267|NCT02060487|78968979|FG002|Overall Study|Death|19|||
44175268|NCT02060487|78968977|FG000|Overall Study|Adverse Event|0|||
44175269|NCT02060487|78968978|FG001|Overall Study|Adverse Event|0|||
44175270|NCT02060487|78968979|FG002|Overall Study|Adverse Event|1|||
44175271|NCT02059395|78968989|FG000|Overall Study|Lost to Follow-up|2|||
44175272|NCT02059395|78968990|FG001|Overall Study|Lost to Follow-up|4|||
44175273|NCT02059239|78968998|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
44175274|NCT02059239|78968999|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
44175275|NCT02059239|78968998|FG000|Overall Study|Physician Decision|1|||
44175276|NCT02059239|78968999|FG001|Overall Study|Physician Decision|0|||
44175277|NCT02059161|78969008|FG000|Overall Study|Pregnancy|0|||
44175278|NCT02059161|78969009|FG001|Overall Study|Pregnancy|2|||
44175279|NCT02059161|78969008|FG000|Overall Study|Adverse Event|2|||
44175280|NCT02059161|78969009|FG001|Overall Study|Adverse Event|6|||
44175281|NCT02059161|78969008|FG000|Overall Study|Lost to Follow-up|20|||
44175282|NCT02059161|78969009|FG001|Overall Study|Lost to Follow-up|12|||
44175283|NCT02059161|78969008|FG000|Overall Study|Physician Decision|4|||
44175284|NCT02059161|78969009|FG001|Overall Study|Physician Decision|4|||
44175285|NCT02059161|78969008|FG000|Overall Study|Protocol Violation|1|||
44175286|NCT02059161|78969009|FG001|Overall Study|Protocol Violation|1|||
44175287|NCT02059161|78969008|FG000|Overall Study|Withdrawal by Subject|16|||
44175288|NCT02059161|78969009|FG001|Overall Study|Withdrawal by Subject|13|||
44175289|NCT02059161|78969008|FG000|Overall Study|Randomized in error, no study drug|0|||
44264468|NCT02469246|79166271|FG001|Double-Blind Phase|Protocol Violation|1|||
44264469|NCT02469246|79166270|FG000|Double-Blind Phase|Withdrew Consent|25|||
44175290|NCT02059161|78969009|FG001|Overall Study|Randomized in error, no study drug|1|||
44175291|NCT02059161|78969008|FG000|Overall Study|Non-compliance with study drug|6|||
44175292|NCT02059161|78969009|FG001|Overall Study|Non-compliance with study drug|2|||
44175293|NCT01897714|78969021|FG000|Phase I (Dose Escalation)|Disease progression|3|||
44175294|NCT01897714|78969022|FG001|Phase I (Dose Escalation)|Disease progression|5|||
44175295|NCT01897714|78969023|FG002|Phase I (Dose Escalation)|Disease progression|1|||
44175296|NCT01897714|78969024|FG003|Phase I (Dose Escalation)|Disease progression|3|||
44175297|NCT01897714|78969025|FG004|Phase I (Dose Escalation)|Disease progression|0|||
44175298|NCT01897714|78969026|FG005|Phase I (Dose Escalation)|Disease progression|0|||
44175299|NCT01897714|78969021|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
44175300|NCT01897714|78969022|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
44175301|NCT01897714|78969023|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
44175302|NCT01897714|78969024|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
44175303|NCT01897714|78969025|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
44175304|NCT01897714|78969026|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
44175305|NCT01897714|78969021|FG000|Phase I (Dose Escalation)|Other|0|||
44175306|NCT01897714|78969022|FG001|Phase I (Dose Escalation)|Other|1|||
44175307|NCT01897714|78969023|FG002|Phase I (Dose Escalation)|Other|0|||
44175308|NCT01897714|78969024|FG003|Phase I (Dose Escalation)|Other|0|||
44175309|NCT01897714|78969025|FG004|Phase I (Dose Escalation)|Other|0|||
44175310|NCT01897714|78969026|FG005|Phase I (Dose Escalation)|Other|0|||
44175311|NCT01897714|78969021|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
44175312|NCT01897714|78969022|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
44175313|NCT01897714|78969023|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
44451101|NCT01712490|79460047|FG000|Overall Study|Withdrawal by Subject|36|||
44175314|NCT01897714|78969024|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
44175315|NCT01897714|78969025|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
44175316|NCT01897714|78969026|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
44175317|NCT01897714|78969021|FG000|Phase II (MTD)|Lost to Follow-up|0|||
44175318|NCT01897714|78969022|FG001|Phase II (MTD)|Lost to Follow-up|0|||
44175319|NCT01897714|78969023|FG002|Phase II (MTD)|Lost to Follow-up|0|||
44175320|NCT01897714|78969024|FG003|Phase II (MTD)|Lost to Follow-up|0|||
44175321|NCT01897714|78969025|FG004|Phase II (MTD)|Lost to Follow-up|1|||
44175322|NCT01897714|78969026|FG005|Phase II (MTD)|Lost to Follow-up|0|||
44175323|NCT01897714|78969021|FG000|Phase II (MTD)|Death|0|||
44175324|NCT01897714|78969022|FG001|Phase II (MTD)|Death|0|||
44175325|NCT01897714|78969023|FG002|Phase II (MTD)|Death|0|||
44175326|NCT01897714|78969024|FG003|Phase II (MTD)|Death|0|||
44175327|NCT01897714|78969025|FG004|Phase II (MTD)|Death|25|||
44175328|NCT01897714|78969026|FG005|Phase II (MTD)|Death|10|||
44175329|NCT01897714|78969021|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
44175330|NCT01897714|78969022|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
44175331|NCT01897714|78969023|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
44175332|NCT01897714|78969024|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
44175333|NCT01897714|78969025|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
44175334|NCT01897714|78969026|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
44175335|NCT01897714|78969021|FG000|Phase II (MTD)|Other|0|||
44175336|NCT01897714|78969022|FG001|Phase II (MTD)|Other|0|||
44175337|NCT01897714|78969023|FG002|Phase II (MTD)|Other|0|||
44175338|NCT01897714|78969024|FG003|Phase II (MTD)|Other|0|||
44175339|NCT01897714|78969025|FG004|Phase II (MTD)|Other|3|||
44175340|NCT01897714|78969026|FG005|Phase II (MTD)|Other|0|||
44175341|NCT01861522|78969044|FG000|Overall Study|Adverse Event|1|||
44175342|NCT01861522|78969045|FG001|Overall Study|Adverse Event|0|||
44175343|NCT01861522|78969044|FG000|Overall Study|Withdrawal by Subject|2|||
44175344|NCT01861522|78969045|FG001|Overall Study|Withdrawal by Subject|0|||
44175345|NCT01860976|78969053|FG000|Blinded Treatment|Adverse Event|1|||
44175346|NCT01860976|78969054|FG001|Blinded Treatment|Adverse Event|3|||
44175347|NCT01860976|78969053|FG000|Blinded Treatment|Lack of Efficacy|5|||
44175348|NCT01860976|78969054|FG001|Blinded Treatment|Lack of Efficacy|12|||
44175349|NCT01860976|78969053|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
44175350|NCT01860976|78969054|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
44175351|NCT01860976|78969053|FG000|Blinded Treatment|Withdrawal by Subject|3|||
44175352|NCT01860976|78969054|FG001|Blinded Treatment|Withdrawal by Subject|5|||
44175353|NCT01860976|78969053|FG000|Blinded Treatment|Subject no longer met criteria|1|||
44175354|NCT01860976|78969054|FG001|Blinded Treatment|Subject no longer met criteria|0|||
44175355|NCT01860976|78969053|FG000|Blinded Treatment|Entered Open-Label in error|0|||
44175356|NCT01860976|78969054|FG001|Blinded Treatment|Entered Open-Label in error|1|||
44175357|NCT01860976|78969053|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
44175358|NCT01860976|78969054|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
44175359|NCT01860976|78969053|FG000|Open-Label|Adverse Event|2|||
44361157|NCT01162421|79366805|FG001|Overall Study|Did not receive study drug|1|||
44361158|NCT01162421|79366804|FG000|Overall Study|Adverse Event|2|||
44451102|NCT01712490|79460048|FG001|Overall Study|Withdrawal by Subject|44|||
44175360|NCT01860976|78969054|FG001|Open-Label|Adverse Event|4|||
44175361|NCT01860976|78969053|FG000|Open-Label|Lack of Efficacy|16|||
44175362|NCT01860976|78969054|FG001|Open-Label|Lack of Efficacy|8|||
44175363|NCT01860976|78969053|FG000|Open-Label|Lost to Follow-up|1|||
44175364|NCT01860976|78969054|FG001|Open-Label|Lost to Follow-up|2|||
44175365|NCT01860976|78969053|FG000|Open-Label|Subject request discontinue treatment|4|||
44175366|NCT01860976|78969054|FG001|Open-Label|Subject request discontinue treatment|3|||
44175367|NCT01860976|78969053|FG000|Open-Label|Withdrawal by Subject|4|||
44175368|NCT01860976|78969054|FG001|Open-Label|Withdrawal by Subject|1|||
44175369|NCT01860976|78969053|FG000|Open-Label|Other Reasons|1|||
44175370|NCT01860976|78969054|FG001|Open-Label|Other Reasons|1|||
44175371|NCT01860976|78969053|FG000|Long Term Extension|Adverse Event|4|||
44175372|NCT01860976|78969054|FG001|Long Term Extension|Adverse Event|0|||
44175373|NCT01860976|78969053|FG000|Long Term Extension|Lack of Efficacy|2|||
44175374|NCT01860976|78969054|FG001|Long Term Extension|Lack of Efficacy|0|||
44175375|NCT01860976|78969053|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
44175376|NCT01860976|78969054|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
44175377|NCT01860976|78969053|FG000|Long Term Extension|Lost to Follow-up|2|||
44175378|NCT01860976|78969054|FG001|Long Term Extension|Lost to Follow-up|0|||
44175379|NCT01860976|78969053|FG000|Long Term Extension|subject withdrew consent|7|||
44175380|NCT01860976|78969054|FG001|Long Term Extension|subject withdrew consent|0|||
44175381|NCT01860040|78969065|FG000|Overall Study|Withdrawal by Subject|1|||
44175382|NCT01860040|78969066|FG001|Overall Study|Withdrawal by Subject|0|||
44175383|NCT01896934|78969071|FG000|Overall Study|Adverse Event|1|||
44175384|NCT01896934|78969071|FG000|Overall Study|Withdrawal by Subject|1|||
44175385|NCT02039505|78969078|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
44175386|NCT02039505|78969079|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
44175387|NCT02039505|78969080|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
44175388|NCT02039505|78969081|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
44175389|NCT02039505|78969082|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
44175390|NCT02039505|78969083|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
44175391|NCT02039505|78969084|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
44175392|NCT02039505|78969078|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
44175393|NCT02039505|78969079|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
44175394|NCT02039505|78969080|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
44175395|NCT02039505|78969081|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
44361159|NCT01162421|79366805|FG001|Overall Study|Adverse Event|5|||
44175396|NCT02039505|78969082|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
44175397|NCT02039505|78969083|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
44175398|NCT02039505|78969084|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
44175399|NCT02039505|78969078|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
44175400|NCT02039505|78969079|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
44175401|NCT02039505|78969080|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
44175402|NCT02039505|78969081|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
44175403|NCT02039505|78969082|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
44175404|NCT02039505|78969083|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
44175405|NCT02039505|78969084|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
44175406|NCT02039505|78969078|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
44175407|NCT02039505|78969079|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
44175408|NCT02039505|78969080|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
44175409|NCT02039505|78969081|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
44175410|NCT02039505|78969082|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
44175411|NCT02039505|78969083|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
44175412|NCT02039505|78969084|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
44175413|NCT02039505|78969078|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
44175414|NCT02039505|78969079|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
44175415|NCT02039505|78969080|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
44175416|NCT02039505|78969081|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
44175417|NCT02039505|78969082|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
44175418|NCT02039505|78969083|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
44175419|NCT02039505|78969084|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
44175420|NCT02039505|78969078|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
44175421|NCT02039505|78969079|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
44175422|NCT02039505|78969080|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
44175423|NCT02039505|78969081|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
44175424|NCT02039505|78969082|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
44175425|NCT02039505|78969083|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
44175426|NCT02039505|78969084|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
44175427|NCT02039505|78969078|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
44175428|NCT02039505|78969079|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
44175429|NCT02039505|78969080|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
44175430|NCT02039505|78969081|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
44175431|NCT02039505|78969082|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
44175432|NCT02039505|78969083|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
44175433|NCT02039505|78969084|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
44175434|NCT02039505|78969078|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
44175435|NCT02039505|78969079|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
44175436|NCT02039505|78969080|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
44175437|NCT02039505|78969081|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
44175438|NCT02039505|78969082|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
44175439|NCT02039505|78969083|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
44175440|NCT02039505|78969084|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
44175441|NCT02039505|78969078|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
44175442|NCT02039505|78969079|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
44175443|NCT02039505|78969080|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
44175444|NCT02039505|78969081|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
44175445|NCT02039505|78969082|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
44175446|NCT02039505|78969083|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
44175447|NCT02039505|78969084|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
44175448|NCT02039505|78969078|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
44175449|NCT02039505|78969079|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
44175450|NCT02039505|78969080|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
44175451|NCT02039505|78969081|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
44175452|NCT02039505|78969082|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
44175453|NCT02039505|78969083|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
44175454|NCT02039505|78969084|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
44175455|NCT02039505|78969078|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
44175456|NCT02039505|78969079|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
44175457|NCT02039505|78969080|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
44175458|NCT02039505|78969081|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
44264470|NCT02469246|79166271|FG001|Double-Blind Phase|Withdrew Consent|25|||
44264471|NCT02469246|79166270|FG000|Double-Blind Phase|Lost to Follow-up|9|||
44264472|NCT02469246|79166271|FG001|Double-Blind Phase|Lost to Follow-up|5|||
44264473|NCT02469168|79166290|FG000|Overall Study|Trial closed|1|||
44264474|NCT02469168|79166291|FG001|Overall Study|Trial closed|0|||
44264475|NCT02469090|79166299|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
44264476|NCT02469090|79166300|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
44264477|NCT02469090|79166301|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
44264478|NCT02469090|79166299|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
44264479|NCT02469090|79166300|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
44264480|NCT02469090|79166301|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
44264481|NCT02469090|79166299|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
44264482|NCT02469090|79166300|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
44264483|NCT02469090|79166301|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
44264484|NCT02469090|79166299|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
44264485|NCT02469090|79166300|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
44264486|NCT02469090|79166301|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
44264487|NCT02469090|79166299|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
44264488|NCT02469090|79166300|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
44264489|NCT02469090|79166301|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
44264490|NCT02469090|79166299|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
44264491|NCT02469090|79166300|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
44264492|NCT02469090|79166301|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
44264493|NCT02469090|79166299|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
44264494|NCT02469090|79166300|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
44264495|NCT02469090|79166301|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
44264496|NCT02469090|79166299|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
44264497|NCT02469090|79166300|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
44264498|NCT02469090|79166301|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
44264499|NCT02496000|79166311|FG000|Overall Study|Withdrawal by Subject|1|||
44264500|NCT02496000|79166312|FG001|Overall Study|Withdrawal by Subject|2|||
44264501|NCT02496000|79166313|FG002|Overall Study|Withdrawal by Subject|0|||
44264502|NCT02496000|79166311|FG000|Overall Study|Lost to Follow-up|1|||
44264503|NCT02496000|79166312|FG001|Overall Study|Lost to Follow-up|0|||
44451103|NCT01712490|79460047|FG000|Overall Study|Lost to Follow-up|16|||
44451104|NCT01712490|79460048|FG001|Overall Study|Lost to Follow-up|29|||
44451105|NCT01266642|79460065|FG000|Overall Study|Protocol Violation|0|||
44451106|NCT01266642|79460066|FG001|Overall Study|Protocol Violation|1|||
44451107|NCT00947531|79460074|FG000|Overall Study|Withdrawal by Subject|10|||
44175459|NCT02039505|78969082|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
44175460|NCT02039505|78969083|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
44175461|NCT02039505|78969084|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
44175462|NCT02095197|78969106|FG000|Overall Study|Lost to Follow-up|0|||
44175463|NCT02095197|78969107|FG001|Overall Study|Lost to Follow-up|3|||
44175464|NCT02039427|78969117|FG000|Overall Study|Duration of surgery > 3h|1|||
44175465|NCT02039427|78969118|FG001|Overall Study|Duration of surgery > 3h|1|||
44175466|NCT02039427|78969119|FG002|Overall Study|Duration of surgery > 3h|0|||
44175467|NCT02039427|78969120|FG003|Overall Study|Duration of surgery > 3h|0|||
44175468|NCT02039427|78969117|FG000|Overall Study|Withdrawal on concent|0|||
44175469|NCT02039427|78969118|FG001|Overall Study|Withdrawal on concent|0|||
44175470|NCT02039427|78969119|FG002|Overall Study|Withdrawal on concent|0|||
44175471|NCT02039427|78969120|FG003|Overall Study|Withdrawal on concent|1|||
44175472|NCT02039427|78969117|FG000|Overall Study|Cancellation of surgery|0|||
44175473|NCT02039427|78969118|FG001|Overall Study|Cancellation of surgery|0|||
44175474|NCT02039427|78969119|FG002|Overall Study|Cancellation of surgery|1|||
44175475|NCT02039427|78969120|FG003|Overall Study|Cancellation of surgery|0|||
44175476|NCT02039427|78969117|FG000|Overall Study|Loss of follow - up|1|||
44175477|NCT02039427|78969118|FG001|Overall Study|Loss of follow - up|0|||
44175478|NCT02039427|78969119|FG002|Overall Study|Loss of follow - up|2|||
44175479|NCT02039427|78969120|FG003|Overall Study|Loss of follow - up|4|||
44175480|NCT02039427|78969117|FG000|Overall Study|Steroid Use|1|||
44175481|NCT02039427|78969118|FG001|Overall Study|Steroid Use|0|||
44175482|NCT02039427|78969119|FG002|Overall Study|Steroid Use|0|||
44175483|NCT02039427|78969120|FG003|Overall Study|Steroid Use|0|||
44264504|NCT02496000|79166313|FG002|Overall Study|Lost to Follow-up|1|||
44264505|NCT02496000|79166311|FG000|Overall Study|Protocol Violation|0|||
44264506|NCT02496000|79166312|FG001|Overall Study|Protocol Violation|0|||
44264507|NCT02496000|79166313|FG002|Overall Study|Protocol Violation|1|||
44264508|NCT02496000|79166311|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
44264509|NCT02496000|79166312|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
44264510|NCT02496000|79166313|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
44264511|NCT02496000|79166311|FG000|Overall Study|undetermined|0|||
44264512|NCT02496000|79166312|FG001|Overall Study|undetermined|1|||
44264513|NCT02496000|79166313|FG002|Overall Study|undetermined|0|||
44264514|NCT02468934|79166322|FG000|Overall Study|Withdrawal by Subject|4|||
44264515|NCT02468934|79166322|FG000|Overall Study|Screen Failure|3|||
44264516|NCT02517528|79166328|FG000|Overall Study|Withdrawal by Subject|1|||
44264517|NCT02495844|79166334|FG000|Overall Study|Lack of Efficacy|1|||
44264518|NCT02495844|79166335|FG001|Overall Study|Lack of Efficacy|2|||
44264519|NCT02495844|79166334|FG000|Overall Study|AE, non-fatal|0|||
44264520|NCT02495844|79166335|FG001|Overall Study|AE, non-fatal|1|||
44264521|NCT02495844|79166334|FG000|Overall Study|Hepatitis Positivity|0|||
44264522|NCT02495844|79166335|FG001|Overall Study|Hepatitis Positivity|1|||
44264523|NCT02468778|79166346|FG000|Overall Study|Death|2|||
44264524|NCT02468778|79166347|FG001|Overall Study|Death|1|||
44264525|NCT02468778|79166348|FG002|Overall Study|Death|0|||
44264526|NCT02468778|79166346|FG000|Overall Study|Lost to Follow-up|1|||
44264527|NCT02468778|79166347|FG001|Overall Study|Lost to Follow-up|2|||
44264528|NCT02468778|79166348|FG002|Overall Study|Lost to Follow-up|2|||
44264529|NCT02468778|79166346|FG000|Overall Study|Withdrawal by Subject|0|||
44264530|NCT02468778|79166347|FG001|Overall Study|Withdrawal by Subject|1|||
44264531|NCT02468778|79166348|FG002|Overall Study|Withdrawal by Subject|1|||
44264532|NCT01727336|79166362|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
44264533|NCT01727336|79166363|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
44264534|NCT01727336|79166364|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
44264535|NCT01727336|79166365|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
44264536|NCT01727336|79166366|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
44264537|NCT01727336|79166367|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
44264538|NCT01727336|79166362|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
44264539|NCT01727336|79166363|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
44264540|NCT01727336|79166364|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
44264541|NCT01727336|79166365|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
44264542|NCT01727336|79166366|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
44264543|NCT01727336|79166367|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
44264544|NCT01727336|79166362|FG000|Part 2 Blinded|Death|0|||
44264545|NCT01727336|79166363|FG001|Part 2 Blinded|Death|0|||
44264546|NCT01727336|79166364|FG002|Part 2 Blinded|Death|0|||
44264547|NCT01727336|79166365|FG003|Part 2 Blinded|Death|0|||
44264548|NCT01727336|79166366|FG004|Part 2 Blinded|Death|20|||
44264549|NCT01727336|79166367|FG005|Part 2 Blinded|Death|16|||
44264550|NCT01727336|79166362|FG000|Part 2 Blinded|Lack of Efficacy|0|||
44264551|NCT01727336|79166363|FG001|Part 2 Blinded|Lack of Efficacy|0|||
44264552|NCT01727336|79166364|FG002|Part 2 Blinded|Lack of Efficacy|0|||
44264553|NCT01727336|79166365|FG003|Part 2 Blinded|Lack of Efficacy|0|||
44264554|NCT01727336|79166366|FG004|Part 2 Blinded|Lack of Efficacy|42|||
44264555|NCT01727336|79166367|FG005|Part 2 Blinded|Lack of Efficacy|44|||
44264556|NCT01727336|79166362|FG000|Part 2 Blinded|Lost to Follow-up|0|||
44264557|NCT01727336|79166363|FG001|Part 2 Blinded|Lost to Follow-up|0|||
44264558|NCT01727336|79166364|FG002|Part 2 Blinded|Lost to Follow-up|0|||
44264559|NCT01727336|79166365|FG003|Part 2 Blinded|Lost to Follow-up|0|||
44264560|NCT01727336|79166366|FG004|Part 2 Blinded|Lost to Follow-up|0|||
44264561|NCT01727336|79166367|FG005|Part 2 Blinded|Lost to Follow-up|1|||
44264562|NCT01727336|79166362|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
44264563|NCT01727336|79166363|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
44264564|NCT01727336|79166364|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
44264565|NCT01727336|79166365|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
44264566|NCT01727336|79166366|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
44264567|NCT01727336|79166367|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
44361160|NCT01162421|79366804|FG000|Overall Study|Lost to Follow-up|0|||
44543028|NCT03655717|79555905|FG005|Overall Study|Lost to Follow-up|1|||
44264568|NCT01727336|79166362|FG000|Part 2 Blinded|use of prohibited medications|0|||
44264569|NCT01727336|79166363|FG001|Part 2 Blinded|use of prohibited medications|0|||
44264570|NCT01727336|79166364|FG002|Part 2 Blinded|use of prohibited medications|0|||
44264571|NCT01727336|79166365|FG003|Part 2 Blinded|use of prohibited medications|0|||
44264572|NCT01727336|79166366|FG004|Part 2 Blinded|use of prohibited medications|1|||
44264573|NCT01727336|79166367|FG005|Part 2 Blinded|use of prohibited medications|3|||
44264574|NCT02466516|79166401|FG000|Overall Study|Adverse Event|1|||
44264575|NCT02466516|79166402|FG001|Overall Study|Adverse Event|1|||
44264576|NCT02466516|79166403|FG002|Overall Study|Adverse Event|0|||
44264577|NCT02466516|79166404|FG003|Overall Study|Adverse Event|0|||
44361161|NCT01162421|79366805|FG001|Overall Study|Lost to Follow-up|2|||
44264578|NCT02466516|79166405|FG004|Overall Study|Adverse Event|0|||
44264579|NCT02466516|79166401|FG000|Overall Study|Withdrew Consent|1|||
44264580|NCT02466516|79166402|FG001|Overall Study|Withdrew Consent|0|||
44264581|NCT02466516|79166403|FG002|Overall Study|Withdrew Consent|0|||
44264582|NCT02466516|79166404|FG003|Overall Study|Withdrew Consent|0|||
44264583|NCT02466516|79166405|FG004|Overall Study|Withdrew Consent|0|||
44264584|NCT02466516|79166401|FG000|Overall Study|Lost to Follow-up|2|||
44264585|NCT02466516|79166402|FG001|Overall Study|Lost to Follow-up|0|||
44264586|NCT02466516|79166403|FG002|Overall Study|Lost to Follow-up|1|||
44264587|NCT02466516|79166404|FG003|Overall Study|Lost to Follow-up|0|||
44264588|NCT02466516|79166405|FG004|Overall Study|Lost to Follow-up|0|||
44264589|NCT01725152|79166419|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
44264590|NCT01725152|79166420|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
44264591|NCT01725152|79166419|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
44264592|NCT01725152|79166420|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
44264593|NCT01725152|79166419|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
44264594|NCT01725152|79166420|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
44264595|NCT01725152|79166419|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
44264596|NCT01725152|79166420|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
44264597|NCT01049984|79166436|FG000|Overall Study|Withdrawal by Subject|1|||
44264598|NCT01049984|79166437|FG001|Overall Study|Withdrawal by Subject|5|||
44264599|NCT01049984|79166436|FG000|Overall Study|Protocol Violation|3|||
44264600|NCT01049984|79166437|FG001|Overall Study|Protocol Violation|4|||
44264601|NCT01049984|79166436|FG000|Overall Study|Lost to Follow-up|2|||
44264602|NCT01049984|79166437|FG001|Overall Study|Lost to Follow-up|1|||
44264603|NCT01049984|79166436|FG000|Overall Study|Adverse Event|13|||
44264604|NCT01049984|79166437|FG001|Overall Study|Adverse Event|7|||
44264605|NCT01049984|79166436|FG000|Overall Study|Treatment failure|0|||
44264606|NCT01049984|79166437|FG001|Overall Study|Treatment failure|2|||
44264607|NCT01049360|79166443|FG000|Period 1|Adverse Event|0|||
44264608|NCT01049360|79166444|FG001|Period 1|Adverse Event|1|||
44264609|NCT01049360|79166445|FG002|Period 1|Adverse Event|0|||
44264610|NCT01049360|79166446|FG003|Period 1|Adverse Event|1|||
44264611|NCT01049360|79166447|FG004|Period 1|Adverse Event|0|||
44264612|NCT01049360|79166448|FG005|Period 1|Adverse Event|0|||
44264613|NCT01049360|79166449|FG006|Period 1|Adverse Event|0|||
44264614|NCT01049360|79166450|FG007|Period 1|Adverse Event|1|||
44264615|NCT01049360|79166451|FG008|Period 1|Adverse Event|0|||
44264616|NCT01049360|79166452|FG009|Period 1|Adverse Event|0|||
44264617|NCT01049360|79166453|FG010|Period 1|Adverse Event|0|||
44264618|NCT01049360|79166454|FG011|Period 1|Adverse Event|0|||
44264619|NCT01049360|79166455|FG012|Period 1|Adverse Event|1|||
44264620|NCT01049360|79166456|FG013|Period 1|Adverse Event|1|||
44264621|NCT01049360|79166457|FG014|Period 1|Adverse Event|0|||
44264622|NCT01049360|79166458|FG015|Period 1|Adverse Event|0|||
44264623|NCT01049360|79166459|FG016|Period 1|Adverse Event|1|||
44264624|NCT01049360|79166460|FG017|Period 1|Adverse Event|0|||
44264625|NCT01049360|79166461|FG018|Period 1|Adverse Event|1|||
44264626|NCT01049360|79166462|FG019|Period 1|Adverse Event|0|||
44264627|NCT01049360|79166443|FG000|Period 1|Did not meet inc/exc criteria|0|||
44264628|NCT01049360|79166444|FG001|Period 1|Did not meet inc/exc criteria|0|||
44264629|NCT01049360|79166445|FG002|Period 1|Did not meet inc/exc criteria|0|||
44264630|NCT01049360|79166446|FG003|Period 1|Did not meet inc/exc criteria|0|||
44264631|NCT01049360|79166447|FG004|Period 1|Did not meet inc/exc criteria|0|||
44264632|NCT01049360|79166448|FG005|Period 1|Did not meet inc/exc criteria|0|||
44264633|NCT01049360|79166449|FG006|Period 1|Did not meet inc/exc criteria|0|||
44264634|NCT01049360|79166450|FG007|Period 1|Did not meet inc/exc criteria|1|||
44264635|NCT01049360|79166451|FG008|Period 1|Did not meet inc/exc criteria|1|||
44264636|NCT01049360|79166452|FG009|Period 1|Did not meet inc/exc criteria|0|||
44264637|NCT01049360|79166453|FG010|Period 1|Did not meet inc/exc criteria|0|||
44264638|NCT01049360|79166454|FG011|Period 1|Did not meet inc/exc criteria|0|||
44264639|NCT01049360|79166455|FG012|Period 1|Did not meet inc/exc criteria|0|||
44264640|NCT01049360|79166456|FG013|Period 1|Did not meet inc/exc criteria|0|||
44264641|NCT01049360|79166457|FG014|Period 1|Did not meet inc/exc criteria|0|||
44451108|NCT00947531|79460075|FG001|Overall Study|Withdrawal by Subject|7|||
44451109|NCT00947531|79460074|FG000|Overall Study|Administrative Reason|0|||
44451110|NCT00947531|79460075|FG001|Overall Study|Administrative Reason|1|||
44264642|NCT01049360|79166458|FG015|Period 1|Did not meet inc/exc criteria|0|||
44264643|NCT01049360|79166459|FG016|Period 1|Did not meet inc/exc criteria|0|||
44264644|NCT01049360|79166460|FG017|Period 1|Did not meet inc/exc criteria|0|||
44264645|NCT01049360|79166461|FG018|Period 1|Did not meet inc/exc criteria|0|||
44264646|NCT01049360|79166462|FG019|Period 1|Did not meet inc/exc criteria|0|||
44264647|NCT01049360|79166443|FG000|Period 1|Withdrawal by Subject|0|||
44264648|NCT01049360|79166444|FG001|Period 1|Withdrawal by Subject|0|||
44264649|NCT01049360|79166445|FG002|Period 1|Withdrawal by Subject|0|||
44264650|NCT01049360|79166446|FG003|Period 1|Withdrawal by Subject|0|||
44264651|NCT01049360|79166447|FG004|Period 1|Withdrawal by Subject|0|||
44264652|NCT01049360|79166448|FG005|Period 1|Withdrawal by Subject|0|||
44451111|NCT00947531|79460074|FG000|Overall Study|Adverse Event|2|||
44264653|NCT01049360|79166449|FG006|Period 1|Withdrawal by Subject|0|||
44264654|NCT01049360|79166450|FG007|Period 1|Withdrawal by Subject|0|||
44264655|NCT01049360|79166451|FG008|Period 1|Withdrawal by Subject|1|||
44264656|NCT01049360|79166452|FG009|Period 1|Withdrawal by Subject|0|||
44264657|NCT01049360|79166453|FG010|Period 1|Withdrawal by Subject|1|||
44264658|NCT01049360|79166454|FG011|Period 1|Withdrawal by Subject|0|||
44264659|NCT01049360|79166455|FG012|Period 1|Withdrawal by Subject|1|||
44264660|NCT01049360|79166456|FG013|Period 1|Withdrawal by Subject|0|||
44264661|NCT01049360|79166457|FG014|Period 1|Withdrawal by Subject|0|||
44264662|NCT01049360|79166458|FG015|Period 1|Withdrawal by Subject|0|||
44264663|NCT01049360|79166459|FG016|Period 1|Withdrawal by Subject|0|||
44264664|NCT01049360|79166460|FG017|Period 1|Withdrawal by Subject|0|||
44264665|NCT01049360|79166461|FG018|Period 1|Withdrawal by Subject|0|||
44264666|NCT01049360|79166462|FG019|Period 1|Withdrawal by Subject|0|||
44264667|NCT01049360|79166443|FG000|Period 2|Protocol Violation|0|||
44264668|NCT01049360|79166444|FG001|Period 2|Protocol Violation|0|||
44264669|NCT01049360|79166445|FG002|Period 2|Protocol Violation|0|||
44264670|NCT01049360|79166446|FG003|Period 2|Protocol Violation|1|||
44175484|NCT02094885|78969136|FG000|Overall Study|Death|1|||
44175485|NCT02094885|78969137|FG001|Overall Study|Death|5|||
44175486|NCT02094885|78969136|FG000|Overall Study|Withdrawn due to age|1|||
44175487|NCT02094885|78969137|FG001|Overall Study|Withdrawn due to age|0|||
44175488|NCT01896856|78969149|FG000|Overall Study|Transportation issues / Non-compliance|0|||
44175489|NCT01896856|78969150|FG001|Overall Study|Transportation issues / Non-compliance|0|||
44175490|NCT01896856|78969151|FG002|Overall Study|Transportation issues / Non-compliance|1|||
44175491|NCT01896856|78969152|FG003|Overall Study|Transportation issues / Non-compliance|0|||
44175492|NCT01896856|78969153|FG004|Overall Study|Transportation issues / Non-compliance|0|||
44175493|NCT01896856|78969154|FG005|Overall Study|Transportation issues / Non-compliance|0|||
44175494|NCT02038959|78969171|FG000|Overall Study|Withdrawal by Subject|6|||
44175495|NCT02038959|78969172|FG001|Overall Study|Withdrawal by Subject|8|||
44175496|NCT01896700|78969180|FG000|Overall Study|Adverse Event|4|||
44175497|NCT01896700|78969181|FG001|Overall Study|Adverse Event|5|||
44175498|NCT01896700|78969180|FG000|Overall Study|Withdrawal by Subject|0|||
44175499|NCT01896700|78969181|FG001|Overall Study|Withdrawal by Subject|1|||
44175500|NCT02352493|78969205|FG000|Overall Study|Pregnancy|0|||
44175501|NCT02352493|78969206|FG001|Overall Study|Pregnancy|0|||
44175502|NCT02352493|78969207|FG002|Overall Study|Pregnancy|0|||
44175503|NCT02352493|78969208|FG003|Overall Study|Pregnancy|0|||
44175504|NCT02352493|78969209|FG004|Overall Study|Pregnancy|0|||
44175505|NCT02352493|78969210|FG005|Overall Study|Pregnancy|0|||
44175506|NCT02352493|78969211|FG006|Overall Study|Pregnancy|1|||
44175507|NCT02352493|78969212|FG007|Overall Study|Pregnancy|0|||
44175508|NCT02352493|78969213|FG008|Overall Study|Pregnancy|1|||
44175509|NCT02352493|78969214|FG009|Overall Study|Pregnancy|0|||
44175510|NCT02352493|78969215|FG010|Overall Study|Pregnancy|0|||
44175511|NCT02352493|78969216|FG011|Overall Study|Pregnancy|0|||
44175512|NCT02352493|78969217|FG012|Overall Study|Pregnancy|0|||
44175513|NCT02352493|78969218|FG013|Overall Study|Pregnancy|0|||
44175514|NCT02352493|78969219|FG014|Overall Study|Pregnancy|0|||
44175515|NCT02352493|78969220|FG015|Overall Study|Pregnancy|0|||
44175516|NCT02352493|78969221|FG016|Overall Study|Pregnancy|0|||
44175517|NCT02352493|78969222|FG017|Overall Study|Pregnancy|0|||
44175518|NCT02352493|78969205|FG000|Overall Study|Withdrawal by Subject|0|||
44175519|NCT02352493|78969206|FG001|Overall Study|Withdrawal by Subject|0|||
44175520|NCT02352493|78969207|FG002|Overall Study|Withdrawal by Subject|0|||
44175521|NCT02352493|78969208|FG003|Overall Study|Withdrawal by Subject|0|||
44175522|NCT02352493|78969209|FG004|Overall Study|Withdrawal by Subject|0|||
44175523|NCT02352493|78969210|FG005|Overall Study|Withdrawal by Subject|0|||
44175524|NCT02352493|78969211|FG006|Overall Study|Withdrawal by Subject|0|||
44175525|NCT02352493|78969212|FG007|Overall Study|Withdrawal by Subject|0|||
44175526|NCT02352493|78969213|FG008|Overall Study|Withdrawal by Subject|1|||
44175527|NCT02352493|78969214|FG009|Overall Study|Withdrawal by Subject|0|||
44175528|NCT02352493|78969215|FG010|Overall Study|Withdrawal by Subject|0|||
44175529|NCT02352493|78969216|FG011|Overall Study|Withdrawal by Subject|0|||
44175530|NCT02352493|78969217|FG012|Overall Study|Withdrawal by Subject|0|||
44264671|NCT01049360|79166447|FG004|Period 2|Protocol Violation|0|||
44175531|NCT02352493|78969218|FG013|Overall Study|Withdrawal by Subject|0|||
44175532|NCT02352493|78969219|FG014|Overall Study|Withdrawal by Subject|1|||
44175533|NCT02352493|78969220|FG015|Overall Study|Withdrawal by Subject|0|||
44175534|NCT02352493|78969221|FG016|Overall Study|Withdrawal by Subject|0|||
44175535|NCT02352493|78969222|FG017|Overall Study|Withdrawal by Subject|0|||
44264672|NCT01049360|79166448|FG005|Period 2|Protocol Violation|0|||
44264673|NCT01049360|79166449|FG006|Period 2|Protocol Violation|0|||
44264674|NCT01049360|79166450|FG007|Period 2|Protocol Violation|0|||
44264675|NCT01049360|79166451|FG008|Period 2|Protocol Violation|0|||
44175536|NCT02352493|78969205|FG000|Overall Study|Lost to Follow-up|0|||
44175537|NCT02352493|78969206|FG001|Overall Study|Lost to Follow-up|0|||
44175538|NCT02352493|78969207|FG002|Overall Study|Lost to Follow-up|0|||
44264676|NCT01049360|79166452|FG009|Period 2|Protocol Violation|0|||
44175539|NCT02352493|78969208|FG003|Overall Study|Lost to Follow-up|0|||
44175540|NCT02352493|78969209|FG004|Overall Study|Lost to Follow-up|0|||
44175541|NCT02352493|78969210|FG005|Overall Study|Lost to Follow-up|0|||
44175542|NCT02352493|78969211|FG006|Overall Study|Lost to Follow-up|0|||
44175543|NCT02352493|78969212|FG007|Overall Study|Lost to Follow-up|0|||
44175544|NCT02352493|78969213|FG008|Overall Study|Lost to Follow-up|0|||
44175545|NCT02352493|78969214|FG009|Overall Study|Lost to Follow-up|1|||
44175546|NCT02352493|78969215|FG010|Overall Study|Lost to Follow-up|0|||
44175547|NCT02352493|78969216|FG011|Overall Study|Lost to Follow-up|0|||
44175548|NCT02352493|78969217|FG012|Overall Study|Lost to Follow-up|1|||
44175549|NCT02352493|78969218|FG013|Overall Study|Lost to Follow-up|2|||
44175550|NCT02352493|78969219|FG014|Overall Study|Lost to Follow-up|0|||
44175551|NCT02352493|78969220|FG015|Overall Study|Lost to Follow-up|0|||
44175552|NCT02352493|78969221|FG016|Overall Study|Lost to Follow-up|0|||
44175553|NCT02352493|78969222|FG017|Overall Study|Lost to Follow-up|0|||
44175554|NCT02286193|78969277|FG000|Overall Study|Referred: CRS unable to make contact|62|||
44175555|NCT02286193|78969277|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
44175556|NCT02286193|78969277|FG000|Overall Study|Referred: Declined service|38|||
44175557|NCT01896232|78969284|FG000|Overall Study|Death|6|||
44175558|NCT01896232|78969285|FG001|Overall Study|Death|10|||
44175559|NCT01896232|78969284|FG000|Overall Study|Withdrawal by Subject|32|||
44175560|NCT01896232|78969285|FG001|Overall Study|Withdrawal by Subject|31|||
44175561|NCT01896232|78969284|FG000|Overall Study|Sponsor Decision|2|||
44175562|NCT01896232|78969285|FG001|Overall Study|Sponsor Decision|0|||
44175563|NCT01896232|78969284|FG000|Overall Study|Lost to Follow-up|9|||
44175564|NCT01896232|78969285|FG001|Overall Study|Lost to Follow-up|12|||
44175565|NCT02460224|78969320|FG000|Overall Study|Adverse Event|0|||
44175566|NCT02460224|78969321|FG001|Overall Study|Adverse Event|0|||
44175567|NCT02460224|78969322|FG002|Overall Study|Adverse Event|0|||
44175568|NCT02460224|78969323|FG003|Overall Study|Adverse Event|0|||
44175569|NCT02460224|78969324|FG004|Overall Study|Adverse Event|0|||
44175570|NCT02460224|78969325|FG005|Overall Study|Adverse Event|0|||
44175571|NCT02460224|78969326|FG006|Overall Study|Adverse Event|1|||
44175572|NCT02460224|78969327|FG007|Overall Study|Adverse Event|0|||
44175573|NCT02460224|78969328|FG008|Overall Study|Adverse Event|0|||
44175574|NCT02460224|78969329|FG009|Overall Study|Adverse Event|0|||
44175575|NCT02460224|78969330|FG010|Overall Study|Adverse Event|0|||
44175576|NCT02460224|78969331|FG011|Overall Study|Adverse Event|0|||
44175577|NCT02460224|78969332|FG012|Overall Study|Adverse Event|1|||
44175578|NCT02460224|78969333|FG013|Overall Study|Adverse Event|0|||
44175579|NCT02460224|78969334|FG014|Overall Study|Adverse Event|0|||
44175580|NCT02460224|78969335|FG015|Overall Study|Adverse Event|0|||
44175581|NCT02460224|78969336|FG016|Overall Study|Adverse Event|1|||
44264677|NCT01049360|79166453|FG010|Period 2|Protocol Violation|0|||
44264678|NCT01049360|79166454|FG011|Period 2|Protocol Violation|0|||
44264679|NCT01049360|79166455|FG012|Period 2|Protocol Violation|0|||
44361162|NCT01162421|79366804|FG000|Overall Study|Lack of Efficacy|2|||
44361163|NCT01162421|79366805|FG001|Overall Study|Lack of Efficacy|2|||
44175582|NCT02460224|78969337|FG017|Overall Study|Adverse Event|0|||
44175583|NCT02460224|78969338|FG018|Overall Study|Adverse Event|1|||
44175584|NCT02460224|78969339|FG019|Overall Study|Adverse Event|0|||
44175585|NCT02460224|78969340|FG020|Overall Study|Adverse Event|1|||
44175586|NCT02460224|78969341|FG021|Overall Study|Adverse Event|1|||
44175587|NCT02460224|78969342|FG022|Overall Study|Adverse Event|1|||
44175588|NCT02460224|78969343|FG023|Overall Study|Adverse Event|0|||
44175589|NCT02460224|78969344|FG024|Overall Study|Adverse Event|0|||
44175590|NCT02460224|78969345|FG025|Overall Study|Adverse Event|0|||
44175591|NCT02460224|78969346|FG026|Overall Study|Adverse Event|11|||
44175592|NCT02460224|78969347|FG027|Overall Study|Adverse Event|1|||
44175593|NCT02460224|78969348|FG028|Overall Study|Adverse Event|6|||
44175594|NCT02460224|78969320|FG000|Overall Study|Death|0|||
44264680|NCT01049360|79166456|FG013|Period 2|Protocol Violation|0|||
44361164|NCT01162421|79366804|FG000|Overall Study|Other|2|||
44175595|NCT02460224|78969321|FG001|Overall Study|Death|0|||
44175596|NCT02460224|78969322|FG002|Overall Study|Death|0|||
44175597|NCT02460224|78969323|FG003|Overall Study|Death|0|||
44175598|NCT02460224|78969324|FG004|Overall Study|Death|0|||
44175599|NCT02460224|78969325|FG005|Overall Study|Death|2|||
44175600|NCT02460224|78969326|FG006|Overall Study|Death|1|||
44175601|NCT02460224|78969327|FG007|Overall Study|Death|0|||
44361165|NCT01162421|79366805|FG001|Overall Study|Other|3|||
44175602|NCT02460224|78969328|FG008|Overall Study|Death|0|||
44175603|NCT02460224|78969329|FG009|Overall Study|Death|1|||
44175604|NCT02460224|78969330|FG010|Overall Study|Death|0|||
44175605|NCT02460224|78969331|FG011|Overall Study|Death|0|||
44175606|NCT02460224|78969332|FG012|Overall Study|Death|0|||
44175607|NCT02460224|78969333|FG013|Overall Study|Death|1|||
44175608|NCT02460224|78969334|FG014|Overall Study|Death|0|||
44264681|NCT01049360|79166457|FG014|Period 2|Protocol Violation|1|||
44264682|NCT01049360|79166458|FG015|Period 2|Protocol Violation|1|||
44264683|NCT01049360|79166459|FG016|Period 2|Protocol Violation|0|||
44175609|NCT02460224|78969335|FG015|Overall Study|Death|0|||
44175610|NCT02460224|78969336|FG016|Overall Study|Death|2|||
44175611|NCT02460224|78969337|FG017|Overall Study|Death|1|||
44175612|NCT02460224|78969338|FG018|Overall Study|Death|0|||
44175613|NCT02460224|78969339|FG019|Overall Study|Death|2|||
44175614|NCT02460224|78969340|FG020|Overall Study|Death|0|||
44175615|NCT02460224|78969341|FG021|Overall Study|Death|0|||
44175616|NCT02460224|78969342|FG022|Overall Study|Death|0|||
44175617|NCT02460224|78969343|FG023|Overall Study|Death|0|||
44175618|NCT02460224|78969344|FG024|Overall Study|Death|1|||
44175619|NCT02460224|78969345|FG025|Overall Study|Death|1|||
44175620|NCT02460224|78969346|FG026|Overall Study|Death|5|||
44175621|NCT02460224|78969347|FG027|Overall Study|Death|0|||
44175622|NCT02460224|78969348|FG028|Overall Study|Death|1|||
44175623|NCT02460224|78969320|FG000|Overall Study|Lost to Follow-up|0|||
44175624|NCT02460224|78969321|FG001|Overall Study|Lost to Follow-up|0|||
44175625|NCT02460224|78969322|FG002|Overall Study|Lost to Follow-up|0|||
44175626|NCT02460224|78969323|FG003|Overall Study|Lost to Follow-up|0|||
44175627|NCT02460224|78969324|FG004|Overall Study|Lost to Follow-up|0|||
44175628|NCT02460224|78969325|FG005|Overall Study|Lost to Follow-up|0|||
44175629|NCT02460224|78969326|FG006|Overall Study|Lost to Follow-up|0|||
44175630|NCT02460224|78969327|FG007|Overall Study|Lost to Follow-up|0|||
44175631|NCT02460224|78969328|FG008|Overall Study|Lost to Follow-up|0|||
44175632|NCT02460224|78969329|FG009|Overall Study|Lost to Follow-up|0|||
44175633|NCT02460224|78969330|FG010|Overall Study|Lost to Follow-up|0|||
44175634|NCT02460224|78969331|FG011|Overall Study|Lost to Follow-up|0|||
44175635|NCT02460224|78969332|FG012|Overall Study|Lost to Follow-up|0|||
44175636|NCT02460224|78969333|FG013|Overall Study|Lost to Follow-up|0|||
44175637|NCT02460224|78969334|FG014|Overall Study|Lost to Follow-up|0|||
44175638|NCT02460224|78969335|FG015|Overall Study|Lost to Follow-up|0|||
44175639|NCT02460224|78969336|FG016|Overall Study|Lost to Follow-up|0|||
44264684|NCT01049360|79166460|FG017|Period 2|Protocol Violation|0|||
44264685|NCT01049360|79166461|FG018|Period 2|Protocol Violation|0|||
44264686|NCT01049360|79166462|FG019|Period 2|Protocol Violation|0|||
44264687|NCT01049360|79166443|FG000|Period 2|Adverse Event|0|||
44264688|NCT01049360|79166444|FG001|Period 2|Adverse Event|1|||
44264689|NCT01049360|79166445|FG002|Period 2|Adverse Event|0|||
44264690|NCT01049360|79166446|FG003|Period 2|Adverse Event|0|||
44264691|NCT01049360|79166447|FG004|Period 2|Adverse Event|0|||
44264692|NCT01049360|79166448|FG005|Period 2|Adverse Event|0|||
44175640|NCT02460224|78969337|FG017|Overall Study|Lost to Follow-up|0|||
44175641|NCT02460224|78969338|FG018|Overall Study|Lost to Follow-up|0|||
44175642|NCT02460224|78969339|FG019|Overall Study|Lost to Follow-up|0|||
44175643|NCT02460224|78969340|FG020|Overall Study|Lost to Follow-up|0|||
44175644|NCT02460224|78969341|FG021|Overall Study|Lost to Follow-up|0|||
44175645|NCT02460224|78969342|FG022|Overall Study|Lost to Follow-up|1|||
44175646|NCT02460224|78969343|FG023|Overall Study|Lost to Follow-up|0|||
44175647|NCT02460224|78969344|FG024|Overall Study|Lost to Follow-up|0|||
44175648|NCT02460224|78969345|FG025|Overall Study|Lost to Follow-up|0|||
44175649|NCT02460224|78969346|FG026|Overall Study|Lost to Follow-up|0|||
44175650|NCT02460224|78969347|FG027|Overall Study|Lost to Follow-up|0|||
44175651|NCT02460224|78969348|FG028|Overall Study|Lost to Follow-up|0|||
44175652|NCT02460224|78969320|FG000|Overall Study|Physician Decision|0|||
44175653|NCT02460224|78969321|FG001|Overall Study|Physician Decision|1|||
44175654|NCT02460224|78969322|FG002|Overall Study|Physician Decision|0|||
44175655|NCT02460224|78969323|FG003|Overall Study|Physician Decision|0|||
44175656|NCT02460224|78969324|FG004|Overall Study|Physician Decision|1|||
44264693|NCT01049360|79166449|FG006|Period 2|Adverse Event|0|||
44264694|NCT01049360|79166450|FG007|Period 2|Adverse Event|0|||
44175657|NCT02460224|78969325|FG005|Overall Study|Physician Decision|0|||
44175658|NCT02460224|78969326|FG006|Overall Study|Physician Decision|0|||
44264695|NCT01049360|79166451|FG008|Period 2|Adverse Event|1|||
44264696|NCT01049360|79166452|FG009|Period 2|Adverse Event|0|||
44264697|NCT01049360|79166453|FG010|Period 2|Adverse Event|0|||
44175659|NCT02460224|78969327|FG007|Overall Study|Physician Decision|1|||
44175660|NCT02460224|78969328|FG008|Overall Study|Physician Decision|0|||
44175661|NCT02460224|78969329|FG009|Overall Study|Physician Decision|0|||
44175662|NCT02460224|78969330|FG010|Overall Study|Physician Decision|0|||
44175663|NCT02460224|78969331|FG011|Overall Study|Physician Decision|1|||
44175664|NCT02460224|78969332|FG012|Overall Study|Physician Decision|0|||
44175665|NCT02460224|78969333|FG013|Overall Study|Physician Decision|1|||
44175666|NCT02460224|78969334|FG014|Overall Study|Physician Decision|0|||
44264698|NCT01049360|79166454|FG011|Period 2|Adverse Event|0|||
44264699|NCT01049360|79166455|FG012|Period 2|Adverse Event|0|||
44175667|NCT02460224|78969335|FG015|Overall Study|Physician Decision|0|||
44175668|NCT02460224|78969336|FG016|Overall Study|Physician Decision|2|||
44175669|NCT02460224|78969337|FG017|Overall Study|Physician Decision|1|||
44175670|NCT02460224|78969338|FG018|Overall Study|Physician Decision|1|||
44175671|NCT02460224|78969339|FG019|Overall Study|Physician Decision|2|||
44175672|NCT02460224|78969340|FG020|Overall Study|Physician Decision|1|||
44175673|NCT02460224|78969341|FG021|Overall Study|Physician Decision|1|||
44175674|NCT02460224|78969342|FG022|Overall Study|Physician Decision|0|||
44175675|NCT02460224|78969343|FG023|Overall Study|Physician Decision|0|||
44175676|NCT02460224|78969344|FG024|Overall Study|Physician Decision|1|||
44175677|NCT02460224|78969345|FG025|Overall Study|Physician Decision|0|||
44175678|NCT02460224|78969346|FG026|Overall Study|Physician Decision|14|||
44175679|NCT02460224|78969347|FG027|Overall Study|Physician Decision|1|||
44175680|NCT02460224|78969348|FG028|Overall Study|Physician Decision|6|||
44175681|NCT02460224|78969320|FG000|Overall Study|Progressive disease|15|||
44175682|NCT02460224|78969321|FG001|Overall Study|Progressive disease|11|||
44175683|NCT02460224|78969322|FG002|Overall Study|Progressive disease|5|||
44175684|NCT02460224|78969323|FG003|Overall Study|Progressive disease|6|||
44175685|NCT02460224|78969324|FG004|Overall Study|Progressive disease|3|||
44175686|NCT02460224|78969325|FG005|Overall Study|Progressive disease|26|||
44175687|NCT02460224|78969326|FG006|Overall Study|Progressive disease|28|||
44175688|NCT02460224|78969327|FG007|Overall Study|Progressive disease|4|||
44175689|NCT02460224|78969328|FG008|Overall Study|Progressive disease|5|||
44175690|NCT02460224|78969329|FG009|Overall Study|Progressive disease|9|||
44175691|NCT02460224|78969330|FG010|Overall Study|Progressive disease|5|||
44175692|NCT02460224|78969331|FG011|Overall Study|Progressive disease|4|||
44175693|NCT02460224|78969332|FG012|Overall Study|Progressive disease|5|||
44175694|NCT02460224|78969333|FG013|Overall Study|Progressive disease|4|||
44175695|NCT02460224|78969334|FG014|Overall Study|Progressive disease|5|||
44175696|NCT02460224|78969335|FG015|Overall Study|Progressive disease|5|||
44175697|NCT02460224|78969336|FG016|Overall Study|Progressive disease|15|||
44175698|NCT02460224|78969337|FG017|Overall Study|Progressive disease|3|||
44175699|NCT02460224|78969338|FG018|Overall Study|Progressive disease|8|||
44175700|NCT02460224|78969339|FG019|Overall Study|Progressive disease|3|||
44175701|NCT02460224|78969340|FG020|Overall Study|Progressive disease|4|||
44175702|NCT02460224|78969341|FG021|Overall Study|Progressive disease|9|||
44175703|NCT02460224|78969342|FG022|Overall Study|Progressive disease|4|||
44175704|NCT02460224|78969343|FG023|Overall Study|Progressive disease|11|||
44175705|NCT02460224|78969344|FG024|Overall Study|Progressive disease|4|||
44175706|NCT02460224|78969345|FG025|Overall Study|Progressive disease|5|||
44175707|NCT02460224|78969346|FG026|Overall Study|Progressive disease|85|||
44175708|NCT02460224|78969347|FG027|Overall Study|Progressive disease|17|||
44175709|NCT02460224|78969348|FG028|Overall Study|Progressive disease|77|||
44175710|NCT02460224|78969320|FG000|Overall Study|Subject/guardian decision|2|||
44175711|NCT02460224|78969321|FG001|Overall Study|Subject/guardian decision|0|||
44175712|NCT02460224|78969322|FG002|Overall Study|Subject/guardian decision|1|||
44175713|NCT02460224|78969323|FG003|Overall Study|Subject/guardian decision|0|||
44175714|NCT02460224|78969324|FG004|Overall Study|Subject/guardian decision|2|||
44175715|NCT02460224|78969325|FG005|Overall Study|Subject/guardian decision|2|||
44175716|NCT02460224|78969326|FG006|Overall Study|Subject/guardian decision|0|||
44175717|NCT02460224|78969327|FG007|Overall Study|Subject/guardian decision|0|||
44175718|NCT02460224|78969328|FG008|Overall Study|Subject/guardian decision|1|||
44175719|NCT02460224|78969329|FG009|Overall Study|Subject/guardian decision|1|||
44175720|NCT02460224|78969330|FG010|Overall Study|Subject/guardian decision|0|||
44175721|NCT02460224|78969331|FG011|Overall Study|Subject/guardian decision|1|||
44175722|NCT02460224|78969332|FG012|Overall Study|Subject/guardian decision|0|||
44175723|NCT02460224|78969333|FG013|Overall Study|Subject/guardian decision|0|||
44175724|NCT02460224|78969334|FG014|Overall Study|Subject/guardian decision|0|||
44175725|NCT02460224|78969335|FG015|Overall Study|Subject/guardian decision|1|||
44175726|NCT02460224|78969336|FG016|Overall Study|Subject/guardian decision|0|||
44175727|NCT02460224|78969337|FG017|Overall Study|Subject/guardian decision|1|||
44175728|NCT02460224|78969338|FG018|Overall Study|Subject/guardian decision|2|||
44175729|NCT02460224|78969339|FG019|Overall Study|Subject/guardian decision|0|||
44175730|NCT02460224|78969340|FG020|Overall Study|Subject/guardian decision|0|||
44175731|NCT02460224|78969341|FG021|Overall Study|Subject/guardian decision|1|||
44175732|NCT02460224|78969342|FG022|Overall Study|Subject/guardian decision|0|||
44451112|NCT00947531|79460075|FG001|Overall Study|Adverse Event|2|||
44175733|NCT02460224|78969343|FG023|Overall Study|Subject/guardian decision|0|||
44175734|NCT02460224|78969344|FG024|Overall Study|Subject/guardian decision|0|||
44175735|NCT02460224|78969345|FG025|Overall Study|Subject/guardian decision|0|||
44175736|NCT02460224|78969346|FG026|Overall Study|Subject/guardian decision|6|||
44175737|NCT02460224|78969347|FG027|Overall Study|Subject/guardian decision|2|||
44175738|NCT02460224|78969348|FG028|Overall Study|Subject/guardian decision|3|||
44175739|NCT02094573|78969422|FG000|Overall Study|Adverse Event|4|||
44175740|NCT02094573|78969423|FG001|Overall Study|Adverse Event|14|||
44175741|NCT02094573|78969422|FG000|Overall Study|Clinical Progressive Disease|9|||
44175742|NCT02094573|78969423|FG001|Overall Study|Clinical Progressive Disease|13|||
44175743|NCT02094573|78969422|FG000|Overall Study|Death|11|||
44175744|NCT02094573|78969423|FG001|Overall Study|Death|3|||
44175745|NCT02094573|78969422|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
44175746|NCT02094573|78969423|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
44175747|NCT02094573|78969422|FG000|Overall Study|Non-compliance with Study Drug|1|||
44175748|NCT02094573|78969423|FG001|Overall Study|Non-compliance with Study Drug|1|||
44175749|NCT02094573|78969422|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
44175750|NCT02094573|78969423|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
44175751|NCT02094573|78969422|FG000|Overall Study|Physician Decision|4|||
44175752|NCT02094573|78969423|FG001|Overall Study|Physician Decision|4|||
44175753|NCT02094573|78969422|FG000|Overall Study|Site Terminated by Sponsor|10|||
44175754|NCT02094573|78969423|FG001|Overall Study|Site Terminated by Sponsor|17|||
44175755|NCT02094573|78969422|FG000|Overall Study|Withdrawal by Subject|6|||
44175756|NCT02094573|78969423|FG001|Overall Study|Withdrawal by Subject|8|||
44175757|NCT02094573|78969422|FG000|Overall Study|Randomized but not Treated|3|||
44175758|NCT02094573|78969423|FG001|Overall Study|Randomized but not Treated|0|||
44175759|NCT01859494|78969429|FG000|Overall Study|Adverse Event|1|||
44175760|NCT01858636|78969433|FG000|Overall Study|No Device Deployment Attempted|24|||
44175761|NCT01858636|78969433|FG000|Overall Study|Physician Decision|1|||
44175762|NCT01858636|78969433|FG000|Overall Study|Death|1|||
44175763|NCT01858636|78969433|FG000|Overall Study|Lost to Follow-up|1|||
44175764|NCT01858636|78969433|FG000|Overall Study|Withdrawal by Subject|1|||
44175765|NCT02058849|78969440|FG000|Overall Study|Hospitalization|1|||
44175766|NCT02058849|78969441|FG001|Overall Study|Hospitalization|1|||
44175767|NCT02058849|78969440|FG000|Overall Study|Death|1|||
44175768|NCT02058849|78969441|FG001|Overall Study|Death|0|||
44175769|NCT02058849|78969440|FG000|Overall Study|Lost to Follow-up|1|||
44175770|NCT02058849|78969441|FG001|Overall Study|Lost to Follow-up|0|||
44175771|NCT02058849|78969440|FG000|Overall Study|Withdrawal by Subject|4|||
44175772|NCT02058849|78969441|FG001|Overall Study|Withdrawal by Subject|0|||
44175773|NCT01858558|78969449|FG000|Overall Study|Death|1|||
44175774|NCT01858558|78969450|FG001|Overall Study|Death|1|||
44175775|NCT01858558|78969449|FG000|Overall Study|Lost to Follow-up|1|||
44175776|NCT01858558|78969450|FG001|Overall Study|Lost to Follow-up|0|||
44175777|NCT01858558|78969449|FG000|Overall Study|Disease progression|3|||
44175778|NCT01858558|78969450|FG001|Overall Study|Disease progression|1|||
44175779|NCT01858558|78969449|FG000|Overall Study|Product contamination|2|||
44175780|NCT01858558|78969450|FG001|Overall Study|Product contamination|0|||
44175781|NCT01858558|78969449|FG000|Overall Study|Failed expansion of cell product|2|||
44175782|NCT01858558|78969450|FG001|Overall Study|Failed expansion of cell product|0|||
44175783|NCT02058537|78969456|FG000|Overall Study|Withdrawal by Subject|1|||
44175784|NCT01612000|78969464|FG000|Overall Study|Lost to Follow-up|6|||
44175785|NCT01612000|78969465|FG001|Overall Study|Lost to Follow-up|4|||
44175786|NCT01612000|78969466|FG002|Overall Study|Lost to Follow-up|4|||
44175787|NCT01612000|78969467|FG003|Overall Study|Lost to Follow-up|8|||
44175788|NCT01612000|78969464|FG000|Overall Study|Physician Decision|0|||
44175789|NCT01612000|78969465|FG001|Overall Study|Physician Decision|0|||
44175790|NCT01612000|78969466|FG002|Overall Study|Physician Decision|1|||
44175791|NCT01612000|78969467|FG003|Overall Study|Physician Decision|0|||
44175792|NCT01612000|78969464|FG000|Overall Study|Withdrawal by Subject|3|||
44175793|NCT01612000|78969465|FG001|Overall Study|Withdrawal by Subject|1|||
44175794|NCT01612000|78969466|FG002|Overall Study|Withdrawal by Subject|2|||
44175795|NCT01612000|78969467|FG003|Overall Study|Withdrawal by Subject|2|||
44175796|NCT01895608|78969481|FG000|Overall Study|change in health status|0|||
44175797|NCT01895608|78969482|FG001|Overall Study|change in health status|1|||
44175798|NCT01895608|78969483|FG002|Overall Study|change in health status|1|||
44175799|NCT01895608|78969484|FG003|Overall Study|change in health status|0|||
44264700|NCT01049360|79166456|FG013|Period 2|Adverse Event|0|||
44264701|NCT01049360|79166457|FG014|Period 2|Adverse Event|0|||
44264702|NCT01049360|79166458|FG015|Period 2|Adverse Event|0|||
44264703|NCT01049360|79166459|FG016|Period 2|Adverse Event|0|||
44264704|NCT01049360|79166460|FG017|Period 2|Adverse Event|0|||
44264705|NCT01049360|79166461|FG018|Period 2|Adverse Event|0|||
44264706|NCT01049360|79166462|FG019|Period 2|Adverse Event|1|||
44264707|NCT01049360|79166443|FG000|Period 2|Withdrawal by Subject|0|||
44264708|NCT01049360|79166444|FG001|Period 2|Withdrawal by Subject|0|||
44264709|NCT01049360|79166445|FG002|Period 2|Withdrawal by Subject|0|||
44264710|NCT01049360|79166446|FG003|Period 2|Withdrawal by Subject|1|||
44264711|NCT01049360|79166447|FG004|Period 2|Withdrawal by Subject|0|||
44264712|NCT01049360|79166448|FG005|Period 2|Withdrawal by Subject|0|||
44264713|NCT01049360|79166449|FG006|Period 2|Withdrawal by Subject|0|||
44451113|NCT00947531|79460074|FG000|Overall Study|Lack of Efficacy|1|||
44175800|NCT01895608|78969481|FG000|Overall Study|Withdrawal by Subject|0|||
44175801|NCT01895608|78969482|FG001|Overall Study|Withdrawal by Subject|0|||
44175802|NCT01895608|78969483|FG002|Overall Study|Withdrawal by Subject|2|||
44175803|NCT01895608|78969484|FG003|Overall Study|Withdrawal by Subject|0|||
44264714|NCT01049360|79166450|FG007|Period 2|Withdrawal by Subject|0|||
44264715|NCT01049360|79166451|FG008|Period 2|Withdrawal by Subject|0|||
44451114|NCT00947531|79460075|FG001|Overall Study|Lack of Efficacy|0|||
44264716|NCT01049360|79166452|FG009|Period 2|Withdrawal by Subject|0|||
44175804|NCT02409680|78969496|FG000|Overall Study|Lost to Follow-up|15|||
44175805|NCT02409680|78969497|FG001|Overall Study|Lost to Follow-up|30|||
44175806|NCT01895452|78969505|FG000|Overall Study|Adverse Event|1|||
44175807|NCT01895452|78969506|FG001|Overall Study|Adverse Event|4|||
44175808|NCT01895452|78969505|FG000|Overall Study|Lost to Follow-up|1|||
44175809|NCT01895452|78969506|FG001|Overall Study|Lost to Follow-up|5|||
44175810|NCT01895452|78969505|FG000|Overall Study|Pregnancy|0|||
44175811|NCT01895452|78969506|FG001|Overall Study|Pregnancy|1|||
44175812|NCT01895452|78969505|FG000|Overall Study|Withdrawal by Subject|2|||
44175813|NCT01895452|78969506|FG001|Overall Study|Withdrawal by Subject|14|||
44175814|NCT01895452|78969505|FG000|Overall Study|Underlying disease|0|||
44175815|NCT01895452|78969506|FG001|Overall Study|Underlying disease|3|||
44175816|NCT01895452|78969505|FG000|Overall Study|Noncompliance with study drug|0|||
44175817|NCT01895452|78969506|FG001|Overall Study|Noncompliance with study drug|1|||
44175818|NCT02094417|78969516|FG000|Overall Study|Adverse Event|0|||
44175819|NCT02094417|78969517|FG001|Overall Study|Adverse Event|0|||
44175820|NCT02094417|78969518|FG002|Overall Study|Adverse Event|0|||
44175821|NCT02094417|78969519|FG003|Overall Study|Adverse Event|1|||
44175822|NCT02094417|78969516|FG000|Overall Study|Eligibility criteria|0|||
44175823|NCT02094417|78969517|FG001|Overall Study|Eligibility criteria|1|||
44175824|NCT02094417|78969518|FG002|Overall Study|Eligibility criteria|0|||
44175825|NCT02094417|78969519|FG003|Overall Study|Eligibility criteria|0|||
44175826|NCT02094417|78969516|FG000|Overall Study|No responder|4|||
44175827|NCT02094417|78969517|FG001|Overall Study|No responder|4|||
44175828|NCT02094417|78969518|FG002|Overall Study|No responder|4|||
44175829|NCT02094417|78969519|FG003|Overall Study|No responder|3|||
44175830|NCT02094417|78969516|FG000|Overall Study|Unable to conduct observations or assess|0|||
44175831|NCT02094417|78969517|FG001|Overall Study|Unable to conduct observations or assess|1|||
44175832|NCT02094417|78969518|FG002|Overall Study|Unable to conduct observations or assess|0|||
44175833|NCT02094417|78969519|FG003|Overall Study|Unable to conduct observations or assess|0|||
44175834|NCT02094417|78969516|FG000|Overall Study|Withdrawal by Subject|1|||
44175835|NCT02094417|78969517|FG001|Overall Study|Withdrawal by Subject|2|||
44175836|NCT02094417|78969518|FG002|Overall Study|Withdrawal by Subject|1|||
44175837|NCT02094417|78969519|FG003|Overall Study|Withdrawal by Subject|3|||
44175838|NCT01894984|78969531|FG000|Overall Study|Other|314|||
44175839|NCT01894984|78969532|FG001|Overall Study|Other|175|||
44175840|NCT02375672|78969538|FG000|Overall Study|remain on follow up|20|||
44175841|NCT01894516|78969546|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
44175842|NCT01894516|78969547|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
44175843|NCT01894516|78969548|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
44175844|NCT01894516|78969549|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
44175845|NCT01894516|78969546|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
44175846|NCT01894516|78969547|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44175847|NCT01894516|78969548|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44175848|NCT01894516|78969549|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44175849|NCT01894516|78969546|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
44175850|NCT01894516|78969547|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
44175851|NCT01894516|78969548|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
44175852|NCT01894516|78969549|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
44175853|NCT01894516|78969546|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
44175854|NCT01894516|78969547|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
44175855|NCT01894516|78969548|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
44175856|NCT01894516|78969549|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
44175857|NCT01894516|78969546|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
44175858|NCT01894516|78969547|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
44175859|NCT01894516|78969548|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
44175860|NCT01894516|78969549|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
44175861|NCT01894516|78969546|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
44175862|NCT01894516|78969547|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
44175863|NCT01894516|78969548|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
44175864|NCT01894516|78969549|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
44175865|NCT01894516|78969546|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
44175866|NCT01894516|78969547|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
44175867|NCT01894516|78969548|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
44175868|NCT01894516|78969549|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
44175869|NCT01894516|78969546|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
44175870|NCT01894516|78969547|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
44175871|NCT01894516|78969548|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
44175872|NCT01894516|78969549|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
44175873|NCT02491463|78969567|FG000|Overall Study|Withdrawal by Subject|1|||
44175874|NCT02491463|78969568|FG001|Overall Study|Withdrawal by Subject|2|||
44175875|NCT02491463|78969569|FG002|Overall Study|Withdrawal by Subject|0|||
44175876|NCT02491463|78969570|FG003|Overall Study|Withdrawal by Subject|0|||
44175877|NCT02491463|78969567|FG000|Overall Study|Migrated/moved from study area|1|||
44175878|NCT02491463|78969568|FG001|Overall Study|Migrated/moved from study area|5|||
44175879|NCT02491463|78969569|FG002|Overall Study|Migrated/moved from study area|1|||
44175880|NCT02491463|78969570|FG003|Overall Study|Migrated/moved from study area|1|||
44175881|NCT02491463|78969567|FG000|Overall Study|Lost to Follow-up|0|||
44175882|NCT02491463|78969568|FG001|Overall Study|Lost to Follow-up|3|||
44175883|NCT02491463|78969569|FG002|Overall Study|Lost to Follow-up|3|||
44175884|NCT02491463|78969570|FG003|Overall Study|Lost to Follow-up|0|||
44175885|NCT02038881|78969583|FG000|Overall Study|Withdrawal by Subject|0|||
44175886|NCT02038881|78969584|FG001|Overall Study|Withdrawal by Subject|0|||
44175887|NCT02038881|78969585|FG002|Overall Study|Withdrawal by Subject|1|||
44175888|NCT02038881|78969583|FG000|Overall Study|Lost to Follow-up|2|||
44175889|NCT02038881|78969584|FG001|Overall Study|Lost to Follow-up|0|||
44175890|NCT02038881|78969585|FG002|Overall Study|Lost to Follow-up|0|||
44175891|NCT02038881|78969583|FG000|Overall Study|incarcerated|1|||
44264717|NCT01049360|79166453|FG010|Period 2|Withdrawal by Subject|0|||
44264718|NCT01049360|79166454|FG011|Period 2|Withdrawal by Subject|0|||
44264719|NCT01049360|79166455|FG012|Period 2|Withdrawal by Subject|0|||
44175892|NCT02038881|78969584|FG001|Overall Study|incarcerated|0|||
44175893|NCT02038881|78969585|FG002|Overall Study|incarcerated|0|||
44175894|NCT01857622|78969598|FG000|Overall Study|Adverse Event|5|||
44175895|NCT01857622|78969599|FG001|Overall Study|Adverse Event|0|||
44175896|NCT01857622|78969600|FG002|Overall Study|Adverse Event|2|||
44175897|NCT01857622|78969598|FG000|Overall Study|Physician Decision|1|||
44175898|NCT01857622|78969599|FG001|Overall Study|Physician Decision|0|||
44175899|NCT01857622|78969600|FG002|Overall Study|Physician Decision|0|||
44175900|NCT01857622|78969598|FG000|Overall Study|Protocol Violation|4|||
44175901|NCT01857622|78969599|FG001|Overall Study|Protocol Violation|1|||
44175902|NCT01857622|78969600|FG002|Overall Study|Protocol Violation|0|||
44175903|NCT01857622|78969598|FG000|Overall Study|Withdrawal by Subject|1|||
44175904|NCT01857622|78969599|FG001|Overall Study|Withdrawal by Subject|0|||
44175905|NCT01857622|78969600|FG002|Overall Study|Withdrawal by Subject|0|||
44175906|NCT01857310|78969610|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
44175907|NCT01857310|78969611|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
44175908|NCT02472353|78969619|FG000|Overall Study|Lost to Follow-up|1|||
44175909|NCT02472353|78969620|FG001|Overall Study|Lost to Follow-up|1|||
44175910|NCT02472353|78969619|FG000|Overall Study|Withdrawal by Subject|2|||
44175911|NCT02472353|78969620|FG001|Overall Study|Withdrawal by Subject|1|||
44175912|NCT02472353|78969619|FG000|Overall Study|Study Termination|1|||
44175913|NCT02472353|78969620|FG001|Overall Study|Study Termination|4|||
44175914|NCT02491073|78969628|FG000|Overall Study|screen failure|1|||
44175915|NCT02491073|78969629|FG001|Overall Study|screen failure|0|||
44175916|NCT02314117|78969653|FG000|Overall Study|Lost to Follow-up|9|||
44175917|NCT02314117|78969654|FG001|Overall Study|Lost to Follow-up|14|||
44175918|NCT02314117|78969653|FG000|Overall Study|Withdrawal by Subject|3|||
44175919|NCT02314117|78969654|FG001|Overall Study|Withdrawal by Subject|2|||
44175920|NCT01893346|78969665|FG000|Overall Study|Lost to Follow-up|0|||
44175921|NCT01893346|78969666|FG001|Overall Study|Lost to Follow-up|1|||
44175922|NCT01893346|78969667|FG002|Overall Study|Lost to Follow-up|0|||
44175923|NCT01893346|78969668|FG003|Overall Study|Lost to Follow-up|0|||
44175924|NCT01893346|78969665|FG000|Overall Study|Protocol Violation|1|||
44175925|NCT01893346|78969666|FG001|Overall Study|Protocol Violation|0|||
44175926|NCT01893346|78969667|FG002|Overall Study|Protocol Violation|0|||
44175927|NCT01893346|78969668|FG003|Overall Study|Protocol Violation|0|||
44175928|NCT01893346|78969665|FG000|Overall Study|Withdrawal by Subject|2|||
44175929|NCT01893346|78969666|FG001|Overall Study|Withdrawal by Subject|0|||
44175930|NCT01893346|78969667|FG002|Overall Study|Withdrawal by Subject|0|||
44175931|NCT01893346|78969668|FG003|Overall Study|Withdrawal by Subject|0|||
44175932|NCT02490371|78969680|FG000|Overall Study|Lost to Follow-up|1|||
44175933|NCT02490371|78969681|FG001|Overall Study|Lost to Follow-up|1|||
44175934|NCT02058147|78969690|FG000|Overall Study|Randomized but not treated|0|||
44175935|NCT02058147|78969691|FG001|Overall Study|Randomized but not treated|0|||
44175936|NCT02058147|78969692|FG002|Overall Study|Randomized but not treated|1|||
44175937|NCT02058147|78969690|FG000|Overall Study|Adverse Event|12|||
44175938|NCT02058147|78969691|FG001|Overall Study|Adverse Event|9|||
44175939|NCT02058147|78969692|FG002|Overall Study|Adverse Event|21|||
44175940|NCT02058147|78969690|FG000|Overall Study|Lack of Efficacy|1|||
44175941|NCT02058147|78969691|FG001|Overall Study|Lack of Efficacy|0|||
44175942|NCT02058147|78969692|FG002|Overall Study|Lack of Efficacy|3|||
44175943|NCT02058147|78969690|FG000|Overall Study|Poor compliance to protocol|8|||
44175944|NCT02058147|78969691|FG001|Overall Study|Poor compliance to protocol|9|||
44175945|NCT02058147|78969692|FG002|Overall Study|Poor compliance to protocol|4|||
44175946|NCT02058147|78969690|FG000|Overall Study|Other than specified|8|||
44175947|NCT02058147|78969691|FG001|Overall Study|Other than specified|9|||
44175948|NCT02058147|78969692|FG002|Overall Study|Other than specified|0|||
44175949|NCT02489981|78969700|FG000|Overall Study|Adverse Event|21|||
44175950|NCT02489981|78969700|FG000|Overall Study|Insufficient effectiveness|16|||
44175951|NCT02489981|78969700|FG000|Overall Study|Improved|31|||
44175952|NCT02489981|78969700|FG000|Overall Study|Lost to Follow-up|31|||
44175953|NCT02489981|78969700|FG000|Overall Study|Other than listed|28|||
44264720|NCT01049360|79166456|FG013|Period 2|Withdrawal by Subject|0|||
44175954|NCT02471183|78969704|FG000|Main Treatment Period|Adverse Event|1|||
44175955|NCT02471183|78969704|FG000|Main Treatment Period|Withdrawal by Subject|1|||
44175956|NCT02471183|78969704|FG000|Extended Treatment Period|Lack of Efficacy|1|||
44175957|NCT01855828|78969708|FG000|Overall Study|Adverse Event|1|||
44175958|NCT01855828|78969708|FG000|Overall Study|Withdrawal by Subject|1|||
44361166|NCT01162343|79366811|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
44175959|NCT02489279|78969719|FG000|Overall Study|Lost to Follow-up|12|||
44175960|NCT02489279|78969720|FG001|Overall Study|Lost to Follow-up|10|||
44175961|NCT02489045|78969726|FG000|Overall Study|unable to collect usable data|53|||
44361167|NCT01162343|79366811|FG000|Overall Study|Refused psychiatrist assessment|12|||
44175962|NCT02489045|78969726|FG000|Follow-up|Lost to Follow-up|10|||
44175963|NCT02488109|78969732|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
44175964|NCT02488109|78969733|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
44175965|NCT02488109|78969732|FG000|12-month Follow-Up|Lost to Follow-up|4|||
44175966|NCT02488109|78969733|FG001|12-month Follow-Up|Lost to Follow-up|7|||
44175967|NCT02351167|78969744|FG000|Overall Study|Withdrawal by Subject|19|||
44175968|NCT02351167|78969745|FG001|Overall Study|Withdrawal by Subject|18|||
44175969|NCT02351167|78969746|FG002|Overall Study|Withdrawal by Subject|21|||
44175970|NCT02350309|78969761|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
44175971|NCT02350309|78969762|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
44175972|NCT02350309|78969763|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
44175973|NCT02350309|78969764|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
44175974|NCT02350309|78969765|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
44175975|NCT02350309|78969766|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
44175976|NCT02350309|78969761|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
44175977|NCT02350309|78969762|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
44175978|NCT02350309|78969763|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
44175979|NCT02350309|78969764|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
44175980|NCT02350309|78969765|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
44175981|NCT02350309|78969766|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
44175982|NCT02038647|78969783|FG000|Overall Study|Progressive Disease|50|||
44175983|NCT02038647|78969784|FG001|Overall Study|Progressive Disease|59|||
44175984|NCT02038647|78969783|FG000|Overall Study|Adverse Event|18|||
44175985|NCT02038647|78969784|FG001|Overall Study|Adverse Event|10|||
44175986|NCT02038647|78969783|FG000|Overall Study|Symptomatic Deterioration|7|||
44175987|NCT02038647|78969784|FG001|Overall Study|Symptomatic Deterioration|7|||
44175988|NCT02038647|78969783|FG000|Overall Study|Withdrawal by Subject|5|||
44175989|NCT02038647|78969784|FG001|Overall Study|Withdrawal by Subject|2|||
44175990|NCT02038647|78969783|FG000|Overall Study|Not Reported|0|||
44175991|NCT02038647|78969784|FG001|Overall Study|Not Reported|1|||
44175992|NCT02038647|78969783|FG000|Overall Study|Ongoing at Datacut|9|||
44175993|NCT02038647|78969784|FG001|Overall Study|Ongoing at Datacut|10|||
44175994|NCT02058069|78969790|FG000|Overall Study|Exclusion due to implant size|5|||
44175995|NCT02058069|78969790|FG000|Overall Study|Withdrawal by Subject|6|||
44175996|NCT02057835|78969804|FG000|Overall Study|Withdrawal by Subject|0|||
44175997|NCT02057835|78969805|FG001|Overall Study|Withdrawal by Subject|2|||
44175998|NCT02057835|78969806|FG002|Overall Study|Withdrawal by Subject|0|||
44175999|NCT02057835|78969807|FG003|Overall Study|Withdrawal by Subject|0|||
44176000|NCT02057835|78969808|FG004|Overall Study|Withdrawal by Subject|0|||
44176001|NCT02057835|78969809|FG005|Overall Study|Withdrawal by Subject|0|||
44176002|NCT02057835|78969810|FG006|Overall Study|Withdrawal by Subject|0|||
44176003|NCT02057835|78969811|FG007|Overall Study|Withdrawal by Subject|0|||
44176004|NCT02057835|78969812|FG008|Overall Study|Withdrawal by Subject|0|||
44176005|NCT02057835|78969813|FG009|Overall Study|Withdrawal by Subject|0|||
44176006|NCT02057757|78969844|FG000|Overall Study|Withdrawal by Subject|3|||
44176007|NCT02057757|78969845|FG001|Overall Study|Withdrawal by Subject|5|||
44176008|NCT02057757|78969844|FG000|Overall Study|Death|2|||
44176009|NCT02057757|78969845|FG001|Overall Study|Death|0|||
44176010|NCT02057757|78969844|FG000|Overall Study|Lost to Follow-up|8|||
44176011|NCT02057757|78969845|FG001|Overall Study|Lost to Follow-up|3|||
44176012|NCT02057757|78969844|FG000|Overall Study|Non-compliance|1|||
44176013|NCT02057757|78969845|FG001|Overall Study|Non-compliance|0|||
44176014|NCT02037477|78969859|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
44176015|NCT02037477|78969860|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
44176016|NCT02037477|78969861|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
44176017|NCT02037477|78969862|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
44176018|NCT02057523|78969872|FG000|Overall Study|Withdrawal by Subject|1|||
44176019|NCT02057523|78969872|FG000|Overall Study|Lack of Efficacy|1|||
44176020|NCT02037165|78969881|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
44176021|NCT02037165|78969882|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
44176022|NCT02037165|78969883|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
44176023|NCT02037165|78969884|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
44176024|NCT02037165|78969885|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
44176025|NCT02470403|78969906|FG000|Overall Study|Adverse Event|1|||
44176026|NCT02470403|78969907|FG001|Overall Study|Adverse Event|0|||
44176027|NCT02470403|78969908|FG002|Overall Study|Adverse Event|0|||
44176028|NCT02470403|78969909|FG003|Overall Study|Adverse Event|0|||
44176029|NCT02470403|78969910|FG004|Overall Study|Adverse Event|0|||
44176030|NCT02470403|78969906|FG000|Overall Study|Lost to Follow-up|0|||
44176031|NCT02470403|78969907|FG001|Overall Study|Lost to Follow-up|1|||
44176032|NCT02470403|78969908|FG002|Overall Study|Lost to Follow-up|0|||
44176033|NCT02470403|78969909|FG003|Overall Study|Lost to Follow-up|0|||
44176034|NCT02470403|78969910|FG004|Overall Study|Lost to Follow-up|0|||
44176035|NCT02470403|78969906|FG000|Overall Study|Subject/guardian decision|1|||
44176036|NCT02470403|78969907|FG001|Overall Study|Subject/guardian decision|0|||
44176037|NCT02470403|78969908|FG002|Overall Study|Subject/guardian decision|0|||
44176038|NCT02470403|78969909|FG003|Overall Study|Subject/guardian decision|4|||
44176039|NCT02470403|78969910|FG004|Overall Study|Subject/guardian decision|0|||
44264721|NCT01049360|79166457|FG014|Period 2|Withdrawal by Subject|1|||
44176040|NCT01855750|78969927|FG000|Overall Study|Death|78|||
44176041|NCT01855750|78969928|FG001|Overall Study|Death|78|||
44176042|NCT01855750|78969927|FG000|Overall Study|Lost to Follow-up|9|||
44176043|NCT01855750|78969928|FG001|Overall Study|Lost to Follow-up|23|||
44176044|NCT01855750|78969927|FG000|Overall Study|Withdrawal by Subject|35|||
44176045|NCT01855750|78969928|FG001|Overall Study|Withdrawal by Subject|28|||
44264722|NCT01049360|79166458|FG015|Period 2|Withdrawal by Subject|0|||
44176046|NCT01855750|78969927|FG000|Overall Study|Sponsor ends the study|297|||
44176047|NCT01855750|78969928|FG001|Overall Study|Sponsor ends the study|290|||
44176048|NCT01855126|78969936|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
44176049|NCT01855126|78969937|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
44176050|NCT01855126|78969936|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
44176051|NCT01855126|78969937|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
44176052|NCT01622673|78969953|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44176053|NCT01622673|78969954|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44176054|NCT01622673|78969955|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44176055|NCT01622673|78969956|FG003|Treatment Period 1|Withdrawal by Subject|1|||
44176056|NCT01622673|78969957|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44176057|NCT01622673|78969958|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44176058|NCT01622673|78969953|FG000|Treatment Period 1|Protocol Violation|0|||
44176059|NCT01622673|78969954|FG001|Treatment Period 1|Protocol Violation|1|||
44176060|NCT01622673|78969955|FG002|Treatment Period 1|Protocol Violation|0|||
44176061|NCT01622673|78969956|FG003|Treatment Period 1|Protocol Violation|0|||
44176062|NCT01622673|78969957|FG004|Treatment Period 1|Protocol Violation|0|||
44176063|NCT01622673|78969958|FG005|Treatment Period 1|Protocol Violation|0|||
44176064|NCT01622673|78969953|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44176065|NCT01622673|78969954|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44176066|NCT01622673|78969955|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44176067|NCT01622673|78969956|FG003|Treatment Period 2|Withdrawal by Subject|1|||
44176068|NCT01622673|78969957|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44176069|NCT01622673|78969958|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44176070|NCT01622673|78969953|FG000|Treatment Period 3|Protocol Violation|0|||
44176071|NCT01622673|78969954|FG001|Treatment Period 3|Protocol Violation|1|||
44176072|NCT01622673|78969955|FG002|Treatment Period 3|Protocol Violation|0|||
44176073|NCT01622673|78969956|FG003|Treatment Period 3|Protocol Violation|0|||
44176074|NCT01622673|78969957|FG004|Treatment Period 3|Protocol Violation|0|||
44176075|NCT01622673|78969958|FG005|Treatment Period 3|Protocol Violation|0|||
44176076|NCT01855048|78969983|FG000|Overall Study|Withdrawal by Subject|0|||
44176077|NCT01855048|78969984|FG001|Overall Study|Withdrawal by Subject|1|||
44176078|NCT01855048|78969985|FG002|Overall Study|Withdrawal by Subject|0|||
44176079|NCT01855048|78969986|FG003|Overall Study|Withdrawal by Subject|0|||
44176080|NCT01855048|78969987|FG004|Overall Study|Withdrawal by Subject|1|||
44176081|NCT01855048|78969988|FG005|Overall Study|Withdrawal by Subject|0|||
44176082|NCT02469857|78970014|FG000|Overall Study|Death|24|||
44176083|NCT02469857|78970015|FG001|Overall Study|Death|29|||
44176084|NCT02469857|78970014|FG000|Overall Study|Discontinuation|1|||
44176085|NCT02469857|78970015|FG001|Overall Study|Discontinuation|3|||
44176086|NCT02036853|78970025|FG000|Overall Study|Adverse Event|0|||
44176087|NCT02036853|78970026|FG001|Overall Study|Adverse Event|2|||
44176088|NCT02036853|78970025|FG000|Overall Study|Lack of Efficacy|0|||
44176089|NCT02036853|78970026|FG001|Overall Study|Lack of Efficacy|2|||
44176090|NCT02036853|78970025|FG000|Overall Study|Physician Decision|0|||
44176091|NCT02036853|78970026|FG001|Overall Study|Physician Decision|1|||
44176092|NCT02036853|78970025|FG000|Overall Study|Withdrawal by Subject|0|||
44176093|NCT02036853|78970026|FG001|Overall Study|Withdrawal by Subject|1|||
44176094|NCT02469623|78970032|FG000|Overall Study|Not consented for long-term follow-up|4|||
44176095|NCT02469623|78970032|FG000|Overall Study|Lost to Follow-up|4|||
44176096|NCT02469623|78970032|FG000|Overall Study|Withdrawal by Subject|2|||
44176097|NCT02469623|78970032|FG000|Overall Study|Death|3|||
44176098|NCT02469077|78970039|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
44176099|NCT02469077|78970040|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
44176100|NCT02469077|78970039|FG000|Post Randomization/Intervention Period|Relocated|1|||
44176101|NCT02469077|78970040|FG001|Post Randomization/Intervention Period|Relocated|1|||
44176102|NCT02469077|78970039|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
44176103|NCT02469077|78970040|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
44176104|NCT02469077|78970039|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
44176105|NCT02469077|78970040|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
44176106|NCT02486627|78970052|FG000|Overall Study|Death|1|||
44176107|NCT02486627|78970053|FG001|Overall Study|Death|0|||
44176108|NCT02486627|78970052|FG000|Overall Study|Other Unspecified|0|||
44176109|NCT02486627|78970053|FG001|Overall Study|Other Unspecified|2|||
44176110|NCT02486627|78970052|FG000|Overall Study|Consent Withdrawn by Participant|4|||
44176111|NCT02486627|78970053|FG001|Overall Study|Consent Withdrawn by Participant|3|||
44176112|NCT02486627|78970052|FG000|Overall Study|Significant Participant Noncompliance|1|||
44176113|NCT02486627|78970053|FG001|Overall Study|Significant Participant Noncompliance|1|||
44176114|NCT02486627|78970052|FG000|Overall Study|Lost to Follow-up|1|||
44176115|NCT02486627|78970053|FG001|Overall Study|Lost to Follow-up|3|||
44176116|NCT01644565|78970059|FG000|Overall Study|Undisclosed Medical History|1|||
44176117|NCT01644565|78970060|FG001|Overall Study|Undisclosed Medical History|0|||
44176118|NCT01644565|78970061|FG002|Overall Study|Undisclosed Medical History|0|||
44176119|NCT01644565|78970062|FG003|Overall Study|Undisclosed Medical History|0|||
44176120|NCT01644565|78970063|FG004|Overall Study|Undisclosed Medical History|0|||
44176121|NCT01644565|78970064|FG005|Overall Study|Undisclosed Medical History|0|||
44176122|NCT01644565|78970065|FG006|Overall Study|Undisclosed Medical History|0|||
44176123|NCT01644565|78970066|FG007|Overall Study|Undisclosed Medical History|0|||
44176124|NCT01644565|78970067|FG008|Overall Study|Undisclosed Medical History|0|||
44176125|NCT01644565|78970059|FG000|Overall Study|Lost to Follow-up|0|||
44176126|NCT01644565|78970060|FG001|Overall Study|Lost to Follow-up|0|||
44264723|NCT01049360|79166459|FG016|Period 2|Withdrawal by Subject|0|||
44361168|NCT01188551|79366819|FG000|Overall Study|Pharmacy issues|1|||
44176127|NCT01644565|78970061|FG002|Overall Study|Lost to Follow-up|0|||
44176128|NCT01644565|78970062|FG003|Overall Study|Lost to Follow-up|1|||
44176129|NCT01644565|78970063|FG004|Overall Study|Lost to Follow-up|0|||
44176130|NCT01644565|78970064|FG005|Overall Study|Lost to Follow-up|0|||
44176131|NCT01644565|78970065|FG006|Overall Study|Lost to Follow-up|0|||
44176132|NCT01644565|78970066|FG007|Overall Study|Lost to Follow-up|2|||
44176133|NCT01644565|78970067|FG008|Overall Study|Lost to Follow-up|0|||
44176134|NCT01644565|78970059|FG000|Overall Study|Family emergency|0|||
44176135|NCT01644565|78970060|FG001|Overall Study|Family emergency|0|||
44176136|NCT01644565|78970061|FG002|Overall Study|Family emergency|0|||
44176137|NCT01644565|78970062|FG003|Overall Study|Family emergency|0|||
44176138|NCT01644565|78970063|FG004|Overall Study|Family emergency|1|||
44176139|NCT01644565|78970064|FG005|Overall Study|Family emergency|0|||
44176140|NCT01644565|78970065|FG006|Overall Study|Family emergency|0|||
44176141|NCT01644565|78970066|FG007|Overall Study|Family emergency|0|||
44176142|NCT01644565|78970067|FG008|Overall Study|Family emergency|0|||
44176143|NCT01644565|78970059|FG000|Overall Study|Relocation|0|||
44176144|NCT01644565|78970060|FG001|Overall Study|Relocation|0|||
44176145|NCT01644565|78970061|FG002|Overall Study|Relocation|0|||
44176146|NCT01644565|78970062|FG003|Overall Study|Relocation|0|||
44176147|NCT01644565|78970063|FG004|Overall Study|Relocation|0|||
44176148|NCT01644565|78970064|FG005|Overall Study|Relocation|0|||
44176149|NCT01644565|78970065|FG006|Overall Study|Relocation|0|||
44176150|NCT01644565|78970066|FG007|Overall Study|Relocation|0|||
44176151|NCT01644565|78970067|FG008|Overall Study|Relocation|1|||
44176152|NCT02485925|78970087|FG000|Overall Study|Withdrawal by Subject|3|||
44176153|NCT02485925|78970087|FG000|Overall Study|Death|1|||
44176154|NCT02485925|78970087|FG000|Overall Study|Lost to Follow-up|11|||
44176155|NCT02282293|78970093|FG000|Overall Study|Lost to Follow-up|2|||
44176156|NCT02282293|78970094|FG001|Overall Study|Lost to Follow-up|2|||
44176157|NCT02282293|78970093|FG000|Overall Study|Unable to comply with study procedures|1|||
44176158|NCT02282293|78970094|FG001|Overall Study|Unable to comply with study procedures|0|||
44176159|NCT02282293|78970093|FG000|Overall Study|Moved out of study area|0|||
44176160|NCT02282293|78970094|FG001|Overall Study|Moved out of study area|1|||
44176161|NCT01854658|78970104|FG000|Overall Study|Protocol Violation|6|||
44176162|NCT01854658|78970105|FG001|Overall Study|Protocol Violation|2|||
44176163|NCT01854658|78970106|FG002|Overall Study|Protocol Violation|2|||
44176164|NCT01854658|78970107|FG003|Overall Study|Protocol Violation|1|||
44176165|NCT01854658|78970104|FG000|Overall Study|Physician Decision|7|||
44176166|NCT01854658|78970105|FG001|Overall Study|Physician Decision|5|||
44176167|NCT01854658|78970106|FG002|Overall Study|Physician Decision|2|||
44176168|NCT01854658|78970107|FG003|Overall Study|Physician Decision|4|||
44176169|NCT01854658|78970104|FG000|Overall Study|Lost to Follow-up|8|||
44176170|NCT01854658|78970105|FG001|Overall Study|Lost to Follow-up|9|||
44176171|NCT01854658|78970106|FG002|Overall Study|Lost to Follow-up|8|||
44176172|NCT01854658|78970107|FG003|Overall Study|Lost to Follow-up|4|||
44176173|NCT01854658|78970104|FG000|Overall Study|Withdrawal by Subject|28|||
44176174|NCT01854658|78970105|FG001|Overall Study|Withdrawal by Subject|21|||
44176175|NCT01854658|78970106|FG002|Overall Study|Withdrawal by Subject|29|||
44176176|NCT01854658|78970107|FG003|Overall Study|Withdrawal by Subject|15|||
44264724|NCT01049360|79166460|FG017|Period 2|Withdrawal by Subject|0|||
44176177|NCT01854658|78970104|FG000|Overall Study|Protocol-specified criteria|15|||
44176178|NCT01854658|78970105|FG001|Overall Study|Protocol-specified criteria|15|||
44176179|NCT01854658|78970106|FG002|Overall Study|Protocol-specified criteria|10|||
44176180|NCT01854658|78970107|FG003|Overall Study|Protocol-specified criteria|7|||
44176181|NCT01854658|78970104|FG000|Overall Study|Lack of Efficacy|3|||
44176182|NCT01854658|78970105|FG001|Overall Study|Lack of Efficacy|8|||
44176183|NCT01854658|78970106|FG002|Overall Study|Lack of Efficacy|4|||
44176184|NCT01854658|78970107|FG003|Overall Study|Lack of Efficacy|7|||
44176185|NCT01854658|78970104|FG000|Overall Study|Adverse Event|21|||
44176186|NCT01854658|78970105|FG001|Overall Study|Adverse Event|14|||
44176187|NCT01854658|78970106|FG002|Overall Study|Adverse Event|23|||
44176188|NCT01854658|78970107|FG003|Overall Study|Adverse Event|19|||
44176189|NCT01854658|78970104|FG000|Overall Study|Administrative reasons|5|||
44176190|NCT01854658|78970105|FG001|Overall Study|Administrative reasons|1|||
44176191|NCT01854658|78970106|FG002|Overall Study|Administrative reasons|2|||
44176192|NCT01854658|78970107|FG003|Overall Study|Administrative reasons|2|||
44176193|NCT01892020|78970117|FG000|Period 1|Adverse Event|1|||
44176194|NCT01892020|78970118|FG001|Period 1|Adverse Event|1|||
44176195|NCT01892020|78970117|FG000|Period 1|Protocol Violation|2|||
44176196|NCT01892020|78970118|FG001|Period 1|Protocol Violation|4|||
44176197|NCT01892020|78970117|FG000|Period 1|Unclassified|0|||
44176198|NCT01892020|78970118|FG001|Period 1|Unclassified|1|||
44176199|NCT01892020|78970117|FG000|Period 2|Protocol Violation|1|||
44176200|NCT01892020|78970118|FG001|Period 2|Protocol Violation|0|||
44176201|NCT02485691|78970126|FG000|Overall Study|Adverse Event|25|||
44176202|NCT02485691|78970127|FG001|Overall Study|Adverse Event|11|||
44176203|NCT02485691|78970126|FG000|Overall Study|Poor compliance to protocol|0|||
44176204|NCT02485691|78970127|FG001|Overall Study|Poor compliance to protocol|1|||
44176205|NCT02485691|78970126|FG000|Overall Study|Disease progression|57|||
44176206|NCT02485691|78970127|FG001|Overall Study|Disease progression|92|||
44176207|NCT02485691|78970126|FG000|Overall Study|Investigator's decision|23|||
44176208|NCT02485691|78970127|FG001|Overall Study|Investigator's decision|5|||
44176209|NCT02485691|78970126|FG000|Overall Study|Participant's request|13|||
44176210|NCT02485691|78970127|FG001|Overall Study|Participant's request|6|||
44176211|NCT02485691|78970126|FG000|Overall Study|Other reason|8|||
44176212|NCT02485691|78970127|FG001|Overall Study|Other reason|9|||
44176213|NCT02485691|78970126|FG000|Overall Study|Randomized and not treated|3|||
44176214|NCT02485691|78970127|FG001|Overall Study|Randomized and not treated|2|||
44176215|NCT02517515|78970136|FG000|Overall Study|Adverse Event|0|||
44176216|NCT02517515|78970137|FG001|Overall Study|Adverse Event|1|||
44176217|NCT02517515|78970136|FG000|Overall Study|Withdrew Consent|0|||
44176218|NCT02517515|78970137|FG001|Overall Study|Withdrew Consent|1|||
44176219|NCT02517515|78970136|FG000|Overall Study|Lost to Follow-up|1|||
44176220|NCT02517515|78970137|FG001|Overall Study|Lost to Follow-up|0|||
44176221|NCT02517515|78970136|FG000|Overall Study|Other|1|||
44176222|NCT02517515|78970137|FG001|Overall Study|Other|0|||
44176223|NCT02466659|78970146|FG000|Overall Study|Lost to Follow-up|5|||
44176224|NCT02466659|78970147|FG001|Overall Study|Lost to Follow-up|2|||
44176225|NCT01891864|78970155|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
44176226|NCT01891864|78970156|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
44176227|NCT01891864|78970157|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
44176228|NCT01891864|78970158|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
44176229|NCT01891864|78970159|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
44176230|NCT01891864|78970160|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
44451115|NCT00947531|79460074|FG000|Overall Study|Other|1|||
44451116|NCT00947531|79460075|FG001|Overall Study|Other|1|||
44451117|NCT00630032|79460083|FG000|Overall Study|Death|55|||
44176231|NCT01891864|78970155|FG000|Treatment Period 1|Physician Decision|0|||
44176232|NCT01891864|78970156|FG001|Treatment Period 1|Physician Decision|1|||
44176233|NCT01891864|78970157|FG002|Treatment Period 1|Physician Decision|0|||
44176234|NCT01891864|78970158|FG003|Treatment Period 1|Physician Decision|0|||
44176235|NCT01891864|78970159|FG004|Treatment Period 1|Physician Decision|0|||
44176236|NCT01891864|78970160|FG005|Treatment Period 1|Physician Decision|0|||
44451118|NCT00630032|79460084|FG001|Overall Study|Death|49|||
44176237|NCT01891864|78970155|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
44264725|NCT01049360|79166461|FG018|Period 2|Withdrawal by Subject|0|||
44176238|NCT01891864|78970156|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
44176239|NCT01891864|78970157|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
44176240|NCT01891864|78970158|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
44176241|NCT01891864|78970159|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
44176242|NCT01891864|78970160|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
44176243|NCT01891864|78970155|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
44176244|NCT01891864|78970156|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
44176245|NCT01891864|78970157|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
44176246|NCT01891864|78970158|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
44176247|NCT01891864|78970159|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
44176248|NCT01891864|78970160|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
44176249|NCT01891864|78970155|FG000|Treatment Period 1|Withdrawal by Subject|2|||
44176250|NCT01891864|78970156|FG001|Treatment Period 1|Withdrawal by Subject|5|||
44176251|NCT01891864|78970157|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44176252|NCT01891864|78970158|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44176253|NCT01891864|78970159|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44176254|NCT01891864|78970160|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44176255|NCT01891864|78970155|FG000|Treatment Period 1|Lost to Follow-up|1|||
44176256|NCT01891864|78970156|FG001|Treatment Period 1|Lost to Follow-up|0|||
44176257|NCT01891864|78970157|FG002|Treatment Period 1|Lost to Follow-up|0|||
44176258|NCT01891864|78970158|FG003|Treatment Period 1|Lost to Follow-up|0|||
44176259|NCT01891864|78970159|FG004|Treatment Period 1|Lost to Follow-up|0|||
44176260|NCT01891864|78970160|FG005|Treatment Period 1|Lost to Follow-up|0|||
44176261|NCT01891864|78970155|FG000|Treatment Period 2|Protocol Violation|0|||
44176262|NCT01891864|78970156|FG001|Treatment Period 2|Protocol Violation|0|||
44176263|NCT01891864|78970157|FG002|Treatment Period 2|Protocol Violation|0|||
44176264|NCT01891864|78970158|FG003|Treatment Period 2|Protocol Violation|1|||
44176265|NCT01891864|78970159|FG004|Treatment Period 2|Protocol Violation|0|||
44176266|NCT01891864|78970160|FG005|Treatment Period 2|Protocol Violation|0|||
44176267|NCT01891864|78970155|FG000|Treatment Period 2|Physician Decision|0|||
44176268|NCT01891864|78970156|FG001|Treatment Period 2|Physician Decision|0|||
44176269|NCT01891864|78970157|FG002|Treatment Period 2|Physician Decision|1|||
44176270|NCT01891864|78970158|FG003|Treatment Period 2|Physician Decision|0|||
44176271|NCT01891864|78970159|FG004|Treatment Period 2|Physician Decision|0|||
44176272|NCT01891864|78970160|FG005|Treatment Period 2|Physician Decision|0|||
44176273|NCT01891864|78970155|FG000|Treatment Period 2|Site Termination|0|||
44176274|NCT01891864|78970156|FG001|Treatment Period 2|Site Termination|0|||
44176275|NCT01891864|78970157|FG002|Treatment Period 2|Site Termination|1|||
44176276|NCT01891864|78970158|FG003|Treatment Period 2|Site Termination|2|||
44176277|NCT01891864|78970159|FG004|Treatment Period 2|Site Termination|0|||
44176278|NCT01891864|78970160|FG005|Treatment Period 2|Site Termination|0|||
44176279|NCT01891864|78970155|FG000|Treatment Period 2|Lack of Efficacy|0|||
44176280|NCT01891864|78970156|FG001|Treatment Period 2|Lack of Efficacy|0|||
44176281|NCT01891864|78970157|FG002|Treatment Period 2|Lack of Efficacy|1|||
44176282|NCT01891864|78970158|FG003|Treatment Period 2|Lack of Efficacy|0|||
44176283|NCT01891864|78970159|FG004|Treatment Period 2|Lack of Efficacy|1|||
44176284|NCT01891864|78970160|FG005|Treatment Period 2|Lack of Efficacy|0|||
44176285|NCT01891864|78970155|FG000|Treatment Period 2|Adverse Event|0|||
44176286|NCT01891864|78970156|FG001|Treatment Period 2|Adverse Event|0|||
44176287|NCT01891864|78970157|FG002|Treatment Period 2|Adverse Event|1|||
44176288|NCT01891864|78970158|FG003|Treatment Period 2|Adverse Event|2|||
44176289|NCT01891864|78970159|FG004|Treatment Period 2|Adverse Event|0|||
44176290|NCT01891864|78970160|FG005|Treatment Period 2|Adverse Event|4|||
44176291|NCT01891864|78970155|FG000|Treatment Period 2|Termination of Site|0|||
44176292|NCT01891864|78970156|FG001|Treatment Period 2|Termination of Site|0|||
44176293|NCT01891864|78970157|FG002|Treatment Period 2|Termination of Site|0|||
44176294|NCT01891864|78970158|FG003|Treatment Period 2|Termination of Site|0|||
44176295|NCT01891864|78970159|FG004|Treatment Period 2|Termination of Site|2|||
44176296|NCT01891864|78970160|FG005|Treatment Period 2|Termination of Site|0|||
44176297|NCT01891864|78970155|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44176298|NCT01891864|78970156|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44176299|NCT01891864|78970157|FG002|Treatment Period 2|Withdrawal by Subject|3|||
44176300|NCT01891864|78970158|FG003|Treatment Period 2|Withdrawal by Subject|4|||
44176301|NCT01891864|78970159|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44176302|NCT01891864|78970160|FG005|Treatment Period 2|Withdrawal by Subject|1|||
44176303|NCT01891864|78970155|FG000|Extension Period|Lack of Efficacy|0|||
44176304|NCT01891864|78970156|FG001|Extension Period|Lack of Efficacy|0|||
44176305|NCT01891864|78970157|FG002|Extension Period|Lack of Efficacy|0|||
44176306|NCT01891864|78970158|FG003|Extension Period|Lack of Efficacy|1|||
44176307|NCT01891864|78970159|FG004|Extension Period|Lack of Efficacy|1|||
44176308|NCT01891864|78970160|FG005|Extension Period|Lack of Efficacy|0|||
44451119|NCT00630032|79460083|FG000|Overall Study|Withdrawal by Subject|3|||
44176309|NCT01891864|78970155|FG000|Extension Period|Pregnancy|0|||
44176310|NCT01891864|78970156|FG001|Extension Period|Pregnancy|0|||
44176311|NCT01891864|78970157|FG002|Extension Period|Pregnancy|1|||
44176312|NCT01891864|78970158|FG003|Extension Period|Pregnancy|0|||
44176313|NCT01891864|78970159|FG004|Extension Period|Pregnancy|0|||
44176314|NCT01891864|78970160|FG005|Extension Period|Pregnancy|0|||
44176315|NCT01891864|78970155|FG000|Extension Period|Adverse Event|0|||
44176316|NCT01891864|78970156|FG001|Extension Period|Adverse Event|0|||
44176317|NCT01891864|78970157|FG002|Extension Period|Adverse Event|4|||
44176318|NCT01891864|78970158|FG003|Extension Period|Adverse Event|2|||
44176319|NCT01891864|78970159|FG004|Extension Period|Adverse Event|2|||
44176320|NCT01891864|78970160|FG005|Extension Period|Adverse Event|0|||
44176321|NCT01891864|78970155|FG000|Extension Period|Withdrawal by Subject|0|||
44176322|NCT01891864|78970156|FG001|Extension Period|Withdrawal by Subject|0|||
44176323|NCT01891864|78970157|FG002|Extension Period|Withdrawal by Subject|1|||
44176324|NCT01891864|78970158|FG003|Extension Period|Withdrawal by Subject|2|||
44176325|NCT01891864|78970159|FG004|Extension Period|Withdrawal by Subject|4|||
44176326|NCT01891864|78970160|FG005|Extension Period|Withdrawal by Subject|0|||
44176327|NCT01891864|78970155|FG000|Extension Period|Lost to Follow-up|0|||
44176328|NCT01891864|78970156|FG001|Extension Period|Lost to Follow-up|0|||
44176329|NCT01891864|78970157|FG002|Extension Period|Lost to Follow-up|2|||
44176330|NCT01891864|78970158|FG003|Extension Period|Lost to Follow-up|0|||
44176331|NCT01891864|78970159|FG004|Extension Period|Lost to Follow-up|0|||
44176332|NCT01891864|78970160|FG005|Extension Period|Lost to Follow-up|0|||
44176333|NCT02485301|78970174|FG000|Overall Study|Serious Adverse Events|2|||
44176334|NCT02485301|78970175|FG001|Overall Study|Serious Adverse Events|1|||
44176335|NCT02485301|78970174|FG000|Overall Study|Protocol Violation|0|||
44176336|NCT02485301|78970175|FG001|Overall Study|Protocol Violation|1|||
44176337|NCT02485301|78970174|FG000|Overall Study|Withdrawal by Subject|6|||
44176338|NCT02485301|78970175|FG001|Overall Study|Withdrawal by Subject|7|||
44176339|NCT02485301|78970174|FG000|Overall Study|Migrated/moved from study area|10|||
44176340|NCT02485301|78970175|FG001|Overall Study|Migrated/moved from study area|19|||
44176341|NCT02485301|78970174|FG000|Overall Study|Lost to Follow-up|17|||
44176342|NCT02485301|78970175|FG001|Overall Study|Lost to Follow-up|17|||
44176343|NCT02485301|78970174|FG000|Overall Study|Other|3|||
44176344|NCT02485301|78970175|FG001|Overall Study|Other|4|||
44176345|NCT02484911|78970183|FG000|Overall Study|Withdrawal by Subject|2|||
44176346|NCT02484911|78970184|FG001|Overall Study|Withdrawal by Subject|1|||
44176347|NCT02484911|78970183|FG000|Overall Study|Protocol Violation|2|||
44176348|NCT02484911|78970184|FG001|Overall Study|Protocol Violation|1|||
44176349|NCT02466425|78970193|FG000|Overall Study|Adverse Event|3|||
44176350|NCT02466425|78970194|FG001|Overall Study|Adverse Event|11|||
44176351|NCT02466425|78970193|FG000|Overall Study|Lack of Efficacy|4|||
44176352|NCT02466425|78970194|FG001|Overall Study|Lack of Efficacy|1|||
44176353|NCT02466425|78970193|FG000|Overall Study|Lost to Follow-up|3|||
44176354|NCT02466425|78970194|FG001|Overall Study|Lost to Follow-up|0|||
44176355|NCT02466425|78970193|FG000|Overall Study|Protocol Violation|1|||
44176356|NCT02466425|78970194|FG001|Overall Study|Protocol Violation|0|||
44176357|NCT02466425|78970193|FG000|Overall Study|Withdrawal by Subject|0|||
44176358|NCT02466425|78970194|FG001|Overall Study|Withdrawal by Subject|1|||
44176359|NCT02466425|78970193|FG000|Overall Study|Other|1|||
44176360|NCT02466425|78970194|FG001|Overall Study|Other|3|||
44176361|NCT02466425|78970193|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
44176362|NCT02466425|78970194|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44176363|NCT02451917|78970202|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
44176364|NCT02451917|78970203|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
44176365|NCT02451917|78970202|FG000|First Intervention (24 Weeks)|Death|0|||
44176366|NCT02451917|78970203|FG001|First Intervention (24 Weeks)|Death|1|||
44176367|NCT02451917|78970202|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
44176368|NCT02451917|78970203|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
44176369|NCT02349451|78970216|FG000|Overall Study|Withdrawal by Subject|0|||
44176370|NCT02349451|78970217|FG001|Overall Study|Withdrawal by Subject|1|||
44176371|NCT02349451|78970218|FG002|Overall Study|Withdrawal by Subject|2|||
44176372|NCT02349451|78970219|FG003|Overall Study|Withdrawal by Subject|1|||
44176373|NCT02409368|78970236|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
44176374|NCT02409368|78970237|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
44176375|NCT02409368|78970238|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
44176376|NCT02409368|78970239|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
44176377|NCT02409368|78970236|FG000|ECOG Reclassification|Death|1|||
44176378|NCT02409368|78970237|FG001|ECOG Reclassification|Death|5|||
44176379|NCT02409368|78970238|FG002|ECOG Reclassification|Death|0|||
44176380|NCT02409368|78970239|FG003|ECOG Reclassification|Death|0|||
44176381|NCT02409368|78970236|FG000|ECOG Reclassification|Disease Progression|113|||
44176382|NCT02409368|78970237|FG001|ECOG Reclassification|Disease Progression|382|||
44176383|NCT02409368|78970238|FG002|ECOG Reclassification|Disease Progression|70|||
44176384|NCT02409368|78970239|FG003|ECOG Reclassification|Disease Progression|1|||
44176385|NCT02409368|78970236|FG000|ECOG Reclassification|Lost to Follow-up|1|||
44176386|NCT02409368|78970237|FG001|ECOG Reclassification|Lost to Follow-up|5|||
44176387|NCT02409368|78970238|FG002|ECOG Reclassification|Lost to Follow-up|0|||
44176388|NCT02409368|78970239|FG003|ECOG Reclassification|Lost to Follow-up|0|||
44176389|NCT02409368|78970236|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
44176390|NCT02409368|78970237|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
44176391|NCT02409368|78970238|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
44176392|NCT02409368|78970239|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
44176393|NCT02409368|78970236|FG000|ECOG Reclassification|Poor/non-compliance|0|||
44176394|NCT02409368|78970237|FG001|ECOG Reclassification|Poor/non-compliance|3|||
44176395|NCT02409368|78970238|FG002|ECOG Reclassification|Poor/non-compliance|2|||
44176396|NCT02409368|78970239|FG003|ECOG Reclassification|Poor/non-compliance|0|||
44176397|NCT02409368|78970236|FG000|ECOG Reclassification|Study drug toxicity|17|||
44176398|NCT02409368|78970237|FG001|ECOG Reclassification|Study drug toxicity|42|||
44176399|NCT02409368|78970238|FG002|ECOG Reclassification|Study drug toxicity|7|||
44176400|NCT02409368|78970239|FG003|ECOG Reclassification|Study drug toxicity|0|||
44176401|NCT02409368|78970236|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
44176402|NCT02409368|78970237|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
44176403|NCT02409368|78970238|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
44176404|NCT02409368|78970239|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
44176405|NCT02409368|78970236|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
44176406|NCT02409368|78970237|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
44176407|NCT02409368|78970238|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
44176408|NCT02409368|78970239|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
44176409|NCT02409368|78970236|FG000|ECOG Reclassification|Participant withdrew consent|2|||
44176410|NCT02409368|78970237|FG001|ECOG Reclassification|Participant withdrew consent|3|||
44176411|NCT02409368|78970238|FG002|ECOG Reclassification|Participant withdrew consent|4|||
44176412|NCT02409368|78970239|FG003|ECOG Reclassification|Participant withdrew consent|0|||
44176413|NCT02409368|78970236|FG000|ECOG Reclassification|Other Reasons|5|||
44176414|NCT02409368|78970237|FG001|ECOG Reclassification|Other Reasons|26|||
44176415|NCT02409368|78970238|FG002|ECOG Reclassification|Other Reasons|2|||
44176416|NCT02409368|78970239|FG003|ECOG Reclassification|Other Reasons|0|||
44176417|NCT02409368|78970236|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
44176418|NCT02409368|78970237|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
44176419|NCT02409368|78970238|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
44176420|NCT02409368|78970239|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
44176421|NCT01853878|78970252|FG000|Overall Study|Recurrence|2|||
44176422|NCT01853878|78970253|FG001|Overall Study|Recurrence|0|||
44176423|NCT01853878|78970252|FG000|Overall Study|Adverse Event|2|||
44176424|NCT01853878|78970253|FG001|Overall Study|Adverse Event|0|||
44176425|NCT01853878|78970252|FG000|Overall Study|Withdrawal by Subject|3|||
44176426|NCT01853878|78970253|FG001|Overall Study|Withdrawal by Subject|1|||
44176427|NCT01853878|78970252|FG000|Overall Study|Migrated/moved from the study area|1|||
44176428|NCT01853878|78970253|FG001|Overall Study|Migrated/moved from the study area|0|||
44176429|NCT01853878|78970252|FG000|Overall Study|Other|55|||
44176430|NCT01853878|78970253|FG001|Overall Study|Other|43|||
44176431|NCT02342678|78970261|FG000|Overall Study|Lost to Follow-up|0|||
44176432|NCT02342678|78970262|FG001|Overall Study|Lost to Follow-up|1|||
44176433|NCT02342678|78970261|FG000|Overall Study|Too busy to complete study|0|||
44176434|NCT02342678|78970262|FG001|Overall Study|Too busy to complete study|2|||
44176435|NCT02342678|78970261|FG000|Overall Study|Family illness/emergency|0|||
44176436|NCT02342678|78970262|FG001|Overall Study|Family illness/emergency|1|||
44176437|NCT02342678|78970261|FG000|Overall Study|Illness/medical reason|1|||
44176438|NCT02342678|78970262|FG001|Overall Study|Illness/medical reason|1|||
44176439|NCT02342288|78970270|FG000|Overall Study|no protocol anesthesiologist available|3|||
44176440|NCT02342288|78970271|FG001|Overall Study|no protocol anesthesiologist available|2|||
44176441|NCT02342288|78970270|FG000|Overall Study|anesthesia leak in system|1|||
44176442|NCT02342288|78970271|FG001|Overall Study|anesthesia leak in system|0|||
44176443|NCT02342288|78970270|FG000|Overall Study|Withdrawal by Subject|1|||
44176444|NCT02342288|78970271|FG001|Overall Study|Withdrawal by Subject|0|||
44176445|NCT02342288|78970270|FG000|Overall Study|coordinator contaminated with blood|0|||
44176446|NCT02342288|78970271|FG001|Overall Study|coordinator contaminated with blood|1|||
44176447|NCT02342288|78970270|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
44176448|NCT02342288|78970271|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
44176449|NCT02342288|78970270|FG000|Overall Study|coordinator not available|0|||
44176450|NCT02342288|78970271|FG001|Overall Study|coordinator not available|2|||
44176451|NCT01853644|78970277|FG000|Registration and Treatment Start|Did not start treatment|1|||
44176452|NCT01853644|78970277|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
44264726|NCT01049360|79166462|FG019|Period 2|Withdrawal by Subject|1|||
44176453|NCT01853644|78970277|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
44176454|NCT01853644|78970277|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
44176455|NCT01853644|78970277|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
44176456|NCT01853644|78970277|FG000|Continued Treatment After First Response|Adverse Event|2|||
44176457|NCT01853644|78970277|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
44176458|NCT02374346|78970281|FG000|Overall Study|operated or discharged during weekend|48|||
44176459|NCT01853254|78970287|FG000|Overall Study|Abnormal Laboratory Test|1|||
44176460|NCT01853254|78970287|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
44176461|NCT01853254|78970287|FG000|Overall Study|Death|1|||
44176462|NCT01853254|78970287|FG000|Overall Study|Failure to Return|43|||
44176463|NCT01853254|78970287|FG000|Overall Study|Insufficient Therapeutic Response|22|||
44176464|NCT01853254|78970287|FG000|Overall Study|Refusal of Treatment|1|||
44176465|NCT01853254|78970287|FG000|Overall Study|Other Protocol Violation|1|||
44176466|NCT01853254|78970287|FG000|Overall Study|Withdrawal of Consent|16|||
44176467|NCT01853254|78970287|FG000|Overall Study|Administrative/Other|16|||
44176468|NCT02373098|78970293|FG000|Overall Study|Lost to Follow-up|1|||
44176469|NCT02373098|78970294|FG001|Overall Study|Lost to Follow-up|0|||
44176470|NCT02373098|78970293|FG000|Overall Study|Protocol Violation|3|||
44176471|NCT02373098|78970294|FG001|Overall Study|Protocol Violation|0|||
44176472|NCT02373098|78970293|FG000|Overall Study|Withdrawal by Subject|5|||
44176473|NCT02373098|78970294|FG001|Overall Study|Withdrawal by Subject|0|||
44176474|NCT02373098|78970293|FG000|Overall Study|Adverse Event|3|||
44176475|NCT02373098|78970294|FG001|Overall Study|Adverse Event|0|||
44176476|NCT01853176|78970308|FG000|Overall Study|Study terminated|4|||
44176477|NCT01853176|78970309|FG001|Overall Study|Study terminated|0|||
44176478|NCT02372396|78970317|FG000|Overall Study|Lost to Follow-up|7|||
44176479|NCT02372396|78970318|FG001|Overall Study|Lost to Follow-up|9|||
44176480|NCT01835548|78970326|FG000|Dose Optimization Period|Adverse Event|0|||
44176481|NCT01835548|78970327|FG001|Dose Optimization Period|Adverse Event|0|||
44176482|NCT01835548|78970328|FG002|Dose Optimization Period|Adverse Event|1|||
44176483|NCT01835548|78970326|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
44176484|NCT01835548|78970327|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
44176485|NCT01835548|78970328|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
44176486|NCT01835548|78970326|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44176487|NCT01835548|78970327|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44176488|NCT01835548|78970328|FG002|Double-Blind Treatment Period|Adverse Event|0|||
44176489|NCT01835548|78970326|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44176490|NCT01835548|78970327|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44176491|NCT01835548|78970328|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44176492|NCT01852942|78970342|FG000|Overall Study|Physician Decision|1|||
44176493|NCT01852942|78970343|FG001|Overall Study|Physician Decision|0|||
44176494|NCT01852942|78970342|FG000|Overall Study|Death|1|||
44176495|NCT01852942|78970343|FG001|Overall Study|Death|1|||
44176496|NCT01852942|78970342|FG000|Overall Study|Withdrawal by Subject|2|||
44176497|NCT01852942|78970343|FG001|Overall Study|Withdrawal by Subject|3|||
44176498|NCT01852942|78970342|FG000|Overall Study|Lost to Follow-up|1|||
44176499|NCT01852942|78970343|FG001|Overall Study|Lost to Follow-up|2|||
44176500|NCT01852162|78970352|FG000|Overall Study|Adverse Event|1|||
44176501|NCT01852162|78970353|FG001|Overall Study|Adverse Event|0|||
44176502|NCT01852162|78970352|FG000|Overall Study|Withdrawal by Subject|3|||
44176503|NCT01852162|78970353|FG001|Overall Study|Withdrawal by Subject|1|||
44176504|NCT01835470|78970359|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
44176505|NCT01835470|78970359|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
44176506|NCT02451137|78970366|FG000|Overall Study|Randomized but not treated|19|||
44176507|NCT02451137|78970367|FG001|Overall Study|Randomized but not treated|27|||
44176508|NCT02451137|78970366|FG000|Overall Study|Adverse Event|43|||
44176509|NCT02451137|78970367|FG001|Overall Study|Adverse Event|42|||
44176510|NCT02451137|78970366|FG000|Overall Study|Lack of Efficacy|4|||
44176511|NCT02451137|78970367|FG001|Overall Study|Lack of Efficacy|9|||
44176512|NCT02451137|78970366|FG000|Overall Study|Participant decision:discontinue insulin|41|||
44176513|NCT02451137|78970367|FG001|Overall Study|Participant decision:discontinue insulin|43|||
44176514|NCT02451137|78970366|FG000|Overall Study|Hypoglycemia|2|||
44176515|NCT02451137|78970367|FG001|Overall Study|Hypoglycemia|1|||
44176516|NCT02451137|78970366|FG000|Overall Study|Investigator's decision|23|||
44176517|NCT02451137|78970367|FG001|Overall Study|Investigator's decision|19|||
44176518|NCT02451137|78970366|FG000|Overall Study|Lost to Follow-up|53|||
44176519|NCT02451137|78970367|FG001|Overall Study|Lost to Follow-up|61|||
44176520|NCT02451137|78970366|FG000|Overall Study|Physician Decision|6|||
44176521|NCT02451137|78970367|FG001|Overall Study|Physician Decision|5|||
44361169|NCT01188551|79366820|FG001|Overall Study|Pharmacy issues|0|||
44176522|NCT02451137|78970366|FG000|Overall Study|Sponsor decision|13|||
44176523|NCT02451137|78970367|FG001|Overall Study|Sponsor decision|25|||
44176524|NCT02451137|78970366|FG000|Overall Study|Withdrawal by Subject|40|||
44176525|NCT02451137|78970367|FG001|Overall Study|Withdrawal by Subject|63|||
44176526|NCT02451137|78970366|FG000|Overall Study|Other than specified above|2|||
44451120|NCT00630032|79460084|FG001|Overall Study|Withdrawal by Subject|2|||
44451121|NCT00630032|79460083|FG000|Overall Study|Lost to Follow-up|18|||
44451122|NCT00630032|79460084|FG001|Overall Study|Lost to Follow-up|31|||
44451123|NCT00630032|79460083|FG000|Overall Study|Protocol Violation|1|||
44451124|NCT00630032|79460084|FG001|Overall Study|Protocol Violation|0|||
44451125|NCT00630032|79460083|FG000|Overall Study|Patient has moved|1|||
44451126|NCT00630032|79460084|FG001|Overall Study|Patient has moved|1|||
44451127|NCT00630032|79460083|FG000|Overall Study|Disease progression|1|||
44451128|NCT00630032|79460084|FG001|Overall Study|Disease progression|1|||
44451129|NCT00630032|79460083|FG000|Overall Study|End of monitoring in US centers|11|||
44176527|NCT02451137|78970367|FG001|Overall Study|Other than specified above|3|||
44451130|NCT00630032|79460084|FG001|Overall Study|End of monitoring in US centers|11|||
44451131|NCT00609791|79460090|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
44451132|NCT00492050|79460106|FG000|Overall Study|Adverse Event|1|||
44451133|NCT00492050|79460106|FG000|Overall Study|Lack of Efficacy|1|||
44451134|NCT00492050|79460106|FG000|Overall Study|Withdrawal by Subject|3|||
44451135|NCT00492050|79460106|FG000|Overall Study|Unable to collect SCT|2|||
44451136|NCT00492050|79460106|FG000|Overall Study|Progressive Disease|2|||
44451137|NCT00418821|79460110|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
44451138|NCT00539994|79460158|FG000|Overall Study|Lost to Follow-up|2|||
44451139|NCT00539994|79460159|FG001|Overall Study|Lost to Follow-up|1|||
44451140|NCT00539994|79460160|FG002|Overall Study|Lost to Follow-up|0|||
44451141|NCT00539994|79460158|FG000|Overall Study|Withdrawal by Subject|1|||
44451142|NCT00539994|79460159|FG001|Overall Study|Withdrawal by Subject|0|||
44451143|NCT00539994|79460160|FG002|Overall Study|Withdrawal by Subject|1|||
44176528|NCT02372006|78970376|FG000|Overall Study|Progressive disease|8|||
44176529|NCT02372006|78970377|FG001|Overall Study|Progressive disease|7|||
44176530|NCT02372006|78970378|FG002|Overall Study|Progressive disease|34|||
44176531|NCT02372006|78970376|FG000|Overall Study|Dose limiting toxicity|0|||
44176532|NCT02372006|78970377|FG001|Overall Study|Dose limiting toxicity|1|||
44176533|NCT02372006|78970378|FG002|Overall Study|Dose limiting toxicity|0|||
44176534|NCT02372006|78970376|FG000|Overall Study|Adverse Event|0|||
44176535|NCT02372006|78970377|FG001|Overall Study|Adverse Event|0|||
44176536|NCT02372006|78970378|FG002|Overall Study|Adverse Event|3|||
44176537|NCT02372006|78970376|FG000|Overall Study|Withdrawal by Subject|0|||
44176538|NCT02372006|78970377|FG001|Overall Study|Withdrawal by Subject|1|||
44176539|NCT02372006|78970378|FG002|Overall Study|Withdrawal by Subject|1|||
44176540|NCT02372006|78970376|FG000|Overall Study|Other reason for not completing|0|||
44176541|NCT02372006|78970377|FG001|Overall Study|Other reason for not completing|0|||
44176542|NCT02372006|78970378|FG002|Overall Study|Other reason for not completing|1|||
44176543|NCT02406248|78970387|FG000|Overall Study|Death|7|||
44176544|NCT02406248|78970387|FG000|Overall Study|Withdrawal by Subject|2|||
44176545|NCT02450903|78970391|FG000|Overall Study|Adverse Event|3|||
44176546|NCT02450903|78970391|FG000|Overall Study|Progressive disease|15|||
44176547|NCT02450903|78970391|FG000|Overall Study|Switched to commercial drug|1|||
44176548|NCT02450903|78970391|FG000|Overall Study|Subject/guardian decision|1|||
44176549|NCT02371616|78970397|FG000|Overall Study|Protocol Violation|2|||
44176550|NCT02371616|78970398|FG001|Overall Study|Protocol Violation|1|||
44176551|NCT02371616|78970397|FG000|Overall Study|Adverse Event|0|||
44176552|NCT02371616|78970398|FG001|Overall Study|Adverse Event|1|||
44176553|NCT02371616|78970397|FG000|Overall Study|Withdrawal of Consent|1|||
44176554|NCT02371616|78970398|FG001|Overall Study|Withdrawal of Consent|0|||
44176555|NCT02371616|78970397|FG000|Overall Study|Other (Not specified)|1|||
44176556|NCT02371616|78970398|FG001|Overall Study|Other (Not specified)|5|||
44176557|NCT02370914|78970404|FG000|Overall Study|Protocol Violation|2|||
44176558|NCT02370602|78970414|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
44176559|NCT02370602|78970415|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
44176560|NCT02370602|78970416|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44264727|NCT01049360|79166443|FG000|Period 2|Lack of Efficacy|0|||
44264728|NCT01049360|79166444|FG001|Period 2|Lack of Efficacy|0|||
44264729|NCT01049360|79166445|FG002|Period 2|Lack of Efficacy|0|||
44264730|NCT01049360|79166446|FG003|Period 2|Lack of Efficacy|0|||
44264731|NCT01049360|79166447|FG004|Period 2|Lack of Efficacy|0|||
44264732|NCT01049360|79166448|FG005|Period 2|Lack of Efficacy|1|||
44264733|NCT01049360|79166449|FG006|Period 2|Lack of Efficacy|0|||
44264734|NCT01049360|79166450|FG007|Period 2|Lack of Efficacy|0|||
44264735|NCT01049360|79166451|FG008|Period 2|Lack of Efficacy|0|||
44176561|NCT02370602|78970417|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
44176562|NCT02370602|78970418|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
44264736|NCT01049360|79166452|FG009|Period 2|Lack of Efficacy|0|||
44264737|NCT01049360|79166453|FG010|Period 2|Lack of Efficacy|0|||
44264738|NCT01049360|79166454|FG011|Period 2|Lack of Efficacy|0|||
44176563|NCT02370602|78970419|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
44176564|NCT02370368|78970438|FG000|Overall Study|Adverse Event|1|||
44264739|NCT01049360|79166455|FG012|Period 2|Lack of Efficacy|0|||
44264740|NCT01049360|79166456|FG013|Period 2|Lack of Efficacy|0|||
44264741|NCT01049360|79166457|FG014|Period 2|Lack of Efficacy|0|||
44264742|NCT01049360|79166458|FG015|Period 2|Lack of Efficacy|0|||
44176565|NCT02370368|78970439|FG001|Overall Study|Adverse Event|2|||
44176566|NCT02370368|78970438|FG000|Overall Study|Withdrawal by Subject|5|||
44176567|NCT02370368|78970439|FG001|Overall Study|Withdrawal by Subject|4|||
44176568|NCT02340806|78970447|FG000|Overall Study|Protocol Violation|2|||
44176569|NCT02340806|78970448|FG001|Overall Study|Protocol Violation|0|||
44176570|NCT02340806|78970447|FG000|Overall Study|epidural catheter replaced|2|||
44176571|NCT02340806|78970448|FG001|Overall Study|epidural catheter replaced|1|||
44176572|NCT02340806|78970447|FG000|Overall Study|history of chronic pain medication|1|||
44176573|NCT02340806|78970448|FG001|Overall Study|history of chronic pain medication|0|||
44176574|NCT02340806|78970447|FG000|Overall Study|re-dose < 90 min of CSE|1|||
44176575|NCT02340806|78970448|FG001|Overall Study|re-dose < 90 min of CSE|3|||
44176576|NCT02338154|78970454|FG000|Overall Study|Death|46|||
44176577|NCT02338154|78970454|FG000|Overall Study|Valve Implant Failure|17|||
44176578|NCT02338154|78970454|FG000|Overall Study|Valve Explant|11|||
44176579|NCT02338154|78970454|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
44176580|NCT02338154|78970454|FG000|Overall Study|Lost to Follow-up|8|||
44176581|NCT02338154|78970454|FG000|Overall Study|Other Reason|3|||
44176582|NCT02338154|78970454|FG000|Overall Study|Patients Without Exit Form|47|||
44176583|NCT02338154|78970454|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
44176584|NCT01835158|78970468|FG000|Overall Study|Withdrawal by Subject|1|||
44176585|NCT01835158|78970469|FG001|Overall Study|Withdrawal by Subject|6|||
44176586|NCT02337764|78970475|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
44176587|NCT02337764|78970475|FG000|Overall Study|Voluntary Withdrawal|12|||
44176588|NCT02337764|78970475|FG000|Overall Study|Lack of Efficacy|2|||
44176589|NCT01834222|78970479|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
44176590|NCT01833832|78970483|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
44176591|NCT01833520|78970489|FG000|Overall Study|Lack of Efficacy|3|||
44176592|NCT01833520|78970490|FG001|Overall Study|Lack of Efficacy|3|||
44176593|NCT01833520|78970491|FG002|Overall Study|Lack of Efficacy|8|||
44176594|NCT01833520|78970492|FG003|Overall Study|Lack of Efficacy|3|||
44176595|NCT01850602|78970506|FG000|Overall Study|Adverse Event|7|||
44176596|NCT01850602|78970507|FG001|Overall Study|Adverse Event|10|||
44176597|NCT01850602|78970506|FG000|Overall Study|Physician Decision|2|||
44264743|NCT01049360|79166459|FG016|Period 2|Lack of Efficacy|0|||
44264744|NCT01049360|79166460|FG017|Period 2|Lack of Efficacy|0|||
44264745|NCT01049360|79166461|FG018|Period 2|Lack of Efficacy|0|||
44264746|NCT01049360|79166462|FG019|Period 2|Lack of Efficacy|0|||
44264747|NCT01049360|79166443|FG000|Period 4|Protocol Violation|0|||
44264748|NCT01049360|79166444|FG001|Period 4|Protocol Violation|0|||
44264749|NCT01049360|79166445|FG002|Period 4|Protocol Violation|0|||
44176598|NCT01850602|78970507|FG001|Overall Study|Physician Decision|1|||
44176599|NCT01850602|78970506|FG000|Overall Study|Withdrawal by Subject|2|||
44176600|NCT01850602|78970507|FG001|Overall Study|Withdrawal by Subject|4|||
44176601|NCT01850602|78970506|FG000|Overall Study|Decrease in serum calcium|2|||
44264750|NCT01049360|79166446|FG003|Period 4|Protocol Violation|0|||
44264751|NCT01049360|79166447|FG004|Period 4|Protocol Violation|0|||
44264752|NCT01049360|79166448|FG005|Period 4|Protocol Violation|0|||
44264753|NCT01049360|79166449|FG006|Period 4|Protocol Violation|0|||
44264754|NCT01049360|79166450|FG007|Period 4|Protocol Violation|0|||
44176602|NCT01850602|78970507|FG001|Overall Study|Decrease in serum calcium|3|||
44176603|NCT01850602|78970506|FG000|Overall Study|Increase in serum ferritin|1|||
44176604|NCT01850602|78970507|FG001|Overall Study|Increase in serum ferritin|0|||
44264755|NCT01049360|79166451|FG008|Period 4|Protocol Violation|0|||
44176605|NCT01832818|78970513|FG000|Overall Study|Lost to Follow-up|6|||
44176606|NCT02405780|78970521|FG000|Period I|Adverse Event|8|||
44176607|NCT02405780|78970522|FG001|Period I|Adverse Event|0|||
44264756|NCT01049360|79166452|FG009|Period 4|Protocol Violation|0|||
44264757|NCT01049360|79166453|FG010|Period 4|Protocol Violation|0|||
44264758|NCT01049360|79166454|FG011|Period 4|Protocol Violation|0|||
44176608|NCT02405780|78970523|FG002|Period I|Adverse Event|3|||
44176609|NCT02405780|78970524|FG003|Period I|Adverse Event|7|||
44176610|NCT02405780|78970521|FG000|Period I|Medical reasons|1|||
44176611|NCT02405780|78970522|FG001|Period I|Medical reasons|1|||
44176612|NCT02405780|78970523|FG002|Period I|Medical reasons|0|||
44176613|NCT02405780|78970524|FG003|Period I|Medical reasons|1|||
44176614|NCT02405780|78970521|FG000|Period I|Screening Failure|1|||
44176615|NCT02405780|78970522|FG001|Period I|Screening Failure|0|||
44176616|NCT02405780|78970523|FG002|Period I|Screening Failure|1|||
44176617|NCT02405780|78970524|FG003|Period I|Screening Failure|0|||
44176618|NCT02405780|78970521|FG000|Period I|Withdrawal by Subject|9|||
44176619|NCT02405780|78970522|FG001|Period I|Withdrawal by Subject|1|||
44176620|NCT02405780|78970523|FG002|Period I|Withdrawal by Subject|3|||
44176621|NCT02405780|78970524|FG003|Period I|Withdrawal by Subject|4|||
44176622|NCT02405780|78970521|FG000|Period I|Non-compliance with study procedures|8|||
44176623|NCT02405780|78970522|FG001|Period I|Non-compliance with study procedures|6|||
44176624|NCT02405780|78970523|FG002|Period I|Non-compliance with study procedures|8|||
44176625|NCT02405780|78970524|FG003|Period I|Non-compliance with study procedures|11|||
44176626|NCT02405780|78970521|FG000|Period II|Adverse Event|3|||
44176627|NCT02405780|78970522|FG001|Period II|Adverse Event|5|||
44176628|NCT02405780|78970523|FG002|Period II|Adverse Event|4|||
44176629|NCT02405780|78970524|FG003|Period II|Adverse Event|11|||
44176630|NCT02405780|78970521|FG000|Period II|Medical reason|0|||
44176631|NCT02405780|78970522|FG001|Period II|Medical reason|1|||
44176632|NCT02405780|78970523|FG002|Period II|Medical reason|0|||
44176633|NCT02405780|78970524|FG003|Period II|Medical reason|0|||
44176634|NCT02405780|78970521|FG000|Period II|Pregnancy|0|||
44176635|NCT02405780|78970522|FG001|Period II|Pregnancy|0|||
44176636|NCT02405780|78970523|FG002|Period II|Pregnancy|1|||
44176637|NCT02405780|78970524|FG003|Period II|Pregnancy|0|||
44176638|NCT02405780|78970521|FG000|Period II|Withdrawal by Subject|7|||
44176639|NCT02405780|78970522|FG001|Period II|Withdrawal by Subject|4|||
44176640|NCT02405780|78970523|FG002|Period II|Withdrawal by Subject|0|||
44176641|NCT02405780|78970524|FG003|Period II|Withdrawal by Subject|3|||
44176642|NCT02405780|78970521|FG000|Period II|Non-compliance with study procedures|5|||
44176643|NCT02405780|78970522|FG001|Period II|Non-compliance with study procedures|2|||
44176644|NCT02405780|78970523|FG002|Period II|Non-compliance with study procedures|7|||
44176645|NCT02405780|78970524|FG003|Period II|Non-compliance with study procedures|4|||
44176646|NCT02369510|78970552|FG000|Overall Study|Spilled Medication|1|||
44176647|NCT02369510|78970553|FG001|Overall Study|Spilled Medication|2|||
44176648|NCT02369510|78970554|FG002|Overall Study|Spilled Medication|1|||
44176649|NCT02369510|78970552|FG000|Overall Study|Epidural Activation|1|||
44176650|NCT02369510|78970553|FG001|Overall Study|Epidural Activation|1|||
44176651|NCT02369510|78970554|FG002|Overall Study|Epidural Activation|5|||
44176652|NCT01650194|78970562|FG000|Overall Study|Progressive Disease (PD)|35|||
44176653|NCT01650194|78970562|FG000|Overall Study|Withdrawal by Subject|2|||
44176654|NCT01650194|78970562|FG000|Overall Study|Miscellaneous|10|||
44176655|NCT02367716|78970567|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
44176656|NCT02366936|78970572|FG000|Overall Study|Withdrawal by Subject|2|||
44176657|NCT02366936|78970572|FG000|Overall Study|Lost to Follow-up|4|||
44176658|NCT02366936|78970572|FG000|Overall Study|Physician Decision|2|||
44176659|NCT01648166|78970578|FG000|Overall Study|inadequate toenail samples|53|||
44176660|NCT01648166|78970579|FG001|Overall Study|inadequate toenail samples|100|||
44176661|NCT02404220|78970589|FG000|Overall Study|Adverse Event|0|||
44176662|NCT02404220|78970590|FG001|Overall Study|Adverse Event|0|||
44176663|NCT02404220|78970591|FG002|Overall Study|Adverse Event|1|||
44176664|NCT02404220|78970592|FG003|Overall Study|Adverse Event|0|||
44176665|NCT02404220|78970589|FG000|Overall Study|Death|5|||
44176666|NCT02404220|78970590|FG001|Overall Study|Death|5|||
44176667|NCT02404220|78970591|FG002|Overall Study|Death|3|||
44176668|NCT02404220|78970592|FG003|Overall Study|Death|8|||
44176669|NCT02404220|78970589|FG000|Overall Study|Progressive Disease|0|||
44176670|NCT02404220|78970590|FG001|Overall Study|Progressive Disease|0|||
44176671|NCT02404220|78970591|FG002|Overall Study|Progressive Disease|1|||
44176672|NCT02404220|78970592|FG003|Overall Study|Progressive Disease|1|||
44176673|NCT02404220|78970589|FG000|Overall Study|Study Terminated by Sponsor|0|||
44176674|NCT02404220|78970590|FG001|Overall Study|Study Terminated by Sponsor|0|||
44176675|NCT02404220|78970591|FG002|Overall Study|Study Terminated by Sponsor|2|||
44176676|NCT02404220|78970592|FG003|Overall Study|Study Terminated by Sponsor|1|||
44264759|NCT01049360|79166455|FG012|Period 4|Protocol Violation|0|||
44176677|NCT02404220|78970589|FG000|Overall Study|Withdrawal by Subject|0|||
44176678|NCT02404220|78970590|FG001|Overall Study|Withdrawal by Subject|1|||
44176679|NCT02404220|78970591|FG002|Overall Study|Withdrawal by Subject|0|||
44176680|NCT02404220|78970592|FG003|Overall Study|Withdrawal by Subject|0|||
44176681|NCT02404220|78970589|FG000|Overall Study|Enrolled but Never Treated|0|||
44176682|NCT02404220|78970590|FG001|Overall Study|Enrolled but Never Treated|2|||
44176683|NCT02404220|78970591|FG002|Overall Study|Enrolled but Never Treated|0|||
44176684|NCT02404220|78970592|FG003|Overall Study|Enrolled but Never Treated|0|||
44176685|NCT02335658|78970604|FG000|Overall Study|Adverse Event|18|||
44176686|NCT02335658|78970605|FG001|Overall Study|Adverse Event|12|||
44176687|NCT02335658|78970604|FG000|Overall Study|Lack of Efficacy|4|||
44176688|NCT02335658|78970605|FG001|Overall Study|Lack of Efficacy|5|||
44176689|NCT02335658|78970604|FG000|Overall Study|Pregnancy|1|||
44264760|NCT01049360|79166456|FG013|Period 4|Protocol Violation|0|||
44176690|NCT02335658|78970605|FG001|Overall Study|Pregnancy|0|||
44176691|NCT02335658|78970604|FG000|Overall Study|Withdrawal by Subject|13|||
44176692|NCT02335658|78970605|FG001|Overall Study|Withdrawal by Subject|21|||
44176693|NCT02335658|78970604|FG000|Overall Study|non-compliance|2|||
44176694|NCT02335658|78970605|FG001|Overall Study|non-compliance|3|||
44176695|NCT02335658|78970604|FG000|Overall Study|other reason|2|||
44176696|NCT02335658|78970605|FG001|Overall Study|other reason|3|||
44176697|NCT02366468|78970615|FG000|Overall Study|Adverse Event|2|||
44176698|NCT02366468|78970616|FG001|Overall Study|Adverse Event|0|||
44176699|NCT02366468|78970615|FG000|Overall Study|Withdrawal by Subject|1|||
44176700|NCT02366468|78970616|FG001|Overall Study|Withdrawal by Subject|5|||
44176701|NCT02366468|78970615|FG000|Overall Study|Lost to Follow-up|2|||
44176702|NCT02366468|78970616|FG001|Overall Study|Lost to Follow-up|0|||
44176703|NCT02366468|78970615|FG000|Overall Study|Death|1|||
44176704|NCT02366468|78970616|FG001|Overall Study|Death|2|||
44176705|NCT02366468|78970615|FG000|Overall Study|Other|0|||
44176706|NCT02366468|78970616|FG001|Overall Study|Other|2|||
44176707|NCT02366312|78970624|FG000|Overall Study|Lost to Follow-up|0|||
44176708|NCT02366312|78970625|FG001|Overall Study|Lost to Follow-up|1|||
44176709|NCT02335346|78970631|FG000|Overall Study|Adverse Event|11|||
44176710|NCT02335346|78970631|FG000|Overall Study|Withdrawal by Subject|1|||
44176711|NCT02403206|78970637|FG000|Overall Study|Lost to Follow-up|4|||
44176712|NCT02403206|78970638|FG001|Overall Study|Lost to Follow-up|3|||
44176713|NCT02403206|78970637|FG000|Overall Study|Physician Decision|2|||
44176714|NCT02403206|78970638|FG001|Overall Study|Physician Decision|0|||
44176715|NCT02403206|78970637|FG000|Overall Study|Withdrawal by Subject|3|||
44176716|NCT02403206|78970638|FG001|Overall Study|Withdrawal by Subject|3|||
44176717|NCT02403206|78970637|FG000|Overall Study|Reason not given|2|||
44176718|NCT02403206|78970638|FG001|Overall Study|Reason not given|4|||
44176719|NCT02333630|78970647|FG000|Overall Study|Lost to Follow-up|5|||
44176720|NCT02333630|78970648|FG001|Overall Study|Lost to Follow-up|2|||
44176721|NCT02401412|78970660|FG000|Overall Study|Lost to Follow-up|1|||
44176722|NCT02401412|78970661|FG001|Overall Study|Lost to Follow-up|0|||
44176723|NCT02401412|78970660|FG000|Overall Study|Discontinued Intervention|15|||
44176724|NCT02401412|78970661|FG001|Overall Study|Discontinued Intervention|21|||
44176725|NCT02401412|78970660|FG000|Overall Study|Withdrawal by Subject|4|||
44176726|NCT02401412|78970661|FG001|Overall Study|Withdrawal by Subject|4|||
44176727|NCT02401412|78970660|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
44176728|NCT02401412|78970661|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
44176729|NCT02401412|78970660|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
44176730|NCT02401412|78970661|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
44176731|NCT02365298|78970667|FG000|Period 2|incorrect Rx dispensed|1|||
44176732|NCT02365298|78970668|FG001|Period 2|incorrect Rx dispensed|0|||
44176733|NCT02365298|78970667|FG000|Period 2|Discontinued at request of Sponsor|1|||
44176734|NCT02365298|78970668|FG001|Period 2|Discontinued at request of Sponsor|0|||
44176735|NCT02365298|78970667|FG000|Period 2|Test Article longer available|0|||
44176736|NCT02365298|78970668|FG001|Period 2|Test Article longer available|1|||
44264761|NCT01049360|79166457|FG014|Period 4|Protocol Violation|0|||
44264762|NCT01049360|79166458|FG015|Period 4|Protocol Violation|0|||
44264763|NCT01049360|79166459|FG016|Period 4|Protocol Violation|0|||
44176737|NCT02365298|78970667|FG000|Period 2|Protocol Violation|0|||
44176738|NCT02365298|78970668|FG001|Period 2|Protocol Violation|1|||
44264764|NCT01049360|79166460|FG017|Period 4|Protocol Violation|1|||
44176739|NCT02365064|78970676|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
44176740|NCT02365064|78970677|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
44361170|NCT01188551|79366821|FG002|Overall Study|Pharmacy issues|0|||
44176741|NCT02365064|78970676|FG000|Overall Study|Withdrawal by Subject|6|||
44176742|NCT02365064|78970677|FG001|Overall Study|Withdrawal by Subject|9|||
44176743|NCT02365064|78970676|FG000|Overall Study|Treatment intolerance|2|||
44176744|NCT02365064|78970677|FG001|Overall Study|Treatment intolerance|4|||
44176745|NCT02401256|78970683|FG000|Overall Study|Adverse Event|5|||
44176746|NCT02401256|78970683|FG000|Overall Study|Withdrawal by Subject|12|||
44176747|NCT02349295|78970692|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
44176748|NCT02349295|78970693|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
44176749|NCT02349295|78970694|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
44176750|NCT02349295|78970695|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176751|NCT02349295|78970696|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176752|NCT02349295|78970697|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176753|NCT02349295|78970698|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176754|NCT02349295|78970699|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176755|NCT02349295|78970700|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176756|NCT02349295|78970701|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176757|NCT02349295|78970702|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176758|NCT02349295|78970703|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176759|NCT02349295|78970704|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176760|NCT02349295|78970705|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
44176761|NCT02349295|78970692|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
44176762|NCT02349295|78970693|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
44176763|NCT02349295|78970694|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
44176764|NCT02349295|78970695|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176765|NCT02349295|78970696|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176766|NCT02349295|78970697|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176767|NCT02349295|78970698|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176768|NCT02349295|78970699|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176769|NCT02349295|78970700|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176770|NCT02349295|78970701|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176771|NCT02349295|78970702|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176772|NCT02349295|78970703|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176773|NCT02349295|78970704|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176774|NCT02349295|78970705|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
44176775|NCT02349295|78970692|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
44176776|NCT02349295|78970693|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
44176777|NCT02349295|78970694|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
44176778|NCT02349295|78970695|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176779|NCT02349295|78970696|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176780|NCT02349295|78970697|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176781|NCT02349295|78970698|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176782|NCT02349295|78970699|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176783|NCT02349295|78970700|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176784|NCT02349295|78970701|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176785|NCT02349295|78970702|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176786|NCT02349295|78970703|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176787|NCT02349295|78970704|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176788|NCT02349295|78970705|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
44176789|NCT02349295|78970692|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
44176790|NCT02349295|78970693|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
44176791|NCT02349295|78970694|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
44176792|NCT02349295|78970695|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176793|NCT02349295|78970696|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176794|NCT02349295|78970697|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176795|NCT02349295|78970698|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176796|NCT02349295|78970699|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176797|NCT02349295|78970700|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176798|NCT02349295|78970701|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176799|NCT02349295|78970702|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176800|NCT02349295|78970703|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176801|NCT02349295|78970704|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176802|NCT02349295|78970705|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
44176803|NCT02349295|78970692|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44264765|NCT01049360|79166461|FG018|Period 4|Protocol Violation|0|||
44264766|NCT01049360|79166462|FG019|Period 4|Protocol Violation|0|||
44176804|NCT02349295|78970693|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
44264767|NCT01049360|79166443|FG000|Period 4|Withdrawal by Subject|0|||
44264768|NCT01049360|79166444|FG001|Period 4|Withdrawal by Subject|0|||
44176805|NCT02349295|78970694|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
44176806|NCT02349295|78970695|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176807|NCT02349295|78970696|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176808|NCT02349295|78970697|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176809|NCT02349295|78970698|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176810|NCT02349295|78970699|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176811|NCT02349295|78970700|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176812|NCT02349295|78970701|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176813|NCT02349295|78970702|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176814|NCT02349295|78970703|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176815|NCT02349295|78970704|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176816|NCT02349295|78970705|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
44176817|NCT02349295|78970692|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
44176818|NCT02349295|78970693|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
44176819|NCT02349295|78970694|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
44176820|NCT02349295|78970695|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
44176821|NCT02349295|78970696|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
44176822|NCT02349295|78970697|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
44176823|NCT02349295|78970698|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
44176824|NCT02349295|78970699|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
44176825|NCT02349295|78970700|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
44176826|NCT02349295|78970701|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
44176827|NCT02349295|78970702|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
44176828|NCT02349295|78970703|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
44176829|NCT02349295|78970704|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
44176830|NCT02349295|78970705|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
44176831|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176832|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176833|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176834|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176835|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176836|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176837|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176838|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
44176839|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
44176840|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
44176841|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
44176842|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176843|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176844|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
44176845|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176846|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176847|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176848|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176849|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176850|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176851|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176852|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
44176853|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
44176854|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
44176855|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
44176856|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176857|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176858|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
44176859|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176860|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176861|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176862|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176863|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176864|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176865|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176866|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
44176867|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176868|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
44176869|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176870|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176871|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44264769|NCT01049360|79166445|FG002|Period 4|Withdrawal by Subject|0|||
44176872|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
44176873|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
44176874|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
44176875|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
44176876|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
44176877|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
44176878|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
44176879|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
44176880|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
44176881|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
44176882|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
44176883|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
44176884|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
44176885|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
44176886|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
44176887|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176888|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176889|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176890|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176891|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176892|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176893|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176894|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
44176895|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
44176896|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
44176897|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
44176898|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176899|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176900|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
44176901|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176902|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176903|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176904|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176905|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176906|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176907|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176908|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
44176909|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
44176910|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176911|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176912|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176913|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176914|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
44176915|NCT02349295|78970692|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176916|NCT02349295|78970693|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176917|NCT02349295|78970694|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176918|NCT02349295|78970695|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176919|NCT02349295|78970696|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176920|NCT02349295|78970697|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176921|NCT02349295|78970698|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176922|NCT02349295|78970699|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
44176923|NCT02349295|78970700|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
44176924|NCT02349295|78970701|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176925|NCT02349295|78970702|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176926|NCT02349295|78970703|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176927|NCT02349295|78970704|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176928|NCT02349295|78970705|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
44176929|NCT02349295|78970692|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44264770|NCT01049360|79166446|FG003|Period 4|Withdrawal by Subject|1|||
44264771|NCT01049360|79166447|FG004|Period 4|Withdrawal by Subject|0|||
44264772|NCT01049360|79166448|FG005|Period 4|Withdrawal by Subject|0|||
44264773|NCT01049360|79166449|FG006|Period 4|Withdrawal by Subject|0|||
44264774|NCT01049360|79166450|FG007|Period 4|Withdrawal by Subject|0|||
44176930|NCT02349295|78970693|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176931|NCT02349295|78970694|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176932|NCT02349295|78970695|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44264775|NCT01049360|79166451|FG008|Period 4|Withdrawal by Subject|0|||
44264776|NCT01049360|79166452|FG009|Period 4|Withdrawal by Subject|0|||
44264777|NCT01049360|79166453|FG010|Period 4|Withdrawal by Subject|0|||
44361171|NCT01188551|79366822|FG003|Overall Study|Pharmacy issues|0|||
44361172|NCT01161407|79366834|FG000|Overall Study|Protocol Violation|3|||
44264778|NCT01049360|79166454|FG011|Period 4|Withdrawal by Subject|0|||
44176933|NCT02349295|78970696|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176934|NCT02349295|78970697|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176935|NCT02349295|78970698|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176936|NCT02349295|78970699|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176937|NCT02349295|78970700|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176938|NCT02349295|78970701|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176939|NCT02349295|78970702|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
44176940|NCT02349295|78970703|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
44176941|NCT02349295|78970704|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
44176942|NCT02349295|78970705|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
44176943|NCT02349295|78970692|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176944|NCT02349295|78970693|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176945|NCT02349295|78970694|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176946|NCT02349295|78970695|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176947|NCT02349295|78970696|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176948|NCT02349295|78970697|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176949|NCT02349295|78970698|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176950|NCT02349295|78970699|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176951|NCT02349295|78970700|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176952|NCT02349295|78970701|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176953|NCT02349295|78970702|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176954|NCT02349295|78970703|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
44176955|NCT02349295|78970704|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
44176956|NCT02349295|78970705|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
44176957|NCT02349295|78970692|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176958|NCT02349295|78970693|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176959|NCT02349295|78970694|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176960|NCT02349295|78970695|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176961|NCT02349295|78970696|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176962|NCT02349295|78970697|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176963|NCT02349295|78970698|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176964|NCT02349295|78970699|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176965|NCT02349295|78970700|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176966|NCT02349295|78970701|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176967|NCT02349295|78970702|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176968|NCT02349295|78970703|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
44176969|NCT02349295|78970704|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
44176970|NCT02349295|78970705|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
44176971|NCT02349295|78970692|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176972|NCT02349295|78970693|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176973|NCT02349295|78970694|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176974|NCT02349295|78970695|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176975|NCT02349295|78970696|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176976|NCT02349295|78970697|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176977|NCT02349295|78970698|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176978|NCT02349295|78970699|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176979|NCT02349295|78970700|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176980|NCT02349295|78970701|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176981|NCT02349295|78970702|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176982|NCT02349295|78970703|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
44176983|NCT02349295|78970704|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176984|NCT02349295|78970705|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
44176985|NCT02349295|78970692|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176986|NCT02349295|78970693|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176987|NCT02349295|78970694|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176988|NCT02349295|78970695|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176989|NCT02349295|78970696|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176990|NCT02349295|78970697|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176991|NCT02349295|78970698|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176992|NCT02349295|78970699|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176993|NCT02349295|78970700|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44264779|NCT01049360|79166455|FG012|Period 4|Withdrawal by Subject|0|||
44176994|NCT02349295|78970701|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44264780|NCT01049360|79166456|FG013|Period 4|Withdrawal by Subject|0|||
44361173|NCT01161407|79366835|FG001|Overall Study|Protocol Violation|1|||
44361174|NCT01161173|79366841|FG000|Overall Study|Protocol Violation|13|||
44176995|NCT02349295|78970702|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176996|NCT02349295|78970703|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
44176997|NCT02349295|78970704|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176998|NCT02349295|78970705|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
44176999|NCT02281357|78970732|FG000|Overall Study|Adverse Event|2|||
44177000|NCT02281357|78970733|FG001|Overall Study|Adverse Event|1|||
44177001|NCT02281357|78970732|FG000|Overall Study|Lost to Follow-up|1|||
44177002|NCT02281357|78970733|FG001|Overall Study|Lost to Follow-up|0|||
44177003|NCT02281357|78970732|FG000|Overall Study|Withdrawal by Subject|4|||
44177004|NCT02281357|78970733|FG001|Overall Study|Withdrawal by Subject|3|||
44177005|NCT02284243|78970741|FG000|Overall Study|Lack of Efficacy|3|||
44177006|NCT02284243|78970742|FG001|Overall Study|Lack of Efficacy|3|||
44177007|NCT02284243|78970741|FG000|Overall Study|Adverse Event|1|||
44177008|NCT02284243|78970742|FG001|Overall Study|Adverse Event|0|||
44177009|NCT02284009|78970750|FG000|Overall Study|Adverse Event|3|||
44177010|NCT02284009|78970751|FG001|Overall Study|Adverse Event|0|||
44177011|NCT02284009|78970750|FG000|Overall Study|Lost to Follow-up|1|||
44177012|NCT02284009|78970751|FG001|Overall Study|Lost to Follow-up|3|||
44177013|NCT02284009|78970750|FG000|Overall Study|Physician Decision|0|||
44177014|NCT02284009|78970751|FG001|Overall Study|Physician Decision|2|||
44177015|NCT02284009|78970750|FG000|Overall Study|Withdrawal by Subject|2|||
44177016|NCT02284009|78970751|FG001|Overall Study|Withdrawal by Subject|5|||
44177017|NCT02280499|78970759|FG000|Overall Study|Death|14|||
44177018|NCT02280499|78970759|FG000|Overall Study|Lost to Follow-up|42|||
44177019|NCT02280499|78970759|FG000|Overall Study|Adverse Event|5|||
44177020|NCT02400476|78970769|FG000|Overall Study|Adverse Event|57|||
44177021|NCT02400476|78970770|FG001|Overall Study|Adverse Event|10|||
44177022|NCT02400476|78970771|FG002|Overall Study|Adverse Event|22|||
44177023|NCT02400476|78970772|FG003|Overall Study|Adverse Event|19|||
44177024|NCT02400476|78970773|FG004|Overall Study|Adverse Event|5|||
44177025|NCT02400476|78970774|FG005|Overall Study|Adverse Event|8|||
44177026|NCT02400476|78970769|FG000|Overall Study|Withdrawal by Subject|4|||
44177027|NCT02400476|78970770|FG001|Overall Study|Withdrawal by Subject|1|||
44177028|NCT02400476|78970771|FG002|Overall Study|Withdrawal by Subject|12|||
44177029|NCT02400476|78970772|FG003|Overall Study|Withdrawal by Subject|7|||
44177030|NCT02400476|78970773|FG004|Overall Study|Withdrawal by Subject|5|||
44177031|NCT02400476|78970774|FG005|Overall Study|Withdrawal by Subject|5|||
44177032|NCT02400476|78970769|FG000|Overall Study|Lost to Follow-up|0|||
44177033|NCT02400476|78970770|FG001|Overall Study|Lost to Follow-up|0|||
44177034|NCT02400476|78970771|FG002|Overall Study|Lost to Follow-up|0|||
44177035|NCT02400476|78970772|FG003|Overall Study|Lost to Follow-up|1|||
44177036|NCT02400476|78970773|FG004|Overall Study|Lost to Follow-up|3|||
44177037|NCT02400476|78970774|FG005|Overall Study|Lost to Follow-up|1|||
44177038|NCT02400476|78970769|FG000|Overall Study|Physician Decision|0|||
44177039|NCT02400476|78970770|FG001|Overall Study|Physician Decision|0|||
44177040|NCT02400476|78970771|FG002|Overall Study|Physician Decision|1|||
44177041|NCT02400476|78970772|FG003|Overall Study|Physician Decision|1|||
44177042|NCT02400476|78970773|FG004|Overall Study|Physician Decision|0|||
44177043|NCT02400476|78970774|FG005|Overall Study|Physician Decision|1|||
44177044|NCT02400476|78970769|FG000|Overall Study|Other, Disease Progression|0|||
44177045|NCT02400476|78970770|FG001|Overall Study|Other, Disease Progression|1|||
44177046|NCT02400476|78970771|FG002|Overall Study|Other, Disease Progression|2|||
44177047|NCT02400476|78970772|FG003|Overall Study|Other, Disease Progression|1|||
44177048|NCT02400476|78970773|FG004|Overall Study|Other, Disease Progression|2|||
44177049|NCT02400476|78970774|FG005|Overall Study|Other, Disease Progression|1|||
44177050|NCT02400476|78970769|FG000|Overall Study|Other, Decreased Quality of Life|0|||
44177051|NCT02400476|78970770|FG001|Overall Study|Other, Decreased Quality of Life|0|||
44177052|NCT02400476|78970771|FG002|Overall Study|Other, Decreased Quality of Life|2|||
44177053|NCT02400476|78970772|FG003|Overall Study|Other, Decreased Quality of Life|0|||
44177054|NCT02400476|78970773|FG004|Overall Study|Other, Decreased Quality of Life|0|||
44264781|NCT01049360|79166457|FG014|Period 4|Withdrawal by Subject|0|||
44264782|NCT01049360|79166458|FG015|Period 4|Withdrawal by Subject|0|||
44264783|NCT01049360|79166459|FG016|Period 4|Withdrawal by Subject|0|||
44361175|NCT01161173|79366841|FG000|Overall Study|Lost to Follow-up|7|||
44361176|NCT01161173|79366841|FG000|Overall Study|Progressive Disease|82|||
44177055|NCT02400476|78970774|FG005|Overall Study|Other, Decreased Quality of Life|0|||
44177056|NCT02400476|78970769|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
44177057|NCT02400476|78970770|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
44177058|NCT02400476|78970771|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
44177059|NCT02400476|78970772|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
44177060|NCT02400476|78970773|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
44177061|NCT02400476|78970774|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
44177062|NCT02363738|78970790|FG000|Overall Study|Adverse Event|5|||
44177063|NCT02363738|78970791|FG001|Overall Study|Adverse Event|2|||
44177064|NCT02363738|78970790|FG000|Overall Study|Lack of Efficacy|1|||
44264784|NCT01049360|79166460|FG017|Period 4|Withdrawal by Subject|0|||
44177065|NCT02363738|78970791|FG001|Overall Study|Lack of Efficacy|2|||
44177066|NCT02363738|78970790|FG000|Overall Study|Lost to Follow-up|2|||
44177067|NCT02363738|78970791|FG001|Overall Study|Lost to Follow-up|1|||
44177068|NCT02331680|78970800|FG000|Overall Study|Adverse Event|3|||
44177069|NCT02331680|78970801|FG001|Overall Study|Adverse Event|0|||
44177070|NCT02331680|78970802|FG002|Overall Study|Adverse Event|2|||
44177071|NCT02331680|78970800|FG000|Overall Study|Physician Decision|1|||
44177072|NCT02331680|78970801|FG001|Overall Study|Physician Decision|1|||
44177073|NCT02331680|78970802|FG002|Overall Study|Physician Decision|2|||
44177074|NCT02331680|78970800|FG000|Overall Study|Withdrawal by Subject|0|||
44177075|NCT02331680|78970801|FG001|Overall Study|Withdrawal by Subject|1|||
44177076|NCT02331680|78970802|FG002|Overall Study|Withdrawal by Subject|2|||
44177077|NCT02331680|78970800|FG000|Overall Study|Met withdrawal criteria|2|||
44177078|NCT02331680|78970801|FG001|Overall Study|Met withdrawal criteria|2|||
44177079|NCT02331680|78970802|FG002|Overall Study|Met withdrawal criteria|5|||
44177080|NCT02331680|78970800|FG000|Overall Study|Non-compliance with study drug|0|||
44177081|NCT02331680|78970801|FG001|Overall Study|Non-compliance with study drug|0|||
44177082|NCT02331680|78970802|FG002|Overall Study|Non-compliance with study drug|1|||
44177083|NCT02331680|78970800|FG000|Overall Study|Protocol Violation|0|||
44177084|NCT02331680|78970801|FG001|Overall Study|Protocol Violation|0|||
44177085|NCT02331680|78970802|FG002|Overall Study|Protocol Violation|3|||
44177086|NCT02331446|78970814|FG000|Overall Study|Lost to Follow-up|2|||
44177087|NCT02331446|78970815|FG001|Overall Study|Lost to Follow-up|1|||
44177088|NCT02331446|78970816|FG002|Overall Study|Lost to Follow-up|0|||
44177089|NCT02331446|78970817|FG003|Overall Study|Lost to Follow-up|1|||
44177090|NCT02331446|78970814|FG000|Overall Study|Personal Problem|2|||
44177091|NCT02331446|78970815|FG001|Overall Study|Personal Problem|0|||
44177092|NCT02331446|78970816|FG002|Overall Study|Personal Problem|0|||
44177093|NCT02331446|78970817|FG003|Overall Study|Personal Problem|0|||
44177094|NCT02331446|78970814|FG000|Overall Study|Disease|0|||
44177095|NCT02331446|78970815|FG001|Overall Study|Disease|2|||
44177096|NCT02331446|78970816|FG002|Overall Study|Disease|2|||
44177097|NCT02331446|78970817|FG003|Overall Study|Disease|1|||
44177098|NCT02331446|78970814|FG000|Overall Study|Physician Decision|0|||
44177099|NCT02331446|78970815|FG001|Overall Study|Physician Decision|1|||
44177100|NCT02331446|78970816|FG002|Overall Study|Physician Decision|0|||
44177101|NCT02331446|78970817|FG003|Overall Study|Physician Decision|1|||
44177102|NCT02331446|78970814|FG000|Overall Study|Lost before baseline analysis|0|||
44177103|NCT02331446|78970815|FG001|Overall Study|Lost before baseline analysis|1|||
44177104|NCT02331446|78970816|FG002|Overall Study|Lost before baseline analysis|1|||
44177105|NCT02331446|78970817|FG003|Overall Study|Lost before baseline analysis|0|||
44177106|NCT02349061|78970829|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
44177107|NCT02349061|78970830|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
44177108|NCT02349061|78970831|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
44177109|NCT02349061|78970829|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
44177110|NCT02349061|78970830|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
44177111|NCT02349061|78970831|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
44451144|NCT00539994|79460158|FG000|Overall Study|Physician Decision|0|||
44451145|NCT00539994|79460159|FG001|Overall Study|Physician Decision|0|||
44177112|NCT02349061|78970829|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
44177113|NCT02349061|78970830|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
44177114|NCT02349061|78970831|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
44177115|NCT02349061|78970829|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
44177116|NCT02349061|78970830|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
44177117|NCT02349061|78970831|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
44177118|NCT02349061|78970829|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
44177119|NCT02349061|78970830|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
44177120|NCT02349061|78970831|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
44177121|NCT02349061|78970829|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
44177122|NCT02349061|78970830|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
44177123|NCT02349061|78970831|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
44177124|NCT02349061|78970829|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
44451146|NCT00539994|79460160|FG002|Overall Study|Physician Decision|1|||
44177125|NCT02349061|78970830|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
44177126|NCT02349061|78970831|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
44177127|NCT02349061|78970829|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
44177128|NCT02349061|78970830|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
44177129|NCT02349061|78970831|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
44177130|NCT02349061|78970829|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
44177131|NCT02349061|78970830|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
44177132|NCT02349061|78970831|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
44177133|NCT02349061|78970829|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
44177134|NCT02349061|78970830|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
44177135|NCT02349061|78970831|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
44451147|NCT00098839|79460177|FG000|Overall Study|Adverse Event|5|||
44177136|NCT02349061|78970829|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
44177137|NCT02349061|78970830|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
44177138|NCT02349061|78970831|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
44177139|NCT02349061|78970829|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
44177140|NCT02349061|78970830|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
44177141|NCT02349061|78970831|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
44177142|NCT02349061|78970829|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
44177143|NCT02349061|78970830|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
44177144|NCT02349061|78970831|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
44177145|NCT02331368|78970841|FG000|Overall Study|Withdrawal by Subject|3|||
44177146|NCT02362724|78970847|FG000|Overall Study|Withdrawal by Subject|3|||
44177147|NCT02362724|78970848|FG001|Overall Study|Withdrawal by Subject|1|||
44177148|NCT02362724|78970847|FG000|Overall Study|Adverse Event|3|||
44177149|NCT02362724|78970848|FG001|Overall Study|Adverse Event|0|||
44177150|NCT02362646|78970856|FG000|Overall Study|Death|15|||
44177151|NCT02362646|78970857|FG001|Overall Study|Death|8|||
44177152|NCT02362646|78970856|FG000|Overall Study|Withdrawal by Subject|2|||
44177153|NCT02362646|78970857|FG001|Overall Study|Withdrawal by Subject|2|||
44177154|NCT02362646|78970856|FG000|Overall Study|received transplant|21|||
44177155|NCT02362646|78970857|FG001|Overall Study|received transplant|14|||
44177156|NCT02280421|78970867|FG000|Washout (2 Weeks)|Adverse Event|0|||
44177157|NCT02280421|78970868|FG001|Washout (2 Weeks)|Adverse Event|1|||
44177158|NCT02280421|78970867|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
44177159|NCT02280421|78970868|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
44177160|NCT02362412|78970886|FG000|Treatment Period III|Lost to Follow-up|0|||
44177161|NCT02362412|78970887|FG001|Treatment Period III|Lost to Follow-up|1|||
44177162|NCT02280187|78970899|FG000|Overall Study|Lost to Follow-up|218|||
44177163|NCT02347813|78970905|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
44177164|NCT02347813|78970906|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
44177165|NCT02347813|78970905|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
44177166|NCT02347813|78970906|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
44177167|NCT02329730|78970916|FG000|Overall Study|Protocol Violation|0|||
44177168|NCT02329730|78970917|FG001|Overall Study|Protocol Violation|0|||
44361177|NCT01161173|79366841|FG000|Overall Study|Withdrawal of Consent|5|||
44361178|NCT01161173|79366841|FG000|Overall Study|Unacceptable Toxicity|21|||
44361179|NCT01161173|79366841|FG000|Overall Study|Death|194|||
44177169|NCT02329730|78970918|FG002|Overall Study|Protocol Violation|0|||
44177170|NCT02329730|78970919|FG003|Overall Study|Protocol Violation|0|||
44177171|NCT02329730|78970920|FG004|Overall Study|Protocol Violation|2|||
44177172|NCT02329730|78970921|FG005|Overall Study|Protocol Violation|2|||
44177173|NCT02329730|78970922|FG006|Overall Study|Protocol Violation|0|||
44177174|NCT02329730|78970923|FG007|Overall Study|Protocol Violation|0|||
44177175|NCT02329730|78970924|FG008|Overall Study|Protocol Violation|0|||
44177176|NCT02329730|78970925|FG009|Overall Study|Protocol Violation|0|||
44177177|NCT02329730|78970926|FG010|Overall Study|Protocol Violation|0|||
44177178|NCT02329730|78970927|FG011|Overall Study|Protocol Violation|0|||
44177179|NCT02329730|78970916|FG000|Overall Study|Withdrawal by Subject|0|||
44177180|NCT02329730|78970917|FG001|Overall Study|Withdrawal by Subject|0|||
44177181|NCT02329730|78970918|FG002|Overall Study|Withdrawal by Subject|0|||
44177182|NCT02329730|78970919|FG003|Overall Study|Withdrawal by Subject|0|||
44177183|NCT02329730|78970920|FG004|Overall Study|Withdrawal by Subject|1|||
44177184|NCT02329730|78970921|FG005|Overall Study|Withdrawal by Subject|0|||
44264785|NCT01049360|79166461|FG018|Period 4|Withdrawal by Subject|0|||
44264786|NCT01049360|79166462|FG019|Period 4|Withdrawal by Subject|0|||
44264787|NCT02494596|79166474|FG000|Overall Study|Insufficient Therapeutic Response|3|||
44264788|NCT02494596|79166475|FG001|Overall Study|Insufficient Therapeutic Response|3|||
44264789|NCT02494596|79166476|FG002|Overall Study|Insufficient Therapeutic Response|1|||
44264790|NCT02494596|79166474|FG000|Overall Study|Adverse Event|0|||
44264791|NCT02494596|79166475|FG001|Overall Study|Adverse Event|1|||
44177185|NCT02329730|78970922|FG006|Overall Study|Withdrawal by Subject|1|||
44177186|NCT02329730|78970923|FG007|Overall Study|Withdrawal by Subject|1|||
44177187|NCT02329730|78970924|FG008|Overall Study|Withdrawal by Subject|1|||
44177188|NCT02329730|78970925|FG009|Overall Study|Withdrawal by Subject|1|||
44177189|NCT02329730|78970926|FG010|Overall Study|Withdrawal by Subject|0|||
44177190|NCT02329730|78970927|FG011|Overall Study|Withdrawal by Subject|0|||
44177191|NCT02328326|78970947|FG000|Overall Study|Withdrawal by Subject|10|||
44177192|NCT02328326|78970948|FG001|Overall Study|Withdrawal by Subject|3|||
44177193|NCT02328326|78970947|FG000|Overall Study|Death|2|||
44177194|NCT02328326|78970948|FG001|Overall Study|Death|1|||
44177195|NCT02328326|78970947|FG000|Overall Study|Lost to Follow-up|10|||
44177196|NCT02328326|78970948|FG001|Overall Study|Lost to Follow-up|4|||
44177197|NCT01649804|78970956|FG000|Overall Study|Administrative/Other|8|||
44177198|NCT02397278|78970962|FG000|Overall Study|Withdrawal by Subject|0|||
44177199|NCT02397278|78970963|FG001|Overall Study|Withdrawal by Subject|2|||
44177200|NCT02397278|78970962|FG000|Overall Study|Deemed ineligible following surgery|1|||
44177201|NCT02397278|78970963|FG001|Overall Study|Deemed ineligible following surgery|1|||
44177202|NCT02360228|78970972|FG000|Overall Study|Withdrawal by Subject|1|||
44177203|NCT02360228|78970973|FG001|Overall Study|Withdrawal by Subject|0|||
44177204|NCT02360228|78970974|FG002|Overall Study|Withdrawal by Subject|0|||
44177205|NCT02360228|78970972|FG000|Overall Study|Self-discontinued medication|0|||
44177206|NCT02360228|78970973|FG001|Overall Study|Self-discontinued medication|1|||
44177207|NCT02360228|78970974|FG002|Overall Study|Self-discontinued medication|0|||
44177208|NCT02360228|78970972|FG000|Overall Study|Unstable symptoms during screening|0|||
44177209|NCT02360228|78970973|FG001|Overall Study|Unstable symptoms during screening|0|||
44177210|NCT02360228|78970974|FG002|Overall Study|Unstable symptoms during screening|1|||
44177211|NCT02359994|78970984|FG000|Overall Population Study|Adverse Event|1|||
44177212|NCT02359994|78970985|FG001|Overall Population Study|Adverse Event|1|||
44177213|NCT02359994|78970984|FG000|Overall Population Study|Death|1|||
44264792|NCT02494596|79166476|FG002|Overall Study|Adverse Event|0|||
44264793|NCT02494596|79166474|FG000|Overall Study|Refused Treatment|0|||
44177214|NCT02359994|78970985|FG001|Overall Population Study|Death|5|||
44177215|NCT02359994|78970984|FG000|Overall Population Study|Lost to Follow-up|1|||
44177216|NCT02359994|78970985|FG001|Overall Population Study|Lost to Follow-up|1|||
44177217|NCT02359994|78970984|FG000|Overall Population Study|Withdrawal by Subject|1|||
44177218|NCT02359994|78970985|FG001|Overall Population Study|Withdrawal by Subject|0|||
44177219|NCT02359994|78970984|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
44177220|NCT02359994|78970985|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
44264794|NCT02494596|79166475|FG001|Overall Study|Refused Treatment|1|||
44264795|NCT02494596|79166476|FG002|Overall Study|Refused Treatment|0|||
44177221|NCT02359994|78970984|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
44177222|NCT02359994|78970985|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
44177223|NCT02359994|78970984|FG000|Extended Oncology 24-Month Survival|Death|19|||
44177224|NCT02359994|78970985|FG001|Extended Oncology 24-Month Survival|Death|21|||
44177225|NCT02359994|78970984|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
44177226|NCT02359994|78970985|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
44177227|NCT02326298|78970994|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177228|NCT02326298|78970995|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177229|NCT02326298|78970996|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
44177230|NCT02326298|78970997|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177231|NCT02326298|78970998|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177232|NCT02326298|78970999|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177233|NCT02326298|78971000|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177234|NCT02326298|78971001|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177235|NCT02326298|78971002|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177236|NCT02326298|78971003|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177237|NCT02326298|78971004|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177238|NCT02326298|78971005|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177239|NCT02326298|78971006|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177240|NCT02326298|78971007|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44177241|NCT02326298|78970994|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
44177242|NCT02326298|78970995|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177243|NCT02326298|78970996|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177244|NCT02326298|78970997|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177245|NCT02326298|78970998|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177246|NCT02326298|78970999|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177247|NCT02326298|78971000|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177248|NCT02326298|78971001|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177249|NCT02326298|78971002|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177250|NCT02326298|78971003|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177251|NCT02326298|78971004|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177252|NCT02326298|78971005|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177253|NCT02326298|78971006|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177254|NCT02326298|78971007|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
44177255|NCT02326298|78970994|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
44177256|NCT02326298|78970995|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
44177257|NCT02326298|78970996|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177258|NCT02326298|78970997|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177259|NCT02326298|78970998|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177260|NCT02326298|78970999|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177261|NCT02326298|78971000|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177262|NCT02326298|78971001|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177263|NCT02326298|78971002|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177264|NCT02326298|78971003|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177265|NCT02326298|78971004|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177266|NCT02326298|78971005|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177267|NCT02326298|78971006|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177268|NCT02326298|78971007|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44177269|NCT02326298|78970994|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
44177270|NCT02326298|78970995|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
44177271|NCT02326298|78970996|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177272|NCT02326298|78970997|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177273|NCT02326298|78970998|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177274|NCT02326298|78970999|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177275|NCT02326298|78971000|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44264796|NCT02494206|79166495|FG000|Overall Study|Adverse Event|1|||
44264797|NCT02494206|79166495|FG000|Overall Study|Disease Progression|1|||
44264798|NCT01048502|79166512|FG000|Overall Study|Lost to Follow-up|2|||
44451148|NCT00098839|79460178|FG001|Overall Study|Adverse Event|2|||
44451149|NCT00098839|79460177|FG000|Overall Study|Death|1|||
44177276|NCT02326298|78971001|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177277|NCT02326298|78971002|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177278|NCT02326298|78971003|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177279|NCT02326298|78971004|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177280|NCT02326298|78971005|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177281|NCT02326298|78971006|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44264799|NCT01048502|79166513|FG001|Overall Study|Lost to Follow-up|0|||
44177282|NCT02326298|78971007|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44177283|NCT02326298|78970994|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177284|NCT02326298|78970995|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177285|NCT02326298|78970996|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
44177286|NCT02326298|78970997|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177287|NCT02326298|78970998|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177288|NCT02326298|78970999|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177289|NCT02326298|78971000|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177290|NCT02326298|78971001|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177291|NCT02326298|78971002|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177292|NCT02326298|78971003|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177293|NCT02326298|78971004|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177294|NCT02326298|78971005|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177295|NCT02326298|78971006|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177296|NCT02326298|78971007|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
44177297|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177298|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177299|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177300|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177301|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177302|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44177303|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
44177304|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44177305|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44177306|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44177307|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177308|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177309|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177310|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44177311|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177312|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177313|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177314|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177315|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177316|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
44177317|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
44177318|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177319|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
44177320|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177321|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177322|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177323|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177324|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
44177325|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177326|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177327|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177328|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177329|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177330|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
44177331|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177332|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177333|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177334|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177335|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177336|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177337|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177338|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
44177339|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44264800|NCT01048502|79166514|FG002|Overall Study|Lost to Follow-up|0|||
44264801|NCT01048502|79166515|FG003|Overall Study|Lost to Follow-up|0|||
44264802|NCT01048502|79166512|FG000|Overall Study|Adverse Event|1|||
44264803|NCT01048502|79166513|FG001|Overall Study|Adverse Event|0|||
44264804|NCT01048502|79166514|FG002|Overall Study|Adverse Event|0|||
44264805|NCT01048502|79166515|FG003|Overall Study|Adverse Event|0|||
44264806|NCT01048502|79166512|FG000|Overall Study|Withdrawal by Subject|1|||
44264807|NCT01048502|79166513|FG001|Overall Study|Withdrawal by Subject|4|||
44264808|NCT01048502|79166514|FG002|Overall Study|Withdrawal by Subject|5|||
44264809|NCT01048502|79166515|FG003|Overall Study|Withdrawal by Subject|3|||
44264810|NCT01048502|79166512|FG000|Overall Study|Physician Decision|0|||
44264811|NCT01048502|79166513|FG001|Overall Study|Physician Decision|3|||
44264812|NCT01048502|79166514|FG002|Overall Study|Physician Decision|0|||
44264813|NCT01048502|79166515|FG003|Overall Study|Physician Decision|1|||
44264814|NCT02465034|79166528|FG000|Overall Study|Withdrawal by Subject|1|||
44264815|NCT02465034|79166529|FG001|Overall Study|Withdrawal by Subject|1|||
44264816|NCT02465034|79166528|FG000|Overall Study|Screen fail|2|||
44264817|NCT02465034|79166529|FG001|Overall Study|Screen fail|0|||
44264818|NCT02465034|79166528|FG000|Overall Study|Could not be scheduled for study visit|0|||
44264819|NCT02465034|79166529|FG001|Overall Study|Could not be scheduled for study visit|5|||
44264820|NCT02516982|79166556|FG000|Overall Study|Called in to antenatal appointment|32|||
44264821|NCT02516982|79166557|FG001|Overall Study|Called in to antenatal appointment|35|||
44264822|NCT02516982|79166558|FG002|Overall Study|Called in to antenatal appointment|0|||
44264823|NCT02516982|79166559|FG003|Overall Study|Called in to antenatal appointment|0|||
44264824|NCT02516982|79166556|FG000|Overall Study|Withdrawal by Subject|0|||
44264825|NCT02516982|79166557|FG001|Overall Study|Withdrawal by Subject|0|||
44264826|NCT02516982|79166558|FG002|Overall Study|Withdrawal by Subject|1|||
44264827|NCT02516982|79166559|FG003|Overall Study|Withdrawal by Subject|2|||
44264828|NCT02516982|79166556|FG000|Overall Study|Protocol Violation|0|||
44264829|NCT02516982|79166557|FG001|Overall Study|Protocol Violation|0|||
44264830|NCT02516982|79166558|FG002|Overall Study|Protocol Violation|1|||
44264831|NCT02516982|79166559|FG003|Overall Study|Protocol Violation|1|||
44264832|NCT02516982|79166556|FG000|Overall Study|Did not install the app|0|||
44264833|NCT02516982|79166557|FG001|Overall Study|Did not install the app|0|||
44264834|NCT02516982|79166558|FG002|Overall Study|Did not install the app|46|||
44264835|NCT02516982|79166559|FG003|Overall Study|Did not install the app|47|||
44264836|NCT02464410|79166604|FG000|Overall Study|Death|3|||
44264837|NCT02464410|79166605|FG001|Overall Study|Death|4|||
44264838|NCT02464410|79166604|FG000|Overall Study|Lost to Follow-up|7|||
44264839|NCT02464410|79166605|FG001|Overall Study|Lost to Follow-up|9|||
44264840|NCT02464410|79166604|FG000|Overall Study|Withdrawal by Subject|12|||
44264841|NCT02464410|79166605|FG001|Overall Study|Withdrawal by Subject|3|||
44264842|NCT01047332|79166613|FG000|Overall Study|SEMS Obstruction|11|||
44264843|NCT01047332|79166614|FG001|Overall Study|SEMS Obstruction|20|||
44264844|NCT01047332|79166613|FG000|Overall Study|Died Unobstructed|38|||
44264845|NCT01047332|79166614|FG001|Overall Study|Died Unobstructed|41|||
44264846|NCT01047332|79166613|FG000|Overall Study|Lost to Follow-up|8|||
44264847|NCT01047332|79166614|FG001|Overall Study|Lost to Follow-up|3|||
44264848|NCT01046396|79166620|FG000|Overall Study|Withdrawal by Subject|5|||
44264849|NCT01046084|79166646|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
44264850|NCT01046084|79166647|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
44264851|NCT01045694|79166666|FG000|Overall Study|Withdrawal by Subject|2|||
44264852|NCT01044290|79166726|FG000|Follow-up 1|Death|3|||
44264853|NCT01044290|79166727|FG001|Follow-up 1|Death|3|||
44264854|NCT01044290|79166728|FG002|Follow-up 1|Death|1|||
44264855|NCT01044290|79166726|FG000|Follow-up 1|Withdrawal by Subject|2|||
44264856|NCT01044290|79166727|FG001|Follow-up 1|Withdrawal by Subject|2|||
44264857|NCT01044290|79166728|FG002|Follow-up 1|Withdrawal by Subject|0|||
44264858|NCT01044290|79166726|FG000|Follow-Up 2|Death|0|||
44264859|NCT01044290|79166727|FG001|Follow-Up 2|Death|1|||
44264860|NCT01044290|79166728|FG002|Follow-Up 2|Death|1|||
44264861|NCT01044290|79166726|FG000|Follow-Up 2|Withdrawal by Subject|0|||
44264862|NCT01044290|79166727|FG001|Follow-Up 2|Withdrawal by Subject|1|||
44264863|NCT01044290|79166728|FG002|Follow-Up 2|Withdrawal by Subject|1|||
44264864|NCT01041638|79166809|FG000|Overall Study|Adverse Event|4|||
44264865|NCT01041638|79166809|FG000|Overall Study|Death|1|||
44264866|NCT01041638|79166809|FG000|Overall Study|Lack of Efficacy|7|||
44177340|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177341|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177342|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177343|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177344|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177345|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
44177346|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177347|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177348|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177349|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177350|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177351|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177352|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44177353|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177354|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177355|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177356|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177357|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177358|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177359|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177360|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
44177361|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177362|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177363|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177364|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44249601|NCT02649894|79083538|FG000|Overall Study|Other, not specified|6|||
44177365|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177366|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
44177367|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177368|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177369|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177370|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177371|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177372|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177373|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
44264867|NCT01041638|79166809|FG000|Overall Study|Physician Decision|4|||
44264868|NCT01041638|79166809|FG000|Overall Study|Withdrawal by Subject|11|||
44264869|NCT01045460|79166833|FG000|Overall Study|Physician Decision|3|||
44264870|NCT01045460|79166834|FG001|Overall Study|Physician Decision|2|||
44264871|NCT01045460|79166833|FG000|Overall Study|Lost to Follow-up|0|||
44264872|NCT01045460|79166834|FG001|Overall Study|Lost to Follow-up|1|||
44264873|NCT01045460|79166833|FG000|Overall Study|Lack of Efficacy|3|||
44264874|NCT01045460|79166834|FG001|Overall Study|Lack of Efficacy|0|||
44264875|NCT05014919|79166845|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
44264876|NCT05014919|79166846|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
44264877|NCT05014919|79166847|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
44264878|NCT05014919|79166845|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
44264879|NCT05014919|79166846|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
44177374|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
44177375|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177376|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177377|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177378|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177379|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177380|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44177381|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177382|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177383|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177384|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177385|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44264880|NCT05014919|79166847|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
44264881|NCT05014919|79166845|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
44264882|NCT05014919|79166846|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
44264883|NCT05014919|79166847|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
44264884|NCT05014919|79166845|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
44264885|NCT05014919|79166846|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
44264886|NCT05014919|79166847|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
44264887|NCT05014919|79166845|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
44264888|NCT05014919|79166846|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
44264889|NCT05014919|79166847|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
44264890|NCT05014919|79166845|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
44264891|NCT05014919|79166846|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
44264892|NCT05014919|79166847|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
44264893|NCT05014919|79166845|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
44264894|NCT05014919|79166846|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
44264895|NCT05014919|79166847|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
44264896|NCT05014919|79166845|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
44277762|NCT02138916|79238746|FG001|Overall Study|Withdrawal by Subject|31|||
44361180|NCT01161173|79366841|FG000|Overall Study|End of Study|2|||
44177386|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177387|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177388|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
44264897|NCT05014919|79166846|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
44177389|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177390|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177391|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177392|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177393|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177394|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44177395|NCT02326298|78970994|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177396|NCT02326298|78970995|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44264898|NCT05014919|79166847|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
44264899|NCT03409796|79166890|FG000|Overall Study|Adverse Event|2|||
44264900|NCT03409796|79166891|FG001|Overall Study|Adverse Event|0|||
44264901|NCT03409796|79166890|FG000|Overall Study|Other|0|||
44264902|NCT03409796|79166891|FG001|Overall Study|Other|1|||
44264903|NCT02462928|79166900|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
44264904|NCT02462928|79166901|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
44264905|NCT02462928|79166902|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
44264906|NCT02462928|79166900|FG000|Overall Study|Adverse Event|47|||
44264907|NCT02462928|79166901|FG001|Overall Study|Adverse Event|51|||
44264908|NCT02462928|79166902|FG002|Overall Study|Adverse Event|25|||
44264909|NCT02462928|79166900|FG000|Overall Study|Lack of Efficacy|3|||
44264910|NCT02462928|79166901|FG001|Overall Study|Lack of Efficacy|8|||
44264911|NCT02462928|79166902|FG002|Overall Study|Lack of Efficacy|3|||
44264912|NCT02462928|79166900|FG000|Overall Study|Lost to Follow-up|4|||
44177397|NCT02326298|78970996|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177398|NCT02326298|78970997|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177399|NCT02326298|78970998|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177400|NCT02326298|78970999|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
44177401|NCT02326298|78971000|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177402|NCT02326298|78971001|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177403|NCT02326298|78971002|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177404|NCT02326298|78971003|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177405|NCT02326298|78971004|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177406|NCT02326298|78971005|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177407|NCT02326298|78971006|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44264913|NCT02462928|79166901|FG001|Overall Study|Lost to Follow-up|4|||
44264914|NCT02462928|79166902|FG002|Overall Study|Lost to Follow-up|1|||
44264915|NCT02462928|79166900|FG000|Overall Study|Withdrawal by Patient|31|||
44264916|NCT02462928|79166901|FG001|Overall Study|Withdrawal by Patient|21|||
44264917|NCT02462928|79166902|FG002|Overall Study|Withdrawal by Patient|21|||
44264918|NCT02462928|79166900|FG000|Overall Study|Protocol Violation|0|||
44264919|NCT02462928|79166901|FG001|Overall Study|Protocol Violation|1|||
44264920|NCT02462928|79166902|FG002|Overall Study|Protocol Violation|0|||
44264921|NCT02462928|79166900|FG000|Overall Study|Reason not Specified|4|||
44264922|NCT02462928|79166901|FG001|Overall Study|Reason not Specified|6|||
44451150|NCT00098839|79460178|FG001|Overall Study|Death|2|||
44177408|NCT02326298|78971007|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
44177409|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
44177410|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
44177411|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
44177412|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
44177413|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
44177414|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
44177415|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
44177416|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
44177417|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
44177418|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
44177419|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
44177420|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
44177421|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
44264923|NCT02462928|79166902|FG002|Overall Study|Reason not Specified|5|||
44264924|NCT00019604|79166919|FG000|Overall Study|Death|1|||
44264925|NCT00019604|79166919|FG000|Overall Study|Progressive disease|23|||
44264926|NCT00019604|79166919|FG000|Overall Study|Refused treatment|1|||
44264927|NCT00019604|79166919|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
44177422|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
44177423|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177424|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177425|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177426|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177427|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177428|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177429|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177430|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177431|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177432|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177433|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177434|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
44177435|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
44177436|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44177437|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177438|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177439|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177440|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177441|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177442|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177443|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177444|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177445|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177446|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177447|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177448|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
44177449|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
44177450|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44177451|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177452|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177453|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177454|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177455|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177456|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177457|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177458|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177459|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177460|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177461|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177462|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177463|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44177464|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
44177465|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177466|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177467|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177468|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177469|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177470|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177471|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177472|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177473|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177474|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177475|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44177476|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
44177477|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
44177478|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
44177479|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177480|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177481|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44361181|NCT01161173|79366841|FG000|Overall Study|Reasons Not Specified|23|||
44361182|NCT01159769|79366845|FG000|Overall Study|Adverse Event|1|||
44451151|NCT00098839|79460177|FG000|Overall Study|Physician Decision|4|||
44451152|NCT00098839|79460178|FG001|Overall Study|Physician Decision|14|||
44264928|NCT00019604|79166919|FG000|Overall Study|Going to have liver transplant|1|||
44361183|NCT01159691|79366849|FG000|Overall Study|Lost to Follow-up|2|||
44177482|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177483|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177484|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177485|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177486|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177487|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177488|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177489|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44177490|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
44177491|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
44177492|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
44177493|NCT02326298|78970994|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177494|NCT02326298|78970995|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177495|NCT02326298|78970996|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177496|NCT02326298|78970997|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177497|NCT02326298|78970998|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177498|NCT02326298|78970999|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177499|NCT02326298|78971000|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177500|NCT02326298|78971001|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177501|NCT02326298|78971002|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177502|NCT02326298|78971003|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177503|NCT02326298|78971004|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44177504|NCT02326298|78971005|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
44177505|NCT02326298|78971006|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
44177506|NCT02326298|78971007|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
44177507|NCT02396420|78971016|FG000|Overall Study|Death|1|||
44177508|NCT02279719|78971028|FG000|Overall Study|Patients randomized but never treated|0|||
44177509|NCT02279719|78971029|FG001|Overall Study|Patients randomized but never treated|0|||
44177510|NCT02279719|78971030|FG002|Overall Study|Patients randomized but never treated|0|||
44177511|NCT02279719|78971031|FG003|Overall Study|Patients randomized but never treated|0|||
44177512|NCT02279719|78971032|FG004|Overall Study|Patients randomized but never treated|3|||
44177513|NCT02279719|78971033|FG005|Overall Study|Patients randomized but never treated|0|||
44177514|NCT02279719|78971034|FG006|Overall Study|Patients randomized but never treated|3|||
44177515|NCT02279407|78971071|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
44177516|NCT02279407|78971072|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
44177517|NCT02279407|78971073|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
44177518|NCT02279407|78971074|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
44177519|NCT02279407|78971071|FG000|Overall Study|Withdrawal by Subject|1|||
44177520|NCT02279407|78971072|FG001|Overall Study|Withdrawal by Subject|0|||
44177521|NCT02279407|78971073|FG002|Overall Study|Withdrawal by Subject|1|||
44177522|NCT02279407|78971074|FG003|Overall Study|Withdrawal by Subject|1|||
44177523|NCT02279407|78971071|FG000|Overall Study|Adverse Event|1|||
44177524|NCT02279407|78971072|FG001|Overall Study|Adverse Event|1|||
44177525|NCT02279407|78971073|FG002|Overall Study|Adverse Event|2|||
44177526|NCT02279407|78971074|FG003|Overall Study|Adverse Event|0|||
44177527|NCT02326220|78971086|FG000|Double-blind Treatment Period|Adverse Event|1|||
44177528|NCT02326220|78971087|FG001|Double-blind Treatment Period|Adverse Event|2|||
44177529|NCT02326220|78971088|FG002|Double-blind Treatment Period|Adverse Event|0|||
44177530|NCT02326220|78971086|FG000|Double-blind Treatment Period|Protocol Violation|0|||
44177531|NCT02326220|78971087|FG001|Double-blind Treatment Period|Protocol Violation|1|||
44177532|NCT02326220|78971088|FG002|Double-blind Treatment Period|Protocol Violation|0|||
44177533|NCT02326220|78971086|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
44177534|NCT02326220|78971087|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
44177535|NCT02326220|78971088|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44177536|NCT02326220|78971086|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
44177537|NCT02326220|78971087|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
44177538|NCT02326220|78971088|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
44177539|NCT02326220|78971086|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
44177540|NCT02326220|78971087|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
44177541|NCT02326220|78971088|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
44177542|NCT02279173|78971098|FG000|Overall Study|Protocol-specified Criteria|67|||
44177543|NCT02279173|78971098|FG000|Overall Study|Withdrawal by Subject|20|||
44177544|NCT02279173|78971098|FG000|Overall Study|Decision by Sponsor|4|||
44177545|NCT02279173|78971098|FG000|Overall Study|Lost to Follow-up|3|||
44177546|NCT02282917|78971104|FG000|Overall Study|Withdrawal by Subject|1|||
44177547|NCT02282917|78971104|FG000|Overall Study|Screen Failure/Not Eligible|1|||
44177548|NCT02358668|78971111|FG000|Overall Study|Adverse Event|2|||
44177549|NCT02358668|78971112|FG001|Overall Study|Adverse Event|0|||
44177550|NCT02358668|78971113|FG002|Overall Study|Adverse Event|0|||
44177551|NCT02358668|78971111|FG000|Overall Study|Withdrawal by Subject|0|||
44177552|NCT02358668|78971112|FG001|Overall Study|Withdrawal by Subject|1|||
44177553|NCT02358668|78971113|FG002|Overall Study|Withdrawal by Subject|0|||
44177554|NCT02282605|78971124|FG000|Overall Study|negative SA result on Day -1|3|||
44177555|NCT02282605|78971125|FG001|Overall Study|negative SA result on Day -1|0|||
44177556|NCT02282605|78971126|FG002|Overall Study|negative SA result on Day -1|0|||
44177557|NCT02282527|78971136|FG000|Overall Study|Lost to Follow-up|0|||
44177558|NCT02282527|78971137|FG001|Overall Study|Lost to Follow-up|1|||
44177559|NCT02282527|78971136|FG000|Overall Study|Lack of home health aid|1|||
44177560|NCT02282527|78971137|FG001|Overall Study|Lack of home health aid|0|||
44177561|NCT02278939|78971148|FG000|Overall Study|lack of time|1|||
44177562|NCT02278939|78971149|FG001|Overall Study|lack of time|0|||
44177563|NCT02278939|78971148|FG000|Overall Study|Lost to Follow-up|1|||
44177564|NCT02278939|78971149|FG001|Overall Study|Lost to Follow-up|1|||
44177565|NCT02278939|78971148|FG000|Overall Study|death in family|1|||
44177566|NCT02278939|78971149|FG001|Overall Study|death in family|0|||
44177567|NCT02278939|78971148|FG000|Overall Study|family emergency unable to commit|2|||
44177568|NCT02278939|78971149|FG001|Overall Study|family emergency unable to commit|0|||
44177569|NCT02278471|78971157|FG000|Overall Study|Lost to Follow-up|6|||
44177570|NCT02278471|78971158|FG001|Overall Study|Lost to Follow-up|15|||
44177571|NCT02278471|78971157|FG000|Overall Study|Death|2|||
44177572|NCT02278471|78971158|FG001|Overall Study|Death|2|||
44177573|NCT02278471|78971157|FG000|Overall Study|Withdrawal by Subject|0|||
44177574|NCT02278471|78971158|FG001|Overall Study|Withdrawal by Subject|3|||
44177575|NCT02278003|78971167|FG000|Overall Study|Withdrawal by Subject|11|||
44177576|NCT02278003|78971168|FG001|Overall Study|Withdrawal by Subject|0|||
44177577|NCT02278003|78971167|FG000|Overall Study|Not Treated|1|||
44177578|NCT02278003|78971168|FG001|Overall Study|Not Treated|0|||
44177579|NCT02278003|78971167|FG000|Overall Study|Recognition task improperly completed|7|||
44177580|NCT02278003|78971168|FG001|Overall Study|Recognition task improperly completed|0|||
44177581|NCT02277769|78971177|FG000|Overall Study|Protocol Violation|3|||
44177582|NCT02277769|78971178|FG001|Overall Study|Protocol Violation|3|||
44177583|NCT02277769|78971179|FG002|Overall Study|Protocol Violation|5|||
44177584|NCT02277769|78971177|FG000|Overall Study|Lack of Efficacy|17|||
44177585|NCT02277769|78971178|FG001|Overall Study|Lack of Efficacy|0|||
44177586|NCT02277769|78971179|FG002|Overall Study|Lack of Efficacy|4|||
44177587|NCT02277769|78971177|FG000|Overall Study|Adverse Event|14|||
44177588|NCT02277769|78971178|FG001|Overall Study|Adverse Event|2|||
44177589|NCT02277769|78971179|FG002|Overall Study|Adverse Event|4|||
44177590|NCT02277769|78971177|FG000|Overall Study|Other than specified above|12|||
44177591|NCT02277769|78971178|FG001|Overall Study|Other than specified above|8|||
44177592|NCT02277769|78971179|FG002|Overall Study|Other than specified above|5|||
44177593|NCT01641991|78971191|FG000|Overall Study|Physician Decision|0|||
44177594|NCT01641991|78971192|FG001|Overall Study|Physician Decision|1|||
44177595|NCT01641991|78971193|FG002|Overall Study|Physician Decision|7|||
44177596|NCT01641991|78971194|FG003|Overall Study|Physician Decision|5|||
44177597|NCT01641991|78971191|FG000|Overall Study|Withdrawal by Subject|4|||
44177598|NCT01641991|78971192|FG001|Overall Study|Withdrawal by Subject|2|||
44177599|NCT01641991|78971193|FG002|Overall Study|Withdrawal by Subject|1|||
44177600|NCT01641991|78971194|FG003|Overall Study|Withdrawal by Subject|5|||
44177601|NCT01641991|78971191|FG000|Overall Study|Adverse Event|2|||
44177602|NCT01641991|78971192|FG001|Overall Study|Adverse Event|1|||
44177603|NCT01641991|78971193|FG002|Overall Study|Adverse Event|2|||
44177604|NCT01641991|78971194|FG003|Overall Study|Adverse Event|1|||
44177605|NCT01641991|78971191|FG000|Overall Study|Lost to Follow-up|0|||
44177606|NCT01641991|78971192|FG001|Overall Study|Lost to Follow-up|2|||
44177607|NCT01641991|78971193|FG002|Overall Study|Lost to Follow-up|3|||
44177608|NCT01641991|78971194|FG003|Overall Study|Lost to Follow-up|1|||
44177609|NCT01641991|78971191|FG000|Overall Study|Protocol Violation|1|||
44177610|NCT01641991|78971192|FG001|Overall Study|Protocol Violation|1|||
44177611|NCT01641991|78971193|FG002|Overall Study|Protocol Violation|3|||
44177612|NCT01641991|78971194|FG003|Overall Study|Protocol Violation|0|||
44177613|NCT01641991|78971191|FG000|Overall Study|Pregnancy|0|||
44264929|NCT00019604|79166919|FG000|Overall Study|Move to a different study|1|||
44264930|NCT00019604|79166919|FG000|Overall Study|Non compliant on systemic CH|1|||
44177614|NCT01641991|78971192|FG001|Overall Study|Pregnancy|0|||
44177615|NCT01641991|78971193|FG002|Overall Study|Pregnancy|1|||
44177616|NCT01641991|78971194|FG003|Overall Study|Pregnancy|0|||
44177617|NCT01641991|78971191|FG000|Overall Study|no longer eligible|2|||
44177618|NCT01641991|78971192|FG001|Overall Study|no longer eligible|1|||
44177619|NCT01641991|78971193|FG002|Overall Study|no longer eligible|0|||
44177620|NCT01641991|78971194|FG003|Overall Study|no longer eligible|4|||
44177621|NCT02277691|78971207|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
44264931|NCT00019604|79166919|FG000|Overall Study|Non compliant|1|||
44177622|NCT02277691|78971207|FG000|Overall Study|Voluntary Withdrawal|7|||
44177623|NCT02277691|78971207|FG000|Overall Study|Lack of Efficacy|5|||
44177624|NCT02277691|78971207|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
44177625|NCT02395172|78971213|FG000|Overall Study|Participants randomized but not treated|3|||
44177626|NCT02395172|78971214|FG001|Overall Study|Participants randomized but not treated|31|||
44177627|NCT02276053|78971220|FG000|Overall Study|Death|2|||
44177628|NCT02276053|78971220|FG000|Overall Study|Adverse Event|5|||
44177629|NCT02276053|78971220|FG000|Overall Study|Lack of Efficacy|2|||
44177630|NCT02276053|78971220|FG000|Overall Study|Withdrawal by Subject|1|||
44177631|NCT02276053|78971220|FG000|Overall Study|Patient does not meet selection criteria|3|||
44177632|NCT02276053|78971220|FG000|Overall Study|Patient needs to increase baseline AED|1|||
44177633|NCT02275819|78971227|FG000|Overall Study|Adverse Event|0|||
44177634|NCT02275819|78971228|FG001|Overall Study|Adverse Event|1|||
44177635|NCT02358044|78971236|FG000|Overall Study|Adverse Event|0|||
44177636|NCT02358044|78971237|FG001|Overall Study|Adverse Event|1|||
44177637|NCT02358044|78971236|FG000|Overall Study|Lost to Follow-up|2|||
44177638|NCT02358044|78971237|FG001|Overall Study|Lost to Follow-up|1|||
44177639|NCT02358044|78971236|FG000|Overall Study|Physician Decision|0|||
44177640|NCT02358044|78971237|FG001|Overall Study|Physician Decision|1|||
44177641|NCT02358044|78971236|FG000|Overall Study|Withdrawal by Subject|0|||
44177642|NCT02358044|78971237|FG001|Overall Study|Withdrawal by Subject|4|||
44177643|NCT02275117|78971248|FG000|Overall Study|Adverse Event|0|||
44177644|NCT02275117|78971249|FG001|Overall Study|Adverse Event|0|||
44177645|NCT02275117|78971250|FG002|Overall Study|Adverse Event|0|||
44177646|NCT02275117|78971251|FG003|Overall Study|Adverse Event|0|||
44177647|NCT02275117|78971252|FG004|Overall Study|Adverse Event|1|||
44177648|NCT02275117|78971248|FG000|Overall Study|Lack of Efficacy|6|||
44177649|NCT02275117|78971249|FG001|Overall Study|Lack of Efficacy|7|||
44177650|NCT02275117|78971250|FG002|Overall Study|Lack of Efficacy|5|||
44177651|NCT02275117|78971251|FG003|Overall Study|Lack of Efficacy|2|||
44177652|NCT02275117|78971252|FG004|Overall Study|Lack of Efficacy|10|||
44177653|NCT02275117|78971248|FG000|Overall Study|Lost to Follow-up|11|||
44177654|NCT02275117|78971249|FG001|Overall Study|Lost to Follow-up|16|||
44177655|NCT02275117|78971250|FG002|Overall Study|Lost to Follow-up|15|||
44177656|NCT02275117|78971251|FG003|Overall Study|Lost to Follow-up|16|||
44177657|NCT02275117|78971252|FG004|Overall Study|Lost to Follow-up|8|||
44177658|NCT02275117|78971248|FG000|Overall Study|Physician Decision|0|||
44177659|NCT02275117|78971249|FG001|Overall Study|Physician Decision|1|||
44177660|NCT02275117|78971250|FG002|Overall Study|Physician Decision|1|||
44177661|NCT02275117|78971251|FG003|Overall Study|Physician Decision|0|||
44177662|NCT02275117|78971252|FG004|Overall Study|Physician Decision|1|||
44177663|NCT02275117|78971248|FG000|Overall Study|Protocol Violation|1|||
44177664|NCT02275117|78971249|FG001|Overall Study|Protocol Violation|0|||
44177665|NCT02275117|78971250|FG002|Overall Study|Protocol Violation|1|||
44177666|NCT02275117|78971251|FG003|Overall Study|Protocol Violation|1|||
44177667|NCT02275117|78971252|FG004|Overall Study|Protocol Violation|0|||
44177668|NCT02275117|78971248|FG000|Overall Study|Withdrawal by Subject|6|||
44177669|NCT02275117|78971249|FG001|Overall Study|Withdrawal by Subject|4|||
44177670|NCT02275117|78971250|FG002|Overall Study|Withdrawal by Subject|7|||
44177671|NCT02275117|78971251|FG003|Overall Study|Withdrawal by Subject|3|||
44177672|NCT02275117|78971252|FG004|Overall Study|Withdrawal by Subject|3|||
44177673|NCT02275117|78971248|FG000|Overall Study|Terminated by Sponsor|4|||
44177674|NCT02275117|78971249|FG001|Overall Study|Terminated by Sponsor|4|||
44177675|NCT02275117|78971250|FG002|Overall Study|Terminated by Sponsor|4|||
44177676|NCT02275117|78971251|FG003|Overall Study|Terminated by Sponsor|6|||
44177677|NCT02275117|78971252|FG004|Overall Study|Terminated by Sponsor|4|||
44177678|NCT02275117|78971248|FG000|Overall Study|Worsening of Study Indication|0|||
44177679|NCT02275117|78971249|FG001|Overall Study|Worsening of Study Indication|1|||
44177680|NCT02275117|78971250|FG002|Overall Study|Worsening of Study Indication|2|||
44177681|NCT02275117|78971251|FG003|Overall Study|Worsening of Study Indication|0|||
44177682|NCT02275117|78971252|FG004|Overall Study|Worsening of Study Indication|0|||
44177683|NCT02275117|78971248|FG000|Overall Study|Study Burden|5|||
44177684|NCT02275117|78971249|FG001|Overall Study|Study Burden|4|||
44177685|NCT02275117|78971250|FG002|Overall Study|Study Burden|7|||
44264932|NCT00019604|79166919|FG000|Overall Study|Resectable disease|1|||
44264933|NCT00019604|79166919|FG000|Overall Study|Started new chemo regimen|1|||
44264934|NCT00019604|79166919|FG000|Overall Study|Pt going to immunotherapy study|1|||
44264935|NCT00019604|79166919|FG000|Overall Study|Too much disease|1|||
44264936|NCT00019604|79166919|FG000|Overall Study|Unable to evaluate|1|||
44177686|NCT02275117|78971251|FG003|Overall Study|Study Burden|5|||
44177687|NCT02275117|78971252|FG004|Overall Study|Study Burden|7|||
44177688|NCT02275117|78971248|FG000|Overall Study|Other|1|||
44177689|NCT02275117|78971249|FG001|Overall Study|Other|0|||
44177690|NCT02275117|78971250|FG002|Overall Study|Other|0|||
44177691|NCT02275117|78971251|FG003|Overall Study|Other|0|||
44177692|NCT02275117|78971252|FG004|Overall Study|Other|2|||
44177693|NCT02274493|78971264|FG000|Overall Study|Withdrawal by Subject|1|||
44177694|NCT02273167|78971271|FG000|Overall Study|Adverse Event|1|||
44177695|NCT02273167|78971272|FG001|Overall Study|Adverse Event|0|||
44177696|NCT02273167|78971273|FG002|Overall Study|Adverse Event|0|||
44177697|NCT02273167|78971271|FG000|Overall Study|Protocol Violation|3|||
44177698|NCT02273167|78971272|FG001|Overall Study|Protocol Violation|1|||
44177699|NCT02273167|78971273|FG002|Overall Study|Protocol Violation|1|||
44177700|NCT02273167|78971271|FG000|Overall Study|Lost to Follow-up|0|||
44177701|NCT02273167|78971272|FG001|Overall Study|Lost to Follow-up|1|||
44177702|NCT02273167|78971273|FG002|Overall Study|Lost to Follow-up|1|||
44177703|NCT02273167|78971271|FG000|Overall Study|Withdrawal by Subject|10|||
44177704|NCT02273167|78971272|FG001|Overall Study|Withdrawal by Subject|12|||
44177705|NCT02273167|78971273|FG002|Overall Study|Withdrawal by Subject|11|||
44177706|NCT02273167|78971271|FG000|Overall Study|Various|10|||
44177707|NCT02273167|78971272|FG001|Overall Study|Various|9|||
44177708|NCT02273167|78971273|FG002|Overall Study|Various|8|||
44177709|NCT02272777|78971284|FG000|Overall Study|Adverse Event|0|||
44177710|NCT02272777|78971285|FG001|Overall Study|Adverse Event|1|||
44177711|NCT02272777|78971284|FG000|Overall Study|Withdrawal by Subject|0|||
44177712|NCT02272777|78971285|FG001|Overall Study|Withdrawal by Subject|3|||
44177713|NCT02272777|78971284|FG000|Overall Study|Lost to Follow-up|2|||
44177714|NCT02272777|78971285|FG001|Overall Study|Lost to Follow-up|0|||
44177715|NCT02272777|78971284|FG000|Overall Study|Other|2|||
44177716|NCT02272777|78971285|FG001|Overall Study|Other|0|||
44177717|NCT02357810|78971291|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
44177718|NCT02357810|78971291|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
44177719|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Adverse Event|5|||
44177720|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
44177721|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
44177722|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
44177723|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Death|1|||
44177724|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Physician Decision|1|||
44177725|NCT02357810|78971291|FG000|Reached 12 Weeks Response|Other|1|||
44177726|NCT02357810|78971291|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
44177727|NCT02357810|78971291|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
44177728|NCT02357810|78971291|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
44177729|NCT02357810|78971291|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
44177730|NCT02357810|78971291|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
44177731|NCT02357810|78971291|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
44177732|NCT02357576|78971297|FG000|Treatment Period|Withdrawal by Subject|0|||
44177733|NCT02357576|78971298|FG001|Treatment Period|Withdrawal by Subject|1|||
44177734|NCT02357576|78971297|FG000|Treatment Period|Physician Decision|0|||
44177735|NCT02357576|78971298|FG001|Treatment Period|Physician Decision|1|||
44177736|NCT02357576|78971297|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
44177737|NCT02357576|78971298|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
44177738|NCT02357576|78971297|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
44177739|NCT02357576|78971298|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
44177740|NCT02357576|78971297|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
44177741|NCT02357576|78971298|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
44177742|NCT02357576|78971297|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
44177743|NCT02357576|78971298|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
44177744|NCT01850446|78971306|FG000|Overall Study|Lack of Efficacy|1|||
44177745|NCT01850446|78971307|FG001|Overall Study|Lack of Efficacy|0|||
44177746|NCT01850446|78971306|FG000|Overall Study|Withdrawal by Subject|4|||
44177747|NCT01850446|78971307|FG001|Overall Study|Withdrawal by Subject|0|||
44177748|NCT01850446|78971306|FG000|Overall Study|Protocol Violation|0|||
44177749|NCT01850446|78971307|FG001|Overall Study|Protocol Violation|2|||
44177750|NCT02465567|78971317|FG000|Overall Study|Adverse Event|118|||
44177751|NCT02465567|78971318|FG001|Overall Study|Adverse Event|113|||
44177752|NCT02465567|78971319|FG002|Overall Study|Adverse Event|147|||
44177753|NCT02465567|78971320|FG003|Overall Study|Adverse Event|138|||
44177754|NCT02465567|78971317|FG000|Overall Study|Lack of Efficacy|103|||
44177755|NCT02465567|78971318|FG001|Overall Study|Lack of Efficacy|102|||
44177756|NCT02465567|78971319|FG002|Overall Study|Lack of Efficacy|171|||
44177757|NCT02465567|78971320|FG003|Overall Study|Lack of Efficacy|135|||
44177758|NCT02465567|78971317|FG000|Overall Study|Withdrawal by Subject|104|||
44177759|NCT02465567|78971318|FG001|Overall Study|Withdrawal by Subject|94|||
44177760|NCT02465567|78971319|FG002|Overall Study|Withdrawal by Subject|123|||
44177761|NCT02465567|78971320|FG003|Overall Study|Withdrawal by Subject|130|||
44177762|NCT02465567|78971317|FG000|Overall Study|Physician Decision|23|||
44177763|NCT02465567|78971318|FG001|Overall Study|Physician Decision|33|||
44177764|NCT02465567|78971319|FG002|Overall Study|Physician Decision|38|||
44177765|NCT02465567|78971320|FG003|Overall Study|Physician Decision|28|||
44177766|NCT02465567|78971317|FG000|Overall Study|Major Protocol Deviation|24|||
44177767|NCT02465567|78971318|FG001|Overall Study|Major Protocol Deviation|26|||
44177768|NCT02465567|78971319|FG002|Overall Study|Major Protocol Deviation|22|||
44177769|NCT02465567|78971320|FG003|Overall Study|Major Protocol Deviation|25|||
44177770|NCT02465567|78971317|FG000|Overall Study|Lost to Follow-up|25|||
44177771|NCT02465567|78971318|FG001|Overall Study|Lost to Follow-up|21|||
44177772|NCT02465567|78971319|FG002|Overall Study|Lost to Follow-up|19|||
44177773|NCT02465567|78971320|FG003|Overall Study|Lost to Follow-up|15|||
44177774|NCT02465567|78971317|FG000|Overall Study|Protocol Specified Criteria|20|||
44177775|NCT02465567|78971318|FG001|Overall Study|Protocol Specified Criteria|10|||
44177776|NCT02465567|78971319|FG002|Overall Study|Protocol Specified Criteria|9|||
44177777|NCT02465567|78971320|FG003|Overall Study|Protocol Specified Criteria|12|||
44177778|NCT02465567|78971317|FG000|Overall Study|Administrative Reasons|12|||
44177779|NCT02465567|78971318|FG001|Overall Study|Administrative Reasons|9|||
44177780|NCT02465567|78971319|FG002|Overall Study|Administrative Reasons|11|||
44177781|NCT02465567|78971320|FG003|Overall Study|Administrative Reasons|5|||
44177782|NCT02465567|78971317|FG000|Overall Study|Randomized but not treated|1|||
44177783|NCT02465567|78971318|FG001|Overall Study|Randomized but not treated|5|||
44177784|NCT02465567|78971319|FG002|Overall Study|Randomized but not treated|4|||
44177785|NCT02465567|78971320|FG003|Overall Study|Randomized but not treated|5|||
44177786|NCT02465567|78971317|FG000|Overall Study|enrolled in >1 studies|18|||
44177787|NCT02465567|78971318|FG001|Overall Study|enrolled in >1 studies|11|||
44177788|NCT02465567|78971319|FG002|Overall Study|enrolled in >1 studies|19|||
44177789|NCT02465567|78971320|FG003|Overall Study|enrolled in >1 studies|15|||
44177790|NCT02465567|78971317|FG000|Overall Study|missing PI Signature|1|||
44177791|NCT02465567|78971318|FG001|Overall Study|missing PI Signature|0|||
44177792|NCT02465567|78971319|FG002|Overall Study|missing PI Signature|0|||
44177793|NCT02465567|78971320|FG003|Overall Study|missing PI Signature|0|||
44177794|NCT01644175|78971332|FG000|Overall Study|Randomized But Not Treated|0|||
44177795|NCT01644175|78971333|FG001|Overall Study|Randomized But Not Treated|2|||
44177796|NCT01644175|78971332|FG000|Overall Study|Adverse Event|8|||
44177797|NCT01644175|78971333|FG001|Overall Study|Adverse Event|13|||
44177798|NCT01644175|78971332|FG000|Overall Study|Death|1|||
44177799|NCT01644175|78971333|FG001|Overall Study|Death|2|||
44361184|NCT01159691|79366849|FG000|Overall Study|Unknown reasons|1|||
44264937|NCT00019604|79166919|FG000|Overall Study|Details for other not available|4|||
44361185|NCT01159691|79366849|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
44177800|NCT01644175|78971332|FG000|Overall Study|Poor compliance to protocol|9|||
44177801|NCT01644175|78971333|FG001|Overall Study|Poor compliance to protocol|10|||
44177802|NCT01644175|78971332|FG000|Overall Study|Physician Decision|1|||
44177803|NCT01644175|78971333|FG001|Overall Study|Physician Decision|2|||
44177804|NCT01644175|78971332|FG000|Overall Study|Participant Moved|1|||
44177805|NCT01644175|78971333|FG001|Overall Study|Participant Moved|2|||
44177806|NCT01644175|78971332|FG000|Overall Study|Consent withdrawn by participant|3|||
44177807|NCT01644175|78971333|FG001|Overall Study|Consent withdrawn by participant|4|||
44177808|NCT01644175|78971332|FG000|Overall Study|Related to Autoinjector Administration|2|||
44177809|NCT01644175|78971333|FG001|Overall Study|Related to Autoinjector Administration|1|||
44177810|NCT01644175|78971332|FG000|Overall Study|Last visit outside protocol visit window|4|||
44177811|NCT01644175|78971333|FG001|Overall Study|Last visit outside protocol visit window|11|||
44177812|NCT01644175|78971332|FG000|Overall Study|Selection criteria finally not met|0|||
44177813|NCT01644175|78971333|FG001|Overall Study|Selection criteria finally not met|1|||
44177814|NCT01644175|78971332|FG000|Overall Study|Site closure|2|||
44177815|NCT01644175|78971333|FG001|Overall Study|Site closure|2|||
44177816|NCT01644175|78971332|FG000|Overall Study|Lost to Follow-up|1|||
44177817|NCT01644175|78971333|FG001|Overall Study|Lost to Follow-up|0|||
44177818|NCT01644175|78971332|FG000|Overall Study|Other than specified above|0|||
44177819|NCT01644175|78971333|FG001|Overall Study|Other than specified above|3|||
44177820|NCT02357420|78971343|FG000|Overall Study|Adverse Event|3|||
44177821|NCT02357420|78971344|FG001|Overall Study|Adverse Event|3|||
44177822|NCT02357420|78971345|FG002|Overall Study|Adverse Event|8|||
44177823|NCT02357420|78971346|FG003|Overall Study|Adverse Event|9|||
44177824|NCT02357420|78971343|FG000|Overall Study|Investigator Decision|1|||
44177825|NCT02357420|78971344|FG001|Overall Study|Investigator Decision|0|||
44177826|NCT02357420|78971345|FG002|Overall Study|Investigator Decision|0|||
44177827|NCT02357420|78971346|FG003|Overall Study|Investigator Decision|0|||
44177828|NCT02357420|78971343|FG000|Overall Study|Prohibited Medication|1|||
44177829|NCT02357420|78971344|FG001|Overall Study|Prohibited Medication|1|||
44177830|NCT02357420|78971345|FG002|Overall Study|Prohibited Medication|0|||
44177831|NCT02357420|78971346|FG003|Overall Study|Prohibited Medication|0|||
44177832|NCT02357420|78971343|FG000|Overall Study|Protocol Non-compliance|0|||
44177833|NCT02357420|78971344|FG001|Overall Study|Protocol Non-compliance|0|||
44177834|NCT02357420|78971345|FG002|Overall Study|Protocol Non-compliance|0|||
44177835|NCT02357420|78971346|FG003|Overall Study|Protocol Non-compliance|1|||
44177836|NCT02357420|78971343|FG000|Overall Study|Withdrawn Consent|4|||
44177837|NCT02357420|78971344|FG001|Overall Study|Withdrawn Consent|8|||
44177838|NCT02357420|78971345|FG002|Overall Study|Withdrawn Consent|6|||
44177839|NCT02357420|78971346|FG003|Overall Study|Withdrawn Consent|6|||
44177840|NCT02357420|78971343|FG000|Overall Study|Lost to Follow-up|3|||
44177841|NCT02357420|78971344|FG001|Overall Study|Lost to Follow-up|0|||
44177842|NCT02357420|78971345|FG002|Overall Study|Lost to Follow-up|2|||
44177843|NCT02357420|78971346|FG003|Overall Study|Lost to Follow-up|3|||
44177844|NCT01832038|78971356|FG000|Overall Study|Death|5|||
44177845|NCT01832038|78971356|FG000|Overall Study|Adverse Event|50|||
44177846|NCT01832038|78971356|FG000|Overall Study|Lack of Efficacy|81|||
44177847|NCT01832038|78971356|FG000|Overall Study|Protocol Violation|7|||
44177848|NCT01832038|78971356|FG000|Overall Study|Lost to Follow-up|10|||
44177849|NCT01832038|78971356|FG000|Overall Study|Withdrawal by Subject|49|||
44177850|NCT01832038|78971356|FG000|Overall Study|Visit non-compliance|2|||
44177851|NCT01832038|78971356|FG000|Overall Study|Subject refused to return visit|2|||
44177852|NCT01832038|78971356|FG000|Overall Study|Not convenient to come back to site|2|||
44177853|NCT01832038|78971356|FG000|Overall Study|Participant was asked to quit|5|||
44177854|NCT01832038|78971356|FG000|Overall Study|Back home|1|||
44177855|NCT01832038|78971356|FG000|Overall Study|Pregnancy|1|||
44177856|NCT01832038|78971356|FG000|Overall Study|Low compliance|3|||
44177857|NCT01832038|78971356|FG000|Overall Study|Prohibit procedure|2|||
44177858|NCT01832038|78971356|FG000|Overall Study|Not possible to visit the hospital|1|||
44177859|NCT01832038|78971356|FG000|Overall Study|Changes of implementation system|3|||
44177860|NCT01832038|78971356|FG000|Overall Study|Plan to pregnancy|7|||
44177861|NCT01832038|78971356|FG000|Overall Study|Bad mood and has suicidal thought|1|||
44177862|NCT01832038|78971356|FG000|Overall Study|Prohibited concomitant medication|1|||
44177863|NCT01832038|78971356|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
44177864|NCT01832038|78971356|FG000|Overall Study|Subject considered the efficacy was poor|1|||
44177865|NCT01849588|78971361|FG000|Overall Study|Lack of Efficacy|3|||
44177866|NCT02357342|78971367|FG000|First 6 Months|Death|2|||
44177867|NCT02357342|78971368|FG001|First 6 Months|Death|0|||
44177868|NCT02271529|78971374|FG000|Overall Study|Withdrawal by Subject|1|||
44177869|NCT02325518|78971380|FG000|Overall Study|Adverse Event|4|||
44177870|NCT02325518|78971381|FG001|Overall Study|Adverse Event|1|||
44177871|NCT02325518|78971380|FG000|Overall Study|Physician Decision|0|||
44177872|NCT02325518|78971381|FG001|Overall Study|Physician Decision|1|||
44177873|NCT02325518|78971380|FG000|Overall Study|Withdrawal by Subject|0|||
44177874|NCT02325518|78971381|FG001|Overall Study|Withdrawal by Subject|1|||
44177875|NCT02270983|78971391|FG000|Overall Study|Adverse Event|3|||
44177876|NCT02270983|78971392|FG001|Overall Study|Adverse Event|2|||
44177877|NCT02270983|78971393|FG002|Overall Study|Adverse Event|6|||
44177878|NCT02270983|78971391|FG000|Overall Study|Lack of Efficacy|2|||
44177879|NCT02270983|78971392|FG001|Overall Study|Lack of Efficacy|1|||
44177880|NCT02270983|78971393|FG002|Overall Study|Lack of Efficacy|1|||
44177881|NCT02270983|78971391|FG000|Overall Study|Withdrawal by Subject|1|||
44177882|NCT02270983|78971392|FG001|Overall Study|Withdrawal by Subject|0|||
44177883|NCT02270983|78971393|FG002|Overall Study|Withdrawal by Subject|2|||
44177884|NCT02270983|78971391|FG000|Overall Study|Lost to Follow-up|1|||
44177885|NCT02270983|78971392|FG001|Overall Study|Lost to Follow-up|1|||
44177886|NCT02270983|78971393|FG002|Overall Study|Lost to Follow-up|2|||
44177887|NCT02270983|78971391|FG000|Overall Study|Protocol Violation|1|||
44177888|NCT02270983|78971392|FG001|Overall Study|Protocol Violation|1|||
44177889|NCT02270983|78971393|FG002|Overall Study|Protocol Violation|1|||
44177890|NCT02270983|78971391|FG000|Overall Study|family emergency|0|||
44177891|NCT02270983|78971392|FG001|Overall Study|family emergency|1|||
44177892|NCT02270983|78971393|FG002|Overall Study|family emergency|0|||
44177893|NCT02270983|78971391|FG000|Overall Study|study procedure non-compliance|1|||
44177894|NCT02270983|78971392|FG001|Overall Study|study procedure non-compliance|0|||
44177895|NCT02270983|78971393|FG002|Overall Study|study procedure non-compliance|0|||
44177896|NCT02270983|78971391|FG000|Overall Study|moved away from study site|0|||
44177897|NCT02270983|78971392|FG001|Overall Study|moved away from study site|1|||
44177898|NCT02270983|78971393|FG002|Overall Study|moved away from study site|0|||
44177899|NCT02449889|78971404|FG000|Overall Study|Adverse Event|1|||
44177900|NCT02449889|78971405|FG001|Overall Study|Adverse Event|2|||
44177901|NCT02449889|78971406|FG002|Overall Study|Adverse Event|0|||
44177902|NCT02449889|78971404|FG000|Overall Study|Protocol Violation|0|||
44177903|NCT02449889|78971405|FG001|Overall Study|Protocol Violation|4|||
44177904|NCT02449889|78971406|FG002|Overall Study|Protocol Violation|1|||
44177905|NCT01831804|78971423|FG000|Overall Study|Adverse Event|0|||
44177906|NCT01831804|78971424|FG001|Overall Study|Adverse Event|0|||
44177907|NCT01831804|78971425|FG002|Overall Study|Adverse Event|0|||
44177908|NCT01831804|78971426|FG003|Overall Study|Adverse Event|0|||
44177909|NCT01831804|78971427|FG004|Overall Study|Adverse Event|0|||
44177910|NCT01831804|78971428|FG005|Overall Study|Adverse Event|0|||
44177911|NCT01831804|78971429|FG006|Overall Study|Adverse Event|1|||
44177912|NCT01831804|78971430|FG007|Overall Study|Adverse Event|0|||
44177913|NCT01831804|78971431|FG008|Overall Study|Adverse Event|1|||
44177914|NCT01831804|78971423|FG000|Overall Study|Protocol Violation|0|||
44177915|NCT01831804|78971424|FG001|Overall Study|Protocol Violation|0|||
44177916|NCT01831804|78971425|FG002|Overall Study|Protocol Violation|2|||
44177917|NCT01831804|78971426|FG003|Overall Study|Protocol Violation|0|||
44177918|NCT01831804|78971427|FG004|Overall Study|Protocol Violation|0|||
44177919|NCT01831804|78971428|FG005|Overall Study|Protocol Violation|0|||
44177920|NCT01831804|78971429|FG006|Overall Study|Protocol Violation|0|||
44177921|NCT01831804|78971430|FG007|Overall Study|Protocol Violation|0|||
44177922|NCT01831804|78971431|FG008|Overall Study|Protocol Violation|0|||
44177923|NCT01831804|78971423|FG000|Overall Study|Protocol defined stopping criteria|1|||
44177924|NCT01831804|78971424|FG001|Overall Study|Protocol defined stopping criteria|1|||
44177925|NCT01831804|78971425|FG002|Overall Study|Protocol defined stopping criteria|3|||
44177926|NCT01831804|78971426|FG003|Overall Study|Protocol defined stopping criteria|0|||
44177927|NCT01831804|78971427|FG004|Overall Study|Protocol defined stopping criteria|1|||
44177928|NCT01831804|78971428|FG005|Overall Study|Protocol defined stopping criteria|0|||
44177929|NCT01831804|78971429|FG006|Overall Study|Protocol defined stopping criteria|0|||
44177930|NCT01831804|78971430|FG007|Overall Study|Protocol defined stopping criteria|0|||
44177931|NCT01831804|78971431|FG008|Overall Study|Protocol defined stopping criteria|0|||
44177932|NCT01831804|78971423|FG000|Overall Study|Lost to Follow-up|0|||
44177933|NCT01831804|78971424|FG001|Overall Study|Lost to Follow-up|0|||
44177934|NCT01831804|78971425|FG002|Overall Study|Lost to Follow-up|1|||
44177935|NCT01831804|78971426|FG003|Overall Study|Lost to Follow-up|0|||
44177936|NCT01831804|78971427|FG004|Overall Study|Lost to Follow-up|0|||
44177937|NCT01831804|78971428|FG005|Overall Study|Lost to Follow-up|0|||
44177938|NCT01831804|78971429|FG006|Overall Study|Lost to Follow-up|0|||
44177939|NCT01831804|78971430|FG007|Overall Study|Lost to Follow-up|0|||
44177940|NCT01831804|78971431|FG008|Overall Study|Lost to Follow-up|1|||
44177941|NCT01831804|78971423|FG000|Overall Study|Investigator discretion|0|||
44177942|NCT01831804|78971424|FG001|Overall Study|Investigator discretion|0|||
44177943|NCT01831804|78971425|FG002|Overall Study|Investigator discretion|0|||
44177944|NCT01831804|78971426|FG003|Overall Study|Investigator discretion|0|||
44177945|NCT01831804|78971427|FG004|Overall Study|Investigator discretion|1|||
44177946|NCT01831804|78971428|FG005|Overall Study|Investigator discretion|0|||
44177947|NCT01831804|78971429|FG006|Overall Study|Investigator discretion|0|||
44177948|NCT01831804|78971430|FG007|Overall Study|Investigator discretion|1|||
44177949|NCT01831804|78971431|FG008|Overall Study|Investigator discretion|0|||
44177950|NCT01831804|78971423|FG000|Overall Study|Withdrew Consent|0|||
44177951|NCT01831804|78971424|FG001|Overall Study|Withdrew Consent|1|||
44177952|NCT01831804|78971425|FG002|Overall Study|Withdrew Consent|0|||
44177953|NCT01831804|78971426|FG003|Overall Study|Withdrew Consent|0|||
44177954|NCT01831804|78971427|FG004|Overall Study|Withdrew Consent|0|||
44177955|NCT01831804|78971428|FG005|Overall Study|Withdrew Consent|0|||
44177956|NCT01831804|78971429|FG006|Overall Study|Withdrew Consent|0|||
44264938|NCT02492958|79166935|FG000|Overall Study|Withdrawal by Subject|0|||
44264939|NCT02492958|79166936|FG001|Overall Study|Withdrawal by Subject|0|||
44177957|NCT01831804|78971430|FG007|Overall Study|Withdrew Consent|2|||
44177958|NCT01831804|78971431|FG008|Overall Study|Withdrew Consent|0|||
44177959|NCT02270671|78971462|FG000|Overall Study|Withdrawal by Subject|1|||
44177960|NCT02270671|78971463|FG001|Overall Study|Withdrawal by Subject|1|||
44177961|NCT02270671|78971462|FG000|Overall Study|Protocol Violation|0|||
44177962|NCT02270671|78971463|FG001|Overall Study|Protocol Violation|1|||
44177963|NCT02270671|78971462|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
44177964|NCT02270671|78971463|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
44177965|NCT02270671|78971462|FG000|Overall Study|Lost to Follow-up|2|||
44177966|NCT02270671|78971463|FG001|Overall Study|Lost to Follow-up|1|||
44177967|NCT02324270|78971472|FG000|Overall Study|Withdrawal by Subject|0|||
44177968|NCT02324270|78971473|FG001|Overall Study|Withdrawal by Subject|1|||
44177969|NCT02324270|78971474|FG002|Overall Study|Withdrawal by Subject|0|||
44177970|NCT02324270|78971472|FG000|Overall Study|Lost to Follow-up|4|||
44177971|NCT02324270|78971473|FG001|Overall Study|Lost to Follow-up|3|||
44177972|NCT02324270|78971474|FG002|Overall Study|Lost to Follow-up|4|||
44177973|NCT02324270|78971472|FG000|Overall Study|Protocol Violation|0|||
44177974|NCT02324270|78971473|FG001|Overall Study|Protocol Violation|1|||
44177975|NCT02324270|78971474|FG002|Overall Study|Protocol Violation|1|||
44177976|NCT02324270|78971472|FG000|Overall Study|Non Compliance with Study Drug|1|||
44177977|NCT02324270|78971473|FG001|Overall Study|Non Compliance with Study Drug|2|||
44177978|NCT02324270|78971474|FG002|Overall Study|Non Compliance with Study Drug|0|||
44177979|NCT02270515|78971482|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
44177980|NCT02270515|78971482|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
44177981|NCT02270515|78971482|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
44177982|NCT02270515|78971482|FG000|Intervention Period 1: 0-6 Months|Death|7|||
44177983|NCT02270515|78971482|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
44177984|NCT02270515|78971482|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
44177985|NCT02270515|78971482|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
44177986|NCT02270515|78971482|FG000|Intervention Period 2: 6-12 Months|Death|5|||
44177987|NCT02270515|78971482|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
44177988|NCT02270515|78971482|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
44177989|NCT02270515|78971482|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
44177990|NCT02270515|78971482|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
44177991|NCT02270515|78971482|FG000|Intervention Period 3: 12-18 Months|Death|3|||
44177992|NCT02270515|78971482|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
44177993|NCT02448875|78971496|FG000|Overall Study|Adverse Event|2|||
44177994|NCT02448875|78971497|FG001|Overall Study|Adverse Event|1|||
44177995|NCT02448875|78971498|FG002|Overall Study|Adverse Event|0|||
44177996|NCT02448875|78971496|FG000|Overall Study|Lost to Follow-up|1|||
44177997|NCT02448875|78971497|FG001|Overall Study|Lost to Follow-up|0|||
44177998|NCT02448875|78971498|FG002|Overall Study|Lost to Follow-up|0|||
44177999|NCT02448875|78971496|FG000|Overall Study|Investigator Decision|3|||
44178000|NCT02448875|78971497|FG001|Overall Study|Investigator Decision|0|||
44178001|NCT02448875|78971498|FG002|Overall Study|Investigator Decision|1|||
44178002|NCT02448875|78971496|FG000|Overall Study|Withdrawal by Subject|1|||
44178003|NCT02448875|78971497|FG001|Overall Study|Withdrawal by Subject|0|||
44178004|NCT02448875|78971498|FG002|Overall Study|Withdrawal by Subject|0|||
44178005|NCT01831726|78971509|FG000|Overall Study|Adverse Event|16|||
44178006|NCT01831726|78971509|FG000|Overall Study|Death|7|||
44178007|NCT01831726|78971509|FG000|Overall Study|Disease Progression|49|||
44178008|NCT01831726|78971509|FG000|Overall Study|Physician Decision|1|||
44178009|NCT01831726|78971509|FG000|Overall Study|Subject/guardian decision|7|||
44178010|NCT01831258|78971513|FG000|Overall Study|Withdrawal by Subject|2|||
44178011|NCT01831258|78971514|FG001|Overall Study|Withdrawal by Subject|1|||
44178012|NCT01831258|78971513|FG000|Overall Study|Lost to Follow-up|3|||
44178013|NCT01831258|78971514|FG001|Overall Study|Lost to Follow-up|2|||
44178014|NCT01849276|78971522|FG000|Followed for Survival for 5 Years|Death|1|||
44178015|NCT01849276|78971522|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
44178016|NCT02465489|78971526|FG000|Overall Study|Adverse Event|5|||
44178017|NCT01829464|78971541|FG000|Overall Study|Adverse Event|1|||
44178018|NCT01829464|78971542|FG001|Overall Study|Adverse Event|0|||
44178019|NCT01829464|78971543|FG002|Overall Study|Adverse Event|0|||
44178020|NCT01829464|78971541|FG000|Overall Study|Lost to Follow-up|0|||
44178021|NCT01829464|78971542|FG001|Overall Study|Lost to Follow-up|0|||
44178022|NCT01829464|78971543|FG002|Overall Study|Lost to Follow-up|1|||
44178023|NCT01829464|78971541|FG000|Overall Study|Withdrawal by Subject|2|||
44178024|NCT01829464|78971542|FG001|Overall Study|Withdrawal by Subject|0|||
44178025|NCT01829464|78971543|FG002|Overall Study|Withdrawal by Subject|0|||
44178026|NCT01829464|78971541|FG000|Overall Study|Study terminated by sponsor|25|||
44178027|NCT01829464|78971542|FG001|Overall Study|Study terminated by sponsor|28|||
44178028|NCT01829464|78971543|FG002|Overall Study|Study terminated by sponsor|25|||
44178029|NCT01829464|78971541|FG000|Overall Study|Lack of Efficacy|0|||
44178030|NCT01829464|78971542|FG001|Overall Study|Lack of Efficacy|1|||
44543029|NCT03655717|79555906|FG006|Overall Study|Lost to Follow-up|0|||
44178031|NCT01829464|78971543|FG002|Overall Study|Lack of Efficacy|0|||
44178032|NCT01847092|78971553|FG000|Overall Study|Adverse Event|12|||
44178033|NCT01847092|78971554|FG001|Overall Study|Adverse Event|3|||
44178034|NCT01847092|78971553|FG000|Overall Study|Withdrawal by Subject|5|||
44178035|NCT01847092|78971554|FG001|Overall Study|Withdrawal by Subject|5|||
44178036|NCT01847092|78971553|FG000|Overall Study|Protocol Specified|8|||
44178037|NCT01847092|78971554|FG001|Overall Study|Protocol Specified|0|||
44178038|NCT01847092|78971553|FG000|Overall Study|Physician Decision|1|||
44178039|NCT01847092|78971554|FG001|Overall Study|Physician Decision|1|||
44178040|NCT01847092|78971553|FG000|Overall Study|Protocol Violation|0|||
44178041|NCT01847092|78971554|FG001|Overall Study|Protocol Violation|2|||
44178042|NCT01601821|78971562|FG000|Overall Study|Death|2|||
44178043|NCT01601821|78971563|FG001|Overall Study|Death|5|||
44178044|NCT01601821|78971562|FG000|Overall Study|Protocol Violation|2|||
44178045|NCT01601821|78971563|FG001|Overall Study|Protocol Violation|2|||
44178046|NCT01601821|78971562|FG000|Overall Study|Lost to Follow-up|6|||
44178047|NCT01601821|78971563|FG001|Overall Study|Lost to Follow-up|14|||
44178048|NCT01601821|78971562|FG000|Overall Study|Withdrawal by Subject|1|||
44178049|NCT01601821|78971563|FG001|Overall Study|Withdrawal by Subject|0|||
44178050|NCT01601821|78971562|FG000|Overall Study|Graft Loss|6|||
44178051|NCT01601821|78971563|FG001|Overall Study|Graft Loss|6|||
44178052|NCT01601821|78971562|FG000|Overall Study|Study Events|7|||
44178053|NCT01601821|78971563|FG001|Overall Study|Study Events|1|||
44178054|NCT01601821|78971562|FG000|Overall Study|Other|5|||
44178055|NCT01601821|78971563|FG001|Overall Study|Other|1|||
44178056|NCT02323646|78971572|FG000|Treatment Course 1|Adverse Event|1|||
44178057|NCT02323646|78971573|FG001|Treatment Course 1|Adverse Event|0|||
44178058|NCT02323646|78971574|FG002|Treatment Course 1|Adverse Event|1|||
44178059|NCT02323646|78971572|FG000|Treatment Course 1|Heavy Bleeding|1|||
44178060|NCT02323646|78971573|FG001|Treatment Course 1|Heavy Bleeding|1|||
44178061|NCT02323646|78971574|FG002|Treatment Course 1|Heavy Bleeding|0|||
44178062|NCT02323646|78971572|FG000|Treatment Course 1|Lost to Follow-up|1|||
44178063|NCT02323646|78971573|FG001|Treatment Course 1|Lost to Follow-up|0|||
44178064|NCT02323646|78971574|FG002|Treatment Course 1|Lost to Follow-up|2|||
44178065|NCT02323646|78971572|FG000|Treatment Course 1|Withdrawal by Subject|0|||
44178066|NCT02323646|78971573|FG001|Treatment Course 1|Withdrawal by Subject|2|||
44178067|NCT02323646|78971574|FG002|Treatment Course 1|Withdrawal by Subject|0|||
44178068|NCT02323646|78971572|FG000|Treatment Course 2|Adverse Event|1|||
44178069|NCT02323646|78971573|FG001|Treatment Course 2|Adverse Event|0|||
44178070|NCT02323646|78971574|FG002|Treatment Course 2|Adverse Event|1|||
44178071|NCT02323646|78971572|FG000|Treatment Course 2|Lost to Follow-up|0|||
44178072|NCT02323646|78971573|FG001|Treatment Course 2|Lost to Follow-up|0|||
44178073|NCT02323646|78971574|FG002|Treatment Course 2|Lost to Follow-up|1|||
44178074|NCT02323646|78971572|FG000|Treatment Course 2|Non-compliance|0|||
44178075|NCT02323646|78971573|FG001|Treatment Course 2|Non-compliance|1|||
44178076|NCT02323646|78971574|FG002|Treatment Course 2|Non-compliance|1|||
44178077|NCT01846624|78971582|FG000|Overall Study|Died during induction, no midostaurin|1|||
44178078|NCT01829230|78971588|FG000|Overall Study|Protocol Violation|0|||
44178079|NCT01829230|78971589|FG001|Overall Study|Protocol Violation|2|||
44178080|NCT01829230|78971588|FG000|Overall Study|Withdrawal by Subject|0|||
44178081|NCT01829230|78971589|FG001|Overall Study|Withdrawal by Subject|1|||
44178082|NCT01829230|78971588|FG000|Overall Study|Lost to Follow-up|1|||
44178083|NCT01829230|78971589|FG001|Overall Study|Lost to Follow-up|1|||
44178084|NCT02269657|78971595|FG000|Overall Study|Protocol Violation|3|||
44178085|NCT02269423|78971605|FG000|Overall Study|Discontinued due to change in residence|0|||
44178086|NCT02269423|78971606|FG001|Overall Study|Discontinued due to change in residence|1|||
44178087|NCT02269423|78971607|FG002|Overall Study|Discontinued due to change in residence|0|||
44178088|NCT02269423|78971608|FG003|Overall Study|Discontinued due to change in residence|1|||
44178089|NCT01827670|78971620|FG000|Overall Study|Withdrawal of Consent|3|||
44178090|NCT01827670|78971621|FG001|Overall Study|Withdrawal of Consent|2|||
44178091|NCT01827670|78971620|FG000|Overall Study|Lost to Follow-up|0|||
44178092|NCT01827670|78971621|FG001|Overall Study|Lost to Follow-up|1|||
44178093|NCT02267317|78971635|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
44178094|NCT02267317|78971636|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
44178095|NCT02267317|78971637|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
44178096|NCT02267317|78971638|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
44178097|NCT02267317|78971639|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
44178098|NCT02267317|78971640|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
44178099|NCT02267317|78971635|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
44178100|NCT02267317|78971636|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
44178101|NCT02267317|78971637|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
44178102|NCT02267317|78971638|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
44178103|NCT02267317|78971639|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
44178104|NCT02267317|78971640|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
44178105|NCT01844830|78971656|FG000|Overall Study|Withdrawal by Subject|1|||
44178106|NCT01844830|78971657|FG001|Overall Study|Withdrawal by Subject|0|||
44178107|NCT01827592|78971666|FG000|Overall Study|Adverse Event|11|||
44178108|NCT01827592|78971667|FG001|Overall Study|Adverse Event|9|||
44178109|NCT01827592|78971668|FG002|Overall Study|Adverse Event|2|||
44178110|NCT01827592|78971666|FG000|Overall Study|Physician Decision|0|||
44178111|NCT01827592|78971667|FG001|Overall Study|Physician Decision|2|||
44178112|NCT01827592|78971668|FG002|Overall Study|Physician Decision|1|||
44178113|NCT01827592|78971666|FG000|Overall Study|Protocol Violation|2|||
44178114|NCT01827592|78971667|FG001|Overall Study|Protocol Violation|1|||
44178115|NCT01827592|78971668|FG002|Overall Study|Protocol Violation|0|||
44178116|NCT01827592|78971666|FG000|Overall Study|Lost to Follow-up|1|||
44178117|NCT01827592|78971667|FG001|Overall Study|Lost to Follow-up|2|||
44178118|NCT01827592|78971668|FG002|Overall Study|Lost to Follow-up|2|||
44178119|NCT01827592|78971666|FG000|Overall Study|Withdrawal by Subject|12|||
44178120|NCT01827592|78971667|FG001|Overall Study|Withdrawal by Subject|11|||
44178121|NCT01827592|78971668|FG002|Overall Study|Withdrawal by Subject|11|||
44178122|NCT01827592|78971666|FG000|Overall Study|Patient's substantial non-compliance|1|||
44178123|NCT01827592|78971667|FG001|Overall Study|Patient's substantial non-compliance|1|||
44178124|NCT01827592|78971668|FG002|Overall Study|Patient's substantial non-compliance|6|||
44178125|NCT01827592|78971666|FG000|Overall Study|Trial terminated by Sponsor|47|||
44178126|NCT01827592|78971667|FG001|Overall Study|Trial terminated by Sponsor|53|||
44178127|NCT01827592|78971668|FG002|Overall Study|Trial terminated by Sponsor|51|||
44178128|NCT01827592|78971666|FG000|Overall Study|Others|0|||
44178129|NCT01827592|78971667|FG001|Overall Study|Others|1|||
44178130|NCT01827592|78971668|FG002|Overall Study|Others|3|||
44178131|NCT02323334|78971686|FG000|Period 3|Lost to Follow-up|0|||
44178132|NCT02323334|78971687|FG001|Period 3|Lost to Follow-up|0|||
44178133|NCT02323334|78971688|FG002|Period 3|Lost to Follow-up|1|||
44178134|NCT02323334|78971689|FG003|Period 3|Lost to Follow-up|0|||
44178135|NCT02323334|78971690|FG004|Period 3|Lost to Follow-up|0|||
44178136|NCT02323334|78971691|FG005|Period 3|Lost to Follow-up|0|||
44178137|NCT02323334|78971692|FG006|Period 3|Lost to Follow-up|0|||
44178138|NCT02323334|78971693|FG007|Period 3|Lost to Follow-up|0|||
44178139|NCT02323334|78971694|FG008|Period 3|Lost to Follow-up|0|||
44178140|NCT02323334|78971695|FG009|Period 3|Lost to Follow-up|0|||
44178141|NCT02323334|78971696|FG010|Period 3|Lost to Follow-up|0|||
44178142|NCT02323334|78971697|FG011|Period 3|Lost to Follow-up|0|||
44178143|NCT02323334|78971698|FG012|Period 3|Lost to Follow-up|0|||
44178144|NCT02323334|78971699|FG013|Period 3|Lost to Follow-up|0|||
44178145|NCT02323334|78971700|FG014|Period 3|Lost to Follow-up|0|||
44178146|NCT02323334|78971701|FG015|Period 3|Lost to Follow-up|0|||
44178147|NCT02323334|78971702|FG016|Period 3|Lost to Follow-up|0|||
44178148|NCT02323334|78971686|FG000|Period 3|Withdrawal by Subject|1|||
44178149|NCT02323334|78971687|FG001|Period 3|Withdrawal by Subject|0|||
44264940|NCT02492958|79166937|FG002|Overall Study|Withdrawal by Subject|1|||
44264941|NCT02492958|79166938|FG003|Overall Study|Withdrawal by Subject|0|||
44451153|NCT00098839|79460177|FG000|Overall Study|Withdrawal by Subject|1|||
44451154|NCT00098839|79460178|FG001|Overall Study|Withdrawal by Subject|0|||
44451155|NCT00098839|79460177|FG000|Overall Study|Refusal of further protocol therapy|3|||
44451156|NCT00098839|79460178|FG001|Overall Study|Refusal of further protocol therapy|1|||
44451157|NCT00098839|79460177|FG000|Overall Study|Relapse|6|||
44451158|NCT00098839|79460178|FG001|Overall Study|Relapse|3|||
44264942|NCT02492958|79166935|FG000|Overall Study|Adverse Event|1|||
44361186|NCT01159691|79366849|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
44178150|NCT02323334|78971688|FG002|Period 3|Withdrawal by Subject|0|||
44178151|NCT02323334|78971689|FG003|Period 3|Withdrawal by Subject|0|||
44178152|NCT02323334|78971690|FG004|Period 3|Withdrawal by Subject|0|||
44178153|NCT02323334|78971691|FG005|Period 3|Withdrawal by Subject|0|||
44178154|NCT02323334|78971692|FG006|Period 3|Withdrawal by Subject|0|||
44361187|NCT01159691|79366849|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
44361188|NCT01159691|79366849|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
44361189|NCT01159691|79366849|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
44361190|NCT01159691|79366849|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
44361191|NCT01157897|79366857|FG000|Overall Study|Lost to Follow-up|2|||
44361192|NCT01157897|79366858|FG001|Overall Study|Lost to Follow-up|0|||
44361193|NCT01157897|79366859|FG002|Overall Study|Lost to Follow-up|0|||
44361194|NCT01157897|79366860|FG003|Overall Study|Lost to Follow-up|1|||
44361195|NCT01157897|79366857|FG000|Overall Study|Relocated|0|||
44361196|NCT01157897|79366858|FG001|Overall Study|Relocated|2|||
44178155|NCT02323334|78971693|FG007|Period 3|Withdrawal by Subject|0|||
44178156|NCT02323334|78971694|FG008|Period 3|Withdrawal by Subject|0|||
44178157|NCT02323334|78971695|FG009|Period 3|Withdrawal by Subject|0|||
44178158|NCT02323334|78971696|FG010|Period 3|Withdrawal by Subject|0|||
44178159|NCT02323334|78971697|FG011|Period 3|Withdrawal by Subject|0|||
44178160|NCT02323334|78971698|FG012|Period 3|Withdrawal by Subject|0|||
44178161|NCT02323334|78971699|FG013|Period 3|Withdrawal by Subject|0|||
44178162|NCT02323334|78971700|FG014|Period 3|Withdrawal by Subject|0|||
44178163|NCT02323334|78971701|FG015|Period 3|Withdrawal by Subject|0|||
44178164|NCT02323334|78971702|FG016|Period 3|Withdrawal by Subject|0|||
44178165|NCT02448719|78971775|FG000|Overall Study|Withdrawal by Subject|0|||
44178166|NCT02448719|78971776|FG001|Overall Study|Withdrawal by Subject|0|||
44178167|NCT02448719|78971777|FG002|Overall Study|Withdrawal by Subject|0|||
44178168|NCT02448719|78971778|FG003|Overall Study|Withdrawal by Subject|0|||
44178169|NCT02448719|78971779|FG004|Overall Study|Withdrawal by Subject|1|||
44178170|NCT02448719|78971780|FG005|Overall Study|Withdrawal by Subject|0|||
44178171|NCT02448719|78971781|FG006|Overall Study|Withdrawal by Subject|0|||
44178172|NCT02448719|78971782|FG007|Overall Study|Withdrawal by Subject|0|||
44178173|NCT02448719|78971783|FG008|Overall Study|Withdrawal by Subject|0|||
44178174|NCT02448719|78971784|FG009|Overall Study|Withdrawal by Subject|0|||
44178175|NCT02448719|78971785|FG010|Overall Study|Withdrawal by Subject|0|||
44178176|NCT02322866|78971848|FG000|Overall Study|Adverse Event|6|||
44178177|NCT02322866|78971849|FG001|Overall Study|Adverse Event|11|||
44178178|NCT02322866|78971848|FG000|Overall Study|Withdrawal of Consent|16|||
44178179|NCT02322866|78971849|FG001|Overall Study|Withdrawal of Consent|25|||
44178180|NCT02322866|78971848|FG000|Overall Study|Lost to Follow-up|36|||
44178181|NCT02322866|78971849|FG001|Overall Study|Lost to Follow-up|39|||
44178182|NCT02322866|78971848|FG000|Overall Study|Protocol Violation|1|||
44178183|NCT02322866|78971849|FG001|Overall Study|Protocol Violation|0|||
44178184|NCT02322866|78971848|FG000|Overall Study|Noncompliance with Treatment|3|||
44178185|NCT02322866|78971849|FG001|Overall Study|Noncompliance with Treatment|4|||
44178186|NCT02322866|78971848|FG000|Overall Study|Lack of Efficacy|3|||
44178187|NCT02322866|78971849|FG001|Overall Study|Lack of Efficacy|1|||
44178188|NCT02322866|78971848|FG000|Overall Study|Other Miscellaneous Reasons|6|||
44178189|NCT02322866|78971849|FG001|Overall Study|Other Miscellaneous Reasons|6|||
44178190|NCT01640353|78971855|FG000|Overall Study|Withdrew prior to treatment|10|||
44178191|NCT01640353|78971855|FG000|Overall Study|Withdrawn from analysis at term site|12|||
44178192|NCT01640353|78971855|FG000|Overall Study|Withdrawal by Subject|5|||
44178193|NCT01640353|78971855|FG000|Overall Study|Death|2|||
44178194|NCT01640353|78971855|FG000|Overall Study|Early site termination|3|||
44178195|NCT01640353|78971855|FG000|Overall Study|Lost to Follow-up|12|||
44178196|NCT01640353|78971855|FG000|Overall Study|Physician Decision|1|||
44178197|NCT02463071|78971862|FG000|Overall Study|Adverse Event|3|||
44178198|NCT02463071|78971863|FG001|Overall Study|Adverse Event|5|||
44178199|NCT02463071|78971864|FG002|Overall Study|Adverse Event|1|||
44178200|NCT02463071|78971862|FG000|Overall Study|Death|1|||
44178201|NCT02463071|78971863|FG001|Overall Study|Death|0|||
44178202|NCT02463071|78971864|FG002|Overall Study|Death|0|||
44178203|NCT02463071|78971862|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
44178204|NCT02463071|78971863|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44178205|NCT02463071|78971864|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
44178206|NCT02463071|78971862|FG000|Overall Study|Reason not specified|7|||
44178207|NCT02463071|78971863|FG001|Overall Study|Reason not specified|9|||
44178208|NCT02463071|78971864|FG002|Overall Study|Reason not specified|4|||
44178209|NCT02463071|78971862|FG000|Overall Study|Protocol Violation|0|||
44178210|NCT02463071|78971863|FG001|Overall Study|Protocol Violation|2|||
44178211|NCT02463071|78971864|FG002|Overall Study|Protocol Violation|0|||
44178212|NCT02463071|78971862|FG000|Overall Study|Lost to Follow-up|0|||
44178213|NCT02463071|78971863|FG001|Overall Study|Lost to Follow-up|0|||
44178214|NCT02463071|78971864|FG002|Overall Study|Lost to Follow-up|1|||
44178215|NCT02266381|78971875|FG000|Overall Study|Physician Decision|3|||
44178216|NCT02266381|78971876|FG001|Overall Study|Physician Decision|5|||
44178217|NCT02266381|78971877|FG002|Overall Study|Physician Decision|4|||
44361197|NCT01157897|79366859|FG002|Overall Study|Relocated|0|||
44178218|NCT01827046|78971889|FG000|Overall Study|Lost to Follow-up|1|||
44178219|NCT01827046|78971890|FG001|Overall Study|Lost to Follow-up|5|||
44178220|NCT01827046|78971889|FG000|Overall Study|Withdrawal by Subject|0|||
44178221|NCT01827046|78971890|FG001|Overall Study|Withdrawal by Subject|4|||
44178222|NCT02356562|78971898|FG000|Overall Study|Withdrawal by Subject|0|||
44178223|NCT02356562|78971899|FG001|Overall Study|Withdrawal by Subject|1|||
44178224|NCT02356562|78971898|FG000|Overall Study|Re-entered treatment in a previous study|1|||
44178225|NCT02356562|78971899|FG001|Overall Study|Re-entered treatment in a previous study|0|||
44178226|NCT02356562|78971898|FG000|Overall Study|site closure|1|||
44178227|NCT02356562|78971899|FG001|Overall Study|site closure|0|||
44178228|NCT02448563|78971910|FG000|Overall Study|Lost to Follow-up|16|||
44178229|NCT02448563|78971911|FG001|Overall Study|Lost to Follow-up|10|||
44178230|NCT02448563|78971910|FG000|Overall Study|Withdrawal by Subject|0|||
44178231|NCT02448563|78971911|FG001|Overall Study|Withdrawal by Subject|1|||
44178232|NCT02266225|78971921|FG000|Overall Study|Lost to Follow-up|2|||
44178233|NCT02266225|78971921|FG000|Overall Study|Death|1|||
44178234|NCT02266225|78971921|FG000|Overall Study|Withdrawal by Subject|13|||
44178235|NCT02354690|78971926|FG000|Overall Study|Physician Decision|1|||
44178236|NCT02354222|78971932|FG000|Overall Study|Adverse Event|0|||
44178237|NCT02354222|78971933|FG001|Overall Study|Adverse Event|3|||
44178238|NCT02354222|78971932|FG000|Overall Study|Physician Decision|1|||
44178239|NCT02354222|78971933|FG001|Overall Study|Physician Decision|1|||
44178240|NCT02354222|78971932|FG000|Overall Study|Pregnancy|1|||
44178241|NCT02354222|78971933|FG001|Overall Study|Pregnancy|0|||
44178242|NCT02354222|78971932|FG000|Overall Study|Withdrawal by Subject|2|||
44178243|NCT02354222|78971933|FG001|Overall Study|Withdrawal by Subject|3|||
44178244|NCT02354222|78971932|FG000|Overall Study|Conflict with the stopping criteria|0|||
44178245|NCT02354222|78971933|FG001|Overall Study|Conflict with the stopping criteria|4|||
44178246|NCT02353442|78971941|FG000|Overall Study|Withdrawal by Subject|3|||
44178247|NCT02353442|78971942|FG001|Overall Study|Withdrawal by Subject|4|||
44178248|NCT02351960|78971950|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
44178249|NCT02351960|78971951|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
44178250|NCT02351960|78971950|FG000|Overall Study|Voluntary Withdrawal|5|||
44178251|NCT02351960|78971951|FG001|Overall Study|Voluntary Withdrawal|4|||
44178252|NCT02351960|78971950|FG000|Overall Study|Significant Protocol Deviation|0|||
44178253|NCT02351960|78971951|FG001|Overall Study|Significant Protocol Deviation|5|||
44178254|NCT02351180|78971960|FG000|Overall Study|Withdrawal by Subject|1|||
44178255|NCT02351180|78971961|FG001|Overall Study|Withdrawal by Subject|0|||
44178256|NCT02350478|78971969|FG000|Overall Study|Lost to Follow-up|5|||
44178257|NCT02350478|78971970|FG001|Overall Study|Lost to Follow-up|1|||
44178258|NCT02349542|78971976|FG000|Overall Study|Withdrawal by Subject|5|||
44178259|NCT02321930|78971980|FG000|Overall Study|Lost to Follow-up|1|||
44178260|NCT01647542|78971987|FG000|Overall Study|Major Protocol Deviation|1|||
44178261|NCT01647542|78971988|FG001|Overall Study|Major Protocol Deviation|0|||
44178262|NCT01647542|78971989|FG002|Overall Study|Major Protocol Deviation|0|||
44178263|NCT01647542|78971987|FG000|Overall Study|Adverse Event|4|||
44178264|NCT01647542|78971988|FG001|Overall Study|Adverse Event|5|||
44178265|NCT01647542|78971989|FG002|Overall Study|Adverse Event|4|||
44178266|NCT01647542|78971987|FG000|Overall Study|Lost to Follow-up|0|||
44178267|NCT01647542|78971988|FG001|Overall Study|Lost to Follow-up|2|||
44178268|NCT01647542|78971989|FG002|Overall Study|Lost to Follow-up|2|||
44178269|NCT01647542|78971987|FG000|Overall Study|Withdrawal by Subject|6|||
44451159|NCT00098839|79460177|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
44178270|NCT01647542|78971988|FG001|Overall Study|Withdrawal by Subject|4|||
44178271|NCT01647542|78971989|FG002|Overall Study|Withdrawal by Subject|0|||
44451160|NCT00098839|79460178|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
44178272|NCT01647542|78971987|FG000|Overall Study|Study Termination|64|||
44178273|NCT01647542|78971988|FG001|Overall Study|Study Termination|61|||
44178274|NCT01647542|78971989|FG002|Overall Study|Study Termination|65|||
44178275|NCT01647542|78971987|FG000|Overall Study|Lack of Efficacy|1|||
44178276|NCT01647542|78971988|FG001|Overall Study|Lack of Efficacy|1|||
44178277|NCT01647542|78971989|FG002|Overall Study|Lack of Efficacy|0|||
44178278|NCT01647542|78971987|FG000|Overall Study|Death|0|||
44178279|NCT01647542|78971988|FG001|Overall Study|Death|0|||
44178280|NCT01647542|78971989|FG002|Overall Study|Death|1|||
44178281|NCT02321462|78971999|FG000|Overall Study|Withdrawal by Subject|5|||
44178282|NCT02321462|78972000|FG001|Overall Study|Withdrawal by Subject|2|||
44178283|NCT02321462|78971999|FG000|Overall Study|Subject withdrawn before any treatment|1|||
44178284|NCT02321462|78972000|FG001|Overall Study|Subject withdrawn before any treatment|1|||
44178285|NCT02391584|78972009|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
44178286|NCT02391584|78972010|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
44178287|NCT02391584|78972009|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
44178288|NCT02391584|78972010|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
44178289|NCT02391584|78972009|FG000|3 Month|Lost to Follow-up|1|||
44451161|NCT00098839|79460177|FG000|Overall Study|Ineligible|2|||
44451162|NCT00098839|79460178|FG001|Overall Study|Ineligible|0|||
44451163|NCT03811093|79460187|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
44451164|NCT03811093|79460188|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
44451165|NCT03811093|79460187|FG000|Overall Study|Unable to measure body fat percentage|2|||
44451166|NCT03811093|79460188|FG001|Overall Study|Unable to measure body fat percentage|0|||
44451167|NCT00485589|79460200|FG000|Overall Study|Death|2|||
44451168|NCT00485589|79460201|FG001|Overall Study|Death|2|||
44451169|NCT00485589|79460202|FG002|Overall Study|Death|0|||
44451170|NCT00485589|79460200|FG000|Overall Study|Failure to return|6|||
44451171|NCT00485589|79460201|FG001|Overall Study|Failure to return|5|||
44451172|NCT00485589|79460202|FG002|Overall Study|Failure to return|1|||
44451173|NCT00485589|79460200|FG000|Overall Study|Protocol Violation|1|||
44451174|NCT00485589|79460201|FG001|Overall Study|Protocol Violation|0|||
44451175|NCT00485589|79460202|FG002|Overall Study|Protocol Violation|0|||
44451176|NCT00485589|79460200|FG000|Overall Study|Violation of selection criteria at entry|0|||
44451177|NCT00485589|79460201|FG001|Overall Study|Violation of selection criteria at entry|3|||
44451178|NCT00485589|79460202|FG002|Overall Study|Violation of selection criteria at entry|1|||
44451179|NCT00485589|79460200|FG000|Overall Study|Administrative/Other|1|||
44451180|NCT00485589|79460201|FG001|Overall Study|Administrative/Other|2|||
44451181|NCT00485589|79460202|FG002|Overall Study|Administrative/Other|1|||
44451182|NCT00485589|79460200|FG000|Overall Study|Insufficient therapeutic response|10|||
44451183|NCT00485589|79460201|FG001|Overall Study|Insufficient therapeutic response|3|||
44451184|NCT00485589|79460202|FG002|Overall Study|Insufficient therapeutic response|1|||
44178290|NCT02391584|78972010|FG001|3 Month|Lost to Follow-up|0|||
44178291|NCT02391584|78972009|FG000|6 Month|Withdrawal by Subject|1|||
44178292|NCT02391584|78972010|FG001|6 Month|Withdrawal by Subject|0|||
44178293|NCT02391584|78972009|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
44178294|NCT02391584|78972010|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
44178295|NCT02266147|78972023|FG000|PART 1: Dose Escalation|Physician Decision|0|||
44178296|NCT02266147|78972024|FG001|PART 1: Dose Escalation|Physician Decision|0|||
44178297|NCT02266147|78972025|FG002|PART 1: Dose Escalation|Physician Decision|1|||
44178298|NCT02266147|78972026|FG003|PART 1: Dose Escalation|Physician Decision|0|||
44178299|NCT02266147|78972023|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
44178300|NCT02266147|78972024|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
44178301|NCT02266147|78972025|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
44178302|NCT02266147|78972026|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
44451185|NCT00485589|79460200|FG000|Overall Study|Refused treatment/did not cooperate|1|||
44451186|NCT00485589|79460201|FG001|Overall Study|Refused treatment/did not cooperate|0|||
44451187|NCT00485589|79460202|FG002|Overall Study|Refused treatment/did not cooperate|2|||
44178303|NCT02266147|78972023|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
44178304|NCT02266147|78972024|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
44264943|NCT02492958|79166936|FG001|Overall Study|Adverse Event|0|||
44178305|NCT02266147|78972025|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
44178306|NCT02266147|78972026|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
44178307|NCT02266147|78972023|FG000|PART 1: Dose Escalation|Other|1|||
44178308|NCT02266147|78972024|FG001|PART 1: Dose Escalation|Other|1|||
44178309|NCT02266147|78972025|FG002|PART 1: Dose Escalation|Other|0|||
44178310|NCT02266147|78972026|FG003|PART 1: Dose Escalation|Other|0|||
44178311|NCT02266147|78972023|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
44178312|NCT02266147|78972024|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
44178313|NCT02266147|78972025|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
44178314|NCT02266147|78972026|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
44178315|NCT02266147|78972023|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
44178316|NCT02266147|78972024|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
44178317|NCT02266147|78972025|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
44178318|NCT02266147|78972026|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
44178319|NCT02264977|78972038|FG000|Overall Study|Death|3|||
44178320|NCT02264977|78972038|FG000|Overall Study|Physician Decision|1|||
44178321|NCT02264977|78972038|FG000|Overall Study|Refuse to return|1|||
44178322|NCT02264821|78972045|FG000|Overall Study|Protocol Violation|1|||
44178323|NCT02264821|78972046|FG001|Overall Study|Protocol Violation|3|||
44178324|NCT02264821|78972047|FG002|Overall Study|Protocol Violation|6|||
44178325|NCT02261467|78972057|FG000|Overall Study|Enrolled in Error|1|||
44178326|NCT02261467|78972058|FG001|Overall Study|Enrolled in Error|0|||
44178327|NCT02261467|78972057|FG000|Overall Study|Protocol Violation|0|||
44178328|NCT02261467|78972058|FG001|Overall Study|Protocol Violation|1|||
44178329|NCT02261467|78972057|FG000|Overall Study|Personal Reasons|17|||
44178330|NCT02261467|78972058|FG001|Overall Study|Personal Reasons|22|||
44178331|NCT02261467|78972057|FG000|Overall Study|Lost to Follow-up|2|||
44178332|NCT02261467|78972058|FG001|Overall Study|Lost to Follow-up|13|||
44178333|NCT02261467|78972057|FG000|Overall Study|Adverse Event|1|||
44178334|NCT02261467|78972058|FG001|Overall Study|Adverse Event|1|||
44178335|NCT01643473|78972066|FG000|Overall Study|Lost to Follow-up|1|||
44178336|NCT01643473|78972067|FG001|Overall Study|Lost to Follow-up|0|||
44178337|NCT02320058|78972075|FG000|Overall Study|Death|25|||
44178338|NCT02320058|78972076|FG001|Overall Study|Death|10|||
44178339|NCT02320058|78972075|FG000|Overall Study|Lost to Follow-up|4|||
44178340|NCT02320058|78972076|FG001|Overall Study|Lost to Follow-up|0|||
44178341|NCT02320058|78972075|FG000|Overall Study|Other reasons|4|||
44178342|NCT02320058|78972076|FG001|Overall Study|Other reasons|1|||
44178343|NCT02320058|78972075|FG000|Overall Study|Withdrawal by Subject|8|||
44178344|NCT02320058|78972076|FG001|Overall Study|Withdrawal by Subject|2|||
44178345|NCT02320058|78972075|FG000|Overall Study|Not reported|1|||
44178346|NCT02320058|78972076|FG001|Overall Study|Not reported|0|||
44178347|NCT02319668|78972084|FG000|Overall Study|Other (Not specified)|0|||
44178348|NCT02319668|78972085|FG001|Overall Study|Other (Not specified)|2|||
44178349|NCT02092467|78972097|FG000|Overall Study|Death|49|||
44178350|NCT02092467|78972098|FG001|Overall Study|Death|66|||
44178351|NCT02092467|78972099|FG002|Overall Study|Death|38|||
44178352|NCT02092467|78972097|FG000|Overall Study|Lost to Follow-up|38|||
44178353|NCT02092467|78972098|FG001|Overall Study|Lost to Follow-up|35|||
44178354|NCT02092467|78972099|FG002|Overall Study|Lost to Follow-up|40|||
44178355|NCT02092467|78972097|FG000|Overall Study|Global Deterioration of Health Status|1|||
44178356|NCT02092467|78972098|FG001|Overall Study|Global Deterioration of Health Status|0|||
44178357|NCT02092467|78972099|FG002|Overall Study|Global Deterioration of Health Status|0|||
44178358|NCT02092467|78972097|FG000|Overall Study|Other|32|||
44178359|NCT02092467|78972098|FG001|Overall Study|Other|30|||
44178360|NCT02092467|78972099|FG002|Overall Study|Other|24|||
44178361|NCT02092467|78972097|FG000|Overall Study|Withdrawal by Subject|282|||
44178362|NCT02092467|78972098|FG001|Overall Study|Withdrawal by Subject|327|||
44178363|NCT02092467|78972099|FG002|Overall Study|Withdrawal by Subject|289|||
44178364|NCT02092467|78972097|FG000|Overall Study|Randomized but not treated|2|||
44178365|NCT02092467|78972098|FG001|Overall Study|Randomized but not treated|1|||
44178366|NCT02092467|78972099|FG002|Overall Study|Randomized but not treated|7|||
44178367|NCT02462759|78972111|FG000|Part 1: Double Blind|Death|1|||
44178368|NCT02462759|78972112|FG001|Part 1: Double Blind|Death|0|||
44178369|NCT02462759|78972113|FG002|Part 1: Double Blind|Death|0|||
44178370|NCT02349386|78972128|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
44178371|NCT02349386|78972129|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
44178372|NCT02349386|78972130|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
44264944|NCT02492958|79166937|FG002|Overall Study|Adverse Event|1|||
44264945|NCT02492958|79166938|FG003|Overall Study|Adverse Event|0|||
44178373|NCT02349386|78972131|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
44178374|NCT02349386|78972128|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
44178375|NCT02349386|78972129|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
44178376|NCT02349386|78972130|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
44178377|NCT02349386|78972131|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
44178378|NCT02349386|78972128|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
44178379|NCT02349386|78972129|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
44178380|NCT02349386|78972130|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
44178381|NCT02349386|78972131|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
44178382|NCT02349386|78972128|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
44178383|NCT02349386|78972129|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
44178384|NCT02349386|78972130|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
44178385|NCT02349386|78972131|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
44178386|NCT02349386|78972128|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
44178387|NCT02349386|78972129|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
44178388|NCT02349386|78972130|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
44178389|NCT02349386|78972131|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
44178390|NCT02349386|78972128|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
44178391|NCT02349386|78972129|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
44178392|NCT02349386|78972130|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
44178393|NCT02349386|78972131|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
44178394|NCT02036775|78972141|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
44178395|NCT02036775|78972142|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
44178396|NCT02036775|78972143|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
44178397|NCT02036775|78972144|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
44178398|NCT02036775|78972145|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
44178399|NCT02036775|78972146|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
44178400|NCT02092389|78972154|FG000|Overall Study|Adverse Event|1|||
44178401|NCT02092389|78972154|FG000|Overall Study|Other|5|||
44178402|NCT02034591|78972158|FG000|Overall Study|Withdrawal by Subject|0|||
44178403|NCT02034591|78972159|FG001|Overall Study|Withdrawal by Subject|0|||
44178404|NCT02034591|78972160|FG002|Overall Study|Withdrawal by Subject|0|||
44178405|NCT02034591|78972161|FG003|Overall Study|Withdrawal by Subject|0|||
44178406|NCT02034591|78972162|FG004|Overall Study|Withdrawal by Subject|1|||
44178407|NCT02034591|78972163|FG005|Overall Study|Withdrawal by Subject|0|||
44178408|NCT02391116|78972172|FG000|Treatment|Withdrawal by Subject|1|||
44178409|NCT02391116|78972172|FG000|Treatment|Protocol Violation|1|||
44178410|NCT02391116|78972172|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
44178411|NCT02391116|78972172|FG000|Treatment|AE with Clinical PD|3|||
44178412|NCT02391116|78972172|FG000|Safety Follow-up|Adverse Event|1|||
44178413|NCT02391116|78972172|FG000|Safety Follow-up|Withdrawal by Subject|4|||
44178414|NCT02391116|78972172|FG000|Safety Follow-up|Switching to Other Therapy|4|||
44178415|NCT02391116|78972172|FG000|Safety Follow-up|No Follow Up|1|||
44178416|NCT02391116|78972172|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
44178417|NCT02391116|78972172|FG000|Active Follow-up|Withdrawal by Subject|1|||
44178418|NCT02391116|78972172|FG000|Active Follow-up|Switching to Other Therapy|2|||
44178419|NCT02391116|78972172|FG000|Survival Follow-up|Withdrawal by Subject|3|||
44178420|NCT02391116|78972172|FG000|Survival Follow-up|Switching to Other Therapy|1|||
44178421|NCT02091921|78972183|FG000|Overall Study|Adverse Event|3|||
44178422|NCT02447081|78972190|FG000|Overall Study|Death|161|||
44178423|NCT02447081|78972190|FG000|Overall Study|Lost to Follow-up|36|||
44178424|NCT02447081|78972190|FG000|Overall Study|Visit not completed|17|||
44178425|NCT02447081|78972190|FG000|Overall Study|unsuccessful implant procedure|10|||
44451188|NCT00485589|79460200|FG000|Overall Study|Withdrawal by Subject|3|||
44178426|NCT02391038|78972194|FG000|Overall Study|Progressive disease|3|||
44178427|NCT02391038|78972195|FG001|Overall Study|Progressive disease|3|||
44178428|NCT02391038|78972196|FG002|Overall Study|Progressive disease|6|||
44178429|NCT02260921|78972207|FG000|Overall Study|Adverse Event|1|||
44178430|NCT02260921|78972208|FG001|Overall Study|Adverse Event|0|||
44178431|NCT02260921|78972207|FG000|Overall Study|Lost to Follow-up|4|||
44178432|NCT02260921|78972208|FG001|Overall Study|Lost to Follow-up|3|||
44178433|NCT02260921|78972207|FG000|Overall Study|Withdraw Consent|4|||
44178434|NCT02260921|78972208|FG001|Overall Study|Withdraw Consent|1|||
44178435|NCT02260921|78972207|FG000|Overall Study|Death|1|||
44178436|NCT02260921|78972208|FG001|Overall Study|Death|0|||
44178437|NCT02260921|78972207|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
44178438|NCT02260921|78972208|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
44178439|NCT02462603|78972214|FG000|Overall Study|Investigator Decision|1|||
44178440|NCT02462603|78972214|FG000|Overall Study|Non-Compliance|1|||
44178441|NCT02462603|78972214|FG000|Overall Study|Withdrawal by Subject|2|||
44178442|NCT02034513|78972220|FG000|Overall Study|Adverse Event|11|||
44178443|NCT02034513|78972221|FG001|Overall Study|Adverse Event|10|||
44178444|NCT02034513|78972220|FG000|Overall Study|Lack of Efficacy|0|||
44178445|NCT02034513|78972221|FG001|Overall Study|Lack of Efficacy|1|||
44178446|NCT02034513|78972220|FG000|Overall Study|Lost to Follow-up|6|||
44178447|NCT02034513|78972221|FG001|Overall Study|Lost to Follow-up|7|||
44178448|NCT02034513|78972220|FG000|Overall Study|Pregnancy|0|||
44178449|NCT02034513|78972221|FG001|Overall Study|Pregnancy|3|||
44178450|NCT02034513|78972220|FG000|Overall Study|Protocol Violation|7|||
44178451|NCT02034513|78972221|FG001|Overall Study|Protocol Violation|10|||
44178452|NCT02034513|78972220|FG000|Overall Study|Withdrawal by Subject|25|||
44178453|NCT02034513|78972221|FG001|Overall Study|Withdrawal by Subject|25|||
44178454|NCT02034513|78972220|FG000|Overall Study|Unclassified|0|||
44178455|NCT02034513|78972221|FG001|Overall Study|Unclassified|1|||
44178456|NCT02348840|78972233|FG000|Overall Study|Withdrawal by Subject|2|||
44178457|NCT02348840|78972234|FG001|Overall Study|Withdrawal by Subject|1|||
44178458|NCT02348840|78972235|FG002|Overall Study|Withdrawal by Subject|0|||
44178459|NCT02348840|78972236|FG003|Overall Study|Withdrawal by Subject|0|||
44178460|NCT02462057|78972251|FG000|Overall Study|Left Vitality|32|||
44178461|NCT02462057|78972252|FG001|Overall Study|Left Vitality|27|||
44178462|NCT02462057|78972253|FG002|Overall Study|Left Vitality|23|||
44178463|NCT02462057|78972254|FG003|Overall Study|Left Vitality|35|||
44178464|NCT02462057|78972255|FG004|Overall Study|Left Vitality|33|||
44178465|NCT02462057|78972251|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
44178466|NCT02462057|78972252|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
44178467|NCT02462057|78972253|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
44178468|NCT02462057|78972254|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
44178469|NCT02462057|78972255|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
44178470|NCT02461745|78972269|FG000|Overall Study|Lack of Efficacy|9|||
44178471|NCT02461745|78972270|FG001|Overall Study|Lack of Efficacy|1|||
44178472|NCT02461745|78972269|FG000|Overall Study|Lost to Follow-up|2|||
44178473|NCT02461745|78972270|FG001|Overall Study|Lost to Follow-up|2|||
44178474|NCT02461745|78972269|FG000|Overall Study|Withdrawal by Subject|3|||
44178475|NCT02461745|78972270|FG001|Overall Study|Withdrawal by Subject|1|||
44178476|NCT02034435|78972280|FG000|Overall Study|Withdrawal by Subject|1|||
44178477|NCT02034435|78972281|FG001|Overall Study|Withdrawal by Subject|0|||
44178478|NCT02034435|78972282|FG002|Overall Study|Withdrawal by Subject|0|||
44178479|NCT02034435|78972283|FG003|Overall Study|Withdrawal by Subject|0|||
44178480|NCT02034435|78972280|FG000|Overall Study|Illness|0|||
44178481|NCT02034435|78972281|FG001|Overall Study|Illness|2|||
44178482|NCT02034435|78972282|FG002|Overall Study|Illness|0|||
44264946|NCT02492880|79166948|FG000|Overall Study|Lost to Follow-up|1|||
44178483|NCT02034435|78972283|FG003|Overall Study|Illness|0|||
44178484|NCT02034435|78972280|FG000|Overall Study|Inadequate IV access|1|||
44178485|NCT02034435|78972281|FG001|Overall Study|Inadequate IV access|0|||
44178486|NCT02034435|78972282|FG002|Overall Study|Inadequate IV access|0|||
44178487|NCT02034435|78972283|FG003|Overall Study|Inadequate IV access|1|||
44178488|NCT02033889|78972296|FG000|Overall Study|Adverse Event|3|||
44178489|NCT02033889|78972297|FG001|Overall Study|Adverse Event|1|||
44178490|NCT02033889|78972298|FG002|Overall Study|Adverse Event|3|||
44178491|NCT02033889|78972296|FG000|Overall Study|Death|3|||
44178492|NCT02033889|78972297|FG001|Overall Study|Death|1|||
44178493|NCT02033889|78972298|FG002|Overall Study|Death|2|||
44178494|NCT02033889|78972296|FG000|Overall Study|Excluded Medication|1|||
44178495|NCT02033889|78972297|FG001|Overall Study|Excluded Medication|1|||
44178496|NCT02033889|78972298|FG002|Overall Study|Excluded Medication|0|||
44178497|NCT02033889|78972296|FG000|Overall Study|Lost to Follow-up|8|||
44264947|NCT02492880|79166948|FG000|Overall Study|Protocol Violation|1|||
44264948|NCT02516592|79166954|FG000|Overall Study|Patient withdrew consent|5|||
44178498|NCT02033889|78972297|FG001|Overall Study|Lost to Follow-up|5|||
44178499|NCT02033889|78972298|FG002|Overall Study|Lost to Follow-up|6|||
44178500|NCT02033889|78972296|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44178501|NCT02033889|78972297|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44178502|NCT02033889|78972298|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44178503|NCT02033889|78972296|FG000|Overall Study|Physician Decision|0|||
44178504|NCT02033889|78972297|FG001|Overall Study|Physician Decision|1|||
44178505|NCT02033889|78972298|FG002|Overall Study|Physician Decision|1|||
44178506|NCT02033889|78972296|FG000|Overall Study|Participant moved|0|||
44178507|NCT02033889|78972297|FG001|Overall Study|Participant moved|1|||
44178508|NCT02033889|78972298|FG002|Overall Study|Participant moved|0|||
44178509|NCT02033889|78972296|FG000|Overall Study|Withdrawal by Subject|18|||
44178510|NCT02033889|78972297|FG001|Overall Study|Withdrawal by Subject|10|||
44178511|NCT02033889|78972298|FG002|Overall Study|Withdrawal by Subject|13|||
44178512|NCT02447003|78972308|FG000|Overall Study|Other|0|||
44178513|NCT02447003|78972309|FG001|Overall Study|Other|4|||
44178514|NCT02447003|78972308|FG000|Overall Study|Site discontinued|0|||
44178515|NCT02447003|78972309|FG001|Overall Study|Site discontinued|2|||
44178516|NCT02447003|78972308|FG000|Overall Study|Physician Decision|0|||
44178517|NCT02447003|78972309|FG001|Overall Study|Physician Decision|1|||
44178518|NCT02447003|78972308|FG000|Overall Study|Withdrawal by Subject|4|||
44178519|NCT02447003|78972309|FG001|Overall Study|Withdrawal by Subject|3|||
44178520|NCT02447003|78972308|FG000|Overall Study|Sponsor Decision|6|||
44178521|NCT02447003|78972309|FG001|Overall Study|Sponsor Decision|11|||
44178522|NCT02447003|78972308|FG000|Overall Study|Progressive Disease|1|||
44178523|NCT02447003|78972309|FG001|Overall Study|Progressive Disease|0|||
44178524|NCT02447003|78972308|FG000|Overall Study|Lost to Follow-up|5|||
44178525|NCT02447003|78972309|FG001|Overall Study|Lost to Follow-up|0|||
44178526|NCT02447003|78972308|FG000|Overall Study|Death|154|||
44178527|NCT02447003|78972309|FG001|Overall Study|Death|63|||
44178528|NCT01844284|78972319|FG000|Overall Study|Lost to Follow-up|12|||
44178529|NCT01844284|78972320|FG001|Overall Study|Lost to Follow-up|7|||
44178530|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Refused|1|||
44178531|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Refused|3|||
44178532|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Medical|0|||
44178533|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Medical|1|||
44178534|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
44178535|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
44178536|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
44178537|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
44178538|NCT02054715|78972328|FG000|Baseline/Follow-up 1|No Reason|0|||
44178539|NCT02054715|78972329|FG001|Baseline/Follow-up 1|No Reason|1|||
44178540|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
44178541|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
44178542|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Ineligible|3|||
44178543|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Ineligible|0|||
44178544|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Hospitalization|1|||
44178545|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Hospitalization|0|||
44178546|NCT02054715|78972328|FG000|Baseline/Follow-up 1|Changed Mind|1|||
44178547|NCT02054715|78972329|FG001|Baseline/Follow-up 1|Changed Mind|0|||
44178548|NCT02054715|78972328|FG000|Follow-up 2|Lost to Followup|3|||
44178549|NCT02054715|78972329|FG001|Follow-up 2|Lost to Followup|1|||
44178550|NCT02054715|78972328|FG000|Follow-up 2|Refused|3|||
44178551|NCT02054715|78972329|FG001|Follow-up 2|Refused|2|||
44178552|NCT02054715|78972328|FG000|Follow-up 2|Followup Not Completed|3|||
44178553|NCT02054715|78972329|FG001|Follow-up 2|Followup Not Completed|4|||
44178554|NCT02054715|78972328|FG000|Follow-up 2|Ineligible|4|||
44178555|NCT02054715|78972329|FG001|Follow-up 2|Ineligible|5|||
44178556|NCT02054715|78972328|FG000|Follow-up 2|Death|3|||
44178557|NCT02054715|78972329|FG001|Follow-up 2|Death|3|||
44178558|NCT02054715|78972328|FG000|Follow-up 2|Hospitalization|0|||
44178559|NCT02054715|78972329|FG001|Follow-up 2|Hospitalization|2|||
44178560|NCT02054715|78972328|FG000|Follow-up 2|Changed MD/Facility|0|||
44178561|NCT02054715|78972329|FG001|Follow-up 2|Changed MD/Facility|1|||
44178562|NCT02054715|78972328|FG000|Follow-up 2|Changed Mind|0|||
44178563|NCT02054715|78972329|FG001|Follow-up 2|Changed Mind|1|||
44178564|NCT02054715|78972328|FG000|Follow-up 2|No Reason|2|||
44178565|NCT02054715|78972329|FG001|Follow-up 2|No Reason|0|||
44178566|NCT02054715|78972328|FG000|Follow-up 2|Treatment Change or Delay|1|||
44178567|NCT02054715|78972329|FG001|Follow-up 2|Treatment Change or Delay|0|||
44178568|NCT02446769|78972335|FG000|Screening Period|Screen Failure|11|||
44178569|NCT02446769|78972336|FG001|Screening Period|Screen Failure|0|||
44178570|NCT02446769|78972337|FG002|Screening Period|Screen Failure|0|||
44178571|NCT02446769|78972335|FG000|Study Period|Randomized in Error|0|||
44178572|NCT02446769|78972336|FG001|Study Period|Randomized in Error|2|||
44178573|NCT02446769|78972337|FG002|Study Period|Randomized in Error|0|||
44178574|NCT02420093|78972346|FG000|Overall Study|Withdrawal by Subject|1|||
44178575|NCT02420093|78972347|FG001|Overall Study|Withdrawal by Subject|1|||
44178576|NCT02419937|78972355|FG000|Overall Study|Lost to Follow-up|1|||
44178577|NCT02419937|78972356|FG001|Overall Study|Lost to Follow-up|0|||
44264949|NCT02516592|79166955|FG001|Overall Study|Patient withdrew consent|2|||
44264950|NCT02516592|79166954|FG000|Overall Study|Protocol deviation|4|||
44264951|NCT02516592|79166955|FG001|Overall Study|Protocol deviation|4|||
44264952|NCT02516592|79166954|FG000|Overall Study|Lost to Follow-up|2|||
44178578|NCT02054481|78972366|FG000|Overall Study|Adverse Event|1|||
44178579|NCT02054481|78972367|FG001|Overall Study|Adverse Event|1|||
44178580|NCT02054481|78972368|FG002|Overall Study|Adverse Event|0|||
44178581|NCT02054481|78972369|FG003|Overall Study|Adverse Event|1|||
44178582|NCT02054481|78972366|FG000|Overall Study|Lost to Follow-up|1|||
44178583|NCT02054481|78972367|FG001|Overall Study|Lost to Follow-up|0|||
44178584|NCT02054481|78972368|FG002|Overall Study|Lost to Follow-up|0|||
44178585|NCT02054481|78972369|FG003|Overall Study|Lost to Follow-up|0|||
44178586|NCT02054481|78972366|FG000|Overall Study|Other reason|2|||
44178587|NCT02054481|78972367|FG001|Overall Study|Other reason|1|||
44178588|NCT02054481|78972368|FG002|Overall Study|Other reason|2|||
44178589|NCT02054481|78972369|FG003|Overall Study|Other reason|0|||
44178590|NCT01610752|78972383|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
44178591|NCT01610752|78972384|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
44178592|NCT01610752|78972385|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
44178593|NCT02054325|78972395|FG000|Overall Study|Lost to Follow-up|8|||
44178594|NCT02054325|78972396|FG001|Overall Study|Lost to Follow-up|5|||
44178595|NCT02446691|78972402|FG000|Overall Study|Withdrawal by Subject|2|||
44178596|NCT02446691|78972402|FG000|Overall Study|Lost to Follow-up|8|||
44178597|NCT02446691|78972402|FG000|Overall Study|Protocol Violation|1|||
44178598|NCT02091375|78972408|FG000|Overall Study|Adverse Event|8|||
44178599|NCT02091375|78972409|FG001|Overall Study|Adverse Event|1|||
44178600|NCT02091375|78972408|FG000|Overall Study|Lost to Follow-up|0|||
44178601|NCT02091375|78972409|FG001|Overall Study|Lost to Follow-up|1|||
44178602|NCT02091375|78972408|FG000|Overall Study|Withdrawal by Subject|0|||
44178603|NCT02091375|78972409|FG001|Overall Study|Withdrawal by Subject|1|||
44178604|NCT02091375|78972408|FG000|Overall Study|Withdrawn by the investigator|1|||
44178605|NCT02091375|78972409|FG001|Overall Study|Withdrawn by the investigator|0|||
44178606|NCT02032875|78972417|FG000|Treatment Period|Adverse Event|1|||
44178607|NCT02032875|78972418|FG001|Treatment Period|Adverse Event|0|||
44178608|NCT02032875|78972417|FG000|Treatment Period|Liver transplant, No extension needed|0|||
44178609|NCT02032875|78972418|FG001|Treatment Period|Liver transplant, No extension needed|1|||
44178610|NCT02032875|78972417|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
44178611|NCT02032875|78972418|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
44178612|NCT02032875|78972417|FG000|Follow-up Period|Death|0|||
44178613|NCT02032875|78972418|FG001|Follow-up Period|Death|1|||
44178614|NCT02032875|78972417|FG000|Follow-up Period|Virologic Relapse|3|||
44178615|NCT02032875|78972418|FG001|Follow-up Period|Virologic Relapse|10|||
44178616|NCT02032407|78972425|FG000|Overall Study|Lost to Follow-up|2|||
44178617|NCT02032407|78972425|FG000|Overall Study|Pregnancy|1|||
44178618|NCT02032407|78972425|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44178619|NCT01843972|78972443|FG000|Overall Study|Withdrawal by Subject|0|||
44178620|NCT01843972|78972444|FG001|Overall Study|Withdrawal by Subject|0|||
44178621|NCT01843972|78972445|FG002|Overall Study|Withdrawal by Subject|0|||
44178622|NCT01843972|78972446|FG003|Overall Study|Withdrawal by Subject|0|||
44178623|NCT01843972|78972447|FG004|Overall Study|Withdrawal by Subject|1|||
44178624|NCT01843972|78972448|FG005|Overall Study|Withdrawal by Subject|0|||
44178625|NCT01843972|78972449|FG006|Overall Study|Withdrawal by Subject|0|||
44178626|NCT01843972|78972450|FG007|Overall Study|Withdrawal by Subject|0|||
44178627|NCT01843972|78972451|FG008|Overall Study|Withdrawal by Subject|0|||
44178628|NCT01843972|78972452|FG009|Overall Study|Withdrawal by Subject|0|||
44178629|NCT01826422|78972490|FG000|Overall Study|Withdrawal by Subject|1|||
44178630|NCT01826422|78972491|FG001|Overall Study|Withdrawal by Subject|3|||
44178631|NCT01843660|78972497|FG000|Overall Study|Other|30|||
44178632|NCT02090283|78972504|FG000|Overall Study|Withdrawal by Subject|6|||
44178633|NCT02090283|78972505|FG001|Overall Study|Withdrawal by Subject|6|||
44178634|NCT02090283|78972506|FG002|Overall Study|Withdrawal by Subject|6|||
44178635|NCT02090283|78972504|FG000|Overall Study|Sponsor Terminated Study|6|||
44178636|NCT02090283|78972505|FG001|Overall Study|Sponsor Terminated Study|6|||
44178637|NCT02090283|78972506|FG002|Overall Study|Sponsor Terminated Study|1|||
44178638|NCT02090283|78972504|FG000|Overall Study|Lost to Follow-up|2|||
44178639|NCT02090283|78972505|FG001|Overall Study|Lost to Follow-up|2|||
44178640|NCT02090283|78972506|FG002|Overall Study|Lost to Follow-up|3|||
44178641|NCT02090283|78972504|FG000|Overall Study|Adverse Event|1|||
44178642|NCT02090283|78972505|FG001|Overall Study|Adverse Event|1|||
44178643|NCT02090283|78972506|FG002|Overall Study|Adverse Event|0|||
44178644|NCT02090283|78972504|FG000|Overall Study|Protocol Violation|2|||
44178645|NCT02090283|78972505|FG001|Overall Study|Protocol Violation|0|||
44178646|NCT02090283|78972506|FG002|Overall Study|Protocol Violation|0|||
44178647|NCT02032173|78972514|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
44178648|NCT02031471|78972518|FG000|24 Week Treatment Period|Adverse Event|6|||
44178649|NCT02031471|78972518|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
44178650|NCT02031471|78972518|FG000|24 Week Treatment Period|Protocol Violation|1|||
44178651|NCT02031471|78972518|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
44178652|NCT02031471|78972518|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
44178653|NCT02031471|78972518|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
44178654|NCT02031471|78972518|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
44178655|NCT02461589|78972532|FG000|Overall Study|Withdrawal by Subject|5|||
44178656|NCT02461589|78972533|FG001|Overall Study|Withdrawal by Subject|1|||
44178657|NCT02461589|78972534|FG002|Overall Study|Withdrawal by Subject|3|||
44178658|NCT02461589|78972535|FG003|Overall Study|Withdrawal by Subject|2|||
44178659|NCT02461589|78972536|FG004|Overall Study|Withdrawal by Subject|1|||
44264953|NCT02516592|79166955|FG001|Overall Study|Lost to Follow-up|3|||
44451189|NCT00485589|79460201|FG001|Overall Study|Withdrawal by Subject|2|||
44178660|NCT02461589|78972537|FG005|Overall Study|Withdrawal by Subject|2|||
44178661|NCT02461589|78972538|FG006|Overall Study|Withdrawal by Subject|1|||
44178662|NCT02461589|78972539|FG007|Overall Study|Withdrawal by Subject|3|||
44178663|NCT02461589|78972540|FG008|Overall Study|Withdrawal by Subject|3|||
44178664|NCT02461589|78972541|FG009|Overall Study|Withdrawal by Subject|1|||
44178665|NCT02461589|78972532|FG000|Overall Study|Lost to Follow-up|0|||
44178666|NCT02461589|78972533|FG001|Overall Study|Lost to Follow-up|0|||
44178667|NCT02461589|78972534|FG002|Overall Study|Lost to Follow-up|2|||
44451190|NCT00485589|79460202|FG002|Overall Study|Withdrawal by Subject|2|||
44178668|NCT02461589|78972535|FG003|Overall Study|Lost to Follow-up|3|||
44178669|NCT02461589|78972536|FG004|Overall Study|Lost to Follow-up|1|||
44178670|NCT02461589|78972537|FG005|Overall Study|Lost to Follow-up|1|||
44178671|NCT02461589|78972538|FG006|Overall Study|Lost to Follow-up|3|||
44178672|NCT02461589|78972539|FG007|Overall Study|Lost to Follow-up|1|||
44178673|NCT02461589|78972540|FG008|Overall Study|Lost to Follow-up|3|||
44178674|NCT02461589|78972541|FG009|Overall Study|Lost to Follow-up|1|||
44178675|NCT02461589|78972532|FG000|Overall Study|Death|0|||
44178676|NCT02461589|78972533|FG001|Overall Study|Death|0|||
44451191|NCT00485589|79460200|FG000|Overall Study|Adverse Event|3|||
44178677|NCT02461589|78972534|FG002|Overall Study|Death|0|||
44178678|NCT02461589|78972535|FG003|Overall Study|Death|0|||
44178679|NCT02461589|78972536|FG004|Overall Study|Death|0|||
44178680|NCT02461589|78972537|FG005|Overall Study|Death|0|||
44178681|NCT02461589|78972538|FG006|Overall Study|Death|0|||
44178682|NCT02461589|78972539|FG007|Overall Study|Death|1|||
44178683|NCT02461589|78972540|FG008|Overall Study|Death|0|||
44178684|NCT02461589|78972541|FG009|Overall Study|Death|0|||
44178685|NCT02461589|78972532|FG000|Overall Study|Unclassified|0|||
44178686|NCT02461589|78972533|FG001|Overall Study|Unclassified|0|||
44178687|NCT02461589|78972534|FG002|Overall Study|Unclassified|0|||
44178688|NCT02461589|78972535|FG003|Overall Study|Unclassified|0|||
44178689|NCT02461589|78972536|FG004|Overall Study|Unclassified|0|||
44178690|NCT02461589|78972537|FG005|Overall Study|Unclassified|0|||
44178691|NCT02461589|78972538|FG006|Overall Study|Unclassified|1|||
44178692|NCT02461589|78972539|FG007|Overall Study|Unclassified|0|||
44178693|NCT02461589|78972540|FG008|Overall Study|Unclassified|0|||
44178694|NCT02461589|78972541|FG009|Overall Study|Unclassified|2|||
44178695|NCT02461589|78972532|FG000|Overall Study|Missing follow-up information|1|||
44178696|NCT02461589|78972533|FG001|Overall Study|Missing follow-up information|1|||
44178697|NCT02461589|78972534|FG002|Overall Study|Missing follow-up information|0|||
44178698|NCT02461589|78972535|FG003|Overall Study|Missing follow-up information|0|||
44178699|NCT02461589|78972536|FG004|Overall Study|Missing follow-up information|0|||
44178700|NCT02461589|78972537|FG005|Overall Study|Missing follow-up information|0|||
44178701|NCT02461589|78972538|FG006|Overall Study|Missing follow-up information|1|||
44178702|NCT02461589|78972539|FG007|Overall Study|Missing follow-up information|0|||
44178703|NCT02461589|78972540|FG008|Overall Study|Missing follow-up information|0|||
44178704|NCT02461589|78972541|FG009|Overall Study|Missing follow-up information|0|||
44178705|NCT02461589|78972532|FG000|Overall Study|Withdrawal from trial before exposure|0|||
44178706|NCT02461589|78972533|FG001|Overall Study|Withdrawal from trial before exposure|0|||
44178707|NCT02461589|78972534|FG002|Overall Study|Withdrawal from trial before exposure|0|||
44178708|NCT02461589|78972535|FG003|Overall Study|Withdrawal from trial before exposure|0|||
44178709|NCT02461589|78972536|FG004|Overall Study|Withdrawal from trial before exposure|0|||
44178710|NCT02461589|78972537|FG005|Overall Study|Withdrawal from trial before exposure|0|||
44178711|NCT02461589|78972538|FG006|Overall Study|Withdrawal from trial before exposure|0|||
44178712|NCT02461589|78972539|FG007|Overall Study|Withdrawal from trial before exposure|0|||
44178713|NCT02461589|78972540|FG008|Overall Study|Withdrawal from trial before exposure|0|||
44178714|NCT02461589|78972541|FG009|Overall Study|Withdrawal from trial before exposure|1|||
44178715|NCT02089737|78972563|FG000|Overall Study|Survey form not completed|5|||
44178716|NCT02089737|78972563|FG000|Overall Study|Not treated|1|||
44178717|NCT02460575|78972570|FG000|Overall Study|Lost to Follow-up|1|||
44178718|NCT02460575|78972571|FG001|Overall Study|Lost to Follow-up|0|||
44178719|NCT02089347|78972579|FG000|Overall Study|Protocol Violation|1|||
44178720|NCT02089347|78972580|FG001|Overall Study|Protocol Violation|0|||
44178721|NCT02445755|78972586|FG000|Overall Study|Withdrawal by Subject|2|||
44178722|NCT02445755|78972586|FG000|Overall Study|Protocol Violation|6|||
44178723|NCT02445755|78972586|FG000|Overall Study|Screen Failure|5|||
44178724|NCT02419469|78972593|FG000|Overall Study|Withdrawal by Subject|1|||
44178725|NCT02419313|78972597|FG000|First Intervention|Lost to Follow-up|2|||
44178726|NCT02419313|78972598|FG001|First Intervention|Lost to Follow-up|0|||
44178727|NCT02419313|78972597|FG000|Second Intervention|Lost to Follow-up|1|||
44178728|NCT02419313|78972598|FG001|Second Intervention|Lost to Follow-up|0|||
44178729|NCT02419001|78972606|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
44178730|NCT02419001|78972607|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
44178731|NCT02031237|78972615|FG000|Overall Study|Death|1|||
44178732|NCT02031237|78972616|FG001|Overall Study|Death|5|||
44178733|NCT02031237|78972617|FG002|Overall Study|Death|0|||
44264954|NCT02516592|79166954|FG000|Overall Study|Patient/guardian decision|2|||
44264955|NCT02516592|79166955|FG001|Overall Study|Patient/guardian decision|1|||
44178734|NCT02031237|78972615|FG000|Overall Study|Physician Decision|0|||
44178735|NCT02031237|78972616|FG001|Overall Study|Physician Decision|1|||
44178736|NCT02031237|78972617|FG002|Overall Study|Physician Decision|0|||
44178737|NCT02031237|78972615|FG000|Overall Study|Withdrawal by Subject|2|||
44178738|NCT02031237|78972616|FG001|Overall Study|Withdrawal by Subject|2|||
44178739|NCT02031237|78972617|FG002|Overall Study|Withdrawal by Subject|0|||
44178740|NCT02031237|78972615|FG000|Overall Study|Protocol Violation|2|||
44178741|NCT02031237|78972616|FG001|Overall Study|Protocol Violation|6|||
44178742|NCT02031237|78972617|FG002|Overall Study|Protocol Violation|0|||
44178743|NCT02031237|78972615|FG000|Overall Study|Alternate Treatment Given|0|||
44178744|NCT02031237|78972616|FG001|Overall Study|Alternate Treatment Given|0|||
44178745|NCT02031237|78972617|FG002|Overall Study|Alternate Treatment Given|3|||
44178746|NCT02088957|78972624|FG000|Overall Study|Lack of Efficacy|1|||
44178747|NCT02088957|78972625|FG001|Overall Study|Lack of Efficacy|0|||
44178748|NCT02418845|78972633|FG000|Overall Study|Lost to Follow-up|7|||
44178749|NCT02418845|78972634|FG001|Overall Study|Lost to Follow-up|2|||
44178750|NCT02418845|78972633|FG000|Overall Study|Lack of Efficacy|0|||
44178751|NCT02418845|78972634|FG001|Overall Study|Lack of Efficacy|3|||
44178752|NCT02418845|78972633|FG000|Overall Study|Physician Decision|5|||
44178753|NCT02418845|78972634|FG001|Overall Study|Physician Decision|5|||
44178754|NCT02418845|78972633|FG000|Overall Study|Protocol Violation|1|||
44178755|NCT02418845|78972634|FG001|Overall Study|Protocol Violation|0|||
44178756|NCT02418845|78972633|FG000|Overall Study|Withdrawal by Subject|3|||
44178757|NCT02418845|78972634|FG001|Overall Study|Withdrawal by Subject|2|||
44178758|NCT02088177|78972640|FG000|Overall Study|Lost to Follow-up|3|||
44178759|NCT02030535|78972644|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
44178760|NCT02029989|78972660|FG000|Overall Study|Withdrawal by Subject|1|||
44178761|NCT02029989|78972661|FG001|Overall Study|Withdrawal by Subject|0|||
44178762|NCT02029989|78972660|FG000|Overall Study|Withdrawal: Fear of needles|1|||
44178763|NCT02029989|78972661|FG001|Overall Study|Withdrawal: Fear of needles|0|||
44178764|NCT02029989|78972660|FG000|Overall Study|Change of location|2|||
44178765|NCT02029989|78972661|FG001|Overall Study|Change of location|3|||
44178766|NCT02029989|78972660|FG000|Overall Study|Physician Decision|2|||
44178767|NCT02029989|78972661|FG001|Overall Study|Physician Decision|0|||
44178768|NCT02029989|78972660|FG000|Overall Study|Lost to Follow-up|9|||
44178769|NCT02029989|78972661|FG001|Overall Study|Lost to Follow-up|7|||
44178770|NCT02029989|78972660|FG000|Overall Study|Death|0|||
44178771|NCT02029989|78972661|FG001|Overall Study|Death|1|||
44178772|NCT02029989|78972660|FG000|Overall Study|Protocol Violation|1|||
44178773|NCT02029989|78972661|FG001|Overall Study|Protocol Violation|0|||
44178774|NCT02048241|78972669|FG000|Overall Study|Withdrawal by Subject|0|||
44178775|NCT02048241|78972670|FG001|Overall Study|Withdrawal by Subject|1|||
44178776|NCT02087943|78972679|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
44178777|NCT02087943|78972680|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
44178778|NCT02087943|78972681|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
44178779|NCT02087943|78972682|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
44178780|NCT02087943|78972683|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
44178781|NCT02087943|78972679|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
44178782|NCT02087943|78972680|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
44178783|NCT02087943|78972681|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
44178784|NCT02087943|78972682|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
44178785|NCT02087943|78972683|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
44178786|NCT02087943|78972679|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
44178787|NCT02087943|78972680|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
44178788|NCT02087943|78972681|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
44178789|NCT02087943|78972682|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
44178790|NCT02087943|78972683|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
44178791|NCT02087943|78972679|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
44178792|NCT02087943|78972680|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
44178793|NCT02087943|78972681|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
44178794|NCT02087943|78972682|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
44178795|NCT02087943|78972683|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
44264956|NCT02516592|79166954|FG000|Overall Study|Adverse Event|1|||
44264957|NCT02516592|79166955|FG001|Overall Study|Adverse Event|2|||
44264958|NCT02516592|79166954|FG000|Overall Study|Abnormal test procedure result|1|||
44178796|NCT02087943|78972679|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
44178797|NCT02087943|78972680|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
44178798|NCT02087943|78972681|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
44178799|NCT02087943|78972682|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
44178800|NCT02087943|78972683|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
44178801|NCT02087943|78972679|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
44178802|NCT02087943|78972680|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
44264959|NCT02516592|79166955|FG001|Overall Study|Abnormal test procedure result|0|||
44264960|NCT02516592|79166954|FG000|Overall Study|Death|1|||
44178803|NCT02087943|78972681|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
44178804|NCT02087943|78972682|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
44178805|NCT02087943|78972683|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
44178806|NCT02087943|78972679|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
44178807|NCT02087943|78972680|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
44178808|NCT02087943|78972681|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
44178809|NCT02087943|78972682|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
44178810|NCT02087943|78972683|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
44178811|NCT02087943|78972679|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
44178812|NCT02087943|78972680|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
44178813|NCT02087943|78972681|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
44178814|NCT02087943|78972682|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
44178815|NCT02087943|78972683|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
44178816|NCT02087943|78972679|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
44178817|NCT02087943|78972680|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
44178818|NCT02087943|78972681|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
44178819|NCT02087943|78972682|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
44178820|NCT02087943|78972683|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
44178821|NCT02087943|78972679|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
44178822|NCT02087943|78972680|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
44178823|NCT02087943|78972681|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
44178824|NCT02087943|78972682|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
44178825|NCT02087943|78972683|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
44178826|NCT02029521|78972697|FG000|Overall Study|Protocol Violation|1|||
44178827|NCT02029521|78972698|FG001|Overall Study|Protocol Violation|0|||
44178828|NCT02029521|78972697|FG000|Overall Study|Withdrawal by Subject|1|||
44178829|NCT02029521|78972698|FG001|Overall Study|Withdrawal by Subject|1|||
44178830|NCT02443883|78972719|FG000|Overall Study|Adverse Event|0|||
44178831|NCT02443883|78972720|FG001|Overall Study|Adverse Event|1|||
44178832|NCT02443883|78972721|FG002|Overall Study|Adverse Event|0|||
44178833|NCT02443883|78972722|FG003|Overall Study|Adverse Event|0|||
44178834|NCT02443883|78972719|FG000|Overall Study|Lost to Follow-up|3|||
44178835|NCT02443883|78972720|FG001|Overall Study|Lost to Follow-up|2|||
44178836|NCT02443883|78972721|FG002|Overall Study|Lost to Follow-up|1|||
44178837|NCT02443883|78972722|FG003|Overall Study|Lost to Follow-up|0|||
44178838|NCT02443883|78972719|FG000|Overall Study|Physician Decision|1|||
44178839|NCT02443883|78972720|FG001|Overall Study|Physician Decision|1|||
44178840|NCT02443883|78972721|FG002|Overall Study|Physician Decision|0|||
44178841|NCT02443883|78972722|FG003|Overall Study|Physician Decision|3|||
44178842|NCT02443883|78972719|FG000|Overall Study|Withdrawal by Subject|1|||
44178843|NCT02443883|78972720|FG001|Overall Study|Withdrawal by Subject|0|||
44178844|NCT02443883|78972721|FG002|Overall Study|Withdrawal by Subject|0|||
44178845|NCT02443883|78972722|FG003|Overall Study|Withdrawal by Subject|2|||
44178846|NCT02443883|78972719|FG000|Overall Study|Randomized, but never treated|1|||
44178847|NCT02443883|78972720|FG001|Overall Study|Randomized, but never treated|0|||
44178848|NCT02443883|78972721|FG002|Overall Study|Randomized, but never treated|0|||
44178849|NCT02443883|78972722|FG003|Overall Study|Randomized, but never treated|0|||
44178850|NCT02460263|78972732|FG000|Transition Period|Withdrawal by Subject|1|||
44178851|NCT02460263|78972732|FG000|Transition Period|Death|1|||
44178852|NCT02443805|78972742|FG000|Overall Study|Adverse Event|100|||
44178853|NCT02443805|78972743|FG001|Overall Study|Adverse Event|18|||
44178854|NCT02443805|78972742|FG000|Overall Study|Withdrawal by Subject|73|||
44178855|NCT02443805|78972743|FG001|Overall Study|Withdrawal by Subject|74|||
44178856|NCT02443805|78972742|FG000|Overall Study|Lost to Follow-up|19|||
44178857|NCT02443805|78972743|FG001|Overall Study|Lost to Follow-up|14|||
44178858|NCT02443805|78972742|FG000|Overall Study|Pregnancy|6|||
44178859|NCT02443805|78972743|FG001|Overall Study|Pregnancy|5|||
44178860|NCT02443805|78972742|FG000|Overall Study|Protocol Violation|2|||
44178861|NCT02443805|78972743|FG001|Overall Study|Protocol Violation|4|||
44178862|NCT02443805|78972742|FG000|Overall Study|Lack of Efficacy|1|||
44178863|NCT02443805|78972743|FG001|Overall Study|Lack of Efficacy|1|||
44178864|NCT02443805|78972742|FG000|Overall Study|Non-compliance with study drug|6|||
44264961|NCT02516592|79166955|FG001|Overall Study|Death|1|||
44178865|NCT02443805|78972743|FG001|Overall Study|Non-compliance with study drug|4|||
44178866|NCT02443805|78972742|FG000|Overall Study|Withdrawal by parent/guardian|3|||
44178867|NCT02443805|78972743|FG001|Overall Study|Withdrawal by parent/guardian|5|||
44178868|NCT02443805|78972742|FG000|Overall Study|Any other reason not above-mentioned|3|||
44178869|NCT02443805|78972743|FG001|Overall Study|Any other reason not above-mentioned|2|||
44178870|NCT01652885|78972749|FG000|Overall Study|Adverse Event|1|||
44178871|NCT02459951|78972753|FG000|Overall Study|Unable to meet holding requirement|1|||
44178872|NCT02087241|78972762|FG000|Overall Study|Death|2|||
44178873|NCT02087241|78972763|FG001|Overall Study|Death|1|||
44178874|NCT02087241|78972764|FG002|Overall Study|Death|1|||
44178875|NCT02087241|78972765|FG003|Overall Study|Death|1|||
44178876|NCT02087241|78972762|FG000|Overall Study|Withdrawal by Subject|1|||
44178877|NCT02087241|78972763|FG001|Overall Study|Withdrawal by Subject|0|||
44178878|NCT02087241|78972764|FG002|Overall Study|Withdrawal by Subject|0|||
44178879|NCT02087241|78972765|FG003|Overall Study|Withdrawal by Subject|1|||
44178880|NCT02087241|78972762|FG000|Overall Study|Progressive Disease|0|||
44178881|NCT02087241|78972763|FG001|Overall Study|Progressive Disease|0|||
44178882|NCT02087241|78972764|FG002|Overall Study|Progressive Disease|0|||
44178883|NCT02087241|78972765|FG003|Overall Study|Progressive Disease|1|||
44178884|NCT02087241|78972762|FG000|Overall Study|Study Terminated by Sponsor|0|||
44178885|NCT02087241|78972763|FG001|Overall Study|Study Terminated by Sponsor|2|||
44178886|NCT02087241|78972764|FG002|Overall Study|Study Terminated by Sponsor|0|||
44178887|NCT02087241|78972765|FG003|Overall Study|Study Terminated by Sponsor|4|||
44178888|NCT02087085|78972781|FG000|Overall Study|Adverse Event|10|||
44178889|NCT02087085|78972782|FG001|Overall Study|Adverse Event|14|||
44178890|NCT02087085|78972781|FG000|Overall Study|Lack of Efficacy|4|||
44178891|NCT02087085|78972782|FG001|Overall Study|Lack of Efficacy|3|||
44178892|NCT02087085|78972781|FG000|Overall Study|Lost to Follow-up|6|||
44178893|NCT02087085|78972782|FG001|Overall Study|Lost to Follow-up|4|||
44178894|NCT02087085|78972781|FG000|Overall Study|Withdrawal by Subject|9|||
44178895|NCT02087085|78972782|FG001|Overall Study|Withdrawal by Subject|11|||
44178896|NCT02087085|78972781|FG000|Overall Study|Protocol Violation|1|||
44178897|NCT02087085|78972782|FG001|Overall Study|Protocol Violation|0|||
44178898|NCT02087085|78972781|FG000|Overall Study|Study Terminated by Sponsor|87|||
44178899|NCT02087085|78972782|FG001|Overall Study|Study Terminated by Sponsor|80|||
44178900|NCT02087085|78972781|FG000|Overall Study|Other Miscellaneous Reasons|3|||
44178901|NCT02087085|78972782|FG001|Overall Study|Other Miscellaneous Reasons|4|||
44178902|NCT02443337|78972790|FG000|Overall Study|Adverse Event|0|||
44178903|NCT02443337|78972791|FG001|Overall Study|Adverse Event|1|||
44178904|NCT02443337|78972790|FG000|Overall Study|Clinical Progressive Disease|3|||
44178905|NCT02443337|78972791|FG001|Overall Study|Clinical Progressive Disease|0|||
44178906|NCT02443337|78972790|FG000|Overall Study|Withdrawal by Subject|2|||
44178907|NCT02443337|78972791|FG001|Overall Study|Withdrawal by Subject|1|||
44178908|NCT02443103|78972802|FG000|Overall Study|Adverse Event|2|||
44178909|NCT02443103|78972802|FG000|Overall Study|Noncompliance|1|||
44178910|NCT02022657|78972806|FG000|Overall Study|Withdrawal by Subject|2|||
44178911|NCT02022657|78972807|FG001|Overall Study|Withdrawal by Subject|0|||
44178912|NCT02022657|78972808|FG002|Overall Study|Withdrawal by Subject|1|||
44178913|NCT02022657|78972809|FG003|Overall Study|Withdrawal by Subject|0|||
44178914|NCT02022657|78972810|FG004|Overall Study|Withdrawal by Subject|0|||
44178915|NCT02022657|78972811|FG005|Overall Study|Withdrawal by Subject|0|||
44178916|NCT02022657|78972806|FG000|Overall Study|Physician Decision|0|||
44178917|NCT02022657|78972807|FG001|Overall Study|Physician Decision|0|||
44178918|NCT02022657|78972808|FG002|Overall Study|Physician Decision|0|||
44178919|NCT02022657|78972809|FG003|Overall Study|Physician Decision|0|||
44178920|NCT02022657|78972810|FG004|Overall Study|Physician Decision|0|||
44178921|NCT02022657|78972811|FG005|Overall Study|Physician Decision|1|||
44178922|NCT02418455|78972817|FG000|48-Week Treatment Period|Other- Not Specified|1|||
44178923|NCT02418455|78972817|FG000|Continuation Period|Sponsor Decision|7|||
44178924|NCT02417753|78972823|FG000|Overall Study|Death|1|||
44178925|NCT02417441|78972829|FG000|Overall Study|Inconclusive due to missing data|52|||
44178926|NCT02417441|78972830|FG001|Overall Study|Inconclusive due to missing data|19|||
44178927|NCT02021643|78972843|FG000|Overall Study|Enrolled but Never Treated|1|||
44178928|NCT02021643|78972844|FG001|Overall Study|Enrolled but Never Treated|0|||
44178929|NCT02021643|78972845|FG002|Overall Study|Enrolled but Never Treated|0|||
44178930|NCT02021643|78972846|FG003|Overall Study|Enrolled but Never Treated|0|||
44178931|NCT02021643|78972843|FG000|Overall Study|Adverse Event|0|||
44178932|NCT02021643|78972844|FG001|Overall Study|Adverse Event|1|||
44178933|NCT02021643|78972845|FG002|Overall Study|Adverse Event|0|||
44178934|NCT02021643|78972846|FG003|Overall Study|Adverse Event|0|||
44178935|NCT02021643|78972843|FG000|Overall Study|Death|0|||
44178936|NCT02021643|78972844|FG001|Overall Study|Death|1|||
44178937|NCT02021643|78972845|FG002|Overall Study|Death|0|||
44178938|NCT02021643|78972846|FG003|Overall Study|Death|0|||
44178939|NCT02021643|78972843|FG000|Overall Study|Investigator's Discretion|1|||
44178940|NCT02021643|78972844|FG001|Overall Study|Investigator's Discretion|0|||
44178941|NCT02021643|78972845|FG002|Overall Study|Investigator's Discretion|0|||
44178942|NCT02021643|78972846|FG003|Overall Study|Investigator's Discretion|0|||
44178943|NCT02021643|78972843|FG000|Overall Study|Lack of Efficacy|7|||
44178944|NCT02021643|78972844|FG001|Overall Study|Lack of Efficacy|6|||
44178945|NCT02021643|78972845|FG002|Overall Study|Lack of Efficacy|0|||
44178946|NCT02021643|78972846|FG003|Overall Study|Lack of Efficacy|12|||
44178947|NCT02021643|78972843|FG000|Overall Study|Lost to Follow-up|0|||
44178948|NCT02021643|78972844|FG001|Overall Study|Lost to Follow-up|1|||
44178949|NCT02021643|78972845|FG002|Overall Study|Lost to Follow-up|0|||
44178950|NCT02021643|78972846|FG003|Overall Study|Lost to Follow-up|0|||
44178951|NCT02021643|78972843|FG000|Overall Study|Withdrew Consent|0|||
44178952|NCT02021643|78972844|FG001|Overall Study|Withdrew Consent|1|||
44178953|NCT02021643|78972845|FG002|Overall Study|Withdrew Consent|0|||
44178954|NCT02021643|78972846|FG003|Overall Study|Withdrew Consent|0|||
44178955|NCT02415959|78972867|FG000|Overall Study|Adverse Event|0|||
44178956|NCT02415959|78972868|FG001|Overall Study|Adverse Event|1|||
44178957|NCT02415959|78972869|FG002|Overall Study|Adverse Event|0|||
44178958|NCT02415959|78972870|FG003|Overall Study|Adverse Event|0|||
44178959|NCT02415959|78972871|FG004|Overall Study|Adverse Event|0|||
44178960|NCT02415959|78972867|FG000|Overall Study|Protocol Violation|0|||
44178961|NCT02415959|78972868|FG001|Overall Study|Protocol Violation|0|||
44178962|NCT02415959|78972869|FG002|Overall Study|Protocol Violation|0|||
44178963|NCT02415959|78972870|FG003|Overall Study|Protocol Violation|1|||
44178964|NCT02415959|78972871|FG004|Overall Study|Protocol Violation|0|||
44178965|NCT02021565|78972885|FG000|Baseline Through Intervention|Death|0|||
44178966|NCT02021565|78972886|FG001|Baseline Through Intervention|Death|1|||
44178967|NCT02021565|78972885|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
44178968|NCT02021565|78972886|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
44178969|NCT02021565|78972885|FG000|Baseline Through Intervention|Protocol Violation|0|||
44178970|NCT02021565|78972886|FG001|Baseline Through Intervention|Protocol Violation|7|||
44178971|NCT02021565|78972885|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
44178972|NCT02021565|78972886|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
44178973|NCT02021565|78972885|FG000|3-month Follow-up|Death|3|||
44178974|NCT02021565|78972886|FG001|3-month Follow-up|Death|0|||
44178975|NCT02021565|78972885|FG000|3-month Follow-up|Withdrawal by Subject|4|||
44178976|NCT02021565|78972886|FG001|3-month Follow-up|Withdrawal by Subject|0|||
44178977|NCT02021565|78972885|FG000|3-month Follow-up|Protocol Violation|3|||
44178978|NCT02021565|78972886|FG001|3-month Follow-up|Protocol Violation|2|||
44178979|NCT02021331|78972896|FG000|Overall Study|Adverse Event|0|||
44178980|NCT02021331|78972897|FG001|Overall Study|Adverse Event|2|||
44178981|NCT02085135|78972905|FG000|Overall Study|Adverse Event|4|||
44178982|NCT02085135|78972906|FG001|Overall Study|Adverse Event|7|||
44178983|NCT02085135|78972905|FG000|Overall Study|Lost to Follow-up|2|||
44178984|NCT02085135|78972906|FG001|Overall Study|Lost to Follow-up|2|||
44178985|NCT02085135|78972905|FG000|Overall Study|Withdrawal by Subject|3|||
44178986|NCT02085135|78972906|FG001|Overall Study|Withdrawal by Subject|0|||
44178987|NCT02085135|78972905|FG000|Overall Study|Lack of Efficacy|2|||
44178988|NCT02085135|78972906|FG001|Overall Study|Lack of Efficacy|0|||
44178989|NCT02441309|78972915|FG000|Overall Study|Disease progression|2|||
44178990|NCT02441309|78972916|FG001|Overall Study|Disease progression|1|||
44178991|NCT02441309|78972917|FG002|Overall Study|Disease progression|2|||
44178992|NCT02441309|78972915|FG000|Overall Study|Adverse Event|0|||
44178993|NCT02441309|78972916|FG001|Overall Study|Adverse Event|1|||
44178994|NCT02441309|78972917|FG002|Overall Study|Adverse Event|0|||
44178995|NCT02441309|78972915|FG000|Overall Study|Withdrawal by Subject|1|||
44178996|NCT02441309|78972916|FG001|Overall Study|Withdrawal by Subject|0|||
44178997|NCT02441309|78972917|FG002|Overall Study|Withdrawal by Subject|1|||
44178998|NCT02027025|78972931|FG000|Overall Study|Adverse Event|0|||
44178999|NCT02027025|78972932|FG001|Overall Study|Adverse Event|1|||
44179000|NCT02027025|78972933|FG002|Overall Study|Adverse Event|1|||
44179001|NCT02027025|78972931|FG000|Overall Study|Protocol Violation|1|||
44179002|NCT02027025|78972932|FG001|Overall Study|Protocol Violation|0|||
44179003|NCT02027025|78972933|FG002|Overall Study|Protocol Violation|0|||
44179004|NCT02027025|78972931|FG000|Overall Study|Lost to Follow-up|0|||
44179005|NCT02027025|78972932|FG001|Overall Study|Lost to Follow-up|2|||
44179006|NCT02027025|78972933|FG002|Overall Study|Lost to Follow-up|0|||
44179007|NCT02027025|78972931|FG000|Overall Study|Withdrawal by Subject|0|||
44179008|NCT02027025|78972932|FG001|Overall Study|Withdrawal by Subject|1|||
44179009|NCT02027025|78972933|FG002|Overall Study|Withdrawal by Subject|0|||
44179010|NCT02027025|78972931|FG000|Overall Study|Sponsor's decision|0|||
44179011|NCT02027025|78972932|FG001|Overall Study|Sponsor's decision|1|||
44179012|NCT02027025|78972933|FG002|Overall Study|Sponsor's decision|0|||
44179013|NCT01652729|78972955|FG000|Overall Study|Withdrawal by Subject|14|||
44179014|NCT01652729|78972956|FG001|Overall Study|Withdrawal by Subject|7|||
44179015|NCT01652729|78972957|FG002|Overall Study|Withdrawal by Subject|7|||
44179016|NCT01652729|78972955|FG000|Overall Study|Adverse Event|4|||
44179017|NCT01652729|78972956|FG001|Overall Study|Adverse Event|0|||
44179018|NCT01652729|78972957|FG002|Overall Study|Adverse Event|3|||
44179019|NCT01652729|78972955|FG000|Overall Study|Physician Decision|1|||
44179020|NCT01652729|78972956|FG001|Overall Study|Physician Decision|0|||
44179021|NCT01652729|78972957|FG002|Overall Study|Physician Decision|1|||
44179022|NCT01652729|78972955|FG000|Overall Study|Protocol Violation|1|||
44179023|NCT01652729|78972956|FG001|Overall Study|Protocol Violation|0|||
44179024|NCT01652729|78972957|FG002|Overall Study|Protocol Violation|0|||
44179025|NCT01652729|78972955|FG000|Overall Study|Lost to Follow-up|6|||
44179026|NCT01652729|78972956|FG001|Overall Study|Lost to Follow-up|6|||
44179027|NCT01652729|78972957|FG002|Overall Study|Lost to Follow-up|3|||
44179028|NCT01652729|78972955|FG000|Overall Study|Administrative|1|||
44179029|NCT01652729|78972956|FG001|Overall Study|Administrative|0|||
44179030|NCT01652729|78972957|FG002|Overall Study|Administrative|0|||
44179031|NCT02083965|78972967|FG000|Treatment Period|Other|1|||
44179032|NCT02083965|78972968|FG001|Treatment Period|Other|0|||
44179033|NCT02438813|78972976|FG000|Overall Study|Patient Decision|59|||
44179034|NCT02438813|78972976|FG000|Overall Study|Patient Lost to Follow-Up|137|||
44179035|NCT02438813|78972976|FG000|Overall Study|Study Ended by Sponsor|80|||
44179036|NCT02438813|78972976|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
44179037|NCT02437409|78972990|FG000|Overall Study|Withdrawal by Subject|3|||
44179038|NCT02437409|78972990|FG000|Overall Study|Screening failure|12|||
44179039|NCT02459093|78972997|FG000|Overall Study|Protocol Violation|6|||
44179040|NCT02459093|78972998|FG001|Overall Study|Protocol Violation|11|||
44451192|NCT00485589|79460201|FG001|Overall Study|Adverse Event|3|||
44451193|NCT00485589|79460202|FG002|Overall Study|Adverse Event|10|||
44451194|NCT00490971|79460221|FG000|Acute/Continuation|Adverse Event|62|||
44451195|NCT00490971|79460222|FG001|Acute/Continuation|Adverse Event|13|||
44179041|NCT02459093|78972997|FG000|Overall Study|Lost to Follow-up|6|||
44179042|NCT02459093|78972998|FG001|Overall Study|Lost to Follow-up|7|||
44179043|NCT02458469|78973004|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
44179044|NCT02458469|78973005|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
44179045|NCT02458469|78973006|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
44179046|NCT02458469|78973007|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
44179047|NCT02458469|78973008|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
44179048|NCT02458469|78973009|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
44179049|NCT02458469|78973004|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
44179050|NCT02458469|78973005|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
44179051|NCT02458469|78973006|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
44179052|NCT02458469|78973007|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
44179053|NCT02458469|78973008|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
44179054|NCT02458469|78973009|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
44179055|NCT02458469|78973004|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179056|NCT02458469|78973005|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179057|NCT02458469|78973006|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179058|NCT02458469|78973007|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179059|NCT02458469|78973008|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179060|NCT02458469|78973009|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
44179061|NCT01843348|78973020|FG000|Overall Study|Withdrawal by Subject|4|||
44179062|NCT01843348|78973021|FG001|Overall Study|Withdrawal by Subject|16|||
44179063|NCT01843348|78973022|FG002|Overall Study|Withdrawal by Subject|18|||
44179064|NCT01843348|78973020|FG000|Overall Study|Lost to Follow-up|5|||
44179065|NCT01843348|78973021|FG001|Overall Study|Lost to Follow-up|4|||
44179066|NCT01843348|78973022|FG002|Overall Study|Lost to Follow-up|2|||
44179067|NCT01843348|78973020|FG000|Overall Study|Death|5|||
44179068|NCT01843348|78973021|FG001|Overall Study|Death|3|||
44179069|NCT01843348|78973022|FG002|Overall Study|Death|4|||
44179070|NCT01843348|78973020|FG000|Overall Study|Graft loss/retransplantation|5|||
44179071|NCT01843348|78973021|FG001|Overall Study|Graft loss/retransplantation|8|||
44179072|NCT01843348|78973022|FG002|Overall Study|Graft loss/retransplantation|11|||
44179073|NCT01843348|78973020|FG000|Overall Study|Various reasons|4|||
44451196|NCT00490971|79460223|FG002|Acute/Continuation|Adverse Event|0|||
44179074|NCT01843348|78973021|FG001|Overall Study|Various reasons|9|||
44179075|NCT01843348|78973022|FG002|Overall Study|Various reasons|6|||
44179076|NCT01843192|78973035|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
44179077|NCT01843192|78973036|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
44179078|NCT01843192|78973037|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
44179079|NCT01825876|78973045|FG000|Period 2|Withdrawal by Subject|0|||
44179080|NCT01825876|78973046|FG001|Period 2|Withdrawal by Subject|1|||
44179081|NCT01842958|78973057|FG000|Overall Study|Lost to Follow-up|1|||
44179082|NCT01842958|78973058|FG001|Overall Study|Lost to Follow-up|1|||
44179083|NCT02413229|78973072|FG000|Overall Study|Adverse Event|0|||
44179084|NCT02413229|78973073|FG001|Overall Study|Adverse Event|0|||
44179085|NCT02413229|78973074|FG002|Overall Study|Adverse Event|0|||
44179086|NCT02413229|78973075|FG003|Overall Study|Adverse Event|1|||
44179087|NCT02413229|78973076|FG004|Overall Study|Adverse Event|0|||
44179088|NCT02413229|78973077|FG005|Overall Study|Adverse Event|0|||
44179089|NCT02413229|78973078|FG006|Overall Study|Adverse Event|0|||
44179090|NCT02413229|78973079|FG007|Overall Study|Adverse Event|1|||
44179091|NCT02413229|78973072|FG000|Overall Study|Lost to Follow-up|0|||
44179092|NCT02413229|78973073|FG001|Overall Study|Lost to Follow-up|0|||
44179093|NCT02413229|78973074|FG002|Overall Study|Lost to Follow-up|1|||
44179094|NCT02413229|78973075|FG003|Overall Study|Lost to Follow-up|0|||
44179095|NCT02413229|78973076|FG004|Overall Study|Lost to Follow-up|2|||
44179096|NCT02413229|78973077|FG005|Overall Study|Lost to Follow-up|0|||
44179097|NCT02413229|78973078|FG006|Overall Study|Lost to Follow-up|0|||
44179098|NCT02413229|78973079|FG007|Overall Study|Lost to Follow-up|0|||
44179099|NCT02413229|78973072|FG000|Overall Study|Withdrawal by Subject|1|||
44179100|NCT02413229|78973073|FG001|Overall Study|Withdrawal by Subject|1|||
44179101|NCT02413229|78973074|FG002|Overall Study|Withdrawal by Subject|0|||
44179102|NCT02413229|78973075|FG003|Overall Study|Withdrawal by Subject|0|||
44179103|NCT02413229|78973076|FG004|Overall Study|Withdrawal by Subject|1|||
44179104|NCT02413229|78973077|FG005|Overall Study|Withdrawal by Subject|0|||
44179105|NCT02413229|78973078|FG006|Overall Study|Withdrawal by Subject|0|||
44179106|NCT02413229|78973079|FG007|Overall Study|Withdrawal by Subject|2|||
44179107|NCT02413229|78973072|FG000|Overall Study|Progressive Disease|0|||
44179108|NCT02413229|78973073|FG001|Overall Study|Progressive Disease|0|||
44179109|NCT02413229|78973074|FG002|Overall Study|Progressive Disease|0|||
44179110|NCT02413229|78973075|FG003|Overall Study|Progressive Disease|0|||
44179111|NCT02413229|78973076|FG004|Overall Study|Progressive Disease|0|||
44179112|NCT02413229|78973077|FG005|Overall Study|Progressive Disease|0|||
44179113|NCT02413229|78973078|FG006|Overall Study|Progressive Disease|0|||
44179114|NCT02413229|78973079|FG007|Overall Study|Progressive Disease|1|||
44179115|NCT01825798|78973099|FG000|Overall Study|Adverse Event|1|||
44179116|NCT01825798|78973100|FG001|Overall Study|Adverse Event|5|||
44179117|NCT01825798|78973099|FG000|Overall Study|Lost to Follow-up|1|||
44179118|NCT01825798|78973100|FG001|Overall Study|Lost to Follow-up|0|||
44179119|NCT01824472|78973109|FG000|Overall Study|Lost to Follow-up|0|||
44179120|NCT01824472|78973110|FG001|Overall Study|Lost to Follow-up|0|||
44179121|NCT01824472|78973111|FG002|Overall Study|Lost to Follow-up|1|||
44179122|NCT01824472|78973109|FG000|Overall Study|Withdrawal by Subject|1|||
44179123|NCT01824472|78973110|FG001|Overall Study|Withdrawal by Subject|5|||
44179124|NCT01824472|78973111|FG002|Overall Study|Withdrawal by Subject|3|||
44179125|NCT01824472|78973109|FG000|Overall Study|Ineligible post randomization&screening|0|||
44179126|NCT01824472|78973110|FG001|Overall Study|Ineligible post randomization&screening|2|||
44179127|NCT01824472|78973111|FG002|Overall Study|Ineligible post randomization&screening|0|||
44179128|NCT02412761|78973119|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179129|NCT02412761|78973120|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
44179130|NCT02412761|78973121|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
44179131|NCT02412761|78973122|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179132|NCT02412761|78973123|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44179133|NCT02412761|78973124|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
44179134|NCT01842334|78973134|FG000|Overall Study|Withdrawal by Subject|3|||
44179135|NCT01842334|78973135|FG001|Overall Study|Withdrawal by Subject|3|||
44179136|NCT01842334|78973134|FG000|Overall Study|Moved away mid-study|0|||
44451197|NCT00490971|79460224|FG003|Acute/Continuation|Adverse Event|0|||
44451198|NCT00490971|79460225|FG004|Acute/Continuation|Adverse Event|0|||
44451199|NCT00490971|79460221|FG000|Acute/Continuation|Death|2|||
44451200|NCT00490971|79460222|FG001|Acute/Continuation|Death|0|||
44451201|NCT00490971|79460223|FG002|Acute/Continuation|Death|0|||
44451202|NCT00490971|79460224|FG003|Acute/Continuation|Death|0|||
44451203|NCT00490971|79460225|FG004|Acute/Continuation|Death|0|||
44451204|NCT00490971|79460221|FG000|Acute/Continuation|Lack of Efficacy|106|||
44451205|NCT00490971|79460222|FG001|Acute/Continuation|Lack of Efficacy|12|||
44179137|NCT01842334|78973135|FG001|Overall Study|Moved away mid-study|1|||
44179138|NCT02457611|78973141|FG000|Overall Study|Lost to Follow-up|3|||
44179139|NCT02457065|78973147|FG000|Overall Study|Lost to Follow-up|9|||
44179140|NCT02457065|78973148|FG001|Overall Study|Lost to Follow-up|11|||
44179141|NCT02083653|78973157|FG000|Overall Study|Randomized but not Treated|0|||
44179142|NCT02083653|78973158|FG001|Overall Study|Randomized but not Treated|2|||
44179143|NCT02083653|78973159|FG002|Overall Study|Randomized but not Treated|7|||
44179144|NCT02083653|78973157|FG000|Overall Study|Adverse Event|12|||
44179145|NCT02083653|78973158|FG001|Overall Study|Adverse Event|5|||
44179146|NCT02083653|78973159|FG002|Overall Study|Adverse Event|4|||
44179147|NCT02083653|78973157|FG000|Overall Study|Lost to Follow-up|1|||
44179148|NCT02083653|78973158|FG001|Overall Study|Lost to Follow-up|0|||
44179149|NCT02083653|78973159|FG002|Overall Study|Lost to Follow-up|0|||
44179150|NCT02083653|78973157|FG000|Overall Study|Death|2|||
44179151|NCT02083653|78973158|FG001|Overall Study|Death|2|||
44179152|NCT02083653|78973159|FG002|Overall Study|Death|2|||
44179153|NCT02083653|78973157|FG000|Overall Study|Progressive Disease|65|||
44179154|NCT02083653|78973158|FG001|Overall Study|Progressive Disease|73|||
44179155|NCT02083653|78973159|FG002|Overall Study|Progressive Disease|63|||
44179156|NCT02083653|78973157|FG000|Overall Study|Withdrawal by Subject|2|||
44179157|NCT02083653|78973158|FG001|Overall Study|Withdrawal by Subject|1|||
44179158|NCT02083653|78973159|FG002|Overall Study|Withdrawal by Subject|2|||
44179159|NCT02083653|78973157|FG000|Overall Study|Other Events|0|||
44179160|NCT02083653|78973158|FG001|Overall Study|Other Events|2|||
44179161|NCT02083653|78973159|FG002|Overall Study|Other Events|2|||
44179162|NCT02083653|78973157|FG000|Overall Study|Reason Missing|0|||
44179163|NCT02083653|78973158|FG001|Overall Study|Reason Missing|0|||
44179164|NCT02083653|78973159|FG002|Overall Study|Reason Missing|4|||
44179165|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Adverse Event|12|||
44179166|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Adverse Event|3|||
44179167|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Adverse Event|4|||
44179168|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Adverse Event|2|||
44179169|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
44179170|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
44179171|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
44179172|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
44179173|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
44179174|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
44179175|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
44179176|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
44179177|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
44179178|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
44451206|NCT00490971|79460223|FG002|Acute/Continuation|Lack of Efficacy|0|||
44179179|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
44451207|NCT00490971|79460224|FG003|Acute/Continuation|Lack of Efficacy|0|||
44451208|NCT00490971|79460225|FG004|Acute/Continuation|Lack of Efficacy|0|||
44179180|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
44179181|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
44179182|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
44179183|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
44179184|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
44179185|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
44179186|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
44179187|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
44179188|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
44179189|NCT02436239|78973171|FG000|Open-Lable Treatment Period|Other Reason|1|||
44179190|NCT02436239|78973172|FG001|Open-Lable Treatment Period|Other Reason|1|||
44179191|NCT02436239|78973173|FG002|Open-Lable Treatment Period|Other Reason|0|||
44179192|NCT02436239|78973174|FG003|Open-Lable Treatment Period|Other Reason|0|||
44179193|NCT02436239|78973171|FG000|Down-Taper Period|Withdrawal by Subject|4|||
44179194|NCT02436239|78973172|FG001|Down-Taper Period|Withdrawal by Subject|4|||
44179195|NCT02436239|78973173|FG002|Down-Taper Period|Withdrawal by Subject|1|||
44179196|NCT02436239|78973174|FG003|Down-Taper Period|Withdrawal by Subject|2|||
44179197|NCT02026011|78973186|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
44179198|NCT02026011|78973187|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
44179199|NCT02026011|78973186|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
44179200|NCT02026011|78973187|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
44179201|NCT02026011|78973186|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
44179202|NCT02026011|78973187|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
44179203|NCT02026011|78973186|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
44179204|NCT02026011|78973187|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
44179205|NCT02436005|78973196|FG000|Second Intervention|Adverse Event|0|||
44179206|NCT02436005|78973197|FG001|Second Intervention|Adverse Event|1|||
44361198|NCT01157897|79366860|FG003|Overall Study|Relocated|0|||
44179207|NCT02456909|78973205|FG000|Overall Study|Did not receive allocated intervention|24|||
44179208|NCT02456909|78973206|FG001|Overall Study|Did not receive allocated intervention|26|||
44179209|NCT02456909|78973205|FG000|Overall Study|Did not complete the primary outcome|0|||
44179210|NCT02456909|78973206|FG001|Overall Study|Did not complete the primary outcome|1|||
44179211|NCT02025621|78973214|FG000|Overall Study|Withdrawal by Subject|1|||
44179212|NCT02025621|78973215|FG001|Overall Study|Withdrawal by Subject|0|||
44179213|NCT02025621|78973214|FG000|Overall Study|Death|0|||
44179214|NCT02025621|78973215|FG001|Overall Study|Death|1|||
44179215|NCT02025621|78973214|FG000|Overall Study|No longer eligible|10|||
44179216|NCT02025621|78973215|FG001|Overall Study|No longer eligible|15|||
44179217|NCT02025621|78973214|FG000|Overall Study|Surgery initiated before infusion|3|||
44179218|NCT02025621|78973215|FG001|Overall Study|Surgery initiated before infusion|3|||
44179219|NCT02020941|78973221|FG000|Overall Study|Adverse Event|1|||
44179220|NCT02020941|78973221|FG000|Overall Study|Physician Decision|2|||
44179221|NCT02020941|78973221|FG000|Overall Study|Withdrawal by Subject|1|||
44179222|NCT02020941|78973221|FG000|Overall Study|Disease Progression|4|||
44179223|NCT02024529|78973227|FG000|Overall Study|Withdrawal by Subject|11|||
44179224|NCT02024529|78973228|FG001|Overall Study|Withdrawal by Subject|21|||
44179225|NCT02024529|78973227|FG000|Overall Study|Lost to Follow-up|2|||
44179226|NCT02024529|78973228|FG001|Overall Study|Lost to Follow-up|4|||
44179227|NCT02020863|78973236|FG000|Overall Study|Discovery of Metastatic disease|4|||
44179228|NCT02020863|78973236|FG000|Overall Study|Team chose not to place an a line|1|||
44179229|NCT01824394|78973243|FG000|Overall Study|Early Termination|1|||
44179230|NCT01824394|78973244|FG001|Overall Study|Early Termination|1|||
44179231|NCT01824394|78973245|FG002|Overall Study|Early Termination|3|||
44179232|NCT01824394|78973243|FG000|Overall Study|Withdrawn due to Study Termination|91|||
44179233|NCT01824394|78973244|FG001|Overall Study|Withdrawn due to Study Termination|83|||
44179234|NCT01824394|78973245|FG002|Overall Study|Withdrawn due to Study Termination|41|||
44179235|NCT01824394|78973243|FG000|Overall Study|Lost to Follow-up|0|||
44179236|NCT01824394|78973244|FG001|Overall Study|Lost to Follow-up|9|||
44179237|NCT01824394|78973245|FG002|Overall Study|Lost to Follow-up|3|||
44179238|NCT01824394|78973243|FG000|Overall Study|Death|3|||
44179239|NCT01824394|78973244|FG001|Overall Study|Death|2|||
44179240|NCT01824394|78973245|FG002|Overall Study|Death|4|||
44179241|NCT01824394|78973243|FG000|Overall Study|Discontinued Subjects|1|||
44179242|NCT01824394|78973244|FG001|Overall Study|Discontinued Subjects|1|||
44179243|NCT01824394|78973245|FG002|Overall Study|Discontinued Subjects|2|||
44179244|NCT01824394|78973243|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
44179245|NCT01824394|78973244|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
44179246|NCT01824394|78973245|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
44179247|NCT01823536|78973259|FG000|Overall Study|Lost to Follow-up|1|||
44179248|NCT01823536|78973260|FG001|Overall Study|Lost to Follow-up|0|||
44179249|NCT01823536|78973261|FG002|Overall Study|Lost to Follow-up|0|||
44179250|NCT01823536|78973262|FG003|Overall Study|Lost to Follow-up|1|||
44179251|NCT01823536|78973263|FG004|Overall Study|Lost to Follow-up|1|||
44179252|NCT01823536|78973264|FG005|Overall Study|Lost to Follow-up|0|||
44179253|NCT01823536|78973259|FG000|Overall Study|Protocol Violation|0|||
44179254|NCT01823536|78973260|FG001|Overall Study|Protocol Violation|1|||
44179255|NCT01823536|78973261|FG002|Overall Study|Protocol Violation|0|||
44179256|NCT01823536|78973262|FG003|Overall Study|Protocol Violation|0|||
44179257|NCT01823536|78973263|FG004|Overall Study|Protocol Violation|0|||
44179258|NCT01823536|78973264|FG005|Overall Study|Protocol Violation|0|||
44179259|NCT01823536|78973259|FG000|Overall Study|Withdrawal by Subject|1|||
44179260|NCT01823536|78973260|FG001|Overall Study|Withdrawal by Subject|1|||
44179261|NCT01823536|78973261|FG002|Overall Study|Withdrawal by Subject|0|||
44179262|NCT01823536|78973262|FG003|Overall Study|Withdrawal by Subject|0|||
44179263|NCT01823536|78973263|FG004|Overall Study|Withdrawal by Subject|0|||
44179264|NCT01823536|78973264|FG005|Overall Study|Withdrawal by Subject|0|||
44179265|NCT01823536|78973259|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
44179266|NCT01823536|78973260|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
44179267|NCT01823536|78973261|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
44179268|NCT01823536|78973262|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
44179269|NCT01823536|78973263|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
44179270|NCT01823536|78973264|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
44179271|NCT01823536|78973259|FG000|Overall Study|Met exclusion criterion No 6|0|||
44179272|NCT01823536|78973260|FG001|Overall Study|Met exclusion criterion No 6|0|||
44179273|NCT01823536|78973261|FG002|Overall Study|Met exclusion criterion No 6|0|||
44179274|NCT01823536|78973262|FG003|Overall Study|Met exclusion criterion No 6|1|||
44179275|NCT01823536|78973263|FG004|Overall Study|Met exclusion criterion No 6|0|||
44179276|NCT01823536|78973264|FG005|Overall Study|Met exclusion criterion No 6|0|||
44179277|NCT01823536|78973259|FG000|Overall Study|Subject moved out of the state|0|||
44179278|NCT01823536|78973260|FG001|Overall Study|Subject moved out of the state|0|||
44179279|NCT01823536|78973261|FG002|Overall Study|Subject moved out of the state|0|||
44179280|NCT01823536|78973262|FG003|Overall Study|Subject moved out of the state|0|||
44179281|NCT01823536|78973263|FG004|Overall Study|Subject moved out of the state|1|||
44179282|NCT01823536|78973264|FG005|Overall Study|Subject moved out of the state|0|||
44179283|NCT01841554|78973277|FG000|Overall Study|Death|7|||
44179284|NCT01841554|78973277|FG000|Overall Study|No Implantation|1|||
44179285|NCT01841554|78973277|FG000|Overall Study|Discontinued Follow Up|5|||
44179286|NCT01841554|78973277|FG000|Overall Study|Study exit due to secondary intervention|6|||
44179287|NCT01823224|78973283|FG000|Overall Study|Lost to Follow-up|5|||
44179288|NCT01823224|78973284|FG001|Overall Study|Lost to Follow-up|6|||
44179289|NCT01823224|78973283|FG000|Overall Study|didn't qualify|1|||
44179290|NCT01823224|78973284|FG001|Overall Study|didn't qualify|2|||
44179291|NCT01823224|78973283|FG000|Overall Study|pharmacy error|0|||
44179292|NCT01823224|78973284|FG001|Overall Study|pharmacy error|1|||
44179293|NCT01823224|78973283|FG000|Overall Study|missed med dose|0|||
44179294|NCT01823224|78973284|FG001|Overall Study|missed med dose|1|||
44179295|NCT01823224|78973283|FG000|Overall Study|Withdrawal by Subject|0|||
44179296|NCT01823224|78973284|FG001|Overall Study|Withdrawal by Subject|1|||
44179297|NCT01840228|78973294|FG000|Overall Study|Lost to Follow-up|1|||
44179298|NCT01840228|78973295|FG001|Overall Study|Lost to Follow-up|1|||
44179299|NCT01839916|78973305|FG000|Overall Study|Death|9|||
44179300|NCT01839916|78973305|FG000|Overall Study|Physician Decision|17|||
44451209|NCT00490971|79460221|FG000|Acute/Continuation|Lost to Follow-up|23|||
44179301|NCT01839916|78973305|FG000|Overall Study|Relapse|12|||
44451210|NCT00490971|79460222|FG001|Acute/Continuation|Lost to Follow-up|7|||
44179302|NCT01839916|78973305|FG000|Overall Study|GVHD|2|||
44179303|NCT01839916|78973305|FG000|Overall Study|Graft Failure|1|||
44179304|NCT01823146|78973311|FG000|Overall Study|Withdrawal by Subject|0|||
44179305|NCT01823146|78973312|FG001|Overall Study|Withdrawal by Subject|1|||
44179306|NCT01823146|78973311|FG000|Overall Study|Lost to Follow-up|2|||
44179307|NCT01823146|78973312|FG001|Overall Study|Lost to Follow-up|1|||
44179308|NCT02083185|78973321|FG000|Overall Study|Lost to Follow-up|0|||
44451211|NCT00490971|79460223|FG002|Acute/Continuation|Lost to Follow-up|0|||
44451212|NCT00490971|79460224|FG003|Acute/Continuation|Lost to Follow-up|0|||
44451213|NCT00490971|79460225|FG004|Acute/Continuation|Lost to Follow-up|0|||
44451214|NCT00490971|79460221|FG000|Acute/Continuation|Protocol Violation|10|||
44451215|NCT00490971|79460222|FG001|Acute/Continuation|Protocol Violation|2|||
44451216|NCT00490971|79460223|FG002|Acute/Continuation|Protocol Violation|0|||
44179309|NCT02083185|78973322|FG001|Overall Study|Lost to Follow-up|3|||
44179310|NCT02083185|78973323|FG002|Overall Study|Lost to Follow-up|0|||
44179311|NCT02083185|78973321|FG000|Overall Study|Withdrawal by Subject|9|||
44179312|NCT02083185|78973322|FG001|Overall Study|Withdrawal by Subject|15|||
44179313|NCT02083185|78973323|FG002|Overall Study|Withdrawal by Subject|1|||
44179314|NCT02083185|78973321|FG000|Overall Study|Death|2|||
44179315|NCT02083185|78973322|FG001|Overall Study|Death|2|||
44179316|NCT02083185|78973323|FG002|Overall Study|Death|1|||
44179317|NCT02083185|78973321|FG000|Overall Study|Reason not Specified|9|||
44179318|NCT02083185|78973322|FG001|Overall Study|Reason not Specified|6|||
44179319|NCT02083185|78973323|FG002|Overall Study|Reason not Specified|5|||
44179320|NCT02083185|78973321|FG000|Overall Study|Study Terminated by Sponsor|0|||
44179321|NCT02083185|78973322|FG001|Overall Study|Study Terminated by Sponsor|1|||
44179322|NCT02083185|78973323|FG002|Overall Study|Study Terminated by Sponsor|0|||
44179323|NCT02083185|78973321|FG000|Overall Study|Did not Receive Study Drug|0|||
44179324|NCT02083185|78973322|FG001|Overall Study|Did not Receive Study Drug|2|||
44179325|NCT02083185|78973323|FG002|Overall Study|Did not Receive Study Drug|0|||
44179326|NCT02019927|78973337|FG000|Overall Study|Lost to Follow-up|2|||
44179327|NCT02019927|78973338|FG001|Overall Study|Lost to Follow-up|4|||
44179328|NCT02019927|78973339|FG002|Overall Study|Lost to Follow-up|1|||
44179329|NCT02019927|78973340|FG003|Overall Study|Lost to Follow-up|2|||
44179330|NCT02019927|78973341|FG004|Overall Study|Lost to Follow-up|3|||
44179331|NCT02019927|78973342|FG005|Overall Study|Lost to Follow-up|1|||
44179332|NCT02412371|78973366|FG000|Overall Study|Withdrawal by Subject|0|||
44179333|NCT02412371|78973367|FG001|Overall Study|Withdrawal by Subject|2|||
44179334|NCT02412371|78973368|FG002|Overall Study|Withdrawal by Subject|0|||
44179335|NCT02412371|78973369|FG003|Overall Study|Withdrawal by Subject|1|||
44179336|NCT02412371|78973370|FG004|Overall Study|Withdrawal by Subject|1|||
44179337|NCT02412371|78973371|FG005|Overall Study|Withdrawal by Subject|0|||
44179338|NCT02412371|78973366|FG000|Overall Study|Sponsor Discontinued Study|1|||
44179339|NCT02412371|78973367|FG001|Overall Study|Sponsor Discontinued Study|4|||
44179340|NCT02412371|78973368|FG002|Overall Study|Sponsor Discontinued Study|6|||
44179341|NCT02412371|78973369|FG003|Overall Study|Sponsor Discontinued Study|4|||
44179342|NCT02412371|78973370|FG004|Overall Study|Sponsor Discontinued Study|5|||
44179343|NCT02412371|78973371|FG005|Overall Study|Sponsor Discontinued Study|0|||
44179344|NCT02412371|78973366|FG000|Overall Study|Death|4|||
44179345|NCT02412371|78973367|FG001|Overall Study|Death|2|||
44179346|NCT02412371|78973368|FG002|Overall Study|Death|1|||
44179347|NCT02412371|78973369|FG003|Overall Study|Death|3|||
44179348|NCT02412371|78973370|FG004|Overall Study|Death|5|||
44179349|NCT02412371|78973371|FG005|Overall Study|Death|2|||
44179350|NCT02412371|78973366|FG000|Overall Study|Other|2|||
44179351|NCT02412371|78973367|FG001|Overall Study|Other|1|||
44179352|NCT02412371|78973368|FG002|Overall Study|Other|0|||
44179353|NCT02412371|78973369|FG003|Overall Study|Other|0|||
44179354|NCT02412371|78973370|FG004|Overall Study|Other|1|||
44179355|NCT02412371|78973371|FG005|Overall Study|Other|3|||
44179356|NCT02411747|78973388|FG000|Overall Study|Withdrawal by Subject|1|||
44179357|NCT02411747|78973389|FG001|Overall Study|Withdrawal by Subject|0|||
44179358|NCT02411747|78973388|FG000|Overall Study|Protocol Violation|2|||
44179359|NCT02411747|78973389|FG001|Overall Study|Protocol Violation|4|||
44179360|NCT01822756|78973400|FG000|Overall Study|Adverse Event|0|||
44179361|NCT01822756|78973401|FG001|Overall Study|Adverse Event|0|||
44179362|NCT01822756|78973402|FG002|Overall Study|Adverse Event|0|||
44179363|NCT01822756|78973403|FG003|Overall Study|Adverse Event|2|||
44451217|NCT00490971|79460224|FG003|Acute/Continuation|Protocol Violation|0|||
44179364|NCT01822756|78973404|FG004|Overall Study|Adverse Event|0|||
44179365|NCT01822756|78973400|FG000|Overall Study|Disease progression|11|||
44179366|NCT01822756|78973401|FG001|Overall Study|Disease progression|1|||
44179367|NCT01822756|78973402|FG002|Overall Study|Disease progression|7|||
44179368|NCT01822756|78973403|FG003|Overall Study|Disease progression|2|||
44179369|NCT01822756|78973404|FG004|Overall Study|Disease progression|6|||
44179370|NCT01822756|78973400|FG000|Overall Study|Death|2|||
44179371|NCT01822756|78973401|FG001|Overall Study|Death|2|||
44179372|NCT01822756|78973402|FG002|Overall Study|Death|1|||
44179373|NCT01822756|78973403|FG003|Overall Study|Death|0|||
44179374|NCT01822756|78973404|FG004|Overall Study|Death|0|||
44179375|NCT01822756|78973400|FG000|Overall Study|Lost to Follow-up|1|||
44179376|NCT01822756|78973401|FG001|Overall Study|Lost to Follow-up|0|||
44179377|NCT01822756|78973402|FG002|Overall Study|Lost to Follow-up|1|||
44179378|NCT01822756|78973403|FG003|Overall Study|Lost to Follow-up|0|||
44179379|NCT01822756|78973404|FG004|Overall Study|Lost to Follow-up|1|||
44179380|NCT01822756|78973400|FG000|Overall Study|Physician Decision|0|||
44179381|NCT01822756|78973401|FG001|Overall Study|Physician Decision|1|||
44179382|NCT01822756|78973402|FG002|Overall Study|Physician Decision|0|||
44179383|NCT01822756|78973403|FG003|Overall Study|Physician Decision|0|||
44179384|NCT01822756|78973404|FG004|Overall Study|Physician Decision|0|||
44179385|NCT01822756|78973400|FG000|Overall Study|disease progression & patient preference|2|||
44179386|NCT01822756|78973401|FG001|Overall Study|disease progression & patient preference|0|||
44179387|NCT01822756|78973402|FG002|Overall Study|disease progression & patient preference|1|||
44179388|NCT01822756|78973403|FG003|Overall Study|disease progression & patient preference|0|||
44179389|NCT01822756|78973404|FG004|Overall Study|disease progression & patient preference|0|||
44179390|NCT01822678|78973419|FG000|Overall Study|Withdrawal by Subject|5|||
44179391|NCT01822678|78973420|FG001|Overall Study|Withdrawal by Subject|4|||
44179392|NCT01822678|78973421|FG002|Overall Study|Withdrawal by Subject|4|||
44179393|NCT01822678|78973419|FG000|Overall Study|Adverse Event|4|||
44179394|NCT01822678|78973420|FG001|Overall Study|Adverse Event|3|||
44179395|NCT01822678|78973421|FG002|Overall Study|Adverse Event|1|||
44179396|NCT01822678|78973419|FG000|Overall Study|Lack of Efficacy|3|||
44179397|NCT01822678|78973420|FG001|Overall Study|Lack of Efficacy|6|||
44179398|NCT01822678|78973421|FG002|Overall Study|Lack of Efficacy|5|||
44179399|NCT01822678|78973419|FG000|Overall Study|Lost to Follow-up|0|||
44179400|NCT01822678|78973420|FG001|Overall Study|Lost to Follow-up|2|||
44179401|NCT01822678|78973421|FG002|Overall Study|Lost to Follow-up|1|||
44179402|NCT01822366|78973433|FG000|Overall Study|Lost to Follow-up|5|||
44179403|NCT01822366|78973434|FG001|Overall Study|Lost to Follow-up|1|||
44179404|NCT01822366|78973435|FG002|Overall Study|Lost to Follow-up|5|||
44179405|NCT01822366|78973436|FG003|Overall Study|Lost to Follow-up|1|||
44179406|NCT01822366|78973433|FG000|Overall Study|Withdrawal by Subject|0|||
44179407|NCT01822366|78973434|FG001|Overall Study|Withdrawal by Subject|6|||
44179408|NCT01822366|78973435|FG002|Overall Study|Withdrawal by Subject|0|||
44179409|NCT01822366|78973436|FG003|Overall Study|Withdrawal by Subject|6|||
44179410|NCT01822366|78973433|FG000|Overall Study|Partial Intervention Completion|0|||
44179411|NCT01822366|78973434|FG001|Overall Study|Partial Intervention Completion|15|||
44179412|NCT01822366|78973435|FG002|Overall Study|Partial Intervention Completion|0|||
44179413|NCT01822366|78973436|FG003|Overall Study|Partial Intervention Completion|15|||
44179414|NCT01838590|78973468|FG000|Overall Study|Lack of Efficacy|12|||
44179415|NCT01838590|78973469|FG001|Overall Study|Lack of Efficacy|4|||
44179416|NCT01838590|78973468|FG000|Overall Study|Lost to Follow-up|0|||
44179417|NCT01838590|78973469|FG001|Overall Study|Lost to Follow-up|1|||
44179418|NCT01611454|78973481|FG000|Overall Study|Lack of Efficacy|18|||
44179419|NCT01611454|78973482|FG001|Overall Study|Lack of Efficacy|10|||
44179420|NCT01611298|78973492|FG000|Overall Study|Relapsed|2|||
44179421|NCT01822132|78973498|FG000|Overall Study|Lost to Follow-up|4|||
44179422|NCT01822132|78973499|FG001|Overall Study|Lost to Follow-up|2|||
44361199|NCT01185821|79366875|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44361200|NCT01185821|79366876|FG001|Overall Study|Abnormal laboratory value(s)|2|||
44361201|NCT01185821|79366877|FG002|Overall Study|Abnormal laboratory value(s)|1|||
44361202|NCT01185821|79366878|FG003|Overall Study|Abnormal laboratory value(s)|0|||
44361203|NCT01185821|79366879|FG004|Overall Study|Abnormal laboratory value(s)|0|||
44451218|NCT00490971|79460225|FG004|Acute/Continuation|Protocol Violation|0|||
44179423|NCT01821898|78973513|FG000|Overall Study|Withdrawal by Subject|2|||
44179424|NCT01821898|78973514|FG001|Overall Study|Withdrawal by Subject|1|||
44179425|NCT02411591|78973524|FG000|Overall Study|Adverse Event|0|||
44179426|NCT02411591|78973525|FG001|Overall Study|Adverse Event|4|||
44179427|NCT02411591|78973526|FG002|Overall Study|Adverse Event|2|||
44179428|NCT02411591|78973524|FG000|Overall Study|Withdrawal by Subject|0|||
44179429|NCT02411591|78973525|FG001|Overall Study|Withdrawal by Subject|3|||
44179430|NCT02411591|78973526|FG002|Overall Study|Withdrawal by Subject|0|||
44179431|NCT02411591|78973524|FG000|Overall Study|Physician Decision|0|||
44179432|NCT02411591|78973525|FG001|Overall Study|Physician Decision|3|||
44179433|NCT02411591|78973526|FG002|Overall Study|Physician Decision|1|||
44179434|NCT02454959|78973542|FG000|Overall Study|Protocol-Specified Criteria|3|||
44179435|NCT02454959|78973542|FG000|Overall Study|Physician Decision|1|||
44179436|NCT02454959|78973542|FG000|Overall Study|Withdrawal by Subject|3|||
44179437|NCT02454959|78973542|FG000|Overall Study|Adverse Event|2|||
44179438|NCT01821118|78973550|FG000|Overall Study|Death|0|||
44361204|NCT01185821|79366875|FG000|Overall Study|Protocol Violation|0|||
44361205|NCT01185821|79366876|FG001|Overall Study|Protocol Violation|0|||
44361206|NCT01185821|79366877|FG002|Overall Study|Protocol Violation|0|||
44179439|NCT01821118|78973551|FG001|Overall Study|Death|1|||
44179440|NCT01650779|78973557|FG000|Overall Study|Withdrawal by Subject|1|||
44179441|NCT02411201|78973561|FG000|Overall Study|Adverse Event|2|||
44179442|NCT02411201|78973561|FG000|Overall Study|Withdrawal by Subject|2|||
44179443|NCT02411201|78973561|FG000|Overall Study|Age group completed|2|||
44179444|NCT01838044|78973569|FG000|Overall Study|Adverse Event|4|||
44179445|NCT01838044|78973570|FG001|Overall Study|Adverse Event|6|||
44179446|NCT01838044|78973569|FG000|Overall Study|Protocol Violation|3|||
44179447|NCT01838044|78973570|FG001|Overall Study|Protocol Violation|3|||
44179448|NCT01838044|78973569|FG000|Overall Study|Withdrawal by Subject|0|||
44179449|NCT01838044|78973570|FG001|Overall Study|Withdrawal by Subject|2|||
44179450|NCT01838044|78973569|FG000|Overall Study|Insufficient clinical response|1|||
44179451|NCT01838044|78973570|FG001|Overall Study|Insufficient clinical response|2|||
44179452|NCT01838044|78973569|FG000|Overall Study|Medication error without associated AE|0|||
44179453|NCT01838044|78973570|FG001|Overall Study|Medication error without associated AE|1|||
44179454|NCT01838044|78973569|FG000|Overall Study|Lost to Follow-up|0|||
44179455|NCT01838044|78973570|FG001|Overall Study|Lost to Follow-up|2|||
44179456|NCT02410811|78973581|FG000|Overall Study|Withdrawal by Subject|0|||
44179457|NCT02410811|78973582|FG001|Overall Study|Withdrawal by Subject|0|||
44179458|NCT02410811|78973583|FG002|Overall Study|Withdrawal by Subject|1|||
44179459|NCT02410811|78973584|FG003|Overall Study|Withdrawal by Subject|0|||
44179460|NCT02435381|78973594|FG000|Overall Study|Lost to Follow-up|2|||
44179461|NCT02435381|78973595|FG001|Overall Study|Lost to Follow-up|1|||
44179462|NCT01837966|78973611|FG000|Overall Study|Withdrawal by Subject|2|||
44179463|NCT01837966|78973612|FG001|Overall Study|Withdrawal by Subject|1|||
44179464|NCT02435147|78973618|FG000|Overall Study|non-evaluable DXA scan|11|||
44179465|NCT02435069|78973622|FG000|Dose Response - First Intervention|Adverse Event|0|||
44179466|NCT02435069|78973623|FG001|Dose Response - First Intervention|Adverse Event|1|||
44179467|NCT02435069|78973624|FG002|Dose Response - First Intervention|Adverse Event|1|||
44179468|NCT02435069|78973625|FG003|Dose Response - First Intervention|Adverse Event|0|||
44179469|NCT02435069|78973626|FG004|Dose Response - First Intervention|Adverse Event|0|||
44179470|NCT02435069|78973622|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
44179471|NCT02435069|78973623|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
44179472|NCT02435069|78973624|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
44179473|NCT02435069|78973625|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
44179474|NCT02435069|78973626|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
44179475|NCT02454101|78973648|FG000|Overall Study|Adverse Event|2|||
44179476|NCT02454101|78973649|FG001|Overall Study|Adverse Event|3|||
44179477|NCT02454101|78973648|FG000|Overall Study|Lost to Follow-up|3|||
44179478|NCT02454101|78973649|FG001|Overall Study|Lost to Follow-up|4|||
44179479|NCT02409719|78973657|FG000|Overall Study|Lost to Follow-up|3|||
44179480|NCT02409719|78973658|FG001|Overall Study|Lost to Follow-up|3|||
44179481|NCT01820572|78973666|FG000|Randomization|Not Treated|2|||
44179482|NCT01820572|78973667|FG001|Randomization|Not Treated|1|||
44179483|NCT01820572|78973666|FG000|Treatment Period|Adverse Event|12|||
44179484|NCT01820572|78973667|FG001|Treatment Period|Adverse Event|7|||
44179485|NCT01820572|78973666|FG000|Treatment Period|Death|3|||
44179486|NCT01820572|78973667|FG001|Treatment Period|Death|3|||
44179487|NCT01820572|78973666|FG000|Treatment Period|Lack of Efficacy|1|||
44179488|NCT01820572|78973667|FG001|Treatment Period|Lack of Efficacy|0|||
44179489|NCT01820572|78973666|FG000|Treatment Period|poor/non compliance|0|||
44179490|NCT01820572|78973667|FG001|Treatment Period|poor/non compliance|3|||
44179491|NCT01820572|78973666|FG000|Treatment Period|request to discontinue|6|||
44179492|NCT01820572|78973667|FG001|Treatment Period|request to discontinue|11|||
44179493|NCT01820572|78973666|FG000|Treatment Period|No longer meets study criteria|3|||
44264962|NCT02492100|79166983|FG000|Overall Study|Death|1|||
44179494|NCT01820572|78973667|FG001|Treatment Period|No longer meets study criteria|10|||
44179495|NCT01820572|78973666|FG000|Treatment Period|withdrew consent|1|||
44179496|NCT01820572|78973667|FG001|Treatment Period|withdrew consent|2|||
44179497|NCT01820260|78973687|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179498|NCT01820260|78973688|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179499|NCT01820260|78973689|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179500|NCT01820260|78973690|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44264963|NCT02461758|79167001|FG000|Overall Study|Lost to Follow-up|0|||
44179501|NCT01820260|78973691|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179502|NCT01820260|78973692|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179503|NCT01820260|78973693|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
44179504|NCT01820260|78973694|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179505|NCT01820260|78973695|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179506|NCT01820260|78973696|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179507|NCT01820260|78973697|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179508|NCT01820260|78973698|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179509|NCT01820260|78973699|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179510|NCT01820260|78973700|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
44179511|NCT01820260|78973687|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179512|NCT01820260|78973688|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179513|NCT01820260|78973689|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179514|NCT01820260|78973690|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179515|NCT01820260|78973691|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179516|NCT01820260|78973692|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179517|NCT01820260|78973693|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179518|NCT01820260|78973694|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179519|NCT01820260|78973695|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179520|NCT01820260|78973696|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
44179521|NCT01820260|78973697|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179522|NCT01820260|78973698|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179523|NCT01820260|78973699|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179524|NCT01820260|78973700|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
44179525|NCT01610596|78973738|FG000|Overall Study|Lost to Follow-up|0|||
44179526|NCT01610596|78973739|FG001|Overall Study|Lost to Follow-up|1|||
44179527|NCT01818700|78973745|FG000|Overall Study|Adverse Event|67|||
44179528|NCT01818700|78973745|FG000|Overall Study|Lack of Efficacy|2|||
44179529|NCT01818700|78973745|FG000|Overall Study|Lost to Follow-up|5|||
44179530|NCT01818700|78973745|FG000|Overall Study|Withdrawal by Subject|27|||
44179531|NCT01818700|78973745|FG000|Overall Study|Protocol Violation|2|||
44179532|NCT01818700|78973745|FG000|Overall Study|Other|1|||
44179533|NCT01817764|78973753|FG000|Overall Study|Adverse Event|7|||
44179534|NCT01817764|78973754|FG001|Overall Study|Adverse Event|10|||
44179535|NCT01817764|78973753|FG000|Overall Study|Lack of Efficacy|9|||
44179536|NCT01817764|78973754|FG001|Overall Study|Lack of Efficacy|7|||
44179537|NCT01817764|78973753|FG000|Overall Study|Protocol Violation|7|||
44179538|NCT01817764|78973754|FG001|Overall Study|Protocol Violation|5|||
44179539|NCT01817764|78973753|FG000|Overall Study|Lost to Follow-up|1|||
44179540|NCT01817764|78973754|FG001|Overall Study|Lost to Follow-up|4|||
44361207|NCT01185821|79366878|FG003|Overall Study|Protocol Violation|1|||
44361208|NCT01185821|79366879|FG004|Overall Study|Protocol Violation|1|||
44179541|NCT01817764|78973753|FG000|Overall Study|Withdrawal by Subject|10|||
44179542|NCT01817764|78973754|FG001|Overall Study|Withdrawal by Subject|12|||
44179543|NCT01803880|78973763|FG000|Overall Study|Adverse Event|1|||
44179544|NCT01803880|78973764|FG001|Overall Study|Adverse Event|0|||
44179545|NCT01803880|78973765|FG002|Overall Study|Adverse Event|0|||
44179546|NCT01803880|78973763|FG000|Overall Study|Withdrawal by Subject|1|||
44179547|NCT01803880|78973764|FG001|Overall Study|Withdrawal by Subject|1|||
44179548|NCT01803880|78973765|FG002|Overall Study|Withdrawal by Subject|4|||
44179549|NCT01803880|78973763|FG000|Overall Study|Physician Decision|0|||
44179550|NCT01803880|78973764|FG001|Overall Study|Physician Decision|0|||
44179551|NCT01803880|78973765|FG002|Overall Study|Physician Decision|1|||
44179552|NCT01803880|78973763|FG000|Overall Study|Unable to return for follow-up visits|0|||
44361209|NCT01185821|79366875|FG000|Overall Study|Abnormal test procedure result|0|||
44361210|NCT01185821|79366876|FG001|Overall Study|Abnormal test procedure result|0|||
44361211|NCT01185821|79366877|FG002|Overall Study|Abnormal test procedure result|0|||
44361212|NCT01185821|79366878|FG003|Overall Study|Abnormal test procedure result|0|||
44179553|NCT01803880|78973764|FG001|Overall Study|Unable to return for follow-up visits|1|||
44179554|NCT01803880|78973765|FG002|Overall Study|Unable to return for follow-up visits|2|||
44179555|NCT01803880|78973763|FG000|Overall Study|Lost to Follow-up|1|||
44179556|NCT01803880|78973764|FG001|Overall Study|Lost to Follow-up|2|||
44179557|NCT01803880|78973765|FG002|Overall Study|Lost to Follow-up|3|||
44179558|NCT01803880|78973763|FG000|Overall Study|Protocol Violation|1|||
44179559|NCT01803880|78973764|FG001|Overall Study|Protocol Violation|0|||
44179560|NCT01803880|78973765|FG002|Overall Study|Protocol Violation|0|||
44179561|NCT01803880|78973763|FG000|Overall Study|Early study termination|0|||
44179562|NCT01803880|78973764|FG001|Overall Study|Early study termination|6|||
44179563|NCT01803880|78973765|FG002|Overall Study|Early study termination|5|||
44179564|NCT01803880|78973763|FG000|Overall Study|Incomplete data entry by sites|2|||
44451219|NCT00490971|79460221|FG000|Acute/Continuation|Withdrawal by Subject|92|||
44451220|NCT00490971|79460222|FG001|Acute/Continuation|Withdrawal by Subject|24|||
44451221|NCT00490971|79460223|FG002|Acute/Continuation|Withdrawal by Subject|0|||
44451222|NCT00490971|79460224|FG003|Acute/Continuation|Withdrawal by Subject|0|||
44451223|NCT00490971|79460225|FG004|Acute/Continuation|Withdrawal by Subject|0|||
44451224|NCT00490971|79460221|FG000|Acute/Continuation|Other|11|||
44451225|NCT00490971|79460222|FG001|Acute/Continuation|Other|4|||
44451226|NCT00490971|79460223|FG002|Acute/Continuation|Other|0|||
44451227|NCT00490971|79460224|FG003|Acute/Continuation|Other|0|||
44451228|NCT00490971|79460225|FG004|Acute/Continuation|Other|0|||
44179565|NCT01803880|78973764|FG001|Overall Study|Incomplete data entry by sites|0|||
44179566|NCT01803880|78973765|FG002|Overall Study|Incomplete data entry by sites|0|||
44179567|NCT01803646|78973777|FG000|Overall Study|Protocol Violation|1|||
44179568|NCT01803646|78973778|FG001|Overall Study|Protocol Violation|0|||
44179569|NCT01803646|78973777|FG000|Overall Study|Adverse Event|1|||
44179570|NCT01803646|78973778|FG001|Overall Study|Adverse Event|1|||
44179571|NCT01803646|78973777|FG000|Overall Study|Withdrawal by Subject|9|||
44179572|NCT01803646|78973778|FG001|Overall Study|Withdrawal by Subject|6|||
44451229|NCT00490971|79460221|FG000|Maintenance|Adverse Event|0|||
44179573|NCT01803646|78973777|FG000|Overall Study|Randomization error|1|||
44179574|NCT01803646|78973778|FG001|Overall Study|Randomization error|2|||
44451230|NCT00490971|79460222|FG001|Maintenance|Adverse Event|0|||
44179575|NCT01803646|78973777|FG000|Overall Study|Lost to Follow-up|5|||
44451231|NCT00490971|79460223|FG002|Maintenance|Adverse Event|4|||
44179576|NCT01803646|78973778|FG001|Overall Study|Lost to Follow-up|1|||
44179577|NCT01817530|78973792|FG000|Overall Study|Exclusionary Medication Received|0|||
44179578|NCT01817530|78973793|FG001|Overall Study|Exclusionary Medication Received|0|||
44179579|NCT01817530|78973794|FG002|Overall Study|Exclusionary Medication Received|0|||
44179580|NCT01817530|78973795|FG003|Overall Study|Exclusionary Medication Received|0|||
44179581|NCT01817530|78973796|FG004|Overall Study|Exclusionary Medication Received|1|||
44179582|NCT01817530|78973797|FG005|Overall Study|Exclusionary Medication Received|0|||
44179583|NCT01817530|78973798|FG006|Overall Study|Exclusionary Medication Received|0|||
44179584|NCT01817530|78973799|FG007|Overall Study|Exclusionary Medication Received|0|||
44179585|NCT01817530|78973792|FG000|Overall Study|Adverse Event|6|||
44179586|NCT01817530|78973793|FG001|Overall Study|Adverse Event|3|||
44179587|NCT01817530|78973794|FG002|Overall Study|Adverse Event|2|||
44179588|NCT01817530|78973795|FG003|Overall Study|Adverse Event|5|||
44179589|NCT01817530|78973796|FG004|Overall Study|Adverse Event|0|||
44179590|NCT01817530|78973797|FG005|Overall Study|Adverse Event|10|||
44179591|NCT01817530|78973798|FG006|Overall Study|Adverse Event|5|||
44179592|NCT01817530|78973799|FG007|Overall Study|Adverse Event|8|||
44179593|NCT01817530|78973792|FG000|Overall Study|Subject Noncompliant|3|||
44179594|NCT01817530|78973793|FG001|Overall Study|Subject Noncompliant|1|||
44179595|NCT01817530|78973794|FG002|Overall Study|Subject Noncompliant|0|||
44179596|NCT01817530|78973795|FG003|Overall Study|Subject Noncompliant|4|||
44179597|NCT01817530|78973796|FG004|Overall Study|Subject Noncompliant|0|||
44179598|NCT01817530|78973797|FG005|Overall Study|Subject Noncompliant|1|||
44179599|NCT01817530|78973798|FG006|Overall Study|Subject Noncompliant|1|||
44179600|NCT01817530|78973799|FG007|Overall Study|Subject Noncompliant|1|||
44179601|NCT01817530|78973792|FG000|Overall Study|Lack of Efficacy|1|||
44179602|NCT01817530|78973793|FG001|Overall Study|Lack of Efficacy|0|||
44179603|NCT01817530|78973794|FG002|Overall Study|Lack of Efficacy|0|||
44179604|NCT01817530|78973795|FG003|Overall Study|Lack of Efficacy|0|||
44264964|NCT02461758|79167002|FG001|Overall Study|Lost to Follow-up|1|||
44264965|NCT02461758|79167003|FG002|Overall Study|Lost to Follow-up|1|||
44179605|NCT01817530|78973796|FG004|Overall Study|Lack of Efficacy|0|||
44179606|NCT01817530|78973797|FG005|Overall Study|Lack of Efficacy|1|||
44179607|NCT01817530|78973798|FG006|Overall Study|Lack of Efficacy|0|||
44179608|NCT01817530|78973799|FG007|Overall Study|Lack of Efficacy|1|||
44179609|NCT01817530|78973792|FG000|Overall Study|Pregnancy|0|||
44179610|NCT01817530|78973793|FG001|Overall Study|Pregnancy|0|||
44179611|NCT01817530|78973794|FG002|Overall Study|Pregnancy|0|||
44179612|NCT01817530|78973795|FG003|Overall Study|Pregnancy|0|||
44179613|NCT01817530|78973796|FG004|Overall Study|Pregnancy|0|||
44179614|NCT01817530|78973797|FG005|Overall Study|Pregnancy|1|||
44179615|NCT01817530|78973798|FG006|Overall Study|Pregnancy|0|||
44179616|NCT01817530|78973799|FG007|Overall Study|Pregnancy|0|||
44179617|NCT01817530|78973792|FG000|Overall Study|Other|0|||
44179618|NCT01817530|78973793|FG001|Overall Study|Other|1|||
44179619|NCT01817530|78973794|FG002|Overall Study|Other|0|||
44179620|NCT01817530|78973795|FG003|Overall Study|Other|0|||
44179621|NCT01817530|78973796|FG004|Overall Study|Other|1|||
44179622|NCT01817530|78973797|FG005|Overall Study|Other|0|||
44179623|NCT01817530|78973798|FG006|Overall Study|Other|5|||
44179624|NCT01817530|78973799|FG007|Overall Study|Other|0|||
44179625|NCT01817530|78973792|FG000|Overall Study|Surgery or Invasive Intervention|1|||
44179626|NCT01817530|78973793|FG001|Overall Study|Surgery or Invasive Intervention|0|||
44179627|NCT01817530|78973794|FG002|Overall Study|Surgery or Invasive Intervention|0|||
44179628|NCT01817530|78973795|FG003|Overall Study|Surgery or Invasive Intervention|0|||
44179629|NCT01817530|78973796|FG004|Overall Study|Surgery or Invasive Intervention|1|||
44179630|NCT01817530|78973797|FG005|Overall Study|Surgery or Invasive Intervention|1|||
44179631|NCT01817530|78973798|FG006|Overall Study|Surgery or Invasive Intervention|1|||
44179632|NCT01817530|78973799|FG007|Overall Study|Surgery or Invasive Intervention|0|||
44179633|NCT01817530|78973792|FG000|Overall Study|Consent Withdrawn by Subject|3|||
44179634|NCT01817530|78973793|FG001|Overall Study|Consent Withdrawn by Subject|4|||
44179635|NCT01817530|78973794|FG002|Overall Study|Consent Withdrawn by Subject|7|||
44179636|NCT01817530|78973795|FG003|Overall Study|Consent Withdrawn by Subject|3|||
44179637|NCT01817530|78973796|FG004|Overall Study|Consent Withdrawn by Subject|5|||
44179638|NCT01817530|78973797|FG005|Overall Study|Consent Withdrawn by Subject|3|||
44179639|NCT01817530|78973798|FG006|Overall Study|Consent Withdrawn by Subject|3|||
44179640|NCT01817530|78973799|FG007|Overall Study|Consent Withdrawn by Subject|10|||
44179641|NCT01817530|78973792|FG000|Overall Study|Lost to Follow-up|1|||
44179642|NCT01817530|78973793|FG001|Overall Study|Lost to Follow-up|4|||
44179643|NCT01817530|78973794|FG002|Overall Study|Lost to Follow-up|2|||
44179644|NCT01817530|78973795|FG003|Overall Study|Lost to Follow-up|1|||
44179645|NCT01817530|78973796|FG004|Overall Study|Lost to Follow-up|3|||
44179646|NCT01817530|78973797|FG005|Overall Study|Lost to Follow-up|2|||
44179647|NCT01817530|78973798|FG006|Overall Study|Lost to Follow-up|8|||
44179648|NCT01817530|78973799|FG007|Overall Study|Lost to Follow-up|4|||
44179649|NCT01816984|78973817|FG000|Overall Study|declining health status|1|||
44179650|NCT01816906|78973823|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
44179651|NCT01816906|78973824|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
44179652|NCT01816906|78973823|FG000|Six Months|Lost to Follow-up|14|||
44179653|NCT01816906|78973824|FG001|Six Months|Lost to Follow-up|16|||
44179654|NCT01816906|78973823|FG000|12 Months|Adverse Event|2|||
44179655|NCT01816906|78973824|FG001|12 Months|Adverse Event|2|||
44179656|NCT01816906|78973823|FG000|12 Months|Death|0|||
44179657|NCT01816906|78973824|FG001|12 Months|Death|2|||
44179658|NCT01816906|78973823|FG000|12 Months|Lost to Follow-up|2|||
44179659|NCT01816906|78973824|FG001|12 Months|Lost to Follow-up|1|||
44179660|NCT01816594|78973833|FG000|Overall Study|Local Progress|0|||
44179661|NCT01816594|78973834|FG001|Overall Study|Local Progress|2|||
44179662|NCT01816594|78973833|FG000|Overall Study|Adverse Event|9|||
44179663|NCT01816594|78973834|FG001|Overall Study|Adverse Event|0|||
44179664|NCT01816594|78973833|FG000|Overall Study|Withdrawal by Subject|1|||
44179665|NCT01816594|78973834|FG001|Overall Study|Withdrawal by Subject|0|||
44179666|NCT01816594|78973833|FG000|Overall Study|Physician Decision|1|||
44179667|NCT01816594|78973834|FG001|Overall Study|Physician Decision|0|||
44179668|NCT01802320|78973846|FG000|Overall Study|Death|1|||
44264966|NCT02461758|79167004|FG003|Overall Study|Lost to Follow-up|0|||
44179669|NCT01802320|78973846|FG000|Overall Study|Withdrawal by Subject|1|||
44179670|NCT02453711|78973859|FG000|Overall Study|Withdrawal by Subject|5|||
44179671|NCT02453711|78973860|FG001|Overall Study|Withdrawal by Subject|4|||
44179672|NCT02453711|78973861|FG002|Overall Study|Withdrawal by Subject|6|||
44179673|NCT02453711|78973862|FG003|Overall Study|Withdrawal by Subject|4|||
44179674|NCT02453711|78973863|FG004|Overall Study|Withdrawal by Subject|1|||
44179675|NCT02453711|78973864|FG005|Overall Study|Withdrawal by Subject|1|||
44179676|NCT02453711|78973865|FG006|Overall Study|Withdrawal by Subject|0|||
44179677|NCT02453711|78973866|FG007|Overall Study|Withdrawal by Subject|1|||
44179678|NCT02453711|78973867|FG008|Overall Study|Withdrawal by Subject|7|||
44179679|NCT02453711|78973859|FG000|Overall Study|Lost to Follow-up|5|||
44179680|NCT02453711|78973860|FG001|Overall Study|Lost to Follow-up|3|||
44179681|NCT02453711|78973861|FG002|Overall Study|Lost to Follow-up|2|||
44179682|NCT02453711|78973862|FG003|Overall Study|Lost to Follow-up|3|||
44179683|NCT02453711|78973863|FG004|Overall Study|Lost to Follow-up|1|||
44179684|NCT02453711|78973864|FG005|Overall Study|Lost to Follow-up|5|||
44179685|NCT02453711|78973865|FG006|Overall Study|Lost to Follow-up|2|||
44179686|NCT02453711|78973866|FG007|Overall Study|Lost to Follow-up|6|||
44179687|NCT02453711|78973867|FG008|Overall Study|Lost to Follow-up|6|||
44179688|NCT02453711|78973859|FG000|Overall Study|Death|0|||
44179689|NCT02453711|78973860|FG001|Overall Study|Death|0|||
44179690|NCT02453711|78973861|FG002|Overall Study|Death|0|||
44179691|NCT02453711|78973862|FG003|Overall Study|Death|0|||
44179692|NCT02453711|78973863|FG004|Overall Study|Death|0|||
44179693|NCT02453711|78973864|FG005|Overall Study|Death|0|||
44179694|NCT02453711|78973865|FG006|Overall Study|Death|1|||
44179695|NCT02453711|78973866|FG007|Overall Study|Death|0|||
44179696|NCT02453711|78973867|FG008|Overall Study|Death|0|||
44179697|NCT02453711|78973859|FG000|Overall Study|Unclassified|1|||
44179698|NCT02453711|78973860|FG001|Overall Study|Unclassified|0|||
44179699|NCT02453711|78973861|FG002|Overall Study|Unclassified|1|||
44179700|NCT02453711|78973862|FG003|Overall Study|Unclassified|0|||
44179701|NCT02453711|78973863|FG004|Overall Study|Unclassified|0|||
44179702|NCT02453711|78973864|FG005|Overall Study|Unclassified|0|||
44179703|NCT02453711|78973865|FG006|Overall Study|Unclassified|0|||
44179704|NCT02453711|78973866|FG007|Overall Study|Unclassified|0|||
44179705|NCT02453711|78973867|FG008|Overall Study|Unclassified|0|||
44179706|NCT02453555|78973889|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
44179707|NCT02453555|78973890|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
44179708|NCT02453555|78973891|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
44179709|NCT02453555|78973892|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
44179710|NCT02453555|78973893|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
44179711|NCT02453555|78973894|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
44179712|NCT02453555|78973889|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
44179713|NCT02453555|78973890|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
44179714|NCT02453555|78973891|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
44179715|NCT02453555|78973892|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
44179716|NCT02453555|78973893|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
44179717|NCT02453555|78973894|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
44179718|NCT02453555|78973889|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
44179719|NCT02453555|78973890|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
44179720|NCT02453555|78973891|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44179721|NCT02453555|78973892|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44179722|NCT02453555|78973893|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44179723|NCT02453555|78973894|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44179724|NCT02453555|78973889|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
44179725|NCT02453555|78973890|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
44179726|NCT02453555|78973891|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
44179727|NCT02453555|78973892|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
44179728|NCT02453555|78973893|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
44179729|NCT02453555|78973894|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
44179730|NCT02453555|78973889|FG000|Extension Period|Adverse Event|0|||
44179731|NCT02453555|78973890|FG001|Extension Period|Adverse Event|0|||
44179732|NCT02453555|78973891|FG002|Extension Period|Adverse Event|1|||
44179733|NCT02453555|78973892|FG003|Extension Period|Adverse Event|2|||
44179734|NCT02453555|78973893|FG004|Extension Period|Adverse Event|1|||
44264967|NCT02461290|79167026|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
44264968|NCT02461290|79167026|FG000|Overall Study|Lost to Follow-up|3|||
44264969|NCT02461134|79167030|FG000|Overall Study|Adverse Event|1|||
44179735|NCT02453555|78973894|FG005|Extension Period|Adverse Event|1|||
44179736|NCT02453555|78973889|FG000|Extension Period|Protocol Violation|0|||
44179737|NCT02453555|78973890|FG001|Extension Period|Protocol Violation|0|||
44179738|NCT02453555|78973891|FG002|Extension Period|Protocol Violation|1|||
44179739|NCT02453555|78973892|FG003|Extension Period|Protocol Violation|0|||
44179740|NCT02453555|78973893|FG004|Extension Period|Protocol Violation|0|||
44179741|NCT02453555|78973894|FG005|Extension Period|Protocol Violation|0|||
44179742|NCT02453555|78973889|FG000|Extension Period|Withdrawal by Subject|0|||
44179743|NCT02453555|78973890|FG001|Extension Period|Withdrawal by Subject|0|||
44179744|NCT02453555|78973891|FG002|Extension Period|Withdrawal by Subject|1|||
44179745|NCT02453555|78973892|FG003|Extension Period|Withdrawal by Subject|0|||
44179746|NCT02453555|78973893|FG004|Extension Period|Withdrawal by Subject|0|||
44179747|NCT02453555|78973894|FG005|Extension Period|Withdrawal by Subject|0|||
44179748|NCT02453321|78973907|FG000|Overall Study|Weakness|1|||
44179749|NCT02453321|78973908|FG001|Overall Study|Weakness|1|||
44179750|NCT02453321|78973909|FG002|Overall Study|Weakness|2|||
44179751|NCT02453321|78973907|FG000|Overall Study|Deep Venous Thrombosis|0|||
44179752|NCT02453321|78973908|FG001|Overall Study|Deep Venous Thrombosis|1|||
44179753|NCT02453321|78973909|FG002|Overall Study|Deep Venous Thrombosis|0|||
44179754|NCT01610284|78973922|FG000|Randomization Phase|Adverse Event|1|||
44179755|NCT01610284|78973923|FG001|Randomization Phase|Adverse Event|0|||
44179756|NCT01610284|78973922|FG000|Randomization Phase|Physician Decision|1|||
44179757|NCT01610284|78973923|FG001|Randomization Phase|Physician Decision|1|||
44179758|NCT01610284|78973922|FG000|Randomization Phase|Death|0|||
44179759|NCT01610284|78973923|FG001|Randomization Phase|Death|1|||
44179760|NCT01610284|78973922|FG000|Treatment Phase|Adverse Event|80|||
44179761|NCT01610284|78973923|FG001|Treatment Phase|Adverse Event|12|||
44179762|NCT01610284|78973922|FG000|Treatment Phase|Lost to Follow-up|1|||
44179763|NCT01610284|78973923|FG001|Treatment Phase|Lost to Follow-up|0|||
44179764|NCT01610284|78973922|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
44179765|NCT01610284|78973923|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
44179766|NCT01610284|78973922|FG000|Treatment Phase|Physician Decision|27|||
44179767|NCT01610284|78973923|FG001|Treatment Phase|Physician Decision|24|||
44179768|NCT01610284|78973922|FG000|Treatment Phase|Progressive Disease|377|||
44179769|NCT01610284|78973923|FG001|Treatment Phase|Progressive Disease|486|||
44179770|NCT01610284|78973922|FG000|Treatment Phase|Protocol Deviation|2|||
44179771|NCT01610284|78973923|FG001|Treatment Phase|Protocol Deviation|3|||
44179772|NCT01610284|78973922|FG000|Treatment Phase|Study terminated by Sponsor|18|||
44179773|NCT01610284|78973923|FG001|Treatment Phase|Study terminated by Sponsor|15|||
44179774|NCT01610284|78973922|FG000|Treatment Phase|Subject/Guardian Decision|55|||
44179775|NCT01610284|78973923|FG001|Treatment Phase|Subject/Guardian Decision|23|||
44179776|NCT01610284|78973922|FG000|Treatment Phase|Death|6|||
44179777|NCT01610284|78973923|FG001|Treatment Phase|Death|5|||
44179778|NCT01610284|78973922|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
44179779|NCT01610284|78973923|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44179780|NCT01610284|78973922|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
44179781|NCT01610284|78973923|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
44179782|NCT01610284|78973922|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
44179783|NCT01610284|78973923|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
44179784|NCT01610284|78973922|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
44179785|NCT01610284|78973923|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
44179786|NCT01610284|78973922|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
44179787|NCT01610284|78973923|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
44179788|NCT01610284|78973922|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
44179789|NCT01610284|78973923|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
44179790|NCT02452463|78973932|FG000|Overall Study|Death|1|||
44179791|NCT02452463|78973933|FG001|Overall Study|Death|0|||
44179792|NCT02452463|78973934|FG002|Overall Study|Death|0|||
44179793|NCT02452463|78973932|FG000|Overall Study|Study Suspended|1|||
44179794|NCT02452463|78973933|FG001|Overall Study|Study Suspended|0|||
44179795|NCT02452463|78973934|FG002|Overall Study|Study Suspended|0|||
44179796|NCT02452463|78973932|FG000|Overall Study|Recommended by DSMB|0|||
44179797|NCT02452463|78973933|FG001|Overall Study|Recommended by DSMB|1|||
44264970|NCT02460978|79167059|FG000|Overall Study|Adverse Event|17|||
44179798|NCT02452463|78973934|FG002|Overall Study|Recommended by DSMB|0|||
44179799|NCT02452463|78973932|FG000|Overall Study|Withdrawal by Subject|0|||
44179800|NCT02452463|78973933|FG001|Overall Study|Withdrawal by Subject|1|||
44179801|NCT02452463|78973934|FG002|Overall Study|Withdrawal by Subject|0|||
44179802|NCT02432105|78973945|FG000|Overall Study|Lost to Follow-up|1|||
44179803|NCT02432105|78973946|FG001|Overall Study|Lost to Follow-up|1|||
44179804|NCT02432105|78973947|FG002|Overall Study|Lost to Follow-up|0|||
44179805|NCT02432105|78973945|FG000|Overall Study|Withdrawal by Subject|1|||
44179806|NCT02432105|78973946|FG001|Overall Study|Withdrawal by Subject|0|||
44179807|NCT02432105|78973947|FG002|Overall Study|Withdrawal by Subject|1|||
44179808|NCT02432105|78973945|FG000|Overall Study|Culture positive for yeast|0|||
44179809|NCT02432105|78973946|FG001|Overall Study|Culture positive for yeast|1|||
44179810|NCT02432105|78973947|FG002|Overall Study|Culture positive for yeast|0|||
44179811|NCT02432105|78973945|FG000|Overall Study|Randomized in error|0|||
44179812|NCT02432105|78973946|FG001|Overall Study|Randomized in error|0|||
44179813|NCT02432105|78973947|FG002|Overall Study|Randomized in error|2|||
44179814|NCT02431793|78973959|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
44179815|NCT02431793|78973960|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
44179816|NCT02431793|78973961|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
44179817|NCT02431793|78973959|FG000|Overall Study|Withdrawal by Subject|7|||
44179818|NCT02431793|78973960|FG001|Overall Study|Withdrawal by Subject|5|||
44179819|NCT02431793|78973961|FG002|Overall Study|Withdrawal by Subject|5|||
44179820|NCT02431793|78973959|FG000|Overall Study|Lost to Follow-up|101|||
44179821|NCT02431793|78973960|FG001|Overall Study|Lost to Follow-up|122|||
44179822|NCT02431793|78973961|FG002|Overall Study|Lost to Follow-up|104|||
44179823|NCT01801930|78973973|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
44179824|NCT01801930|78973974|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
44179825|NCT01801930|78973975|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
44179826|NCT01801930|78973976|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
44179827|NCT01801930|78973973|FG000|Overall Study|DLT occurs|0|||
44179828|NCT01801930|78973974|FG001|Overall Study|DLT occurs|1|||
44179829|NCT01801930|78973975|FG002|Overall Study|DLT occurs|0|||
44179830|NCT01801930|78973976|FG003|Overall Study|DLT occurs|0|||
44179831|NCT01610206|78973988|FG000|Overall Study|Adverse Event|10|||
44179832|NCT01610206|78973989|FG001|Overall Study|Adverse Event|30|||
44179833|NCT01816048|78973995|FG000|Overall Study|Adverse Event|1|||
44179834|NCT01816048|78973995|FG000|Overall Study|Death|1|||
44179835|NCT01816048|78973995|FG000|Overall Study|Withdrawal by Subject|1|||
44179836|NCT01816048|78973995|FG000|Overall Study|Disease Progression|3|||
44179837|NCT01612858|78974002|FG000|Overall Study|Withdrawal by Subject|5|||
44179838|NCT01612858|78974003|FG001|Overall Study|Withdrawal by Subject|1|||
44179839|NCT01612780|78974009|FG000|Overall Study|Treatment not completed|1|||
44179840|NCT01612780|78974009|FG000|Overall Study|Withdrawal by Subject|5|||
44179841|NCT01612702|78974015|FG000|Overall Study|Protocol Violation|11|||
44179842|NCT01612702|78974016|FG001|Overall Study|Protocol Violation|11|||
44179843|NCT02431559|78974026|FG000|Overall Study|Adverse Event|0|||
44179844|NCT02431559|78974027|FG001|Overall Study|Adverse Event|1|||
44179845|NCT02431559|78974028|FG002|Overall Study|Adverse Event|0|||
44179846|NCT02431559|78974029|FG003|Overall Study|Adverse Event|4|||
44179847|NCT02431559|78974026|FG000|Overall Study|Progressive disease|2|||
44179848|NCT02431559|78974027|FG001|Overall Study|Progressive disease|1|||
44179849|NCT02431559|78974028|FG002|Overall Study|Progressive disease|4|||
44179850|NCT02431559|78974029|FG003|Overall Study|Progressive disease|22|||
44179851|NCT02431559|78974026|FG000|Overall Study|Withdrawal by Subject|0|||
44179852|NCT02431559|78974027|FG001|Overall Study|Withdrawal by Subject|1|||
44179853|NCT02431559|78974028|FG002|Overall Study|Withdrawal by Subject|0|||
44179854|NCT02431559|78974029|FG003|Overall Study|Withdrawal by Subject|4|||
44451232|NCT00490971|79460224|FG003|Maintenance|Adverse Event|5|||
44179855|NCT02431559|78974026|FG000|Overall Study|Physician Decision|0|||
44179856|NCT02431559|78974027|FG001|Overall Study|Physician Decision|0|||
44179857|NCT02431559|78974028|FG002|Overall Study|Physician Decision|0|||
44179858|NCT02431559|78974029|FG003|Overall Study|Physician Decision|1|||
44179859|NCT02388269|78974043|FG000|Overall Study|Adverse Event|2|||
44179860|NCT02388269|78974044|FG001|Overall Study|Adverse Event|0|||
44179861|NCT02388269|78974045|FG002|Overall Study|Adverse Event|0|||
44179862|NCT02388269|78974043|FG000|Overall Study|Withdrawal by Subject|1|||
44179863|NCT02388269|78974044|FG001|Overall Study|Withdrawal by Subject|2|||
44179864|NCT02388269|78974045|FG002|Overall Study|Withdrawal by Subject|0|||
44179865|NCT02388269|78974043|FG000|Overall Study|less than 50% stimulations|1|||
44179866|NCT02388269|78974044|FG001|Overall Study|less than 50% stimulations|0|||
44179867|NCT02388269|78974045|FG002|Overall Study|less than 50% stimulations|0|||
44179868|NCT02388269|78974043|FG000|Overall Study|no diary data|3|||
44179869|NCT02388269|78974044|FG001|Overall Study|no diary data|0|||
44179870|NCT02388269|78974045|FG002|Overall Study|no diary data|0|||
44179871|NCT02388269|78974043|FG000|Overall Study|Protocol Violation|2|||
44179872|NCT02388269|78974044|FG001|Overall Study|Protocol Violation|0|||
44179873|NCT02388269|78974045|FG002|Overall Study|Protocol Violation|0|||
44179874|NCT02388269|78974043|FG000|Overall Study|Screen Failure|0|||
44179875|NCT02388269|78974044|FG001|Overall Study|Screen Failure|0|||
44179876|NCT02388269|78974045|FG002|Overall Study|Screen Failure|10|||
44179877|NCT01652573|78974071|FG000|Overall Study|Adverse Event|0|||
44179878|NCT01652573|78974072|FG001|Overall Study|Adverse Event|1|||
44179879|NCT02388191|78974080|FG000|Overall Study|Patient did not receive IUD|1|||
44179880|NCT02388191|78974081|FG001|Overall Study|Patient did not receive IUD|0|||
44179881|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
44179882|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
44179883|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
44179884|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
44179885|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
44179886|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
44179887|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
44179888|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
44179889|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
44179890|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
44179891|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
44179892|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
44179893|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
44179894|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
44179895|NCT01815736|78974089|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
44179896|NCT01815736|78974090|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
44179897|NCT01815736|78974089|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
44179898|NCT01815736|78974090|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
44179899|NCT01815736|78974089|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
44179900|NCT01815736|78974090|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
44179901|NCT01815736|78974089|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
44179902|NCT01815736|78974090|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
44179903|NCT01815736|78974089|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
44179904|NCT01815736|78974090|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
44179905|NCT01815736|78974089|FG000|Extension Treatment Phase- After Week 96|Death|1|||
44179906|NCT01815736|78974090|FG001|Extension Treatment Phase- After Week 96|Death|0|||
44179907|NCT01651949|78974101|FG000|Overall Study|Unknown status|4|||
44179908|NCT01651949|78974102|FG001|Overall Study|Unknown status|4|||
44179909|NCT01651949|78974103|FG002|Overall Study|Unknown status|0|||
44179910|NCT01651949|78974101|FG000|Overall Study|Lost to Follow-up|30|||
44179911|NCT01651949|78974102|FG001|Overall Study|Lost to Follow-up|56|||
44179912|NCT01651949|78974103|FG002|Overall Study|Lost to Follow-up|20|||
44179913|NCT01651949|78974101|FG000|Overall Study|Protocol Violation|0|||
44179914|NCT01651949|78974102|FG001|Overall Study|Protocol Violation|2|||
44179915|NCT01651949|78974103|FG002|Overall Study|Protocol Violation|1|||
44179916|NCT01651949|78974101|FG000|Overall Study|Physician Decision|0|||
44179917|NCT01651949|78974102|FG001|Overall Study|Physician Decision|2|||
44361213|NCT01185821|79366879|FG004|Overall Study|Abnormal test procedure result|1|||
44179918|NCT01651949|78974103|FG002|Overall Study|Physician Decision|0|||
44179919|NCT01651949|78974101|FG000|Overall Study|Adverse Event|0|||
44179920|NCT01651949|78974102|FG001|Overall Study|Adverse Event|2|||
44179921|NCT01651949|78974103|FG002|Overall Study|Adverse Event|1|||
44179922|NCT01651949|78974101|FG000|Overall Study|Screen failure|2|||
44179923|NCT01651949|78974102|FG001|Overall Study|Screen failure|2|||
44179924|NCT01651949|78974103|FG002|Overall Study|Screen failure|0|||
44179925|NCT01651949|78974101|FG000|Overall Study|Withdrawal by Subject|17|||
44179926|NCT01651949|78974102|FG001|Overall Study|Withdrawal by Subject|18|||
44361214|NCT01185821|79366875|FG000|Overall Study|Death|0|||
44179927|NCT01651949|78974103|FG002|Overall Study|Withdrawal by Subject|9|||
44179928|NCT01800916|78974111|FG000|Test Period 1 (1 Week)|Convex product user|0|||
44179929|NCT01800916|78974112|FG001|Test Period 1 (1 Week)|Convex product user|0|||
44179930|NCT01800916|78974113|FG002|Test Period 1 (1 Week)|Convex product user|0|||
44179931|NCT01800916|78974114|FG003|Test Period 1 (1 Week)|Convex product user|1|||
44179932|NCT01800916|78974115|FG004|Test Period 1 (1 Week)|Convex product user|0|||
44179933|NCT01800916|78974116|FG005|Test Period 1 (1 Week)|Convex product user|0|||
44179934|NCT01800916|78974117|FG006|Test Period 1 (1 Week)|Convex product user|0|||
44179935|NCT01800916|78974118|FG007|Test Period 1 (1 Week)|Convex product user|0|||
44179936|NCT01800916|78974119|FG008|Test Period 1 (1 Week)|Convex product user|0|||
44179937|NCT01800916|78974111|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
44179938|NCT01800916|78974112|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
44179939|NCT01800916|78974113|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
44179940|NCT01800916|78974114|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
44179941|NCT01800916|78974115|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
44179942|NCT01800916|78974116|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
44179943|NCT01800916|78974117|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
44179944|NCT01800916|78974118|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
44179945|NCT01800916|78974119|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
44179946|NCT01800058|78974129|FG000|Overall Study|Lost to Follow-up|1|||
44179947|NCT01815580|78974136|FG000|Overall Study|Lost to Follow-up|4|||
44179948|NCT01815580|78974137|FG001|Overall Study|Lost to Follow-up|7|||
44179949|NCT01815580|78974136|FG000|Overall Study|Withdrawal by Subject|3|||
44179950|NCT01815580|78974137|FG001|Overall Study|Withdrawal by Subject|4|||
44179951|NCT01815580|78974136|FG000|Overall Study|Excluded from analysis|5|||
44179952|NCT01815580|78974137|FG001|Overall Study|Excluded from analysis|4|||
44179953|NCT01799590|78974151|FG000|Overall Study|Adverse Event|13|||
44179954|NCT01799590|78974152|FG001|Overall Study|Adverse Event|7|||
44179955|NCT01799590|78974153|FG002|Overall Study|Adverse Event|5|||
44179956|NCT01799590|78974151|FG000|Overall Study|Pregnancy|2|||
44179957|NCT01799590|78974152|FG001|Overall Study|Pregnancy|0|||
44179958|NCT01799590|78974153|FG002|Overall Study|Pregnancy|0|||
44179959|NCT01799590|78974151|FG000|Overall Study|Lack of Efficacy|3|||
44179960|NCT01799590|78974152|FG001|Overall Study|Lack of Efficacy|1|||
44179961|NCT01799590|78974153|FG002|Overall Study|Lack of Efficacy|3|||
44179962|NCT01799590|78974151|FG000|Overall Study|Participants convenience|4|||
44179963|NCT01799590|78974152|FG001|Overall Study|Participants convenience|4|||
44179964|NCT01799590|78974153|FG002|Overall Study|Participants convenience|2|||
44179965|NCT01799590|78974151|FG000|Overall Study|Aggravation of complications|0|||
44179966|NCT01799590|78974152|FG001|Overall Study|Aggravation of complications|1|||
44179967|NCT01799590|78974153|FG002|Overall Study|Aggravation of complications|1|||
44179968|NCT01799590|78974151|FG000|Overall Study|Using drugs with restricted days of use|0|||
44179969|NCT01799590|78974152|FG001|Overall Study|Using drugs with restricted days of use|3|||
44179970|NCT01799590|78974153|FG002|Overall Study|Using drugs with restricted days of use|2|||
44179971|NCT01799590|78974151|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
44179972|NCT01799590|78974152|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
44179973|NCT01799590|78974153|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
44179974|NCT01799590|78974151|FG000|Overall Study|Other|3|||
44179975|NCT01799590|78974152|FG001|Overall Study|Other|0|||
44179976|NCT01799590|78974153|FG002|Overall Study|Other|1|||
44179977|NCT01815424|78974164|FG000|Week 0 to 16|Adverse Event|1|||
44179978|NCT01815424|78974165|FG001|Week 0 to 16|Adverse Event|3|||
44179979|NCT01815424|78974166|FG002|Week 0 to 16|Adverse Event|3|||
44179980|NCT01815424|78974167|FG003|Week 0 to 16|Adverse Event|0|||
44179981|NCT01815424|78974168|FG004|Week 0 to 16|Adverse Event|0|||
44179982|NCT01815424|78974164|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
44179983|NCT01815424|78974165|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
44179984|NCT01815424|78974166|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
44179985|NCT01815424|78974167|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
44179986|NCT01815424|78974168|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
44179987|NCT01815424|78974164|FG000|Week 0 to 16|Lost to Follow-up|0|||
44179988|NCT01815424|78974165|FG001|Week 0 to 16|Lost to Follow-up|1|||
44179989|NCT01815424|78974166|FG002|Week 0 to 16|Lost to Follow-up|0|||
44179990|NCT01815424|78974167|FG003|Week 0 to 16|Lost to Follow-up|0|||
44179991|NCT01815424|78974168|FG004|Week 0 to 16|Lost to Follow-up|0|||
44179992|NCT01815424|78974164|FG000|Week 0 to 16|Withdrawal by Subject|0|||
44179993|NCT01815424|78974165|FG001|Week 0 to 16|Withdrawal by Subject|0|||
44179994|NCT01815424|78974166|FG002|Week 0 to 16|Withdrawal by Subject|1|||
44179995|NCT01815424|78974167|FG003|Week 0 to 16|Withdrawal by Subject|0|||
44179996|NCT01815424|78974168|FG004|Week 0 to 16|Withdrawal by Subject|0|||
44179997|NCT01815424|78974164|FG000|Week 0 to 16|Other|1|||
44179998|NCT01815424|78974165|FG001|Week 0 to 16|Other|0|||
44179999|NCT01815424|78974166|FG002|Week 0 to 16|Other|3|||
44180000|NCT01815424|78974167|FG003|Week 0 to 16|Other|0|||
44180001|NCT01815424|78974168|FG004|Week 0 to 16|Other|0|||
44180002|NCT01815424|78974164|FG000|Week 0 to 16|Protocol Violation|1|||
44180003|NCT01815424|78974165|FG001|Week 0 to 16|Protocol Violation|0|||
44180004|NCT01815424|78974166|FG002|Week 0 to 16|Protocol Violation|0|||
44180005|NCT01815424|78974167|FG003|Week 0 to 16|Protocol Violation|0|||
44180006|NCT01815424|78974168|FG004|Week 0 to 16|Protocol Violation|0|||
44180007|NCT01815424|78974164|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
44180008|NCT01815424|78974165|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
44180009|NCT01815424|78974166|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
44180010|NCT01815424|78974167|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
44180011|NCT01815424|78974168|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
44180012|NCT01815424|78974164|FG000|Week 16 to 52|Other|0|||
44180013|NCT01815424|78974165|FG001|Week 16 to 52|Other|1|||
44180014|NCT01815424|78974166|FG002|Week 16 to 52|Other|0|||
44180015|NCT01815424|78974167|FG003|Week 16 to 52|Other|0|||
44180016|NCT01815424|78974168|FG004|Week 16 to 52|Other|0|||
44180017|NCT01815424|78974164|FG000|Week 16 to 52|Adverse Event|0|||
44180018|NCT01815424|78974165|FG001|Week 16 to 52|Adverse Event|0|||
44180019|NCT01815424|78974166|FG002|Week 16 to 52|Adverse Event|0|||
44180020|NCT01815424|78974167|FG003|Week 16 to 52|Adverse Event|0|||
44180021|NCT01815424|78974168|FG004|Week 16 to 52|Adverse Event|1|||
44180022|NCT01815424|78974164|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
44180023|NCT01815424|78974165|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
44180024|NCT01815424|78974166|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
44180025|NCT01815424|78974167|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
44180026|NCT01815424|78974168|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
44180027|NCT01815424|78974164|FG000|Week 16 to 52|Lost to Follow-up|0|||
44180028|NCT01815424|78974165|FG001|Week 16 to 52|Lost to Follow-up|2|||
44180029|NCT01815424|78974166|FG002|Week 16 to 52|Lost to Follow-up|0|||
44180030|NCT01815424|78974167|FG003|Week 16 to 52|Lost to Follow-up|2|||
44180031|NCT01815424|78974168|FG004|Week 16 to 52|Lost to Follow-up|1|||
44180032|NCT01815424|78974164|FG000|Week 16 to 52|Withdrawal by Subject|1|||
44180033|NCT01815424|78974165|FG001|Week 16 to 52|Withdrawal by Subject|2|||
44180034|NCT01815424|78974166|FG002|Week 16 to 52|Withdrawal by Subject|0|||
44180035|NCT01815424|78974167|FG003|Week 16 to 52|Withdrawal by Subject|0|||
44180036|NCT01815424|78974168|FG004|Week 16 to 52|Withdrawal by Subject|0|||
44180037|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
44180038|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
44180039|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
44180040|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
44180041|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
44180042|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
44180043|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
44180044|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
44180045|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
44180046|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
44180047|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
44180048|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
44180049|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
44180050|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
44180051|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
44180052|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
44180053|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
44180054|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
44180055|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
44180056|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
44180057|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
44180058|NCT02431247|78974183|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
44180059|NCT02431247|78974184|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
44180060|NCT02431247|78974185|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
44180061|NCT02431247|78974183|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
44180062|NCT02431247|78974184|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
44180063|NCT02431247|78974185|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
44180064|NCT02431247|78974183|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
44180065|NCT02431247|78974184|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
44180066|NCT02431247|78974185|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
44180067|NCT02431247|78974183|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
44180068|NCT02431247|78974184|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
44180069|NCT02431247|78974185|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
44180070|NCT02431247|78974183|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
44180071|NCT02431247|78974184|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
44180072|NCT02431247|78974185|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
44180073|NCT02431247|78974183|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
44180074|NCT02431247|78974184|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
44180075|NCT02431247|78974185|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
44180076|NCT02431247|78974183|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
44180077|NCT02431247|78974184|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
44180078|NCT02431247|78974185|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
44180079|NCT01814878|78974199|FG000|Overall Study|Adverse Event|16|||
44180080|NCT01814878|78974200|FG001|Overall Study|Adverse Event|5|||
44180081|NCT01814878|78974199|FG000|Overall Study|Withdrawal by Subject|20|||
44180082|NCT01814878|78974200|FG001|Overall Study|Withdrawal by Subject|16|||
44180083|NCT01814878|78974199|FG000|Overall Study|Protocol Violation|5|||
44180084|NCT01814878|78974200|FG001|Overall Study|Protocol Violation|5|||
44180085|NCT01814878|78974199|FG000|Overall Study|Physician Decision|3|||
44180086|NCT01814878|78974200|FG001|Overall Study|Physician Decision|1|||
44180087|NCT01814878|78974199|FG000|Overall Study|Screening failure (drop-out)|0|||
44180088|NCT01814878|78974200|FG001|Overall Study|Screening failure (drop-out)|3|||
44180089|NCT01814878|78974199|FG000|Overall Study|Other|2|||
44180090|NCT01814878|78974200|FG001|Overall Study|Other|0|||
44180091|NCT02407457|78974208|FG000|1 Month|Death|3|||
44180092|NCT02407457|78974209|FG001|1 Month|Death|0|||
44180093|NCT02407457|78974208|FG000|1 Month|Lost to Follow-up|1|||
44180094|NCT02407457|78974209|FG001|1 Month|Lost to Follow-up|1|||
44264971|NCT02460978|79167060|FG001|Overall Study|Adverse Event|11|||
44361215|NCT01185821|79366876|FG001|Overall Study|Death|1|||
44451233|NCT00490971|79460225|FG004|Maintenance|Adverse Event|7|||
44180095|NCT02407457|78974208|FG000|1 Month|missed visit|2|||
44180096|NCT02407457|78974209|FG001|1 Month|missed visit|6|||
44180097|NCT02407457|78974208|FG000|6-Month|Death|2|||
44180098|NCT02407457|78974209|FG001|6-Month|Death|8|||
44180099|NCT02407457|78974208|FG000|6-Month|Lost to Follow-up|2|||
44180100|NCT02407457|78974209|FG001|6-Month|Lost to Follow-up|2|||
44180101|NCT02407457|78974208|FG000|6-Month|missed visit|15|||
44180102|NCT02407457|78974209|FG001|6-Month|missed visit|12|||
44180103|NCT02407457|78974208|FG000|6-Month|Over Due|1|||
44180104|NCT02407457|78974209|FG001|6-Month|Over Due|2|||
44180105|NCT02407457|78974208|FG000|6-Month|Open Repair|0|||
44180106|NCT02407457|78974209|FG001|6-Month|Open Repair|1|||
44180107|NCT02407457|78974208|FG000|1 Year|Death|6|||
44180108|NCT02407457|78974209|FG001|1 Year|Death|11|||
44180109|NCT02407457|78974208|FG000|1 Year|Lost to Follow-up|3|||
44180110|NCT02407457|78974209|FG001|1 Year|Lost to Follow-up|2|||
44180111|NCT02407457|78974208|FG000|1 Year|Missed Visit|18|||
44180112|NCT02407457|78974209|FG001|1 Year|Missed Visit|10|||
44180113|NCT02407457|78974208|FG000|1 Year|Over Due|6|||
44180114|NCT02407457|78974209|FG001|1 Year|Over Due|4|||
44180115|NCT02407457|78974208|FG000|1 Year|Open Repair|0|||
44180116|NCT02407457|78974209|FG001|1 Year|Open Repair|1|||
44180117|NCT02407457|78974208|FG000|2-year|Death|14|||
44180118|NCT02407457|78974209|FG001|2-year|Death|8|||
44180119|NCT02407457|78974208|FG000|2-year|Lost to Follow-up|6|||
44180120|NCT02407457|78974209|FG001|2-year|Lost to Follow-up|9|||
44180121|NCT02407457|78974208|FG000|2-year|Missed Visit|13|||
44180122|NCT02407457|78974209|FG001|2-year|Missed Visit|11|||
44180123|NCT02407457|78974208|FG000|2-year|Over Due|1|||
44180124|NCT02407457|78974209|FG001|2-year|Over Due|5|||
44180125|NCT02407457|78974208|FG000|2-year|Open Repair|0|||
44180126|NCT02407457|78974209|FG001|2-year|Open Repair|2|||
44180127|NCT02407457|78974208|FG000|3-year|Death|11|||
44180128|NCT02407457|78974209|FG001|3-year|Death|10|||
44180129|NCT02407457|78974208|FG000|3-year|Lost to Follow-up|6|||
44180130|NCT02407457|78974209|FG001|3-year|Lost to Follow-up|9|||
44180131|NCT02407457|78974208|FG000|3-year|Missed Visit|21|||
44180132|NCT02407457|78974209|FG001|3-year|Missed Visit|16|||
44180133|NCT02407457|78974208|FG000|3-year|Over Due|4|||
44180134|NCT02407457|78974209|FG001|3-year|Over Due|3|||
44180135|NCT02407457|78974208|FG000|4-year|Death|14|||
44180136|NCT02407457|78974209|FG001|4-year|Death|7|||
44180137|NCT02407457|78974208|FG000|4-year|Lost to Follow-up|9|||
44180138|NCT02407457|78974209|FG001|4-year|Lost to Follow-up|12|||
44180139|NCT02407457|78974208|FG000|4-year|Over Due|10|||
44180140|NCT02407457|78974209|FG001|4-year|Over Due|5|||
44180141|NCT02407457|78974208|FG000|4-year|Missed Visit|13|||
44180142|NCT02407457|78974209|FG001|4-year|Missed Visit|13|||
44180143|NCT02407457|78974208|FG000|4-year|Pending visit|19|||
44180144|NCT02407457|78974209|FG001|4-year|Pending visit|14|||
44180145|NCT02407457|78974208|FG000|4-year|Not Due|16|||
44180146|NCT02407457|78974209|FG001|4-year|Not Due|10|||
44180147|NCT02407457|78974208|FG000|5-year|Death|6|||
44180148|NCT02407457|78974209|FG001|5-year|Death|1|||
44180149|NCT02407457|78974208|FG000|5-year|Lost to Follow-up|4|||
44180150|NCT02407457|78974209|FG001|5-year|Lost to Follow-up|4|||
44180151|NCT02407457|78974208|FG000|5-year|Missed Visit|10|||
44180152|NCT02407457|78974209|FG001|5-year|Missed Visit|9|||
44180153|NCT02407457|78974208|FG000|5-year|Pending Visit|18|||
44180154|NCT02407457|78974209|FG001|5-year|Pending Visit|17|||
44180155|NCT02407457|78974208|FG000|5-year|Not Due|54|||
44180156|NCT02407457|78974209|FG001|5-year|Not Due|46|||
44180157|NCT01814800|78974215|FG000|Overall Study|Adverse Event|2|||
44180158|NCT01814800|78974215|FG000|Overall Study|Pregnancy|1|||
44361216|NCT01185821|79366877|FG002|Overall Study|Death|0|||
44361217|NCT01185821|79366878|FG003|Overall Study|Death|0|||
44180159|NCT01814800|78974215|FG000|Overall Study|Sponsor decision|1|||
44180160|NCT01814800|78974215|FG000|Overall Study|Subject relocation|1|||
44180161|NCT01814332|78974221|FG000|Overall Study|Adverse Event|8|||
44180162|NCT01814332|78974222|FG001|Overall Study|Adverse Event|3|||
44180163|NCT01814332|78974221|FG000|Overall Study|Withdrawal by Subject|3|||
44180164|NCT01814332|78974222|FG001|Overall Study|Withdrawal by Subject|8|||
44180165|NCT01814332|78974221|FG000|Overall Study|Protocol Violation|0|||
44180166|NCT01814332|78974222|FG001|Overall Study|Protocol Violation|4|||
44180167|NCT01814332|78974221|FG000|Overall Study|Lost to Follow-up|5|||
44180168|NCT01814332|78974222|FG001|Overall Study|Lost to Follow-up|1|||
44180169|NCT02407223|78974231|FG000|Overall Study|Adverse Event|1|||
44180170|NCT02407223|78974232|FG001|Overall Study|Adverse Event|0|||
44180171|NCT02407223|78974233|FG002|Overall Study|Adverse Event|1|||
44180172|NCT02407223|78974231|FG000|Overall Study|Lack of Efficacy|6|||
44180173|NCT02407223|78974232|FG001|Overall Study|Lack of Efficacy|6|||
44180174|NCT02407223|78974233|FG002|Overall Study|Lack of Efficacy|4|||
44180175|NCT02407223|78974231|FG000|Overall Study|Lost to Follow-up|1|||
44180176|NCT02407223|78974232|FG001|Overall Study|Lost to Follow-up|0|||
44180177|NCT02407223|78974233|FG002|Overall Study|Lost to Follow-up|2|||
44180178|NCT02407223|78974231|FG000|Overall Study|Withdrawal by Subject|2|||
44180179|NCT02407223|78974232|FG001|Overall Study|Withdrawal by Subject|4|||
44180180|NCT02407223|78974233|FG002|Overall Study|Withdrawal by Subject|4|||
44180181|NCT02407223|78974231|FG000|Overall Study|Study Terminated by Sponsor|77|||
44180182|NCT02407223|78974232|FG001|Overall Study|Study Terminated by Sponsor|80|||
44180183|NCT02407223|78974233|FG002|Overall Study|Study Terminated by Sponsor|86|||
44180184|NCT02407223|78974231|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
44180185|NCT02407223|78974232|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
44180186|NCT02407223|78974233|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
44180187|NCT02407223|78974231|FG000|Overall Study|Other|29|||
44180188|NCT02407223|78974232|FG001|Overall Study|Other|27|||
44180189|NCT02407223|78974233|FG002|Overall Study|Other|25|||
44180190|NCT01797562|78974243|FG000|Overall Study|Protocol Violation|5|||
44180191|NCT01813474|78974251|FG000|Overall Study|Withdrawal by Subject|0|||
44180192|NCT01813474|78974252|FG001|Overall Study|Withdrawal by Subject|0|||
44180193|NCT01813474|78974253|FG002|Overall Study|Withdrawal by Subject|1|||
44180194|NCT01813474|78974251|FG000|Overall Study|Adverse Event|1|||
44180195|NCT01813474|78974252|FG001|Overall Study|Adverse Event|1|||
44180196|NCT01813474|78974253|FG002|Overall Study|Adverse Event|0|||
44180197|NCT01813474|78974251|FG000|Overall Study|Lack of Efficacy|2|||
44180198|NCT01813474|78974252|FG001|Overall Study|Lack of Efficacy|6|||
44180199|NCT01813474|78974253|FG002|Overall Study|Lack of Efficacy|9|||
44180200|NCT01813474|78974251|FG000|Overall Study|Death|0|||
44180201|NCT01813474|78974252|FG001|Overall Study|Death|0|||
44180202|NCT01813474|78974253|FG002|Overall Study|Death|1|||
44180203|NCT01868542|78974264|FG000|Overall Study|Protocol Violation|0|||
44180204|NCT01868542|78974265|FG001|Overall Study|Protocol Violation|1|||
44180205|NCT01868542|78974264|FG000|Overall Study|Unclassified|0|||
44180206|NCT01868542|78974265|FG001|Overall Study|Unclassified|1|||
44180207|NCT01797094|78974273|FG000|Overall Study|Adverse Event|1|||
44180208|NCT01797094|78974274|FG001|Overall Study|Adverse Event|1|||
44180209|NCT01797094|78974273|FG000|Overall Study|Personal Reasons|4|||
44180210|NCT01797094|78974274|FG001|Overall Study|Personal Reasons|0|||
44180211|NCT01797094|78974273|FG000|Overall Study|Protocol Violation|0|||
44180212|NCT01797094|78974274|FG001|Overall Study|Protocol Violation|1|||
44180213|NCT01797094|78974273|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44180214|NCT01797094|78974274|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44180215|NCT02383589|78974282|FG000|Treatment Period|Adverse Event|1|||
44180216|NCT02383589|78974283|FG001|Treatment Period|Adverse Event|3|||
44180217|NCT02383589|78974282|FG000|Treatment Period|Lost to Follow-up|0|||
44180218|NCT02383589|78974283|FG001|Treatment Period|Lost to Follow-up|1|||
44180219|NCT02383589|78974282|FG000|Treatment Period|Withdrawal by Subject|0|||
44180220|NCT02383589|78974283|FG001|Treatment Period|Withdrawal by Subject|5|||
44180221|NCT02383589|78974282|FG000|Treatment Period|Non-compliance with study drug|0|||
44180222|NCT02383589|78974283|FG001|Treatment Period|Non-compliance with study drug|1|||
44180223|NCT02383589|78974282|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
44180224|NCT02383589|78974283|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
44180225|NCT02383589|78974282|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
44180226|NCT02383589|78974283|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
44180227|NCT02383589|78974282|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
44180228|NCT02383589|78974283|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
44180229|NCT01810432|78974291|FG000|Washout|Protocol Violation|0|||
44180230|NCT01810432|78974292|FG001|Washout|Protocol Violation|1|||
44180231|NCT01810432|78974291|FG000|Washout|Adverse Event|1|||
44180232|NCT01810432|78974292|FG001|Washout|Adverse Event|0|||
44180233|NCT01810432|78974291|FG000|Period 2|Withdrawal by Subject|2|||
44180234|NCT01810432|78974292|FG001|Period 2|Withdrawal by Subject|1|||
44180235|NCT01810432|78974291|FG000|Period 2|Physician Decision|1|||
44180236|NCT01810432|78974292|FG001|Period 2|Physician Decision|0|||
44180237|NCT01810432|78974291|FG000|Period 2|Lost to Follow-up|1|||
44180238|NCT01810432|78974292|FG001|Period 2|Lost to Follow-up|1|||
44180239|NCT01796860|78974298|FG000|Overall Study|Withdrawal by Subject|3|||
44180240|NCT01796548|78974302|FG000|Overall Study|Lost to Follow-up|1|||
44180241|NCT01796548|78974302|FG000|Overall Study|Other|2|||
44180242|NCT02406677|78974308|FG000|Overall Study|Death|16|||
44180243|NCT02406677|78974309|FG001|Overall Study|Death|8|||
44180244|NCT02406677|78974308|FG000|Overall Study|Discharged without P2Y12|1|||
44180245|NCT02406677|78974309|FG001|Overall Study|Discharged without P2Y12|3|||
44180246|NCT02406677|78974308|FG000|Overall Study|Discharged on prasugrel|283|||
44180247|NCT02406677|78974309|FG001|Overall Study|Discharged on prasugrel|587|||
44180248|NCT02406677|78974308|FG000|Overall Study|Withdrawal by Subject|1|||
44180249|NCT02406677|78974309|FG001|Overall Study|Withdrawal by Subject|0|||
44180250|NCT02404805|78974325|FG000|Overall Study|Withdrawal by Subject|1|||
44180251|NCT02404805|78974326|FG001|Overall Study|Withdrawal by Subject|0|||
44180252|NCT02404805|78974327|FG002|Overall Study|Withdrawal by Subject|0|||
44180253|NCT02404805|78974328|FG003|Overall Study|Withdrawal by Subject|0|||
44180254|NCT02404805|78974329|FG004|Overall Study|Withdrawal by Subject|0|||
44180255|NCT02404805|78974330|FG005|Overall Study|Withdrawal by Subject|0|||
44180256|NCT02430311|78974341|FG000|Part A|Adverse Event|0|||
44180257|NCT02430311|78974342|FG001|Part A|Adverse Event|1|||
44180258|NCT02430311|78974341|FG000|Part A|Withdrawal by Subject|1|||
44180259|NCT02430311|78974342|FG001|Part A|Withdrawal by Subject|0|||
44180260|NCT02430311|78974341|FG000|Part B|Meet study-specific withdrawal criteria|6|||
44180261|NCT02430311|78974342|FG001|Part B|Meet study-specific withdrawal criteria|6|||
44180262|NCT02430311|78974341|FG000|Part B|Withdrawal by Subject|2|||
44180263|NCT02430311|78974342|FG001|Part B|Withdrawal by Subject|2|||
44180264|NCT02430311|78974341|FG000|Part B|Adverse Event|1|||
44180265|NCT02430311|78974342|FG001|Part B|Adverse Event|0|||
44180266|NCT02430311|78974341|FG000|Part B|Death|1|||
44180267|NCT02430311|78974342|FG001|Part B|Death|0|||
44180268|NCT02404649|78974359|FG000|Overall Study|Adverse Event|1|||
44180269|NCT02404649|78974360|FG001|Overall Study|Adverse Event|2|||
44180270|NCT02383355|78974368|FG000|Overall Study|Adverse Event|2|||
44180271|NCT02383355|78974369|FG001|Overall Study|Adverse Event|0|||
44180272|NCT02381795|78974375|FG000|Overall Study|Withdrawal by Subject|1|||
44180273|NCT02381795|78974375|FG000|Overall Study|Study Terminated|2|||
44180274|NCT02404493|78974381|FG000|Overall Study|Adverse Event|1|||
44180275|NCT02404493|78974382|FG001|Overall Study|Adverse Event|1|||
44180276|NCT02380859|78974390|FG000|Overall Study|Withdrawal by Subject|2|||
44180277|NCT02380859|78974391|FG001|Overall Study|Withdrawal by Subject|0|||
44180278|NCT02380703|78974399|FG000|Overall Study|Withdrawal by Subject|12|||
44180279|NCT02380703|78974400|FG001|Overall Study|Withdrawal by Subject|9|||
44180280|NCT02380703|78974399|FG000|Overall Study|Lost to Follow-up|12|||
44180281|NCT02380703|78974400|FG001|Overall Study|Lost to Follow-up|12|||
44180282|NCT02380703|78974399|FG000|Overall Study|Caregiver death|1|||
44180283|NCT02380703|78974400|FG001|Overall Study|Caregiver death|0|||
44180284|NCT02380703|78974399|FG000|Overall Study|Person with dementia (PWD) death|7|||
44180285|NCT02380703|78974400|FG001|Overall Study|Person with dementia (PWD) death|8|||
44180286|NCT02380703|78974399|FG000|Overall Study|Entered Long-term Care|4|||
44180287|NCT02380703|78974400|FG001|Overall Study|Entered Long-term Care|7|||
44180288|NCT02379923|78974406|FG000|Overall Study|Death|5|||
44180289|NCT02379221|78974413|FG000|Overall Study|Lost to Follow-up|1|||
44180290|NCT02404103|78974424|FG000|Overall Study|Adverse Event|1|||
44180291|NCT02404103|78974425|FG001|Overall Study|Adverse Event|0|||
44180292|NCT02404103|78974424|FG000|Overall Study|Lost to Follow-up|3|||
44180293|NCT02404103|78974425|FG001|Overall Study|Lost to Follow-up|3|||
44180294|NCT02404025|78974441|FG000|Overall Study|Adverse Event|1|||
44180295|NCT02404025|78974441|FG000|Overall Study|Lack of Efficacy|3|||
44180296|NCT02377817|78974447|FG000|Overall Study|Transportation/childcare barriers.|2|||
44180297|NCT02377817|78974448|FG001|Overall Study|Transportation/childcare barriers.|0|||
44180298|NCT02377817|78974447|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
44180299|NCT02377817|78974448|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
44180300|NCT02403635|78974456|FG000|Overall Study|Not eligible|9|||
44180301|NCT02402933|78974476|FG000|Overall Study|Withdrawal by Subject|4|||
44180302|NCT02402933|78974476|FG000|Overall Study|Discontinued; Site Termination|10|||
44180303|NCT01796470|78974485|FG000|Overall Study|Adverse Event|4|||
44180304|NCT01796470|78974486|FG001|Overall Study|Adverse Event|2|||
44180305|NCT01796470|78974487|FG002|Overall Study|Adverse Event|2|||
44180306|NCT01796470|78974488|FG003|Overall Study|Adverse Event|1|||
44180307|NCT01796470|78974489|FG004|Overall Study|Adverse Event|3|||
44180308|NCT01796470|78974485|FG000|Overall Study|Death|2|||
44180309|NCT01796470|78974486|FG001|Overall Study|Death|0|||
44180310|NCT01796470|78974487|FG002|Overall Study|Death|0|||
44180311|NCT01796470|78974488|FG003|Overall Study|Death|0|||
44180312|NCT01796470|78974489|FG004|Overall Study|Death|1|||
44180313|NCT01796470|78974485|FG000|Overall Study|Initiated New Therapy|9|||
44451234|NCT00490971|79460221|FG000|Maintenance|Death|0|||
44451235|NCT00490971|79460222|FG001|Maintenance|Death|0|||
44180314|NCT01796470|78974486|FG001|Overall Study|Initiated New Therapy|0|||
44180315|NCT01796470|78974487|FG002|Overall Study|Initiated New Therapy|0|||
44180316|NCT01796470|78974488|FG003|Overall Study|Initiated New Therapy|0|||
44180317|NCT01796470|78974489|FG004|Overall Study|Initiated New Therapy|2|||
44180318|NCT01796470|78974485|FG000|Overall Study|Lost to Follow-up|0|||
44180319|NCT01796470|78974486|FG001|Overall Study|Lost to Follow-up|1|||
44180320|NCT01796470|78974487|FG002|Overall Study|Lost to Follow-up|0|||
44180321|NCT01796470|78974488|FG003|Overall Study|Lost to Follow-up|0|||
44180322|NCT01796470|78974489|FG004|Overall Study|Lost to Follow-up|0|||
44180323|NCT01796470|78974485|FG000|Overall Study|Physician Decision|5|||
44180324|NCT01796470|78974486|FG001|Overall Study|Physician Decision|4|||
44180325|NCT01796470|78974487|FG002|Overall Study|Physician Decision|1|||
44180326|NCT01796470|78974488|FG003|Overall Study|Physician Decision|0|||
44180327|NCT01796470|78974489|FG004|Overall Study|Physician Decision|1|||
44180328|NCT01796470|78974485|FG000|Overall Study|Progressive Disease|7|||
44180329|NCT01796470|78974486|FG001|Overall Study|Progressive Disease|7|||
44180330|NCT01796470|78974487|FG002|Overall Study|Progressive Disease|3|||
44180331|NCT01796470|78974488|FG003|Overall Study|Progressive Disease|2|||
44180332|NCT01796470|78974489|FG004|Overall Study|Progressive Disease|0|||
44264972|NCT02460978|79167061|FG002|Overall Study|Adverse Event|11|||
44180333|NCT01796470|78974485|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
44180334|NCT01796470|78974486|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
44180335|NCT01796470|78974487|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
44180336|NCT01796470|78974488|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
44180337|NCT01796470|78974489|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
44180338|NCT01796470|78974485|FG000|Overall Study|Withdrawal by Subject|7|||
44180339|NCT01796470|78974486|FG001|Overall Study|Withdrawal by Subject|0|||
44180340|NCT01796470|78974487|FG002|Overall Study|Withdrawal by Subject|0|||
44180341|NCT01796470|78974488|FG003|Overall Study|Withdrawal by Subject|0|||
44180342|NCT01796470|78974489|FG004|Overall Study|Withdrawal by Subject|1|||
44180343|NCT01868074|78974507|FG000|Overall Study|Lost to Follow-up|3|||
44180344|NCT01868074|78974508|FG001|Overall Study|Lost to Follow-up|2|||
44180345|NCT01868074|78974507|FG000|Overall Study|Withdrawal by Subject|4|||
44180346|NCT01868074|78974508|FG001|Overall Study|Withdrawal by Subject|2|||
44180347|NCT01810042|78974514|FG000|Overall Study|Lost to Follow-up|10|||
44180348|NCT02424539|78974521|FG000|Overall Study|Adverse Event|0|||
44180349|NCT02424539|78974522|FG001|Overall Study|Adverse Event|0|||
44180350|NCT02424539|78974523|FG002|Overall Study|Adverse Event|1|||
44180351|NCT02424539|78974521|FG000|Overall Study|Physician Decision|0|||
44180352|NCT02424539|78974522|FG001|Overall Study|Physician Decision|0|||
44180353|NCT02424539|78974523|FG002|Overall Study|Physician Decision|1|||
44180354|NCT02424539|78974521|FG000|Overall Study|Withdrawal by Subject|3|||
44180355|NCT02424539|78974522|FG001|Overall Study|Withdrawal by Subject|1|||
44180356|NCT02424539|78974523|FG002|Overall Study|Withdrawal by Subject|0|||
44180357|NCT02424539|78974521|FG000|Overall Study|Other: Reached stopping criteria|11|||
44180358|NCT02424539|78974522|FG001|Overall Study|Other: Reached stopping criteria|7|||
44180359|NCT02424539|78974523|FG002|Overall Study|Other: Reached stopping criteria|6|||
44180360|NCT01809262|78974531|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180361|NCT01809262|78974532|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180362|NCT01809262|78974533|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180363|NCT01809262|78974534|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180364|NCT01809262|78974535|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
44180365|NCT01809262|78974536|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180366|NCT01809262|78974537|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180367|NCT01809262|78974538|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180368|NCT01809262|78974539|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180369|NCT01809262|78974540|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
44180370|NCT01809262|78974531|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180371|NCT01809262|78974532|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
44180372|NCT01809262|78974533|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180373|NCT01809262|78974534|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180374|NCT01809262|78974535|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180375|NCT01809262|78974536|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180376|NCT01809262|78974537|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180377|NCT01809262|78974538|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180378|NCT01809262|78974539|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180379|NCT01809262|78974540|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
44180380|NCT01808248|78974554|FG000|Overall Study|Lack of Efficacy|3|||
44180381|NCT01808248|78974554|FG000|Overall Study|Withdrawal by Subject|1|||
44180382|NCT01808248|78974554|FG000|Overall Study|Lost to Follow-up|1|||
44180383|NCT02424383|78974560|FG000|Overall Study|Withdrawal by Subject|32|||
44180384|NCT02424383|78974560|FG000|Overall Study|Death|170|||
44180385|NCT02424383|78974560|FG000|Overall Study|Sponsor's decision|3|||
44180386|NCT02424383|78974560|FG000|Overall Study|Investigator's decision|44|||
44180387|NCT02424383|78974560|FG000|Overall Study|Lost to Follow-up|81|||
44180388|NCT02424383|78974560|FG000|Overall Study|Other|7|||
44180389|NCT02424383|78974560|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
44180390|NCT01867294|78974568|FG000|Overall Study|Withdrawal by Subject|1|||
44180391|NCT01867294|78974569|FG001|Overall Study|Withdrawal by Subject|1|||
44180392|NCT01867294|78974570|FG002|Overall Study|Withdrawal by Subject|0|||
44180393|NCT01867294|78974571|FG003|Overall Study|Withdrawal by Subject|0|||
44180394|NCT02424149|78974581|FG000|Overall Study|surgery cancelled|2|||
44180395|NCT02424149|78974582|FG001|Overall Study|surgery cancelled|0|||
44180396|NCT02424149|78974581|FG000|Overall Study|Withdrawal by Subject|0|||
44180397|NCT02424149|78974582|FG001|Overall Study|Withdrawal by Subject|1|||
44180398|NCT02423291|78974588|FG000|Overall Study|Lack of Efficacy|14|||
44180399|NCT02423291|78974588|FG000|Overall Study|Adverse Event|1|||
44180400|NCT02401529|78974594|FG000|Overall Study|Lost to Follow-up|2|||
44180401|NCT02401529|78974595|FG001|Overall Study|Lost to Follow-up|1|||
44180402|NCT02401529|78974594|FG000|Overall Study|Physician Decision|2|||
44180403|NCT02401529|78974595|FG001|Overall Study|Physician Decision|6|||
44180404|NCT02401529|78974594|FG000|Overall Study|Protocol Violation|5|||
44180405|NCT02401529|78974595|FG001|Overall Study|Protocol Violation|0|||
44180406|NCT01867216|78974609|FG000|Overall Study|Withdrawal by Subject|2|||
44180407|NCT01867216|78974610|FG001|Overall Study|Withdrawal by Subject|0|||
44180408|NCT01867216|78974611|FG002|Overall Study|Withdrawal by Subject|0|||
44180409|NCT01867216|78974612|FG003|Overall Study|Withdrawal by Subject|0|||
44180410|NCT01867216|78974613|FG004|Overall Study|Withdrawal by Subject|1|||
44180411|NCT01867216|78974614|FG005|Overall Study|Withdrawal by Subject|0|||
44180412|NCT01867216|78974615|FG006|Overall Study|Withdrawal by Subject|1|||
44180413|NCT01867216|78974609|FG000|Overall Study|Physician Decision|1|||
44180414|NCT01867216|78974610|FG001|Overall Study|Physician Decision|0|||
44180415|NCT01867216|78974611|FG002|Overall Study|Physician Decision|0|||
44180416|NCT01867216|78974612|FG003|Overall Study|Physician Decision|0|||
44180417|NCT01867216|78974613|FG004|Overall Study|Physician Decision|0|||
44180418|NCT01867216|78974614|FG005|Overall Study|Physician Decision|0|||
44180419|NCT01867216|78974615|FG006|Overall Study|Physician Decision|0|||
44180420|NCT01867216|78974609|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
44180421|NCT01867216|78974610|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
44180422|NCT01867216|78974611|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
44180423|NCT01867216|78974612|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
44180424|NCT01867216|78974613|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
44180425|NCT01867216|78974614|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
44180426|NCT01867216|78974615|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
44180427|NCT01866826|78974637|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
44180428|NCT01866826|78974638|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
44180429|NCT01866826|78974637|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
44180430|NCT01866826|78974638|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
44180431|NCT01866826|78974637|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
44180432|NCT01866826|78974638|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
44180433|NCT01791244|78974655|FG000|Overall Study|Adverse Event|5|||
44180434|NCT01791244|78974656|FG001|Overall Study|Adverse Event|7|||
44180435|NCT01791244|78974655|FG000|Overall Study|Insufficient clinical response|10|||
44180436|NCT01791244|78974656|FG001|Overall Study|Insufficient clinical response|10|||
44180437|NCT01791244|78974655|FG000|Overall Study|Laboratory Abnormality|0|||
44180438|NCT01791244|78974656|FG001|Overall Study|Laboratory Abnormality|1|||
44180439|NCT01865812|78974664|FG000|Primary Treatment Phase|Adverse Event|2|||
44180440|NCT01865812|78974665|FG001|Primary Treatment Phase|Adverse Event|0|||
44180441|NCT01865812|78974664|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
44180442|NCT01865812|78974665|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
44180443|NCT01865812|78974664|FG000|Long-term Safety Extension Phase|Pruritus|0|||
44180444|NCT01865812|78974665|FG001|Long-term Safety Extension Phase|Pruritus|3|||
44180445|NCT01865812|78974664|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
44180446|NCT01865812|78974665|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
44180447|NCT01865812|78974664|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
44180448|NCT01865812|78974665|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
44180449|NCT01808092|78974674|FG000|Overall Study|Death|39|||
44180450|NCT01808092|78974675|FG001|Overall Study|Death|29|||
44180451|NCT01808092|78974674|FG000|Overall Study|Lost to Follow-up|3|||
44180452|NCT01808092|78974675|FG001|Overall Study|Lost to Follow-up|7|||
44180453|NCT01808092|78974674|FG000|Overall Study|Withdrawal by Subject|9|||
44180454|NCT01808092|78974675|FG001|Overall Study|Withdrawal by Subject|4|||
44180455|NCT01808092|78974674|FG000|Overall Study|Other Eligibility criteria|3|||
44180456|NCT01808092|78974675|FG001|Overall Study|Other Eligibility criteria|5|||
44180457|NCT01774084|78974683|FG000|Overall Study|Personal reasons|1|||
44180458|NCT01774084|78974684|FG001|Overall Study|Personal reasons|0|||
44180459|NCT01807234|78974696|FG000|Overall Study|Lost to Follow-up|2|||
44180460|NCT01807234|78974697|FG001|Overall Study|Lost to Follow-up|5|||
44180461|NCT01807234|78974698|FG002|Overall Study|Lost to Follow-up|1|||
44180462|NCT01807234|78974699|FG003|Overall Study|Lost to Follow-up|1|||
44180463|NCT01807234|78974700|FG004|Overall Study|Lost to Follow-up|1|||
44180464|NCT01807234|78974701|FG005|Overall Study|Lost to Follow-up|2|||
44180465|NCT01807234|78974696|FG000|Overall Study|Withdrawal by Subject|3|||
44180466|NCT01807234|78974697|FG001|Overall Study|Withdrawal by Subject|1|||
44180467|NCT01807234|78974698|FG002|Overall Study|Withdrawal by Subject|1|||
44180468|NCT01807234|78974699|FG003|Overall Study|Withdrawal by Subject|1|||
44180469|NCT01807234|78974700|FG004|Overall Study|Withdrawal by Subject|2|||
44180470|NCT01807234|78974701|FG005|Overall Study|Withdrawal by Subject|1|||
44180471|NCT01807234|78974696|FG000|Overall Study|Lack of Efficacy|0|||
44180472|NCT01807234|78974697|FG001|Overall Study|Lack of Efficacy|0|||
44180473|NCT01807234|78974698|FG002|Overall Study|Lack of Efficacy|0|||
44180474|NCT01807234|78974699|FG003|Overall Study|Lack of Efficacy|0|||
44180475|NCT01807234|78974700|FG004|Overall Study|Lack of Efficacy|1|||
44180476|NCT01807234|78974701|FG005|Overall Study|Lack of Efficacy|1|||
44180477|NCT01790932|78974711|FG000|Overall Study|Disease Progression|41|||
44180478|NCT01790932|78974711|FG000|Overall Study|Adverse Event|7|||
44180479|NCT01790932|78974711|FG000|Overall Study|Physician Decision|1|||
44180480|NCT01790932|78974711|FG000|Overall Study|Withdrawal by Subject|1|||
44180481|NCT02377427|78974717|FG000|Part A (Up to Week 20)|Physician Decision|1|||
44180482|NCT02377427|78974718|FG001|Part A (Up to Week 20)|Physician Decision|0|||
44180483|NCT02377427|78974719|FG002|Part A (Up to Week 20)|Physician Decision|0|||
44180484|NCT02377427|78974720|FG003|Part A (Up to Week 20)|Physician Decision|0|||
44180485|NCT02377427|78974721|FG004|Part A (Up to Week 20)|Physician Decision|0|||
44180486|NCT02377427|78974717|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
44180487|NCT02377427|78974718|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
44180488|NCT02377427|78974719|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
44180489|NCT02377427|78974720|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
44180490|NCT02377427|78974721|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
44180491|NCT02377427|78974717|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
44180492|NCT02377427|78974718|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
44180493|NCT02377427|78974719|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
44180494|NCT02377427|78974720|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
44180495|NCT02377427|78974721|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
44180496|NCT02377427|78974717|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
44180497|NCT02377427|78974718|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
44180498|NCT02377427|78974719|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
44180499|NCT02377427|78974720|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
44180500|NCT02377427|78974721|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
44180501|NCT02421887|78974736|FG000|Overall Study|Lost to Follow-up|5|||
44264973|NCT02460978|79167059|FG000|Overall Study|Withdrawal by Subject|5|||
44264974|NCT02460978|79167060|FG001|Overall Study|Withdrawal by Subject|5|||
44264975|NCT02460978|79167061|FG002|Overall Study|Withdrawal by Subject|14|||
44264976|NCT02460978|79167059|FG000|Overall Study|Lost to Follow-up|2|||
44180502|NCT02421887|78974737|FG001|Overall Study|Lost to Follow-up|0|||
44180503|NCT02421887|78974736|FG000|Overall Study|Withdrawal by Subject|8|||
44180504|NCT02421887|78974737|FG001|Overall Study|Withdrawal by Subject|5|||
44180505|NCT02421887|78974736|FG000|Overall Study|Physician Decision|2|||
44180506|NCT02421887|78974737|FG001|Overall Study|Physician Decision|4|||
44180507|NCT02421887|78974736|FG000|Overall Study|Adverse Event|2|||
44180508|NCT02421887|78974737|FG001|Overall Study|Adverse Event|0|||
44180509|NCT01609582|78974745|FG000|Overall Study|Adverse Event|20|||
44180510|NCT01609582|78974746|FG001|Overall Study|Adverse Event|18|||
44180511|NCT01609582|78974745|FG000|Overall Study|Lost to Follow-up|10|||
44180512|NCT01609582|78974746|FG001|Overall Study|Lost to Follow-up|10|||
44180513|NCT01609582|78974745|FG000|Overall Study|Withdrawal by Subject|21|||
44180514|NCT01609582|78974746|FG001|Overall Study|Withdrawal by Subject|15|||
44180515|NCT01609582|78974745|FG000|Overall Study|Study Terminated by Sponsor|1543|||
44180516|NCT01609582|78974746|FG001|Overall Study|Study Terminated by Sponsor|1548|||
44180517|NCT01609582|78974745|FG000|Overall Study|Other|9|||
44180518|NCT01609582|78974746|FG001|Overall Study|Other|10|||
44180519|NCT01609582|78974745|FG000|Overall Study|Randomized, but not treated|0|||
44180520|NCT01609582|78974746|FG001|Overall Study|Randomized, but not treated|3|||
44180521|NCT01789606|78974754|FG000|Overall Study|Participant not Purchased the Product|0|||
44180522|NCT01789606|78974755|FG001|Overall Study|Participant not Purchased the Product|20|||
44180523|NCT01789606|78974754|FG000|Overall Study|Withdrawal by Subject|0|||
44180524|NCT01789606|78974755|FG001|Overall Study|Withdrawal by Subject|1|||
44180525|NCT01789606|78974754|FG000|Overall Study|Ineligible|6|||
44264977|NCT02460978|79167060|FG001|Overall Study|Lost to Follow-up|3|||
44264978|NCT02460978|79167061|FG002|Overall Study|Lost to Follow-up|1|||
44180526|NCT01789606|78974755|FG001|Overall Study|Ineligible|2|||
44180527|NCT01789606|78974754|FG000|Overall Study|Administrative Reasons|17|||
44180528|NCT01789606|78974755|FG001|Overall Study|Administrative Reasons|6|||
44180529|NCT01789606|78974754|FG000|Overall Study|No Study Medication Taken|0|||
44180530|NCT01789606|78974755|FG001|Overall Study|No Study Medication Taken|1|||
44180531|NCT01789606|78974754|FG000|Overall Study|Protocol Violation|0|||
44180532|NCT01789606|78974755|FG001|Overall Study|Protocol Violation|55|||
44180533|NCT01789606|78974754|FG000|Overall Study|Adverse Event|0|||
44180534|NCT01789606|78974755|FG001|Overall Study|Adverse Event|3|||
44180535|NCT01789606|78974754|FG000|Overall Study|Lost to Follow-up|0|||
44180536|NCT01789606|78974755|FG001|Overall Study|Lost to Follow-up|14|||
44180537|NCT01789606|78974754|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
44180538|NCT01789606|78974755|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
44180539|NCT01788358|78974760|FG000|Overall Study|Other|11|||
44180540|NCT01788358|78974760|FG000|Overall Study|Logistical difficulties|1|||
44180541|NCT01788358|78974760|FG000|Overall Study|Lost to Follow-up|5|||
44180542|NCT01788358|78974760|FG000|Overall Study|Protocol Violation|3|||
44180543|NCT01788358|78974760|FG000|Overall Study|Withdrawal by Subject|26|||
44180544|NCT01788358|78974760|FG000|Overall Study|Lack of Efficacy|1|||
44180545|NCT01788358|78974760|FG000|Overall Study|Adverse Event|51|||
44180546|NCT01773226|78974764|FG000|Overall Study|Withdrawal by Subject|1|||
44180547|NCT01773070|78974768|FG000|Overall Study|Withdrawal by Subject|24|||
44180548|NCT01773070|78974768|FG000|Overall Study|Lost to Follow-up|39|||
44180549|NCT01773070|78974768|FG000|Overall Study|Other|15|||
44180550|NCT01773070|78974768|FG000|Overall Study|Death (unrelated to study procedures)|3|||
44180551|NCT01772368|78974772|FG000|Overall Study|Adverse Event|1|||
44180552|NCT01772368|78974772|FG000|Overall Study|Withdrawal by Subject|3|||
44180553|NCT01772368|78974772|FG000|Overall Study|Protocol Violation|2|||
44180554|NCT01772368|78974772|FG000|Overall Study|Other|1|||
44180555|NCT01788046|78974790|FG000|Overall Study|Withdrawal by Subject|12|||
44180556|NCT01788046|78974791|FG001|Overall Study|Withdrawal by Subject|12|||
44180557|NCT01788046|78974790|FG000|Overall Study|Lost to Follow-up|12|||
44180558|NCT01788046|78974791|FG001|Overall Study|Lost to Follow-up|19|||
44180559|NCT01788046|78974790|FG000|Overall Study|Death|7|||
44180560|NCT01788046|78974791|FG001|Overall Study|Death|5|||
44180561|NCT01788046|78974790|FG000|Overall Study|Protocol Specified Criteria|25|||
44180562|NCT01788046|78974791|FG001|Overall Study|Protocol Specified Criteria|1|||
44180563|NCT01806298|78974797|FG000|Overall Study|Adverse Event|3|||
44180564|NCT01806298|78974797|FG000|Overall Study|Protocol Non-compliance|1|||
44180565|NCT01806298|78974797|FG000|Overall Study|Withdrawal by Subject|1|||
44180566|NCT01806298|78974797|FG000|Overall Study|Other|5|||
44180567|NCT01772134|78974804|FG000|Overall Study|Adverse Event|6|||
44180568|NCT01772134|78974805|FG001|Overall Study|Adverse Event|5|||
44180569|NCT01772134|78974806|FG002|Overall Study|Adverse Event|10|||
44180570|NCT01772134|78974804|FG000|Overall Study|Withdrew Consent|3|||
44180571|NCT01772134|78974805|FG001|Overall Study|Withdrew Consent|1|||
44180572|NCT01772134|78974806|FG002|Overall Study|Withdrew Consent|5|||
44180573|NCT01772134|78974804|FG000|Overall Study|Lost to Follow-up|2|||
44180574|NCT01772134|78974805|FG001|Overall Study|Lost to Follow-up|0|||
44180575|NCT01772134|78974806|FG002|Overall Study|Lost to Follow-up|0|||
44180576|NCT01772134|78974804|FG000|Overall Study|Protocol Deviation|4|||
44180577|NCT01772134|78974805|FG001|Overall Study|Protocol Deviation|3|||
44180578|NCT01772134|78974806|FG002|Overall Study|Protocol Deviation|3|||
44180579|NCT01772134|78974804|FG000|Overall Study|Lack of Efficacy|11|||
44180580|NCT01772134|78974805|FG001|Overall Study|Lack of Efficacy|5|||
44180581|NCT01772134|78974806|FG002|Overall Study|Lack of Efficacy|3|||
44180582|NCT01772134|78974804|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
44180583|NCT01772134|78974805|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
44180584|NCT01772134|78974806|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
44180585|NCT01772134|78974804|FG000|Overall Study|Randomized Study Medication Not Received|2|||
44180586|NCT01772134|78974805|FG001|Overall Study|Randomized Study Medication Not Received|0|||
44180587|NCT01772134|78974806|FG002|Overall Study|Randomized Study Medication Not Received|1|||
44180588|NCT01994889|78974817|FG000|Overall Study|Adverse Event|5|||
44180589|NCT01994889|78974818|FG001|Overall Study|Adverse Event|12|||
44180590|NCT01994889|78974819|FG002|Overall Study|Adverse Event|11|||
44180591|NCT01994889|78974817|FG000|Overall Study|Cardiac Device Implantation|0|||
44180592|NCT01994889|78974818|FG001|Overall Study|Cardiac Device Implantation|2|||
44180593|NCT01994889|78974819|FG002|Overall Study|Cardiac Device Implantation|0|||
44180594|NCT01994889|78974817|FG000|Overall Study|Organ Transplantation|1|||
44180595|NCT01994889|78974818|FG001|Overall Study|Organ Transplantation|5|||
44180596|NCT01994889|78974819|FG002|Overall Study|Organ Transplantation|5|||
44180597|NCT01994889|78974817|FG000|Overall Study|No longer willing to participate|8|||
44180598|NCT01994889|78974818|FG001|Overall Study|No longer willing to participate|17|||
44180599|NCT01994889|78974819|FG002|Overall Study|No longer willing to participate|37|||
44180600|NCT01994889|78974817|FG000|Overall Study|Lost to Follow-up|0|||
44180601|NCT01994889|78974818|FG001|Overall Study|Lost to Follow-up|1|||
44180602|NCT01994889|78974819|FG002|Overall Study|Lost to Follow-up|0|||
44180603|NCT01994889|78974817|FG000|Overall Study|Protocol Violation|0|||
44180604|NCT01994889|78974818|FG001|Overall Study|Protocol Violation|1|||
44180605|NCT01994889|78974819|FG002|Overall Study|Protocol Violation|1|||
44180606|NCT01994889|78974817|FG000|Overall Study|Death|14|||
44180607|NCT01994889|78974818|FG001|Overall Study|Death|25|||
44180608|NCT01994889|78974819|FG002|Overall Study|Death|38|||
44180609|NCT02082483|78974828|FG000|Overall Study|Lost to Follow-up|1|||
44180610|NCT02082483|78974829|FG001|Overall Study|Lost to Follow-up|1|||
44180611|NCT02082483|78974828|FG000|Overall Study|Withdrawal by Subject|2|||
44180612|NCT02082483|78974829|FG001|Overall Study|Withdrawal by Subject|1|||
44180613|NCT02082483|78974828|FG000|Overall Study|Physician Decision|1|||
44180614|NCT02082483|78974829|FG001|Overall Study|Physician Decision|1|||
44180615|NCT02082483|78974828|FG000|Overall Study|Death|2|||
44180616|NCT02082483|78974829|FG001|Overall Study|Death|3|||
44180617|NCT02017899|78974842|FG000|Overall Study|Withdrawal by Subject|0|||
44180618|NCT02017899|78974843|FG001|Overall Study|Withdrawal by Subject|0|||
44180619|NCT02017899|78974844|FG002|Overall Study|Withdrawal by Subject|0|||
44180620|NCT02017899|78974845|FG003|Overall Study|Withdrawal by Subject|1|||
44180621|NCT02017899|78974846|FG004|Overall Study|Withdrawal by Subject|1|||
44180622|NCT02017899|78974847|FG005|Overall Study|Withdrawal by Subject|0|||
44180623|NCT01993329|78974867|FG000|Period 2|Adverse Event|0|||
44180624|NCT01993329|78974868|FG001|Period 2|Adverse Event|0|||
44180625|NCT01993329|78974869|FG002|Period 2|Adverse Event|0|||
44180626|NCT01993329|78974870|FG003|Period 2|Adverse Event|0|||
44180627|NCT01993329|78974871|FG004|Period 2|Adverse Event|0|||
44180628|NCT01993329|78974872|FG005|Period 2|Adverse Event|1|||
44180629|NCT01993329|78974867|FG000|Wash-out|Personal reasons|0|||
44180630|NCT01993329|78974868|FG001|Wash-out|Personal reasons|1|||
44180631|NCT01993329|78974869|FG002|Wash-out|Personal reasons|0|||
44180632|NCT01993329|78974870|FG003|Wash-out|Personal reasons|0|||
44180633|NCT01993329|78974871|FG004|Wash-out|Personal reasons|0|||
44180634|NCT01993329|78974872|FG005|Wash-out|Personal reasons|0|||
44180635|NCT02016183|78974884|FG000|Overall Study|Case Report Forms Uncollected|13|||
44180636|NCT02016183|78974884|FG000|Overall Study|Protocol Violation|52|||
44180637|NCT02377349|78974890|FG000|Overall Study|Serious Adverse Event|1|||
44451236|NCT00490971|79460223|FG002|Maintenance|Death|0|||
44451237|NCT00490971|79460224|FG003|Maintenance|Death|2|||
44180638|NCT02377349|78974891|FG001|Overall Study|Serious Adverse Event|0|||
44180639|NCT02377349|78974890|FG000|Overall Study|Protocol Violation|3|||
44180640|NCT02377349|78974891|FG001|Overall Study|Protocol Violation|2|||
44180641|NCT02377349|78974890|FG000|Overall Study|Withdrawal by Subject|5|||
44180642|NCT02377349|78974891|FG001|Overall Study|Withdrawal by Subject|3|||
44180643|NCT02377349|78974890|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
44180644|NCT02377349|78974891|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
44180645|NCT02377349|78974890|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
44180646|NCT02377349|78974891|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
44180647|NCT02377349|78974890|FG000|Overall Study|Other|0|||
44180648|NCT02377349|78974891|FG001|Overall Study|Other|1|||
44180649|NCT02421419|78974909|FG000|Overall Study|Physician Decision|0|||
44180650|NCT02421419|78974910|FG001|Overall Study|Physician Decision|0|||
44180651|NCT02421419|78974911|FG002|Overall Study|Physician Decision|1|||
44180652|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
44180653|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
44180654|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
44264979|NCT02460978|79167059|FG000|Overall Study|Protocol Violation|1|||
44264980|NCT02460978|79167060|FG001|Overall Study|Protocol Violation|1|||
44264981|NCT02460978|79167061|FG002|Overall Study|Protocol Violation|1|||
44264982|NCT02460978|79167059|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
44264983|NCT02460978|79167060|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
44180655|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
44180656|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
44180657|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
44180658|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
44180659|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
44180660|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
44180661|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
44180662|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
44180663|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
44180664|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
44264984|NCT02460978|79167061|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
44264985|NCT02460978|79167059|FG000|Overall Study|Pregnancy|0|||
44264986|NCT02460978|79167060|FG001|Overall Study|Pregnancy|0|||
44264987|NCT02460978|79167061|FG002|Overall Study|Pregnancy|2|||
44180665|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
44180666|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
44180667|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
44451238|NCT00490971|79460225|FG004|Maintenance|Death|0|||
44180668|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
44180669|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
44180670|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
44180671|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
44180672|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
44180673|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
44180674|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
44180675|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
44180676|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
44180677|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
44180678|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
44180679|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
44180680|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
44180681|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
44180682|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
44180683|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
44180684|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
44180685|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
44180686|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
44180687|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
44180688|NCT02016105|78974921|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
44180689|NCT02016105|78974922|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
44180690|NCT02016105|78974923|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
44180691|NCT02016105|78974924|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
44180692|NCT02016105|78974925|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
44180693|NCT02016105|78974926|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
44180694|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
44180695|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
44180696|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
44180697|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
44180698|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
44180699|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
44180700|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
44180701|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
44180702|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
44180703|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
44180704|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
44180705|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
44180706|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
44180707|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
44180708|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
44180709|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
44180710|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
44180711|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
44180712|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Death|0|||
44180713|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Death|0|||
44180714|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Death|0|||
44180715|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Death|0|||
44180716|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Death|0|||
44180717|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Death|1|||
44180718|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
44180719|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
44180720|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
44180721|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
44180722|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
44180723|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
44180724|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
44180725|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
44180726|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
44180727|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
44180728|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
44180729|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
44180730|NCT02016105|78974921|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
44180731|NCT02016105|78974922|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
44180732|NCT02016105|78974923|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
44180733|NCT02016105|78974924|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
44180734|NCT02016105|78974925|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
44180735|NCT02016105|78974926|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
44180736|NCT02016105|78974921|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
44180737|NCT02016105|78974922|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
44180738|NCT02016105|78974923|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
44180739|NCT02016105|78974924|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
44180740|NCT02016105|78974925|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
44180741|NCT02016105|78974926|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
44180742|NCT02016105|78974921|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
44180743|NCT02016105|78974922|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
44180744|NCT02016105|78974923|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
44180745|NCT02016105|78974924|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
44180746|NCT02016105|78974925|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
44180747|NCT02016105|78974926|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
44180748|NCT02016105|78974921|FG000|EXTENSION PERIOD|Adverse Event|0|||
44180749|NCT02016105|78974922|FG001|EXTENSION PERIOD|Adverse Event|0|||
44180750|NCT02016105|78974923|FG002|EXTENSION PERIOD|Adverse Event|2|||
44180751|NCT02016105|78974924|FG003|EXTENSION PERIOD|Adverse Event|0|||
44180752|NCT02016105|78974925|FG004|EXTENSION PERIOD|Adverse Event|1|||
44180753|NCT02016105|78974926|FG005|EXTENSION PERIOD|Adverse Event|0|||
44180754|NCT02016105|78974921|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
44180755|NCT02016105|78974922|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
44180756|NCT02016105|78974923|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
44180757|NCT02016105|78974924|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
44180758|NCT02016105|78974925|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
44180759|NCT02016105|78974926|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
44180760|NCT02016105|78974921|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
44180761|NCT02016105|78974922|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
44180762|NCT02016105|78974923|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
44180763|NCT02016105|78974924|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
44180764|NCT02016105|78974925|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
44180765|NCT02016105|78974926|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
44180766|NCT02016105|78974921|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
44180767|NCT02016105|78974922|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
44180768|NCT02016105|78974923|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
44180769|NCT02016105|78974924|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
44180770|NCT02016105|78974925|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
44180771|NCT02016105|78974926|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
44180772|NCT02400905|78974940|FG000|Overall Study|Death|24|||
44180773|NCT02400905|78974940|FG000|Overall Study|Lost to Follow-up|18|||
44180774|NCT02400905|78974940|FG000|Overall Study|Withdrawal by Subject|16|||
44180775|NCT02400905|78974940|FG000|Overall Study|Physician Decision|4|||
44180776|NCT02400905|78974940|FG000|Overall Study|Other|1|||
44180777|NCT02400749|78974947|FG000|Week 0 -16|Withdrawal by Subject|5|||
44180778|NCT02400749|78974948|FG001|Week 0 -16|Withdrawal by Subject|5|||
44180779|NCT02400749|78974947|FG000|Week 0 -16|Adverse Event|3|||
44180780|NCT02400749|78974948|FG001|Week 0 -16|Adverse Event|1|||
44180781|NCT02400749|78974947|FG000|Week 0 -16|Lost to Follow-up|2|||
44180782|NCT02400749|78974948|FG001|Week 0 -16|Lost to Follow-up|0|||
44180783|NCT02400749|78974947|FG000|Week 0 -16|Protocol Violation|1|||
44180784|NCT02400749|78974948|FG001|Week 0 -16|Protocol Violation|0|||
44180785|NCT02400749|78974947|FG000|Week 17 - 32|Withdrawal by Subject|3|||
44180786|NCT02400749|78974948|FG001|Week 17 - 32|Withdrawal by Subject|2|||
44180787|NCT02400749|78974947|FG000|Week 17 - 32|Adverse Event|2|||
44180788|NCT02400749|78974948|FG001|Week 17 - 32|Adverse Event|1|||
44180789|NCT02420327|78974954|FG000|Overall Study|Adverse Event|7|||
44180790|NCT02420327|78974954|FG000|Overall Study|Pregnancy|1|||
44180791|NCT02420327|78974954|FG000|Overall Study|Withdrawal by Subject|6|||
44180792|NCT02420327|78974954|FG000|Overall Study|Lost to Follow-up|1|||
44180793|NCT02420327|78974954|FG000|Overall Study|Protocol Violation|1|||
44180794|NCT02374853|78974966|FG000|Overall Study|Surgery Cancelled|5|||
44180795|NCT02374853|78974967|FG001|Overall Study|Surgery Cancelled|11|||
44180796|NCT02015793|78974975|FG000|Overall Study|Adverse Event|3|||
44180797|NCT02015793|78974976|FG001|Overall Study|Adverse Event|3|||
44180798|NCT02015793|78974975|FG000|Overall Study|Withdrawal by Subject|1|||
44180799|NCT02015793|78974976|FG001|Overall Study|Withdrawal by Subject|1|||
44180800|NCT02347631|78974990|FG000|First Intervention (2 Months)|Adverse Event|1|||
44180801|NCT02347631|78974991|FG001|First Intervention (2 Months)|Adverse Event|1|||
44180802|NCT02347631|78974990|FG000|First Intervention (2 Months)|Pregnancy|1|||
44180803|NCT02347631|78974991|FG001|First Intervention (2 Months)|Pregnancy|0|||
44180804|NCT02347631|78974990|FG000|First Intervention (2 Months)|Moved out of area|0|||
44180805|NCT02347631|78974991|FG001|First Intervention (2 Months)|Moved out of area|2|||
44180806|NCT02347631|78974990|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
44180807|NCT02347631|78974991|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
44180808|NCT02347631|78974990|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
44180809|NCT02347631|78974991|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
44180810|NCT02347631|78974990|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
44180811|NCT02347631|78974991|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
44264988|NCT02489448|79167076|FG000|Overall Study|Death|3|||
44180812|NCT02347631|78974990|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
44180813|NCT02347631|78974991|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
44180814|NCT02347631|78974990|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
44180815|NCT02347631|78974991|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
44264989|NCT02489448|79167076|FG000|Overall Study|Withdrawal by Subject|2|||
44264990|NCT02488980|79167097|FG000|Overall Study|Protocol Violation|2|||
44180816|NCT02015637|78975001|FG000|Overall Study|Lost to Follow-up|3|||
44180817|NCT02015637|78975002|FG001|Overall Study|Lost to Follow-up|5|||
44180818|NCT02015637|78975001|FG000|Overall Study|Adverse Event|3|||
44180819|NCT02015637|78975002|FG001|Overall Study|Adverse Event|0|||
44180820|NCT02015637|78975001|FG000|Overall Study|Did not take study drug|2|||
44180821|NCT02015637|78975002|FG001|Overall Study|Did not take study drug|0|||
44180822|NCT02347085|78975008|FG000|Overall Study|Adverse Event|2|||
44180823|NCT02347085|78975008|FG000|Overall Study|Lack of Efficacy|1|||
44180824|NCT02347085|78975008|FG000|Overall Study|Withdrawal by Subject|4|||
44180825|NCT02347085|78975008|FG000|Overall Study|Lost to Follow-up|1|||
44180826|NCT02347085|78975008|FG000|Overall Study|Protocol Criteria|2|||
44264991|NCT02488980|79167098|FG001|Overall Study|Protocol Violation|2|||
44264992|NCT02488980|79167099|FG002|Overall Study|Protocol Violation|2|||
44264993|NCT02460822|79167111|FG000|Overall Study|Withdrawal by Subject|1|||
44264994|NCT02488824|79167117|FG000|Overall Study|Adverse Event|1|||
44264995|NCT02488824|79167118|FG001|Overall Study|Adverse Event|1|||
44264996|NCT02308241|79167230|FG000|Overall Study|Withdrawal by Subject|3|||
44264997|NCT02460198|79167269|FG000|Overall Study|Adverse Event|1|||
44264998|NCT02460198|79167270|FG001|Overall Study|Adverse Event|3|||
44264999|NCT02460198|79167269|FG000|Overall Study|Death|36|||
44265000|NCT02460198|79167270|FG001|Overall Study|Death|28|||
44361218|NCT01185821|79366879|FG004|Overall Study|Death|0|||
44451239|NCT00490971|79460221|FG000|Maintenance|Lost to Follow-up|0|||
44180827|NCT02374463|78975016|FG000|Overall Study|Withdrawal by Subject|3|||
44180828|NCT02374463|78975017|FG001|Overall Study|Withdrawal by Subject|3|||
44180829|NCT02015481|78975024|FG000|Overall Study|Death|1|||
44180830|NCT02374307|78975031|FG000|3-months Follow-up|Lost to Follow-up|1|||
44180831|NCT02374307|78975032|FG001|3-months Follow-up|Lost to Follow-up|2|||
44180832|NCT02374307|78975031|FG000|3-months Follow-up|Withdrawal by Subject|1|||
44180833|NCT02374307|78975032|FG001|3-months Follow-up|Withdrawal by Subject|4|||
44180834|NCT02374307|78975031|FG000|3-months Follow-up|Death|1|||
44451240|NCT00490971|79460222|FG001|Maintenance|Lost to Follow-up|0|||
44451241|NCT00490971|79460223|FG002|Maintenance|Lost to Follow-up|5|||
44180835|NCT02374307|78975032|FG001|3-months Follow-up|Death|2|||
44180836|NCT02374307|78975031|FG000|3-months Follow-up|Missed first follow-up|5|||
44180837|NCT02374307|78975032|FG001|3-months Follow-up|Missed first follow-up|1|||
44180838|NCT02374307|78975031|FG000|6-months Follow-up|Lost to Follow-up|1|||
44180839|NCT02374307|78975032|FG001|6-months Follow-up|Lost to Follow-up|2|||
44180840|NCT02374307|78975031|FG000|6-months Follow-up|Death|2|||
44180841|NCT02374307|78975032|FG001|6-months Follow-up|Death|1|||
44180842|NCT02374307|78975031|FG000|6-months Follow-up|Withdrawal by Subject|0|||
44180843|NCT02374307|78975032|FG001|6-months Follow-up|Withdrawal by Subject|3|||
44180844|NCT02397473|78975040|FG000|Treatment Phase|Adverse Event|1|||
44180845|NCT02397473|78975041|FG001|Treatment Phase|Adverse Event|2|||
44180846|NCT02397473|78975040|FG000|Treatment Phase|Lack of Efficacy|8|||
44180847|NCT02397473|78975041|FG001|Treatment Phase|Lack of Efficacy|1|||
44180848|NCT02397473|78975040|FG000|Treatment Phase|Lost to Follow-up|1|||
44180849|NCT02397473|78975041|FG001|Treatment Phase|Lost to Follow-up|0|||
44180850|NCT02397473|78975040|FG000|Treatment Phase|Withdrawal by Subject|2|||
44180851|NCT02397473|78975041|FG001|Treatment Phase|Withdrawal by Subject|1|||
44180852|NCT02397473|78975040|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
44180853|NCT02397473|78975041|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
44180854|NCT02397473|78975040|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
44180855|NCT02397473|78975041|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
44180856|NCT02397473|78975040|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
44180857|NCT02397473|78975041|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
44180858|NCT02397473|78975040|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
44265001|NCT02460198|79167269|FG000|Overall Study|Lost to Follow-up|1|||
44265002|NCT02460198|79167270|FG001|Overall Study|Lost to Follow-up|1|||
44451242|NCT00490971|79460224|FG003|Maintenance|Lost to Follow-up|8|||
44180859|NCT02397473|78975041|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
44180860|NCT02397473|78975040|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
44180861|NCT02397473|78975041|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
44180862|NCT02344745|78975052|FG000|Overall Study|Data collection sheets were lost|2|||
44180863|NCT02344745|78975053|FG001|Overall Study|Data collection sheets were lost|0|||
44265003|NCT02460198|79167269|FG000|Overall Study|Transferred to Extension Study|15|||
44180864|NCT02370641|78975061|FG000|Overall Study|dropped study|4|||
44451243|NCT00490971|79460225|FG004|Maintenance|Lost to Follow-up|10|||
44180865|NCT02370641|78975062|FG001|Overall Study|dropped study|2|||
44180866|NCT01621191|78975068|FG000|Overall Study|Adverse Event|9|||
44180867|NCT01621191|78975068|FG000|Overall Study|Withdrawal by Subject|8|||
44180868|NCT01621191|78975068|FG000|Overall Study|Lack of Efficacy|6|||
44180869|NCT01621191|78975068|FG000|Overall Study|Lost to Follow-up|1|||
44180870|NCT01621191|78975068|FG000|Overall Study|Site Removed From Study|1|||
44180871|NCT02343263|78975076|FG000|Overall Study|Physician Decision|5|||
44180872|NCT02343263|78975077|FG001|Overall Study|Physician Decision|3|||
44180873|NCT02343263|78975078|FG002|Overall Study|Physician Decision|1|||
44180874|NCT02081859|78975092|FG000|Overall Study|No fertilization|2|||
44180875|NCT02081859|78975093|FG001|Overall Study|No fertilization|2|||
44180876|NCT02081859|78975092|FG000|Overall Study|No sperm|1|||
44180877|NCT02081859|78975093|FG001|Overall Study|No sperm|0|||
44180878|NCT02081859|78975092|FG000|Overall Study|Unanticipated freeze all cycle|2|||
44180879|NCT02081859|78975093|FG001|Overall Study|Unanticipated freeze all cycle|6|||
44180880|NCT02081859|78975092|FG000|Overall Study|< 4 embryos|27|||
44180881|NCT02081859|78975093|FG001|Overall Study|< 4 embryos|23|||
44180882|NCT02081859|78975092|FG000|Overall Study|Other reasons|2|||
44180883|NCT02081859|78975093|FG001|Overall Study|Other reasons|0|||
44180884|NCT02342639|78975101|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
44180885|NCT02342639|78975102|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
44180886|NCT02342639|78975101|FG000|Overall Study|Protocol Violation|0|||
44180887|NCT02342639|78975102|FG001|Overall Study|Protocol Violation|2|||
44180888|NCT01625091|78975112|FG000|Intervention|Death|1|||
44180889|NCT01625091|78975113|FG001|Intervention|Death|1|||
44180890|NCT01625091|78975112|FG000|Intervention|Withdrawal by Subject|4|||
44180891|NCT01625091|78975113|FG001|Intervention|Withdrawal by Subject|1|||
44180892|NCT01625091|78975112|FG000|Intervention|Adverse Event|0|||
44180893|NCT01625091|78975113|FG001|Intervention|Adverse Event|2|||
44180894|NCT01625091|78975112|FG000|Intervention|Lost to Follow-up|4|||
44180895|NCT01625091|78975113|FG001|Intervention|Lost to Follow-up|4|||
44180896|NCT01625091|78975112|FG000|Intervention|Study termination|2|||
44180897|NCT01625091|78975113|FG001|Intervention|Study termination|3|||
44180898|NCT01625091|78975112|FG000|Post-intervention|Death|0|||
44180899|NCT01625091|78975113|FG001|Post-intervention|Death|1|||
44180900|NCT01625091|78975112|FG000|Post-intervention|Lost to Follow-up|2|||
44180901|NCT01625091|78975113|FG001|Post-intervention|Lost to Follow-up|0|||
44180902|NCT01625091|78975112|FG000|Post-intervention|Study termination|2|||
44180903|NCT01625091|78975113|FG001|Post-intervention|Study termination|1|||
44180904|NCT02396849|78975121|FG000|Overall Study|Lost to Follow-up|1|||
44180905|NCT02396849|78975122|FG001|Overall Study|Lost to Follow-up|1|||
44180906|NCT02396849|78975121|FG000|Overall Study|Did not tolerate intervention|1|||
44180907|NCT02396849|78975122|FG001|Overall Study|Did not tolerate intervention|1|||
44361219|NCT01185821|79366875|FG000|Overall Study|Condition no longer required study drug|0|||
44180908|NCT02370251|78975130|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
44180909|NCT02370251|78975130|FG000|Overall Study|Death|4|||
44180910|NCT02396537|78975136|FG000|Overall Study|Protocol Violation|0|||
44180911|NCT02396537|78975137|FG001|Overall Study|Protocol Violation|1|||
44180912|NCT02342171|78975145|FG000|Overall Study|Death|4|||
44180913|NCT02342171|78975146|FG001|Overall Study|Death|87|||
44180914|NCT02342171|78975145|FG000|Overall Study|Received favipiravir|10|||
44180915|NCT02342171|78975146|FG001|Overall Study|Received favipiravir|0|||
44180916|NCT02342171|78975145|FG000|Overall Study|Missing cycle treshold value|1|||
44180917|NCT02342171|78975146|FG001|Overall Study|Missing cycle treshold value|0|||
44180918|NCT02342171|78975145|FG000|Overall Study|Unknown outcome|0|||
44180919|NCT02342171|78975146|FG001|Overall Study|Unknown outcome|1|||
44180920|NCT02342171|78975145|FG000|Overall Study|Missing age data|0|||
44180921|NCT02342171|78975146|FG001|Overall Study|Missing age data|1|||
44180922|NCT01624467|78975151|FG000|Overall Study|Withdrawal by Subject|2|||
44180923|NCT01624467|78975151|FG000|Overall Study|Lost to Follow-up|1|||
44180924|NCT01624467|78975151|FG000|Overall Study|Adverse Event|7|||
44180925|NCT01624467|78975151|FG000|Overall Study|Progressive Disease|19|||
44180926|NCT01624467|78975151|FG000|Overall Study|Per Sponsor Requirement|1|||
44180927|NCT01624467|78975151|FG000|Overall Study|Subject Withdrew from Treatment|1|||
44180928|NCT01624233|78975157|FG000|Period 2 - Induction|Adverse Event|1|||
44180929|NCT01624233|78975157|FG000|Period 3 - Maintenance|Adverse Event|2|||
44180930|NCT01624233|78975157|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
44180931|NCT01624233|78975157|FG000|Period 3 - Maintenance|Physician Decision|2|||
44180932|NCT01624233|78975157|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
44180933|NCT01624233|78975157|FG000|Period 4 - Drug Free Period|Relapsed|61|||
44180934|NCT01624233|78975157|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
44180935|NCT01624233|78975157|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
44180936|NCT01624233|78975157|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
44180937|NCT01624233|78975157|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
44180938|NCT01624233|78975157|FG000|Period 6: Follow-up|Adverse Event|3|||
44180939|NCT01624233|78975157|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
44180940|NCT01624233|78975157|FG000|Period 6: Follow-up|Physician Decision|1|||
44180941|NCT01624233|78975157|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
44180942|NCT01993017|78975168|FG000|Overall Study|Death|23|||
44180943|NCT01993017|78975169|FG001|Overall Study|Death|26|||
44180944|NCT01993017|78975170|FG002|Overall Study|Death|18|||
44180945|NCT01993017|78975168|FG000|Overall Study|Could not be contacted|43|||
44180946|NCT01993017|78975169|FG001|Overall Study|Could not be contacted|42|||
44180947|NCT01993017|78975170|FG002|Overall Study|Could not be contacted|38|||
44180948|NCT01993017|78975168|FG000|Overall Study|Dropped out|19|||
44180949|NCT01993017|78975169|FG001|Overall Study|Dropped out|6|||
44180950|NCT01993017|78975170|FG002|Overall Study|Dropped out|11|||
44180951|NCT01993017|78975168|FG000|Overall Study|Other reasons|17|||
44180952|NCT01993017|78975169|FG001|Overall Study|Other reasons|11|||
44180953|NCT01993017|78975170|FG002|Overall Study|Other reasons|7|||
44180954|NCT01993017|78975168|FG000|Overall Study|Ineligible after randomization|4|||
44180955|NCT01993017|78975169|FG001|Overall Study|Ineligible after randomization|5|||
44180956|NCT01993017|78975170|FG002|Overall Study|Ineligible after randomization|5|||
44180957|NCT01992549|78975179|FG000|Overall Study|Lost to Follow-up|2|||
44180958|NCT01992549|78975179|FG000|Overall Study|Serious Adverse Event|1|||
44180959|NCT01992549|78975179|FG000|Overall Study|Product Switch to Extend Half Life|1|||
44180960|NCT01992159|78975193|FG000|Overall Study|Withdrawal by Subject|4|||
44180961|NCT01992159|78975194|FG001|Overall Study|Withdrawal by Subject|7|||
44180962|NCT01992159|78975195|FG002|Overall Study|Withdrawal by Subject|0|||
44265004|NCT02460198|79167270|FG001|Overall Study|Transferred to Extension Study|15|||
44265005|NCT02460198|79167269|FG000|Overall Study|Withdrawal by Subject|2|||
44265006|NCT02460198|79167270|FG001|Overall Study|Withdrawal by Subject|4|||
44265007|NCT02460198|79167269|FG000|Overall Study|Site Terminated By Sponsor|0|||
44265008|NCT02460198|79167270|FG001|Overall Study|Site Terminated By Sponsor|1|||
44265009|NCT02460198|79167269|FG000|Overall Study|Did Not Continue on Extension Study|6|||
44265010|NCT02460198|79167270|FG001|Overall Study|Did Not Continue on Extension Study|11|||
44265011|NCT02487810|79167290|FG000|Overall Study|Withdrawal by Subject|1|||
44265012|NCT02487810|79167291|FG001|Overall Study|Withdrawal by Subject|0|||
44180963|NCT01992159|78975196|FG003|Overall Study|Withdrawal by Subject|3|||
44180964|NCT01992159|78975193|FG000|Overall Study|Adverse Event|0|||
44180965|NCT01992159|78975194|FG001|Overall Study|Adverse Event|1|||
44180966|NCT01992159|78975195|FG002|Overall Study|Adverse Event|0|||
44265013|NCT02452320|79167299|FG000|Overall Study|Adverse Event|0|||
44265014|NCT02452320|79167300|FG001|Overall Study|Adverse Event|1|||
44180967|NCT01992159|78975196|FG003|Overall Study|Adverse Event|1|||
44180968|NCT01992159|78975193|FG000|Overall Study|Death|0|||
44180969|NCT01992159|78975194|FG001|Overall Study|Death|0|||
44180970|NCT01992159|78975195|FG002|Overall Study|Death|1|||
44180971|NCT01992159|78975196|FG003|Overall Study|Death|0|||
44180972|NCT01988493|78975211|FG000|Overall Study|Randomized but not treated|0|||
44265015|NCT02459964|79167309|FG000|Overall Study|Withdrawal by Subject|0|||
44180973|NCT01988493|78975212|FG001|Overall Study|Randomized but not treated|0|||
44180974|NCT01988493|78975213|FG002|Overall Study|Randomized but not treated|0|||
44180975|NCT01988493|78975214|FG003|Overall Study|Randomized but not treated|0|||
44180976|NCT01988493|78975215|FG004|Overall Study|Randomized but not treated|1|||
44180977|NCT02081079|78975231|FG000|Overall Study|Lack of Efficacy|3|||
44180978|NCT02081079|78975232|FG001|Overall Study|Lack of Efficacy|2|||
44180979|NCT02081079|78975231|FG000|Overall Study|Lost to Follow-up|1|||
44180980|NCT02081079|78975232|FG001|Overall Study|Lost to Follow-up|0|||
44180981|NCT02081001|78975244|FG000|Overall Study|Adverse Event|0|||
44180982|NCT02081001|78975245|FG001|Overall Study|Adverse Event|0|||
44180983|NCT02081001|78975246|FG002|Overall Study|Adverse Event|0|||
44180984|NCT02081001|78975247|FG003|Overall Study|Adverse Event|0|||
44180985|NCT02081001|78975248|FG004|Overall Study|Adverse Event|1|||
44451244|NCT00490971|79460221|FG000|Maintenance|Pregnancy|0|||
44180986|NCT02081001|78975249|FG005|Overall Study|Adverse Event|0|||
44180987|NCT02081001|78975250|FG006|Overall Study|Adverse Event|0|||
44180988|NCT02081001|78975251|FG007|Overall Study|Adverse Event|0|||
44180989|NCT02081001|78975252|FG008|Overall Study|Adverse Event|0|||
44180990|NCT02081001|78975253|FG009|Overall Study|Adverse Event|0|||
44180991|NCT02081001|78975254|FG010|Overall Study|Adverse Event|0|||
44180992|NCT02081001|78975255|FG011|Overall Study|Adverse Event|0|||
44180993|NCT02080221|78975266|FG000|Overall Study|Withdrawal by Subject|1|||
44180994|NCT02080221|78975266|FG000|Overall Study|Clinical Progression of Disease|1|||
44180995|NCT02079909|78975273|FG000|Overall Study|Adverse Event|23|||
44180996|NCT02079909|78975274|FG001|Overall Study|Adverse Event|23|||
44180997|NCT02079909|78975275|FG002|Overall Study|Adverse Event|7|||
44180998|NCT02079909|78975273|FG000|Overall Study|Withdrawal by Subject|9|||
44180999|NCT02079909|78975274|FG001|Overall Study|Withdrawal by Subject|17|||
44181000|NCT02079909|78975275|FG002|Overall Study|Withdrawal by Subject|4|||
44181001|NCT02079909|78975273|FG000|Overall Study|Lost to Follow-up|2|||
44181002|NCT02079909|78975274|FG001|Overall Study|Lost to Follow-up|3|||
44181003|NCT02079909|78975275|FG002|Overall Study|Lost to Follow-up|1|||
44181004|NCT02079909|78975273|FG000|Overall Study|Death|2|||
44181005|NCT02079909|78975274|FG001|Overall Study|Death|2|||
44181006|NCT02079909|78975275|FG002|Overall Study|Death|0|||
44181007|NCT02079909|78975273|FG000|Overall Study|Lack of Efficacy|0|||
44181008|NCT02079909|78975274|FG001|Overall Study|Lack of Efficacy|0|||
44181009|NCT02079909|78975275|FG002|Overall Study|Lack of Efficacy|1|||
44181010|NCT02079909|78975273|FG000|Overall Study|Protocol Violation|0|||
44181011|NCT02079909|78975274|FG001|Overall Study|Protocol Violation|1|||
44181012|NCT02079909|78975275|FG002|Overall Study|Protocol Violation|1|||
44181013|NCT02079909|78975273|FG000|Overall Study|Physician Decision|0|||
44181014|NCT02079909|78975274|FG001|Overall Study|Physician Decision|1|||
44181015|NCT02079909|78975275|FG002|Overall Study|Physician Decision|1|||
44181016|NCT02079909|78975273|FG000|Overall Study|Relocation etc.|2|||
44181017|NCT02079909|78975274|FG001|Overall Study|Relocation etc.|2|||
44181018|NCT02079909|78975275|FG002|Overall Study|Relocation etc.|3|||
44181019|NCT02014467|78975285|FG000|Overall Study|Adverse Event|4|||
44181020|NCT02014467|78975286|FG001|Overall Study|Adverse Event|0|||
44181021|NCT02014467|78975285|FG000|Overall Study|Protocol Violation|3|||
44181022|NCT02014467|78975286|FG001|Overall Study|Protocol Violation|0|||
44181023|NCT02014467|78975285|FG000|Overall Study|Physician Decision|2|||
44181024|NCT02014467|78975286|FG001|Overall Study|Physician Decision|3|||
44181025|NCT02014467|78975285|FG000|Overall Study|Withdrawal by Subject|16|||
44181026|NCT02014467|78975286|FG001|Overall Study|Withdrawal by Subject|4|||
44181027|NCT02013765|78975292|FG000|Overall Study|Trial was terminated by sponsor|1|||
44181028|NCT02013687|78975300|FG000|Overall Study|Lost to Follow-up|0|||
44181029|NCT02013687|78975301|FG001|Overall Study|Lost to Follow-up|0|||
44451245|NCT00490971|79460222|FG001|Maintenance|Pregnancy|0|||
44451246|NCT00490971|79460223|FG002|Maintenance|Pregnancy|1|||
44181030|NCT02013687|78975302|FG002|Overall Study|Lost to Follow-up|1|||
44181031|NCT02013687|78975303|FG003|Overall Study|Lost to Follow-up|0|||
44181032|NCT02013687|78975300|FG000|Overall Study|Protocol Violation|0|||
44181033|NCT02013687|78975301|FG001|Overall Study|Protocol Violation|0|||
44181034|NCT02013687|78975302|FG002|Overall Study|Protocol Violation|0|||
44181035|NCT02013687|78975303|FG003|Overall Study|Protocol Violation|1|||
44181036|NCT02013687|78975300|FG000|Overall Study|Withdrawal by Subject|0|||
44181037|NCT02013687|78975301|FG001|Overall Study|Withdrawal by Subject|0|||
44181038|NCT02013687|78975302|FG002|Overall Study|Withdrawal by Subject|0|||
44181039|NCT02013687|78975303|FG003|Overall Study|Withdrawal by Subject|1|||
44181040|NCT02013687|78975300|FG000|Overall Study|Missed visits due to patient travel|0|||
44181041|NCT02013687|78975301|FG001|Overall Study|Missed visits due to patient travel|0|||
44181042|NCT02013687|78975302|FG002|Overall Study|Missed visits due to patient travel|1|||
44451247|NCT00490971|79460224|FG003|Maintenance|Pregnancy|0|||
44181043|NCT02013687|78975303|FG003|Overall Study|Missed visits due to patient travel|0|||
44181044|NCT02013609|78975317|FG000|Overall Study|Withdrawal by Subject|9|||
44181045|NCT02013609|78975317|FG000|Overall Study|Lost to Follow-up|3|||
44265016|NCT02459964|79167310|FG001|Overall Study|Withdrawal by Subject|0|||
44265017|NCT02459964|79167311|FG002|Overall Study|Withdrawal by Subject|1|||
44181046|NCT02013609|78975317|FG000|Overall Study|Adverse Event|3|||
44181047|NCT02013609|78975317|FG000|Overall Study|Met Withdrawal Criteria|3|||
44451248|NCT00490971|79460225|FG004|Maintenance|Pregnancy|0|||
44181048|NCT01988337|78975321|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
44181049|NCT02013531|78975327|FG000|Overall Study|Lost to Follow-up|3|||
44181050|NCT02013531|78975327|FG000|Overall Study|Met Withdrawal Criteria|1|||
44181051|NCT02013531|78975327|FG000|Overall Study|Withdrawal by Subject|1|||
44181052|NCT01988103|78975334|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
44181053|NCT01988103|78975335|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
44181054|NCT01988103|78975336|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
44181055|NCT01988103|78975337|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
44181056|NCT01988103|78975338|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
44181057|NCT01988103|78975334|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
44181058|NCT01988103|78975335|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
44181059|NCT01988103|78975336|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
44181060|NCT01988103|78975337|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
44181061|NCT01988103|78975338|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
44181062|NCT01988103|78975334|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
44181063|NCT01988103|78975335|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
44181064|NCT01988103|78975336|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
44181065|NCT01988103|78975337|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
44181066|NCT01988103|78975338|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
44181067|NCT01988103|78975334|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
44181068|NCT01988103|78975335|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
44181069|NCT01988103|78975336|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
44181070|NCT01988103|78975337|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
44181071|NCT01988103|78975338|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
44181072|NCT01988103|78975334|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
44181073|NCT01988103|78975335|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
44181074|NCT01988103|78975336|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
44181075|NCT01988103|78975337|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
44181076|NCT01988103|78975338|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
44181077|NCT01988103|78975334|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
44181078|NCT01988103|78975335|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
44181079|NCT01988103|78975336|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
44181080|NCT01988103|78975337|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
44181081|NCT01988103|78975338|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
44181082|NCT01988103|78975334|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
44181083|NCT01988103|78975335|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
44181084|NCT01988103|78975336|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
44181085|NCT01988103|78975337|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
44181086|NCT01988103|78975338|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
44181087|NCT02013375|78975353|FG000|Overall Study|Did not engraft|1|||
44181088|NCT02013375|78975353|FG000|Overall Study|Did not engraft|1|||
44181089|NCT02079519|78975358|FG000|Overall Study|Disease Progression|9|||
44181090|NCT02079519|78975358|FG000|Overall Study|Adverse Event|1|||
44181091|NCT01987557|78975365|FG000|Overall Study|Protocol Violation|1|||
44181092|NCT01987557|78975366|FG001|Overall Study|Protocol Violation|0|||
44181093|NCT01987557|78975367|FG002|Overall Study|Protocol Violation|1|||
44181094|NCT01987557|78975365|FG000|Overall Study|Withdrawal by Subject|2|||
44181095|NCT01987557|78975366|FG001|Overall Study|Withdrawal by Subject|1|||
44181096|NCT01987557|78975367|FG002|Overall Study|Withdrawal by Subject|2|||
44181097|NCT01987557|78975365|FG000|Overall Study|Adverse Event|0|||
44181098|NCT01987557|78975366|FG001|Overall Study|Adverse Event|2|||
44181099|NCT01987557|78975367|FG002|Overall Study|Adverse Event|0|||
44181100|NCT02078817|78975375|FG000|Overall Study|Withdrawal by Subject|1|||
44181101|NCT02011893|78975379|FG000|Enrollment to Randomization|Adverse Event|2|||
44181102|NCT02011893|78975380|FG001|Enrollment to Randomization|Adverse Event|0|||
44181103|NCT02011893|78975381|FG002|Enrollment to Randomization|Adverse Event|0|||
44181104|NCT02011893|78975379|FG000|Enrollment to Randomization|Physician Decision|10|||
44181105|NCT02011893|78975380|FG001|Enrollment to Randomization|Physician Decision|0|||
44181106|NCT02011893|78975381|FG002|Enrollment to Randomization|Physician Decision|0|||
44181107|NCT02011893|78975379|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
44181108|NCT02011893|78975380|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
44181109|NCT02011893|78975381|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
44265018|NCT02459964|79167309|FG000|Overall Study|Abnormal EKG changes|0|||
44181110|NCT02011893|78975379|FG000|Enrollment to Randomization|Screening Failure|29|||
44181111|NCT02011893|78975380|FG001|Enrollment to Randomization|Screening Failure|0|||
44181112|NCT02011893|78975381|FG002|Enrollment to Randomization|Screening Failure|0|||
44181113|NCT02011893|78975379|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
44451249|NCT00490971|79460221|FG000|Maintenance|Protocol Violation|0|||
44181114|NCT02011893|78975380|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
44181115|NCT02011893|78975381|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
44181116|NCT02011893|78975379|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
44181117|NCT02011893|78975380|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
44181118|NCT02011893|78975381|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
44181119|NCT02011893|78975379|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
44181120|NCT02011893|78975380|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
44181121|NCT02011893|78975381|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
44181122|NCT02011893|78975379|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
44181123|NCT02011893|78975380|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
44181124|NCT02011893|78975381|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
44181125|NCT02011893|78975379|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
44181126|NCT02011893|78975380|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
44181127|NCT02011893|78975381|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
44181128|NCT02011113|78975386|FG000|Overall Study|Adverse Event|4|||
44181129|NCT02011113|78975386|FG000|Overall Study|Disease Progression (DP)|16|||
44181130|NCT02011113|78975386|FG000|Overall Study|Death|1|||
44181131|NCT02011113|78975386|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
44181132|NCT02011113|78975386|FG000|Overall Study|Investigator's judgement- DP|3|||
44181133|NCT02011113|78975386|FG000|Overall Study|Study terminated by sponsor|11|||
44181134|NCT01807156|78975391|FG000|Overall Study|Physician Decision|1|||
44181135|NCT01987479|78975395|FG000|Overall Study|Protocol Violation|1|||
44181136|NCT01987479|78975395|FG000|Overall Study|Physician Decision|2|||
44181137|NCT01987479|78975395|FG000|Overall Study|Participant/legal guardian decision|1|||
44181138|NCT01987479|78975395|FG000|Overall Study|Other|5|||
44181139|NCT01987479|78975395|FG000|Overall Study|Lost to Follow-up|1|||
44181140|NCT01987479|78975395|FG000|Overall Study|Adverse Event|7|||
44181141|NCT01620489|78975401|FG000|Overall Study|Adverse Event|17|||
44181142|NCT01620489|78975402|FG001|Overall Study|Adverse Event|4|||
44181143|NCT01620489|78975401|FG000|Overall Study|Protocol Violation|0|||
44181144|NCT01620489|78975402|FG001|Overall Study|Protocol Violation|3|||
44181145|NCT01620489|78975401|FG000|Overall Study|Withdrawal Criteria|17|||
44181146|NCT01620489|78975402|FG001|Overall Study|Withdrawal Criteria|25|||
44181147|NCT01620489|78975401|FG000|Overall Study|Unclassified|1|||
44181148|NCT01620489|78975402|FG001|Overall Study|Unclassified|2|||
44181149|NCT02076165|78975410|FG000|Overall Study|Lost to Follow-up|7|||
44181150|NCT02076165|78975411|FG001|Overall Study|Lost to Follow-up|5|||
44181151|NCT02076165|78975410|FG000|Overall Study|Refused follow-up assessment|1|||
44181152|NCT02076165|78975411|FG001|Overall Study|Refused follow-up assessment|1|||
44181153|NCT01620255|78975422|FG000|Overall Study|Withdrawal by Subject|4|||
44181154|NCT01620255|78975423|FG001|Overall Study|Withdrawal by Subject|1|||
44181155|NCT01620255|78975424|FG002|Overall Study|Withdrawal by Subject|1|||
44181156|NCT01620255|78975425|FG003|Overall Study|Withdrawal by Subject|2|||
44181157|NCT01620255|78975426|FG004|Overall Study|Withdrawal by Subject|4|||
44181158|NCT01620255|78975422|FG000|Overall Study|Participant underwent fecal transplant|0|||
44181159|NCT01620255|78975423|FG001|Overall Study|Participant underwent fecal transplant|0|||
44181160|NCT01620255|78975424|FG002|Overall Study|Participant underwent fecal transplant|1|||
44181161|NCT01620255|78975425|FG003|Overall Study|Participant underwent fecal transplant|0|||
44181162|NCT01620255|78975426|FG004|Overall Study|Participant underwent fecal transplant|0|||
44181163|NCT01620255|78975422|FG000|Overall Study|Non-compliance|0|||
44181164|NCT01620255|78975423|FG001|Overall Study|Non-compliance|1|||
44181165|NCT01620255|78975424|FG002|Overall Study|Non-compliance|0|||
44181166|NCT01620255|78975425|FG003|Overall Study|Non-compliance|0|||
44181167|NCT01620255|78975426|FG004|Overall Study|Non-compliance|0|||
44181168|NCT01620255|78975422|FG000|Overall Study|Adverse Event|0|||
44181169|NCT01620255|78975423|FG001|Overall Study|Adverse Event|4|||
44181170|NCT01620255|78975424|FG002|Overall Study|Adverse Event|0|||
44181171|NCT01620255|78975425|FG003|Overall Study|Adverse Event|1|||
44181172|NCT01620255|78975426|FG004|Overall Study|Adverse Event|1|||
44181173|NCT01620255|78975422|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
44181174|NCT01620255|78975423|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
44181175|NCT01620255|78975424|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
44181176|NCT01620255|78975425|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
44181177|NCT01620255|78975426|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
44181178|NCT02010567|78975443|FG000|Overall Study|Adverse Event|0|||
44181179|NCT02010567|78975444|FG001|Overall Study|Adverse Event|0|||
44181180|NCT02010567|78975445|FG002|Overall Study|Adverse Event|1|||
44181181|NCT02010567|78975446|FG003|Overall Study|Adverse Event|0|||
44181182|NCT02010567|78975447|FG004|Overall Study|Adverse Event|1|||
44181183|NCT01806064|78975462|FG000|Overall Study|Randomized Not Enrolled|0|||
44181184|NCT01806064|78975463|FG001|Overall Study|Randomized Not Enrolled|0|||
44181185|NCT01806064|78975464|FG002|Overall Study|Randomized Not Enrolled|0|||
44181186|NCT01806064|78975465|FG003|Overall Study|Randomized Not Enrolled|1|||
44451250|NCT00490971|79460222|FG001|Maintenance|Protocol Violation|0|||
44181187|NCT01806064|78975466|FG004|Overall Study|Randomized Not Enrolled|2|||
44181188|NCT01804582|78975484|FG000|Overall Study|Lost to Follow-up|47|||
44181189|NCT01804582|78975485|FG001|Overall Study|Lost to Follow-up|56|||
44181190|NCT01804582|78975484|FG000|Overall Study|Physician Decision|2|||
44181191|NCT01804582|78975485|FG001|Overall Study|Physician Decision|0|||
44181192|NCT01787188|78975495|FG000|Overall Study|Adverse Event|2|||
44181193|NCT01787188|78975496|FG001|Overall Study|Adverse Event|4|||
44181194|NCT01787188|78975497|FG002|Overall Study|Adverse Event|6|||
44181195|NCT01787188|78975495|FG000|Overall Study|Lack of Efficacy|7|||
44181196|NCT01787188|78975496|FG001|Overall Study|Lack of Efficacy|3|||
44181197|NCT01787188|78975497|FG002|Overall Study|Lack of Efficacy|5|||
44181198|NCT01787188|78975495|FG000|Overall Study|Non-compliance with Study Drug|0|||
44181199|NCT01787188|78975496|FG001|Overall Study|Non-compliance with Study Drug|1|||
44181200|NCT01787188|78975497|FG002|Overall Study|Non-compliance with Study Drug|0|||
44181201|NCT01787188|78975495|FG000|Overall Study|Withdrawal by Subject|4|||
44181202|NCT01787188|78975496|FG001|Overall Study|Withdrawal by Subject|3|||
44181203|NCT01787188|78975497|FG002|Overall Study|Withdrawal by Subject|2|||
44181204|NCT01787188|78975495|FG000|Overall Study|Protocol Violation|3|||
44181205|NCT01787188|78975496|FG001|Overall Study|Protocol Violation|2|||
44181206|NCT01787188|78975497|FG002|Overall Study|Protocol Violation|3|||
44181207|NCT01787188|78975495|FG000|Overall Study|Lost to Follow-up|1|||
44181208|NCT01787188|78975496|FG001|Overall Study|Lost to Follow-up|2|||
44181209|NCT01787188|78975497|FG002|Overall Study|Lost to Follow-up|2|||
44181210|NCT01787188|78975495|FG000|Overall Study|Other, including patient moved|0|||
44181211|NCT01787188|78975496|FG001|Overall Study|Other, including patient moved|3|||
44181212|NCT01787188|78975497|FG002|Overall Study|Other, including patient moved|0|||
44181213|NCT01787032|78975511|FG000|Overall Study|Protocol Violation|0|||
44181214|NCT01787032|78975512|FG001|Overall Study|Protocol Violation|0|||
44181215|NCT01787032|78975513|FG002|Overall Study|Protocol Violation|0|||
44181216|NCT01787032|78975514|FG003|Overall Study|Protocol Violation|0|||
44181217|NCT01787032|78975515|FG004|Overall Study|Protocol Violation|1|||
44181218|NCT01787032|78975516|FG005|Overall Study|Protocol Violation|1|||
44181219|NCT01737268|78975526|FG000|Overall Study|Adverse Event|6|||
44181220|NCT01737268|78975526|FG000|Overall Study|Worsening of Target Disease|2|||
44181221|NCT01737268|78975526|FG000|Overall Study|In consideration of the patient's safety|1|||
44181222|NCT01769404|78975531|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
44181223|NCT01769404|78975532|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
44181224|NCT01769404|78975531|FG000|Treatment Period 1|Withdrawal by Subject|3|||
44181225|NCT01769404|78975532|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44181226|NCT01769404|78975531|FG000|Treatment Period 1|Sponsor decision|1|||
44181227|NCT01769404|78975532|FG001|Treatment Period 1|Sponsor decision|0|||
44181228|NCT01769404|78975531|FG000|Treatment Period 2|Sponsor decision|7|||
44181229|NCT01769404|78975532|FG001|Treatment Period 2|Sponsor decision|0|||
44181230|NCT01769326|78975544|FG000|Overall Study|Lost to Follow-up|1|||
44181231|NCT01769326|78975545|FG001|Overall Study|Lost to Follow-up|2|||
44181232|NCT01769326|78975546|FG002|Overall Study|Lost to Follow-up|0|||
44181233|NCT01769326|78975547|FG003|Overall Study|Lost to Follow-up|0|||
44451251|NCT00490971|79460223|FG002|Maintenance|Protocol Violation|4|||
44181234|NCT01769326|78975544|FG000|Overall Study|unrelated injry|1|||
44181235|NCT01769326|78975545|FG001|Overall Study|unrelated injry|1|||
44181236|NCT01769326|78975546|FG002|Overall Study|unrelated injry|0|||
44181237|NCT01769326|78975547|FG003|Overall Study|unrelated injry|0|||
44181238|NCT01769326|78975544|FG000|Overall Study|got a job|0|||
44181239|NCT01769326|78975545|FG001|Overall Study|got a job|1|||
44181240|NCT01769326|78975546|FG002|Overall Study|got a job|0|||
44181241|NCT01769326|78975547|FG003|Overall Study|got a job|0|||
44181242|NCT01769326|78975544|FG000|Overall Study|Got sick and could not complete study|0|||
44181243|NCT01769326|78975545|FG001|Overall Study|Got sick and could not complete study|0|||
44181244|NCT01769326|78975546|FG002|Overall Study|Got sick and could not complete study|1|||
44181245|NCT01769326|78975547|FG003|Overall Study|Got sick and could not complete study|0|||
44181246|NCT01786564|78975557|FG000|Overall Study|Lost to Follow-up|47|||
44181247|NCT01786564|78975557|FG000|Overall Study|Ineligible|17|||
44181248|NCT01786330|78975563|FG000|Overall Study|Withdrawal by Subject|0|||
44181249|NCT01786330|78975564|FG001|Overall Study|Withdrawal by Subject|1|||
44181250|NCT01786330|78975563|FG000|Overall Study|Lost to Follow-up|0|||
44181251|NCT01786330|78975564|FG001|Overall Study|Lost to Follow-up|1|||
44181252|NCT01786330|78975563|FG000|Overall Study|Excluded intraoperatively|0|||
44181253|NCT01786330|78975564|FG001|Overall Study|Excluded intraoperatively|1|||
44181254|NCT01786330|78975563|FG000|Overall Study|Protocol Violation|1|||
44181255|NCT01786330|78975564|FG001|Overall Study|Protocol Violation|0|||
44181256|NCT01786174|78975572|FG000|Overall Study|Discontinued Study Drug|2|||
44181257|NCT01786174|78975573|FG001|Overall Study|Discontinued Study Drug|0|||
44181258|NCT01736566|78975584|FG000|Long Term Follow-up|Still collecting data|42|||
44181259|NCT01736566|78975585|FG001|Long Term Follow-up|Still collecting data|0|||
44181260|NCT01736566|78975586|FG002|Long Term Follow-up|Still collecting data|49|||
44181261|NCT01736566|78975587|FG003|Long Term Follow-up|Still collecting data|0|||
44181262|NCT01736566|78975588|FG004|Long Term Follow-up|Still collecting data|1|||
44181263|NCT01768858|78975613|FG000|Overall Study|Lost to Follow-up|9|||
44181264|NCT01768858|78975613|FG000|Overall Study|Lack of Efficacy|8|||
44181265|NCT01768858|78975613|FG000|Overall Study|Serious Adverse Event|1|||
44181266|NCT01768858|78975613|FG000|Overall Study|Participant moved to Germany|1|||
44181267|NCT01768858|78975613|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
44181268|NCT01768858|78975613|FG000|Overall Study|Exanthema|1|||
44181269|NCT01768858|78975613|FG000|Overall Study|Withdrawal by Subject|1|||
44181270|NCT01736254|78975617|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
44181271|NCT01736254|78975617|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
44181272|NCT01767376|78975628|FG000|Overall Study|Lost to Follow-up|3|||
44181273|NCT01767376|78975629|FG001|Overall Study|Lost to Follow-up|2|||
44181274|NCT01767376|78975630|FG002|Overall Study|Lost to Follow-up|0|||
44181275|NCT01767376|78975628|FG000|Overall Study|Withdrawal by Subject|1|||
44181276|NCT01767376|78975629|FG001|Overall Study|Withdrawal by Subject|1|||
44181277|NCT01767376|78975630|FG002|Overall Study|Withdrawal by Subject|0|||
44181278|NCT01767142|78975640|FG000|Overall Study|Lost to Follow-up|3|||
44181279|NCT01785628|78975646|FG000|Overall Study|Lost to Follow-up|2|||
44181280|NCT01785628|78975647|FG001|Overall Study|Lost to Follow-up|3|||
44181281|NCT01785472|78975656|FG000|Overall Study|Adverse Event|5|||
44181282|NCT01785472|78975657|FG001|Overall Study|Adverse Event|4|||
44181283|NCT01785472|78975658|FG002|Overall Study|Adverse Event|6|||
44181284|NCT01785472|78975656|FG000|Overall Study|Lack of Efficacy|2|||
44181285|NCT01785472|78975657|FG001|Overall Study|Lack of Efficacy|0|||
44181286|NCT01785472|78975658|FG002|Overall Study|Lack of Efficacy|1|||
44181287|NCT01785472|78975656|FG000|Overall Study|Lost to Follow-up|1|||
44181288|NCT01785472|78975657|FG001|Overall Study|Lost to Follow-up|2|||
44181289|NCT01785472|78975658|FG002|Overall Study|Lost to Follow-up|0|||
44181290|NCT01785472|78975656|FG000|Overall Study|Physician Decision|1|||
44181291|NCT01785472|78975657|FG001|Overall Study|Physician Decision|1|||
44181292|NCT01785472|78975658|FG002|Overall Study|Physician Decision|1|||
44181293|NCT01785472|78975656|FG000|Overall Study|Protocol deviation|0|||
44181294|NCT01785472|78975657|FG001|Overall Study|Protocol deviation|2|||
44181295|NCT01785472|78975658|FG002|Overall Study|Protocol deviation|2|||
44181296|NCT01785472|78975656|FG000|Overall Study|Subject/guardian decision|15|||
44181297|NCT01785472|78975657|FG001|Overall Study|Subject/guardian decision|10|||
44181298|NCT01785472|78975658|FG002|Overall Study|Subject/guardian decision|11|||
44181299|NCT01785472|78975656|FG000|Overall Study|Technical problems|0|||
44181300|NCT01785472|78975657|FG001|Overall Study|Technical problems|0|||
44181301|NCT01785472|78975658|FG002|Overall Study|Technical problems|1|||
44181302|NCT01785160|78975668|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
44181303|NCT01785160|78975668|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
44181304|NCT01736176|78975674|FG000|Overall Study|Adverse Event|3|||
44181305|NCT01736176|78975674|FG000|Overall Study|Withdrawal by Subject|4|||
44181306|NCT01736176|78975674|FG000|Overall Study|Lack of Efficacy|3|||
44265019|NCT02459964|79167310|FG001|Overall Study|Abnormal EKG changes|0|||
44265020|NCT02459964|79167311|FG002|Overall Study|Abnormal EKG changes|1|||
44181307|NCT01736176|78975674|FG000|Overall Study|Unable to Complete PEG Placement|1|||
44181308|NCT01735630|78975684|FG000|Overall Study|Adverse Event|8|||
44181309|NCT01735630|78975685|FG001|Overall Study|Adverse Event|7|||
44181310|NCT01735630|78975684|FG000|Overall Study|Lost to Follow-up|1|||
44181311|NCT01735630|78975685|FG001|Overall Study|Lost to Follow-up|0|||
44265021|NCT02451930|79167388|FG000|Overall Study|Death|0|||
44181312|NCT01735630|78975684|FG000|Overall Study|Physician Decision|0|||
44181313|NCT01735630|78975685|FG001|Overall Study|Physician Decision|1|||
44181314|NCT01735630|78975684|FG000|Overall Study|Sponsor Decision|2|||
44181315|NCT01735630|78975685|FG001|Overall Study|Sponsor Decision|1|||
44181316|NCT01735630|78975684|FG000|Overall Study|Withdrawal by Subject|7|||
44181317|NCT01735630|78975685|FG001|Overall Study|Withdrawal by Subject|9|||
44181318|NCT01735396|78975691|FG000|Overall Study|not evaluable|1|||
44181319|NCT01766206|78975695|FG000|Overall Study|Withdrawal by Subject|22|||
44181320|NCT01766206|78975695|FG000|Overall Study|Lost to Follow-up|10|||
44181321|NCT01766206|78975695|FG000|Overall Study|Inappropriate enrollment|18|||
44181322|NCT01766206|78975695|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
44181323|NCT01734850|78975702|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
44181324|NCT01734850|78975703|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
44181325|NCT01734850|78975704|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
44181326|NCT01734850|78975702|FG000|Overall Study|Not infused due to manufacturing failure|0|||
44181327|NCT01734850|78975703|FG001|Overall Study|Not infused due to manufacturing failure|0|||
44181328|NCT01734850|78975704|FG002|Overall Study|Not infused due to manufacturing failure|1|||
44181329|NCT01766050|78975715|FG000|Overall Study|Adverse Event|1|||
44181330|NCT01766050|78975715|FG000|Overall Study|Lost to Follow-up|1|||
44181331|NCT01766050|78975715|FG000|Overall Study|Withdrawal by Subject|2|||
44181332|NCT02341625|78975743|FG000|Overall Study|Disease Progression|2|||
44181333|NCT02341625|78975744|FG001|Overall Study|Disease Progression|2|||
44181334|NCT02341625|78975745|FG002|Overall Study|Disease Progression|3|||
44181335|NCT02341625|78975746|FG003|Overall Study|Disease Progression|6|||
44181336|NCT02341625|78975747|FG004|Overall Study|Disease Progression|7|||
44181337|NCT02341625|78975748|FG005|Overall Study|Disease Progression|7|||
44181338|NCT02341625|78975749|FG006|Overall Study|Disease Progression|28|||
44181339|NCT02341625|78975750|FG007|Overall Study|Disease Progression|5|||
44181340|NCT02341625|78975751|FG008|Overall Study|Disease Progression|4|||
44181341|NCT02341625|78975752|FG009|Overall Study|Disease Progression|19|||
44181342|NCT02341625|78975743|FG000|Overall Study|Study Drug Toxicity|0|||
44181343|NCT02341625|78975744|FG001|Overall Study|Study Drug Toxicity|0|||
44181344|NCT02341625|78975745|FG002|Overall Study|Study Drug Toxicity|0|||
44181345|NCT02341625|78975746|FG003|Overall Study|Study Drug Toxicity|1|||
44181346|NCT02341625|78975747|FG004|Overall Study|Study Drug Toxicity|0|||
44181347|NCT02341625|78975748|FG005|Overall Study|Study Drug Toxicity|3|||
44181348|NCT02341625|78975749|FG006|Overall Study|Study Drug Toxicity|10|||
44181349|NCT02341625|78975750|FG007|Overall Study|Study Drug Toxicity|0|||
44181350|NCT02341625|78975751|FG008|Overall Study|Study Drug Toxicity|0|||
44181351|NCT02341625|78975752|FG009|Overall Study|Study Drug Toxicity|3|||
44181352|NCT02341625|78975743|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181353|NCT02341625|78975744|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181354|NCT02341625|78975745|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181355|NCT02341625|78975746|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181356|NCT02341625|78975747|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181357|NCT02341625|78975748|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181358|NCT02341625|78975749|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
44181359|NCT02341625|78975750|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
44181360|NCT02341625|78975751|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44181361|NCT02341625|78975752|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
44181362|NCT02341625|78975743|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181363|NCT02341625|78975744|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181364|NCT02341625|78975745|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181365|NCT02341625|78975746|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181366|NCT02341625|78975747|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181367|NCT02341625|78975748|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181368|NCT02341625|78975749|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
44181369|NCT02341625|78975750|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
44181370|NCT02341625|78975751|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181371|NCT02341625|78975752|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
44181372|NCT02341625|78975743|FG000|Overall Study|Participant Withdrew Consent|0|||
44181373|NCT02341625|78975744|FG001|Overall Study|Participant Withdrew Consent|0|||
44181374|NCT02341625|78975745|FG002|Overall Study|Participant Withdrew Consent|0|||
44181375|NCT02341625|78975746|FG003|Overall Study|Participant Withdrew Consent|1|||
44181376|NCT02341625|78975747|FG004|Overall Study|Participant Withdrew Consent|0|||
44181377|NCT02341625|78975748|FG005|Overall Study|Participant Withdrew Consent|0|||
44181378|NCT02341625|78975749|FG006|Overall Study|Participant Withdrew Consent|0|||
44181379|NCT02341625|78975750|FG007|Overall Study|Participant Withdrew Consent|0|||
44181380|NCT02341625|78975751|FG008|Overall Study|Participant Withdrew Consent|0|||
44181381|NCT02341625|78975752|FG009|Overall Study|Participant Withdrew Consent|0|||
44181382|NCT02341625|78975743|FG000|Overall Study|Completed Treatment as per Protocol|0|||
44181383|NCT02341625|78975744|FG001|Overall Study|Completed Treatment as per Protocol|0|||
44181384|NCT02341625|78975745|FG002|Overall Study|Completed Treatment as per Protocol|0|||
44181385|NCT02341625|78975746|FG003|Overall Study|Completed Treatment as per Protocol|0|||
44181386|NCT02341625|78975747|FG004|Overall Study|Completed Treatment as per Protocol|0|||
44181387|NCT02341625|78975748|FG005|Overall Study|Completed Treatment as per Protocol|0|||
44181388|NCT02341625|78975749|FG006|Overall Study|Completed Treatment as per Protocol|0|||
44265022|NCT02451930|79167389|FG001|Overall Study|Death|15|||
44451252|NCT00490971|79460224|FG003|Maintenance|Protocol Violation|1|||
44451253|NCT00490971|79460225|FG004|Maintenance|Protocol Violation|1|||
44181389|NCT02341625|78975750|FG007|Overall Study|Completed Treatment as per Protocol|0|||
44181390|NCT02341625|78975751|FG008|Overall Study|Completed Treatment as per Protocol|0|||
44181391|NCT02341625|78975752|FG009|Overall Study|Completed Treatment as per Protocol|1|||
44181392|NCT02341625|78975743|FG000|Overall Study|Other Reasons|0|||
44181393|NCT02341625|78975744|FG001|Overall Study|Other Reasons|0|||
44181394|NCT02341625|78975745|FG002|Overall Study|Other Reasons|0|||
44181395|NCT02341625|78975746|FG003|Overall Study|Other Reasons|0|||
44181396|NCT02341625|78975747|FG004|Overall Study|Other Reasons|1|||
44181397|NCT02341625|78975748|FG005|Overall Study|Other Reasons|0|||
44181398|NCT02341625|78975749|FG006|Overall Study|Other Reasons|5|||
44181399|NCT02341625|78975750|FG007|Overall Study|Other Reasons|0|||
44181400|NCT02341625|78975751|FG008|Overall Study|Other Reasons|0|||
44181401|NCT02341625|78975752|FG009|Overall Study|Other Reasons|2|||
44181402|NCT02341625|78975743|FG000|Overall Study|Not Reported|0|||
44181403|NCT02341625|78975744|FG001|Overall Study|Not Reported|0|||
44181404|NCT02341625|78975745|FG002|Overall Study|Not Reported|0|||
44181405|NCT02341625|78975746|FG003|Overall Study|Not Reported|0|||
44181406|NCT02341625|78975747|FG004|Overall Study|Not Reported|0|||
44181407|NCT02341625|78975748|FG005|Overall Study|Not Reported|0|||
44181408|NCT02341625|78975749|FG006|Overall Study|Not Reported|0|||
44181409|NCT02341625|78975750|FG007|Overall Study|Not Reported|0|||
44181410|NCT02341625|78975751|FG008|Overall Study|Not Reported|0|||
44181411|NCT02341625|78975752|FG009|Overall Study|Not Reported|3|||
44181412|NCT02370095|78975799|FG000|Overall Study|Withdrawal by Subject|0|||
44181413|NCT02370095|78975800|FG001|Overall Study|Withdrawal by Subject|1|||
44181414|NCT01783678|78975812|FG000|Overall Study|Randomized but Not Treated|0|||
44181415|NCT01783678|78975813|FG001|Overall Study|Randomized but Not Treated|0|||
44181416|NCT01783678|78975814|FG002|Overall Study|Randomized but Not Treated|0|||
44181417|NCT01783678|78975815|FG003|Overall Study|Randomized but Not Treated|1|||
44181418|NCT01783678|78975816|FG004|Overall Study|Randomized but Not Treated|0|||
44181419|NCT01783678|78975817|FG005|Overall Study|Randomized but Not Treated|0|||
44181420|NCT01783678|78975812|FG000|Overall Study|Lack of Efficacy|1|||
44181421|NCT01783678|78975813|FG001|Overall Study|Lack of Efficacy|13|||
44361220|NCT01185821|79366876|FG001|Overall Study|Condition no longer required study drug|0|||
44181422|NCT01783678|78975814|FG002|Overall Study|Lack of Efficacy|1|||
44181423|NCT01783678|78975815|FG003|Overall Study|Lack of Efficacy|3|||
44181424|NCT01783678|78975816|FG004|Overall Study|Lack of Efficacy|6|||
44181425|NCT01783678|78975817|FG005|Overall Study|Lack of Efficacy|5|||
44181426|NCT01783678|78975812|FG000|Overall Study|Lost to Follow-up|0|||
44181427|NCT01783678|78975813|FG001|Overall Study|Lost to Follow-up|4|||
44361221|NCT01185821|79366877|FG002|Overall Study|Condition no longer required study drug|0|||
44181428|NCT01783678|78975814|FG002|Overall Study|Lost to Follow-up|0|||
44181429|NCT01783678|78975815|FG003|Overall Study|Lost to Follow-up|2|||
44265023|NCT02451930|79167388|FG000|Overall Study|Lost to Follow-up|0|||
44265024|NCT02451930|79167389|FG001|Overall Study|Lost to Follow-up|3|||
44265025|NCT02451930|79167388|FG000|Overall Study|Sponsor Decision|2|||
44265026|NCT02451930|79167389|FG001|Overall Study|Sponsor Decision|10|||
44265027|NCT02451930|79167388|FG000|Overall Study|Withdrawal by Subject|0|||
44265028|NCT02451930|79167389|FG001|Overall Study|Withdrawal by Subject|1|||
44265029|NCT02451930|79167388|FG000|Overall Study|Other|0|||
44265030|NCT02451930|79167389|FG001|Overall Study|Other|1|||
44265031|NCT02451696|79167425|FG000|Overall Study|Surgery postponed|1|||
44265032|NCT02451696|79167426|FG001|Overall Study|Surgery postponed|0|||
44265033|NCT02459418|79167449|FG000|Overall Study|Exclusion Criteria|4|||
44265034|NCT02459418|79167450|FG001|Overall Study|Exclusion Criteria|0|||
44265035|NCT02459418|79167449|FG000|Overall Study|Protocol Violation|0|||
44265036|NCT02459418|79167450|FG001|Overall Study|Protocol Violation|2|||
44265037|NCT02459418|79167449|FG000|Overall Study|Physician Decision|0|||
44265038|NCT02459418|79167450|FG001|Overall Study|Physician Decision|2|||
44265039|NCT02459418|79167449|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
44265040|NCT02459418|79167450|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
44265041|NCT02459418|79167449|FG000|Overall Study|Adverse Event|0|||
44265042|NCT02459418|79167450|FG001|Overall Study|Adverse Event|1|||
44265043|NCT02459418|79167449|FG000|Overall Study|Withdrawal by Subject|1|||
44265044|NCT02459418|79167450|FG001|Overall Study|Withdrawal by Subject|1|||
44265045|NCT02459418|79167449|FG000|Overall Study|Elevated Creatine Kinase|1|||
44265046|NCT02459418|79167450|FG001|Overall Study|Elevated Creatine Kinase|0|||
44265047|NCT02459418|79167449|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
44265048|NCT02459418|79167450|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
44265049|NCT02487498|79167480|FG000|Period: Period 1|Adverse Event|2|||
44265050|NCT02487498|79167481|FG001|Period: Period 1|Adverse Event|4|||
44265051|NCT02487498|79167480|FG000|Period: Period 1|Subject/guardian decision|2|||
44265052|NCT02487498|79167481|FG001|Period: Period 1|Subject/guardian decision|4|||
44265053|NCT02487498|79167480|FG000|Period: Period 1|Lost to Follow-up|0|||
44265054|NCT02487498|79167481|FG001|Period: Period 1|Lost to Follow-up|2|||
44265055|NCT02487498|79167480|FG000|Period: Period 1|Lack of Efficacy|1|||
44265056|NCT02487498|79167481|FG001|Period: Period 1|Lack of Efficacy|0|||
44265057|NCT02487498|79167480|FG000|Period: Period 1|Physician Decision|0|||
44265058|NCT02487498|79167481|FG001|Period: Period 1|Physician Decision|1|||
44265059|NCT02487498|79167480|FG000|Period: Period 1|Protocol deviation|1|||
44265060|NCT02487498|79167481|FG001|Period: Period 1|Protocol deviation|0|||
44265061|NCT02487498|79167480|FG000|Period: Washout|Subject/guardian decision|0|||
44265062|NCT02487498|79167481|FG001|Period: Washout|Subject/guardian decision|5|||
44265063|NCT02487498|79167480|FG000|Period: Washout|Lack of Efficacy|1|||
44265064|NCT02487498|79167481|FG001|Period: Washout|Lack of Efficacy|1|||
44265065|NCT02487498|79167480|FG000|Period: Washout|Physician Decision|1|||
44265066|NCT02487498|79167481|FG001|Period: Washout|Physician Decision|0|||
44265067|NCT02487498|79167480|FG000|Period: Washout|Non-compliance with study treatment|0|||
44265068|NCT02487498|79167481|FG001|Period: Washout|Non-compliance with study treatment|1|||
44265069|NCT02487498|79167480|FG000|Period: Period 2|Adverse Event|2|||
44265070|NCT02487498|79167481|FG001|Period: Period 2|Adverse Event|2|||
44265071|NCT02487498|79167480|FG000|Period: Period 2|Subject/guardian decision|2|||
44265072|NCT02487498|79167481|FG001|Period: Period 2|Subject/guardian decision|1|||
44265073|NCT02487498|79167480|FG000|Period: Period 2|Lost to Follow-up|1|||
44265074|NCT02487498|79167481|FG001|Period: Period 2|Lost to Follow-up|1|||
44265075|NCT02487498|79167480|FG000|Period: Period 2|Death|0|||
44265076|NCT02487498|79167481|FG001|Period: Period 2|Death|1|||
44265077|NCT02487498|79167480|FG000|Period: Period 2|Physician Decision|1|||
44265078|NCT02487498|79167481|FG001|Period: Period 2|Physician Decision|0|||
44265079|NCT02487108|79167492|FG000|Overall Study|Adverse Event|1|||
44181430|NCT01783678|78975816|FG004|Overall Study|Lost to Follow-up|1|||
44265080|NCT02487108|79167493|FG001|Overall Study|Adverse Event|6|||
44265081|NCT02487108|79167494|FG002|Overall Study|Adverse Event|12|||
44265082|NCT02487108|79167495|FG003|Overall Study|Adverse Event|6|||
44265083|NCT02487108|79167492|FG000|Overall Study|Withdrawal by Subject|8|||
44265084|NCT02487108|79167493|FG001|Overall Study|Withdrawal by Subject|5|||
44265085|NCT02487108|79167494|FG002|Overall Study|Withdrawal by Subject|5|||
44265086|NCT02487108|79167495|FG003|Overall Study|Withdrawal by Subject|0|||
44451254|NCT00490971|79460221|FG000|Maintenance|Withdrawal by Subject|0|||
44451255|NCT00490971|79460222|FG001|Maintenance|Withdrawal by Subject|0|||
44181431|NCT01783678|78975817|FG005|Overall Study|Lost to Follow-up|0|||
44181432|NCT01783678|78975812|FG000|Overall Study|Withdrew Consent|1|||
44181433|NCT01783678|78975813|FG001|Overall Study|Withdrew Consent|1|||
44181434|NCT01783678|78975814|FG002|Overall Study|Withdrew Consent|0|||
44181435|NCT01783678|78975815|FG003|Overall Study|Withdrew Consent|2|||
44181436|NCT01783678|78975816|FG004|Overall Study|Withdrew Consent|0|||
44265087|NCT02487108|79167492|FG000|Overall Study|Non-compliance to study medication|3|||
44265088|NCT02487108|79167493|FG001|Overall Study|Non-compliance to study medication|2|||
44181437|NCT01783678|78975817|FG005|Overall Study|Withdrew Consent|0|||
44181438|NCT01734772|78975834|FG000|Overall Study|Adverse Event|1|||
44265089|NCT02487108|79167494|FG002|Overall Study|Non-compliance to study medication|5|||
44181439|NCT01734772|78975835|FG001|Overall Study|Adverse Event|2|||
44181440|NCT01734772|78975834|FG000|Overall Study|Withdrawal by Subject|0|||
44265090|NCT02487108|79167495|FG003|Overall Study|Non-compliance to study medication|4|||
44265091|NCT02487108|79167492|FG000|Overall Study|Protocol Violation|1|||
44265092|NCT02487108|79167493|FG001|Overall Study|Protocol Violation|1|||
44265093|NCT02487108|79167494|FG002|Overall Study|Protocol Violation|2|||
44265094|NCT02487108|79167495|FG003|Overall Study|Protocol Violation|0|||
44181441|NCT01734772|78975835|FG001|Overall Study|Withdrawal by Subject|1|||
44181442|NCT02340221|78975849|FG000|Overall Study|Death|100|||
44181443|NCT02340221|78975850|FG001|Overall Study|Death|197|||
44181444|NCT02340221|78975849|FG000|Overall Study|Withdrawal by Participant|24|||
44181445|NCT02340221|78975850|FG001|Overall Study|Withdrawal by Participant|37|||
44181446|NCT02340221|78975849|FG000|Overall Study|Lost to Follow-up|4|||
44181447|NCT02340221|78975850|FG001|Overall Study|Lost to Follow-up|15|||
44181448|NCT02340221|78975849|FG000|Overall Study|Reason Not Specified|85|||
44181449|NCT02340221|78975850|FG001|Overall Study|Reason Not Specified|165|||
44181450|NCT02340221|78975849|FG000|Overall Study|Study Terminated by Sponsor|1|||
44181451|NCT02340221|78975850|FG001|Overall Study|Study Terminated by Sponsor|3|||
44181452|NCT02395133|78975861|FG000|Overall Study|Adverse Event|4|||
44181453|NCT02395133|78975862|FG001|Overall Study|Adverse Event|1|||
44181454|NCT02395133|78975863|FG002|Overall Study|Adverse Event|3|||
44181455|NCT02395133|78975864|FG003|Overall Study|Adverse Event|0|||
44181456|NCT02395133|78975861|FG000|Overall Study|Lack of Efficacy|1|||
44181457|NCT02395133|78975862|FG001|Overall Study|Lack of Efficacy|0|||
44181458|NCT02395133|78975863|FG002|Overall Study|Lack of Efficacy|1|||
44181459|NCT02395133|78975864|FG003|Overall Study|Lack of Efficacy|1|||
44181460|NCT02395133|78975861|FG000|Overall Study|Protocol Violation|1|||
44181461|NCT02395133|78975862|FG001|Overall Study|Protocol Violation|1|||
44181462|NCT02395133|78975863|FG002|Overall Study|Protocol Violation|0|||
44181463|NCT02395133|78975864|FG003|Overall Study|Protocol Violation|3|||
44181464|NCT02395133|78975861|FG000|Overall Study|Lost to Follow-up|0|||
44181465|NCT02395133|78975862|FG001|Overall Study|Lost to Follow-up|1|||
44181466|NCT02395133|78975863|FG002|Overall Study|Lost to Follow-up|1|||
44181467|NCT02395133|78975864|FG003|Overall Study|Lost to Follow-up|0|||
44181468|NCT02395133|78975861|FG000|Overall Study|Pregnancy|0|||
44181469|NCT02395133|78975862|FG001|Overall Study|Pregnancy|0|||
44181470|NCT02395133|78975863|FG002|Overall Study|Pregnancy|3|||
44181471|NCT02395133|78975864|FG003|Overall Study|Pregnancy|0|||
44181472|NCT02395133|78975861|FG000|Overall Study|Consent withdrawn with no reason given|1|||
44181473|NCT02395133|78975862|FG001|Overall Study|Consent withdrawn with no reason given|3|||
44181474|NCT02395133|78975863|FG002|Overall Study|Consent withdrawn with no reason given|0|||
44181475|NCT02395133|78975864|FG003|Overall Study|Consent withdrawn with no reason given|2|||
44181476|NCT02395133|78975861|FG000|Overall Study|Consent withdrawn with personal reason|0|||
44181477|NCT02395133|78975862|FG001|Overall Study|Consent withdrawn with personal reason|1|||
44181478|NCT02395133|78975863|FG002|Overall Study|Consent withdrawn with personal reason|0|||
44181479|NCT02395133|78975864|FG003|Overall Study|Consent withdrawn with personal reason|3|||
44181480|NCT02395133|78975861|FG000|Overall Study|Sponsor decision|2|||
44181481|NCT02395133|78975862|FG001|Overall Study|Sponsor decision|0|||
44181482|NCT02395133|78975863|FG002|Overall Study|Sponsor decision|0|||
44181483|NCT02395133|78975864|FG003|Overall Study|Sponsor decision|1|||
44181484|NCT02395133|78975861|FG000|Overall Study|Other than specified above|5|||
44181485|NCT02395133|78975862|FG001|Overall Study|Other than specified above|2|||
44181486|NCT02395133|78975863|FG002|Overall Study|Other than specified above|2|||
44181487|NCT02395133|78975864|FG003|Overall Study|Other than specified above|4|||
44181488|NCT02395055|78975876|FG000|Overall Study|Withdrawal by Subject|7|||
44181489|NCT02395055|78975877|FG001|Overall Study|Withdrawal by Subject|3|||
44181490|NCT02369159|78975885|FG000|Overall Study|Adverse Event|0|||
44181491|NCT02369159|78975886|FG001|Overall Study|Adverse Event|1|||
44181492|NCT02369159|78975885|FG000|Overall Study|Lost to Follow-up|1|||
44181493|NCT02369159|78975886|FG001|Overall Study|Lost to Follow-up|1|||
44181494|NCT02369159|78975885|FG000|Overall Study|Withdrawal by Subject|7|||
44181495|NCT02369159|78975886|FG001|Overall Study|Withdrawal by Subject|0|||
44181496|NCT02368691|78975903|FG000|Overall Study|Death|13|||
44181497|NCT02368691|78975903|FG000|Overall Study|Lack of Efficacy|15|||
44181498|NCT02368691|78975903|FG000|Overall Study|Physician Decision|4|||
44181499|NCT02394665|78975910|FG000|Overall Study|Physician Decision|1|||
44181500|NCT02394665|78975911|FG001|Overall Study|Physician Decision|0|||
44181501|NCT02394665|78975912|FG002|Overall Study|Physician Decision|0|||
44181502|NCT02367911|78975922|FG000|Overall Study|Withdrawal by Subject|3|||
44181503|NCT02367911|78975923|FG001|Overall Study|Withdrawal by Subject|2|||
44181504|NCT02367911|78975922|FG000|Overall Study|Lost to Follow-up|2|||
44181505|NCT02367911|78975923|FG001|Overall Study|Lost to Follow-up|2|||
44181506|NCT02339285|78975932|FG000|Overall Study|Withdrawal by Subject|0|||
44181507|NCT02339285|78975933|FG001|Overall Study|Withdrawal by Subject|1|||
44181508|NCT02339285|78975934|FG002|Overall Study|Withdrawal by Subject|1|||
44181509|NCT02339285|78975932|FG000|Overall Study|Lost to Follow-up|1|||
44181510|NCT02339285|78975933|FG001|Overall Study|Lost to Follow-up|1|||
44181511|NCT02339285|78975934|FG002|Overall Study|Lost to Follow-up|1|||
44181512|NCT02339285|78975932|FG000|Overall Study|Protocol Deviation|0|||
44181513|NCT02339285|78975933|FG001|Overall Study|Protocol Deviation|1|||
44181514|NCT02339285|78975934|FG002|Overall Study|Protocol Deviation|0|||
44181515|NCT02367833|78975945|FG000|Overall Study|Withdrawal by Subject|1|||
44181516|NCT02367833|78975946|FG001|Overall Study|Withdrawal by Subject|1|||
44181517|NCT02367833|78975947|FG002|Overall Study|Withdrawal by Subject|0|||
44181518|NCT02367521|78975957|FG000|Overall Study|severe headache after intervention|2|||
44181519|NCT02367521|78975958|FG001|Overall Study|severe headache after intervention|0|||
44181520|NCT02367521|78975957|FG000|Overall Study|unable to find transportation|2|||
44181521|NCT02367521|78975958|FG001|Overall Study|unable to find transportation|0|||
44181522|NCT02338193|78975967|FG000|Overall Study|Withdrawal by Subject|0|||
44181523|NCT02338193|78975968|FG001|Overall Study|Withdrawal by Subject|0|||
44181524|NCT02338193|78975969|FG002|Overall Study|Withdrawal by Subject|2|||
44181525|NCT02338193|78975967|FG000|Overall Study|Pregnancy|0|||
44181526|NCT02338193|78975968|FG001|Overall Study|Pregnancy|1|||
44181527|NCT02338193|78975969|FG002|Overall Study|Pregnancy|1|||
44181528|NCT02338193|78975967|FG000|Overall Study|Noncompliant with visits|2|||
44181529|NCT02338193|78975968|FG001|Overall Study|Noncompliant with visits|2|||
44181530|NCT02338193|78975969|FG002|Overall Study|Noncompliant with visits|7|||
44181531|NCT02338193|78975967|FG000|Overall Study|moved out of state|0|||
44181532|NCT02338193|78975968|FG001|Overall Study|moved out of state|1|||
44181533|NCT02338193|78975969|FG002|Overall Study|moved out of state|0|||
44181534|NCT02338193|78975967|FG000|Overall Study|intolerant of side effects|1|||
44181535|NCT02338193|78975968|FG001|Overall Study|intolerant of side effects|0|||
44181536|NCT02338193|78975969|FG002|Overall Study|intolerant of side effects|0|||
44181537|NCT01783444|78975980|FG000|Treatment Phase|Adverse Event|9|||
44181538|NCT01783444|78975981|FG001|Treatment Phase|Adverse Event|20|||
44181539|NCT01783444|78975982|FG002|Treatment Phase|Adverse Event|19|||
44181540|NCT01783444|78975980|FG000|Treatment Phase|Disease Progression|76|||
44181541|NCT01783444|78975981|FG001|Treatment Phase|Disease Progression|66|||
44181542|NCT01783444|78975982|FG002|Treatment Phase|Disease Progression|64|||
44181543|NCT01783444|78975980|FG000|Treatment Phase|Death|2|||
44181544|NCT01783444|78975981|FG001|Treatment Phase|Death|2|||
44181545|NCT01783444|78975982|FG002|Treatment Phase|Death|2|||
44181546|NCT01783444|78975980|FG000|Treatment Phase|Protocol Violation|1|||
44181547|NCT01783444|78975981|FG001|Treatment Phase|Protocol Violation|1|||
44181548|NCT01783444|78975982|FG002|Treatment Phase|Protocol Violation|2|||
44181549|NCT01783444|78975980|FG000|Treatment Phase|Withdrawal by Subject|6|||
44181550|NCT01783444|78975981|FG001|Treatment Phase|Withdrawal by Subject|8|||
44181551|NCT01783444|78975982|FG002|Treatment Phase|Withdrawal by Subject|9|||
44181552|NCT01783444|78975980|FG000|Treatment Phase|Administrative problems|2|||
44181553|NCT01783444|78975981|FG001|Treatment Phase|Administrative problems|0|||
44181554|NCT01783444|78975982|FG002|Treatment Phase|Administrative problems|1|||
44181555|NCT01783444|78975980|FG000|Treatment Phase|Physician Decision|8|||
44181556|NCT01783444|78975981|FG001|Treatment Phase|Physician Decision|6|||
44181557|NCT01783444|78975982|FG002|Treatment Phase|Physician Decision|5|||
44181558|NCT01783444|78975980|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
44181559|NCT01783444|78975981|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
44181560|NCT01783444|78975982|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
44181561|NCT01783444|78975980|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
44181562|NCT01783444|78975981|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
44181563|NCT01783444|78975982|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
44181564|NCT01783444|78975980|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
44181565|NCT01783444|78975981|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
44181566|NCT01783444|78975982|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
44181567|NCT01783444|78975980|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
44181568|NCT01783444|78975981|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
44181569|NCT01783444|78975982|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
44181570|NCT01783444|78975980|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
44181571|NCT01783444|78975981|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
44181572|NCT01783444|78975982|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
44181573|NCT01783444|78975980|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
44181574|NCT01783444|78975981|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
44181575|NCT01783444|78975982|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
44181576|NCT02367131|78975991|FG000|Overall Study|Adverse Event|64|||
44181577|NCT02367131|78975991|FG000|Overall Study|No visit since the first visit|4|||
44265095|NCT02487108|79167492|FG000|Overall Study|Non-compliance to study procedures|0|||
44265096|NCT02487108|79167493|FG001|Overall Study|Non-compliance to study procedures|0|||
44265097|NCT02487108|79167494|FG002|Overall Study|Non-compliance to study procedures|0|||
44265098|NCT02487108|79167495|FG003|Overall Study|Non-compliance to study procedures|1|||
44181578|NCT02367131|78975991|FG000|Overall Study|Request by patient|54|||
44181579|NCT02367131|78975991|FG000|Overall Study|Improvement/remission|2|||
44181580|NCT02367131|78975991|FG000|Overall Study|No change/progressive disease|78|||
44181581|NCT02367131|78975991|FG000|Overall Study|Other than stated above|20|||
44181582|NCT02394275|78975995|FG000|Overall Study|Adverse Event|22|||
44181583|NCT02394275|78975995|FG000|Overall Study|Lost to Follow-up|7|||
44181584|NCT01608724|78976000|FG000|Overall Study|Withdrawal by Subject|131|||
44181585|NCT01608724|78976000|FG000|Overall Study|Lost to Follow-up|41|||
44181586|NCT01608724|78976000|FG000|Overall Study|Study-specific discontinuation criteria|32|||
44181587|NCT01608724|78976000|FG000|Overall Study|Adverse Event|29|||
44181588|NCT01608724|78976000|FG000|Overall Study|Protocol Violation|6|||
44181589|NCT01608724|78976000|FG000|Overall Study|bood sugar too high, etc.|3|||
44181590|NCT01608724|78976000|FG000|Overall Study|Safety reasons|1|||
44181591|NCT02366195|78976004|FG000|Overall Study|Protocol-specified criteria|3|||
44181592|NCT02366195|78976004|FG000|Overall Study|Withdrawal by Subject|9|||
44181593|NCT02366195|78976004|FG000|Overall Study|Lost to Follow-up|1|||
44181594|NCT02366195|78976004|FG000|Overall Study|Death|41|||
44181595|NCT02364947|78976011|FG000|Overall Study|Withdrawal by Subject|10|||
44181596|NCT02364947|78976012|FG001|Overall Study|Withdrawal by Subject|8|||
44181597|NCT02364947|78976013|FG002|Overall Study|Withdrawal by Subject|9|||
44181598|NCT02364947|78976011|FG000|Overall Study|Adverse Event|45|||
44181599|NCT02364947|78976012|FG001|Overall Study|Adverse Event|33|||
44181600|NCT02364947|78976013|FG002|Overall Study|Adverse Event|11|||
44181601|NCT02364947|78976011|FG000|Overall Study|Protocol Violation|1|||
44181602|NCT02364947|78976012|FG001|Overall Study|Protocol Violation|1|||
44181603|NCT02364947|78976013|FG002|Overall Study|Protocol Violation|1|||
44181604|NCT02364947|78976011|FG000|Overall Study|Physician Decision|3|||
44181605|NCT02364947|78976012|FG001|Overall Study|Physician Decision|2|||
44181606|NCT02364947|78976013|FG002|Overall Study|Physician Decision|5|||
44181607|NCT02364947|78976011|FG000|Overall Study|Death|0|||
44181608|NCT02364947|78976012|FG001|Overall Study|Death|1|||
44181609|NCT02364947|78976013|FG002|Overall Study|Death|0|||
44181610|NCT02392481|78976025|FG000|Overall Study|Adverse Event|0|||
44181611|NCT02392481|78976026|FG001|Overall Study|Adverse Event|0|||
44181612|NCT02392481|78976027|FG002|Overall Study|Adverse Event|1|||
44181613|NCT02392481|78976028|FG003|Overall Study|Adverse Event|2|||
44181614|NCT02392481|78976025|FG000|Overall Study|Withdrawal by Subject|0|||
44181615|NCT02392481|78976026|FG001|Overall Study|Withdrawal by Subject|0|||
44181616|NCT02392481|78976027|FG002|Overall Study|Withdrawal by Subject|1|||
44181617|NCT02392481|78976028|FG003|Overall Study|Withdrawal by Subject|0|||
44181618|NCT02392403|78976038|FG000|Overall Study|Adverse Event|1|||
44181619|NCT02392403|78976038|FG000|Overall Study|Death|1|||
44181620|NCT02392403|78976038|FG000|Overall Study|Withdrawal by Subject|1|||
44181621|NCT02392247|78976042|FG000|Overall Study|Withdrawal by Subject|1|||
44181622|NCT02392247|78976042|FG000|Overall Study|Surgery cancelled; no data|1|||
44181623|NCT02337725|78976048|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
44181624|NCT02337725|78976049|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
44181625|NCT02337725|78976048|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
44181626|NCT02337725|78976049|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
44181627|NCT02337725|78976048|FG000|Overall Study|Major Protocol Deviation|0|||
44181628|NCT02337725|78976049|FG001|Overall Study|Major Protocol Deviation|1|||
44181629|NCT02337725|78976048|FG000|Overall Study|Voluntary Withdrawal|14|||
44181630|NCT02337725|78976049|FG001|Overall Study|Voluntary Withdrawal|3|||
44181631|NCT02337725|78976048|FG000|Overall Study|Lack of Efficacy|4|||
44181632|NCT02337725|78976049|FG001|Overall Study|Lack of Efficacy|0|||
44181633|NCT02337491|78976057|FG000|Overall Study|Death|1|||
44181634|NCT02337491|78976058|FG001|Overall Study|Death|1|||
44181635|NCT02337491|78976057|FG000|Overall Study|Adverse Event|0|||
44181636|NCT02337491|78976058|FG001|Overall Study|Adverse Event|1|||
44181637|NCT02337491|78976057|FG000|Overall Study|Withdrawal by Subject|3|||
44181638|NCT02337491|78976058|FG001|Overall Study|Withdrawal by Subject|0|||
44181639|NCT02337491|78976057|FG000|Overall Study|Progressive Disease|44|||
44181640|NCT02337491|78976058|FG001|Overall Study|Progressive Disease|28|||
44181641|NCT02337491|78976057|FG000|Overall Study|On Treatment|2|||
44181642|NCT02337491|78976058|FG001|Overall Study|On Treatment|0|||
44181643|NCT01765582|78976068|FG000|Overall Study|Other|3|||
44181644|NCT01765582|78976069|FG001|Overall Study|Other|6|||
44181645|NCT01765582|78976070|FG002|Overall Study|Other|9|||
44181646|NCT01765582|78976068|FG000|Overall Study|Lost to Follow-up|2|||
44181647|NCT01765582|78976069|FG001|Overall Study|Lost to Follow-up|2|||
44181648|NCT01765582|78976070|FG002|Overall Study|Lost to Follow-up|1|||
44181649|NCT01765582|78976068|FG000|Overall Study|Death|31|||
44181650|NCT01765582|78976069|FG001|Overall Study|Death|36|||
44451256|NCT00490971|79460223|FG002|Maintenance|Withdrawal by Subject|26|||
44451257|NCT00490971|79460224|FG003|Maintenance|Withdrawal by Subject|28|||
44451258|NCT00490971|79460225|FG004|Maintenance|Withdrawal by Subject|18|||
44451259|NCT00490971|79460221|FG000|Maintenance|Other|0|||
44451260|NCT00490971|79460222|FG001|Maintenance|Other|0|||
44181651|NCT01765582|78976070|FG002|Overall Study|Death|33|||
44181652|NCT01765582|78976068|FG000|Overall Study|Sponsor Decision|46|||
44181653|NCT01765582|78976069|FG001|Overall Study|Sponsor Decision|42|||
44181654|NCT01765582|78976070|FG002|Overall Study|Sponsor Decision|42|||
44181655|NCT01765582|78976068|FG000|Overall Study|Withdrawal of Consent|11|||
44181656|NCT01765582|78976069|FG001|Overall Study|Withdrawal of Consent|6|||
44181657|NCT01765582|78976070|FG002|Overall Study|Withdrawal of Consent|10|||
44181658|NCT01649375|78976082|FG000|Up to Week 16|Adverse Event|2|||
44181659|NCT01649375|78976083|FG001|Up to Week 16|Adverse Event|5|||
44181660|NCT01649375|78976084|FG002|Up to Week 16|Adverse Event|4|||
44181661|NCT01649375|78976085|FG003|Up to Week 16|Adverse Event|0|||
44181662|NCT01649375|78976086|FG004|Up to Week 16|Adverse Event|0|||
44181663|NCT01649375|78976082|FG000|Up to Week 16|Lack of Efficacy|0|||
44181664|NCT01649375|78976083|FG001|Up to Week 16|Lack of Efficacy|0|||
44181665|NCT01649375|78976084|FG002|Up to Week 16|Lack of Efficacy|1|||
44181666|NCT01649375|78976085|FG003|Up to Week 16|Lack of Efficacy|0|||
44181667|NCT01649375|78976086|FG004|Up to Week 16|Lack of Efficacy|0|||
44181668|NCT01649375|78976082|FG000|Up to Week 16|Physician Decision|0|||
44181669|NCT01649375|78976083|FG001|Up to Week 16|Physician Decision|0|||
44181670|NCT01649375|78976084|FG002|Up to Week 16|Physician Decision|1|||
44181671|NCT01649375|78976085|FG003|Up to Week 16|Physician Decision|0|||
44181672|NCT01649375|78976086|FG004|Up to Week 16|Physician Decision|0|||
44181673|NCT01649375|78976082|FG000|Up to Week 16|Withdrawal by Subject|2|||
44181674|NCT01649375|78976083|FG001|Up to Week 16|Withdrawal by Subject|1|||
44181675|NCT01649375|78976084|FG002|Up to Week 16|Withdrawal by Subject|2|||
44451261|NCT00490971|79460223|FG002|Maintenance|Other|11|||
44451262|NCT00490971|79460224|FG003|Maintenance|Other|9|||
44451263|NCT00490971|79460225|FG004|Maintenance|Other|3|||
44181676|NCT01649375|78976085|FG003|Up to Week 16|Withdrawal by Subject|0|||
44181677|NCT01649375|78976086|FG004|Up to Week 16|Withdrawal by Subject|0|||
44181678|NCT01649375|78976082|FG000|Up to Week 16|Death|1|||
44181679|NCT01649375|78976083|FG001|Up to Week 16|Death|0|||
44181680|NCT01649375|78976084|FG002|Up to Week 16|Death|0|||
44181681|NCT01649375|78976085|FG003|Up to Week 16|Death|0|||
44181682|NCT01649375|78976086|FG004|Up to Week 16|Death|0|||
44181683|NCT01649375|78976082|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
44181684|NCT01649375|78976083|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
44181685|NCT01649375|78976084|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
44181686|NCT01649375|78976085|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
44181687|NCT01649375|78976086|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
44181688|NCT01649375|78976082|FG000|Week 16 up to Week 260|Non-compliance|0|||
44181689|NCT01649375|78976083|FG001|Week 16 up to Week 260|Non-compliance|1|||
44181690|NCT01649375|78976084|FG002|Week 16 up to Week 260|Non-compliance|0|||
44181691|NCT01649375|78976085|FG003|Week 16 up to Week 260|Non-compliance|1|||
44181692|NCT01649375|78976086|FG004|Week 16 up to Week 260|Non-compliance|0|||
44181693|NCT01649375|78976082|FG000|Week 16 up to Week 260|Physician Decision|0|||
44181694|NCT01649375|78976083|FG001|Week 16 up to Week 260|Physician Decision|2|||
44181695|NCT01649375|78976084|FG002|Week 16 up to Week 260|Physician Decision|0|||
44181696|NCT01649375|78976085|FG003|Week 16 up to Week 260|Physician Decision|0|||
44181697|NCT01649375|78976086|FG004|Week 16 up to Week 260|Physician Decision|0|||
44181698|NCT01649375|78976082|FG000|Week 16 up to Week 260|Technical issues|0|||
44181699|NCT01649375|78976083|FG001|Week 16 up to Week 260|Technical issues|1|||
44181700|NCT01649375|78976084|FG002|Week 16 up to Week 260|Technical issues|0|||
44181701|NCT01649375|78976085|FG003|Week 16 up to Week 260|Technical issues|1|||
44181702|NCT01649375|78976086|FG004|Week 16 up to Week 260|Technical issues|0|||
44181703|NCT01649375|78976082|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
44181704|NCT01649375|78976083|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
44181705|NCT01649375|78976084|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
44181706|NCT01649375|78976085|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
44181707|NCT01649375|78976086|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
44181708|NCT01649375|78976082|FG000|Week 16 up to Week 260|Death|1|||
44181709|NCT01649375|78976083|FG001|Week 16 up to Week 260|Death|1|||
44181710|NCT01649375|78976084|FG002|Week 16 up to Week 260|Death|0|||
44181711|NCT01649375|78976085|FG003|Week 16 up to Week 260|Death|0|||
44181712|NCT01649375|78976086|FG004|Week 16 up to Week 260|Death|0|||
44181713|NCT01649375|78976082|FG000|Week 16 up to Week 260|Adverse Event|5|||
44181714|NCT01649375|78976083|FG001|Week 16 up to Week 260|Adverse Event|2|||
44181715|NCT01649375|78976084|FG002|Week 16 up to Week 260|Adverse Event|0|||
44181716|NCT01649375|78976085|FG003|Week 16 up to Week 260|Adverse Event|3|||
44181717|NCT01649375|78976086|FG004|Week 16 up to Week 260|Adverse Event|2|||
44181718|NCT02336555|78976096|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44181719|NCT02336555|78976097|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
44181720|NCT02336555|78976096|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
44181721|NCT02336555|78976097|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
44181722|NCT02336555|78976096|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
44181723|NCT02336555|78976097|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
44181724|NCT01648283|78976103|FG000|Overall Study|Withdrawal by Subject|14|||
44181725|NCT01649297|78976114|FG000|Overall Study|Adverse Event|5|||
44181726|NCT01649297|78976115|FG001|Overall Study|Adverse Event|5|||
44181727|NCT01649297|78976116|FG002|Overall Study|Adverse Event|4|||
44451264|NCT00686075|79460247|FG000|Overall Study|Withdrawal by Subject|4|||
44181728|NCT01649297|78976117|FG003|Overall Study|Adverse Event|13|||
44181729|NCT01649297|78976118|FG004|Overall Study|Adverse Event|1|||
44181730|NCT01649297|78976114|FG000|Overall Study|Lack of Efficacy|0|||
44181731|NCT01649297|78976115|FG001|Overall Study|Lack of Efficacy|0|||
44181732|NCT01649297|78976116|FG002|Overall Study|Lack of Efficacy|0|||
44181733|NCT01649297|78976117|FG003|Overall Study|Lack of Efficacy|0|||
44451265|NCT00686075|79460248|FG001|Overall Study|Withdrawal by Subject|3|||
44543030|NCT03655717|79555907|FG007|Overall Study|Lost to Follow-up|0|||
44181734|NCT01649297|78976118|FG004|Overall Study|Lack of Efficacy|1|||
44181735|NCT01649297|78976114|FG000|Overall Study|Non compliant with Protocol|1|||
44181736|NCT01649297|78976115|FG001|Overall Study|Non compliant with Protocol|0|||
44181737|NCT01649297|78976116|FG002|Overall Study|Non compliant with Protocol|3|||
44181738|NCT01649297|78976117|FG003|Overall Study|Non compliant with Protocol|2|||
44181739|NCT01649297|78976118|FG004|Overall Study|Non compliant with Protocol|1|||
44181740|NCT01649297|78976114|FG000|Overall Study|Lost to Follow-up|1|||
44181741|NCT01649297|78976115|FG001|Overall Study|Lost to Follow-up|1|||
44181742|NCT01649297|78976116|FG002|Overall Study|Lost to Follow-up|4|||
44181743|NCT01649297|78976117|FG003|Overall Study|Lost to Follow-up|3|||
44181744|NCT01649297|78976118|FG004|Overall Study|Lost to Follow-up|0|||
44181745|NCT01649297|78976114|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
44181746|NCT01649297|78976115|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
44181747|NCT01649297|78976116|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
44181748|NCT01649297|78976117|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
44181749|NCT01649297|78976118|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
44181750|NCT01649297|78976114|FG000|Overall Study|For other reason|4|||
44181751|NCT01649297|78976115|FG001|Overall Study|For other reason|1|||
44181752|NCT01649297|78976116|FG002|Overall Study|For other reason|2|||
44181753|NCT01649297|78976117|FG003|Overall Study|For other reason|0|||
44181754|NCT01649297|78976118|FG004|Overall Study|For other reason|0|||
44181755|NCT01648205|78976130|FG000|Placebo|Pregnancy|1|||
44181756|NCT01648205|78976130|FG000|Placebo|Withdrawal by Subject|1|||
44181757|NCT01648205|78976130|FG000|Placebo|Protocol Violation|2|||
44181758|NCT01648205|78976130|FG000|Ranolazine|Death|1|||
44181759|NCT01648205|78976130|FG000|Ranolazine|Withdrawal by Subject|1|||
44181760|NCT01648205|78976130|FG000|Ranolazine|Protocol Violation|3|||
44181761|NCT02362451|78976140|FG000|Overall Study|Withdrawal by Subject|0|||
44181762|NCT02362451|78976141|FG001|Overall Study|Withdrawal by Subject|1|||
44181763|NCT02362451|78976140|FG000|Overall Study|Lack of Efficacy|2|||
44181764|NCT02362451|78976141|FG001|Overall Study|Lack of Efficacy|0|||
44181765|NCT02362451|78976140|FG000|Overall Study|Progression|1|||
44181766|NCT02362451|78976141|FG001|Overall Study|Progression|0|||
44181767|NCT02362451|78976140|FG000|Overall Study|Participant chose other therapy.|1|||
44181768|NCT02362451|78976141|FG001|Overall Study|Participant chose other therapy.|0|||
44181769|NCT01734382|78976150|FG000|Part 1|Adverse Event|2|||
44181770|NCT01734382|78976151|FG001|Part 1|Adverse Event|0|||
44181771|NCT01734382|78976152|FG002|Part 1|Adverse Event|0|||
44181772|NCT01734382|78976150|FG000|Part 2|Adverse Event|0|||
44181773|NCT01734382|78976151|FG001|Part 2|Adverse Event|0|||
44181774|NCT01734382|78976152|FG002|Part 2|Adverse Event|1|||
44181775|NCT01734382|78976150|FG000|Part 2|Lack of Efficacy|0|||
44181776|NCT01734382|78976151|FG001|Part 2|Lack of Efficacy|1|||
44181777|NCT01734382|78976152|FG002|Part 2|Lack of Efficacy|1|||
44181778|NCT01734382|78976150|FG000|Part 2|Other|0|||
44181779|NCT01734382|78976151|FG001|Part 2|Other|0|||
44181780|NCT01734382|78976152|FG002|Part 2|Other|1|||
44181781|NCT01734382|78976150|FG000|Part 2|Physician Decision|0|||
44181782|NCT01734382|78976151|FG001|Part 2|Physician Decision|0|||
44181783|NCT01734382|78976152|FG002|Part 2|Physician Decision|3|||
44181784|NCT01734382|78976150|FG000|Part 2|Protocol Violation|0|||
44181785|NCT01734382|78976151|FG001|Part 2|Protocol Violation|1|||
44181786|NCT01734382|78976152|FG002|Part 2|Protocol Violation|0|||
44181787|NCT01734382|78976150|FG000|Part 2|Withdrawal by Subject|0|||
44181788|NCT01734382|78976151|FG001|Part 2|Withdrawal by Subject|0|||
44181789|NCT01734382|78976152|FG002|Part 2|Withdrawal by Subject|1|||
44181790|NCT02391311|78976166|FG000|Overall Study|Lost to Follow-up|2|||
44181791|NCT02391311|78976167|FG001|Overall Study|Lost to Follow-up|1|||
44181792|NCT02391311|78976166|FG000|Overall Study|deemed ineligible after baseline|1|||
44265099|NCT02487108|79167492|FG000|Overall Study|Other than specified|3|||
44265100|NCT02487108|79167493|FG001|Overall Study|Other than specified|2|||
44181793|NCT02391311|78976167|FG001|Overall Study|deemed ineligible after baseline|1|||
44181794|NCT01765426|78976177|FG000|Overall Study|Lost to Follow-up|0|||
44181795|NCT01765426|78976178|FG001|Overall Study|Lost to Follow-up|1|||
44181796|NCT01765426|78976179|FG002|Overall Study|Lost to Follow-up|0|||
44181797|NCT01765426|78976180|FG003|Overall Study|Lost to Follow-up|0|||
44181798|NCT01765270|78976192|FG000|Overall Study|Physician Decision|1|||
44543031|NCT03655717|79555908|FG008|Overall Study|Lost to Follow-up|0|||
44181799|NCT01765270|78976193|FG001|Overall Study|Physician Decision|0|||
44181800|NCT01765270|78976192|FG000|Overall Study|Withdrawal by Subject|0|||
44181801|NCT01765270|78976193|FG001|Overall Study|Withdrawal by Subject|1|||
44181802|NCT01733758|78976204|FG000|Overall Study|Adverse Event|5|||
44181803|NCT01733758|78976205|FG001|Overall Study|Adverse Event|7|||
44181804|NCT01733758|78976206|FG002|Overall Study|Adverse Event|8|||
44181805|NCT01733758|78976207|FG003|Overall Study|Adverse Event|1|||
44181806|NCT01733758|78976204|FG000|Overall Study|Withdrawal by Subject|1|||
44181807|NCT01733758|78976205|FG001|Overall Study|Withdrawal by Subject|1|||
44181808|NCT01733758|78976206|FG002|Overall Study|Withdrawal by Subject|5|||
44181809|NCT01733758|78976207|FG003|Overall Study|Withdrawal by Subject|3|||
44181810|NCT01733758|78976204|FG000|Overall Study|Persistent Hyperglycemia|3|||
44181811|NCT01733758|78976205|FG001|Overall Study|Persistent Hyperglycemia|2|||
44181812|NCT01733758|78976206|FG002|Overall Study|Persistent Hyperglycemia|0|||
44181813|NCT01733758|78976207|FG003|Overall Study|Persistent Hyperglycemia|0|||
44181814|NCT01733758|78976204|FG000|Overall Study|Protocol Violation|0|||
44181815|NCT01733758|78976205|FG001|Overall Study|Protocol Violation|1|||
44181816|NCT01733758|78976206|FG002|Overall Study|Protocol Violation|2|||
44181817|NCT01733758|78976207|FG003|Overall Study|Protocol Violation|2|||
44181818|NCT01733758|78976204|FG000|Overall Study|Non-compliance|1|||
44181819|NCT01733758|78976205|FG001|Overall Study|Non-compliance|0|||
44181820|NCT01733758|78976206|FG002|Overall Study|Non-compliance|0|||
44181821|NCT01733758|78976207|FG003|Overall Study|Non-compliance|0|||
44181822|NCT01733758|78976204|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
44181823|NCT01733758|78976205|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
44181824|NCT01733758|78976206|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
44181825|NCT01733758|78976207|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
44181826|NCT01733758|78976204|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
44181827|NCT01733758|78976205|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
44181828|NCT01733758|78976206|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
44181829|NCT01733758|78976207|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
44181830|NCT01607554|78976219|FG000|Overall Study|Disease progression|2|||
44181831|NCT01607476|78976226|FG000|Overall Study|Withdrawal by Subject|1|||
44181832|NCT01607476|78976227|FG001|Overall Study|Withdrawal by Subject|0|||
44181833|NCT01607476|78976228|FG002|Overall Study|Withdrawal by Subject|1|||
44181834|NCT01607476|78976226|FG000|Overall Study|Lost to Follow-up|0|||
44181835|NCT01607476|78976227|FG001|Overall Study|Lost to Follow-up|0|||
44181836|NCT01607476|78976228|FG002|Overall Study|Lost to Follow-up|2|||
44181837|NCT01765192|78976238|FG000|Treatment Period 1|Adverse Event|0|||
44181838|NCT01765192|78976239|FG001|Treatment Period 1|Adverse Event|1|||
44181839|NCT01765192|78976238|FG000|Washout Period|Voluntary Withdrawal|1|||
44181840|NCT01765192|78976239|FG001|Washout Period|Voluntary Withdrawal|1|||
44181841|NCT01765192|78976238|FG000|Washout Period|Reason not specified|1|||
44181842|NCT01765192|78976239|FG001|Washout Period|Reason not specified|0|||
44181843|NCT01765192|78976238|FG000|Treatment Period 2|Reason not specified|0|||
44181844|NCT01765192|78976239|FG001|Treatment Period 2|Reason not specified|2|||
44181845|NCT01765192|78976238|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
44181846|NCT01765192|78976239|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
44181847|NCT01733680|78976247|FG000|Overall Study|Withdrawal by Subject|0|||
44181848|NCT01733680|78976248|FG001|Overall Study|Withdrawal by Subject|1|||
44181849|NCT02336165|78976263|FG000|Overall Study|Death|3|||
44181850|NCT02336165|78976264|FG001|Overall Study|Death|0|||
44181851|NCT02336165|78976265|FG002|Overall Study|Death|0|||
44181852|NCT02336165|78976266|FG003|Overall Study|Death|0|||
44181853|NCT02336165|78976267|FG004|Overall Study|Death|1|||
44181854|NCT02336165|78976263|FG000|Overall Study|Physician Decision|2|||
44181855|NCT02336165|78976264|FG001|Overall Study|Physician Decision|2|||
44181856|NCT02336165|78976265|FG002|Overall Study|Physician Decision|1|||
44181857|NCT02336165|78976266|FG003|Overall Study|Physician Decision|1|||
44181858|NCT02336165|78976267|FG004|Overall Study|Physician Decision|0|||
44181859|NCT02336165|78976263|FG000|Overall Study|Withdrawal by Subject|0|||
44181860|NCT02336165|78976264|FG001|Overall Study|Withdrawal by Subject|0|||
44181861|NCT02336165|78976265|FG002|Overall Study|Withdrawal by Subject|1|||
44181862|NCT02336165|78976266|FG003|Overall Study|Withdrawal by Subject|0|||
44181863|NCT02336165|78976267|FG004|Overall Study|Withdrawal by Subject|1|||
44181864|NCT02336165|78976263|FG000|Overall Study|Adverse Event|4|||
44181865|NCT02336165|78976264|FG001|Overall Study|Adverse Event|1|||
44181866|NCT02336165|78976265|FG002|Overall Study|Adverse Event|2|||
44181867|NCT02336165|78976266|FG003|Overall Study|Adverse Event|4|||
44181868|NCT02336165|78976267|FG004|Overall Study|Adverse Event|1|||
44181869|NCT02336165|78976263|FG000|Overall Study|Progressive disease|23|||
44181870|NCT02336165|78976264|FG001|Overall Study|Progressive disease|22|||
44181871|NCT02336165|78976265|FG002|Overall Study|Progressive disease|27|||
44181872|NCT02336165|78976266|FG003|Overall Study|Progressive disease|24|||
44181873|NCT02336165|78976267|FG004|Overall Study|Progressive disease|19|||
44181874|NCT02336165|78976263|FG000|Overall Study|Non-compliance|1|||
44181875|NCT02336165|78976264|FG001|Overall Study|Non-compliance|0|||
44181876|NCT02336165|78976265|FG002|Overall Study|Non-compliance|0|||
44181877|NCT02336165|78976266|FG003|Overall Study|Non-compliance|1|||
44181878|NCT02336165|78976267|FG004|Overall Study|Non-compliance|0|||
44181879|NCT02336165|78976263|FG000|Overall Study|Other|1|||
44181880|NCT02336165|78976264|FG001|Overall Study|Other|0|||
44181881|NCT02336165|78976265|FG002|Overall Study|Other|0|||
44181882|NCT02336165|78976266|FG003|Overall Study|Other|1|||
44181883|NCT02336165|78976267|FG004|Overall Study|Other|0|||
44181884|NCT02360111|78976283|FG000|Overall Study|Death|2|||
44181885|NCT02334683|78976289|FG000|First 12 Week Period|Lost to Follow-up|1|||
44181886|NCT02334683|78976290|FG001|First 12 Week Period|Lost to Follow-up|0|||
44181887|NCT02334683|78976289|FG000|Second 12 Week Period|Adverse Event|0|||
44181888|NCT02334683|78976290|FG001|Second 12 Week Period|Adverse Event|1|||
44181889|NCT02319044|78976299|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
44181890|NCT02319044|78976300|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
44181891|NCT02319044|78976301|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
44181892|NCT02319044|78976299|FG000|Overall Study|Withdrawal by Subject|3|||
44181893|NCT02319044|78976300|FG001|Overall Study|Withdrawal by Subject|3|||
44181894|NCT02319044|78976301|FG002|Overall Study|Withdrawal by Subject|6|||
44181895|NCT02319044|78976299|FG000|Overall Study|Condition under investigation worsened|100|||
44181896|NCT02319044|78976300|FG001|Overall Study|Condition under investigation worsened|50|||
44181897|NCT02319044|78976301|FG002|Overall Study|Condition under investigation worsened|46|||
44181898|NCT02319044|78976299|FG000|Overall Study|Adverse Event|17|||
44181899|NCT02319044|78976300|FG001|Overall Study|Adverse Event|2|||
44181900|NCT02319044|78976301|FG002|Overall Study|Adverse Event|8|||
44181901|NCT02319044|78976299|FG000|Overall Study|Study specific discontinuation criteria|2|||
44181902|NCT02319044|78976300|FG001|Overall Study|Study specific discontinuation criteria|2|||
44181903|NCT02319044|78976301|FG002|Overall Study|Study specific discontinuation criteria|1|||
44181904|NCT02319044|78976299|FG000|Overall Study|Not treated|0|||
44181905|NCT02319044|78976300|FG001|Overall Study|Not treated|2|||
44181906|NCT02319044|78976301|FG002|Overall Study|Not treated|2|||
44181907|NCT01649765|78976312|FG000|Overall Study|Adverse Event|5|||
44181908|NCT01649765|78976313|FG001|Overall Study|Adverse Event|3|||
44181909|NCT01649765|78976312|FG000|Overall Study|Lack of Efficacy|1|||
44181910|NCT01649765|78976313|FG001|Overall Study|Lack of Efficacy|1|||
44181911|NCT01649765|78976312|FG000|Overall Study|Physician Decision|0|||
44181912|NCT01649765|78976313|FG001|Overall Study|Physician Decision|3|||
44181913|NCT01649765|78976312|FG000|Overall Study|Protocol Violation|1|||
44181914|NCT01649765|78976313|FG001|Overall Study|Protocol Violation|0|||
44181915|NCT01649765|78976312|FG000|Overall Study|Withdrawal by Subject|2|||
44181916|NCT01649765|78976313|FG001|Overall Study|Withdrawal by Subject|1|||
44181917|NCT02317562|78976320|FG000|Overall Study|Physician Decision|1|||
44181918|NCT02317562|78976320|FG000|Overall Study|early termination of the study|8|||
44181919|NCT02317562|78976320|FG000|Overall Study|Lack of Efficacy|4|||
44181920|NCT02317562|78976320|FG000|Overall Study|Withdrawal by Subject|1|||
44181921|NCT02317016|78976324|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
44181922|NCT02317016|78976324|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
44181923|NCT02317016|78976324|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
44181924|NCT02317016|78976324|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
44181925|NCT02317016|78976324|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
44181926|NCT02317016|78976324|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
44181927|NCT02317016|78976324|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
44181928|NCT02311478|78976332|FG000|Overall Study|Withdrawal by Subject|1|||
44181929|NCT02311478|78976332|FG000|Overall Study|Lost to Follow-up|5|||
44181930|NCT02311478|78976332|FG000|Overall Study|Failed IUD Insertion|1|||
44181931|NCT02388932|78976337|FG000|Overall Study|Death|1|||
44181932|NCT02388776|78976342|FG000|Overall Study|Death|1|||
44181933|NCT02388776|78976342|FG000|Overall Study|Lost to Follow-up|1|||
44181934|NCT02316548|78976349|FG000|Overall Study|Protocol Violation|0|||
44181935|NCT02316548|78976350|FG001|Overall Study|Protocol Violation|1|||
44181936|NCT02281760|78976356|FG000|Overall Study|Withdrawal by Subject|1|||
44181937|NCT02390531|78976368|FG000|Overall Study|Death|0|||
44181938|NCT02390531|78976369|FG001|Overall Study|Death|2|||
44181939|NCT02390531|78976370|FG002|Overall Study|Death|0|||
44181940|NCT02390531|78976371|FG003|Overall Study|Death|1|||
44181941|NCT02390531|78976372|FG004|Overall Study|Death|0|||
44181942|NCT02390531|78976373|FG005|Overall Study|Death|0|||
44181943|NCT02390531|78976374|FG006|Overall Study|Death|0|||
44181944|NCT02390531|78976375|FG007|Overall Study|Death|1|||
44181945|NCT02390531|78976368|FG000|Overall Study|Protocol Violation|0|||
44181946|NCT02390531|78976369|FG001|Overall Study|Protocol Violation|0|||
44181947|NCT02390531|78976370|FG002|Overall Study|Protocol Violation|0|||
44181948|NCT02390531|78976371|FG003|Overall Study|Protocol Violation|0|||
44265101|NCT02487108|79167494|FG002|Overall Study|Other than specified|2|||
44451266|NCT00686075|79460249|FG002|Overall Study|Withdrawal by Subject|3|||
44451267|NCT00686075|79460250|FG003|Overall Study|Withdrawal by Subject|7|||
44265102|NCT02487108|79167495|FG003|Overall Study|Other than specified|0|||
44451268|NCT00686075|79460251|FG004|Overall Study|Withdrawal by Subject|1|||
44181949|NCT02390531|78976372|FG004|Overall Study|Protocol Violation|1|||
44181950|NCT02390531|78976373|FG005|Overall Study|Protocol Violation|0|||
44181951|NCT02390531|78976374|FG006|Overall Study|Protocol Violation|2|||
44181952|NCT02390531|78976375|FG007|Overall Study|Protocol Violation|0|||
44181953|NCT02390219|78976411|FG000|Overall Study|Death|1|||
44181954|NCT02390219|78976411|FG000|Overall Study|Physician Decision|1|||
44181955|NCT02390219|78976411|FG000|Overall Study|Adverse Event|6|||
44181956|NCT02390219|78976411|FG000|Overall Study|Withdrawal by Subject|1|||
44181957|NCT02390219|78976411|FG000|Overall Study|Lost to Follow-up|2|||
44265103|NCT02487030|79167512|FG000|Overall Study|Lack of Efficacy|2|||
44451269|NCT00686075|79460252|FG005|Overall Study|Withdrawal by Subject|0|||
44181958|NCT02390219|78976411|FG000|Overall Study|Other|2|||
44181959|NCT02334215|78976418|FG000|Overall Study|Death|1|||
44181960|NCT02334215|78976419|FG001|Overall Study|Death|1|||
44181961|NCT02334215|78976420|FG002|Overall Study|Death|0|||
44181962|NCT02334215|78976418|FG000|Overall Study|Lost to Follow-up|1|||
44181963|NCT02334215|78976419|FG001|Overall Study|Lost to Follow-up|0|||
44181964|NCT02334215|78976420|FG002|Overall Study|Lost to Follow-up|4|||
44181965|NCT02334215|78976418|FG000|Overall Study|Withdrawal by Subject|2|||
44181966|NCT02334215|78976419|FG001|Overall Study|Withdrawal by Subject|2|||
44181967|NCT02334215|78976420|FG002|Overall Study|Withdrawal by Subject|1|||
44181968|NCT02334215|78976418|FG000|Overall Study|Not released from incarceration on time|3|||
44181969|NCT02334215|78976419|FG001|Overall Study|Not released from incarceration on time|3|||
44181970|NCT02334215|78976420|FG002|Overall Study|Not released from incarceration on time|3|||
44181971|NCT02334215|78976418|FG000|Overall Study|Incarcerated|0|||
44451270|NCT00686075|79460253|FG006|Overall Study|Withdrawal by Subject|0|||
44451271|NCT00686075|79460254|FG007|Overall Study|Withdrawal by Subject|2|||
44451272|NCT00686075|79460255|FG008|Overall Study|Withdrawal by Subject|4|||
44451273|NCT00686075|79460256|FG009|Overall Study|Withdrawal by Subject|6|||
44451274|NCT00686075|79460247|FG000|Overall Study|Lost to Follow-up|3|||
44451275|NCT00686075|79460248|FG001|Overall Study|Lost to Follow-up|6|||
44451276|NCT00686075|79460249|FG002|Overall Study|Lost to Follow-up|3|||
44451277|NCT00686075|79460250|FG003|Overall Study|Lost to Follow-up|2|||
44181972|NCT02334215|78976419|FG001|Overall Study|Incarcerated|0|||
44181973|NCT02334215|78976420|FG002|Overall Study|Incarcerated|7|||
44181974|NCT02359877|78976432|FG000|Overall Study|Withdrawal by Subject|1|||
44181975|NCT02359877|78976433|FG001|Overall Study|Withdrawal by Subject|0|||
44181976|NCT02359877|78976434|FG002|Overall Study|Withdrawal by Subject|0|||
44181977|NCT02359877|78976435|FG003|Overall Study|Withdrawal by Subject|2|||
44181978|NCT02359877|78976432|FG000|Overall Study|Adverse Event|0|||
44181979|NCT02359877|78976433|FG001|Overall Study|Adverse Event|0|||
44181980|NCT02359877|78976434|FG002|Overall Study|Adverse Event|0|||
44181981|NCT02359877|78976435|FG003|Overall Study|Adverse Event|1|||
44181982|NCT02389829|78976465|FG000|Overall Study|Lost to Follow-up|0|||
44181983|NCT02389829|78976466|FG001|Overall Study|Lost to Follow-up|1|||
44181984|NCT02358863|78976472|FG000|Overall Study|Physician Decision|3|||
44181985|NCT02358473|78976476|FG000|Overall Study|Disease Progession|6|||
44181986|NCT02358473|78976476|FG000|Overall Study|Adverse Event|3|||
44181987|NCT02358473|78976476|FG000|Overall Study|Withdrawal by Subject|2|||
44181988|NCT02358473|78976476|FG000|Overall Study|Physician Decision|2|||
44181989|NCT02357459|78976483|FG000|Overall Study|Adverse Event|0|||
44181990|NCT02357459|78976484|FG001|Overall Study|Adverse Event|1|||
44181991|NCT02357459|78976485|FG002|Overall Study|Adverse Event|1|||
44181992|NCT02357459|78976483|FG000|Overall Study|Withdrawal by Subject|5|||
44181993|NCT02357459|78976484|FG001|Overall Study|Withdrawal by Subject|3|||
44181994|NCT02357459|78976485|FG002|Overall Study|Withdrawal by Subject|3|||
44181995|NCT02357459|78976483|FG000|Overall Study|Physician Decision|0|||
44181996|NCT02357459|78976484|FG001|Overall Study|Physician Decision|2|||
44181997|NCT02357459|78976485|FG002|Overall Study|Physician Decision|0|||
44181998|NCT02357459|78976483|FG000|Overall Study|Protocol Violation|1|||
44181999|NCT02357459|78976484|FG001|Overall Study|Protocol Violation|1|||
44182000|NCT02357459|78976485|FG002|Overall Study|Protocol Violation|0|||
44182001|NCT02357459|78976483|FG000|Overall Study|Lost to Follow-up|1|||
44182002|NCT02357459|78976484|FG001|Overall Study|Lost to Follow-up|3|||
44182003|NCT02357459|78976485|FG002|Overall Study|Lost to Follow-up|0|||
44182004|NCT02357459|78976483|FG000|Overall Study|Lack of Efficacy|7|||
44182005|NCT02357459|78976484|FG001|Overall Study|Lack of Efficacy|4|||
44182006|NCT02357459|78976485|FG002|Overall Study|Lack of Efficacy|4|||
44182007|NCT02357459|78976483|FG000|Overall Study|Patient Relocated|2|||
44182008|NCT02357459|78976484|FG001|Overall Study|Patient Relocated|0|||
44182009|NCT02357459|78976485|FG002|Overall Study|Patient Relocated|0|||
44182010|NCT02357459|78976483|FG000|Overall Study|Instruction from PCP|1|||
44182011|NCT02357459|78976484|FG001|Overall Study|Instruction from PCP|0|||
44182012|NCT02357459|78976485|FG002|Overall Study|Instruction from PCP|0|||
44451278|NCT00686075|79460251|FG004|Overall Study|Lost to Follow-up|3|||
44182013|NCT02357459|78976483|FG000|Overall Study|Incarceration|0|||
44182014|NCT02357459|78976484|FG001|Overall Study|Incarceration|0|||
44182015|NCT02357459|78976485|FG002|Overall Study|Incarceration|1|||
44182016|NCT02357459|78976483|FG000|Overall Study|Pre-planned Knee surgery|0|||
44182017|NCT02357459|78976484|FG001|Overall Study|Pre-planned Knee surgery|0|||
44182018|NCT02357459|78976485|FG002|Overall Study|Pre-planned Knee surgery|2|||
44182019|NCT02357459|78976483|FG000|Overall Study|Job Commitments|0|||
44182020|NCT02357459|78976484|FG001|Overall Study|Job Commitments|0|||
44182021|NCT02357459|78976485|FG002|Overall Study|Job Commitments|1|||
44182022|NCT02332889|78976496|FG000|Overall Study|Physician Decision|1|||
44182023|NCT02357147|78976502|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
44182024|NCT02357147|78976503|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
44182025|NCT02357147|78976502|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
44182026|NCT02357147|78976503|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
44182027|NCT02357147|78976502|FG000|Combination Treatment Phase|Investigator Discretion|1|||
44182028|NCT02357147|78976503|FG001|Combination Treatment Phase|Investigator Discretion|1|||
44182029|NCT02357147|78976502|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
44182030|NCT02357147|78976503|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
44182031|NCT02357147|78976502|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
44182032|NCT02357147|78976503|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
44182033|NCT02357147|78976502|FG000|Combination Treatment Phase|Adverse Event|12|||
44182034|NCT02357147|78976503|FG001|Combination Treatment Phase|Adverse Event|4|||
44182035|NCT02357147|78976502|FG000|Combination Treatment Phase|Death|1|||
44182036|NCT02357147|78976503|FG001|Combination Treatment Phase|Death|1|||
44182037|NCT02357147|78976502|FG000|Combination Treatment Phase|Sponsor Decision|0|||
44182038|NCT02357147|78976503|FG001|Combination Treatment Phase|Sponsor Decision|12|||
44182039|NCT02357147|78976502|FG000|Combination Treatment Phase|Other|1|||
44182040|NCT02357147|78976503|FG001|Combination Treatment Phase|Other|0|||
44182041|NCT02357147|78976502|FG000|Combination Treatment Phase|Not treated|0|||
44182042|NCT02357147|78976503|FG001|Combination Treatment Phase|Not treated|2|||
44182043|NCT02357147|78976502|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
44182044|NCT02357147|78976503|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
44182045|NCT02357147|78976502|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44182046|NCT02357147|78976503|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
44182047|NCT02357147|78976502|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
44182048|NCT02357147|78976503|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
44182049|NCT02357147|78976502|FG000|Maintenance Treatment Phase|Adverse Event|0|||
44182050|NCT02357147|78976503|FG001|Maintenance Treatment Phase|Adverse Event|3|||
44182051|NCT02357147|78976502|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
44182052|NCT02357147|78976503|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
44182053|NCT02357147|78976502|FG000|Maintenance Treatment Phase|Not Treated|1|||
44182054|NCT02357147|78976503|FG001|Maintenance Treatment Phase|Not Treated|0|||
44182055|NCT02356211|78976515|FG000|Overall Study|Withdrawal by Subject|2|||
44182056|NCT02356211|78976516|FG001|Overall Study|Withdrawal by Subject|2|||
44182057|NCT02356211|78976515|FG000|Overall Study|ineligible|1|||
44182058|NCT02356211|78976516|FG001|Overall Study|ineligible|8|||
44182059|NCT02332655|78976522|FG000|Overall Study|Lack of Efficacy|1|||
44182060|NCT02388737|78976529|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
44182061|NCT02388737|78976530|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
44182062|NCT02388737|78976531|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
44182063|NCT02388737|78976529|FG000|Overall Study|Major Protocol Deviation|18|||
44182064|NCT02388737|78976530|FG001|Overall Study|Major Protocol Deviation|25|||
44182065|NCT02388737|78976531|FG002|Overall Study|Major Protocol Deviation|22|||
44182066|NCT02388737|78976529|FG000|Overall Study|Lost to Follow-up|5|||
44182067|NCT02388737|78976530|FG001|Overall Study|Lost to Follow-up|1|||
44182068|NCT02388737|78976531|FG002|Overall Study|Lost to Follow-up|4|||
44182069|NCT02388737|78976529|FG000|Overall Study|Voluntary Withdrawal|10|||
44182070|NCT02388737|78976530|FG001|Overall Study|Voluntary Withdrawal|18|||
44182071|NCT02388737|78976531|FG002|Overall Study|Voluntary Withdrawal|17|||
44182072|NCT02388737|78976529|FG000|Overall Study|Lack of Efficacy|3|||
44182073|NCT02388737|78976530|FG001|Overall Study|Lack of Efficacy|0|||
44182074|NCT02388737|78976531|FG002|Overall Study|Lack of Efficacy|3|||
44182075|NCT02388737|78976529|FG000|Overall Study|Reason Not Specified|5|||
44182076|NCT02388737|78976530|FG001|Overall Study|Reason Not Specified|5|||
44182077|NCT02388737|78976531|FG002|Overall Study|Reason Not Specified|4|||
44182078|NCT02355743|78976539|FG000|Overall Study|Withdrawal by Subject|1|||
44265104|NCT02487030|79167513|FG001|Overall Study|Lack of Efficacy|4|||
44265105|NCT02487030|79167514|FG002|Overall Study|Lack of Efficacy|1|||
44265106|NCT02487030|79167515|FG003|Overall Study|Lack of Efficacy|0|||
44265107|NCT02487030|79167516|FG004|Overall Study|Lack of Efficacy|1|||
44265108|NCT02487030|79167517|FG005|Overall Study|Lack of Efficacy|0|||
44182079|NCT02355743|78976539|FG000|Overall Study|Lost to Follow-up|1|||
44182080|NCT02388347|78976548|FG000|Overall Study|Withdrawal by Subject|0|||
44182081|NCT02388347|78976549|FG001|Overall Study|Withdrawal by Subject|0|||
44182082|NCT02388347|78976550|FG002|Overall Study|Withdrawal by Subject|1|||
44182083|NCT02388347|78976551|FG003|Overall Study|Withdrawal by Subject|0|||
44182084|NCT02388347|78976552|FG004|Overall Study|Withdrawal by Subject|0|||
44182085|NCT02355665|78976570|FG000|Overall Study|Adverse Event|16|||
44182086|NCT02355665|78976571|FG001|Overall Study|Adverse Event|24|||
44265109|NCT02487030|79167518|FG006|Overall Study|Lack of Efficacy|0|||
44265110|NCT02487030|79167512|FG000|Overall Study|Lost to Follow-up|0|||
44182087|NCT02355665|78976570|FG000|Overall Study|Protocol Violation|2|||
44182088|NCT02355665|78976571|FG001|Overall Study|Protocol Violation|0|||
44182089|NCT02355665|78976570|FG000|Overall Study|Withdrawal by Subject|90|||
44182090|NCT02355665|78976571|FG001|Overall Study|Withdrawal by Subject|100|||
44182091|NCT02355665|78976570|FG000|Overall Study|Lost to Follow-up|131|||
44265111|NCT02487030|79167513|FG001|Overall Study|Lost to Follow-up|0|||
44451279|NCT00686075|79460252|FG005|Overall Study|Lost to Follow-up|3|||
44451280|NCT00686075|79460253|FG006|Overall Study|Lost to Follow-up|0|||
44182092|NCT02355665|78976571|FG001|Overall Study|Lost to Follow-up|103|||
44182093|NCT02355665|78976570|FG000|Overall Study|Death|4|||
44182094|NCT02355665|78976571|FG001|Overall Study|Death|2|||
44182095|NCT02355665|78976570|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
44182096|NCT02355665|78976571|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
44182097|NCT02010255|78976591|FG000|Overall Study|Death|0|||
44182098|NCT02010255|78976592|FG001|Overall Study|Death|1|||
44182099|NCT02010255|78976593|FG002|Overall Study|Death|4|||
44182100|NCT02010255|78976594|FG003|Overall Study|Death|4|||
44182101|NCT02010255|78976595|FG004|Overall Study|Death|2|||
44182102|NCT02010255|78976596|FG005|Overall Study|Death|0|||
44182103|NCT02010255|78976597|FG006|Overall Study|Death|1|||
44182104|NCT02010255|78976598|FG007|Overall Study|Death|1|||
44182105|NCT02010255|78976599|FG008|Overall Study|Death|1|||
44182106|NCT02010255|78976600|FG009|Overall Study|Death|0|||
44182107|NCT02010255|78976601|FG010|Overall Study|Death|1|||
44182108|NCT02010255|78976602|FG011|Overall Study|Death|1|||
44182109|NCT02010255|78976603|FG012|Overall Study|Death|0|||
44182110|NCT02010255|78976604|FG013|Overall Study|Death|0|||
44182111|NCT02010255|78976591|FG000|Overall Study|Lack of Efficacy|4|||
44182112|NCT02010255|78976592|FG001|Overall Study|Lack of Efficacy|1|||
44182113|NCT02010255|78976593|FG002|Overall Study|Lack of Efficacy|2|||
44182114|NCT02010255|78976594|FG003|Overall Study|Lack of Efficacy|1|||
44182115|NCT02010255|78976595|FG004|Overall Study|Lack of Efficacy|1|||
44182116|NCT02010255|78976596|FG005|Overall Study|Lack of Efficacy|0|||
44182117|NCT02010255|78976597|FG006|Overall Study|Lack of Efficacy|0|||
44182118|NCT02010255|78976598|FG007|Overall Study|Lack of Efficacy|0|||
44182119|NCT02010255|78976599|FG008|Overall Study|Lack of Efficacy|0|||
44182120|NCT02010255|78976600|FG009|Overall Study|Lack of Efficacy|0|||
44182121|NCT02010255|78976601|FG010|Overall Study|Lack of Efficacy|1|||
44182122|NCT02010255|78976602|FG011|Overall Study|Lack of Efficacy|0|||
44182123|NCT02010255|78976603|FG012|Overall Study|Lack of Efficacy|0|||
44182124|NCT02010255|78976604|FG013|Overall Study|Lack of Efficacy|0|||
44182125|NCT02010255|78976591|FG000|Overall Study|Withdrew Consent|1|||
44182126|NCT02010255|78976592|FG001|Overall Study|Withdrew Consent|0|||
44182127|NCT02010255|78976593|FG002|Overall Study|Withdrew Consent|0|||
44182128|NCT02010255|78976594|FG003|Overall Study|Withdrew Consent|1|||
44182129|NCT02010255|78976595|FG004|Overall Study|Withdrew Consent|0|||
44182130|NCT02010255|78976596|FG005|Overall Study|Withdrew Consent|0|||
44182131|NCT02010255|78976597|FG006|Overall Study|Withdrew Consent|0|||
44182132|NCT02010255|78976598|FG007|Overall Study|Withdrew Consent|0|||
44182133|NCT02010255|78976599|FG008|Overall Study|Withdrew Consent|0|||
44182134|NCT02010255|78976600|FG009|Overall Study|Withdrew Consent|0|||
44182135|NCT02010255|78976601|FG010|Overall Study|Withdrew Consent|0|||
44182136|NCT02010255|78976602|FG011|Overall Study|Withdrew Consent|0|||
44182137|NCT02010255|78976603|FG012|Overall Study|Withdrew Consent|0|||
44182138|NCT02010255|78976604|FG013|Overall Study|Withdrew Consent|0|||
44182139|NCT02010255|78976591|FG000|Overall Study|Adverse Event|1|||
44182140|NCT02010255|78976592|FG001|Overall Study|Adverse Event|0|||
44182141|NCT02010255|78976593|FG002|Overall Study|Adverse Event|0|||
44182142|NCT02010255|78976594|FG003|Overall Study|Adverse Event|0|||
44182143|NCT02010255|78976595|FG004|Overall Study|Adverse Event|0|||
44182144|NCT02010255|78976596|FG005|Overall Study|Adverse Event|0|||
44265112|NCT02487030|79167514|FG002|Overall Study|Lost to Follow-up|1|||
44265113|NCT02487030|79167515|FG003|Overall Study|Lost to Follow-up|1|||
44265114|NCT02487030|79167516|FG004|Overall Study|Lost to Follow-up|0|||
44182145|NCT02010255|78976597|FG006|Overall Study|Adverse Event|0|||
44182146|NCT02010255|78976598|FG007|Overall Study|Adverse Event|0|||
44182147|NCT02010255|78976599|FG008|Overall Study|Adverse Event|0|||
44182148|NCT02010255|78976600|FG009|Overall Study|Adverse Event|0|||
44182149|NCT02010255|78976601|FG010|Overall Study|Adverse Event|0|||
44182150|NCT02010255|78976602|FG011|Overall Study|Adverse Event|0|||
44182151|NCT02010255|78976603|FG012|Overall Study|Adverse Event|0|||
44182152|NCT02010255|78976604|FG013|Overall Study|Adverse Event|0|||
44182153|NCT02010255|78976591|FG000|Overall Study|Lost to Follow-up|0|||
44182154|NCT02010255|78976592|FG001|Overall Study|Lost to Follow-up|0|||
44182155|NCT02010255|78976593|FG002|Overall Study|Lost to Follow-up|1|||
44182156|NCT02010255|78976594|FG003|Overall Study|Lost to Follow-up|0|||
44265115|NCT02487030|79167517|FG005|Overall Study|Lost to Follow-up|1|||
44265116|NCT02487030|79167518|FG006|Overall Study|Lost to Follow-up|0|||
44265117|NCT02487030|79167512|FG000|Overall Study|Adverse Event|0|||
44182157|NCT02010255|78976595|FG004|Overall Study|Lost to Follow-up|1|||
44182158|NCT02010255|78976596|FG005|Overall Study|Lost to Follow-up|0|||
44265118|NCT02487030|79167513|FG001|Overall Study|Adverse Event|0|||
44265119|NCT02487030|79167514|FG002|Overall Study|Adverse Event|0|||
44182159|NCT02010255|78976597|FG006|Overall Study|Lost to Follow-up|0|||
44182160|NCT02010255|78976598|FG007|Overall Study|Lost to Follow-up|0|||
44182161|NCT02010255|78976599|FG008|Overall Study|Lost to Follow-up|0|||
44182162|NCT02010255|78976600|FG009|Overall Study|Lost to Follow-up|0|||
44182163|NCT02010255|78976601|FG010|Overall Study|Lost to Follow-up|0|||
44182164|NCT02010255|78976602|FG011|Overall Study|Lost to Follow-up|0|||
44182165|NCT02010255|78976603|FG012|Overall Study|Lost to Follow-up|0|||
44182166|NCT02010255|78976604|FG013|Overall Study|Lost to Follow-up|0|||
44182167|NCT02010255|78976591|FG000|Overall Study|Randomized but Not Treated|0|||
44182168|NCT02010255|78976592|FG001|Overall Study|Randomized but Not Treated|0|||
44182169|NCT02010255|78976593|FG002|Overall Study|Randomized but Not Treated|0|||
44182170|NCT02010255|78976594|FG003|Overall Study|Randomized but Not Treated|0|||
44182171|NCT02010255|78976595|FG004|Overall Study|Randomized but Not Treated|0|||
44182172|NCT02010255|78976596|FG005|Overall Study|Randomized but Not Treated|0|||
44182173|NCT02010255|78976597|FG006|Overall Study|Randomized but Not Treated|0|||
44182174|NCT02010255|78976598|FG007|Overall Study|Randomized but Not Treated|0|||
44182175|NCT02010255|78976599|FG008|Overall Study|Randomized but Not Treated|0|||
44182176|NCT02010255|78976600|FG009|Overall Study|Randomized but Not Treated|0|||
44182177|NCT02010255|78976601|FG010|Overall Study|Randomized but Not Treated|0|||
44451281|NCT00686075|79460254|FG007|Overall Study|Lost to Follow-up|0|||
44451282|NCT00686075|79460255|FG008|Overall Study|Lost to Follow-up|2|||
44451283|NCT00686075|79460256|FG009|Overall Study|Lost to Follow-up|3|||
44451284|NCT00686075|79460247|FG000|Overall Study|Other|1|||
44451285|NCT00686075|79460248|FG001|Overall Study|Other|1|||
44451286|NCT00686075|79460249|FG002|Overall Study|Other|0|||
44451287|NCT00686075|79460250|FG003|Overall Study|Other|0|||
44451288|NCT00686075|79460251|FG004|Overall Study|Other|0|||
44451289|NCT00686075|79460252|FG005|Overall Study|Other|0|||
44451290|NCT00686075|79460253|FG006|Overall Study|Other|0|||
44451291|NCT00686075|79460254|FG007|Overall Study|Other|0|||
44451292|NCT00686075|79460255|FG008|Overall Study|Other|0|||
44451293|NCT00686075|79460256|FG009|Overall Study|Other|1|||
44451294|NCT00685763|79460278|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
44451295|NCT00685763|79460278|FG000|Overall Study|Protocol Violation|1|||
44451296|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Adverse Event|14|||
44451297|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Adverse Event|27|||
44451298|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Adverse Event|60|||
44451299|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Adverse Event|0|||
44451300|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Adverse Event|0|||
44451301|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Pregnancy|0|||
44182178|NCT02010255|78976602|FG011|Overall Study|Randomized but Not Treated|0|||
44182179|NCT02010255|78976603|FG012|Overall Study|Randomized but Not Treated|0|||
44182180|NCT02010255|78976604|FG013|Overall Study|Randomized but Not Treated|1|||
44182181|NCT02354417|78976659|FG000|Overall Study|Physician Decision|1|||
44182182|NCT02332187|78976665|FG000|Overall Study|Withdrawal by Subject|2|||
44182183|NCT02332187|78976666|FG001|Overall Study|Withdrawal by Subject|2|||
44182184|NCT02332187|78976665|FG000|Overall Study|Adverse Event|0|||
44182185|NCT02332187|78976666|FG001|Overall Study|Adverse Event|1|||
44182186|NCT02330549|78976674|FG000|Overall Study|Adverse Event|1|||
44182187|NCT02330549|78976675|FG001|Overall Study|Adverse Event|0|||
44182188|NCT02330549|78976674|FG000|Overall Study|Subject withdrew consent|2|||
44182189|NCT02330549|78976675|FG001|Overall Study|Subject withdrew consent|1|||
44182190|NCT02330549|78976674|FG000|Overall Study|Failure to meet randomization criteria|1|||
44182191|NCT02330549|78976675|FG001|Overall Study|Failure to meet randomization criteria|0|||
44182192|NCT02009865|78976683|FG000|Overall Study|Adverse Event|0|||
44182193|NCT02009865|78976684|FG001|Overall Study|Adverse Event|2|||
44182194|NCT02009865|78976683|FG000|Overall Study|Protocol Violation|0|||
44182195|NCT02009865|78976684|FG001|Overall Study|Protocol Violation|2|||
44182196|NCT02009865|78976683|FG000|Overall Study|Withdrawal by Subject|1|||
44182197|NCT02009865|78976684|FG001|Overall Study|Withdrawal by Subject|1|||
44182198|NCT01620177|78976690|FG000|Overall Study|Failure at Screening Visit|43|||
44182199|NCT01620177|78976690|FG000|Overall Study|Withdrawal by Subject|26|||
44182200|NCT01620177|78976690|FG000|Overall Study|Lost to Follow-up|7|||
44182201|NCT01620177|78976690|FG000|Overall Study|Physician Decision|2|||
44182202|NCT01620177|78976690|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
44182203|NCT02075541|78976709|FG000|Overall Study|Serious Adverse Event|1|||
44182204|NCT02075541|78976710|FG001|Overall Study|Serious Adverse Event|4|||
44182205|NCT02075541|78976709|FG000|Overall Study|Protocol Violation|1|||
44182206|NCT02075541|78976710|FG001|Overall Study|Protocol Violation|0|||
44182207|NCT02075541|78976709|FG000|Overall Study|Withdrawal by Subject|1|||
44182208|NCT02075541|78976710|FG001|Overall Study|Withdrawal by Subject|3|||
44182209|NCT02075541|78976709|FG000|Overall Study|Sponsor study termination|0|||
44265120|NCT02487030|79167515|FG003|Overall Study|Adverse Event|1|||
44265121|NCT02487030|79167516|FG004|Overall Study|Adverse Event|0|||
44451302|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Pregnancy|7|||
44451303|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Pregnancy|9|||
44182210|NCT02075541|78976710|FG001|Overall Study|Sponsor study termination|1|||
44182211|NCT02075541|78976709|FG000|Overall Study|Other- unable to perform study procedure|1|||
44451304|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Pregnancy|0|||
44451305|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Pregnancy|0|||
44451306|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
44182212|NCT02075541|78976710|FG001|Overall Study|Other- unable to perform study procedure|0|||
44182213|NCT02330081|78976716|FG000|Overall Study|Adverse Event|1|||
44182214|NCT02330081|78976716|FG000|Overall Study|Donation did not meet criteria|1|||
44182215|NCT02330081|78976716|FG000|Overall Study|Protocol Violation|6|||
44182216|NCT01986855|78976726|FG000|Overall Study|Adverse Event|1|||
44182217|NCT01986855|78976727|FG001|Overall Study|Adverse Event|0|||
44182218|NCT01986855|78976728|FG002|Overall Study|Adverse Event|0|||
44182219|NCT01986855|78976726|FG000|Overall Study|Death|3|||
44182220|NCT01986855|78976727|FG001|Overall Study|Death|4|||
44182221|NCT01986855|78976728|FG002|Overall Study|Death|4|||
44182222|NCT01986855|78976726|FG000|Overall Study|Lost to Follow-up|2|||
44182223|NCT01986855|78976727|FG001|Overall Study|Lost to Follow-up|1|||
44182224|NCT01986855|78976728|FG002|Overall Study|Lost to Follow-up|0|||
44182225|NCT01986855|78976726|FG000|Overall Study|Screen Failure|0|||
44182226|NCT01986855|78976727|FG001|Overall Study|Screen Failure|1|||
44182227|NCT01986855|78976728|FG002|Overall Study|Screen Failure|0|||
44182228|NCT01986855|78976726|FG000|Overall Study|Participant Moved|0|||
44182229|NCT01986855|78976727|FG001|Overall Study|Participant Moved|0|||
44182230|NCT01986855|78976728|FG002|Overall Study|Participant Moved|2|||
44182231|NCT01986855|78976726|FG000|Overall Study|Withdrawal by Subject|7|||
44182232|NCT01986855|78976727|FG001|Overall Study|Withdrawal by Subject|8|||
44182233|NCT01986855|78976728|FG002|Overall Study|Withdrawal by Subject|5|||
44182234|NCT02075463|78976736|FG000|Overall Study|Adverse Event|3|||
44182235|NCT02075463|78976736|FG000|Overall Study|Par. reached stopping criteria|4|||
44182236|NCT02075463|78976736|FG000|Overall Study|Withdrawal by Subject|1|||
44182237|NCT02353871|78976743|FG000|Overall Study|Protocol deviation|0|||
44182238|NCT02353871|78976744|FG001|Overall Study|Protocol deviation|1|||
44182239|NCT02353871|78976743|FG000|Overall Study|Consent withdrawn|1|||
44182240|NCT02353871|78976744|FG001|Overall Study|Consent withdrawn|8|||
44182241|NCT02353871|78976743|FG000|Overall Study|Lost to Follow-up|2|||
44182242|NCT02353871|78976744|FG001|Overall Study|Lost to Follow-up|0|||
44182243|NCT02009397|78976750|FG000|Overall Study|Protocol Violation|6|||
44182244|NCT02009397|78976750|FG000|Overall Study|Death|8|||
44182245|NCT02009397|78976750|FG000|Overall Study|Lost to Follow-up|6|||
44182246|NCT02312219|78976756|FG000|Overall Study|Withdrawal by Subject|1|||
44182247|NCT02312219|78976757|FG001|Overall Study|Withdrawal by Subject|2|||
44182248|NCT02312219|78976756|FG000|Overall Study|could not schedule imaging in time|0|||
44182249|NCT02312219|78976757|FG001|Overall Study|could not schedule imaging in time|2|||
44182250|NCT02312219|78976756|FG000|Overall Study|Other|0|||
44182251|NCT02312219|78976757|FG001|Overall Study|Other|1|||
44182252|NCT02312219|78976756|FG000|Overall Study|Not randomized. Ineligible|0|||
44182253|NCT02312219|78976757|FG001|Overall Study|Not randomized. Ineligible|1|||
44182254|NCT01986231|78976763|FG000|Overall Study|Adverse Event|1|||
44182255|NCT02312063|78976769|FG000|Overall Study|Withdrawal by Subject|0|||
44182256|NCT02312063|78976770|FG001|Overall Study|Withdrawal by Subject|1|||
44182257|NCT02353169|78976781|FG000|Overall Study|QTc > 450 msec|1|||
44182258|NCT02353169|78976782|FG001|Overall Study|QTc > 450 msec|1|||
44182259|NCT02353169|78976783|FG002|Overall Study|QTc > 450 msec|1|||
44182260|NCT02353169|78976784|FG003|Overall Study|QTc > 450 msec|1|||
44182261|NCT02353169|78976781|FG000|Overall Study|OR team declined|2|||
44182262|NCT02353169|78976782|FG001|Overall Study|OR team declined|0|||
44182263|NCT02353169|78976783|FG002|Overall Study|OR team declined|0|||
44182264|NCT02353169|78976784|FG003|Overall Study|OR team declined|0|||
44182265|NCT02353169|78976781|FG000|Overall Study|Inhalational induction|0|||
44182266|NCT02353169|78976782|FG001|Overall Study|Inhalational induction|2|||
44182267|NCT02353169|78976783|FG002|Overall Study|Inhalational induction|0|||
44182268|NCT02353169|78976784|FG003|Overall Study|Inhalational induction|0|||
44182269|NCT02353169|78976781|FG000|Overall Study|ECG data error|0|||
44182270|NCT02353169|78976782|FG001|Overall Study|ECG data error|3|||
44182271|NCT02353169|78976783|FG002|Overall Study|ECG data error|2|||
44182272|NCT02353169|78976784|FG003|Overall Study|ECG data error|2|||
44182273|NCT02353169|78976781|FG000|Overall Study|Pre-op medication|0|||
44182274|NCT02353169|78976782|FG001|Overall Study|Pre-op medication|0|||
44182275|NCT02353169|78976783|FG002|Overall Study|Pre-op medication|1|||
44182276|NCT02353169|78976784|FG003|Overall Study|Pre-op medication|0|||
44182277|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
44182278|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
44265122|NCT02487030|79167517|FG005|Overall Study|Adverse Event|0|||
44265123|NCT02487030|79167518|FG006|Overall Study|Adverse Event|0|||
44265124|NCT02487030|79167512|FG000|Overall Study|Death|0|||
44265125|NCT02487030|79167513|FG001|Overall Study|Death|0|||
44182279|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
44182280|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
44182281|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
44182282|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
44182283|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
44182284|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
44182285|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
44182286|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
44182287|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
44182288|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
44182289|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
44182290|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
44182291|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
44182292|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
44182293|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
44182294|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
44182295|NCT02009163|78976794|FG000|Open-label Period (Non-randomized)|Other|13|||
44182296|NCT02009163|78976795|FG001|Open-label Period (Non-randomized)|Other|0|||
44182297|NCT02009163|78976796|FG002|Open-label Period (Non-randomized)|Other|0|||
44182298|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
44182299|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
44182300|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
44182301|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
44182302|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
44182303|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
44182304|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Adverse Event|0|||
44182305|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Adverse Event|0|||
44182306|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Adverse Event|6|||
44182307|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
44182308|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
44182309|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
44182310|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
44182311|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
44182312|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
44182313|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Pregnancy|0|||
44182314|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Pregnancy|0|||
44182315|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Pregnancy|2|||
44182316|NCT02009163|78976794|FG000|Randomized-withdrawal Period|Other|0|||
44182317|NCT02009163|78976795|FG001|Randomized-withdrawal Period|Other|9|||
44182318|NCT02009163|78976796|FG002|Randomized-withdrawal Period|Other|5|||
44182319|NCT01983969|78976809|FG000|Overall Study|Disease Progression|0|||
44182320|NCT01983969|78976810|FG001|Overall Study|Disease Progression|1|||
44182321|NCT01983969|78976811|FG002|Overall Study|Disease Progression|0|||
44182322|NCT02008773|78976827|FG000|Overall Study|Adverse Event|3|||
44182323|NCT02008773|78976828|FG001|Overall Study|Adverse Event|3|||
44182324|NCT02008773|78976829|FG002|Overall Study|Adverse Event|1|||
44182325|NCT02008773|78976830|FG003|Overall Study|Adverse Event|2|||
44182326|NCT02008773|78976827|FG000|Overall Study|Medication Non-compliance|2|||
44182327|NCT02008773|78976828|FG001|Overall Study|Medication Non-compliance|1|||
44182328|NCT02008773|78976829|FG002|Overall Study|Medication Non-compliance|3|||
44182329|NCT02008773|78976830|FG003|Overall Study|Medication Non-compliance|2|||
44182330|NCT02008773|78976827|FG000|Overall Study|Withdrawal by Subject|8|||
44182331|NCT02008773|78976828|FG001|Overall Study|Withdrawal by Subject|4|||
44182332|NCT02008773|78976829|FG002|Overall Study|Withdrawal by Subject|7|||
44182333|NCT02008773|78976830|FG003|Overall Study|Withdrawal by Subject|6|||
44182334|NCT02008773|78976827|FG000|Overall Study|Lost to Follow-up|0|||
44182335|NCT02008773|78976828|FG001|Overall Study|Lost to Follow-up|1|||
44182336|NCT02008773|78976829|FG002|Overall Study|Lost to Follow-up|3|||
44182337|NCT02008773|78976830|FG003|Overall Study|Lost to Follow-up|2|||
44182338|NCT02257567|78976849|FG000|Overall Study|Adverse Event|0|||
44182339|NCT02257567|78976850|FG001|Overall Study|Adverse Event|0|||
44182340|NCT02257567|78976851|FG002|Overall Study|Adverse Event|0|||
44182341|NCT02257567|78976852|FG003|Overall Study|Adverse Event|1|||
44182342|NCT02257567|78976853|FG004|Overall Study|Adverse Event|1|||
44182343|NCT02257567|78976854|FG005|Overall Study|Adverse Event|0|||
44182344|NCT02257567|78976855|FG006|Overall Study|Adverse Event|0|||
44182345|NCT02257567|78976856|FG007|Overall Study|Adverse Event|0|||
44182346|NCT02257567|78976857|FG008|Overall Study|Adverse Event|1|||
44182347|NCT02257567|78976858|FG009|Overall Study|Adverse Event|0|||
44182348|NCT02257567|78976859|FG010|Overall Study|Adverse Event|0|||
44182349|NCT02257567|78976849|FG000|Overall Study|Death|2|||
44265126|NCT02487030|79167514|FG002|Overall Study|Death|0|||
44182350|NCT02257567|78976850|FG001|Overall Study|Death|2|||
44182351|NCT02257567|78976851|FG002|Overall Study|Death|2|||
44182352|NCT02257567|78976852|FG003|Overall Study|Death|4|||
44182353|NCT02257567|78976853|FG004|Overall Study|Death|15|||
44182354|NCT02257567|78976854|FG005|Overall Study|Death|11|||
44182355|NCT02257567|78976855|FG006|Overall Study|Death|26|||
44182356|NCT02257567|78976856|FG007|Overall Study|Death|30|||
44182357|NCT02257567|78976857|FG008|Overall Study|Death|2|||
44265127|NCT02487030|79167515|FG003|Overall Study|Death|0|||
44182358|NCT02257567|78976858|FG009|Overall Study|Death|18|||
44182359|NCT02257567|78976859|FG010|Overall Study|Death|65|||
44182360|NCT02257567|78976849|FG000|Overall Study|Lost to Follow-up|0|||
44182361|NCT02257567|78976850|FG001|Overall Study|Lost to Follow-up|0|||
44182362|NCT02257567|78976851|FG002|Overall Study|Lost to Follow-up|0|||
44182363|NCT02257567|78976852|FG003|Overall Study|Lost to Follow-up|0|||
44182364|NCT02257567|78976853|FG004|Overall Study|Lost to Follow-up|2|||
44182365|NCT02257567|78976854|FG005|Overall Study|Lost to Follow-up|2|||
44182366|NCT02257567|78976855|FG006|Overall Study|Lost to Follow-up|0|||
44182367|NCT02257567|78976856|FG007|Overall Study|Lost to Follow-up|0|||
44182368|NCT02257567|78976857|FG008|Overall Study|Lost to Follow-up|0|||
44182369|NCT02257567|78976858|FG009|Overall Study|Lost to Follow-up|1|||
44182370|NCT02257567|78976859|FG010|Overall Study|Lost to Follow-up|1|||
44182371|NCT02257567|78976849|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182372|NCT02257567|78976850|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182373|NCT02257567|78976851|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182374|NCT02257567|78976852|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182375|NCT02257567|78976853|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
44182376|NCT02257567|78976854|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182377|NCT02257567|78976855|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
44182378|NCT02257567|78976856|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182379|NCT02257567|78976857|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182380|NCT02257567|78976858|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182381|NCT02257567|78976859|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
44182382|NCT02257567|78976849|FG000|Overall Study|Physician Decision|0|||
44182383|NCT02257567|78976850|FG001|Overall Study|Physician Decision|0|||
44182384|NCT02257567|78976851|FG002|Overall Study|Physician Decision|0|||
44182385|NCT02257567|78976852|FG003|Overall Study|Physician Decision|0|||
44182386|NCT02257567|78976853|FG004|Overall Study|Physician Decision|0|||
44182387|NCT02257567|78976854|FG005|Overall Study|Physician Decision|0|||
44182388|NCT02257567|78976855|FG006|Overall Study|Physician Decision|0|||
44182389|NCT02257567|78976856|FG007|Overall Study|Physician Decision|2|||
44182390|NCT02257567|78976857|FG008|Overall Study|Physician Decision|0|||
44182391|NCT02257567|78976858|FG009|Overall Study|Physician Decision|1|||
44182392|NCT02257567|78976859|FG010|Overall Study|Physician Decision|0|||
44182393|NCT02257567|78976849|FG000|Overall Study|Withdrawal by Subject|0|||
44182394|NCT02257567|78976850|FG001|Overall Study|Withdrawal by Subject|0|||
44182395|NCT02257567|78976851|FG002|Overall Study|Withdrawal by Subject|2|||
44182396|NCT02257567|78976852|FG003|Overall Study|Withdrawal by Subject|0|||
44182397|NCT02257567|78976853|FG004|Overall Study|Withdrawal by Subject|0|||
44182398|NCT02257567|78976854|FG005|Overall Study|Withdrawal by Subject|6|||
44182399|NCT02257567|78976855|FG006|Overall Study|Withdrawal by Subject|6|||
44182400|NCT02257567|78976856|FG007|Overall Study|Withdrawal by Subject|6|||
44182401|NCT02257567|78976857|FG008|Overall Study|Withdrawal by Subject|1|||
44182402|NCT02257567|78976858|FG009|Overall Study|Withdrawal by Subject|1|||
44182403|NCT02257567|78976859|FG010|Overall Study|Withdrawal by Subject|10|||
44182404|NCT01642615|78976916|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
44182405|NCT01642615|78976917|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
44182406|NCT01642615|78976918|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
44182407|NCT01642615|78976916|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
44182408|NCT01642615|78976917|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
44182409|NCT01642615|78976918|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
44182410|NCT01642615|78976916|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
44182411|NCT01642615|78976917|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
44182412|NCT01642615|78976918|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
44265128|NCT02487030|79167516|FG004|Overall Study|Death|1|||
44265129|NCT02487030|79167517|FG005|Overall Study|Death|0|||
44265130|NCT02487030|79167518|FG006|Overall Study|Death|0|||
44265131|NCT02486952|79167535|FG000|Overall Study|Not Started Induction Therapy|3|||
44265132|NCT02486952|79167535|FG000|Overall Study|Adverse Event|1|||
44265133|NCT02486952|79167535|FG000|Overall Study|Death|15|||
44265134|NCT02486952|79167535|FG000|Overall Study|Lack of Efficacy|3|||
44265135|NCT02486952|79167535|FG000|Overall Study|Lost to Follow-up|26|||
44182413|NCT01642615|78976916|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
44182414|NCT01642615|78976917|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
44265136|NCT02486952|79167535|FG000|Overall Study|Other|2|||
44182415|NCT01642615|78976918|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
44265137|NCT02486796|79167541|FG000|Overall Study|Withdrawal by Subject|1|||
44182416|NCT01642615|78976916|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
44265138|NCT02486796|79167542|FG001|Overall Study|Withdrawal by Subject|1|||
44265139|NCT02486796|79167541|FG000|Overall Study|Physician Decision|1|||
44265140|NCT02486796|79167542|FG001|Overall Study|Physician Decision|0|||
44265141|NCT02459262|79167559|FG000|Overall Study|Withdrawal by Subject|0|||
44265142|NCT02459262|79167560|FG001|Overall Study|Withdrawal by Subject|0|||
44265143|NCT02459262|79167561|FG002|Overall Study|Withdrawal by Subject|0|||
44265144|NCT02459262|79167562|FG003|Overall Study|Withdrawal by Subject|0|||
44265145|NCT02459262|79167563|FG004|Overall Study|Withdrawal by Subject|0|||
44265146|NCT02459262|79167564|FG005|Overall Study|Withdrawal by Subject|0|||
44265147|NCT02459262|79167565|FG006|Overall Study|Withdrawal by Subject|0|||
44265148|NCT02459262|79167566|FG007|Overall Study|Withdrawal by Subject|0|||
44265149|NCT02459262|79167567|FG008|Overall Study|Withdrawal by Subject|0|||
44265150|NCT02459262|79167568|FG009|Overall Study|Withdrawal by Subject|1|||
44265151|NCT02459262|79167569|FG010|Overall Study|Withdrawal by Subject|0|||
44265152|NCT02450526|79167653|FG000|DB Period (Cycle 1)|Adverse Event|0|||
44265153|NCT02450526|79167654|FG001|DB Period (Cycle 1)|Adverse Event|0|||
44265154|NCT02450526|79167655|FG002|DB Period (Cycle 1)|Adverse Event|2|||
44265155|NCT02450526|79167656|FG003|DB Period (Cycle 1)|Adverse Event|0|||
44265156|NCT02450526|79167657|FG004|DB Period (Cycle 1)|Adverse Event|0|||
44265157|NCT02450526|79167653|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
44265158|NCT02450526|79167654|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
44265159|NCT02450526|79167655|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
44265160|NCT02450526|79167656|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
44265161|NCT02450526|79167657|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
44265162|NCT02450526|79167653|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
44265163|NCT02450526|79167654|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
44265164|NCT02450526|79167655|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
44265165|NCT02450526|79167656|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
44265166|NCT02450526|79167657|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
44265167|NCT02450526|79167653|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
44265168|NCT02450526|79167654|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
44265169|NCT02450526|79167655|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
44265170|NCT02450526|79167656|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
44265171|NCT02450526|79167657|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
44265172|NCT02450526|79167653|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
44265173|NCT02450526|79167654|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
44265174|NCT02450526|79167655|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
44265175|NCT02450526|79167656|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
44265176|NCT02450526|79167657|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
44451307|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
44182417|NCT01642615|78976917|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
44182418|NCT01642615|78976918|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
44182419|NCT01642615|78976916|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
44182420|NCT01642615|78976917|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
44182421|NCT01642615|78976918|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
44182422|NCT01642615|78976916|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
44182423|NCT01642615|78976917|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
44182424|NCT01642615|78976918|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
44182425|NCT01642615|78976916|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
44182426|NCT01642615|78976917|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
44182427|NCT01642615|78976918|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
44182428|NCT01642615|78976916|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
44182429|NCT01642615|78976917|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
44182430|NCT01642615|78976918|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
44182431|NCT02311361|78976930|FG000|Overall Study|Did not receive treatment|0|||
44182432|NCT02311361|78976931|FG001|Overall Study|Did not receive treatment|1|||
44182433|NCT02311361|78976932|FG002|Overall Study|Did not receive treatment|0|||
44182434|NCT02311361|78976933|FG003|Overall Study|Did not receive treatment|1|||
44182435|NCT02352779|78976950|FG000|Overall Study|Personal Issues|1|||
44265177|NCT02450526|79167653|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
44265178|NCT02450526|79167654|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
44265179|NCT02450526|79167655|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
44265180|NCT02450526|79167656|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
44265181|NCT02450526|79167657|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
44265182|NCT02450526|79167653|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
44265183|NCT02450526|79167654|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
44265184|NCT02450526|79167655|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
44265185|NCT02450526|79167656|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
44265186|NCT02450526|79167657|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
44265187|NCT02450526|79167653|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
44265188|NCT02450526|79167654|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
44265189|NCT02450526|79167655|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
44265190|NCT02450526|79167656|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
44265191|NCT02450526|79167657|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
44265192|NCT02458638|79167724|FG000|Overall Study|Death|309|||
44265193|NCT02458638|79167724|FG000|Overall Study|End of Cohort/End of Study|67|||
44265194|NCT02458638|79167724|FG000|Overall Study|Lost to Follow-up|31|||
44265195|NCT02458638|79167724|FG000|Overall Study|Other Reasons|4|||
44265196|NCT02458638|79167724|FG000|Overall Study|Physician Decision|1|||
44265197|NCT02458638|79167724|FG000|Overall Study|Withdrawal by Subject|47|||
44265198|NCT02458092|79167862|FG000|Overall Study|Withdrawal by Subject|1|||
44265199|NCT02458092|79167863|FG001|Overall Study|Withdrawal by Subject|0|||
44265200|NCT02449902|79167886|FG000|Overall Study|Adverse Event|0|||
44265201|NCT02449902|79167887|FG001|Overall Study|Adverse Event|1|||
44265202|NCT02449902|79167886|FG000|Overall Study|Withdrawal by Subject|0|||
44265203|NCT02449902|79167887|FG001|Overall Study|Withdrawal by Subject|1|||
44265204|NCT02449044|79167895|FG000|Overall Study|Lost to Follow-up|2|||
44265205|NCT02449044|79167895|FG000|Overall Study|Withdrawal by Subject|13|||
44265206|NCT02449044|79167895|FG000|Overall Study|Adverse Event|30|||
44265207|NCT02449044|79167895|FG000|Overall Study|Met Withdrawal Criteria|7|||
44265208|NCT02449044|79167895|FG000|Overall Study|Physician Decision|9|||
44265209|NCT02449044|79167895|FG000|Overall Study|Sponsor Discontinued Trial|3|||
44265210|NCT02448810|79168757|FG000|Overall Study|Adverse Event|0|||
44265211|NCT02448810|79168758|FG001|Overall Study|Adverse Event|0|||
44265212|NCT02448810|79168759|FG002|Overall Study|Adverse Event|1|||
44265213|NCT02448810|79168760|FG003|Overall Study|Adverse Event|0|||
44265214|NCT02448810|79168761|FG004|Overall Study|Adverse Event|0|||
44265215|NCT02448810|79168762|FG005|Overall Study|Adverse Event|0|||
44265216|NCT02448810|79168763|FG006|Overall Study|Adverse Event|0|||
44265217|NCT02448810|79168764|FG007|Overall Study|Adverse Event|0|||
44182436|NCT02352779|78976951|FG001|Overall Study|Personal Issues|1|||
44182437|NCT02352779|78976952|FG002|Overall Study|Personal Issues|0|||
44182438|NCT02352779|78976950|FG000|Overall Study|Too Many Forms|2|||
44182439|NCT02352779|78976951|FG001|Overall Study|Too Many Forms|0|||
44182440|NCT02352779|78976952|FG002|Overall Study|Too Many Forms|0|||
44182441|NCT02352779|78976950|FG000|Overall Study|Feeling Overwhelmed|1|||
44182442|NCT02352779|78976951|FG001|Overall Study|Feeling Overwhelmed|0|||
44182443|NCT02352779|78976952|FG002|Overall Study|Feeling Overwhelmed|0|||
44182444|NCT02352779|78976950|FG000|Overall Study|Disliked Intervention|1|||
44182445|NCT02352779|78976951|FG001|Overall Study|Disliked Intervention|0|||
44182446|NCT02352779|78976952|FG002|Overall Study|Disliked Intervention|0|||
44182447|NCT02352779|78976950|FG000|Overall Study|Changed Mind|1|||
44182448|NCT02352779|78976951|FG001|Overall Study|Changed Mind|0|||
44182449|NCT02352779|78976952|FG002|Overall Study|Changed Mind|0|||
44182450|NCT02352779|78976950|FG000|Overall Study|Study Related Symptoms|1|||
44182451|NCT02352779|78976951|FG001|Overall Study|Study Related Symptoms|0|||
44182452|NCT02352779|78976952|FG002|Overall Study|Study Related Symptoms|0|||
44182453|NCT02352779|78976950|FG000|Overall Study|Absence of Symptoms|1|||
44182454|NCT02352779|78976951|FG001|Overall Study|Absence of Symptoms|0|||
44182455|NCT02352779|78976952|FG002|Overall Study|Absence of Symptoms|0|||
44182456|NCT02352779|78976950|FG000|Overall Study|Other Medical Reason|0|||
44182457|NCT02352779|78976951|FG001|Overall Study|Other Medical Reason|0|||
44182458|NCT02352779|78976952|FG002|Overall Study|Other Medical Reason|1|||
44182459|NCT02352779|78976950|FG000|Overall Study|No Reason|0|||
44182460|NCT02352779|78976951|FG001|Overall Study|No Reason|0|||
44265218|NCT02448810|79168757|FG000|Overall Study|Withdrawal by Subject|0|||
44265219|NCT02448810|79168758|FG001|Overall Study|Withdrawal by Subject|0|||
44265220|NCT02448810|79168759|FG002|Overall Study|Withdrawal by Subject|1|||
44265221|NCT02448810|79168760|FG003|Overall Study|Withdrawal by Subject|0|||
44543032|NCT03655717|79555909|FG009|Overall Study|Lost to Follow-up|0|||
44182461|NCT02352779|78976952|FG002|Overall Study|No Reason|1|||
44182462|NCT02257489|78976969|FG000|Overall Study|Withdrawal by Subject|0|||
44182463|NCT02257489|78976970|FG001|Overall Study|Withdrawal by Subject|0|||
44182464|NCT02257489|78976971|FG002|Overall Study|Withdrawal by Subject|0|||
44265222|NCT02448810|79168761|FG004|Overall Study|Withdrawal by Subject|3|||
44265223|NCT02448810|79168762|FG005|Overall Study|Withdrawal by Subject|5|||
44265224|NCT02448810|79168763|FG006|Overall Study|Withdrawal by Subject|0|||
44265225|NCT02448810|79168764|FG007|Overall Study|Withdrawal by Subject|2|||
44265226|NCT02448810|79168757|FG000|Overall Study|Other (study terminated by sponsor)|0|||
44265227|NCT02448810|79168758|FG001|Overall Study|Other (study terminated by sponsor)|0|||
44265228|NCT02448810|79168759|FG002|Overall Study|Other (study terminated by sponsor)|0|||
44265229|NCT02448810|79168760|FG003|Overall Study|Other (study terminated by sponsor)|0|||
44265230|NCT02448810|79168761|FG004|Overall Study|Other (study terminated by sponsor)|4|||
44265231|NCT02448810|79168762|FG005|Overall Study|Other (study terminated by sponsor)|2|||
44265232|NCT02448810|79168763|FG006|Overall Study|Other (study terminated by sponsor)|2|||
44265233|NCT02448810|79168764|FG007|Overall Study|Other (study terminated by sponsor)|1|||
44265234|NCT02448810|79168757|FG000|Overall Study|Death|1|||
44265235|NCT02448810|79168758|FG001|Overall Study|Death|0|||
44265236|NCT02448810|79168759|FG002|Overall Study|Death|1|||
44265237|NCT02448810|79168760|FG003|Overall Study|Death|0|||
44265238|NCT02448810|79168761|FG004|Overall Study|Death|1|||
44265239|NCT02448810|79168762|FG005|Overall Study|Death|0|||
44265240|NCT02448810|79168763|FG006|Overall Study|Death|0|||
44265241|NCT02448810|79168764|FG007|Overall Study|Death|0|||
44265242|NCT02448810|79168757|FG000|Overall Study|Other (Progressive disease)|2|||
44265243|NCT02448810|79168758|FG001|Overall Study|Other (Progressive disease)|2|||
44265244|NCT02448810|79168759|FG002|Overall Study|Other (Progressive disease)|0|||
44265245|NCT02448810|79168760|FG003|Overall Study|Other (Progressive disease)|3|||
44265246|NCT02448810|79168761|FG004|Overall Study|Other (Progressive disease)|23|||
44265247|NCT02448810|79168762|FG005|Overall Study|Other (Progressive disease)|9|||
44265248|NCT02448810|79168763|FG006|Overall Study|Other (Progressive disease)|14|||
44265249|NCT02448810|79168764|FG007|Overall Study|Other (Progressive disease)|5|||
44265250|NCT02448810|79168757|FG000|Overall Study|Lost to Follow-up|0|||
44265251|NCT02448810|79168758|FG001|Overall Study|Lost to Follow-up|1|||
44265252|NCT02448810|79168759|FG002|Overall Study|Lost to Follow-up|0|||
44265253|NCT02448810|79168760|FG003|Overall Study|Lost to Follow-up|0|||
44265254|NCT02448810|79168761|FG004|Overall Study|Lost to Follow-up|0|||
44265255|NCT02448810|79168762|FG005|Overall Study|Lost to Follow-up|0|||
44265256|NCT02448810|79168763|FG006|Overall Study|Lost to Follow-up|0|||
44265257|NCT02448810|79168764|FG007|Overall Study|Lost to Follow-up|0|||
44265258|NCT02448810|79168757|FG000|Overall Study|Other (unspecified)|0|||
44265259|NCT02448810|79168758|FG001|Overall Study|Other (unspecified)|0|||
44265260|NCT02448810|79168759|FG002|Overall Study|Other (unspecified)|0|||
44265261|NCT02448810|79168760|FG003|Overall Study|Other (unspecified)|0|||
44265262|NCT02448810|79168761|FG004|Overall Study|Other (unspecified)|0|||
44265263|NCT02448810|79168762|FG005|Overall Study|Other (unspecified)|0|||
44265264|NCT02448810|79168763|FG006|Overall Study|Other (unspecified)|2|||
44265265|NCT02448810|79168764|FG007|Overall Study|Other (unspecified)|0|||
44265266|NCT02457546|79168837|FG000|Overall Study|Other reasons|4|||
44265267|NCT02457546|79168838|FG001|Overall Study|Other reasons|1|||
44265268|NCT02457546|79168837|FG000|Overall Study|Refused to complete study/procedures|1|||
44265269|NCT02457546|79168838|FG001|Overall Study|Refused to complete study/procedures|1|||
44265270|NCT02457546|79168837|FG000|Overall Study|Lost to Follow-up|4|||
44265271|NCT02457546|79168838|FG001|Overall Study|Lost to Follow-up|1|||
44265272|NCT02457546|79168837|FG000|Overall Study|Adverse Event|0|||
44265273|NCT02457546|79168838|FG001|Overall Study|Adverse Event|1|||
44265274|NCT02447952|79168859|FG000|Overall Study|Adverse Event|2|||
44182465|NCT02257489|78976972|FG003|Overall Study|Withdrawal by Subject|1|||
44182466|NCT02257489|78976973|FG004|Overall Study|Withdrawal by Subject|0|||
44182467|NCT02257489|78976974|FG005|Overall Study|Withdrawal by Subject|0|||
44182468|NCT02257489|78976975|FG006|Overall Study|Withdrawal by Subject|0|||
44182469|NCT02257489|78976976|FG007|Overall Study|Withdrawal by Subject|0|||
44182470|NCT02257489|78976977|FG008|Overall Study|Withdrawal by Subject|0|||
44182471|NCT02329223|78977000|FG000|Overall Study|Withdrawal by Subject|1|||
44182472|NCT02329223|78977001|FG001|Overall Study|Withdrawal by Subject|2|||
44265275|NCT02447952|79168859|FG000|Overall Study|Physician Decision|1|||
44265276|NCT02447952|79168859|FG000|Overall Study|Withdrawal by Subject|4|||
44265277|NCT02447718|79168893|FG000|Overall Study|Lost to Follow-up|8|||
44265278|NCT02447718|79168894|FG001|Overall Study|Lost to Follow-up|0|||
44265279|NCT02447718|79168893|FG000|Overall Study|Withdrawal by Subject|3|||
44265280|NCT02447718|79168894|FG001|Overall Study|Withdrawal by Subject|0|||
44265281|NCT02447718|79168893|FG000|Overall Study|Screen Failure|1|||
44265282|NCT02447718|79168894|FG001|Overall Study|Screen Failure|0|||
44265283|NCT02486406|79169071|FG000|Overall Study|Withdrew consent|1|||
44265284|NCT02486406|79169072|FG001|Overall Study|Withdrew consent|0|||
44265285|NCT02486406|79169073|FG002|Overall Study|Withdrew consent|0|||
44265286|NCT02486406|79169074|FG003|Overall Study|Withdrew consent|1|||
44265287|NCT02486406|79169071|FG000|Overall Study|Lost to Follow-up|1|||
44265288|NCT02486406|79169072|FG001|Overall Study|Lost to Follow-up|3|||
44265289|NCT02486406|79169073|FG002|Overall Study|Lost to Follow-up|1|||
44182473|NCT02329223|78977002|FG002|Overall Study|Withdrawal by Subject|5|||
44182474|NCT02329223|78977000|FG000|Overall Study|Physician Decision|0|||
44265290|NCT02486406|79169074|FG003|Overall Study|Lost to Follow-up|3|||
44265291|NCT02486406|79169071|FG000|Overall Study|Other, not specified|0|||
44265292|NCT02486406|79169072|FG001|Overall Study|Other, not specified|0|||
44265293|NCT02486406|79169073|FG002|Overall Study|Other, not specified|1|||
44265294|NCT02486406|79169074|FG003|Overall Study|Other, not specified|0|||
44265295|NCT02485704|79169146|FG000|Overall Study|Lost to Follow-up|4|||
44265296|NCT02485704|79169147|FG001|Overall Study|Lost to Follow-up|5|||
44265297|NCT02485704|79169146|FG000|Overall Study|Withdrawal by Subject|0|||
44265298|NCT02485704|79169147|FG001|Overall Study|Withdrawal by Subject|3|||
44265299|NCT02485704|79169146|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
44265300|NCT02485704|79169147|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
44265301|NCT02485158|79169157|FG000|Overall Study|Withdrawal by Subject|3|||
44265302|NCT02485158|79169157|FG000|Overall Study|expected drug side effect|1|||
44265303|NCT02455518|79169176|FG000|Overall Study|Protocol Violation|0|||
44265304|NCT02455518|79169177|FG001|Overall Study|Protocol Violation|1|||
44265305|NCT02455518|79169178|FG002|Overall Study|Protocol Violation|1|||
44265306|NCT02455518|79169179|FG003|Overall Study|Protocol Violation|3|||
44265307|NCT02240069|79169397|FG000|Overall Study|Withdrawal by Subject|5|||
44265308|NCT02240069|79169398|FG001|Overall Study|Withdrawal by Subject|5|||
44265309|NCT02240069|79169399|FG002|Overall Study|Withdrawal by Subject|2|||
44265310|NCT02484690|79169485|FG000|Overall Study|Adverse Event|1|||
44265311|NCT02484690|79169486|FG001|Overall Study|Adverse Event|3|||
44265312|NCT02484690|79169487|FG002|Overall Study|Adverse Event|0|||
44265313|NCT02484690|79169488|FG003|Overall Study|Adverse Event|0|||
44265314|NCT02484690|79169489|FG004|Overall Study|Adverse Event|5|||
44265315|NCT02484690|79169485|FG000|Overall Study|Death|0|||
44265316|NCT02484690|79169486|FG001|Overall Study|Death|0|||
44265317|NCT02484690|79169487|FG002|Overall Study|Death|0|||
44265318|NCT02484690|79169488|FG003|Overall Study|Death|0|||
44265319|NCT02484690|79169489|FG004|Overall Study|Death|1|||
44265320|NCT02484690|79169485|FG000|Overall Study|Withdrawal by Subject|1|||
44265321|NCT02484690|79169486|FG001|Overall Study|Withdrawal by Subject|3|||
44265322|NCT02484690|79169487|FG002|Overall Study|Withdrawal by Subject|1|||
44265323|NCT02484690|79169488|FG003|Overall Study|Withdrawal by Subject|2|||
44265324|NCT02484690|79169489|FG004|Overall Study|Withdrawal by Subject|0|||
44265325|NCT02484690|79169485|FG000|Overall Study|Physician Decision|2|||
44265326|NCT02484690|79169486|FG001|Overall Study|Physician Decision|0|||
44265327|NCT02484690|79169487|FG002|Overall Study|Physician Decision|1|||
44265328|NCT02484690|79169488|FG003|Overall Study|Physician Decision|0|||
44265329|NCT02484690|79169489|FG004|Overall Study|Physician Decision|0|||
44265330|NCT02484690|79169485|FG000|Overall Study|Lost to Follow-up|0|||
44265331|NCT02484690|79169486|FG001|Overall Study|Lost to Follow-up|0|||
44265332|NCT02484690|79169487|FG002|Overall Study|Lost to Follow-up|1|||
44265333|NCT02484690|79169488|FG003|Overall Study|Lost to Follow-up|0|||
44265334|NCT02484690|79169489|FG004|Overall Study|Lost to Follow-up|0|||
44265335|NCT01654224|79169513|FG000|Overall Study|Lost to Follow-up|2|||
44265336|NCT01654224|79169514|FG001|Overall Study|Lost to Follow-up|2|||
44265337|NCT01654224|79169513|FG000|Overall Study|Did not receive allocation|1|||
44265338|NCT01654224|79169514|FG001|Overall Study|Did not receive allocation|8|||
44265339|NCT01654224|79169513|FG000|Overall Study|Insufficient blood sample|3|||
44265340|NCT01654224|79169514|FG001|Overall Study|Insufficient blood sample|2|||
44265341|NCT02447328|79169520|FG000|Overall Study|Withdrawal by Subject|1|||
44265342|NCT02447250|79169524|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
44265343|NCT02447250|79169524|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
44265344|NCT02447250|79169524|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
44265345|NCT02447172|79169628|FG000|Overall Study|Adverse Event|11|||
44265346|NCT02447172|79169629|FG001|Overall Study|Adverse Event|8|||
44265347|NCT02447172|79169630|FG002|Overall Study|Adverse Event|7|||
44265348|NCT02447172|79169628|FG000|Overall Study|Death|3|||
44265349|NCT02447172|79169629|FG001|Overall Study|Death|1|||
44265350|NCT02447172|79169630|FG002|Overall Study|Death|0|||
44265351|NCT02447172|79169628|FG000|Overall Study|Protocol Violation|2|||
44265352|NCT02447172|79169629|FG001|Overall Study|Protocol Violation|1|||
44265353|NCT02447172|79169630|FG002|Overall Study|Protocol Violation|2|||
44451308|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
44451309|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
44451310|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
44451311|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
44451312|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
44265354|NCT02447172|79169628|FG000|Overall Study|Lost to Follow-up|7|||
44265355|NCT02447172|79169629|FG001|Overall Study|Lost to Follow-up|4|||
44265356|NCT02447172|79169630|FG002|Overall Study|Lost to Follow-up|4|||
44265357|NCT02447172|79169628|FG000|Overall Study|Withdrawal by Subject|5|||
44265358|NCT02447172|79169629|FG001|Overall Study|Withdrawal by Subject|1|||
44265359|NCT02447172|79169630|FG002|Overall Study|Withdrawal by Subject|3|||
44451313|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
44451314|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
44265360|NCT02447172|79169628|FG000|Overall Study|protocol specific treatment unrelated|3|||
44265361|NCT02447172|79169629|FG001|Overall Study|protocol specific treatment unrelated|0|||
44265362|NCT02447172|79169630|FG002|Overall Study|protocol specific treatment unrelated|2|||
44265363|NCT02455050|79169663|FG000|Treatment Period 1|Lost to Follow-up|1|||
44265364|NCT02455050|79169664|FG001|Treatment Period 1|Lost to Follow-up|1|||
44265365|NCT02455050|79169665|FG002|Treatment Period 1|Lost to Follow-up|1|||
44265366|NCT02455050|79169666|FG003|Treatment Period 1|Lost to Follow-up|2|||
44265367|NCT02455050|79169663|FG000|Treatment Period 2|Lost to Follow-up|1|||
44265368|NCT02455050|79169664|FG001|Treatment Period 2|Lost to Follow-up|0|||
44265369|NCT02455050|79169665|FG002|Treatment Period 2|Lost to Follow-up|2|||
44265370|NCT02455050|79169666|FG003|Treatment Period 2|Lost to Follow-up|1|||
44265371|NCT02418468|79169706|FG000|Overall Study|Adverse Event|1|||
44265372|NCT02418468|79169707|FG001|Overall Study|Adverse Event|0|||
44265373|NCT02418468|79169706|FG000|Overall Study|Withdrawal of informed consent|1|||
44265374|NCT02418468|79169707|FG001|Overall Study|Withdrawal of informed consent|1|||
44265375|NCT02418000|79169838|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
44265376|NCT02418000|79169839|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265377|NCT02418000|79169840|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265378|NCT02418000|79169841|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265379|NCT02418000|79169842|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265380|NCT02418000|79169838|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
44265381|NCT02418000|79169839|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
44265382|NCT02418000|79169840|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
44265383|NCT02418000|79169841|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
44265384|NCT02418000|79169842|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
44265385|NCT02418000|79169838|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
44265386|NCT02418000|79169839|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
44265387|NCT02418000|79169840|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
44265388|NCT02418000|79169841|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
44265389|NCT02418000|79169842|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
44265390|NCT02418000|79169838|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265391|NCT02418000|79169839|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
44265392|NCT02418000|79169840|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265393|NCT02418000|79169841|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265394|NCT02418000|79169842|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
44265395|NCT02418000|79169838|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
44265396|NCT02418000|79169839|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
44543033|NCT03655717|79555910|FG010|Overall Study|Lost to Follow-up|0|||
44182475|NCT02329223|78977001|FG001|Overall Study|Physician Decision|0|||
44182476|NCT02329223|78977002|FG002|Overall Study|Physician Decision|1|||
44182477|NCT02329223|78977000|FG000|Overall Study|Adverse Event|0|||
44182478|NCT02329223|78977001|FG001|Overall Study|Adverse Event|1|||
44182479|NCT02329223|78977002|FG002|Overall Study|Adverse Event|0|||
44182480|NCT01641601|78977012|FG000|Overall Study|Study discontinued.|3|||
44182481|NCT01641601|78977013|FG001|Overall Study|Study discontinued.|5|||
44182482|NCT02350127|78977021|FG000|4-Month Assessment|Withdrawal by Subject|10|||
44182483|NCT02350127|78977022|FG001|4-Month Assessment|Withdrawal by Subject|9|||
44182484|NCT02350127|78977021|FG000|4-Month Assessment|Death|1|||
44182485|NCT02350127|78977022|FG001|4-Month Assessment|Death|0|||
44182486|NCT02350127|78977021|FG000|8-Month Assessment|Death|1|||
44182487|NCT02350127|78977022|FG001|8-Month Assessment|Death|1|||
44182488|NCT02350127|78977021|FG000|8-Month Assessment|Withdrawal by Subject|5|||
44182489|NCT02350127|78977022|FG001|8-Month Assessment|Withdrawal by Subject|8|||
44182490|NCT02256553|78977029|FG000|Period I|Adverse Event|5|||
44182491|NCT02256553|78977029|FG000|Period I|Protocol Violation|1|||
44182492|NCT02256553|78977029|FG000|Period II|Adverse Event|1|||
44182493|NCT02256553|78977029|FG000|Period II|Subject Moved|1|||
44182494|NCT02256553|78977029|FG000|Period III|Adverse Event|3|||
44182495|NCT02349425|78977039|FG000|Period 1|Adverse Event|1|||
44182496|NCT02349425|78977040|FG001|Period 1|Adverse Event|1|||
44182497|NCT02349425|78977041|FG002|Period 1|Adverse Event|0|||
44182498|NCT02349425|78977042|FG003|Period 1|Adverse Event|0|||
44182499|NCT02349425|78977039|FG000|Period 2|Adverse Event|0|||
44182500|NCT02349425|78977040|FG001|Period 2|Adverse Event|1|||
44182501|NCT02349425|78977041|FG002|Period 2|Adverse Event|1|||
44182502|NCT02349425|78977042|FG003|Period 2|Adverse Event|0|||
44182503|NCT02310581|78977084|FG000|Overall Study|Adverse Event|1|||
44182504|NCT02310581|78977085|FG001|Overall Study|Adverse Event|1|||
44182505|NCT02310581|78977086|FG002|Overall Study|Adverse Event|1|||
44182506|NCT02310581|78977087|FG003|Overall Study|Adverse Event|0|||
44182507|NCT02310581|78977084|FG000|Overall Study|Withdrawal by Subject|2|||
44182508|NCT02310581|78977085|FG001|Overall Study|Withdrawal by Subject|1|||
44182509|NCT02310581|78977086|FG002|Overall Study|Withdrawal by Subject|0|||
44182510|NCT02310581|78977087|FG003|Overall Study|Withdrawal by Subject|1|||
44182511|NCT02309723|78977100|FG000|Overall Study|Withdrawal by Subject|24|||
44182512|NCT02309723|78977101|FG001|Overall Study|Withdrawal by Subject|23|||
44265397|NCT02418000|79169840|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
44265398|NCT02418000|79169841|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
44265399|NCT02418000|79169842|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
44265400|NCT02418000|79169838|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265401|NCT02418000|79169839|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265402|NCT02418000|79169840|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
44265403|NCT02418000|79169841|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265404|NCT02418000|79169842|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265405|NCT02418000|79169838|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265406|NCT02418000|79169839|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265407|NCT02418000|79169840|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265408|NCT02418000|79169841|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
44265409|NCT02418000|79169842|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265410|NCT02418000|79169838|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
44265411|NCT02418000|79169839|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
44265412|NCT02418000|79169840|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
44265413|NCT02418000|79169841|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
44265414|NCT02418000|79169842|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
44265415|NCT02418000|79169838|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265416|NCT02418000|79169839|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265417|NCT02418000|79169840|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265418|NCT02418000|79169841|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
44265419|NCT02418000|79169842|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
44265420|NCT02417064|79169946|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
44265421|NCT02417064|79169947|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
44265422|NCT02417064|79169948|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
44265423|NCT02417064|79169946|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
44265424|NCT02417064|79169947|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
44265425|NCT02417064|79169948|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
44265426|NCT02417064|79169946|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
44265427|NCT02417064|79169947|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
44265428|NCT02417064|79169948|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
44265429|NCT02417064|79169946|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
44265430|NCT02417064|79169947|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
44265431|NCT02417064|79169948|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
44182513|NCT02309723|78977102|FG002|Overall Study|Withdrawal by Subject|24|||
44182514|NCT02309411|78977113|FG000|Overall Study|Physician Decision|1|||
44182515|NCT02309411|78977114|FG001|Overall Study|Physician Decision|0|||
44182516|NCT02309411|78977115|FG002|Overall Study|Physician Decision|0|||
44182517|NCT02309411|78977113|FG000|Overall Study|Withdrawal by Subject|1|||
44182518|NCT02309411|78977114|FG001|Overall Study|Withdrawal by Subject|1|||
44182519|NCT02309411|78977115|FG002|Overall Study|Withdrawal by Subject|0|||
44182520|NCT02008227|78977124|FG000|Overall Study|Lost to Follow-up|7|||
44182521|NCT02008227|78977125|FG001|Overall Study|Lost to Follow-up|9|||
44182522|NCT02008227|78977124|FG000|Overall Study|Death|494|||
44182523|NCT02008227|78977125|FG001|Overall Study|Death|485|||
44182524|NCT02008227|78977124|FG000|Overall Study|Withdrawal by Subject|67|||
44182525|NCT02008227|78977125|FG001|Overall Study|Withdrawal by Subject|36|||
44182526|NCT02008227|78977124|FG000|Overall Study|Study Terminated By Sponsor|44|||
44182527|NCT02008227|78977125|FG001|Overall Study|Study Terminated By Sponsor|83|||
44182528|NCT02006979|78977134|FG000|Overall Study|Withdrawal by Subject|1|||
44182529|NCT02006979|78977135|FG001|Overall Study|Withdrawal by Subject|1|||
44182530|NCT02006979|78977134|FG000|Overall Study|Protocol Violation|0|||
44182531|NCT02006979|78977135|FG001|Overall Study|Protocol Violation|1|||
44182532|NCT02348723|78977143|FG000|Overall Study|No ablation|21|||
44182533|NCT02348723|78977144|FG001|Overall Study|No ablation|20|||
44182534|NCT02348723|78977143|FG000|Overall Study|Non-compliant with Protocol|1|||
44182535|NCT02348723|78977144|FG001|Overall Study|Non-compliant with Protocol|0|||
44182536|NCT02348723|78977143|FG000|Overall Study|Lost to Follow-up|1|||
44182537|NCT02348723|78977144|FG001|Overall Study|Lost to Follow-up|1|||
44182538|NCT02348723|78977143|FG000|Overall Study|Consent withdrawn|1|||
44182539|NCT02348723|78977144|FG001|Overall Study|Consent withdrawn|3|||
44182540|NCT02348723|78977143|FG000|Overall Study|Reason other than specified|1|||
44182541|NCT02348723|78977144|FG001|Overall Study|Reason other than specified|1|||
44182542|NCT02348723|78977143|FG000|Overall Study|Adverse Event|3|||
44182543|NCT02348723|78977144|FG001|Overall Study|Adverse Event|1|||
44182544|NCT01967277|78977152|FG000|Overall Study|Lost to Follow-up|1|||
44182545|NCT01967277|78977153|FG001|Overall Study|Lost to Follow-up|2|||
44182546|NCT01967277|78977152|FG000|Overall Study|Unrelated illness|0|||
44182547|NCT01967277|78977153|FG001|Overall Study|Unrelated illness|1|||
44182548|NCT02326883|78977162|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
44265432|NCT02417064|79169946|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
44265433|NCT02417064|79169947|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
44182549|NCT02326883|78977163|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
44182550|NCT02326883|78977164|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
44182551|NCT02006667|78977172|FG000|Overall Study|Adverse Event|3|||
44182552|NCT02006667|78977172|FG000|Overall Study|Death|2|||
44182553|NCT02006667|78977172|FG000|Overall Study|Withdrawal by Subject|1|||
44182554|NCT01983111|78977178|FG000|Overall Study|Withdrawal by Subject|8|||
44182555|NCT01983111|78977179|FG001|Overall Study|Withdrawal by Subject|6|||
44182556|NCT01983111|78977178|FG000|Overall Study|Adverse Event|4|||
44182557|NCT01983111|78977179|FG001|Overall Study|Adverse Event|0|||
44182558|NCT01983111|78977178|FG000|Overall Study|Protocol Violation|0|||
44182559|NCT01983111|78977179|FG001|Overall Study|Protocol Violation|1|||
44182560|NCT02348489|78977187|FG000|Overall Study|Death|336|||
44182561|NCT02348489|78977188|FG001|Overall Study|Death|335|||
44182562|NCT02348489|78977187|FG000|Overall Study|Withdrawal by Subject|14|||
44182563|NCT02348489|78977188|FG001|Overall Study|Withdrawal by Subject|27|||
44182564|NCT02348489|78977187|FG000|Overall Study|Lost to Follow-up|3|||
44182565|NCT02348489|78977188|FG001|Overall Study|Lost to Follow-up|5|||
44182566|NCT02309099|78977198|FG000|Overall Study|Adverse Event|2|||
44182567|NCT02309099|78977199|FG001|Overall Study|Adverse Event|0|||
44182568|NCT01966107|78977207|FG000|Overall Study|excluded from FAS|21|||
44182569|NCT01966107|78977208|FG001|Overall Study|excluded from FAS|20|||
44182570|NCT01966107|78977207|FG000|Overall Study|discontinued treatment|345|||
44182571|NCT01966107|78977208|FG001|Overall Study|discontinued treatment|372|||
44182572|NCT01966107|78977207|FG000|Overall Study|due to study closure|164|||
44182573|NCT01966107|78977208|FG001|Overall Study|due to study closure|186|||
44182574|NCT01966107|78977207|FG000|Overall Study|withdrew from the study|272|||
44182575|NCT01966107|78977208|FG001|Overall Study|withdrew from the study|303|||
44182576|NCT02347943|78977217|FG000|Overall Study|Study was cancelled|140|||
44182577|NCT02347943|78977218|FG001|Overall Study|Study was cancelled|67|||
44182578|NCT02347943|78977219|FG002|Overall Study|Study was cancelled|45|||
44182579|NCT01982331|78977229|FG000|Received Vaccination 2|Adverse Event|1|||
44182580|NCT01982331|78977230|FG001|Received Vaccination 2|Adverse Event|2|||
44182581|NCT01982331|78977229|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
44182582|NCT01982331|78977230|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
44182583|NCT01982331|78977229|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
44182584|NCT01982331|78977230|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
44182585|NCT02326025|78977238|FG000|Overall Study|Adverse Event|3|||
44182586|NCT02326025|78977239|FG001|Overall Study|Adverse Event|0|||
44182587|NCT02326025|78977238|FG000|Overall Study|Physician Decision|1|||
44182588|NCT02326025|78977239|FG001|Overall Study|Physician Decision|2|||
44182589|NCT02326025|78977238|FG000|Overall Study|Physician and Participant Decision|1|||
44182590|NCT02326025|78977239|FG001|Overall Study|Physician and Participant Decision|0|||
44182591|NCT02326025|78977238|FG000|Overall Study|Withdrawal by Subject|0|||
44182592|NCT02326025|78977239|FG001|Overall Study|Withdrawal by Subject|2|||
44182593|NCT02326025|78977238|FG000|Overall Study|Protocol Violation|0|||
44182594|NCT02326025|78977239|FG001|Overall Study|Protocol Violation|1|||
44182595|NCT01619865|78977258|FG000|Overall Study|Adverse Event|1|||
44182596|NCT01619865|78977258|FG000|Overall Study|Death|2|||
44182597|NCT01619865|78977258|FG000|Overall Study|subject not able to comply|1|||
44182598|NCT02006121|78977265|FG000|Double Blind Phase|Adverse Event|6|||
44182599|NCT02006121|78977266|FG001|Double Blind Phase|Adverse Event|0|||
44182600|NCT02006121|78977265|FG000|Double Blind Phase|Lack of Efficacy|1|||
44182601|NCT02006121|78977266|FG001|Double Blind Phase|Lack of Efficacy|16|||
44182602|NCT02006121|78977265|FG000|Double Blind Phase|Withdrawal by Subject|3|||
44182603|NCT02006121|78977266|FG001|Double Blind Phase|Withdrawal by Subject|4|||
44265434|NCT02417064|79169948|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
44451315|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
44451316|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Death|1|||
44451317|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Death|2|||
44451318|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Death|2|||
44451319|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Death|0|||
44451320|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Death|0|||
44182604|NCT02006121|78977265|FG000|Double Blind Phase|Non-compliance with study drug|1|||
44182605|NCT02006121|78977266|FG001|Double Blind Phase|Non-compliance with study drug|3|||
44265435|NCT02417064|79169946|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
44451321|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
44182606|NCT02006121|78977265|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
44182607|NCT02006121|78977266|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
44182608|NCT02006121|78977265|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
44182609|NCT02006121|78977266|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
44451322|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
44182610|NCT02006121|78977265|FG000|Open Label Phase|Adverse Event|15|||
44182611|NCT02006121|78977266|FG001|Open Label Phase|Adverse Event|0|||
44182612|NCT02006121|78977265|FG000|Open Label Phase|Lack of Efficacy|2|||
44182613|NCT02006121|78977266|FG001|Open Label Phase|Lack of Efficacy|0|||
44182614|NCT02006121|78977265|FG000|Open Label Phase|Protocol Violation|2|||
44182615|NCT02006121|78977266|FG001|Open Label Phase|Protocol Violation|0|||
44182616|NCT02006121|78977265|FG000|Open Label Phase|Withdrawal by Subject|3|||
44182617|NCT02006121|78977266|FG001|Open Label Phase|Withdrawal by Subject|0|||
44182618|NCT02006121|78977265|FG000|Open Label Phase|Non-compliance with study drug|3|||
44182619|NCT02006121|78977266|FG001|Open Label Phase|Non-compliance with study drug|0|||
44182620|NCT02005887|78977278|FG000|Overall Study|Protocol Violation|0|||
44182621|NCT02005887|78977279|FG001|Overall Study|Protocol Violation|2|||
44182622|NCT01982253|78977288|FG000|Overall Study|Withdrawal by Subject|1|||
44182623|NCT01982253|78977289|FG001|Overall Study|Withdrawal by Subject|0|||
44182624|NCT01982253|78977290|FG002|Overall Study|Withdrawal by Subject|0|||
44182625|NCT01982253|78977288|FG000|Overall Study|Study terminated by sponsor|1|||
44182626|NCT01982253|78977289|FG001|Overall Study|Study terminated by sponsor|4|||
44182627|NCT01982253|78977290|FG002|Overall Study|Study terminated by sponsor|4|||
44182628|NCT01619787|78977300|FG000|Overall Study|Lost to Follow-up|5|||
44182629|NCT01981473|78977309|FG000|Overall Study|Incorrect diagnosis of RA|0|||
44182630|NCT01981473|78977310|FG001|Overall Study|Incorrect diagnosis of RA|0|||
44182631|NCT01981473|78977311|FG002|Overall Study|Incorrect diagnosis of RA|1|||
44182632|NCT01981473|78977309|FG000|Overall Study|Received treatment for < 6 months|0|||
44182633|NCT01981473|78977310|FG001|Overall Study|Received treatment for < 6 months|0|||
44182634|NCT01981473|78977311|FG002|Overall Study|Received treatment for < 6 months|1|||
44182635|NCT01981473|78977309|FG000|Overall Study|Received treatment for >24 months|2|||
44182636|NCT01981473|78977310|FG001|Overall Study|Received treatment for >24 months|0|||
44182637|NCT01981473|78977311|FG002|Overall Study|Received treatment for >24 months|6|||
44182638|NCT02005029|78977324|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
44182639|NCT02005029|78977325|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
44182640|NCT02325791|78977353|FG000|Overall Study|Adverse Event|0|||
44182641|NCT02325791|78977354|FG001|Overall Study|Adverse Event|1|||
44182642|NCT02325791|78977355|FG002|Overall Study|Adverse Event|1|||
44182643|NCT02325791|78977356|FG003|Overall Study|Adverse Event|0|||
44182644|NCT02325791|78977353|FG000|Overall Study|Death|0|||
44182645|NCT02325791|78977354|FG001|Overall Study|Death|3|||
44182646|NCT02325791|78977355|FG002|Overall Study|Death|0|||
44182647|NCT02325791|78977356|FG003|Overall Study|Death|1|||
44182648|NCT02325791|78977353|FG000|Overall Study|Lost to Follow-up|0|||
44182649|NCT02325791|78977354|FG001|Overall Study|Lost to Follow-up|15|||
44182650|NCT02325791|78977355|FG002|Overall Study|Lost to Follow-up|14|||
44182651|NCT02325791|78977356|FG003|Overall Study|Lost to Follow-up|9|||
44182652|NCT02325791|78977353|FG000|Overall Study|Physician Decision|0|||
44182653|NCT02325791|78977354|FG001|Overall Study|Physician Decision|1|||
44182654|NCT02325791|78977355|FG002|Overall Study|Physician Decision|1|||
44182655|NCT02325791|78977356|FG003|Overall Study|Physician Decision|0|||
44182656|NCT02325791|78977353|FG000|Overall Study|Protocol Violation|0|||
44182657|NCT02325791|78977354|FG001|Overall Study|Protocol Violation|0|||
44182658|NCT02325791|78977355|FG002|Overall Study|Protocol Violation|1|||
44182659|NCT02325791|78977356|FG003|Overall Study|Protocol Violation|0|||
44182660|NCT02325791|78977353|FG000|Overall Study|Withdrawal by Subject|0|||
44182661|NCT02325791|78977354|FG001|Overall Study|Withdrawal by Subject|5|||
44182662|NCT02325791|78977355|FG002|Overall Study|Withdrawal by Subject|8|||
44182663|NCT02325791|78977356|FG003|Overall Study|Withdrawal by Subject|16|||
44182664|NCT02004873|78977369|FG000|Overall Study|Implant unsuccessful|6|||
44182665|NCT02004873|78977369|FG000|Overall Study|Awaiting 6-month visit|390|||
44182666|NCT02004873|78977369|FG000|Overall Study|Missed 6-month visit|4|||
44182667|NCT02004873|78977369|FG000|Overall Study|Death|23|||
44182668|NCT02004873|78977369|FG000|Overall Study|Withdrawal by Subject|1|||
44182669|NCT02347787|78977378|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
44182670|NCT02347787|78977379|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
44182671|NCT02347787|78977378|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
44182672|NCT02347787|78977379|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
44182673|NCT02347787|78977378|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
44182674|NCT02347787|78977379|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
44182675|NCT02347787|78977378|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
44182676|NCT02347787|78977379|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
44182677|NCT01979835|78977390|FG000|Primary Outcome SA Measurment|failed insertion|18|||
44182678|NCT01979835|78977390|FG000|Follow-up|Lost to Follow-up|32|||
44182679|NCT02282345|78977396|FG000|Overall Study|Progression|0|||
44182680|NCT02282345|78977397|FG001|Overall Study|Progression|1|||
44182681|NCT01732822|78977408|FG000|Overall Study|Withdrawal by Subject|123|||
44182682|NCT01732822|78977409|FG001|Overall Study|Withdrawal by Subject|113|||
44182683|NCT02004093|78977439|FG000|Overall Study|Death|2|||
44182684|NCT02004093|78977440|FG001|Overall Study|Death|1|||
44182685|NCT02004093|78977439|FG000|Overall Study|Lack of Efficacy|66|||
44182686|NCT02004093|78977440|FG001|Overall Study|Lack of Efficacy|62|||
44182687|NCT02004093|78977439|FG000|Overall Study|Protocol Violation|0|||
44182688|NCT02004093|78977440|FG001|Overall Study|Protocol Violation|1|||
44182689|NCT02004093|78977439|FG000|Overall Study|Lost to Follow-up|0|||
44182690|NCT02004093|78977440|FG001|Overall Study|Lost to Follow-up|1|||
44182691|NCT02004093|78977439|FG000|Overall Study|Withdrawal by Subject|3|||
44182692|NCT02004093|78977440|FG001|Overall Study|Withdrawal by Subject|7|||
44182693|NCT02004093|78977439|FG000|Overall Study|Other|3|||
44182694|NCT02004093|78977440|FG001|Overall Study|Other|1|||
44182695|NCT01641367|78977455|FG000|Cohorts|Death|18|||
44182696|NCT01641367|78977456|FG001|Cohorts|Death|1|||
44182697|NCT01641367|78977457|FG002|Cohorts|Death|2|||
44182698|NCT01641367|78977458|FG003|Cohorts|Death|0|||
44182699|NCT01641367|78977459|FG004|Cohorts|Death|1|||
44182700|NCT01641367|78977460|FG005|Cohorts|Death|1|||
44182701|NCT01641367|78977461|FG006|Cohorts|Death|0|||
44182702|NCT01641367|78977462|FG007|Cohorts|Death|0|||
44182703|NCT01641367|78977455|FG000|Cohorts|Lost to Follow-up|16|||
44182704|NCT01641367|78977456|FG001|Cohorts|Lost to Follow-up|0|||
44182705|NCT01641367|78977457|FG002|Cohorts|Lost to Follow-up|2|||
44182706|NCT01641367|78977458|FG003|Cohorts|Lost to Follow-up|0|||
44182707|NCT01641367|78977459|FG004|Cohorts|Lost to Follow-up|2|||
44182708|NCT01641367|78977460|FG005|Cohorts|Lost to Follow-up|0|||
44182709|NCT01641367|78977461|FG006|Cohorts|Lost to Follow-up|0|||
44182710|NCT01641367|78977462|FG007|Cohorts|Lost to Follow-up|0|||
44182711|NCT01641367|78977455|FG000|Randomized Adherence Intervention|Death|0|||
44182712|NCT01641367|78977456|FG001|Randomized Adherence Intervention|Death|0|||
44182713|NCT01641367|78977457|FG002|Randomized Adherence Intervention|Death|0|||
44182714|NCT01641367|78977458|FG003|Randomized Adherence Intervention|Death|0|||
44182715|NCT01641367|78977459|FG004|Randomized Adherence Intervention|Death|0|||
44182716|NCT01641367|78977460|FG005|Randomized Adherence Intervention|Death|0|||
44182717|NCT01641367|78977461|FG006|Randomized Adherence Intervention|Death|11|||
44182718|NCT01641367|78977462|FG007|Randomized Adherence Intervention|Death|12|||
44182719|NCT01641367|78977455|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
44182720|NCT01641367|78977456|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
44182721|NCT01641367|78977457|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
44182722|NCT01641367|78977458|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
44182723|NCT01641367|78977459|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
44182724|NCT01641367|78977460|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
44182725|NCT01641367|78977461|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
44182726|NCT01641367|78977462|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
44182727|NCT02325713|78977501|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182728|NCT02325713|78977502|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182729|NCT02325713|78977503|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182730|NCT02325713|78977504|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182731|NCT02325713|78977505|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182732|NCT02325713|78977506|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182733|NCT02325713|78977507|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182734|NCT02325713|78977508|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182735|NCT02325713|78977509|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182736|NCT02325713|78977510|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182737|NCT02325713|78977511|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
44182738|NCT02325713|78977512|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182739|NCT02325713|78977513|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182740|NCT02325713|78977514|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182741|NCT02325713|78977515|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182742|NCT02325713|78977516|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
44182743|NCT02325713|78977501|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
44182744|NCT02325713|78977502|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182745|NCT02325713|78977503|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182746|NCT02325713|78977504|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182747|NCT02325713|78977505|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182748|NCT02325713|78977506|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182749|NCT02325713|78977507|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182750|NCT02325713|78977508|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182751|NCT02325713|78977509|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182752|NCT02325713|78977510|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182753|NCT02325713|78977511|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182754|NCT02325713|78977512|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182755|NCT02325713|78977513|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182756|NCT02325713|78977514|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182757|NCT02325713|78977515|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182758|NCT02325713|78977516|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
44182759|NCT02325713|78977501|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182760|NCT02325713|78977502|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182761|NCT02325713|78977503|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182762|NCT02325713|78977504|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182763|NCT02325713|78977505|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182764|NCT02325713|78977506|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182765|NCT02325713|78977507|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182766|NCT02325713|78977508|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182767|NCT02325713|78977509|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182768|NCT02325713|78977510|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
44182769|NCT02325713|78977511|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182770|NCT02325713|78977512|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182771|NCT02325713|78977513|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182772|NCT02325713|78977514|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182773|NCT02325713|78977515|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182774|NCT02325713|78977516|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
44182775|NCT02325401|78977531|FG000|Overall Study|Withdrawal by Subject|0|||
44182776|NCT02325401|78977532|FG001|Overall Study|Withdrawal by Subject|1|||
44182777|NCT02325401|78977533|FG002|Overall Study|Withdrawal by Subject|1|||
44182778|NCT02324699|78977547|FG000|Overall Study|study terminated|1|||
44182779|NCT01764256|78977555|FG000|Received All Vaccinations|Adverse Event|1|||
44182780|NCT01764256|78977556|FG001|Received All Vaccinations|Adverse Event|1|||
44182781|NCT01764256|78977557|FG002|Received All Vaccinations|Adverse Event|0|||
44182782|NCT01764256|78977558|FG003|Received All Vaccinations|Adverse Event|0|||
44182783|NCT01764256|78977555|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
44182784|NCT01764256|78977556|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
44182785|NCT01764256|78977557|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
44182786|NCT01764256|78977558|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
44182787|NCT01764256|78977555|FG000|Received All Vaccinations|Lost to Follow-up|1|||
44182788|NCT01764256|78977556|FG001|Received All Vaccinations|Lost to Follow-up|0|||
44182789|NCT01764256|78977557|FG002|Received All Vaccinations|Lost to Follow-up|0|||
44182790|NCT01764256|78977558|FG003|Received All Vaccinations|Lost to Follow-up|0|||
44182791|NCT01764256|78977555|FG000|Completed Study|Lost to Follow-up|0|||
44182792|NCT01764256|78977556|FG001|Completed Study|Lost to Follow-up|0|||
44182793|NCT01764256|78977557|FG002|Completed Study|Lost to Follow-up|0|||
44182794|NCT01764256|78977558|FG003|Completed Study|Lost to Follow-up|1|||
44182795|NCT01979523|78977574|FG000|Overall Study|Withdrawal by Subject|1|||
44182796|NCT01979523|78977575|FG001|Overall Study|Withdrawal by Subject|0|||
44182797|NCT02255461|78977587|FG000|Overall Study|Adverse Event|0|||
44182798|NCT02255461|78977588|FG001|Overall Study|Adverse Event|1|||
44182799|NCT02255461|78977589|FG002|Overall Study|Adverse Event|0|||
44182800|NCT02255461|78977590|FG003|Overall Study|Adverse Event|0|||
44182801|NCT02255461|78977591|FG004|Overall Study|Adverse Event|1|||
44182802|NCT02255461|78977587|FG000|Overall Study|Withdrawal by Subject|0|||
44182803|NCT02255461|78977588|FG001|Overall Study|Withdrawal by Subject|0|||
44182804|NCT02255461|78977589|FG002|Overall Study|Withdrawal by Subject|1|||
44182805|NCT02255461|78977590|FG003|Overall Study|Withdrawal by Subject|0|||
44182806|NCT02255461|78977591|FG004|Overall Study|Withdrawal by Subject|1|||
44182807|NCT02255461|78977587|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
44182808|NCT02255461|78977588|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
44182809|NCT02255461|78977589|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
44182810|NCT02255461|78977590|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
44182811|NCT02255461|78977591|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
44182812|NCT01764022|78977610|FG000|Overall Study|Death|3|||
44182813|NCT01764022|78977611|FG001|Overall Study|Death|5|||
44182814|NCT01764022|78977610|FG000|Overall Study|Withdrawal by Subject|2|||
44182815|NCT01764022|78977611|FG001|Overall Study|Withdrawal by Subject|6|||
44182816|NCT01764022|78977610|FG000|Overall Study|Lack of Efficacy|0|||
44182817|NCT01764022|78977611|FG001|Overall Study|Lack of Efficacy|1|||
44182818|NCT01764022|78977610|FG000|Overall Study|Physician Decision|0|||
44182819|NCT01764022|78977611|FG001|Overall Study|Physician Decision|2|||
44182820|NCT01764022|78977610|FG000|Overall Study|Lost to Follow-up|2|||
44182821|NCT01764022|78977611|FG001|Overall Study|Lost to Follow-up|0|||
44182822|NCT01764022|78977610|FG000|Overall Study|Protocol Violation|1|||
44182823|NCT01764022|78977611|FG001|Overall Study|Protocol Violation|0|||
44182824|NCT02003391|78977621|FG000|Overall Study|Withdrawal by Subject|2|||
44182825|NCT02003391|78977622|FG001|Overall Study|Withdrawal by Subject|1|||
44182826|NCT02003391|78977621|FG000|Overall Study|Protocol Violation|0|||
44182827|NCT02003391|78977622|FG001|Overall Study|Protocol Violation|1|||
44182828|NCT02003391|78977621|FG000|Overall Study|Adverse Event|1|||
44182829|NCT02003391|78977622|FG001|Overall Study|Adverse Event|0|||
44182830|NCT02254681|78977628|FG000|Overall Study|Lack of Efficacy|6|||
44182831|NCT01965327|78977633|FG000|Overall Study|Physician Decision|2|||
44182832|NCT02002689|78977637|FG000|Overall Study|Disease Progression|7|||
44182833|NCT02002689|78977637|FG000|Overall Study|Adverse Event|3|||
44182834|NCT01639729|78977641|FG000|Overall Study|Withdrawal by Subject|1|||
44182835|NCT01639729|78977642|FG001|Overall Study|Withdrawal by Subject|0|||
44182836|NCT01639729|78977643|FG002|Overall Study|Withdrawal by Subject|1|||
44182837|NCT01639729|78977644|FG003|Overall Study|Withdrawal by Subject|1|||
44182838|NCT01639729|78977645|FG004|Overall Study|Withdrawal by Subject|0|||
44182839|NCT01639729|78977646|FG005|Overall Study|Withdrawal by Subject|0|||
44182840|NCT02002533|78977658|FG000|Overall Study|Withdrawal by Subject|6|||
44182841|NCT02002533|78977659|FG001|Overall Study|Withdrawal by Subject|13|||
44182842|NCT02002533|78977658|FG000|Overall Study|Protocol Violation|0|||
44182843|NCT02002533|78977659|FG001|Overall Study|Protocol Violation|1|||
44182844|NCT02002533|78977658|FG000|Overall Study|Adverse Event|0|||
44182845|NCT02002533|78977659|FG001|Overall Study|Adverse Event|3|||
44182846|NCT02002533|78977658|FG000|Overall Study|Lost to Follow-up|0|||
44182847|NCT02002533|78977659|FG001|Overall Study|Lost to Follow-up|1|||
44182848|NCT02002221|78977668|FG000|Overall Study|Adverse Event|2|||
44182849|NCT02002221|78977669|FG001|Overall Study|Adverse Event|1|||
44182850|NCT02002221|78977668|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44182851|NCT02002221|78977669|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44182852|NCT02002221|78977668|FG000|Overall Study|Patient withdrew consent|0|||
44182853|NCT02002221|78977669|FG001|Overall Study|Patient withdrew consent|1|||
44182854|NCT01639495|78977675|FG000|Overall Study|Lost to Follow-up|6|||
44182855|NCT01639495|78977675|FG000|Overall Study|Consented but didn't have study catheter|4|||
44182856|NCT01639495|78977675|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
44182857|NCT01639495|78977675|FG000|Overall Study|No radiofrequency energy applied|2|||
44182858|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
44182859|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Death|1|||
44182860|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
44182861|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
44182862|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
44182863|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
44182864|NCT02001987|78977679|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
44182865|NCT02001987|78977679|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
44182866|NCT02001987|78977679|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
44182867|NCT02001987|78977679|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
44182868|NCT02001987|78977679|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
44182869|NCT02001987|78977679|FG000|LTE Period (52 Weeks)|Other|3|||
44182870|NCT01363765|78977690|FG000|Overall Study|non-diagnostic|2621|||
44182871|NCT01363765|78977691|FG001|Overall Study|non-diagnostic|1124|||
44182872|NCT01363765|78977690|FG000|Overall Study|duplicate records|736|||
44182873|NCT01363765|78977691|FG001|Overall Study|duplicate records|3177|||
44182874|NCT01363765|78977690|FG000|Overall Study|non-resident|156|||
44182875|NCT01363765|78977691|FG001|Overall Study|non-resident|76|||
44182876|NCT01363765|78977690|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
44182877|NCT01363765|78977691|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
44182878|NCT01363765|78977690|FG000|Overall Study|smear during intervention|2170|||
44182879|NCT01363765|78977691|FG001|Overall Study|smear during intervention|0|||
44182880|NCT02001051|78977701|FG000|Overall Study|Deemed not eligible following enrollment|0|||
44182881|NCT02001051|78977702|FG001|Overall Study|Deemed not eligible following enrollment|1|||
44182882|NCT01763164|78977710|FG000|Treatment Phase|Participant/Guardian decision|26|||
44182883|NCT01763164|78977711|FG001|Treatment Phase|Participant/Guardian decision|14|||
44182884|NCT01763164|78977710|FG000|Treatment Phase|Protocol Violation|1|||
44182885|NCT01763164|78977711|FG001|Treatment Phase|Protocol Violation|1|||
44182886|NCT01763164|78977710|FG000|Treatment Phase|Progressive Disease|142|||
44182887|NCT01763164|78977711|FG001|Treatment Phase|Progressive Disease|76|||
44182888|NCT01763164|78977710|FG000|Treatment Phase|Physician Decision|24|||
44182889|NCT01763164|78977711|FG001|Treatment Phase|Physician Decision|13|||
44182890|NCT01763164|78977710|FG000|Treatment Phase|Death|10|||
44182891|NCT01763164|78977711|FG001|Treatment Phase|Death|1|||
44182892|NCT01763164|78977710|FG000|Treatment Phase|Adverse Event|66|||
44182893|NCT01763164|78977711|FG001|Treatment Phase|Adverse Event|8|||
44182894|NCT01763164|78977710|FG000|Treatment Phase|Randomized but not Treated|0|||
44182895|NCT01763164|78977711|FG001|Treatment Phase|Randomized but not Treated|19|||
44182896|NCT01763164|78977710|FG000|Treatment Phase|Other|0|||
44182897|NCT01763164|78977711|FG001|Treatment Phase|Other|1|||
44182898|NCT01763164|78977710|FG000|Follow up Phase|New therapy for study indication|12|||
44182899|NCT01763164|78977711|FG001|Follow up Phase|New therapy for study indication|3|||
44182900|NCT01763164|78977710|FG000|Follow up Phase|Death|21|||
44182901|NCT01763164|78977711|FG001|Follow up Phase|Death|4|||
44182902|NCT01763164|78977710|FG000|Follow up Phase|Subject/guardian decision|9|||
44182903|NCT01763164|78977711|FG001|Follow up Phase|Subject/guardian decision|2|||
44182904|NCT01763164|78977710|FG000|Follow up Phase|Progressive disease|127|||
44182905|NCT01763164|78977711|FG001|Follow up Phase|Progressive disease|62|||
44182906|NCT01763164|78977710|FG000|Follow up Phase|Physician Decision|10|||
44182907|NCT01763164|78977711|FG001|Follow up Phase|Physician Decision|3|||
44182908|NCT01763164|78977710|FG000|Follow up Phase|Lost to Follow-up|1|||
44182909|NCT01763164|78977711|FG001|Follow up Phase|Lost to Follow-up|0|||
44182910|NCT01763164|78977710|FG000|Follow up Phase|Adverse Event|17|||
44182911|NCT01763164|78977711|FG001|Follow up Phase|Adverse Event|1|||
44182912|NCT01782742|78977719|FG000|Double-blind Treatment Phase|Adverse Event|1|||
44182913|NCT01782742|78977720|FG001|Double-blind Treatment Phase|Adverse Event|0|||
44182914|NCT01782664|78977734|FG000|Overall Study|Adverse Event|2|||
44182915|NCT01782664|78977735|FG001|Overall Study|Adverse Event|2|||
44182916|NCT01782664|78977736|FG002|Overall Study|Adverse Event|2|||
44182917|NCT01782664|78977737|FG003|Overall Study|Adverse Event|2|||
44182918|NCT01782664|78977738|FG004|Overall Study|Adverse Event|0|||
44182919|NCT01782664|78977739|FG005|Overall Study|Adverse Event|0|||
44182920|NCT01782664|78977734|FG000|Overall Study|Lack of Efficacy|2|||
44182921|NCT01782664|78977735|FG001|Overall Study|Lack of Efficacy|0|||
44182922|NCT01782664|78977736|FG002|Overall Study|Lack of Efficacy|2|||
44182923|NCT01782664|78977737|FG003|Overall Study|Lack of Efficacy|2|||
44182924|NCT01782664|78977738|FG004|Overall Study|Lack of Efficacy|0|||
44182925|NCT01782664|78977739|FG005|Overall Study|Lack of Efficacy|0|||
44182926|NCT01782664|78977734|FG000|Overall Study|Protocol Violation|0|||
44182927|NCT01782664|78977735|FG001|Overall Study|Protocol Violation|1|||
44182928|NCT01782664|78977736|FG002|Overall Study|Protocol Violation|0|||
44182929|NCT01782664|78977737|FG003|Overall Study|Protocol Violation|1|||
44182930|NCT01782664|78977738|FG004|Overall Study|Protocol Violation|0|||
44182931|NCT01782664|78977739|FG005|Overall Study|Protocol Violation|0|||
44182932|NCT01782664|78977734|FG000|Overall Study|Withdrawal by Subject|2|||
44182933|NCT01782664|78977735|FG001|Overall Study|Withdrawal by Subject|2|||
44182934|NCT01782664|78977736|FG002|Overall Study|Withdrawal by Subject|0|||
44182935|NCT01782664|78977737|FG003|Overall Study|Withdrawal by Subject|0|||
44182936|NCT01782664|78977738|FG004|Overall Study|Withdrawal by Subject|0|||
44182937|NCT01782664|78977739|FG005|Overall Study|Withdrawal by Subject|0|||
44182938|NCT01732588|78977756|FG000|First Intervention (7 Days)|Adverse Event|0|||
44182939|NCT01732588|78977757|FG001|First Intervention (7 Days)|Adverse Event|1|||
44182940|NCT01732588|78977758|FG002|First Intervention (7 Days)|Adverse Event|0|||
44182941|NCT01781962|78977766|FG000|Overall Study|Other Miscellaneous Reasons|5|||
44182942|NCT01639339|78977772|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
44182943|NCT01639339|78977773|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
44182944|NCT01639339|78977772|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
44182945|NCT01639339|78977773|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
44182946|NCT01639339|78977772|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
44182947|NCT01639339|78977773|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
44182948|NCT01639339|78977772|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
44182949|NCT01639339|78977773|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
44182950|NCT01639339|78977772|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
44182951|NCT01639339|78977773|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
44182952|NCT01639339|78977772|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
44182953|NCT01639339|78977773|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
44182954|NCT01639339|78977772|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
44182955|NCT01639339|78977773|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
44182956|NCT01639339|78977772|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
44182957|NCT01639339|78977773|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
44182958|NCT01639339|78977772|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
44182959|NCT01639339|78977773|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
44182960|NCT01639339|78977772|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
44182961|NCT01639339|78977773|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
44182962|NCT02000817|78977787|FG000|Overall Study|Withdrawal by Subject|2|||
44182963|NCT02000817|78977788|FG001|Overall Study|Withdrawal by Subject|0|||
44182964|NCT02000817|78977789|FG002|Overall Study|Withdrawal by Subject|0|||
44182965|NCT02000817|78977790|FG003|Overall Study|Withdrawal by Subject|0|||
44182966|NCT02000817|78977787|FG000|Overall Study|Adverse Event|0|||
44182967|NCT02000817|78977788|FG001|Overall Study|Adverse Event|1|||
44182968|NCT02000817|78977789|FG002|Overall Study|Adverse Event|0|||
44182969|NCT02000817|78977790|FG003|Overall Study|Adverse Event|0|||
44182970|NCT02000817|78977787|FG000|Overall Study|Lost to Follow-up|0|||
44182971|NCT02000817|78977788|FG001|Overall Study|Lost to Follow-up|0|||
44182972|NCT02000817|78977789|FG002|Overall Study|Lost to Follow-up|1|||
44182973|NCT02000817|78977790|FG003|Overall Study|Lost to Follow-up|0|||
44182974|NCT01641133|78977806|FG000|Overall Study|Protocol Violation|0|||
44182975|NCT01641133|78977807|FG001|Overall Study|Protocol Violation|1|||
44182976|NCT01641133|78977808|FG002|Overall Study|Protocol Violation|1|||
44182977|NCT01641133|78977806|FG000|Overall Study|Migrated/moved from study area|5|||
44182978|NCT01641133|78977807|FG001|Overall Study|Migrated/moved from study area|3|||
44182979|NCT01641133|78977808|FG002|Overall Study|Migrated/moved from study area|1|||
44182980|NCT01641133|78977806|FG000|Overall Study|Adverse Event|0|||
44182981|NCT01641133|78977807|FG001|Overall Study|Adverse Event|0|||
44182982|NCT01641133|78977808|FG002|Overall Study|Adverse Event|1|||
44182983|NCT01641133|78977806|FG000|Overall Study|Withdrawal by Subject|5|||
44182984|NCT01641133|78977807|FG001|Overall Study|Withdrawal by Subject|3|||
44182985|NCT01641133|78977808|FG002|Overall Study|Withdrawal by Subject|3|||
44182986|NCT01641133|78977806|FG000|Overall Study|Lost to Follow-up|0|||
44182987|NCT01641133|78977807|FG001|Overall Study|Lost to Follow-up|2|||
44182988|NCT01641133|78977808|FG002|Overall Study|Lost to Follow-up|2|||
44182989|NCT02000427|78977816|FG000|Overall Study|Death|22|||
44182990|NCT01600885|78977820|FG000|First Period|Adverse Event|1|||
44182991|NCT01600885|78977821|FG001|First Period|Adverse Event|1|||
44182992|NCT01600885|78977820|FG000|First Period|moved out of area|1|||
44182993|NCT01600885|78977821|FG001|First Period|moved out of area|0|||
44182994|NCT01732510|78977834|FG000|Overall Study|Adverse Event|0|||
44182995|NCT01732510|78977835|FG001|Overall Study|Adverse Event|1|||
44182996|NCT01732510|78977836|FG002|Overall Study|Adverse Event|1|||
44182997|NCT01732510|78977837|FG003|Overall Study|Adverse Event|0|||
44182998|NCT01732510|78977838|FG004|Overall Study|Adverse Event|0|||
44182999|NCT01732510|78977839|FG005|Overall Study|Adverse Event|0|||
44183000|NCT01732510|78977840|FG006|Overall Study|Adverse Event|1|||
44183001|NCT01732510|78977834|FG000|Overall Study|Protocol Violation|0|||
44183002|NCT01732510|78977835|FG001|Overall Study|Protocol Violation|0|||
44183003|NCT01732510|78977836|FG002|Overall Study|Protocol Violation|0|||
44183004|NCT01732510|78977837|FG003|Overall Study|Protocol Violation|1|||
44183005|NCT01732510|78977838|FG004|Overall Study|Protocol Violation|0|||
44183006|NCT01732510|78977839|FG005|Overall Study|Protocol Violation|0|||
44183007|NCT01732510|78977840|FG006|Overall Study|Protocol Violation|0|||
44183008|NCT01732510|78977834|FG000|Overall Study|Withdrawal by Subject|1|||
44183009|NCT01732510|78977835|FG001|Overall Study|Withdrawal by Subject|3|||
44183010|NCT01732510|78977836|FG002|Overall Study|Withdrawal by Subject|2|||
44183011|NCT01732510|78977837|FG003|Overall Study|Withdrawal by Subject|1|||
44183012|NCT01732510|78977838|FG004|Overall Study|Withdrawal by Subject|5|||
44183013|NCT01732510|78977839|FG005|Overall Study|Withdrawal by Subject|0|||
44183014|NCT01732510|78977840|FG006|Overall Study|Withdrawal by Subject|1|||
44183015|NCT01732510|78977834|FG000|Overall Study|Lost to Follow-up|0|||
44183016|NCT01732510|78977835|FG001|Overall Study|Lost to Follow-up|0|||
44183017|NCT01732510|78977836|FG002|Overall Study|Lost to Follow-up|1|||
44183018|NCT01732510|78977837|FG003|Overall Study|Lost to Follow-up|1|||
44183019|NCT01732510|78977838|FG004|Overall Study|Lost to Follow-up|0|||
44183020|NCT01732510|78977839|FG005|Overall Study|Lost to Follow-up|1|||
44183021|NCT01732510|78977840|FG006|Overall Study|Lost to Follow-up|0|||
44183022|NCT01732510|78977834|FG000|Overall Study|Physician Decision|0|||
44183023|NCT01732510|78977835|FG001|Overall Study|Physician Decision|1|||
44183024|NCT01732510|78977836|FG002|Overall Study|Physician Decision|0|||
44183025|NCT01732510|78977837|FG003|Overall Study|Physician Decision|0|||
44183026|NCT01732510|78977838|FG004|Overall Study|Physician Decision|0|||
44183027|NCT01732510|78977839|FG005|Overall Study|Physician Decision|0|||
44183028|NCT01732510|78977840|FG006|Overall Study|Physician Decision|0|||
44183029|NCT01732510|78977834|FG000|Overall Study|Pregnancy|0|||
44183030|NCT01732510|78977835|FG001|Overall Study|Pregnancy|0|||
44183031|NCT01732510|78977836|FG002|Overall Study|Pregnancy|0|||
44183032|NCT01732510|78977837|FG003|Overall Study|Pregnancy|1|||
44183033|NCT01732510|78977838|FG004|Overall Study|Pregnancy|0|||
44183034|NCT01732510|78977839|FG005|Overall Study|Pregnancy|0|||
44183035|NCT01732510|78977840|FG006|Overall Study|Pregnancy|0|||
44183036|NCT01732510|78977834|FG000|Overall Study|Study Terminated By Sponsor|0|||
44183037|NCT01732510|78977835|FG001|Overall Study|Study Terminated By Sponsor|0|||
44183038|NCT01732510|78977836|FG002|Overall Study|Study Terminated By Sponsor|0|||
44183039|NCT01732510|78977837|FG003|Overall Study|Study Terminated By Sponsor|1|||
44183040|NCT01732510|78977838|FG004|Overall Study|Study Terminated By Sponsor|0|||
44183041|NCT01732510|78977839|FG005|Overall Study|Study Terminated By Sponsor|12|||
44183042|NCT01732510|78977840|FG006|Overall Study|Study Terminated By Sponsor|6|||
44183043|NCT01637077|78977861|FG000|Overall Study|Cancel|1|||
44183044|NCT01637077|78977862|FG001|Overall Study|Cancel|1|||
44183045|NCT01637077|78977861|FG000|Overall Study|Withdrawal by Subject|1|||
44265436|NCT02417064|79169947|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
44361222|NCT01185821|79366878|FG003|Overall Study|Condition no longer required study drug|0|||
44183046|NCT01637077|78977862|FG001|Overall Study|Withdrawal by Subject|0|||
44183047|NCT01637077|78977861|FG000|Overall Study|No cycle 1 questionnaire data|2|||
44183048|NCT01637077|78977862|FG001|Overall Study|No cycle 1 questionnaire data|0|||
44183049|NCT02308163|78977872|FG000|Overall Study|Not fulfill eligible criteria|1|||
44183050|NCT02308163|78977873|FG001|Overall Study|Not fulfill eligible criteria|2|||
44183051|NCT02308163|78977874|FG002|Overall Study|Not fulfill eligible criteria|0|||
44183052|NCT02308163|78977875|FG003|Overall Study|Not fulfill eligible criteria|1|||
44183053|NCT02308163|78977876|FG004|Overall Study|Not fulfill eligible criteria|1|||
44183054|NCT02308163|78977872|FG000|Overall Study|Adverse Event|9|||
44183055|NCT02308163|78977873|FG001|Overall Study|Adverse Event|5|||
44183056|NCT02308163|78977874|FG002|Overall Study|Adverse Event|2|||
44183057|NCT02308163|78977875|FG003|Overall Study|Adverse Event|2|||
44183058|NCT02308163|78977876|FG004|Overall Study|Adverse Event|11|||
44183059|NCT02308163|78977872|FG000|Overall Study|Lack of Efficacy|11|||
44183060|NCT02308163|78977873|FG001|Overall Study|Lack of Efficacy|3|||
44183061|NCT02308163|78977874|FG002|Overall Study|Lack of Efficacy|8|||
44183062|NCT02308163|78977875|FG003|Overall Study|Lack of Efficacy|4|||
44183063|NCT02308163|78977876|FG004|Overall Study|Lack of Efficacy|6|||
44183064|NCT02308163|78977872|FG000|Overall Study|Withdrawal of consent|2|||
44183065|NCT02308163|78977873|FG001|Overall Study|Withdrawal of consent|3|||
44183066|NCT02308163|78977874|FG002|Overall Study|Withdrawal of consent|0|||
44183067|NCT02308163|78977875|FG003|Overall Study|Withdrawal of consent|2|||
44183068|NCT02308163|78977876|FG004|Overall Study|Withdrawal of consent|6|||
44183069|NCT02308163|78977872|FG000|Overall Study|Protocol Violation|3|||
44183070|NCT02308163|78977873|FG001|Overall Study|Protocol Violation|3|||
44183071|NCT02308163|78977874|FG002|Overall Study|Protocol Violation|3|||
44183072|NCT02308163|78977875|FG003|Overall Study|Protocol Violation|2|||
44183073|NCT02308163|78977876|FG004|Overall Study|Protocol Violation|5|||
44183074|NCT02308163|78977872|FG000|Overall Study|Lab data met discontinuation criteria|3|||
44183075|NCT02308163|78977873|FG001|Overall Study|Lab data met discontinuation criteria|0|||
44183076|NCT02308163|78977874|FG002|Overall Study|Lab data met discontinuation criteria|0|||
44183077|NCT02308163|78977875|FG003|Overall Study|Lab data met discontinuation criteria|2|||
44183078|NCT02308163|78977876|FG004|Overall Study|Lab data met discontinuation criteria|0|||
44183079|NCT02308163|78977872|FG000|Overall Study|Miscellaneous|2|||
44183080|NCT02308163|78977873|FG001|Overall Study|Miscellaneous|2|||
44183081|NCT02308163|78977874|FG002|Overall Study|Miscellaneous|1|||
44183082|NCT02308163|78977875|FG003|Overall Study|Miscellaneous|0|||
44183083|NCT02308163|78977876|FG004|Overall Study|Miscellaneous|5|||
44183084|NCT01999335|78977908|FG000|Overall Study|Discontinued before receiving treatment|0|||
44183085|NCT01999335|78977909|FG001|Overall Study|Discontinued before receiving treatment|0|||
44183086|NCT01999335|78977910|FG002|Overall Study|Discontinued before receiving treatment|0|||
44183087|NCT01999335|78977911|FG003|Overall Study|Discontinued before receiving treatment|0|||
44183088|NCT01999335|78977912|FG004|Overall Study|Discontinued before receiving treatment|2|||
44183089|NCT01978119|78977927|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
44183090|NCT01978119|78977928|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
44183091|NCT01978119|78977927|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
44183092|NCT01978119|78977928|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44183093|NCT01978119|78977927|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44183094|NCT01978119|78977928|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
44183095|NCT01999179|78977934|FG000|Overall Study|Adverse Event|1|||
44183096|NCT01999179|78977934|FG000|Overall Study|Lost to Follow-up|1|||
44183097|NCT01999179|78977934|FG000|Overall Study|Change in Therapy|3|||
44183098|NCT01999179|78977934|FG000|Overall Study|New catheter|2|||
44183099|NCT01977729|78977938|FG000|Overall Study|Study terminated|1|||
44183100|NCT01998477|78977946|FG000|Overall Study|Lost to Follow-up|4|||
44183101|NCT01998477|78977947|FG001|Overall Study|Lost to Follow-up|5|||
44183102|NCT01998477|78977946|FG000|Overall Study|Withdrawal by Subject|6|||
44183103|NCT01998477|78977947|FG001|Overall Study|Withdrawal by Subject|0|||
44183104|NCT01998399|78977980|FG000|Overall Study|Lost to Follow-up|1|||
44183105|NCT01998399|78977981|FG001|Overall Study|Lost to Follow-up|3|||
44183106|NCT01998399|78977980|FG000|Overall Study|Death|4|||
44183107|NCT01998399|78977981|FG001|Overall Study|Death|2|||
44183108|NCT01998399|78977980|FG000|Overall Study|Study stopped before dosing completed|3|||
44183109|NCT01998399|78977981|FG001|Overall Study|Study stopped before dosing completed|3|||
44183110|NCT01998399|78977980|FG000|Overall Study|Withdrawal by Subject|0|||
44183111|NCT01998399|78977981|FG001|Overall Study|Withdrawal by Subject|1|||
44183112|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
44183113|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
44183114|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
44183115|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
44183116|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
44183117|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
44183118|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
44183119|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
44183120|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
44183121|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
44183122|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
44265437|NCT02417064|79169948|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
44265438|NCT02417064|79169946|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
44183123|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
44183124|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
44183125|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
44183126|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
44183127|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
44183128|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
44265439|NCT02417064|79169947|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
44265440|NCT02417064|79169948|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
44183129|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
44183130|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
44183131|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
44183132|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
44183133|NCT01781572|78977998|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
44183134|NCT01781572|78977999|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
44183135|NCT01781572|78978000|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
44183136|NCT01781572|78977998|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
44183137|NCT01781572|78977999|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
44183138|NCT01781572|78978000|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
44183139|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
44183140|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
44183141|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
44183142|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
44183143|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
44183144|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
44183145|NCT01781572|78977998|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
44183146|NCT01781572|78977999|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
44183147|NCT01781572|78978000|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
44183148|NCT01781572|78977998|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
44183149|NCT01781572|78977999|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
44183150|NCT01781572|78978000|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
44183151|NCT01781572|78977998|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
44183152|NCT01781572|78977999|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
44183153|NCT01781572|78978000|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
44183154|NCT01781572|78977998|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
44183155|NCT01781572|78977999|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
44183156|NCT01781572|78978000|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
44183157|NCT01781572|78977998|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
44183158|NCT01781572|78977999|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
44183159|NCT01781572|78978000|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
44183160|NCT01781572|78977998|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
44183161|NCT01781572|78977999|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
44183162|NCT01781572|78978000|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
44183163|NCT01781572|78977998|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
44183164|NCT01781572|78977999|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
44183165|NCT01781572|78978000|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
44183166|NCT01998243|78978031|FG000|Overall Study|Pregnancy|0|||
44183167|NCT01998243|78978032|FG001|Overall Study|Pregnancy|1|||
44183168|NCT01998243|78978031|FG000|Overall Study|Protocol Violation|5|||
44183169|NCT01998243|78978032|FG001|Overall Study|Protocol Violation|2|||
44183170|NCT01998243|78978031|FG000|Overall Study|Withdrawal by Subject|3|||
44183171|NCT01998243|78978032|FG001|Overall Study|Withdrawal by Subject|4|||
44183172|NCT01977573|78978044|FG000|Overall Study|Adverse Event|7|||
44183173|NCT01977573|78978045|FG001|Overall Study|Adverse Event|0|||
44183174|NCT01977573|78978046|FG002|Overall Study|Adverse Event|2|||
44183175|NCT01977573|78978047|FG003|Overall Study|Adverse Event|1|||
44183176|NCT01977573|78978044|FG000|Overall Study|Lost to Follow-up|1|||
44183177|NCT01977573|78978045|FG001|Overall Study|Lost to Follow-up|0|||
44183178|NCT01977573|78978046|FG002|Overall Study|Lost to Follow-up|0|||
44183179|NCT01977573|78978047|FG003|Overall Study|Lost to Follow-up|1|||
44183180|NCT01977573|78978044|FG000|Overall Study|Physician Decision|1|||
44183181|NCT01977573|78978045|FG001|Overall Study|Physician Decision|0|||
44265441|NCT02417064|79169946|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
44265442|NCT02417064|79169947|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
44265443|NCT02417064|79169948|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
44265444|NCT02417064|79169946|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
44265445|NCT02417064|79169947|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
44265446|NCT02417064|79169948|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
44265447|NCT02417064|79169946|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
44265448|NCT02417064|79169947|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
44265449|NCT02417064|79169948|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
44265450|NCT02417064|79169946|FG000|Follow-up Phase (24 Weeks)|Other|2|||
44265451|NCT02417064|79169947|FG001|Follow-up Phase (24 Weeks)|Other|2|||
44265452|NCT02417064|79169948|FG002|Follow-up Phase (24 Weeks)|Other|3|||
44265453|NCT01653132|79169963|FG000|First Intervention|Protocol Violation|1|||
44183182|NCT01977573|78978046|FG002|Overall Study|Physician Decision|0|||
44183183|NCT01977573|78978047|FG003|Overall Study|Physician Decision|0|||
44183184|NCT01977573|78978044|FG000|Overall Study|Protocol Violation|3|||
44183185|NCT01977573|78978045|FG001|Overall Study|Protocol Violation|1|||
44183186|NCT01977573|78978046|FG002|Overall Study|Protocol Violation|0|||
44265454|NCT01653132|79169964|FG001|First Intervention|Protocol Violation|0|||
44265455|NCT02453334|79169989|FG000|Overall Study|Death|15|||
44265456|NCT02453334|79169990|FG001|Overall Study|Death|13|||
44265457|NCT02453334|79169989|FG000|Overall Study|Adverse Event|2|||
44183187|NCT01977573|78978047|FG003|Overall Study|Protocol Violation|0|||
44183188|NCT01977573|78978044|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
44183189|NCT01977573|78978045|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
44183190|NCT01977573|78978046|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
44183191|NCT01977573|78978047|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
44183192|NCT01977573|78978044|FG000|Overall Study|Withdrawal by Subject|6|||
44183193|NCT01977573|78978045|FG001|Overall Study|Withdrawal by Subject|1|||
44183194|NCT01977573|78978046|FG002|Overall Study|Withdrawal by Subject|1|||
44183195|NCT01977573|78978047|FG003|Overall Study|Withdrawal by Subject|1|||
44183196|NCT01963767|78978060|FG000|Overall Study|Withdrawal by Subject|4|||
44183197|NCT01963767|78978061|FG001|Overall Study|Withdrawal by Subject|2|||
44183198|NCT01963767|78978060|FG000|Overall Study|Adverse Event|2|||
44183199|NCT01963767|78978061|FG001|Overall Study|Adverse Event|0|||
44183200|NCT01731886|78978069|FG000|Overall Study|Death|1|||
44183201|NCT01731886|78978070|FG001|Overall Study|Death|0|||
44183202|NCT01731886|78978069|FG000|Overall Study|Never started treatment|0|||
44183203|NCT01731886|78978070|FG001|Overall Study|Never started treatment|1|||
44183204|NCT01731886|78978069|FG000|Overall Study|Non-compliant|1|||
44183205|NCT01731886|78978070|FG001|Overall Study|Non-compliant|0|||
44183206|NCT01759420|78978077|FG000|Overall Study|Screen failure|5|||
44183207|NCT01759420|78978077|FG000|Overall Study|Inaccurate EKG machine readings|1|||
44183208|NCT01781026|78978081|FG000|Overall Study|Lack of Efficacy|2|||
44183209|NCT01607398|78978087|FG000|Overall Study|Adverse Event|0|||
44183210|NCT01607398|78978088|FG001|Overall Study|Adverse Event|2|||
44183211|NCT01607398|78978087|FG000|Overall Study|Severe COPD|2|||
44183212|NCT01607398|78978088|FG001|Overall Study|Severe COPD|0|||
44183213|NCT01779856|78978094|FG000|Overall Study|Withdrawal by Subject|15|||
44183214|NCT01779856|78978094|FG000|Overall Study|Death|3|||
44183215|NCT01779856|78978094|FG000|Overall Study|Physician Decision|1|||
44183216|NCT01779856|78978094|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
44183217|NCT01779856|78978094|FG000|Overall Study|Delays in scheduling implant|1|||
44183218|NCT01779856|78978094|FG000|Overall Study|Subject ineligible for Implant|2|||
44183219|NCT01729156|78978108|FG000|Overall Study|Withdrawal by Subject|1|||
44183220|NCT01729156|78978109|FG001|Overall Study|Withdrawal by Subject|0|||
44183221|NCT01729156|78978110|FG002|Overall Study|Withdrawal by Subject|0|||
44183222|NCT01779700|78978121|FG000|Overall Study|Adverse Event|4|||
44183223|NCT01779700|78978122|FG001|Overall Study|Adverse Event|3|||
44183224|NCT01779700|78978121|FG000|Overall Study|Withdrawal by Subject|0|||
44183225|NCT01779700|78978122|FG001|Overall Study|Withdrawal by Subject|2|||
44183226|NCT01778530|78978128|FG000|Overall Study|Progression on study|1|||
44183227|NCT01778530|78978128|FG000|Overall Study|Adverse event/side effect|1|||
44183228|NCT01778062|78978134|FG000|Overall Study|Adverse Event|1|||
44183229|NCT01778062|78978135|FG001|Overall Study|Adverse Event|3|||
44183230|NCT01778062|78978134|FG000|Overall Study|Consent Withdrawal|1|||
44183231|NCT01778062|78978135|FG001|Overall Study|Consent Withdrawal|5|||
44183232|NCT01778062|78978134|FG000|Overall Study|major protocol deviation|4|||
44183233|NCT01778062|78978135|FG001|Overall Study|major protocol deviation|3|||
44183234|NCT01759264|78978141|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
44183235|NCT01759264|78978141|FG000|Overall Study|Adverse Event|1|||
44183236|NCT01759264|78978141|FG000|Overall Study|Other|2|||
44183237|NCT01759264|78978141|FG000|Overall Study|Lost to Follow-up|2|||
44183238|NCT01759264|78978141|FG000|Overall Study|Withdrawal by Subject|3|||
44183239|NCT01759264|78978141|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
44183240|NCT01757704|78978148|FG000|Overall Study|Protocol Violation|1|||
44183241|NCT01757704|78978149|FG001|Overall Study|Protocol Violation|3|||
44183242|NCT01757392|78978155|FG000|Overall Study|Withdrawal by Subject|1|||
44183243|NCT01757392|78978155|FG000|Overall Study|Screen Fail|3|||
44183244|NCT01756846|78978161|FG000|Overall Study|Lost to Follow-up|5|||
44183245|NCT01756846|78978162|FG001|Overall Study|Lost to Follow-up|10|||
44183246|NCT01756846|78978161|FG000|Overall Study|Withdrawal by Subject|1|||
44183247|NCT01756846|78978162|FG001|Overall Study|Withdrawal by Subject|2|||
44183248|NCT01963611|78978173|FG000|Overall Study|Adverse Event|1|||
44183249|NCT01963611|78978174|FG001|Overall Study|Adverse Event|1|||
44183250|NCT01963611|78978175|FG002|Overall Study|Adverse Event|3|||
44183251|NCT01963611|78978176|FG003|Overall Study|Adverse Event|4|||
44183252|NCT01963611|78978177|FG004|Overall Study|Adverse Event|3|||
44183253|NCT01963611|78978173|FG000|Overall Study|Protocol Violation|0|||
44183254|NCT01963611|78978174|FG001|Overall Study|Protocol Violation|0|||
44183255|NCT01963611|78978175|FG002|Overall Study|Protocol Violation|0|||
44183256|NCT01963611|78978176|FG003|Overall Study|Protocol Violation|1|||
44183257|NCT01963611|78978177|FG004|Overall Study|Protocol Violation|0|||
44183258|NCT01963611|78978173|FG000|Overall Study|Lack of Efficacy|0|||
44183259|NCT01963611|78978174|FG001|Overall Study|Lack of Efficacy|0|||
44183260|NCT01963611|78978175|FG002|Overall Study|Lack of Efficacy|0|||
44183261|NCT01963611|78978176|FG003|Overall Study|Lack of Efficacy|1|||
44183262|NCT01963611|78978177|FG004|Overall Study|Lack of Efficacy|0|||
44183263|NCT01963611|78978173|FG000|Overall Study|Withdrawal by Subject|3|||
44183264|NCT01963611|78978174|FG001|Overall Study|Withdrawal by Subject|2|||
44183265|NCT01963611|78978175|FG002|Overall Study|Withdrawal by Subject|1|||
44183266|NCT01963611|78978176|FG003|Overall Study|Withdrawal by Subject|1|||
44183267|NCT01963611|78978177|FG004|Overall Study|Withdrawal by Subject|3|||
44183268|NCT01963611|78978173|FG000|Overall Study|Other|47|||
44183269|NCT01963611|78978174|FG001|Overall Study|Other|46|||
44183270|NCT01963611|78978175|FG002|Overall Study|Other|48|||
44183271|NCT01963611|78978176|FG003|Overall Study|Other|45|||
44183272|NCT01963611|78978177|FG004|Overall Study|Other|45|||
44183273|NCT01975701|78978190|FG000|Overall Study|Lost to Follow-up|1|||
44183274|NCT01975701|78978190|FG000|Overall Study|Death|23|||
44183275|NCT01975701|78978190|FG000|Overall Study|Physician Decision|1|||
44183276|NCT01962987|78978197|FG000|Overall Study|Adverse Event|4|||
44183277|NCT01962987|78978198|FG001|Overall Study|Adverse Event|4|||
44183278|NCT01962987|78978199|FG002|Overall Study|Adverse Event|0|||
44183279|NCT01962987|78978197|FG000|Overall Study|Lost to Follow-up|0|||
44183280|NCT01962987|78978198|FG001|Overall Study|Lost to Follow-up|0|||
44183281|NCT01962987|78978199|FG002|Overall Study|Lost to Follow-up|1|||
44183282|NCT01962987|78978197|FG000|Overall Study|Non compliance with dosing requirements|4|||
44183283|NCT01962987|78978198|FG001|Overall Study|Non compliance with dosing requirements|2|||
44183284|NCT01962987|78978199|FG002|Overall Study|Non compliance with dosing requirements|0|||
44183285|NCT01962987|78978197|FG000|Overall Study|Miscellaneous|1|||
44183286|NCT01962987|78978198|FG001|Overall Study|Miscellaneous|9|||
44183287|NCT01962987|78978199|FG002|Overall Study|Miscellaneous|2|||
44183288|NCT01962987|78978197|FG000|Overall Study|Restricted medication|5|||
44183289|NCT01962987|78978198|FG001|Overall Study|Restricted medication|1|||
44183290|NCT01962987|78978199|FG002|Overall Study|Restricted medication|1|||
44183291|NCT01962987|78978197|FG000|Overall Study|Serious Adverse Event|1|||
44183292|NCT01962987|78978198|FG001|Overall Study|Serious Adverse Event|0|||
44183293|NCT01962987|78978199|FG002|Overall Study|Serious Adverse Event|0|||
44183294|NCT01962987|78978197|FG000|Overall Study|Withdrawal by Subject|11|||
44183295|NCT01962987|78978198|FG001|Overall Study|Withdrawal by Subject|10|||
44183296|NCT01962987|78978199|FG002|Overall Study|Withdrawal by Subject|6|||
44183297|NCT01962987|78978197|FG000|Overall Study|Randomized in Error|4|||
44183298|NCT01962987|78978198|FG001|Overall Study|Randomized in Error|2|||
44183299|NCT01962987|78978199|FG002|Overall Study|Randomized in Error|2|||
44183300|NCT01962441|78978210|FG000|Randomized Period|Randomized but Never Treated|4|||
44183301|NCT01962441|78978211|FG001|Randomized Period|Randomized but Never Treated|2|||
44183302|NCT01962441|78978212|FG002|Randomized Period|Randomized but Never Treated|3|||
44183303|NCT01962441|78978210|FG000|Randomized Period|Lost to Follow-up|2|||
44183304|NCT01962441|78978211|FG001|Randomized Period|Lost to Follow-up|4|||
44183305|NCT01962441|78978212|FG002|Randomized Period|Lost to Follow-up|4|||
44183306|NCT01962441|78978210|FG000|Randomized Period|Withdrew Consent|3|||
44183307|NCT01962441|78978211|FG001|Randomized Period|Withdrew Consent|3|||
44183308|NCT01962441|78978212|FG002|Randomized Period|Withdrew Consent|2|||
44183309|NCT01962441|78978210|FG000|Randomized Period|Adverse Event|1|||
44183310|NCT01962441|78978211|FG001|Randomized Period|Adverse Event|1|||
44183311|NCT01962441|78978212|FG002|Randomized Period|Adverse Event|0|||
44183312|NCT01962441|78978210|FG000|Randomized Period|Death|0|||
44183313|NCT01962441|78978211|FG001|Randomized Period|Death|0|||
44183314|NCT01962441|78978212|FG002|Randomized Period|Death|2|||
44183315|NCT01962441|78978210|FG000|Randomized Period|Protocol Violation|0|||
44183316|NCT01962441|78978211|FG001|Randomized Period|Protocol Violation|1|||
44183317|NCT01962441|78978212|FG002|Randomized Period|Protocol Violation|0|||
44183318|NCT01962441|78978210|FG000|Retreatment Substudy|Lack of Efficacy|1|||
44183319|NCT01962441|78978211|FG001|Retreatment Substudy|Lack of Efficacy|0|||
44183320|NCT01962441|78978212|FG002|Retreatment Substudy|Lack of Efficacy|0|||
44183321|NCT01962441|78978210|FG000|Retreatment Substudy|Lost to Follow-up|1|||
44183322|NCT01962441|78978211|FG001|Retreatment Substudy|Lost to Follow-up|0|||
44183323|NCT01962441|78978212|FG002|Retreatment Substudy|Lost to Follow-up|0|||
44183324|NCT01638013|78978224|FG000|Overall Study|Adverse Event|36|||
44183325|NCT01638013|78978225|FG001|Overall Study|Adverse Event|29|||
44183326|NCT01638013|78978226|FG002|Overall Study|Adverse Event|48|||
44265458|NCT02453334|79169990|FG001|Overall Study|Adverse Event|1|||
44265459|NCT02453334|79169989|FG000|Overall Study|Lost to Follow-up|5|||
44265460|NCT02453334|79169990|FG001|Overall Study|Lost to Follow-up|9|||
44183327|NCT01638013|78978224|FG000|Overall Study|Lack of Efficacy|39|||
44183328|NCT01638013|78978225|FG001|Overall Study|Lack of Efficacy|11|||
44183329|NCT01638013|78978226|FG002|Overall Study|Lack of Efficacy|14|||
44183330|NCT01638013|78978224|FG000|Overall Study|Protocol Violation|10|||
44183331|NCT01638013|78978225|FG001|Overall Study|Protocol Violation|7|||
44183332|NCT01638013|78978226|FG002|Overall Study|Protocol Violation|11|||
44183333|NCT01638013|78978224|FG000|Overall Study|Met discontinuation criteria|4|||
44183334|NCT01638013|78978225|FG001|Overall Study|Met discontinuation criteria|0|||
44183335|NCT01638013|78978226|FG002|Overall Study|Met discontinuation criteria|7|||
44183336|NCT01638013|78978224|FG000|Overall Study|Subject Lost to Follow up|1|||
44183337|NCT01638013|78978225|FG001|Overall Study|Subject Lost to Follow up|0|||
44183338|NCT01638013|78978226|FG002|Overall Study|Subject Lost to Follow up|1|||
44265461|NCT02453334|79169989|FG000|Overall Study|Physician Decision|1|||
44183339|NCT01638013|78978224|FG000|Overall Study|Miscellaneous|25|||
44183340|NCT01638013|78978225|FG001|Overall Study|Miscellaneous|19|||
44183341|NCT01638013|78978226|FG002|Overall Study|Miscellaneous|23|||
44183342|NCT01638013|78978224|FG000|Overall Study|Withdrawal of Consent|16|||
44183343|NCT01638013|78978225|FG001|Overall Study|Withdrawal of Consent|12|||
44183344|NCT01638013|78978226|FG002|Overall Study|Withdrawal of Consent|16|||
44183345|NCT01638013|78978224|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
44183346|NCT01638013|78978225|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
44183347|NCT01638013|78978226|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
44183348|NCT01637623|78978241|FG000|Overall Study|Lost to Follow-up|0|||
44183349|NCT01637623|78978242|FG001|Overall Study|Lost to Follow-up|0|||
44183350|NCT01637623|78978243|FG002|Overall Study|Lost to Follow-up|2|||
44183351|NCT01637623|78978241|FG000|Overall Study|Physician Decision|1|||
44183352|NCT01637623|78978242|FG001|Overall Study|Physician Decision|0|||
44183353|NCT01637623|78978243|FG002|Overall Study|Physician Decision|1|||
44183354|NCT01962207|78978255|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
44183355|NCT01962207|78978256|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
44183356|NCT01962207|78978257|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
44183357|NCT01962207|78978258|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
44183358|NCT01962207|78978255|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
44183359|NCT01962207|78978256|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
44183360|NCT01962207|78978257|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
44183361|NCT01962207|78978258|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
44183362|NCT01962207|78978255|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
44183363|NCT01962207|78978256|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
44183364|NCT01962207|78978257|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
44183365|NCT01962207|78978258|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
44183366|NCT01962207|78978255|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
44183367|NCT01962207|78978256|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
44183368|NCT01962207|78978257|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
44183369|NCT01962207|78978258|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
44183370|NCT01962207|78978255|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
44183371|NCT01962207|78978256|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
44183372|NCT01962207|78978257|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
44183373|NCT01962207|78978258|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
44183374|NCT01962207|78978255|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
44183375|NCT01962207|78978256|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
44183376|NCT01962207|78978257|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
44183377|NCT01962207|78978258|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
44183378|NCT01995825|78978274|FG000|Overall Study|Withdrawal by Subject|1|||
44183379|NCT01995825|78978275|FG001|Overall Study|Withdrawal by Subject|0|||
44183380|NCT01995357|78978281|FG000|Period 5|Lack of Efficacy|1|||
44183381|NCT01995357|78978282|FG001|Period 5|Lack of Efficacy|0|||
44183382|NCT01995357|78978283|FG002|Period 5|Lack of Efficacy|0|||
44183383|NCT01995357|78978284|FG003|Period 5|Lack of Efficacy|0|||
44183384|NCT01995357|78978285|FG004|Period 5|Lack of Efficacy|0|||
44183385|NCT01995357|78978286|FG005|Period 5|Lack of Efficacy|0|||
44183386|NCT01995357|78978281|FG000|Period 5|Adverse Event|1|||
44183387|NCT01995357|78978282|FG001|Period 5|Adverse Event|0|||
44183388|NCT01995357|78978283|FG002|Period 5|Adverse Event|1|||
44183389|NCT01995357|78978284|FG003|Period 5|Adverse Event|0|||
44183390|NCT01995357|78978285|FG004|Period 5|Adverse Event|0|||
44183391|NCT01995357|78978286|FG005|Period 5|Adverse Event|0|||
44183392|NCT01638559|78978302|FG000|Overall Study|Lost to Follow-up|1|||
44183393|NCT01638559|78978302|FG000|Overall Study|Withdrawal by Subject|1|||
44183394|NCT01638559|78978302|FG000|Overall Study|Subject declined to travel for biopsy|1|||
44183395|NCT01756300|78978317|FG000|Overall Study|Death|1|||
44183396|NCT01756300|78978317|FG000|Overall Study|Withdrawal by Subject|1|||
44183397|NCT01995201|78978340|FG000|From Baseline Until Week 24|Adverse Event|4|||
44265462|NCT02453334|79169990|FG001|Overall Study|Physician Decision|0|||
44265463|NCT02453334|79169989|FG000|Overall Study|Withdrawal by Subject|17|||
44265464|NCT02453334|79169990|FG001|Overall Study|Withdrawal by Subject|13|||
44265465|NCT02453334|79169989|FG000|Overall Study|Other reason|1|||
44265466|NCT02453334|79169990|FG001|Overall Study|Other reason|4|||
44265467|NCT02443740|79170076|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
44183398|NCT01995201|78978341|FG001|From Baseline Until Week 24|Adverse Event|15|||
44183399|NCT01995201|78978342|FG002|From Baseline Until Week 24|Adverse Event|0|||
44183400|NCT01995201|78978343|FG003|From Baseline Until Week 24|Adverse Event|0|||
44183401|NCT01995201|78978344|FG004|From Baseline Until Week 24|Adverse Event|0|||
44183402|NCT01995201|78978345|FG005|From Baseline Until Week 24|Adverse Event|0|||
44183403|NCT01995201|78978346|FG006|From Baseline Until Week 24|Adverse Event|0|||
44183404|NCT01995201|78978340|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
44249602|NCT02649894|79083539|FG001|Overall Study|Other, not specified|0|||
44265468|NCT02443740|79170077|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
44183405|NCT01995201|78978341|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
44183406|NCT01995201|78978342|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
44183407|NCT01995201|78978343|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
44183408|NCT01995201|78978344|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
44183409|NCT01995201|78978345|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
44183410|NCT01995201|78978346|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
44183411|NCT01995201|78978340|FG000|From Baseline Until Week 24|Death|0|||
44183412|NCT01995201|78978341|FG001|From Baseline Until Week 24|Death|1|||
44183413|NCT01995201|78978342|FG002|From Baseline Until Week 24|Death|0|||
44183414|NCT01995201|78978343|FG003|From Baseline Until Week 24|Death|0|||
44183415|NCT01995201|78978344|FG004|From Baseline Until Week 24|Death|0|||
44183416|NCT01995201|78978345|FG005|From Baseline Until Week 24|Death|0|||
44183417|NCT01995201|78978346|FG006|From Baseline Until Week 24|Death|0|||
44183418|NCT01995201|78978340|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
44183419|NCT01995201|78978341|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
44183420|NCT01995201|78978342|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
44183421|NCT01995201|78978343|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
44183422|NCT01995201|78978344|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
44183423|NCT01995201|78978345|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
44183424|NCT01995201|78978346|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
44183425|NCT01995201|78978340|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
44183426|NCT01995201|78978341|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
44183427|NCT01995201|78978342|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
44183428|NCT01995201|78978343|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
44183429|NCT01995201|78978344|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
44183430|NCT01995201|78978345|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
44183431|NCT01995201|78978346|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
44183432|NCT01995201|78978340|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
44183433|NCT01995201|78978341|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
44183434|NCT01995201|78978342|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
44183435|NCT01995201|78978343|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
44183436|NCT01995201|78978344|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
44183437|NCT01995201|78978345|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
44183438|NCT01995201|78978346|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
44183439|NCT01995201|78978340|FG000|From Baseline Until Week 24|Physician Decision|0|||
44183440|NCT01995201|78978341|FG001|From Baseline Until Week 24|Physician Decision|2|||
44183441|NCT01995201|78978342|FG002|From Baseline Until Week 24|Physician Decision|0|||
44183442|NCT01995201|78978343|FG003|From Baseline Until Week 24|Physician Decision|0|||
44183443|NCT01995201|78978344|FG004|From Baseline Until Week 24|Physician Decision|0|||
44183444|NCT01995201|78978345|FG005|From Baseline Until Week 24|Physician Decision|0|||
44183445|NCT01995201|78978346|FG006|From Baseline Until Week 24|Physician Decision|0|||
44183446|NCT01995201|78978340|FG000|From Baseline Until Week 24|Protocol Violation|0|||
44183447|NCT01995201|78978341|FG001|From Baseline Until Week 24|Protocol Violation|9|||
44183448|NCT01995201|78978342|FG002|From Baseline Until Week 24|Protocol Violation|0|||
44183449|NCT01995201|78978343|FG003|From Baseline Until Week 24|Protocol Violation|0|||
44183450|NCT01995201|78978344|FG004|From Baseline Until Week 24|Protocol Violation|0|||
44183451|NCT01995201|78978345|FG005|From Baseline Until Week 24|Protocol Violation|0|||
44183452|NCT01995201|78978346|FG006|From Baseline Until Week 24|Protocol Violation|0|||
44183453|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Adverse Event|0|||
44183454|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Adverse Event|0|||
44183455|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Adverse Event|2|||
44183456|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Adverse Event|1|||
44183457|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Adverse Event|1|||
44183458|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Adverse Event|3|||
44183459|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Adverse Event|1|||
44183460|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Death|0|||
44183461|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Death|0|||
44183462|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Death|0|||
44183463|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Death|0|||
44183464|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Death|0|||
44183465|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Death|2|||
44183466|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Death|0|||
44265469|NCT02443740|79170078|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
44265470|NCT02443740|79170079|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
44451323|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
44451324|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
44183467|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
44183468|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
44183469|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
44183470|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
44183471|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
44183472|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
44183473|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
44183474|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
44183475|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
44183476|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
44183477|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
44183478|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
44183479|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
44183480|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
44183481|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
44183482|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
44183483|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
44183484|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
44183485|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
44183486|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
44183487|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
44183488|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Physician Decision|0|||
44183489|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Physician Decision|0|||
44183490|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Physician Decision|0|||
44183491|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Physician Decision|0|||
44183492|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Physician Decision|1|||
44183493|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Physician Decision|0|||
44183494|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Physician Decision|0|||
44183495|NCT01995201|78978340|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
44183496|NCT01995201|78978341|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
44183497|NCT01995201|78978342|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
44183498|NCT01995201|78978343|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
44183499|NCT01995201|78978344|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
44183500|NCT01995201|78978345|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
44183501|NCT01995201|78978346|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
44183502|NCT01728454|78978370|FG000|Stage 1 and 2|Pregnancy|1|||
44183503|NCT01728454|78978371|FG001|Stage 1 and 2|Pregnancy|0|||
44183504|NCT01728454|78978372|FG002|Stage 1 and 2|Pregnancy|0|||
44183505|NCT01728454|78978370|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
44183506|NCT01728454|78978371|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
44183507|NCT01728454|78978372|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
44183508|NCT01728454|78978370|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
44183509|NCT01728454|78978371|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
44183510|NCT01728454|78978372|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
44183511|NCT01728454|78978370|FG000|Stage 1 and 2|Lost to Follow-up|1|||
44183512|NCT01728454|78978371|FG001|Stage 1 and 2|Lost to Follow-up|1|||
44183513|NCT01728454|78978372|FG002|Stage 1 and 2|Lost to Follow-up|0|||
44183514|NCT01728454|78978370|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
44183515|NCT01728454|78978371|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
44183516|NCT01728454|78978372|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
44183517|NCT01728454|78978370|FG000|Stage 3|Reason Missing|0|||
44183518|NCT01728454|78978371|FG001|Stage 3|Reason Missing|0|||
44183519|NCT01728454|78978372|FG002|Stage 3|Reason Missing|1|||
44183520|NCT01728454|78978370|FG000|Stage 3|Subject Required Other Treatment|0|||
44183521|NCT01728454|78978371|FG001|Stage 3|Subject Required Other Treatment|1|||
44183522|NCT01728454|78978372|FG002|Stage 3|Subject Required Other Treatment|0|||
44183523|NCT01728454|78978370|FG000|Stage 3|Pregnancy|1|||
44183524|NCT01728454|78978371|FG001|Stage 3|Pregnancy|0|||
44183525|NCT01728454|78978372|FG002|Stage 3|Pregnancy|0|||
44183526|NCT01728454|78978370|FG000|Stage 3|Withdrew Consent|1|||
44183527|NCT01728454|78978371|FG001|Stage 3|Withdrew Consent|0|||
44183528|NCT01728454|78978372|FG002|Stage 3|Withdrew Consent|1|||
44183529|NCT01728454|78978370|FG000|Stage 3|Non-compliance with Protocol|0|||
44183530|NCT01728454|78978371|FG001|Stage 3|Non-compliance with Protocol|0|||
44183531|NCT01728454|78978372|FG002|Stage 3|Non-compliance with Protocol|1|||
44183532|NCT01728454|78978370|FG000|Stage 3|Lost to Follow-up|0|||
44183533|NCT01728454|78978371|FG001|Stage 3|Lost to Follow-up|3|||
44183534|NCT01728454|78978372|FG002|Stage 3|Lost to Follow-up|1|||
44183535|NCT01728454|78978370|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
44183536|NCT01728454|78978371|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
44183537|NCT01728454|78978372|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
44183538|NCT01636687|78978386|FG000|Induction Period|Withdrawal by Subject|1|||
44183539|NCT01636687|78978387|FG001|Induction Period|Withdrawal by Subject|0|||
44183540|NCT01636687|78978388|FG002|Induction Period|Withdrawal by Subject|0|||
44183541|NCT01636687|78978389|FG003|Induction Period|Withdrawal by Subject|0|||
44183542|NCT01636687|78978390|FG004|Induction Period|Withdrawal by Subject|0|||
44183543|NCT01636687|78978386|FG000|Induction Period|Adverse Event|1|||
44183544|NCT01636687|78978387|FG001|Induction Period|Adverse Event|0|||
44183545|NCT01636687|78978388|FG002|Induction Period|Adverse Event|0|||
44183546|NCT01636687|78978389|FG003|Induction Period|Adverse Event|0|||
44183547|NCT01636687|78978390|FG004|Induction Period|Adverse Event|1|||
44183548|NCT01636687|78978386|FG000|Induction Period|Lack of Efficacy|0|||
44183549|NCT01636687|78978387|FG001|Induction Period|Lack of Efficacy|0|||
44183550|NCT01636687|78978388|FG002|Induction Period|Lack of Efficacy|0|||
44183551|NCT01636687|78978389|FG003|Induction Period|Lack of Efficacy|0|||
44183552|NCT01636687|78978390|FG004|Induction Period|Lack of Efficacy|1|||
44183553|NCT01636687|78978386|FG000|Induction Period|Physician Decision|1|||
44183554|NCT01636687|78978387|FG001|Induction Period|Physician Decision|0|||
44183555|NCT01636687|78978388|FG002|Induction Period|Physician Decision|0|||
44183556|NCT01636687|78978389|FG003|Induction Period|Physician Decision|0|||
44183557|NCT01636687|78978390|FG004|Induction Period|Physician Decision|0|||
44183558|NCT01636687|78978386|FG000|Maintenance Period|Withdrawal by Subject|2|||
44183559|NCT01636687|78978387|FG001|Maintenance Period|Withdrawal by Subject|0|||
44183560|NCT01636687|78978388|FG002|Maintenance Period|Withdrawal by Subject|2|||
44183561|NCT01636687|78978389|FG003|Maintenance Period|Withdrawal by Subject|0|||
44183562|NCT01636687|78978390|FG004|Maintenance Period|Withdrawal by Subject|0|||
44183563|NCT01636687|78978386|FG000|Maintenance Period|Adverse Event|1|||
44183564|NCT01636687|78978387|FG001|Maintenance Period|Adverse Event|0|||
44183565|NCT01636687|78978388|FG002|Maintenance Period|Adverse Event|0|||
44183566|NCT01636687|78978389|FG003|Maintenance Period|Adverse Event|0|||
44183567|NCT01636687|78978390|FG004|Maintenance Period|Adverse Event|0|||
44183568|NCT01636687|78978386|FG000|Maintenance Period|Lack of Efficacy|4|||
44183569|NCT01636687|78978387|FG001|Maintenance Period|Lack of Efficacy|1|||
44183570|NCT01636687|78978388|FG002|Maintenance Period|Lack of Efficacy|0|||
44183571|NCT01636687|78978389|FG003|Maintenance Period|Lack of Efficacy|0|||
44183572|NCT01636687|78978390|FG004|Maintenance Period|Lack of Efficacy|0|||
44183573|NCT01636687|78978386|FG000|Maintenance Period|Lost to Follow-up|1|||
44183574|NCT01636687|78978387|FG001|Maintenance Period|Lost to Follow-up|1|||
44183575|NCT01636687|78978388|FG002|Maintenance Period|Lost to Follow-up|0|||
44183576|NCT01636687|78978389|FG003|Maintenance Period|Lost to Follow-up|0|||
44183577|NCT01636687|78978390|FG004|Maintenance Period|Lost to Follow-up|1|||
44183578|NCT01636687|78978386|FG000|Maintenance Period|Physician Decision|0|||
44183579|NCT01636687|78978387|FG001|Maintenance Period|Physician Decision|0|||
44183580|NCT01636687|78978388|FG002|Maintenance Period|Physician Decision|0|||
44183581|NCT01636687|78978389|FG003|Maintenance Period|Physician Decision|0|||
44183582|NCT01636687|78978390|FG004|Maintenance Period|Physician Decision|1|||
44183583|NCT01636687|78978386|FG000|Extension Period|technical problems|0|||
44183584|NCT01636687|78978387|FG001|Extension Period|technical problems|1|||
44183585|NCT01636687|78978388|FG002|Extension Period|technical problems|2|||
44183586|NCT01636687|78978389|FG003|Extension Period|technical problems|1|||
44183587|NCT01636687|78978390|FG004|Extension Period|technical problems|0|||
44183588|NCT01636687|78978386|FG000|Extension Period|Adverse Event|4|||
44183589|NCT01636687|78978387|FG001|Extension Period|Adverse Event|3|||
44183590|NCT01636687|78978388|FG002|Extension Period|Adverse Event|2|||
44183591|NCT01636687|78978389|FG003|Extension Period|Adverse Event|1|||
44183592|NCT01636687|78978390|FG004|Extension Period|Adverse Event|0|||
44183593|NCT01636687|78978386|FG000|Extension Period|Lack of Efficacy|7|||
44183594|NCT01636687|78978387|FG001|Extension Period|Lack of Efficacy|0|||
44183595|NCT01636687|78978388|FG002|Extension Period|Lack of Efficacy|2|||
44183596|NCT01636687|78978389|FG003|Extension Period|Lack of Efficacy|1|||
44183597|NCT01636687|78978390|FG004|Extension Period|Lack of Efficacy|0|||
44183598|NCT01636687|78978386|FG000|Extension Period|Lost to Follow-up|1|||
44183599|NCT01636687|78978387|FG001|Extension Period|Lost to Follow-up|0|||
44183600|NCT01636687|78978388|FG002|Extension Period|Lost to Follow-up|1|||
44183601|NCT01636687|78978389|FG003|Extension Period|Lost to Follow-up|0|||
44183602|NCT01636687|78978390|FG004|Extension Period|Lost to Follow-up|0|||
44265471|NCT02443740|79170080|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
44265472|NCT02443740|79170081|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
44265473|NCT02443740|79170082|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
44265474|NCT02443740|79170083|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
44265475|NCT02443740|79170084|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
44265476|NCT02443740|79170085|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
44451325|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
44451326|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
44183603|NCT01636687|78978386|FG000|Extension Period|Physician Decision|1|||
44183604|NCT01636687|78978387|FG001|Extension Period|Physician Decision|0|||
44183605|NCT01636687|78978388|FG002|Extension Period|Physician Decision|0|||
44183606|NCT01636687|78978389|FG003|Extension Period|Physician Decision|1|||
44183607|NCT01636687|78978390|FG004|Extension Period|Physician Decision|0|||
44183608|NCT01636687|78978386|FG000|Extension Period|study terminated by sponsor|33|||
44183609|NCT01636687|78978387|FG001|Extension Period|study terminated by sponsor|50|||
44183610|NCT01636687|78978388|FG002|Extension Period|study terminated by sponsor|17|||
44183611|NCT01636687|78978389|FG003|Extension Period|study terminated by sponsor|23|||
44183612|NCT01636687|78978390|FG004|Extension Period|study terminated by sponsor|0|||
44451327|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
44183613|NCT01636687|78978386|FG000|Extension Period|Withdrawal by Subject|1|||
44183614|NCT01636687|78978387|FG001|Extension Period|Withdrawal by Subject|0|||
44183615|NCT01636687|78978388|FG002|Extension Period|Withdrawal by Subject|1|||
44183616|NCT01636687|78978389|FG003|Extension Period|Withdrawal by Subject|1|||
44183617|NCT01636687|78978390|FG004|Extension Period|Withdrawal by Subject|0|||
44183618|NCT01636687|78978386|FG000|Follow-up Period|Withdrawal by Subject|1|||
44183619|NCT01636687|78978387|FG001|Follow-up Period|Withdrawal by Subject|0|||
44183620|NCT01636687|78978388|FG002|Follow-up Period|Withdrawal by Subject|0|||
44183621|NCT01636687|78978389|FG003|Follow-up Period|Withdrawal by Subject|0|||
44183622|NCT01636687|78978390|FG004|Follow-up Period|Withdrawal by Subject|1|||
44183623|NCT01634659|78978410|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
44183624|NCT01634659|78978411|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
44183625|NCT01634659|78978410|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
44183626|NCT01634659|78978411|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
44249603|NCT01278615|79083545|FG000|Overall Study|Withdrawal by Subject|2|||
44249604|NCT01505114|79083571|FG000|Overall Study|Withdrawal by Subject|5|||
44249605|NCT01505114|79083572|FG001|Overall Study|Withdrawal by Subject|4|||
44249606|NCT01505114|79083573|FG002|Overall Study|Withdrawal by Subject|4|||
44249607|NCT01505114|79083574|FG003|Overall Study|Withdrawal by Subject|7|||
44249608|NCT01505114|79083571|FG000|Overall Study|Death|1|||
44249609|NCT01505114|79083572|FG001|Overall Study|Death|0|||
44249610|NCT01505114|79083573|FG002|Overall Study|Death|0|||
44249611|NCT01505114|79083574|FG003|Overall Study|Death|1|||
44249612|NCT01505114|79083571|FG000|Overall Study|unable to adhere to visit schedule|3|||
44249613|NCT01505114|79083572|FG001|Overall Study|unable to adhere to visit schedule|2|||
44249614|NCT01505114|79083573|FG002|Overall Study|unable to adhere to visit schedule|3|||
44249615|NCT01505114|79083574|FG003|Overall Study|unable to adhere to visit schedule|3|||
44249616|NCT01505114|79083571|FG000|Overall Study|Lost to Follow-up|11|||
44249617|NCT01505114|79083572|FG001|Overall Study|Lost to Follow-up|5|||
44249618|NCT01505114|79083573|FG002|Overall Study|Lost to Follow-up|8|||
44249619|NCT01505114|79083574|FG003|Overall Study|Lost to Follow-up|7|||
44249620|NCT01505114|79083571|FG000|Overall Study|relocated|4|||
44249621|NCT01505114|79083572|FG001|Overall Study|relocated|2|||
44249622|NCT01505114|79083573|FG002|Overall Study|relocated|2|||
44249623|NCT01505114|79083574|FG003|Overall Study|relocated|3|||
44249624|NCT01505114|79083571|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
44249625|NCT01505114|79083572|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
44249626|NCT01505114|79083573|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
44249627|NCT01505114|79083574|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
44249628|NCT01505114|79083571|FG000|Overall Study|staff safety concerns|0|||
44249629|NCT01505114|79083572|FG001|Overall Study|staff safety concerns|0|||
44249630|NCT01505114|79083573|FG002|Overall Study|staff safety concerns|0|||
44249631|NCT01505114|79083574|FG003|Overall Study|staff safety concerns|1|||
44249632|NCT01505114|79083571|FG000|Overall Study|investigator decision|1|||
44249633|NCT01505114|79083572|FG001|Overall Study|investigator decision|0|||
44249634|NCT01505114|79083573|FG002|Overall Study|investigator decision|1|||
44249635|NCT01505114|79083574|FG003|Overall Study|investigator decision|0|||
44249636|NCT02651922|79083606|FG000|Overall Study|due to exclusion criteria|2|||
44249637|NCT01277757|79083610|FG000|Overall Study|Disease Progression|1|||
44249638|NCT01277757|79083610|FG000|Overall Study|Withdrawal by Subject|1|||
44249639|NCT01276821|79083616|FG000|Overall Study|Protocol Violation|0|||
44265477|NCT02443740|79170086|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
44265478|NCT02443740|79170076|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
44265479|NCT02443740|79170077|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265480|NCT02443740|79170078|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265481|NCT02443740|79170079|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44249640|NCT01276821|79083617|FG001|Overall Study|Protocol Violation|1|||
44249641|NCT00245037|79083623|FG000|Overall Study|Death|17|||
44249642|NCT00241839|79083629|FG000|Overall Study|Withdrawal by Subject|18|||
44249643|NCT00241839|79083630|FG001|Overall Study|Withdrawal by Subject|17|||
44249644|NCT00241839|79083629|FG000|Overall Study|Adverse Event|1|||
44249645|NCT00241839|79083630|FG001|Overall Study|Adverse Event|1|||
44249646|NCT02651688|79083639|FG000|Overall Study|Non-compliance|0|||
44249647|NCT02651688|79083640|FG001|Overall Study|Non-compliance|0|||
44249648|NCT02651688|79083641|FG002|Overall Study|Non-compliance|1|||
44249649|NCT02651688|79083639|FG000|Overall Study|Principal Investigator (PI) decision|0|||
44249650|NCT02651688|79083640|FG001|Overall Study|Principal Investigator (PI) decision|2|||
44249651|NCT02651688|79083641|FG002|Overall Study|Principal Investigator (PI) decision|0|||
44249652|NCT02651688|79083639|FG000|Overall Study|Lost to Follow-up|1|||
44249653|NCT02651688|79083640|FG001|Overall Study|Lost to Follow-up|3|||
44543034|NCT03655717|79555911|FG011|Overall Study|Lost to Follow-up|1|||
44249654|NCT02651688|79083641|FG002|Overall Study|Lost to Follow-up|0|||
44249655|NCT02651688|79083639|FG000|Overall Study|Withdrawal by Subject|1|||
44249656|NCT02651688|79083640|FG001|Overall Study|Withdrawal by Subject|0|||
44249657|NCT02651688|79083641|FG002|Overall Study|Withdrawal by Subject|2|||
44249658|NCT01276353|79083651|FG000|Double-blind|Adverse Event|2|||
44249659|NCT01276353|79083652|FG001|Double-blind|Adverse Event|0|||
44265482|NCT02443740|79170080|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265483|NCT02443740|79170081|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265484|NCT02443740|79170082|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
44265485|NCT02443740|79170083|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265486|NCT02443740|79170084|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265487|NCT02443740|79170085|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265488|NCT02443740|79170086|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
44265489|NCT02443740|79170076|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265490|NCT02443740|79170077|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265491|NCT02443740|79170078|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265492|NCT02443740|79170079|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265493|NCT02443740|79170080|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265494|NCT02443740|79170081|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
44265495|NCT02443740|79170082|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265496|NCT02443740|79170083|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265497|NCT02443740|79170084|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265498|NCT02443740|79170085|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265499|NCT02443740|79170086|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
44265500|NCT02416908|79170317|FG000|Dose Escalation Phase|Adverse Event|0|||
44265501|NCT02416908|79170318|FG001|Dose Escalation Phase|Adverse Event|0|||
44265502|NCT02416908|79170319|FG002|Dose Escalation Phase|Adverse Event|3|||
44265503|NCT02416908|79170320|FG003|Dose Escalation Phase|Adverse Event|0|||
44265504|NCT02416908|79170317|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
44265505|NCT02416908|79170318|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
44265506|NCT02416908|79170319|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
44265507|NCT02416908|79170320|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44265508|NCT02453256|79170410|FG000|Double Blind Period|Death|1|||
44265509|NCT02453256|79170411|FG001|Double Blind Period|Death|1|||
44265510|NCT02453256|79170410|FG000|Double Blind Period|Adverse Event|3|||
44265511|NCT02453256|79170411|FG001|Double Blind Period|Adverse Event|2|||
44183627|NCT04863248|78978423|FG000|Overall Study|Sponsor Terminated|4|||
44183628|NCT04863248|78978424|FG001|Overall Study|Sponsor Terminated|1|||
44183629|NCT04863248|78978423|FG000|Overall Study|Death|0|||
44183630|NCT04863248|78978424|FG001|Overall Study|Death|1|||
44183631|NCT04863248|78978423|FG000|Overall Study|Withdrawal by Subject|0|||
44183632|NCT04863248|78978424|FG001|Overall Study|Withdrawal by Subject|1|||
44183633|NCT04285229|78978432|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44183634|NCT04285229|78978433|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44183635|NCT04285229|78978434|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44183636|NCT04285229|78978435|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44183637|NCT04285229|78978436|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44183638|NCT04285229|78978437|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44183639|NCT04285229|78978432|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
44183640|NCT04285229|78978433|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
44183641|NCT04285229|78978434|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
44183642|NCT04285229|78978435|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
44183643|NCT04285229|78978436|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
44183644|NCT04285229|78978437|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
44183645|NCT04285229|78978432|FG000|Extended Treatment Period|Adverse Event|0|||
44183646|NCT04285229|78978433|FG001|Extended Treatment Period|Adverse Event|0|||
44183647|NCT04285229|78978434|FG002|Extended Treatment Period|Adverse Event|0|||
44183648|NCT04285229|78978435|FG003|Extended Treatment Period|Adverse Event|1|||
44183649|NCT04285229|78978436|FG004|Extended Treatment Period|Adverse Event|0|||
44183650|NCT04285229|78978437|FG005|Extended Treatment Period|Adverse Event|0|||
44183651|NCT04285229|78978432|FG000|Extended Treatment Period|Physician Decision|0|||
44183652|NCT04285229|78978433|FG001|Extended Treatment Period|Physician Decision|0|||
44183653|NCT04285229|78978434|FG002|Extended Treatment Period|Physician Decision|1|||
44265512|NCT02453256|79170410|FG000|Double Blind Period|Withdrawal by Subject|9|||
44265513|NCT02453256|79170411|FG001|Double Blind Period|Withdrawal by Subject|5|||
44265514|NCT02453256|79170410|FG000|Double Blind Period|Other|0|||
44265515|NCT02453256|79170411|FG001|Double Blind Period|Other|1|||
44265516|NCT02453256|79170410|FG000|Open Label Period|Adverse Event|1|||
44265517|NCT02453256|79170411|FG001|Open Label Period|Adverse Event|3|||
44265518|NCT02453256|79170410|FG000|Open Label Period|Death|0|||
44265519|NCT02453256|79170411|FG001|Open Label Period|Death|1|||
44265520|NCT02453256|79170410|FG000|Open Label Period|Lost to Follow-up|1|||
44265521|NCT02453256|79170411|FG001|Open Label Period|Lost to Follow-up|0|||
44265522|NCT02453256|79170410|FG000|Open Label Period|Other|0|||
44265523|NCT02453256|79170411|FG001|Open Label Period|Other|2|||
44451328|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
44183654|NCT04285229|78978435|FG003|Extended Treatment Period|Physician Decision|0|||
44183655|NCT04285229|78978436|FG004|Extended Treatment Period|Physician Decision|0|||
44183656|NCT04285229|78978437|FG005|Extended Treatment Period|Physician Decision|0|||
44265524|NCT02453256|79170410|FG000|Open Label Period|Withdrawal by Subject|5|||
44265525|NCT02453256|79170411|FG001|Open Label Period|Withdrawal by Subject|1|||
44265526|NCT02442804|79170426|FG000|Overall Study|Withdrawal by Subject|0|||
44265527|NCT02442804|79170427|FG001|Overall Study|Withdrawal by Subject|1|||
44265528|NCT02442804|79170426|FG000|Overall Study|Adverse Event|1|||
44183657|NCT04285229|78978432|FG000|Follow-up Period|Adverse Event|0|||
44183658|NCT04285229|78978433|FG001|Follow-up Period|Adverse Event|0|||
44183659|NCT04285229|78978434|FG002|Follow-up Period|Adverse Event|0|||
44183660|NCT04285229|78978435|FG003|Follow-up Period|Adverse Event|0|||
44183661|NCT04285229|78978436|FG004|Follow-up Period|Adverse Event|1|||
44183662|NCT04285229|78978437|FG005|Follow-up Period|Adverse Event|4|||
44183663|NCT04285229|78978432|FG000|Follow-up Period|Withdrawal by Subject|0|||
44183664|NCT04285229|78978433|FG001|Follow-up Period|Withdrawal by Subject|0|||
44183665|NCT04285229|78978434|FG002|Follow-up Period|Withdrawal by Subject|0|||
44183666|NCT04285229|78978435|FG003|Follow-up Period|Withdrawal by Subject|0|||
44183667|NCT04285229|78978436|FG004|Follow-up Period|Withdrawal by Subject|0|||
44183668|NCT04285229|78978437|FG005|Follow-up Period|Withdrawal by Subject|5|||
44183669|NCT04285229|78978432|FG000|Follow-up Period|Covid-19|0|||
44183670|NCT04285229|78978433|FG001|Follow-up Period|Covid-19|0|||
44183671|NCT04285229|78978434|FG002|Follow-up Period|Covid-19|0|||
44183672|NCT04285229|78978435|FG003|Follow-up Period|Covid-19|0|||
44183673|NCT04285229|78978436|FG004|Follow-up Period|Covid-19|0|||
44183674|NCT04285229|78978437|FG005|Follow-up Period|Covid-19|2|||
44183675|NCT04285229|78978432|FG000|Follow-up Period|Physician Decision|0|||
44183676|NCT04285229|78978433|FG001|Follow-up Period|Physician Decision|0|||
44183677|NCT04285229|78978434|FG002|Follow-up Period|Physician Decision|0|||
44183678|NCT04285229|78978435|FG003|Follow-up Period|Physician Decision|0|||
44183679|NCT04285229|78978436|FG004|Follow-up Period|Physician Decision|0|||
44183680|NCT04285229|78978437|FG005|Follow-up Period|Physician Decision|1|||
44183681|NCT04263454|78978454|FG000|Overall Study|Adverse Event|0|||
44183682|NCT04263454|78978455|FG001|Overall Study|Adverse Event|2|||
44183683|NCT04263454|78978454|FG000|Overall Study|Physician Decision|3|||
44183684|NCT04263454|78978455|FG001|Overall Study|Physician Decision|5|||
44183685|NCT04263454|78978454|FG000|Overall Study|Poor Data Quality|0|||
44183686|NCT04263454|78978455|FG001|Overall Study|Poor Data Quality|1|||
44183687|NCT04155463|78978465|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
44183688|NCT04155463|78978466|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
44183689|NCT04056611|78978472|FG000|Overall Study|Physician Decision|1|||
44183690|NCT04001803|78978476|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
44183691|NCT04001803|78978476|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
44183692|NCT04001803|78978476|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
44183693|NCT04001803|78978476|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
44183694|NCT04001803|78978476|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
44183695|NCT04001803|78978476|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
44183696|NCT04001803|78978476|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
44183697|NCT04001803|78978476|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
44183698|NCT04001803|78978476|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
44183699|NCT04001803|78978476|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
44183700|NCT03768427|78978485|FG000|Overall Study|Death|0|||
44183701|NCT03768427|78978486|FG001|Overall Study|Death|0|||
44183702|NCT03768427|78978487|FG002|Overall Study|Death|1|||
44183703|NCT03768427|78978488|FG003|Overall Study|Death|0|||
44183704|NCT03768427|78978485|FG000|Overall Study|Lost to Follow-up|2|||
44183705|NCT03768427|78978486|FG001|Overall Study|Lost to Follow-up|0|||
44183706|NCT03768427|78978487|FG002|Overall Study|Lost to Follow-up|0|||
44183707|NCT03768427|78978488|FG003|Overall Study|Lost to Follow-up|0|||
44183708|NCT03768427|78978485|FG000|Overall Study|Physician Decision|3|||
44265529|NCT02442804|79170427|FG001|Overall Study|Adverse Event|0|||
44265530|NCT02414958|79170516|FG000|Overall Study|Adverse Event|6|||
44265531|NCT02414958|79170517|FG001|Overall Study|Adverse Event|6|||
44183709|NCT03768427|78978486|FG001|Overall Study|Physician Decision|2|||
44183710|NCT03768427|78978487|FG002|Overall Study|Physician Decision|4|||
44183711|NCT03768427|78978488|FG003|Overall Study|Physician Decision|4|||
44183712|NCT03768427|78978485|FG000|Overall Study|Withdrawal by Subject|7|||
44183713|NCT03768427|78978486|FG001|Overall Study|Withdrawal by Subject|2|||
44183714|NCT03768427|78978487|FG002|Overall Study|Withdrawal by Subject|6|||
44183715|NCT03768427|78978488|FG003|Overall Study|Withdrawal by Subject|7|||
44183716|NCT03595228|78978502|FG000|Overall Study|Death|2|||
44183717|NCT03595228|78978502|FG000|Overall Study|Lack of Efficacy|13|||
44183718|NCT03595228|78978502|FG000|Overall Study|Withdrawal by Subject|3|||
44183719|NCT03595228|78978502|FG000|Overall Study|Withdrawal by Sponsor|1|||
44183720|NCT03572933|78978508|FG000|Overall Study|Adverse Event|4|||
44183721|NCT03572933|78978509|FG001|Overall Study|Adverse Event|1|||
44183722|NCT03572933|78978508|FG000|Overall Study|Withdrawal by Subject|0|||
44183723|NCT03572933|78978509|FG001|Overall Study|Withdrawal by Subject|1|||
44183724|NCT03558152|78978520|FG000|Overall Study|Adverse Event|0|||
44183725|NCT03558152|78978521|FG001|Overall Study|Adverse Event|0|||
44183726|NCT03558152|78978522|FG002|Overall Study|Adverse Event|1|||
44183727|NCT03558152|78978523|FG003|Overall Study|Adverse Event|1|||
44183728|NCT03558152|78978524|FG004|Overall Study|Adverse Event|2|||
44183729|NCT03558152|78978525|FG005|Overall Study|Adverse Event|1|||
44183730|NCT03558152|78978526|FG006|Overall Study|Adverse Event|1|||
44183731|NCT03558152|78978527|FG007|Overall Study|Adverse Event|0|||
44183732|NCT03558152|78978520|FG000|Overall Study|Death|0|||
44183733|NCT03558152|78978521|FG001|Overall Study|Death|0|||
44183734|NCT03558152|78978522|FG002|Overall Study|Death|0|||
44183735|NCT03558152|78978523|FG003|Overall Study|Death|0|||
44183736|NCT03558152|78978524|FG004|Overall Study|Death|1|||
44183737|NCT03558152|78978525|FG005|Overall Study|Death|0|||
44183738|NCT03558152|78978526|FG006|Overall Study|Death|0|||
44183739|NCT03558152|78978527|FG007|Overall Study|Death|0|||
44183740|NCT03558152|78978520|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
44183741|NCT03558152|78978521|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183742|NCT03558152|78978522|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183743|NCT03558152|78978523|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183744|NCT03558152|78978524|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183745|NCT03558152|78978525|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183746|NCT03558152|78978526|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183747|NCT03558152|78978527|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
44183748|NCT03558152|78978520|FG000|Overall Study|Miscalculation in mmcs|0|||
44183749|NCT03558152|78978521|FG001|Overall Study|Miscalculation in mmcs|0|||
44183750|NCT03558152|78978522|FG002|Overall Study|Miscalculation in mmcs|0|||
44183751|NCT03558152|78978523|FG003|Overall Study|Miscalculation in mmcs|0|||
44183752|NCT03558152|78978524|FG004|Overall Study|Miscalculation in mmcs|0|||
44183753|NCT03558152|78978525|FG005|Overall Study|Miscalculation in mmcs|0|||
44183754|NCT03558152|78978526|FG006|Overall Study|Miscalculation in mmcs|1|||
44183755|NCT03558152|78978527|FG007|Overall Study|Miscalculation in mmcs|0|||
44183756|NCT03558152|78978520|FG000|Overall Study|Mistake in calculation|0|||
44183757|NCT03558152|78978521|FG001|Overall Study|Mistake in calculation|0|||
44183758|NCT03558152|78978522|FG002|Overall Study|Mistake in calculation|0|||
44183759|NCT03558152|78978523|FG003|Overall Study|Mistake in calculation|1|||
44183760|NCT03558152|78978524|FG004|Overall Study|Mistake in calculation|0|||
44183761|NCT03558152|78978525|FG005|Overall Study|Mistake in calculation|0|||
44183762|NCT03558152|78978526|FG006|Overall Study|Mistake in calculation|0|||
44183763|NCT03558152|78978527|FG007|Overall Study|Mistake in calculation|0|||
44183764|NCT03558152|78978520|FG000|Overall Study|Mistake in evaluation of disease status|0|||
44183765|NCT03558152|78978521|FG001|Overall Study|Mistake in evaluation of disease status|0|||
44183766|NCT03558152|78978522|FG002|Overall Study|Mistake in evaluation of disease status|0|||
44183767|NCT03558152|78978523|FG003|Overall Study|Mistake in evaluation of disease status|0|||
44183768|NCT03558152|78978524|FG004|Overall Study|Mistake in evaluation of disease status|0|||
44265532|NCT02414958|79170518|FG002|Overall Study|Adverse Event|3|||
44265533|NCT02414958|79170516|FG000|Overall Study|Protocol Violation|10|||
44265534|NCT02414958|79170517|FG001|Overall Study|Protocol Violation|3|||
44265535|NCT02414958|79170518|FG002|Overall Study|Protocol Violation|1|||
44183769|NCT03558152|78978525|FG005|Overall Study|Mistake in evaluation of disease status|0|||
44183770|NCT03558152|78978526|FG006|Overall Study|Mistake in evaluation of disease status|0|||
44183771|NCT03558152|78978527|FG007|Overall Study|Mistake in evaluation of disease status|1|||
44183772|NCT03558152|78978520|FG000|Overall Study|Physician Decision|0|||
44183773|NCT03558152|78978521|FG001|Overall Study|Physician Decision|0|||
44183774|NCT03558152|78978522|FG002|Overall Study|Physician Decision|0|||
44183775|NCT03558152|78978523|FG003|Overall Study|Physician Decision|0|||
44265536|NCT02414958|79170516|FG000|Overall Study|Lost to Follow-up|7|||
44265537|NCT02414958|79170517|FG001|Overall Study|Lost to Follow-up|4|||
44183776|NCT03558152|78978524|FG004|Overall Study|Physician Decision|0|||
44183777|NCT03558152|78978525|FG005|Overall Study|Physician Decision|0|||
44183778|NCT03558152|78978526|FG006|Overall Study|Physician Decision|1|||
44183779|NCT03558152|78978527|FG007|Overall Study|Physician Decision|0|||
44183780|NCT03558152|78978520|FG000|Overall Study|Withdrawal by Subject|2|||
44183781|NCT03558152|78978521|FG001|Overall Study|Withdrawal by Subject|3|||
44183782|NCT03558152|78978522|FG002|Overall Study|Withdrawal by Subject|2|||
44183783|NCT03558152|78978523|FG003|Overall Study|Withdrawal by Subject|1|||
44183784|NCT03558152|78978524|FG004|Overall Study|Withdrawal by Subject|1|||
44183785|NCT03558152|78978525|FG005|Overall Study|Withdrawal by Subject|1|||
44183786|NCT03558152|78978526|FG006|Overall Study|Withdrawal by Subject|3|||
44183787|NCT03558152|78978527|FG007|Overall Study|Withdrawal by Subject|2|||
44183788|NCT03558152|78978520|FG000|Overall Study|Lack of Efficacy|11|||
44183789|NCT03558152|78978521|FG001|Overall Study|Lack of Efficacy|11|||
44183790|NCT03558152|78978522|FG002|Overall Study|Lack of Efficacy|10|||
44183791|NCT03558152|78978523|FG003|Overall Study|Lack of Efficacy|11|||
44183792|NCT03558152|78978524|FG004|Overall Study|Lack of Efficacy|14|||
44183793|NCT03558152|78978525|FG005|Overall Study|Lack of Efficacy|12|||
44183794|NCT03558152|78978526|FG006|Overall Study|Lack of Efficacy|14|||
44183795|NCT03558152|78978527|FG007|Overall Study|Lack of Efficacy|13|||
44183796|NCT03558152|78978520|FG000|Overall Study|Protocol Violation|1|||
44183797|NCT03558152|78978521|FG001|Overall Study|Protocol Violation|1|||
44183798|NCT03558152|78978522|FG002|Overall Study|Protocol Violation|0|||
44183799|NCT03558152|78978523|FG003|Overall Study|Protocol Violation|1|||
44183800|NCT03558152|78978524|FG004|Overall Study|Protocol Violation|1|||
44183801|NCT03558152|78978525|FG005|Overall Study|Protocol Violation|0|||
44183802|NCT03558152|78978526|FG006|Overall Study|Protocol Violation|2|||
44183803|NCT03558152|78978527|FG007|Overall Study|Protocol Violation|0|||
44183804|NCT03461406|78978567|FG000|Overall Study|Death|1|||
44183805|NCT03461406|78978568|FG001|Overall Study|Death|2|||
44183806|NCT03461406|78978567|FG000|Overall Study|Consent Withdrawn by Participant|0|||
44183807|NCT03461406|78978568|FG001|Overall Study|Consent Withdrawn by Participant|1|||
44183808|NCT03461406|78978567|FG000|Overall Study|Screen Failure|3|||
44183809|NCT03461406|78978568|FG001|Overall Study|Screen Failure|1|||
44183810|NCT03461406|78978567|FG000|Overall Study|Reason not Specified|1|||
44183811|NCT03461406|78978568|FG001|Overall Study|Reason not Specified|3|||
44183812|NCT03461406|78978567|FG000|Overall Study|Lost to Follow-up|3|||
44183813|NCT03461406|78978568|FG001|Overall Study|Lost to Follow-up|0|||
44183814|NCT03408899|78978583|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
44183815|NCT02528643|78978604|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
44183816|NCT02528643|78978605|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
44183817|NCT02528643|78978604|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
44183818|NCT02528643|78978605|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
44183819|NCT02528643|78978604|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
44183820|NCT02528643|78978605|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
44183821|NCT02528643|78978604|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
44183822|NCT02528643|78978605|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
44183823|NCT02528643|78978604|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
44183824|NCT02528643|78978605|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
44183825|NCT02528643|78978604|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
44183826|NCT02528643|78978605|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
44183827|NCT02528643|78978604|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
44183828|NCT02528643|78978605|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
44183829|NCT02175680|78978626|FG000|Overall Study|non-compliance|1|||
44183830|NCT02175680|78978626|FG000|Overall Study|other non-medical reason|1|||
44183831|NCT01983462|78978640|FG000|Overall Study|Adverse Event|1|||
44183832|NCT01983462|78978641|FG001|Overall Study|Adverse Event|0|||
44183833|NCT01983462|78978642|FG002|Overall Study|Adverse Event|0|||
44183834|NCT01559935|78978661|FG000|Car Phase|Toxicity|4|||
44183835|NCT01559935|78978661|FG000|Car Phase|Death|1|||
44183836|NCT01559935|78978661|FG000|Car Phase|Lack of Efficacy|2|||
44183837|NCT01559935|78978661|FG000|Car Phase|Lost to Follow-up|1|||
44183838|NCT01559935|78978661|FG000|Car Phase|Physician Decision|1|||
44183839|NCT01559935|78978661|FG000|Car Phase|Withdrawal by Subject|2|||
44183840|NCT01559935|78978661|FG000|Car Phase|Per protocol|1|||
44183841|NCT01559935|78978661|FG000|Car Phase|Insurance|1|||
44183842|NCT01559935|78978661|FG000|Car Phase|non-compliance|1|||
44183843|NCT01559935|78978661|FG000|BiRD Phase|Toxicity|1|||
44183844|NCT01559935|78978661|FG000|BiRD Phase|Lack of Efficacy|1|||
44183845|NCT01559935|78978661|FG000|BiRD Phase|Withdrawal by Subject|2|||
44183846|NCT01559935|78978661|FG000|Maintenance Phase|Remains on study|28|||
44183847|NCT01559935|78978661|FG000|Maintenance Phase|Toxicity|1|||
44183848|NCT01559935|78978661|FG000|Maintenance Phase|Lack of Efficacy|18|||
44183849|NCT01559935|78978661|FG000|Maintenance Phase|Withdrawal by Subject|5|||
44183850|NCT01559935|78978661|FG000|Maintenance Phase|Non-compliance|2|||
44183851|NCT00981058|78978667|FG000|Overall Study|Adverse Event|1|||
44183852|NCT00981058|78978668|FG001|Overall Study|Adverse Event|1|||
44183853|NCT00981058|78978667|FG000|Overall Study|Progressive Disease|61|||
44183854|NCT00981058|78978668|FG001|Overall Study|Progressive Disease|49|||
44183855|NCT00981058|78978667|FG000|Overall Study|Lost to Follow-up|16|||
44183856|NCT00981058|78978668|FG001|Overall Study|Lost to Follow-up|15|||
44183857|NCT00981058|78978667|FG000|Overall Study|New Anticancer Therapy|6|||
44183858|NCT00981058|78978668|FG001|Overall Study|New Anticancer Therapy|6|||
44183859|NCT00981058|78978667|FG000|Overall Study|Noncompliance|1|||
44183860|NCT00981058|78978668|FG001|Overall Study|Noncompliance|0|||
44183861|NCT00981058|78978667|FG000|Overall Study|Radiologist Error|0|||
44183862|NCT00981058|78978668|FG001|Overall Study|Radiologist Error|1|||
44183863|NCT00981058|78978667|FG000|Overall Study|Randomization Error|1|||
44183864|NCT00981058|78978668|FG001|Overall Study|Randomization Error|2|||
44183865|NCT00981058|78978667|FG000|Overall Study|Withdrawal by Subject|25|||
44183866|NCT00981058|78978668|FG001|Overall Study|Withdrawal by Subject|23|||
44183867|NCT00981058|78978667|FG000|Overall Study|On study treatment at conclusion|9|||
44183868|NCT00981058|78978668|FG001|Overall Study|On study treatment at conclusion|0|||
44183869|NCT00565851|78978682|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
44183870|NCT00565851|78978683|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
44183871|NCT00565851|78978684|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
44183872|NCT00565851|78978685|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
44183873|NCT00565851|78978686|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
44183874|NCT00565851|78978687|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
44183875|NCT00565851|78978688|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
44183876|NCT00565851|78978689|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
44183877|NCT00565851|78978682|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
44183878|NCT00565851|78978683|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
44183879|NCT00565851|78978684|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
44183880|NCT00565851|78978685|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
44183881|NCT00565851|78978686|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
44183882|NCT00565851|78978687|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
44183883|NCT00565851|78978688|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
44183884|NCT00565851|78978689|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
44183885|NCT00305227|78978713|FG000|Overall Study|Lost to Follow-up|7|||
44183886|NCT00305227|78978714|FG001|Overall Study|Lost to Follow-up|6|||
44183887|NCT01599793|78978722|FG000|Overall Study|Adverse Event|2|||
44183888|NCT01755598|78978737|FG000|Overall Study|Other|109|||
44183889|NCT01755598|78978738|FG001|Overall Study|Other|109|||
44183890|NCT01755598|78978737|FG000|Overall Study|Lost to Follow-up|32|||
44183891|NCT01755598|78978738|FG001|Overall Study|Lost to Follow-up|43|||
44183892|NCT01755598|78978737|FG000|Overall Study|Migrated/moved from study area|76|||
44183893|NCT01755598|78978738|FG001|Overall Study|Migrated/moved from study area|65|||
44183894|NCT01755598|78978737|FG000|Overall Study|Withdrawal by Subject|22|||
44183895|NCT01755598|78978738|FG001|Overall Study|Withdrawal by Subject|31|||
44183896|NCT01755598|78978737|FG000|Overall Study|Protocol Violation|7|||
44183897|NCT01755598|78978738|FG001|Overall Study|Protocol Violation|7|||
44183898|NCT01755598|78978737|FG000|Overall Study|Adverse Event|19|||
44183899|NCT01755598|78978738|FG001|Overall Study|Adverse Event|28|||
44183900|NCT01606306|78978750|FG000|Overall Study|Lack of Efficacy|2|||
44183901|NCT01606306|78978751|FG001|Overall Study|Lack of Efficacy|1|||
44183902|NCT01606306|78978752|FG002|Overall Study|Lack of Efficacy|4|||
44183903|NCT01606306|78978753|FG003|Overall Study|Lack of Efficacy|4|||
44183904|NCT01606306|78978754|FG004|Overall Study|Lack of Efficacy|1|||
44183905|NCT01606306|78978755|FG005|Overall Study|Lack of Efficacy|2|||
44183906|NCT01606306|78978750|FG000|Overall Study|Adverse Event|1|||
44183907|NCT01606306|78978751|FG001|Overall Study|Adverse Event|0|||
44183908|NCT01606306|78978752|FG002|Overall Study|Adverse Event|1|||
44183909|NCT01606306|78978753|FG003|Overall Study|Adverse Event|1|||
44183910|NCT01606306|78978754|FG004|Overall Study|Adverse Event|2|||
44183911|NCT01606306|78978755|FG005|Overall Study|Adverse Event|0|||
44183912|NCT01606306|78978750|FG000|Overall Study|Lost to Follow-up|7|||
44183913|NCT01606306|78978751|FG001|Overall Study|Lost to Follow-up|4|||
44183914|NCT01606306|78978752|FG002|Overall Study|Lost to Follow-up|5|||
44183915|NCT01606306|78978753|FG003|Overall Study|Lost to Follow-up|4|||
44183916|NCT01606306|78978754|FG004|Overall Study|Lost to Follow-up|3|||
44183917|NCT01606306|78978755|FG005|Overall Study|Lost to Follow-up|5|||
44183918|NCT01606306|78978750|FG000|Overall Study|Withdrawal by Subject|4|||
44183919|NCT01606306|78978751|FG001|Overall Study|Withdrawal by Subject|3|||
44183920|NCT01606306|78978752|FG002|Overall Study|Withdrawal by Subject|4|||
44183921|NCT01606306|78978753|FG003|Overall Study|Withdrawal by Subject|4|||
44183922|NCT01606306|78978754|FG004|Overall Study|Withdrawal by Subject|5|||
44183923|NCT01606306|78978755|FG005|Overall Study|Withdrawal by Subject|4|||
44183924|NCT01606306|78978750|FG000|Overall Study|Physician Decision|1|||
44183925|NCT01606306|78978751|FG001|Overall Study|Physician Decision|2|||
44183926|NCT01606306|78978752|FG002|Overall Study|Physician Decision|0|||
44183927|NCT01606306|78978753|FG003|Overall Study|Physician Decision|0|||
44183928|NCT01606306|78978754|FG004|Overall Study|Physician Decision|0|||
44183929|NCT01606306|78978755|FG005|Overall Study|Physician Decision|0|||
44183930|NCT01754194|78978763|FG000|Overall Study|Lost to Follow-up|39|||
44183931|NCT01754194|78978764|FG001|Overall Study|Lost to Follow-up|14|||
44183932|NCT01754194|78978763|FG000|Overall Study|Withdrawal by Subject|4|||
44183933|NCT01754194|78978764|FG001|Overall Study|Withdrawal by Subject|5|||
44183934|NCT01754194|78978763|FG000|Overall Study|Other|9|||
44183935|NCT01754194|78978764|FG001|Overall Study|Other|8|||
44183936|NCT01753570|78978775|FG000|Overall Study|Adverse Event|1|||
44183937|NCT01753570|78978776|FG001|Overall Study|Adverse Event|0|||
44183938|NCT01753570|78978777|FG002|Overall Study|Adverse Event|1|||
44183939|NCT01753570|78978775|FG000|Overall Study|Physician Decision|0|||
44183940|NCT01753570|78978776|FG001|Overall Study|Physician Decision|1|||
44183941|NCT01753570|78978777|FG002|Overall Study|Physician Decision|0|||
44183942|NCT01753570|78978775|FG000|Overall Study|Withdrawal by Subject|1|||
44183943|NCT01753570|78978776|FG001|Overall Study|Withdrawal by Subject|4|||
44183944|NCT01753570|78978777|FG002|Overall Study|Withdrawal by Subject|0|||
44183945|NCT01753336|78978786|FG000|Overall Study|Patient decision|12|||
44183946|NCT01753336|78978786|FG000|Overall Study|Lost to Follow-up|3|||
44183947|NCT01753336|78978786|FG000|Overall Study|Physician Decision|2|||
44183948|NCT01753336|78978786|FG000|Overall Study|Sponsor's decision|2|||
44183949|NCT01753336|78978786|FG000|Overall Study|Withdrawal by Subject|1|||
44183950|NCT01777282|78978795|FG000|Overall Study|Persistent Hyperglycemia|0|||
44183951|NCT01777282|78978796|FG001|Overall Study|Persistent Hyperglycemia|0|||
44183952|NCT01777282|78978797|FG002|Overall Study|Persistent Hyperglycemia|1|||
44183953|NCT01777282|78978798|FG003|Overall Study|Persistent Hyperglycemia|0|||
44183954|NCT01777282|78978799|FG004|Overall Study|Persistent Hyperglycemia|0|||
44183955|NCT01777282|78978795|FG000|Overall Study|New Antidiabetic Medication|0|||
44183956|NCT01777282|78978796|FG001|Overall Study|New Antidiabetic Medication|0|||
44183957|NCT01777282|78978797|FG002|Overall Study|New Antidiabetic Medication|1|||
44183958|NCT01777282|78978798|FG003|Overall Study|New Antidiabetic Medication|0|||
44183959|NCT01777282|78978799|FG004|Overall Study|New Antidiabetic Medication|0|||
44183960|NCT01777282|78978795|FG000|Overall Study|Adverse Event|4|||
44183961|NCT01777282|78978796|FG001|Overall Study|Adverse Event|4|||
44183962|NCT01777282|78978797|FG002|Overall Study|Adverse Event|2|||
44183963|NCT01777282|78978798|FG003|Overall Study|Adverse Event|1|||
44183964|NCT01777282|78978799|FG004|Overall Study|Adverse Event|3|||
44183965|NCT01777282|78978795|FG000|Overall Study|Withdrawal by Subject|4|||
44183966|NCT01777282|78978796|FG001|Overall Study|Withdrawal by Subject|0|||
44183967|NCT01777282|78978797|FG002|Overall Study|Withdrawal by Subject|0|||
44183968|NCT01777282|78978798|FG003|Overall Study|Withdrawal by Subject|1|||
44183969|NCT01777282|78978799|FG004|Overall Study|Withdrawal by Subject|2|||
44183970|NCT01777282|78978795|FG000|Overall Study|Protocol Violation|2|||
44183971|NCT01777282|78978796|FG001|Overall Study|Protocol Violation|0|||
44183972|NCT01777282|78978797|FG002|Overall Study|Protocol Violation|1|||
44183973|NCT01777282|78978798|FG003|Overall Study|Protocol Violation|0|||
44183974|NCT01777282|78978799|FG004|Overall Study|Protocol Violation|2|||
44183975|NCT01777282|78978795|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
44183976|NCT01777282|78978796|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
44183977|NCT01777282|78978797|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
44183978|NCT01777282|78978798|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
44183979|NCT01777282|78978799|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
44183980|NCT01975389|78978813|FG000|Overall Study|Adverse Event|10|||
44183981|NCT01975389|78978814|FG001|Overall Study|Adverse Event|6|||
44183982|NCT01975389|78978813|FG000|Overall Study|Death|61|||
44183983|NCT01975389|78978814|FG001|Overall Study|Death|54|||
44183984|NCT01975389|78978813|FG000|Overall Study|Lost to Follow-up|81|||
44183985|NCT01975389|78978814|FG001|Overall Study|Lost to Follow-up|86|||
44183986|NCT01975389|78978813|FG000|Overall Study|Withdrawal by Subject|90|||
44183987|NCT01975389|78978814|FG001|Overall Study|Withdrawal by Subject|76|||
44265538|NCT02414958|79170518|FG002|Overall Study|Lost to Follow-up|0|||
44265539|NCT02414958|79170516|FG000|Overall Study|Withdrawal by Subject|5|||
44183988|NCT01975389|78978813|FG000|Overall Study|Other|6|||
44183989|NCT01975389|78978814|FG001|Overall Study|Other|9|||
44183990|NCT01975389|78978813|FG000|Overall Study|Randomized, not treated|4|||
44183991|NCT01975389|78978814|FG001|Overall Study|Randomized, not treated|5|||
44183992|NCT01974141|78978822|FG000|Overall Study|Other Reasons|28|||
44183993|NCT01974141|78978823|FG001|Overall Study|Other Reasons|18|||
44183994|NCT01974141|78978822|FG000|Overall Study|Protocol Violation|2|||
44183995|NCT01974141|78978823|FG001|Overall Study|Protocol Violation|6|||
44265540|NCT02414958|79170517|FG001|Overall Study|Withdrawal by Subject|3|||
44183996|NCT01974141|78978822|FG000|Overall Study|Personal Reasons|21|||
44183997|NCT01974141|78978823|FG001|Overall Study|Personal Reasons|20|||
44183998|NCT01974141|78978822|FG000|Overall Study|Lost to Follow-up|38|||
44183999|NCT01974141|78978823|FG001|Overall Study|Lost to Follow-up|29|||
44184000|NCT01974141|78978822|FG000|Overall Study|Pregnancy|3|||
44265541|NCT02414958|79170518|FG002|Overall Study|Withdrawal by Subject|5|||
44184001|NCT01974141|78978823|FG001|Overall Study|Pregnancy|3|||
44184002|NCT01974141|78978822|FG000|Overall Study|Lack of Efficacy|0|||
44184003|NCT01974141|78978823|FG001|Overall Study|Lack of Efficacy|1|||
44184004|NCT01974141|78978822|FG000|Overall Study|Adverse Event|4|||
44184005|NCT01974141|78978823|FG001|Overall Study|Adverse Event|5|||
44184006|NCT01945593|78978833|FG000|Overall Study|Adverse Event|0|||
44184007|NCT01945593|78978834|FG001|Overall Study|Adverse Event|0|||
44184008|NCT01945593|78978835|FG002|Overall Study|Adverse Event|0|||
44184009|NCT01945593|78978836|FG003|Overall Study|Adverse Event|5|||
44184010|NCT01945593|78978833|FG000|Overall Study|Physician Decision|0|||
44184011|NCT01945593|78978834|FG001|Overall Study|Physician Decision|0|||
44184012|NCT01945593|78978835|FG002|Overall Study|Physician Decision|1|||
44184013|NCT01945593|78978836|FG003|Overall Study|Physician Decision|1|||
44184014|NCT01945593|78978833|FG000|Overall Study|Withdrawal by Subject|0|||
44184015|NCT01945593|78978834|FG001|Overall Study|Withdrawal by Subject|2|||
44184016|NCT01945593|78978835|FG002|Overall Study|Withdrawal by Subject|0|||
44184017|NCT01945593|78978836|FG003|Overall Study|Withdrawal by Subject|4|||
44184018|NCT01945593|78978833|FG000|Overall Study|Protocol Violation|0|||
44184019|NCT01945593|78978834|FG001|Overall Study|Protocol Violation|2|||
44184020|NCT01945593|78978835|FG002|Overall Study|Protocol Violation|1|||
44184021|NCT01945593|78978836|FG003|Overall Study|Protocol Violation|3|||
44184022|NCT01945593|78978833|FG000|Overall Study|Death|0|||
44184023|NCT01945593|78978834|FG001|Overall Study|Death|0|||
44184024|NCT01945593|78978835|FG002|Overall Study|Death|1|||
44184025|NCT01945593|78978836|FG003|Overall Study|Death|0|||
44184026|NCT01945593|78978833|FG000|Overall Study|Other: Terminated|0|||
44184027|NCT01945593|78978834|FG001|Overall Study|Other: Terminated|0|||
44184028|NCT01945593|78978835|FG002|Overall Study|Other: Terminated|0|||
44184029|NCT01945593|78978836|FG003|Overall Study|Other: Terminated|1|||
44184030|NCT01945593|78978833|FG000|Overall Study|Other: Surgical Procedure|0|||
44184031|NCT01945593|78978834|FG001|Overall Study|Other: Surgical Procedure|2|||
44184032|NCT01945593|78978835|FG002|Overall Study|Other: Surgical Procedure|0|||
44184033|NCT01945593|78978836|FG003|Overall Study|Other: Surgical Procedure|6|||
44184034|NCT01945593|78978833|FG000|Overall Study|Other: Screen Failure|0|||
44184035|NCT01945593|78978834|FG001|Overall Study|Other: Screen Failure|2|||
44184036|NCT01945593|78978835|FG002|Overall Study|Other: Screen Failure|0|||
44184037|NCT01945593|78978836|FG003|Overall Study|Other: Screen Failure|0|||
44184038|NCT01945281|78978853|FG000|Overall Study|Adverse Event|1|||
44184039|NCT01945281|78978854|FG001|Overall Study|Adverse Event|0|||
44184040|NCT01945281|78978853|FG000|Overall Study|Death|3|||
44184041|NCT01945281|78978854|FG001|Overall Study|Death|3|||
44184042|NCT01945281|78978853|FG000|Overall Study|Physician Decision|1|||
44184043|NCT01945281|78978854|FG001|Overall Study|Physician Decision|1|||
44184044|NCT01945281|78978853|FG000|Overall Study|Technical Problems|1|||
44184045|NCT01945281|78978854|FG001|Overall Study|Technical Problems|0|||
44184046|NCT01961349|78978863|FG000|Overall Study|Withdrawal by Subject|1|||
44184047|NCT01961349|78978864|FG001|Overall Study|Withdrawal by Subject|4|||
44184048|NCT01961349|78978865|FG002|Overall Study|Withdrawal by Subject|0|||
44184049|NCT01961349|78978863|FG000|Overall Study|Adverse Event|0|||
44184050|NCT01961349|78978864|FG001|Overall Study|Adverse Event|0|||
44184051|NCT01961349|78978865|FG002|Overall Study|Adverse Event|1|||
44184052|NCT01961349|78978863|FG000|Overall Study|registration error, personal reason etc|2|||
44184053|NCT01961349|78978864|FG001|Overall Study|registration error, personal reason etc|2|||
44184054|NCT01961349|78978865|FG002|Overall Study|registration error, personal reason etc|1|||
44184055|NCT01973595|78978877|FG000|Washout|Withdrawal by Subject|1|||
44184056|NCT01973595|78978878|FG001|Washout|Withdrawal by Subject|0|||
44184057|NCT01973595|78978879|FG002|Washout|Withdrawal by Subject|1|||
44184058|NCT01973595|78978880|FG003|Washout|Withdrawal by Subject|0|||
44184059|NCT01944969|78978891|FG000|Overall Study|Adverse Event|1|||
44184060|NCT01944969|78978891|FG000|Overall Study|Lack of Efficacy|1|||
44184061|NCT01944969|78978891|FG000|Overall Study|Non-compliance with IMP|1|||
44184062|NCT01944969|78978891|FG000|Overall Study|Administrative or other reasons|23|||
44184063|NCT01961115|78978900|FG000|Overall Study|Disease Progression|1|||
44184064|NCT01961115|78978901|FG001|Overall Study|Disease Progression|0|||
44184065|NCT01961115|78978902|FG002|Overall Study|Disease Progression|3|||
44184066|NCT01961115|78978900|FG000|Overall Study|Adverse Event|1|||
44184067|NCT01961115|78978901|FG001|Overall Study|Adverse Event|0|||
44451329|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
44451330|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
44184068|NCT01961115|78978902|FG002|Overall Study|Adverse Event|1|||
44184069|NCT01973439|78978910|FG000|Overall Study|Lost samples from one PK Day|2|||
44184070|NCT01973439|78978910|FG000|Overall Study|Vomiting after commencing once daily|1|||
44184071|NCT01973439|78978910|FG000|Overall Study|PK curve incomplete|2|||
44184072|NCT01973283|78978914|FG000|Overall Study|Lost to Follow-up|4|||
44184073|NCT01943799|78978924|FG000|Overall Study|Lost to Follow-up|0|||
44184074|NCT01943799|78978925|FG001|Overall Study|Lost to Follow-up|1|||
44451331|NCT00098293|79460285|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
44543035|NCT03655717|79555912|FG012|Overall Study|Lost to Follow-up|0|||
44184075|NCT01943799|78978926|FG002|Overall Study|Lost to Follow-up|1|||
44184076|NCT01943799|78978927|FG003|Overall Study|Lost to Follow-up|0|||
44184077|NCT01943799|78978924|FG000|Overall Study|Protocol Violation|1|||
44184078|NCT01943799|78978925|FG001|Overall Study|Protocol Violation|0|||
44184079|NCT01943799|78978926|FG002|Overall Study|Protocol Violation|0|||
44184080|NCT01943799|78978927|FG003|Overall Study|Protocol Violation|0|||
44184081|NCT01943799|78978924|FG000|Overall Study|Withdrawal by Subject|4|||
44184082|NCT01943799|78978925|FG001|Overall Study|Withdrawal by Subject|2|||
44184083|NCT01943799|78978926|FG002|Overall Study|Withdrawal by Subject|1|||
44184084|NCT01943799|78978927|FG003|Overall Study|Withdrawal by Subject|0|||
44184085|NCT01972659|78978939|FG000|Overall Study|Protocol Violation|2|||
44184086|NCT01972659|78978940|FG001|Overall Study|Protocol Violation|2|||
44184087|NCT01972659|78978939|FG000|Overall Study|problems realted to acceleromyograph|2|||
44184088|NCT01972659|78978940|FG001|Overall Study|problems realted to acceleromyograph|1|||
44184089|NCT01971723|78978948|FG000|Overall Study|Withdrawal by Subject|1|||
44184090|NCT01971723|78978949|FG001|Overall Study|Withdrawal by Subject|1|||
44184091|NCT01971723|78978948|FG000|Overall Study|Protocol Violation|1|||
44184092|NCT01971723|78978949|FG001|Overall Study|Protocol Violation|2|||
44184093|NCT01942785|78978955|FG000|Overall Study|Adverse Event|2|||
44184094|NCT01942785|78978955|FG000|Overall Study|Withdrawal by Subject|1|||
44184095|NCT01942785|78978955|FG000|Overall Study|Protocol Violation|1|||
44184096|NCT01774786|78978963|FG000|Overall Study|Death|300|||
44184097|NCT01774786|78978964|FG001|Overall Study|Death|319|||
44184098|NCT01774786|78978963|FG000|Overall Study|Lost to Follow-up|6|||
44184099|NCT01774786|78978964|FG001|Overall Study|Lost to Follow-up|7|||
44184100|NCT01774786|78978963|FG000|Overall Study|Withdrawal by Subject|18|||
44184101|NCT01774786|78978964|FG001|Overall Study|Withdrawal by Subject|14|||
44184102|NCT01774786|78978963|FG000|Overall Study|Physician Decision|2|||
44184103|NCT01774786|78978964|FG001|Overall Study|Physician Decision|0|||
44184104|NCT01774786|78978963|FG000|Overall Study|Non-compliance|0|||
44184105|NCT01774786|78978964|FG001|Overall Study|Non-compliance|1|||
44184106|NCT01774786|78978963|FG000|Overall Study|Reason Not Specified|2|||
44184107|NCT01774786|78978964|FG001|Overall Study|Reason Not Specified|5|||
44184108|NCT01960725|78978972|FG000|Overall Study|Lost to Follow-up|4|||
44184109|NCT01960725|78978973|FG001|Overall Study|Lost to Follow-up|3|||
44184110|NCT01960725|78978972|FG000|Overall Study|Withdrawal by Subject|1|||
44184111|NCT01960725|78978973|FG001|Overall Study|Withdrawal by Subject|0|||
44184112|NCT01960725|78978972|FG000|Overall Study|unable to obtain blood sample|1|||
44184113|NCT01960725|78978973|FG001|Overall Study|unable to obtain blood sample|2|||
44184114|NCT01942161|78978982|FG000|Overall Study|Adverse Event|1|||
44184115|NCT01942161|78978983|FG001|Overall Study|Adverse Event|2|||
44184116|NCT01942161|78978984|FG002|Overall Study|Adverse Event|5|||
44184117|NCT01942161|78978982|FG000|Overall Study|Physician Decision|3|||
44184118|NCT01942161|78978983|FG001|Overall Study|Physician Decision|1|||
44184119|NCT01942161|78978984|FG002|Overall Study|Physician Decision|0|||
44184120|NCT01942161|78978982|FG000|Overall Study|Protocol Violation|1|||
44184121|NCT01942161|78978983|FG001|Overall Study|Protocol Violation|0|||
44184122|NCT01942161|78978984|FG002|Overall Study|Protocol Violation|0|||
44184123|NCT01942161|78978982|FG000|Overall Study|Withdrawal by Subject|3|||
44184124|NCT01942161|78978983|FG001|Overall Study|Withdrawal by Subject|3|||
44184125|NCT01942161|78978984|FG002|Overall Study|Withdrawal by Subject|1|||
44184126|NCT01971645|78978995|FG000|Overall Study|Adverse Event|1|||
44184127|NCT01971645|78978996|FG001|Overall Study|Adverse Event|0|||
44184128|NCT01971645|78978997|FG002|Overall Study|Adverse Event|0|||
44184129|NCT01971645|78978995|FG000|Overall Study|Lost to Follow-up|1|||
44184130|NCT01971645|78978996|FG001|Overall Study|Lost to Follow-up|0|||
44184131|NCT01971645|78978997|FG002|Overall Study|Lost to Follow-up|1|||
44184132|NCT01971645|78978995|FG000|Overall Study|Protocol Violation|0|||
44184133|NCT01971645|78978996|FG001|Overall Study|Protocol Violation|0|||
44184134|NCT01971645|78978997|FG002|Overall Study|Protocol Violation|1|||
44184135|NCT01941537|78979007|FG000|Overall Study|Lack of Efficacy|1|||
44184136|NCT01941537|78979008|FG001|Overall Study|Lack of Efficacy|2|||
44184137|NCT01941537|78979007|FG000|Overall Study|Lost to Follow-up|1|||
44184138|NCT01941537|78979008|FG001|Overall Study|Lost to Follow-up|0|||
44184139|NCT01941537|78979007|FG000|Overall Study|Pregnancy|1|||
44184140|NCT01941537|78979008|FG001|Overall Study|Pregnancy|0|||
44265542|NCT02414958|79170516|FG000|Overall Study|Other than specified|4|||
44265543|NCT02414958|79170517|FG001|Overall Study|Other than specified|4|||
44265544|NCT02414958|79170518|FG002|Overall Study|Other than specified|5|||
44184141|NCT01941537|78979007|FG000|Overall Study|Adverse Event|1|||
44184142|NCT01941537|78979008|FG001|Overall Study|Adverse Event|0|||
44265545|NCT02452476|79170591|FG000|Overall Study|Death|4|||
44184143|NCT01941537|78979007|FG000|Overall Study|Withdrawal by Subject|0|||
44184144|NCT01941537|78979008|FG001|Overall Study|Withdrawal by Subject|1|||
44265546|NCT02452476|79170592|FG001|Overall Study|Death|7|||
44265547|NCT02452476|79170591|FG000|Overall Study|Lost to Follow-up|1|||
44451332|NCT00098293|79460286|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
44184145|NCT01971567|78979017|FG000|Overall Study|Withdrawal by Subject|3|||
44184146|NCT01971567|78979018|FG001|Overall Study|Withdrawal by Subject|2|||
44184147|NCT01971567|78979017|FG000|Overall Study|Lost to Follow-up|1|||
44184148|NCT01971567|78979018|FG001|Overall Study|Lost to Follow-up|0|||
44184149|NCT01960413|78979026|FG000|Overall Study|Withdrawal by Subject|1|||
44184150|NCT01960413|78979027|FG001|Overall Study|Withdrawal by Subject|1|||
44184151|NCT01960413|78979026|FG000|Overall Study|Physician Decision|1|||
44184152|NCT01960413|78979027|FG001|Overall Study|Physician Decision|0|||
44184153|NCT01960413|78979026|FG000|Overall Study|Lost to Follow-up|2|||
44184154|NCT01960413|78979027|FG001|Overall Study|Lost to Follow-up|0|||
44184155|NCT01970475|78979035|FG000|Overall Study|Withdrawal by Subject|11|||
44184156|NCT01970475|78979036|FG001|Overall Study|Withdrawal by Subject|6|||
44184157|NCT01970475|78979035|FG000|Overall Study|Adverse Event|7|||
44184158|NCT01970475|78979036|FG001|Overall Study|Adverse Event|3|||
44184159|NCT01970475|78979035|FG000|Overall Study|Lost to Follow-up|2|||
44184160|NCT01970475|78979036|FG001|Overall Study|Lost to Follow-up|2|||
44184161|NCT01970475|78979035|FG000|Overall Study|Protocol Violation|1|||
44184162|NCT01970475|78979036|FG001|Overall Study|Protocol Violation|0|||
44184163|NCT01939977|78979044|FG000|Overall Study|Adverse Event|4|||
44184164|NCT01939977|78979045|FG001|Overall Study|Adverse Event|3|||
44184165|NCT01939977|78979044|FG000|Overall Study|Lack of Efficacy|3|||
44184166|NCT01939977|78979045|FG001|Overall Study|Lack of Efficacy|0|||
44184167|NCT01939977|78979044|FG000|Overall Study|Physician Decision|1|||
44184168|NCT01939977|78979045|FG001|Overall Study|Physician Decision|1|||
44184169|NCT01939977|78979044|FG000|Overall Study|Withdrawal by Subject|0|||
44184170|NCT01939977|78979045|FG001|Overall Study|Withdrawal by Subject|2|||
44184171|NCT01939977|78979044|FG000|Overall Study|Did not meet inclusion criteria|1|||
44184172|NCT01939977|78979045|FG001|Overall Study|Did not meet inclusion criteria|0|||
44184173|NCT01939977|78979044|FG000|Overall Study|Did not receive study medication|0|||
44184174|NCT01939977|78979045|FG001|Overall Study|Did not receive study medication|1|||
44184175|NCT01939899|78979056|FG000|Lead-in Dose Finding Phase|Death|0|||
44184176|NCT01939899|78979057|FG001|Lead-in Dose Finding Phase|Death|3|||
44184177|NCT01939899|78979058|FG002|Lead-in Dose Finding Phase|Death|1|||
44184178|NCT01939899|78979059|FG003|Lead-in Dose Finding Phase|Death|0|||
44184179|NCT01939899|78979060|FG004|Lead-in Dose Finding Phase|Death|0|||
44184180|NCT01939899|78979056|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
44184181|NCT01939899|78979057|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
44184182|NCT01939899|78979058|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
44184183|NCT01939899|78979059|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
44184184|NCT01939899|78979060|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
44184185|NCT01939899|78979056|FG000|Lead-in Dose Finding Phase|Other|0|||
44184186|NCT01939899|78979057|FG001|Lead-in Dose Finding Phase|Other|0|||
44184187|NCT01939899|78979058|FG002|Lead-in Dose Finding Phase|Other|1|||
44184188|NCT01939899|78979059|FG003|Lead-in Dose Finding Phase|Other|0|||
44184189|NCT01939899|78979060|FG004|Lead-in Dose Finding Phase|Other|0|||
44184190|NCT01939899|78979056|FG000|Phase 2|Withdrawal by Subject|0|||
44184191|NCT01939899|78979057|FG001|Phase 2|Withdrawal by Subject|0|||
44184192|NCT01939899|78979058|FG002|Phase 2|Withdrawal by Subject|0|||
44184193|NCT01939899|78979059|FG003|Phase 2|Withdrawal by Subject|2|||
44184194|NCT01939899|78979060|FG004|Phase 2|Withdrawal by Subject|0|||
44184195|NCT01939899|78979056|FG000|Phase 2|Disease Progression|0|||
44184196|NCT01939899|78979057|FG001|Phase 2|Disease Progression|0|||
44184197|NCT01939899|78979058|FG002|Phase 2|Disease Progression|0|||
44184198|NCT01939899|78979059|FG003|Phase 2|Disease Progression|9|||
44184199|NCT01939899|78979060|FG004|Phase 2|Disease Progression|1|||
44184200|NCT01970397|78979080|FG000|Overall Study|Adverse Event|0|||
44184201|NCT01970397|78979081|FG001|Overall Study|Adverse Event|1|||
44184202|NCT01970397|78979080|FG000|Overall Study|Lost to Follow-up|0|||
44184203|NCT01970397|78979081|FG001|Overall Study|Lost to Follow-up|1|||
44184204|NCT01970397|78979080|FG000|Overall Study|Personal Reasons|1|||
44184205|NCT01970397|78979081|FG001|Overall Study|Personal Reasons|2|||
44184206|NCT01970397|78979080|FG000|Overall Study|Protocol Violation|1|||
44184207|NCT01970397|78979081|FG001|Overall Study|Protocol Violation|1|||
44184208|NCT01970241|78979089|FG000|Overall Study|Withdrawal by Subject|2|||
44184209|NCT01970241|78979090|FG001|Overall Study|Withdrawal by Subject|0|||
44184210|NCT01970241|78979089|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
44184211|NCT01970241|78979090|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
44184212|NCT01939353|78979098|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
44184213|NCT01939353|78979098|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
44184214|NCT01939353|78979098|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
44184215|NCT01939353|78979098|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
44184216|NCT01939353|78979098|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
44184217|NCT01970007|78979102|FG000|Overall Study|Death|5|||
44184218|NCT01970007|78979102|FG000|Overall Study|Withdrawal by Subject|23|||
44184219|NCT01970007|78979102|FG000|Overall Study|Lost to Follow-up|24|||
44184220|NCT01970007|78979102|FG000|Overall Study|"Other endpoint"|3|||
44265548|NCT02452476|79170592|FG001|Overall Study|Lost to Follow-up|1|||
44184221|NCT01728376|78979112|FG000|Overall Study|Adverse Event|1|||
44184222|NCT01728376|78979113|FG001|Overall Study|Adverse Event|1|||
44184223|NCT01728376|78979114|FG002|Overall Study|Adverse Event|1|||
44184224|NCT01728376|78979115|FG003|Overall Study|Adverse Event|1|||
44184225|NCT01728376|78979116|FG004|Overall Study|Adverse Event|1|||
44184226|NCT01728376|78979117|FG005|Overall Study|Adverse Event|0|||
44184227|NCT01728376|78979112|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
44265549|NCT02452476|79170591|FG000|Overall Study|Physician Decision|1|||
44184228|NCT01728376|78979113|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
44184229|NCT01728376|78979114|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
44184230|NCT01728376|78979115|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
44184231|NCT01728376|78979116|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
44184232|NCT01728376|78979117|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
44184233|NCT01728376|78979112|FG000|Overall Study|No relevant bacteria|2|||
44184234|NCT01728376|78979113|FG001|Overall Study|No relevant bacteria|0|||
44184235|NCT01728376|78979114|FG002|Overall Study|No relevant bacteria|0|||
44184236|NCT01728376|78979115|FG003|Overall Study|No relevant bacteria|0|||
44184237|NCT01728376|78979116|FG004|Overall Study|No relevant bacteria|1|||
44184238|NCT01728376|78979117|FG005|Overall Study|No relevant bacteria|1|||
44184239|NCT01728376|78979112|FG000|Overall Study|Did not receive treatment|0|||
44184240|NCT01728376|78979113|FG001|Overall Study|Did not receive treatment|1|||
44184241|NCT01728376|78979114|FG002|Overall Study|Did not receive treatment|0|||
44184242|NCT01728376|78979115|FG003|Overall Study|Did not receive treatment|0|||
44184243|NCT01728376|78979116|FG004|Overall Study|Did not receive treatment|0|||
44184244|NCT01728376|78979117|FG005|Overall Study|Did not receive treatment|0|||
44184245|NCT01728376|78979112|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
44184246|NCT01728376|78979113|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
44184247|NCT01728376|78979114|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
44184248|NCT01728376|78979115|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
44184249|NCT01728376|78979116|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
44184250|NCT01728376|78979117|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
44184251|NCT01708174|78979134|FG000|Treatment Period|Withdrawal by Subject|1|||
44184252|NCT01708174|78979135|FG001|Treatment Period|Withdrawal by Subject|0|||
44184253|NCT01708174|78979136|FG002|Treatment Period|Withdrawal by Subject|0|||
44184254|NCT01708174|78979134|FG000|Treatment Period|Progressive disease|0|||
44184255|NCT01708174|78979135|FG001|Treatment Period|Progressive disease|1|||
44184256|NCT01708174|78979136|FG002|Treatment Period|Progressive disease|0|||
44184257|NCT01708174|78979134|FG000|Treatment Period|Death|0|||
44184258|NCT01708174|78979135|FG001|Treatment Period|Death|0|||
44184259|NCT01708174|78979136|FG002|Treatment Period|Death|1|||
44184260|NCT01708174|78979134|FG000|Treatment Period|Adverse Event|0|||
44184261|NCT01708174|78979135|FG001|Treatment Period|Adverse Event|1|||
44184262|NCT01708174|78979136|FG002|Treatment Period|Adverse Event|0|||
44184263|NCT01605916|78979150|FG000|Overall Study|Adverse Event|1|||
44184264|NCT01605916|78979151|FG001|Overall Study|Adverse Event|0|||
44184265|NCT01605916|78979152|FG002|Overall Study|Adverse Event|0|||
44184266|NCT01605916|78979153|FG003|Overall Study|Adverse Event|1|||
44184267|NCT01605916|78979154|FG004|Overall Study|Adverse Event|0|||
44184268|NCT01605916|78979150|FG000|Overall Study|Lack of Efficacy|2|||
44184269|NCT01605916|78979151|FG001|Overall Study|Lack of Efficacy|3|||
44184270|NCT01605916|78979152|FG002|Overall Study|Lack of Efficacy|3|||
44184271|NCT01605916|78979153|FG003|Overall Study|Lack of Efficacy|5|||
44184272|NCT01605916|78979154|FG004|Overall Study|Lack of Efficacy|4|||
44184273|NCT01605916|78979150|FG000|Overall Study|Withdrawal by Subject|1|||
44184274|NCT01605916|78979151|FG001|Overall Study|Withdrawal by Subject|1|||
44184275|NCT01605916|78979152|FG002|Overall Study|Withdrawal by Subject|0|||
44184276|NCT01605916|78979153|FG003|Overall Study|Withdrawal by Subject|0|||
44184277|NCT01605916|78979154|FG004|Overall Study|Withdrawal by Subject|2|||
44184278|NCT01635283|78979167|FG000|Overall Study|Tumor Progression|3|||
44184279|NCT01635283|78979167|FG000|Overall Study|Lost to Follow-up|1|||
44184280|NCT01707004|78979174|FG000|Overall Study|Physician Decision|3|||
44184281|NCT01939197|78979186|FG000|Overall Study|Withdrawal by Subject|1|||
44265550|NCT02452476|79170592|FG001|Overall Study|Physician Decision|1|||
44265551|NCT02452476|79170591|FG000|Overall Study|Not treated|5|||
44265552|NCT02452476|79170592|FG001|Overall Study|Not treated|1|||
44265553|NCT02442336|79170607|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
44184282|NCT01939197|78979187|FG001|Overall Study|Withdrawal by Subject|0|||
44184283|NCT01939197|78979188|FG002|Overall Study|Withdrawal by Subject|0|||
44184284|NCT01939197|78979189|FG003|Overall Study|Withdrawal by Subject|0|||
44184285|NCT01939197|78979190|FG004|Overall Study|Withdrawal by Subject|1|||
44184286|NCT01939197|78979191|FG005|Overall Study|Withdrawal by Subject|0|||
44184287|NCT01939197|78979192|FG006|Overall Study|Withdrawal by Subject|0|||
44184288|NCT01939197|78979186|FG000|Overall Study|Lost to Follow-up|0|||
44184289|NCT01939197|78979187|FG001|Overall Study|Lost to Follow-up|1|||
44184290|NCT01939197|78979188|FG002|Overall Study|Lost to Follow-up|0|||
44184291|NCT01939197|78979189|FG003|Overall Study|Lost to Follow-up|1|||
44184292|NCT01939197|78979190|FG004|Overall Study|Lost to Follow-up|3|||
44184293|NCT01939197|78979191|FG005|Overall Study|Lost to Follow-up|1|||
44265554|NCT02442336|79170607|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
44184294|NCT01939197|78979192|FG006|Overall Study|Lost to Follow-up|2|||
44184295|NCT01969851|78979225|FG000|Overall Study|Adverse Event|0|||
44184296|NCT01969851|78979226|FG001|Overall Study|Adverse Event|0|||
44184297|NCT01969851|78979227|FG002|Overall Study|Adverse Event|3|||
44184298|NCT01969851|78979225|FG000|Overall Study|Lack of Efficacy|0|||
44184299|NCT01969851|78979226|FG001|Overall Study|Lack of Efficacy|3|||
44184300|NCT01969851|78979227|FG002|Overall Study|Lack of Efficacy|1|||
44184301|NCT01969851|78979225|FG000|Overall Study|Withdrawal by Subject|1|||
44184302|NCT01969851|78979226|FG001|Overall Study|Withdrawal by Subject|0|||
44184303|NCT01969851|78979227|FG002|Overall Study|Withdrawal by Subject|1|||
44184304|NCT01969851|78979225|FG000|Overall Study|No effective dose in Titration period|0|||
44184305|NCT01969851|78979226|FG001|Overall Study|No effective dose in Titration period|0|||
44184306|NCT01969851|78979227|FG002|Overall Study|No effective dose in Titration period|1|||
44184307|NCT01969851|78979225|FG000|Overall Study|Sponsor decision|0|||
44184308|NCT01969851|78979226|FG001|Overall Study|Sponsor decision|0|||
44184309|NCT01969851|78979227|FG002|Overall Study|Sponsor decision|1|||
44184310|NCT01938573|78979235|FG000|Overall Study|Lack of Efficacy|1|||
44184311|NCT01938573|78979236|FG001|Overall Study|Lack of Efficacy|0|||
44184312|NCT01938573|78979235|FG000|Overall Study|Operation at other hospital|1|||
44184313|NCT01938573|78979236|FG001|Overall Study|Operation at other hospital|0|||
44184314|NCT01937871|78979244|FG000|Overall Study|Adverse Event|6|||
44184315|NCT01937871|78979245|FG001|Overall Study|Adverse Event|6|||
44184316|NCT01937871|78979246|FG002|Overall Study|Adverse Event|2|||
44184317|NCT01937871|78979244|FG000|Overall Study|Lost to Follow-up|8|||
44184318|NCT01937871|78979245|FG001|Overall Study|Lost to Follow-up|2|||
44184319|NCT01937871|78979246|FG002|Overall Study|Lost to Follow-up|4|||
44184320|NCT01937871|78979244|FG000|Overall Study|Withdrawal by Subject|9|||
44184321|NCT01937871|78979245|FG001|Overall Study|Withdrawal by Subject|6|||
44184322|NCT01937871|78979246|FG002|Overall Study|Withdrawal by Subject|4|||
44184323|NCT01937871|78979244|FG000|Overall Study|Physician Decision|0|||
44184324|NCT01937871|78979245|FG001|Overall Study|Physician Decision|1|||
44184325|NCT01937871|78979246|FG002|Overall Study|Physician Decision|0|||
44184326|NCT01937871|78979244|FG000|Overall Study|Entry Criteria Not Met|1|||
44184327|NCT01937871|78979245|FG001|Overall Study|Entry Criteria Not Met|2|||
44184328|NCT01937871|78979246|FG002|Overall Study|Entry Criteria Not Met|1|||
44184329|NCT01269463|78979257|FG000|First Intervention|Withdrawal by Subject|1|||
44184330|NCT01269463|78979258|FG001|First Intervention|Withdrawal by Subject|0|||
44184331|NCT01269463|78979257|FG000|First Intervention|Adverse Event|1|||
44184332|NCT01269463|78979258|FG001|First Intervention|Adverse Event|0|||
44184333|NCT01269463|78979257|FG000|First Intervention|Lack of Efficacy|0|||
44184334|NCT01269463|78979258|FG001|First Intervention|Lack of Efficacy|1|||
44184335|NCT01269463|78979257|FG000|First Intervention|Physician Decision|0|||
44184336|NCT01269463|78979258|FG001|First Intervention|Physician Decision|1|||
44184337|NCT01706926|78979273|FG000|Overall Study|Lost to Follow-up|0|||
44184338|NCT01706926|78979274|FG001|Overall Study|Lost to Follow-up|0|||
44184339|NCT01706926|78979275|FG002|Overall Study|Lost to Follow-up|1|||
44184340|NCT01706926|78979276|FG003|Overall Study|Lost to Follow-up|0|||
44184341|NCT01706926|78979273|FG000|Overall Study|Withdrawal by Subject|2|||
44184342|NCT01706926|78979274|FG001|Overall Study|Withdrawal by Subject|0|||
44184343|NCT01706926|78979275|FG002|Overall Study|Withdrawal by Subject|1|||
44184344|NCT01706926|78979276|FG003|Overall Study|Withdrawal by Subject|2|||
44184345|NCT01706926|78979273|FG000|Overall Study|Other|4|||
44184346|NCT01706926|78979274|FG001|Overall Study|Other|4|||
44184347|NCT01706926|78979275|FG002|Overall Study|Other|4|||
44184348|NCT01706926|78979276|FG003|Overall Study|Other|3|||
44184349|NCT01634113|78979292|FG000|Overall Study|Not treated|0|||
44184350|NCT01634113|78979293|FG001|Overall Study|Not treated|0|||
44184351|NCT01634113|78979294|FG002|Overall Study|Not treated|1|||
44184352|NCT01706770|78979304|FG000|Overall Study|Lost to Follow-up|1|||
44184353|NCT01706770|78979305|FG001|Overall Study|Lost to Follow-up|0|||
44184354|NCT01706770|78979304|FG000|Overall Study|Physician Decision|1|||
44184355|NCT01706770|78979305|FG001|Overall Study|Physician Decision|0|||
44184356|NCT01937715|78979316|FG000|Overall Study|Death|0|||
44184357|NCT01937715|78979317|FG001|Overall Study|Death|0|||
44184358|NCT01937715|78979318|FG002|Overall Study|Death|0|||
44184359|NCT01937715|78979319|FG003|Overall Study|Death|1|||
44184360|NCT01937715|78979320|FG004|Overall Study|Death|0|||
44184361|NCT01937715|78979316|FG000|Overall Study|Withdrawal by Subject|0|||
44184362|NCT01937715|78979317|FG001|Overall Study|Withdrawal by Subject|1|||
44184363|NCT01937715|78979318|FG002|Overall Study|Withdrawal by Subject|0|||
44184364|NCT01937715|78979319|FG003|Overall Study|Withdrawal by Subject|0|||
44184365|NCT01937715|78979320|FG004|Overall Study|Withdrawal by Subject|2|||
44184366|NCT01937715|78979316|FG000|Overall Study|Other|0|||
44184367|NCT01937715|78979317|FG001|Overall Study|Other|0|||
44184368|NCT01937715|78979318|FG002|Overall Study|Other|0|||
44184369|NCT01937715|78979319|FG003|Overall Study|Other|3|||
44184370|NCT01937715|78979320|FG004|Overall Study|Other|0|||
44184371|NCT01937559|78979335|FG000|Overall Study|Physician Decision|3|||
44184372|NCT01937559|78979336|FG001|Overall Study|Physician Decision|3|||
44184373|NCT01937559|78979337|FG002|Overall Study|Physician Decision|0|||
44184374|NCT01937559|78979335|FG000|Overall Study|Withdrawal by Subject|6|||
44184375|NCT01937559|78979336|FG001|Overall Study|Withdrawal by Subject|4|||
44184376|NCT01937559|78979337|FG002|Overall Study|Withdrawal by Subject|0|||
44184377|NCT01937559|78979335|FG000|Overall Study|screen fail|2|||
44184378|NCT01937559|78979336|FG001|Overall Study|screen fail|4|||
44184379|NCT01937559|78979337|FG002|Overall Study|screen fail|0|||
44184380|NCT01960257|78979349|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
44184381|NCT01960257|78979350|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
44184382|NCT01960257|78979351|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
44184383|NCT01960257|78979349|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
44184384|NCT01960257|78979350|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
44184385|NCT01960257|78979351|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
44184386|NCT01960257|78979349|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
44184387|NCT01960257|78979350|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
44184388|NCT01960257|78979351|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
44184389|NCT01918371|78979363|FG000|Overall Study|Missing Data|1|||
44184390|NCT01918371|78979364|FG001|Overall Study|Missing Data|1|||
44184391|NCT01917747|78979372|FG000|Overall Study|Withdrawal by Subject|1|||
44184392|NCT01917747|78979373|FG001|Overall Study|Withdrawal by Subject|2|||
44184393|NCT01917747|78979372|FG000|Overall Study|Lost to Follow-up|18|||
44184394|NCT01917747|78979373|FG001|Overall Study|Lost to Follow-up|9|||
44184395|NCT01597791|78979385|FG000|Overall Study|Physician Decision|2|||
44184396|NCT01597791|78979386|FG001|Overall Study|Physician Decision|1|||
44184397|NCT01597791|78979385|FG000|Overall Study|Cesarean Section|6|||
44184398|NCT01597791|78979386|FG001|Overall Study|Cesarean Section|7|||
44184399|NCT01597791|78979385|FG000|Overall Study|Subject withdrawal|0|||
44184400|NCT01597791|78979386|FG001|Overall Study|Subject withdrawal|1|||
44184401|NCT01597791|78979385|FG000|Overall Study|Protocol Violation|0|||
44184402|NCT01597791|78979386|FG001|Overall Study|Protocol Violation|1|||
44184403|NCT01916967|78979395|FG000|Overall Study|Adverse Event|0|||
44184404|NCT01916967|78979396|FG001|Overall Study|Adverse Event|0|||
44184405|NCT01916967|78979397|FG002|Overall Study|Adverse Event|2|||
44184406|NCT01916967|78979395|FG000|Overall Study|Lack of Efficacy|0|||
44184407|NCT01916967|78979396|FG001|Overall Study|Lack of Efficacy|0|||
44184408|NCT01916967|78979397|FG002|Overall Study|Lack of Efficacy|6|||
44184409|NCT01916967|78979395|FG000|Overall Study|Physician Decision|0|||
44184410|NCT01916967|78979396|FG001|Overall Study|Physician Decision|0|||
44184411|NCT01916967|78979397|FG002|Overall Study|Physician Decision|1|||
44184412|NCT01916967|78979395|FG000|Overall Study|Protocol Violation|0|||
44184413|NCT01916967|78979396|FG001|Overall Study|Protocol Violation|1|||
44184414|NCT01916967|78979397|FG002|Overall Study|Protocol Violation|0|||
44184415|NCT01936623|78979409|FG000|Overall Study|Lost to Follow-up|0|||
44184416|NCT01936623|78979410|FG001|Overall Study|Lost to Follow-up|5|||
44184417|NCT01959243|78979418|FG000|Overall Study|Investigator Decision|3|||
44184418|NCT01959243|78979419|FG001|Overall Study|Investigator Decision|0|||
44184419|NCT01959243|78979418|FG000|Overall Study|Adverse Event|5|||
44184420|NCT01959243|78979419|FG001|Overall Study|Adverse Event|2|||
44184421|NCT01959243|78979418|FG000|Overall Study|Administrative reasons|2|||
44184422|NCT01959243|78979419|FG001|Overall Study|Administrative reasons|1|||
44184423|NCT01959243|78979418|FG000|Overall Study|Lost to Follow-up|3|||
44184424|NCT01959243|78979419|FG001|Overall Study|Lost to Follow-up|1|||
44184425|NCT01959165|78979429|FG000|Overall Study|Adverse Event|0|||
44184426|NCT01959165|78979430|FG001|Overall Study|Adverse Event|0|||
44184427|NCT01959165|78979431|FG002|Overall Study|Adverse Event|0|||
44184428|NCT01959165|78979432|FG003|Overall Study|Adverse Event|1|||
44184429|NCT01959165|78979429|FG000|Overall Study|Lack of Efficacy|1|||
44184430|NCT01959165|78979430|FG001|Overall Study|Lack of Efficacy|0|||
44184431|NCT01959165|78979431|FG002|Overall Study|Lack of Efficacy|0|||
44184432|NCT01959165|78979432|FG003|Overall Study|Lack of Efficacy|0|||
44184433|NCT01959165|78979429|FG000|Overall Study|overdose|0|||
44184434|NCT01959165|78979430|FG001|Overall Study|overdose|0|||
44265555|NCT02442336|79170607|FG000|Overall Study|Lost to Follow-up|11|||
44265556|NCT02452398|79170611|FG000|Overall Study|Adverse Event|1|||
44265557|NCT02452398|79170611|FG000|Overall Study|Lost to Follow-up|28|||
44265558|NCT02452398|79170611|FG000|Overall Study|Physician Decision|2|||
44265559|NCT02452398|79170611|FG000|Overall Study|Withdrawal by Subject|6|||
44451333|NCT00098293|79460287|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
44451334|NCT00098293|79460288|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
44184435|NCT01959165|78979431|FG002|Overall Study|overdose|0|||
44265560|NCT02452398|79170611|FG000|Overall Study|Moved away|4|||
44265561|NCT02413398|79170617|FG000|Overall Study|Lost to Follow-up|2|||
44265562|NCT02413398|79170618|FG001|Overall Study|Lost to Follow-up|4|||
44184436|NCT01959165|78979432|FG003|Overall Study|overdose|1|||
44184437|NCT01959165|78979429|FG000|Overall Study|Welfare recipient|0|||
44184438|NCT01959165|78979430|FG001|Overall Study|Welfare recipient|1|||
44184439|NCT01959165|78979431|FG002|Overall Study|Welfare recipient|0|||
44184440|NCT01959165|78979432|FG003|Overall Study|Welfare recipient|0|||
44451335|NCT00098293|79460289|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
44265563|NCT02413398|79170617|FG000|Overall Study|Withdrawal by Subject|1|||
44184441|NCT01916109|78979442|FG000|Overall Study|Withdrawal by Subject|1|||
44184442|NCT01915095|78979453|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
44184443|NCT01915095|78979454|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
44265564|NCT02413398|79170618|FG001|Overall Study|Withdrawal by Subject|1|||
44265565|NCT02413398|79170617|FG000|Overall Study|Other Eligibility criteria|1|||
44265566|NCT02413398|79170618|FG001|Overall Study|Other Eligibility criteria|2|||
44265567|NCT02441946|79170627|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
44265568|NCT02441946|79170628|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
44265569|NCT02441946|79170629|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
44265570|NCT02441946|79170627|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
44265571|NCT02441946|79170628|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
44265572|NCT02441946|79170629|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
44265573|NCT02441946|79170627|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
44265574|NCT02441946|79170628|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
44265575|NCT02441946|79170629|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
44265576|NCT02441946|79170627|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
44184444|NCT01915095|78979455|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
44184445|NCT01915095|78979456|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
44184446|NCT01915095|78979457|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
44184447|NCT01958619|78979482|FG000|Overall Study|Protocol Violation|2|||
44184448|NCT01958619|78979483|FG001|Overall Study|Protocol Violation|0|||
44184449|NCT01958619|78979484|FG002|Overall Study|Protocol Violation|1|||
44184450|NCT01958619|78979485|FG003|Overall Study|Protocol Violation|0|||
44184451|NCT01752634|78979501|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
44184452|NCT01752634|78979502|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
44184453|NCT01752634|78979503|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
44184454|NCT01752634|78979504|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
44184455|NCT01752634|78979505|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
44184456|NCT01752634|78979506|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
44184457|NCT01752634|78979501|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
44184458|NCT01752634|78979502|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
44184459|NCT01752634|78979503|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
44184460|NCT01752634|78979504|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
44184461|NCT01752634|78979505|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
44184462|NCT01752634|78979506|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
44184463|NCT01752634|78979501|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
44184464|NCT01752634|78979502|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
44184465|NCT01752634|78979503|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
44184466|NCT01752634|78979504|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
44184467|NCT01752634|78979505|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
44184468|NCT01752634|78979506|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
44184469|NCT01752634|78979501|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
44184470|NCT01752634|78979502|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
44184471|NCT01752634|78979503|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
44184472|NCT01752634|78979504|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
44184473|NCT01752634|78979505|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
44184474|NCT01752634|78979506|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
44184475|NCT01752634|78979501|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
44184476|NCT01752634|78979502|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
44184477|NCT01752634|78979503|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
44184478|NCT01752634|78979504|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
44184479|NCT01752634|78979505|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
44184480|NCT01752634|78979506|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
44184481|NCT01752634|78979501|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
44184482|NCT01752634|78979502|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
44184483|NCT01752634|78979503|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
44184484|NCT01752634|78979504|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
44184485|NCT01752634|78979505|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
44184486|NCT01752634|78979506|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
44184487|NCT01752634|78979501|FG000|Week 24 to Week 260|Physician Decision|1|||
44184488|NCT01752634|78979502|FG001|Week 24 to Week 260|Physician Decision|2|||
44184489|NCT01752634|78979503|FG002|Week 24 to Week 260|Physician Decision|4|||
44265577|NCT02441946|79170628|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
44184490|NCT01752634|78979504|FG003|Week 24 to Week 260|Physician Decision|2|||
44184491|NCT01752634|78979505|FG004|Week 24 to Week 260|Physician Decision|1|||
44184492|NCT01752634|78979506|FG005|Week 24 to Week 260|Physician Decision|0|||
44184493|NCT01752634|78979501|FG000|Week 24 to Week 260|Death|0|||
44184494|NCT01752634|78979502|FG001|Week 24 to Week 260|Death|1|||
44184495|NCT01752634|78979503|FG002|Week 24 to Week 260|Death|0|||
44184496|NCT01752634|78979504|FG003|Week 24 to Week 260|Death|0|||
44265578|NCT02441946|79170629|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
44543036|NCT03655717|79555913|FG013|Overall Study|Lost to Follow-up|0|||
44184497|NCT01752634|78979505|FG004|Week 24 to Week 260|Death|0|||
44184498|NCT01752634|78979506|FG005|Week 24 to Week 260|Death|0|||
44184499|NCT01752634|78979501|FG000|Week 24 to Week 260|Pregnancy|0|||
44184500|NCT01752634|78979502|FG001|Week 24 to Week 260|Pregnancy|0|||
44184501|NCT01752634|78979503|FG002|Week 24 to Week 260|Pregnancy|1|||
44184502|NCT01752634|78979504|FG003|Week 24 to Week 260|Pregnancy|0|||
44184503|NCT01752634|78979505|FG004|Week 24 to Week 260|Pregnancy|0|||
44184504|NCT01752634|78979506|FG005|Week 24 to Week 260|Pregnancy|0|||
44184505|NCT01752634|78979501|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
44184506|NCT01752634|78979502|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
44184507|NCT01752634|78979503|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
44184508|NCT01752634|78979504|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
44184509|NCT01752634|78979505|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
44184510|NCT01752634|78979506|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
44184511|NCT01752634|78979501|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
44184512|NCT01752634|78979502|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
44184513|NCT01752634|78979503|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
44184514|NCT01752634|78979504|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
44184515|NCT01752634|78979505|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
44184516|NCT01752634|78979506|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
44184517|NCT01752634|78979501|FG000|Week 24 to Week 260|Adverse Event|4|||
44184518|NCT01752634|78979502|FG001|Week 24 to Week 260|Adverse Event|8|||
44184519|NCT01752634|78979503|FG002|Week 24 to Week 260|Adverse Event|8|||
44184520|NCT01752634|78979504|FG003|Week 24 to Week 260|Adverse Event|4|||
44184521|NCT01752634|78979505|FG004|Week 24 to Week 260|Adverse Event|2|||
44184522|NCT01752634|78979506|FG005|Week 24 to Week 260|Adverse Event|0|||
44184523|NCT01726270|78979516|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
44184524|NCT01726270|78979516|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
44184525|NCT01726270|78979516|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
44184526|NCT01726270|78979516|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
44184527|NCT01726270|78979516|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
44184528|NCT01726270|78979516|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
44184529|NCT01914393|78979525|FG000|Overall Study|Protocol Violation|11|||
44184530|NCT01914393|78979526|FG001|Overall Study|Protocol Violation|3|||
44184531|NCT01914393|78979527|FG002|Overall Study|Protocol Violation|19|||
44184532|NCT01914393|78979525|FG000|Overall Study|Lack of Efficacy|11|||
44184533|NCT01914393|78979526|FG001|Overall Study|Lack of Efficacy|16|||
44184534|NCT01914393|78979527|FG002|Overall Study|Lack of Efficacy|5|||
44184535|NCT01914393|78979525|FG000|Overall Study|no reason given|14|||
44184536|NCT01914393|78979526|FG001|Overall Study|no reason given|8|||
44184537|NCT01914393|78979527|FG002|Overall Study|no reason given|16|||
44184538|NCT01914393|78979525|FG000|Overall Study|Adverse Event|29|||
44184539|NCT01914393|78979526|FG001|Overall Study|Adverse Event|18|||
44184540|NCT01914393|78979527|FG002|Overall Study|Adverse Event|31|||
44184541|NCT01914393|78979525|FG000|Overall Study|Withdrawal by Subject|38|||
44184542|NCT01914393|78979526|FG001|Overall Study|Withdrawal by Subject|20|||
44184543|NCT01914393|78979527|FG002|Overall Study|Withdrawal by Subject|47|||
44184544|NCT01914393|78979525|FG000|Overall Study|Lost to Follow-up|12|||
44184545|NCT01914393|78979526|FG001|Overall Study|Lost to Follow-up|6|||
44184546|NCT01914393|78979527|FG002|Overall Study|Lost to Follow-up|19|||
44184547|NCT01914393|78979525|FG000|Overall Study|subject never dosed|0|||
44184548|NCT01914393|78979526|FG001|Overall Study|subject never dosed|0|||
44184549|NCT01914393|78979527|FG002|Overall Study|subject never dosed|1|||
44184550|NCT01931865|78979539|FG000|Overall Study|Lost to Follow-up|2|||
44184551|NCT01931865|78979539|FG000|Overall Study|Withdrawal by Subject|2|||
44184552|NCT01617447|78979546|FG000|Overall Study|Adverse Event|0|||
44184553|NCT01617447|78979547|FG001|Overall Study|Adverse Event|1|||
44184554|NCT01617447|78979546|FG000|Overall Study|Physician Decision|0|||
44184555|NCT01617447|78979547|FG001|Overall Study|Physician Decision|2|||
44184556|NCT00432679|78979555|FG000|Overall Study|Adverse Event|2|||
44184557|NCT00432679|78979556|FG001|Overall Study|Adverse Event|1|||
44265579|NCT02441946|79170627|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
44265580|NCT02441946|79170628|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
44265581|NCT02441946|79170629|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
44265582|NCT02441946|79170627|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
44265583|NCT02441946|79170628|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
44265584|NCT02441946|79170629|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
44265585|NCT02441946|79170627|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
44265586|NCT02441946|79170628|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
44184558|NCT00432679|78979555|FG000|Overall Study|Withdrawal by Subject|3|||
44184559|NCT00432679|78979556|FG001|Overall Study|Withdrawal by Subject|2|||
44184560|NCT01600105|78979564|FG000|Total Participants|Withdrawal by Subject|1|||
44184561|NCT01600105|78979565|FG001|Total Participants|Withdrawal by Subject|0|||
44184562|NCT01600105|78979564|FG000|Total Participants|No images in PACS|10|||
44184563|NCT01600105|78979565|FG001|Total Participants|No images in PACS|0|||
44184564|NCT01600105|78979564|FG000|Total Participants|Insufficient image quality|30|||
44184565|NCT01600105|78979565|FG001|Total Participants|Insufficient image quality|10|||
44184566|NCT01600105|78979564|FG000|Sub Study I|Insufficient image quality|0|||
44184567|NCT01600105|78979565|FG001|Sub Study I|Insufficient image quality|10|||
44184568|NCT01600105|78979564|FG000|Sub Study II|Withdrawal by Subject|1|||
44184569|NCT01600105|78979565|FG001|Sub Study II|Withdrawal by Subject|0|||
44184570|NCT01600105|78979564|FG000|Sub Study II|No images in PACS|1|||
44184571|NCT01600105|78979565|FG001|Sub Study II|No images in PACS|0|||
44184572|NCT01600105|78979564|FG000|Sub Study II|Insufficient image quality|3|||
44184573|NCT01600105|78979565|FG001|Sub Study II|Insufficient image quality|0|||
44184574|NCT01600105|78979564|FG000|Sub Study III|Insufficient image quality|5|||
44184575|NCT01600105|78979565|FG001|Sub Study III|Insufficient image quality|0|||
44184576|NCT01600105|78979564|FG000|Sub Study V|Poor Image Quality|2|||
44184577|NCT01600105|78979565|FG001|Sub Study V|Poor Image Quality|0|||
44184578|NCT02246647|78979577|FG000|Overall Study|Withdrawal by Subject|1|||
44184579|NCT02246647|78979578|FG001|Overall Study|Withdrawal by Subject|1|||
44184580|NCT01933113|78979598|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
44184581|NCT02244619|78979604|FG000|Overall Study|Did not receive study intervention|8|||
44184582|NCT02244619|78979605|FG001|Overall Study|Did not receive study intervention|21|||
44184583|NCT02243371|78979613|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
44184584|NCT02243371|78979614|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
44184585|NCT02243371|78979613|FG000|Overall Study|Death (unrelated)|2|||
44184586|NCT02243371|78979614|FG001|Overall Study|Death (unrelated)|4|||
44184587|NCT02243371|78979613|FG000|Overall Study|Adverse Event (unrelated)|0|||
44184588|NCT02243371|78979614|FG001|Overall Study|Adverse Event (unrelated)|1|||
44184589|NCT02243371|78979613|FG000|Overall Study|Lack of Clinical Benefit|0|||
44184590|NCT02243371|78979614|FG001|Overall Study|Lack of Clinical Benefit|1|||
44184591|NCT02243371|78979613|FG000|Overall Study|Withdrawal by Subject|0|||
44184592|NCT02243371|78979614|FG001|Overall Study|Withdrawal by Subject|2|||
44184593|NCT01931475|78979622|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
44184594|NCT01931475|78979623|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
44184595|NCT01931475|78979622|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
44184596|NCT01931475|78979623|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
44184597|NCT01931475|78979622|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
44184598|NCT01931475|78979623|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
44184599|NCT01931475|78979622|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
44184600|NCT01931475|78979623|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
44184601|NCT01931475|78979622|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
44184602|NCT01931475|78979623|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
44184603|NCT01931475|78979622|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
44184604|NCT01931475|78979623|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
44184605|NCT01931475|78979622|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
44184606|NCT01931475|78979623|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
44184607|NCT01931475|78979622|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
44184608|NCT01931475|78979623|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
44184609|NCT01931475|78979622|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
44184610|NCT01931475|78979623|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
44184611|NCT01931475|78979622|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
44184612|NCT01931475|78979623|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
44184613|NCT01931475|78979622|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
44184614|NCT01931475|78979623|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
44184615|NCT01931397|78979634|FG000|Overall Study|Physician Decision|2|||
44184616|NCT01931397|78979634|FG000|Overall Study|Withdrawal by Subject|8|||
44184617|NCT01931397|78979634|FG000|Overall Study|moved out of state|1|||
44184618|NCT01929993|78979644|FG000|Overall Study|Protocol Violation|4|||
44184619|NCT01929993|78979645|FG001|Overall Study|Protocol Violation|6|||
44184620|NCT01929993|78979644|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
44184621|NCT01929993|78979645|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
44184622|NCT01912599|78979653|FG000|Overall Study|Withdrawal by Subject|0|||
44184623|NCT01912599|78979654|FG001|Overall Study|Withdrawal by Subject|1|||
44184624|NCT01929681|78979662|FG000|Overall Study|Withdrawal by Subject|1|||
44184625|NCT01929681|78979663|FG001|Overall Study|Withdrawal by Subject|0|||
44184626|NCT01929681|78979662|FG000|Overall Study|Physician Decision|1|||
44184627|NCT01929681|78979663|FG001|Overall Study|Physician Decision|1|||
44184628|NCT01646177|78979673|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
44184629|NCT01646177|78979674|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
44184630|NCT01646177|78979675|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
44184631|NCT01646177|78979676|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
44184632|NCT01646177|78979677|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184633|NCT01646177|78979678|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184634|NCT01646177|78979679|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184635|NCT01646177|78979680|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184636|NCT01646177|78979681|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184637|NCT01646177|78979682|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184638|NCT01646177|78979683|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184639|NCT01646177|78979684|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
44184640|NCT01646177|78979673|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
44184641|NCT01646177|78979674|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
44184642|NCT01646177|78979675|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
44184643|NCT01646177|78979676|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
44184644|NCT01646177|78979677|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184645|NCT01646177|78979678|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184646|NCT01646177|78979679|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184647|NCT01646177|78979680|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184648|NCT01646177|78979681|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184649|NCT01646177|78979682|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184650|NCT01646177|78979683|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184651|NCT01646177|78979684|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
44184652|NCT01646177|78979673|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
44184653|NCT01646177|78979674|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
44184654|NCT01646177|78979675|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
44184655|NCT01646177|78979676|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
44184656|NCT01646177|78979677|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184657|NCT01646177|78979678|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184658|NCT01646177|78979679|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184659|NCT01646177|78979680|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184660|NCT01646177|78979681|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184661|NCT01646177|78979682|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184662|NCT01646177|78979683|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184663|NCT01646177|78979684|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
44184664|NCT01646177|78979673|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
44184665|NCT01646177|78979674|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
44184666|NCT01646177|78979675|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
44184667|NCT01646177|78979676|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
44184668|NCT01646177|78979677|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184669|NCT01646177|78979678|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184670|NCT01646177|78979679|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184671|NCT01646177|78979680|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184672|NCT01646177|78979681|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184673|NCT01646177|78979682|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184674|NCT01646177|78979683|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184675|NCT01646177|78979684|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
44184676|NCT01646177|78979673|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184677|NCT01646177|78979674|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184678|NCT01646177|78979675|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
44184679|NCT01646177|78979676|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
44184680|NCT01646177|78979677|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184681|NCT01646177|78979678|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184682|NCT01646177|78979679|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184683|NCT01646177|78979680|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184684|NCT01646177|78979681|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184685|NCT01646177|78979682|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184686|NCT01646177|78979683|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184687|NCT01646177|78979684|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
44184688|NCT01646177|78979673|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
44184689|NCT01646177|78979674|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
44184690|NCT01646177|78979675|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
44184691|NCT01646177|78979676|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184692|NCT01646177|78979677|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184693|NCT01646177|78979678|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184694|NCT01646177|78979679|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184695|NCT01646177|78979680|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44265587|NCT02441946|79170629|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
44265588|NCT02441946|79170627|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
44184696|NCT01646177|78979681|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184697|NCT01646177|78979682|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44265589|NCT02441946|79170628|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
44265590|NCT02441946|79170629|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
44265591|NCT02441946|79170627|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
44184698|NCT01646177|78979683|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184699|NCT01646177|78979684|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
44184700|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184701|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184702|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184703|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184704|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
44184705|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
44184706|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
44184707|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
44184708|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184709|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184710|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184711|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
44184712|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184713|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184714|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184715|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184716|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
44184717|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
44184718|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
44184719|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
44184720|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184721|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184722|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184723|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
44184724|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184725|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184726|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184727|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184728|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
44184729|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
44184730|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
44184731|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
44184732|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184733|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44265592|NCT02441946|79170628|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
44265593|NCT02441946|79170629|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
44265594|NCT02441946|79170627|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
44184734|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184735|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
44184736|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44265595|NCT02441946|79170628|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
44265596|NCT02441946|79170629|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
44265597|NCT02441946|79170627|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
44265598|NCT02441946|79170628|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44265599|NCT02441946|79170629|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44184737|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184738|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184739|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184740|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
44184741|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
44184742|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
44184743|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
44184744|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184745|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184746|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184747|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
44184748|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184749|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184750|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184751|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184752|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
44184753|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
44184754|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
44184755|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
44184756|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184757|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184758|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184759|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
44184760|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184761|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184762|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184763|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184764|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
44184765|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
44184766|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184767|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
44184768|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184769|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184770|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184771|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
44184772|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184773|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184774|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184775|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184776|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
44184777|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
44184778|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
44184779|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
44184780|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184781|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184782|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184783|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
44184784|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
44184785|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
44184786|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
44184787|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
44184788|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
44184789|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
44184790|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
44184791|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
44265600|NCT02387580|79170663|FG000|Overall Study|Withdrawal by Subject|0|||
44265601|NCT02387580|79170664|FG001|Overall Study|Withdrawal by Subject|0|||
44265602|NCT02387580|79170665|FG002|Overall Study|Withdrawal by Subject|0|||
44265603|NCT02387580|79170666|FG003|Overall Study|Withdrawal by Subject|1|||
44265604|NCT02387580|79170667|FG004|Overall Study|Withdrawal by Subject|0|||
44184792|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
44184793|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
44184794|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
44265605|NCT02387580|79170668|FG005|Overall Study|Withdrawal by Subject|0|||
44265606|NCT02440854|79170684|FG000|Overall Study|Relocation of patient|1|||
44265607|NCT02440854|79170684|FG000|Overall Study|Death|6|||
44184795|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
44184796|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184797|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184798|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184799|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184800|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
44184801|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
44184802|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
44184803|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
44184804|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184805|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184806|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184807|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
44184808|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184809|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184810|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184811|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184812|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184813|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184814|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184815|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
44184816|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184817|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184818|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184819|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
44184820|NCT01646177|78979673|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184821|NCT01646177|78979674|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184822|NCT01646177|78979675|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184823|NCT01646177|78979676|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184824|NCT01646177|78979677|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184825|NCT01646177|78979678|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
44184826|NCT01646177|78979679|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
44184827|NCT01646177|78979680|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
44184828|NCT01646177|78979681|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184829|NCT01646177|78979682|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184830|NCT01646177|78979683|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184831|NCT01646177|78979684|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
44184832|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184833|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184834|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184835|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184836|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184837|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184838|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184839|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
44184840|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
44184841|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
44184842|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
44184843|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
44184844|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184845|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184846|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184847|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184848|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184849|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184850|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184851|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
44184852|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
44184853|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
44184854|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
44265608|NCT02440854|79170684|FG000|Overall Study|Lost to Follow-up|10|||
44265609|NCT02440854|79170684|FG000|Overall Study|Afatinib discontinuation|46|||
44265610|NCT02440854|79170684|FG000|Overall Study|stopped study at earlier timepoint|14|||
44184855|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
44184856|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184857|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184858|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184859|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184860|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184861|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184862|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184863|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
44184864|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
44184865|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
44184866|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
44184867|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
44184868|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184869|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184870|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184871|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184872|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184873|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184874|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184875|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
44184876|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
44184877|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
44184878|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
44184879|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
44184880|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184881|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184882|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184883|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184884|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184885|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184886|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184887|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
44184888|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
44184889|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
44184890|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
44184891|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
44184892|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184893|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184894|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184895|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184896|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184897|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184898|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184899|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
44184900|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
44184901|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
44184902|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
44184903|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
44184904|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184905|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184906|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184907|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184908|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184909|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184910|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184911|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184912|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
44184913|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
44184914|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
44184915|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
44184916|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44265611|NCT02440854|79170684|FG000|Overall Study|Study medication not received|1|||
44265612|NCT02440854|79170684|FG000|Overall Study|Violation of inclusion criteria|2|||
44265613|NCT02412852|79170739|FG000|Overall Study|Withdrawal by Subject|0|||
44265614|NCT02412852|79170740|FG001|Overall Study|Withdrawal by Subject|1|||
44184917|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184918|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184919|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184920|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184921|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184922|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184923|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184924|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
44184925|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
44184926|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
44184927|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
44184928|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184929|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184930|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184931|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184932|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184933|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184934|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184935|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184936|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
44184937|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
44184938|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
44184939|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
44184940|NCT01646177|78979673|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184941|NCT01646177|78979674|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184942|NCT01646177|78979675|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184943|NCT01646177|78979676|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184944|NCT01646177|78979677|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184945|NCT01646177|78979678|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184946|NCT01646177|78979679|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184947|NCT01646177|78979680|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184948|NCT01646177|78979681|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184949|NCT01646177|78979682|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
44184950|NCT01646177|78979683|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
44184951|NCT01646177|78979684|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
44184952|NCT01912287|78979707|FG000|Overall Study|Ineligible|1|||
44184953|NCT01912287|78979708|FG001|Overall Study|Ineligible|0|||
44184954|NCT01912287|78979709|FG002|Overall Study|Ineligible|1|||
44184955|NCT01912287|78979707|FG000|Overall Study|No-show|0|||
44184956|NCT01912287|78979708|FG001|Overall Study|No-show|0|||
44184957|NCT01912287|78979709|FG002|Overall Study|No-show|1|||
44184958|NCT01912287|78979707|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
44184959|NCT01912287|78979708|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
44184960|NCT01912287|78979709|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
44184961|NCT01912287|78979707|FG000|Overall Study|Felt treatment no longer needed|0|||
44184962|NCT01912287|78979708|FG001|Overall Study|Felt treatment no longer needed|1|||
44184963|NCT01912287|78979709|FG002|Overall Study|Felt treatment no longer needed|0|||
44184964|NCT01912287|78979707|FG000|Overall Study|Life circumstances|4|||
44184965|NCT01912287|78979708|FG001|Overall Study|Life circumstances|2|||
44184966|NCT01912287|78979709|FG002|Overall Study|Life circumstances|0|||
44184967|NCT01912287|78979707|FG000|Overall Study|Lost Interest|1|||
44184968|NCT01912287|78979708|FG001|Overall Study|Lost Interest|0|||
44184969|NCT01912287|78979709|FG002|Overall Study|Lost Interest|0|||
44184970|NCT01912287|78979707|FG000|Overall Study|Uknown reason - subject drop out|5|||
44184971|NCT01912287|78979708|FG001|Overall Study|Uknown reason - subject drop out|7|||
44184972|NCT01912287|78979709|FG002|Overall Study|Uknown reason - subject drop out|3|||
44184973|NCT01912287|78979707|FG000|Overall Study|Missed Assesment|1|||
44184974|NCT01912287|78979708|FG001|Overall Study|Missed Assesment|1|||
44184975|NCT01912287|78979709|FG002|Overall Study|Missed Assesment|1|||
44184976|NCT01912287|78979707|FG000|Overall Study|Scheduling/change in availability|17|||
44184977|NCT01912287|78979708|FG001|Overall Study|Scheduling/change in availability|10|||
44184978|NCT01912287|78979709|FG002|Overall Study|Scheduling/change in availability|8|||
44184979|NCT01929135|78979719|FG000|Overall Study|Lost to Follow-up|1|||
44184980|NCT01929135|78979720|FG001|Overall Study|Lost to Follow-up|1|||
44184981|NCT01911819|78979731|FG000|Overall Study|Adverse Event|0|||
44184982|NCT01911819|78979732|FG001|Overall Study|Adverse Event|1|||
44184983|NCT01911819|78979733|FG002|Overall Study|Adverse Event|0|||
44184984|NCT01911819|78979731|FG000|Overall Study|Withdrawal by Subject|1|||
44184985|NCT01911819|78979732|FG001|Overall Study|Withdrawal by Subject|1|||
44184986|NCT01911819|78979733|FG002|Overall Study|Withdrawal by Subject|0|||
44361223|NCT01185821|79366879|FG004|Overall Study|Condition no longer required study drug|1|||
44184987|NCT02280863|78979743|FG000|Integrated Platform|Met stopping criteria|0|||
44184988|NCT02280863|78979744|FG001|Integrated Platform|Met stopping criteria|1|||
44184989|NCT01911429|78979757|FG000|Overall Study|Adverse Event|5|||
44184990|NCT01911429|78979758|FG001|Overall Study|Adverse Event|3|||
44184991|NCT01911429|78979759|FG002|Overall Study|Adverse Event|9|||
44184992|NCT01911429|78979757|FG000|Overall Study|Lack of Efficacy|1|||
44184993|NCT01911429|78979758|FG001|Overall Study|Lack of Efficacy|2|||
44184994|NCT01911429|78979759|FG002|Overall Study|Lack of Efficacy|4|||
44184995|NCT01911429|78979757|FG000|Overall Study|Lost to Follow-up|0|||
44184996|NCT01911429|78979758|FG001|Overall Study|Lost to Follow-up|0|||
44184997|NCT01911429|78979759|FG002|Overall Study|Lost to Follow-up|1|||
44184998|NCT01911429|78979757|FG000|Overall Study|Protocol Violation|0|||
44184999|NCT01911429|78979758|FG001|Overall Study|Protocol Violation|0|||
44185000|NCT01911429|78979759|FG002|Overall Study|Protocol Violation|1|||
44185001|NCT01911429|78979757|FG000|Overall Study|Withdrawal by Subject|5|||
44185002|NCT01911429|78979758|FG001|Overall Study|Withdrawal by Subject|5|||
44185003|NCT01911429|78979759|FG002|Overall Study|Withdrawal by Subject|4|||
44185004|NCT01911429|78979757|FG000|Overall Study|Accidental randomization|0|||
44185005|NCT01911429|78979758|FG001|Overall Study|Accidental randomization|0|||
44185006|NCT01911429|78979759|FG002|Overall Study|Accidental randomization|1|||
44185007|NCT01911429|78979757|FG000|Overall Study|subject left study|1|||
44185008|NCT01911429|78979758|FG001|Overall Study|subject left study|0|||
44185009|NCT01911429|78979759|FG002|Overall Study|subject left study|0|||
44185010|NCT02324465|78979769|FG000|Overall Study|device failure|0|||
44185011|NCT02324465|78979770|FG001|Overall Study|device failure|1|||
44185012|NCT02324153|78979778|FG000|Overall Study|Withdrawal by Subject|4|||
44185013|NCT02324153|78979779|FG001|Overall Study|Withdrawal by Subject|1|||
44185014|NCT02324153|78979778|FG000|Overall Study|Surgery postponed after randomization|3|||
44185015|NCT02324153|78979779|FG001|Overall Study|Surgery postponed after randomization|0|||
44185016|NCT02324153|78979778|FG000|Overall Study|Developed delirium preoperatively|1|||
44185017|NCT02324153|78979779|FG001|Overall Study|Developed delirium preoperatively|0|||
44185018|NCT02280473|78979787|FG000|Overall Study|Adverse Event|1|||
44185019|NCT02280473|78979788|FG001|Overall Study|Adverse Event|1|||
44185020|NCT02280473|78979787|FG000|Overall Study|Lack of Efficacy|0|||
44185021|NCT02280473|78979788|FG001|Overall Study|Lack of Efficacy|1|||
44185022|NCT02280473|78979787|FG000|Overall Study|Lost to Follow-up|0|||
44185023|NCT02280473|78979788|FG001|Overall Study|Lost to Follow-up|1|||
44185024|NCT01911273|78979796|FG000|Overall Study|Progression of Disease|1|||
44185025|NCT01911273|78979797|FG001|Overall Study|Progression of Disease|0|||
44185026|NCT01911273|78979796|FG000|Overall Study|Withdrawal by Subject|0|||
44185027|NCT01911273|78979797|FG001|Overall Study|Withdrawal by Subject|2|||
44185028|NCT02308007|78979806|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
44185029|NCT02308007|78979807|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
44185030|NCT02308007|78979808|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
44185031|NCT02308007|78979806|FG000|Overall Study|Positive for STD at Baseline|7|||
44185032|NCT02308007|78979807|FG001|Overall Study|Positive for STD at Baseline|11|||
44185033|NCT02308007|78979808|FG002|Overall Study|Positive for STD at Baseline|7|||
44185034|NCT02308007|78979806|FG000|Overall Study|Lost to Follow-up|3|||
44185035|NCT02308007|78979807|FG001|Overall Study|Lost to Follow-up|0|||
44185036|NCT02308007|78979808|FG002|Overall Study|Lost to Follow-up|1|||
44185037|NCT02278367|78979818|FG000|Overall Study|Physician Decision|5|||
44185038|NCT02278367|78979819|FG001|Overall Study|Physician Decision|0|||
44185039|NCT02278367|78979818|FG000|Overall Study|Withdrawal by Subject|5|||
44185040|NCT02278367|78979819|FG001|Overall Study|Withdrawal by Subject|0|||
44185041|NCT01910181|78979825|FG000|Overall Study|Death|37|||
44185042|NCT01910181|78979825|FG000|Overall Study|Lost to Follow-up|3|||
44185043|NCT01910181|78979825|FG000|Overall Study|Study Terminated by Sponsor|6|||
44185044|NCT01957215|78979832|FG000|Overall Study|Adverse Event|2|||
44185045|NCT01957215|78979833|FG001|Overall Study|Adverse Event|2|||
44185046|NCT01957215|78979832|FG000|Overall Study|Lost to Follow-up|3|||
44185047|NCT01957215|78979833|FG001|Overall Study|Lost to Follow-up|3|||
44185048|NCT01957215|78979832|FG000|Overall Study|Protocol Violation|1|||
44185049|NCT01957215|78979833|FG001|Overall Study|Protocol Violation|2|||
44185050|NCT01957215|78979832|FG000|Overall Study|Withdrawal by Subject|7|||
44185051|NCT01957215|78979833|FG001|Overall Study|Withdrawal by Subject|5|||
44185052|NCT02322749|78979843|FG000|Period 2|Adverse Event|0|||
44185053|NCT02322749|78979844|FG001|Period 2|Adverse Event|0|||
44185054|NCT02322749|78979845|FG002|Period 2|Adverse Event|0|||
44185055|NCT02322749|78979846|FG003|Period 2|Adverse Event|1|||
44185056|NCT02322749|78979847|FG004|Period 2|Adverse Event|0|||
44185057|NCT02322749|78979848|FG005|Period 2|Adverse Event|0|||
44185058|NCT02322749|78979843|FG000|Period 2|Withdrawal by Subject|0|||
44185059|NCT02322749|78979844|FG001|Period 2|Withdrawal by Subject|0|||
44185060|NCT02322749|78979845|FG002|Period 2|Withdrawal by Subject|0|||
44185061|NCT02322749|78979846|FG003|Period 2|Withdrawal by Subject|1|||
44185062|NCT02322749|78979847|FG004|Period 2|Withdrawal by Subject|0|||
44361224|NCT01185821|79366875|FG000|Overall Study|Adverse Event|2|||
44185063|NCT02322749|78979848|FG005|Period 2|Withdrawal by Subject|0|||
44185064|NCT02322749|78979843|FG000|Period 3|Withdrawal by Subject|0|||
44185065|NCT02322749|78979844|FG001|Period 3|Withdrawal by Subject|0|||
44185066|NCT02322749|78979845|FG002|Period 3|Withdrawal by Subject|1|||
44185067|NCT02322749|78979846|FG003|Period 3|Withdrawal by Subject|0|||
44185068|NCT02322749|78979847|FG004|Period 3|Withdrawal by Subject|0|||
44185069|NCT02322749|78979848|FG005|Period 3|Withdrawal by Subject|0|||
44185070|NCT01957137|78979857|FG000|Randomized Portion|Adverse Event|1|||
44185071|NCT01957137|78979857|FG000|Randomized Portion|Withdrawal by Subject|1|||
44185072|NCT01928433|78979872|FG000|Overall Study|Adverse Event|5|||
44185073|NCT01928433|78979873|FG001|Overall Study|Adverse Event|2|||
44185074|NCT01928433|78979874|FG002|Overall Study|Adverse Event|5|||
44185075|NCT01928433|78979872|FG000|Overall Study|Protocol Violation|0|||
44185076|NCT01928433|78979873|FG001|Overall Study|Protocol Violation|0|||
44185077|NCT01928433|78979874|FG002|Overall Study|Protocol Violation|2|||
44185078|NCT01928433|78979872|FG000|Overall Study|Lack of Efficacy|5|||
44185079|NCT01928433|78979873|FG001|Overall Study|Lack of Efficacy|4|||
44185080|NCT01928433|78979874|FG002|Overall Study|Lack of Efficacy|4|||
44185081|NCT01928433|78979872|FG000|Overall Study|Withdrawal by Subject|0|||
44185082|NCT01928433|78979873|FG001|Overall Study|Withdrawal by Subject|4|||
44185083|NCT01928433|78979874|FG002|Overall Study|Withdrawal by Subject|0|||
44185084|NCT01928433|78979872|FG000|Overall Study|Negative screening urine culture|7|||
44185085|NCT01928433|78979873|FG001|Overall Study|Negative screening urine culture|6|||
44185086|NCT01928433|78979874|FG002|Overall Study|Negative screening urine culture|10|||
44185087|NCT01928433|78979872|FG000|Overall Study|Lost to Follow-up|0|||
44185088|NCT01928433|78979873|FG001|Overall Study|Lost to Follow-up|2|||
44185089|NCT01928433|78979874|FG002|Overall Study|Lost to Follow-up|3|||
44185090|NCT01928433|78979872|FG000|Overall Study|Other reasons|3|||
44185091|NCT01928433|78979873|FG001|Overall Study|Other reasons|3|||
44185092|NCT01928433|78979874|FG002|Overall Study|Other reasons|4|||
44185093|NCT02322281|78979888|FG000|Overall Study|Progressive Disease|42|||
44185094|NCT02322281|78979889|FG001|Overall Study|Progressive Disease|14|||
44185095|NCT02322281|78979890|FG002|Overall Study|Progressive Disease|49|||
44185096|NCT02322281|78979888|FG000|Overall Study|Adverse Event|3|||
44185097|NCT02322281|78979889|FG001|Overall Study|Adverse Event|4|||
44185098|NCT02322281|78979890|FG002|Overall Study|Adverse Event|6|||
44185099|NCT02322281|78979888|FG000|Overall Study|Death|3|||
44185100|NCT02322281|78979889|FG001|Overall Study|Death|3|||
44185101|NCT02322281|78979890|FG002|Overall Study|Death|3|||
44185102|NCT02322281|78979888|FG000|Overall Study|Withdrawal by Subject|1|||
44185103|NCT02322281|78979889|FG001|Overall Study|Withdrawal by Subject|1|||
44185104|NCT02322281|78979890|FG002|Overall Study|Withdrawal by Subject|6|||
44185105|NCT02322281|78979888|FG000|Overall Study|Physician Decision|2|||
44185106|NCT02322281|78979889|FG001|Overall Study|Physician Decision|0|||
44185107|NCT02322281|78979890|FG002|Overall Study|Physician Decision|5|||
44185108|NCT02322281|78979888|FG000|Overall Study|Study Terminated by Sponsor|2|||
44185109|NCT02322281|78979889|FG001|Overall Study|Study Terminated by Sponsor|0|||
44185110|NCT02322281|78979890|FG002|Overall Study|Study Terminated by Sponsor|0|||
44185111|NCT02322281|78979888|FG000|Overall Study|Missing|0|||
44185112|NCT02322281|78979889|FG001|Overall Study|Missing|0|||
44185113|NCT02322281|78979890|FG002|Overall Study|Missing|1|||
44185114|NCT02322281|78979888|FG000|Overall Study|Miscellaneous|0|||
44185115|NCT02322281|78979889|FG001|Overall Study|Miscellaneous|0|||
44185116|NCT02322281|78979890|FG002|Overall Study|Miscellaneous|4|||
44185117|NCT02322125|78979900|FG000|Overall Study|Withdrawal by Subject|2|||
44185118|NCT02243293|78979921|FG000|Overall Study|Adverse Event|1|||
44185119|NCT02243293|78979922|FG001|Overall Study|Adverse Event|0|||
44185120|NCT02243293|78979923|FG002|Overall Study|Adverse Event|0|||
44185121|NCT02243293|78979924|FG003|Overall Study|Adverse Event|0|||
44185122|NCT02243293|78979925|FG004|Overall Study|Adverse Event|0|||
44185123|NCT02243293|78979926|FG005|Overall Study|Adverse Event|0|||
44185124|NCT02243293|78979927|FG006|Overall Study|Adverse Event|0|||
44185125|NCT02243293|78979928|FG007|Overall Study|Adverse Event|0|||
44185126|NCT02243293|78979929|FG008|Overall Study|Adverse Event|0|||
44185127|NCT02243293|78979930|FG009|Overall Study|Adverse Event|0|||
44265615|NCT02412852|79170741|FG002|Overall Study|Withdrawal by Subject|0|||
44185128|NCT02243293|78979931|FG010|Overall Study|Adverse Event|0|||
44185129|NCT02243293|78979932|FG011|Overall Study|Adverse Event|0|||
44185130|NCT02243293|78979933|FG012|Overall Study|Adverse Event|0|||
44185131|NCT02243293|78979934|FG013|Overall Study|Adverse Event|0|||
44185132|NCT02243293|78979935|FG014|Overall Study|Adverse Event|0|||
44185133|NCT02243293|78979936|FG015|Overall Study|Adverse Event|1|||
44185134|NCT02243293|78979937|FG016|Overall Study|Adverse Event|0|||
44185135|NCT02243293|78979938|FG017|Overall Study|Adverse Event|0|||
44265616|NCT02412852|79170742|FG003|Overall Study|Withdrawal by Subject|0|||
44185136|NCT02243293|78979939|FG018|Overall Study|Adverse Event|0|||
44185137|NCT02243293|78979940|FG019|Overall Study|Adverse Event|0|||
44185138|NCT02243293|78979941|FG020|Overall Study|Adverse Event|1|||
44185139|NCT02243293|78979942|FG021|Overall Study|Adverse Event|0|||
44185140|NCT02243293|78979921|FG000|Overall Study|Withdrawal by Subject|1|||
44185141|NCT02243293|78979922|FG001|Overall Study|Withdrawal by Subject|0|||
44185142|NCT02243293|78979923|FG002|Overall Study|Withdrawal by Subject|0|||
44185143|NCT02243293|78979924|FG003|Overall Study|Withdrawal by Subject|0|||
44185144|NCT02243293|78979925|FG004|Overall Study|Withdrawal by Subject|0|||
44185145|NCT02243293|78979926|FG005|Overall Study|Withdrawal by Subject|0|||
44185146|NCT02243293|78979927|FG006|Overall Study|Withdrawal by Subject|0|||
44185147|NCT02243293|78979928|FG007|Overall Study|Withdrawal by Subject|0|||
44185148|NCT02243293|78979929|FG008|Overall Study|Withdrawal by Subject|0|||
44185149|NCT02243293|78979930|FG009|Overall Study|Withdrawal by Subject|1|||
44185150|NCT02243293|78979931|FG010|Overall Study|Withdrawal by Subject|0|||
44185151|NCT02243293|78979932|FG011|Overall Study|Withdrawal by Subject|1|||
44185152|NCT02243293|78979933|FG012|Overall Study|Withdrawal by Subject|0|||
44185153|NCT02243293|78979934|FG013|Overall Study|Withdrawal by Subject|0|||
44185154|NCT02243293|78979935|FG014|Overall Study|Withdrawal by Subject|0|||
44185155|NCT02243293|78979936|FG015|Overall Study|Withdrawal by Subject|0|||
44185156|NCT02243293|78979937|FG016|Overall Study|Withdrawal by Subject|0|||
44185157|NCT02243293|78979938|FG017|Overall Study|Withdrawal by Subject|0|||
44185158|NCT02243293|78979939|FG018|Overall Study|Withdrawal by Subject|0|||
44185159|NCT02243293|78979940|FG019|Overall Study|Withdrawal by Subject|0|||
44185160|NCT02243293|78979941|FG020|Overall Study|Withdrawal by Subject|0|||
44185161|NCT02243293|78979942|FG021|Overall Study|Withdrawal by Subject|1|||
44185162|NCT02243293|78979921|FG000|Overall Study|Lost to Follow-up|0|||
44185163|NCT02243293|78979922|FG001|Overall Study|Lost to Follow-up|1|||
44185164|NCT02243293|78979923|FG002|Overall Study|Lost to Follow-up|1|||
44185165|NCT02243293|78979924|FG003|Overall Study|Lost to Follow-up|1|||
44185166|NCT02243293|78979925|FG004|Overall Study|Lost to Follow-up|0|||
44185167|NCT02243293|78979926|FG005|Overall Study|Lost to Follow-up|0|||
44185168|NCT02243293|78979927|FG006|Overall Study|Lost to Follow-up|3|||
44185169|NCT02243293|78979928|FG007|Overall Study|Lost to Follow-up|0|||
44185170|NCT02243293|78979929|FG008|Overall Study|Lost to Follow-up|0|||
44185171|NCT02243293|78979930|FG009|Overall Study|Lost to Follow-up|0|||
44185172|NCT02243293|78979931|FG010|Overall Study|Lost to Follow-up|0|||
44185173|NCT02243293|78979932|FG011|Overall Study|Lost to Follow-up|2|||
44185174|NCT02243293|78979933|FG012|Overall Study|Lost to Follow-up|0|||
44185175|NCT02243293|78979934|FG013|Overall Study|Lost to Follow-up|0|||
44185176|NCT02243293|78979935|FG014|Overall Study|Lost to Follow-up|0|||
44185177|NCT02243293|78979936|FG015|Overall Study|Lost to Follow-up|0|||
44185178|NCT02243293|78979937|FG016|Overall Study|Lost to Follow-up|3|||
44185179|NCT02243293|78979938|FG017|Overall Study|Lost to Follow-up|1|||
44185180|NCT02243293|78979939|FG018|Overall Study|Lost to Follow-up|0|||
44185181|NCT02243293|78979940|FG019|Overall Study|Lost to Follow-up|0|||
44185182|NCT02243293|78979941|FG020|Overall Study|Lost to Follow-up|1|||
44185183|NCT02243293|78979942|FG021|Overall Study|Lost to Follow-up|2|||
44185184|NCT02243293|78979921|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
44185185|NCT02243293|78979922|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
44185186|NCT02243293|78979923|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
44185187|NCT02243293|78979924|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
44185188|NCT02243293|78979925|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
44185189|NCT02243293|78979926|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
44185190|NCT02243293|78979927|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
44185191|NCT02243293|78979928|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
44185192|NCT02243293|78979929|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
44185193|NCT02243293|78979930|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
44185194|NCT02243293|78979931|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
44185195|NCT02243293|78979932|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
44185196|NCT02243293|78979933|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
44185197|NCT02243293|78979934|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
44185198|NCT02243293|78979935|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
44185199|NCT02243293|78979936|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
44185200|NCT02243293|78979937|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
44185201|NCT02243293|78979938|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
44185202|NCT02243293|78979939|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
44185203|NCT02243293|78979940|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
44185204|NCT02243293|78979941|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
44185205|NCT02243293|78979942|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
44451336|NCT00098293|79460285|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
44185206|NCT02243293|78979921|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
44185207|NCT02243293|78979922|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
44185208|NCT02243293|78979923|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
44185209|NCT02243293|78979924|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
44185210|NCT02243293|78979925|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
44185211|NCT02243293|78979926|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
44185212|NCT02243293|78979927|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
44185213|NCT02243293|78979928|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
44361225|NCT01185821|79366876|FG001|Overall Study|Adverse Event|3|||
44185214|NCT02243293|78979929|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
44185215|NCT02243293|78979930|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
44185216|NCT02243293|78979931|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
44185217|NCT02243293|78979932|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
44185218|NCT02243293|78979933|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
44185219|NCT02243293|78979934|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
44185220|NCT02243293|78979935|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
44185221|NCT02243293|78979936|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
44185222|NCT02243293|78979937|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
44185223|NCT02243293|78979938|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
44185224|NCT02243293|78979939|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
44185225|NCT02243293|78979940|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
44185226|NCT02243293|78979941|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
44185227|NCT02243293|78979942|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
44185228|NCT02322047|78979983|FG000|Overall Study|Physician Decision|1|||
44185229|NCT02322047|78979984|FG001|Overall Study|Physician Decision|0|||
44185230|NCT02322047|78979985|FG002|Overall Study|Physician Decision|0|||
44185231|NCT02322047|78979986|FG003|Overall Study|Physician Decision|0|||
44185232|NCT02322047|78979983|FG000|Overall Study|Withdrawal by Subject|1|||
44185233|NCT02322047|78979984|FG001|Overall Study|Withdrawal by Subject|0|||
44185234|NCT02322047|78979985|FG002|Overall Study|Withdrawal by Subject|0|||
44185235|NCT02322047|78979986|FG003|Overall Study|Withdrawal by Subject|1|||
44185236|NCT02322047|78979983|FG000|Overall Study|Adverse Event|0|||
44185237|NCT02322047|78979984|FG001|Overall Study|Adverse Event|1|||
44185238|NCT02322047|78979985|FG002|Overall Study|Adverse Event|0|||
44185239|NCT02322047|78979986|FG003|Overall Study|Adverse Event|0|||
44185240|NCT02322047|78979983|FG000|Overall Study|Lost to Follow-up|0|||
44185241|NCT02322047|78979984|FG001|Overall Study|Lost to Follow-up|0|||
44185242|NCT02322047|78979985|FG002|Overall Study|Lost to Follow-up|1|||
44185243|NCT02322047|78979986|FG003|Overall Study|Lost to Follow-up|1|||
44185244|NCT02254291|78979999|FG000|Overall Study|Withdrawal by Subject|0|||
44185245|NCT02254291|78980000|FG001|Overall Study|Withdrawal by Subject|3|||
44185246|NCT02254291|78980001|FG002|Overall Study|Withdrawal by Subject|1|||
44185247|NCT02254291|78979999|FG000|Overall Study|Missing follow-up information|0|||
44185248|NCT02254291|78980000|FG001|Overall Study|Missing follow-up information|0|||
44185249|NCT02254291|78980001|FG002|Overall Study|Missing follow-up information|1|||
44185250|NCT02253433|78980011|FG000|Overall Study|Unable to Contact|9|||
44185251|NCT02253433|78980012|FG001|Overall Study|Unable to Contact|16|||
44185252|NCT02253433|78980011|FG000|Overall Study|Death|1|||
44185253|NCT02253433|78980012|FG001|Overall Study|Death|1|||
44185254|NCT02253433|78980011|FG000|Overall Study|No Longer Interested|3|||
44185255|NCT02253433|78980012|FG001|Overall Study|No Longer Interested|15|||
44185256|NCT02253433|78980011|FG000|Overall Study|Out of Study Area|2|||
44185257|NCT02253433|78980012|FG001|Overall Study|Out of Study Area|7|||
44185258|NCT02253433|78980011|FG000|Overall Study|Uncomfortable with home visitors|0|||
44185259|NCT02253433|78980012|FG001|Overall Study|Uncomfortable with home visitors|3|||
44185260|NCT02253433|78980011|FG000|Overall Study|Unstable Housing/Homeless|0|||
44185261|NCT02253433|78980012|FG001|Overall Study|Unstable Housing/Homeless|7|||
44185262|NCT02253433|78980011|FG000|Overall Study|Too Busy|0|||
44185263|NCT02253433|78980012|FG001|Overall Study|Too Busy|4|||
44185264|NCT02253433|78980011|FG000|Overall Study|Medical or Other Concerns|1|||
44185265|NCT02253433|78980012|FG001|Overall Study|Medical or Other Concerns|2|||
44185266|NCT02242981|78980019|FG000|Overall Study|Withdrawal by Subject|1|||
44185267|NCT02277743|78980026|FG000|Overall Study|Protocol Violation|1|||
44185268|NCT02277743|78980027|FG001|Overall Study|Protocol Violation|1|||
44185269|NCT02277743|78980028|FG002|Overall Study|Protocol Violation|1|||
44185270|NCT02277743|78980026|FG000|Overall Study|Adverse Event|10|||
44185271|NCT02277743|78980027|FG001|Overall Study|Adverse Event|6|||
44185272|NCT02277743|78980028|FG002|Overall Study|Adverse Event|6|||
44185273|NCT02277743|78980026|FG000|Overall Study|Lack of Efficacy|11|||
44185274|NCT02277743|78980027|FG001|Overall Study|Lack of Efficacy|4|||
44185275|NCT02277743|78980028|FG002|Overall Study|Lack of Efficacy|3|||
44185276|NCT02277743|78980026|FG000|Overall Study|Other than specified above|18|||
44185277|NCT02277743|78980027|FG001|Overall Study|Other than specified above|5|||
44265617|NCT02412852|79170739|FG000|Overall Study|Physician Decision|0|||
44185278|NCT02277743|78980028|FG002|Overall Study|Other than specified above|16|||
44185279|NCT02242903|78980043|FG000|Overall Study|Withdrawal by Subject|1|||
44185280|NCT02242903|78980044|FG001|Overall Study|Withdrawal by Subject|0|||
44185281|NCT02242903|78980045|FG002|Overall Study|Withdrawal by Subject|0|||
44185282|NCT02242903|78980046|FG003|Overall Study|Withdrawal by Subject|0|||
44185283|NCT02242903|78980047|FG004|Overall Study|Withdrawal by Subject|0|||
44265618|NCT02412852|79170740|FG001|Overall Study|Physician Decision|0|||
44185284|NCT02242903|78980048|FG005|Overall Study|Withdrawal by Subject|0|||
44185285|NCT02242903|78980049|FG006|Overall Study|Withdrawal by Subject|0|||
44185286|NCT02320721|78980073|FG000|Overall Study|Adverse Event|6|||
44185287|NCT02320721|78980074|FG001|Overall Study|Adverse Event|6|||
44185288|NCT02320721|78980073|FG000|Overall Study|Lack of Efficacy|2|||
44185289|NCT02320721|78980074|FG001|Overall Study|Lack of Efficacy|0|||
44185290|NCT02320721|78980073|FG000|Overall Study|Poor compliance to protocol|3|||
44185291|NCT02320721|78980074|FG001|Overall Study|Poor compliance to protocol|7|||
44185292|NCT02320721|78980073|FG000|Overall Study|Randomized but not treated|0|||
44185293|NCT02320721|78980074|FG001|Overall Study|Randomized but not treated|1|||
44185294|NCT02320721|78980073|FG000|Overall Study|Hypoglycemia|1|||
44185295|NCT02320721|78980074|FG001|Overall Study|Hypoglycemia|0|||
44185296|NCT02320721|78980073|FG000|Overall Study|Other than specified above|15|||
44185297|NCT02320721|78980074|FG001|Overall Study|Other than specified above|20|||
44185298|NCT02320487|78980080|FG000|Overall Study|Reason not Specified|1|||
44185299|NCT02320487|78980080|FG000|Overall Study|Physician Decision|5|||
44185300|NCT02320487|78980080|FG000|Overall Study|Withdrawal by Subject|1|||
44185301|NCT02320487|78980080|FG000|Overall Study|Death|3|||
44185302|NCT02320487|78980080|FG000|Overall Study|Adverse Event|11|||
44185303|NCT02277119|78980087|FG000|Overall Study|Lack of Efficacy|1|||
44185304|NCT02277119|78980088|FG001|Overall Study|Lack of Efficacy|1|||
44185305|NCT02277119|78980089|FG002|Overall Study|Lack of Efficacy|1|||
44185306|NCT02277119|78980087|FG000|Overall Study|Protocol Violation|2|||
44185307|NCT02277119|78980088|FG001|Overall Study|Protocol Violation|3|||
44185308|NCT02277119|78980089|FG002|Overall Study|Protocol Violation|7|||
44185309|NCT02320253|78980100|FG000|Overall Study|Withdrawal by Subject|3|||
44185310|NCT02320253|78980101|FG001|Overall Study|Withdrawal by Subject|0|||
44185311|NCT02320253|78980102|FG002|Overall Study|Withdrawal by Subject|0|||
44185312|NCT02320253|78980100|FG000|Overall Study|Lost to Follow-up|2|||
44185313|NCT02320253|78980101|FG001|Overall Study|Lost to Follow-up|2|||
44185314|NCT02320253|78980102|FG002|Overall Study|Lost to Follow-up|1|||
44185315|NCT02320253|78980100|FG000|Overall Study|Death|1|||
44185316|NCT02320253|78980101|FG001|Overall Study|Death|0|||
44185317|NCT02320253|78980102|FG002|Overall Study|Death|1|||
44185318|NCT02276807|78980112|FG000|Overall Study|Withdrawal by Subject|8|||
44185319|NCT02276807|78980113|FG001|Overall Study|Withdrawal by Subject|7|||
44185320|NCT02276807|78980112|FG000|Overall Study|Lost to Follow-up|10|||
44185321|NCT02276807|78980113|FG001|Overall Study|Lost to Follow-up|10|||
44185322|NCT02252965|78980121|FG000|Overall Study|Adverse Event|9|||
44185323|NCT02252965|78980122|FG001|Overall Study|Adverse Event|14|||
44185324|NCT02252965|78980121|FG000|Overall Study|Lost to Follow-up|16|||
44185325|NCT02252965|78980122|FG001|Overall Study|Lost to Follow-up|8|||
44185326|NCT02252965|78980121|FG000|Overall Study|Protocol Violation|4|||
44185327|NCT02252965|78980122|FG001|Overall Study|Protocol Violation|5|||
44185328|NCT02252965|78980121|FG000|Overall Study|Lack of Efficacy|0|||
44185329|NCT02252965|78980122|FG001|Overall Study|Lack of Efficacy|2|||
44185330|NCT02252965|78980121|FG000|Overall Study|Withdrawal by Subject|7|||
44185331|NCT02252965|78980122|FG001|Overall Study|Withdrawal by Subject|9|||
44185332|NCT02252965|78980121|FG000|Overall Study|Other|4|||
44185333|NCT02252965|78980122|FG001|Overall Study|Other|5|||
44185334|NCT02242435|78980132|FG000|Overall Study|Lost to Follow-up|3|||
44185335|NCT02242435|78980133|FG001|Overall Study|Lost to Follow-up|4|||
44185336|NCT02242435|78980132|FG000|Overall Study|Adverse Event|3|||
44185337|NCT02242435|78980133|FG001|Overall Study|Adverse Event|2|||
44185338|NCT02242435|78980132|FG000|Overall Study|Withdrawal by Subject|13|||
44185339|NCT02242435|78980133|FG001|Overall Study|Withdrawal by Subject|8|||
44185340|NCT02242435|78980132|FG000|Overall Study|Death|0|||
44185341|NCT02242435|78980133|FG001|Overall Study|Death|1|||
44185342|NCT02242435|78980132|FG000|Overall Study|Protocol Violation|1|||
44185343|NCT02242435|78980133|FG001|Overall Study|Protocol Violation|0|||
44185344|NCT02242435|78980132|FG000|Overall Study|Physician Decision|0|||
44185345|NCT02242435|78980133|FG001|Overall Study|Physician Decision|1|||
44185346|NCT02251717|78980141|FG000|Overall Study|Adverse Event|0|||
44185347|NCT02251717|78980142|FG001|Overall Study|Adverse Event|1|||
44185348|NCT02251717|78980141|FG000|Overall Study|Withdrew Consent|1|||
44185349|NCT02251717|78980142|FG001|Overall Study|Withdrew Consent|0|||
44185350|NCT02242201|78980151|FG000|Overall Study|preoperative identified neuropathy|2|||
44185351|NCT02242201|78980152|FG001|Overall Study|preoperative identified neuropathy|0|||
44185352|NCT02242201|78980153|FG002|Overall Study|preoperative identified neuropathy|0|||
44185353|NCT02242201|78980151|FG000|Overall Study|planned post-op anticoagulation|1|||
44185354|NCT02242201|78980152|FG001|Overall Study|planned post-op anticoagulation|0|||
44185355|NCT02242201|78980153|FG002|Overall Study|planned post-op anticoagulation|0|||
44185356|NCT02242201|78980151|FG000|Overall Study|changed surgical procedure|1|||
44185357|NCT02242201|78980152|FG001|Overall Study|changed surgical procedure|0|||
44185358|NCT02242201|78980153|FG002|Overall Study|changed surgical procedure|0|||
44185359|NCT02242201|78980151|FG000|Overall Study|postponed surgery|0|||
44185360|NCT02242201|78980152|FG001|Overall Study|postponed surgery|0|||
44185361|NCT02242201|78980153|FG002|Overall Study|postponed surgery|1|||
44185362|NCT02242201|78980151|FG000|Overall Study|preoperative opioid consumption|0|||
44185363|NCT02242201|78980152|FG001|Overall Study|preoperative opioid consumption|1|||
44185364|NCT02242201|78980153|FG002|Overall Study|preoperative opioid consumption|0|||
44185365|NCT02242045|78980161|FG000|Overall Study|Investigator's Discretion|1|||
44185366|NCT02242045|78980161|FG000|Overall Study|Progressive Disease|2|||
44185367|NCT02242045|78980161|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
44185368|NCT02242045|78980161|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
44185369|NCT02241889|78980165|FG000|Overall Study|device issues|0|||
44185370|NCT02241889|78980166|FG001|Overall Study|device issues|0|||
44185371|NCT02241889|78980167|FG002|Overall Study|device issues|1|||
44185372|NCT02241889|78980168|FG003|Overall Study|device issues|0|||
44185373|NCT02241889|78980169|FG004|Overall Study|device issues|0|||
44185374|NCT02241889|78980170|FG005|Overall Study|device issues|0|||
44185375|NCT02241889|78980165|FG000|Overall Study|Withdrawal by Subject|0|||
44185376|NCT02241889|78980166|FG001|Overall Study|Withdrawal by Subject|0|||
44185377|NCT02241889|78980167|FG002|Overall Study|Withdrawal by Subject|0|||
44185378|NCT02241889|78980168|FG003|Overall Study|Withdrawal by Subject|0|||
44185379|NCT02241889|78980169|FG004|Overall Study|Withdrawal by Subject|0|||
44185380|NCT02241889|78980170|FG005|Overall Study|Withdrawal by Subject|1|||
44185381|NCT02241733|78980180|FG000|Overall Study|Lost to Follow-up|9|||
44185382|NCT02241733|78980181|FG001|Overall Study|Lost to Follow-up|4|||
44185383|NCT02241733|78980180|FG000|Overall Study|Physician Decision|6|||
44185384|NCT02241733|78980181|FG001|Overall Study|Physician Decision|2|||
44185385|NCT02241733|78980180|FG000|Overall Study|Withdrawal by Subject|0|||
44185386|NCT02241733|78980181|FG001|Overall Study|Withdrawal by Subject|2|||
44185387|NCT02241733|78980180|FG000|Overall Study|Death|0|||
44185388|NCT02241733|78980181|FG001|Overall Study|Death|2|||
44185389|NCT02241343|78980187|FG000|Overall Study|Adverse Event|1|||
44185390|NCT02241187|78980192|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
44185391|NCT02249767|78980199|FG000|Overall Study|Did not use medication|8|||
44185392|NCT02249767|78980200|FG001|Overall Study|Did not use medication|9|||
44185393|NCT02249767|78980201|FG002|Overall Study|Did not use medication|8|||
44185394|NCT02239939|78980211|FG000|Overall Study|Adverse Event|1|||
44185395|NCT02239939|78980212|FG001|Overall Study|Adverse Event|0|||
44185396|NCT02239939|78980211|FG000|Overall Study|Withdrawal by Subject|1|||
44185397|NCT02239939|78980212|FG001|Overall Study|Withdrawal by Subject|1|||
44185398|NCT02239939|78980211|FG000|Overall Study|Lost to Follow-up|0|||
44185399|NCT02239939|78980212|FG001|Overall Study|Lost to Follow-up|1|||
44185400|NCT02248675|78980222|FG000|Overall Study|Lost to Follow-up|3|||
44185401|NCT02248675|78980223|FG001|Overall Study|Lost to Follow-up|1|||
44185402|NCT02238379|78980231|FG000|Overall Study|Lost to Follow-up|1|||
44185403|NCT02238379|78980232|FG001|Overall Study|Lost to Follow-up|0|||
44185404|NCT02238067|78980238|FG000|Overall Study|Not completed survey at Month 6|45|||
44185405|NCT02237911|78980245|FG000|Overall Study|Withdrawal by Subject|4|||
44185406|NCT02237911|78980246|FG001|Overall Study|Withdrawal by Subject|7|||
44185407|NCT02237911|78980247|FG002|Overall Study|Withdrawal by Subject|2|||
44185408|NCT02237911|78980245|FG000|Overall Study|Lost to Follow-up|3|||
44185409|NCT02237911|78980246|FG001|Overall Study|Lost to Follow-up|1|||
44185410|NCT02237911|78980247|FG002|Overall Study|Lost to Follow-up|1|||
44185411|NCT02234479|78980257|FG000|Overall Study|Withdrawal by Subject|1|||
44185412|NCT02234479|78980258|FG001|Overall Study|Withdrawal by Subject|3|||
44185413|NCT02207491|78980266|FG000|Overall Study|Adverse Event|20|||
44185414|NCT02207491|78980267|FG001|Overall Study|Adverse Event|4|||
44185415|NCT02207491|78980266|FG000|Overall Study|Withdrawal by Subject|3|||
44185416|NCT02207491|78980267|FG001|Overall Study|Withdrawal by Subject|2|||
44185417|NCT02207491|78980266|FG000|Overall Study|Non-compliant|0|||
44185418|NCT02207491|78980267|FG001|Overall Study|Non-compliant|1|||
44185419|NCT02207491|78980266|FG000|Overall Study|Lost to Follow-up|0|||
44185420|NCT02207491|78980267|FG001|Overall Study|Lost to Follow-up|1|||
44185421|NCT02207491|78980266|FG000|Overall Study|Lack of Efficacy|3|||
44185422|NCT02207491|78980267|FG001|Overall Study|Lack of Efficacy|0|||
44185423|NCT02207491|78980266|FG000|Overall Study|Physician Decision|2|||
44185424|NCT02207491|78980267|FG001|Overall Study|Physician Decision|0|||
44185425|NCT02207491|78980266|FG000|Overall Study|Protocol Violation|3|||
44185426|NCT02207491|78980267|FG001|Overall Study|Protocol Violation|5|||
44185427|NCT02315066|78980287|FG000|Overall Study|Lost to Follow-up|0|||
44185428|NCT02315066|78980288|FG001|Overall Study|Lost to Follow-up|1|||
44185429|NCT02315066|78980289|FG002|Overall Study|Lost to Follow-up|1|||
44185430|NCT02315066|78980290|FG003|Overall Study|Lost to Follow-up|0|||
44185431|NCT02315066|78980291|FG004|Overall Study|Lost to Follow-up|1|||
44185432|NCT02315066|78980292|FG005|Overall Study|Lost to Follow-up|0|||
44185433|NCT02315066|78980293|FG006|Overall Study|Lost to Follow-up|2|||
44185434|NCT02315066|78980294|FG007|Overall Study|Lost to Follow-up|1|||
44185435|NCT02315066|78980295|FG008|Overall Study|Lost to Follow-up|0|||
44185436|NCT02315066|78980296|FG009|Overall Study|Lost to Follow-up|0|||
44185437|NCT02315066|78980297|FG010|Overall Study|Lost to Follow-up|1|||
44185438|NCT02315066|78980298|FG011|Overall Study|Lost to Follow-up|2|||
44185439|NCT02315066|78980299|FG012|Overall Study|Lost to Follow-up|0|||
44185440|NCT02315066|78980300|FG013|Overall Study|Lost to Follow-up|4|||
44185441|NCT02315066|78980287|FG000|Overall Study|Death|2|||
44185442|NCT02315066|78980288|FG001|Overall Study|Death|7|||
44185443|NCT02315066|78980289|FG002|Overall Study|Death|6|||
44185444|NCT02315066|78980290|FG003|Overall Study|Death|11|||
44185445|NCT02315066|78980291|FG004|Overall Study|Death|10|||
44185446|NCT02315066|78980292|FG005|Overall Study|Death|3|||
44185447|NCT02315066|78980293|FG006|Overall Study|Death|9|||
44185448|NCT02315066|78980294|FG007|Overall Study|Death|9|||
44185449|NCT02315066|78980295|FG008|Overall Study|Death|10|||
44185450|NCT02315066|78980296|FG009|Overall Study|Death|8|||
44185451|NCT02315066|78980297|FG010|Overall Study|Death|10|||
44185452|NCT02315066|78980298|FG011|Overall Study|Death|7|||
44185453|NCT02315066|78980299|FG012|Overall Study|Death|8|||
44185454|NCT02315066|78980300|FG013|Overall Study|Death|21|||
44185455|NCT02315066|78980287|FG000|Overall Study|Other|0|||
44185456|NCT02315066|78980288|FG001|Overall Study|Other|0|||
44185457|NCT02315066|78980289|FG002|Overall Study|Other|0|||
44185458|NCT02315066|78980290|FG003|Overall Study|Other|0|||
44185459|NCT02315066|78980291|FG004|Overall Study|Other|0|||
44185460|NCT02315066|78980292|FG005|Overall Study|Other|0|||
44185461|NCT02315066|78980293|FG006|Overall Study|Other|0|||
44185462|NCT02315066|78980294|FG007|Overall Study|Other|1|||
44185463|NCT02315066|78980295|FG008|Overall Study|Other|1|||
44185464|NCT02315066|78980296|FG009|Overall Study|Other|2|||
44185465|NCT02315066|78980297|FG010|Overall Study|Other|0|||
44185466|NCT02315066|78980298|FG011|Overall Study|Other|0|||
44185467|NCT02315066|78980299|FG012|Overall Study|Other|0|||
44185468|NCT02315066|78980300|FG013|Overall Study|Other|0|||
44185469|NCT02315066|78980287|FG000|Overall Study|Subject refused further follow-up|0|||
44185470|NCT02315066|78980288|FG001|Overall Study|Subject refused further follow-up|2|||
44185471|NCT02315066|78980289|FG002|Overall Study|Subject refused further follow-up|2|||
44185472|NCT02315066|78980290|FG003|Overall Study|Subject refused further follow-up|0|||
44185473|NCT02315066|78980291|FG004|Overall Study|Subject refused further follow-up|0|||
44185474|NCT02315066|78980292|FG005|Overall Study|Subject refused further follow-up|0|||
44185475|NCT02315066|78980293|FG006|Overall Study|Subject refused further follow-up|2|||
44185476|NCT02315066|78980294|FG007|Overall Study|Subject refused further follow-up|3|||
44185477|NCT02315066|78980295|FG008|Overall Study|Subject refused further follow-up|0|||
44185478|NCT02315066|78980296|FG009|Overall Study|Subject refused further follow-up|1|||
44185479|NCT02315066|78980297|FG010|Overall Study|Subject refused further follow-up|1|||
44185480|NCT02315066|78980298|FG011|Overall Study|Subject refused further follow-up|2|||
44185481|NCT02315066|78980299|FG012|Overall Study|Subject refused further follow-up|2|||
44185482|NCT02315066|78980300|FG013|Overall Study|Subject refused further follow-up|4|||
44185483|NCT02315066|78980287|FG000|Overall Study|Study ongoing at date of cut-off|0|||
44185484|NCT02315066|78980288|FG001|Overall Study|Study ongoing at date of cut-off|0|||
44185485|NCT02315066|78980289|FG002|Overall Study|Study ongoing at date of cut-off|0|||
44185486|NCT02315066|78980290|FG003|Overall Study|Study ongoing at date of cut-off|0|||
44185487|NCT02315066|78980291|FG004|Overall Study|Study ongoing at date of cut-off|0|||
44185488|NCT02315066|78980292|FG005|Overall Study|Study ongoing at date of cut-off|0|||
44185489|NCT02315066|78980293|FG006|Overall Study|Study ongoing at date of cut-off|0|||
44185490|NCT02315066|78980294|FG007|Overall Study|Study ongoing at date of cut-off|0|||
44185491|NCT02315066|78980295|FG008|Overall Study|Study ongoing at date of cut-off|0|||
44185492|NCT02315066|78980296|FG009|Overall Study|Study ongoing at date of cut-off|0|||
44185493|NCT02315066|78980297|FG010|Overall Study|Study ongoing at date of cut-off|0|||
44185494|NCT02315066|78980298|FG011|Overall Study|Study ongoing at date of cut-off|0|||
44185495|NCT02315066|78980299|FG012|Overall Study|Study ongoing at date of cut-off|0|||
44185496|NCT02315066|78980300|FG013|Overall Study|Study ongoing at date of cut-off|1|||
44185497|NCT02207413|78980336|FG000|Overall Study|Withdrawal by Subject|1|||
44185498|NCT02207413|78980337|FG001|Overall Study|Withdrawal by Subject|0|||
44185499|NCT02207413|78980338|FG002|Overall Study|Withdrawal by Subject|0|||
44185500|NCT02207413|78980339|FG003|Overall Study|Withdrawal by Subject|0|||
44185501|NCT02207413|78980340|FG004|Overall Study|Withdrawal by Subject|3|||
44185502|NCT02207413|78980341|FG005|Overall Study|Withdrawal by Subject|7|||
44185503|NCT02207413|78980336|FG000|Overall Study|Lost to Follow-up|0|||
44185504|NCT02207413|78980337|FG001|Overall Study|Lost to Follow-up|0|||
44185505|NCT02207413|78980338|FG002|Overall Study|Lost to Follow-up|0|||
44185506|NCT02207413|78980339|FG003|Overall Study|Lost to Follow-up|1|||
44185507|NCT02207413|78980340|FG004|Overall Study|Lost to Follow-up|1|||
44185508|NCT02207413|78980341|FG005|Overall Study|Lost to Follow-up|5|||
44185509|NCT02207413|78980336|FG000|Overall Study|Adverse Event|0|||
44185510|NCT02207413|78980337|FG001|Overall Study|Adverse Event|0|||
44185511|NCT02207413|78980338|FG002|Overall Study|Adverse Event|0|||
44185512|NCT02207413|78980339|FG003|Overall Study|Adverse Event|0|||
44185513|NCT02207413|78980340|FG004|Overall Study|Adverse Event|2|||
44185514|NCT02207413|78980341|FG005|Overall Study|Adverse Event|1|||
44185515|NCT02207413|78980336|FG000|Overall Study|Migrated/moved from study area|0|||
44185516|NCT02207413|78980337|FG001|Overall Study|Migrated/moved from study area|0|||
44185517|NCT02207413|78980338|FG002|Overall Study|Migrated/moved from study area|0|||
44185518|NCT02207413|78980339|FG003|Overall Study|Migrated/moved from study area|0|||
44361226|NCT01185821|79366877|FG002|Overall Study|Adverse Event|1|||
44185519|NCT02207413|78980340|FG004|Overall Study|Migrated/moved from study area|1|||
44185520|NCT02207413|78980341|FG005|Overall Study|Migrated/moved from study area|0|||
44185521|NCT02309372|78980363|FG000|Overall Study|Lost to Follow-up|3|||
44185522|NCT02309372|78980364|FG001|Overall Study|Lost to Follow-up|2|||
44185523|NCT02276027|78980374|FG000|Overall Study|Death|1|||
44185524|NCT02276027|78980375|FG001|Overall Study|Death|0|||
44185525|NCT02276027|78980376|FG002|Overall Study|Death|0|||
44185526|NCT02276027|78980377|FG003|Overall Study|Death|2|||
44185527|NCT02276027|78980374|FG000|Overall Study|Physician Decision|0|||
44185528|NCT02276027|78980375|FG001|Overall Study|Physician Decision|0|||
44185529|NCT02276027|78980376|FG002|Overall Study|Physician Decision|0|||
44185530|NCT02276027|78980377|FG003|Overall Study|Physician Decision|1|||
44185531|NCT02276027|78980374|FG000|Overall Study|Progressive disease|1|||
44185532|NCT02276027|78980375|FG001|Overall Study|Progressive disease|13|||
44185533|NCT02276027|78980376|FG002|Overall Study|Progressive disease|12|||
44185534|NCT02276027|78980377|FG003|Overall Study|Progressive disease|14|||
44185535|NCT02276027|78980374|FG000|Overall Study|Subject/guardian decision|0|||
44185536|NCT02276027|78980375|FG001|Overall Study|Subject/guardian decision|1|||
44185537|NCT02276027|78980376|FG002|Overall Study|Subject/guardian decision|0|||
44185538|NCT02276027|78980377|FG003|Overall Study|Subject/guardian decision|3|||
44185539|NCT02276027|78980374|FG000|Overall Study|Adverse Event|0|||
44185540|NCT02276027|78980375|FG001|Overall Study|Adverse Event|2|||
44185541|NCT02276027|78980376|FG002|Overall Study|Adverse Event|8|||
44185542|NCT02276027|78980377|FG003|Overall Study|Adverse Event|2|||
44185543|NCT02309294|78980387|FG000|Overall Study|Withdrawal by Subject|2|||
44185544|NCT02233543|78980391|FG000|Period 1|Withdrawal by Subject|1|||
44185545|NCT02233543|78980392|FG001|Period 1|Withdrawal by Subject|0|||
44185546|NCT02233543|78980391|FG000|Period 1|Participants required other treatment.|2|||
44185547|NCT02233543|78980392|FG001|Period 1|Participants required other treatment.|3|||
44185548|NCT02233543|78980391|FG000|Period 2|Adverse Event|1|||
44185549|NCT02233543|78980392|FG001|Period 2|Adverse Event|0|||
44185550|NCT02233543|78980391|FG000|Period 2|Participant required other treatment.|0|||
44185551|NCT02233543|78980392|FG001|Period 2|Participant required other treatment.|1|||
44185552|NCT02233543|78980391|FG000|Period 2|COPD exacerbation|1|||
44185553|NCT02233543|78980392|FG001|Period 2|COPD exacerbation|0|||
44185554|NCT02309138|78980400|FG000|Overall Study|Withdrawal by Subject|44|||
44185555|NCT02309138|78980401|FG001|Overall Study|Withdrawal by Subject|15|||
44185556|NCT02309138|78980400|FG000|Overall Study|Protocol Violation|4|||
44185557|NCT02309138|78980401|FG001|Overall Study|Protocol Violation|2|||
44185558|NCT02309138|78980400|FG000|Overall Study|delivered before visit 2|0|||
44185559|NCT02309138|78980401|FG001|Overall Study|delivered before visit 2|1|||
44185560|NCT02233309|78980417|FG000|Overall Study|Physician Decision|5|||
44185561|NCT02204917|78980421|FG000|Overall Study|Protocol Violation|1|||
44185562|NCT02280044|78980430|FG000|Overall Study|Planned alternate|0|||
44185563|NCT02280044|78980431|FG001|Overall Study|Planned alternate|2|||
44185564|NCT02308748|78980437|FG000|Period 1|Withdrawal by Subject|0|||
44185565|NCT02308748|78980438|FG001|Period 1|Withdrawal by Subject|0|||
44185566|NCT02308748|78980439|FG002|Period 1|Withdrawal by Subject|1|||
44185567|NCT02308748|78980440|FG003|Period 1|Withdrawal by Subject|0|||
44185568|NCT02308748|78980441|FG004|Period 1|Withdrawal by Subject|0|||
44185569|NCT02308748|78980442|FG005|Period 1|Withdrawal by Subject|0|||
44185570|NCT02308748|78980443|FG006|Period 1|Withdrawal by Subject|0|||
44185571|NCT02308748|78980444|FG007|Period 1|Withdrawal by Subject|0|||
44185572|NCT02308748|78980445|FG008|Period 1|Withdrawal by Subject|0|||
44185573|NCT02308748|78980446|FG009|Period 1|Withdrawal by Subject|0|||
44185574|NCT02308748|78980437|FG000|Period 2|Adverse Event|0|||
44185575|NCT02308748|78980438|FG001|Period 2|Adverse Event|0|||
44185576|NCT02308748|78980439|FG002|Period 2|Adverse Event|0|||
44185577|NCT02308748|78980440|FG003|Period 2|Adverse Event|0|||
44185578|NCT02308748|78980441|FG004|Period 2|Adverse Event|0|||
44185579|NCT02308748|78980442|FG005|Period 2|Adverse Event|0|||
44185580|NCT02308748|78980443|FG006|Period 2|Adverse Event|0|||
44185581|NCT02308748|78980444|FG007|Period 2|Adverse Event|1|||
44185582|NCT02308748|78980445|FG008|Period 2|Adverse Event|0|||
44185583|NCT02308748|78980446|FG009|Period 2|Adverse Event|0|||
44265619|NCT02412852|79170741|FG002|Overall Study|Physician Decision|0|||
44185584|NCT02308748|78980437|FG000|Period 3|Protocol Violation|0|||
44185585|NCT02308748|78980438|FG001|Period 3|Protocol Violation|0|||
44185586|NCT02308748|78980439|FG002|Period 3|Protocol Violation|0|||
44185587|NCT02308748|78980440|FG003|Period 3|Protocol Violation|0|||
44185588|NCT02308748|78980441|FG004|Period 3|Protocol Violation|0|||
44185589|NCT02308748|78980442|FG005|Period 3|Protocol Violation|0|||
44185590|NCT02308748|78980443|FG006|Period 3|Protocol Violation|0|||
44185591|NCT02308748|78980444|FG007|Period 3|Protocol Violation|0|||
44185592|NCT02308748|78980445|FG008|Period 3|Protocol Violation|0|||
44185593|NCT02308748|78980446|FG009|Period 3|Protocol Violation|1|||
44185594|NCT02308748|78980437|FG000|Period 5|Adverse Event|1|||
44185595|NCT02308748|78980438|FG001|Period 5|Adverse Event|0|||
44185596|NCT02308748|78980439|FG002|Period 5|Adverse Event|0|||
44185597|NCT02308748|78980440|FG003|Period 5|Adverse Event|0|||
44185598|NCT02308748|78980441|FG004|Period 5|Adverse Event|0|||
44185599|NCT02308748|78980442|FG005|Period 5|Adverse Event|0|||
44185600|NCT02308748|78980443|FG006|Period 5|Adverse Event|0|||
44265620|NCT02412852|79170742|FG003|Overall Study|Physician Decision|1|||
44185601|NCT02308748|78980444|FG007|Period 5|Adverse Event|0|||
44185602|NCT02308748|78980445|FG008|Period 5|Adverse Event|1|||
44185603|NCT02308748|78980446|FG009|Period 5|Adverse Event|0|||
44185604|NCT01646216|78980460|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
44185605|NCT01646216|78980461|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
44185606|NCT01646216|78980460|FG000|Overall Study|Did not complete training|0|||
44185607|NCT01646216|78980461|FG001|Overall Study|Did not complete training|2|||
44185608|NCT01646216|78980460|FG000|Overall Study|Investigator decision|1|||
44265621|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
44265622|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
44265623|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
44265624|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
44265625|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
44265626|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
44265627|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
44265628|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
44265629|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
44265630|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
44265631|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
44265632|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
44265633|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
44265634|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
44265635|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
44265636|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
44265637|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
44265638|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
44265639|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
44265640|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
44265641|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
44265642|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
44265643|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
44265644|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
44265645|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
44265646|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Other|1|||
44265647|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Other|0|||
44265648|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Other|0|||
44265649|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Other|0|||
44265650|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Other|0|||
44265651|NCT02386098|79170798|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
44265652|NCT02386098|79170799|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
44265653|NCT02386098|79170800|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
44265654|NCT02386098|79170801|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
44265655|NCT02386098|79170802|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
44265656|NCT02412618|79170845|FG000|Overall Study|Withdrawal by Subject|1|||
44265657|NCT02412618|79170846|FG001|Overall Study|Withdrawal by Subject|1|||
44265658|NCT02412618|79170845|FG000|Overall Study|Expulsion|1|||
44185609|NCT01646216|78980461|FG001|Overall Study|Investigator decision|1|||
44185610|NCT02308124|78980474|FG000|Overall Study|Lost to Follow-up|6|||
44185611|NCT02308124|78980475|FG001|Overall Study|Lost to Follow-up|6|||
44265659|NCT02412618|79170846|FG001|Overall Study|Expulsion|1|||
44265660|NCT00585195|79171043|FG000|Overall Study|Adverse Event|0|||
44265661|NCT00585195|79171044|FG001|Overall Study|Adverse Event|0|||
44265662|NCT00585195|79171045|FG002|Overall Study|Adverse Event|0|||
44265663|NCT00585195|79171046|FG003|Overall Study|Adverse Event|0|||
44265664|NCT00585195|79171047|FG004|Overall Study|Adverse Event|2|||
44265665|NCT00585195|79171048|FG005|Overall Study|Adverse Event|1|||
44265666|NCT00585195|79171049|FG006|Overall Study|Adverse Event|0|||
44265667|NCT00585195|79171050|FG007|Overall Study|Adverse Event|1|||
44265668|NCT00585195|79171051|FG008|Overall Study|Adverse Event|0|||
44265669|NCT00585195|79171052|FG009|Overall Study|Adverse Event|0|||
44265670|NCT00585195|79171053|FG010|Overall Study|Adverse Event|3|||
44265671|NCT00585195|79171054|FG011|Overall Study|Adverse Event|0|||
44265672|NCT00585195|79171055|FG012|Overall Study|Adverse Event|8|||
44185612|NCT02308124|78980476|FG002|Overall Study|Lost to Follow-up|6|||
44185613|NCT02308124|78980474|FG000|Overall Study|Adverse Event|0|||
44185614|NCT02308124|78980475|FG001|Overall Study|Adverse Event|2|||
44185615|NCT02308124|78980476|FG002|Overall Study|Adverse Event|2|||
44185616|NCT02232061|78980484|FG000|Overall Study|Administrative problems|1|||
44185617|NCT02232061|78980484|FG000|Overall Study|Withdrawal by Subject|1|||
44185618|NCT02275481|78980490|FG000|Overall Study|Death|2|||
44185619|NCT02275481|78980491|FG001|Overall Study|Death|1|||
44265673|NCT00585195|79171056|FG013|Overall Study|Adverse Event|6|||
44265674|NCT00585195|79171057|FG014|Overall Study|Adverse Event|4|||
44265675|NCT00585195|79171058|FG015|Overall Study|Adverse Event|1|||
44265676|NCT00585195|79171059|FG016|Overall Study|Adverse Event|14|||
44265677|NCT00585195|79171060|FG017|Overall Study|Adverse Event|9|||
44185620|NCT02275481|78980490|FG000|Overall Study|Lost to Follow-up|2|||
44265678|NCT00585195|79171061|FG018|Overall Study|Adverse Event|2|||
44265679|NCT00585195|79171062|FG019|Overall Study|Adverse Event|3|||
44265680|NCT00585195|79171063|FG020|Overall Study|Adverse Event|1|||
44265681|NCT00585195|79171043|FG000|Overall Study|Progressive Disease|2|||
44265682|NCT00585195|79171044|FG001|Overall Study|Progressive Disease|2|||
44265683|NCT00585195|79171045|FG002|Overall Study|Progressive Disease|5|||
44265684|NCT00585195|79171046|FG003|Overall Study|Progressive Disease|4|||
44265685|NCT00585195|79171047|FG004|Overall Study|Progressive Disease|6|||
44265686|NCT00585195|79171048|FG005|Overall Study|Progressive Disease|4|||
44265687|NCT00585195|79171049|FG006|Overall Study|Progressive Disease|6|||
44265688|NCT00585195|79171050|FG007|Overall Study|Progressive Disease|3|||
44265689|NCT00585195|79171051|FG008|Overall Study|Progressive Disease|0|||
44265690|NCT00585195|79171052|FG009|Overall Study|Progressive Disease|5|||
44265691|NCT00585195|79171053|FG010|Overall Study|Progressive Disease|2|||
44265692|NCT00585195|79171054|FG011|Overall Study|Progressive Disease|25|||
44265693|NCT00585195|79171055|FG012|Overall Study|Progressive Disease|29|||
44265694|NCT00585195|79171056|FG013|Overall Study|Progressive Disease|26|||
44265695|NCT00585195|79171057|FG014|Overall Study|Progressive Disease|21|||
44265696|NCT00585195|79171058|FG015|Overall Study|Progressive Disease|12|||
44265697|NCT00585195|79171059|FG016|Overall Study|Progressive Disease|94|||
44265698|NCT00585195|79171060|FG017|Overall Study|Progressive Disease|42|||
44265699|NCT00585195|79171061|FG018|Overall Study|Progressive Disease|4|||
44265700|NCT00585195|79171062|FG019|Overall Study|Progressive Disease|9|||
44265701|NCT00585195|79171063|FG020|Overall Study|Progressive Disease|8|||
44265702|NCT00585195|79171043|FG000|Overall Study|Withdrawal by Subject|1|||
44265703|NCT00585195|79171044|FG001|Overall Study|Withdrawal by Subject|1|||
44265704|NCT00585195|79171045|FG002|Overall Study|Withdrawal by Subject|2|||
44265705|NCT00585195|79171046|FG003|Overall Study|Withdrawal by Subject|2|||
44265706|NCT00585195|79171047|FG004|Overall Study|Withdrawal by Subject|0|||
44265707|NCT00585195|79171048|FG005|Overall Study|Withdrawal by Subject|0|||
44265708|NCT00585195|79171049|FG006|Overall Study|Withdrawal by Subject|0|||
44265709|NCT00585195|79171050|FG007|Overall Study|Withdrawal by Subject|1|||
44265710|NCT00585195|79171051|FG008|Overall Study|Withdrawal by Subject|0|||
44265711|NCT00585195|79171052|FG009|Overall Study|Withdrawal by Subject|0|||
44265712|NCT00585195|79171053|FG010|Overall Study|Withdrawal by Subject|3|||
44265713|NCT00585195|79171054|FG011|Overall Study|Withdrawal by Subject|8|||
44265714|NCT00585195|79171055|FG012|Overall Study|Withdrawal by Subject|15|||
44265715|NCT00585195|79171056|FG013|Overall Study|Withdrawal by Subject|0|||
44265716|NCT00585195|79171057|FG014|Overall Study|Withdrawal by Subject|3|||
44265717|NCT00585195|79171058|FG015|Overall Study|Withdrawal by Subject|0|||
44265718|NCT00585195|79171059|FG016|Overall Study|Withdrawal by Subject|7|||
44265719|NCT00585195|79171060|FG017|Overall Study|Withdrawal by Subject|1|||
44265720|NCT00585195|79171061|FG018|Overall Study|Withdrawal by Subject|2|||
44265721|NCT00585195|79171062|FG019|Overall Study|Withdrawal by Subject|2|||
44265722|NCT00585195|79171063|FG020|Overall Study|Withdrawal by Subject|0|||
44265723|NCT00585195|79171043|FG000|Overall Study|Other|0|||
44265724|NCT00585195|79171044|FG001|Overall Study|Other|1|||
44265725|NCT00585195|79171045|FG002|Overall Study|Other|1|||
44265726|NCT00585195|79171046|FG003|Overall Study|Other|1|||
44265727|NCT00585195|79171047|FG004|Overall Study|Other|0|||
44265728|NCT00585195|79171048|FG005|Overall Study|Other|1|||
44265729|NCT00585195|79171049|FG006|Overall Study|Other|0|||
44265730|NCT00585195|79171050|FG007|Overall Study|Other|0|||
44265731|NCT00585195|79171051|FG008|Overall Study|Other|2|||
44265732|NCT00585195|79171052|FG009|Overall Study|Other|1|||
44265733|NCT00585195|79171053|FG010|Overall Study|Other|0|||
44265734|NCT00585195|79171054|FG011|Overall Study|Other|19|||
44265735|NCT00585195|79171055|FG012|Overall Study|Other|24|||
44265736|NCT00585195|79171056|FG013|Overall Study|Other|7|||
44265737|NCT00585195|79171057|FG014|Overall Study|Other|11|||
44265738|NCT00585195|79171058|FG015|Overall Study|Other|3|||
44265739|NCT00585195|79171059|FG016|Overall Study|Other|28|||
44185621|NCT02275481|78980491|FG001|Overall Study|Lost to Follow-up|0|||
44185622|NCT02275481|78980490|FG000|Overall Study|Withdrawal by Subject|3|||
44185623|NCT02275481|78980491|FG001|Overall Study|Withdrawal by Subject|0|||
44185624|NCT02275481|78980490|FG000|Overall Study|all other reasons combined|2|||
44185625|NCT02275481|78980491|FG001|Overall Study|all other reasons combined|1|||
44185626|NCT02275481|78980490|FG000|Overall Study|Physician Decision|0|||
44185627|NCT02275481|78980491|FG001|Overall Study|Physician Decision|1|||
44185628|NCT02204449|78980499|FG000|Overall Study|Lost to Follow-up|7|||
44185629|NCT02204449|78980500|FG001|Overall Study|Lost to Follow-up|9|||
44185630|NCT02204449|78980499|FG000|Overall Study|Death|0|||
44265740|NCT00585195|79171060|FG017|Overall Study|Other|12|||
44185631|NCT02204449|78980500|FG001|Overall Study|Death|1|||
44265741|NCT00585195|79171061|FG018|Overall Study|Other|10|||
44265742|NCT00585195|79171062|FG019|Overall Study|Other|4|||
44265743|NCT00585195|79171063|FG020|Overall Study|Other|2|||
44265744|NCT00585195|79171043|FG000|Overall Study|Randomized not treated|0|||
44265745|NCT00585195|79171044|FG001|Overall Study|Randomized not treated|0|||
44265746|NCT00585195|79171045|FG002|Overall Study|Randomized not treated|1|||
44265747|NCT00585195|79171046|FG003|Overall Study|Randomized not treated|0|||
44265748|NCT00585195|79171047|FG004|Overall Study|Randomized not treated|1|||
44265749|NCT00585195|79171048|FG005|Overall Study|Randomized not treated|0|||
44265750|NCT00585195|79171049|FG006|Overall Study|Randomized not treated|1|||
44265751|NCT00585195|79171050|FG007|Overall Study|Randomized not treated|0|||
44265752|NCT00585195|79171051|FG008|Overall Study|Randomized not treated|0|||
44265753|NCT00585195|79171052|FG009|Overall Study|Randomized not treated|0|||
44265754|NCT00585195|79171053|FG010|Overall Study|Randomized not treated|2|||
44265755|NCT00585195|79171054|FG011|Overall Study|Randomized not treated|0|||
44265756|NCT00585195|79171055|FG012|Overall Study|Randomized not treated|0|||
44185632|NCT02204449|78980499|FG000|Overall Study|Withdrawal by Subject|0|||
44185633|NCT02204449|78980500|FG001|Overall Study|Withdrawal by Subject|1|||
44185634|NCT02308046|78980508|FG000|Overall Study|Negative yeast culture at Baseline|32|||
44185635|NCT02308046|78980509|FG001|Overall Study|Negative yeast culture at Baseline|33|||
44185636|NCT02308046|78980508|FG000|Overall Study|Positive for STD at Baseline|1|||
44185637|NCT02308046|78980509|FG001|Overall Study|Positive for STD at Baseline|2|||
44185638|NCT02308046|78980508|FG000|Overall Study|Lost to Follow-up|1|||
44185639|NCT02308046|78980509|FG001|Overall Study|Lost to Follow-up|3|||
44185640|NCT02318693|78980517|FG000|Overall Study|Protocol Violation|0|||
44185641|NCT02318693|78980518|FG001|Overall Study|Protocol Violation|1|||
44185642|NCT02230891|78980527|FG000|Baseline|Did not meet inclusion|0|||
44185643|NCT02230891|78980528|FG001|Baseline|Did not meet inclusion|1|||
44185644|NCT02230891|78980529|FG002|Baseline|Did not meet inclusion|1|||
44185645|NCT02230891|78980527|FG000|2 Week|Withdrawal by Subject|2|||
44185646|NCT02230891|78980528|FG001|2 Week|Withdrawal by Subject|2|||
44185647|NCT02230891|78980529|FG002|2 Week|Withdrawal by Subject|0|||
44185648|NCT02230891|78980527|FG000|2 Week|Consent withdrawn|1|||
44185649|NCT02230891|78980528|FG001|2 Week|Consent withdrawn|0|||
44185650|NCT02230891|78980529|FG002|2 Week|Consent withdrawn|0|||
44185651|NCT02230891|78980527|FG000|6 Month|Withdrawal by Subject|1|||
44185652|NCT02230891|78980528|FG001|6 Month|Withdrawal by Subject|1|||
44185653|NCT02230891|78980529|FG002|6 Month|Withdrawal by Subject|1|||
44185654|NCT02230891|78980527|FG000|6 Month|Physician Decision|0|||
44185655|NCT02230891|78980528|FG001|6 Month|Physician Decision|2|||
44185656|NCT02230891|78980529|FG002|6 Month|Physician Decision|0|||
44185657|NCT02230891|78980527|FG000|12 Month|Death|1|||
44185658|NCT02230891|78980528|FG001|12 Month|Death|0|||
44185659|NCT02230891|78980529|FG002|12 Month|Death|0|||
44185660|NCT02230891|78980527|FG000|12 Month|Lost to Follow-up|0|||
44185661|NCT02230891|78980528|FG001|12 Month|Lost to Follow-up|1|||
44185662|NCT02230891|78980529|FG002|12 Month|Lost to Follow-up|0|||
44185663|NCT02230891|78980527|FG000|12 Month|Withdrawal by Subject|0|||
44185664|NCT02230891|78980528|FG001|12 Month|Withdrawal by Subject|2|||
44185665|NCT02230891|78980529|FG002|12 Month|Withdrawal by Subject|0|||
44185666|NCT02230891|78980527|FG000|18 Month End of Study|Death|0|||
44185667|NCT02230891|78980528|FG001|18 Month End of Study|Death|0|||
44185668|NCT02230891|78980529|FG002|18 Month End of Study|Death|1|||
44185669|NCT02230891|78980527|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
44185670|NCT02230891|78980528|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
44185671|NCT02230891|78980529|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
44185672|NCT01646138|78980544|FG000|Overall Study|Lost to Follow-up|0|||
44185673|NCT01646138|78980545|FG001|Overall Study|Lost to Follow-up|0|||
44185674|NCT01646138|78980546|FG002|Overall Study|Lost to Follow-up|0|||
44185675|NCT01646138|78980547|FG003|Overall Study|Lost to Follow-up|0|||
44185676|NCT01646138|78980548|FG004|Overall Study|Lost to Follow-up|2|||
44185677|NCT02204371|78980560|FG000|Overall Study|Adverse Event|1|||
44185678|NCT02274857|78980566|FG000|Overall Study|Adverse Event|1|||
44185679|NCT02274857|78980567|FG001|Overall Study|Adverse Event|0|||
44185680|NCT02274857|78980566|FG000|Overall Study|Death|1|||
44185681|NCT02274857|78980567|FG001|Overall Study|Death|2|||
44185682|NCT02274857|78980566|FG000|Overall Study|Lost to Follow-up|3|||
44185683|NCT02274857|78980567|FG001|Overall Study|Lost to Follow-up|0|||
44185684|NCT02274857|78980566|FG000|Overall Study|Physician Decision|2|||
44185685|NCT02274857|78980567|FG001|Overall Study|Physician Decision|0|||
44185686|NCT02274857|78980566|FG000|Overall Study|Trial screen failure|0|||
44185687|NCT02274857|78980567|FG001|Overall Study|Trial screen failure|2|||
44185688|NCT02274857|78980566|FG000|Overall Study|Withdrawal by Subject|11|||
44185689|NCT02274857|78980567|FG001|Overall Study|Withdrawal by Subject|2|||
44185690|NCT02274857|78980566|FG000|Overall Study|Other|2|||
44185691|NCT02274857|78980567|FG001|Overall Study|Other|0|||
44185692|NCT02302859|78980576|FG000|Overall Study|Lost Phone|1|||
44185693|NCT02302859|78980577|FG001|Overall Study|Lost Phone|1|||
44185694|NCT02302859|78980576|FG000|Overall Study|Withdrawal by Subject|0|||
44185695|NCT02302859|78980577|FG001|Overall Study|Withdrawal by Subject|1|||
44185696|NCT02274311|78980583|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
44265757|NCT00585195|79171056|FG013|Overall Study|Randomized not treated|0|||
44265758|NCT00585195|79171057|FG014|Overall Study|Randomized not treated|0|||
44451337|NCT00098293|79460286|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
44185697|NCT02316353|78980591|FG000|Overall Study|Pregnancy|1|||
44185698|NCT02316353|78980592|FG001|Overall Study|Pregnancy|3|||
44185699|NCT02316353|78980591|FG000|Overall Study|Adverse Event|1|||
44185700|NCT02316353|78980592|FG001|Overall Study|Adverse Event|3|||
44185701|NCT02316353|78980591|FG000|Overall Study|Withdrawal by Subject|6|||
44185702|NCT02316353|78980592|FG001|Overall Study|Withdrawal by Subject|2|||
44185703|NCT02273141|78980603|FG000|Overall Study|Adverse Event|0|||
44185704|NCT02273141|78980604|FG001|Overall Study|Adverse Event|1|||
44185705|NCT02273141|78980603|FG000|Overall Study|Lost to Follow-up|1|||
44185706|NCT02273141|78980604|FG001|Overall Study|Lost to Follow-up|3|||
44185707|NCT02273141|78980603|FG000|Overall Study|Withdrawal by Subject|10|||
44185708|NCT02273141|78980604|FG001|Overall Study|Withdrawal by Subject|15|||
44185709|NCT02273141|78980603|FG000|Overall Study|Various|6|||
44185710|NCT02273141|78980604|FG001|Overall Study|Various|6|||
44185711|NCT02314052|78980610|FG000|Cycle One|Adverse Event|0|||
44185712|NCT02314052|78980611|FG001|Cycle One|Adverse Event|0|||
44185713|NCT02314052|78980612|FG002|Cycle One|Adverse Event|0|||
44185714|NCT02314052|78980613|FG003|Cycle One|Adverse Event|1|||
44185715|NCT02314052|78980614|FG004|Cycle One|Adverse Event|0|||
44185716|NCT02314052|78980615|FG005|Cycle One|Adverse Event|0|||
44185717|NCT02279732|78980631|FG000|Overall Study|Death|23|||
44185718|NCT02279732|78980632|FG001|Overall Study|Death|20|||
44185719|NCT02279732|78980631|FG000|Overall Study|Disease Progression|13|||
44185720|NCT02279732|78980632|FG001|Overall Study|Disease Progression|3|||
44185721|NCT02279732|78980631|FG000|Overall Study|Withdrawal by Subject|2|||
44185722|NCT02279732|78980632|FG001|Overall Study|Withdrawal by Subject|7|||
44185723|NCT02279732|78980631|FG000|Overall Study|Adverse Event|1|||
44185724|NCT02279732|78980632|FG001|Overall Study|Adverse Event|2|||
44185725|NCT02279732|78980631|FG000|Overall Study|Administrative Reason By Sponsor|0|||
44185726|NCT02279732|78980632|FG001|Overall Study|Administrative Reason By Sponsor|2|||
44185727|NCT02279732|78980631|FG000|Overall Study|Study Drug Toxicity|2|||
44185728|NCT02279732|78980632|FG001|Overall Study|Study Drug Toxicity|0|||
44185729|NCT02279732|78980631|FG000|Overall Study|Lost to Follow-up|0|||
44185730|NCT02279732|78980632|FG001|Overall Study|Lost to Follow-up|1|||
44185731|NCT02279732|78980631|FG000|Overall Study|Maximum Clinical Benefit|1|||
44185732|NCT02279732|78980632|FG001|Overall Study|Maximum Clinical Benefit|0|||
44185733|NCT02279732|78980631|FG000|Overall Study|Subject Requested to Discontinue|0|||
44185734|NCT02279732|78980632|FG001|Overall Study|Subject Requested to Discontinue|1|||
44185735|NCT02279732|78980631|FG000|Overall Study|Other|53|||
44185736|NCT02279732|78980632|FG001|Overall Study|Other|67|||
44185737|NCT02279732|78980631|FG000|Overall Study|Other|3|||
44185738|NCT02279732|78980632|FG001|Overall Study|Other|3|||
44185739|NCT02279498|78980640|FG000|Overall Study|Adverse Event|3|||
44185740|NCT02279498|78980641|FG001|Overall Study|Adverse Event|0|||
44185741|NCT02279498|78980640|FG000|Overall Study|Lack of Efficacy|4|||
44185742|NCT02279498|78980641|FG001|Overall Study|Lack of Efficacy|0|||
44185743|NCT02279498|78980640|FG000|Overall Study|Lost to Follow-up|0|||
44185744|NCT02279498|78980641|FG001|Overall Study|Lost to Follow-up|1|||
44185745|NCT02279498|78980640|FG000|Overall Study|Withdrawal by Subject|9|||
44185746|NCT02279498|78980641|FG001|Overall Study|Withdrawal by Subject|2|||
44185747|NCT02279498|78980640|FG000|Overall Study|Undefined|2|||
44185748|NCT02279498|78980641|FG001|Overall Study|Undefined|1|||
44185749|NCT02307266|78980651|FG000|Overall Study|Adverse Event|3|||
44185750|NCT02307266|78980652|FG001|Overall Study|Adverse Event|1|||
44185751|NCT02307266|78980653|FG002|Overall Study|Adverse Event|5|||
44185752|NCT02307266|78980651|FG000|Overall Study|Withdrawal by Subject|2|||
44185753|NCT02307266|78980652|FG001|Overall Study|Withdrawal by Subject|0|||
44185754|NCT02307266|78980653|FG002|Overall Study|Withdrawal by Subject|1|||
44185755|NCT02307266|78980651|FG000|Overall Study|Lost to Follow-up|3|||
44185756|NCT02307266|78980652|FG001|Overall Study|Lost to Follow-up|0|||
44185757|NCT02307266|78980653|FG002|Overall Study|Lost to Follow-up|0|||
44185758|NCT02279420|78980661|FG000|Overall Study|Lost to Follow-up|23|||
44185759|NCT02278952|78980665|FG000|Overall Study|Insufficient Sample|6|||
44185760|NCT02278328|78980675|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
44185761|NCT02278328|78980676|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
44185762|NCT02278328|78980677|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
44185763|NCT02278328|78980675|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
44185764|NCT02278328|78980676|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
44185765|NCT02278328|78980677|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
44185766|NCT02278328|78980675|FG000|Neuropsych Screening|incomplete consent|0|||
44185767|NCT02278328|78980676|FG001|Neuropsych Screening|incomplete consent|0|||
44185768|NCT02278328|78980677|FG002|Neuropsych Screening|incomplete consent|2|||
44185769|NCT02314637|78980685|FG000|Overall Study|Adverse Event|4|||
44185770|NCT02314637|78980686|FG001|Overall Study|Adverse Event|8|||
44185771|NCT02314637|78980685|FG000|Overall Study|Lack of Efficacy|1|||
44185772|NCT02314637|78980686|FG001|Overall Study|Lack of Efficacy|0|||
44185773|NCT02314637|78980685|FG000|Overall Study|Physician Decision|5|||
44185774|NCT02314637|78980686|FG001|Overall Study|Physician Decision|2|||
44185775|NCT02314637|78980685|FG000|Overall Study|Withdrawal by Subject|5|||
44185776|NCT02314637|78980686|FG001|Overall Study|Withdrawal by Subject|4|||
44185777|NCT02314637|78980685|FG000|Overall Study|Other Reason|1|||
44185778|NCT02314637|78980686|FG001|Overall Study|Other Reason|0|||
44185779|NCT01646645|78980692|FG000|Overall Study|No Treated|1|||
44185780|NCT01646645|78980692|FG000|Overall Study|Inevaluable Donor|29|||
44185781|NCT02272985|78980696|FG000|Overall Study|Withdrawal by Subject|1|||
44185782|NCT02272985|78980696|FG000|Overall Study|hip fracture|1|||
44185783|NCT02272985|78980696|FG000|Overall Study|kidney transplantation|1|||
44185784|NCT01644149|78980703|FG000|Overall Study|Withdrawal by Subject|1|||
44185785|NCT01644149|78980704|FG001|Overall Study|Withdrawal by Subject|0|||
44185786|NCT01644149|78980703|FG000|Overall Study|Lost to Follow-up|3|||
44185787|NCT01644149|78980704|FG001|Overall Study|Lost to Follow-up|1|||
44185788|NCT02313233|78980713|FG000|Overall Study|Withdrawal by Subject|1|||
44185789|NCT02313233|78980714|FG001|Overall Study|Withdrawal by Subject|2|||
44185790|NCT02313233|78980713|FG000|Overall Study|Administrative reason|1|||
44185791|NCT02313233|78980714|FG001|Overall Study|Administrative reason|1|||
44185792|NCT02313155|78980724|FG000|Overall Study|Lost to Follow-up|0|||
44185793|NCT02313155|78980725|FG001|Overall Study|Lost to Follow-up|1|||
44185794|NCT02204293|78980733|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
44185795|NCT02204293|78980734|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
44185796|NCT02204293|78980735|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
44185797|NCT02204293|78980736|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
44185798|NCT02204293|78980737|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
44185799|NCT02204293|78980738|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
44185800|NCT02204293|78980733|FG000|Core Study Part I|Adverse Event|1|||
44265759|NCT00585195|79171058|FG015|Overall Study|Randomized not treated|1|||
44265760|NCT00585195|79171059|FG016|Overall Study|Randomized not treated|0|||
44265761|NCT00585195|79171060|FG017|Overall Study|Randomized not treated|1|||
44185801|NCT02204293|78980734|FG001|Core Study Part I|Adverse Event|0|||
44185802|NCT02204293|78980735|FG002|Core Study Part I|Adverse Event|0|||
44185803|NCT02204293|78980736|FG003|Core Study Part I|Adverse Event|0|||
44185804|NCT02204293|78980737|FG004|Core Study Part I|Adverse Event|0|||
44185805|NCT02204293|78980738|FG005|Core Study Part I|Adverse Event|0|||
44185806|NCT02204293|78980733|FG000|Core Study Part I|Physician Decision|0|||
44185807|NCT02204293|78980734|FG001|Core Study Part I|Physician Decision|3|||
44185808|NCT02204293|78980735|FG002|Core Study Part I|Physician Decision|0|||
44185809|NCT02204293|78980736|FG003|Core Study Part I|Physician Decision|0|||
44185810|NCT02204293|78980737|FG004|Core Study Part I|Physician Decision|0|||
44185811|NCT02204293|78980738|FG005|Core Study Part I|Physician Decision|0|||
44265762|NCT00585195|79171061|FG018|Overall Study|Randomized not treated|3|||
44185812|NCT02204293|78980733|FG000|LTE Phase|Study Suspended|0|||
44185813|NCT02204293|78980734|FG001|LTE Phase|Study Suspended|0|||
44185814|NCT02204293|78980735|FG002|LTE Phase|Study Suspended|0|||
44185815|NCT02204293|78980736|FG003|LTE Phase|Study Suspended|0|||
44185816|NCT02204293|78980737|FG004|LTE Phase|Study Suspended|0|||
44185817|NCT02204293|78980738|FG005|LTE Phase|Study Suspended|7|||
44185818|NCT02304926|78980754|FG000|Overall Study|Lost to Follow-up|2|||
44185819|NCT02304926|78980755|FG001|Overall Study|Lost to Follow-up|1|||
44185820|NCT01646255|78980765|FG000|Overall Study|Adverse Event|7|||
44185821|NCT01646255|78980766|FG001|Overall Study|Adverse Event|8|||
44185822|NCT01646255|78980765|FG000|Overall Study|Lack of Efficacy|2|||
44185823|NCT01646255|78980766|FG001|Overall Study|Lack of Efficacy|0|||
44185824|NCT01646255|78980765|FG000|Overall Study|Withdrawal by Subject|10|||
44185825|NCT01646255|78980766|FG001|Overall Study|Withdrawal by Subject|6|||
44185826|NCT01646255|78980765|FG000|Overall Study|Compliance is not well|1|||
44185827|NCT01646255|78980766|FG001|Overall Study|Compliance is not well|0|||
44185828|NCT01646255|78980765|FG000|Overall Study|Inclusion Criteria Deviation|1|||
44185829|NCT01646255|78980766|FG001|Overall Study|Inclusion Criteria Deviation|0|||
44185830|NCT02304380|78980779|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
44185831|NCT02304380|78980780|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
44185832|NCT02304380|78980781|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
44185833|NCT02304380|78980782|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
44185834|NCT02304380|78980783|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
44185835|NCT02304380|78980784|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
44185836|NCT02203591|78980806|FG000|Overall Study|Did not meet treatment day baseline|147|||
44185837|NCT02203591|78980807|FG001|Overall Study|Did not meet treatment day baseline|141|||
44185838|NCT02203591|78980808|FG002|Overall Study|Did not meet treatment day baseline|150|||
44185839|NCT02203591|78980809|FG003|Overall Study|Did not meet treatment day baseline|45|||
44185840|NCT02203591|78980810|FG004|Overall Study|Did not meet treatment day baseline|33|||
44185841|NCT02203591|78980811|FG005|Overall Study|Did not meet treatment day baseline|35|||
44185842|NCT02203591|78980812|FG006|Overall Study|Did not meet treatment day baseline|29|||
44185843|NCT02203591|78980813|FG007|Overall Study|Did not meet treatment day baseline|12|||
44185844|NCT02203591|78980806|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
44185845|NCT02203591|78980807|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
44185846|NCT02203591|78980808|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
44185847|NCT02203591|78980809|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
44185848|NCT02203591|78980810|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
44185849|NCT02203591|78980811|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
44185850|NCT02203591|78980812|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
44185851|NCT02203591|78980813|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
44185852|NCT01642277|78980837|FG000|Overall Study|Adverse Event|10|||
44185853|NCT01642277|78980838|FG001|Overall Study|Adverse Event|0|||
44185854|NCT01642277|78980837|FG000|Overall Study|Physician Decision|2|||
44185855|NCT01642277|78980838|FG001|Overall Study|Physician Decision|0|||
44185856|NCT01642277|78980837|FG000|Overall Study|Protocol Violation|1|||
44185857|NCT01642277|78980838|FG001|Overall Study|Protocol Violation|0|||
44185858|NCT01642277|78980837|FG000|Overall Study|Withdrawal by Subject|11|||
44185859|NCT01642277|78980838|FG001|Overall Study|Withdrawal by Subject|0|||
44185860|NCT02230189|78980848|FG000|Overall Study|Withdrawal by Subject|3|||
44185861|NCT02230189|78980849|FG001|Overall Study|Withdrawal by Subject|0|||
44185862|NCT02230189|78980850|FG002|Overall Study|Withdrawal by Subject|1|||
44185863|NCT02230189|78980848|FG000|Overall Study|Lost to Follow-up|1|||
44185864|NCT02230189|78980849|FG001|Overall Study|Lost to Follow-up|0|||
44185865|NCT02230189|78980850|FG002|Overall Study|Lost to Follow-up|0|||
44185866|NCT02230189|78980848|FG000|Overall Study|Physician Decision|1|||
44185867|NCT02230189|78980849|FG001|Overall Study|Physician Decision|0|||
44185868|NCT02230189|78980850|FG002|Overall Study|Physician Decision|0|||
44185869|NCT02304302|78980861|FG000|Overall Study|Adverse Event|2|||
44185870|NCT02304302|78980862|FG001|Overall Study|Adverse Event|3|||
44185871|NCT02304302|78980861|FG000|Overall Study|Lost to Follow-up|1|||
44185872|NCT02304302|78980862|FG001|Overall Study|Lost to Follow-up|4|||
44185873|NCT02304302|78980861|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
44185874|NCT02304302|78980862|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
44185875|NCT02276612|78980874|FG000|Overall Study|Death|1|||
44185876|NCT02276612|78980875|FG001|Overall Study|Death|0|||
44185877|NCT02276612|78980874|FG000|Overall Study|Pregnancy|1|||
44185878|NCT02276612|78980875|FG001|Overall Study|Pregnancy|0|||
44185879|NCT02276612|78980874|FG000|Overall Study|Withdrew Consent|1|||
44185880|NCT02276612|78980875|FG001|Overall Study|Withdrew Consent|0|||
44185881|NCT02276612|78980874|FG000|Overall Study|Lost to Follow-up|1|||
44185882|NCT02276612|78980875|FG001|Overall Study|Lost to Follow-up|0|||
44185883|NCT02301143|78980881|FG000|Induction Period|Enrolled But Not Treated|1|||
44185884|NCT02301143|78980882|FG001|Induction Period|Enrolled But Not Treated|0|||
44185885|NCT02301143|78980881|FG000|Induction Period|Death|1|||
44185886|NCT02301143|78980882|FG001|Induction Period|Death|0|||
44185887|NCT02301143|78980881|FG000|Induction Period|Adverse Event|22|||
44185888|NCT02301143|78980882|FG001|Induction Period|Adverse Event|0|||
44185889|NCT02301143|78980881|FG000|Induction Period|Progressive Disease|8|||
44185890|NCT02301143|78980882|FG001|Induction Period|Progressive Disease|0|||
44185891|NCT02301143|78980881|FG000|Induction Period|Withdrawal by Subject|3|||
44185892|NCT02301143|78980882|FG001|Induction Period|Withdrawal by Subject|0|||
44185893|NCT02301143|78980881|FG000|Induction Period|Noncompliance with Study Drug|1|||
44185894|NCT02301143|78980882|FG001|Induction Period|Noncompliance with Study Drug|0|||
44185895|NCT02301143|78980881|FG000|Induction Period|Physician Decision|4|||
44185896|NCT02301143|78980882|FG001|Induction Period|Physician Decision|0|||
44185897|NCT02301143|78980881|FG000|Induction Period|Symptomatic Deterioration|2|||
44185898|NCT02301143|78980882|FG001|Induction Period|Symptomatic Deterioration|0|||
44185899|NCT02301143|78980881|FG000|Induction Period|Protocol Violation|2|||
44185900|NCT02301143|78980882|FG001|Induction Period|Protocol Violation|0|||
44185901|NCT02301143|78980881|FG000|Induction Period|Other|1|||
44185902|NCT02301143|78980882|FG001|Induction Period|Other|0|||
44185903|NCT02301143|78980881|FG000|Investigator's Choice|Adverse Event|0|||
44185904|NCT02301143|78980882|FG001|Investigator's Choice|Adverse Event|3|||
44185905|NCT02301143|78980881|FG000|Investigator's Choice|Progressive Disease|0|||
44185906|NCT02301143|78980882|FG001|Investigator's Choice|Progressive Disease|3|||
44185907|NCT02301143|78980881|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
44185908|NCT02301143|78980882|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
44185909|NCT02301143|78980881|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
44185910|NCT02301143|78980882|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
44185911|NCT02301143|78980881|FG000|Investigator's Choice|Other|0|||
44185912|NCT02301143|78980882|FG001|Investigator's Choice|Other|1|||
44185913|NCT02301143|78980881|FG000|Investigator's Choice|Unresectable Surgery|0|||
44185914|NCT02301143|78980882|FG001|Investigator's Choice|Unresectable Surgery|1|||
44185915|NCT02276222|78980895|FG000|Overall Study|Adverse Event|62|||
44185916|NCT02276222|78980896|FG001|Overall Study|Adverse Event|11|||
44185917|NCT02276222|78980895|FG000|Overall Study|Death|3|||
44185918|NCT02276222|78980896|FG001|Overall Study|Death|4|||
44185919|NCT02276222|78980895|FG000|Overall Study|Lack of Efficacy|13|||
44185920|NCT02276222|78980896|FG001|Overall Study|Lack of Efficacy|3|||
44185921|NCT02276222|78980895|FG000|Overall Study|Protocol Violation|3|||
44185922|NCT02276222|78980896|FG001|Overall Study|Protocol Violation|2|||
44185923|NCT02276222|78980895|FG000|Overall Study|Withdrawal by Subject|79|||
44185924|NCT02276222|78980896|FG001|Overall Study|Withdrawal by Subject|33|||
44185925|NCT02276222|78980895|FG000|Overall Study|non compliance with study medication|6|||
44185926|NCT02276222|78980896|FG001|Overall Study|non compliance with study medication|2|||
44185927|NCT02276222|78980895|FG000|Overall Study|sponsor decision|0|||
44185928|NCT02276222|78980896|FG001|Overall Study|sponsor decision|3|||
44185929|NCT02276222|78980895|FG000|Overall Study|Lost to Follow-up|15|||
44185930|NCT02276222|78980896|FG001|Overall Study|Lost to Follow-up|5|||
44185931|NCT02276222|78980895|FG000|Overall Study|Physician Decision|2|||
44185932|NCT02276222|78980896|FG001|Overall Study|Physician Decision|1|||
44185933|NCT02276222|78980895|FG000|Overall Study|sheduling conflict|1|||
44185934|NCT02276222|78980896|FG001|Overall Study|sheduling conflict|0|||
44185935|NCT02276222|78980895|FG000|Overall Study|subject withdrew after randomization|1|||
44185936|NCT02276222|78980896|FG001|Overall Study|subject withdrew after randomization|0|||
44185937|NCT02275364|78980902|FG000|Period 1|Withdrawal by Subject|1|||
44185938|NCT02275364|78980903|FG001|Period 1|Withdrawal by Subject|0|||
44185939|NCT02275364|78980902|FG000|Period 1|Other reason|1|||
44185940|NCT02275364|78980903|FG001|Period 1|Other reason|0|||
44185941|NCT02275052|78980920|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44185942|NCT02275052|78980921|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
44185943|NCT02275052|78980922|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44185944|NCT02275052|78980923|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44185945|NCT02275052|78980920|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
44185946|NCT02275052|78980921|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
44185947|NCT02275052|78980922|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
44185948|NCT02275052|78980923|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
44185949|NCT02275052|78980920|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
44361227|NCT01185821|79366878|FG003|Overall Study|Adverse Event|2|||
44185950|NCT02275052|78980921|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
44185951|NCT02275052|78980922|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44185952|NCT02275052|78980923|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44185953|NCT02275052|78980920|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
44185954|NCT02275052|78980921|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
44265763|NCT00585195|79171062|FG019|Overall Study|Randomized not treated|0|||
44265764|NCT00585195|79171063|FG020|Overall Study|Randomized not treated|2|||
44361228|NCT01185821|79366879|FG004|Overall Study|Adverse Event|5|||
44361229|NCT01185821|79366875|FG000|Overall Study|Lack of Efficacy|0|||
44185955|NCT02275052|78980922|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
44185956|NCT02275052|78980923|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
44185957|NCT02275052|78980920|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
44185958|NCT02275052|78980921|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
44185959|NCT02275052|78980922|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
44185960|NCT02275052|78980923|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
44185961|NCT02275052|78980920|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
44185962|NCT02275052|78980921|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
44185963|NCT02275052|78980922|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
44185964|NCT02275052|78980923|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
44185965|NCT02275052|78980920|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
44185966|NCT02275052|78980921|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
44185967|NCT02275052|78980922|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
44185968|NCT02275052|78980923|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
44185969|NCT02275052|78980920|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
44185970|NCT02275052|78980921|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
44185971|NCT02275052|78980922|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
44185972|NCT02275052|78980923|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
44185973|NCT02275052|78980920|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44185974|NCT02275052|78980921|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44185975|NCT02275052|78980922|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44185976|NCT02275052|78980923|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
44185977|NCT02275052|78980920|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
44185978|NCT02275052|78980921|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
44185979|NCT02275052|78980922|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
44185980|NCT02275052|78980923|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
44185981|NCT02275052|78980920|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44185982|NCT02275052|78980921|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44185983|NCT02275052|78980922|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44185984|NCT02275052|78980923|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
44185985|NCT02274038|78980929|FG000|Overall Study|Death|1|||
44185986|NCT02300558|78980935|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
44185987|NCT02300558|78980935|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
44185988|NCT02300558|78980935|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
44185989|NCT02300558|78980935|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
44185990|NCT02273960|78980947|FG000|Short Term Period|Lost to Follow-up|1|||
44185991|NCT02273960|78980948|FG001|Short Term Period|Lost to Follow-up|0|||
44185992|NCT02273960|78980949|FG002|Short Term Period|Lost to Follow-up|0|||
44185993|NCT02273960|78980950|FG003|Short Term Period|Lost to Follow-up|0|||
44185994|NCT02273960|78980947|FG000|Short Term Period|Lack of Efficacy|0|||
44185995|NCT02273960|78980948|FG001|Short Term Period|Lack of Efficacy|0|||
44185996|NCT02273960|78980949|FG002|Short Term Period|Lack of Efficacy|0|||
44185997|NCT02273960|78980950|FG003|Short Term Period|Lack of Efficacy|1|||
44185998|NCT02273960|78980947|FG000|Short Term Period|ST complete, not entering LTE|4|||
44185999|NCT02273960|78980948|FG001|Short Term Period|ST complete, not entering LTE|6|||
44186000|NCT02273960|78980949|FG002|Short Term Period|ST complete, not entering LTE|4|||
44186001|NCT02273960|78980950|FG003|Short Term Period|ST complete, not entering LTE|5|||
44186002|NCT02273960|78980947|FG000|Long Term Extension|Death|0|||
44186003|NCT02273960|78980948|FG001|Long Term Extension|Death|0|||
44186004|NCT02273960|78980949|FG002|Long Term Extension|Death|0|||
44186005|NCT02273960|78980950|FG003|Long Term Extension|Death|1|||
44265765|NCT00585195|79171043|FG000|Overall Study|Death|0|||
44265766|NCT00585195|79171044|FG001|Overall Study|Death|0|||
44265767|NCT00585195|79171045|FG002|Overall Study|Death|0|||
44265768|NCT00585195|79171046|FG003|Overall Study|Death|0|||
44265769|NCT00585195|79171047|FG004|Overall Study|Death|0|||
44265770|NCT00585195|79171048|FG005|Overall Study|Death|0|||
44265771|NCT00585195|79171049|FG006|Overall Study|Death|0|||
44265772|NCT00585195|79171050|FG007|Overall Study|Death|0|||
44265773|NCT00585195|79171051|FG008|Overall Study|Death|1|||
44265774|NCT00585195|79171052|FG009|Overall Study|Death|0|||
44265775|NCT00585195|79171053|FG010|Overall Study|Death|1|||
44265776|NCT00585195|79171054|FG011|Overall Study|Death|1|||
44265777|NCT00585195|79171055|FG012|Overall Study|Death|7|||
44265778|NCT00585195|79171056|FG013|Overall Study|Death|2|||
44186006|NCT01646021|78980962|FG000|Overall Study|Death|77|||
44361230|NCT01185821|79366876|FG001|Overall Study|Lack of Efficacy|0|||
44361231|NCT01185821|79366877|FG002|Overall Study|Lack of Efficacy|3|||
44265779|NCT00585195|79171057|FG014|Overall Study|Death|8|||
44265780|NCT00585195|79171058|FG015|Overall Study|Death|2|||
44265781|NCT00585195|79171059|FG016|Overall Study|Death|11|||
44451338|NCT00098293|79460287|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
44543037|NCT03655717|79555914|FG014|Overall Study|Lost to Follow-up|0|||
44186007|NCT01646021|78980963|FG001|Overall Study|Death|83|||
44186008|NCT01646021|78980962|FG000|Overall Study|Study Terminated by Sponsor|50|||
44186009|NCT01646021|78980963|FG001|Overall Study|Study Terminated by Sponsor|41|||
44186010|NCT01646021|78980962|FG000|Overall Study|Lost to Follow-up|2|||
44186011|NCT01646021|78980963|FG001|Overall Study|Lost to Follow-up|2|||
44186012|NCT01646021|78980962|FG000|Overall Study|Withdrawal by Subject|10|||
44186013|NCT01646021|78980963|FG001|Overall Study|Withdrawal by Subject|15|||
44186014|NCT01750918|78980980|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
44186015|NCT01750918|78980981|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
44186016|NCT01750918|78980982|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
44186017|NCT01750918|78980983|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
44186018|NCT01750918|78980984|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
44186019|NCT01750918|78980985|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
44186020|NCT01750918|78980986|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
44186021|NCT01750918|78980987|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
44186022|NCT01750918|78980980|FG000|Overall Study|Lost to Follow-up|0|||
44186023|NCT01750918|78980981|FG001|Overall Study|Lost to Follow-up|0|||
44186024|NCT01750918|78980982|FG002|Overall Study|Lost to Follow-up|2|||
44186025|NCT01750918|78980983|FG003|Overall Study|Lost to Follow-up|2|||
44186026|NCT01750918|78980984|FG004|Overall Study|Lost to Follow-up|0|||
44186027|NCT01750918|78980985|FG005|Overall Study|Lost to Follow-up|0|||
44186028|NCT01750918|78980986|FG006|Overall Study|Lost to Follow-up|0|||
44186029|NCT01750918|78980987|FG007|Overall Study|Lost to Follow-up|1|||
44186030|NCT01750918|78980980|FG000|Overall Study|Withdrawal by Subject|0|||
44186031|NCT01750918|78980981|FG001|Overall Study|Withdrawal by Subject|0|||
44186032|NCT01750918|78980982|FG002|Overall Study|Withdrawal by Subject|1|||
44186033|NCT01750918|78980983|FG003|Overall Study|Withdrawal by Subject|2|||
44186034|NCT01750918|78980984|FG004|Overall Study|Withdrawal by Subject|1|||
44186035|NCT01750918|78980985|FG005|Overall Study|Withdrawal by Subject|1|||
44186036|NCT01750918|78980986|FG006|Overall Study|Withdrawal by Subject|2|||
44186037|NCT01750918|78980987|FG007|Overall Study|Withdrawal by Subject|2|||
44186038|NCT02300987|78981019|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
44186039|NCT02300987|78981020|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
44186040|NCT02300987|78981019|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
44186041|NCT02300987|78981020|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
44186042|NCT02300987|78981019|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
44186043|NCT02300987|78981020|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
44186044|NCT02300987|78981019|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
44186045|NCT02300987|78981020|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
44186046|NCT02300987|78981019|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
44186047|NCT02300987|78981020|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
44186048|NCT01750840|78981027|FG000|Overall Study|Lost to Follow-up|4|||
44186049|NCT01606228|78981032|FG000|Overall Study|Lost to Follow-up|20|||
44186050|NCT01606228|78981032|FG000|Overall Study|Withdrawal by Subject|3|||
44186051|NCT01606228|78981032|FG000|Overall Study|Non-compliant|3|||
44186052|NCT01606228|78981032|FG000|Overall Study|Lack of Efficacy|2|||
44186053|NCT01606228|78981032|FG000|Overall Study|Adverse Event|1|||
44186054|NCT01706536|78981041|FG000|Overall Study|Withdrawal by Subject|1|||
44186055|NCT01706536|78981042|FG001|Overall Study|Withdrawal by Subject|0|||
44186056|NCT01706536|78981043|FG002|Overall Study|Withdrawal by Subject|1|||
44186057|NCT01706536|78981044|FG003|Overall Study|Withdrawal by Subject|0|||
44186058|NCT01706536|78981045|FG004|Overall Study|Withdrawal by Subject|0|||
44186059|NCT01706536|78981041|FG000|Overall Study|Adverse Event|2|||
44186060|NCT01706536|78981042|FG001|Overall Study|Adverse Event|3|||
44186061|NCT01706536|78981043|FG002|Overall Study|Adverse Event|4|||
44186062|NCT01706536|78981044|FG003|Overall Study|Adverse Event|3|||
44186063|NCT01706536|78981045|FG004|Overall Study|Adverse Event|2|||
44186064|NCT01706536|78981041|FG000|Overall Study|Lack of Efficacy|1|||
44186065|NCT01706536|78981042|FG001|Overall Study|Lack of Efficacy|0|||
44186066|NCT01706536|78981043|FG002|Overall Study|Lack of Efficacy|0|||
44186067|NCT01706536|78981044|FG003|Overall Study|Lack of Efficacy|1|||
44186068|NCT01706536|78981045|FG004|Overall Study|Lack of Efficacy|0|||
44186069|NCT01706536|78981041|FG000|Overall Study|non compliance|0|||
44265782|NCT00585195|79171060|FG017|Overall Study|Death|0|||
44265783|NCT00585195|79171061|FG018|Overall Study|Death|0|||
44186070|NCT01706536|78981042|FG001|Overall Study|non compliance|1|||
44186071|NCT01706536|78981043|FG002|Overall Study|non compliance|0|||
44186072|NCT01706536|78981044|FG003|Overall Study|non compliance|0|||
44186073|NCT01706536|78981045|FG004|Overall Study|non compliance|0|||
44186074|NCT02269943|78981060|FG000|Treatment Period|Death|0|||
44186075|NCT02269943|78981061|FG001|Treatment Period|Death|1|||
44186076|NCT02269943|78981060|FG000|Treatment Period|Adverse Event|1|||
44186077|NCT02269943|78981061|FG001|Treatment Period|Adverse Event|10|||
44186078|NCT02269943|78981060|FG000|Treatment Period|Progressive Disease|5|||
44186079|NCT02269943|78981061|FG001|Treatment Period|Progressive Disease|17|||
44186080|NCT02269943|78981060|FG000|Treatment Period|Symptomatic Deterioration|0|||
44186081|NCT02269943|78981061|FG001|Treatment Period|Symptomatic Deterioration|2|||
44186082|NCT02269943|78981060|FG000|Follow-Up Survival Period|Death|3|||
44186083|NCT02269943|78981061|FG001|Follow-Up Survival Period|Death|16|||
44186084|NCT02269943|78981060|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
44186085|NCT02269943|78981061|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
44186086|NCT02269943|78981060|FG000|Follow-Up Survival Period|Alive|2|||
44186087|NCT02269943|78981061|FG001|Follow-Up Survival Period|Alive|8|||
44186088|NCT01706458|78981069|FG000|Overall Study|Physician Decision|3|||
44186089|NCT01706458|78981070|FG001|Overall Study|Physician Decision|4|||
44186090|NCT02269787|78981078|FG000|Overall Study|Lost to Follow-up|20|||
44186091|NCT02269787|78981079|FG001|Overall Study|Lost to Follow-up|6|||
44186092|NCT02269787|78981078|FG000|Overall Study|Death|2|||
44186093|NCT02269787|78981079|FG001|Overall Study|Death|3|||
44186094|NCT02269787|78981078|FG000|Overall Study|Incapacitated|0|||
44186095|NCT02269787|78981079|FG001|Overall Study|Incapacitated|1|||
44186096|NCT01605370|78981087|FG000|Overall Study|Adverse Event|1|||
44186097|NCT01605370|78981088|FG001|Overall Study|Adverse Event|0|||
44186098|NCT02269709|78981094|FG000|Time of Enrollment|Withdrawal by Subject|3|||
44186099|NCT02269709|78981094|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
44186100|NCT02269709|78981094|FG000|Six Month Follow-up|Lost to Follow-up|12|||
44186101|NCT02269475|78981101|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
44186102|NCT02269475|78981102|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
44186103|NCT02269475|78981101|FG000|Overall Study|Withdrawal by Subject|0|||
44186104|NCT02269475|78981102|FG001|Overall Study|Withdrawal by Subject|1|||
44186105|NCT01605136|78981111|FG000|Study Period|Withdrawal by Subject|2|||
44186106|NCT01605136|78981112|FG001|Study Period|Withdrawal by Subject|0|||
44186107|NCT01605136|78981111|FG000|Study Period|Physician Decision|1|||
44186108|NCT01605136|78981112|FG001|Study Period|Physician Decision|1|||
44186109|NCT01605136|78981111|FG000|Study Period|Lost to Follow-up|0|||
44186110|NCT01605136|78981112|FG001|Study Period|Lost to Follow-up|2|||
44186111|NCT01605136|78981111|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
44186112|NCT01605136|78981112|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
44186113|NCT01706146|78981118|FG000|Overall Study|Withdrawal by Subject|1|||
44186114|NCT01706146|78981118|FG000|Overall Study|Adverse Event|3|||
44186115|NCT01706146|78981118|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
44186116|NCT02269241|78981122|FG000|Overall Study|Lost to Follow-up|269|||
44186117|NCT02269241|78981122|FG000|Overall Study|Withdrawal by Subject|155|||
44186118|NCT02269241|78981122|FG000|Overall Study|Protocol Violation|1|||
44186119|NCT02269241|78981122|FG000|Overall Study|Physician Decision|7|||
44186120|NCT02269241|78981122|FG000|Overall Study|Pregnancy|15|||
44186121|NCT02269241|78981122|FG000|Overall Study|Wish for pregnancy|5|||
44186122|NCT02269241|78981122|FG000|Overall Study|Development of an exclusion criteria|16|||
44186123|NCT02269241|78981122|FG000|Overall Study|Adverse Event|113|||
44186124|NCT02269241|78981122|FG000|Overall Study|At the specific request of the sponsor|20|||
44186125|NCT02269241|78981122|FG000|Overall Study|Several reasons not classified|53|||
44186126|NCT02269241|78981122|FG000|Overall Study|Screening failures|546|||
44186127|NCT01750684|78981129|FG000|Overall Study|Death|1|||
44186128|NCT01750684|78981130|FG001|Overall Study|Death|0|||
44186129|NCT01750684|78981129|FG000|Overall Study|Non-compliance with Study Drug|0|||
44186130|NCT01750684|78981130|FG001|Overall Study|Non-compliance with Study Drug|1|||
44186131|NCT01750684|78981129|FG000|Overall Study|Withdrawn by Sponsor|0|||
44186132|NCT01750684|78981130|FG001|Overall Study|Withdrawn by Sponsor|1|||
44186133|NCT01750684|78981129|FG000|Overall Study|Protocol Violation|1|||
44186134|NCT01750684|78981130|FG001|Overall Study|Protocol Violation|0|||
44186135|NCT01750294|78981137|FG000|Overall Study|Withdrawal by Subject|1|||
44186136|NCT01750294|78981137|FG000|Overall Study|Safety Endpoint|1|||
44265784|NCT00585195|79171062|FG019|Overall Study|Death|0|||
44265785|NCT00585195|79171063|FG020|Overall Study|Death|1|||
44265786|NCT00585195|79171043|FG000|Overall Study|Lost to Follow-up|0|||
44186137|NCT01749982|78981145|FG000|Overall Study|Physician Decision|0|||
44186138|NCT01749982|78981146|FG001|Overall Study|Physician Decision|0|||
44186139|NCT01749982|78981147|FG002|Overall Study|Physician Decision|0|||
44186140|NCT01749982|78981148|FG003|Overall Study|Physician Decision|1|||
44186141|NCT01749982|78981145|FG000|Overall Study|Lost to Follow-up|0|||
44186142|NCT01749982|78981146|FG001|Overall Study|Lost to Follow-up|0|||
44186143|NCT01749982|78981147|FG002|Overall Study|Lost to Follow-up|0|||
44186144|NCT01749982|78981148|FG003|Overall Study|Lost to Follow-up|1|||
44186145|NCT01749982|78981145|FG000|Overall Study|Withdrawal by Subject|0|||
44186146|NCT01749982|78981146|FG001|Overall Study|Withdrawal by Subject|0|||
44186147|NCT01749982|78981147|FG002|Overall Study|Withdrawal by Subject|0|||
44265787|NCT00585195|79171044|FG001|Overall Study|Lost to Follow-up|0|||
44186148|NCT01749982|78981148|FG003|Overall Study|Withdrawal by Subject|1|||
44186149|NCT02269163|78981160|FG000|Overall Study|Lost to Follow-up|1|||
44186150|NCT02269163|78981161|FG001|Overall Study|Lost to Follow-up|0|||
44265788|NCT00585195|79171045|FG002|Overall Study|Lost to Follow-up|0|||
44186151|NCT02269163|78981160|FG000|Overall Study|Major protocol violation|0|||
44186152|NCT02269163|78981161|FG001|Overall Study|Major protocol violation|1|||
44186153|NCT02269163|78981160|FG000|Overall Study|Other|2|||
44186154|NCT02269163|78981161|FG001|Overall Study|Other|2|||
44186155|NCT02269163|78981160|FG000|Overall Study|Withdrawal by Subject|0|||
44186156|NCT02269163|78981161|FG001|Overall Study|Withdrawal by Subject|3|||
44186157|NCT02269163|78981160|FG000|Overall Study|Physician Decision|0|||
44186158|NCT02269163|78981161|FG001|Overall Study|Physician Decision|1|||
44186159|NCT01749826|78981171|FG000|Overall Study|Study Terminated|20|||
44186160|NCT01749826|78981172|FG001|Overall Study|Study Terminated|0|||
44186161|NCT02300129|78981178|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
44186162|NCT02300129|78981179|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
44186163|NCT02300129|78981180|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
44186164|NCT02300129|78981181|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
44186165|NCT02300129|78981178|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
44186166|NCT02300129|78981179|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
44186167|NCT02300129|78981180|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
44186168|NCT02300129|78981181|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
44186169|NCT02300129|78981178|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
44186170|NCT02300129|78981179|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
44186171|NCT02300129|78981180|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
44186172|NCT02300129|78981181|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
44186173|NCT02267135|78981193|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
44186174|NCT02267135|78981194|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
44186175|NCT02267135|78981193|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
44186176|NCT02267135|78981194|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
44186177|NCT02267135|78981193|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
44186178|NCT02267135|78981194|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
44186179|NCT02267135|78981193|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
44186180|NCT02267135|78981194|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
44186181|NCT02267135|78981193|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
44186182|NCT02267135|78981194|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
44186183|NCT02299427|78981205|FG000|Overall Study|Withdrawal by Subject|1|||
44186184|NCT02299427|78981206|FG001|Overall Study|Withdrawal by Subject|0|||
44186185|NCT02299427|78981205|FG000|Overall Study|Lost to Follow-up|1|||
44186186|NCT02299427|78981206|FG001|Overall Study|Lost to Follow-up|3|||
44186187|NCT02299427|78981205|FG000|Overall Study|not adherent to dog website use|21|||
44186188|NCT02299427|78981206|FG001|Overall Study|not adherent to dog website use|0|||
44186189|NCT01724866|78981216|FG000|Overall Study|Adverse Event|0|||
44186190|NCT01724866|78981217|FG001|Overall Study|Adverse Event|0|||
44186191|NCT01724866|78981218|FG002|Overall Study|Adverse Event|1|||
44186192|NCT01724866|78981219|FG003|Overall Study|Adverse Event|1|||
44186193|NCT01724866|78981216|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
44186194|NCT01724866|78981217|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
44186195|NCT01724866|78981218|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
44186196|NCT01724866|78981219|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
44186197|NCT01724866|78981216|FG000|Overall Study|Investigator's Discretion|0|||
44186198|NCT01724866|78981217|FG001|Overall Study|Investigator's Discretion|1|||
44186199|NCT01724866|78981218|FG002|Overall Study|Investigator's Discretion|1|||
44186200|NCT01724866|78981219|FG003|Overall Study|Investigator's Discretion|0|||
44186201|NCT01724866|78981216|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
44186202|NCT01724866|78981217|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
44186203|NCT01724866|78981218|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
44186204|NCT01724866|78981219|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
44186205|NCT01724866|78981216|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
44265789|NCT00585195|79171046|FG003|Overall Study|Lost to Follow-up|0|||
44265790|NCT00585195|79171047|FG004|Overall Study|Lost to Follow-up|0|||
44265791|NCT00585195|79171048|FG005|Overall Study|Lost to Follow-up|0|||
44265792|NCT00585195|79171049|FG006|Overall Study|Lost to Follow-up|0|||
44265793|NCT00585195|79171050|FG007|Overall Study|Lost to Follow-up|0|||
44265794|NCT00585195|79171051|FG008|Overall Study|Lost to Follow-up|0|||
44186206|NCT01724866|78981217|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
44186207|NCT01724866|78981218|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
44186208|NCT01724866|78981219|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
44265795|NCT00585195|79171052|FG009|Overall Study|Lost to Follow-up|0|||
44186209|NCT02266433|78981231|FG000|Overall Study|Lost to Follow-up|54|||
44186210|NCT02266433|78981232|FG001|Overall Study|Lost to Follow-up|46|||
44186211|NCT02266433|78981231|FG000|Overall Study|Withdrawal by Subject|5|||
44186212|NCT02266433|78981232|FG001|Overall Study|Withdrawal by Subject|7|||
44186213|NCT01748890|78981239|FG000|Overall Study|Insufficient recruitment for analysis|4|||
44186214|NCT01747876|78981246|FG000|Overall Study|Adverse Event|1|||
44186215|NCT01747876|78981247|FG001|Overall Study|Adverse Event|0|||
44186216|NCT01747876|78981248|FG002|Overall Study|Adverse Event|2|||
44186217|NCT01747876|78981246|FG000|Overall Study|Withdrawal by Subject|0|||
44186218|NCT01747876|78981247|FG001|Overall Study|Withdrawal by Subject|1|||
44186219|NCT01747876|78981248|FG002|Overall Study|Withdrawal by Subject|1|||
44186220|NCT01747876|78981246|FG000|Overall Study|Disease progression|4|||
44186221|NCT01747876|78981247|FG001|Overall Study|Disease progression|13|||
44186222|NCT01747876|78981248|FG002|Overall Study|Disease progression|8|||
44186223|NCT01747876|78981246|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
44186224|NCT01747876|78981247|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
44186225|NCT01747876|78981248|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
44186226|NCT02273726|78981261|FG000|Overall Study|Death|70|||
44186227|NCT02273726|78981262|FG001|Overall Study|Death|62|||
44186228|NCT02273726|78981261|FG000|Overall Study|Withdrawal by Subject|41|||
44186229|NCT02273726|78981262|FG001|Overall Study|Withdrawal by Subject|29|||
44186230|NCT02273726|78981261|FG000|Overall Study|Kidney transplant|31|||
44186231|NCT02273726|78981262|FG001|Overall Study|Kidney transplant|39|||
44186232|NCT02273726|78981261|FG000|Overall Study|Physician Decision|30|||
44186233|NCT02273726|78981262|FG001|Overall Study|Physician Decision|15|||
44186234|NCT02273726|78981261|FG000|Overall Study|Adverse Event|27|||
44186235|NCT02273726|78981262|FG001|Overall Study|Adverse Event|9|||
44186236|NCT02273726|78981261|FG000|Overall Study|Lost to Follow-up|6|||
44186237|NCT02273726|78981262|FG001|Overall Study|Lost to Follow-up|3|||
44186238|NCT02273726|78981261|FG000|Overall Study|Lack of Efficacy|6|||
44186239|NCT02273726|78981262|FG001|Overall Study|Lack of Efficacy|1|||
44186240|NCT02273726|78981261|FG000|Overall Study|Protocol Violation|4|||
44186241|NCT02273726|78981262|FG001|Overall Study|Protocol Violation|0|||
44186242|NCT02273726|78981261|FG000|Overall Study|Other than specified|28|||
44186243|NCT02273726|78981262|FG001|Overall Study|Other than specified|30|||
44186244|NCT01723228|78981270|FG000|Overall Study|Adverse Event|2|||
44186245|NCT01723228|78981271|FG001|Overall Study|Adverse Event|6|||
44186246|NCT01723228|78981270|FG000|Overall Study|Withdrawal by Subject|2|||
44186247|NCT01723228|78981271|FG001|Overall Study|Withdrawal by Subject|1|||
44186248|NCT01723228|78981270|FG000|Overall Study|Protocol Violation|0|||
44186249|NCT01723228|78981271|FG001|Overall Study|Protocol Violation|2|||
44186250|NCT01723228|78981270|FG000|Overall Study|Lost to Follow-up|2|||
44186251|NCT01723228|78981271|FG001|Overall Study|Lost to Follow-up|1|||
44186252|NCT01723228|78981270|FG000|Overall Study|Other|2|||
44186253|NCT01723228|78981271|FG001|Overall Study|Other|1|||
44186254|NCT02273180|78981279|FG000|Overall Study|Adverse Event|2|||
44186255|NCT02273180|78981280|FG001|Overall Study|Adverse Event|2|||
44186256|NCT02273180|78981279|FG000|Overall Study|Lack of Efficacy|1|||
44186257|NCT02273180|78981280|FG001|Overall Study|Lack of Efficacy|0|||
44186258|NCT02273180|78981279|FG000|Overall Study|Protocol Violation|1|||
44186259|NCT02273180|78981280|FG001|Overall Study|Protocol Violation|7|||
44186260|NCT02273180|78981279|FG000|Overall Study|Randomized but not treated|1|||
44186261|NCT02273180|78981280|FG001|Overall Study|Randomized but not treated|0|||
44186262|NCT02273180|78981279|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
44186263|NCT02273180|78981280|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
44186264|NCT02273180|78981279|FG000|Overall Study|Other than specified above|21|||
44186265|NCT02273180|78981280|FG001|Overall Study|Other than specified above|10|||
44265796|NCT00585195|79171053|FG010|Overall Study|Lost to Follow-up|0|||
44265797|NCT00585195|79171054|FG011|Overall Study|Lost to Follow-up|0|||
44265798|NCT00585195|79171055|FG012|Overall Study|Lost to Follow-up|1|||
44265799|NCT00585195|79171056|FG013|Overall Study|Lost to Follow-up|0|||
44186266|NCT01746862|78981288|FG000|Overall Study|Withdrawal by Subject|1|||
44186267|NCT01746862|78981289|FG001|Overall Study|Withdrawal by Subject|1|||
44186268|NCT01746862|78981288|FG000|Overall Study|Protocol Violation|1|||
44186269|NCT01746862|78981289|FG001|Overall Study|Protocol Violation|0|||
44186270|NCT01746862|78981288|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
44186271|NCT01746862|78981289|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
44186272|NCT01746862|78981288|FG000|Overall Study|Entered puberty during the study|1|||
44186273|NCT01746862|78981289|FG001|Overall Study|Entered puberty during the study|0|||
44186274|NCT01745848|78981296|FG000|Overall Study|Adverse Event|6|||
44186275|NCT01745380|78981302|FG000|Overall Study|Lost to Follow-up|1|||
44186276|NCT01745380|78981303|FG001|Overall Study|Lost to Follow-up|0|||
44186277|NCT01745380|78981302|FG000|Overall Study|Lack of Efficacy|0|||
44186278|NCT01745380|78981303|FG001|Overall Study|Lack of Efficacy|1|||
44186279|NCT01745146|78981311|FG000|Overall Study|Withdrawal by Subject|1|||
44186280|NCT01745146|78981312|FG001|Overall Study|Withdrawal by Subject|3|||
44265800|NCT00585195|79171057|FG014|Overall Study|Lost to Follow-up|0|||
44186281|NCT01745146|78981311|FG000|Overall Study|Lost to Follow-up|2|||
44186282|NCT01745146|78981312|FG001|Overall Study|Lost to Follow-up|0|||
44186283|NCT02203513|78981324|FG000|Overall Study|Refused further treatment|2|||
44186284|NCT02203513|78981325|FG001|Overall Study|Refused further treatment|0|||
44186285|NCT02203513|78981326|FG002|Overall Study|Refused further treatment|1|||
44186286|NCT02203513|78981327|FG003|Overall Study|Refused further treatment|0|||
44186287|NCT02203513|78981328|FG004|Overall Study|Refused further treatment|0|||
44186288|NCT02203513|78981324|FG000|Overall Study|Switched to alternative treatment|3|||
44186289|NCT02203513|78981325|FG001|Overall Study|Switched to alternative treatment|4|||
44186290|NCT02203513|78981326|FG002|Overall Study|Switched to alternative treatment|0|||
44186291|NCT02203513|78981327|FG003|Overall Study|Switched to alternative treatment|0|||
44186292|NCT02203513|78981328|FG004|Overall Study|Switched to alternative treatment|4|||
44186293|NCT02203513|78981324|FG000|Overall Study|Did not receive investigational product (IP)|0|||
44186294|NCT02203513|78981325|FG001|Overall Study|Did not receive investigational product (IP)|1|||
44186295|NCT02203513|78981326|FG002|Overall Study|Did not receive investigational product (IP)|0|||
44186296|NCT02203513|78981327|FG003|Overall Study|Did not receive investigational product (IP)|0|||
44186297|NCT02203513|78981328|FG004|Overall Study|Did not receive investigational product (IP)|0|||
44186298|NCT02203513|78981324|FG000|Overall Study|Death (unrelated to study therapy)|1|||
44186299|NCT02203513|78981325|FG001|Overall Study|Death (unrelated to study therapy)|3|||
44186300|NCT02203513|78981326|FG002|Overall Study|Death (unrelated to study therapy)|1|||
44186301|NCT02203513|78981327|FG003|Overall Study|Death (unrelated to study therapy)|0|||
44186302|NCT02203513|78981328|FG004|Overall Study|Death (unrelated to study therapy)|2|||
44186303|NCT02203513|78981324|FG000|Overall Study|Lost to Follow-up|0|||
44186304|NCT02203513|78981325|FG001|Overall Study|Lost to Follow-up|0|||
44186305|NCT02203513|78981326|FG002|Overall Study|Lost to Follow-up|1|||
44186306|NCT02203513|78981327|FG003|Overall Study|Lost to Follow-up|1|||
44186307|NCT02203513|78981328|FG004|Overall Study|Lost to Follow-up|0|||
44186308|NCT02299934|78981342|FG000|Overall Study|Termination of study|13|||
44186309|NCT01703260|78981349|FG000|Overall Study|Adverse Event|1|||
44186310|NCT01703260|78981350|FG001|Overall Study|Adverse Event|2|||
44186311|NCT01703260|78981351|FG002|Overall Study|Adverse Event|2|||
44186312|NCT01703260|78981349|FG000|Overall Study|Lost to Follow-up|1|||
44186313|NCT01703260|78981350|FG001|Overall Study|Lost to Follow-up|0|||
44186314|NCT01703260|78981351|FG002|Overall Study|Lost to Follow-up|0|||
44186315|NCT01703260|78981349|FG000|Overall Study|Withdrawal by Subject|0|||
44186316|NCT01703260|78981350|FG001|Overall Study|Withdrawal by Subject|0|||
44186317|NCT01703260|78981351|FG002|Overall Study|Withdrawal by Subject|1|||
44186318|NCT01703260|78981349|FG000|Overall Study|Study Termination|1|||
44186319|NCT01703260|78981350|FG001|Overall Study|Study Termination|2|||
44186320|NCT01703260|78981351|FG002|Overall Study|Study Termination|0|||
44186321|NCT02203357|78981362|FG000|Overall Study|Lost to Follow-up|58|||
44186322|NCT02203357|78981363|FG001|Overall Study|Lost to Follow-up|66|||
44186323|NCT02203357|78981364|FG002|Overall Study|Lost to Follow-up|70|||
44186324|NCT02299388|78981377|FG000|Overall Study|Withdrawal by Subject|0|||
44186325|NCT02299388|78981378|FG001|Overall Study|Withdrawal by Subject|1|||
44186326|NCT02202577|78981386|FG000|Overall Study|Lost to Follow-up|6|||
44186327|NCT02202577|78981387|FG001|Overall Study|Lost to Follow-up|16|||
44186328|NCT02202577|78981386|FG000|Overall Study|Protocol Violation|7|||
44186329|NCT02202577|78981387|FG001|Overall Study|Protocol Violation|3|||
44186330|NCT02299076|78981395|FG000|Overall Study|Fraudulent Entries|20|||
44186331|NCT02299076|78981396|FG001|Overall Study|Fraudulent Entries|14|||
44186332|NCT01723072|78981404|FG000|Overall Study|Withdrawal by Subject|7|||
44186333|NCT01723072|78981405|FG001|Overall Study|Withdrawal by Subject|13|||
44186334|NCT01723072|78981404|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
44186335|NCT01723072|78981405|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
44186336|NCT01723072|78981404|FG000|Overall Study|Other|4|||
44186337|NCT01723072|78981405|FG001|Overall Study|Other|3|||
44186338|NCT01722994|78981413|FG000|Overall Study|Missing data|25|||
44186339|NCT01722994|78981414|FG001|Overall Study|Missing data|17|||
44186340|NCT02228395|78981422|FG000|First Intervention Period|No longer willing to participate|1|||
44186341|NCT02228395|78981423|FG001|First Intervention Period|No longer willing to participate|0|||
44186342|NCT02228395|78981424|FG002|First Intervention Period|No longer willing to participate|0|||
44186343|NCT02228395|78981422|FG000|First Intervention Period|Unable to comply with study dates|0|||
44186344|NCT02228395|78981423|FG001|First Intervention Period|Unable to comply with study dates|1|||
44186345|NCT02228395|78981424|FG002|First Intervention Period|Unable to comply with study dates|1|||
44186346|NCT02170051|78981436|FG000|Overall Study|Withdrawal by Subject|10|||
44186347|NCT02170051|78981437|FG001|Overall Study|Withdrawal by Subject|10|||
44186348|NCT02170051|78981436|FG000|Overall Study|Lost to Follow-up|1|||
44186349|NCT02170051|78981437|FG001|Overall Study|Lost to Follow-up|3|||
44186350|NCT02169739|78981445|FG000|Overall Study|Lost to Follow-up|0|||
44186351|NCT02169739|78981446|FG001|Overall Study|Lost to Follow-up|4|||
44186352|NCT02169505|78981453|FG000|Overall Study|Withdrawal by Subject|1|||
44186353|NCT01909791|78981460|FG000|Overall Study|Death|9|||
44186354|NCT01909791|78981461|FG001|Overall Study|Death|8|||
44186355|NCT01909791|78981462|FG002|Overall Study|Death|4|||
44186356|NCT01909791|78981460|FG000|Overall Study|Withdrawal by Subject|5|||
44186357|NCT01909791|78981461|FG001|Overall Study|Withdrawal by Subject|9|||
44186358|NCT01909791|78981462|FG002|Overall Study|Withdrawal by Subject|13|||
44186359|NCT01909791|78981460|FG000|Overall Study|Lost to Follow-up|5|||
44186360|NCT01909791|78981461|FG001|Overall Study|Lost to Follow-up|11|||
44186361|NCT01909791|78981462|FG002|Overall Study|Lost to Follow-up|10|||
44186362|NCT01909791|78981460|FG000|Overall Study|Missed Visit|2|||
44186363|NCT01909791|78981461|FG001|Overall Study|Missed Visit|0|||
44186364|NCT01909791|78981462|FG002|Overall Study|Missed Visit|1|||
44186365|NCT02202499|78981478|FG000|Overall Study|Cancer diagnosis|0|||
44186366|NCT02202499|78981479|FG001|Overall Study|Cancer diagnosis|0|||
44186367|NCT02202499|78981480|FG002|Overall Study|Cancer diagnosis|1|||
44186368|NCT02202499|78981478|FG000|Overall Study|Moved from area|0|||
44186369|NCT02202499|78981479|FG001|Overall Study|Moved from area|0|||
44186370|NCT02202499|78981480|FG002|Overall Study|Moved from area|1|||
44186371|NCT02202499|78981478|FG000|Overall Study|Declined before randomization|1|||
44186372|NCT02202499|78981479|FG001|Overall Study|Declined before randomization|0|||
44186373|NCT02202499|78981480|FG002|Overall Study|Declined before randomization|0|||
44186374|NCT02202499|78981478|FG000|Overall Study|Auto accident|1|||
44186375|NCT02202499|78981479|FG001|Overall Study|Auto accident|0|||
44186376|NCT02202499|78981480|FG002|Overall Study|Auto accident|0|||
44186377|NCT02202109|78981495|FG000|Overall Study|Lost to Follow-up|88|||
44186378|NCT02202109|78981496|FG001|Overall Study|Lost to Follow-up|87|||
44186379|NCT02202109|78981495|FG000|Overall Study|Withdrawal by Subject|2|||
44265801|NCT00585195|79171058|FG015|Overall Study|Lost to Follow-up|0|||
44265802|NCT00585195|79171059|FG016|Overall Study|Lost to Follow-up|0|||
44265803|NCT00585195|79171060|FG017|Overall Study|Lost to Follow-up|2|||
44265804|NCT00585195|79171061|FG018|Overall Study|Lost to Follow-up|0|||
44265805|NCT00585195|79171062|FG019|Overall Study|Lost to Follow-up|0|||
44265806|NCT00585195|79171063|FG020|Overall Study|Lost to Follow-up|0|||
44265807|NCT00585195|79171043|FG000|Overall Study|Site Terminated by Sponsor|0|||
44265808|NCT00585195|79171044|FG001|Overall Study|Site Terminated by Sponsor|0|||
44265809|NCT00585195|79171045|FG002|Overall Study|Site Terminated by Sponsor|0|||
44265810|NCT00585195|79171046|FG003|Overall Study|Site Terminated by Sponsor|0|||
44265811|NCT00585195|79171047|FG004|Overall Study|Site Terminated by Sponsor|0|||
44265812|NCT00585195|79171048|FG005|Overall Study|Site Terminated by Sponsor|0|||
44265813|NCT00585195|79171049|FG006|Overall Study|Site Terminated by Sponsor|0|||
44265814|NCT00585195|79171050|FG007|Overall Study|Site Terminated by Sponsor|0|||
44265815|NCT00585195|79171051|FG008|Overall Study|Site Terminated by Sponsor|0|||
44265816|NCT00585195|79171052|FG009|Overall Study|Site Terminated by Sponsor|0|||
44265817|NCT00585195|79171053|FG010|Overall Study|Site Terminated by Sponsor|0|||
44265818|NCT00585195|79171054|FG011|Overall Study|Site Terminated by Sponsor|0|||
44265819|NCT00585195|79171055|FG012|Overall Study|Site Terminated by Sponsor|1|||
44265820|NCT00585195|79171056|FG013|Overall Study|Site Terminated by Sponsor|0|||
44265821|NCT00585195|79171057|FG014|Overall Study|Site Terminated by Sponsor|0|||
44265822|NCT00585195|79171058|FG015|Overall Study|Site Terminated by Sponsor|0|||
44265823|NCT00585195|79171059|FG016|Overall Study|Site Terminated by Sponsor|0|||
44265824|NCT00585195|79171060|FG017|Overall Study|Site Terminated by Sponsor|0|||
44265825|NCT00585195|79171061|FG018|Overall Study|Site Terminated by Sponsor|0|||
44265826|NCT00585195|79171062|FG019|Overall Study|Site Terminated by Sponsor|0|||
44265827|NCT00585195|79171063|FG020|Overall Study|Site Terminated by Sponsor|0|||
44265828|NCT00585195|79171043|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
44265829|NCT00585195|79171044|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
44265830|NCT00585195|79171045|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
44265831|NCT00585195|79171046|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
44265832|NCT00585195|79171047|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
44265833|NCT00585195|79171048|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
44265834|NCT00585195|79171049|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
44265835|NCT00585195|79171050|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
44186380|NCT02202109|78981496|FG001|Overall Study|Withdrawal by Subject|0|||
44265836|NCT00585195|79171051|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
44186381|NCT02227849|78981502|FG000|Overall Study|Adverse Event|4|||
44265837|NCT00585195|79171052|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
44265838|NCT00585195|79171053|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
44361232|NCT01185821|79366878|FG003|Overall Study|Lack of Efficacy|0|||
44186382|NCT02227849|78981502|FG000|Overall Study|Physician Decision|1|||
44186383|NCT02227849|78981502|FG000|Overall Study|Withdrawal by Subject|3|||
44186384|NCT01927497|78981508|FG000|Overall Study|Death|0|||
44186385|NCT01927497|78981509|FG001|Overall Study|Death|1|||
44186386|NCT01927497|78981508|FG000|Overall Study|Protocol Violation|2|||
44186387|NCT01927497|78981509|FG001|Overall Study|Protocol Violation|0|||
44186388|NCT02169271|78981517|FG000|Overall Study|Protocol Violation|1|||
44186389|NCT02169271|78981518|FG001|Overall Study|Protocol Violation|2|||
44186390|NCT02202031|78981526|FG000|Overall Study|Lost to Follow-up|1|||
44186391|NCT02202031|78981527|FG001|Overall Study|Lost to Follow-up|0|||
44186392|NCT02202031|78981526|FG000|Overall Study|Too Busy|1|||
44186393|NCT02202031|78981527|FG001|Overall Study|Too Busy|3|||
44186394|NCT02202031|78981526|FG000|Overall Study|Illness/Medical Reason|0|||
44186395|NCT02202031|78981527|FG001|Overall Study|Illness/Medical Reason|2|||
44186396|NCT02202031|78981526|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
44186397|NCT02202031|78981527|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
44186398|NCT01644188|78981535|FG000|Overall Study|Adverse Event|44|||
44186399|NCT01644188|78981536|FG001|Overall Study|Adverse Event|20|||
44186400|NCT01644188|78981535|FG000|Overall Study|Poor compliance to protocol|26|||
44186401|NCT01644188|78981536|FG001|Overall Study|Poor compliance to protocol|14|||
44186402|NCT01644188|78981535|FG000|Overall Study|Physician Decision|1|||
44186403|NCT01644188|78981536|FG001|Overall Study|Physician Decision|3|||
44186404|NCT01644188|78981535|FG000|Overall Study|Participant moved|7|||
44186405|NCT01644188|78981536|FG001|Overall Study|Participant moved|2|||
44186406|NCT01644188|78981535|FG000|Overall Study|Related to auto-injector administration|2|||
44186407|NCT01644188|78981536|FG001|Overall Study|Related to auto-injector administration|2|||
44186408|NCT01644188|78981535|FG000|Overall Study|Consent withdrawn by participant|14|||
44186409|NCT01644188|78981536|FG001|Overall Study|Consent withdrawn by participant|7|||
44186410|NCT01644188|78981535|FG000|Overall Study|Selection criteria finally not met|2|||
44186411|NCT01644188|78981536|FG001|Overall Study|Selection criteria finally not met|0|||
44186412|NCT01644188|78981535|FG000|Overall Study|Lost to Follow-up|1|||
44186413|NCT01644188|78981536|FG001|Overall Study|Lost to Follow-up|0|||
44186414|NCT01644188|78981535|FG000|Overall Study|Death|4|||
44186415|NCT01644188|78981536|FG001|Overall Study|Death|3|||
44186416|NCT01644188|78981535|FG000|Overall Study|Last visit outside protocol visit window|14|||
44186417|NCT01644188|78981536|FG001|Overall Study|Last visit outside protocol visit window|16|||
44186418|NCT01644188|78981535|FG000|Overall Study|Site closure|1|||
44186419|NCT01644188|78981536|FG001|Overall Study|Site closure|1|||
44186420|NCT01644188|78981535|FG000|Overall Study|Other than specified above|6|||
44186421|NCT01644188|78981536|FG001|Overall Study|Other than specified above|7|||
44186422|NCT02201953|78981544|FG000|Overall Study|Randomized but Never Treated|1|||
44186423|NCT02201953|78981545|FG001|Overall Study|Randomized but Never Treated|5|||
44186424|NCT02201953|78981544|FG000|Overall Study|Lack of Efficacy|9|||
44186425|NCT02201953|78981545|FG001|Overall Study|Lack of Efficacy|30|||
44186426|NCT02201953|78981544|FG000|Overall Study|Lost to Follow-up|8|||
44186427|NCT02201953|78981545|FG001|Overall Study|Lost to Follow-up|8|||
44186428|NCT02201953|78981544|FG000|Overall Study|Withdrew Consent|2|||
44186429|NCT02201953|78981545|FG001|Overall Study|Withdrew Consent|5|||
44186430|NCT02201953|78981544|FG000|Overall Study|Adverse Event|0|||
44186431|NCT02201953|78981545|FG001|Overall Study|Adverse Event|5|||
44186432|NCT02201953|78981544|FG000|Overall Study|Death|0|||
44186433|NCT02201953|78981545|FG001|Overall Study|Death|3|||
44186434|NCT02271854|78981551|FG000|Overall Study|Withdrawal by Subject|2|||
44186435|NCT02271854|78981551|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
44186436|NCT02271854|78981551|FG000|Overall Study|Lost to Follow-up|1|||
44186437|NCT02296892|78981559|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
44186438|NCT02296892|78981560|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
44186439|NCT02296892|78981561|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
44186440|NCT02296892|78981559|FG000|Overall Study|Lost to Follow-up|5|||
44186441|NCT02296892|78981560|FG001|Overall Study|Lost to Follow-up|0|||
44186442|NCT02296892|78981561|FG002|Overall Study|Lost to Follow-up|1|||
44186443|NCT02270684|78981571|FG000|Overall Study|Lost to Follow-up|0|||
44186444|NCT02270684|78981572|FG001|Overall Study|Lost to Follow-up|3|||
44186445|NCT02270684|78981571|FG000|Overall Study|Study terminated|1|||
44186446|NCT02270684|78981572|FG001|Overall Study|Study terminated|0|||
44186447|NCT02168803|78981581|FG000|Overall Study|Lost to Follow-up|1|||
44186448|NCT02168803|78981582|FG001|Overall Study|Lost to Follow-up|0|||
44186449|NCT02168803|78981583|FG002|Overall Study|Lost to Follow-up|1|||
44186450|NCT02168803|78981581|FG000|Overall Study|Withdrawal by Subject|1|||
44186451|NCT02168803|78981582|FG001|Overall Study|Withdrawal by Subject|1|||
44186452|NCT02168803|78981583|FG002|Overall Study|Withdrawal by Subject|2|||
44186453|NCT02168803|78981581|FG000|Overall Study|Physician Decision|0|||
44186454|NCT02168803|78981582|FG001|Overall Study|Physician Decision|1|||
44186455|NCT02168803|78981583|FG002|Overall Study|Physician Decision|0|||
44186456|NCT02168803|78981581|FG000|Overall Study|Adverse Event|0|||
44186457|NCT02168803|78981582|FG001|Overall Study|Adverse Event|1|||
44186458|NCT02168803|78981583|FG002|Overall Study|Adverse Event|1|||
44186459|NCT02168803|78981581|FG000|Overall Study|Death|0|||
44186460|NCT02168803|78981582|FG001|Overall Study|Death|0|||
44186461|NCT02168803|78981583|FG002|Overall Study|Death|1|||
44186462|NCT02168803|78981581|FG000|Overall Study|Sponsor Decision|0|||
44186463|NCT02168803|78981582|FG001|Overall Study|Sponsor Decision|0|||
44186464|NCT02168803|78981583|FG002|Overall Study|Sponsor Decision|1|||
44186465|NCT02201329|78981598|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
44186466|NCT02201329|78981598|FG000|Overall Study|Withdrawal by Subject|2|||
44186467|NCT01927419|78981604|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44186468|NCT01927419|78981605|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
44186469|NCT01927419|78981604|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
44186470|NCT01927419|78981605|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
44186471|NCT01927419|78981604|FG000|Treatment Period|Disease progression|17|||
44186472|NCT01927419|78981605|FG001|Treatment Period|Disease progression|20|||
44186473|NCT01927419|78981604|FG000|Treatment Period|Study drug toxicity|48|||
44186474|NCT01927419|78981605|FG001|Treatment Period|Study drug toxicity|10|||
44186475|NCT01927419|78981604|FG000|Treatment Period|Death|0|||
44186476|NCT01927419|78981605|FG001|Treatment Period|Death|1|||
44186477|NCT01927419|78981604|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
44186478|NCT01927419|78981605|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
44186479|NCT01927419|78981604|FG000|Treatment Period|Participant request to discontinue|12|||
44186480|NCT01927419|78981605|FG001|Treatment Period|Participant request to discontinue|4|||
44186481|NCT01927419|78981604|FG000|Treatment Period|Withdrawal by Subject|1|||
44186482|NCT01927419|78981605|FG001|Treatment Period|Withdrawal by Subject|1|||
44186483|NCT01927419|78981604|FG000|Treatment Period|Maximum Clinical Benefit|6|||
44186484|NCT01927419|78981605|FG001|Treatment Period|Maximum Clinical Benefit|2|||
44186485|NCT01927419|78981604|FG000|Treatment Period|Other reasons|3|||
44186486|NCT01927419|78981605|FG001|Treatment Period|Other reasons|4|||
44186487|NCT01927419|78981604|FG000|Treatment Period|Not Reported|1|||
44186488|NCT01927419|78981605|FG001|Treatment Period|Not Reported|1|||
44186489|NCT02168491|78981611|FG000|Overall Study|Withdrawal by Subject|1|||
44186490|NCT02225743|78981615|FG000|Overall Study|Withdrawal by Subject|18|||
44186491|NCT01721746|78981621|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
44186492|NCT01721746|78981622|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
44186493|NCT01721746|78981621|FG000|Pre-Treatment|Withdrawal by Subject|1|||
44186494|NCT01721746|78981622|FG001|Pre-Treatment|Withdrawal by Subject|16|||
44186495|NCT01721746|78981621|FG000|Pre-Treatment|Poor/Non-compliance|1|||
44186496|NCT01721746|78981622|FG001|Pre-Treatment|Poor/Non-compliance|0|||
44186497|NCT01721746|78981621|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
44186498|NCT01721746|78981622|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
44186499|NCT01721746|78981621|FG000|Treatment|Disease Progression|192|||
44186500|NCT01721746|78981622|FG001|Treatment|Disease Progression|74|||
44186501|NCT01721746|78981621|FG000|Treatment|Study Drug Toxicity|19|||
44186502|NCT01721746|78981622|FG001|Treatment|Study Drug Toxicity|11|||
44186503|NCT01721746|78981621|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
44186504|NCT01721746|78981622|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
44186505|NCT01721746|78981621|FG000|Treatment|Participant request to discontinue Study treatment|26|||
44186506|NCT01721746|78981622|FG001|Treatment|Participant request to discontinue Study treatment|7|||
44186507|NCT01721746|78981621|FG000|Treatment|Participant withdrew consent|4|||
44186508|NCT01721746|78981622|FG001|Treatment|Participant withdrew consent|2|||
44186509|NCT01721746|78981621|FG000|Treatment|Maximum Clinical Benefit|9|||
44186510|NCT01721746|78981622|FG001|Treatment|Maximum Clinical Benefit|3|||
44186511|NCT01721746|78981621|FG000|Treatment|Poor/Non-compliance|2|||
44186512|NCT01721746|78981622|FG001|Treatment|Poor/Non-compliance|0|||
44186513|NCT01721746|78981621|FG000|Treatment|Participant no longer met Study criteria|4|||
44186514|NCT01721746|78981622|FG001|Treatment|Participant no longer met Study criteria|0|||
44186515|NCT01721746|78981621|FG000|Treatment|Other reasons|6|||
44186516|NCT01721746|78981622|FG001|Treatment|Other reasons|2|||
44186517|NCT02225665|78981631|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
44186518|NCT02225665|78981632|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
44186519|NCT02225665|78981631|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
44186520|NCT02225665|78981632|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
44186521|NCT01721200|78981640|FG000|Overall Study|Lost to Follow-up|3|||
44186522|NCT01721200|78981641|FG001|Overall Study|Lost to Follow-up|5|||
44186523|NCT02225587|78981654|FG000|Overall Study|Adverse Event|5|||
44186524|NCT02225587|78981655|FG001|Overall Study|Adverse Event|5|||
44186525|NCT02225587|78981654|FG000|Overall Study|Lost to Follow-up|5|||
44186526|NCT02225587|78981655|FG001|Overall Study|Lost to Follow-up|5|||
44186527|NCT02225587|78981654|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44186528|NCT02225587|78981655|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44186529|NCT02225587|78981654|FG000|Overall Study|Physician Decision|2|||
44186530|NCT02225587|78981655|FG001|Overall Study|Physician Decision|0|||
44186531|NCT02225587|78981654|FG000|Overall Study|Protocol Violation|1|||
44186532|NCT02225587|78981655|FG001|Overall Study|Protocol Violation|0|||
44186533|NCT02225587|78981654|FG000|Overall Study|Participant Moved|1|||
44186534|NCT02225587|78981655|FG001|Overall Study|Participant Moved|0|||
44186535|NCT02225587|78981654|FG000|Overall Study|Withdrawal by Subject|13|||
44186536|NCT02225587|78981655|FG001|Overall Study|Withdrawal by Subject|28|||
44186537|NCT02296424|78981663|FG000|Part 1|New therapy for study indication|0|||
44186538|NCT02296424|78981664|FG001|Part 1|New therapy for study indication|1|||
44186539|NCT02296424|78981665|FG002|Part 1|New therapy for study indication|0|||
44186540|NCT02296424|78981666|FG003|Part 1|New therapy for study indication|0|||
44186541|NCT02296424|78981663|FG000|Part 1|Protocol Violation|0|||
44186542|NCT02296424|78981664|FG001|Part 1|Protocol Violation|1|||
44186543|NCT02296424|78981665|FG002|Part 1|Protocol Violation|0|||
44186544|NCT02296424|78981666|FG003|Part 1|Protocol Violation|0|||
44186545|NCT02296424|78981663|FG000|Part 1|Withdrawal by Subject|0|||
44186546|NCT02296424|78981664|FG001|Part 1|Withdrawal by Subject|2|||
44186547|NCT02296424|78981665|FG002|Part 1|Withdrawal by Subject|0|||
44186548|NCT02296424|78981666|FG003|Part 1|Withdrawal by Subject|0|||
44186549|NCT02296424|78981663|FG000|Part 1|Study terminated by sponsor|0|||
44186550|NCT02296424|78981664|FG001|Part 1|Study terminated by sponsor|1|||
44186551|NCT02296424|78981665|FG002|Part 1|Study terminated by sponsor|0|||
44186552|NCT02296424|78981666|FG003|Part 1|Study terminated by sponsor|0|||
44186553|NCT02296424|78981663|FG000|Part 1|Adverse Event|2|||
44186554|NCT02296424|78981664|FG001|Part 1|Adverse Event|11|||
44186555|NCT02296424|78981665|FG002|Part 1|Adverse Event|0|||
44186556|NCT02296424|78981666|FG003|Part 1|Adverse Event|0|||
44186557|NCT02296424|78981663|FG000|Part 1|Lack of Efficacy|5|||
44186558|NCT02296424|78981664|FG001|Part 1|Lack of Efficacy|17|||
44186559|NCT02296424|78981665|FG002|Part 1|Lack of Efficacy|0|||
44186560|NCT02296424|78981666|FG003|Part 1|Lack of Efficacy|0|||
44186561|NCT02296424|78981663|FG000|Part 1|16 directly started part II|16|||
44186562|NCT02296424|78981664|FG001|Part 1|16 directly started part II|0|||
44186563|NCT02296424|78981665|FG002|Part 1|16 directly started part II|0|||
44186564|NCT02296424|78981666|FG003|Part 1|16 directly started part II|0|||
44186565|NCT02296424|78981663|FG000|Part 2|Lack of Efficacy|0|||
44186566|NCT02296424|78981664|FG001|Part 2|Lack of Efficacy|0|||
44186567|NCT02296424|78981665|FG002|Part 2|Lack of Efficacy|1|||
44265839|NCT00585195|79171054|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
44265840|NCT00585195|79171055|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
44265841|NCT00585195|79171056|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
44265842|NCT00585195|79171057|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
44265843|NCT00585195|79171058|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
44265844|NCT00585195|79171059|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
44451339|NCT00098293|79460288|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
44186568|NCT02296424|78981666|FG003|Part 2|Lack of Efficacy|0|||
44186569|NCT02296424|78981663|FG000|Part 2|Adverse Event|0|||
44186570|NCT02296424|78981664|FG001|Part 2|Adverse Event|0|||
44186571|NCT02296424|78981665|FG002|Part 2|Adverse Event|1|||
44186572|NCT02296424|78981666|FG003|Part 2|Adverse Event|0|||
44186573|NCT02296424|78981663|FG000|Part 2|Lost to Follow-up|0|||
44186574|NCT02296424|78981664|FG001|Part 2|Lost to Follow-up|0|||
44186575|NCT02296424|78981665|FG002|Part 2|Lost to Follow-up|1|||
44186576|NCT02296424|78981666|FG003|Part 2|Lost to Follow-up|0|||
44186577|NCT02296190|78981680|FG000|Overall Study|Lost to Follow-up|0|||
44186578|NCT02296190|78981681|FG001|Overall Study|Lost to Follow-up|0|||
44186579|NCT02296190|78981682|FG002|Overall Study|Lost to Follow-up|0|||
44186580|NCT02296190|78981683|FG003|Overall Study|Lost to Follow-up|0|||
44186581|NCT02296190|78981684|FG004|Overall Study|Lost to Follow-up|1|||
44186582|NCT02296190|78981685|FG005|Overall Study|Lost to Follow-up|0|||
44186583|NCT02296190|78981680|FG000|Overall Study|Failure to induce PSVT|6|||
44186584|NCT02296190|78981681|FG001|Overall Study|Failure to induce PSVT|10|||
44186585|NCT02296190|78981682|FG002|Overall Study|Failure to induce PSVT|5|||
44186586|NCT02296190|78981683|FG003|Overall Study|Failure to induce PSVT|13|||
44186587|NCT02296190|78981684|FG004|Overall Study|Failure to induce PSVT|8|||
44186588|NCT02296190|78981685|FG005|Overall Study|Failure to induce PSVT|0|||
44186589|NCT02296190|78981680|FG000|Overall Study|Physician Decision|1|||
44451340|NCT00098293|79460289|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
44186590|NCT02296190|78981681|FG001|Overall Study|Physician Decision|1|||
44186591|NCT02296190|78981682|FG002|Overall Study|Physician Decision|0|||
44186592|NCT02296190|78981683|FG003|Overall Study|Physician Decision|1|||
44186593|NCT02296190|78981684|FG004|Overall Study|Physician Decision|2|||
44186594|NCT02296190|78981685|FG005|Overall Study|Physician Decision|0|||
44186595|NCT02296190|78981680|FG000|Overall Study|Withdrawal by Subject|0|||
44265845|NCT00585195|79171060|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
44186596|NCT02296190|78981681|FG001|Overall Study|Withdrawal by Subject|1|||
44186597|NCT02296190|78981682|FG002|Overall Study|Withdrawal by Subject|0|||
44186598|NCT02296190|78981683|FG003|Overall Study|Withdrawal by Subject|0|||
44186599|NCT02296190|78981684|FG004|Overall Study|Withdrawal by Subject|0|||
44186600|NCT02296190|78981685|FG005|Overall Study|Withdrawal by Subject|0|||
44186601|NCT02296190|78981680|FG000|Overall Study|PSVT < 5 minutes|5|||
44186602|NCT02296190|78981681|FG001|Overall Study|PSVT < 5 minutes|6|||
44186603|NCT02296190|78981682|FG002|Overall Study|PSVT < 5 minutes|6|||
44265846|NCT00585195|79171061|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
44186604|NCT02296190|78981683|FG003|Overall Study|PSVT < 5 minutes|6|||
44186605|NCT02296190|78981684|FG004|Overall Study|PSVT < 5 minutes|5|||
44186606|NCT02296190|78981685|FG005|Overall Study|PSVT < 5 minutes|0|||
44186607|NCT02296190|78981680|FG000|Overall Study|Patient was given Propofol|0|||
44186608|NCT02296190|78981681|FG001|Overall Study|Patient was given Propofol|1|||
44186609|NCT02296190|78981682|FG002|Overall Study|Patient was given Propofol|0|||
44186610|NCT02296190|78981683|FG003|Overall Study|Patient was given Propofol|1|||
44186611|NCT02296190|78981684|FG004|Overall Study|Patient was given Propofol|0|||
44186612|NCT02296190|78981685|FG005|Overall Study|Patient was given Propofol|0|||
44186613|NCT02296190|78981680|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
44186614|NCT02296190|78981681|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
44186615|NCT02296190|78981682|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
44186616|NCT02296190|78981683|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
44186617|NCT02296190|78981684|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
44186618|NCT02296190|78981685|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
44186619|NCT02296190|78981680|FG000|Overall Study|Blood pressure <100 after sedation|0|||
44186620|NCT02296190|78981681|FG001|Overall Study|Blood pressure <100 after sedation|0|||
44186621|NCT02296190|78981682|FG002|Overall Study|Blood pressure <100 after sedation|0|||
44186622|NCT02296190|78981683|FG003|Overall Study|Blood pressure <100 after sedation|1|||
44186623|NCT02296190|78981684|FG004|Overall Study|Blood pressure <100 after sedation|0|||
44186624|NCT02296190|78981685|FG005|Overall Study|Blood pressure <100 after sedation|0|||
44186625|NCT02296190|78981680|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
44186626|NCT02296190|78981681|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
44186627|NCT02296190|78981682|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
44186628|NCT02296190|78981683|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
44186629|NCT02296190|78981684|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
44186630|NCT02296190|78981685|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
44186631|NCT02296190|78981680|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
44186632|NCT02296190|78981681|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
44186633|NCT02296190|78981682|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
44186634|NCT02296190|78981683|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
44186635|NCT02296190|78981684|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
44186636|NCT02296190|78981685|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
44186637|NCT02296190|78981680|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
44186638|NCT02296190|78981681|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
44186639|NCT02296190|78981682|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
44186640|NCT02296190|78981683|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
44186641|NCT02296190|78981684|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
44186642|NCT02296190|78981685|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
44186643|NCT02296190|78981680|FG000|Overall Study|Lab result not available in time|1|||
44186644|NCT02296190|78981681|FG001|Overall Study|Lab result not available in time|0|||
44186645|NCT02296190|78981682|FG002|Overall Study|Lab result not available in time|0|||
44186646|NCT02296190|78981683|FG003|Overall Study|Lab result not available in time|0|||
44186647|NCT02296190|78981684|FG004|Overall Study|Lab result not available in time|0|||
44186648|NCT02296190|78981685|FG005|Overall Study|Lab result not available in time|0|||
44186649|NCT02296112|78981698|FG000|Overall Study|Disease progression|7|||
44186650|NCT02296112|78981698|FG000|Overall Study|Toxicity|1|||
44186651|NCT02296112|78981698|FG000|Overall Study|Began an alternate therapy|1|||
44186652|NCT02295644|78981711|FG000|Overall Study|Did not meet inclusion criterion|0|||
44186653|NCT02295644|78981712|FG001|Overall Study|Did not meet inclusion criterion|0|||
44186654|NCT02295644|78981713|FG002|Overall Study|Did not meet inclusion criterion|1|||
44186655|NCT02295644|78981714|FG003|Overall Study|Did not meet inclusion criterion|2|||
44186656|NCT02269670|78981724|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
44186657|NCT02225353|78981731|FG000|Overall Study|Lost to Follow-up|0|||
44186658|NCT02225353|78981732|FG001|Overall Study|Lost to Follow-up|1|||
44186659|NCT02225353|78981733|FG002|Overall Study|Lost to Follow-up|3|||
44186660|NCT02225353|78981731|FG000|Overall Study|Protocol Violation|4|||
44186661|NCT02225353|78981732|FG001|Overall Study|Protocol Violation|5|||
44186662|NCT02225353|78981733|FG002|Overall Study|Protocol Violation|12|||
44186663|NCT01641926|78981748|FG000|Overall Study|Adverse Event|5|||
44186664|NCT01641926|78981749|FG001|Overall Study|Adverse Event|2|||
44186665|NCT01641926|78981750|FG002|Overall Study|Adverse Event|3|||
44186666|NCT01641926|78981751|FG003|Overall Study|Adverse Event|1|||
44186667|NCT01641926|78981748|FG000|Overall Study|Lost to Follow-up|2|||
44265847|NCT00585195|79171062|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
44265848|NCT00585195|79171063|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
44265849|NCT02439216|79171235|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
44186668|NCT01641926|78981749|FG001|Overall Study|Lost to Follow-up|2|||
44186669|NCT01641926|78981750|FG002|Overall Study|Lost to Follow-up|1|||
44186670|NCT01641926|78981751|FG003|Overall Study|Lost to Follow-up|0|||
44186671|NCT01641926|78981748|FG000|Overall Study|Physician Decision|6|||
44186672|NCT01641926|78981749|FG001|Overall Study|Physician Decision|5|||
44186673|NCT01641926|78981750|FG002|Overall Study|Physician Decision|0|||
44186674|NCT01641926|78981751|FG003|Overall Study|Physician Decision|1|||
44186675|NCT01641926|78981748|FG000|Overall Study|Protocol Violation|1|||
44186676|NCT01641926|78981749|FG001|Overall Study|Protocol Violation|0|||
44186677|NCT01641926|78981750|FG002|Overall Study|Protocol Violation|0|||
44186678|NCT01641926|78981751|FG003|Overall Study|Protocol Violation|1|||
44186679|NCT01641926|78981748|FG000|Overall Study|Withdrawal by Subject|13|||
44186680|NCT01641926|78981749|FG001|Overall Study|Withdrawal by Subject|5|||
44186681|NCT01641926|78981750|FG002|Overall Study|Withdrawal by Subject|6|||
44186682|NCT01641926|78981751|FG003|Overall Study|Withdrawal by Subject|1|||
44186683|NCT01641926|78981748|FG000|Overall Study|Not Treated|1|||
44186684|NCT01641926|78981749|FG001|Overall Study|Not Treated|1|||
44186685|NCT01641926|78981750|FG002|Overall Study|Not Treated|1|||
44186686|NCT01641926|78981751|FG003|Overall Study|Not Treated|0|||
44186687|NCT02295020|78981763|FG000|Overall Study|Adverse Event|0|||
44186688|NCT02295020|78981764|FG001|Overall Study|Adverse Event|1|||
44186689|NCT02295020|78981763|FG000|Overall Study|Withdrawal by Subject|3|||
44186690|NCT02295020|78981764|FG001|Overall Study|Withdrawal by Subject|2|||
44186691|NCT02200939|78981778|FG000|Overall Study|Participant withdrew consent|0|||
44186692|NCT02200939|78981779|FG001|Overall Study|Participant withdrew consent|1|||
44186693|NCT02200939|78981778|FG000|Overall Study|Lost to Follow-up|2|||
44186694|NCT02200939|78981779|FG001|Overall Study|Lost to Follow-up|9|||
44186695|NCT02200939|78981778|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
44186696|NCT02200939|78981779|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
44186697|NCT02294786|78981791|FG000|Overall Study|Withdrawal by Subject|0|||
44186698|NCT02294786|78981792|FG001|Overall Study|Withdrawal by Subject|1|||
44186699|NCT02294786|78981791|FG000|Overall Study|Physician Decision|6|||
44186700|NCT02294786|78981792|FG001|Overall Study|Physician Decision|7|||
44186701|NCT02294786|78981791|FG000|Overall Study|Lost to Follow-up|1|||
44186702|NCT02294786|78981792|FG001|Overall Study|Lost to Follow-up|2|||
44186703|NCT02294786|78981791|FG000|Overall Study|Protocol Violation|1|||
44186704|NCT02294786|78981792|FG001|Overall Study|Protocol Violation|0|||
44186705|NCT02294786|78981791|FG000|Overall Study|Adverse Event|1|||
44186706|NCT02294786|78981792|FG001|Overall Study|Adverse Event|1|||
44186707|NCT02294786|78981791|FG000|Overall Study|Death|2|||
44186708|NCT02294786|78981792|FG001|Overall Study|Death|3|||
44186709|NCT02269124|78981801|FG000|Overall Study|Lost to Follow-up|1|||
44186710|NCT02269124|78981802|FG001|Overall Study|Lost to Follow-up|0|||
44186711|NCT02269124|78981801|FG000|Overall Study|Withdrawal by Subject|0|||
44186712|NCT02269124|78981802|FG001|Overall Study|Withdrawal by Subject|2|||
44186713|NCT01927341|78981814|FG000|Phase 1b|Lost to Follow-up|1|||
44186714|NCT01927341|78981815|FG001|Phase 1b|Lost to Follow-up|0|||
44186715|NCT01927341|78981816|FG002|Phase 1b|Lost to Follow-up|0|||
44186716|NCT01927341|78981817|FG003|Phase 1b|Lost to Follow-up|0|||
44186717|NCT01927341|78981818|FG004|Phase 1b|Lost to Follow-up|0|||
44186718|NCT01927341|78981814|FG000|Phase 1b|Death|2|||
44186719|NCT01927341|78981815|FG001|Phase 1b|Death|0|||
44186720|NCT01927341|78981816|FG002|Phase 1b|Death|0|||
44186721|NCT01927341|78981817|FG003|Phase 1b|Death|0|||
44186722|NCT01927341|78981818|FG004|Phase 1b|Death|0|||
44186723|NCT01927341|78981814|FG000|Phase 1b|Follow-up completed|7|||
44186724|NCT01927341|78981815|FG001|Phase 1b|Follow-up completed|0|||
44186725|NCT01927341|78981816|FG002|Phase 1b|Follow-up completed|0|||
44186726|NCT01927341|78981817|FG003|Phase 1b|Follow-up completed|0|||
44186727|NCT01927341|78981818|FG004|Phase 1b|Follow-up completed|0|||
44186728|NCT01927341|78981814|FG000|Phase 2|Lost to Follow-up|0|||
44186729|NCT01927341|78981815|FG001|Phase 2|Lost to Follow-up|1|||
44186730|NCT01927341|78981816|FG002|Phase 2|Lost to Follow-up|0|||
44186731|NCT01927341|78981817|FG003|Phase 2|Lost to Follow-up|0|||
44186732|NCT01927341|78981818|FG004|Phase 2|Lost to Follow-up|0|||
44186733|NCT01927341|78981814|FG000|Phase 2|Participant withdrew consent|0|||
44186734|NCT01927341|78981815|FG001|Phase 2|Participant withdrew consent|2|||
44265850|NCT02439216|79171236|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44265851|NCT02439216|79171237|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44265852|NCT02439216|79171238|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44186735|NCT01927341|78981816|FG002|Phase 2|Participant withdrew consent|1|||
44186736|NCT01927341|78981817|FG003|Phase 2|Participant withdrew consent|2|||
44186737|NCT01927341|78981818|FG004|Phase 2|Participant withdrew consent|3|||
44186738|NCT01927341|78981814|FG000|Phase 2|Death|0|||
44186739|NCT01927341|78981815|FG001|Phase 2|Death|4|||
44265853|NCT02439216|79171239|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44186740|NCT01927341|78981816|FG002|Phase 2|Death|0|||
44186741|NCT01927341|78981817|FG003|Phase 2|Death|3|||
44186742|NCT01927341|78981818|FG004|Phase 2|Death|2|||
44186743|NCT01927341|78981814|FG000|Phase 2|New cancer therapy|0|||
44186744|NCT01927341|78981815|FG001|Phase 2|New cancer therapy|1|||
44186745|NCT01927341|78981816|FG002|Phase 2|New cancer therapy|0|||
44186746|NCT01927341|78981817|FG003|Phase 2|New cancer therapy|4|||
44186747|NCT01927341|78981818|FG004|Phase 2|New cancer therapy|1|||
44186748|NCT01927341|78981814|FG000|Phase 2|Disease progression|0|||
44186749|NCT01927341|78981815|FG001|Phase 2|Disease progression|1|||
44186750|NCT01927341|78981816|FG002|Phase 2|Disease progression|1|||
44186751|NCT01927341|78981817|FG003|Phase 2|Disease progression|1|||
44186752|NCT01927341|78981818|FG004|Phase 2|Disease progression|0|||
44186753|NCT01927341|78981814|FG000|Phase 2|Follow-up completed|0|||
44186754|NCT01927341|78981815|FG001|Phase 2|Follow-up completed|6|||
44186755|NCT01927341|78981816|FG002|Phase 2|Follow-up completed|3|||
44186756|NCT01927341|78981817|FG003|Phase 2|Follow-up completed|5|||
44186757|NCT01927341|78981818|FG004|Phase 2|Follow-up completed|2|||
44186758|NCT02294474|78981836|FG000|Overall Study|Adverse Event|7|||
44186759|NCT02294474|78981837|FG001|Overall Study|Adverse Event|7|||
44186760|NCT02294474|78981836|FG000|Overall Study|Lack of Efficacy|2|||
44186761|NCT02294474|78981837|FG001|Overall Study|Lack of Efficacy|1|||
44186762|NCT02294474|78981836|FG000|Overall Study|Protocol Violation|4|||
44186763|NCT02294474|78981837|FG001|Overall Study|Protocol Violation|2|||
44186764|NCT02294474|78981836|FG000|Overall Study|Other than specified above|12|||
44186765|NCT02294474|78981837|FG001|Overall Study|Other than specified above|12|||
44186766|NCT02168101|78981847|FG000|Overall Study|Death|2|||
44186767|NCT02168101|78981848|FG001|Overall Study|Death|2|||
44186768|NCT02168101|78981849|FG002|Overall Study|Death|1|||
44186769|NCT02298179|78981870|FG000|Overall Study|Lost to Follow-up|0|||
44186770|NCT02298179|78981871|FG001|Overall Study|Lost to Follow-up|0|||
44186771|NCT02298179|78981872|FG002|Overall Study|Lost to Follow-up|1|||
44186772|NCT02298179|78981873|FG003|Overall Study|Lost to Follow-up|0|||
44186773|NCT02298179|78981874|FG004|Overall Study|Lost to Follow-up|0|||
44186774|NCT02298179|78981875|FG005|Overall Study|Lost to Follow-up|0|||
44186775|NCT02298179|78981876|FG006|Overall Study|Lost to Follow-up|0|||
44186776|NCT02298179|78981877|FG007|Overall Study|Lost to Follow-up|1|||
44186777|NCT02298179|78981878|FG008|Overall Study|Lost to Follow-up|0|||
44186778|NCT02298179|78981879|FG009|Overall Study|Lost to Follow-up|0|||
44186779|NCT02298179|78981880|FG010|Overall Study|Lost to Follow-up|0|||
44186780|NCT02298179|78981881|FG011|Overall Study|Lost to Follow-up|0|||
44186781|NCT02298023|78981910|FG000|Overall Study|Withdrawal by Subject|1|||
44186782|NCT02298023|78981911|FG001|Overall Study|Withdrawal by Subject|0|||
44186783|NCT02298023|78981912|FG002|Overall Study|Withdrawal by Subject|0|||
44186784|NCT02296931|78981925|FG000|Overall Study|Protocol Violation|0|||
44186785|NCT02296931|78981926|FG001|Overall Study|Protocol Violation|2|||
44186786|NCT02166697|78981932|FG000|Overall Study|Protocol Violation|347|||
44186787|NCT01909479|78981938|FG000|From Baseline to Week 26|Adverse Event|3|||
44186788|NCT01909479|78981939|FG001|From Baseline to Week 26|Adverse Event|2|||
44186789|NCT01909479|78981938|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
44186790|NCT01909479|78981939|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
44186791|NCT01909479|78981938|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
44186792|NCT01909479|78981939|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
44186793|NCT01909479|78981938|FG000|26 - 52 Weeks|Adverse Event|0|||
44186794|NCT01909479|78981939|FG001|26 - 52 Weeks|Adverse Event|1|||
44186795|NCT01909479|78981938|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
44186796|NCT01909479|78981939|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
44186797|NCT01909479|78981938|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
44186798|NCT01909479|78981939|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
44186799|NCT01909479|78981938|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
44186800|NCT01909479|78981939|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
44186801|NCT01909479|78981938|FG000|52 Weeks to End of Study|Adverse Event|2|||
44186802|NCT01909479|78981939|FG001|52 Weeks to End of Study|Adverse Event|1|||
44186803|NCT01909479|78981938|FG000|52 Weeks to End of Study|Death|0|||
44186804|NCT01909479|78981939|FG001|52 Weeks to End of Study|Death|1|||
44186805|NCT01909479|78981938|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
44186806|NCT01909479|78981939|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
44186807|NCT01909479|78981938|FG000|52 Weeks to End of Study|Protocol Violation|1|||
44186808|NCT01909479|78981939|FG001|52 Weeks to End of Study|Protocol Violation|0|||
44186809|NCT01909479|78981938|FG000|52 Weeks to End of Study|Progressive disease|1|||
44186810|NCT01909479|78981939|FG001|52 Weeks to End of Study|Progressive disease|1|||
44186811|NCT01909479|78981938|FG000|52 Weeks to End of Study|Personal reasons|2|||
44186812|NCT01909479|78981939|FG001|52 Weeks to End of Study|Personal reasons|1|||
44186813|NCT01909479|78981938|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
44186814|NCT01909479|78981939|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
44186815|NCT01909479|78981938|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
44186816|NCT01909479|78981939|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
44186817|NCT01909479|78981938|FG000|52 Weeks to End of Study|Lack of contact|1|||
44186818|NCT01909479|78981939|FG001|52 Weeks to End of Study|Lack of contact|0|||
44186819|NCT01909479|78981938|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
44186820|NCT01909479|78981939|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
44186821|NCT01909479|78981938|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
44186822|NCT01909479|78981939|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
44186823|NCT01955733|78981952|FG000|Period 1|Lost to Follow-up|1|||
44186824|NCT01955733|78981953|FG001|Period 1|Lost to Follow-up|0|||
44186825|NCT01955733|78981954|FG002|Period 1|Lost to Follow-up|0|||
44186826|NCT01955733|78981952|FG000|Period 2|Adverse Event|1|||
44186827|NCT01955733|78981953|FG001|Period 2|Adverse Event|0|||
44186828|NCT01955733|78981954|FG002|Period 2|Adverse Event|0|||
44186829|NCT01955733|78981952|FG000|Period 2|Physician Decision|0|||
44186830|NCT01955733|78981953|FG001|Period 2|Physician Decision|0|||
44186831|NCT01955733|78981954|FG002|Period 2|Physician Decision|1|||
44186832|NCT01955733|78981952|FG000|Period 2|Withdrawal by Subject|1|||
44186833|NCT01955733|78981953|FG001|Period 2|Withdrawal by Subject|3|||
44186834|NCT01955733|78981954|FG002|Period 2|Withdrawal by Subject|2|||
44186835|NCT01955733|78981952|FG000|Period 2|Study terminated by sponsor|8|||
44186836|NCT01955733|78981953|FG001|Period 2|Study terminated by sponsor|14|||
44186837|NCT01955733|78981954|FG002|Period 2|Study terminated by sponsor|16|||
44186838|NCT01955733|78981952|FG000|Period 2|Lost to Follow-up|2|||
44186839|NCT01955733|78981953|FG001|Period 2|Lost to Follow-up|0|||
44186840|NCT01955733|78981954|FG002|Period 2|Lost to Follow-up|0|||
44265854|NCT02439216|79171240|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44265855|NCT02439216|79171241|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44265856|NCT02439216|79171242|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44265857|NCT02439216|79171243|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
44265858|NCT02439216|79171235|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44186841|NCT01955733|78981952|FG000|Period 2|Other not defined above|0|||
44186842|NCT01955733|78981953|FG001|Period 2|Other not defined above|2|||
44186843|NCT01955733|78981954|FG002|Period 2|Other not defined above|2|||
44186844|NCT02197897|78981962|FG000|Overall Study|not eligible|1|||
44186845|NCT02223793|78981969|FG000|Overall Study|Lost to Follow-up|10|||
44186846|NCT02223793|78981970|FG001|Overall Study|Lost to Follow-up|1|||
44186847|NCT02223793|78981971|FG002|Overall Study|Lost to Follow-up|2|||
44186848|NCT02223793|78981969|FG000|Overall Study|Withdrawal by Subject|3|||
44186849|NCT02223793|78981970|FG001|Overall Study|Withdrawal by Subject|2|||
44186850|NCT02223793|78981971|FG002|Overall Study|Withdrawal by Subject|3|||
44186851|NCT02223793|78981969|FG000|Overall Study|Moved/studycenter unable to participate|4|||
44186852|NCT02223793|78981970|FG001|Overall Study|Moved/studycenter unable to participate|6|||
44186853|NCT02223793|78981971|FG002|Overall Study|Moved/studycenter unable to participate|8|||
44186854|NCT01926015|78981981|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44186855|NCT01926015|78981982|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44186856|NCT01926015|78981981|FG000|Overall Study|Randomized not treated|2|||
44186857|NCT01926015|78981982|FG001|Overall Study|Randomized not treated|0|||
44186858|NCT02223715|78981988|FG000|Overall Study|Death|31|||
44186859|NCT02223715|78981988|FG000|Overall Study|Lost to Follow-up|73|||
44186860|NCT02196259|78981998|FG000|Overall Study|Researcher choice|0|||
44186861|NCT02196259|78981999|FG001|Overall Study|Researcher choice|0|||
44186862|NCT02196259|78982000|FG002|Overall Study|Researcher choice|1|||
44186863|NCT02196259|78981998|FG000|Overall Study|Partial data analysis|0|||
44186864|NCT02196259|78981999|FG001|Overall Study|Partial data analysis|3|||
44186865|NCT02196259|78982000|FG002|Overall Study|Partial data analysis|0|||
44186866|NCT02294396|78982011|FG000|Overall Study|Adverse Event|26|||
44186867|NCT02294396|78982012|FG001|Overall Study|Adverse Event|25|||
44186868|NCT02294396|78982013|FG002|Overall Study|Adverse Event|21|||
44186869|NCT02294396|78982014|FG003|Overall Study|Adverse Event|24|||
44186870|NCT02294396|78982011|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
44186871|NCT02294396|78982012|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
44186872|NCT02294396|78982013|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
44186873|NCT02294396|78982014|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
44186874|NCT02294396|78982011|FG000|Overall Study|Withdrawal by Subject|8|||
44186875|NCT02294396|78982012|FG001|Overall Study|Withdrawal by Subject|6|||
44186876|NCT02294396|78982013|FG002|Overall Study|Withdrawal by Subject|6|||
44186877|NCT02294396|78982014|FG003|Overall Study|Withdrawal by Subject|8|||
44186878|NCT02294396|78982011|FG000|Overall Study|Lost to Follow-up|0|||
44186879|NCT02294396|78982012|FG001|Overall Study|Lost to Follow-up|0|||
44186880|NCT02294396|78982013|FG002|Overall Study|Lost to Follow-up|1|||
44186881|NCT02294396|78982014|FG003|Overall Study|Lost to Follow-up|1|||
44186882|NCT02294396|78982011|FG000|Overall Study|Protocol Deviation|3|||
44186883|NCT02294396|78982012|FG001|Overall Study|Protocol Deviation|2|||
44186884|NCT02294396|78982013|FG002|Overall Study|Protocol Deviation|2|||
44186885|NCT02294396|78982014|FG003|Overall Study|Protocol Deviation|1|||
44186886|NCT02294396|78982011|FG000|Overall Study|Miscellaneous|2|||
44186887|NCT02294396|78982012|FG001|Overall Study|Miscellaneous|0|||
44265859|NCT02439216|79171236|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44361233|NCT01185821|79366879|FG004|Overall Study|Lack of Efficacy|9|||
44186888|NCT02294396|78982013|FG002|Overall Study|Miscellaneous|5|||
44186889|NCT02294396|78982014|FG003|Overall Study|Miscellaneous|2|||
44186890|NCT01721044|78982027|FG000|Treatment Period|Adverse Event|7|||
44186891|NCT01721044|78982028|FG001|Treatment Period|Adverse Event|7|||
44186892|NCT01721044|78982029|FG002|Treatment Period|Adverse Event|10|||
44186893|NCT01721044|78982027|FG000|Treatment Period|Death|0|||
44186894|NCT01721044|78982028|FG001|Treatment Period|Death|0|||
44186895|NCT01721044|78982029|FG002|Treatment Period|Death|1|||
44186896|NCT01721044|78982027|FG000|Treatment Period|Lack of Efficacy|16|||
44186897|NCT01721044|78982028|FG001|Treatment Period|Lack of Efficacy|4|||
44186898|NCT01721044|78982029|FG002|Treatment Period|Lack of Efficacy|4|||
44186899|NCT01721044|78982027|FG000|Treatment Period|Lost to Follow-up|0|||
44186900|NCT01721044|78982028|FG001|Treatment Period|Lost to Follow-up|0|||
44186901|NCT01721044|78982029|FG002|Treatment Period|Lost to Follow-up|1|||
44186902|NCT01721044|78982027|FG000|Treatment Period|Physician Decision|1|||
44186903|NCT01721044|78982028|FG001|Treatment Period|Physician Decision|0|||
44186904|NCT01721044|78982029|FG002|Treatment Period|Physician Decision|2|||
44186905|NCT01721044|78982027|FG000|Treatment Period|Protocol Violation|1|||
44186906|NCT01721044|78982028|FG001|Treatment Period|Protocol Violation|0|||
44186907|NCT01721044|78982029|FG002|Treatment Period|Protocol Violation|0|||
44186908|NCT01721044|78982027|FG000|Treatment Period|Withdrawal by Subject|7|||
44186909|NCT01721044|78982028|FG001|Treatment Period|Withdrawal by Subject|6|||
44186910|NCT01721044|78982029|FG002|Treatment Period|Withdrawal by Subject|1|||
44186911|NCT02164981|78982051|FG000|Started|Withdrawal by Subject|2|||
44186912|NCT02164981|78982052|FG001|Started|Withdrawal by Subject|1|||
44186913|NCT02164981|78982053|FG002|Started|Withdrawal by Subject|0|||
44186914|NCT02164981|78982051|FG000|Started|Protocol Violation|2|||
44186915|NCT02164981|78982052|FG001|Started|Protocol Violation|0|||
44186916|NCT02164981|78982053|FG002|Started|Protocol Violation|0|||
44186917|NCT02164981|78982051|FG000|Started|Adverse Event|1|||
44186918|NCT02164981|78982052|FG001|Started|Adverse Event|2|||
44186919|NCT02164981|78982053|FG002|Started|Adverse Event|0|||
44186920|NCT02164981|78982051|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
44186921|NCT02164981|78982052|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
44186922|NCT02164981|78982053|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
44186923|NCT02164981|78982051|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
44186924|NCT02164981|78982052|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
44186925|NCT02164981|78982053|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
44186926|NCT02164981|78982051|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
44186927|NCT02164981|78982052|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
44186928|NCT02164981|78982053|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
44186929|NCT02195869|78982074|FG000|Overall Study|cGVHD Progression|5|||
44186930|NCT02195869|78982074|FG000|Overall Study|Malignancy Progression/relapse|2|||
44186931|NCT02195869|78982074|FG000|Overall Study|Adverse Event|15|||
44186932|NCT02195869|78982074|FG000|Overall Study|Withdrawal by Subject|7|||
44186933|NCT02195869|78982074|FG000|Overall Study|Physician Decision|4|||
44186934|NCT02195869|78982074|FG000|Overall Study|Study Terminated by Sponsor|7|||
44186935|NCT02195869|78982074|FG000|Overall Study|Noncompliance with study drug|2|||
44186936|NCT01908699|78982083|FG000|Overall Study|Adverse Event|8|||
44186937|NCT01908699|78982084|FG001|Overall Study|Adverse Event|12|||
44186938|NCT01908699|78982083|FG000|Overall Study|Lack of Efficacy|2|||
44186939|NCT01908699|78982084|FG001|Overall Study|Lack of Efficacy|2|||
44186940|NCT01908699|78982083|FG000|Overall Study|Lost to Follow-up|2|||
44186941|NCT01908699|78982084|FG001|Overall Study|Lost to Follow-up|4|||
44186942|NCT01908699|78982083|FG000|Overall Study|Physician Decision|8|||
44186943|NCT01908699|78982084|FG001|Overall Study|Physician Decision|8|||
44186944|NCT01908699|78982083|FG000|Overall Study|Withdrawal by Subject|15|||
44186945|NCT01908699|78982084|FG001|Overall Study|Withdrawal by Subject|10|||
44186946|NCT01908699|78982083|FG000|Overall Study|Pregnancy|0|||
44186947|NCT01908699|78982084|FG001|Overall Study|Pregnancy|1|||
44186948|NCT01908699|78982083|FG000|Overall Study|Randomized in Error|1|||
44186949|NCT01908699|78982084|FG001|Overall Study|Randomized in Error|0|||
44186950|NCT01908699|78982083|FG000|Overall Study|Death|9|||
44186951|NCT01908699|78982084|FG001|Overall Study|Death|12|||
44186952|NCT01908699|78982083|FG000|Overall Study|Progressive Disease|30|||
44186953|NCT01908699|78982084|FG001|Overall Study|Progressive Disease|29|||
44186954|NCT01599637|78982093|FG000|Overall Study|administrative problems|0|||
44186955|NCT01599637|78982094|FG001|Overall Study|administrative problems|2|||
44186956|NCT01599637|78982095|FG002|Overall Study|administrative problems|0|||
44186957|NCT01599637|78982093|FG000|Overall Study|Adverse Event|1|||
44186958|NCT01599637|78982094|FG001|Overall Study|Adverse Event|0|||
44186959|NCT01599637|78982095|FG002|Overall Study|Adverse Event|0|||
44186960|NCT02264639|78982110|FG000|Overall Study|Death (after completing single-dose phase)|1|||
44186961|NCT02264639|78982111|FG001|Overall Study|Death (after completing single-dose phase)|0|||
44186962|NCT02264639|78982112|FG002|Overall Study|Death (after completing single-dose phase)|0|||
44186963|NCT02264639|78982113|FG003|Overall Study|Death (after completing single-dose phase)|0|||
44186964|NCT02264639|78982114|FG004|Overall Study|Death (after completing single-dose phase)|0|||
44186965|NCT02264639|78982110|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
44186966|NCT02264639|78982111|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
44186967|NCT02264639|78982112|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
44186968|NCT02264639|78982113|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
44186969|NCT02264639|78982114|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
44186970|NCT02264639|78982110|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
44186971|NCT02264639|78982111|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
44186972|NCT02264639|78982112|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
44186973|NCT02264639|78982113|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
44186974|NCT02264639|78982114|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
44186975|NCT02264639|78982110|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
44186976|NCT02264639|78982111|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
44186977|NCT02264639|78982112|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
44186978|NCT02264639|78982113|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
44186979|NCT02264639|78982114|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
44186980|NCT01363011|78982131|FG000|Main Study|Adverse Event|2|||
44186981|NCT01363011|78982132|FG001|Main Study|Adverse Event|3|||
44186982|NCT01363011|78982131|FG000|Main Study|Investigator's Discretion|1|||
44186983|NCT01363011|78982132|FG001|Main Study|Investigator's Discretion|1|||
44186984|NCT01363011|78982131|FG000|Main Study|Withdrew Consent|1|||
44186985|NCT01363011|78982132|FG001|Main Study|Withdrew Consent|4|||
44186986|NCT01363011|78982131|FG000|Main Study|Protocol Violation|0|||
44186987|NCT01363011|78982132|FG001|Main Study|Protocol Violation|1|||
44186988|NCT01363011|78982131|FG000|Extension Phase|Adverse Event|1|||
44186989|NCT01363011|78982132|FG001|Extension Phase|Adverse Event|1|||
44186990|NCT01363011|78982131|FG000|Extension Phase|Lack of Efficacy|0|||
44186991|NCT01363011|78982132|FG001|Extension Phase|Lack of Efficacy|1|||
44186992|NCT01363011|78982131|FG000|Extension Phase|Investigator's Discretion|2|||
44186993|NCT01363011|78982132|FG001|Extension Phase|Investigator's Discretion|2|||
44186994|NCT01363011|78982131|FG000|Extension Phase|Withdrew Consent|0|||
44186995|NCT01363011|78982132|FG001|Extension Phase|Withdrew Consent|1|||
44186996|NCT01363011|78982131|FG000|Extension Phase|Lost to Follow-up|0|||
44186997|NCT01363011|78982132|FG001|Extension Phase|Lost to Follow-up|2|||
44186998|NCT01363011|78982131|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
44186999|NCT01363011|78982132|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
44187000|NCT02263547|78982138|FG000|Overall Study|Adverse Event|1|||
44187001|NCT02263547|78982138|FG000|Overall Study|Lost to Follow-up|2|||
44187002|NCT01925703|78982142|FG000|Overall Study|Physician Decision|1|||
44187003|NCT01925703|78982142|FG000|Overall Study|Lost to Follow-up|2|||
44187004|NCT01925703|78982142|FG000|Overall Study|Discharge prior to full iron repletion|1|||
44187005|NCT01617681|78982150|FG000|Period 1 Double Blind|Adverse Event|2|||
44187006|NCT01617681|78982151|FG001|Period 1 Double Blind|Adverse Event|0|||
44187007|NCT01617681|78982152|FG002|Period 1 Double Blind|Adverse Event|0|||
44187008|NCT01617681|78982153|FG003|Period 1 Double Blind|Adverse Event|2|||
44187009|NCT01617681|78982154|FG004|Period 1 Double Blind|Adverse Event|0|||
44187010|NCT01617681|78982150|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
44187011|NCT01617681|78982151|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
44187012|NCT01617681|78982152|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
44187013|NCT01617681|78982153|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
44187014|NCT01617681|78982154|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
44187015|NCT01617681|78982150|FG000|Period 2 Open Label|Adverse Event|0|||
44187016|NCT01617681|78982151|FG001|Period 2 Open Label|Adverse Event|0|||
44187017|NCT01617681|78982152|FG002|Period 2 Open Label|Adverse Event|0|||
44187018|NCT01617681|78982153|FG003|Period 2 Open Label|Adverse Event|0|||
44187019|NCT01617681|78982154|FG004|Period 2 Open Label|Adverse Event|3|||
44187020|NCT01617681|78982150|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
44187021|NCT01617681|78982151|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
44187022|NCT01617681|78982152|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
44187023|NCT01617681|78982153|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
44187024|NCT01617681|78982154|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
44187025|NCT02263079|78982166|FG000|Overall Study|Physician Decision|1|||
44187026|NCT02263079|78982167|FG001|Overall Study|Physician Decision|0|||
44187027|NCT02263079|78982168|FG002|Overall Study|Physician Decision|0|||
44187028|NCT02263079|78982166|FG000|Overall Study|Withdrawal by Subject|2|||
44187029|NCT02263079|78982167|FG001|Overall Study|Withdrawal by Subject|8|||
44187030|NCT02263079|78982168|FG002|Overall Study|Withdrawal by Subject|0|||
44187031|NCT02295995|78982178|FG000|Overall Study|Lost to Follow-up|5|||
44187032|NCT02295995|78982179|FG001|Overall Study|Lost to Follow-up|1|||
44187033|NCT02294981|78982186|FG000|Overall Study|Lost to Follow-up|1|||
44187034|NCT02262377|78982192|FG000|Overall Study|Lost to Follow-up|5|||
44187035|NCT02262377|78982193|FG001|Overall Study|Lost to Follow-up|6|||
44187036|NCT02262377|78982192|FG000|Overall Study|Found ineligible after enrollment|3|||
44187037|NCT02262377|78982193|FG001|Overall Study|Found ineligible after enrollment|0|||
44187038|NCT02262377|78982192|FG000|Overall Study|Withdrawal by Subject|4|||
44187039|NCT02262377|78982193|FG001|Overall Study|Withdrawal by Subject|0|||
44187040|NCT02260817|78982202|FG000|Overall Study|Lost to Follow-up|0|||
44187041|NCT02260817|78982203|FG001|Overall Study|Lost to Follow-up|14|||
44187042|NCT02260817|78982202|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
44187043|NCT02260817|78982203|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
44187044|NCT02260817|78982202|FG000|Overall Study|Observation, no biopsy|0|||
44187045|NCT02260817|78982203|FG001|Overall Study|Observation, no biopsy|1|||
44187046|NCT02260817|78982202|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
44187047|NCT02260817|78982203|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
44187048|NCT02260817|78982202|FG000|Overall Study|Protocol Violation|0|||
44187049|NCT02260817|78982203|FG001|Overall Study|Protocol Violation|14|||
44187050|NCT01642589|78982211|FG000|Overall Study|Withdrawal by Subject|1|||
44187051|NCT01642589|78982212|FG001|Overall Study|Withdrawal by Subject|1|||
44187052|NCT02268812|78982222|FG000|Overall Study|Adverse Event|8|||
44187053|NCT02268812|78982223|FG001|Overall Study|Adverse Event|26|||
44187054|NCT02268812|78982224|FG002|Overall Study|Adverse Event|7|||
44187055|NCT02268812|78982225|FG003|Overall Study|Adverse Event|10|||
44187056|NCT02268812|78982222|FG000|Overall Study|Protocol deviation|0|||
44187057|NCT02268812|78982223|FG001|Overall Study|Protocol deviation|0|||
44187058|NCT02268812|78982224|FG002|Overall Study|Protocol deviation|1|||
44187059|NCT02268812|78982225|FG003|Overall Study|Protocol deviation|0|||
44187060|NCT02268812|78982222|FG000|Overall Study|Withdrawal by Subject|0|||
44187061|NCT02268812|78982223|FG001|Overall Study|Withdrawal by Subject|1|||
44187062|NCT02268812|78982224|FG002|Overall Study|Withdrawal by Subject|0|||
44187063|NCT02268812|78982225|FG003|Overall Study|Withdrawal by Subject|0|||
44187064|NCT02268812|78982222|FG000|Overall Study|Physician Decision|3|||
44187065|NCT02268812|78982223|FG001|Overall Study|Physician Decision|1|||
44187066|NCT02268812|78982224|FG002|Overall Study|Physician Decision|0|||
44187067|NCT02268812|78982225|FG003|Overall Study|Physician Decision|1|||
44187068|NCT02268812|78982222|FG000|Overall Study|Other|5|||
44187069|NCT02268812|78982223|FG001|Overall Study|Other|4|||
44265860|NCT02439216|79171237|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44265861|NCT02439216|79171238|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44265862|NCT02439216|79171239|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44187070|NCT02268812|78982224|FG002|Overall Study|Other|1|||
44187071|NCT02268812|78982225|FG003|Overall Study|Other|3|||
44187072|NCT01954251|78982237|FG000|Overall Study|Adverse Event|5|||
44187073|NCT01954251|78982238|FG001|Overall Study|Adverse Event|7|||
44187074|NCT01954251|78982237|FG000|Overall Study|Lost to Follow-up|6|||
44187075|NCT01954251|78982238|FG001|Overall Study|Lost to Follow-up|6|||
44187076|NCT01954251|78982237|FG000|Overall Study|Withdrawal by Subject|2|||
44187077|NCT01954251|78982238|FG001|Overall Study|Withdrawal by Subject|6|||
44187078|NCT01644617|78982248|FG000|Overall Study|Withdrawal by Subject|3|||
44187079|NCT01644617|78982249|FG001|Overall Study|Withdrawal by Subject|4|||
44187080|NCT01644617|78982250|FG002|Overall Study|Withdrawal by Subject|1|||
44187081|NCT01644617|78982248|FG000|Overall Study|Lost to Follow-up|0|||
44187082|NCT01644617|78982249|FG001|Overall Study|Lost to Follow-up|1|||
44187083|NCT01644617|78982250|FG002|Overall Study|Lost to Follow-up|0|||
44187084|NCT01644617|78982248|FG000|Overall Study|Adverse Event|3|||
44187085|NCT01644617|78982249|FG001|Overall Study|Adverse Event|0|||
44187086|NCT01644617|78982250|FG002|Overall Study|Adverse Event|6|||
44187087|NCT02294318|78982260|FG000|Overall Study|Worsening of drinking|3|||
44187088|NCT02294318|78982261|FG001|Overall Study|Worsening of drinking|0|||
44187089|NCT02294318|78982260|FG000|Overall Study|Not exposed to intervention|0|||
44187090|NCT02294318|78982261|FG001|Overall Study|Not exposed to intervention|2|||
44187091|NCT02293499|78982270|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
44187092|NCT02293499|78982271|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
44187093|NCT02293499|78982272|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
44187094|NCT02293499|78982270|FG000|Intervention - Camp|Withdrawal by Subject|3|||
44187095|NCT02293499|78982271|FG001|Intervention - Camp|Withdrawal by Subject|6|||
44187096|NCT02293499|78982272|FG002|Intervention - Camp|Withdrawal by Subject|2|||
44187097|NCT02293499|78982270|FG000|Intervention - Camp|these are those not showing up at camp|24|||
44187098|NCT02293499|78982271|FG001|Intervention - Camp|these are those not showing up at camp|28|||
44187099|NCT02293499|78982272|FG002|Intervention - Camp|these are those not showing up at camp|4|||
44187100|NCT02293499|78982270|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
44187101|NCT02293499|78982271|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
44187102|NCT02293499|78982272|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
44187103|NCT02293499|78982270|FG000|3 Month Follow Up|Lost to Follow-up|14|||
44187104|NCT02293499|78982271|FG001|3 Month Follow Up|Lost to Follow-up|15|||
44187105|NCT02293499|78982272|FG002|3 Month Follow Up|Lost to Follow-up|6|||
44187106|NCT02293499|78982270|FG000|6 Month Follow Up|Lost to Follow-up|17|||
44187107|NCT02293499|78982271|FG001|6 Month Follow Up|Lost to Follow-up|27|||
44187108|NCT02293499|78982272|FG002|6 Month Follow Up|Lost to Follow-up|6|||
44187109|NCT02293499|78982270|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
44187110|NCT02293499|78982271|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
44187111|NCT02293499|78982272|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
44187112|NCT02293499|78982270|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
44187113|NCT02293499|78982271|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
44187114|NCT02293499|78982272|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
44187115|NCT02293499|78982270|FG000|9 Month Follow Up|Lost to Follow-up|24|||
44187116|NCT02293499|78982271|FG001|9 Month Follow Up|Lost to Follow-up|28|||
44187117|NCT02293499|78982272|FG002|9 Month Follow Up|Lost to Follow-up|4|||
44187118|NCT02293499|78982270|FG000|12 Month Follow Up|Lost to Follow-up|26|||
44187119|NCT02293499|78982271|FG001|12 Month Follow Up|Lost to Follow-up|25|||
44187120|NCT02293499|78982272|FG002|12 Month Follow Up|Lost to Follow-up|6|||
44187121|NCT02293499|78982270|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
44187122|NCT02293499|78982271|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
44187123|NCT02293499|78982272|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
44187124|NCT02293499|78982270|FG000|15 Month Follow Up|Lost to Follow-up|22|||
44187125|NCT02293499|78982271|FG001|15 Month Follow Up|Lost to Follow-up|22|||
44187126|NCT02293499|78982272|FG002|15 Month Follow Up|Lost to Follow-up|7|||
44187127|NCT02257385|78982283|FG000|Overall Study|Adverse Event|12|||
44187128|NCT02257385|78982284|FG001|Overall Study|Adverse Event|8|||
44187129|NCT02257385|78982283|FG000|Overall Study|Lack of Efficacy|1|||
44187130|NCT02257385|78982284|FG001|Overall Study|Lack of Efficacy|2|||
44187131|NCT02257385|78982283|FG000|Overall Study|Protocol Violation|5|||
44187132|NCT02257385|78982284|FG001|Overall Study|Protocol Violation|7|||
44187133|NCT02257385|78982283|FG000|Overall Study|Lost to Follow-up|0|||
44187134|NCT02257385|78982284|FG001|Overall Study|Lost to Follow-up|1|||
44187135|NCT02257385|78982283|FG000|Overall Study|Withdrawal by Subject|4|||
44187136|NCT02257385|78982284|FG001|Overall Study|Withdrawal by Subject|4|||
44187137|NCT01629667|78982293|FG000|Overall Study|Lost to Follow-up|0|||
44187138|NCT01629667|78982294|FG001|Overall Study|Lost to Follow-up|1|||
44187139|NCT01629667|78982295|FG002|Overall Study|Lost to Follow-up|1|||
44187140|NCT01629667|78982293|FG000|Overall Study|Withdrawal by Subject|31|||
44187141|NCT01629667|78982294|FG001|Overall Study|Withdrawal by Subject|20|||
44187142|NCT01629667|78982295|FG002|Overall Study|Withdrawal by Subject|28|||
44187143|NCT01629667|78982293|FG000|Overall Study|Death|1|||
44187144|NCT01629667|78982294|FG001|Overall Study|Death|5|||
44187145|NCT01629667|78982295|FG002|Overall Study|Death|3|||
44265863|NCT02439216|79171240|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44187146|NCT01629667|78982293|FG000|Overall Study|Randomized, not treated|2|||
44187147|NCT01629667|78982294|FG001|Overall Study|Randomized, not treated|1|||
44451341|NCT00098293|79460285|FG000|Open-label (OL) Phase|Adverse Event|0|||
44187148|NCT01629667|78982295|FG002|Overall Study|Randomized, not treated|0|||
44187149|NCT01629667|78982293|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
44187150|NCT01629667|78982294|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
44187151|NCT01629667|78982295|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
44187152|NCT01629667|78982293|FG000|Overall Study|Requiring lung transplant|2|||
44187153|NCT01629667|78982294|FG001|Overall Study|Requiring lung transplant|1|||
44187154|NCT01629667|78982295|FG002|Overall Study|Requiring lung transplant|3|||
44187155|NCT01629667|78982293|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
44187156|NCT01629667|78982294|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
44187157|NCT01629667|78982295|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
44187158|NCT01629667|78982293|FG000|Overall Study|Started other medicine|1|||
44187159|NCT01629667|78982294|FG001|Overall Study|Started other medicine|0|||
44187160|NCT01629667|78982295|FG002|Overall Study|Started other medicine|1|||
44187161|NCT01629667|78982293|FG000|Overall Study|Site error in safety follow-up|0|||
44187162|NCT01629667|78982294|FG001|Overall Study|Site error in safety follow-up|0|||
44187163|NCT01629667|78982295|FG002|Overall Study|Site error in safety follow-up|1|||
44187164|NCT01629667|78982293|FG000|Overall Study|Enrolled in another clinical study|0|||
44187165|NCT01629667|78982294|FG001|Overall Study|Enrolled in another clinical study|1|||
44187166|NCT01629667|78982295|FG002|Overall Study|Enrolled in another clinical study|0|||
44187167|NCT01629667|78982293|FG000|Overall Study|Code break|1|||
44187168|NCT01629667|78982294|FG001|Overall Study|Code break|0|||
44187169|NCT01629667|78982295|FG002|Overall Study|Code break|0|||
44187170|NCT01645280|78982310|FG000|Overall Study|Death|0|||
44187171|NCT01645280|78982311|FG001|Overall Study|Death|1|||
44187172|NCT01645280|78982312|FG002|Overall Study|Death|0|||
44187173|NCT01645280|78982313|FG003|Overall Study|Death|0|||
44187174|NCT01645280|78982314|FG004|Overall Study|Death|0|||
44187175|NCT01645280|78982310|FG000|Overall Study|Withdrawal by Subject|4|||
44187176|NCT01645280|78982311|FG001|Overall Study|Withdrawal by Subject|0|||
44187177|NCT01645280|78982312|FG002|Overall Study|Withdrawal by Subject|2|||
44187178|NCT01645280|78982313|FG003|Overall Study|Withdrawal by Subject|4|||
44187179|NCT01645280|78982314|FG004|Overall Study|Withdrawal by Subject|5|||
44187180|NCT01645280|78982310|FG000|Overall Study|Lost to Follow-up|0|||
44187181|NCT01645280|78982311|FG001|Overall Study|Lost to Follow-up|0|||
44187182|NCT01645280|78982312|FG002|Overall Study|Lost to Follow-up|0|||
44187183|NCT01645280|78982313|FG003|Overall Study|Lost to Follow-up|2|||
44187184|NCT01645280|78982314|FG004|Overall Study|Lost to Follow-up|1|||
44187185|NCT01645280|78982310|FG000|Overall Study|Other|1|||
44187186|NCT01645280|78982311|FG001|Overall Study|Other|1|||
44187187|NCT01645280|78982312|FG002|Overall Study|Other|2|||
44187188|NCT01645280|78982313|FG003|Overall Study|Other|0|||
44187189|NCT01645280|78982314|FG004|Overall Study|Other|0|||
44187190|NCT01645280|78982310|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
44187191|NCT01645280|78982311|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
44187192|NCT01645280|78982312|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
44187193|NCT01645280|78982313|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
44187194|NCT01645280|78982314|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
44187195|NCT02256917|78982327|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
44187196|NCT02256917|78982327|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
44187197|NCT02256917|78982327|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
44187198|NCT02256917|78982327|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
44187199|NCT02256917|78982327|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
44187200|NCT01629589|78982340|FG000|Overall Study|Protocol Violation|4|||
44187201|NCT01629589|78982341|FG001|Overall Study|Protocol Violation|2|||
44187202|NCT01629589|78982340|FG000|Overall Study|Lost to Follow-up|2|||
44187203|NCT01629589|78982341|FG001|Overall Study|Lost to Follow-up|1|||
44187204|NCT01629589|78982340|FG000|Overall Study|Withdrawal by Subject|2|||
44187205|NCT01629589|78982341|FG001|Overall Study|Withdrawal by Subject|3|||
44187206|NCT01629589|78982340|FG000|Overall Study|Did not receive study vaccine|0|||
44187207|NCT01629589|78982341|FG001|Overall Study|Did not receive study vaccine|1|||
44187208|NCT02256839|78982349|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
44187209|NCT02256839|78982350|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
44187210|NCT02220907|78982356|FG000|Overall Study|Adverse Event|7|||
44187211|NCT02220907|78982356|FG000|Overall Study|Physician Decision|1|||
44187212|NCT02220907|78982356|FG000|Overall Study|Withdrawal by Subject|2|||
44187213|NCT02220907|78982356|FG000|Overall Study|Conflict with the stopping criteria|1|||
44187214|NCT02255981|78982360|FG000|Overall Study|Lost to Follow-up|3|||
44187215|NCT02255981|78982360|FG000|Overall Study|Withdrawal by Subject|1|||
44187216|NCT01601873|78982372|FG000|Overall Study|Lost to Follow-up|2|||
44187217|NCT01601873|78982373|FG001|Overall Study|Lost to Follow-up|3|||
44187218|NCT02194933|78982381|FG000|Overall Study|Lost to Follow-up|1|||
44187219|NCT02194933|78982382|FG001|Overall Study|Lost to Follow-up|2|||
44187220|NCT02194933|78982381|FG000|Overall Study|Participant met withdrawal criteria|1|||
44187221|NCT02194933|78982382|FG001|Overall Study|Participant met withdrawal criteria|3|||
44187222|NCT02194933|78982381|FG000|Overall Study|Withdrawal by Subject|0|||
44543038|NCT03655717|79555915|FG015|Overall Study|Lost to Follow-up|0|||
44187223|NCT02194933|78982382|FG001|Overall Study|Withdrawal by Subject|2|||
44187224|NCT02194933|78982381|FG000|Overall Study|Lack of Efficacy|1|||
44187225|NCT02194933|78982382|FG001|Overall Study|Lack of Efficacy|2|||
44187226|NCT01644890|78982392|FG000|Overall Study|Adverse Event|7|||
44187227|NCT01644890|78982393|FG001|Overall Study|Adverse Event|20|||
44187228|NCT01644890|78982392|FG000|Overall Study|Death|1|||
44187229|NCT01644890|78982393|FG001|Overall Study|Death|3|||
44187230|NCT01644890|78982392|FG000|Overall Study|Physician Decision|3|||
44187231|NCT01644890|78982393|FG001|Overall Study|Physician Decision|9|||
44187232|NCT01644890|78982392|FG000|Overall Study|Protocol Violation|6|||
44187233|NCT01644890|78982393|FG001|Overall Study|Protocol Violation|7|||
44187234|NCT01644890|78982392|FG000|Overall Study|Withdrawal by Subject|19|||
44187235|NCT01644890|78982393|FG001|Overall Study|Withdrawal by Subject|27|||
44187236|NCT01644890|78982392|FG000|Overall Study|Progression Disease|160|||
44187237|NCT01644890|78982393|FG001|Overall Study|Progression Disease|131|||
44187238|NCT01644890|78982392|FG000|Overall Study|Clinical Progression|6|||
44187239|NCT01644890|78982393|FG001|Overall Study|Clinical Progression|6|||
44187240|NCT01644890|78982392|FG000|Overall Study|> 28 days since last dose of study drug|6|||
44187241|NCT01644890|78982393|FG001|Overall Study|> 28 days since last dose of study drug|3|||
44187242|NCT01644890|78982392|FG000|Overall Study|Other|8|||
44187243|NCT01644890|78982393|FG001|Overall Study|Other|9|||
44187244|NCT01628965|78982399|FG000|Overall Study|Adverse Event|30|||
44187245|NCT01628965|78982399|FG000|Overall Study|Lack of Efficacy|7|||
44187246|NCT01628965|78982399|FG000|Overall Study|Withdrawal by Subject|3|||
44187247|NCT01628965|78982399|FG000|Overall Study|Lost to Follow-up|1|||
44187248|NCT01628965|78982399|FG000|Overall Study|Discontinuation criteria|8|||
44187249|NCT01644734|78982403|FG000|Overall Study|Adverse Event|4|||
44187250|NCT01644734|78982403|FG000|Overall Study|Lost to Follow-up|17|||
44187251|NCT01644734|78982403|FG000|Overall Study|Reasons other than stated above|7|||
44187252|NCT01644734|78982403|FG000|Overall Study|Missing documentation|238|||
44187253|NCT02255279|78982409|FG000|Overall Study|Lost to Follow-up|2|||
44187254|NCT02255279|78982410|FG001|Overall Study|Lost to Follow-up|2|||
44187255|NCT02255279|78982409|FG000|Overall Study|Protocol Violation|0|||
44187256|NCT02255279|78982410|FG001|Overall Study|Protocol Violation|1|||
44187257|NCT02255279|78982409|FG000|Overall Study|Withdrawal by Subject|3|||
44187258|NCT02255279|78982410|FG001|Overall Study|Withdrawal by Subject|6|||
44187259|NCT01643798|78982430|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
44187260|NCT01643798|78982431|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
44187261|NCT02194699|78982444|FG000|Randomised|Did not receive treatment|1|||
44187262|NCT02194699|78982445|FG001|Randomised|Did not receive treatment|5|||
44187263|NCT02194699|78982444|FG000|Randomised|Without potential for 52 weeks of IP|5|||
44187264|NCT02194699|78982445|FG001|Randomised|Without potential for 52 weeks of IP|5|||
44187265|NCT02194699|78982444|FG000|Randomised|Duplicate patient|2|||
44187266|NCT02194699|78982445|FG001|Randomised|Duplicate patient|1|||
44187267|NCT02194699|78982444|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
44187268|NCT02194699|78982445|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
44187269|NCT02194699|78982444|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
44187270|NCT02194699|78982445|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
44187271|NCT02194699|78982444|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
44187272|NCT02194699|78982445|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
44187273|NCT02194699|78982444|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
44187274|NCT02194699|78982445|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
44187275|NCT02194699|78982444|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
44187276|NCT02194699|78982445|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
44187277|NCT02194699|78982444|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
44187278|NCT02194699|78982445|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
44187279|NCT02293538|78982461|FG000|Overall Study|Adverse Event|0|||
44187280|NCT02293538|78982462|FG001|Overall Study|Adverse Event|1|||
44187281|NCT02293538|78982461|FG000|Overall Study|Lost to Follow-up|1|||
44187282|NCT02293538|78982462|FG001|Overall Study|Lost to Follow-up|0|||
44187283|NCT02293538|78982461|FG000|Overall Study|Withdrawal by Subject|0|||
44187284|NCT02293538|78982462|FG001|Overall Study|Withdrawal by Subject|1|||
44187285|NCT02194621|78982472|FG000|Overall Study|6 withdrew prior to randomization|2|||
44187286|NCT02194621|78982473|FG001|Overall Study|6 withdrew prior to randomization|2|||
44187287|NCT02194621|78982474|FG002|Overall Study|6 withdrew prior to randomization|2|||
44265864|NCT02439216|79171241|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44187288|NCT02194621|78982472|FG000|Overall Study|Withdrawal by Subject|4|||
44187289|NCT02194621|78982473|FG001|Overall Study|Withdrawal by Subject|4|||
44187290|NCT02194621|78982474|FG002|Overall Study|Withdrawal by Subject|7|||
44187291|NCT02220205|78982484|FG000|Overall Study|Withdrawal by Subject|1|||
44265865|NCT02439216|79171242|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
44265866|NCT02439216|79171243|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
44451342|NCT00098293|79460286|FG001|Open-label (OL) Phase|Adverse Event|3|||
44543039|NCT03655717|79555916|FG016|Overall Study|Lost to Follow-up|0|||
44187292|NCT02220205|78982485|FG001|Overall Study|Withdrawal by Subject|0|||
44187293|NCT02266706|78982500|FG000|Overall Study|Withdrawal by Subject|0|||
44187294|NCT02266706|78982501|FG001|Overall Study|Withdrawal by Subject|1|||
44187295|NCT02266706|78982502|FG002|Overall Study|Withdrawal by Subject|1|||
44187296|NCT02266706|78982503|FG003|Overall Study|Withdrawal by Subject|0|||
44187297|NCT02266706|78982504|FG004|Overall Study|Withdrawal by Subject|0|||
44187298|NCT02266706|78982505|FG005|Overall Study|Withdrawal by Subject|1|||
44187299|NCT02266706|78982506|FG006|Overall Study|Withdrawal by Subject|0|||
44187300|NCT02266706|78982507|FG007|Overall Study|Withdrawal by Subject|0|||
44187301|NCT02266706|78982508|FG008|Overall Study|Withdrawal by Subject|0|||
44187302|NCT02266706|78982500|FG000|Overall Study|Screen failure|0|||
44187303|NCT02266706|78982501|FG001|Overall Study|Screen failure|0|||
44187304|NCT02266706|78982502|FG002|Overall Study|Screen failure|0|||
44187305|NCT02266706|78982503|FG003|Overall Study|Screen failure|0|||
44187306|NCT02266706|78982504|FG004|Overall Study|Screen failure|0|||
44187307|NCT02266706|78982505|FG005|Overall Study|Screen failure|1|||
44187308|NCT02266706|78982506|FG006|Overall Study|Screen failure|1|||
44187309|NCT02266706|78982507|FG007|Overall Study|Screen failure|0|||
44187310|NCT02266706|78982508|FG008|Overall Study|Screen failure|0|||
44187311|NCT02266706|78982500|FG000|Overall Study|Enrollment in another study|0|||
44187312|NCT02266706|78982501|FG001|Overall Study|Enrollment in another study|0|||
44187313|NCT02266706|78982502|FG002|Overall Study|Enrollment in another study|0|||
44187314|NCT02266706|78982503|FG003|Overall Study|Enrollment in another study|1|||
44187315|NCT02266706|78982504|FG004|Overall Study|Enrollment in another study|0|||
44187316|NCT02266706|78982505|FG005|Overall Study|Enrollment in another study|0|||
44187317|NCT02266706|78982506|FG006|Overall Study|Enrollment in another study|0|||
44187318|NCT02266706|78982507|FG007|Overall Study|Enrollment in another study|0|||
44187319|NCT02266706|78982508|FG008|Overall Study|Enrollment in another study|0|||
44187320|NCT02293460|78982528|FG000|Overall Study|Protocol Violation|1|||
44187321|NCT02293460|78982528|FG000|Overall Study|Lack of Efficacy|2|||
44187322|NCT02293460|78982528|FG000|Overall Study|Adverse Event|2|||
44187323|NCT02293460|78982528|FG000|Overall Study|Withdrawal by Subject|1|||
44187324|NCT02266004|78982532|FG000|Overall Study|unrelated adverse event|1|||
44187325|NCT02266004|78982532|FG000|Overall Study|Physician Decision|1|||
44187326|NCT02292719|78982542|FG000|Overall Study|Withdrawal by Subject|0|||
44187327|NCT02292719|78982543|FG001|Overall Study|Withdrawal by Subject|0|||
44187328|NCT02292719|78982544|FG002|Overall Study|Withdrawal by Subject|0|||
44187329|NCT02292719|78982545|FG003|Overall Study|Withdrawal by Subject|1|||
44187330|NCT02292719|78982546|FG004|Overall Study|Withdrawal by Subject|1|||
44187331|NCT02292719|78982547|FG005|Overall Study|Withdrawal by Subject|0|||
44187332|NCT02292719|78982542|FG000|Overall Study|Subject enrolled in new study.|0|||
44187333|NCT02292719|78982543|FG001|Overall Study|Subject enrolled in new study.|0|||
44187334|NCT02292719|78982544|FG002|Overall Study|Subject enrolled in new study.|1|||
44187335|NCT02292719|78982545|FG003|Overall Study|Subject enrolled in new study.|0|||
44187336|NCT02292719|78982546|FG004|Overall Study|Subject enrolled in new study.|0|||
44187337|NCT02292719|78982547|FG005|Overall Study|Subject enrolled in new study.|0|||
44187338|NCT02291861|78982565|FG000|Overall Study|Adverse Event|2|||
44187339|NCT02291861|78982566|FG001|Overall Study|Adverse Event|4|||
44187340|NCT02291861|78982567|FG002|Overall Study|Adverse Event|1|||
44187341|NCT02291861|78982568|FG003|Overall Study|Adverse Event|2|||
44187342|NCT02291861|78982565|FG000|Overall Study|Death|0|||
44187343|NCT02291861|78982566|FG001|Overall Study|Death|0|||
44187344|NCT02291861|78982567|FG002|Overall Study|Death|1|||
44187345|NCT02291861|78982568|FG003|Overall Study|Death|1|||
44187346|NCT02291861|78982565|FG000|Overall Study|Protocol Violation|1|||
44187347|NCT02291861|78982566|FG001|Overall Study|Protocol Violation|0|||
44187348|NCT02291861|78982567|FG002|Overall Study|Protocol Violation|0|||
44187349|NCT02291861|78982568|FG003|Overall Study|Protocol Violation|1|||
44187350|NCT02291861|78982565|FG000|Overall Study|Withdrawal by Subject|1|||
44187351|NCT02291861|78982566|FG001|Overall Study|Withdrawal by Subject|2|||
44187352|NCT02291861|78982567|FG002|Overall Study|Withdrawal by Subject|1|||
44187353|NCT02291861|78982568|FG003|Overall Study|Withdrawal by Subject|4|||
44187354|NCT02291861|78982565|FG000|Overall Study|Noncompliance|1|||
44187355|NCT02291861|78982566|FG001|Overall Study|Noncompliance|1|||
44187356|NCT02291861|78982567|FG002|Overall Study|Noncompliance|2|||
44187357|NCT02291861|78982568|FG003|Overall Study|Noncompliance|1|||
44187358|NCT02291861|78982565|FG000|Overall Study|Lost to Follow-up|2|||
44187359|NCT02291861|78982566|FG001|Overall Study|Lost to Follow-up|1|||
44187360|NCT02291861|78982567|FG002|Overall Study|Lost to Follow-up|4|||
44187361|NCT02291861|78982568|FG003|Overall Study|Lost to Follow-up|0|||
44187362|NCT02291861|78982565|FG000|Overall Study|Other|0|||
44187363|NCT02291861|78982566|FG001|Overall Study|Other|0|||
44187364|NCT02291861|78982567|FG002|Overall Study|Other|0|||
44187365|NCT02291861|78982568|FG003|Overall Study|Other|1|||
44187366|NCT02291549|78982580|FG000|Overall Study|Lost to Follow-up|1|||
44187367|NCT02291549|78982581|FG001|Overall Study|Lost to Follow-up|0|||
44187368|NCT02291549|78982580|FG000|Overall Study|Withdrawal by Subject|0|||
44187369|NCT02291549|78982581|FG001|Overall Study|Withdrawal by Subject|1|||
44187370|NCT02264990|78982591|FG000|Overall Study|Death|255|||
44187371|NCT02264990|78982592|FG001|Overall Study|Death|250|||
44187372|NCT02264990|78982591|FG000|Overall Study|Withdrawal by Subject|4|||
44187373|NCT02264990|78982592|FG001|Overall Study|Withdrawal by Subject|5|||
44187374|NCT02264990|78982591|FG000|Overall Study|Lost to Follow-up|1|||
44187375|NCT02264990|78982592|FG001|Overall Study|Lost to Follow-up|3|||
44187376|NCT02264990|78982591|FG000|Overall Study|Other|0|||
44187377|NCT02264990|78982592|FG001|Overall Study|Other|1|||
44187378|NCT02291237|78982601|FG000|Overall Study|Study Terminated by Sponsor|72|||
44187379|NCT02291237|78982602|FG001|Overall Study|Study Terminated by Sponsor|67|||
44187380|NCT02291237|78982601|FG000|Overall Study|Adverse Event|1|||
44187381|NCT02291237|78982602|FG001|Overall Study|Adverse Event|3|||
44187382|NCT02291237|78982601|FG000|Overall Study|Investigator's Discretion|0|||
44187383|NCT02291237|78982602|FG001|Overall Study|Investigator's Discretion|3|||
44187384|NCT02291237|78982601|FG000|Overall Study|Withdrew Consent|11|||
44187385|NCT02291237|78982602|FG001|Overall Study|Withdrew Consent|11|||
44187386|NCT02291237|78982601|FG000|Overall Study|Lost to Follow-up|0|||
44187387|NCT02291237|78982602|FG001|Overall Study|Lost to Follow-up|2|||
44187388|NCT02291237|78982601|FG000|Overall Study|Subject Required Prohibited Medication|2|||
44187389|NCT02291237|78982602|FG001|Overall Study|Subject Required Prohibited Medication|0|||
44187390|NCT02292446|78982608|FG000|Overall Study|Adverse Event|12|||
44187391|NCT02292446|78982608|FG000|Overall Study|Death|1|||
44187392|NCT02292446|78982608|FG000|Overall Study|Disease progression|2|||
44187393|NCT02292446|78982608|FG000|Overall Study|Subject/guardian decision|2|||
44187394|NCT02292446|78982608|FG000|Overall Study|Withdrawal by Subject|3|||
44187395|NCT02290925|78982617|FG000|First Period of Three Months|Lost to Follow-up|2|||
44187396|NCT02290925|78982618|FG001|First Period of Three Months|Lost to Follow-up|1|||
44187397|NCT02290925|78982617|FG000|First Period of Three Months|Death|1|||
44187398|NCT02290925|78982618|FG001|First Period of Three Months|Death|0|||
44187399|NCT02290925|78982617|FG000|First Period of Three Months|Insulin Started|1|||
44187400|NCT02290925|78982618|FG001|First Period of Three Months|Insulin Started|1|||
44187401|NCT02290925|78982617|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
44187402|NCT02290925|78982618|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
44187403|NCT02290925|78982617|FG000|Second Period of 3 Months|insulin started|0|||
44187404|NCT02290925|78982618|FG001|Second Period of 3 Months|insulin started|1|||
44187405|NCT02290691|78982628|FG000|Overall Study|Noncompliance|0|||
44187406|NCT02290691|78982629|FG001|Overall Study|Noncompliance|1|||
44187407|NCT02290691|78982628|FG000|Overall Study|Withdrawal by Subject|1|||
44187408|NCT02290691|78982629|FG001|Overall Study|Withdrawal by Subject|1|||
44187409|NCT02290691|78982628|FG000|Overall Study|Lost to Follow-up|7|||
44187410|NCT02290691|78982629|FG001|Overall Study|Lost to Follow-up|7|||
44187411|NCT02292212|78982635|FG000|ViE Phase|Withdrawal by Subject|1|||
44187412|NCT02292212|78982635|FG000|ViE Phase|Protocol Violation|2|||
44187413|NCT02291510|78982650|FG000|Overall Study|Adverse Event|0|||
44187414|NCT02291510|78982651|FG001|Overall Study|Adverse Event|0|||
44187415|NCT02291510|78982652|FG002|Overall Study|Adverse Event|0|||
44187416|NCT02291510|78982653|FG003|Overall Study|Adverse Event|1|||
44187417|NCT02290223|78982665|FG000|6 Months|Lost to Follow-up|9|||
44187418|NCT02290223|78982666|FG001|6 Months|Lost to Follow-up|6|||
44187419|NCT02290223|78982665|FG000|6 Months|Withdrawal by Subject|5|||
44187420|NCT02290223|78982666|FG001|6 Months|Withdrawal by Subject|0|||
44187421|NCT02290223|78982665|FG000|6 Months|deceased (not related to study)|2|||
44187422|NCT02290223|78982666|FG001|6 Months|deceased (not related to study)|0|||
44187423|NCT02290223|78982665|FG000|12 Months|Lost to Follow-up|16|||
44187424|NCT02290223|78982666|FG001|12 Months|Lost to Follow-up|10|||
44187425|NCT02290223|78982665|FG000|12 Months|Refusal|0|||
44187426|NCT02290223|78982666|FG001|12 Months|Refusal|1|||
44187427|NCT02289833|78982674|FG000|Overall Study|Study discontinuation|0|||
44187428|NCT02289833|78982675|FG001|Overall Study|Study discontinuation|1|||
44187429|NCT02289833|78982674|FG000|Overall Study|Lost to Follow-up|4|||
44187430|NCT02289833|78982675|FG001|Overall Study|Lost to Follow-up|0|||
44187431|NCT02289833|78982674|FG000|Overall Study|Death|23|||
44187432|NCT02289833|78982675|FG001|Overall Study|Death|16|||
44187433|NCT01702558|78982688|FG000|Overall Study|Withdrawal by Subject|0|||
44187434|NCT01702558|78982689|FG001|Overall Study|Withdrawal by Subject|0|||
44187435|NCT01702558|78982690|FG002|Overall Study|Withdrawal by Subject|0|||
44187436|NCT01702558|78982691|FG003|Overall Study|Withdrawal by Subject|12|||
44187437|NCT01702558|78982692|FG004|Overall Study|Withdrawal by Subject|4|||
44187438|NCT01702558|78982688|FG000|Overall Study|Lost to Follow-up|0|||
44187439|NCT01702558|78982689|FG001|Overall Study|Lost to Follow-up|0|||
44187440|NCT01702558|78982690|FG002|Overall Study|Lost to Follow-up|0|||
44187441|NCT01702558|78982691|FG003|Overall Study|Lost to Follow-up|3|||
44187442|NCT01702558|78982692|FG004|Overall Study|Lost to Follow-up|0|||
44187443|NCT01702558|78982688|FG000|Overall Study|Death|4|||
44187444|NCT01702558|78982689|FG001|Overall Study|Death|3|||
44187445|NCT01702558|78982690|FG002|Overall Study|Death|3|||
44187446|NCT01702558|78982691|FG003|Overall Study|Death|16|||
44187447|NCT01702558|78982692|FG004|Overall Study|Death|20|||
44187448|NCT01702558|78982688|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
44187449|NCT01702558|78982689|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
44187450|NCT01702558|78982690|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
44187451|NCT01702558|78982691|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
44187452|NCT01702558|78982692|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
44187453|NCT01702558|78982688|FG000|Overall Study|Study Terminated by Sponsor|0|||
44187454|NCT01702558|78982689|FG001|Overall Study|Study Terminated by Sponsor|1|||
44187455|NCT01702558|78982690|FG002|Overall Study|Study Terminated by Sponsor|0|||
44187456|NCT01702558|78982691|FG003|Overall Study|Study Terminated by Sponsor|0|||
44187457|NCT01702558|78982692|FG004|Overall Study|Study Terminated by Sponsor|1|||
44187458|NCT01702558|78982688|FG000|Overall Study|Other|0|||
44187459|NCT01702558|78982689|FG001|Overall Study|Other|0|||
44187460|NCT01702558|78982690|FG002|Overall Study|Other|0|||
44187461|NCT01702558|78982691|FG003|Overall Study|Other|16|||
44187462|NCT01702558|78982692|FG004|Overall Study|Other|17|||
44187463|NCT02287883|78982707|FG000|Overall Study|Death|8|||
44187464|NCT02287883|78982708|FG001|Overall Study|Death|7|||
44187465|NCT02287883|78982707|FG000|Overall Study|No longer eligible|222|||
44187466|NCT02287883|78982708|FG001|Overall Study|No longer eligible|182|||
44187467|NCT02287883|78982707|FG000|Overall Study|Non-response to survey|229|||
44187468|NCT02287883|78982708|FG001|Overall Study|Non-response to survey|237|||
44187469|NCT01743040|78982714|FG000|Overall Study|Death|1|||
44187470|NCT01743040|78982714|FG000|Overall Study|Lost to Follow-up|66|||
44187471|NCT01743040|78982714|FG000|Overall Study|Physician Decision|40|||
44187472|NCT01743040|78982714|FG000|Overall Study|Protocol Violation|1|||
44187473|NCT01743040|78982714|FG000|Overall Study|Withdrawal by Subject|121|||
44187474|NCT02194465|78982725|FG000|Overall Study|Adverse Event|6|||
44187475|NCT02194465|78982726|FG001|Overall Study|Adverse Event|1|||
44187476|NCT02194465|78982727|FG002|Overall Study|Adverse Event|4|||
44187477|NCT02194465|78982728|FG003|Overall Study|Adverse Event|4|||
44187478|NCT02194465|78982729|FG004|Overall Study|Adverse Event|4|||
44187479|NCT02194465|78982730|FG005|Overall Study|Adverse Event|2|||
44187480|NCT02194465|78982731|FG006|Overall Study|Adverse Event|0|||
44187481|NCT02194465|78982725|FG000|Overall Study|Lost to Follow-up|0|||
44187482|NCT02194465|78982726|FG001|Overall Study|Lost to Follow-up|0|||
44187483|NCT02194465|78982727|FG002|Overall Study|Lost to Follow-up|0|||
44187484|NCT02194465|78982728|FG003|Overall Study|Lost to Follow-up|1|||
44187485|NCT02194465|78982729|FG004|Overall Study|Lost to Follow-up|0|||
44187486|NCT02194465|78982730|FG005|Overall Study|Lost to Follow-up|1|||
44187487|NCT02194465|78982731|FG006|Overall Study|Lost to Follow-up|0|||
44187488|NCT02194465|78982725|FG000|Overall Study|Physician Decision|1|||
44187489|NCT02194465|78982726|FG001|Overall Study|Physician Decision|0|||
44187490|NCT02194465|78982727|FG002|Overall Study|Physician Decision|0|||
44187491|NCT02194465|78982728|FG003|Overall Study|Physician Decision|0|||
44187492|NCT02194465|78982729|FG004|Overall Study|Physician Decision|0|||
44187493|NCT02194465|78982730|FG005|Overall Study|Physician Decision|0|||
44187494|NCT02194465|78982731|FG006|Overall Study|Physician Decision|0|||
44187495|NCT02194465|78982725|FG000|Overall Study|Protocol Violation|1|||
44187496|NCT02194465|78982726|FG001|Overall Study|Protocol Violation|1|||
44187497|NCT02194465|78982727|FG002|Overall Study|Protocol Violation|2|||
44187498|NCT02194465|78982728|FG003|Overall Study|Protocol Violation|1|||
44187499|NCT02194465|78982729|FG004|Overall Study|Protocol Violation|1|||
44187500|NCT02194465|78982730|FG005|Overall Study|Protocol Violation|0|||
44187501|NCT02194465|78982731|FG006|Overall Study|Protocol Violation|0|||
44187502|NCT02194465|78982725|FG000|Overall Study|Withdrawal by Subject|1|||
44187503|NCT02194465|78982726|FG001|Overall Study|Withdrawal by Subject|3|||
44187504|NCT02194465|78982727|FG002|Overall Study|Withdrawal by Subject|1|||
44187505|NCT02194465|78982728|FG003|Overall Study|Withdrawal by Subject|2|||
44265867|NCT02439216|79171235|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44265868|NCT02439216|79171236|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44265869|NCT02439216|79171237|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44265870|NCT02439216|79171238|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44265871|NCT02439216|79171239|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44187506|NCT02194465|78982729|FG004|Overall Study|Withdrawal by Subject|2|||
44187507|NCT02194465|78982730|FG005|Overall Study|Withdrawal by Subject|1|||
44187508|NCT02194465|78982731|FG006|Overall Study|Withdrawal by Subject|2|||
44187509|NCT02194465|78982725|FG000|Overall Study|Discontinued follow-up period|0|||
44187510|NCT02194465|78982726|FG001|Overall Study|Discontinued follow-up period|2|||
44187511|NCT02194465|78982727|FG002|Overall Study|Discontinued follow-up period|1|||
44187512|NCT02194465|78982728|FG003|Overall Study|Discontinued follow-up period|0|||
44187513|NCT02194465|78982729|FG004|Overall Study|Discontinued follow-up period|2|||
44187514|NCT02194465|78982730|FG005|Overall Study|Discontinued follow-up period|0|||
44187515|NCT02194465|78982731|FG006|Overall Study|Discontinued follow-up period|0|||
44187516|NCT02287025|78982753|FG000|Overall Study|Not treated|2|||
44187517|NCT02287025|78982754|FG001|Overall Study|Not treated|0|||
44187518|NCT02287025|78982753|FG000|Overall Study|Progression of disease|3|||
44187519|NCT02287025|78982754|FG001|Overall Study|Progression of disease|2|||
44187520|NCT02287025|78982753|FG000|Overall Study|Adverse Event|2|||
44187521|NCT02287025|78982754|FG001|Overall Study|Adverse Event|4|||
44187522|NCT02287025|78982753|FG000|Overall Study|Withdrawal by Subject|2|||
44187523|NCT02287025|78982754|FG001|Overall Study|Withdrawal by Subject|2|||
44187524|NCT02287025|78982753|FG000|Overall Study|Screening failed|1|||
44187525|NCT02287025|78982754|FG001|Overall Study|Screening failed|1|||
44187526|NCT01720264|78982758|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
44187527|NCT01720264|78982758|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
44187528|NCT01720264|78982758|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
44187529|NCT01702246|78982762|FG000|Overall Study|Lost to Follow-up|2|||
44187530|NCT01702246|78982762|FG000|Overall Study|Withdrawal by Subject|2|||
44187531|NCT01702246|78982762|FG000|Overall Study|Physician Decision|1|||
44265872|NCT02439216|79171240|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44265873|NCT02439216|79171241|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
44265874|NCT02439216|79171242|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
44265875|NCT02439216|79171243|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
44265876|NCT02439216|79171235|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44265877|NCT02439216|79171236|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44543040|NCT03655717|79555917|FG017|Overall Study|Lost to Follow-up|0|||
44265878|NCT02439216|79171237|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44265879|NCT02439216|79171238|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44265880|NCT02439216|79171239|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44265881|NCT02439216|79171240|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44265882|NCT02439216|79171241|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44187532|NCT01631227|78982771|FG000|Overall Study|withdrawn consent|27|||
44187533|NCT01631227|78982772|FG001|Overall Study|withdrawn consent|21|||
44187534|NCT01631227|78982771|FG000|Overall Study|Adverse Event|1|||
44187535|NCT01631227|78982772|FG001|Overall Study|Adverse Event|0|||
44187536|NCT01631227|78982771|FG000|Overall Study|administrative|2|||
44187537|NCT01631227|78982772|FG001|Overall Study|administrative|1|||
44187538|NCT01719172|78982778|FG000|Overall Study|Lost to Follow-up|1|||
44187539|NCT01719172|78982778|FG000|Overall Study|Death|1|||
44187540|NCT02286947|78982782|FG000|Overall Study|Withdrawal by Subject|2|||
44187541|NCT02286713|78982790|FG000|One Week Follow-Up|Death|1|||
44187542|NCT02286713|78982791|FG001|One Week Follow-Up|Death|0|||
44187543|NCT02286713|78982790|FG000|One Week Follow-Up|Lost to Follow-up|17|||
44187544|NCT02286713|78982791|FG001|One Week Follow-Up|Lost to Follow-up|21|||
44187545|NCT02286713|78982790|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
44265883|NCT02439216|79171242|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
44265884|NCT02439216|79171243|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
44265885|NCT02439216|79171235|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44265886|NCT02439216|79171236|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44265887|NCT02439216|79171237|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44265888|NCT02439216|79171238|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44265889|NCT02439216|79171239|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44265890|NCT02439216|79171240|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44187546|NCT02286713|78982791|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
44187547|NCT02286713|78982790|FG000|Three Month Follow-Up|Death|1|||
44187548|NCT02286713|78982791|FG001|Three Month Follow-Up|Death|1|||
44187549|NCT02286713|78982790|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
44187550|NCT02286713|78982791|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
44187551|NCT02286713|78982790|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
44187552|NCT02286713|78982791|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
44187553|NCT02286713|78982790|FG000|Six Month Follow-Up|Death|2|||
44187554|NCT02286713|78982791|FG001|Six Month Follow-Up|Death|0|||
44187555|NCT02286713|78982790|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
44187556|NCT02286713|78982791|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
44187557|NCT02285855|78982799|FG000|Overall Study|Withdrawal by Subject|2|||
44187558|NCT02285855|78982800|FG001|Overall Study|Withdrawal by Subject|1|||
44187559|NCT02285777|78982808|FG000|Overall Study|Withdrawal by Subject|1|||
44187560|NCT02285777|78982809|FG001|Overall Study|Withdrawal by Subject|1|||
44187561|NCT02285777|78982808|FG000|Overall Study|Lost to Follow-up|4|||
44187562|NCT02285777|78982809|FG001|Overall Study|Lost to Follow-up|2|||
44187563|NCT02285153|78982817|FG000|Overall Study|Adverse Event|1|||
44187564|NCT02285153|78982818|FG001|Overall Study|Adverse Event|0|||
44187565|NCT02284373|78982827|FG000|Overall Study|Withdrawal by Subject|0|||
44187566|NCT02284373|78982828|FG001|Overall Study|Withdrawal by Subject|1|||
44187567|NCT02284373|78982829|FG002|Overall Study|Withdrawal by Subject|0|||
44187568|NCT02284373|78982827|FG000|Overall Study|Other|0|||
44187569|NCT02284373|78982828|FG001|Overall Study|Other|1|||
44187570|NCT02284373|78982829|FG002|Overall Study|Other|0|||
44187571|NCT02284373|78982827|FG000|Overall Study|Lost to Follow-up|0|||
44187572|NCT02284373|78982828|FG001|Overall Study|Lost to Follow-up|1|||
44187573|NCT02284373|78982829|FG002|Overall Study|Lost to Follow-up|0|||
44187574|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
44187575|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
44265891|NCT02439216|79171241|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
44361234|NCT01185821|79366875|FG000|Overall Study|Withdrawal by Subject|3|||
44361235|NCT01185821|79366876|FG001|Overall Study|Withdrawal by Subject|2|||
44361236|NCT01185821|79366877|FG002|Overall Study|Withdrawal by Subject|2|||
44187576|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
44361237|NCT01185821|79366878|FG003|Overall Study|Withdrawal by Subject|1|||
44187577|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
44187578|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
44187579|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
44187580|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
44187581|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
44187582|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
44187583|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
44187584|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
44187585|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
44187586|NCT01632241|78982839|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
44187587|NCT01632241|78982840|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
44187588|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
44187589|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
44187590|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
44187591|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
44187592|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
44187593|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
44187594|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
44187595|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
44187596|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
44187597|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
44187598|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
44187599|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
44265892|NCT02439216|79171242|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
44265893|NCT02439216|79171243|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
44265894|NCT02439138|79171267|FG000|Overall Study|Adverse Event|1|||
44265895|NCT02439138|79171267|FG000|Overall Study|PI decision to terminate the study|2|||
44265896|NCT02438826|79171643|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
44265897|NCT02438826|79171644|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
44265898|NCT02438826|79171645|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
44265899|NCT02438826|79171646|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
44265900|NCT02438826|79171643|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
44265901|NCT02438826|79171644|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44265902|NCT02438826|79171645|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44187600|NCT01632241|78982839|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
44187601|NCT01632241|78982840|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
44187602|NCT02263508|78982855|FG000|Overall Study|Withdrawal by Subject|1|||
44187603|NCT02263508|78982856|FG001|Overall Study|Withdrawal by Subject|23|||
44187604|NCT02263508|78982857|FG002|Overall Study|Withdrawal by Subject|17|||
44187605|NCT02263508|78982855|FG000|Overall Study|Sponsor Decision|12|||
44187606|NCT02263508|78982856|FG001|Overall Study|Sponsor Decision|165|||
44187607|NCT02263508|78982857|FG002|Overall Study|Sponsor Decision|182|||
44187608|NCT02263508|78982855|FG000|Overall Study|Lost to Follow-up|2|||
44187609|NCT02263508|78982856|FG001|Overall Study|Lost to Follow-up|7|||
44187610|NCT02263508|78982857|FG002|Overall Study|Lost to Follow-up|7|||
44187611|NCT02263508|78982855|FG000|Overall Study|Death|6|||
44187612|NCT02263508|78982856|FG001|Overall Study|Death|151|||
44187613|NCT02263508|78982857|FG002|Overall Study|Death|140|||
44187614|NCT02291432|78982868|FG000|Overall Study|Withdrawal by Subject|2|||
44187615|NCT02290340|78982876|FG000|Overall Study|Lost to Follow-up|0|||
44187616|NCT02290340|78982877|FG001|Overall Study|Lost to Follow-up|0|||
44187617|NCT02290340|78982878|FG002|Overall Study|Lost to Follow-up|0|||
44187618|NCT02290340|78982879|FG003|Overall Study|Lost to Follow-up|1|||
44187619|NCT02290340|78982876|FG000|Overall Study|Withdrawal by Subject|1|||
44187620|NCT02290340|78982877|FG001|Overall Study|Withdrawal by Subject|0|||
44187621|NCT02290340|78982878|FG002|Overall Study|Withdrawal by Subject|0|||
44187622|NCT02290340|78982879|FG003|Overall Study|Withdrawal by Subject|0|||
44187623|NCT02290340|78982876|FG000|Overall Study|Other|1|||
44187624|NCT02290340|78982877|FG001|Overall Study|Other|0|||
44187625|NCT02290340|78982878|FG002|Overall Study|Other|0|||
44187626|NCT02290340|78982879|FG003|Overall Study|Other|1|||
44187627|NCT02290028|78982892|FG000|Overall Study|Death|217|||
44187628|NCT02290028|78982892|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
44187629|NCT02290028|78982892|FG000|Overall Study|No longer under care of study physician|76|||
44187630|NCT02290028|78982892|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
44187631|NCT02290028|78982892|FG000|Overall Study|Withdrawal by Subject|52|||
44265903|NCT02438826|79171646|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44265904|NCT02438826|79171643|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
44265905|NCT02438826|79171644|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
44265906|NCT02438826|79171645|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44265907|NCT02438826|79171646|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44265908|NCT02438826|79171643|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
44265909|NCT02438826|79171644|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
44187632|NCT02290028|78982892|FG000|Overall Study|Study site closure|44|||
44187633|NCT02290028|78982892|FG000|Overall Study|Lost to Follow-up|34|||
44187634|NCT02290028|78982892|FG000|Overall Study|Miscellaneous|10|||
44187635|NCT02290028|78982892|FG000|Overall Study|Transition to EP PASSION|1295|||
44187636|NCT02290028|78982892|FG000|Overall Study|Planned study completion at 12 months|257|||
44187637|NCT01741792|78982902|FG000|Overall Study|Death|6|||
44187638|NCT01741792|78982903|FG001|Overall Study|Death|1|||
44187639|NCT01741792|78982904|FG002|Overall Study|Death|12|||
44265910|NCT02438826|79171645|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
44265911|NCT02438826|79171646|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
44187640|NCT02289950|78982920|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
44187641|NCT02289950|78982921|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
44187642|NCT02289950|78982920|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
44187643|NCT02289950|78982921|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
44187644|NCT02289950|78982920|FG000|Overall Study|Lost to Follow-up|1|||
44187645|NCT02289950|78982921|FG001|Overall Study|Lost to Follow-up|0|||
44187646|NCT02289950|78982920|FG000|Overall Study|Physician Decision|9|||
44187647|NCT02289950|78982921|FG001|Overall Study|Physician Decision|3|||
44187648|NCT02289950|78982920|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
44187649|NCT02289950|78982921|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
44187650|NCT02289950|78982920|FG000|Overall Study|Withdrawal by Subject|1|||
44187651|NCT02289950|78982921|FG001|Overall Study|Withdrawal by Subject|3|||
44187652|NCT02289950|78982920|FG000|Overall Study|Test article held for greater than 28 days|0|||
44187653|NCT02289950|78982921|FG001|Overall Study|Test article held for greater than 28 days|1|||
44187654|NCT02289950|78982920|FG000|Overall Study|Adverse Event|11|||
44187655|NCT02289950|78982921|FG001|Overall Study|Adverse Event|3|||
44187656|NCT02289950|78982920|FG000|Overall Study|Death|1|||
44187657|NCT02289950|78982921|FG001|Overall Study|Death|1|||
44187658|NCT02289950|78982920|FG000|Overall Study|Other|5|||
44187659|NCT02289950|78982921|FG001|Overall Study|Other|2|||
44187660|NCT02289950|78982920|FG000|Overall Study|Not Treated|2|||
44187661|NCT02289950|78982921|FG001|Overall Study|Not Treated|1|||
44187662|NCT01741012|78982927|FG000|Overall Study|Lost to Follow-up|1|||
44361238|NCT01185821|79366879|FG004|Overall Study|Withdrawal by Subject|3|||
44361239|NCT01185821|79366875|FG000|Overall Study|Lost to Follow-up|1|||
44361240|NCT01185821|79366876|FG001|Overall Study|Lost to Follow-up|1|||
44187663|NCT01741012|78982927|FG000|Overall Study|Withdrawal by Subject|2|||
44187664|NCT02288312|78982935|FG000|Overall Study|Pregnancy|1|||
44187665|NCT02288312|78982936|FG001|Overall Study|Pregnancy|0|||
44187666|NCT02288312|78982937|FG002|Overall Study|Pregnancy|0|||
44187667|NCT01740388|78982947|FG000|Overall Study|Withdrawal by Subject|1|||
44187668|NCT01740388|78982948|FG001|Overall Study|Withdrawal by Subject|2|||
44187669|NCT01740388|78982947|FG000|Overall Study|Lost to Follow-up|2|||
44187670|NCT01740388|78982948|FG001|Overall Study|Lost to Follow-up|0|||
44187671|NCT01740388|78982947|FG000|Overall Study|Physician Decision|2|||
44187672|NCT01740388|78982948|FG001|Overall Study|Physician Decision|6|||
44187673|NCT01740388|78982947|FG000|Overall Study|Subjects missing data, completed|41|||
44187674|NCT01740388|78982948|FG001|Overall Study|Subjects missing data, completed|36|||
44187675|NCT01740154|78982954|FG000|Overall Study|Adverse Event|1|||
44187676|NCT02287922|78982962|FG000|Overall Study|Adverse Event|1|||
44187677|NCT02287922|78982963|FG001|Overall Study|Adverse Event|1|||
44187678|NCT02287922|78982964|FG002|Overall Study|Adverse Event|3|||
44187679|NCT02287922|78982965|FG003|Overall Study|Adverse Event|4|||
44187680|NCT02287922|78982962|FG000|Overall Study|Withdrawal by Subject|1|||
44187681|NCT02287922|78982963|FG001|Overall Study|Withdrawal by Subject|1|||
44187682|NCT02287922|78982964|FG002|Overall Study|Withdrawal by Subject|1|||
44187683|NCT02287922|78982965|FG003|Overall Study|Withdrawal by Subject|2|||
44187684|NCT02287922|78982962|FG000|Overall Study|Lost to Follow-up|0|||
44187685|NCT02287922|78982963|FG001|Overall Study|Lost to Follow-up|0|||
44187686|NCT02287922|78982964|FG002|Overall Study|Lost to Follow-up|1|||
44187687|NCT02287922|78982965|FG003|Overall Study|Lost to Follow-up|0|||
44187688|NCT02287922|78982962|FG000|Overall Study|Sponsor's decision|0|||
44187689|NCT02287922|78982963|FG001|Overall Study|Sponsor's decision|0|||
44187690|NCT02287922|78982964|FG002|Overall Study|Sponsor's decision|0|||
44187691|NCT02287922|78982965|FG003|Overall Study|Sponsor's decision|1|||
44187692|NCT02287922|78982962|FG000|Overall Study|Other|1|||
44187693|NCT02287922|78982963|FG001|Overall Study|Other|0|||
44187694|NCT02287922|78982964|FG002|Overall Study|Other|2|||
44187695|NCT02287922|78982965|FG003|Overall Study|Other|0|||
44187696|NCT02287610|78982976|FG000|Overall Study|Lost to Follow-up|3|||
44187697|NCT02287610|78982976|FG000|Overall Study|Withdrawal by Subject|8|||
44187698|NCT02287610|78982976|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
44187699|NCT02262728|78982982|FG000|Follow-up Phase (3 Years)|Death|0|||
44187700|NCT02262728|78982983|FG001|Follow-up Phase (3 Years)|Death|1|||
44187701|NCT02262728|78982982|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
44187702|NCT02262728|78982983|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
44187703|NCT02262728|78982982|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
44187704|NCT02262728|78982983|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
44187705|NCT02262260|78982991|FG000|Overall Study|Adverse Event|4|||
44187706|NCT02262260|78982992|FG001|Overall Study|Adverse Event|1|||
44187707|NCT02262260|78982991|FG000|Overall Study|Withdrawal of consent|4|||
44187708|NCT02262260|78982992|FG001|Overall Study|Withdrawal of consent|2|||
44187709|NCT02262260|78982991|FG000|Overall Study|Lost to Follow-up|1|||
44187710|NCT02262260|78982992|FG001|Overall Study|Lost to Follow-up|2|||
44187711|NCT02262260|78982991|FG000|Overall Study|Protocol deviation|2|||
44187712|NCT02262260|78982992|FG001|Overall Study|Protocol deviation|5|||
44187713|NCT02285270|78982998|FG000|Overall Study|Lost to Follow-up|1|||
44187714|NCT02285270|78982998|FG000|Overall Study|Physician Decision|3|||
44187715|NCT02285270|78982998|FG000|Overall Study|Determined to be ineligible|1|||
44187716|NCT01717768|78983012|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187717|NCT01717768|78983013|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
44187718|NCT01717768|78983014|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187719|NCT01717768|78983015|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187720|NCT01717768|78983016|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187721|NCT01717768|78983017|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187722|NCT01717768|78983018|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187723|NCT01717768|78983019|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187724|NCT01717768|78983020|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187725|NCT01717768|78983021|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187726|NCT01717768|78983022|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187727|NCT01717768|78983023|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
44187728|NCT01717768|78983012|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187729|NCT01717768|78983013|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187730|NCT01717768|78983014|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187731|NCT01717768|78983015|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187732|NCT01717768|78983016|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187733|NCT01717768|78983017|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187734|NCT01717768|78983018|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187735|NCT01717768|78983019|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187736|NCT01717768|78983020|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187737|NCT01717768|78983021|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187738|NCT01717768|78983022|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
44187739|NCT01717768|78983023|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
44361241|NCT01185821|79366877|FG002|Overall Study|Lost to Follow-up|2|||
44187740|NCT01717768|78983012|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187741|NCT01717768|78983013|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187742|NCT01717768|78983014|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187743|NCT01717768|78983015|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187744|NCT01717768|78983016|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187745|NCT01717768|78983017|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44265912|NCT02438826|79171643|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
44265913|NCT02438826|79171644|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
44265914|NCT02438826|79171645|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
44265915|NCT02438826|79171646|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
44265916|NCT02438826|79171643|FG000|Open-Label Treatment Phase|Adverse Event|11|||
44265917|NCT02438826|79171644|FG001|Open-Label Treatment Phase|Adverse Event|6|||
44265918|NCT02438826|79171645|FG002|Open-Label Treatment Phase|Adverse Event|0|||
44265919|NCT02438826|79171646|FG003|Open-Label Treatment Phase|Adverse Event|0|||
44265920|NCT02438826|79171643|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
44265921|NCT02438826|79171644|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
44265922|NCT02438826|79171645|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
44265923|NCT02438826|79171646|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
44265924|NCT02438826|79171643|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
44265925|NCT02438826|79171644|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
44265926|NCT02438826|79171645|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
44265927|NCT02438826|79171646|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
44265928|NCT02438826|79171643|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
44265929|NCT02438826|79171644|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
44265930|NCT02438826|79171645|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
44265931|NCT02438826|79171646|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
44265932|NCT02438826|79171643|FG000|Post-Treatment Phase|Adverse Event|3|||
44265933|NCT02438826|79171644|FG001|Post-Treatment Phase|Adverse Event|0|||
44265934|NCT02438826|79171645|FG002|Post-Treatment Phase|Adverse Event|0|||
44265935|NCT02438826|79171646|FG003|Post-Treatment Phase|Adverse Event|0|||
44451343|NCT00098293|79460287|FG002|Open-label (OL) Phase|Adverse Event|7|||
44451344|NCT00098293|79460288|FG003|Open-label (OL) Phase|Adverse Event|6|||
44451345|NCT00098293|79460289|FG004|Open-label (OL) Phase|Adverse Event|0|||
44451346|NCT00098293|79460285|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
44451347|NCT00098293|79460286|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
44451348|NCT00098293|79460287|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
44451349|NCT00098293|79460288|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
44451350|NCT00098293|79460289|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
44451351|NCT00098293|79460285|FG000|Open-label (OL) Phase|Pregnancy|0|||
44451352|NCT00098293|79460286|FG001|Open-label (OL) Phase|Pregnancy|1|||
44451353|NCT00098293|79460287|FG002|Open-label (OL) Phase|Pregnancy|0|||
44451354|NCT00098293|79460288|FG003|Open-label (OL) Phase|Pregnancy|3|||
44451355|NCT00098293|79460289|FG004|Open-label (OL) Phase|Pregnancy|0|||
44451356|NCT00098293|79460285|FG000|Open-label (OL) Phase|Protocol Violation|0|||
44451357|NCT00098293|79460286|FG001|Open-label (OL) Phase|Protocol Violation|6|||
44451358|NCT00098293|79460287|FG002|Open-label (OL) Phase|Protocol Violation|13|||
44451359|NCT00098293|79460288|FG003|Open-label (OL) Phase|Protocol Violation|16|||
44451360|NCT00098293|79460289|FG004|Open-label (OL) Phase|Protocol Violation|0|||
44451361|NCT00098293|79460285|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
44451362|NCT00098293|79460286|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
44451363|NCT00098293|79460287|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
44451364|NCT00098293|79460288|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
44451365|NCT00098293|79460289|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
44187746|NCT01717768|78983018|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44265936|NCT02438826|79171643|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
44265937|NCT02438826|79171644|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
44265938|NCT02438826|79171645|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
44265939|NCT02438826|79171646|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
44451366|NCT00098293|79460285|FG000|Open-label (OL) Phase|Death|0|||
44451367|NCT00098293|79460286|FG001|Open-label (OL) Phase|Death|2|||
44451368|NCT00098293|79460287|FG002|Open-label (OL) Phase|Death|3|||
44451369|NCT00098293|79460288|FG003|Open-label (OL) Phase|Death|0|||
44451370|NCT00098293|79460289|FG004|Open-label (OL) Phase|Death|0|||
44451371|NCT00098293|79460285|FG000|Supplemental Phase (SP)|Death|0|||
44451372|NCT00098293|79460286|FG001|Supplemental Phase (SP)|Death|0|||
44451373|NCT00098293|79460287|FG002|Supplemental Phase (SP)|Death|0|||
44451374|NCT00098293|79460288|FG003|Supplemental Phase (SP)|Death|0|||
44451375|NCT00098293|79460289|FG004|Supplemental Phase (SP)|Death|1|||
44451376|NCT00098293|79460285|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
44187747|NCT01717768|78983019|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
44187748|NCT01717768|78983020|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187749|NCT01717768|78983021|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187750|NCT01717768|78983022|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187751|NCT01717768|78983023|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
44187752|NCT01717768|78983012|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187753|NCT01717768|78983013|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187754|NCT01717768|78983014|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187755|NCT01717768|78983015|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187756|NCT01717768|78983016|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187757|NCT01717768|78983017|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187758|NCT01717768|78983018|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187759|NCT01717768|78983019|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187760|NCT01717768|78983020|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44451377|NCT00098293|79460286|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
44451378|NCT00098293|79460287|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
44187761|NCT01717768|78983021|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
44187762|NCT01717768|78983022|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187763|NCT01717768|78983023|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
44187764|NCT02260934|78983051|FG000|Overall Study|Lost to Follow-up|2|||
44187765|NCT02260934|78983052|FG001|Overall Study|Lost to Follow-up|1|||
44187766|NCT02260934|78983051|FG000|Overall Study|Withdrawal by Subject|0|||
44187767|NCT02260934|78983052|FG001|Overall Study|Withdrawal by Subject|2|||
44187768|NCT02260934|78983051|FG000|Overall Study|Participant Relocated|1|||
44187769|NCT02260934|78983052|FG001|Overall Study|Participant Relocated|0|||
44187770|NCT02260934|78983051|FG000|Overall Study|Site error|0|||
44187771|NCT02260934|78983052|FG001|Overall Study|Site error|1|||
44187772|NCT02260388|78983069|FG000|Overall Study|Lost to Follow-up|2|||
44187773|NCT02260388|78983070|FG001|Overall Study|Lost to Follow-up|8|||
44187774|NCT02260388|78983071|FG002|Overall Study|Lost to Follow-up|3|||
44187775|NCT02260388|78983072|FG003|Overall Study|Lost to Follow-up|4|||
44187776|NCT02260154|78983082|FG000|Overall Study|Screening failure|2|||
44187777|NCT02284178|78983089|FG000|Overall Study|Met exclusion criteria|49|||
44187778|NCT02284178|78983090|FG001|Overall Study|Met exclusion criteria|54|||
44187779|NCT01643408|78983096|FG000|Overall Study|Adverse Event|12|||
44187780|NCT01643408|78983096|FG000|Overall Study|Other|2|||
44187781|NCT02283788|78983104|FG000|Overall Study|Adverse Event|1|||
44187782|NCT02283788|78983105|FG001|Overall Study|Adverse Event|3|||
44187783|NCT02283788|78983106|FG002|Overall Study|Adverse Event|5|||
44187784|NCT02283788|78983107|FG003|Overall Study|Adverse Event|1|||
44187785|NCT02283788|78983104|FG000|Overall Study|Withdrawal by Subject|0|||
44187786|NCT02283788|78983105|FG001|Overall Study|Withdrawal by Subject|1|||
44187787|NCT02283788|78983106|FG002|Overall Study|Withdrawal by Subject|0|||
44187788|NCT02283788|78983107|FG003|Overall Study|Withdrawal by Subject|1|||
44187789|NCT01739764|78983120|FG000|Overall Study|Adverse Event|0|||
44187790|NCT01739764|78983121|FG001|Overall Study|Adverse Event|3|||
44187791|NCT01739764|78983122|FG002|Overall Study|Adverse Event|4|||
44187792|NCT01739764|78983120|FG000|Overall Study|Death|4|||
44187793|NCT01739764|78983121|FG001|Overall Study|Death|6|||
44187794|NCT01739764|78983122|FG002|Overall Study|Death|38|||
44187795|NCT01739764|78983120|FG000|Overall Study|Lost to Follow-up|0|||
44187796|NCT01739764|78983121|FG001|Overall Study|Lost to Follow-up|0|||
44187797|NCT01739764|78983122|FG002|Overall Study|Lost to Follow-up|5|||
44187798|NCT01739764|78983120|FG000|Overall Study|Non-Compliance|0|||
44187799|NCT01739764|78983121|FG001|Overall Study|Non-Compliance|0|||
44187800|NCT01739764|78983122|FG002|Overall Study|Non-Compliance|1|||
44187801|NCT01739764|78983120|FG000|Overall Study|Multiple Reasons|3|||
44187802|NCT01739764|78983121|FG001|Overall Study|Multiple Reasons|2|||
44187803|NCT01739764|78983122|FG002|Overall Study|Multiple Reasons|3|||
44187804|NCT01739764|78983120|FG000|Overall Study|Physician Decision|2|||
44187805|NCT01739764|78983121|FG001|Overall Study|Physician Decision|2|||
44187806|NCT01739764|78983122|FG002|Overall Study|Physician Decision|4|||
44187807|NCT01739764|78983120|FG000|Overall Study|Progressive Disease|3|||
44187808|NCT01739764|78983121|FG001|Overall Study|Progressive Disease|5|||
44451379|NCT00098293|79460288|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
44451380|NCT00098293|79460289|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
44451381|NCT00098293|79460285|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
44187809|NCT01739764|78983122|FG002|Overall Study|Progressive Disease|16|||
44187810|NCT01739764|78983120|FG000|Overall Study|Protocol Violation|0|||
44187811|NCT01739764|78983121|FG001|Overall Study|Protocol Violation|0|||
44187812|NCT01739764|78983122|FG002|Overall Study|Protocol Violation|2|||
44187813|NCT01739764|78983120|FG000|Overall Study|Study Terminated by Sponsor|8|||
44187814|NCT01739764|78983121|FG001|Overall Study|Study Terminated by Sponsor|13|||
44187815|NCT01739764|78983122|FG002|Overall Study|Study Terminated by Sponsor|26|||
44187816|NCT01739764|78983120|FG000|Overall Study|Withdrawal by Subject|6|||
44187817|NCT01739764|78983121|FG001|Overall Study|Withdrawal by Subject|5|||
44187818|NCT01739764|78983122|FG002|Overall Study|Withdrawal by Subject|27|||
44187819|NCT01700530|78983133|FG000|Overall Study|Withdrawal by Subject|0|||
44187820|NCT01700530|78983134|FG001|Overall Study|Withdrawal by Subject|3|||
44187821|NCT01700530|78983135|FG002|Overall Study|Withdrawal by Subject|1|||
44187822|NCT01700140|78983146|FG000|Overall Study|Use of rescue drugs|3|||
44187823|NCT01700140|78983147|FG001|Overall Study|Use of rescue drugs|3|||
44187824|NCT01700140|78983148|FG002|Overall Study|Use of rescue drugs|1|||
44187825|NCT01700140|78983146|FG000|Overall Study|Discontinuation of radiotherapy|1|||
44187826|NCT01700140|78983147|FG001|Overall Study|Discontinuation of radiotherapy|0|||
44187827|NCT01700140|78983148|FG002|Overall Study|Discontinuation of radiotherapy|0|||
44187828|NCT01700140|78983146|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
44187829|NCT01700140|78983147|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
44187830|NCT01700140|78983148|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
44187831|NCT01700140|78983146|FG000|Overall Study|Aggravation of symptoms|1|||
44187832|NCT01700140|78983147|FG001|Overall Study|Aggravation of symptoms|0|||
44187833|NCT01700140|78983148|FG002|Overall Study|Aggravation of symptoms|0|||
44187834|NCT01700140|78983146|FG000|Overall Study|Adverse Event|0|||
44187835|NCT01700140|78983147|FG001|Overall Study|Adverse Event|1|||
44187836|NCT01700140|78983148|FG002|Overall Study|Adverse Event|0|||
44187837|NCT01700140|78983146|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
44187838|NCT01700140|78983147|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
44187839|NCT01700140|78983148|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
44187840|NCT01717456|78983161|FG000|End of Treatment|Physician Decision|0|||
44187841|NCT01717456|78983162|FG001|End of Treatment|Physician Decision|1|||
44187842|NCT01717456|78983161|FG000|End of Treatment|Lost to Follow-up|0|||
44187843|NCT01717456|78983162|FG001|End of Treatment|Lost to Follow-up|1|||
44187844|NCT01717456|78983161|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
44187845|NCT01717456|78983162|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
44187846|NCT01699750|78983171|FG000|Overall Study|Withdrew Consent|0|||
44187847|NCT01699750|78983172|FG001|Overall Study|Withdrew Consent|1|||
44187848|NCT01699750|78983171|FG000|Overall Study|Other|0|||
44187849|NCT01699750|78983172|FG001|Overall Study|Other|2|||
44187850|NCT01716754|78983186|FG000|Overall Study|Death|0|||
44187851|NCT01716754|78983187|FG001|Overall Study|Death|0|||
44187852|NCT01716754|78983188|FG002|Overall Study|Death|0|||
44187853|NCT01716754|78983189|FG003|Overall Study|Death|1|||
44187854|NCT01716754|78983186|FG000|Overall Study|Protocol deviation|0|||
44187855|NCT01716754|78983187|FG001|Overall Study|Protocol deviation|2|||
44187856|NCT01716754|78983188|FG002|Overall Study|Protocol deviation|7|||
44187857|NCT01716754|78983189|FG003|Overall Study|Protocol deviation|2|||
44187858|NCT01716754|78983186|FG000|Overall Study|Non-compliance with study treatment|0|||
44187859|NCT01716754|78983187|FG001|Overall Study|Non-compliance with study treatment|0|||
44187860|NCT01716754|78983188|FG002|Overall Study|Non-compliance with study treatment|1|||
44187861|NCT01716754|78983189|FG003|Overall Study|Non-compliance with study treatment|0|||
44187862|NCT01716754|78983186|FG000|Overall Study|Physician Decision|1|||
44187863|NCT01716754|78983187|FG001|Overall Study|Physician Decision|0|||
44187864|NCT01716754|78983188|FG002|Overall Study|Physician Decision|0|||
44187865|NCT01716754|78983189|FG003|Overall Study|Physician Decision|0|||
44187866|NCT01716754|78983186|FG000|Overall Study|Lost to Follow-up|1|||
44187867|NCT01716754|78983187|FG001|Overall Study|Lost to Follow-up|0|||
44187868|NCT01716754|78983188|FG002|Overall Study|Lost to Follow-up|0|||
44187869|NCT01716754|78983189|FG003|Overall Study|Lost to Follow-up|1|||
44187870|NCT01716754|78983186|FG000|Overall Study|Adverse Event|4|||
44187871|NCT01716754|78983187|FG001|Overall Study|Adverse Event|2|||
44187872|NCT01716754|78983188|FG002|Overall Study|Adverse Event|2|||
44187873|NCT01716754|78983189|FG003|Overall Study|Adverse Event|1|||
44265940|NCT02438826|79171643|FG000|Post-Treatment Phase|Physician Decision|1|||
44187874|NCT01716754|78983186|FG000|Overall Study|Withdrawal by Subject|5|||
44187875|NCT01716754|78983187|FG001|Overall Study|Withdrawal by Subject|0|||
44187876|NCT01716754|78983188|FG002|Overall Study|Withdrawal by Subject|4|||
44187877|NCT01716754|78983189|FG003|Overall Study|Withdrawal by Subject|3|||
44187878|NCT01698814|78983200|FG000|Overall Study|Adverse Event|0|||
44187879|NCT01698814|78983201|FG001|Overall Study|Adverse Event|2|||
44187880|NCT01698814|78983200|FG000|Overall Study|Lost to Follow-up|0|||
44187881|NCT01698814|78983201|FG001|Overall Study|Lost to Follow-up|1|||
44187882|NCT01698814|78983200|FG000|Overall Study|Pregnancy|1|||
44187883|NCT01698814|78983201|FG001|Overall Study|Pregnancy|0|||
44187884|NCT01698814|78983200|FG000|Overall Study|Randomized in error|1|||
44187885|NCT01698814|78983201|FG001|Overall Study|Randomized in error|0|||
44187886|NCT01738984|78983209|FG000|Overall Study|Pregnancy|4|||
44187887|NCT01738984|78983210|FG001|Overall Study|Pregnancy|0|||
44187888|NCT01738984|78983209|FG000|Overall Study|Withdrawal by Subject|1|||
44187889|NCT01738984|78983210|FG001|Overall Study|Withdrawal by Subject|0|||
44187890|NCT01738984|78983209|FG000|Overall Study|Lost to Follow-up|59|||
44187891|NCT01738984|78983210|FG001|Overall Study|Lost to Follow-up|39|||
44187892|NCT01738594|78983219|FG000|Registration and Treatment Start|Adverse Event|0|||
44187893|NCT01738594|78983220|FG001|Registration and Treatment Start|Adverse Event|1|||
44187894|NCT01738594|78983221|FG002|Registration and Treatment Start|Adverse Event|0|||
44187895|NCT01738594|78983222|FG003|Registration and Treatment Start|Adverse Event|0|||
44187896|NCT01738594|78983223|FG004|Registration and Treatment Start|Adverse Event|0|||
44187897|NCT01738594|78983224|FG005|Registration and Treatment Start|Adverse Event|0|||
44187898|NCT01738594|78983225|FG006|Registration and Treatment Start|Adverse Event|0|||
44187899|NCT01738594|78983226|FG007|Registration and Treatment Start|Adverse Event|0|||
44187900|NCT01738594|78983219|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187901|NCT01738594|78983220|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187902|NCT01738594|78983221|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187903|NCT01738594|78983222|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187904|NCT01738594|78983223|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187905|NCT01738594|78983224|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
44187906|NCT01738594|78983225|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187907|NCT01738594|78983226|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
44187908|NCT01738594|78983219|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187909|NCT01738594|78983220|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
44187910|NCT01738594|78983221|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187911|NCT01738594|78983222|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187912|NCT01738594|78983223|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187913|NCT01738594|78983224|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187914|NCT01738594|78983225|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187915|NCT01738594|78983226|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
44187916|NCT01738594|78983219|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187917|NCT01738594|78983220|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187918|NCT01738594|78983221|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187919|NCT01738594|78983222|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187920|NCT01738594|78983223|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187921|NCT01738594|78983224|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
44187922|NCT01738594|78983225|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187923|NCT01738594|78983226|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
44187924|NCT01738594|78983219|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44187925|NCT01738594|78983220|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44187926|NCT01738594|78983221|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44187927|NCT01738594|78983222|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44187928|NCT01738594|78983223|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44187929|NCT01738594|78983224|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
44187930|NCT01738594|78983225|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44187931|NCT01738594|78983226|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
44451382|NCT00098293|79460286|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
44451383|NCT00098293|79460287|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
44187932|NCT01738594|78983219|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44187933|NCT01738594|78983220|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44187934|NCT01738594|78983221|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44187935|NCT01738594|78983222|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44187936|NCT01738594|78983223|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
44187937|NCT01738594|78983224|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44187938|NCT01738594|78983225|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44451384|NCT00098293|79460288|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
44187939|NCT01738594|78983226|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
44187940|NCT01738594|78983219|FG000|Follow up for 1 Year|Death|0|||
44187941|NCT01738594|78983220|FG001|Follow up for 1 Year|Death|0|||
44187942|NCT01738594|78983221|FG002|Follow up for 1 Year|Death|0|||
44187943|NCT01738594|78983222|FG003|Follow up for 1 Year|Death|0|||
44187944|NCT01738594|78983223|FG004|Follow up for 1 Year|Death|0|||
44187945|NCT01738594|78983224|FG005|Follow up for 1 Year|Death|1|||
44187946|NCT01738594|78983225|FG006|Follow up for 1 Year|Death|0|||
44187947|NCT01738594|78983226|FG007|Follow up for 1 Year|Death|0|||
44187948|NCT01738594|78983219|FG000|Follow up for 1 Year|Other|0|||
44187949|NCT01738594|78983220|FG001|Follow up for 1 Year|Other|0|||
44187950|NCT01738594|78983221|FG002|Follow up for 1 Year|Other|0|||
44187951|NCT01738594|78983222|FG003|Follow up for 1 Year|Other|0|||
44187952|NCT01738594|78983223|FG004|Follow up for 1 Year|Other|0|||
44187953|NCT01738594|78983224|FG005|Follow up for 1 Year|Other|2|||
44187954|NCT01738594|78983225|FG006|Follow up for 1 Year|Other|0|||
44187955|NCT01738594|78983226|FG007|Follow up for 1 Year|Other|0|||
44187956|NCT01738438|78983236|FG000|Overall Study|Disease Progression|32|||
44187957|NCT01738438|78983236|FG000|Overall Study|Adverse Event|3|||
44187958|NCT01716520|78983240|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
44187959|NCT01716520|78983241|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
44187960|NCT01716520|78983242|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
44187961|NCT01716520|78983243|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
44187962|NCT01716520|78983244|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
44187963|NCT01716520|78983245|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
44187964|NCT01716520|78983240|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
44187965|NCT01716520|78983241|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
44187966|NCT01716520|78983242|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
44187967|NCT01716520|78983243|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
44187968|NCT01716520|78983244|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
44187969|NCT01716520|78983245|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
44187970|NCT01716520|78983240|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44187971|NCT01716520|78983241|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44187972|NCT01716520|78983242|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44187973|NCT01716520|78983243|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44187974|NCT01716520|78983244|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44187975|NCT01716520|78983245|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44187976|NCT01716520|78983240|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
44187977|NCT01716520|78983241|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
44187978|NCT01716520|78983242|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
44187979|NCT01716520|78983243|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
44187980|NCT01716520|78983244|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
44187981|NCT01716520|78983245|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
44187982|NCT01716520|78983240|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44187983|NCT01716520|78983241|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44187984|NCT01716520|78983242|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44187985|NCT01716520|78983243|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44187986|NCT01716520|78983244|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44187987|NCT01716520|78983245|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
44187988|NCT01716520|78983240|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
44187989|NCT01716520|78983241|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
44187990|NCT01716520|78983242|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
44187991|NCT01716520|78983243|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
44187992|NCT01716520|78983244|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
44187993|NCT01716520|78983245|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
44187994|NCT01716520|78983240|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
44187995|NCT01716520|78983241|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
44187996|NCT01716520|78983242|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
44187997|NCT01716520|78983243|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
44187998|NCT01716520|78983244|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
44187999|NCT01716520|78983245|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
44188000|NCT01716520|78983240|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44188001|NCT01716520|78983241|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44188002|NCT01716520|78983242|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44188003|NCT01716520|78983243|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44188004|NCT01716520|78983244|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
44188005|NCT01716520|78983245|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44188006|NCT01716520|78983240|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
44188007|NCT01716520|78983241|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
44265941|NCT02438826|79171644|FG001|Post-Treatment Phase|Physician Decision|0|||
44361242|NCT01185821|79366878|FG003|Overall Study|Lost to Follow-up|1|||
44188008|NCT01716520|78983242|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
44188009|NCT01716520|78983243|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
44188010|NCT01716520|78983244|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
44188011|NCT01716520|78983245|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
44188012|NCT01716520|78983240|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
44188013|NCT01716520|78983241|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
44188014|NCT01716520|78983242|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
44188015|NCT01716520|78983243|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
44188016|NCT01716520|78983244|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
44188017|NCT01716520|78983245|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
44188018|NCT01716520|78983240|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
44188019|NCT01716520|78983241|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
44188020|NCT01716520|78983242|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
44188021|NCT01716520|78983243|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
44188022|NCT01716520|78983244|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
44188023|NCT01716520|78983245|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
44188024|NCT01716520|78983240|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
44188025|NCT01716520|78983241|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
44188026|NCT01716520|78983242|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
44188027|NCT01716520|78983243|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
44188028|NCT01716520|78983244|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
44188029|NCT01716520|78983245|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
44188030|NCT01716520|78983240|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
44188031|NCT01716520|78983241|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
44188032|NCT01716520|78983242|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
44188033|NCT01716520|78983243|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
44188034|NCT01716520|78983244|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
44188035|NCT01716520|78983245|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
44188036|NCT01716520|78983240|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44188037|NCT01716520|78983241|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44188038|NCT01716520|78983242|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44188039|NCT01716520|78983243|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44188040|NCT01716520|78983244|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44188041|NCT01716520|78983245|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
44188042|NCT01716520|78983240|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44188043|NCT01716520|78983241|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44188044|NCT01716520|78983242|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
44188045|NCT01716520|78983243|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44188046|NCT01716520|78983244|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44188047|NCT01716520|78983245|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44188048|NCT01698268|78983255|FG000|Overall Study|Physician Decision|2|||
44188049|NCT01698268|78983256|FG001|Overall Study|Physician Decision|1|||
44188050|NCT01697956|78983264|FG000|Overall Study|Protocol Violation|1|||
44188051|NCT01697956|78983265|FG001|Overall Study|Protocol Violation|1|||
44188052|NCT01697800|78983279|FG000|Overall Study|Death|0|||
44188053|NCT01697800|78983280|FG001|Overall Study|Death|1|||
44188054|NCT01644500|78983289|FG000|Overall Study|Adverse Event|6|||
44188055|NCT01644500|78983290|FG001|Overall Study|Adverse Event|1|||
44188056|NCT01644500|78983291|FG002|Overall Study|Adverse Event|2|||
44188057|NCT01644500|78983289|FG000|Overall Study|Death|0|||
44188058|NCT01644500|78983290|FG001|Overall Study|Death|1|||
44188059|NCT01644500|78983291|FG002|Overall Study|Death|0|||
44188060|NCT01644500|78983289|FG000|Overall Study|Lost to Follow-up|3|||
44188061|NCT01644500|78983290|FG001|Overall Study|Lost to Follow-up|8|||
44188062|NCT01644500|78983291|FG002|Overall Study|Lost to Follow-up|0|||
44188063|NCT01644500|78983289|FG000|Overall Study|Protocol Violation|1|||
44188064|NCT01644500|78983290|FG001|Overall Study|Protocol Violation|1|||
44188065|NCT01644500|78983291|FG002|Overall Study|Protocol Violation|0|||
44188066|NCT01644500|78983289|FG000|Overall Study|Withdrawal by Subject|11|||
44188067|NCT01644500|78983290|FG001|Overall Study|Withdrawal by Subject|12|||
44188068|NCT01644500|78983291|FG002|Overall Study|Withdrawal by Subject|12|||
44188069|NCT01644500|78983289|FG000|Overall Study|Physician Decision|1|||
44188070|NCT01644500|78983290|FG001|Overall Study|Physician Decision|1|||
44188071|NCT01644500|78983291|FG002|Overall Study|Physician Decision|1|||
44188072|NCT01604824|78983303|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
44188073|NCT01604824|78983304|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
44188074|NCT01604824|78983305|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
44188075|NCT01604824|78983306|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
44543041|NCT03655717|79555918|FG018|Overall Study|Lost to Follow-up|0|||
44265942|NCT02438826|79171645|FG002|Post-Treatment Phase|Physician Decision|0|||
44361243|NCT01185821|79366879|FG004|Overall Study|Lost to Follow-up|2|||
44188076|NCT01604824|78983307|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
44188077|NCT01604824|78983308|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
44188078|NCT01604824|78983303|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
44188079|NCT01604824|78983304|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
44188080|NCT01604824|78983305|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
44188081|NCT01604824|78983306|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
44188082|NCT01604824|78983307|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
44188083|NCT01604824|78983308|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
44188084|NCT01716052|78983322|FG000|Overall Study|Withdrawal of funding|1|||
44188085|NCT01716052|78983323|FG001|Overall Study|Withdrawal of funding|1|||
44188086|NCT01641692|78983329|FG000|Treatment Period 1|Adverse Event|1|||
44188087|NCT01641692|78983330|FG001|Treatment Period 1|Adverse Event|0|||
44188088|NCT01641692|78983331|FG002|Treatment Period 1|Adverse Event|0|||
44188089|NCT01641692|78983332|FG003|Treatment Period 1|Adverse Event|0|||
44188090|NCT01641692|78983333|FG004|Treatment Period 1|Adverse Event|0|||
44188091|NCT01641692|78983334|FG005|Treatment Period 1|Adverse Event|0|||
44188092|NCT01641692|78983335|FG006|Treatment Period 1|Adverse Event|0|||
44188093|NCT01641692|78983336|FG007|Treatment Period 1|Adverse Event|0|||
44188094|NCT01641692|78983329|FG000|Treatment Period 1|Lack of Efficacy|0|||
44188095|NCT01641692|78983330|FG001|Treatment Period 1|Lack of Efficacy|0|||
44188096|NCT01641692|78983331|FG002|Treatment Period 1|Lack of Efficacy|0|||
44188097|NCT01641692|78983332|FG003|Treatment Period 1|Lack of Efficacy|0|||
44188098|NCT01641692|78983333|FG004|Treatment Period 1|Lack of Efficacy|0|||
44188099|NCT01641692|78983334|FG005|Treatment Period 1|Lack of Efficacy|0|||
44188100|NCT01641692|78983335|FG006|Treatment Period 1|Lack of Efficacy|0|||
44188101|NCT01641692|78983336|FG007|Treatment Period 1|Lack of Efficacy|1|||
44188102|NCT01641692|78983329|FG000|Treatment Period 1|Protocol Violation|1|||
44188103|NCT01641692|78983330|FG001|Treatment Period 1|Protocol Violation|0|||
44188104|NCT01641692|78983331|FG002|Treatment Period 1|Protocol Violation|0|||
44188105|NCT01641692|78983332|FG003|Treatment Period 1|Protocol Violation|0|||
44188106|NCT01641692|78983333|FG004|Treatment Period 1|Protocol Violation|2|||
44188107|NCT01641692|78983334|FG005|Treatment Period 1|Protocol Violation|0|||
44188108|NCT01641692|78983335|FG006|Treatment Period 1|Protocol Violation|0|||
44188109|NCT01641692|78983336|FG007|Treatment Period 1|Protocol Violation|0|||
44188110|NCT01641692|78983329|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
44188111|NCT01641692|78983330|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
44188112|NCT01641692|78983331|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
44188113|NCT01641692|78983332|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
44188114|NCT01641692|78983333|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
44188115|NCT01641692|78983334|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
44188116|NCT01641692|78983335|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
44188117|NCT01641692|78983336|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
44188118|NCT01641692|78983329|FG000|Treatment Period 1|Lost to Follow-up|0|||
44188119|NCT01641692|78983330|FG001|Treatment Period 1|Lost to Follow-up|0|||
44188120|NCT01641692|78983331|FG002|Treatment Period 1|Lost to Follow-up|1|||
44188121|NCT01641692|78983332|FG003|Treatment Period 1|Lost to Follow-up|0|||
44188122|NCT01641692|78983333|FG004|Treatment Period 1|Lost to Follow-up|0|||
44188123|NCT01641692|78983334|FG005|Treatment Period 1|Lost to Follow-up|0|||
44188124|NCT01641692|78983335|FG006|Treatment Period 1|Lost to Follow-up|0|||
44188125|NCT01641692|78983336|FG007|Treatment Period 1|Lost to Follow-up|0|||
44188126|NCT01641692|78983329|FG000|Treatment Period 1|Physician Decision|0|||
44188127|NCT01641692|78983330|FG001|Treatment Period 1|Physician Decision|0|||
44188128|NCT01641692|78983331|FG002|Treatment Period 1|Physician Decision|0|||
44188129|NCT01641692|78983332|FG003|Treatment Period 1|Physician Decision|0|||
44188130|NCT01641692|78983333|FG004|Treatment Period 1|Physician Decision|1|||
44188131|NCT01641692|78983334|FG005|Treatment Period 1|Physician Decision|0|||
44188132|NCT01641692|78983335|FG006|Treatment Period 1|Physician Decision|0|||
44451385|NCT00098293|79460289|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
44451386|NCT00098293|79460285|FG000|Supplemental Phase (SP)|Other|0|||
44265943|NCT02438826|79171646|FG003|Post-Treatment Phase|Physician Decision|0|||
44188133|NCT01641692|78983336|FG007|Treatment Period 1|Physician Decision|0|||
44265944|NCT02438826|79171643|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
44188134|NCT01641692|78983329|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44188135|NCT01641692|78983330|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44188136|NCT01641692|78983331|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44188137|NCT01641692|78983332|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44188138|NCT01641692|78983333|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44188139|NCT01641692|78983334|FG005|Treatment Period 1|Withdrawal by Subject|2|||
44188140|NCT01641692|78983335|FG006|Treatment Period 1|Withdrawal by Subject|0|||
44188141|NCT01641692|78983336|FG007|Treatment Period 1|Withdrawal by Subject|1|||
44188142|NCT01641692|78983329|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
44188143|NCT01641692|78983330|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44451387|NCT00098293|79460286|FG001|Supplemental Phase (SP)|Other|0|||
44188144|NCT01641692|78983331|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44188145|NCT01641692|78983332|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44188146|NCT01641692|78983333|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44188147|NCT01641692|78983334|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44188148|NCT01641692|78983335|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44188149|NCT01641692|78983336|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
44188150|NCT01641692|78983329|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188151|NCT01641692|78983330|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188152|NCT01641692|78983331|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188153|NCT01641692|78983332|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188154|NCT01641692|78983333|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188155|NCT01641692|78983334|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188156|NCT01641692|78983335|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
44188157|NCT01641692|78983336|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44188158|NCT01641692|78983329|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
44188159|NCT01641692|78983330|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188160|NCT01641692|78983331|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
44188161|NCT01641692|78983332|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
44188162|NCT01641692|78983333|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
44188163|NCT01641692|78983334|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188164|NCT01641692|78983335|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188165|NCT01641692|78983336|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
44188166|NCT01641692|78983329|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
44188167|NCT01641692|78983330|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
44188168|NCT01641692|78983331|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44188169|NCT01641692|78983332|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
44188170|NCT01641692|78983333|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
44188171|NCT01641692|78983334|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44188172|NCT01641692|78983335|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
44188173|NCT01641692|78983336|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44188174|NCT01641692|78983329|FG000|Treatment Period 2|Lack of Efficacy|1|||
44188175|NCT01641692|78983330|FG001|Treatment Period 2|Lack of Efficacy|0|||
44188176|NCT01641692|78983331|FG002|Treatment Period 2|Lack of Efficacy|0|||
44188177|NCT01641692|78983332|FG003|Treatment Period 2|Lack of Efficacy|0|||
44188178|NCT01641692|78983333|FG004|Treatment Period 2|Lack of Efficacy|0|||
44188179|NCT01641692|78983334|FG005|Treatment Period 2|Lack of Efficacy|0|||
44188180|NCT01641692|78983335|FG006|Treatment Period 2|Lack of Efficacy|0|||
44188181|NCT01641692|78983336|FG007|Treatment Period 2|Lack of Efficacy|0|||
44188182|NCT01641692|78983329|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
44265945|NCT02438826|79171644|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
44265946|NCT02438826|79171645|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
44265947|NCT02438826|79171646|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
44265948|NCT02438280|79171663|FG000|Overall Study|Physician Decision|1|||
44265949|NCT02438280|79171664|FG001|Overall Study|Physician Decision|0|||
44265950|NCT02385708|79171682|FG000|Overall Study|Withdrawal by Subject|0|||
44188183|NCT01641692|78983330|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44265951|NCT02385708|79171683|FG001|Overall Study|Withdrawal by Subject|2|||
44265952|NCT02385708|79171682|FG000|Overall Study|Withdrawn - surgery canceled|2|||
44265953|NCT02385708|79171683|FG001|Overall Study|Withdrawn - surgery canceled|5|||
44265954|NCT02385708|79171682|FG000|Overall Study|Investigator decision|5|||
44265955|NCT02385708|79171683|FG001|Overall Study|Investigator decision|7|||
44265956|NCT02385708|79171682|FG000|Overall Study|Protocol Violation|1|||
44265957|NCT02385708|79171683|FG001|Overall Study|Protocol Violation|1|||
44265958|NCT02385084|79172422|FG000|Period 2|Protocol Violation|0|||
44265959|NCT02385084|79172423|FG001|Period 2|Protocol Violation|0|||
44265960|NCT02385084|79172424|FG002|Period 2|Protocol Violation|1|||
44265961|NCT02385084|79172425|FG003|Period 2|Protocol Violation|0|||
44265962|NCT02385084|79172426|FG004|Period 2|Protocol Violation|0|||
44265963|NCT02385084|79172427|FG005|Period 2|Protocol Violation|0|||
44265964|NCT02411292|79172436|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
44265965|NCT02411292|79172436|FG000|Overall Study|Death|2|||
44265966|NCT02411292|79172436|FG000|Overall Study|Lost to Follow-up|3|||
44265967|NCT02384850|79172499|FG000|Overall Study|Withdrawal by Subject|2|||
44265968|NCT02384850|79172500|FG001|Overall Study|Withdrawal by Subject|2|||
44265969|NCT02437890|79172722|FG000|Overall Study|Non-compliance to study drug|0|||
44265970|NCT02437890|79172723|FG001|Overall Study|Non-compliance to study drug|1|||
44265971|NCT02437890|79172724|FG002|Overall Study|Non-compliance to study drug|0|||
44265972|NCT02437890|79172725|FG003|Overall Study|Non-compliance to study drug|0|||
44265973|NCT02437890|79172726|FG004|Overall Study|Non-compliance to study drug|1|||
44265974|NCT02437890|79172722|FG000|Overall Study|Sponsor's decision|1|||
44265975|NCT02437890|79172723|FG001|Overall Study|Sponsor's decision|1|||
44265976|NCT02437890|79172724|FG002|Overall Study|Sponsor's decision|4|||
44265977|NCT02437890|79172725|FG003|Overall Study|Sponsor's decision|0|||
44265978|NCT02437890|79172726|FG004|Overall Study|Sponsor's decision|2|||
44188184|NCT01641692|78983331|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44188185|NCT01641692|78983332|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44188186|NCT01641692|78983333|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44188187|NCT01641692|78983334|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44188188|NCT01641692|78983335|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44188189|NCT01641692|78983336|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44188190|NCT01641692|78983329|FG000|Treatment Period 2|Lost to Follow-up|0|||
44188191|NCT01641692|78983330|FG001|Treatment Period 2|Lost to Follow-up|0|||
44188192|NCT01641692|78983331|FG002|Treatment Period 2|Lost to Follow-up|0|||
44188193|NCT01641692|78983332|FG003|Treatment Period 2|Lost to Follow-up|0|||
44188194|NCT01641692|78983333|FG004|Treatment Period 2|Lost to Follow-up|0|||
44188195|NCT01641692|78983334|FG005|Treatment Period 2|Lost to Follow-up|1|||
44188196|NCT01641692|78983335|FG006|Treatment Period 2|Lost to Follow-up|0|||
44188197|NCT01641692|78983336|FG007|Treatment Period 2|Lost to Follow-up|0|||
44188198|NCT01641692|78983329|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44188199|NCT01641692|78983330|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44188200|NCT01641692|78983331|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44188201|NCT01641692|78983332|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44188202|NCT01641692|78983333|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44188203|NCT01641692|78983334|FG005|Treatment Period 2|Withdrawal by Subject|1|||
44188204|NCT01641692|78983335|FG006|Treatment Period 2|Withdrawal by Subject|0|||
44188205|NCT01641692|78983336|FG007|Treatment Period 2|Withdrawal by Subject|1|||
44188206|NCT01641692|78983329|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188207|NCT01641692|78983330|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188208|NCT01641692|78983331|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188209|NCT01641692|78983332|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188210|NCT01641692|78983333|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
44188211|NCT01641692|78983334|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188212|NCT01641692|78983335|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
44188213|NCT01641692|78983336|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
44188214|NCT01641692|78983329|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44188215|NCT01641692|78983330|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44188216|NCT01641692|78983331|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
44188217|NCT01641692|78983332|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44188218|NCT01641692|78983333|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44188219|NCT01641692|78983334|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
44188220|NCT01641692|78983335|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44188221|NCT01641692|78983336|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
44188222|NCT01641692|78983329|FG000|Treatment Period 3|Adverse Event|0|||
44265979|NCT02437890|79172722|FG000|Overall Study|Physician Decision|0|||
44265980|NCT02437890|79172723|FG001|Overall Study|Physician Decision|0|||
44265981|NCT02437890|79172724|FG002|Overall Study|Physician Decision|0|||
44265982|NCT02437890|79172725|FG003|Overall Study|Physician Decision|1|||
44265983|NCT02437890|79172726|FG004|Overall Study|Physician Decision|0|||
44265984|NCT02437890|79172722|FG000|Overall Study|Unable to attend visit(s)|1|||
44265985|NCT02437890|79172723|FG001|Overall Study|Unable to attend visit(s)|0|||
44265986|NCT02437890|79172724|FG002|Overall Study|Unable to attend visit(s)|0|||
44265987|NCT02437890|79172725|FG003|Overall Study|Unable to attend visit(s)|0|||
44265988|NCT02437890|79172726|FG004|Overall Study|Unable to attend visit(s)|0|||
44265989|NCT02437890|79172722|FG000|Overall Study|Lack of Efficacy|1|||
44265990|NCT02437890|79172723|FG001|Overall Study|Lack of Efficacy|3|||
44265991|NCT02437890|79172724|FG002|Overall Study|Lack of Efficacy|0|||
44265992|NCT02437890|79172725|FG003|Overall Study|Lack of Efficacy|3|||
44265993|NCT02437890|79172726|FG004|Overall Study|Lack of Efficacy|1|||
44265994|NCT02437890|79172722|FG000|Overall Study|Adverse Event|4|||
44265995|NCT02437890|79172723|FG001|Overall Study|Adverse Event|9|||
44188223|NCT01641692|78983330|FG001|Treatment Period 3|Adverse Event|0|||
44188224|NCT01641692|78983331|FG002|Treatment Period 3|Adverse Event|0|||
44265996|NCT02437890|79172724|FG002|Overall Study|Adverse Event|5|||
44265997|NCT02437890|79172725|FG003|Overall Study|Adverse Event|11|||
44188225|NCT01641692|78983332|FG003|Treatment Period 3|Adverse Event|0|||
44188226|NCT01641692|78983333|FG004|Treatment Period 3|Adverse Event|0|||
44265998|NCT02437890|79172726|FG004|Overall Study|Adverse Event|7|||
44265999|NCT02437890|79172722|FG000|Overall Study|Withdrawal by Subject|1|||
44266000|NCT02437890|79172723|FG001|Overall Study|Withdrawal by Subject|2|||
44266001|NCT02437890|79172724|FG002|Overall Study|Withdrawal by Subject|6|||
44266002|NCT02437890|79172725|FG003|Overall Study|Withdrawal by Subject|5|||
44188227|NCT01641692|78983334|FG005|Treatment Period 3|Adverse Event|0|||
44188228|NCT01641692|78983335|FG006|Treatment Period 3|Adverse Event|1|||
44188229|NCT01641692|78983336|FG007|Treatment Period 3|Adverse Event|0|||
44188230|NCT01641692|78983329|FG000|Treatment Period 3|Protocol Violation|0|||
44188231|NCT01641692|78983330|FG001|Treatment Period 3|Protocol Violation|0|||
44188232|NCT01641692|78983331|FG002|Treatment Period 3|Protocol Violation|1|||
44188233|NCT01641692|78983332|FG003|Treatment Period 3|Protocol Violation|0|||
44188234|NCT01641692|78983333|FG004|Treatment Period 3|Protocol Violation|0|||
44188235|NCT01641692|78983334|FG005|Treatment Period 3|Protocol Violation|0|||
44188236|NCT01641692|78983335|FG006|Treatment Period 3|Protocol Violation|0|||
44188237|NCT01641692|78983336|FG007|Treatment Period 3|Protocol Violation|0|||
44188238|NCT01641692|78983329|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188239|NCT01641692|78983330|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188240|NCT01641692|78983331|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188241|NCT01641692|78983332|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188242|NCT01641692|78983333|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188243|NCT01641692|78983334|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188244|NCT01641692|78983335|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
44188245|NCT01641692|78983336|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44188246|NCT01641692|78983329|FG000|Treatment Period 3|Lost to Follow-up|0|||
44188247|NCT01641692|78983330|FG001|Treatment Period 3|Lost to Follow-up|1|||
44188248|NCT01641692|78983331|FG002|Treatment Period 3|Lost to Follow-up|0|||
44188249|NCT01641692|78983332|FG003|Treatment Period 3|Lost to Follow-up|0|||
44188250|NCT01641692|78983333|FG004|Treatment Period 3|Lost to Follow-up|0|||
44188251|NCT01641692|78983334|FG005|Treatment Period 3|Lost to Follow-up|0|||
44188252|NCT01641692|78983335|FG006|Treatment Period 3|Lost to Follow-up|0|||
44188253|NCT01641692|78983336|FG007|Treatment Period 3|Lost to Follow-up|0|||
44188254|NCT01641692|78983329|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188255|NCT01641692|78983330|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188256|NCT01641692|78983331|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188257|NCT01641692|78983332|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188258|NCT01641692|78983333|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188259|NCT01641692|78983334|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
44188260|NCT01641692|78983335|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188261|NCT01641692|78983336|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
44188262|NCT01641692|78983329|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
44188263|NCT01641692|78983330|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
44188264|NCT01641692|78983331|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
44188265|NCT01641692|78983332|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
44188266|NCT01641692|78983333|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
44188267|NCT01641692|78983334|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
44188268|NCT01641692|78983335|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
44188269|NCT01641692|78983336|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
44188270|NCT01682512|78983358|FG000|Overall Study|Adverse Event|6|||
44188271|NCT01682512|78983359|FG001|Overall Study|Adverse Event|5|||
44451388|NCT00098293|79460287|FG002|Supplemental Phase (SP)|Other|0|||
44188272|NCT01682512|78983360|FG002|Overall Study|Adverse Event|2|||
44188273|NCT01682512|78983358|FG000|Overall Study|Withdrawal by Subject|2|||
44188274|NCT01682512|78983359|FG001|Overall Study|Withdrawal by Subject|6|||
44188275|NCT01682512|78983360|FG002|Overall Study|Withdrawal by Subject|3|||
44188276|NCT01682512|78983358|FG000|Overall Study|Physician Decision|0|||
44188277|NCT01682512|78983359|FG001|Overall Study|Physician Decision|2|||
44188278|NCT01682512|78983360|FG002|Overall Study|Physician Decision|0|||
44188279|NCT01682512|78983358|FG000|Overall Study|Study terminated by sponsor|46|||
44188280|NCT01682512|78983359|FG001|Overall Study|Study terminated by sponsor|43|||
44188281|NCT01682512|78983360|FG002|Overall Study|Study terminated by sponsor|0|||
44188282|NCT01682512|78983358|FG000|Overall Study|Lost to Follow-up|3|||
44188283|NCT01682512|78983359|FG001|Overall Study|Lost to Follow-up|0|||
44188284|NCT01682512|78983360|FG002|Overall Study|Lost to Follow-up|2|||
44188285|NCT01682512|78983358|FG000|Overall Study|Protocol Violation|2|||
44188286|NCT01682512|78983359|FG001|Overall Study|Protocol Violation|3|||
44188287|NCT01682512|78983360|FG002|Overall Study|Protocol Violation|2|||
44188288|NCT01682512|78983358|FG000|Overall Study|Primary lack of efficacy|10|||
44188289|NCT01682512|78983359|FG001|Overall Study|Primary lack of efficacy|7|||
44188290|NCT01682512|78983360|FG002|Overall Study|Primary lack of efficacy|7|||
44188291|NCT01682512|78983358|FG000|Overall Study|Secondary lack of efficacy|1|||
44188292|NCT01682512|78983359|FG001|Overall Study|Secondary lack of efficacy|1|||
44188293|NCT01682512|78983360|FG002|Overall Study|Secondary lack of efficacy|0|||
44188294|NCT01682512|78983358|FG000|Overall Study|Other than stated above|2|||
44188295|NCT01682512|78983359|FG001|Overall Study|Other than stated above|4|||
44188296|NCT01682512|78983360|FG002|Overall Study|Other than stated above|2|||
44188297|NCT02256488|78983372|FG000|Overall Study|Lost to Follow-up|6|||
44188298|NCT02256488|78983373|FG001|Overall Study|Lost to Follow-up|6|||
44188299|NCT02256488|78983374|FG002|Overall Study|Lost to Follow-up|9|||
44188300|NCT02256488|78983375|FG003|Overall Study|Lost to Follow-up|3|||
44188301|NCT02256488|78983372|FG000|Overall Study|OTHER|1|||
44188302|NCT02256488|78983373|FG001|Overall Study|OTHER|0|||
44188303|NCT02256488|78983374|FG002|Overall Study|OTHER|1|||
44188304|NCT02256488|78983375|FG003|Overall Study|OTHER|1|||
44188305|NCT02256488|78983372|FG000|Overall Study|Withdrawal by Subject|1|||
44188306|NCT02256488|78983373|FG001|Overall Study|Withdrawal by Subject|0|||
44188307|NCT02256488|78983374|FG002|Overall Study|Withdrawal by Subject|0|||
44188308|NCT02256488|78983375|FG003|Overall Study|Withdrawal by Subject|2|||
44188309|NCT01715896|78983388|FG000|Overall Study|Lost to Follow-up|0|||
44188310|NCT01715896|78983389|FG001|Overall Study|Lost to Follow-up|2|||
44188311|NCT01715896|78983388|FG000|Overall Study|Withdrawal by Subject|1|||
44188312|NCT01715896|78983389|FG001|Overall Study|Withdrawal by Subject|4|||
44188313|NCT01715896|78983388|FG000|Overall Study|Other|2|||
44188314|NCT01715896|78983389|FG001|Overall Study|Other|5|||
44188315|NCT02255552|78983398|FG000|Overall Study|Participants enrolled into another study|0|||
44188316|NCT02255552|78983399|FG001|Overall Study|Participants enrolled into another study|11|||
44188317|NCT02255552|78983398|FG000|Overall Study|Withdrawal by Subject|1|||
44188318|NCT02255552|78983399|FG001|Overall Study|Withdrawal by Subject|4|||
44188319|NCT01714726|78983407|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
44188320|NCT01714726|78983408|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
44188321|NCT01714726|78983409|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
44188322|NCT01714726|78983410|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
44188323|NCT01714726|78983407|FG000|Double-Blinded Induction Period|Adverse Event|0|||
44188324|NCT01714726|78983408|FG001|Double-Blinded Induction Period|Adverse Event|1|||
44188325|NCT01714726|78983409|FG002|Double-Blinded Induction Period|Adverse Event|0|||
44188326|NCT01714726|78983410|FG003|Double-Blinded Induction Period|Adverse Event|0|||
44188327|NCT01714726|78983407|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
44188328|NCT01714726|78983408|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
44188329|NCT01714726|78983409|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
44188330|NCT01714726|78983410|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
44188331|NCT01714726|78983407|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
44188332|NCT01714726|78983408|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
44188333|NCT01714726|78983409|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
44188334|NCT01714726|78983410|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
44188335|NCT01714726|78983407|FG000|Open-Label Period|Other|0|||
44188336|NCT01714726|78983408|FG001|Open-Label Period|Other|0|||
44188337|NCT01714726|78983409|FG002|Open-Label Period|Other|1|||
44188338|NCT01714726|78983410|FG003|Open-Label Period|Other|3|||
44188339|NCT01714726|78983407|FG000|Open-Label Period|Adverse Event|0|||
44188340|NCT01714726|78983408|FG001|Open-Label Period|Adverse Event|0|||
44188341|NCT01714726|78983409|FG002|Open-Label Period|Adverse Event|1|||
44188342|NCT01714726|78983410|FG003|Open-Label Period|Adverse Event|0|||
44188343|NCT01714726|78983407|FG000|Open-Label Period|Withdrawal by Subject|0|||
44188344|NCT01714726|78983408|FG001|Open-Label Period|Withdrawal by Subject|0|||
44188345|NCT01714726|78983409|FG002|Open-Label Period|Withdrawal by Subject|9|||
44188346|NCT01714726|78983410|FG003|Open-Label Period|Withdrawal by Subject|19|||
44188347|NCT01714726|78983407|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
44188348|NCT01714726|78983408|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
44188349|NCT01714726|78983409|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
44188350|NCT01714726|78983410|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
44188351|NCT01714726|78983407|FG000|Open-Label Period|Lost to Follow-up|0|||
44188352|NCT01714726|78983408|FG001|Open-Label Period|Lost to Follow-up|0|||
44188353|NCT01714726|78983409|FG002|Open-Label Period|Lost to Follow-up|3|||
44188354|NCT01714726|78983410|FG003|Open-Label Period|Lost to Follow-up|4|||
44188355|NCT02255474|78983423|FG000|Overall Study|Lost to Follow-up|1|||
44188356|NCT02255474|78983424|FG001|Overall Study|Lost to Follow-up|1|||
44188357|NCT02255474|78983425|FG002|Overall Study|Lost to Follow-up|3|||
44188358|NCT02255474|78983423|FG000|Overall Study|Withdrawal by Subject|1|||
44188359|NCT02255474|78983424|FG001|Overall Study|Withdrawal by Subject|1|||
44188360|NCT02255474|78983425|FG002|Overall Study|Withdrawal by Subject|0|||
44188361|NCT02254772|78983434|FG000|Overall Study|Ineligible|1|||
44188362|NCT02254772|78983434|FG000|Overall Study|Withdrawal by Subject|1|||
44188363|NCT02254460|78983438|FG000|Overall Study|Adverse Event|1|||
44188364|NCT02254460|78983439|FG001|Overall Study|Adverse Event|0|||
44361244|NCT01185821|79366875|FG000|Overall Study|Administrative problems|0|||
44188365|NCT01682044|78983445|FG000|Overall Study|Death|1|||
44188366|NCT01682044|78983445|FG000|Overall Study|Progression|3|||
44188367|NCT01696942|78983451|FG000|Overall Study|Withdrawal by Subject|1|||
44188368|NCT01696942|78983452|FG001|Overall Study|Withdrawal by Subject|0|||
44188369|NCT01696942|78983451|FG000|Overall Study|Protocol Violation|1|||
44188370|NCT01696942|78983452|FG001|Overall Study|Protocol Violation|2|||
44188371|NCT01696942|78983451|FG000|Overall Study|screen failure|0|||
44188372|NCT01696942|78983452|FG001|Overall Study|screen failure|1|||
44188373|NCT01640366|78983458|FG000|Overall Study|Withdrawal by Subject|1|||
44188374|NCT01640366|78983458|FG000|Overall Study|Protocol Violation|16|||
44188375|NCT01640366|78983458|FG000|Overall Study|Lost to Follow-up|5|||
44188376|NCT01640288|78983466|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
44188377|NCT01640288|78983467|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
44188378|NCT01640288|78983466|FG000|Overall Study|Screen Failure|20|||
44188379|NCT01640288|78983467|FG001|Overall Study|Screen Failure|18|||
44188380|NCT01640288|78983466|FG000|Overall Study|Withdrawn by PI|5|||
44188381|NCT01640288|78983467|FG001|Overall Study|Withdrawn by PI|0|||
44188382|NCT01640288|78983466|FG000|Overall Study|Withdrawal by Subject|1|||
44188383|NCT01640288|78983467|FG001|Overall Study|Withdrawal by Subject|0|||
44188384|NCT01639040|78983476|FG000|Overall Study|Adverse Event|1|||
44188385|NCT01639040|78983477|FG001|Overall Study|Adverse Event|0|||
44188386|NCT01640054|78983486|FG000|Overall Study|Study-specific disc criteria|1|||
44188387|NCT01640054|78983486|FG000|Overall Study|Lack of Efficacy|3|||
44188388|NCT01640054|78983486|FG000|Overall Study|Adverse Event|2|||
44188389|NCT01600586|78983492|FG000|Overall Study|Physician Decision|3|||
44188390|NCT01600586|78983493|FG001|Overall Study|Physician Decision|3|||
44188391|NCT01639742|78983506|FG000|Overall Study|Study Ongoing|17|||
44188392|NCT01639742|78983506|FG000|Overall Study|Lost to Follow-up|1|||
44188393|NCT02164513|78983513|FG000|Overall Study|Adverse Event|162|||
44188394|NCT02164513|78983514|FG001|Overall Study|Adverse Event|180|||
44188395|NCT02164513|78983515|FG002|Overall Study|Adverse Event|111|||
44188396|NCT02164513|78983513|FG000|Overall Study|Other: Study Closed or terminated|5|||
44188397|NCT02164513|78983514|FG001|Overall Study|Other: Study Closed or terminated|2|||
44188398|NCT02164513|78983515|FG002|Overall Study|Other: Study Closed or terminated|4|||
44188399|NCT02164513|78983513|FG000|Overall Study|Lost to Follow-up|30|||
44188400|NCT02164513|78983514|FG001|Overall Study|Lost to Follow-up|36|||
44188401|NCT02164513|78983515|FG002|Overall Study|Lost to Follow-up|22|||
44188402|NCT02164513|78983513|FG000|Overall Study|Physician Decision|47|||
44188403|NCT02164513|78983514|FG001|Overall Study|Physician Decision|57|||
44188404|NCT02164513|78983515|FG002|Overall Study|Physician Decision|28|||
44188405|NCT02164513|78983513|FG000|Overall Study|Withdrawal by Subject|192|||
44188406|NCT02164513|78983514|FG001|Overall Study|Withdrawal by Subject|261|||
44188407|NCT02164513|78983515|FG002|Overall Study|Withdrawal by Subject|130|||
44188408|NCT02164513|78983513|FG000|Overall Study|Other: Reason not provided by site|1|||
44188409|NCT02164513|78983514|FG001|Overall Study|Other: Reason not provided by site|0|||
44188410|NCT02164513|78983515|FG002|Overall Study|Other: Reason not provided by site|0|||
44188411|NCT02218489|78983535|FG000|Overall Study|Withdrawal by Subject|4|||
44188412|NCT02218489|78983536|FG001|Overall Study|Withdrawal by Subject|3|||
44188413|NCT02218489|78983535|FG000|Overall Study|Lost to Follow-up|1|||
44188414|NCT02218489|78983536|FG001|Overall Study|Lost to Follow-up|0|||
44188415|NCT02192905|78983543|FG000|Overall Study|Lost to Follow-up|1|||
44188416|NCT01713946|78983551|FG000|Overall Study|Death|0|||
44188417|NCT01713946|78983552|FG001|Overall Study|Death|2|||
44188418|NCT01713946|78983553|FG002|Overall Study|Death|2|||
44188419|NCT01713946|78983551|FG000|Overall Study|Adverse Event|19|||
44188420|NCT01713946|78983552|FG001|Overall Study|Adverse Event|14|||
44188421|NCT01713946|78983553|FG002|Overall Study|Adverse Event|13|||
44188422|NCT01713946|78983551|FG000|Overall Study|Withdrawal by Subject|12|||
44188423|NCT01713946|78983552|FG001|Overall Study|Withdrawal by Subject|12|||
44188424|NCT01713946|78983553|FG002|Overall Study|Withdrawal by Subject|8|||
44188425|NCT01713946|78983551|FG000|Overall Study|Lack of Efficacy|8|||
44188426|NCT01713946|78983552|FG001|Overall Study|Lack of Efficacy|8|||
44188427|NCT01713946|78983553|FG002|Overall Study|Lack of Efficacy|14|||
44188428|NCT01713946|78983551|FG000|Overall Study|Protocol Violation|2|||
44188429|NCT01713946|78983552|FG001|Overall Study|Protocol Violation|4|||
44188430|NCT01713946|78983553|FG002|Overall Study|Protocol Violation|1|||
44188431|NCT01713946|78983551|FG000|Overall Study|Lost to Follow-up|0|||
44188432|NCT01713946|78983552|FG001|Overall Study|Lost to Follow-up|0|||
44188433|NCT01713946|78983553|FG002|Overall Study|Lost to Follow-up|1|||
44188434|NCT01713946|78983551|FG000|Overall Study|Administrative problems|1|||
44361245|NCT01185821|79366876|FG001|Overall Study|Administrative problems|0|||
44188435|NCT01713946|78983552|FG001|Overall Study|Administrative problems|0|||
44188436|NCT01713946|78983553|FG002|Overall Study|Administrative problems|0|||
44188437|NCT01713946|78983551|FG000|Overall Study|Did not continue in Ext|0|||
44361246|NCT01185821|79366877|FG002|Overall Study|Administrative problems|1|||
44188438|NCT01713946|78983552|FG001|Overall Study|Did not continue in Ext|3|||
44188439|NCT01713946|78983553|FG002|Overall Study|Did not continue in Ext|0|||
44188440|NCT01713946|78983551|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
44188441|NCT01713946|78983552|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
44188442|NCT01713946|78983553|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
44188443|NCT01713946|78983551|FG000|Overall Study|Patients never switched to everolimus|0|||
44188444|NCT01713946|78983552|FG001|Overall Study|Patients never switched to everolimus|0|||
44188445|NCT01713946|78983553|FG002|Overall Study|Patients never switched to everolimus|5|||
44188446|NCT02163499|78983579|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
44188447|NCT02163499|78983579|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
44188448|NCT02163499|78983579|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
44188449|NCT02163499|78983579|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
44188450|NCT02163499|78983579|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
44188451|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
44188452|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
44188453|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
44188454|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
44188455|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
44188456|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
44188457|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
44188458|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
44188459|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
44188460|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Death|8|||
44188461|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
44188462|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
44188463|NCT02163499|78983579|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
44188464|NCT02163187|78983589|FG000|Overall Study|Device removed|1|||
44188465|NCT02163187|78983590|FG001|Overall Study|Device removed|0|||
44188466|NCT02163187|78983589|FG000|Overall Study|Progressive disease|1|||
44188467|NCT02163187|78983590|FG001|Overall Study|Progressive disease|0|||
44188468|NCT02191579|78983598|FG000|Treatment 1|Multiple Reasons Specified|27|||
44188469|NCT02191579|78983599|FG001|Treatment 1|Multiple Reasons Specified|58|||
44188470|NCT02191579|78983598|FG000|Treatment 2|Multiple Reasons Specified|0|||
44188471|NCT02191579|78983599|FG001|Treatment 2|Multiple Reasons Specified|25|||
44188472|NCT01363700|78983608|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
44188473|NCT01363700|78983609|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
44188474|NCT01363700|78983610|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
44188475|NCT01363700|78983611|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
44188476|NCT01363700|78983612|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
44188477|NCT01637402|78983623|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
44188478|NCT01637402|78983624|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
44188479|NCT01637402|78983623|FG000|Standard Dose Regimen|Adverse Event|1|||
44188480|NCT01637402|78983624|FG001|Standard Dose Regimen|Adverse Event|0|||
44188481|NCT01637402|78983623|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
44188482|NCT01637402|78983624|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
44188483|NCT01637402|78983623|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
44188484|NCT01637402|78983624|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
44188485|NCT01637402|78983623|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
44188486|NCT01637402|78983624|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
44188487|NCT01637402|78983623|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
44188488|NCT01637402|78983624|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
44188489|NCT02217475|78983652|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
44188490|NCT02217475|78983653|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
44188491|NCT02217475|78983654|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
44188492|NCT02217475|78983652|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
44188493|NCT02217475|78983653|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
44188494|NCT02217475|78983654|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
44188495|NCT02217475|78983652|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
44188496|NCT02217475|78983653|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
44188497|NCT02217475|78983654|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
44188498|NCT02217475|78983652|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
44188499|NCT02217475|78983653|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
44188500|NCT02217475|78983654|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
44188501|NCT02217475|78983652|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
44188502|NCT02217475|78983653|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
44188503|NCT02217475|78983654|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
44188504|NCT02217475|78983652|FG000|Discontinued After Period 1|Adverse Event|1|||
44188505|NCT02217475|78983653|FG001|Discontinued After Period 1|Adverse Event|2|||
44188506|NCT02217475|78983654|FG002|Discontinued After Period 1|Adverse Event|0|||
44188507|NCT02217475|78983652|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
44188508|NCT02217475|78983653|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
44188509|NCT02217475|78983654|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
44266003|NCT02437890|79172726|FG004|Overall Study|Withdrawal by Subject|5|||
44188510|NCT02217475|78983652|FG000|Discontinued After Period 1|Physician Decision|0|||
44188511|NCT02217475|78983653|FG001|Discontinued After Period 1|Physician Decision|0|||
44188512|NCT02217475|78983654|FG002|Discontinued After Period 1|Physician Decision|1|||
44188513|NCT02217475|78983652|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
44188514|NCT02217475|78983653|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
44188515|NCT02217475|78983654|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
44188516|NCT02217475|78983652|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
44188517|NCT02217475|78983653|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
44188518|NCT02217475|78983654|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
44188519|NCT02217475|78983652|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
44188520|NCT02217475|78983653|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
44188521|NCT02217475|78983654|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
44188522|NCT02217475|78983652|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
44188523|NCT02217475|78983653|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
44188524|NCT02217475|78983654|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
44188525|NCT02217475|78983652|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
44188526|NCT02217475|78983653|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
44188527|NCT02217475|78983654|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
44188528|NCT02191267|78983674|FG000|Overall Study|Withdrawal by Subject|1|||
44188529|NCT02191267|78983675|FG001|Overall Study|Withdrawal by Subject|0|||
44188530|NCT02191267|78983676|FG002|Overall Study|Withdrawal by Subject|0|||
44188531|NCT02189941|78983684|FG000|Overall Study|Non-compliance|0|||
44188532|NCT02189941|78983685|FG001|Overall Study|Non-compliance|0|||
44188533|NCT02189941|78983686|FG002|Overall Study|Non-compliance|1|||
44188534|NCT02216773|78983696|FG000|Overall Study|Disease progression|4|||
44188535|NCT02216773|78983697|FG001|Overall Study|Disease progression|2|||
44188536|NCT02216773|78983696|FG000|Overall Study|Insufficient FLRV|4|||
44188537|NCT02216773|78983697|FG001|Overall Study|Insufficient FLRV|0|||
44188538|NCT02216773|78983696|FG000|Overall Study|Abandoned|4|||
44188539|NCT02216773|78983697|FG001|Overall Study|Abandoned|3|||
44188540|NCT01601132|78983703|FG000|Overall Study|Patient withdrew consent|1|||
44188541|NCT01601132|78983703|FG000|Overall Study|Protocol deviation|1|||
44188542|NCT02162719|78983712|FG000|Overall Study|Death|41|||
44188543|NCT02162719|78983713|FG001|Overall Study|Death|46|||
44188544|NCT02162719|78983712|FG000|Overall Study|Lost to Follow-up|1|||
44188545|NCT02162719|78983713|FG001|Overall Study|Lost to Follow-up|3|||
44188546|NCT02162719|78983712|FG000|Overall Study|Disease Progression|2|||
44188547|NCT02162719|78983713|FG001|Overall Study|Disease Progression|1|||
44188548|NCT02162719|78983712|FG000|Overall Study|Withdrawal by Subject|8|||
44188549|NCT02162719|78983713|FG001|Overall Study|Withdrawal by Subject|2|||
44188550|NCT02162719|78983712|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
44188551|NCT02162719|78983713|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
44188552|NCT02161549|78983721|FG000|Overall Study|Physician Decision|6|||
44188553|NCT02161549|78983722|FG001|Overall Study|Physician Decision|2|||
44188554|NCT02189863|78983728|FG000|First 2 Weeks|Motion Sickness|4|||
44188555|NCT02189863|78983729|FG001|First 2 Weeks|Motion Sickness|2|||
44188556|NCT02189473|78983740|FG000|Overall Study|Death|22|||
44188557|NCT02189473|78983741|FG001|Overall Study|Death|23|||
44188558|NCT02189473|78983740|FG000|Overall Study|Lost to Follow-up|1|||
44188559|NCT02189473|78983741|FG001|Overall Study|Lost to Follow-up|2|||
44188560|NCT02188849|78983749|FG000|Overall Study|Lost to Follow-up|3|||
44188561|NCT02188849|78983750|FG001|Overall Study|Lost to Follow-up|8|||
44188562|NCT01636076|78983758|FG000|Overall Study|Terminated by sponsor|1|||
44188563|NCT01636076|78983759|FG001|Overall Study|Terminated by sponsor|1|||
44188564|NCT01636076|78983758|FG000|Overall Study|Lack of Efficacy|0|||
44188565|NCT01636076|78983759|FG001|Overall Study|Lack of Efficacy|1|||
44188566|NCT01636076|78983758|FG000|Overall Study|Lost to Follow-up|1|||
44188567|NCT01636076|78983759|FG001|Overall Study|Lost to Follow-up|0|||
44188568|NCT01636076|78983758|FG000|Overall Study|Physician Decision|1|||
44188569|NCT01636076|78983759|FG001|Overall Study|Physician Decision|1|||
44188570|NCT01636076|78983758|FG000|Overall Study|Non-compliance with study treatment|1|||
44188571|NCT01636076|78983759|FG001|Overall Study|Non-compliance with study treatment|1|||
44188572|NCT01636076|78983758|FG000|Overall Study|Adverse Event|6|||
44188573|NCT01636076|78983759|FG001|Overall Study|Adverse Event|11|||
44188574|NCT01636076|78983758|FG000|Overall Study|Withdrawal by Subject|7|||
44188575|NCT01636076|78983759|FG001|Overall Study|Withdrawal by Subject|10|||
44451389|NCT00098293|79460288|FG003|Supplemental Phase (SP)|Other|0|||
44188576|NCT01635998|78983774|FG000|Overall Study|Death|1|||
44188577|NCT01635998|78983775|FG001|Overall Study|Death|1|||
44188578|NCT01635998|78983774|FG000|Overall Study|Lost to Follow-up|2|||
44188579|NCT01635998|78983775|FG001|Overall Study|Lost to Follow-up|1|||
44188580|NCT01635998|78983774|FG000|Overall Study|Withdrawal by Subject|1|||
44188581|NCT01635998|78983775|FG001|Overall Study|Withdrawal by Subject|5|||
44188582|NCT01635920|78983783|FG000|Overall Study|Adverse Event|1|||
44451390|NCT00098293|79460289|FG004|Supplemental Phase (SP)|Other|22|||
44451391|NCT00685685|79460300|FG000|Washout Period of 7 Days|Adverse Event|2|||
44188583|NCT01635920|78983784|FG001|Overall Study|Adverse Event|0|||
44451392|NCT00685685|79460301|FG001|Washout Period of 7 Days|Adverse Event|0|||
44188584|NCT01635920|78983783|FG000|Overall Study|Lost to Follow-up|0|||
44188585|NCT01635920|78983784|FG001|Overall Study|Lost to Follow-up|1|||
44188586|NCT01635920|78983783|FG000|Overall Study|Subject decision|2|||
44188587|NCT01635920|78983784|FG001|Overall Study|Subject decision|0|||
44188588|NCT02160145|78983801|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
44188589|NCT02160145|78983802|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
44188590|NCT02160145|78983803|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
44188591|NCT02160145|78983801|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
44188592|NCT02160145|78983802|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
44188593|NCT02160145|78983803|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
44188594|NCT02160145|78983801|FG000|Randomized Double-blind Period|Subject decision|0|||
44188595|NCT02160145|78983802|FG001|Randomized Double-blind Period|Subject decision|21|||
44188596|NCT02160145|78983803|FG002|Randomized Double-blind Period|Subject decision|20|||
44188597|NCT02160145|78983801|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
44188598|NCT02160145|78983802|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
44188599|NCT02160145|78983803|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
44188600|NCT02160145|78983801|FG000|Randomized Double-blind Period|Physician Decision|0|||
44188601|NCT02160145|78983802|FG001|Randomized Double-blind Period|Physician Decision|7|||
44188602|NCT02160145|78983803|FG002|Randomized Double-blind Period|Physician Decision|5|||
44188603|NCT01696396|78983814|FG000|Overall Study|Withdrawal by Subject|19|||
44188604|NCT01696396|78983815|FG001|Overall Study|Withdrawal by Subject|5|||
44188605|NCT01696396|78983816|FG002|Overall Study|Withdrawal by Subject|19|||
44188606|NCT01696396|78983817|FG003|Overall Study|Withdrawal by Subject|11|||
44188607|NCT01696396|78983814|FG000|Overall Study|Decision by Sponsor|3|||
44188608|NCT01696396|78983815|FG001|Overall Study|Decision by Sponsor|1|||
44188609|NCT01696396|78983816|FG002|Overall Study|Decision by Sponsor|2|||
44188610|NCT01696396|78983817|FG003|Overall Study|Decision by Sponsor|2|||
44188611|NCT01696396|78983814|FG000|Overall Study|Lost to Follow-up|9|||
44188612|NCT01696396|78983815|FG001|Overall Study|Lost to Follow-up|1|||
44188613|NCT01696396|78983816|FG002|Overall Study|Lost to Follow-up|4|||
44188614|NCT01696396|78983817|FG003|Overall Study|Lost to Follow-up|1|||
44188615|NCT01696396|78983814|FG000|Overall Study|Death|0|||
44188616|NCT01696396|78983815|FG001|Overall Study|Death|0|||
44188617|NCT01696396|78983816|FG002|Overall Study|Death|1|||
44188618|NCT01696396|78983817|FG003|Overall Study|Death|0|||
44188619|NCT02216071|78983833|FG000|Overall Study|Withdrawal by Subject|7|||
44188620|NCT02216071|78983834|FG001|Overall Study|Withdrawal by Subject|2|||
44188621|NCT02216071|78983833|FG000|Overall Study|Lost to Follow-up|3|||
44188622|NCT02216071|78983834|FG001|Overall Study|Lost to Follow-up|3|||
44188623|NCT02216071|78983833|FG000|Overall Study|Protocol Violation|3|||
44188624|NCT02216071|78983834|FG001|Overall Study|Protocol Violation|5|||
44188625|NCT02216071|78983833|FG000|Overall Study|Other|2|||
44188626|NCT02216071|78983834|FG001|Overall Study|Other|2|||
44188627|NCT01681576|78983842|FG000|Period 1|Adverse Event|1|||
44188628|NCT01681576|78983843|FG001|Period 1|Adverse Event|0|||
44188629|NCT01681576|78983842|FG000|Period 1|Protocol Deviation|1|||
44188630|NCT01681576|78983843|FG001|Period 1|Protocol Deviation|0|||
44188631|NCT01681576|78983842|FG000|Period 2|subject/guardian decision|3|||
44188632|NCT01681576|78983843|FG001|Period 2|subject/guardian decision|1|||
44188633|NCT01681576|78983842|FG000|Period 2|Non-compliance with study treatment|1|||
44188634|NCT01681576|78983843|FG001|Period 2|Non-compliance with study treatment|0|||
44188635|NCT02188459|78983853|FG000|Overall Study|Lost to Follow-up|3|||
44188636|NCT02188459|78983854|FG001|Overall Study|Lost to Follow-up|4|||
44188637|NCT02188459|78983853|FG000|Overall Study|Early Termination|0|||
44188638|NCT02188459|78983854|FG001|Overall Study|Early Termination|3|||
44188639|NCT02214121|78983876|FG000|Part A|Patient decision|2|||
44188640|NCT02214121|78983877|FG001|Part A|Patient decision|0|||
44188641|NCT02214121|78983878|FG002|Part A|Patient decision|0|||
44188642|NCT02214121|78983876|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
44188643|NCT02214121|78983877|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
44188644|NCT02214121|78983878|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
44188645|NCT02214121|78983876|FG000|Part A|Other|1|||
44188646|NCT02214121|78983877|FG001|Part A|Other|0|||
44188647|NCT02214121|78983878|FG002|Part A|Other|0|||
44188648|NCT02214121|78983876|FG000|Part B|Patient decision|0|||
44188649|NCT02214121|78983877|FG001|Part B|Patient decision|1|||
44188650|NCT02214121|78983878|FG002|Part B|Patient decision|0|||
44188651|NCT02214121|78983876|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
44266004|NCT02437890|79172722|FG000|Overall Study|Death|0|||
44188652|NCT02214121|78983877|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
44188653|NCT02214121|78983878|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
44188654|NCT02214121|78983876|FG000|Part B|Lost to Follow-up|0|||
44188655|NCT02214121|78983877|FG001|Part B|Lost to Follow-up|0|||
44188656|NCT02214121|78983878|FG002|Part B|Lost to Follow-up|1|||
44188657|NCT01681186|78983906|FG000|Washout Period From Second Intervention|Adverse Event|0|||
44188658|NCT01681186|78983907|FG001|Washout Period From Second Intervention|Adverse Event|0|||
44188659|NCT01681186|78983908|FG002|Washout Period From Second Intervention|Adverse Event|0|||
44188660|NCT01681186|78983909|FG003|Washout Period From Second Intervention|Adverse Event|0|||
44188661|NCT01681186|78983910|FG004|Washout Period From Second Intervention|Adverse Event|0|||
44188662|NCT01681186|78983911|FG005|Washout Period From Second Intervention|Adverse Event|0|||
44188663|NCT01681186|78983912|FG006|Washout Period From Second Intervention|Adverse Event|1|||
44188664|NCT01681186|78983913|FG007|Washout Period From Second Intervention|Adverse Event|0|||
44188665|NCT01681186|78983906|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
44188666|NCT01681186|78983907|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
44188667|NCT01681186|78983908|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
44188668|NCT01681186|78983909|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
44188669|NCT01681186|78983910|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
44188670|NCT01681186|78983911|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
44188671|NCT01681186|78983912|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
44188672|NCT01681186|78983913|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
44188673|NCT01681186|78983906|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
44188674|NCT01681186|78983907|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
44266005|NCT02437890|79172723|FG001|Overall Study|Death|0|||
44266006|NCT02437890|79172724|FG002|Overall Study|Death|0|||
44188675|NCT01681186|78983908|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
44188676|NCT01681186|78983909|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
44188677|NCT01681186|78983910|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
44188678|NCT01681186|78983911|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
44188679|NCT01681186|78983912|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
44188680|NCT01681186|78983913|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
44188681|NCT01681186|78983906|FG000|Fourth Intervention|Protocol Violation|0|||
44188682|NCT01681186|78983907|FG001|Fourth Intervention|Protocol Violation|0|||
44188683|NCT01681186|78983908|FG002|Fourth Intervention|Protocol Violation|0|||
44188684|NCT01681186|78983909|FG003|Fourth Intervention|Protocol Violation|0|||
44188685|NCT01681186|78983910|FG004|Fourth Intervention|Protocol Violation|0|||
44188686|NCT01681186|78983911|FG005|Fourth Intervention|Protocol Violation|0|||
44188687|NCT01681186|78983912|FG006|Fourth Intervention|Protocol Violation|0|||
44188688|NCT01681186|78983913|FG007|Fourth Intervention|Protocol Violation|1|||
44188689|NCT03597464|78983945|FG000|Overall Study|Withdrawal by Subject|4|||
44188690|NCT03597464|78983946|FG001|Overall Study|Withdrawal by Subject|5|||
44188691|NCT03597464|78983945|FG000|Overall Study|Lost to Follow-up|3|||
44188692|NCT03597464|78983946|FG001|Overall Study|Lost to Follow-up|1|||
44188693|NCT03597464|78983945|FG000|Overall Study|Pregnancy|3|||
44188694|NCT03597464|78983946|FG001|Overall Study|Pregnancy|1|||
44188695|NCT03597464|78983945|FG000|Overall Study|Lack of Efficacy|2|||
44188696|NCT03597464|78983946|FG001|Overall Study|Lack of Efficacy|0|||
44188697|NCT03597464|78983945|FG000|Overall Study|Physician Decision|2|||
44188698|NCT03597464|78983946|FG001|Overall Study|Physician Decision|2|||
44188699|NCT03597464|78983945|FG000|Overall Study|Protocol Violation|1|||
44188700|NCT03597464|78983946|FG001|Overall Study|Protocol Violation|1|||
44188701|NCT03597464|78983945|FG000|Overall Study|Adverse Event|0|||
44188702|NCT03597464|78983946|FG001|Overall Study|Adverse Event|2|||
44188703|NCT03597464|78983945|FG000|Overall Study|Death|0|||
44188704|NCT03597464|78983946|FG001|Overall Study|Death|3|||
44361247|NCT01185821|79366878|FG003|Overall Study|Administrative problems|1|||
44451393|NCT00685685|79460300|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
44451394|NCT00685685|79460301|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44451395|NCT00684671|79460310|FG000|Overall Study|Adverse Event|1|||
44451396|NCT00684671|79460311|FG001|Overall Study|Adverse Event|0|||
44188705|NCT01695772|78983954|FG000|Overall Study|Withdrawal by Subject|18|||
44188706|NCT01695772|78983954|FG000|Overall Study|Progressive Disease|8|||
44188707|NCT01695772|78983954|FG000|Overall Study|Investigator Decision|5|||
44188708|NCT01695772|78983954|FG000|Overall Study|Lost to Follow-up|4|||
44188709|NCT01695772|78983954|FG000|Overall Study|Protocol Violation|2|||
44361248|NCT01185821|79366879|FG004|Overall Study|Administrative problems|2|||
44188710|NCT01695772|78983954|FG000|Overall Study|Unspecified Reason|1|||
44188711|NCT02159521|78983958|FG000|Overall Study|Enrolled but not treated|3|||
44188712|NCT02159521|78983958|FG000|Overall Study|Withdrawal by Subject|7|||
44188713|NCT02159521|78983958|FG000|Overall Study|Lost to Follow-up|6|||
44188714|NCT02159521|78983958|FG000|Overall Study|Death|1|||
44188715|NCT02159521|78983958|FG000|Overall Study|Other than specified|1|||
44188716|NCT01636934|78983964|FG000|Overall Study|Withdrawal by Subject|3|||
44188717|NCT01636934|78983965|FG001|Overall Study|Withdrawal by Subject|2|||
44188718|NCT01636934|78983964|FG000|Overall Study|Chemo cancel|1|||
44188719|NCT01636934|78983965|FG001|Overall Study|Chemo cancel|0|||
44188720|NCT01636934|78983964|FG000|Overall Study|Too ill to continue|1|||
44188721|NCT01636934|78983965|FG001|Overall Study|Too ill to continue|0|||
44188722|NCT01636934|78983964|FG000|Overall Study|Never started study medication|1|||
44188723|NCT01636934|78983965|FG001|Overall Study|Never started study medication|1|||
44188724|NCT01712854|78983971|FG000|Overall Study|Physician Decision|1|||
44188725|NCT01693120|78983975|FG000|Enrollment|Lost to Follow-up|1|||
44188726|NCT01693120|78983975|FG000|Enrollment|Withdrawal by Subject|10|||
44188727|NCT01693120|78983975|FG000|Enrollment|Protocol Violation|46|||
44188728|NCT01693120|78983975|FG000|Enrollment|Physician Decision|3|||
44188729|NCT01693120|78983975|FG000|Enrollment|Adverse Event|1|||
44188730|NCT01693120|78983975|FG000|Enrollment|Study closed|8|||
44188731|NCT01693120|78983975|FG000|Enrollment|Other|1|||
44188732|NCT01693120|78983975|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
44188733|NCT01693120|78983975|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
44188734|NCT01693120|78983975|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
44188735|NCT01693120|78983975|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
44188736|NCT01693120|78983975|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
44188737|NCT02159365|78983979|FG000|Overall Study|Disease Progression|23|||
44188738|NCT02159365|78983979|FG000|Overall Study|Other reasons|11|||
44188739|NCT02159365|78983979|FG000|Overall Study|Administrative reason by Sponsor|9|||
44188740|NCT02159365|78983979|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
44188741|NCT02159365|78983979|FG000|Overall Study|Study drug toxicity|7|||
44188742|NCT02159365|78983979|FG000|Overall Study|Maximum clinical benefit|3|||
44188743|NCT02159365|78983979|FG000|Overall Study|Subject request to discontinue treatment|3|||
44188744|NCT02159365|78983979|FG000|Overall Study|Subject withdrew consent|3|||
44188745|NCT02159365|78983979|FG000|Overall Study|Death|1|||
44188746|NCT02159365|78983979|FG000|Overall Study|Lost to Follow-up|1|||
44188747|NCT01712074|78983986|FG000|Placebo Run-in Period|Adverse Event|2|||
44188748|NCT01712074|78983987|FG001|Placebo Run-in Period|Adverse Event|0|||
44188749|NCT01712074|78983988|FG002|Placebo Run-in Period|Adverse Event|0|||
44188750|NCT01712074|78983986|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
44188751|NCT01712074|78983987|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
44188752|NCT01712074|78983988|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
44188753|NCT01712074|78983986|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
44188754|NCT01712074|78983987|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
44188755|NCT01712074|78983988|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
44188756|NCT01712074|78983986|FG000|Placebo Run-in Period|Other|1|||
44188757|NCT01712074|78983987|FG001|Placebo Run-in Period|Other|0|||
44188758|NCT01712074|78983988|FG002|Placebo Run-in Period|Other|0|||
44188759|NCT01712074|78983986|FG000|Placebo Run-in Period|No longer willing to participate|1|||
44188760|NCT01712074|78983987|FG001|Placebo Run-in Period|No longer willing to participate|0|||
44188761|NCT01712074|78983988|FG002|Placebo Run-in Period|No longer willing to participate|0|||
44188762|NCT01712074|78983986|FG000|Double Blind Period|Adverse Event|0|||
44188763|NCT01712074|78983987|FG001|Double Blind Period|Adverse Event|2|||
44188764|NCT01712074|78983988|FG002|Double Blind Period|Adverse Event|1|||
44188765|NCT01712074|78983986|FG000|Double Blind Period|No longer willing to participate|0|||
44188766|NCT01712074|78983987|FG001|Double Blind Period|No longer willing to participate|2|||
44188767|NCT01712074|78983988|FG002|Double Blind Period|No longer willing to participate|4|||
44188768|NCT01712074|78983986|FG000|Double Blind Period|Death|0|||
44188769|NCT01712074|78983987|FG001|Double Blind Period|Death|1|||
44188770|NCT01712074|78983988|FG002|Double Blind Period|Death|0|||
44188771|NCT01712074|78983986|FG000|Double Blind Period|Lost to Follow-up|0|||
44188772|NCT01712074|78983987|FG001|Double Blind Period|Lost to Follow-up|2|||
44188773|NCT01712074|78983988|FG002|Double Blind Period|Lost to Follow-up|1|||
44188774|NCT01712074|78983986|FG000|Double Blind Period|Other|0|||
44188775|NCT01712074|78983987|FG001|Double Blind Period|Other|4|||
44451397|NCT00684671|79460312|FG002|Overall Study|Adverse Event|0|||
44451398|NCT00684671|79460310|FG000|Overall Study|Lost to Follow-up|1|||
44188776|NCT01712074|78983988|FG002|Double Blind Period|Other|1|||
44188777|NCT01712074|78983986|FG000|Double Blind Period|Protocol Violation|0|||
44188778|NCT01712074|78983987|FG001|Double Blind Period|Protocol Violation|0|||
44188779|NCT01712074|78983988|FG002|Double Blind Period|Protocol Violation|1|||
44188780|NCT01712074|78983986|FG000|Double Blind Period|No longer met eligibility criteria|0|||
44451399|NCT00684671|79460311|FG001|Overall Study|Lost to Follow-up|0|||
44451400|NCT00684671|79460312|FG002|Overall Study|Lost to Follow-up|0|||
44451401|NCT00684671|79460310|FG000|Overall Study|Alcoholic dependance|1|||
44188781|NCT01712074|78983987|FG001|Double Blind Period|No longer met eligibility criteria|3|||
44188782|NCT01712074|78983988|FG002|Double Blind Period|No longer met eligibility criteria|0|||
44188783|NCT01711216|78984003|FG000|Overall Study|Adverse Event|4|||
44188784|NCT01711216|78984003|FG000|Overall Study|Pregnancy|56|||
44188785|NCT01711216|78984003|FG000|Overall Study|Withdrawal by Subject|6|||
44188786|NCT01711216|78984003|FG000|Overall Study|Lost to Follow-up|46|||
44188787|NCT01711216|78984003|FG000|Overall Study|variety of other minor reasons|83|||
44188788|NCT01711216|78984003|FG000|Overall Study|no reason specified|22|||
44188789|NCT01692730|78984013|FG000|Overall Study|Lost to Follow-up|225|||
44188790|NCT01692730|78984014|FG001|Overall Study|Lost to Follow-up|227|||
44188791|NCT01691794|78984023|FG000|Overall Study|Poor/Non-Compliance|1|||
44188792|NCT01691794|78984024|FG001|Overall Study|Poor/Non-Compliance|4|||
44188793|NCT01691794|78984025|FG002|Overall Study|Poor/Non-Compliance|1|||
44188794|NCT01691794|78984023|FG000|Overall Study|Death|0|||
44188795|NCT01691794|78984024|FG001|Overall Study|Death|0|||
44188796|NCT01691794|78984025|FG002|Overall Study|Death|1|||
44188797|NCT01691794|78984023|FG000|Overall Study|Lack of Efficacy|0|||
44188798|NCT01691794|78984024|FG001|Overall Study|Lack of Efficacy|7|||
44188799|NCT01691794|78984025|FG002|Overall Study|Lack of Efficacy|1|||
44188800|NCT01691794|78984023|FG000|Overall Study|Participant request to discontinue|0|||
44188801|NCT01691794|78984024|FG001|Overall Study|Participant request to discontinue|1|||
44188802|NCT01691794|78984025|FG002|Overall Study|Participant request to discontinue|0|||
44188803|NCT01691794|78984023|FG000|Overall Study|Adverse Event|0|||
44188804|NCT01691794|78984024|FG001|Overall Study|Adverse Event|1|||
44188805|NCT01691794|78984025|FG002|Overall Study|Adverse Event|1|||
44188806|NCT01691794|78984023|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
44188807|NCT01691794|78984024|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
44188808|NCT01691794|78984025|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
44188809|NCT01691794|78984023|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
44188810|NCT01691794|78984024|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
44188811|NCT01691794|78984025|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
44188812|NCT01710514|78984035|FG000|Overall Study|Adverse Event|6|||
44188813|NCT01710514|78984036|FG001|Overall Study|Adverse Event|7|||
44188814|NCT01710514|78984035|FG000|Overall Study|Withdrawal by Subject|1|||
44188815|NCT01710514|78984036|FG001|Overall Study|Withdrawal by Subject|0|||
44188816|NCT01592344|78984047|FG000|Overall Study|Adverse Event|1|||
44188817|NCT01592344|78984048|FG001|Overall Study|Adverse Event|1|||
44188818|NCT01592344|78984047|FG000|Overall Study|Lack of Efficacy|1|||
44188819|NCT01592344|78984048|FG001|Overall Study|Lack of Efficacy|0|||
44188820|NCT01592344|78984047|FG000|Overall Study|not available at primary outcome visit|2|||
44188821|NCT01592344|78984048|FG001|Overall Study|not available at primary outcome visit|4|||
44188822|NCT01636778|78984054|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
44188823|NCT01636778|78984055|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
44188824|NCT01636778|78984056|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
44188825|NCT01636778|78984054|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
44188826|NCT01636778|78984055|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
44188827|NCT01636778|78984056|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
44188828|NCT01636778|78984054|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
44188829|NCT01636778|78984055|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
44188830|NCT01636778|78984056|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
44188831|NCT01636778|78984054|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
44188832|NCT01636778|78984055|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
44451402|NCT00684671|79460311|FG001|Overall Study|Alcoholic dependance|0|||
44451403|NCT00684671|79460312|FG002|Overall Study|Alcoholic dependance|0|||
44451404|NCT03859323|79460333|FG000|Overall Study|Lost to Follow-up|0|||
44188833|NCT01636778|78984056|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
44266007|NCT02437890|79172725|FG003|Overall Study|Death|2|||
44188834|NCT01636778|78984054|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
44188835|NCT01636778|78984055|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
44188836|NCT01636778|78984056|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
44188837|NCT01636778|78984054|FG000|Follow-up Period After Part 2|Other|0|||
44188838|NCT01636778|78984055|FG001|Follow-up Period After Part 2|Other|0|||
44188839|NCT01636778|78984056|FG002|Follow-up Period After Part 2|Other|1|||
44188840|NCT01636778|78984054|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
44188841|NCT01636778|78984055|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
44188842|NCT01636778|78984056|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
44188843|NCT01636778|78984054|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
44188844|NCT01636778|78984055|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
44188845|NCT01636778|78984056|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
44188846|NCT02159053|78984067|FG000|Overall Study|Death|2|||
44188847|NCT02159053|78984068|FG001|Overall Study|Death|0|||
44188848|NCT02159053|78984069|FG002|Overall Study|Death|1|||
44188849|NCT02159053|78984067|FG000|Overall Study|Physician Decision|0|||
44188850|NCT02159053|78984068|FG001|Overall Study|Physician Decision|1|||
44188851|NCT02159053|78984069|FG002|Overall Study|Physician Decision|1|||
44188852|NCT02159053|78984067|FG000|Overall Study|Lack of Efficacy|3|||
44188853|NCT02159053|78984068|FG001|Overall Study|Lack of Efficacy|4|||
44188854|NCT02159053|78984069|FG002|Overall Study|Lack of Efficacy|7|||
44188855|NCT02159053|78984067|FG000|Overall Study|Adverse Event|7|||
44188856|NCT02159053|78984068|FG001|Overall Study|Adverse Event|6|||
44188857|NCT02159053|78984069|FG002|Overall Study|Adverse Event|5|||
44188858|NCT02159053|78984067|FG000|Overall Study|Participants/guardian decision|8|||
44188859|NCT02159053|78984068|FG001|Overall Study|Participants/guardian decision|10|||
44188860|NCT02159053|78984069|FG002|Overall Study|Participants/guardian decision|6|||
44188861|NCT02158975|78984079|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
44188862|NCT02158663|78984086|FG000|Overall Study|Withdrawal by Subject|5|||
44188863|NCT02158663|78984087|FG001|Overall Study|Withdrawal by Subject|4|||
44188864|NCT02158039|78984095|FG000|Overall Study|Withdrawal by Subject|1|||
44188865|NCT02158039|78984095|FG000|Overall Study|Screen Failure|9|||
44188866|NCT01635764|78984113|FG000|Overall Study|Adverse Event|46|||
44188867|NCT01635764|78984113|FG000|Overall Study|Lack of Efficacy|76|||
44188868|NCT01635764|78984113|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
44188869|NCT01635764|78984113|FG000|Overall Study|Protocol Deviation|1|||
44188870|NCT01635764|78984113|FG000|Overall Study|Withdrew Consent|67|||
44188871|NCT01635764|78984113|FG000|Overall Study|Lost to Follow-up|53|||
44188872|NCT01635764|78984113|FG000|Overall Study|Other|28|||
44188873|NCT03432260|78984129|FG000|Overall Study|Lost to Follow-up|1|||
44188874|NCT03432260|78984130|FG001|Overall Study|Lost to Follow-up|1|||
44188875|NCT03432260|78984131|FG002|Overall Study|Lost to Follow-up|0|||
44188876|NCT03432260|78984132|FG003|Overall Study|Lost to Follow-up|0|||
44188877|NCT03432260|78984133|FG004|Overall Study|Lost to Follow-up|1|||
44188878|NCT01634360|78984147|FG000|Overall Study|Adverse Event|10|||
44188879|NCT01634360|78984148|FG001|Overall Study|Adverse Event|34|||
44188880|NCT01634360|78984147|FG000|Overall Study|subject withdrew consent|13|||
44188881|NCT01634360|78984148|FG001|Overall Study|subject withdrew consent|23|||
44188882|NCT01634360|78984147|FG000|Overall Study|Protocol Violation|1|||
44188883|NCT01634360|78984148|FG001|Overall Study|Protocol Violation|1|||
44188884|NCT01634360|78984147|FG000|Overall Study|Lack of Efficacy|4|||
44188885|NCT01634360|78984148|FG001|Overall Study|Lack of Efficacy|14|||
44188886|NCT01634360|78984147|FG000|Overall Study|Other|3|||
44188887|NCT01634360|78984148|FG001|Overall Study|Other|20|||
44188888|NCT01634360|78984147|FG000|Overall Study|Study termination by sponsor|18|||
44188889|NCT01634360|78984148|FG001|Overall Study|Study termination by sponsor|44|||
44188890|NCT01635218|78984165|FG000|Overall Study|Lost to Follow-up|3|||
44188891|NCT01635218|78984166|FG001|Overall Study|Lost to Follow-up|7|||
44188892|NCT01635218|78984167|FG002|Overall Study|Lost to Follow-up|6|||
44188893|NCT02049866|78984175|FG000|Overall Study|Withdrawal by Subject|1|||
44188894|NCT04307186|78984179|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
44188895|NCT04307186|78984179|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
44188896|NCT04307186|78984179|FG000|Washout 3-14 Days|Progressive disease|1|||
44188897|NCT04307186|78984179|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
44188898|NCT04307186|78984179|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
44188899|NCT04274894|78984191|FG000|Overall Study|Adverse Event|7|||
44188900|NCT04274894|78984191|FG000|Overall Study|Withdrew consent|5|||
44188901|NCT04274894|78984191|FG000|Overall Study|Lost to Follow-up|9|||
44188902|NCT04274894|78984191|FG000|Overall Study|COVID-19 infection|1|||
44188903|NCT04274894|78984191|FG000|Overall Study|Other, not specified|20|||
44188904|NCT02213263|78984197|FG000|Overall Study|Insufficient clinical response|4|||
44188905|NCT02213263|78984198|FG001|Overall Study|Insufficient clinical response|3|||
44188906|NCT02213263|78984197|FG000|Overall Study|Lost to Follow-up|0|||
44188907|NCT02213263|78984198|FG001|Overall Study|Lost to Follow-up|1|||
44188908|NCT02213263|78984197|FG000|Overall Study|No longer willing to participate|3|||
44188909|NCT02213263|78984198|FG001|Overall Study|No longer willing to participate|4|||
44188910|NCT02213263|78984197|FG000|Overall Study|Progressive disease|20|||
44188911|NCT02213263|78984198|FG001|Overall Study|Progressive disease|14|||
44188912|NCT02213263|78984197|FG000|Overall Study|Protocol Violation|0|||
44188913|NCT02213263|78984198|FG001|Overall Study|Protocol Violation|1|||
44188914|NCT02213263|78984197|FG000|Overall Study|Adverse Event|1|||
44188915|NCT02213263|78984198|FG001|Overall Study|Adverse Event|3|||
44188916|NCT02211313|78984206|FG000|Overall Study|Treatment Failure|5|||
44188917|NCT02211313|78984207|FG001|Overall Study|Treatment Failure|2|||
44188918|NCT02211313|78984206|FG000|Overall Study|No Follow up Questionnaires|1|||
44188919|NCT02211313|78984207|FG001|Overall Study|No Follow up Questionnaires|1|||
44188920|NCT02210689|78984216|FG000|Overall Study|Withdrawal by Subject|7|||
44188921|NCT02210689|78984217|FG001|Overall Study|Withdrawal by Subject|4|||
44188922|NCT02210689|78984218|FG002|Overall Study|Withdrawal by Subject|2|||
44188923|NCT02210689|78984216|FG000|Overall Study|Adverse Event|0|||
44188924|NCT02210689|78984217|FG001|Overall Study|Adverse Event|1|||
44188925|NCT02210689|78984218|FG002|Overall Study|Adverse Event|0|||
44188926|NCT02210689|78984216|FG000|Overall Study|Protocol Violation|1|||
44188927|NCT02210689|78984217|FG001|Overall Study|Protocol Violation|0|||
44188928|NCT02210689|78984218|FG002|Overall Study|Protocol Violation|0|||
44188929|NCT02210689|78984216|FG000|Overall Study|Lost to Follow-up|11|||
44188930|NCT02210689|78984217|FG001|Overall Study|Lost to Follow-up|9|||
44188931|NCT02210689|78984218|FG002|Overall Study|Lost to Follow-up|5|||
44188932|NCT02210689|78984216|FG000|Overall Study|Pregnancy|0|||
44188933|NCT02210689|78984217|FG001|Overall Study|Pregnancy|1|||
44188934|NCT02210689|78984218|FG002|Overall Study|Pregnancy|0|||
44188935|NCT02210689|78984216|FG000|Overall Study|Lack of Efficacy|0|||
44188936|NCT02210689|78984217|FG001|Overall Study|Lack of Efficacy|1|||
44188937|NCT02210689|78984218|FG002|Overall Study|Lack of Efficacy|5|||
44188938|NCT02210689|78984216|FG000|Overall Study|Prohibited medication|2|||
44188939|NCT02210689|78984217|FG001|Overall Study|Prohibited medication|8|||
44188940|NCT02210689|78984218|FG002|Overall Study|Prohibited medication|1|||
44188941|NCT02210689|78984216|FG000|Overall Study|Negative Nugent score at baseline|6|||
44188942|NCT02210689|78984217|FG001|Overall Study|Negative Nugent score at baseline|2|||
44188943|NCT02210689|78984218|FG002|Overall Study|Negative Nugent score at baseline|2|||
44188944|NCT02210689|78984216|FG000|Overall Study|Other|25|||
44188945|NCT02210689|78984217|FG001|Overall Study|Other|21|||
44188946|NCT02210689|78984218|FG002|Overall Study|Other|8|||
44188947|NCT02209597|78984226|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
44188948|NCT02209597|78984226|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
44188949|NCT02209597|78984226|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
44188950|NCT02209597|78984226|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
44188951|NCT02188303|78984255|FG000|Overall Study|Adverse Event|0|||
44188952|NCT02188303|78984256|FG001|Overall Study|Adverse Event|0|||
44188953|NCT02188303|78984257|FG002|Overall Study|Adverse Event|0|||
44188954|NCT02188303|78984258|FG003|Overall Study|Adverse Event|0|||
44188955|NCT02188303|78984259|FG004|Overall Study|Adverse Event|0|||
44188956|NCT02188303|78984260|FG005|Overall Study|Adverse Event|2|||
44188957|NCT02188303|78984261|FG006|Overall Study|Adverse Event|0|||
44188958|NCT02188303|78984262|FG007|Overall Study|Adverse Event|2|||
44188959|NCT02188303|78984255|FG000|Overall Study|Dose Termination Criteria Met|0|||
44188960|NCT02188303|78984256|FG001|Overall Study|Dose Termination Criteria Met|0|||
44188961|NCT02188303|78984257|FG002|Overall Study|Dose Termination Criteria Met|0|||
44188962|NCT02188303|78984258|FG003|Overall Study|Dose Termination Criteria Met|0|||
44188963|NCT02188303|78984259|FG004|Overall Study|Dose Termination Criteria Met|0|||
44188964|NCT02188303|78984260|FG005|Overall Study|Dose Termination Criteria Met|0|||
44188965|NCT02188303|78984261|FG006|Overall Study|Dose Termination Criteria Met|2|||
44188966|NCT02188303|78984262|FG007|Overall Study|Dose Termination Criteria Met|4|||
44188967|NCT04867382|78984288|FG000|Overall Study|Did not complete the survey|2|||
44188968|NCT04867382|78984289|FG001|Overall Study|Did not complete the survey|1|||
44188969|NCT02187055|78984298|FG000|Overall Study|Lack of Efficacy|10|||
44188970|NCT02187055|78984299|FG001|Overall Study|Lack of Efficacy|3|||
44188971|NCT02187055|78984300|FG002|Overall Study|Lack of Efficacy|7|||
44188972|NCT02187055|78984298|FG000|Overall Study|Lost to Follow-up|2|||
44188973|NCT02187055|78984299|FG001|Overall Study|Lost to Follow-up|7|||
44188974|NCT02187055|78984300|FG002|Overall Study|Lost to Follow-up|3|||
44188975|NCT02187055|78984298|FG000|Overall Study|No longer meets eligibility criteria|0|||
44188976|NCT02187055|78984299|FG001|Overall Study|No longer meets eligibility criteria|2|||
44188977|NCT02187055|78984300|FG002|Overall Study|No longer meets eligibility criteria|0|||
44188978|NCT02187055|78984298|FG000|Overall Study|No longer willing to participate|6|||
44188979|NCT02187055|78984299|FG001|Overall Study|No longer willing to participate|8|||
44188980|NCT02187055|78984300|FG002|Overall Study|No longer willing to participate|10|||
44266008|NCT02437890|79172726|FG004|Overall Study|Death|0|||
44188981|NCT02187055|78984298|FG000|Overall Study|Other|5|||
44188982|NCT02187055|78984299|FG001|Overall Study|Other|6|||
44188983|NCT02187055|78984300|FG002|Overall Study|Other|3|||
44266009|NCT02384538|79172787|FG000|Overall Study|Adverse Event|1|||
44188984|NCT02187055|78984298|FG000|Overall Study|Protocol Violation|9|||
44188985|NCT02187055|78984299|FG001|Overall Study|Protocol Violation|9|||
44188986|NCT02187055|78984300|FG002|Overall Study|Protocol Violation|4|||
44188987|NCT02187055|78984298|FG000|Overall Study|Pregnancy|3|||
44188988|NCT02187055|78984299|FG001|Overall Study|Pregnancy|1|||
44188989|NCT02187055|78984300|FG002|Overall Study|Pregnancy|0|||
44188990|NCT02187055|78984298|FG000|Overall Study|Withdrawal by Subject|11|||
44188991|NCT02187055|78984299|FG001|Overall Study|Withdrawal by Subject|11|||
44188992|NCT02187055|78984300|FG002|Overall Study|Withdrawal by Subject|11|||
44188993|NCT02187055|78984298|FG000|Overall Study|Adverse Event|21|||
44188994|NCT02187055|78984299|FG001|Overall Study|Adverse Event|26|||
44188995|NCT02187055|78984300|FG002|Overall Study|Adverse Event|36|||
44188996|NCT02187055|78984298|FG000|Overall Study|Death|2|||
44188997|NCT02187055|78984299|FG001|Overall Study|Death|0|||
44188998|NCT02187055|78984300|FG002|Overall Study|Death|0|||
44188999|NCT02246660|78984340|FG000|Overall Study|Withdrawal by Subject|0|||
44189000|NCT02246660|78984341|FG001|Overall Study|Withdrawal by Subject|1|||
44189001|NCT02246660|78984342|FG002|Overall Study|Withdrawal by Subject|0|||
44189002|NCT02246660|78984340|FG000|Overall Study|Death|0|||
44189003|NCT02246660|78984341|FG001|Overall Study|Death|0|||
44189004|NCT02246660|78984342|FG002|Overall Study|Death|1|||
44189005|NCT02246582|78984350|FG000|Overall Study|Withdrawal by Subject|3|||
44189006|NCT02246582|78984351|FG001|Overall Study|Withdrawal by Subject|4|||
44189007|NCT02137369|78984357|FG000|Overall Study|Withdrawal by Subject|3|||
44189008|NCT02137369|78984358|FG001|Overall Study|Withdrawal by Subject|2|||
44189009|NCT02137369|78984357|FG000|Overall Study|Adverse Event|2|||
44189010|NCT02137369|78984358|FG001|Overall Study|Adverse Event|0|||
44189011|NCT02137369|78984357|FG000|Overall Study|Lost to Follow-up|1|||
44189012|NCT02137369|78984358|FG001|Overall Study|Lost to Follow-up|0|||
44189013|NCT02137369|78984357|FG000|Overall Study|Moved away|2|||
44189014|NCT02137369|78984358|FG001|Overall Study|Moved away|0|||
44189015|NCT02155309|78984367|FG000|Overall Study|Protocol Violation|0|||
44189016|NCT02155309|78984368|FG001|Overall Study|Protocol Violation|0|||
44189017|NCT02155309|78984369|FG002|Overall Study|Protocol Violation|1|||
44189018|NCT02186821|78984376|FG000|Overall Study|Adverse Event|9|||
44189019|NCT02186821|78984376|FG000|Overall Study|Death|2|||
44189020|NCT02186821|78984376|FG000|Overall Study|Disease progression|32|||
44189021|NCT02186821|78984376|FG000|Overall Study|Protocol Violation|1|||
44189022|NCT02186821|78984376|FG000|Overall Study|Physician Decision|1|||
44189023|NCT02186821|78984376|FG000|Overall Study|Study terminated by sponsor|2|||
44189024|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
44189025|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
44189026|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
44189027|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
44189028|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
44189029|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
44189030|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
44189031|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
44189032|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
44189033|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
44189034|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
44189035|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
44189036|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
44189037|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
44266010|NCT02384538|79172788|FG001|Overall Study|Adverse Event|4|||
44266011|NCT02384538|79172787|FG000|Overall Study|Lack of Efficacy|4|||
44266012|NCT02384538|79172788|FG001|Overall Study|Lack of Efficacy|4|||
44266013|NCT02384538|79172787|FG000|Overall Study|Withdrew Consent|0|||
44266014|NCT02384538|79172788|FG001|Overall Study|Withdrew Consent|4|||
44266015|NCT02384538|79172787|FG000|Overall Study|Other|1|||
44266016|NCT02384538|79172788|FG001|Overall Study|Other|3|||
44266017|NCT02410824|79172812|FG000|First Intervention (One Week)|Headache|0|||
44266018|NCT02410824|79172813|FG001|First Intervention (One Week)|Headache|1|||
44266019|NCT02384460|79172843|FG000|Overall Study|Protocol Violation|0|||
44266020|NCT02384460|79172844|FG001|Overall Study|Protocol Violation|1|||
44266021|NCT02384460|79172843|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
44189038|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
44189039|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
44189040|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
44451405|NCT03859323|79460334|FG001|Overall Study|Lost to Follow-up|0|||
44189041|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
44189042|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
44189043|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
44266022|NCT02384460|79172844|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
44266023|NCT02384460|79172843|FG000|Overall Study|Adverse Event|5|||
44266024|NCT02384460|79172844|FG001|Overall Study|Adverse Event|2|||
44266025|NCT02384460|79172843|FG000|Overall Study|Withdrawal by Subject|0|||
44266026|NCT02384460|79172844|FG001|Overall Study|Withdrawal by Subject|3|||
44266027|NCT02384460|79172843|FG000|Overall Study|Elective medical treatment|1|||
44266028|NCT02384460|79172844|FG001|Overall Study|Elective medical treatment|0|||
44266029|NCT02384460|79172843|FG000|Overall Study|Non-compliance|1|||
44189044|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
44189045|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
44189046|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
44189047|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
44189048|NCT01710358|78984383|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
44189049|NCT01710358|78984384|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
44189050|NCT01710358|78984385|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
44189051|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
44189052|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
44189053|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
44189054|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
44189055|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
44189056|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
44189057|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
44189058|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
44189059|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
44189060|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
44189061|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
44189062|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
44189063|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
44189064|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
44189065|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
44189066|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
44189067|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
44189068|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
44189069|NCT01710358|78984383|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
44189070|NCT01710358|78984384|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
44189071|NCT01710358|78984385|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
44189072|NCT01710358|78984383|FG000|Rescue Period|Adverse Event|0|||
44189073|NCT01710358|78984384|FG001|Rescue Period|Adverse Event|15|||
44189074|NCT01710358|78984385|FG002|Rescue Period|Adverse Event|0|||
44189075|NCT01710358|78984383|FG000|Rescue Period|Death|0|||
44189076|NCT01710358|78984384|FG001|Rescue Period|Death|1|||
44189077|NCT01710358|78984385|FG002|Rescue Period|Death|0|||
44189078|NCT01710358|78984383|FG000|Rescue Period|Lack of Efficacy|0|||
44189079|NCT01710358|78984384|FG001|Rescue Period|Lack of Efficacy|7|||
44189080|NCT01710358|78984385|FG002|Rescue Period|Lack of Efficacy|0|||
44189081|NCT01710358|78984383|FG000|Rescue Period|Withdrawal by Subject|0|||
44189082|NCT01710358|78984384|FG001|Rescue Period|Withdrawal by Subject|8|||
44189083|NCT01710358|78984385|FG002|Rescue Period|Withdrawal by Subject|0|||
44189084|NCT01633112|78984409|FG000|Overall Study|Lack of Efficacy|1|||
44189085|NCT01633112|78984410|FG001|Overall Study|Lack of Efficacy|6|||
44189086|NCT01633112|78984411|FG002|Overall Study|Lack of Efficacy|13|||
44189087|NCT01633112|78984409|FG000|Overall Study|Abnormal laboratory value(s)|3|||
44189088|NCT01633112|78984410|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44189089|NCT01633112|78984411|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44189090|NCT01633112|78984409|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44189091|NCT01633112|78984410|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44189092|NCT01633112|78984411|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44189093|NCT01633112|78984409|FG000|Overall Study|Administrative problems|1|||
44189094|NCT01633112|78984410|FG001|Overall Study|Administrative problems|2|||
44189095|NCT01633112|78984411|FG002|Overall Study|Administrative problems|5|||
44189096|NCT01633112|78984409|FG000|Overall Study|Adverse Event|16|||
44189097|NCT01633112|78984410|FG001|Overall Study|Adverse Event|18|||
44189098|NCT01633112|78984411|FG002|Overall Study|Adverse Event|20|||
44189099|NCT01633112|78984409|FG000|Overall Study|Lost to Follow-up|7|||
44189100|NCT01633112|78984410|FG001|Overall Study|Lost to Follow-up|19|||
44189101|NCT01633112|78984411|FG002|Overall Study|Lost to Follow-up|6|||
44189102|NCT01633112|78984409|FG000|Overall Study|Protocol Violation|4|||
44189103|NCT01633112|78984410|FG001|Overall Study|Protocol Violation|0|||
44189104|NCT01633112|78984411|FG002|Overall Study|Protocol Violation|2|||
44189105|NCT01633112|78984409|FG000|Overall Study|Subject no longer requires study drug|0|||
44189106|NCT01633112|78984410|FG001|Overall Study|Subject no longer requires study drug|0|||
44189107|NCT01633112|78984411|FG002|Overall Study|Subject no longer requires study drug|1|||
44266030|NCT02384460|79172844|FG001|Overall Study|Non-compliance|0|||
44451406|NCT03859323|79460335|FG002|Overall Study|Lost to Follow-up|0|||
44266031|NCT02384382|79172867|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
44189108|NCT01633112|78984409|FG000|Overall Study|Withdrawal by Subject|20|||
44189109|NCT01633112|78984410|FG001|Overall Study|Withdrawal by Subject|12|||
44189110|NCT01633112|78984411|FG002|Overall Study|Withdrawal by Subject|41|||
44189111|NCT01633112|78984409|FG000|Overall Study|missing Study Completion CRF|1|||
44189112|NCT01633112|78984410|FG001|Overall Study|missing Study Completion CRF|1|||
44189113|NCT01633112|78984411|FG002|Overall Study|missing Study Completion CRF|4|||
44189114|NCT01691482|78984420|FG000|Treatment Period 2|Adverse Event|0|||
44189115|NCT01691482|78984421|FG001|Treatment Period 2|Adverse Event|1|||
44189116|NCT01691482|78984420|FG000|Treatment Period 2|Protocol Violation|1|||
44189117|NCT01691482|78984421|FG001|Treatment Period 2|Protocol Violation|1|||
44189118|NCT02246114|78984430|FG000|Overall Study|miscarriage|1|||
44189119|NCT02246114|78984431|FG001|Overall Study|miscarriage|0|||
44189120|NCT01710046|78984439|FG000|Overall Study|Lost to Follow-up|1|||
44189121|NCT01710046|78984440|FG001|Overall Study|Lost to Follow-up|0|||
44189122|NCT02154529|78984450|FG000|Overall Study|Death|1|||
44189123|NCT02154529|78984451|FG001|Overall Study|Death|1|||
44189124|NCT02154529|78984452|FG002|Overall Study|Death|5|||
44189125|NCT02154529|78984453|FG003|Overall Study|Death|1|||
44189126|NCT02154529|78984450|FG000|Overall Study|Termination of study by sponsor|2|||
44189127|NCT02154529|78984451|FG001|Overall Study|Termination of study by sponsor|2|||
44189128|NCT02154529|78984452|FG002|Overall Study|Termination of study by sponsor|3|||
44189129|NCT02154529|78984453|FG003|Overall Study|Termination of study by sponsor|1|||
44189130|NCT02154529|78984450|FG000|Overall Study|Lost to Follow-up|1|||
44189131|NCT02154529|78984451|FG001|Overall Study|Lost to Follow-up|0|||
44189132|NCT02154529|78984452|FG002|Overall Study|Lost to Follow-up|0|||
44189133|NCT02154529|78984453|FG003|Overall Study|Lost to Follow-up|0|||
44189134|NCT01954017|78984468|FG000|Overall Study|Adverse Event|0|||
44189135|NCT01954017|78984469|FG001|Overall Study|Adverse Event|0|||
44189136|NCT01954017|78984470|FG002|Overall Study|Adverse Event|1|||
44189137|NCT01954017|78984468|FG000|Overall Study|Death|2|||
44189138|NCT01954017|78984469|FG001|Overall Study|Death|1|||
44189139|NCT01954017|78984470|FG002|Overall Study|Death|1|||
44189140|NCT01954017|78984468|FG000|Overall Study|Withdrawal by Subject|0|||
44189141|NCT01954017|78984469|FG001|Overall Study|Withdrawal by Subject|1|||
44189142|NCT01954017|78984470|FG002|Overall Study|Withdrawal by Subject|0|||
44189143|NCT01954017|78984468|FG000|Overall Study|Protocol Violation|0|||
44189144|NCT01954017|78984469|FG001|Overall Study|Protocol Violation|3|||
44189145|NCT01954017|78984470|FG002|Overall Study|Protocol Violation|2|||
44189146|NCT01954017|78984468|FG000|Overall Study|Necrotizing enterocolitis|1|||
44189147|NCT01954017|78984469|FG001|Overall Study|Necrotizing enterocolitis|0|||
44189148|NCT01954017|78984470|FG002|Overall Study|Necrotizing enterocolitis|1|||
44189149|NCT01954017|78984468|FG000|Overall Study|Enteral intake stopped >7 days|0|||
44189150|NCT01954017|78984469|FG001|Overall Study|Enteral intake stopped >7 days|1|||
44189151|NCT01954017|78984470|FG002|Overall Study|Enteral intake stopped >7 days|1|||
44189152|NCT01954017|78984468|FG000|Overall Study|All other reasons|2|||
44189153|NCT01954017|78984469|FG001|Overall Study|All other reasons|2|||
44189154|NCT01954017|78984470|FG002|Overall Study|All other reasons|7|||
44189155|NCT02154139|78984504|FG000|Overall Study|Injection not administered|2|||
44189156|NCT02154139|78984504|FG000|Overall Study|Other|2|||
44189157|NCT02154139|78984504|FG000|Overall Study|Investigator transferred|3|||
44189158|NCT02245568|78984508|FG000|Overall Study|Study terminated by Sponsor|346|||
44189159|NCT02245568|78984508|FG000|Overall Study|Adverse Event|144|||
44189160|NCT02245568|78984508|FG000|Overall Study|Lack of Efficacy|98|||
44189161|NCT02245568|78984508|FG000|Overall Study|Withdrawal by Caregiver|85|||
44189162|NCT02245568|78984508|FG000|Overall Study|Withdrawal by Subject|77|||
44189163|NCT02245568|78984508|FG000|Overall Study|Withdrawal by Legal Representative|31|||
44189164|NCT02245568|78984508|FG000|Overall Study|Missing (Site closure)|16|||
44189165|NCT02245568|78984508|FG000|Overall Study|Physician Decision|14|||
44189166|NCT02245568|78984508|FG000|Overall Study|Non-compliance with study drug|11|||
44189167|NCT02245568|78984508|FG000|Overall Study|Death|9|||
44189168|NCT02245568|78984508|FG000|Overall Study|Blue staining|6|||
44189169|NCT02245568|78984508|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
44189170|NCT02245568|78984508|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
44189171|NCT02245568|78984508|FG000|Overall Study|Lost to Follow-up|5|||
44189172|NCT02154061|78984514|FG000|Overall Study|Pregnancy|1|||
44266032|NCT02384382|79172867|FG000|Overall Study|Death|1|||
44266033|NCT02384382|79172867|FG000|Overall Study|Adverse Event|1|||
44266034|NCT02384382|79172867|FG000|Overall Study|Disease progression|16|||
44189173|NCT02154061|78984515|FG001|Overall Study|Pregnancy|0|||
44189174|NCT02154061|78984514|FG000|Overall Study|enrolled but not vaccinated|1|||
44189175|NCT02154061|78984515|FG001|Overall Study|enrolled but not vaccinated|0|||
44189176|NCT01907217|78984523|FG000|Overall Study|Withdrawal by Subject|0|||
44189177|NCT01907217|78984524|FG001|Overall Study|Withdrawal by Subject|2|||
44361249|NCT00893464|79366901|FG000|Overall Study|Did not complete therapy/experience PD|0|||
44189178|NCT01953783|78984532|FG000|Overall Study|Progressive disease|2|||
44189179|NCT02134015|78984538|FG000|Overall Study|Protocol Violation|0|||
44189180|NCT02134015|78984539|FG001|Overall Study|Protocol Violation|1|||
44189181|NCT02134015|78984538|FG000|Overall Study|Death|2|||
44189182|NCT02134015|78984539|FG001|Overall Study|Death|1|||
44189183|NCT02134015|78984538|FG000|Overall Study|Reason not provided|1|||
44189184|NCT02134015|78984539|FG001|Overall Study|Reason not provided|2|||
44189185|NCT02134015|78984538|FG000|Overall Study|Clinical progression|14|||
44189186|NCT02134015|78984539|FG001|Overall Study|Clinical progression|7|||
44189187|NCT02134015|78984538|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
44189188|NCT02134015|78984539|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
44189189|NCT02134015|78984538|FG000|Overall Study|Study terminated by sponsor|2|||
44189190|NCT02134015|78984539|FG001|Overall Study|Study terminated by sponsor|3|||
44189191|NCT02134015|78984538|FG000|Overall Study|Adverse Event|9|||
44189192|NCT02134015|78984539|FG001|Overall Study|Adverse Event|10|||
44189193|NCT02134015|78984538|FG000|Overall Study|Withdrawal by Subject|3|||
44189194|NCT02134015|78984539|FG001|Overall Study|Withdrawal by Subject|7|||
44189195|NCT01924845|78984545|FG000|Overall Study|Adverse Event|3|||
44189196|NCT01924845|78984545|FG000|Overall Study|Withdrawal by Subject|2|||
44189197|NCT01924845|78984545|FG000|Overall Study|Protocol Violation|1|||
44189198|NCT01630135|78984551|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
44189199|NCT01630135|78984552|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
44189200|NCT01691248|78984560|FG000|Overall Study|Protocol Violation|43|||
44189201|NCT01691248|78984561|FG001|Overall Study|Protocol Violation|27|||
44189202|NCT01691248|78984560|FG000|Overall Study|Adverse Event|24|||
44189203|NCT01691248|78984561|FG001|Overall Study|Adverse Event|22|||
44189204|NCT01691248|78984560|FG000|Overall Study|Withdrawal by Subject|20|||
44189205|NCT01691248|78984561|FG001|Overall Study|Withdrawal by Subject|18|||
44189206|NCT01691248|78984560|FG000|Overall Study|Confirmed CDAD|14|||
44189207|NCT01691248|78984561|FG001|Overall Study|Confirmed CDAD|31|||
44189208|NCT01691248|78984560|FG000|Overall Study|Lost to Follow-up|2|||
44189209|NCT01691248|78984561|FG001|Overall Study|Lost to Follow-up|5|||
44189210|NCT01691248|78984560|FG000|Overall Study|Reason not provided|4|||
44189211|NCT01691248|78984561|FG001|Overall Study|Reason not provided|4|||
44189212|NCT01691248|78984560|FG000|Overall Study|Not Treated|4|||
44189213|NCT01691248|78984561|FG001|Overall Study|Not Treated|7|||
44189214|NCT01924767|78984572|FG000|Overall Study|Adverse Event|1|||
44189215|NCT01924767|78984573|FG001|Overall Study|Adverse Event|0|||
44189216|NCT01924767|78984574|FG002|Overall Study|Adverse Event|1|||
44189217|NCT01924767|78984575|FG003|Overall Study|Adverse Event|0|||
44189218|NCT01924767|78984576|FG004|Overall Study|Adverse Event|0|||
44189219|NCT01691092|78984593|FG000|Overall Study|Lost to Follow-up|10|||
44189220|NCT01691092|78984593|FG000|Overall Study|Physician Decision|4|||
44189221|NCT01691092|78984593|FG000|Overall Study|Withdrawal by Subject|3|||
44189222|NCT01691092|78984593|FG000|Overall Study|non-compliance|3|||
44189223|NCT01691092|78984593|FG000|Overall Study|used for different study|2|||
44189224|NCT01691092|78984593|FG000|Overall Study|screen fail|19|||
44189225|NCT02133001|78984599|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
44189226|NCT02133001|78984600|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
44189227|NCT02133001|78984599|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
44189228|NCT02133001|78984600|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
44189229|NCT02133001|78984599|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
44189230|NCT02133001|78984600|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
44189231|NCT02133001|78984599|FG000|Double Blind (Day 1-25)|Other|2|||
44189232|NCT02133001|78984600|FG001|Double Blind (Day 1-25)|Other|2|||
44189233|NCT02133001|78984599|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
44189234|NCT02133001|78984600|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
44189235|NCT02133001|78984599|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
44189236|NCT02133001|78984600|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
44189237|NCT02133001|78984599|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
44189238|NCT02133001|78984600|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
44189239|NCT02133001|78984599|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
44189240|NCT02133001|78984600|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
44189241|NCT01709578|78984611|FG000|Overall Study|Rescued and entered in long term safety|63|||
44189242|NCT01709578|78984612|FG001|Overall Study|Rescued and entered in long term safety|25|||
44189243|NCT01709578|78984613|FG002|Overall Study|Rescued and entered in long term safety|26|||
44189244|NCT01709578|78984611|FG000|Overall Study|Adverse Event|9|||
44189245|NCT01709578|78984612|FG001|Overall Study|Adverse Event|18|||
44189246|NCT01709578|78984613|FG002|Overall Study|Adverse Event|17|||
44189247|NCT01709578|78984611|FG000|Overall Study|Lack of Efficacy|5|||
44189248|NCT01709578|78984612|FG001|Overall Study|Lack of Efficacy|4|||
44266035|NCT02437188|79172887|FG000|Overall Study|Randomized but did not receive surgery|4|||
44266036|NCT02437188|79172888|FG001|Overall Study|Randomized but did not receive surgery|8|||
44189249|NCT01709578|78984613|FG002|Overall Study|Lack of Efficacy|2|||
44189250|NCT01709578|78984611|FG000|Overall Study|Poor compliance to protocol|1|||
44189251|NCT01709578|78984612|FG001|Overall Study|Poor compliance to protocol|2|||
44189252|NCT01709578|78984613|FG002|Overall Study|Poor compliance to protocol|1|||
44189253|NCT01709578|78984611|FG000|Overall Study|Other, not related to safety or efficacy|2|||
44189254|NCT01709578|78984612|FG001|Overall Study|Other, not related to safety or efficacy|7|||
44189255|NCT01709578|78984613|FG002|Overall Study|Other, not related to safety or efficacy|5|||
44189256|NCT02132767|78984623|FG000|Overall Study|Death|3|||
44189257|NCT02132767|78984624|FG001|Overall Study|Death|2|||
44189258|NCT02132767|78984623|FG000|Overall Study|Withdrawal by Subject|10|||
44189259|NCT02132767|78984624|FG001|Overall Study|Withdrawal by Subject|9|||
44189260|NCT02132767|78984623|FG000|Overall Study|Lost to Follow-up|4|||
44189261|NCT02132767|78984624|FG001|Overall Study|Lost to Follow-up|4|||
44189262|NCT02153905|78984632|FG000|Overall Study|Death|1|||
44189263|NCT02153905|78984633|FG001|Overall Study|Death|0|||
44189264|NCT02153827|78984641|FG000|Overall Study|Lost to Follow-up|3|||
44189265|NCT02153827|78984642|FG001|Overall Study|Lost to Follow-up|9|||
44189266|NCT02153359|78984648|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
44189267|NCT02153359|78984649|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
44189268|NCT01691014|78984662|FG000|Overall Study|Premature Termination|1|||
44189269|NCT01691014|78984663|FG001|Overall Study|Premature Termination|6|||
44189270|NCT01691014|78984664|FG002|Overall Study|Premature Termination|0|||
44189271|NCT01691014|78984665|FG003|Overall Study|Premature Termination|3|||
44189272|NCT01691014|78984662|FG000|Overall Study|Other|0|||
44189273|NCT01691014|78984663|FG001|Overall Study|Other|0|||
44189274|NCT01691014|78984664|FG002|Overall Study|Other|2|||
44189275|NCT01691014|78984665|FG003|Overall Study|Other|0|||
44189276|NCT01691014|78984662|FG000|Overall Study|Withdrawal by Subject|0|||
44189277|NCT01691014|78984663|FG001|Overall Study|Withdrawal by Subject|1|||
44189278|NCT01691014|78984664|FG002|Overall Study|Withdrawal by Subject|1|||
44189279|NCT01691014|78984665|FG003|Overall Study|Withdrawal by Subject|1|||
44189280|NCT01691014|78984662|FG000|Overall Study|Adverse Event|0|||
44189281|NCT01691014|78984663|FG001|Overall Study|Adverse Event|5|||
44189282|NCT01691014|78984664|FG002|Overall Study|Adverse Event|1|||
44189283|NCT01691014|78984665|FG003|Overall Study|Adverse Event|1|||
44189284|NCT01691014|78984662|FG000|Overall Study|Lack of Efficacy|2|||
44189285|NCT01691014|78984663|FG001|Overall Study|Lack of Efficacy|3|||
44189286|NCT01691014|78984664|FG002|Overall Study|Lack of Efficacy|7|||
44189287|NCT01691014|78984665|FG003|Overall Study|Lack of Efficacy|0|||
44189288|NCT02245412|78984678|FG000|Treatment Period|Death|1|||
44189289|NCT02245412|78984679|FG001|Treatment Period|Death|1|||
44189290|NCT02245412|78984680|FG002|Treatment Period|Death|0|||
44189291|NCT02245412|78984678|FG000|Treatment Period|Physician Decision|1|||
44189292|NCT02245412|78984679|FG001|Treatment Period|Physician Decision|1|||
44189293|NCT02245412|78984680|FG002|Treatment Period|Physician Decision|0|||
44189294|NCT02245412|78984678|FG000|Treatment Period|Withdrawal by Subject|2|||
44189295|NCT02245412|78984679|FG001|Treatment Period|Withdrawal by Subject|1|||
44189296|NCT02245412|78984680|FG002|Treatment Period|Withdrawal by Subject|0|||
44189297|NCT02245412|78984678|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
44189298|NCT02245412|78984679|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
44189299|NCT02245412|78984680|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
44189300|NCT02245412|78984678|FG000|Follow-Up Period|Death|4|||
44189301|NCT02245412|78984679|FG001|Follow-Up Period|Death|2|||
44189302|NCT02245412|78984680|FG002|Follow-Up Period|Death|1|||
44189303|NCT02245412|78984678|FG000|Follow-Up Period|Physician Decision|1|||
44189304|NCT02245412|78984679|FG001|Follow-Up Period|Physician Decision|0|||
44189305|NCT02245412|78984680|FG002|Follow-Up Period|Physician Decision|0|||
44189306|NCT02245412|78984678|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
44189307|NCT02245412|78984679|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
44189308|NCT02245412|78984680|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
44189309|NCT02244944|78984688|FG000|Overall Study|Withdrawal by Subject|1|||
44189310|NCT02244944|78984688|FG000|Overall Study|Study Terminated|1|||
44189311|NCT01689532|78984694|FG000|Overall Study|Adverse Event|9|||
44189312|NCT01689532|78984695|FG001|Overall Study|Adverse Event|5|||
44189313|NCT01689532|78984694|FG000|Overall Study|Lack of Efficacy|2|||
44189314|NCT01689532|78984695|FG001|Overall Study|Lack of Efficacy|2|||
44189315|NCT01689532|78984694|FG000|Overall Study|Withdrawal by Subject|1|||
44189316|NCT01689532|78984695|FG001|Overall Study|Withdrawal by Subject|2|||
44189317|NCT01689532|78984694|FG000|Overall Study|Physician Decision|2|||
44266037|NCT02437188|79172887|FG000|Overall Study|Adverse Event|0|||
44266038|NCT02437188|79172888|FG001|Overall Study|Adverse Event|1|||
44266039|NCT02383758|79172910|FG000|Overall Study|Withdrawal by Subject|0|||
44189318|NCT01689532|78984695|FG001|Overall Study|Physician Decision|0|||
44189319|NCT01924689|78984707|FG000|Overall Study|Death|0|||
44189320|NCT01924689|78984708|FG001|Overall Study|Death|1|||
44189321|NCT01924689|78984709|FG002|Overall Study|Death|0|||
44189322|NCT01924689|78984710|FG003|Overall Study|Death|1|||
44189323|NCT01924689|78984711|FG004|Overall Study|Death|0|||
44189324|NCT01924689|78984712|FG005|Overall Study|Death|0|||
44189325|NCT01924689|78984707|FG000|Overall Study|Disease progression|0|||
44189326|NCT01924689|78984708|FG001|Overall Study|Disease progression|0|||
44189327|NCT01924689|78984709|FG002|Overall Study|Disease progression|2|||
44189328|NCT01924689|78984710|FG003|Overall Study|Disease progression|0|||
44189329|NCT01924689|78984711|FG004|Overall Study|Disease progression|3|||
44189330|NCT01924689|78984712|FG005|Overall Study|Disease progression|2|||
44189331|NCT01924689|78984707|FG000|Overall Study|New therapy or study|3|||
44266040|NCT02383758|79172911|FG001|Overall Study|Withdrawal by Subject|2|||
44189332|NCT01924689|78984708|FG001|Overall Study|New therapy or study|2|||
44189333|NCT01924689|78984709|FG002|Overall Study|New therapy or study|1|||
44189334|NCT01924689|78984710|FG003|Overall Study|New therapy or study|4|||
44189335|NCT01924689|78984711|FG004|Overall Study|New therapy or study|2|||
44189336|NCT01924689|78984712|FG005|Overall Study|New therapy or study|0|||
44189337|NCT01924689|78984707|FG000|Overall Study|Withdrawal of consent|0|||
44189338|NCT01924689|78984708|FG001|Overall Study|Withdrawal of consent|0|||
44189339|NCT01924689|78984709|FG002|Overall Study|Withdrawal of consent|1|||
44189340|NCT01924689|78984710|FG003|Overall Study|Withdrawal of consent|1|||
44189341|NCT01924689|78984711|FG004|Overall Study|Withdrawal of consent|0|||
44189342|NCT01924689|78984712|FG005|Overall Study|Withdrawal of consent|0|||
44189343|NCT01924689|78984707|FG000|Overall Study|Other|0|||
44189344|NCT01924689|78984708|FG001|Overall Study|Other|0|||
44189345|NCT01924689|78984709|FG002|Overall Study|Other|0|||
44189346|NCT01924689|78984710|FG003|Overall Study|Other|0|||
44189347|NCT01924689|78984711|FG004|Overall Study|Other|1|||
44189348|NCT01924689|78984712|FG005|Overall Study|Other|0|||
44189349|NCT01591330|78984730|FG000|Period 1|Adverse Event|1|||
44189350|NCT01591330|78984731|FG001|Period 1|Adverse Event|0|||
44189351|NCT01591330|78984732|FG002|Period 1|Adverse Event|0|||
44189352|NCT01591330|78984733|FG003|Period 1|Adverse Event|0|||
44189353|NCT01591330|78984730|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
44189354|NCT01591330|78984731|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
44189355|NCT01591330|78984732|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
44189356|NCT01591330|78984733|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
44189357|NCT01591330|78984730|FG000|Period 2|Adverse Event|1|||
44189358|NCT01591330|78984731|FG001|Period 2|Adverse Event|0|||
44189359|NCT01591330|78984732|FG002|Period 2|Adverse Event|0|||
44189360|NCT01591330|78984733|FG003|Period 2|Adverse Event|0|||
44189361|NCT01591096|78984743|FG000|Overall Study|Adverse Event|1|||
44189362|NCT01953003|78984749|FG000|Overall Study|Not treated|0|||
44189363|NCT01953003|78984750|FG001|Overall Study|Not treated|1|||
44189364|NCT01953003|78984749|FG000|Overall Study|Progressive disease|35|||
44189365|NCT01953003|78984750|FG001|Overall Study|Progressive disease|45|||
44189366|NCT01953003|78984749|FG000|Overall Study|Related Adverse events|7|||
44189367|NCT01953003|78984750|FG001|Overall Study|Related Adverse events|2|||
44189368|NCT01953003|78984749|FG000|Overall Study|Non-related adverse events|0|||
44189369|NCT01953003|78984750|FG001|Overall Study|Non-related adverse events|2|||
44189370|NCT01953003|78984749|FG000|Overall Study|Protocol Violation|0|||
44189371|NCT01953003|78984750|FG001|Overall Study|Protocol Violation|1|||
44189372|NCT01953003|78984749|FG000|Overall Study|Withdrawal by Subject|14|||
44189373|NCT01953003|78984750|FG001|Overall Study|Withdrawal by Subject|4|||
44189374|NCT01952691|78984756|FG000|Overall Study|Lost to Follow-up|2|||
44189375|NCT01709500|78984762|FG000|Overall Study|Randomized but not treated|0|||
44189376|NCT01709500|78984763|FG001|Overall Study|Randomized but not treated|1|||
44189377|NCT01709500|78984762|FG000|Overall Study|Adverse Event|5|||
44189378|NCT01709500|78984763|FG001|Overall Study|Adverse Event|1|||
44189379|NCT01709500|78984762|FG000|Overall Study|Poor compliance to protocol|2|||
44189380|NCT01709500|78984763|FG001|Overall Study|Poor compliance to protocol|1|||
44189381|NCT01709500|78984762|FG000|Overall Study|Other|3|||
44189382|NCT01709500|78984763|FG001|Overall Study|Other|1|||
44189383|NCT01709500|78984762|FG000|Overall Study|Related to IMP administration|1|||
44189384|NCT01709500|78984763|FG001|Overall Study|Related to IMP administration|0|||
44189385|NCT01709500|78984762|FG000|Overall Study|Treatment ongoing|156|||
44189386|NCT01709500|78984763|FG001|Overall Study|Treatment ongoing|78|||
44189387|NCT01599806|78984771|FG000|Overall Study|Lost to Follow-up|20|||
44189388|NCT01599806|78984772|FG001|Overall Study|Lost to Follow-up|20|||
44189389|NCT01599806|78984771|FG000|Overall Study|Withdrawal by Subject|12|||
44189390|NCT01599806|78984772|FG001|Overall Study|Withdrawal by Subject|12|||
44189391|NCT01599806|78984771|FG000|Overall Study|Other Eligibility criteria|11|||
44189392|NCT01599806|78984772|FG001|Overall Study|Other Eligibility criteria|9|||
44189393|NCT01599325|78984778|FG000|Primary Parent Phase|Adverse Event|5|||
44189394|NCT01599325|78984778|FG000|Primary Parent Phase|Disease Progression|7|||
44189395|NCT01599325|78984778|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
44189396|NCT01599325|78984778|FG000|Primary Parent Phase|Death|13|||
44189397|NCT01599325|78984778|FG000|Primary Parent Phase|Protocol Violation|1|||
44189398|NCT01599325|78984778|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
44189399|NCT01599325|78984778|FG000|Primary Parent Phase|Other|2|||
44189400|NCT01599325|78984778|FG000|Extension Phase|Study Closure|1|||
44189401|NCT01599325|78984778|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
44189402|NCT01599325|78984778|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
44189403|NCT01599325|78984778|FG000|Extension Phase|Disease Progression|1|||
44189404|NCT01599325|78984778|FG000|Extension Phase|Withdrawal by Subject|8|||
44189405|NCT01924299|78984785|FG000|Period 2|Withdrawal by Subject|1|||
44189406|NCT01924299|78984786|FG001|Period 2|Withdrawal by Subject|0|||
44189407|NCT01924299|78984785|FG000|Period 2|Adverse Event|0|||
44189408|NCT01924299|78984786|FG001|Period 2|Adverse Event|1|||
44189409|NCT02182999|78984800|FG000|Overall Study|Adverse Event|4|||
44189410|NCT02182999|78984801|FG001|Overall Study|Adverse Event|3|||
44189411|NCT02182999|78984800|FG000|Overall Study|Physician Decision|1|||
44189412|NCT02182999|78984801|FG001|Overall Study|Physician Decision|0|||
44189413|NCT02243696|78984807|FG000|Overall Study|Death|282|||
44189414|NCT02243696|78984807|FG000|Overall Study|Withdrawal by Subject|79|||
44189415|NCT02243696|78984807|FG000|Overall Study|Lost to Follow-up|57|||
44189416|NCT02243696|78984807|FG000|Overall Study|Subject No Longer has Study System|42|||
44189417|NCT02243696|78984807|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
44189418|NCT02243696|78984807|FG000|Overall Study|Study Terminated for EP PASSION|961|||
44189419|NCT01598311|78984813|FG000|Overall Study|Physician Decision|4|||
44189420|NCT01598311|78984814|FG001|Overall Study|Physician Decision|5|||
44189421|NCT01598311|78984813|FG000|Overall Study|Adverse Event|9|||
44189422|NCT01598311|78984814|FG001|Overall Study|Adverse Event|13|||
44189423|NCT01598311|78984813|FG000|Overall Study|Lost to Follow-up|7|||
44189424|NCT01598311|78984814|FG001|Overall Study|Lost to Follow-up|12|||
44189425|NCT01598311|78984813|FG000|Overall Study|Withdrawal by Subject|9|||
44189426|NCT01598311|78984814|FG001|Overall Study|Withdrawal by Subject|13|||
44189427|NCT01598311|78984813|FG000|Overall Study|No reason provided.|0|||
44189428|NCT01598311|78984814|FG001|Overall Study|No reason provided.|5|||
44189429|NCT01598311|78984813|FG000|Overall Study|Randomized but never treated|8|||
44189430|NCT01598311|78984814|FG001|Overall Study|Randomized but never treated|5|||
44189431|NCT01598311|78984813|FG000|Overall Study|Treated but no confirmed CDAD|9|||
44189432|NCT01598311|78984814|FG001|Overall Study|Treated but no confirmed CDAD|8|||
44189433|NCT01598311|78984813|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
44189434|NCT01598311|78984814|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
44189435|NCT02182843|78984820|FG000|Overall Study|Withdrawal by Subject|7|||
44189436|NCT02182843|78984820|FG000|Overall Study|Lost to Follow-up|2|||
44189437|NCT02182843|78984820|FG000|Overall Study|Adverse Event|1|||
44189438|NCT02208050|78984826|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
44189439|NCT02208050|78984827|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
44189440|NCT02978222|78984849|FG000|Overall Study|Withdrawal by Subject|2|||
44189441|NCT02978222|78984850|FG001|Overall Study|Withdrawal by Subject|2|||
44189442|NCT02978222|78984849|FG000|Overall Study|Physician Decision|2|||
44189443|NCT02978222|78984850|FG001|Overall Study|Physician Decision|0|||
44189444|NCT02978222|78984849|FG000|Overall Study|Adverse Event|0|||
44189445|NCT02978222|78984850|FG001|Overall Study|Adverse Event|1|||
44189446|NCT02978222|78984849|FG000|Overall Study|Death|1|||
44189447|NCT02978222|78984850|FG001|Overall Study|Death|0|||
44189448|NCT02978222|78984849|FG000|Overall Study|Disease Progression|32|||
44189449|NCT02978222|78984850|FG001|Overall Study|Disease Progression|32|||
44189450|NCT02978222|78984849|FG000|Overall Study|Early Study Termination|24|||
44189451|NCT02978222|78984850|FG001|Overall Study|Early Study Termination|21|||
44189452|NCT02181673|78984858|FG000|Up to Week 24|Adverse Event|2|||
44189453|NCT02181673|78984859|FG001|Up to Week 24|Adverse Event|0|||
44189454|NCT02181673|78984860|FG002|Up to Week 24|Adverse Event|3|||
44189455|NCT02181673|78984858|FG000|Up to Week 24|Death|1|||
44189456|NCT02181673|78984859|FG001|Up to Week 24|Death|0|||
44189457|NCT02181673|78984860|FG002|Up to Week 24|Death|0|||
44189458|NCT02181673|78984858|FG000|Up to Week 24|Lack of Efficacy|1|||
44189459|NCT02181673|78984859|FG001|Up to Week 24|Lack of Efficacy|0|||
44189460|NCT02181673|78984860|FG002|Up to Week 24|Lack of Efficacy|0|||
44189461|NCT02181673|78984858|FG000|Up to Week 24|Lost to Follow-up|1|||
44189462|NCT02181673|78984859|FG001|Up to Week 24|Lost to Follow-up|0|||
44189463|NCT02181673|78984860|FG002|Up to Week 24|Lost to Follow-up|0|||
44189464|NCT02181673|78984858|FG000|Up to Week 24|Physician Decision|0|||
44189465|NCT02181673|78984859|FG001|Up to Week 24|Physician Decision|0|||
44189466|NCT02181673|78984860|FG002|Up to Week 24|Physician Decision|3|||
44189467|NCT02181673|78984858|FG000|Up to Week 24|Withdrawal by Subject|10|||
44189468|NCT02181673|78984859|FG001|Up to Week 24|Withdrawal by Subject|0|||
44189469|NCT02181673|78984860|FG002|Up to Week 24|Withdrawal by Subject|1|||
44189470|NCT02181673|78984858|FG000|Up to Week 24|Other|2|||
44189471|NCT02181673|78984859|FG001|Up to Week 24|Other|0|||
44189472|NCT02181673|78984860|FG002|Up to Week 24|Other|3|||
44189473|NCT02181673|78984858|FG000|Up to Week 24|Randomized not Treated|0|||
44189474|NCT02181673|78984859|FG001|Up to Week 24|Randomized not Treated|0|||
44189475|NCT02181673|78984860|FG002|Up to Week 24|Randomized not Treated|1|||
44266041|NCT02410278|79172961|FG000|Run-in Period|Adverse Event|5|||
44189476|NCT02181673|78984858|FG000|Week 24-Week 60|Adverse Event|0|||
44189477|NCT02181673|78984859|FG001|Week 24-Week 60|Adverse Event|4|||
44189478|NCT02181673|78984860|FG002|Week 24-Week 60|Adverse Event|10|||
44189479|NCT02181673|78984858|FG000|Week 24-Week 60|Other|0|||
44189480|NCT02181673|78984859|FG001|Week 24-Week 60|Other|2|||
44189481|NCT02181673|78984860|FG002|Week 24-Week 60|Other|1|||
44189482|NCT02181673|78984858|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
44189483|NCT02181673|78984859|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
44189484|NCT02181673|78984860|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
44189485|NCT02181673|78984858|FG000|Week 24-Week 60|Pregnancy|0|||
44189486|NCT02181673|78984859|FG001|Week 24-Week 60|Pregnancy|0|||
44189487|NCT02181673|78984860|FG002|Week 24-Week 60|Pregnancy|1|||
44189488|NCT02181673|78984858|FG000|Week 24-Week 60|Lack of Efficacy|0|||
44189489|NCT02181673|78984859|FG001|Week 24-Week 60|Lack of Efficacy|0|||
44189490|NCT02181673|78984860|FG002|Week 24-Week 60|Lack of Efficacy|1|||
44189491|NCT02181673|78984858|FG000|Week 24-Week 60|Lost to Follow-up|0|||
44189492|NCT02181673|78984859|FG001|Week 24-Week 60|Lost to Follow-up|0|||
44189493|NCT02181673|78984860|FG002|Week 24-Week 60|Lost to Follow-up|1|||
44189494|NCT02181673|78984858|FG000|Week 24-Week 60|Physician Decision|0|||
44189495|NCT02181673|78984859|FG001|Week 24-Week 60|Physician Decision|0|||
44189496|NCT02181673|78984860|FG002|Week 24-Week 60|Physician Decision|1|||
44266042|NCT02410278|79172962|FG001|Run-in Period|Adverse Event|0|||
44266043|NCT02410278|79172963|FG002|Run-in Period|Adverse Event|0|||
44189497|NCT02131129|78984869|FG000|Overall Study|Withdrawal by Subject|1|||
44189498|NCT02131129|78984870|FG001|Overall Study|Withdrawal by Subject|0|||
44189499|NCT02152345|78984878|FG000|Overall Study|Case Cancellations|2|||
44189500|NCT02152345|78984879|FG001|Overall Study|Case Cancellations|4|||
44189501|NCT02152345|78984878|FG000|Overall Study|Withdrawal by Subject|2|||
44189502|NCT02152345|78984879|FG001|Overall Study|Withdrawal by Subject|1|||
44189503|NCT02180659|78984887|FG000|Overall Study|Adverse Event|1|||
44189504|NCT02180659|78984888|FG001|Overall Study|Adverse Event|0|||
44189505|NCT02180659|78984887|FG000|Overall Study|Lost to Follow-up|4|||
44189506|NCT02180659|78984888|FG001|Overall Study|Lost to Follow-up|2|||
44189507|NCT02180659|78984887|FG000|Overall Study|Subject incarcerated during conduct|1|||
44189508|NCT02180659|78984888|FG001|Overall Study|Subject incarcerated during conduct|0|||
44189509|NCT02180659|78984887|FG000|Overall Study|Withdrawal by Subject|0|||
44189510|NCT02180659|78984888|FG001|Overall Study|Withdrawal by Subject|2|||
44189511|NCT02180659|78984887|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
44189512|NCT02180659|78984888|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
44189513|NCT02130427|78984894|FG000|Overall Study|Imaging results not interpretable|30|||
44189514|NCT02207816|78984901|FG000|Overall Study|Serious Adverse Event|0|||
44189515|NCT02207816|78984902|FG001|Overall Study|Serious Adverse Event|5|||
44189516|NCT02207816|78984903|FG002|Overall Study|Serious Adverse Event|2|||
44189517|NCT02207816|78984901|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
44189518|NCT02207816|78984902|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
44189519|NCT02207816|78984903|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
44189520|NCT02207816|78984901|FG000|Overall Study|Withdrawal by Subject|4|||
44189521|NCT02207816|78984902|FG001|Overall Study|Withdrawal by Subject|9|||
44189522|NCT02207816|78984903|FG002|Overall Study|Withdrawal by Subject|7|||
44189523|NCT02207816|78984901|FG000|Overall Study|Migrated/Moved From Study Area|41|||
44189524|NCT02207816|78984902|FG001|Overall Study|Migrated/Moved From Study Area|60|||
44189525|NCT02207816|78984903|FG002|Overall Study|Migrated/Moved From Study Area|51|||
44266044|NCT02410278|79172961|FG000|Run-in Period|GSRS Threshold Not Met|30|||
44266045|NCT02410278|79172962|FG001|Run-in Period|GSRS Threshold Not Met|0|||
44266046|NCT02410278|79172963|FG002|Run-in Period|GSRS Threshold Not Met|0|||
44266047|NCT02410278|79172961|FG000|Run-in Period|Lost to Follow-up|1|||
44266048|NCT02410278|79172962|FG001|Run-in Period|Lost to Follow-up|0|||
44266049|NCT02410278|79172963|FG002|Run-in Period|Lost to Follow-up|0|||
44266050|NCT02410278|79172961|FG000|Run-in Period|Withdrawal by Subject|1|||
44266051|NCT02410278|79172962|FG001|Run-in Period|Withdrawal by Subject|0|||
44266052|NCT02410278|79172963|FG002|Run-in Period|Withdrawal by Subject|0|||
44266053|NCT02410278|79172961|FG000|Run-in Period|Pregnancy|1|||
44266054|NCT02410278|79172962|FG001|Run-in Period|Pregnancy|0|||
44266055|NCT02410278|79172963|FG002|Run-in Period|Pregnancy|0|||
44266056|NCT02410278|79172961|FG000|Study Treatment Period|Adverse Event|0|||
44266057|NCT02410278|79172962|FG001|Study Treatment Period|Adverse Event|6|||
44189526|NCT02207816|78984901|FG000|Overall Study|Lost to Follow-up|3|||
44266058|NCT02410278|79172963|FG002|Study Treatment Period|Adverse Event|3|||
44266059|NCT02410278|79172961|FG000|Study Treatment Period|Physician Decision|0|||
44266060|NCT02410278|79172962|FG001|Study Treatment Period|Physician Decision|0|||
44266061|NCT02410278|79172963|FG002|Study Treatment Period|Physician Decision|1|||
44266062|NCT02410278|79172961|FG000|Study Treatment Period|Withdrawal by Subject|0|||
44189527|NCT02207816|78984902|FG001|Overall Study|Lost to Follow-up|9|||
44189528|NCT02207816|78984903|FG002|Overall Study|Lost to Follow-up|1|||
44189529|NCT02207816|78984901|FG000|Overall Study|Other|1|||
44189530|NCT02207816|78984902|FG001|Overall Study|Other|2|||
44189531|NCT02207816|78984903|FG002|Overall Study|Other|4|||
44189532|NCT02241512|78984916|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
44189533|NCT02241512|78984917|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
44189534|NCT02205476|78984925|FG000|Overall Study|Study termination by Sponsor|7|||
44189535|NCT02205476|78984926|FG001|Overall Study|Study termination by Sponsor|3|||
44266063|NCT02410278|79172962|FG001|Study Treatment Period|Withdrawal by Subject|1|||
44266064|NCT02410278|79172963|FG002|Study Treatment Period|Withdrawal by Subject|0|||
44266065|NCT02410278|79172961|FG000|Study Treatment Period|Other|0|||
44266066|NCT02410278|79172962|FG001|Study Treatment Period|Other|3|||
44189536|NCT01709110|78984940|FG000|Overall Study|Adverse Event|56|||
44189537|NCT01709110|78984941|FG001|Overall Study|Adverse Event|48|||
44189538|NCT01709110|78984940|FG000|Overall Study|Death|14|||
44189539|NCT01709110|78984941|FG001|Overall Study|Death|6|||
44189540|NCT01709110|78984940|FG000|Overall Study|Lost to Follow-up|7|||
44189541|NCT01709110|78984941|FG001|Overall Study|Lost to Follow-up|5|||
44189542|NCT01709110|78984940|FG000|Overall Study|Protocol Violation|4|||
44189543|NCT01709110|78984941|FG001|Overall Study|Protocol Violation|6|||
44189544|NCT01709110|78984940|FG000|Overall Study|Withdrawal by Subject|96|||
44189545|NCT01709110|78984941|FG001|Overall Study|Withdrawal by Subject|89|||
44189546|NCT01709110|78984940|FG000|Overall Study|Physician Decision|4|||
44189547|NCT01709110|78984941|FG001|Overall Study|Physician Decision|10|||
44189548|NCT01709110|78984940|FG000|Overall Study|Sponsor Decision|2|||
44189549|NCT01709110|78984941|FG001|Overall Study|Sponsor Decision|2|||
44189550|NCT01709110|78984940|FG000|Overall Study|Lack of Efficacy|1|||
44189551|NCT01709110|78984941|FG001|Overall Study|Lack of Efficacy|1|||
44189552|NCT01709110|78984940|FG000|Overall Study|Caregiver Decision|1|||
44189553|NCT01709110|78984941|FG001|Overall Study|Caregiver Decision|1|||
44189554|NCT02240108|78984949|FG000|Overall Study|Other than specified|8|||
44189555|NCT02240108|78984950|FG001|Overall Study|Other than specified|6|||
44189556|NCT02240108|78984949|FG000|Overall Study|Adverse Event|1|||
44189557|NCT02240108|78984950|FG001|Overall Study|Adverse Event|9|||
44266067|NCT02410278|79172963|FG002|Study Treatment Period|Other|0|||
44189558|NCT02240108|78984949|FG000|Overall Study|Pregnancy|1|||
44189559|NCT02240108|78984950|FG001|Overall Study|Pregnancy|0|||
44189560|NCT02240108|78984949|FG000|Overall Study|Withdrawal by Subject|4|||
44189561|NCT02240108|78984950|FG001|Overall Study|Withdrawal by Subject|9|||
44189562|NCT02240108|78984949|FG000|Overall Study|StudyTerminated by Sponsor|0|||
44189563|NCT02240108|78984950|FG001|Overall Study|StudyTerminated by Sponsor|1|||
44189564|NCT02239640|78984956|FG000|Overall Study|Withdrawal by Subject|3|||
44189565|NCT02239640|78984956|FG000|Overall Study|Lost to Follow-up|72|||
44189566|NCT02239640|78984956|FG000|Overall Study|Death|142|||
44189567|NCT01590628|78984968|FG000|Overall Study|Death|2|||
44189568|NCT01590628|78984969|FG001|Overall Study|Death|0|||
44189569|NCT02130193|78984981|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
44189570|NCT02130193|78984982|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
44189571|NCT02130193|78984983|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
44189572|NCT02130193|78984981|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
44189573|NCT02130193|78984982|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
44189574|NCT02130193|78984983|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
44189575|NCT02130193|78984981|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
44189576|NCT02130193|78984982|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
44189577|NCT02130193|78984983|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
44189578|NCT02130193|78984981|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
44189579|NCT02130193|78984982|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
44189580|NCT02130193|78984983|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
44189581|NCT01590082|78984994|FG000|Overall Study|Withdrawal by Subject|1|||
44189582|NCT01590082|78984995|FG001|Overall Study|Withdrawal by Subject|0|||
44189583|NCT01590082|78984994|FG000|Overall Study|Ineligible|1|||
44189584|NCT01590082|78984995|FG001|Overall Study|Ineligible|0|||
44189585|NCT01631474|78985006|FG000|Overall Study|Lost to Follow-up|8|||
44189586|NCT01631474|78985007|FG001|Overall Study|Lost to Follow-up|5|||
44189587|NCT01631474|78985008|FG002|Overall Study|Lost to Follow-up|7|||
44189588|NCT01631474|78985009|FG003|Overall Study|Lost to Follow-up|5|||
44189589|NCT01631474|78985010|FG004|Overall Study|Lost to Follow-up|5|||
44189590|NCT01631474|78985006|FG000|Overall Study|Withdrawal by Subject|4|||
44266068|NCT02410278|79172961|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
44266069|NCT02410278|79172962|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
44266070|NCT02410278|79172963|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
44266071|NCT02410200|79172996|FG000|Overall Study|Adverse Event|2|||
44189591|NCT01631474|78985007|FG001|Overall Study|Withdrawal by Subject|4|||
44189592|NCT01631474|78985008|FG002|Overall Study|Withdrawal by Subject|2|||
44189593|NCT01631474|78985009|FG003|Overall Study|Withdrawal by Subject|6|||
44189594|NCT01631474|78985010|FG004|Overall Study|Withdrawal by Subject|5|||
44189595|NCT01631474|78985006|FG000|Overall Study|Lack of Efficacy|2|||
44189596|NCT01631474|78985007|FG001|Overall Study|Lack of Efficacy|2|||
44189597|NCT01631474|78985008|FG002|Overall Study|Lack of Efficacy|0|||
44189598|NCT01631474|78985009|FG003|Overall Study|Lack of Efficacy|0|||
44189599|NCT01631474|78985010|FG004|Overall Study|Lack of Efficacy|2|||
44189600|NCT01631474|78985006|FG000|Overall Study|Noncompliance with Study Drug|0|||
44189601|NCT01631474|78985007|FG001|Overall Study|Noncompliance with Study Drug|0|||
44189602|NCT01631474|78985008|FG002|Overall Study|Noncompliance with Study Drug|0|||
44189603|NCT01631474|78985009|FG003|Overall Study|Noncompliance with Study Drug|0|||
44189604|NCT01631474|78985010|FG004|Overall Study|Noncompliance with Study Drug|1|||
44266072|NCT02383056|79173015|FG000|Overall Study|Adverse Event|1|||
44189605|NCT01631474|78985006|FG000|Overall Study|Adverse Event|0|||
44266073|NCT02383056|79173016|FG001|Overall Study|Adverse Event|0|||
44189606|NCT01631474|78985007|FG001|Overall Study|Adverse Event|1|||
44189607|NCT01631474|78985008|FG002|Overall Study|Adverse Event|0|||
44189608|NCT01631474|78985009|FG003|Overall Study|Adverse Event|0|||
44189609|NCT01631474|78985010|FG004|Overall Study|Adverse Event|0|||
44189610|NCT02203916|78985025|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
44189611|NCT02203916|78985026|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
44189612|NCT02203916|78985027|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
44189613|NCT02203916|78985025|FG000|Overall Study|Major Protocol Deviation|1|||
44189614|NCT02203916|78985026|FG001|Overall Study|Major Protocol Deviation|1|||
44189615|NCT02203916|78985027|FG002|Overall Study|Major Protocol Deviation|0|||
44189616|NCT02203916|78985025|FG000|Overall Study|Lost to Follow-up|0|||
44189617|NCT02203916|78985026|FG001|Overall Study|Lost to Follow-up|1|||
44189618|NCT02203916|78985027|FG002|Overall Study|Lost to Follow-up|0|||
44189619|NCT02203916|78985025|FG000|Overall Study|Voluntary Withdrawal|3|||
44189620|NCT02203916|78985026|FG001|Overall Study|Voluntary Withdrawal|3|||
44189621|NCT02203916|78985027|FG002|Overall Study|Voluntary Withdrawal|8|||
44189622|NCT02203916|78985025|FG000|Overall Study|Lack of Efficacy|3|||
44189623|NCT02203916|78985026|FG001|Overall Study|Lack of Efficacy|0|||
44189624|NCT02203916|78985027|FG002|Overall Study|Lack of Efficacy|0|||
44189625|NCT02203916|78985025|FG000|Overall Study|Reason Not Specified|0|||
44189626|NCT02203916|78985026|FG001|Overall Study|Reason Not Specified|2|||
44189627|NCT02203916|78985027|FG002|Overall Study|Reason Not Specified|1|||
44189628|NCT02179177|78985051|FG000|Overall Study|Lost to Follow-up|1|||
44189629|NCT02179177|78985052|FG001|Overall Study|Lost to Follow-up|1|||
44189630|NCT02179177|78985051|FG000|Overall Study|Withdrawal by Subject|1|||
44189631|NCT02179177|78985052|FG001|Overall Study|Withdrawal by Subject|1|||
44189632|NCT02239328|78985058|FG000|Overall Study|Benign disease noted at time of surgery|6|||
44189633|NCT02239328|78985058|FG000|Overall Study|Equipment or website malfunction|2|||
44189634|NCT02129803|78985064|FG000|Overall Study|Protocol Violation|4|||
44189635|NCT02129803|78985065|FG001|Overall Study|Protocol Violation|0|||
44189636|NCT02129803|78985064|FG000|Overall Study|Physician Decision|0|||
44189637|NCT02129803|78985065|FG001|Overall Study|Physician Decision|1|||
44189638|NCT02129803|78985064|FG000|Overall Study|Difficulty sleeping|1|||
44189639|NCT02129803|78985065|FG001|Overall Study|Difficulty sleeping|0|||
44189640|NCT02129803|78985064|FG000|Overall Study|Morning headache|0|||
44189641|NCT02129803|78985065|FG001|Overall Study|Morning headache|1|||
44189642|NCT02129803|78985064|FG000|Overall Study|Withdrawal by Subject|1|||
44189643|NCT02129803|78985065|FG001|Overall Study|Withdrawal by Subject|1|||
44189644|NCT02239094|78985071|FG000|Overall Study|Withdrawal by Subject|1|||
44189645|NCT02239094|78985071|FG000|Overall Study|Remitted before started|1|||
44189646|NCT02129647|78985075|FG000|Overall Study|Adverse Event|2|||
44189647|NCT02129647|78985075|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
44189648|NCT02238626|78985083|FG000|Overall Study|Adverse Event|3|||
44189649|NCT02238626|78985084|FG001|Overall Study|Adverse Event|5|||
44189650|NCT02238626|78985085|FG002|Overall Study|Adverse Event|0|||
44189651|NCT02238626|78985086|FG003|Overall Study|Adverse Event|3|||
44189652|NCT02238626|78985083|FG000|Overall Study|Lost to Follow-up|2|||
44189653|NCT02238626|78985084|FG001|Overall Study|Lost to Follow-up|4|||
44189654|NCT02238626|78985085|FG002|Overall Study|Lost to Follow-up|2|||
44189655|NCT02238626|78985086|FG003|Overall Study|Lost to Follow-up|2|||
44189656|NCT02238626|78985083|FG000|Overall Study|Withdrawal by Subject|0|||
44189657|NCT02238626|78985084|FG001|Overall Study|Withdrawal by Subject|3|||
44189658|NCT02238626|78985085|FG002|Overall Study|Withdrawal by Subject|0|||
44189659|NCT02238626|78985086|FG003|Overall Study|Withdrawal by Subject|1|||
44189660|NCT02238626|78985083|FG000|Overall Study|Death|0|||
44189661|NCT02238626|78985084|FG001|Overall Study|Death|0|||
44189662|NCT02238626|78985085|FG002|Overall Study|Death|1|||
44189663|NCT02238626|78985086|FG003|Overall Study|Death|1|||
44189664|NCT02238626|78985083|FG000|Overall Study|Other|0|||
44189665|NCT02238626|78985084|FG001|Overall Study|Other|2|||
44189666|NCT02238626|78985085|FG002|Overall Study|Other|0|||
44189667|NCT02238626|78985086|FG003|Overall Study|Other|0|||
44189668|NCT02151643|78985112|FG000|Overall Study|Adverse Event|2|||
44189669|NCT02151643|78985113|FG001|Overall Study|Adverse Event|0|||
44189670|NCT02151643|78985114|FG002|Overall Study|Adverse Event|1|||
44189671|NCT02151643|78985115|FG003|Overall Study|Adverse Event|4|||
44189672|NCT02151643|78985116|FG004|Overall Study|Adverse Event|0|||
44189673|NCT02151643|78985112|FG000|Overall Study|Withdrawal by Subject|0|||
44189674|NCT02151643|78985113|FG001|Overall Study|Withdrawal by Subject|1|||
44189675|NCT02151643|78985114|FG002|Overall Study|Withdrawal by Subject|1|||
44189676|NCT02151643|78985115|FG003|Overall Study|Withdrawal by Subject|1|||
44189677|NCT02151643|78985116|FG004|Overall Study|Withdrawal by Subject|1|||
44189678|NCT02151643|78985112|FG000|Overall Study|Hyperphosphataemia|1|||
44189679|NCT02151643|78985113|FG001|Overall Study|Hyperphosphataemia|0|||
44189680|NCT02151643|78985114|FG002|Overall Study|Hyperphosphataemia|0|||
44189681|NCT02151643|78985115|FG003|Overall Study|Hyperphosphataemia|0|||
44189682|NCT02151643|78985116|FG004|Overall Study|Hyperphosphataemia|1|||
44189683|NCT02151643|78985112|FG000|Overall Study|High Ferritin levels|3|||
44266074|NCT02383056|79173015|FG000|Overall Study|Lost to Follow-up|0|||
44189684|NCT02151643|78985113|FG001|Overall Study|High Ferritin levels|3|||
44189685|NCT02151643|78985114|FG002|Overall Study|High Ferritin levels|2|||
44189686|NCT02151643|78985115|FG003|Overall Study|High Ferritin levels|2|||
44189687|NCT02151643|78985116|FG004|Overall Study|High Ferritin levels|1|||
44189688|NCT02203838|78985132|FG000|Overall Study|Lack of Efficacy|7|||
44189689|NCT02203838|78985133|FG001|Overall Study|Lack of Efficacy|0|||
44189690|NCT02203838|78985134|FG002|Overall Study|Lack of Efficacy|1|||
44189691|NCT02203838|78985135|FG003|Overall Study|Lack of Efficacy|1|||
44189692|NCT02203838|78985132|FG000|Overall Study|Adverse Event|46|||
44189693|NCT02203838|78985133|FG001|Overall Study|Adverse Event|6|||
44189694|NCT02203838|78985134|FG002|Overall Study|Adverse Event|3|||
44189695|NCT02203838|78985135|FG003|Overall Study|Adverse Event|2|||
44189696|NCT02203838|78985132|FG000|Overall Study|Lost to Follow-up|39|||
44189697|NCT02203838|78985133|FG001|Overall Study|Lost to Follow-up|3|||
44189698|NCT02203838|78985134|FG002|Overall Study|Lost to Follow-up|2|||
44189699|NCT02203838|78985135|FG003|Overall Study|Lost to Follow-up|1|||
44189700|NCT02203838|78985132|FG000|Overall Study|Protocol Violation|7|||
44189701|NCT02203838|78985133|FG001|Overall Study|Protocol Violation|3|||
44189702|NCT02203838|78985134|FG002|Overall Study|Protocol Violation|0|||
44189703|NCT02203838|78985135|FG003|Overall Study|Protocol Violation|0|||
44189704|NCT02203838|78985132|FG000|Overall Study|Withdrawal by Subject|83|||
44189705|NCT02203838|78985133|FG001|Overall Study|Withdrawal by Subject|10|||
44189706|NCT02203838|78985134|FG002|Overall Study|Withdrawal by Subject|8|||
44189707|NCT02203838|78985135|FG003|Overall Study|Withdrawal by Subject|11|||
44189708|NCT02203838|78985132|FG000|Overall Study|Physician Decision|27|||
44189709|NCT02203838|78985133|FG001|Overall Study|Physician Decision|0|||
44189710|NCT02203838|78985134|FG002|Overall Study|Physician Decision|2|||
44189711|NCT02203838|78985135|FG003|Overall Study|Physician Decision|3|||
44189712|NCT02203838|78985132|FG000|Overall Study|Other|1|||
44189713|NCT02203838|78985133|FG001|Overall Study|Other|0|||
44189714|NCT02203838|78985134|FG002|Overall Study|Other|0|||
44189715|NCT02203838|78985135|FG003|Overall Study|Other|0|||
44189716|NCT02178787|78985147|FG000|Overall Study|Lost to Follow-up|1|||
44189717|NCT02178787|78985148|FG001|Overall Study|Lost to Follow-up|0|||
44189718|NCT02178787|78985147|FG000|Overall Study|Withdrawal by Subject|0|||
44189719|NCT02178787|78985148|FG001|Overall Study|Withdrawal by Subject|2|||
44189720|NCT02178787|78985147|FG000|Overall Study|No TCD window|3|||
44189721|NCT02178787|78985148|FG001|Overall Study|No TCD window|7|||
44189722|NCT02178787|78985147|FG000|Overall Study|Physician Decision|1|||
44189723|NCT02178787|78985148|FG001|Overall Study|Physician Decision|0|||
44189724|NCT02178709|78985156|FG000|Overall Study|Adverse Event|5|||
44189725|NCT02178709|78985156|FG000|Overall Study|Death|2|||
44189726|NCT02178709|78985156|FG000|Overall Study|Withdrawal by Subject|2|||
44189727|NCT02178709|78985156|FG000|Overall Study|Physician Decision|2|||
44189728|NCT02178709|78985156|FG000|Overall Study|Disease Progression|5|||
44189729|NCT02238080|78985160|FG000|Overall Study|Death|13|||
44189730|NCT02238080|78985160|FG000|Overall Study|Treatment interrupted|6|||
44189731|NCT02238080|78985160|FG000|Overall Study|Withdrawal by Subject|2|||
44189732|NCT02238080|78985160|FG000|Overall Study|Other|4|||
44189733|NCT02150863|78985167|FG000|Overall Study|Lost to Follow-up|0|||
44189734|NCT02150863|78985168|FG001|Overall Study|Lost to Follow-up|1|||
44189735|NCT02150863|78985169|FG002|Overall Study|Lost to Follow-up|0|||
44189736|NCT02178553|78985179|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
44189737|NCT02178553|78985180|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
44189738|NCT02178553|78985179|FG000|Overall Study|Physician Decision|0|||
44189739|NCT02178553|78985180|FG001|Overall Study|Physician Decision|4|||
44189740|NCT02178553|78985179|FG000|Overall Study|Technical problem with injection|1|||
44189741|NCT02178553|78985180|FG001|Overall Study|Technical problem with injection|3|||
44189742|NCT01627327|78985188|FG000|Overall Study|Adverse Event|6|||
44189743|NCT01627327|78985189|FG001|Overall Study|Adverse Event|12|||
44189744|NCT01627327|78985188|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
44189745|NCT01627327|78985189|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
44189746|NCT01627327|78985188|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
44266075|NCT02383056|79173016|FG001|Overall Study|Lost to Follow-up|2|||
44189747|NCT01627327|78985189|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
44189748|NCT01627327|78985188|FG000|Overall Study|Protocol Violation|4|||
44189749|NCT01627327|78985189|FG001|Overall Study|Protocol Violation|10|||
44189750|NCT01627327|78985188|FG000|Overall Study|Lost to Follow-up|1|||
44189751|NCT01627327|78985189|FG001|Overall Study|Lost to Follow-up|3|||
44189752|NCT01627327|78985188|FG000|Overall Study|Physician Decision|1|||
44189753|NCT01627327|78985189|FG001|Overall Study|Physician Decision|0|||
44189754|NCT01627327|78985188|FG000|Overall Study|Withdrawal by Subject|3|||
44189755|NCT01627327|78985189|FG001|Overall Study|Withdrawal by Subject|3|||
44189756|NCT01627249|78985198|FG000|Overall Study|Death|3|||
44189757|NCT01627249|78985199|FG001|Overall Study|Death|5|||
44189758|NCT01627249|78985200|FG002|Overall Study|Death|3|||
44189759|NCT01627249|78985198|FG000|Overall Study|Withdrawal by Subject|12|||
44189760|NCT01627249|78985199|FG001|Overall Study|Withdrawal by Subject|6|||
44189761|NCT01627249|78985200|FG002|Overall Study|Withdrawal by Subject|9|||
44189762|NCT01627249|78985198|FG000|Overall Study|Missed Visit|1|||
44189763|NCT01627249|78985199|FG001|Overall Study|Missed Visit|1|||
44189764|NCT01627249|78985200|FG002|Overall Study|Missed Visit|0|||
44189765|NCT01688830|78985229|FG000|Overall Study|Lost to Follow-up|0|||
44189766|NCT01688830|78985230|FG001|Overall Study|Lost to Follow-up|0|||
44189767|NCT01688830|78985231|FG002|Overall Study|Lost to Follow-up|0|||
44189768|NCT01688830|78985232|FG003|Overall Study|Lost to Follow-up|0|||
44189769|NCT01688830|78985233|FG004|Overall Study|Lost to Follow-up|0|||
44189770|NCT01688830|78985234|FG005|Overall Study|Lost to Follow-up|0|||
44189771|NCT01688830|78985235|FG006|Overall Study|Lost to Follow-up|0|||
44189772|NCT01688830|78985236|FG007|Overall Study|Lost to Follow-up|0|||
44189773|NCT01688830|78985237|FG008|Overall Study|Lost to Follow-up|0|||
44189774|NCT01688830|78985238|FG009|Overall Study|Lost to Follow-up|0|||
44189775|NCT01688830|78985239|FG010|Overall Study|Lost to Follow-up|1|||
44189776|NCT01688830|78985240|FG011|Overall Study|Lost to Follow-up|0|||
44189777|NCT01688830|78985241|FG012|Overall Study|Lost to Follow-up|0|||
44189778|NCT01688830|78985242|FG013|Overall Study|Lost to Follow-up|0|||
44189779|NCT01688830|78985243|FG014|Overall Study|Lost to Follow-up|0|||
44189780|NCT01688830|78985244|FG015|Overall Study|Lost to Follow-up|0|||
44189781|NCT01688830|78985245|FG016|Overall Study|Lost to Follow-up|0|||
44189782|NCT01688830|78985246|FG017|Overall Study|Lost to Follow-up|0|||
44189783|NCT01688830|78985247|FG018|Overall Study|Lost to Follow-up|0|||
44189784|NCT01688830|78985248|FG019|Overall Study|Lost to Follow-up|0|||
44189785|NCT01688830|78985249|FG020|Overall Study|Lost to Follow-up|0|||
44189786|NCT02178475|78985333|FG000|Overall Study|Withdrawal by Subject|7|||
44189787|NCT02178475|78985333|FG000|Overall Study|Lost to Follow-up|10|||
44189788|NCT02178475|78985333|FG000|Overall Study|Death|13|||
44189789|NCT02178475|78985333|FG000|Overall Study|Protocol-specified Criteria|99|||
44189790|NCT01569022|78985337|FG000|First Intervention|Lost to Follow-up|2|||
44189791|NCT01569022|78985338|FG001|First Intervention|Lost to Follow-up|1|||
44189792|NCT01569022|78985337|FG000|Second Intervention|Lost to Follow-up|2|||
44189793|NCT01569022|78985338|FG001|Second Intervention|Lost to Follow-up|2|||
44189794|NCT01629823|78985349|FG000|Trial Period|Missed visit|11|||
44189795|NCT01629823|78985350|FG001|Trial Period|Missed visit|9|||
44189796|NCT01629823|78985351|FG002|Trial Period|Missed visit|8|||
44189797|NCT01629823|78985349|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
44189798|NCT01629823|78985350|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
44189799|NCT01629823|78985351|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
44189800|NCT01629823|78985349|FG000|Trial Period|Pregnancy|1|||
44189801|NCT01629823|78985350|FG001|Trial Period|Pregnancy|0|||
44189802|NCT01629823|78985351|FG002|Trial Period|Pregnancy|0|||
44189803|NCT01629823|78985349|FG000|Trial Period|Adverse Event|0|||
44189804|NCT01629823|78985350|FG001|Trial Period|Adverse Event|1|||
44189805|NCT01629823|78985351|FG002|Trial Period|Adverse Event|0|||
44189806|NCT01629823|78985349|FG000|Trial Period|Out-of-window visit|0|||
44189807|NCT01629823|78985350|FG001|Trial Period|Out-of-window visit|2|||
44189808|NCT01629823|78985351|FG002|Trial Period|Out-of-window visit|0|||
44189809|NCT01629823|78985349|FG000|Trial Period|Failed to hold medication|0|||
44189810|NCT01629823|78985350|FG001|Trial Period|Failed to hold medication|0|||
44189811|NCT01629823|78985351|FG002|Trial Period|Failed to hold medication|1|||
44189812|NCT01629823|78985349|FG000|Washout Period|Safety|2|||
44189813|NCT01629823|78985350|FG001|Washout Period|Safety|5|||
44189814|NCT01629823|78985351|FG002|Washout Period|Safety|0|||
44189815|NCT01629823|78985349|FG000|Washout Period|Pregnancy|1|||
44189816|NCT01629823|78985350|FG001|Washout Period|Pregnancy|0|||
44189817|NCT01629823|78985351|FG002|Washout Period|Pregnancy|0|||
44189818|NCT01629823|78985349|FG000|Washout Period|Protocol Violation|0|||
44189819|NCT01629823|78985350|FG001|Washout Period|Protocol Violation|1|||
44189820|NCT01629823|78985351|FG002|Washout Period|Protocol Violation|0|||
44266076|NCT02409732|79173022|FG000|Overall Study|Withdrawal by Subject|4|||
44266077|NCT02409732|79173022|FG000|Overall Study|Lost to Follow-up|2|||
44266078|NCT01650636|79173033|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
44266079|NCT01650636|79173034|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
44266080|NCT01650636|79173033|FG000|Washout up to 5 Months|Physician Decision|2|||
44189821|NCT01688050|78985359|FG000|Overall Study|Death|7|||
44189822|NCT01688050|78985359|FG000|Overall Study|Conversion to open repair|1|||
44189823|NCT01688050|78985359|FG000|Overall Study|Lost to Follow-up|13|||
44189824|NCT01688050|78985359|FG000|Overall Study|Withdrawal by Subject|10|||
44266081|NCT01650636|79173034|FG001|Washout up to 5 Months|Physician Decision|2|||
44189825|NCT01604278|78985365|FG000|Overall Study|Lack of Efficacy|0|||
44189826|NCT01604278|78985366|FG001|Overall Study|Lack of Efficacy|1|||
44189827|NCT01604278|78985365|FG000|Overall Study|Lost to Follow-up|1|||
44189828|NCT01604278|78985366|FG001|Overall Study|Lost to Follow-up|0|||
44189829|NCT01604278|78985365|FG000|Overall Study|Administrative problems|2|||
44189830|NCT01604278|78985366|FG001|Overall Study|Administrative problems|1|||
44189831|NCT01604278|78985365|FG000|Overall Study|Withdrawal by Subject|3|||
44189832|NCT01604278|78985366|FG001|Overall Study|Withdrawal by Subject|3|||
44189833|NCT01604278|78985365|FG000|Overall Study|Adverse Event|3|||
44189834|NCT01604278|78985366|FG001|Overall Study|Adverse Event|5|||
44266082|NCT01650636|79173033|FG000|Washout up to 5 Months|Death|1|||
44189835|NCT01604278|78985365|FG000|Overall Study|Protocol Deviation|5|||
44189836|NCT01604278|78985366|FG001|Overall Study|Protocol Deviation|3|||
44189837|NCT01687270|78985372|FG000|Overall Study|Lack of Efficacy|11|||
44189838|NCT01687270|78985372|FG000|Overall Study|Lost to Follow-up|1|||
44189839|NCT01589770|78985378|FG000|Overall Study|EGFR <60ml/min|6|||
44189840|NCT01589770|78985379|FG001|Overall Study|EGFR <60ml/min|4|||
44189841|NCT01589770|78985378|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
44189842|NCT01589770|78985379|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
44189843|NCT01588990|78985385|FG000|Phase A|Withdrawal by Subject|5|||
44189844|NCT01588990|78985385|FG000|Phase A|Physician Decision|11|||
44189845|NCT01588990|78985385|FG000|Phase A|Other|14|||
44189846|NCT01588990|78985385|FG000|Phase A|Lost to Follow-up|1|||
44189847|NCT01588990|78985385|FG000|Phase A|Death|5|||
44189848|NCT01588990|78985385|FG000|Phase A|Adverse Event|28|||
44189849|NCT01588990|78985385|FG000|Phase A|Still on therapy at end of study|6|||
44189850|NCT01588990|78985385|FG000|Phase B|Adverse Event|2|||
44189851|NCT01588990|78985385|FG000|Phase B|Still on therapy at end of study|5|||
44189852|NCT01588990|78985385|FG000|Phase B|Withdrawal by Subject|3|||
44189853|NCT01588990|78985385|FG000|Phase B|Physician Decision|4|||
44189854|NCT01588990|78985385|FG000|Phase B|Other|2|||
44189855|NCT02176525|78985401|FG000|Overall Study|Adverse Event|0|||
44189856|NCT02176525|78985402|FG001|Overall Study|Adverse Event|0|||
44189857|NCT02176525|78985403|FG002|Overall Study|Adverse Event|0|||
44189858|NCT02176525|78985404|FG003|Overall Study|Adverse Event|1|||
44189859|NCT02176525|78985405|FG004|Overall Study|Adverse Event|1|||
44189860|NCT02176525|78985406|FG005|Overall Study|Adverse Event|0|||
44189861|NCT02176525|78985407|FG006|Overall Study|Adverse Event|1|||
44189862|NCT02176525|78985408|FG007|Overall Study|Adverse Event|0|||
44189863|NCT02176525|78985401|FG000|Overall Study|not treated|1|||
44189864|NCT02176525|78985402|FG001|Overall Study|not treated|0|||
44189865|NCT02176525|78985403|FG002|Overall Study|not treated|0|||
44189866|NCT02176525|78985404|FG003|Overall Study|not treated|0|||
44189867|NCT02176525|78985405|FG004|Overall Study|not treated|0|||
44189868|NCT02176525|78985406|FG005|Overall Study|not treated|1|||
44189869|NCT02176525|78985407|FG006|Overall Study|not treated|0|||
44189870|NCT02176525|78985408|FG007|Overall Study|not treated|0|||
44189871|NCT02127931|78985434|FG000|Overall Study|Glitch in Game|1|||
44189872|NCT02127307|78985439|FG000|Overall Study|Protocol Violation|36|||
44189873|NCT02127307|78985439|FG000|Overall Study|Lost to Follow-up|2|||
44189874|NCT02127307|78985439|FG000|Overall Study|Death|101|||
44189875|NCT02127307|78985439|FG000|Overall Study|Other than specified above|169|||
44189876|NCT02126839|78985445|FG000|Overall Study|Adverse Event|0|||
44189877|NCT02126839|78985446|FG001|Overall Study|Adverse Event|1|||
44189878|NCT02126839|78985445|FG000|Overall Study|Withdrawal by Subject|1|||
44189879|NCT02126839|78985446|FG001|Overall Study|Withdrawal by Subject|0|||
44189880|NCT02126839|78985445|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44189881|NCT02126839|78985446|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44189882|NCT02126839|78985445|FG000|Overall Study|Protocol Violation|2|||
44189883|NCT02126839|78985446|FG001|Overall Study|Protocol Violation|3|||
44189884|NCT02126839|78985445|FG000|Overall Study|Sponsor request|0|||
44189885|NCT02126839|78985446|FG001|Overall Study|Sponsor request|1|||
44189886|NCT02126839|78985445|FG000|Overall Study|Lost to Follow-up|1|||
44189887|NCT02126839|78985446|FG001|Overall Study|Lost to Follow-up|4|||
44189888|NCT02126839|78985445|FG000|Overall Study|Other|5|||
44189889|NCT02126839|78985446|FG001|Overall Study|Other|5|||
44189890|NCT02125279|78985452|FG000|Overall Study|Lack of Efficacy|2|||
44189891|NCT02125279|78985452|FG000|Overall Study|Withdrawal by Subject|6|||
44189892|NCT02125279|78985452|FG000|Overall Study|Protocol Violation|1|||
44189893|NCT02125279|78985452|FG000|Overall Study|Lost to Follow-up|4|||
44189894|NCT02124811|78985460|FG000|Overall Study|Early termination|2|||
44189895|NCT02124811|78985461|FG001|Overall Study|Early termination|2|||
44189896|NCT02124811|78985460|FG000|Overall Study|Withdrawal by Subject|1|||
44266083|NCT01650636|79173034|FG001|Washout up to 5 Months|Death|0|||
44451407|NCT03859323|79460336|FG003|Overall Study|Lost to Follow-up|0|||
44189897|NCT02124811|78985461|FG001|Overall Study|Withdrawal by Subject|0|||
44189898|NCT02148445|78985469|FG000|Overall Study|Death|1|||
44189899|NCT02148445|78985470|FG001|Overall Study|Death|3|||
44189900|NCT02148211|78985478|FG000|Overall Study|Lost to Follow-up|352|||
44189901|NCT02147587|78985484|FG000|Overall Study|Adverse Event|9|||
44189902|NCT02147587|78985485|FG001|Overall Study|Adverse Event|4|||
44189903|NCT02147587|78985484|FG000|Overall Study|Lack of Efficacy|2|||
44189904|NCT02147587|78985485|FG001|Overall Study|Lack of Efficacy|1|||
44189905|NCT02147353|78985493|FG000|Overall Study|Lost to Follow-up|2|||
44189906|NCT02147353|78985494|FG001|Overall Study|Lost to Follow-up|0|||
44189907|NCT02147353|78985493|FG000|Overall Study|unable to make visits|4|||
44189908|NCT02147353|78985494|FG001|Overall Study|unable to make visits|0|||
44189909|NCT02147353|78985493|FG000|Overall Study|medication noncompliance|3|||
44189910|NCT02147353|78985494|FG001|Overall Study|medication noncompliance|0|||
44189911|NCT02147197|78985503|FG000|Overall Study|Adverse Event|1|||
44189912|NCT02147197|78985504|FG001|Overall Study|Adverse Event|0|||
44266084|NCT01650636|79173033|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
44189913|NCT02147197|78985505|FG002|Overall Study|Adverse Event|0|||
44189914|NCT02147197|78985503|FG000|Overall Study|Withdrawal of Consent|4|||
44189915|NCT02147197|78985504|FG001|Overall Study|Withdrawal of Consent|3|||
44189916|NCT02147197|78985505|FG002|Overall Study|Withdrawal of Consent|2|||
44189917|NCT02147197|78985503|FG000|Overall Study|Lost to Follow-up|2|||
44189918|NCT02147197|78985504|FG001|Overall Study|Lost to Follow-up|3|||
44189919|NCT02147197|78985505|FG002|Overall Study|Lost to Follow-up|1|||
44189920|NCT02147197|78985503|FG000|Overall Study|Protocol Violation|1|||
44189921|NCT02147197|78985504|FG001|Overall Study|Protocol Violation|0|||
44189922|NCT02147197|78985505|FG002|Overall Study|Protocol Violation|3|||
44189923|NCT02147197|78985503|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44189924|NCT02147197|78985504|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44189925|NCT02147197|78985505|FG002|Overall Study|Other Miscellaneous Reasons|3|||
44189926|NCT02176291|78985515|FG000|Overall Study|Death|1|||
44189927|NCT02176291|78985516|FG001|Overall Study|Death|0|||
44189928|NCT02176291|78985515|FG000|Overall Study|non compliance with protocol|2|||
44189929|NCT02176291|78985516|FG001|Overall Study|non compliance with protocol|0|||
44189930|NCT02176291|78985515|FG000|Overall Study|Withdrawal by Subject|2|||
44189931|NCT02176291|78985516|FG001|Overall Study|Withdrawal by Subject|0|||
44189932|NCT02175745|78985522|FG000|Overall Study|Not Eligible|1|||
44189933|NCT02175277|78985526|FG000|Overall Study|Protocol-specified Criteria|1|||
44189934|NCT02124265|78985530|FG000|Overall Study|Adverse Event|1|||
44189935|NCT02146105|78985534|FG000|Overall Study|Adverse Event|1|||
44189936|NCT02146105|78985534|FG000|Overall Study|Withdrawal by Subject|5|||
44189937|NCT02175199|78985540|FG000|Overall Study|Withdrawal by Subject|1|||
44189938|NCT02175199|78985541|FG001|Overall Study|Withdrawal by Subject|5|||
44189939|NCT02175199|78985540|FG000|Overall Study|Randomized in Error|1|||
44189940|NCT02175199|78985541|FG001|Overall Study|Randomized in Error|0|||
44189941|NCT02175199|78985540|FG000|Overall Study|Sponsor Decision|1|||
44189942|NCT02175199|78985541|FG001|Overall Study|Sponsor Decision|0|||
44189943|NCT02123797|78985550|FG000|Baseline Intervention|Death|9|||
44189944|NCT02123797|78985551|FG001|Baseline Intervention|Death|16|||
44189945|NCT02123797|78985552|FG002|Baseline Intervention|Death|0|||
44189946|NCT02123797|78985553|FG003|Baseline Intervention|Death|0|||
44189947|NCT02123797|78985554|FG004|Baseline Intervention|Death|0|||
44189948|NCT02123797|78985550|FG000|Baseline Intervention|Withdrawal by Subject|2|||
44266085|NCT01650636|79173034|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
44189949|NCT02123797|78985551|FG001|Baseline Intervention|Withdrawal by Subject|8|||
44189950|NCT02123797|78985552|FG002|Baseline Intervention|Withdrawal by Subject|0|||
44189951|NCT02123797|78985553|FG003|Baseline Intervention|Withdrawal by Subject|0|||
44189952|NCT02123797|78985554|FG004|Baseline Intervention|Withdrawal by Subject|0|||
44189953|NCT02123797|78985550|FG000|Baseline Intervention|Relocation|2|||
44189954|NCT02123797|78985551|FG001|Baseline Intervention|Relocation|0|||
44189955|NCT02123797|78985552|FG002|Baseline Intervention|Relocation|0|||
44189956|NCT02123797|78985553|FG003|Baseline Intervention|Relocation|0|||
44189957|NCT02123797|78985554|FG004|Baseline Intervention|Relocation|0|||
44189958|NCT02123797|78985550|FG000|Baseline Intervention|Out of window for initial survey|6|||
44189959|NCT02123797|78985551|FG001|Baseline Intervention|Out of window for initial survey|13|||
44189960|NCT02123797|78985552|FG002|Baseline Intervention|Out of window for initial survey|0|||
44189961|NCT02123797|78985553|FG003|Baseline Intervention|Out of window for initial survey|0|||
44189962|NCT02123797|78985554|FG004|Baseline Intervention|Out of window for initial survey|0|||
44189963|NCT02123797|78985550|FG000|Baseline Intervention|Lost to Follow-up|0|||
44189964|NCT02123797|78985551|FG001|Baseline Intervention|Lost to Follow-up|5|||
44189965|NCT02123797|78985552|FG002|Baseline Intervention|Lost to Follow-up|0|||
44189966|NCT02123797|78985553|FG003|Baseline Intervention|Lost to Follow-up|0|||
44266086|NCT01650636|79173033|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
44266087|NCT01650636|79173034|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
44266088|NCT01650636|79173033|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
44266089|NCT01650636|79173034|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
44266090|NCT02436876|79173044|FG000|Overall Study|Lost to Follow-up|0|||
44266091|NCT02436876|79173045|FG001|Overall Study|Lost to Follow-up|1|||
44266092|NCT02436876|79173046|FG002|Overall Study|Lost to Follow-up|1|||
44189967|NCT02123797|78985554|FG004|Baseline Intervention|Lost to Follow-up|0|||
44266093|NCT02436876|79173047|FG003|Overall Study|Lost to Follow-up|1|||
44266094|NCT02436876|79173044|FG000|Overall Study|Withdrawal by Subject|1|||
44266095|NCT02436876|79173045|FG001|Overall Study|Withdrawal by Subject|0|||
44266096|NCT02436876|79173046|FG002|Overall Study|Withdrawal by Subject|0|||
44266097|NCT02436876|79173047|FG003|Overall Study|Withdrawal by Subject|1|||
44266098|NCT02436876|79173044|FG000|Overall Study|Physician Decision|0|||
44189968|NCT02123797|78985550|FG000|Baseline Intervention|Other Disease|3|||
44189969|NCT02123797|78985551|FG001|Baseline Intervention|Other Disease|0|||
44266099|NCT02436876|79173045|FG001|Overall Study|Physician Decision|2|||
44266100|NCT02436876|79173046|FG002|Overall Study|Physician Decision|1|||
44189970|NCT02123797|78985552|FG002|Baseline Intervention|Other Disease|0|||
44189971|NCT02123797|78985553|FG003|Baseline Intervention|Other Disease|0|||
44189972|NCT02123797|78985554|FG004|Baseline Intervention|Other Disease|0|||
44189973|NCT02123797|78985550|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
44189974|NCT02123797|78985551|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
44189975|NCT02123797|78985552|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
44189976|NCT02123797|78985553|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
44189977|NCT02123797|78985554|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
44189978|NCT02123797|78985550|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
44189979|NCT02123797|78985551|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
44189980|NCT02123797|78985552|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
44189981|NCT02123797|78985553|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
44189982|NCT02123797|78985554|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
44189983|NCT02123797|78985550|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
44189984|NCT02123797|78985551|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
44189985|NCT02123797|78985552|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
44189986|NCT02123797|78985553|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
44189987|NCT02123797|78985554|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
44189988|NCT02123797|78985550|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
44189989|NCT02123797|78985551|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
44189990|NCT02123797|78985552|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
44189991|NCT02123797|78985553|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
44189992|NCT02123797|78985554|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
44189993|NCT02123797|78985550|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
44189994|NCT02123797|78985551|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
44189995|NCT02123797|78985552|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
44189996|NCT02123797|78985553|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
44189997|NCT02123797|78985554|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
44189998|NCT02123797|78985550|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
44189999|NCT02123797|78985551|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
44190000|NCT02123797|78985552|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
44190001|NCT02123797|78985553|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
44190002|NCT02123797|78985554|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
44190003|NCT02123797|78985550|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
44190004|NCT02123797|78985551|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
44190005|NCT02123797|78985552|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
44190006|NCT02123797|78985553|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
44190007|NCT02123797|78985554|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
44190008|NCT02123797|78985550|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
44190009|NCT02123797|78985551|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
44190010|NCT02123797|78985552|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
44190011|NCT02123797|78985553|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
44190012|NCT02123797|78985554|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
44190013|NCT02123797|78985550|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
44190014|NCT02123797|78985551|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
44190015|NCT02123797|78985552|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
44190016|NCT02123797|78985553|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
44190017|NCT02123797|78985554|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
44190018|NCT02175121|78985579|FG000|Overall Study|Lack of Efficacy|1|||
44190019|NCT02175121|78985580|FG001|Overall Study|Lack of Efficacy|0|||
44190020|NCT02175121|78985581|FG002|Overall Study|Lack of Efficacy|0|||
44190021|NCT02175121|78985582|FG003|Overall Study|Lack of Efficacy|0|||
44190022|NCT02175121|78985583|FG004|Overall Study|Lack of Efficacy|0|||
44190023|NCT02175121|78985579|FG000|Overall Study|Lost to Follow-up|0|||
44190024|NCT02175121|78985580|FG001|Overall Study|Lost to Follow-up|1|||
44190025|NCT02175121|78985581|FG002|Overall Study|Lost to Follow-up|0|||
44190026|NCT02175121|78985582|FG003|Overall Study|Lost to Follow-up|1|||
44190027|NCT02175121|78985583|FG004|Overall Study|Lost to Follow-up|0|||
44190028|NCT02175121|78985579|FG000|Overall Study|Personal emergency|0|||
44190029|NCT02175121|78985580|FG001|Overall Study|Personal emergency|0|||
44190030|NCT02175121|78985581|FG002|Overall Study|Personal emergency|0|||
44190031|NCT02175121|78985582|FG003|Overall Study|Personal emergency|0|||
44190032|NCT02175121|78985583|FG004|Overall Study|Personal emergency|1|||
44190033|NCT02175121|78985579|FG000|Overall Study|Schedule conflict|0|||
44266101|NCT02436876|79173047|FG003|Overall Study|Physician Decision|0|||
44190034|NCT02175121|78985580|FG001|Overall Study|Schedule conflict|0|||
44190035|NCT02175121|78985581|FG002|Overall Study|Schedule conflict|1|||
44190036|NCT02175121|78985582|FG003|Overall Study|Schedule conflict|0|||
44190037|NCT02175121|78985583|FG004|Overall Study|Schedule conflict|0|||
44190038|NCT02175121|78985579|FG000|Overall Study|Time issues|0|||
44190039|NCT02175121|78985580|FG001|Overall Study|Time issues|0|||
44266102|NCT02436876|79173044|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
44190040|NCT02175121|78985581|FG002|Overall Study|Time issues|1|||
44190041|NCT02175121|78985582|FG003|Overall Study|Time issues|0|||
44190042|NCT02175121|78985583|FG004|Overall Study|Time issues|0|||
44190043|NCT01568866|78985601|FG000|Overall Study|Disease Progression|208|||
44190044|NCT01568866|78985602|FG001|Overall Study|Disease Progression|183|||
44190045|NCT01568866|78985601|FG000|Overall Study|Adverse Event|94|||
44190046|NCT01568866|78985602|FG001|Overall Study|Adverse Event|96|||
44190047|NCT01568866|78985601|FG000|Overall Study|Patient Request|55|||
44190048|NCT01568866|78985602|FG001|Overall Study|Patient Request|71|||
44190049|NCT01568866|78985601|FG000|Overall Study|Physician Decision|40|||
44190050|NCT01568866|78985602|FG001|Overall Study|Physician Decision|32|||
44190051|NCT01568866|78985601|FG000|Overall Study|Withdrawal by Subject|19|||
44190052|NCT01568866|78985602|FG001|Overall Study|Withdrawal by Subject|11|||
44190053|NCT01568866|78985601|FG000|Overall Study|Death|10|||
44190054|NCT01568866|78985602|FG001|Overall Study|Death|18|||
44190055|NCT01568866|78985601|FG000|Overall Study|Protocol Non-compliance|2|||
44190056|NCT01568866|78985602|FG001|Overall Study|Protocol Non-compliance|4|||
44190057|NCT01568866|78985601|FG000|Overall Study|Lost to Follow-up|1|||
44190058|NCT01568866|78985602|FG001|Overall Study|Lost to Follow-up|0|||
44190059|NCT01568866|78985601|FG000|Overall Study|Randomized but Not Dosed|9|||
44190060|NCT01568866|78985602|FG001|Overall Study|Randomized but Not Dosed|1|||
44190061|NCT01568320|78985608|FG000|Overall Study|Death|20|||
44190062|NCT01568320|78985608|FG000|Overall Study|Lost to Follow-up|9|||
44190063|NCT01568320|78985608|FG000|Overall Study|Withdrawal by Subject|10|||
44190064|NCT01568320|78985608|FG000|Overall Study|Conversion to open repair|1|||
44190065|NCT01568320|78985608|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
44190066|NCT01567852|78985614|FG000|Overall Study|Withdrawal by Subject|3|||
44190067|NCT01567852|78985615|FG001|Overall Study|Withdrawal by Subject|6|||
44190068|NCT01567852|78985614|FG000|Overall Study|ECT discontinued|1|||
44190069|NCT01567852|78985615|FG001|Overall Study|ECT discontinued|1|||
44190070|NCT01588366|78985626|FG000|Overall Study|Adverse Event|0|||
44190071|NCT01588366|78985627|FG001|Overall Study|Adverse Event|1|||
44190072|NCT01588366|78985628|FG002|Overall Study|Adverse Event|0|||
44190073|NCT01588366|78985629|FG003|Overall Study|Adverse Event|1|||
44190074|NCT01588366|78985630|FG004|Overall Study|Adverse Event|0|||
44190075|NCT01588366|78985631|FG005|Overall Study|Adverse Event|2|||
44190076|NCT01686958|78985647|FG000|Overall Study|Withdrawal by Subject|1|||
44190077|NCT01686568|78985654|FG000|Main Study|Withdrawal by Subject|1|||
44190078|NCT01686568|78985655|FG001|Main Study|Withdrawal by Subject|3|||
44190079|NCT01686568|78985654|FG000|Main Study|Noncompliance with protocol|0|||
44190080|NCT01686568|78985655|FG001|Main Study|Noncompliance with protocol|1|||
44190081|NCT01686568|78985654|FG000|Main Study|Liver enzymes above range of exclusion|1|||
44190082|NCT01686568|78985655|FG001|Main Study|Liver enzymes above range of exclusion|0|||
44190083|NCT01686568|78985654|FG000|Sub-Study|Not consented for sub-study|2|||
44190084|NCT01686568|78985655|FG001|Sub-Study|Not consented for sub-study|2|||
44190085|NCT01567462|78985663|FG000|Overall Study|Withdrawal by Subject|4|||
44190086|NCT01567462|78985664|FG001|Overall Study|Withdrawal by Subject|7|||
44190087|NCT01587898|78985674|FG000|Overall Study|Adverse Event|1|||
44190088|NCT01587898|78985675|FG001|Overall Study|Adverse Event|1|||
44190089|NCT01587898|78985676|FG002|Overall Study|Adverse Event|0|||
44190090|NCT01587898|78985677|FG003|Overall Study|Adverse Event|0|||
44190091|NCT01587898|78985674|FG000|Overall Study|Protocol Violation|0|||
44190092|NCT01587898|78985675|FG001|Overall Study|Protocol Violation|2|||
44190093|NCT01587898|78985676|FG002|Overall Study|Protocol Violation|1|||
44190094|NCT01587898|78985677|FG003|Overall Study|Protocol Violation|1|||
44190095|NCT01587898|78985674|FG000|Overall Study|Lost to Follow-up|0|||
44190096|NCT01587898|78985675|FG001|Overall Study|Lost to Follow-up|0|||
44190097|NCT01587898|78985676|FG002|Overall Study|Lost to Follow-up|0|||
44190098|NCT01587898|78985677|FG003|Overall Study|Lost to Follow-up|1|||
44190099|NCT01587898|78985674|FG000|Overall Study|Withdrawal by Subject|2|||
44190100|NCT01587898|78985675|FG001|Overall Study|Withdrawal by Subject|1|||
44190101|NCT01587898|78985676|FG002|Overall Study|Withdrawal by Subject|0|||
44190102|NCT01587898|78985677|FG003|Overall Study|Withdrawal by Subject|0|||
44451408|NCT03859323|79460337|FG004|Overall Study|Lost to Follow-up|0|||
44190103|NCT01587898|78985674|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
44190104|NCT01587898|78985675|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
44190105|NCT01587898|78985676|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
44190106|NCT01587898|78985677|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
44190107|NCT01567306|78985696|FG000|Overall Study|Protocol Violation|2|||
44190108|NCT01567306|78985697|FG001|Overall Study|Protocol Violation|2|||
44190109|NCT01567306|78985698|FG002|Overall Study|Protocol Violation|0|||
44190110|NCT01567306|78985699|FG003|Overall Study|Protocol Violation|3|||
44190111|NCT01567306|78985700|FG004|Overall Study|Protocol Violation|1|||
44190112|NCT01567306|78985701|FG005|Overall Study|Protocol Violation|1|||
44190113|NCT01567306|78985696|FG000|Overall Study|Change site living|1|||
44190114|NCT01567306|78985697|FG001|Overall Study|Change site living|0|||
44190115|NCT01567306|78985698|FG002|Overall Study|Change site living|0|||
44190116|NCT01567306|78985699|FG003|Overall Study|Change site living|0|||
44190117|NCT01567306|78985700|FG004|Overall Study|Change site living|0|||
44190118|NCT01567306|78985701|FG005|Overall Study|Change site living|0|||
44190119|NCT01567306|78985696|FG000|Overall Study|Adverse Event|0|||
44190120|NCT01567306|78985697|FG001|Overall Study|Adverse Event|0|||
44190121|NCT01567306|78985698|FG002|Overall Study|Adverse Event|0|||
44190122|NCT01567306|78985699|FG003|Overall Study|Adverse Event|2|||
44190123|NCT01567306|78985700|FG004|Overall Study|Adverse Event|4|||
44190124|NCT01567306|78985701|FG005|Overall Study|Adverse Event|1|||
44190125|NCT01567306|78985696|FG000|Overall Study|Lost to Follow-up|0|||
44190126|NCT01567306|78985697|FG001|Overall Study|Lost to Follow-up|0|||
44190127|NCT01567306|78985698|FG002|Overall Study|Lost to Follow-up|0|||
44190128|NCT01567306|78985699|FG003|Overall Study|Lost to Follow-up|0|||
44190129|NCT01567306|78985700|FG004|Overall Study|Lost to Follow-up|2|||
44266103|NCT02436876|79173045|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
44266104|NCT02436876|79173046|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
44266105|NCT02436876|79173047|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
44266106|NCT02382276|79173076|FG000|Overall Study|Withdrawal by Subject|4|||
44266107|NCT02382276|79173077|FG001|Overall Study|Withdrawal by Subject|8|||
44266108|NCT02382276|79173078|FG002|Overall Study|Withdrawal by Subject|5|||
44266109|NCT02382276|79173076|FG000|Overall Study|Adverse Event|7|||
44266110|NCT02382276|79173077|FG001|Overall Study|Adverse Event|2|||
44266111|NCT02382276|79173078|FG002|Overall Study|Adverse Event|32|||
44266112|NCT02382276|79173076|FG000|Overall Study|Physician Decision|0|||
44266113|NCT02382276|79173077|FG001|Overall Study|Physician Decision|0|||
44266114|NCT02382276|79173078|FG002|Overall Study|Physician Decision|2|||
44266115|NCT02436408|79173119|FG000|Overall Study|Death|1|||
44266116|NCT02436330|79173142|FG000|Cohort 1|Lost to Follow-up|5|||
44266117|NCT02436330|79173143|FG001|Cohort 1|Lost to Follow-up|2|||
44266118|NCT02436330|79173142|FG000|Cohort 1|Withdrawal by Subject|0|||
44266119|NCT02436330|79173143|FG001|Cohort 1|Withdrawal by Subject|1|||
44266120|NCT02436330|79173142|FG000|Cohort 2|Lost to Follow-up|2|||
44266121|NCT02436330|79173143|FG001|Cohort 2|Lost to Follow-up|0|||
44266122|NCT02436330|79173142|FG000|Cohort 2|Withdrawal by Subject|2|||
44266123|NCT02436330|79173143|FG001|Cohort 2|Withdrawal by Subject|3|||
44266124|NCT02436330|79173142|FG000|Cohort 3|Lost to Follow-up|1|||
44266125|NCT02436330|79173143|FG001|Cohort 3|Lost to Follow-up|0|||
44266126|NCT02436330|79173142|FG000|Cohort 3|Withdrawal by Subject|4|||
44266127|NCT02436330|79173143|FG001|Cohort 3|Withdrawal by Subject|0|||
44266128|NCT02436330|79173142|FG000|Cohort 4|Lost to Follow-up|1|||
44266129|NCT02436330|79173143|FG001|Cohort 4|Lost to Follow-up|0|||
44266130|NCT02436330|79173142|FG000|Cohort 4|Withdrawal by Subject|1|||
44266131|NCT02436330|79173143|FG001|Cohort 4|Withdrawal by Subject|0|||
44266132|NCT02436330|79173142|FG000|Cohort 5|Lost to Follow-up|3|||
44266133|NCT02436330|79173143|FG001|Cohort 5|Lost to Follow-up|2|||
44266134|NCT02436330|79173142|FG000|Cohort 5|Withdrawal by Subject|3|||
44266135|NCT02436330|79173143|FG001|Cohort 5|Withdrawal by Subject|2|||
44266136|NCT02436330|79173142|FG000|Cohort 6|Lost to Follow-up|2|||
44266137|NCT02436330|79173143|FG001|Cohort 6|Lost to Follow-up|0|||
44266138|NCT02436330|79173142|FG000|Cohort 6|Withdrawal by Subject|1|||
44266139|NCT02436330|79173143|FG001|Cohort 6|Withdrawal by Subject|1|||
44266140|NCT01650558|79173180|FG000|Overall Study|Migration out of study area|61|||
44266141|NCT01650558|79173181|FG001|Overall Study|Migration out of study area|71|||
44266142|NCT01650558|79173182|FG002|Overall Study|Migration out of study area|56|||
44266143|NCT01650558|79173180|FG000|Overall Study|Lost to Follow-up|10|||
44266144|NCT01650558|79173181|FG001|Overall Study|Lost to Follow-up|13|||
44266145|NCT01650558|79173182|FG002|Overall Study|Lost to Follow-up|6|||
44266146|NCT01650558|79173180|FG000|Overall Study|Death|10|||
44266147|NCT01650558|79173181|FG001|Overall Study|Death|6|||
44266148|NCT01650558|79173182|FG002|Overall Study|Death|8|||
44266149|NCT01650558|79173180|FG000|Overall Study|Withdrawal by Subject|1|||
44266150|NCT01650558|79173181|FG001|Overall Study|Withdrawal by Subject|1|||
44266151|NCT01650558|79173182|FG002|Overall Study|Withdrawal by Subject|3|||
44190130|NCT01567306|78985701|FG005|Overall Study|Lost to Follow-up|0|||
44190131|NCT01567306|78985696|FG000|Overall Study|Withdrawal by Subject|0|||
44190132|NCT01567306|78985697|FG001|Overall Study|Withdrawal by Subject|0|||
44190133|NCT01567306|78985698|FG002|Overall Study|Withdrawal by Subject|0|||
44266152|NCT01650558|79173180|FG000|Overall Study|Non-compliant participant|1|||
44266153|NCT01650558|79173181|FG001|Overall Study|Non-compliant participant|0|||
44266154|NCT01650558|79173182|FG002|Overall Study|Non-compliant participant|2|||
44266155|NCT01650558|79173180|FG000|Overall Study|Physician Decision|0|||
44266156|NCT01650558|79173181|FG001|Overall Study|Physician Decision|1|||
44266157|NCT01650558|79173182|FG002|Overall Study|Physician Decision|0|||
44266158|NCT02408484|79173221|FG000|Overall Study|Withdrawal by Subject|3|||
44266159|NCT02408484|79173221|FG000|Overall Study|Not treated during study period|1|||
44266160|NCT02380248|79173249|FG000|Overall Study|Lost to Follow-up|11|||
44266161|NCT02380248|79173249|FG000|Overall Study|Withdrawal by Subject|3|||
44190134|NCT01567306|78985699|FG003|Overall Study|Withdrawal by Subject|0|||
44190135|NCT01567306|78985700|FG004|Overall Study|Withdrawal by Subject|0|||
44190136|NCT01567306|78985701|FG005|Overall Study|Withdrawal by Subject|1|||
44451409|NCT03859323|79460338|FG005|Overall Study|Lost to Follow-up|0|||
44451410|NCT03859323|79460339|FG006|Overall Study|Lost to Follow-up|1|||
44451411|NCT03859323|79460340|FG007|Overall Study|Lost to Follow-up|0|||
44451412|NCT03859323|79460341|FG008|Overall Study|Lost to Follow-up|0|||
44451413|NCT03859323|79460342|FG009|Overall Study|Lost to Follow-up|0|||
44451414|NCT03859323|79460343|FG010|Overall Study|Lost to Follow-up|0|||
44451415|NCT03859323|79460344|FG011|Overall Study|Lost to Follow-up|0|||
44451416|NCT03859323|79460345|FG012|Overall Study|Lost to Follow-up|0|||
44451417|NCT03859323|79460333|FG000|Overall Study|Withdrawal by Subject|0|||
44451418|NCT03859323|79460334|FG001|Overall Study|Withdrawal by Subject|0|||
44190137|NCT01587274|78985718|FG000|Overall Study|Lost to Follow-up|4|||
44190138|NCT01587274|78985719|FG001|Overall Study|Lost to Follow-up|5|||
44190139|NCT01587274|78985720|FG002|Overall Study|Lost to Follow-up|3|||
44190140|NCT01587118|78985728|FG000|Overall Study|Adverse Event|3|||
44190141|NCT01587118|78985728|FG000|Overall Study|Lost to Follow-up|2|||
44190142|NCT01587118|78985728|FG000|Overall Study|Relocation|1|||
44190143|NCT01587118|78985728|FG000|Overall Study|nonresponse|1|||
44190144|NCT01905657|78985735|FG000|Overall Study|Adverse Event|23|||
44190145|NCT01905657|78985736|FG001|Overall Study|Adverse Event|17|||
44190146|NCT01905657|78985737|FG002|Overall Study|Adverse Event|18|||
44190147|NCT01905657|78985735|FG000|Overall Study|Clinical Progression|103|||
44190148|NCT01905657|78985736|FG001|Overall Study|Clinical Progression|78|||
44190149|NCT01905657|78985737|FG002|Overall Study|Clinical Progression|59|||
44190150|NCT01905657|78985735|FG000|Overall Study|Death|40|||
44190151|NCT01905657|78985736|FG001|Overall Study|Death|43|||
44190152|NCT01905657|78985737|FG002|Overall Study|Death|47|||
44190153|NCT01905657|78985735|FG000|Overall Study|Excluded Medication|13|||
44190154|NCT01905657|78985736|FG001|Overall Study|Excluded Medication|16|||
44190155|NCT01905657|78985737|FG002|Overall Study|Excluded Medication|9|||
44190156|NCT01905657|78985735|FG000|Overall Study|Lost to Follow-up|1|||
44190157|NCT01905657|78985736|FG001|Overall Study|Lost to Follow-up|2|||
44190158|NCT01905657|78985737|FG002|Overall Study|Lost to Follow-up|1|||
44190159|NCT01905657|78985735|FG000|Overall Study|Physician Decision|5|||
44190160|NCT01905657|78985736|FG001|Overall Study|Physician Decision|8|||
44190161|NCT01905657|78985737|FG002|Overall Study|Physician Decision|12|||
44190162|NCT01905657|78985735|FG000|Overall Study|Protocol Violation|2|||
44190163|NCT01905657|78985736|FG001|Overall Study|Protocol Violation|1|||
44190164|NCT01905657|78985737|FG002|Overall Study|Protocol Violation|1|||
44190165|NCT01905657|78985735|FG000|Overall Study|Screen Failure|0|||
44190166|NCT01905657|78985736|FG001|Overall Study|Screen Failure|1|||
44190167|NCT01905657|78985737|FG002|Overall Study|Screen Failure|0|||
44190168|NCT01905657|78985735|FG000|Overall Study|Withdrawal by Subject|15|||
44190169|NCT01905657|78985736|FG001|Overall Study|Withdrawal by Subject|21|||
44190170|NCT01905657|78985737|FG002|Overall Study|Withdrawal by Subject|53|||
44190171|NCT01905657|78985735|FG000|Overall Study|Sponsor Decision|1|||
44190172|NCT01905657|78985736|FG001|Overall Study|Sponsor Decision|0|||
44190173|NCT01905657|78985737|FG002|Overall Study|Sponsor Decision|0|||
44190174|NCT02202980|78985762|FG000|Overall Study|Lack of Efficacy|1|||
44190175|NCT02202980|78985763|FG001|Overall Study|Lack of Efficacy|0|||
44190176|NCT02202980|78985764|FG002|Overall Study|Lack of Efficacy|7|||
44190177|NCT02202980|78985765|FG003|Overall Study|Lack of Efficacy|0|||
44190178|NCT02202980|78985766|FG004|Overall Study|Lack of Efficacy|3|||
44190179|NCT02202980|78985767|FG005|Overall Study|Lack of Efficacy|1|||
44190180|NCT02202980|78985768|FG006|Overall Study|Lack of Efficacy|11|||
44190181|NCT02202980|78985769|FG007|Overall Study|Lack of Efficacy|2|||
44190182|NCT02202980|78985770|FG008|Overall Study|Lack of Efficacy|2|||
44190183|NCT02202980|78985771|FG009|Overall Study|Lack of Efficacy|0|||
44190184|NCT02202980|78985772|FG010|Overall Study|Lack of Efficacy|0|||
44190185|NCT02202980|78985773|FG011|Overall Study|Lack of Efficacy|3|||
44190186|NCT02202980|78985774|FG012|Overall Study|Lack of Efficacy|10|||
44190187|NCT02202980|78985775|FG013|Overall Study|Lack of Efficacy|0|||
44266162|NCT02408016|79173296|FG000|Overall Study|Death|6|||
44266163|NCT02408016|79173297|FG001|Overall Study|Death|1|||
44266164|NCT02408016|79173298|FG002|Overall Study|Death|0|||
44451419|NCT03859323|79460335|FG002|Overall Study|Withdrawal by Subject|1|||
44190188|NCT02202980|78985762|FG000|Overall Study|Protocol Violation|0|||
44190189|NCT02202980|78985763|FG001|Overall Study|Protocol Violation|0|||
44190190|NCT02202980|78985764|FG002|Overall Study|Protocol Violation|0|||
44190191|NCT02202980|78985765|FG003|Overall Study|Protocol Violation|3|||
44190192|NCT02202980|78985766|FG004|Overall Study|Protocol Violation|3|||
44190193|NCT02202980|78985767|FG005|Overall Study|Protocol Violation|0|||
44190194|NCT02202980|78985768|FG006|Overall Study|Protocol Violation|0|||
44190195|NCT02202980|78985769|FG007|Overall Study|Protocol Violation|0|||
44190196|NCT02202980|78985770|FG008|Overall Study|Protocol Violation|0|||
44190197|NCT02202980|78985771|FG009|Overall Study|Protocol Violation|0|||
44190198|NCT02202980|78985772|FG010|Overall Study|Protocol Violation|0|||
44190199|NCT02202980|78985773|FG011|Overall Study|Protocol Violation|0|||
44190200|NCT02202980|78985774|FG012|Overall Study|Protocol Violation|0|||
44190201|NCT02202980|78985775|FG013|Overall Study|Protocol Violation|0|||
44451420|NCT03859323|79460336|FG003|Overall Study|Withdrawal by Subject|0|||
44451421|NCT03859323|79460337|FG004|Overall Study|Withdrawal by Subject|0|||
44190202|NCT02202980|78985762|FG000|Overall Study|Lost to Follow-up|0|||
44190203|NCT02202980|78985763|FG001|Overall Study|Lost to Follow-up|1|||
44190204|NCT02202980|78985764|FG002|Overall Study|Lost to Follow-up|1|||
44190205|NCT02202980|78985765|FG003|Overall Study|Lost to Follow-up|1|||
44190206|NCT02202980|78985766|FG004|Overall Study|Lost to Follow-up|0|||
44190207|NCT02202980|78985767|FG005|Overall Study|Lost to Follow-up|0|||
44190208|NCT02202980|78985768|FG006|Overall Study|Lost to Follow-up|0|||
44190209|NCT02202980|78985769|FG007|Overall Study|Lost to Follow-up|1|||
44190210|NCT02202980|78985770|FG008|Overall Study|Lost to Follow-up|1|||
44190211|NCT02202980|78985771|FG009|Overall Study|Lost to Follow-up|0|||
44190212|NCT02202980|78985772|FG010|Overall Study|Lost to Follow-up|0|||
44190213|NCT02202980|78985773|FG011|Overall Study|Lost to Follow-up|0|||
44190214|NCT02202980|78985774|FG012|Overall Study|Lost to Follow-up|1|||
44190215|NCT02202980|78985775|FG013|Overall Study|Lost to Follow-up|0|||
44190216|NCT02202980|78985762|FG000|Overall Study|Withdrew Consent|0|||
44190217|NCT02202980|78985763|FG001|Overall Study|Withdrew Consent|1|||
44190218|NCT02202980|78985764|FG002|Overall Study|Withdrew Consent|2|||
44190219|NCT02202980|78985765|FG003|Overall Study|Withdrew Consent|0|||
44190220|NCT02202980|78985766|FG004|Overall Study|Withdrew Consent|0|||
44190221|NCT02202980|78985767|FG005|Overall Study|Withdrew Consent|0|||
44190222|NCT02202980|78985768|FG006|Overall Study|Withdrew Consent|0|||
44190223|NCT02202980|78985769|FG007|Overall Study|Withdrew Consent|0|||
44190224|NCT02202980|78985770|FG008|Overall Study|Withdrew Consent|1|||
44190225|NCT02202980|78985771|FG009|Overall Study|Withdrew Consent|0|||
44190226|NCT02202980|78985772|FG010|Overall Study|Withdrew Consent|0|||
44190227|NCT02202980|78985773|FG011|Overall Study|Withdrew Consent|0|||
44190228|NCT02202980|78985774|FG012|Overall Study|Withdrew Consent|0|||
44190229|NCT02202980|78985775|FG013|Overall Study|Withdrew Consent|0|||
44190230|NCT01952145|78985807|FG000|Overall Study|Protocol Violation|2|||
44190231|NCT01952145|78985808|FG001|Overall Study|Protocol Violation|1|||
44190232|NCT01952145|78985807|FG000|Overall Study|Death|0|||
44190233|NCT01952145|78985808|FG001|Overall Study|Death|1|||
44190234|NCT01952145|78985807|FG000|Overall Study|Adverse Event|9|||
44190235|NCT01952145|78985808|FG001|Overall Study|Adverse Event|0|||
44190236|NCT01952145|78985807|FG000|Overall Study|Withdrawal Criteria|16|||
44190237|NCT01952145|78985808|FG001|Overall Study|Withdrawal Criteria|11|||
44190238|NCT01952145|78985807|FG000|Overall Study|Unclassified|1|||
44190239|NCT01952145|78985808|FG001|Overall Study|Unclassified|1|||
44190240|NCT01923363|78985814|FG000|Overall Study|Protocol Violation|1|||
44190241|NCT01905267|78985820|FG000|Overall Study|Physician Decision|2|||
44190242|NCT01905267|78985821|FG001|Overall Study|Physician Decision|2|||
44190243|NCT01923285|78985829|FG000|Overall Study|Withdrawal by Subject|7|||
44190244|NCT01923285|78985830|FG001|Overall Study|Withdrawal by Subject|6|||
44190245|NCT01904721|78985843|FG000|Overall Study|Other Reasons|0|||
44190246|NCT01904721|78985844|FG001|Overall Study|Other Reasons|0|||
44190247|NCT01904721|78985845|FG002|Overall Study|Other Reasons|1|||
44190248|NCT01904721|78985846|FG003|Overall Study|Other Reasons|1|||
44190249|NCT01904721|78985847|FG004|Overall Study|Other Reasons|2|||
44190250|NCT01904721|78985848|FG005|Overall Study|Other Reasons|2|||
44190251|NCT01904721|78985849|FG006|Overall Study|Other Reasons|2|||
44190252|NCT01904721|78985843|FG000|Overall Study|Personal Reasons|0|||
44190253|NCT01904721|78985844|FG001|Overall Study|Personal Reasons|0|||
44190254|NCT01904721|78985845|FG002|Overall Study|Personal Reasons|0|||
44190255|NCT01904721|78985846|FG003|Overall Study|Personal Reasons|0|||
44190256|NCT01904721|78985847|FG004|Overall Study|Personal Reasons|2|||
44190257|NCT01904721|78985848|FG005|Overall Study|Personal Reasons|3|||
44190258|NCT01904721|78985849|FG006|Overall Study|Personal Reasons|3|||
44190259|NCT01904721|78985843|FG000|Overall Study|Lost to Follow-up|0|||
44190260|NCT01904721|78985844|FG001|Overall Study|Lost to Follow-up|0|||
44190261|NCT01904721|78985845|FG002|Overall Study|Lost to Follow-up|0|||
44190262|NCT01904721|78985846|FG003|Overall Study|Lost to Follow-up|0|||
44190263|NCT01904721|78985847|FG004|Overall Study|Lost to Follow-up|1|||
44190264|NCT01904721|78985848|FG005|Overall Study|Lost to Follow-up|3|||
44190265|NCT01904721|78985849|FG006|Overall Study|Lost to Follow-up|1|||
44190266|NCT01904721|78985843|FG000|Overall Study|Lack of Efficacy|0|||
44190267|NCT01904721|78985844|FG001|Overall Study|Lack of Efficacy|0|||
44190268|NCT01904721|78985845|FG002|Overall Study|Lack of Efficacy|0|||
44190269|NCT01904721|78985846|FG003|Overall Study|Lack of Efficacy|0|||
44190270|NCT01904721|78985847|FG004|Overall Study|Lack of Efficacy|0|||
44190271|NCT01904721|78985848|FG005|Overall Study|Lack of Efficacy|0|||
44190272|NCT01904721|78985849|FG006|Overall Study|Lack of Efficacy|1|||
44190273|NCT01904721|78985843|FG000|Overall Study|Adverse Event|0|||
44190274|NCT01904721|78985844|FG001|Overall Study|Adverse Event|0|||
44190275|NCT01904721|78985845|FG002|Overall Study|Adverse Event|0|||
44190276|NCT01904721|78985846|FG003|Overall Study|Adverse Event|0|||
44190277|NCT01904721|78985847|FG004|Overall Study|Adverse Event|3|||
44190278|NCT01904721|78985848|FG005|Overall Study|Adverse Event|1|||
44190279|NCT01904721|78985849|FG006|Overall Study|Adverse Event|0|||
44190280|NCT01904019|78985861|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
44190281|NCT01904019|78985861|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
44190282|NCT01904019|78985861|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
44190283|NCT01904019|78985861|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
44190284|NCT01904019|78985861|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
44190285|NCT01904019|78985861|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
44190286|NCT01922895|78985867|FG000|Overall Study|Death|0|||
44190287|NCT01922895|78985868|FG001|Overall Study|Death|1|||
44190288|NCT01922895|78985867|FG000|Overall Study|Withdrawal by Subject|1|||
44190289|NCT01922895|78985868|FG001|Overall Study|Withdrawal by Subject|2|||
44190290|NCT01922895|78985867|FG000|Overall Study|Lost to Follow-up|5|||
44190291|NCT01922895|78985868|FG001|Overall Study|Lost to Follow-up|11|||
44190292|NCT01922739|78985876|FG000|Titration/Adjustment Period|Adverse Event|3|||
44190293|NCT01922739|78985876|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
44190294|NCT01922739|78985876|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
44190295|NCT01922739|78985876|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
44190296|NCT01922739|78985876|FG000|Open-label Treatment Period|Adverse Event|6|||
44190297|NCT01922739|78985876|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
44190298|NCT01922739|78985876|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
44190299|NCT01922739|78985876|FG000|Open-label Treatment Period|Protocol Violation|5|||
44190300|NCT01922739|78985876|FG000|Open-label Treatment Period|Pregnancy|1|||
44190301|NCT01922739|78985876|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
44190302|NCT01922739|78985876|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
44190303|NCT01922739|78985876|FG000|Open-label Treatment Period|Physician Decision|1|||
44190304|NCT01922739|78985876|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
44190305|NCT02236988|78985896|FG000|Overall Study|Lost to Follow-up|0|||
44190306|NCT02236988|78985897|FG001|Overall Study|Lost to Follow-up|0|||
44190307|NCT02236988|78985898|FG002|Overall Study|Lost to Follow-up|0|||
44190308|NCT02236988|78985899|FG003|Overall Study|Lost to Follow-up|1|||
44190309|NCT02236988|78985896|FG000|Overall Study|Unable to Comply with Study Visits|0|||
44190310|NCT02236988|78985897|FG001|Overall Study|Unable to Comply with Study Visits|0|||
44190311|NCT02236988|78985898|FG002|Overall Study|Unable to Comply with Study Visits|0|||
44190312|NCT02236988|78985899|FG003|Overall Study|Unable to Comply with Study Visits|2|||
44190313|NCT02236598|78985952|FG000|Overall Study|Adverse Event|0|||
44190314|NCT02236598|78985953|FG001|Overall Study|Adverse Event|1|||
44190315|NCT02236598|78985952|FG000|Overall Study|Withdrawal by Subject|0|||
44190316|NCT02236598|78985953|FG001|Overall Study|Withdrawal by Subject|1|||
44190317|NCT01922349|78985963|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
44190318|NCT01922349|78985964|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
44190319|NCT01922349|78985965|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
44190320|NCT01922349|78985966|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
44190321|NCT02236520|78986004|FG000|Overall Study|Physician Decision|0|||
44190322|NCT02236520|78986005|FG001|Overall Study|Physician Decision|5|||
44190323|NCT02236520|78986006|FG002|Overall Study|Physician Decision|0|||
44190324|NCT02236520|78986007|FG003|Overall Study|Physician Decision|0|||
44190325|NCT02236520|78986004|FG000|Overall Study|Withdrawal by Subject|1|||
44190326|NCT02236520|78986005|FG001|Overall Study|Withdrawal by Subject|0|||
44190327|NCT02236520|78986006|FG002|Overall Study|Withdrawal by Subject|0|||
44190328|NCT02236520|78986007|FG003|Overall Study|Withdrawal by Subject|1|||
44190329|NCT02236520|78986004|FG000|Overall Study|Pregnancy|1|||
44190330|NCT02236520|78986005|FG001|Overall Study|Pregnancy|0|||
44190331|NCT02236520|78986006|FG002|Overall Study|Pregnancy|0|||
44190332|NCT02236520|78986007|FG003|Overall Study|Pregnancy|0|||
44190333|NCT01922271|78986019|FG000|WASHOUT Period|Withdrawal by Subject|1|||
44190334|NCT01922271|78986020|FG001|WASHOUT Period|Withdrawal by Subject|0|||
44190335|NCT02236130|78986028|FG000|Overall Study|Lost to Follow-up|7|||
44190336|NCT02236130|78986029|FG001|Overall Study|Lost to Follow-up|12|||
44190337|NCT02233946|78986037|FG000|Baseline|Withdrawal by Subject|2|||
44190338|NCT02233946|78986038|FG001|Baseline|Withdrawal by Subject|0|||
44190339|NCT02233946|78986037|FG000|3-months Follow-up|Lost to Follow-up|53|||
44190340|NCT02233946|78986038|FG001|3-months Follow-up|Lost to Follow-up|29|||
44190341|NCT02233946|78986037|FG000|6-months Follow-up|Lost to Follow-up|21|||
44190342|NCT02233946|78986038|FG001|6-months Follow-up|Lost to Follow-up|2|||
44190343|NCT02233946|78986037|FG000|9-month Follow-up|Lost to Follow-up|20|||
44190344|NCT02233946|78986038|FG001|9-month Follow-up|Lost to Follow-up|11|||
44190345|NCT02233946|78986037|FG000|12-month Follow-up|Lost to Follow-up|28|||
44190346|NCT02233946|78986038|FG001|12-month Follow-up|Lost to Follow-up|11|||
44190347|NCT02232698|78986046|FG000|Overall Study|Pregnancy|1|||
44190348|NCT02232698|78986047|FG001|Overall Study|Pregnancy|1|||
44190349|NCT02232698|78986046|FG000|Overall Study|Met exclusion criteria|1|||
44190350|NCT02232698|78986047|FG001|Overall Study|Met exclusion criteria|1|||
44190351|NCT02232698|78986046|FG000|Overall Study|Had device-associated symptoms|7|||
44190352|NCT02232698|78986047|FG001|Overall Study|Had device-associated symptoms|0|||
44266165|NCT02408016|79173296|FG000|Overall Study|Physician Decision|0|||
44190353|NCT02232698|78986046|FG000|Overall Study|Non-compliance with study device|1|||
44190354|NCT02232698|78986047|FG001|Overall Study|Non-compliance with study device|4|||
44190355|NCT02232698|78986046|FG000|Overall Study|Allocated to control group|0|||
44190356|NCT02232698|78986047|FG001|Overall Study|Allocated to control group|3|||
44190357|NCT02232698|78986046|FG000|Overall Study|Withdrawal by Subject|0|||
44190358|NCT02232698|78986047|FG001|Overall Study|Withdrawal by Subject|11|||
44190359|NCT01632878|78986055|FG000|Screening|Physician Decision|268|||
44190360|NCT01632878|78986055|FG000|Treatment|Lost to Follow-up|41|||
44190361|NCT01632878|78986055|FG000|Treatment|Withdrawal by Subject|36|||
44190362|NCT01632878|78986055|FG000|Treatment|Physician Decision|34|||
44190363|NCT01632878|78986055|FG000|Treatment|missing information|4|||
44190364|NCT01632878|78986055|FG000|Treatment|no information on study completion|43|||
44190365|NCT01632800|78986059|FG000|Overall Study|Subject did not fit in apparatus|1|||
44190366|NCT01641809|78986067|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
44190367|NCT01641809|78986068|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
44190368|NCT01641809|78986069|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
44190369|NCT01641809|78986070|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
44190370|NCT01641809|78986067|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
44190371|NCT01641809|78986068|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
44190372|NCT01641809|78986069|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
44190373|NCT01641809|78986070|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
44190374|NCT01641809|78986067|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
44190375|NCT01641809|78986068|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
44190376|NCT01641809|78986069|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
44190377|NCT01641809|78986070|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
44190378|NCT01641809|78986067|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
44190379|NCT01641809|78986068|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
44190380|NCT01641809|78986069|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
44190381|NCT01641809|78986070|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
44190382|NCT01641809|78986067|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
44190383|NCT01641809|78986068|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
44190384|NCT01641809|78986069|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
44190385|NCT01641809|78986070|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
44190386|NCT01641809|78986067|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
44190387|NCT01641809|78986068|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
44190388|NCT01641809|78986069|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
44190389|NCT01641809|78986070|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
44190390|NCT01641809|78986067|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
44190391|NCT01641809|78986068|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
44190392|NCT01641809|78986069|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
44190393|NCT01641809|78986070|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
44190394|NCT01641809|78986067|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
44190395|NCT01641809|78986068|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
44190396|NCT01641809|78986069|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
44190397|NCT01641809|78986070|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
44190398|NCT01641809|78986067|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
44190399|NCT01641809|78986068|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
44190400|NCT01641809|78986069|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
44190401|NCT01641809|78986070|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
44190402|NCT01641809|78986067|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
44190403|NCT01641809|78986068|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
44190404|NCT01641809|78986069|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
44190405|NCT01641809|78986070|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
44190406|NCT01641809|78986067|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
44190407|NCT01641809|78986068|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
44190408|NCT01641809|78986069|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
44190409|NCT01641809|78986070|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
44190410|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
44190411|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
44190412|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
44190413|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
44190414|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
44190415|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
44190416|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
44190417|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
44190418|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
44190419|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
44190420|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
44190421|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
44266166|NCT02408016|79173297|FG001|Overall Study|Physician Decision|2|||
44190422|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
44190423|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
44190424|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
44190425|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
44190426|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
44190427|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
44190428|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
44190429|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
44190430|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
44190431|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
44190432|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
44190433|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
44190434|NCT01641809|78986067|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
44190435|NCT01641809|78986068|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
44190436|NCT01641809|78986069|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
44190437|NCT01641809|78986070|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
44190438|NCT01632566|78986093|FG000|Overall Study|Withdrawal by Subject|0|||
44190439|NCT01632566|78986094|FG001|Overall Study|Withdrawal by Subject|1|||
44190440|NCT01632566|78986095|FG002|Overall Study|Withdrawal by Subject|0|||
44190441|NCT01632566|78986096|FG003|Overall Study|Withdrawal by Subject|0|||
44190442|NCT01632566|78986097|FG004|Overall Study|Withdrawal by Subject|0|||
44190443|NCT01632566|78986093|FG000|Overall Study|Sponsor Decision|0|||
44190444|NCT01632566|78986094|FG001|Overall Study|Sponsor Decision|2|||
44190445|NCT01632566|78986095|FG002|Overall Study|Sponsor Decision|9|||
44190446|NCT01632566|78986096|FG003|Overall Study|Sponsor Decision|2|||
44190447|NCT01632566|78986097|FG004|Overall Study|Sponsor Decision|2|||
44190448|NCT02254304|78986115|FG000|Overall Study|Adverse Event|2|||
44190449|NCT02254304|78986116|FG001|Overall Study|Adverse Event|1|||
44190450|NCT02254304|78986115|FG000|Overall Study|Lost to Follow-up|2|||
44190451|NCT02254304|78986116|FG001|Overall Study|Lost to Follow-up|2|||
44190452|NCT02254304|78986115|FG000|Overall Study|Protocol Violation|1|||
44190453|NCT02254304|78986116|FG001|Overall Study|Protocol Violation|0|||
44190454|NCT02254304|78986115|FG000|Overall Study|Withdrawal by Subject|3|||
44190455|NCT02254304|78986116|FG001|Overall Study|Withdrawal by Subject|0|||
44190456|NCT02254304|78986115|FG000|Overall Study|Injection site pain and Injection fear|1|||
44190457|NCT02254304|78986116|FG001|Overall Study|Injection site pain and Injection fear|0|||
44190458|NCT02254304|78986115|FG000|Overall Study|Personal causes|4|||
44190459|NCT02254304|78986116|FG001|Overall Study|Personal causes|1|||
44190460|NCT02254304|78986115|FG000|Overall Study|Personal decision|1|||
44190461|NCT02254304|78986116|FG001|Overall Study|Personal decision|0|||
44190462|NCT02174731|78986126|FG000|Overall Study|Participant decision|67|||
44190463|NCT02174731|78986127|FG001|Overall Study|Participant decision|64|||
44190464|NCT02174731|78986126|FG000|Overall Study|Incorrect enrolment before randomization|0|||
44190465|NCT02174731|78986127|FG001|Overall Study|Incorrect enrolment before randomization|1|||
44190466|NCT02174731|78986126|FG000|Overall Study|Missing|2|||
44190467|NCT02174731|78986127|FG001|Overall Study|Missing|0|||
44190468|NCT01922037|78986135|FG000|Overall Study|Withdrawal by Subject|2|||
44190469|NCT01922037|78986136|FG001|Overall Study|Withdrawal by Subject|44|||
44190470|NCT01922037|78986135|FG000|Overall Study|Adverse Event|1|||
44190471|NCT01922037|78986136|FG001|Overall Study|Adverse Event|7|||
44190472|NCT01922037|78986135|FG000|Overall Study|Death|0|||
44190473|NCT01922037|78986136|FG001|Overall Study|Death|5|||
44190474|NCT01922037|78986135|FG000|Overall Study|Pregnancy|0|||
44190475|NCT01922037|78986136|FG001|Overall Study|Pregnancy|2|||
44190476|NCT01922037|78986135|FG000|Overall Study|Participant non-compliance|4|||
44190477|NCT01922037|78986136|FG001|Overall Study|Participant non-compliance|46|||
44190478|NCT01922037|78986135|FG000|Overall Study|Investigator/Sponsor decision|1|||
44190479|NCT01922037|78986136|FG001|Overall Study|Investigator/Sponsor decision|4|||
44190480|NCT01922037|78986135|FG000|Overall Study|Other unspecified|2|||
44190481|NCT01922037|78986136|FG001|Overall Study|Other unspecified|66|||
44190482|NCT02282813|78986147|FG000|Overall Study|Withdrawal by Subject|4|||
44190483|NCT02282813|78986148|FG001|Overall Study|Withdrawal by Subject|5|||
44190484|NCT02282813|78986149|FG002|Overall Study|Withdrawal by Subject|0|||
44190485|NCT02282813|78986147|FG000|Overall Study|Adverse Event|3|||
44190486|NCT02282813|78986148|FG001|Overall Study|Adverse Event|10|||
44190487|NCT02282813|78986149|FG002|Overall Study|Adverse Event|1|||
44190488|NCT02282813|78986147|FG000|Overall Study|Subject non-compliance|1|||
44190489|NCT02282813|78986148|FG001|Overall Study|Subject non-compliance|4|||
44190490|NCT02282813|78986149|FG002|Overall Study|Subject non-compliance|0|||
44190491|NCT02282813|78986147|FG000|Overall Study|Physician Decision|0|||
44190492|NCT02282813|78986148|FG001|Overall Study|Physician Decision|3|||
44190493|NCT02282813|78986149|FG002|Overall Study|Physician Decision|1|||
44190494|NCT02282813|78986147|FG000|Overall Study|Lost to Follow-up|2|||
44190495|NCT02282813|78986148|FG001|Overall Study|Lost to Follow-up|0|||
44190496|NCT02282813|78986149|FG002|Overall Study|Lost to Follow-up|1|||
44190497|NCT02282813|78986147|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
44190498|NCT02282813|78986148|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
44190499|NCT02282813|78986149|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
44190500|NCT02282813|78986147|FG000|Overall Study|Lack of Efficacy|1|||
44190501|NCT02282813|78986148|FG001|Overall Study|Lack of Efficacy|0|||
44190502|NCT02282813|78986149|FG002|Overall Study|Lack of Efficacy|0|||
44190503|NCT02282813|78986147|FG000|Overall Study|Administrative reasons|0|||
44190504|NCT02282813|78986148|FG001|Overall Study|Administrative reasons|1|||
44190505|NCT02282813|78986149|FG002|Overall Study|Administrative reasons|0|||
44190506|NCT01903863|78986161|FG000|Overall Study|Physician Decision|2|||
44190507|NCT01903863|78986162|FG001|Overall Study|Physician Decision|0|||
44190508|NCT02123251|78986170|FG000|Overall Study|Death|1|||
44190509|NCT02123251|78986171|FG001|Overall Study|Death|1|||
44190510|NCT02123251|78986170|FG000|Overall Study|Withdrawal by Subject|0|||
44190511|NCT02123251|78986171|FG001|Overall Study|Withdrawal by Subject|3|||
44190512|NCT02123251|78986170|FG000|Overall Study|Lost Medicaid eligibility|29|||
44190513|NCT02123251|78986171|FG001|Overall Study|Lost Medicaid eligibility|22|||
44190514|NCT02123251|78986170|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
44190515|NCT02123251|78986171|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
44190516|NCT01902303|78986180|FG000|Overall Study|Adverse Event|0|||
44190517|NCT01902303|78986181|FG001|Overall Study|Adverse Event|1|||
44190518|NCT01902303|78986180|FG000|Overall Study|Lost to Follow-up|0|||
44190519|NCT01902303|78986181|FG001|Overall Study|Lost to Follow-up|1|||
44190520|NCT01902303|78986180|FG000|Overall Study|Protocol Violation|2|||
44190521|NCT01902303|78986181|FG001|Overall Study|Protocol Violation|2|||
44190522|NCT01902303|78986180|FG000|Overall Study|subject lost investigational product|0|||
44190523|NCT01902303|78986181|FG001|Overall Study|subject lost investigational product|1|||
44190524|NCT01902303|78986180|FG000|Overall Study|Did not develop a cold sore|21|||
44190525|NCT01902303|78986181|FG001|Overall Study|Did not develop a cold sore|19|||
44190526|NCT02122783|78986191|FG000|Overall Study|Adverse Event|0|||
44190527|NCT02122783|78986192|FG001|Overall Study|Adverse Event|1|||
44190528|NCT01921257|78986201|FG000|Overall Study|Adverse Event|1|||
44190529|NCT01921257|78986201|FG000|Overall Study|Protocol Violation|1|||
44190530|NCT01921257|78986201|FG000|Overall Study|Withdrawal by Subject|1|||
44190531|NCT02121847|78986206|FG000|Overall Study|Administrative Reasons|1|||
44190532|NCT02121847|78986206|FG000|Overall Study|Adverse Event|2|||
44190533|NCT01921179|78986212|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
44190534|NCT01921179|78986213|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
44190535|NCT01921179|78986212|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
44190536|NCT01921179|78986213|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
44190537|NCT01587040|78986224|FG000|Overall Study|Protocol Violation|0|||
44190538|NCT01587040|78986225|FG001|Overall Study|Protocol Violation|0|||
44190539|NCT01587040|78986226|FG002|Overall Study|Protocol Violation|1|||
44190540|NCT01587040|78986227|FG003|Overall Study|Protocol Violation|0|||
44190541|NCT01587040|78986224|FG000|Overall Study|Adverse Event|0|||
44190542|NCT01587040|78986225|FG001|Overall Study|Adverse Event|1|||
44190543|NCT01587040|78986226|FG002|Overall Study|Adverse Event|10|||
44190544|NCT01587040|78986227|FG003|Overall Study|Adverse Event|0|||
44190545|NCT01587040|78986224|FG000|Overall Study|Disease progression|12|||
44190546|NCT01587040|78986225|FG001|Overall Study|Disease progression|1|||
44190547|NCT01587040|78986226|FG002|Overall Study|Disease progression|15|||
44190548|NCT01587040|78986227|FG003|Overall Study|Disease progression|3|||
44190549|NCT01587040|78986224|FG000|Overall Study|Other than specified|5|||
44190550|NCT01587040|78986225|FG001|Overall Study|Other than specified|1|||
44190551|NCT01587040|78986226|FG002|Overall Study|Other than specified|11|||
44190552|NCT01587040|78986227|FG003|Overall Study|Other than specified|1|||
44190553|NCT02144701|78986239|FG000|Overall Study|development of relapse, GVHD or death|9|||
44190554|NCT02144701|78986240|FG001|Overall Study|development of relapse, GVHD or death|3|||
44190555|NCT01921101|78986248|FG000|Overall Study|Death|16|||
44190556|NCT01921101|78986249|FG001|Overall Study|Death|6|||
44190557|NCT01586806|78986258|FG000|Overall Study|Protocol Violation|0|||
44190558|NCT01586806|78986259|FG001|Overall Study|Protocol Violation|1|||
44190559|NCT01586806|78986260|FG002|Overall Study|Protocol Violation|0|||
44190560|NCT01586806|78986258|FG000|Overall Study|Withdrawal by Subject|1|||
44190561|NCT01586806|78986259|FG001|Overall Study|Withdrawal by Subject|0|||
44190562|NCT01586806|78986260|FG002|Overall Study|Withdrawal by Subject|0|||
44190563|NCT01586806|78986258|FG000|Overall Study|Lost to Follow-up|2|||
44190564|NCT01586806|78986259|FG001|Overall Study|Lost to Follow-up|3|||
44190565|NCT01586806|78986260|FG002|Overall Study|Lost to Follow-up|2|||
44190566|NCT02144077|78986270|FG000|Overall Study|Withdrawal by Subject|3|||
44190567|NCT02144077|78986271|FG001|Overall Study|Withdrawal by Subject|3|||
44190568|NCT02144077|78986270|FG000|Overall Study|Adverse Event|2|||
44190569|NCT02144077|78986271|FG001|Overall Study|Adverse Event|3|||
44190570|NCT02144077|78986270|FG000|Overall Study|Lost to Follow-up|2|||
44190571|NCT02144077|78986271|FG001|Overall Study|Lost to Follow-up|2|||
44190572|NCT02144077|78986270|FG000|Overall Study|Protocol Violation|1|||
44190573|NCT02144077|78986271|FG001|Overall Study|Protocol Violation|2|||
44190574|NCT02144077|78986270|FG000|Overall Study|Death|0|||
44190575|NCT02144077|78986271|FG001|Overall Study|Death|1|||
44190576|NCT02144077|78986270|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
44190577|NCT02144077|78986271|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
44190578|NCT02172625|78986279|FG000|Overall Study|Adverse Event|0|||
44190579|NCT02172625|78986280|FG001|Overall Study|Adverse Event|1|||
44190580|NCT02172625|78986279|FG000|Overall Study|Pregnancy|0|||
44190581|NCT02172625|78986280|FG001|Overall Study|Pregnancy|1|||
44190582|NCT02172625|78986279|FG000|Overall Study|car accident|0|||
44190583|NCT02172625|78986280|FG001|Overall Study|car accident|1|||
44190584|NCT02143843|78986290|FG000|Overall Study|Adverse Event|8|||
44190585|NCT02143843|78986290|FG000|Overall Study|Lack of Efficacy|2|||
44190586|NCT02143843|78986290|FG000|Overall Study|Withdrawal by Subject|2|||
44190587|NCT02121535|78986296|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
44190588|NCT02121535|78986297|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
44190589|NCT02121535|78986296|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
44190590|NCT02121535|78986297|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
44190591|NCT01586338|78986304|FG000|Overall Study|Adverse Event|3|||
44190592|NCT01586338|78986304|FG000|Overall Study|Lost to Follow-up|1|||
44190593|NCT01586338|78986304|FG000|Overall Study|Withdrawal by participant|3|||
44190594|NCT01586338|78986304|FG000|Overall Study|Other|1|||
44190595|NCT02143141|78986310|FG000|Overall Study|pain scores at 24 hours not collected|1|||
44190596|NCT02143141|78986311|FG001|Overall Study|pain scores at 24 hours not collected|0|||
44190597|NCT02171065|78986320|FG000|Overall Study|Withdrawal by Subject|1|||
44190598|NCT02171065|78986321|FG001|Overall Study|Withdrawal by Subject|0|||
44190599|NCT02171065|78986322|FG002|Overall Study|Withdrawal by Subject|0|||
44190600|NCT02171065|78986320|FG000|Overall Study|Lost to Follow-up|0|||
44190601|NCT02171065|78986321|FG001|Overall Study|Lost to Follow-up|0|||
44190602|NCT02171065|78986322|FG002|Overall Study|Lost to Follow-up|1|||
44190603|NCT01566604|78986334|FG000|Overall Study|Patient's inability to use the device|1|||
44190604|NCT01566604|78986335|FG001|Overall Study|Patient's inability to use the device|0|||
44190605|NCT01566604|78986334|FG000|Overall Study|Administrative problems|1|||
44190606|NCT01566604|78986335|FG001|Overall Study|Administrative problems|0|||
44190607|NCT01566604|78986334|FG000|Overall Study|Lack of Efficacy|1|||
44190608|NCT01566604|78986335|FG001|Overall Study|Lack of Efficacy|2|||
44190609|NCT01566604|78986334|FG000|Overall Study|Protocol deviation|2|||
44190610|NCT01566604|78986335|FG001|Overall Study|Protocol deviation|0|||
44190611|NCT01566604|78986334|FG000|Overall Study|Abnormal laboratory value|2|||
44190612|NCT01566604|78986335|FG001|Overall Study|Abnormal laboratory value|0|||
44190613|NCT01566604|78986334|FG000|Overall Study|Death|4|||
44190614|NCT01566604|78986335|FG001|Overall Study|Death|1|||
44190615|NCT01566604|78986334|FG000|Overall Study|Adverse Event|4|||
44190616|NCT01566604|78986335|FG001|Overall Study|Adverse Event|2|||
44190617|NCT01566604|78986334|FG000|Overall Study|Withdrawal by Subject|9|||
44190618|NCT01566604|78986335|FG001|Overall Study|Withdrawal by Subject|6|||
44190619|NCT01684930|78986343|FG000|Overall Study|Withdrawal by Subject|3|||
44190620|NCT01684930|78986344|FG001|Overall Study|Withdrawal by Subject|1|||
44190621|NCT01566214|78986352|FG000|Overall Study|Lost to Follow-up|3|||
44190622|NCT01566214|78986353|FG001|Overall Study|Lost to Follow-up|0|||
44190623|NCT02253992|78986362|FG000|Overall Study|Study drug toxicity|1|||
44190624|NCT02253992|78986363|FG001|Overall Study|Study drug toxicity|0|||
44190625|NCT02253992|78986364|FG002|Overall Study|Study drug toxicity|10|||
44190626|NCT02253992|78986362|FG000|Overall Study|Disease progression|4|||
44190627|NCT02253992|78986363|FG001|Overall Study|Disease progression|3|||
44190628|NCT02253992|78986364|FG002|Overall Study|Disease progression|98|||
44190629|NCT02253992|78986362|FG000|Overall Study|Withdrawal by Subject|0|||
44190630|NCT02253992|78986363|FG001|Overall Study|Withdrawal by Subject|0|||
44190631|NCT02253992|78986364|FG002|Overall Study|Withdrawal by Subject|3|||
44190632|NCT02253992|78986362|FG000|Overall Study|Adverse Event|0|||
44190633|NCT02253992|78986363|FG001|Overall Study|Adverse Event|0|||
44190634|NCT02253992|78986364|FG002|Overall Study|Adverse Event|8|||
44190635|NCT02253992|78986362|FG000|Overall Study|Death|0|||
44190636|NCT02253992|78986363|FG001|Overall Study|Death|0|||
44190637|NCT02253992|78986364|FG002|Overall Study|Death|1|||
44190638|NCT02253992|78986362|FG000|Overall Study|Subject discontinued study drug|1|||
44190639|NCT02253992|78986363|FG001|Overall Study|Subject discontinued study drug|0|||
44190640|NCT02253992|78986364|FG002|Overall Study|Subject discontinued study drug|1|||
44190641|NCT02253992|78986362|FG000|Overall Study|Completed treatment as per protocol|0|||
44190642|NCT02253992|78986363|FG001|Overall Study|Completed treatment as per protocol|1|||
44190643|NCT02253992|78986364|FG002|Overall Study|Completed treatment as per protocol|22|||
44190644|NCT02253992|78986362|FG000|Overall Study|Other|0|||
44190645|NCT02253992|78986363|FG001|Overall Study|Other|0|||
44190646|NCT02253992|78986364|FG002|Overall Study|Other|1|||
44190647|NCT02252588|78986388|FG000|Overall Study|Withdrawal by Subject|4|||
44190648|NCT02252588|78986389|FG001|Overall Study|Withdrawal by Subject|0|||
44190649|NCT01585558|78986398|FG000|Overall Study|Withdrawal by Subject|4|||
44190650|NCT01585558|78986399|FG001|Overall Study|Withdrawal by Subject|5|||
44190651|NCT01585558|78986400|FG002|Overall Study|Withdrawal by Subject|8|||
44190652|NCT01585558|78986398|FG000|Overall Study|Lost to Follow-up|2|||
44190653|NCT01585558|78986399|FG001|Overall Study|Lost to Follow-up|0|||
44190654|NCT01585558|78986400|FG002|Overall Study|Lost to Follow-up|3|||
44190655|NCT01585558|78986398|FG000|Overall Study|Adverse Event|3|||
44190656|NCT01585558|78986399|FG001|Overall Study|Adverse Event|4|||
44190657|NCT01585558|78986400|FG002|Overall Study|Adverse Event|1|||
44190658|NCT01585558|78986398|FG000|Overall Study|Protocol Violation|4|||
44190659|NCT01585558|78986399|FG001|Overall Study|Protocol Violation|3|||
44190660|NCT01585558|78986400|FG002|Overall Study|Protocol Violation|2|||
44190661|NCT01585558|78986398|FG000|Overall Study|Lack of Efficacy|0|||
44190662|NCT01585558|78986399|FG001|Overall Study|Lack of Efficacy|0|||
44190663|NCT01585558|78986400|FG002|Overall Study|Lack of Efficacy|1|||
44190664|NCT01565980|78986410|FG000|Overall Study|Death|1|||
44190665|NCT01565980|78986411|FG001|Overall Study|Death|0|||
44190666|NCT01565980|78986410|FG000|Overall Study|Lost to Follow-up|1|||
44190667|NCT01565980|78986411|FG001|Overall Study|Lost to Follow-up|0|||
44190668|NCT01565980|78986410|FG000|Overall Study|health complications|1|||
44190669|NCT01565980|78986411|FG001|Overall Study|health complications|1|||
44190670|NCT01565980|78986410|FG000|Overall Study|stopped medical treatment|1|||
44190671|NCT01565980|78986411|FG001|Overall Study|stopped medical treatment|0|||
44190672|NCT01565980|78986410|FG000|Overall Study|Withdrawal by Subject|0|||
44190673|NCT01565980|78986411|FG001|Overall Study|Withdrawal by Subject|3|||
44190674|NCT01585246|78986426|FG000|Overall Study|Lost to Follow-up|0|||
44190675|NCT01585246|78986427|FG001|Overall Study|Lost to Follow-up|0|||
44190676|NCT01585246|78986428|FG002|Overall Study|Lost to Follow-up|2|||
44190677|NCT01585246|78986429|FG003|Overall Study|Lost to Follow-up|1|||
44190678|NCT01585246|78986430|FG004|Overall Study|Lost to Follow-up|0|||
44190679|NCT01585246|78986426|FG000|Overall Study|Protocol Violation|0|||
44190680|NCT01585246|78986427|FG001|Overall Study|Protocol Violation|0|||
44190681|NCT01585246|78986428|FG002|Overall Study|Protocol Violation|0|||
44190682|NCT01585246|78986429|FG003|Overall Study|Protocol Violation|0|||
44190683|NCT01585246|78986430|FG004|Overall Study|Protocol Violation|1|||
44190684|NCT01585246|78986426|FG000|Overall Study|Withdrawal by Subject|0|||
44190685|NCT01585246|78986427|FG001|Overall Study|Withdrawal by Subject|0|||
44190686|NCT01585246|78986428|FG002|Overall Study|Withdrawal by Subject|1|||
44190687|NCT01585246|78986429|FG003|Overall Study|Withdrawal by Subject|2|||
44190688|NCT01585246|78986430|FG004|Overall Study|Withdrawal by Subject|1|||
44190689|NCT01585246|78986426|FG000|Overall Study|Other|0|||
44190690|NCT01585246|78986427|FG001|Overall Study|Other|1|||
44190691|NCT01585246|78986428|FG002|Overall Study|Other|1|||
44190692|NCT01585246|78986429|FG003|Overall Study|Other|1|||
44190693|NCT01585246|78986430|FG004|Overall Study|Other|0|||
44190694|NCT01585168|78986447|FG000|Overall Study|Lost to Follow-up|3|||
44190695|NCT01585168|78986448|FG001|Overall Study|Lost to Follow-up|1|||
44190696|NCT01585168|78986449|FG002|Overall Study|Lost to Follow-up|1|||
44190697|NCT01585168|78986450|FG003|Overall Study|Lost to Follow-up|1|||
44190698|NCT02232074|78986460|FG000|Overall Study|Withdrawal by Subject|5|||
44190699|NCT02232074|78986461|FG001|Overall Study|Withdrawal by Subject|3|||
44190700|NCT02232074|78986460|FG000|Overall Study|No legal concerns at baseline|36|||
44190701|NCT02232074|78986461|FG001|Overall Study|No legal concerns at baseline|41|||
44190702|NCT02232074|78986460|FG000|Overall Study|deemed ineligible|0|||
44190703|NCT02232074|78986461|FG001|Overall Study|deemed ineligible|1|||
44190704|NCT02142283|78986475|FG000|Overall Study|Death|20|||
44190705|NCT02142283|78986476|FG001|Overall Study|Death|18|||
44190706|NCT02142283|78986475|FG000|Overall Study|Withdrawal by Subject|1|||
44190707|NCT02142283|78986476|FG001|Overall Study|Withdrawal by Subject|3|||
44190708|NCT02231918|78986485|FG000|Overall Study|Withdrawal by Subject|0|||
44190709|NCT02231918|78986486|FG001|Overall Study|Withdrawal by Subject|1|||
44190710|NCT02231918|78986487|FG002|Overall Study|Withdrawal by Subject|0|||
44190711|NCT02231918|78986485|FG000|Overall Study|Adverse Event|0|||
44190712|NCT02231918|78986486|FG001|Overall Study|Adverse Event|0|||
44190713|NCT02231918|78986487|FG002|Overall Study|Adverse Event|1|||
44190714|NCT02199314|78986495|FG000|Overall Study|Withdrawal by Subject|6|||
44190715|NCT02199314|78986495|FG000|Overall Study|Physician Decision|10|||
44190716|NCT02251652|78986499|FG000|Overall Study|Withdrawal by Subject|1|||
44190717|NCT02197520|78986505|FG000|Period 1|Withdrawal by Subject|1|||
44190718|NCT02197520|78986506|FG001|Period 1|Withdrawal by Subject|0|||
44190719|NCT02197520|78986505|FG000|Period 2|Adverse Event|0|||
44190720|NCT02197520|78986506|FG001|Period 2|Adverse Event|2|||
44190721|NCT02197520|78986505|FG000|Period 2|Withdrawal by Subject|1|||
44190722|NCT02197520|78986506|FG001|Period 2|Withdrawal by Subject|0|||
44190723|NCT02230904|78986516|FG000|Overall Study|Safety follow up could not take place|0|||
44190724|NCT02230904|78986517|FG001|Overall Study|Safety follow up could not take place|1|||
44190725|NCT02230670|78986527|FG000|Overall Study|Adverse Event|1|||
44190726|NCT02230670|78986528|FG001|Overall Study|Adverse Event|2|||
44190727|NCT02230670|78986527|FG000|Overall Study|Withdrawal by Subject|2|||
44190728|NCT02230670|78986528|FG001|Overall Study|Withdrawal by Subject|2|||
44190729|NCT02230670|78986527|FG000|Overall Study|Physician Decision|0|||
44190730|NCT02230670|78986528|FG001|Overall Study|Physician Decision|1|||
44190731|NCT02230670|78986527|FG000|Overall Study|Protocol Violation|0|||
44190732|NCT02230670|78986528|FG001|Overall Study|Protocol Violation|1|||
44190733|NCT02230670|78986527|FG000|Overall Study|Progression to Child-Pugh C|1|||
44190734|NCT02230670|78986528|FG001|Overall Study|Progression to Child-Pugh C|2|||
44190735|NCT02197130|78986537|FG000|Overall Study|Adverse Event|13|||
44190736|NCT02197130|78986538|FG001|Overall Study|Adverse Event|4|||
44190737|NCT02197130|78986539|FG002|Overall Study|Adverse Event|23|||
44190738|NCT02197130|78986537|FG000|Overall Study|Death|0|||
44190739|NCT02197130|78986538|FG001|Overall Study|Death|1|||
44190740|NCT02197130|78986539|FG002|Overall Study|Death|0|||
44190741|NCT02197130|78986537|FG000|Overall Study|Lost to Follow-up|2|||
44190742|NCT02197130|78986538|FG001|Overall Study|Lost to Follow-up|0|||
44190743|NCT02197130|78986539|FG002|Overall Study|Lost to Follow-up|1|||
44190744|NCT02197130|78986537|FG000|Overall Study|Does not meet entrance criteria|0|||
44190745|NCT02197130|78986538|FG001|Overall Study|Does not meet entrance criteria|0|||
44190746|NCT02197130|78986539|FG002|Overall Study|Does not meet entrance criteria|1|||
44190747|NCT02197130|78986537|FG000|Overall Study|Withdrawal by Subject|0|||
44190748|NCT02197130|78986538|FG001|Overall Study|Withdrawal by Subject|3|||
44190749|NCT02197130|78986539|FG002|Overall Study|Withdrawal by Subject|4|||
44190750|NCT02197130|78986537|FG000|Overall Study|Other|1|||
44190751|NCT02197130|78986538|FG001|Overall Study|Other|0|||
44190752|NCT02197130|78986539|FG002|Overall Study|Other|3|||
44190753|NCT02196506|78986549|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
44190754|NCT02196506|78986550|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
44190755|NCT02196506|78986551|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
44190756|NCT02196506|78986552|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
44190757|NCT02196506|78986549|FG000|Phase A|Withdrawal by Subject|34|||
44190758|NCT02196506|78986550|FG001|Phase A|Withdrawal by Subject|0|||
44190759|NCT02196506|78986551|FG002|Phase A|Withdrawal by Subject|0|||
44190760|NCT02196506|78986552|FG003|Phase A|Withdrawal by Subject|0|||
44190761|NCT02196506|78986549|FG000|Phase A|Adverse Event|22|||
44190762|NCT02196506|78986550|FG001|Phase A|Adverse Event|0|||
44190763|NCT02196506|78986551|FG002|Phase A|Adverse Event|0|||
44190764|NCT02196506|78986552|FG003|Phase A|Adverse Event|0|||
44190765|NCT02196506|78986549|FG000|Phase A|Lost to Follow-up|9|||
44190766|NCT02196506|78986550|FG001|Phase A|Lost to Follow-up|0|||
44190767|NCT02196506|78986551|FG002|Phase A|Lost to Follow-up|0|||
44190768|NCT02196506|78986552|FG003|Phase A|Lost to Follow-up|0|||
44190769|NCT02196506|78986549|FG000|Phase A|Protocol deviation|12|||
44190770|NCT02196506|78986550|FG001|Phase A|Protocol deviation|0|||
44190771|NCT02196506|78986551|FG002|Phase A|Protocol deviation|0|||
44190772|NCT02196506|78986552|FG003|Phase A|Protocol deviation|0|||
44190773|NCT02196506|78986549|FG000|Phase A|Participant withdrawn by investigator|10|||
44190774|NCT02196506|78986550|FG001|Phase A|Participant withdrawn by investigator|0|||
44190775|NCT02196506|78986551|FG002|Phase A|Participant withdrawn by investigator|0|||
44190776|NCT02196506|78986552|FG003|Phase A|Participant withdrawn by investigator|0|||
44190777|NCT02196506|78986549|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
44190778|NCT02196506|78986550|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
44190779|NCT02196506|78986551|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
44190780|NCT02196506|78986552|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
44190781|NCT02196506|78986549|FG000|Phase B|Lack of Efficacy|0|||
44190782|NCT02196506|78986550|FG001|Phase B|Lack of Efficacy|1|||
44190783|NCT02196506|78986551|FG002|Phase B|Lack of Efficacy|2|||
44190784|NCT02196506|78986552|FG003|Phase B|Lack of Efficacy|0|||
44190785|NCT02196506|78986549|FG000|Phase B|Withdrawal by Participant|0|||
44190786|NCT02196506|78986550|FG001|Phase B|Withdrawal by Participant|8|||
44190787|NCT02196506|78986551|FG002|Phase B|Withdrawal by Participant|1|||
44190788|NCT02196506|78986552|FG003|Phase B|Withdrawal by Participant|0|||
44190789|NCT02196506|78986549|FG000|Phase B|Adverse Event|0|||
44190790|NCT02196506|78986550|FG001|Phase B|Adverse Event|4|||
44190791|NCT02196506|78986551|FG002|Phase B|Adverse Event|1|||
44190792|NCT02196506|78986552|FG003|Phase B|Adverse Event|0|||
44190793|NCT02196506|78986549|FG000|Phase B|Lost to Follow-up|0|||
44190794|NCT02196506|78986550|FG001|Phase B|Lost to Follow-up|2|||
44190795|NCT02196506|78986551|FG002|Phase B|Lost to Follow-up|1|||
44190796|NCT02196506|78986552|FG003|Phase B|Lost to Follow-up|0|||
44190797|NCT02196506|78986549|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
44190798|NCT02196506|78986550|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
44190799|NCT02196506|78986551|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
44190800|NCT02196506|78986552|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
44190801|NCT02196506|78986549|FG000|Phase A+|Withdrawal by Participant|0|||
44190802|NCT02196506|78986550|FG001|Phase A+|Withdrawal by Participant|0|||
44190803|NCT02196506|78986551|FG002|Phase A+|Withdrawal by Participant|0|||
44190804|NCT02196506|78986552|FG003|Phase A+|Withdrawal by Participant|5|||
44190805|NCT02196506|78986549|FG000|Phase A+|Adverse Event|0|||
44190806|NCT02196506|78986550|FG001|Phase A+|Adverse Event|0|||
44190807|NCT02196506|78986551|FG002|Phase A+|Adverse Event|0|||
44190808|NCT02196506|78986552|FG003|Phase A+|Adverse Event|1|||
44190809|NCT02196506|78986549|FG000|Phase A+|Lost to Follow-up|0|||
44190810|NCT02196506|78986550|FG001|Phase A+|Lost to Follow-up|0|||
44190811|NCT02196506|78986551|FG002|Phase A+|Lost to Follow-up|0|||
44190812|NCT02196506|78986552|FG003|Phase A+|Lost to Follow-up|6|||
44190813|NCT02196506|78986549|FG000|Phase A+|Participant withdrawn by investigator|0|||
44190814|NCT02196506|78986550|FG001|Phase A+|Participant withdrawn by investigator|0|||
44190815|NCT02196506|78986551|FG002|Phase A+|Participant withdrawn by investigator|0|||
44190816|NCT02196506|78986552|FG003|Phase A+|Participant withdrawn by investigator|1|||
44190817|NCT02228720|78986558|FG000|Open Label - Day 30|Lost to Follow-up|1|||
44190818|NCT02228564|78986562|FG000|Overall Study|Withdrawal by Subject|10|||
44190819|NCT02228564|78986562|FG000|Overall Study|Death|11|||
44190820|NCT02228564|78986562|FG000|Overall Study|Physician Decision|5|||
44190821|NCT02228564|78986562|FG000|Overall Study|Lost to Follow-up|17|||
44190822|NCT02228564|78986562|FG000|Overall Study|Other|6|||
44190823|NCT01640951|78986574|FG000|Overall Study|Adverse Event|8|||
44190824|NCT01640951|78986575|FG001|Overall Study|Adverse Event|3|||
44190825|NCT01640951|78986576|FG002|Overall Study|Adverse Event|10|||
44190826|NCT01640951|78986577|FG003|Overall Study|Adverse Event|6|||
44190827|NCT01640951|78986578|FG004|Overall Study|Adverse Event|1|||
44190828|NCT01640951|78986579|FG005|Overall Study|Adverse Event|11|||
44190829|NCT01640951|78986580|FG006|Overall Study|Adverse Event|1|||
44190830|NCT01640951|78986581|FG007|Overall Study|Adverse Event|3|||
44190831|NCT01640951|78986574|FG000|Overall Study|Lack of Efficacy|20|||
44190832|NCT01640951|78986575|FG001|Overall Study|Lack of Efficacy|1|||
44190833|NCT01640951|78986576|FG002|Overall Study|Lack of Efficacy|7|||
44190834|NCT01640951|78986577|FG003|Overall Study|Lack of Efficacy|14|||
44190835|NCT01640951|78986578|FG004|Overall Study|Lack of Efficacy|0|||
44190836|NCT01640951|78986579|FG005|Overall Study|Lack of Efficacy|6|||
44190837|NCT01640951|78986580|FG006|Overall Study|Lack of Efficacy|5|||
44190838|NCT01640951|78986581|FG007|Overall Study|Lack of Efficacy|6|||
44190839|NCT01640951|78986574|FG000|Overall Study|Lost to Follow-up|1|||
44190840|NCT01640951|78986575|FG001|Overall Study|Lost to Follow-up|0|||
44190841|NCT01640951|78986576|FG002|Overall Study|Lost to Follow-up|6|||
44190842|NCT01640951|78986577|FG003|Overall Study|Lost to Follow-up|2|||
44190843|NCT01640951|78986578|FG004|Overall Study|Lost to Follow-up|2|||
44190844|NCT01640951|78986579|FG005|Overall Study|Lost to Follow-up|3|||
44190845|NCT01640951|78986580|FG006|Overall Study|Lost to Follow-up|1|||
44190846|NCT01640951|78986581|FG007|Overall Study|Lost to Follow-up|1|||
44190847|NCT01640951|78986574|FG000|Overall Study|Non-compliance with study treatment|0|||
44190848|NCT01640951|78986575|FG001|Overall Study|Non-compliance with study treatment|0|||
44190849|NCT01640951|78986576|FG002|Overall Study|Non-compliance with study treatment|1|||
44190850|NCT01640951|78986577|FG003|Overall Study|Non-compliance with study treatment|1|||
44190851|NCT01640951|78986578|FG004|Overall Study|Non-compliance with study treatment|1|||
44190852|NCT01640951|78986579|FG005|Overall Study|Non-compliance with study treatment|4|||
44190853|NCT01640951|78986580|FG006|Overall Study|Non-compliance with study treatment|1|||
44190854|NCT01640951|78986581|FG007|Overall Study|Non-compliance with study treatment|0|||
44190855|NCT01640951|78986574|FG000|Overall Study|Physician Decision|2|||
44190856|NCT01640951|78986575|FG001|Overall Study|Physician Decision|5|||
44190857|NCT01640951|78986576|FG002|Overall Study|Physician Decision|2|||
44190858|NCT01640951|78986577|FG003|Overall Study|Physician Decision|2|||
44190859|NCT01640951|78986578|FG004|Overall Study|Physician Decision|2|||
44190860|NCT01640951|78986579|FG005|Overall Study|Physician Decision|3|||
44190861|NCT01640951|78986580|FG006|Overall Study|Physician Decision|3|||
44190862|NCT01640951|78986581|FG007|Overall Study|Physician Decision|0|||
44190863|NCT01640951|78986574|FG000|Overall Study|Pregnancy|3|||
44190864|NCT01640951|78986575|FG001|Overall Study|Pregnancy|0|||
44190865|NCT01640951|78986576|FG002|Overall Study|Pregnancy|0|||
44190866|NCT01640951|78986577|FG003|Overall Study|Pregnancy|4|||
44190867|NCT01640951|78986578|FG004|Overall Study|Pregnancy|0|||
44190868|NCT01640951|78986579|FG005|Overall Study|Pregnancy|0|||
44190869|NCT01640951|78986580|FG006|Overall Study|Pregnancy|2|||
44190870|NCT01640951|78986581|FG007|Overall Study|Pregnancy|0|||
44190871|NCT01640951|78986574|FG000|Overall Study|Protocol Deviation|0|||
44190872|NCT01640951|78986575|FG001|Overall Study|Protocol Deviation|1|||
44190873|NCT01640951|78986576|FG002|Overall Study|Protocol Deviation|2|||
44190874|NCT01640951|78986577|FG003|Overall Study|Protocol Deviation|1|||
44266167|NCT02408016|79173298|FG002|Overall Study|Physician Decision|0|||
44266168|NCT02407704|79173362|FG000|Overall Study|Lost to Follow-up|0|||
44266169|NCT02407704|79173363|FG001|Overall Study|Lost to Follow-up|0|||
44451422|NCT03859323|79460338|FG005|Overall Study|Withdrawal by Subject|1|||
44266170|NCT02407704|79173364|FG002|Overall Study|Lost to Follow-up|0|||
44190875|NCT01640951|78986578|FG004|Overall Study|Protocol Deviation|0|||
44190876|NCT01640951|78986579|FG005|Overall Study|Protocol Deviation|1|||
44190877|NCT01640951|78986580|FG006|Overall Study|Protocol Deviation|0|||
44190878|NCT01640951|78986581|FG007|Overall Study|Protocol Deviation|0|||
44190879|NCT01640951|78986574|FG000|Overall Study|Subject/Guardian decision|12|||
44190880|NCT01640951|78986575|FG001|Overall Study|Subject/Guardian decision|4|||
44190881|NCT01640951|78986576|FG002|Overall Study|Subject/Guardian decision|13|||
44190882|NCT01640951|78986577|FG003|Overall Study|Subject/Guardian decision|15|||
44190883|NCT01640951|78986578|FG004|Overall Study|Subject/Guardian decision|7|||
44190884|NCT01640951|78986579|FG005|Overall Study|Subject/Guardian decision|19|||
44190885|NCT01640951|78986580|FG006|Overall Study|Subject/Guardian decision|5|||
44190886|NCT01640951|78986581|FG007|Overall Study|Subject/Guardian decision|4|||
44190887|NCT01640951|78986574|FG000|Overall Study|Death|0|||
44190888|NCT01640951|78986575|FG001|Overall Study|Death|1|||
44190889|NCT01640951|78986576|FG002|Overall Study|Death|1|||
44190890|NCT01640951|78986577|FG003|Overall Study|Death|0|||
44190891|NCT01640951|78986578|FG004|Overall Study|Death|0|||
44190892|NCT01640951|78986579|FG005|Overall Study|Death|0|||
44190893|NCT01640951|78986580|FG006|Overall Study|Death|0|||
44190894|NCT01640951|78986581|FG007|Overall Study|Death|2|||
44190895|NCT02228096|78986603|FG000|Overall Study|Study terminated by Sponsor|24|||
44190896|NCT02228096|78986603|FG000|Overall Study|Lack of Efficacy|18|||
44190897|NCT02228096|78986603|FG000|Overall Study|Death|12|||
44190898|NCT02228096|78986603|FG000|Overall Study|Physician Decision|3|||
44190899|NCT02228096|78986603|FG000|Overall Study|Subject/guardian decision|2|||
44190900|NCT02228096|78986603|FG000|Overall Study|New therapy for study indication|1|||
44190901|NCT02228096|78986603|FG000|Overall Study|Enrolled, not infused|11|||
44190902|NCT01640873|78986623|FG000|Overall Study|Protocol Violation|2|||
44190903|NCT01640873|78986624|FG001|Overall Study|Protocol Violation|1|||
44190904|NCT01683994|78986635|FG000|Overall Study|Withdrawal by Subject|1|||
44190905|NCT01683994|78986636|FG001|Overall Study|Withdrawal by Subject|0|||
44190906|NCT01683994|78986637|FG002|Overall Study|Withdrawal by Subject|0|||
44190907|NCT01683994|78986638|FG003|Overall Study|Withdrawal by Subject|1|||
44190908|NCT01683994|78986639|FG004|Overall Study|Withdrawal by Subject|0|||
44190909|NCT01683994|78986635|FG000|Overall Study|Intercurrent illness|0|||
44190910|NCT01683994|78986636|FG001|Overall Study|Intercurrent illness|0|||
44190911|NCT01683994|78986637|FG002|Overall Study|Intercurrent illness|0|||
44190912|NCT01683994|78986638|FG003|Overall Study|Intercurrent illness|2|||
44190913|NCT01683994|78986639|FG004|Overall Study|Intercurrent illness|1|||
44190914|NCT02247440|78986657|FG000|Overall Study|Withdrawal by Subject|1|||
44190915|NCT02247440|78986657|FG000|Overall Study|Lack of Efficacy|3|||
44190916|NCT01683838|78986663|FG000|Overall Study|Adverse Event|12|||
44190917|NCT01683838|78986664|FG001|Overall Study|Adverse Event|2|||
44190918|NCT01683838|78986663|FG000|Overall Study|Protocol Violation|3|||
44190919|NCT01683838|78986664|FG001|Overall Study|Protocol Violation|1|||
44190920|NCT01683838|78986663|FG000|Overall Study|Withdrawal by Subject|6|||
44190921|NCT01683838|78986664|FG001|Overall Study|Withdrawal by Subject|5|||
44190922|NCT01683838|78986663|FG000|Overall Study|Lost to Follow-up|1|||
44190923|NCT01683838|78986664|FG001|Overall Study|Lost to Follow-up|1|||
44190924|NCT01683838|78986663|FG000|Overall Study|Other|4|||
44190925|NCT01683838|78986664|FG001|Overall Study|Other|3|||
44190926|NCT01683604|78986670|FG000|Overall Study|Adverse Event|2|||
44190927|NCT01683604|78986670|FG000|Overall Study|Lack of Efficacy|1|||
44190928|NCT01683604|78986670|FG000|Overall Study|Other|2|||
44190929|NCT02196038|78986681|FG000|Overall Study|Death|16|||
44190930|NCT02196038|78986682|FG001|Overall Study|Death|21|||
44190931|NCT02196038|78986681|FG000|Overall Study|Withdrawal by Subject|0|||
44190932|NCT02196038|78986682|FG001|Overall Study|Withdrawal by Subject|1|||
44190933|NCT02196038|78986681|FG000|Overall Study|Lost to Follow-up|1|||
44190934|NCT02196038|78986682|FG001|Overall Study|Lost to Follow-up|0|||
44190935|NCT02141659|78986694|FG000|Overall Study|Major Protocol Deviation|0|||
44190936|NCT02141659|78986695|FG001|Overall Study|Major Protocol Deviation|1|||
44190937|NCT02141659|78986696|FG002|Overall Study|Major Protocol Deviation|0|||
44190938|NCT02141659|78986697|FG003|Overall Study|Major Protocol Deviation|0|||
44190939|NCT02141659|78986698|FG004|Overall Study|Major Protocol Deviation|0|||
44190940|NCT02141659|78986699|FG005|Overall Study|Major Protocol Deviation|0|||
44190941|NCT02141659|78986694|FG000|Overall Study|Lack of Efficacy|0|||
44190942|NCT02141659|78986695|FG001|Overall Study|Lack of Efficacy|0|||
44190943|NCT02141659|78986696|FG002|Overall Study|Lack of Efficacy|0|||
44190944|NCT02141659|78986697|FG003|Overall Study|Lack of Efficacy|0|||
44190945|NCT02141659|78986698|FG004|Overall Study|Lack of Efficacy|0|||
44190946|NCT02141659|78986699|FG005|Overall Study|Lack of Efficacy|1|||
44451423|NCT03859323|79460339|FG006|Overall Study|Withdrawal by Subject|0|||
44190947|NCT02141659|78986694|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
44190948|NCT02141659|78986695|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
44190949|NCT02141659|78986696|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
44190950|NCT02141659|78986697|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
44190951|NCT02141659|78986698|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
44190952|NCT02141659|78986699|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
44190953|NCT01640249|78986720|FG000|Period 1|Withdrawal by Subject|1|||
44190954|NCT01640249|78986721|FG001|Period 1|Withdrawal by Subject|0|||
44190955|NCT01640249|78986722|FG002|Period 1|Withdrawal by Subject|0|||
44190956|NCT01640249|78986723|FG003|Period 1|Withdrawal by Subject|0|||
44190957|NCT01640249|78986724|FG004|Period 1|Withdrawal by Subject|0|||
44190958|NCT01640249|78986725|FG005|Period 1|Withdrawal by Subject|1|||
44190959|NCT01640249|78986726|FG006|Period 1|Withdrawal by Subject|0|||
44190960|NCT02121301|78986748|FG000|Overall Study|Protocol Violation|1|||
44190961|NCT02121301|78986749|FG001|Overall Study|Protocol Violation|4|||
44451424|NCT03859323|79460340|FG007|Overall Study|Withdrawal by Subject|0|||
44190962|NCT02121301|78986750|FG002|Overall Study|Protocol Violation|1|||
44190963|NCT02227862|78986760|FG000|Overall Study|Protocol Violation|7|||
44190964|NCT02227862|78986761|FG001|Overall Study|Protocol Violation|9|||
44190965|NCT02227862|78986760|FG000|Overall Study|Other|0|||
44190966|NCT02227862|78986761|FG001|Overall Study|Other|2|||
44190967|NCT02227862|78986760|FG000|Overall Study|Adverse Event|4|||
44190968|NCT02227862|78986761|FG001|Overall Study|Adverse Event|3|||
44190969|NCT02227862|78986760|FG000|Overall Study|Withdrawal by Subject|7|||
44190970|NCT02227862|78986761|FG001|Overall Study|Withdrawal by Subject|6|||
44190971|NCT02227862|78986760|FG000|Overall Study|Lost to Follow-up|1|||
44190972|NCT02227862|78986761|FG001|Overall Study|Lost to Follow-up|2|||
44190973|NCT02120833|78986769|FG000|Overall Study|Adverse Event|1|||
44190974|NCT02120833|78986770|FG001|Overall Study|Adverse Event|0|||
44190975|NCT02120833|78986769|FG000|Overall Study|Withdrawal by Subject|2|||
44190976|NCT02120833|78986770|FG001|Overall Study|Withdrawal by Subject|0|||
44190977|NCT02120833|78986769|FG000|Overall Study|Lost to Follow-up|1|||
44190978|NCT02120833|78986770|FG001|Overall Study|Lost to Follow-up|1|||
44190979|NCT02170207|78986776|FG000|Overall Study|Case report forms unavailable|5|||
44190980|NCT02227784|78986784|FG000|Double-Blind Phase|Adverse Event|3|||
44190981|NCT02227784|78986785|FG001|Double-Blind Phase|Adverse Event|2|||
44190982|NCT02227784|78986786|FG002|Double-Blind Phase|Adverse Event|1|||
44190983|NCT02227784|78986787|FG003|Double-Blind Phase|Adverse Event|3|||
44190984|NCT02227784|78986788|FG004|Double-Blind Phase|Adverse Event|0|||
44190985|NCT02227784|78986784|FG000|Double-Blind Phase|Physician Decision|1|||
44190986|NCT02227784|78986785|FG001|Double-Blind Phase|Physician Decision|0|||
44190987|NCT02227784|78986786|FG002|Double-Blind Phase|Physician Decision|0|||
44190988|NCT02227784|78986787|FG003|Double-Blind Phase|Physician Decision|1|||
44190989|NCT02227784|78986788|FG004|Double-Blind Phase|Physician Decision|0|||
44190990|NCT02227784|78986784|FG000|Double-Blind Phase|Protocol Violation|0|||
44190991|NCT02227784|78986785|FG001|Double-Blind Phase|Protocol Violation|0|||
44190992|NCT02227784|78986786|FG002|Double-Blind Phase|Protocol Violation|1|||
44190993|NCT02227784|78986787|FG003|Double-Blind Phase|Protocol Violation|1|||
44190994|NCT02227784|78986788|FG004|Double-Blind Phase|Protocol Violation|0|||
44190995|NCT02227784|78986784|FG000|Double-Blind Phase|Sponsor Decision|34|||
44190996|NCT02227784|78986785|FG001|Double-Blind Phase|Sponsor Decision|15|||
44190997|NCT02227784|78986786|FG002|Double-Blind Phase|Sponsor Decision|14|||
44190998|NCT02227784|78986787|FG003|Double-Blind Phase|Sponsor Decision|32|||
44190999|NCT02227784|78986788|FG004|Double-Blind Phase|Sponsor Decision|0|||
44191000|NCT02227784|78986784|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
44191001|NCT02227784|78986785|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
44191002|NCT02227784|78986786|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
44191003|NCT02227784|78986787|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
44191004|NCT02227784|78986788|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
44191005|NCT02227784|78986784|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
44191006|NCT02227784|78986785|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
44191007|NCT02227784|78986786|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
44191008|NCT02227784|78986787|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
44191009|NCT02227784|78986788|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
44191010|NCT02227784|78986784|FG000|Open-Label Extension Phase (OLE)|Death|0|||
44191011|NCT02227784|78986785|FG001|Open-Label Extension Phase (OLE)|Death|0|||
44191012|NCT02227784|78986786|FG002|Open-Label Extension Phase (OLE)|Death|0|||
44191013|NCT02227784|78986787|FG003|Open-Label Extension Phase (OLE)|Death|0|||
44191014|NCT02227784|78986788|FG004|Open-Label Extension Phase (OLE)|Death|1|||
44191015|NCT02227784|78986784|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
44191016|NCT02227784|78986785|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
44191017|NCT02227784|78986786|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
44191018|NCT02227784|78986787|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
44191019|NCT02227784|78986788|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
44191020|NCT02227784|78986784|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
44191021|NCT02227784|78986785|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
44191022|NCT02227784|78986786|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
44191023|NCT02227784|78986787|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
44191024|NCT02227784|78986788|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
44191025|NCT01565668|78986803|FG000|Overall Study|Death|2|||
44191026|NCT01565668|78986804|FG001|Overall Study|Death|1|||
44191027|NCT01565668|78986803|FG000|Overall Study|Lack of Efficacy|4|||
44191028|NCT01565668|78986804|FG001|Overall Study|Lack of Efficacy|2|||
44191029|NCT01565668|78986803|FG000|Overall Study|Participant went on Hospice Care|1|||
44191030|NCT01565668|78986804|FG001|Overall Study|Participant went on Hospice Care|0|||
44191031|NCT01565668|78986803|FG000|Overall Study|Adverse Event|6|||
44191032|NCT01565668|78986804|FG001|Overall Study|Adverse Event|1|||
44191033|NCT01565668|78986803|FG000|Overall Study|Randomized, but never received drug|0|||
44191034|NCT01565668|78986804|FG001|Overall Study|Randomized, but never received drug|2|||
44191035|NCT01565668|78986803|FG000|Overall Study|Progressive disease|13|||
44191036|NCT01565668|78986804|FG001|Overall Study|Progressive disease|14|||
44451425|NCT03859323|79460341|FG008|Overall Study|Withdrawal by Subject|0|||
44543042|NCT03655717|79555919|FG019|Overall Study|Lost to Follow-up|0|||
44191037|NCT01565668|78986803|FG000|Overall Study|Withdrawal by Subject|1|||
44191038|NCT01565668|78986804|FG001|Overall Study|Withdrawal by Subject|3|||
44191039|NCT01565668|78986803|FG000|Overall Study|HSCT Transplant|11|||
44191040|NCT01565668|78986804|FG001|Overall Study|HSCT Transplant|15|||
44191041|NCT01683058|78986810|FG000|Overall Study|Lost to Follow-up|9|||
44191042|NCT01683058|78986810|FG000|Overall Study|Adverse Event|6|||
44191043|NCT01683058|78986810|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
44191044|NCT01683058|78986810|FG000|Overall Study|Withdrawal by Subject|7|||
44191045|NCT01683058|78986810|FG000|Overall Study|Lack of Efficacy|2|||
44191046|NCT01626859|78986818|FG000|Overall Study|Adverse Event|1|||
44191047|NCT01626859|78986819|FG001|Overall Study|Adverse Event|3|||
44191048|NCT01626859|78986820|FG002|Overall Study|Adverse Event|2|||
44191049|NCT01626859|78986818|FG000|Overall Study|Physician Decision|0|||
44191050|NCT01626859|78986819|FG001|Overall Study|Physician Decision|1|||
44191051|NCT01626859|78986820|FG002|Overall Study|Physician Decision|0|||
44191052|NCT01626859|78986818|FG000|Overall Study|Withdrawal by Subject|1|||
44191053|NCT01626859|78986819|FG001|Overall Study|Withdrawal by Subject|4|||
44191054|NCT01626859|78986820|FG002|Overall Study|Withdrawal by Subject|2|||
44191055|NCT02193776|78986832|FG000|Overall Study|Consent withdrawn|1|||
44191056|NCT02193776|78986833|FG001|Overall Study|Consent withdrawn|0|||
44191057|NCT02193776|78986834|FG002|Overall Study|Consent withdrawn|0|||
44191058|NCT02193776|78986835|FG003|Overall Study|Consent withdrawn|0|||
44191059|NCT02193776|78986832|FG000|Overall Study|Failure to comply with protocol|0|||
44191060|NCT02193776|78986833|FG001|Overall Study|Failure to comply with protocol|1|||
44191061|NCT02193776|78986834|FG002|Overall Study|Failure to comply with protocol|0|||
44191062|NCT02193776|78986835|FG003|Overall Study|Failure to comply with protocol|0|||
44191063|NCT02193776|78986832|FG000|Overall Study|Investigator/Sponsor decision|1|||
44191064|NCT02193776|78986833|FG001|Overall Study|Investigator/Sponsor decision|1|||
44191065|NCT02193776|78986834|FG002|Overall Study|Investigator/Sponsor decision|0|||
44191066|NCT02193776|78986835|FG003|Overall Study|Investigator/Sponsor decision|0|||
44191067|NCT02193776|78986832|FG000|Overall Study|Death|1|||
44191068|NCT02193776|78986833|FG001|Overall Study|Death|0|||
44191069|NCT02193776|78986834|FG002|Overall Study|Death|0|||
44191070|NCT02193776|78986835|FG003|Overall Study|Death|0|||
44191071|NCT02193776|78986832|FG000|Overall Study|Adverse event/Specific toxicity|5|||
44191072|NCT02193776|78986833|FG001|Overall Study|Adverse event/Specific toxicity|5|||
44191073|NCT02193776|78986834|FG002|Overall Study|Adverse event/Specific toxicity|2|||
44191074|NCT02193776|78986835|FG003|Overall Study|Adverse event/Specific toxicity|2|||
44191075|NCT02170064|78986848|FG000|Overall Study|Withdrawal by Subject|5|||
44191076|NCT02170064|78986849|FG001|Overall Study|Withdrawal by Subject|1|||
44191077|NCT02170064|78986850|FG002|Overall Study|Withdrawal by Subject|1|||
44191078|NCT02170064|78986848|FG000|Overall Study|Physician Decision|1|||
44191079|NCT02170064|78986849|FG001|Overall Study|Physician Decision|1|||
44191080|NCT02170064|78986850|FG002|Overall Study|Physician Decision|0|||
44191081|NCT02169830|78986861|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
44191082|NCT02169830|78986862|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
44191083|NCT02169830|78986863|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
44191084|NCT02169830|78986861|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
44191085|NCT02169830|78986862|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
44191086|NCT02169830|78986863|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
44191087|NCT02169830|78986861|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
44191088|NCT02169830|78986862|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
44191089|NCT02169830|78986863|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
44191090|NCT02169830|78986861|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
44191091|NCT02169830|78986862|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
44191092|NCT02169830|78986863|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
44191093|NCT02169830|78986861|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
44191094|NCT02169830|78986862|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
44191095|NCT02169830|78986863|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
44191096|NCT02169674|78986873|FG000|Overall Study|Withdrawal by Subject|2|||
44191097|NCT02169674|78986874|FG001|Overall Study|Withdrawal by Subject|1|||
44191098|NCT02169674|78986873|FG000|Overall Study|Seroprotected|30|||
44191099|NCT02169674|78986874|FG001|Overall Study|Seroprotected|76|||
44191100|NCT02169674|78986873|FG000|Overall Study|Lost to Follow-up|0|||
44191101|NCT02169674|78986874|FG001|Overall Study|Lost to Follow-up|1|||
44191102|NCT02169284|78986882|FG000|Overall Study|Physician Decision|0|||
44191103|NCT02169284|78986883|FG001|Overall Study|Physician Decision|1|||
44191104|NCT02119819|78986897|FG000|Overall Study|Adverse Event|3|||
44191105|NCT02119819|78986898|FG001|Overall Study|Adverse Event|1|||
44191106|NCT02119819|78986899|FG002|Overall Study|Adverse Event|2|||
44191107|NCT02119819|78986900|FG003|Overall Study|Adverse Event|3|||
44191108|NCT02119819|78986901|FG004|Overall Study|Adverse Event|0|||
44191109|NCT02119819|78986902|FG005|Overall Study|Adverse Event|1|||
44191110|NCT02119819|78986897|FG000|Overall Study|Lack of Efficacy|0|||
44191111|NCT02119819|78986898|FG001|Overall Study|Lack of Efficacy|0|||
44191112|NCT02119819|78986899|FG002|Overall Study|Lack of Efficacy|0|||
44191113|NCT02119819|78986900|FG003|Overall Study|Lack of Efficacy|0|||
44191114|NCT02119819|78986901|FG004|Overall Study|Lack of Efficacy|0|||
44191115|NCT02119819|78986902|FG005|Overall Study|Lack of Efficacy|1|||
44191116|NCT02119819|78986897|FG000|Overall Study|Lost to Follow-up|0|||
44191117|NCT02119819|78986898|FG001|Overall Study|Lost to Follow-up|0|||
44191118|NCT02119819|78986899|FG002|Overall Study|Lost to Follow-up|1|||
44191119|NCT02119819|78986900|FG003|Overall Study|Lost to Follow-up|2|||
44191120|NCT02119819|78986901|FG004|Overall Study|Lost to Follow-up|1|||
44191121|NCT02119819|78986902|FG005|Overall Study|Lost to Follow-up|2|||
44191122|NCT02119819|78986897|FG000|Overall Study|Physician Decision|1|||
44191123|NCT02119819|78986898|FG001|Overall Study|Physician Decision|1|||
44191124|NCT02119819|78986899|FG002|Overall Study|Physician Decision|0|||
44191125|NCT02119819|78986900|FG003|Overall Study|Physician Decision|0|||
44191126|NCT02119819|78986901|FG004|Overall Study|Physician Decision|0|||
44191127|NCT02119819|78986902|FG005|Overall Study|Physician Decision|1|||
44191128|NCT02119819|78986897|FG000|Overall Study|Withdrawal by Subject|5|||
44191129|NCT02119819|78986898|FG001|Overall Study|Withdrawal by Subject|3|||
44191130|NCT02119819|78986899|FG002|Overall Study|Withdrawal by Subject|0|||
44191131|NCT02119819|78986900|FG003|Overall Study|Withdrawal by Subject|0|||
44191132|NCT02119819|78986901|FG004|Overall Study|Withdrawal by Subject|6|||
44191133|NCT02119819|78986902|FG005|Overall Study|Withdrawal by Subject|10|||
44191134|NCT02119819|78986897|FG000|Overall Study|Jury Duty|0|||
44191135|NCT02119819|78986898|FG001|Overall Study|Jury Duty|0|||
44191136|NCT02119819|78986899|FG002|Overall Study|Jury Duty|1|||
44191137|NCT02119819|78986900|FG003|Overall Study|Jury Duty|0|||
44191138|NCT02119819|78986901|FG004|Overall Study|Jury Duty|0|||
44191139|NCT02119819|78986902|FG005|Overall Study|Jury Duty|0|||
44191140|NCT02119819|78986897|FG000|Overall Study|Protocol Violation|0|||
44191141|NCT02119819|78986898|FG001|Overall Study|Protocol Violation|0|||
44191142|NCT02119819|78986899|FG002|Overall Study|Protocol Violation|0|||
44191143|NCT02119819|78986900|FG003|Overall Study|Protocol Violation|1|||
44191144|NCT02119819|78986901|FG004|Overall Study|Protocol Violation|0|||
44191145|NCT02119819|78986902|FG005|Overall Study|Protocol Violation|0|||
44191146|NCT02119819|78986897|FG000|Overall Study|Left the city to get a job|0|||
44191147|NCT02119819|78986898|FG001|Overall Study|Left the city to get a job|0|||
44191148|NCT02119819|78986899|FG002|Overall Study|Left the city to get a job|0|||
44191149|NCT02119819|78986900|FG003|Overall Study|Left the city to get a job|1|||
44191150|NCT02119819|78986901|FG004|Overall Study|Left the city to get a job|0|||
44191151|NCT02119819|78986902|FG005|Overall Study|Left the city to get a job|0|||
44191152|NCT02168816|78986918|FG000|Overall Study|Lost to Follow-up|2|||
44191153|NCT02168816|78986919|FG001|Overall Study|Lost to Follow-up|2|||
44191154|NCT01584232|78986927|FG000|Overall Study|Adverse Event|3|||
44191155|NCT01584232|78986928|FG001|Overall Study|Adverse Event|1|||
44191156|NCT01584232|78986927|FG000|Overall Study|Withdrawal by Subject|2|||
44191157|NCT01584232|78986928|FG001|Overall Study|Withdrawal by Subject|1|||
44191158|NCT01584232|78986927|FG000|Overall Study|Physician Decision|2|||
44191159|NCT01584232|78986928|FG001|Overall Study|Physician Decision|1|||
44191160|NCT01584232|78986927|FG000|Overall Study|Lost to Follow-up|1|||
44191161|NCT01584232|78986928|FG001|Overall Study|Lost to Follow-up|0|||
44191162|NCT01639703|78986934|FG000|Overall Study|Withdrawal by Subject|5|||
44191163|NCT01639703|78986934|FG000|Overall Study|Other reason|7|||
44191164|NCT02119663|78986952|FG000|Overall Study|Disease progression|26|||
44191165|NCT02119663|78986953|FG001|Overall Study|Disease progression|27|||
44191166|NCT02119663|78986952|FG000|Overall Study|Adverse Event|5|||
44191167|NCT02119663|78986953|FG001|Overall Study|Adverse Event|5|||
44191168|NCT02119663|78986952|FG000|Overall Study|Death|3|||
44191169|NCT02119663|78986953|FG001|Overall Study|Death|2|||
44191170|NCT02119663|78986952|FG000|Overall Study|Physician Decision|1|||
44191171|NCT02119663|78986953|FG001|Overall Study|Physician Decision|2|||
44191172|NCT02119663|78986952|FG000|Overall Study|Other unspecified|2|||
44191173|NCT02119663|78986953|FG001|Overall Study|Other unspecified|0|||
44191174|NCT02119663|78986952|FG000|Overall Study|Subject decision|0|||
44191175|NCT02119663|78986953|FG001|Overall Study|Subject decision|1|||
44191176|NCT02119663|78986952|FG000|Overall Study|Study Terminated by the Sponsor|3|||
44451426|NCT03859323|79460342|FG009|Overall Study|Withdrawal by Subject|1|||
44191177|NCT02119663|78986953|FG001|Overall Study|Study Terminated by the Sponsor|4|||
44191178|NCT01639469|78986961|FG000|Overall Study|Death|4|||
44191179|NCT01639469|78986962|FG001|Overall Study|Death|2|||
44191180|NCT01639469|78986961|FG000|Overall Study|Lost to Follow-up|1|||
44191181|NCT01639469|78986962|FG001|Overall Study|Lost to Follow-up|1|||
44191182|NCT02193074|78986970|FG000|Overall Study|Withdrawal by Subject|1|||
44191183|NCT02193074|78986971|FG001|Overall Study|Withdrawal by Subject|2|||
44191184|NCT02193074|78986970|FG000|Overall Study|Adverse Event|16|||
44451427|NCT03859323|79460343|FG010|Overall Study|Withdrawal by Subject|1|||
44191185|NCT02193074|78986971|FG001|Overall Study|Adverse Event|13|||
44191186|NCT02192606|78986979|FG000|Overall Study|surgery type was changed|1|||
44191187|NCT02192606|78986980|FG001|Overall Study|surgery type was changed|1|||
44191188|NCT02192606|78986979|FG000|Overall Study|Physician Decision|1|||
44191189|NCT02192606|78986980|FG001|Overall Study|Physician Decision|2|||
44191190|NCT02192606|78986979|FG000|Overall Study|3D equipment rep unable to join|0|||
44191191|NCT02192606|78986980|FG001|Overall Study|3D equipment rep unable to join|1|||
44191192|NCT01628107|78986986|FG000|Overall Study|Withdrawal by Subject|17|||
44191193|NCT01628107|78986986|FG000|Overall Study|Lost to Follow-up|4|||
44191194|NCT01628107|78986986|FG000|Overall Study|Adverse Event|33|||
44191195|NCT01628107|78986986|FG000|Overall Study|Physician Decision|2|||
44191196|NCT01628107|78986986|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
44191197|NCT01628107|78986986|FG000|Overall Study|Non-compliant with Study Procedures|10|||
44191198|NCT01628107|78986986|FG000|Overall Study|Not Treated|8|||
44191199|NCT01628107|78986986|FG000|Overall Study|Sponsor Decision|11|||
44191200|NCT01628107|78986986|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
44191201|NCT01628107|78986986|FG000|Overall Study|Relocated|8|||
44191202|NCT01628107|78986986|FG000|Overall Study|Kidney Transplant|9|||
44191203|NCT01628107|78986986|FG000|Overall Study|Use of Standard of Care|9|||
44191204|NCT01583530|78986996|FG000|Overall Study|Adverse Event|0|||
44191205|NCT01583530|78986997|FG001|Overall Study|Adverse Event|0|||
44191206|NCT01583530|78986998|FG002|Overall Study|Adverse Event|0|||
44191207|NCT01583530|78986999|FG003|Overall Study|Adverse Event|0|||
44191208|NCT01583530|78987000|FG004|Overall Study|Adverse Event|0|||
44191209|NCT01583530|78987001|FG005|Overall Study|Adverse Event|1|||
44191210|NCT01583530|78986996|FG000|Overall Study|Withdrawal by Subject|0|||
44191211|NCT01583530|78986997|FG001|Overall Study|Withdrawal by Subject|3|||
44191212|NCT01583530|78986998|FG002|Overall Study|Withdrawal by Subject|0|||
44191213|NCT01583530|78986999|FG003|Overall Study|Withdrawal by Subject|1|||
44191214|NCT01583530|78987000|FG004|Overall Study|Withdrawal by Subject|1|||
44191215|NCT01583530|78987001|FG005|Overall Study|Withdrawal by Subject|2|||
44191216|NCT01583530|78986996|FG000|Overall Study|Lost to Follow-up|0|||
44191217|NCT01583530|78986997|FG001|Overall Study|Lost to Follow-up|0|||
44191218|NCT01583530|78986998|FG002|Overall Study|Lost to Follow-up|0|||
44191219|NCT01583530|78986999|FG003|Overall Study|Lost to Follow-up|0|||
44191220|NCT01583530|78987000|FG004|Overall Study|Lost to Follow-up|3|||
44191221|NCT01583530|78987001|FG005|Overall Study|Lost to Follow-up|0|||
44191222|NCT01583530|78986996|FG000|Overall Study|Lack of compliance|0|||
44191223|NCT01583530|78986997|FG001|Overall Study|Lack of compliance|0|||
44191224|NCT01583530|78986998|FG002|Overall Study|Lack of compliance|0|||
44191225|NCT01583530|78986999|FG003|Overall Study|Lack of compliance|0|||
44191226|NCT01583530|78987000|FG004|Overall Study|Lack of compliance|1|||
44191227|NCT01583530|78987001|FG005|Overall Study|Lack of compliance|0|||
44191228|NCT01639001|78987020|FG000|Overall Study|Refused further follow-up|9|||
44191229|NCT01639001|78987021|FG001|Overall Study|Refused further follow-up|12|||
44191230|NCT01639001|78987020|FG000|Overall Study|Lost to Follow-up|3|||
44191231|NCT01639001|78987021|FG001|Overall Study|Lost to Follow-up|0|||
44191232|NCT01639001|78987020|FG000|Overall Study|Death|62|||
44191233|NCT01639001|78987021|FG001|Overall Study|Death|61|||
44191234|NCT01639001|78987020|FG000|Overall Study|Randomized but not treated|0|||
44191235|NCT01639001|78987021|FG001|Overall Study|Randomized but not treated|2|||
44191236|NCT01639001|78987020|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
44191237|NCT01639001|78987021|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
44191238|NCT02224664|78987029|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
44191239|NCT02224664|78987030|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
44191240|NCT02224664|78987031|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
44191241|NCT02224664|78987032|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
44191242|NCT02224664|78987033|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
44191243|NCT02224664|78987029|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
44191244|NCT02224664|78987030|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
44191245|NCT02224664|78987031|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
44191246|NCT02224664|78987032|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
44191247|NCT02224664|78987033|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
44191248|NCT02224664|78987029|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
44191249|NCT02224664|78987030|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
44191250|NCT02224664|78987031|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
44191251|NCT02224664|78987032|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
44191252|NCT02224664|78987033|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
44191253|NCT02167256|78987051|FG000|Overall Study|Adverse Event|13|||
44191254|NCT02167256|78987052|FG001|Overall Study|Adverse Event|6|||
44191255|NCT02167256|78987051|FG000|Overall Study|Withdrawal by Subject|4|||
44191256|NCT02167256|78987052|FG001|Overall Study|Withdrawal by Subject|4|||
44191257|NCT02167256|78987051|FG000|Overall Study|non-compliance|3|||
44191258|NCT02167256|78987052|FG001|Overall Study|non-compliance|0|||
44191259|NCT02167256|78987051|FG000|Overall Study|Study partner unable to participate|1|||
44191260|NCT02167256|78987052|FG001|Overall Study|Study partner unable to participate|0|||
44191261|NCT02191046|78987060|FG000|Overall Study|low compliance|5|||
44191262|NCT02191046|78987061|FG001|Overall Study|low compliance|1|||
44191263|NCT02166476|78987069|FG000|Overall Study|Withdrawal by Subject|5|||
44191264|NCT02166476|78987070|FG001|Overall Study|Withdrawal by Subject|7|||
44191265|NCT02166476|78987069|FG000|Overall Study|Adverse Event|3|||
44191266|NCT02166476|78987070|FG001|Overall Study|Adverse Event|3|||
44191267|NCT02166476|78987069|FG000|Overall Study|Lost to Follow-up|5|||
44191268|NCT02166476|78987070|FG001|Overall Study|Lost to Follow-up|10|||
44191269|NCT02166476|78987069|FG000|Overall Study|Physician Decision|1|||
44191270|NCT02166476|78987070|FG001|Overall Study|Physician Decision|0|||
44191271|NCT02166476|78987069|FG000|Overall Study|Unable to Come for Visit|0|||
44191272|NCT02166476|78987070|FG001|Overall Study|Unable to Come for Visit|3|||
44191273|NCT02224274|78987081|FG000|Overall Study|Death|1|||
44191274|NCT02224274|78987082|FG001|Overall Study|Death|0|||
44191275|NCT02189252|78987096|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
44191276|NCT02189252|78987097|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
44191277|NCT02189252|78987098|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
44191278|NCT02189252|78987099|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
44191279|NCT02189252|78987096|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
44191280|NCT02189252|78987097|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
44191281|NCT02189252|78987098|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
44191282|NCT02189252|78987099|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
44191283|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
44191284|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
44191285|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
44191286|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44191287|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44191288|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44191289|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44191290|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44191291|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44191292|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
44191293|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
44191294|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
44191295|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44191296|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44191297|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44191298|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44191299|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44191300|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44191301|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
44191302|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
44191303|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191304|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191305|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191306|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191307|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191308|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191309|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44191310|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
44191311|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
44191312|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
44191313|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44191314|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44191315|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44191316|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44191317|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44191318|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44191319|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
44191320|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
44191321|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191322|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191323|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191324|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191325|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191326|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191327|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
44191328|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191329|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191330|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
44191331|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191332|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191333|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191334|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191335|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191336|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44191337|NCT01583374|78987113|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191338|NCT01583374|78987114|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
44191339|NCT01583374|78987115|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191340|NCT01583374|78987116|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191341|NCT01583374|78987117|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191342|NCT01583374|78987118|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191343|NCT01583374|78987119|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191344|NCT01583374|78987120|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191345|NCT01583374|78987121|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
44191346|NCT01583374|78987113|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191347|NCT01583374|78987114|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191348|NCT01583374|78987115|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191349|NCT01583374|78987116|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191350|NCT01583374|78987117|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191351|NCT01583374|78987118|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191352|NCT01583374|78987119|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191353|NCT01583374|78987120|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
44191354|NCT01583374|78987121|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44191355|NCT01583374|78987113|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
44191356|NCT01583374|78987114|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
44191357|NCT01583374|78987115|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
44191358|NCT01583374|78987116|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
44191359|NCT01583374|78987117|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
44191360|NCT01583374|78987118|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
44191361|NCT01583374|78987119|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
44191362|NCT01583374|78987120|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
44191363|NCT01583374|78987121|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
44191364|NCT01583374|78987113|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
44191365|NCT01583374|78987114|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
44191366|NCT01583374|78987115|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
44191367|NCT01583374|78987116|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
44191368|NCT01583374|78987117|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
44191369|NCT01583374|78987118|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
44191370|NCT01583374|78987119|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
44191371|NCT01583374|78987120|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
44191372|NCT01583374|78987121|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
44191373|NCT01583374|78987113|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
44191374|NCT01583374|78987114|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
44191375|NCT01583374|78987115|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
44191376|NCT01583374|78987116|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
44191377|NCT01583374|78987117|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
44191378|NCT01583374|78987118|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
44191379|NCT01583374|78987119|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
44191380|NCT01583374|78987120|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
44191381|NCT01583374|78987121|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
44191382|NCT01583374|78987113|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44191383|NCT01583374|78987114|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44191384|NCT01583374|78987115|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
44191385|NCT01583374|78987116|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44191386|NCT01583374|78987117|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
44191387|NCT01583374|78987118|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
44191388|NCT01583374|78987119|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44191389|NCT01583374|78987120|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44191390|NCT01583374|78987121|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44191391|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
44191392|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
44191393|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
44543043|NCT03655717|79555920|FG020|Overall Study|Lost to Follow-up|0|||
44191394|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
44191395|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
44191396|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
44191397|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
44191398|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
44191399|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
44191400|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
44191401|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
44191402|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
44191403|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
44191404|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
44191405|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
44191406|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
44191407|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
44191408|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
44191409|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
44191410|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
44191411|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
44191412|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
44191413|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
44191414|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
44191415|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
44191416|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
44191417|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
44191418|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
44191419|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
44191420|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
44191421|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
44191422|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
44191423|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
44191424|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
44191425|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
44191426|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
44191427|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191428|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191429|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191430|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191431|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
44191432|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191433|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
44191434|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191435|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
44191436|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
44191437|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
44191438|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
44191439|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
44191440|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
44191441|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
44191442|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
44191443|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
44191444|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
44191445|NCT01583374|78987113|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
44191446|NCT01583374|78987114|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
44191447|NCT01583374|78987115|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
44191448|NCT01583374|78987116|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
44191449|NCT01583374|78987117|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
44191450|NCT01583374|78987118|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
44191451|NCT01583374|78987119|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
44191452|NCT01583374|78987120|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
44191453|NCT01583374|78987121|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
44191454|NCT01583296|78987142|FG000|Overall Study|Withdrawal by Subject|11|||
44191455|NCT01583296|78987143|FG001|Overall Study|Withdrawal by Subject|10|||
44191456|NCT02222714|78987154|FG000|Overall Study|Death|0|||
44191457|NCT02222714|78987155|FG001|Overall Study|Death|2|||
44451428|NCT03859323|79460344|FG011|Overall Study|Withdrawal by Subject|2|||
44191458|NCT02222714|78987156|FG002|Overall Study|Death|3|||
44191459|NCT02222714|78987157|FG003|Overall Study|Death|4|||
44191460|NCT02222714|78987158|FG004|Overall Study|Death|6|||
44191461|NCT02222714|78987154|FG000|Overall Study|Withdrawal by Subject|0|||
44191462|NCT02222714|78987155|FG001|Overall Study|Withdrawal by Subject|0|||
44191463|NCT02222714|78987156|FG002|Overall Study|Withdrawal by Subject|1|||
44191464|NCT02222714|78987157|FG003|Overall Study|Withdrawal by Subject|0|||
44191465|NCT02222714|78987158|FG004|Overall Study|Withdrawal by Subject|1|||
44191466|NCT02164916|78987175|FG000|Overall Study|Adverse Event|3|||
44191467|NCT02164916|78987176|FG001|Overall Study|Adverse Event|8|||
44191468|NCT02164916|78987175|FG000|Overall Study|Death|1|||
44191469|NCT02164916|78987176|FG001|Overall Study|Death|1|||
44191470|NCT02164916|78987175|FG000|Overall Study|Refusal unrelated to adverse event|3|||
44191471|NCT02164916|78987176|FG001|Overall Study|Refusal unrelated to adverse event|7|||
44191472|NCT02164916|78987175|FG000|Overall Study|Progression|37|||
44191473|NCT02164916|78987176|FG001|Overall Study|Progression|26|||
44191474|NCT02164916|78987175|FG000|Overall Study|Not protocol specified|5|||
44191475|NCT02164916|78987176|FG001|Overall Study|Not protocol specified|1|||
44191476|NCT02164916|78987175|FG000|Overall Study|Reason under review|1|||
44191477|NCT02164916|78987176|FG001|Overall Study|Reason under review|6|||
44191478|NCT02164916|78987175|FG000|Overall Study|Not eligible|2|||
44191479|NCT02164916|78987176|FG001|Overall Study|Not eligible|5|||
44191480|NCT02222558|78987187|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
44191481|NCT02222558|78987188|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
44191482|NCT02222558|78987189|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
44191483|NCT02222558|78987190|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
44191484|NCT02222558|78987191|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
44191485|NCT02222558|78987192|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
44191486|NCT02222558|78987187|FG000|Period 3|Withdrawal by Subject|0|||
44191487|NCT02222558|78987188|FG001|Period 3|Withdrawal by Subject|0|||
44191488|NCT02222558|78987189|FG002|Period 3|Withdrawal by Subject|0|||
44191489|NCT02222558|78987190|FG003|Period 3|Withdrawal by Subject|0|||
44191490|NCT02222558|78987191|FG004|Period 3|Withdrawal by Subject|0|||
44191491|NCT02222558|78987192|FG005|Period 3|Withdrawal by Subject|1|||
44191492|NCT02188784|78987208|FG000|Overall Study|Death|3|||
44191493|NCT02188784|78987209|FG001|Overall Study|Death|1|||
44191494|NCT02188784|78987208|FG000|Overall Study|Lost to Follow-up|1|||
44191495|NCT02188784|78987209|FG001|Overall Study|Lost to Follow-up|0|||
44191496|NCT02188784|78987208|FG000|Overall Study|Withdrawal by Subject|3|||
44191497|NCT02188784|78987209|FG001|Overall Study|Withdrawal by Subject|9|||
44191498|NCT02188784|78987208|FG000|Overall Study|Physician Decision|2|||
44191499|NCT02188784|78987209|FG001|Overall Study|Physician Decision|3|||
44191500|NCT02222246|78987232|FG000|Overall Study|No Emergency Department Visits|27|||
44191501|NCT02222246|78987233|FG001|Overall Study|No Emergency Department Visits|26|||
44191502|NCT02222246|78987232|FG000|Overall Study|Physician Decision|0|||
44191503|NCT02222246|78987233|FG001|Overall Study|Physician Decision|1|||
44191504|NCT02188160|78987243|FG000|Overall Study|Adverse Event|1|||
44191505|NCT02188160|78987244|FG001|Overall Study|Adverse Event|0|||
44191506|NCT02188160|78987243|FG000|Overall Study|Use of an excluded medication|0|||
44191507|NCT02188160|78987244|FG001|Overall Study|Use of an excluded medication|1|||
44191508|NCT02220998|78987252|FG000|Overall Study|Randomized but Never Treated|1|||
44191509|NCT02220998|78987253|FG001|Overall Study|Randomized but Never Treated|2|||
44191510|NCT02220998|78987252|FG000|Overall Study|Death|2|||
44191511|NCT02220998|78987253|FG001|Overall Study|Death|0|||
44191512|NCT02220998|78987252|FG000|Overall Study|Lack of Efficacy|0|||
44191513|NCT02220998|78987253|FG001|Overall Study|Lack of Efficacy|5|||
44191514|NCT02220998|78987252|FG000|Overall Study|Lost to Follow-up|4|||
44191515|NCT02220998|78987253|FG001|Overall Study|Lost to Follow-up|4|||
44191516|NCT02220920|78987261|FG000|Overall Study|Adverse Event|1|||
44191517|NCT02220920|78987262|FG001|Overall Study|Adverse Event|0|||
44191518|NCT02220920|78987261|FG000|Overall Study|Lack of Efficacy|0|||
44191519|NCT02220920|78987262|FG001|Overall Study|Lack of Efficacy|1|||
44191520|NCT02220920|78987261|FG000|Overall Study|Withdrawal by Subject|1|||
44191521|NCT02220920|78987262|FG001|Overall Study|Withdrawal by Subject|0|||
44191522|NCT02220920|78987261|FG000|Overall Study|Conflict with the stopping criteria|1|||
44191523|NCT02220920|78987262|FG001|Overall Study|Conflict with the stopping criteria|2|||
44191524|NCT03966053|78987268|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
44191525|NCT01634555|78987281|FG000|Overall Study|Adverse Event|3|||
44191526|NCT01634555|78987281|FG000|Overall Study|Physician Decision|1|||
44191527|NCT01634243|78987288|FG000|Overall Study|Adverse Event|5|||
44191528|NCT01634243|78987289|FG001|Overall Study|Adverse Event|5|||
44191529|NCT01634243|78987288|FG000|Overall Study|Lack of Efficacy|1|||
44191530|NCT01634243|78987289|FG001|Overall Study|Lack of Efficacy|0|||
44191531|NCT01542034|78987306|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
44191532|NCT01542034|78987307|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
44191533|NCT01542034|78987306|FG000|Overall Study|Administrative decision|0|||
44191534|NCT01542034|78987307|FG001|Overall Study|Administrative decision|3|||
44191535|NCT01542034|78987306|FG000|Overall Study|Subject Noncompliance|1|||
44191536|NCT01542034|78987307|FG001|Overall Study|Subject Noncompliance|0|||
44191537|NCT01542034|78987306|FG000|Overall Study|Adverse Event|2|||
44191538|NCT01542034|78987307|FG001|Overall Study|Adverse Event|2|||
44191539|NCT01542034|78987306|FG000|Overall Study|Lost to Follow-up|7|||
44191540|NCT01542034|78987307|FG001|Overall Study|Lost to Follow-up|6|||
44191541|NCT01564732|78987315|FG000|Overall Study|Early termination by the study sponsor|6|||
44191542|NCT01564732|78987316|FG001|Overall Study|Early termination by the study sponsor|5|||
44191543|NCT01541644|78987322|FG000|Overall Study|Withdrawal by Subject|3|||
44191544|NCT01582282|78987329|FG000|Overall Study|Adverse Event|1|||
44191545|NCT01582282|78987330|FG001|Overall Study|Adverse Event|1|||
44191546|NCT01582282|78987331|FG002|Overall Study|Adverse Event|0|||
44191547|NCT01582282|78987329|FG000|Overall Study|Lost to Follow-up|1|||
44191548|NCT01582282|78987330|FG001|Overall Study|Lost to Follow-up|0|||
44191549|NCT01582282|78987331|FG002|Overall Study|Lost to Follow-up|0|||
44191550|NCT01582282|78987329|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
44191551|NCT01582282|78987330|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
44191552|NCT01582282|78987331|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
44191553|NCT01599650|78987342|FG000|Overall Study|Administrative issue|1|||
44191554|NCT01599650|78987343|FG001|Overall Study|Administrative issue|0|||
44191555|NCT01599650|78987344|FG002|Overall Study|Administrative issue|1|||
44191556|NCT01599650|78987342|FG000|Overall Study|Physician Decision|2|||
44191557|NCT01599650|78987343|FG001|Overall Study|Physician Decision|0|||
44191558|NCT01599650|78987344|FG002|Overall Study|Physician Decision|7|||
44191559|NCT01599650|78987342|FG000|Overall Study|Protocol Violation|0|||
44191560|NCT01599650|78987343|FG001|Overall Study|Protocol Violation|3|||
44191561|NCT01599650|78987344|FG002|Overall Study|Protocol Violation|0|||
44191562|NCT01599650|78987342|FG000|Overall Study|Death|2|||
44191563|NCT01599650|78987343|FG001|Overall Study|Death|1|||
44191564|NCT01599650|78987344|FG002|Overall Study|Death|2|||
44191565|NCT01599650|78987342|FG000|Overall Study|Lost to Follow-up|3|||
44191566|NCT01599650|78987343|FG001|Overall Study|Lost to Follow-up|3|||
44191567|NCT01599650|78987344|FG002|Overall Study|Lost to Follow-up|3|||
44191568|NCT01599650|78987342|FG000|Overall Study|Withdrawal by Subject|11|||
44191569|NCT01599650|78987343|FG001|Overall Study|Withdrawal by Subject|11|||
44191570|NCT01599650|78987344|FG002|Overall Study|Withdrawal by Subject|10|||
44191571|NCT01599650|78987342|FG000|Overall Study|Adverse Event|3|||
44191572|NCT01599650|78987343|FG001|Overall Study|Adverse Event|8|||
44191573|NCT01599650|78987344|FG002|Overall Study|Adverse Event|4|||
44191574|NCT01541254|78987354|FG000|Overall Study|Withdrawal by Subject|1|||
44191575|NCT01541254|78987354|FG000|Overall Study|excluded - metal allergy|1|||
44191576|NCT01541254|78987354|FG000|Overall Study|enrolled after study closed|1|||
44191577|NCT01541254|78987354|FG000|Overall Study|GI bleed prior to procedure|1|||
44191578|NCT01541254|78987354|FG000|Overall Study|stent not required|1|||
44191579|NCT01541254|78987354|FG000|Overall Study|alternate stent used|1|||
44191580|NCT02163902|78987360|FG000|Overall Study|Subject's Request|3|||
44191581|NCT02163902|78987361|FG001|Overall Study|Subject's Request|4|||
44191582|NCT02163902|78987360|FG000|Overall Study|Lost to Follow-up|6|||
44191583|NCT02163902|78987361|FG001|Overall Study|Lost to Follow-up|7|||
44191584|NCT02163902|78987360|FG000|Overall Study|Administrative Decision|2|||
44191585|NCT02163902|78987361|FG001|Overall Study|Administrative Decision|2|||
44191586|NCT01630616|78987373|FG000|Overall Study|Adverse Event|0|||
44191587|NCT01630616|78987374|FG001|Overall Study|Adverse Event|0|||
44191588|NCT01630616|78987375|FG002|Overall Study|Adverse Event|0|||
44191589|NCT01630616|78987376|FG003|Overall Study|Adverse Event|1|||
44191590|NCT01630616|78987377|FG004|Overall Study|Adverse Event|0|||
44191591|NCT01630616|78987378|FG005|Overall Study|Adverse Event|0|||
44191592|NCT01630616|78987373|FG000|Overall Study|Withdrawal by Subject|0|||
44191593|NCT01630616|78987374|FG001|Overall Study|Withdrawal by Subject|0|||
44191594|NCT01630616|78987375|FG002|Overall Study|Withdrawal by Subject|0|||
44191595|NCT01630616|78987376|FG003|Overall Study|Withdrawal by Subject|2|||
44191596|NCT01630616|78987377|FG004|Overall Study|Withdrawal by Subject|0|||
44191597|NCT01630616|78987378|FG005|Overall Study|Withdrawal by Subject|0|||
44191598|NCT03774875|78987397|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
44191599|NCT03774875|78987398|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
44191600|NCT03774875|78987397|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
44191601|NCT03774875|78987398|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
44191602|NCT03774875|78987397|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
44191603|NCT03774875|78987398|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
44191604|NCT03774875|78987397|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
44191605|NCT03774875|78987398|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
44191606|NCT03774875|78987397|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
44191607|NCT03774875|78987398|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
44191608|NCT03774875|78987397|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
44191609|NCT03774875|78987398|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
44191610|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
44191611|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
44191612|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
44191613|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
44191614|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
44191615|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
44191616|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
44191617|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
44191618|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
44191619|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
44191620|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
44191621|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
44191622|NCT03774875|78987397|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
44191623|NCT03774875|78987398|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
44191624|NCT02220764|78987411|FG000|Overall Study|Lost to Follow-up|3|||
44191625|NCT02220764|78987412|FG001|Overall Study|Lost to Follow-up|1|||
44191626|NCT02220764|78987411|FG000|Overall Study|Death|1|||
44191627|NCT02220764|78987412|FG001|Overall Study|Death|0|||
44191628|NCT01563172|78987418|FG000|Overall Study|Adverse Event|5|||
44191629|NCT01563172|78987418|FG000|Overall Study|Lost to Follow-up|2|||
44191630|NCT01563172|78987418|FG000|Overall Study|Other (Protocol deviation)|5|||
44191631|NCT01563172|78987418|FG000|Overall Study|Other (Not specified)|1|||
44191632|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
44191633|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
44191634|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
44191635|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
44191636|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
44191637|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
44191638|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
44191639|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
44191640|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
44191641|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
44191642|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
44191643|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
44191644|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
44191645|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
44191646|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
44191647|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
44191648|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
44191649|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
44191650|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
44191651|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
44191652|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
44191653|NCT02161718|78987435|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
44191654|NCT02161718|78987436|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
44191655|NCT02161718|78987437|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
44191656|NCT02161718|78987435|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
44191657|NCT02161718|78987436|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
44191658|NCT02161718|78987437|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
44191659|NCT02161718|78987435|FG000|Post- Randomization Period|Lost to Follow-up|0|||
44191660|NCT02161718|78987436|FG001|Post- Randomization Period|Lost to Follow-up|9|||
44191661|NCT02161718|78987437|FG002|Post- Randomization Period|Lost to Follow-up|15|||
44191662|NCT02161718|78987435|FG000|Post- Randomization Period|Adverse Event|0|||
44191663|NCT02161718|78987436|FG001|Post- Randomization Period|Adverse Event|9|||
44191664|NCT02161718|78987437|FG002|Post- Randomization Period|Adverse Event|10|||
44191665|NCT02161718|78987435|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
44191666|NCT02161718|78987436|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
44191667|NCT02161718|78987437|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
44191668|NCT02161718|78987435|FG000|Post- Randomization Period|Physician Decision|0|||
44191669|NCT02161718|78987436|FG001|Post- Randomization Period|Physician Decision|2|||
44191670|NCT02161718|78987437|FG002|Post- Randomization Period|Physician Decision|4|||
44191671|NCT02161718|78987435|FG000|Post- Randomization Period|Protocol Violation|0|||
44191672|NCT02161718|78987436|FG001|Post- Randomization Period|Protocol Violation|2|||
44191673|NCT02161718|78987437|FG002|Post- Randomization Period|Protocol Violation|3|||
44191674|NCT02161718|78987435|FG000|Post- Randomization Period|Lack of Efficacy|0|||
44191675|NCT02161718|78987436|FG001|Post- Randomization Period|Lack of Efficacy|0|||
44191676|NCT02161718|78987437|FG002|Post- Randomization Period|Lack of Efficacy|1|||
44191677|NCT02161718|78987435|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
44191678|NCT02161718|78987436|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
44191679|NCT02161718|78987437|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
44191680|NCT02161718|78987435|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
44191681|NCT02161718|78987436|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
44191682|NCT02161718|78987437|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
44191683|NCT02161718|78987435|FG000|Post- Randomization Period|Relocation|0|||
44191684|NCT02161718|78987436|FG001|Post- Randomization Period|Relocation|3|||
44191685|NCT02161718|78987437|FG002|Post- Randomization Period|Relocation|0|||
44191686|NCT02219048|78987446|FG000|Overall Study|Adverse Event|2|||
44191687|NCT02219048|78987447|FG001|Overall Study|Adverse Event|5|||
44191688|NCT02219048|78987446|FG000|Overall Study|No longer meets eligibility criteria|1|||
44191689|NCT02219048|78987447|FG001|Overall Study|No longer meets eligibility criteria|0|||
44191690|NCT02219048|78987446|FG000|Overall Study|Study terminated by sponsor|16|||
44191691|NCT02219048|78987447|FG001|Overall Study|Study terminated by sponsor|15|||
44191692|NCT02219048|78987446|FG000|Overall Study|Withdrawal by Subject|2|||
44191693|NCT02219048|78987447|FG001|Overall Study|Withdrawal by Subject|0|||
44191694|NCT02219048|78987446|FG000|Overall Study|Other|0|||
44191695|NCT02219048|78987447|FG001|Overall Study|Other|1|||
44191696|NCT02218736|78987455|FG000|Overall Study|Withdrawal by Subject|10|||
44191697|NCT02218736|78987456|FG001|Overall Study|Withdrawal by Subject|9|||
44191698|NCT02218736|78987455|FG000|Overall Study|Protocol Violation|2|||
44191699|NCT02218736|78987456|FG001|Overall Study|Protocol Violation|0|||
44191700|NCT01540474|78987466|FG000|Vaccination Period|Lost to Follow-up|0|||
44191701|NCT01540474|78987467|FG001|Vaccination Period|Lost to Follow-up|1|||
44191702|NCT01540474|78987468|FG002|Vaccination Period|Lost to Follow-up|0|||
44191703|NCT01540474|78987469|FG003|Vaccination Period|Lost to Follow-up|0|||
44191704|NCT01580488|78987480|FG000|Overall Study|Withdrawal by Subject|1|||
44191705|NCT01580020|78987496|FG000|Overall Study|Lack of Efficacy|0|||
44191706|NCT01580020|78987497|FG001|Overall Study|Lack of Efficacy|5|||
44191707|NCT01580020|78987498|FG002|Overall Study|Lack of Efficacy|0|||
44191708|NCT01580020|78987499|FG003|Overall Study|Lack of Efficacy|1|||
44191709|NCT01580020|78987496|FG000|Overall Study|Withdrawal by Subject|0|||
44191710|NCT01580020|78987497|FG001|Overall Study|Withdrawal by Subject|1|||
44191711|NCT01580020|78987498|FG002|Overall Study|Withdrawal by Subject|1|||
44191712|NCT01580020|78987499|FG003|Overall Study|Withdrawal by Subject|0|||
44191713|NCT01580020|78987496|FG000|Overall Study|Adverse Event|1|||
44191714|NCT01580020|78987497|FG001|Overall Study|Adverse Event|1|||
44191715|NCT01580020|78987498|FG002|Overall Study|Adverse Event|1|||
44191716|NCT01580020|78987499|FG003|Overall Study|Adverse Event|1|||
44191717|NCT01580020|78987496|FG000|Overall Study|Administrative Problems|0|||
44191718|NCT01580020|78987497|FG001|Overall Study|Administrative Problems|0|||
44191719|NCT01580020|78987498|FG002|Overall Study|Administrative Problems|1|||
44191720|NCT01580020|78987499|FG003|Overall Study|Administrative Problems|0|||
44191721|NCT01580020|78987496|FG000|Overall Study|Lost to Follow-up|0|||
44191722|NCT01580020|78987497|FG001|Overall Study|Lost to Follow-up|0|||
44191723|NCT01580020|78987498|FG002|Overall Study|Lost to Follow-up|1|||
44191724|NCT01580020|78987499|FG003|Overall Study|Lost to Follow-up|0|||
44191725|NCT01579474|78987515|FG000|Overall Study|Adverse Event|1|||
44191726|NCT01579474|78987516|FG001|Overall Study|Adverse Event|13|||
44191727|NCT01579474|78987517|FG002|Overall Study|Adverse Event|2|||
44191728|NCT01579474|78987518|FG003|Overall Study|Adverse Event|0|||
44191729|NCT01579474|78987519|FG004|Overall Study|Adverse Event|0|||
44191730|NCT01579474|78987520|FG005|Overall Study|Adverse Event|1|||
44191731|NCT01579474|78987515|FG000|Overall Study|Lack of Efficacy|1|||
44191732|NCT01579474|78987516|FG001|Overall Study|Lack of Efficacy|0|||
44191733|NCT01579474|78987517|FG002|Overall Study|Lack of Efficacy|0|||
44191734|NCT01579474|78987518|FG003|Overall Study|Lack of Efficacy|0|||
44191735|NCT01579474|78987519|FG004|Overall Study|Lack of Efficacy|1|||
44191736|NCT01579474|78987520|FG005|Overall Study|Lack of Efficacy|0|||
44191737|NCT01579474|78987515|FG000|Overall Study|Withdrawal by Subject|1|||
44191738|NCT01579474|78987516|FG001|Overall Study|Withdrawal by Subject|0|||
44191739|NCT01579474|78987517|FG002|Overall Study|Withdrawal by Subject|0|||
44191740|NCT01579474|78987518|FG003|Overall Study|Withdrawal by Subject|0|||
44191741|NCT01579474|78987519|FG004|Overall Study|Withdrawal by Subject|0|||
44191742|NCT01579474|78987520|FG005|Overall Study|Withdrawal by Subject|0|||
44191743|NCT01579318|78987533|FG000|Overall Study|Disease Progression|1|||
44191744|NCT01562782|78987539|FG000|Overall Study|Withdrawal by Subject|3|||
44191745|NCT01562782|78987540|FG001|Overall Study|Withdrawal by Subject|3|||
44266171|NCT02407704|79173365|FG003|Overall Study|Lost to Follow-up|2|||
44266172|NCT02407704|79173362|FG000|Overall Study|Protocol Violation|0|||
44191746|NCT01562782|78987539|FG000|Overall Study|screen failure|1|||
44191747|NCT01562782|78987540|FG001|Overall Study|screen failure|2|||
44191748|NCT01579006|78987546|FG000|Overall Study|Lack of Efficacy|10|||
44191749|NCT01579006|78987546|FG000|Overall Study|Adverse Event|13|||
44191750|NCT01579006|78987546|FG000|Overall Study|Withdrawal by Subject|5|||
44191751|NCT01579006|78987546|FG000|Overall Study|Non-compliance|3|||
44191752|NCT01579006|78987546|FG000|Overall Study|Due to participant's health fund|1|||
44191753|NCT01579006|78987546|FG000|Overall Study|Scheduled surgery|1|||
44191754|NCT01578850|78987552|FG000|Period 1|Insufficient Clinical Response|1|||
44191755|NCT01578850|78987553|FG001|Period 1|Insufficient Clinical Response|0|||
44191756|NCT01578850|78987554|FG002|Period 1|Insufficient Clinical Response|0|||
44191757|NCT01578850|78987552|FG000|Period 1|Adverse Event|11|||
44191758|NCT01578850|78987553|FG001|Period 1|Adverse Event|0|||
44191759|NCT01578850|78987554|FG002|Period 1|Adverse Event|0|||
44191760|NCT01578850|78987552|FG000|Period 1|Death|1|||
44191761|NCT01578850|78987553|FG001|Period 1|Death|0|||
44191762|NCT01578850|78987554|FG002|Period 1|Death|0|||
44191763|NCT01578850|78987552|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
44191764|NCT01578850|78987553|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
44191765|NCT01578850|78987554|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
44191766|NCT01578850|78987552|FG000|Period 1|Withdrawal by Subject|9|||
44191767|NCT01578850|78987553|FG001|Period 1|Withdrawal by Subject|0|||
44191768|NCT01578850|78987554|FG002|Period 1|Withdrawal by Subject|0|||
44191769|NCT01578850|78987552|FG000|Period 1|Study Terminated by Sponsor|3|||
44191770|NCT01578850|78987553|FG001|Period 1|Study Terminated by Sponsor|0|||
44191771|NCT01578850|78987554|FG002|Period 1|Study Terminated by Sponsor|0|||
44191772|NCT01578850|78987552|FG000|Period 2|Insufficient Clinical Response|0|||
44266173|NCT02407704|79173363|FG001|Overall Study|Protocol Violation|0|||
44191773|NCT01578850|78987553|FG001|Period 2|Insufficient Clinical Response|1|||
44191774|NCT01578850|78987554|FG002|Period 2|Insufficient Clinical Response|0|||
44191775|NCT01578850|78987552|FG000|Period 2|Adverse Event|0|||
44191776|NCT01578850|78987553|FG001|Period 2|Adverse Event|3|||
44191777|NCT01578850|78987554|FG002|Period 2|Adverse Event|6|||
44191778|NCT01578850|78987552|FG000|Period 2|Lost to Follow-up|0|||
44191779|NCT01578850|78987553|FG001|Period 2|Lost to Follow-up|1|||
44191780|NCT01578850|78987554|FG002|Period 2|Lost to Follow-up|2|||
44191781|NCT01578850|78987552|FG000|Period 2|Withdrawal by Subject|0|||
44191782|NCT01578850|78987553|FG001|Period 2|Withdrawal by Subject|2|||
44191783|NCT01578850|78987554|FG002|Period 2|Withdrawal by Subject|2|||
44191784|NCT01578850|78987552|FG000|Period 2|Study Terminated by Sponsor|0|||
44191785|NCT01578850|78987553|FG001|Period 2|Study Terminated by Sponsor|5|||
44191786|NCT01578850|78987554|FG002|Period 2|Study Terminated by Sponsor|4|||
44191787|NCT01578850|78987552|FG000|Period 2|Unspecified Reasons|0|||
44191788|NCT01578850|78987553|FG001|Period 2|Unspecified Reasons|1|||
44191789|NCT01578850|78987554|FG002|Period 2|Unspecified Reasons|0|||
44191790|NCT01539538|78987564|FG000|Overall Study|Adverse Event|13|||
44191791|NCT01539538|78987565|FG001|Overall Study|Adverse Event|18|||
44191792|NCT01539538|78987564|FG000|Overall Study|Lack of Efficacy|13|||
44191793|NCT01539538|78987565|FG001|Overall Study|Lack of Efficacy|16|||
44191794|NCT01539538|78987564|FG000|Overall Study|Withdrawal by Subject|2|||
44191795|NCT01539538|78987565|FG001|Overall Study|Withdrawal by Subject|3|||
44191796|NCT01539538|78987564|FG000|Overall Study|PCA no longer required or PCA problem|3|||
44191797|NCT01539538|78987565|FG001|Overall Study|PCA no longer required or PCA problem|7|||
44191798|NCT01562548|78987575|FG000|Overall Study|Lost to Follow-up|0|||
44191799|NCT01562548|78987576|FG001|Overall Study|Lost to Follow-up|0|||
44191800|NCT01562548|78987577|FG002|Overall Study|Lost to Follow-up|1|||
44191801|NCT01562548|78987578|FG003|Overall Study|Lost to Follow-up|0|||
44191802|NCT01562314|78987592|FG000|Overall Study|Adverse Event|10|||
44191803|NCT01562314|78987593|FG001|Overall Study|Adverse Event|5|||
44191804|NCT01562314|78987592|FG000|Overall Study|Met Withdrawal Criteria|3|||
44191805|NCT01562314|78987593|FG001|Overall Study|Met Withdrawal Criteria|2|||
44191806|NCT01562314|78987592|FG000|Overall Study|Withdrawal by Subject|0|||
44191807|NCT01562314|78987593|FG001|Overall Study|Withdrawal by Subject|1|||
44191808|NCT01539226|78987601|FG000|Overall Study|Withdrawal by Subject|24|||
44191809|NCT01539226|78987602|FG001|Overall Study|Withdrawal by Subject|54|||
44191810|NCT01539226|78987601|FG000|Overall Study|Lost to Follow-up|20|||
44191811|NCT01539226|78987602|FG001|Overall Study|Lost to Follow-up|54|||
44191812|NCT01539226|78987601|FG000|Overall Study|Death|1|||
44191813|NCT01539226|78987602|FG001|Overall Study|Death|2|||
44191814|NCT01539226|78987601|FG000|Overall Study|Adverse Event|2|||
44191815|NCT01539226|78987602|FG001|Overall Study|Adverse Event|0|||
44191816|NCT01539226|78987601|FG000|Overall Study|Pregnancy|13|||
44191817|NCT01539226|78987602|FG001|Overall Study|Pregnancy|29|||
44191818|NCT01539226|78987601|FG000|Overall Study|inappropriate enrollment|0|||
44191819|NCT01539226|78987602|FG001|Overall Study|inappropriate enrollment|1|||
44191820|NCT01539226|78987601|FG000|Overall Study|Multiple Reasons|3|||
44191821|NCT01539226|78987602|FG001|Overall Study|Multiple Reasons|1|||
44191822|NCT01539226|78987601|FG000|Overall Study|not HIV seroconversion-related|93|||
44191823|NCT01539226|78987602|FG001|Overall Study|not HIV seroconversion-related|176|||
44191824|NCT01539226|78987601|FG000|Overall Study|HIV seroconversion-related|55|||
44191825|NCT01539226|78987602|FG001|Overall Study|HIV seroconversion-related|80|||
44191826|NCT01539226|78987601|FG000|Overall Study|Non-compliance|6|||
44191827|NCT01539226|78987602|FG001|Overall Study|Non-compliance|8|||
44191828|NCT01577758|78987608|FG000|Dose Escalation Phase|Adverse Event|0|||
44191829|NCT01577758|78987609|FG001|Dose Escalation Phase|Adverse Event|0|||
44191830|NCT01577758|78987610|FG002|Dose Escalation Phase|Adverse Event|0|||
44191831|NCT01577758|78987611|FG003|Dose Escalation Phase|Adverse Event|0|||
44191832|NCT01577758|78987612|FG004|Dose Escalation Phase|Adverse Event|0|||
44191833|NCT01577758|78987613|FG005|Dose Escalation Phase|Adverse Event|2|||
44191834|NCT01577758|78987614|FG006|Dose Escalation Phase|Adverse Event|1|||
44191835|NCT01577758|78987615|FG007|Dose Escalation Phase|Adverse Event|0|||
44191836|NCT01577758|78987608|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
44191837|NCT01577758|78987609|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
44191838|NCT01577758|78987610|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
44191839|NCT01577758|78987611|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
44191840|NCT01577758|78987612|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
44191841|NCT01577758|78987613|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
44191842|NCT01577758|78987614|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
44191843|NCT01577758|78987615|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
44191844|NCT01577758|78987608|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
44191845|NCT01577758|78987609|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
44191846|NCT01577758|78987610|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
44191847|NCT01577758|78987611|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44191848|NCT01577758|78987612|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
44191849|NCT01577758|78987613|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
44191850|NCT01577758|78987614|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
44191851|NCT01577758|78987615|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
44191852|NCT01577758|78987608|FG000|Dose Escalation Phase|Progression Disease|2|||
44191853|NCT01577758|78987609|FG001|Dose Escalation Phase|Progression Disease|2|||
44191854|NCT01577758|78987610|FG002|Dose Escalation Phase|Progression Disease|1|||
44191855|NCT01577758|78987611|FG003|Dose Escalation Phase|Progression Disease|2|||
44191856|NCT01577758|78987612|FG004|Dose Escalation Phase|Progression Disease|5|||
44191857|NCT01577758|78987613|FG005|Dose Escalation Phase|Progression Disease|0|||
44191858|NCT01577758|78987614|FG006|Dose Escalation Phase|Progression Disease|0|||
44191859|NCT01577758|78987615|FG007|Dose Escalation Phase|Progression Disease|0|||
44191860|NCT01577758|78987608|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191861|NCT01577758|78987609|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191862|NCT01577758|78987610|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191863|NCT01577758|78987611|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191864|NCT01577758|78987612|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191865|NCT01577758|78987613|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191866|NCT01577758|78987614|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
44191867|NCT01577758|78987615|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
44191868|NCT01577758|78987608|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191869|NCT01577758|78987609|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191870|NCT01577758|78987610|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191871|NCT01577758|78987611|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191872|NCT01577758|78987612|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191873|NCT01577758|78987613|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191874|NCT01577758|78987614|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
44191875|NCT01577758|78987615|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
44191876|NCT01577758|78987608|FG000|mCRC Expansion Phase|Progression Disease|0|||
44191877|NCT01577758|78987609|FG001|mCRC Expansion Phase|Progression Disease|0|||
44191878|NCT01577758|78987610|FG002|mCRC Expansion Phase|Progression Disease|0|||
44191879|NCT01577758|78987611|FG003|mCRC Expansion Phase|Progression Disease|0|||
44191880|NCT01577758|78987612|FG004|mCRC Expansion Phase|Progression Disease|0|||
44191881|NCT01577758|78987613|FG005|mCRC Expansion Phase|Progression Disease|0|||
44191882|NCT01577758|78987614|FG006|mCRC Expansion Phase|Progression Disease|0|||
44191883|NCT01577758|78987615|FG007|mCRC Expansion Phase|Progression Disease|19|||
44191884|NCT01537432|78987637|FG000|Overall Study|Lost to Follow-up|3|||
44191885|NCT01537432|78987638|FG001|Overall Study|Lost to Follow-up|1|||
44191886|NCT01537432|78987637|FG000|Overall Study|Withdrawal by Subject|0|||
44191887|NCT01537432|78987638|FG001|Overall Study|Withdrawal by Subject|1|||
44191888|NCT01537432|78987637|FG000|Overall Study|Administrative problems|1|||
44191889|NCT01537432|78987638|FG001|Overall Study|Administrative problems|0|||
44191890|NCT01537432|78987637|FG000|Overall Study|Adverse Event|1|||
44191891|NCT01537432|78987638|FG001|Overall Study|Adverse Event|0|||
44191892|NCT01537432|78987637|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44191893|NCT01537432|78987638|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44191894|NCT01537198|78987644|FG000|Overall Study|RSV infection|2|||
44191895|NCT01537198|78987644|FG000|Overall Study|Adverse Event|4|||
44191896|NCT01537198|78987644|FG000|Overall Study|No Further Visits to the Clinic|37|||
44191897|NCT01537198|78987644|FG000|Overall Study|Other|111|||
44191898|NCT01537120|78987648|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
44191899|NCT01537120|78987648|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
44191900|NCT01537042|78987656|FG000|Overall Study|Adverse Event|0|||
44191901|NCT01537042|78987657|FG001|Overall Study|Adverse Event|2|||
44191902|NCT01537042|78987656|FG000|Overall Study|Lack of Efficacy|0|||
44191903|NCT01537042|78987657|FG001|Overall Study|Lack of Efficacy|1|||
44191904|NCT01537042|78987656|FG000|Overall Study|Protocol Violation|0|||
44191905|NCT01537042|78987657|FG001|Overall Study|Protocol Violation|1|||
44191906|NCT01537042|78987656|FG000|Overall Study|Other|0|||
44191907|NCT01537042|78987657|FG001|Overall Study|Other|1|||
44191908|NCT01536574|78987678|FG000|Overall Study|Adverse Event|4|||
44191909|NCT01536574|78987679|FG001|Overall Study|Adverse Event|5|||
44191910|NCT01536574|78987678|FG000|Overall Study|Withdrawal by Subject|1|||
44191911|NCT01536574|78987679|FG001|Overall Study|Withdrawal by Subject|2|||
44191912|NCT01536574|78987678|FG000|Overall Study|Lack of Efficacy|1|||
44191913|NCT01536574|78987679|FG001|Overall Study|Lack of Efficacy|0|||
44191914|NCT01536418|78987687|FG000|Overall Study|Protocol Violation|2|||
44191915|NCT01536418|78987688|FG001|Overall Study|Protocol Violation|3|||
44191916|NCT01536418|78987687|FG000|Overall Study|Physician Decision|1|||
44191917|NCT01536418|78987688|FG001|Overall Study|Physician Decision|3|||
44191918|NCT01536418|78987687|FG000|Overall Study|Study closed/terminated|41|||
44191919|NCT01536418|78987688|FG001|Overall Study|Study closed/terminated|37|||
44191920|NCT01536418|78987687|FG000|Overall Study|Lack of Efficacy|10|||
44191921|NCT01536418|78987688|FG001|Overall Study|Lack of Efficacy|16|||
44191922|NCT01536418|78987687|FG000|Overall Study|Adverse Event|9|||
44191923|NCT01536418|78987688|FG001|Overall Study|Adverse Event|4|||
44191924|NCT01536418|78987687|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
44191925|NCT01536418|78987688|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
44191926|NCT01536418|78987687|FG000|Overall Study|Withdrawal by Subject|5|||
44191927|NCT01536418|78987688|FG001|Overall Study|Withdrawal by Subject|3|||
44191928|NCT01576042|78987697|FG000|Overall Study|Physician Decision|2|||
44191929|NCT01576042|78987698|FG001|Overall Study|Physician Decision|0|||
44191930|NCT01561300|78987704|FG000|Run in on Placebo|Adverse Event|1|||
44191931|NCT01561300|78987705|FG001|Run in on Placebo|Adverse Event|0|||
44191932|NCT01536262|78987715|FG000|Overall Study|Adverse Event|6|||
44191933|NCT01536262|78987716|FG001|Overall Study|Adverse Event|1|||
44191934|NCT01536262|78987717|FG002|Overall Study|Adverse Event|2|||
44191935|NCT01536262|78987715|FG000|Overall Study|Withdrawal by Subject|1|||
44191936|NCT01536262|78987716|FG001|Overall Study|Withdrawal by Subject|1|||
44191937|NCT01536262|78987717|FG002|Overall Study|Withdrawal by Subject|0|||
44191938|NCT01536262|78987715|FG000|Overall Study|Other than stated above|1|||
44191939|NCT01536262|78987716|FG001|Overall Study|Other than stated above|0|||
44191940|NCT01536262|78987717|FG002|Overall Study|Other than stated above|0|||
44191941|NCT01560988|78987726|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
44191942|NCT01560988|78987727|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
44191943|NCT01560988|78987726|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
44191944|NCT01560988|78987727|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
44191945|NCT01560988|78987726|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
44191946|NCT01560988|78987727|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
44191947|NCT01535638|78987738|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
44191948|NCT01535638|78987739|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
44191949|NCT01535638|78987740|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
44191950|NCT01535638|78987741|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
44191951|NCT01535638|78987742|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
44191952|NCT01535638|78987743|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
44191953|NCT01535638|78987738|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
44191954|NCT01535638|78987739|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
44191955|NCT01535638|78987740|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
44191956|NCT01535638|78987741|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
44191957|NCT01535638|78987742|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
44191958|NCT01535638|78987743|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
44191959|NCT01535560|78987754|FG000|Overall Study|Adverse Event|12|||
44191960|NCT01535560|78987755|FG001|Overall Study|Adverse Event|7|||
44191961|NCT01535560|78987754|FG000|Overall Study|Lost to Follow-up|1|||
44191962|NCT01535560|78987755|FG001|Overall Study|Lost to Follow-up|3|||
44191963|NCT01535560|78987754|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
44191964|NCT01535560|78987755|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
44191965|NCT01535560|78987754|FG000|Overall Study|Treatment Failure|21|||
44191966|NCT01535560|78987755|FG001|Overall Study|Treatment Failure|83|||
44191967|NCT01535560|78987754|FG000|Overall Study|Other|0|||
44191968|NCT01535560|78987755|FG001|Overall Study|Other|1|||
44191969|NCT01535560|78987754|FG000|Overall Study|Randomized in Error|0|||
44191970|NCT01535560|78987755|FG001|Overall Study|Randomized in Error|1|||
44191971|NCT01575028|78987763|FG000|Overall Study|Physician Decision|0|||
44191972|NCT01575028|78987764|FG001|Overall Study|Physician Decision|1|||
44191973|NCT01574716|78987789|FG000|Part 1|Death|3|||
44191974|NCT01574716|78987790|FG001|Part 1|Death|1|||
44191975|NCT01574716|78987791|FG002|Part 1|Death|8|||
44191976|NCT01574716|78987792|FG003|Part 1|Death|0|||
44191977|NCT01574716|78987793|FG004|Part 1|Death|0|||
44191978|NCT01574716|78987789|FG000|Part 1|Discontinuation of study by sponsor|0|||
44191979|NCT01574716|78987790|FG001|Part 1|Discontinuation of study by sponsor|0|||
44191980|NCT01574716|78987791|FG002|Part 1|Discontinuation of study by sponsor|1|||
44191981|NCT01574716|78987792|FG003|Part 1|Discontinuation of study by sponsor|0|||
44191982|NCT01574716|78987793|FG004|Part 1|Discontinuation of study by sponsor|0|||
44191983|NCT01574716|78987789|FG000|Part 1|Withdrawal by Subject|0|||
44191984|NCT01574716|78987790|FG001|Part 1|Withdrawal by Subject|2|||
44191985|NCT01574716|78987791|FG002|Part 1|Withdrawal by Subject|0|||
44191986|NCT01574716|78987792|FG003|Part 1|Withdrawal by Subject|0|||
44191987|NCT01574716|78987793|FG004|Part 1|Withdrawal by Subject|0|||
44191988|NCT01574716|78987789|FG000|Part 1|Lost to Follow-up|0|||
44191989|NCT01574716|78987790|FG001|Part 1|Lost to Follow-up|1|||
44191990|NCT01574716|78987791|FG002|Part 1|Lost to Follow-up|0|||
44191991|NCT01574716|78987792|FG003|Part 1|Lost to Follow-up|0|||
44191992|NCT01574716|78987793|FG004|Part 1|Lost to Follow-up|0|||
44191993|NCT01574716|78987789|FG000|Part 2|Progressive disease|0|||
44191994|NCT01574716|78987790|FG001|Part 2|Progressive disease|0|||
44191995|NCT01574716|78987791|FG002|Part 2|Progressive disease|0|||
44191996|NCT01574716|78987792|FG003|Part 2|Progressive disease|1|||
44191997|NCT01574716|78987793|FG004|Part 2|Progressive disease|0|||
44191998|NCT01574716|78987789|FG000|Part 2|Death|0|||
44191999|NCT01574716|78987790|FG001|Part 2|Death|0|||
44192000|NCT01574716|78987791|FG002|Part 2|Death|0|||
44192001|NCT01574716|78987792|FG003|Part 2|Death|76|||
44192002|NCT01574716|78987793|FG004|Part 2|Death|35|||
44192003|NCT01574716|78987789|FG000|Part 2|Discontinuation of study by sponsor|0|||
44192004|NCT01574716|78987790|FG001|Part 2|Discontinuation of study by sponsor|0|||
44192005|NCT01574716|78987791|FG002|Part 2|Discontinuation of study by sponsor|0|||
44192006|NCT01574716|78987792|FG003|Part 2|Discontinuation of study by sponsor|51|||
44192007|NCT01574716|78987793|FG004|Part 2|Discontinuation of study by sponsor|31|||
44192008|NCT01574716|78987789|FG000|Part 2|Withdrawal by Subject|0|||
44192009|NCT01574716|78987790|FG001|Part 2|Withdrawal by Subject|0|||
44192010|NCT01574716|78987791|FG002|Part 2|Withdrawal by Subject|0|||
44192011|NCT01574716|78987792|FG003|Part 2|Withdrawal by Subject|5|||
44192012|NCT01574716|78987793|FG004|Part 2|Withdrawal by Subject|4|||
44192013|NCT01574716|78987789|FG000|Part 2|Brain metastases|0|||
44192014|NCT01574716|78987790|FG001|Part 2|Brain metastases|0|||
44192015|NCT01574716|78987791|FG002|Part 2|Brain metastases|0|||
44192016|NCT01574716|78987792|FG003|Part 2|Brain metastases|1|||
44192017|NCT01574716|78987793|FG004|Part 2|Brain metastases|0|||
44192018|NCT01574716|78987789|FG000|Part 2|Lost to Follow-up|0|||
44192019|NCT01574716|78987790|FG001|Part 2|Lost to Follow-up|0|||
44192020|NCT01574716|78987791|FG002|Part 2|Lost to Follow-up|0|||
44192021|NCT01574716|78987792|FG003|Part 2|Lost to Follow-up|3|||
44192022|NCT01574716|78987793|FG004|Part 2|Lost to Follow-up|0|||
44192023|NCT02161562|78987804|FG000|Overall Study|Withdrawal by Subject|5|||
44192024|NCT02161562|78987805|FG001|Overall Study|Withdrawal by Subject|8|||
44192025|NCT02161562|78987804|FG000|Overall Study|Protocol Violation|9|||
44192026|NCT02161562|78987805|FG001|Overall Study|Protocol Violation|4|||
44192027|NCT02161562|78987804|FG000|Overall Study|Pregnancy|1|||
44192028|NCT02161562|78987805|FG001|Overall Study|Pregnancy|2|||
44192029|NCT02161562|78987804|FG000|Overall Study|Lost to Follow-up|3|||
44192030|NCT02161562|78987805|FG001|Overall Study|Lost to Follow-up|1|||
44192031|NCT02161562|78987804|FG000|Overall Study|Lack of Efficacy|4|||
44192032|NCT02161562|78987805|FG001|Overall Study|Lack of Efficacy|1|||
44192033|NCT02161562|78987804|FG000|Overall Study|Adverse Event|1|||
44192034|NCT02161562|78987805|FG001|Overall Study|Adverse Event|1|||
44192035|NCT02161562|78987804|FG000|Overall Study|Participant moved back to home country|1|||
44192036|NCT02161562|78987805|FG001|Overall Study|Participant moved back to home country|0|||
44192037|NCT02161562|78987804|FG000|Overall Study|Withdrew due to being out of the country|1|||
44192038|NCT02161562|78987805|FG001|Overall Study|Withdrew due to being out of the country|0|||
44192039|NCT02161562|78987804|FG000|Overall Study|Participant moved out of province|1|||
44192040|NCT02161562|78987805|FG001|Overall Study|Participant moved out of province|0|||
44192041|NCT01559116|78987824|FG000|Overall Study|Adverse Event|10|||
44192042|NCT01559116|78987824|FG000|Overall Study|Lack of Efficacy|1|||
44192043|NCT01559116|78987824|FG000|Overall Study|Lost to Follow-up|1|||
44192044|NCT01559116|78987824|FG000|Overall Study|Protocol Violation|1|||
44192045|NCT01559116|78987824|FG000|Overall Study|Withdrawal by Subject|4|||
44192046|NCT01559116|78987824|FG000|Overall Study|other than stated above|9|||
44192047|NCT01574326|78987843|FG000|Overall Study|Randomized but not treated|0|||
44192048|NCT01574326|78987844|FG001|Overall Study|Randomized but not treated|1|||
44192049|NCT01574326|78987843|FG000|Overall Study|Withdrawal by Participant|2|||
44192050|NCT01574326|78987844|FG001|Overall Study|Withdrawal by Participant|4|||
44192051|NCT01574326|78987843|FG000|Overall Study|Physician Decision|5|||
44192052|NCT01574326|78987844|FG001|Overall Study|Physician Decision|3|||
44192053|NCT01574326|78987843|FG000|Overall Study|Adverse Event|1|||
44192054|NCT01574326|78987844|FG001|Overall Study|Adverse Event|3|||
44192055|NCT01574326|78987843|FG000|Overall Study|Other: Mainly kidney transplant|8|||
44192056|NCT01574326|78987844|FG001|Overall Study|Other: Mainly kidney transplant|8|||
44192057|NCT01574248|78987857|FG000|Overall Study|Withdrawal by Subject|2|||
44192058|NCT01574248|78987858|FG001|Overall Study|Withdrawal by Subject|0|||
44192059|NCT01574248|78987857|FG000|Overall Study|Missing primary endpoint data|1|||
44192060|NCT01574248|78987858|FG001|Overall Study|Missing primary endpoint data|0|||
44192061|NCT01573624|78987864|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
44192062|NCT01573624|78987865|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
44192063|NCT01573624|78987866|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
44192064|NCT01573624|78987867|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
44192065|NCT01573624|78987868|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
44192066|NCT01573624|78987869|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
44192067|NCT01573624|78987870|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
44192068|NCT01573624|78987864|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
44192069|NCT01573624|78987865|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
44192070|NCT01573624|78987866|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
44192071|NCT01573624|78987867|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
44192072|NCT01573624|78987868|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
44192073|NCT01573624|78987869|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
44192074|NCT01573624|78987870|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
44192075|NCT01573624|78987864|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
44192076|NCT01573624|78987865|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
44192077|NCT01573624|78987866|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
44192078|NCT01573624|78987867|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
44192079|NCT01573624|78987868|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
44192080|NCT01573624|78987869|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
44192081|NCT01573624|78987870|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
44192082|NCT01573624|78987864|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44192083|NCT01573624|78987865|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44192084|NCT01573624|78987866|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44192085|NCT01573624|78987867|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44192086|NCT01573624|78987868|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44192087|NCT01573624|78987869|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
44192088|NCT01573624|78987870|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44192089|NCT01573624|78987864|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
44192090|NCT01573624|78987865|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
44192091|NCT01573624|78987866|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
44192092|NCT01573624|78987867|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
44192093|NCT01573624|78987868|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
44192094|NCT01573624|78987869|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
44192095|NCT01573624|78987870|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
44192096|NCT01573624|78987864|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
44192097|NCT01573624|78987865|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
44192098|NCT01573624|78987866|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
44192099|NCT01573624|78987867|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
44192100|NCT01573624|78987868|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
44192101|NCT01573624|78987869|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
44192102|NCT01573624|78987870|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
44192103|NCT01573624|78987864|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
44192104|NCT01573624|78987865|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
44192105|NCT01573624|78987866|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
44192106|NCT01573624|78987867|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
44192107|NCT01573624|78987868|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
44192108|NCT01573624|78987869|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
44192109|NCT01573624|78987870|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
44192110|NCT01573624|78987864|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
44192111|NCT01573624|78987865|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44192112|NCT01573624|78987866|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
44192113|NCT01573624|78987867|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
44192114|NCT01573624|78987868|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44192115|NCT01573624|78987869|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44192116|NCT01573624|78987870|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
44192117|NCT01573624|78987864|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
44192118|NCT01573624|78987865|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
44192119|NCT01573624|78987866|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
44192120|NCT01573624|78987867|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
44192121|NCT01573624|78987868|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
44192122|NCT01573624|78987869|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
44192123|NCT01573624|78987870|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
44192124|NCT01573624|78987864|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44192125|NCT01573624|78987865|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44192126|NCT01573624|78987866|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44192127|NCT01573624|78987867|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
44192128|NCT01573624|78987868|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44192129|NCT01573624|78987869|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
44192130|NCT01573624|78987870|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
44192131|NCT01573624|78987864|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192132|NCT01573624|78987865|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192133|NCT01573624|78987866|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
44266174|NCT02407704|79173364|FG002|Overall Study|Protocol Violation|0|||
44266175|NCT02407704|79173365|FG003|Overall Study|Protocol Violation|1|||
44266176|NCT02407704|79173362|FG000|Overall Study|Withdrawal by Subject|0|||
44266177|NCT02407704|79173363|FG001|Overall Study|Withdrawal by Subject|0|||
44266178|NCT02407704|79173364|FG002|Overall Study|Withdrawal by Subject|1|||
44266179|NCT02407704|79173365|FG003|Overall Study|Withdrawal by Subject|0|||
44266180|NCT02406612|79173386|FG000|Overall Study|Screening Failure|3|||
44192134|NCT01573624|78987867|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
44192135|NCT01573624|78987868|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192136|NCT01573624|78987869|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
44192137|NCT01573624|78987870|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192138|NCT01573624|78987864|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
44192139|NCT01573624|78987865|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
44192140|NCT01573624|78987866|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
44192141|NCT01573624|78987867|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
44192142|NCT01573624|78987868|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
44192143|NCT01573624|78987869|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
44192144|NCT01573624|78987870|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
44192145|NCT01573624|78987864|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
44192146|NCT01573624|78987865|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
44192147|NCT01573624|78987866|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
44192148|NCT01573624|78987867|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
44192149|NCT01573624|78987868|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
44192150|NCT01573624|78987869|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
44192151|NCT01573624|78987870|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
44192152|NCT01573624|78987864|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
44192153|NCT01573624|78987865|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
44192154|NCT01573624|78987866|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
44192155|NCT01573624|78987867|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
44192156|NCT01573624|78987868|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
44192157|NCT01573624|78987869|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
44192158|NCT01573624|78987870|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
44192159|NCT01573624|78987864|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44266181|NCT02406612|79173387|FG001|Overall Study|Screening Failure|0|||
44266182|NCT02406612|79173386|FG000|Overall Study|Intra-procedural Exclusion|1|||
44361250|NCT00893464|79366902|FG001|Overall Study|Did not complete therapy/experience PD|0|||
44192160|NCT01573624|78987865|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
44192161|NCT01573624|78987866|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
44192162|NCT01573624|78987867|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44192163|NCT01573624|78987868|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44192164|NCT01573624|78987869|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
44192165|NCT01573624|78987870|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44192166|NCT01573624|78987864|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
44192167|NCT01573624|78987865|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
44192168|NCT01573624|78987866|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
44192169|NCT01573624|78987867|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
44192170|NCT01573624|78987868|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
44192171|NCT01573624|78987869|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
44192172|NCT01573624|78987870|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
44192173|NCT01573624|78987864|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
44192174|NCT01573624|78987865|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
44192175|NCT01573624|78987866|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
44192176|NCT01573624|78987867|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
44192177|NCT01573624|78987868|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
44192178|NCT01573624|78987869|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
44192179|NCT01573624|78987870|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
44192180|NCT01573624|78987864|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
44192181|NCT01573624|78987865|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
44192182|NCT01573624|78987866|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
44192183|NCT01573624|78987867|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
44192184|NCT01573624|78987868|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
44192185|NCT01573624|78987869|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
44192186|NCT01573624|78987870|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
44192187|NCT01573624|78987864|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
44192188|NCT01573624|78987865|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
44192189|NCT01573624|78987866|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
44192190|NCT01573624|78987867|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
44192191|NCT01573624|78987868|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
44192192|NCT01573624|78987869|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
44192193|NCT01573624|78987870|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
44192194|NCT01573624|78987864|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
44192195|NCT01573624|78987865|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
44192196|NCT01573624|78987866|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
44192197|NCT01573624|78987867|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
44192198|NCT01573624|78987868|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
44192199|NCT01573624|78987869|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
44192200|NCT01573624|78987870|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
44192201|NCT01573624|78987864|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44192202|NCT01573624|78987865|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44192203|NCT01573624|78987866|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44192204|NCT01573624|78987867|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44192205|NCT01573624|78987868|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
44192206|NCT01573624|78987869|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
44192207|NCT01573624|78987870|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
44192208|NCT01573624|78987864|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192209|NCT01573624|78987865|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
44192210|NCT01573624|78987866|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
44192211|NCT01573624|78987867|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
44192212|NCT01573624|78987868|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192213|NCT01573624|78987869|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
44266183|NCT02406612|79173387|FG001|Overall Study|Intra-procedural Exclusion|3|||
44266184|NCT02406612|79173386|FG000|Overall Study|Guidewire Failure|0|||
44266185|NCT02406612|79173387|FG001|Overall Study|Guidewire Failure|1|||
44451429|NCT03859323|79460345|FG012|Overall Study|Withdrawal by Subject|1|||
44451430|NCT03859323|79460333|FG000|Overall Study|Pregnancy|0|||
44451431|NCT03859323|79460334|FG001|Overall Study|Pregnancy|0|||
44192214|NCT01573624|78987870|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
44192215|NCT01573624|78987864|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
44192216|NCT01573624|78987865|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44192217|NCT01573624|78987866|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44192218|NCT01573624|78987867|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44192219|NCT01573624|78987868|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
44192220|NCT01573624|78987869|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
44192221|NCT01573624|78987870|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
44192222|NCT01573624|78987864|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
44192223|NCT01573624|78987865|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
44192224|NCT01573624|78987866|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
44192225|NCT01573624|78987867|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
44192226|NCT01573624|78987868|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
44192227|NCT01573624|78987869|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
44192228|NCT01573624|78987870|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
44192229|NCT01573624|78987864|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
44192230|NCT01573624|78987865|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
44192231|NCT01573624|78987866|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
44192232|NCT01573624|78987867|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
44192233|NCT01573624|78987868|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
44192234|NCT01573624|78987869|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
44192235|NCT01573624|78987870|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
44192236|NCT01573624|78987864|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
44192237|NCT01573624|78987865|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
44192238|NCT01573624|78987866|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
44192239|NCT01573624|78987867|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
44192240|NCT01573624|78987868|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
44192241|NCT01573624|78987869|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
44192242|NCT01573624|78987870|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
44266186|NCT02405442|79173531|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
44266187|NCT02405442|79173532|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
44266188|NCT02405442|79173533|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
44266189|NCT02405442|79173534|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
44266190|NCT02405442|79173531|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
44266191|NCT02405442|79173532|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
44266192|NCT02405442|79173533|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
44192243|NCT01573624|78987864|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
44192244|NCT01573624|78987865|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
44192245|NCT01573624|78987866|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
44192246|NCT01573624|78987867|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
44192247|NCT01573624|78987868|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
44192248|NCT01573624|78987869|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
44192249|NCT01573624|78987870|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
44192250|NCT01557946|78987894|FG000|Overall Study|Adverse Event|3|||
44192251|NCT01557946|78987895|FG001|Overall Study|Adverse Event|0|||
44192252|NCT01534078|78987900|FG000|Overall Study|Death|1|||
44192253|NCT01534078|78987900|FG000|Overall Study|Withdrawal by Subject|1|||
44192254|NCT02185040|78987909|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
44192255|NCT02185040|78987910|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
44192256|NCT02185040|78987911|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
44192257|NCT02185040|78987912|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
44192258|NCT02185040|78987913|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
44192259|NCT02185040|78987914|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
44192260|NCT02185040|78987915|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
44192261|NCT02185040|78987909|FG000|Part 1 Treatment Phase|Adverse Event|1|||
44192262|NCT02185040|78987910|FG001|Part 1 Treatment Phase|Adverse Event|0|||
44192263|NCT02185040|78987911|FG002|Part 1 Treatment Phase|Adverse Event|0|||
44192264|NCT02185040|78987912|FG003|Part 1 Treatment Phase|Adverse Event|2|||
44192265|NCT02185040|78987913|FG004|Part 1 Treatment Phase|Adverse Event|3|||
44192266|NCT02185040|78987914|FG005|Part 1 Treatment Phase|Adverse Event|0|||
44266193|NCT02405442|79173534|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
44266194|NCT02405442|79173531|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
44192267|NCT02185040|78987915|FG006|Part 1 Treatment Phase|Adverse Event|0|||
44192268|NCT02185040|78987909|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
44192269|NCT02185040|78987910|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
44192270|NCT02185040|78987911|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
44192271|NCT02185040|78987912|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
44192272|NCT02185040|78987913|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
44192273|NCT02185040|78987914|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
44192274|NCT02185040|78987915|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
44266195|NCT02405442|79173532|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
44266196|NCT02405442|79173533|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
44266197|NCT02405442|79173534|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
44266198|NCT02405442|79173531|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
44266199|NCT02405442|79173532|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
44266200|NCT02405442|79173533|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
44266201|NCT02405442|79173534|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
44266202|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
44266203|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
44266204|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
44266205|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
44266206|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
44266207|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
44266208|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
44266209|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
44266210|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
44266211|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
44266212|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
44266213|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
44266214|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
44266215|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
44266216|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
44266217|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
44266218|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
44266219|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
44266220|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
44266221|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
44266222|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
44266223|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
44192275|NCT02185040|78987909|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
44192276|NCT02185040|78987910|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
44192277|NCT02185040|78987911|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
44192278|NCT02185040|78987912|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
44192279|NCT02185040|78987913|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
44192280|NCT02185040|78987914|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
44192281|NCT02185040|78987915|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
44192282|NCT02185040|78987909|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
44192283|NCT02185040|78987910|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
44192284|NCT02185040|78987911|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
44192285|NCT02185040|78987912|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
44192286|NCT02185040|78987913|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
44192287|NCT02185040|78987914|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
44192288|NCT02185040|78987915|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
44192289|NCT02185040|78987909|FG000|Active Treatment Extension Phase|Adverse Event|0|||
44192290|NCT02185040|78987910|FG001|Active Treatment Extension Phase|Adverse Event|0|||
44192291|NCT02185040|78987911|FG002|Active Treatment Extension Phase|Adverse Event|0|||
44192292|NCT02185040|78987912|FG003|Active Treatment Extension Phase|Adverse Event|0|||
44192293|NCT02185040|78987913|FG004|Active Treatment Extension Phase|Adverse Event|0|||
44192294|NCT02185040|78987914|FG005|Active Treatment Extension Phase|Adverse Event|1|||
44192295|NCT02185040|78987915|FG006|Active Treatment Extension Phase|Adverse Event|4|||
44192296|NCT02185040|78987909|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
44192297|NCT02185040|78987910|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
44192298|NCT02185040|78987911|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
44192299|NCT02185040|78987912|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
44192300|NCT02185040|78987913|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
44361251|NCT00893464|79366903|FG002|Overall Study|Did not complete therapy/experience PD|0|||
44192301|NCT02185040|78987914|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
44192302|NCT02185040|78987915|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
44192303|NCT02185040|78987909|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
44192304|NCT02185040|78987910|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
44192305|NCT02185040|78987911|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
44192306|NCT02185040|78987912|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
44192307|NCT02185040|78987913|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
44192308|NCT02185040|78987914|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
44192309|NCT02185040|78987915|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
44192310|NCT02161406|78987937|FG000|Overall Study|Death|2|||
44192311|NCT02161406|78987938|FG001|Overall Study|Death|1|||
44192312|NCT02161406|78987937|FG000|Overall Study|Lost to Follow-up|2|||
44192313|NCT02161406|78987938|FG001|Overall Study|Lost to Follow-up|1|||
44192314|NCT02161406|78987937|FG000|Overall Study|Withdrawal by Subject|2|||
44192315|NCT02161406|78987938|FG001|Overall Study|Withdrawal by Subject|4|||
44192316|NCT02161406|78987937|FG000|Overall Study|investigator withdrew subject|3|||
44192317|NCT02161406|78987938|FG001|Overall Study|investigator withdrew subject|1|||
44192318|NCT02161406|78987937|FG000|Overall Study|Lack of Efficacy|1|||
44192319|NCT02161406|78987938|FG001|Overall Study|Lack of Efficacy|1|||
44192320|NCT02161406|78987937|FG000|Overall Study|relocation|0|||
44192321|NCT02161406|78987938|FG001|Overall Study|relocation|1|||
44192322|NCT02161016|78987944|FG000|Overall Study|withdrawn by IRB|1|||
44192323|NCT01573000|78987950|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
44192324|NCT01573000|78987951|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
44192325|NCT01573000|78987950|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
44192326|NCT01573000|78987951|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
44192327|NCT01573000|78987950|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
44192328|NCT01573000|78987951|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
44192329|NCT01573000|78987950|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
44192330|NCT01573000|78987951|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
44192331|NCT01573000|78987950|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
44192332|NCT01573000|78987951|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
44192333|NCT01573000|78987950|FG000|Crossover Phase|Lack of Efficacy|0|||
44192334|NCT01573000|78987951|FG001|Crossover Phase|Lack of Efficacy|13|||
44192335|NCT01573000|78987950|FG000|Crossover Phase|Lost to Follow-up|0|||
44192336|NCT01573000|78987951|FG001|Crossover Phase|Lost to Follow-up|2|||
44192337|NCT01573000|78987950|FG000|Crossover Phase|Death|0|||
44192338|NCT01573000|78987951|FG001|Crossover Phase|Death|3|||
44192339|NCT01573000|78987950|FG000|Long-Term Follow-Up|Death|3|||
44192340|NCT01573000|78987951|FG001|Long-Term Follow-Up|Death|0|||
44192341|NCT01573000|78987950|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
44192342|NCT01573000|78987951|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
44192343|NCT01572922|78987961|FG000|Overall Study|Adverse Event|1|||
44192344|NCT01572922|78987961|FG000|Overall Study|Protocol Violation|1|||
44192345|NCT01572922|78987961|FG000|Overall Study|Death|1|||
44192346|NCT01572844|78987970|FG000|Overall Study|Physician Decision|1|||
44192347|NCT01572844|78987971|FG001|Overall Study|Physician Decision|1|||
44192348|NCT01557400|78987980|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
44192349|NCT01557400|78987980|FG000|Overall Study|Adverse Event|3|||
44192350|NCT01557400|78987980|FG000|Overall Study|Lost to Follow-up|5|||
44192351|NCT01557400|78987980|FG000|Overall Study|Withdrawal by Subject|9|||
44192352|NCT01533922|78987984|FG000|Overall Study|Adverse Event|5|||
44192353|NCT01533922|78987985|FG001|Overall Study|Adverse Event|8|||
44192354|NCT01533922|78987986|FG002|Overall Study|Adverse Event|6|||
44192355|NCT01533922|78987987|FG003|Overall Study|Adverse Event|3|||
44192356|NCT01533922|78987988|FG004|Overall Study|Adverse Event|4|||
44192357|NCT01533922|78987984|FG000|Overall Study|Lack of Efficacy|0|||
44192358|NCT01533922|78987985|FG001|Overall Study|Lack of Efficacy|0|||
44192359|NCT01533922|78987986|FG002|Overall Study|Lack of Efficacy|1|||
44192360|NCT01533922|78987987|FG003|Overall Study|Lack of Efficacy|0|||
44192361|NCT01533922|78987988|FG004|Overall Study|Lack of Efficacy|0|||
44192362|NCT01533922|78987984|FG000|Overall Study|Protocol Violation|0|||
44192363|NCT01533922|78987985|FG001|Overall Study|Protocol Violation|3|||
44192364|NCT01533922|78987986|FG002|Overall Study|Protocol Violation|0|||
44192365|NCT01533922|78987987|FG003|Overall Study|Protocol Violation|0|||
44192366|NCT01533922|78987988|FG004|Overall Study|Protocol Violation|1|||
44192367|NCT01533922|78987984|FG000|Overall Study|Withdrawal by Subject|3|||
44192368|NCT01533922|78987985|FG001|Overall Study|Withdrawal by Subject|1|||
44192369|NCT01533922|78987986|FG002|Overall Study|Withdrawal by Subject|2|||
44192370|NCT01533922|78987987|FG003|Overall Study|Withdrawal by Subject|2|||
44192371|NCT01533922|78987988|FG004|Overall Study|Withdrawal by Subject|1|||
44192372|NCT01533922|78987984|FG000|Overall Study|Other reason not defined above|2|||
44192373|NCT01533922|78987985|FG001|Overall Study|Other reason not defined above|0|||
44192374|NCT01533922|78987986|FG002|Overall Study|Other reason not defined above|1|||
44192375|NCT01533922|78987987|FG003|Overall Study|Other reason not defined above|0|||
44192376|NCT01533922|78987988|FG004|Overall Study|Other reason not defined above|0|||
44192377|NCT01533688|78988003|FG000|Overall Study|Withdrawal by Subject|5|||
44192378|NCT01533688|78988004|FG001|Overall Study|Withdrawal by Subject|4|||
44192379|NCT01533688|78988005|FG002|Overall Study|Withdrawal by Subject|3|||
44451432|NCT03859323|79460335|FG002|Overall Study|Pregnancy|0|||
44451433|NCT03859323|79460336|FG003|Overall Study|Pregnancy|0|||
44451434|NCT03859323|79460337|FG004|Overall Study|Pregnancy|0|||
44451435|NCT03859323|79460338|FG005|Overall Study|Pregnancy|0|||
44451436|NCT03859323|79460339|FG006|Overall Study|Pregnancy|0|||
44451437|NCT03859323|79460340|FG007|Overall Study|Pregnancy|0|||
44451438|NCT03859323|79460341|FG008|Overall Study|Pregnancy|0|||
44451439|NCT03859323|79460342|FG009|Overall Study|Pregnancy|1|||
44451440|NCT03859323|79460343|FG010|Overall Study|Pregnancy|0|||
44451441|NCT03859323|79460344|FG011|Overall Study|Pregnancy|0|||
44451442|NCT03859323|79460345|FG012|Overall Study|Pregnancy|0|||
44451443|NCT03857841|79460388|FG000|Overall Study|Death|1|||
44451444|NCT03857841|79460389|FG001|Overall Study|Death|0|||
44451445|NCT03857841|79460390|FG002|Overall Study|Death|0|||
44451446|NCT03857841|79460391|FG003|Overall Study|Death|0|||
44451447|NCT03857841|79460388|FG000|Overall Study|Study Terminated by Sponsor|1|||
44451448|NCT03857841|79460389|FG001|Overall Study|Study Terminated by Sponsor|0|||
44451449|NCT03857841|79460390|FG002|Overall Study|Study Terminated by Sponsor|0|||
44451450|NCT03857841|79460391|FG003|Overall Study|Study Terminated by Sponsor|0|||
44451451|NCT00500331|79460408|FG000|Overall Study|Adverse Event|0|||
44451452|NCT00500331|79460409|FG001|Overall Study|Adverse Event|2|||
44451453|NCT00500331|79460410|FG002|Overall Study|Adverse Event|0|||
44451454|NCT00500331|79460411|FG003|Overall Study|Adverse Event|1|||
44451455|NCT00500331|79460412|FG004|Overall Study|Adverse Event|2|||
44192380|NCT01533688|78988003|FG000|Overall Study|Medically unstable|1|||
44192381|NCT01533688|78988004|FG001|Overall Study|Medically unstable|3|||
44192382|NCT01533688|78988005|FG002|Overall Study|Medically unstable|3|||
44192383|NCT01533688|78988003|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
44192384|NCT01533688|78988004|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
44192385|NCT01533688|78988005|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
44192386|NCT01532986|78988017|FG000|Overall Study|Death|9|||
44192387|NCT01532986|78988018|FG001|Overall Study|Death|9|||
44361252|NCT00893464|79366904|FG003|Overall Study|Did not complete therapy/experience PD|0|||
44361253|NCT00893464|79366905|FG004|Overall Study|Did not complete therapy/experience PD|0|||
44361254|NCT00893464|79366906|FG005|Overall Study|Did not complete therapy/experience PD|0|||
44361255|NCT00893464|79366907|FG006|Overall Study|Did not complete therapy/experience PD|2|||
44361256|NCT00893464|79366908|FG007|Overall Study|Did not complete therapy/experience PD|2|||
44361257|NCT00891904|79366931|FG000|Overall Study|Death|1|||
44361258|NCT00891904|79366931|FG000|Overall Study|Adverse Event|1|||
44361259|NCT01157351|79366937|FG000|Overall Study|Adverse Event|5|||
44361260|NCT01157351|79366938|FG001|Overall Study|Adverse Event|4|||
44361261|NCT01157351|79366937|FG000|Overall Study|Death|1|||
44361262|NCT01157351|79366938|FG001|Overall Study|Death|0|||
44361263|NCT01157351|79366937|FG000|Overall Study|Lost to Follow-up|53|||
44361264|NCT01157351|79366938|FG001|Overall Study|Lost to Follow-up|55|||
44361265|NCT01157351|79366937|FG000|Overall Study|Withdrawal by Subject|37|||
44361266|NCT01157351|79366938|FG001|Overall Study|Withdrawal by Subject|27|||
44361267|NCT01157351|79366937|FG000|Overall Study|Physician Decision|5|||
44361268|NCT01157351|79366938|FG001|Overall Study|Physician Decision|4|||
44361269|NCT01157351|79366937|FG000|Overall Study|Protocol Violation|0|||
44361270|NCT01157351|79366938|FG001|Overall Study|Protocol Violation|1|||
44361271|NCT01157351|79366937|FG000|Overall Study|Other|32|||
44361272|NCT01157351|79366938|FG001|Overall Study|Other|36|||
44451456|NCT00500331|79460413|FG005|Overall Study|Adverse Event|2|||
44192388|NCT01532986|78988017|FG000|Overall Study|Withdrawal by Subject|7|||
44192389|NCT01532986|78988018|FG001|Overall Study|Withdrawal by Subject|10|||
44192390|NCT01532986|78988017|FG000|Overall Study|Physician Decision|7|||
44192391|NCT01532986|78988018|FG001|Overall Study|Physician Decision|5|||
44192392|NCT01532908|78988027|FG000|Overall Study|Not Transplanted|1|||
44192393|NCT01532908|78988028|FG001|Overall Study|Not Transplanted|0|||
44192394|NCT02160782|78988034|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
44192395|NCT02160782|78988035|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
44192396|NCT02160782|78988036|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
44192397|NCT02160782|78988037|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
44192398|NCT02160782|78988038|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
44192399|NCT02160782|78988034|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
44192400|NCT02160782|78988035|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
44192401|NCT02160782|78988036|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
44192402|NCT02160782|78988037|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
44192403|NCT02160782|78988038|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
44192404|NCT02160782|78988034|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
44192405|NCT02160782|78988035|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
44192406|NCT02160782|78988036|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
44192407|NCT02160782|78988037|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
44192408|NCT02160782|78988038|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
44192409|NCT02160782|78988034|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
44192410|NCT02160782|78988035|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
44192411|NCT02160782|78988036|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
44192412|NCT02160782|78988037|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
44192413|NCT02160782|78988038|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
44192414|NCT02160782|78988034|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
44192415|NCT02160782|78988035|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
44192416|NCT02160782|78988036|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
44192417|NCT02160782|78988037|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
44192418|NCT02160782|78988038|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
44192419|NCT02160782|78988034|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
44192420|NCT02160782|78988035|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
44192421|NCT02160782|78988036|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
44192422|NCT02160782|78988037|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
44192423|NCT02160782|78988038|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
44192424|NCT02160782|78988034|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
44192425|NCT02160782|78988035|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
44192426|NCT02160782|78988036|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
44266224|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
44266225|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
44266226|NCT02405442|79173531|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
44266227|NCT02405442|79173532|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
44266228|NCT02405442|79173533|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
44266229|NCT02405442|79173534|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
44192427|NCT02160782|78988037|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
44192428|NCT02160782|78988038|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
44192429|NCT02160626|78988065|FG000|Overall Study|Adverse Event|1|||
44192430|NCT02160626|78988066|FG001|Overall Study|Adverse Event|0|||
44192431|NCT02160626|78988067|FG002|Overall Study|Adverse Event|0|||
44192432|NCT02160626|78988065|FG000|Overall Study|Schedule not conducive to study visits|0|||
44192433|NCT02160626|78988066|FG001|Overall Study|Schedule not conducive to study visits|0|||
44192434|NCT02160626|78988067|FG002|Overall Study|Schedule not conducive to study visits|1|||
44192435|NCT02160626|78988065|FG000|Overall Study|Withdrawal by Subject|0|||
44192436|NCT02160626|78988066|FG001|Overall Study|Withdrawal by Subject|1|||
44192437|NCT02160626|78988067|FG002|Overall Study|Withdrawal by Subject|0|||
44192438|NCT02160314|78988079|FG000|Overall Study|Adverse Event|0|||
44192439|NCT02160314|78988080|FG001|Overall Study|Adverse Event|6|||
44266230|NCT02405442|79173531|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
44266231|NCT02405442|79173532|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
44266232|NCT02405442|79173533|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
44192440|NCT02160314|78988079|FG000|Overall Study|Protocol Violation|0|||
44192441|NCT02160314|78988080|FG001|Overall Study|Protocol Violation|4|||
44266233|NCT02405442|79173534|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
44451457|NCT00500331|79460414|FG006|Overall Study|Adverse Event|0|||
44192442|NCT02160314|78988079|FG000|Overall Study|Withdrawal by Subject|1|||
44192443|NCT02160314|78988080|FG001|Overall Study|Withdrawal by Subject|2|||
44192444|NCT02160314|78988079|FG000|Overall Study|Lost to Follow-up|0|||
44192445|NCT02160314|78988080|FG001|Overall Study|Lost to Follow-up|1|||
44192446|NCT02160002|78988088|FG000|Overall Study|Withdrawal by Subject|2|||
44192447|NCT02160002|78988089|FG001|Overall Study|Withdrawal by Subject|1|||
44192448|NCT02218268|78988095|FG000|24 Hour Washout|Physician Decision|11|||
44192449|NCT02218268|78988096|FG001|24 Hour Washout|Physician Decision|9|||
44192450|NCT02217878|78988104|FG000|Overall Study|required morphine due to chest pain|1|||
44192451|NCT02217878|78988105|FG001|Overall Study|required morphine due to chest pain|2|||
44192452|NCT02217878|78988104|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
44192453|NCT02217878|78988105|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
44192454|NCT02217566|78988111|FG000|Overall Study|Lost to Follow-up|2|||
44192455|NCT02217566|78988111|FG000|Overall Study|Death|3|||
44192456|NCT02217566|78988111|FG000|Overall Study|Early study termination|6|||
44192457|NCT02217410|78988118|FG000|Overall Study|Graft Loss|0|||
44192458|NCT02217410|78988119|FG001|Overall Study|Graft Loss|0|||
44192459|NCT02217410|78988120|FG002|Overall Study|Graft Loss|2|||
44192460|NCT02217410|78988118|FG000|Overall Study|Withdrawal by Subject|0|||
44192461|NCT02217410|78988119|FG001|Overall Study|Withdrawal by Subject|0|||
44192462|NCT02217410|78988120|FG002|Overall Study|Withdrawal by Subject|2|||
44192463|NCT02217410|78988118|FG000|Overall Study|Lost to Follow-up|0|||
44192464|NCT02217410|78988119|FG001|Overall Study|Lost to Follow-up|0|||
44192465|NCT02217410|78988120|FG002|Overall Study|Lost to Follow-up|1|||
44192466|NCT02217410|78988118|FG000|Overall Study|Lack of Efficacy|0|||
44192467|NCT02217410|78988119|FG001|Overall Study|Lack of Efficacy|1|||
44192468|NCT02217410|78988120|FG002|Overall Study|Lack of Efficacy|0|||
44192469|NCT02217410|78988118|FG000|Overall Study|Physician Decision|1|||
44192470|NCT02217410|78988119|FG001|Overall Study|Physician Decision|3|||
44192471|NCT02217410|78988120|FG002|Overall Study|Physician Decision|0|||
44192472|NCT02217332|78988133|FG000|Overall Study|Adverse Event|3|||
44192473|NCT02217332|78988133|FG000|Overall Study|Dose interruption >1 month|1|||
44192474|NCT02217332|78988133|FG000|Overall Study|Protocol Violation (eligibility)|1|||
44192475|NCT02217332|78988133|FG000|Overall Study|Withdrawal by Subject|1|||
44192476|NCT02217332|78988133|FG000|Overall Study|Lost to Follow-up|1|||
44192477|NCT02184572|78988139|FG000|Overall Study|Lost to Follow-up|29|||
44192478|NCT02184572|78988140|FG001|Overall Study|Lost to Follow-up|21|||
44192479|NCT02184572|78988139|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
44192480|NCT02184572|78988140|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
44192481|NCT02184572|78988139|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
44192482|NCT02184572|78988140|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
44192483|NCT02184572|78988139|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
44192484|NCT02184572|78988140|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
44192485|NCT02184572|78988139|FG000|Overall Study|Traveling Outside The Country|1|||
44192486|NCT02184572|78988140|FG001|Overall Study|Traveling Outside The Country|0|||
44192487|NCT02184572|78988139|FG000|Overall Study|Withdrawal by Subject|14|||
44192488|NCT02184572|78988140|FG001|Overall Study|Withdrawal by Subject|9|||
44192489|NCT02181842|78988148|FG000|Overall Study|Case Report Forms Uncollected|2|||
44192490|NCT01632020|78988154|FG000|Overall Study|Withdrawal by Subject|1|||
44192491|NCT01632020|78988155|FG001|Overall Study|Withdrawal by Subject|0|||
44192492|NCT01632020|78988154|FG000|Overall Study|Adverse Event|1|||
44192493|NCT01632020|78988155|FG001|Overall Study|Adverse Event|0|||
44192494|NCT02181296|78988163|FG000|Overall Study|Lost to Follow-up|7|||
44192495|NCT02181296|78988164|FG001|Overall Study|Lost to Follow-up|6|||
44192496|NCT02215616|78988174|FG000|Overall Study|Sponsor requested to stop study drug|0|||
44192497|NCT02215616|78988175|FG001|Overall Study|Sponsor requested to stop study drug|0|||
44192498|NCT02215616|78988176|FG002|Overall Study|Sponsor requested to stop study drug|1|||
44192499|NCT02215616|78988177|FG003|Overall Study|Sponsor requested to stop study drug|4|||
44192500|NCT02215616|78988174|FG000|Overall Study|Death|1|||
44192501|NCT02215616|78988175|FG001|Overall Study|Death|0|||
44192502|NCT02215616|78988176|FG002|Overall Study|Death|0|||
44192503|NCT02215616|78988177|FG003|Overall Study|Death|0|||
44192504|NCT02215616|78988174|FG000|Overall Study|Adverse Event|7|||
44192505|NCT02215616|78988175|FG001|Overall Study|Adverse Event|4|||
44192506|NCT02215616|78988176|FG002|Overall Study|Adverse Event|9|||
44192507|NCT02215616|78988177|FG003|Overall Study|Adverse Event|2|||
44192508|NCT02215616|78988174|FG000|Overall Study|Withdrawal by Subject|1|||
44192509|NCT02215616|78988175|FG001|Overall Study|Withdrawal by Subject|8|||
44192510|NCT02215616|78988176|FG002|Overall Study|Withdrawal by Subject|2|||
44192511|NCT02215616|78988177|FG003|Overall Study|Withdrawal by Subject|5|||
44192512|NCT02215616|78988174|FG000|Overall Study|Non-compliance|0|||
44192513|NCT02215616|78988175|FG001|Overall Study|Non-compliance|2|||
44192514|NCT02215616|78988176|FG002|Overall Study|Non-compliance|1|||
44192515|NCT02215616|78988177|FG003|Overall Study|Non-compliance|0|||
44192516|NCT02215616|78988174|FG000|Overall Study|Protocol Violation|0|||
44192517|NCT02215616|78988175|FG001|Overall Study|Protocol Violation|2|||
44192518|NCT02215616|78988176|FG002|Overall Study|Protocol Violation|0|||
44192519|NCT02215616|78988177|FG003|Overall Study|Protocol Violation|0|||
44192520|NCT02215616|78988174|FG000|Overall Study|Lost to Follow-up|1|||
44192521|NCT02215616|78988175|FG001|Overall Study|Lost to Follow-up|1|||
44192522|NCT02215616|78988176|FG002|Overall Study|Lost to Follow-up|0|||
44192523|NCT02215616|78988177|FG003|Overall Study|Lost to Follow-up|1|||
44192524|NCT02215616|78988174|FG000|Overall Study|Other than specified|1|||
44192525|NCT02215616|78988175|FG001|Overall Study|Other than specified|0|||
44192526|NCT02215616|78988176|FG002|Overall Study|Other than specified|1|||
44192527|NCT02215616|78988177|FG003|Overall Study|Other than specified|1|||
44192528|NCT02213666|78988187|FG000|Overall Study|Withdrawal by Subject|1|||
44192529|NCT02213510|78988193|FG000|Overall Study|Death|0|||
44192530|NCT02213510|78988194|FG001|Overall Study|Death|1|||
44192531|NCT02213510|78988193|FG000|Overall Study|Lost to Follow-up|1|||
44192532|NCT02213510|78988194|FG001|Overall Study|Lost to Follow-up|0|||
44192533|NCT02158442|78988202|FG000|Overall Study|Withdrawal by Subject|1|||
44192534|NCT02158442|78988203|FG001|Overall Study|Withdrawal by Subject|0|||
44192535|NCT02158442|78988202|FG000|Overall Study|Perfusion staff not available|1|||
44192536|NCT02158442|78988203|FG001|Overall Study|Perfusion staff not available|0|||
44192537|NCT02158364|78988209|FG000|Overall Study|Case report forms uncollected|10|||
44192538|NCT02158364|78988209|FG000|Overall Study|Protocol Deviation|50|||
44192539|NCT02180672|78988215|FG000|Overall Study|Lost to Follow-up|5|||
44192540|NCT02180672|78988216|FG001|Overall Study|Lost to Follow-up|7|||
44192541|NCT02213198|78988224|FG000|Baseline|No show for intake|7|||
44192542|NCT02213198|78988225|FG001|Baseline|No show for intake|9|||
44192543|NCT02213198|78988224|FG000|Baseline|Withdrawal by Subject|34|||
44192544|NCT02213198|78988225|FG001|Baseline|Withdrawal by Subject|11|||
44192545|NCT02213198|78988224|FG000|Baseline|transferred out of clinic|7|||
44192546|NCT02213198|78988225|FG001|Baseline|transferred out of clinic|9|||
44192547|NCT02213198|78988224|FG000|Baseline|Lost to Follow-up|40|||
44192548|NCT02213198|78988225|FG001|Baseline|Lost to Follow-up|21|||
44192549|NCT02213198|78988224|FG000|Baseline|incarcerated,violent|0|||
44192550|NCT02213198|78988225|FG001|Baseline|incarcerated,violent|1|||
44192551|NCT02213198|78988224|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
44192552|NCT02213198|78988225|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
44192553|NCT02213198|78988224|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
44192554|NCT02213198|78988225|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
44192555|NCT02213198|78988224|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
44192556|NCT02213198|78988225|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
44192557|NCT02213198|78988224|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
44192558|NCT02213198|78988225|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
44192559|NCT02213198|78988224|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
44192560|NCT02213198|78988225|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
44192561|NCT02213198|78988224|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
44192562|NCT02213198|78988225|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
44192563|NCT02157506|78988236|FG000|Overall Study|Adverse Event|0|||
44192564|NCT02157506|78988237|FG001|Overall Study|Adverse Event|1|||
44192565|NCT02157506|78988238|FG002|Overall Study|Adverse Event|0|||
44192566|NCT02157506|78988239|FG003|Overall Study|Adverse Event|0|||
44192567|NCT02157506|78988240|FG004|Overall Study|Adverse Event|0|||
44192568|NCT02157506|78988236|FG000|Overall Study|Lost to Follow-up|0|||
44192569|NCT02157506|78988237|FG001|Overall Study|Lost to Follow-up|0|||
44192570|NCT02157506|78988238|FG002|Overall Study|Lost to Follow-up|1|||
44192571|NCT02157506|78988239|FG003|Overall Study|Lost to Follow-up|0|||
44192572|NCT02157506|78988240|FG004|Overall Study|Lost to Follow-up|0|||
44192573|NCT01920711|78988254|FG000|Overall Study|Death|347|||
44192574|NCT01920711|78988255|FG001|Overall Study|Death|356|||
44192575|NCT01920711|78988254|FG000|Overall Study|Lost to Follow-up|13|||
44192576|NCT01920711|78988255|FG001|Overall Study|Lost to Follow-up|14|||
44192577|NCT01920711|78988254|FG000|Overall Study|Withdrawal by Subject|4|||
44192578|NCT01920711|78988255|FG001|Overall Study|Withdrawal by Subject|3|||
44192579|NCT02180438|78988262|FG000|Overall Study|Lost to Follow-up|1|||
44192580|NCT02179190|78988266|FG000|Enrollment|Exit Prior to Device Attempt|11|||
44192581|NCT02179190|78988266|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
44192582|NCT02179190|78988266|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
44192583|NCT02179190|78988266|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
44192584|NCT02179190|78988266|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
44192585|NCT02179190|78988266|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
44266234|NCT02405442|79173531|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
44451458|NCT00500331|79460408|FG000|Overall Study|Lost to Follow-up|1|||
44451459|NCT00500331|79460409|FG001|Overall Study|Lost to Follow-up|1|||
44192586|NCT02157116|78988270|FG000|Overall Study|Withdrawal by Subject|4|||
44192587|NCT02157116|78988270|FG000|Overall Study|Physician Decision|3|||
44192588|NCT02157116|78988270|FG000|Overall Study|Failed Screening|2|||
44192589|NCT01920555|78988279|FG000|Overall Study|Physician Decision|1|||
44192590|NCT01920555|78988280|FG001|Overall Study|Physician Decision|2|||
44192591|NCT01920555|78988281|FG002|Overall Study|Physician Decision|1|||
44192592|NCT01920555|78988282|FG003|Overall Study|Physician Decision|2|||
44192593|NCT01920555|78988283|FG004|Overall Study|Physician Decision|0|||
44192594|NCT01920555|78988279|FG000|Overall Study|Lack of Efficacy|2|||
44192595|NCT01920555|78988280|FG001|Overall Study|Lack of Efficacy|0|||
44192596|NCT01920555|78988281|FG002|Overall Study|Lack of Efficacy|0|||
44192597|NCT01920555|78988282|FG003|Overall Study|Lack of Efficacy|0|||
44192598|NCT01920555|78988283|FG004|Overall Study|Lack of Efficacy|0|||
44192599|NCT01920555|78988279|FG000|Overall Study|Travel Difficulties|1|||
44192600|NCT01920555|78988280|FG001|Overall Study|Travel Difficulties|1|||
44192601|NCT01920555|78988281|FG002|Overall Study|Travel Difficulties|0|||
44192602|NCT01920555|78988282|FG003|Overall Study|Travel Difficulties|0|||
44192603|NCT01920555|78988283|FG004|Overall Study|Travel Difficulties|1|||
44192604|NCT01920555|78988279|FG000|Overall Study|Lost to Follow-up|0|||
44192605|NCT01920555|78988280|FG001|Overall Study|Lost to Follow-up|1|||
44192606|NCT01920555|78988281|FG002|Overall Study|Lost to Follow-up|0|||
44192607|NCT01920555|78988282|FG003|Overall Study|Lost to Follow-up|1|||
44192608|NCT01920555|78988283|FG004|Overall Study|Lost to Follow-up|0|||
44192609|NCT02156804|78988295|FG000|Overall Study|Withdrawal by Subject|1|||
44192610|NCT02156492|78988302|FG000|Period 1|No Reason Given|0|||
44192611|NCT02156492|78988303|FG001|Period 1|No Reason Given|1|||
44192612|NCT02156492|78988304|FG002|Period 1|No Reason Given|0|||
44192613|NCT02156492|78988302|FG000|Period 3|Adverse Event|0|||
44192614|NCT02156492|78988303|FG001|Period 3|Adverse Event|1|||
44192615|NCT02156492|78988304|FG002|Period 3|Adverse Event|0|||
44192616|NCT01920477|78988324|FG000|Overall Study|Adverse Event|0|||
44192617|NCT01920477|78988325|FG001|Overall Study|Adverse Event|1|||
44192618|NCT01920477|78988324|FG000|Overall Study|Lack of Efficacy|1|||
44192619|NCT01920477|78988325|FG001|Overall Study|Lack of Efficacy|0|||
44192620|NCT01920477|78988324|FG000|Overall Study|Study closed/terminated|14|||
44192621|NCT01920477|78988325|FG001|Overall Study|Study closed/terminated|15|||
44192622|NCT01920477|78988324|FG000|Overall Study|Withdrawal by Subject|0|||
44192623|NCT01920477|78988325|FG001|Overall Study|Withdrawal by Subject|1|||
44192624|NCT02213042|78988334|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
44192625|NCT02213042|78988335|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
44192626|NCT02213042|78988336|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
44192627|NCT02213042|78988334|FG000|Overall Study|Adverse Event|2|||
44192628|NCT02213042|78988335|FG001|Overall Study|Adverse Event|1|||
44192629|NCT02213042|78988336|FG002|Overall Study|Adverse Event|0|||
44192630|NCT02213042|78988334|FG000|Overall Study|Withdrawal by Subject|0|||
44192631|NCT02213042|78988335|FG001|Overall Study|Withdrawal by Subject|1|||
44192632|NCT02213042|78988336|FG002|Overall Study|Withdrawal by Subject|1|||
44192633|NCT02213042|78988334|FG000|Overall Study|Protocol Violation|1|||
44192634|NCT02213042|78988335|FG001|Overall Study|Protocol Violation|0|||
44192635|NCT02213042|78988336|FG002|Overall Study|Protocol Violation|0|||
44192636|NCT02213042|78988334|FG000|Overall Study|Investigator discretion|0|||
44192637|NCT02213042|78988335|FG001|Overall Study|Investigator discretion|0|||
44192638|NCT02213042|78988336|FG002|Overall Study|Investigator discretion|1|||
44192639|NCT02212730|78988348|FG000|Overall Study|Tumor not of the required cell histology|1|||
44192640|NCT02212730|78988349|FG001|Overall Study|Tumor not of the required cell histology|0|||
44192641|NCT02212730|78988348|FG000|Overall Study|Withdrawal by Subject|1|||
44192642|NCT02212730|78988349|FG001|Overall Study|Withdrawal by Subject|0|||
44192643|NCT02212730|78988348|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
44192644|NCT02212730|78988349|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
44192645|NCT02178956|78988359|FG000|Overall Study|Lost to Follow-up|4|||
44192646|NCT02178956|78988360|FG001|Overall Study|Lost to Follow-up|4|||
44192647|NCT02178956|78988359|FG000|Overall Study|Sponsor terminated study|49|||
44192648|NCT02178956|78988360|FG001|Overall Study|Sponsor terminated study|58|||
44192649|NCT02178956|78988359|FG000|Overall Study|Withdrawal by Subject|15|||
44192650|NCT02178956|78988360|FG001|Overall Study|Withdrawal by Subject|11|||
44192651|NCT02178956|78988359|FG000|Overall Study|Various Reasons|3|||
44192652|NCT02178956|78988360|FG001|Overall Study|Various Reasons|5|||
44192653|NCT02211638|78988370|FG000|Overall Study|Case Report Forms Uncollected|291|||
44192654|NCT02211638|78988370|FG000|Overall Study|Protocol Violation|692|||
44192655|NCT02178566|78988376|FG000|Overall Study|patient did not complete due to noncompliance|0|||
44192656|NCT02178566|78988377|FG001|Overall Study|patient did not complete due to noncompliance|1|||
44192657|NCT02211014|78988385|FG000|Overall Study|Adverse Event|0|||
44192658|NCT02211014|78988386|FG001|Overall Study|Adverse Event|2|||
44192659|NCT02211014|78988385|FG000|Overall Study|Physician Decision|1|||
44192660|NCT02211014|78988386|FG001|Overall Study|Physician Decision|2|||
44192661|NCT02211014|78988385|FG000|Overall Study|Started another cancer therapy|1|||
44192662|NCT02211014|78988386|FG001|Overall Study|Started another cancer therapy|0|||
44192663|NCT02211014|78988385|FG000|Overall Study|Withdrawal by Subject|0|||
44192664|NCT02211014|78988386|FG001|Overall Study|Withdrawal by Subject|1|||
44192665|NCT02211014|78988385|FG000|Overall Study|In agreement with patient, no benefit|0|||
44192666|NCT02211014|78988386|FG001|Overall Study|In agreement with patient, no benefit|1|||
44192667|NCT01631864|78988410|FG000|Overall Study|Withdrawal by Subject|0|||
44192668|NCT01631864|78988411|FG001|Overall Study|Withdrawal by Subject|1|||
44192669|NCT01631864|78988410|FG000|Overall Study|Adverse Event|2|||
44192670|NCT01631864|78988411|FG001|Overall Study|Adverse Event|3|||
44192671|NCT02210780|78988419|FG000|Overall Study|Adverse Event|0|||
44192672|NCT02210780|78988420|FG001|Overall Study|Adverse Event|5|||
44192673|NCT02210780|78988419|FG000|Overall Study|Lost to Follow-up|2|||
44192674|NCT02210780|78988420|FG001|Overall Study|Lost to Follow-up|1|||
44192675|NCT02210780|78988419|FG000|Overall Study|Withdrawal by Subject|1|||
44192676|NCT02210780|78988420|FG001|Overall Study|Withdrawal by Subject|1|||
44192677|NCT02210780|78988419|FG000|Overall Study|Physician Decision|1|||
44192678|NCT02210780|78988420|FG001|Overall Study|Physician Decision|0|||
44192679|NCT02210780|78988419|FG000|Overall Study|Protocol Violation|1|||
44192680|NCT02210780|78988420|FG001|Overall Study|Protocol Violation|0|||
44192681|NCT02210780|78988419|FG000|Overall Study|Other than specified above|0|||
44192682|NCT02210780|78988420|FG001|Overall Study|Other than specified above|1|||
44192683|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
44192684|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
44192685|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
44192686|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
44266235|NCT02405442|79173532|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
44266236|NCT02405442|79173533|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
44266237|NCT02405442|79173534|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
44266238|NCT02405442|79173531|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
44266239|NCT02405442|79173532|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
44266240|NCT02405442|79173533|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
44266241|NCT02405442|79173534|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
44266242|NCT02404350|79173650|FG000|Overall Study|Adverse Event|2|||
44266243|NCT02404350|79173651|FG001|Overall Study|Adverse Event|2|||
44192687|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
44192688|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
44192689|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
44192690|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
44192691|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
44192692|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
44192693|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
44192694|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
44192695|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
44192696|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
44192697|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
44192698|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
44192699|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
44192700|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
44192701|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
44192702|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
44192703|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
44192704|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
44192705|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
44192706|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
44192707|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
44192708|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
44192709|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
44192710|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
44192711|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
44192712|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
44192713|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
44192714|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
44192715|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
44192716|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
44192717|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
44266244|NCT02404350|79173652|FG002|Overall Study|Adverse Event|3|||
44192718|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
44361273|NCT01157351|79366937|FG000|Overall Study|Noncompliance with Study Drug|0|||
44361274|NCT01157351|79366938|FG001|Overall Study|Noncompliance with Study Drug|3|||
44361275|NCT01157351|79366937|FG000|Overall Study|Randomized but not Treated|4|||
44192719|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
44192720|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
44192721|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
44192722|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
44192723|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
44192724|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
44192725|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
44192726|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
44192727|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
44192728|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
44192729|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
44192730|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
44192731|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
44192732|NCT01557244|78988431|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
44192733|NCT01557244|78988432|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
44192734|NCT01557244|78988433|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
44192735|NCT01557244|78988434|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
44192736|NCT01557244|78988435|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
44192737|NCT01557244|78988436|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
44192738|NCT01557244|78988437|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
44192739|NCT01557244|78988431|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
44192740|NCT01557244|78988432|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
44192741|NCT01557244|78988433|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
44192742|NCT01557244|78988434|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
44192743|NCT01557244|78988435|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
44192744|NCT01557244|78988436|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
44192745|NCT01557244|78988437|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
44192746|NCT01557244|78988431|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
44192747|NCT01557244|78988432|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
44192748|NCT01557244|78988433|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
44192749|NCT01557244|78988434|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
44192750|NCT01557244|78988435|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
44192751|NCT01557244|78988436|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
44192752|NCT01557244|78988437|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
44192753|NCT01557244|78988431|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
44192754|NCT01557244|78988432|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
44192755|NCT01557244|78988433|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
44192756|NCT01557244|78988434|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
44192757|NCT01557244|78988435|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
44192758|NCT01557244|78988436|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
44192759|NCT01557244|78988437|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
44192760|NCT01557244|78988431|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
44192761|NCT01557244|78988432|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
44192762|NCT01557244|78988433|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
44192763|NCT01557244|78988434|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
44192764|NCT01557244|78988435|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
44192765|NCT01557244|78988436|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
44192766|NCT01557244|78988437|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
44192767|NCT02177942|78988467|FG000|Overall Study|Adverse Event|1|||
44192768|NCT02177942|78988468|FG001|Overall Study|Adverse Event|0|||
44192769|NCT02177942|78988467|FG000|Overall Study|Lost to Follow-up|1|||
44192770|NCT02177942|78988468|FG001|Overall Study|Lost to Follow-up|1|||
44192771|NCT02177942|78988467|FG000|Overall Study|Protocol Violation|4|||
44192772|NCT02177942|78988468|FG001|Overall Study|Protocol Violation|6|||
44192773|NCT02177942|78988467|FG000|Overall Study|Withdrawal by Subject|71|||
44192774|NCT02177942|78988468|FG001|Overall Study|Withdrawal by Subject|81|||
44192775|NCT02155322|78988478|FG000|Overall Study|Adverse Event|1|||
44192776|NCT02155322|78988478|FG000|Overall Study|Physician Decision|1|||
44192777|NCT02155322|78988478|FG000|Overall Study|Relapse/Recurrence|8|||
44192778|NCT02155322|78988478|FG000|Overall Study|Withdrawal by Subject|4|||
44192779|NCT02210000|78988484|FG000|Overall Study|Study Terminated|11|||
44361276|NCT01157351|79366938|FG001|Overall Study|Randomized but not Treated|2|||
44361277|NCT01157117|79366947|FG000|Overall Study|Dosing Symptoms|0|||
44361278|NCT01157117|79366948|FG001|Overall Study|Dosing Symptoms|4|||
44361279|NCT01157117|79366949|FG002|Overall Study|Dosing Symptoms|0|||
44361280|NCT01157117|79366947|FG000|Overall Study|Withdrawal by Subject|4|||
44192780|NCT02210000|78988485|FG001|Overall Study|Study Terminated|12|||
44192781|NCT02210000|78988484|FG000|Overall Study|Withdrawal by Subject|7|||
44192782|NCT02210000|78988485|FG001|Overall Study|Withdrawal by Subject|1|||
44192783|NCT02210000|78988484|FG000|Overall Study|Adverse Event|1|||
44192784|NCT02210000|78988485|FG001|Overall Study|Adverse Event|5|||
44192785|NCT02210000|78988484|FG000|Overall Study|Lost to Follow-up|0|||
44192786|NCT02210000|78988485|FG001|Overall Study|Lost to Follow-up|2|||
44192787|NCT02210000|78988484|FG000|Overall Study|Physician Decision|0|||
44192788|NCT02210000|78988485|FG001|Overall Study|Physician Decision|1|||
44192789|NCT01531894|78988491|FG000|Overall Study|Physician Decision|8|||
44192790|NCT01531894|78988491|FG000|Overall Study|Death|1|||
44192791|NCT02209766|78988499|FG000|Overall Study|Withdrawal by Subject|0|||
44192792|NCT02209766|78988500|FG001|Overall Study|Withdrawal by Subject|0|||
44192793|NCT02209766|78988501|FG002|Overall Study|Withdrawal by Subject|0|||
44192794|NCT02209766|78988502|FG003|Overall Study|Withdrawal by Subject|1|||
44192795|NCT02209766|78988503|FG004|Overall Study|Withdrawal by Subject|0|||
44192796|NCT02209454|78988513|FG000|Second Period|Adverse Event|1|||
44192797|NCT02209454|78988514|FG001|Second Period|Adverse Event|0|||
44192798|NCT01571596|78988523|FG000|Overall Study|Adverse Event|2|||
44192799|NCT01571596|78988524|FG001|Overall Study|Adverse Event|0|||
44192800|NCT01571596|78988525|FG002|Overall Study|Adverse Event|0|||
44192801|NCT01571596|78988523|FG000|Overall Study|Study Terminated by the Sponsor|0|||
44192802|NCT01571596|78988524|FG001|Overall Study|Study Terminated by the Sponsor|1|||
44192803|NCT01571596|78988525|FG002|Overall Study|Study Terminated by the Sponsor|1|||
44192804|NCT01557166|78988537|FG000|Overall Study|Adverse Event|20|||
44192805|NCT01557166|78988538|FG001|Overall Study|Adverse Event|6|||
44192806|NCT01557166|78988537|FG000|Overall Study|Lack of Efficacy|2|||
44192807|NCT01557166|78988538|FG001|Overall Study|Lack of Efficacy|1|||
44192808|NCT01557166|78988537|FG000|Overall Study|Protocol Violation|8|||
44192809|NCT01557166|78988538|FG001|Overall Study|Protocol Violation|5|||
44192810|NCT01557166|78988537|FG000|Overall Study|Withdrawn consent|12|||
44192811|NCT01557166|78988538|FG001|Overall Study|Withdrawn consent|20|||
44192812|NCT01557166|78988537|FG000|Overall Study|Target dose not tolerated|1|||
44192813|NCT01557166|78988538|FG001|Overall Study|Target dose not tolerated|0|||
44192814|NCT01557166|78988537|FG000|Overall Study|Psychiatric disorder|1|||
44192815|NCT01557166|78988538|FG001|Overall Study|Psychiatric disorder|0|||
44192816|NCT01557166|78988537|FG000|Overall Study|Unclassified|2|||
44192817|NCT01557166|78988538|FG001|Overall Study|Unclassified|5|||
44192818|NCT01556932|78988544|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
44192819|NCT01556932|78988545|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
44192820|NCT02177786|78988554|FG000|Overall Study|Withdrew Consent|2|||
44192821|NCT02177786|78988555|FG001|Overall Study|Withdrew Consent|6|||
44192822|NCT02177786|78988556|FG002|Overall Study|Withdrew Consent|9|||
44192823|NCT02177786|78988557|FG003|Overall Study|Withdrew Consent|5|||
44192824|NCT02177786|78988554|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
44192825|NCT02177786|78988555|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
44192826|NCT02177786|78988556|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
44192827|NCT02177786|78988557|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
44192828|NCT02177786|78988554|FG000|Overall Study|Adverse Event|1|||
44192829|NCT02177786|78988555|FG001|Overall Study|Adverse Event|1|||
44192830|NCT02177786|78988556|FG002|Overall Study|Adverse Event|2|||
44192831|NCT02177786|78988557|FG003|Overall Study|Adverse Event|3|||
44192832|NCT02177786|78988554|FG000|Overall Study|Death|1|||
44192833|NCT02177786|78988555|FG001|Overall Study|Death|1|||
44192834|NCT02177786|78988556|FG002|Overall Study|Death|1|||
44192835|NCT02177786|78988557|FG003|Overall Study|Death|1|||
44361281|NCT01157117|79366948|FG001|Overall Study|Withdrawal by Subject|1|||
44192836|NCT02177786|78988554|FG000|Overall Study|Lost to Follow-up|0|||
44192837|NCT02177786|78988555|FG001|Overall Study|Lost to Follow-up|0|||
44192838|NCT02177786|78988556|FG002|Overall Study|Lost to Follow-up|2|||
44192839|NCT02177786|78988557|FG003|Overall Study|Lost to Follow-up|2|||
44192840|NCT02177786|78988554|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44192841|NCT02177786|78988555|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44361282|NCT01157117|79366949|FG002|Overall Study|Withdrawal by Subject|1|||
44192842|NCT02177786|78988556|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44192843|NCT02177786|78988557|FG003|Overall Study|Non-Compliance with Study Drug|1|||
44192844|NCT02177786|78988554|FG000|Overall Study|Protocol Violation|0|||
44192845|NCT02177786|78988555|FG001|Overall Study|Protocol Violation|0|||
44192846|NCT02177786|78988556|FG002|Overall Study|Protocol Violation|2|||
44192847|NCT02177786|78988557|FG003|Overall Study|Protocol Violation|0|||
44192848|NCT02177786|78988554|FG000|Overall Study|Progressive Disease|0|||
44192849|NCT02177786|78988555|FG001|Overall Study|Progressive Disease|1|||
44192850|NCT02177786|78988556|FG002|Overall Study|Progressive Disease|0|||
44192851|NCT02177786|78988557|FG003|Overall Study|Progressive Disease|0|||
44192852|NCT02177786|78988554|FG000|Overall Study|Missing study completion status|0|||
44192853|NCT02177786|78988555|FG001|Overall Study|Missing study completion status|1|||
44192854|NCT02177786|78988556|FG002|Overall Study|Missing study completion status|0|||
44192855|NCT02177786|78988557|FG003|Overall Study|Missing study completion status|0|||
44192856|NCT01555762|78988567|FG000|Overall Study|No information on Bevacizumab intake|11|||
44192857|NCT01555762|78988567|FG000|Overall Study|Missing start date of infusion|8|||
44192858|NCT01555762|78988567|FG000|Overall Study|75 years old or more ticked No|1|||
44192859|NCT01555762|78988567|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
44192860|NCT01555762|78988567|FG000|Overall Study|Death linked to progression of disease|165|||
44192861|NCT01555762|78988567|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
44192862|NCT01555762|78988567|FG000|Overall Study|Investigator's decision|10|||
44192863|NCT01555762|78988567|FG000|Overall Study|Participant not wishing to continue|5|||
44192864|NCT01555762|78988567|FG000|Overall Study|Missing data|1|||
44192865|NCT01555762|78988567|FG000|Overall Study|Death linked to an adverse event|14|||
44192866|NCT02153918|78988571|FG000|Overall Study|Refused further treatment|1|||
44192867|NCT02176928|78988577|FG000|Overall Study|Lost to Follow-up|2|||
44192868|NCT02176928|78988578|FG001|Overall Study|Lost to Follow-up|4|||
44192869|NCT01628510|78988586|FG000|Overall Study|Withdrawal by Subject|0|||
44192870|NCT01628510|78988587|FG001|Overall Study|Withdrawal by Subject|4|||
44192871|NCT01628510|78988586|FG000|Overall Study|Death|3|||
44192872|NCT01628510|78988587|FG001|Overall Study|Death|1|||
44192873|NCT01571362|78988595|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
44192874|NCT01571362|78988596|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
44192875|NCT01571362|78988597|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
44192876|NCT01571362|78988595|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
44192877|NCT01571362|78988596|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
44192878|NCT01571362|78988597|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
44192879|NCT01571362|78988595|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
44192880|NCT01571362|78988596|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
44192881|NCT01571362|78988597|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
44192882|NCT01571362|78988595|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
44192883|NCT01571362|78988596|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
44192884|NCT01571362|78988597|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
44192885|NCT01571362|78988595|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
44192886|NCT01571362|78988596|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
44192887|NCT01571362|78988597|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
44192888|NCT01571362|78988595|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
44192889|NCT01571362|78988596|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
44192890|NCT01571362|78988597|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
44192891|NCT01571362|78988595|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44192892|NCT01571362|78988596|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
44192893|NCT01571362|78988597|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
44192894|NCT01571362|78988595|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
44192895|NCT01571362|78988596|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
44192896|NCT01571362|78988597|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
44192897|NCT01571362|78988595|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44192898|NCT01571362|78988596|FG001|Double-Blind Treatment Period|Adverse Event|9|||
44192899|NCT01571362|78988597|FG002|Double-Blind Treatment Period|Adverse Event|14|||
44192900|NCT01571362|78988595|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44192901|NCT01571362|78988596|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
44192902|NCT01571362|78988597|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
44192903|NCT01571362|78988595|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
44192904|NCT01571362|78988596|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
44192905|NCT01571362|78988597|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
44192906|NCT01571362|78988595|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
44192907|NCT01571362|78988596|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
44192908|NCT01571362|78988597|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
44192909|NCT01571284|78988605|FG000|Overall Study|Participant's decision|84|||
44266245|NCT02404350|79173653|FG003|Overall Study|Adverse Event|9|||
44192910|NCT01571284|78988605|FG000|Overall Study|Lost to Follow-up|3|||
44192911|NCT01571284|78988605|FG000|Overall Study|Enrolled but not treated|2|||
44192912|NCT01571284|78988605|FG000|Overall Study|Other than specified above|80|||
44192913|NCT02137772|78988611|FG000|Overall Study|Adverse Event|6|||
44192914|NCT02137772|78988612|FG001|Overall Study|Adverse Event|3|||
44192915|NCT02137772|78988611|FG000|Overall Study|Death|71|||
44192916|NCT02137772|78988612|FG001|Overall Study|Death|44|||
44192917|NCT02137772|78988611|FG000|Overall Study|Lost to Follow-up|8|||
44192918|NCT02137772|78988612|FG001|Overall Study|Lost to Follow-up|4|||
44192919|NCT02137772|78988611|FG000|Overall Study|Physician Decision|15|||
44192920|NCT02137772|78988612|FG001|Overall Study|Physician Decision|5|||
44192921|NCT02137772|78988611|FG000|Overall Study|Withdrawal by Subject|28|||
44192922|NCT02137772|78988612|FG001|Overall Study|Withdrawal by Subject|17|||
44192923|NCT02137772|78988611|FG000|Overall Study|Non-compliance with study drug|1|||
44192924|NCT02137772|78988612|FG001|Overall Study|Non-compliance with study drug|0|||
44192925|NCT02137772|78988611|FG000|Overall Study|Not treated|3|||
44192926|NCT02137772|78988612|FG001|Overall Study|Not treated|2|||
44192927|NCT01555138|78988620|FG000|Overall Study|Death|0|||
44192928|NCT01555138|78988621|FG001|Overall Study|Death|1|||
44192929|NCT01555138|78988620|FG000|Overall Study|Lost to Follow-up|1|||
44192930|NCT01555138|78988621|FG001|Overall Study|Lost to Follow-up|0|||
44192931|NCT01555138|78988620|FG000|Overall Study|Abnormal Lab reults|1|||
44192932|NCT01555138|78988621|FG001|Overall Study|Abnormal Lab reults|3|||
44192933|NCT01555138|78988620|FG000|Overall Study|Lack of Efficacy|2|||
44192934|NCT01555138|78988621|FG001|Overall Study|Lack of Efficacy|2|||
44192935|NCT01555138|78988620|FG000|Overall Study|Protocol Violation|5|||
44192936|NCT01555138|78988621|FG001|Overall Study|Protocol Violation|3|||
44192937|NCT01555138|78988620|FG000|Overall Study|Administrative problems|8|||
44192938|NCT01555138|78988621|FG001|Overall Study|Administrative problems|0|||
44192939|NCT01555138|78988620|FG000|Overall Study|Withdrawal by Subject|16|||
44192940|NCT01555138|78988621|FG001|Overall Study|Withdrawal by Subject|15|||
44192941|NCT01555138|78988620|FG000|Overall Study|Adverse Event|14|||
44192942|NCT01555138|78988621|FG001|Overall Study|Adverse Event|14|||
44192943|NCT02137226|78988629|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
44192944|NCT02137226|78988630|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
44192945|NCT02137226|78988631|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
44192946|NCT02137226|78988632|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
44192947|NCT02137226|78988633|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
44192948|NCT02137226|78988629|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
44192949|NCT02137226|78988630|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
44192950|NCT02137226|78988631|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
44192951|NCT02137226|78988632|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
44192952|NCT02137226|78988633|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
44192953|NCT02137226|78988629|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
44192954|NCT02137226|78988630|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
44192955|NCT02137226|78988631|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
44192956|NCT02137226|78988632|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
44192957|NCT02137226|78988633|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
44192958|NCT02137226|78988629|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
44192959|NCT02137226|78988630|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
44192960|NCT02137226|78988631|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
44192961|NCT02137226|78988632|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
44192962|NCT02137226|78988633|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
44192963|NCT02137226|78988629|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
44192964|NCT02137226|78988630|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
44192965|NCT02137226|78988631|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
44192966|NCT02137226|78988632|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
44192967|NCT02137226|78988633|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
44192968|NCT02137226|78988629|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
44192969|NCT02137226|78988630|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
44192970|NCT02137226|78988631|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
44192971|NCT02137226|78988632|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
44192972|NCT02137226|78988633|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
44192973|NCT02137226|78988629|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
44192974|NCT02137226|78988630|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
44192975|NCT02137226|78988631|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
44192976|NCT02137226|78988632|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
44192977|NCT02137226|78988633|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
44266246|NCT02404350|79173650|FG000|Overall Study|Lack of Efficacy|3|||
44192978|NCT02137226|78988629|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
44192979|NCT02137226|78988630|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
44192980|NCT02137226|78988631|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
44192981|NCT02137226|78988632|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
44192982|NCT02137226|78988633|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
44192983|NCT02137226|78988629|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
44192984|NCT02137226|78988630|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
44192985|NCT02137226|78988631|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
44192986|NCT02137226|78988632|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
44192987|NCT02137226|78988633|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
44192988|NCT02137226|78988629|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
44192989|NCT02137226|78988630|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
44192990|NCT02137226|78988631|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
44192991|NCT02137226|78988632|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
44192992|NCT02137226|78988633|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
44192993|NCT02137226|78988629|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
44192994|NCT02137226|78988630|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
44192995|NCT02137226|78988631|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
44192996|NCT02137226|78988632|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
44192997|NCT02137226|78988633|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
44192998|NCT02137226|78988629|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
44192999|NCT02137226|78988630|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
44193000|NCT02137226|78988631|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
44193001|NCT02137226|78988632|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
44193002|NCT02137226|78988633|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
44193003|NCT01530334|78988641|FG000|Overall Study|Adverse Event|3|||
44193004|NCT01530334|78988641|FG000|Overall Study|unknown reason|1|||
44193005|NCT01530334|78988641|FG000|Overall Study|Progressive disease|47|||
44193006|NCT01570192|78988647|FG000|Overall Study|no qualifying organism|6|||
44193007|NCT01570192|78988648|FG001|Overall Study|no qualifying organism|12|||
44193008|NCT01570192|78988647|FG000|Overall Study|changed to palliative care|1|||
44193009|NCT01570192|78988648|FG001|Overall Study|changed to palliative care|0|||
44193010|NCT01570192|78988647|FG000|Overall Study|Physician Decision|0|||
44193011|NCT01570192|78988648|FG001|Overall Study|Physician Decision|1|||
44193012|NCT02136914|78988661|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
44193013|NCT02136914|78988662|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
44193014|NCT02136914|78988661|FG000|Overall Study|Withdrawal by Subject|3|||
44193015|NCT02136914|78988662|FG001|Overall Study|Withdrawal by Subject|10|||
44193016|NCT02136914|78988661|FG000|Overall Study|Subject Unwilling to Proceed|7|||
44193017|NCT02136914|78988662|FG001|Overall Study|Subject Unwilling to Proceed|2|||
44193018|NCT02136914|78988661|FG000|Overall Study|Lost to Follow-up|1|||
44193019|NCT02136914|78988662|FG001|Overall Study|Lost to Follow-up|1|||
44193020|NCT02136914|78988661|FG000|Overall Study|Did Not Receive Study Drug|2|||
44193021|NCT02136914|78988662|FG001|Overall Study|Did Not Receive Study Drug|0|||
44193022|NCT02136914|78988661|FG000|Overall Study|Lack of Efficacy|1|||
44193023|NCT02136914|78988662|FG001|Overall Study|Lack of Efficacy|0|||
44193024|NCT02136914|78988661|FG000|Overall Study|Death|0|||
44193025|NCT02136914|78988662|FG001|Overall Study|Death|1|||
44193026|NCT01530256|78988668|FG000|Overall Study|Death|2|||
44193027|NCT01554904|78988672|FG000|Overall Study|Withdrawal by Subject|3|||
44193028|NCT01554904|78988672|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
44193029|NCT01529632|78988678|FG000|Overall Study|Administrative problem|2|||
44193030|NCT01529632|78988679|FG001|Overall Study|Administrative problem|1|||
44193031|NCT01529632|78988678|FG000|Overall Study|Protocol Violation|0|||
44193032|NCT01529632|78988679|FG001|Overall Study|Protocol Violation|1|||
44193033|NCT01529632|78988678|FG000|Overall Study|Adverse Event|1|||
44193034|NCT01529632|78988679|FG001|Overall Study|Adverse Event|1|||
44193035|NCT01554514|78988685|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
44193036|NCT01554514|78988685|FG000|Overall Study|Physician Decision|1|||
44193037|NCT01553188|78988693|FG000|Overall Study|Patient choice|1|||
44193038|NCT01553188|78988694|FG001|Overall Study|Patient choice|0|||
44193039|NCT01553188|78988695|FG002|Overall Study|Patient choice|0|||
44193040|NCT01553188|78988696|FG003|Overall Study|Patient choice|0|||
44193041|NCT01553188|78988693|FG000|Overall Study|Intercurrent illness and adverse event|0|||
44193042|NCT01553188|78988694|FG001|Overall Study|Intercurrent illness and adverse event|1|||
44193043|NCT01553188|78988695|FG002|Overall Study|Intercurrent illness and adverse event|2|||
44193044|NCT01553188|78988696|FG003|Overall Study|Intercurrent illness and adverse event|0|||
44193045|NCT02175758|78988715|FG000|Treatment Phase|Lost to Follow-up|0|||
44193046|NCT02175758|78988716|FG001|Treatment Phase|Lost to Follow-up|1|||
44193047|NCT02175758|78988717|FG002|Treatment Phase|Lost to Follow-up|0|||
44193048|NCT02175758|78988718|FG003|Treatment Phase|Lost to Follow-up|0|||
44193049|NCT02175758|78988719|FG004|Treatment Phase|Lost to Follow-up|0|||
44193050|NCT02175758|78988720|FG005|Treatment Phase|Lost to Follow-up|0|||
44193051|NCT02175758|78988715|FG000|Treatment Phase|Adverse Event|0|||
44193052|NCT02175758|78988716|FG001|Treatment Phase|Adverse Event|0|||
44193053|NCT02175758|78988717|FG002|Treatment Phase|Adverse Event|0|||
44193054|NCT02175758|78988718|FG003|Treatment Phase|Adverse Event|0|||
44193055|NCT02175758|78988719|FG004|Treatment Phase|Adverse Event|1|||
44193056|NCT02175758|78988720|FG005|Treatment Phase|Adverse Event|0|||
44193057|NCT01529008|78988762|FG000|Bone Marrow Harvesting|Physician Decision|1|||
44193058|NCT01529008|78988763|FG001|Bone Marrow Harvesting|Physician Decision|1|||
44193059|NCT01529008|78988762|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
44193060|NCT01529008|78988763|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
44193061|NCT01529008|78988762|FG000|Treatment|Adverse Event|6|||
44193062|NCT01529008|78988763|FG001|Treatment|Adverse Event|0|||
44193063|NCT01529008|78988762|FG000|Treatment|Other|3|||
44193064|NCT01529008|78988763|FG001|Treatment|Other|1|||
44193065|NCT01529008|78988762|FG000|Efficacy Analysis|Protocol Violation|2|||
44193066|NCT01529008|78988763|FG001|Efficacy Analysis|Protocol Violation|0|||
44193067|NCT01529008|78988762|FG000|Efficacy Analysis|Physician Decision|0|||
44193068|NCT01529008|78988763|FG001|Efficacy Analysis|Physician Decision|1|||
44193069|NCT01529008|78988762|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
44193070|NCT01529008|78988763|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
44193071|NCT01599104|78988772|FG000|Overall Study|Withdrawal by Subject|1|||
44193072|NCT01599104|78988773|FG001|Overall Study|Withdrawal by Subject|1|||
44193073|NCT01599104|78988774|FG002|Overall Study|Withdrawal by Subject|2|||
44193074|NCT01599104|78988772|FG000|Overall Study|Technical Problems|1|||
44193075|NCT01599104|78988773|FG001|Overall Study|Technical Problems|0|||
44193076|NCT01599104|78988774|FG002|Overall Study|Technical Problems|0|||
44193077|NCT01599104|78988772|FG000|Overall Study|Physician Decision|3|||
44193078|NCT01599104|78988773|FG001|Overall Study|Physician Decision|2|||
44193079|NCT01599104|78988774|FG002|Overall Study|Physician Decision|2|||
44193080|NCT01599104|78988772|FG000|Overall Study|Non-compliance with study treatment|0|||
44193081|NCT01599104|78988773|FG001|Overall Study|Non-compliance with study treatment|1|||
44193082|NCT01599104|78988774|FG002|Overall Study|Non-compliance with study treatment|0|||
44193083|NCT01599104|78988772|FG000|Overall Study|Lack of Efficacy|4|||
44193084|NCT01599104|78988773|FG001|Overall Study|Lack of Efficacy|4|||
44193085|NCT01599104|78988774|FG002|Overall Study|Lack of Efficacy|10|||
44193086|NCT01599104|78988772|FG000|Overall Study|Adverse Event|7|||
44193087|NCT01599104|78988773|FG001|Overall Study|Adverse Event|6|||
44193088|NCT01599104|78988774|FG002|Overall Study|Adverse Event|12|||
44193089|NCT01569568|78988784|FG000|Overall Study|Physician Decision|0|||
44193090|NCT01569568|78988785|FG001|Overall Study|Physician Decision|2|||
44193091|NCT02136680|78988793|FG000|Overall Study|No Longer Interested|1|||
44193092|NCT02136680|78988794|FG001|Overall Study|No Longer Interested|1|||
44193093|NCT02136680|78988793|FG000|Overall Study|No longer receiving care at clinic|3|||
44193094|NCT02136680|78988794|FG001|Overall Study|No longer receiving care at clinic|5|||
44193095|NCT02136680|78988793|FG000|Overall Study|Moved away|5|||
44193096|NCT02136680|78988794|FG001|Overall Study|Moved away|4|||
44193097|NCT02136680|78988793|FG000|Overall Study|Unable to schedule|17|||
44193098|NCT02136680|78988794|FG001|Overall Study|Unable to schedule|16|||
44193099|NCT02136680|78988793|FG000|Overall Study|Study ended before interview due|6|||
44193100|NCT02136680|78988794|FG001|Overall Study|Study ended before interview due|3|||
44193101|NCT01552954|78988802|FG000|Overall Study|Adverse Event|1|||
44193102|NCT01552954|78988803|FG001|Overall Study|Adverse Event|2|||
44193103|NCT01552954|78988802|FG000|Overall Study|Lost to Follow-up|1|||
44193104|NCT01552954|78988803|FG001|Overall Study|Lost to Follow-up|1|||
44193105|NCT01552954|78988802|FG000|Overall Study|Withdrawal by Subject|1|||
44193106|NCT01552954|78988803|FG001|Overall Study|Withdrawal by Subject|1|||
44193107|NCT01552954|78988802|FG000|Overall Study|Protocol Violation|1|||
44193108|NCT01552954|78988803|FG001|Overall Study|Protocol Violation|2|||
44193109|NCT01552954|78988802|FG000|Overall Study|diagnosed DM|1|||
44193110|NCT01552954|78988803|FG001|Overall Study|diagnosed DM|0|||
44193111|NCT02175368|78988809|FG000|Overall Study|Lost to Follow-up|1|||
44193112|NCT01518244|78988813|FG000|Overall Study|Adverse Event|3|||
44193113|NCT01552408|78988819|FG000|Overall Study|Lost to Follow-up|2|||
44193114|NCT01552408|78988820|FG001|Overall Study|Lost to Follow-up|0|||
44193115|NCT01552408|78988819|FG000|Overall Study|Relocation|0|||
44193116|NCT01552408|78988820|FG001|Overall Study|Relocation|1|||
44193117|NCT01552408|78988819|FG000|Overall Study|Withdrawal by Subject|2|||
44193118|NCT01552408|78988820|FG001|Overall Study|Withdrawal by Subject|1|||
44193119|NCT01528696|78988829|FG000|Overall Study|See detailed description|18|||
44193120|NCT01528696|78988830|FG001|Overall Study|See detailed description|19|||
44193121|NCT02174276|78988840|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
44193122|NCT02174276|78988841|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
44193123|NCT02174276|78988842|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
44193124|NCT02174276|78988843|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
44193125|NCT02174276|78988840|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
44193126|NCT02174276|78988841|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
44193127|NCT02174276|78988842|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
44193128|NCT02174276|78988843|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
44193129|NCT02174276|78988840|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
44193130|NCT02174276|78988841|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
44193131|NCT02174276|78988842|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
44193132|NCT02174276|78988843|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
44193133|NCT02174276|78988840|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
44193134|NCT02174276|78988841|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
44193135|NCT02174276|78988842|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
44193136|NCT02174276|78988843|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
44193137|NCT02174276|78988840|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
44193138|NCT02174276|78988841|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
44193139|NCT02174276|78988842|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
44193140|NCT02174276|78988843|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
44193141|NCT02174276|78988840|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
44193142|NCT02174276|78988841|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
44193143|NCT02174276|78988842|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
44193144|NCT02174276|78988843|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
44193145|NCT01528072|78988853|FG000|Overall Study|Withdrawal by Subject|5|||
44193146|NCT01528072|78988853|FG000|Overall Study|Physician Decision|1|||
44193147|NCT01528072|78988853|FG000|Overall Study|Determined not eligible by AEAC|1|||
44193148|NCT01528072|78988853|FG000|Overall Study|Missed Visit|2|||
44193149|NCT01528072|78988853|FG000|Overall Study|Lost to Follow-up|5|||
44193150|NCT01528072|78988853|FG000|Overall Study|Explanted|2|||
44193151|NCT01528072|78988853|FG000|Overall Study|Site Closure|4|||
44193152|NCT01528072|78988853|FG000|Overall Study|Death|2|||
44193153|NCT01528072|78988853|FG000|Overall Study|Early Termination of Study|52|||
44193154|NCT01527682|78988857|FG000|Overall Study|Protocol Violation|8|||
44193155|NCT01527370|78988861|FG000|Overall Study|Withdrawal by Subject|4|||
44193156|NCT01527370|78988861|FG000|Overall Study|Physician Decision|1|||
44193157|NCT01527370|78988861|FG000|Overall Study|Death|1|||
44193158|NCT01527292|78988867|FG000|Overall Study|Physician Decision|0|||
44193159|NCT01527292|78988868|FG001|Overall Study|Physician Decision|3|||
44193160|NCT01516216|78988876|FG000|Overall Study|Adverse Event|2|||
44193161|NCT01516216|78988877|FG001|Overall Study|Adverse Event|4|||
44193162|NCT01516216|78988876|FG000|Overall Study|Disease Progression|38|||
44193163|NCT01516216|78988877|FG001|Overall Study|Disease Progression|34|||
44193164|NCT01516216|78988876|FG000|Overall Study|Withdrawal by Subject|9|||
44193165|NCT01516216|78988877|FG001|Overall Study|Withdrawal by Subject|11|||
44193166|NCT01516216|78988876|FG000|Overall Study|Potentially Curative Resection|6|||
44193167|NCT01516216|78988877|FG001|Overall Study|Potentially Curative Resection|12|||
44193168|NCT01516216|78988876|FG000|Overall Study|Nonadherence|2|||
44193169|NCT01516216|78988877|FG001|Overall Study|Nonadherence|3|||
44193170|NCT01516216|78988876|FG000|Overall Study|Physician Decision|6|||
44193171|NCT01516216|78988877|FG001|Overall Study|Physician Decision|3|||
44193172|NCT01516216|78988876|FG000|Overall Study|Prolonged Treatment Delay|5|||
44193173|NCT01516216|78988877|FG001|Overall Study|Prolonged Treatment Delay|1|||
44193174|NCT01516216|78988876|FG000|Overall Study|Intercurrent Illness|1|||
44193175|NCT01516216|78988877|FG001|Overall Study|Intercurrent Illness|0|||
44193176|NCT01516216|78988876|FG000|Overall Study|Death|1|||
44193177|NCT01516216|78988877|FG001|Overall Study|Death|1|||
44193178|NCT01950819|78988887|FG000|Overall Study|Graft Loss|35|||
44193179|NCT01950819|78988888|FG001|Overall Study|Graft Loss|30|||
44193180|NCT01950819|78988887|FG000|Overall Study|Death|29|||
44193181|NCT01950819|78988888|FG001|Overall Study|Death|34|||
44193182|NCT01950819|78988887|FG000|Overall Study|Subject / Gardian decision|54|||
44193183|NCT01950819|78988888|FG001|Overall Study|Subject / Gardian decision|51|||
44193184|NCT01950819|78988887|FG000|Overall Study|technical problems|2|||
44193185|NCT01950819|78988888|FG001|Overall Study|technical problems|0|||
44193186|NCT01950819|78988887|FG000|Overall Study|Pregnancy|0|||
44193187|NCT01950819|78988888|FG001|Overall Study|Pregnancy|2|||
44193188|NCT01950819|78988887|FG000|Overall Study|Lost to Follow-up|9|||
44193189|NCT01950819|78988888|FG001|Overall Study|Lost to Follow-up|17|||
44193190|NCT01514422|78988894|FG000|Overall Study|Lost to Follow-up|1|||
44193191|NCT01513330|78988898|FG000|SenSura Mio First,|Adverse Event|2|||
44193192|NCT01513330|78988899|FG001|SenSura Mio First,|Adverse Event|0|||
44193193|NCT01513330|78988898|FG000|SenSura Mio First,|Lack of Efficacy|0|||
44193194|NCT01513330|78988899|FG001|SenSura Mio First,|Lack of Efficacy|1|||
44193195|NCT01513330|78988898|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
44193196|NCT01513330|78988899|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
44193197|NCT01513330|78988898|FG000|SenSura Mio First,|Other|1|||
44193198|NCT01513330|78988899|FG001|SenSura Mio First,|Other|0|||
44193199|NCT01513330|78988898|FG000|Standard Care First,|Lack of Efficacy|2|||
44193200|NCT01513330|78988899|FG001|Standard Care First,|Lack of Efficacy|2|||
44193201|NCT01513330|78988898|FG000|Standard Care First,|Withdrawal by Subject|1|||
44193202|NCT01513330|78988899|FG001|Standard Care First,|Withdrawal by Subject|2|||
44193203|NCT01513330|78988898|FG000|Standard Care First,|Other|1|||
44193204|NCT01513330|78988899|FG001|Standard Care First,|Other|0|||
44193205|NCT01524796|78988905|FG000|Overall Study|Adverse Event|13|||
44193206|NCT01524796|78988905|FG000|Overall Study|Lack of Efficacy|3|||
44193207|NCT01524796|78988905|FG000|Overall Study|Lost to Follow-up|1|||
44193208|NCT01524796|78988905|FG000|Overall Study|The price|1|||
44193209|NCT01524796|78988905|FG000|Overall Study|Withdrawal by Subject|4|||
44193210|NCT01524796|78988905|FG000|Overall Study|Move|1|||
44193211|NCT01524796|78988905|FG000|Overall Study|Deterioration of pains|1|||
44193212|NCT01524796|78988905|FG000|Overall Study|Gall stone surgery|1|||
44193213|NCT01524796|78988905|FG000|Overall Study|Nervous about confidentiality|1|||
44193214|NCT01524796|78988905|FG000|Overall Study|Switch to carbamazapine|1|||
44193215|NCT01524796|78988905|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
44193216|NCT01547728|78988909|FG000|Overall Study|Change in procedure and equipment|1|||
44193217|NCT01547728|78988909|FG000|Overall Study|Drug not ready for subject|1|||
44193218|NCT01547728|78988909|FG000|Overall Study|Screen failure|39|||
44193219|NCT01523392|78988915|FG000|Treatment Period 1|Withdrawal by Subject|2|||
44193220|NCT01523392|78988916|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44193221|NCT01523392|78988915|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
44193222|NCT01523392|78988916|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
44193223|NCT01523392|78988915|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
44193224|NCT01523392|78988916|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
44193225|NCT01512160|78988928|FG000|Overall Study|Lost to Follow-up|1|||
44193226|NCT01512160|78988929|FG001|Overall Study|Lost to Follow-up|0|||
44193227|NCT01512160|78988930|FG002|Overall Study|Lost to Follow-up|0|||
44193228|NCT01512160|78988931|FG003|Overall Study|Lost to Follow-up|0|||
44193229|NCT01512160|78988928|FG000|Overall Study|Withdrawal by Subject|1|||
44193230|NCT01512160|78988929|FG001|Overall Study|Withdrawal by Subject|0|||
44193231|NCT01512160|78988930|FG002|Overall Study|Withdrawal by Subject|0|||
44193232|NCT01512160|78988931|FG003|Overall Study|Withdrawal by Subject|1|||
44193233|NCT01546168|78988944|FG000|Overall Study|Lost to Follow-up|1|||
44193234|NCT01546168|78988945|FG001|Overall Study|Lost to Follow-up|0|||
44193235|NCT01546168|78988944|FG000|Overall Study|Withdrawal by Subject|1|||
44193236|NCT01546168|78988945|FG001|Overall Study|Withdrawal by Subject|0|||
44193237|NCT01546168|78988944|FG000|Overall Study|ineligible after signing consent|2|||
44193238|NCT01546168|78988945|FG001|Overall Study|ineligible after signing consent|0|||
44193239|NCT01901289|78988951|FG000|Overall Study|Death|32|||
44193240|NCT01901289|78988951|FG000|Overall Study|Lost to Follow-up|16|||
44193241|NCT01901289|78988951|FG000|Overall Study|Withdrawal by Subject|35|||
44193242|NCT01901289|78988951|FG000|Overall Study|Other type of endpoint met|2|||
44193243|NCT01950741|78988955|FG000|Overall Study|Lost to Follow-up|1|||
44193244|NCT01950741|78988955|FG000|Overall Study|Death|1|||
44193245|NCT01950741|78988955|FG000|Overall Study|Withdrawal by Subject|1|||
44193246|NCT01950273|78988961|FG000|Overall Study|Protocol Violation|1|||
44193247|NCT01950273|78988962|FG001|Overall Study|Protocol Violation|0|||
44193248|NCT01950273|78988961|FG000|Overall Study|Withdrawal by Subject|2|||
44193249|NCT01950273|78988962|FG001|Overall Study|Withdrawal by Subject|0|||
44193250|NCT01950273|78988961|FG000|Overall Study|Other not defined above|1|||
44193251|NCT01950273|78988962|FG001|Overall Study|Other not defined above|0|||
44193252|NCT01919307|78988968|FG000|Overall Study|Withdrawal by Subject|9|||
44193253|NCT01919229|78988975|FG000|Overall Study|Subject/guardian decision|0|||
44193254|NCT01919229|78988976|FG001|Overall Study|Subject/guardian decision|0|||
44193255|NCT01919229|78988977|FG002|Overall Study|Subject/guardian decision|1|||
44193256|NCT01901055|78988987|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
44193257|NCT01901055|78988988|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
44193258|NCT01901055|78988987|FG000|Randomization But Not Titrated|Physician Decision|0|||
44193259|NCT01901055|78988988|FG001|Randomization But Not Titrated|Physician Decision|1|||
44193260|NCT01901055|78988987|FG000|Started Protocol to Week 6|Physician Decision|2|||
44193261|NCT01901055|78988988|FG001|Started Protocol to Week 6|Physician Decision|1|||
44193262|NCT01901055|78988987|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
44193263|NCT01901055|78988988|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
44193264|NCT01901055|78988987|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
44193265|NCT01901055|78988988|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
44193266|NCT01901055|78988987|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
44193267|NCT01901055|78988988|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
44193268|NCT01901055|78988987|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
44193269|NCT01901055|78988988|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
44193270|NCT01901055|78988987|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
44266247|NCT02404350|79173651|FG001|Overall Study|Lack of Efficacy|1|||
44266248|NCT02404350|79173652|FG002|Overall Study|Lack of Efficacy|0|||
44266249|NCT02404350|79173653|FG003|Overall Study|Lack of Efficacy|3|||
44193271|NCT01901055|78988988|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
44193272|NCT01901055|78988987|FG000|Week 24|Withdrawal by Subject|13|||
44193273|NCT01901055|78988988|FG001|Week 24|Withdrawal by Subject|19|||
44193274|NCT01901055|78988987|FG000|Week 24|Physician Decision|1|||
44193275|NCT01901055|78988988|FG001|Week 24|Physician Decision|0|||
44193276|NCT01901055|78988987|FG000|Week 36|Withdrawal by Subject|0|||
44266250|NCT02404350|79173650|FG000|Overall Study|Lost to Follow-up|2|||
44193277|NCT01901055|78988988|FG001|Week 36|Withdrawal by Subject|5|||
44193278|NCT01511536|78989000|FG000|Phase 1|Other|0|||
44193279|NCT01511536|78989001|FG001|Phase 1|Other|1|||
44193280|NCT01511536|78989002|FG002|Phase 1|Other|0|||
44193281|NCT01511536|78989000|FG000|Phase 2|Other|0|||
44193282|NCT01511536|78989001|FG001|Phase 2|Other|0|||
44193283|NCT01511536|78989002|FG002|Phase 2|Other|9|||
44193284|NCT01890759|78989012|FG000|Overall Study|Protocol Violation|0|||
44193285|NCT01890759|78989013|FG001|Overall Study|Protocol Violation|2|||
44193286|NCT01890759|78989012|FG000|Overall Study|Lost to Follow-up|0|||
44193287|NCT01890759|78989013|FG001|Overall Study|Lost to Follow-up|2|||
44193288|NCT01890759|78989012|FG000|Overall Study|Withdrawal by Subject|2|||
44193289|NCT01890759|78989013|FG001|Overall Study|Withdrawal by Subject|8|||
44193290|NCT01900899|78989021|FG000|Overall Study|Withdrawal by Subject|7|||
44193291|NCT01900899|78989022|FG001|Overall Study|Withdrawal by Subject|1|||
44193292|NCT01900899|78989021|FG000|Overall Study|Migrated from study area|2|||
44193293|NCT01900899|78989022|FG001|Overall Study|Migrated from study area|0|||
44193294|NCT01510912|78989028|FG000|Overall Study|Adverse Event|99|||
44193295|NCT01510912|78989028|FG000|Overall Study|Lack of Efficacy|12|||
44193296|NCT01510912|78989028|FG000|Overall Study|Non-compliance with trial drug|23|||
44193297|NCT01510912|78989028|FG000|Overall Study|Withdrawal by Subject|49|||
44193298|NCT01510912|78989028|FG000|Overall Study|Physician Decision|1|||
44193299|NCT01510912|78989028|FG000|Overall Study|Protocol Violation|27|||
44193300|NCT01510912|78989028|FG000|Overall Study|Lost to Follow-up|26|||
44193301|NCT01510912|78989028|FG000|Overall Study|Other, including joint replacement|5|||
44193302|NCT01510756|78989032|FG000|Overall Study|Death|1|||
44193303|NCT01510756|78989032|FG000|Overall Study|Lack of Efficacy|2|||
44193304|NCT01510756|78989032|FG000|Overall Study|Physician Decision|1|||
44193305|NCT01522456|78989036|FG000|Overall Study|Adverse Event|2|||
44193306|NCT01522456|78989036|FG000|Overall Study|Lost to Follow-up|2|||
44193307|NCT01522456|78989036|FG000|Overall Study|Withdrawal by Subject|2|||
44193308|NCT01522456|78989036|FG000|Overall Study|Pregnancy|1|||
44193309|NCT01522456|78989036|FG000|Overall Study|Tolerability Assessment|1|||
44193310|NCT01545934|78989049|FG000|Overall Study|Withdrawal by Subject|4|||
44193311|NCT01545934|78989050|FG001|Overall Study|Withdrawal by Subject|3|||
44193312|NCT01545934|78989049|FG000|Overall Study|Lost to Follow-up|1|||
44193313|NCT01545934|78989050|FG001|Overall Study|Lost to Follow-up|0|||
44193314|NCT01521364|78989057|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
44193315|NCT01521364|78989057|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
44193316|NCT01545388|78989071|FG000|Overall Study|Adverse Event|2|||
44193317|NCT01545388|78989072|FG001|Overall Study|Adverse Event|4|||
44193318|NCT01545388|78989073|FG002|Overall Study|Adverse Event|1|||
44193319|NCT01545388|78989071|FG000|Overall Study|Lack of Efficacy|3|||
44193320|NCT01545388|78989072|FG001|Overall Study|Lack of Efficacy|2|||
44193321|NCT01545388|78989073|FG002|Overall Study|Lack of Efficacy|5|||
44193322|NCT01545388|78989071|FG000|Overall Study|Participant moved or relocated|1|||
44193323|NCT01545388|78989072|FG001|Overall Study|Participant moved or relocated|0|||
44193324|NCT01545388|78989073|FG002|Overall Study|Participant moved or relocated|0|||
44193325|NCT01545388|78989071|FG000|Overall Study|Withdrawal by Subject|1|||
44193326|NCT01545388|78989072|FG001|Overall Study|Withdrawal by Subject|4|||
44193327|NCT01545388|78989073|FG002|Overall Study|Withdrawal by Subject|2|||
44193328|NCT01545388|78989071|FG000|Overall Study|Other|1|||
44193329|NCT01545388|78989072|FG001|Overall Study|Other|1|||
44193330|NCT01545388|78989073|FG002|Overall Study|Other|0|||
44193331|NCT01545076|78989081|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
44193332|NCT01545076|78989082|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
44193333|NCT01545076|78989083|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
44266251|NCT02404350|79173651|FG001|Overall Study|Lost to Follow-up|0|||
44266252|NCT02404350|79173652|FG002|Overall Study|Lost to Follow-up|0|||
44266253|NCT02404350|79173653|FG003|Overall Study|Lost to Follow-up|1|||
44266254|NCT02404350|79173650|FG000|Overall Study|Physician Decision|1|||
44266255|NCT02404350|79173651|FG001|Overall Study|Physician Decision|0|||
44193334|NCT01545076|78989084|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
44193335|NCT01545076|78989085|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
44193336|NCT01545076|78989081|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
44266256|NCT02404350|79173652|FG002|Overall Study|Physician Decision|0|||
44266257|NCT02404350|79173653|FG003|Overall Study|Physician Decision|2|||
44193337|NCT01545076|78989082|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
44193338|NCT01545076|78989083|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
44193339|NCT01545076|78989084|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
44193340|NCT01545076|78989085|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
44193341|NCT01545076|78989081|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
44193342|NCT01545076|78989082|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
44193343|NCT01545076|78989083|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
44266258|NCT02404350|79173650|FG000|Overall Study|Pregnancy|0|||
44266259|NCT02404350|79173651|FG001|Overall Study|Pregnancy|0|||
44266260|NCT02404350|79173652|FG002|Overall Study|Pregnancy|0|||
44193344|NCT01545076|78989084|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
44193345|NCT01545076|78989085|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
44193346|NCT01545076|78989081|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
44193347|NCT01545076|78989082|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
44193348|NCT01545076|78989083|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
44193349|NCT01545076|78989084|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
44193350|NCT01545076|78989085|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
44193351|NCT01545076|78989081|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
44193352|NCT01545076|78989082|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
44193353|NCT01545076|78989083|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
44193354|NCT01545076|78989084|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
44193355|NCT01545076|78989085|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
44193356|NCT01545076|78989081|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
44193357|NCT01545076|78989082|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
44193358|NCT01545076|78989083|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
44193359|NCT01545076|78989084|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
44193360|NCT01545076|78989085|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
44193361|NCT01545076|78989081|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
44193362|NCT01545076|78989082|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
44193363|NCT01545076|78989083|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
44193364|NCT01545076|78989084|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
44193365|NCT01545076|78989085|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
44193366|NCT01545076|78989081|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
44193367|NCT01545076|78989082|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
44193368|NCT01545076|78989083|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
44193369|NCT01545076|78989084|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
44193370|NCT01545076|78989085|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
44193371|NCT01545076|78989081|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
44193372|NCT01545076|78989082|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
44193373|NCT01545076|78989083|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
44193374|NCT01545076|78989084|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
44193375|NCT01545076|78989085|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
44193376|NCT01544920|78989100|FG000|Overall Study|Adverse Event|0|||
44193377|NCT01544920|78989101|FG001|Overall Study|Adverse Event|3|||
44193378|NCT01544920|78989100|FG000|Overall Study|Death|0|||
44193379|NCT01544920|78989101|FG001|Overall Study|Death|1|||
44193380|NCT01544920|78989100|FG000|Overall Study|Lost to Follow-up|11|||
44193381|NCT01544920|78989101|FG001|Overall Study|Lost to Follow-up|12|||
44193382|NCT01544920|78989100|FG000|Overall Study|Protocol Violation|0|||
44193383|NCT01544920|78989101|FG001|Overall Study|Protocol Violation|2|||
44193384|NCT01544920|78989100|FG000|Overall Study|Physician Decision|4|||
44193385|NCT01544920|78989101|FG001|Overall Study|Physician Decision|1|||
44193386|NCT01544920|78989100|FG000|Overall Study|Withdrawal by Subject|4|||
44193387|NCT01544920|78989101|FG001|Overall Study|Withdrawal by Subject|4|||
44193388|NCT01509664|78989111|FG000|Overall Study|Lost to Follow-up|15|||
44193389|NCT01509664|78989112|FG001|Overall Study|Lost to Follow-up|21|||
44193390|NCT01543828|78989120|FG000|Treatment 2|Lost to Follow-up|1|||
44193391|NCT01543828|78989121|FG001|Treatment 2|Lost to Follow-up|0|||
44193392|NCT01520506|78989129|FG000|Overall Study|Missed Visit|4|||
44193393|NCT01520506|78989129|FG000|Overall Study|Lost to Follow-up|1|||
44193394|NCT01520506|78989129|FG000|Overall Study|Withdrawal by Subject|1|||
44193395|NCT01519960|78989136|FG000|Overall Study|Withdrawal from the study|26|||
44193396|NCT01519960|78989137|FG001|Overall Study|Withdrawal from the study|22|||
44193397|NCT01519960|78989138|FG002|Overall Study|Withdrawal from the study|5|||
44193398|NCT01543204|78989154|FG000|Overall Study|Non-compliance|1|||
44193399|NCT01543204|78989154|FG000|Overall Study|Adverse Event|1|||
44193400|NCT01543204|78989154|FG000|Overall Study|Withdrawal by Subject|4|||
44193401|NCT01543204|78989154|FG000|Overall Study|Requirement for Alternative Therapy|1|||
44193402|NCT01543204|78989154|FG000|Overall Study|Lost to Follow-up|1|||
44193403|NCT01488994|78989164|FG000|Overall Study|Withdrawal by Subject|0|||
44193404|NCT01488994|78989165|FG001|Overall Study|Withdrawal by Subject|1|||
44266261|NCT02404350|79173653|FG003|Overall Study|Pregnancy|1|||
44193405|NCT01508650|78989178|FG000|Overall Study|Lost to Follow-up|0|||
44193406|NCT01508650|78989179|FG001|Overall Study|Lost to Follow-up|3|||
44193407|NCT01488448|78989187|FG000|Overall Study|Withdrawal by Subject|3|||
44266262|NCT02404350|79173650|FG000|Overall Study|Withdrawal by Subject|7|||
44266263|NCT02404350|79173651|FG001|Overall Study|Withdrawal by Subject|3|||
44266264|NCT02404350|79173652|FG002|Overall Study|Withdrawal by Subject|3|||
44266265|NCT02404350|79173653|FG003|Overall Study|Withdrawal by Subject|19|||
44193408|NCT01488448|78989188|FG001|Overall Study|Withdrawal by Subject|1|||
44193409|NCT01488448|78989187|FG000|Overall Study|Adverse Event|9|||
44193410|NCT01488448|78989188|FG001|Overall Study|Adverse Event|4|||
44193411|NCT01488448|78989187|FG000|Overall Study|Physician Decision|4|||
44193412|NCT01488448|78989188|FG001|Overall Study|Physician Decision|9|||
44193413|NCT01488448|78989187|FG000|Overall Study|Protocol Violation|4|||
44193414|NCT01488448|78989188|FG001|Overall Study|Protocol Violation|3|||
44193415|NCT01518946|78989198|FG000|Open-label Phase|Other|4|||
44193416|NCT01518946|78989199|FG001|Open-label Phase|Other|0|||
44193417|NCT01518946|78989200|FG002|Open-label Phase|Other|0|||
44193418|NCT01518946|78989198|FG000|Randomized Phase (First Intervention)|Other|0|||
44193419|NCT01518946|78989199|FG001|Randomized Phase (First Intervention)|Other|1|||
44193420|NCT01518946|78989200|FG002|Randomized Phase (First Intervention)|Other|0|||
44193421|NCT01488370|78989210|FG000|Overall Study|Protocol Violation|0|||
44193422|NCT01488370|78989211|FG001|Overall Study|Protocol Violation|1|||
44193423|NCT01488370|78989212|FG002|Overall Study|Protocol Violation|1|||
44193424|NCT01518322|78989220|FG000|Overall Study|FeNO measurement was missing|13|||
44193425|NCT01507246|78989231|FG000|Overall Study|Required different surgical procedures|2|||
44193426|NCT01507246|78989232|FG001|Overall Study|Required different surgical procedures|1|||
44193427|NCT01507090|78989241|FG000|Overall Study|incomplete dataset|18|||
44193428|NCT01464346|78989255|FG000|Overall Study|Withdrawal by Subject|0|||
44193429|NCT01464346|78989256|FG001|Overall Study|Withdrawal by Subject|0|||
44193430|NCT01464346|78989257|FG002|Overall Study|Withdrawal by Subject|1|||
44193431|NCT01487200|78989284|FG000|Overall Study|Withdrawal by Subject|0|||
44193432|NCT01487200|78989285|FG001|Overall Study|Withdrawal by Subject|1|||
44193433|NCT01487200|78989286|FG002|Overall Study|Withdrawal by Subject|0|||
44193434|NCT01487200|78989287|FG003|Overall Study|Withdrawal by Subject|0|||
44193435|NCT01463878|78989300|FG000|Overall Study|no longer met criteria for tube feed|2|||
44193436|NCT01463878|78989301|FG001|Overall Study|no longer met criteria for tube feed|2|||
44193437|NCT01486966|78989309|FG000|Overall Study|Adverse Event|0|||
44193438|NCT01486966|78989310|FG001|Overall Study|Adverse Event|1|||
44193439|NCT01486966|78989309|FG000|Overall Study|Withdrawal by Subject|0|||
44193440|NCT01486966|78989310|FG001|Overall Study|Withdrawal by Subject|1|||
44193441|NCT01900665|78989318|FG000|Placebo Controlled Period|Death|9|||
44193442|NCT01900665|78989319|FG001|Placebo Controlled Period|Death|16|||
44193443|NCT01900665|78989318|FG000|Placebo Controlled Period|Adverse Event|48|||
44193444|NCT01900665|78989319|FG001|Placebo Controlled Period|Adverse Event|39|||
44193445|NCT01900665|78989318|FG000|Placebo Controlled Period|Protocol Violation|1|||
44193446|NCT01900665|78989319|FG001|Placebo Controlled Period|Protocol Violation|7|||
44193447|NCT01900665|78989318|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
44193448|NCT01900665|78989319|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
44193449|NCT01900665|78989318|FG000|Placebo Controlled Period|Physician Decision|11|||
44193450|NCT01900665|78989319|FG001|Placebo Controlled Period|Physician Decision|7|||
44193451|NCT01900665|78989318|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
44193452|NCT01900665|78989319|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
44193453|NCT01900665|78989318|FG000|Placebo Controlled Period|Caregiver Decision|33|||
44193454|NCT01900665|78989319|FG001|Placebo Controlled Period|Caregiver Decision|41|||
44193455|NCT01900665|78989318|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
44193456|NCT01900665|78989319|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
44193457|NCT01900665|78989318|FG000|Open Label Period|Adverse Event|16|||
44193458|NCT01900665|78989319|FG001|Open Label Period|Adverse Event|20|||
44193459|NCT01900665|78989318|FG000|Open Label Period|Death|5|||
44193460|NCT01900665|78989319|FG001|Open Label Period|Death|6|||
44193461|NCT01900665|78989318|FG000|Open Label Period|Lost to Follow-up|1|||
44193462|NCT01900665|78989319|FG001|Open Label Period|Lost to Follow-up|1|||
44193463|NCT01900665|78989318|FG000|Open Label Period|Parent/Caregiver Decision|33|||
44193464|NCT01900665|78989319|FG001|Open Label Period|Parent/Caregiver Decision|34|||
44193465|NCT01900665|78989318|FG000|Open Label Period|Physician Decision|4|||
44193466|NCT01900665|78989319|FG001|Open Label Period|Physician Decision|4|||
44193467|NCT01900665|78989318|FG000|Open Label Period|Protocol Violation|0|||
44193468|NCT01900665|78989319|FG001|Open Label Period|Protocol Violation|1|||
44193469|NCT01900665|78989318|FG000|Open Label Period|Sponsor Decision|802|||
44193470|NCT01900665|78989319|FG001|Open Label Period|Sponsor Decision|765|||
44193471|NCT01900665|78989318|FG000|Open Label Period|Withdrawal by Subject|20|||
44193472|NCT01900665|78989319|FG001|Open Label Period|Withdrawal by Subject|28|||
44193473|NCT01900431|78989330|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
44193474|NCT01900431|78989331|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
44193475|NCT01900431|78989332|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
44193476|NCT01900431|78989330|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
44193477|NCT01900431|78989331|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
44193478|NCT01900431|78989332|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
44193479|NCT01900431|78989330|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
44193480|NCT01900431|78989331|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
44193481|NCT01900431|78989332|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
44193482|NCT01900431|78989330|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
44193483|NCT01900431|78989331|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
44193484|NCT01900431|78989332|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
44193485|NCT01900431|78989330|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
44193486|NCT01900431|78989331|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
44193487|NCT01900431|78989332|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
44193488|NCT01900431|78989330|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
44193489|NCT01900431|78989331|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
44193490|NCT01900431|78989332|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
44193491|NCT01900431|78989330|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
44193492|NCT01900431|78989331|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
44193493|NCT01900431|78989332|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
44193494|NCT01900431|78989330|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
44193495|NCT01900431|78989331|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
44193496|NCT01900431|78989332|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
44193497|NCT01900431|78989330|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
44193498|NCT01900431|78989331|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
44193499|NCT01900431|78989332|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
44193500|NCT01948791|78989340|FG000|Overall Study|Adverse Event|12|||
44193501|NCT01948791|78989340|FG000|Overall Study|Lack of Efficacy|3|||
44193502|NCT01948791|78989340|FG000|Overall Study|Protocol Violation|2|||
44193503|NCT01948791|78989340|FG000|Overall Study|Withdrawal by Subject|5|||
44193504|NCT01948791|78989340|FG000|Overall Study|Lost to Follow-up|6|||
44193505|NCT01948791|78989340|FG000|Overall Study|Management issues|1|||
44193506|NCT01948791|78989340|FG000|Overall Study|Others|7|||
44193507|NCT01948791|78989340|FG000|Overall Study|Screening failure|35|||
44193508|NCT01899729|78989349|FG000|Overall Study|Adverse Event|1|||
44193509|NCT01899729|78989350|FG001|Overall Study|Adverse Event|0|||
44193510|NCT01899729|78989351|FG002|Overall Study|Adverse Event|0|||
44193511|NCT01899729|78989352|FG003|Overall Study|Adverse Event|0|||
44193512|NCT01899729|78989353|FG004|Overall Study|Adverse Event|1|||
44193513|NCT01899729|78989349|FG000|Overall Study|Withdrawal by Subject|1|||
44193514|NCT01899729|78989350|FG001|Overall Study|Withdrawal by Subject|2|||
44193515|NCT01899729|78989351|FG002|Overall Study|Withdrawal by Subject|0|||
44193516|NCT01899729|78989352|FG003|Overall Study|Withdrawal by Subject|0|||
44193517|NCT01899729|78989353|FG004|Overall Study|Withdrawal by Subject|0|||
44193518|NCT01899729|78989349|FG000|Overall Study|Lack of Efficacy|0|||
44193519|NCT01899729|78989350|FG001|Overall Study|Lack of Efficacy|0|||
44193520|NCT01899729|78989351|FG002|Overall Study|Lack of Efficacy|2|||
44193521|NCT01899729|78989352|FG003|Overall Study|Lack of Efficacy|0|||
44193522|NCT01899729|78989353|FG004|Overall Study|Lack of Efficacy|1|||
44193523|NCT01898091|78989367|FG000|Overall Study|Lost to Follow-up|1|||
44193524|NCT01898091|78989368|FG001|Overall Study|Lost to Follow-up|1|||
44193525|NCT01898091|78989367|FG000|Overall Study|Withdrawal by Subject|1|||
44193526|NCT01898091|78989368|FG001|Overall Study|Withdrawal by Subject|5|||
44193527|NCT01947855|78989377|FG000|Overall Study|Withdrawal by Subject|1|||
44193528|NCT01947855|78989378|FG001|Overall Study|Withdrawal by Subject|0|||
44193529|NCT01947855|78989379|FG002|Overall Study|Withdrawal by Subject|0|||
44193530|NCT01888965|78989387|FG000|Overall Study|Adverse Event|5|||
44193531|NCT01888965|78989387|FG000|Overall Study|Lack of Efficacy|4|||
44193532|NCT01888497|78989391|FG000|Washout Period 1|Withdrawal by Subject|0|||
44193533|NCT01888497|78989392|FG001|Washout Period 1|Withdrawal by Subject|0|||
44193534|NCT01888497|78989393|FG002|Washout Period 1|Withdrawal by Subject|1|||
44193535|NCT01888497|78989394|FG003|Washout Period 1|Withdrawal by Subject|1|||
44193536|NCT01888497|78989391|FG000|Washout Period 2|Adverse Event|0|||
44193537|NCT01888497|78989392|FG001|Washout Period 2|Adverse Event|0|||
44193538|NCT01888497|78989393|FG002|Washout Period 2|Adverse Event|0|||
44193539|NCT01888497|78989394|FG003|Washout Period 2|Adverse Event|1|||
44193540|NCT01888497|78989391|FG000|Washout Period 2|Withdrawal by Subject|0|||
44193541|NCT01888497|78989392|FG001|Washout Period 2|Withdrawal by Subject|0|||
44193542|NCT01888497|78989393|FG002|Washout Period 2|Withdrawal by Subject|0|||
44193543|NCT01888497|78989394|FG003|Washout Period 2|Withdrawal by Subject|1|||
44193544|NCT01505530|78989407|FG000|Overall Study|Progressive Disease|19|||
44193545|NCT01505530|78989408|FG001|Overall Study|Progressive Disease|17|||
44193546|NCT01505530|78989409|FG002|Overall Study|Progressive Disease|18|||
44193547|NCT01505530|78989407|FG000|Overall Study|Adverse Event|1|||
44193548|NCT01505530|78989408|FG001|Overall Study|Adverse Event|1|||
44193549|NCT01505530|78989409|FG002|Overall Study|Adverse Event|0|||
44193550|NCT01505530|78989407|FG000|Overall Study|Withdrawal by Subject|7|||
44193551|NCT01505530|78989408|FG001|Overall Study|Withdrawal by Subject|8|||
44193552|NCT01505530|78989409|FG002|Overall Study|Withdrawal by Subject|6|||
44193553|NCT01505530|78989407|FG000|Overall Study|Physician Decision|6|||
44193554|NCT01505530|78989408|FG001|Overall Study|Physician Decision|2|||
44193555|NCT01505530|78989409|FG002|Overall Study|Physician Decision|5|||
44193556|NCT01505530|78989407|FG000|Overall Study|Sponsor Decision|1|||
44193557|NCT01505530|78989408|FG001|Overall Study|Sponsor Decision|8|||
44193558|NCT01505530|78989409|FG002|Overall Study|Sponsor Decision|7|||
44193559|NCT01505530|78989407|FG000|Overall Study|Death|7|||
44193560|NCT01505530|78989408|FG001|Overall Study|Death|6|||
44193561|NCT01505530|78989409|FG002|Overall Study|Death|5|||
44193562|NCT01505530|78989407|FG000|Overall Study|entry criteria not met|0|||
44193563|NCT01505530|78989408|FG001|Overall Study|entry criteria not met|1|||
44193564|NCT01505530|78989409|FG002|Overall Study|entry criteria not met|0|||
44193565|NCT01485796|78989417|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
44193566|NCT01485796|78989417|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
44193567|NCT01485796|78989417|FG000|Period 2: Epoch 2|Adverse Event|3|||
44193568|NCT01485796|78989417|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
44193569|NCT01485796|78989417|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
44193570|NCT01485796|78989417|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
44193571|NCT01485796|78989417|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
44193572|NCT01485796|78989417|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
44193573|NCT01505374|78989425|FG000|Overall Study|Lost to Follow-up|1|||
44193574|NCT01505374|78989426|FG001|Overall Study|Lost to Follow-up|0|||
44193575|NCT01897233|78989433|FG000|Part B (24 Weeks)|Adverse Event|1|||
44193576|NCT01897233|78989433|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
44193577|NCT01897233|78989433|FG000|Part B (24 Weeks)|Physician Decision|1|||
44193578|NCT01887717|78989443|FG000|Overall Study|Withdrawal by Subject|1|||
44193579|NCT01887717|78989444|FG001|Overall Study|Withdrawal by Subject|7|||
44193580|NCT01887717|78989443|FG000|Overall Study|Physician Decision|0|||
44193581|NCT01887717|78989444|FG001|Overall Study|Physician Decision|2|||
44193582|NCT01887717|78989443|FG000|Overall Study|Administrative reasons|5|||
44193583|NCT01887717|78989444|FG001|Overall Study|Administrative reasons|2|||
44193584|NCT01886781|78989452|FG000|Overall Study|Protocol Violation|5|||
44193585|NCT01886781|78989453|FG001|Overall Study|Protocol Violation|0|||
44193586|NCT01886781|78989452|FG000|Overall Study|Adverse Event|1|||
44193587|NCT01886781|78989453|FG001|Overall Study|Adverse Event|0|||
44193588|NCT01886781|78989452|FG000|Overall Study|Lost to Follow-up|5|||
44193589|NCT01886781|78989453|FG001|Overall Study|Lost to Follow-up|0|||
44193590|NCT01886781|78989452|FG000|Overall Study|Withdrawal by Subject|2|||
44193591|NCT01886781|78989453|FG001|Overall Study|Withdrawal by Subject|1|||
44193592|NCT01886781|78989452|FG000|Overall Study|Worsening of symptoms|1|||
44193593|NCT01886781|78989453|FG001|Overall Study|Worsening of symptoms|1|||
44193594|NCT01463098|78989473|FG000|Part A (11 Days)|Participant Choice|2|||
44193595|NCT01463098|78989474|FG001|Part A (11 Days)|Participant Choice|0|||
44193596|NCT01463098|78989475|FG002|Part A (11 Days)|Participant Choice|0|||
44193597|NCT01463098|78989476|FG003|Part A (11 Days)|Participant Choice|0|||
44193598|NCT01463098|78989477|FG004|Part A (11 Days)|Participant Choice|0|||
44193599|NCT01463098|78989478|FG005|Part A (11 Days)|Participant Choice|0|||
44193600|NCT01463098|78989479|FG006|Part A (11 Days)|Participant Choice|0|||
44193601|NCT01463098|78989480|FG007|Part A (11 Days)|Participant Choice|0|||
44193602|NCT01463098|78989481|FG008|Part A (11 Days)|Participant Choice|1|||
44193603|NCT01463098|78989482|FG009|Part A (11 Days)|Participant Choice|0|||
44193604|NCT01463098|78989483|FG010|Part A (11 Days)|Participant Choice|0|||
44193605|NCT01463098|78989484|FG011|Part A (11 Days)|Participant Choice|0|||
44193606|NCT01463098|78989485|FG012|Part A (11 Days)|Participant Choice|0|||
44193607|NCT01463098|78989486|FG013|Part A (11 Days)|Participant Choice|0|||
44193608|NCT01463098|78989473|FG000|Part A (11 Days)|Lost to Follow-up|0|||
44193609|NCT01463098|78989474|FG001|Part A (11 Days)|Lost to Follow-up|0|||
44193610|NCT01463098|78989475|FG002|Part A (11 Days)|Lost to Follow-up|0|||
44193611|NCT01463098|78989476|FG003|Part A (11 Days)|Lost to Follow-up|0|||
44193612|NCT01463098|78989477|FG004|Part A (11 Days)|Lost to Follow-up|1|||
44193613|NCT01463098|78989478|FG005|Part A (11 Days)|Lost to Follow-up|0|||
44193614|NCT01463098|78989479|FG006|Part A (11 Days)|Lost to Follow-up|0|||
44193615|NCT01463098|78989480|FG007|Part A (11 Days)|Lost to Follow-up|0|||
44193616|NCT01463098|78989481|FG008|Part A (11 Days)|Lost to Follow-up|0|||
44193617|NCT01463098|78989482|FG009|Part A (11 Days)|Lost to Follow-up|0|||
44193618|NCT01463098|78989483|FG010|Part A (11 Days)|Lost to Follow-up|0|||
44193619|NCT01463098|78989484|FG011|Part A (11 Days)|Lost to Follow-up|0|||
44193620|NCT01463098|78989485|FG012|Part A (11 Days)|Lost to Follow-up|0|||
44193621|NCT01463098|78989486|FG013|Part A (11 Days)|Lost to Follow-up|0|||
44193622|NCT01463098|78989473|FG000|Part B (11 Days)|Participant Choice|0|||
44193623|NCT01463098|78989474|FG001|Part B (11 Days)|Participant Choice|0|||
44193624|NCT01463098|78989475|FG002|Part B (11 Days)|Participant Choice|0|||
44193625|NCT01463098|78989476|FG003|Part B (11 Days)|Participant Choice|0|||
44193626|NCT01463098|78989477|FG004|Part B (11 Days)|Participant Choice|0|||
44193627|NCT01463098|78989478|FG005|Part B (11 Days)|Participant Choice|0|||
44193628|NCT01463098|78989479|FG006|Part B (11 Days)|Participant Choice|0|||
44193629|NCT01463098|78989480|FG007|Part B (11 Days)|Participant Choice|0|||
44266266|NCT02404350|79173650|FG000|Overall Study|Due to Non-compliance with treatment|0|||
44193630|NCT01463098|78989481|FG008|Part B (11 Days)|Participant Choice|0|||
44193631|NCT01463098|78989482|FG009|Part B (11 Days)|Participant Choice|0|||
44193632|NCT01463098|78989483|FG010|Part B (11 Days)|Participant Choice|0|||
44193633|NCT01463098|78989484|FG011|Part B (11 Days)|Participant Choice|1|||
44193634|NCT01463098|78989485|FG012|Part B (11 Days)|Participant Choice|0|||
44193635|NCT01463098|78989486|FG013|Part B (11 Days)|Participant Choice|0|||
44193636|NCT01462942|78989540|FG000|Overall Study|Adverse Event|7|||
44193637|NCT01462942|78989541|FG001|Overall Study|Adverse Event|12|||
44193638|NCT01462942|78989542|FG002|Overall Study|Adverse Event|10|||
44193639|NCT01462942|78989543|FG003|Overall Study|Adverse Event|11|||
44193640|NCT01462942|78989544|FG004|Overall Study|Adverse Event|11|||
44193641|NCT01462942|78989540|FG000|Overall Study|Other, including COPD exacerbation|3|||
44193642|NCT01462942|78989541|FG001|Overall Study|Other, including COPD exacerbation|5|||
44193643|NCT01462942|78989542|FG002|Overall Study|Other, including COPD exacerbation|2|||
44193644|NCT01462942|78989543|FG003|Overall Study|Other, including COPD exacerbation|8|||
44193645|NCT01462942|78989544|FG004|Overall Study|Other, including COPD exacerbation|5|||
44193646|NCT01462942|78989540|FG000|Overall Study|Withdrawal by Subject|14|||
44193647|NCT01462942|78989541|FG001|Overall Study|Withdrawal by Subject|10|||
44193648|NCT01462942|78989542|FG002|Overall Study|Withdrawal by Subject|14|||
44193649|NCT01462942|78989543|FG003|Overall Study|Withdrawal by Subject|16|||
44193650|NCT01462942|78989544|FG004|Overall Study|Withdrawal by Subject|19|||
44193651|NCT01462942|78989540|FG000|Overall Study|Lack of Efficacy|6|||
44193652|NCT01462942|78989541|FG001|Overall Study|Lack of Efficacy|0|||
44193653|NCT01462942|78989542|FG002|Overall Study|Lack of Efficacy|4|||
44193654|NCT01462942|78989543|FG003|Overall Study|Lack of Efficacy|5|||
44193655|NCT01462942|78989544|FG004|Overall Study|Lack of Efficacy|3|||
44193656|NCT01462942|78989540|FG000|Overall Study|Lost to Follow-up|0|||
44193657|NCT01462942|78989541|FG001|Overall Study|Lost to Follow-up|1|||
44193658|NCT01462942|78989542|FG002|Overall Study|Lost to Follow-up|1|||
44193659|NCT01462942|78989543|FG003|Overall Study|Lost to Follow-up|1|||
44193660|NCT01462942|78989544|FG004|Overall Study|Lost to Follow-up|1|||
44193661|NCT01462942|78989540|FG000|Overall Study|Protocol Violation|4|||
44193662|NCT01462942|78989541|FG001|Overall Study|Protocol Violation|6|||
44193663|NCT01462942|78989542|FG002|Overall Study|Protocol Violation|9|||
44193664|NCT01462942|78989543|FG003|Overall Study|Protocol Violation|9|||
44193665|NCT01462942|78989544|FG004|Overall Study|Protocol Violation|6|||
44193666|NCT01462630|78989556|FG000|Overall Study|Did not initiate therapy|3|||
44193667|NCT01462630|78989556|FG000|Overall Study|Death|1|||
44193668|NCT01462630|78989556|FG000|Overall Study|Protocol Violation|2|||
44193669|NCT01462630|78989556|FG000|Overall Study|Adverse Event|1|||
44193670|NCT01504204|78989562|FG000|Overall Study|Lost to Follow-up|1|||
44193671|NCT01504204|78989563|FG001|Overall Study|Lost to Follow-up|1|||
44193672|NCT01485640|78989569|FG000|Overall Study|Adverse Event|10|||
44193673|NCT01485640|78989569|FG000|Overall Study|Lack of Efficacy|2|||
44193674|NCT01485640|78989569|FG000|Overall Study|Protocol Violation|1|||
44193675|NCT01485640|78989569|FG000|Overall Study|Withdrawal by Subject|14|||
44193676|NCT01485640|78989569|FG000|Overall Study|Terminated by Sponsor|95|||
44193677|NCT02118961|78989575|FG000|Overall Study|Withdrawal by Subject|1|||
44193678|NCT02118961|78989576|FG001|Overall Study|Withdrawal by Subject|0|||
44193679|NCT02140645|78989588|FG000|Overall Study|Not linked|5489|||
44193680|NCT02140645|78989589|FG001|Overall Study|Not linked|61654|||
44193681|NCT02140645|78989590|FG002|Overall Study|Not linked|4236|||
44193682|NCT02140645|78989591|FG003|Overall Study|Not linked|13833|||
44193683|NCT02140645|78989592|FG004|Overall Study|Not linked|3286|||
44193684|NCT02140645|78989593|FG005|Overall Study|Not linked|70896|||
44193685|NCT02140567|78989602|FG000|Overall Study|Problems with recording equipment|6|||
44193686|NCT02140411|78989607|FG000|Overall Study|Adverse Event|1|||
44193687|NCT02139943|78989614|FG000|Overall Study|Adverse Event|0|||
44193688|NCT02139943|78989615|FG001|Overall Study|Adverse Event|1|||
44193689|NCT02139943|78989616|FG002|Overall Study|Adverse Event|2|||
44193690|NCT02139943|78989614|FG000|Overall Study|Lost to Follow-up|3|||
44193691|NCT02139943|78989615|FG001|Overall Study|Lost to Follow-up|2|||
44193692|NCT02139943|78989616|FG002|Overall Study|Lost to Follow-up|2|||
44193693|NCT02139943|78989614|FG000|Overall Study|Withdrawal by Subject|4|||
44193694|NCT02139943|78989615|FG001|Overall Study|Withdrawal by Subject|3|||
44193695|NCT02139943|78989616|FG002|Overall Study|Withdrawal by Subject|0|||
44193696|NCT02139943|78989614|FG000|Overall Study|Other|0|||
44193697|NCT02139943|78989615|FG001|Overall Study|Other|0|||
44193698|NCT02139943|78989616|FG002|Overall Study|Other|1|||
44193699|NCT02139943|78989614|FG000|Overall Study|Participant wishes to discontinue|2|||
44193700|NCT02139943|78989615|FG001|Overall Study|Participant wishes to discontinue|0|||
44193701|NCT02139943|78989616|FG002|Overall Study|Participant wishes to discontinue|0|||
44193702|NCT02139943|78989614|FG000|Overall Study|Participant in Poor Compliance|1|||
44193703|NCT02139943|78989615|FG001|Overall Study|Participant in Poor Compliance|0|||
44193704|NCT02139943|78989616|FG002|Overall Study|Participant in Poor Compliance|1|||
44193705|NCT02139943|78989614|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
44193706|NCT02139943|78989615|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
44193707|NCT02139943|78989616|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
44193708|NCT01485172|78989630|FG000|Overall Study|Adverse Event|2|||
44193709|NCT01485172|78989631|FG001|Overall Study|Adverse Event|1|||
44193710|NCT01485172|78989632|FG002|Overall Study|Adverse Event|2|||
44193711|NCT01485172|78989633|FG003|Overall Study|Adverse Event|2|||
44193712|NCT01485172|78989634|FG004|Overall Study|Adverse Event|1|||
44193713|NCT01485172|78989635|FG005|Overall Study|Adverse Event|2|||
44193714|NCT01485172|78989630|FG000|Overall Study|Lack of Efficacy|2|||
44193715|NCT01485172|78989631|FG001|Overall Study|Lack of Efficacy|0|||
44193716|NCT01485172|78989632|FG002|Overall Study|Lack of Efficacy|0|||
44193717|NCT01485172|78989633|FG003|Overall Study|Lack of Efficacy|0|||
44193718|NCT01485172|78989634|FG004|Overall Study|Lack of Efficacy|0|||
44193719|NCT01485172|78989635|FG005|Overall Study|Lack of Efficacy|0|||
44193720|NCT01485172|78989630|FG000|Overall Study|Protocol Violation|0|||
44193721|NCT01485172|78989631|FG001|Overall Study|Protocol Violation|0|||
44193722|NCT01485172|78989632|FG002|Overall Study|Protocol Violation|4|||
44193723|NCT01485172|78989633|FG003|Overall Study|Protocol Violation|5|||
44193724|NCT01485172|78989634|FG004|Overall Study|Protocol Violation|1|||
44193725|NCT01485172|78989635|FG005|Overall Study|Protocol Violation|0|||
44193726|NCT01485172|78989630|FG000|Overall Study|Protocol defined stopping criteria|1|||
44193727|NCT01485172|78989631|FG001|Overall Study|Protocol defined stopping criteria|0|||
44193728|NCT01485172|78989632|FG002|Overall Study|Protocol defined stopping criteria|0|||
44193729|NCT01485172|78989633|FG003|Overall Study|Protocol defined stopping criteria|0|||
44193730|NCT01485172|78989634|FG004|Overall Study|Protocol defined stopping criteria|1|||
44193731|NCT01485172|78989635|FG005|Overall Study|Protocol defined stopping criteria|0|||
44193732|NCT01485172|78989630|FG000|Overall Study|Lost to Follow-up|0|||
44193733|NCT01485172|78989631|FG001|Overall Study|Lost to Follow-up|0|||
44193734|NCT01485172|78989632|FG002|Overall Study|Lost to Follow-up|1|||
44193735|NCT01485172|78989633|FG003|Overall Study|Lost to Follow-up|0|||
44193736|NCT01485172|78989634|FG004|Overall Study|Lost to Follow-up|0|||
44193737|NCT01485172|78989635|FG005|Overall Study|Lost to Follow-up|1|||
44193738|NCT01485172|78989630|FG000|Overall Study|Physician Decision|0|||
44193739|NCT01485172|78989631|FG001|Overall Study|Physician Decision|0|||
44193740|NCT01485172|78989632|FG002|Overall Study|Physician Decision|0|||
44193741|NCT01485172|78989633|FG003|Overall Study|Physician Decision|0|||
44193742|NCT01485172|78989634|FG004|Overall Study|Physician Decision|1|||
44193743|NCT01485172|78989635|FG005|Overall Study|Physician Decision|0|||
44193744|NCT01485172|78989630|FG000|Overall Study|Withdrawal by Subject|2|||
44193745|NCT01485172|78989631|FG001|Overall Study|Withdrawal by Subject|0|||
44193746|NCT01485172|78989632|FG002|Overall Study|Withdrawal by Subject|0|||
44193747|NCT01485172|78989633|FG003|Overall Study|Withdrawal by Subject|1|||
44193748|NCT01485172|78989634|FG004|Overall Study|Withdrawal by Subject|1|||
44193749|NCT01485172|78989635|FG005|Overall Study|Withdrawal by Subject|1|||
44193750|NCT02105701|78989653|FG000|Overall Study|Lost to Follow-up|1|||
44193751|NCT02105701|78989654|FG001|Overall Study|Lost to Follow-up|0|||
44193752|NCT02105701|78989655|FG002|Overall Study|Lost to Follow-up|2|||
44193753|NCT02105701|78989656|FG003|Overall Study|Lost to Follow-up|1|||
44193754|NCT02105701|78989653|FG000|Overall Study|Protocol Violation|0|||
44193755|NCT02105701|78989654|FG001|Overall Study|Protocol Violation|0|||
44193756|NCT02105701|78989655|FG002|Overall Study|Protocol Violation|1|||
44193757|NCT02105701|78989656|FG003|Overall Study|Protocol Violation|0|||
44193758|NCT02105701|78989653|FG000|Overall Study|Withdrawal by Subject|2|||
44193759|NCT02105701|78989654|FG001|Overall Study|Withdrawal by Subject|1|||
44193760|NCT02105701|78989655|FG002|Overall Study|Withdrawal by Subject|0|||
44193761|NCT02105701|78989656|FG003|Overall Study|Withdrawal by Subject|1|||
44193762|NCT02105701|78989653|FG000|Overall Study|Death|1|||
44193763|NCT02105701|78989654|FG001|Overall Study|Death|0|||
44193764|NCT02105701|78989655|FG002|Overall Study|Death|0|||
44193765|NCT02105701|78989656|FG003|Overall Study|Death|0|||
44193766|NCT01502956|78989668|FG000|Overall Study|Death|0|||
44193767|NCT01502956|78989669|FG001|Overall Study|Death|2|||
44193768|NCT01502956|78989668|FG000|Overall Study|Lost to Follow-up|14|||
44193769|NCT01502956|78989669|FG001|Overall Study|Lost to Follow-up|11|||
44193770|NCT01502956|78989668|FG000|Overall Study|Physician Decision|2|||
44193771|NCT01502956|78989669|FG001|Overall Study|Physician Decision|3|||
44193772|NCT01502956|78989668|FG000|Overall Study|Withdrawal by Subject|8|||
44193773|NCT01502956|78989669|FG001|Overall Study|Withdrawal by Subject|10|||
44193774|NCT01502644|78989678|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
44193775|NCT01502644|78989679|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
44193776|NCT01502644|78989680|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
44193777|NCT01502644|78989681|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
44193778|NCT01502644|78989678|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
44193779|NCT01502644|78989679|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
44193780|NCT01502644|78989680|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
44193781|NCT01502644|78989681|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
44193782|NCT01502644|78989678|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
44249660|NCT01276353|79083651|FG000|Double-blind|Withdrawal by Subject|1|||
44193783|NCT01502644|78989679|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
44193784|NCT01502644|78989680|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
44193785|NCT01502644|78989681|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
44193786|NCT01502644|78989678|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
44193787|NCT01502644|78989679|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
44193788|NCT01502644|78989680|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
44193789|NCT01502644|78989681|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
44193790|NCT01502644|78989678|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
44193791|NCT01502644|78989679|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
44193792|NCT01502644|78989680|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
44193793|NCT01502644|78989681|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
44193794|NCT01462318|78989691|FG000|Main Study / TP-DI Study|Other|2|||
44193795|NCT01462318|78989692|FG001|Main Study / TP-DI Study|Other|0|||
44193796|NCT01462318|78989693|FG002|Main Study / TP-DI Study|Other|0|||
44193797|NCT01462318|78989691|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
44193798|NCT01462318|78989692|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
44193799|NCT01462318|78989693|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
44193800|NCT01462318|78989691|FG000|Main Study / TP-DI Study|Adverse Event|4|||
44193801|NCT01462318|78989692|FG001|Main Study / TP-DI Study|Adverse Event|0|||
44193802|NCT01462318|78989693|FG002|Main Study / TP-DI Study|Adverse Event|0|||
44193803|NCT01462318|78989691|FG000|Extension Phase|Lost to Follow-up|0|||
44193804|NCT01462318|78989692|FG001|Extension Phase|Lost to Follow-up|0|||
44193805|NCT01462318|78989693|FG002|Extension Phase|Lost to Follow-up|1|||
44193806|NCT01462318|78989691|FG000|Extension Phase|Other|0|||
44193807|NCT01462318|78989692|FG001|Extension Phase|Other|0|||
44193808|NCT01462318|78989693|FG002|Extension Phase|Other|1|||
44193809|NCT01462318|78989691|FG000|Extension Phase|Disease Progression|0|||
44193810|NCT01462318|78989692|FG001|Extension Phase|Disease Progression|0|||
44193811|NCT01462318|78989693|FG002|Extension Phase|Disease Progression|1|||
44193812|NCT01462318|78989691|FG000|Extension Phase|Withdrawal by Subject|0|||
44193813|NCT01462318|78989692|FG001|Extension Phase|Withdrawal by Subject|0|||
44193814|NCT01462318|78989693|FG002|Extension Phase|Withdrawal by Subject|15|||
44193815|NCT01462318|78989691|FG000|Extension Phase|Investigator Decision|0|||
44193816|NCT01462318|78989692|FG001|Extension Phase|Investigator Decision|0|||
44193817|NCT01462318|78989693|FG002|Extension Phase|Investigator Decision|5|||
44193818|NCT01462318|78989691|FG000|Extension Phase|Adverse Event|0|||
44193819|NCT01462318|78989692|FG001|Extension Phase|Adverse Event|0|||
44193820|NCT01462318|78989693|FG002|Extension Phase|Adverse Event|22|||
44193821|NCT01485094|78989701|FG000|Overall Study|Adverse Event|1|||
44193822|NCT01485094|78989702|FG001|Overall Study|Adverse Event|1|||
44193823|NCT01485094|78989703|FG002|Overall Study|Adverse Event|1|||
44193824|NCT01485094|78989701|FG000|Overall Study|Lost to Follow-up|1|||
44193825|NCT01485094|78989702|FG001|Overall Study|Lost to Follow-up|0|||
44193826|NCT01485094|78989703|FG002|Overall Study|Lost to Follow-up|0|||
44193827|NCT01485094|78989701|FG000|Overall Study|Withdrawal by Subject|1|||
44193828|NCT01485094|78989702|FG001|Overall Study|Withdrawal by Subject|1|||
44193829|NCT01485094|78989703|FG002|Overall Study|Withdrawal by Subject|0|||
44193830|NCT01484938|78989711|FG000|Overall Study|Adverse Event|2|||
44193831|NCT01484938|78989711|FG000|Overall Study|Lost to Follow-up|1|||
44193832|NCT01484938|78989711|FG000|Overall Study|Noncompliance|1|||
44193833|NCT01502410|78989719|FG000|Overall Study|Adverse Event|1|||
44193834|NCT01502410|78989720|FG001|Overall Study|Adverse Event|2|||
44193835|NCT01502410|78989721|FG002|Overall Study|Adverse Event|0|||
44193836|NCT01502410|78989722|FG003|Overall Study|Adverse Event|0|||
44193837|NCT01502410|78989719|FG000|Overall Study|Lack of Efficacy|7|||
44193838|NCT01502410|78989720|FG001|Overall Study|Lack of Efficacy|7|||
44193839|NCT01502410|78989721|FG002|Overall Study|Lack of Efficacy|0|||
44193840|NCT01502410|78989722|FG003|Overall Study|Lack of Efficacy|0|||
44193841|NCT01502410|78989719|FG000|Overall Study|Physician Decision|0|||
44193842|NCT01502410|78989720|FG001|Overall Study|Physician Decision|1|||
44193843|NCT01502410|78989721|FG002|Overall Study|Physician Decision|0|||
44193844|NCT01502410|78989722|FG003|Overall Study|Physician Decision|0|||
44266267|NCT02404350|79173651|FG001|Overall Study|Due to Non-compliance with treatment|0|||
44266268|NCT02404350|79173652|FG002|Overall Study|Due to Non-compliance with treatment|0|||
44266269|NCT02404350|79173653|FG003|Overall Study|Due to Non-compliance with treatment|1|||
44266270|NCT02404350|79173650|FG000|Overall Study|Due to Technical problems|0|||
44266271|NCT02404350|79173651|FG001|Overall Study|Due to Technical problems|0|||
44266272|NCT02404350|79173652|FG002|Overall Study|Due to Technical problems|0|||
44193845|NCT01502410|78989719|FG000|Overall Study|Withdrawal by Subject|2|||
44266273|NCT02404350|79173653|FG003|Overall Study|Due to Technical problems|1|||
44193846|NCT01502410|78989720|FG001|Overall Study|Withdrawal by Subject|0|||
44193847|NCT01502410|78989721|FG002|Overall Study|Withdrawal by Subject|0|||
44193848|NCT01502410|78989722|FG003|Overall Study|Withdrawal by Subject|0|||
44193849|NCT01462162|78989731|FG000|Overall Study|Adverse Event|5|||
44193850|NCT01462162|78989731|FG000|Overall Study|Lack of Efficacy|4|||
44193851|NCT01462162|78989731|FG000|Overall Study|Abnormal laboratory parameters|1|||
44193852|NCT01462162|78989731|FG000|Overall Study|Other|2|||
44193853|NCT01483924|78989741|FG000|Overall Study|Withdrawal by Subject|2|||
44193854|NCT01483924|78989742|FG001|Overall Study|Withdrawal by Subject|0|||
44193855|NCT01483924|78989743|FG002|Overall Study|Withdrawal by Subject|0|||
44193856|NCT01483924|78989744|FG003|Overall Study|Withdrawal by Subject|1|||
44193857|NCT01483924|78989745|FG004|Overall Study|Withdrawal by Subject|1|||
44193858|NCT01483924|78989741|FG000|Overall Study|Adverse Event|0|||
44193859|NCT01483924|78989742|FG001|Overall Study|Adverse Event|0|||
44193860|NCT01483924|78989743|FG002|Overall Study|Adverse Event|1|||
44193861|NCT01483924|78989744|FG003|Overall Study|Adverse Event|1|||
44193862|NCT01483924|78989745|FG004|Overall Study|Adverse Event|0|||
44193863|NCT01483924|78989741|FG000|Overall Study|Non-compliance|0|||
44193864|NCT01483924|78989742|FG001|Overall Study|Non-compliance|0|||
44193865|NCT01483924|78989743|FG002|Overall Study|Non-compliance|0|||
44193866|NCT01483924|78989744|FG003|Overall Study|Non-compliance|1|||
44193867|NCT01483924|78989745|FG004|Overall Study|Non-compliance|1|||
44193868|NCT01483924|78989741|FG000|Overall Study|Sponsor concern over ECG result|0|||
44193869|NCT01483924|78989742|FG001|Overall Study|Sponsor concern over ECG result|0|||
44193870|NCT01483924|78989743|FG002|Overall Study|Sponsor concern over ECG result|0|||
44193871|NCT01483924|78989744|FG003|Overall Study|Sponsor concern over ECG result|1|||
44193872|NCT01483924|78989745|FG004|Overall Study|Sponsor concern over ECG result|0|||
44193873|NCT01462084|78989766|FG000|Overall Study|Withdrawal by Subject|1|||
44193874|NCT01462084|78989767|FG001|Overall Study|Withdrawal by Subject|0|||
44193875|NCT01462084|78989766|FG000|Overall Study|Protocol Violation|1|||
44193876|NCT01462084|78989767|FG001|Overall Study|Protocol Violation|1|||
44193877|NCT02134028|78989782|FG000|Overall Study|Lack of Efficacy|1|||
44193878|NCT02134028|78989783|FG001|Overall Study|Lack of Efficacy|0|||
44193879|NCT02134028|78989784|FG002|Overall Study|Lack of Efficacy|3|||
44193880|NCT02134028|78989785|FG003|Overall Study|Lack of Efficacy|2|||
44193881|NCT02134028|78989786|FG004|Overall Study|Lack of Efficacy|1|||
44193882|NCT02134028|78989787|FG005|Overall Study|Lack of Efficacy|2|||
44193883|NCT02134028|78989788|FG006|Overall Study|Lack of Efficacy|1|||
44193884|NCT02134028|78989789|FG007|Overall Study|Lack of Efficacy|0|||
44193885|NCT02134028|78989782|FG000|Overall Study|Poor compliance to protocol|1|||
44193886|NCT02134028|78989783|FG001|Overall Study|Poor compliance to protocol|1|||
44193887|NCT02134028|78989784|FG002|Overall Study|Poor compliance to protocol|3|||
44193888|NCT02134028|78989785|FG003|Overall Study|Poor compliance to protocol|7|||
44193889|NCT02134028|78989786|FG004|Overall Study|Poor compliance to protocol|1|||
44193890|NCT02134028|78989787|FG005|Overall Study|Poor compliance to protocol|1|||
44193891|NCT02134028|78989788|FG006|Overall Study|Poor compliance to protocol|0|||
44193892|NCT02134028|78989789|FG007|Overall Study|Poor compliance to protocol|0|||
44193893|NCT02134028|78989782|FG000|Overall Study|Other unspecified|4|||
44193894|NCT02134028|78989783|FG001|Overall Study|Other unspecified|22|||
44193895|NCT02134028|78989784|FG002|Overall Study|Other unspecified|33|||
44193896|NCT02134028|78989785|FG003|Overall Study|Other unspecified|64|||
44193897|NCT02134028|78989786|FG004|Overall Study|Other unspecified|8|||
44193898|NCT02134028|78989787|FG005|Overall Study|Other unspecified|6|||
44193899|NCT02134028|78989788|FG006|Overall Study|Other unspecified|2|||
44193900|NCT02134028|78989789|FG007|Overall Study|Other unspecified|1|||
44193901|NCT02134028|78989782|FG000|Overall Study|Adverse Event|3|||
44193902|NCT02134028|78989783|FG001|Overall Study|Adverse Event|19|||
44193903|NCT02134028|78989784|FG002|Overall Study|Adverse Event|13|||
44193904|NCT02134028|78989785|FG003|Overall Study|Adverse Event|32|||
44451460|NCT00500331|79460410|FG002|Overall Study|Lost to Follow-up|1|||
44193905|NCT02134028|78989786|FG004|Overall Study|Adverse Event|4|||
44193906|NCT02134028|78989787|FG005|Overall Study|Adverse Event|5|||
44193907|NCT02134028|78989788|FG006|Overall Study|Adverse Event|1|||
44193908|NCT02134028|78989789|FG007|Overall Study|Adverse Event|2|||
44193909|NCT02172950|78989811|FG000|Overall Study|Physician Decision|3|||
44193910|NCT02172950|78989812|FG001|Overall Study|Physician Decision|3|||
44193911|NCT02172950|78989811|FG000|Overall Study|Lack of Efficacy|1|||
44193912|NCT02172950|78989812|FG001|Overall Study|Lack of Efficacy|0|||
44193913|NCT02172950|78989811|FG000|Overall Study|Adverse Event|4|||
44193914|NCT02172950|78989812|FG001|Overall Study|Adverse Event|1|||
44193915|NCT02172950|78989811|FG000|Overall Study|Withdrawal by Subject|10|||
44193916|NCT02172950|78989812|FG001|Overall Study|Withdrawal by Subject|0|||
44193917|NCT02172950|78989811|FG000|Overall Study|Protocol Violation|1|||
44193918|NCT02172950|78989812|FG001|Overall Study|Protocol Violation|0|||
44193919|NCT02172950|78989811|FG000|Overall Study|Lost to Follow-up|1|||
44193920|NCT02172950|78989812|FG001|Overall Study|Lost to Follow-up|0|||
44193921|NCT02172950|78989811|FG000|Overall Study|Death|1|||
44193922|NCT02172950|78989812|FG001|Overall Study|Death|0|||
44193923|NCT02172950|78989811|FG000|Overall Study|Patient traveling|1|||
44193924|NCT02172950|78989812|FG001|Overall Study|Patient traveling|0|||
44193925|NCT02172950|78989811|FG000|Overall Study|Patient went to other country|1|||
44193926|NCT02172950|78989812|FG001|Overall Study|Patient went to other country|0|||
44193927|NCT02172950|78989811|FG000|Overall Study|Patient relocated overseas|1|||
44193928|NCT02172950|78989812|FG001|Overall Study|Patient relocated overseas|1|||
44193929|NCT02172950|78989811|FG000|Overall Study|Patient moving|1|||
44193930|NCT02172950|78989812|FG001|Overall Study|Patient moving|0|||
44193931|NCT02151266|78989822|FG000|Overall Study|Lost to Follow-up|1|||
44193932|NCT02151266|78989823|FG001|Overall Study|Lost to Follow-up|4|||
44193933|NCT02151266|78989824|FG002|Overall Study|Lost to Follow-up|1|||
44193934|NCT02151266|78989822|FG000|Overall Study|Did NOT receive intervention|3|||
44193935|NCT02151266|78989823|FG001|Overall Study|Did NOT receive intervention|6|||
44193936|NCT02151266|78989824|FG002|Overall Study|Did NOT receive intervention|2|||
44193937|NCT02151266|78989822|FG000|Overall Study|Not able to exercise|4|||
44193938|NCT02151266|78989823|FG001|Overall Study|Not able to exercise|5|||
44193939|NCT02151266|78989824|FG002|Overall Study|Not able to exercise|4|||
44193940|NCT02151110|78989840|FG000|Overall Study|Withdrawal by Subject|0|||
44193941|NCT02151110|78989841|FG001|Overall Study|Withdrawal by Subject|0|||
44193942|NCT02151110|78989842|FG002|Overall Study|Withdrawal by Subject|0|||
44193943|NCT02151110|78989843|FG003|Overall Study|Withdrawal by Subject|0|||
44193944|NCT02151110|78989844|FG004|Overall Study|Withdrawal by Subject|0|||
44193945|NCT02151110|78989845|FG005|Overall Study|Withdrawal by Subject|0|||
44193946|NCT02151110|78989846|FG006|Overall Study|Withdrawal by Subject|0|||
44193947|NCT02151110|78989847|FG007|Overall Study|Withdrawal by Subject|1|||
44193948|NCT02151110|78989840|FG000|Overall Study|Lost to Follow-up|0|||
44193949|NCT02151110|78989841|FG001|Overall Study|Lost to Follow-up|0|||
44193950|NCT02151110|78989842|FG002|Overall Study|Lost to Follow-up|0|||
44193951|NCT02151110|78989843|FG003|Overall Study|Lost to Follow-up|0|||
44193952|NCT02151110|78989844|FG004|Overall Study|Lost to Follow-up|0|||
44193953|NCT02151110|78989845|FG005|Overall Study|Lost to Follow-up|0|||
44193954|NCT02151110|78989846|FG006|Overall Study|Lost to Follow-up|0|||
44193955|NCT02151110|78989847|FG007|Overall Study|Lost to Follow-up|2|||
44193956|NCT02132312|78989874|FG000|Overall Study|Adverse Event|2|||
44193957|NCT02132312|78989875|FG001|Overall Study|Adverse Event|0|||
44193958|NCT02132312|78989874|FG000|Overall Study|Physician Decision|1|||
44193959|NCT02132312|78989875|FG001|Overall Study|Physician Decision|1|||
44193960|NCT02132312|78989874|FG000|Overall Study|Protocol Violation|0|||
44193961|NCT02132312|78989875|FG001|Overall Study|Protocol Violation|1|||
44193962|NCT02132312|78989874|FG000|Overall Study|Withdrawal by Subject|1|||
44193963|NCT02132312|78989875|FG001|Overall Study|Withdrawal by Subject|0|||
44193964|NCT02132312|78989874|FG000|Overall Study|Lost to Follow-up|2|||
44193965|NCT02132312|78989875|FG001|Overall Study|Lost to Follow-up|1|||
44193966|NCT02131766|78989881|FG000|Overall Study|Withdrawal by Subject|4|||
44193967|NCT02150954|78989890|FG000|Overall Study|Protocol Violation|1|||
44193968|NCT02150954|78989891|FG001|Overall Study|Protocol Violation|0|||
44193969|NCT02131532|78989897|FG000|Overall Study|Withdrawal by Subject|1|||
44193970|NCT02131532|78989897|FG000|Overall Study|Physician Decision|1|||
44193971|NCT02131532|78989897|FG000|Overall Study|Other health conditions|2|||
44193972|NCT02170688|78989911|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
44193973|NCT02170688|78989912|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
44193974|NCT02170688|78989913|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
44193975|NCT02170688|78989914|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
44193976|NCT02170688|78989915|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
44193977|NCT02170688|78989911|FG000|Overall Study|Full dose not received|0|||
44193978|NCT02170688|78989912|FG001|Overall Study|Full dose not received|1|||
44193979|NCT02170688|78989913|FG002|Overall Study|Full dose not received|0|||
44193980|NCT02170688|78989914|FG003|Overall Study|Full dose not received|0|||
44193981|NCT02170688|78989915|FG004|Overall Study|Full dose not received|0|||
44193982|NCT02170688|78989911|FG000|Overall Study|Physician Decision|0|||
44193983|NCT02170688|78989912|FG001|Overall Study|Physician Decision|0|||
44193984|NCT02170688|78989913|FG002|Overall Study|Physician Decision|1|||
44193985|NCT02170688|78989914|FG003|Overall Study|Physician Decision|0|||
44193986|NCT02170688|78989915|FG004|Overall Study|Physician Decision|0|||
44193987|NCT02170298|78989929|FG000|Overall Study|Withdrawal by Subject|0|||
44193988|NCT02170298|78989930|FG001|Overall Study|Withdrawal by Subject|1|||
44193989|NCT02170298|78989929|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
44193990|NCT02170298|78989930|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
44193991|NCT02131064|78989938|FG000|Overall Study|Death|5|||
44193992|NCT02131064|78989939|FG001|Overall Study|Death|6|||
44193993|NCT02131064|78989938|FG000|Overall Study|Lost to Follow-up|4|||
44193994|NCT02131064|78989939|FG001|Overall Study|Lost to Follow-up|8|||
44193995|NCT02131064|78989938|FG000|Overall Study|Withdrawal by Subject|14|||
44193996|NCT02131064|78989939|FG001|Overall Study|Withdrawal by Subject|18|||
44193997|NCT02131064|78989938|FG000|Overall Study|Other|2|||
44193998|NCT02131064|78989939|FG001|Overall Study|Other|2|||
44193999|NCT02130986|78989948|FG000|Overall Study|Withdrawal by Subject|4|||
44194000|NCT02130986|78989949|FG001|Overall Study|Withdrawal by Subject|4|||
44194001|NCT02130986|78989948|FG000|Overall Study|Lost to Follow-up|151|||
44194002|NCT02130986|78989949|FG001|Overall Study|Lost to Follow-up|160|||
44194003|NCT02130284|78989957|FG000|Overall Study|Withdrawal by Subject|3|||
44194004|NCT02130284|78989957|FG000|Overall Study|Subject Withdrew Consent|1|||
44194005|NCT02130284|78989957|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
44194006|NCT02130284|78989957|FG000|Overall Study|Subject was screened as backup for study|3|||
44194007|NCT02130284|78989957|FG000|Overall Study|Screen Failure|1|||
44194008|NCT02147288|78989963|FG000|Overall Study|post-operative hematoma|1|||
44194009|NCT02147288|78989964|FG001|Overall Study|post-operative hematoma|1|||
44194010|NCT02147288|78989965|FG002|Overall Study|post-operative hematoma|0|||
44194011|NCT02147288|78989966|FG003|Overall Study|post-operative hematoma|0|||
44194012|NCT02147288|78989967|FG004|Overall Study|post-operative hematoma|0|||
44194013|NCT02147288|78989968|FG005|Overall Study|post-operative hematoma|0|||
44194014|NCT02147288|78989969|FG006|Overall Study|post-operative hematoma|0|||
44194015|NCT02147288|78989970|FG007|Overall Study|post-operative hematoma|0|||
44194016|NCT02147288|78989971|FG008|Overall Study|post-operative hematoma|0|||
44194017|NCT02147288|78989972|FG009|Overall Study|post-operative hematoma|0|||
44194018|NCT02147288|78989963|FG000|Overall Study|complications from concurrent hernia rep|0|||
44194019|NCT02147288|78989964|FG001|Overall Study|complications from concurrent hernia rep|1|||
44194020|NCT02147288|78989965|FG002|Overall Study|complications from concurrent hernia rep|0|||
44194021|NCT02147288|78989966|FG003|Overall Study|complications from concurrent hernia rep|0|||
44194022|NCT02147288|78989967|FG004|Overall Study|complications from concurrent hernia rep|0|||
44194023|NCT02147288|78989968|FG005|Overall Study|complications from concurrent hernia rep|0|||
44194024|NCT02147288|78989969|FG006|Overall Study|complications from concurrent hernia rep|0|||
44194025|NCT02147288|78989970|FG007|Overall Study|complications from concurrent hernia rep|0|||
44194026|NCT02147288|78989971|FG008|Overall Study|complications from concurrent hernia rep|0|||
44194027|NCT02147288|78989972|FG009|Overall Study|complications from concurrent hernia rep|0|||
44194028|NCT02147132|78989978|FG000|Overall Study|Lost to Follow-up|1|||
44194029|NCT02147132|78989979|FG001|Overall Study|Lost to Follow-up|0|||
44194030|NCT02147132|78989980|FG002|Overall Study|Lost to Follow-up|0|||
44194031|NCT02147132|78989981|FG003|Overall Study|Lost to Follow-up|0|||
44194032|NCT02146430|78989995|FG000|Overall Study|Protocol Violation|5|||
44194033|NCT02146430|78989996|FG001|Overall Study|Protocol Violation|4|||
44194034|NCT02146430|78989997|FG002|Overall Study|Protocol Violation|8|||
44194035|NCT02146430|78989998|FG003|Overall Study|Protocol Violation|6|||
44194036|NCT02146430|78989995|FG000|Overall Study|Lack of Efficacy|13|||
44194037|NCT02146430|78989996|FG001|Overall Study|Lack of Efficacy|11|||
44194038|NCT02146430|78989997|FG002|Overall Study|Lack of Efficacy|8|||
44194039|NCT02146430|78989998|FG003|Overall Study|Lack of Efficacy|5|||
44194040|NCT02146430|78989995|FG000|Overall Study|Adverse Event|20|||
44194041|NCT02146430|78989996|FG001|Overall Study|Adverse Event|40|||
44194042|NCT02146430|78989997|FG002|Overall Study|Adverse Event|32|||
44194043|NCT02146430|78989998|FG003|Overall Study|Adverse Event|49|||
44194044|NCT02146430|78989995|FG000|Overall Study|Reason missing or not reported|2|||
44194045|NCT02146430|78989996|FG001|Overall Study|Reason missing or not reported|3|||
44194046|NCT02146430|78989997|FG002|Overall Study|Reason missing or not reported|4|||
44194047|NCT02146430|78989998|FG003|Overall Study|Reason missing or not reported|5|||
44194048|NCT02146430|78989995|FG000|Overall Study|Withdrawal by Subject|27|||
44194049|NCT02146430|78989996|FG001|Overall Study|Withdrawal by Subject|29|||
44194050|NCT02146430|78989997|FG002|Overall Study|Withdrawal by Subject|30|||
44194051|NCT02146430|78989998|FG003|Overall Study|Withdrawal by Subject|34|||
44194052|NCT02129192|78990014|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
44194053|NCT02129192|78990015|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
44194054|NCT02105948|78990028|FG000|Overall Study|Adverse Event|10|||
44194055|NCT02105948|78990029|FG001|Overall Study|Adverse Event|7|||
44194056|NCT02105948|78990030|FG002|Overall Study|Adverse Event|11|||
44194057|NCT02105948|78990031|FG003|Overall Study|Adverse Event|11|||
44194058|NCT02105948|78990028|FG000|Overall Study|Lack of Efficacy|0|||
44194059|NCT02105948|78990029|FG001|Overall Study|Lack of Efficacy|1|||
44194060|NCT02105948|78990030|FG002|Overall Study|Lack of Efficacy|3|||
44194061|NCT02105948|78990031|FG003|Overall Study|Lack of Efficacy|2|||
44194062|NCT02105948|78990028|FG000|Overall Study|Lost to Follow-up|0|||
44194063|NCT02105948|78990029|FG001|Overall Study|Lost to Follow-up|0|||
44194064|NCT02105948|78990030|FG002|Overall Study|Lost to Follow-up|2|||
44194065|NCT02105948|78990031|FG003|Overall Study|Lost to Follow-up|1|||
44194066|NCT02105948|78990028|FG000|Overall Study|Physician Decision|2|||
44194067|NCT02105948|78990029|FG001|Overall Study|Physician Decision|2|||
44194068|NCT02105948|78990030|FG002|Overall Study|Physician Decision|2|||
44194069|NCT02105948|78990031|FG003|Overall Study|Physician Decision|2|||
44194070|NCT02105948|78990028|FG000|Overall Study|Withdrawal by Subject|15|||
44194071|NCT02105948|78990029|FG001|Overall Study|Withdrawal by Subject|10|||
44194072|NCT02105948|78990030|FG002|Overall Study|Withdrawal by Subject|10|||
44194073|NCT02105948|78990031|FG003|Overall Study|Withdrawal by Subject|11|||
44194074|NCT02128724|78990046|FG000|Overall Study|Death|1|||
44194075|NCT02128724|78990047|FG001|Overall Study|Death|0|||
44194076|NCT02128724|78990048|FG002|Overall Study|Death|0|||
44194077|NCT02128724|78990049|FG003|Overall Study|Death|0|||
44194078|NCT02128724|78990046|FG000|Overall Study|Adverse Event|0|||
44194079|NCT02128724|78990047|FG001|Overall Study|Adverse Event|1|||
44194080|NCT02128724|78990048|FG002|Overall Study|Adverse Event|0|||
44194081|NCT02128724|78990049|FG003|Overall Study|Adverse Event|0|||
44194082|NCT02128724|78990046|FG000|Overall Study|Physician Decision|0|||
44194083|NCT02128724|78990047|FG001|Overall Study|Physician Decision|0|||
44194084|NCT02128724|78990048|FG002|Overall Study|Physician Decision|0|||
44194085|NCT02128724|78990049|FG003|Overall Study|Physician Decision|2|||
44194086|NCT02128724|78990046|FG000|Overall Study|Withdrawal by Subject|0|||
44194087|NCT02128724|78990047|FG001|Overall Study|Withdrawal by Subject|0|||
44194088|NCT02128724|78990048|FG002|Overall Study|Withdrawal by Subject|0|||
44194089|NCT02128724|78990049|FG003|Overall Study|Withdrawal by Subject|1|||
44194090|NCT02128490|78990063|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
44194091|NCT02128490|78990064|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
44194092|NCT02128490|78990065|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
44194093|NCT02128490|78990066|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
44194094|NCT02128490|78990067|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
44194095|NCT02128490|78990063|FG000|Overall Study|Major Protocol Deviation|1|||
44194096|NCT02128490|78990064|FG001|Overall Study|Major Protocol Deviation|2|||
44194097|NCT02128490|78990065|FG002|Overall Study|Major Protocol Deviation|0|||
44194098|NCT02128490|78990066|FG003|Overall Study|Major Protocol Deviation|2|||
44194099|NCT02128490|78990067|FG004|Overall Study|Major Protocol Deviation|2|||
44194100|NCT02128490|78990063|FG000|Overall Study|Lost to Follow-up|0|||
44194101|NCT02128490|78990064|FG001|Overall Study|Lost to Follow-up|0|||
44194102|NCT02128490|78990065|FG002|Overall Study|Lost to Follow-up|1|||
44194103|NCT02128490|78990066|FG003|Overall Study|Lost to Follow-up|1|||
44194104|NCT02128490|78990067|FG004|Overall Study|Lost to Follow-up|1|||
44194105|NCT02128490|78990063|FG000|Overall Study|Voluntary Withdrawal|3|||
44194106|NCT02128490|78990064|FG001|Overall Study|Voluntary Withdrawal|3|||
44194107|NCT02128490|78990065|FG002|Overall Study|Voluntary Withdrawal|1|||
44194108|NCT02128490|78990066|FG003|Overall Study|Voluntary Withdrawal|1|||
44194109|NCT02128490|78990067|FG004|Overall Study|Voluntary Withdrawal|2|||
44194110|NCT02128490|78990063|FG000|Overall Study|Lack of Efficacy|0|||
44194111|NCT02128490|78990064|FG001|Overall Study|Lack of Efficacy|1|||
44194112|NCT02128490|78990065|FG002|Overall Study|Lack of Efficacy|0|||
44194113|NCT02128490|78990066|FG003|Overall Study|Lack of Efficacy|0|||
44194114|NCT02128490|78990067|FG004|Overall Study|Lack of Efficacy|0|||
44194115|NCT02128490|78990063|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
44194116|NCT02128490|78990064|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
44194117|NCT02128490|78990065|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
44194118|NCT02128490|78990066|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
44194119|NCT02128490|78990067|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
44194120|NCT02128490|78990063|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44194121|NCT02128490|78990064|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44194122|NCT02128490|78990065|FG002|Overall Study|Other Miscellaneous Reasons|2|||
44194123|NCT02128490|78990066|FG003|Overall Study|Other Miscellaneous Reasons|1|||
44194124|NCT02128490|78990067|FG004|Overall Study|Other Miscellaneous Reasons|1|||
44194125|NCT02146352|78990079|FG000|Overall Study|Death|1|||
44194126|NCT02146352|78990079|FG000|Overall Study|Patient entered hospice care|1|||
44194127|NCT02146274|78990083|FG000|Overall Study|Protocol Violation|73|||
44194128|NCT02105636|78990092|FG000|Pre-Treatment|Disease Progression|1|||
44194129|NCT02105636|78990093|FG001|Pre-Treatment|Disease Progression|0|||
44194130|NCT02105636|78990092|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
44194131|NCT02105636|78990093|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
44194132|NCT02105636|78990092|FG000|Pre-Treatment|Participant withdrew consent|0|||
44194133|NCT02105636|78990093|FG001|Pre-Treatment|Participant withdrew consent|6|||
44194134|NCT02105636|78990092|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
44194135|NCT02105636|78990093|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
44194136|NCT02105636|78990092|FG000|Treatment|Study Drug Toxicity|14|||
44194137|NCT02105636|78990093|FG001|Treatment|Study Drug Toxicity|10|||
44194138|NCT02105636|78990092|FG000|Treatment|Adverse event unrelated to study drug|19|||
44194139|NCT02105636|78990093|FG001|Treatment|Adverse event unrelated to study drug|3|||
44194140|NCT02105636|78990092|FG000|Treatment|Participant request to discontinue study treatment|8|||
44194141|NCT02105636|78990093|FG001|Treatment|Participant request to discontinue study treatment|6|||
44194142|NCT02105636|78990092|FG000|Treatment|Participant withdrew consent|5|||
44194143|NCT02105636|78990093|FG001|Treatment|Participant withdrew consent|1|||
44194144|NCT02105636|78990092|FG000|Treatment|Lost to Follow-up|1|||
44194145|NCT02105636|78990093|FG001|Treatment|Lost to Follow-up|0|||
44194146|NCT02105636|78990092|FG000|Treatment|Maximum Clinical Benefit|1|||
44194147|NCT02105636|78990093|FG001|Treatment|Maximum Clinical Benefit|3|||
44194148|NCT02105636|78990092|FG000|Treatment|Poor/Non-compliance|0|||
44194149|NCT02105636|78990093|FG001|Treatment|Poor/Non-compliance|1|||
44194150|NCT02105636|78990092|FG000|Treatment|Participant no longer meets study criteria|1|||
44194151|NCT02105636|78990093|FG001|Treatment|Participant no longer meets study criteria|0|||
44194152|NCT02105636|78990092|FG000|Treatment|Other reasons|1|||
44194153|NCT02105636|78990093|FG001|Treatment|Other reasons|0|||
44194154|NCT02105636|78990092|FG000|Treatment|Disease Progression|185|||
44194155|NCT02105636|78990093|FG001|Treatment|Disease Progression|87|||
44194156|NCT01626872|78990102|FG000|Overall Study|Physician Decision|13|||
44194157|NCT01626872|78990103|FG001|Overall Study|Physician Decision|9|||
44194158|NCT01626872|78990104|FG002|Overall Study|Physician Decision|6|||
44194159|NCT01626872|78990102|FG000|Overall Study|Withdrawal by Subject|19|||
44194160|NCT01626872|78990103|FG001|Overall Study|Withdrawal by Subject|27|||
44194161|NCT01626872|78990104|FG002|Overall Study|Withdrawal by Subject|8|||
44194162|NCT01626872|78990102|FG000|Overall Study|Adverse Event (including Death)|20|||
44194163|NCT01626872|78990103|FG001|Overall Study|Adverse Event (including Death)|28|||
44194164|NCT01626872|78990104|FG002|Overall Study|Adverse Event (including Death)|8|||
44194165|NCT01626872|78990102|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
44194166|NCT01626872|78990103|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
44194167|NCT01626872|78990104|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
44194168|NCT01598090|78990115|FG000|Treatment Period|Poor/non-compliance|0|||
44194169|NCT01598090|78990116|FG001|Treatment Period|Poor/non-compliance|2|||
44194170|NCT01598090|78990117|FG002|Treatment Period|Poor/non-compliance|0|||
44194171|NCT01598090|78990115|FG000|Treatment Period|No longer meet study criteria|0|||
44194172|NCT01598090|78990116|FG001|Treatment Period|No longer meet study criteria|1|||
44194173|NCT01598090|78990117|FG002|Treatment Period|No longer meet study criteria|0|||
44194174|NCT01598090|78990115|FG000|Treatment Period|Lack of Efficacy|5|||
44194175|NCT01598090|78990116|FG001|Treatment Period|Lack of Efficacy|14|||
44194176|NCT01598090|78990117|FG002|Treatment Period|Lack of Efficacy|6|||
44194177|NCT01598090|78990115|FG000|Treatment Period|Adverse Event|2|||
44194178|NCT01598090|78990116|FG001|Treatment Period|Adverse Event|33|||
44194179|NCT01598090|78990117|FG002|Treatment Period|Adverse Event|17|||
44194180|NCT01598090|78990115|FG000|Treatment Period|Other reasons|0|||
44194181|NCT01598090|78990116|FG001|Treatment Period|Other reasons|4|||
44194182|NCT01598090|78990117|FG002|Treatment Period|Other reasons|1|||
44194183|NCT01598090|78990115|FG000|Treatment Period|Withdrawal by Subject|3|||
44194184|NCT01598090|78990116|FG001|Treatment Period|Withdrawal by Subject|13|||
44194185|NCT01598090|78990117|FG002|Treatment Period|Withdrawal by Subject|10|||
44194186|NCT01598090|78990115|FG000|Treatment Period|Lost to Follow-up|1|||
44194187|NCT01598090|78990116|FG001|Treatment Period|Lost to Follow-up|5|||
44194188|NCT01598090|78990117|FG002|Treatment Period|Lost to Follow-up|1|||
44194189|NCT01598090|78990115|FG000|Follow-up Period|Death|0|||
44194190|NCT01598090|78990116|FG001|Follow-up Period|Death|1|||
44194191|NCT01598090|78990117|FG002|Follow-up Period|Death|0|||
44194192|NCT01598090|78990115|FG000|Follow-up Period|No longer required per protocol|1|||
44194193|NCT01598090|78990116|FG001|Follow-up Period|No longer required per protocol|3|||
44194194|NCT01598090|78990117|FG002|Follow-up Period|No longer required per protocol|2|||
44194195|NCT01598090|78990115|FG000|Follow-up Period|Not reported|0|||
44194196|NCT01598090|78990116|FG001|Follow-up Period|Not reported|10|||
44194197|NCT01598090|78990117|FG002|Follow-up Period|Not reported|4|||
44194198|NCT01598090|78990115|FG000|Follow-up Period|Withdrawal by Subject|0|||
44194199|NCT01598090|78990116|FG001|Follow-up Period|Withdrawal by Subject|3|||
44194200|NCT01598090|78990117|FG002|Follow-up Period|Withdrawal by Subject|2|||
44194201|NCT01598090|78990115|FG000|Follow-up Period|Other reasons|2|||
44194202|NCT01598090|78990116|FG001|Follow-up Period|Other reasons|8|||
44194203|NCT01598090|78990117|FG002|Follow-up Period|Other reasons|8|||
44194204|NCT01598090|78990115|FG000|Follow-up Period|Lost to Follow-up|2|||
44194205|NCT01598090|78990116|FG001|Follow-up Period|Lost to Follow-up|10|||
44194206|NCT01598090|78990117|FG002|Follow-up Period|Lost to Follow-up|12|||
44194207|NCT02105012|78990128|FG000|Overall Study|Withdrawal by Subject|11|||
44194208|NCT02105012|78990128|FG000|Overall Study|Protocol Specified Criteria|9|||
44194209|NCT02105012|78990128|FG000|Overall Study|Lost to Follow-up|4|||
44194210|NCT02105012|78990128|FG000|Overall Study|Protocol Violation|4|||
44194211|NCT02105012|78990128|FG000|Overall Study|Physician Decision|3|||
44194212|NCT02105012|78990128|FG000|Overall Study|Adverse Event|1|||
44194213|NCT02105012|78990128|FG000|Overall Study|Lack of Efficacy|1|||
44194214|NCT02145182|78990142|FG000|Overall Study|Adverse Event|4|||
44194215|NCT02145182|78990143|FG001|Overall Study|Adverse Event|1|||
44194216|NCT02145182|78990142|FG000|Overall Study|Death|7|||
44194217|NCT02145182|78990143|FG001|Overall Study|Death|7|||
44194218|NCT02145182|78990142|FG000|Overall Study|Lost to Follow-up|2|||
44194219|NCT02145182|78990143|FG001|Overall Study|Lost to Follow-up|2|||
44194220|NCT02145182|78990142|FG000|Overall Study|Pre-transplant Withdrawal|0|||
44194221|NCT02145182|78990143|FG001|Overall Study|Pre-transplant Withdrawal|2|||
44194222|NCT02145182|78990142|FG000|Overall Study|Withdrawal by Subject|5|||
44194223|NCT02145182|78990143|FG001|Overall Study|Withdrawal by Subject|4|||
44194224|NCT02145026|78990149|FG000|Overall Study|Adverse Event|2|||
44194225|NCT02145026|78990149|FG000|Overall Study|Death|4|||
44194226|NCT02145026|78990149|FG000|Overall Study|Withdrawal by Subject|2|||
44194227|NCT02145026|78990149|FG000|Overall Study|Physician Decision|4|||
44194228|NCT02144012|78990155|FG000|Overall Study|Adverse Event|1|||
44194229|NCT02144012|78990156|FG001|Overall Study|Adverse Event|0|||
44194230|NCT02144012|78990155|FG000|Overall Study|Death|1|||
44194231|NCT02144012|78990156|FG001|Overall Study|Death|0|||
44194232|NCT02144012|78990155|FG000|Overall Study|Withdrawal by Subject|11|||
44194233|NCT02144012|78990156|FG001|Overall Study|Withdrawal by Subject|3|||
44194234|NCT02144012|78990155|FG000|Overall Study|Study Terminated by Sponsor|18|||
44194235|NCT02144012|78990156|FG001|Overall Study|Study Terminated by Sponsor|12|||
44194236|NCT02144012|78990155|FG000|Overall Study|Other|3|||
44194237|NCT02144012|78990156|FG001|Overall Study|Other|0|||
44194238|NCT02103062|78990164|FG000|Overall Study|Adverse Event|1|||
44194239|NCT02103062|78990165|FG001|Overall Study|Adverse Event|2|||
44194240|NCT02103062|78990164|FG000|Overall Study|Progressive Disease|17|||
44194241|NCT02103062|78990165|FG001|Overall Study|Progressive Disease|20|||
44194242|NCT02103062|78990164|FG000|Overall Study|Death|0|||
44194243|NCT02103062|78990165|FG001|Overall Study|Death|1|||
44194244|NCT02141984|78990173|FG000|Overall Study|Lack of Efficacy|2|||
44194245|NCT02141672|78990180|FG000|Overall Study|Adverse Event|0|||
44194246|NCT02141672|78990181|FG001|Overall Study|Adverse Event|1|||
44266274|NCT02434770|79173952|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
44266275|NCT02434770|79173953|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
44266276|NCT02434770|79173954|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
44266277|NCT02434770|79173952|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
44266278|NCT02434770|79173953|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
44266279|NCT02434770|79173954|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
44266280|NCT02434770|79173952|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
44266281|NCT02434770|79173953|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
44266282|NCT02434770|79173954|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
44266283|NCT02434770|79173952|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
44266284|NCT02434770|79173953|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
44266285|NCT02434770|79173954|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
44194247|NCT02141672|78990182|FG002|Overall Study|Adverse Event|0|||
44194248|NCT02141672|78990180|FG000|Overall Study|Death|10|||
44194249|NCT02141672|78990181|FG001|Overall Study|Death|2|||
44194250|NCT02141672|78990182|FG002|Overall Study|Death|1|||
44194251|NCT02141672|78990180|FG000|Overall Study|Lack of Efficacy|0|||
44194252|NCT02141672|78990181|FG001|Overall Study|Lack of Efficacy|0|||
44194253|NCT02141672|78990182|FG002|Overall Study|Lack of Efficacy|2|||
44194254|NCT02141672|78990180|FG000|Overall Study|Lost to Follow-up|1|||
44194255|NCT02141672|78990181|FG001|Overall Study|Lost to Follow-up|1|||
44194256|NCT02141672|78990182|FG002|Overall Study|Lost to Follow-up|3|||
44194257|NCT02141672|78990180|FG000|Overall Study|Physician Decision|1|||
44194258|NCT02141672|78990181|FG001|Overall Study|Physician Decision|2|||
44266286|NCT02434770|79173952|FG000|Week 1 to Week 18|Death|1|||
44266287|NCT02434770|79173953|FG001|Week 1 to Week 18|Death|0|||
44266288|NCT02434770|79173954|FG002|Week 1 to Week 18|Death|0|||
44266289|NCT02434770|79173952|FG000|Week 18 to Week|Lost to Follow-up|2|||
44266290|NCT02434770|79173953|FG001|Week 18 to Week|Lost to Follow-up|2|||
44266291|NCT02434770|79173954|FG002|Week 18 to Week|Lost to Follow-up|1|||
44266292|NCT02434770|79173952|FG000|Week 18 to Week|Withdrawal by Subject|0|||
44266293|NCT02434770|79173953|FG001|Week 18 to Week|Withdrawal by Subject|0|||
44266294|NCT02434770|79173954|FG002|Week 18 to Week|Withdrawal by Subject|2|||
44266295|NCT02434770|79173952|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
44361283|NCT01157117|79366947|FG000|Overall Study|Lack of Efficacy|1|||
44194259|NCT02141672|78990182|FG002|Overall Study|Physician Decision|5|||
44194260|NCT02141672|78990180|FG000|Overall Study|Protocol Violation|0|||
44194261|NCT02141672|78990181|FG001|Overall Study|Protocol Violation|0|||
44194262|NCT02141672|78990182|FG002|Overall Study|Protocol Violation|1|||
44194263|NCT02141672|78990180|FG000|Overall Study|Withdrawal by Subject|3|||
44194264|NCT02141672|78990181|FG001|Overall Study|Withdrawal by Subject|2|||
44194265|NCT02141672|78990182|FG002|Overall Study|Withdrawal by Subject|5|||
44194266|NCT02141672|78990180|FG000|Overall Study|refused to follow-up|1|||
44194267|NCT02141672|78990181|FG001|Overall Study|refused to follow-up|0|||
44194268|NCT02141672|78990182|FG002|Overall Study|refused to follow-up|1|||
44194269|NCT02141516|78990193|FG000|Overall Study|Adverse Event|0|||
44194270|NCT02141516|78990194|FG001|Overall Study|Adverse Event|1|||
44194271|NCT02141516|78990195|FG002|Overall Study|Adverse Event|0|||
44194272|NCT02141516|78990193|FG000|Overall Study|Lost to Follow-up|0|||
44194273|NCT02141516|78990194|FG001|Overall Study|Lost to Follow-up|1|||
44194274|NCT02141516|78990195|FG002|Overall Study|Lost to Follow-up|0|||
44194275|NCT02141516|78990193|FG000|Overall Study|Other|0|||
44194276|NCT02141516|78990194|FG001|Overall Study|Other|3|||
44194277|NCT02141516|78990195|FG002|Overall Study|Other|0|||
44194278|NCT02141360|78990209|FG000|Overall Study|Withdrawal by Subject|6|||
44194279|NCT02141360|78990210|FG001|Overall Study|Withdrawal by Subject|0|||
44194280|NCT02141360|78990211|FG002|Overall Study|Withdrawal by Subject|0|||
44194281|NCT02141360|78990209|FG000|Overall Study|Study Terminated before Visit|1|||
44194282|NCT02141360|78990210|FG001|Overall Study|Study Terminated before Visit|0|||
44194283|NCT02141360|78990211|FG002|Overall Study|Study Terminated before Visit|0|||
44194284|NCT01628198|78990219|FG000|Overall Study|Lost to Follow-up|7|||
44194285|NCT01628198|78990219|FG000|Overall Study|Withdrawal by Subject|10|||
44194286|NCT01628198|78990219|FG000|Overall Study|Screen failure|1|||
44194287|NCT01628120|78990223|FG000|Overall Study|Withdrawal by Subject|7|||
44194288|NCT01628120|78990223|FG000|Overall Study|Adverse Event|12|||
44194289|NCT01628120|78990223|FG000|Overall Study|Lost to Follow-up|1|||
44194290|NCT01628120|78990223|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
44194291|NCT01628120|78990223|FG000|Overall Study|Non-compliant with Study Procedures|1|||
44194292|NCT01628120|78990223|FG000|Overall Study|Not Treated|3|||
44194293|NCT01628120|78990223|FG000|Overall Study|Sponsor Decision|5|||
44194294|NCT01628120|78990223|FG000|Overall Study|Switched Dialysis Method|2|||
44194295|NCT01628120|78990223|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
44194296|NCT01628120|78990223|FG000|Overall Study|Moved or Relocated|5|||
44361284|NCT01157117|79366948|FG001|Overall Study|Lack of Efficacy|1|||
44194297|NCT01628120|78990223|FG000|Overall Study|Kidney Transplant|2|||
44194298|NCT01628120|78990223|FG000|Overall Study|Use of Standard of Care|1|||
44266296|NCT02434770|79173953|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
44266297|NCT02434770|79173954|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
44361285|NCT01157117|79366949|FG002|Overall Study|Lack of Efficacy|0|||
44194299|NCT01627340|78990229|FG000|Overall Study|Adverse Event|1|||
44194300|NCT01627340|78990230|FG001|Overall Study|Adverse Event|0|||
44194301|NCT01627340|78990229|FG000|Overall Study|Lost to Follow-up|8|||
44194302|NCT01627340|78990230|FG001|Overall Study|Lost to Follow-up|4|||
44194303|NCT01627340|78990229|FG000|Overall Study|Pregnancy|1|||
44194304|NCT01627340|78990230|FG001|Overall Study|Pregnancy|0|||
44194305|NCT01627340|78990229|FG000|Overall Study|Withdrawal by Subject|2|||
44194306|NCT01627340|78990230|FG001|Overall Study|Withdrawal by Subject|0|||
44194307|NCT02125838|78990240|FG000|Overall Study|Lost to Follow-up|4|||
44194308|NCT02125838|78990241|FG001|Overall Study|Lost to Follow-up|4|||
44194309|NCT02125604|78990247|FG000|Overall Study|Other|4|||
44194310|NCT02125604|78990247|FG000|Overall Study|Investigator Decision|1|||
44194311|NCT02125604|78990247|FG000|Overall Study|Lost to Follow-up|2|||
44194312|NCT02125604|78990247|FG000|Overall Study|Consent Withdrawn|4|||
44194313|NCT02125604|78990247|FG000|Overall Study|Adverse Event|20|||
44194314|NCT02124746|78990254|FG000|Overall Study|Adverse Event|2|||
44194315|NCT02124746|78990255|FG001|Overall Study|Adverse Event|1|||
44194316|NCT02124746|78990256|FG002|Overall Study|Adverse Event|2|||
44194317|NCT02124746|78990254|FG000|Overall Study|Death|2|||
44194318|NCT02124746|78990255|FG001|Overall Study|Death|1|||
44194319|NCT02124746|78990256|FG002|Overall Study|Death|3|||
44194320|NCT02124746|78990254|FG000|Overall Study|Lack of Efficacy|3|||
44194321|NCT02124746|78990255|FG001|Overall Study|Lack of Efficacy|2|||
44194322|NCT02124746|78990256|FG002|Overall Study|Lack of Efficacy|2|||
44194323|NCT02124746|78990254|FG000|Overall Study|Physician Decision|6|||
44194324|NCT02124746|78990255|FG001|Overall Study|Physician Decision|4|||
44194325|NCT02124746|78990256|FG002|Overall Study|Physician Decision|5|||
44194326|NCT02124746|78990254|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44194327|NCT02124746|78990255|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44194328|NCT02124746|78990256|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44194329|NCT02124746|78990254|FG000|Overall Study|Withdrawal by Subject|3|||
44194330|NCT02124746|78990255|FG001|Overall Study|Withdrawal by Subject|3|||
44194331|NCT02124746|78990256|FG002|Overall Study|Withdrawal by Subject|0|||
44194332|NCT02124746|78990254|FG000|Overall Study|Study Terminated by Sponsor|0|||
44194333|NCT02124746|78990255|FG001|Overall Study|Study Terminated by Sponsor|0|||
44194334|NCT02124746|78990256|FG002|Overall Study|Study Terminated by Sponsor|6|||
44194335|NCT02124746|78990254|FG000|Overall Study|Disease Progression|3|||
44194336|NCT02124746|78990255|FG001|Overall Study|Disease Progression|6|||
44194337|NCT02124746|78990256|FG002|Overall Study|Disease Progression|4|||
44194338|NCT02123966|78990264|FG000|Overall Study|Intercurrent Illness|1|||
44194339|NCT02123576|78990270|FG000|Overall Study|Adverse Event|1|||
44194340|NCT02123576|78990271|FG001|Overall Study|Adverse Event|0|||
44194341|NCT01177397|78990289|FG000|Overall Study|Protocol Violation|0|||
44194342|NCT01177397|78990290|FG001|Overall Study|Protocol Violation|0|||
44194343|NCT01177397|78990291|FG002|Overall Study|Protocol Violation|0|||
44194344|NCT01177397|78990292|FG003|Overall Study|Protocol Violation|0|||
44194345|NCT01177397|78990293|FG004|Overall Study|Protocol Violation|0|||
44194346|NCT01177397|78990294|FG005|Overall Study|Protocol Violation|1|||
44194347|NCT01177397|78990295|FG006|Overall Study|Protocol Violation|0|||
44194348|NCT01177397|78990296|FG007|Overall Study|Protocol Violation|0|||
44194349|NCT01177397|78990297|FG008|Overall Study|Protocol Violation|0|||
44194350|NCT01177397|78990298|FG009|Overall Study|Protocol Violation|0|||
44194351|NCT01177397|78990299|FG010|Overall Study|Protocol Violation|0|||
44194352|NCT01177397|78990300|FG011|Overall Study|Protocol Violation|0|||
44194353|NCT01177397|78990289|FG000|Overall Study|Lost to Follow-up|0|||
44194354|NCT01177397|78990290|FG001|Overall Study|Lost to Follow-up|0|||
44194355|NCT01177397|78990291|FG002|Overall Study|Lost to Follow-up|0|||
44194356|NCT01177397|78990292|FG003|Overall Study|Lost to Follow-up|0|||
44194357|NCT01177397|78990293|FG004|Overall Study|Lost to Follow-up|1|||
44194358|NCT01177397|78990294|FG005|Overall Study|Lost to Follow-up|0|||
44194359|NCT01177397|78990295|FG006|Overall Study|Lost to Follow-up|0|||
44194360|NCT01177397|78990296|FG007|Overall Study|Lost to Follow-up|2|||
44194361|NCT01177397|78990297|FG008|Overall Study|Lost to Follow-up|0|||
44194362|NCT01177397|78990298|FG009|Overall Study|Lost to Follow-up|0|||
44194363|NCT01177397|78990299|FG010|Overall Study|Lost to Follow-up|0|||
44194364|NCT01177397|78990300|FG011|Overall Study|Lost to Follow-up|0|||
44194365|NCT01177397|78990289|FG000|Overall Study|Death|0|||
44194366|NCT01177397|78990290|FG001|Overall Study|Death|0|||
44194367|NCT01177397|78990291|FG002|Overall Study|Death|1|||
44194368|NCT01177397|78990292|FG003|Overall Study|Death|1|||
44194369|NCT01177397|78990293|FG004|Overall Study|Death|0|||
44194370|NCT01177397|78990294|FG005|Overall Study|Death|0|||
44194371|NCT01177397|78990295|FG006|Overall Study|Death|0|||
44194372|NCT01177397|78990296|FG007|Overall Study|Death|5|||
44194373|NCT01177397|78990297|FG008|Overall Study|Death|2|||
44194374|NCT01177397|78990298|FG009|Overall Study|Death|1|||
44194375|NCT01177397|78990299|FG010|Overall Study|Death|0|||
44194376|NCT01177397|78990300|FG011|Overall Study|Death|0|||
44194377|NCT01177397|78990289|FG000|Overall Study|Withdrawal by Subject|0|||
44194378|NCT01177397|78990290|FG001|Overall Study|Withdrawal by Subject|0|||
44194379|NCT01177397|78990291|FG002|Overall Study|Withdrawal by Subject|1|||
44194380|NCT01177397|78990292|FG003|Overall Study|Withdrawal by Subject|1|||
44194381|NCT01177397|78990293|FG004|Overall Study|Withdrawal by Subject|1|||
44194382|NCT01177397|78990294|FG005|Overall Study|Withdrawal by Subject|2|||
44194383|NCT01177397|78990295|FG006|Overall Study|Withdrawal by Subject|0|||
44194384|NCT01177397|78990296|FG007|Overall Study|Withdrawal by Subject|5|||
44194385|NCT01177397|78990297|FG008|Overall Study|Withdrawal by Subject|9|||
44194386|NCT01177397|78990298|FG009|Overall Study|Withdrawal by Subject|1|||
44194387|NCT01177397|78990299|FG010|Overall Study|Withdrawal by Subject|1|||
44194388|NCT01177397|78990300|FG011|Overall Study|Withdrawal by Subject|0|||
44194389|NCT01177397|78990289|FG000|Overall Study|Adverse Event|0|||
44194390|NCT01177397|78990290|FG001|Overall Study|Adverse Event|0|||
44194391|NCT01177397|78990291|FG002|Overall Study|Adverse Event|1|||
44194392|NCT01177397|78990292|FG003|Overall Study|Adverse Event|2|||
44194393|NCT01177397|78990293|FG004|Overall Study|Adverse Event|0|||
44194394|NCT01177397|78990294|FG005|Overall Study|Adverse Event|12|||
44194395|NCT01177397|78990295|FG006|Overall Study|Adverse Event|1|||
44194396|NCT01177397|78990296|FG007|Overall Study|Adverse Event|14|||
44194397|NCT01177397|78990297|FG008|Overall Study|Adverse Event|8|||
44194398|NCT01177397|78990298|FG009|Overall Study|Adverse Event|6|||
44194399|NCT01177397|78990299|FG010|Overall Study|Adverse Event|3|||
44194400|NCT01177397|78990300|FG011|Overall Study|Adverse Event|7|||
44194401|NCT01177397|78990289|FG000|Overall Study|Disease progression|1|||
44194402|NCT01177397|78990290|FG001|Overall Study|Disease progression|2|||
44194403|NCT01177397|78990291|FG002|Overall Study|Disease progression|5|||
44194404|NCT01177397|78990292|FG003|Overall Study|Disease progression|5|||
44194405|NCT01177397|78990293|FG004|Overall Study|Disease progression|4|||
44194406|NCT01177397|78990294|FG005|Overall Study|Disease progression|10|||
44194407|NCT01177397|78990295|FG006|Overall Study|Disease progression|10|||
44194408|NCT01177397|78990296|FG007|Overall Study|Disease progression|21|||
44194409|NCT01177397|78990297|FG008|Overall Study|Disease progression|18|||
44194410|NCT01177397|78990298|FG009|Overall Study|Disease progression|12|||
44194411|NCT01177397|78990299|FG010|Overall Study|Disease progression|10|||
44194412|NCT01177397|78990300|FG011|Overall Study|Disease progression|8|||
44194413|NCT01177397|78990289|FG000|Overall Study|Other reasons|0|||
44194414|NCT01177397|78990290|FG001|Overall Study|Other reasons|0|||
44194415|NCT01177397|78990291|FG002|Overall Study|Other reasons|1|||
44194416|NCT01177397|78990292|FG003|Overall Study|Other reasons|0|||
44194417|NCT01177397|78990293|FG004|Overall Study|Other reasons|1|||
44194418|NCT01177397|78990294|FG005|Overall Study|Other reasons|1|||
44194419|NCT01177397|78990295|FG006|Overall Study|Other reasons|2|||
44194420|NCT01177397|78990296|FG007|Overall Study|Other reasons|6|||
44194421|NCT01177397|78990297|FG008|Overall Study|Other reasons|10|||
44194422|NCT01177397|78990298|FG009|Overall Study|Other reasons|8|||
44194423|NCT01177397|78990299|FG010|Overall Study|Other reasons|0|||
44194424|NCT01177397|78990300|FG011|Overall Study|Other reasons|2|||
44194425|NCT00864227|78990341|FG000|Overall Study|Withdrawal by Subject|1|||
44194426|NCT00864227|78990341|FG000|Overall Study|Disease Relapse/Progression|3|||
44194427|NCT02102204|78990345|FG000|Overall Study|Withdrawal by Subject|137|||
44194428|NCT02102204|78990345|FG000|Overall Study|Death|92|||
44194429|NCT02102204|78990345|FG000|Overall Study|Lost to Follow-up|65|||
44194430|NCT02102204|78990345|FG000|Overall Study|Sponsor Decision|5|||
44194431|NCT02102204|78990345|FG000|Overall Study|Ongoing|5|||
44194432|NCT02141204|78990351|FG000|Overall Study|Lost to Follow-up|2|||
44194433|NCT02141204|78990352|FG001|Overall Study|Lost to Follow-up|1|||
44194434|NCT02141204|78990351|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
44194435|NCT02141204|78990352|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
44194436|NCT02141204|78990351|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
44194437|NCT02141204|78990352|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
44194438|NCT02141204|78990351|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
44194439|NCT02141204|78990352|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
44194440|NCT02140970|78990360|FG000|Overall Study|Lost to Follow-up|1|||
44194441|NCT02140970|78990361|FG001|Overall Study|Lost to Follow-up|2|||
44194442|NCT02140970|78990360|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
44194443|NCT02140970|78990361|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
44194444|NCT02140970|78990360|FG000|Overall Study|Did not meet inclusion criteria|0|||
44194445|NCT02140970|78990361|FG001|Overall Study|Did not meet inclusion criteria|1|||
44194446|NCT02101112|78990367|FG000|Overall Study|Adverse Event|0|||
44266298|NCT02433834|79173985|FG000|Overall Study|Protocol-specified criteria|7|||
44194447|NCT02101112|78990368|FG001|Overall Study|Adverse Event|0|||
44194448|NCT02101112|78990369|FG002|Overall Study|Adverse Event|1|||
44194449|NCT02101112|78990370|FG003|Overall Study|Adverse Event|0|||
44194450|NCT02101112|78990371|FG004|Overall Study|Adverse Event|0|||
44194451|NCT02101112|78990372|FG005|Overall Study|Adverse Event|0|||
44194452|NCT02101112|78990367|FG000|Overall Study|Withdrawal by Subject|0|||
44194453|NCT02101112|78990368|FG001|Overall Study|Withdrawal by Subject|0|||
44194454|NCT02101112|78990369|FG002|Overall Study|Withdrawal by Subject|0|||
44194455|NCT02101112|78990370|FG003|Overall Study|Withdrawal by Subject|0|||
44194456|NCT02101112|78990371|FG004|Overall Study|Withdrawal by Subject|1|||
44194457|NCT02101112|78990372|FG005|Overall Study|Withdrawal by Subject|0|||
44266299|NCT02433834|79173985|FG000|Overall Study|Protocol Violation|3|||
44194458|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
44194459|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44194460|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44194461|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44194462|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44194463|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44194464|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
44194465|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44194466|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44194467|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44194468|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44194469|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44194470|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
44194471|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44194472|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44194473|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44194474|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44194475|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44194476|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
44194477|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44194478|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44194479|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44194480|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44194481|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44194482|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
44194483|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44194484|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44194485|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44194486|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44194487|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44194488|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
44194489|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
44194490|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
44194491|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
44194492|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
44194493|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
44194494|NCT02139644|78990387|FG000|Run-In Period (Pre-assignment)|Other|6|||
44194495|NCT02139644|78990388|FG001|Run-In Period (Pre-assignment)|Other|0|||
44194496|NCT02139644|78990389|FG002|Run-In Period (Pre-assignment)|Other|0|||
44194497|NCT02139644|78990390|FG003|Run-In Period (Pre-assignment)|Other|0|||
44194498|NCT02139644|78990391|FG004|Run-In Period (Pre-assignment)|Other|0|||
44194499|NCT02139644|78990392|FG005|Run-In Period (Pre-assignment)|Other|0|||
44194500|NCT02139644|78990387|FG000|Treatment Period|Adverse Event|0|||
44194501|NCT02139644|78990388|FG001|Treatment Period|Adverse Event|0|||
44194502|NCT02139644|78990389|FG002|Treatment Period|Adverse Event|3|||
44194503|NCT02139644|78990390|FG003|Treatment Period|Adverse Event|2|||
44194504|NCT02139644|78990391|FG004|Treatment Period|Adverse Event|1|||
44194505|NCT02139644|78990392|FG005|Treatment Period|Adverse Event|6|||
44194506|NCT02139644|78990387|FG000|Treatment Period|Withdrawal by Subject|0|||
44194507|NCT02139644|78990388|FG001|Treatment Period|Withdrawal by Subject|0|||
44194508|NCT02139644|78990389|FG002|Treatment Period|Withdrawal by Subject|2|||
44194509|NCT02139644|78990390|FG003|Treatment Period|Withdrawal by Subject|2|||
44194510|NCT02139644|78990391|FG004|Treatment Period|Withdrawal by Subject|3|||
44194511|NCT02139644|78990392|FG005|Treatment Period|Withdrawal by Subject|2|||
44194512|NCT02139644|78990387|FG000|Treatment Period|Non-compliance|0|||
44194513|NCT02139644|78990388|FG001|Treatment Period|Non-compliance|0|||
44194514|NCT02139644|78990389|FG002|Treatment Period|Non-compliance|0|||
44194515|NCT02139644|78990390|FG003|Treatment Period|Non-compliance|1|||
44194516|NCT02139644|78990391|FG004|Treatment Period|Non-compliance|0|||
44194517|NCT02139644|78990392|FG005|Treatment Period|Non-compliance|0|||
44194518|NCT02139644|78990387|FG000|Treatment Period|Protocol Violation|0|||
44194519|NCT02139644|78990388|FG001|Treatment Period|Protocol Violation|0|||
44194520|NCT02139644|78990389|FG002|Treatment Period|Protocol Violation|0|||
44194521|NCT02139644|78990390|FG003|Treatment Period|Protocol Violation|1|||
44194522|NCT02139644|78990391|FG004|Treatment Period|Protocol Violation|1|||
44194523|NCT02139644|78990392|FG005|Treatment Period|Protocol Violation|1|||
44266300|NCT02433834|79173985|FG000|Overall Study|Lost to Follow-up|6|||
44266301|NCT02433834|79173985|FG000|Overall Study|Withdrawal by Subject|14|||
44266302|NCT02433834|79173985|FG000|Overall Study|Adverse Event|6|||
44266303|NCT02433834|79173985|FG000|Overall Study|Physician Decision|1|||
44194524|NCT02139644|78990387|FG000|Treatment Period|Disease progression|0|||
44194525|NCT02139644|78990388|FG001|Treatment Period|Disease progression|0|||
44194526|NCT02139644|78990389|FG002|Treatment Period|Disease progression|0|||
44194527|NCT02139644|78990390|FG003|Treatment Period|Disease progression|1|||
44194528|NCT02139644|78990391|FG004|Treatment Period|Disease progression|1|||
44266304|NCT02433678|79174029|FG000|Overall Study|Lost to Follow-up|1|||
44194529|NCT02139644|78990392|FG005|Treatment Period|Disease progression|2|||
44194530|NCT02139644|78990387|FG000|Treatment Period|Lost to Follow-up|0|||
44194531|NCT02139644|78990388|FG001|Treatment Period|Lost to Follow-up|0|||
44194532|NCT02139644|78990389|FG002|Treatment Period|Lost to Follow-up|1|||
44194533|NCT02139644|78990390|FG003|Treatment Period|Lost to Follow-up|1|||
44194534|NCT02139644|78990391|FG004|Treatment Period|Lost to Follow-up|1|||
44194535|NCT02139644|78990392|FG005|Treatment Period|Lost to Follow-up|1|||
44194536|NCT02139644|78990387|FG000|Treatment Period|Lack of Efficacy|0|||
44194537|NCT02139644|78990388|FG001|Treatment Period|Lack of Efficacy|0|||
44194538|NCT02139644|78990389|FG002|Treatment Period|Lack of Efficacy|1|||
44194539|NCT02139644|78990390|FG003|Treatment Period|Lack of Efficacy|0|||
44194540|NCT02139644|78990391|FG004|Treatment Period|Lack of Efficacy|1|||
44194541|NCT02139644|78990392|FG005|Treatment Period|Lack of Efficacy|4|||
44194542|NCT02139644|78990387|FG000|Treatment Period|Other|0|||
44194543|NCT02139644|78990388|FG001|Treatment Period|Other|3|||
44194544|NCT02139644|78990389|FG002|Treatment Period|Other|1|||
44194545|NCT02139644|78990390|FG003|Treatment Period|Other|1|||
44194546|NCT02139644|78990391|FG004|Treatment Period|Other|0|||
44194547|NCT02139644|78990392|FG005|Treatment Period|Other|1|||
44194548|NCT02100644|78990404|FG000|LTG Escalation Phase|Adverse Event|9|||
44194549|NCT02100644|78990405|FG001|LTG Escalation Phase|Adverse Event|0|||
44194550|NCT02100644|78990406|FG002|LTG Escalation Phase|Adverse Event|0|||
44194551|NCT02100644|78990404|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
44194552|NCT02100644|78990405|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
44194553|NCT02100644|78990406|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
44194554|NCT02100644|78990404|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
44194555|NCT02100644|78990405|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
44194556|NCT02100644|78990406|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
44194557|NCT02074982|78990412|FG000|Overall Study|Adverse Event|15|||
44194558|NCT02074982|78990413|FG001|Overall Study|Adverse Event|7|||
44194559|NCT02074982|78990412|FG000|Overall Study|Lack of Efficacy|6|||
44194560|NCT02074982|78990413|FG001|Overall Study|Lack of Efficacy|1|||
44194561|NCT02074982|78990412|FG000|Overall Study|Lost to Follow-up|9|||
44194562|NCT02074982|78990413|FG001|Overall Study|Lost to Follow-up|10|||
44194563|NCT02074982|78990412|FG000|Overall Study|Non-compliance with study treatment|0|||
44194564|NCT02074982|78990413|FG001|Overall Study|Non-compliance with study treatment|2|||
44194565|NCT02074982|78990412|FG000|Overall Study|Physician Decision|1|||
44194566|NCT02074982|78990413|FG001|Overall Study|Physician Decision|1|||
44194567|NCT02074982|78990412|FG000|Overall Study|Pregnancy|1|||
44194568|NCT02074982|78990413|FG001|Overall Study|Pregnancy|2|||
44194569|NCT02074982|78990412|FG000|Overall Study|Protocol deviation|4|||
44194570|NCT02074982|78990413|FG001|Overall Study|Protocol deviation|3|||
44194571|NCT02074982|78990412|FG000|Overall Study|Technical problems|0|||
44194572|NCT02074982|78990413|FG001|Overall Study|Technical problems|2|||
44194573|NCT02074982|78990412|FG000|Overall Study|Subject/guardian decision|15|||
44194574|NCT02074982|78990413|FG001|Overall Study|Subject/guardian decision|24|||
44194575|NCT02074982|78990412|FG000|Overall Study|Death|0|||
44194576|NCT02074982|78990413|FG001|Overall Study|Death|2|||
44194577|NCT02074514|78990423|FG000|Overall Study|Lack of Efficacy|3|||
44194578|NCT02074514|78990424|FG001|Overall Study|Lack of Efficacy|2|||
44194579|NCT02074514|78990423|FG000|Overall Study|Lost to Follow-up|0|||
44194580|NCT02074514|78990424|FG001|Overall Study|Lost to Follow-up|1|||
44194581|NCT02074514|78990423|FG000|Overall Study|Withdrew Consent|0|||
44194582|NCT02074514|78990424|FG001|Overall Study|Withdrew Consent|1|||
44194583|NCT02099708|78990434|FG000|Overall Study|Data Not Available|30|||
44194584|NCT02099708|78990434|FG000|Overall Study|Lost to Follow-up|141|||
44194585|NCT02099708|78990434|FG000|Overall Study|Other|29|||
44266305|NCT02433678|79174030|FG001|Overall Study|Lost to Follow-up|2|||
44266306|NCT02433288|79174043|FG000|Overall Study|Severe non-compliance to protocol|13|||
44266307|NCT02433288|79174044|FG001|Overall Study|Severe non-compliance to protocol|7|||
44266308|NCT02433288|79174043|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
44266309|NCT02433288|79174044|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
44266310|NCT02433288|79174043|FG000|Overall Study|Withdrawal by Subject|101|||
44194586|NCT02073656|78990438|FG000|Primary Study|Lost to Follow-up|6|||
44194587|NCT02073656|78990438|FG000|Primary Study|Death|1|||
44266311|NCT02433288|79174044|FG001|Overall Study|Withdrawal by Subject|99|||
44266312|NCT02433288|79174043|FG000|Overall Study|Lost to Follow-up|2|||
44451461|NCT00500331|79460411|FG003|Overall Study|Lost to Follow-up|2|||
44451462|NCT00500331|79460412|FG004|Overall Study|Lost to Follow-up|1|||
44194588|NCT02073656|78990438|FG000|Primary Study|Withdrew Consent|1|||
44194589|NCT02242643|78990446|FG000|Overall Study|Protocol Violation|1|||
44194590|NCT02242643|78990447|FG001|Overall Study|Protocol Violation|2|||
44194591|NCT02242643|78990446|FG000|Overall Study|Withdrawal by Subject|15|||
44194592|NCT02242643|78990447|FG001|Overall Study|Withdrawal by Subject|10|||
44194593|NCT02242643|78990446|FG000|Overall Study|Migrated/moved from study area|1|||
44451463|NCT00500331|79460413|FG005|Overall Study|Lost to Follow-up|0|||
44451464|NCT00500331|79460414|FG006|Overall Study|Lost to Follow-up|0|||
44451465|NCT00500331|79460408|FG000|Overall Study|Protocol Violation|3|||
44451466|NCT00500331|79460409|FG001|Overall Study|Protocol Violation|1|||
44451467|NCT00500331|79460410|FG002|Overall Study|Protocol Violation|1|||
44451468|NCT00500331|79460411|FG003|Overall Study|Protocol Violation|0|||
44451469|NCT00500331|79460412|FG004|Overall Study|Protocol Violation|1|||
44451470|NCT00500331|79460413|FG005|Overall Study|Protocol Violation|1|||
44451471|NCT00500331|79460414|FG006|Overall Study|Protocol Violation|1|||
44451472|NCT00500331|79460408|FG000|Overall Study|Withdrawal by Subject|4|||
44451473|NCT00500331|79460409|FG001|Overall Study|Withdrawal by Subject|0|||
44194594|NCT02242643|78990447|FG001|Overall Study|Migrated/moved from study area|3|||
44194595|NCT02242643|78990446|FG000|Overall Study|Lost to Follow-up|54|||
44194596|NCT02242643|78990447|FG001|Overall Study|Lost to Follow-up|61|||
44194597|NCT02242643|78990446|FG000|Overall Study|Child placed in foster care by family|0|||
44194598|NCT02242643|78990447|FG001|Overall Study|Child placed in foster care by family|1|||
44194599|NCT02242643|78990446|FG000|Overall Study|Non-compliance|1|||
44194600|NCT02242643|78990447|FG001|Overall Study|Non-compliance|0|||
44194601|NCT02242643|78990446|FG000|Overall Study|Consent withdrawal by parent|1|||
44194602|NCT02242643|78990447|FG001|Overall Study|Consent withdrawal by parent|0|||
44194603|NCT02242643|78990446|FG000|Overall Study|Protocol requirements not followed|1|||
44194604|NCT02242643|78990447|FG001|Overall Study|Protocol requirements not followed|0|||
44194605|NCT02242643|78990446|FG000|Overall Study|Language barrier|1|||
44194606|NCT02242643|78990447|FG001|Overall Study|Language barrier|0|||
44194607|NCT02242643|78990446|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
44194608|NCT02242643|78990447|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
44194609|NCT02097290|78990455|FG000|Overall Study|Death|6|||
44194610|NCT02097290|78990455|FG000|Overall Study|Total Withdrawals|3|||
44194611|NCT02097290|78990455|FG000|Overall Study|Attempt|8|||
44194612|NCT02072174|78990461|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
44194613|NCT02072174|78990462|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
44194614|NCT02072174|78990461|FG000|Overall Study|Protocol Violation|16|||
44451474|NCT00500331|79460410|FG002|Overall Study|Withdrawal by Subject|1|||
44451475|NCT00500331|79460411|FG003|Overall Study|Withdrawal by Subject|5|||
44266313|NCT02433288|79174044|FG001|Overall Study|Lost to Follow-up|14|||
44266314|NCT02433288|79174043|FG000|Overall Study|Death|0|||
44266315|NCT02433288|79174044|FG001|Overall Study|Death|3|||
44266316|NCT02433210|79174064|FG000|Overall Study|Physician Decision|1|||
44266317|NCT02433210|79174065|FG001|Overall Study|Physician Decision|0|||
44266318|NCT02433210|79174066|FG002|Overall Study|Physician Decision|0|||
44266319|NCT02432040|79174201|FG000|Overall Study|Lack of Efficacy|3|||
44266320|NCT02432040|79174202|FG001|Overall Study|Lack of Efficacy|0|||
44266321|NCT02432040|79174201|FG000|Overall Study|Lost to Follow-up|4|||
44266322|NCT02432040|79174202|FG001|Overall Study|Lost to Follow-up|5|||
44266323|NCT02432040|79174201|FG000|Overall Study|Physician Decision|1|||
44266324|NCT02432040|79174202|FG001|Overall Study|Physician Decision|1|||
44266325|NCT04418076|79174248|FG000|Overall Study|Death|1|||
44266326|NCT04418076|79174249|FG001|Overall Study|Death|0|||
44266327|NCT04418076|79174250|FG002|Overall Study|Death|0|||
44266328|NCT04418076|79174251|FG003|Overall Study|Death|0|||
44266329|NCT04418076|79174248|FG000|Overall Study|Lost to Follow-up|2|||
44266330|NCT04418076|79174249|FG001|Overall Study|Lost to Follow-up|5|||
44266331|NCT04418076|79174250|FG002|Overall Study|Lost to Follow-up|1|||
44266332|NCT04418076|79174251|FG003|Overall Study|Lost to Follow-up|2|||
44266333|NCT04418076|79174248|FG000|Overall Study|Withdrawal by Subject|1|||
44266334|NCT04418076|79174249|FG001|Overall Study|Withdrawal by Subject|0|||
44266335|NCT04418076|79174250|FG002|Overall Study|Withdrawal by Subject|1|||
44266336|NCT04418076|79174251|FG003|Overall Study|Withdrawal by Subject|1|||
44266337|NCT04418076|79174248|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
44266338|NCT04418076|79174249|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
44266339|NCT04418076|79174250|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
44266340|NCT04418076|79174251|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
44266341|NCT04165824|79174261|FG000|Overall Study|Adverse Event|23|||
44266342|NCT04165824|79174261|FG000|Overall Study|Physician Decision|1|||
44266343|NCT04165824|79174261|FG000|Overall Study|Withdrawal by Subject|17|||
44266344|NCT04165824|79174261|FG000|Overall Study|Other|5|||
44266345|NCT03809039|79174274|FG000|Part 1|Withdrawal by Subject|1|||
44266346|NCT03809039|79174275|FG001|Part 1|Withdrawal by Subject|0|||
44266347|NCT03809039|79174276|FG002|Part 1|Withdrawal by Subject|0|||
44266348|NCT03809039|79174277|FG003|Part 1|Withdrawal by Subject|1|||
44266349|NCT03809039|79174278|FG004|Part 1|Withdrawal by Subject|0|||
44266350|NCT03809039|79174279|FG005|Part 1|Withdrawal by Subject|0|||
44266351|NCT03809039|79174280|FG006|Part 1|Withdrawal by Subject|0|||
44266352|NCT03809039|79174281|FG007|Part 1|Withdrawal by Subject|0|||
44266353|NCT03809039|79174282|FG008|Part 1|Withdrawal by Subject|0|||
44194615|NCT02072174|78990462|FG001|Overall Study|Protocol Violation|23|||
44194616|NCT02072174|78990461|FG000|Overall Study|Physician Decision|0|||
44194617|NCT02072174|78990462|FG001|Overall Study|Physician Decision|1|||
44194618|NCT02072174|78990461|FG000|Overall Study|Non-compliance with protocol requirement|2|||
44194619|NCT02072174|78990462|FG001|Overall Study|Non-compliance with protocol requirement|0|||
44194620|NCT02209181|78990474|FG000|Overall Study|Adverse Event|1|||
44194621|NCT02209181|78990475|FG001|Overall Study|Adverse Event|0|||
44194622|NCT02209181|78990476|FG002|Overall Study|Adverse Event|1|||
44194623|NCT02209181|78990477|FG003|Overall Study|Adverse Event|0|||
44194624|NCT02209181|78990474|FG000|Overall Study|Withdrawal by Subject|0|||
44194625|NCT02209181|78990475|FG001|Overall Study|Withdrawal by Subject|1|||
44194626|NCT02209181|78990476|FG002|Overall Study|Withdrawal by Subject|0|||
44194627|NCT02209181|78990477|FG003|Overall Study|Withdrawal by Subject|0|||
44194628|NCT02208089|78990489|FG000|Overall Study|Withdrawal by Subject|1|||
44194629|NCT02208089|78990490|FG001|Overall Study|Withdrawal by Subject|0|||
44194630|NCT02208089|78990489|FG000|Overall Study|Lost to Follow-up|6|||
44266354|NCT03809039|79174274|FG000|Part 3|Withdrawn by study termination|0|||
44266355|NCT03809039|79174275|FG001|Part 3|Withdrawn by study termination|0|||
44266356|NCT03809039|79174276|FG002|Part 3|Withdrawn by study termination|0|||
44266357|NCT03809039|79174277|FG003|Part 3|Withdrawn by study termination|0|||
44266358|NCT03809039|79174278|FG004|Part 3|Withdrawn by study termination|0|||
44266359|NCT03809039|79174279|FG005|Part 3|Withdrawn by study termination|0|||
44194631|NCT02208089|78990490|FG001|Overall Study|Lost to Follow-up|0|||
44194632|NCT02242487|78990499|FG000|Overall Study|Adverse Event|13|||
44194633|NCT02242487|78990500|FG001|Overall Study|Adverse Event|15|||
44194634|NCT02242487|78990499|FG000|Overall Study|Lack of Efficacy|4|||
44194635|NCT02242487|78990500|FG001|Overall Study|Lack of Efficacy|6|||
44194636|NCT02242487|78990499|FG000|Overall Study|Protocol Violation|2|||
44194637|NCT02242487|78990500|FG001|Overall Study|Protocol Violation|0|||
44194638|NCT02242487|78990499|FG000|Overall Study|Lost to Follow-up|2|||
44194639|NCT02242487|78990500|FG001|Overall Study|Lost to Follow-up|1|||
44194640|NCT02242487|78990499|FG000|Overall Study|Other - Miscellaneous|4|||
44194641|NCT02242487|78990500|FG001|Overall Study|Other - Miscellaneous|6|||
44194642|NCT02242487|78990499|FG000|Overall Study|Withdrawal by Subject|37|||
44194643|NCT02242487|78990500|FG001|Overall Study|Withdrawal by Subject|19|||
44194644|NCT02241785|78990508|FG000|Overall Study|Sponsor Termination|43|||
44194645|NCT02241785|78990508|FG000|Overall Study|Withdrawal by Subject|1|||
44194646|NCT02241785|78990508|FG000|Overall Study|Lost to Follow-up|2|||
44194647|NCT02241785|78990508|FG000|Overall Study|Adverse Event|1|||
44194648|NCT02241551|78990514|FG000|Overall Study|Adverse Event|1|||
44194649|NCT02241551|78990515|FG001|Overall Study|Adverse Event|0|||
44194650|NCT02207621|78990526|FG000|Overall Study|Adverse Event|71|||
44194651|NCT02207621|78990527|FG001|Overall Study|Adverse Event|15|||
44194652|NCT02207621|78990528|FG002|Overall Study|Adverse Event|132|||
44194653|NCT02207621|78990526|FG000|Overall Study|Withdrawal by Subject|9|||
44194654|NCT02207621|78990527|FG001|Overall Study|Withdrawal by Subject|9|||
44194655|NCT02207621|78990528|FG002|Overall Study|Withdrawal by Subject|13|||
44194656|NCT02207621|78990526|FG000|Overall Study|Non-Compliant|3|||
44194657|NCT02207621|78990527|FG001|Overall Study|Non-Compliant|3|||
44194658|NCT02207621|78990528|FG002|Overall Study|Non-Compliant|1|||
44194659|NCT02207621|78990526|FG000|Overall Study|Lost to Follow-up|1|||
44194660|NCT02207621|78990527|FG001|Overall Study|Lost to Follow-up|0|||
44194661|NCT02207621|78990528|FG002|Overall Study|Lost to Follow-up|3|||
44194662|NCT02207621|78990526|FG000|Overall Study|Lack of Efficacy|10|||
44194663|NCT02207621|78990527|FG001|Overall Study|Lack of Efficacy|2|||
44361286|NCT01157117|79366947|FG000|Overall Study|Lost to Follow-up|0|||
44361287|NCT01157117|79366948|FG001|Overall Study|Lost to Follow-up|0|||
44361288|NCT01157117|79366949|FG002|Overall Study|Lost to Follow-up|1|||
44361289|NCT01157117|79366947|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
44194664|NCT02207621|78990528|FG002|Overall Study|Lack of Efficacy|4|||
44194665|NCT02207621|78990526|FG000|Overall Study|Disallowed Concurrent Medication|2|||
44194666|NCT02207621|78990527|FG001|Overall Study|Disallowed Concurrent Medication|5|||
44194667|NCT02207621|78990528|FG002|Overall Study|Disallowed Concurrent Medication|2|||
44194668|NCT02207621|78990526|FG000|Overall Study|Physician Decision|1|||
44194669|NCT02207621|78990527|FG001|Overall Study|Physician Decision|2|||
44194670|NCT02207621|78990528|FG002|Overall Study|Physician Decision|2|||
44194671|NCT02207621|78990526|FG000|Overall Study|Protocol Violation|4|||
44194672|NCT02207621|78990527|FG001|Overall Study|Protocol Violation|10|||
44194673|NCT02207621|78990528|FG002|Overall Study|Protocol Violation|6|||
44194674|NCT02207621|78990526|FG000|Overall Study|Death|2|||
44194675|NCT02207621|78990527|FG001|Overall Study|Death|0|||
44194676|NCT02207621|78990528|FG002|Overall Study|Death|0|||
44194677|NCT02207621|78990526|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
44194678|NCT02207621|78990527|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
44194679|NCT02207621|78990528|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
44194680|NCT02240693|78990542|FG000|Overall Study|Adverse Event|0|||
44194681|NCT02240693|78990543|FG001|Overall Study|Adverse Event|0|||
44194682|NCT02240693|78990544|FG002|Overall Study|Adverse Event|0|||
44194683|NCT02240693|78990545|FG003|Overall Study|Adverse Event|0|||
44194684|NCT02240693|78990546|FG004|Overall Study|Adverse Event|1|||
44194685|NCT02240693|78990542|FG000|Overall Study|Withdrawal by Subject|0|||
44194686|NCT02240693|78990543|FG001|Overall Study|Withdrawal by Subject|0|||
44194687|NCT02240693|78990544|FG002|Overall Study|Withdrawal by Subject|2|||
44194688|NCT02240693|78990545|FG003|Overall Study|Withdrawal by Subject|1|||
44194689|NCT02240693|78990546|FG004|Overall Study|Withdrawal by Subject|0|||
44194690|NCT02240693|78990542|FG000|Overall Study|Other than specified|0|||
44194691|NCT02240693|78990543|FG001|Overall Study|Other than specified|0|||
44194692|NCT02240693|78990544|FG002|Overall Study|Other than specified|2|||
44194693|NCT02240693|78990545|FG003|Overall Study|Other than specified|0|||
44194694|NCT02240693|78990546|FG004|Overall Study|Other than specified|0|||
44194695|NCT02239679|78990563|FG000|Overall Study|Lost to Follow-up|1|||
44451476|NCT00500331|79460412|FG004|Overall Study|Withdrawal by Subject|0|||
44451477|NCT00500331|79460413|FG005|Overall Study|Withdrawal by Subject|1|||
44451478|NCT00500331|79460414|FG006|Overall Study|Withdrawal by Subject|1|||
44451479|NCT00500331|79460408|FG000|Overall Study|Lack of Efficacy|3|||
44451480|NCT00500331|79460409|FG001|Overall Study|Lack of Efficacy|1|||
44194696|NCT02239679|78990564|FG001|Overall Study|Lost to Follow-up|0|||
44194697|NCT02239679|78990565|FG002|Overall Study|Lost to Follow-up|0|||
44194698|NCT02239679|78990563|FG000|Overall Study|Withdrawal by Subject|2|||
44194699|NCT02239679|78990564|FG001|Overall Study|Withdrawal by Subject|3|||
44194700|NCT02239679|78990565|FG002|Overall Study|Withdrawal by Subject|1|||
44451481|NCT00500331|79460410|FG002|Overall Study|Lack of Efficacy|0|||
44194701|NCT02072096|78990575|FG000|Overall Study|Lack of Efficacy|18|||
44194702|NCT02072096|78990576|FG001|Overall Study|Lack of Efficacy|29|||
44194703|NCT02072096|78990575|FG000|Overall Study|Protocol Violation|7|||
44194704|NCT02072096|78990576|FG001|Overall Study|Protocol Violation|7|||
44194705|NCT02072096|78990575|FG000|Overall Study|Withdrawal by Subject|5|||
44194706|NCT02072096|78990576|FG001|Overall Study|Withdrawal by Subject|7|||
44194707|NCT02072096|78990575|FG000|Overall Study|Adverse Event|5|||
44194708|NCT02072096|78990576|FG001|Overall Study|Adverse Event|2|||
44266360|NCT03809039|79174280|FG006|Part 3|Withdrawn by study termination|0|||
44194709|NCT02072096|78990575|FG000|Overall Study|No Reason Provided|4|||
44194710|NCT02072096|78990576|FG001|Overall Study|No Reason Provided|2|||
44194711|NCT02072096|78990575|FG000|Overall Study|Death|2|||
44194712|NCT02072096|78990576|FG001|Overall Study|Death|0|||
44194713|NCT02072096|78990575|FG000|Overall Study|Physician Decision|0|||
44194714|NCT02072096|78990576|FG001|Overall Study|Physician Decision|1|||
44194715|NCT02072096|78990575|FG000|Overall Study|Study Terminated by Sponsor|43|||
44194716|NCT02072096|78990576|FG001|Overall Study|Study Terminated by Sponsor|30|||
44194717|NCT02072096|78990575|FG000|Overall Study|Lost to Follow-up|1|||
44194718|NCT02072096|78990576|FG001|Overall Study|Lost to Follow-up|0|||
44194719|NCT02071706|78990583|FG000|Overall Study|Adverse Event|1|||
44194720|NCT02071706|78990583|FG000|Overall Study|Withdrawal by Subject|2|||
44194721|NCT01631825|78990587|FG000|Overall Study|Adverse Event|42|||
44194722|NCT01631825|78990587|FG000|Overall Study|Lack of Efficacy|7|||
44194723|NCT01631825|78990587|FG000|Overall Study|Withdrawal by Subject|9|||
44194724|NCT01631825|78990587|FG000|Overall Study|Protocol Violation|4|||
44194725|NCT01631825|78990587|FG000|Overall Study|Discontinuation criteria|1|||
44194726|NCT01631825|78990587|FG000|Overall Study|Physician Decision|2|||
44194727|NCT02071082|78990593|FG000|Overall Study|Enrolled and Never Treated|1|||
44194728|NCT02071082|78990594|FG001|Overall Study|Enrolled and Never Treated|1|||
44194729|NCT02071082|78990593|FG000|Overall Study|Adverse Event|0|||
44266361|NCT03809039|79174281|FG007|Part 3|Withdrawn by study termination|2|||
44194730|NCT02071082|78990594|FG001|Overall Study|Adverse Event|1|||
44194731|NCT02071082|78990593|FG000|Overall Study|Withdrew Consent|0|||
44194732|NCT02071082|78990594|FG001|Overall Study|Withdrew Consent|4|||
44194733|NCT02071082|78990593|FG000|Overall Study|Lost to Follow-up|1|||
44194734|NCT02071082|78990594|FG001|Overall Study|Lost to Follow-up|1|||
44194735|NCT02123108|78990602|FG000|Overall Study|Death|2|||
44194736|NCT02123108|78990603|FG001|Overall Study|Death|3|||
44194737|NCT02121392|78990611|FG000|Prior to Intervention|Protocol Violation|40|||
44194738|NCT02121392|78990612|FG001|Prior to Intervention|Protocol Violation|35|||
44194739|NCT02121392|78990611|FG000|Prior to Intervention|Withdrawal by Subject|8|||
44194740|NCT02121392|78990612|FG001|Prior to Intervention|Withdrawal by Subject|6|||
44194741|NCT02121392|78990611|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
44194742|NCT02121392|78990612|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
44194743|NCT02121392|78990611|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
44194744|NCT02121392|78990612|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
44194745|NCT02097056|78990618|FG000|Overall Study|Protocol Violation|2|||
44194746|NCT02097056|78990618|FG000|Overall Study|Withdrawal by Subject|15|||
44194747|NCT02097056|78990618|FG000|Overall Study|Lost to Follow-up|2|||
44194748|NCT02097056|78990618|FG000|Overall Study|Adverse Event|37|||
44194749|NCT02097056|78990618|FG000|Overall Study|Other|2|||
44194750|NCT02121002|78990625|FG000|Overall Study|Physician Decision|2|||
44194751|NCT02121002|78990626|FG001|Overall Study|Physician Decision|0|||
44194752|NCT02121002|78990627|FG002|Overall Study|Physician Decision|0|||
44194753|NCT02121002|78990625|FG000|Overall Study|Withdrawal by Subject|3|||
44194754|NCT02121002|78990626|FG001|Overall Study|Withdrawal by Subject|1|||
44194755|NCT02121002|78990627|FG002|Overall Study|Withdrawal by Subject|4|||
44194756|NCT02121002|78990625|FG000|Overall Study|Protocol Violation|1|||
44194757|NCT02121002|78990626|FG001|Overall Study|Protocol Violation|2|||
44194758|NCT02121002|78990627|FG002|Overall Study|Protocol Violation|4|||
44266362|NCT03809039|79174282|FG008|Part 3|Withdrawn by study termination|6|||
44266363|NCT03541200|79174315|FG000|Overall Study|Adverse Event|19|||
44266364|NCT03541200|79174315|FG000|Overall Study|Death|1|||
44266365|NCT03541200|79174315|FG000|Overall Study|Lost to Follow-up|10|||
44266366|NCT03541200|79174315|FG000|Overall Study|Physician Decision|1|||
44266367|NCT03541200|79174315|FG000|Overall Study|Protocol Violation|51|||
44194759|NCT02121002|78990625|FG000|Overall Study|Concomitant therapy|0|||
44194760|NCT02121002|78990626|FG001|Overall Study|Concomitant therapy|1|||
44194761|NCT02121002|78990627|FG002|Overall Study|Concomitant therapy|1|||
44266368|NCT03541200|79174315|FG000|Overall Study|Withdrawal by Subject|23|||
44266369|NCT03541200|79174315|FG000|Overall Study|other|8|||
44194762|NCT02121002|78990625|FG000|Overall Study|Others|1|||
44194763|NCT02121002|78990626|FG001|Overall Study|Others|0|||
44194764|NCT02121002|78990627|FG002|Overall Study|Others|1|||
44194765|NCT02096900|78990637|FG000|Overall Study|Did not receive medication|3|||
44194766|NCT02096900|78990638|FG001|Overall Study|Did not receive medication|1|||
44194767|NCT02096900|78990637|FG000|Overall Study|Surgery cancelled- medication received|1|||
44194768|NCT02096900|78990638|FG001|Overall Study|Surgery cancelled- medication received|1|||
44194769|NCT02120924|78990647|FG000|Overall Study|Lack of Efficacy|1|||
44194770|NCT02120924|78990648|FG001|Overall Study|Lack of Efficacy|2|||
44194771|NCT02120924|78990649|FG002|Overall Study|Lack of Efficacy|3|||
44194772|NCT02120924|78990647|FG000|Overall Study|Adverse Event|0|||
44194773|NCT02120924|78990648|FG001|Overall Study|Adverse Event|1|||
44194774|NCT02120924|78990649|FG002|Overall Study|Adverse Event|3|||
44194775|NCT02120924|78990647|FG000|Overall Study|Withdrawal by Subject|16|||
44194776|NCT02120924|78990648|FG001|Overall Study|Withdrawal by Subject|20|||
44194777|NCT02120924|78990649|FG002|Overall Study|Withdrawal by Subject|8|||
44194778|NCT02120924|78990647|FG000|Overall Study|Lost to Follow-up|14|||
44194779|NCT02120924|78990648|FG001|Overall Study|Lost to Follow-up|14|||
44194780|NCT02120924|78990649|FG002|Overall Study|Lost to Follow-up|11|||
44194781|NCT02120924|78990647|FG000|Overall Study|Pregnancy|2|||
44194782|NCT02120924|78990648|FG001|Overall Study|Pregnancy|0|||
44194783|NCT02120924|78990649|FG002|Overall Study|Pregnancy|0|||
44194784|NCT02120924|78990647|FG000|Overall Study|Protocol Violation|3|||
44194785|NCT02120924|78990648|FG001|Overall Study|Protocol Violation|7|||
44194786|NCT02120924|78990649|FG002|Overall Study|Protocol Violation|2|||
44194787|NCT02120924|78990647|FG000|Overall Study|Physician Decision|0|||
44194788|NCT02120924|78990648|FG001|Overall Study|Physician Decision|1|||
44194789|NCT02120924|78990649|FG002|Overall Study|Physician Decision|1|||
44194790|NCT02120924|78990647|FG000|Overall Study|Death|1|||
44194791|NCT02120924|78990648|FG001|Overall Study|Death|0|||
44194792|NCT02120924|78990649|FG002|Overall Study|Death|0|||
44194793|NCT02120924|78990647|FG000|Overall Study|Compliance with IP|5|||
44194794|NCT02120924|78990648|FG001|Overall Study|Compliance with IP|1|||
44194795|NCT02120924|78990649|FG002|Overall Study|Compliance with IP|1|||
44194796|NCT02096744|78990658|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
44194797|NCT02096744|78990659|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
44194798|NCT02096744|78990658|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
44194799|NCT02096744|78990659|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
44194800|NCT02096744|78990658|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
44194801|NCT02096744|78990659|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
44194802|NCT02120456|78990676|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194803|NCT02120456|78990677|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194804|NCT02120456|78990678|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194805|NCT02120456|78990679|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194806|NCT02120456|78990680|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194807|NCT02120456|78990681|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194808|NCT02120456|78990682|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
44194809|NCT02120456|78990683|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194810|NCT02120456|78990684|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
44194811|NCT02120456|78990676|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194812|NCT02120456|78990677|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194813|NCT02120456|78990678|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194814|NCT02120456|78990679|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194815|NCT02120456|78990680|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194816|NCT02120456|78990681|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194817|NCT02120456|78990682|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
44194818|NCT02120456|78990683|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194819|NCT02120456|78990684|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
44194820|NCT02120456|78990676|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194821|NCT02120456|78990677|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194822|NCT02120456|78990678|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194823|NCT02120456|78990679|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194824|NCT02120456|78990680|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194825|NCT02120456|78990681|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194826|NCT02120456|78990682|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194827|NCT02120456|78990683|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
44194828|NCT02120456|78990684|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
44194829|NCT02120300|78990708|FG000|Overall Study|Enrolled but Never Treated|2|||
44194830|NCT02120300|78990709|FG001|Overall Study|Enrolled but Never Treated|0|||
44194831|NCT02120300|78990710|FG002|Overall Study|Enrolled but Never Treated|0|||
44194832|NCT02120300|78990711|FG003|Overall Study|Enrolled but Never Treated|0|||
44194833|NCT02120300|78990708|FG000|Overall Study|Lack of Efficacy|0|||
44194834|NCT02120300|78990709|FG001|Overall Study|Lack of Efficacy|0|||
44194835|NCT02120300|78990710|FG002|Overall Study|Lack of Efficacy|0|||
44194836|NCT02120300|78990711|FG003|Overall Study|Lack of Efficacy|1|||
44194837|NCT02120300|78990708|FG000|Overall Study|Lost to Follow-up|1|||
44194838|NCT02120300|78990709|FG001|Overall Study|Lost to Follow-up|0|||
44194839|NCT02120300|78990710|FG002|Overall Study|Lost to Follow-up|0|||
44194840|NCT02120300|78990711|FG003|Overall Study|Lost to Follow-up|0|||
44194841|NCT02070380|78990727|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
44194842|NCT02070380|78990728|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
44194843|NCT02070380|78990729|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
44194844|NCT02070380|78990730|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
44194845|NCT02070380|78990727|FG000|Second Injection|Image sets missing or technically inadeq|0|||
44194846|NCT02070380|78990728|FG001|Second Injection|Image sets missing or technically inadeq|1|||
44194847|NCT02070380|78990729|FG002|Second Injection|Image sets missing or technically inadeq|0|||
44194848|NCT02070380|78990730|FG003|Second Injection|Image sets missing or technically inadeq|0|||
44194849|NCT02070380|78990727|FG000|Second Injection|Protocol Violation|0|||
44194850|NCT02070380|78990728|FG001|Second Injection|Protocol Violation|1|||
44194851|NCT02070380|78990729|FG002|Second Injection|Protocol Violation|1|||
44194852|NCT02070380|78990730|FG003|Second Injection|Protocol Violation|5|||
44194853|NCT02069366|78990748|FG000|Overall Study|Lost to Follow-up|0|||
44194854|NCT02069366|78990749|FG001|Overall Study|Lost to Follow-up|0|||
44194855|NCT02069366|78990750|FG002|Overall Study|Lost to Follow-up|1|||
44194856|NCT02069366|78990751|FG003|Overall Study|Lost to Follow-up|0|||
44194857|NCT02069366|78990752|FG004|Overall Study|Lost to Follow-up|0|||
44194858|NCT02069366|78990753|FG005|Overall Study|Lost to Follow-up|2|||
44194859|NCT02069366|78990748|FG000|Overall Study|Protocol Violation|0|||
44194860|NCT02069366|78990749|FG001|Overall Study|Protocol Violation|0|||
44194861|NCT02069366|78990750|FG002|Overall Study|Protocol Violation|1|||
44194862|NCT02069366|78990751|FG003|Overall Study|Protocol Violation|0|||
44194863|NCT02069366|78990752|FG004|Overall Study|Protocol Violation|0|||
44194864|NCT02069366|78990753|FG005|Overall Study|Protocol Violation|0|||
44194865|NCT02069366|78990748|FG000|Overall Study|Withdrawal by Subject|1|||
44194866|NCT02069366|78990749|FG001|Overall Study|Withdrawal by Subject|0|||
44194867|NCT02069366|78990750|FG002|Overall Study|Withdrawal by Subject|1|||
44194868|NCT02069366|78990751|FG003|Overall Study|Withdrawal by Subject|2|||
44194869|NCT02069366|78990752|FG004|Overall Study|Withdrawal by Subject|0|||
44194870|NCT02069366|78990753|FG005|Overall Study|Withdrawal by Subject|0|||
44194871|NCT02068508|78990768|FG000|Overall Study|Case report forms uncollected|27|||
44194872|NCT02068508|78990768|FG000|Overall Study|Patient did not visit the study site|1|||
44194873|NCT02068508|78990768|FG000|Overall Study|Protocol Violation|4|||
44194874|NCT02068352|78990775|FG000|Overall Study|Lost to Follow-up|0|||
44194875|NCT02068352|78990776|FG001|Overall Study|Lost to Follow-up|2|||
44194876|NCT02068352|78990777|FG002|Overall Study|Lost to Follow-up|0|||
44194877|NCT02068352|78990775|FG000|Overall Study|Adverse Event|4|||
44194878|NCT02068352|78990776|FG001|Overall Study|Adverse Event|2|||
44194879|NCT02068352|78990777|FG002|Overall Study|Adverse Event|7|||
44194880|NCT02068352|78990775|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
44194881|NCT02068352|78990776|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
44194882|NCT02068352|78990777|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
44194883|NCT02068352|78990775|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
44194884|NCT02068352|78990776|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
44194885|NCT02068352|78990777|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
44194886|NCT02068352|78990775|FG000|Overall Study|Protocol Deviation|0|||
44194887|NCT02068352|78990776|FG001|Overall Study|Protocol Deviation|0|||
44194888|NCT02068352|78990777|FG002|Overall Study|Protocol Deviation|1|||
44194889|NCT02207231|78990788|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
44194890|NCT02207231|78990789|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
44194891|NCT02207231|78990790|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
44194892|NCT02207231|78990791|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
44194893|NCT02207231|78990788|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
44194894|NCT02207231|78990789|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
44194895|NCT02207231|78990790|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
44194896|NCT02207231|78990791|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
44194897|NCT02207231|78990788|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
44194898|NCT02207231|78990789|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
44194899|NCT02207231|78990790|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
44194900|NCT02207231|78990791|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
44194901|NCT02207231|78990788|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
44194902|NCT02207231|78990789|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
44194903|NCT02207231|78990790|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
44194904|NCT02207231|78990791|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
44194905|NCT02207231|78990788|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
44194906|NCT02207231|78990789|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
44194907|NCT02207231|78990790|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
44194908|NCT02207231|78990791|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
44194909|NCT02207231|78990788|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
44194910|NCT02207231|78990789|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
44194911|NCT02207231|78990790|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
44266382|NCT03505710|79174335|FG000|Overall Study|Progressive Disease|22|||
44266383|NCT03505710|79174336|FG001|Overall Study|Progressive Disease|9|||
44266384|NCT03505710|79174337|FG002|Overall Study|Progressive Disease|34|||
44266385|NCT03505710|79174335|FG000|Overall Study|Clinical Progression|6|||
44266386|NCT03505710|79174336|FG001|Overall Study|Clinical Progression|6|||
44266387|NCT03505710|79174337|FG002|Overall Study|Clinical Progression|3|||
44266388|NCT03505710|79174335|FG000|Overall Study|Adverse Event|12|||
44266389|NCT03505710|79174336|FG001|Overall Study|Adverse Event|5|||
44266390|NCT03505710|79174337|FG002|Overall Study|Adverse Event|27|||
44266391|NCT03505710|79174335|FG000|Overall Study|Withdrawal by Subject|1|||
44266392|NCT03505710|79174336|FG001|Overall Study|Withdrawal by Subject|3|||
44266393|NCT03505710|79174337|FG002|Overall Study|Withdrawal by Subject|3|||
44266394|NCT03505710|79174335|FG000|Overall Study|Physician Decision|1|||
44266395|NCT03505710|79174336|FG001|Overall Study|Physician Decision|0|||
44266396|NCT03505710|79174337|FG002|Overall Study|Physician Decision|2|||
44266397|NCT03505710|79174335|FG000|Overall Study|Death|4|||
44266398|NCT03505710|79174336|FG001|Overall Study|Death|3|||
44266399|NCT03505710|79174337|FG002|Overall Study|Death|6|||
44266400|NCT03505710|79174335|FG000|Overall Study|Other Reasons|1|||
44266401|NCT03505710|79174336|FG001|Overall Study|Other Reasons|1|||
44194912|NCT02207231|78990791|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
44194913|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
44194914|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
44194915|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
44194916|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
44194917|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
44194918|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
44194919|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
44194920|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
44194921|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
44194922|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
44194923|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
44194924|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
44194925|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
44194926|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
44194927|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
44194928|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
44194929|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
44194930|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
44194931|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
44194932|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
44194933|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
44194934|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
44194935|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
44194936|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
44194937|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
44194938|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
44194939|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
44194940|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
44194941|NCT02207231|78990788|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
44194942|NCT02207231|78990789|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
44194943|NCT02207231|78990790|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
44194944|NCT02207231|78990791|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
44194945|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
44266402|NCT03505710|79174337|FG002|Overall Study|Other Reasons|1|||
44451482|NCT00500331|79460411|FG003|Overall Study|Lack of Efficacy|0|||
44266404|NCT03291067|79174353|FG000|Overall Study|Adverse Event|0|||
44266405|NCT03291067|79174354|FG001|Overall Study|Adverse Event|2|||
44266406|NCT03291067|79174355|FG002|Overall Study|Adverse Event|17|||
44266407|NCT03291067|79174356|FG003|Overall Study|Adverse Event|3|||
44266408|NCT03291067|79174353|FG000|Overall Study|Lost to Follow-up|2|||
44266409|NCT03291067|79174354|FG001|Overall Study|Lost to Follow-up|1|||
44266410|NCT03291067|79174355|FG002|Overall Study|Lost to Follow-up|0|||
44194946|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
44194947|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
44194948|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
44194949|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
44194950|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
44194951|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
44194952|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
44194953|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
44194954|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
44194955|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
44194956|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
44194957|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
44194958|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
44194959|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
44194960|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
44194961|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
44194962|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
44194963|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
44194964|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
44194965|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
44194966|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
44194967|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
44194968|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
44194969|NCT02207231|78990788|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
44194970|NCT02207231|78990789|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
44194971|NCT02207231|78990790|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
44194972|NCT02207231|78990791|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
44194973|NCT02239601|78990811|FG000|Overall Study|Withdrawal by Subject|3|||
44194974|NCT02239601|78990812|FG001|Overall Study|Withdrawal by Subject|4|||
44194975|NCT02239601|78990811|FG000|Overall Study|Protocol Violation|4|||
44194976|NCT02239601|78990812|FG001|Overall Study|Protocol Violation|2|||
44194977|NCT02236559|78990825|FG000|Overall Study|Met Exclusion|3|||
44194978|NCT02236559|78990826|FG001|Overall Study|Met Exclusion|6|||
44194979|NCT02236559|78990825|FG000|Overall Study|Did not Meet Inclusion|3|||
44194980|NCT02236559|78990826|FG001|Overall Study|Did not Meet Inclusion|3|||
44194981|NCT02236559|78990825|FG000|Overall Study|Subject Did Not Consent|4|||
44194982|NCT02236559|78990826|FG001|Overall Study|Subject Did Not Consent|2|||
44194983|NCT02236559|78990825|FG000|Overall Study|Physician Decision|1|||
44194984|NCT02236559|78990826|FG001|Overall Study|Physician Decision|1|||
44194985|NCT02236559|78990825|FG000|Overall Study|Withdrawal by Subject|1|||
44194986|NCT02236559|78990826|FG001|Overall Study|Withdrawal by Subject|0|||
44194987|NCT02206685|78990834|FG000|Overall Study|Surgery cancelled/changed|2|||
44194988|NCT02206685|78990835|FG001|Overall Study|Surgery cancelled/changed|3|||
44194989|NCT02206685|78990834|FG000|Overall Study|Withdrawal by Subject|1|||
44194990|NCT02206685|78990835|FG001|Overall Study|Withdrawal by Subject|2|||
44194991|NCT02206685|78990834|FG000|Overall Study|Protocol Violation|2|||
44194992|NCT02206685|78990835|FG001|Overall Study|Protocol Violation|2|||
44194993|NCT02206607|78990841|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
44194994|NCT02206607|78990842|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
44194995|NCT02206607|78990843|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
44194996|NCT02206607|78990844|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
44194997|NCT02206607|78990845|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
44194998|NCT02206607|78990841|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
44194999|NCT02206607|78990842|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
44195000|NCT02206607|78990843|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
44195001|NCT02206607|78990844|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
44195002|NCT02206607|78990845|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
44195003|NCT02119676|78990865|FG000|Overall Study|Adverse Event|9|||
44195004|NCT02119676|78990866|FG001|Overall Study|Adverse Event|17|||
44195005|NCT02119676|78990867|FG002|Overall Study|Adverse Event|10|||
44195006|NCT02119676|78990868|FG003|Overall Study|Adverse Event|10|||
44195007|NCT02119676|78990865|FG000|Overall Study|Disease progression|53|||
44195008|NCT02119676|78990866|FG001|Overall Study|Disease progression|55|||
44195009|NCT02119676|78990867|FG002|Overall Study|Disease progression|68|||
44195010|NCT02119676|78990868|FG003|Overall Study|Disease progression|73|||
44195011|NCT02119676|78990865|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
44195012|NCT02119676|78990866|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
44195013|NCT02119676|78990867|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
44195014|NCT02119676|78990868|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
44195015|NCT02119676|78990865|FG000|Overall Study|Physician Decision|4|||
44195016|NCT02119676|78990866|FG001|Overall Study|Physician Decision|2|||
44195017|NCT02119676|78990867|FG002|Overall Study|Physician Decision|3|||
44195018|NCT02119676|78990868|FG003|Overall Study|Physician Decision|2|||
44195019|NCT02119676|78990865|FG000|Overall Study|Death|9|||
44195020|NCT02119676|78990866|FG001|Overall Study|Death|3|||
44195021|NCT02119676|78990867|FG002|Overall Study|Death|2|||
44195022|NCT02119676|78990868|FG003|Overall Study|Death|1|||
44195023|NCT02119676|78990865|FG000|Overall Study|Noncompliance|0|||
44195024|NCT02119676|78990866|FG001|Overall Study|Noncompliance|1|||
44195025|NCT02119676|78990867|FG002|Overall Study|Noncompliance|0|||
44195026|NCT02119676|78990868|FG003|Overall Study|Noncompliance|0|||
44195027|NCT02119676|78990865|FG000|Overall Study|Lost to Follow-up|0|||
44195028|NCT02119676|78990866|FG001|Overall Study|Lost to Follow-up|0|||
44195029|NCT02119676|78990867|FG002|Overall Study|Lost to Follow-up|1|||
44195030|NCT02119676|78990868|FG003|Overall Study|Lost to Follow-up|0|||
44195031|NCT02119676|78990865|FG000|Overall Study|Protocol deviation|0|||
44195032|NCT02119676|78990866|FG001|Overall Study|Protocol deviation|0|||
44195033|NCT02119676|78990867|FG002|Overall Study|Protocol deviation|1|||
44195034|NCT02119676|78990868|FG003|Overall Study|Protocol deviation|0|||
44195035|NCT02119676|78990865|FG000|Overall Study|Other, unspecified|2|||
44195036|NCT02119676|78990866|FG001|Overall Study|Other, unspecified|1|||
44195037|NCT02119676|78990867|FG002|Overall Study|Other, unspecified|3|||
44195038|NCT02119676|78990868|FG003|Overall Study|Other, unspecified|4|||
44195039|NCT02119676|78990865|FG000|Overall Study|Did not receive study med|2|||
44195040|NCT02119676|78990866|FG001|Overall Study|Did not receive study med|2|||
44195041|NCT02119676|78990867|FG002|Overall Study|Did not receive study med|4|||
44195042|NCT02119676|78990868|FG003|Overall Study|Did not receive study med|5|||
44195043|NCT02206061|78990881|FG000|Overall Study|Withdrawal by Subject|4|||
44195044|NCT02206061|78990882|FG001|Overall Study|Withdrawal by Subject|7|||
44195045|NCT02206061|78990883|FG002|Overall Study|Withdrawal by Subject|1|||
44195046|NCT02206061|78990881|FG000|Overall Study|Lost to Follow-up|14|||
44195047|NCT02206061|78990882|FG001|Overall Study|Lost to Follow-up|7|||
44195048|NCT02206061|78990883|FG002|Overall Study|Lost to Follow-up|20|||
44195049|NCT02095106|78990893|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
44195050|NCT02095106|78990894|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
44195051|NCT01631747|78990906|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
44195052|NCT01631747|78990907|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
44195053|NCT01631747|78990906|FG000|Live Birth|Pregnancy Termination|1|||
44195054|NCT01631747|78990907|FG001|Live Birth|Pregnancy Termination|0|||
44195055|NCT01631747|78990906|FG000|Live Birth|MIscarriage|2|||
44195056|NCT01631747|78990907|FG001|Live Birth|MIscarriage|0|||
44195057|NCT01631747|78990906|FG000|Live Birth|Stillbirth|1|||
44195058|NCT01631747|78990907|FG001|Live Birth|Stillbirth|1|||
44195059|NCT01631747|78990906|FG000|One Year Infant Outcomes|Patient Refused|13|||
44195060|NCT01631747|78990907|FG001|One Year Infant Outcomes|Patient Refused|9|||
44195061|NCT02068118|78990916|FG000|18-month Comparative Study Period|Death|90|||
44195062|NCT02068118|78990917|FG001|18-month Comparative Study Period|Death|97|||
44195063|NCT02068118|78990916|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
44195064|NCT02068118|78990917|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
44195065|NCT02068118|78990916|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
44195066|NCT02068118|78990917|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
44195067|NCT02068118|78990916|FG000|18-month Comparative Study Period|Heart transplant|9|||
44195068|NCT02068118|78990917|FG001|18-month Comparative Study Period|Heart transplant|15|||
44195069|NCT02068118|78990916|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
44195070|NCT02068118|78990917|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
44195071|NCT02068118|78990916|FG000|18-month Comparative Study Period|Hemiplegia|0|||
44195072|NCT02068118|78990917|FG001|18-month Comparative Study Period|Hemiplegia|1|||
44195073|NCT02068118|78990916|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
44195074|NCT02068118|78990917|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
44195075|NCT02068118|78990916|FG000|18-month Comparative Study Period|Move|0|||
44195076|NCT02068118|78990917|FG001|18-month Comparative Study Period|Move|1|||
44195077|NCT02068118|78990916|FG000|18-month Comparative Study Period|Hearing loss|0|||
44195078|NCT02068118|78990917|FG001|18-month Comparative Study Period|Hearing loss|1|||
44195079|NCT02068118|78990916|FG000|Extension Period|Death|0|||
44195080|NCT02068118|78990917|FG001|Extension Period|Death|2|||
44195081|NCT02068118|78990916|FG000|Extension Period|Withdrawal by Subject|1|||
44195082|NCT02068118|78990917|FG001|Extension Period|Withdrawal by Subject|0|||
44195083|NCT02068118|78990916|FG000|Extension Period|Heart transplant|1|||
44195084|NCT02068118|78990917|FG001|Extension Period|Heart transplant|0|||
44195085|NCT02068118|78990916|FG000|Extension Period|Wrong device use|0|||
44195086|NCT02068118|78990917|FG001|Extension Period|Wrong device use|1|||
44195087|NCT01623830|78990927|FG000|Overall Study|Withdrawal by Subject|6|||
44195088|NCT01623830|78990928|FG001|Overall Study|Withdrawal by Subject|7|||
44451483|NCT00500331|79460412|FG004|Overall Study|Lack of Efficacy|0|||
44195089|NCT01623830|78990927|FG000|Overall Study|Exclusion from Study|1|||
44195090|NCT01623830|78990928|FG001|Overall Study|Exclusion from Study|2|||
44195091|NCT01634165|78990934|FG000|Period 2|Adverse Event|0|||
44195092|NCT01634165|78990935|FG001|Period 2|Adverse Event|1|||
44195093|NCT01634165|78990936|FG002|Period 2|Adverse Event|0|||
44195094|NCT01634165|78990937|FG003|Period 2|Adverse Event|0|||
44195095|NCT02235311|78990949|FG000|Overall Study|Lost to Follow-up|0|||
44195096|NCT02235311|78990950|FG001|Overall Study|Lost to Follow-up|1|||
44195097|NCT02235311|78990949|FG000|Overall Study|Protocol Violation|0|||
44195098|NCT02235311|78990950|FG001|Overall Study|Protocol Violation|1|||
44195099|NCT02204579|78990956|FG000|Overall Study|Screen failures|2|||
44195100|NCT02235077|78990967|FG000|Overall Study|Death|5|||
44195101|NCT02235077|78990968|FG001|Overall Study|Death|7|||
44195102|NCT02235077|78990967|FG000|Overall Study|Lost to Follow-up|5|||
44195103|NCT02235077|78990968|FG001|Overall Study|Lost to Follow-up|6|||
44195104|NCT02235077|78990967|FG000|Overall Study|Withdrawal by Subject|8|||
44195105|NCT02235077|78990968|FG001|Overall Study|Withdrawal by Subject|5|||
44195106|NCT02235077|78990967|FG000|Overall Study|Physician Decision|0|||
44195107|NCT02235077|78990968|FG001|Overall Study|Physician Decision|1|||
44195108|NCT02234141|78990978|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
44195109|NCT02234141|78990979|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
44195110|NCT02234141|78990980|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
44195111|NCT02234141|78990981|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
44195112|NCT02234141|78990982|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
44195113|NCT02234141|78990983|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
44195114|NCT02234141|78990984|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
44195115|NCT02234141|78990978|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
44195116|NCT02234141|78990979|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
44195117|NCT02234141|78990980|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
44195118|NCT02234141|78990981|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
44195119|NCT02234141|78990982|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
44195120|NCT02234141|78990983|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
44195121|NCT02234141|78990984|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
44195122|NCT02234141|78990978|FG000|Treatment Period (24 Weeks)|Death|1|||
44195123|NCT02234141|78990979|FG001|Treatment Period (24 Weeks)|Death|2|||
44195124|NCT02234141|78990980|FG002|Treatment Period (24 Weeks)|Death|0|||
44195125|NCT02234141|78990981|FG003|Treatment Period (24 Weeks)|Death|1|||
44195126|NCT02234141|78990982|FG004|Treatment Period (24 Weeks)|Death|0|||
44195127|NCT02234141|78990983|FG005|Treatment Period (24 Weeks)|Death|0|||
44195128|NCT02234141|78990984|FG006|Treatment Period (24 Weeks)|Death|0|||
44195129|NCT02234141|78990978|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
44195130|NCT02234141|78990979|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
44195131|NCT02234141|78990980|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
44195132|NCT02234141|78990981|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
44195133|NCT02234141|78990982|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
44195134|NCT02234141|78990983|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
44195135|NCT02234141|78990984|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
44195136|NCT02234141|78990978|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
44195137|NCT02234141|78990979|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
44195138|NCT02234141|78990980|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
44195139|NCT02234141|78990981|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
44195140|NCT02234141|78990982|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
44195141|NCT02234141|78990983|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
44195142|NCT02234141|78990984|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
44195143|NCT02234141|78990978|FG000|Long-Term Treatment Period|Death|0|||
44195144|NCT02234141|78990979|FG001|Long-Term Treatment Period|Death|0|||
44195145|NCT02234141|78990980|FG002|Long-Term Treatment Period|Death|0|||
44195146|NCT02234141|78990981|FG003|Long-Term Treatment Period|Death|0|||
44195147|NCT02234141|78990982|FG004|Long-Term Treatment Period|Death|0|||
44195148|NCT02234141|78990983|FG005|Long-Term Treatment Period|Death|1|||
44195149|NCT02234141|78990984|FG006|Long-Term Treatment Period|Death|0|||
44195150|NCT02234141|78990978|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
44195151|NCT02234141|78990979|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
44195152|NCT02234141|78990980|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
44195153|NCT02234141|78990981|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
44195154|NCT02234141|78990982|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
44195155|NCT02234141|78990983|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
44195156|NCT02234141|78990984|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
44195157|NCT02234141|78990978|FG000|Long-Term Treatment Period|Adverse Event|4|||
44195158|NCT02234141|78990979|FG001|Long-Term Treatment Period|Adverse Event|0|||
44195159|NCT02234141|78990980|FG002|Long-Term Treatment Period|Adverse Event|5|||
44195160|NCT02234141|78990981|FG003|Long-Term Treatment Period|Adverse Event|0|||
44195161|NCT02234141|78990982|FG004|Long-Term Treatment Period|Adverse Event|1|||
44195162|NCT02234141|78990983|FG005|Long-Term Treatment Period|Adverse Event|1|||
44195163|NCT02234141|78990984|FG006|Long-Term Treatment Period|Adverse Event|1|||
44195164|NCT02234141|78990978|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
44195165|NCT02234141|78990979|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
44195166|NCT02234141|78990980|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
44195167|NCT02234141|78990981|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
44195168|NCT02234141|78990982|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
44195169|NCT02234141|78990983|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
44195170|NCT02234141|78990984|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
44195171|NCT02234141|78990978|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
44195172|NCT02234141|78990979|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
44195173|NCT02234141|78990980|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
44195174|NCT02234141|78990981|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
44195175|NCT02234141|78990982|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
44195176|NCT02234141|78990983|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
44195177|NCT02234141|78990984|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
44195178|NCT02234063|78990997|FG000|Overall Study|Lost to Follow-up|235|||
44195179|NCT02234063|78990998|FG001|Overall Study|Lost to Follow-up|42|||
44195180|NCT02234063|78990997|FG000|Overall Study|Withdrawal by Subject|20|||
44195181|NCT02234063|78990998|FG001|Overall Study|Withdrawal by Subject|1|||
44195182|NCT02232893|78991011|FG000|Overall Study|Withdrawal by Subject|4|||
44195183|NCT02232893|78991012|FG001|Overall Study|Withdrawal by Subject|1|||
44195184|NCT02232893|78991011|FG000|Overall Study|Adverse Event|0|||
44195185|NCT02232893|78991012|FG001|Overall Study|Adverse Event|1|||
44195186|NCT02232893|78991011|FG000|Overall Study|Sponsor request early termination|0|||
44195187|NCT02232893|78991012|FG001|Overall Study|Sponsor request early termination|1|||
44195188|NCT02232893|78991011|FG000|Overall Study|Developed exclusion criteria|0|||
44195189|NCT02232893|78991012|FG001|Overall Study|Developed exclusion criteria|1|||
44195190|NCT02232893|78991011|FG000|Overall Study|Other|0|||
44195191|NCT02232893|78991012|FG001|Overall Study|Other|3|||
44195192|NCT02203721|78991020|FG000|Overall Study|Lost to Follow-up|1|||
44195193|NCT02203721|78991021|FG001|Overall Study|Lost to Follow-up|0|||
44195194|NCT02203721|78991020|FG000|Overall Study|Death|0|||
44195195|NCT02203721|78991021|FG001|Overall Study|Death|2|||
44195196|NCT02203721|78991020|FG000|Overall Study|Illness|0|||
44195197|NCT02203721|78991021|FG001|Overall Study|Illness|1|||
44195198|NCT01618695|78991031|FG000|Core Phase|Adverse Event|4|||
44195199|NCT01618695|78991032|FG001|Core Phase|Adverse Event|5|||
44195200|NCT01618695|78991033|FG002|Core Phase|Adverse Event|15|||
44195201|NCT01618695|78991034|FG003|Core Phase|Adverse Event|20|||
44195202|NCT01618695|78991031|FG000|Core Phase|Lost to Follow-up|0|||
44195203|NCT01618695|78991032|FG001|Core Phase|Lost to Follow-up|0|||
44195204|NCT01618695|78991033|FG002|Core Phase|Lost to Follow-up|1|||
44195205|NCT01618695|78991034|FG003|Core Phase|Lost to Follow-up|0|||
44195206|NCT01618695|78991031|FG000|Core Phase|Withdrawal by Subject|16|||
44195207|NCT01618695|78991032|FG001|Core Phase|Withdrawal by Subject|11|||
44195208|NCT01618695|78991033|FG002|Core Phase|Withdrawal by Subject|9|||
44195209|NCT01618695|78991034|FG003|Core Phase|Withdrawal by Subject|13|||
44195210|NCT01618695|78991031|FG000|Core Phase|Pregnancy|2|||
44195211|NCT01618695|78991032|FG001|Core Phase|Pregnancy|0|||
44195212|NCT01618695|78991033|FG002|Core Phase|Pregnancy|0|||
44195213|NCT01618695|78991034|FG003|Core Phase|Pregnancy|0|||
44195214|NCT01618695|78991031|FG000|Core Phase|Lack of Efficacy|1|||
44195215|NCT01618695|78991032|FG001|Core Phase|Lack of Efficacy|2|||
44195216|NCT01618695|78991033|FG002|Core Phase|Lack of Efficacy|1|||
44195217|NCT01618695|78991034|FG003|Core Phase|Lack of Efficacy|1|||
44195218|NCT01618695|78991031|FG000|Core Phase|Other than specified|1|||
44195219|NCT01618695|78991032|FG001|Core Phase|Other than specified|2|||
44195220|NCT01618695|78991033|FG002|Core Phase|Other than specified|2|||
44195221|NCT01618695|78991034|FG003|Core Phase|Other than specified|2|||
44195222|NCT01618695|78991031|FG000|Core Phase|Not treated|1|||
44195223|NCT01618695|78991032|FG001|Core Phase|Not treated|0|||
44195224|NCT01618695|78991033|FG002|Core Phase|Not treated|2|||
44195225|NCT01618695|78991034|FG003|Core Phase|Not treated|0|||
44195226|NCT01618695|78991031|FG000|Extension Phase|Lack of Efficacy|17|||
44195227|NCT01618695|78991032|FG001|Extension Phase|Lack of Efficacy|33|||
44195228|NCT01618695|78991033|FG002|Extension Phase|Lack of Efficacy|26|||
44195229|NCT01618695|78991034|FG003|Extension Phase|Lack of Efficacy|24|||
44195230|NCT01618695|78991031|FG000|Extension Phase|Pregnancy|2|||
44195231|NCT01618695|78991032|FG001|Extension Phase|Pregnancy|0|||
44195232|NCT01618695|78991033|FG002|Extension Phase|Pregnancy|1|||
44195233|NCT01618695|78991034|FG003|Extension Phase|Pregnancy|1|||
44195234|NCT01618695|78991031|FG000|Extension Phase|Withdrawal by Subject|43|||
44451484|NCT00500331|79460413|FG005|Overall Study|Lack of Efficacy|0|||
44195235|NCT01618695|78991032|FG001|Extension Phase|Withdrawal by Subject|48|||
44195236|NCT01618695|78991033|FG002|Extension Phase|Withdrawal by Subject|42|||
44195237|NCT01618695|78991034|FG003|Extension Phase|Withdrawal by Subject|33|||
44195238|NCT01618695|78991031|FG000|Extension Phase|Adverse Event|18|||
44195239|NCT01618695|78991032|FG001|Extension Phase|Adverse Event|16|||
44195240|NCT01618695|78991033|FG002|Extension Phase|Adverse Event|9|||
44195241|NCT01618695|78991034|FG003|Extension Phase|Adverse Event|20|||
44195242|NCT01618695|78991031|FG000|Extension Phase|Lost to Follow-up|2|||
44195243|NCT01618695|78991032|FG001|Extension Phase|Lost to Follow-up|1|||
44195244|NCT01618695|78991033|FG002|Extension Phase|Lost to Follow-up|1|||
44195245|NCT01618695|78991034|FG003|Extension Phase|Lost to Follow-up|1|||
44195246|NCT01618695|78991031|FG000|Extension Phase|Other than specified|13|||
44195247|NCT01618695|78991032|FG001|Extension Phase|Other than specified|18|||
44195248|NCT01618695|78991033|FG002|Extension Phase|Other than specified|13|||
44195249|NCT01618695|78991034|FG003|Extension Phase|Other than specified|18|||
44195250|NCT01896531|78991047|FG000|Overall Study|Death|57|||
44195251|NCT01896531|78991048|FG001|Overall Study|Death|59|||
44195252|NCT01896531|78991047|FG000|Overall Study|Lost to Follow-up|3|||
44195253|NCT01896531|78991048|FG001|Overall Study|Lost to Follow-up|0|||
44195254|NCT01896531|78991047|FG000|Overall Study|Non-compliance|0|||
44195255|NCT01896531|78991048|FG001|Overall Study|Non-compliance|1|||
44195256|NCT01896531|78991047|FG000|Overall Study|Study Ended by Sponsor|7|||
44195257|NCT01896531|78991048|FG001|Overall Study|Study Ended by Sponsor|20|||
44195258|NCT01896531|78991047|FG000|Overall Study|Withdrawal by Subject|3|||
44195259|NCT01896531|78991048|FG001|Overall Study|Withdrawal by Subject|2|||
44195260|NCT01896531|78991047|FG000|Overall Study|Death Prior to Treatment|1|||
44195261|NCT01896531|78991048|FG001|Overall Study|Death Prior to Treatment|0|||
44195262|NCT01618305|78991056|FG000|Overall Study|Death|0|||
44195263|NCT01618305|78991057|FG001|Overall Study|Death|1|||
44195264|NCT01618305|78991056|FG000|Overall Study|Lost to Follow-up|11|||
44195265|NCT01618305|78991057|FG001|Overall Study|Lost to Follow-up|7|||
44195266|NCT01618305|78991056|FG000|Overall Study|Protocol Violation|1|||
44195267|NCT01618305|78991057|FG001|Overall Study|Protocol Violation|0|||
44195268|NCT01618305|78991056|FG000|Overall Study|Withdrawal by Subject|3|||
44195269|NCT01618305|78991057|FG001|Overall Study|Withdrawal by Subject|2|||
44195270|NCT01886313|78991069|FG000|Overall Study|Adverse Event|1|||
44195271|NCT01886313|78991070|FG001|Overall Study|Adverse Event|1|||
44195272|NCT01896297|78991076|FG000|Overall Study|Died in post treatment phase|1|||
44195273|NCT01884675|78991082|FG000|Overall Study|Study closed/terminated|3|||
44195274|NCT01884675|78991083|FG001|Overall Study|Study closed/terminated|2|||
44195275|NCT01884597|78991094|FG000|Overall Study|Adverse Event|0|||
44195276|NCT01884597|78991095|FG001|Overall Study|Adverse Event|0|||
44195277|NCT01884597|78991096|FG002|Overall Study|Adverse Event|1|||
44195278|NCT01884597|78991094|FG000|Overall Study|Lack of Efficacy|1|||
44195279|NCT01884597|78991095|FG001|Overall Study|Lack of Efficacy|0|||
44195280|NCT01884597|78991096|FG002|Overall Study|Lack of Efficacy|0|||
44195281|NCT01884597|78991094|FG000|Overall Study|Death|0|||
44195282|NCT01884597|78991095|FG001|Overall Study|Death|1|||
44195283|NCT01884597|78991096|FG002|Overall Study|Death|0|||
44195284|NCT01895361|78991113|FG000|Overall Study|Adverse Event|1|||
44195285|NCT01895361|78991114|FG001|Overall Study|Adverse Event|1|||
44195286|NCT01895361|78991115|FG002|Overall Study|Adverse Event|3|||
44195287|NCT01895361|78991113|FG000|Overall Study|Death|2|||
44195288|NCT01895361|78991114|FG001|Overall Study|Death|1|||
44195289|NCT01895361|78991115|FG002|Overall Study|Death|2|||
44195290|NCT01895361|78991113|FG000|Overall Study|Lost to Follow-up|4|||
44195291|NCT01895361|78991114|FG001|Overall Study|Lost to Follow-up|4|||
44195292|NCT01895361|78991115|FG002|Overall Study|Lost to Follow-up|6|||
44195293|NCT01895361|78991113|FG000|Overall Study|Non-compliance with study|1|||
44195294|NCT01895361|78991114|FG001|Overall Study|Non-compliance with study|3|||
44195295|NCT01895361|78991115|FG002|Overall Study|Non-compliance with study|1|||
44195296|NCT01895361|78991113|FG000|Overall Study|Physician Decision|2|||
44195297|NCT01895361|78991114|FG001|Overall Study|Physician Decision|2|||
44195298|NCT01895361|78991115|FG002|Overall Study|Physician Decision|2|||
44195299|NCT01895361|78991113|FG000|Overall Study|Withdrawal by Subject|7|||
44195300|NCT01895361|78991114|FG001|Overall Study|Withdrawal by Subject|6|||
44195301|NCT01895361|78991115|FG002|Overall Study|Withdrawal by Subject|6|||
44195302|NCT01895361|78991113|FG000|Overall Study|Lack of Efficacy|0|||
44195303|NCT01895361|78991114|FG001|Overall Study|Lack of Efficacy|1|||
44195304|NCT01895361|78991115|FG002|Overall Study|Lack of Efficacy|0|||
44195305|NCT01895361|78991113|FG000|Overall Study|Reasons different from categories above|7|||
44195306|NCT01895361|78991114|FG001|Overall Study|Reasons different from categories above|3|||
44195307|NCT01895361|78991115|FG002|Overall Study|Reasons different from categories above|4|||
44195308|NCT01883895|78991123|FG000|Overall Study|Lost to Follow-up|2|||
44195309|NCT01864005|78991129|FG000|Overall Study|Protocol Violation|0|||
44195310|NCT01864005|78991130|FG001|Overall Study|Protocol Violation|1|||
44195311|NCT01864005|78991129|FG000|Overall Study|Withdrawal by Subject|0|||
44195312|NCT01864005|78991130|FG001|Overall Study|Withdrawal by Subject|1|||
44195313|NCT01864005|78991129|FG000|Overall Study|Incorrect enrolment|1|||
44195314|NCT01864005|78991130|FG001|Overall Study|Incorrect enrolment|0|||
44195315|NCT01864005|78991129|FG000|Overall Study|Disease need|1|||
44195316|NCT01864005|78991130|FG001|Overall Study|Disease need|1|||
44195317|NCT01864005|78991129|FG000|Overall Study|Need GP IIb/IIIa|1|||
44195318|NCT01864005|78991130|FG001|Overall Study|Need GP IIb/IIIa|3|||
44195319|NCT01863849|78991138|FG000|Overall Study|Lost to Follow-up|1|||
44195320|NCT01863849|78991139|FG001|Overall Study|Lost to Follow-up|0|||
44195321|NCT01863771|78991146|FG000|Induction Phase|Adverse Event|9|||
44195322|NCT01863771|78991147|FG001|Induction Phase|Adverse Event|0|||
44195323|NCT01863771|78991148|FG002|Induction Phase|Adverse Event|0|||
44195324|NCT01863771|78991149|FG003|Induction Phase|Adverse Event|0|||
44195325|NCT01863771|78991146|FG000|Induction Phase|Lack of Efficacy|10|||
44195326|NCT01863771|78991147|FG001|Induction Phase|Lack of Efficacy|0|||
44195327|NCT01863771|78991148|FG002|Induction Phase|Lack of Efficacy|0|||
44195328|NCT01863771|78991149|FG003|Induction Phase|Lack of Efficacy|0|||
44195329|NCT01863771|78991146|FG000|Induction Phase|Withdrawal by Subject|2|||
44195330|NCT01863771|78991147|FG001|Induction Phase|Withdrawal by Subject|0|||
44195331|NCT01863771|78991148|FG002|Induction Phase|Withdrawal by Subject|0|||
44195332|NCT01863771|78991149|FG003|Induction Phase|Withdrawal by Subject|0|||
44195333|NCT01863771|78991146|FG000|Maintenance Phase|Adverse Event|0|||
44195334|NCT01863771|78991147|FG001|Maintenance Phase|Adverse Event|0|||
44195335|NCT01863771|78991148|FG002|Maintenance Phase|Adverse Event|1|||
44195336|NCT01863771|78991149|FG003|Maintenance Phase|Adverse Event|1|||
44195337|NCT01863771|78991146|FG000|Maintenance Phase|Lack of Efficacy|0|||
44195338|NCT01863771|78991147|FG001|Maintenance Phase|Lack of Efficacy|3|||
44195339|NCT01863771|78991148|FG002|Maintenance Phase|Lack of Efficacy|7|||
44195340|NCT01863771|78991149|FG003|Maintenance Phase|Lack of Efficacy|38|||
44195341|NCT01863771|78991146|FG000|Maintenance Phase|Physician Decision|0|||
44195342|NCT01863771|78991147|FG001|Maintenance Phase|Physician Decision|0|||
44195343|NCT01863771|78991148|FG002|Maintenance Phase|Physician Decision|2|||
44195344|NCT01863771|78991149|FG003|Maintenance Phase|Physician Decision|1|||
44195345|NCT01863771|78991146|FG000|Maintenance Phase|Pregnancy|0|||
44195346|NCT01863771|78991147|FG001|Maintenance Phase|Pregnancy|1|||
44195347|NCT01863771|78991148|FG002|Maintenance Phase|Pregnancy|0|||
44195348|NCT01863771|78991149|FG003|Maintenance Phase|Pregnancy|0|||
44195349|NCT01863771|78991146|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44195350|NCT01863771|78991147|FG001|Maintenance Phase|Withdrawal by Subject|1|||
44195351|NCT01863771|78991148|FG002|Maintenance Phase|Withdrawal by Subject|2|||
44195352|NCT01863771|78991149|FG003|Maintenance Phase|Withdrawal by Subject|3|||
44195353|NCT01894581|78991159|FG000|Overall Study|Withdrawal by Subject|2|||
44195354|NCT01894581|78991160|FG001|Overall Study|Withdrawal by Subject|3|||
44195355|NCT01894581|78991159|FG000|Overall Study|Screen Failure|3|||
44195356|NCT01894581|78991160|FG001|Overall Study|Screen Failure|4|||
44195357|NCT01893411|78991169|FG000|Overall Study|Protocol Violation|1|||
44195358|NCT01893411|78991170|FG001|Overall Study|Protocol Violation|0|||
44195359|NCT01893411|78991171|FG002|Overall Study|Protocol Violation|0|||
44195360|NCT01893411|78991169|FG000|Overall Study|Physician Decision|1|||
44195361|NCT01893411|78991170|FG001|Overall Study|Physician Decision|1|||
44195362|NCT01893411|78991171|FG002|Overall Study|Physician Decision|2|||
44195363|NCT01893411|78991169|FG000|Overall Study|Lack of Efficacy|2|||
44195364|NCT01893411|78991170|FG001|Overall Study|Lack of Efficacy|1|||
44195365|NCT01893411|78991171|FG002|Overall Study|Lack of Efficacy|0|||
44195366|NCT01893411|78991169|FG000|Overall Study|Other|3|||
44195367|NCT01893411|78991170|FG001|Overall Study|Other|1|||
44195368|NCT01893411|78991171|FG002|Overall Study|Other|3|||
44195369|NCT01893411|78991169|FG000|Overall Study|Adverse Event|1|||
44195370|NCT01893411|78991170|FG001|Overall Study|Adverse Event|0|||
44195371|NCT01893411|78991171|FG002|Overall Study|Adverse Event|0|||
44195372|NCT01893411|78991169|FG000|Overall Study|Withdrawal by Subject|7|||
44195373|NCT01893411|78991170|FG001|Overall Study|Withdrawal by Subject|4|||
44195374|NCT01893411|78991171|FG002|Overall Study|Withdrawal by Subject|3|||
44195375|NCT01893411|78991169|FG000|Overall Study|Lost to Follow-up|2|||
44195376|NCT01893411|78991170|FG001|Overall Study|Lost to Follow-up|0|||
44195377|NCT01893411|78991171|FG002|Overall Study|Lost to Follow-up|1|||
44195378|NCT02232425|78991181|FG000|Overall Study|Lost to Follow-up|6|||
44195379|NCT02232425|78991182|FG001|Overall Study|Lost to Follow-up|2|||
44195380|NCT02232425|78991181|FG000|Overall Study|Adverse Event|2|||
44195381|NCT02232425|78991182|FG001|Overall Study|Adverse Event|0|||
44195382|NCT02232425|78991181|FG000|Overall Study|Withdrawal by Subject|5|||
44195383|NCT02232425|78991182|FG001|Overall Study|Withdrawal by Subject|6|||
44195384|NCT02232425|78991181|FG000|Overall Study|Lack of Efficacy|1|||
44195385|NCT02232425|78991182|FG001|Overall Study|Lack of Efficacy|0|||
44195386|NCT01631435|78991188|FG000|Overall Study|Adverse Event|2|||
44195387|NCT01631435|78991188|FG000|Overall Study|Withdrawal by Subject|2|||
44195388|NCT01631435|78991188|FG000|Overall Study|incomplete study procedure|5|||
44195389|NCT02230085|78991193|FG000|Overall Study|Physician Decision|1|||
44195390|NCT02230085|78991193|FG000|Overall Study|Withdrawal by Subject|3|||
44195391|NCT02202785|78991200|FG000|Overall Study|Study Terminated by Sponsor|1|||
44195392|NCT02202785|78991201|FG001|Overall Study|Study Terminated by Sponsor|6|||
44195393|NCT02202785|78991202|FG002|Overall Study|Study Terminated by Sponsor|4|||
44195394|NCT02202785|78991200|FG000|Overall Study|Withdrawal by Subject|0|||
44195395|NCT02202785|78991201|FG001|Overall Study|Withdrawal by Subject|1|||
44195396|NCT02202785|78991202|FG002|Overall Study|Withdrawal by Subject|0|||
44195397|NCT02202785|78991200|FG000|Overall Study|Lost to Follow-up|0|||
44195398|NCT02202785|78991201|FG001|Overall Study|Lost to Follow-up|1|||
44195399|NCT02202785|78991202|FG002|Overall Study|Lost to Follow-up|0|||
44195400|NCT02202785|78991200|FG000|Overall Study|Reason not Specified|10|||
44195401|NCT02202785|78991201|FG001|Overall Study|Reason not Specified|7|||
44195402|NCT02202785|78991202|FG002|Overall Study|Reason not Specified|13|||
44195403|NCT01882647|78991212|FG000|Overall Study|Lost to Follow-up|2|||
44195404|NCT01882647|78991213|FG001|Overall Study|Lost to Follow-up|2|||
44195405|NCT01882647|78991212|FG000|Overall Study|Withdrawal by Subject|0|||
44195406|NCT01882647|78991213|FG001|Overall Study|Withdrawal by Subject|4|||
44195407|NCT01882257|78991222|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
44195408|NCT01882257|78991223|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
44195409|NCT01882257|78991224|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
44195410|NCT01882257|78991222|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
44195411|NCT01882257|78991223|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
44195412|NCT01882257|78991224|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
44195413|NCT02202551|78991235|FG000|Overall Study|Adverse Event|8|||
44195414|NCT02202551|78991236|FG001|Overall Study|Adverse Event|19|||
44195415|NCT02202551|78991237|FG002|Overall Study|Adverse Event|5|||
44195416|NCT02202551|78991238|FG003|Overall Study|Adverse Event|9|||
44195417|NCT02202551|78991235|FG000|Overall Study|Death|3|||
44195418|NCT02202551|78991236|FG001|Overall Study|Death|2|||
44195419|NCT02202551|78991237|FG002|Overall Study|Death|1|||
44195420|NCT02202551|78991238|FG003|Overall Study|Death|1|||
44195421|NCT02202551|78991235|FG000|Overall Study|Lost to Follow-up|0|||
44195422|NCT02202551|78991236|FG001|Overall Study|Lost to Follow-up|1|||
44195423|NCT02202551|78991237|FG002|Overall Study|Lost to Follow-up|0|||
44195424|NCT02202551|78991238|FG003|Overall Study|Lost to Follow-up|1|||
44195425|NCT02202551|78991235|FG000|Overall Study|Needed to take excluded medication|0|||
44195426|NCT02202551|78991236|FG001|Overall Study|Needed to take excluded medication|2|||
44195427|NCT02202551|78991237|FG002|Overall Study|Needed to take excluded medication|0|||
44195428|NCT02202551|78991238|FG003|Overall Study|Needed to take excluded medication|1|||
44195429|NCT02202551|78991235|FG000|Overall Study|Subject moved away|0|||
44195430|NCT02202551|78991236|FG001|Overall Study|Subject moved away|1|||
44195431|NCT02202551|78991237|FG002|Overall Study|Subject moved away|0|||
44195432|NCT02202551|78991238|FG003|Overall Study|Subject moved away|0|||
44195433|NCT02202551|78991235|FG000|Overall Study|DBS surgery|3|||
44195434|NCT02202551|78991236|FG001|Overall Study|DBS surgery|0|||
44195435|NCT02202551|78991237|FG002|Overall Study|DBS surgery|0|||
44195436|NCT02202551|78991238|FG003|Overall Study|DBS surgery|0|||
44195437|NCT02202551|78991235|FG000|Overall Study|Dyskinesia upon taper|1|||
44195438|NCT02202551|78991236|FG001|Overall Study|Dyskinesia upon taper|0|||
44195439|NCT02202551|78991237|FG002|Overall Study|Dyskinesia upon taper|0|||
44195440|NCT02202551|78991238|FG003|Overall Study|Dyskinesia upon taper|0|||
44195441|NCT02202551|78991235|FG000|Overall Study|Lack of Efficacy|0|||
44195442|NCT02202551|78991236|FG001|Overall Study|Lack of Efficacy|1|||
44195443|NCT02202551|78991237|FG002|Overall Study|Lack of Efficacy|0|||
44195444|NCT02202551|78991238|FG003|Overall Study|Lack of Efficacy|0|||
44195445|NCT02202551|78991235|FG000|Overall Study|Physician Decision|1|||
44195446|NCT02202551|78991236|FG001|Overall Study|Physician Decision|0|||
44195447|NCT02202551|78991237|FG002|Overall Study|Physician Decision|0|||
44266411|NCT03291067|79174356|FG003|Overall Study|Lost to Follow-up|1|||
44266412|NCT03291067|79174353|FG000|Overall Study|Physician Decision|0|||
44361290|NCT01157117|79366948|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
44451485|NCT00500331|79460414|FG006|Overall Study|Lack of Efficacy|0|||
44195448|NCT02202551|78991238|FG003|Overall Study|Physician Decision|0|||
44195449|NCT02202551|78991235|FG000|Overall Study|Site closure|3|||
44195450|NCT02202551|78991236|FG001|Overall Study|Site closure|0|||
44195451|NCT02202551|78991237|FG002|Overall Study|Site closure|0|||
44195452|NCT02202551|78991238|FG003|Overall Study|Site closure|1|||
44195453|NCT02202551|78991235|FG000|Overall Study|Unable to complete visits per protocol|1|||
44195454|NCT02202551|78991236|FG001|Overall Study|Unable to complete visits per protocol|0|||
44195455|NCT02202551|78991237|FG002|Overall Study|Unable to complete visits per protocol|0|||
44195456|NCT02202551|78991238|FG003|Overall Study|Unable to complete visits per protocol|0|||
44195457|NCT02202551|78991235|FG000|Overall Study|Worsening Dyskinesia|0|||
44195458|NCT02202551|78991236|FG001|Overall Study|Worsening Dyskinesia|0|||
44195459|NCT02202551|78991237|FG002|Overall Study|Worsening Dyskinesia|0|||
44195460|NCT02202551|78991238|FG003|Overall Study|Worsening Dyskinesia|1|||
44195461|NCT02202551|78991235|FG000|Overall Study|Protocol Violation|0|||
44195462|NCT02202551|78991236|FG001|Overall Study|Protocol Violation|1|||
44195463|NCT02202551|78991237|FG002|Overall Study|Protocol Violation|0|||
44195464|NCT02202551|78991238|FG003|Overall Study|Protocol Violation|0|||
44195465|NCT02202551|78991235|FG000|Overall Study|Sponsor's decision|2|||
44195466|NCT02202551|78991236|FG001|Overall Study|Sponsor's decision|0|||
44195467|NCT02202551|78991237|FG002|Overall Study|Sponsor's decision|0|||
44195468|NCT02202551|78991238|FG003|Overall Study|Sponsor's decision|0|||
44195469|NCT02202551|78991235|FG000|Overall Study|Subject unwilling to proceed|1|||
44195470|NCT02202551|78991236|FG001|Overall Study|Subject unwilling to proceed|5|||
44195471|NCT02202551|78991237|FG002|Overall Study|Subject unwilling to proceed|3|||
44195472|NCT02202551|78991238|FG003|Overall Study|Subject unwilling to proceed|5|||
44195473|NCT02202551|78991235|FG000|Overall Study|Subject consent withdrawn|0|||
44195474|NCT02202551|78991236|FG001|Overall Study|Subject consent withdrawn|3|||
44195475|NCT02202551|78991237|FG002|Overall Study|Subject consent withdrawn|1|||
44195476|NCT02202551|78991238|FG003|Overall Study|Subject consent withdrawn|2|||
44195477|NCT02202551|78991235|FG000|Overall Study|eGFR<50mL/min/m2|2|||
44195478|NCT02202551|78991236|FG001|Overall Study|eGFR<50mL/min/m2|2|||
44195479|NCT02202551|78991237|FG002|Overall Study|eGFR<50mL/min/m2|0|||
44195480|NCT02202551|78991238|FG003|Overall Study|eGFR<50mL/min/m2|1|||
44195481|NCT02202317|78991252|FG000|Overall Study|Lost to Follow-up|1|||
44195482|NCT02118337|78991265|FG000|Overall Study|Other|1|||
44195483|NCT02118337|78991266|FG001|Overall Study|Other|0|||
44195484|NCT02118337|78991267|FG002|Overall Study|Other|0|||
44195485|NCT02118337|78991268|FG003|Overall Study|Other|0|||
44195486|NCT02118337|78991269|FG004|Overall Study|Other|2|||
44195487|NCT02118337|78991270|FG005|Overall Study|Other|3|||
44195488|NCT02118337|78991271|FG006|Overall Study|Other|1|||
44195489|NCT02118337|78991272|FG007|Overall Study|Other|28|||
44195490|NCT02118337|78991273|FG008|Overall Study|Other|15|||
44195491|NCT02118337|78991265|FG000|Overall Study|Lost to Follow-up|0|||
44195492|NCT02118337|78991266|FG001|Overall Study|Lost to Follow-up|0|||
44195493|NCT02118337|78991267|FG002|Overall Study|Lost to Follow-up|0|||
44195494|NCT02118337|78991268|FG003|Overall Study|Lost to Follow-up|0|||
44195495|NCT02118337|78991269|FG004|Overall Study|Lost to Follow-up|0|||
44195496|NCT02118337|78991270|FG005|Overall Study|Lost to Follow-up|0|||
44195497|NCT02118337|78991271|FG006|Overall Study|Lost to Follow-up|0|||
44195498|NCT02118337|78991272|FG007|Overall Study|Lost to Follow-up|1|||
44195499|NCT02118337|78991273|FG008|Overall Study|Lost to Follow-up|0|||
44195500|NCT02118337|78991265|FG000|Overall Study|Withdrawal by Subject|1|||
44195501|NCT02118337|78991266|FG001|Overall Study|Withdrawal by Subject|3|||
44195502|NCT02118337|78991267|FG002|Overall Study|Withdrawal by Subject|2|||
44195503|NCT02118337|78991268|FG003|Overall Study|Withdrawal by Subject|1|||
44195504|NCT02118337|78991269|FG004|Overall Study|Withdrawal by Subject|2|||
44195505|NCT02118337|78991270|FG005|Overall Study|Withdrawal by Subject|2|||
44195506|NCT02118337|78991271|FG006|Overall Study|Withdrawal by Subject|1|||
44195507|NCT02118337|78991272|FG007|Overall Study|Withdrawal by Subject|4|||
44195508|NCT02118337|78991273|FG008|Overall Study|Withdrawal by Subject|2|||
44195509|NCT02118337|78991265|FG000|Overall Study|Death|2|||
44195510|NCT02118337|78991266|FG001|Overall Study|Death|2|||
44195511|NCT02118337|78991267|FG002|Overall Study|Death|1|||
44195512|NCT02118337|78991268|FG003|Overall Study|Death|2|||
44195513|NCT02118337|78991269|FG004|Overall Study|Death|5|||
44195514|NCT02118337|78991270|FG005|Overall Study|Death|1|||
44195515|NCT02118337|78991271|FG006|Overall Study|Death|2|||
44195516|NCT02118337|78991272|FG007|Overall Study|Death|9|||
44195517|NCT02118337|78991273|FG008|Overall Study|Death|4|||
44195518|NCT02117713|78991297|FG000|Week 48|Adverse Event|4|||
44195519|NCT02117713|78991297|FG000|Week 48|Withdrawal by caregiver|2|||
44195520|NCT02117713|78991297|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
44195521|NCT02117713|78991297|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
44195522|NCT02117713|78991297|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
44195523|NCT02117713|78991297|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
44195524|NCT02105467|78991311|FG000|Period 1|Lost to Follow-up|1|||
44195525|NCT02105467|78991312|FG001|Period 1|Lost to Follow-up|0|||
44266413|NCT03291067|79174354|FG001|Overall Study|Physician Decision|0|||
44266414|NCT03291067|79174355|FG002|Overall Study|Physician Decision|1|||
44195526|NCT02105467|78991311|FG000|Period 1|Death|1|||
44195527|NCT02105467|78991312|FG001|Period 1|Death|0|||
44195528|NCT02105467|78991311|FG000|Period 2|Lost to Follow-up|1|||
44195529|NCT02105467|78991312|FG001|Period 2|Lost to Follow-up|0|||
44195530|NCT02105467|78991311|FG000|Period 2|Death|1|||
44195531|NCT02105467|78991312|FG001|Period 2|Death|0|||
44266415|NCT03291067|79174356|FG003|Overall Study|Physician Decision|0|||
44195532|NCT02105467|78991311|FG000|Period 2|Withdrawal by Subject|0|||
44195533|NCT02105467|78991312|FG001|Period 2|Withdrawal by Subject|2|||
44195534|NCT02105467|78991311|FG000|Period 3|Lost to Follow-up|0|||
44195535|NCT02105467|78991312|FG001|Period 3|Lost to Follow-up|1|||
44195536|NCT02202161|78991327|FG000|Overall Study|Adverse Event|1|||
44195537|NCT02202161|78991328|FG001|Overall Study|Adverse Event|1|||
44195538|NCT02202161|78991329|FG002|Overall Study|Adverse Event|0|||
44195539|NCT02202161|78991330|FG003|Overall Study|Adverse Event|0|||
44195540|NCT02202161|78991331|FG004|Overall Study|Adverse Event|0|||
44195541|NCT02202161|78991332|FG005|Overall Study|Adverse Event|1|||
44266416|NCT03291067|79174353|FG000|Overall Study|Protocol Violation|5|||
44195542|NCT02202161|78991333|FG006|Overall Study|Adverse Event|0|||
44195543|NCT02202161|78991334|FG007|Overall Study|Adverse Event|0|||
44195544|NCT02202161|78991327|FG000|Overall Study|Did not meet continuation criteria|0|||
44195545|NCT02202161|78991328|FG001|Overall Study|Did not meet continuation criteria|0|||
44195546|NCT02202161|78991329|FG002|Overall Study|Did not meet continuation criteria|0|||
44195547|NCT02202161|78991330|FG003|Overall Study|Did not meet continuation criteria|0|||
44195548|NCT02202161|78991331|FG004|Overall Study|Did not meet continuation criteria|0|||
44195549|NCT02202161|78991332|FG005|Overall Study|Did not meet continuation criteria|0|||
44195550|NCT02202161|78991333|FG006|Overall Study|Did not meet continuation criteria|0|||
44195551|NCT02202161|78991334|FG007|Overall Study|Did not meet continuation criteria|3|||
44195552|NCT02202161|78991327|FG000|Overall Study|Physician Decision|0|||
44195553|NCT02202161|78991328|FG001|Overall Study|Physician Decision|0|||
44195554|NCT02202161|78991329|FG002|Overall Study|Physician Decision|0|||
44195555|NCT02202161|78991330|FG003|Overall Study|Physician Decision|0|||
44195556|NCT02202161|78991331|FG004|Overall Study|Physician Decision|0|||
44195557|NCT02202161|78991332|FG005|Overall Study|Physician Decision|0|||
44195558|NCT02202161|78991333|FG006|Overall Study|Physician Decision|0|||
44195559|NCT02202161|78991334|FG007|Overall Study|Physician Decision|3|||
44195560|NCT02202161|78991327|FG000|Overall Study|Withdrawal by Subject|0|||
44195561|NCT02202161|78991328|FG001|Overall Study|Withdrawal by Subject|0|||
44195562|NCT02202161|78991329|FG002|Overall Study|Withdrawal by Subject|0|||
44195563|NCT02202161|78991330|FG003|Overall Study|Withdrawal by Subject|0|||
44195564|NCT02202161|78991331|FG004|Overall Study|Withdrawal by Subject|1|||
44195565|NCT02202161|78991332|FG005|Overall Study|Withdrawal by Subject|0|||
44195566|NCT02202161|78991333|FG006|Overall Study|Withdrawal by Subject|0|||
44195567|NCT02202161|78991334|FG007|Overall Study|Withdrawal by Subject|0|||
44195568|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Adverse Event|76|||
44195569|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Adverse Event|0|||
44195570|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Adverse Event|0|||
44195571|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Death|3|||
44195572|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Death|0|||
44195573|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Death|0|||
44195574|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
44195575|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
44195576|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
44195577|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Physician Decision|9|||
44195578|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Physician Decision|0|||
44195579|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Physician Decision|0|||
44195580|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
44195581|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
44195582|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
44195583|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Disease progression|45|||
44195584|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Disease progression|0|||
44195585|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Disease progression|0|||
44195586|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
44195587|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
44195588|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
44195589|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
44195590|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
44195591|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
44195592|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
44195593|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
44195594|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
44195595|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
44195596|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
44195597|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
44195598|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
44195599|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
44195600|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
44195601|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
44195602|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
44195603|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
44195604|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
44266417|NCT03291067|79174354|FG001|Overall Study|Protocol Violation|3|||
44195605|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
44195606|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
44195607|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
44195608|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
44195609|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
44266418|NCT03291067|79174355|FG002|Overall Study|Protocol Violation|4|||
44195610|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
44195611|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
44195612|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
44195613|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Promotor request|1|||
44195614|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Promotor request|0|||
44195615|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Promotor request|0|||
44195616|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
44195617|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
44195618|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
44195619|NCT01461928|78991353|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
44195620|NCT01461928|78991354|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
44195621|NCT01461928|78991355|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
44195622|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Death|3|||
44195623|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Death|0|||
44195624|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Death|0|||
44195625|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
44195626|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
44195627|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
44195628|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
44195629|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
44195630|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
44195631|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Diseases progression|91|||
44195632|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Diseases progression|0|||
44195633|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Diseases progression|0|||
44195634|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Adverse Event|70|||
44195635|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Adverse Event|0|||
44195636|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Adverse Event|0|||
44195637|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Physician Decision|9|||
44195638|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Physician Decision|0|||
44195639|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Physician Decision|0|||
44195640|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
44195641|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
44195642|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
44195643|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
44195644|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
44195645|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
44195646|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
44195647|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
44195648|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
44195649|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Not compliant|1|||
44195650|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Not compliant|0|||
44195651|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Not compliant|0|||
44195652|NCT01461928|78991353|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
44195653|NCT01461928|78991354|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
44195654|NCT01461928|78991355|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
44195655|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Adverse Event|0|||
44195656|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Adverse Event|2|||
44195657|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Adverse Event|0|||
44195658|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Death|0|||
44195659|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Death|10|||
44195660|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Death|8|||
44195661|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Physician Decision|0|||
44195662|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Physician Decision|0|||
44195663|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Physician Decision|4|||
44195664|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
44195665|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
44195666|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
44195667|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Moved to another town|0|||
44195668|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Moved to another town|1|||
44195669|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Moved to another town|0|||
44195670|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Disease progression|0|||
44195671|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Disease progression|0|||
44195672|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Disease progression|3|||
44195673|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
44195674|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
44195675|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
44195676|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
44195677|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
44195678|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
44195679|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
44195680|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
44195681|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
44195682|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
44195683|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
44195684|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
44195685|NCT01461928|78991353|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
44195686|NCT01461928|78991354|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
44195687|NCT01461928|78991355|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
44195688|NCT03097991|78991368|FG000|Overall Study|Didn't meet study criteria|8|||
44195689|NCT03097991|78991369|FG001|Overall Study|Didn't meet study criteria|0|||
44195690|NCT03097991|78991368|FG000|Overall Study|Withdrawal by Subject|12|||
44195691|NCT03097991|78991369|FG001|Overall Study|Withdrawal by Subject|6|||
44195692|NCT03097991|78991368|FG000|Overall Study|Death of Baby|3|||
44195693|NCT03097991|78991369|FG001|Overall Study|Death of Baby|1|||
44195694|NCT03097991|78991368|FG000|Overall Study|Lost to Follow-up|24|||
44195695|NCT03097991|78991369|FG001|Overall Study|Lost to Follow-up|38|||
44195696|NCT03097991|78991368|FG000|Overall Study|Adverse Event|3|||
44195697|NCT03097991|78991369|FG001|Overall Study|Adverse Event|5|||
44195698|NCT02623205|78991381|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
44195699|NCT02623205|78991382|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
44195700|NCT01500694|78991391|FG000|Overall Study|Adverse Event|4|||
44195701|NCT01500694|78991392|FG001|Overall Study|Adverse Event|3|||
44195702|NCT01500694|78991391|FG000|Overall Study|Protocol Violation|0|||
44195703|NCT01500694|78991392|FG001|Overall Study|Protocol Violation|1|||
44195704|NCT01500694|78991391|FG000|Overall Study|Withdrawal by Subject|23|||
44195705|NCT01500694|78991392|FG001|Overall Study|Withdrawal by Subject|14|||
44195706|NCT01500694|78991391|FG000|Overall Study|Lost to Follow-up|2|||
44195707|NCT01500694|78991392|FG001|Overall Study|Lost to Follow-up|3|||
44195708|NCT01500694|78991391|FG000|Overall Study|Lack of Efficacy|14|||
44195709|NCT01500694|78991392|FG001|Overall Study|Lack of Efficacy|5|||
44195710|NCT01500694|78991391|FG000|Overall Study|Other|9|||
44195711|NCT01500694|78991392|FG001|Overall Study|Other|3|||
44195712|NCT01500382|78991402|FG000|Washout Period|Study site went out of business|0|||
44195713|NCT01500382|78991403|FG001|Washout Period|Study site went out of business|0|||
44195714|NCT01500382|78991404|FG002|Washout Period|Study site went out of business|1|||
44195715|NCT01500382|78991405|FG003|Washout Period|Study site went out of business|0|||
44195716|NCT02137837|78991418|FG000|Overall Study|Adverse Event|0|||
44195717|NCT02137837|78991419|FG001|Overall Study|Adverse Event|2|||
44195718|NCT02137837|78991420|FG002|Overall Study|Adverse Event|1|||
44195719|NCT02137837|78991418|FG000|Overall Study|Refusal unrelated to adverse event|2|||
44195720|NCT02137837|78991419|FG001|Overall Study|Refusal unrelated to adverse event|2|||
44195721|NCT02137837|78991420|FG002|Overall Study|Refusal unrelated to adverse event|1|||
44195722|NCT02137837|78991418|FG000|Overall Study|Progression/relapse|9|||
44451486|NCT00500331|79460408|FG000|Overall Study|Liver function test abnormality|0|||
44451487|NCT00500331|79460409|FG001|Overall Study|Liver function test abnormality|0|||
44195723|NCT02137837|78991419|FG001|Overall Study|Progression/relapse|7|||
44195724|NCT02137837|78991420|FG002|Overall Study|Progression/relapse|7|||
44195725|NCT02137837|78991418|FG000|Overall Study|Not protocol specified|2|||
44195726|NCT02137837|78991419|FG001|Overall Study|Not protocol specified|1|||
44195727|NCT02137837|78991420|FG002|Overall Study|Not protocol specified|3|||
44195728|NCT01483690|78991435|FG000|Overall Study|Adverse Event|1|||
44195729|NCT01483690|78991436|FG001|Overall Study|Adverse Event|2|||
44195730|NCT01483690|78991435|FG000|Overall Study|clinical deterioration|1|||
44195731|NCT01483690|78991436|FG001|Overall Study|clinical deterioration|0|||
44195732|NCT01483690|78991435|FG000|Overall Study|Physician Decision|0|||
44195733|NCT01483690|78991436|FG001|Overall Study|Physician Decision|2|||
44195734|NCT01483690|78991435|FG000|Overall Study|exclusionary procedure|0|||
44195735|NCT01483690|78991436|FG001|Overall Study|exclusionary procedure|1|||
44195736|NCT02104765|78991449|FG000|Overall Study|Lost to Follow-up|0|||
44266419|NCT03291067|79174356|FG003|Overall Study|Protocol Violation|2|||
44266420|NCT03291067|79174353|FG000|Overall Study|Withdrawal by Subject|3|||
44266421|NCT03291067|79174354|FG001|Overall Study|Withdrawal by Subject|4|||
44266422|NCT03291067|79174355|FG002|Overall Study|Withdrawal by Subject|7|||
44266423|NCT03291067|79174356|FG003|Overall Study|Withdrawal by Subject|5|||
44266424|NCT03291067|79174353|FG000|Overall Study|Other|0|||
44195737|NCT02104765|78991450|FG001|Overall Study|Lost to Follow-up|0|||
44195738|NCT02104765|78991451|FG002|Overall Study|Lost to Follow-up|1|||
44266425|NCT03291067|79174354|FG001|Overall Study|Other|4|||
44451488|NCT00500331|79460410|FG002|Overall Study|Liver function test abnormality|1|||
44195739|NCT02104765|78991452|FG003|Overall Study|Lost to Follow-up|0|||
44195740|NCT02104765|78991453|FG004|Overall Study|Lost to Follow-up|0|||
44266426|NCT03291067|79174355|FG002|Overall Study|Other|4|||
44266427|NCT03291067|79174356|FG003|Overall Study|Other|6|||
44543044|NCT03655717|79555921|FG021|Overall Study|Lost to Follow-up|0|||
44195741|NCT02104765|78991454|FG005|Overall Study|Lost to Follow-up|0|||
44195742|NCT02104765|78991455|FG006|Overall Study|Lost to Follow-up|0|||
44195743|NCT02104765|78991449|FG000|Overall Study|Withdrawal by Subject|0|||
44195744|NCT02104765|78991450|FG001|Overall Study|Withdrawal by Subject|0|||
44195745|NCT02104765|78991451|FG002|Overall Study|Withdrawal by Subject|0|||
44195746|NCT02104765|78991452|FG003|Overall Study|Withdrawal by Subject|1|||
44195747|NCT02104765|78991453|FG004|Overall Study|Withdrawal by Subject|1|||
44195748|NCT02104765|78991454|FG005|Overall Study|Withdrawal by Subject|0|||
44195749|NCT02104765|78991455|FG006|Overall Study|Withdrawal by Subject|1|||
44195750|NCT01483144|78991480|FG000|Overall Study|Adverse Event|9|||
44195751|NCT01483144|78991481|FG001|Overall Study|Adverse Event|4|||
44195752|NCT01483144|78991482|FG002|Overall Study|Adverse Event|6|||
44195753|NCT01483144|78991480|FG000|Overall Study|Withdrawal by Subject|0|||
44195754|NCT01483144|78991481|FG001|Overall Study|Withdrawal by Subject|2|||
44195755|NCT01483144|78991482|FG002|Overall Study|Withdrawal by Subject|5|||
44195756|NCT01483144|78991480|FG000|Overall Study|Physician Decision|1|||
44195757|NCT01483144|78991481|FG001|Overall Study|Physician Decision|0|||
44195758|NCT01483144|78991482|FG002|Overall Study|Physician Decision|0|||
44195759|NCT01483144|78991480|FG000|Overall Study|Lost to Follow-up|2|||
44195760|NCT01483144|78991481|FG001|Overall Study|Lost to Follow-up|4|||
44195761|NCT01483144|78991482|FG002|Overall Study|Lost to Follow-up|1|||
44195762|NCT01483144|78991480|FG000|Overall Study|Protocol Violation|3|||
44195763|NCT01483144|78991481|FG001|Overall Study|Protocol Violation|3|||
44195764|NCT01483144|78991482|FG002|Overall Study|Protocol Violation|3|||
44195765|NCT01881789|78991496|FG000|Overall Study|Withdrawal by Subject|0|||
44195766|NCT01881789|78991497|FG001|Overall Study|Withdrawal by Subject|2|||
44195767|NCT01881789|78991498|FG002|Overall Study|Withdrawal by Subject|1|||
44195768|NCT01881789|78991499|FG003|Overall Study|Withdrawal by Subject|0|||
44195769|NCT01881789|78991500|FG004|Overall Study|Withdrawal by Subject|1|||
44195770|NCT01881789|78991501|FG005|Overall Study|Withdrawal by Subject|1|||
44195771|NCT01881789|78991496|FG000|Overall Study|Study Terminated by Sponsor|0|||
44195772|NCT01881789|78991497|FG001|Overall Study|Study Terminated by Sponsor|0|||
44195773|NCT01881789|78991498|FG002|Overall Study|Study Terminated by Sponsor|0|||
44195774|NCT01881789|78991499|FG003|Overall Study|Study Terminated by Sponsor|0|||
44195775|NCT01881789|78991500|FG004|Overall Study|Study Terminated by Sponsor|0|||
44195776|NCT01881789|78991501|FG005|Overall Study|Study Terminated by Sponsor|1|||
44195777|NCT01881789|78991496|FG000|Overall Study|Other|3|||
44195778|NCT01881789|78991497|FG001|Overall Study|Other|5|||
44195779|NCT01881789|78991498|FG002|Overall Study|Other|2|||
44195780|NCT01881789|78991499|FG003|Overall Study|Other|3|||
44195781|NCT01881789|78991500|FG004|Overall Study|Other|1|||
44195782|NCT01881789|78991501|FG005|Overall Study|Other|1|||
44195783|NCT02075203|78991519|FG000|Overall Study|Withdrawal by Subject|1|||
44195784|NCT02075203|78991520|FG001|Overall Study|Withdrawal by Subject|0|||
44195785|NCT02075203|78991521|FG002|Overall Study|Withdrawal by Subject|1|||
44195786|NCT02075203|78991519|FG000|Overall Study|Adverse Event|1|||
44195787|NCT02075203|78991520|FG001|Overall Study|Adverse Event|0|||
44195788|NCT02075203|78991521|FG002|Overall Study|Adverse Event|0|||
44195789|NCT02075203|78991519|FG000|Overall Study|participant refused to use contraception|1|||
44195790|NCT02075203|78991520|FG001|Overall Study|participant refused to use contraception|0|||
44195791|NCT02075203|78991521|FG002|Overall Study|participant refused to use contraception|0|||
44195792|NCT01892163|78991531|FG000|Overall Study|Death|1|||
44195793|NCT01892163|78991532|FG001|Overall Study|Death|1|||
44195794|NCT01892163|78991531|FG000|Overall Study|Lost to Follow-up|1|||
44195795|NCT01892163|78991532|FG001|Overall Study|Lost to Follow-up|0|||
44195796|NCT01881009|78991540|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
44195797|NCT01881009|78991541|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
44266428|NCT02841280|79174368|FG000|Overall Study|Adverse Event|2|||
44266429|NCT02841280|79174369|FG001|Overall Study|Adverse Event|1|||
44266430|NCT02841280|79174368|FG000|Overall Study|Death|1|||
44266431|NCT02841280|79174369|FG001|Overall Study|Death|0|||
44266432|NCT02841280|79174368|FG000|Overall Study|Lost to Follow-up|2|||
44266433|NCT02841280|79174369|FG001|Overall Study|Lost to Follow-up|2|||
44195798|NCT01500226|78991550|FG000|Overall Study|Adverse Event|31|||
44195799|NCT01500226|78991551|FG001|Overall Study|Adverse Event|38|||
44195800|NCT01500226|78991550|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
44195801|NCT01500226|78991551|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
44195802|NCT01500226|78991550|FG000|Overall Study|Withdrawal by Subject|93|||
44195803|NCT01500226|78991551|FG001|Overall Study|Withdrawal by Subject|96|||
44195804|NCT01500226|78991550|FG000|Overall Study|Death|12|||
44195805|NCT01500226|78991551|FG001|Overall Study|Death|4|||
44195806|NCT01500226|78991550|FG000|Overall Study|Disease Progression|16|||
44195807|NCT01500226|78991551|FG001|Overall Study|Disease Progression|14|||
44195808|NCT01500226|78991550|FG000|Overall Study|Protocol Violation|53|||
44195809|NCT01500226|78991551|FG001|Overall Study|Protocol Violation|39|||
44195810|NCT01500226|78991550|FG000|Overall Study|Physician Decision|17|||
44195811|NCT01500226|78991551|FG001|Overall Study|Physician Decision|15|||
44195812|NCT01500226|78991550|FG000|Overall Study|Lack of Efficacy|14|||
44195813|NCT01500226|78991551|FG001|Overall Study|Lack of Efficacy|30|||
44195814|NCT01500226|78991550|FG000|Overall Study|Lost to Follow-up|9|||
44195815|NCT01500226|78991551|FG001|Overall Study|Lost to Follow-up|5|||
44195816|NCT01500226|78991550|FG000|Overall Study|Other Reasons|19|||
44195817|NCT01500226|78991551|FG001|Overall Study|Other Reasons|16|||
44195818|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
44195819|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
44195820|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
44195821|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
44195822|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
44195823|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
44195824|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
44195825|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
44195826|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
44195827|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
44195828|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Other|1|||
44195829|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Other|1|||
44195830|NCT02075047|78991559|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
44195831|NCT02075047|78991560|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
44195832|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
44195833|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
44195834|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
44195835|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
44195836|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
44195837|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
44195838|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
44195839|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
44195840|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
44195841|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
44195842|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Other|1|||
44195843|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Other|2|||
44195844|NCT02075047|78991559|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
44195845|NCT02075047|78991560|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
44195846|NCT01859949|78991568|FG000|Overall Study|Family Matters|0|||
44195847|NCT01859949|78991569|FG001|Overall Study|Family Matters|1|||
44266434|NCT02841280|79174368|FG000|Overall Study|Withdrawal by Subject|7|||
44195848|NCT01859949|78991568|FG000|Overall Study|Physician Decision|2|||
44195849|NCT01859949|78991569|FG001|Overall Study|Physician Decision|4|||
44195850|NCT01859949|78991568|FG000|Overall Study|Withdrawal by Subject|11|||
44266435|NCT02841280|79174369|FG001|Overall Study|Withdrawal by Subject|3|||
44195851|NCT01859949|78991569|FG001|Overall Study|Withdrawal by Subject|10|||
44195852|NCT01859949|78991568|FG000|Overall Study|Protocol Violation|1|||
44195853|NCT01859949|78991569|FG001|Overall Study|Protocol Violation|1|||
44195854|NCT01859949|78991568|FG000|Overall Study|Adverse Event|0|||
44195855|NCT01859949|78991569|FG001|Overall Study|Adverse Event|1|||
44195856|NCT01859793|78991577|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
44195857|NCT01859793|78991578|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
44195858|NCT01859793|78991577|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
44195859|NCT01859793|78991578|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
44195860|NCT01859793|78991577|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
44195861|NCT01859793|78991578|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
44195862|NCT01859793|78991577|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
44195863|NCT01859793|78991578|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
44195864|NCT01859715|78991587|FG000|Overall Study|No 2nd VAS|16|||
44266436|NCT02841280|79174368|FG000|Overall Study|Stop Point: BP above threshold|2|||
44266437|NCT02841280|79174369|FG001|Overall Study|Stop Point: BP above threshold|0|||
44266438|NCT02345330|79174383|FG000|Overall Study|Death|1|||
44266439|NCT02345330|79174383|FG000|Overall Study|Progressive Disease|2|||
44266440|NCT01513343|79174398|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
44266441|NCT01513343|79174399|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
44266442|NCT01513343|79174398|FG000|Post Data Collection|Dropped/withdrew from study|7|||
44266443|NCT01513343|79174399|FG001|Post Data Collection|Dropped/withdrew from study|1|||
44266444|NCT01513343|79174398|FG000|Post Data Collection|Lost to Follow-up|10|||
44266445|NCT01513343|79174399|FG001|Post Data Collection|Lost to Follow-up|23|||
44266446|NCT01513343|79174398|FG000|6-month Follow-up|Lost to Follow-up|28|||
44266447|NCT01513343|79174399|FG001|6-month Follow-up|Lost to Follow-up|17|||
44266448|NCT01513343|79174398|FG000|12-month Follow-up|Lost to Follow-up|10|||
44266449|NCT01513343|79174399|FG001|12-month Follow-up|Lost to Follow-up|3|||
44266450|NCT01440816|79174426|FG000|Overall Study|Disease Progression|0|||
44266451|NCT01440816|79174427|FG001|Overall Study|Disease Progression|9|||
44266452|NCT01440816|79174426|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
44266453|NCT01440816|79174427|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
44266454|NCT01348919|79174438|FG000|Overall Study|Adverse Event|3|||
44266455|NCT01348919|79174439|FG001|Overall Study|Adverse Event|1|||
44266456|NCT01348919|79174440|FG002|Overall Study|Adverse Event|0|||
44266457|NCT01348919|79174438|FG000|Overall Study|Withdrawal by Subject|0|||
44266458|NCT01348919|79174439|FG001|Overall Study|Withdrawal by Subject|1|||
44266459|NCT01348919|79174440|FG002|Overall Study|Withdrawal by Subject|0|||
44266460|NCT01348919|79174438|FG000|Overall Study|Disease progression|0|||
44266461|NCT01348919|79174439|FG001|Overall Study|Disease progression|1|||
44266462|NCT01348919|79174440|FG002|Overall Study|Disease progression|1|||
44266463|NCT00966381|79174452|FG000|Overall Study|Withdrawal by Subject|2|||
44266464|NCT00966381|79174453|FG001|Overall Study|Withdrawal by Subject|2|||
44266465|NCT02431806|79174465|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
44266466|NCT02431806|79174466|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
44266467|NCT02431806|79174467|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
44266468|NCT02431806|79174468|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
44266469|NCT02431806|79174465|FG000|Double-blind Treatment Period|Adverse Event|4|||
44266470|NCT02431806|79174466|FG001|Double-blind Treatment Period|Adverse Event|7|||
44266471|NCT02431806|79174467|FG002|Double-blind Treatment Period|Adverse Event|11|||
44266472|NCT02431806|79174468|FG003|Double-blind Treatment Period|Adverse Event|7|||
44266473|NCT02431806|79174465|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
44266474|NCT02431806|79174466|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
44266475|NCT02431806|79174467|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
44266476|NCT02431806|79174468|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
44266477|NCT02431806|79174465|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
44266478|NCT02431806|79174466|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
44266479|NCT02431806|79174467|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
44195865|NCT01859715|78991588|FG001|Overall Study|No 2nd VAS|8|||
44195866|NCT01859715|78991589|FG002|Overall Study|No 2nd VAS|23|||
44195867|NCT01890915|78991601|FG000|Overall Study|Adverse Event|1|||
44195868|NCT01890915|78991602|FG001|Overall Study|Adverse Event|0|||
44266480|NCT02431806|79174468|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
44266481|NCT02431806|79174465|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
44195869|NCT01890915|78991601|FG000|Overall Study|Protocol Violation|2|||
44195870|NCT01890915|78991602|FG001|Overall Study|Protocol Violation|0|||
44195871|NCT01890915|78991601|FG000|Overall Study|Equipment Malfunction|0|||
44266482|NCT02431806|79174466|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
44266483|NCT02431806|79174467|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
44266484|NCT02431806|79174468|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
44195872|NCT01890915|78991602|FG001|Overall Study|Equipment Malfunction|1|||
44195873|NCT01615263|78991610|FG000|Overall Study|Post-randomization exclusion|0|||
44195874|NCT01615263|78991611|FG001|Overall Study|Post-randomization exclusion|2|||
44195875|NCT01859403|78991628|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
44195876|NCT01859403|78991629|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
44195877|NCT01859403|78991628|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
44195878|NCT01859403|78991629|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
44195879|NCT01859403|78991628|FG000|Primary Endpoint Measure|Physician Decision|0|||
44195880|NCT01859403|78991629|FG001|Primary Endpoint Measure|Physician Decision|1|||
44195881|NCT01859403|78991628|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
44195882|NCT01859403|78991629|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
44195883|NCT01858701|78991635|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
44195884|NCT01858701|78991636|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
44195885|NCT01858701|78991635|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
44195886|NCT01858701|78991636|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
44195887|NCT01858701|78991635|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
44195888|NCT01858701|78991636|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
44195889|NCT01858701|78991635|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
44195890|NCT01858701|78991636|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
44195891|NCT01461538|78991645|FG000|Overall Study|Death|15|||
44195892|NCT01461538|78991646|FG001|Overall Study|Death|6|||
44195893|NCT01461538|78991647|FG002|Overall Study|Death|2|||
44195894|NCT01461538|78991645|FG000|Overall Study|Study Stopped by Sponsor|2|||
44195895|NCT01461538|78991646|FG001|Overall Study|Study Stopped by Sponsor|1|||
44195896|NCT01461538|78991647|FG002|Overall Study|Study Stopped by Sponsor|0|||
44195897|NCT01461538|78991645|FG000|Overall Study|Withdrawal by Subject|1|||
44195898|NCT01461538|78991646|FG001|Overall Study|Withdrawal by Subject|1|||
44195899|NCT01461538|78991647|FG002|Overall Study|Withdrawal by Subject|0|||
44195900|NCT02117479|78991659|FG000|Overall Study|Death|13|||
44195901|NCT02117479|78991660|FG001|Overall Study|Death|8|||
44195902|NCT02117479|78991659|FG000|Overall Study|Adverse Event|8|||
44195903|NCT02117479|78991660|FG001|Overall Study|Adverse Event|16|||
44195904|NCT02117479|78991659|FG000|Overall Study|Subject decision|8|||
44195905|NCT02117479|78991660|FG001|Overall Study|Subject decision|9|||
44195906|NCT02117479|78991659|FG000|Overall Study|Disease progression|104|||
44195907|NCT02117479|78991660|FG001|Overall Study|Disease progression|108|||
44195908|NCT02117479|78991659|FG000|Overall Study|Noncompliance with study treatment|1|||
44195909|NCT02117479|78991660|FG001|Overall Study|Noncompliance with study treatment|0|||
44195910|NCT02117479|78991659|FG000|Overall Study|Study terminated by the sponsor|4|||
44195911|NCT02117479|78991660|FG001|Overall Study|Study terminated by the sponsor|6|||
44195912|NCT02117479|78991659|FG000|Overall Study|Physician Decision|7|||
44195913|NCT02117479|78991660|FG001|Overall Study|Physician Decision|2|||
44195914|NCT02117479|78991659|FG000|Overall Study|Other unspecified|11|||
44195915|NCT02117479|78991660|FG001|Overall Study|Other unspecified|7|||
44195916|NCT02229851|78991669|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
44195917|NCT02229851|78991670|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
44195918|NCT02229851|78991671|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
44195919|NCT02229851|78991672|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
44195920|NCT02229851|78991673|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
44195921|NCT02229851|78991674|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
44195922|NCT02229851|78991675|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
44195923|NCT02229851|78991669|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
44195924|NCT02229851|78991670|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
44195925|NCT02229851|78991671|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
44195926|NCT02229851|78991672|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
44195927|NCT02229851|78991673|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
44195928|NCT02229851|78991674|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
44195929|NCT02229851|78991675|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
44195930|NCT02229851|78991669|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
44195931|NCT02229851|78991670|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
44195932|NCT02229851|78991671|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
44195933|NCT02229851|78991672|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
44195934|NCT02229851|78991673|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
44195935|NCT02229851|78991674|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
44195936|NCT02229851|78991675|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
44195937|NCT02229851|78991669|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
44195938|NCT02229851|78991670|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
44195939|NCT02229851|78991671|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
44195940|NCT02229851|78991672|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
44195941|NCT02229851|78991673|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
44195942|NCT02229851|78991674|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
44195943|NCT02229851|78991675|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
44195944|NCT02229851|78991669|FG000|Main Phase (Double-blind Phase)|Death|1|||
44195945|NCT02229851|78991670|FG001|Main Phase (Double-blind Phase)|Death|1|||
44195946|NCT02229851|78991671|FG002|Main Phase (Double-blind Phase)|Death|0|||
44195947|NCT02229851|78991672|FG003|Main Phase (Double-blind Phase)|Death|0|||
44195948|NCT02229851|78991673|FG004|Main Phase (Double-blind Phase)|Death|0|||
44195949|NCT02229851|78991674|FG005|Main Phase (Double-blind Phase)|Death|0|||
44195950|NCT02229851|78991675|FG006|Main Phase (Double-blind Phase)|Death|0|||
44195951|NCT02229851|78991669|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
44266485|NCT02431806|79174465|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
44266486|NCT02431806|79174466|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
44266487|NCT02431806|79174467|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
44266488|NCT02431806|79174468|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
44266489|NCT02431806|79174465|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
44195952|NCT02229851|78991670|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
44195953|NCT02229851|78991671|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
44195954|NCT02229851|78991672|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
44266490|NCT02431806|79174466|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
44195955|NCT02229851|78991673|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
44195956|NCT02229851|78991674|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
44195957|NCT02229851|78991675|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
44195958|NCT02229851|78991669|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
44195959|NCT02229851|78991670|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
44195960|NCT02229851|78991671|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
44195961|NCT02229851|78991672|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
44195962|NCT02229851|78991673|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
44195963|NCT02229851|78991674|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
44195964|NCT02229851|78991675|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
44195965|NCT02229851|78991669|FG000|Extension Phase (Open-label Phase)|Death|0|||
44195966|NCT02229851|78991670|FG001|Extension Phase (Open-label Phase)|Death|0|||
44195967|NCT02229851|78991671|FG002|Extension Phase (Open-label Phase)|Death|0|||
44195968|NCT02229851|78991672|FG003|Extension Phase (Open-label Phase)|Death|1|||
44195969|NCT02229851|78991673|FG004|Extension Phase (Open-label Phase)|Death|0|||
44195970|NCT02229851|78991674|FG005|Extension Phase (Open-label Phase)|Death|1|||
44195971|NCT02229851|78991675|FG006|Extension Phase (Open-label Phase)|Death|1|||
44195972|NCT01482910|78991692|FG000|Overall Study|Adverse Event|6|||
44195973|NCT01482910|78991693|FG001|Overall Study|Adverse Event|5|||
44195974|NCT01482910|78991692|FG000|Overall Study|Lost to Follow-up|0|||
44195975|NCT01482910|78991693|FG001|Overall Study|Lost to Follow-up|1|||
44195976|NCT01482910|78991692|FG000|Overall Study|Protocol Violation|1|||
44195977|NCT01482910|78991693|FG001|Overall Study|Protocol Violation|1|||
44195978|NCT01482910|78991692|FG000|Overall Study|Withdrawal by Subject|7|||
44195979|NCT01482910|78991693|FG001|Overall Study|Withdrawal by Subject|2|||
44195980|NCT01482910|78991692|FG000|Overall Study|Death|1|||
44195981|NCT01482910|78991693|FG001|Overall Study|Death|0|||
44195982|NCT01626391|78991703|FG000|Overall Study|Physician Decision|1|||
44195983|NCT01626391|78991704|FG001|Overall Study|Physician Decision|0|||
44195984|NCT01626391|78991703|FG000|Overall Study|Withdrawal by Subject|1|||
44195985|NCT01626391|78991704|FG001|Overall Study|Withdrawal by Subject|0|||
44195986|NCT02103439|78991712|FG000|Overall Study|Adverse Event|0|||
44195987|NCT02103439|78991713|FG001|Overall Study|Adverse Event|2|||
44195988|NCT02103439|78991712|FG000|Overall Study|Withdrawal by Subject|3|||
44195989|NCT02103439|78991713|FG001|Overall Study|Withdrawal by Subject|1|||
44195990|NCT02229539|78991726|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
44195991|NCT02229539|78991727|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
44195992|NCT02229539|78991728|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
44195993|NCT02229539|78991726|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
44195994|NCT02229539|78991727|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
44195995|NCT02229539|78991728|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
44195996|NCT02229539|78991726|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
44195997|NCT02229539|78991727|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
44195998|NCT02229539|78991728|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
44195999|NCT02229539|78991726|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
44196000|NCT02229539|78991727|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
44196001|NCT02229539|78991728|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
44196002|NCT02229539|78991726|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
44196003|NCT02229539|78991727|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
44196004|NCT02229539|78991728|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
44196005|NCT02229539|78991726|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
44196006|NCT02229539|78991727|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
44196007|NCT02229539|78991728|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
44196008|NCT02229539|78991726|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
44196009|NCT02229539|78991727|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
44196010|NCT02229539|78991728|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
44196011|NCT02229539|78991726|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
44196012|NCT02229539|78991727|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
44543045|NCT03655717|79555922|FG022|Overall Study|Lost to Follow-up|0|||
44196013|NCT02229539|78991728|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
44196014|NCT02229539|78991726|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
44196015|NCT02229539|78991727|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
44196016|NCT02229539|78991728|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
44196017|NCT01835223|78991738|FG000|Overall Study|Adverse Event|1|||
44196018|NCT01835223|78991739|FG001|Overall Study|Adverse Event|0|||
44196019|NCT01835223|78991738|FG000|Overall Study|Withdrawal by Subject|2|||
44196020|NCT01835223|78991739|FG001|Overall Study|Withdrawal by Subject|0|||
44196021|NCT01835223|78991738|FG000|Overall Study|Disease progression|2|||
44196022|NCT01835223|78991739|FG001|Overall Study|Disease progression|1|||
44196023|NCT01835223|78991738|FG000|Overall Study|Became Inelligible|4|||
44196024|NCT01835223|78991739|FG001|Overall Study|Became Inelligible|0|||
44196025|NCT01482598|78991749|FG000|Overall Study|Death|7|||
44196026|NCT01482598|78991750|FG001|Overall Study|Death|10|||
44196027|NCT01482598|78991749|FG000|Overall Study|Physician Decision|0|||
44196028|NCT01482598|78991750|FG001|Overall Study|Physician Decision|3|||
44196029|NCT01482598|78991749|FG000|Overall Study|Withdrawal by Subject|4|||
44196030|NCT01482598|78991750|FG001|Overall Study|Withdrawal by Subject|5|||
44196031|NCT01482598|78991749|FG000|Overall Study|Lost to Follow-up|5|||
44196032|NCT01482598|78991750|FG001|Overall Study|Lost to Follow-up|4|||
44196033|NCT01460446|78991758|FG000|Overall Study|Non-compliance|2|||
44196034|NCT01460446|78991759|FG001|Overall Study|Non-compliance|9|||
44196035|NCT01460446|78991758|FG000|Overall Study|Consent Withdrawn|0|||
44196036|NCT01460446|78991759|FG001|Overall Study|Consent Withdrawn|4|||
44196037|NCT01460446|78991758|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
44196038|NCT01460446|78991759|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
44196039|NCT01460446|78991758|FG000|Overall Study|Surgery/Illness|1|||
44196040|NCT01460446|78991759|FG001|Overall Study|Surgery/Illness|1|||
44196041|NCT01460446|78991758|FG000|Overall Study|Pregnancy|1|||
44196042|NCT01460446|78991759|FG001|Overall Study|Pregnancy|0|||
44196043|NCT01460446|78991758|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
44196044|NCT01460446|78991759|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
44196045|NCT02229383|78991768|FG000|Overall Study|Adverse Event|7|||
44196046|NCT02229383|78991769|FG001|Overall Study|Adverse Event|4|||
44196047|NCT02229383|78991768|FG000|Overall Study|Death|0|||
44196048|NCT02229383|78991769|FG001|Overall Study|Death|1|||
44196049|NCT02229383|78991768|FG000|Overall Study|Lost to Follow-up|5|||
44196050|NCT02229383|78991769|FG001|Overall Study|Lost to Follow-up|3|||
44196051|NCT02229383|78991768|FG000|Overall Study|Withdrawal by Subject|4|||
44196052|NCT02229383|78991769|FG001|Overall Study|Withdrawal by Subject|6|||
44196053|NCT02229383|78991768|FG000|Overall Study|Did not receive treatment|1|||
44196054|NCT02229383|78991769|FG001|Overall Study|Did not receive treatment|0|||
44196055|NCT02229383|78991768|FG000|Overall Study|Other|3|||
44196056|NCT02229383|78991769|FG001|Overall Study|Other|8|||
44196057|NCT01499368|78991778|FG000|Overall Study|Did not meet I/E criteria|8|||
44196058|NCT01499368|78991779|FG001|Overall Study|Did not meet I/E criteria|4|||
44196059|NCT01499368|78991780|FG002|Overall Study|Did not meet I/E criteria|4|||
44196060|NCT01499368|78991778|FG000|Overall Study|Prohibited Concomitant medication|1|||
44196061|NCT01499368|78991779|FG001|Overall Study|Prohibited Concomitant medication|1|||
44196062|NCT01499368|78991780|FG002|Overall Study|Prohibited Concomitant medication|0|||
44196063|NCT01499368|78991778|FG000|Overall Study|Withdrawal by Subject|11|||
44196064|NCT01499368|78991779|FG001|Overall Study|Withdrawal by Subject|10|||
44196065|NCT01499368|78991780|FG002|Overall Study|Withdrawal by Subject|8|||
44196066|NCT01499368|78991778|FG000|Overall Study|Lost to Follow-up|3|||
44196067|NCT01499368|78991779|FG001|Overall Study|Lost to Follow-up|2|||
44196068|NCT01499368|78991780|FG002|Overall Study|Lost to Follow-up|5|||
44196069|NCT01499368|78991778|FG000|Overall Study|Adverse Event|4|||
44196070|NCT01499368|78991779|FG001|Overall Study|Adverse Event|0|||
44196071|NCT01499368|78991780|FG002|Overall Study|Adverse Event|2|||
44196072|NCT01499368|78991778|FG000|Overall Study|Physician Decision|0|||
44196073|NCT01499368|78991779|FG001|Overall Study|Physician Decision|1|||
44196074|NCT01499368|78991780|FG002|Overall Study|Physician Decision|0|||
44196075|NCT01499368|78991778|FG000|Overall Study|Deviation from visit window|0|||
44196076|NCT01499368|78991779|FG001|Overall Study|Deviation from visit window|0|||
44196077|NCT01499368|78991780|FG002|Overall Study|Deviation from visit window|1|||
44196078|NCT01499368|78991778|FG000|Overall Study|Error of Prescriptions|0|||
44196079|NCT01499368|78991779|FG001|Overall Study|Error of Prescriptions|0|||
44196080|NCT01499368|78991780|FG002|Overall Study|Error of Prescriptions|1|||
44196081|NCT01835145|78991790|FG000|Overall Study|Ineligible prior to treatment|1|||
44196082|NCT01835145|78991791|FG001|Overall Study|Ineligible prior to treatment|0|||
44196083|NCT02229227|78991801|FG000|Overall Study|Adverse Event|14|||
44196084|NCT02229227|78991802|FG001|Overall Study|Adverse Event|9|||
44196085|NCT02229227|78991801|FG000|Overall Study|Lack of Efficacy|3|||
44196086|NCT02229227|78991802|FG001|Overall Study|Lack of Efficacy|3|||
44196087|NCT02229227|78991801|FG000|Overall Study|Protocol Violation|6|||
44196088|NCT02229227|78991802|FG001|Overall Study|Protocol Violation|8|||
44196089|NCT02229227|78991801|FG000|Overall Study|Protocol defined stopping criteria|1|||
44196090|NCT02229227|78991802|FG001|Overall Study|Protocol defined stopping criteria|3|||
44196091|NCT02229227|78991801|FG000|Overall Study|Lost to Follow-up|3|||
44196092|NCT02229227|78991802|FG001|Overall Study|Lost to Follow-up|3|||
44196093|NCT02229227|78991801|FG000|Overall Study|Study terminated by sponsor|11|||
44196094|NCT02229227|78991802|FG001|Overall Study|Study terminated by sponsor|11|||
44196095|NCT02229227|78991801|FG000|Overall Study|Withdrawal by Subject|8|||
44196096|NCT02229227|78991802|FG001|Overall Study|Withdrawal by Subject|12|||
44196097|NCT02229227|78991801|FG000|Overall Study|Other|0|||
44196098|NCT02229227|78991802|FG001|Overall Study|Other|1|||
44196099|NCT02229227|78991801|FG000|Overall Study|Physician Decision|5|||
44196100|NCT02229227|78991802|FG001|Overall Study|Physician Decision|12|||
44196101|NCT01499290|78991810|FG000|Overall Study|Withdrawal by Subject|22|||
44196102|NCT01499290|78991811|FG001|Overall Study|Withdrawal by Subject|15|||
44196103|NCT01499290|78991810|FG000|Overall Study|Not specified in study report|11|||
44196104|NCT01499290|78991811|FG001|Overall Study|Not specified in study report|5|||
44196105|NCT01499290|78991810|FG000|Overall Study|Condition improved/subject recovered|1|||
44196106|NCT01499290|78991811|FG001|Overall Study|Condition improved/subject recovered|0|||
44196107|NCT01499290|78991810|FG000|Overall Study|Lack of Efficacy|7|||
44196108|NCT01499290|78991811|FG001|Overall Study|Lack of Efficacy|8|||
44196109|NCT01499290|78991810|FG000|Overall Study|Adverse Event|14|||
44196110|NCT01499290|78991811|FG001|Overall Study|Adverse Event|7|||
44196111|NCT01833897|78991836|FG000|Overall Study|Lack of Efficacy|1|||
44196112|NCT01481896|78991840|FG000|Overall Study|Lost to Follow-up|12|||
44196113|NCT02226653|78991856|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
44196114|NCT02226653|78991857|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
44196115|NCT02226653|78991856|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
44196116|NCT02226653|78991857|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
44196117|NCT02201771|78991873|FG000|Overall Study|Death|3|||
44196118|NCT02201771|78991874|FG001|Overall Study|Death|2|||
44196119|NCT02201771|78991875|FG002|Overall Study|Death|0|||
44196120|NCT02201771|78991873|FG000|Overall Study|Protocol Violation|10|||
44196121|NCT02201771|78991874|FG001|Overall Study|Protocol Violation|8|||
44196122|NCT02201771|78991875|FG002|Overall Study|Protocol Violation|10|||
44196123|NCT01460368|78991885|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
44196124|NCT01460368|78991886|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
44196125|NCT01460368|78991887|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
44196126|NCT01460368|78991888|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
44196127|NCT01460368|78991889|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
44196128|NCT01460368|78991890|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
44196129|NCT01460368|78991891|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
44196130|NCT01460368|78991885|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
44196131|NCT01460368|78991886|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
44196132|NCT01460368|78991887|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
44196133|NCT01460368|78991888|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
44196134|NCT01460368|78991889|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
44196135|NCT01460368|78991890|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
44196136|NCT01460368|78991891|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
44196137|NCT01460368|78991885|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
44196138|NCT01460368|78991886|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
44451489|NCT00500331|79460411|FG003|Overall Study|Liver function test abnormality|0|||
44196139|NCT01460368|78991887|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
44196140|NCT01460368|78991888|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
44543046|NCT03655717|79555923|FG023|Overall Study|Lost to Follow-up|0|||
44196141|NCT01460368|78991889|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
44196142|NCT01460368|78991890|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
44196143|NCT01460368|78991891|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
44196144|NCT01460368|78991885|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
44196145|NCT01460368|78991886|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
44196146|NCT01460368|78991887|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
44196147|NCT01460368|78991888|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
44196148|NCT01460368|78991889|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
44196149|NCT01460368|78991890|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
44196150|NCT01460368|78991891|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
44196151|NCT01460368|78991885|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
44196152|NCT01460368|78991886|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
44196153|NCT01460368|78991887|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
44196154|NCT01460368|78991888|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
44196155|NCT01460368|78991889|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
44196156|NCT01460368|78991890|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
44196157|NCT01460368|78991891|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
44196158|NCT01460290|78991900|FG000|Overall Study|Adverse Event|3|||
44196159|NCT01460290|78991900|FG000|Overall Study|Elevated liver function|1|||
44196160|NCT02200211|78991909|FG000|Overall Study|Lost to Follow-up|7|||
44196161|NCT02200211|78991910|FG001|Overall Study|Lost to Follow-up|7|||
44196162|NCT02200211|78991911|FG002|Overall Study|Lost to Follow-up|1|||
44196163|NCT02200211|78991912|FG003|Overall Study|Lost to Follow-up|2|||
44196164|NCT02200211|78991909|FG000|Overall Study|Withdrawal by Subject|1|||
44196165|NCT02200211|78991910|FG001|Overall Study|Withdrawal by Subject|0|||
44196166|NCT02200211|78991911|FG002|Overall Study|Withdrawal by Subject|0|||
44196167|NCT02200211|78991912|FG003|Overall Study|Withdrawal by Subject|0|||
44196168|NCT01459666|78991932|FG000|Overall Study|PI left institution|5|||
44196169|NCT01459666|78991933|FG001|Overall Study|PI left institution|4|||
44196170|NCT01858389|78991941|FG000|Overall Study|Death|1|||
44196171|NCT01858389|78991942|FG001|Overall Study|Death|3|||
44196172|NCT01858389|78991941|FG000|Overall Study|Study terminated by sponsor|0|||
44196173|NCT01858389|78991942|FG001|Overall Study|Study terminated by sponsor|2|||
44196174|NCT01858389|78991941|FG000|Overall Study|Withdrawal by Subject|0|||
44196175|NCT01858389|78991942|FG001|Overall Study|Withdrawal by Subject|1|||
44196176|NCT01858389|78991941|FG000|Overall Study|Progressive disease|10|||
44196177|NCT01858389|78991942|FG001|Overall Study|Progressive disease|11|||
44196178|NCT01858389|78991941|FG000|Overall Study|Other|2|||
44196179|NCT01858389|78991942|FG001|Overall Study|Other|4|||
44196180|NCT01858389|78991941|FG000|Overall Study|Adverse Event|3|||
44196181|NCT01858389|78991942|FG001|Overall Study|Adverse Event|1|||
44196182|NCT01858389|78991941|FG000|Overall Study|Did not receive treatment|0|||
44196183|NCT01858389|78991942|FG001|Overall Study|Did not receive treatment|3|||
44196184|NCT02199509|78991950|FG000|Overall Study|Suicidal Ideation|0|||
44196185|NCT02199509|78991951|FG001|Overall Study|Suicidal Ideation|1|||
44196186|NCT02199509|78991950|FG000|Overall Study|Misunderstood titration schedule|1|||
44196187|NCT02199509|78991951|FG001|Overall Study|Misunderstood titration schedule|0|||
44196188|NCT01458574|78991964|FG000|Overall Study|Adverse Event|5|||
44196189|NCT01458574|78991965|FG001|Overall Study|Adverse Event|9|||
44196190|NCT01458574|78991966|FG002|Overall Study|Adverse Event|7|||
44196191|NCT01458574|78991964|FG000|Overall Study|Lack of Efficacy|70|||
44196192|NCT01458574|78991965|FG001|Overall Study|Lack of Efficacy|53|||
44196193|NCT01458574|78991966|FG002|Overall Study|Lack of Efficacy|132|||
44196194|NCT01458574|78991964|FG000|Overall Study|Lost to Follow-up|3|||
44196195|NCT01458574|78991965|FG001|Overall Study|Lost to Follow-up|2|||
44196196|NCT01458574|78991966|FG002|Overall Study|Lost to Follow-up|1|||
44196197|NCT01458574|78991964|FG000|Overall Study|Pregnancy|1|||
44196198|NCT01458574|78991965|FG001|Overall Study|Pregnancy|1|||
44196199|NCT01458574|78991966|FG002|Overall Study|Pregnancy|0|||
44196200|NCT01458574|78991964|FG000|Overall Study|Protocol Violation|0|||
44196201|NCT01458574|78991965|FG001|Overall Study|Protocol Violation|1|||
44196202|NCT01458574|78991966|FG002|Overall Study|Protocol Violation|0|||
44196203|NCT01458574|78991964|FG000|Overall Study|Withdrawal by Subject|6|||
44196204|NCT01458574|78991965|FG001|Overall Study|Withdrawal by Subject|3|||
44196205|NCT01458574|78991966|FG002|Overall Study|Withdrawal by Subject|5|||
44196206|NCT01458574|78991964|FG000|Overall Study|Other|2|||
44196207|NCT01458574|78991965|FG001|Overall Study|Other|1|||
44196208|NCT01458574|78991966|FG002|Overall Study|Other|0|||
44196209|NCT01458574|78991964|FG000|Overall Study|Randomized but not treated|0|||
44196210|NCT01458574|78991965|FG001|Overall Study|Randomized but not treated|1|||
44196211|NCT01458574|78991966|FG002|Overall Study|Randomized but not treated|0|||
44196212|NCT02224703|78991977|FG000|Overall Study|Adverse Event|0|||
44196213|NCT02224703|78991978|FG001|Overall Study|Adverse Event|5|||
44196214|NCT02224703|78991979|FG002|Overall Study|Adverse Event|0|||
44196215|NCT02224703|78991977|FG000|Overall Study|Withdrawn by investigator|1|||
44543047|NCT03655717|79555924|FG024|Overall Study|Lost to Follow-up|0|||
44196216|NCT02224703|78991978|FG001|Overall Study|Withdrawn by investigator|0|||
44196217|NCT02224703|78991979|FG002|Overall Study|Withdrawn by investigator|0|||
44196218|NCT02224703|78991977|FG000|Overall Study|Advised by medical monitor|1|||
44196219|NCT02224703|78991978|FG001|Overall Study|Advised by medical monitor|0|||
44196220|NCT02224703|78991979|FG002|Overall Study|Advised by medical monitor|0|||
44196221|NCT02224703|78991977|FG000|Overall Study|Withdrawn by parent/guardian|0|||
44196222|NCT02224703|78991978|FG001|Overall Study|Withdrawn by parent/guardian|1|||
44196223|NCT02224703|78991979|FG002|Overall Study|Withdrawn by parent/guardian|0|||
44196224|NCT02224703|78991977|FG000|Overall Study|Lack of Efficacy|1|||
44196225|NCT02224703|78991978|FG001|Overall Study|Lack of Efficacy|0|||
44196226|NCT02224703|78991979|FG002|Overall Study|Lack of Efficacy|0|||
44196227|NCT02198963|78991988|FG000|Overall Study|Adverse Event|1|||
44196228|NCT02198963|78991988|FG000|Overall Study|Withdrawal by Subject|6|||
44196229|NCT01458106|78992012|FG000|Overall Study|Withdrawal by Subject|2|||
44196230|NCT01458106|78992013|FG001|Overall Study|Withdrawal by Subject|0|||
44196231|NCT01458106|78992012|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
44196232|NCT01458106|78992013|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
44196233|NCT01458106|78992012|FG000|Overall Study|Withdrawn Per Protocol|0|||
44196234|NCT01458106|78992013|FG001|Overall Study|Withdrawn Per Protocol|1|||
44196235|NCT01457950|78992024|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
44196236|NCT01457950|78992025|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
44196237|NCT01457950|78992026|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
44196238|NCT01457950|78992027|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
44196239|NCT01457950|78992024|FG000|Double-Blind Phase|Protocol Violation|2|||
44196240|NCT01457950|78992025|FG001|Double-Blind Phase|Protocol Violation|1|||
44196241|NCT01457950|78992026|FG002|Double-Blind Phase|Protocol Violation|0|||
44196242|NCT01457950|78992027|FG003|Double-Blind Phase|Protocol Violation|0|||
44196243|NCT01457950|78992024|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
44196244|NCT01457950|78992025|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
44196245|NCT01457950|78992026|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
44196246|NCT01457950|78992027|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44196247|NCT01457950|78992024|FG000|Open-Label Phase|Adverse Event|0|||
44196248|NCT01457950|78992025|FG001|Open-Label Phase|Adverse Event|0|||
44196249|NCT01457950|78992026|FG002|Open-Label Phase|Adverse Event|0|||
44196250|NCT01457950|78992027|FG003|Open-Label Phase|Adverse Event|1|||
44196251|NCT01457950|78992024|FG000|Open-Label Phase|Protocol Violation|0|||
44196252|NCT01457950|78992025|FG001|Open-Label Phase|Protocol Violation|0|||
44196253|NCT01457950|78992026|FG002|Open-Label Phase|Protocol Violation|0|||
44196254|NCT01457950|78992027|FG003|Open-Label Phase|Protocol Violation|1|||
44196255|NCT01457950|78992024|FG000|Open-Label Phase|Withdrawal by Subject|0|||
44196256|NCT01457950|78992025|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44196257|NCT01457950|78992026|FG002|Open-Label Phase|Withdrawal by Subject|2|||
44196258|NCT01457950|78992027|FG003|Open-Label Phase|Withdrawal by Subject|0|||
44196259|NCT01499134|78992040|FG000|Overall Study|Withdrawal by Subject|0|||
44196260|NCT01499134|78992041|FG001|Overall Study|Withdrawal by Subject|1|||
44196261|NCT02198651|78992047|FG000|Lead-in Period|Withdrew consent|13|||
44196262|NCT02198651|78992048|FG001|Lead-in Period|Withdrew consent|0|||
44196263|NCT02198651|78992049|FG002|Lead-in Period|Withdrew consent|0|||
44196264|NCT02198651|78992050|FG003|Lead-in Period|Withdrew consent|0|||
44196265|NCT02198651|78992051|FG004|Lead-in Period|Withdrew consent|0|||
44196266|NCT02198651|78992047|FG000|Lead-in Period|Adverse Event|2|||
44196267|NCT02198651|78992048|FG001|Lead-in Period|Adverse Event|0|||
44196268|NCT02198651|78992049|FG002|Lead-in Period|Adverse Event|0|||
44196269|NCT02198651|78992050|FG003|Lead-in Period|Adverse Event|0|||
44196270|NCT02198651|78992051|FG004|Lead-in Period|Adverse Event|0|||
44196271|NCT02198651|78992047|FG000|Lead-in Period|Other, not specified|22|||
44196272|NCT02198651|78992048|FG001|Lead-in Period|Other, not specified|0|||
44196273|NCT02198651|78992049|FG002|Lead-in Period|Other, not specified|0|||
44196274|NCT02198651|78992050|FG003|Lead-in Period|Other, not specified|0|||
44196275|NCT02198651|78992051|FG004|Lead-in Period|Other, not specified|0|||
44196276|NCT02198651|78992047|FG000|Double-blind Period|Withdrew consent|0|||
44196277|NCT02198651|78992048|FG001|Double-blind Period|Withdrew consent|4|||
44196278|NCT02198651|78992049|FG002|Double-blind Period|Withdrew consent|0|||
44196279|NCT02198651|78992050|FG003|Double-blind Period|Withdrew consent|0|||
44196280|NCT02198651|78992051|FG004|Double-blind Period|Withdrew consent|0|||
44451490|NCT00500331|79460412|FG004|Overall Study|Liver function test abnormality|0|||
44196281|NCT02198651|78992047|FG000|Double-blind Period|Adverse Event|0|||
44196282|NCT02198651|78992048|FG001|Double-blind Period|Adverse Event|1|||
44196283|NCT02198651|78992049|FG002|Double-blind Period|Adverse Event|0|||
44196284|NCT02198651|78992050|FG003|Double-blind Period|Adverse Event|0|||
44196285|NCT02198651|78992051|FG004|Double-blind Period|Adverse Event|0|||
44361291|NCT01157117|79366949|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
44196286|NCT02198651|78992047|FG000|Double-blind Period|Other, not specified|0|||
44196287|NCT02198651|78992048|FG001|Double-blind Period|Other, not specified|4|||
44361292|NCT00891202|79366959|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
44361293|NCT00891202|79366960|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
44196288|NCT02198651|78992049|FG002|Double-blind Period|Other, not specified|1|||
44196289|NCT02198651|78992050|FG003|Double-blind Period|Other, not specified|0|||
44196290|NCT02198651|78992051|FG004|Double-blind Period|Other, not specified|0|||
44196291|NCT02198651|78992047|FG000|Open-label Rescue Period|Withdrew consent|0|||
44196292|NCT02198651|78992048|FG001|Open-label Rescue Period|Withdrew consent|0|||
44196293|NCT02198651|78992049|FG002|Open-label Rescue Period|Withdrew consent|0|||
44196294|NCT02198651|78992050|FG003|Open-label Rescue Period|Withdrew consent|2|||
44196295|NCT02198651|78992051|FG004|Open-label Rescue Period|Withdrew consent|0|||
44196296|NCT02198651|78992047|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
44196297|NCT02198651|78992048|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
44196298|NCT02198651|78992049|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
44196299|NCT02198651|78992050|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
44196300|NCT02198651|78992051|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
44196301|NCT01498822|78992066|FG000|Overall Study|Protocol Violation|8|||
44196302|NCT01498822|78992067|FG001|Overall Study|Protocol Violation|4|||
44196303|NCT01498822|78992066|FG000|Overall Study|Other Reason|5|||
44196304|NCT01498822|78992067|FG001|Overall Study|Other Reason|2|||
44196305|NCT01498822|78992066|FG000|Overall Study|Lack of Efficacy|7|||
44196306|NCT01498822|78992067|FG001|Overall Study|Lack of Efficacy|2|||
44196307|NCT01498822|78992066|FG000|Overall Study|AE, non-serious non-fatal|8|||
44196308|NCT01498822|78992067|FG001|Overall Study|AE, non-serious non-fatal|17|||
44196309|NCT01498822|78992066|FG000|Overall Study|SAE, non-fatal|2|||
44196310|NCT01498822|78992067|FG001|Overall Study|SAE, non-fatal|2|||
44196311|NCT01498822|78992066|FG000|Overall Study|Adverse Event, serious fatal|1|||
44196312|NCT01498822|78992067|FG001|Overall Study|Adverse Event, serious fatal|1|||
44196313|NCT01498822|78992066|FG000|Overall Study|Withdrawal by Subject|15|||
44196314|NCT01498822|78992067|FG001|Overall Study|Withdrawal by Subject|25|||
44196315|NCT01498822|78992066|FG000|Overall Study|Lost to Follow-up|8|||
44196316|NCT01498822|78992067|FG001|Overall Study|Lost to Follow-up|3|||
44196317|NCT01498120|78992075|FG000|Overall Study|Lost to Follow-up|1|||
44196318|NCT01498120|78992075|FG000|Overall Study|Withdrawal by Subject|5|||
44196319|NCT01498120|78992075|FG000|Overall Study|AE, non-serious non-fatal|3|||
44196320|NCT01498120|78992075|FG000|Overall Study|Other|4|||
44196321|NCT01497262|78992079|FG000|Overall Study|Abnormal Lab Values|4|||
44196322|NCT01497262|78992079|FG000|Overall Study|Abnormal Test Procedure Result|1|||
44196323|NCT01497262|78992079|FG000|Overall Study|Physician Decision|1|||
44196324|NCT01497262|78992079|FG000|Overall Study|Withdrawal by Subject|2|||
44196325|NCT01497262|78992079|FG000|Overall Study|Adverse Event|2|||
44196326|NCT01497262|78992079|FG000|Overall Study|Protocol Violation|1|||
44196327|NCT02224625|78992083|FG000|Irritation|Adverse Event|6|||
44196328|NCT02224625|78992083|FG000|Sensitization|Adverse Event|55|||
44196329|NCT02197247|78992095|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
44196330|NCT02197247|78992095|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
44196331|NCT02197247|78992095|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
44196332|NCT02197247|78992095|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
44196333|NCT02197247|78992095|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
44196334|NCT02197247|78992095|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
44196335|NCT02197247|78992095|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
44196336|NCT02197247|78992095|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
44196337|NCT02224157|78992107|FG000|Overall Study|Severe non-compliance to protocol|2|||
44196338|NCT02224157|78992108|FG001|Overall Study|Severe non-compliance to protocol|2|||
44196339|NCT02224157|78992107|FG000|Overall Study|Other|13|||
44196340|NCT02224157|78992108|FG001|Overall Study|Other|10|||
44196341|NCT02224157|78992107|FG000|Overall Study|Subject decision|58|||
44196342|NCT02224157|78992108|FG001|Overall Study|Subject decision|50|||
44196343|NCT02224157|78992107|FG000|Overall Study|Prematurely closed site|4|||
44196344|NCT02224157|78992108|FG001|Overall Study|Prematurely closed site|2|||
44196345|NCT02224157|78992107|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
44196346|NCT02224157|78992108|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
44196347|NCT02224157|78992107|FG000|Overall Study|Lost to Follow-up|27|||
44196348|NCT02224157|78992108|FG001|Overall Study|Lost to Follow-up|35|||
44196349|NCT02224157|78992107|FG000|Overall Study|Death|1|||
44196350|NCT02224157|78992108|FG001|Overall Study|Death|1|||
44266491|NCT02431806|79174467|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
44451491|NCT00500331|79460413|FG005|Overall Study|Liver function test abnormality|0|||
44451492|NCT00500331|79460414|FG006|Overall Study|Liver function test abnormality|0|||
44451493|NCT00500331|79460408|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
44543048|NCT03655717|79555925|FG025|Overall Study|Lost to Follow-up|0|||
44196351|NCT02224157|78992107|FG000|Overall Study|Adverse Event|1|||
44196352|NCT02224157|78992108|FG001|Overall Study|Adverse Event|3|||
44196353|NCT02196701|78992116|FG000|Overall Study|Adverse Event|1|||
44196354|NCT02196701|78992116|FG000|Overall Study|Lost to Follow-up|1|||
44196355|NCT02196701|78992116|FG000|Overall Study|Non-adherence to Protocol|1|||
44266492|NCT02431806|79174468|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
44196356|NCT01481116|78992126|FG000|Overall Study|Adverse Event|26|||
44196357|NCT01481116|78992127|FG001|Overall Study|Adverse Event|26|||
44196358|NCT01481116|78992128|FG002|Overall Study|Adverse Event|42|||
44196359|NCT01481116|78992126|FG000|Overall Study|Major Protocol Deviation|3|||
44196360|NCT01481116|78992127|FG001|Overall Study|Major Protocol Deviation|7|||
44196361|NCT01481116|78992128|FG002|Overall Study|Major Protocol Deviation|1|||
44196362|NCT01481116|78992126|FG000|Overall Study|Lost to Follow-up|8|||
44196363|NCT01481116|78992127|FG001|Overall Study|Lost to Follow-up|12|||
44196364|NCT01481116|78992128|FG002|Overall Study|Lost to Follow-up|11|||
44196365|NCT01481116|78992126|FG000|Overall Study|Withdrawal by Subject|37|||
44196366|NCT01481116|78992127|FG001|Overall Study|Withdrawal by Subject|33|||
44196367|NCT01481116|78992128|FG002|Overall Study|Withdrawal by Subject|37|||
44196368|NCT01481116|78992126|FG000|Overall Study|Study Termination|730|||
44196369|NCT01481116|78992127|FG001|Overall Study|Study Termination|729|||
44196370|NCT01481116|78992128|FG002|Overall Study|Study Termination|713|||
44196371|NCT01481116|78992126|FG000|Overall Study|Pregnancy|0|||
44196372|NCT01481116|78992127|FG001|Overall Study|Pregnancy|0|||
44196373|NCT01481116|78992128|FG002|Overall Study|Pregnancy|1|||
44196374|NCT01481116|78992126|FG000|Overall Study|Lack of Efficacy|3|||
44196375|NCT01481116|78992127|FG001|Overall Study|Lack of Efficacy|3|||
44196376|NCT01481116|78992128|FG002|Overall Study|Lack of Efficacy|1|||
44196377|NCT01481116|78992126|FG000|Overall Study|Contraindications|1|||
44196378|NCT01481116|78992127|FG001|Overall Study|Contraindications|1|||
44196379|NCT01481116|78992128|FG002|Overall Study|Contraindications|0|||
44196380|NCT01481116|78992126|FG000|Overall Study|Other|1|||
44196381|NCT01481116|78992127|FG001|Overall Study|Other|1|||
44196382|NCT01481116|78992128|FG002|Overall Study|Other|0|||
44196383|NCT01481116|78992126|FG000|Overall Study|Participant Started Taking Glipizide|1|||
44196384|NCT01481116|78992127|FG001|Overall Study|Participant Started Taking Glipizide|0|||
44196385|NCT01481116|78992128|FG002|Overall Study|Participant Started Taking Glipizide|0|||
44196386|NCT01481116|78992126|FG000|Overall Study|Participant Moved Out of Area|2|||
44196387|NCT01481116|78992127|FG001|Overall Study|Participant Moved Out of Area|0|||
44196388|NCT01481116|78992128|FG002|Overall Study|Participant Moved Out of Area|1|||
44196389|NCT01481116|78992126|FG000|Overall Study|Participant Moved Out of Country|1|||
44196390|NCT01481116|78992127|FG001|Overall Study|Participant Moved Out of Country|0|||
44196391|NCT01481116|78992128|FG002|Overall Study|Participant Moved Out of Country|1|||
44196392|NCT01481116|78992126|FG000|Overall Study|Investigator Decision|3|||
44196393|NCT01481116|78992127|FG001|Overall Study|Investigator Decision|2|||
44196394|NCT01481116|78992128|FG002|Overall Study|Investigator Decision|1|||
44196395|NCT01481116|78992126|FG000|Overall Study|Sponsor Decision|0|||
44196396|NCT01481116|78992127|FG001|Overall Study|Sponsor Decision|1|||
44196397|NCT01481116|78992128|FG002|Overall Study|Sponsor Decision|3|||
44196398|NCT01481116|78992126|FG000|Overall Study|Non-Compliant With Study Drug|0|||
44196399|NCT01481116|78992127|FG001|Overall Study|Non-Compliant With Study Drug|1|||
44196400|NCT01481116|78992128|FG002|Overall Study|Non-Compliant With Study Drug|1|||
44196401|NCT01481116|78992126|FG000|Overall Study|Investigator's Discretion|2|||
44196402|NCT01481116|78992127|FG001|Overall Study|Investigator's Discretion|0|||
44196403|NCT01481116|78992128|FG002|Overall Study|Investigator's Discretion|0|||
44196404|NCT01481116|78992126|FG000|Overall Study|Death|2|||
44196405|NCT01481116|78992127|FG001|Overall Study|Death|1|||
44196406|NCT01481116|78992128|FG002|Overall Study|Death|0|||
44196407|NCT01481116|78992126|FG000|Overall Study|Hypoglycemic Event|4|||
44196408|NCT01481116|78992127|FG001|Overall Study|Hypoglycemic Event|0|||
44196409|NCT01481116|78992128|FG002|Overall Study|Hypoglycemic Event|0|||
44196410|NCT02222207|78992136|FG000|Overall Study|Death|1|||
44196411|NCT02222207|78992136|FG000|Overall Study|Other reasons|2|||
44196412|NCT02222207|78992136|FG000|Overall Study|Adverse Event|1|||
44196413|NCT01457014|78992140|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
44196414|NCT01457014|78992141|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
44196415|NCT01457014|78992142|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
44196416|NCT01457014|78992143|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
44196417|NCT01457014|78992140|FG000|First Night|Withdrawal by Subject|3|||
44196418|NCT01457014|78992141|FG001|First Night|Withdrawal by Subject|0|||
44196419|NCT01457014|78992142|FG002|First Night|Withdrawal by Subject|0|||
44196420|NCT01457014|78992143|FG003|First Night|Withdrawal by Subject|0|||
44196421|NCT02254421|78992153|FG000|Overall Study|Randomized but Not Treated|1|||
44196422|NCT02254421|78992154|FG001|Overall Study|Randomized but Not Treated|0|||
44196423|NCT02254421|78992153|FG000|Overall Study|Death|0|||
44196424|NCT02254421|78992154|FG001|Overall Study|Death|2|||
44196425|NCT02254421|78992153|FG000|Overall Study|Withdrew Consent|1|||
44196426|NCT02254421|78992154|FG001|Overall Study|Withdrew Consent|1|||
44196427|NCT02252939|78992160|FG000|Overall Study|Lost to Follow-up|3|||
44196428|NCT02196077|78992169|FG000|Overall Study|Adverse Event|4|||
44196429|NCT02196077|78992169|FG000|Overall Study|Lack of Efficacy|1|||
44196430|NCT02196077|78992169|FG000|Overall Study|Withdrawal by Subject|14|||
44196431|NCT02196077|78992169|FG000|Overall Study|Physician Decision|1|||
44196432|NCT02196077|78992169|FG000|Overall Study|Lost to Follow-up|3|||
44196433|NCT02196077|78992169|FG000|Overall Study|Protocol Violation|24|||
44196434|NCT02195687|78992183|FG000|Overall Study|Personal Reasons|1|||
44196435|NCT02195687|78992184|FG001|Overall Study|Personal Reasons|1|||
44196436|NCT02195687|78992183|FG000|Overall Study|Lost to Follow-up|4|||
44196437|NCT02195687|78992184|FG001|Overall Study|Lost to Follow-up|1|||
44196438|NCT02195531|78992193|FG000|Overall Study|Withdrawal by Subject|1|||
44196439|NCT02195531|78992194|FG001|Overall Study|Withdrawal by Subject|1|||
44196440|NCT02195531|78992195|FG002|Overall Study|Withdrawal by Subject|1|||
44196441|NCT02252081|78992205|FG000|Overall Study|Withdrawal by Subject|2|||
44196442|NCT02252081|78992206|FG001|Overall Study|Withdrawal by Subject|1|||
44196443|NCT02252081|78992205|FG000|Overall Study|Adverse Event|4|||
44196444|NCT02252081|78992206|FG001|Overall Study|Adverse Event|1|||
44196445|NCT02252081|78992205|FG000|Overall Study|non compliance & others|0|||
44196446|NCT02252081|78992206|FG001|Overall Study|non compliance & others|2|||
44196447|NCT01623752|78992220|FG000|Phase 1 (78 Weeks)|No Data|249|||
44196448|NCT01623752|78992221|FG001|Phase 1 (78 Weeks)|No Data|66|||
44196449|NCT01623752|78992222|FG002|Phase 1 (78 Weeks)|No Data|2|||
44196450|NCT01623752|78992220|FG000|Phase 1 (78 Weeks)|Other|33|||
44196451|NCT01623752|78992221|FG001|Phase 1 (78 Weeks)|Other|20|||
44196452|NCT01623752|78992222|FG002|Phase 1 (78 Weeks)|Other|0|||
44196453|NCT01623752|78992220|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
44196454|NCT01623752|78992221|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
44196455|NCT01623752|78992222|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
44196456|NCT01623752|78992220|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
44196457|NCT01623752|78992221|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
44196458|NCT01623752|78992222|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
44196459|NCT01623752|78992220|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
44196460|NCT01623752|78992221|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
44196461|NCT01623752|78992222|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
44196462|NCT01623752|78992220|FG000|Phase 2 (78 Weeks)|Other|5|||
44196463|NCT01623752|78992221|FG001|Phase 2 (78 Weeks)|Other|1|||
44196464|NCT01623752|78992222|FG002|Phase 2 (78 Weeks)|Other|0|||
44196465|NCT01623752|78992220|FG000|Phase 2 (78 Weeks)|No Data|43|||
44196466|NCT01623752|78992221|FG001|Phase 2 (78 Weeks)|No Data|11|||
44196467|NCT01623752|78992222|FG002|Phase 2 (78 Weeks)|No Data|0|||
44196468|NCT01623752|78992220|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
44196469|NCT01623752|78992221|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
44196470|NCT01623752|78992222|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
44196471|NCT01623596|78992233|FG000|Overall Study|Abnormal laboratory values|2|||
44196472|NCT01623596|78992234|FG001|Overall Study|Abnormal laboratory values|0|||
44196473|NCT01623596|78992233|FG000|Overall Study|Administrative problems|9|||
44196474|NCT01623596|78992234|FG001|Overall Study|Administrative problems|13|||
44196475|NCT01623596|78992233|FG000|Overall Study|Adverse Event|20|||
44196476|NCT01623596|78992234|FG001|Overall Study|Adverse Event|29|||
44196477|NCT01623596|78992233|FG000|Overall Study|Death|0|||
44196478|NCT01623596|78992234|FG001|Overall Study|Death|2|||
44196479|NCT01623596|78992233|FG000|Overall Study|Lost to Follow-up|12|||
44196480|NCT01623596|78992234|FG001|Overall Study|Lost to Follow-up|16|||
44196481|NCT01623596|78992233|FG000|Overall Study|Withdrawal by Subject|13|||
44196482|NCT01623596|78992234|FG001|Overall Study|Withdrawal by Subject|31|||
44196483|NCT01623596|78992233|FG000|Overall Study|Patient no longer requires study drug|1|||
44196484|NCT01623596|78992234|FG001|Overall Study|Patient no longer requires study drug|0|||
44196485|NCT01623596|78992233|FG000|Overall Study|Protocol Violation|0|||
44196486|NCT01623596|78992234|FG001|Overall Study|Protocol Violation|6|||
44196487|NCT01623596|78992233|FG000|Overall Study|Lack of Efficacy|5|||
44196488|NCT01623596|78992234|FG001|Overall Study|Lack of Efficacy|3|||
44196489|NCT02219477|78992245|FG000|Overall Study|Adverse Event|0|||
44196490|NCT02219477|78992246|FG001|Overall Study|Adverse Event|1|||
44196491|NCT02219477|78992247|FG002|Overall Study|Adverse Event|1|||
44196492|NCT02219477|78992245|FG000|Overall Study|Withdrawal by Subject|0|||
44196493|NCT02219477|78992246|FG001|Overall Study|Withdrawal by Subject|1|||
44196494|NCT02219477|78992247|FG002|Overall Study|Withdrawal by Subject|0|||
44196495|NCT02119286|78992259|FG000|Overall Study|Adverse Event|9|||
44266493|NCT01650246|79174509|FG000|Overall Study|Adverse Event|23|||
44266494|NCT01650246|79174509|FG000|Overall Study|Protocol Violation|5|||
44266495|NCT01650246|79174509|FG000|Overall Study|Sponsor terminated study|53|||
44266496|NCT01650246|79174509|FG000|Overall Study|Lost to Follow-up|5|||
44196496|NCT02119286|78992260|FG001|Overall Study|Adverse Event|7|||
44196497|NCT02119286|78992261|FG002|Overall Study|Adverse Event|2|||
44196498|NCT02119286|78992259|FG000|Overall Study|Lack of Efficacy|11|||
44196499|NCT02119286|78992260|FG001|Overall Study|Lack of Efficacy|3|||
44196500|NCT02119286|78992261|FG002|Overall Study|Lack of Efficacy|4|||
44196501|NCT02119286|78992259|FG000|Overall Study|Lost to Follow-up|2|||
44266497|NCT01650246|79174509|FG000|Overall Study|Withdrawal by Subject|26|||
44266498|NCT01650246|79174509|FG000|Overall Study|Death|1|||
44196502|NCT02119286|78992260|FG001|Overall Study|Lost to Follow-up|0|||
44196503|NCT02119286|78992261|FG002|Overall Study|Lost to Follow-up|1|||
44196504|NCT02119286|78992259|FG000|Overall Study|Withdrawal by Subject|4|||
44196505|NCT02119286|78992260|FG001|Overall Study|Withdrawal by Subject|1|||
44196506|NCT02119286|78992261|FG002|Overall Study|Withdrawal by Subject|0|||
44196507|NCT02250443|78992269|FG000|Overall Study|Administrative problems|7|||
44196508|NCT02250443|78992269|FG000|Overall Study|Adverse Event|3|||
44196509|NCT02093390|78992275|FG000|Overall Study|Withdrawal by Subject|0|||
44196510|NCT02093390|78992276|FG001|Overall Study|Withdrawal by Subject|1|||
44196511|NCT02194985|78992283|FG000|Overall Study|Adverse Event|1|||
44196512|NCT02194985|78992283|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
44196513|NCT02194985|78992283|FG000|Overall Study|Physician Decision|4|||
44196514|NCT02194985|78992283|FG000|Overall Study|Lost to Follow-up|1|||
44196515|NCT02194985|78992283|FG000|Overall Study|Withdrawal by Subject|2|||
44196516|NCT02219087|78992289|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
44196517|NCT02219087|78992290|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
44196518|NCT02248961|78992298|FG000|Overall Study|Adverse Event|1|||
44196519|NCT02248961|78992299|FG001|Overall Study|Adverse Event|0|||
44196520|NCT02248961|78992298|FG000|Overall Study|Withdrawal by Subject|1|||
44196521|NCT02248961|78992299|FG001|Overall Study|Withdrawal by Subject|2|||
44196522|NCT02248961|78992298|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
44196523|NCT02248961|78992299|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
44196524|NCT02219009|78992307|FG000|Overall Study|Withdrawal by Subject|5|||
44196525|NCT02219009|78992308|FG001|Overall Study|Withdrawal by Subject|1|||
44196526|NCT02219009|78992307|FG000|Overall Study|Adverse Event|2|||
44196527|NCT02219009|78992308|FG001|Overall Study|Adverse Event|4|||
44196528|NCT02219009|78992307|FG000|Overall Study|Lost to Follow-up|2|||
44196529|NCT02219009|78992308|FG001|Overall Study|Lost to Follow-up|2|||
44196530|NCT02219009|78992307|FG000|Overall Study|Protocol deviation|1|||
44196531|NCT02219009|78992308|FG001|Overall Study|Protocol deviation|0|||
44196532|NCT02219009|78992307|FG000|Overall Study|Physician Decision|0|||
44196533|NCT02219009|78992308|FG001|Overall Study|Physician Decision|1|||
44196534|NCT02248649|78992316|FG000|Overall Study|Death|7|||
44196535|NCT02248649|78992317|FG001|Overall Study|Death|11|||
44196536|NCT02248649|78992316|FG000|Overall Study|Lost to Follow-up|14|||
44196537|NCT02248649|78992317|FG001|Overall Study|Lost to Follow-up|10|||
44196538|NCT02218541|78992325|FG000|Overall Study|Lost to Follow-up|2|||
44196539|NCT02218541|78992326|FG001|Overall Study|Lost to Follow-up|1|||
44196540|NCT02218541|78992325|FG000|Overall Study|Implant Failure|4|||
44196541|NCT02218541|78992326|FG001|Overall Study|Implant Failure|1|||
44196542|NCT02217527|78992335|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
44196543|NCT02217527|78992336|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
44196544|NCT02217527|78992335|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
44196545|NCT02217527|78992336|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
44196546|NCT01456936|78992346|FG000|Overall Study|Other reason|41|||
44196547|NCT01456936|78992347|FG001|Overall Study|Other reason|30|||
44196548|NCT01456936|78992348|FG002|Overall Study|Other reason|36|||
44196549|NCT01456936|78992349|FG003|Overall Study|Other reason|33|||
44196550|NCT01456936|78992346|FG000|Overall Study|No longer meets eligibility criteria|4|||
44196551|NCT01456936|78992347|FG001|Overall Study|No longer meets eligibility criteria|8|||
44196552|NCT01456936|78992348|FG002|Overall Study|No longer meets eligibility criteria|6|||
44196553|NCT01456936|78992349|FG003|Overall Study|No longer meets eligibility criteria|5|||
44196554|NCT01456936|78992346|FG000|Overall Study|Protocol Violation|4|||
44196555|NCT01456936|78992347|FG001|Overall Study|Protocol Violation|2|||
44196556|NCT01456936|78992348|FG002|Overall Study|Protocol Violation|5|||
44196557|NCT01456936|78992349|FG003|Overall Study|Protocol Violation|5|||
44196558|NCT01456936|78992346|FG000|Overall Study|Pregnancy|1|||
44196559|NCT01456936|78992347|FG001|Overall Study|Pregnancy|0|||
44196560|NCT01456936|78992348|FG002|Overall Study|Pregnancy|0|||
44196561|NCT01456936|78992349|FG003|Overall Study|Pregnancy|1|||
44196562|NCT01456936|78992346|FG000|Overall Study|Insufficient clinical response|4|||
44196563|NCT01456936|78992347|FG001|Overall Study|Insufficient clinical response|4|||
44196564|NCT01456936|78992348|FG002|Overall Study|Insufficient clinical response|14|||
44196565|NCT01456936|78992349|FG003|Overall Study|Insufficient clinical response|13|||
44196566|NCT01456936|78992346|FG000|Overall Study|No longer willing to participate|195|||
44196567|NCT01456936|78992347|FG001|Overall Study|No longer willing to participate|218|||
44196568|NCT01456936|78992348|FG002|Overall Study|No longer willing to participate|224|||
44196569|NCT01456936|78992349|FG003|Overall Study|No longer willing to participate|248|||
44196570|NCT01456936|78992346|FG000|Overall Study|Lost to Follow-up|135|||
44196571|NCT01456936|78992347|FG001|Overall Study|Lost to Follow-up|126|||
44196572|NCT01456936|78992348|FG002|Overall Study|Lost to Follow-up|144|||
44196573|NCT01456936|78992349|FG003|Overall Study|Lost to Follow-up|127|||
44196574|NCT01456936|78992346|FG000|Overall Study|Medication error|0|||
44196575|NCT01456936|78992347|FG001|Overall Study|Medication error|1|||
44196576|NCT01456936|78992348|FG002|Overall Study|Medication error|0|||
44196577|NCT01456936|78992349|FG003|Overall Study|Medication error|1|||
44196578|NCT01456936|78992346|FG000|Overall Study|Adverse event (study drug)|25|||
44266499|NCT01650246|79174509|FG000|Overall Study|Lack of Efficacy|30|||
44451494|NCT00500331|79460409|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
44196579|NCT01456936|78992347|FG001|Overall Study|Adverse event (study drug)|21|||
44196580|NCT01456936|78992348|FG002|Overall Study|Adverse event (study drug)|26|||
44196581|NCT01456936|78992349|FG003|Overall Study|Adverse event (study drug)|17|||
44196582|NCT01456936|78992346|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
44196583|NCT01456936|78992347|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
44196584|NCT01456936|78992348|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
44196585|NCT01456936|78992349|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
44196586|NCT01456936|78992346|FG000|Overall Study|Death|0|||
44196587|NCT01456936|78992347|FG001|Overall Study|Death|3|||
44196588|NCT01456936|78992348|FG002|Overall Study|Death|1|||
44196589|NCT01456936|78992349|FG003|Overall Study|Death|3|||
44196590|NCT01456936|78992346|FG000|Overall Study|Randomized but not treated|21|||
44196591|NCT01456936|78992347|FG001|Overall Study|Randomized but not treated|28|||
44196592|NCT01456936|78992348|FG002|Overall Study|Randomized but not treated|16|||
44196593|NCT01456936|78992349|FG003|Overall Study|Randomized but not treated|21|||
44196594|NCT01456780|78992362|FG000|Overall Study|Lost to Follow-up|3|||
44196595|NCT01456780|78992363|FG001|Overall Study|Lost to Follow-up|3|||
44196596|NCT01456780|78992364|FG002|Overall Study|Lost to Follow-up|0|||
44196597|NCT01480258|78992374|FG000|Infant Series|Protocol Violation|2|||
44196598|NCT01480258|78992375|FG001|Infant Series|Protocol Violation|0|||
44196599|NCT01480258|78992374|FG000|Infant Series|Physician Decision|0|||
44196600|NCT01480258|78992375|FG001|Infant Series|Physician Decision|1|||
44196601|NCT01480258|78992374|FG000|Infant Series|Not Vaccinated|3|||
44196602|NCT01480258|78992375|FG001|Infant Series|Not Vaccinated|0|||
44196603|NCT01480258|78992374|FG000|Infant Series|Adverse Event|1|||
44196604|NCT01480258|78992375|FG001|Infant Series|Adverse Event|1|||
44196605|NCT01480258|78992374|FG000|Infant Series|Withdrawal by Subject|1|||
44196606|NCT01480258|78992375|FG001|Infant Series|Withdrawal by Subject|6|||
44196607|NCT01480258|78992374|FG000|Interim Period|Lost to Follow-up|0|||
44196608|NCT01480258|78992375|FG001|Interim Period|Lost to Follow-up|2|||
44196609|NCT01480258|78992374|FG000|Interim Period|Physician Decision|1|||
44196610|NCT01480258|78992375|FG001|Interim Period|Physician Decision|0|||
44196611|NCT01480258|78992374|FG000|Interim Period|Protocol Violation|0|||
44196612|NCT01480258|78992375|FG001|Interim Period|Protocol Violation|1|||
44196613|NCT01480258|78992374|FG000|Interim Period|Withdrawal by Subject|9|||
44196614|NCT01480258|78992375|FG001|Interim Period|Withdrawal by Subject|6|||
44196615|NCT01479868|78992381|FG000|Overall Study|Adverse Event|1|||
44196616|NCT01479868|78992381|FG000|Overall Study|Lost to Follow-up|4|||
44196617|NCT01479868|78992381|FG000|Overall Study|Protocol Violation|1|||
44196618|NCT01479868|78992381|FG000|Overall Study|Withdrawal by Subject|1|||
44196619|NCT01479868|78992381|FG000|Overall Study|Sponsor's Decision|1|||
44196620|NCT01479868|78992381|FG000|Overall Study|Initiation of new HCV Therapy|1|||
44196621|NCT01478620|78992385|FG000|Overall Study|Lost to Follow-up|6|||
44196622|NCT01455220|78992389|FG000|Overall Study|screen fail|30|||
44196623|NCT01454830|78992398|FG000|Overall Study|Withdrawal by Subject|4|||
44196624|NCT01454830|78992399|FG001|Overall Study|Withdrawal by Subject|4|||
44196625|NCT01454830|78992398|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
44196626|NCT01454830|78992399|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
44196627|NCT01454830|78992398|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
44196628|NCT01454830|78992399|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
44196629|NCT01454830|78992398|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
44196630|NCT01454830|78992399|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
44196631|NCT01454830|78992398|FG000|Overall Study|Withdrawal - no polysomnography|3|||
44196632|NCT01454830|78992399|FG001|Overall Study|Withdrawal - no polysomnography|2|||
44196633|NCT01454596|78992417|FG000|Overall Study|Death|0|||
44196634|NCT01454596|78992418|FG001|Overall Study|Death|0|||
44196635|NCT01454596|78992419|FG002|Overall Study|Death|0|||
44196636|NCT01454596|78992420|FG003|Overall Study|Death|0|||
44196637|NCT01454596|78992421|FG004|Overall Study|Death|0|||
44196638|NCT01454596|78992422|FG005|Overall Study|Death|0|||
44196639|NCT01454596|78992423|FG006|Overall Study|Death|0|||
44196640|NCT01454596|78992424|FG007|Overall Study|Death|0|||
44196641|NCT01454596|78992425|FG008|Overall Study|Death|0|||
44196642|NCT01454596|78992426|FG009|Overall Study|Death|1|||
44196643|NCT01454596|78992427|FG010|Overall Study|Death|1|||
44196644|NCT01454596|78992428|FG011|Overall Study|Death|0|||
44196645|NCT02247479|78992457|FG000|Overall Study|Adverse Event|8|||
44196646|NCT02247479|78992458|FG001|Overall Study|Adverse Event|9|||
44196647|NCT02247479|78992459|FG002|Overall Study|Adverse Event|8|||
44196648|NCT02247479|78992457|FG000|Overall Study|Death|5|||
44196649|NCT02247479|78992458|FG001|Overall Study|Death|4|||
44196650|NCT02247479|78992459|FG002|Overall Study|Death|6|||
44196651|NCT02247479|78992457|FG000|Overall Study|Lost to Follow-up|3|||
44196652|NCT02247479|78992458|FG001|Overall Study|Lost to Follow-up|3|||
44196653|NCT02247479|78992459|FG002|Overall Study|Lost to Follow-up|1|||
44196654|NCT02247479|78992457|FG000|Overall Study|Non-compliance|0|||
44196655|NCT02247479|78992458|FG001|Overall Study|Non-compliance|0|||
44196656|NCT02247479|78992459|FG002|Overall Study|Non-compliance|1|||
44196657|NCT02247479|78992457|FG000|Overall Study|Withdrawal by Subject|25|||
44196658|NCT02247479|78992458|FG001|Overall Study|Withdrawal by Subject|29|||
44196659|NCT02247479|78992459|FG002|Overall Study|Withdrawal by Subject|24|||
44196660|NCT02247479|78992457|FG000|Overall Study|Study Terminated by Sponsor|98|||
44196661|NCT02247479|78992458|FG001|Overall Study|Study Terminated by Sponsor|88|||
44196662|NCT02247479|78992459|FG002|Overall Study|Study Terminated by Sponsor|94|||
44196663|NCT02247479|78992457|FG000|Overall Study|Physician Decision|1|||
44196664|NCT02247479|78992458|FG001|Overall Study|Physician Decision|0|||
44196665|NCT02247479|78992459|FG002|Overall Study|Physician Decision|2|||
44196666|NCT02247479|78992457|FG000|Overall Study|Unspecified Reason|2|||
44196667|NCT02247479|78992458|FG001|Overall Study|Unspecified Reason|5|||
44196668|NCT02247479|78992459|FG002|Overall Study|Unspecified Reason|2|||
44196669|NCT01454284|78992469|FG000|Overall Study|Adverse Event|20|||
44196670|NCT01454284|78992470|FG001|Overall Study|Adverse Event|7|||
44196671|NCT01454284|78992469|FG000|Overall Study|Death|0|||
44196672|NCT01454284|78992470|FG001|Overall Study|Death|3|||
44196673|NCT01454284|78992469|FG000|Overall Study|Lost to Follow-up|13|||
44196674|NCT01454284|78992470|FG001|Overall Study|Lost to Follow-up|8|||
44196675|NCT01454284|78992469|FG000|Overall Study|Protocol Violation|9|||
44196676|NCT01454284|78992470|FG001|Overall Study|Protocol Violation|6|||
44196677|NCT01454284|78992469|FG000|Overall Study|Withdrawal by Subject|58|||
44196678|NCT01454284|78992470|FG001|Overall Study|Withdrawal by Subject|36|||
44196679|NCT01454284|78992469|FG000|Overall Study|Physician Decision|16|||
44196680|NCT01454284|78992470|FG001|Overall Study|Physician Decision|11|||
44196681|NCT01454284|78992469|FG000|Overall Study|Sponsor Decision|0|||
44196682|NCT01454284|78992470|FG001|Overall Study|Sponsor Decision|2|||
44196683|NCT02247401|78992479|FG000|Overall Study|Adverse Event|1|||
44196684|NCT02247401|78992480|FG001|Overall Study|Adverse Event|0|||
44196685|NCT02247401|78992481|FG002|Overall Study|Adverse Event|0|||
44196686|NCT02247401|78992479|FG000|Overall Study|Withdrawal by Subject|4|||
44196687|NCT02247401|78992480|FG001|Overall Study|Withdrawal by Subject|1|||
44196688|NCT02247401|78992481|FG002|Overall Study|Withdrawal by Subject|1|||
44196689|NCT02247401|78992479|FG000|Overall Study|Lost to Follow-up|1|||
44196690|NCT02247401|78992480|FG001|Overall Study|Lost to Follow-up|1|||
44196691|NCT02247401|78992481|FG002|Overall Study|Lost to Follow-up|1|||
44196692|NCT02247011|78992492|FG000|Overall Study|Poor quality of radiological results|125|||
44196693|NCT02246777|78992499|FG000|Overall Study|Adverse Event|2|||
44196694|NCT02246777|78992499|FG000|Overall Study|Change of residence|1|||
44196695|NCT01495702|78992510|FG000|Randomized Phase|Randomized But Not Treated|1|||
44196696|NCT01495702|78992511|FG001|Randomized Phase|Randomized But Not Treated|4|||
44196697|NCT01495702|78992510|FG000|Randomized Phase|Adverse Event|2|||
44196698|NCT01495702|78992511|FG001|Randomized Phase|Adverse Event|2|||
44196699|NCT01495702|78992510|FG000|Randomized Phase|Death|1|||
44196700|NCT01495702|78992511|FG001|Randomized Phase|Death|0|||
44196701|NCT01495702|78992510|FG000|Randomized Phase|Lack of Efficacy|2|||
44196702|NCT01495702|78992511|FG001|Randomized Phase|Lack of Efficacy|0|||
44196703|NCT01495702|78992510|FG000|Randomized Phase|Investigators Discretion|2|||
44196704|NCT01495702|78992511|FG001|Randomized Phase|Investigators Discretion|0|||
44196705|NCT01495702|78992510|FG000|Randomized Phase|Withdrew Consent|10|||
44196706|NCT01495702|78992511|FG001|Randomized Phase|Withdrew Consent|18|||
44196707|NCT01495702|78992510|FG000|Randomized Phase|Lost to Follow-up|4|||
44196708|NCT01495702|78992511|FG001|Randomized Phase|Lost to Follow-up|3|||
44196709|NCT01495702|78992510|FG000|Randomized Phase|Participant Noncompliance|1|||
44196710|NCT01495702|78992511|FG001|Randomized Phase|Participant Noncompliance|0|||
44196711|NCT01495702|78992510|FG000|Randomized Phase|Protocol Violation|3|||
44196712|NCT01495702|78992511|FG001|Randomized Phase|Protocol Violation|1|||
44196713|NCT01630889|78992518|FG000|Overall Study|Death|2|||
44196714|NCT01630889|78992518|FG000|Overall Study|Withdrawal by Subject|1|||
44196715|NCT01630889|78992518|FG000|Overall Study|Other than Specified|2|||
44196716|NCT01630889|78992518|FG000|Overall Study|Lost to Follow-up|4|||
44196717|NCT01630889|78992518|FG000|Overall Study|Other|1|||
44196718|NCT01495000|78992524|FG000|Overall Study|Lost to Follow-up|2|||
44196719|NCT01495000|78992525|FG001|Overall Study|Lost to Follow-up|2|||
44196720|NCT01495000|78992524|FG000|Overall Study|Protocol Violation|1|||
44196721|NCT01495000|78992525|FG001|Overall Study|Protocol Violation|0|||
44196722|NCT01495000|78992524|FG000|Overall Study|Withdrawal by Subject|10|||
44196723|NCT01495000|78992525|FG001|Overall Study|Withdrawal by Subject|10|||
44196724|NCT01494922|78992531|FG000|Overall Study|Adverse Event|1|||
44196725|NCT02192099|78992535|FG000|Overall Study|Adverse Event|1|||
44196726|NCT02192099|78992535|FG000|Overall Study|Lost to Follow-up|2|||
44196727|NCT02192099|78992535|FG000|Overall Study|Physician Decision|1|||
44196728|NCT02192099|78992535|FG000|Overall Study|Pregnancy|1|||
44196729|NCT02192099|78992535|FG000|Overall Study|Protocol Violation|8|||
44196730|NCT02192099|78992535|FG000|Overall Study|Study Terminated by Sponsor|32|||
44196731|NCT02192099|78992535|FG000|Overall Study|Withdrawal by Subject|11|||
44451495|NCT00500331|79460410|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
44196732|NCT02192099|78992535|FG000|Overall Study|Miscellaneous Reasons|5|||
44196733|NCT01494610|78992539|FG000|Period 1|Withdrawal by Subject|1|||
44196734|NCT01494610|78992540|FG001|Period 1|Withdrawal by Subject|1|||
44196735|NCT01494610|78992539|FG000|Period 3|Adverse Event|1|||
44196736|NCT01494610|78992540|FG001|Period 3|Adverse Event|0|||
44196737|NCT01494610|78992539|FG000|Period 3|Withdrawal by Subject|1|||
44196738|NCT01494610|78992540|FG001|Period 3|Withdrawal by Subject|0|||
44196739|NCT01494610|78992539|FG000|Period 4|Protocol Violation|1|||
44196740|NCT01494610|78992540|FG001|Period 4|Protocol Violation|0|||
44196741|NCT02116777|78992559|FG000|Overall Study|Adverse Event|0|||
44196742|NCT02116777|78992560|FG001|Overall Study|Adverse Event|0|||
44196743|NCT02116777|78992561|FG002|Overall Study|Adverse Event|0|||
44196744|NCT02116777|78992562|FG003|Overall Study|Adverse Event|0|||
44196745|NCT02116777|78992563|FG004|Overall Study|Adverse Event|2|||
44196746|NCT02116777|78992564|FG005|Overall Study|Adverse Event|2|||
44196747|NCT02116777|78992565|FG006|Overall Study|Adverse Event|0|||
44196748|NCT02116777|78992559|FG000|Overall Study|Death|0|||
44196749|NCT02116777|78992560|FG001|Overall Study|Death|0|||
44196750|NCT02116777|78992561|FG002|Overall Study|Death|0|||
44196751|NCT02116777|78992562|FG003|Overall Study|Death|1|||
44196752|NCT02116777|78992563|FG004|Overall Study|Death|0|||
44196753|NCT02116777|78992564|FG005|Overall Study|Death|0|||
44196754|NCT02116777|78992565|FG006|Overall Study|Death|0|||
44196755|NCT02116777|78992559|FG000|Overall Study|Lack of Efficacy|3|||
44196756|NCT02116777|78992560|FG001|Overall Study|Lack of Efficacy|3|||
44196757|NCT02116777|78992561|FG002|Overall Study|Lack of Efficacy|3|||
44196758|NCT02116777|78992562|FG003|Overall Study|Lack of Efficacy|8|||
44196759|NCT02116777|78992563|FG004|Overall Study|Lack of Efficacy|4|||
44196760|NCT02116777|78992564|FG005|Overall Study|Lack of Efficacy|1|||
44196761|NCT02116777|78992565|FG006|Overall Study|Lack of Efficacy|9|||
44196762|NCT02116777|78992559|FG000|Overall Study|Physician Decision|0|||
44196763|NCT02116777|78992560|FG001|Overall Study|Physician Decision|0|||
44196764|NCT02116777|78992561|FG002|Overall Study|Physician Decision|0|||
44196765|NCT02116777|78992562|FG003|Overall Study|Physician Decision|2|||
44196766|NCT02116777|78992563|FG004|Overall Study|Physician Decision|0|||
44196767|NCT02116777|78992564|FG005|Overall Study|Physician Decision|0|||
44196768|NCT02116777|78992565|FG006|Overall Study|Physician Decision|0|||
44196769|NCT02116777|78992559|FG000|Overall Study|Protocol Violation|0|||
44196770|NCT02116777|78992560|FG001|Overall Study|Protocol Violation|0|||
44196771|NCT02116777|78992561|FG002|Overall Study|Protocol Violation|0|||
44196772|NCT02116777|78992562|FG003|Overall Study|Protocol Violation|1|||
44196773|NCT02116777|78992563|FG004|Overall Study|Protocol Violation|0|||
44196774|NCT02116777|78992564|FG005|Overall Study|Protocol Violation|0|||
44196775|NCT02116777|78992565|FG006|Overall Study|Protocol Violation|0|||
44196776|NCT02116777|78992559|FG000|Overall Study|Withdrawal by Subject|0|||
44196777|NCT02116777|78992560|FG001|Overall Study|Withdrawal by Subject|0|||
44196778|NCT02116777|78992561|FG002|Overall Study|Withdrawal by Subject|0|||
44196779|NCT02116777|78992562|FG003|Overall Study|Withdrawal by Subject|1|||
44196780|NCT02116777|78992563|FG004|Overall Study|Withdrawal by Subject|0|||
44196781|NCT02116777|78992564|FG005|Overall Study|Withdrawal by Subject|0|||
44196782|NCT02116777|78992565|FG006|Overall Study|Withdrawal by Subject|0|||
44196783|NCT01494532|78992590|FG000|Overall Study|Adverse Event|4|||
44196784|NCT01494532|78992591|FG001|Overall Study|Adverse Event|1|||
44196785|NCT01494532|78992592|FG002|Overall Study|Adverse Event|8|||
44196786|NCT01494532|78992593|FG003|Overall Study|Adverse Event|6|||
44196787|NCT01494532|78992594|FG004|Overall Study|Adverse Event|5|||
44196788|NCT01494532|78992595|FG005|Overall Study|Adverse Event|0|||
44196789|NCT01494532|78992590|FG000|Overall Study|Lack of Efficacy|0|||
44196790|NCT01494532|78992591|FG001|Overall Study|Lack of Efficacy|0|||
44196791|NCT01494532|78992592|FG002|Overall Study|Lack of Efficacy|0|||
44196792|NCT01494532|78992593|FG003|Overall Study|Lack of Efficacy|0|||
44196793|NCT01494532|78992594|FG004|Overall Study|Lack of Efficacy|2|||
44196794|NCT01494532|78992595|FG005|Overall Study|Lack of Efficacy|0|||
44196795|NCT01494532|78992590|FG000|Overall Study|Protocol deviation|2|||
44196796|NCT01494532|78992591|FG001|Overall Study|Protocol deviation|1|||
44196797|NCT01494532|78992592|FG002|Overall Study|Protocol deviation|3|||
44196798|NCT01494532|78992593|FG003|Overall Study|Protocol deviation|2|||
44196799|NCT01494532|78992594|FG004|Overall Study|Protocol deviation|3|||
44196800|NCT01494532|78992595|FG005|Overall Study|Protocol deviation|0|||
44196801|NCT01494532|78992590|FG000|Overall Study|Protocol-defined stopping criteria|0|||
44196802|NCT01494532|78992591|FG001|Overall Study|Protocol-defined stopping criteria|0|||
44196803|NCT01494532|78992592|FG002|Overall Study|Protocol-defined stopping criteria|1|||
44196804|NCT01494532|78992593|FG003|Overall Study|Protocol-defined stopping criteria|0|||
44196805|NCT01494532|78992594|FG004|Overall Study|Protocol-defined stopping criteria|0|||
44196806|NCT01494532|78992595|FG005|Overall Study|Protocol-defined stopping criteria|0|||
44196807|NCT01494532|78992590|FG000|Overall Study|Lost to Follow-up|1|||
44196808|NCT01494532|78992591|FG001|Overall Study|Lost to Follow-up|0|||
44196809|NCT01494532|78992592|FG002|Overall Study|Lost to Follow-up|0|||
44196810|NCT01494532|78992593|FG003|Overall Study|Lost to Follow-up|2|||
44196811|NCT01494532|78992594|FG004|Overall Study|Lost to Follow-up|0|||
44196812|NCT01494532|78992595|FG005|Overall Study|Lost to Follow-up|0|||
44196813|NCT01494532|78992590|FG000|Overall Study|Physician Decision|0|||
44196814|NCT01494532|78992591|FG001|Overall Study|Physician Decision|1|||
44196815|NCT01494532|78992592|FG002|Overall Study|Physician Decision|1|||
44196816|NCT01494532|78992593|FG003|Overall Study|Physician Decision|2|||
44196817|NCT01494532|78992594|FG004|Overall Study|Physician Decision|0|||
44196818|NCT01494532|78992595|FG005|Overall Study|Physician Decision|0|||
44196819|NCT01494532|78992590|FG000|Overall Study|Withdrawal by Subject|3|||
44196820|NCT01494532|78992591|FG001|Overall Study|Withdrawal by Subject|1|||
44196821|NCT01494532|78992592|FG002|Overall Study|Withdrawal by Subject|4|||
44196822|NCT01494532|78992593|FG003|Overall Study|Withdrawal by Subject|3|||
44196823|NCT01494532|78992594|FG004|Overall Study|Withdrawal by Subject|2|||
44196824|NCT01494532|78992595|FG005|Overall Study|Withdrawal by Subject|0|||
44196825|NCT02191397|78992612|FG000|Overall Study|Adverse Event|28|||
44196826|NCT02191397|78992613|FG001|Overall Study|Adverse Event|17|||
44196827|NCT02191397|78992612|FG000|Overall Study|Lack of Efficacy|10|||
44196828|NCT02191397|78992613|FG001|Overall Study|Lack of Efficacy|5|||
44266500|NCT01652664|79174528|FG000|Overall Study|Treatment Failure|5|||
44266501|NCT01652664|79174529|FG001|Overall Study|Treatment Failure|1|||
44266502|NCT01652664|79174528|FG000|Overall Study|Inadequate IOP control|1|||
44266503|NCT01652664|79174529|FG001|Overall Study|Inadequate IOP control|0|||
44266504|NCT02379390|79174569|FG000|Overall Study|Adverse Event|1|||
44266505|NCT02379390|79174570|FG001|Overall Study|Adverse Event|1|||
44266506|NCT02379390|79174569|FG000|Overall Study|Investigator's decision|1|||
44266507|NCT02379390|79174570|FG001|Overall Study|Investigator's decision|0|||
44266508|NCT02379390|79174569|FG000|Overall Study|Study Termination|0|||
44266509|NCT02379390|79174570|FG001|Overall Study|Study Termination|1|||
44266510|NCT02379078|79174581|FG000|Overall Study|Lost to Follow-up|33|||
44266511|NCT02379078|79174582|FG001|Overall Study|Lost to Follow-up|30|||
44266512|NCT02379078|79174581|FG000|Overall Study|Withdrawal by Subject|6|||
44266513|NCT02379078|79174582|FG001|Overall Study|Withdrawal by Subject|5|||
44266514|NCT01714739|79174675|FG000|Overall Study|Disease progression|3|||
44266515|NCT01714739|79174676|FG001|Overall Study|Disease progression|5|||
44266516|NCT01714739|79174677|FG002|Overall Study|Disease progression|5|||
44266517|NCT01714739|79174678|FG003|Overall Study|Disease progression|204|||
44266518|NCT01714739|79174679|FG004|Overall Study|Disease progression|1|||
44266519|NCT01714739|79174680|FG005|Overall Study|Disease progression|3|||
44266520|NCT01714739|79174681|FG006|Overall Study|Disease progression|5|||
44266521|NCT01714739|79174675|FG000|Overall Study|Study drug toxicity|1|||
44266522|NCT01714739|79174676|FG001|Overall Study|Study drug toxicity|1|||
44196829|NCT02191397|78992612|FG000|Overall Study|Protocol Violation|0|||
44266523|NCT01714739|79174677|FG002|Overall Study|Study drug toxicity|1|||
44266524|NCT01714739|79174678|FG003|Overall Study|Study drug toxicity|15|||
44266525|NCT01714739|79174679|FG004|Overall Study|Study drug toxicity|0|||
44266526|NCT01714739|79174680|FG005|Overall Study|Study drug toxicity|0|||
44266527|NCT01714739|79174681|FG006|Overall Study|Study drug toxicity|5|||
44196830|NCT02191397|78992613|FG001|Overall Study|Protocol Violation|3|||
44266528|NCT01714739|79174675|FG000|Overall Study|Death|0|||
44266529|NCT01714739|79174676|FG001|Overall Study|Death|0|||
44266530|NCT01714739|79174677|FG002|Overall Study|Death|0|||
44266531|NCT01714739|79174678|FG003|Overall Study|Death|1|||
44266532|NCT01714739|79174679|FG004|Overall Study|Death|0|||
44266533|NCT01714739|79174680|FG005|Overall Study|Death|0|||
44266534|NCT01714739|79174681|FG006|Overall Study|Death|0|||
44266535|NCT01714739|79174675|FG000|Overall Study|Adverse Event unrelated to drug|0|||
44266536|NCT01714739|79174676|FG001|Overall Study|Adverse Event unrelated to drug|0|||
44266537|NCT01714739|79174677|FG002|Overall Study|Adverse Event unrelated to drug|3|||
44266538|NCT01714739|79174678|FG003|Overall Study|Adverse Event unrelated to drug|21|||
44266539|NCT01714739|79174679|FG004|Overall Study|Adverse Event unrelated to drug|0|||
44266540|NCT01714739|79174680|FG005|Overall Study|Adverse Event unrelated to drug|0|||
44266541|NCT01714739|79174681|FG006|Overall Study|Adverse Event unrelated to drug|0|||
44266542|NCT01714739|79174675|FG000|Overall Study|Participant request to stop therapy|0|||
44266543|NCT01714739|79174676|FG001|Overall Study|Participant request to stop therapy|1|||
44266544|NCT01714739|79174677|FG002|Overall Study|Participant request to stop therapy|0|||
44266545|NCT01714739|79174678|FG003|Overall Study|Participant request to stop therapy|6|||
44196831|NCT02191397|78992612|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
44266546|NCT01714739|79174679|FG004|Overall Study|Participant request to stop therapy|0|||
44266547|NCT01714739|79174680|FG005|Overall Study|Participant request to stop therapy|0|||
44266548|NCT01714739|79174681|FG006|Overall Study|Participant request to stop therapy|0|||
44266549|NCT01714739|79174675|FG000|Overall Study|Participant withdrew consent|0|||
44266550|NCT01714739|79174676|FG001|Overall Study|Participant withdrew consent|1|||
44266551|NCT01714739|79174677|FG002|Overall Study|Participant withdrew consent|0|||
44266552|NCT01714739|79174678|FG003|Overall Study|Participant withdrew consent|8|||
44266553|NCT01714739|79174679|FG004|Overall Study|Participant withdrew consent|0|||
44266554|NCT01714739|79174680|FG005|Overall Study|Participant withdrew consent|0|||
44266555|NCT01714739|79174681|FG006|Overall Study|Participant withdrew consent|0|||
44266556|NCT01714739|79174675|FG000|Overall Study|Lost to Follow-up|0|||
44266557|NCT01714739|79174676|FG001|Overall Study|Lost to Follow-up|0|||
44266558|NCT01714739|79174677|FG002|Overall Study|Lost to Follow-up|0|||
44266559|NCT01714739|79174678|FG003|Overall Study|Lost to Follow-up|1|||
44266560|NCT01714739|79174679|FG004|Overall Study|Lost to Follow-up|0|||
44266561|NCT01714739|79174680|FG005|Overall Study|Lost to Follow-up|0|||
44196832|NCT02191397|78992613|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
44196833|NCT02191397|78992612|FG000|Overall Study|Lost to Follow-up|10|||
44196834|NCT02191397|78992613|FG001|Overall Study|Lost to Follow-up|11|||
44196835|NCT02191397|78992612|FG000|Overall Study|Physician Decision|8|||
44196836|NCT02191397|78992613|FG001|Overall Study|Physician Decision|3|||
44196837|NCT02191397|78992612|FG000|Overall Study|Withdrawal by Subject|22|||
44196838|NCT02191397|78992613|FG001|Overall Study|Withdrawal by Subject|27|||
44196839|NCT01630811|78992619|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
44196840|NCT01630811|78992620|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
44196841|NCT01494298|78992630|FG000|Overall Study|Protocol Violation|2|||
44196842|NCT01494298|78992631|FG001|Overall Study|Protocol Violation|8|||
44266562|NCT01714739|79174681|FG006|Overall Study|Lost to Follow-up|0|||
44266563|NCT01714739|79174675|FG000|Overall Study|Maximum clinical benefit|0|||
44266564|NCT01714739|79174676|FG001|Overall Study|Maximum clinical benefit|1|||
44266565|NCT01714739|79174677|FG002|Overall Study|Maximum clinical benefit|1|||
44266566|NCT01714739|79174678|FG003|Overall Study|Maximum clinical benefit|3|||
44266567|NCT01714739|79174679|FG004|Overall Study|Maximum clinical benefit|0|||
44266568|NCT01714739|79174680|FG005|Overall Study|Maximum clinical benefit|0|||
44266569|NCT01714739|79174681|FG006|Overall Study|Maximum clinical benefit|0|||
44266570|NCT01714739|79174675|FG000|Overall Study|Poor/non-comliance|0|||
44266571|NCT01714739|79174676|FG001|Overall Study|Poor/non-comliance|1|||
44266572|NCT01714739|79174677|FG002|Overall Study|Poor/non-comliance|0|||
44266573|NCT01714739|79174678|FG003|Overall Study|Poor/non-comliance|1|||
44266574|NCT01714739|79174679|FG004|Overall Study|Poor/non-comliance|0|||
44266575|NCT01714739|79174680|FG005|Overall Study|Poor/non-comliance|0|||
44266576|NCT01714739|79174681|FG006|Overall Study|Poor/non-comliance|0|||
44266577|NCT01714739|79174675|FG000|Overall Study|No longer meets study criteria|0|||
44266578|NCT01714739|79174676|FG001|Overall Study|No longer meets study criteria|0|||
44266579|NCT01714739|79174677|FG002|Overall Study|No longer meets study criteria|0|||
44266580|NCT01714739|79174678|FG003|Overall Study|No longer meets study criteria|1|||
44266581|NCT01714739|79174679|FG004|Overall Study|No longer meets study criteria|0|||
44266582|NCT01714739|79174680|FG005|Overall Study|No longer meets study criteria|0|||
44196843|NCT02169791|78992639|FG000|Overall Study|Death|6|||
44266583|NCT01714739|79174681|FG006|Overall Study|No longer meets study criteria|0|||
44266584|NCT01714739|79174675|FG000|Overall Study|Other reason|0|||
44266585|NCT01714739|79174676|FG001|Overall Study|Other reason|0|||
44266586|NCT01714739|79174677|FG002|Overall Study|Other reason|0|||
44361294|NCT00891202|79366961|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
44361295|NCT00891202|79366962|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
44266587|NCT01714739|79174678|FG003|Overall Study|Other reason|3|||
44196844|NCT02169791|78992639|FG000|Overall Study|patient withdrew consent|1|||
44196845|NCT02216591|78992645|FG000|Overall Study|Lost to Follow-up|0|||
44196846|NCT02216591|78992646|FG001|Overall Study|Lost to Follow-up|1|||
44196847|NCT02216357|78992654|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
44196848|NCT02216357|78992655|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
44196849|NCT01492426|78992663|FG000|Treatment|Death|0|||
44196850|NCT01492426|78992664|FG001|Treatment|Death|1|||
44196851|NCT01492426|78992663|FG000|Treatment|Other|1|||
44196852|NCT01492426|78992664|FG001|Treatment|Other|0|||
44196853|NCT01492426|78992663|FG000|Treatment|Adverse Event|25|||
44196854|NCT01492426|78992664|FG001|Treatment|Adverse Event|25|||
44196855|NCT01492426|78992663|FG000|Treatment|Lack of Efficacy|38|||
44196856|NCT01492426|78992664|FG001|Treatment|Lack of Efficacy|5|||
44196857|NCT01492426|78992663|FG000|Treatment|Participant withdrew consent|1|||
44196858|NCT01492426|78992664|FG001|Treatment|Participant withdrew consent|2|||
44196859|NCT01492426|78992663|FG000|Treatment|Poor compliance/noncompliance|1|||
44196860|NCT01492426|78992664|FG001|Treatment|Poor compliance/noncompliance|0|||
44196861|NCT01492426|78992663|FG000|Treatment|Subject requested discontinue study drug|7|||
44196862|NCT01492426|78992664|FG001|Treatment|Subject requested discontinue study drug|3|||
44196863|NCT01492426|78992663|FG000|Treatment|Lost to Follow-up|9|||
44196864|NCT01492426|78992664|FG001|Treatment|Lost to Follow-up|4|||
44196865|NCT01492426|78992663|FG000|Treatment|Participant does not meet study criteria|1|||
44196866|NCT01492426|78992664|FG001|Treatment|Participant does not meet study criteria|0|||
44196867|NCT01492426|78992663|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
44196868|NCT01492426|78992664|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
44196869|NCT01492426|78992663|FG000|Follow-Up|Death|1|||
44196870|NCT01492426|78992664|FG001|Follow-Up|Death|0|||
44196871|NCT01492426|78992663|FG000|Follow-Up|Other|4|||
44196872|NCT01492426|78992664|FG001|Follow-Up|Other|2|||
44196873|NCT01492426|78992663|FG000|Follow-Up|Participant Withdrew Consent|6|||
44196874|NCT01492426|78992664|FG001|Follow-Up|Participant Withdrew Consent|1|||
44196875|NCT01492426|78992663|FG000|Follow-Up|Lost to Follow-up|12|||
44196876|NCT01492426|78992664|FG001|Follow-Up|Lost to Follow-up|6|||
44196877|NCT01453348|78992677|FG000|Overall Study|Death|0|||
44196878|NCT01453348|78992678|FG001|Overall Study|Death|0|||
44196879|NCT01453348|78992679|FG002|Overall Study|Death|1|||
44196880|NCT01453348|78992677|FG000|Overall Study|Withdrawal by Subject|0|||
44196881|NCT01453348|78992678|FG001|Overall Study|Withdrawal by Subject|1|||
44196882|NCT01453348|78992679|FG002|Overall Study|Withdrawal by Subject|0|||
44196883|NCT01453348|78992677|FG000|Overall Study|Protocol Violation|1|||
44196884|NCT01453348|78992678|FG001|Overall Study|Protocol Violation|0|||
44196885|NCT01453348|78992679|FG002|Overall Study|Protocol Violation|0|||
44196886|NCT01453036|78992693|FG000|Overall Study|Lost to Follow-up|26|||
44196887|NCT01453036|78992694|FG001|Overall Study|Lost to Follow-up|115|||
44196888|NCT01453036|78992695|FG002|Overall Study|Lost to Follow-up|31|||
44196889|NCT01475734|78992705|FG000|Overall Study|Withdrawal by Subject|1|||
44196890|NCT01475734|78992706|FG001|Overall Study|Withdrawal by Subject|0|||
44196891|NCT01475734|78992705|FG000|Overall Study|Protocol Violation|1|||
44196892|NCT01475734|78992706|FG001|Overall Study|Protocol Violation|0|||
44196893|NCT01475734|78992705|FG000|Overall Study|Physician Decision|0|||
44196894|NCT01475734|78992706|FG001|Overall Study|Physician Decision|1|||
44196895|NCT01452412|78992714|FG000|Overall Study|Withdrawal by Subject|15|||
44196896|NCT01452412|78992715|FG001|Overall Study|Withdrawal by Subject|11|||
44196897|NCT01452412|78992714|FG000|Overall Study|Adverse Event|4|||
44196898|NCT01452412|78992715|FG001|Overall Study|Adverse Event|3|||
44196899|NCT01452412|78992714|FG000|Overall Study|Lost to Follow-up|5|||
44196900|NCT01452412|78992715|FG001|Overall Study|Lost to Follow-up|3|||
44196901|NCT01452412|78992714|FG000|Overall Study|Death|1|||
44196902|NCT01452412|78992715|FG001|Overall Study|Death|0|||
44196903|NCT01452412|78992714|FG000|Overall Study|Initiated dialysis|1|||
44196904|NCT01452412|78992715|FG001|Overall Study|Initiated dialysis|0|||
44196905|NCT01452412|78992714|FG000|Overall Study|Other|2|||
44196906|NCT01452412|78992715|FG001|Overall Study|Other|0|||
44266588|NCT01714739|79174679|FG004|Overall Study|Other reason|1|||
44196907|NCT01474876|78992724|FG000|Overall Study|Adverse Event|11|||
44196908|NCT01474876|78992725|FG001|Overall Study|Adverse Event|5|||
44196909|NCT01474876|78992726|FG002|Overall Study|Adverse Event|0|||
44196910|NCT01474876|78992724|FG000|Overall Study|Serious Adverse Event|2|||
44196911|NCT01474876|78992725|FG001|Overall Study|Serious Adverse Event|3|||
44196912|NCT01474876|78992726|FG002|Overall Study|Serious Adverse Event|0|||
44196913|NCT01474876|78992724|FG000|Overall Study|Lost to Follow-up|5|||
44196914|NCT01474876|78992725|FG001|Overall Study|Lost to Follow-up|4|||
44196915|NCT01474876|78992726|FG002|Overall Study|Lost to Follow-up|0|||
44196916|NCT01474876|78992724|FG000|Overall Study|Investigator's decision|28|||
44196917|NCT01474876|78992725|FG001|Overall Study|Investigator's decision|6|||
44196918|NCT01474876|78992726|FG002|Overall Study|Investigator's decision|0|||
44196919|NCT01474876|78992724|FG000|Overall Study|Patient's request|19|||
44196920|NCT01474876|78992725|FG001|Overall Study|Patient's request|5|||
44196921|NCT01474876|78992726|FG002|Overall Study|Patient's request|0|||
44196922|NCT01474876|78992724|FG000|Overall Study|Investigator's decision and pt request|1|||
44196923|NCT01474876|78992725|FG001|Overall Study|Investigator's decision and pt request|0|||
44196924|NCT01474876|78992726|FG002|Overall Study|Investigator's decision and pt request|0|||
44196925|NCT01491802|78992732|FG000|Overall Study|Adverse Event|1|||
44196926|NCT01491802|78992733|FG001|Overall Study|Adverse Event|1|||
44196927|NCT01491802|78992732|FG000|Overall Study|Withdrawal by Subject|0|||
44196928|NCT01491802|78992733|FG001|Overall Study|Withdrawal by Subject|1|||
44196929|NCT02168777|78992743|FG000|Overall Study|Withdrawal by Subject|1|||
44196930|NCT02168777|78992744|FG001|Overall Study|Withdrawal by Subject|0|||
44196931|NCT02168777|78992745|FG002|Overall Study|Withdrawal by Subject|2|||
44196932|NCT02168777|78992743|FG000|Overall Study|Adverse Event|1|||
44196933|NCT02168777|78992744|FG001|Overall Study|Adverse Event|0|||
44196934|NCT02168777|78992745|FG002|Overall Study|Adverse Event|1|||
44196935|NCT02168777|78992743|FG000|Overall Study|Disease recurrence|0|||
44196936|NCT02168777|78992744|FG001|Overall Study|Disease recurrence|0|||
44196937|NCT02168777|78992745|FG002|Overall Study|Disease recurrence|1|||
44196938|NCT02168777|78992743|FG000|Overall Study|Radiological disease progression|0|||
44196939|NCT02168777|78992744|FG001|Overall Study|Radiological disease progression|5|||
44196940|NCT02168777|78992745|FG002|Overall Study|Radiological disease progression|5|||
44196941|NCT02168777|78992743|FG000|Overall Study|Clinical disease progression|0|||
44196942|NCT02168777|78992744|FG001|Overall Study|Clinical disease progression|1|||
44196943|NCT02168777|78992745|FG002|Overall Study|Clinical disease progression|2|||
44196944|NCT02168777|78992743|FG000|Overall Study|Other reason|0|||
44196945|NCT02168777|78992744|FG001|Overall Study|Other reason|1|||
44196946|NCT02168777|78992745|FG002|Overall Study|Other reason|0|||
44196947|NCT01491178|78992756|FG000|Overall Study|Adverse Event|1016|||
44196948|NCT01491178|78992756|FG000|Overall Study|Improvement of NVAF|210|||
44196949|NCT01491178|78992756|FG000|Overall Study|To conduct invasive treatment|59|||
44196950|NCT01491178|78992756|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
44196951|NCT01491178|78992756|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
44196952|NCT01491178|78992756|FG000|Overall Study|To take a contraindication|20|||
44196953|NCT01491178|78992756|FG000|Overall Study|Other than specified above|657|||
44196954|NCT02189837|78992764|FG000|Overall Study|Withdrawal by Subject|2|||
44196955|NCT02189837|78992765|FG001|Overall Study|Withdrawal by Subject|1|||
44196956|NCT02189837|78992766|FG002|Overall Study|Withdrawal by Subject|3|||
44196957|NCT02189837|78992767|FG003|Overall Study|Withdrawal by Subject|1|||
44196958|NCT02189837|78992764|FG000|Overall Study|Sponsor Decision|0|||
44196959|NCT02189837|78992765|FG001|Overall Study|Sponsor Decision|0|||
44196960|NCT02189837|78992766|FG002|Overall Study|Sponsor Decision|0|||
44196961|NCT02189837|78992767|FG003|Overall Study|Sponsor Decision|1|||
44196962|NCT02216123|78992779|FG000|Overall Study|Lost to Follow-up|4|||
44196963|NCT02216123|78992780|FG001|Overall Study|Lost to Follow-up|2|||
44196964|NCT02216123|78992779|FG000|Overall Study|Withdrawal by Subject|2|||
44196965|NCT02216123|78992780|FG001|Overall Study|Withdrawal by Subject|0|||
44196966|NCT02189759|78992794|FG000|Overall Study|Lost to Follow-up|0|||
44196967|NCT02189759|78992795|FG001|Overall Study|Lost to Follow-up|0|||
44196968|NCT02189759|78992796|FG002|Overall Study|Lost to Follow-up|2|||
44196969|NCT02189759|78992797|FG003|Overall Study|Lost to Follow-up|5|||
44196970|NCT01490866|78992809|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
44196971|NCT01490866|78992809|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
44196972|NCT01490866|78992809|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
44196973|NCT01490866|78992809|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
44196974|NCT01490866|78992809|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
44196975|NCT01490866|78992809|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
44196976|NCT01490866|78992809|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
44196977|NCT01490866|78992809|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
44196978|NCT01490866|78992809|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
44196979|NCT01490866|78992809|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
44196980|NCT01490866|78992809|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
44196981|NCT02215967|78992820|FG000|Overall Study|Patient became ineligible for treatment|0|||
44196982|NCT02215967|78992821|FG001|Overall Study|Patient became ineligible for treatment|0|||
44196983|NCT02215967|78992822|FG002|Overall Study|Patient became ineligible for treatment|0|||
44196984|NCT02215967|78992823|FG003|Overall Study|Patient became ineligible for treatment|3|||
44196985|NCT02215967|78992820|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
44196986|NCT02215967|78992821|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
44196987|NCT02215967|78992822|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
44196988|NCT02215967|78992823|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
44196989|NCT02168387|78992835|FG000|Overall Study|Planned exubation|6|||
44196990|NCT02168387|78992836|FG001|Overall Study|Planned exubation|3|||
44196991|NCT02168387|78992835|FG000|Overall Study|Death|1|||
44196992|NCT02168387|78992836|FG001|Overall Study|Death|0|||
44196993|NCT02188589|78992842|FG000|Overall Study|Withdrawal by Subject|5|||
44196994|NCT02167451|78992847|FG000|Overall Study|Withdrawal by Subject|1|||
44196995|NCT02167139|78992853|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
44196996|NCT02167139|78992854|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
44196997|NCT02167139|78992855|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
44196998|NCT02167139|78992856|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
44196999|NCT02167139|78992853|FG000|Randomised, Double-blind|Adverse Event|2|||
44197000|NCT02167139|78992854|FG001|Randomised, Double-blind|Adverse Event|9|||
44197001|NCT02167139|78992855|FG002|Randomised, Double-blind|Adverse Event|0|||
44197002|NCT02167139|78992856|FG003|Randomised, Double-blind|Adverse Event|0|||
44197003|NCT02167139|78992853|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
44197004|NCT02167139|78992854|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
44197005|NCT02167139|78992855|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
44197006|NCT02167139|78992856|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
44197007|NCT02167139|78992853|FG000|Randomised, Double-blind|Other|3|||
44197008|NCT02167139|78992854|FG001|Randomised, Double-blind|Other|0|||
44197009|NCT02167139|78992855|FG002|Randomised, Double-blind|Other|0|||
44197010|NCT02167139|78992856|FG003|Randomised, Double-blind|Other|0|||
44197011|NCT02167139|78992853|FG000|Transition-extension|Adverse Event|2|||
44197012|NCT02167139|78992854|FG001|Transition-extension|Adverse Event|0|||
44197013|NCT02167139|78992855|FG002|Transition-extension|Adverse Event|2|||
44197014|NCT02167139|78992856|FG003|Transition-extension|Adverse Event|3|||
44197015|NCT02167139|78992853|FG000|Transition-extension|Withdrawal by Subject|2|||
44197016|NCT02167139|78992854|FG001|Transition-extension|Withdrawal by Subject|0|||
44197017|NCT02167139|78992855|FG002|Transition-extension|Withdrawal by Subject|4|||
44197018|NCT02167139|78992856|FG003|Transition-extension|Withdrawal by Subject|1|||
44197019|NCT02167139|78992853|FG000|Transition-extension|Lack of Efficacy|0|||
44197020|NCT02167139|78992854|FG001|Transition-extension|Lack of Efficacy|0|||
44197021|NCT02167139|78992855|FG002|Transition-extension|Lack of Efficacy|1|||
44197022|NCT02167139|78992856|FG003|Transition-extension|Lack of Efficacy|1|||
44197023|NCT02167139|78992853|FG000|Transition-extension|Other|1|||
44197024|NCT02167139|78992854|FG001|Transition-extension|Other|0|||
44197025|NCT02167139|78992855|FG002|Transition-extension|Other|1|||
44197026|NCT02167139|78992856|FG003|Transition-extension|Other|0|||
44197027|NCT02167139|78992853|FG000|Transition-extension|Lost to Follow-up|1|||
44197028|NCT02167139|78992854|FG001|Transition-extension|Lost to Follow-up|0|||
44197029|NCT02167139|78992855|FG002|Transition-extension|Lost to Follow-up|0|||
44197030|NCT02167139|78992856|FG003|Transition-extension|Lost to Follow-up|0|||
44197031|NCT02116621|78992872|FG000|Baseline|Withdrawal by Subject|0|||
44197032|NCT02116621|78992873|FG001|Baseline|Withdrawal by Subject|4|||
44197033|NCT02116621|78992872|FG000|Three Month Follow-up|Death|1|||
44197034|NCT02116621|78992873|FG001|Three Month Follow-up|Death|1|||
44197035|NCT02116621|78992872|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
44197036|NCT02116621|78992873|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
44197037|NCT02116621|78992872|FG000|Three Month Follow-up|Lost to Follow-up|0|||
44197038|NCT02116621|78992873|FG001|Three Month Follow-up|Lost to Follow-up|1|||
44197039|NCT02116621|78992872|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
44197040|NCT02116621|78992873|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
44197041|NCT02116621|78992872|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
44197042|NCT02116621|78992873|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
44197043|NCT02116621|78992872|FG000|Six Month Follow-up|Lost to Follow-up|2|||
44197044|NCT02116621|78992873|FG001|Six Month Follow-up|Lost to Follow-up|1|||
44197045|NCT02116621|78992872|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
44197046|NCT02116621|78992873|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
44197047|NCT02116621|78992872|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
44197048|NCT02116621|78992873|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
44197049|NCT02116621|78992872|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
44197050|NCT02116621|78992873|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
44197051|NCT02116621|78992872|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
44197052|NCT02116621|78992873|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
44197053|NCT02116621|78992872|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
44197054|NCT02116621|78992873|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
44197055|NCT02116309|78992881|FG000|Overall Study|Lost to Follow-up|0|||
44197056|NCT02116309|78992882|FG001|Overall Study|Lost to Follow-up|1|||
44197057|NCT02115607|78992888|FG000|Overall Study|Withdrawal by Subject|1|||
44197058|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
44197059|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
44197060|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
44197061|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
44197062|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
44197063|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
44197064|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
44197065|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
44197066|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
44197067|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
44197068|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
44197069|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
44197070|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
44197071|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
44197072|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
44197073|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
44197074|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
44197075|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
44197076|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
44197077|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
44197078|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
44197079|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
44197080|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
44197081|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
44197082|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197083|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197084|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197085|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197086|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197087|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197088|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197089|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197090|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197091|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197092|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197093|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197094|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197095|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197096|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197097|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
44197098|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197099|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197100|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
44197101|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
44266589|NCT01714739|79174680|FG005|Overall Study|Other reason|0|||
44266590|NCT01714739|79174681|FG006|Overall Study|Other reason|0|||
44277763|NCT02138916|79238747|FG002|Overall Study|Withdrawal by Subject|32|||
44277764|NCT02138916|79238745|FG000|Overall Study|Study specific withdrawal criteria|0|||
44277765|NCT02138916|79238746|FG001|Overall Study|Study specific withdrawal criteria|0|||
44277766|NCT02138916|79238747|FG002|Overall Study|Study specific withdrawal criteria|1|||
44361296|NCT00891202|79366959|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
44451496|NCT00500331|79460411|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
44197102|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
44197103|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197104|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197105|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197106|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197107|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197108|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197109|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197110|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197111|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197112|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197113|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197114|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197115|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197116|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197117|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
44197118|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
44197119|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
44197120|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
44197121|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
44197122|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
44197123|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
44197124|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
44197125|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
44197126|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
44277767|NCT02138916|79238745|FG000|Overall Study|incorrect enrolment|1|||
44197127|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
44197128|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
44197129|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
44197130|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
44197131|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
44197132|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
44197133|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
44197134|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
44197135|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
44197136|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
44197137|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
44197138|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
44197139|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197140|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197141|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197142|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197143|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197144|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197145|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197146|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197147|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197148|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197149|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197150|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197151|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197152|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197153|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197154|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197155|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197156|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197157|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
44197158|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
44197159|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
44197160|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197161|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
44197162|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
44197163|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197164|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197165|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197166|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197167|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197168|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197169|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197170|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197171|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197172|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197173|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197174|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197175|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197176|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197177|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
44197178|NCT01490632|78992897|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197179|NCT01490632|78992898|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197180|NCT01490632|78992899|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197181|NCT01490632|78992900|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197182|NCT01490632|78992901|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
44197183|NCT01490632|78992902|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197184|NCT01490632|78992903|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197185|NCT01490632|78992904|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197186|NCT01490632|78992905|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197187|NCT01490632|78992906|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197188|NCT01490632|78992907|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197189|NCT01490632|78992908|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197190|NCT01490632|78992909|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197191|NCT01490632|78992910|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197192|NCT01490632|78992911|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197193|NCT01490632|78992912|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197194|NCT01490632|78992913|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197195|NCT01490632|78992914|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197196|NCT01490632|78992915|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197197|NCT01490632|78992916|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
44197198|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197199|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197200|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197201|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197202|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197203|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
44197204|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
44197205|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197206|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197207|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
44197208|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
44197209|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
44197210|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197211|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197212|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197213|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197214|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197215|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197216|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197217|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
44197218|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197219|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197220|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197221|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197222|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197223|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197224|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
44197225|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197226|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
44197227|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
44197228|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
44197229|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197230|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197231|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197232|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197233|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197234|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197235|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197236|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197237|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
44197238|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197239|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197240|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197241|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197242|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197243|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197244|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
44197245|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197246|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197247|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
44197248|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197249|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197250|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197251|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197252|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197253|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197254|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197255|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197256|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197257|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
44197258|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197259|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197260|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197261|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197262|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197263|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197264|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
44197265|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197266|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197267|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197268|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197269|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197270|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197271|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197272|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197273|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197274|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197275|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197276|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197277|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
44197278|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197279|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197280|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197281|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197282|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197283|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
44197284|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197285|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197286|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197287|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197288|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197289|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197290|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197291|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197292|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197293|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197294|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197295|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197296|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197297|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
44197298|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197299|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197300|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197301|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197302|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197303|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197304|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
44197305|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197306|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
44197307|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197308|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
44197309|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
44197310|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197311|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197312|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197313|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197314|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197315|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197316|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197317|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
44197318|NCT01490632|78992897|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197319|NCT01490632|78992898|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197320|NCT01490632|78992899|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197321|NCT01490632|78992900|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44249661|NCT01276353|79083652|FG001|Double-blind|Withdrawal by Subject|0|||
44197322|NCT01490632|78992901|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197323|NCT01490632|78992902|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
44197324|NCT01490632|78992903|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
44197325|NCT01490632|78992904|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
44197326|NCT01490632|78992905|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
44197327|NCT01490632|78992906|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
44197328|NCT01490632|78992907|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
44197329|NCT01490632|78992908|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
44197330|NCT01490632|78992909|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197331|NCT01490632|78992910|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197332|NCT01490632|78992911|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197333|NCT01490632|78992912|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197334|NCT01490632|78992913|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197335|NCT01490632|78992914|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197336|NCT01490632|78992915|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197337|NCT01490632|78992916|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
44197338|NCT01490632|78992897|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197339|NCT01490632|78992898|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197340|NCT01490632|78992899|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197341|NCT01490632|78992900|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197342|NCT01490632|78992901|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197343|NCT01490632|78992902|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197344|NCT01490632|78992903|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197345|NCT01490632|78992904|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197346|NCT01490632|78992905|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197347|NCT01490632|78992906|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197348|NCT01490632|78992907|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197349|NCT01490632|78992908|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197350|NCT01490632|78992909|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197351|NCT01490632|78992910|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197352|NCT01490632|78992911|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
44197353|NCT01490632|78992912|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
44197354|NCT01490632|78992913|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197355|NCT01490632|78992914|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197356|NCT01490632|78992915|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197357|NCT01490632|78992916|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
44197358|NCT01490632|78992897|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197359|NCT01490632|78992898|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197360|NCT01490632|78992899|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197361|NCT01490632|78992900|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197362|NCT01490632|78992901|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197363|NCT01490632|78992902|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197364|NCT01490632|78992903|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197365|NCT01490632|78992904|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197366|NCT01490632|78992905|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197367|NCT01490632|78992906|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197368|NCT01490632|78992907|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197369|NCT01490632|78992908|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197370|NCT01490632|78992909|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197371|NCT01490632|78992910|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
44197372|NCT01490632|78992911|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197373|NCT01490632|78992912|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197374|NCT01490632|78992913|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197375|NCT01490632|78992914|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197376|NCT01490632|78992915|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197377|NCT01490632|78992916|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
44197378|NCT01490632|78992897|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197379|NCT01490632|78992898|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197380|NCT01490632|78992899|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197381|NCT01490632|78992900|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197382|NCT01490632|78992901|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44249662|NCT01276353|79083651|FG000|Extension|Adverse Event|2|||
44197383|NCT01490632|78992902|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197384|NCT01490632|78992903|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197385|NCT01490632|78992904|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197386|NCT01490632|78992905|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197387|NCT01490632|78992906|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197388|NCT01490632|78992907|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197389|NCT01490632|78992908|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197390|NCT01490632|78992909|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197391|NCT01490632|78992910|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197392|NCT01490632|78992911|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
44197393|NCT01490632|78992912|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
44197394|NCT01490632|78992913|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197395|NCT01490632|78992914|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197396|NCT01490632|78992915|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197397|NCT01490632|78992916|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
44197398|NCT01490632|78992897|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197399|NCT01490632|78992898|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197400|NCT01490632|78992899|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197401|NCT01490632|78992900|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197402|NCT01490632|78992901|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197403|NCT01490632|78992902|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197404|NCT01490632|78992903|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197405|NCT01490632|78992904|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197406|NCT01490632|78992905|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197407|NCT01490632|78992906|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197408|NCT01490632|78992907|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197409|NCT01490632|78992908|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197410|NCT01490632|78992909|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
44197411|NCT01490632|78992910|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
44197412|NCT01490632|78992911|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
44197413|NCT01490632|78992912|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
44197414|NCT01490632|78992913|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197415|NCT01490632|78992914|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197416|NCT01490632|78992915|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197417|NCT01490632|78992916|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
44197418|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
44197419|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
44197420|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
44197421|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
44197422|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
44197423|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
44197424|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
44197425|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
44197426|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
44197427|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
44197428|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
44197429|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
44197430|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
44197431|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
44197432|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
44197433|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
44197434|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
44197435|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
44197436|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
44197437|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
44197438|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Death|0|||
44197439|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Death|0|||
44197440|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Death|0|||
44197441|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Death|0|||
44197442|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Death|0|||
44197443|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Death|0|||
44197444|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Death|0|||
44197445|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Death|0|||
44197446|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Death|0|||
44197447|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Death|0|||
44197448|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Death|0|||
44197449|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Death|0|||
44197450|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Death|0|||
44197451|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Death|0|||
44197452|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Death|0|||
44197453|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Death|0|||
44197454|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Death|0|||
44197455|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Death|0|||
44197456|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Death|1|||
44197457|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Death|0|||
44197458|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197459|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197460|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197461|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197462|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197463|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197464|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197465|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197466|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197467|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197468|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197469|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197470|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197471|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197472|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197473|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197474|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
44197475|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
44197476|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
44197477|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
44197478|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197479|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197480|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197481|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197482|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197483|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197484|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197485|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197486|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197487|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197488|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197489|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197490|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197491|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197492|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197493|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197494|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197495|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197496|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
44197497|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
44197498|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
44197499|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
44197500|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
44197501|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
44197502|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
44197503|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
44197504|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
44197505|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
44197506|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
44197507|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
44197508|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
44266591|NCT03823287|79176662|FG000|Overall Study|Withdrawal by Subject|25|||
44266592|NCT03823287|79176663|FG001|Overall Study|Withdrawal by Subject|17|||
44197509|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
44266593|NCT03823287|79176662|FG000|Overall Study|Death|13|||
44266594|NCT03823287|79176663|FG001|Overall Study|Death|7|||
44451497|NCT00500331|79460412|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
44197510|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
44197511|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
44197512|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
44197513|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
44197514|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
44197515|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
44197516|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
44197517|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
44197518|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
44197519|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
44197520|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
44197521|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
44197522|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
44197523|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
44197524|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
44197525|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
44197526|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
44197527|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
44197528|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
44197529|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
44197530|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
44197531|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
44197532|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
44197533|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
44197534|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
44197535|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
44197536|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
44197537|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
44197538|NCT01490632|78992897|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197539|NCT01490632|78992898|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197540|NCT01490632|78992899|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197541|NCT01490632|78992900|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197542|NCT01490632|78992901|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197543|NCT01490632|78992902|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197544|NCT01490632|78992903|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197545|NCT01490632|78992904|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197546|NCT01490632|78992905|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197547|NCT01490632|78992906|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197548|NCT01490632|78992907|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197549|NCT01490632|78992908|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197550|NCT01490632|78992909|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197551|NCT01490632|78992910|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197552|NCT01490632|78992911|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197553|NCT01490632|78992912|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197554|NCT01490632|78992913|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
44197555|NCT01490632|78992914|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
44197556|NCT01490632|78992915|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
44197557|NCT01490632|78992916|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
44197558|NCT02073643|78992959|FG000|Overall Study|Lost to Follow-up|24|||
44197559|NCT01451554|78992965|FG000|Overall Study|Withdrawal by Subject|14|||
44197560|NCT01451554|78992966|FG001|Overall Study|Withdrawal by Subject|9|||
44197561|NCT01474486|78992972|FG000|Overall Study|Death|2|||
44197562|NCT01474486|78992972|FG000|Overall Study|Withdrawal by Subject|4|||
44197563|NCT01474486|78992972|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
44197564|NCT01451398|78992982|FG000|Overall Study|Adverse Event|7|||
44197565|NCT01451398|78992983|FG001|Overall Study|Adverse Event|9|||
44197566|NCT01451398|78992982|FG000|Overall Study|Protocol Violation|1|||
44197567|NCT01451398|78992983|FG001|Overall Study|Protocol Violation|2|||
44197568|NCT01451398|78992982|FG000|Overall Study|Physician Decision|1|||
44197569|NCT01451398|78992983|FG001|Overall Study|Physician Decision|1|||
44197570|NCT01451398|78992982|FG000|Overall Study|Withdrawal by Subject|10|||
44197571|NCT01451398|78992983|FG001|Overall Study|Withdrawal by Subject|14|||
44197572|NCT01451398|78992982|FG000|Overall Study|Lost to Follow-up|6|||
44197573|NCT01451398|78992983|FG001|Overall Study|Lost to Follow-up|4|||
44197574|NCT01451398|78992982|FG000|Overall Study|Non-compliance with study drug|1|||
44197575|NCT01451398|78992983|FG001|Overall Study|Non-compliance with study drug|3|||
44197576|NCT01451398|78992982|FG000|Overall Study|Non-compliance with protocol|1|||
44197577|NCT01451398|78992983|FG001|Overall Study|Non-compliance with protocol|1|||
44266595|NCT03823287|79176662|FG000|Overall Study|Lost to Follow-up|7|||
44361297|NCT00891202|79366960|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
44197578|NCT01451398|78992982|FG000|Overall Study|Moved out of country|0|||
44197579|NCT01451398|78992983|FG001|Overall Study|Moved out of country|1|||
44197580|NCT01451398|78992982|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
44266596|NCT03823287|79176663|FG001|Overall Study|Lost to Follow-up|8|||
44197581|NCT01451398|78992983|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
44197582|NCT01451398|78992982|FG000|Overall Study|Lack of Efficacy|0|||
44197583|NCT01451398|78992983|FG001|Overall Study|Lack of Efficacy|1|||
44197584|NCT02073565|78992991|FG000|Cohort A|Withdrawal by Subject|1|||
44197585|NCT02073565|78992992|FG001|Cohort A|Withdrawal by Subject|0|||
44197586|NCT02073565|78992991|FG000|Cohort B|Withdrawal by Subject|1|||
44197587|NCT02073565|78992992|FG001|Cohort B|Withdrawal by Subject|2|||
44197588|NCT02073565|78992991|FG000|Cohort C|Withdrawal by Subject|0|||
44197589|NCT02073565|78992992|FG001|Cohort C|Withdrawal by Subject|2|||
44197590|NCT02073565|78992991|FG000|Cohort C|Lost to Follow-up|0|||
44197591|NCT02073565|78992992|FG001|Cohort C|Lost to Follow-up|2|||
44197592|NCT02072941|78993000|FG000|Overall Study|Withdrawal by Subject|29|||
44197593|NCT02072941|78993001|FG001|Overall Study|Withdrawal by Subject|21|||
44197594|NCT02072941|78993000|FG000|Overall Study|Lost to Follow-up|4|||
44197595|NCT02072941|78993001|FG001|Overall Study|Lost to Follow-up|4|||
44197596|NCT02072941|78993000|FG000|Overall Study|Death|3|||
44197597|NCT02072941|78993001|FG001|Overall Study|Death|2|||
44197598|NCT02072941|78993000|FG000|Overall Study|Removed by Study Staff|2|||
44197599|NCT02072941|78993001|FG001|Overall Study|Removed by Study Staff|2|||
44197600|NCT02100631|78993010|FG000|Overall Study|Withdrawal by Subject|1|||
44197601|NCT02100631|78993011|FG001|Overall Study|Withdrawal by Subject|0|||
44197602|NCT02100631|78993012|FG002|Overall Study|Withdrawal by Subject|0|||
44197603|NCT02100631|78993010|FG000|Overall Study|Lost to Follow-up|3|||
44197604|NCT02100631|78993011|FG001|Overall Study|Lost to Follow-up|4|||
44197605|NCT02100631|78993012|FG002|Overall Study|Lost to Follow-up|0|||
44197606|NCT02100631|78993010|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
44197607|NCT02100631|78993011|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
44197608|NCT02100631|78993012|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
44197609|NCT01451164|78993024|FG000|Overall Study|Adverse Event|19|||
44197610|NCT01451164|78993025|FG001|Overall Study|Adverse Event|12|||
44197611|NCT01451164|78993026|FG002|Overall Study|Adverse Event|18|||
44197612|NCT01451164|78993027|FG003|Overall Study|Adverse Event|21|||
44197613|NCT01451164|78993024|FG000|Overall Study|Withdrawal Criteria|1|||
44197614|NCT01451164|78993025|FG001|Overall Study|Withdrawal Criteria|1|||
44197615|NCT01451164|78993026|FG002|Overall Study|Withdrawal Criteria|1|||
44197616|NCT01451164|78993027|FG003|Overall Study|Withdrawal Criteria|1|||
44197617|NCT01451164|78993024|FG000|Overall Study|Physician Decision|2|||
44197618|NCT01451164|78993025|FG001|Overall Study|Physician Decision|0|||
44197619|NCT01451164|78993026|FG002|Overall Study|Physician Decision|1|||
44197620|NCT01451164|78993027|FG003|Overall Study|Physician Decision|0|||
44197621|NCT01451164|78993024|FG000|Overall Study|Withdrawal by Subject|14|||
44197622|NCT01451164|78993025|FG001|Overall Study|Withdrawal by Subject|11|||
44197623|NCT01451164|78993026|FG002|Overall Study|Withdrawal by Subject|16|||
44197624|NCT01451164|78993027|FG003|Overall Study|Withdrawal by Subject|17|||
44197625|NCT01451164|78993024|FG000|Overall Study|Protocol Violation|0|||
44197626|NCT01451164|78993025|FG001|Overall Study|Protocol Violation|1|||
44197627|NCT01451164|78993026|FG002|Overall Study|Protocol Violation|0|||
44197628|NCT01451164|78993027|FG003|Overall Study|Protocol Violation|0|||
44197629|NCT01451164|78993024|FG000|Overall Study|Lack of Efficacy|7|||
44197630|NCT01451164|78993025|FG001|Overall Study|Lack of Efficacy|9|||
44197631|NCT01451164|78993026|FG002|Overall Study|Lack of Efficacy|9|||
44197632|NCT01451164|78993027|FG003|Overall Study|Lack of Efficacy|7|||
44197633|NCT02071849|78993037|FG000|6-month Primary Endpoint|Did not receive device|4|||
44197634|NCT02071849|78993037|FG000|6-month Primary Endpoint|Adverse Event|1|||
44197635|NCT02071849|78993037|FG000|2-year Extended Follow-up|Adverse Event|1|||
44197636|NCT02071771|78993041|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
44197637|NCT02071771|78993042|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
44266597|NCT03823287|79176662|FG000|Overall Study|Adverse Event|6|||
44266598|NCT03823287|79176663|FG001|Overall Study|Adverse Event|8|||
44266599|NCT03823287|79176662|FG000|Overall Study|Physician Decision|5|||
44197638|NCT02071771|78993041|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
44197639|NCT02071771|78993042|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
44197640|NCT02071225|78993048|FG000|Overall Study|Withdrawal of Consent|2|||
44197641|NCT02071225|78993048|FG000|Overall Study|Protocol Deviation|1|||
44197642|NCT02071225|78993048|FG000|Overall Study|Lost to Follow-up|2|||
44197643|NCT02071225|78993048|FG000|Overall Study|Death|25|||
44266600|NCT03823287|79176663|FG001|Overall Study|Physician Decision|2|||
44266601|NCT03823287|79176662|FG000|Overall Study|Lack of Efficacy|2|||
44197644|NCT01450696|78993054|FG000|Overall Study|Never Treated|1|||
44197645|NCT01450696|78993055|FG001|Overall Study|Never Treated|1|||
44197646|NCT01450696|78993054|FG000|Overall Study|Death|77|||
44197647|NCT01450696|78993055|FG001|Overall Study|Death|84|||
44197648|NCT01450696|78993054|FG000|Overall Study|Lost to Follow-up|3|||
44197649|NCT01450696|78993055|FG001|Overall Study|Lost to Follow-up|3|||
44266602|NCT03823287|79176663|FG001|Overall Study|Lack of Efficacy|0|||
44266603|NCT03823287|79176662|FG000|Overall Study|Other|2|||
44197650|NCT01450696|78993054|FG000|Overall Study|Non-Compliance|1|||
44266604|NCT03823287|79176663|FG001|Overall Study|Other|4|||
44266605|NCT03707925|79176824|FG000|Overall Study|Inevaluable|1|||
44197651|NCT01450696|78993055|FG001|Overall Study|Non-Compliance|0|||
44197652|NCT01450696|78993054|FG000|Overall Study|Withdrawal by Subject|13|||
44197653|NCT01450696|78993055|FG001|Overall Study|Withdrawal by Subject|2|||
44197654|NCT01450696|78993054|FG000|Overall Study|Study Terminated by Sponsor|53|||
44197655|NCT01450696|78993055|FG001|Overall Study|Study Terminated by Sponsor|58|||
44197656|NCT02070991|78993063|FG000|Overall Study|Death|2|||
44197657|NCT02070991|78993064|FG001|Overall Study|Death|0|||
44197658|NCT02070991|78993063|FG000|Overall Study|Withdrawal by Subject|1|||
44197659|NCT02070991|78993064|FG001|Overall Study|Withdrawal by Subject|0|||
44197660|NCT02114515|78993072|FG000|Overall Study|Lost to Follow-up|52|||
44197661|NCT02114515|78993073|FG001|Overall Study|Lost to Follow-up|55|||
44197662|NCT02114515|78993072|FG000|Overall Study|Death|12|||
44197663|NCT02114515|78993073|FG001|Overall Study|Death|12|||
44197664|NCT02114515|78993072|FG000|Overall Study|Withdrawal by Subject|4|||
44197665|NCT02114515|78993073|FG001|Overall Study|Withdrawal by Subject|22|||
44197666|NCT02114515|78993072|FG000|Overall Study|Other|65|||
44197667|NCT02114515|78993073|FG001|Overall Study|Other|61|||
44197668|NCT01490086|78993084|FG000|Overall Study|Consent withdrawn|4|||
44197669|NCT01490086|78993085|FG001|Overall Study|Consent withdrawn|4|||
44197670|NCT01490086|78993086|FG002|Overall Study|Consent withdrawn|3|||
44197671|NCT01490086|78993087|FG003|Overall Study|Consent withdrawn|0|||
44197672|NCT01490086|78993088|FG004|Overall Study|Consent withdrawn|1|||
44197673|NCT01490086|78993084|FG000|Overall Study|Non-compliance|0|||
44197674|NCT01490086|78993085|FG001|Overall Study|Non-compliance|1|||
44197675|NCT01490086|78993086|FG002|Overall Study|Non-compliance|0|||
44197676|NCT01490086|78993087|FG003|Overall Study|Non-compliance|0|||
44197677|NCT01490086|78993088|FG004|Overall Study|Non-compliance|0|||
44197678|NCT01490086|78993084|FG000|Overall Study|Abnormal laboratory findings|1|||
44197679|NCT01490086|78993085|FG001|Overall Study|Abnormal laboratory findings|0|||
44197680|NCT01490086|78993086|FG002|Overall Study|Abnormal laboratory findings|0|||
44197681|NCT01490086|78993087|FG003|Overall Study|Abnormal laboratory findings|0|||
44197682|NCT01490086|78993088|FG004|Overall Study|Abnormal laboratory findings|0|||
44197683|NCT01490086|78993084|FG000|Overall Study|Lost to Follow-up|0|||
44197684|NCT01490086|78993085|FG001|Overall Study|Lost to Follow-up|0|||
44197685|NCT01490086|78993086|FG002|Overall Study|Lost to Follow-up|0|||
44197686|NCT01490086|78993087|FG003|Overall Study|Lost to Follow-up|0|||
44197687|NCT01490086|78993088|FG004|Overall Study|Lost to Follow-up|1|||
44197688|NCT01490086|78993084|FG000|Overall Study|Physician Decision|3|||
44197689|NCT01490086|78993085|FG001|Overall Study|Physician Decision|4|||
44197690|NCT01490086|78993086|FG002|Overall Study|Physician Decision|2|||
44197691|NCT01490086|78993087|FG003|Overall Study|Physician Decision|3|||
44197692|NCT01490086|78993088|FG004|Overall Study|Physician Decision|1|||
44197693|NCT01490086|78993084|FG000|Overall Study|Adverse Event|0|||
44197694|NCT01490086|78993085|FG001|Overall Study|Adverse Event|0|||
44197695|NCT01490086|78993086|FG002|Overall Study|Adverse Event|1|||
44197696|NCT01490086|78993087|FG003|Overall Study|Adverse Event|2|||
44197697|NCT01490086|78993088|FG004|Overall Study|Adverse Event|0|||
44197698|NCT01490086|78993084|FG000|Overall Study|Lack of Efficacy|0|||
44197699|NCT01490086|78993085|FG001|Overall Study|Lack of Efficacy|3|||
44197700|NCT01490086|78993086|FG002|Overall Study|Lack of Efficacy|1|||
44197701|NCT01490086|78993087|FG003|Overall Study|Lack of Efficacy|0|||
44197702|NCT01490086|78993088|FG004|Overall Study|Lack of Efficacy|8|||
44197703|NCT01490086|78993084|FG000|Overall Study|Worsening of symptoms|0|||
44197704|NCT01490086|78993085|FG001|Overall Study|Worsening of symptoms|1|||
44197705|NCT01490086|78993086|FG002|Overall Study|Worsening of symptoms|0|||
44197706|NCT01490086|78993087|FG003|Overall Study|Worsening of symptoms|1|||
44197707|NCT01490086|78993088|FG004|Overall Study|Worsening of symptoms|0|||
44197708|NCT01490086|78993084|FG000|Overall Study|Subject uncontrollable and abusive|0|||
44197709|NCT01490086|78993085|FG001|Overall Study|Subject uncontrollable and abusive|1|||
44197710|NCT01490086|78993086|FG002|Overall Study|Subject uncontrollable and abusive|0|||
44197711|NCT01490086|78993087|FG003|Overall Study|Subject uncontrollable and abusive|0|||
44197712|NCT01490086|78993088|FG004|Overall Study|Subject uncontrollable and abusive|0|||
44197713|NCT01490086|78993084|FG000|Overall Study|Subject left hospital|0|||
44197714|NCT01490086|78993085|FG001|Overall Study|Subject left hospital|1|||
44197715|NCT01490086|78993086|FG002|Overall Study|Subject left hospital|0|||
44266606|NCT03461757|79176884|FG000|Overall Study|Adverse Event|1|||
44266607|NCT03461757|79176885|FG001|Overall Study|Adverse Event|0|||
44197716|NCT01490086|78993087|FG003|Overall Study|Subject left hospital|1|||
44266608|NCT03461757|79176884|FG000|Overall Study|Lost to Follow-up|13|||
44266609|NCT03461757|79176885|FG001|Overall Study|Lost to Follow-up|7|||
44361298|NCT00891202|79366961|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
44197717|NCT01490086|78993088|FG004|Overall Study|Subject left hospital|0|||
44197718|NCT02114203|78993103|FG000|Overall Study|Adverse Event|0|||
44197719|NCT02114203|78993104|FG001|Overall Study|Adverse Event|1|||
44197720|NCT02114203|78993105|FG002|Overall Study|Adverse Event|0|||
44361299|NCT00891202|79366962|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
44197721|NCT02114203|78993103|FG000|Overall Study|Withdrawal by Subject|0|||
44197722|NCT02114203|78993104|FG001|Overall Study|Withdrawal by Subject|1|||
44197723|NCT02114203|78993105|FG002|Overall Study|Withdrawal by Subject|0|||
44197724|NCT02113579|78993115|FG000|Overall Study|Adverse Event|1|||
44197725|NCT02113579|78993116|FG001|Overall Study|Adverse Event|0|||
44197726|NCT02113579|78993115|FG000|Overall Study|Withdrawal by Subject|3|||
44197727|NCT02113579|78993116|FG001|Overall Study|Withdrawal by Subject|2|||
44197728|NCT02113579|78993115|FG000|Overall Study|Lost to Follow-up|6|||
44197729|NCT02113579|78993116|FG001|Overall Study|Lost to Follow-up|2|||
44197730|NCT01474018|78993124|FG000|Overall Study|Lost to Follow-up|0|||
44197731|NCT01474018|78993125|FG001|Overall Study|Lost to Follow-up|1|||
44197732|NCT01474018|78993124|FG000|Overall Study|Withdrawal by Subject|0|||
44197733|NCT01474018|78993125|FG001|Overall Study|Withdrawal by Subject|2|||
44197734|NCT02100475|78993133|FG000|Overall Study|Unclassified|1|||
44197735|NCT02100475|78993134|FG001|Overall Study|Unclassified|2|||
44197736|NCT02100475|78993133|FG000|Overall Study|Withdrawal criteria|1|||
44197737|NCT02100475|78993134|FG001|Overall Study|Withdrawal criteria|0|||
44197738|NCT02113189|78993143|FG000|Overall Study|Lost to follow up|2|||
44197739|NCT02113189|78993144|FG001|Overall Study|Lost to follow up|1|||
44197740|NCT02113189|78993145|FG002|Overall Study|Lost to follow up|3|||
44197741|NCT01440946|78993158|FG000|Overall Study|Lost to Follow-up|1|||
44197742|NCT01440946|78993159|FG001|Overall Study|Lost to Follow-up|1|||
44197743|NCT01440946|78993158|FG000|Overall Study|Physician Decision|1|||
44197744|NCT01440946|78993159|FG001|Overall Study|Physician Decision|0|||
44197745|NCT01450540|78993168|FG000|Overall Study|Withdrawal by Subject|19|||
44197746|NCT01450540|78993169|FG001|Overall Study|Withdrawal by Subject|13|||
44197747|NCT01450540|78993168|FG000|Overall Study|protocol deviation|3|||
44197748|NCT01450540|78993169|FG001|Overall Study|protocol deviation|23|||
44197749|NCT02070757|78993179|FG000|Overall Study|Adverse Event|107|||
44197750|NCT02070757|78993180|FG001|Overall Study|Adverse Event|99|||
44197751|NCT02070757|78993179|FG000|Overall Study|Lost to Follow-up|7|||
44197752|NCT02070757|78993180|FG001|Overall Study|Lost to Follow-up|4|||
44197753|NCT02070757|78993179|FG000|Overall Study|Protocol Violation|0|||
44197754|NCT02070757|78993180|FG001|Overall Study|Protocol Violation|4|||
44197755|NCT02070757|78993179|FG000|Overall Study|Withdrawal by Subject|1|||
44197756|NCT02070757|78993180|FG001|Overall Study|Withdrawal by Subject|3|||
44197757|NCT02070757|78993179|FG000|Overall Study|Investigator Decision|0|||
44197758|NCT02070757|78993180|FG001|Overall Study|Investigator Decision|2|||
44197759|NCT02070757|78993179|FG000|Overall Study|Discharged from Study Hospital|2|||
44197760|NCT02070757|78993180|FG001|Overall Study|Discharged from Study Hospital|2|||
44197761|NCT02100319|78993186|FG000|Overall Study|Case Report Forms Uncollected|11|||
44197762|NCT02100319|78993186|FG000|Overall Study|Protocol Deviation|5|||
44197763|NCT01625845|78993192|FG000|Overall Study|Adverse Event|1|||
44197764|NCT01625845|78993193|FG001|Overall Study|Adverse Event|2|||
44197765|NCT01625845|78993192|FG000|Overall Study|Lost to Follow-up|2|||
44197766|NCT01625845|78993193|FG001|Overall Study|Lost to Follow-up|1|||
44197767|NCT01625845|78993192|FG000|Overall Study|Withdrawal by Subject|2|||
44197768|NCT01625845|78993193|FG001|Overall Study|Withdrawal by Subject|0|||
44197769|NCT01473940|78993203|FG000|Induction Therapy|Death|0|||
44197770|NCT01473940|78993204|FG001|Induction Therapy|Death|0|||
44197771|NCT01473940|78993205|FG002|Induction Therapy|Death|1|||
44197772|NCT01473940|78993206|FG003|Induction Therapy|Death|1|||
44197773|NCT01473940|78993203|FG000|Induction Therapy|Progressive Disease|0|||
44197774|NCT01473940|78993204|FG001|Induction Therapy|Progressive Disease|1|||
44197775|NCT01473940|78993205|FG002|Induction Therapy|Progressive Disease|1|||
44197776|NCT01473940|78993206|FG003|Induction Therapy|Progressive Disease|0|||
44197777|NCT01473940|78993203|FG000|Maintenance Therapy|Progressive Disease|1|||
44197778|NCT01473940|78993204|FG001|Maintenance Therapy|Progressive Disease|2|||
44197779|NCT01473940|78993205|FG002|Maintenance Therapy|Progressive Disease|1|||
44197780|NCT01473940|78993206|FG003|Maintenance Therapy|Progressive Disease|4|||
44197781|NCT01832727|78993228|FG000|Overall Study|Adverse Event|4|||
44197782|NCT01832727|78993229|FG001|Overall Study|Adverse Event|6|||
44197783|NCT01832727|78993230|FG002|Overall Study|Adverse Event|1|||
44197784|NCT01832727|78993231|FG003|Overall Study|Adverse Event|0|||
44197785|NCT01832727|78993232|FG004|Overall Study|Adverse Event|1|||
44197786|NCT01832727|78993233|FG005|Overall Study|Adverse Event|1|||
44197787|NCT01832727|78993234|FG006|Overall Study|Adverse Event|2|||
44197788|NCT01832727|78993235|FG007|Overall Study|Adverse Event|1|||
44197789|NCT01832727|78993236|FG008|Overall Study|Adverse Event|9|||
44197790|NCT01832727|78993228|FG000|Overall Study|Disease progression|3|||
44197791|NCT01832727|78993229|FG001|Overall Study|Disease progression|0|||
44197792|NCT01832727|78993230|FG002|Overall Study|Disease progression|2|||
44197793|NCT01832727|78993231|FG003|Overall Study|Disease progression|1|||
44197794|NCT01832727|78993232|FG004|Overall Study|Disease progression|3|||
44197795|NCT01832727|78993233|FG005|Overall Study|Disease progression|3|||
44197796|NCT01832727|78993234|FG006|Overall Study|Disease progression|6|||
44197797|NCT01832727|78993235|FG007|Overall Study|Disease progression|2|||
44197798|NCT01832727|78993236|FG008|Overall Study|Disease progression|7|||
44197799|NCT01832727|78993228|FG000|Overall Study|Lost to Follow-up|0|||
44197800|NCT01832727|78993229|FG001|Overall Study|Lost to Follow-up|0|||
44197801|NCT01832727|78993230|FG002|Overall Study|Lost to Follow-up|0|||
44197802|NCT01832727|78993231|FG003|Overall Study|Lost to Follow-up|1|||
44197803|NCT01832727|78993232|FG004|Overall Study|Lost to Follow-up|0|||
44197804|NCT01832727|78993233|FG005|Overall Study|Lost to Follow-up|0|||
44197805|NCT01832727|78993234|FG006|Overall Study|Lost to Follow-up|0|||
44197806|NCT01832727|78993235|FG007|Overall Study|Lost to Follow-up|0|||
44197807|NCT01832727|78993236|FG008|Overall Study|Lost to Follow-up|0|||
44197808|NCT01832727|78993228|FG000|Overall Study|Physician Decision|1|||
44197809|NCT01832727|78993229|FG001|Overall Study|Physician Decision|0|||
44197810|NCT01832727|78993230|FG002|Overall Study|Physician Decision|0|||
44197811|NCT01832727|78993231|FG003|Overall Study|Physician Decision|1|||
44197812|NCT01832727|78993232|FG004|Overall Study|Physician Decision|0|||
44197813|NCT01832727|78993233|FG005|Overall Study|Physician Decision|1|||
44197814|NCT01832727|78993234|FG006|Overall Study|Physician Decision|0|||
44197815|NCT01832727|78993235|FG007|Overall Study|Physician Decision|0|||
44197816|NCT01832727|78993236|FG008|Overall Study|Physician Decision|0|||
44197817|NCT01832727|78993228|FG000|Overall Study|Withdrawal by Subject|1|||
44197818|NCT01832727|78993229|FG001|Overall Study|Withdrawal by Subject|1|||
44197819|NCT01832727|78993230|FG002|Overall Study|Withdrawal by Subject|0|||
44197820|NCT01832727|78993231|FG003|Overall Study|Withdrawal by Subject|1|||
44197821|NCT01832727|78993232|FG004|Overall Study|Withdrawal by Subject|0|||
44197822|NCT01832727|78993233|FG005|Overall Study|Withdrawal by Subject|1|||
44197823|NCT01832727|78993234|FG006|Overall Study|Withdrawal by Subject|0|||
44197824|NCT01832727|78993235|FG007|Overall Study|Withdrawal by Subject|2|||
44197825|NCT01832727|78993236|FG008|Overall Study|Withdrawal by Subject|1|||
44197826|NCT01832727|78993228|FG000|Overall Study|Study terminated by sponsor|0|||
44197827|NCT01832727|78993229|FG001|Overall Study|Study terminated by sponsor|0|||
44197828|NCT01832727|78993230|FG002|Overall Study|Study terminated by sponsor|0|||
44197829|NCT01832727|78993231|FG003|Overall Study|Study terminated by sponsor|0|||
44197830|NCT01832727|78993232|FG004|Overall Study|Study terminated by sponsor|0|||
44197831|NCT01832727|78993233|FG005|Overall Study|Study terminated by sponsor|0|||
44197832|NCT01832727|78993234|FG006|Overall Study|Study terminated by sponsor|0|||
44197833|NCT01832727|78993235|FG007|Overall Study|Study terminated by sponsor|1|||
44197834|NCT01832727|78993236|FG008|Overall Study|Study terminated by sponsor|1|||
44197835|NCT01473394|78993267|FG000|Overall Study|Adverse Event|13|||
44197836|NCT01473394|78993268|FG001|Overall Study|Adverse Event|16|||
44197837|NCT01473394|78993267|FG000|Overall Study|Insufficient Therapeutic Response|4|||
44197838|NCT01473394|78993268|FG001|Overall Study|Insufficient Therapeutic Response|1|||
44197839|NCT01473394|78993267|FG000|Overall Study|Protocol Violation|7|||
44197840|NCT01473394|78993268|FG001|Overall Study|Protocol Violation|5|||
44197841|NCT01473394|78993267|FG000|Overall Study|Withdrew Consent|12|||
44197842|NCT01473394|78993268|FG001|Overall Study|Withdrew Consent|10|||
44197843|NCT01473394|78993267|FG000|Overall Study|Lost to Follow-up|9|||
44197844|NCT01473394|78993268|FG001|Overall Study|Lost to Follow-up|11|||
44197845|NCT01449682|78993276|FG000|Overall Study|Death|0|||
44197846|NCT01449682|78993277|FG001|Overall Study|Death|1|||
44197847|NCT01449682|78993276|FG000|Overall Study|Adverse Event|1|||
44197848|NCT01449682|78993277|FG001|Overall Study|Adverse Event|0|||
44197849|NCT01449526|78993285|FG000|Overall Study|Lost to Follow-up|1|||
44197850|NCT01449526|78993286|FG001|Overall Study|Lost to Follow-up|2|||
44197851|NCT01449526|78993285|FG000|Overall Study|Withdrawal by Subject|1|||
44197852|NCT01449526|78993286|FG001|Overall Study|Withdrawal by Subject|1|||
44197853|NCT01449526|78993285|FG000|Overall Study|Symptoms/complaints|0|||
44197854|NCT01449526|78993286|FG001|Overall Study|Symptoms/complaints|1|||
44197855|NCT01449526|78993285|FG000|Overall Study|Lack of Motivation|0|||
44197856|NCT01449526|78993286|FG001|Overall Study|Lack of Motivation|1|||
44197857|NCT01449526|78993285|FG000|Overall Study|Cannot maintain visits|0|||
44197858|NCT01449526|78993286|FG001|Overall Study|Cannot maintain visits|1|||
44197859|NCT01440322|78993294|FG000|Overall Study|Discomfort|2|||
44197860|NCT01440322|78993295|FG001|Overall Study|Discomfort|0|||
44197861|NCT01440322|78993294|FG000|Overall Study|Biomicroscopy|1|||
44197862|NCT01440322|78993295|FG001|Overall Study|Biomicroscopy|0|||
44197863|NCT01440322|78993294|FG000|Overall Study|Symptoms and Problems|1|||
44197864|NCT01440322|78993295|FG001|Overall Study|Symptoms and Problems|0|||
44197865|NCT01440322|78993294|FG000|Overall Study|Unacceptable Subjective Vision|1|||
44197866|NCT01440322|78993295|FG001|Overall Study|Unacceptable Subjective Vision|0|||
44197867|NCT01440322|78993294|FG000|Overall Study|Other Product Related|1|||
44197868|NCT01440322|78993295|FG001|Overall Study|Other Product Related|0|||
44197869|NCT01440322|78993294|FG000|Overall Study|Unrelated Medical Problem|0|||
44197870|NCT01440322|78993295|FG001|Overall Study|Unrelated Medical Problem|1|||
44197871|NCT01440322|78993294|FG000|Overall Study|Other Non-Product Related|1|||
44197872|NCT01440322|78993295|FG001|Overall Study|Other Non-Product Related|0|||
44197873|NCT01832493|78993301|FG000|Overall Study|Physician Decision|2|||
44197874|NCT01832493|78993301|FG000|Overall Study|Protocol Violation|4|||
44197875|NCT01832493|78993301|FG000|Overall Study|Unable to place LV lead|2|||
44197876|NCT01831791|78993305|FG000|Overall Study|Withdrawal by Subject|10|||
44197877|NCT01857531|78993309|FG000|Overall Study|Withdrawal by Subject|4|||
44197878|NCT02166047|78993325|FG000|Overall Study|Withdrawal by Participant|0|||
44197879|NCT02166047|78993326|FG001|Overall Study|Withdrawal by Participant|1|||
44197880|NCT02166047|78993327|FG002|Overall Study|Withdrawal by Participant|2|||
44197881|NCT02166047|78993328|FG003|Overall Study|Withdrawal by Participant|0|||
44197882|NCT02166047|78993329|FG004|Overall Study|Withdrawal by Participant|0|||
44197883|NCT02166047|78993330|FG005|Overall Study|Withdrawal by Participant|0|||
44197884|NCT02166047|78993331|FG006|Overall Study|Withdrawal by Participant|1|||
44197885|NCT02166047|78993332|FG007|Overall Study|Withdrawal by Participant|0|||
44197886|NCT02166047|78993333|FG008|Overall Study|Withdrawal by Participant|0|||
44197887|NCT02166047|78993334|FG009|Overall Study|Withdrawal by Participant|0|||
44197888|NCT02166047|78993335|FG010|Overall Study|Withdrawal by Participant|0|||
44197889|NCT02166047|78993336|FG011|Overall Study|Withdrawal by Participant|0|||
44197890|NCT02166047|78993325|FG000|Overall Study|Adverse Event|0|||
44197891|NCT02166047|78993326|FG001|Overall Study|Adverse Event|0|||
44197892|NCT02166047|78993327|FG002|Overall Study|Adverse Event|0|||
44197893|NCT02166047|78993328|FG003|Overall Study|Adverse Event|0|||
44197894|NCT02166047|78993329|FG004|Overall Study|Adverse Event|1|||
44197895|NCT02166047|78993330|FG005|Overall Study|Adverse Event|0|||
44197896|NCT02166047|78993331|FG006|Overall Study|Adverse Event|1|||
44197897|NCT02166047|78993332|FG007|Overall Study|Adverse Event|0|||
44197898|NCT02166047|78993333|FG008|Overall Study|Adverse Event|0|||
44197899|NCT02166047|78993334|FG009|Overall Study|Adverse Event|0|||
44197900|NCT02166047|78993335|FG010|Overall Study|Adverse Event|2|||
44197901|NCT02166047|78993336|FG011|Overall Study|Adverse Event|0|||
44197902|NCT01493284|78993362|FG000|Overall Study|Death|29|||
44197903|NCT01493284|78993362|FG000|Overall Study|Withdrawal by Subject|32|||
44197904|NCT02165735|78993368|FG000|Overall Study|Lost to Follow-up|12|||
44197905|NCT02165735|78993369|FG001|Overall Study|Lost to Follow-up|10|||
44197906|NCT02165735|78993368|FG000|Overall Study|Withdrawal by Subject|3|||
44197907|NCT02165735|78993369|FG001|Overall Study|Withdrawal by Subject|0|||
44197908|NCT02165735|78993368|FG000|Overall Study|Participant indicated lack of time|1|||
44197909|NCT02165735|78993369|FG001|Overall Study|Participant indicated lack of time|3|||
44197910|NCT02165735|78993368|FG000|Overall Study|Protocol Violation|0|||
44197911|NCT02165735|78993369|FG001|Overall Study|Protocol Violation|1|||
44197912|NCT02069899|78993378|FG000|Overall Study|Adverse Event|6|||
44197913|NCT02069899|78993379|FG001|Overall Study|Adverse Event|0|||
44197914|NCT02069899|78993380|FG002|Overall Study|Adverse Event|1|||
44197915|NCT02069899|78993378|FG000|Overall Study|Withdrawal by Participant|2|||
44197916|NCT02069899|78993379|FG001|Overall Study|Withdrawal by Participant|0|||
44197917|NCT02069899|78993380|FG002|Overall Study|Withdrawal by Participant|0|||
44197918|NCT02069899|78993378|FG000|Overall Study|Lost to Follow-up|1|||
44197919|NCT02069899|78993379|FG001|Overall Study|Lost to Follow-up|0|||
44197920|NCT02069899|78993380|FG002|Overall Study|Lost to Follow-up|1|||
44197921|NCT02069899|78993378|FG000|Overall Study|Other|4|||
44197922|NCT02069899|78993379|FG001|Overall Study|Other|0|||
44197923|NCT02069899|78993380|FG002|Overall Study|Other|0|||
44197924|NCT02069899|78993378|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
44197925|NCT02069899|78993379|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
44197926|NCT02069899|78993380|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
44197927|NCT02069899|78993378|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
44197928|NCT02069899|78993379|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
44197929|NCT02069899|78993380|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
44197930|NCT01831089|78993395|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
44197931|NCT01831089|78993396|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
44197932|NCT01831089|78993397|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
44197933|NCT01831089|78993398|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
44197934|NCT01831089|78993399|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
44197935|NCT01831089|78993400|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
44197936|NCT01831089|78993395|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
44197937|NCT01831089|78993396|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
44197938|NCT01831089|78993397|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
44197939|NCT01831089|78993398|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
44197940|NCT01831089|78993399|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
44249663|NCT01276353|79083652|FG001|Extension|Adverse Event|5|||
44197941|NCT01831089|78993400|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
44197942|NCT01831089|78993395|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
44197943|NCT01831089|78993396|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
44197944|NCT01831089|78993397|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
44197945|NCT01831089|78993398|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
44197946|NCT01831089|78993399|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
44197947|NCT01831089|78993400|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
44197948|NCT01831089|78993395|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
44197949|NCT01831089|78993396|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
44197950|NCT01831089|78993397|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
44197951|NCT01831089|78993398|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
44197952|NCT01831089|78993399|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
44197953|NCT01831089|78993400|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
44197954|NCT01831089|78993395|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
44197955|NCT01831089|78993396|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
44197956|NCT01831089|78993397|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
44197957|NCT01831089|78993398|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
44197958|NCT01831089|78993399|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
44197959|NCT01831089|78993400|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
44197960|NCT01831089|78993395|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
44197961|NCT01831089|78993396|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
44197962|NCT01831089|78993397|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
44197963|NCT01831089|78993398|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
44197964|NCT01831089|78993399|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
44197965|NCT01831089|78993400|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
44197966|NCT01831089|78993395|FG000|Cohort III: Dose Level 3|Global end of study|0|||
44197967|NCT01831089|78993396|FG001|Cohort III: Dose Level 3|Global end of study|0|||
44197968|NCT01831089|78993397|FG002|Cohort III: Dose Level 3|Global end of study|1|||
44197969|NCT01831089|78993398|FG003|Cohort III: Dose Level 3|Global end of study|0|||
44197970|NCT01831089|78993399|FG004|Cohort III: Dose Level 3|Global end of study|0|||
44197971|NCT01831089|78993400|FG005|Cohort III: Dose Level 3|Global end of study|0|||
44197972|NCT01831089|78993395|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
44197973|NCT01831089|78993396|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
44197974|NCT01831089|78993397|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
44197975|NCT01831089|78993398|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
44197976|NCT01831089|78993399|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
44197977|NCT01831089|78993400|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
44197978|NCT01831089|78993395|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
44197979|NCT01831089|78993396|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
44197980|NCT01831089|78993397|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
44197981|NCT01831089|78993398|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
44197982|NCT01831089|78993399|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
44197983|NCT01831089|78993400|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
44197984|NCT01831089|78993395|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
44197985|NCT01831089|78993396|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
44197986|NCT01831089|78993397|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
44197987|NCT01831089|78993398|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
44197988|NCT01831089|78993399|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
44197989|NCT01831089|78993400|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
44197990|NCT01831089|78993395|FG000|Cohort V: Dose Level 5|Death|0|||
44197991|NCT01831089|78993396|FG001|Cohort V: Dose Level 5|Death|0|||
44197992|NCT01831089|78993397|FG002|Cohort V: Dose Level 5|Death|0|||
44197993|NCT01831089|78993398|FG003|Cohort V: Dose Level 5|Death|0|||
44197994|NCT01831089|78993399|FG004|Cohort V: Dose Level 5|Death|1|||
44197995|NCT01831089|78993400|FG005|Cohort V: Dose Level 5|Death|0|||
44197996|NCT01831089|78993395|FG000|Cohort V: Dose Level 5|Global end of study|0|||
44197997|NCT01831089|78993396|FG001|Cohort V: Dose Level 5|Global end of study|0|||
44197998|NCT01831089|78993397|FG002|Cohort V: Dose Level 5|Global end of study|0|||
44197999|NCT01831089|78993398|FG003|Cohort V: Dose Level 5|Global end of study|0|||
44198000|NCT01831089|78993399|FG004|Cohort V: Dose Level 5|Global end of study|2|||
44198001|NCT01831089|78993400|FG005|Cohort V: Dose Level 5|Global end of study|0|||
44198002|NCT01831089|78993395|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
44198003|NCT01831089|78993396|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
44198004|NCT01831089|78993397|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
44198005|NCT01831089|78993398|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
44198006|NCT01831089|78993399|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
44198007|NCT01831089|78993400|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
44198008|NCT01831089|78993395|FG000|Cohort B: Arm B|Progressive disease|0|||
44198009|NCT01831089|78993396|FG001|Cohort B: Arm B|Progressive disease|0|||
44198010|NCT01831089|78993397|FG002|Cohort B: Arm B|Progressive disease|0|||
44361300|NCT00891202|79366959|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
44198011|NCT01831089|78993398|FG003|Cohort B: Arm B|Progressive disease|0|||
44198012|NCT01831089|78993399|FG004|Cohort B: Arm B|Progressive disease|0|||
44198013|NCT01831089|78993400|FG005|Cohort B: Arm B|Progressive disease|8|||
44198014|NCT01831089|78993395|FG000|Cohort B: Arm B|Physician Decision|0|||
44198015|NCT01831089|78993396|FG001|Cohort B: Arm B|Physician Decision|0|||
44198016|NCT01831089|78993397|FG002|Cohort B: Arm B|Physician Decision|0|||
44198017|NCT01831089|78993398|FG003|Cohort B: Arm B|Physician Decision|0|||
44198018|NCT01831089|78993399|FG004|Cohort B: Arm B|Physician Decision|0|||
44198019|NCT01831089|78993400|FG005|Cohort B: Arm B|Physician Decision|2|||
44198020|NCT01831089|78993395|FG000|Cohort B: Arm B|Never treated|0|||
44198021|NCT01831089|78993396|FG001|Cohort B: Arm B|Never treated|0|||
44198022|NCT01831089|78993397|FG002|Cohort B: Arm B|Never treated|0|||
44198023|NCT01831089|78993398|FG003|Cohort B: Arm B|Never treated|0|||
44198024|NCT01831089|78993399|FG004|Cohort B: Arm B|Never treated|0|||
44198025|NCT01831089|78993400|FG005|Cohort B: Arm B|Never treated|2|||
44198026|NCT01831089|78993395|FG000|Cohort B: Arm B|Adverse Event|0|||
44198027|NCT01831089|78993396|FG001|Cohort B: Arm B|Adverse Event|0|||
44198028|NCT01831089|78993397|FG002|Cohort B: Arm B|Adverse Event|0|||
44198029|NCT01831089|78993398|FG003|Cohort B: Arm B|Adverse Event|0|||
44198030|NCT01831089|78993399|FG004|Cohort B: Arm B|Adverse Event|0|||
44198031|NCT01831089|78993400|FG005|Cohort B: Arm B|Adverse Event|1|||
44198032|NCT01831089|78993395|FG000|Cohort B: Arm B|Global end of study|0|||
44198033|NCT01831089|78993396|FG001|Cohort B: Arm B|Global end of study|0|||
44198034|NCT01831089|78993397|FG002|Cohort B: Arm B|Global end of study|0|||
44198035|NCT01831089|78993398|FG003|Cohort B: Arm B|Global end of study|0|||
44198036|NCT01831089|78993399|FG004|Cohort B: Arm B|Global end of study|0|||
44198037|NCT01831089|78993400|FG005|Cohort B: Arm B|Global end of study|1|||
44198038|NCT02112877|78993417|FG000|Overall Study|Withdrawal by Subject|1|||
44198039|NCT02112877|78993418|FG001|Overall Study|Withdrawal by Subject|7|||
44198040|NCT02112877|78993417|FG000|Overall Study|Visit Missed|1|||
44198041|NCT02112877|78993418|FG001|Overall Study|Visit Missed|6|||
44198042|NCT02098369|78993429|FG000|Overall Study|Withdrawal by Subject|1|||
44198043|NCT02098369|78993430|FG001|Overall Study|Withdrawal by Subject|5|||
44198044|NCT02098369|78993431|FG002|Overall Study|Withdrawal by Subject|0|||
44198045|NCT02098369|78993429|FG000|Overall Study|Lost to Follow-up|5|||
44198046|NCT02098369|78993430|FG001|Overall Study|Lost to Follow-up|1|||
44198047|NCT02098369|78993431|FG002|Overall Study|Lost to Follow-up|3|||
44198048|NCT02098369|78993429|FG000|Overall Study|Death|1|||
44198049|NCT02098369|78993430|FG001|Overall Study|Death|1|||
44198050|NCT02098369|78993431|FG002|Overall Study|Death|1|||
44198051|NCT02098369|78993429|FG000|Overall Study|Other|0|||
44198052|NCT02098369|78993430|FG001|Overall Study|Other|2|||
44198053|NCT02098369|78993431|FG002|Overall Study|Other|1|||
44198054|NCT02111785|78993443|FG000|Overall Study|Death|0|||
44198055|NCT02111785|78993444|FG001|Overall Study|Death|1|||
44198056|NCT02111785|78993445|FG002|Overall Study|Death|0|||
44198057|NCT02111785|78993446|FG003|Overall Study|Death|0|||
44198058|NCT02068885|78993463|FG000|Overall Study|Withdrew|3|||
44198059|NCT02068885|78993464|FG001|Overall Study|Withdrew|5|||
44198060|NCT02068885|78993465|FG002|Overall Study|Withdrew|8|||
44198061|NCT02068495|78993474|FG000|Overall Study|Case Report Forms Uncollected|60|||
44198062|NCT02068495|78993474|FG000|Overall Study|Protocol Deviation|49|||
44198063|NCT02097823|78993480|FG000|Overall Study|Withdrawal by Subject|1|||
44198064|NCT02097823|78993481|FG001|Overall Study|Withdrawal by Subject|1|||
44198065|NCT01830855|78993492|FG000|Overall Study|Other|7|||
44198066|NCT01830855|78993493|FG001|Overall Study|Other|1|||
44198067|NCT01830855|78993494|FG002|Overall Study|Other|4|||
44198068|NCT01830855|78993495|FG003|Overall Study|Other|4|||
44198069|NCT01830855|78993492|FG000|Overall Study|Medication error without associated AE|1|||
44198070|NCT01830855|78993493|FG001|Overall Study|Medication error without associated AE|0|||
44266610|NCT03461757|79176884|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
44266611|NCT03461757|79176885|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
44266612|NCT03461757|79176884|FG000|Overall Study|Non-compliance with study treatment|0|||
44266613|NCT03461757|79176885|FG001|Overall Study|Non-compliance with study treatment|1|||
44266614|NCT03461757|79176884|FG000|Overall Study|Pregnancy|2|||
44266615|NCT03461757|79176885|FG001|Overall Study|Pregnancy|0|||
44266616|NCT03461757|79176884|FG000|Overall Study|Protocol Violation|1|||
44266617|NCT03461757|79176885|FG001|Overall Study|Protocol Violation|1|||
44266618|NCT03461757|79176884|FG000|Overall Study|Withdrawal by Subject|7|||
44198071|NCT01830855|78993494|FG002|Overall Study|Medication error without associated AE|0|||
44266619|NCT03461757|79176885|FG001|Overall Study|Withdrawal by Subject|7|||
44266620|NCT03461757|79176884|FG000|Overall Study|Other Reasons|1|||
44266621|NCT03461757|79176885|FG001|Overall Study|Other Reasons|4|||
44198072|NCT01830855|78993495|FG003|Overall Study|Medication error without associated AE|1|||
44198073|NCT01830855|78993492|FG000|Overall Study|Pregnancy|3|||
44198074|NCT01830855|78993493|FG001|Overall Study|Pregnancy|1|||
44198075|NCT01830855|78993494|FG002|Overall Study|Pregnancy|2|||
44198076|NCT01830855|78993495|FG003|Overall Study|Pregnancy|1|||
44198077|NCT01830855|78993492|FG000|Overall Study|No longer meets eligibility criteria|11|||
44266622|NCT03235479|79177373|FG000|Overall Study|Lost to Follow-up|8|||
44198078|NCT01830855|78993493|FG001|Overall Study|No longer meets eligibility criteria|2|||
44198079|NCT01830855|78993494|FG002|Overall Study|No longer meets eligibility criteria|3|||
44198080|NCT01830855|78993495|FG003|Overall Study|No longer meets eligibility criteria|5|||
44198081|NCT01830855|78993492|FG000|Overall Study|Adverse Event|11|||
44198082|NCT01830855|78993493|FG001|Overall Study|Adverse Event|5|||
44198083|NCT01830855|78993494|FG002|Overall Study|Adverse Event|6|||
44198084|NCT01830855|78993495|FG003|Overall Study|Adverse Event|3|||
44198085|NCT01830855|78993492|FG000|Overall Study|Protocol deviation|10|||
44198086|NCT01830855|78993493|FG001|Overall Study|Protocol deviation|5|||
44198087|NCT01830855|78993494|FG002|Overall Study|Protocol deviation|6|||
44198088|NCT01830855|78993495|FG003|Overall Study|Protocol deviation|6|||
44198089|NCT01830855|78993492|FG000|Overall Study|Withdrawal by Subject|33|||
44198090|NCT01830855|78993493|FG001|Overall Study|Withdrawal by Subject|14|||
44198091|NCT01830855|78993494|FG002|Overall Study|Withdrawal by Subject|10|||
44198092|NCT01830855|78993495|FG003|Overall Study|Withdrawal by Subject|12|||
44198093|NCT01830855|78993492|FG000|Overall Study|No longer willing to participate|32|||
44198094|NCT01830855|78993493|FG001|Overall Study|No longer willing to participate|13|||
44198095|NCT01830855|78993494|FG002|Overall Study|No longer willing to participate|12|||
44198096|NCT01830855|78993495|FG003|Overall Study|No longer willing to participate|17|||
44198097|NCT01830855|78993492|FG000|Overall Study|Lost to Follow-up|47|||
44198098|NCT01830855|78993493|FG001|Overall Study|Lost to Follow-up|20|||
44198099|NCT01830855|78993494|FG002|Overall Study|Lost to Follow-up|23|||
44198100|NCT01830855|78993495|FG003|Overall Study|Lost to Follow-up|33|||
44198101|NCT01857063|78993512|FG000|Period 1 (7 Days)|Adverse Event|0|||
44198102|NCT01857063|78993513|FG001|Period 1 (7 Days)|Adverse Event|1|||
44198103|NCT01857063|78993512|FG000|Period 1 (7 Days)|Physician Decision|1|||
44198104|NCT01857063|78993513|FG001|Period 1 (7 Days)|Physician Decision|0|||
44198105|NCT01857063|78993512|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
44198106|NCT01857063|78993513|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
44198107|NCT01857063|78993512|FG000|Period 2 (7 Days)|Adverse Event|2|||
44198108|NCT01857063|78993513|FG001|Period 2 (7 Days)|Adverse Event|1|||
44198109|NCT01857063|78993512|FG000|Period 2 (7 Days)|Physician Decision|1|||
44198110|NCT01857063|78993513|FG001|Period 2 (7 Days)|Physician Decision|1|||
44198111|NCT01857063|78993512|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
44198112|NCT01857063|78993513|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
44198113|NCT01856907|78993522|FG000|Overall Study|Pregnancy|0|||
44198114|NCT01856907|78993523|FG001|Overall Study|Pregnancy|1|||
44198115|NCT01856907|78993524|FG002|Overall Study|Pregnancy|0|||
44198116|NCT01856907|78993522|FG000|Overall Study|Pregnancy|0|||
44198117|NCT01856907|78993523|FG001|Overall Study|Pregnancy|1|||
44198118|NCT01856907|78993524|FG002|Overall Study|Pregnancy|0|||
44198119|NCT01856907|78993522|FG000|Overall Study|Withdrawal by Subject|0|||
44198120|NCT01856907|78993523|FG001|Overall Study|Withdrawal by Subject|1|||
44198121|NCT01856907|78993524|FG002|Overall Study|Withdrawal by Subject|0|||
44198122|NCT02212457|78993541|FG000|Overall Study|Adverse Event|1|||
44198123|NCT02212457|78993542|FG001|Overall Study|Adverse Event|2|||
44198124|NCT02212457|78993543|FG002|Overall Study|Adverse Event|2|||
44198125|NCT02212457|78993544|FG003|Overall Study|Adverse Event|2|||
44198126|NCT02212457|78993545|FG004|Overall Study|Adverse Event|0|||
44198127|NCT02212457|78993546|FG005|Overall Study|Adverse Event|1|||
44198128|NCT02212457|78993541|FG000|Overall Study|Withdrawal by Subject|8|||
44198129|NCT02212457|78993542|FG001|Overall Study|Withdrawal by Subject|10|||
44198130|NCT02212457|78993543|FG002|Overall Study|Withdrawal by Subject|8|||
44198131|NCT02212457|78993544|FG003|Overall Study|Withdrawal by Subject|6|||
44198132|NCT02212457|78993545|FG004|Overall Study|Withdrawal by Subject|5|||
44198133|NCT02212457|78993546|FG005|Overall Study|Withdrawal by Subject|4|||
44198134|NCT02212457|78993541|FG000|Overall Study|Lost to Follow-up|6|||
44198135|NCT02212457|78993542|FG001|Overall Study|Lost to Follow-up|7|||
44198136|NCT02212457|78993543|FG002|Overall Study|Lost to Follow-up|4|||
44198137|NCT02212457|78993544|FG003|Overall Study|Lost to Follow-up|1|||
44198138|NCT02212457|78993545|FG004|Overall Study|Lost to Follow-up|8|||
44198139|NCT02212457|78993546|FG005|Overall Study|Lost to Follow-up|4|||
44198140|NCT02212457|78993541|FG000|Overall Study|Protocol Violation|2|||
44198141|NCT02212457|78993542|FG001|Overall Study|Protocol Violation|1|||
44198142|NCT02212457|78993543|FG002|Overall Study|Protocol Violation|0|||
44198143|NCT02212457|78993544|FG003|Overall Study|Protocol Violation|1|||
44198144|NCT02212457|78993545|FG004|Overall Study|Protocol Violation|2|||
44198145|NCT02212457|78993546|FG005|Overall Study|Protocol Violation|3|||
44198146|NCT02212457|78993541|FG000|Overall Study|Other|2|||
44198147|NCT02212457|78993542|FG001|Overall Study|Other|1|||
44198148|NCT02212457|78993543|FG002|Overall Study|Other|2|||
44198149|NCT02212457|78993544|FG003|Overall Study|Other|1|||
44266623|NCT03235479|79177374|FG001|Overall Study|Lost to Follow-up|11|||
44361301|NCT00891202|79366960|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
44198150|NCT02212457|78993545|FG004|Overall Study|Other|0|||
44198151|NCT02212457|78993546|FG005|Overall Study|Other|1|||
44198152|NCT02097745|78993567|FG000|Overall Study|Adverse Event|25|||
44198153|NCT02097745|78993567|FG000|Overall Study|Death|16|||
44198154|NCT02097745|78993567|FG000|Overall Study|Failure to Return|14|||
44198155|NCT02097745|78993567|FG000|Overall Study|Administrative/Other|27|||
44198156|NCT02097745|78993567|FG000|Overall Study|Reason Not Specified|96|||
44198157|NCT02111083|78993576|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
44198158|NCT02111083|78993577|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
44198159|NCT01629563|78993585|FG000|Overall Study|Adverse Event|16|||
44198160|NCT01629563|78993586|FG001|Overall Study|Adverse Event|16|||
44198161|NCT01629563|78993585|FG000|Overall Study|Death|2|||
44198162|NCT01629563|78993586|FG001|Overall Study|Death|0|||
44198163|NCT01629563|78993585|FG000|Overall Study|Lack of Efficacy|2|||
44198164|NCT01629563|78993586|FG001|Overall Study|Lack of Efficacy|3|||
44198165|NCT01629563|78993585|FG000|Overall Study|Lost to Follow-up|1|||
44198166|NCT01629563|78993586|FG001|Overall Study|Lost to Follow-up|0|||
44361302|NCT00891202|79366961|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
44198167|NCT01629563|78993585|FG000|Overall Study|Pregnancy|1|||
44198168|NCT01629563|78993586|FG001|Overall Study|Pregnancy|2|||
44198169|NCT01629563|78993585|FG000|Overall Study|Protocol Violation|0|||
44198170|NCT01629563|78993586|FG001|Overall Study|Protocol Violation|1|||
44198171|NCT01629563|78993585|FG000|Overall Study|Withdrawal by Subject|27|||
44198172|NCT01629563|78993586|FG001|Overall Study|Withdrawal by Subject|20|||
44198173|NCT01629563|78993585|FG000|Overall Study|surgery|0|||
44198174|NCT01629563|78993586|FG001|Overall Study|surgery|3|||
44198175|NCT01629563|78993585|FG000|Overall Study|Lack of return of menses|12|||
44198176|NCT01629563|78993586|FG001|Overall Study|Lack of return of menses|7|||
44198177|NCT01629563|78993585|FG000|Overall Study|Protocol Violation|0|||
44198178|NCT01629563|78993586|FG001|Overall Study|Protocol Violation|1|||
44198179|NCT02097277|78993597|FG000|Overall Study|Subject no longer meets study criteria|0|||
44198180|NCT02097277|78993598|FG001|Overall Study|Subject no longer meets study criteria|1|||
44198181|NCT02097277|78993599|FG002|Overall Study|Subject no longer meets study criteria|0|||
44198182|NCT02097277|78993600|FG003|Overall Study|Subject no longer meets study criteria|1|||
44198183|NCT02097277|78993601|FG004|Overall Study|Subject no longer meets study criteria|0|||
44198184|NCT02097277|78993597|FG000|Overall Study|Subject request to discontinue treatment|0|||
44198185|NCT02097277|78993598|FG001|Overall Study|Subject request to discontinue treatment|0|||
44198186|NCT02097277|78993599|FG002|Overall Study|Subject request to discontinue treatment|0|||
44198187|NCT02097277|78993600|FG003|Overall Study|Subject request to discontinue treatment|0|||
44198188|NCT02097277|78993601|FG004|Overall Study|Subject request to discontinue treatment|1|||
44198189|NCT02097277|78993597|FG000|Overall Study|Lost to Follow-up|0|||
44198190|NCT02097277|78993598|FG001|Overall Study|Lost to Follow-up|1|||
44198191|NCT02097277|78993599|FG002|Overall Study|Lost to Follow-up|1|||
44198192|NCT02097277|78993600|FG003|Overall Study|Lost to Follow-up|0|||
44198193|NCT02097277|78993601|FG004|Overall Study|Lost to Follow-up|0|||
44198194|NCT02097277|78993597|FG000|Overall Study|Withdrawal by Subject|2|||
44198195|NCT02097277|78993598|FG001|Overall Study|Withdrawal by Subject|1|||
44198196|NCT02097277|78993599|FG002|Overall Study|Withdrawal by Subject|0|||
44198197|NCT02097277|78993600|FG003|Overall Study|Withdrawal by Subject|1|||
44198198|NCT02097277|78993601|FG004|Overall Study|Withdrawal by Subject|0|||
44198199|NCT02097277|78993597|FG000|Overall Study|Adverse Event|0|||
44198200|NCT02097277|78993598|FG001|Overall Study|Adverse Event|0|||
44198201|NCT02097277|78993599|FG002|Overall Study|Adverse Event|1|||
44198202|NCT02097277|78993600|FG003|Overall Study|Adverse Event|2|||
44198203|NCT02097277|78993601|FG004|Overall Study|Adverse Event|0|||
44198204|NCT02212379|78993617|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
44198205|NCT02212379|78993617|FG000|From Baseline to Week 48|Adverse Event|7|||
44198206|NCT02212379|78993617|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
44198207|NCT02212379|78993617|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
44198208|NCT02212379|78993617|FG000|From Week 48 to Week 96|Adverse Event|1|||
44198209|NCT02212379|78993617|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
44198210|NCT02110693|78993624|FG000|Overall Study|Withdrawal by Subject|6|||
44198211|NCT02110693|78993625|FG001|Overall Study|Withdrawal by Subject|7|||
44198212|NCT02110693|78993624|FG000|Overall Study|skipped assessment|15|||
44198213|NCT02110693|78993625|FG001|Overall Study|skipped assessment|18|||
44198214|NCT02110693|78993624|FG000|Overall Study|technical difficulties|6|||
44198215|NCT02110693|78993625|FG001|Overall Study|technical difficulties|4|||
44198216|NCT02110693|78993624|FG000|Overall Study|Other|1|||
44198217|NCT02110693|78993625|FG001|Overall Study|Other|0|||
44198218|NCT02212301|78993645|FG000|Period 1|Lost to Follow-up|0|||
44198219|NCT02212301|78993646|FG001|Period 1|Lost to Follow-up|1|||
44198220|NCT02211209|78993655|FG000|Overall Study|Investigator judgment|0|||
44198221|NCT02211209|78993656|FG001|Overall Study|Investigator judgment|1|||
44198222|NCT02211209|78993655|FG000|Overall Study|Voluntary withdrawal|1|||
44198223|NCT02211209|78993656|FG001|Overall Study|Voluntary withdrawal|4|||
44198224|NCT02211209|78993655|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
44198225|NCT02211209|78993656|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
44198226|NCT02211209|78993655|FG000|Overall Study|Reason Not Specified|1|||
44198227|NCT02211209|78993656|FG001|Overall Study|Reason Not Specified|0|||
44198228|NCT02187809|78993662|FG000|Overall Study|The study was terminated|3|||
44198229|NCT02187029|78993670|FG000|Overall Study|Adverse Event|0|||
44198230|NCT02187029|78993671|FG001|Overall Study|Adverse Event|1|||
44198231|NCT02187029|78993672|FG002|Overall Study|Adverse Event|1|||
44198232|NCT02187029|78993673|FG003|Overall Study|Adverse Event|0|||
44198233|NCT02187029|78993670|FG000|Overall Study|Study Terminated by Sponsor|0|||
44198234|NCT02187029|78993671|FG001|Overall Study|Study Terminated by Sponsor|0|||
44198235|NCT02187029|78993672|FG002|Overall Study|Study Terminated by Sponsor|10|||
44198236|NCT02187029|78993673|FG003|Overall Study|Study Terminated by Sponsor|3|||
44198237|NCT02187029|78993670|FG000|Overall Study|Withdrawal by Subject|1|||
44198238|NCT02187029|78993671|FG001|Overall Study|Withdrawal by Subject|0|||
44198239|NCT02187029|78993672|FG002|Overall Study|Withdrawal by Subject|0|||
44198240|NCT02187029|78993673|FG003|Overall Study|Withdrawal by Subject|0|||
44198241|NCT02162771|78993685|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
44198242|NCT02162771|78993686|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
44198243|NCT02162771|78993685|FG000|Core Study Period (Part 2)|Adverse Event|4|||
44198244|NCT02162771|78993686|FG001|Core Study Period (Part 2)|Adverse Event|1|||
44198245|NCT02162771|78993685|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
44198246|NCT02162771|78993686|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
44198247|NCT02162771|78993685|FG000|Core Study Period (Part 2)|Physician Decision|0|||
44198248|NCT02162771|78993686|FG001|Core Study Period (Part 2)|Physician Decision|2|||
44198249|NCT02162771|78993685|FG000|Core Study Period (Part 2)|Death|1|||
44198250|NCT02162771|78993686|FG001|Core Study Period (Part 2)|Death|0|||
44198251|NCT02162771|78993685|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
44198252|NCT02162771|78993686|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
44198253|NCT02162771|78993685|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
44198254|NCT02162771|78993686|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
44198255|NCT02162771|78993685|FG000|Maintenance Study Period (Part 2)|Death|2|||
44198256|NCT02162771|78993686|FG001|Maintenance Study Period (Part 2)|Death|1|||
44198257|NCT02162771|78993685|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
44198258|NCT02162771|78993686|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
44198259|NCT02162771|78993685|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
44198260|NCT02162771|78993686|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
44198261|NCT02162771|78993685|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
44198262|NCT02162771|78993686|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
44198263|NCT02161757|78993695|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
44198264|NCT02161757|78993696|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
44198265|NCT02161757|78993697|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
44198266|NCT02161757|78993695|FG000|Treatment Through Study Completion|Adverse Event|1|||
44198267|NCT02161757|78993696|FG001|Treatment Through Study Completion|Adverse Event|1|||
44198268|NCT02161757|78993697|FG002|Treatment Through Study Completion|Adverse Event|0|||
44198269|NCT02161757|78993695|FG000|Treatment Through Study Completion|Protocol Violation|0|||
44198270|NCT02161757|78993696|FG001|Treatment Through Study Completion|Protocol Violation|1|||
44198271|NCT02161757|78993697|FG002|Treatment Through Study Completion|Protocol Violation|2|||
44198272|NCT02161757|78993695|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
44198273|NCT02161757|78993696|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
44198274|NCT02161757|78993697|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
44198275|NCT02161757|78993695|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
44198276|NCT02161757|78993696|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
44198277|NCT02161757|78993697|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
44198278|NCT02161757|78993695|FG000|Treatment Through Study Completion|Other|20|||
44198279|NCT02161757|78993696|FG001|Treatment Through Study Completion|Other|19|||
44198280|NCT02161757|78993697|FG002|Treatment Through Study Completion|Other|12|||
44198281|NCT02161757|78993695|FG000|Treatment Through Study Completion|Death|2|||
44198282|NCT02161757|78993696|FG001|Treatment Through Study Completion|Death|1|||
44198283|NCT02161757|78993697|FG002|Treatment Through Study Completion|Death|1|||
44198284|NCT02160977|78993707|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
44198285|NCT02160977|78993708|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
44198286|NCT02160977|78993707|FG000|Three Months After Surgery|Lost to Follow-up|0|||
44198287|NCT02160977|78993708|FG001|Three Months After Surgery|Lost to Follow-up|2|||
44198288|NCT02160977|78993707|FG000|Six Months After Surgery|Lost to Follow-up|2|||
44451498|NCT00500331|79460413|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
44198289|NCT02160977|78993708|FG001|Six Months After Surgery|Lost to Follow-up|1|||
44198290|NCT02160899|78993720|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
44198291|NCT02160899|78993721|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
44198292|NCT02160899|78993722|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
44198293|NCT02160899|78993723|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
44198294|NCT02160899|78993724|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
44198295|NCT02160899|78993725|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
44198296|NCT02160041|78993739|FG000|Overall Study|Adverse Event|11|||
44198297|NCT02160041|78993739|FG000|Overall Study|Death|2|||
44198298|NCT02160041|78993739|FG000|Overall Study|disease progression|57|||
44198299|NCT02160041|78993739|FG000|Overall Study|Protocol Violation|1|||
44198300|NCT02160041|78993739|FG000|Overall Study|non-compliance with study|1|||
44198301|NCT02160041|78993739|FG000|Overall Study|Physician Decision|3|||
44198302|NCT02160041|78993739|FG000|Overall Study|Withdrawal by Subject|8|||
44198303|NCT02160041|78993739|FG000|Overall Study|study terminated by by sponsor|1|||
44198304|NCT02186873|78993745|FG000|Overall Study|Adverse Event|1|||
44198305|NCT02186873|78993746|FG001|Overall Study|Adverse Event|3|||
44451499|NCT00500331|79460414|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
44451500|NCT00500331|79460408|FG000|Overall Study|Didn't return for continuation of study|1|||
44451501|NCT00500331|79460409|FG001|Overall Study|Didn't return for continuation of study|0|||
44451502|NCT00500331|79460410|FG002|Overall Study|Didn't return for continuation of study|0|||
44451503|NCT00500331|79460411|FG003|Overall Study|Didn't return for continuation of study|0|||
44451504|NCT00500331|79460412|FG004|Overall Study|Didn't return for continuation of study|0|||
44451505|NCT00500331|79460413|FG005|Overall Study|Didn't return for continuation of study|0|||
44451506|NCT00500331|79460414|FG006|Overall Study|Didn't return for continuation of study|0|||
44451507|NCT00500331|79460408|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
44451508|NCT00500331|79460409|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
44451509|NCT00500331|79460410|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
44451510|NCT00500331|79460411|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
44451511|NCT00500331|79460412|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
44451512|NCT00500331|79460413|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
44198306|NCT02186873|78993745|FG000|Overall Study|Lack of Efficacy|0|||
44198307|NCT02186873|78993746|FG001|Overall Study|Lack of Efficacy|1|||
44198308|NCT02186873|78993745|FG000|Overall Study|Lost to Follow-up|1|||
44198309|NCT02186873|78993746|FG001|Overall Study|Lost to Follow-up|2|||
44198310|NCT02186873|78993745|FG000|Overall Study|Withdrawal by Subject|7|||
44198311|NCT02186873|78993746|FG001|Overall Study|Withdrawal by Subject|2|||
44198312|NCT02096263|78993756|FG000|Overall Study|Adverse Event|1|||
44198313|NCT02096263|78993757|FG001|Overall Study|Adverse Event|0|||
44198314|NCT02096263|78993758|FG002|Overall Study|Adverse Event|1|||
44198315|NCT02096263|78993756|FG000|Overall Study|Lost to Follow-up|14|||
44198316|NCT02096263|78993757|FG001|Overall Study|Lost to Follow-up|18|||
44198317|NCT02096263|78993758|FG002|Overall Study|Lost to Follow-up|15|||
44198318|NCT02096263|78993756|FG000|Overall Study|Other|7|||
44198319|NCT02096263|78993757|FG001|Overall Study|Other|9|||
44198320|NCT02096263|78993758|FG002|Overall Study|Other|6|||
44198321|NCT02096263|78993756|FG000|Overall Study|Sponsor study termination|0|||
44198322|NCT02096263|78993757|FG001|Overall Study|Sponsor study termination|0|||
44198323|NCT02096263|78993758|FG002|Overall Study|Sponsor study termination|1|||
44198324|NCT02096263|78993756|FG000|Overall Study|Protocol Violation|7|||
44198325|NCT02096263|78993757|FG001|Overall Study|Protocol Violation|2|||
44198326|NCT02096263|78993758|FG002|Overall Study|Protocol Violation|8|||
44198327|NCT02096263|78993756|FG000|Overall Study|Withdrawal by Subject|5|||
44198328|NCT02096263|78993757|FG001|Overall Study|Withdrawal by Subject|7|||
44198329|NCT02096263|78993758|FG002|Overall Study|Withdrawal by Subject|8|||
44198330|NCT01830543|78993769|FG000|Overall Study|Subject Decision|19|||
44198331|NCT01830543|78993770|FG001|Overall Study|Subject Decision|21|||
44198332|NCT01830543|78993771|FG002|Overall Study|Subject Decision|57|||
44198333|NCT01830543|78993769|FG000|Overall Study|Adverse Event|91|||
44198334|NCT01830543|78993770|FG001|Overall Study|Adverse Event|77|||
44198335|NCT01830543|78993771|FG002|Overall Study|Adverse Event|76|||
44198336|NCT01830543|78993769|FG000|Overall Study|Death|20|||
44198337|NCT01830543|78993770|FG001|Overall Study|Death|22|||
44198338|NCT01830543|78993771|FG002|Overall Study|Death|22|||
44198339|NCT01830543|78993769|FG000|Overall Study|Protocol Violation|3|||
44198340|NCT01830543|78993770|FG001|Overall Study|Protocol Violation|7|||
44198341|NCT01830543|78993771|FG002|Overall Study|Protocol Violation|7|||
44198342|NCT01830543|78993769|FG000|Overall Study|Physician Decision|11|||
44198343|NCT01830543|78993770|FG001|Overall Study|Physician Decision|5|||
44198344|NCT01830543|78993771|FG002|Overall Study|Physician Decision|12|||
44198345|NCT01830543|78993769|FG000|Overall Study|Withdrawal by consent|3|||
44198346|NCT01830543|78993770|FG001|Overall Study|Withdrawal by consent|3|||
44198347|NCT01830543|78993771|FG002|Overall Study|Withdrawal by consent|3|||
44198348|NCT01830543|78993769|FG000|Overall Study|Other|12|||
44451513|NCT00500331|79460414|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
44451514|NCT00500331|79460408|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
44198349|NCT01830543|78993770|FG001|Overall Study|Other|17|||
44198350|NCT01830543|78993771|FG002|Overall Study|Other|37|||
44198351|NCT02109445|78993779|FG000|Overall Study|Symptomatic deterioration|2|||
44198352|NCT02109445|78993779|FG000|Overall Study|Adverse Event|1|||
44198353|NCT02109133|78993785|FG000|Overall Study|Lost to Follow-up|1|||
44198354|NCT02109133|78993786|FG001|Overall Study|Lost to Follow-up|0|||
44198355|NCT01623271|78993794|FG000|Overall Study|Withdrawal by Subject|2|||
44198356|NCT01856673|78993801|FG000|Overall Study|Withdrawal by Subject|44|||
44198357|NCT01856673|78993802|FG001|Overall Study|Withdrawal by Subject|50|||
44198358|NCT01856673|78993803|FG002|Overall Study|Withdrawal by Subject|33|||
44198359|NCT01856673|78993801|FG000|Overall Study|Lost to Follow-up|31|||
44198360|NCT01856673|78993802|FG001|Overall Study|Lost to Follow-up|34|||
44198361|NCT01856673|78993803|FG002|Overall Study|Lost to Follow-up|0|||
44198362|NCT01856673|78993801|FG000|Overall Study|Unknown reasons|9|||
44198363|NCT01856673|78993802|FG001|Overall Study|Unknown reasons|0|||
44198364|NCT01856673|78993803|FG002|Overall Study|Unknown reasons|0|||
44451515|NCT00500331|79460409|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
44451516|NCT00500331|79460410|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
44451517|NCT00500331|79460411|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
44451518|NCT00500331|79460412|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
44451519|NCT00500331|79460413|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
44451520|NCT00500331|79460414|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
44451521|NCT00500331|79460408|FG000|Overall Study|Participant was randomized by mistake|1|||
44451522|NCT00500331|79460409|FG001|Overall Study|Participant was randomized by mistake|0|||
44451523|NCT00500331|79460410|FG002|Overall Study|Participant was randomized by mistake|0|||
44451524|NCT00500331|79460411|FG003|Overall Study|Participant was randomized by mistake|0|||
44451525|NCT00500331|79460412|FG004|Overall Study|Participant was randomized by mistake|0|||
44451526|NCT00500331|79460413|FG005|Overall Study|Participant was randomized by mistake|0|||
44451527|NCT00500331|79460414|FG006|Overall Study|Participant was randomized by mistake|0|||
44451528|NCT00500331|79460408|FG000|Overall Study|Diabetologist nurse in the study|0|||
44451529|NCT00500331|79460409|FG001|Overall Study|Diabetologist nurse in the study|0|||
44451530|NCT00500331|79460410|FG002|Overall Study|Diabetologist nurse in the study|1|||
44451531|NCT00500331|79460411|FG003|Overall Study|Diabetologist nurse in the study|0|||
44451532|NCT00500331|79460412|FG004|Overall Study|Diabetologist nurse in the study|0|||
44451533|NCT00500331|79460413|FG005|Overall Study|Diabetologist nurse in the study|0|||
44451534|NCT00500331|79460414|FG006|Overall Study|Diabetologist nurse in the study|0|||
44451535|NCT00500331|79460408|FG000|Overall Study|State ban of biological samples export|0|||
44451536|NCT00500331|79460409|FG001|Overall Study|State ban of biological samples export|0|||
44451537|NCT00500331|79460410|FG002|Overall Study|State ban of biological samples export|0|||
44451538|NCT00500331|79460411|FG003|Overall Study|State ban of biological samples export|1|||
44451539|NCT00500331|79460412|FG004|Overall Study|State ban of biological samples export|0|||
44451540|NCT00500331|79460413|FG005|Overall Study|State ban of biological samples export|0|||
44451541|NCT00500331|79460414|FG006|Overall Study|State ban of biological samples export|0|||
44451542|NCT00500331|79460408|FG000|Overall Study|Protocol violated|0|||
44451543|NCT00500331|79460409|FG001|Overall Study|Protocol violated|0|||
44451544|NCT00500331|79460410|FG002|Overall Study|Protocol violated|0|||
44451545|NCT00500331|79460411|FG003|Overall Study|Protocol violated|1|||
44451546|NCT00500331|79460412|FG004|Overall Study|Protocol violated|0|||
44451547|NCT00500331|79460413|FG005|Overall Study|Protocol violated|0|||
44451548|NCT00500331|79460414|FG006|Overall Study|Protocol violated|0|||
44451549|NCT00499863|79460433|FG000|Overall Study|Lack of Efficacy|21|||
44451550|NCT00499863|79460434|FG001|Overall Study|Lack of Efficacy|27|||
44451551|NCT00499863|79460433|FG000|Overall Study|Protocol Violation|12|||
44451552|NCT00499863|79460434|FG001|Overall Study|Protocol Violation|7|||
44451553|NCT00499863|79460433|FG000|Overall Study|Withdrawal by Subject|6|||
44451554|NCT00499863|79460434|FG001|Overall Study|Withdrawal by Subject|4|||
44451555|NCT00499863|79460433|FG000|Overall Study|Adverse Event|8|||
44451556|NCT00499863|79460434|FG001|Overall Study|Adverse Event|2|||
44451557|NCT00499863|79460433|FG000|Overall Study|Sponsor decision|2|||
44451558|NCT00499863|79460434|FG001|Overall Study|Sponsor decision|2|||
44451559|NCT00499863|79460433|FG000|Overall Study|Lost to Follow-up|1|||
44451560|NCT00499863|79460434|FG001|Overall Study|Lost to Follow-up|1|||
44451561|NCT00484185|79460440|FG000|Overall Study|Lost to Follow-up|44|||
44451562|NCT00484185|79460440|FG000|Overall Study|Other|20|||
44451563|NCT00484185|79460440|FG000|Overall Study|Randomized but not treated|5|||
44451564|NCT00484185|79460440|FG000|Overall Study|Death|2|||
44451565|NCT00097981|79460446|FG000|Overall Study|Adverse Event|31|||
44451566|NCT00097981|79460447|FG001|Overall Study|Adverse Event|44|||
44451567|NCT00097981|79460446|FG000|Overall Study|Withdrawal by Subject|10|||
44451568|NCT00097981|79460447|FG001|Overall Study|Withdrawal by Subject|8|||
44451569|NCT00097981|79460446|FG000|Overall Study|Protocol Violation|1|||
44451570|NCT00097981|79460447|FG001|Overall Study|Protocol Violation|1|||
44451571|NCT00097981|79460446|FG000|Overall Study|Death|2|||
44451572|NCT00097981|79460447|FG001|Overall Study|Death|4|||
44451573|NCT00097981|79460446|FG000|Overall Study|Physician Decision|7|||
44451574|NCT00097981|79460447|FG001|Overall Study|Physician Decision|1|||
44451575|NCT00097981|79460446|FG000|Overall Study|Disease Progression|8|||
44198365|NCT01856673|78993801|FG000|Overall Study|Psychologist decision|1|||
44198366|NCT01856673|78993802|FG001|Overall Study|Psychologist decision|0|||
44451576|NCT00097981|79460447|FG001|Overall Study|Disease Progression|2|||
44451577|NCT00097981|79460446|FG000|Overall Study|Transplant planned|28|||
44451578|NCT00097981|79460447|FG001|Overall Study|Transplant planned|27|||
44198367|NCT01856673|78993803|FG002|Overall Study|Psychologist decision|0|||
44451579|NCT00097981|79460446|FG000|Overall Study|Other|19|||
44451580|NCT00097981|79460447|FG001|Overall Study|Other|13|||
44451581|NCT00572195|79460453|FG000|Overall Study|Withdrawal by Subject|50|||
44451582|NCT00572195|79460453|FG000|Overall Study|Death|9|||
44451583|NCT00572195|79460453|FG000|Overall Study|Adverse Event|4|||
44451584|NCT00572195|79460453|FG000|Overall Study|Lost to Follow-up|5|||
44451585|NCT00572039|79460459|FG000|Overall Study|Withdrawal by Subject|9|||
44451586|NCT00572039|79460460|FG001|Overall Study|Withdrawal by Subject|6|||
44451587|NCT00572039|79460459|FG000|Overall Study|Death|2|||
44451588|NCT00572039|79460460|FG001|Overall Study|Death|3|||
44198368|NCT01856673|78993801|FG000|Overall Study|Paperwork errors|8|||
44198369|NCT01856673|78993802|FG001|Overall Study|Paperwork errors|0|||
44198370|NCT01856673|78993803|FG002|Overall Study|Paperwork errors|0|||
44198371|NCT01856673|78993801|FG000|Overall Study|Death|1|||
44198372|NCT01856673|78993802|FG001|Overall Study|Death|1|||
44198373|NCT01856673|78993803|FG002|Overall Study|Death|0|||
44198374|NCT01856673|78993801|FG000|Overall Study|Protocol Violation|1|||
44198375|NCT01856673|78993802|FG001|Overall Study|Protocol Violation|0|||
44198376|NCT01856673|78993803|FG002|Overall Study|Protocol Violation|1|||
44198377|NCT02095951|78993813|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
44198378|NCT02095951|78993814|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
44198379|NCT02095873|78993826|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
44198380|NCT02095873|78993827|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
44198381|NCT02095873|78993826|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
44198382|NCT02095873|78993827|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
44198383|NCT02095873|78993826|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
44198384|NCT02095873|78993827|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
44198385|NCT02094937|78993835|FG000|8 Weeks in Period 1|Adverse Event|9|||
44198386|NCT02094937|78993836|FG001|8 Weeks in Period 1|Adverse Event|0|||
44198387|NCT02094937|78993837|FG002|8 Weeks in Period 1|Adverse Event|0|||
44198388|NCT02094937|78993838|FG003|8 Weeks in Period 1|Adverse Event|0|||
44198389|NCT02094937|78993835|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
44198390|NCT02094937|78993836|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
44198391|NCT02094937|78993837|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
44198392|NCT02094937|78993838|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
44198393|NCT02094937|78993835|FG000|8 Weeks in Period 1|Protocol Violation|2|||
44198394|NCT02094937|78993836|FG001|8 Weeks in Period 1|Protocol Violation|0|||
44198395|NCT02094937|78993837|FG002|8 Weeks in Period 1|Protocol Violation|0|||
44198396|NCT02094937|78993838|FG003|8 Weeks in Period 1|Protocol Violation|0|||
44198397|NCT02094937|78993835|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
44198398|NCT02094937|78993836|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
44198399|NCT02094937|78993837|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
44198400|NCT02094937|78993838|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
44198401|NCT02094937|78993835|FG000|8 Weeks in Period 1|Physician Decision|1|||
44198402|NCT02094937|78993836|FG001|8 Weeks in Period 1|Physician Decision|0|||
44198403|NCT02094937|78993837|FG002|8 Weeks in Period 1|Physician Decision|0|||
44198404|NCT02094937|78993838|FG003|8 Weeks in Period 1|Physician Decision|0|||
44198405|NCT02094937|78993835|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
44198406|NCT02094937|78993836|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
44198407|NCT02094937|78993837|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
44198408|NCT02094937|78993838|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
44198409|NCT02094937|78993835|FG000|12 Weeks in Period 2|Adverse Event|0|||
44198410|NCT02094937|78993836|FG001|12 Weeks in Period 2|Adverse Event|2|||
44198411|NCT02094937|78993837|FG002|12 Weeks in Period 2|Adverse Event|4|||
44198412|NCT02094937|78993838|FG003|12 Weeks in Period 2|Adverse Event|1|||
44198413|NCT02094937|78993835|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
44198414|NCT02094937|78993836|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
44198415|NCT02094937|78993837|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
44198416|NCT02094937|78993838|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
44198417|NCT02094937|78993835|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
44198418|NCT02094937|78993836|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
44198419|NCT02094937|78993837|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
44198420|NCT02094937|78993838|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
44198421|NCT02094937|78993835|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
44451589|NCT00572039|79460459|FG000|Overall Study|Ill|5|||
44198422|NCT02094937|78993836|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
44198423|NCT02094937|78993837|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
44198424|NCT02094937|78993838|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
44198425|NCT02094937|78993835|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
44198426|NCT02094937|78993836|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
44198427|NCT02094937|78993837|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
44198428|NCT02094937|78993838|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
44198429|NCT02093923|78993852|FG000|Overall Study|Lost to Follow-up|0|||
44451590|NCT00572039|79460460|FG001|Overall Study|Ill|1|||
44451591|NCT00684593|79460470|FG000|Overall Study|Adverse Event|0|||
44451592|NCT00684593|79460471|FG001|Overall Study|Adverse Event|2|||
44198430|NCT02093923|78993853|FG001|Overall Study|Lost to Follow-up|0|||
44198431|NCT02093923|78993854|FG002|Overall Study|Lost to Follow-up|0|||
44198432|NCT02093923|78993855|FG003|Overall Study|Lost to Follow-up|1|||
44198433|NCT02093923|78993856|FG004|Overall Study|Lost to Follow-up|0|||
44198434|NCT02093923|78993852|FG000|Overall Study|Screen failure after randomization|0|||
44198435|NCT02093923|78993853|FG001|Overall Study|Screen failure after randomization|0|||
44198436|NCT02093923|78993854|FG002|Overall Study|Screen failure after randomization|0|||
44198437|NCT02093923|78993855|FG003|Overall Study|Screen failure after randomization|1|||
44198438|NCT02093923|78993856|FG004|Overall Study|Screen failure after randomization|0|||
44198439|NCT02186561|78993872|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
44198440|NCT02186561|78993872|FG000|Enrollment|Enrollment Cap Reached|5|||
44198441|NCT02186561|78993872|FG000|Enrollment|Insurance Denial|2|||
44198442|NCT02186561|78993872|FG000|Enrollment|Withdrawal by Subject|2|||
44198443|NCT02186561|78993872|FG000|Enrollment|Investigator Withdrew Consent|1|||
44198444|NCT02186561|78993872|FG000|30-Day Post Index Procedure Visit|Death|1|||
44198445|NCT02186561|78993872|FG000|1- Year Post Index Procedure Visit|Death|1|||
44198446|NCT02186561|78993872|FG000|1- Year Post Index Procedure Visit|Missed|1|||
44198447|NCT02066467|78993878|FG000|Overall Study|Did not undergo implant procedure|24|||
44198448|NCT02066467|78993878|FG000|Overall Study|Attempted to implant withoput success|43|||
44198449|NCT02066467|78993878|FG000|Overall Study|Consent ineligible|1|||
44198450|NCT02066467|78993878|FG000|Overall Study|Death|54|||
44198451|NCT02066467|78993878|FG000|Overall Study|Lost to Follow-up|51|||
44198452|NCT02066467|78993878|FG000|Overall Study|Adverse Event|20|||
44198453|NCT02066467|78993878|FG000|Overall Study|Withdrawal by Subject|16|||
44198454|NCT02066467|78993878|FG000|Overall Study|Physician Decision|2|||
44198455|NCT02066467|78993878|FG000|Overall Study|Not defined|4|||
44198456|NCT02186171|78993884|FG000|Overall Study|Withdrawal by Subject|1|||
44198457|NCT02186171|78993885|FG001|Overall Study|Withdrawal by Subject|9|||
44198458|NCT02186171|78993884|FG000|Overall Study|Lost to Follow-up|2|||
44198459|NCT02186171|78993885|FG001|Overall Study|Lost to Follow-up|2|||
44198460|NCT02186171|78993884|FG000|Overall Study|Death|1|||
44198461|NCT02186171|78993885|FG001|Overall Study|Death|2|||
44198462|NCT02186171|78993884|FG000|Overall Study|Protocol-specified Criteria|0|||
44198463|NCT02186171|78993885|FG001|Overall Study|Protocol-specified Criteria|2|||
44198464|NCT02186015|78993893|FG000|Overall Study|Physician Decision|1|||
44198465|NCT02186015|78993894|FG001|Overall Study|Physician Decision|0|||
44198466|NCT02066389|78993907|FG000|Overall Study|Adverse Event|1|||
44198467|NCT02066389|78993908|FG001|Overall Study|Adverse Event|1|||
44198468|NCT02066389|78993909|FG002|Overall Study|Adverse Event|1|||
44198469|NCT02066389|78993910|FG003|Overall Study|Adverse Event|1|||
44198470|NCT02066389|78993911|FG004|Overall Study|Adverse Event|5|||
44198471|NCT02066389|78993912|FG005|Overall Study|Adverse Event|1|||
44198472|NCT02066389|78993907|FG000|Overall Study|Withdrawal by Subject|4|||
44198473|NCT02066389|78993908|FG001|Overall Study|Withdrawal by Subject|0|||
44198474|NCT02066389|78993909|FG002|Overall Study|Withdrawal by Subject|5|||
44198475|NCT02066389|78993910|FG003|Overall Study|Withdrawal by Subject|1|||
44198476|NCT02066389|78993911|FG004|Overall Study|Withdrawal by Subject|1|||
44198477|NCT02066389|78993912|FG005|Overall Study|Withdrawal by Subject|2|||
44198478|NCT02066389|78993907|FG000|Overall Study|Lost to Follow-up|0|||
44198479|NCT02066389|78993908|FG001|Overall Study|Lost to Follow-up|0|||
44198480|NCT02066389|78993909|FG002|Overall Study|Lost to Follow-up|0|||
44198481|NCT02066389|78993910|FG003|Overall Study|Lost to Follow-up|1|||
44198482|NCT02066389|78993911|FG004|Overall Study|Lost to Follow-up|1|||
44198483|NCT02066389|78993912|FG005|Overall Study|Lost to Follow-up|1|||
44198484|NCT02066389|78993907|FG000|Overall Study|Randomized in Error|0|||
44198485|NCT02066389|78993908|FG001|Overall Study|Randomized in Error|0|||
44198486|NCT02066389|78993909|FG002|Overall Study|Randomized in Error|0|||
44198487|NCT02066389|78993910|FG003|Overall Study|Randomized in Error|0|||
44198488|NCT02066389|78993911|FG004|Overall Study|Randomized in Error|0|||
44198489|NCT02066389|78993912|FG005|Overall Study|Randomized in Error|1|||
44198490|NCT02106403|78993926|FG000|Follow-Up Visit 3|Other Reason|0|||
44198491|NCT02106403|78993927|FG001|Follow-Up Visit 3|Other Reason|0|||
44198492|NCT02106403|78993928|FG002|Follow-Up Visit 3|Other Reason|0|||
44198493|NCT02106403|78993929|FG003|Follow-Up Visit 3|Other Reason|0|||
44198494|NCT02106403|78993930|FG004|Follow-Up Visit 3|Other Reason|0|||
44198495|NCT02106403|78993931|FG005|Follow-Up Visit 3|Other Reason|1|||
44198496|NCT02133131|78993948|FG000|Overall Study|Adverse Event|0|||
44198497|NCT02133131|78993949|FG001|Overall Study|Adverse Event|0|||
44198498|NCT02133131|78993950|FG002|Overall Study|Adverse Event|0|||
44198499|NCT02133131|78993951|FG003|Overall Study|Adverse Event|1|||
44198500|NCT02133131|78993952|FG004|Overall Study|Adverse Event|0|||
44198501|NCT02133131|78993953|FG005|Overall Study|Adverse Event|0|||
44198502|NCT02133131|78993954|FG006|Overall Study|Adverse Event|0|||
44198503|NCT02133131|78993948|FG000|Overall Study|Lost to Follow-up|1|||
44198504|NCT02133131|78993949|FG001|Overall Study|Lost to Follow-up|0|||
44198505|NCT02133131|78993950|FG002|Overall Study|Lost to Follow-up|0|||
44198506|NCT02133131|78993951|FG003|Overall Study|Lost to Follow-up|1|||
44198507|NCT02133131|78993952|FG004|Overall Study|Lost to Follow-up|0|||
44198508|NCT02133131|78993953|FG005|Overall Study|Lost to Follow-up|0|||
44198509|NCT02133131|78993954|FG006|Overall Study|Lost to Follow-up|0|||
44198510|NCT02133131|78993948|FG000|Overall Study|Status not recorded|4|||
44198511|NCT02133131|78993949|FG001|Overall Study|Status not recorded|5|||
44198512|NCT02133131|78993950|FG002|Overall Study|Status not recorded|1|||
44198513|NCT02133131|78993951|FG003|Overall Study|Status not recorded|4|||
44198514|NCT02133131|78993952|FG004|Overall Study|Status not recorded|0|||
44198515|NCT02133131|78993953|FG005|Overall Study|Status not recorded|0|||
44198516|NCT02133131|78993954|FG006|Overall Study|Status not recorded|0|||
44198517|NCT02133131|78993948|FG000|Overall Study|Ongoing in study|0|||
44198518|NCT02133131|78993949|FG001|Overall Study|Ongoing in study|0|||
44198519|NCT02133131|78993950|FG002|Overall Study|Ongoing in study|0|||
44198520|NCT02133131|78993951|FG003|Overall Study|Ongoing in study|0|||
44198521|NCT02133131|78993952|FG004|Overall Study|Ongoing in study|15|||
44198522|NCT02133131|78993953|FG005|Overall Study|Ongoing in study|14|||
44198523|NCT02133131|78993954|FG006|Overall Study|Ongoing in study|11|||
44198524|NCT02133131|78993948|FG000|Overall Study|Protocol Violation|0|||
44198525|NCT02133131|78993949|FG001|Overall Study|Protocol Violation|0|||
44198526|NCT02133131|78993950|FG002|Overall Study|Protocol Violation|0|||
44198527|NCT02133131|78993951|FG003|Overall Study|Protocol Violation|0|||
44198528|NCT02133131|78993952|FG004|Overall Study|Protocol Violation|0|||
44198529|NCT02133131|78993953|FG005|Overall Study|Protocol Violation|0|||
44198530|NCT02133131|78993954|FG006|Overall Study|Protocol Violation|1|||
44198531|NCT02106325|78993972|FG000|Phase 1|Lost to Follow-up|2|||
44198532|NCT02106325|78993973|FG001|Phase 1|Lost to Follow-up|2|||
44198533|NCT02106325|78993972|FG000|Phase 2|Lost to Follow-up|2|||
44198534|NCT02106325|78993973|FG001|Phase 2|Lost to Follow-up|3|||
44198535|NCT02106325|78993972|FG000|Phase 3|Lost to Follow-up|2|||
44198536|NCT02106325|78993973|FG001|Phase 3|Lost to Follow-up|1|||
44198537|NCT01625689|78993981|FG000|Overall Study|Migration|2|||
44198538|NCT01625689|78993982|FG001|Overall Study|Migration|1|||
44198539|NCT02184611|78993990|FG000|Overall Study|Lack of Efficacy|11|||
44198540|NCT02184611|78993991|FG001|Overall Study|Lack of Efficacy|15|||
44198541|NCT02184611|78993990|FG000|Overall Study|Withdrawal by Subject|5|||
44198542|NCT02184611|78993991|FG001|Overall Study|Withdrawal by Subject|6|||
44198543|NCT02184611|78993990|FG000|Overall Study|Adverse Event|4|||
44198544|NCT02184611|78993991|FG001|Overall Study|Adverse Event|5|||
44198545|NCT02184611|78993990|FG000|Overall Study|Protocol Violation|1|||
44198546|NCT02184611|78993991|FG001|Overall Study|Protocol Violation|1|||
44198547|NCT02184611|78993990|FG000|Overall Study|Protocol defined stopping criteria|0|||
44198548|NCT02184611|78993991|FG001|Overall Study|Protocol defined stopping criteria|1|||
44198549|NCT02066311|78993997|FG000|Overall Study|Adverse Event|4|||
44198550|NCT02066311|78993997|FG000|Overall Study|Withdrawal by Subject|1|||
44198551|NCT02184455|78994001|FG000|Overall Study|Lost to Follow-up|1|||
44198552|NCT02184143|78994007|FG000|Overall Study|Withdrawal by Subject|4|||
44198553|NCT02184143|78994008|FG001|Overall Study|Withdrawal by Subject|4|||
44198554|NCT02184143|78994007|FG000|Overall Study|Lost to Follow-up|5|||
44198555|NCT02184143|78994008|FG001|Overall Study|Lost to Follow-up|3|||
44198556|NCT02184143|78994007|FG000|Overall Study|Death|1|||
44198557|NCT02184143|78994008|FG001|Overall Study|Death|0|||
44198558|NCT01625611|78994018|FG000|Overall Study|No adlib drinks Lab 1|3|||
44198559|NCT01625611|78994019|FG001|Overall Study|No adlib drinks Lab 1|0|||
44198560|NCT01625611|78994018|FG000|Overall Study|Technical issues with PET|1|||
44266624|NCT03235479|79177373|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
44266625|NCT03235479|79177374|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
44266626|NCT03235479|79177373|FG000|Overall Study|Pregnancy|1|||
44198561|NCT01625611|78994019|FG001|Overall Study|Technical issues with PET|0|||
44198562|NCT01625611|78994018|FG000|Overall Study|Unable to complete study procedures|1|||
44198563|NCT01625611|78994019|FG001|Overall Study|Unable to complete study procedures|0|||
44198564|NCT01625611|78994018|FG000|Overall Study|Withdrawal by Subject|3|||
44198565|NCT01625611|78994019|FG001|Overall Study|Withdrawal by Subject|0|||
44198566|NCT02159807|78994029|FG000|Overall Study|Adverse Event|0|||
44198567|NCT02159807|78994030|FG001|Overall Study|Adverse Event|0|||
44198568|NCT02159807|78994031|FG002|Overall Study|Adverse Event|1|||
44198569|NCT02159807|78994029|FG000|Overall Study|No CSF|1|||
44198570|NCT02159807|78994030|FG001|Overall Study|No CSF|1|||
44198571|NCT02159807|78994031|FG002|Overall Study|No CSF|1|||
44198572|NCT02159807|78994029|FG000|Overall Study|elevated blood pressure|0|||
44198573|NCT02159807|78994030|FG001|Overall Study|elevated blood pressure|0|||
44198574|NCT02159807|78994031|FG002|Overall Study|elevated blood pressure|1|||
44198575|NCT02066233|78994041|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
44198576|NCT02066233|78994042|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
44198577|NCT02159729|78994050|FG000|Overall Study|Adverse Event|0|||
44198578|NCT02159729|78994051|FG001|Overall Study|Adverse Event|1|||
44198579|NCT02159729|78994050|FG000|Overall Study|Subject's Request|13|||
44198580|NCT02159729|78994051|FG001|Overall Study|Subject's Request|10|||
44198581|NCT02159729|78994050|FG000|Overall Study|Lost to Follow-up|24|||
44198582|NCT02159729|78994051|FG001|Overall Study|Lost to Follow-up|9|||
44198583|NCT02159729|78994050|FG000|Overall Study|Non compliance|2|||
44198584|NCT02159729|78994051|FG001|Overall Study|Non compliance|0|||
44198585|NCT02159729|78994050|FG000|Overall Study|Other Unspecified|3|||
44198586|NCT02159729|78994051|FG001|Overall Study|Other Unspecified|1|||
44198587|NCT02159183|78994059|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
44198588|NCT02159183|78994060|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
44198589|NCT02159183|78994059|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
44198590|NCT02159183|78994060|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
44198591|NCT02159183|78994059|FG000|Analysis After the 36 Months Follow-up|Death|0|||
44198592|NCT02159183|78994060|FG001|Analysis After the 36 Months Follow-up|Death|1|||
44198593|NCT02159183|78994059|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
44198594|NCT02159183|78994060|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
44198595|NCT02159183|78994059|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
44198596|NCT02159183|78994060|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
44198597|NCT02183675|78994072|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
44198598|NCT02183675|78994073|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
44198599|NCT02183675|78994074|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
44198600|NCT02183675|78994075|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
44198601|NCT02183675|78994076|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
44198602|NCT02183675|78994077|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
44198603|NCT02183519|78994089|FG000|Overall Study|computer error|3|||
44198604|NCT02183519|78994090|FG001|Overall Study|computer error|0|||
44198605|NCT02183519|78994089|FG000|Overall Study|Did not respond to cough inducter|0|||
44198606|NCT02183519|78994090|FG001|Overall Study|Did not respond to cough inducter|3|||
44198607|NCT02132195|78994099|FG000|Initial Assignment|Relapsed|14|||
44198608|NCT02132195|78994100|FG001|Initial Assignment|Relapsed|0|||
44198609|NCT02132195|78994101|FG002|Initial Assignment|Relapsed|0|||
44198610|NCT02132195|78994099|FG000|Rescue Therapy|Relapsed|0|||
44198611|NCT02132195|78994100|FG001|Rescue Therapy|Relapsed|0|||
44198612|NCT02132195|78994101|FG002|Rescue Therapy|Relapsed|7|||
44198613|NCT02132195|78994099|FG000|Rescue Therapy|Physician Decision|0|||
44198614|NCT02132195|78994100|FG001|Rescue Therapy|Physician Decision|0|||
44198615|NCT02132195|78994101|FG002|Rescue Therapy|Physician Decision|1|||
44198616|NCT02132195|78994099|FG000|Rescue Therapy|Withdrawal by Subject|0|||
44198617|NCT02132195|78994100|FG001|Rescue Therapy|Withdrawal by Subject|0|||
44198618|NCT02132195|78994101|FG002|Rescue Therapy|Withdrawal by Subject|1|||
44198619|NCT02132195|78994099|FG000|Rescue Therapy|Adverse Event|0|||
44198620|NCT02132195|78994100|FG001|Rescue Therapy|Adverse Event|0|||
44198621|NCT02132195|78994101|FG002|Rescue Therapy|Adverse Event|2|||
44198622|NCT02182973|78994111|FG000|Overall Study|Withdrawal by Subject|3|||
44198623|NCT02182973|78994112|FG001|Overall Study|Withdrawal by Subject|0|||
44198624|NCT02182895|78994121|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
44198625|NCT02182895|78994122|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
44198626|NCT01625377|78994130|FG000|Overall Study|Death|1|||
44198627|NCT01625377|78994131|FG001|Overall Study|Death|1|||
44198628|NCT01625377|78994130|FG000|Overall Study|Administrative Problem|1|||
44198629|NCT01625377|78994131|FG001|Overall Study|Administrative Problem|1|||
44198630|NCT01625377|78994130|FG000|Overall Study|Protocol Violation|0|||
44198631|NCT01625377|78994131|FG001|Overall Study|Protocol Violation|3|||
44198632|NCT01625377|78994130|FG000|Overall Study|Adverse Event|3|||
44198633|NCT01625377|78994131|FG001|Overall Study|Adverse Event|16|||
44198634|NCT01625377|78994130|FG000|Overall Study|Graft loss|1|||
44198635|NCT01625377|78994131|FG001|Overall Study|Graft loss|0|||
44198636|NCT01625377|78994130|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44198637|NCT01625377|78994131|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44198638|NCT01625377|78994130|FG000|Overall Study|Abnormal laboratory values|1|||
44198639|NCT01625377|78994131|FG001|Overall Study|Abnormal laboratory values|0|||
44198640|NCT02158949|78994139|FG000|Overall Study|Withdrawal by Subject|1|||
44198641|NCT02158949|78994140|FG001|Overall Study|Withdrawal by Subject|0|||
44198642|NCT02158949|78994139|FG000|Overall Study|Lost to Follow-up|5|||
44198643|NCT02158949|78994140|FG001|Overall Study|Lost to Follow-up|11|||
44198644|NCT02132117|78994148|FG000|Overall Study|Adverse Event|6|||
44198645|NCT02132117|78994149|FG001|Overall Study|Adverse Event|1|||
44198646|NCT02132117|78994148|FG000|Overall Study|Lost to Follow-up|2|||
44198647|NCT02132117|78994149|FG001|Overall Study|Lost to Follow-up|2|||
44198648|NCT02132117|78994148|FG000|Overall Study|Personal Reasons|1|||
44198649|NCT02132117|78994149|FG001|Overall Study|Personal Reasons|2|||
44198650|NCT02132117|78994148|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44198651|NCT02132117|78994149|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44198652|NCT02093689|78994158|FG000|Overall Study|Physician Decision|4|||
44266627|NCT03235479|79177374|FG001|Overall Study|Pregnancy|0|||
44198653|NCT02093689|78994159|FG001|Overall Study|Physician Decision|0|||
44266628|NCT03235479|79177373|FG000|Overall Study|Protocol Deviation|1|||
44266629|NCT03235479|79177374|FG001|Overall Study|Protocol Deviation|3|||
44266630|NCT03235479|79177373|FG000|Overall Study|Technical Problems|3|||
44266631|NCT03235479|79177374|FG001|Overall Study|Technical Problems|2|||
44266632|NCT03235479|79177373|FG000|Overall Study|Withdrawal by Subject|2|||
44266633|NCT03235479|79177374|FG001|Overall Study|Withdrawal by Subject|2|||
44198654|NCT02093689|78994160|FG002|Overall Study|Physician Decision|0|||
44198655|NCT02047045|78994168|FG000|Baseline|Withdrawal by Subject|3|||
44198656|NCT02047045|78994169|FG001|Baseline|Withdrawal by Subject|2|||
44198657|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
44198658|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
44198659|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
44198660|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
44198661|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
44198662|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
44198663|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
44198664|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
44198665|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
44198666|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
44198667|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
44198668|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
44198669|NCT02047045|78994168|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
44198670|NCT02047045|78994169|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
44198671|NCT02047045|78994168|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
44198672|NCT02047045|78994169|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
44198673|NCT02131259|78994175|FG000|Overall Study|Progressive disease|751|||
44198674|NCT02131259|78994175|FG000|Overall Study|Adverse Event|341|||
44198675|NCT02131259|78994175|FG000|Overall Study|Lost to Follow-up|7|||
44198676|NCT02131259|78994175|FG000|Overall Study|Relocation|32|||
44198677|NCT02131259|78994175|FG000|Overall Study|Other|63|||
44198678|NCT02131259|78994175|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
44198679|NCT02131259|78994175|FG000|Overall Study|Progressive disease/relocation|1|||
44198680|NCT02131259|78994175|FG000|Overall Study|Progressive disease/other|2|||
44198681|NCT02131259|78994175|FG000|Overall Study|AE/lost to follow-up|1|||
44198682|NCT02131259|78994175|FG000|Overall Study|AE/other|1|||
44198683|NCT02131259|78994175|FG000|Overall Study|Progressive disease/AE/other|1|||
44198684|NCT02131259|78994175|FG000|Overall Study|Missing|3|||
44198685|NCT01856595|78994188|FG000|Overall Study|Withdrawal by Subject|0|||
44266634|NCT03235479|79177373|FG000|Overall Study|Other Reasons|3|||
44266635|NCT03235479|79177374|FG001|Overall Study|Other Reasons|5|||
44266636|NCT03193437|79177430|FG000|Overall Study|Adverse Event|4|||
44266637|NCT03193437|79177430|FG000|Overall Study|Withdrawal by Subject|2|||
44266638|NCT03193437|79177430|FG000|Overall Study|Disease Progression|2|||
44266639|NCT02906787|79177472|FG000|Overall Study|Withdrawal by Subject|12|||
44198686|NCT01856595|78994189|FG001|Overall Study|Withdrawal by Subject|1|||
44198687|NCT01856595|78994190|FG002|Overall Study|Withdrawal by Subject|0|||
44198688|NCT01856595|78994191|FG003|Overall Study|Withdrawal by Subject|0|||
44198689|NCT01856595|78994192|FG004|Overall Study|Withdrawal by Subject|0|||
44198690|NCT01856595|78994193|FG005|Overall Study|Withdrawal by Subject|0|||
44198691|NCT01856595|78994194|FG006|Overall Study|Withdrawal by Subject|1|||
44198692|NCT01856595|78994195|FG007|Overall Study|Withdrawal by Subject|0|||
44198693|NCT01856595|78994196|FG008|Overall Study|Withdrawal by Subject|0|||
44198694|NCT02158247|78994233|FG000|Overall Study|Invisible vocal cords|5|||
44198695|NCT01829295|78994255|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
44266640|NCT02906787|79177473|FG001|Overall Study|Withdrawal by Subject|10|||
44198696|NCT01829295|78994256|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
44198697|NCT01829295|78994257|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
44198698|NCT01829295|78994258|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
44198699|NCT01829295|78994255|FG000|6-12 Months|Adverse Event|0|||
44198700|NCT01829295|78994256|FG001|6-12 Months|Adverse Event|0|||
44198701|NCT01829295|78994257|FG002|6-12 Months|Adverse Event|3|||
44198702|NCT01829295|78994258|FG003|6-12 Months|Adverse Event|2|||
44198703|NCT01829295|78994255|FG000|6-12 Months|Lost to Follow-up|2|||
44198704|NCT01829295|78994256|FG001|6-12 Months|Lost to Follow-up|0|||
44198705|NCT01829295|78994257|FG002|6-12 Months|Lost to Follow-up|0|||
44198706|NCT01829295|78994258|FG003|6-12 Months|Lost to Follow-up|0|||
44198707|NCT01829295|78994255|FG000|6-12 Months|Withdrawal by Subject|2|||
44198708|NCT01829295|78994256|FG001|6-12 Months|Withdrawal by Subject|2|||
44198709|NCT01829295|78994257|FG002|6-12 Months|Withdrawal by Subject|0|||
44198710|NCT01829295|78994258|FG003|6-12 Months|Withdrawal by Subject|0|||
44198711|NCT02157935|78994270|FG000|Overall Study|Withdrawal by Subject|25|||
44198712|NCT02157935|78994271|FG001|Overall Study|Withdrawal by Subject|39|||
44198713|NCT02157935|78994270|FG000|Overall Study|Screen failure|1|||
44198714|NCT02157935|78994271|FG001|Overall Study|Screen failure|2|||
44198715|NCT02157935|78994270|FG000|Overall Study|Protocol Violation|1|||
44198716|NCT02157935|78994271|FG001|Overall Study|Protocol Violation|0|||
44198717|NCT02157935|78994270|FG000|Overall Study|Progressive disease|0|||
44198718|NCT02157935|78994271|FG001|Overall Study|Progressive disease|2|||
44198719|NCT02157935|78994270|FG000|Overall Study|Other|5|||
44198720|NCT02157935|78994271|FG001|Overall Study|Other|12|||
44198721|NCT02157935|78994270|FG000|Overall Study|Lack of Efficacy|0|||
44198722|NCT02157935|78994271|FG001|Overall Study|Lack of Efficacy|1|||
44198723|NCT02157935|78994270|FG000|Overall Study|Death|4|||
44198724|NCT02157935|78994271|FG001|Overall Study|Death|4|||
44198725|NCT02157935|78994270|FG000|Overall Study|Adverse Event|3|||
44198726|NCT02157935|78994271|FG001|Overall Study|Adverse Event|5|||
44198727|NCT02157779|78994279|FG000|Overall Study|Logistical|9|||
44198728|NCT02157779|78994280|FG001|Overall Study|Logistical|3|||
44266641|NCT02906787|79177472|FG000|Overall Study|Missed|24|||
44266642|NCT02906787|79177473|FG001|Overall Study|Missed|22|||
44266643|NCT02107443|79178046|FG000|Overall Study|Death|42|||
44266644|NCT02107443|79178047|FG001|Overall Study|Death|30|||
44266645|NCT02107443|79178046|FG000|Overall Study|Study Protocol Violation|3|||
44266646|NCT02107443|79178047|FG001|Overall Study|Study Protocol Violation|1|||
44266647|NCT02107443|79178046|FG000|Overall Study|Registered but Not Eligible|0|||
44198729|NCT02157779|78994279|FG000|Overall Study|Stopped attending, reason unknown|11|||
44266648|NCT02107443|79178047|FG001|Overall Study|Registered but Not Eligible|1|||
44266649|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
44198730|NCT02157779|78994280|FG001|Overall Study|Stopped attending, reason unknown|7|||
44266650|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
44198731|NCT02157779|78994279|FG000|Overall Study|No response to outreach after Baseline|1|||
44198732|NCT02157779|78994280|FG001|Overall Study|No response to outreach after Baseline|1|||
44198733|NCT02157779|78994279|FG000|Overall Study|Moved|1|||
44198734|NCT02157779|78994280|FG001|Overall Study|Moved|0|||
44198735|NCT02157779|78994279|FG000|Overall Study|Medical|1|||
44198736|NCT02157779|78994280|FG001|Overall Study|Medical|0|||
44198737|NCT02157779|78994279|FG000|Overall Study|Legal issue|1|||
44198738|NCT02157779|78994280|FG001|Overall Study|Legal issue|0|||
44198739|NCT02093221|78994294|FG000|Overall Study|Adverse Event|1|||
44198740|NCT02093221|78994295|FG001|Overall Study|Adverse Event|0|||
44198741|NCT02093221|78994296|FG002|Overall Study|Adverse Event|0|||
44266651|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
44266652|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
44266653|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Changed Mind|2|||
44198742|NCT02093221|78994297|FG003|Overall Study|Adverse Event|0|||
44198743|NCT02093221|78994298|FG004|Overall Study|Adverse Event|0|||
44266654|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Changed Mind|0|||
44266655|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
44266656|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
44266657|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
44266658|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
44198744|NCT02093221|78994294|FG000|Overall Study|Withdrawal by Subject|1|||
44198745|NCT02093221|78994295|FG001|Overall Study|Withdrawal by Subject|1|||
44198746|NCT02093221|78994296|FG002|Overall Study|Withdrawal by Subject|4|||
44198747|NCT02093221|78994297|FG003|Overall Study|Withdrawal by Subject|1|||
44198748|NCT02093221|78994298|FG004|Overall Study|Withdrawal by Subject|1|||
44198749|NCT02093221|78994294|FG000|Overall Study|Lost to Follow-up|2|||
44198750|NCT02093221|78994295|FG001|Overall Study|Lost to Follow-up|0|||
44198751|NCT02093221|78994296|FG002|Overall Study|Lost to Follow-up|1|||
44198752|NCT02093221|78994297|FG003|Overall Study|Lost to Follow-up|1|||
44198753|NCT02093221|78994298|FG004|Overall Study|Lost to Follow-up|0|||
44198754|NCT02093221|78994294|FG000|Overall Study|Death|0|||
44198755|NCT02093221|78994295|FG001|Overall Study|Death|1|||
44266659|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
44198756|NCT02093221|78994296|FG002|Overall Study|Death|0|||
44198757|NCT02093221|78994297|FG003|Overall Study|Death|0|||
44198758|NCT02093221|78994298|FG004|Overall Study|Death|0|||
44198759|NCT02093221|78994294|FG000|Overall Study|Protocol Violation|0|||
44198760|NCT02093221|78994295|FG001|Overall Study|Protocol Violation|1|||
44198761|NCT02093221|78994296|FG002|Overall Study|Protocol Violation|0|||
44198762|NCT02093221|78994297|FG003|Overall Study|Protocol Violation|0|||
44198763|NCT02093221|78994298|FG004|Overall Study|Protocol Violation|0|||
44198764|NCT02093221|78994294|FG000|Overall Study|Study termination|6|||
44198765|NCT02093221|78994295|FG001|Overall Study|Study termination|5|||
44198766|NCT02093221|78994296|FG002|Overall Study|Study termination|4|||
44198767|NCT02093221|78994297|FG003|Overall Study|Study termination|6|||
44198768|NCT02093221|78994298|FG004|Overall Study|Study termination|7|||
44198769|NCT02092909|78994314|FG000|Overall Study|Adverse Event|0|||
44198770|NCT02092909|78994315|FG001|Overall Study|Adverse Event|0|||
44198771|NCT02092909|78994316|FG002|Overall Study|Adverse Event|4|||
44198772|NCT02092909|78994317|FG003|Overall Study|Adverse Event|2|||
44198773|NCT02092909|78994314|FG000|Overall Study|Lack of Efficacy|0|||
44198774|NCT02092909|78994315|FG001|Overall Study|Lack of Efficacy|2|||
44198775|NCT02092909|78994316|FG002|Overall Study|Lack of Efficacy|1|||
44198776|NCT02092909|78994317|FG003|Overall Study|Lack of Efficacy|0|||
44198777|NCT02092909|78994314|FG000|Overall Study|Withdrawal by Subject|0|||
44198778|NCT02092909|78994315|FG001|Overall Study|Withdrawal by Subject|0|||
44198779|NCT02092909|78994316|FG002|Overall Study|Withdrawal by Subject|2|||
44198780|NCT02092909|78994317|FG003|Overall Study|Withdrawal by Subject|1|||
44198781|NCT02092909|78994314|FG000|Overall Study|Study terminated by Sponsor|0|||
44198782|NCT02092909|78994315|FG001|Overall Study|Study terminated by Sponsor|0|||
44198783|NCT02092909|78994316|FG002|Overall Study|Study terminated by Sponsor|0|||
44198784|NCT02092909|78994317|FG003|Overall Study|Study terminated by Sponsor|2|||
44198785|NCT02092909|78994314|FG000|Overall Study|Miscellaneous|1|||
44198786|NCT02092909|78994315|FG001|Overall Study|Miscellaneous|1|||
44198787|NCT02092909|78994316|FG002|Overall Study|Miscellaneous|2|||
44198788|NCT02092909|78994317|FG003|Overall Study|Miscellaneous|1|||
44198789|NCT01623115|78994329|FG000|Overall Study|Randomized but not treated|0|||
44198790|NCT01623115|78994330|FG001|Overall Study|Randomized but not treated|1|||
44198791|NCT01623115|78994329|FG000|Overall Study|Physician Decision|1|||
44198792|NCT01623115|78994330|FG001|Overall Study|Physician Decision|0|||
44198793|NCT01623115|78994329|FG000|Overall Study|Participants moved|1|||
44198794|NCT01623115|78994330|FG001|Overall Study|Participants moved|5|||
44198795|NCT01623115|78994329|FG000|Overall Study|Adverse Event|10|||
44198796|NCT01623115|78994330|FG001|Overall Study|Adverse Event|13|||
44198797|NCT01623115|78994329|FG000|Overall Study|Poor compliance to protocol|4|||
44198798|NCT01623115|78994330|FG001|Overall Study|Poor compliance to protocol|10|||
44198799|NCT01623115|78994329|FG000|Overall Study|Consent withdrawn by participant|2|||
44198800|NCT01623115|78994330|FG001|Overall Study|Consent withdrawn by participant|6|||
44198801|NCT01623115|78994329|FG000|Overall Study|Related to study drug administration|0|||
44198802|NCT01623115|78994330|FG001|Overall Study|Related to study drug administration|2|||
44198803|NCT01623115|78994329|FG000|Overall Study|Last visit outside protocol visit window|14|||
44198804|NCT01623115|78994330|FG001|Overall Study|Last visit outside protocol visit window|26|||
44198805|NCT01623115|78994329|FG000|Overall Study|Site closure|1|||
44198806|NCT01623115|78994330|FG001|Overall Study|Site closure|7|||
44198807|NCT01623115|78994329|FG000|Overall Study|Death|0|||
44198808|NCT01623115|78994330|FG001|Overall Study|Death|4|||
44198809|NCT01623115|78994329|FG000|Overall Study|Other than specified above|0|||
44198810|NCT01623115|78994330|FG001|Overall Study|Other than specified above|3|||
44198811|NCT02092285|78994336|FG000|Induction Phase|Adverse Event|7|||
44198812|NCT02092285|78994336|FG000|Induction Phase|Physician Decision|4|||
44198813|NCT02092285|78994336|FG000|Induction Phase|Pregnancy|1|||
44451593|NCT00685373|79460477|FG000|Overall Study|Adverse Event|3|||
44451594|NCT00685373|79460477|FG000|Overall Study|Withdrawal by Subject|5|||
44198814|NCT02092285|78994336|FG000|Induction Phase|Relapse/Recurrence|7|||
44198815|NCT02092285|78994336|FG000|Induction Phase|Withdrawal by Subject|2|||
44198816|NCT02092285|78994336|FG000|Induction Phase|Lack of Efficacy|14|||
44198817|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
44198818|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
44451595|NCT00685373|79460477|FG000|Overall Study|Lack of Efficacy|3|||
44198819|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
44198820|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
44198821|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
44198822|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
44198823|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
44198824|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
44198825|NCT02092285|78994336|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
44198826|NCT02091739|78994343|FG000|MP: 16 Weeks|Adverse Event|1|||
44198827|NCT02091739|78994344|FG001|MP: 16 Weeks|Adverse Event|1|||
44198828|NCT02091739|78994345|FG002|MP: 16 Weeks|Adverse Event|1|||
44198829|NCT02091739|78994346|FG003|MP: 16 Weeks|Adverse Event|0|||
44198830|NCT02091739|78994347|FG004|MP: 16 Weeks|Adverse Event|0|||
44198831|NCT02091739|78994343|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
44198832|NCT02091739|78994344|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
44198833|NCT02091739|78994345|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
44198834|NCT02091739|78994346|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
44198835|NCT02091739|78994347|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
44198836|NCT02091739|78994343|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
44198837|NCT02091739|78994344|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
44198838|NCT02091739|78994345|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
44198839|NCT02091739|78994346|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
44198840|NCT02091739|78994347|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
44198841|NCT02091739|78994343|FG000|EP: 48 Weeks|Other|0|||
44198842|NCT02091739|78994344|FG001|EP: 48 Weeks|Other|0|||
44198843|NCT02091739|78994345|FG002|EP: 48 Weeks|Other|0|||
44198844|NCT02091739|78994346|FG003|EP: 48 Weeks|Other|1|||
44198845|NCT02091739|78994347|FG004|EP: 48 Weeks|Other|0|||
44198846|NCT02091739|78994343|FG000|EP: 48 Weeks|Death|0|||
44198847|NCT02091739|78994344|FG001|EP: 48 Weeks|Death|0|||
44198848|NCT02091739|78994345|FG002|EP: 48 Weeks|Death|0|||
44198849|NCT02091739|78994346|FG003|EP: 48 Weeks|Death|3|||
44198850|NCT02091739|78994347|FG004|EP: 48 Weeks|Death|2|||
44198851|NCT02091739|78994343|FG000|EP: 48 Weeks|Adverse Event|0|||
44198852|NCT02091739|78994344|FG001|EP: 48 Weeks|Adverse Event|0|||
44198853|NCT02091739|78994345|FG002|EP: 48 Weeks|Adverse Event|0|||
44198854|NCT02091739|78994346|FG003|EP: 48 Weeks|Adverse Event|2|||
44198855|NCT02091739|78994347|FG004|EP: 48 Weeks|Adverse Event|6|||
44198856|NCT02091739|78994343|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
44198857|NCT02091739|78994344|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
44198858|NCT02091739|78994345|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
44198859|NCT02091739|78994346|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
44198860|NCT02091739|78994347|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
44198861|NCT02045875|78994359|FG000|Overall Study|Lost to Follow-up|3|||
44198862|NCT02045875|78994360|FG001|Overall Study|Lost to Follow-up|0|||
44198863|NCT02045875|78994359|FG000|Overall Study|Withdrawal by Subject|4|||
44198864|NCT02045875|78994360|FG001|Overall Study|Withdrawal by Subject|3|||
44198865|NCT01597635|78994369|FG000|Part A|Adverse Event|3|||
44198866|NCT01597635|78994370|FG001|Part A|Adverse Event|0|||
44198867|NCT01597635|78994371|FG002|Part A|Adverse Event|0|||
44198868|NCT01597635|78994369|FG000|Part B|Adverse Event|0|||
44198869|NCT01597635|78994370|FG001|Part B|Adverse Event|0|||
44198870|NCT01597635|78994371|FG002|Part B|Adverse Event|1|||
44198871|NCT01597635|78994369|FG000|Part B|Protocol Violation|0|||
44198872|NCT01597635|78994370|FG001|Part B|Protocol Violation|1|||
44198873|NCT01597635|78994371|FG002|Part B|Protocol Violation|0|||
44198874|NCT01597635|78994369|FG000|Part B|Protocol-defined stopping criteria|0|||
44198875|NCT01597635|78994370|FG001|Part B|Protocol-defined stopping criteria|4|||
44198876|NCT01597635|78994371|FG002|Part B|Protocol-defined stopping criteria|3|||
44198877|NCT01597635|78994369|FG000|Part B|Withdrawal by Subject|0|||
44198878|NCT01597635|78994370|FG001|Part B|Withdrawal by Subject|1|||
44198879|NCT01597635|78994371|FG002|Part B|Withdrawal by Subject|0|||
44198880|NCT01828281|78994382|FG000|Overall Study|Withdrawal by Subject|1|||
44198881|NCT01828281|78994383|FG001|Overall Study|Withdrawal by Subject|0|||
44198882|NCT01827267|78994392|FG000|Overall Study|Did not receive study drug|1|||
44198883|NCT01827267|78994393|FG001|Overall Study|Did not receive study drug|1|||
44198884|NCT01827267|78994392|FG000|Overall Study|Physician Decision|1|||
44198885|NCT01827267|78994393|FG001|Overall Study|Physician Decision|0|||
44198886|NCT01827267|78994392|FG000|Overall Study|Disease Progression|1|||
44198887|NCT01827267|78994393|FG001|Overall Study|Disease Progression|1|||
44198888|NCT01827267|78994392|FG000|Overall Study|Sponsor Discontinued Study|2|||
44198889|NCT01827267|78994393|FG001|Overall Study|Sponsor Discontinued Study|8|||
44198890|NCT01827267|78994392|FG000|Overall Study|Still on study|0|||
44198891|NCT01827267|78994393|FG001|Overall Study|Still on study|2|||
44198892|NCT01855425|78994400|FG000|Overall Study|Physician Decision|20|||
44198893|NCT01854879|78994404|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
44198894|NCT01854879|78994404|FG000|Overall Study|screen fail|3|||
44198895|NCT01854879|78994404|FG000|Overall Study|incomplete data set|1|||
44198896|NCT01827111|78994408|FG000|Overall Study|Disease Progression|1|||
44198897|NCT02045095|78994412|FG000|Overall Study|Other|0|||
44198898|NCT02045095|78994413|FG001|Overall Study|Other|0|||
44198899|NCT02045095|78994414|FG002|Overall Study|Other|1|||
44198900|NCT02045095|78994415|FG003|Overall Study|Other|0|||
44198901|NCT02045095|78994416|FG004|Overall Study|Other|0|||
44198902|NCT02045095|78994417|FG005|Overall Study|Other|2|||
44198903|NCT02045095|78994418|FG006|Overall Study|Other|0|||
44198904|NCT02045095|78994412|FG000|Overall Study|Progressive Disease|3|||
44198905|NCT02045095|78994413|FG001|Overall Study|Progressive Disease|3|||
44198906|NCT02045095|78994414|FG002|Overall Study|Progressive Disease|2|||
44198907|NCT02045095|78994415|FG003|Overall Study|Progressive Disease|4|||
44198908|NCT02045095|78994416|FG004|Overall Study|Progressive Disease|2|||
44198909|NCT02045095|78994417|FG005|Overall Study|Progressive Disease|4|||
44198910|NCT02045095|78994418|FG006|Overall Study|Progressive Disease|1|||
44198911|NCT02045095|78994412|FG000|Overall Study|Withdrawal by Subject|0|||
44198912|NCT02045095|78994413|FG001|Overall Study|Withdrawal by Subject|0|||
44198913|NCT02045095|78994414|FG002|Overall Study|Withdrawal by Subject|0|||
44198914|NCT02045095|78994415|FG003|Overall Study|Withdrawal by Subject|0|||
44277768|NCT02138916|79238746|FG001|Overall Study|incorrect enrolment|1|||
44198915|NCT02045095|78994416|FG004|Overall Study|Withdrawal by Subject|3|||
44198916|NCT02045095|78994417|FG005|Overall Study|Withdrawal by Subject|0|||
44198917|NCT02045095|78994418|FG006|Overall Study|Withdrawal by Subject|0|||
44198918|NCT02045095|78994412|FG000|Overall Study|Adverse Event|0|||
44198919|NCT02045095|78994413|FG001|Overall Study|Adverse Event|1|||
44198920|NCT02045095|78994414|FG002|Overall Study|Adverse Event|1|||
44198921|NCT02045095|78994415|FG003|Overall Study|Adverse Event|0|||
44198922|NCT02045095|78994416|FG004|Overall Study|Adverse Event|0|||
44198923|NCT02045095|78994417|FG005|Overall Study|Adverse Event|2|||
44198924|NCT02045095|78994418|FG006|Overall Study|Adverse Event|0|||
44198925|NCT02181803|78994443|FG000|Overall Study|Withdrawal by Subject|0|||
44198926|NCT02181803|78994444|FG001|Overall Study|Withdrawal by Subject|2|||
44198927|NCT02181803|78994445|FG002|Overall Study|Withdrawal by Subject|0|||
44198928|NCT02181803|78994446|FG003|Overall Study|Withdrawal by Subject|0|||
44198929|NCT02181803|78994447|FG004|Overall Study|Withdrawal by Subject|0|||
44198930|NCT02181803|78994448|FG005|Overall Study|Withdrawal by Subject|0|||
44198931|NCT02181803|78994449|FG006|Overall Study|Withdrawal by Subject|0|||
44198932|NCT02181803|78994450|FG007|Overall Study|Withdrawal by Subject|0|||
44198933|NCT02181803|78994451|FG008|Overall Study|Withdrawal by Subject|0|||
44198934|NCT02181803|78994443|FG000|Overall Study|Physician Decision|0|||
44198935|NCT02181803|78994444|FG001|Overall Study|Physician Decision|0|||
44198936|NCT02181803|78994445|FG002|Overall Study|Physician Decision|0|||
44198937|NCT02181803|78994446|FG003|Overall Study|Physician Decision|1|||
44198938|NCT02181803|78994447|FG004|Overall Study|Physician Decision|0|||
44198939|NCT02181803|78994448|FG005|Overall Study|Physician Decision|0|||
44198940|NCT02181803|78994449|FG006|Overall Study|Physician Decision|0|||
44198941|NCT02181803|78994450|FG007|Overall Study|Physician Decision|1|||
44198942|NCT02181803|78994451|FG008|Overall Study|Physician Decision|0|||
44198943|NCT02181803|78994443|FG000|Overall Study|Adverse Event|0|||
44198944|NCT02181803|78994444|FG001|Overall Study|Adverse Event|2|||
44198945|NCT02181803|78994445|FG002|Overall Study|Adverse Event|0|||
44198946|NCT02181803|78994446|FG003|Overall Study|Adverse Event|1|||
44198947|NCT02181803|78994447|FG004|Overall Study|Adverse Event|0|||
44198948|NCT02181803|78994448|FG005|Overall Study|Adverse Event|0|||
44198949|NCT02181803|78994449|FG006|Overall Study|Adverse Event|1|||
44198950|NCT02181803|78994450|FG007|Overall Study|Adverse Event|0|||
44198951|NCT02181803|78994451|FG008|Overall Study|Adverse Event|0|||
44198952|NCT01826487|78994498|FG000|Overall Study|Adverse Event|1|||
44198953|NCT01826487|78994499|FG001|Overall Study|Adverse Event|1|||
44198954|NCT01826487|78994498|FG000|Overall Study|Lost to Follow-up|1|||
44198955|NCT01826487|78994499|FG001|Overall Study|Lost to Follow-up|0|||
44198956|NCT01826487|78994498|FG000|Overall Study|Withdrawal by Subject|1|||
44198957|NCT01826487|78994499|FG001|Overall Study|Withdrawal by Subject|3|||
44198958|NCT01826487|78994498|FG000|Overall Study|Protocol Violation|1|||
44198959|NCT01826487|78994499|FG001|Overall Study|Protocol Violation|1|||
44198960|NCT02064439|78994509|FG000|Overall Study|Adverse Event|51|||
44198961|NCT02064439|78994510|FG001|Overall Study|Adverse Event|47|||
44198962|NCT02064439|78994511|FG002|Overall Study|Adverse Event|46|||
44198963|NCT02064439|78994509|FG000|Overall Study|Death|0|||
44198964|NCT02064439|78994510|FG001|Overall Study|Death|2|||
44198965|NCT02064439|78994511|FG002|Overall Study|Death|3|||
44198966|NCT02064439|78994509|FG000|Overall Study|Withdrawal by Subject|29|||
44198967|NCT02064439|78994510|FG001|Overall Study|Withdrawal by Subject|18|||
44198968|NCT02064439|78994511|FG002|Overall Study|Withdrawal by Subject|26|||
44198969|NCT02064439|78994509|FG000|Overall Study|Protocol Violation|3|||
44198970|NCT02064439|78994510|FG001|Overall Study|Protocol Violation|5|||
44198971|NCT02064439|78994511|FG002|Overall Study|Protocol Violation|3|||
44198972|NCT02064439|78994509|FG000|Overall Study|Lost to Follow-up|1|||
44198973|NCT02064439|78994510|FG001|Overall Study|Lost to Follow-up|3|||
44198974|NCT02064439|78994511|FG002|Overall Study|Lost to Follow-up|4|||
44198975|NCT02064439|78994509|FG000|Overall Study|Non-compliance with study medication|21|||
44198976|NCT02064439|78994510|FG001|Overall Study|Non-compliance with study medication|19|||
44198977|NCT02064439|78994511|FG002|Overall Study|Non-compliance with study medication|23|||
44198978|NCT02064439|78994509|FG000|Overall Study|Physician Decision|0|||
44198979|NCT02064439|78994510|FG001|Overall Study|Physician Decision|1|||
44198980|NCT02064439|78994511|FG002|Overall Study|Physician Decision|1|||
44198981|NCT02064439|78994509|FG000|Overall Study|Logistical difficulties|6|||
44198982|NCT02064439|78994510|FG001|Overall Study|Logistical difficulties|5|||
44198983|NCT02064439|78994511|FG002|Overall Study|Logistical difficulties|2|||
44198984|NCT02064439|78994509|FG000|Overall Study|Efficacy outcome reached|18|||
44198985|NCT02064439|78994510|FG001|Overall Study|Efficacy outcome reached|16|||
44198986|NCT02064439|78994511|FG002|Overall Study|Efficacy outcome reached|57|||
44198987|NCT02064439|78994509|FG000|Overall Study|Safety outcome reached|12|||
44198988|NCT02064439|78994510|FG001|Overall Study|Safety outcome reached|20|||
44198989|NCT02064439|78994511|FG002|Overall Study|Safety outcome reached|10|||
44198990|NCT02064439|78994509|FG000|Overall Study|Other|2|||
44198991|NCT02064439|78994510|FG001|Overall Study|Other|2|||
44198992|NCT02064439|78994511|FG002|Overall Study|Other|7|||
44198993|NCT02130557|78994521|FG000|Overall Study|Withdrawal by Subject|12|||
44198994|NCT02130557|78994522|FG001|Overall Study|Withdrawal by Subject|12|||
44198995|NCT02130557|78994521|FG000|Overall Study|Investigator Request|0|||
44198996|NCT02130557|78994522|FG001|Overall Study|Investigator Request|2|||
44198997|NCT02130557|78994521|FG000|Overall Study|Deceased|14|||
44198998|NCT02130557|78994522|FG001|Overall Study|Deceased|14|||
44198999|NCT02130557|78994521|FG000|Overall Study|Lost to Follow-up|6|||
44199000|NCT02130557|78994522|FG001|Overall Study|Lost to Follow-up|7|||
44199001|NCT02130557|78994521|FG000|Overall Study|Other|2|||
44199002|NCT02130557|78994522|FG001|Overall Study|Other|1|||
44199003|NCT02130557|78994521|FG000|Overall Study|Missing|2|||
44199004|NCT02130557|78994522|FG001|Overall Study|Missing|1|||
44199005|NCT01854645|78994533|FG000|Overall Study|Protocol-Specified Criteria|13|||
44199006|NCT01854645|78994534|FG001|Overall Study|Protocol-Specified Criteria|10|||
44199007|NCT01854645|78994535|FG002|Overall Study|Protocol-Specified Criteria|8|||
44199008|NCT01854645|78994536|FG003|Overall Study|Protocol-Specified Criteria|5|||
44199009|NCT01854645|78994537|FG004|Overall Study|Protocol-Specified Criteria|7|||
44199010|NCT01854645|78994533|FG000|Overall Study|Administrative Reasons / Missing|0|||
44199011|NCT01854645|78994534|FG001|Overall Study|Administrative Reasons / Missing|0|||
44199012|NCT01854645|78994535|FG002|Overall Study|Administrative Reasons / Missing|0|||
44199013|NCT01854645|78994536|FG003|Overall Study|Administrative Reasons / Missing|1|||
44199014|NCT01854645|78994537|FG004|Overall Study|Administrative Reasons / Missing|1|||
44199015|NCT01854645|78994533|FG000|Overall Study|Protocol Violation|3|||
44199016|NCT01854645|78994534|FG001|Overall Study|Protocol Violation|0|||
44199017|NCT01854645|78994535|FG002|Overall Study|Protocol Violation|5|||
44199018|NCT01854645|78994536|FG003|Overall Study|Protocol Violation|4|||
44199019|NCT01854645|78994537|FG004|Overall Study|Protocol Violation|1|||
44199020|NCT01854645|78994533|FG000|Overall Study|Lost to Follow-up|10|||
44199021|NCT01854645|78994534|FG001|Overall Study|Lost to Follow-up|7|||
44199022|NCT01854645|78994535|FG002|Overall Study|Lost to Follow-up|8|||
44199023|NCT01854645|78994536|FG003|Overall Study|Lost to Follow-up|5|||
44199024|NCT01854645|78994537|FG004|Overall Study|Lost to Follow-up|0|||
44199025|NCT01854645|78994533|FG000|Overall Study|Physician Decision|1|||
44199026|NCT01854645|78994534|FG001|Overall Study|Physician Decision|5|||
44199027|NCT01854645|78994535|FG002|Overall Study|Physician Decision|3|||
44199028|NCT01854645|78994536|FG003|Overall Study|Physician Decision|3|||
44199029|NCT01854645|78994537|FG004|Overall Study|Physician Decision|7|||
44199030|NCT01854645|78994533|FG000|Overall Study|Withdrawal by Subject|31|||
44199031|NCT01854645|78994534|FG001|Overall Study|Withdrawal by Subject|41|||
44199032|NCT01854645|78994535|FG002|Overall Study|Withdrawal by Subject|30|||
44199033|NCT01854645|78994536|FG003|Overall Study|Withdrawal by Subject|21|||
44199034|NCT01854645|78994537|FG004|Overall Study|Withdrawal by Subject|24|||
44199035|NCT01854645|78994533|FG000|Overall Study|Lack of Efficacy|7|||
44199036|NCT01854645|78994534|FG001|Overall Study|Lack of Efficacy|12|||
44199037|NCT01854645|78994535|FG002|Overall Study|Lack of Efficacy|9|||
44266660|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
44266661|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
44199038|NCT01854645|78994536|FG003|Overall Study|Lack of Efficacy|3|||
44199039|NCT01854645|78994537|FG004|Overall Study|Lack of Efficacy|9|||
44199040|NCT01854645|78994533|FG000|Overall Study|Adverse Event|33|||
44266662|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
44199041|NCT01854645|78994534|FG001|Overall Study|Adverse Event|31|||
44199042|NCT01854645|78994535|FG002|Overall Study|Adverse Event|19|||
44199043|NCT01854645|78994536|FG003|Overall Study|Adverse Event|20|||
44199044|NCT01854645|78994537|FG004|Overall Study|Adverse Event|11|||
44199045|NCT01825941|78994551|FG000|Overall Study|Lost to Follow-up|4|||
44199046|NCT01825941|78994552|FG001|Overall Study|Lost to Follow-up|1|||
44199047|NCT02064205|78994558|FG000|Overall Study|Withdrawal by Subject|1|||
44199048|NCT02090959|78994574|FG000|Overall Study|Withdrawal by Subject|10|||
44199049|NCT02090959|78994574|FG000|Overall Study|Adverse Event|1|||
44199050|NCT02090959|78994574|FG000|Overall Study|Investigator decision|2|||
44199051|NCT02090959|78994574|FG000|Overall Study|Study termination|6|||
44199052|NCT02090959|78994574|FG000|Overall Study|Enrolled but not treated|1|||
44199053|NCT02090959|78994574|FG000|Overall Study|Transfer for compassionate use medicine|4|||
44199054|NCT02090959|78994574|FG000|Overall Study|Move to medical need program|3|||
44199055|NCT02090959|78994574|FG000|Overall Study|Entered in to other study|34|||
44199056|NCT02090959|78994574|FG000|Overall Study|Switched to commercial supply|88|||
44199057|NCT02090959|78994574|FG000|Overall Study|Other than specified|2|||
44199058|NCT02044159|78994580|FG000|Overall Study|Consent declined (deferred consent)|2|||
44199059|NCT02044159|78994581|FG001|Overall Study|Consent declined (deferred consent)|4|||
44199060|NCT02044159|78994580|FG000|Overall Study|No longer eligible, drug not given|1|||
44199061|NCT02044159|78994581|FG001|Overall Study|No longer eligible, drug not given|0|||
44199062|NCT02044159|78994580|FG000|Overall Study|Nurse declined to give study drug|1|||
44199063|NCT02044159|78994581|FG001|Overall Study|Nurse declined to give study drug|0|||
44199064|NCT02090725|78994590|FG000|Overall Study|Withdrawal by Subject|1|||
44199065|NCT02090725|78994590|FG000|Overall Study|participants moved from area|3|||
44199066|NCT02180165|78994598|FG000|Overall Study|Not Treated|0|||
44199067|NCT02180165|78994599|FG001|Overall Study|Not Treated|0|||
44199068|NCT02180165|78994600|FG002|Overall Study|Not Treated|1|||
44199069|NCT02180165|78994601|FG003|Overall Study|Not Treated|0|||
44199070|NCT02180165|78994598|FG000|Overall Study|Adverse Event|7|||
44199071|NCT02180165|78994599|FG001|Overall Study|Adverse Event|0|||
44199072|NCT02180165|78994600|FG002|Overall Study|Adverse Event|18|||
44199073|NCT02180165|78994601|FG003|Overall Study|Adverse Event|3|||
44199074|NCT02180165|78994598|FG000|Overall Study|Lack of Efficacy|0|||
44199075|NCT02180165|78994599|FG001|Overall Study|Lack of Efficacy|1|||
44199076|NCT02180165|78994600|FG002|Overall Study|Lack of Efficacy|3|||
44199077|NCT02180165|78994601|FG003|Overall Study|Lack of Efficacy|2|||
44199078|NCT02180165|78994598|FG000|Overall Study|Physician Decision|1|||
44199079|NCT02180165|78994599|FG001|Overall Study|Physician Decision|0|||
44199080|NCT02180165|78994600|FG002|Overall Study|Physician Decision|5|||
44199081|NCT02180165|78994601|FG003|Overall Study|Physician Decision|0|||
44199082|NCT02180165|78994598|FG000|Overall Study|Withdrawal by Subject|3|||
44199083|NCT02180165|78994599|FG001|Overall Study|Withdrawal by Subject|0|||
44199084|NCT02180165|78994600|FG002|Overall Study|Withdrawal by Subject|2|||
44199085|NCT02180165|78994601|FG003|Overall Study|Withdrawal by Subject|1|||
44199086|NCT02155985|78994616|FG000|Overall Study|Withdrawal by Subject|0|||
44199087|NCT02155985|78994617|FG001|Overall Study|Withdrawal by Subject|0|||
44199088|NCT02155985|78994618|FG002|Overall Study|Withdrawal by Subject|1|||
44199089|NCT02155985|78994616|FG000|Overall Study|Lost to Follow-up|1|||
44199090|NCT02155985|78994617|FG001|Overall Study|Lost to Follow-up|0|||
44199091|NCT02155985|78994618|FG002|Overall Study|Lost to Follow-up|0|||
44199092|NCT02155829|78994628|FG000|Overall Study|Adverse Event|1|||
44361303|NCT00891202|79366962|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
44199093|NCT02155829|78994629|FG001|Overall Study|Adverse Event|0|||
44199094|NCT02155829|78994628|FG000|Overall Study|Withdrawal by Subject|3|||
44199095|NCT02155829|78994629|FG001|Overall Study|Withdrawal by Subject|3|||
44199096|NCT02155829|78994628|FG000|Overall Study|Protocol Violation|2|||
44199097|NCT02155829|78994629|FG001|Overall Study|Protocol Violation|0|||
44199098|NCT02129777|78994641|FG000|Double-Blind Period|Adverse Event|0|||
44199099|NCT02129777|78994642|FG001|Double-Blind Period|Adverse Event|0|||
44199100|NCT02129777|78994643|FG002|Double-Blind Period|Adverse Event|0|||
44199101|NCT02129777|78994644|FG003|Double-Blind Period|Adverse Event|0|||
44199102|NCT02129777|78994645|FG004|Double-Blind Period|Adverse Event|1|||
44199103|NCT02129777|78994646|FG005|Double-Blind Period|Adverse Event|0|||
44199104|NCT02129777|78994647|FG006|Double-Blind Period|Adverse Event|0|||
44199105|NCT02129777|78994641|FG000|Double-Blind Period|Lost to Follow-up|1|||
44199106|NCT02129777|78994642|FG001|Double-Blind Period|Lost to Follow-up|1|||
44199107|NCT02129777|78994643|FG002|Double-Blind Period|Lost to Follow-up|1|||
44199108|NCT02129777|78994644|FG003|Double-Blind Period|Lost to Follow-up|2|||
44199109|NCT02129777|78994645|FG004|Double-Blind Period|Lost to Follow-up|0|||
44199110|NCT02129777|78994646|FG005|Double-Blind Period|Lost to Follow-up|0|||
44199111|NCT02129777|78994647|FG006|Double-Blind Period|Lost to Follow-up|0|||
44199112|NCT02129777|78994641|FG000|Double-Blind Period|Withdrawal by Subject|2|||
44199113|NCT02129777|78994642|FG001|Double-Blind Period|Withdrawal by Subject|4|||
44199114|NCT02129777|78994643|FG002|Double-Blind Period|Withdrawal by Subject|3|||
44199115|NCT02129777|78994644|FG003|Double-Blind Period|Withdrawal by Subject|2|||
44199116|NCT02129777|78994645|FG004|Double-Blind Period|Withdrawal by Subject|3|||
44199117|NCT02129777|78994646|FG005|Double-Blind Period|Withdrawal by Subject|0|||
44199118|NCT02129777|78994647|FG006|Double-Blind Period|Withdrawal by Subject|0|||
44199119|NCT02129777|78994641|FG000|Double-Blind Period|Pregnancy|0|||
44199120|NCT02129777|78994642|FG001|Double-Blind Period|Pregnancy|0|||
44199121|NCT02129777|78994643|FG002|Double-Blind Period|Pregnancy|0|||
44199122|NCT02129777|78994644|FG003|Double-Blind Period|Pregnancy|0|||
44199123|NCT02129777|78994645|FG004|Double-Blind Period|Pregnancy|1|||
44199124|NCT02129777|78994646|FG005|Double-Blind Period|Pregnancy|0|||
44199125|NCT02129777|78994647|FG006|Double-Blind Period|Pregnancy|0|||
44199126|NCT02129777|78994641|FG000|Double-Blind Period|Lack of Efficacy|3|||
44199127|NCT02129777|78994642|FG001|Double-Blind Period|Lack of Efficacy|1|||
44199128|NCT02129777|78994643|FG002|Double-Blind Period|Lack of Efficacy|0|||
44199129|NCT02129777|78994644|FG003|Double-Blind Period|Lack of Efficacy|3|||
44199130|NCT02129777|78994645|FG004|Double-Blind Period|Lack of Efficacy|2|||
44199131|NCT02129777|78994646|FG005|Double-Blind Period|Lack of Efficacy|0|||
44199132|NCT02129777|78994647|FG006|Double-Blind Period|Lack of Efficacy|0|||
44199133|NCT02129777|78994641|FG000|Double-Blind Period|Other|1|||
44199134|NCT02129777|78994642|FG001|Double-Blind Period|Other|2|||
44199135|NCT02129777|78994643|FG002|Double-Blind Period|Other|0|||
44199136|NCT02129777|78994644|FG003|Double-Blind Period|Other|0|||
44199137|NCT02129777|78994645|FG004|Double-Blind Period|Other|0|||
44199138|NCT02129777|78994646|FG005|Double-Blind Period|Other|0|||
44199139|NCT02129777|78994647|FG006|Double-Blind Period|Other|0|||
44199140|NCT02129777|78994641|FG000|Open-Label Period|Lack of Efficacy|0|||
44199141|NCT02129777|78994642|FG001|Open-Label Period|Lack of Efficacy|0|||
44199142|NCT02129777|78994643|FG002|Open-Label Period|Lack of Efficacy|0|||
44199143|NCT02129777|78994644|FG003|Open-Label Period|Lack of Efficacy|0|||
44199144|NCT02129777|78994645|FG004|Open-Label Period|Lack of Efficacy|0|||
44199145|NCT02129777|78994646|FG005|Open-Label Period|Lack of Efficacy|0|||
44266663|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Other Medical|9|||
44266664|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Other Medical|5|||
44266665|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Disease Progression|4|||
44266666|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Disease Progression|2|||
44266667|NCT02107443|79178046|FG000|Overall Study|Withdrawal: Personal Issues|0|||
44266668|NCT02107443|79178047|FG001|Overall Study|Withdrawal: Personal Issues|3|||
44266669|NCT00559949|79178942|FG000|Overall Study|Progressive Disease during cycle 1|1|||
44266670|NCT00559949|79178942|FG000|Overall Study|Adverse Event|1|||
44266671|NCT00559949|79178942|FG000|Overall Study|Withdrawal by Subject|4|||
44361304|NCT00891202|79366959|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
44199146|NCT02129777|78994647|FG006|Open-Label Period|Lack of Efficacy|5|||
44199147|NCT02129777|78994641|FG000|Open-Label Period|Lost to Follow-up|0|||
44199148|NCT02129777|78994642|FG001|Open-Label Period|Lost to Follow-up|0|||
44199149|NCT02129777|78994643|FG002|Open-Label Period|Lost to Follow-up|0|||
44266672|NCT00559949|79178942|FG000|Overall Study|No disease evaluation per protocol|1|||
44451596|NCT00685373|79460477|FG000|Overall Study|Condition no longer requires study drug|1|||
44266673|NCT00559637|79178994|FG000|Overall Study|Adverse Event|22|||
44266674|NCT00559637|79178994|FG000|Overall Study|Withdrawal by Subject|4|||
44199150|NCT02129777|78994644|FG003|Open-Label Period|Lost to Follow-up|0|||
44199151|NCT02129777|78994645|FG004|Open-Label Period|Lost to Follow-up|0|||
44199152|NCT02129777|78994646|FG005|Open-Label Period|Lost to Follow-up|1|||
44199153|NCT02129777|78994647|FG006|Open-Label Period|Lost to Follow-up|1|||
44199154|NCT02129777|78994641|FG000|Open-Label Period|Withdrawal by Subject|0|||
44199155|NCT02129777|78994642|FG001|Open-Label Period|Withdrawal by Subject|0|||
44266675|NCT00559637|79178994|FG000|Overall Study|Protocol Violation|6|||
44266676|NCT00559637|79178994|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
44266677|NCT00559637|79178994|FG000|Overall Study|Failure to return|6|||
44266678|NCT00559637|79178994|FG000|Overall Study|Insufficient response|3|||
44266679|NCT00559637|79178994|FG000|Overall Study|Started requiring dialysis after month 7|2|||
44266680|NCT00559637|79178994|FG000|Overall Study|Suspected lung cancer|1|||
44266681|NCT00559637|79178994|FG000|Overall Study|Participation in another study|1|||
44266682|NCT00559637|79178994|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
44266683|NCT00559637|79178994|FG000|Overall Study|Change of center|1|||
44266684|NCT00559637|79178994|FG000|Overall Study|Change of home|1|||
44266685|NCT00559637|79178994|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
44266686|NCT02578641|79179067|FG000|Overall Study|Adverse Event|5|||
44266687|NCT02578641|79179068|FG001|Overall Study|Adverse Event|15|||
44266688|NCT02578641|79179067|FG000|Overall Study|Death|16|||
44266689|NCT02578641|79179068|FG001|Overall Study|Death|8|||
44266690|NCT02578641|79179067|FG000|Overall Study|Lost to Follow-up|0|||
44266691|NCT02578641|79179068|FG001|Overall Study|Lost to Follow-up|1|||
44266692|NCT02578641|79179067|FG000|Overall Study|Withdrawal by Subject|14|||
44266693|NCT02578641|79179068|FG001|Overall Study|Withdrawal by Subject|7|||
44266694|NCT02578641|79179067|FG000|Overall Study|Progressive Disease|69|||
44266695|NCT02578641|79179068|FG001|Overall Study|Progressive Disease|21|||
44266696|NCT02578641|79179067|FG000|Overall Study|No Study Drug|2|||
44266697|NCT02578641|79179068|FG001|Overall Study|No Study Drug|0|||
44266698|NCT02578641|79179067|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
44266699|NCT02578641|79179068|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
44266700|NCT02578641|79179067|FG000|Overall Study|Non-compliance with Study Schedule|1|||
44266701|NCT02578641|79179068|FG001|Overall Study|Non-compliance with Study Schedule|0|||
44266702|NCT02578641|79179067|FG000|Overall Study|Other|1|||
44266703|NCT02578641|79179068|FG001|Overall Study|Other|10|||
44266704|NCT02578641|79179067|FG000|Overall Study|Not treated|1|||
44266705|NCT02578641|79179068|FG001|Overall Study|Not treated|4|||
44266706|NCT02431260|79179096|FG000|Overall Study|Subject Decision|0|||
44266707|NCT02431260|79179097|FG001|Overall Study|Subject Decision|1|||
44266708|NCT02431260|79179098|FG002|Overall Study|Subject Decision|1|||
44266709|NCT02431260|79179099|FG003|Overall Study|Subject Decision|0|||
44266710|NCT02431260|79179100|FG004|Overall Study|Subject Decision|0|||
44266711|NCT02431260|79179101|FG005|Overall Study|Subject Decision|0|||
44266712|NCT02431260|79179102|FG006|Overall Study|Subject Decision|0|||
44266713|NCT02431260|79179103|FG007|Overall Study|Subject Decision|0|||
44266714|NCT02431260|79179104|FG008|Overall Study|Subject Decision|1|||
44266715|NCT02431260|79179105|FG009|Overall Study|Subject Decision|1|||
44266716|NCT02431260|79179106|FG010|Overall Study|Subject Decision|0|||
44266717|NCT02431260|79179107|FG011|Overall Study|Subject Decision|1|||
44266718|NCT02431260|79179108|FG012|Overall Study|Subject Decision|0|||
44266719|NCT02431260|79179109|FG013|Overall Study|Subject Decision|0|||
44266720|NCT02431260|79179096|FG000|Overall Study|Death|4|||
44266721|NCT02431260|79179097|FG001|Overall Study|Death|4|||
44266722|NCT02431260|79179098|FG002|Overall Study|Death|3|||
44266723|NCT02431260|79179099|FG003|Overall Study|Death|4|||
44266724|NCT02431260|79179100|FG004|Overall Study|Death|2|||
44266725|NCT02431260|79179101|FG005|Overall Study|Death|2|||
44266726|NCT02431260|79179102|FG006|Overall Study|Death|3|||
44266727|NCT02431260|79179103|FG007|Overall Study|Death|1|||
44266728|NCT02431260|79179104|FG008|Overall Study|Death|6|||
44266729|NCT02431260|79179105|FG009|Overall Study|Death|6|||
44266730|NCT02431260|79179106|FG010|Overall Study|Death|3|||
44266731|NCT02431260|79179107|FG011|Overall Study|Death|2|||
44266732|NCT02431260|79179108|FG012|Overall Study|Death|5|||
44266733|NCT02431260|79179109|FG013|Overall Study|Death|1|||
44266734|NCT02431260|79179096|FG000|Overall Study|Lost to Follow-up|0|||
44266735|NCT02431260|79179097|FG001|Overall Study|Lost to Follow-up|0|||
44266736|NCT02431260|79179098|FG002|Overall Study|Lost to Follow-up|0|||
44266737|NCT02431260|79179099|FG003|Overall Study|Lost to Follow-up|0|||
44266738|NCT02431260|79179100|FG004|Overall Study|Lost to Follow-up|0|||
44266739|NCT02431260|79179101|FG005|Overall Study|Lost to Follow-up|1|||
44266740|NCT02431260|79179102|FG006|Overall Study|Lost to Follow-up|0|||
44451597|NCT00685373|79460477|FG000|Overall Study|Lost to Follow-up|2|||
44266741|NCT02431260|79179103|FG007|Overall Study|Lost to Follow-up|0|||
44266742|NCT02431260|79179104|FG008|Overall Study|Lost to Follow-up|0|||
44266743|NCT02431260|79179105|FG009|Overall Study|Lost to Follow-up|0|||
44266744|NCT02431260|79179106|FG010|Overall Study|Lost to Follow-up|0|||
44266745|NCT02431260|79179107|FG011|Overall Study|Lost to Follow-up|0|||
44266746|NCT02431260|79179108|FG012|Overall Study|Lost to Follow-up|0|||
44266747|NCT02431260|79179109|FG013|Overall Study|Lost to Follow-up|0|||
44266748|NCT02431260|79179096|FG000|Overall Study|Study Terminated by the Sponsor|0|||
44266749|NCT02431260|79179097|FG001|Overall Study|Study Terminated by the Sponsor|0|||
44266750|NCT02431260|79179098|FG002|Overall Study|Study Terminated by the Sponsor|2|||
44266751|NCT02431260|79179099|FG003|Overall Study|Study Terminated by the Sponsor|1|||
44266752|NCT02431260|79179100|FG004|Overall Study|Study Terminated by the Sponsor|1|||
44266753|NCT02431260|79179101|FG005|Overall Study|Study Terminated by the Sponsor|0|||
44266754|NCT02431260|79179102|FG006|Overall Study|Study Terminated by the Sponsor|1|||
44266755|NCT02431260|79179103|FG007|Overall Study|Study Terminated by the Sponsor|2|||
44266756|NCT02431260|79179104|FG008|Overall Study|Study Terminated by the Sponsor|1|||
44266757|NCT02431260|79179105|FG009|Overall Study|Study Terminated by the Sponsor|1|||
44266758|NCT02431260|79179106|FG010|Overall Study|Study Terminated by the Sponsor|1|||
44266759|NCT02431260|79179107|FG011|Overall Study|Study Terminated by the Sponsor|0|||
44266760|NCT02431260|79179108|FG012|Overall Study|Study Terminated by the Sponsor|4|||
44266761|NCT02431260|79179109|FG013|Overall Study|Study Terminated by the Sponsor|0|||
44266762|NCT02431260|79179096|FG000|Overall Study|Physician Decision|0|||
44266763|NCT02431260|79179097|FG001|Overall Study|Physician Decision|0|||
44266764|NCT02431260|79179098|FG002|Overall Study|Physician Decision|0|||
44266765|NCT02431260|79179099|FG003|Overall Study|Physician Decision|0|||
44266766|NCT02431260|79179100|FG004|Overall Study|Physician Decision|0|||
44361305|NCT00891202|79366960|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
44361306|NCT00891202|79366961|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
44361307|NCT00891202|79366962|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
44361308|NCT01185509|79366972|FG000|Overall Study|Progression/Relapse|9|||
44361309|NCT01185509|79366973|FG001|Overall Study|Progression/Relapse|15|||
44361310|NCT01185509|79366972|FG000|Overall Study|Physician Decision|2|||
44361311|NCT01185509|79366973|FG001|Overall Study|Physician Decision|2|||
44361312|NCT01185509|79366972|FG000|Overall Study|Withdrawal by Subject|0|||
44361313|NCT01185509|79366973|FG001|Overall Study|Withdrawal by Subject|1|||
44361314|NCT01185509|79366972|FG000|Overall Study|Death|0|||
44361315|NCT01185509|79366973|FG001|Overall Study|Death|1|||
44361316|NCT01185509|79366972|FG000|Overall Study|Intercurrent Illness|0|||
44361317|NCT01185509|79366973|FG001|Overall Study|Intercurrent Illness|1|||
44361318|NCT00891046|79366985|FG000|Overall Study|Protocol Violation|1|||
44361319|NCT00891046|79366986|FG001|Overall Study|Protocol Violation|1|||
44361320|NCT00891046|79366987|FG002|Overall Study|Protocol Violation|0|||
44361321|NCT00891046|79366988|FG003|Overall Study|Protocol Violation|0|||
44361322|NCT00891046|79366989|FG004|Overall Study|Protocol Violation|1|||
44361323|NCT00891046|79366985|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
44361324|NCT00891046|79366986|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44361325|NCT00891046|79366987|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
44361326|NCT00891046|79366988|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
44361327|NCT00891046|79366989|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
44361328|NCT00891046|79366985|FG000|Overall Study|Administrative problems|0|||
44361329|NCT00891046|79366986|FG001|Overall Study|Administrative problems|0|||
44361330|NCT00891046|79366987|FG002|Overall Study|Administrative problems|0|||
44361331|NCT00891046|79366988|FG003|Overall Study|Administrative problems|0|||
44361332|NCT00891046|79366989|FG004|Overall Study|Administrative problems|1|||
44361333|NCT00891046|79366985|FG000|Overall Study|Participant no longer required drug|0|||
44361334|NCT00891046|79366986|FG001|Overall Study|Participant no longer required drug|2|||
44361335|NCT00891046|79366987|FG002|Overall Study|Participant no longer required drug|0|||
44361336|NCT00891046|79366988|FG003|Overall Study|Participant no longer required drug|0|||
44361337|NCT00891046|79366989|FG004|Overall Study|Participant no longer required drug|1|||
44361338|NCT00891046|79366985|FG000|Overall Study|Adverse Event|4|||
44361339|NCT00891046|79366986|FG001|Overall Study|Adverse Event|3|||
44361340|NCT00891046|79366987|FG002|Overall Study|Adverse Event|2|||
44361341|NCT00891046|79366988|FG003|Overall Study|Adverse Event|0|||
44361342|NCT00891046|79366989|FG004|Overall Study|Adverse Event|14|||
44361343|NCT00891046|79366985|FG000|Overall Study|Withdrawal by Subject|2|||
44361344|NCT00891046|79366986|FG001|Overall Study|Withdrawal by Subject|1|||
44361345|NCT00891046|79366987|FG002|Overall Study|Withdrawal by Subject|2|||
44361346|NCT00891046|79366988|FG003|Overall Study|Withdrawal by Subject|1|||
44361347|NCT00891046|79366989|FG004|Overall Study|Withdrawal by Subject|1|||
44361348|NCT00891046|79366985|FG000|Overall Study|Lost to Follow-up|0|||
44266767|NCT02431260|79179101|FG005|Overall Study|Physician Decision|1|||
44266768|NCT02431260|79179102|FG006|Overall Study|Physician Decision|0|||
44361349|NCT00891046|79366986|FG001|Overall Study|Lost to Follow-up|0|||
44361350|NCT00891046|79366987|FG002|Overall Study|Lost to Follow-up|0|||
44361351|NCT00891046|79366988|FG003|Overall Study|Lost to Follow-up|0|||
44361352|NCT00891046|79366989|FG004|Overall Study|Lost to Follow-up|1|||
44361353|NCT00889720|79367016|FG000|Overall Study|Withdrawal by Subject|4|||
44361354|NCT00889720|79367016|FG000|Overall Study|Other|4|||
44266769|NCT02431260|79179103|FG007|Overall Study|Physician Decision|0|||
44266770|NCT02431260|79179104|FG008|Overall Study|Physician Decision|0|||
44266771|NCT02431260|79179105|FG009|Overall Study|Physician Decision|0|||
44361355|NCT00880087|79367022|FG000|Overall Study|Lost to Follow-up|0|||
44266772|NCT02431260|79179106|FG010|Overall Study|Physician Decision|0|||
44266773|NCT02431260|79179107|FG011|Overall Study|Physician Decision|0|||
44266774|NCT02431260|79179108|FG012|Overall Study|Physician Decision|0|||
44266775|NCT02431260|79179109|FG013|Overall Study|Physician Decision|0|||
44266776|NCT02431260|79179096|FG000|Overall Study|Other Unspecified|0|||
44361356|NCT00880087|79367023|FG001|Overall Study|Lost to Follow-up|2|||
44361357|NCT00889252|79367031|FG000|Overall Study|Adverse Event|2|||
44361358|NCT00889252|79367032|FG001|Overall Study|Adverse Event|4|||
44266777|NCT02431260|79179097|FG001|Overall Study|Other Unspecified|0|||
44266778|NCT02431260|79179098|FG002|Overall Study|Other Unspecified|0|||
44266779|NCT02431260|79179099|FG003|Overall Study|Other Unspecified|0|||
44266780|NCT02431260|79179100|FG004|Overall Study|Other Unspecified|0|||
44266781|NCT02431260|79179101|FG005|Overall Study|Other Unspecified|0|||
44266782|NCT02431260|79179102|FG006|Overall Study|Other Unspecified|0|||
44266783|NCT02431260|79179103|FG007|Overall Study|Other Unspecified|0|||
44266784|NCT02431260|79179104|FG008|Overall Study|Other Unspecified|0|||
44266785|NCT02431260|79179105|FG009|Overall Study|Other Unspecified|0|||
44266786|NCT02431260|79179106|FG010|Overall Study|Other Unspecified|0|||
44266787|NCT02431260|79179107|FG011|Overall Study|Other Unspecified|1|||
44266788|NCT02431260|79179108|FG012|Overall Study|Other Unspecified|1|||
44266789|NCT02431260|79179109|FG013|Overall Study|Other Unspecified|0|||
44266790|NCT02430870|79179304|FG000|Part 2|Voluntary Withdrawal|0|||
44266791|NCT02430870|79179305|FG001|Part 2|Voluntary Withdrawal|0|||
44266792|NCT02430870|79179306|FG002|Part 2|Voluntary Withdrawal|0|||
44266793|NCT02430870|79179307|FG003|Part 2|Voluntary Withdrawal|0|||
44266794|NCT02430870|79179308|FG004|Part 2|Voluntary Withdrawal|0|||
44266795|NCT02430870|79179309|FG005|Part 2|Voluntary Withdrawal|0|||
44266796|NCT02430870|79179310|FG006|Part 2|Voluntary Withdrawal|1|||
44266797|NCT02430870|79179311|FG007|Part 2|Voluntary Withdrawal|0|||
44266798|NCT02430870|79179304|FG000|Part 2|Other Reason Not Specified|0|||
44266799|NCT02430870|79179305|FG001|Part 2|Other Reason Not Specified|0|||
44266800|NCT02430870|79179306|FG002|Part 2|Other Reason Not Specified|0|||
44266801|NCT02430870|79179307|FG003|Part 2|Other Reason Not Specified|0|||
44266802|NCT02430870|79179308|FG004|Part 2|Other Reason Not Specified|0|||
44266803|NCT02430870|79179309|FG005|Part 2|Other Reason Not Specified|0|||
44266804|NCT02430870|79179310|FG006|Part 2|Other Reason Not Specified|0|||
44266805|NCT02430870|79179311|FG007|Part 2|Other Reason Not Specified|1|||
44266806|NCT02429934|79179377|FG000|Overall Study|Withdrawal by Subject|0|||
44361359|NCT00889252|79367031|FG000|Overall Study|Withdrawal by Subject|3|||
44199156|NCT02129777|78994643|FG002|Open-Label Period|Withdrawal by Subject|0|||
44199157|NCT02129777|78994644|FG003|Open-Label Period|Withdrawal by Subject|0|||
44199158|NCT02129777|78994645|FG004|Open-Label Period|Withdrawal by Subject|0|||
44199159|NCT02129777|78994646|FG005|Open-Label Period|Withdrawal by Subject|1|||
44199160|NCT02129777|78994647|FG006|Open-Label Period|Withdrawal by Subject|3|||
44199161|NCT02129777|78994641|FG000|Open-Label Period|Study Termination|0|||
44266807|NCT02429934|79179378|FG001|Overall Study|Withdrawal by Subject|2|||
44266808|NCT02429934|79179377|FG000|Overall Study|Adverse Event|2|||
44266809|NCT02429934|79179378|FG001|Overall Study|Adverse Event|0|||
44266810|NCT02429934|79179377|FG000|Overall Study|Lost to Follow-up|1|||
44266811|NCT02429934|79179378|FG001|Overall Study|Lost to Follow-up|1|||
44266812|NCT02429934|79179377|FG000|Overall Study|Physician Decision|1|||
44266813|NCT02429934|79179378|FG001|Overall Study|Physician Decision|0|||
44361360|NCT00889252|79367032|FG001|Overall Study|Withdrawal by Subject|0|||
44199162|NCT02129777|78994642|FG001|Open-Label Period|Study Termination|0|||
44199163|NCT02129777|78994643|FG002|Open-Label Period|Study Termination|0|||
44361361|NCT00889252|79367031|FG000|Overall Study|Protocol Violation|2|||
44199164|NCT02129777|78994644|FG003|Open-Label Period|Study Termination|0|||
44199165|NCT02129777|78994645|FG004|Open-Label Period|Study Termination|0|||
44266814|NCT02429856|79179392|FG000|Overall Study|Death|12|||
44266815|NCT02429856|79179393|FG001|Overall Study|Death|13|||
44266816|NCT02429856|79179392|FG000|Overall Study|Lost to Follow-up|6|||
44266817|NCT02429856|79179393|FG001|Overall Study|Lost to Follow-up|5|||
44266818|NCT02429856|79179392|FG000|Overall Study|Withdrawal by Subject|1|||
44199166|NCT02129777|78994646|FG005|Open-Label Period|Study Termination|10|||
44199167|NCT02129777|78994647|FG006|Open-Label Period|Study Termination|39|||
44199168|NCT02178995|78994668|FG000|Double Blind|Adverse Event|0|||
44199169|NCT02178995|78994669|FG001|Double Blind|Adverse Event|0|||
44199170|NCT02178995|78994670|FG002|Double Blind|Adverse Event|0|||
44199171|NCT02178995|78994671|FG003|Double Blind|Adverse Event|0|||
44199172|NCT02178995|78994672|FG004|Double Blind|Adverse Event|0|||
44199173|NCT02178995|78994673|FG005|Double Blind|Adverse Event|1|||
44199174|NCT02178995|78994674|FG006|Double Blind|Adverse Event|0|||
44199175|NCT02178995|78994675|FG007|Double Blind|Adverse Event|1|||
44199176|NCT02178995|78994676|FG008|Double Blind|Adverse Event|1|||
44199177|NCT02178995|78994668|FG000|Double Blind|Lost to Follow-up|0|||
44199178|NCT02178995|78994669|FG001|Double Blind|Lost to Follow-up|1|||
44266819|NCT02429856|79179393|FG001|Overall Study|Withdrawal by Subject|1|||
44266820|NCT02429778|79179403|FG000|Overall Study|Lost to Follow-up|2|||
44266821|NCT02429778|79179404|FG001|Overall Study|Lost to Follow-up|0|||
44266822|NCT02429778|79179403|FG000|Overall Study|Withdrawal by Subject|5|||
44266823|NCT02429778|79179404|FG001|Overall Study|Withdrawal by Subject|0|||
44266824|NCT02403180|79179412|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
44266825|NCT02403180|79179413|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
44266826|NCT02403180|79179412|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
44266827|NCT02403180|79179413|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
44266828|NCT00558467|79179447|FG000|Overall Study|Adverse Event|1|||
44266829|NCT00558467|79179448|FG001|Overall Study|Adverse Event|2|||
44199179|NCT02178995|78994670|FG002|Double Blind|Lost to Follow-up|0|||
44199180|NCT02178995|78994671|FG003|Double Blind|Lost to Follow-up|0|||
44199181|NCT02178995|78994672|FG004|Double Blind|Lost to Follow-up|0|||
44199182|NCT02178995|78994673|FG005|Double Blind|Lost to Follow-up|0|||
44199183|NCT02178995|78994674|FG006|Double Blind|Lost to Follow-up|0|||
44199184|NCT02178995|78994675|FG007|Double Blind|Lost to Follow-up|1|||
44199185|NCT02178995|78994676|FG008|Double Blind|Lost to Follow-up|0|||
44199186|NCT02178995|78994668|FG000|Open Label|Adverse Event|2|||
44199187|NCT02178995|78994669|FG001|Open Label|Adverse Event|0|||
44199188|NCT02178995|78994670|FG002|Open Label|Adverse Event|0|||
44199189|NCT02178995|78994671|FG003|Open Label|Adverse Event|0|||
44199190|NCT02178995|78994672|FG004|Open Label|Adverse Event|0|||
44199191|NCT02178995|78994673|FG005|Open Label|Adverse Event|0|||
44199192|NCT02178995|78994674|FG006|Open Label|Adverse Event|0|||
44199193|NCT02178995|78994675|FG007|Open Label|Adverse Event|0|||
44199194|NCT02178995|78994676|FG008|Open Label|Adverse Event|0|||
44199195|NCT02128997|78994702|FG000|Overall Study|Lost to Follow-up|6|||
44199196|NCT02128997|78994703|FG001|Overall Study|Lost to Follow-up|11|||
44199197|NCT02155283|78994709|FG000|Overall Study|Lost to Follow-up|3|||
44199198|NCT02155283|78994709|FG000|Overall Study|Withdrawal by Subject|1|||
44199199|NCT02155283|78994709|FG000|Overall Study|Protocol Violation|3|||
44199200|NCT02154581|78994715|FG000|Overall Study|Lost to Follow-up|7|||
44199201|NCT02154581|78994716|FG001|Overall Study|Lost to Follow-up|8|||
44199202|NCT02154425|78994724|FG000|Screening Period|Adverse Event|1|||
44199203|NCT02154347|78994734|FG000|Double-blind Period|Adverse Event|1|||
44199204|NCT02154347|78994735|FG001|Double-blind Period|Adverse Event|2|||
44199205|NCT02154347|78994734|FG000|Double-blind Period|Lack of Efficacy|1|||
44199206|NCT02154347|78994735|FG001|Double-blind Period|Lack of Efficacy|0|||
44199207|NCT02154347|78994734|FG000|Double-blind Period|Physician Decision|0|||
44199208|NCT02154347|78994735|FG001|Double-blind Period|Physician Decision|1|||
44199209|NCT02154347|78994734|FG000|Double-blind Period|Withdrawal by Subject|1|||
44199210|NCT02154347|78994735|FG001|Double-blind Period|Withdrawal by Subject|1|||
44199211|NCT02154347|78994734|FG000|Open-label Period|Adverse Event|3|||
44199212|NCT02154347|78994735|FG001|Open-label Period|Adverse Event|4|||
44199213|NCT02154347|78994734|FG000|Open-label Period|Lack of Efficacy|4|||
44199214|NCT02154347|78994735|FG001|Open-label Period|Lack of Efficacy|19|||
44199215|NCT02154347|78994734|FG000|Open-label Period|Protocol Violation|0|||
44199216|NCT02154347|78994735|FG001|Open-label Period|Protocol Violation|1|||
44266830|NCT00558467|79179447|FG000|Overall Study|Lack of Efficacy|0|||
44361362|NCT00889252|79367032|FG001|Overall Study|Protocol Violation|0|||
44199217|NCT02154347|78994734|FG000|Open-label Period|Withdrawal by Subject|0|||
44199218|NCT02154347|78994735|FG001|Open-label Period|Withdrawal by Subject|1|||
44199219|NCT01627067|78994742|FG000|Overall Study|Screen Failure|1|||
44199220|NCT02178059|78994748|FG000|Washout|Physician Decision|1|||
44451598|NCT00685373|79460477|FG000|Overall Study|Protocol Violation|1|||
44199221|NCT02178059|78994749|FG001|Washout|Physician Decision|0|||
44199222|NCT01626989|78994755|FG000|Screening Period|Screen Failure|15|||
44199223|NCT01626989|78994756|FG001|Screening Period|Screen Failure|0|||
44199224|NCT01626989|78994757|FG002|Screening Period|Screen Failure|0|||
44199225|NCT01626989|78994755|FG000|Screening Period|Withdrawal by Subject|2|||
44199226|NCT01626989|78994756|FG001|Screening Period|Withdrawal by Subject|0|||
44266831|NCT00558467|79179448|FG001|Overall Study|Lack of Efficacy|1|||
44266832|NCT00558467|79179447|FG000|Overall Study|Patient moving out of state|0|||
44199227|NCT01626989|78994757|FG002|Screening Period|Withdrawal by Subject|0|||
44199228|NCT02128217|78994768|FG000|Overall Study|Lost to Follow-up|0|||
44199229|NCT02128217|78994769|FG001|Overall Study|Lost to Follow-up|1|||
44199230|NCT01629953|78994782|FG000|Overall Study|Death|3|||
44199231|NCT01629953|78994783|FG001|Overall Study|Death|1|||
44199232|NCT01629953|78994782|FG000|Overall Study|Lost to Follow-up|10|||
44199233|NCT01629953|78994783|FG001|Overall Study|Lost to Follow-up|14|||
44199234|NCT02127281|78994791|FG000|Overall Study|Lost to Follow-up|1|||
44199235|NCT02127281|78994792|FG001|Overall Study|Lost to Follow-up|0|||
44199236|NCT01628549|78994802|FG000|Overall Study|Adverse Event|1|||
44199237|NCT01628549|78994803|FG001|Overall Study|Adverse Event|1|||
44199238|NCT01628549|78994804|FG002|Overall Study|Adverse Event|0|||
44199239|NCT01628549|78994805|FG003|Overall Study|Adverse Event|4|||
44199240|NCT01628549|78994802|FG000|Overall Study|Lost to Follow-up|3|||
44199241|NCT01628549|78994803|FG001|Overall Study|Lost to Follow-up|4|||
44199242|NCT01628549|78994804|FG002|Overall Study|Lost to Follow-up|3|||
44199243|NCT01628549|78994805|FG003|Overall Study|Lost to Follow-up|3|||
44199244|NCT01628549|78994802|FG000|Overall Study|Withdrawal by Subject|3|||
44199245|NCT01628549|78994803|FG001|Overall Study|Withdrawal by Subject|4|||
44199246|NCT01628549|78994804|FG002|Overall Study|Withdrawal by Subject|4|||
44199247|NCT01628549|78994805|FG003|Overall Study|Withdrawal by Subject|1|||
44199248|NCT01628549|78994802|FG000|Overall Study|Protocol Violation|2|||
44199249|NCT01628549|78994803|FG001|Overall Study|Protocol Violation|1|||
44199250|NCT01628549|78994804|FG002|Overall Study|Protocol Violation|1|||
44199251|NCT01628549|78994805|FG003|Overall Study|Protocol Violation|0|||
44199252|NCT01628549|78994802|FG000|Overall Study|withdrawn for noncompliance|0|||
44199253|NCT01628549|78994803|FG001|Overall Study|withdrawn for noncompliance|2|||
44199254|NCT01628549|78994804|FG002|Overall Study|withdrawn for noncompliance|1|||
44199255|NCT01628549|78994805|FG003|Overall Study|withdrawn for noncompliance|0|||
44199256|NCT01628549|78994802|FG000|Overall Study|abnormal laboratory test results|0|||
44199257|NCT01628549|78994803|FG001|Overall Study|abnormal laboratory test results|0|||
44199258|NCT01628549|78994804|FG002|Overall Study|abnormal laboratory test results|1|||
44199259|NCT01628549|78994805|FG003|Overall Study|abnormal laboratory test results|0|||
44199260|NCT01628549|78994802|FG000|Overall Study|positive pregnancy test|0|||
44199261|NCT01628549|78994803|FG001|Overall Study|positive pregnancy test|0|||
44199262|NCT01628549|78994804|FG002|Overall Study|positive pregnancy test|0|||
44199263|NCT01628549|78994805|FG003|Overall Study|positive pregnancy test|1|||
44199264|NCT02127125|78994824|FG000|Overall Study|Lost to Follow-up|0|||
44199265|NCT02127125|78994825|FG001|Overall Study|Lost to Follow-up|0|||
44199266|NCT02127125|78994826|FG002|Overall Study|Lost to Follow-up|0|||
44199267|NCT02127125|78994827|FG003|Overall Study|Lost to Follow-up|0|||
44199268|NCT02127125|78994828|FG004|Overall Study|Lost to Follow-up|2|||
44199269|NCT02127125|78994829|FG005|Overall Study|Lost to Follow-up|1|||
44199270|NCT02127125|78994830|FG006|Overall Study|Lost to Follow-up|0|||
44199271|NCT02127125|78994831|FG007|Overall Study|Lost to Follow-up|0|||
44199272|NCT02127125|78994832|FG008|Overall Study|Lost to Follow-up|0|||
44199273|NCT02127125|78994824|FG000|Overall Study|Withdrawal by Subject|0|||
44199274|NCT02127125|78994825|FG001|Overall Study|Withdrawal by Subject|0|||
44199275|NCT02127125|78994826|FG002|Overall Study|Withdrawal by Subject|0|||
44199276|NCT02127125|78994827|FG003|Overall Study|Withdrawal by Subject|1|||
44199277|NCT02127125|78994828|FG004|Overall Study|Withdrawal by Subject|0|||
44199278|NCT02127125|78994829|FG005|Overall Study|Withdrawal by Subject|0|||
44199279|NCT02127125|78994830|FG006|Overall Study|Withdrawal by Subject|0|||
44199280|NCT02127125|78994831|FG007|Overall Study|Withdrawal by Subject|0|||
44199281|NCT02127125|78994832|FG008|Overall Study|Withdrawal by Subject|0|||
44199282|NCT02127125|78994824|FG000|Overall Study|Physician Decision|0|||
44199283|NCT02127125|78994825|FG001|Overall Study|Physician Decision|0|||
44199284|NCT02127125|78994826|FG002|Overall Study|Physician Decision|1|||
44199285|NCT02127125|78994827|FG003|Overall Study|Physician Decision|0|||
44199286|NCT02127125|78994828|FG004|Overall Study|Physician Decision|1|||
44199287|NCT02127125|78994829|FG005|Overall Study|Physician Decision|2|||
44199288|NCT02127125|78994830|FG006|Overall Study|Physician Decision|0|||
44199289|NCT02127125|78994831|FG007|Overall Study|Physician Decision|0|||
44199290|NCT02127125|78994832|FG008|Overall Study|Physician Decision|0|||
44451599|NCT00684515|79460484|FG000|Overall Study|Adverse Event|3|||
44451600|NCT00684515|79460485|FG001|Overall Study|Adverse Event|3|||
44199291|NCT02090413|78994855|FG000|Overall Study|Adverse Event|11|||
44199292|NCT02090413|78994856|FG001|Overall Study|Adverse Event|15|||
44199293|NCT02090413|78994857|FG002|Overall Study|Adverse Event|20|||
44199294|NCT02090413|78994855|FG000|Overall Study|Flushing event|2|||
44199295|NCT02090413|78994856|FG001|Overall Study|Flushing event|0|||
44199296|NCT02090413|78994857|FG002|Overall Study|Flushing event|1|||
44199297|NCT02090413|78994855|FG000|Overall Study|Withdrawal by Subject|2|||
44199298|NCT02090413|78994856|FG001|Overall Study|Withdrawal by Subject|2|||
44361363|NCT01110330|79367041|FG000|Overall Study|Adverse Event|0|||
44199299|NCT02090413|78994857|FG002|Overall Study|Withdrawal by Subject|2|||
44199300|NCT02090413|78994855|FG000|Overall Study|Investigator Decision|1|||
44199301|NCT02090413|78994856|FG001|Overall Study|Investigator Decision|1|||
44199302|NCT02090413|78994857|FG002|Overall Study|Investigator Decision|0|||
44199303|NCT02090413|78994855|FG000|Overall Study|Other|2|||
44199304|NCT02090413|78994856|FG001|Overall Study|Other|1|||
44199305|NCT02090413|78994857|FG002|Overall Study|Other|0|||
44199306|NCT02090413|78994855|FG000|Overall Study|Lost to Follow-up|1|||
44199307|NCT02090413|78994856|FG001|Overall Study|Lost to Follow-up|1|||
44199308|NCT02090413|78994857|FG002|Overall Study|Lost to Follow-up|0|||
44199309|NCT02063737|78994868|FG000|Overall Study|Lost to Follow-up|11|||
44199310|NCT02063737|78994869|FG001|Overall Study|Lost to Follow-up|4|||
44199311|NCT02125877|78994877|FG000|Overall Study|Physician Decision|1|||
44199312|NCT02125877|78994878|FG001|Overall Study|Physician Decision|0|||
44199313|NCT02125877|78994877|FG000|Overall Study|Death|0|||
44199314|NCT02125877|78994878|FG001|Overall Study|Death|1|||
44199315|NCT02125877|78994877|FG000|Overall Study|Administrative problems|0|||
44199316|NCT02125877|78994878|FG001|Overall Study|Administrative problems|1|||
44199317|NCT02125877|78994877|FG000|Overall Study|Participant/guardian decision|0|||
44199318|NCT02125877|78994878|FG001|Overall Study|Participant/guardian decision|2|||
44199319|NCT02125877|78994877|FG000|Overall Study|Withdrawal by Subject|2|||
44199320|NCT02125877|78994878|FG001|Overall Study|Withdrawal by Subject|1|||
44199321|NCT02125877|78994877|FG000|Overall Study|Protocol deviation|4|||
44199322|NCT02125877|78994878|FG001|Overall Study|Protocol deviation|1|||
44199323|NCT02125877|78994877|FG000|Overall Study|Adverse Event|6|||
44199324|NCT02125877|78994878|FG001|Overall Study|Adverse Event|4|||
44199325|NCT01598987|78994884|FG000|Baseline to Month 12|Administrative problems|2|||
44199326|NCT01598987|78994884|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
44199327|NCT01598987|78994884|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
44199328|NCT01598987|78994884|FG000|Baseline to 24 Month|Administrative problems|2|||
44199329|NCT01598987|78994884|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
44199330|NCT02063659|78994898|FG000|Double-Blind Treatment Period|Adverse Event|1|||
44199331|NCT02063659|78994899|FG001|Double-Blind Treatment Period|Adverse Event|2|||
44199332|NCT02063659|78994900|FG002|Double-Blind Treatment Period|Adverse Event|0|||
44199333|NCT02063659|78994901|FG003|Double-Blind Treatment Period|Adverse Event|0|||
44199334|NCT02063659|78994898|FG000|Double-Blind Treatment Period|Physician Decision|1|||
44199335|NCT02063659|78994899|FG001|Double-Blind Treatment Period|Physician Decision|0|||
44199336|NCT02063659|78994900|FG002|Double-Blind Treatment Period|Physician Decision|0|||
44199337|NCT02063659|78994901|FG003|Double-Blind Treatment Period|Physician Decision|0|||
44199338|NCT02063659|78994898|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
44199339|NCT02063659|78994899|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
44199340|NCT02063659|78994900|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
44199341|NCT02063659|78994901|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
44199342|NCT02063659|78994898|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
44199343|NCT02063659|78994899|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
44199344|NCT02063659|78994900|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
44199345|NCT02063659|78994901|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
44199346|NCT02063659|78994898|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
44199347|NCT02063659|78994899|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
44199348|NCT02063659|78994900|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
44199349|NCT02063659|78994901|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
44199350|NCT02063659|78994898|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
44199351|NCT02063659|78994899|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
44199352|NCT02063659|78994900|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
44199353|NCT02063659|78994901|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
44199354|NCT02063659|78994898|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
44199355|NCT02063659|78994899|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
44199356|NCT02063659|78994900|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
44199357|NCT02063659|78994901|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
44199358|NCT02063659|78994898|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
44199359|NCT02063659|78994899|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
44199360|NCT02063659|78994900|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
44199361|NCT02063659|78994901|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
44199362|NCT02062879|78994917|FG000|Overall Study|Withdrawal by Subject|4|||
44199363|NCT02062879|78994918|FG001|Overall Study|Withdrawal by Subject|1|||
44199364|NCT02062645|78994924|FG000|Overall Study|Adverse Event|2|||
44199365|NCT02062645|78994924|FG000|Overall Study|Protocol Violation|8|||
44199366|NCT02062645|78994924|FG000|Overall Study|Lost to Follow-up|5|||
44199367|NCT02088697|78994930|FG000|Period I|Physician Decision|1|||
44199368|NCT02088697|78994931|FG001|Period I|Physician Decision|4|||
44199369|NCT02088697|78994930|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
44199370|NCT02088697|78994931|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
44199371|NCT01825785|78994944|FG000|Overall Study|Adverse Event|0|||
44199372|NCT01825785|78994945|FG001|Overall Study|Adverse Event|0|||
44199373|NCT01825785|78994946|FG002|Overall Study|Adverse Event|0|||
44199374|NCT01825785|78994947|FG003|Overall Study|Adverse Event|0|||
44199375|NCT01825785|78994948|FG004|Overall Study|Adverse Event|1|||
44199376|NCT01825785|78994949|FG005|Overall Study|Adverse Event|0|||
44199377|NCT01825785|78994950|FG006|Overall Study|Adverse Event|0|||
44199378|NCT01825785|78994944|FG000|Overall Study|Withdrawal by Subject|0|||
44199379|NCT01825785|78994945|FG001|Overall Study|Withdrawal by Subject|0|||
44199380|NCT01825785|78994946|FG002|Overall Study|Withdrawal by Subject|0|||
44199381|NCT01825785|78994947|FG003|Overall Study|Withdrawal by Subject|0|||
44199382|NCT01825785|78994948|FG004|Overall Study|Withdrawal by Subject|1|||
44199383|NCT01825785|78994949|FG005|Overall Study|Withdrawal by Subject|1|||
44199384|NCT01825785|78994950|FG006|Overall Study|Withdrawal by Subject|0|||
44199385|NCT02043301|78994975|FG000|Overall Study|Discontinued|0|||
44199386|NCT02043301|78994976|FG001|Overall Study|Discontinued|1|||
44199387|NCT02043301|78994977|FG002|Overall Study|Discontinued|0|||
44199388|NCT01598753|78994989|FG000|Overall Study|Adverse Event|1|||
44199389|NCT01598753|78994990|FG001|Overall Study|Adverse Event|9|||
44199390|NCT01598753|78994991|FG002|Overall Study|Adverse Event|1|||
44199391|NCT01598753|78994992|FG003|Overall Study|Adverse Event|7|||
44199392|NCT01598753|78994989|FG000|Overall Study|Lost to Follow-up|4|||
44199393|NCT01598753|78994990|FG001|Overall Study|Lost to Follow-up|3|||
44199394|NCT01598753|78994991|FG002|Overall Study|Lost to Follow-up|7|||
44199395|NCT01598753|78994992|FG003|Overall Study|Lost to Follow-up|5|||
44199396|NCT01598753|78994989|FG000|Overall Study|Physician Decision|0|||
44199397|NCT01598753|78994990|FG001|Overall Study|Physician Decision|1|||
44199398|NCT01598753|78994991|FG002|Overall Study|Physician Decision|0|||
44199399|NCT01598753|78994992|FG003|Overall Study|Physician Decision|2|||
44199400|NCT01598753|78994989|FG000|Overall Study|Withdrawal by Subject|7|||
44199401|NCT01598753|78994990|FG001|Overall Study|Withdrawal by Subject|2|||
44199402|NCT01598753|78994991|FG002|Overall Study|Withdrawal by Subject|0|||
44199403|NCT01598753|78994992|FG003|Overall Study|Withdrawal by Subject|1|||
44199404|NCT02177123|78995002|FG000|Overall Study|Lost to Follow-up|6|||
44199405|NCT02177123|78995002|FG000|Overall Study|Withdrawal by Subject|4|||
44199406|NCT02177123|78995002|FG000|Overall Study|Adverse Event|4|||
44199407|NCT02177123|78995002|FG000|Overall Study|Physician Decision|3|||
44199408|NCT02177123|78995002|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
44199409|NCT02177123|78995002|FG000|Overall Study|Excluded for medical reasons|2|||
44199410|NCT02177123|78995002|FG000|Overall Study|Death|1|||
44199411|NCT02177123|78995002|FG000|Overall Study|Other|1|||
44199412|NCT02177123|78995002|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
44199413|NCT01824693|78995012|FG000|Overall Study|Death|0|||
44199414|NCT01824693|78995013|FG001|Overall Study|Death|1|||
44199415|NCT01824693|78995014|FG002|Overall Study|Death|0|||
44199416|NCT01824693|78995012|FG000|Overall Study|Physician Decision|1|||
44199417|NCT01824693|78995013|FG001|Overall Study|Physician Decision|1|||
44199418|NCT01824693|78995014|FG002|Overall Study|Physician Decision|1|||
44199419|NCT01824693|78995012|FG000|Overall Study|Withdrawal by Subject|0|||
44199420|NCT01824693|78995013|FG001|Overall Study|Withdrawal by Subject|0|||
44199421|NCT01824693|78995014|FG002|Overall Study|Withdrawal by Subject|1|||
44199422|NCT01824693|78995012|FG000|Overall Study|Progressive Disease|0|||
44199423|NCT01824693|78995013|FG001|Overall Study|Progressive Disease|5|||
44199424|NCT01824693|78995014|FG002|Overall Study|Progressive Disease|0|||
44199425|NCT01824693|78995012|FG000|Overall Study|Ineligible|0|||
44199426|NCT01824693|78995013|FG001|Overall Study|Ineligible|0|||
44199427|NCT01824693|78995014|FG002|Overall Study|Ineligible|3|||
44199428|NCT01824693|78995012|FG000|Overall Study|No Transplant Planned|0|||
44199429|NCT01824693|78995013|FG001|Overall Study|No Transplant Planned|0|||
44199430|NCT01824693|78995014|FG002|Overall Study|No Transplant Planned|10|||
44199431|NCT02176655|78995021|FG000|Overall Study|Subjects did not treat|6|||
44199432|NCT02125331|78995028|FG000|Overall Study|Protocol Violation|1|||
44199433|NCT02125331|78995029|FG001|Overall Study|Protocol Violation|0|||
44199434|NCT02125331|78995028|FG000|Overall Study|technical problem|2|||
44199435|NCT02125331|78995029|FG001|Overall Study|technical problem|0|||
44199436|NCT02125331|78995028|FG000|Overall Study|screen failure|2|||
44266833|NCT00558467|79179448|FG001|Overall Study|Patient moving out of state|1|||
44266834|NCT02402166|79179454|FG000|Overall Study|Adverse Event|2|||
44266835|NCT02402166|79179454|FG000|Overall Study|Withdrawal by Subject|2|||
44266836|NCT02402166|79179454|FG000|Overall Study|Lost to Follow-up|1|||
44266837|NCT02378220|79179474|FG000|Overall Study|Death|6|||
44266838|NCT02378220|79179475|FG001|Overall Study|Death|1|||
44266839|NCT02401308|79179484|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
44266840|NCT02401308|79179485|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
44199437|NCT02125331|78995029|FG001|Overall Study|screen failure|0|||
44266841|NCT02401230|79179494|FG000|Overall Study|Adverse Event|3|||
44266842|NCT02401230|79179495|FG001|Overall Study|Adverse Event|2|||
44361364|NCT01110330|79367042|FG001|Overall Study|Adverse Event|4|||
44199438|NCT01622569|78995039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
44199439|NCT01622569|78995040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
44199440|NCT01622569|78995041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
44199441|NCT01622569|78995042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
44199442|NCT01622569|78995039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
44199443|NCT01622569|78995040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
44199444|NCT01622569|78995041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
44199445|NCT01622569|78995042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
44199446|NCT01622569|78995039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
44199447|NCT01622569|78995040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
44199448|NCT01622569|78995041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
44199449|NCT01622569|78995042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
44199450|NCT01622569|78995039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
44199451|NCT01622569|78995040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
44199452|NCT01622569|78995041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
44199453|NCT01622569|78995042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
44199454|NCT01622569|78995039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
44199455|NCT01622569|78995040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
44199456|NCT01622569|78995041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
44199457|NCT01622569|78995042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
44199458|NCT01622569|78995039|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
44199459|NCT01622569|78995040|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
44199460|NCT01622569|78995041|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
44199461|NCT01622569|78995042|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
44199462|NCT01622569|78995039|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
44199463|NCT01622569|78995040|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
44199464|NCT01622569|78995041|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
44199465|NCT01622569|78995042|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
44199466|NCT01622569|78995039|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
44199467|NCT01622569|78995040|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
44199468|NCT01622569|78995041|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
44199469|NCT01622569|78995042|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
44199470|NCT01824303|78995064|FG000|Randomized Study|Withdrawal by Subject|1|||
44199471|NCT01824303|78995065|FG001|Randomized Study|Withdrawal by Subject|1|||
44199472|NCT01824303|78995064|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
44199473|NCT01824303|78995065|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
44199474|NCT01853397|78995077|FG000|Overall Study|Withdrawal by Subject|0|||
44199475|NCT01853397|78995078|FG001|Overall Study|Withdrawal by Subject|0|||
44199476|NCT01853397|78995079|FG002|Overall Study|Withdrawal by Subject|0|||
44199477|NCT01853397|78995080|FG003|Overall Study|Withdrawal by Subject|1|||
44199478|NCT01853397|78995077|FG000|Overall Study|Subject Noncompliance|0|||
44199479|NCT01853397|78995078|FG001|Overall Study|Subject Noncompliance|0|||
44199480|NCT01853397|78995079|FG002|Overall Study|Subject Noncompliance|0|||
44199481|NCT01853397|78995080|FG003|Overall Study|Subject Noncompliance|1|||
44199482|NCT02088073|78995095|FG000|Acute Phase|Withdrawal by Subject|5|||
44199483|NCT02088073|78995096|FG001|Acute Phase|Withdrawal by Subject|0|||
44199484|NCT02088073|78995097|FG002|Acute Phase|Withdrawal by Subject|0|||
44199485|NCT02088073|78995098|FG003|Acute Phase|Withdrawal by Subject|0|||
44199486|NCT02088073|78995099|FG004|Acute Phase|Withdrawal by Subject|0|||
44199487|NCT02088073|78995095|FG000|Acute Phase|Hyperkalemia|2|||
44199488|NCT02088073|78995096|FG001|Acute Phase|Hyperkalemia|0|||
44199489|NCT02088073|78995097|FG002|Acute Phase|Hyperkalemia|0|||
44199490|NCT02088073|78995098|FG003|Acute Phase|Hyperkalemia|0|||
44199491|NCT02088073|78995099|FG004|Acute Phase|Hyperkalemia|0|||
44199492|NCT02088073|78995095|FG000|Maintanance Phase|Withdrawal by Subject|0|||
44199493|NCT02088073|78995096|FG001|Maintanance Phase|Withdrawal by Subject|2|||
44199494|NCT02088073|78995097|FG002|Maintanance Phase|Withdrawal by Subject|0|||
44199495|NCT02088073|78995098|FG003|Maintanance Phase|Withdrawal by Subject|0|||
44199496|NCT02088073|78995099|FG004|Maintanance Phase|Withdrawal by Subject|0|||
44199497|NCT02088073|78995095|FG000|Maintanance Phase|Adverse Event|0|||
44199498|NCT02088073|78995096|FG001|Maintanance Phase|Adverse Event|0|||
44199499|NCT02088073|78995097|FG002|Maintanance Phase|Adverse Event|3|||
44199500|NCT02088073|78995098|FG003|Maintanance Phase|Adverse Event|0|||
44199501|NCT02088073|78995099|FG004|Maintanance Phase|Adverse Event|1|||
44199502|NCT02088073|78995095|FG000|Maintanance Phase|Physician Decision|0|||
44199503|NCT02088073|78995096|FG001|Maintanance Phase|Physician Decision|0|||
44199504|NCT02088073|78995097|FG002|Maintanance Phase|Physician Decision|0|||
44199505|NCT02088073|78995098|FG003|Maintanance Phase|Physician Decision|0|||
44199506|NCT02088073|78995099|FG004|Maintanance Phase|Physician Decision|1|||
44199507|NCT02088073|78995095|FG000|Maintanance Phase|Sponsor's decision|0|||
44199508|NCT02088073|78995096|FG001|Maintanance Phase|Sponsor's decision|2|||
44199509|NCT02088073|78995097|FG002|Maintanance Phase|Sponsor's decision|0|||
44199510|NCT02088073|78995098|FG003|Maintanance Phase|Sponsor's decision|2|||
44199511|NCT02088073|78995099|FG004|Maintanance Phase|Sponsor's decision|1|||
44199512|NCT02088073|78995095|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
44199513|NCT02088073|78995096|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
44199514|NCT02088073|78995097|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
44199515|NCT02088073|78995098|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
44199516|NCT02088073|78995099|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
44199517|NCT02088073|78995095|FG000|Maintanance Phase|Miscellaneous|0|||
44199518|NCT02088073|78995096|FG001|Maintanance Phase|Miscellaneous|2|||
44199519|NCT02088073|78995097|FG002|Maintanance Phase|Miscellaneous|1|||
44199520|NCT02088073|78995098|FG003|Maintanance Phase|Miscellaneous|2|||
44199521|NCT02088073|78995099|FG004|Maintanance Phase|Miscellaneous|1|||
44199522|NCT02088073|78995095|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
44199523|NCT02088073|78995096|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
44199524|NCT02088073|78995097|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
44199525|NCT02088073|78995098|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
44199526|NCT02088073|78995099|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
44199527|NCT02088073|78995095|FG000|Maintanance Phase|Subject compliance|0|||
44199528|NCT02088073|78995096|FG001|Maintanance Phase|Subject compliance|1|||
44199529|NCT02088073|78995097|FG002|Maintanance Phase|Subject compliance|0|||
44199530|NCT02088073|78995098|FG003|Maintanance Phase|Subject compliance|0|||
44199531|NCT02088073|78995099|FG004|Maintanance Phase|Subject compliance|0|||
44199532|NCT01823991|78995114|FG000|Overall Study|Withdrawal by Subject|8|||
44199533|NCT01823991|78995115|FG001|Overall Study|Withdrawal by Subject|5|||
44199534|NCT02087059|78995125|FG000|Overall Study|Disease Progression|1|||
44199535|NCT02087059|78995125|FG000|Overall Study|Adverse Event|5|||
44199536|NCT02087059|78995125|FG000|Overall Study|Lost to Follow-up|1|||
44199537|NCT02152163|78995131|FG000|Overall Study|Physician Decision|12|||
44199538|NCT02152163|78995132|FG001|Overall Study|Physician Decision|13|||
44199539|NCT02152007|78995138|FG000|Overall Study|Withdrawal by Subject|1|||
44199540|NCT02151851|78995145|FG000|Overall Study|Lack of Efficacy|67|||
44199541|NCT02151851|78995146|FG001|Overall Study|Lack of Efficacy|94|||
44199542|NCT02151851|78995145|FG000|Overall Study|Protocol Violation|0|||
44199543|NCT02151851|78995146|FG001|Overall Study|Protocol Violation|1|||
44199544|NCT02151851|78995145|FG000|Overall Study|Withdrawal by Subject|2|||
44199545|NCT02151851|78995146|FG001|Overall Study|Withdrawal by Subject|5|||
44199546|NCT02151851|78995145|FG000|Overall Study|Medical impairment|1|||
44199547|NCT02151851|78995146|FG001|Overall Study|Medical impairment|0|||
44199548|NCT02151851|78995145|FG000|Overall Study|Low compliance to study visits|0|||
44199549|NCT02151851|78995146|FG001|Overall Study|Low compliance to study visits|1|||
44199550|NCT02151851|78995145|FG000|Overall Study|Subject entered into study in error|0|||
44199551|NCT02151851|78995146|FG001|Overall Study|Subject entered into study in error|1|||
44199552|NCT02151851|78995145|FG000|Overall Study|Adverse Event|6|||
44199553|NCT02151851|78995146|FG001|Overall Study|Adverse Event|28|||
44199554|NCT02176421|78995152|FG000|Overall Study|Lost to Follow-up|4|||
44199555|NCT02176421|78995152|FG000|Overall Study|Adverse Event|1|||
44199556|NCT02042443|78995158|FG000|Overall Study|Adverse Event|2|||
44199557|NCT02042443|78995159|FG001|Overall Study|Adverse Event|1|||
44199558|NCT02042443|78995158|FG000|Overall Study|Withdrawal by Subject|0|||
44199559|NCT02042443|78995159|FG001|Overall Study|Withdrawal by Subject|1|||
44199560|NCT02042443|78995158|FG000|Overall Study|Progression|21|||
44199561|NCT02042443|78995159|FG001|Overall Study|Progression|17|||
44199562|NCT02042443|78995158|FG000|Overall Study|not protocol specified|1|||
44199563|NCT02042443|78995159|FG001|Overall Study|not protocol specified|1|||
44199564|NCT02042443|78995158|FG000|Overall Study|Not eligible/not analyzable|3|||
44199565|NCT02042443|78995159|FG001|Overall Study|Not eligible/not analyzable|6|||
44199566|NCT02118896|78995176|FG000|Overall Study|Death|4|||
44199567|NCT02118896|78995177|FG001|Overall Study|Death|0|||
44199568|NCT02118896|78995178|FG002|Overall Study|Death|4|||
44199569|NCT02118896|78995179|FG003|Overall Study|Death|6|||
44199570|NCT02118896|78995180|FG004|Overall Study|Death|3|||
44199571|NCT02118896|78995181|FG005|Overall Study|Death|1|||
44199572|NCT02118896|78995182|FG006|Overall Study|Death|0|||
44199573|NCT02118896|78995183|FG007|Overall Study|Death|0|||
44199574|NCT02118896|78995184|FG008|Overall Study|Death|0|||
44199575|NCT02118896|78995185|FG009|Overall Study|Death|0|||
44199576|NCT02118896|78995176|FG000|Overall Study|Adverse Event|5|||
44199577|NCT02118896|78995177|FG001|Overall Study|Adverse Event|4|||
44199578|NCT02118896|78995178|FG002|Overall Study|Adverse Event|4|||
44199579|NCT02118896|78995179|FG003|Overall Study|Adverse Event|5|||
44199580|NCT02118896|78995180|FG004|Overall Study|Adverse Event|5|||
44199581|NCT02118896|78995181|FG005|Overall Study|Adverse Event|9|||
44199582|NCT02118896|78995182|FG006|Overall Study|Adverse Event|1|||
44199583|NCT02118896|78995183|FG007|Overall Study|Adverse Event|1|||
44199584|NCT02118896|78995184|FG008|Overall Study|Adverse Event|4|||
44199585|NCT02118896|78995185|FG009|Overall Study|Adverse Event|0|||
44199586|NCT02118896|78995176|FG000|Overall Study|Consent withdrawn|2|||
44199587|NCT02118896|78995177|FG001|Overall Study|Consent withdrawn|0|||
44361365|NCT01110330|79367043|FG002|Overall Study|Adverse Event|3|||
44199588|NCT02118896|78995178|FG002|Overall Study|Consent withdrawn|3|||
44199589|NCT02118896|78995179|FG003|Overall Study|Consent withdrawn|4|||
44199590|NCT02118896|78995180|FG004|Overall Study|Consent withdrawn|1|||
44199591|NCT02118896|78995181|FG005|Overall Study|Consent withdrawn|4|||
44199592|NCT02118896|78995182|FG006|Overall Study|Consent withdrawn|0|||
44199593|NCT02118896|78995183|FG007|Overall Study|Consent withdrawn|0|||
44199594|NCT02118896|78995184|FG008|Overall Study|Consent withdrawn|0|||
44199595|NCT02118896|78995185|FG009|Overall Study|Consent withdrawn|0|||
44199596|NCT02118896|78995176|FG000|Overall Study|Non-compliance|2|||
44199597|NCT02118896|78995177|FG001|Overall Study|Non-compliance|1|||
44199598|NCT02118896|78995178|FG002|Overall Study|Non-compliance|1|||
44199599|NCT02118896|78995179|FG003|Overall Study|Non-compliance|5|||
44199600|NCT02118896|78995180|FG004|Overall Study|Non-compliance|0|||
44199601|NCT02118896|78995181|FG005|Overall Study|Non-compliance|1|||
44199602|NCT02118896|78995182|FG006|Overall Study|Non-compliance|0|||
44199603|NCT02118896|78995183|FG007|Overall Study|Non-compliance|1|||
44199604|NCT02118896|78995184|FG008|Overall Study|Non-compliance|0|||
44199605|NCT02118896|78995185|FG009|Overall Study|Non-compliance|0|||
44199606|NCT02118896|78995176|FG000|Overall Study|Pregnancy|1|||
44199607|NCT02118896|78995177|FG001|Overall Study|Pregnancy|1|||
44199608|NCT02118896|78995178|FG002|Overall Study|Pregnancy|0|||
44199609|NCT02118896|78995179|FG003|Overall Study|Pregnancy|0|||
44199610|NCT02118896|78995180|FG004|Overall Study|Pregnancy|1|||
44199611|NCT02118896|78995181|FG005|Overall Study|Pregnancy|3|||
44199612|NCT02118896|78995182|FG006|Overall Study|Pregnancy|1|||
44199613|NCT02118896|78995183|FG007|Overall Study|Pregnancy|0|||
44199614|NCT02118896|78995184|FG008|Overall Study|Pregnancy|0|||
44199615|NCT02118896|78995185|FG009|Overall Study|Pregnancy|0|||
44199616|NCT02118896|78995176|FG000|Overall Study|Lost to Follow-up|1|||
44199617|NCT02118896|78995177|FG001|Overall Study|Lost to Follow-up|2|||
44199618|NCT02118896|78995178|FG002|Overall Study|Lost to Follow-up|1|||
44199619|NCT02118896|78995179|FG003|Overall Study|Lost to Follow-up|0|||
44199620|NCT02118896|78995180|FG004|Overall Study|Lost to Follow-up|2|||
44199621|NCT02118896|78995181|FG005|Overall Study|Lost to Follow-up|1|||
44199622|NCT02118896|78995182|FG006|Overall Study|Lost to Follow-up|0|||
44199623|NCT02118896|78995183|FG007|Overall Study|Lost to Follow-up|0|||
44199624|NCT02118896|78995184|FG008|Overall Study|Lost to Follow-up|0|||
44199625|NCT02118896|78995185|FG009|Overall Study|Lost to Follow-up|0|||
44199626|NCT02118896|78995176|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
44199627|NCT02118896|78995177|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
44199628|NCT02118896|78995178|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
44199629|NCT02118896|78995179|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
44199630|NCT02118896|78995180|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
44199631|NCT02118896|78995181|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
44199632|NCT02118896|78995182|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
44199633|NCT02118896|78995183|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
44199634|NCT02118896|78995184|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
44199635|NCT02118896|78995185|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
44199636|NCT02118896|78995176|FG000|Overall Study|Prohibited medication|0|||
44199637|NCT02118896|78995177|FG001|Overall Study|Prohibited medication|0|||
44199638|NCT02118896|78995178|FG002|Overall Study|Prohibited medication|0|||
44199639|NCT02118896|78995179|FG003|Overall Study|Prohibited medication|0|||
44199640|NCT02118896|78995180|FG004|Overall Study|Prohibited medication|1|||
44199641|NCT02118896|78995181|FG005|Overall Study|Prohibited medication|3|||
44199642|NCT02118896|78995182|FG006|Overall Study|Prohibited medication|0|||
44199643|NCT02118896|78995183|FG007|Overall Study|Prohibited medication|0|||
44199644|NCT02118896|78995184|FG008|Overall Study|Prohibited medication|0|||
44199645|NCT02118896|78995185|FG009|Overall Study|Prohibited medication|0|||
44199646|NCT02118896|78995176|FG000|Overall Study|Miscellaneous|1|||
44199647|NCT02118896|78995177|FG001|Overall Study|Miscellaneous|2|||
44199648|NCT02118896|78995178|FG002|Overall Study|Miscellaneous|0|||
44199649|NCT02118896|78995179|FG003|Overall Study|Miscellaneous|2|||
44199650|NCT02118896|78995180|FG004|Overall Study|Miscellaneous|0|||
44199651|NCT02118896|78995181|FG005|Overall Study|Miscellaneous|4|||
44199652|NCT02118896|78995182|FG006|Overall Study|Miscellaneous|0|||
44199653|NCT02118896|78995183|FG007|Overall Study|Miscellaneous|0|||
44199654|NCT02118896|78995184|FG008|Overall Study|Miscellaneous|0|||
44199655|NCT02118896|78995185|FG009|Overall Study|Miscellaneous|0|||
44199656|NCT02124707|78995208|FG000|Overall Study|Adverse Event|5|||
44199657|NCT02124707|78995208|FG000|Overall Study|Physician Decision|1|||
44199658|NCT02124707|78995208|FG000|Overall Study|Death|1|||
44199659|NCT02067728|78995215|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
44199660|NCT02067728|78995216|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
44199661|NCT02067728|78995215|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
44199662|NCT02067728|78995216|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
44199663|NCT02067728|78995215|FG000|6 Month Measurements|Unable to attend|114|||
44199664|NCT02067728|78995216|FG001|6 Month Measurements|Unable to attend|97|||
44199665|NCT02118428|78995224|FG000|Overall Study|Physician Decision|0|||
44199666|NCT02118428|78995225|FG001|Overall Study|Physician Decision|1|||
44199667|NCT02118428|78995226|FG002|Overall Study|Physician Decision|0|||
44199668|NCT02118428|78995224|FG000|Overall Study|Withdrawal by Subject|2|||
44199669|NCT02118428|78995225|FG001|Overall Study|Withdrawal by Subject|2|||
44199670|NCT02118428|78995226|FG002|Overall Study|Withdrawal by Subject|0|||
44199671|NCT02118428|78995224|FG000|Overall Study|Death|7|||
44199672|NCT02118428|78995225|FG001|Overall Study|Death|5|||
44199673|NCT02118428|78995226|FG002|Overall Study|Death|0|||
44199674|NCT02118428|78995224|FG000|Overall Study|Lost to Follow-up|3|||
44199675|NCT02118428|78995225|FG001|Overall Study|Lost to Follow-up|1|||
44199676|NCT02118428|78995226|FG002|Overall Study|Lost to Follow-up|0|||
44199677|NCT02118428|78995224|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
44199678|NCT02118428|78995225|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
44199679|NCT02118428|78995226|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
44199680|NCT02067104|78995234|FG000|Overall Study|Study termination due to low accrual|4|||
44199681|NCT02067104|78995235|FG001|Overall Study|Study termination due to low accrual|5|||
44199682|NCT02092220|78995241|FG000|Period 1|Unrelated Illness|0|||
44199683|NCT02092220|78995242|FG001|Period 1|Unrelated Illness|2|||
44199684|NCT02092220|78995241|FG000|Period 2|Severe Hypoglycaemia|1|||
44199685|NCT02092220|78995242|FG001|Period 2|Severe Hypoglycaemia|0|||
44199686|NCT02092220|78995241|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
44199687|NCT02092220|78995242|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
44199688|NCT02066402|78995252|FG000|Overall Study|Adverse Event|1|||
44199689|NCT02066402|78995253|FG001|Overall Study|Adverse Event|2|||
44199690|NCT02066402|78995252|FG000|Overall Study|Lost to Follow-up|11|||
44199691|NCT02066402|78995253|FG001|Overall Study|Lost to Follow-up|8|||
44199692|NCT02066402|78995252|FG000|Overall Study|Withdrawal by Subject|14|||
44199693|NCT02066402|78995253|FG001|Overall Study|Withdrawal by Subject|11|||
44199694|NCT02066402|78995252|FG000|Overall Study|Progressive disease-clinical progression|0|||
44199695|NCT02066402|78995253|FG001|Overall Study|Progressive disease-clinical progression|1|||
44199696|NCT02066402|78995252|FG000|Overall Study|Protocol driven decision point|0|||
44199697|NCT02066402|78995253|FG001|Overall Study|Protocol driven decision point|1|||
44199698|NCT02060383|78995264|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
44199699|NCT02060383|78995265|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
44199700|NCT02060383|78995266|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
44199701|NCT02060383|78995267|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
44199702|NCT02060383|78995268|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
44199703|NCT02060383|78995264|FG000|Core Phase|Adverse Event|2|||
44199704|NCT02060383|78995265|FG001|Core Phase|Adverse Event|0|||
44199705|NCT02060383|78995266|FG002|Core Phase|Adverse Event|0|||
44199706|NCT02060383|78995267|FG003|Core Phase|Adverse Event|2|||
44199707|NCT02060383|78995268|FG004|Core Phase|Adverse Event|6|||
44199708|NCT02060383|78995264|FG000|Core Phase|Administrative problems|0|||
44199709|NCT02060383|78995265|FG001|Core Phase|Administrative problems|1|||
44199710|NCT02060383|78995266|FG002|Core Phase|Administrative problems|0|||
44199711|NCT02060383|78995267|FG003|Core Phase|Administrative problems|0|||
44199712|NCT02060383|78995268|FG004|Core Phase|Administrative problems|0|||
44199713|NCT02060383|78995264|FG000|Core Phase|Protocol Violation|0|||
44199714|NCT02060383|78995265|FG001|Core Phase|Protocol Violation|0|||
44199715|NCT02060383|78995266|FG002|Core Phase|Protocol Violation|0|||
44199716|NCT02060383|78995267|FG003|Core Phase|Protocol Violation|1|||
44199717|NCT02060383|78995268|FG004|Core Phase|Protocol Violation|0|||
44199718|NCT02060383|78995264|FG000|Core Phase|Withdrawal by Subject|0|||
44199719|NCT02060383|78995265|FG001|Core Phase|Withdrawal by Subject|0|||
44199720|NCT02060383|78995266|FG002|Core Phase|Withdrawal by Subject|0|||
44199721|NCT02060383|78995267|FG003|Core Phase|Withdrawal by Subject|4|||
44199722|NCT02060383|78995268|FG004|Core Phase|Withdrawal by Subject|2|||
44199723|NCT02060383|78995264|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
44199724|NCT02060383|78995265|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
44199725|NCT02060383|78995266|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
44199726|NCT02060383|78995267|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
44199727|NCT02060383|78995268|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
44199728|NCT02060383|78995264|FG000|Extension Phase|Adverse Event|1|||
44361366|NCT01110330|79367041|FG000|Overall Study|Lack of Efficacy|3|||
44361367|NCT01110330|79367042|FG001|Overall Study|Lack of Efficacy|1|||
44361368|NCT01110330|79367043|FG002|Overall Study|Lack of Efficacy|1|||
44199729|NCT02060383|78995265|FG001|Extension Phase|Adverse Event|1|||
44199730|NCT02060383|78995266|FG002|Extension Phase|Adverse Event|2|||
44199731|NCT02060383|78995267|FG003|Extension Phase|Adverse Event|0|||
44199732|NCT02060383|78995268|FG004|Extension Phase|Adverse Event|1|||
44199733|NCT02060383|78995264|FG000|Extension Phase|Withdrawal by Subject|0|||
44199734|NCT02060383|78995265|FG001|Extension Phase|Withdrawal by Subject|1|||
44199735|NCT02060383|78995266|FG002|Extension Phase|Withdrawal by Subject|0|||
44199736|NCT02060383|78995267|FG003|Extension Phase|Withdrawal by Subject|0|||
44199737|NCT02060383|78995268|FG004|Extension Phase|Withdrawal by Subject|2|||
44199738|NCT02060383|78995264|FG000|Extension Phase|Administrative problems|1|||
44199739|NCT02060383|78995265|FG001|Extension Phase|Administrative problems|0|||
44199740|NCT02060383|78995266|FG002|Extension Phase|Administrative problems|0|||
44199741|NCT02060383|78995267|FG003|Extension Phase|Administrative problems|0|||
44361369|NCT01110330|79367041|FG000|Overall Study|Lost to Follow-up|9|||
44361370|NCT01110330|79367042|FG001|Overall Study|Lost to Follow-up|10|||
44361371|NCT01110330|79367043|FG002|Overall Study|Lost to Follow-up|15|||
44361372|NCT01110330|79367041|FG000|Overall Study|Physician Decision|0|||
44361373|NCT01110330|79367042|FG001|Overall Study|Physician Decision|1|||
44199742|NCT02060383|78995268|FG004|Extension Phase|Administrative problems|0|||
44199743|NCT02060383|78995264|FG000|Extension Phase|Death|0|||
44199744|NCT02060383|78995265|FG001|Extension Phase|Death|0|||
44199745|NCT02060383|78995266|FG002|Extension Phase|Death|1|||
44199746|NCT02060383|78995267|FG003|Extension Phase|Death|0|||
44199747|NCT02060383|78995268|FG004|Extension Phase|Death|1|||
44199748|NCT02060383|78995264|FG000|Extension Phase|Protocol Violation|0|||
44199749|NCT02060383|78995265|FG001|Extension Phase|Protocol Violation|0|||
44199750|NCT02060383|78995266|FG002|Extension Phase|Protocol Violation|0|||
44199751|NCT02060383|78995267|FG003|Extension Phase|Protocol Violation|0|||
44199752|NCT02060383|78995268|FG004|Extension Phase|Protocol Violation|1|||
44199753|NCT02086591|78995280|FG000|Overall Study|Adverse Event|1|||
44199754|NCT02086591|78995280|FG000|Overall Study|Withdrawal by Subject|1|||
44199755|NCT02086591|78995280|FG000|Overall Study|protocol terminated|3|||
44199756|NCT02065622|78995286|FG000|Induction Study|Adverse Event|13|||
44199757|NCT02065622|78995287|FG001|Induction Study|Adverse Event|19|||
44199758|NCT02065622|78995288|FG002|Induction Study|Adverse Event|0|||
44199759|NCT02065622|78995289|FG003|Induction Study|Adverse Event|0|||
44199760|NCT02065622|78995290|FG004|Induction Study|Adverse Event|0|||
44199761|NCT02065622|78995286|FG000|Induction Study|Withdrawal by Subject|3|||
44199762|NCT02065622|78995287|FG001|Induction Study|Withdrawal by Subject|5|||
44199763|NCT02065622|78995288|FG002|Induction Study|Withdrawal by Subject|0|||
44199764|NCT02065622|78995289|FG003|Induction Study|Withdrawal by Subject|0|||
44199765|NCT02065622|78995290|FG004|Induction Study|Withdrawal by Subject|0|||
44199766|NCT02065622|78995286|FG000|Induction Study|Lost to Follow-up|1|||
44199767|NCT02065622|78995287|FG001|Induction Study|Lost to Follow-up|0|||
44199768|NCT02065622|78995288|FG002|Induction Study|Lost to Follow-up|0|||
44199769|NCT02065622|78995289|FG003|Induction Study|Lost to Follow-up|0|||
44199770|NCT02065622|78995290|FG004|Induction Study|Lost to Follow-up|0|||
44199771|NCT02065622|78995286|FG000|Induction Study|Lack of Efficacy|22|||
44199772|NCT02065622|78995287|FG001|Induction Study|Lack of Efficacy|27|||
44199773|NCT02065622|78995288|FG002|Induction Study|Lack of Efficacy|0|||
44199774|NCT02065622|78995289|FG003|Induction Study|Lack of Efficacy|0|||
44199775|NCT02065622|78995290|FG004|Induction Study|Lack of Efficacy|0|||
44199776|NCT02065622|78995286|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
44199777|NCT02065622|78995287|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
44199778|NCT02065622|78995288|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
44199779|NCT02065622|78995289|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
44199780|NCT02065622|78995290|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
44199781|NCT02065622|78995286|FG000|Induction Study|Subject Noncompliance|1|||
44199782|NCT02065622|78995287|FG001|Induction Study|Subject Noncompliance|1|||
44199783|NCT02065622|78995288|FG002|Induction Study|Subject Noncompliance|0|||
44199784|NCT02065622|78995289|FG003|Induction Study|Subject Noncompliance|0|||
44199785|NCT02065622|78995290|FG004|Induction Study|Subject Noncompliance|0|||
44199786|NCT02065622|78995286|FG000|Induction Study|Other, Not Specified|3|||
44199787|NCT02065622|78995287|FG001|Induction Study|Other, Not Specified|2|||
44199788|NCT02065622|78995288|FG002|Induction Study|Other, Not Specified|0|||
44199789|NCT02065622|78995289|FG003|Induction Study|Other, Not Specified|0|||
44199790|NCT02065622|78995290|FG004|Induction Study|Other, Not Specified|0|||
44199791|NCT02065622|78995286|FG000|Maintenance Study|Adverse Event|0|||
44199792|NCT02065622|78995287|FG001|Maintenance Study|Adverse Event|0|||
44199793|NCT02065622|78995288|FG002|Maintenance Study|Adverse Event|25|||
44199794|NCT02065622|78995289|FG003|Maintenance Study|Adverse Event|22|||
44199795|NCT02065622|78995290|FG004|Maintenance Study|Adverse Event|11|||
44199796|NCT02065622|78995286|FG000|Maintenance Study|Withdrawal by Subject|0|||
44199797|NCT02065622|78995287|FG001|Maintenance Study|Withdrawal by Subject|0|||
44199798|NCT02065622|78995288|FG002|Maintenance Study|Withdrawal by Subject|11|||
44199799|NCT02065622|78995289|FG003|Maintenance Study|Withdrawal by Subject|5|||
44199800|NCT02065622|78995290|FG004|Maintenance Study|Withdrawal by Subject|7|||
44199801|NCT02065622|78995286|FG000|Maintenance Study|Lost to Follow-up|0|||
44199802|NCT02065622|78995287|FG001|Maintenance Study|Lost to Follow-up|0|||
44199803|NCT02065622|78995288|FG002|Maintenance Study|Lost to Follow-up|4|||
44199804|NCT02065622|78995289|FG003|Maintenance Study|Lost to Follow-up|1|||
44199805|NCT02065622|78995290|FG004|Maintenance Study|Lost to Follow-up|1|||
44199806|NCT02065622|78995286|FG000|Maintenance Study|Lack of Efficacy|0|||
44199807|NCT02065622|78995287|FG001|Maintenance Study|Lack of Efficacy|0|||
44199808|NCT02065622|78995288|FG002|Maintenance Study|Lack of Efficacy|70|||
44199809|NCT02065622|78995289|FG003|Maintenance Study|Lack of Efficacy|55|||
44199810|NCT02065622|78995290|FG004|Maintenance Study|Lack of Efficacy|19|||
44199811|NCT02065622|78995286|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
44199812|NCT02065622|78995287|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
44199813|NCT02065622|78995288|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
44199814|NCT02065622|78995289|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
44199815|NCT02065622|78995290|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
44199816|NCT02065622|78995286|FG000|Maintenance Study|Subject Non-Compliance|0|||
44199817|NCT02065622|78995287|FG001|Maintenance Study|Subject Non-Compliance|0|||
44199818|NCT02065622|78995288|FG002|Maintenance Study|Subject Non-Compliance|1|||
44199819|NCT02065622|78995289|FG003|Maintenance Study|Subject Non-Compliance|3|||
44199820|NCT02065622|78995290|FG004|Maintenance Study|Subject Non-Compliance|2|||
44199821|NCT02065622|78995286|FG000|Maintenance Study|Other, Not Specified|0|||
44199822|NCT02065622|78995287|FG001|Maintenance Study|Other, Not Specified|0|||
44199823|NCT02065622|78995288|FG002|Maintenance Study|Other, Not Specified|6|||
44199824|NCT02065622|78995289|FG003|Maintenance Study|Other, Not Specified|14|||
44199825|NCT02065622|78995290|FG004|Maintenance Study|Other, Not Specified|2|||
44199826|NCT02065622|78995286|FG000|Maintenance Study|Unknown Reason|0|||
44199827|NCT02065622|78995287|FG001|Maintenance Study|Unknown Reason|0|||
44199828|NCT02065622|78995288|FG002|Maintenance Study|Unknown Reason|0|||
44199829|NCT02065622|78995289|FG003|Maintenance Study|Unknown Reason|1|||
44199830|NCT02065622|78995290|FG004|Maintenance Study|Unknown Reason|0|||
44199831|NCT02117648|78995305|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
44199832|NCT02117648|78995305|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
44199833|NCT02117648|78995305|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
44199834|NCT02117648|78995305|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
44199835|NCT02117648|78995305|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
44199836|NCT02117648|78995305|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
44199837|NCT02117648|78995305|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
44199838|NCT02117648|78995305|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
44199839|NCT02117648|78995305|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
44199840|NCT02117648|78995305|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
44199841|NCT02117648|78995305|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
44199842|NCT02124161|78995315|FG000|Overall Study|Other unspecified|0|||
44199843|NCT02124161|78995316|FG001|Overall Study|Other unspecified|1|||
44199844|NCT02124161|78995315|FG000|Overall Study|Death|1|||
44199845|NCT02124161|78995316|FG001|Overall Study|Death|0|||
44199846|NCT02124161|78995315|FG000|Overall Study|Protocol Violation|2|||
44199847|NCT02124161|78995316|FG001|Overall Study|Protocol Violation|1|||
44199848|NCT02124161|78995315|FG000|Overall Study|Withdrawal by Subject|1|||
44199849|NCT02124161|78995316|FG001|Overall Study|Withdrawal by Subject|2|||
44199850|NCT02124161|78995315|FG000|Overall Study|Adverse Event|2|||
44199851|NCT02124161|78995316|FG001|Overall Study|Adverse Event|0|||
44199852|NCT02124161|78995315|FG000|Overall Study|Does not meet entrance criteria|2|||
44199853|NCT02124161|78995316|FG001|Overall Study|Does not meet entrance criteria|3|||
44199854|NCT02124161|78995315|FG000|Overall Study|No longer meets eligibility criteria|5|||
44199855|NCT02124161|78995316|FG001|Overall Study|No longer meets eligibility criteria|4|||
44199856|NCT02124161|78995315|FG000|Overall Study|Lost to Follow-up|3|||
44199857|NCT02124161|78995316|FG001|Overall Study|Lost to Follow-up|4|||
44199858|NCT02175641|78995331|FG000|Overall Study|Death|3|||
44199859|NCT02175641|78995332|FG001|Overall Study|Death|4|||
44199860|NCT02175641|78995331|FG000|Overall Study|Lost to Follow-up|4|||
44199861|NCT02175641|78995332|FG001|Overall Study|Lost to Follow-up|4|||
44199862|NCT02175641|78995331|FG000|Overall Study|Withdrawal by Subject|7|||
44199863|NCT02175641|78995332|FG001|Overall Study|Withdrawal by Subject|4|||
44199864|NCT02175641|78995331|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
44199865|NCT02175641|78995332|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
44199866|NCT02175641|78995331|FG000|Overall Study|Developed Contraindicated Condition|8|||
44199867|NCT02175641|78995332|FG001|Overall Study|Developed Contraindicated Condition|0|||
44199868|NCT02117570|78995341|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
44199869|NCT02117570|78995342|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
44199870|NCT02117570|78995343|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
44199871|NCT02117570|78995341|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
44199872|NCT02117570|78995342|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
44199873|NCT02117570|78995343|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
44199874|NCT02117570|78995341|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
44199875|NCT02117570|78995342|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
44199876|NCT02117570|78995343|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
44199877|NCT02117570|78995341|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
44199878|NCT02117570|78995342|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
44199879|NCT02117570|78995343|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
44199880|NCT02117570|78995341|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
44199881|NCT02117570|78995342|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
44199882|NCT02117570|78995343|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
44199883|NCT02117570|78995341|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
44199884|NCT02117570|78995342|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
44199885|NCT02117570|78995343|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
44199886|NCT02117570|78995341|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
44199887|NCT02117570|78995342|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
44249664|NCT01276353|79083651|FG000|Extension|Withdrawal by Subject|1|||
44199888|NCT02117570|78995343|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
44199889|NCT02123459|78995354|FG000|Washout Period (1 Day)|Adverse Event|1|||
44199890|NCT02123459|78995355|FG001|Washout Period (1 Day)|Adverse Event|0|||
44199891|NCT01853475|78995364|FG000|Overall Study|Withdrawal by Subject|0|||
44199892|NCT01853475|78995365|FG001|Overall Study|Withdrawal by Subject|1|||
44199893|NCT01853475|78995366|FG002|Overall Study|Withdrawal by Subject|0|||
44199894|NCT02151773|78995374|FG000|Overall Study|Protocol Deviation|64|||
44199895|NCT02151461|78995382|FG000|Overall Study|Adverse Event|5|||
44199896|NCT02151461|78995383|FG001|Overall Study|Adverse Event|1|||
44199897|NCT02151461|78995384|FG002|Overall Study|Adverse Event|0|||
44199898|NCT02151461|78995385|FG003|Overall Study|Adverse Event|2|||
44199899|NCT02151461|78995382|FG000|Overall Study|Lost to Follow-up|0|||
44199900|NCT02151461|78995383|FG001|Overall Study|Lost to Follow-up|0|||
44199901|NCT02151461|78995384|FG002|Overall Study|Lost to Follow-up|1|||
44199902|NCT02151461|78995385|FG003|Overall Study|Lost to Follow-up|1|||
44199903|NCT02151461|78995382|FG000|Overall Study|Withdrawal by Subject|1|||
44199904|NCT02151461|78995383|FG001|Overall Study|Withdrawal by Subject|0|||
44199905|NCT02151461|78995384|FG002|Overall Study|Withdrawal by Subject|1|||
44199906|NCT02151461|78995385|FG003|Overall Study|Withdrawal by Subject|1|||
44199907|NCT02151461|78995382|FG000|Overall Study|Treatment discontinuation|0|||
44199908|NCT02151461|78995383|FG001|Overall Study|Treatment discontinuation|0|||
44199909|NCT02151461|78995384|FG002|Overall Study|Treatment discontinuation|1|||
44199910|NCT02151461|78995385|FG003|Overall Study|Treatment discontinuation|0|||
44199911|NCT02117414|78995397|FG000|Overall Study|Death|5|||
44199912|NCT02117414|78995398|FG001|Overall Study|Death|2|||
44199913|NCT02117414|78995397|FG000|Overall Study|Withdrawal by Subject|10|||
44199914|NCT02117414|78995398|FG001|Overall Study|Withdrawal by Subject|4|||
44199915|NCT02091986|78995409|FG000|Overall Study|7 rand in error 1 patient decision|2|||
44199916|NCT02091986|78995410|FG001|Overall Study|7 rand in error 1 patient decision|3|||
44199917|NCT02091986|78995411|FG002|Overall Study|7 rand in error 1 patient decision|3|||
44199918|NCT02091986|78995409|FG000|Overall Study|Lost to Follow-up|1|||
44199919|NCT02091986|78995410|FG001|Overall Study|Lost to Follow-up|0|||
44199920|NCT02091986|78995411|FG002|Overall Study|Lost to Follow-up|0|||
44199921|NCT02091986|78995409|FG000|Overall Study|Withdrawal by Subject|4|||
44199922|NCT02091986|78995410|FG001|Overall Study|Withdrawal by Subject|8|||
44199923|NCT02091986|78995411|FG002|Overall Study|Withdrawal by Subject|3|||
44199924|NCT02091986|78995409|FG000|Overall Study|Adverse Event|0|||
44199925|NCT02091986|78995410|FG001|Overall Study|Adverse Event|0|||
44199926|NCT02091986|78995411|FG002|Overall Study|Adverse Event|2|||
44199927|NCT02091752|78995419|FG000|Overall Study|Study terminated by Sponsor|2|||
44199928|NCT02091752|78995419|FG000|Overall Study|Adverse Event|1|||
44199929|NCT02117024|78995425|FG000|Overall Study|Progressive Disease|26|||
44199930|NCT02117024|78995426|FG001|Overall Study|Progressive Disease|9|||
44199931|NCT02117024|78995425|FG000|Overall Study|Significant Clinical Progression|7|||
44199932|NCT02117024|78995426|FG001|Overall Study|Significant Clinical Progression|4|||
44199933|NCT02117024|78995425|FG000|Overall Study|Death|5|||
44199934|NCT02117024|78995426|FG001|Overall Study|Death|0|||
44199935|NCT02117024|78995425|FG000|Overall Study|Withdrawal by Subject|3|||
44199936|NCT02117024|78995426|FG001|Overall Study|Withdrawal by Subject|1|||
44199937|NCT02117024|78995425|FG000|Overall Study|Protocol Violation|1|||
44199938|NCT02117024|78995426|FG001|Overall Study|Protocol Violation|0|||
44199939|NCT02117024|78995425|FG000|Overall Study|Adverse Event|1|||
44199940|NCT02117024|78995426|FG001|Overall Study|Adverse Event|2|||
44199941|NCT02117024|78995425|FG000|Overall Study|Randomized in Error|1|||
44199942|NCT02117024|78995426|FG001|Overall Study|Randomized in Error|0|||
44199943|NCT02117024|78995425|FG000|Overall Study|Patient returned to primary oncologist|0|||
44199944|NCT02117024|78995426|FG001|Overall Study|Patient returned to primary oncologist|1|||
44199945|NCT02117024|78995425|FG000|Overall Study|Patient took treatment break|0|||
44199946|NCT02117024|78995426|FG001|Overall Study|Patient took treatment break|1|||
44199947|NCT02117024|78995425|FG000|Overall Study|Physician Decision|0|||
44199948|NCT02117024|78995426|FG001|Overall Study|Physician Decision|2|||
44199949|NCT02091440|78995432|FG000|Overall Study|Death|2|||
44199950|NCT02064920|78995438|FG000|Overall Study|Adverse Event|0|||
44199951|NCT02064920|78995439|FG001|Overall Study|Adverse Event|4|||
44199952|NCT02064920|78995438|FG000|Overall Study|Physician Decision|0|||
44199953|NCT02064920|78995439|FG001|Overall Study|Physician Decision|1|||
44199954|NCT02064920|78995438|FG000|Overall Study|Technical Problems|0|||
44199955|NCT02064920|78995439|FG001|Overall Study|Technical Problems|1|||
44199956|NCT02064920|78995438|FG000|Overall Study|Withdrawal by Subject|1|||
44199957|NCT02064920|78995439|FG001|Overall Study|Withdrawal by Subject|3|||
44199958|NCT02151149|78995447|FG000|Treatment Period|Death|2|||
44199959|NCT02151149|78995448|FG001|Treatment Period|Death|3|||
44199960|NCT02151149|78995447|FG000|Treatment Period|Adverse Event|17|||
44199961|NCT02151149|78995448|FG001|Treatment Period|Adverse Event|14|||
44199962|NCT02151149|78995447|FG000|Treatment Period|Progressive Disease|25|||
44199963|NCT02151149|78995448|FG001|Treatment Period|Progressive Disease|24|||
44199964|NCT02151149|78995447|FG000|Treatment Period|Symptomatic Deterioration|2|||
44199965|NCT02151149|78995448|FG001|Treatment Period|Symptomatic Deterioration|10|||
44199966|NCT02151149|78995447|FG000|Treatment Period|Withdrawal by Subject|13|||
44199967|NCT02151149|78995448|FG001|Treatment Period|Withdrawal by Subject|11|||
44199968|NCT02151149|78995447|FG000|Treatment Period|Miscellaneous|8|||
44199969|NCT02151149|78995448|FG001|Treatment Period|Miscellaneous|7|||
44199970|NCT02151149|78995447|FG000|Treatment Period|Participants randomized but not treated|3|||
44199971|NCT02151149|78995448|FG001|Treatment Period|Participants randomized but not treated|2|||
44199972|NCT02151149|78995447|FG000|Follow-Up Period|Lost to Follow-up|2|||
44199973|NCT02151149|78995448|FG001|Follow-Up Period|Lost to Follow-up|3|||
44199974|NCT02151149|78995447|FG000|Follow-Up Period|Death|37|||
44199975|NCT02151149|78995448|FG001|Follow-Up Period|Death|34|||
44199976|NCT02150213|78995454|FG000|Overall Study|Lost to Follow-up|1|||
44199977|NCT02150213|78995454|FG000|Overall Study|Withdrawal by Subject|1|||
44199978|NCT02091362|78995460|FG000|Period 1|Protocol Violation|1|||
44361374|NCT01110330|79367043|FG002|Overall Study|Physician Decision|0|||
44361375|NCT01110330|79367041|FG000|Overall Study|Protocol Violation|2|||
44361376|NCT01110330|79367042|FG001|Overall Study|Protocol Violation|0|||
44199979|NCT02091362|78995461|FG001|Period 1|Protocol Violation|0|||
44199980|NCT02091362|78995460|FG000|Period 1|Withdrawal by Subject|2|||
44199981|NCT02091362|78995461|FG001|Period 1|Withdrawal by Subject|3|||
44199982|NCT02091362|78995460|FG000|Period 1|Lost to Follow-up|0|||
44199983|NCT02091362|78995461|FG001|Period 1|Lost to Follow-up|1|||
44199984|NCT02091362|78995460|FG000|Period 1|Adverse Event|2|||
44199985|NCT02091362|78995461|FG001|Period 1|Adverse Event|0|||
44199986|NCT02091362|78995460|FG000|Wash-out|Lost to Follow-up|1|||
44199987|NCT02091362|78995461|FG001|Wash-out|Lost to Follow-up|1|||
44199988|NCT02091362|78995460|FG000|Wash-out|Withdrawal by Subject|0|||
44199989|NCT02091362|78995461|FG001|Wash-out|Withdrawal by Subject|2|||
44199990|NCT02091362|78995460|FG000|Period 2|Adverse Event|1|||
44199991|NCT02091362|78995461|FG001|Period 2|Adverse Event|0|||
44199992|NCT02091362|78995460|FG000|Period 2|Lost to Follow-up|0|||
44199993|NCT02091362|78995461|FG001|Period 2|Lost to Follow-up|1|||
44199994|NCT02091362|78995460|FG000|Period 2|Withdrawal by Subject|1|||
44361377|NCT01110330|79367043|FG002|Overall Study|Protocol Violation|4|||
44199995|NCT02091362|78995461|FG001|Period 2|Withdrawal by Subject|1|||
44199996|NCT02150057|78995473|FG000|Overall Study|Lost to Follow-up|6|||
44199997|NCT02150057|78995474|FG001|Overall Study|Lost to Follow-up|4|||
44199998|NCT02064296|78995483|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
44199999|NCT02064296|78995484|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
44200000|NCT02064296|78995485|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
44200001|NCT02064296|78995483|FG000|Intervention|Withdrawal by Subject|0|||
44200002|NCT02064296|78995484|FG001|Intervention|Withdrawal by Subject|1|||
44200003|NCT02064296|78995485|FG002|Intervention|Withdrawal by Subject|2|||
44200004|NCT02063984|78995497|FG000|Overall Study|Lost to Follow-up|6|||
44200005|NCT02063984|78995498|FG001|Overall Study|Lost to Follow-up|5|||
44200006|NCT02091284|78995510|FG000|Overall Study|Withdrawal by Subject|2|||
44200007|NCT02091284|78995511|FG001|Overall Study|Withdrawal by Subject|1|||
44200008|NCT02091284|78995510|FG000|Overall Study|unreliable data|1|||
44200009|NCT02091284|78995511|FG001|Overall Study|unreliable data|0|||
44200010|NCT02115386|78995519|FG000|Overall Study|Protocol Violation|1|||
44200011|NCT02115386|78995519|FG000|Overall Study|Administrative - trial was terminated|6|||
44200012|NCT02091206|78995527|FG000|Treatment Period|Adverse Event|0|||
44200013|NCT02091206|78995528|FG001|Treatment Period|Adverse Event|1|||
44200014|NCT02091206|78995529|FG002|Treatment Period|Adverse Event|0|||
44200015|NCT02091206|78995530|FG003|Treatment Period|Adverse Event|0|||
44200016|NCT02091206|78995527|FG000|Treatment Period|Met withdrawal criteria|0|||
44200017|NCT02091206|78995528|FG001|Treatment Period|Met withdrawal criteria|0|||
44200018|NCT02091206|78995529|FG002|Treatment Period|Met withdrawal criteria|1|||
44200019|NCT02091206|78995530|FG003|Treatment Period|Met withdrawal criteria|0|||
44200020|NCT02091206|78995527|FG000|Taper Period|Participant refused study drug|1|||
44200021|NCT02091206|78995528|FG001|Taper Period|Participant refused study drug|0|||
44200022|NCT02091206|78995529|FG002|Taper Period|Participant refused study drug|0|||
44200023|NCT02091206|78995530|FG003|Taper Period|Participant refused study drug|1|||
44200024|NCT02091206|78995527|FG000|Taper Period|Lost to Follow-up|0|||
44200025|NCT02091206|78995528|FG001|Taper Period|Lost to Follow-up|0|||
44200026|NCT02091206|78995529|FG002|Taper Period|Lost to Follow-up|0|||
44200027|NCT02091206|78995530|FG003|Taper Period|Lost to Follow-up|1|||
44200028|NCT02090426|78995542|FG000|Overall Study|Lost to Follow-up|12|||
44200029|NCT02090426|78995543|FG001|Overall Study|Lost to Follow-up|6|||
44200030|NCT02063828|78995552|FG000|Overall Study|Withdrawal by Subject|4|||
44200031|NCT02063828|78995553|FG001|Overall Study|Withdrawal by Subject|6|||
44200032|NCT02063828|78995554|FG002|Overall Study|Withdrawal by Subject|3|||
44200033|NCT02063828|78995552|FG000|Overall Study|Death|0|||
44200034|NCT02063828|78995553|FG001|Overall Study|Death|0|||
44200035|NCT02063828|78995554|FG002|Overall Study|Death|1|||
44200036|NCT02063672|78995564|FG000|Overall Study|Ongoing Follow-up|27|||
44200037|NCT02063672|78995565|FG001|Overall Study|Ongoing Follow-up|14|||
44200038|NCT02063672|78995564|FG000|Overall Study|Death|5|||
44200039|NCT02063672|78995565|FG001|Overall Study|Death|3|||
44200040|NCT02063672|78995564|FG000|Overall Study|Lost to Follow-up|1|||
44200041|NCT02063672|78995565|FG001|Overall Study|Lost to Follow-up|3|||
44200042|NCT02063672|78995564|FG000|Overall Study|Withdrawal by Subject|2|||
44200043|NCT02063672|78995565|FG001|Overall Study|Withdrawal by Subject|2|||
44200044|NCT02062658|78995571|FG000|Overall Study|Withdrawal by Subject|1|||
44200045|NCT02062658|78995571|FG000|Overall Study|Lack of Efficacy|1|||
44200046|NCT02115308|78995577|FG000|Overall Study|Safety Screening|2|||
44200047|NCT02115308|78995578|FG001|Overall Study|Safety Screening|2|||
44200048|NCT02114684|78995590|FG000|Overall Study|Death|6|||
44200049|NCT02114684|78995591|FG001|Overall Study|Death|4|||
44200050|NCT02114684|78995590|FG000|Overall Study|Lost to Follow-up|1|||
44200051|NCT02114684|78995591|FG001|Overall Study|Lost to Follow-up|2|||
44200052|NCT02114684|78995590|FG000|Overall Study|Withdrawal by Subject|1|||
44200053|NCT02114684|78995591|FG001|Overall Study|Withdrawal by Subject|2|||
44200054|NCT02114684|78995590|FG000|Overall Study|Relocation|3|||
44200055|NCT02114684|78995591|FG001|Overall Study|Relocation|1|||
44200056|NCT02114684|78995590|FG000|Overall Study|Rifampicin resistant on culture|0|||
44200057|NCT02114684|78995591|FG001|Overall Study|Rifampicin resistant on culture|1|||
44200058|NCT02114684|78995590|FG000|Overall Study|Patient Incarcerated|1|||
44200059|NCT02114684|78995591|FG001|Overall Study|Patient Incarcerated|0|||
44200060|NCT02090114|78995605|FG000|Overall Study|Withdrawal by Subject|3|||
44200061|NCT02090114|78995606|FG001|Overall Study|Withdrawal by Subject|6|||
44200062|NCT02090114|78995607|FG002|Overall Study|Withdrawal by Subject|2|||
44200063|NCT02090114|78995608|FG003|Overall Study|Withdrawal by Subject|1|||
44200064|NCT02090114|78995605|FG000|Overall Study|Physician Decision|5|||
44200065|NCT02090114|78995606|FG001|Overall Study|Physician Decision|0|||
44200066|NCT02090114|78995607|FG002|Overall Study|Physician Decision|1|||
44200067|NCT02090114|78995608|FG003|Overall Study|Physician Decision|1|||
44200068|NCT02090114|78995605|FG000|Overall Study|Adverse Event|1|||
44200069|NCT02090114|78995606|FG001|Overall Study|Adverse Event|2|||
44200070|NCT02090114|78995607|FG002|Overall Study|Adverse Event|2|||
44200071|NCT02090114|78995608|FG003|Overall Study|Adverse Event|0|||
44200072|NCT02090114|78995605|FG000|Overall Study|Progressive Disease|20|||
44200073|NCT02090114|78995606|FG001|Overall Study|Progressive Disease|21|||
44200074|NCT02090114|78995607|FG002|Overall Study|Progressive Disease|23|||
44200075|NCT02090114|78995608|FG003|Overall Study|Progressive Disease|6|||
44200076|NCT02090114|78995605|FG000|Overall Study|Death|1|||
44200077|NCT02090114|78995606|FG001|Overall Study|Death|0|||
44200078|NCT02090114|78995607|FG002|Overall Study|Death|1|||
44200079|NCT02090114|78995608|FG003|Overall Study|Death|0|||
44200080|NCT01623050|78995618|FG000|Overall Study|Lost to Follow-up|9|||
44200081|NCT02089334|78995626|FG000|Overall Study|Withdrawal by Subject|0|||
44200082|NCT02089334|78995627|FG001|Overall Study|Withdrawal by Subject|0|||
44200083|NCT02089334|78995628|FG002|Overall Study|Withdrawal by Subject|0|||
44200084|NCT02089334|78995629|FG003|Overall Study|Withdrawal by Subject|2|||
44200085|NCT02089334|78995626|FG000|Overall Study|Adverse Event|0|||
44200086|NCT02089334|78995627|FG001|Overall Study|Adverse Event|0|||
44200087|NCT02089334|78995628|FG002|Overall Study|Adverse Event|0|||
44200088|NCT02089334|78995629|FG003|Overall Study|Adverse Event|2|||
44200089|NCT02089334|78995626|FG000|Overall Study|Progressive disease|0|||
44200090|NCT02089334|78995627|FG001|Overall Study|Progressive disease|0|||
44200091|NCT02089334|78995628|FG002|Overall Study|Progressive disease|0|||
44200092|NCT02089334|78995629|FG003|Overall Study|Progressive disease|2|||
44200093|NCT02089334|78995626|FG000|Overall Study|Physician Decision|0|||
44200094|NCT02089334|78995627|FG001|Overall Study|Physician Decision|0|||
44200095|NCT02089334|78995628|FG002|Overall Study|Physician Decision|1|||
44200096|NCT02089334|78995629|FG003|Overall Study|Physician Decision|1|||
44200097|NCT02114606|78995642|FG000|Overall Study|Unable to swallow Cytosponge|6|||
44200098|NCT02113436|78995648|FG000|Period 1: 8 Weeks|Adverse Event|1|||
44200099|NCT02113436|78995649|FG001|Period 1: 8 Weeks|Adverse Event|0|||
44200100|NCT02113436|78995650|FG002|Period 1: 8 Weeks|Adverse Event|0|||
44200101|NCT02113436|78995651|FG003|Period 1: 8 Weeks|Adverse Event|0|||
44200102|NCT02113436|78995648|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
44200103|NCT02113436|78995649|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
44200104|NCT02113436|78995650|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
44200105|NCT02113436|78995651|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
44200106|NCT02113436|78995648|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
44200107|NCT02113436|78995649|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
44200108|NCT02113436|78995650|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
44200109|NCT02113436|78995651|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
44200110|NCT02113436|78995648|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
44200111|NCT02113436|78995649|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
44200112|NCT02113436|78995650|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
44200113|NCT02113436|78995651|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
44200114|NCT02113436|78995648|FG000|Period 2: 16 Weeks|Adverse Event|0|||
44200115|NCT02113436|78995649|FG001|Period 2: 16 Weeks|Adverse Event|0|||
44200116|NCT02113436|78995650|FG002|Period 2: 16 Weeks|Adverse Event|4|||
44200117|NCT02113436|78995651|FG003|Period 2: 16 Weeks|Adverse Event|5|||
44200118|NCT02113436|78995648|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
44200119|NCT02113436|78995649|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
44200120|NCT02113436|78995650|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
44200121|NCT02113436|78995651|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
44200122|NCT02113436|78995648|FG000|Period 2: 16 Weeks|Physician Decision|0|||
44200123|NCT02113436|78995649|FG001|Period 2: 16 Weeks|Physician Decision|0|||
44200124|NCT02113436|78995650|FG002|Period 2: 16 Weeks|Physician Decision|2|||
44200125|NCT02113436|78995651|FG003|Period 2: 16 Weeks|Physician Decision|0|||
44200126|NCT02113436|78995648|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
44200127|NCT02113436|78995649|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
44200128|NCT02113436|78995650|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
44200129|NCT02113436|78995651|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
44200130|NCT02113124|78995662|FG000|Overall Study|Unable to retrieve blood sample|1|||
44200131|NCT02113124|78995663|FG001|Overall Study|Unable to retrieve blood sample|1|||
44200132|NCT02087774|78995671|FG000|Overall Study|Were absent day of data collection|8|||
44200133|NCT02087774|78995672|FG001|Overall Study|Were absent day of data collection|20|||
44200134|NCT02111564|78995680|FG000|Overall Study|Death|109|||
44200135|NCT02111564|78995681|FG001|Overall Study|Death|120|||
44200136|NCT02111564|78995680|FG000|Overall Study|Lost to Follow-up|2|||
44200137|NCT02111564|78995681|FG001|Overall Study|Lost to Follow-up|3|||
44266843|NCT02401230|79179496|FG002|Overall Study|Adverse Event|0|||
44200138|NCT02111564|78995680|FG000|Overall Study|Withdrawal by Subject|20|||
44200139|NCT02111564|78995681|FG001|Overall Study|Withdrawal by Subject|20|||
44200140|NCT02087150|78995690|FG000|Overall Study|Death|0|||
44266844|NCT02401230|79179494|FG000|Overall Study|Withdrawal by Subject|2|||
44200141|NCT02087150|78995691|FG001|Overall Study|Death|1|||
44200142|NCT02087150|78995692|FG002|Overall Study|Death|0|||
44200143|NCT02087150|78995690|FG000|Overall Study|Lost to Follow-up|6|||
44200144|NCT02087150|78995691|FG001|Overall Study|Lost to Follow-up|13|||
44200145|NCT02087150|78995692|FG002|Overall Study|Lost to Follow-up|7|||
44200146|NCT02087150|78995690|FG000|Overall Study|Withdrawal by Subject|2|||
44200147|NCT02087150|78995691|FG001|Overall Study|Withdrawal by Subject|5|||
44200148|NCT02087150|78995692|FG002|Overall Study|Withdrawal by Subject|3|||
44200149|NCT02087150|78995690|FG000|Overall Study|Physician Decision|0|||
44200150|NCT02087150|78995691|FG001|Overall Study|Physician Decision|1|||
44200151|NCT02087150|78995692|FG002|Overall Study|Physician Decision|0|||
44200152|NCT02087150|78995690|FG000|Overall Study|Procedure not done|1|||
44200153|NCT02087150|78995691|FG001|Overall Study|Procedure not done|13|||
44200154|NCT02087150|78995692|FG002|Overall Study|Procedure not done|0|||
44200155|NCT02087150|78995690|FG000|Overall Study|F/U not completed w/in study window|0|||
44200156|NCT02087150|78995691|FG001|Overall Study|F/U not completed w/in study window|0|||
44200157|NCT02087150|78995692|FG002|Overall Study|F/U not completed w/in study window|1|||
44200158|NCT02087150|78995690|FG000|Overall Study|Other|1|||
44200159|NCT02087150|78995691|FG001|Overall Study|Other|0|||
44200160|NCT02087150|78995692|FG002|Overall Study|Other|0|||
44200161|NCT02087150|78995690|FG000|Overall Study|Pt moved out of town|0|||
44200162|NCT02087150|78995691|FG001|Overall Study|Pt moved out of town|1|||
44200163|NCT02087150|78995692|FG002|Overall Study|Pt moved out of town|0|||
44200164|NCT02111174|78995703|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
44200165|NCT02111174|78995704|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
44200166|NCT02111174|78995703|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
44200167|NCT02111174|78995704|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
44200168|NCT02111174|78995703|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
44200169|NCT02111174|78995704|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
44200170|NCT02111174|78995703|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
44200171|NCT02111174|78995704|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
44200172|NCT02111096|78995713|FG000|Overall Study|Adverse Event|4|||
44200173|NCT02111096|78995714|FG001|Overall Study|Adverse Event|1|||
44200174|NCT02111096|78995715|FG002|Overall Study|Adverse Event|2|||
44200175|NCT02111096|78995713|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44200176|NCT02111096|78995714|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44200177|NCT02111096|78995715|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44200178|NCT02111096|78995713|FG000|Overall Study|Lost to Follow Up|1|||
44200179|NCT02111096|78995714|FG001|Overall Study|Lost to Follow Up|1|||
44200180|NCT02111096|78995715|FG002|Overall Study|Lost to Follow Up|1|||
44200181|NCT02111096|78995713|FG000|Overall Study|Physician Decision|0|||
44200182|NCT02111096|78995714|FG001|Overall Study|Physician Decision|1|||
44200183|NCT02111096|78995715|FG002|Overall Study|Physician Decision|0|||
44200184|NCT02111096|78995713|FG000|Overall Study|Protocol Violation|1|||
44200185|NCT02111096|78995714|FG001|Overall Study|Protocol Violation|0|||
44200186|NCT02111096|78995715|FG002|Overall Study|Protocol Violation|1|||
44200187|NCT02111096|78995713|FG000|Overall Study|Terminated by Sponsor|53|||
44200188|NCT02111096|78995714|FG001|Overall Study|Terminated by Sponsor|35|||
44200189|NCT02111096|78995715|FG002|Overall Study|Terminated by Sponsor|54|||
44200190|NCT02111096|78995713|FG000|Overall Study|Withdrawal by Subject|4|||
44200191|NCT02111096|78995714|FG001|Overall Study|Withdrawal by Subject|2|||
44200192|NCT02111096|78995715|FG002|Overall Study|Withdrawal by Subject|8|||
44200193|NCT02110706|78995728|FG000|Overall Study|Adverse Event|2|||
44200194|NCT02110706|78995729|FG001|Overall Study|Adverse Event|3|||
44200195|NCT02110706|78995728|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
44200196|NCT02110706|78995729|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
44200197|NCT02110238|78995739|FG000|12 Week Pivotal Phase|Adverse Event|3|||
44200198|NCT02110238|78995740|FG001|12 Week Pivotal Phase|Adverse Event|0|||
44200199|NCT02110238|78995739|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
44200200|NCT02110238|78995740|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
44200201|NCT02110238|78995739|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
44200202|NCT02110238|78995740|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
44200203|NCT02110238|78995739|FG000|12 Week Pivotal Phase|Physician Decision|0|||
44200204|NCT02110238|78995740|FG001|12 Week Pivotal Phase|Physician Decision|2|||
44200205|NCT02110238|78995739|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
44200206|NCT02110238|78995740|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
44200207|NCT02110238|78995739|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
44200208|NCT02110238|78995740|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
44200209|NCT02110238|78995739|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
44200210|NCT02110238|78995740|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
44200211|NCT02110238|78995739|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
44200212|NCT02110238|78995740|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
44200213|NCT02110238|78995739|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
44266845|NCT02401230|79179495|FG001|Overall Study|Withdrawal by Subject|1|||
44200214|NCT02110238|78995740|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
44200215|NCT02110238|78995739|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
44200216|NCT02110238|78995740|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
44200217|NCT02110238|78995739|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
44200218|NCT02110238|78995740|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
44200219|NCT02108912|78995748|FG000|Overall Study|Lost to Follow-up|1|||
44200220|NCT02108912|78995749|FG001|Overall Study|Lost to Follow-up|1|||
44200221|NCT02108912|78995748|FG000|Overall Study|lack of transportation|1|||
44200222|NCT02108912|78995749|FG001|Overall Study|lack of transportation|0|||
44200223|NCT02108912|78995748|FG000|Overall Study|high blood pressure|1|||
44200224|NCT02108912|78995749|FG001|Overall Study|high blood pressure|0|||
44200225|NCT02108600|78995757|FG000|Overall Study|Withdrawal by Subject|2|||
44200226|NCT02108600|78995758|FG001|Overall Study|Withdrawal by Subject|0|||
44200227|NCT02108600|78995757|FG000|Overall Study|Lost to Follow-up|1|||
44200228|NCT02108600|78995758|FG001|Overall Study|Lost to Follow-up|1|||
44200229|NCT02107898|78995766|FG000|Overall Study|Adverse Event|4|||
44200230|NCT02107898|78995767|FG001|Overall Study|Adverse Event|7|||
44200231|NCT02107898|78995766|FG000|Overall Study|Poor compliance to protocol|0|||
44200232|NCT02107898|78995767|FG001|Overall Study|Poor compliance to protocol|1|||
44200233|NCT02107898|78995766|FG000|Overall Study|Participant moved|0|||
44200234|NCT02107898|78995767|FG001|Overall Study|Participant moved|2|||
44200235|NCT02107898|78995766|FG000|Overall Study|Consent withdrawn by participant|2|||
44200236|NCT02107898|78995767|FG001|Overall Study|Consent withdrawn by participant|1|||
44200237|NCT02107898|78995766|FG000|Overall Study|Randomized but not treated|0|||
44200238|NCT02107898|78995767|FG001|Overall Study|Randomized but not treated|1|||
44200239|NCT02059148|78995773|FG000|Treatment 1|Protocol Violation|0|||
44266846|NCT02401230|79179496|FG002|Overall Study|Withdrawal by Subject|1|||
44266847|NCT02401230|79179494|FG000|Overall Study|Lost to Follow-up|1|||
44266848|NCT02401230|79179495|FG001|Overall Study|Lost to Follow-up|3|||
44266849|NCT02401230|79179496|FG002|Overall Study|Lost to Follow-up|3|||
44266850|NCT02429310|79179537|FG000|Overall Study|Lost to Follow-up|1|||
44266851|NCT02429310|79179538|FG001|Overall Study|Lost to Follow-up|2|||
44266852|NCT02429310|79179537|FG000|Overall Study|Protocol Violation|1|||
44266853|NCT02429310|79179538|FG001|Overall Study|Protocol Violation|1|||
44266854|NCT02428608|79179564|FG000|Overall Study|Pregnancy|2|||
44266855|NCT02428608|79179564|FG000|Overall Study|Lost to Follow-up|37|||
44266856|NCT02428608|79179564|FG000|Overall Study|Withdrawal by Subject|2|||
44266857|NCT02428608|79179564|FG000|Overall Study|scheduling conflicts|15|||
44266858|NCT02428608|79179564|FG000|Overall Study|moved away|10|||
44266859|NCT02428608|79179564|FG000|Overall Study|Death|1|||
44266860|NCT02428608|79179564|FG000|Overall Study|various|16|||
44266861|NCT02428296|79179584|FG000|Overall Study|Adverse Event|7|||
44266862|NCT02428296|79179584|FG000|Overall Study|Withdrawal by Subject|2|||
44266863|NCT02427984|79179598|FG000|Overall Study|Lost to Follow-up|13|||
44266864|NCT02427984|79179599|FG001|Overall Study|Lost to Follow-up|5|||
44266865|NCT02427984|79179600|FG002|Overall Study|Lost to Follow-up|18|||
44266866|NCT00556673|79179818|FG000|Overall Study|Protocol deviation|3|||
44266867|NCT00556673|79179819|FG001|Overall Study|Protocol deviation|2|||
44266868|NCT02402322|79179843|FG000|Pretreatment|Withdrawal by Subject|3|||
44266869|NCT02402322|79179844|FG001|Pretreatment|Withdrawal by Subject|1|||
44266870|NCT02402322|79179845|FG002|Pretreatment|Withdrawal by Subject|1|||
44266871|NCT02402322|79179843|FG000|Follow-up|Withdrawal by Subject|6|||
44266872|NCT02402322|79179844|FG001|Follow-up|Withdrawal by Subject|3|||
44266873|NCT02402322|79179845|FG002|Follow-up|Withdrawal by Subject|24|||
44266874|NCT00555425|79179961|FG000|Overall Study|Missed Medication > 1 wk|34|||
44266875|NCT00555425|79179962|FG001|Overall Study|Missed Medication > 1 wk|15|||
44266876|NCT00555425|79179961|FG000|Overall Study|Missed 3 physician management visits|1|||
44266877|NCT00555425|79179962|FG001|Overall Study|Missed 3 physician management visits|0|||
44266878|NCT00555425|79179961|FG000|Overall Study|Met criteria for protective transfer|16|||
44266879|NCT00555425|79179962|FG001|Overall Study|Met criteria for protective transfer|3|||
44266880|NCT00555425|79179961|FG000|Overall Study|Became pregnant and transferred care|0|||
44266881|NCT00555425|79179962|FG001|Overall Study|Became pregnant and transferred care|1|||
44266882|NCT00554099|79180143|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
44266883|NCT00554099|79180144|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
44266884|NCT00554099|79180145|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
44266885|NCT00554099|79180143|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
44266886|NCT00554099|79180144|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
44266887|NCT00554099|79180145|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
44266888|NCT00554099|79180143|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
44266889|NCT00554099|79180144|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
44200240|NCT02059148|78995774|FG001|Treatment 1|Protocol Violation|0|||
44200241|NCT02059148|78995775|FG002|Treatment 1|Protocol Violation|0|||
44266890|NCT00554099|79180145|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
44266891|NCT00554099|79180143|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
44200242|NCT02059148|78995776|FG003|Treatment 1|Protocol Violation|0|||
44266892|NCT00554099|79180144|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
44200243|NCT02059148|78995777|FG004|Treatment 1|Protocol Violation|0|||
44266893|NCT00554099|79180145|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
44266894|NCT00554099|79180143|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
44266895|NCT00554099|79180144|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
44200244|NCT02059148|78995778|FG005|Treatment 1|Protocol Violation|1|||
44200245|NCT02058992|78995789|FG000|Overall Study|Lost to Follow-up|4|||
44200246|NCT02058992|78995789|FG000|Overall Study|Protocol Violation|92|||
44200247|NCT02058992|78995789|FG000|Overall Study|CRF Uncollected|20|||
44200248|NCT02058836|78995795|FG000|Overall Study|Withdrawal by Subject|1|||
44451601|NCT00684515|79460486|FG002|Overall Study|Adverse Event|1|||
44451602|NCT00684515|79460484|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
44451603|NCT00684515|79460485|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
44451604|NCT00684515|79460486|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
44200249|NCT02058836|78995796|FG001|Overall Study|Withdrawal by Subject|1|||
44200250|NCT02107274|78995804|FG000|Treatment vs. Placebo|Adverse Event|3|||
44200251|NCT02107274|78995805|FG001|Treatment vs. Placebo|Adverse Event|0|||
44200252|NCT02107274|78995804|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
44200253|NCT02107274|78995805|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
44200254|NCT02107274|78995804|FG000|Control Phase|Lost to Follow-up|1|||
44200255|NCT02107274|78995805|FG001|Control Phase|Lost to Follow-up|1|||
44200256|NCT02107274|78995804|FG000|Control Phase|Death|2|||
44200257|NCT02107274|78995805|FG001|Control Phase|Death|0|||
44200258|NCT02107274|78995804|FG000|Control Phase|Adverse Event|0|||
44200259|NCT02107274|78995805|FG001|Control Phase|Adverse Event|1|||
44200260|NCT02174627|78995813|FG000|Overall Study|Missing|0|||
44200261|NCT02174627|78995814|FG001|Overall Study|Missing|1|||
44200262|NCT02174627|78995813|FG000|Overall Study|Incorrect enrolment before randomization|0|||
44200263|NCT02174627|78995814|FG001|Overall Study|Incorrect enrolment before randomization|1|||
44200264|NCT02174627|78995813|FG000|Overall Study|Participant decision|84|||
44200265|NCT02174627|78995814|FG001|Overall Study|Participant decision|128|||
44200266|NCT02173769|78995820|FG000|Overall Study|Protocol Violation|4|||
44200267|NCT02121509|78995827|FG000|Washout Period (35 Days)|Adverse Event|1|||
44200268|NCT02121509|78995828|FG001|Washout Period (35 Days)|Adverse Event|1|||
44200269|NCT02121509|78995829|FG002|Washout Period (35 Days)|Adverse Event|0|||
44200270|NCT02121509|78995830|FG003|Washout Period (35 Days)|Adverse Event|0|||
44200271|NCT02121509|78995827|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
44200272|NCT02121509|78995828|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
44200273|NCT02121509|78995829|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
44200274|NCT02121509|78995830|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
44266896|NCT00554099|79180145|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
44266897|NCT00554099|79180143|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
44266898|NCT00554099|79180144|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
44266899|NCT00554099|79180145|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
44266900|NCT00554099|79180143|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
44266901|NCT00554099|79180144|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
44266902|NCT00554099|79180145|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
44266903|NCT00554099|79180143|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
44266904|NCT00554099|79180144|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
44266905|NCT00554099|79180145|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
44266906|NCT00554099|79180143|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
44266907|NCT00554099|79180144|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
44266908|NCT00554099|79180145|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
44266909|NCT02377362|79180179|FG000|Part A Second Treatment|Protocol Violation|0|||
44266910|NCT02377362|79180180|FG001|Part A Second Treatment|Protocol Violation|0|||
44266911|NCT02377362|79180181|FG002|Part A Second Treatment|Protocol Violation|0|||
44266912|NCT02377362|79180182|FG003|Part A Second Treatment|Protocol Violation|0|||
44266913|NCT02377362|79180183|FG004|Part A Second Treatment|Protocol Violation|1|||
44266914|NCT02377362|79180184|FG005|Part A Second Treatment|Protocol Violation|0|||
44266915|NCT02377362|79180185|FG006|Part A Second Treatment|Protocol Violation|0|||
44266916|NCT02377362|79180186|FG007|Part A Second Treatment|Protocol Violation|0|||
44266917|NCT02377362|79180187|FG008|Part A Second Treatment|Protocol Violation|0|||
44266918|NCT02377362|79180188|FG009|Part A Second Treatment|Protocol Violation|0|||
44266919|NCT02377362|79180189|FG010|Part A Second Treatment|Protocol Violation|0|||
44266920|NCT02377362|79180190|FG011|Part A Second Treatment|Protocol Violation|0|||
44266921|NCT02377362|79180191|FG012|Part A Second Treatment|Protocol Violation|0|||
44266922|NCT02377362|79180179|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
44266923|NCT02377362|79180180|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
44266924|NCT02377362|79180181|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
44266925|NCT02377362|79180182|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
44266926|NCT02377362|79180183|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
44266927|NCT02377362|79180184|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
44266928|NCT02377362|79180185|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
44200275|NCT02121509|78995827|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
44266929|NCT02377362|79180186|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
44266930|NCT02377362|79180187|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
44277769|NCT02138916|79238747|FG002|Overall Study|incorrect enrolment|0|||
44200276|NCT02121509|78995828|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
44451605|NCT00490815|79460496|FG000|Overall Study|Adverse Event|2|||
44451606|NCT00490815|79460497|FG001|Overall Study|Adverse Event|3|||
44200277|NCT02121509|78995829|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
44200278|NCT02121509|78995830|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
44200279|NCT02149199|78995843|FG000|Overall Study|Study specific withdrawal criteria|4|||
44200280|NCT02149199|78995844|FG001|Overall Study|Study specific withdrawal criteria|21|||
44200281|NCT02149199|78995845|FG002|Overall Study|Study specific withdrawal criteria|6|||
44200282|NCT02149199|78995843|FG000|Overall Study|Other|20|||
44200283|NCT02149199|78995844|FG001|Overall Study|Other|25|||
44200284|NCT02149199|78995845|FG002|Overall Study|Other|20|||
44200285|NCT02149199|78995843|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
44200286|NCT02149199|78995844|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
44200287|NCT02149199|78995845|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
44200288|NCT02149199|78995843|FG000|Overall Study|Withdrawal by Subject|75|||
44200289|NCT02149199|78995844|FG001|Overall Study|Withdrawal by Subject|93|||
44200290|NCT02149199|78995845|FG002|Overall Study|Withdrawal by Subject|77|||
44200291|NCT02149199|78995843|FG000|Overall Study|Protocol Violation|16|||
44200292|NCT02149199|78995844|FG001|Overall Study|Protocol Violation|13|||
44200293|NCT02149199|78995845|FG002|Overall Study|Protocol Violation|15|||
44200294|NCT02149199|78995843|FG000|Overall Study|Lost to Follow-up|3|||
44200295|NCT02149199|78995844|FG001|Overall Study|Lost to Follow-up|12|||
44200296|NCT02149199|78995845|FG002|Overall Study|Lost to Follow-up|11|||
44200297|NCT02149199|78995843|FG000|Overall Study|Death|0|||
44200298|NCT02149199|78995844|FG001|Overall Study|Death|0|||
44200299|NCT02149199|78995845|FG002|Overall Study|Death|1|||
44200300|NCT02149199|78995843|FG000|Overall Study|Adverse Event|6|||
44200301|NCT02149199|78995844|FG001|Overall Study|Adverse Event|15|||
44200302|NCT02149199|78995845|FG002|Overall Study|Adverse Event|9|||
44200303|NCT02120417|78995855|FG000|Overall Study|Death|5|||
44200304|NCT02120417|78995856|FG001|Overall Study|Death|1|||
44200305|NCT02120417|78995855|FG000|Overall Study|Adverse Event|3|||
44200306|NCT02120417|78995856|FG001|Overall Study|Adverse Event|9|||
44200307|NCT02120417|78995855|FG000|Overall Study|Participant decision|4|||
44200308|NCT02120417|78995856|FG001|Overall Study|Participant decision|4|||
44200309|NCT02120417|78995855|FG000|Overall Study|Disease progression|41|||
44200310|NCT02120417|78995856|FG001|Overall Study|Disease progression|45|||
44200311|NCT02120417|78995855|FG000|Overall Study|Noncompliance with study treatment|0|||
44200312|NCT02120417|78995856|FG001|Overall Study|Noncompliance with study treatment|2|||
44200313|NCT02120417|78995855|FG000|Overall Study|Physician Decision|2|||
44200314|NCT02120417|78995856|FG001|Overall Study|Physician Decision|3|||
44200315|NCT02120417|78995855|FG000|Overall Study|Other unspecified|5|||
44200316|NCT02120417|78995856|FG001|Overall Study|Other unspecified|4|||
44200317|NCT02148263|78995864|FG000|Overall Study|Withdrawal by Subject|3|||
44200318|NCT02148263|78995865|FG001|Overall Study|Withdrawal by Subject|2|||
44200319|NCT02147561|78995871|FG000|Overall Study|Lost to Follow-up|3|||
44200320|NCT02147561|78995871|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
44200321|NCT02058368|78995877|FG000|Overall Study|Adverse Event|15|||
44200322|NCT02058368|78995878|FG001|Overall Study|Adverse Event|20|||
44200323|NCT02058368|78995877|FG000|Overall Study|Lack of Efficacy|0|||
44200324|NCT02058368|78995878|FG001|Overall Study|Lack of Efficacy|1|||
44200325|NCT02058368|78995877|FG000|Overall Study|Protocol Violation|0|||
44200326|NCT02058368|78995878|FG001|Overall Study|Protocol Violation|4|||
44200327|NCT02058368|78995877|FG000|Overall Study|Lost to Follow-up|2|||
44200328|NCT02058368|78995878|FG001|Overall Study|Lost to Follow-up|0|||
44266931|NCT02377362|79180188|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
44451607|NCT00490815|79460496|FG000|Overall Study|Withdrawal by Subject|4|||
44200329|NCT02058368|78995877|FG000|Overall Study|Physician Decision|2|||
44200330|NCT02058368|78995878|FG001|Overall Study|Physician Decision|3|||
44200331|NCT02058368|78995877|FG000|Overall Study|Withdrawal by Subject|22|||
44200332|NCT02058368|78995878|FG001|Overall Study|Withdrawal by Subject|26|||
44200333|NCT02107196|78995886|FG000|12-week Treatment Period|Adverse Event|6|||
44200334|NCT02107196|78995887|FG001|12-week Treatment Period|Adverse Event|3|||
44200335|NCT02107196|78995886|FG000|12-week Treatment Period|Lack of Efficacy|2|||
44200336|NCT02107196|78995887|FG001|12-week Treatment Period|Lack of Efficacy|1|||
44200337|NCT02107196|78995886|FG000|12-week Treatment Period|Lost to Follow-up|3|||
44200338|NCT02107196|78995887|FG001|12-week Treatment Period|Lost to Follow-up|6|||
44200339|NCT02107196|78995886|FG000|12-week Treatment Period|Physician Decision|0|||
44200340|NCT02107196|78995887|FG001|12-week Treatment Period|Physician Decision|1|||
44200341|NCT02107196|78995886|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
44200342|NCT02107196|78995887|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
44200343|NCT02107196|78995886|FG000|12-week Treatment Period|Protocol Violation|7|||
44200344|NCT02107196|78995887|FG001|12-week Treatment Period|Protocol Violation|8|||
44200345|NCT02107196|78995886|FG000|12-week Treatment Period|Reason Missing|11|||
44200346|NCT02107196|78995887|FG001|12-week Treatment Period|Reason Missing|8|||
44200347|NCT02107196|78995886|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
44200348|NCT02107196|78995887|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
44200349|NCT02107196|78995886|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
44200350|NCT02107196|78995887|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
44200351|NCT02107196|78995886|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
44200352|NCT02107196|78995887|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
44200353|NCT02107196|78995886|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
44200354|NCT02107196|78995887|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
44200355|NCT02058290|78995895|FG000|Overall Study|Protocol Violation|2|||
44200356|NCT02058290|78995896|FG001|Overall Study|Protocol Violation|1|||
44200357|NCT02058290|78995895|FG000|Overall Study|Physician Decision|1|||
44200358|NCT02058290|78995896|FG001|Overall Study|Physician Decision|0|||
44200359|NCT02058290|78995895|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
44200360|NCT02058290|78995896|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
44200361|NCT02058290|78995895|FG000|Overall Study|Withdrawal by Subject|0|||
44200362|NCT02058290|78995896|FG001|Overall Study|Withdrawal by Subject|1|||
44200363|NCT02082158|78995908|FG000|Overall Study|Withdrawal by Subject|0|||
44200364|NCT02082158|78995909|FG001|Overall Study|Withdrawal by Subject|0|||
44200365|NCT02082158|78995910|FG002|Overall Study|Withdrawal by Subject|0|||
44200366|NCT02082158|78995911|FG003|Overall Study|Withdrawal by Subject|0|||
44200367|NCT02082158|78995912|FG004|Overall Study|Withdrawal by Subject|1|||
44200368|NCT02082158|78995913|FG005|Overall Study|Withdrawal by Subject|0|||
44200369|NCT02082158|78995908|FG000|Overall Study|Failed Fit-testing|8|||
44200370|NCT02082158|78995909|FG001|Overall Study|Failed Fit-testing|8|||
44200371|NCT02082158|78995910|FG002|Overall Study|Failed Fit-testing|14|||
44200372|NCT02082158|78995911|FG003|Overall Study|Failed Fit-testing|4|||
44200373|NCT02082158|78995912|FG004|Overall Study|Failed Fit-testing|3|||
44200374|NCT02082158|78995913|FG005|Overall Study|Failed Fit-testing|7|||
44200375|NCT02106884|78995935|FG000|Overall Study|Change of diagnosis/exclusion|0|||
44200376|NCT02106884|78995936|FG001|Overall Study|Change of diagnosis/exclusion|1|||
44200377|NCT02081846|78995947|FG000|Overall Study|Withdrawal by Subject|1|||
44200378|NCT02081846|78995948|FG001|Overall Study|Withdrawal by Subject|0|||
44200379|NCT02081846|78995947|FG000|Overall Study|invalid consent|1|||
44200380|NCT02081846|78995948|FG001|Overall Study|invalid consent|0|||
44200381|NCT02081690|78995954|FG000|Overall Study|Death|3|||
44200382|NCT02081690|78995954|FG000|Overall Study|Physician Decision|3|||
44200383|NCT02081690|78995954|FG000|Overall Study|Withdrawal by Subject|1|||
44200384|NCT02057666|78995960|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
44200385|NCT02057666|78995961|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
44200386|NCT02057666|78995960|FG000|Double Blind Treatment Period|Poor tolerability|7|||
44200387|NCT02057666|78995961|FG001|Double Blind Treatment Period|Poor tolerability|2|||
44200388|NCT02057666|78995960|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
44200389|NCT02057666|78995961|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
44200390|NCT02057666|78995960|FG000|Double Blind Treatment Period|Physician Decision|1|||
44200391|NCT02057666|78995961|FG001|Double Blind Treatment Period|Physician Decision|0|||
44200392|NCT02057666|78995960|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
44266932|NCT02377362|79180189|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
44266933|NCT02377362|79180190|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
44200393|NCT02057666|78995961|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
44200394|NCT02057666|78995960|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
44200395|NCT02057666|78995961|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
44200396|NCT02057666|78995960|FG000|Double Blind Treatment Period|Sponsor's request|70|||
44200397|NCT02057666|78995961|FG001|Double Blind Treatment Period|Sponsor's request|34|||
44200398|NCT02057666|78995960|FG000|Open-Label Treatment Period|Poor tolerability|0|||
44200399|NCT02057666|78995961|FG001|Open-Label Treatment Period|Poor tolerability|1|||
44200400|NCT02057666|78995960|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
44200401|NCT02057666|78995961|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
44200402|NCT02057666|78995960|FG000|Open-Label Treatment Period|Sponsor's request|0|||
44200403|NCT02057666|78995961|FG001|Open-Label Treatment Period|Sponsor's request|4|||
44200404|NCT01625000|78995972|FG000|Overall Study|Physician Decision|15|||
44200405|NCT01625000|78995973|FG001|Overall Study|Physician Decision|7|||
44200406|NCT01625000|78995974|FG002|Overall Study|Physician Decision|7|||
44200407|NCT01625000|78995975|FG003|Overall Study|Physician Decision|2|||
44200408|NCT01625000|78995976|FG004|Overall Study|Physician Decision|15|||
44200409|NCT01625000|78995972|FG000|Overall Study|Protocol Violation|3|||
44200410|NCT01625000|78995973|FG001|Overall Study|Protocol Violation|10|||
44200411|NCT01625000|78995974|FG002|Overall Study|Protocol Violation|4|||
44200412|NCT01625000|78995975|FG003|Overall Study|Protocol Violation|1|||
44200413|NCT01625000|78995976|FG004|Overall Study|Protocol Violation|2|||
44200414|NCT01625000|78995972|FG000|Overall Study|Withdrawal by Subject|19|||
44200415|NCT01625000|78995973|FG001|Overall Study|Withdrawal by Subject|16|||
44200416|NCT01625000|78995974|FG002|Overall Study|Withdrawal by Subject|11|||
44200417|NCT01625000|78995975|FG003|Overall Study|Withdrawal by Subject|9|||
44200418|NCT01625000|78995976|FG004|Overall Study|Withdrawal by Subject|17|||
44200419|NCT01625000|78995972|FG000|Overall Study|Adverse Event (including Death)|15|||
44200420|NCT01625000|78995973|FG001|Overall Study|Adverse Event (including Death)|19|||
44200421|NCT01625000|78995974|FG002|Overall Study|Adverse Event (including Death)|11|||
44200422|NCT01625000|78995975|FG003|Overall Study|Adverse Event (including Death)|7|||
44200423|NCT01625000|78995976|FG004|Overall Study|Adverse Event (including Death)|21|||
44200424|NCT02081534|78995995|FG000|Overall Study|Adverse Event|5|||
44200425|NCT02081534|78995996|FG001|Overall Study|Adverse Event|4|||
44200426|NCT02081534|78995997|FG002|Overall Study|Adverse Event|3|||
44200427|NCT02081534|78995998|FG003|Overall Study|Adverse Event|10|||
44200428|NCT02081534|78995999|FG004|Overall Study|Adverse Event|2|||
44200429|NCT02081534|78996000|FG005|Overall Study|Adverse Event|8|||
44200430|NCT02081534|78996001|FG006|Overall Study|Adverse Event|2|||
44200431|NCT02081534|78995995|FG000|Overall Study|Withdrawal by Subject|0|||
44200432|NCT02081534|78995996|FG001|Overall Study|Withdrawal by Subject|1|||
44200433|NCT02081534|78995997|FG002|Overall Study|Withdrawal by Subject|1|||
44200434|NCT02081534|78995998|FG003|Overall Study|Withdrawal by Subject|1|||
44200435|NCT02081534|78995999|FG004|Overall Study|Withdrawal by Subject|1|||
44200436|NCT02081534|78996000|FG005|Overall Study|Withdrawal by Subject|0|||
44200437|NCT02081534|78996001|FG006|Overall Study|Withdrawal by Subject|1|||
44200438|NCT02081534|78995995|FG000|Overall Study|Protocol Violation|0|||
44200439|NCT02081534|78995996|FG001|Overall Study|Protocol Violation|3|||
44200440|NCT02081534|78995997|FG002|Overall Study|Protocol Violation|0|||
44200441|NCT02081534|78995998|FG003|Overall Study|Protocol Violation|0|||
44200442|NCT02081534|78995999|FG004|Overall Study|Protocol Violation|0|||
44200443|NCT02081534|78996000|FG005|Overall Study|Protocol Violation|0|||
44200444|NCT02081534|78996001|FG006|Overall Study|Protocol Violation|1|||
44200445|NCT02081534|78995995|FG000|Overall Study|Lost to Follow-up|0|||
44200446|NCT02081534|78995996|FG001|Overall Study|Lost to Follow-up|0|||
44200447|NCT02081534|78995997|FG002|Overall Study|Lost to Follow-up|0|||
44200448|NCT02081534|78995998|FG003|Overall Study|Lost to Follow-up|2|||
44200449|NCT02081534|78995999|FG004|Overall Study|Lost to Follow-up|1|||
44266934|NCT02377362|79180191|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
44266935|NCT02377362|79180179|FG000|Part B Overall|Protocol Violation|0|||
44266936|NCT02377362|79180180|FG001|Part B Overall|Protocol Violation|0|||
44266937|NCT02377362|79180181|FG002|Part B Overall|Protocol Violation|0|||
44266938|NCT02377362|79180182|FG003|Part B Overall|Protocol Violation|0|||
44266939|NCT02377362|79180183|FG004|Part B Overall|Protocol Violation|0|||
44266940|NCT02377362|79180184|FG005|Part B Overall|Protocol Violation|0|||
44266941|NCT02377362|79180185|FG006|Part B Overall|Protocol Violation|0|||
44266942|NCT02377362|79180186|FG007|Part B Overall|Protocol Violation|0|||
44266943|NCT02377362|79180187|FG008|Part B Overall|Protocol Violation|0|||
44266944|NCT02377362|79180188|FG009|Part B Overall|Protocol Violation|1|||
44266945|NCT02377362|79180189|FG010|Part B Overall|Protocol Violation|0|||
44266946|NCT02377362|79180190|FG011|Part B Overall|Protocol Violation|0|||
44266947|NCT02377362|79180191|FG012|Part B Overall|Protocol Violation|0|||
44266948|NCT02377362|79180179|FG000|Part B Overall|Adverse Event|0|||
44266949|NCT02377362|79180180|FG001|Part B Overall|Adverse Event|0|||
44266950|NCT02377362|79180181|FG002|Part B Overall|Adverse Event|0|||
44451608|NCT00490815|79460497|FG001|Overall Study|Withdrawal by Subject|0|||
44200450|NCT02081534|78996000|FG005|Overall Study|Lost to Follow-up|1|||
44200451|NCT02081534|78996001|FG006|Overall Study|Lost to Follow-up|0|||
44200452|NCT02057198|78996020|FG000|Overall Study|Death|0|||
44200453|NCT02057198|78996021|FG001|Overall Study|Death|0|||
44200454|NCT02057198|78996022|FG002|Overall Study|Death|1|||
44200455|NCT02057198|78996020|FG000|Overall Study|Discharged early; lost to followup|0|||
44200456|NCT02057198|78996021|FG001|Overall Study|Discharged early; lost to followup|1|||
44266951|NCT02377362|79180182|FG003|Part B Overall|Adverse Event|0|||
44266952|NCT02377362|79180183|FG004|Part B Overall|Adverse Event|0|||
44200457|NCT02057198|78996022|FG002|Overall Study|Discharged early; lost to followup|0|||
44200458|NCT02056652|78996032|FG000|Overall Study|Withdrawal by Subject|1|||
44200459|NCT02056652|78996033|FG001|Overall Study|Withdrawal by Subject|0|||
44200460|NCT02056652|78996032|FG000|Overall Study|Lost to Follow-up|0|||
44200461|NCT02056652|78996033|FG001|Overall Study|Lost to Follow-up|3|||
44200462|NCT02056340|78996041|FG000|Overall Study|Lost to Follow-up|5|||
44200463|NCT02056340|78996042|FG001|Overall Study|Lost to Follow-up|5|||
44200464|NCT02056340|78996041|FG000|Overall Study|Withdrawal by Subject|2|||
44200465|NCT02056340|78996042|FG001|Overall Study|Withdrawal by Subject|6|||
44200466|NCT02046122|78996048|FG000|Overall Study|Physician Decision|8|||
44200467|NCT02046122|78996048|FG000|Overall Study|Withdrawal by Subject|1|||
44200468|NCT02080832|78996055|FG000|Overall Study|Excluded from analysis by MRI|9|||
44200469|NCT02080832|78996056|FG001|Overall Study|Excluded from analysis by MRI|10|||
44200470|NCT02080832|78996057|FG002|Overall Study|Excluded from analysis by MRI|14|||
44200471|NCT02080832|78996055|FG000|Overall Study|Lost to Follow-up|0|||
44200472|NCT02080832|78996056|FG001|Overall Study|Lost to Follow-up|2|||
44200473|NCT02080832|78996057|FG002|Overall Study|Lost to Follow-up|2|||
44200474|NCT02080364|78996071|FG000|Baseline Period|Protocol Violation|2|||
44200475|NCT02080364|78996072|FG001|Baseline Period|Protocol Violation|1|||
44200476|NCT02080364|78996073|FG002|Baseline Period|Protocol Violation|0|||
44200477|NCT02080364|78996074|FG003|Baseline Period|Protocol Violation|0|||
44200478|NCT02080364|78996071|FG000|Baseline Period|Other|0|||
44200479|NCT02080364|78996072|FG001|Baseline Period|Other|1|||
44200480|NCT02080364|78996073|FG002|Baseline Period|Other|1|||
44200481|NCT02080364|78996074|FG003|Baseline Period|Other|0|||
44200482|NCT02080364|78996071|FG000|Treatment Period|Adverse Event|10|||
44200483|NCT02080364|78996072|FG001|Treatment Period|Adverse Event|15|||
44200484|NCT02080364|78996073|FG002|Treatment Period|Adverse Event|11|||
44200485|NCT02080364|78996074|FG003|Treatment Period|Adverse Event|14|||
44200486|NCT02080364|78996071|FG000|Treatment Period|Lost to Follow-up|2|||
44200487|NCT02080364|78996072|FG001|Treatment Period|Lost to Follow-up|3|||
44200488|NCT02080364|78996073|FG002|Treatment Period|Lost to Follow-up|5|||
44200489|NCT02080364|78996074|FG003|Treatment Period|Lost to Follow-up|0|||
44200490|NCT02080364|78996071|FG000|Treatment Period|Protocol Violation|5|||
44200491|NCT02080364|78996072|FG001|Treatment Period|Protocol Violation|3|||
44200492|NCT02080364|78996073|FG002|Treatment Period|Protocol Violation|5|||
44200493|NCT02080364|78996074|FG003|Treatment Period|Protocol Violation|1|||
44200494|NCT02080364|78996071|FG000|Treatment Period|Withdrawal by Subject|16|||
44200495|NCT02080364|78996072|FG001|Treatment Period|Withdrawal by Subject|16|||
44200496|NCT02080364|78996073|FG002|Treatment Period|Withdrawal by Subject|15|||
44200497|NCT02080364|78996074|FG003|Treatment Period|Withdrawal by Subject|10|||
44200498|NCT02080364|78996071|FG000|Treatment Period|Study Terminated by Sponsor|0|||
44200499|NCT02080364|78996072|FG001|Treatment Period|Study Terminated by Sponsor|0|||
44200500|NCT02080364|78996073|FG002|Treatment Period|Study Terminated by Sponsor|180|||
44200501|NCT02080364|78996074|FG003|Treatment Period|Study Terminated by Sponsor|183|||
44200502|NCT02080364|78996071|FG000|Treatment Period|Other|14|||
44200503|NCT02080364|78996072|FG001|Treatment Period|Other|12|||
44200504|NCT02080364|78996073|FG002|Treatment Period|Other|21|||
44200505|NCT02080364|78996074|FG003|Treatment Period|Other|16|||
44200506|NCT02079038|78996086|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
44200507|NCT02079038|78996087|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
44200508|NCT02079038|78996086|FG000|Modified Intent to Treat Population|Death|1|||
44200509|NCT02079038|78996087|FG001|Modified Intent to Treat Population|Death|0|||
44200510|NCT02079038|78996086|FG000|Completed 6 Months|Lost to Follow-up|2|||
44266953|NCT02377362|79180184|FG005|Part B Overall|Adverse Event|0|||
44266954|NCT02377362|79180185|FG006|Part B Overall|Adverse Event|1|||
44266955|NCT02377362|79180186|FG007|Part B Overall|Adverse Event|1|||
44266956|NCT02377362|79180187|FG008|Part B Overall|Adverse Event|0|||
44266957|NCT02377362|79180188|FG009|Part B Overall|Adverse Event|0|||
44266958|NCT02377362|79180189|FG010|Part B Overall|Adverse Event|0|||
44451609|NCT00490815|79460496|FG000|Overall Study|Lost to Follow-up|1|||
44451610|NCT00490815|79460497|FG001|Overall Study|Lost to Follow-up|3|||
44266959|NCT02377362|79180190|FG011|Part B Overall|Adverse Event|0|||
44266960|NCT02377362|79180191|FG012|Part B Overall|Adverse Event|0|||
44200511|NCT02079038|78996087|FG001|Completed 6 Months|Lost to Follow-up|1|||
44200512|NCT02045732|78996095|FG000|Overall Study|At the discretion of the investigator|1|||
44200513|NCT02045732|78996096|FG001|Overall Study|At the discretion of the investigator|1|||
44200514|NCT02044874|78996105|FG000|Overall Study|Adverse Event|5|||
44200515|NCT02044874|78996106|FG001|Overall Study|Adverse Event|6|||
44200516|NCT02044874|78996107|FG002|Overall Study|Adverse Event|6|||
44200517|NCT02044874|78996105|FG000|Overall Study|Withdrawal by Subject|8|||
44200518|NCT02044874|78996106|FG001|Overall Study|Withdrawal by Subject|16|||
44200519|NCT02044874|78996107|FG002|Overall Study|Withdrawal by Subject|23|||
44200520|NCT02044874|78996105|FG000|Overall Study|Physician Decision|0|||
44200521|NCT02044874|78996106|FG001|Overall Study|Physician Decision|2|||
44266961|NCT02377362|79180179|FG000|Part B Overall|Withdrawal by Subject|0|||
44266962|NCT02377362|79180180|FG001|Part B Overall|Withdrawal by Subject|0|||
44361378|NCT01110330|79367041|FG000|Overall Study|Withdrawal by Subject|0|||
44361379|NCT01110330|79367042|FG001|Overall Study|Withdrawal by Subject|6|||
44200522|NCT02044874|78996107|FG002|Overall Study|Physician Decision|1|||
44200523|NCT02044874|78996105|FG000|Overall Study|Lost to Follow-up|10|||
44200524|NCT02044874|78996106|FG001|Overall Study|Lost to Follow-up|27|||
44200525|NCT02044874|78996107|FG002|Overall Study|Lost to Follow-up|21|||
44200526|NCT02044874|78996105|FG000|Overall Study|Sponsor Decision|0|||
44200527|NCT02044874|78996106|FG001|Overall Study|Sponsor Decision|1|||
44200528|NCT02044874|78996107|FG002|Overall Study|Sponsor Decision|1|||
44200529|NCT02044874|78996105|FG000|Overall Study|Other|7|||
44200530|NCT02044874|78996106|FG001|Overall Study|Other|3|||
44200531|NCT02044874|78996107|FG002|Overall Study|Other|8|||
44200532|NCT02078960|78996120|FG000|Treatment Period|Other|0|||
44200533|NCT02078960|78996121|FG001|Treatment Period|Other|0|||
44200534|NCT02078960|78996122|FG002|Treatment Period|Other|1|||
44200535|NCT02078960|78996120|FG000|Treatment Period|Lack of Efficacy|0|||
44200536|NCT02078960|78996121|FG001|Treatment Period|Lack of Efficacy|1|||
44200537|NCT02078960|78996122|FG002|Treatment Period|Lack of Efficacy|0|||
44200538|NCT02078960|78996120|FG000|Treatment Period|Disease progression - accelerated phase|0|||
44200539|NCT02078960|78996121|FG001|Treatment Period|Disease progression - accelerated phase|1|||
44200540|NCT02078960|78996122|FG002|Treatment Period|Disease progression - accelerated phase|0|||
44200541|NCT02078960|78996120|FG000|Treatment Period|Disease progression - blast phase|1|||
44200542|NCT02078960|78996121|FG001|Treatment Period|Disease progression - blast phase|0|||
44200543|NCT02078960|78996122|FG002|Treatment Period|Disease progression - blast phase|0|||
44200544|NCT02078960|78996120|FG000|Treatment Period|Withdrawal by Subject|0|||
44200545|NCT02078960|78996121|FG001|Treatment Period|Withdrawal by Subject|1|||
44200546|NCT02078960|78996122|FG002|Treatment Period|Withdrawal by Subject|1|||
44200547|NCT02078960|78996120|FG000|Treatment Period|Adverse Event|1|||
44200548|NCT02078960|78996121|FG001|Treatment Period|Adverse Event|0|||
44200549|NCT02078960|78996122|FG002|Treatment Period|Adverse Event|0|||
44200550|NCT02078960|78996120|FG000|Treatment Period|Death|0|||
44200551|NCT02078960|78996121|FG001|Treatment Period|Death|0|||
44200552|NCT02078960|78996122|FG002|Treatment Period|Death|1|||
44200553|NCT02078960|78996120|FG000|Follow-up Period|Death|2|||
44200554|NCT02078960|78996121|FG001|Follow-up Period|Death|0|||
44200555|NCT02078960|78996122|FG002|Follow-up Period|Death|0|||
44200556|NCT02078960|78996120|FG000|Follow-up Period|Lost to Follow-up|0|||
44200557|NCT02078960|78996121|FG001|Follow-up Period|Lost to Follow-up|1|||
44200558|NCT02078960|78996122|FG002|Follow-up Period|Lost to Follow-up|0|||
44200559|NCT02078102|78996134|FG000|Overall Study|Adverse Event|1|||
44200560|NCT02078102|78996135|FG001|Overall Study|Adverse Event|0|||
44200561|NCT02078102|78996134|FG000|Overall Study|Withdrawal by Subject|1|||
44200562|NCT02078102|78996135|FG001|Overall Study|Withdrawal by Subject|0|||
44200563|NCT02078102|78996134|FG000|Overall Study|Physician Decision|0|||
44200564|NCT02078102|78996135|FG001|Overall Study|Physician Decision|1|||
44200565|NCT02054702|78996144|FG000|Overall Study|Lost to Follow-up|3|||
44200566|NCT02054702|78996145|FG001|Overall Study|Lost to Follow-up|5|||
44200567|NCT02054702|78996144|FG000|Overall Study|Adverse Event|3|||
44200568|NCT02054702|78996145|FG001|Overall Study|Adverse Event|1|||
44200569|NCT02054702|78996144|FG000|Overall Study|Met Withdrawal Criteria|4|||
44200570|NCT02054702|78996145|FG001|Overall Study|Met Withdrawal Criteria|1|||
44200571|NCT02054702|78996144|FG000|Overall Study|Physician Decision|0|||
44200572|NCT02054702|78996145|FG001|Overall Study|Physician Decision|1|||
44200573|NCT02054702|78996144|FG000|Overall Study|Withdrawal by Subject|14|||
44200574|NCT02054702|78996145|FG001|Overall Study|Withdrawal by Subject|4|||
44200575|NCT02044094|78996151|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
44200576|NCT02044094|78996151|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
44200577|NCT02044094|78996151|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
44200578|NCT02044094|78996151|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
44200579|NCT02044094|78996151|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
44200580|NCT02044094|78996151|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
44200581|NCT02044094|78996151|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
44200582|NCT02044094|78996151|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
44200583|NCT02043938|78996166|FG000|Overall Study|Withdrawal by Subject|7|||
44200584|NCT02043938|78996166|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
44200585|NCT02043938|78996166|FG000|Overall Study|No show by subject|1|||
44200586|NCT02043938|78996166|FG000|Overall Study|Investigator decision|1|||
44200587|NCT02053610|78996175|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
44200588|NCT02053610|78996176|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
44200589|NCT02053610|78996175|FG000|Overall Study|Withdrew Consent|2|||
44200590|NCT02053610|78996176|FG001|Overall Study|Withdrew Consent|9|||
44200591|NCT02053610|78996175|FG000|Overall Study|Death|5|||
44451611|NCT00490815|79460496|FG000|Overall Study|Death|1|||
44200592|NCT02053610|78996176|FG001|Overall Study|Death|5|||
44200593|NCT02053610|78996175|FG000|Overall Study|Administrative/Other|1|||
44200594|NCT02053610|78996176|FG001|Overall Study|Administrative/Other|1|||
44361380|NCT01110330|79367043|FG002|Overall Study|Withdrawal by Subject|2|||
44200595|NCT02053610|78996175|FG000|Overall Study|Disease Progression|2|||
44200596|NCT02053610|78996176|FG001|Overall Study|Disease Progression|3|||
44200597|NCT02053610|78996175|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
44200598|NCT02053610|78996176|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
44200599|NCT02053610|78996175|FG000|Overall Study|Did not Receive Treatment|4|||
44200600|NCT02053610|78996176|FG001|Overall Study|Did not Receive Treatment|2|||
44200601|NCT02053610|78996175|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44200602|NCT02053610|78996176|FG001|Overall Study|Insufficient Therapeutic Response|1|||
44200603|NCT02053610|78996175|FG000|Overall Study|Violation of Selection Criteria|1|||
44200604|NCT02053610|78996176|FG001|Overall Study|Violation of Selection Criteria|0|||
44200605|NCT02075606|78996182|FG000|Overall Study|Adverse Event|5|||
44200606|NCT02075606|78996182|FG000|Overall Study|Withdrawal by Subject|1|||
44200607|NCT02075606|78996182|FG000|Overall Study|Death|1|||
44200608|NCT02075606|78996182|FG000|Overall Study|Investigator's decision|1|||
44200609|NCT02075606|78996182|FG000|Overall Study|Symptom management|1|||
44200610|NCT02075606|78996182|FG000|Overall Study|Increasing Symptoms|1|||
44200611|NCT02043782|78996191|FG000|Period 1|Adverse Event|0|||
44200612|NCT02043782|78996192|FG001|Period 1|Adverse Event|0|||
44200613|NCT02043782|78996193|FG002|Period 1|Adverse Event|1|||
44200614|NCT02043782|78996194|FG003|Period 1|Adverse Event|0|||
44200615|NCT02043782|78996195|FG004|Period 1|Adverse Event|0|||
44200616|NCT02043782|78996196|FG005|Period 1|Adverse Event|0|||
44200617|NCT02052596|78996206|FG000|Active Phase|Adverse Event|3|||
44200618|NCT02052596|78996207|FG001|Active Phase|Adverse Event|2|||
44200619|NCT02052596|78996206|FG000|Active Phase|Lost to Follow-up|8|||
44200620|NCT02052596|78996207|FG001|Active Phase|Lost to Follow-up|11|||
44200621|NCT02052596|78996206|FG000|Active Phase|Protocol Violation|1|||
44200622|NCT02052596|78996207|FG001|Active Phase|Protocol Violation|2|||
44200623|NCT02052596|78996206|FG000|Active Phase|Withdrawal by Subject|3|||
44200624|NCT02052596|78996207|FG001|Active Phase|Withdrawal by Subject|4|||
44200625|NCT02052596|78996206|FG000|Active Phase|Enrolled in error|1|||
44200626|NCT02052596|78996207|FG001|Active Phase|Enrolled in error|0|||
44200627|NCT02052596|78996206|FG000|Active Phase|Lost due to Crohn's disease|0|||
44200628|NCT02052596|78996207|FG001|Active Phase|Lost due to Crohn's disease|1|||
44200629|NCT02052596|78996206|FG000|Safety Phase|Adverse Event|6|||
44200630|NCT02052596|78996207|FG001|Safety Phase|Adverse Event|3|||
44200631|NCT02052596|78996206|FG000|Safety Phase|Lost to Follow-up|11|||
44200632|NCT02052596|78996207|FG001|Safety Phase|Lost to Follow-up|18|||
44200633|NCT02052596|78996206|FG000|Safety Phase|Protocol Violation|1|||
44200634|NCT02052596|78996207|FG001|Safety Phase|Protocol Violation|2|||
44200635|NCT02052596|78996206|FG000|Safety Phase|Withdrawal by Subject|8|||
44200636|NCT02052596|78996207|FG001|Safety Phase|Withdrawal by Subject|11|||
44200637|NCT02052596|78996206|FG000|Safety Phase|Enrolled in error|1|||
44200638|NCT02052596|78996207|FG001|Safety Phase|Enrolled in error|0|||
44200639|NCT02052596|78996206|FG000|Safety Phase|Lost due to Crohn's disease|0|||
44200640|NCT02052596|78996207|FG001|Safety Phase|Lost due to Crohn's disease|1|||
44200641|NCT02052440|78996215|FG000|Overall Study|Withdrawal by Subject|0|||
44200642|NCT02052440|78996216|FG001|Overall Study|Withdrawal by Subject|1|||
44200643|NCT02049944|78996222|FG000|Overall Study|Protocol Violation|2|||
44200644|NCT02043548|78996228|FG000|Overall Study|Lack of Efficacy|1|||
44200645|NCT02043548|78996229|FG001|Overall Study|Lack of Efficacy|0|||
44200646|NCT02043548|78996228|FG000|Overall Study|Adverse Event|0|||
44200647|NCT02043548|78996229|FG001|Overall Study|Adverse Event|1|||
44200648|NCT01622348|78996238|FG000|Overall Study|Withdrawal by Subject|1|||
44200649|NCT01622348|78996239|FG001|Overall Study|Withdrawal by Subject|0|||
44200650|NCT01622348|78996240|FG002|Overall Study|Withdrawal by Subject|1|||
44200651|NCT01621880|78996250|FG000|Overall Study|Adverse Event|5|||
44200652|NCT01621880|78996251|FG001|Overall Study|Adverse Event|1|||
44200653|NCT01621880|78996250|FG000|Overall Study|Withdrawal by Subject|5|||
44200654|NCT01621880|78996251|FG001|Overall Study|Withdrawal by Subject|4|||
44200655|NCT01621802|78996264|FG000|Overall Study|Protocol Violation|0|||
44200656|NCT01621802|78996265|FG001|Overall Study|Protocol Violation|0|||
44200657|NCT01621802|78996266|FG002|Overall Study|Protocol Violation|0|||
44200658|NCT01621802|78996267|FG003|Overall Study|Protocol Violation|0|||
44200659|NCT01621802|78996268|FG004|Overall Study|Protocol Violation|0|||
44200660|NCT01621802|78996269|FG005|Overall Study|Protocol Violation|1|||
44200661|NCT01621802|78996264|FG000|Overall Study|Withdrawal by Subject|8|||
44200662|NCT01621802|78996265|FG001|Overall Study|Withdrawal by Subject|4|||
44200663|NCT01621802|78996266|FG002|Overall Study|Withdrawal by Subject|4|||
44200664|NCT01621802|78996267|FG003|Overall Study|Withdrawal by Subject|2|||
44200665|NCT01621802|78996268|FG004|Overall Study|Withdrawal by Subject|2|||
44200666|NCT01621802|78996269|FG005|Overall Study|Withdrawal by Subject|0|||
44200667|NCT01621802|78996264|FG000|Overall Study|Migrated/moved from study area|0|||
44200668|NCT01621802|78996265|FG001|Overall Study|Migrated/moved from study area|0|||
44200669|NCT01621802|78996266|FG002|Overall Study|Migrated/moved from study area|2|||
44200670|NCT01621802|78996267|FG003|Overall Study|Migrated/moved from study area|0|||
44200671|NCT01621802|78996268|FG004|Overall Study|Migrated/moved from study area|1|||
44200672|NCT01621802|78996269|FG005|Overall Study|Migrated/moved from study area|0|||
44200673|NCT01621802|78996264|FG000|Overall Study|Others|3|||
44200674|NCT01621802|78996265|FG001|Overall Study|Others|3|||
44200675|NCT01621802|78996266|FG002|Overall Study|Others|3|||
44200676|NCT01621802|78996267|FG003|Overall Study|Others|2|||
44200677|NCT01621802|78996268|FG004|Overall Study|Others|1|||
44200678|NCT01621802|78996269|FG005|Overall Study|Others|0|||
44200679|NCT01621802|78996264|FG000|Overall Study|Lost to Follow-up|36|||
44200680|NCT01621802|78996265|FG001|Overall Study|Lost to Follow-up|16|||
44200681|NCT01621802|78996266|FG002|Overall Study|Lost to Follow-up|24|||
44200682|NCT01621802|78996267|FG003|Overall Study|Lost to Follow-up|7|||
44200683|NCT01621802|78996268|FG004|Overall Study|Lost to Follow-up|31|||
44200684|NCT01621802|78996269|FG005|Overall Study|Lost to Follow-up|11|||
44200685|NCT02059291|78996295|FG000|Epoch 2|Lack of Efficacy|0|||
44200686|NCT02059291|78996296|FG001|Epoch 2|Lack of Efficacy|0|||
44200687|NCT02059291|78996297|FG002|Epoch 2|Lack of Efficacy|0|||
44200688|NCT02059291|78996298|FG003|Epoch 2|Lack of Efficacy|1|||
44200689|NCT02059291|78996299|FG004|Epoch 2|Lack of Efficacy|0|||
44200690|NCT02059291|78996300|FG005|Epoch 2|Lack of Efficacy|1|||
44200691|NCT02059291|78996301|FG006|Epoch 2|Lack of Efficacy|0|||
44200692|NCT02059291|78996302|FG007|Epoch 2|Lack of Efficacy|0|||
44200693|NCT02059291|78996303|FG008|Epoch 2|Lack of Efficacy|0|||
44200694|NCT02059291|78996304|FG009|Epoch 2|Lack of Efficacy|0|||
44200695|NCT02059291|78996305|FG010|Epoch 2|Lack of Efficacy|0|||
44200696|NCT02059291|78996306|FG011|Epoch 2|Lack of Efficacy|0|||
44200697|NCT02059291|78996307|FG012|Epoch 2|Lack of Efficacy|0|||
44200698|NCT02059291|78996308|FG013|Epoch 2|Lack of Efficacy|0|||
44200699|NCT02059291|78996309|FG014|Epoch 2|Lack of Efficacy|0|||
44200700|NCT02059291|78996310|FG015|Epoch 2|Lack of Efficacy|0|||
44200701|NCT02059291|78996311|FG016|Epoch 2|Lack of Efficacy|0|||
44200702|NCT02059291|78996312|FG017|Epoch 2|Lack of Efficacy|0|||
44200703|NCT02059291|78996313|FG018|Epoch 2|Lack of Efficacy|0|||
44200704|NCT02059291|78996314|FG019|Epoch 2|Lack of Efficacy|0|||
44200705|NCT02059291|78996315|FG020|Epoch 2|Lack of Efficacy|0|||
44200706|NCT02059291|78996316|FG021|Epoch 2|Lack of Efficacy|0|||
44200707|NCT02059291|78996317|FG022|Epoch 2|Lack of Efficacy|0|||
44200708|NCT02059291|78996318|FG023|Epoch 2|Lack of Efficacy|0|||
44266963|NCT02377362|79180181|FG002|Part B Overall|Withdrawal by Subject|0|||
44266964|NCT02377362|79180182|FG003|Part B Overall|Withdrawal by Subject|0|||
44266965|NCT02377362|79180183|FG004|Part B Overall|Withdrawal by Subject|0|||
44266966|NCT02377362|79180184|FG005|Part B Overall|Withdrawal by Subject|0|||
44266967|NCT02377362|79180185|FG006|Part B Overall|Withdrawal by Subject|1|||
44266968|NCT02377362|79180186|FG007|Part B Overall|Withdrawal by Subject|0|||
44266969|NCT02377362|79180187|FG008|Part B Overall|Withdrawal by Subject|0|||
44266970|NCT02377362|79180188|FG009|Part B Overall|Withdrawal by Subject|0|||
44266971|NCT02377362|79180189|FG010|Part B Overall|Withdrawal by Subject|0|||
44266972|NCT02377362|79180190|FG011|Part B Overall|Withdrawal by Subject|1|||
44266973|NCT02377362|79180191|FG012|Part B Overall|Withdrawal by Subject|0|||
44266974|NCT00553631|79180231|FG000|Overall Study|Withdrawal by Subject|0|||
44266975|NCT00553631|79180232|FG001|Overall Study|Withdrawal by Subject|1|||
44266976|NCT00553631|79180231|FG000|Overall Study|Lost to Follow-up|1|||
44266977|NCT00553631|79180232|FG001|Overall Study|Lost to Follow-up|0|||
44266978|NCT00553319|79180241|FG000|Overall Study|Lost to Follow-up|10|||
44266979|NCT00553319|79180242|FG001|Overall Study|Lost to Follow-up|9|||
44266980|NCT00553319|79180243|FG002|Overall Study|Lost to Follow-up|5|||
44266981|NCT00553319|79180241|FG000|Overall Study|wanted treatment elsewhere|2|||
44266982|NCT00553319|79180242|FG001|Overall Study|wanted treatment elsewhere|1|||
44266983|NCT00553319|79180243|FG002|Overall Study|wanted treatment elsewhere|1|||
44266984|NCT00553319|79180241|FG000|Overall Study|non-compliance|0|||
44266985|NCT00553319|79180242|FG001|Overall Study|non-compliance|0|||
44266986|NCT00553319|79180243|FG002|Overall Study|non-compliance|2|||
44266987|NCT00553319|79180241|FG000|Overall Study|incarceration|1|||
44266988|NCT00553319|79180242|FG001|Overall Study|incarceration|0|||
44266989|NCT00553319|79180243|FG002|Overall Study|incarceration|0|||
44266990|NCT00553319|79180241|FG000|Overall Study|moved|1|||
44266991|NCT00553319|79180242|FG001|Overall Study|moved|0|||
44266992|NCT00553319|79180243|FG002|Overall Study|moved|1|||
44266993|NCT01649856|79180429|FG000|Overall Study|Withdrawal by Subject|14|||
44266994|NCT01649856|79180430|FG001|Overall Study|Withdrawal by Subject|14|||
44266995|NCT01649856|79180429|FG000|Overall Study|Protocol Violation|4|||
44266996|NCT01649856|79180430|FG001|Overall Study|Protocol Violation|4|||
44266997|NCT01649856|79180429|FG000|Overall Study|Treatment Failure|1|||
44266998|NCT01649856|79180430|FG001|Overall Study|Treatment Failure|1|||
44266999|NCT01649856|79180429|FG000|Overall Study|Death|69|||
44267000|NCT01649856|79180430|FG001|Overall Study|Death|34|||
44267001|NCT01649856|79180429|FG000|Overall Study|Stable or Progressed Disease|5|||
44267002|NCT01649856|79180430|FG001|Overall Study|Stable or Progressed Disease|3|||
44267003|NCT01649856|79180429|FG000|Overall Study|Lost to Follow-up|20|||
44267004|NCT01649856|79180430|FG001|Overall Study|Lost to Follow-up|16|||
44267005|NCT01649856|79180429|FG000|Overall Study|Lack of Compliance|6|||
44267006|NCT01649856|79180430|FG001|Overall Study|Lack of Compliance|1|||
44267007|NCT01649856|79180429|FG000|Overall Study|Other|20|||
44267008|NCT01649856|79180430|FG001|Overall Study|Other|5|||
44267009|NCT02375724|79180451|FG000|Overall Study|Lack of Efficacy|1|||
44267010|NCT02375724|79180452|FG001|Overall Study|Lack of Efficacy|1|||
44267011|NCT02375724|79180451|FG000|Overall Study|Withdrawal by Subject|1|||
44267012|NCT02375724|79180452|FG001|Overall Study|Withdrawal by Subject|1|||
44267013|NCT02375724|79180451|FG000|Overall Study|Lost to Follow-up|1|||
44267014|NCT02375724|79180452|FG001|Overall Study|Lost to Follow-up|0|||
44267015|NCT02375724|79180451|FG000|Overall Study|Protocol Violation|1|||
44267016|NCT02375724|79180452|FG001|Overall Study|Protocol Violation|0|||
44267017|NCT02375724|79180451|FG000|Overall Study|Adverse Event|2|||
44267018|NCT02375724|79180452|FG001|Overall Study|Adverse Event|4|||
44267019|NCT02398188|79180460|FG000|Overall Study|Adverse Event|2|||
44267020|NCT02398188|79180461|FG001|Overall Study|Adverse Event|3|||
44267021|NCT02398188|79180460|FG000|Overall Study|Lost to Follow-up|5|||
44267022|NCT02398188|79180461|FG001|Overall Study|Lost to Follow-up|0|||
44267023|NCT02398188|79180460|FG000|Overall Study|Non-compliance|4|||
44267024|NCT02398188|79180461|FG001|Overall Study|Non-compliance|4|||
44267025|NCT02398188|79180460|FG000|Overall Study|Protocol Violation|6|||
44267026|NCT02398188|79180461|FG001|Overall Study|Protocol Violation|10|||
44267027|NCT02398188|79180460|FG000|Overall Study|Sponsor Decision|2|||
44267028|NCT02398188|79180461|FG001|Overall Study|Sponsor Decision|1|||
44267029|NCT02398188|79180460|FG000|Overall Study|Pregnancy|1|||
44267030|NCT02398188|79180461|FG001|Overall Study|Pregnancy|0|||
44267031|NCT02398188|79180460|FG000|Overall Study|Withdrawal by Subject|7|||
44267032|NCT02398188|79180461|FG001|Overall Study|Withdrawal by Subject|16|||
44267033|NCT02426580|79180469|FG000|Overall Study|Death|2|||
44267034|NCT02426580|79180470|FG001|Overall Study|Death|2|||
44267035|NCT02426580|79180469|FG000|Overall Study|Lost to Follow-up|0|||
44267036|NCT02426580|79180470|FG001|Overall Study|Lost to Follow-up|9|||
44267037|NCT02426580|79180469|FG000|Overall Study|transfer to hemodialysis|5|||
44267038|NCT02426580|79180470|FG001|Overall Study|transfer to hemodialysis|5|||
44267039|NCT02426580|79180469|FG000|Overall Study|Kidney transplant|3|||
44267040|NCT02426580|79180470|FG001|Overall Study|Kidney transplant|0|||
44267041|NCT02426580|79180469|FG000|Overall Study|Allergic to egg white|1|||
44267042|NCT02426580|79180470|FG001|Overall Study|Allergic to egg white|0|||
44267043|NCT01651260|79180476|FG000|Overall Study|unable to apply product|3|||
44267044|NCT02425098|79180496|FG000|Overall Study|Lost to Follow-up|7|||
44267045|NCT02425098|79180497|FG001|Overall Study|Lost to Follow-up|7|||
44267046|NCT02425098|79180496|FG000|Overall Study|Withdrawal by Subject|4|||
44267047|NCT02425098|79180497|FG001|Overall Study|Withdrawal by Subject|8|||
44267048|NCT02425098|79180496|FG000|Overall Study|Pregnancy|2|||
44267049|NCT02425098|79180497|FG001|Overall Study|Pregnancy|0|||
44267050|NCT02425098|79180496|FG000|Overall Study|Reason not Specified|0|||
44267051|NCT02425098|79180497|FG001|Overall Study|Reason not Specified|1|||
44267052|NCT02424630|79180505|FG000|Overall Study|No rotator cuff tear|1|||
44267053|NCT02424630|79180506|FG001|Overall Study|No rotator cuff tear|2|||
44267054|NCT02424630|79180505|FG000|Overall Study|Open procedure|0|||
44267055|NCT02424630|79180506|FG001|Overall Study|Open procedure|1|||
44267056|NCT02397408|79180512|FG000|Overall Study|Physician Decision|4|||
44267057|NCT02397408|79180512|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
44267058|NCT02397096|79180518|FG000|Day 1 to Week 24|Adverse Event|7|||
44267059|NCT02397096|79180519|FG001|Day 1 to Week 24|Adverse Event|1|||
44267060|NCT02397096|79180518|FG000|Day 1 to Week 24|Death|1|||
44267061|NCT02397096|79180519|FG001|Day 1 to Week 24|Death|0|||
44267062|NCT02397096|79180518|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
44267063|NCT02397096|79180519|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
44267064|NCT02397096|79180518|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
44267065|NCT02397096|79180519|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
44267066|NCT02397096|79180518|FG000|Day 1 to Week 24|Physician Decision|2|||
44267067|NCT02397096|79180519|FG001|Day 1 to Week 24|Physician Decision|3|||
44267068|NCT02397096|79180518|FG000|Day 1 to Week 24|Protocol Violation|1|||
44267069|NCT02397096|79180519|FG001|Day 1 to Week 24|Protocol Violation|4|||
44267070|NCT02397096|79180518|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
44267071|NCT02397096|79180519|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
44267072|NCT02397096|79180518|FG000|Week 24 to Week 48|Adverse Event|6|||
44267073|NCT02397096|79180519|FG001|Week 24 to Week 48|Adverse Event|2|||
44267074|NCT02397096|79180518|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
44267075|NCT02397096|79180519|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
44267076|NCT02397096|79180518|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
44267077|NCT02397096|79180519|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
44267078|NCT02397096|79180518|FG000|Week 24 to Week 48|Physician Decision|2|||
44267079|NCT02397096|79180519|FG001|Week 24 to Week 48|Physician Decision|1|||
44267080|NCT02397096|79180518|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
44267081|NCT02397096|79180519|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
44267082|NCT02397096|79180518|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
44267083|NCT02397096|79180519|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
44267084|NCT02397096|79180518|FG000|Study Extensions|Ongoing|399|||
44267085|NCT02397096|79180519|FG001|Study Extensions|Ongoing|202|||
44267086|NCT02372058|79180529|FG000|Overall Study|Withdrawal by Subject|3|||
44267087|NCT02396316|79180537|FG000|Overall Study|Physician Decision|1|||
44267088|NCT02396316|79180538|FG001|Overall Study|Physician Decision|0|||
44267089|NCT02396316|79180537|FG000|Overall Study|Progressive disease|6|||
44267090|NCT02396316|79180538|FG001|Overall Study|Progressive disease|3|||
44267091|NCT02396316|79180537|FG000|Overall Study|Protocol Violation|0|||
44267092|NCT02396316|79180538|FG001|Overall Study|Protocol Violation|1|||
44267093|NCT02396316|79180537|FG000|Overall Study|Treatment unblinded|0|||
44267094|NCT02396316|79180538|FG001|Overall Study|Treatment unblinded|1|||
44267095|NCT02395536|79180548|FG000|Overall Study|Lost to Follow-up|4|||
44267096|NCT02395536|79180549|FG001|Overall Study|Lost to Follow-up|4|||
44267097|NCT02395536|79180548|FG000|Overall Study|Death|2|||
44267098|NCT02395536|79180549|FG001|Overall Study|Death|0|||
44267099|NCT02395536|79180548|FG000|Overall Study|Physician Decision|4|||
44267100|NCT02395536|79180549|FG001|Overall Study|Physician Decision|6|||
44267101|NCT02395536|79180548|FG000|Overall Study|Withdrawal by Subject|9|||
44267102|NCT02395536|79180549|FG001|Overall Study|Withdrawal by Subject|17|||
44267103|NCT02395536|79180548|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
44267104|NCT02395536|79180549|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
44267105|NCT02395536|79180548|FG000|Overall Study|Insurance issue|0|||
44267106|NCT02395536|79180549|FG001|Overall Study|Insurance issue|1|||
44267107|NCT00552929|79180565|FG000|Overall Study|Lost to Follow-up|0|||
44267108|NCT00552929|79180566|FG001|Overall Study|Lost to Follow-up|0|||
44267109|NCT00552929|79180567|FG002|Overall Study|Lost to Follow-up|0|||
44267110|NCT00552929|79180568|FG003|Overall Study|Lost to Follow-up|0|||
44267111|NCT00552929|79180569|FG004|Overall Study|Lost to Follow-up|0|||
44267112|NCT00552929|79180570|FG005|Overall Study|Lost to Follow-up|0|||
44267113|NCT00552929|79180571|FG006|Overall Study|Lost to Follow-up|0|||
44267114|NCT00552929|79180572|FG007|Overall Study|Lost to Follow-up|0|||
44267115|NCT00552929|79180573|FG008|Overall Study|Lost to Follow-up|1|||
44267116|NCT00552929|79180574|FG009|Overall Study|Lost to Follow-up|0|||
44267117|NCT00552929|79180565|FG000|Overall Study|Not Eligible|0|||
44267118|NCT00552929|79180566|FG001|Overall Study|Not Eligible|0|||
44267119|NCT00552929|79180567|FG002|Overall Study|Not Eligible|0|||
44267120|NCT00552929|79180568|FG003|Overall Study|Not Eligible|0|||
44267121|NCT00552929|79180569|FG004|Overall Study|Not Eligible|0|||
44267122|NCT00552929|79180570|FG005|Overall Study|Not Eligible|1|||
44267123|NCT00552929|79180571|FG006|Overall Study|Not Eligible|0|||
44267124|NCT00552929|79180572|FG007|Overall Study|Not Eligible|0|||
44267125|NCT00552929|79180573|FG008|Overall Study|Not Eligible|0|||
44267126|NCT00552929|79180574|FG009|Overall Study|Not Eligible|0|||
44267127|NCT02395302|79180596|FG000|Overall Study|Screen Failure|3|||
44267128|NCT02395302|79180596|FG000|Overall Study|Run In Failure|7|||
44267129|NCT02395302|79180596|FG000|Overall Study|Withdrawal by Subject|2|||
44267130|NCT02395302|79180596|FG000|Overall Study|Physician Decision|2|||
44267131|NCT02371980|79180630|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
44267132|NCT02371980|79180631|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
44267133|NCT02371980|79180632|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
44267134|NCT02371980|79180633|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
44267135|NCT02371980|79180634|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
44267136|NCT02371980|79180630|FG000|Open-label Period|Significant Protocol Deviation|19|||
44267137|NCT02371980|79180631|FG001|Open-label Period|Significant Protocol Deviation|0|||
44267138|NCT02371980|79180632|FG002|Open-label Period|Significant Protocol Deviation|0|||
44267139|NCT02371980|79180633|FG003|Open-label Period|Significant Protocol Deviation|0|||
44267140|NCT02371980|79180634|FG004|Open-label Period|Significant Protocol Deviation|0|||
44267141|NCT02371980|79180630|FG000|Open-label Period|Noncompliance with Study Drug|10|||
44267142|NCT02371980|79180631|FG001|Open-label Period|Noncompliance with Study Drug|0|||
44267143|NCT02371980|79180632|FG002|Open-label Period|Noncompliance with Study Drug|0|||
44267144|NCT02371980|79180633|FG003|Open-label Period|Noncompliance with Study Drug|0|||
44267145|NCT02371980|79180634|FG004|Open-label Period|Noncompliance with Study Drug|0|||
44267146|NCT02371980|79180630|FG000|Open-label Period|Lost to Follow-up|55|||
44267147|NCT02371980|79180631|FG001|Open-label Period|Lost to Follow-up|0|||
44267148|NCT02371980|79180632|FG002|Open-label Period|Lost to Follow-up|0|||
44267149|NCT02371980|79180633|FG003|Open-label Period|Lost to Follow-up|0|||
44267150|NCT02371980|79180634|FG004|Open-label Period|Lost to Follow-up|0|||
44267151|NCT02371980|79180630|FG000|Open-label Period|Voluntary Withdrawal|91|||
44267152|NCT02371980|79180631|FG001|Open-label Period|Voluntary Withdrawal|0|||
44267153|NCT02371980|79180632|FG002|Open-label Period|Voluntary Withdrawal|0|||
44267154|NCT02371980|79180633|FG003|Open-label Period|Voluntary Withdrawal|0|||
44267155|NCT02371980|79180634|FG004|Open-label Period|Voluntary Withdrawal|0|||
44267156|NCT02371980|79180630|FG000|Open-label Period|Pregnancy|1|||
44267157|NCT02371980|79180631|FG001|Open-label Period|Pregnancy|0|||
44267158|NCT02371980|79180632|FG002|Open-label Period|Pregnancy|0|||
44267159|NCT02371980|79180633|FG003|Open-label Period|Pregnancy|0|||
44267160|NCT02371980|79180634|FG004|Open-label Period|Pregnancy|0|||
44267161|NCT02371980|79180630|FG000|Open-label Period|Lack of Efficacy|116|||
44267162|NCT02371980|79180631|FG001|Open-label Period|Lack of Efficacy|0|||
44267163|NCT02371980|79180632|FG002|Open-label Period|Lack of Efficacy|0|||
44267164|NCT02371980|79180633|FG003|Open-label Period|Lack of Efficacy|0|||
44267165|NCT02371980|79180634|FG004|Open-label Period|Lack of Efficacy|0|||
44267166|NCT02371980|79180630|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
44267167|NCT02371980|79180631|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
44267168|NCT02371980|79180632|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
44267169|NCT02371980|79180633|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
44267170|NCT02371980|79180634|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
44267171|NCT02371980|79180630|FG000|Open-label Period|Reason not Specified|9|||
44267172|NCT02371980|79180631|FG001|Open-label Period|Reason not Specified|0|||
44267173|NCT02371980|79180632|FG002|Open-label Period|Reason not Specified|0|||
44267174|NCT02371980|79180633|FG003|Open-label Period|Reason not Specified|0|||
44267175|NCT02371980|79180634|FG004|Open-label Period|Reason not Specified|0|||
44267176|NCT02371980|79180630|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
44267177|NCT02371980|79180631|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
44267178|NCT02371980|79180632|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
44267179|NCT02371980|79180633|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
44267180|NCT02371980|79180634|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
44267181|NCT02371980|79180630|FG000|Double-blind Period|Significant Protocol Deviation|0|||
44267182|NCT02371980|79180631|FG001|Double-blind Period|Significant Protocol Deviation|2|||
44267183|NCT02371980|79180632|FG002|Double-blind Period|Significant Protocol Deviation|7|||
44267184|NCT02371980|79180633|FG003|Double-blind Period|Significant Protocol Deviation|3|||
44267185|NCT02371980|79180634|FG004|Double-blind Period|Significant Protocol Deviation|3|||
44267186|NCT02371980|79180630|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
44267187|NCT02371980|79180631|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
44267188|NCT02371980|79180632|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
44267189|NCT02371980|79180633|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
44267190|NCT02371980|79180634|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
44267191|NCT02371980|79180630|FG000|Double-blind Period|Lost to Follow-up|0|||
44267192|NCT02371980|79180631|FG001|Double-blind Period|Lost to Follow-up|8|||
44267193|NCT02371980|79180632|FG002|Double-blind Period|Lost to Follow-up|8|||
44267194|NCT02371980|79180633|FG003|Double-blind Period|Lost to Follow-up|6|||
44267195|NCT02371980|79180634|FG004|Double-blind Period|Lost to Follow-up|5|||
44267196|NCT02371980|79180630|FG000|Double-blind Period|Voluntary Withdrawal|0|||
44267197|NCT02371980|79180631|FG001|Double-blind Period|Voluntary Withdrawal|12|||
44267198|NCT02371980|79180632|FG002|Double-blind Period|Voluntary Withdrawal|8|||
44267199|NCT02371980|79180633|FG003|Double-blind Period|Voluntary Withdrawal|9|||
44267200|NCT02371980|79180634|FG004|Double-blind Period|Voluntary Withdrawal|11|||
44267201|NCT02371980|79180630|FG000|Double-blind Period|Relapse|0|||
44267202|NCT02371980|79180631|FG001|Double-blind Period|Relapse|50|||
44267203|NCT02371980|79180632|FG002|Double-blind Period|Relapse|25|||
44267204|NCT02371980|79180633|FG003|Double-blind Period|Relapse|25|||
44267205|NCT02371980|79180634|FG004|Double-blind Period|Relapse|26|||
44267206|NCT02371980|79180630|FG000|Double-blind Period|Reason not Specified|0|||
44267207|NCT02371980|79180631|FG001|Double-blind Period|Reason not Specified|3|||
44267208|NCT02371980|79180632|FG002|Double-blind Period|Reason not Specified|3|||
44267209|NCT02371980|79180633|FG003|Double-blind Period|Reason not Specified|2|||
44267210|NCT02371980|79180634|FG004|Double-blind Period|Reason not Specified|1|||
44267211|NCT02371980|79180630|FG000|Double-blind Period|Missing|0|||
44267212|NCT02371980|79180631|FG001|Double-blind Period|Missing|1|||
44267213|NCT02371980|79180632|FG002|Double-blind Period|Missing|0|||
44267214|NCT02371980|79180633|FG003|Double-blind Period|Missing|0|||
44267215|NCT02371980|79180634|FG004|Double-blind Period|Missing|0|||
44267216|NCT02371746|79180774|FG000|Overall Study|Consent withdrawn|0|||
44267217|NCT02371746|79180775|FG001|Overall Study|Consent withdrawn|0|||
44267218|NCT02371746|79180776|FG002|Overall Study|Consent withdrawn|0|||
44267219|NCT02371746|79180777|FG003|Overall Study|Consent withdrawn|0|||
44267220|NCT02371746|79180778|FG004|Overall Study|Consent withdrawn|0|||
44200709|NCT02059291|78996319|FG024|Epoch 2|Lack of Efficacy|0|||
44200710|NCT02059291|78996295|FG000|Epoch 2|Adverse Event|0|||
44200711|NCT02059291|78996296|FG001|Epoch 2|Adverse Event|0|||
44267221|NCT02371746|79180779|FG005|Overall Study|Consent withdrawn|0|||
44267222|NCT02371746|79180780|FG006|Overall Study|Consent withdrawn|1|||
44267223|NCT02421666|79180828|FG000|6-month Follow-up|Lost to Follow-up|8|||
44267224|NCT02421666|79180829|FG001|6-month Follow-up|Lost to Follow-up|7|||
44267225|NCT02421666|79180828|FG000|6-month Follow-up|Withdrawal by Subject|5|||
44267226|NCT02421666|79180829|FG001|6-month Follow-up|Withdrawal by Subject|6|||
44267227|NCT02421666|79180828|FG000|12-month Follow-up|Lost to Follow-up|5|||
44267228|NCT02421666|79180829|FG001|12-month Follow-up|Lost to Follow-up|5|||
44267229|NCT02421666|79180828|FG000|12-month Follow-up|Withdrawal by Subject|6|||
44267230|NCT02421666|79180829|FG001|12-month Follow-up|Withdrawal by Subject|11|||
44267231|NCT02394756|79180839|FG000|Period 1|Lens Discomfort|0|||
44267232|NCT02394756|79180840|FG001|Period 1|Lens Discomfort|0|||
44267233|NCT02394756|79180841|FG002|Period 1|Lens Discomfort|0|||
44267234|NCT02394756|79180842|FG003|Period 1|Lens Discomfort|0|||
44267235|NCT02394756|79180843|FG004|Period 1|Lens Discomfort|0|||
44267236|NCT02394756|79180844|FG005|Period 1|Lens Discomfort|1|||
44267237|NCT02394756|79180839|FG000|Period 1|Withdrawal by Subject|0|||
44267238|NCT02394756|79180840|FG001|Period 1|Withdrawal by Subject|1|||
44200712|NCT02059291|78996297|FG002|Epoch 2|Adverse Event|1|||
44200713|NCT02059291|78996298|FG003|Epoch 2|Adverse Event|1|||
44200714|NCT02059291|78996299|FG004|Epoch 2|Adverse Event|0|||
44200715|NCT02059291|78996300|FG005|Epoch 2|Adverse Event|0|||
44200716|NCT02059291|78996301|FG006|Epoch 2|Adverse Event|0|||
44200717|NCT02059291|78996302|FG007|Epoch 2|Adverse Event|1|||
44200718|NCT02059291|78996303|FG008|Epoch 2|Adverse Event|1|||
44200719|NCT02059291|78996304|FG009|Epoch 2|Adverse Event|0|||
44200720|NCT02059291|78996305|FG010|Epoch 2|Adverse Event|0|||
44200721|NCT02059291|78996306|FG011|Epoch 2|Adverse Event|0|||
44200722|NCT02059291|78996307|FG012|Epoch 2|Adverse Event|0|||
44200723|NCT02059291|78996308|FG013|Epoch 2|Adverse Event|0|||
44200724|NCT02059291|78996309|FG014|Epoch 2|Adverse Event|0|||
44267239|NCT02394756|79180841|FG002|Period 1|Withdrawal by Subject|1|||
44267240|NCT02394756|79180842|FG003|Period 1|Withdrawal by Subject|1|||
44267241|NCT02394756|79180843|FG004|Period 1|Withdrawal by Subject|0|||
44267242|NCT02394756|79180844|FG005|Period 1|Withdrawal by Subject|0|||
44267243|NCT02394756|79180839|FG000|Period 2|Unsatisfactory Visual Response|0|||
44267244|NCT02394756|79180840|FG001|Period 2|Unsatisfactory Visual Response|0|||
44267245|NCT02394756|79180841|FG002|Period 2|Unsatisfactory Visual Response|0|||
44267246|NCT02394756|79180842|FG003|Period 2|Unsatisfactory Visual Response|0|||
44267247|NCT02394756|79180843|FG004|Period 2|Unsatisfactory Visual Response|1|||
44267248|NCT02394756|79180844|FG005|Period 2|Unsatisfactory Visual Response|0|||
44200725|NCT02059291|78996310|FG015|Epoch 2|Adverse Event|0|||
44200726|NCT02059291|78996311|FG016|Epoch 2|Adverse Event|0|||
44200727|NCT02059291|78996312|FG017|Epoch 2|Adverse Event|0|||
44200728|NCT02059291|78996313|FG018|Epoch 2|Adverse Event|0|||
44200729|NCT02059291|78996314|FG019|Epoch 2|Adverse Event|0|||
44200730|NCT02059291|78996315|FG020|Epoch 2|Adverse Event|0|||
44200731|NCT02059291|78996316|FG021|Epoch 2|Adverse Event|0|||
44267249|NCT02370888|79180865|FG000|Overall Study|disease progression|2|||
44267250|NCT02370888|79180865|FG000|Overall Study|did not meet chimerism criteria|6|||
44267251|NCT02394600|79180889|FG000|Overall Study|Adverse Event|3|||
44267252|NCT02394600|79180890|FG001|Overall Study|Adverse Event|0|||
44267253|NCT02394600|79180889|FG000|Overall Study|Lost to Follow-up|0|||
44267254|NCT02394600|79180890|FG001|Overall Study|Lost to Follow-up|1|||
44267255|NCT02394600|79180889|FG000|Overall Study|Withdrawal by Subject|0|||
44267256|NCT02394600|79180890|FG001|Overall Study|Withdrawal by Subject|1|||
44267257|NCT02394600|79180889|FG000|Overall Study|Protocol Violation|1|||
44267258|NCT02394600|79180890|FG001|Overall Study|Protocol Violation|0|||
44267259|NCT04685499|79180906|FG000|Overall Study|Study Terminated Early|1|||
44267260|NCT02421588|79180982|FG000|Overall Study|Non-treatment-related AE|8|||
44267261|NCT02421588|79180983|FG001|Overall Study|Non-treatment-related AE|8|||
44267262|NCT02421588|79180982|FG000|Overall Study|Progressive disease|152|||
44267263|NCT02421588|79180983|FG001|Overall Study|Progressive disease|135|||
44267264|NCT02421588|79180982|FG000|Overall Study|Death|11|||
44267265|NCT02421588|79180983|FG001|Overall Study|Death|3|||
44267266|NCT02421588|79180982|FG000|Overall Study|Physician Decision|8|||
44267267|NCT02421588|79180983|FG001|Overall Study|Physician Decision|17|||
44267268|NCT02421588|79180982|FG000|Overall Study|Other reason not specified|3|||
44267269|NCT02421588|79180983|FG001|Overall Study|Other reason not specified|1|||
44267270|NCT02421588|79180982|FG000|Overall Study|Symptomatic deterioration|13|||
44267271|NCT02421588|79180983|FG001|Overall Study|Symptomatic deterioration|19|||
44267272|NCT02421588|79180982|FG000|Overall Study|Treatment-related AE|10|||
44267273|NCT02421588|79180983|FG001|Overall Study|Treatment-related AE|14|||
44267274|NCT02421588|79180982|FG000|Overall Study|Withdrawal by Subject|14|||
44267275|NCT02421588|79180983|FG001|Overall Study|Withdrawal by Subject|16|||
44267276|NCT02421588|79180982|FG000|Overall Study|Not treated|2|||
44267277|NCT02421588|79180983|FG001|Overall Study|Not treated|8|||
44267278|NCT02421510|79180992|FG000|Overall Study|Other|4|||
44267279|NCT02421510|79180993|FG001|Overall Study|Other|2|||
44267280|NCT02421510|79180994|FG002|Overall Study|Other|3|||
44267281|NCT02421510|79180992|FG000|Overall Study|Protocol Violation|1|||
44267282|NCT02421510|79180993|FG001|Overall Study|Protocol Violation|2|||
44267283|NCT02421510|79180994|FG002|Overall Study|Protocol Violation|0|||
44267284|NCT02421510|79180992|FG000|Overall Study|Death|1|||
44267285|NCT02421510|79180993|FG001|Overall Study|Death|0|||
44267286|NCT02421510|79180994|FG002|Overall Study|Death|0|||
44267287|NCT02421510|79180992|FG000|Overall Study|Noncompliance with study drug|1|||
44267288|NCT02421510|79180993|FG001|Overall Study|Noncompliance with study drug|0|||
44267289|NCT02421510|79180994|FG002|Overall Study|Noncompliance with study drug|0|||
44267290|NCT02421510|79180992|FG000|Overall Study|Physician Decision|1|||
44267291|NCT02421510|79180993|FG001|Overall Study|Physician Decision|1|||
44267292|NCT02421510|79180994|FG002|Overall Study|Physician Decision|3|||
44267293|NCT02421510|79180992|FG000|Overall Study|Adverse Event|9|||
44267294|NCT02421510|79180993|FG001|Overall Study|Adverse Event|10|||
44267295|NCT02421510|79180994|FG002|Overall Study|Adverse Event|18|||
44267296|NCT02421510|79180992|FG000|Overall Study|Pregnancy|1|||
44267297|NCT02421510|79180993|FG001|Overall Study|Pregnancy|1|||
44267298|NCT02421510|79180994|FG002|Overall Study|Pregnancy|0|||
44267299|NCT02421510|79180992|FG000|Overall Study|Withdrawal by Subject|14|||
44267300|NCT02421510|79180993|FG001|Overall Study|Withdrawal by Subject|18|||
44267301|NCT02421510|79180994|FG002|Overall Study|Withdrawal by Subject|12|||
44267302|NCT02421510|79180992|FG000|Overall Study|Lost to Follow-up|1|||
44267303|NCT02421510|79180993|FG001|Overall Study|Lost to Follow-up|1|||
44267304|NCT02421510|79180994|FG002|Overall Study|Lost to Follow-up|0|||
44267305|NCT00552617|79181012|FG000|Overall Study|Not Treated|0|||
44267306|NCT00552617|79181013|FG001|Overall Study|Not Treated|0|||
44267307|NCT00552617|79181014|FG002|Overall Study|Not Treated|1|||
44267308|NCT00552617|79181015|FG003|Overall Study|Not Treated|0|||
44267309|NCT00552617|79181016|FG004|Overall Study|Not Treated|0|||
44267310|NCT00552617|79181017|FG005|Overall Study|Not Treated|0|||
44267311|NCT00552617|79181018|FG006|Overall Study|Not Treated|0|||
44267312|NCT00552617|79181019|FG007|Overall Study|Not Treated|0|||
44267313|NCT00552617|79181020|FG008|Overall Study|Not Treated|0|||
44267314|NCT00552617|79181021|FG009|Overall Study|Not Treated|1|||
44267315|NCT00552617|79181012|FG000|Overall Study|Lost to Follow-up|0|||
44267316|NCT00552617|79181013|FG001|Overall Study|Lost to Follow-up|0|||
44361381|NCT01110330|79367041|FG000|Overall Study|Other|1|||
44267317|NCT00552617|79181014|FG002|Overall Study|Lost to Follow-up|0|||
44361382|NCT01110330|79367042|FG001|Overall Study|Other|1|||
44267318|NCT00552617|79181015|FG003|Overall Study|Lost to Follow-up|1|||
44361383|NCT01110330|79367043|FG002|Overall Study|Other|1|||
44451612|NCT00490815|79460497|FG001|Overall Study|Death|3|||
44451613|NCT03855189|79460506|FG000|Overall Study|Adverse Event|5|||
44267319|NCT00552617|79181016|FG004|Overall Study|Lost to Follow-up|0|||
44267320|NCT00552617|79181017|FG005|Overall Study|Lost to Follow-up|2|||
44267321|NCT00552617|79181018|FG006|Overall Study|Lost to Follow-up|0|||
44267322|NCT00552617|79181019|FG007|Overall Study|Lost to Follow-up|0|||
44267323|NCT00552617|79181020|FG008|Overall Study|Lost to Follow-up|2|||
44267324|NCT00552617|79181021|FG009|Overall Study|Lost to Follow-up|0|||
44267325|NCT02421120|79181043|FG000|Overall Study|Adverse Event|1|||
44267326|NCT02420262|79181049|FG000|Overall Study|Adverse Event|1|||
44451614|NCT03855189|79460507|FG001|Overall Study|Adverse Event|2|||
44267327|NCT02420262|79181050|FG001|Overall Study|Adverse Event|0|||
44267328|NCT02420262|79181049|FG000|Overall Study|Withdrawal by Subject|1|||
44267329|NCT02420262|79181050|FG001|Overall Study|Withdrawal by Subject|4|||
44267330|NCT02420262|79181049|FG000|Overall Study|Unclassified|0|||
44267331|NCT02420262|79181050|FG001|Overall Study|Unclassified|1|||
44267332|NCT00552305|79181056|FG000|Overall Study|Adverse Event|43|||
44267333|NCT00552305|79181056|FG000|Overall Study|Lack of Efficacy|120|||
44267334|NCT00552305|79181056|FG000|Overall Study|Lost to Follow-up|4|||
44267335|NCT00552305|79181056|FG000|Overall Study|Protocol Violation|3|||
44267336|NCT00552305|79181056|FG000|Overall Study|Withdrawal by Subject|44|||
44267337|NCT00552305|79181056|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
44267338|NCT00552305|79181056|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
44267339|NCT00552305|79181056|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
44267340|NCT00552305|79181056|FG000|Overall Study|Unsatisfactory compliance|11|||
44267341|NCT00552305|79181056|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
44267342|NCT00552305|79181056|FG000|Overall Study|AE/Other: prohibited drug required|1|||
44267343|NCT00552305|79181056|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
44267344|NCT00552305|79181056|FG000|Overall Study|Other: Site closed|4|||
44267345|NCT00552305|79181056|FG000|Overall Study|Other: Personal problems|1|||
44267346|NCT00552305|79181056|FG000|Overall Study|Other: Unable to attend visits|1|||
44267347|NCT00552305|79181056|FG000|Overall Study|Other: Subject underwent surgery|4|||
44267348|NCT00552305|79181056|FG000|Overall Study|Other: Subject became pregnant|1|||
44267349|NCT00552305|79181056|FG000|Overall Study|Other: Health problems, not drug related|1|||
44267350|NCT00552305|79181056|FG000|Overall Study|Other: Subject moved from area|2|||
44267351|NCT00552305|79181056|FG000|Overall Study|Other: Subject incarcerated|1|||
44267352|NCT00552305|79181056|FG000|Overall Study|Other: Subject went to rehab|1|||
44267353|NCT00552071|79181082|FG000|Overall Study|Adverse Event|1|||
44267354|NCT00552071|79181083|FG001|Overall Study|Adverse Event|0|||
44267355|NCT00552071|79181082|FG000|Overall Study|Lack of Efficacy|1|||
44267356|NCT00552071|79181083|FG001|Overall Study|Lack of Efficacy|0|||
44267357|NCT00552071|79181082|FG000|Overall Study|Physician Decision|1|||
44267358|NCT00552071|79181083|FG001|Overall Study|Physician Decision|0|||
44267359|NCT00552071|79181082|FG000|Overall Study|Pregnancy|1|||
44267360|NCT00552071|79181083|FG001|Overall Study|Pregnancy|0|||
44267361|NCT00552071|79181082|FG000|Overall Study|Death|0|||
44267362|NCT00552071|79181083|FG001|Overall Study|Death|1|||
44267363|NCT00552071|79181082|FG000|Overall Study|Withdrawal by Subject|0|||
44267364|NCT00552071|79181083|FG001|Overall Study|Withdrawal by Subject|1|||
44267365|NCT00551525|79181091|FG000|Overall Study|Protocol Violation|5|||
44267366|NCT02370498|79181118|FG000|Overall Study|Adverse Event|10|||
44267367|NCT02370498|79181119|FG001|Overall Study|Adverse Event|8|||
44267368|NCT02370498|79181118|FG000|Overall Study|Death|263|||
44267369|NCT02370498|79181119|FG001|Overall Study|Death|265|||
44267370|NCT02370498|79181118|FG000|Overall Study|Protocol Violation|1|||
44267371|NCT02370498|79181119|FG001|Overall Study|Protocol Violation|2|||
44267372|NCT02370498|79181118|FG000|Overall Study|Withdrawal by Subject|7|||
44267373|NCT02370498|79181119|FG001|Overall Study|Withdrawal by Subject|12|||
44267374|NCT02370498|79181118|FG000|Overall Study|Sponsor's decision|15|||
44267375|NCT02370498|79181119|FG001|Overall Study|Sponsor's decision|9|||
44267376|NCT02347332|79181144|FG000|Overall Study|Not treated|5|||
44267377|NCT02347332|79181145|FG001|Overall Study|Not treated|2|||
44267378|NCT02347332|79181144|FG000|Overall Study|Progressive disease|141|||
44267379|NCT02347332|79181145|FG001|Overall Study|Progressive disease|159|||
44267380|NCT02347332|79181144|FG000|Overall Study|Adverse Event|50|||
44267381|NCT02347332|79181145|FG001|Overall Study|Adverse Event|41|||
44267382|NCT02347332|79181144|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
44200732|NCT02059291|78996317|FG022|Epoch 2|Adverse Event|0|||
44200733|NCT02059291|78996318|FG023|Epoch 2|Adverse Event|0|||
44200734|NCT02059291|78996319|FG024|Epoch 2|Adverse Event|0|||
44200735|NCT02059291|78996295|FG000|Epoch 2|Withdrawal by Subject|0|||
44200736|NCT02059291|78996296|FG001|Epoch 2|Withdrawal by Subject|1|||
44200737|NCT02059291|78996297|FG002|Epoch 2|Withdrawal by Subject|0|||
44200738|NCT02059291|78996298|FG003|Epoch 2|Withdrawal by Subject|0|||
44200739|NCT02059291|78996299|FG004|Epoch 2|Withdrawal by Subject|0|||
44200740|NCT02059291|78996300|FG005|Epoch 2|Withdrawal by Subject|1|||
44200741|NCT02059291|78996301|FG006|Epoch 2|Withdrawal by Subject|0|||
44200742|NCT02059291|78996302|FG007|Epoch 2|Withdrawal by Subject|0|||
44267383|NCT02347332|79181145|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
44361384|NCT00596947|79367053|FG000|Overall Study|study halted due to low enrollment|5|||
44200743|NCT02059291|78996303|FG008|Epoch 2|Withdrawal by Subject|1|||
44267384|NCT02347332|79181144|FG000|Overall Study|Protocol Violation|1|||
44267385|NCT02347332|79181145|FG001|Overall Study|Protocol Violation|1|||
44267386|NCT02347332|79181144|FG000|Overall Study|Lost to Follow-up|2|||
44267387|NCT02347332|79181145|FG001|Overall Study|Lost to Follow-up|1|||
44267388|NCT02347332|79181144|FG000|Overall Study|Physician Decision|4|||
44200744|NCT02059291|78996304|FG009|Epoch 2|Withdrawal by Subject|0|||
44200745|NCT02059291|78996305|FG010|Epoch 2|Withdrawal by Subject|0|||
44200746|NCT02059291|78996306|FG011|Epoch 2|Withdrawal by Subject|0|||
44267389|NCT02347332|79181145|FG001|Overall Study|Physician Decision|3|||
44267390|NCT02347332|79181144|FG000|Overall Study|Withdrawal by Subject|20|||
44267391|NCT02347332|79181145|FG001|Overall Study|Withdrawal by Subject|14|||
44267392|NCT02347332|79181144|FG000|Overall Study|Protocol requirement|1|||
44267393|NCT02347332|79181145|FG001|Overall Study|Protocol requirement|1|||
44267394|NCT02347332|79181144|FG000|Overall Study|Switch Post-Trial program|0|||
44267395|NCT02347332|79181145|FG001|Overall Study|Switch Post-Trial program|1|||
44267396|NCT02347176|79181168|FG000|Overall Study|Lost to Follow-up|2|||
44267397|NCT02347176|79181169|FG001|Overall Study|Lost to Follow-up|3|||
44267398|NCT02347176|79181170|FG002|Overall Study|Lost to Follow-up|1|||
44267399|NCT02347176|79181171|FG003|Overall Study|Lost to Follow-up|1|||
44200747|NCT02059291|78996307|FG012|Epoch 2|Withdrawal by Subject|0|||
44200748|NCT02059291|78996308|FG013|Epoch 2|Withdrawal by Subject|0|||
44200749|NCT02059291|78996309|FG014|Epoch 2|Withdrawal by Subject|0|||
44200750|NCT02059291|78996310|FG015|Epoch 2|Withdrawal by Subject|0|||
44267400|NCT02347176|79181168|FG000|Overall Study|Withdrawal by Subject|9|||
44267401|NCT02347176|79181169|FG001|Overall Study|Withdrawal by Subject|5|||
44267402|NCT02347176|79181170|FG002|Overall Study|Withdrawal by Subject|5|||
44267403|NCT02347176|79181171|FG003|Overall Study|Withdrawal by Subject|3|||
44267404|NCT02347176|79181168|FG000|Overall Study|Other|1|||
44267405|NCT02347176|79181169|FG001|Overall Study|Other|2|||
44267406|NCT02347176|79181170|FG002|Overall Study|Other|2|||
44267407|NCT02347176|79181171|FG003|Overall Study|Other|0|||
44267408|NCT02370420|79181183|FG000|Overall Study|Physician Decision|3|||
44267409|NCT02370420|79181184|FG001|Overall Study|Physician Decision|3|||
44267410|NCT02370420|79181183|FG000|Overall Study|Lost to Follow-up|11|||
44267411|NCT02370420|79181184|FG001|Overall Study|Lost to Follow-up|9|||
44267412|NCT02347098|79181206|FG000|Overall Study|Death|1|||
44267413|NCT02347098|79181207|FG001|Overall Study|Death|0|||
44267414|NCT02347098|79181206|FG000|Overall Study|Withdrawal by Subject|1|||
44267415|NCT02347098|79181207|FG001|Overall Study|Withdrawal by Subject|0|||
44267416|NCT02347098|79181206|FG000|Overall Study|Lost to Follow-up|2|||
44267417|NCT02347098|79181207|FG001|Overall Study|Lost to Follow-up|2|||
44267418|NCT02347098|79181206|FG000|Overall Study|Refuse Follow-up Visit|1|||
44200751|NCT02059291|78996311|FG016|Epoch 2|Withdrawal by Subject|0|||
44267419|NCT02347098|79181207|FG001|Overall Study|Refuse Follow-up Visit|5|||
44200752|NCT02059291|78996312|FG017|Epoch 2|Withdrawal by Subject|0|||
44200753|NCT02059291|78996313|FG018|Epoch 2|Withdrawal by Subject|0|||
44200754|NCT02059291|78996314|FG019|Epoch 2|Withdrawal by Subject|0|||
44267420|NCT02347098|79181206|FG000|Overall Study|no visit due to illness|2|||
44267421|NCT02347098|79181207|FG001|Overall Study|no visit due to illness|1|||
44267422|NCT02346708|79181224|FG000|Overall Study|Adverse Event|2|||
44267423|NCT02346708|79181225|FG001|Overall Study|Adverse Event|0|||
44267424|NCT02346708|79181224|FG000|Overall Study|Protocol Violation|0|||
44267425|NCT02346708|79181225|FG001|Overall Study|Protocol Violation|1|||
44267426|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267427|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
44267428|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
44267429|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
44267430|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267431|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267432|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267433|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267434|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267435|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267436|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267437|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267438|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267439|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267440|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267441|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267442|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267443|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267444|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267445|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267446|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267447|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267448|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267449|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
44267450|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267451|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
44267452|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44200755|NCT02059291|78996315|FG020|Epoch 2|Withdrawal by Subject|0|||
44200756|NCT02059291|78996316|FG021|Epoch 2|Withdrawal by Subject|0|||
44200757|NCT02059291|78996317|FG022|Epoch 2|Withdrawal by Subject|0|||
44200758|NCT02059291|78996318|FG023|Epoch 2|Withdrawal by Subject|0|||
44200759|NCT02059291|78996319|FG024|Epoch 2|Withdrawal by Subject|0|||
44200760|NCT02059291|78996295|FG000|Epoch 3|Physician Decision|0|||
44200761|NCT02059291|78996296|FG001|Epoch 3|Physician Decision|0|||
44200762|NCT02059291|78996297|FG002|Epoch 3|Physician Decision|0|||
44200763|NCT02059291|78996298|FG003|Epoch 3|Physician Decision|0|||
44200764|NCT02059291|78996299|FG004|Epoch 3|Physician Decision|0|||
44200765|NCT02059291|78996300|FG005|Epoch 3|Physician Decision|0|||
44200766|NCT02059291|78996301|FG006|Epoch 3|Physician Decision|0|||
44200767|NCT02059291|78996302|FG007|Epoch 3|Physician Decision|0|||
44200768|NCT02059291|78996303|FG008|Epoch 3|Physician Decision|0|||
44200769|NCT02059291|78996304|FG009|Epoch 3|Physician Decision|0|||
44200770|NCT02059291|78996305|FG010|Epoch 3|Physician Decision|0|||
44200771|NCT02059291|78996306|FG011|Epoch 3|Physician Decision|0|||
44200772|NCT02059291|78996307|FG012|Epoch 3|Physician Decision|0|||
44200773|NCT02059291|78996308|FG013|Epoch 3|Physician Decision|1|||
44200774|NCT02059291|78996309|FG014|Epoch 3|Physician Decision|0|||
44200775|NCT02059291|78996310|FG015|Epoch 3|Physician Decision|1|||
44200776|NCT02059291|78996311|FG016|Epoch 3|Physician Decision|0|||
44200777|NCT02059291|78996312|FG017|Epoch 3|Physician Decision|0|||
44200778|NCT02059291|78996313|FG018|Epoch 3|Physician Decision|0|||
44200779|NCT02059291|78996314|FG019|Epoch 3|Physician Decision|0|||
44200780|NCT02059291|78996315|FG020|Epoch 3|Physician Decision|0|||
44200781|NCT02059291|78996316|FG021|Epoch 3|Physician Decision|0|||
44200782|NCT02059291|78996317|FG022|Epoch 3|Physician Decision|0|||
44200783|NCT02059291|78996318|FG023|Epoch 3|Physician Decision|0|||
44200784|NCT02059291|78996319|FG024|Epoch 3|Physician Decision|0|||
44200785|NCT02059291|78996295|FG000|Epoch 3|Adverse Event|0|||
44200786|NCT02059291|78996296|FG001|Epoch 3|Adverse Event|0|||
44200787|NCT02059291|78996297|FG002|Epoch 3|Adverse Event|0|||
44200788|NCT02059291|78996298|FG003|Epoch 3|Adverse Event|0|||
44200789|NCT02059291|78996299|FG004|Epoch 3|Adverse Event|0|||
44200790|NCT02059291|78996300|FG005|Epoch 3|Adverse Event|0|||
44200791|NCT02059291|78996301|FG006|Epoch 3|Adverse Event|0|||
44200792|NCT02059291|78996302|FG007|Epoch 3|Adverse Event|0|||
44200793|NCT02059291|78996303|FG008|Epoch 3|Adverse Event|0|||
44200794|NCT02059291|78996304|FG009|Epoch 3|Adverse Event|0|||
44200795|NCT02059291|78996305|FG010|Epoch 3|Adverse Event|0|||
44200796|NCT02059291|78996306|FG011|Epoch 3|Adverse Event|0|||
44200797|NCT02059291|78996307|FG012|Epoch 3|Adverse Event|0|||
44200798|NCT02059291|78996308|FG013|Epoch 3|Adverse Event|0|||
44200799|NCT02059291|78996309|FG014|Epoch 3|Adverse Event|0|||
44200800|NCT02059291|78996310|FG015|Epoch 3|Adverse Event|1|||
44200801|NCT02059291|78996311|FG016|Epoch 3|Adverse Event|0|||
44200802|NCT02059291|78996312|FG017|Epoch 3|Adverse Event|0|||
44200803|NCT02059291|78996313|FG018|Epoch 3|Adverse Event|0|||
44200804|NCT02059291|78996314|FG019|Epoch 3|Adverse Event|0|||
44200805|NCT02059291|78996315|FG020|Epoch 3|Adverse Event|0|||
44200806|NCT02059291|78996316|FG021|Epoch 3|Adverse Event|0|||
44200807|NCT02059291|78996317|FG022|Epoch 3|Adverse Event|0|||
44200808|NCT02059291|78996318|FG023|Epoch 3|Adverse Event|0|||
44200809|NCT02059291|78996319|FG024|Epoch 3|Adverse Event|0|||
44200810|NCT02059291|78996295|FG000|Epoch 3|Lack of Efficacy|0|||
44200811|NCT02059291|78996296|FG001|Epoch 3|Lack of Efficacy|0|||
44200812|NCT02059291|78996297|FG002|Epoch 3|Lack of Efficacy|0|||
44200813|NCT02059291|78996298|FG003|Epoch 3|Lack of Efficacy|0|||
44200814|NCT02059291|78996299|FG004|Epoch 3|Lack of Efficacy|0|||
44200815|NCT02059291|78996300|FG005|Epoch 3|Lack of Efficacy|0|||
44200816|NCT02059291|78996301|FG006|Epoch 3|Lack of Efficacy|0|||
44200817|NCT02059291|78996302|FG007|Epoch 3|Lack of Efficacy|0|||
44200818|NCT02059291|78996303|FG008|Epoch 3|Lack of Efficacy|0|||
44200819|NCT02059291|78996304|FG009|Epoch 3|Lack of Efficacy|0|||
44200820|NCT02059291|78996305|FG010|Epoch 3|Lack of Efficacy|0|||
44200821|NCT02059291|78996306|FG011|Epoch 3|Lack of Efficacy|0|||
44200822|NCT02059291|78996307|FG012|Epoch 3|Lack of Efficacy|0|||
44200823|NCT02059291|78996308|FG013|Epoch 3|Lack of Efficacy|0|||
44200824|NCT02059291|78996309|FG014|Epoch 3|Lack of Efficacy|0|||
44200825|NCT02059291|78996310|FG015|Epoch 3|Lack of Efficacy|3|||
44200826|NCT02059291|78996311|FG016|Epoch 3|Lack of Efficacy|0|||
44200827|NCT02059291|78996312|FG017|Epoch 3|Lack of Efficacy|0|||
44200828|NCT02059291|78996313|FG018|Epoch 3|Lack of Efficacy|0|||
44200829|NCT02059291|78996314|FG019|Epoch 3|Lack of Efficacy|0|||
44200830|NCT02059291|78996315|FG020|Epoch 3|Lack of Efficacy|0|||
44200831|NCT02059291|78996316|FG021|Epoch 3|Lack of Efficacy|0|||
44200832|NCT02059291|78996317|FG022|Epoch 3|Lack of Efficacy|0|||
44200833|NCT02059291|78996318|FG023|Epoch 3|Lack of Efficacy|0|||
44200834|NCT02059291|78996319|FG024|Epoch 3|Lack of Efficacy|0|||
44200835|NCT02059291|78996295|FG000|Epoch 3|Withdrawal by Subject|0|||
44200836|NCT02059291|78996296|FG001|Epoch 3|Withdrawal by Subject|0|||
44200837|NCT02059291|78996297|FG002|Epoch 3|Withdrawal by Subject|0|||
44200838|NCT02059291|78996298|FG003|Epoch 3|Withdrawal by Subject|0|||
44200839|NCT02059291|78996299|FG004|Epoch 3|Withdrawal by Subject|0|||
44200840|NCT02059291|78996300|FG005|Epoch 3|Withdrawal by Subject|0|||
44200841|NCT02059291|78996301|FG006|Epoch 3|Withdrawal by Subject|0|||
44361385|NCT00596947|79367054|FG001|Overall Study|study halted due to low enrollment|3|||
44361386|NCT00596947|79367053|FG000|Overall Study|Lost to Follow-up|1|||
44361387|NCT00596947|79367054|FG001|Overall Study|Lost to Follow-up|0|||
44361388|NCT00888940|79367062|FG000|Overall Study|Adverse Event|12|||
44361389|NCT00888940|79367063|FG001|Overall Study|Adverse Event|3|||
44361390|NCT00888940|79367062|FG000|Overall Study|Lost to Follow-up|5|||
44361391|NCT00888940|79367063|FG001|Overall Study|Lost to Follow-up|5|||
44361392|NCT00888940|79367062|FG000|Overall Study|Randomized Not Treated|11|||
44361393|NCT00888940|79367063|FG001|Overall Study|Randomized Not Treated|13|||
44361394|NCT00595621|79367071|FG000|Open Label Run in|Adverse Event|1|||
44361395|NCT00595621|79367072|FG001|Open Label Run in|Adverse Event|0|||
44361396|NCT00595621|79367071|FG000|Open Label Run in|Physician Decision|1|||
44361397|NCT00595621|79367072|FG001|Open Label Run in|Physician Decision|0|||
44361398|NCT00595621|79367071|FG000|Open Label Run in|Withdrawal by Subject|1|||
44361399|NCT00595621|79367072|FG001|Open Label Run in|Withdrawal by Subject|0|||
44361400|NCT00595621|79367071|FG000|Randomization and Study|Adverse Event|2|||
44361401|NCT00595621|79367072|FG001|Randomization and Study|Adverse Event|0|||
44361402|NCT00595621|79367071|FG000|Randomization and Study|Withdrawal by Subject|0|||
44361403|NCT00595621|79367072|FG001|Randomization and Study|Withdrawal by Subject|1|||
44361404|NCT00888238|79367079|FG000|Washout Period After Period 2|Adverse Event|0|||
44361405|NCT00888238|79367080|FG001|Washout Period After Period 2|Adverse Event|0|||
44361406|NCT00888238|79367081|FG002|Washout Period After Period 2|Adverse Event|1|||
44361407|NCT00595465|79367090|FG000|Overall Study|Adverse Event|4|||
44361408|NCT00595465|79367091|FG001|Overall Study|Adverse Event|3|||
44361409|NCT00595465|79367092|FG002|Overall Study|Adverse Event|3|||
44361410|NCT00595465|79367090|FG000|Overall Study|Pregnancy|0|||
44361411|NCT00595465|79367091|FG001|Overall Study|Pregnancy|0|||
44361412|NCT00595465|79367092|FG002|Overall Study|Pregnancy|1|||
44361413|NCT00595465|79367090|FG000|Overall Study|Protocol Violation|2|||
44361414|NCT00595465|79367091|FG001|Overall Study|Protocol Violation|1|||
44361415|NCT00595465|79367092|FG002|Overall Study|Protocol Violation|0|||
44361416|NCT00595465|79367090|FG000|Overall Study|Lost to Follow-up|0|||
44361417|NCT00595465|79367091|FG001|Overall Study|Lost to Follow-up|0|||
44361418|NCT00595465|79367092|FG002|Overall Study|Lost to Follow-up|2|||
44361419|NCT00595465|79367090|FG000|Overall Study|administrative reason|0|||
44361420|NCT00595465|79367091|FG001|Overall Study|administrative reason|0|||
44361421|NCT00595465|79367092|FG002|Overall Study|administrative reason|1|||
44451615|NCT03855189|79460508|FG002|Overall Study|Adverse Event|4|||
44451616|NCT03855189|79460506|FG000|Overall Study|Treatment Failure|1|||
44451617|NCT03855189|79460507|FG001|Overall Study|Treatment Failure|1|||
44200842|NCT02059291|78996302|FG007|Epoch 3|Withdrawal by Subject|0|||
44200843|NCT02059291|78996303|FG008|Epoch 3|Withdrawal by Subject|0|||
44200844|NCT02059291|78996304|FG009|Epoch 3|Withdrawal by Subject|0|||
44200845|NCT02059291|78996305|FG010|Epoch 3|Withdrawal by Subject|0|||
44200846|NCT02059291|78996306|FG011|Epoch 3|Withdrawal by Subject|0|||
44200847|NCT02059291|78996307|FG012|Epoch 3|Withdrawal by Subject|0|||
44200848|NCT02059291|78996308|FG013|Epoch 3|Withdrawal by Subject|0|||
44200849|NCT02059291|78996309|FG014|Epoch 3|Withdrawal by Subject|0|||
44200850|NCT02059291|78996310|FG015|Epoch 3|Withdrawal by Subject|1|||
44200851|NCT02059291|78996311|FG016|Epoch 3|Withdrawal by Subject|0|||
44200852|NCT02059291|78996312|FG017|Epoch 3|Withdrawal by Subject|0|||
44200853|NCT02059291|78996313|FG018|Epoch 3|Withdrawal by Subject|0|||
44200854|NCT02059291|78996314|FG019|Epoch 3|Withdrawal by Subject|0|||
44200855|NCT02059291|78996315|FG020|Epoch 3|Withdrawal by Subject|0|||
44200856|NCT02059291|78996316|FG021|Epoch 3|Withdrawal by Subject|0|||
44200857|NCT02059291|78996317|FG022|Epoch 3|Withdrawal by Subject|0|||
44200858|NCT02059291|78996318|FG023|Epoch 3|Withdrawal by Subject|0|||
44200859|NCT02059291|78996319|FG024|Epoch 3|Withdrawal by Subject|0|||
44200860|NCT02059291|78996295|FG000|Epoch 4|Adverse Event|0|||
44200861|NCT02059291|78996296|FG001|Epoch 4|Adverse Event|0|||
44200862|NCT02059291|78996297|FG002|Epoch 4|Adverse Event|0|||
44200863|NCT02059291|78996298|FG003|Epoch 4|Adverse Event|0|||
44200864|NCT02059291|78996299|FG004|Epoch 4|Adverse Event|0|||
44200865|NCT02059291|78996300|FG005|Epoch 4|Adverse Event|0|||
44200866|NCT02059291|78996301|FG006|Epoch 4|Adverse Event|0|||
44200867|NCT02059291|78996302|FG007|Epoch 4|Adverse Event|0|||
44200868|NCT02059291|78996303|FG008|Epoch 4|Adverse Event|0|||
44200869|NCT02059291|78996304|FG009|Epoch 4|Adverse Event|0|||
44200870|NCT02059291|78996305|FG010|Epoch 4|Adverse Event|0|||
44200871|NCT02059291|78996306|FG011|Epoch 4|Adverse Event|0|||
44200872|NCT02059291|78996307|FG012|Epoch 4|Adverse Event|0|||
44200873|NCT02059291|78996308|FG013|Epoch 4|Adverse Event|0|||
44200874|NCT02059291|78996309|FG014|Epoch 4|Adverse Event|0|||
44200875|NCT02059291|78996310|FG015|Epoch 4|Adverse Event|0|||
44200876|NCT02059291|78996311|FG016|Epoch 4|Adverse Event|1|||
44200877|NCT02059291|78996312|FG017|Epoch 4|Adverse Event|0|||
44200878|NCT02059291|78996313|FG018|Epoch 4|Adverse Event|0|||
44200879|NCT02059291|78996314|FG019|Epoch 4|Adverse Event|0|||
44200880|NCT02059291|78996315|FG020|Epoch 4|Adverse Event|0|||
44361422|NCT01205438|79367103|FG000|Overall Study|Adverse Event|19|||
44361423|NCT01205438|79367104|FG001|Overall Study|Adverse Event|17|||
44267453|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267454|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267455|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267456|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267457|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267458|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267459|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267460|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267461|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267462|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267463|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267464|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267465|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267466|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267467|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267468|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267469|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267470|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267471|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267472|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267473|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
44267474|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267475|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
44267476|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267477|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267478|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267479|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267480|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267481|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267482|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267483|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267484|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267485|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267486|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267487|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267488|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267489|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267490|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267491|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267492|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267493|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267494|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267495|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267496|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267497|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
44267498|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
44267499|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
44267500|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
44267501|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
44267502|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267503|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267504|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267505|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267506|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267507|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267508|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267509|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267510|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267511|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267512|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267513|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267514|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44451618|NCT03855189|79460508|FG002|Overall Study|Treatment Failure|2|||
44267515|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267516|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44451619|NCT03855189|79460506|FG000|Overall Study|Noncompliance with Protocol|0|||
44267517|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267518|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267519|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267520|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267521|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
44267522|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
44267523|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
44267524|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
44267525|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
44267526|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267527|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267528|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267529|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267530|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267531|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44451620|NCT03855189|79460507|FG001|Overall Study|Noncompliance with Protocol|1|||
44451621|NCT03855189|79460508|FG002|Overall Study|Noncompliance with Protocol|0|||
44451622|NCT03855189|79460506|FG000|Overall Study|Did Not Return|4|||
44451623|NCT03855189|79460507|FG001|Overall Study|Did Not Return|3|||
44451624|NCT03855189|79460508|FG002|Overall Study|Did Not Return|0|||
44200881|NCT02059291|78996316|FG021|Epoch 4|Adverse Event|0|||
44200882|NCT02059291|78996317|FG022|Epoch 4|Adverse Event|1|||
44200883|NCT02059291|78996318|FG023|Epoch 4|Adverse Event|0|||
44200884|NCT02059291|78996319|FG024|Epoch 4|Adverse Event|0|||
44200885|NCT02059291|78996295|FG000|Epoch 4|Pregnancy|0|||
44200886|NCT02059291|78996296|FG001|Epoch 4|Pregnancy|0|||
44200887|NCT02059291|78996297|FG002|Epoch 4|Pregnancy|0|||
44200888|NCT02059291|78996298|FG003|Epoch 4|Pregnancy|0|||
44200889|NCT02059291|78996299|FG004|Epoch 4|Pregnancy|0|||
44200890|NCT02059291|78996300|FG005|Epoch 4|Pregnancy|0|||
44200891|NCT02059291|78996301|FG006|Epoch 4|Pregnancy|0|||
44267532|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267533|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267534|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267535|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267536|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267537|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267538|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267539|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267540|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267541|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267542|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267543|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267544|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267545|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
44267546|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267547|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
44267548|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44361424|NCT01205438|79367105|FG002|Overall Study|Adverse Event|24|||
44451625|NCT03853551|79460516|FG000|Overall Study|Death|2|||
44451626|NCT03853551|79460516|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
44451627|NCT00423670|79460527|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
44451628|NCT00423670|79460528|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
44451629|NCT00423670|79460529|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
44451630|NCT00423670|79460530|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
44361425|NCT01205438|79367103|FG000|Overall Study|Death|1|||
44361426|NCT01205438|79367104|FG001|Overall Study|Death|1|||
44361427|NCT01205438|79367105|FG002|Overall Study|Death|3|||
44361428|NCT01205438|79367103|FG000|Overall Study|Entry Criteria Not Met|16|||
44361429|NCT01205438|79367104|FG001|Overall Study|Entry Criteria Not Met|15|||
44361430|NCT01205438|79367105|FG002|Overall Study|Entry Criteria Not Met|13|||
44361431|NCT01205438|79367103|FG000|Overall Study|Lack of Efficacy|14|||
44361432|NCT01205438|79367104|FG001|Overall Study|Lack of Efficacy|11|||
44451631|NCT00423670|79460531|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
44451632|NCT00423670|79460532|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
44451633|NCT00423670|79460533|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
44451634|NCT00423670|79460534|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
44200892|NCT02059291|78996302|FG007|Epoch 4|Pregnancy|0|||
44200893|NCT02059291|78996303|FG008|Epoch 4|Pregnancy|0|||
44200894|NCT02059291|78996304|FG009|Epoch 4|Pregnancy|0|||
44200895|NCT02059291|78996305|FG010|Epoch 4|Pregnancy|0|||
44200896|NCT02059291|78996306|FG011|Epoch 4|Pregnancy|0|||
44267549|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
44267550|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267551|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267552|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267553|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267554|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267555|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267556|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267557|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267558|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267559|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267560|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267561|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267562|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267563|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267564|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267565|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267566|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267567|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267568|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267569|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
44267570|NCT02346240|79181715|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44451635|NCT00423670|79460527|FG000|Treatment Period|Adverse Event|8|||
44451636|NCT00423670|79460528|FG001|Treatment Period|Adverse Event|12|||
44451637|NCT00423670|79460529|FG002|Treatment Period|Adverse Event|15|||
44451638|NCT00423670|79460530|FG003|Treatment Period|Adverse Event|20|||
44451639|NCT00423670|79460531|FG004|Treatment Period|Adverse Event|9|||
44451640|NCT00423670|79460532|FG005|Treatment Period|Adverse Event|4|||
44451641|NCT00423670|79460533|FG006|Treatment Period|Adverse Event|7|||
44451642|NCT00423670|79460534|FG007|Treatment Period|Adverse Event|2|||
44200897|NCT02059291|78996307|FG012|Epoch 4|Pregnancy|0|||
44200898|NCT02059291|78996308|FG013|Epoch 4|Pregnancy|0|||
44267571|NCT02346240|79181716|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267572|NCT02346240|79181717|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
44267573|NCT02346240|79181718|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267574|NCT02346240|79181719|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267575|NCT02346240|79181720|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267576|NCT02346240|79181721|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267577|NCT02346240|79181722|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267578|NCT02346240|79181723|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267579|NCT02346240|79181724|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267580|NCT02346240|79181725|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267581|NCT02346240|79181726|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267582|NCT02346240|79181727|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267583|NCT02346240|79181728|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267584|NCT02346240|79181729|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267585|NCT02346240|79181730|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267586|NCT02346240|79181731|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267587|NCT02346240|79181732|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267588|NCT02346240|79181733|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267589|NCT02346240|79181734|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267590|NCT02346240|79181735|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267591|NCT02346240|79181736|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44451643|NCT00423670|79460527|FG000|Treatment Period|Protocol-defined clinical event|0|||
44200899|NCT02059291|78996309|FG014|Epoch 4|Pregnancy|0|||
44200900|NCT02059291|78996310|FG015|Epoch 4|Pregnancy|0|||
44200901|NCT02059291|78996311|FG016|Epoch 4|Pregnancy|1|||
44200902|NCT02059291|78996312|FG017|Epoch 4|Pregnancy|0|||
44200903|NCT02059291|78996313|FG018|Epoch 4|Pregnancy|0|||
44200904|NCT02059291|78996314|FG019|Epoch 4|Pregnancy|0|||
44200905|NCT02059291|78996315|FG020|Epoch 4|Pregnancy|0|||
44200906|NCT02059291|78996316|FG021|Epoch 4|Pregnancy|0|||
44200907|NCT02059291|78996317|FG022|Epoch 4|Pregnancy|0|||
44200908|NCT02059291|78996318|FG023|Epoch 4|Pregnancy|0|||
44200909|NCT02059291|78996319|FG024|Epoch 4|Pregnancy|0|||
44200910|NCT02059291|78996295|FG000|Epoch 4|Withdrawal by Subject|0|||
44200911|NCT02059291|78996296|FG001|Epoch 4|Withdrawal by Subject|0|||
44267592|NCT02346240|79181737|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267593|NCT02346240|79181738|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
44267594|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267595|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267596|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267597|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267598|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267599|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267600|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267601|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
44267602|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
44267603|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267604|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267605|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267606|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267607|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
44200912|NCT02059291|78996297|FG002|Epoch 4|Withdrawal by Subject|0|||
44200913|NCT02059291|78996298|FG003|Epoch 4|Withdrawal by Subject|0|||
44200914|NCT02059291|78996299|FG004|Epoch 4|Withdrawal by Subject|0|||
44200915|NCT02059291|78996300|FG005|Epoch 4|Withdrawal by Subject|0|||
44200916|NCT02059291|78996301|FG006|Epoch 4|Withdrawal by Subject|0|||
44200917|NCT02059291|78996302|FG007|Epoch 4|Withdrawal by Subject|0|||
44200918|NCT02059291|78996303|FG008|Epoch 4|Withdrawal by Subject|0|||
44200919|NCT02059291|78996304|FG009|Epoch 4|Withdrawal by Subject|0|||
44200920|NCT02059291|78996305|FG010|Epoch 4|Withdrawal by Subject|0|||
44200921|NCT02059291|78996306|FG011|Epoch 4|Withdrawal by Subject|0|||
44200922|NCT02059291|78996307|FG012|Epoch 4|Withdrawal by Subject|0|||
44200923|NCT02059291|78996308|FG013|Epoch 4|Withdrawal by Subject|0|||
44200924|NCT02059291|78996309|FG014|Epoch 4|Withdrawal by Subject|0|||
44200925|NCT02059291|78996310|FG015|Epoch 4|Withdrawal by Subject|0|||
44200926|NCT02059291|78996311|FG016|Epoch 4|Withdrawal by Subject|0|||
44200927|NCT02059291|78996312|FG017|Epoch 4|Withdrawal by Subject|0|||
44200928|NCT02059291|78996313|FG018|Epoch 4|Withdrawal by Subject|0|||
44200929|NCT02059291|78996314|FG019|Epoch 4|Withdrawal by Subject|0|||
44200930|NCT02059291|78996315|FG020|Epoch 4|Withdrawal by Subject|1|||
44200931|NCT02059291|78996316|FG021|Epoch 4|Withdrawal by Subject|0|||
44200932|NCT02059291|78996317|FG022|Epoch 4|Withdrawal by Subject|0|||
44200933|NCT02059291|78996318|FG023|Epoch 4|Withdrawal by Subject|0|||
44200934|NCT02059291|78996319|FG024|Epoch 4|Withdrawal by Subject|0|||
44200935|NCT02059291|78996295|FG000|Epoch 4|Lack of Efficacy|0|||
44200936|NCT02059291|78996296|FG001|Epoch 4|Lack of Efficacy|0|||
44200937|NCT02059291|78996297|FG002|Epoch 4|Lack of Efficacy|0|||
44200938|NCT02059291|78996298|FG003|Epoch 4|Lack of Efficacy|0|||
44200939|NCT02059291|78996299|FG004|Epoch 4|Lack of Efficacy|0|||
44200940|NCT02059291|78996300|FG005|Epoch 4|Lack of Efficacy|0|||
44200941|NCT02059291|78996301|FG006|Epoch 4|Lack of Efficacy|0|||
44200942|NCT02059291|78996302|FG007|Epoch 4|Lack of Efficacy|0|||
44200943|NCT02059291|78996303|FG008|Epoch 4|Lack of Efficacy|0|||
44200944|NCT02059291|78996304|FG009|Epoch 4|Lack of Efficacy|0|||
44200945|NCT02059291|78996305|FG010|Epoch 4|Lack of Efficacy|0|||
44200946|NCT02059291|78996306|FG011|Epoch 4|Lack of Efficacy|0|||
44200947|NCT02059291|78996307|FG012|Epoch 4|Lack of Efficacy|0|||
44200948|NCT02059291|78996308|FG013|Epoch 4|Lack of Efficacy|0|||
44200949|NCT02059291|78996309|FG014|Epoch 4|Lack of Efficacy|0|||
44200950|NCT02059291|78996310|FG015|Epoch 4|Lack of Efficacy|0|||
44200951|NCT02059291|78996311|FG016|Epoch 4|Lack of Efficacy|0|||
44200952|NCT02059291|78996312|FG017|Epoch 4|Lack of Efficacy|0|||
44200953|NCT02059291|78996313|FG018|Epoch 4|Lack of Efficacy|0|||
44200954|NCT02059291|78996314|FG019|Epoch 4|Lack of Efficacy|0|||
44200955|NCT02059291|78996315|FG020|Epoch 4|Lack of Efficacy|0|||
44200956|NCT02059291|78996316|FG021|Epoch 4|Lack of Efficacy|0|||
44200957|NCT02059291|78996317|FG022|Epoch 4|Lack of Efficacy|0|||
44200958|NCT02059291|78996318|FG023|Epoch 4|Lack of Efficacy|1|||
44200959|NCT02059291|78996319|FG024|Epoch 4|Lack of Efficacy|0|||
44200960|NCT02042924|78996347|FG000|Overall Study|Early Death|1|||
44200961|NCT02041520|78996353|FG000|Overall Study|Adverse Event|2|||
44200962|NCT02041520|78996354|FG001|Overall Study|Adverse Event|1|||
44200963|NCT02041520|78996353|FG000|Overall Study|Withdrawal by Subject|3|||
44200964|NCT02041520|78996354|FG001|Overall Study|Withdrawal by Subject|4|||
44200965|NCT02041520|78996353|FG000|Overall Study|Protocol Violation|1|||
44200966|NCT02041520|78996354|FG001|Overall Study|Protocol Violation|0|||
44200967|NCT02041520|78996353|FG000|Overall Study|Lost to Follow-up|0|||
44200968|NCT02041520|78996354|FG001|Overall Study|Lost to Follow-up|1|||
44200969|NCT02041520|78996353|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
44200970|NCT02041520|78996354|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
44200971|NCT02041429|78996366|FG000|Overall Study|Progressive Disease|2|||
44200972|NCT02041429|78996367|FG001|Overall Study|Progressive Disease|2|||
44200973|NCT02041429|78996368|FG002|Overall Study|Progressive Disease|3|||
44200974|NCT02041429|78996369|FG003|Overall Study|Progressive Disease|2|||
44267608|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
44267609|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
44267610|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
44267611|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267612|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267613|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267614|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267615|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267616|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267617|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44267618|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267619|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267620|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267621|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267622|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267623|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267624|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267625|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267626|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267627|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267628|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267629|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267630|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267631|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
44267632|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267633|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
44267634|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267635|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267636|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267637|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267638|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267639|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267640|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44200975|NCT02041429|78996366|FG000|Overall Study|Toxicity|0|||
44200976|NCT02041429|78996367|FG001|Overall Study|Toxicity|1|||
44200977|NCT02041429|78996368|FG002|Overall Study|Toxicity|4|||
44200978|NCT02041429|78996369|FG003|Overall Study|Toxicity|2|||
44200979|NCT02041429|78996366|FG000|Overall Study|Withdrawal by Subject|0|||
44200980|NCT02041429|78996367|FG001|Overall Study|Withdrawal by Subject|1|||
44200981|NCT02041429|78996368|FG002|Overall Study|Withdrawal by Subject|0|||
44200982|NCT02041429|78996369|FG003|Overall Study|Withdrawal by Subject|0|||
44200983|NCT02041429|78996366|FG000|Overall Study|On Maintenance Therapy|1|||
44200984|NCT02041429|78996367|FG001|Overall Study|On Maintenance Therapy|0|||
44200985|NCT02041429|78996368|FG002|Overall Study|On Maintenance Therapy|0|||
44200986|NCT02041429|78996369|FG003|Overall Study|On Maintenance Therapy|2|||
44200987|NCT02083783|78996386|FG000|Overall Study|Withdrawal by Subject|1|||
44200988|NCT02083783|78996387|FG001|Overall Study|Withdrawal by Subject|0|||
44200989|NCT02083081|78996397|FG000|Overall Study|Lost to Follow-up|31|||
44200990|NCT02083081|78996398|FG001|Overall Study|Lost to Follow-up|9|||
44200991|NCT02040805|78996406|FG000|Overall Study|Lost to Follow-up|14|||
44200992|NCT02040805|78996407|FG001|Overall Study|Lost to Follow-up|9|||
44200993|NCT02040805|78996406|FG000|Overall Study|Withdrawal by Subject|28|||
44200994|NCT02040805|78996407|FG001|Overall Study|Withdrawal by Subject|41|||
44200995|NCT02040259|78996413|FG000|Overall Study|Death|280|||
44267641|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44267642|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267643|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267644|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267645|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267646|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267647|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44200996|NCT02040259|78996413|FG000|Overall Study|Lost to Follow-up|76|||
44200997|NCT02040259|78996413|FG000|Overall Study|Assessment not completed|3|||
44267648|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267649|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267650|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44200998|NCT02040259|78996413|FG000|Overall Study|Withdrawal by Subject|4|||
44200999|NCT02059135|78996421|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
44267651|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267652|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267653|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267654|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267655|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267656|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
44267657|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267658|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267659|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267660|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267661|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267662|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267663|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267664|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267665|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44267666|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267667|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267668|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267669|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267670|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267671|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44267672|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44267673|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44267674|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44267675|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267676|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44267677|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
44267678|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267679|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
44451644|NCT00423670|79460528|FG001|Treatment Period|Protocol-defined clinical event|7|||
44451645|NCT00423670|79460529|FG002|Treatment Period|Protocol-defined clinical event|4|||
44201000|NCT02059135|78996422|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
44201001|NCT02059135|78996421|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
44201002|NCT02059135|78996422|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
44201003|NCT02059135|78996421|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
44201004|NCT02059135|78996422|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
44201005|NCT02059135|78996421|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
44201006|NCT02059135|78996422|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
44201007|NCT02059135|78996421|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
44201008|NCT02059135|78996422|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
44201009|NCT02059135|78996421|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
44201010|NCT02059135|78996422|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
44201011|NCT02059135|78996421|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
44201012|NCT02059135|78996422|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
44201013|NCT02059135|78996421|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
44201014|NCT02059135|78996422|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
44201015|NCT02081677|78996434|FG000|Overall Study|Adverse Event|0|||
44201016|NCT02081677|78996435|FG001|Overall Study|Adverse Event|0|||
44201017|NCT02081677|78996436|FG002|Overall Study|Adverse Event|1|||
44201018|NCT02081677|78996437|FG003|Overall Study|Adverse Event|0|||
44201019|NCT02081677|78996434|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44201020|NCT02081677|78996435|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44201021|NCT02081677|78996436|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
44201022|NCT02081677|78996437|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
44201023|NCT02081677|78996434|FG000|Overall Study|Not comfortable with lens care system|1|||
44201024|NCT02081677|78996435|FG001|Overall Study|Not comfortable with lens care system|0|||
44201025|NCT02081677|78996436|FG002|Overall Study|Not comfortable with lens care system|0|||
44201026|NCT02081677|78996437|FG003|Overall Study|Not comfortable with lens care system|0|||
44201027|NCT02081677|78996434|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
44201028|NCT02081677|78996435|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
44201029|NCT02081677|78996436|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
44267680|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
44267681|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
44267682|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44267683|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267684|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267685|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267686|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267687|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267688|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267689|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44267690|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267691|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267692|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267693|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267694|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267695|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267696|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267697|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267698|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267699|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267700|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267701|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267702|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267703|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
44267704|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
44361433|NCT01205438|79367105|FG002|Overall Study|Lack of Efficacy|14|||
44361434|NCT01205438|79367103|FG000|Overall Study|Lost to Follow-up|6|||
44361435|NCT01205438|79367104|FG001|Overall Study|Lost to Follow-up|7|||
44267705|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
44267706|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
44267707|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267708|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267709|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267710|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44361436|NCT01205438|79367105|FG002|Overall Study|Lost to Follow-up|8|||
44361437|NCT01205438|79367103|FG000|Overall Study|Withdrawal by Subject|19|||
44361438|NCT01205438|79367104|FG001|Overall Study|Withdrawal by Subject|25|||
44361439|NCT01205438|79367105|FG002|Overall Study|Withdrawal by Subject|19|||
44361440|NCT01205438|79367103|FG000|Overall Study|Physician Decision|0|||
44361441|NCT01205438|79367104|FG001|Overall Study|Physician Decision|3|||
44361442|NCT01205438|79367105|FG002|Overall Study|Physician Decision|2|||
44361443|NCT01205438|79367103|FG000|Overall Study|Protocol Violation|2|||
44361444|NCT01205438|79367104|FG001|Overall Study|Protocol Violation|7|||
44361445|NCT01205438|79367105|FG002|Overall Study|Protocol Violation|4|||
44361446|NCT01205438|79367103|FG000|Overall Study|Sponsor Decision|0|||
44267711|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267712|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44267713|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44361447|NCT01205438|79367104|FG001|Overall Study|Sponsor Decision|1|||
44361448|NCT01205438|79367105|FG002|Overall Study|Sponsor Decision|1|||
44361449|NCT01104870|79367119|FG000|Overall Study|Adverse Event|1|||
44361450|NCT01104870|79367120|FG001|Overall Study|Adverse Event|1|||
44267714|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267715|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44361451|NCT01104870|79367121|FG002|Overall Study|Adverse Event|0|||
44361452|NCT01104870|79367119|FG000|Overall Study|Death|0|||
44361453|NCT01104870|79367120|FG001|Overall Study|Death|0|||
44361454|NCT01104870|79367121|FG002|Overall Study|Death|1|||
44361455|NCT01104870|79367119|FG000|Overall Study|Withdrawal by Subject|0|||
44361456|NCT01104870|79367120|FG001|Overall Study|Withdrawal by Subject|0|||
44361457|NCT01104870|79367121|FG002|Overall Study|Withdrawal by Subject|1|||
44361458|NCT01104792|79367129|FG000|Overall Study|Adverse Event|77|||
44361459|NCT01104792|79367129|FG000|Overall Study|Insufficient Therapeutic Response|22|||
44361460|NCT01104792|79367129|FG000|Overall Study|Protocol Violation|45|||
44361461|NCT01104792|79367129|FG000|Overall Study|Withdrawal of Consent|179|||
44361462|NCT01104792|79367129|FG000|Overall Study|Lost to Follow-up|43|||
44361463|NCT01104792|79367129|FG000|Overall Study|Reasons Not Specified|27|||
44361464|NCT01104792|79367129|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
44361465|NCT01205126|79367135|FG000|Titration Phase|Adverse Event|5|||
44361466|NCT01205126|79367136|FG001|Titration Phase|Adverse Event|3|||
44361467|NCT01205126|79367135|FG000|Titration Phase|Withdrawal by Subject|5|||
44361468|NCT01205126|79367136|FG001|Titration Phase|Withdrawal by Subject|5|||
44361469|NCT01205126|79367135|FG000|Titration Phase|Lost to Follow-up|2|||
44361470|NCT01205126|79367136|FG001|Titration Phase|Lost to Follow-up|2|||
44267716|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267717|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267718|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267719|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267720|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
44267721|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267722|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267723|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267724|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267725|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267726|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267727|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267728|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267729|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267730|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267731|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267732|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267733|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267734|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267735|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267736|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267737|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
44267738|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267739|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267740|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267741|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267742|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267743|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267744|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267745|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267746|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
44267747|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267748|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267749|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
44267750|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267751|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
44267752|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
44267753|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267754|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267755|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267756|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44361471|NCT01205126|79367135|FG000|Titration Phase|No stable titration dose|1|||
44361472|NCT01205126|79367136|FG001|Titration Phase|No stable titration dose|0|||
44361473|NCT01205126|79367135|FG000|Titration Phase|More than maximum dosage required|2|||
44361474|NCT01205126|79367136|FG001|Titration Phase|More than maximum dosage required|3|||
44267757|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267758|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267759|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267760|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267761|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
44267762|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267763|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267764|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267765|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267766|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267767|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267768|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267769|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44201030|NCT02081677|78996437|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
44201031|NCT02038933|78996449|FG000|Overall Study|Disease progression|104|||
44201032|NCT02038933|78996449|FG000|Overall Study|Study drug toxicity|6|||
44267770|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267771|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
44267772|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267773|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267774|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267775|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267776|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44361475|NCT01205126|79367135|FG000|Titration Phase|Other|8|||
44201033|NCT02038933|78996449|FG000|Overall Study|Adverse event unrelated to study drug|6|||
44201034|NCT02038933|78996449|FG000|Overall Study|Participant request to discontinue treatment|2|||
44201035|NCT02038933|78996449|FG000|Overall Study|Lost to Follow-up|1|||
44201036|NCT02038933|78996449|FG000|Overall Study|Other reasons|2|||
44201037|NCT02081599|78996456|FG000|Period 1：Double-blind Period|Adverse Event|3|||
44201038|NCT02081599|78996457|FG001|Period 1：Double-blind Period|Adverse Event|0|||
44201039|NCT02081599|78996456|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
44201040|NCT02081599|78996457|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
44201041|NCT02081599|78996456|FG000|Period 1：Double-blind Period|Physician Decision|1|||
44201042|NCT02081599|78996457|FG001|Period 1：Double-blind Period|Physician Decision|0|||
44201043|NCT02081599|78996456|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
44201044|NCT02081599|78996457|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
44201045|NCT02081599|78996456|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
44201046|NCT02081599|78996457|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
44201047|NCT02081599|78996456|FG000|Period 1：Double-blind Period|stopping criteria|1|||
44201048|NCT02081599|78996457|FG001|Period 1：Double-blind Period|stopping criteria|0|||
44201049|NCT02081599|78996456|FG000|Period 2：Open-label Period|Adverse Event|1|||
44201050|NCT02081599|78996457|FG001|Period 2：Open-label Period|Adverse Event|0|||
44201051|NCT02081599|78996456|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
44201052|NCT02081599|78996457|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
44201053|NCT02081599|78996456|FG000|Period 2：Open-label Period|Physician Decision|1|||
44201054|NCT02081599|78996457|FG001|Period 2：Open-label Period|Physician Decision|0|||
44201055|NCT02081599|78996456|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
44201056|NCT02081599|78996457|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
44201057|NCT02038543|78996469|FG000|Overall Study|Screen Failure|0|||
44201058|NCT02038543|78996470|FG001|Overall Study|Screen Failure|0|||
44201059|NCT02038543|78996471|FG002|Overall Study|Screen Failure|0|||
44201060|NCT02038543|78996472|FG003|Overall Study|Screen Failure|1|||
44201061|NCT02038543|78996469|FG000|Overall Study|Withdrawal by Subject|0|||
44201062|NCT02038543|78996470|FG001|Overall Study|Withdrawal by Subject|0|||
44201063|NCT02038543|78996471|FG002|Overall Study|Withdrawal by Subject|0|||
44201064|NCT02038543|78996472|FG003|Overall Study|Withdrawal by Subject|1|||
44201065|NCT02038153|78996482|FG000|Overall Study|Withdrawal by Subject|1|||
44201066|NCT02058589|78996488|FG000|Overall Study|Serious Adverse Event|1|||
44201067|NCT02058589|78996489|FG001|Overall Study|Serious Adverse Event|1|||
44201068|NCT02058589|78996488|FG000|Overall Study|Non-Serious Adverse Event|1|||
44201069|NCT02058589|78996489|FG001|Overall Study|Non-Serious Adverse Event|0|||
44201070|NCT02058589|78996488|FG000|Overall Study|Withdrawal by Subject|0|||
44201071|NCT02058589|78996489|FG001|Overall Study|Withdrawal by Subject|1|||
44201072|NCT02079805|78996499|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44201073|NCT02079805|78996500|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
44201074|NCT02079805|78996499|FG000|Overall Study|Voluntary Withdrawal|0|||
44267777|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267778|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267779|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267780|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267781|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267782|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267783|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267784|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267785|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
44267786|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267787|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267788|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267789|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267790|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267791|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267792|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267793|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267794|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267795|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267796|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
44267797|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267798|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267799|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267800|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267801|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267802|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267803|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267804|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267805|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267806|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267807|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267808|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267809|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
44267810|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267811|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267812|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267813|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267814|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267815|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44361476|NCT01205126|79367136|FG001|Titration Phase|Other|6|||
44361477|NCT01205126|79367135|FG000|Between Titration & Maintenance Phase|Other|0|||
44361478|NCT01205126|79367136|FG001|Between Titration & Maintenance Phase|Other|4|||
44361479|NCT01205126|79367135|FG000|Maintenance Phase|Adverse Event|3|||
44201075|NCT02079805|78996500|FG001|Overall Study|Voluntary Withdrawal|1|||
44201076|NCT02037295|78996510|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
44201077|NCT02037295|78996511|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
44201078|NCT02037295|78996512|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
44201079|NCT02037295|78996513|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
44201080|NCT02079649|78996529|FG000|Overall Study|Lost to Follow-up|0|||
44201081|NCT02079649|78996530|FG001|Overall Study|Lost to Follow-up|0|||
44201082|NCT02079649|78996531|FG002|Overall Study|Lost to Follow-up|0|||
44201083|NCT02079649|78996532|FG003|Overall Study|Lost to Follow-up|1|||
44201084|NCT02079649|78996529|FG000|Overall Study|Withdrawal by Subject|0|||
44201085|NCT02079649|78996530|FG001|Overall Study|Withdrawal by Subject|0|||
44201086|NCT02079649|78996531|FG002|Overall Study|Withdrawal by Subject|0|||
44201087|NCT02079649|78996532|FG003|Overall Study|Withdrawal by Subject|1|||
44201088|NCT02079649|78996529|FG000|Overall Study|Randomization error (prior to treatment)|1|||
44201089|NCT02079649|78996530|FG001|Overall Study|Randomization error (prior to treatment)|0|||
44201090|NCT02079649|78996531|FG002|Overall Study|Randomization error (prior to treatment)|1|||
44201091|NCT02079649|78996532|FG003|Overall Study|Randomization error (prior to treatment)|0|||
44201092|NCT02036515|78996546|FG000|Overall Study|Adverse Event|1|||
44201093|NCT02036515|78996547|FG001|Overall Study|Adverse Event|1|||
44201094|NCT02036515|78996548|FG002|Overall Study|Adverse Event|2|||
44201095|NCT02036515|78996546|FG000|Overall Study|Lost to Follow-up|0|||
44201096|NCT02036515|78996547|FG001|Overall Study|Lost to Follow-up|2|||
44201097|NCT02036515|78996548|FG002|Overall Study|Lost to Follow-up|0|||
44201098|NCT02036515|78996546|FG000|Overall Study|Non-compliance with study drug|0|||
44201099|NCT02036515|78996547|FG001|Overall Study|Non-compliance with study drug|0|||
44201100|NCT02036515|78996548|FG002|Overall Study|Non-compliance with study drug|2|||
44201101|NCT02036515|78996546|FG000|Overall Study|Screen failure|0|||
44201102|NCT02036515|78996547|FG001|Overall Study|Screen failure|2|||
44201103|NCT02036515|78996548|FG002|Overall Study|Screen failure|0|||
44201104|NCT02036515|78996546|FG000|Overall Study|Withdrawal by Subject|4|||
44201105|NCT02036515|78996547|FG001|Overall Study|Withdrawal by Subject|7|||
44201106|NCT02036515|78996548|FG002|Overall Study|Withdrawal by Subject|9|||
44201107|NCT02036515|78996546|FG000|Overall Study|Hyperglycemia|0|||
44201108|NCT02036515|78996547|FG001|Overall Study|Hyperglycemia|0|||
44201109|NCT02036515|78996548|FG002|Overall Study|Hyperglycemia|1|||
44201110|NCT02078713|78996560|FG000|Overall Study|Lost to Follow-up|49|||
44201111|NCT02078713|78996561|FG001|Overall Study|Lost to Follow-up|55|||
44201112|NCT02078713|78996562|FG002|Overall Study|Lost to Follow-up|0|||
44201113|NCT02078713|78996563|FG003|Overall Study|Lost to Follow-up|0|||
44201114|NCT02078713|78996560|FG000|Overall Study|Pregnant at baseline|3|||
44201115|NCT02078713|78996561|FG001|Overall Study|Pregnant at baseline|5|||
44201116|NCT02078713|78996562|FG002|Overall Study|Pregnant at baseline|0|||
44201117|NCT02078713|78996563|FG003|Overall Study|Pregnant at baseline|0|||
44201118|NCT02078713|78996560|FG000|Overall Study|Enrolled twice|0|||
44201119|NCT02078713|78996561|FG001|Overall Study|Enrolled twice|1|||
44201120|NCT02078713|78996562|FG002|Overall Study|Enrolled twice|0|||
44201121|NCT02078713|78996563|FG003|Overall Study|Enrolled twice|0|||
44201122|NCT02035267|78996579|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
44201123|NCT02035267|78996580|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
44201124|NCT02035267|78996581|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
44201125|NCT02035267|78996582|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
44201126|NCT02035267|78996579|FG000|Overall Study|Adverse Event|0|||
44201127|NCT02035267|78996580|FG001|Overall Study|Adverse Event|0|||
44201128|NCT02035267|78996581|FG002|Overall Study|Adverse Event|1|||
44201129|NCT02035267|78996582|FG003|Overall Study|Adverse Event|0|||
44201130|NCT02035267|78996579|FG000|Overall Study|Lost to Follow-up|0|||
44201131|NCT02035267|78996580|FG001|Overall Study|Lost to Follow-up|0|||
44201132|NCT02035267|78996581|FG002|Overall Study|Lost to Follow-up|0|||
44201133|NCT02035267|78996582|FG003|Overall Study|Lost to Follow-up|1|||
44201134|NCT02035267|78996579|FG000|Overall Study|Other unspecified|0|||
44201135|NCT02035267|78996580|FG001|Overall Study|Other unspecified|1|||
44201136|NCT02035267|78996581|FG002|Overall Study|Other unspecified|0|||
44201137|NCT02035267|78996582|FG003|Overall Study|Other unspecified|0|||
44201138|NCT04373460|78996616|FG000|Overall Study|Did not receive tranfusion|18|||
44201139|NCT04373460|78996617|FG001|Overall Study|Did not receive tranfusion|26|||
44201140|NCT04280081|78996627|FG000|Overall Study|Adverse Event|4|||
44201141|NCT04280081|78996627|FG000|Overall Study|Death|2|||
44201142|NCT04280081|78996627|FG000|Overall Study|Progressive Disease|6|||
44201143|NCT04159805|78996643|FG000|Overall Study|Withdrawal by Subject|0|||
44201144|NCT04159805|78996644|FG001|Overall Study|Withdrawal by Subject|2|||
44201145|NCT04159805|78996645|FG002|Overall Study|Withdrawal by Subject|2|||
44201146|NCT03901456|78996656|FG000|Overall Study|Withdrawal by Subject|0|||
44201147|NCT03901456|78996657|FG001|Overall Study|Withdrawal by Subject|0|||
44201148|NCT03901456|78996658|FG002|Overall Study|Withdrawal by Subject|1|||
44201149|NCT03901456|78996656|FG000|Overall Study|Lost to Follow-up|0|||
44201150|NCT03901456|78996657|FG001|Overall Study|Lost to Follow-up|1|||
44201151|NCT03901456|78996658|FG002|Overall Study|Lost to Follow-up|0|||
44201152|NCT03226249|78996709|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
44201153|NCT03226249|78996709|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
44201154|NCT03226249|78996709|FG000|Survival Follow-up|Patients still in follow-up.|30|||
44201155|NCT02849548|78996715|FG000|Overall Study|Lost to Follow-up|1|||
44201156|NCT02849548|78996716|FG001|Overall Study|Lost to Follow-up|2|||
44201157|NCT02849548|78996715|FG000|Overall Study|Protocol Violation|1|||
44201158|NCT02849548|78996716|FG001|Overall Study|Protocol Violation|0|||
44201159|NCT02411448|78996734|FG000|Overall Study|Withdrawal by Subject|1|||
44201160|NCT02411448|78996735|FG001|Overall Study|Withdrawal by Subject|14|||
44201161|NCT02411448|78996736|FG002|Overall Study|Withdrawal by Subject|9|||
44201162|NCT02411448|78996734|FG000|Overall Study|Other|0|||
44201163|NCT02411448|78996735|FG001|Overall Study|Other|2|||
44201164|NCT02411448|78996736|FG002|Overall Study|Other|0|||
44201165|NCT02411448|78996734|FG000|Overall Study|Did not receive study treatment|0|||
44201166|NCT02411448|78996735|FG001|Overall Study|Did not receive study treatment|3|||
44201167|NCT02411448|78996736|FG002|Overall Study|Did not receive study treatment|0|||
44201168|NCT02411448|78996734|FG000|Overall Study|Alive on study treatment|3|||
44201169|NCT02411448|78996735|FG001|Overall Study|Alive on study treatment|64|||
44201170|NCT02411448|78996736|FG002|Overall Study|Alive on study treatment|43|||
44201171|NCT02321514|78996748|FG000|Overall Study|Death|15|||
44201172|NCT02321514|78996748|FG000|Overall Study|Missed Visit|7|||
44267816|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267817|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267818|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267819|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267820|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267821|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267822|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267823|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267824|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
44267825|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267826|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267827|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267828|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267829|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267830|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267831|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267832|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44267833|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
44201173|NCT02321514|78996748|FG000|Overall Study|Study Exit|3|||
44201174|NCT02266134|78996756|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
44201175|NCT02266134|78996757|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
44201176|NCT02266134|78996758|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
44201177|NCT02266134|78996759|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
44201178|NCT02266134|78996756|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
44201179|NCT02266134|78996757|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
44201180|NCT02266134|78996758|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
44201181|NCT02266134|78996759|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
44267834|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267835|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44361480|NCT01205126|79367136|FG001|Maintenance Phase|Adverse Event|7|||
44201182|NCT02266134|78996756|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
44361481|NCT01205126|79367135|FG000|Maintenance Phase|Death|4|||
44361482|NCT01205126|79367136|FG001|Maintenance Phase|Death|4|||
44361483|NCT01205126|79367135|FG000|Maintenance Phase|More than the maximum dosage required|5|||
44361484|NCT01205126|79367136|FG001|Maintenance Phase|More than the maximum dosage required|5|||
44201183|NCT02266134|78996757|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
44201184|NCT02266134|78996758|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
44201185|NCT02266134|78996759|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
44201186|NCT02266134|78996756|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
44201187|NCT02266134|78996757|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
44201188|NCT02266134|78996758|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
44201189|NCT02266134|78996759|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
44201190|NCT02266134|78996756|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
44201191|NCT02266134|78996757|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
44201192|NCT02266134|78996758|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
44201193|NCT02266134|78996759|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
44201194|NCT02266134|78996756|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
44201195|NCT02266134|78996757|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
44201196|NCT02266134|78996758|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
44201197|NCT02266134|78996759|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
44201198|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
44201199|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
44201200|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
44201201|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
44201202|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201203|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201204|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201205|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201206|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201207|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201208|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
44201209|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
44201210|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
44201211|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
44201212|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
44201213|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201214|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201215|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201216|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201217|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201218|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201219|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
44201220|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
44201221|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
44201222|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
44201223|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
44201224|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201225|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201226|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201227|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201228|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201229|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201230|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
44201231|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201232|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201233|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201234|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
44201235|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201236|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44267836|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44249665|NCT01276353|79083652|FG001|Extension|Withdrawal by Subject|2|||
44267837|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267838|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267839|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44361485|NCT01205126|79367135|FG000|Maintenance Phase|Prohibited drugs used|1|||
44361486|NCT01205126|79367136|FG001|Maintenance Phase|Prohibited drugs used|0|||
44361487|NCT01205126|79367135|FG000|Maintenance Phase|Other|11|||
44361488|NCT01205126|79367136|FG001|Maintenance Phase|Other|8|||
44361489|NCT01205126|79367135|FG000|Maintenance Phase|Lost to Follow-up|5|||
44361490|NCT01205126|79367136|FG001|Maintenance Phase|Lost to Follow-up|5|||
44361491|NCT01205126|79367135|FG000|Maintenance Phase|Withdrawal by Subject|8|||
44361492|NCT01205126|79367136|FG001|Maintenance Phase|Withdrawal by Subject|11|||
44361493|NCT00946647|79367147|FG000|Phase 1 Part|Adverse Event|2|||
44361494|NCT00946647|79367148|FG001|Phase 1 Part|Adverse Event|5|||
44361495|NCT00946647|79367149|FG002|Phase 1 Part|Adverse Event|3|||
44361496|NCT00946647|79367150|FG003|Phase 1 Part|Adverse Event|0|||
44361497|NCT00946647|79367151|FG004|Phase 1 Part|Adverse Event|0|||
44361498|NCT00946647|79367147|FG000|Phase 1 Part|Disease progression|3|||
44361499|NCT00946647|79367148|FG001|Phase 1 Part|Disease progression|6|||
44361500|NCT00946647|79367149|FG002|Phase 1 Part|Disease progression|1|||
44361501|NCT00946647|79367150|FG003|Phase 1 Part|Disease progression|0|||
44361502|NCT00946647|79367151|FG004|Phase 1 Part|Disease progression|0|||
44361503|NCT00946647|79367147|FG000|Phase 1 Part|Withdrawal by Subject|1|||
44361504|NCT00946647|79367148|FG001|Phase 1 Part|Withdrawal by Subject|4|||
44361505|NCT00946647|79367149|FG002|Phase 1 Part|Withdrawal by Subject|3|||
44361506|NCT00946647|79367150|FG003|Phase 1 Part|Withdrawal by Subject|0|||
44201237|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201238|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201239|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201240|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201241|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
44201242|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
44361507|NCT00946647|79367151|FG004|Phase 1 Part|Withdrawal by Subject|0|||
44361508|NCT00946647|79367147|FG000|Phase 1 Part|Abnormal values|0|||
44201243|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
44201244|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
44201245|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
44201246|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201247|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201248|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201249|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201250|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201251|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201252|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
44201253|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
44201254|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
44201255|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
44201256|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
44201257|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201258|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201259|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201260|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201261|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201262|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201263|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
44201264|NCT01847274|78996787|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
44201265|NCT01847274|78996788|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
44201266|NCT01847274|78996789|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
44267840|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267841|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267842|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267843|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267844|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267845|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267846|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267847|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44361509|NCT00946647|79367148|FG001|Phase 1 Part|Abnormal values|2|||
44361510|NCT00946647|79367149|FG002|Phase 1 Part|Abnormal values|0|||
44361511|NCT00946647|79367150|FG003|Phase 1 Part|Abnormal values|0|||
44361512|NCT00946647|79367151|FG004|Phase 1 Part|Abnormal values|0|||
44361513|NCT00946647|79367147|FG000|Phase 1 Part|Reason missing|0|||
44361514|NCT00946647|79367148|FG001|Phase 1 Part|Reason missing|1|||
44361515|NCT00946647|79367149|FG002|Phase 1 Part|Reason missing|0|||
44201267|NCT01847274|78996790|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
44201268|NCT01847274|78996791|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201269|NCT01847274|78996792|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201270|NCT01847274|78996793|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201271|NCT01847274|78996794|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201272|NCT01847274|78996795|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201273|NCT01847274|78996796|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201274|NCT01847274|78996797|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
44201275|NCT01847274|78996787|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201276|NCT01847274|78996788|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201277|NCT01847274|78996789|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201278|NCT01847274|78996790|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201279|NCT01847274|78996791|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201280|NCT01847274|78996792|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
44201281|NCT01847274|78996793|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201282|NCT01847274|78996794|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201283|NCT01847274|78996795|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201284|NCT01847274|78996796|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201285|NCT01847274|78996797|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
44201286|NCT01847274|78996787|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44361516|NCT00946647|79367150|FG003|Phase 1 Part|Reason missing|0|||
44361517|NCT00946647|79367151|FG004|Phase 1 Part|Reason missing|0|||
44361518|NCT00946647|79367147|FG000|Phase ll Part|Untreated|0|||
44361519|NCT00946647|79367148|FG001|Phase ll Part|Untreated|0|||
44201287|NCT01847274|78996788|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44361520|NCT00946647|79367149|FG002|Phase ll Part|Untreated|0|||
44361521|NCT00946647|79367150|FG003|Phase ll Part|Untreated|0|||
44201288|NCT01847274|78996789|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44361522|NCT00946647|79367151|FG004|Phase ll Part|Untreated|2|||
44361523|NCT00946647|79367147|FG000|Phase ll Part|Adverse Event|0|||
44361524|NCT00946647|79367148|FG001|Phase ll Part|Adverse Event|0|||
44361525|NCT00946647|79367149|FG002|Phase ll Part|Adverse Event|0|||
44361526|NCT00946647|79367150|FG003|Phase ll Part|Adverse Event|10|||
44361527|NCT00946647|79367151|FG004|Phase ll Part|Adverse Event|6|||
44361528|NCT00946647|79367147|FG000|Phase ll Part|Withdrawal by Subject|0|||
44361529|NCT00946647|79367148|FG001|Phase ll Part|Withdrawal by Subject|0|||
44361530|NCT00946647|79367149|FG002|Phase ll Part|Withdrawal by Subject|0|||
44361531|NCT00946647|79367150|FG003|Phase ll Part|Withdrawal by Subject|8|||
44361532|NCT00946647|79367151|FG004|Phase ll Part|Withdrawal by Subject|6|||
44361533|NCT00946647|79367147|FG000|Phase ll Part|Administrative problems|0|||
44361534|NCT00946647|79367148|FG001|Phase ll Part|Administrative problems|0|||
44361535|NCT00946647|79367149|FG002|Phase ll Part|Administrative problems|0|||
44361536|NCT00946647|79367150|FG003|Phase ll Part|Administrative problems|3|||
44361537|NCT00946647|79367151|FG004|Phase ll Part|Administrative problems|8|||
44361538|NCT00946647|79367147|FG000|Phase ll Part|Death|0|||
44361539|NCT00946647|79367148|FG001|Phase ll Part|Death|0|||
44361540|NCT00946647|79367149|FG002|Phase ll Part|Death|0|||
44361541|NCT00946647|79367150|FG003|Phase ll Part|Death|7|||
44361542|NCT00946647|79367151|FG004|Phase ll Part|Death|4|||
44361543|NCT00946647|79367147|FG000|Phase ll Part|Disease progression|0|||
44361544|NCT00946647|79367148|FG001|Phase ll Part|Disease progression|0|||
44361545|NCT00946647|79367149|FG002|Phase ll Part|Disease progression|0|||
44361546|NCT00946647|79367150|FG003|Phase ll Part|Disease progression|6|||
44361547|NCT00946647|79367151|FG004|Phase ll Part|Disease progression|14|||
44361548|NCT00946647|79367147|FG000|Phase ll Part|Protocol Violation|0|||
44361549|NCT00946647|79367148|FG001|Phase ll Part|Protocol Violation|0|||
44361550|NCT00946647|79367149|FG002|Phase ll Part|Protocol Violation|0|||
44361551|NCT00946647|79367150|FG003|Phase ll Part|Protocol Violation|4|||
44361552|NCT00946647|79367151|FG004|Phase ll Part|Protocol Violation|2|||
44361553|NCT00946647|79367147|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
44361554|NCT00946647|79367148|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
44361555|NCT00946647|79367149|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
44361556|NCT00946647|79367150|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
44361557|NCT00946647|79367151|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
44361558|NCT00946101|79367166|FG000|Overall Study|Lost to Follow-up|2|||
44361559|NCT00946101|79367167|FG001|Overall Study|Lost to Follow-up|1|||
44361560|NCT00946101|79367166|FG000|Overall Study|Withdrawal of consent|2|||
44361561|NCT00946101|79367167|FG001|Overall Study|Withdrawal of consent|0|||
44361562|NCT00946101|79367166|FG000|Overall Study|Physician Decision|0|||
44361563|NCT00946101|79367167|FG001|Overall Study|Physician Decision|1|||
44361564|NCT01109940|79367181|FG000|Overall Study|Administrative problems|2|||
44361565|NCT01109940|79367182|FG001|Overall Study|Administrative problems|0|||
44361566|NCT01109940|79367183|FG002|Overall Study|Administrative problems|0|||
44361567|NCT01109940|79367184|FG003|Overall Study|Administrative problems|0|||
44361568|NCT01109940|79367181|FG000|Overall Study|Serious Adverse Event|2|||
44361569|NCT01109940|79367182|FG001|Overall Study|Serious Adverse Event|1|||
44361570|NCT01109940|79367183|FG002|Overall Study|Serious Adverse Event|0|||
44361571|NCT01109940|79367184|FG003|Overall Study|Serious Adverse Event|0|||
44361572|NCT01109940|79367181|FG000|Overall Study|Lost to Follow-up|1|||
44361573|NCT01109940|79367182|FG001|Overall Study|Lost to Follow-up|0|||
44361574|NCT01109940|79367183|FG002|Overall Study|Lost to Follow-up|0|||
44361575|NCT01109940|79367184|FG003|Overall Study|Lost to Follow-up|0|||
44361576|NCT01109940|79367181|FG000|Overall Study|Patient withdrew consent|1|||
44361577|NCT01109940|79367182|FG001|Overall Study|Patient withdrew consent|1|||
44361578|NCT01109940|79367183|FG002|Overall Study|Patient withdrew consent|0|||
44361579|NCT01109940|79367184|FG003|Overall Study|Patient withdrew consent|0|||
44361580|NCT01109940|79367181|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44361581|NCT01109940|79367182|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44361582|NCT01109940|79367183|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
44361583|NCT01109940|79367184|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
44361584|NCT00595309|79367194|FG000|Overall Study|Lost to Follow-up|1|||
44361585|NCT00595309|79367194|FG000|Overall Study|planned vaccination against yellow fever|1|||
44361586|NCT00595309|79367194|FG000|Overall Study|acute infection after V0|1|||
44361587|NCT00595309|79367194|FG000|Overall Study|personal reason|1|||
44361588|NCT00595075|79367200|FG000|Overall Study|Withdrawal by Subject|1|||
44361589|NCT00595075|79367201|FG001|Overall Study|Withdrawal by Subject|0|||
44361590|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
44361591|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
44361592|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
44361593|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
44361594|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
44361595|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
44361596|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
44361597|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
44361598|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
44361599|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
44361600|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
44361601|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
44267848|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
44267849|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267850|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267851|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267852|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267853|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267854|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267855|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267856|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267857|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
44267858|NCT02346240|79181715|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267859|NCT02346240|79181716|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267860|NCT02346240|79181717|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267861|NCT02346240|79181718|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267862|NCT02346240|79181719|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267863|NCT02346240|79181720|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44361602|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Other|1|||
44361603|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Other|0|||
44361604|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Other|0|||
44361605|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
44361606|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
44361607|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
44361608|NCT00887224|79367210|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
44361609|NCT00887224|79367211|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
44451646|NCT00423670|79460530|FG003|Treatment Period|Protocol-defined clinical event|12|||
44451647|NCT00423670|79460531|FG004|Treatment Period|Protocol-defined clinical event|5|||
44451648|NCT00423670|79460532|FG005|Treatment Period|Protocol-defined clinical event|4|||
44451649|NCT00423670|79460533|FG006|Treatment Period|Protocol-defined clinical event|16|||
44451650|NCT00423670|79460534|FG007|Treatment Period|Protocol-defined clinical event|15|||
44451651|NCT00423670|79460527|FG000|Treatment Period|Lost to Follow-up|2|||
44201289|NCT01847274|78996790|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201290|NCT01847274|78996791|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
44201291|NCT01847274|78996792|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201292|NCT01847274|78996793|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201293|NCT01847274|78996794|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201294|NCT01847274|78996795|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201295|NCT01847274|78996796|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201296|NCT01847274|78996797|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
44201297|NCT01847274|78996787|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201298|NCT01847274|78996788|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201299|NCT01847274|78996789|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201300|NCT01847274|78996790|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201301|NCT01847274|78996791|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201302|NCT01847274|78996792|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201303|NCT01847274|78996793|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
44201304|NCT01847274|78996794|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201305|NCT01847274|78996795|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201306|NCT01847274|78996796|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201307|NCT01847274|78996797|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
44201308|NCT01847274|78996787|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201309|NCT01847274|78996788|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201310|NCT01847274|78996789|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201311|NCT01847274|78996790|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201312|NCT01847274|78996791|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201313|NCT01847274|78996792|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201314|NCT01847274|78996793|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
44201315|NCT01847274|78996794|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201316|NCT01847274|78996795|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201317|NCT01847274|78996796|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201318|NCT01847274|78996797|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
44201319|NCT01847274|78996787|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201320|NCT01847274|78996788|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201321|NCT01847274|78996789|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201322|NCT01847274|78996790|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201323|NCT01847274|78996791|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201324|NCT01847274|78996792|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201325|NCT01847274|78996793|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
44201326|NCT01847274|78996794|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201327|NCT01847274|78996795|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201328|NCT01847274|78996796|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201329|NCT01847274|78996797|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
44201330|NCT01847274|78996787|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201331|NCT01847274|78996788|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201332|NCT01847274|78996789|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201333|NCT01847274|78996790|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201334|NCT01847274|78996791|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201335|NCT01847274|78996792|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201336|NCT01847274|78996793|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
44201337|NCT01847274|78996794|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
44201338|NCT01847274|78996795|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
44201339|NCT01847274|78996796|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
44201340|NCT01847274|78996797|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
44201341|NCT01847274|78996787|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201342|NCT01847274|78996788|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201343|NCT01847274|78996789|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201344|NCT01847274|78996790|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201345|NCT01847274|78996791|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201346|NCT01847274|78996792|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201347|NCT01847274|78996793|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201348|NCT01847274|78996794|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
44201349|NCT01847274|78996795|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201350|NCT01847274|78996796|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
44201351|NCT01847274|78996797|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
44201352|NCT01847274|78996787|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201353|NCT01847274|78996788|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201354|NCT01847274|78996789|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201355|NCT01847274|78996790|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201356|NCT01847274|78996791|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201357|NCT01847274|78996792|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201358|NCT01847274|78996793|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201359|NCT01847274|78996794|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
44201360|NCT01847274|78996795|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
44201361|NCT01847274|78996796|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
44201362|NCT01847274|78996797|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
44201363|NCT01847274|78996787|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201364|NCT01847274|78996788|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201365|NCT01847274|78996789|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201366|NCT01847274|78996790|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201367|NCT01847274|78996791|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201368|NCT01847274|78996792|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201369|NCT01847274|78996793|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201370|NCT01847274|78996794|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201371|NCT01847274|78996795|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44201372|NCT01847274|78996796|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
44201373|NCT01847274|78996797|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
44361610|NCT00887224|79367212|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
44361611|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
44361612|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
44361613|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
44361614|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
44361615|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
44361616|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
44361617|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
44361618|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
44361619|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
44361620|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
44361621|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
44361622|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
44361623|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Other|1|||
44361624|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Other|0|||
44361625|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Other|0|||
44361626|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
44361627|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
44361628|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
44361629|NCT00887224|79367210|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
44361630|NCT00887224|79367211|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
44361631|NCT00887224|79367212|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
44361632|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
44361633|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
44361634|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
44361635|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
44361636|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
44361637|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
44361638|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
44361639|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
44361640|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
44361641|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
44361642|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
44361643|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
44361644|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Other|30|||
44361645|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Other|0|||
44361646|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Other|0|||
44361647|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
44361648|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
44361649|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
44361650|NCT00887224|79367210|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
44361651|NCT00887224|79367211|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
44361652|NCT00887224|79367212|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
44361653|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Adverse Event|0|||
44267864|NCT02346240|79181721|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267865|NCT02346240|79181722|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267866|NCT02346240|79181723|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267867|NCT02346240|79181724|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267868|NCT02346240|79181725|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267869|NCT02346240|79181726|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267870|NCT02346240|79181727|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267871|NCT02346240|79181728|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267872|NCT02346240|79181729|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
44267873|NCT02346240|79181730|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267874|NCT02346240|79181731|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267875|NCT02346240|79181732|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267876|NCT02346240|79181733|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267877|NCT02346240|79181734|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267878|NCT02346240|79181735|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44361654|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Adverse Event|7|||
44361655|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Adverse Event|2|||
44361656|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Failed to return|0|||
44361657|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Failed to return|2|||
44361658|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Failed to return|2|||
44361659|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
44451652|NCT00423670|79460528|FG001|Treatment Period|Lost to Follow-up|1|||
44361660|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
44361661|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
44361662|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
44361663|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
44361664|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
44361665|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Other|0|||
44361666|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Other|2|||
44361667|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Other|0|||
44361668|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
44361669|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
44361670|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
44361671|NCT00887224|79367210|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
44361672|NCT00887224|79367211|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
44361673|NCT00887224|79367212|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
44361674|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
44361675|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
44361676|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
44361677|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
44361678|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
44361679|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
44361680|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
44361681|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
44361682|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
44361683|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
44361684|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
44361685|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
44361686|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
44361687|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
44361688|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
44361689|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
44361690|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
44361691|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
44361692|NCT00887224|79367210|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
44361693|NCT00887224|79367211|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
44361694|NCT00887224|79367212|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
44361695|NCT01109316|79367230|FG000|Study Period 1|Adverse Event|0|||
44361696|NCT01109316|79367231|FG001|Study Period 1|Adverse Event|0|||
44361697|NCT01109316|79367232|FG002|Study Period 1|Adverse Event|1|||
44361698|NCT01109316|79367233|FG003|Study Period 1|Adverse Event|0|||
44361699|NCT01109316|79367234|FG004|Study Period 1|Adverse Event|0|||
44361700|NCT01109316|79367235|FG005|Study Period 1|Adverse Event|0|||
44361701|NCT01109316|79367230|FG000|Study Period 1|Lost to Follow-up|0|||
44361702|NCT01109316|79367231|FG001|Study Period 1|Lost to Follow-up|0|||
44361703|NCT01109316|79367232|FG002|Study Period 1|Lost to Follow-up|1|||
44361704|NCT01109316|79367233|FG003|Study Period 1|Lost to Follow-up|1|||
44361705|NCT01109316|79367234|FG004|Study Period 1|Lost to Follow-up|0|||
44361706|NCT01109316|79367235|FG005|Study Period 1|Lost to Follow-up|0|||
44361707|NCT01109316|79367230|FG000|Study Period 1|Withdrawal by Subject|0|||
44361708|NCT01109316|79367231|FG001|Study Period 1|Withdrawal by Subject|0|||
44361709|NCT01109316|79367232|FG002|Study Period 1|Withdrawal by Subject|1|||
44361710|NCT01109316|79367233|FG003|Study Period 1|Withdrawal by Subject|0|||
44361711|NCT01109316|79367234|FG004|Study Period 1|Withdrawal by Subject|2|||
44361712|NCT01109316|79367235|FG005|Study Period 1|Withdrawal by Subject|0|||
44361713|NCT01109316|79367230|FG000|Study Period 1|Sponsor Decision|0|||
44361714|NCT01109316|79367231|FG001|Study Period 1|Sponsor Decision|0|||
44361715|NCT01109316|79367232|FG002|Study Period 1|Sponsor Decision|0|||
44361716|NCT01109316|79367233|FG003|Study Period 1|Sponsor Decision|0|||
44361717|NCT01109316|79367234|FG004|Study Period 1|Sponsor Decision|0|||
44361718|NCT01109316|79367235|FG005|Study Period 1|Sponsor Decision|2|||
44361719|NCT01109316|79367230|FG000|Study Period 2|Entry Criteria Not Met|0|||
44361720|NCT01109316|79367231|FG001|Study Period 2|Entry Criteria Not Met|1|||
44361721|NCT01109316|79367232|FG002|Study Period 2|Entry Criteria Not Met|0|||
44361722|NCT01109316|79367233|FG003|Study Period 2|Entry Criteria Not Met|0|||
44361723|NCT01109316|79367234|FG004|Study Period 2|Entry Criteria Not Met|0|||
44361724|NCT01109316|79367235|FG005|Study Period 2|Entry Criteria Not Met|0|||
44361725|NCT01109316|79367230|FG000|Study Period 2|Physician Decision|0|||
44361726|NCT01109316|79367231|FG001|Study Period 2|Physician Decision|0|||
44361727|NCT01109316|79367232|FG002|Study Period 2|Physician Decision|0|||
44361728|NCT01109316|79367233|FG003|Study Period 2|Physician Decision|1|||
44361729|NCT01109316|79367234|FG004|Study Period 2|Physician Decision|0|||
44361730|NCT01109316|79367235|FG005|Study Period 2|Physician Decision|0|||
44361731|NCT01109316|79367230|FG000|Study Period 2|Protocol Violation|1|||
44361732|NCT01109316|79367231|FG001|Study Period 2|Protocol Violation|0|||
44361733|NCT01109316|79367232|FG002|Study Period 2|Protocol Violation|0|||
44361734|NCT01109316|79367233|FG003|Study Period 2|Protocol Violation|0|||
44361735|NCT01109316|79367234|FG004|Study Period 2|Protocol Violation|0|||
44361736|NCT01109316|79367235|FG005|Study Period 2|Protocol Violation|0|||
44361737|NCT01109316|79367230|FG000|Study Period 2|Withdrawal by Subject|0|||
44361738|NCT01109316|79367231|FG001|Study Period 2|Withdrawal by Subject|0|||
44361739|NCT01109316|79367232|FG002|Study Period 2|Withdrawal by Subject|1|||
44361740|NCT01109316|79367233|FG003|Study Period 2|Withdrawal by Subject|0|||
44361741|NCT01109316|79367234|FG004|Study Period 2|Withdrawal by Subject|0|||
44361742|NCT01109316|79367235|FG005|Study Period 2|Withdrawal by Subject|1|||
44361743|NCT01109316|79367230|FG000|Study Period 3|Lost to Follow-up|0|||
44361744|NCT01109316|79367231|FG001|Study Period 3|Lost to Follow-up|0|||
44361745|NCT01109316|79367232|FG002|Study Period 3|Lost to Follow-up|0|||
44361746|NCT01109316|79367233|FG003|Study Period 3|Lost to Follow-up|0|||
44361747|NCT01109316|79367234|FG004|Study Period 3|Lost to Follow-up|1|||
44361748|NCT01109316|79367235|FG005|Study Period 3|Lost to Follow-up|0|||
44361749|NCT01109316|79367230|FG000|Study Period 3|Withdrawal by Subject|1|||
44361750|NCT01109316|79367231|FG001|Study Period 3|Withdrawal by Subject|0|||
44201374|NCT01560819|78996836|FG000|Overall Study|Physician Decision|1|||
44201375|NCT01560819|78996837|FG001|Overall Study|Physician Decision|0|||
44201376|NCT01425528|78996843|FG000|Overall Study|Withdrawal by Subject|1|||
44201377|NCT01425528|78996844|FG001|Overall Study|Withdrawal by Subject|1|||
44201378|NCT00442104|78996850|FG000|Overall Study|Adverse Event|5|||
44201379|NCT00442104|78996850|FG000|Overall Study|Death|2|||
44201380|NCT00442104|78996850|FG000|Overall Study|Lost to Follow-up|3|||
44361751|NCT01109316|79367232|FG002|Study Period 3|Withdrawal by Subject|0|||
44361752|NCT01109316|79367233|FG003|Study Period 3|Withdrawal by Subject|0|||
44361753|NCT01109316|79367234|FG004|Study Period 3|Withdrawal by Subject|1|||
44361754|NCT01109316|79367235|FG005|Study Period 3|Withdrawal by Subject|0|||
44361755|NCT00887068|79367245|FG000|Overall Study|Withdrawal by Subject|2|||
44361756|NCT00887068|79367246|FG001|Overall Study|Withdrawal by Subject|0|||
44361757|NCT00887068|79367245|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
44361758|NCT00887068|79367246|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
44361759|NCT00941031|79367256|FG000|Induction Period|Lack of Efficacy|2|||
44361760|NCT00941031|79367257|FG001|Induction Period|Lack of Efficacy|1|||
44361761|NCT00941031|79367258|FG002|Induction Period|Lack of Efficacy|0|||
44361762|NCT00941031|79367259|FG003|Induction Period|Lack of Efficacy|5|||
44361763|NCT00941031|79367260|FG004|Induction Period|Lack of Efficacy|0|||
44361764|NCT00941031|79367261|FG005|Induction Period|Lack of Efficacy|0|||
44361765|NCT00941031|79367262|FG006|Induction Period|Lack of Efficacy|0|||
44361766|NCT00941031|79367256|FG000|Induction Period|Withdrawal by Subject|1|||
44361767|NCT00941031|79367257|FG001|Induction Period|Withdrawal by Subject|2|||
44361768|NCT00941031|79367258|FG002|Induction Period|Withdrawal by Subject|2|||
44361769|NCT00941031|79367259|FG003|Induction Period|Withdrawal by Subject|2|||
44361770|NCT00941031|79367260|FG004|Induction Period|Withdrawal by Subject|0|||
44201381|NCT00442104|78996850|FG000|Overall Study|Withdrawal by Subject|5|||
44201382|NCT00442104|78996850|FG000|Overall Study|Insufficient Clinical Response|10|||
44201383|NCT00442104|78996850|FG000|Overall Study|Other|21|||
44361771|NCT00941031|79367261|FG005|Induction Period|Withdrawal by Subject|0|||
44361772|NCT00941031|79367262|FG006|Induction Period|Withdrawal by Subject|0|||
44361773|NCT00941031|79367256|FG000|Induction Period|Adminstative Problems|1|||
44361774|NCT00941031|79367257|FG001|Induction Period|Adminstative Problems|1|||
44361775|NCT00941031|79367258|FG002|Induction Period|Adminstative Problems|1|||
44361776|NCT00941031|79367259|FG003|Induction Period|Adminstative Problems|0|||
44361777|NCT00941031|79367260|FG004|Induction Period|Adminstative Problems|0|||
44361778|NCT00941031|79367261|FG005|Induction Period|Adminstative Problems|0|||
44361779|NCT00941031|79367262|FG006|Induction Period|Adminstative Problems|0|||
44361780|NCT00941031|79367256|FG000|Induction Period|Adverse Event|1|||
44361781|NCT00941031|79367257|FG001|Induction Period|Adverse Event|0|||
44361782|NCT00941031|79367258|FG002|Induction Period|Adverse Event|3|||
44361783|NCT00941031|79367259|FG003|Induction Period|Adverse Event|2|||
44361784|NCT00941031|79367260|FG004|Induction Period|Adverse Event|0|||
44361785|NCT00941031|79367261|FG005|Induction Period|Adverse Event|0|||
44201384|NCT00442104|78996850|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
44201385|NCT00441896|78996864|FG000|Overall Study|Withdrawal by Subject|0|||
44361786|NCT00941031|79367262|FG006|Induction Period|Adverse Event|0|||
44361787|NCT00941031|79367256|FG000|Maintenance Period|Withdrawal by Subject|0|||
44361788|NCT00941031|79367257|FG001|Maintenance Period|Withdrawal by Subject|0|||
44361789|NCT00941031|79367258|FG002|Maintenance Period|Withdrawal by Subject|0|||
44361790|NCT00941031|79367259|FG003|Maintenance Period|Withdrawal by Subject|0|||
44361791|NCT00941031|79367260|FG004|Maintenance Period|Withdrawal by Subject|6|||
44361792|NCT00941031|79367261|FG005|Maintenance Period|Withdrawal by Subject|2|||
44361793|NCT00941031|79367262|FG006|Maintenance Period|Withdrawal by Subject|13|||
44361794|NCT00941031|79367256|FG000|Maintenance Period|Administrative Problems|0|||
44361795|NCT00941031|79367257|FG001|Maintenance Period|Administrative Problems|0|||
44361796|NCT00941031|79367258|FG002|Maintenance Period|Administrative Problems|0|||
44361797|NCT00941031|79367259|FG003|Maintenance Period|Administrative Problems|0|||
44361798|NCT00941031|79367260|FG004|Maintenance Period|Administrative Problems|1|||
44361799|NCT00941031|79367261|FG005|Maintenance Period|Administrative Problems|0|||
44361800|NCT00941031|79367262|FG006|Maintenance Period|Administrative Problems|1|||
44361801|NCT00941031|79367256|FG000|Maintenance Period|Protocol Violation|0|||
44361802|NCT00941031|79367257|FG001|Maintenance Period|Protocol Violation|0|||
44361803|NCT00941031|79367258|FG002|Maintenance Period|Protocol Violation|0|||
44361804|NCT00941031|79367259|FG003|Maintenance Period|Protocol Violation|0|||
44361805|NCT00941031|79367260|FG004|Maintenance Period|Protocol Violation|0|||
44361806|NCT00941031|79367261|FG005|Maintenance Period|Protocol Violation|0|||
44361807|NCT00941031|79367262|FG006|Maintenance Period|Protocol Violation|1|||
44361808|NCT00941031|79367256|FG000|Maintenance Period|Adverse Event|0|||
44361809|NCT00941031|79367257|FG001|Maintenance Period|Adverse Event|0|||
44201386|NCT00441896|78996865|FG001|Overall Study|Withdrawal by Subject|0|||
44201387|NCT00441896|78996866|FG002|Overall Study|Withdrawal by Subject|0|||
44201388|NCT00441896|78996867|FG003|Overall Study|Withdrawal by Subject|1|||
44201389|NCT00441896|78996868|FG004|Overall Study|Withdrawal by Subject|0|||
44201390|NCT00441896|78996869|FG005|Overall Study|Withdrawal by Subject|0|||
44201391|NCT00441896|78996870|FG006|Overall Study|Withdrawal by Subject|0|||
44201392|NCT00441896|78996871|FG007|Overall Study|Withdrawal by Subject|0|||
44201393|NCT00441896|78996872|FG008|Overall Study|Withdrawal by Subject|0|||
44201394|NCT00441896|78996873|FG009|Overall Study|Withdrawal by Subject|0|||
44201395|NCT00441896|78996864|FG000|Overall Study|Other|0|||
44201396|NCT00441896|78996865|FG001|Overall Study|Other|0|||
44201397|NCT00441896|78996866|FG002|Overall Study|Other|0|||
44201398|NCT00441896|78996867|FG003|Overall Study|Other|0|||
44201399|NCT00441896|78996868|FG004|Overall Study|Other|1|||
44201400|NCT00441896|78996869|FG005|Overall Study|Other|0|||
44201401|NCT00441896|78996870|FG006|Overall Study|Other|0|||
44201402|NCT00441896|78996871|FG007|Overall Study|Other|0|||
44201403|NCT00441896|78996872|FG008|Overall Study|Other|0|||
44201404|NCT00441896|78996873|FG009|Overall Study|Other|0|||
44201405|NCT02034877|78996901|FG000|Overall Study|Lost to Follow-up|0|||
44267879|NCT02346240|79181736|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267880|NCT02346240|79181737|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267881|NCT02346240|79181738|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
44267882|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267883|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267884|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267885|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267886|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267887|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267888|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267889|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267890|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267891|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267892|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267893|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267894|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267895|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267896|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267897|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267898|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
44267899|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
44267900|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
44267901|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
44267902|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
44267903|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
44267904|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
44267905|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
44267906|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267907|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267908|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267909|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267910|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
44201406|NCT02034877|78996902|FG001|Overall Study|Lost to Follow-up|3|||
44361810|NCT00941031|79367258|FG002|Maintenance Period|Adverse Event|0|||
44361811|NCT00941031|79367259|FG003|Maintenance Period|Adverse Event|0|||
44201407|NCT02034877|78996901|FG000|Overall Study|No Longer Willing to Participate|0|||
44361812|NCT00941031|79367260|FG004|Maintenance Period|Adverse Event|0|||
44361813|NCT00941031|79367261|FG005|Maintenance Period|Adverse Event|2|||
44361814|NCT00941031|79367262|FG006|Maintenance Period|Adverse Event|8|||
44361815|NCT00941031|79367256|FG000|Maintenance Period|Lost to Follow-up|0|||
44361816|NCT00941031|79367257|FG001|Maintenance Period|Lost to Follow-up|0|||
44361817|NCT00941031|79367258|FG002|Maintenance Period|Lost to Follow-up|0|||
44361818|NCT00941031|79367259|FG003|Maintenance Period|Lost to Follow-up|0|||
44361819|NCT00941031|79367260|FG004|Maintenance Period|Lost to Follow-up|2|||
44451653|NCT00423670|79460529|FG002|Treatment Period|Lost to Follow-up|3|||
44201408|NCT02034877|78996902|FG001|Overall Study|No Longer Willing to Participate|3|||
44201409|NCT02034799|78996910|FG000|Overall Study|Withdrawal by Subject|0|||
44201410|NCT02034799|78996911|FG001|Overall Study|Withdrawal by Subject|2|||
44201411|NCT02034799|78996910|FG000|Overall Study|Lost to Follow-up|0|||
44201412|NCT02034799|78996911|FG001|Overall Study|Lost to Follow-up|1|||
44201413|NCT02034799|78996910|FG000|Overall Study|Death|2|||
44201414|NCT02034799|78996911|FG001|Overall Study|Death|1|||
44201415|NCT02057575|78996921|FG000|Overall Study|Adverse Event|0|||
44201416|NCT02057575|78996922|FG001|Overall Study|Adverse Event|2|||
44201417|NCT02057575|78996923|FG002|Overall Study|Adverse Event|0|||
44201418|NCT02057575|78996924|FG003|Overall Study|Adverse Event|1|||
44201419|NCT02057575|78996921|FG000|Overall Study|Withdrawal by Subject|1|||
44201420|NCT02057575|78996922|FG001|Overall Study|Withdrawal by Subject|0|||
44201421|NCT02057575|78996923|FG002|Overall Study|Withdrawal by Subject|0|||
44201422|NCT02057575|78996924|FG003|Overall Study|Withdrawal by Subject|0|||
44201423|NCT02057575|78996921|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
44201424|NCT02057575|78996922|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
44267911|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267912|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267913|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267914|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267915|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267916|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267917|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267918|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267919|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267920|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267921|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267922|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267923|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267924|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
44267925|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
44267926|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267927|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
44267928|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267929|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
44267930|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267931|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267932|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267933|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267934|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267935|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267936|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267937|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267938|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267939|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267940|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267941|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267942|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267943|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267944|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267945|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267946|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267947|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267948|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
44267949|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267950|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267951|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
44267952|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44361820|NCT00941031|79367261|FG005|Maintenance Period|Lost to Follow-up|2|||
44451654|NCT00423670|79460530|FG003|Treatment Period|Lost to Follow-up|1|||
44201425|NCT02057575|78996923|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
44201426|NCT02057575|78996924|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
44201427|NCT02057575|78996921|FG000|Overall Study|Protocol Violation|0|||
44201428|NCT02057575|78996922|FG001|Overall Study|Protocol Violation|1|||
44361821|NCT00941031|79367262|FG006|Maintenance Period|Lost to Follow-up|7|||
44361822|NCT00941031|79367256|FG000|Maintenance Period|Lack of Efficacy|0|||
44361823|NCT00941031|79367257|FG001|Maintenance Period|Lack of Efficacy|0|||
44361824|NCT00941031|79367258|FG002|Maintenance Period|Lack of Efficacy|0|||
44361825|NCT00941031|79367259|FG003|Maintenance Period|Lack of Efficacy|0|||
44361826|NCT00941031|79367260|FG004|Maintenance Period|Lack of Efficacy|0|||
44361827|NCT00941031|79367261|FG005|Maintenance Period|Lack of Efficacy|0|||
44361828|NCT00941031|79367262|FG006|Maintenance Period|Lack of Efficacy|13|||
44361829|NCT00886834|79367283|FG000|Overall Study|Protocol Violation|0|||
44267953|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44267954|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267955|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267956|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267957|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267958|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267959|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267960|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267961|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267962|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267963|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267964|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267965|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267966|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267967|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267968|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267969|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267970|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267971|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267972|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267973|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267974|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267975|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
44267976|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267977|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
44267978|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267979|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267980|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267981|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267982|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267983|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267984|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267985|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267986|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267987|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267988|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267989|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267990|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267991|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267992|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267993|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267994|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44361830|NCT00886834|79367284|FG001|Overall Study|Protocol Violation|3|||
44267995|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
44267996|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
44267997|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
44267998|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44267999|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
44268000|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
44268001|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
44268002|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268003|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268004|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268005|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268006|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268007|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268008|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268009|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268010|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268011|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268012|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268013|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44361831|NCT00880009|79367290|FG000|Overall Study|Study terminated by sponsor|14|||
44361832|NCT00880009|79367290|FG000|Overall Study|Withdrawal by Subject|1|||
44361833|NCT00880009|79367290|FG000|Overall Study|Protocol Violation|1|||
44361834|NCT01104636|79367297|FG000|Overall Study|Lack of Efficacy|43|||
44361835|NCT01104636|79367297|FG000|Overall Study|Lost to Follow-up|24|||
44361836|NCT01104636|79367297|FG000|Overall Study|Withdrawal by Subject|4|||
44361837|NCT01104636|79367297|FG000|Overall Study|Other|43|||
44361838|NCT01104636|79367297|FG000|Overall Study|Study terminated by sponsor|1|||
44361839|NCT01104636|79367297|FG000|Overall Study|Pregnancy|2|||
44361840|NCT01104636|79367297|FG000|Overall Study|Adverse Event|40|||
44361841|NCT01104636|79367297|FG000|Overall Study|Ongoing|21|||
44361842|NCT01104558|79367301|FG000|Overall Study|Protocol Violation|6|||
44361843|NCT01104558|79367301|FG000|Overall Study|Missing of primary efficacy assessment|10|||
44201429|NCT02057575|78996923|FG002|Overall Study|Protocol Violation|0|||
44201430|NCT02057575|78996924|FG003|Overall Study|Protocol Violation|0|||
44201431|NCT02077465|78996936|FG000|Overall Study|Withdrew Consent|0|||
44201432|NCT02077465|78996937|FG001|Overall Study|Withdrew Consent|1|||
44201433|NCT02077465|78996936|FG000|Overall Study|Lost to Follow-up|1|||
44201434|NCT02077465|78996937|FG001|Overall Study|Lost to Follow-up|0|||
44201435|NCT02034565|78996943|FG000|Overall Study|Adverse Event|1|||
44201436|NCT02034565|78996944|FG001|Overall Study|Adverse Event|0|||
44201437|NCT02075515|78996955|FG000|Overall Study|Serious Adverse Event|1|||
44201438|NCT02075515|78996956|FG001|Overall Study|Serious Adverse Event|1|||
44201439|NCT02075515|78996957|FG002|Overall Study|Serious Adverse Event|1|||
44201440|NCT02075515|78996955|FG000|Overall Study|Non-Serious Adverse Event|0|||
44201441|NCT02075515|78996956|FG001|Overall Study|Non-Serious Adverse Event|1|||
44201442|NCT02075515|78996957|FG002|Overall Study|Non-Serious Adverse Event|0|||
44201443|NCT02075515|78996955|FG000|Overall Study|Withdrawal by Subject|2|||
44201444|NCT02075515|78996956|FG001|Overall Study|Withdrawal by Subject|0|||
44201445|NCT02075515|78996957|FG002|Overall Study|Withdrawal by Subject|1|||
44201446|NCT02075515|78996955|FG000|Overall Study|Lost to Follow-up|1|||
44201447|NCT02075515|78996956|FG001|Overall Study|Lost to Follow-up|3|||
44201448|NCT02075515|78996957|FG002|Overall Study|Lost to Follow-up|6|||
44201449|NCT02034409|78996968|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
44201450|NCT02034409|78996969|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
44201451|NCT02034409|78996968|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
44201452|NCT02034409|78996969|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
44201453|NCT02034409|78996968|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
44201454|NCT02034409|78996969|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
44201455|NCT02034409|78996968|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
44201456|NCT02034409|78996969|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
44201457|NCT02034409|78996968|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
44201458|NCT02034409|78996969|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
44201459|NCT02034409|78996968|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
44201460|NCT02034409|78996969|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
44201461|NCT02021318|78996977|FG000|Overall Study|Adverse Event|2|||
44201462|NCT02021318|78996978|FG001|Overall Study|Adverse Event|1|||
44451655|NCT00423670|79460531|FG004|Treatment Period|Lost to Follow-up|6|||
44201463|NCT02021318|78996977|FG000|Overall Study|Death|33|||
44201464|NCT02021318|78996978|FG001|Overall Study|Death|34|||
44361844|NCT01104558|79367301|FG000|Overall Study|Missing of genetic analysis results|1|||
44361845|NCT00886288|79367307|FG000|Overall Study|no respect of the 12 weeks period|657|||
44361846|NCT00886288|79367308|FG001|Overall Study|no respect of the 12 weeks period|227|||
44361847|NCT00886288|79367307|FG000|Overall Study|Lost to Follow-up|86|||
44361848|NCT00886288|79367308|FG001|Overall Study|Lost to Follow-up|0|||
44361849|NCT01204658|79367320|FG000|Primary Phase|Adverse Event|0|||
44361850|NCT01204658|79367321|FG001|Primary Phase|Adverse Event|0|||
44361851|NCT01204658|79367322|FG002|Primary Phase|Adverse Event|1|||
44361852|NCT01204658|79367323|FG003|Primary Phase|Adverse Event|0|||
44361853|NCT00951483|79367338|FG000|Overall Study|Physician Decision|4|||
44361854|NCT00951483|79367339|FG001|Overall Study|Physician Decision|0|||
44361855|NCT00951483|79367338|FG000|Overall Study|Withdrawal by Subject|15|||
44361856|NCT00951483|79367339|FG001|Overall Study|Withdrawal by Subject|0|||
44361857|NCT01104246|79367347|FG000|Overall Study|Withdrawal by Subject|1|||
44361858|NCT01104246|79367347|FG000|Overall Study|did not meet inclusion criteria|4|||
44361859|NCT01103778|79367351|FG000|Overall Study|Lost to Follow-up|1|||
44361860|NCT01103778|79367351|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
44361861|NCT01103778|79367351|FG000|Overall Study|Screen failure|1|||
44361862|NCT01103466|79367357|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
44361863|NCT01103466|79367358|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
44361864|NCT01103466|79367359|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
44361865|NCT01103466|79367357|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
44361866|NCT01103466|79367358|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
44361867|NCT01103466|79367359|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
44361868|NCT01103466|79367357|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
44361869|NCT01103466|79367358|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
44361870|NCT01103466|79367359|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
44361871|NCT01103466|79367357|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
44361872|NCT01103466|79367358|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
44361873|NCT01103466|79367359|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
44361874|NCT01103466|79367357|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
44361875|NCT01103466|79367358|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
44361876|NCT01103466|79367359|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
44361877|NCT01103466|79367357|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
44361878|NCT01103466|79367358|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
44361879|NCT01103466|79367359|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
44361880|NCT00945945|79367369|FG000|Overall Study|Adverse Event|15|||
44361881|NCT00945945|79367370|FG001|Overall Study|Adverse Event|35|||
44361882|NCT00945945|79367369|FG000|Overall Study|Withdrawal by Subject|7|||
44361883|NCT00945945|79367370|FG001|Overall Study|Withdrawal by Subject|10|||
44361884|NCT00945945|79367369|FG000|Overall Study|Lost to Follow-up|4|||
44361885|NCT00945945|79367370|FG001|Overall Study|Lost to Follow-up|5|||
44361886|NCT00945945|79367369|FG000|Overall Study|Lack of Efficacy|6|||
44361887|NCT00945945|79367370|FG001|Overall Study|Lack of Efficacy|2|||
44361888|NCT00945945|79367369|FG000|Overall Study|Protocol Violation|4|||
44361889|NCT00945945|79367370|FG001|Overall Study|Protocol Violation|2|||
44361890|NCT00945945|79367369|FG000|Overall Study|Entry Criteria Not Met|0|||
44361891|NCT00945945|79367370|FG001|Overall Study|Entry Criteria Not Met|1|||
44361892|NCT01203956|79367376|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
44361893|NCT01203956|79367377|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
44361894|NCT01103232|79367386|FG000|Overall Study|Withdrawal by Subject|1|||
44361895|NCT01103232|79367387|FG001|Overall Study|Withdrawal by Subject|1|||
44361896|NCT01103232|79367386|FG000|Overall Study|Protocol Violation|0|||
44361897|NCT01103232|79367387|FG001|Overall Study|Protocol Violation|1|||
44361898|NCT01112982|79367393|FG000|Overall Study|Withdrawal by Subject|1|||
44361899|NCT01112982|79367393|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
44361900|NCT01203878|79367403|FG000|Overall Study|Withdrawal by Subject|0|||
44451656|NCT00423670|79460532|FG005|Treatment Period|Lost to Follow-up|0|||
44268014|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268015|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268016|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268017|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268018|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268019|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268020|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
44268021|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
44361901|NCT01203878|79367404|FG001|Overall Study|Withdrawal by Subject|0|||
44361902|NCT01203878|79367405|FG002|Overall Study|Withdrawal by Subject|1|||
44361903|NCT01203878|79367403|FG000|Overall Study|Adverse Event|0|||
44361904|NCT01203878|79367404|FG001|Overall Study|Adverse Event|0|||
44361905|NCT01203878|79367405|FG002|Overall Study|Adverse Event|2|||
44361906|NCT01112514|79367412|FG000|Overall Study|Lost to Follow-up|1|||
44361907|NCT01203098|79367419|FG000|Overall Study|Adverse Event|3|||
44361908|NCT01203098|79367420|FG001|Overall Study|Adverse Event|1|||
44361909|NCT01203098|79367421|FG002|Overall Study|Adverse Event|7|||
44361910|NCT01203098|79367419|FG000|Overall Study|Lost to Follow-up|0|||
44361911|NCT01203098|79367420|FG001|Overall Study|Lost to Follow-up|0|||
44361912|NCT01203098|79367421|FG002|Overall Study|Lost to Follow-up|1|||
44361913|NCT01203098|79367419|FG000|Overall Study|Physician Decision|2|||
44361914|NCT01203098|79367420|FG001|Overall Study|Physician Decision|2|||
44201465|NCT02021318|78996977|FG000|Overall Study|Lost to Follow-up|3|||
44201466|NCT02021318|78996978|FG001|Overall Study|Lost to Follow-up|3|||
44201467|NCT02021318|78996977|FG000|Overall Study|Progressive Disease|0|||
44201468|NCT02021318|78996978|FG001|Overall Study|Progressive Disease|1|||
44201469|NCT02021318|78996977|FG000|Overall Study|Withdrawal by Subject|30|||
44201470|NCT02021318|78996978|FG001|Overall Study|Withdrawal by Subject|18|||
44201471|NCT02021318|78996977|FG000|Overall Study|Physician Decision|3|||
44201472|NCT02021318|78996978|FG001|Overall Study|Physician Decision|3|||
44201473|NCT02021318|78996977|FG000|Overall Study|Miscellaneous|2|||
44201474|NCT02021318|78996978|FG001|Overall Study|Miscellaneous|3|||
44201475|NCT02041286|78996985|FG000|Overall Study|Adverse Event|1|||
44201476|NCT02020616|78996998|FG000|Overall Study|Adverse Event|0|||
44201477|NCT02020616|78996999|FG001|Overall Study|Adverse Event|0|||
44268022|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44268023|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
44268024|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
44268025|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
44268026|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268027|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268028|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268029|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268030|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268031|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268032|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268033|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268034|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268035|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268036|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268037|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268038|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268039|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268040|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268041|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268042|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268043|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268044|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
44268045|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268046|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
44268047|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
44268048|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
44268049|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
44268050|NCT02346240|79181715|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268051|NCT02346240|79181716|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268052|NCT02346240|79181717|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268053|NCT02346240|79181718|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268054|NCT02346240|79181719|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268055|NCT02346240|79181720|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268056|NCT02346240|79181721|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268057|NCT02346240|79181722|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268058|NCT02346240|79181723|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268059|NCT02346240|79181724|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268060|NCT02346240|79181725|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268061|NCT02346240|79181726|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44361915|NCT01203098|79367421|FG002|Overall Study|Physician Decision|0|||
44361916|NCT01203098|79367419|FG000|Overall Study|Withdrawal by Subject|1|||
44361917|NCT01203098|79367420|FG001|Overall Study|Withdrawal by Subject|1|||
44361918|NCT01203098|79367421|FG002|Overall Study|Withdrawal by Subject|3|||
44201478|NCT02020616|78997000|FG002|Overall Study|Adverse Event|0|||
44201479|NCT02020616|78997001|FG003|Overall Study|Adverse Event|0|||
44201480|NCT02020616|78997002|FG004|Overall Study|Adverse Event|0|||
44201481|NCT02020616|78997003|FG005|Overall Study|Adverse Event|1|||
44201482|NCT02020616|78997004|FG006|Overall Study|Adverse Event|1|||
44361919|NCT00945555|79367429|FG000|Overall Study|Referred to another hospital|5|||
44361920|NCT00945555|79367429|FG000|Overall Study|Worsening condition, intensive care unit|1|||
44361921|NCT00945555|79367429|FG000|Overall Study|Withdrawal by Subject|2|||
44361922|NCT00945555|79367429|FG000|Overall Study|Participant continued treatment at home|1|||
44361923|NCT00945555|79367429|FG000|Overall Study|Death|18|||
44361924|NCT00945555|79367429|FG000|Overall Study|Other|1|||
44361925|NCT01108458|79367433|FG000|Overall Study|Withdrawal by Subject|1|||
44361926|NCT01108068|79367439|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
44361927|NCT01108068|79367440|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
44361928|NCT01201850|79367447|FG000|Overall Study|Tumor progression|4|||
44361929|NCT00951171|79367453|FG000|Overall Study|Adverse Event|2|||
44361930|NCT00951171|79367454|FG001|Overall Study|Adverse Event|0|||
44361931|NCT01200992|79367462|FG000|Overall Study|Study terminated early|35|||
44361932|NCT01200992|79367463|FG001|Overall Study|Study terminated early|41|||
44361933|NCT01200992|79367462|FG000|Overall Study|Randomized but not treated|2|||
44361934|NCT01200992|79367463|FG001|Overall Study|Randomized but not treated|0|||
44361935|NCT00878215|79367475|FG000|Overall Study|Determined to be ineligible|0|||
44361936|NCT00878215|79367476|FG001|Overall Study|Determined to be ineligible|10|||
44361937|NCT00878215|79367477|FG002|Overall Study|Determined to be ineligible|0|||
44361938|NCT00878215|79367478|FG003|Overall Study|Determined to be ineligible|0|||
44361939|NCT01200758|79367490|FG000|Stage I|Death|0|||
44361940|NCT01200758|79367491|FG001|Stage I|Death|1|||
44361941|NCT01200758|79367492|FG002|Stage I|Death|0|||
44201483|NCT02020616|78996998|FG000|Overall Study|Physician Decision|0|||
44201484|NCT02020616|78996999|FG001|Overall Study|Physician Decision|0|||
44201485|NCT02020616|78997000|FG002|Overall Study|Physician Decision|0|||
44201486|NCT02020616|78997001|FG003|Overall Study|Physician Decision|0|||
44201487|NCT02020616|78997002|FG004|Overall Study|Physician Decision|0|||
44201488|NCT02020616|78997003|FG005|Overall Study|Physician Decision|1|||
44201489|NCT02020616|78997004|FG006|Overall Study|Physician Decision|2|||
44201490|NCT02020616|78996998|FG000|Overall Study|Withdrawal by Subject|0|||
44201491|NCT02020616|78996999|FG001|Overall Study|Withdrawal by Subject|0|||
44201492|NCT02020616|78997000|FG002|Overall Study|Withdrawal by Subject|1|||
44201493|NCT02020616|78997001|FG003|Overall Study|Withdrawal by Subject|0|||
44201494|NCT02020616|78997002|FG004|Overall Study|Withdrawal by Subject|0|||
44201495|NCT02020616|78997003|FG005|Overall Study|Withdrawal by Subject|1|||
44201496|NCT02020616|78997004|FG006|Overall Study|Withdrawal by Subject|1|||
44201497|NCT02020616|78996998|FG000|Overall Study|Lost to Follow-up|0|||
44201498|NCT02020616|78996999|FG001|Overall Study|Lost to Follow-up|1|||
44201499|NCT02020616|78997000|FG002|Overall Study|Lost to Follow-up|0|||
44201500|NCT02020616|78997001|FG003|Overall Study|Lost to Follow-up|1|||
44201501|NCT02020616|78997002|FG004|Overall Study|Lost to Follow-up|1|||
44201502|NCT02020616|78997003|FG005|Overall Study|Lost to Follow-up|1|||
44201503|NCT02020616|78997004|FG006|Overall Study|Lost to Follow-up|0|||
44201504|NCT02020616|78996998|FG000|Overall Study|Early Termination Criteria Met|0|||
44201505|NCT02020616|78996999|FG001|Overall Study|Early Termination Criteria Met|0|||
44268062|NCT02346240|79181727|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268063|NCT02346240|79181728|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268064|NCT02346240|79181729|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268065|NCT02346240|79181730|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268066|NCT02346240|79181731|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268067|NCT02346240|79181732|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268068|NCT02346240|79181733|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
44268069|NCT02346240|79181734|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268070|NCT02346240|79181735|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268071|NCT02346240|79181736|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268072|NCT02346240|79181737|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268073|NCT02346240|79181738|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
44268074|NCT02392104|79181789|FG000|Overall Study|discontinuation of warfarin|3|||
44268075|NCT02392104|79181789|FG000|Overall Study|bleeding event|1|||
44268076|NCT02392104|79181789|FG000|Overall Study|transferred care to another doctor|2|||
44268077|NCT02392104|79181789|FG000|Overall Study|INR goal range changed|1|||
44268078|NCT02392104|79181789|FG000|Overall Study|admitted to skilled nursing facility|3|||
44361942|NCT01200758|79367493|FG003|Stage I|Death|0|||
44361943|NCT01200758|79367490|FG000|Stage I|Physician Decision|1|||
44361944|NCT01200758|79367491|FG001|Stage I|Physician Decision|1|||
44201506|NCT02020616|78997000|FG002|Overall Study|Early Termination Criteria Met|1|||
44201507|NCT02020616|78997001|FG003|Overall Study|Early Termination Criteria Met|0|||
44361945|NCT01200758|79367492|FG002|Stage I|Physician Decision|0|||
44361946|NCT01200758|79367493|FG003|Stage I|Physician Decision|0|||
44361947|NCT01200758|79367490|FG000|Stage I|Lack of Efficacy|2|||
44361948|NCT01200758|79367491|FG001|Stage I|Lack of Efficacy|1|||
44361949|NCT01200758|79367492|FG002|Stage I|Lack of Efficacy|0|||
44361950|NCT01200758|79367493|FG003|Stage I|Lack of Efficacy|0|||
44361951|NCT01200758|79367490|FG000|Stage I|Adverse Event|5|||
44361952|NCT01200758|79367491|FG001|Stage I|Adverse Event|5|||
44361953|NCT01200758|79367492|FG002|Stage I|Adverse Event|0|||
44361954|NCT01200758|79367493|FG003|Stage I|Adverse Event|0|||
44361955|NCT01200758|79367490|FG000|Stage I|Withdrawal by Subject|1|||
44361956|NCT01200758|79367491|FG001|Stage I|Withdrawal by Subject|2|||
44361957|NCT01200758|79367492|FG002|Stage I|Withdrawal by Subject|0|||
44361958|NCT01200758|79367493|FG003|Stage I|Withdrawal by Subject|0|||
44361959|NCT01200758|79367490|FG000|Stage I|Disease Progression|9|||
44361960|NCT01200758|79367491|FG001|Stage I|Disease Progression|7|||
44361961|NCT01200758|79367492|FG002|Stage I|Disease Progression|0|||
44361962|NCT01200758|79367493|FG003|Stage I|Disease Progression|0|||
44361963|NCT01200758|79367490|FG000|Stage 2|Disease Progression|0|||
44361964|NCT01200758|79367491|FG001|Stage 2|Disease Progression|0|||
44361965|NCT01200758|79367492|FG002|Stage 2|Disease Progression|16|||
44361966|NCT01200758|79367493|FG003|Stage 2|Disease Progression|21|||
44361967|NCT01200758|79367490|FG000|Stage 2|Lack of Efficacy|0|||
44361968|NCT01200758|79367491|FG001|Stage 2|Lack of Efficacy|0|||
44361969|NCT01200758|79367492|FG002|Stage 2|Lack of Efficacy|4|||
44361970|NCT01200758|79367493|FG003|Stage 2|Lack of Efficacy|2|||
44361971|NCT01200758|79367490|FG000|Stage 2|Physician Decision|0|||
44361972|NCT01200758|79367491|FG001|Stage 2|Physician Decision|0|||
44361973|NCT01200758|79367492|FG002|Stage 2|Physician Decision|5|||
44361974|NCT01200758|79367493|FG003|Stage 2|Physician Decision|7|||
44361975|NCT01200758|79367490|FG000|Stage 2|Adverse Event|0|||
44361976|NCT01200758|79367491|FG001|Stage 2|Adverse Event|0|||
44361977|NCT01200758|79367492|FG002|Stage 2|Adverse Event|5|||
44361978|NCT01200758|79367493|FG003|Stage 2|Adverse Event|9|||
44361979|NCT01200758|79367490|FG000|Stage 2|Withdrawal by Subject|0|||
44361980|NCT01200758|79367491|FG001|Stage 2|Withdrawal by Subject|0|||
44361981|NCT01200758|79367492|FG002|Stage 2|Withdrawal by Subject|4|||
44361982|NCT01200758|79367493|FG003|Stage 2|Withdrawal by Subject|1|||
44361983|NCT01200758|79367490|FG000|Stage 2|Lost to Follow-up|0|||
44361984|NCT01200758|79367491|FG001|Stage 2|Lost to Follow-up|0|||
44361985|NCT01200758|79367492|FG002|Stage 2|Lost to Follow-up|3|||
44361986|NCT01200758|79367493|FG003|Stage 2|Lost to Follow-up|1|||
44361987|NCT01200758|79367490|FG000|Stage 2|Protocol Violation|0|||
44361988|NCT01200758|79367491|FG001|Stage 2|Protocol Violation|0|||
44361989|NCT01200758|79367492|FG002|Stage 2|Protocol Violation|1|||
44361990|NCT01200758|79367493|FG003|Stage 2|Protocol Violation|4|||
44361991|NCT01200758|79367490|FG000|Stage 2|Death|0|||
44361992|NCT01200758|79367491|FG001|Stage 2|Death|0|||
44361993|NCT01200758|79367492|FG002|Stage 2|Death|3|||
44451657|NCT00423670|79460533|FG006|Treatment Period|Lost to Follow-up|3|||
44451658|NCT00423670|79460534|FG007|Treatment Period|Lost to Follow-up|1|||
44201508|NCT02020616|78997002|FG004|Overall Study|Early Termination Criteria Met|0|||
44201509|NCT02020616|78997003|FG005|Overall Study|Early Termination Criteria Met|1|||
44201510|NCT02020616|78997004|FG006|Overall Study|Early Termination Criteria Met|0|||
44201511|NCT02020616|78996998|FG000|Overall Study|Randomized in Error|0|||
44201512|NCT02020616|78996999|FG001|Overall Study|Randomized in Error|0|||
44201513|NCT02020616|78997000|FG002|Overall Study|Randomized in Error|0|||
44201514|NCT02020616|78997001|FG003|Overall Study|Randomized in Error|1|||
44201515|NCT02020616|78997002|FG004|Overall Study|Randomized in Error|0|||
44268079|NCT02392104|79181789|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
44268080|NCT02391948|79181807|FG000|6-month Assessment|Death|0|||
44268081|NCT02391948|79181808|FG001|6-month Assessment|Death|0|||
44268082|NCT02391948|79181809|FG002|6-month Assessment|Death|0|||
44268083|NCT02391948|79181810|FG003|6-month Assessment|Death|0|||
44268084|NCT02391948|79181811|FG004|6-month Assessment|Death|1|||
44268085|NCT02391948|79181807|FG000|6-month Assessment|Withdrawal by Subject|0|||
44268086|NCT02391948|79181808|FG001|6-month Assessment|Withdrawal by Subject|0|||
44268087|NCT02391948|79181809|FG002|6-month Assessment|Withdrawal by Subject|1|||
44268088|NCT02391948|79181810|FG003|6-month Assessment|Withdrawal by Subject|2|||
44268089|NCT02391948|79181811|FG004|6-month Assessment|Withdrawal by Subject|0|||
44268090|NCT02391948|79181807|FG000|6-month Assessment|Lost to Follow-up|4|||
44361994|NCT01200758|79367493|FG003|Stage 2|Death|5|||
44361995|NCT00876343|79367508|FG000|Overall Study|Adverse Event|7|||
44361996|NCT00876343|79367509|FG001|Overall Study|Adverse Event|8|||
44361997|NCT00876343|79367510|FG002|Overall Study|Adverse Event|2|||
44361998|NCT00876343|79367508|FG000|Overall Study|Withdrawal by Subject|4|||
44361999|NCT00876343|79367509|FG001|Overall Study|Withdrawal by Subject|4|||
44362000|NCT00876343|79367510|FG002|Overall Study|Withdrawal by Subject|3|||
44362001|NCT00876343|79367508|FG000|Overall Study|Lack of Efficacy|0|||
44362002|NCT00876343|79367509|FG001|Overall Study|Lack of Efficacy|0|||
44362003|NCT00876343|79367510|FG002|Overall Study|Lack of Efficacy|1|||
44362004|NCT00876343|79367508|FG000|Overall Study|Protocol Violation|4|||
44362005|NCT00876343|79367509|FG001|Overall Study|Protocol Violation|1|||
44362006|NCT00876343|79367510|FG002|Overall Study|Protocol Violation|1|||
44362007|NCT00876343|79367508|FG000|Overall Study|Physician Decision|0|||
44362008|NCT00876343|79367509|FG001|Overall Study|Physician Decision|1|||
44362009|NCT00876343|79367510|FG002|Overall Study|Physician Decision|1|||
44362010|NCT00876343|79367508|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
44362011|NCT00876343|79367509|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
44362012|NCT00876343|79367510|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
44362013|NCT00876343|79367508|FG000|Overall Study|Change of residence or other commitments|2|||
44362014|NCT00876343|79367509|FG001|Overall Study|Change of residence or other commitments|2|||
44362015|NCT00876343|79367510|FG002|Overall Study|Change of residence or other commitments|3|||
44362016|NCT01107912|79367522|FG000|Period 1|Adverse Event|0|||
44362017|NCT01107912|79367523|FG001|Period 1|Adverse Event|0|||
44362018|NCT01107912|79367524|FG002|Period 1|Adverse Event|0|||
44362019|NCT01107912|79367525|FG003|Period 1|Adverse Event|0|||
44362020|NCT01107912|79367526|FG004|Period 1|Adverse Event|2|||
44362021|NCT01107912|79367527|FG005|Period 1|Adverse Event|0|||
44362022|NCT01107912|79367522|FG000|Period 1|Physician Decision|0|||
44362023|NCT01107912|79367523|FG001|Period 1|Physician Decision|0|||
44362024|NCT01107912|79367524|FG002|Period 1|Physician Decision|0|||
44362025|NCT01107912|79367525|FG003|Period 1|Physician Decision|0|||
44362026|NCT01107912|79367526|FG004|Period 1|Physician Decision|1|||
44362027|NCT01107912|79367527|FG005|Period 1|Physician Decision|0|||
44362028|NCT01107912|79367522|FG000|Period 1|Withdrawal by Subject|1|||
44362029|NCT01107912|79367523|FG001|Period 1|Withdrawal by Subject|0|||
44362030|NCT01107912|79367524|FG002|Period 1|Withdrawal by Subject|0|||
44362031|NCT01107912|79367525|FG003|Period 1|Withdrawal by Subject|0|||
44362032|NCT01107912|79367526|FG004|Period 1|Withdrawal by Subject|0|||
44362033|NCT01107912|79367527|FG005|Period 1|Withdrawal by Subject|0|||
44362034|NCT01107912|79367522|FG000|Period 2|Physician Decision|0|||
44362035|NCT01107912|79367523|FG001|Period 2|Physician Decision|0|||
44362036|NCT01107912|79367524|FG002|Period 2|Physician Decision|1|||
44362037|NCT01107912|79367525|FG003|Period 2|Physician Decision|0|||
44451659|NCT00423670|79460527|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
44451660|NCT00423670|79460528|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
44451661|NCT00423670|79460529|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
44451662|NCT00423670|79460530|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
44451663|NCT00423670|79460531|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
44451664|NCT00423670|79460532|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
44201516|NCT02020616|78997003|FG005|Overall Study|Randomized in Error|0|||
44201517|NCT02020616|78997004|FG006|Overall Study|Randomized in Error|0|||
44201518|NCT02020616|78996998|FG000|Overall Study|Lack of Efficacy|0|||
44201519|NCT02020616|78996999|FG001|Overall Study|Lack of Efficacy|0|||
44201520|NCT02020616|78997000|FG002|Overall Study|Lack of Efficacy|0|||
44201521|NCT02020616|78997001|FG003|Overall Study|Lack of Efficacy|0|||
44201522|NCT02020616|78997002|FG004|Overall Study|Lack of Efficacy|1|||
44268091|NCT02391948|79181808|FG001|6-month Assessment|Lost to Follow-up|5|||
44268092|NCT02391948|79181809|FG002|6-month Assessment|Lost to Follow-up|2|||
44268093|NCT02391948|79181810|FG003|6-month Assessment|Lost to Follow-up|3|||
44268094|NCT02391948|79181811|FG004|6-month Assessment|Lost to Follow-up|1|||
44268095|NCT02391948|79181807|FG000|6-month Assessment|Medical issue/illness|1|||
44268096|NCT02391948|79181808|FG001|6-month Assessment|Medical issue/illness|1|||
44268097|NCT02391948|79181809|FG002|6-month Assessment|Medical issue/illness|0|||
44268098|NCT02391948|79181810|FG003|6-month Assessment|Medical issue/illness|0|||
44268099|NCT02391948|79181811|FG004|6-month Assessment|Medical issue/illness|0|||
44268100|NCT02391948|79181807|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
44268101|NCT02391948|79181808|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
44268102|NCT02391948|79181809|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
44268103|NCT02391948|79181810|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
44268104|NCT02391948|79181811|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
44268105|NCT02391948|79181807|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
44268106|NCT02391948|79181808|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
44268107|NCT02391948|79181809|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
44268108|NCT02391948|79181810|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
44362038|NCT01107912|79367526|FG004|Period 2|Physician Decision|0|||
44201523|NCT02020616|78997003|FG005|Overall Study|Lack of Efficacy|0|||
44201524|NCT02020616|78997004|FG006|Overall Study|Lack of Efficacy|0|||
44268109|NCT02391948|79181811|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
44268110|NCT02391948|79181807|FG000|12-month Assessment|Death|0|||
44268111|NCT02391948|79181808|FG001|12-month Assessment|Death|0|||
44362039|NCT01107912|79367527|FG005|Period 2|Physician Decision|0|||
44362040|NCT01107912|79367522|FG000|Period 3|Adverse Event|0|||
44362041|NCT01107912|79367523|FG001|Period 3|Adverse Event|1|||
44362042|NCT01107912|79367524|FG002|Period 3|Adverse Event|1|||
44362043|NCT01107912|79367525|FG003|Period 3|Adverse Event|0|||
44362044|NCT01107912|79367526|FG004|Period 3|Adverse Event|0|||
44362045|NCT01107912|79367527|FG005|Period 3|Adverse Event|0|||
44362046|NCT01107912|79367522|FG000|Period 3|Withdrawal by Subject|0|||
44362047|NCT01107912|79367523|FG001|Period 3|Withdrawal by Subject|0|||
44362048|NCT01107912|79367524|FG002|Period 3|Withdrawal by Subject|0|||
44362049|NCT01107912|79367525|FG003|Period 3|Withdrawal by Subject|1|||
44362050|NCT01107912|79367526|FG004|Period 3|Withdrawal by Subject|0|||
44362051|NCT01107912|79367527|FG005|Period 3|Withdrawal by Subject|0|||
44362052|NCT01200524|79367545|FG000|Overall Study|Withdrawal by Subject|1|||
44362053|NCT01200524|79367546|FG001|Overall Study|Withdrawal by Subject|1|||
44362054|NCT01200524|79367547|FG002|Overall Study|Withdrawal by Subject|3|||
44362055|NCT01200524|79367545|FG000|Overall Study|Adverse Event|1|||
44362056|NCT01200524|79367546|FG001|Overall Study|Adverse Event|0|||
44362057|NCT01200524|79367547|FG002|Overall Study|Adverse Event|0|||
44362058|NCT01200524|79367545|FG000|Overall Study|Non availability of study nurse|0|||
44362059|NCT01200524|79367546|FG001|Overall Study|Non availability of study nurse|0|||
44362060|NCT01200524|79367547|FG002|Overall Study|Non availability of study nurse|1|||
44362061|NCT01100034|79367555|FG000|Overall Study|Lost to Follow-up|11|||
44362062|NCT01100034|79367555|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
44362063|NCT01100034|79367555|FG000|Overall Study|Withdrawal by Subject|4|||
44362064|NCT01100034|79367555|FG000|Overall Study|Sponsor decision|21|||
44362065|NCT01100034|79367555|FG000|Overall Study|Participated in another clinical trial|1|||
44362066|NCT01100034|79367555|FG000|Overall Study|Participants moved to another hospital|4|||
44362067|NCT01100034|79367555|FG000|Overall Study|Site closed due to non-responsiveness|1|||
44362068|NCT00876265|79367559|FG000|Overall Study|Miscellaneous reasons|4|||
44362069|NCT00876265|79367559|FG000|Overall Study|Lost to Follow-up|6|||
44362070|NCT00876265|79367559|FG000|Overall Study|Withdrawal by Subject|2|||
44362071|NCT01107444|79367567|FG000|Overall Study|Withdrawal by Subject|8|||
44362072|NCT01107444|79367568|FG001|Overall Study|Withdrawal by Subject|12|||
44362073|NCT01107444|79367567|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
44362074|NCT01107444|79367568|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
44362075|NCT00876187|79367582|FG000|Overall Study|Adverse Event|14|||
44362076|NCT00876187|79367583|FG001|Overall Study|Adverse Event|12|||
44362077|NCT00876187|79367584|FG002|Overall Study|Adverse Event|19|||
44362078|NCT00876187|79367585|FG003|Overall Study|Adverse Event|29|||
44451665|NCT00423670|79460533|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
44451666|NCT00423670|79460534|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
44451667|NCT00423670|79460527|FG000|Treatment Period|Investigator decision|0|||
44201525|NCT02048072|78997034|FG000|Overall Study|Adverse Event|3|||
44201526|NCT02048072|78997034|FG000|Overall Study|Lost to Follow-up|1|||
44201527|NCT02047604|78997044|FG000|Overall Study|Withdrawal by Subject|0|||
44201528|NCT02047604|78997045|FG001|Overall Study|Withdrawal by Subject|0|||
44201529|NCT02047604|78997046|FG002|Overall Study|Withdrawal by Subject|0|||
44201530|NCT02047604|78997047|FG003|Overall Study|Withdrawal by Subject|0|||
44201531|NCT02047604|78997048|FG004|Overall Study|Withdrawal by Subject|1|||
44201532|NCT02047604|78997049|FG005|Overall Study|Withdrawal by Subject|1|||
44201533|NCT01622660|78997063|FG000|Overall Study|Adverse Event|1|||
44201534|NCT02019602|78997069|FG000|Screening Period|Ineligibility|4|||
44201535|NCT02019602|78997070|FG001|Screening Period|Ineligibility|0|||
44201536|NCT02019602|78997069|FG000|Screening Period|Adverse Event|1|||
44201537|NCT02019602|78997070|FG001|Screening Period|Adverse Event|0|||
44201538|NCT01994876|78997077|FG000|Test Period 1|Withdrawal by Subject|0|||
44201539|NCT01994876|78997078|FG001|Test Period 1|Withdrawal by Subject|1|||
44201540|NCT01994876|78997077|FG000|Test Period 1|Adverse Event|0|||
44268112|NCT02391948|79181809|FG002|12-month Assessment|Death|0|||
44268113|NCT02391948|79181810|FG003|12-month Assessment|Death|1|||
44268114|NCT02391948|79181811|FG004|12-month Assessment|Death|0|||
44268115|NCT02391948|79181807|FG000|12-month Assessment|Withdrawal by Subject|1|||
44268116|NCT02391948|79181808|FG001|12-month Assessment|Withdrawal by Subject|0|||
44268117|NCT02391948|79181809|FG002|12-month Assessment|Withdrawal by Subject|0|||
44268118|NCT02391948|79181810|FG003|12-month Assessment|Withdrawal by Subject|1|||
44268119|NCT02391948|79181811|FG004|12-month Assessment|Withdrawal by Subject|0|||
44268120|NCT02391948|79181807|FG000|12-month Assessment|Lost to Follow-up|5|||
44268121|NCT02391948|79181808|FG001|12-month Assessment|Lost to Follow-up|4|||
44201541|NCT01994876|78997078|FG001|Test Period 1|Adverse Event|1|||
44201542|NCT01994876|78997077|FG000|Test Period 2|Adverse Event|1|||
44268122|NCT02391948|79181809|FG002|12-month Assessment|Lost to Follow-up|4|||
44268123|NCT02391948|79181810|FG003|12-month Assessment|Lost to Follow-up|4|||
44362079|NCT00876187|79367586|FG004|Overall Study|Adverse Event|10|||
44362080|NCT00876187|79367582|FG000|Overall Study|Lack of Efficacy|59|||
44362081|NCT00876187|79367583|FG001|Overall Study|Lack of Efficacy|34|||
44362082|NCT00876187|79367584|FG002|Overall Study|Lack of Efficacy|45|||
44362083|NCT00876187|79367585|FG003|Overall Study|Lack of Efficacy|34|||
44362084|NCT00876187|79367586|FG004|Overall Study|Lack of Efficacy|59|||
44362085|NCT00876187|79367582|FG000|Overall Study|Lost to Follow-up|9|||
44362086|NCT00876187|79367583|FG001|Overall Study|Lost to Follow-up|10|||
44362087|NCT00876187|79367584|FG002|Overall Study|Lost to Follow-up|8|||
44362088|NCT00876187|79367585|FG003|Overall Study|Lost to Follow-up|8|||
44362089|NCT00876187|79367586|FG004|Overall Study|Lost to Follow-up|11|||
44362090|NCT00876187|79367582|FG000|Overall Study|Protocol Violation|6|||
44201543|NCT01994876|78997078|FG001|Test Period 2|Adverse Event|0|||
44201544|NCT01994876|78997077|FG000|Test Period 2|Protocol Violation|0|||
44201545|NCT01994876|78997078|FG001|Test Period 2|Protocol Violation|1|||
44201546|NCT02040428|78997088|FG000|Overall Study|Death|4|||
44201547|NCT02040428|78997089|FG001|Overall Study|Death|3|||
44201548|NCT02040428|78997088|FG000|Overall Study|Withdrawal by Subject|1|||
44201549|NCT02040428|78997089|FG001|Overall Study|Withdrawal by Subject|1|||
44201550|NCT02018822|78997097|FG000|Overall Study|filling replaced by crown|0|||
44201551|NCT02018822|78997098|FG001|Overall Study|filling replaced by crown|1|||
44201552|NCT02018822|78997099|FG002|Overall Study|filling replaced by crown|0|||
44201553|NCT02018822|78997097|FG000|Overall Study|Physician Decision|0|||
44201554|NCT02018822|78997098|FG001|Overall Study|Physician Decision|1|||
44201555|NCT02018822|78997099|FG002|Overall Study|Physician Decision|1|||
44201556|NCT02018822|78997097|FG000|Overall Study|Lost to Follow-up|6|||
44201557|NCT02018822|78997098|FG001|Overall Study|Lost to Follow-up|6|||
44201558|NCT02018822|78997099|FG002|Overall Study|Lost to Follow-up|5|||
44201559|NCT02055157|78997114|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
44201560|NCT02055157|78997115|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
44201561|NCT02055157|78997116|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
44201562|NCT02055157|78997117|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
44201563|NCT02055157|78997114|FG000|Initial 6 Months|Adverse Event|0|||
44201564|NCT02055157|78997115|FG001|Initial 6 Months|Adverse Event|0|||
44201565|NCT02055157|78997116|FG002|Initial 6 Months|Adverse Event|0|||
44362091|NCT00876187|79367583|FG001|Overall Study|Protocol Violation|7|||
44362092|NCT00876187|79367584|FG002|Overall Study|Protocol Violation|7|||
44362093|NCT00876187|79367585|FG003|Overall Study|Protocol Violation|6|||
44268124|NCT02391948|79181811|FG004|12-month Assessment|Lost to Follow-up|5|||
44268125|NCT02391948|79181807|FG000|12-month Assessment|Medical issue/illness|0|||
44268126|NCT02391948|79181808|FG001|12-month Assessment|Medical issue/illness|1|||
44268127|NCT02391948|79181809|FG002|12-month Assessment|Medical issue/illness|0|||
44268128|NCT02391948|79181810|FG003|12-month Assessment|Medical issue/illness|1|||
44268129|NCT02391948|79181811|FG004|12-month Assessment|Medical issue/illness|0|||
44268130|NCT02391948|79181807|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
44268131|NCT02391948|79181808|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
44268132|NCT02391948|79181809|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
44268133|NCT02391948|79181810|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
44268134|NCT02391948|79181811|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
44268135|NCT02391948|79181807|FG000|18-month Assessment|Death|0|||
44268136|NCT02391948|79181808|FG001|18-month Assessment|Death|0|||
44268137|NCT02391948|79181809|FG002|18-month Assessment|Death|0|||
44268138|NCT02391948|79181810|FG003|18-month Assessment|Death|1|||
44268139|NCT02391948|79181811|FG004|18-month Assessment|Death|1|||
44268140|NCT02391948|79181807|FG000|18-month Assessment|Withdrawal by Subject|1|||
44268141|NCT02391948|79181808|FG001|18-month Assessment|Withdrawal by Subject|0|||
44362094|NCT00876187|79367586|FG004|Overall Study|Protocol Violation|3|||
44362095|NCT00876187|79367582|FG000|Overall Study|Withdrawal by Subject|16|||
44201566|NCT02055157|78997117|FG003|Initial 6 Months|Adverse Event|1|||
44268142|NCT02391948|79181809|FG002|18-month Assessment|Withdrawal by Subject|0|||
44201567|NCT02055157|78997114|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
44201568|NCT02055157|78997115|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
44201569|NCT02055157|78997116|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
44362096|NCT00876187|79367583|FG001|Overall Study|Withdrawal by Subject|26|||
44362097|NCT00876187|79367584|FG002|Overall Study|Withdrawal by Subject|32|||
44362098|NCT00876187|79367585|FG003|Overall Study|Withdrawal by Subject|38|||
44362099|NCT00876187|79367586|FG004|Overall Study|Withdrawal by Subject|37|||
44362100|NCT00876187|79367582|FG000|Overall Study|Entered extension study|101|||
44362101|NCT00876187|79367583|FG001|Overall Study|Entered extension study|120|||
44362102|NCT00876187|79367584|FG002|Overall Study|Entered extension study|156|||
44362103|NCT00876187|79367585|FG003|Overall Study|Entered extension study|151|||
44362104|NCT00876187|79367586|FG004|Overall Study|Entered extension study|144|||
44362105|NCT00876187|79367582|FG000|Overall Study|Randomized but not treated|3|||
44451668|NCT00423670|79460528|FG001|Treatment Period|Investigator decision|0|||
44451669|NCT00423670|79460529|FG002|Treatment Period|Investigator decision|0|||
44268143|NCT02391948|79181810|FG003|18-month Assessment|Withdrawal by Subject|1|||
44268144|NCT02391948|79181811|FG004|18-month Assessment|Withdrawal by Subject|0|||
44201570|NCT02055157|78997117|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
44268145|NCT02391948|79181807|FG000|18-month Assessment|Lost to Follow-up|2|||
44268146|NCT02391948|79181808|FG001|18-month Assessment|Lost to Follow-up|6|||
44268147|NCT02391948|79181809|FG002|18-month Assessment|Lost to Follow-up|2|||
44268148|NCT02391948|79181810|FG003|18-month Assessment|Lost to Follow-up|2|||
44268149|NCT02391948|79181811|FG004|18-month Assessment|Lost to Follow-up|3|||
44268150|NCT02391948|79181807|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
44268151|NCT02391948|79181808|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
44268152|NCT02391948|79181809|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
44268153|NCT02391948|79181810|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
44268154|NCT02391948|79181811|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
44268155|NCT02391948|79181807|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
44268156|NCT02391948|79181808|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
44362106|NCT00876187|79367583|FG001|Overall Study|Randomized but not treated|1|||
44201571|NCT02055157|78997114|FG000|18-month Extension|Investigator decision|0|||
44201572|NCT02055157|78997115|FG001|18-month Extension|Investigator decision|1|||
44201573|NCT02055157|78997116|FG002|18-month Extension|Investigator decision|0|||
44201574|NCT02055157|78997117|FG003|18-month Extension|Investigator decision|0|||
44201575|NCT02055157|78997114|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
44201576|NCT02055157|78997115|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
44201577|NCT02055157|78997116|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
44201578|NCT02055157|78997117|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
44201579|NCT02022007|78997141|FG000|Overall Study|Withdrawal by Subject|1|||
44201580|NCT02022007|78997142|FG001|Overall Study|Withdrawal by Subject|1|||
44362107|NCT00876187|79367584|FG002|Overall Study|Randomized but not treated|3|||
44362108|NCT00876187|79367585|FG003|Overall Study|Randomized but not treated|2|||
44362109|NCT00876187|79367586|FG004|Overall Study|Randomized but not treated|3|||
44362110|NCT00876187|79367582|FG000|Overall Study|Other|2|||
44362111|NCT00876187|79367583|FG001|Overall Study|Other|5|||
44362112|NCT00876187|79367584|FG002|Overall Study|Other|9|||
44362113|NCT00876187|79367585|FG003|Overall Study|Other|7|||
44362114|NCT00876187|79367586|FG004|Overall Study|Other|4|||
44362115|NCT01102374|79367603|FG000|Overall Study|Death|9|||
44362116|NCT01102374|79367604|FG001|Overall Study|Death|13|||
44362117|NCT01102374|79367603|FG000|Overall Study|Lost to Follow-up|7|||
44362118|NCT01102374|79367604|FG001|Overall Study|Lost to Follow-up|6|||
44362119|NCT01106976|79367610|FG000|Overall Study|Lost to Follow-up|8|||
44362120|NCT00875485|79367616|FG000|Challenge Dose Epoch|Pregnancy|1|||
44362121|NCT00875485|79367617|FG001|Challenge Dose Epoch|Pregnancy|0|||
44362122|NCT04547140|79367625|FG000|Overall Study|Adverse Event|0|||
44362123|NCT04547140|79367626|FG001|Overall Study|Adverse Event|1|||
44362124|NCT04547140|79367625|FG000|Overall Study|Withdrawal by Subject|0|||
44362125|NCT04547140|79367626|FG001|Overall Study|Withdrawal by Subject|1|||
44362126|NCT04547140|79367625|FG000|Overall Study|Lost to Follow-up|3|||
44362127|NCT04547140|79367626|FG001|Overall Study|Lost to Follow-up|1|||
44362128|NCT04547140|79367625|FG000|Overall Study|Death|2|||
44362129|NCT04547140|79367626|FG001|Overall Study|Death|1|||
44362130|NCT04547140|79367625|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
44362131|NCT04547140|79367626|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
44362132|NCT04547140|79367625|FG000|Overall Study|Pregnancy|1|||
44362133|NCT04547140|79367626|FG001|Overall Study|Pregnancy|0|||
44362134|NCT04547140|79367625|FG000|Overall Study|Reason Not Specified|4|||
44362135|NCT04547140|79367626|FG001|Overall Study|Reason Not Specified|1|||
44362136|NCT01098474|79367638|FG000|Active Phase|Other|0|||
44201581|NCT02022007|78997143|FG002|Overall Study|Withdrawal by Subject|1|||
44201582|NCT02022007|78997141|FG000|Overall Study|Noncompliant|0|||
44201583|NCT02022007|78997142|FG001|Overall Study|Noncompliant|0|||
44201584|NCT02022007|78997143|FG002|Overall Study|Noncompliant|1|||
44201585|NCT02031679|78997153|FG000|Overall Study|Protocol Violation|0|||
44201586|NCT02031679|78997154|FG001|Overall Study|Protocol Violation|1|||
44201587|NCT02031679|78997153|FG000|Overall Study|Lack of Efficacy|0|||
44201588|NCT02031679|78997154|FG001|Overall Study|Lack of Efficacy|1|||
44201589|NCT02053753|78997162|FG000|Overall Study|Withdrawal by Subject|2|||
44201590|NCT02053753|78997163|FG001|Overall Study|Withdrawal by Subject|4|||
44201591|NCT02053753|78997162|FG000|Overall Study|Decision by Sponsor|1|||
44201592|NCT02053753|78997163|FG001|Overall Study|Decision by Sponsor|1|||
44201593|NCT02053753|78997162|FG000|Overall Study|Lost to Follow-up|4|||
44201594|NCT02053753|78997163|FG001|Overall Study|Lost to Follow-up|3|||
44201595|NCT02019979|78997169|FG000|Overall Study|study terminated|14|||
44201596|NCT02019667|78997173|FG000|First Intervention (6 Months)|Adverse Event|0|||
44268157|NCT02391948|79181809|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
44268158|NCT02391948|79181810|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
44268159|NCT02391948|79181811|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
44268160|NCT02391948|79181807|FG000|24-month Assessment|Death|0|||
44268161|NCT02391948|79181808|FG001|24-month Assessment|Death|0|||
44268162|NCT02391948|79181809|FG002|24-month Assessment|Death|0|||
44268163|NCT02391948|79181810|FG003|24-month Assessment|Death|0|||
44268164|NCT02391948|79181811|FG004|24-month Assessment|Death|1|||
44268165|NCT02391948|79181807|FG000|24-month Assessment|Withdrawal by Subject|1|||
44268166|NCT02391948|79181808|FG001|24-month Assessment|Withdrawal by Subject|1|||
44268167|NCT02391948|79181809|FG002|24-month Assessment|Withdrawal by Subject|0|||
44268168|NCT02391948|79181810|FG003|24-month Assessment|Withdrawal by Subject|0|||
44362137|NCT01098474|79367639|FG001|Active Phase|Other|0|||
44362138|NCT01098474|79367640|FG002|Active Phase|Other|3|||
44362139|NCT01098474|79367641|FG003|Active Phase|Other|0|||
44362140|NCT01098474|79367642|FG004|Active Phase|Other|0|||
44362141|NCT01098474|79367643|FG005|Active Phase|Other|0|||
44362142|NCT01098474|79367638|FG000|Active Phase|Withdrawal by Subject|1|||
44362143|NCT01098474|79367639|FG001|Active Phase|Withdrawal by Subject|1|||
44362144|NCT01098474|79367640|FG002|Active Phase|Withdrawal by Subject|2|||
44362145|NCT01098474|79367641|FG003|Active Phase|Withdrawal by Subject|0|||
44362146|NCT01098474|79367642|FG004|Active Phase|Withdrawal by Subject|0|||
44201597|NCT02019667|78997174|FG001|First Intervention (6 Months)|Adverse Event|1|||
44201598|NCT02019667|78997173|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
44201599|NCT02019667|78997174|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
44201600|NCT02019667|78997173|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
44201601|NCT02019667|78997174|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
44201602|NCT02030821|78997186|FG000|Overall Study|Physician Decision|2|||
44201603|NCT02030821|78997187|FG001|Overall Study|Physician Decision|2|||
44201604|NCT02030821|78997188|FG002|Overall Study|Physician Decision|5|||
44201605|NCT02030821|78997189|FG003|Overall Study|Physician Decision|2|||
44201606|NCT02052739|78997201|FG000|Overall Study|Withdrew due to Adverse Event|3|||
44201607|NCT02052739|78997202|FG001|Overall Study|Withdrew due to Adverse Event|0|||
44201608|NCT02052739|78997201|FG000|Overall Study|Participant Died|2|||
44201609|NCT02052739|78997202|FG001|Overall Study|Participant Died|1|||
44201610|NCT02019277|78997210|FG000|Overall Study|Withdrawal by Subject|3|||
44201611|NCT02019277|78997210|FG000|Overall Study|Death|7|||
44201612|NCT02019277|78997210|FG000|Overall Study|Did no Cooperate|1|||
44201613|NCT02019277|78997210|FG000|Overall Study|Adverse Event|1|||
44201614|NCT02030119|78997218|FG000|Overall Study|Withdrawal by Subject|3|||
44201615|NCT02030119|78997219|FG001|Overall Study|Withdrawal by Subject|1|||
44201616|NCT02030119|78997220|FG002|Overall Study|Withdrawal by Subject|5|||
44201617|NCT02030119|78997221|FG003|Overall Study|Withdrawal by Subject|3|||
44201618|NCT02030119|78997218|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
44201619|NCT02030119|78997219|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
44201620|NCT02030119|78997220|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
44201621|NCT02030119|78997221|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
44201622|NCT01823835|78997246|FG000|Overall Study|Adverse Event|0|||
44201623|NCT01823835|78997247|FG001|Overall Study|Adverse Event|0|||
44201624|NCT01823835|78997248|FG002|Overall Study|Adverse Event|0|||
44201625|NCT01823835|78997249|FG003|Overall Study|Adverse Event|0|||
44201626|NCT01823835|78997250|FG004|Overall Study|Adverse Event|1|||
44201627|NCT01823835|78997251|FG005|Overall Study|Adverse Event|0|||
44201628|NCT01823835|78997252|FG006|Overall Study|Adverse Event|1|||
44201629|NCT01823835|78997253|FG007|Overall Study|Adverse Event|0|||
44201630|NCT01823835|78997254|FG008|Overall Study|Adverse Event|0|||
44201631|NCT01823835|78997255|FG009|Overall Study|Adverse Event|0|||
44201632|NCT01823835|78997256|FG010|Overall Study|Adverse Event|1|||
44201633|NCT01823835|78997257|FG011|Overall Study|Adverse Event|2|||
44201634|NCT01823835|78997258|FG012|Overall Study|Adverse Event|0|||
44201635|NCT01823835|78997259|FG013|Overall Study|Adverse Event|0|||
44201636|NCT01823835|78997260|FG014|Overall Study|Adverse Event|0|||
44201637|NCT01823835|78997246|FG000|Overall Study|Physician Decision|0|||
44201638|NCT01823835|78997247|FG001|Overall Study|Physician Decision|0|||
44201639|NCT01823835|78997248|FG002|Overall Study|Physician Decision|0|||
44201640|NCT01823835|78997249|FG003|Overall Study|Physician Decision|0|||
44201641|NCT01823835|78997250|FG004|Overall Study|Physician Decision|0|||
44201642|NCT01823835|78997251|FG005|Overall Study|Physician Decision|0|||
44201643|NCT01823835|78997252|FG006|Overall Study|Physician Decision|0|||
44268169|NCT02391948|79181811|FG004|24-month Assessment|Withdrawal by Subject|1|||
44362147|NCT01098474|79367643|FG005|Active Phase|Withdrawal by Subject|0|||
44362148|NCT01098474|79367638|FG000|Active Phase|Lost to Follow-up|1|||
44268170|NCT02391948|79181807|FG000|24-month Assessment|Lost to Follow-up|5|||
44268171|NCT02391948|79181808|FG001|24-month Assessment|Lost to Follow-up|4|||
44268172|NCT02391948|79181809|FG002|24-month Assessment|Lost to Follow-up|0|||
44268173|NCT02391948|79181810|FG003|24-month Assessment|Lost to Follow-up|0|||
44268174|NCT02391948|79181811|FG004|24-month Assessment|Lost to Follow-up|0|||
44268175|NCT02391948|79181807|FG000|24-month Assessment|Medical issue/illness|0|||
44268176|NCT02391948|79181808|FG001|24-month Assessment|Medical issue/illness|0|||
44268177|NCT02391948|79181809|FG002|24-month Assessment|Medical issue/illness|1|||
44268178|NCT02391948|79181810|FG003|24-month Assessment|Medical issue/illness|0|||
44268179|NCT02391948|79181811|FG004|24-month Assessment|Medical issue/illness|0|||
44268180|NCT02391948|79181807|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
44268181|NCT02391948|79181808|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
44268182|NCT02391948|79181809|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
44362149|NCT01098474|79367639|FG001|Active Phase|Lost to Follow-up|0|||
44362150|NCT01098474|79367640|FG002|Active Phase|Lost to Follow-up|0|||
44201644|NCT01823835|78997253|FG007|Overall Study|Physician Decision|0|||
44201645|NCT01823835|78997254|FG008|Overall Study|Physician Decision|0|||
44201646|NCT01823835|78997255|FG009|Overall Study|Physician Decision|0|||
44268183|NCT02391948|79181810|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
44201647|NCT01823835|78997256|FG010|Overall Study|Physician Decision|0|||
44201648|NCT01823835|78997257|FG011|Overall Study|Physician Decision|2|||
44201649|NCT01823835|78997258|FG012|Overall Study|Physician Decision|0|||
44362151|NCT01098474|79367641|FG003|Active Phase|Lost to Follow-up|0|||
44362152|NCT01098474|79367642|FG004|Active Phase|Lost to Follow-up|0|||
44362153|NCT01098474|79367643|FG005|Active Phase|Lost to Follow-up|0|||
44362154|NCT01098474|79367638|FG000|Follow Up Phase|Travelled out of study area|0|||
44362155|NCT01098474|79367639|FG001|Follow Up Phase|Travelled out of study area|0|||
44362156|NCT01098474|79367640|FG002|Follow Up Phase|Travelled out of study area|0|||
44362157|NCT01098474|79367641|FG003|Follow Up Phase|Travelled out of study area|0|||
44362158|NCT01098474|79367642|FG004|Follow Up Phase|Travelled out of study area|1|||
44362159|NCT01098474|79367643|FG005|Follow Up Phase|Travelled out of study area|0|||
44362160|NCT01098474|79367638|FG000|Follow Up Phase|Other|0|||
44362161|NCT01098474|79367639|FG001|Follow Up Phase|Other|0|||
44362162|NCT01098474|79367640|FG002|Follow Up Phase|Other|0|||
44362163|NCT01098474|79367641|FG003|Follow Up Phase|Other|0|||
44362164|NCT01098474|79367642|FG004|Follow Up Phase|Other|0|||
44362165|NCT01098474|79367643|FG005|Follow Up Phase|Other|4|||
44362166|NCT01098474|79367638|FG000|Follow Up Phase|Withdrawal by Subject|0|||
44362167|NCT01098474|79367639|FG001|Follow Up Phase|Withdrawal by Subject|0|||
44362168|NCT01098474|79367640|FG002|Follow Up Phase|Withdrawal by Subject|0|||
44362169|NCT01098474|79367641|FG003|Follow Up Phase|Withdrawal by Subject|2|||
44362170|NCT01098474|79367642|FG004|Follow Up Phase|Withdrawal by Subject|0|||
44362171|NCT01098474|79367643|FG005|Follow Up Phase|Withdrawal by Subject|1|||
44362172|NCT01098474|79367638|FG000|Follow Up Phase|Lost to Follow-up|0|||
44362173|NCT01098474|79367639|FG001|Follow Up Phase|Lost to Follow-up|0|||
44362174|NCT01098474|79367640|FG002|Follow Up Phase|Lost to Follow-up|0|||
44362175|NCT01098474|79367641|FG003|Follow Up Phase|Lost to Follow-up|0|||
44362176|NCT01098474|79367642|FG004|Follow Up Phase|Lost to Follow-up|1|||
44362177|NCT01098474|79367643|FG005|Follow Up Phase|Lost to Follow-up|0|||
44362178|NCT00876733|79367671|FG000|Overall Study|Adverse Event|34|||
44201650|NCT01823835|78997259|FG013|Overall Study|Physician Decision|0|||
44201651|NCT01823835|78997260|FG014|Overall Study|Physician Decision|0|||
44201652|NCT01823835|78997246|FG000|Overall Study|Progressive Disease|3|||
44201653|NCT01823835|78997247|FG001|Overall Study|Progressive Disease|4|||
44201654|NCT01823835|78997248|FG002|Overall Study|Progressive Disease|3|||
44201655|NCT01823835|78997249|FG003|Overall Study|Progressive Disease|6|||
44201656|NCT01823835|78997250|FG004|Overall Study|Progressive Disease|4|||
44201657|NCT01823835|78997251|FG005|Overall Study|Progressive Disease|6|||
44201658|NCT01823835|78997252|FG006|Overall Study|Progressive Disease|5|||
44201659|NCT01823835|78997253|FG007|Overall Study|Progressive Disease|3|||
44201660|NCT01823835|78997254|FG008|Overall Study|Progressive Disease|3|||
44201661|NCT01823835|78997255|FG009|Overall Study|Progressive Disease|18|||
44201662|NCT01823835|78997256|FG010|Overall Study|Progressive Disease|8|||
44201663|NCT01823835|78997257|FG011|Overall Study|Progressive Disease|46|||
44201664|NCT01823835|78997258|FG012|Overall Study|Progressive Disease|18|||
44201665|NCT01823835|78997259|FG013|Overall Study|Progressive Disease|4|||
44201666|NCT01823835|78997260|FG014|Overall Study|Progressive Disease|6|||
44201667|NCT01823835|78997246|FG000|Overall Study|Study Termination|0|||
44201668|NCT01823835|78997247|FG001|Overall Study|Study Termination|0|||
44201669|NCT01823835|78997248|FG002|Overall Study|Study Termination|0|||
44268184|NCT02391948|79181811|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
44268185|NCT02369874|79182054|FG000|Overall Study|Lost to Follow-up|2|||
44268186|NCT02369874|79182055|FG001|Overall Study|Lost to Follow-up|2|||
44268187|NCT02369874|79182056|FG002|Overall Study|Lost to Follow-up|2|||
44268188|NCT02369874|79182054|FG000|Overall Study|Withdrawal by Subject|7|||
44268189|NCT02369874|79182055|FG001|Overall Study|Withdrawal by Subject|9|||
44268190|NCT02369874|79182056|FG002|Overall Study|Withdrawal by Subject|27|||
44268191|NCT02369874|79182054|FG000|Overall Study|Miscellaneous|1|||
44268192|NCT02369874|79182055|FG001|Overall Study|Miscellaneous|1|||
44268193|NCT02369874|79182056|FG002|Overall Study|Miscellaneous|0|||
44268194|NCT02369874|79182054|FG000|Overall Study|On Treatment/Off Study|34|||
44268195|NCT02369874|79182055|FG001|Overall Study|On Treatment/Off Study|45|||
44268196|NCT02369874|79182056|FG002|Overall Study|On Treatment/Off Study|32|||
44268197|NCT02368314|79182199|FG000|Overall Study|Withdrawal by Subject|2|||
44268198|NCT02368314|79182200|FG001|Overall Study|Withdrawal by Subject|1|||
44268199|NCT02368314|79182199|FG000|Overall Study|Adverse Event|1|||
44268200|NCT02368314|79182200|FG001|Overall Study|Adverse Event|2|||
44268201|NCT02366910|79182210|FG000|Overall Study|Withdrawal by Subject|2|||
44201670|NCT01823835|78997249|FG003|Overall Study|Study Termination|0|||
44268202|NCT02366910|79182210|FG000|Overall Study|Screen Failure|3|||
44268203|NCT05608629|79182321|FG000|Overall Study|Lost to Follow-up|2|||
44268204|NCT05180500|79182327|FG000|Overall Study|Adverse Event|1|||
44268205|NCT05180500|79182328|FG001|Overall Study|Adverse Event|0|||
44362179|NCT00876733|79367672|FG001|Overall Study|Adverse Event|20|||
44362180|NCT00876733|79367673|FG002|Overall Study|Adverse Event|10|||
44362181|NCT00876733|79367674|FG003|Overall Study|Adverse Event|3|||
44362182|NCT00876733|79367671|FG000|Overall Study|Lack of Efficacy|17|||
44362183|NCT00876733|79367672|FG001|Overall Study|Lack of Efficacy|9|||
44362184|NCT00876733|79367673|FG002|Overall Study|Lack of Efficacy|10|||
44362185|NCT00876733|79367674|FG003|Overall Study|Lack of Efficacy|1|||
44362186|NCT00876733|79367671|FG000|Overall Study|Lost to Follow-up|26|||
44362187|NCT00876733|79367672|FG001|Overall Study|Lost to Follow-up|10|||
44362188|NCT00876733|79367673|FG002|Overall Study|Lost to Follow-up|3|||
44362189|NCT00876733|79367674|FG003|Overall Study|Lost to Follow-up|2|||
44362190|NCT00876733|79367671|FG000|Overall Study|Data not available|14|||
44362191|NCT00876733|79367672|FG001|Overall Study|Data not available|3|||
44362192|NCT00876733|79367673|FG002|Overall Study|Data not available|7|||
44362193|NCT00876733|79367674|FG003|Overall Study|Data not available|1|||
44362194|NCT00875017|79367694|FG000|First Intervention|Withdrawal by Subject|1|||
44362195|NCT00875017|79367695|FG001|First Intervention|Withdrawal by Subject|0|||
44362196|NCT00875017|79367696|FG002|First Intervention|Withdrawal by Subject|1|||
44362197|NCT00875017|79367697|FG003|First Intervention|Withdrawal by Subject|0|||
44362198|NCT00875017|79367698|FG004|First Intervention|Withdrawal by Subject|0|||
44362199|NCT00875017|79367699|FG005|First Intervention|Withdrawal by Subject|0|||
44362200|NCT00875017|79367694|FG000|First Intervention|Adverse Event|0|||
44362201|NCT00875017|79367695|FG001|First Intervention|Adverse Event|0|||
44362202|NCT00875017|79367696|FG002|First Intervention|Adverse Event|0|||
44362203|NCT00875017|79367697|FG003|First Intervention|Adverse Event|1|||
44362204|NCT00875017|79367698|FG004|First Intervention|Adverse Event|0|||
44362205|NCT00875017|79367699|FG005|First Intervention|Adverse Event|0|||
44362206|NCT00875017|79367694|FG000|First Intervention|Problems collecting rectal effluent|1|||
44362207|NCT00875017|79367695|FG001|First Intervention|Problems collecting rectal effluent|0|||
44362208|NCT00875017|79367696|FG002|First Intervention|Problems collecting rectal effluent|0|||
44268206|NCT05180500|79182327|FG000|Overall Study|Withdrawal by Subject|2|||
44268207|NCT05180500|79182328|FG001|Overall Study|Withdrawal by Subject|0|||
44268208|NCT05001945|79182342|FG000|Overall Study|Adverse Event|0|||
44268209|NCT05001945|79182343|FG001|Overall Study|Adverse Event|0|||
44268210|NCT05001945|79182344|FG002|Overall Study|Adverse Event|0|||
44268211|NCT05001945|79182345|FG003|Overall Study|Adverse Event|1|||
44268212|NCT05001945|79182346|FG004|Overall Study|Adverse Event|0|||
44268213|NCT05001945|79182347|FG005|Overall Study|Adverse Event|0|||
44268214|NCT05001945|79182348|FG006|Overall Study|Adverse Event|0|||
44268215|NCT05001945|79182349|FG007|Overall Study|Adverse Event|0|||
44268216|NCT05001945|79182342|FG000|Overall Study|Lost to Follow-up|0|||
44268217|NCT05001945|79182343|FG001|Overall Study|Lost to Follow-up|1|||
44268218|NCT05001945|79182344|FG002|Overall Study|Lost to Follow-up|1|||
44268219|NCT05001945|79182345|FG003|Overall Study|Lost to Follow-up|2|||
44268220|NCT05001945|79182346|FG004|Overall Study|Lost to Follow-up|0|||
44268221|NCT05001945|79182347|FG005|Overall Study|Lost to Follow-up|1|||
44268222|NCT05001945|79182348|FG006|Overall Study|Lost to Follow-up|0|||
44268223|NCT05001945|79182349|FG007|Overall Study|Lost to Follow-up|0|||
44268224|NCT05001945|79182342|FG000|Overall Study|Protocol Violation|1|||
44268225|NCT05001945|79182343|FG001|Overall Study|Protocol Violation|0|||
44268226|NCT05001945|79182344|FG002|Overall Study|Protocol Violation|1|||
44268227|NCT05001945|79182345|FG003|Overall Study|Protocol Violation|1|||
44268228|NCT05001945|79182346|FG004|Overall Study|Protocol Violation|0|||
44268229|NCT05001945|79182347|FG005|Overall Study|Protocol Violation|1|||
44268230|NCT05001945|79182348|FG006|Overall Study|Protocol Violation|0|||
44268231|NCT05001945|79182349|FG007|Overall Study|Protocol Violation|0|||
44268232|NCT05001945|79182342|FG000|Overall Study|Withdrawal by Subject|0|||
44268233|NCT05001945|79182343|FG001|Overall Study|Withdrawal by Subject|0|||
44268234|NCT05001945|79182344|FG002|Overall Study|Withdrawal by Subject|0|||
44268235|NCT05001945|79182345|FG003|Overall Study|Withdrawal by Subject|1|||
44268236|NCT05001945|79182346|FG004|Overall Study|Withdrawal by Subject|1|||
44268237|NCT05001945|79182347|FG005|Overall Study|Withdrawal by Subject|1|||
44268238|NCT05001945|79182348|FG006|Overall Study|Withdrawal by Subject|0|||
44268239|NCT05001945|79182349|FG007|Overall Study|Withdrawal by Subject|1|||
44268240|NCT05001945|79182342|FG000|Overall Study|Not specified by Investigator|0|||
44268241|NCT05001945|79182343|FG001|Overall Study|Not specified by Investigator|3|||
44268242|NCT05001945|79182344|FG002|Overall Study|Not specified by Investigator|0|||
44268243|NCT05001945|79182345|FG003|Overall Study|Not specified by Investigator|0|||
44268244|NCT05001945|79182346|FG004|Overall Study|Not specified by Investigator|1|||
44268245|NCT05001945|79182347|FG005|Overall Study|Not specified by Investigator|0|||
44268246|NCT05001945|79182348|FG006|Overall Study|Not specified by Investigator|0|||
44268247|NCT05001945|79182349|FG007|Overall Study|Not specified by Investigator|0|||
44268248|NCT04955639|79182370|FG000|Overall Study|Withdrawal by Subject|2|||
44268249|NCT04955639|79182371|FG001|Overall Study|Withdrawal by Subject|2|||
44268250|NCT04955639|79182370|FG000|Overall Study|Week 26 survey not completed|2|||
44268251|NCT04955639|79182371|FG001|Overall Study|Week 26 survey not completed|2|||
44268252|NCT04919564|79182379|FG000|Overall Study|Lost to Follow-up|1|||
44268253|NCT04919564|79182380|FG001|Overall Study|Lost to Follow-up|0|||
44362209|NCT00875017|79367697|FG003|First Intervention|Problems collecting rectal effluent|0|||
44362210|NCT00875017|79367698|FG004|First Intervention|Problems collecting rectal effluent|0|||
44362211|NCT00875017|79367699|FG005|First Intervention|Problems collecting rectal effluent|0|||
44362212|NCT00875017|79367694|FG000|First Intervention|Intolerance to nasogastric tube|0|||
44362213|NCT00875017|79367695|FG001|First Intervention|Intolerance to nasogastric tube|0|||
44362214|NCT00875017|79367696|FG002|First Intervention|Intolerance to nasogastric tube|0|||
44362215|NCT00875017|79367697|FG003|First Intervention|Intolerance to nasogastric tube|0|||
44362216|NCT00875017|79367698|FG004|First Intervention|Intolerance to nasogastric tube|1|||
44362217|NCT00875017|79367699|FG005|First Intervention|Intolerance to nasogastric tube|0|||
44362218|NCT00875017|79367694|FG000|Washout|Problem collecting rectal effluent|0|||
44362219|NCT00875017|79367695|FG001|Washout|Problem collecting rectal effluent|0|||
44362220|NCT00875017|79367696|FG002|Washout|Problem collecting rectal effluent|1|||
44362221|NCT00875017|79367697|FG003|Washout|Problem collecting rectal effluent|0|||
44362222|NCT00875017|79367698|FG004|Washout|Problem collecting rectal effluent|0|||
44362223|NCT00875017|79367699|FG005|Washout|Problem collecting rectal effluent|0|||
44362224|NCT00875017|79367694|FG000|Second Intervention|Adverse Event|0|||
44362225|NCT00875017|79367695|FG001|Second Intervention|Adverse Event|0|||
44362226|NCT00875017|79367696|FG002|Second Intervention|Adverse Event|0|||
44362227|NCT00875017|79367697|FG003|Second Intervention|Adverse Event|1|||
44362228|NCT00875017|79367698|FG004|Second Intervention|Adverse Event|0|||
44362229|NCT00875017|79367699|FG005|Second Intervention|Adverse Event|0|||
44362230|NCT00875017|79367694|FG000|Washout|Problems collecting rectal effluent|0|||
44362231|NCT00875017|79367695|FG001|Washout|Problems collecting rectal effluent|1|||
44362232|NCT00875017|79367696|FG002|Washout|Problems collecting rectal effluent|0|||
44362233|NCT00875017|79367697|FG003|Washout|Problems collecting rectal effluent|0|||
44362234|NCT00875017|79367698|FG004|Washout|Problems collecting rectal effluent|0|||
44362235|NCT00875017|79367699|FG005|Washout|Problems collecting rectal effluent|0|||
44362236|NCT00875017|79367694|FG000|Third Intervention|Adverse Event|0|||
44362237|NCT00875017|79367695|FG001|Third Intervention|Adverse Event|1|||
44362238|NCT00875017|79367696|FG002|Third Intervention|Adverse Event|1|||
44362239|NCT00875017|79367697|FG003|Third Intervention|Adverse Event|0|||
44362240|NCT00875017|79367698|FG004|Third Intervention|Adverse Event|0|||
44362241|NCT00875017|79367699|FG005|Third Intervention|Adverse Event|0|||
44362242|NCT00875017|79367694|FG000|Washout|Withdrawal by Subject|0|||
44362243|NCT00875017|79367695|FG001|Washout|Withdrawal by Subject|0|||
44362244|NCT00875017|79367696|FG002|Washout|Withdrawal by Subject|0|||
44362245|NCT00875017|79367697|FG003|Washout|Withdrawal by Subject|0|||
44362246|NCT00875017|79367698|FG004|Washout|Withdrawal by Subject|1|||
44362247|NCT00875017|79367699|FG005|Washout|Withdrawal by Subject|0|||
44362248|NCT00875017|79367694|FG000|Fourth Intervention|Inability to comply with fasting|0|||
44362249|NCT00875017|79367695|FG001|Fourth Intervention|Inability to comply with fasting|0|||
44362250|NCT00875017|79367696|FG002|Fourth Intervention|Inability to comply with fasting|0|||
44362251|NCT00875017|79367697|FG003|Fourth Intervention|Inability to comply with fasting|0|||
44362252|NCT00875017|79367698|FG004|Fourth Intervention|Inability to comply with fasting|0|||
44362253|NCT00875017|79367699|FG005|Fourth Intervention|Inability to comply with fasting|1|||
44362254|NCT00875797|79367724|FG000|Overall Study|Protocol Violation|6|||
44362255|NCT00875797|79367725|FG001|Overall Study|Protocol Violation|3|||
44362256|NCT00874939|79367751|FG000|Overall Study|Study terminated|4|||
44362257|NCT00875563|79367761|FG000|Overall Study|Death|4|||
44362258|NCT00875563|79367761|FG000|Overall Study|Withdrawal by Subject|7|||
44362259|NCT00875563|79367761|FG000|Overall Study|No long-term (3-5 year) consent|6|||
44201671|NCT01823835|78997250|FG004|Overall Study|Study Termination|1|||
44201672|NCT01823835|78997251|FG005|Overall Study|Study Termination|0|||
44201673|NCT01823835|78997252|FG006|Overall Study|Study Termination|0|||
44201674|NCT01823835|78997253|FG007|Overall Study|Study Termination|0|||
44201675|NCT01823835|78997254|FG008|Overall Study|Study Termination|0|||
44201676|NCT01823835|78997255|FG009|Overall Study|Study Termination|0|||
44201677|NCT01823835|78997256|FG010|Overall Study|Study Termination|0|||
44201678|NCT01823835|78997257|FG011|Overall Study|Study Termination|1|||
44201679|NCT01823835|78997258|FG012|Overall Study|Study Termination|0|||
44201680|NCT01823835|78997259|FG013|Overall Study|Study Termination|0|||
44201681|NCT01823835|78997260|FG014|Overall Study|Study Termination|0|||
44201682|NCT01823835|78997246|FG000|Overall Study|Withdrawal by Subject|0|||
44201683|NCT01823835|78997247|FG001|Overall Study|Withdrawal by Subject|0|||
44201684|NCT01823835|78997248|FG002|Overall Study|Withdrawal by Subject|1|||
44201685|NCT01823835|78997249|FG003|Overall Study|Withdrawal by Subject|0|||
44201686|NCT01823835|78997250|FG004|Overall Study|Withdrawal by Subject|0|||
44201687|NCT01823835|78997251|FG005|Overall Study|Withdrawal by Subject|0|||
44201688|NCT01823835|78997252|FG006|Overall Study|Withdrawal by Subject|0|||
44201689|NCT01823835|78997253|FG007|Overall Study|Withdrawal by Subject|0|||
44362260|NCT00875563|79367761|FG000|Overall Study|Still be eligible for follow-up|7|||
44362261|NCT01155869|79367767|FG000|Overall Study|Lost to Follow-up|3|||
44362262|NCT01155869|79367768|FG001|Overall Study|Lost to Follow-up|1|||
44362263|NCT01185353|79367779|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
44362264|NCT01185353|79367780|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
44362265|NCT01185353|79367781|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
44362266|NCT01185353|79367782|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
44362267|NCT01185353|79367783|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
44362268|NCT01185353|79367784|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
44362269|NCT01185353|79367785|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
44362270|NCT01185353|79367786|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
44362271|NCT01185353|79367787|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
44362272|NCT01185353|79367788|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
44362273|NCT01185353|79367779|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362274|NCT01185353|79367780|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362275|NCT01185353|79367781|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362276|NCT01185353|79367782|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362277|NCT01185353|79367783|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
44362278|NCT01185353|79367784|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362279|NCT01185353|79367785|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362280|NCT01185353|79367786|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362281|NCT01185353|79367787|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362282|NCT01185353|79367788|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
44362283|NCT01185353|79367779|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
44362284|NCT01185353|79367780|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362285|NCT01185353|79367781|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362286|NCT01185353|79367782|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362287|NCT01185353|79367783|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
44362288|NCT01185353|79367784|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362289|NCT01185353|79367785|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362290|NCT01185353|79367786|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362291|NCT01185353|79367787|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362292|NCT01185353|79367788|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
44362293|NCT01185353|79367779|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362294|NCT01185353|79367780|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362295|NCT01185353|79367781|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
44362296|NCT01185353|79367782|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362297|NCT01185353|79367783|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
44362298|NCT01185353|79367784|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362299|NCT01185353|79367785|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362300|NCT01185353|79367786|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362301|NCT01185353|79367787|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362302|NCT01185353|79367788|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
44362303|NCT01185353|79367779|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362304|NCT01185353|79367780|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362305|NCT01185353|79367781|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362306|NCT01185353|79367782|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362307|NCT01185353|79367783|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
44362308|NCT01185353|79367784|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362309|NCT01185353|79367785|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362310|NCT01185353|79367786|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362311|NCT01185353|79367787|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44362312|NCT01185353|79367788|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
44451670|NCT00423670|79460530|FG003|Treatment Period|Investigator decision|0|||
44451671|NCT00423670|79460531|FG004|Treatment Period|Investigator decision|0|||
44451672|NCT00423670|79460532|FG005|Treatment Period|Investigator decision|0|||
44451673|NCT00423670|79460533|FG006|Treatment Period|Investigator decision|0|||
44451674|NCT00423670|79460534|FG007|Treatment Period|Investigator decision|1|||
44451675|NCT00423670|79460527|FG000|Treatment Period|Non-compliance with protocol|3|||
44268254|NCT04919564|79182379|FG000|Overall Study|Physician Decision|1|||
44268255|NCT04919564|79182380|FG001|Overall Study|Physician Decision|1|||
44268256|NCT04908800|79182399|FG000|Overall Study|Adverse Event|0|||
44451676|NCT00423670|79460528|FG001|Treatment Period|Non-compliance with protocol|1|||
44268257|NCT04908800|79182400|FG001|Overall Study|Adverse Event|0|||
44268258|NCT04908800|79182401|FG002|Overall Study|Adverse Event|0|||
44268259|NCT04908800|79182402|FG003|Overall Study|Adverse Event|0|||
44268260|NCT04908800|79182403|FG004|Overall Study|Adverse Event|0|||
44268261|NCT04908800|79182404|FG005|Overall Study|Adverse Event|0|||
44268262|NCT04908800|79182405|FG006|Overall Study|Adverse Event|0|||
44268263|NCT04908800|79182406|FG007|Overall Study|Adverse Event|0|||
44268264|NCT04908800|79182407|FG008|Overall Study|Adverse Event|0|||
44268265|NCT04908800|79182408|FG009|Overall Study|Adverse Event|0|||
44268266|NCT04908800|79182409|FG010|Overall Study|Adverse Event|1|||
44268267|NCT04908800|79182410|FG011|Overall Study|Adverse Event|0|||
44268268|NCT04908800|79182411|FG012|Overall Study|Adverse Event|0|||
44362313|NCT01185353|79367779|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
44362314|NCT01185353|79367780|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362315|NCT01185353|79367781|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44268269|NCT04889040|79182459|FG000|Overall Study|Withdrawal by Subject|3|||
44268270|NCT04889040|79182460|FG001|Overall Study|Withdrawal by Subject|3|||
44268271|NCT04889040|79182459|FG000|Overall Study|Lost to Follow-up|0|||
44362316|NCT01185353|79367782|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362317|NCT01185353|79367783|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
44362318|NCT01185353|79367784|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362319|NCT01185353|79367785|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362320|NCT01185353|79367786|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362321|NCT01185353|79367787|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362322|NCT01185353|79367788|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
44362323|NCT01185353|79367779|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362324|NCT01185353|79367780|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362325|NCT01185353|79367781|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
44362326|NCT01185353|79367782|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362327|NCT01185353|79367783|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362328|NCT01185353|79367784|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
44362329|NCT01185353|79367785|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362330|NCT01185353|79367786|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362331|NCT01185353|79367787|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362332|NCT01185353|79367788|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
44362333|NCT01185353|79367779|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362334|NCT01185353|79367780|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
44362335|NCT01185353|79367781|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362336|NCT01185353|79367782|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
44362337|NCT01185353|79367783|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362338|NCT01185353|79367784|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362339|NCT01185353|79367785|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362340|NCT01185353|79367786|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362341|NCT01185353|79367787|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362342|NCT01185353|79367788|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
44362343|NCT01185353|79367779|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362344|NCT01185353|79367780|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362345|NCT01185353|79367781|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362346|NCT01185353|79367782|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
44362347|NCT01185353|79367783|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362348|NCT01185353|79367784|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362349|NCT01185353|79367785|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
44362350|NCT01185353|79367786|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362351|NCT01185353|79367787|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362352|NCT01185353|79367788|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
44362353|NCT01185353|79367779|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
44362354|NCT01185353|79367780|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
44362355|NCT01185353|79367781|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
44362356|NCT01185353|79367782|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
44362357|NCT01185353|79367783|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
44362358|NCT01185353|79367784|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
44362359|NCT01185353|79367785|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
44268272|NCT04889040|79182460|FG001|Overall Study|Lost to Follow-up|1|||
44268273|NCT04889040|79182459|FG000|Overall Study|Adverse Event|2|||
44268274|NCT04889040|79182460|FG001|Overall Study|Adverse Event|1|||
44268275|NCT04794803|79182469|FG000|Overall Study|Death|1|||
44268276|NCT04794803|79182470|FG001|Overall Study|Death|3|||
44268277|NCT04794803|79182469|FG000|Overall Study|Lost to Follow-up|2|||
44268278|NCT04794803|79182470|FG001|Overall Study|Lost to Follow-up|2|||
44268279|NCT04794803|79182469|FG000|Overall Study|Withdrawal by Subject|1|||
44268280|NCT04794803|79182470|FG001|Overall Study|Withdrawal by Subject|0|||
44268281|NCT04794803|79182469|FG000|Overall Study|Physician Decision|1|||
44268282|NCT04794803|79182470|FG001|Overall Study|Physician Decision|1|||
44268283|NCT04794803|79182469|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
44268284|NCT04794803|79182470|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
44268285|NCT04794803|79182469|FG000|Overall Study|Refused to continue the treatment|1|||
44268286|NCT04794803|79182470|FG001|Overall Study|Refused to continue the treatment|0|||
44268287|NCT04794803|79182469|FG000|Overall Study|Patient admitted to ICU|0|||
44268288|NCT04794803|79182470|FG001|Overall Study|Patient admitted to ICU|1|||
44268289|NCT04676152|79182489|FG000|Overall Study|screen fail|9|||
44268290|NCT04546425|79182501|FG000|Overall Study|Protocol Violation|1|||
44268291|NCT04546425|79182502|FG001|Overall Study|Protocol Violation|1|||
44268292|NCT04546425|79182503|FG002|Overall Study|Protocol Violation|0|||
44268293|NCT04546425|79182504|FG003|Overall Study|Protocol Violation|0|||
44268294|NCT04546425|79182501|FG000|Overall Study|Adverse Event|3|||
44268295|NCT04546425|79182502|FG001|Overall Study|Adverse Event|0|||
44268296|NCT04546425|79182503|FG002|Overall Study|Adverse Event|0|||
44362360|NCT01185353|79367786|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
44362361|NCT01185353|79367787|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
44362362|NCT01185353|79367788|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
44362363|NCT01185353|79367779|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362364|NCT01185353|79367780|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362365|NCT01185353|79367781|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362366|NCT01185353|79367782|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362367|NCT01185353|79367783|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362368|NCT01185353|79367784|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362369|NCT01185353|79367785|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
44362370|NCT01185353|79367786|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44362371|NCT01185353|79367787|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44201690|NCT01823835|78997254|FG008|Overall Study|Withdrawal by Subject|0|||
44362372|NCT01185353|79367788|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
44201691|NCT01823835|78997255|FG009|Overall Study|Withdrawal by Subject|1|||
44201692|NCT01823835|78997256|FG010|Overall Study|Withdrawal by Subject|1|||
44201693|NCT01823835|78997257|FG011|Overall Study|Withdrawal by Subject|2|||
44201694|NCT01823835|78997258|FG012|Overall Study|Withdrawal by Subject|1|||
44201695|NCT01823835|78997259|FG013|Overall Study|Withdrawal by Subject|0|||
44201696|NCT01823835|78997260|FG014|Overall Study|Withdrawal by Subject|0|||
44201697|NCT01823679|78997300|FG000|Overall Study|Death|1|||
44201698|NCT01823289|78997305|FG000|Overall Study|Lost to Follow-up|5|||
44201699|NCT01823289|78997305|FG000|Overall Study|Adverse Event|5|||
44201700|NCT01823289|78997305|FG000|Overall Study|Lack of Efficacy|1|||
44201701|NCT01823289|78997305|FG000|Overall Study|Physician Decision|9|||
44201702|NCT01823289|78997305|FG000|Overall Study|Administered contraindicated medicine|1|||
44268297|NCT04546425|79182504|FG003|Overall Study|Adverse Event|0|||
44268298|NCT04546425|79182501|FG000|Overall Study|Lost to Follow-up|5|||
44268299|NCT04546425|79182502|FG001|Overall Study|Lost to Follow-up|4|||
44268300|NCT04546425|79182503|FG002|Overall Study|Lost to Follow-up|0|||
44268301|NCT04546425|79182504|FG003|Overall Study|Lost to Follow-up|0|||
44268302|NCT04546425|79182501|FG000|Overall Study|No Longer met eligibility criteria|3|||
44268303|NCT04546425|79182502|FG001|Overall Study|No Longer met eligibility criteria|3|||
44268304|NCT04546425|79182503|FG002|Overall Study|No Longer met eligibility criteria|1|||
44268305|NCT04546425|79182504|FG003|Overall Study|No Longer met eligibility criteria|1|||
44268306|NCT04546425|79182501|FG000|Overall Study|Withdrawal by parent/guardian|6|||
44268307|NCT04546425|79182502|FG001|Overall Study|Withdrawal by parent/guardian|5|||
44268308|NCT04546425|79182503|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44268309|NCT04546425|79182504|FG003|Overall Study|Withdrawal by parent/guardian|1|||
44268310|NCT04537949|79182522|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
44268311|NCT04537949|79182523|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
44268312|NCT04537949|79182524|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
44268313|NCT04537949|79182525|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
44268314|NCT04537949|79182526|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
44268315|NCT04537949|79182527|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
44268316|NCT04537949|79182528|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
44268317|NCT04537949|79182529|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
44268318|NCT04537949|79182522|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
44268319|NCT04537949|79182523|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
44268320|NCT04537949|79182524|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
44268321|NCT04537949|79182525|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
44268322|NCT04537949|79182526|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
44268323|NCT04537949|79182527|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
44268324|NCT04537949|79182528|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
44268325|NCT04537949|79182529|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
44268326|NCT04537949|79182522|FG000|Follow-up Phase|Lost to Follow-up|0|||
44268327|NCT04537949|79182523|FG001|Follow-up Phase|Lost to Follow-up|3|||
44268328|NCT04537949|79182524|FG002|Follow-up Phase|Lost to Follow-up|0|||
44268329|NCT04537949|79182525|FG003|Follow-up Phase|Lost to Follow-up|0|||
44268330|NCT04537949|79182526|FG004|Follow-up Phase|Lost to Follow-up|0|||
44268331|NCT04537949|79182527|FG005|Follow-up Phase|Lost to Follow-up|0|||
44268332|NCT04537949|79182528|FG006|Follow-up Phase|Lost to Follow-up|0|||
44268333|NCT04537949|79182529|FG007|Follow-up Phase|Lost to Follow-up|0|||
44268334|NCT04537949|79182522|FG000|Follow-up Phase|personal reasons|0|||
44268335|NCT04537949|79182523|FG001|Follow-up Phase|personal reasons|0|||
44268336|NCT04537949|79182524|FG002|Follow-up Phase|personal reasons|0|||
44268337|NCT04537949|79182525|FG003|Follow-up Phase|personal reasons|1|||
44201703|NCT01823289|78997305|FG000|Overall Study|Transaminase increased more than 3 times|1|||
44201704|NCT01823289|78997305|FG000|Overall Study|Drug affected efficacy and safety|1|||
44268338|NCT04537949|79182526|FG004|Follow-up Phase|personal reasons|1|||
44268339|NCT04537949|79182527|FG005|Follow-up Phase|personal reasons|0|||
44268340|NCT04537949|79182528|FG006|Follow-up Phase|personal reasons|0|||
44268341|NCT04537949|79182529|FG007|Follow-up Phase|personal reasons|0|||
44268342|NCT04537949|79182522|FG000|Follow-up Phase|Withdrawal by Subject|0|||
44268343|NCT04537949|79182523|FG001|Follow-up Phase|Withdrawal by Subject|0|||
44268344|NCT04537949|79182524|FG002|Follow-up Phase|Withdrawal by Subject|0|||
44362373|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44362374|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44362375|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44362376|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44451677|NCT00423670|79460529|FG002|Treatment Period|Non-compliance with protocol|1|||
44451678|NCT00423670|79460530|FG003|Treatment Period|Non-compliance with protocol|3|||
44451679|NCT00423670|79460531|FG004|Treatment Period|Non-compliance with protocol|2|||
44451680|NCT00423670|79460532|FG005|Treatment Period|Non-compliance with protocol|0|||
44362377|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44362378|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44362379|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
44451681|NCT00423670|79460533|FG006|Treatment Period|Non-compliance with protocol|2|||
44268345|NCT04537949|79182525|FG003|Follow-up Phase|Withdrawal by Subject|0|||
44268346|NCT04537949|79182526|FG004|Follow-up Phase|Withdrawal by Subject|1|||
44268347|NCT04537949|79182527|FG005|Follow-up Phase|Withdrawal by Subject|0|||
44268348|NCT04537949|79182528|FG006|Follow-up Phase|Withdrawal by Subject|0|||
44268349|NCT04537949|79182529|FG007|Follow-up Phase|Withdrawal by Subject|0|||
44268350|NCT04439201|79182547|FG000|Overall Study|Ineligible|2|||
44268351|NCT04439201|79182547|FG000|Overall Study|Never start protocol therapy|1|||
44268352|NCT04439201|79182547|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
44268353|NCT04439201|79182547|FG000|Overall Study|Mutation status not confirmed|4|||
44268354|NCT04439201|79182547|FG000|Overall Study|Adverse Event|1|||
44362380|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
44451682|NCT00423670|79460534|FG007|Treatment Period|Non-compliance with protocol|2|||
44451683|NCT00423670|79460527|FG000|Follow-up Period|Lost to Follow-up|0|||
44451684|NCT00423670|79460528|FG001|Follow-up Period|Lost to Follow-up|12|||
44451685|NCT00423670|79460529|FG002|Follow-up Period|Lost to Follow-up|8|||
44451686|NCT00423670|79460530|FG003|Follow-up Period|Lost to Follow-up|3|||
44451687|NCT00423670|79460531|FG004|Follow-up Period|Lost to Follow-up|1|||
44451688|NCT00423670|79460532|FG005|Follow-up Period|Lost to Follow-up|0|||
44451689|NCT00423670|79460533|FG006|Follow-up Period|Lost to Follow-up|5|||
44451690|NCT00423670|79460534|FG007|Follow-up Period|Lost to Follow-up|0|||
44451691|NCT00423670|79460527|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
44451692|NCT00423670|79460528|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
44451693|NCT00423670|79460529|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
44451694|NCT00423670|79460530|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
44451695|NCT00423670|79460531|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
44451696|NCT00423670|79460532|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
44451697|NCT00423670|79460533|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
44451698|NCT00423670|79460534|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
44268355|NCT04439201|79182547|FG000|Overall Study|Death|7|||
44268356|NCT04439201|79182547|FG000|Overall Study|Withdrawal by Subject|2|||
44362381|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
44362382|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
44362383|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362384|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362385|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362386|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362387|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362388|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362389|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
44362390|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
44201705|NCT01823289|78997305|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
44362391|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
44362392|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
44362393|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44451699|NCT00423670|79460527|FG000|Follow-up Period|Non-compliance with protocol|2|||
44451700|NCT00423670|79460528|FG001|Follow-up Period|Non-compliance with protocol|0|||
44451701|NCT00423670|79460529|FG002|Follow-up Period|Non-compliance with protocol|1|||
44451702|NCT00423670|79460530|FG003|Follow-up Period|Non-compliance with protocol|1|||
44201706|NCT01822899|78997311|FG000|Overall Study|Adverse Event|6|||
44201707|NCT01822899|78997312|FG001|Overall Study|Adverse Event|5|||
44201708|NCT01822899|78997311|FG000|Overall Study|Lack of Efficacy|6|||
44201709|NCT01822899|78997312|FG001|Overall Study|Lack of Efficacy|3|||
44201710|NCT01822899|78997311|FG000|Overall Study|Protocol Violation|6|||
44201711|NCT01822899|78997312|FG001|Overall Study|Protocol Violation|3|||
44201712|NCT01822899|78997311|FG000|Overall Study|Lost to Follow-up|1|||
44201713|NCT01822899|78997312|FG001|Overall Study|Lost to Follow-up|0|||
44201714|NCT01822899|78997311|FG000|Overall Study|Withdrawal by Subject|5|||
44201715|NCT01822899|78997312|FG001|Overall Study|Withdrawal by Subject|7|||
44201716|NCT01822821|78997320|FG000|Overall Study|Eligible surgery cancelled|1|||
44201717|NCT01822821|78997321|FG001|Overall Study|Eligible surgery cancelled|1|||
44201718|NCT01822821|78997320|FG000|Overall Study|Other reasons|1|||
44201719|NCT01822821|78997321|FG001|Overall Study|Other reasons|0|||
44201720|NCT01822665|78997327|FG000|Overall Study|Adverse Event|3|||
44201721|NCT01822665|78997327|FG000|Overall Study|Other Reason|5|||
44201722|NCT02173301|78997349|FG000|Overall Study|Adverse Event|7|||
44201723|NCT02173301|78997350|FG001|Overall Study|Adverse Event|8|||
44201724|NCT02173301|78997351|FG002|Overall Study|Adverse Event|13|||
44362394|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44362395|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44362396|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44362397|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44362398|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44362399|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
44362400|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
44362401|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
44362402|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
44362403|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362404|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362405|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362406|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362407|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44201725|NCT02173301|78997352|FG003|Overall Study|Adverse Event|5|||
44201726|NCT02173301|78997349|FG000|Overall Study|Withdrawal by Subject|8|||
44362408|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362409|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362410|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362411|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
44201727|NCT02173301|78997350|FG001|Overall Study|Withdrawal by Subject|10|||
44201728|NCT02173301|78997351|FG002|Overall Study|Withdrawal by Subject|4|||
44201729|NCT02173301|78997352|FG003|Overall Study|Withdrawal by Subject|8|||
44201730|NCT02173301|78997349|FG000|Overall Study|Lost to Follow-up|4|||
44201731|NCT02173301|78997350|FG001|Overall Study|Lost to Follow-up|4|||
44201732|NCT02173301|78997351|FG002|Overall Study|Lost to Follow-up|2|||
44201733|NCT02173301|78997352|FG003|Overall Study|Lost to Follow-up|2|||
44201734|NCT02173301|78997349|FG000|Overall Study|Protocol Violation|0|||
44201735|NCT02173301|78997350|FG001|Overall Study|Protocol Violation|1|||
44201736|NCT02173301|78997351|FG002|Overall Study|Protocol Violation|0|||
44201737|NCT02173301|78997352|FG003|Overall Study|Protocol Violation|0|||
44201738|NCT02173301|78997349|FG000|Overall Study|Physician Decision|0|||
44201739|NCT02173301|78997350|FG001|Overall Study|Physician Decision|0|||
44201740|NCT02173301|78997351|FG002|Overall Study|Physician Decision|1|||
44201741|NCT02173301|78997352|FG003|Overall Study|Physician Decision|0|||
44201742|NCT02173301|78997349|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
44201743|NCT02173301|78997350|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
44201744|NCT02173301|78997351|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
44201745|NCT02173301|78997352|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
44201746|NCT01822587|78997365|FG000|Overall Study|Lost to Follow-up|7|||
44201747|NCT01822587|78997366|FG001|Overall Study|Lost to Follow-up|9|||
44201748|NCT01822587|78997367|FG002|Overall Study|Lost to Follow-up|12|||
44201749|NCT01822587|78997365|FG000|Overall Study|Physician Decision|9|||
44201750|NCT01822587|78997366|FG001|Overall Study|Physician Decision|6|||
44201751|NCT01822587|78997367|FG002|Overall Study|Physician Decision|6|||
44201752|NCT01822353|78997378|FG000|Overall Study|Adverse Event|1|||
44201753|NCT01822353|78997379|FG001|Overall Study|Adverse Event|3|||
44201754|NCT01822353|78997380|FG002|Overall Study|Adverse Event|1|||
44201755|NCT01822353|78997378|FG000|Overall Study|Pregnancy|0|||
44201756|NCT01822353|78997379|FG001|Overall Study|Pregnancy|1|||
44201757|NCT01822353|78997380|FG002|Overall Study|Pregnancy|0|||
44201758|NCT01822353|78997378|FG000|Overall Study|Withdrawal by Subject|3|||
44362412|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
44362413|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Death|0|||
44362414|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Death|0|||
44362415|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Death|0|||
44362416|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Death|0|||
44362417|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Death|0|||
44362418|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Death|0|||
44362419|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Death|0|||
44362420|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Death|0|||
44362421|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Death|0|||
44362422|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Death|1|||
44362423|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362424|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362425|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362426|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362427|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362428|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362429|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362430|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362431|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
44362432|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
44362433|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362434|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44201759|NCT01822353|78997379|FG001|Overall Study|Withdrawal by Subject|1|||
44201760|NCT01822353|78997380|FG002|Overall Study|Withdrawal by Subject|0|||
44201761|NCT01821963|78997391|FG000|Overall Study|Adverse Event|1|||
44201762|NCT01821807|78997397|FG000|Overall Study|Lost to Follow-up|3|||
44201763|NCT01821807|78997398|FG001|Overall Study|Lost to Follow-up|1|||
44201764|NCT01821729|78997404|FG000|Overall Study|Withdrawal by Subject|1|||
44201765|NCT01820637|78997408|FG000|Overall Study|Death|2|||
44201766|NCT01820637|78997408|FG000|Overall Study|Withdrawal by Subject|1|||
44201767|NCT02172911|78997414|FG000|Overall Study|Serious Adverse Event|0|||
44201768|NCT02172911|78997415|FG001|Overall Study|Serious Adverse Event|1|||
44201769|NCT02172911|78997414|FG000|Overall Study|Progression of Disease|0|||
44201770|NCT02172911|78997415|FG001|Overall Study|Progression of Disease|1|||
44201771|NCT02172911|78997414|FG000|Overall Study|Loss of insurance coverage|1|||
44201772|NCT02172911|78997415|FG001|Overall Study|Loss of insurance coverage|0|||
44201773|NCT02120027|78997423|FG000|Overall Study|Adverse Event|4|||
44201774|NCT02120027|78997424|FG001|Overall Study|Adverse Event|5|||
44201775|NCT02120027|78997423|FG000|Overall Study|Lack of Efficacy|3|||
44201776|NCT02120027|78997424|FG001|Overall Study|Lack of Efficacy|5|||
44201777|NCT02120027|78997423|FG000|Overall Study|Lost to Follow-up|5|||
44201778|NCT02120027|78997424|FG001|Overall Study|Lost to Follow-up|13|||
44201779|NCT02120027|78997423|FG000|Overall Study|Other|4|||
44201780|NCT02120027|78997424|FG001|Overall Study|Other|0|||
44201781|NCT02120027|78997423|FG000|Overall Study|Physician Decision|4|||
44362435|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362436|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362437|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362438|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44201782|NCT02120027|78997424|FG001|Overall Study|Physician Decision|3|||
44362439|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362440|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362441|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
44362442|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
44362443|NCT01185353|79367779|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
44362444|NCT01185353|79367780|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
44362445|NCT01185353|79367781|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
44201783|NCT02120027|78997423|FG000|Overall Study|Protocol Violation|18|||
44201784|NCT02120027|78997424|FG001|Overall Study|Protocol Violation|21|||
44201785|NCT02120027|78997423|FG000|Overall Study|Study terminated by Sponsor|45|||
44201786|NCT02120027|78997424|FG001|Overall Study|Study terminated by Sponsor|47|||
44201787|NCT02120027|78997423|FG000|Overall Study|Withdrawal by Subject|33|||
44201788|NCT02120027|78997424|FG001|Overall Study|Withdrawal by Subject|25|||
44201789|NCT01850823|78997433|FG000|Overall Study|Early Visit Window|0|||
44201790|NCT01850823|78997434|FG001|Overall Study|Early Visit Window|1|||
44201791|NCT01850823|78997435|FG002|Overall Study|Early Visit Window|4|||
44201792|NCT01850823|78997433|FG000|Overall Study|Enrolled in Error|0|||
44201793|NCT01850823|78997434|FG001|Overall Study|Enrolled in Error|1|||
44201794|NCT01850823|78997435|FG002|Overall Study|Enrolled in Error|2|||
44201795|NCT01850823|78997433|FG000|Overall Study|Lack of Efficacy|1|||
44201796|NCT01850823|78997434|FG001|Overall Study|Lack of Efficacy|0|||
44268357|NCT04439201|79182547|FG000|Overall Study|Disease progression|20|||
44268358|NCT04439201|79182547|FG000|Overall Study|Alternative therapy|1|||
44268359|NCT04439201|79182547|FG000|Overall Study|Physician Decision|1|||
44268360|NCT04425902|79182551|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
44268361|NCT04421586|79182564|FG000|Overall Study|Death|0|||
44268362|NCT04421586|79182565|FG001|Overall Study|Death|1|||
44268363|NCT04421586|79182564|FG000|Overall Study|Lost to Follow-up|2|||
44268364|NCT04421586|79182565|FG001|Overall Study|Lost to Follow-up|2|||
44268365|NCT04421586|79182564|FG000|Overall Study|Withdrawn by PI|1|||
44268366|NCT04421586|79182565|FG001|Overall Study|Withdrawn by PI|0|||
44268367|NCT04421586|79182564|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
44268368|NCT04421586|79182565|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
44201797|NCT01850823|78997435|FG002|Overall Study|Lack of Efficacy|0|||
44201798|NCT01850823|78997433|FG000|Overall Study|Lost to Follow-up|0|||
44201799|NCT01850823|78997434|FG001|Overall Study|Lost to Follow-up|0|||
44201800|NCT01850823|78997435|FG002|Overall Study|Lost to Follow-up|1|||
44201801|NCT01850823|78997433|FG000|Overall Study|Restricted Medication|0|||
44268369|NCT04407234|79182573|FG000|Overall Study|Adverse Event|3|||
44268370|NCT04407234|79182574|FG001|Overall Study|Adverse Event|3|||
44268371|NCT04270747|79182592|FG000|Through Week 16|Adverse Event|1|||
44362446|NCT01185353|79367782|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
44201802|NCT01850823|78997434|FG001|Overall Study|Restricted Medication|0|||
44201803|NCT01850823|78997435|FG002|Overall Study|Restricted Medication|2|||
44201804|NCT01850823|78997433|FG000|Overall Study|Significant worstening of SAR|0|||
44201805|NCT01850823|78997434|FG001|Overall Study|Significant worstening of SAR|1|||
44201806|NCT01850823|78997435|FG002|Overall Study|Significant worstening of SAR|0|||
44201807|NCT01850823|78997433|FG000|Overall Study|Withdrawal by Subject|2|||
44201808|NCT01850823|78997434|FG001|Overall Study|Withdrawal by Subject|0|||
44201809|NCT01850823|78997435|FG002|Overall Study|Withdrawal by Subject|1|||
44201810|NCT01820559|78997448|FG000|Overall Study|Adverse Event|4|||
44201811|NCT01820559|78997449|FG001|Overall Study|Adverse Event|6|||
44201812|NCT01820559|78997450|FG002|Overall Study|Adverse Event|13|||
44201813|NCT01820559|78997448|FG000|Overall Study|Withdrawal by Subject|1|||
44201814|NCT01820559|78997449|FG001|Overall Study|Withdrawal by Subject|2|||
44201815|NCT01820559|78997450|FG002|Overall Study|Withdrawal by Subject|5|||
44201816|NCT01820559|78997448|FG000|Overall Study|Protocol Violation|2|||
44201817|NCT01820559|78997449|FG001|Overall Study|Protocol Violation|1|||
44201818|NCT01820559|78997450|FG002|Overall Study|Protocol Violation|3|||
44201819|NCT01820559|78997448|FG000|Overall Study|Subject's non-compliance|1|||
44201820|NCT01820559|78997449|FG001|Overall Study|Subject's non-compliance|0|||
44201821|NCT01820559|78997450|FG002|Overall Study|Subject's non-compliance|2|||
44201822|NCT01820559|78997448|FG000|Overall Study|Lost to Follow-up|3|||
44201823|NCT01820559|78997449|FG001|Overall Study|Lost to Follow-up|2|||
44201824|NCT01820559|78997450|FG002|Overall Study|Lost to Follow-up|2|||
44201825|NCT01820559|78997448|FG000|Overall Study|At sponsor request|0|||
44201826|NCT01820559|78997449|FG001|Overall Study|At sponsor request|0|||
44201827|NCT01820559|78997450|FG002|Overall Study|At sponsor request|1|||
44201828|NCT01820559|78997448|FG000|Overall Study|Lack of Efficacy|3|||
44201829|NCT01820559|78997449|FG001|Overall Study|Lack of Efficacy|2|||
44201830|NCT01820559|78997450|FG002|Overall Study|Lack of Efficacy|3|||
44201831|NCT01818765|78997458|FG000|Overall Study|Death|2|||
44201832|NCT01850589|78997465|FG000|Overall Study|Withdrawal by Subject|8|||
44201833|NCT01850589|78997466|FG001|Overall Study|Withdrawal by Subject|0|||
44201834|NCT01818531|78997474|FG000|Overall Study|Withdrawn for case delay after block|1|||
44201835|NCT01818531|78997475|FG001|Overall Study|Withdrawn for case delay after block|0|||
44201836|NCT01818531|78997474|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
44201837|NCT01818531|78997475|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
44201838|NCT01818531|78997474|FG000|Overall Study|Withdrawn for failure to place block|0|||
44201839|NCT01818531|78997475|FG001|Overall Study|Withdrawn for failure to place block|1|||
44201840|NCT02171429|78997484|FG000|Overall Study|Other|0|||
44201841|NCT02171429|78997485|FG001|Overall Study|Other|1|||
44201842|NCT02171429|78997486|FG002|Overall Study|Other|1|||
44201843|NCT02171429|78997484|FG000|Overall Study|Non-Compliance|0|||
44268372|NCT04270747|79182593|FG001|Through Week 16|Adverse Event|2|||
44268373|NCT04270747|79182594|FG002|Through Week 16|Adverse Event|0|||
44201844|NCT02171429|78997485|FG001|Overall Study|Non-Compliance|0|||
44201845|NCT02171429|78997486|FG002|Overall Study|Non-Compliance|1|||
44268374|NCT04270747|79182592|FG000|Through Week 16|Death|0|||
44201846|NCT02171429|78997484|FG000|Overall Study|Physician Decision|0|||
44201847|NCT02171429|78997485|FG001|Overall Study|Physician Decision|0|||
44201848|NCT02171429|78997486|FG002|Overall Study|Physician Decision|1|||
44201849|NCT02171429|78997484|FG000|Overall Study|Withdrawal by Subject|1|||
44201850|NCT02171429|78997485|FG001|Overall Study|Withdrawal by Subject|1|||
44451703|NCT00423670|79460531|FG004|Follow-up Period|Non-compliance with protocol|0|||
44451704|NCT00423670|79460532|FG005|Follow-up Period|Non-compliance with protocol|0|||
44451705|NCT00423670|79460533|FG006|Follow-up Period|Non-compliance with protocol|3|||
44451706|NCT00423670|79460534|FG007|Follow-up Period|Non-compliance with protocol|2|||
44451707|NCT00483717|79460557|FG000|Overall Study|Protocol Violation|5|||
44451708|NCT00483717|79460558|FG001|Overall Study|Protocol Violation|7|||
44451709|NCT00483717|79460557|FG000|Overall Study|Time of dosing missing|1|||
44451710|NCT00483717|79460558|FG001|Overall Study|Time of dosing missing|1|||
44451711|NCT00483717|79460557|FG000|Overall Study|No treatment for migraine|16|||
44451712|NCT00483717|79460558|FG001|Overall Study|No treatment for migraine|13|||
44451713|NCT00483717|79460557|FG000|Overall Study|Lost to Follow-up|1|||
44451714|NCT00483717|79460558|FG001|Overall Study|Lost to Follow-up|0|||
44451715|NCT00483717|79460557|FG000|Overall Study|Withdrawal by Subject|1|||
44451716|NCT00483717|79460558|FG001|Overall Study|Withdrawal by Subject|0|||
44451717|NCT00406354|79460567|FG000|All Randomized Patients|Protocol Violation|0|||
44451718|NCT00406354|79460568|FG001|All Randomized Patients|Protocol Violation|0|||
44451719|NCT00406354|79460569|FG002|All Randomized Patients|Protocol Violation|1|||
44451720|NCT00406354|79460567|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
44451721|NCT00406354|79460568|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
44451722|NCT00406354|79460569|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
44451723|NCT00406354|79460567|FG000|All Randomized and Treated Patients|Adverse Event|6|||
44451724|NCT00406354|79460568|FG001|All Randomized and Treated Patients|Adverse Event|2|||
44451725|NCT00406354|79460569|FG002|All Randomized and Treated Patients|Adverse Event|1|||
44451726|NCT00406354|79460567|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
44451727|NCT00406354|79460568|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
44451728|NCT00406354|79460569|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
44451729|NCT00406354|79460567|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
44451730|NCT00406354|79460568|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
44451731|NCT00406354|79460569|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
44451732|NCT00406354|79460567|FG000|All Randomized and Treated Patients|Physician Decision|0|||
44451733|NCT00406354|79460568|FG001|All Randomized and Treated Patients|Physician Decision|0|||
44451734|NCT00406354|79460569|FG002|All Randomized and Treated Patients|Physician Decision|1|||
44451735|NCT00483405|79460577|FG000|Overall Study|Adverse Event|8|||
44451736|NCT00483405|79460577|FG000|Overall Study|Lack of Efficacy|14|||
44451737|NCT00483405|79460577|FG000|Overall Study|Death|3|||
44451738|NCT00483405|79460577|FG000|Overall Study|Withdrawal by Subject|2|||
44451739|NCT00483405|79460577|FG000|Overall Study|Other complicating disease|1|||
44451740|NCT00483327|79460585|FG000|Overall Study|Adverse Event|1|||
44451741|NCT00483327|79460585|FG000|Overall Study|Withdrawal by Subject|3|||
44451742|NCT00483327|79460585|FG000|Overall Study|Lost to Follow-up|4|||
44451743|NCT00483327|79460585|FG000|Overall Study|Patient Non Compliance|2|||
44451744|NCT00684203|79460597|FG000|Overall Study|Adverse Event|6|||
44451745|NCT00684203|79460598|FG001|Overall Study|Adverse Event|4|||
44451746|NCT00684203|79460599|FG002|Overall Study|Adverse Event|8|||
44451747|NCT00684203|79460600|FG003|Overall Study|Adverse Event|0|||
44451748|NCT00684203|79460601|FG004|Overall Study|Adverse Event|0|||
44451749|NCT00684203|79460602|FG005|Overall Study|Adverse Event|0|||
44451750|NCT00684203|79460597|FG000|Overall Study|Protocol-defined clinical event|3|||
44451751|NCT00684203|79460598|FG001|Overall Study|Protocol-defined clinical event|1|||
44451752|NCT00684203|79460599|FG002|Overall Study|Protocol-defined clinical event|0|||
44451753|NCT00684203|79460600|FG003|Overall Study|Protocol-defined clinical event|0|||
44451754|NCT00684203|79460601|FG004|Overall Study|Protocol-defined clinical event|0|||
44451755|NCT00684203|79460602|FG005|Overall Study|Protocol-defined clinical event|0|||
44451756|NCT00684203|79460597|FG000|Overall Study|Withdrawal by Subject|0|||
44451757|NCT00684203|79460598|FG001|Overall Study|Withdrawal by Subject|2|||
44451758|NCT00684203|79460599|FG002|Overall Study|Withdrawal by Subject|1|||
44451759|NCT00684203|79460600|FG003|Overall Study|Withdrawal by Subject|0|||
44451760|NCT00684203|79460601|FG004|Overall Study|Withdrawal by Subject|0|||
44451761|NCT00684203|79460602|FG005|Overall Study|Withdrawal by Subject|0|||
44268375|NCT04270747|79182593|FG001|Through Week 16|Death|2|||
44268376|NCT04270747|79182594|FG002|Through Week 16|Death|0|||
44451762|NCT00684203|79460597|FG000|Overall Study|Did not meet protocol eligibility|0|||
44451763|NCT00684203|79460598|FG001|Overall Study|Did not meet protocol eligibility|1|||
44451764|NCT00684203|79460599|FG002|Overall Study|Did not meet protocol eligibility|0|||
44451765|NCT00684203|79460600|FG003|Overall Study|Did not meet protocol eligibility|0|||
44451766|NCT00684203|79460601|FG004|Overall Study|Did not meet protocol eligibility|0|||
44451767|NCT00684203|79460602|FG005|Overall Study|Did not meet protocol eligibility|0|||
44451768|NCT00423592|79460623|FG000|Overall Study|Adverse Event (through Week 12)|2|||
44451769|NCT00423592|79460623|FG000|Overall Study|Adverse Event (post Week 12)|5|||
44451770|NCT00683657|79460629|FG000|Overall Study|Adverse Event|0|||
44451771|NCT00683657|79460630|FG001|Overall Study|Adverse Event|1|||
44451772|NCT00683657|79460629|FG000|Overall Study|Subject Withdrew Consent|1|||
44451773|NCT00683657|79460630|FG001|Overall Study|Subject Withdrew Consent|0|||
44451774|NCT00680771|79460638|FG000|Overall Study|Withdrawal by Subject|1|||
44451775|NCT00680771|79460639|FG001|Overall Study|Withdrawal by Subject|0|||
44451776|NCT00680771|79460638|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
44451777|NCT00680771|79460639|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
44451778|NCT00680771|79460638|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
44451779|NCT00680771|79460639|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
44201851|NCT02171429|78997486|FG002|Overall Study|Withdrawal by Subject|1|||
44201852|NCT02171429|78997484|FG000|Overall Study|Lost to Follow-up|0|||
44201853|NCT02171429|78997485|FG001|Overall Study|Lost to Follow-up|1|||
44201854|NCT02171429|78997486|FG002|Overall Study|Lost to Follow-up|0|||
44201855|NCT02171429|78997484|FG000|Overall Study|Death|0|||
44201856|NCT02171429|78997485|FG001|Overall Study|Death|0|||
44201857|NCT02171429|78997486|FG002|Overall Study|Death|1|||
44201858|NCT01818297|78997499|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
44201859|NCT01818297|78997500|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
44201860|NCT01818297|78997499|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
44201861|NCT01818297|78997500|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
44201862|NCT01818297|78997499|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
44201863|NCT01818297|78997500|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
44201864|NCT01818141|78997508|FG000|Overall Study|Withdrawal by Subject|2|||
44201865|NCT01818141|78997509|FG001|Overall Study|Withdrawal by Subject|0|||
44201866|NCT01818141|78997508|FG000|Overall Study|No baseline C.diff colonies|1|||
44201867|NCT01818141|78997509|FG001|Overall Study|No baseline C.diff colonies|1|||
44201868|NCT01818141|78997508|FG000|Overall Study|Lost to Follow-up|0|||
44268377|NCT04270747|79182592|FG000|Through Week 16|Consent Withdrawn|3|||
44268378|NCT04270747|79182593|FG001|Through Week 16|Consent Withdrawn|3|||
44268379|NCT04270747|79182594|FG002|Through Week 16|Consent Withdrawn|0|||
44268380|NCT04270747|79182592|FG000|Through Week 16|Physician Decision|1|||
44268381|NCT04270747|79182593|FG001|Through Week 16|Physician Decision|1|||
44268382|NCT04270747|79182594|FG002|Through Week 16|Physician Decision|0|||
44268383|NCT04270747|79182592|FG000|Through Week 16|Lost to Follow-up|2|||
44268384|NCT04270747|79182593|FG001|Through Week 16|Lost to Follow-up|0|||
44268385|NCT04270747|79182594|FG002|Through Week 16|Lost to Follow-up|0|||
44268386|NCT04270747|79182592|FG000|Through Week 16|Protocol Violation|1|||
44268387|NCT04270747|79182593|FG001|Through Week 16|Protocol Violation|2|||
44268388|NCT04270747|79182594|FG002|Through Week 16|Protocol Violation|0|||
44268389|NCT04270747|79182592|FG000|Through Week 16|Protocol Specified Criteria|6|||
44268390|NCT04270747|79182593|FG001|Through Week 16|Protocol Specified Criteria|7|||
44451780|NCT00482703|79460647|FG000|Overall Study|Poor compliance|1|||
44451781|NCT00482703|79460648|FG001|Overall Study|Poor compliance|0|||
44451782|NCT00482391|79460661|FG000|Overall Study|Withdrawal by Subject|1|||
44451783|NCT00482391|79460661|FG000|Overall Study|Adverse Event|1|||
44201869|NCT01818141|78997509|FG001|Overall Study|Lost to Follow-up|2|||
44201870|NCT01849497|78997517|FG000|Overall Study|Withdrawal by Subject|1|||
44451784|NCT00482391|79460661|FG000|Overall Study|Death|1|||
44201871|NCT01849497|78997518|FG001|Overall Study|Withdrawal by Subject|2|||
44201872|NCT01849497|78997517|FG000|Overall Study|Sponsor Decision|0|||
44268391|NCT04270747|79182594|FG002|Through Week 16|Protocol Specified Criteria|0|||
44268392|NCT04270747|79182592|FG000|Through Week 16|Miscellaneous|1|||
44268393|NCT04270747|79182593|FG001|Through Week 16|Miscellaneous|1|||
44201873|NCT01849497|78997518|FG001|Overall Study|Sponsor Decision|1|||
44201874|NCT01849497|78997517|FG000|Overall Study|Lost to Follow-up|0|||
44201875|NCT01849497|78997518|FG001|Overall Study|Lost to Follow-up|1|||
44201876|NCT02147093|78997526|FG000|Period 1|Lost to Follow-up|0|||
44201877|NCT02147093|78997527|FG001|Period 1|Lost to Follow-up|1|||
44201878|NCT02147093|78997526|FG000|Period 2|Protocol Violation|2|||
44201879|NCT02147093|78997527|FG001|Period 2|Protocol Violation|0|||
44201880|NCT02119325|78997533|FG000|Washout Period 1|Adverse Event|0|||
44201881|NCT02119325|78997534|FG001|Washout Period 1|Adverse Event|1|||
44201882|NCT01816893|78997544|FG000|Washout Period|Withdrawal by Subject|2|||
44201883|NCT01816893|78997545|FG001|Washout Period|Withdrawal by Subject|0|||
44201884|NCT01848483|78997553|FG000|Overall Study|Death|2|||
44201885|NCT01848483|78997554|FG001|Overall Study|Death|1|||
44201886|NCT01848483|78997553|FG000|Overall Study|Lost to Follow-up|6|||
44201887|NCT01848483|78997554|FG001|Overall Study|Lost to Follow-up|8|||
44201888|NCT01848483|78997553|FG000|Overall Study|Withdrawal by Subject|1|||
44201889|NCT01848483|78997554|FG001|Overall Study|Withdrawal by Subject|0|||
44201890|NCT01848483|78997553|FG000|Overall Study|Incarceration|2|||
44201891|NCT01848483|78997554|FG001|Overall Study|Incarceration|2|||
44201892|NCT01610271|78997563|FG000|Overall Study|Surgery not complete|0|||
44201893|NCT01610271|78997564|FG001|Overall Study|Surgery not complete|1|||
44201894|NCT01610271|78997563|FG000|Overall Study|Prosthesis not implanted|2|||
44201895|NCT01610271|78997564|FG001|Overall Study|Prosthesis not implanted|3|||
44201896|NCT02170727|78997574|FG000|Overall Study|Lost to Follow-up|1|||
44201897|NCT02170727|78997575|FG001|Overall Study|Lost to Follow-up|0|||
44201898|NCT02170727|78997574|FG000|Overall Study|Withdrawal by Subject|2|||
44201899|NCT02170727|78997575|FG001|Overall Study|Withdrawal by Subject|0|||
44201900|NCT01847313|78997586|FG000|Overall Study|Death|0|||
44201901|NCT01847313|78997587|FG001|Overall Study|Death|1|||
44201902|NCT01847313|78997586|FG000|Overall Study|Withdrawal by Subject|0|||
44201903|NCT01847313|78997587|FG001|Overall Study|Withdrawal by Subject|1|||
44201904|NCT02144285|78997603|FG000|Overall Study|Withdrawal by Subject|0|||
44201905|NCT02144285|78997604|FG001|Overall Study|Withdrawal by Subject|0|||
44201906|NCT02144285|78997605|FG002|Overall Study|Withdrawal by Subject|0|||
44201907|NCT02144285|78997606|FG003|Overall Study|Withdrawal by Subject|0|||
44201908|NCT02144285|78997607|FG004|Overall Study|Withdrawal by Subject|1|||
44201909|NCT02144285|78997608|FG005|Overall Study|Withdrawal by Subject|0|||
44201910|NCT02144285|78997609|FG006|Overall Study|Withdrawal by Subject|0|||
44451785|NCT00423046|79460668|FG000|Overall Study|Other|340|||
44451786|NCT00423046|79460669|FG001|Overall Study|Other|345|||
44451787|NCT00496587|79460677|FG000|Overall Study|Adverse Event|2|||
44451788|NCT00496587|79460677|FG000|Overall Study|Progressive Disease|24|||
44451789|NCT00496587|79460677|FG000|Overall Study|Withdrawal by Subject|2|||
44451790|NCT00496587|79460677|FG000|Overall Study|Death|1|||
44451791|NCT00496587|79460677|FG000|Overall Study|Complications unrelated|2|||
44451792|NCT00405652|79460681|FG000|Overall Study|Adverse Event|4|||
44451793|NCT00422734|79460687|FG000|Overall Study|Physician Decision|1|||
44451794|NCT00422734|79460688|FG001|Overall Study|Physician Decision|1|||
44451795|NCT00422734|79460687|FG000|Overall Study|Protocol Violation|1|||
44451796|NCT00422734|79460688|FG001|Overall Study|Protocol Violation|6|||
44451797|NCT00422734|79460687|FG000|Overall Study|Withdrawal by Subject|12|||
44451798|NCT00422734|79460688|FG001|Overall Study|Withdrawal by Subject|8|||
44451799|NCT00422734|79460687|FG000|Overall Study|Adverse Event|0|||
44451800|NCT00422734|79460688|FG001|Overall Study|Adverse Event|3|||
44451801|NCT00422734|79460687|FG000|Overall Study|Partner Decision|0|||
44451802|NCT00422734|79460688|FG001|Overall Study|Partner Decision|3|||
44268394|NCT04270747|79182594|FG002|Through Week 16|Miscellaneous|0|||
44268395|NCT04270747|79182592|FG000|Post Week 16|Adverse Event|7|||
44268396|NCT04270747|79182593|FG001|Post Week 16|Adverse Event|5|||
44268397|NCT04270747|79182594|FG002|Post Week 16|Adverse Event|1|||
44268398|NCT04270747|79182592|FG000|Post Week 16|Death|2|||
44268399|NCT04270747|79182593|FG001|Post Week 16|Death|0|||
44451803|NCT00422422|79460694|FG000|Overall Study|Lack of Efficacy|1|||
44201911|NCT02144285|78997610|FG007|Overall Study|Withdrawal by Subject|0|||
44201912|NCT02144285|78997611|FG008|Overall Study|Withdrawal by Subject|0|||
44201913|NCT02144285|78997612|FG009|Overall Study|Withdrawal by Subject|0|||
44201914|NCT02117687|78997650|FG000|Overall Study|Lost to Follow-up|0|||
44201915|NCT02117687|78997651|FG001|Overall Study|Lost to Follow-up|1|||
44451804|NCT00422422|79460694|FG000|Overall Study|Protocol Violation|1|||
44201916|NCT02117687|78997650|FG000|Overall Study|Adverse Event|0|||
44201917|NCT02117687|78997651|FG001|Overall Study|Adverse Event|2|||
44201918|NCT02117687|78997650|FG000|Overall Study|Other Reasons|1|||
44201919|NCT02117687|78997651|FG001|Overall Study|Other Reasons|1|||
44451805|NCT00422422|79460694|FG000|Overall Study|Withdrawal by Subject|2|||
44451806|NCT00422422|79460694|FG000|Overall Study|SAE, non-fatal|1|||
44201920|NCT02143583|78997660|FG000|Overall Study|Withdrawal by Subject|1|||
44201921|NCT02143583|78997661|FG001|Overall Study|Withdrawal by Subject|0|||
44201922|NCT02143583|78997662|FG002|Overall Study|Withdrawal by Subject|1|||
44268400|NCT04270747|79182594|FG002|Post Week 16|Death|2|||
44268401|NCT04270747|79182592|FG000|Post Week 16|Consent Withdrawn|4|||
44451807|NCT00422422|79460694|FG000|Overall Study|AE, non-serious non-fatal|5|||
44451808|NCT00413374|79460702|FG000|Overall Study|Ineligible due to screening criteria.|3|||
44451809|NCT00413374|79460703|FG001|Overall Study|Ineligible due to screening criteria.|0|||
44451810|NCT00413374|79460702|FG000|Overall Study|Adverse Event|1|||
44451811|NCT00413374|79460703|FG001|Overall Study|Adverse Event|0|||
44451812|NCT00413374|79460702|FG000|Overall Study|Lost to Follow-up|1|||
44201923|NCT02143583|78997660|FG000|Overall Study|husband illness|0|||
44201924|NCT02143583|78997661|FG001|Overall Study|husband illness|0|||
44201925|NCT02143583|78997662|FG002|Overall Study|husband illness|1|||
44201926|NCT02105987|78997672|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
44201927|NCT02105987|78997673|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
44201928|NCT02105987|78997674|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
44201929|NCT02105987|78997675|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
44201930|NCT02105987|78997676|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
44201931|NCT02105987|78997677|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
44201932|NCT02105987|78997672|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
44201933|NCT02105987|78997673|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
44201934|NCT02105987|78997674|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
44201935|NCT02105987|78997675|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
44201936|NCT02105987|78997676|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
44201937|NCT02105987|78997677|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
44201938|NCT02105987|78997672|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
44451813|NCT00413374|79460703|FG001|Overall Study|Lost to Follow-up|0|||
44451814|NCT00413374|79460702|FG000|Overall Study|Surgery|1|||
44451815|NCT00413374|79460703|FG001|Overall Study|Surgery|0|||
44451816|NCT00682643|79460714|FG000|Overall Study|Adverse Event|12|||
44451817|NCT00682643|79460715|FG001|Overall Study|Adverse Event|23|||
44451818|NCT00682643|79460714|FG000|Overall Study|Lack of Efficacy|2|||
44451819|NCT00682643|79460715|FG001|Overall Study|Lack of Efficacy|0|||
44451820|NCT00682643|79460714|FG000|Overall Study|Protocol Violation|38|||
44451821|NCT00682643|79460715|FG001|Overall Study|Protocol Violation|76|||
44201939|NCT02105987|78997673|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
44201940|NCT02105987|78997674|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201941|NCT02105987|78997675|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201942|NCT02105987|78997676|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201943|NCT02105987|78997677|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201944|NCT02105987|78997672|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
44201945|NCT02105987|78997673|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
44451822|NCT00682643|79460714|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
44451823|NCT00682643|79460715|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
44451824|NCT00682643|79460714|FG000|Overall Study|Lost to Follow-up|1|||
44451825|NCT00682643|79460715|FG001|Overall Study|Lost to Follow-up|6|||
44451826|NCT00682643|79460714|FG000|Overall Study|Physician Decision|2|||
44451827|NCT00682643|79460715|FG001|Overall Study|Physician Decision|6|||
44451828|NCT00682643|79460714|FG000|Overall Study|Withdrawal by Subject|19|||
44201946|NCT02105987|78997674|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201947|NCT02105987|78997675|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201948|NCT02105987|78997676|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201949|NCT02105987|78997677|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201950|NCT02105987|78997672|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
44201951|NCT02105987|78997673|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
44201952|NCT02105987|78997674|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
44201953|NCT02105987|78997675|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
44201954|NCT02105987|78997676|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
44268402|NCT04270747|79182593|FG001|Post Week 16|Consent Withdrawn|3|||
44268403|NCT04270747|79182594|FG002|Post Week 16|Consent Withdrawn|6|||
44268404|NCT04270747|79182592|FG000|Post Week 16|Physician Decision|3|||
44268405|NCT04270747|79182593|FG001|Post Week 16|Physician Decision|1|||
44268406|NCT04270747|79182594|FG002|Post Week 16|Physician Decision|1|||
44268407|NCT04270747|79182592|FG000|Post Week 16|Lost to Follow-up|2|||
44268408|NCT04270747|79182593|FG001|Post Week 16|Lost to Follow-up|1|||
44268409|NCT04270747|79182594|FG002|Post Week 16|Lost to Follow-up|0|||
44362447|NCT01185353|79367783|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
44362448|NCT01185353|79367784|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
44362449|NCT01185353|79367785|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
44362450|NCT01185353|79367786|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
44362451|NCT01185353|79367787|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
44451829|NCT00682643|79460715|FG001|Overall Study|Withdrawal by Subject|53|||
44451830|NCT00682643|79460714|FG000|Overall Study|Did Not Receive Study Drug|1|||
44268410|NCT04270747|79182592|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
44362452|NCT01185353|79367788|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
44451831|NCT00682643|79460715|FG001|Overall Study|Did Not Receive Study Drug|1|||
44451832|NCT00421408|79460724|FG000|Overall Study|Lost to Follow-up|30|||
44451833|NCT00421408|79460725|FG001|Overall Study|Lost to Follow-up|20|||
44451834|NCT00421408|79460724|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
44451835|NCT00421408|79460725|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
44451836|NCT00679913|79460733|FG000|Overall Study|Protocol Violation|18|||
44451837|NCT00679913|79460734|FG001|Overall Study|Protocol Violation|13|||
44451838|NCT00482001|79460743|FG000|Overall Study|Protocol Violation|1|||
44451839|NCT00482001|79460744|FG001|Overall Study|Protocol Violation|1|||
44451840|NCT00490035|79460756|FG000|Overall Study|AE, non-serious non-fatal|3|||
44451841|NCT00490035|79460757|FG001|Overall Study|AE, non-serious non-fatal|4|||
44451842|NCT00490035|79460758|FG002|Overall Study|AE, non-serious non-fatal|4|||
44451843|NCT00490035|79460759|FG003|Overall Study|AE, non-serious non-fatal|5|||
44451844|NCT00490035|79460756|FG000|Overall Study|Lost to Follow-up|2|||
44451845|NCT00490035|79460757|FG001|Overall Study|Lost to Follow-up|0|||
44451846|NCT00490035|79460758|FG002|Overall Study|Lost to Follow-up|1|||
44451847|NCT00490035|79460759|FG003|Overall Study|Lost to Follow-up|0|||
44451848|NCT00490035|79460756|FG000|Overall Study|Withdrawal by Subject|2|||
44451849|NCT00490035|79460757|FG001|Overall Study|Withdrawal by Subject|1|||
44451850|NCT00490035|79460758|FG002|Overall Study|Withdrawal by Subject|1|||
44451851|NCT00490035|79460759|FG003|Overall Study|Withdrawal by Subject|0|||
44451852|NCT00490035|79460756|FG000|Overall Study|Other reason|0|||
44201955|NCT02105987|78997677|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
44201956|NCT02105987|78997672|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
44201957|NCT02105987|78997673|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
44201958|NCT02105987|78997674|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
44201959|NCT02105987|78997675|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
44201960|NCT02105987|78997676|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
44201961|NCT02105987|78997677|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
44201962|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
44201963|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
44201964|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
44201965|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
44201966|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
44201967|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
44201968|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
44201969|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
44201970|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
44201971|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
44201972|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
44201973|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
44201974|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201975|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201976|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
44362453|NCT01185353|79367779|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44451853|NCT00490035|79460757|FG001|Overall Study|Other reason|1|||
44451854|NCT00490035|79460758|FG002|Overall Study|Other reason|3|||
44451855|NCT00490035|79460759|FG003|Overall Study|Other reason|1|||
44451856|NCT00490035|79460756|FG000|Overall Study|AE, serious fatal|1|||
44201977|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
44201978|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44268411|NCT04270747|79182593|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
44268412|NCT04270747|79182594|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
44362454|NCT01185353|79367780|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44451857|NCT00490035|79460757|FG001|Overall Study|AE, serious fatal|0|||
44451858|NCT00490035|79460758|FG002|Overall Study|AE, serious fatal|0|||
44268413|NCT04270747|79182592|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
44268414|NCT04270747|79182593|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
44268415|NCT04270747|79182594|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
44362455|NCT01185353|79367781|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44362456|NCT01185353|79367782|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44362457|NCT01185353|79367783|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44362458|NCT01185353|79367784|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44362459|NCT01185353|79367785|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44362460|NCT01185353|79367786|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
44362461|NCT01185353|79367787|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
44362462|NCT01185353|79367788|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
44362463|NCT01185353|79367779|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362464|NCT01185353|79367780|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362465|NCT01185353|79367781|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362466|NCT01185353|79367782|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362467|NCT01185353|79367783|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362468|NCT01185353|79367784|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362469|NCT01185353|79367785|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
44362470|NCT01185353|79367786|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
44362471|NCT01185353|79367787|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
44362472|NCT01185353|79367788|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
44362473|NCT01185353|79367779|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362474|NCT01185353|79367780|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362475|NCT01185353|79367781|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44451859|NCT00490035|79460759|FG003|Overall Study|AE, serious fatal|0|||
44451860|NCT00490035|79460756|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
44451861|NCT00490035|79460757|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
44451862|NCT00490035|79460758|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
44451863|NCT00490035|79460759|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
44451864|NCT00490035|79460756|FG000|Overall Study|AE of unknown type|0|||
44451865|NCT00490035|79460757|FG001|Overall Study|AE of unknown type|0|||
44451866|NCT00490035|79460758|FG002|Overall Study|AE of unknown type|2|||
44451867|NCT00490035|79460759|FG003|Overall Study|AE of unknown type|0|||
44362476|NCT01185353|79367782|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362477|NCT01185353|79367783|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362478|NCT01185353|79367784|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362479|NCT01185353|79367785|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362480|NCT01185353|79367786|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
44362481|NCT01185353|79367787|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
44362482|NCT01185353|79367788|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
44362483|NCT01098240|79367827|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
44451868|NCT00404248|79460772|FG000|Overall Study|pts declining status|0|||
44451869|NCT00404248|79460773|FG001|Overall Study|pts declining status|1|||
44451870|NCT00404248|79460774|FG002|Overall Study|pts declining status|0|||
44451871|NCT00404248|79460775|FG003|Overall Study|pts declining status|0|||
44451872|NCT00404248|79460776|FG004|Overall Study|pts declining status|0|||
44451873|NCT00404248|79460777|FG005|Overall Study|pts declining status|0|||
44451874|NCT00404248|79460778|FG006|Overall Study|pts declining status|0|||
44451875|NCT00404248|79460779|FG007|Overall Study|pts declining status|0|||
44451876|NCT00404248|79460780|FG008|Overall Study|pts declining status|0|||
44451877|NCT00421174|79460808|FG000|Overall Study|Withdrawal by Subject|0|||
44451878|NCT00421174|79460809|FG001|Overall Study|Withdrawal by Subject|1|||
44362484|NCT01098240|79367828|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
44362485|NCT01098240|79367829|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
44362486|NCT01098240|79367827|FG000|Open-Label Phase|Protocol Violation|4|||
44362487|NCT01098240|79367828|FG001|Open-Label Phase|Protocol Violation|0|||
44362488|NCT01098240|79367829|FG002|Open-Label Phase|Protocol Violation|0|||
44362489|NCT01098240|79367827|FG000|Open-Label Phase|Lost to Follow-up|13|||
44362490|NCT01098240|79367828|FG001|Open-Label Phase|Lost to Follow-up|0|||
44362491|NCT01098240|79367829|FG002|Open-Label Phase|Lost to Follow-up|0|||
44362492|NCT01098240|79367827|FG000|Open-Label Phase|Other|19|||
44362493|NCT01098240|79367828|FG001|Open-Label Phase|Other|0|||
44362494|NCT01098240|79367829|FG002|Open-Label Phase|Other|0|||
44362495|NCT01098240|79367827|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
44362496|NCT01098240|79367828|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
44362497|NCT01098240|79367829|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
44362498|NCT01098240|79367827|FG000|Open-Label Phase|Pregnancy|1|||
44362499|NCT01098240|79367828|FG001|Open-Label Phase|Pregnancy|0|||
44362500|NCT01098240|79367829|FG002|Open-Label Phase|Pregnancy|0|||
44362501|NCT01098240|79367827|FG000|Open-Label Phase|Withdrawal by Subject|9|||
44362502|NCT01098240|79367828|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44362503|NCT01098240|79367829|FG002|Open-Label Phase|Withdrawal by Subject|0|||
44362504|NCT01098240|79367827|FG000|Open-Label Phase|Adverse Event|12|||
44362505|NCT01098240|79367828|FG001|Open-Label Phase|Adverse Event|0|||
44362506|NCT01098240|79367829|FG002|Open-Label Phase|Adverse Event|0|||
44451879|NCT00421174|79460808|FG000|Overall Study|Ineligible due to infection|2|||
44451880|NCT00421174|79460809|FG001|Overall Study|Ineligible due to infection|0|||
44451881|NCT00496197|79460815|FG000|Overall Study|Discontinued study due to death|43|||
44362507|NCT01098240|79367827|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
44451882|NCT00496197|79460815|FG000|Overall Study|Adverse Event|13|||
44451883|NCT00496197|79460815|FG000|Overall Study|Does not meet entrance criteria|5|||
44451884|NCT00496197|79460815|FG000|Overall Study|Insufficient clinical response|3|||
44362508|NCT01098240|79367828|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
44362509|NCT01098240|79367829|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
44362510|NCT01098240|79367827|FG000|Double-Blind Phase|Protocol Violation|0|||
44362511|NCT01098240|79367828|FG001|Double-Blind Phase|Protocol Violation|2|||
44362512|NCT01098240|79367829|FG002|Double-Blind Phase|Protocol Violation|4|||
44362513|NCT01098240|79367827|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44362514|NCT01098240|79367828|FG001|Double-Blind Phase|Lost to Follow-up|2|||
44362515|NCT01098240|79367829|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44362516|NCT01098240|79367827|FG000|Double-Blind Phase|Other|0|||
44451885|NCT00496197|79460815|FG000|Overall Study|Insufficient bacteriological response|10|||
44451886|NCT00496197|79460815|FG000|Overall Study|Lost to Follow-up|11|||
44451887|NCT00496197|79460815|FG000|Overall Study|Withdrawal by Subject|11|||
44451888|NCT00496197|79460815|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
44451889|NCT00496197|79460815|FG000|Overall Study|Other|14|||
44362517|NCT01098240|79367828|FG001|Double-Blind Phase|Other|2|||
44362518|NCT01098240|79367829|FG002|Double-Blind Phase|Other|2|||
44362519|NCT01098240|79367827|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
44362520|NCT01098240|79367828|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
44362521|NCT01098240|79367829|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
44362522|NCT01098240|79367827|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
44362523|NCT01098240|79367828|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
44362524|NCT01098240|79367829|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
44362525|NCT01098240|79367827|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
44362526|NCT01098240|79367828|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
44362527|NCT01098240|79367829|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
44362528|NCT01098240|79367827|FG000|Double-Blind Phase|Adverse Event|0|||
44362529|NCT01098240|79367828|FG001|Double-Blind Phase|Adverse Event|3|||
44362530|NCT01098240|79367829|FG002|Double-Blind Phase|Adverse Event|3|||
44362531|NCT01098162|79367836|FG000|Overall Study|Adverse Event|37|||
44362532|NCT01098162|79367836|FG000|Overall Study|Lack of Efficacy|4|||
44362533|NCT01098162|79367836|FG000|Overall Study|Wish of Patient|7|||
44362534|NCT01098162|79367836|FG000|Overall Study|Lost to Follow-up|9|||
44362535|NCT01098162|79367836|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
44362536|NCT01098162|79367836|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
44362537|NCT01098162|79367836|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
44362538|NCT01098162|79367836|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
44362539|NCT01098162|79367836|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
44362540|NCT01098162|79367836|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
44362541|NCT01098162|79367836|FG000|Overall Study|Other Reason|1|||
44362542|NCT01098162|79367836|FG000|Overall Study|Reason Unknown|26|||
44362543|NCT01097694|79367842|FG000|Overall Study|Adverse Event|5|||
44362544|NCT01097694|79367843|FG001|Overall Study|Adverse Event|0|||
44362545|NCT01097694|79367842|FG000|Overall Study|Lost to Follow-up|0|||
44362546|NCT01097694|79367843|FG001|Overall Study|Lost to Follow-up|3|||
44362547|NCT01097694|79367842|FG000|Overall Study|Withdrawal by Subject|3|||
44362548|NCT01097694|79367843|FG001|Overall Study|Withdrawal by Subject|1|||
44362549|NCT01102140|79367851|FG000|Overall Study|Lost to Follow-up|1|||
44362550|NCT01102140|79367852|FG001|Overall Study|Lost to Follow-up|0|||
44362551|NCT01102140|79367851|FG000|Overall Study|Investigator terminated study|2|||
44362552|NCT01102140|79367852|FG001|Overall Study|Investigator terminated study|2|||
44362553|NCT00874549|79367864|FG000|Overall Study|Adverse Event|0|||
44362554|NCT00874549|79367865|FG001|Overall Study|Adverse Event|0|||
44362555|NCT00874549|79367866|FG002|Overall Study|Adverse Event|1|||
44362556|NCT00874549|79367867|FG003|Overall Study|Adverse Event|0|||
44362557|NCT00874549|79367864|FG000|Overall Study|Protocol Violation|1|||
44362558|NCT00874549|79367865|FG001|Overall Study|Protocol Violation|0|||
44362559|NCT00874549|79367866|FG002|Overall Study|Protocol Violation|2|||
44362560|NCT00874549|79367867|FG003|Overall Study|Protocol Violation|1|||
44362561|NCT00874549|79367864|FG000|Overall Study|Lost to Follow-up|0|||
44362562|NCT00874549|79367865|FG001|Overall Study|Lost to Follow-up|0|||
44362563|NCT00874549|79367866|FG002|Overall Study|Lost to Follow-up|1|||
44362564|NCT00874549|79367867|FG003|Overall Study|Lost to Follow-up|0|||
44362565|NCT00874549|79367864|FG000|Overall Study|Withdrawal by Subject|0|||
44362566|NCT00874549|79367865|FG001|Overall Study|Withdrawal by Subject|1|||
44362567|NCT00874549|79367866|FG002|Overall Study|Withdrawal by Subject|0|||
44362568|NCT00874549|79367867|FG003|Overall Study|Withdrawal by Subject|1|||
44362569|NCT01155479|79367882|FG000|Part I|Adverse Event|13|||
44362570|NCT01155479|79367883|FG001|Part I|Adverse Event|8|||
44362571|NCT01155479|79367884|FG002|Part I|Adverse Event|18|||
44451890|NCT00496197|79460815|FG000|Overall Study|Protocol Violation|8|||
44451891|NCT00495495|79460819|FG000|Overall Study|Protocol Violation|99|||
44451892|NCT00404092|79460828|FG000|Overall Study|Death|1|||
44362572|NCT01155479|79367885|FG003|Part I|Adverse Event|7|||
44362573|NCT01155479|79367886|FG004|Part I|Adverse Event|6|||
44362574|NCT01155479|79367882|FG000|Part I|Administrative|2|||
44362575|NCT01155479|79367883|FG001|Part I|Administrative|2|||
44362576|NCT01155479|79367884|FG002|Part I|Administrative|2|||
44451893|NCT00404092|79460829|FG001|Overall Study|Death|0|||
44362577|NCT01155479|79367885|FG003|Part I|Administrative|0|||
44362578|NCT01155479|79367886|FG004|Part I|Administrative|0|||
44362579|NCT01155479|79367882|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
44362580|NCT01155479|79367883|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
44362581|NCT01155479|79367884|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
44362582|NCT01155479|79367885|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
44362583|NCT01155479|79367886|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
44362584|NCT01155479|79367882|FG000|Part I|Withdrawal by Subject|11|||
44362585|NCT01155479|79367883|FG001|Part I|Withdrawal by Subject|13|||
44362586|NCT01155479|79367884|FG002|Part I|Withdrawal by Subject|8|||
44362587|NCT01155479|79367885|FG003|Part I|Withdrawal by Subject|8|||
44362588|NCT01155479|79367886|FG004|Part I|Withdrawal by Subject|9|||
44362589|NCT01155479|79367882|FG000|Part I|Lost to Follow-up|0|||
44362590|NCT01155479|79367883|FG001|Part I|Lost to Follow-up|0|||
44362591|NCT01155479|79367884|FG002|Part I|Lost to Follow-up|1|||
44362592|NCT01155479|79367885|FG003|Part I|Lost to Follow-up|1|||
44362593|NCT01155479|79367886|FG004|Part I|Lost to Follow-up|0|||
44362594|NCT01155479|79367882|FG000|Part I|Treatment Failure|3|||
44362595|NCT01155479|79367883|FG001|Part I|Treatment Failure|0|||
44362596|NCT01155479|79367884|FG002|Part I|Treatment Failure|3|||
44362597|NCT01155479|79367885|FG003|Part I|Treatment Failure|1|||
44362598|NCT01155479|79367886|FG004|Part I|Treatment Failure|2|||
44362599|NCT01155479|79367882|FG000|Part I|Did Not Receive Treatment|4|||
44362600|NCT01155479|79367883|FG001|Part I|Did Not Receive Treatment|2|||
44362601|NCT01155479|79367884|FG002|Part I|Did Not Receive Treatment|2|||
44362602|NCT01155479|79367885|FG003|Part I|Did Not Receive Treatment|6|||
44362603|NCT01155479|79367886|FG004|Part I|Did Not Receive Treatment|1|||
44362604|NCT01155479|79367882|FG000|Part I|Non-Compliance with Protocol|2|||
44362605|NCT01155479|79367883|FG001|Part I|Non-Compliance with Protocol|1|||
44362606|NCT01155479|79367884|FG002|Part I|Non-Compliance with Protocol|3|||
44362607|NCT01155479|79367885|FG003|Part I|Non-Compliance with Protocol|3|||
44362608|NCT01155479|79367886|FG004|Part I|Non-Compliance with Protocol|2|||
44362609|NCT01155479|79367882|FG000|Part II|Adverse Event|7|||
44362610|NCT01155479|79367883|FG001|Part II|Adverse Event|6|||
44362611|NCT01155479|79367884|FG002|Part II|Adverse Event|8|||
44362612|NCT01155479|79367885|FG003|Part II|Adverse Event|3|||
44362613|NCT01155479|79367886|FG004|Part II|Adverse Event|4|||
44362614|NCT01155479|79367882|FG000|Part II|Administrative|43|||
44362615|NCT01155479|79367883|FG001|Part II|Administrative|49|||
44362616|NCT01155479|79367884|FG002|Part II|Administrative|36|||
44362617|NCT01155479|79367885|FG003|Part II|Administrative|38|||
44362618|NCT01155479|79367886|FG004|Part II|Administrative|46|||
44362619|NCT01155479|79367882|FG000|Part II|Withdrawal by Subject|8|||
44362620|NCT01155479|79367883|FG001|Part II|Withdrawal by Subject|4|||
44362621|NCT01155479|79367884|FG002|Part II|Withdrawal by Subject|12|||
44362622|NCT01155479|79367885|FG003|Part II|Withdrawal by Subject|7|||
44362623|NCT01155479|79367886|FG004|Part II|Withdrawal by Subject|3|||
44362624|NCT01155479|79367882|FG000|Part II|Lost to Follow-up|1|||
44362625|NCT01155479|79367883|FG001|Part II|Lost to Follow-up|0|||
44362626|NCT01155479|79367884|FG002|Part II|Lost to Follow-up|0|||
44362627|NCT01155479|79367885|FG003|Part II|Lost to Follow-up|0|||
44362628|NCT01155479|79367886|FG004|Part II|Lost to Follow-up|1|||
44362629|NCT01155479|79367882|FG000|Part II|Treatment Failure|0|||
44362630|NCT01155479|79367883|FG001|Part II|Treatment Failure|1|||
44362631|NCT01155479|79367884|FG002|Part II|Treatment Failure|2|||
44451894|NCT00404092|79460830|FG002|Overall Study|Death|0|||
44268416|NCT04270747|79182592|FG000|Post Week 16|Miscellaneous|1|||
44268417|NCT04270747|79182593|FG001|Post Week 16|Miscellaneous|0|||
44268418|NCT04270747|79182594|FG002|Post Week 16|Miscellaneous|1|||
44268419|NCT04238728|79182625|FG000|Overall Study|Withdrawal by Subject|1|||
44268420|NCT04238728|79182625|FG000|Overall Study|Lost to Follow-up|2|||
44268421|NCT04106557|79182641|FG000|Overall Study|Physician Decision|0|||
44268422|NCT04106557|79182642|FG001|Overall Study|Physician Decision|1|||
44268423|NCT04106557|79182643|FG002|Overall Study|Physician Decision|0|||
44268424|NCT04106557|79182641|FG000|Overall Study|Protocol Violation|0|||
44268425|NCT04106557|79182642|FG001|Overall Study|Protocol Violation|1|||
44268426|NCT04106557|79182643|FG002|Overall Study|Protocol Violation|0|||
44268427|NCT04085614|79182652|FG000|Overall Study|Protocol Violation|9|||
44268428|NCT04085614|79182653|FG001|Overall Study|Protocol Violation|6|||
44362632|NCT01155479|79367885|FG003|Part II|Treatment Failure|0|||
44362633|NCT01155479|79367886|FG004|Part II|Treatment Failure|1|||
44362634|NCT01155479|79367882|FG000|Part II|Non-Compliance with Protocol|0|||
44268429|NCT04056455|79182661|FG000|Overall Study|Adverse Event|1|||
44268430|NCT04056455|79182662|FG001|Overall Study|Adverse Event|0|||
44362635|NCT01155479|79367883|FG001|Part II|Non-Compliance with Protocol|1|||
44362636|NCT01155479|79367884|FG002|Part II|Non-Compliance with Protocol|0|||
44362637|NCT01155479|79367885|FG003|Part II|Non-Compliance with Protocol|2|||
44362638|NCT01155479|79367886|FG004|Part II|Non-Compliance with Protocol|0|||
44362639|NCT01155323|79367914|FG000|First Intervention|exclusion criteria|1|||
44362640|NCT01155323|79367915|FG001|First Intervention|exclusion criteria|1|||
44362641|NCT01155323|79367914|FG000|Second Intervention|Lost to Follow-up|1|||
44362642|NCT01155323|79367915|FG001|Second Intervention|Lost to Follow-up|1|||
44362643|NCT01155167|79367923|FG000|Overall Study|Insufficient ultrasound data|2|||
44362644|NCT01155167|79367924|FG001|Overall Study|Insufficient ultrasound data|0|||
44362645|NCT01155167|79367923|FG000|Overall Study|Access site changed to femoral artery|1|||
44362646|NCT01155167|79367924|FG001|Overall Study|Access site changed to femoral artery|0|||
44362647|NCT01106586|79367932|FG000|Overall Study|Adverse Event|9|||
44362648|NCT01106586|79367933|FG001|Overall Study|Adverse Event|15|||
44362649|NCT01106586|79367932|FG000|Overall Study|Death|1|||
44362650|NCT01106586|79367933|FG001|Overall Study|Death|3|||
44362651|NCT01106586|79367932|FG000|Overall Study|Pregnancy|2|||
44362652|NCT01106586|79367933|FG001|Overall Study|Pregnancy|2|||
44362653|NCT01106586|79367932|FG000|Overall Study|Lack of Efficacy|1|||
44201979|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
44201980|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201981|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201982|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
44201983|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
44201984|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201985|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
44201986|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
44201987|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
44201988|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
44201989|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
44201990|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
44201991|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
44201992|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
44201993|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
44201994|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
44201995|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
44201996|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
44362654|NCT01106586|79367933|FG001|Overall Study|Lack of Efficacy|0|||
44362655|NCT01106586|79367932|FG000|Overall Study|Investigator's Discretion|5|||
44362656|NCT01106586|79367933|FG001|Overall Study|Investigator's Discretion|8|||
44362657|NCT01106586|79367932|FG000|Overall Study|Withdrew Consent|18|||
44362658|NCT01106586|79367933|FG001|Overall Study|Withdrew Consent|30|||
44362659|NCT01106586|79367932|FG000|Overall Study|Lost to Follow-up|24|||
44362660|NCT01106586|79367933|FG001|Overall Study|Lost to Follow-up|20|||
44362661|NCT01106586|79367932|FG000|Overall Study|Participant Noncompliance|12|||
44362662|NCT01106586|79367933|FG001|Overall Study|Participant Noncompliance|10|||
44362663|NCT01106586|79367932|FG000|Overall Study|Protocol Violation|1|||
44362664|NCT01106586|79367933|FG001|Overall Study|Protocol Violation|0|||
44362665|NCT01106586|79367932|FG000|Overall Study|Participant Transferred to Another Study|212|||
44362666|NCT01106586|79367933|FG001|Overall Study|Participant Transferred to Another Study|197|||
44362667|NCT01155011|79367941|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
44362668|NCT01155011|79367942|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
44362669|NCT01155011|79367941|FG000|Baseline to 6 Months|investigator decision, moved|4|||
44362670|NCT01155011|79367942|FG001|Baseline to 6 Months|investigator decision, moved|5|||
44362671|NCT01155011|79367941|FG000|Baseline to 6 Months|Death|0|||
44362672|NCT01155011|79367942|FG001|Baseline to 6 Months|Death|1|||
44362673|NCT01155011|79367941|FG000|6 to 12 Months|Withdrawal by Subject|8|||
44362674|NCT01155011|79367942|FG001|6 to 12 Months|Withdrawal by Subject|5|||
44201997|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
44362675|NCT01155011|79367941|FG000|6 to 12 Months|Death|1|||
44362676|NCT01155011|79367942|FG001|6 to 12 Months|Death|5|||
44362677|NCT01106430|79367954|FG000|Overall Study|Adverse Event|8|||
44362678|NCT01106430|79367955|FG001|Overall Study|Adverse Event|10|||
44362679|NCT01106430|79367954|FG000|Overall Study|Lack of Efficacy|2|||
44362680|NCT01106430|79367955|FG001|Overall Study|Lack of Efficacy|13|||
44362681|NCT01106430|79367954|FG000|Overall Study|Lost to Follow-up|5|||
44362682|NCT01106430|79367955|FG001|Overall Study|Lost to Follow-up|1|||
44362683|NCT01106430|79367954|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
44362684|NCT01106430|79367955|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
44362685|NCT01106430|79367954|FG000|Overall Study|Moved Out Of State|0|||
44362686|NCT01106430|79367955|FG001|Overall Study|Moved Out Of State|1|||
44362687|NCT01106430|79367954|FG000|Overall Study|Refused To Take Medication|0|||
44362688|NCT01106430|79367955|FG001|Overall Study|Refused To Take Medication|1|||
44362689|NCT01106430|79367954|FG000|Overall Study|Noncompliance|0|||
44362690|NCT01106430|79367955|FG001|Overall Study|Noncompliance|1|||
44362691|NCT01106430|79367954|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
44362692|NCT01106430|79367955|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
44362693|NCT01106430|79367954|FG000|Overall Study|Previous Use Of Marijuana|1|||
44362694|NCT01106430|79367955|FG001|Overall Study|Previous Use Of Marijuana|0|||
44362695|NCT01106430|79367954|FG000|Overall Study|Protocol Violation|7|||
44362696|NCT01106430|79367955|FG001|Overall Study|Protocol Violation|2|||
44362697|NCT01106430|79367954|FG000|Overall Study|Withdrawal by Subject|8|||
44362698|NCT01106430|79367955|FG001|Overall Study|Withdrawal by Subject|4|||
44362699|NCT01154231|79367961|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
44362700|NCT01154231|79367961|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
44362701|NCT01154153|79367967|FG000|Overall Study|Poor compliance to protocol|2|||
44362702|NCT01154153|79367968|FG001|Overall Study|Poor compliance to protocol|0|||
44362703|NCT01154153|79367967|FG000|Overall Study|Unable to use labs|2|||
44362704|NCT01154153|79367968|FG001|Overall Study|Unable to use labs|3|||
44362705|NCT01154153|79367967|FG000|Overall Study|Withdrew consent|1|||
44362706|NCT01154153|79367968|FG001|Overall Study|Withdrew consent|0|||
44362707|NCT00874237|79367974|FG000|Overall Study|Physician Decision|0|||
44362708|NCT00874237|79367975|FG001|Overall Study|Physician Decision|1|||
44362709|NCT00874237|79367976|FG002|Overall Study|Physician Decision|0|||
44362710|NCT00874237|79367977|FG003|Overall Study|Physician Decision|0|||
44362711|NCT00874237|79367978|FG004|Overall Study|Physician Decision|0|||
44362712|NCT00874237|79367979|FG005|Overall Study|Physician Decision|0|||
44362713|NCT00874237|79367974|FG000|Overall Study|Withdrawal by Subject|0|||
44362714|NCT00874237|79367975|FG001|Overall Study|Withdrawal by Subject|0|||
44362715|NCT00874237|79367976|FG002|Overall Study|Withdrawal by Subject|1|||
44362716|NCT00874237|79367977|FG003|Overall Study|Withdrawal by Subject|0|||
44362717|NCT00874237|79367978|FG004|Overall Study|Withdrawal by Subject|0|||
44362718|NCT00874237|79367979|FG005|Overall Study|Withdrawal by Subject|0|||
44362719|NCT01153841|79367991|FG000|Overall Study|Adverse Event|1|||
44362720|NCT01153841|79367992|FG001|Overall Study|Adverse Event|0|||
44362721|NCT01153841|79367991|FG000|Overall Study|Withdrawal by Subject|1|||
44362722|NCT01153841|79367992|FG001|Overall Study|Withdrawal by Subject|0|||
44362723|NCT01153841|79367991|FG000|Overall Study|Protocol Violation|2|||
44362724|NCT01153841|79367992|FG001|Overall Study|Protocol Violation|0|||
44362725|NCT01153841|79367991|FG000|Overall Study|Lost to Follow-up|2|||
44362726|NCT01153841|79367992|FG001|Overall Study|Lost to Follow-up|0|||
44362727|NCT01153763|79367998|FG000|Overall Study|Study Closed|16|||
44362728|NCT01153763|79367998|FG000|Overall Study|Lost to Follow-up|1|||
44362729|NCT01153763|79367998|FG000|Overall Study|Physician Decision|2|||
44362730|NCT01153763|79367998|FG000|Overall Study|Withdrawal by Subject|2|||
44362731|NCT00871741|79368004|FG000|Overall Study|Premature study termination|9|||
44362732|NCT00871741|79368005|FG001|Overall Study|Premature study termination|7|||
44362733|NCT01152437|79368014|FG000|Overall Study|Other Adverse Event|8|||
44362734|NCT01152437|79368015|FG001|Overall Study|Other Adverse Event|1|||
44362735|NCT01152437|79368016|FG002|Overall Study|Other Adverse Event|7|||
44362736|NCT01152437|79368014|FG000|Overall Study|Not treated|0|||
44362737|NCT01152437|79368015|FG001|Overall Study|Not treated|1|||
44362738|NCT01152437|79368016|FG002|Overall Study|Not treated|2|||
44362739|NCT01152437|79368014|FG000|Overall Study|Progressive disease|27|||
44362740|NCT01152437|79368015|FG001|Overall Study|Progressive disease|13|||
44362741|NCT01152437|79368016|FG002|Overall Study|Progressive disease|32|||
44451895|NCT00404092|79460831|FG003|Overall Study|Death|0|||
44451896|NCT00404092|79460828|FG000|Overall Study|Adverse Event|0|||
44362742|NCT01152437|79368014|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
44362743|NCT01152437|79368015|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
44362744|NCT01152437|79368016|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
44362745|NCT01151579|79368028|FG000|Overall Study|Physician Decision|3|||
44362746|NCT01151579|79368029|FG001|Overall Study|Physician Decision|1|||
44362747|NCT01151579|79368028|FG000|Overall Study|Withdrawal by Subject|3|||
44362748|NCT01151579|79368029|FG001|Overall Study|Withdrawal by Subject|2|||
44362749|NCT01151579|79368028|FG000|Overall Study|Not meet inclusion criteria|6|||
44362750|NCT01151579|79368029|FG001|Overall Study|Not meet inclusion criteria|4|||
44362751|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
44362752|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
44362753|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
44362754|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44362755|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44362756|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44362757|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44362758|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44362759|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
44362760|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
44362761|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
44362762|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44362763|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44362764|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44362765|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44362766|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44362767|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
44362768|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
44362769|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
44362770|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44362771|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44362772|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44362773|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44362774|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44362775|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
44362776|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
44362777|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44362778|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44362779|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44362780|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44362781|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44362782|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44451897|NCT00404092|79460829|FG001|Overall Study|Adverse Event|0|||
44451898|NCT00404092|79460830|FG002|Overall Study|Adverse Event|1|||
44201998|NCT02105987|78997672|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
44201999|NCT02105987|78997673|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
44202000|NCT02105987|78997674|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
44268431|NCT03980184|79182670|FG000|Overall Study|Dropped out before treatment|2|||
44268432|NCT03980184|79182671|FG001|Overall Study|Dropped out before treatment|2|||
44268433|NCT03980184|79182670|FG000|Overall Study|Lost to Follow-up|11|||
44268434|NCT03980184|79182671|FG001|Overall Study|Lost to Follow-up|13|||
44268435|NCT03917459|79182679|FG000|Overall Study|Adverse Event|1|||
44268436|NCT03917459|79182680|FG001|Overall Study|Adverse Event|0|||
44268437|NCT03917459|79182679|FG000|Overall Study|Withdrawal by Subject|0|||
44268438|NCT03917459|79182680|FG001|Overall Study|Withdrawal by Subject|1|||
44268439|NCT03807778|79182691|FG000|Overall Study|Adverse Event|0|||
44268440|NCT03807778|79182692|FG001|Overall Study|Adverse Event|0|||
44268441|NCT03807778|79182693|FG002|Overall Study|Adverse Event|3|||
44268442|NCT03807778|79182694|FG003|Overall Study|Adverse Event|5|||
44268443|NCT03807778|79182691|FG000|Overall Study|Progressive Disease|4|||
44268444|NCT03807778|79182692|FG001|Overall Study|Progressive Disease|2|||
44268445|NCT03807778|79182693|FG002|Overall Study|Progressive Disease|8|||
44268446|NCT03807778|79182694|FG003|Overall Study|Progressive Disease|15|||
44268447|NCT03807778|79182691|FG000|Overall Study|Symptomatic Deterioration|0|||
44268448|NCT03807778|79182692|FG001|Overall Study|Symptomatic Deterioration|1|||
44268449|NCT03807778|79182693|FG002|Overall Study|Symptomatic Deterioration|0|||
44362783|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
44362784|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
44202001|NCT02105987|78997675|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
44202002|NCT02105987|78997676|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
44202003|NCT02105987|78997677|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
44202004|NCT02105987|78997672|FG000|Continuation Phase|Protocol Violation|0|||
44202005|NCT02105987|78997673|FG001|Continuation Phase|Protocol Violation|0|||
44202006|NCT02105987|78997674|FG002|Continuation Phase|Protocol Violation|0|||
44202007|NCT02105987|78997675|FG003|Continuation Phase|Protocol Violation|0|||
44202008|NCT02105987|78997676|FG004|Continuation Phase|Protocol Violation|1|||
44451899|NCT00404092|79460831|FG003|Overall Study|Adverse Event|0|||
44202009|NCT02105987|78997677|FG005|Continuation Phase|Protocol Violation|0|||
44268450|NCT03807778|79182694|FG003|Overall Study|Symptomatic Deterioration|1|||
44268451|NCT03807778|79182691|FG000|Overall Study|Withdrawal by Subject|0|||
44268452|NCT03807778|79182692|FG001|Overall Study|Withdrawal by Subject|1|||
44362785|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
44362786|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44362787|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44362788|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44362789|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44362790|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44362791|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
44362792|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
44362793|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
44362794|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
44362795|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
44362796|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
44362797|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
44362798|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
44202010|NCT02141633|78997685|FG000|Overall Study|Physician Decision|1|||
44362799|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
44362800|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
44362801|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44362802|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44362803|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44362804|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44362805|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44362806|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44362807|NCT01097616|79368038|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362808|NCT01097616|79368039|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362809|NCT01097616|79368040|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
44362810|NCT01097616|79368041|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362811|NCT01097616|79368042|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362812|NCT01097616|79368043|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362813|NCT01097616|79368044|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362814|NCT01097616|79368045|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44362815|NCT01097616|79368038|FG000|Optional DB EXT Phase|Adverse Event|0|||
44362816|NCT01097616|79368039|FG001|Optional DB EXT Phase|Adverse Event|7|||
44362817|NCT01097616|79368040|FG002|Optional DB EXT Phase|Adverse Event|2|||
44362818|NCT01097616|79368041|FG003|Optional DB EXT Phase|Adverse Event|0|||
44362819|NCT01097616|79368042|FG004|Optional DB EXT Phase|Adverse Event|0|||
44202011|NCT02141633|78997686|FG001|Overall Study|Physician Decision|0|||
44202012|NCT01846611|78997694|FG000|Overall Study|Lost to Follow-up|4|||
44202013|NCT01846611|78997695|FG001|Overall Study|Lost to Follow-up|6|||
44202014|NCT01846611|78997694|FG000|Overall Study|Withdrawal by Subject|15|||
44202015|NCT01846611|78997695|FG001|Overall Study|Withdrawal by Subject|19|||
44362820|NCT01097616|79368043|FG005|Optional DB EXT Phase|Adverse Event|0|||
44362821|NCT01097616|79368044|FG006|Optional DB EXT Phase|Adverse Event|0|||
44202016|NCT01846611|78997694|FG000|Overall Study|Other|19|||
44202017|NCT01846611|78997695|FG001|Overall Study|Other|18|||
44202018|NCT02141399|78997701|FG000|Overall Study|Adverse Event|158|||
44202019|NCT02141399|78997701|FG000|Overall Study|Lack of Efficacy|62|||
44362822|NCT01097616|79368045|FG007|Optional DB EXT Phase|Adverse Event|0|||
44362823|NCT01097616|79368038|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
44362824|NCT01097616|79368039|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
44362825|NCT01097616|79368040|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
44362826|NCT01097616|79368041|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
44362827|NCT01097616|79368042|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
44362828|NCT01097616|79368043|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
44362829|NCT01097616|79368044|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
44202020|NCT02141399|78997701|FG000|Overall Study|Lost to Follow-up|151|||
44202021|NCT02141399|78997701|FG000|Overall Study|Non-compliance with study drug|18|||
44202022|NCT02141399|78997701|FG000|Overall Study|Other|45|||
44362830|NCT01097616|79368045|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
44362831|NCT01097616|79368038|FG000|Optional DB EXT Phase|Protocol Violation|0|||
44362832|NCT01097616|79368039|FG001|Optional DB EXT Phase|Protocol Violation|2|||
44362833|NCT01097616|79368040|FG002|Optional DB EXT Phase|Protocol Violation|3|||
44362834|NCT01097616|79368041|FG003|Optional DB EXT Phase|Protocol Violation|0|||
44362835|NCT01097616|79368042|FG004|Optional DB EXT Phase|Protocol Violation|0|||
44362836|NCT01097616|79368043|FG005|Optional DB EXT Phase|Protocol Violation|0|||
44362837|NCT01097616|79368044|FG006|Optional DB EXT Phase|Protocol Violation|0|||
44202023|NCT02141399|78997701|FG000|Overall Study|Physician Decision|17|||
44202024|NCT02141399|78997701|FG000|Overall Study|Pregnancy|3|||
44202025|NCT02141399|78997701|FG000|Overall Study|Protocol Violation|38|||
44202026|NCT02141399|78997701|FG000|Overall Study|Withdrawal by Subject|238|||
44202027|NCT02141399|78997701|FG000|Overall Study|Failure to meet eligibility criteria|14|||
44202028|NCT01846299|78997707|FG000|Overall Study|Physician Decision|4|||
44202029|NCT01846299|78997708|FG001|Overall Study|Physician Decision|2|||
44202030|NCT01846299|78997707|FG000|Overall Study|Protocol deviation|1|||
44202031|NCT01846299|78997708|FG001|Overall Study|Protocol deviation|0|||
44202032|NCT01846299|78997707|FG000|Overall Study|Death|1|||
44202033|NCT01846299|78997708|FG001|Overall Study|Death|2|||
44202034|NCT01846299|78997707|FG000|Overall Study|Lost to Follow-up|3|||
44202035|NCT01846299|78997708|FG001|Overall Study|Lost to Follow-up|0|||
44362838|NCT01097616|79368045|FG007|Optional DB EXT Phase|Protocol Violation|0|||
44362839|NCT01097616|79368038|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
44362840|NCT01097616|79368039|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
44362841|NCT01097616|79368040|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
44362842|NCT01097616|79368041|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
44362843|NCT01097616|79368042|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
44362844|NCT01097616|79368043|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
44362845|NCT01097616|79368044|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
44362846|NCT01097616|79368045|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
44362847|NCT01097616|79368038|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
44362848|NCT01097616|79368039|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
44362849|NCT01097616|79368040|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
44362850|NCT01097616|79368041|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
44362851|NCT01097616|79368042|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
44362852|NCT01097616|79368043|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
44362853|NCT01097616|79368044|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
44362854|NCT01097616|79368045|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
44362855|NCT01097616|79368038|FG000|Optional DB EXT Phase|Physician Decision|1|||
44362856|NCT01097616|79368039|FG001|Optional DB EXT Phase|Physician Decision|0|||
44362857|NCT01097616|79368040|FG002|Optional DB EXT Phase|Physician Decision|0|||
44362858|NCT01097616|79368041|FG003|Optional DB EXT Phase|Physician Decision|0|||
44362859|NCT01097616|79368042|FG004|Optional DB EXT Phase|Physician Decision|0|||
44362860|NCT01097616|79368043|FG005|Optional DB EXT Phase|Physician Decision|0|||
44362861|NCT01097616|79368044|FG006|Optional DB EXT Phase|Physician Decision|0|||
44362862|NCT01097616|79368045|FG007|Optional DB EXT Phase|Physician Decision|0|||
44362863|NCT01097616|79368038|FG000|DB RO Phase|Adverse Event|0|||
44362864|NCT01097616|79368039|FG001|DB RO Phase|Adverse Event|0|||
44362865|NCT01097616|79368040|FG002|DB RO Phase|Adverse Event|0|||
44202036|NCT01846299|78997707|FG000|Overall Study|Withdrawal by Subject|1|||
44202037|NCT01846299|78997708|FG001|Overall Study|Withdrawal by Subject|6|||
44202038|NCT01846299|78997707|FG000|Overall Study|Adverse Event|2|||
44202039|NCT01846299|78997708|FG001|Overall Study|Adverse Event|0|||
44202040|NCT01628393|78997719|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
44202041|NCT01628393|78997720|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44202042|NCT01628393|78997721|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44202043|NCT01628393|78997722|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44202044|NCT01628393|78997723|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44202045|NCT01628393|78997719|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
44202046|NCT01628393|78997720|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
44202047|NCT01628393|78997721|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
44202048|NCT01628393|78997722|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
44362866|NCT01097616|79368041|FG003|DB RO Phase|Adverse Event|0|||
44362867|NCT01097616|79368042|FG004|DB RO Phase|Adverse Event|0|||
44362868|NCT01097616|79368043|FG005|DB RO Phase|Adverse Event|0|||
44362869|NCT01097616|79368044|FG006|DB RO Phase|Adverse Event|1|||
44451900|NCT00481767|79460843|FG000|Overall Study|Withdrawal by Subject|16|||
44451901|NCT00481767|79460844|FG001|Overall Study|Withdrawal by Subject|11|||
44451902|NCT00481767|79460843|FG000|Overall Study|Lost to Follow-up|16|||
44451903|NCT00481767|79460844|FG001|Overall Study|Lost to Follow-up|10|||
44451904|NCT00489489|79460853|FG000|Overall Study|Not treated due to protocol violation|0|||
44451905|NCT00489489|79460854|FG001|Overall Study|Not treated due to protocol violation|1|||
44451906|NCT00489489|79460855|FG002|Overall Study|Not treated due to protocol violation|1|||
44451907|NCT00489489|79460853|FG000|Overall Study|Adverse Event|1|||
44451908|NCT00489489|79460854|FG001|Overall Study|Adverse Event|1|||
44451909|NCT00489489|79460855|FG002|Overall Study|Adverse Event|1|||
44202049|NCT01628393|78997723|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
44202050|NCT01628393|78997719|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
44202051|NCT01628393|78997720|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
44362870|NCT01097616|79368045|FG007|DB RO Phase|Adverse Event|0|||
44362871|NCT01097616|79368038|FG000|DB RO Phase|Withdrawal by Subject|0|||
44362872|NCT01097616|79368039|FG001|DB RO Phase|Withdrawal by Subject|0|||
44362873|NCT01097616|79368040|FG002|DB RO Phase|Withdrawal by Subject|0|||
44362874|NCT01097616|79368041|FG003|DB RO Phase|Withdrawal by Subject|0|||
44362875|NCT01097616|79368042|FG004|DB RO Phase|Withdrawal by Subject|0|||
44362876|NCT01097616|79368043|FG005|DB RO Phase|Withdrawal by Subject|1|||
44451910|NCT00489489|79460853|FG000|Overall Study|Protocol Violation|1|||
44451911|NCT00489489|79460854|FG001|Overall Study|Protocol Violation|0|||
44362877|NCT01097616|79368044|FG006|DB RO Phase|Withdrawal by Subject|0|||
44362878|NCT01097616|79368045|FG007|DB RO Phase|Withdrawal by Subject|0|||
44362879|NCT01097616|79368038|FG000|DB RO Phase|Lost to Follow-up|0|||
44362880|NCT01097616|79368039|FG001|DB RO Phase|Lost to Follow-up|0|||
44451912|NCT00489489|79460855|FG002|Overall Study|Protocol Violation|1|||
44362881|NCT01097616|79368040|FG002|DB RO Phase|Lost to Follow-up|0|||
44362882|NCT01097616|79368041|FG003|DB RO Phase|Lost to Follow-up|1|||
44362883|NCT01097616|79368042|FG004|DB RO Phase|Lost to Follow-up|1|||
44362884|NCT01097616|79368043|FG005|DB RO Phase|Lost to Follow-up|0|||
44362885|NCT01097616|79368044|FG006|DB RO Phase|Lost to Follow-up|0|||
44362886|NCT01097616|79368045|FG007|DB RO Phase|Lost to Follow-up|1|||
44362887|NCT01097616|79368038|FG000|DB RO Phase|Not Treated in RO|0|||
44362888|NCT01097616|79368039|FG001|DB RO Phase|Not Treated in RO|0|||
44362889|NCT01097616|79368040|FG002|DB RO Phase|Not Treated in RO|0|||
44362890|NCT01097616|79368041|FG003|DB RO Phase|Not Treated in RO|0|||
44362891|NCT01097616|79368042|FG004|DB RO Phase|Not Treated in RO|0|||
44362892|NCT01097616|79368043|FG005|DB RO Phase|Not Treated in RO|1|||
44362893|NCT01097616|79368044|FG006|DB RO Phase|Not Treated in RO|0|||
44362894|NCT01097616|79368045|FG007|DB RO Phase|Not Treated in RO|0|||
44362895|NCT00871429|79368071|FG000|Overall Study|Lost to Follow-up|6|||
44362896|NCT00871429|79368071|FG000|Overall Study|Withdrawal by Subject|17|||
44362897|NCT00871429|79368071|FG000|Overall Study|Questionnaire not completed|1|||
44362898|NCT01151345|79368079|FG000|First Intervention Period|Protocol Violation|0|||
44362899|NCT01151345|79368080|FG001|First Intervention Period|Protocol Violation|1|||
44362900|NCT00593827|79368088|FG000|Overall Study|On Active Treatment/Pending|0|||
44362901|NCT00593827|79368089|FG001|Overall Study|On Active Treatment/Pending|2|||
44451913|NCT00489489|79460853|FG000|Overall Study|Progressive disease|0|||
44362902|NCT01150097|79368098|FG000|Months 24 to 36 Post-transplantation|Death|2|||
44362903|NCT01150097|79368099|FG001|Months 24 to 36 Post-transplantation|Death|0|||
44362904|NCT01150097|79368100|FG002|Months 24 to 36 Post-transplantation|Death|0|||
44362905|NCT01150097|79368098|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
44451914|NCT00489489|79460854|FG001|Overall Study|Progressive disease|1|||
44202052|NCT01628393|78997721|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
44202053|NCT01628393|78997722|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
44202054|NCT01628393|78997723|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
44202055|NCT01628393|78997719|FG000|Blinded Active Extension Period|Adverse Event|0|||
44202056|NCT01628393|78997720|FG001|Blinded Active Extension Period|Adverse Event|1|||
44202057|NCT01628393|78997721|FG002|Blinded Active Extension Period|Adverse Event|0|||
44202058|NCT01628393|78997722|FG003|Blinded Active Extension Period|Adverse Event|2|||
44202059|NCT01628393|78997723|FG004|Blinded Active Extension Period|Adverse Event|2|||
44202060|NCT01628393|78997719|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
44202061|NCT01628393|78997720|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
44202062|NCT01628393|78997721|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
44202063|NCT01628393|78997722|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
44202064|NCT01628393|78997723|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
44202065|NCT01628393|78997719|FG000|Blinded Active Extension Period|Physician Decision|0|||
44202066|NCT01628393|78997720|FG001|Blinded Active Extension Period|Physician Decision|3|||
44202067|NCT01628393|78997721|FG002|Blinded Active Extension Period|Physician Decision|0|||
44202068|NCT01628393|78997722|FG003|Blinded Active Extension Period|Physician Decision|1|||
44202069|NCT01628393|78997723|FG004|Blinded Active Extension Period|Physician Decision|0|||
44202070|NCT01628393|78997719|FG000|Blinded Active Extension Period|Protocol Violation|0|||
44202071|NCT01628393|78997720|FG001|Blinded Active Extension Period|Protocol Violation|0|||
44202072|NCT01628393|78997721|FG002|Blinded Active Extension Period|Protocol Violation|2|||
44202073|NCT01628393|78997722|FG003|Blinded Active Extension Period|Protocol Violation|1|||
44202074|NCT01628393|78997723|FG004|Blinded Active Extension Period|Protocol Violation|0|||
44202075|NCT01628393|78997719|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
44202076|NCT01628393|78997720|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
44202077|NCT01628393|78997721|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
44202078|NCT01628393|78997722|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
44202079|NCT01628393|78997723|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
44202080|NCT01846221|78997739|FG000|Overall Study|Catheter Failure|2|||
44202081|NCT01846221|78997740|FG001|Overall Study|Catheter Failure|0|||
44202082|NCT01846221|78997739|FG000|Overall Study|Age Exclusion|1|||
44202083|NCT01846221|78997740|FG001|Overall Study|Age Exclusion|0|||
44202084|NCT01815099|78997746|FG000|Overall Study|Lack of Efficacy|1|||
44202085|NCT01815099|78997746|FG000|Overall Study|unable to attend study visits|1|||
44202086|NCT01845831|78997753|FG000|Inpatient Phase|Withdrawal by Subject|1|||
44202087|NCT01845831|78997754|FG001|Inpatient Phase|Withdrawal by Subject|1|||
44202088|NCT01845831|78997755|FG002|Inpatient Phase|Withdrawal by Subject|0|||
44202089|NCT01845831|78997756|FG003|Inpatient Phase|Withdrawal by Subject|0|||
44202090|NCT01845831|78997757|FG004|Inpatient Phase|Withdrawal by Subject|0|||
44202091|NCT01627691|78997768|FG000|Overall Study|Death|11|||
44202092|NCT01627691|78997768|FG000|Overall Study|Lost to Follow-up|3|||
44202093|NCT01627691|78997768|FG000|Overall Study|Withdrawal by Subject|1|||
44202094|NCT01627691|78997768|FG000|Overall Study|Missed the visit|3|||
44202095|NCT01844895|78997772|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
44202096|NCT01844895|78997772|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
44202097|NCT01844895|78997772|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
44202098|NCT01844895|78997772|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
44202099|NCT01844895|78997772|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
44202100|NCT01844895|78997772|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
44202101|NCT01844895|78997772|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
44202102|NCT02116361|78997789|FG000|Overall Study|Pregnancy|0|||
44202103|NCT02116361|78997790|FG001|Overall Study|Pregnancy|0|||
44202104|NCT02116361|78997791|FG002|Overall Study|Pregnancy|0|||
44202105|NCT02116361|78997792|FG003|Overall Study|Pregnancy|1|||
44202106|NCT02116361|78997789|FG000|Overall Study|Protocol Violation|1|||
44202107|NCT02116361|78997790|FG001|Overall Study|Protocol Violation|0|||
44202108|NCT02116361|78997791|FG002|Overall Study|Protocol Violation|0|||
44202109|NCT02116361|78997792|FG003|Overall Study|Protocol Violation|2|||
44202110|NCT02116361|78997789|FG000|Overall Study|Physician Decision|2|||
44202111|NCT02116361|78997790|FG001|Overall Study|Physician Decision|3|||
44202112|NCT02116361|78997791|FG002|Overall Study|Physician Decision|0|||
44202113|NCT02116361|78997792|FG003|Overall Study|Physician Decision|0|||
44202114|NCT02116361|78997789|FG000|Overall Study|Adverse Event|1|||
44202115|NCT02116361|78997790|FG001|Overall Study|Adverse Event|0|||
44202116|NCT02116361|78997791|FG002|Overall Study|Adverse Event|0|||
44202117|NCT02116361|78997792|FG003|Overall Study|Adverse Event|3|||
44202118|NCT02116361|78997789|FG000|Overall Study|Other Reasons|3|||
44202119|NCT02116361|78997790|FG001|Overall Study|Other Reasons|3|||
44202120|NCT02116361|78997791|FG002|Overall Study|Other Reasons|3|||
44202121|NCT02116361|78997792|FG003|Overall Study|Other Reasons|3|||
44202122|NCT02116361|78997789|FG000|Overall Study|Lack of Efficacy|5|||
44202123|NCT02116361|78997790|FG001|Overall Study|Lack of Efficacy|7|||
44202124|NCT02116361|78997791|FG002|Overall Study|Lack of Efficacy|4|||
44362906|NCT01150097|79368099|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
44362907|NCT01150097|79368100|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
44362908|NCT01150097|79368098|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
44362909|NCT01150097|79368099|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
44362910|NCT01150097|79368100|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
44362911|NCT01150097|79368098|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
44362912|NCT01150097|79368099|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
44362913|NCT01150097|79368100|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
44362914|NCT01150097|79368098|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
44362915|NCT01150097|79368099|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
44362916|NCT01150097|79368100|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
44362917|NCT01150097|79368098|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
44362918|NCT01150097|79368099|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
44362919|NCT01150097|79368100|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
44362920|NCT01150097|79368098|FG000|Months 24 to 48 Post-transplantation|Death|2|||
44362921|NCT01150097|79368099|FG001|Months 24 to 48 Post-transplantation|Death|0|||
44362922|NCT01150097|79368100|FG002|Months 24 to 48 Post-transplantation|Death|0|||
44362923|NCT01149863|79368110|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
44362924|NCT01149473|79368116|FG000|First Intervention|Adverse Event|1|||
44362925|NCT01149473|79368117|FG001|First Intervention|Adverse Event|1|||
44362926|NCT01149473|79368116|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44362927|NCT01149473|79368117|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
44362928|NCT00872989|79368125|FG000|Overall Study|Adverse Event|7|||
44362929|NCT00872989|79368126|FG001|Overall Study|Adverse Event|15|||
44362930|NCT00872989|79368125|FG000|Overall Study|Withdrawal by Subject|8|||
44362931|NCT00872989|79368126|FG001|Overall Study|Withdrawal by Subject|5|||
44451915|NCT00489489|79460855|FG002|Overall Study|Progressive disease|0|||
44202125|NCT02116361|78997792|FG003|Overall Study|Lack of Efficacy|3|||
44362932|NCT00872989|79368125|FG000|Overall Study|Progression/relapse|47|||
44362933|NCT00872989|79368126|FG001|Overall Study|Progression/relapse|35|||
44451916|NCT00489489|79460853|FG000|Overall Study|Participant did not wish to continue|1|||
44451917|NCT00489489|79460854|FG001|Overall Study|Participant did not wish to continue|1|||
44451918|NCT00489489|79460855|FG002|Overall Study|Participant did not wish to continue|0|||
44451919|NCT00489489|79460853|FG000|Overall Study|Other than above|0|||
44451920|NCT00489489|79460854|FG001|Overall Study|Other than above|1|||
44451921|NCT00489489|79460855|FG002|Overall Study|Other than above|0|||
44451922|NCT00489411|79460867|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
44451923|NCT00489411|79460868|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
44451924|NCT00489411|79460867|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
44451925|NCT00489411|79460868|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
44451926|NCT00489411|79460867|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
44451927|NCT00489411|79460868|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
44451928|NCT00489411|79460867|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
44451929|NCT00489411|79460868|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
44451930|NCT00489411|79460867|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
44451931|NCT00489411|79460868|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
44451932|NCT00420784|79460878|FG000|Overall Study|Adverse Event|11|||
44451933|NCT00420784|79460879|FG001|Overall Study|Adverse Event|29|||
44451934|NCT00420784|79460880|FG002|Overall Study|Adverse Event|10|||
44451935|NCT00420784|79460881|FG003|Overall Study|Adverse Event|5|||
44451936|NCT00420784|79460878|FG000|Overall Study|Withdrawal by Subject|0|||
44451937|NCT00420784|79460879|FG001|Overall Study|Withdrawal by Subject|1|||
44451938|NCT00420784|79460880|FG002|Overall Study|Withdrawal by Subject|0|||
44451939|NCT00420784|79460881|FG003|Overall Study|Withdrawal by Subject|0|||
44451940|NCT00420784|79460878|FG000|Overall Study|Lost to Follow-up|0|||
44451941|NCT00420784|79460879|FG001|Overall Study|Lost to Follow-up|0|||
44202126|NCT02116361|78997789|FG000|Overall Study|Lost to Follow-up|4|||
44202127|NCT02116361|78997790|FG001|Overall Study|Lost to Follow-up|5|||
44451942|NCT00420784|79460880|FG002|Overall Study|Lost to Follow-up|2|||
44202128|NCT02116361|78997791|FG002|Overall Study|Lost to Follow-up|7|||
44362934|NCT00872989|79368125|FG000|Overall Study|Not protocol specified|3|||
44362935|NCT00872989|79368126|FG001|Overall Study|Not protocol specified|8|||
44362936|NCT01148771|79368140|FG000|Washout Period|Withdrawal by Subject|0|||
44362937|NCT01148771|79368141|FG001|Washout Period|Withdrawal by Subject|1|||
44362938|NCT01148693|79368153|FG000|Overall Study|Attempts for cannulation were failed|13|||
44362939|NCT01148693|79368154|FG001|Overall Study|Attempts for cannulation were failed|10|||
44362940|NCT00872599|79368160|FG000|Second Washout Period|Adverse Event|1|||
44362941|NCT00872599|79368161|FG001|Second Washout Period|Adverse Event|1|||
44362942|NCT01148537|79368170|FG000|Overall Study|Withdrawal by Subject|1|||
44362943|NCT01148537|79368171|FG001|Overall Study|Withdrawal by Subject|0|||
44362944|NCT01148537|79368172|FG002|Overall Study|Withdrawal by Subject|2|||
44362945|NCT01148537|79368170|FG000|Overall Study|Adverse Event|2|||
44362946|NCT01148537|79368171|FG001|Overall Study|Adverse Event|0|||
44362947|NCT01148537|79368172|FG002|Overall Study|Adverse Event|1|||
44362948|NCT01148459|79368183|FG000|Overall Study|Serious Adverse Event|5|||
44362949|NCT01148459|79368184|FG001|Overall Study|Serious Adverse Event|4|||
44362950|NCT01148459|79368183|FG000|Overall Study|Withdrawal by Subject|1|||
44362951|NCT01148459|79368184|FG001|Overall Study|Withdrawal by Subject|0|||
44362952|NCT01148459|79368183|FG000|Overall Study|Migrated/moved from study area|3|||
44362953|NCT01148459|79368184|FG001|Overall Study|Migrated/moved from study area|6|||
44362954|NCT01148459|79368183|FG000|Overall Study|Lost to Follow-up|2|||
44362955|NCT01148459|79368184|FG001|Overall Study|Lost to Follow-up|0|||
44362956|NCT01148459|79368183|FG000|Overall Study|Refusal|1|||
44362957|NCT01148459|79368184|FG001|Overall Study|Refusal|0|||
44362958|NCT01148459|79368183|FG000|Overall Study|Failure to comply with study procedures|0|||
44362959|NCT01148459|79368184|FG001|Overall Study|Failure to comply with study procedures|1|||
44362960|NCT00872521|79368193|FG000|Completed PAD Induction|Patient choice|0|||
44362961|NCT00872521|79368194|FG001|Completed PAD Induction|Patient choice|1|||
44362962|NCT00872521|79368195|FG002|Completed PAD Induction|Patient choice|0|||
44362963|NCT00872521|79368193|FG000|Completed PAD Induction|Disease progression|0|||
44362964|NCT00872521|79368194|FG001|Completed PAD Induction|Disease progression|2|||
44362965|NCT00872521|79368195|FG002|Completed PAD Induction|Disease progression|0|||
44362966|NCT00872521|79368193|FG000|Completed PAD Induction|Adverse Event|4|||
44362967|NCT00872521|79368194|FG001|Completed PAD Induction|Adverse Event|0|||
44362968|NCT00872521|79368195|FG002|Completed PAD Induction|Adverse Event|0|||
44362969|NCT00872521|79368193|FG000|Completed PAD Induction|Death|1|||
44362970|NCT00872521|79368194|FG001|Completed PAD Induction|Death|1|||
44362971|NCT00872521|79368195|FG002|Completed PAD Induction|Death|0|||
44362972|NCT00872521|79368193|FG000|Primary Endpoint Analysis|Other|1|||
44362973|NCT00872521|79368194|FG001|Primary Endpoint Analysis|Other|2|||
44362974|NCT00872521|79368195|FG002|Primary Endpoint Analysis|Other|0|||
44362975|NCT00872521|79368193|FG000|Primary Endpoint Analysis|Patient choice|0|||
44362976|NCT00872521|79368194|FG001|Primary Endpoint Analysis|Patient choice|1|||
44362977|NCT00872521|79368195|FG002|Primary Endpoint Analysis|Patient choice|0|||
44362978|NCT00872521|79368193|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
44362979|NCT00872521|79368194|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
44362980|NCT00872521|79368195|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
44362981|NCT00872521|79368193|FG000|Primary Endpoint Analysis|Patient response missing|0|||
44362982|NCT00872521|79368194|FG001|Primary Endpoint Analysis|Patient response missing|0|||
44362983|NCT00872521|79368195|FG002|Primary Endpoint Analysis|Patient response missing|1|||
44362984|NCT00872521|79368193|FG000|Completed 3-month Follow up|Other|0|||
44362985|NCT00872521|79368194|FG001|Completed 3-month Follow up|Other|2|||
44362986|NCT00872521|79368195|FG002|Completed 3-month Follow up|Other|0|||
44362987|NCT00872521|79368193|FG000|Completed 3-month Follow up|Physician Decision|0|||
44362988|NCT00872521|79368194|FG001|Completed 3-month Follow up|Physician Decision|1|||
44362989|NCT00872521|79368195|FG002|Completed 3-month Follow up|Physician Decision|0|||
44362990|NCT00872521|79368193|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
44362991|NCT00872521|79368194|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
44362992|NCT00872521|79368195|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
44362993|NCT01148225|79368214|FG000|Overall Study|Other|185|||
44202129|NCT02116361|78997792|FG003|Overall Study|Lost to Follow-up|5|||
44202130|NCT02116361|78997789|FG000|Overall Study|Personal Reasons|6|||
44202131|NCT02116361|78997790|FG001|Overall Study|Personal Reasons|6|||
44202132|NCT02116361|78997791|FG002|Overall Study|Personal Reasons|4|||
44202133|NCT02116361|78997792|FG003|Overall Study|Personal Reasons|9|||
44202134|NCT02116361|78997789|FG000|Overall Study|Investigator Decision - Relapse|9|||
44202135|NCT02116361|78997790|FG001|Overall Study|Investigator Decision - Relapse|7|||
44362994|NCT01190891|79368223|FG000|Overall Study|Protocol Violation|1|||
44362995|NCT01190891|79368224|FG001|Overall Study|Protocol Violation|0|||
44362996|NCT01190891|79368223|FG000|Overall Study|Withdrawal by Subject|5|||
44362997|NCT01190891|79368224|FG001|Overall Study|Withdrawal by Subject|0|||
44362998|NCT00871975|79368230|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
44362999|NCT00871975|79368230|FG000|Overall Study|Catheters could not be inserted|1|||
44363000|NCT00871975|79368230|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
44363001|NCT00871975|79368230|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
44363002|NCT01190813|79368236|FG000|Overall Study|Lost to Follow-up|1|||
44363003|NCT01190813|79368237|FG001|Overall Study|Lost to Follow-up|2|||
44363004|NCT01190813|79368236|FG000|Overall Study|Withdrawal by Subject|2|||
44363005|NCT01190813|79368237|FG001|Overall Study|Withdrawal by Subject|1|||
44363006|NCT01190813|79368236|FG000|Overall Study|Refused study treatment after randomized|1|||
44363007|NCT01190813|79368237|FG001|Overall Study|Refused study treatment after randomized|0|||
44363008|NCT01190813|79368236|FG000|Overall Study|Adverse Event|0|||
44363009|NCT01190813|79368237|FG001|Overall Study|Adverse Event|1|||
44363010|NCT00870727|79368259|FG000|Overall Study|Lost to Follow-up|0|||
44363011|NCT00870727|79368260|FG001|Overall Study|Lost to Follow-up|1|||
44363012|NCT00870727|79368259|FG000|Overall Study|Lack of Efficacy|1|||
44363013|NCT00870727|79368260|FG001|Overall Study|Lack of Efficacy|3|||
44363014|NCT00870727|79368259|FG000|Overall Study|Adverse Event|0|||
44363015|NCT00870727|79368260|FG001|Overall Study|Adverse Event|1|||
44363016|NCT01147055|79368266|FG000|First Intervention Period|Lost to Follow-up|1|||
44363017|NCT01147055|79368267|FG001|First Intervention Period|Lost to Follow-up|0|||
44363018|NCT01146665|79368275|FG000|Overall Study|Withdrawal by Subject|10|||
44363019|NCT01146665|79368276|FG001|Overall Study|Withdrawal by Subject|16|||
44363020|NCT01145885|79368291|FG000|Overall Study|Progressive Disease|7|||
44363021|NCT01190267|79368303|FG000|Overall Study|Adverse Event|10|||
44363022|NCT01190267|79368304|FG001|Overall Study|Adverse Event|0|||
44363023|NCT01190267|79368303|FG000|Overall Study|Treatment Failure|8|||
44363024|NCT01190267|79368304|FG001|Overall Study|Treatment Failure|2|||
44202136|NCT02116361|78997791|FG002|Overall Study|Investigator Decision - Relapse|8|||
44202137|NCT02116361|78997792|FG003|Overall Study|Investigator Decision - Relapse|5|||
44202138|NCT02140775|78997804|FG000|Overall Study|Withdrawal by Subject|30|||
44202139|NCT02140775|78997805|FG001|Overall Study|Withdrawal by Subject|7|||
44202140|NCT01844817|78997815|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
44202141|NCT01844817|78997816|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
44202142|NCT01844817|78997815|FG000|Treatment|Progressive Disease|27|||
44202143|NCT01844817|78997816|FG001|Treatment|Progressive Disease|36|||
44202144|NCT01844817|78997815|FG000|Treatment|Adverse Event|17|||
44202145|NCT01844817|78997816|FG001|Treatment|Adverse Event|9|||
44202146|NCT01844817|78997815|FG000|Treatment|Withdrawal by Subject|10|||
44268453|NCT03807778|79182693|FG002|Overall Study|Withdrawal by Subject|0|||
44202147|NCT01844817|78997816|FG001|Treatment|Withdrawal by Subject|6|||
44202148|NCT01844817|78997815|FG000|Treatment|Death|10|||
44202149|NCT01844817|78997816|FG001|Treatment|Death|8|||
44202150|NCT01844817|78997815|FG000|Treatment|Lost to Follow-up|0|||
44202151|NCT01844817|78997816|FG001|Treatment|Lost to Follow-up|1|||
44202152|NCT01844817|78997815|FG000|Treatment|Other|0|||
44202153|NCT01844817|78997816|FG001|Treatment|Other|3|||
44202154|NCT04594239|78997827|FG000|Overall Study|Withdrawal by Subject|3|||
44202155|NCT04594239|78997828|FG001|Overall Study|Withdrawal by Subject|4|||
44202156|NCT04594239|78997829|FG002|Overall Study|Withdrawal by Subject|2|||
44202157|NCT04594239|78997830|FG003|Overall Study|Withdrawal by Subject|4|||
44202158|NCT04594239|78997827|FG000|Overall Study|Lost to Follow-up|8|||
44202159|NCT04594239|78997828|FG001|Overall Study|Lost to Follow-up|5|||
44202160|NCT04594239|78997829|FG002|Overall Study|Lost to Follow-up|4|||
44202161|NCT04594239|78997830|FG003|Overall Study|Lost to Follow-up|6|||
44268454|NCT03807778|79182694|FG003|Overall Study|Withdrawal by Subject|1|||
44268455|NCT03807778|79182691|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
44268456|NCT03807778|79182692|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
44268457|NCT03807778|79182693|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
44268458|NCT03807778|79182694|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
44268459|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
44268460|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
44268461|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
44363025|NCT01190267|79368303|FG000|Overall Study|Lost to Follow-up|2|||
44363026|NCT01190267|79368304|FG001|Overall Study|Lost to Follow-up|0|||
44363027|NCT01190267|79368303|FG000|Overall Study|Withdrawal by Subject|13|||
44202162|NCT04594239|78997827|FG000|Overall Study|Subject relocated|0|||
44202163|NCT04594239|78997828|FG001|Overall Study|Subject relocated|0|||
44202164|NCT04594239|78997829|FG002|Overall Study|Subject relocated|0|||
44202165|NCT04594239|78997830|FG003|Overall Study|Subject relocated|1|||
44363028|NCT01190267|79368304|FG001|Overall Study|Withdrawal by Subject|1|||
44363029|NCT01190267|79368303|FG000|Overall Study|Protocol Violation|8|||
44363030|NCT01190267|79368304|FG001|Overall Study|Protocol Violation|1|||
44363031|NCT00869089|79368310|FG000|Overall Study|Lost to Follow-up|1|||
44363032|NCT00869089|79368310|FG000|Overall Study|Withdrawal by Subject|1|||
44363033|NCT00869089|79368310|FG000|Overall Study|Screen Fail|1|||
44202166|NCT01814553|78997848|FG000|Overall Study|PD per clinical progression|6|||
44202167|NCT01814553|78997849|FG001|Overall Study|PD per clinical progression|8|||
44202168|NCT01814553|78997848|FG000|Overall Study|Other Adverse Event|4|||
44202169|NCT01814553|78997849|FG001|Overall Study|Other Adverse Event|5|||
44268462|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
44363034|NCT01190189|79368314|FG000|Overall Study|Lost to Follow-up|4|||
44363035|NCT01190189|79368314|FG000|Overall Study|Withdrawal by Subject|1|||
44363036|NCT01190189|79368314|FG000|Overall Study|Migrated/moved from study area|1|||
44363037|NCT00871117|79368320|FG000|Overall Study|Lost to Follow-up|5|||
44363038|NCT00871117|79368321|FG001|Overall Study|Lost to Follow-up|6|||
44363039|NCT00871117|79368320|FG000|Overall Study|Other|0|||
44363040|NCT00871117|79368321|FG001|Overall Study|Other|4|||
44363041|NCT00870103|79368328|FG000|Overall Study|Physician Decision|2|||
44363042|NCT00870103|79368328|FG000|Overall Study|Lost to Follow-up|2|||
44363043|NCT01145417|79368347|FG000|Overall Study|Death|1|||
44363044|NCT01145417|79368348|FG001|Overall Study|Death|0|||
44363045|NCT01145417|79368347|FG000|Overall Study|Lost to Follow-up|2|||
44363046|NCT01145417|79368348|FG001|Overall Study|Lost to Follow-up|1|||
44363047|NCT01145417|79368347|FG000|Overall Study|Withdrawal by Subject|1|||
44363048|NCT01145417|79368348|FG001|Overall Study|Withdrawal by Subject|2|||
44363049|NCT01145417|79368347|FG000|Overall Study|Pregnancy|1|||
44363050|NCT01145417|79368348|FG001|Overall Study|Pregnancy|0|||
44363051|NCT01145417|79368347|FG000|Overall Study|Adverse Event|0|||
44363052|NCT01145417|79368348|FG001|Overall Study|Adverse Event|1|||
44363053|NCT01145417|79368347|FG000|Overall Study|Study terminated by sponsor|35|||
44363054|NCT01145417|79368348|FG001|Overall Study|Study terminated by sponsor|43|||
44363055|NCT01145417|79368347|FG000|Overall Study|Other|1|||
44363056|NCT01145417|79368348|FG001|Overall Study|Other|0|||
44363057|NCT01144715|79368356|FG000|Overall Study|Lost to Follow-up|2|||
44363058|NCT01144715|79368357|FG001|Overall Study|Lost to Follow-up|1|||
44363059|NCT01144715|79368356|FG000|Overall Study|Withdrawal by Subject|2|||
44363060|NCT01144715|79368357|FG001|Overall Study|Withdrawal by Subject|1|||
44363061|NCT01144715|79368356|FG000|Overall Study|Adverse Event|0|||
44451943|NCT00420784|79460881|FG003|Overall Study|Lost to Follow-up|1|||
44451944|NCT00420784|79460878|FG000|Overall Study|Virologic Stopping Rule|17|||
44451945|NCT00420784|79460879|FG001|Overall Study|Virologic Stopping Rule|26|||
44202170|NCT01814553|78997848|FG000|Overall Study|Withdrawal by Subject|1|||
44202171|NCT01814553|78997849|FG001|Overall Study|Withdrawal by Subject|1|||
44202172|NCT01814553|78997848|FG000|Overall Study|Other than stated|7|||
44202173|NCT01814553|78997849|FG001|Overall Study|Other than stated|8|||
44202174|NCT02116205|78997859|FG000|Overall Study|Withdrawal by Subject|2|||
44202175|NCT02116205|78997860|FG001|Overall Study|Withdrawal by Subject|4|||
44202176|NCT02116205|78997861|FG002|Overall Study|Withdrawal by Subject|1|||
44202177|NCT02116205|78997862|FG003|Overall Study|Withdrawal by Subject|3|||
44202178|NCT02116205|78997859|FG000|Overall Study|Lost to Follow-up|0|||
44202179|NCT02116205|78997860|FG001|Overall Study|Lost to Follow-up|2|||
44202180|NCT02116205|78997861|FG002|Overall Study|Lost to Follow-up|1|||
44202181|NCT02116205|78997862|FG003|Overall Study|Lost to Follow-up|2|||
44202182|NCT02116205|78997859|FG000|Overall Study|Physician Decision|0|||
44202183|NCT02116205|78997860|FG001|Overall Study|Physician Decision|1|||
44202184|NCT02116205|78997861|FG002|Overall Study|Physician Decision|1|||
44202185|NCT02116205|78997862|FG003|Overall Study|Physician Decision|1|||
44202186|NCT02116205|78997859|FG000|Overall Study|Exclusion criteria|0|||
44202187|NCT02116205|78997860|FG001|Overall Study|Exclusion criteria|0|||
44202188|NCT02116205|78997861|FG002|Overall Study|Exclusion criteria|1|||
44202189|NCT02116205|78997862|FG003|Overall Study|Exclusion criteria|0|||
44202190|NCT01844583|78997874|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
44202191|NCT01844583|78997875|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
44202192|NCT02115815|78997893|FG000|Overall Study|Withdrawal by Subject|2|||
44202193|NCT02115815|78997894|FG001|Overall Study|Withdrawal by Subject|0|||
44202194|NCT02115815|78997895|FG002|Overall Study|Withdrawal by Subject|0|||
44202195|NCT02115815|78997896|FG003|Overall Study|Withdrawal by Subject|0|||
44202196|NCT02115815|78997897|FG004|Overall Study|Withdrawal by Subject|0|||
44202197|NCT02115815|78997898|FG005|Overall Study|Withdrawal by Subject|0|||
44202198|NCT02115815|78997899|FG006|Overall Study|Withdrawal by Subject|0|||
44363062|NCT01144715|79368357|FG001|Overall Study|Adverse Event|1|||
44363063|NCT01189487|79368363|FG000|Overall Study|Lack of Efficacy|2|||
44202199|NCT02115815|78997893|FG000|Overall Study|Not enough drug to dose participant|0|||
44202200|NCT02115815|78997894|FG001|Overall Study|Not enough drug to dose participant|0|||
44202201|NCT02115815|78997895|FG002|Overall Study|Not enough drug to dose participant|0|||
44202202|NCT02115815|78997896|FG003|Overall Study|Not enough drug to dose participant|0|||
44363064|NCT01189487|79368363|FG000|Overall Study|Adverse Event|1|||
44363065|NCT01106352|79368372|FG000|Overall Study|Subjects untreated|0|||
44363066|NCT01106352|79368373|FG001|Overall Study|Subjects untreated|0|||
44451946|NCT00420784|79460880|FG002|Overall Study|Virologic Stopping Rule|41|||
44451947|NCT00420784|79460881|FG003|Overall Study|Virologic Stopping Rule|67|||
44451948|NCT00420784|79460878|FG000|Overall Study|Other|1|||
44451949|NCT00420784|79460879|FG001|Overall Study|Other|2|||
44451950|NCT00420784|79460880|FG002|Overall Study|Other|0|||
44451951|NCT00420784|79460881|FG003|Overall Study|Other|5|||
44451952|NCT00420628|79460894|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
44451953|NCT00420628|79460895|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
44451954|NCT00420628|79460894|FG000|Overall Study|Lost to Follow-up|3|||
44451955|NCT00420628|79460895|FG001|Overall Study|Lost to Follow-up|2|||
44363067|NCT01106352|79368374|FG002|Overall Study|Subjects untreated|0|||
44363068|NCT01106352|79368375|FG003|Overall Study|Subjects untreated|3|||
44363069|NCT01106352|79368376|FG004|Overall Study|Subjects untreated|4|||
44363070|NCT01106352|79368372|FG000|Overall Study|Sponsor Decision|1|||
44363071|NCT01106352|79368373|FG001|Overall Study|Sponsor Decision|0|||
44363072|NCT01106352|79368374|FG002|Overall Study|Sponsor Decision|0|||
44202203|NCT02115815|78997897|FG004|Overall Study|Not enough drug to dose participant|0|||
44202204|NCT02115815|78997898|FG005|Overall Study|Not enough drug to dose participant|1|||
44202205|NCT02115815|78997899|FG006|Overall Study|Not enough drug to dose participant|0|||
44202206|NCT02115815|78997893|FG000|Overall Study|Missed appointment, randomized in error|0|||
44202207|NCT02115815|78997894|FG001|Overall Study|Missed appointment, randomized in error|0|||
44202208|NCT02115815|78997895|FG002|Overall Study|Missed appointment, randomized in error|0|||
44202209|NCT02115815|78997896|FG003|Overall Study|Missed appointment, randomized in error|0|||
44202210|NCT02115815|78997897|FG004|Overall Study|Missed appointment, randomized in error|0|||
44202211|NCT02115815|78997898|FG005|Overall Study|Missed appointment, randomized in error|1|||
44202212|NCT02115815|78997899|FG006|Overall Study|Missed appointment, randomized in error|0|||
44202213|NCT02115269|78997915|FG000|Overall Study|Lost to Follow-up|43|||
44202214|NCT02115269|78997915|FG000|Overall Study|Did not complete patient diary|3|||
44202215|NCT02115269|78997915|FG000|Overall Study|Moved to another city|7|||
44202216|NCT02115269|78997915|FG000|Overall Study|Withdrawal by Subject|2|||
44202217|NCT02115269|78997915|FG000|Overall Study|Didn't take study drug|2|||
44202218|NCT02115113|78997930|FG000|Participants in Run-in Period|Death|0|||
44202219|NCT02115113|78997931|FG001|Participants in Run-in Period|Death|0|||
44363073|NCT01106352|79368375|FG003|Overall Study|Sponsor Decision|0|||
44202220|NCT02115113|78997932|FG002|Participants in Run-in Period|Death|1|||
44202221|NCT02115113|78997930|FG000|Participants in Run-in Period|Administrative problems|0|||
44363074|NCT01106352|79368376|FG004|Overall Study|Sponsor Decision|0|||
44363075|NCT01106352|79368372|FG000|Overall Study|Too ill to come in for the visit|0|||
44363076|NCT01106352|79368373|FG001|Overall Study|Too ill to come in for the visit|0|||
44363077|NCT01106352|79368374|FG002|Overall Study|Too ill to come in for the visit|1|||
44363078|NCT01106352|79368375|FG003|Overall Study|Too ill to come in for the visit|0|||
44202222|NCT02115113|78997931|FG001|Participants in Run-in Period|Administrative problems|0|||
44363079|NCT01106352|79368376|FG004|Overall Study|Too ill to come in for the visit|0|||
44363080|NCT01106352|79368372|FG000|Overall Study|Lost to Follow-up|0|||
44363081|NCT01106352|79368373|FG001|Overall Study|Lost to Follow-up|0|||
44363082|NCT01106352|79368374|FG002|Overall Study|Lost to Follow-up|0|||
44363083|NCT01106352|79368375|FG003|Overall Study|Lost to Follow-up|0|||
44363084|NCT01106352|79368376|FG004|Overall Study|Lost to Follow-up|1|||
44363085|NCT01106352|79368372|FG000|Overall Study|Death|0|||
44363086|NCT01106352|79368373|FG001|Overall Study|Death|0|||
44363087|NCT01106352|79368374|FG002|Overall Study|Death|1|||
44363088|NCT01106352|79368375|FG003|Overall Study|Death|3|||
44363089|NCT01106352|79368376|FG004|Overall Study|Death|1|||
44363090|NCT01106352|79368372|FG000|Overall Study|Disease progression|0|||
44363091|NCT01106352|79368373|FG001|Overall Study|Disease progression|0|||
44363092|NCT01106352|79368374|FG002|Overall Study|Disease progression|0|||
44363093|NCT01106352|79368375|FG003|Overall Study|Disease progression|1|||
44363094|NCT01106352|79368376|FG004|Overall Study|Disease progression|0|||
44363095|NCT01106352|79368372|FG000|Overall Study|Withdrawal by Subject|0|||
44363096|NCT01106352|79368373|FG001|Overall Study|Withdrawal by Subject|0|||
44363097|NCT01106352|79368374|FG002|Overall Study|Withdrawal by Subject|0|||
44451956|NCT00420628|79460894|FG000|Overall Study|Adverse Event|1|||
44451957|NCT00420628|79460895|FG001|Overall Study|Adverse Event|0|||
44451958|NCT00489255|79460903|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
44451959|NCT00489255|79460904|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
44451960|NCT00489255|79460903|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
44451961|NCT00489255|79460904|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
44451962|NCT00489255|79460903|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
44451963|NCT00489255|79460904|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
44363098|NCT01106352|79368375|FG003|Overall Study|Withdrawal by Subject|3|||
44363099|NCT01106352|79368376|FG004|Overall Study|Withdrawal by Subject|2|||
44363100|NCT01106352|79368372|FG000|Overall Study|Went on hospice|0|||
44363101|NCT01106352|79368373|FG001|Overall Study|Went on hospice|0|||
44363102|NCT01106352|79368374|FG002|Overall Study|Went on hospice|0|||
44363103|NCT01106352|79368375|FG003|Overall Study|Went on hospice|1|||
44363104|NCT01106352|79368376|FG004|Overall Study|Went on hospice|0|||
44363105|NCT01106352|79368372|FG000|Overall Study|Subject entered hospice|0|||
44363106|NCT01106352|79368373|FG001|Overall Study|Subject entered hospice|0|||
44363107|NCT01106352|79368374|FG002|Overall Study|Subject entered hospice|0|||
44363108|NCT01106352|79368375|FG003|Overall Study|Subject entered hospice|1|||
44363109|NCT01106352|79368376|FG004|Overall Study|Subject entered hospice|0|||
44363110|NCT01106352|79368372|FG000|Overall Study|Home hospice since July 2013|0|||
44363111|NCT01106352|79368373|FG001|Overall Study|Home hospice since July 2013|0|||
44363112|NCT01106352|79368374|FG002|Overall Study|Home hospice since July 2013|0|||
44363113|NCT01106352|79368375|FG003|Overall Study|Home hospice since July 2013|1|||
44363114|NCT01106352|79368376|FG004|Overall Study|Home hospice since July 2013|0|||
44363115|NCT01144403|79368392|FG000|Overall Study|Lost to Follow-up|3|||
44363116|NCT01144403|79368392|FG000|Overall Study|Death|1|||
44363117|NCT01144403|79368392|FG000|Overall Study|Adverse Event|1|||
44363118|NCT01143389|79368399|FG000|Overall Study|Lost to Follow-up|26|||
44363119|NCT01143389|79368400|FG001|Overall Study|Lost to Follow-up|25|||
44363120|NCT00868231|79368406|FG000|Treatment Period 1|Adverse Event|0|||
44363121|NCT00868231|79368407|FG001|Treatment Period 1|Adverse Event|0|||
44363122|NCT00868231|79368408|FG002|Treatment Period 1|Adverse Event|0|||
44363123|NCT00868231|79368409|FG003|Treatment Period 1|Adverse Event|0|||
44363124|NCT00868231|79368410|FG004|Treatment Period 1|Adverse Event|1|||
44363125|NCT00868231|79368411|FG005|Treatment Period 1|Adverse Event|0|||
44363126|NCT00868231|79368406|FG000|Treatment Period 2|Adverse Event|1|||
44363127|NCT00868231|79368407|FG001|Treatment Period 2|Adverse Event|0|||
44363128|NCT00868231|79368408|FG002|Treatment Period 2|Adverse Event|0|||
44363129|NCT00868231|79368409|FG003|Treatment Period 2|Adverse Event|0|||
44363130|NCT00868231|79368410|FG004|Treatment Period 2|Adverse Event|0|||
44363131|NCT00868231|79368411|FG005|Treatment Period 2|Adverse Event|0|||
44363132|NCT00868231|79368406|FG000|Treatment Period 3|Adverse Event|0|||
44363133|NCT00868231|79368407|FG001|Treatment Period 3|Adverse Event|0|||
44363134|NCT00868231|79368408|FG002|Treatment Period 3|Adverse Event|1|||
44363135|NCT00868231|79368409|FG003|Treatment Period 3|Adverse Event|0|||
44363136|NCT00868231|79368410|FG004|Treatment Period 3|Adverse Event|0|||
44363137|NCT00868231|79368411|FG005|Treatment Period 3|Adverse Event|0|||
44363138|NCT01143077|79368422|FG000|Overall Study|Lack of Efficacy|0|||
44363139|NCT01143077|79368423|FG001|Overall Study|Lack of Efficacy|2|||
44363140|NCT01143077|79368424|FG002|Overall Study|Lack of Efficacy|1|||
44363141|NCT01143077|79368422|FG000|Overall Study|Adverse Event|5|||
44363142|NCT01143077|79368423|FG001|Overall Study|Adverse Event|6|||
44363143|NCT01143077|79368424|FG002|Overall Study|Adverse Event|5|||
44363144|NCT01143077|79368422|FG000|Overall Study|Lost to Follow-up|2|||
44363145|NCT01143077|79368423|FG001|Overall Study|Lost to Follow-up|3|||
44363146|NCT01143077|79368424|FG002|Overall Study|Lost to Follow-up|4|||
44363147|NCT01143077|79368422|FG000|Overall Study|Protocol Violation|2|||
44363148|NCT01143077|79368423|FG001|Overall Study|Protocol Violation|0|||
44363149|NCT01143077|79368424|FG002|Overall Study|Protocol Violation|0|||
44363150|NCT01143077|79368422|FG000|Overall Study|Withdrawal by Subject|4|||
44363151|NCT01143077|79368423|FG001|Overall Study|Withdrawal by Subject|3|||
44363152|NCT01143077|79368424|FG002|Overall Study|Withdrawal by Subject|3|||
44363153|NCT01143077|79368422|FG000|Overall Study|Non-compliance with study drug|0|||
44363154|NCT01143077|79368423|FG001|Overall Study|Non-compliance with study drug|1|||
44363155|NCT01143077|79368424|FG002|Overall Study|Non-compliance with study drug|1|||
44363156|NCT01143077|79368422|FG000|Overall Study|Administrative|1|||
44363157|NCT01143077|79368423|FG001|Overall Study|Administrative|0|||
44363158|NCT01143077|79368424|FG002|Overall Study|Administrative|0|||
44363159|NCT01143077|79368422|FG000|Overall Study|Principal Investigator Decision|2|||
44363160|NCT01143077|79368423|FG001|Overall Study|Principal Investigator Decision|0|||
44363161|NCT01143077|79368424|FG002|Overall Study|Principal Investigator Decision|1|||
44363162|NCT01096446|79368434|FG000|Overall Study|Death|1|||
44363163|NCT01096446|79368435|FG001|Overall Study|Death|0|||
44363164|NCT01096446|79368434|FG000|Overall Study|Protocol Violation|2|||
44363165|NCT01096446|79368435|FG001|Overall Study|Protocol Violation|0|||
44363166|NCT00864721|79368440|FG000|Overall Study|Patient request|11|||
44363167|NCT00864721|79368440|FG000|Overall Study|Hospitalized|1|||
44363168|NCT00864721|79368440|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
44363169|NCT00864721|79368440|FG000|Overall Study|Adverse Event|21|||
44363170|NCT01095666|79368447|FG000|Overall Study|Lack of Efficacy|0|||
44363171|NCT01095666|79368448|FG001|Overall Study|Lack of Efficacy|0|||
44363172|NCT01095666|79368449|FG002|Overall Study|Lack of Efficacy|1|||
44363173|NCT01095666|79368447|FG000|Overall Study|Adverse Event|2|||
44363174|NCT01095666|79368448|FG001|Overall Study|Adverse Event|1|||
44363175|NCT01095666|79368449|FG002|Overall Study|Adverse Event|3|||
44363176|NCT01095666|79368447|FG000|Overall Study|Lost to Follow-up|2|||
44363177|NCT01095666|79368448|FG001|Overall Study|Lost to Follow-up|2|||
44363178|NCT01095666|79368449|FG002|Overall Study|Lost to Follow-up|0|||
44363179|NCT01095666|79368447|FG000|Overall Study|Withdrawal by Subject|6|||
44363180|NCT01095666|79368448|FG001|Overall Study|Withdrawal by Subject|6|||
44363181|NCT01095666|79368449|FG002|Overall Study|Withdrawal by Subject|1|||
44363182|NCT01095666|79368447|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
44363183|NCT01095666|79368448|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
44363184|NCT01095666|79368449|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
44363185|NCT01100658|79368457|FG000|Overall Study|Withdrawal by Subject|1|||
44363186|NCT01100502|79368463|FG000|Overall Study|Withdrawal by Subject|18|||
44363187|NCT01100502|79368464|FG001|Overall Study|Withdrawal by Subject|25|||
44363188|NCT01100502|79368463|FG000|Overall Study|Lost to Follow-up|13|||
44363189|NCT01100502|79368464|FG001|Overall Study|Lost to Follow-up|28|||
44363190|NCT01100502|79368463|FG000|Overall Study|Site request to end participation in study|0|||
44363191|NCT01100502|79368464|FG001|Overall Study|Site request to end participation in study|1|||
44363192|NCT01100502|79368463|FG000|Overall Study|Death|45|||
44363193|NCT01100502|79368464|FG001|Overall Study|Death|40|||
44363194|NCT01094886|79368470|FG000|Overall Study|Adverse Event|2|||
44363195|NCT01094886|79368470|FG000|Overall Study|Withdrawal by Subject|5|||
44363196|NCT01094808|79368477|FG000|Overall Study|Withdrawal by Subject|1|||
44363197|NCT01094808|79368478|FG001|Overall Study|Withdrawal by Subject|1|||
44363198|NCT01094808|79368479|FG002|Overall Study|Withdrawal by Subject|0|||
44363199|NCT00864253|79368489|FG000|Overall Study|Adverse Event|56|||
44363200|NCT00864253|79368490|FG001|Overall Study|Adverse Event|11|||
44363201|NCT00864253|79368489|FG000|Overall Study|Unrelated Adverse Event|3|||
44363202|NCT00864253|79368490|FG001|Overall Study|Unrelated Adverse Event|1|||
44363203|NCT00864253|79368489|FG000|Overall Study|Physician Decision|11|||
44363204|NCT00864253|79368490|FG001|Overall Study|Physician Decision|15|||
44363205|NCT00864253|79368489|FG000|Overall Study|Protocol Violation|0|||
44363206|NCT00864253|79368490|FG001|Overall Study|Protocol Violation|2|||
44363207|NCT00864253|79368489|FG000|Overall Study|Lost to Follow-up|1|||
44363208|NCT00864253|79368490|FG001|Overall Study|Lost to Follow-up|1|||
44363209|NCT00864253|79368489|FG000|Overall Study|Withdrawal by Subject|18|||
44363210|NCT00864253|79368490|FG001|Overall Study|Withdrawal by Subject|18|||
44363211|NCT00864253|79368489|FG000|Overall Study|Death|1|||
44363212|NCT00864253|79368490|FG001|Overall Study|Death|0|||
44363213|NCT00864253|79368489|FG000|Overall Study|Ongoing|2|||
44363214|NCT00864253|79368490|FG001|Overall Study|Ongoing|3|||
44363215|NCT00864253|79368489|FG000|Overall Study|Untreated|7|||
44363216|NCT00864253|79368490|FG001|Overall Study|Untreated|7|||
44363217|NCT01094730|79368498|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
44363218|NCT01094730|79368499|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
44363219|NCT01094730|79368498|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
44363220|NCT01094730|79368499|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
44363221|NCT01094730|79368498|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
44363222|NCT01094730|79368499|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
44363223|NCT01094730|79368498|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
44363224|NCT01094730|79368499|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
44363225|NCT01094730|79368498|FG000|Period 2 (14 Days)|Protocol Violation|2|||
44363226|NCT01094730|79368499|FG001|Period 2 (14 Days)|Protocol Violation|0|||
44363227|NCT01094730|79368498|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
44363228|NCT01094730|79368499|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
44363229|NCT01094730|79368498|FG000|Period 2 (14 Days)|Adverse Event|0|||
44363230|NCT01094730|79368499|FG001|Period 2 (14 Days)|Adverse Event|1|||
44363231|NCT01094730|79368498|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
44363232|NCT01094730|79368499|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
44363233|NCT00864097|79368514|FG000|Overall Study|Death|0|||
44363234|NCT00864097|79368515|FG001|Overall Study|Death|1|||
44363235|NCT00864097|79368516|FG002|Overall Study|Death|0|||
44363236|NCT00864097|79368517|FG003|Overall Study|Death|0|||
44363237|NCT00864097|79368514|FG000|Overall Study|Adverse Event|6|||
44363238|NCT00864097|79368515|FG001|Overall Study|Adverse Event|8|||
44363239|NCT00864097|79368516|FG002|Overall Study|Adverse Event|11|||
44363240|NCT00864097|79368517|FG003|Overall Study|Adverse Event|9|||
44363241|NCT00864097|79368514|FG000|Overall Study|Lack of Efficacy|9|||
44363242|NCT00864097|79368515|FG001|Overall Study|Lack of Efficacy|3|||
44363243|NCT00864097|79368516|FG002|Overall Study|Lack of Efficacy|7|||
44363244|NCT00864097|79368517|FG003|Overall Study|Lack of Efficacy|2|||
44363245|NCT00864097|79368514|FG000|Overall Study|Lost to Follow-up|0|||
44363246|NCT00864097|79368515|FG001|Overall Study|Lost to Follow-up|1|||
44363247|NCT00864097|79368516|FG002|Overall Study|Lost to Follow-up|0|||
44363248|NCT00864097|79368517|FG003|Overall Study|Lost to Follow-up|1|||
44363249|NCT00864097|79368514|FG000|Overall Study|Withdrawal by Subject|15|||
44363250|NCT00864097|79368515|FG001|Overall Study|Withdrawal by Subject|11|||
44363251|NCT00864097|79368516|FG002|Overall Study|Withdrawal by Subject|11|||
44363252|NCT00864097|79368517|FG003|Overall Study|Withdrawal by Subject|12|||
44363253|NCT00864097|79368514|FG000|Overall Study|Protocol Violation|2|||
44363254|NCT00864097|79368515|FG001|Overall Study|Protocol Violation|1|||
44363255|NCT00864097|79368516|FG002|Overall Study|Protocol Violation|0|||
44363256|NCT00864097|79368517|FG003|Overall Study|Protocol Violation|1|||
44363257|NCT00864097|79368514|FG000|Overall Study|Terminated by sponsor|105|||
44363258|NCT00864097|79368515|FG001|Overall Study|Terminated by sponsor|112|||
44363259|NCT00864097|79368516|FG002|Overall Study|Terminated by sponsor|102|||
44363260|NCT00864097|79368517|FG003|Overall Study|Terminated by sponsor|99|||
44363261|NCT00864097|79368514|FG000|Overall Study|Randomized but not treated|2|||
44363262|NCT00864097|79368515|FG001|Overall Study|Randomized but not treated|0|||
44363263|NCT00864097|79368516|FG002|Overall Study|Randomized but not treated|1|||
44202223|NCT02115113|78997932|FG002|Participants in Run-in Period|Administrative problems|1|||
44202224|NCT02115113|78997930|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
44202225|NCT02115113|78997931|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
44202226|NCT02115113|78997932|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
44202227|NCT02115113|78997930|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
44202228|NCT02115113|78997931|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
44202229|NCT02115113|78997932|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
44202230|NCT02115113|78997930|FG000|Participants Randomized|Lost to Follow-up|1|||
44202231|NCT02115113|78997931|FG001|Participants Randomized|Lost to Follow-up|0|||
44202232|NCT02115113|78997932|FG002|Participants Randomized|Lost to Follow-up|0|||
44202233|NCT02115113|78997930|FG000|Participants Randomized|Death|1|||
44202234|NCT02115113|78997931|FG001|Participants Randomized|Death|0|||
44202235|NCT02115113|78997932|FG002|Participants Randomized|Death|0|||
44202236|NCT02114879|78997943|FG000|Overall Study|Withdrawal by Subject|9|||
44202237|NCT02114879|78997944|FG001|Overall Study|Withdrawal by Subject|5|||
44202238|NCT02114879|78997943|FG000|Overall Study|Death|6|||
44202239|NCT02114879|78997944|FG001|Overall Study|Death|11|||
44202240|NCT02114879|78997943|FG000|Overall Study|Lost to Follow-up|4|||
44202241|NCT02114879|78997944|FG001|Overall Study|Lost to Follow-up|6|||
44202242|NCT02114879|78997943|FG000|Overall Study|Physician Decision|0|||
44202243|NCT02114879|78997944|FG001|Overall Study|Physician Decision|2|||
44202244|NCT02114177|78997952|FG000|Overall Study|Lost to Follow-up|1|||
44202245|NCT02114177|78997953|FG001|Overall Study|Lost to Follow-up|2|||
44202246|NCT02114177|78997952|FG000|Overall Study|Withdrawal by Subject|6|||
44202247|NCT02114177|78997953|FG001|Overall Study|Withdrawal by Subject|1|||
44202248|NCT02114177|78997952|FG000|Overall Study|Other|2|||
44202249|NCT02114177|78997953|FG001|Overall Study|Other|1|||
44202250|NCT02138825|78997961|FG000|Main Study Treatment|Adverse Event|11|||
44202251|NCT02138825|78997962|FG001|Main Study Treatment|Adverse Event|3|||
44202252|NCT02138825|78997961|FG000|Main Study Treatment|Death|1|||
44202253|NCT02138825|78997962|FG001|Main Study Treatment|Death|2|||
44202254|NCT02138825|78997961|FG000|Main Study Treatment|Protocol Violation|2|||
44202255|NCT02138825|78997962|FG001|Main Study Treatment|Protocol Violation|2|||
44202256|NCT02138825|78997961|FG000|Main Study Treatment|Sponsor decision|12|||
44202257|NCT02138825|78997962|FG001|Main Study Treatment|Sponsor decision|18|||
44202258|NCT02138825|78997961|FG000|Main Study Treatment|Study terminated by sponsor|10|||
44202259|NCT02138825|78997962|FG001|Main Study Treatment|Study terminated by sponsor|9|||
44202260|NCT02138825|78997961|FG000|Main Study Treatment|Withdrawal by Subject|3|||
44202261|NCT02138825|78997962|FG001|Main Study Treatment|Withdrawal by Subject|1|||
44202262|NCT02138825|78997961|FG000|Main Study Treatment|Medical decision|1|||
44268463|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
44268464|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
44268465|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
44268466|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
44268467|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
44268468|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
44268469|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
44268470|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
44268471|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
44268472|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
44268473|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
44268474|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
44268475|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
44202263|NCT02138825|78997962|FG001|Main Study Treatment|Medical decision|0|||
44363264|NCT00864097|79368517|FG003|Overall Study|Randomized but not treated|0|||
44363265|NCT00864097|79368514|FG000|Overall Study|Other|0|||
44363266|NCT00864097|79368515|FG001|Overall Study|Other|0|||
44363267|NCT00864097|79368516|FG002|Overall Study|Other|0|||
44363268|NCT00864097|79368517|FG003|Overall Study|Other|1|||
44363269|NCT01183013|79368534|FG000|Overall Study|Adverse Event|6|||
44363270|NCT01183013|79368535|FG001|Overall Study|Adverse Event|8|||
44363271|NCT01183013|79368536|FG002|Overall Study|Adverse Event|5|||
44363272|NCT01183013|79368537|FG003|Overall Study|Adverse Event|5|||
44363273|NCT01183013|79368538|FG004|Overall Study|Adverse Event|10|||
44363274|NCT01183013|79368539|FG005|Overall Study|Adverse Event|10|||
44363275|NCT01183013|79368540|FG006|Overall Study|Adverse Event|6|||
44363276|NCT01183013|79368534|FG000|Overall Study|Lack of Efficacy|3|||
44363277|NCT01183013|79368535|FG001|Overall Study|Lack of Efficacy|2|||
44202264|NCT02138825|78997961|FG000|Long-term Extension|Study termination by sponsor|32|||
44202265|NCT02138825|78997962|FG001|Long-term Extension|Study termination by sponsor|38|||
44202266|NCT02138825|78997961|FG000|Safety Follow-up|Adverse Event|4|||
44202267|NCT02138825|78997962|FG001|Safety Follow-up|Adverse Event|3|||
44202268|NCT02138825|78997961|FG000|Safety Follow-up|Death|11|||
44202269|NCT02138825|78997962|FG001|Safety Follow-up|Death|5|||
44202270|NCT02138825|78997961|FG000|Safety Follow-up|Withdrawal by Subject|5|||
44202271|NCT02138825|78997962|FG001|Safety Follow-up|Withdrawal by Subject|3|||
44202272|NCT02138825|78997961|FG000|Safety Follow-up|clinic worsening|1|||
44202273|NCT02138825|78997962|FG001|Safety Follow-up|clinic worsening|0|||
44202274|NCT02138825|78997961|FG000|Safety Follow-up|withdrawal by PI|1|||
44202275|NCT02138825|78997962|FG001|Safety Follow-up|withdrawal by PI|0|||
44202276|NCT02138825|78997961|FG000|Safety Follow-up|logistical difficulties|0|||
44202277|NCT02138825|78997962|FG001|Safety Follow-up|logistical difficulties|1|||
44202278|NCT02138825|78997961|FG000|Safety Follow-up|progressive disease|0|||
44202279|NCT02138825|78997962|FG001|Safety Follow-up|progressive disease|2|||
44202280|NCT02138825|78997961|FG000|Safety Follow-up|too unwell to attend the visit|0|||
44202281|NCT02138825|78997962|FG001|Safety Follow-up|too unwell to attend the visit|1|||
44202282|NCT02138825|78997961|FG000|Safety Follow-up|treatment unblinded|0|||
44202283|NCT02138825|78997962|FG001|Safety Follow-up|treatment unblinded|1|||
44202284|NCT02138825|78997961|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
44202285|NCT02138825|78997962|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
44202286|NCT02138747|78997977|FG000|Treatment Period 1|Adverse Event|10|||
44268476|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
44363278|NCT01183013|79368536|FG002|Overall Study|Lack of Efficacy|1|||
44363279|NCT01183013|79368537|FG003|Overall Study|Lack of Efficacy|2|||
44363280|NCT01183013|79368538|FG004|Overall Study|Lack of Efficacy|1|||
44363281|NCT01183013|79368539|FG005|Overall Study|Lack of Efficacy|2|||
44363282|NCT01183013|79368540|FG006|Overall Study|Lack of Efficacy|0|||
44363283|NCT01183013|79368534|FG000|Overall Study|Protocol Violation|5|||
44363284|NCT01183013|79368535|FG001|Overall Study|Protocol Violation|2|||
44363285|NCT01183013|79368536|FG002|Overall Study|Protocol Violation|4|||
44363286|NCT01183013|79368537|FG003|Overall Study|Protocol Violation|0|||
44363287|NCT01183013|79368538|FG004|Overall Study|Protocol Violation|4|||
44363288|NCT01183013|79368539|FG005|Overall Study|Protocol Violation|3|||
44363289|NCT01183013|79368540|FG006|Overall Study|Protocol Violation|3|||
44363290|NCT01183013|79368534|FG000|Overall Study|Lost to Follow-up|7|||
44363291|NCT01183013|79368535|FG001|Overall Study|Lost to Follow-up|3|||
44363292|NCT01183013|79368536|FG002|Overall Study|Lost to Follow-up|4|||
44363293|NCT01183013|79368537|FG003|Overall Study|Lost to Follow-up|3|||
44363294|NCT01183013|79368538|FG004|Overall Study|Lost to Follow-up|2|||
44363295|NCT01183013|79368539|FG005|Overall Study|Lost to Follow-up|6|||
44363296|NCT01183013|79368540|FG006|Overall Study|Lost to Follow-up|5|||
44363297|NCT01183013|79368534|FG000|Overall Study|Withdrawal by Subject|9|||
44363298|NCT01183013|79368535|FG001|Overall Study|Withdrawal by Subject|13|||
44363299|NCT01183013|79368536|FG002|Overall Study|Withdrawal by Subject|10|||
44268477|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
44268478|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
44268479|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
44268480|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
44268481|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
44268482|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
44268483|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
44268484|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
44268485|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
44363300|NCT01183013|79368537|FG003|Overall Study|Withdrawal by Subject|8|||
44363301|NCT01183013|79368538|FG004|Overall Study|Withdrawal by Subject|7|||
44363302|NCT01183013|79368539|FG005|Overall Study|Withdrawal by Subject|9|||
44363303|NCT01183013|79368540|FG006|Overall Study|Withdrawal by Subject|10|||
44363304|NCT01183013|79368534|FG000|Overall Study|Reasons other than stated above|15|||
44363305|NCT01183013|79368535|FG001|Overall Study|Reasons other than stated above|11|||
44363306|NCT01183013|79368536|FG002|Overall Study|Reasons other than stated above|17|||
44363307|NCT01183013|79368537|FG003|Overall Study|Reasons other than stated above|12|||
44363308|NCT01183013|79368538|FG004|Overall Study|Reasons other than stated above|12|||
44363309|NCT01183013|79368539|FG005|Overall Study|Reasons other than stated above|15|||
44363310|NCT01183013|79368540|FG006|Overall Study|Reasons other than stated above|13|||
44363311|NCT01141283|79368564|FG000|Overall Study|Adverse Event|56|||
44363312|NCT01141283|79368564|FG000|Overall Study|Lost to Follow-up|4|||
44363313|NCT01141283|79368564|FG000|Overall Study|Withdrawal by Subject|14|||
44363314|NCT01141283|79368564|FG000|Overall Study|Administrative|4|||
44363315|NCT01141283|79368564|FG000|Overall Study|Lack of Efficacy|10|||
44363316|NCT00863707|79368570|FG000|Overall Study|Randomized, but drug not received|4|||
44363317|NCT00863707|79368571|FG001|Overall Study|Randomized, but drug not received|3|||
44363318|NCT01094184|79368579|FG000|Overall Study|Death|35|||
44363319|NCT01094184|79368580|FG001|Overall Study|Death|11|||
44363320|NCT01134731|79368589|FG000|Overall Study|Adverse Event|3|||
44363321|NCT01134731|79368590|FG001|Overall Study|Adverse Event|2|||
44363322|NCT01134731|79368591|FG002|Overall Study|Adverse Event|1|||
44363323|NCT01134731|79368589|FG000|Overall Study|Physician Decision|2|||
44363324|NCT01134731|79368590|FG001|Overall Study|Physician Decision|2|||
44363325|NCT01134731|79368591|FG002|Overall Study|Physician Decision|2|||
44363326|NCT01134731|79368589|FG000|Overall Study|Lack of Efficacy|0|||
44363327|NCT01134731|79368590|FG001|Overall Study|Lack of Efficacy|0|||
44363328|NCT01134731|79368591|FG002|Overall Study|Lack of Efficacy|1|||
44363329|NCT01134731|79368589|FG000|Overall Study|Withdrawal by Subject|3|||
44363330|NCT01134731|79368590|FG001|Overall Study|Withdrawal by Subject|3|||
44363331|NCT01134731|79368591|FG002|Overall Study|Withdrawal by Subject|1|||
44202287|NCT02138747|78997978|FG001|Treatment Period 1|Adverse Event|14|||
44202288|NCT02138747|78997979|FG002|Treatment Period 1|Adverse Event|2|||
44202289|NCT02138747|78997980|FG003|Treatment Period 1|Adverse Event|1|||
44202290|NCT02138747|78997977|FG000|Treatment Period 1|Lost to Follow-up|0|||
44202291|NCT02138747|78997978|FG001|Treatment Period 1|Lost to Follow-up|1|||
44202292|NCT02138747|78997979|FG002|Treatment Period 1|Lost to Follow-up|1|||
44202293|NCT02138747|78997980|FG003|Treatment Period 1|Lost to Follow-up|0|||
44202294|NCT02138747|78997977|FG000|Treatment Period 1|Protocol Violation|0|||
44363332|NCT01134731|79368589|FG000|Overall Study|Lost to Follow-up|5|||
44363333|NCT01134731|79368590|FG001|Overall Study|Lost to Follow-up|4|||
44363334|NCT01134731|79368591|FG002|Overall Study|Lost to Follow-up|3|||
44363335|NCT01141205|79368602|FG000|Overall Study|Physician Decision|1|||
44363336|NCT01141205|79368603|FG001|Overall Study|Physician Decision|1|||
44363337|NCT01141205|79368602|FG000|Overall Study|Lost to Follow-up|1|||
44363338|NCT01141205|79368603|FG001|Overall Study|Lost to Follow-up|0|||
44363339|NCT01141205|79368602|FG000|Overall Study|Withdrawal by Subject|1|||
44363340|NCT01141205|79368603|FG001|Overall Study|Withdrawal by Subject|1|||
44363341|NCT01140503|79368613|FG000|Overall Study|Withdrawal by Subject|1|||
44363342|NCT00863317|79368619|FG000|Overall Study|Lost to Follow-up|8|||
44363343|NCT00863317|79368620|FG001|Overall Study|Lost to Follow-up|9|||
44363344|NCT01200368|79368629|FG000|Infant Series|Adverse Event|2|||
44363345|NCT01200368|79368630|FG001|Infant Series|Adverse Event|2|||
44363346|NCT01200368|79368631|FG002|Infant Series|Adverse Event|3|||
44363347|NCT01200368|79368629|FG000|Infant Series|Withdrawal by Subject|0|||
44363348|NCT01200368|79368630|FG001|Infant Series|Withdrawal by Subject|2|||
44363349|NCT01200368|79368631|FG002|Infant Series|Withdrawal by Subject|2|||
44363350|NCT01200368|79368629|FG000|Infant Series|Did not meet entrance criteria|0|||
44363351|NCT01200368|79368630|FG001|Infant Series|Did not meet entrance criteria|1|||
44363352|NCT01200368|79368631|FG002|Infant Series|Did not meet entrance criteria|0|||
44363353|NCT01200368|79368629|FG000|Infant Series|Randomized, not vaccinated|0|||
44363354|NCT01200368|79368630|FG001|Infant Series|Randomized, not vaccinated|1|||
44363355|NCT01200368|79368631|FG002|Infant Series|Randomized, not vaccinated|1|||
44363356|NCT01200368|79368629|FG000|Infant Series|Other|1|||
44363357|NCT01200368|79368630|FG001|Infant Series|Other|0|||
44363358|NCT01200368|79368631|FG002|Infant Series|Other|0|||
44363359|NCT01200368|79368629|FG000|After Infant Series|Adverse Event|6|||
44363360|NCT01200368|79368630|FG001|After Infant Series|Adverse Event|6|||
44363361|NCT01200368|79368631|FG002|After Infant Series|Adverse Event|3|||
44202295|NCT02138747|78997978|FG001|Treatment Period 1|Protocol Violation|2|||
44363362|NCT01200368|79368629|FG000|After Infant Series|Withdrawal by Subject|10|||
44363363|NCT01200368|79368630|FG001|After Infant Series|Withdrawal by Subject|8|||
44363364|NCT01200368|79368631|FG002|After Infant Series|Withdrawal by Subject|4|||
44363365|NCT01200368|79368629|FG000|After Infant Series|Lost to Follow-up|1|||
44363366|NCT01200368|79368630|FG001|After Infant Series|Lost to Follow-up|0|||
44202296|NCT02138747|78997979|FG002|Treatment Period 1|Protocol Violation|0|||
44363367|NCT01200368|79368631|FG002|After Infant Series|Lost to Follow-up|0|||
44363368|NCT01200368|79368629|FG000|After Infant Series|Other|1|||
44363369|NCT01200368|79368630|FG001|After Infant Series|Other|2|||
44363370|NCT01200368|79368631|FG002|After Infant Series|Other|2|||
44363371|NCT01200368|79368629|FG000|Toddler Dose|Adverse Event|0|||
44363372|NCT01200368|79368630|FG001|Toddler Dose|Adverse Event|3|||
44363373|NCT01200368|79368631|FG002|Toddler Dose|Adverse Event|1|||
44363374|NCT01079130|79368652|FG000|Overall Study|Adverse Event|1|||
44202297|NCT02138747|78997980|FG003|Treatment Period 1|Protocol Violation|0|||
44202298|NCT02138747|78997977|FG000|Treatment Period 1|Withdrawal by Subject|8|||
44363375|NCT01079130|79368653|FG001|Overall Study|Adverse Event|1|||
44363376|NCT01079130|79368654|FG002|Overall Study|Adverse Event|0|||
44363377|NCT01079130|79368655|FG003|Overall Study|Adverse Event|1|||
44363378|NCT01079130|79368656|FG004|Overall Study|Adverse Event|5|||
44202299|NCT02138747|78997978|FG001|Treatment Period 1|Withdrawal by Subject|4|||
44202300|NCT02138747|78997979|FG002|Treatment Period 1|Withdrawal by Subject|1|||
44202301|NCT02138747|78997980|FG003|Treatment Period 1|Withdrawal by Subject|3|||
44202302|NCT02138747|78997977|FG000|Treatment Period 1|Other - Miscellaneous|2|||
44202303|NCT02138747|78997978|FG001|Treatment Period 1|Other - Miscellaneous|4|||
44202304|NCT02138747|78997979|FG002|Treatment Period 1|Other - Miscellaneous|0|||
44202305|NCT02138747|78997980|FG003|Treatment Period 1|Other - Miscellaneous|0|||
44202306|NCT02138747|78997977|FG000|Treatment Period 2|Adverse Event|6|||
44202307|NCT02138747|78997978|FG001|Treatment Period 2|Adverse Event|3|||
44202308|NCT02138747|78997979|FG002|Treatment Period 2|Adverse Event|1|||
44268486|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
44268487|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
44268488|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
44268489|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
44268490|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
44268491|NCT03747939|79182709|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
44268492|NCT03747939|79182710|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
44268493|NCT03747939|79182711|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
44268494|NCT03747939|79182712|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
44268495|NCT03747939|79182709|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
44268496|NCT03747939|79182710|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
44268497|NCT03747939|79182711|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
44268498|NCT03747939|79182712|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
44268499|NCT03747939|79182709|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
44363379|NCT01079130|79368657|FG005|Overall Study|Adverse Event|1|||
44363380|NCT01079130|79368652|FG000|Overall Study|Administrative problems|1|||
44363381|NCT01079130|79368653|FG001|Overall Study|Administrative problems|3|||
44363382|NCT01079130|79368654|FG002|Overall Study|Administrative problems|0|||
44363383|NCT01079130|79368655|FG003|Overall Study|Administrative problems|0|||
44363384|NCT01079130|79368656|FG004|Overall Study|Administrative problems|0|||
44363385|NCT01079130|79368657|FG005|Overall Study|Administrative problems|1|||
44268500|NCT03747939|79182710|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
44268501|NCT03747939|79182711|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
44268502|NCT03747939|79182712|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
44268503|NCT03747939|79182709|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
44268504|NCT03747939|79182710|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
44268505|NCT03747939|79182711|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
44268506|NCT03747939|79182712|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
44363386|NCT01079130|79368652|FG000|Overall Study|Withdrawal by Subject|0|||
44363387|NCT01079130|79368653|FG001|Overall Study|Withdrawal by Subject|1|||
44363388|NCT01079130|79368654|FG002|Overall Study|Withdrawal by Subject|0|||
44363389|NCT01079130|79368655|FG003|Overall Study|Withdrawal by Subject|0|||
44363390|NCT01079130|79368656|FG004|Overall Study|Withdrawal by Subject|1|||
44363391|NCT01079130|79368657|FG005|Overall Study|Withdrawal by Subject|3|||
44363392|NCT01079130|79368652|FG000|Overall Study|Protocol deviation|0|||
44363393|NCT01079130|79368653|FG001|Overall Study|Protocol deviation|2|||
44363394|NCT01079130|79368654|FG002|Overall Study|Protocol deviation|1|||
44363395|NCT01079130|79368655|FG003|Overall Study|Protocol deviation|2|||
44363396|NCT01079130|79368656|FG004|Overall Study|Protocol deviation|0|||
44202309|NCT02138747|78997980|FG003|Treatment Period 2|Adverse Event|1|||
44202310|NCT02138747|78997977|FG000|Treatment Period 2|Lost to Follow-up|2|||
44202311|NCT02138747|78997978|FG001|Treatment Period 2|Lost to Follow-up|0|||
44268507|NCT03747939|79182709|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
44268508|NCT03747939|79182710|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
44363397|NCT01079130|79368657|FG005|Overall Study|Protocol deviation|0|||
44363398|NCT01079130|79368652|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44363399|NCT01079130|79368653|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44363400|NCT01079130|79368654|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44363401|NCT01079130|79368655|FG003|Overall Study|Abnormal test procedure result(s)|0|||
44363402|NCT01079130|79368656|FG004|Overall Study|Abnormal test procedure result(s)|1|||
44363403|NCT01079130|79368657|FG005|Overall Study|Abnormal test procedure result(s)|0|||
44363404|NCT01079130|79368652|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44363405|NCT01079130|79368653|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44363406|NCT01079130|79368654|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44363407|NCT01079130|79368655|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
44363408|NCT01079130|79368656|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
44202312|NCT02138747|78997979|FG002|Treatment Period 2|Lost to Follow-up|0|||
44202313|NCT02138747|78997980|FG003|Treatment Period 2|Lost to Follow-up|0|||
44202314|NCT02138747|78997977|FG000|Treatment Period 2|Protocol Violation|1|||
44202315|NCT02138747|78997978|FG001|Treatment Period 2|Protocol Violation|0|||
44202316|NCT02138747|78997979|FG002|Treatment Period 2|Protocol Violation|0|||
44202317|NCT02138747|78997980|FG003|Treatment Period 2|Protocol Violation|0|||
44202318|NCT02138747|78997977|FG000|Treatment Period 2|Withdrawal by Subject|5|||
44202319|NCT02138747|78997978|FG001|Treatment Period 2|Withdrawal by Subject|4|||
44202320|NCT02138747|78997979|FG002|Treatment Period 2|Withdrawal by Subject|1|||
44202321|NCT02138747|78997980|FG003|Treatment Period 2|Withdrawal by Subject|2|||
44202322|NCT02138747|78997977|FG000|Treatment Period 2|Other - Miscellaneous|3|||
44202323|NCT02138747|78997978|FG001|Treatment Period 2|Other - Miscellaneous|0|||
44202324|NCT02138747|78997979|FG002|Treatment Period 2|Other - Miscellaneous|0|||
44202325|NCT02138747|78997980|FG003|Treatment Period 2|Other - Miscellaneous|0|||
44202326|NCT02105285|78997993|FG000|Overall Study|Adverse Event|1|||
44202327|NCT02105285|78997994|FG001|Overall Study|Adverse Event|1|||
44202328|NCT02105285|78997995|FG002|Overall Study|Adverse Event|0|||
44202329|NCT02105285|78997993|FG000|Overall Study|Protocol Violation|0|||
44202330|NCT02105285|78997994|FG001|Overall Study|Protocol Violation|1|||
44202331|NCT02105285|78997995|FG002|Overall Study|Protocol Violation|0|||
44202332|NCT02105285|78997993|FG000|Overall Study|Withdrawal by Subject|1|||
44202333|NCT02105285|78997994|FG001|Overall Study|Withdrawal by Subject|0|||
44202334|NCT02105285|78997995|FG002|Overall Study|Withdrawal by Subject|0|||
44202335|NCT02104895|78998004|FG000|Overall Study|Withdrawal by Subject|0|||
44202336|NCT02104895|78998005|FG001|Overall Study|Withdrawal by Subject|14|||
44202337|NCT01621490|78998020|FG000|Overall Study|Participant completed treatment|4|||
44202338|NCT01621490|78998021|FG001|Overall Study|Participant completed treatment|4|||
44202339|NCT01621490|78998022|FG002|Overall Study|Participant completed treatment|1|||
44202340|NCT01621490|78998023|FG003|Overall Study|Participant completed treatment|0|||
44202341|NCT01621490|78998024|FG004|Overall Study|Participant completed treatment|0|||
44202342|NCT01621490|78998025|FG005|Overall Study|Participant completed treatment|0|||
44202343|NCT01621490|78998026|FG006|Overall Study|Participant completed treatment|0|||
44202344|NCT01621490|78998027|FG007|Overall Study|Participant completed treatment|1|||
44202345|NCT01621490|78998028|FG008|Overall Study|Participant completed treatment|0|||
44363409|NCT01079130|79368657|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
44363410|NCT01079130|79368652|FG000|Overall Study|Lost to Follow-up|0|||
44363411|NCT01079130|79368653|FG001|Overall Study|Lost to Follow-up|0|||
44363412|NCT01079130|79368654|FG002|Overall Study|Lost to Follow-up|0|||
44363413|NCT01079130|79368655|FG003|Overall Study|Lost to Follow-up|0|||
44363414|NCT01079130|79368656|FG004|Overall Study|Lost to Follow-up|1|||
44363415|NCT01079130|79368657|FG005|Overall Study|Lost to Follow-up|0|||
44363416|NCT01078974|79368671|FG000|Overall Study|Adverse Event|3|||
44363417|NCT00869557|79368677|FG000|Randomized Phase|Lost to Follow-up|2|||
44363418|NCT00869557|79368678|FG001|Randomized Phase|Lost to Follow-up|1|||
44363419|NCT00869557|79368677|FG000|Randomized Phase|Investigator's Discretion|1|||
44363420|NCT00869557|79368678|FG001|Randomized Phase|Investigator's Discretion|0|||
44363421|NCT00869557|79368677|FG000|Randomized Phase|Withdrew Consent|0|||
44363422|NCT00869557|79368678|FG001|Randomized Phase|Withdrew Consent|1|||
44363423|NCT00869557|79368677|FG000|Extension Phase|Adverse Event|2|||
44363424|NCT00869557|79368678|FG001|Extension Phase|Adverse Event|2|||
44363425|NCT00869557|79368677|FG000|Extension Phase|Lack of Efficacy|1|||
44363426|NCT00869557|79368678|FG001|Extension Phase|Lack of Efficacy|0|||
44363427|NCT00869557|79368677|FG000|Extension Phase|Lost to Follow-up|3|||
44363428|NCT00869557|79368678|FG001|Extension Phase|Lost to Follow-up|1|||
44363429|NCT00869557|79368677|FG000|Extension Phase|Investigator's Discretion|2|||
44363430|NCT00869557|79368678|FG001|Extension Phase|Investigator's Discretion|0|||
44363431|NCT00869557|79368677|FG000|Extension Phase|Withdrew Consent|2|||
44363432|NCT00869557|79368678|FG001|Extension Phase|Withdrew Consent|0|||
44202346|NCT01621490|78998020|FG000|Overall Study|Patient could not travel|1|||
44202347|NCT01621490|78998021|FG001|Overall Study|Patient could not travel|0|||
44202348|NCT01621490|78998022|FG002|Overall Study|Patient could not travel|0|||
44363433|NCT01200290|79368685|FG000|Treatment Period|Adverse Event|1|||
44363434|NCT01200290|79368685|FG000|Post-Treatment Follow-Up Period|Death|2|||
44363435|NCT01134263|79368694|FG000|Overall Study|Serious adverse event|2|||
44363436|NCT01134263|79368695|FG001|Overall Study|Serious adverse event|1|||
44363437|NCT01134263|79368696|FG002|Overall Study|Serious adverse event|1|||
44363438|NCT01134263|79368697|FG003|Overall Study|Serious adverse event|1|||
44202349|NCT01621490|78998023|FG003|Overall Study|Patient could not travel|0|||
44202350|NCT01621490|78998024|FG004|Overall Study|Patient could not travel|0|||
44202351|NCT01621490|78998025|FG005|Overall Study|Patient could not travel|0|||
44202352|NCT01621490|78998026|FG006|Overall Study|Patient could not travel|0|||
44202353|NCT01621490|78998027|FG007|Overall Study|Patient could not travel|0|||
44202354|NCT01621490|78998028|FG008|Overall Study|Patient could not travel|0|||
44202355|NCT01621490|78998020|FG000|Overall Study|Subject no longer meets study criteria|0|||
44202356|NCT01621490|78998021|FG001|Overall Study|Subject no longer meets study criteria|0|||
44363439|NCT01134263|79368698|FG004|Overall Study|Serious adverse event|1|||
44363440|NCT01134263|79368694|FG000|Overall Study|Other adverse event|1|||
44363441|NCT01134263|79368695|FG001|Overall Study|Other adverse event|2|||
44363442|NCT01134263|79368696|FG002|Overall Study|Other adverse event|5|||
44363443|NCT01134263|79368697|FG003|Overall Study|Other adverse event|3|||
44363444|NCT01134263|79368698|FG004|Overall Study|Other adverse event|0|||
44363445|NCT01134263|79368694|FG000|Overall Study|Protocol Violation|8|||
44363446|NCT01134263|79368695|FG001|Overall Study|Protocol Violation|7|||
44363447|NCT01134263|79368696|FG002|Overall Study|Protocol Violation|2|||
44363448|NCT01134263|79368697|FG003|Overall Study|Protocol Violation|4|||
44363449|NCT01134263|79368698|FG004|Overall Study|Protocol Violation|2|||
44363450|NCT01134263|79368694|FG000|Overall Study|Lost to Follow-up|4|||
44363451|NCT01134263|79368695|FG001|Overall Study|Lost to Follow-up|3|||
44363452|NCT01134263|79368696|FG002|Overall Study|Lost to Follow-up|5|||
44363453|NCT01134263|79368697|FG003|Overall Study|Lost to Follow-up|3|||
44363454|NCT01134263|79368698|FG004|Overall Study|Lost to Follow-up|1|||
44363455|NCT01134263|79368694|FG000|Overall Study|Withdrawal by Subject|8|||
44363456|NCT01134263|79368695|FG001|Overall Study|Withdrawal by Subject|6|||
44363457|NCT01134263|79368696|FG002|Overall Study|Withdrawal by Subject|16|||
44363458|NCT01134263|79368697|FG003|Overall Study|Withdrawal by Subject|7|||
44363459|NCT01134263|79368698|FG004|Overall Study|Withdrawal by Subject|5|||
44363460|NCT01134263|79368694|FG000|Overall Study|Enrolled, but not treated|1|||
44363461|NCT01134263|79368695|FG001|Overall Study|Enrolled, but not treated|1|||
44363462|NCT01134263|79368696|FG002|Overall Study|Enrolled, but not treated|0|||
44363463|NCT01134263|79368697|FG003|Overall Study|Enrolled, but not treated|1|||
44363464|NCT01134263|79368698|FG004|Overall Study|Enrolled, but not treated|0|||
44363465|NCT01199822|79368719|FG000|Overall Study|Investigator discontinued therapy|0|||
44363466|NCT01199822|79368720|FG001|Overall Study|Investigator discontinued therapy|1|||
44363467|NCT01199822|79368721|FG002|Overall Study|Investigator discontinued therapy|0|||
44363468|NCT01096056|79368738|FG000|Overall Study|Lost to Follow-up|0|||
44363469|NCT01096056|79368739|FG001|Overall Study|Lost to Follow-up|1|||
44363470|NCT00866359|79368747|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
44363471|NCT00866359|79368748|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
44363472|NCT00866359|79368749|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
44363473|NCT00866359|79368750|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
44363474|NCT00866359|79368747|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
44363475|NCT00866359|79368748|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
44363476|NCT00866359|79368749|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
44363477|NCT00866359|79368750|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
44363478|NCT00866359|79368747|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
44363479|NCT00866359|79368748|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
44363480|NCT00866359|79368749|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
44363481|NCT00866359|79368750|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
44363482|NCT00866359|79368747|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
44363483|NCT00866359|79368748|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
44363484|NCT00866359|79368749|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
44363485|NCT00866359|79368750|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
44363486|NCT00866359|79368747|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
44363487|NCT00866359|79368748|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
44363488|NCT00866359|79368749|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
44363489|NCT00866359|79368750|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
44363490|NCT00866359|79368747|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
44363491|NCT00866359|79368748|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
44363492|NCT00866359|79368749|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
44363493|NCT00866359|79368750|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
44363494|NCT01199198|79368779|FG000|Overall Study|Adverse Event|3|||
44363495|NCT01199198|79368780|FG001|Overall Study|Adverse Event|0|||
44363496|NCT01199198|79368779|FG000|Overall Study|Lost to Follow-up|1|||
44363497|NCT01199198|79368780|FG001|Overall Study|Lost to Follow-up|5|||
44363498|NCT01199198|79368779|FG000|Overall Study|Withdrawal by Subject|1|||
44202357|NCT01621490|78998022|FG002|Overall Study|Subject no longer meets study criteria|0|||
44202358|NCT01621490|78998023|FG003|Overall Study|Subject no longer meets study criteria|0|||
44202359|NCT01621490|78998024|FG004|Overall Study|Subject no longer meets study criteria|1|||
44202360|NCT01621490|78998025|FG005|Overall Study|Subject no longer meets study criteria|0|||
44202361|NCT01621490|78998026|FG006|Overall Study|Subject no longer meets study criteria|0|||
44202362|NCT01621490|78998027|FG007|Overall Study|Subject no longer meets study criteria|0|||
44202363|NCT01621490|78998028|FG008|Overall Study|Subject no longer meets study criteria|0|||
44202364|NCT01621490|78998020|FG000|Overall Study|Maximum clinical benefit|3|||
44202365|NCT01621490|78998021|FG001|Overall Study|Maximum clinical benefit|2|||
44202366|NCT01621490|78998022|FG002|Overall Study|Maximum clinical benefit|0|||
44202367|NCT01621490|78998023|FG003|Overall Study|Maximum clinical benefit|0|||
44202368|NCT01621490|78998024|FG004|Overall Study|Maximum clinical benefit|0|||
44202369|NCT01621490|78998025|FG005|Overall Study|Maximum clinical benefit|0|||
44202370|NCT01621490|78998026|FG006|Overall Study|Maximum clinical benefit|1|||
44202371|NCT01621490|78998027|FG007|Overall Study|Maximum clinical benefit|2|||
44202372|NCT01621490|78998028|FG008|Overall Study|Maximum clinical benefit|0|||
44202373|NCT01621490|78998020|FG000|Overall Study|Withdrawal by Subject|1|||
44202374|NCT01621490|78998021|FG001|Overall Study|Withdrawal by Subject|0|||
44202375|NCT01621490|78998022|FG002|Overall Study|Withdrawal by Subject|0|||
44202376|NCT01621490|78998023|FG003|Overall Study|Withdrawal by Subject|0|||
44268509|NCT03747939|79182711|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
44268510|NCT03747939|79182712|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
44268511|NCT03747939|79182709|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
44268512|NCT03747939|79182710|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
44268513|NCT03747939|79182711|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
44268514|NCT03747939|79182712|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
44268515|NCT03688620|79182731|FG000|Overall Study|Other|0|||
44268516|NCT03688620|79182732|FG001|Overall Study|Other|0|||
44268517|NCT03688620|79182733|FG002|Overall Study|Other|1|||
44268518|NCT03688620|79182731|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
44268519|NCT03688620|79182732|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
44268520|NCT03688620|79182733|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
44268521|NCT03688620|79182731|FG000|Overall Study|Lost to Follow-up|16|||
44268522|NCT03688620|79182732|FG001|Overall Study|Lost to Follow-up|0|||
44268523|NCT03688620|79182733|FG002|Overall Study|Lost to Follow-up|1|||
44268524|NCT03688620|79182731|FG000|Overall Study|Withdrawal by Subject|0|||
44268525|NCT03688620|79182732|FG001|Overall Study|Withdrawal by Subject|0|||
44268526|NCT03688620|79182733|FG002|Overall Study|Withdrawal by Subject|6|||
44268527|NCT03683173|79182745|FG000|Completed Follow-up|Unavailable|235|||
44268528|NCT03683173|79182746|FG001|Completed Follow-up|Unavailable|217|||
44268529|NCT03683173|79182745|FG000|Completed Follow-up|Refused|69|||
44268530|NCT03683173|79182746|FG001|Completed Follow-up|Refused|59|||
44268531|NCT03683173|79182745|FG000|Completed Follow-up|Disconnected phone|65|||
44268532|NCT03683173|79182746|FG001|Completed Follow-up|Disconnected phone|95|||
44268533|NCT03683173|79182745|FG000|Completed Follow-up|Health issue/deceased|10|||
44268534|NCT03683173|79182746|FG001|Completed Follow-up|Health issue/deceased|4|||
44268535|NCT03683173|79182745|FG000|Completed Follow-up|Moved away|8|||
44363499|NCT01199198|79368780|FG001|Overall Study|Withdrawal by Subject|2|||
44268536|NCT03683173|79182746|FG001|Completed Follow-up|Moved away|1|||
44202377|NCT01621490|78998024|FG004|Overall Study|Withdrawal by Subject|0|||
44202378|NCT01621490|78998025|FG005|Overall Study|Withdrawal by Subject|3|||
44202379|NCT01621490|78998026|FG006|Overall Study|Withdrawal by Subject|0|||
44202380|NCT01621490|78998027|FG007|Overall Study|Withdrawal by Subject|0|||
44202381|NCT01621490|78998028|FG008|Overall Study|Withdrawal by Subject|0|||
44202382|NCT01621490|78998020|FG000|Overall Study|Subject request to discontinue study|1|||
44363500|NCT01199198|79368779|FG000|Overall Study|ICU Transfer|1|||
44363501|NCT01199198|79368780|FG001|Overall Study|ICU Transfer|2|||
44363502|NCT01199198|79368779|FG000|Overall Study|Hospice-care transfer|1|||
44363503|NCT01199198|79368780|FG001|Overall Study|Hospice-care transfer|2|||
44363504|NCT01095978|79368786|FG000|Overall Study|Did not take Klacid SR|2|||
44363505|NCT01095978|79368786|FG000|Overall Study|Adverse Event|1|||
44363506|NCT01134107|79368794|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
44363507|NCT01134107|79368795|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
44363508|NCT01134107|79368794|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
44363509|NCT01134107|79368795|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
44363510|NCT01134107|79368794|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
44363511|NCT01134107|79368795|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
44363512|NCT01134107|79368794|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
44363513|NCT01134107|79368795|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
44363514|NCT01134107|79368794|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
44363515|NCT01134107|79368795|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
44363516|NCT01134107|79368794|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
44363517|NCT01134107|79368795|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
44363518|NCT01134107|79368794|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
44363519|NCT01134107|79368795|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
44363520|NCT01199042|79368801|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
44363521|NCT01199042|79368801|FG000|At Home (3 Months)|Lost to Follow-up|1|||
44363522|NCT01198574|79368814|FG000|Overall Study|Resigned from schools|4|||
44363523|NCT01198574|79368815|FG001|Overall Study|Resigned from schools|1|||
44363524|NCT01198574|79368816|FG002|Overall Study|Resigned from schools|1|||
44363525|NCT01198574|79368817|FG003|Overall Study|Resigned from schools|4|||
44363526|NCT01198028|79368827|FG000|Overall Study|Adverse Event|5|||
44363527|NCT01198028|79368827|FG000|Overall Study|Death|3|||
44363528|NCT01198028|79368827|FG000|Overall Study|Physician Decision|2|||
44363529|NCT01197950|79368834|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
44363530|NCT01197950|79368835|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
44363531|NCT01197950|79368836|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
44363532|NCT01092780|79368844|FG000|Washout Period 1|Adverse Event|0|||
44202383|NCT01621490|78998021|FG001|Overall Study|Subject request to discontinue study|3|||
44202384|NCT01621490|78998022|FG002|Overall Study|Subject request to discontinue study|1|||
44202385|NCT01621490|78998023|FG003|Overall Study|Subject request to discontinue study|1|||
44202386|NCT01621490|78998024|FG004|Overall Study|Subject request to discontinue study|0|||
44268537|NCT03652961|79182765|FG000|Overall Study|Lost to Follow-up|3|||
44268538|NCT03652961|79182765|FG000|Overall Study|Screen Failure|1|||
44268539|NCT03492177|79182808|FG000|Overall Study|Adverse Event|1|||
44268540|NCT03492177|79182809|FG001|Overall Study|Adverse Event|0|||
44268541|NCT03492177|79182810|FG002|Overall Study|Adverse Event|0|||
44268542|NCT03492177|79182808|FG000|Overall Study|Death|3|||
44202387|NCT01621490|78998025|FG005|Overall Study|Subject request to discontinue study|2|||
44202388|NCT01621490|78998026|FG006|Overall Study|Subject request to discontinue study|1|||
44202389|NCT01621490|78998027|FG007|Overall Study|Subject request to discontinue study|0|||
44268543|NCT03492177|79182809|FG001|Overall Study|Death|0|||
44268544|NCT03492177|79182810|FG002|Overall Study|Death|3|||
44268545|NCT03492177|79182808|FG000|Overall Study|Lack of Efficacy|1|||
44268546|NCT03492177|79182809|FG001|Overall Study|Lack of Efficacy|2|||
44268547|NCT03492177|79182810|FG002|Overall Study|Lack of Efficacy|0|||
44268548|NCT03492177|79182808|FG000|Overall Study|Other|1|||
44363533|NCT01092780|79368845|FG001|Washout Period 1|Adverse Event|1|||
44363534|NCT01092780|79368846|FG002|Washout Period 1|Adverse Event|0|||
44363535|NCT01092780|79368847|FG003|Washout Period 1|Adverse Event|0|||
44363536|NCT01092780|79368844|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
44363537|NCT01092780|79368845|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
44363538|NCT01092780|79368846|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
44363539|NCT01092780|79368847|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
44363540|NCT01092780|79368844|FG000|Washout Period 2|Adverse Event|0|||
44268549|NCT03492177|79182809|FG001|Overall Study|Other|0|||
44363541|NCT01092780|79368845|FG001|Washout Period 2|Adverse Event|1|||
44363542|NCT01092780|79368846|FG002|Washout Period 2|Adverse Event|1|||
44363543|NCT01092780|79368847|FG003|Washout Period 2|Adverse Event|0|||
44363544|NCT01092546|79368857|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
44363545|NCT01197794|79368868|FG000|Overall Study|Adverse Event|3|||
44363546|NCT01197794|79368869|FG001|Overall Study|Adverse Event|2|||
44363547|NCT01197794|79368870|FG002|Overall Study|Adverse Event|4|||
44363548|NCT01197794|79368871|FG003|Overall Study|Adverse Event|4|||
44363549|NCT01197794|79368872|FG004|Overall Study|Adverse Event|4|||
44363550|NCT01197794|79368873|FG005|Overall Study|Adverse Event|2|||
44363551|NCT01197794|79368874|FG006|Overall Study|Adverse Event|3|||
44363552|NCT01197794|79368868|FG000|Overall Study|Protocol Violation|0|||
44363553|NCT01197794|79368869|FG001|Overall Study|Protocol Violation|0|||
44363554|NCT01197794|79368870|FG002|Overall Study|Protocol Violation|0|||
44363555|NCT01197794|79368871|FG003|Overall Study|Protocol Violation|0|||
44363556|NCT01197794|79368872|FG004|Overall Study|Protocol Violation|2|||
44363557|NCT01197794|79368873|FG005|Overall Study|Protocol Violation|0|||
44363558|NCT01197794|79368874|FG006|Overall Study|Protocol Violation|1|||
44363559|NCT01197794|79368868|FG000|Overall Study|Development of study withdrawal criteria|3|||
44363560|NCT01197794|79368869|FG001|Overall Study|Development of study withdrawal criteria|0|||
44202390|NCT01621490|78998028|FG008|Overall Study|Subject request to discontinue study|1|||
44202391|NCT01621490|78998020|FG000|Overall Study|Adverse event unrelated to study drug|2|||
44202392|NCT01621490|78998021|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44202393|NCT01621490|78998022|FG002|Overall Study|Adverse event unrelated to study drug|0|||
44202394|NCT01621490|78998023|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44202395|NCT01621490|78998024|FG004|Overall Study|Adverse event unrelated to study drug|0|||
44202396|NCT01621490|78998025|FG005|Overall Study|Adverse event unrelated to study drug|0|||
44202397|NCT01621490|78998026|FG006|Overall Study|Adverse event unrelated to study drug|0|||
44202398|NCT01621490|78998027|FG007|Overall Study|Adverse event unrelated to study drug|2|||
44202399|NCT01621490|78998028|FG008|Overall Study|Adverse event unrelated to study drug|1|||
44202400|NCT01621490|78998020|FG000|Overall Study|Disease progression|27|||
44202401|NCT01621490|78998021|FG001|Overall Study|Disease progression|28|||
44202402|NCT01621490|78998022|FG002|Overall Study|Disease progression|1|||
44202403|NCT01621490|78998023|FG003|Overall Study|Disease progression|5|||
44202404|NCT01621490|78998024|FG004|Overall Study|Disease progression|3|||
44202405|NCT01621490|78998025|FG005|Overall Study|Disease progression|8|||
44202406|NCT01621490|78998026|FG006|Overall Study|Disease progression|7|||
44202407|NCT01621490|78998027|FG007|Overall Study|Disease progression|0|||
44202408|NCT01621490|78998028|FG008|Overall Study|Disease progression|4|||
44202409|NCT01621490|78998020|FG000|Overall Study|Study drug toxicity|1|||
44202410|NCT01621490|78998021|FG001|Overall Study|Study drug toxicity|4|||
44202411|NCT01621490|78998022|FG002|Overall Study|Study drug toxicity|5|||
44363561|NCT01197794|79368870|FG002|Overall Study|Development of study withdrawal criteria|0|||
44363562|NCT01197794|79368871|FG003|Overall Study|Development of study withdrawal criteria|1|||
44363563|NCT01197794|79368872|FG004|Overall Study|Development of study withdrawal criteria|0|||
44363564|NCT01197794|79368873|FG005|Overall Study|Development of study withdrawal criteria|0|||
44363565|NCT01197794|79368874|FG006|Overall Study|Development of study withdrawal criteria|1|||
44363566|NCT01197794|79368868|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
44202412|NCT01621490|78998023|FG003|Overall Study|Study drug toxicity|3|||
44202413|NCT01621490|78998024|FG004|Overall Study|Study drug toxicity|1|||
44202414|NCT01621490|78998025|FG005|Overall Study|Study drug toxicity|10|||
44268550|NCT03492177|79182810|FG002|Overall Study|Other|0|||
44268551|NCT03492177|79182808|FG000|Overall Study|Ongoing|16|||
44268552|NCT03492177|79182809|FG001|Overall Study|Ongoing|19|||
44268553|NCT03492177|79182810|FG002|Overall Study|Ongoing|17|||
44268554|NCT03484403|79182820|FG000|Overall Study|Withdrawal by Subject|6|||
44268555|NCT03484403|79182821|FG001|Overall Study|Withdrawal by Subject|4|||
44268556|NCT03431350|79182839|FG000|Overall Study|ONGOING|0|||
44268557|NCT03431350|79182840|FG001|Overall Study|ONGOING|0|||
44268558|NCT03431350|79182841|FG002|Overall Study|ONGOING|2|||
44268559|NCT03431350|79182842|FG003|Overall Study|ONGOING|0|||
44268560|NCT03431350|79182843|FG004|Overall Study|ONGOING|1|||
44268561|NCT03431350|79182844|FG005|Overall Study|ONGOING|3|||
44268562|NCT03431350|79182845|FG006|Overall Study|ONGOING|0|||
44268563|NCT03431350|79182846|FG007|Overall Study|ONGOING|1|||
44363567|NCT01197794|79368869|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
44363568|NCT01197794|79368870|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
44363569|NCT01197794|79368871|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
44268564|NCT03431350|79182847|FG008|Overall Study|ONGOING|3|||
44268565|NCT03431350|79182848|FG009|Overall Study|ONGOING|4|||
44268566|NCT03431350|79182849|FG010|Overall Study|ONGOING|2|||
44363570|NCT01197794|79368872|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
44202415|NCT01621490|78998026|FG006|Overall Study|Study drug toxicity|1|||
44202416|NCT01621490|78998027|FG007|Overall Study|Study drug toxicity|4|||
44268567|NCT03431350|79182850|FG011|Overall Study|ONGOING|1|||
44268568|NCT03431350|79182839|FG000|Overall Study|Death|6|||
44268569|NCT03431350|79182840|FG001|Overall Study|Death|5|||
44363571|NCT01197794|79368873|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
44363572|NCT01197794|79368874|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
44363573|NCT01197794|79368868|FG000|Overall Study|Withdrawal by Subject|3|||
44363574|NCT01197794|79368869|FG001|Overall Study|Withdrawal by Subject|3|||
44363575|NCT01197794|79368870|FG002|Overall Study|Withdrawal by Subject|4|||
44363576|NCT01197794|79368871|FG003|Overall Study|Withdrawal by Subject|1|||
44363577|NCT01197794|79368872|FG004|Overall Study|Withdrawal by Subject|1|||
44363578|NCT01197794|79368873|FG005|Overall Study|Withdrawal by Subject|5|||
44363579|NCT01197794|79368874|FG006|Overall Study|Withdrawal by Subject|6|||
44363580|NCT01197794|79368868|FG000|Overall Study|Lost to Follow-up|1|||
44363581|NCT01197794|79368869|FG001|Overall Study|Lost to Follow-up|1|||
44363582|NCT01197794|79368870|FG002|Overall Study|Lost to Follow-up|0|||
44363583|NCT01197794|79368871|FG003|Overall Study|Lost to Follow-up|1|||
44363584|NCT01197794|79368872|FG004|Overall Study|Lost to Follow-up|0|||
44363585|NCT01197794|79368873|FG005|Overall Study|Lost to Follow-up|1|||
44363586|NCT01197794|79368874|FG006|Overall Study|Lost to Follow-up|0|||
44363587|NCT01197794|79368868|FG000|Overall Study|Other|1|||
44363588|NCT01197794|79368869|FG001|Overall Study|Other|1|||
44363589|NCT01197794|79368870|FG002|Overall Study|Other|3|||
44363590|NCT01197794|79368871|FG003|Overall Study|Other|0|||
44363591|NCT01197794|79368872|FG004|Overall Study|Other|2|||
44202417|NCT01621490|78998028|FG008|Overall Study|Study drug toxicity|1|||
44363592|NCT01197794|79368873|FG005|Overall Study|Other|2|||
44363593|NCT01197794|79368874|FG006|Overall Study|Other|4|||
44363594|NCT01078662|79368896|FG000|Overall Study|Death|41|||
44363595|NCT01078662|79368897|FG001|Overall Study|Death|103|||
44363596|NCT01078662|79368898|FG002|Overall Study|Death|18|||
44363597|NCT01078662|79368899|FG003|Overall Study|Death|5|||
44363598|NCT01078662|79368900|FG004|Overall Study|Death|8|||
44363599|NCT01078662|79368896|FG000|Overall Study|Patients reached data cut-off|12|||
44363600|NCT01078662|79368897|FG001|Overall Study|Patients reached data cut-off|53|||
44363601|NCT01078662|79368898|FG002|Overall Study|Patients reached data cut-off|2|||
44363602|NCT01078662|79368899|FG003|Overall Study|Patients reached data cut-off|2|||
44363603|NCT01078662|79368900|FG004|Overall Study|Patients reached data cut-off|3|||
44363604|NCT01078662|79368896|FG000|Overall Study|Withdrawal by Subject|4|||
44363605|NCT01078662|79368897|FG001|Overall Study|Withdrawal by Subject|11|||
44363606|NCT01078662|79368898|FG002|Overall Study|Withdrawal by Subject|1|||
44363607|NCT01078662|79368899|FG003|Overall Study|Withdrawal by Subject|0|||
44363608|NCT01078662|79368900|FG004|Overall Study|Withdrawal by Subject|0|||
44202418|NCT01621490|78998020|FG000|Overall Study|Death|0|||
44202419|NCT01621490|78998021|FG001|Overall Study|Death|0|||
44202420|NCT01621490|78998022|FG002|Overall Study|Death|0|||
44202421|NCT01621490|78998023|FG003|Overall Study|Death|0|||
44202422|NCT01621490|78998024|FG004|Overall Study|Death|0|||
44202423|NCT01621490|78998025|FG005|Overall Study|Death|0|||
44268570|NCT03431350|79182841|FG002|Overall Study|Death|18|||
44268571|NCT03431350|79182842|FG003|Overall Study|Death|7|||
44268572|NCT03431350|79182843|FG004|Overall Study|Death|4|||
44268573|NCT03431350|79182844|FG005|Overall Study|Death|3|||
44268574|NCT03431350|79182845|FG006|Overall Study|Death|2|||
44268575|NCT03431350|79182846|FG007|Overall Study|Death|0|||
44268576|NCT03431350|79182847|FG008|Overall Study|Death|0|||
44268577|NCT03431350|79182848|FG009|Overall Study|Death|0|||
44268578|NCT03431350|79182849|FG010|Overall Study|Death|4|||
44202424|NCT01621490|78998026|FG006|Overall Study|Death|0|||
44202425|NCT01621490|78998027|FG007|Overall Study|Death|1|||
44202426|NCT01621490|78998028|FG008|Overall Study|Death|0|||
44202427|NCT01621490|78998020|FG000|Overall Study|Grade 4 Lipase elevation|1|||
44202428|NCT01621490|78998021|FG001|Overall Study|Grade 4 Lipase elevation|0|||
44202429|NCT01621490|78998022|FG002|Overall Study|Grade 4 Lipase elevation|0|||
44202430|NCT01621490|78998023|FG003|Overall Study|Grade 4 Lipase elevation|0|||
44202431|NCT01621490|78998024|FG004|Overall Study|Grade 4 Lipase elevation|0|||
44202432|NCT01621490|78998025|FG005|Overall Study|Grade 4 Lipase elevation|0|||
44202433|NCT01621490|78998026|FG006|Overall Study|Grade 4 Lipase elevation|0|||
44202434|NCT01621490|78998027|FG007|Overall Study|Grade 4 Lipase elevation|0|||
44202435|NCT01621490|78998028|FG008|Overall Study|Grade 4 Lipase elevation|0|||
44202436|NCT01621490|78998020|FG000|Overall Study|BMS informed of patient status|0|||
44202437|NCT01621490|78998021|FG001|Overall Study|BMS informed of patient status|0|||
44202438|NCT01621490|78998022|FG002|Overall Study|BMS informed of patient status|1|||
44202439|NCT01621490|78998023|FG003|Overall Study|BMS informed of patient status|0|||
44202440|NCT01621490|78998024|FG004|Overall Study|BMS informed of patient status|0|||
44202441|NCT01621490|78998025|FG005|Overall Study|BMS informed of patient status|0|||
44268579|NCT03431350|79182850|FG011|Overall Study|Death|0|||
44268580|NCT03431350|79182839|FG000|Overall Study|Lost to Follow-up|0|||
44268581|NCT03431350|79182840|FG001|Overall Study|Lost to Follow-up|1|||
44363609|NCT01078662|79368896|FG000|Overall Study|Protocol Violation|0|||
44363610|NCT01078662|79368897|FG001|Overall Study|Protocol Violation|1|||
44363611|NCT01078662|79368898|FG002|Overall Study|Protocol Violation|0|||
44363612|NCT01078662|79368899|FG003|Overall Study|Protocol Violation|0|||
44363613|NCT01078662|79368900|FG004|Overall Study|Protocol Violation|0|||
44363614|NCT01078662|79368896|FG000|Overall Study|Lost to Follow-up|1|||
44363615|NCT01078662|79368897|FG001|Overall Study|Lost to Follow-up|0|||
44363616|NCT01078662|79368898|FG002|Overall Study|Lost to Follow-up|0|||
44363617|NCT01078662|79368899|FG003|Overall Study|Lost to Follow-up|0|||
44363618|NCT01078662|79368900|FG004|Overall Study|Lost to Follow-up|0|||
44363619|NCT01091454|79368909|FG000|Overall Study|Ineligible|1|||
44363620|NCT01140347|79368915|FG000|Overall Study|Lost to Follow-up|5|||
44363621|NCT01140347|79368916|FG001|Overall Study|Lost to Follow-up|6|||
44363622|NCT01140347|79368915|FG000|Overall Study|Withdrawal by Subject|13|||
44363623|NCT01140347|79368916|FG001|Overall Study|Withdrawal by Subject|8|||
44363624|NCT01197560|79368924|FG000|Overall Study|Adverse Event|6|||
44363625|NCT01197560|79368925|FG001|Overall Study|Adverse Event|8|||
44363626|NCT01197560|79368924|FG000|Overall Study|Death|3|||
44363627|NCT01197560|79368925|FG001|Overall Study|Death|5|||
44363628|NCT01197560|79368924|FG000|Overall Study|Withdrawal by Subject|1|||
44363629|NCT01197560|79368925|FG001|Overall Study|Withdrawal by Subject|1|||
44363630|NCT01197560|79368924|FG000|Overall Study|Disease progression|40|||
44363631|NCT01197560|79368925|FG001|Overall Study|Disease progression|35|||
44363632|NCT01197560|79368924|FG000|Overall Study|Miscellaneous|4|||
44363633|NCT01197560|79368925|FG001|Overall Study|Miscellaneous|3|||
44363634|NCT01197560|79368924|FG000|Overall Study|Missing|0|||
44202442|NCT01621490|78998026|FG006|Overall Study|BMS informed of patient status|0|||
44202443|NCT01621490|78998027|FG007|Overall Study|BMS informed of patient status|0|||
44202444|NCT01621490|78998028|FG008|Overall Study|BMS informed of patient status|0|||
44202445|NCT01621490|78998020|FG000|Overall Study|Investigator decision|0|||
44202446|NCT01621490|78998021|FG001|Overall Study|Investigator decision|0|||
44202447|NCT01621490|78998022|FG002|Overall Study|Investigator decision|1|||
44202448|NCT01621490|78998023|FG003|Overall Study|Investigator decision|0|||
44202449|NCT01621490|78998024|FG004|Overall Study|Investigator decision|1|||
44202450|NCT01621490|78998025|FG005|Overall Study|Investigator decision|0|||
44202451|NCT01621490|78998026|FG006|Overall Study|Investigator decision|1|||
44202452|NCT01621490|78998027|FG007|Overall Study|Investigator decision|0|||
44202453|NCT01621490|78998028|FG008|Overall Study|Investigator decision|0|||
44202454|NCT01621490|78998020|FG000|Overall Study|Documented disease progression|0|||
44268582|NCT03431350|79182841|FG002|Overall Study|Lost to Follow-up|0|||
44268583|NCT03431350|79182842|FG003|Overall Study|Lost to Follow-up|0|||
44268584|NCT03431350|79182843|FG004|Overall Study|Lost to Follow-up|0|||
44268585|NCT03431350|79182844|FG005|Overall Study|Lost to Follow-up|0|||
44268586|NCT03431350|79182845|FG006|Overall Study|Lost to Follow-up|0|||
44268587|NCT03431350|79182846|FG007|Overall Study|Lost to Follow-up|0|||
44268588|NCT03431350|79182847|FG008|Overall Study|Lost to Follow-up|0|||
44268589|NCT03431350|79182848|FG009|Overall Study|Lost to Follow-up|0|||
44268590|NCT03431350|79182849|FG010|Overall Study|Lost to Follow-up|0|||
44268591|NCT03431350|79182850|FG011|Overall Study|Lost to Follow-up|0|||
44268592|NCT03431350|79182839|FG000|Overall Study|Withdrawal by Subject|0|||
44268593|NCT03431350|79182840|FG001|Overall Study|Withdrawal by Subject|0|||
44268594|NCT03431350|79182841|FG002|Overall Study|Withdrawal by Subject|0|||
44268595|NCT03431350|79182842|FG003|Overall Study|Withdrawal by Subject|1|||
44268596|NCT03431350|79182843|FG004|Overall Study|Withdrawal by Subject|1|||
44268597|NCT03431350|79182844|FG005|Overall Study|Withdrawal by Subject|1|||
44268598|NCT03431350|79182845|FG006|Overall Study|Withdrawal by Subject|0|||
44268599|NCT03431350|79182846|FG007|Overall Study|Withdrawal by Subject|0|||
44268600|NCT03431350|79182847|FG008|Overall Study|Withdrawal by Subject|0|||
44268601|NCT03431350|79182848|FG009|Overall Study|Withdrawal by Subject|2|||
44268602|NCT03431350|79182849|FG010|Overall Study|Withdrawal by Subject|0|||
44268603|NCT03431350|79182850|FG011|Overall Study|Withdrawal by Subject|1|||
44268604|NCT03431350|79182839|FG000|Overall Study|Other|0|||
44268605|NCT03431350|79182840|FG001|Overall Study|Other|0|||
44268606|NCT03431350|79182841|FG002|Overall Study|Other|1|||
44268607|NCT03431350|79182842|FG003|Overall Study|Other|3|||
44268608|NCT03431350|79182843|FG004|Overall Study|Other|2|||
44268609|NCT03431350|79182844|FG005|Overall Study|Other|2|||
44268610|NCT03431350|79182845|FG006|Overall Study|Other|4|||
44268611|NCT03431350|79182846|FG007|Overall Study|Other|0|||
44268612|NCT03431350|79182847|FG008|Overall Study|Other|14|||
44268613|NCT03431350|79182848|FG009|Overall Study|Other|11|||
44268614|NCT03431350|79182849|FG010|Overall Study|Other|11|||
44268615|NCT03431350|79182850|FG011|Overall Study|Other|15|||
44363635|NCT01197560|79368925|FG001|Overall Study|Missing|1|||
44268616|NCT03299049|79182886|FG000|Overall Study|On-going|486|||
44268617|NCT03299049|79182887|FG001|Overall Study|On-going|481|||
44268618|NCT03299049|79182886|FG000|Overall Study|Withdrawal by Subject|6|||
44268619|NCT03299049|79182887|FG001|Overall Study|Withdrawal by Subject|21|||
44268620|NCT03299049|79182886|FG000|Overall Study|Physician Decision|5|||
44363636|NCT01133405|79368942|FG000|Period 1|Withdrawal by Subject|0|||
44363637|NCT01133405|79368943|FG001|Period 1|Withdrawal by Subject|1|||
44202455|NCT01621490|78998021|FG001|Overall Study|Documented disease progression|0|||
44268621|NCT03299049|79182887|FG001|Overall Study|Physician Decision|1|||
44268622|NCT03299049|79182886|FG000|Overall Study|Lost to Follow-up|2|||
44268623|NCT03299049|79182887|FG001|Overall Study|Lost to Follow-up|0|||
44363638|NCT01133405|79368944|FG002|Period 1|Withdrawal by Subject|0|||
44363639|NCT01133405|79368945|FG003|Period 1|Withdrawal by Subject|1|||
44363640|NCT01133405|79368946|FG004|Period 1|Withdrawal by Subject|0|||
44363641|NCT01133405|79368947|FG005|Period 1|Withdrawal by Subject|1|||
44363642|NCT01133405|79368948|FG006|Period 1|Withdrawal by Subject|0|||
44363643|NCT01133405|79368949|FG007|Period 1|Withdrawal by Subject|0|||
44363644|NCT01133405|79368950|FG008|Period 1|Withdrawal by Subject|0|||
44363645|NCT01133405|79368951|FG009|Period 1|Withdrawal by Subject|0|||
44363646|NCT01133405|79368942|FG000|Period 1|Physician Decision|0|||
44363647|NCT01133405|79368943|FG001|Period 1|Physician Decision|0|||
44363648|NCT01133405|79368944|FG002|Period 1|Physician Decision|0|||
44363649|NCT01133405|79368945|FG003|Period 1|Physician Decision|1|||
44363650|NCT01133405|79368946|FG004|Period 1|Physician Decision|0|||
44363651|NCT01133405|79368947|FG005|Period 1|Physician Decision|0|||
44363652|NCT01133405|79368948|FG006|Period 1|Physician Decision|0|||
44363653|NCT01133405|79368949|FG007|Period 1|Physician Decision|0|||
44363654|NCT01133405|79368950|FG008|Period 1|Physician Decision|0|||
44363655|NCT01133405|79368951|FG009|Period 1|Physician Decision|0|||
44363656|NCT01133405|79368942|FG000|Period 1|Discontinued after randomization|1|||
44363657|NCT01133405|79368943|FG001|Period 1|Discontinued after randomization|0|||
44363658|NCT01133405|79368944|FG002|Period 1|Discontinued after randomization|0|||
44363659|NCT01133405|79368945|FG003|Period 1|Discontinued after randomization|0|||
44363660|NCT01133405|79368946|FG004|Period 1|Discontinued after randomization|0|||
44363661|NCT01133405|79368947|FG005|Period 1|Discontinued after randomization|0|||
44363662|NCT01133405|79368948|FG006|Period 1|Discontinued after randomization|1|||
44363663|NCT01133405|79368949|FG007|Period 1|Discontinued after randomization|0|||
44363664|NCT01133405|79368950|FG008|Period 1|Discontinued after randomization|0|||
44363665|NCT01133405|79368951|FG009|Period 1|Discontinued after randomization|0|||
44363666|NCT01133405|79368942|FG000|Period 1|Received drug only in period 2|0|||
44363667|NCT01133405|79368943|FG001|Period 1|Received drug only in period 2|1|||
44363668|NCT01133405|79368944|FG002|Period 1|Received drug only in period 2|0|||
44363669|NCT01133405|79368945|FG003|Period 1|Received drug only in period 2|2|||
44363670|NCT01133405|79368946|FG004|Period 1|Received drug only in period 2|0|||
44363671|NCT01133405|79368947|FG005|Period 1|Received drug only in period 2|1|||
44363672|NCT01133405|79368948|FG006|Period 1|Received drug only in period 2|0|||
44363673|NCT01133405|79368949|FG007|Period 1|Received drug only in period 2|0|||
44363674|NCT01133405|79368950|FG008|Period 1|Received drug only in period 2|0|||
44363675|NCT01133405|79368951|FG009|Period 1|Received drug only in period 2|0|||
44363676|NCT01133405|79368942|FG000|Period 1|Received drug only in period 3|0|||
44363677|NCT01133405|79368943|FG001|Period 1|Received drug only in period 3|1|||
44363678|NCT01133405|79368944|FG002|Period 1|Received drug only in period 3|1|||
44363679|NCT01133405|79368945|FG003|Period 1|Received drug only in period 3|0|||
44363680|NCT01133405|79368946|FG004|Period 1|Received drug only in period 3|0|||
44363681|NCT01133405|79368947|FG005|Period 1|Received drug only in period 3|0|||
44363682|NCT01133405|79368948|FG006|Period 1|Received drug only in period 3|0|||
44363683|NCT01133405|79368949|FG007|Period 1|Received drug only in period 3|0|||
44363684|NCT01133405|79368950|FG008|Period 1|Received drug only in period 3|0|||
44363685|NCT01133405|79368951|FG009|Period 1|Received drug only in period 3|0|||
44363686|NCT01133405|79368942|FG000|Period 2|Adverse Event|0|||
44363687|NCT01133405|79368943|FG001|Period 2|Adverse Event|0|||
44363688|NCT01133405|79368944|FG002|Period 2|Adverse Event|1|||
44363689|NCT01133405|79368945|FG003|Period 2|Adverse Event|0|||
44363690|NCT01133405|79368946|FG004|Period 2|Adverse Event|0|||
44363691|NCT01133405|79368947|FG005|Period 2|Adverse Event|0|||
44363692|NCT01133405|79368948|FG006|Period 2|Adverse Event|0|||
44363693|NCT01133405|79368949|FG007|Period 2|Adverse Event|0|||
44363694|NCT01133405|79368950|FG008|Period 2|Adverse Event|0|||
44363695|NCT01133405|79368951|FG009|Period 2|Adverse Event|0|||
44363696|NCT01133405|79368942|FG000|Period 2|Withdrawal by Subject|0|||
44363697|NCT01133405|79368943|FG001|Period 2|Withdrawal by Subject|0|||
44363698|NCT01133405|79368944|FG002|Period 2|Withdrawal by Subject|0|||
44363699|NCT01133405|79368945|FG003|Period 2|Withdrawal by Subject|1|||
44363700|NCT01133405|79368946|FG004|Period 2|Withdrawal by Subject|0|||
44363701|NCT01133405|79368947|FG005|Period 2|Withdrawal by Subject|1|||
44363702|NCT01133405|79368948|FG006|Period 2|Withdrawal by Subject|0|||
44363703|NCT01133405|79368949|FG007|Period 2|Withdrawal by Subject|0|||
44363704|NCT01133405|79368950|FG008|Period 2|Withdrawal by Subject|0|||
44363705|NCT01133405|79368951|FG009|Period 2|Withdrawal by Subject|0|||
44363706|NCT01133405|79368942|FG000|Period 2|Entry Criteria Not Met|0|||
44363707|NCT01133405|79368943|FG001|Period 2|Entry Criteria Not Met|1|||
44363708|NCT01133405|79368944|FG002|Period 2|Entry Criteria Not Met|0|||
44363709|NCT01133405|79368945|FG003|Period 2|Entry Criteria Not Met|0|||
44363710|NCT01133405|79368946|FG004|Period 2|Entry Criteria Not Met|0|||
44363711|NCT01133405|79368947|FG005|Period 2|Entry Criteria Not Met|0|||
44363712|NCT01133405|79368948|FG006|Period 2|Entry Criteria Not Met|0|||
44363713|NCT01133405|79368949|FG007|Period 2|Entry Criteria Not Met|0|||
44363714|NCT01133405|79368950|FG008|Period 2|Entry Criteria Not Met|0|||
44363715|NCT01133405|79368951|FG009|Period 2|Entry Criteria Not Met|0|||
44363716|NCT01133405|79368942|FG000|Period 2|Physician Decision|0|||
44363717|NCT01133405|79368943|FG001|Period 2|Physician Decision|0|||
44363718|NCT01133405|79368944|FG002|Period 2|Physician Decision|0|||
44363719|NCT01133405|79368945|FG003|Period 2|Physician Decision|0|||
44363720|NCT01133405|79368946|FG004|Period 2|Physician Decision|0|||
44202456|NCT01621490|78998022|FG002|Overall Study|Documented disease progression|1|||
44363721|NCT01133405|79368947|FG005|Period 2|Physician Decision|1|||
44363722|NCT01133405|79368948|FG006|Period 2|Physician Decision|0|||
44363723|NCT01133405|79368949|FG007|Period 2|Physician Decision|0|||
44363724|NCT01133405|79368950|FG008|Period 2|Physician Decision|0|||
44363725|NCT01133405|79368951|FG009|Period 2|Physician Decision|0|||
44363726|NCT01196078|79368983|FG000|Overall Study|Withdrawal by Subject|3|||
44363727|NCT01196078|79368984|FG001|Overall Study|Withdrawal by Subject|5|||
44363728|NCT01196078|79368983|FG000|Overall Study|Adverse Event|4|||
44363729|NCT01196078|79368984|FG001|Overall Study|Adverse Event|4|||
44363730|NCT01196078|79368983|FG000|Overall Study|Protocol Violation|2|||
44363731|NCT01196078|79368984|FG001|Overall Study|Protocol Violation|1|||
44363732|NCT01196078|79368983|FG000|Overall Study|Lack of Efficacy|17|||
44363733|NCT01196078|79368984|FG001|Overall Study|Lack of Efficacy|23|||
44363734|NCT01196078|79368983|FG000|Overall Study|Lost to Follow-up|1|||
44363735|NCT01196078|79368984|FG001|Overall Study|Lost to Follow-up|0|||
44363736|NCT01196078|79368983|FG000|Overall Study|Death|6|||
44363737|NCT01196078|79368984|FG001|Overall Study|Death|4|||
44363738|NCT01078584|79368990|FG000|Overall Study|Final Status Unknown|1073|||
44363739|NCT01078584|79368990|FG000|Overall Study|Lost to Follow-up|670|||
44363740|NCT01078584|79368990|FG000|Overall Study|Non-serious Adverse Event|577|||
44363741|NCT01078584|79368990|FG000|Overall Study|Withdrawal of Consent|244|||
44363742|NCT01078584|79368990|FG000|Overall Study|Physician Withdrew from Study|90|||
44363743|NCT01078584|79368990|FG000|Overall Study|Non-compliance|67|||
44363744|NCT01078584|79368990|FG000|Overall Study|Blood Pressure Controlled|49|||
44363745|NCT01078584|79368990|FG000|Overall Study|Physician Switched Medication|26|||
44363746|NCT01078584|79368990|FG000|Overall Study|Physician Discontinued Patient|12|||
44363747|NCT01078584|79368990|FG000|Overall Study|Lack of Efficacy|98|||
44363748|NCT01078584|79368990|FG000|Overall Study|Protocol Violation|75|||
44363749|NCT01078584|79368990|FG000|Overall Study|Serious Adverse Event|27|||
44363750|NCT01078584|79368990|FG000|Overall Study|Multiple Reasons|2|||
44363751|NCT01133171|79369010|FG000|Overall Study|Withdrawal by Subject|1|||
44363752|NCT01133171|79369011|FG001|Overall Study|Withdrawal by Subject|2|||
44363753|NCT01133171|79369012|FG002|Overall Study|Withdrawal by Subject|0|||
44363754|NCT01195844|79369020|FG000|Overall Study|Fecal sample not collected|40|||
44363755|NCT01132547|79369036|FG000|Overall Study|Withdrawal by Subject|3|||
44363756|NCT01132547|79369037|FG001|Overall Study|Withdrawal by Subject|1|||
44363757|NCT01132547|79369036|FG000|Overall Study|Death|1|||
44363758|NCT01132547|79369037|FG001|Overall Study|Death|0|||
44363759|NCT01194830|79369045|FG000|Overall Study|Adverse Event|3|||
44363760|NCT01194830|79369046|FG001|Overall Study|Adverse Event|2|||
44363761|NCT01194830|79369045|FG000|Overall Study|Protocol Violation|5|||
44363762|NCT01194830|79369046|FG001|Overall Study|Protocol Violation|4|||
44363763|NCT01194830|79369045|FG000|Overall Study|Lost to Follow-up|9|||
44363764|NCT01194830|79369046|FG001|Overall Study|Lost to Follow-up|7|||
44363765|NCT01194830|79369045|FG000|Overall Study|Withdrawal by Subject|2|||
44363766|NCT01194830|79369046|FG001|Overall Study|Withdrawal by Subject|1|||
44202457|NCT01621490|78998023|FG003|Overall Study|Documented disease progression|0|||
44202458|NCT01621490|78998024|FG004|Overall Study|Documented disease progression|0|||
44202459|NCT01621490|78998025|FG005|Overall Study|Documented disease progression|0|||
44363767|NCT01194830|79369045|FG000|Overall Study|Lack of Efficacy|1|||
44363768|NCT01194830|79369046|FG001|Overall Study|Lack of Efficacy|1|||
44363769|NCT01194830|79369045|FG000|Overall Study|Non-compliance issues|4|||
44363770|NCT01194830|79369046|FG001|Overall Study|Non-compliance issues|4|||
44363771|NCT01194830|79369045|FG000|Overall Study|Other Reason|12|||
44363772|NCT01194830|79369046|FG001|Overall Study|Other Reason|8|||
44363773|NCT01194440|79369052|FG000|Baseline (First Dose)|Reason not specified|4|||
44363774|NCT01194440|79369052|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
44363775|NCT01194440|79369052|FG000|Baseline (First Dose)|Change in therapy|1|||
44268624|NCT03299049|79182886|FG000|Overall Study|Pregnancy|1|||
44363776|NCT01194440|79369052|FG000|Baseline (First Dose)|Adverse Event|1|||
44363777|NCT01194440|79369052|FG000|6-months (2nd Dose)|Change in therapy|4|||
44363778|NCT00951015|79369061|FG000|Randomization Phase 96 Week|Adverse Event|1|||
44363779|NCT00951015|79369062|FG001|Randomization Phase 96 Week|Adverse Event|1|||
44202460|NCT01621490|78998026|FG006|Overall Study|Documented disease progression|0|||
44202461|NCT01621490|78998027|FG007|Overall Study|Documented disease progression|0|||
44202462|NCT01621490|78998028|FG008|Overall Study|Documented disease progression|0|||
44202463|NCT01621490|78998020|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
44202464|NCT01621490|78998021|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
44202465|NCT01621490|78998022|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
44202466|NCT01621490|78998023|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
44202467|NCT01621490|78998024|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
44202468|NCT01621490|78998025|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
44202469|NCT01621490|78998026|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
44202470|NCT01621490|78998027|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
44202471|NCT01621490|78998028|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
44202472|NCT01621490|78998020|FG000|Overall Study|Clinical deterioration|0|||
44202473|NCT01621490|78998021|FG001|Overall Study|Clinical deterioration|1|||
44202474|NCT01621490|78998022|FG002|Overall Study|Clinical deterioration|0|||
44202475|NCT01621490|78998023|FG003|Overall Study|Clinical deterioration|0|||
44202476|NCT01621490|78998024|FG004|Overall Study|Clinical deterioration|0|||
44202477|NCT01621490|78998025|FG005|Overall Study|Clinical deterioration|0|||
44202478|NCT01621490|78998026|FG006|Overall Study|Clinical deterioration|0|||
44202479|NCT01621490|78998027|FG007|Overall Study|Clinical deterioration|0|||
44202480|NCT01621490|78998028|FG008|Overall Study|Clinical deterioration|0|||
44202481|NCT01621490|78998020|FG000|Overall Study|Complete response|0|||
44202482|NCT01621490|78998021|FG001|Overall Study|Complete response|0|||
44202483|NCT01621490|78998022|FG002|Overall Study|Complete response|0|||
44202484|NCT01621490|78998023|FG003|Overall Study|Complete response|0|||
44202485|NCT01621490|78998024|FG004|Overall Study|Complete response|0|||
44202486|NCT01621490|78998025|FG005|Overall Study|Complete response|0|||
44202487|NCT01621490|78998026|FG006|Overall Study|Complete response|0|||
44202488|NCT01621490|78998027|FG007|Overall Study|Complete response|0|||
44202489|NCT01621490|78998028|FG008|Overall Study|Complete response|1|||
44202490|NCT01621490|78998020|FG000|Overall Study|Patient delayed due to toxicity|0|||
44202491|NCT01621490|78998021|FG001|Overall Study|Patient delayed due to toxicity|0|||
44202492|NCT01621490|78998022|FG002|Overall Study|Patient delayed due to toxicity|0|||
44202493|NCT01621490|78998023|FG003|Overall Study|Patient delayed due to toxicity|0|||
44202494|NCT01621490|78998024|FG004|Overall Study|Patient delayed due to toxicity|0|||
44202495|NCT01621490|78998025|FG005|Overall Study|Patient delayed due to toxicity|1|||
44202496|NCT01621490|78998026|FG006|Overall Study|Patient delayed due to toxicity|0|||
44202497|NCT01621490|78998027|FG007|Overall Study|Patient delayed due to toxicity|0|||
44202498|NCT01621490|78998028|FG008|Overall Study|Patient delayed due to toxicity|0|||
44202499|NCT02018887|78998149|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
44202500|NCT02018887|78998150|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202501|NCT02018887|78998151|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202502|NCT02018887|78998152|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202503|NCT02018887|78998153|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202504|NCT02018887|78998154|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202505|NCT02018887|78998155|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202506|NCT02018887|78998156|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202507|NCT02018887|78998157|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202508|NCT02018887|78998158|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202509|NCT02018887|78998159|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
44202510|NCT02018887|78998149|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202511|NCT02018887|78998150|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202512|NCT02018887|78998151|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202513|NCT02018887|78998152|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202514|NCT02018887|78998153|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
44202515|NCT02018887|78998154|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202516|NCT02018887|78998155|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
44202517|NCT02018887|78998156|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
44202518|NCT02018887|78998157|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202519|NCT02018887|78998158|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202520|NCT02018887|78998159|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
44202521|NCT02018887|78998149|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
44451964|NCT00489255|79460903|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
44451965|NCT00489255|79460904|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
44202522|NCT02018887|78998150|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
44202523|NCT02018887|78998151|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
44202524|NCT02018887|78998152|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
44202525|NCT02018887|78998153|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
44202526|NCT02018887|78998154|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
44202527|NCT02018887|78998155|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
44202528|NCT02018887|78998156|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
44202529|NCT02018887|78998157|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
44202530|NCT02018887|78998158|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
44202531|NCT02018887|78998159|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
44202532|NCT02018887|78998149|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
44202533|NCT02018887|78998150|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
44202534|NCT02018887|78998151|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
44202535|NCT02018887|78998152|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
44202536|NCT02018887|78998153|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
44202537|NCT02018887|78998154|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
44202538|NCT02018887|78998155|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
44202539|NCT02018887|78998156|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
44202540|NCT02018887|78998157|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
44202541|NCT02018887|78998158|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
44202542|NCT02018887|78998159|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
44202543|NCT02030041|78998228|FG000|Overall Study|Withdrawal by Subject|2|||
44202544|NCT02030041|78998229|FG001|Overall Study|Withdrawal by Subject|2|||
44202545|NCT02030041|78998230|FG002|Overall Study|Withdrawal by Subject|1|||
44202546|NCT01994720|78998240|FG000|Overall Study|Withdrawal by Subject|46|||
44202547|NCT01994720|78998241|FG001|Overall Study|Withdrawal by Subject|56|||
44202548|NCT01814007|78998247|FG000|Overall Study|Withdrawal by Subject|1|||
44202549|NCT01844115|78998254|FG000|Overall Study|Adverse Event|4|||
44202550|NCT01844115|78998255|FG001|Overall Study|Adverse Event|22|||
44202551|NCT01844115|78998254|FG000|Overall Study|Lack of Efficacy|1|||
44202552|NCT01844115|78998255|FG001|Overall Study|Lack of Efficacy|4|||
44202553|NCT01844115|78998254|FG000|Overall Study|Protocol Violation|12|||
44202554|NCT01844115|78998255|FG001|Overall Study|Protocol Violation|10|||
44202555|NCT01844115|78998254|FG000|Overall Study|Withdrawal by Subject|11|||
44202556|NCT01844115|78998255|FG001|Overall Study|Withdrawal by Subject|11|||
44202557|NCT01844115|78998254|FG000|Overall Study|Lost to Follow-up|11|||
44202558|NCT01844115|78998255|FG001|Overall Study|Lost to Follow-up|10|||
44202559|NCT01844115|78998254|FG000|Overall Study|Pregnancy|0|||
44202560|NCT01844115|78998255|FG001|Overall Study|Pregnancy|1|||
44202561|NCT02018042|78998261|FG000|Overall Study|Withdrawal by Subject|1|||
44202562|NCT01813305|78998267|FG000|Overall Study|Withdrawal by Subject|12|||
44202563|NCT01813305|78998268|FG001|Overall Study|Withdrawal by Subject|5|||
44202564|NCT01813305|78998267|FG000|Overall Study|Safety Concern|4|||
44202565|NCT01813305|78998268|FG001|Overall Study|Safety Concern|0|||
44202566|NCT01813305|78998267|FG000|Overall Study|Ulcer became worse|4|||
44202567|NCT01813305|78998268|FG001|Overall Study|Ulcer became worse|0|||
44202568|NCT01813305|78998267|FG000|Overall Study|Physician Decision|4|||
44202569|NCT01813305|78998268|FG001|Overall Study|Physician Decision|0|||
44202570|NCT01813305|78998267|FG000|Overall Study|Lost to Follow-up|3|||
44202571|NCT01813305|78998268|FG001|Overall Study|Lost to Follow-up|1|||
44202572|NCT01813305|78998267|FG000|Overall Study|Protocol Violation|1|||
44202573|NCT01813305|78998268|FG001|Overall Study|Protocol Violation|0|||
44202574|NCT01813305|78998267|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
44202575|NCT01813305|78998268|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
44202576|NCT01993940|78998278|FG000|Overall Study|Adverse Event|16|||
44202577|NCT01993940|78998279|FG001|Overall Study|Adverse Event|11|||
44202578|NCT01993940|78998278|FG000|Overall Study|Withdrawal by Subject|15|||
44202579|NCT01993940|78998279|FG001|Overall Study|Withdrawal by Subject|19|||
44202580|NCT01993940|78998278|FG000|Overall Study|Lost to Follow-up|2|||
44451966|NCT00489255|79460903|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
44451967|NCT00489255|79460904|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
44451968|NCT00489255|79460903|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
44451969|NCT00489255|79460904|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
44202581|NCT01993940|78998279|FG001|Overall Study|Lost to Follow-up|5|||
44202582|NCT01993940|78998278|FG000|Overall Study|Protocol Violation|5|||
44202583|NCT01993940|78998279|FG001|Overall Study|Protocol Violation|8|||
44202584|NCT01993940|78998278|FG000|Overall Study|Death|1|||
44202585|NCT01993940|78998279|FG001|Overall Study|Death|0|||
44202586|NCT01993940|78998278|FG000|Overall Study|Other - Miscellaneous|1|||
44202587|NCT01993940|78998279|FG001|Overall Study|Other - Miscellaneous|1|||
44202588|NCT01843803|78998287|FG000|Overall Study|not a Veteran, did not see provider|1|||
44202589|NCT01843803|78998288|FG001|Overall Study|not a Veteran, did not see provider|3|||
44202590|NCT02017171|78998296|FG000|Overall Study|Death|10|||
44202591|NCT02017171|78998297|FG001|Overall Study|Death|4|||
44202592|NCT02017171|78998296|FG000|Overall Study|Withdrawal by Subject|23|||
44202593|NCT02017171|78998297|FG001|Overall Study|Withdrawal by Subject|17|||
44202594|NCT02017171|78998296|FG000|Overall Study|Lost to Follow-up|21|||
44202595|NCT02017171|78998297|FG001|Overall Study|Lost to Follow-up|20|||
44202596|NCT02017171|78998296|FG000|Overall Study|ESKD|6|||
44202597|NCT02017171|78998297|FG001|Overall Study|ESKD|2|||
44202598|NCT02017171|78998296|FG000|Overall Study|Miscellaneous|2|||
44202599|NCT02017171|78998297|FG001|Overall Study|Miscellaneous|3|||
44451970|NCT00489255|79460903|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
44451971|NCT00489255|79460904|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
44202600|NCT02029417|78998304|FG000|Overall Study|Death|1|||
44202601|NCT02029417|78998304|FG000|Overall Study|Adverse Event|1|||
44202602|NCT02016716|78998311|FG000|Overall Study|Withdrawal by Subject|5|||
44202603|NCT02016716|78998312|FG001|Overall Study|Withdrawal by Subject|5|||
44202604|NCT02016716|78998313|FG002|Overall Study|Withdrawal by Subject|5|||
44202605|NCT02016716|78998311|FG000|Overall Study|Protocol-specified Criteria|0|||
44202606|NCT02016716|78998312|FG001|Overall Study|Protocol-specified Criteria|1|||
44202607|NCT02016716|78998313|FG002|Overall Study|Protocol-specified Criteria|0|||
44202608|NCT02016716|78998311|FG000|Overall Study|Lost to Follow-up|1|||
44202609|NCT02016716|78998312|FG001|Overall Study|Lost to Follow-up|2|||
44202610|NCT02016716|78998313|FG002|Overall Study|Lost to Follow-up|1|||
44202611|NCT02050321|78998322|FG000|Overall Study|Withdrawal by Subject|1|||
44202612|NCT02050321|78998322|FG000|Overall Study|Adverse Event|1|||
44202613|NCT02039414|78998328|FG000|Overall Study|Delivered|1|||
44202614|NCT02039414|78998329|FG001|Overall Study|Delivered|1|||
44202615|NCT02039414|78998328|FG000|Overall Study|Lost to Follow-up|2|||
44202616|NCT02039414|78998329|FG001|Overall Study|Lost to Follow-up|0|||
44202617|NCT02039414|78998328|FG000|Overall Study|Protocol Violation|3|||
44202618|NCT02039414|78998329|FG001|Overall Study|Protocol Violation|1|||
44202619|NCT02017015|78998335|FG000|Overall Study|Adverse Event|9|||
44202620|NCT02017015|78998335|FG000|Overall Study|Withdrawal by Subject|21|||
44202621|NCT02017015|78998335|FG000|Overall Study|Death|4|||
44202622|NCT02017015|78998335|FG000|Overall Study|Progressive Disease|31|||
44202623|NCT02017015|78998335|FG000|Overall Study|Non-compliance with study drug|2|||
44202624|NCT02017015|78998335|FG000|Overall Study|Physician Decision|2|||
44202625|NCT02016625|78998342|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
44202626|NCT02016625|78998343|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
44202627|NCT02016625|78998342|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
44202628|NCT02016625|78998343|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
44202629|NCT02016625|78998342|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
44363780|NCT00951015|79369063|FG002|Randomization Phase 96 Week|Adverse Event|2|||
44363781|NCT00951015|79369064|FG003|Randomization Phase 96 Week|Adverse Event|5|||
44363782|NCT00951015|79369065|FG004|Randomization Phase 96 Week|Adverse Event|0|||
44363783|NCT00951015|79369061|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
44363784|NCT00951015|79369062|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
44363785|NCT00951015|79369063|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
44363786|NCT00951015|79369064|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
44363787|NCT00951015|79369065|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
44363788|NCT00951015|79369061|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
44363789|NCT00951015|79369062|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
44363790|NCT00951015|79369063|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
44363791|NCT00951015|79369064|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
44363792|NCT00951015|79369065|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
44363793|NCT00951015|79369061|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
44363794|NCT00951015|79369062|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
44363795|NCT00951015|79369063|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
44363796|NCT00951015|79369064|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
44363797|NCT00951015|79369065|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
44363798|NCT00951015|79369061|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
44363799|NCT00951015|79369062|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
44363800|NCT00951015|79369063|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
44363801|NCT00951015|79369064|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
44363802|NCT00951015|79369065|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
44363803|NCT00951015|79369061|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
44363804|NCT00951015|79369062|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
44363805|NCT00951015|79369063|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
44363806|NCT00951015|79369064|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
44363807|NCT00951015|79369065|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
44363808|NCT00951015|79369061|FG000|Open-label Phase|Adverse Event|0|||
44202630|NCT02016625|78998343|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
44202631|NCT02016482|78998361|FG000|Period A|Adverse Event|3|||
44202632|NCT02016482|78998362|FG001|Period A|Adverse Event|5|||
44202633|NCT02016482|78998361|FG000|Period A|Withdrawal by Subject|3|||
44202634|NCT02016482|78998362|FG001|Period A|Withdrawal by Subject|4|||
44202635|NCT02016482|78998361|FG000|Period A|Lost to Follow-up|3|||
44202636|NCT02016482|78998362|FG001|Period A|Lost to Follow-up|3|||
44202637|NCT02016482|78998361|FG000|Period A|Lack of Efficacy|2|||
44202638|NCT02016482|78998362|FG001|Period A|Lack of Efficacy|1|||
44202639|NCT02016482|78998361|FG000|Period A|Other|3|||
44202640|NCT02016482|78998362|FG001|Period A|Other|0|||
44202641|NCT02016482|78998361|FG000|Period A|Protocol Violation|0|||
44363809|NCT00951015|79369062|FG001|Open-label Phase|Adverse Event|0|||
44363810|NCT00951015|79369063|FG002|Open-label Phase|Adverse Event|0|||
44202642|NCT02016482|78998362|FG001|Period A|Protocol Violation|1|||
44202643|NCT02016482|78998361|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
44268625|NCT03299049|79182887|FG001|Overall Study|Pregnancy|3|||
44202644|NCT02016482|78998362|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
44202645|NCT02016482|78998361|FG000|Period B|Withdrawal by Subject|1|||
44202646|NCT02016482|78998362|FG001|Period B|Withdrawal by Subject|1|||
44202647|NCT02016482|78998361|FG000|Period B|Lost to Follow-up|2|||
44202648|NCT02016482|78998362|FG001|Period B|Lost to Follow-up|0|||
44202649|NCT02016482|78998361|FG000|Period B|Lack of Efficacy|6|||
44202650|NCT02016482|78998362|FG001|Period B|Lack of Efficacy|4|||
44202651|NCT02016482|78998361|FG000|Period B|Other|4|||
44202652|NCT02016482|78998362|FG001|Period B|Other|0|||
44202653|NCT02016482|78998361|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
44202654|NCT02016482|78998362|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
44202655|NCT02028871|78998372|FG000|Overall Study|Positive urine drug screen|1|||
44202656|NCT02028871|78998373|FG001|Overall Study|Positive urine drug screen|1|||
44202657|NCT02028871|78998372|FG000|Overall Study|Withdrawal by Subject|1|||
44202658|NCT02028871|78998373|FG001|Overall Study|Withdrawal by Subject|2|||
44202659|NCT02028871|78998372|FG000|Overall Study|IV placement difficulty|1|||
44202660|NCT02028871|78998373|FG001|Overall Study|IV placement difficulty|0|||
44202661|NCT02028871|78998372|FG000|Overall Study|Current Illness|1|||
44202662|NCT02028871|78998373|FG001|Overall Study|Current Illness|0|||
44202663|NCT02028715|78998384|FG000|Overall Study|Adverse Event|2|||
44202664|NCT02028715|78998385|FG001|Overall Study|Adverse Event|2|||
44202665|NCT02028715|78998384|FG000|Overall Study|Physician Decision|1|||
44202666|NCT02028715|78998385|FG001|Overall Study|Physician Decision|0|||
44202667|NCT02028715|78998384|FG000|Overall Study|Did not complete satisfaction surveys|2|||
44202668|NCT02028715|78998385|FG001|Overall Study|Did not complete satisfaction surveys|2|||
44202669|NCT02016170|78998394|FG000|Overall Study|Adverse Event|1|||
44202670|NCT02016170|78998395|FG001|Overall Study|Adverse Event|1|||
44202671|NCT02016170|78998396|FG002|Overall Study|Adverse Event|0|||
44202672|NCT02016170|78998394|FG000|Overall Study|Protocol Violation|1|||
44202673|NCT02016170|78998395|FG001|Overall Study|Protocol Violation|0|||
44202674|NCT02016170|78998396|FG002|Overall Study|Protocol Violation|0|||
44202675|NCT02028169|78998403|FG000|Overall Study|Lost to Follow-up|21|||
44202676|NCT02028169|78998403|FG000|Overall Study|Lack of Efficacy|2|||
44202677|NCT02028169|78998403|FG000|Overall Study|Withdrawal by Subject|2|||
44268626|NCT03299049|79182886|FG000|Overall Study|Protocol Violation|1|||
44268627|NCT03299049|79182887|FG001|Overall Study|Protocol Violation|1|||
44268628|NCT03299049|79182886|FG000|Overall Study|Lack of Efficacy|9|||
44363811|NCT00951015|79369064|FG003|Open-label Phase|Adverse Event|0|||
44363812|NCT00951015|79369065|FG004|Open-label Phase|Adverse Event|3|||
44363813|NCT00951015|79369061|FG000|Open-label Phase|Lack of Efficacy|0|||
44363814|NCT00951015|79369062|FG001|Open-label Phase|Lack of Efficacy|0|||
44363815|NCT00951015|79369063|FG002|Open-label Phase|Lack of Efficacy|0|||
44363816|NCT00951015|79369064|FG003|Open-label Phase|Lack of Efficacy|0|||
44363817|NCT00951015|79369065|FG004|Open-label Phase|Lack of Efficacy|1|||
44363818|NCT00951015|79369061|FG000|Open-label Phase|Protocol Violation|0|||
44363819|NCT00951015|79369062|FG001|Open-label Phase|Protocol Violation|0|||
44202678|NCT02028169|78998403|FG000|Overall Study|Adverse Event|1|||
44202679|NCT02028169|78998403|FG000|Overall Study|Cessation of Drug|1|||
44268629|NCT03299049|79182887|FG001|Overall Study|Lack of Efficacy|3|||
44268630|NCT03299049|79182886|FG000|Overall Study|Adverse Event|12|||
44268631|NCT03299049|79182887|FG001|Overall Study|Adverse Event|13|||
44268632|NCT03298022|79182900|FG000|Overall Study|Lack of Efficacy|4|||
44268633|NCT03298022|79182900|FG000|Overall Study|Withdrawal by Subject|7|||
44268634|NCT03298022|79182900|FG000|Overall Study|Adverse Event|1|||
44268635|NCT03298022|79182900|FG000|Overall Study|disease relapse|1|||
44268636|NCT03277105|79182912|FG000|Overall Study|Death|129|||
44268637|NCT03277105|79182913|FG001|Overall Study|Death|124|||
44268638|NCT03277105|79182912|FG000|Overall Study|Lost to Follow-up|2|||
44268639|NCT03277105|79182913|FG001|Overall Study|Lost to Follow-up|4|||
44268640|NCT03277105|79182912|FG000|Overall Study|Withdrawal by Subject|10|||
44268641|NCT03277105|79182913|FG001|Overall Study|Withdrawal by Subject|10|||
44268642|NCT03277105|79182912|FG000|Overall Study|Other|118|||
44268643|NCT03277105|79182913|FG001|Overall Study|Other|125|||
44268644|NCT03247413|79182919|FG000|Overall Study|Lost to Follow-up|28|||
44268645|NCT03206203|79182927|FG000|Treatment|Death|38|||
44268646|NCT03206203|79182928|FG001|Treatment|Death|26|||
44268647|NCT03206203|79182929|FG002|Treatment|Death|0|||
44202680|NCT02028169|78998403|FG000|Overall Study|Concomitant Medication Usage|1|||
44202681|NCT02015546|78998410|FG000|Overall Study|Withdrawal by Subject|1|||
44202682|NCT02015546|78998411|FG001|Overall Study|Withdrawal by Subject|1|||
44202683|NCT02015546|78998412|FG002|Overall Study|Withdrawal by Subject|1|||
44202684|NCT02015546|78998410|FG000|Overall Study|Screem Failure|2|||
44202685|NCT02015546|78998411|FG001|Overall Study|Screem Failure|1|||
44202686|NCT02015546|78998412|FG002|Overall Study|Screem Failure|3|||
44202687|NCT02027701|78998420|FG000|Overall Study|Adverse Event|3|||
44202688|NCT02027701|78998420|FG000|Overall Study|Lack of Efficacy|8|||
44268648|NCT03206203|79182927|FG000|Treatment|Withdrawal by Subject|1|||
44268649|NCT03206203|79182928|FG001|Treatment|Withdrawal by Subject|0|||
44363820|NCT00951015|79369063|FG002|Open-label Phase|Protocol Violation|0|||
44363821|NCT00951015|79369064|FG003|Open-label Phase|Protocol Violation|0|||
44363822|NCT00951015|79369065|FG004|Open-label Phase|Protocol Violation|12|||
44363823|NCT00951015|79369061|FG000|Open-label Phase|Lost to Follow-up|0|||
44363824|NCT00951015|79369062|FG001|Open-label Phase|Lost to Follow-up|0|||
44363825|NCT00951015|79369063|FG002|Open-label Phase|Lost to Follow-up|0|||
44363826|NCT00951015|79369064|FG003|Open-label Phase|Lost to Follow-up|0|||
44363827|NCT00951015|79369065|FG004|Open-label Phase|Lost to Follow-up|12|||
44363828|NCT00951015|79369061|FG000|Open-label Phase|Withdrawal by Subject|0|||
44363829|NCT00951015|79369062|FG001|Open-label Phase|Withdrawal by Subject|0|||
44363830|NCT00951015|79369063|FG002|Open-label Phase|Withdrawal by Subject|0|||
44202689|NCT02027701|78998420|FG000|Overall Study|Physician Decision|2|||
44202690|NCT02027701|78998420|FG000|Overall Study|Withdrawal by Subject|3|||
44202691|NCT02038790|78998426|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
44202692|NCT02038790|78998427|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
44202693|NCT02027623|78998436|FG000|Overall Study|Lost to Follow-up|3|||
44202694|NCT02027623|78998437|FG001|Overall Study|Lost to Follow-up|3|||
44202695|NCT02027623|78998436|FG000|Overall Study|Withdrawal by Subject|6|||
44202696|NCT02027623|78998437|FG001|Overall Study|Withdrawal by Subject|9|||
44202697|NCT02015221|78998446|FG000|Overall Study|Withdrawal by Subject|8|||
44202698|NCT02015221|78998447|FG001|Overall Study|Withdrawal by Subject|6|||
44202699|NCT02015221|78998446|FG000|Overall Study|Lost to Follow-up|1|||
44202700|NCT02015221|78998447|FG001|Overall Study|Lost to Follow-up|0|||
44202701|NCT02027311|78998455|FG000|Overall Study|Protocol Violation|3|||
44202702|NCT02027311|78998456|FG001|Overall Study|Protocol Violation|2|||
44202703|NCT02047903|78998464|FG000|Overall Study|Adverse Event|14|||
44202704|NCT02047903|78998464|FG000|Overall Study|Serious adverse event|10|||
44202705|NCT02047903|78998464|FG000|Overall Study|Withdrawal by Subject|16|||
44202706|NCT02047903|78998464|FG000|Overall Study|Lost to Follow-up|4|||
44202707|NCT02047903|78998464|FG000|Overall Study|Reason not listed|6|||
44202708|NCT02047903|78998464|FG000|Overall Study|Not Treated|9|||
44202709|NCT02015065|78998471|FG000|Overall Study|Death on study|1|||
44202710|NCT02015065|78998472|FG001|Overall Study|Death on study|2|||
44202711|NCT02015065|78998473|FG002|Overall Study|Death on study|1|||
44202712|NCT02026141|78998483|FG000|Overall Study|Protocol Violation|0|||
44202713|NCT02026141|78998484|FG001|Overall Study|Protocol Violation|1|||
44202714|NCT02026063|78998492|FG000|Overall Study|Physician Decision|0|||
44202715|NCT02026063|78998493|FG001|Overall Study|Physician Decision|10|||
44202716|NCT02026063|78998492|FG000|Overall Study|Noncompliance with Study Drug|1|||
44202717|NCT02026063|78998493|FG001|Overall Study|Noncompliance with Study Drug|1|||
44202718|NCT02026063|78998492|FG000|Overall Study|Withdrawal of Consent|1|||
44202719|NCT02026063|78998493|FG001|Overall Study|Withdrawal of Consent|6|||
44202720|NCT02026063|78998492|FG000|Overall Study|Adverse Event|5|||
44202721|NCT02026063|78998493|FG001|Overall Study|Adverse Event|20|||
44202722|NCT02026063|78998492|FG000|Overall Study|Lack of Efficacy|0|||
44202723|NCT02026063|78998493|FG001|Overall Study|Lack of Efficacy|4|||
44202724|NCT02026063|78998492|FG000|Overall Study|Lost to Follow-up|0|||
44202725|NCT02026063|78998493|FG001|Overall Study|Lost to Follow-up|1|||
44202726|NCT02026063|78998492|FG000|Overall Study|Reason not Specified|2|||
44202727|NCT02026063|78998493|FG001|Overall Study|Reason not Specified|7|||
44202728|NCT02025907|78998502|FG000|Overall Study|Lack of Efficacy|1|||
44202729|NCT02025907|78998503|FG001|Overall Study|Lack of Efficacy|0|||
44363831|NCT00951015|79369064|FG003|Open-label Phase|Withdrawal by Subject|0|||
44363832|NCT00951015|79369065|FG004|Open-label Phase|Withdrawal by Subject|14|||
44363833|NCT00951015|79369061|FG000|Open-label Phase|Physician Decision|0|||
44363834|NCT00951015|79369062|FG001|Open-label Phase|Physician Decision|0|||
44363835|NCT00951015|79369063|FG002|Open-label Phase|Physician Decision|0|||
44363836|NCT00951015|79369064|FG003|Open-label Phase|Physician Decision|0|||
44363837|NCT00951015|79369065|FG004|Open-label Phase|Physician Decision|8|||
44363838|NCT01139021|79369094|FG000|Overall Study|Adverse Event|0|||
44363839|NCT01139021|79369095|FG001|Overall Study|Adverse Event|0|||
44363840|NCT01139021|79369096|FG002|Overall Study|Adverse Event|0|||
44202730|NCT02025907|78998502|FG000|Overall Study|Withdrawal by Subject|15|||
44202731|NCT02025907|78998503|FG001|Overall Study|Withdrawal by Subject|8|||
44202732|NCT02025907|78998502|FG000|Overall Study|Protocol Violation|2|||
44202733|NCT02025907|78998503|FG001|Overall Study|Protocol Violation|0|||
44202734|NCT02025907|78998502|FG000|Overall Study|Physician Decision|2|||
44202735|NCT02025907|78998503|FG001|Overall Study|Physician Decision|0|||
44202736|NCT02025907|78998502|FG000|Overall Study|Lost to Follow-up|2|||
44202737|NCT02025907|78998503|FG001|Overall Study|Lost to Follow-up|2|||
44202738|NCT02025907|78998502|FG000|Overall Study|Adverse Event|3|||
44202739|NCT02025907|78998503|FG001|Overall Study|Adverse Event|1|||
44202740|NCT02025907|78998502|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
44202741|NCT02025907|78998503|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
44202742|NCT01813071|78998518|FG000|Overall Study|Protocol Violation|0|||
44202743|NCT01813071|78998519|FG001|Overall Study|Protocol Violation|0|||
44363841|NCT01139021|79369097|FG003|Overall Study|Adverse Event|0|||
44363842|NCT01139021|79369098|FG004|Overall Study|Adverse Event|1|||
44363843|NCT01139021|79369099|FG005|Overall Study|Adverse Event|0|||
44202744|NCT01813071|78998520|FG002|Overall Study|Protocol Violation|0|||
44202745|NCT01813071|78998521|FG003|Overall Study|Protocol Violation|0|||
44202746|NCT01813071|78998522|FG004|Overall Study|Protocol Violation|1|||
44202747|NCT01813071|78998523|FG005|Overall Study|Protocol Violation|4|||
44202748|NCT01813071|78998524|FG006|Overall Study|Protocol Violation|2|||
44202749|NCT01813071|78998525|FG007|Overall Study|Protocol Violation|4|||
44202750|NCT01813071|78998526|FG008|Overall Study|Protocol Violation|2|||
44202751|NCT01813071|78998518|FG000|Overall Study|Withdrawal by Subject|0|||
44202752|NCT01813071|78998519|FG001|Overall Study|Withdrawal by Subject|0|||
44202753|NCT01813071|78998520|FG002|Overall Study|Withdrawal by Subject|0|||
44202754|NCT01813071|78998521|FG003|Overall Study|Withdrawal by Subject|0|||
44202755|NCT01813071|78998522|FG004|Overall Study|Withdrawal by Subject|0|||
44202756|NCT01813071|78998523|FG005|Overall Study|Withdrawal by Subject|1|||
44202757|NCT01813071|78998524|FG006|Overall Study|Withdrawal by Subject|0|||
44202758|NCT01813071|78998525|FG007|Overall Study|Withdrawal by Subject|0|||
44202759|NCT01813071|78998526|FG008|Overall Study|Withdrawal by Subject|0|||
44202760|NCT01813071|78998518|FG000|Overall Study|Adverse Event|0|||
44202761|NCT01813071|78998519|FG001|Overall Study|Adverse Event|0|||
44202762|NCT01813071|78998520|FG002|Overall Study|Adverse Event|0|||
44202763|NCT01813071|78998521|FG003|Overall Study|Adverse Event|0|||
44202764|NCT01813071|78998522|FG004|Overall Study|Adverse Event|0|||
44202765|NCT01813071|78998523|FG005|Overall Study|Adverse Event|1|||
44202766|NCT01813071|78998524|FG006|Overall Study|Adverse Event|0|||
44202767|NCT01813071|78998525|FG007|Overall Study|Adverse Event|0|||
44202768|NCT01813071|78998526|FG008|Overall Study|Adverse Event|0|||
44202769|NCT01813071|78998518|FG000|Overall Study|Physician Decision|0|||
44202770|NCT01813071|78998519|FG001|Overall Study|Physician Decision|0|||
44202771|NCT01813071|78998520|FG002|Overall Study|Physician Decision|0|||
44202772|NCT01813071|78998521|FG003|Overall Study|Physician Decision|0|||
44202773|NCT01813071|78998522|FG004|Overall Study|Physician Decision|0|||
44202774|NCT01813071|78998523|FG005|Overall Study|Physician Decision|0|||
44202775|NCT01813071|78998524|FG006|Overall Study|Physician Decision|1|||
44202776|NCT01813071|78998525|FG007|Overall Study|Physician Decision|0|||
44202777|NCT01813071|78998526|FG008|Overall Study|Physician Decision|0|||
44202778|NCT01813071|78998518|FG000|Overall Study|Met inc/exc criteria|0|||
44202779|NCT01813071|78998519|FG001|Overall Study|Met inc/exc criteria|0|||
44202780|NCT01813071|78998520|FG002|Overall Study|Met inc/exc criteria|0|||
44202781|NCT01813071|78998521|FG003|Overall Study|Met inc/exc criteria|0|||
44202782|NCT01813071|78998522|FG004|Overall Study|Met inc/exc criteria|0|||
44202783|NCT01813071|78998523|FG005|Overall Study|Met inc/exc criteria|1|||
44202784|NCT01813071|78998524|FG006|Overall Study|Met inc/exc criteria|0|||
44202785|NCT01813071|78998525|FG007|Overall Study|Met inc/exc criteria|1|||
44202786|NCT01813071|78998526|FG008|Overall Study|Met inc/exc criteria|1|||
44202787|NCT02025751|78998562|FG000|Overall Study|Lost to Follow-up|1|||
44202788|NCT02025751|78998563|FG001|Overall Study|Lost to Follow-up|0|||
44363844|NCT01139021|79369094|FG000|Overall Study|Lost to Follow-up|0|||
44363845|NCT01139021|79369095|FG001|Overall Study|Lost to Follow-up|0|||
44363846|NCT01139021|79369096|FG002|Overall Study|Lost to Follow-up|0|||
44363847|NCT01139021|79369097|FG003|Overall Study|Lost to Follow-up|0|||
44363848|NCT01139021|79369098|FG004|Overall Study|Lost to Follow-up|2|||
44363849|NCT01139021|79369099|FG005|Overall Study|Lost to Follow-up|0|||
44363850|NCT01139021|79369094|FG000|Overall Study|Protocol Violation|1|||
44363851|NCT01139021|79369095|FG001|Overall Study|Protocol Violation|0|||
44363852|NCT01139021|79369096|FG002|Overall Study|Protocol Violation|0|||
44363853|NCT01139021|79369097|FG003|Overall Study|Protocol Violation|0|||
44363854|NCT01139021|79369098|FG004|Overall Study|Protocol Violation|2|||
44363855|NCT01139021|79369099|FG005|Overall Study|Protocol Violation|0|||
44363856|NCT01139021|79369094|FG000|Overall Study|Withdrawal by Subject|0|||
44202789|NCT02025751|78998562|FG000|Overall Study|Adverse Event|0|||
44202790|NCT02025751|78998563|FG001|Overall Study|Adverse Event|1|||
44202791|NCT02025751|78998562|FG000|Overall Study|Physician Decision|0|||
44202792|NCT02025751|78998563|FG001|Overall Study|Physician Decision|1|||
44202793|NCT02025751|78998562|FG000|Overall Study|Withdrawal by Subject|0|||
44202794|NCT02025751|78998563|FG001|Overall Study|Withdrawal by Subject|1|||
44202795|NCT02025205|78998571|FG000|Overall Study|Withdrawal by Subject|1|||
44202796|NCT02025205|78998572|FG001|Overall Study|Withdrawal by Subject|1|||
44202797|NCT02025205|78998571|FG000|Overall Study|Protocol Violation|2|||
44363857|NCT01139021|79369095|FG001|Overall Study|Withdrawal by Subject|0|||
44202798|NCT02025205|78998572|FG001|Overall Study|Protocol Violation|1|||
44202799|NCT02025205|78998571|FG000|Overall Study|Death|0|||
44363858|NCT01139021|79369096|FG002|Overall Study|Withdrawal by Subject|0|||
44363859|NCT01139021|79369097|FG003|Overall Study|Withdrawal by Subject|1|||
44202800|NCT02025205|78998572|FG001|Overall Study|Death|1|||
44202801|NCT01812837|78998581|FG000|Overall Study|Lost to Follow-up|1|||
44202802|NCT01812837|78998582|FG001|Overall Study|Lost to Follow-up|1|||
44202803|NCT01812837|78998583|FG002|Overall Study|Lost to Follow-up|0|||
44202804|NCT01812837|78998581|FG000|Overall Study|Protocol Violation|1|||
44363860|NCT01139021|79369098|FG004|Overall Study|Withdrawal by Subject|4|||
44202805|NCT01812837|78998582|FG001|Overall Study|Protocol Violation|0|||
44202806|NCT01812837|78998583|FG002|Overall Study|Protocol Violation|0|||
44202807|NCT02024971|78998591|FG000|Overall Study|Data Not Available|30|||
44202808|NCT02024971|78998591|FG000|Overall Study|Lost to Follow-up|6|||
44202809|NCT01843023|78998597|FG000|Overall Study|Death|1|||
44202810|NCT01843023|78998598|FG001|Overall Study|Death|0|||
44202811|NCT01843023|78998597|FG000|Overall Study|Lost to Follow-up|24|||
44202812|NCT01843023|78998598|FG001|Overall Study|Lost to Follow-up|29|||
44202813|NCT01843023|78998597|FG000|Overall Study|Withdrawal by Subject|8|||
44202814|NCT01843023|78998598|FG001|Overall Study|Withdrawal by Subject|6|||
44202815|NCT01812759|78998607|FG000|Overall Study|Physician Decision|0|||
44202816|NCT01812759|78998608|FG001|Overall Study|Physician Decision|0|||
44202817|NCT01812759|78998609|FG002|Overall Study|Physician Decision|1|||
44202818|NCT01812057|78998619|FG000|Overall Study|Protocol Violation|1|||
44202819|NCT01812057|78998620|FG001|Overall Study|Protocol Violation|0|||
44202820|NCT01812057|78998619|FG000|Overall Study|Physician Decision|1|||
44202821|NCT01812057|78998620|FG001|Overall Study|Physician Decision|0|||
44202822|NCT01842633|78998633|FG000|Overall Study|Screen Failure|1|||
44202823|NCT01842633|78998634|FG001|Overall Study|Screen Failure|0|||
44202824|NCT01842633|78998635|FG002|Overall Study|Screen Failure|0|||
44202825|NCT01842633|78998633|FG000|Overall Study|Adverse Event|1|||
44202826|NCT01842633|78998634|FG001|Overall Study|Adverse Event|1|||
44202827|NCT01842633|78998635|FG002|Overall Study|Adverse Event|0|||
44202828|NCT01842633|78998633|FG000|Overall Study|Withdrawal by Subject|0|||
44202829|NCT01842633|78998634|FG001|Overall Study|Withdrawal by Subject|1|||
44202830|NCT01842633|78998635|FG002|Overall Study|Withdrawal by Subject|0|||
44202831|NCT01842633|78998633|FG000|Overall Study|Technical issues|1|||
44202832|NCT01842633|78998634|FG001|Overall Study|Technical issues|0|||
44202833|NCT01842633|78998635|FG002|Overall Study|Technical issues|0|||
44202834|NCT01810263|78998647|FG000|Overall Study|Lost to Follow-up|8|||
44202835|NCT01810263|78998648|FG001|Overall Study|Lost to Follow-up|7|||
44202836|NCT01841697|78998656|FG000|Overall Study|Death|0|||
44202837|NCT01841697|78998657|FG001|Overall Study|Death|1|||
44202838|NCT01841697|78998656|FG000|Overall Study|Lost to Follow-up|4|||
44202839|NCT01841697|78998657|FG001|Overall Study|Lost to Follow-up|1|||
44202840|NCT01841697|78998656|FG000|Overall Study|Withdrawal by Subject|16|||
44202841|NCT01841697|78998657|FG001|Overall Study|Withdrawal by Subject|16|||
44202842|NCT01841073|78998665|FG000|Overall Study|Adverse Event|1|||
44202843|NCT01841073|78998666|FG001|Overall Study|Adverse Event|1|||
44202844|NCT01841073|78998665|FG000|Overall Study|Physician Decision|1|||
44202845|NCT01841073|78998666|FG001|Overall Study|Physician Decision|0|||
44202846|NCT01841073|78998665|FG000|Overall Study|Lost to Follow-up|0|||
44202847|NCT01841073|78998666|FG001|Overall Study|Lost to Follow-up|2|||
44202848|NCT01809327|78998679|FG000|Overall Study|Lost to Follow-up|5|||
44202849|NCT01809327|78998680|FG001|Overall Study|Lost to Follow-up|2|||
44202850|NCT01809327|78998681|FG002|Overall Study|Lost to Follow-up|4|||
44202851|NCT01809327|78998682|FG003|Overall Study|Lost to Follow-up|2|||
44202852|NCT01809327|78998683|FG004|Overall Study|Lost to Follow-up|3|||
44202853|NCT01809327|78998679|FG000|Overall Study|Withdrawal by Subject|6|||
44202854|NCT01809327|78998680|FG001|Overall Study|Withdrawal by Subject|4|||
44202855|NCT01809327|78998681|FG002|Overall Study|Withdrawal by Subject|4|||
44202856|NCT01809327|78998682|FG003|Overall Study|Withdrawal by Subject|2|||
44202857|NCT01809327|78998683|FG004|Overall Study|Withdrawal by Subject|5|||
44202858|NCT01809327|78998679|FG000|Overall Study|Adverse Event|4|||
44202859|NCT01809327|78998680|FG001|Overall Study|Adverse Event|3|||
44202860|NCT01809327|78998681|FG002|Overall Study|Adverse Event|7|||
44202861|NCT01809327|78998682|FG003|Overall Study|Adverse Event|4|||
44202862|NCT01809327|78998683|FG004|Overall Study|Adverse Event|8|||
44202863|NCT01809327|78998679|FG000|Overall Study|Death|1|||
44202864|NCT01809327|78998680|FG001|Overall Study|Death|0|||
44202865|NCT01809327|78998681|FG002|Overall Study|Death|0|||
44202866|NCT01809327|78998682|FG003|Overall Study|Death|0|||
44202867|NCT01809327|78998683|FG004|Overall Study|Death|0|||
44202868|NCT01809327|78998679|FG000|Overall Study|Protocol Violation|0|||
44202869|NCT01809327|78998680|FG001|Overall Study|Protocol Violation|1|||
44202870|NCT01809327|78998681|FG002|Overall Study|Protocol Violation|0|||
44202871|NCT01809327|78998682|FG003|Overall Study|Protocol Violation|0|||
44202872|NCT01809327|78998683|FG004|Overall Study|Protocol Violation|0|||
44202873|NCT01809327|78998679|FG000|Overall Study|Physician Decision|1|||
44202874|NCT01809327|78998680|FG001|Overall Study|Physician Decision|1|||
44202875|NCT01809327|78998681|FG002|Overall Study|Physician Decision|0|||
44202876|NCT01809327|78998682|FG003|Overall Study|Physician Decision|0|||
44202877|NCT01809327|78998683|FG004|Overall Study|Physician Decision|0|||
44202878|NCT01809327|78998679|FG000|Overall Study|Pregnancy|1|||
44202879|NCT01809327|78998680|FG001|Overall Study|Pregnancy|0|||
44268650|NCT03206203|79182929|FG002|Treatment|Withdrawal by Subject|0|||
44202880|NCT01809327|78998681|FG002|Overall Study|Pregnancy|0|||
44202881|NCT01809327|78998682|FG003|Overall Study|Pregnancy|0|||
44202882|NCT01809327|78998683|FG004|Overall Study|Pregnancy|0|||
44202883|NCT01809327|78998679|FG000|Overall Study|Other|14|||
44202884|NCT01809327|78998680|FG001|Overall Study|Other|15|||
44202885|NCT01809327|78998681|FG002|Overall Study|Other|7|||
44202886|NCT01809327|78998682|FG003|Overall Study|Other|4|||
44202887|NCT01809327|78998683|FG004|Overall Study|Other|9|||
44202888|NCT01808313|78998704|FG000|Overall Study|Adverse Event|5|||
44202889|NCT01808313|78998704|FG000|Overall Study|Protocol Violation|2|||
44202890|NCT01808313|78998704|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44202891|NCT01808313|78998704|FG000|Overall Study|Lost to Follow-up|1|||
44202892|NCT01808313|78998704|FG000|Overall Study|Physician Decision|1|||
44202893|NCT01840605|78998710|FG000|Overall Study|Adverse Event|0|||
44202894|NCT01840605|78998711|FG001|Overall Study|Adverse Event|1|||
44202895|NCT01840605|78998710|FG000|Overall Study|Physician Decision|2|||
44202896|NCT01840605|78998711|FG001|Overall Study|Physician Decision|1|||
44202897|NCT02023879|78998720|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
44202898|NCT02023879|78998721|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
44202899|NCT02023879|78998722|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
44202900|NCT02023879|78998720|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
44202901|NCT02023879|78998721|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
44202902|NCT02023879|78998722|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
44202903|NCT02023879|78998720|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
44202904|NCT02023879|78998721|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
44202905|NCT02023879|78998722|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
44202906|NCT02023879|78998720|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
44202907|NCT02023879|78998721|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
44202908|NCT02023879|78998722|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
44202909|NCT02023879|78998720|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
44202910|NCT02023879|78998721|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
44202911|NCT02023879|78998722|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
44202912|NCT02023879|78998720|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
44202913|NCT02023879|78998721|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
44202914|NCT02023879|78998722|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
44202915|NCT02023879|78998720|FG000|Extension Open Label Treatment|Adverse Event|1|||
44202916|NCT02023879|78998721|FG001|Extension Open Label Treatment|Adverse Event|7|||
44202917|NCT02023879|78998722|FG002|Extension Open Label Treatment|Adverse Event|3|||
44202918|NCT02023879|78998720|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
44202919|NCT02023879|78998721|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
44202920|NCT02023879|78998722|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
44202921|NCT02023879|78998720|FG000|Extension Open Label Treatment|Participant moved|1|||
44202922|NCT02023879|78998721|FG001|Extension Open Label Treatment|Participant moved|2|||
44202923|NCT02023879|78998722|FG002|Extension Open Label Treatment|Participant moved|0|||
44202924|NCT02023879|78998720|FG000|Extension Open Label Treatment|Other than specified above|2|||
44202925|NCT02023879|78998721|FG001|Extension Open Label Treatment|Other than specified above|7|||
44202926|NCT02023879|78998722|FG002|Extension Open Label Treatment|Other than specified above|2|||
44202927|NCT02014441|78998737|FG000|Overall Study|Withdrawal by Subject|12|||
44202928|NCT02013817|78998743|FG000|Overall Study|Adverse Event|12|||
44202929|NCT02013817|78998743|FG000|Overall Study|Withdrawal by Subject|4|||
44202930|NCT02013817|78998743|FG000|Overall Study|Death|2|||
44202931|NCT02013817|78998743|FG000|Overall Study|Other|9|||
44202932|NCT01994863|78998747|FG000|Period 1|Adverse Event|4|||
44202933|NCT01994863|78998748|FG001|Period 1|Adverse Event|0|||
44202934|NCT01994863|78998747|FG000|Period 1|Withdrawal by Subject|1|||
44202935|NCT01994863|78998748|FG001|Period 1|Withdrawal by Subject|0|||
44202936|NCT01994863|78998747|FG000|Period 1|Trial stopped by sponsor|1|||
44202937|NCT01994863|78998748|FG001|Period 1|Trial stopped by sponsor|3|||
44202938|NCT01994863|78998747|FG000|Period 1|Lack of Efficacy|1|||
44202939|NCT01994863|78998748|FG001|Period 1|Lack of Efficacy|0|||
44202940|NCT01994863|78998747|FG000|Period 2|Adverse Event|0|||
44202941|NCT01994863|78998748|FG001|Period 2|Adverse Event|1|||
44202942|NCT01994863|78998747|FG000|Period 2|Lack of Efficacy|0|||
44202943|NCT01994863|78998748|FG001|Period 2|Lack of Efficacy|2|||
44202944|NCT01994863|78998747|FG000|Period 2|Withdrawal by Subject|1|||
44202945|NCT01994863|78998748|FG001|Period 2|Withdrawal by Subject|1|||
44268651|NCT03206203|79182927|FG000|Treatment|Lost to Follow-up|4|||
44268652|NCT03206203|79182928|FG001|Treatment|Lost to Follow-up|0|||
44268653|NCT03206203|79182929|FG002|Treatment|Lost to Follow-up|0|||
44268654|NCT03206203|79182927|FG000|Treatment|N/A in Follow-Up|8|||
44268655|NCT03206203|79182928|FG001|Treatment|N/A in Follow-Up|1|||
44268656|NCT03206203|79182929|FG002|Treatment|N/A in Follow-Up|0|||
44268657|NCT03206203|79182927|FG000|Treatment|Disease progression|0|||
44268658|NCT03206203|79182928|FG001|Treatment|Disease progression|1|||
44268659|NCT03206203|79182929|FG002|Treatment|Disease progression|0|||
44268660|NCT03206203|79182927|FG000|Treatment|Refused follow-up|0|||
44268661|NCT03206203|79182928|FG001|Treatment|Refused follow-up|1|||
44268662|NCT03206203|79182929|FG002|Treatment|Refused follow-up|0|||
44363861|NCT01139021|79369099|FG005|Overall Study|Withdrawal by Subject|0|||
44363862|NCT01193660|79369117|FG000|Overall Study|Withdrawal by Subject|2|||
44202946|NCT02023099|78998757|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
44202947|NCT02023099|78998758|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
44202948|NCT02023099|78998759|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
44202949|NCT02023099|78998757|FG000|Overall Study|Withdrawn Consent|3|||
44202950|NCT02023099|78998758|FG001|Overall Study|Withdrawn Consent|0|||
44202951|NCT02023099|78998759|FG002|Overall Study|Withdrawn Consent|1|||
44202952|NCT02023099|78998757|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
44202953|NCT02023099|78998758|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
44202954|NCT02023099|78998759|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
44202955|NCT02013037|78998767|FG000|Overall Study|Death|6|||
44202956|NCT02013037|78998767|FG000|Overall Study|Withdrawal by Subject|1|||
44202957|NCT02013037|78998767|FG000|Overall Study|Awaiting Transplantation|7|||
44202958|NCT02013037|78998767|FG000|Overall Study|Transplanted without DSA|2|||
44202959|NCT01967719|78998774|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
44202960|NCT01967719|78998775|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
44202961|NCT01967719|78998776|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
44202962|NCT01967719|78998777|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
44202963|NCT01967719|78998774|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
44202964|NCT01967719|78998775|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
44202965|NCT01967719|78998776|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
44202966|NCT01967719|78998777|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
44202967|NCT01967173|78998795|FG000|Overall Study|Lost to Follow-up|5|||
44202968|NCT01967173|78998796|FG001|Overall Study|Lost to Follow-up|3|||
44202969|NCT01967173|78998797|FG002|Overall Study|Lost to Follow-up|2|||
44202970|NCT01967173|78998798|FG003|Overall Study|Lost to Follow-up|4|||
44202971|NCT01967173|78998799|FG004|Overall Study|Lost to Follow-up|8|||
44202972|NCT01967173|78998800|FG005|Overall Study|Lost to Follow-up|12|||
44202973|NCT01967173|78998801|FG006|Overall Study|Lost to Follow-up|6|||
44202974|NCT01967173|78998802|FG007|Overall Study|Lost to Follow-up|8|||
44202975|NCT01967173|78998795|FG000|Overall Study|Physician Decision|2|||
44202976|NCT01967173|78998796|FG001|Overall Study|Physician Decision|0|||
44202977|NCT01967173|78998797|FG002|Overall Study|Physician Decision|2|||
44202978|NCT01967173|78998798|FG003|Overall Study|Physician Decision|1|||
44202979|NCT01967173|78998799|FG004|Overall Study|Physician Decision|1|||
44202980|NCT01967173|78998800|FG005|Overall Study|Physician Decision|1|||
44202981|NCT01967173|78998801|FG006|Overall Study|Physician Decision|1|||
44202982|NCT01967173|78998802|FG007|Overall Study|Physician Decision|0|||
44202983|NCT01967173|78998795|FG000|Overall Study|Lack of Efficacy|2|||
44202984|NCT01967173|78998796|FG001|Overall Study|Lack of Efficacy|0|||
44202985|NCT01967173|78998797|FG002|Overall Study|Lack of Efficacy|2|||
44202986|NCT01967173|78998798|FG003|Overall Study|Lack of Efficacy|2|||
44202987|NCT01967173|78998799|FG004|Overall Study|Lack of Efficacy|0|||
44202988|NCT01967173|78998800|FG005|Overall Study|Lack of Efficacy|1|||
44202989|NCT01967173|78998801|FG006|Overall Study|Lack of Efficacy|0|||
44202990|NCT01967173|78998802|FG007|Overall Study|Lack of Efficacy|2|||
44202991|NCT01967173|78998795|FG000|Overall Study|Pregnancy|0|||
44202992|NCT01967173|78998796|FG001|Overall Study|Pregnancy|0|||
44202993|NCT01967173|78998797|FG002|Overall Study|Pregnancy|0|||
44202994|NCT01967173|78998798|FG003|Overall Study|Pregnancy|0|||
44202995|NCT01967173|78998799|FG004|Overall Study|Pregnancy|0|||
44202996|NCT01967173|78998800|FG005|Overall Study|Pregnancy|0|||
44202997|NCT01967173|78998801|FG006|Overall Study|Pregnancy|1|||
44202998|NCT01967173|78998802|FG007|Overall Study|Pregnancy|1|||
44202999|NCT01967173|78998795|FG000|Overall Study|Adverse Event|0|||
44203000|NCT01967173|78998796|FG001|Overall Study|Adverse Event|0|||
44203001|NCT01967173|78998797|FG002|Overall Study|Adverse Event|0|||
44203002|NCT01967173|78998798|FG003|Overall Study|Adverse Event|0|||
44203003|NCT01967173|78998799|FG004|Overall Study|Adverse Event|0|||
44203004|NCT01967173|78998800|FG005|Overall Study|Adverse Event|0|||
44203005|NCT01967173|78998801|FG006|Overall Study|Adverse Event|0|||
44203006|NCT01967173|78998802|FG007|Overall Study|Adverse Event|1|||
44203007|NCT01967173|78998795|FG000|Overall Study|Withdrawal by Subject|15|||
44203008|NCT01967173|78998796|FG001|Overall Study|Withdrawal by Subject|14|||
44203009|NCT01967173|78998797|FG002|Overall Study|Withdrawal by Subject|10|||
44203010|NCT01967173|78998798|FG003|Overall Study|Withdrawal by Subject|7|||
44203011|NCT01967173|78998799|FG004|Overall Study|Withdrawal by Subject|8|||
44203012|NCT01967173|78998800|FG005|Overall Study|Withdrawal by Subject|9|||
44203013|NCT01967173|78998801|FG006|Overall Study|Withdrawal by Subject|10|||
44203014|NCT01967173|78998802|FG007|Overall Study|Withdrawal by Subject|12|||
44203015|NCT01994629|78998816|FG000|Overall Study|Withdrawal by Subject|1|||
44203016|NCT01994629|78998817|FG001|Overall Study|Withdrawal by Subject|0|||
44203017|NCT01994629|78998816|FG000|Overall Study|Lost to Follow-up|0|||
44203018|NCT01994629|78998817|FG001|Overall Study|Lost to Follow-up|3|||
44203019|NCT01994395|78998825|FG000|Overall Study|Withdrawal by Subject|1|||
44203020|NCT01994395|78998826|FG001|Overall Study|Withdrawal by Subject|2|||
44203021|NCT01992536|78998842|FG000|Overall Study|Administrative Reason|0|||
44203022|NCT01992536|78998843|FG001|Overall Study|Administrative Reason|0|||
44203023|NCT01992536|78998844|FG002|Overall Study|Administrative Reason|0|||
44203024|NCT01992536|78998845|FG003|Overall Study|Administrative Reason|0|||
44203025|NCT01992536|78998846|FG004|Overall Study|Administrative Reason|0|||
44203026|NCT01992536|78998847|FG005|Overall Study|Administrative Reason|0|||
44203027|NCT01992536|78998848|FG006|Overall Study|Administrative Reason|7|||
44203028|NCT01992536|78998849|FG007|Overall Study|Administrative Reason|0|||
44203029|NCT01992536|78998850|FG008|Overall Study|Administrative Reason|0|||
44203030|NCT01992536|78998851|FG009|Overall Study|Administrative Reason|0|||
44203031|NCT01992536|78998842|FG000|Overall Study|Lost to Follow-up|4|||
44203032|NCT01992536|78998843|FG001|Overall Study|Lost to Follow-up|2|||
44203033|NCT01992536|78998844|FG002|Overall Study|Lost to Follow-up|1|||
44203034|NCT01992536|78998845|FG003|Overall Study|Lost to Follow-up|0|||
44203035|NCT01992536|78998846|FG004|Overall Study|Lost to Follow-up|0|||
44203036|NCT01992536|78998847|FG005|Overall Study|Lost to Follow-up|1|||
44203037|NCT01992536|78998848|FG006|Overall Study|Lost to Follow-up|0|||
44203038|NCT01992536|78998849|FG007|Overall Study|Lost to Follow-up|0|||
44203039|NCT01992536|78998850|FG008|Overall Study|Lost to Follow-up|1|||
44203040|NCT01992536|78998851|FG009|Overall Study|Lost to Follow-up|1|||
44203041|NCT01992536|78998842|FG000|Overall Study|Withdrawal by Subject|0|||
44203042|NCT01992536|78998843|FG001|Overall Study|Withdrawal by Subject|1|||
44203043|NCT01992536|78998844|FG002|Overall Study|Withdrawal by Subject|0|||
44203044|NCT01992536|78998845|FG003|Overall Study|Withdrawal by Subject|2|||
44203045|NCT01992536|78998846|FG004|Overall Study|Withdrawal by Subject|0|||
44203046|NCT01992536|78998847|FG005|Overall Study|Withdrawal by Subject|0|||
44203047|NCT01992536|78998848|FG006|Overall Study|Withdrawal by Subject|0|||
44203048|NCT01992536|78998849|FG007|Overall Study|Withdrawal by Subject|0|||
44203049|NCT01992536|78998850|FG008|Overall Study|Withdrawal by Subject|0|||
44203050|NCT01992536|78998851|FG009|Overall Study|Withdrawal by Subject|0|||
44268663|NCT03206203|79182927|FG000|Treatment|Cross over to Arm 1|0|||
44268664|NCT03206203|79182928|FG001|Treatment|Cross over to Arm 1|19|||
44268665|NCT03206203|79182929|FG002|Treatment|Cross over to Arm 1|0|||
44268666|NCT03206203|79182927|FG000|Optional Cross-Over|Death|0|||
44268667|NCT03206203|79182928|FG001|Optional Cross-Over|Death|0|||
44268668|NCT03206203|79182929|FG002|Optional Cross-Over|Death|14|||
44268669|NCT03206203|79182927|FG000|Optional Cross-Over|Refused follow-up|0|||
44363863|NCT01193660|79369118|FG001|Overall Study|Withdrawal by Subject|3|||
44363864|NCT01193660|79369119|FG002|Overall Study|Withdrawal by Subject|1|||
44363865|NCT01193660|79369117|FG000|Overall Study|Death|1|||
44363866|NCT01193660|79369118|FG001|Overall Study|Death|0|||
44363867|NCT01193660|79369119|FG002|Overall Study|Death|0|||
44363868|NCT01193660|79369117|FG000|Overall Study|Physician Decision|1|||
44363869|NCT01193660|79369118|FG001|Overall Study|Physician Decision|0|||
44363870|NCT01193660|79369119|FG002|Overall Study|Physician Decision|1|||
44363871|NCT01076166|79369127|FG000|Overall Study|Adverse Event|3|||
44363872|NCT01076166|79369127|FG000|Overall Study|Symptoms improved/resolved|6|||
44363873|NCT01193582|79369138|FG000|Vaccination Series|Withdrawal by Subject|11|||
44363874|NCT01193582|79369139|FG001|Vaccination Series|Withdrawal by Subject|13|||
44363875|NCT01193582|79369140|FG002|Vaccination Series|Withdrawal by Subject|8|||
44363876|NCT01193582|79369141|FG003|Vaccination Series|Withdrawal by Subject|3|||
44363877|NCT01193582|79369138|FG000|12 Month Follow-up|Death|0|||
44363878|NCT01193582|79369139|FG001|12 Month Follow-up|Death|0|||
44363879|NCT01193582|79369140|FG002|12 Month Follow-up|Death|1|||
44363880|NCT01193582|79369141|FG003|12 Month Follow-up|Death|0|||
44363881|NCT01193582|79369138|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
44363882|NCT01193582|79369139|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
44203051|NCT01993927|78998893|FG000|Overall Study|Case Report Forms Uncollected|18|||
44203052|NCT01993927|78998893|FG000|Overall Study|Protocol Violation|11|||
44203053|NCT02015390|78998899|FG000|Overall Study|Lost to Follow-up|1|||
44203054|NCT02015390|78998900|FG001|Overall Study|Lost to Follow-up|0|||
44203055|NCT02015390|78998899|FG000|Overall Study|Adverse Event|0|||
44203056|NCT02015390|78998900|FG001|Overall Study|Adverse Event|3|||
44203057|NCT02015390|78998899|FG000|Overall Study|Physician Decision|0|||
44203058|NCT02015390|78998900|FG001|Overall Study|Physician Decision|1|||
44268670|NCT03206203|79182928|FG001|Optional Cross-Over|Refused follow-up|0|||
44268671|NCT03206203|79182929|FG002|Optional Cross-Over|Refused follow-up|2|||
44268672|NCT03126019|79182938|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
44268673|NCT03126019|79182939|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
44268674|NCT03126019|79182938|FG000|Overall Study|Death|2|||
44268675|NCT03126019|79182939|FG001|Overall Study|Death|7|||
44363883|NCT01193582|79369140|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
44203059|NCT02012959|78998907|FG000|Treatment Phase A|Adverse Event|2|||
44203060|NCT02012959|78998908|FG001|Treatment Phase A|Adverse Event|0|||
44203061|NCT02012959|78998909|FG002|Treatment Phase A|Adverse Event|0|||
44203062|NCT02012959|78998910|FG003|Treatment Phase A|Adverse Event|0|||
44203063|NCT02012959|78998911|FG004|Treatment Phase A|Adverse Event|0|||
44363884|NCT01193582|79369141|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
44363885|NCT00945477|79369153|FG000|Overall Study|Adverse Event|3|||
44203064|NCT01990742|78998923|FG000|Overall Study|Withdrawal by facility|407|||
44203065|NCT01990742|78998924|FG001|Overall Study|Withdrawal by facility|1083|||
44268676|NCT03126019|79182938|FG000|Overall Study|Lost to Follow-up|2|||
44268677|NCT03126019|79182939|FG001|Overall Study|Lost to Follow-up|3|||
44268678|NCT03126019|79182938|FG000|Overall Study|Withdrawal by Participant|1|||
44268679|NCT03126019|79182939|FG001|Overall Study|Withdrawal by Participant|3|||
44268680|NCT03126019|79182938|FG000|Overall Study|Reason not Specified|1|||
44268681|NCT03126019|79182939|FG001|Overall Study|Reason not Specified|3|||
44268682|NCT03072862|79182946|FG000|Overall Study|Withdrawal by Subject|4|||
44268683|NCT03072862|79182946|FG000|Overall Study|Lost to Follow-up|6|||
44268684|NCT03072862|79182946|FG000|Overall Study|Protocol Violation|4|||
44203066|NCT01990742|78998923|FG000|Overall Study|Facility closed|0|||
44203067|NCT01990742|78998924|FG001|Overall Study|Facility closed|270|||
44203068|NCT02012491|78998932|FG000|Overall Study|Lost to Follow-up|1|||
44203069|NCT02012491|78998933|FG001|Overall Study|Lost to Follow-up|0|||
44203070|NCT02012491|78998932|FG000|Overall Study|Protocol Violation|0|||
44203071|NCT02012491|78998933|FG001|Overall Study|Protocol Violation|1|||
44203072|NCT02012491|78998932|FG000|Overall Study|Withdrawal by Subject|1|||
44203073|NCT02012491|78998933|FG001|Overall Study|Withdrawal by Subject|0|||
44203074|NCT01990664|78998941|FG000|Overall Study|Lost to Follow-up|2|||
44203075|NCT01990664|78998942|FG001|Overall Study|Lost to Follow-up|6|||
44203076|NCT01990664|78998941|FG000|Overall Study|Withdrawal by Subject|2|||
44203077|NCT01990664|78998942|FG001|Overall Study|Withdrawal by Subject|3|||
44203078|NCT01990664|78998941|FG000|Overall Study|Protocol Violation|1|||
44203079|NCT01990664|78998942|FG001|Overall Study|Protocol Violation|0|||
44268685|NCT03072862|79182946|FG000|Overall Study|Physician Decision|2|||
44268686|NCT03072862|79182946|FG000|Overall Study|Death|1|||
44268687|NCT03072862|79182946|FG000|Overall Study|Adverse Event|1|||
44268688|NCT03055221|79182950|FG000|Overall Study|Adverse Event|2|||
44268689|NCT03055221|79182950|FG000|Overall Study|Withdrawal by Subject|4|||
44268690|NCT03055221|79182950|FG000|Overall Study|Death|6|||
44268691|NCT03055221|79182950|FG000|Overall Study|Physician Decision|1|||
44268692|NCT03055221|79182950|FG000|Overall Study|Study terminated by Sponsor|3|||
44268693|NCT03055221|79182950|FG000|Overall Study|Lost to Follow-up|4|||
44268694|NCT02913482|79182958|FG000|Overall Study|Death|0|||
44268695|NCT02913482|79182959|FG001|Overall Study|Death|2|||
44268696|NCT02913482|79182960|FG002|Overall Study|Death|2|||
44268697|NCT02913482|79182958|FG000|Overall Study|Progressive Disease|1|||
44268698|NCT02913482|79182959|FG001|Overall Study|Progressive Disease|1|||
44268699|NCT02913482|79182960|FG002|Overall Study|Progressive Disease|1|||
44363886|NCT00945477|79369153|FG000|Overall Study|Lack of Efficacy|2|||
44363887|NCT00945477|79369153|FG000|Overall Study|Withdrawal by Subject|1|||
44363888|NCT01076088|79369164|FG000|Overall Study|Adverse Event|1|||
44363889|NCT01076088|79369165|FG001|Overall Study|Adverse Event|6|||
44363890|NCT01076088|79369166|FG002|Overall Study|Adverse Event|3|||
44363891|NCT01076088|79369167|FG003|Overall Study|Adverse Event|2|||
44363892|NCT01076088|79369168|FG004|Overall Study|Adverse Event|3|||
44363893|NCT01076088|79369169|FG005|Overall Study|Adverse Event|3|||
44363894|NCT01076088|79369164|FG000|Overall Study|Lost to Follow-up|1|||
44363895|NCT01076088|79369165|FG001|Overall Study|Lost to Follow-up|1|||
44363896|NCT01076088|79369166|FG002|Overall Study|Lost to Follow-up|0|||
44363897|NCT01076088|79369167|FG003|Overall Study|Lost to Follow-up|1|||
44363898|NCT01076088|79369168|FG004|Overall Study|Lost to Follow-up|1|||
44363899|NCT01076088|79369169|FG005|Overall Study|Lost to Follow-up|2|||
44363900|NCT01076088|79369164|FG000|Overall Study|Non-compliance with study drug|0|||
44203080|NCT01990664|78998941|FG000|Overall Study|Lens Discomfort|1|||
44268700|NCT02838420|79182972|FG000|Overall Study|Ongoing in Study|113|||
44268701|NCT02838420|79182973|FG001|Overall Study|Ongoing in Study|45|||
44268702|NCT02838420|79182972|FG000|Overall Study|Lost to Follow-up|1|||
44363901|NCT01076088|79369165|FG001|Overall Study|Non-compliance with study drug|0|||
44363902|NCT01076088|79369166|FG002|Overall Study|Non-compliance with study drug|0|||
44363903|NCT01076088|79369167|FG003|Overall Study|Non-compliance with study drug|1|||
44363904|NCT01076088|79369168|FG004|Overall Study|Non-compliance with study drug|0|||
44203081|NCT01990664|78998942|FG001|Overall Study|Lens Discomfort|1|||
44268703|NCT02838420|79182973|FG001|Overall Study|Lost to Follow-up|0|||
44268704|NCT02838420|79182972|FG000|Overall Study|Withdrawal by Subject|3|||
44268705|NCT02838420|79182973|FG001|Overall Study|Withdrawal by Subject|4|||
44268706|NCT02838420|79182972|FG000|Overall Study|Death|8|||
44268707|NCT02838420|79182973|FG001|Overall Study|Death|13|||
44268708|NCT02728076|79182979|FG000|Overall Study|Physician Decision|4|||
44363905|NCT01076088|79369169|FG005|Overall Study|Non-compliance with study drug|0|||
44363906|NCT01076088|79369164|FG000|Overall Study|Physician Decision|1|||
44363907|NCT01076088|79369165|FG001|Overall Study|Physician Decision|3|||
44203082|NCT01990664|78998941|FG000|Overall Study|Lens Handling Difficulties|1|||
44203083|NCT01990664|78998942|FG001|Overall Study|Lens Handling Difficulties|0|||
44268709|NCT02632409|79182985|FG000|Randomized|AE unrelated to study Drug|0|||
44203084|NCT01990664|78998941|FG000|Overall Study|Unsatisfactory Visual Response|0|||
44203085|NCT01990664|78998942|FG001|Overall Study|Unsatisfactory Visual Response|1|||
44203086|NCT02038010|78998948|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
44203087|NCT02038010|78998949|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
44203088|NCT02038010|78998950|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
44203089|NCT02038010|78998951|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
44203090|NCT02038010|78998948|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
44203091|NCT02038010|78998949|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
44203092|NCT02038010|78998950|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
44203093|NCT02038010|78998951|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
44203094|NCT02038010|78998948|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
44203095|NCT02038010|78998949|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
44203096|NCT02038010|78998950|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
44203097|NCT02038010|78998951|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
44203098|NCT02038010|78998948|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
44203099|NCT02038010|78998949|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
44203100|NCT02038010|78998950|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
44203101|NCT02038010|78998951|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
44203102|NCT02038010|78998948|FG000|Follow Up|Death|4|||
44203103|NCT02038010|78998949|FG001|Follow Up|Death|3|||
44203104|NCT02038010|78998950|FG002|Follow Up|Death|0|||
44203105|NCT02038010|78998951|FG003|Follow Up|Death|0|||
44203106|NCT02038010|78998948|FG000|Follow Up|Other|3|||
44203107|NCT02038010|78998949|FG001|Follow Up|Other|0|||
44203108|NCT02038010|78998950|FG002|Follow Up|Other|0|||
44203109|NCT02038010|78998951|FG003|Follow Up|Other|0|||
44203110|NCT01989572|78998965|FG000|Overall Study|Lack of Efficacy|35|||
44203111|NCT01989572|78998966|FG001|Overall Study|Lack of Efficacy|48|||
44203112|NCT01989572|78998967|FG002|Overall Study|Lack of Efficacy|48|||
44203113|NCT01989572|78998968|FG003|Overall Study|Lack of Efficacy|43|||
44203114|NCT01989572|78998969|FG004|Overall Study|Lack of Efficacy|71|||
44203115|NCT01989572|78998970|FG005|Overall Study|Lack of Efficacy|79|||
44203116|NCT01989572|78998965|FG000|Overall Study|Adverse Event|2|||
44203117|NCT01989572|78998966|FG001|Overall Study|Adverse Event|1|||
44203118|NCT01989572|78998967|FG002|Overall Study|Adverse Event|3|||
44203119|NCT01989572|78998968|FG003|Overall Study|Adverse Event|0|||
44203120|NCT01989572|78998969|FG004|Overall Study|Adverse Event|3|||
44203121|NCT01989572|78998970|FG005|Overall Study|Adverse Event|0|||
44203122|NCT01989572|78998965|FG000|Overall Study|Death|0|||
44203123|NCT01989572|78998966|FG001|Overall Study|Death|0|||
44203124|NCT01989572|78998967|FG002|Overall Study|Death|0|||
44203125|NCT01989572|78998968|FG003|Overall Study|Death|0|||
44203126|NCT01989572|78998969|FG004|Overall Study|Death|1|||
44203127|NCT01989572|78998970|FG005|Overall Study|Death|0|||
44203128|NCT01989572|78998965|FG000|Overall Study|Withdrawal by Subject|4|||
44203129|NCT01989572|78998966|FG001|Overall Study|Withdrawal by Subject|1|||
44203130|NCT01989572|78998967|FG002|Overall Study|Withdrawal by Subject|5|||
44203131|NCT01989572|78998968|FG003|Overall Study|Withdrawal by Subject|1|||
44203132|NCT01989572|78998969|FG004|Overall Study|Withdrawal by Subject|12|||
44203133|NCT01989572|78998970|FG005|Overall Study|Withdrawal by Subject|4|||
44203134|NCT01989572|78998965|FG000|Overall Study|complicating disease|1|||
44203135|NCT01989572|78998966|FG001|Overall Study|complicating disease|1|||
44203136|NCT01989572|78998967|FG002|Overall Study|complicating disease|2|||
44203137|NCT01989572|78998968|FG003|Overall Study|complicating disease|0|||
44203138|NCT01989572|78998969|FG004|Overall Study|complicating disease|1|||
44203139|NCT01989572|78998970|FG005|Overall Study|complicating disease|0|||
44203140|NCT01989572|78998965|FG000|Overall Study|error|2|||
44203141|NCT01989572|78998966|FG001|Overall Study|error|1|||
44203142|NCT01989572|78998967|FG002|Overall Study|error|1|||
44203143|NCT01989572|78998968|FG003|Overall Study|error|1|||
44203144|NCT01989572|78998969|FG004|Overall Study|error|1|||
44203145|NCT01989572|78998970|FG005|Overall Study|error|1|||
44203146|NCT01989572|78998965|FG000|Overall Study|maximum dose reached|0|||
44203147|NCT01989572|78998966|FG001|Overall Study|maximum dose reached|1|||
44203148|NCT01989572|78998967|FG002|Overall Study|maximum dose reached|0|||
44203149|NCT01989572|78998968|FG003|Overall Study|maximum dose reached|0|||
44203150|NCT01989572|78998969|FG004|Overall Study|maximum dose reached|1|||
44203151|NCT01989572|78998970|FG005|Overall Study|maximum dose reached|0|||
44203152|NCT01989572|78998965|FG000|Overall Study|unknown/not specify|3|||
44363908|NCT01076088|79369166|FG002|Overall Study|Physician Decision|0|||
44203153|NCT01989572|78998966|FG001|Overall Study|unknown/not specify|4|||
44203154|NCT01989572|78998967|FG002|Overall Study|unknown/not specify|1|||
44203155|NCT01989572|78998968|FG003|Overall Study|unknown/not specify|3|||
44203156|NCT01989572|78998969|FG004|Overall Study|unknown/not specify|3|||
44203157|NCT01989572|78998970|FG005|Overall Study|unknown/not specify|5|||
44268710|NCT02632409|79182986|FG001|Randomized|AE unrelated to study Drug|1|||
44203158|NCT01989572|78998965|FG000|Overall Study|not start protocol therapy|5|||
44203159|NCT01989572|78998966|FG001|Overall Study|not start protocol therapy|1|||
44203160|NCT01989572|78998967|FG002|Overall Study|not start protocol therapy|2|||
44203161|NCT01989572|78998968|FG003|Overall Study|not start protocol therapy|3|||
44203162|NCT01989572|78998969|FG004|Overall Study|not start protocol therapy|4|||
44203163|NCT01989572|78998970|FG005|Overall Study|not start protocol therapy|18|||
44203164|NCT01989572|78998965|FG000|Overall Study|alternative therapy|3|||
44203165|NCT01989572|78998966|FG001|Overall Study|alternative therapy|0|||
44203166|NCT01989572|78998967|FG002|Overall Study|alternative therapy|0|||
44203167|NCT01989572|78998968|FG003|Overall Study|alternative therapy|0|||
44203168|NCT01989572|78998969|FG004|Overall Study|alternative therapy|1|||
44203169|NCT01989572|78998970|FG005|Overall Study|alternative therapy|3|||
44203170|NCT02036294|78998990|FG000|Overall Study|Death|7|||
44203171|NCT02036294|78998991|FG001|Overall Study|Death|8|||
44203172|NCT02036294|78998990|FG000|Overall Study|Withdrawal by Subject|2|||
44203173|NCT02036294|78998991|FG001|Overall Study|Withdrawal by Subject|3|||
44203174|NCT02035748|78998997|FG000|Overall Study|Adverse Event|5|||
44203175|NCT02035748|78998997|FG000|Overall Study|Death|3|||
44203176|NCT02035748|78998997|FG000|Overall Study|Lost to Follow-up|2|||
44203177|NCT02035748|78998997|FG000|Overall Study|Physician Decision|3|||
44203178|NCT02035748|78998997|FG000|Overall Study|Withdrawal by Subject|6|||
44203179|NCT02035748|78998997|FG000|Overall Study|Progressive Disease|1|||
44203180|NCT02014376|78999005|FG000|Overall Study|Adverse Event|1|||
44203181|NCT02014376|78999006|FG001|Overall Study|Adverse Event|1|||
44203182|NCT02014376|78999007|FG002|Overall Study|Adverse Event|0|||
44203183|NCT02014376|78999005|FG000|Overall Study|Lost to Follow-up|2|||
44203184|NCT02014376|78999006|FG001|Overall Study|Lost to Follow-up|0|||
44203185|NCT02014376|78999007|FG002|Overall Study|Lost to Follow-up|0|||
44203186|NCT02035202|78999018|FG000|Overall Study|Lost to Follow-up|8|||
44203187|NCT02035202|78999019|FG001|Overall Study|Lost to Follow-up|16|||
44203188|NCT02035202|78999020|FG002|Overall Study|Lost to Follow-up|2|||
44203189|NCT01988402|78999030|FG000|Overall Study|Adverse Event|1|||
44203190|NCT01988402|78999031|FG001|Overall Study|Adverse Event|2|||
44203191|NCT01988402|78999030|FG000|Overall Study|Withdrawal by Subject|1|||
44203192|NCT01988402|78999031|FG001|Overall Study|Withdrawal by Subject|0|||
44203193|NCT01988090|78999039|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
44203194|NCT01988090|78999040|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
44203195|NCT01988090|78999039|FG000|Start Treament After Randomization|Protocol Violation|0|||
44203196|NCT01988090|78999040|FG001|Start Treament After Randomization|Protocol Violation|1|||
44203197|NCT01988090|78999039|FG000|Complete Study After Start|Withdrawal by Subject|2|||
44203198|NCT01988090|78999040|FG001|Complete Study After Start|Withdrawal by Subject|0|||
44203199|NCT01988090|78999039|FG000|Complete Study After Start|Protocol Violation|1|||
44203200|NCT01988090|78999040|FG001|Complete Study After Start|Protocol Violation|1|||
44203201|NCT01988012|78999046|FG000|Overall Study|Adverse Event|5|||
44203202|NCT01988012|78999046|FG000|Overall Study|Insufficient Therapeutic Response|3|||
44203203|NCT01988012|78999046|FG000|Overall Study|Patient Withdrawal of Consent|4|||
44203204|NCT01988012|78999046|FG000|Overall Study|Lost to Follow-up|1|||
44203205|NCT01988012|78999046|FG000|Overall Study|Physician Decision|1|||
44203206|NCT01988012|78999046|FG000|Overall Study|Protocol Violation|1|||
44203207|NCT02011945|78999053|FG000|Overall Study|Participant requested to Discontinue|0|||
44203208|NCT02011945|78999054|FG001|Overall Study|Participant requested to Discontinue|1|||
44203209|NCT02011945|78999055|FG002|Overall Study|Participant requested to Discontinue|1|||
44203210|NCT02011945|78999053|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
44203211|NCT02011945|78999054|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
44203212|NCT02011945|78999055|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
44203213|NCT02011945|78999053|FG000|Overall Study|Study Drug Toxicity|0|||
44203214|NCT02011945|78999054|FG001|Overall Study|Study Drug Toxicity|0|||
44203215|NCT02011945|78999055|FG002|Overall Study|Study Drug Toxicity|1|||
44203216|NCT02011945|78999053|FG000|Overall Study|Treatment Failure|0|||
44203217|NCT02011945|78999054|FG001|Overall Study|Treatment Failure|7|||
44203218|NCT02011945|78999055|FG002|Overall Study|Treatment Failure|6|||
44203219|NCT02011945|78999053|FG000|Overall Study|No Longer Meets Study Criteria|1|||
44203220|NCT02011945|78999054|FG001|Overall Study|No Longer Meets Study Criteria|0|||
44203221|NCT02011945|78999055|FG002|Overall Study|No Longer Meets Study Criteria|0|||
44203222|NCT02011945|78999053|FG000|Overall Study|Proceeded to stem cell transplant|0|||
44203223|NCT02011945|78999054|FG001|Overall Study|Proceeded to stem cell transplant|0|||
44203224|NCT02011945|78999055|FG002|Overall Study|Proceeded to stem cell transplant|1|||
44203225|NCT02011945|78999053|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
44203226|NCT02011945|78999054|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
44203227|NCT02011945|78999055|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
44203228|NCT02013830|78999063|FG000|Overall Study|Adverse Event|3|||
44203229|NCT02013830|78999063|FG000|Overall Study|Death|1|||
44203230|NCT02013830|78999063|FG000|Overall Study|Insufficient therapeutic response|25|||
44203231|NCT02013830|78999063|FG000|Overall Study|Refused treatment|1|||
44203232|NCT02010775|78999072|FG000|Overall Study|Adverse Event|0|||
44203233|NCT02010775|78999073|FG001|Overall Study|Adverse Event|0|||
44203234|NCT02010775|78999074|FG002|Overall Study|Adverse Event|0|||
44203235|NCT02010775|78999075|FG003|Overall Study|Adverse Event|0|||
44203236|NCT02010775|78999076|FG004|Overall Study|Adverse Event|1|||
44203237|NCT02010775|78999072|FG000|Overall Study|Pregnancy|0|||
44203238|NCT02010775|78999073|FG001|Overall Study|Pregnancy|0|||
44203239|NCT02010775|78999074|FG002|Overall Study|Pregnancy|2|||
44203240|NCT02010775|78999075|FG003|Overall Study|Pregnancy|0|||
44203241|NCT02010775|78999076|FG004|Overall Study|Pregnancy|0|||
44203242|NCT02010775|78999072|FG000|Overall Study|Lost to Follow-up|2|||
44203243|NCT02010775|78999073|FG001|Overall Study|Lost to Follow-up|0|||
44203244|NCT02010775|78999074|FG002|Overall Study|Lost to Follow-up|0|||
44203245|NCT02010775|78999075|FG003|Overall Study|Lost to Follow-up|1|||
44203246|NCT02010775|78999076|FG004|Overall Study|Lost to Follow-up|1|||
44203247|NCT02010775|78999072|FG000|Overall Study|Personal Reasons|3|||
44203248|NCT02010775|78999073|FG001|Overall Study|Personal Reasons|3|||
44203249|NCT02010775|78999074|FG002|Overall Study|Personal Reasons|1|||
44203250|NCT02010775|78999075|FG003|Overall Study|Personal Reasons|2|||
44203251|NCT02010775|78999076|FG004|Overall Study|Personal Reasons|4|||
44203252|NCT01993615|78999090|FG000|Overall Study|Death|1|||
44203253|NCT01993615|78999091|FG001|Overall Study|Death|0|||
44203254|NCT01619059|78999099|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
44203255|NCT01619059|78999100|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
44203256|NCT01619059|78999099|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
44203257|NCT01619059|78999100|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
44203258|NCT01619059|78999099|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
44203259|NCT01619059|78999100|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
44203260|NCT01619059|78999099|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
44203261|NCT01619059|78999100|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
44203262|NCT01619059|78999099|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
44203263|NCT01619059|78999100|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
44203264|NCT01619059|78999099|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
44203265|NCT01619059|78999100|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
44203266|NCT01619059|78999099|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
44203267|NCT01619059|78999100|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
44203268|NCT01619059|78999099|FG000|Long-Term (LT) Treatment Period|Death|1|||
44203269|NCT01619059|78999100|FG001|Long-Term (LT) Treatment Period|Death|0|||
44203270|NCT01619059|78999099|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
44203271|NCT01619059|78999100|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
44203272|NCT01619059|78999099|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
44203273|NCT01619059|78999100|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
44203274|NCT02013206|78999108|FG000|Overall Study|Progressive disease (PD)|14|||
44203275|NCT02013206|78999109|FG001|Overall Study|Progressive disease (PD)|17|||
44203276|NCT02013206|78999108|FG000|Overall Study|Symptomatic deterioration|3|||
44203277|NCT02013206|78999109|FG001|Overall Study|Symptomatic deterioration|1|||
44203278|NCT02013206|78999108|FG000|Overall Study|Adverse Event|1|||
44203279|NCT02013206|78999109|FG001|Overall Study|Adverse Event|0|||
44203280|NCT02013206|78999108|FG000|Overall Study|Patient refusal|2|||
44203281|NCT02013206|78999109|FG001|Overall Study|Patient refusal|0|||
44203282|NCT02013206|78999108|FG000|Overall Study|Patient non-compliance|1|||
44203283|NCT02013206|78999109|FG001|Overall Study|Patient non-compliance|0|||
44203284|NCT02013206|78999108|FG000|Overall Study|Death|1|||
44203285|NCT02013206|78999109|FG001|Overall Study|Death|2|||
44203286|NCT02013206|78999108|FG000|Overall Study|Other reasons off treatment|5|||
44203287|NCT02013206|78999109|FG001|Overall Study|Other reasons off treatment|2|||
44203288|NCT01807923|78999118|FG000|Overall Study|Adverse Event|2|||
44203289|NCT01807923|78999119|FG001|Overall Study|Adverse Event|1|||
44203290|NCT01807923|78999120|FG002|Overall Study|Adverse Event|2|||
44203291|NCT01807923|78999118|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
44203292|NCT01807923|78999119|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
44203293|NCT01807923|78999120|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
44203294|NCT01807923|78999118|FG000|Overall Study|Physician Decision|0|||
44203295|NCT01807923|78999119|FG001|Overall Study|Physician Decision|0|||
44203296|NCT01807923|78999120|FG002|Overall Study|Physician Decision|1|||
44203297|NCT01807923|78999118|FG000|Overall Study|Not Eligible (Genotype)|0|||
44203298|NCT01807923|78999119|FG001|Overall Study|Not Eligible (Genotype)|0|||
44203299|NCT01807923|78999120|FG002|Overall Study|Not Eligible (Genotype)|1|||
44203300|NCT01807923|78999118|FG000|Overall Study|Randomized But Not Treated|3|||
44203301|NCT01807923|78999119|FG001|Overall Study|Randomized But Not Treated|2|||
44203302|NCT01807923|78999120|FG002|Overall Study|Randomized But Not Treated|5|||
44203303|NCT01966003|78999132|FG000|Overall Study|Death|43|||
44203304|NCT01966003|78999133|FG001|Overall Study|Death|36|||
44203305|NCT01966003|78999132|FG000|Overall Study|Protocol Violation|6|||
44203306|NCT01966003|78999133|FG001|Overall Study|Protocol Violation|4|||
44203307|NCT01966003|78999132|FG000|Overall Study|Lost to Follow-up|4|||
44203308|NCT01966003|78999133|FG001|Overall Study|Lost to Follow-up|3|||
44203309|NCT01966003|78999132|FG000|Overall Study|Physician Decision|12|||
44203310|NCT01966003|78999133|FG001|Overall Study|Physician Decision|13|||
44363909|NCT01076088|79369167|FG003|Overall Study|Physician Decision|1|||
44363910|NCT01076088|79369168|FG004|Overall Study|Physician Decision|1|||
44203311|NCT01966003|78999132|FG000|Overall Study|Withdrawal by Subject|29|||
44203312|NCT01966003|78999133|FG001|Overall Study|Withdrawal by Subject|19|||
44203313|NCT01966003|78999132|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
44203314|NCT01966003|78999133|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
44203315|NCT01966003|78999132|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
44203316|NCT01966003|78999133|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
44203317|NCT01966003|78999132|FG000|Overall Study|Other|1|||
44203318|NCT01966003|78999133|FG001|Overall Study|Other|1|||
44203319|NCT01839279|78999142|FG000|Overall Study|Adverse Event|4|||
44203320|NCT01839279|78999143|FG001|Overall Study|Adverse Event|1|||
44203321|NCT01839279|78999144|FG002|Overall Study|Adverse Event|1|||
44203322|NCT01839279|78999142|FG000|Overall Study|Withdrawal by Subject|4|||
44203323|NCT01839279|78999143|FG001|Overall Study|Withdrawal by Subject|1|||
44203324|NCT01839279|78999144|FG002|Overall Study|Withdrawal by Subject|1|||
44203325|NCT01839279|78999142|FG000|Overall Study|Classified as 'Other'|5|||
44203326|NCT01839279|78999143|FG001|Overall Study|Classified as 'Other'|0|||
44203327|NCT01839279|78999144|FG002|Overall Study|Classified as 'Other'|0|||
44203328|NCT01807299|78999163|FG000|Overall Study|Protocol Violation|3|||
44203329|NCT01807299|78999164|FG001|Overall Study|Protocol Violation|1|||
44203330|NCT01807299|78999165|FG002|Overall Study|Protocol Violation|0|||
44203331|NCT01807299|78999166|FG003|Overall Study|Protocol Violation|2|||
44203332|NCT01965535|78999178|FG000|Overall Study|Lack of Efficacy|2|||
44203333|NCT01965535|78999179|FG001|Overall Study|Lack of Efficacy|1|||
44203334|NCT01964755|78999185|FG000|Overall Study|Death|2|||
44203335|NCT01964521|78999189|FG000|Overall Study|Lost to Follow-up|4|||
44203336|NCT01992757|78999194|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
44203337|NCT01991743|78999203|FG000|Overall Study|external cephalic version not performed|0|||
44203338|NCT01991743|78999204|FG001|Overall Study|external cephalic version not performed|0|||
44203339|NCT01991743|78999205|FG002|Overall Study|external cephalic version not performed|1|||
44203340|NCT01991743|78999206|FG003|Overall Study|external cephalic version not performed|0|||
44203341|NCT01991197|78999218|FG000|Overall Study|Lost to Follow-up|1|||
44203342|NCT01991197|78999219|FG001|Overall Study|Lost to Follow-up|1|||
44203343|NCT01991197|78999218|FG000|Overall Study|Physician Decision|0|||
44203344|NCT01991197|78999219|FG001|Overall Study|Physician Decision|2|||
44203345|NCT01991197|78999218|FG000|Overall Study|Withdrawal by Subject|2|||
44203346|NCT01991197|78999219|FG001|Overall Study|Withdrawal by Subject|0|||
44203347|NCT01990573|78999233|FG000|Overall Study|Physician Decision|0|||
44203348|NCT01990573|78999234|FG001|Overall Study|Physician Decision|0|||
44203349|NCT01990573|78999235|FG002|Overall Study|Physician Decision|1|||
44203350|NCT01990495|78999245|FG000|Overall Study|Physician Decision|5|||
44203351|NCT01990495|78999246|FG001|Overall Study|Physician Decision|4|||
44203352|NCT01990339|78999254|FG000|Overall Study|Data Not Available|49|||
44203353|NCT01990339|78999254|FG000|Overall Study|Voluntary Withdrawal|1402|||
44203354|NCT01990339|78999254|FG000|Overall Study|Lost to Follow-up|861|||
44203355|NCT02007577|78999260|FG000|Overall Study|Adverse Event|1|||
44203356|NCT02007577|78999261|FG001|Overall Study|Adverse Event|0|||
44203357|NCT02007577|78999260|FG000|Overall Study|Withdrawal by Subject|0|||
44203358|NCT02007577|78999261|FG001|Overall Study|Withdrawal by Subject|1|||
44203359|NCT01990261|78999267|FG000|Overall Study|Death Before Treatment Start|2|||
44203360|NCT01990261|78999267|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
44203361|NCT01990261|78999267|FG000|Overall Study|Death From other Causes|1|||
44203362|NCT01990261|78999267|FG000|Overall Study|Disease Progression (PD)|8|||
44203363|NCT01990261|78999267|FG000|Overall Study|PD Before Treatment Start|1|||
44203364|NCT01990261|78999267|FG000|Overall Study|Dossier not Approved|1|||
44203365|NCT01990261|78999267|FG000|Overall Study|Lost to Follow-up|2|||
44203366|NCT01963117|78999271|FG000|Overall Study|Death|1|||
44203367|NCT02007109|78999275|FG000|Overall Study|Diary not returned or excluded|102|||
44203368|NCT02007109|78999275|FG000|Overall Study|Excluded - Age<7yo|9|||
44203369|NCT02006719|78999284|FG000|Overall Study|Withdrawal by Subject|10|||
44203370|NCT02006719|78999285|FG001|Overall Study|Withdrawal by Subject|2|||
44203371|NCT02006719|78999284|FG000|Overall Study|Lost to Follow-up|5|||
44203372|NCT02006719|78999285|FG001|Overall Study|Lost to Follow-up|1|||
44203373|NCT02006719|78999284|FG000|Overall Study|Protocol Violation|2|||
44203374|NCT02006719|78999285|FG001|Overall Study|Protocol Violation|0|||
44203375|NCT02006719|78999284|FG000|Overall Study|Adverse Event|1|||
44203376|NCT02006719|78999285|FG001|Overall Study|Adverse Event|1|||
44203377|NCT02006719|78999284|FG000|Overall Study|Other/Unknown|0|||
44203378|NCT02006719|78999285|FG001|Overall Study|Other/Unknown|1|||
44203379|NCT01962493|78999293|FG000|Overall Study|Adverse Event|1|||
44203380|NCT01962493|78999294|FG001|Overall Study|Adverse Event|2|||
44203381|NCT01962493|78999293|FG000|Overall Study|Protocol Violation|0|||
44203382|NCT01962493|78999294|FG001|Overall Study|Protocol Violation|1|||
44451972|NCT00489255|79460903|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
44203383|NCT01962493|78999293|FG000|Overall Study|Withdrawal by Subject|4|||
44203384|NCT01962493|78999294|FG001|Overall Study|Withdrawal by Subject|2|||
44203385|NCT01989169|78999302|FG000|Period 2|Adverse Event|0|||
44203386|NCT01989169|78999303|FG001|Period 2|Adverse Event|1|||
44203387|NCT01988779|78999311|FG000|Overall Study|Withdrawal by Subject|2|||
44203388|NCT01988779|78999312|FG001|Overall Study|Withdrawal by Subject|2|||
44203389|NCT01988779|78999311|FG000|Overall Study|Protocol Violation|1|||
44203390|NCT01988779|78999312|FG001|Overall Study|Protocol Violation|0|||
44203391|NCT01988233|78999320|FG000|Overall Study|Lost to Follow-up|64|||
44203392|NCT01988233|78999321|FG001|Overall Study|Lost to Follow-up|51|||
44203393|NCT01987765|78999327|FG000|Overall Study|Protocol Violation|65|||
44203394|NCT01987765|78999327|FG000|Overall Study|Lost to Follow-up|37|||
44203395|NCT01987609|78999331|FG000|Overall Study|Adverse Event|1|||
44203396|NCT02013674|78999347|FG000|Overall Study|Death|0|||
44203397|NCT02013674|78999348|FG001|Overall Study|Death|1|||
44203398|NCT02013674|78999347|FG000|Overall Study|Lost to Follow-up|1|||
44203399|NCT02013674|78999348|FG001|Overall Study|Lost to Follow-up|0|||
44203400|NCT01987232|78999359|FG000|Overall Study|Ongoing in Study|0|||
44203401|NCT01987232|78999360|FG001|Overall Study|Ongoing in Study|0|||
44203402|NCT01987232|78999361|FG002|Overall Study|Ongoing in Study|0|||
44203403|NCT01987232|78999362|FG003|Overall Study|Ongoing in Study|1|||
44203404|NCT01987232|78999363|FG004|Overall Study|Ongoing in Study|0|||
44203405|NCT01986920|78999377|FG000|A- 101 25%|Withdrawal by Subject|1|||
44203406|NCT01986920|78999378|FG001|A- 101 25%|Withdrawal by Subject|0|||
44203407|NCT01986920|78999379|FG002|A- 101 25%|Withdrawal by Subject|0|||
44203408|NCT01986920|78999380|FG003|A- 101 25%|Withdrawal by Subject|0|||
44203409|NCT01986920|78999377|FG000|A-101 32.5%|Withdrawal by Subject|0|||
44203410|NCT01986920|78999378|FG001|A-101 32.5%|Withdrawal by Subject|1|||
44203411|NCT01986920|78999379|FG002|A-101 32.5%|Withdrawal by Subject|0|||
44203412|NCT01986920|78999380|FG003|A-101 32.5%|Withdrawal by Subject|0|||
44203413|NCT01986920|78999377|FG000|A-101 40%|Withdrawal by Subject|0|||
44203414|NCT01986920|78999378|FG001|A-101 40%|Withdrawal by Subject|0|||
44203415|NCT01986920|78999379|FG002|A-101 40%|Withdrawal by Subject|1|||
44203416|NCT01986920|78999380|FG003|A-101 40%|Withdrawal by Subject|0|||
44203417|NCT01986920|78999377|FG000|Placebo|Withdrawal by Subject|0|||
44203418|NCT01986920|78999378|FG001|Placebo|Withdrawal by Subject|0|||
44203419|NCT01986920|78999379|FG002|Placebo|Withdrawal by Subject|0|||
44203420|NCT01986920|78999380|FG003|Placebo|Withdrawal by Subject|1|||
44203421|NCT02010632|78999390|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
44203422|NCT02010632|78999391|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
44203423|NCT01986140|78999399|FG000|Overall Study|Withdrawal by Subject|31|||
44203424|NCT01986140|78999400|FG001|Overall Study|Withdrawal by Subject|25|||
44203425|NCT01986140|78999399|FG000|Overall Study|alternative treatment|1|||
44203426|NCT01986140|78999400|FG001|Overall Study|alternative treatment|1|||
44203427|NCT01986140|78999399|FG000|Overall Study|found not eligible|3|||
44203428|NCT01986140|78999400|FG001|Overall Study|found not eligible|0|||
44203429|NCT01986140|78999399|FG000|Overall Study|Adverse Event|0|||
44203430|NCT01986140|78999400|FG001|Overall Study|Adverse Event|1|||
44203431|NCT01986140|78999399|FG000|Overall Study|progression disease|0|||
44203432|NCT01986140|78999400|FG001|Overall Study|progression disease|1|||
44203433|NCT01986062|78999408|FG000|Overall Study|Lost to Follow-up|1|||
44203434|NCT01986062|78999409|FG001|Overall Study|Lost to Follow-up|0|||
44203435|NCT01986062|78999408|FG000|Overall Study|Withdrawal by Subject|0|||
44203436|NCT01986062|78999409|FG001|Overall Study|Withdrawal by Subject|1|||
44203437|NCT01985360|78999417|FG000|Overall Study|Withdrawal by Subject|4|||
44203438|NCT01985360|78999418|FG001|Overall Study|Withdrawal by Subject|0|||
44203439|NCT01985360|78999417|FG000|Overall Study|Lost to Follow-up|5|||
44203440|NCT01985360|78999418|FG001|Overall Study|Lost to Follow-up|3|||
44203441|NCT02032706|78999424|FG000|Overall Study|Did not qualify|5|||
44203442|NCT02032706|78999424|FG000|Overall Study|Protocol Violation|1|||
44203443|NCT02032238|78999430|FG000|Overall Study|Lost to Follow-up|2|||
44203444|NCT02032238|78999431|FG001|Overall Study|Lost to Follow-up|0|||
44203445|NCT02009930|78999437|FG000|Overall Study|withdrawn|5|||
44203446|NCT01985126|78999450|FG000|Overall Study|Death|15|||
44203447|NCT01985126|78999451|FG001|Overall Study|Death|69|||
44203448|NCT01985126|78999450|FG000|Overall Study|Lost to Follow-up|0|||
44203449|NCT01985126|78999451|FG001|Overall Study|Lost to Follow-up|8|||
44363911|NCT01076088|79369169|FG005|Overall Study|Physician Decision|0|||
44203450|NCT01985126|78999450|FG000|Overall Study|Study Terminated By Sponsor|1|||
44203451|NCT01985126|78999451|FG001|Overall Study|Study Terminated By Sponsor|22|||
44203452|NCT01985126|78999450|FG000|Overall Study|Withdrawal by Subject|2|||
44203453|NCT01985126|78999451|FG001|Overall Study|Withdrawal by Subject|7|||
44203454|NCT01984892|78999457|FG000|Overall Study|Progressive disease|7|||
44203455|NCT01807221|78999467|FG000|Overall Study|Progressive disease|1|||
44203456|NCT01807221|78999468|FG001|Overall Study|Progressive disease|0|||
44203457|NCT01807221|78999469|FG002|Overall Study|Progressive disease|1|||
44203458|NCT01807221|78999470|FG003|Overall Study|Progressive disease|0|||
44203459|NCT01807221|78999471|FG004|Overall Study|Progressive disease|0|||
44203460|NCT01807221|78999472|FG005|Overall Study|Progressive disease|0|||
44203461|NCT01807221|78999467|FG000|Overall Study|Death|7|||
44203462|NCT01807221|78999468|FG001|Overall Study|Death|9|||
44203463|NCT01807221|78999469|FG002|Overall Study|Death|4|||
44203464|NCT01807221|78999470|FG003|Overall Study|Death|2|||
44203465|NCT01807221|78999471|FG004|Overall Study|Death|1|||
44268711|NCT02632409|79182985|FG000|Randomized|Participant withdrew consent|2|||
44268712|NCT02632409|79182986|FG001|Randomized|Participant withdrew consent|1|||
44363912|NCT01076088|79369164|FG000|Overall Study|Withdrawal by Subject|8|||
44363913|NCT01076088|79369165|FG001|Overall Study|Withdrawal by Subject|8|||
44363914|NCT01076088|79369166|FG002|Overall Study|Withdrawal by Subject|14|||
44363915|NCT01076088|79369167|FG003|Overall Study|Withdrawal by Subject|10|||
44363916|NCT01076088|79369168|FG004|Overall Study|Withdrawal by Subject|11|||
44363917|NCT01076088|79369169|FG005|Overall Study|Withdrawal by Subject|17|||
44363918|NCT01076088|79369164|FG000|Overall Study|Other protocol specified criteria|0|||
44363919|NCT01076088|79369165|FG001|Overall Study|Other protocol specified criteria|0|||
44203466|NCT01807221|78999472|FG005|Overall Study|Death|6|||
44203467|NCT01807221|78999467|FG000|Overall Study|Physician Decision|2|||
44203468|NCT01807221|78999468|FG001|Overall Study|Physician Decision|1|||
44203469|NCT01807221|78999469|FG002|Overall Study|Physician Decision|0|||
44203470|NCT01807221|78999470|FG003|Overall Study|Physician Decision|0|||
44203471|NCT01807221|78999471|FG004|Overall Study|Physician Decision|0|||
44203472|NCT01807221|78999472|FG005|Overall Study|Physician Decision|0|||
44203473|NCT01807221|78999467|FG000|Overall Study|Adverse Event|33|||
44203474|NCT01807221|78999468|FG001|Overall Study|Adverse Event|22|||
44203475|NCT01807221|78999469|FG002|Overall Study|Adverse Event|26|||
44268713|NCT02632409|79182985|FG000|Randomized|No Longer meets study criteria|5|||
44268714|NCT02632409|79182986|FG001|Randomized|No Longer meets study criteria|0|||
44268715|NCT02632409|79182985|FG000|Randomized|other reasons|1|||
44268716|NCT02632409|79182986|FG001|Randomized|other reasons|0|||
44268717|NCT02632409|79182985|FG000|Treatment Period|Ongoing Treatment|20|||
44268718|NCT02632409|79182986|FG001|Treatment Period|Ongoing Treatment|21|||
44268719|NCT02632409|79182985|FG000|Treatment Period|Disease Recurrence|147|||
44268720|NCT02632409|79182986|FG001|Treatment Period|Disease Recurrence|90|||
44268721|NCT02632409|79182985|FG000|Treatment Period|Study Drug Toxicity|8|||
44268722|NCT02632409|79182986|FG001|Treatment Period|Study Drug Toxicity|49|||
44268723|NCT02632409|79182985|FG000|Treatment Period|Death|1|||
44268724|NCT02632409|79182986|FG001|Treatment Period|Death|0|||
44268725|NCT02632409|79182985|FG000|Treatment Period|AE unrelated to study drug|15|||
44268726|NCT02632409|79182986|FG001|Treatment Period|AE unrelated to study drug|16|||
44268727|NCT02632409|79182985|FG000|Treatment Period|Request to discontinue treatment|4|||
44268728|NCT02632409|79182986|FG001|Treatment Period|Request to discontinue treatment|19|||
44268729|NCT02632409|79182985|FG000|Treatment Period|Participant withdrew consent|7|||
44268730|NCT02632409|79182986|FG001|Treatment Period|Participant withdrew consent|5|||
44268731|NCT02632409|79182985|FG000|Treatment Period|Lost to Follow-up|0|||
44268732|NCT02632409|79182986|FG001|Treatment Period|Lost to Follow-up|1|||
44268733|NCT02632409|79182985|FG000|Treatment Period|Maximum clinical benefit|1|||
44268734|NCT02632409|79182986|FG001|Treatment Period|Maximum clinical benefit|0|||
44268735|NCT02632409|79182985|FG000|Treatment Period|No longer meets study criteria|3|||
44268736|NCT02632409|79182986|FG001|Treatment Period|No longer meets study criteria|0|||
44268737|NCT02632409|79182985|FG000|Treatment Period|Administrative Reason by sponsor|0|||
44268738|NCT02632409|79182986|FG001|Treatment Period|Administrative Reason by sponsor|1|||
44268739|NCT02632409|79182985|FG000|Treatment Period|Other Reasons|10|||
44268740|NCT02632409|79182986|FG001|Treatment Period|Other Reasons|6|||
44268741|NCT02489318|79182994|FG000|Randomized|Withdrawal by Subject|0|||
44268742|NCT02489318|79182995|FG001|Randomized|Withdrawal by Subject|1|||
44268743|NCT02489318|79182994|FG000|Treated|Adverse Event|19|||
44268744|NCT02489318|79182995|FG001|Treated|Adverse Event|62|||
44268745|NCT02489318|79182994|FG000|Treated|Death|13|||
44268746|NCT02489318|79182995|FG001|Treated|Death|11|||
44268747|NCT02489318|79182994|FG000|Treated|Physician Decision|4|||
44268748|NCT02489318|79182995|FG001|Treated|Physician Decision|6|||
44268749|NCT02489318|79182994|FG000|Treated|Protocol Violation|1|||
44268750|NCT02489318|79182995|FG001|Treated|Protocol Violation|2|||
44268751|NCT02489318|79182994|FG000|Treated|Withdrawal by Subject|37|||
44268752|NCT02489318|79182995|FG001|Treated|Withdrawal by Subject|36|||
44268753|NCT02489318|79182994|FG000|Treated|Other: Progressive Disease|245|||
44268754|NCT02489318|79182995|FG001|Treated|Other: Progressive Disease|138|||
44268755|NCT02489318|79182994|FG000|Treated|Other|0|||
44268756|NCT02489318|79182995|FG001|Treated|Other|2|||
44268757|NCT02489318|79182994|FG000|Treated|Ongoing|0|||
44363920|NCT01076088|79369166|FG002|Overall Study|Other protocol specified criteria|0|||
44363921|NCT01076088|79369167|FG003|Overall Study|Other protocol specified criteria|0|||
44203476|NCT01807221|78999470|FG003|Overall Study|Adverse Event|25|||
44203477|NCT01807221|78999471|FG004|Overall Study|Adverse Event|18|||
44268758|NCT02489318|79182995|FG001|Treated|Ongoing|267|||
44203478|NCT01807221|78999472|FG005|Overall Study|Adverse Event|21|||
44268759|NCT02333227|79183013|FG000|Overall Study|Lost to Follow-up|137|||
44268760|NCT02333227|79183014|FG001|Overall Study|Lost to Follow-up|106|||
44268761|NCT02333227|79183013|FG000|Overall Study|Pregnancy Interrupted|42|||
44268762|NCT02333227|79183014|FG001|Overall Study|Pregnancy Interrupted|89|||
44363922|NCT01076088|79369168|FG004|Overall Study|Other protocol specified criteria|0|||
44363923|NCT01076088|79369169|FG005|Overall Study|Other protocol specified criteria|1|||
44363924|NCT01193348|79369184|FG000|Screening Period|Screen Failure|5|||
44363925|NCT01193348|79369184|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
44363926|NCT01193348|79369184|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
44363927|NCT01193348|79369184|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
44363928|NCT01193348|79369184|FG000|Extension Treatment Period|Physician Decision|1|||
44363929|NCT01193348|79369184|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
44363930|NCT00945321|79369193|FG000|Period 1|Adverse Event|0|||
44363931|NCT00945321|79369194|FG001|Period 1|Adverse Event|0|||
44363932|NCT00945321|79369195|FG002|Period 1|Adverse Event|0|||
44363933|NCT00945321|79369196|FG003|Period 1|Adverse Event|0|||
44363934|NCT00945321|79369197|FG004|Period 1|Adverse Event|1|||
44363935|NCT00945321|79369198|FG005|Period 1|Adverse Event|0|||
44363936|NCT00945321|79369193|FG000|Period 4|Lost to Follow-up|0|||
44363937|NCT00945321|79369194|FG001|Period 4|Lost to Follow-up|0|||
44363938|NCT00945321|79369195|FG002|Period 4|Lost to Follow-up|0|||
44363939|NCT00945321|79369196|FG003|Period 4|Lost to Follow-up|0|||
44363940|NCT00945321|79369197|FG004|Period 4|Lost to Follow-up|0|||
44363941|NCT00945321|79369198|FG005|Period 4|Lost to Follow-up|1|||
44268763|NCT02333227|79183013|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
44268764|NCT02333227|79183014|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
44268765|NCT02277444|79183020|FG000|Overall Study|Adverse Event|10|||
44268766|NCT02277444|79183020|FG000|Overall Study|Withdrawal by Subject|3|||
44268767|NCT02277444|79183020|FG000|Overall Study|Other|1|||
44268768|NCT02277444|79183020|FG000|Overall Study|Enrolled and not Treated|3|||
44268769|NCT02277444|79183020|FG000|Overall Study|Ongoing|113|||
44268770|NCT02257736|79183026|FG000|Overall Study|Progressive disease|365|||
44268771|NCT02257736|79183027|FG001|Overall Study|Progressive disease|327|||
44268772|NCT02257736|79183026|FG000|Overall Study|Adverse Event|45|||
44268773|NCT02257736|79183027|FG001|Overall Study|Adverse Event|56|||
44268774|NCT02257736|79183026|FG000|Overall Study|Withdrawal by Subject|21|||
44268775|NCT02257736|79183027|FG001|Overall Study|Withdrawal by Subject|38|||
44268776|NCT02257736|79183026|FG000|Overall Study|Death|11|||
44268777|NCT02257736|79183027|FG001|Overall Study|Death|6|||
44268778|NCT02257736|79183026|FG000|Overall Study|Physician Decision|5|||
44268779|NCT02257736|79183027|FG001|Overall Study|Physician Decision|9|||
44268780|NCT02257736|79183026|FG000|Overall Study|Non-Compliance with study drug|1|||
44268781|NCT02257736|79183027|FG001|Overall Study|Non-Compliance with study drug|2|||
44268782|NCT02257736|79183026|FG000|Overall Study|Protocol Violation|1|||
44268783|NCT02257736|79183027|FG001|Overall Study|Protocol Violation|0|||
44268784|NCT02257736|79183026|FG000|Overall Study|Other|1|||
44268785|NCT02257736|79183027|FG001|Overall Study|Other|7|||
44268786|NCT02257736|79183026|FG000|Overall Study|Randomized, not treated|1|||
44268787|NCT02257736|79183027|FG001|Overall Study|Randomized, not treated|2|||
44268788|NCT02252172|79183035|FG000|Overall Study|Lost to Follow-up|3|||
44268789|NCT02252172|79183036|FG001|Overall Study|Lost to Follow-up|1|||
44268790|NCT02252172|79183035|FG000|Overall Study|Ongoing|276|||
44268791|NCT02252172|79183036|FG001|Overall Study|Ongoing|298|||
44268792|NCT02195479|79183044|FG000|Overall Study|Lost to Follow-up|3|||
44268793|NCT02195479|79183045|FG001|Overall Study|Lost to Follow-up|0|||
44268794|NCT02195479|79183044|FG000|Overall Study|Death|48|||
44268795|NCT02195479|79183045|FG001|Overall Study|Death|45|||
44268796|NCT02195479|79183044|FG000|Overall Study|Physician Decision|1|||
44363942|NCT00945243|79369216|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
44363943|NCT01192412|79369222|FG000|Overall Study|Lost to Follow-up|2|||
44268797|NCT02195479|79183045|FG001|Overall Study|Physician Decision|0|||
44268798|NCT02195479|79183044|FG000|Overall Study|Withdrawal by Subject|11|||
44268799|NCT02195479|79183045|FG001|Overall Study|Withdrawal by Subject|6|||
44268800|NCT02195479|79183044|FG000|Overall Study|Other|2|||
44363944|NCT01192412|79369223|FG001|Overall Study|Lost to Follow-up|1|||
44363945|NCT01192412|79369222|FG000|Overall Study|Withdrawal by Subject|2|||
44363946|NCT01192412|79369223|FG001|Overall Study|Withdrawal by Subject|1|||
44363947|NCT01192178|79369231|FG000|Overall Study|Withdrawal by Subject|6|||
44268801|NCT02195479|79183045|FG001|Overall Study|Other|2|||
44268802|NCT02195479|79183044|FG000|Overall Study|Ongoing|291|||
44268803|NCT02195479|79183045|FG001|Overall Study|Ongoing|297|||
44268804|NCT01831635|79183054|FG000|Overall Study|Withdrawal by Subject|0|||
44268805|NCT01831635|79183055|FG001|Overall Study|Withdrawal by Subject|2|||
44268806|NCT01831635|79183056|FG002|Overall Study|Withdrawal by Subject|0|||
44268807|NCT01606878|79183075|FG000|Overall Study|Adverse Event|1|||
44268808|NCT01606878|79183076|FG001|Overall Study|Adverse Event|1|||
44268809|NCT01606878|79183077|FG002|Overall Study|Adverse Event|0|||
44268810|NCT01606878|79183078|FG003|Overall Study|Adverse Event|0|||
44268811|NCT01606878|79183079|FG004|Overall Study|Adverse Event|0|||
44363948|NCT01192178|79369232|FG001|Overall Study|Withdrawal by Subject|10|||
44363949|NCT01192178|79369231|FG000|Overall Study|Protocol Violation|10|||
44363950|NCT01192178|79369232|FG001|Overall Study|Protocol Violation|3|||
44451973|NCT00489255|79460904|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
44451974|NCT00489255|79460903|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
44451975|NCT00489255|79460904|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
44451976|NCT00489255|79460903|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
44451977|NCT00489255|79460904|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
44451978|NCT00413218|79460912|FG000|Overall Study|Randomized but didn't receive study drug|2|||
44451979|NCT00413218|79460913|FG001|Overall Study|Randomized but didn't receive study drug|8|||
44451980|NCT00413218|79460912|FG000|Overall Study|Death|57|||
44451981|NCT00413218|79460913|FG001|Overall Study|Death|56|||
44451982|NCT00413218|79460912|FG000|Overall Study|Lost to Follow-up|14|||
44451983|NCT00413218|79460913|FG001|Overall Study|Lost to Follow-up|17|||
44451984|NCT00413218|79460912|FG000|Overall Study|Admin|20|||
44451985|NCT00413218|79460913|FG001|Overall Study|Admin|14|||
44451986|NCT00413218|79460912|FG000|Overall Study|Missing|1|||
44203479|NCT01807221|78999467|FG000|Overall Study|Protocol Violation|0|||
44203480|NCT01807221|78999468|FG001|Overall Study|Protocol Violation|2|||
44363951|NCT01192178|79369231|FG000|Overall Study|Physician Decision|2|||
44363952|NCT01192178|79369232|FG001|Overall Study|Physician Decision|4|||
44363953|NCT01192178|79369231|FG000|Overall Study|Lost to Follow-up|3|||
44363954|NCT01192178|79369232|FG001|Overall Study|Lost to Follow-up|3|||
44363955|NCT01192178|79369231|FG000|Overall Study|Adverse Event|2|||
44363956|NCT01192178|79369232|FG001|Overall Study|Adverse Event|1|||
44363957|NCT01192178|79369231|FG000|Overall Study|Lack of Efficacy|1|||
44363958|NCT01192178|79369232|FG001|Overall Study|Lack of Efficacy|2|||
44363959|NCT01192100|79369240|FG000|Overall Study|Withdrawal by Subject|0|||
44363960|NCT01192100|79369241|FG001|Overall Study|Withdrawal by Subject|0|||
44363961|NCT01192100|79369242|FG002|Overall Study|Withdrawal by Subject|0|||
44363962|NCT01192100|79369243|FG003|Overall Study|Withdrawal by Subject|0|||
44363963|NCT01192100|79369244|FG004|Overall Study|Withdrawal by Subject|1|||
44363964|NCT01192100|79369245|FG005|Overall Study|Withdrawal by Subject|0|||
44363965|NCT01192100|79369240|FG000|Overall Study|Protocol Violation|0|||
44363966|NCT01192100|79369241|FG001|Overall Study|Protocol Violation|0|||
44363967|NCT01192100|79369242|FG002|Overall Study|Protocol Violation|0|||
44363968|NCT01192100|79369243|FG003|Overall Study|Protocol Violation|1|||
44363969|NCT01192100|79369244|FG004|Overall Study|Protocol Violation|0|||
44363970|NCT01192100|79369245|FG005|Overall Study|Protocol Violation|0|||
44363971|NCT00869401|79369258|FG000|Overall Study|Withdrawal by Subject|0|||
44363972|NCT00869401|79369259|FG001|Overall Study|Withdrawal by Subject|0|||
44363973|NCT00869401|79369260|FG002|Overall Study|Withdrawal by Subject|0|||
44363974|NCT00869401|79369261|FG003|Overall Study|Withdrawal by Subject|5|||
44363975|NCT00869401|79369262|FG004|Overall Study|Withdrawal by Subject|3|||
44363976|NCT01076010|79369277|FG000|Overall Study|Death|15|||
44363977|NCT01076010|79369278|FG001|Overall Study|Death|1|||
44363978|NCT01076010|79369279|FG002|Overall Study|Death|0|||
44451987|NCT00413218|79460913|FG001|Overall Study|Missing|0|||
44203481|NCT01807221|78999469|FG002|Overall Study|Protocol Violation|1|||
44203482|NCT01807221|78999470|FG003|Overall Study|Protocol Violation|2|||
44203483|NCT01807221|78999471|FG004|Overall Study|Protocol Violation|0|||
44203484|NCT01807221|78999472|FG005|Overall Study|Protocol Violation|1|||
44203485|NCT01807221|78999467|FG000|Overall Study|Non-compliance|1|||
44203486|NCT01807221|78999468|FG001|Overall Study|Non-compliance|2|||
44203487|NCT01807221|78999469|FG002|Overall Study|Non-compliance|0|||
44268812|NCT01606878|79183080|FG005|Overall Study|Adverse Event|0|||
44268813|NCT01606878|79183081|FG006|Overall Study|Adverse Event|1|||
44268814|NCT01606878|79183082|FG007|Overall Study|Adverse Event|0|||
44268815|NCT01606878|79183083|FG008|Overall Study|Adverse Event|1|||
44268816|NCT01606878|79183084|FG009|Overall Study|Adverse Event|3|||
44268817|NCT01606878|79183085|FG010|Overall Study|Adverse Event|0|||
44268818|NCT01606878|79183075|FG000|Overall Study|Lack of Efficacy|1|||
44268819|NCT01606878|79183076|FG001|Overall Study|Lack of Efficacy|1|||
44268820|NCT01606878|79183077|FG002|Overall Study|Lack of Efficacy|1|||
44363979|NCT01076010|79369277|FG000|Overall Study|Adverse Event|7|||
44363980|NCT01076010|79369278|FG001|Overall Study|Adverse Event|2|||
44363981|NCT01076010|79369279|FG002|Overall Study|Adverse Event|0|||
44363982|NCT01076010|79369277|FG000|Overall Study|Progressive disease|90|||
44363983|NCT01076010|79369278|FG001|Overall Study|Progressive disease|30|||
44363984|NCT01076010|79369279|FG002|Overall Study|Progressive disease|1|||
44203488|NCT01807221|78999470|FG003|Overall Study|Non-compliance|1|||
44203489|NCT01807221|78999471|FG004|Overall Study|Non-compliance|0|||
44203490|NCT01807221|78999472|FG005|Overall Study|Non-compliance|0|||
44268821|NCT01606878|79183078|FG003|Overall Study|Lack of Efficacy|2|||
44363985|NCT01076010|79369277|FG000|Overall Study|Lack of Efficacy|4|||
44363986|NCT01076010|79369278|FG001|Overall Study|Lack of Efficacy|0|||
44363987|NCT01076010|79369279|FG002|Overall Study|Lack of Efficacy|0|||
44363988|NCT01076010|79369277|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
44363989|NCT01076010|79369278|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
44451988|NCT00413218|79460912|FG000|Overall Study|Withdrawal by Subject|9|||
44363990|NCT01076010|79369279|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
44363991|NCT01076010|79369277|FG000|Overall Study|Significant Surgical Procedure|0|||
44363992|NCT01076010|79369278|FG001|Overall Study|Significant Surgical Procedure|1|||
44363993|NCT01076010|79369279|FG002|Overall Study|Significant Surgical Procedure|0|||
44363994|NCT01076010|79369277|FG000|Overall Study|Protocol Violation|0|||
44363995|NCT01076010|79369278|FG001|Overall Study|Protocol Violation|1|||
44363996|NCT01076010|79369279|FG002|Overall Study|Protocol Violation|0|||
44363997|NCT01076010|79369277|FG000|Overall Study|Noncompliance|1|||
44363998|NCT01076010|79369278|FG001|Overall Study|Noncompliance|1|||
44363999|NCT01076010|79369279|FG002|Overall Study|Noncompliance|0|||
44364000|NCT01076010|79369277|FG000|Overall Study|Withdrawal by Subject|3|||
44364001|NCT01076010|79369278|FG001|Overall Study|Withdrawal by Subject|0|||
44364002|NCT01076010|79369279|FG002|Overall Study|Withdrawal by Subject|1|||
44364003|NCT01076010|79369277|FG000|Overall Study|Other|5|||
44364004|NCT01076010|79369278|FG001|Overall Study|Other|2|||
44364005|NCT01076010|79369279|FG002|Overall Study|Other|0|||
44364006|NCT01075152|79369289|FG000|Overall Study|Withdrawal by Subject|1|||
44364007|NCT01075152|79369290|FG001|Overall Study|Withdrawal by Subject|0|||
44364008|NCT01078116|79369298|FG000|Overall Study|Lost to Follow-up|17|||
44364009|NCT01078116|79369298|FG000|Overall Study|Adverse Event|5|||
44364010|NCT01078116|79369298|FG000|Overall Study|Withdrawal by Subject|8|||
44364011|NCT01078116|79369298|FG000|Overall Study|Lack of effectiveness|15|||
44364012|NCT01078116|79369298|FG000|Overall Study|Case report form not completed|3|||
44364013|NCT00950859|79369304|FG000|Overall Study|Adverse Event|3|||
44364014|NCT00950859|79369305|FG001|Overall Study|Adverse Event|3|||
44364015|NCT00950859|79369304|FG000|Overall Study|Insufficient Viral Load Response|12|||
44364016|NCT00950859|79369305|FG001|Overall Study|Insufficient Viral Load Response|3|||
44364017|NCT00950859|79369304|FG000|Overall Study|Protocol Violation|1|||
44364018|NCT00950859|79369305|FG001|Overall Study|Protocol Violation|1|||
44364019|NCT00950859|79369304|FG000|Overall Study|Lost to Follow-up|0|||
44364020|NCT00950859|79369305|FG001|Overall Study|Lost to Follow-up|3|||
44364021|NCT00862849|79369311|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
44364022|NCT00862849|79369312|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
44364023|NCT00862849|79369313|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
44364024|NCT00862849|79369314|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
44364025|NCT00862849|79369315|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
44364026|NCT00862849|79369316|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
44364027|NCT00862849|79369311|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
44364028|NCT00862849|79369312|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
44364029|NCT00862849|79369313|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
44364030|NCT00862849|79369314|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
44364031|NCT00862849|79369315|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
44364032|NCT00862849|79369316|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
44364033|NCT01090050|79369326|FG000|Overall Study|Lost to Follow-up|0|||
44364034|NCT01090050|79369327|FG001|Overall Study|Lost to Follow-up|1|||
44364035|NCT01090050|79369326|FG000|Overall Study|Lack of Efficacy|1|||
44364036|NCT01090050|79369327|FG001|Overall Study|Lack of Efficacy|5|||
44364037|NCT01090050|79369326|FG000|Overall Study|Physician Decision|0|||
44364038|NCT01090050|79369327|FG001|Overall Study|Physician Decision|1|||
44364039|NCT00944229|79369337|FG000|Overall Study|Withdrawal by Subject|11|||
44364040|NCT00944229|79369337|FG000|Overall Study|Physician Decision|14|||
44364041|NCT01077960|79369341|FG000|Overall Study|Adverse Event|6|||
44364042|NCT01077960|79369341|FG000|Overall Study|Protocol Violation|3|||
44364043|NCT01077960|79369341|FG000|Overall Study|Lost to Follow-up|5|||
44364044|NCT01077960|79369341|FG000|Overall Study|Subject decision|1|||
44364045|NCT01077960|79369341|FG000|Overall Study|Reason unspecified|1|||
44364046|NCT00944697|79369347|FG000|Overall Study|Withdrawal by Subject|1|||
44364047|NCT00944697|79369348|FG001|Overall Study|Withdrawal by Subject|1|||
44364048|NCT00944697|79369347|FG000|Overall Study|Adverse Event|0|||
44364049|NCT00944697|79369348|FG001|Overall Study|Adverse Event|3|||
44364050|NCT00944697|79369347|FG000|Overall Study|Administrative|1|||
44451989|NCT00413218|79460913|FG001|Overall Study|Withdrawal by Subject|1|||
44451990|NCT00420316|79460922|FG000|Overall Study|Withdrawal by Subject|0|||
44268822|NCT01606878|79183079|FG004|Overall Study|Lack of Efficacy|1|||
44364051|NCT00944697|79369348|FG001|Overall Study|Administrative|1|||
44364052|NCT01077804|79369354|FG000|Overall Study|Unreachable|102|||
44364053|NCT01077804|79369354|FG000|Overall Study|Refused to continue|79|||
44364054|NCT01077804|79369354|FG000|Overall Study|Other|18|||
44364055|NCT01075074|79369378|FG000|Overall Study|Surgeon changed to open incisional case|1|||
44364056|NCT01075074|79369379|FG001|Overall Study|Surgeon changed to open incisional case|2|||
44364057|NCT01075074|79369380|FG002|Overall Study|Surgeon changed to open incisional case|2|||
44364058|NCT00866281|79369394|FG000|Overall Study|Adverse Event|1|||
44364059|NCT00866281|79369395|FG001|Overall Study|Adverse Event|0|||
44364060|NCT00866281|79369394|FG000|Overall Study|Withdrawal by participants|3|||
44364061|NCT00866281|79369395|FG001|Overall Study|Withdrawal by participants|0|||
44364062|NCT00866281|79369394|FG000|Overall Study|Disease progression|3|||
44364063|NCT00866281|79369395|FG001|Overall Study|Disease progression|11|||
44364064|NCT00866281|79369394|FG000|Overall Study|New cancer therapy|0|||
44364065|NCT00866281|79369395|FG001|Overall Study|New cancer therapy|4|||
44364066|NCT01077258|79369404|FG000|Overall Study|Lost to Follow-up|1390|||
44364067|NCT01077258|79369404|FG000|Overall Study|Adverse drug reaction|218|||
44364068|NCT01077258|79369404|FG000|Overall Study|Lack of Efficacy|663|||
44364069|NCT01077258|79369404|FG000|Overall Study|Clinical remission|37|||
44364070|NCT01077258|79369404|FG000|Overall Study|Other reasons|260|||
44364071|NCT00943917|79369432|FG000|Stage I|Adverse Event|1|||
44364072|NCT00943917|79369433|FG001|Stage I|Adverse Event|2|||
44364073|NCT00943917|79369434|FG002|Stage I|Adverse Event|2|||
44364074|NCT00943917|79369435|FG003|Stage I|Adverse Event|0|||
44364075|NCT00943917|79369436|FG004|Stage I|Adverse Event|0|||
44364076|NCT00943917|79369437|FG005|Stage I|Adverse Event|0|||
44364077|NCT00943917|79369438|FG006|Stage I|Adverse Event|0|||
44364078|NCT00943917|79369439|FG007|Stage I|Adverse Event|0|||
44364079|NCT00943917|79369440|FG008|Stage I|Adverse Event|0|||
44203491|NCT01807221|78999467|FG000|Overall Study|Logistical difficulties|0|||
44203492|NCT01807221|78999468|FG001|Overall Study|Logistical difficulties|1|||
44203493|NCT01807221|78999469|FG002|Overall Study|Logistical difficulties|0|||
44203494|NCT01807221|78999470|FG003|Overall Study|Logistical difficulties|0|||
44203495|NCT01807221|78999471|FG004|Overall Study|Logistical difficulties|1|||
44203496|NCT01807221|78999472|FG005|Overall Study|Logistical difficulties|0|||
44203497|NCT01807221|78999467|FG000|Overall Study|Withdrawal by Subject|33|||
44364080|NCT00943917|79369441|FG009|Stage I|Adverse Event|0|||
44203498|NCT01807221|78999468|FG001|Overall Study|Withdrawal by Subject|15|||
44203499|NCT01807221|78999469|FG002|Overall Study|Withdrawal by Subject|8|||
44203500|NCT01807221|78999470|FG003|Overall Study|Withdrawal by Subject|14|||
44268823|NCT01606878|79183080|FG005|Overall Study|Lack of Efficacy|2|||
44268824|NCT01606878|79183081|FG006|Overall Study|Lack of Efficacy|1|||
44268825|NCT01606878|79183082|FG007|Overall Study|Lack of Efficacy|2|||
44268826|NCT01606878|79183083|FG008|Overall Study|Lack of Efficacy|2|||
44268827|NCT01606878|79183084|FG009|Overall Study|Lack of Efficacy|0|||
44268828|NCT01606878|79183085|FG010|Overall Study|Lack of Efficacy|1|||
44268829|NCT01606878|79183075|FG000|Overall Study|Physician Decision|1|||
44268830|NCT01606878|79183076|FG001|Overall Study|Physician Decision|0|||
44268831|NCT01606878|79183077|FG002|Overall Study|Physician Decision|2|||
44268832|NCT01606878|79183078|FG003|Overall Study|Physician Decision|1|||
44268833|NCT01606878|79183079|FG004|Overall Study|Physician Decision|1|||
44268834|NCT01606878|79183080|FG005|Overall Study|Physician Decision|1|||
44268835|NCT01606878|79183081|FG006|Overall Study|Physician Decision|2|||
44268836|NCT01606878|79183082|FG007|Overall Study|Physician Decision|0|||
44268837|NCT01606878|79183083|FG008|Overall Study|Physician Decision|1|||
44268838|NCT01606878|79183084|FG009|Overall Study|Physician Decision|0|||
44268839|NCT01606878|79183085|FG010|Overall Study|Physician Decision|0|||
44268840|NCT01606878|79183075|FG000|Overall Study|Withdrawal by Subject|3|||
44268841|NCT01606878|79183076|FG001|Overall Study|Withdrawal by Subject|2|||
44268842|NCT01606878|79183077|FG002|Overall Study|Withdrawal by Subject|2|||
44268843|NCT01606878|79183078|FG003|Overall Study|Withdrawal by Subject|0|||
44268844|NCT01606878|79183079|FG004|Overall Study|Withdrawal by Subject|1|||
44268845|NCT01606878|79183080|FG005|Overall Study|Withdrawal by Subject|1|||
44268846|NCT01606878|79183081|FG006|Overall Study|Withdrawal by Subject|2|||
44268847|NCT01606878|79183082|FG007|Overall Study|Withdrawal by Subject|1|||
44268848|NCT01606878|79183083|FG008|Overall Study|Withdrawal by Subject|2|||
44268849|NCT01606878|79183084|FG009|Overall Study|Withdrawal by Subject|0|||
44268850|NCT01606878|79183085|FG010|Overall Study|Withdrawal by Subject|2|||
44268851|NCT01314118|79183117|FG000|Overall Study|Adverse Event|9|||
44268852|NCT01314118|79183117|FG000|Overall Study|Progressive disease|27|||
44268853|NCT01314118|79183117|FG000|Overall Study|Physician Decision|11|||
44268854|NCT01314118|79183117|FG000|Overall Study|Death|4|||
44268855|NCT01314118|79183117|FG000|Overall Study|Protocol Violation|5|||
44268856|NCT01314118|79183117|FG000|Overall Study|Withdrawal by Subject|11|||
44364081|NCT00943917|79369442|FG010|Stage I|Adverse Event|0|||
44364082|NCT00943917|79369443|FG011|Stage I|Adverse Event|0|||
44364083|NCT00943917|79369444|FG012|Stage I|Adverse Event|0|||
44364084|NCT00943917|79369445|FG013|Stage I|Adverse Event|0|||
44364085|NCT00943917|79369446|FG014|Stage I|Adverse Event|0|||
44364086|NCT00943917|79369432|FG000|Stage I|Lost to Follow-up|0|||
44364087|NCT00943917|79369433|FG001|Stage I|Lost to Follow-up|0|||
44364088|NCT00943917|79369434|FG002|Stage I|Lost to Follow-up|1|||
44203501|NCT01807221|78999471|FG004|Overall Study|Withdrawal by Subject|16|||
44203502|NCT01807221|78999472|FG005|Overall Study|Withdrawal by Subject|13|||
44268857|NCT01314118|79183117|FG000|Overall Study|Other|2|||
44268858|NCT01314118|79183117|FG000|Overall Study|Ongoing|62|||
44268859|NCT01175356|79183121|FG000|Overall Study|Death|1|||
44268860|NCT01175356|79183121|FG000|Overall Study|Lack of Efficacy|12|||
44268861|NCT01175356|79183121|FG000|Overall Study|Lost to Follow-up|1|||
44268862|NCT01175356|79183121|FG000|Overall Study|Physician Decision|23|||
44268863|NCT01175356|79183121|FG000|Overall Study|Ineligible|1|||
44268864|NCT01175356|79183121|FG000|Overall Study|Treatment Slot Not Available|18|||
44364089|NCT00943917|79369435|FG003|Stage I|Lost to Follow-up|0|||
44364090|NCT00943917|79369436|FG004|Stage I|Lost to Follow-up|0|||
44268865|NCT01175356|79183121|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
44268866|NCT01175356|79183121|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
44364091|NCT00943917|79369437|FG005|Stage I|Lost to Follow-up|0|||
44364092|NCT00943917|79369438|FG006|Stage I|Lost to Follow-up|0|||
44364093|NCT00943917|79369439|FG007|Stage I|Lost to Follow-up|0|||
44364094|NCT00943917|79369440|FG008|Stage I|Lost to Follow-up|0|||
44364095|NCT00943917|79369441|FG009|Stage I|Lost to Follow-up|0|||
44364096|NCT00943917|79369442|FG010|Stage I|Lost to Follow-up|0|||
44364097|NCT00943917|79369443|FG011|Stage I|Lost to Follow-up|0|||
44451991|NCT00420316|79460923|FG001|Overall Study|Withdrawal by Subject|1|||
44203503|NCT01807221|78999467|FG000|Overall Study|Sponsor decision|2|||
44203504|NCT01807221|78999468|FG001|Overall Study|Sponsor decision|0|||
44203505|NCT01807221|78999469|FG002|Overall Study|Sponsor decision|1|||
44203506|NCT01807221|78999470|FG003|Overall Study|Sponsor decision|1|||
44203507|NCT01807221|78999471|FG004|Overall Study|Sponsor decision|0|||
44203508|NCT01807221|78999472|FG005|Overall Study|Sponsor decision|0|||
44203509|NCT01807221|78999467|FG000|Overall Study|Lost to Follow-up|1|||
44203510|NCT01807221|78999468|FG001|Overall Study|Lost to Follow-up|0|||
44203511|NCT01807221|78999469|FG002|Overall Study|Lost to Follow-up|2|||
44203512|NCT01807221|78999470|FG003|Overall Study|Lost to Follow-up|1|||
44203513|NCT01807221|78999471|FG004|Overall Study|Lost to Follow-up|0|||
44203514|NCT01807221|78999472|FG005|Overall Study|Lost to Follow-up|0|||
44203515|NCT01838499|78999488|FG000|Overall Study|Protocol Violation|0|||
44203516|NCT01838499|78999489|FG001|Overall Study|Protocol Violation|1|||
44203517|NCT01838499|78999488|FG000|Overall Study|Lost to Follow-up|2|||
44203518|NCT01838499|78999489|FG001|Overall Study|Lost to Follow-up|4|||
44203519|NCT01838499|78999488|FG000|Overall Study|Lack of Efficacy|1|||
44203520|NCT01838499|78999489|FG001|Overall Study|Lack of Efficacy|2|||
44203521|NCT01838499|78999488|FG000|Overall Study|Adverse Event|2|||
44203522|NCT01838499|78999489|FG001|Overall Study|Adverse Event|1|||
44203523|NCT01838499|78999488|FG000|Overall Study|Withdrawal by Subject|19|||
44203524|NCT01838499|78999489|FG001|Overall Study|Withdrawal by Subject|9|||
44203525|NCT01807065|78999497|FG000|Overall Study|Receive no sip-T due to IV access|1|||
44203526|NCT01807065|78999498|FG001|Overall Study|Receive no sip-T due to IV access|1|||
44203527|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Death|89|||
44203528|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Death|193|||
44203529|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Death|198|||
44203530|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
44203531|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
44203532|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
44203533|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
44203534|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
44203535|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
44203536|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
44203537|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
44203538|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
44203539|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
44203540|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
44203541|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
44203542|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
44203543|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
44203544|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
44203545|NCT02031458|78999511|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
44268867|NCT01175356|79183121|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
44268868|NCT01175356|79183121|FG000|Overall Study|Inadequate stem cell for transplant|1|||
44268869|NCT01175356|79183121|FG000|Overall Study|Initiation other tx prior to completion|9|||
44268870|NCT01171898|79183129|FG000|Overall Study|Death|0|||
44268871|NCT01171898|79183130|FG001|Overall Study|Death|0|||
44268872|NCT01171898|79183131|FG002|Overall Study|Death|2|||
44364098|NCT00943917|79369444|FG012|Stage I|Lost to Follow-up|0|||
44364099|NCT00943917|79369445|FG013|Stage I|Lost to Follow-up|0|||
44451992|NCT00420316|79460922|FG000|Overall Study|Lost to Follow-up|12|||
44451993|NCT00420316|79460923|FG001|Overall Study|Lost to Follow-up|8|||
44203546|NCT02031458|78999512|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
44203547|NCT02031458|78999513|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
44203548|NCT02031458|78999511|FG000|Baseline to May 8, 2015|Death|36|||
44203549|NCT02031458|78999512|FG001|Baseline to May 8, 2015|Death|87|||
44203550|NCT02031458|78999513|FG002|Baseline to May 8, 2015|Death|100|||
44203551|NCT02031458|78999511|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
44268873|NCT01171898|79183132|FG003|Overall Study|Death|0|||
44268874|NCT01171898|79183129|FG000|Overall Study|Lost to Follow-up|0|||
44268875|NCT01171898|79183130|FG001|Overall Study|Lost to Follow-up|1|||
44268876|NCT01171898|79183131|FG002|Overall Study|Lost to Follow-up|1|||
44364100|NCT00943917|79369446|FG014|Stage I|Lost to Follow-up|0|||
44364101|NCT00943917|79369432|FG000|Stage I|hyperglycemia|0|||
44203552|NCT02031458|78999512|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
44203553|NCT02031458|78999513|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
44203554|NCT02031458|78999511|FG000|Baseline to May 8, 2015|Physician Decision|0|||
44203555|NCT02031458|78999512|FG001|Baseline to May 8, 2015|Physician Decision|1|||
44203556|NCT02031458|78999513|FG002|Baseline to May 8, 2015|Physician Decision|0|||
44203557|NCT02031458|78999511|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
44203558|NCT02031458|78999512|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
44203559|NCT02031458|78999513|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
44451994|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
44451995|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
44203560|NCT02031458|78999511|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
44364102|NCT00943917|79369433|FG001|Stage I|hyperglycemia|0|||
44364103|NCT00943917|79369434|FG002|Stage I|hyperglycemia|1|||
44364104|NCT00943917|79369435|FG003|Stage I|hyperglycemia|0|||
44364105|NCT00943917|79369436|FG004|Stage I|hyperglycemia|0|||
44364106|NCT00943917|79369437|FG005|Stage I|hyperglycemia|0|||
44364107|NCT00943917|79369438|FG006|Stage I|hyperglycemia|0|||
44203561|NCT02031458|78999512|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
44203562|NCT02031458|78999513|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
44203563|NCT02031458|78999511|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
44203564|NCT02031458|78999512|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
44203565|NCT02031458|78999513|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
44203566|NCT02031458|78999511|FG000|Baseline to May 8, 2015|On Treatment|43|||
44203567|NCT02031458|78999512|FG001|Baseline to May 8, 2015|On Treatment|81|||
44203568|NCT02031458|78999513|FG002|Baseline to May 8, 2015|On Treatment|73|||
44203569|NCT02031458|78999511|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
44203570|NCT02031458|78999512|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
44203571|NCT02031458|78999513|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
44203572|NCT02009696|78999523|FG000|Overall Study|Withdrawal by Subject|2|||
44203573|NCT01806597|78999530|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
44203574|NCT01806597|78999531|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
44203575|NCT01806597|78999532|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
44203576|NCT01806597|78999533|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
44203577|NCT01806597|78999534|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
44364108|NCT00943917|79369439|FG007|Stage I|hyperglycemia|0|||
44364109|NCT00943917|79369440|FG008|Stage I|hyperglycemia|0|||
44364110|NCT00943917|79369441|FG009|Stage I|hyperglycemia|0|||
44364111|NCT00943917|79369442|FG010|Stage I|hyperglycemia|0|||
44364112|NCT00943917|79369443|FG011|Stage I|hyperglycemia|0|||
44364113|NCT00943917|79369444|FG012|Stage I|hyperglycemia|0|||
44364114|NCT00943917|79369445|FG013|Stage I|hyperglycemia|0|||
44364115|NCT00943917|79369446|FG014|Stage I|hyperglycemia|0|||
44364116|NCT00943917|79369432|FG000|Stage I|A1C elevation|1|||
44364117|NCT00943917|79369433|FG001|Stage I|A1C elevation|0|||
44364118|NCT00943917|79369434|FG002|Stage I|A1C elevation|0|||
44364119|NCT00943917|79369435|FG003|Stage I|A1C elevation|0|||
44364120|NCT00943917|79369436|FG004|Stage I|A1C elevation|0|||
44364121|NCT00943917|79369437|FG005|Stage I|A1C elevation|0|||
44364122|NCT00943917|79369438|FG006|Stage I|A1C elevation|0|||
44203578|NCT01806597|78999535|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
44203579|NCT01806597|78999530|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
44203580|NCT01806597|78999531|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
44203581|NCT01806597|78999532|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
44364123|NCT00943917|79369439|FG007|Stage I|A1C elevation|0|||
44364124|NCT00943917|79369440|FG008|Stage I|A1C elevation|0|||
44364125|NCT00943917|79369441|FG009|Stage I|A1C elevation|0|||
44364126|NCT00943917|79369442|FG010|Stage I|A1C elevation|0|||
44364127|NCT00943917|79369443|FG011|Stage I|A1C elevation|0|||
44203582|NCT01806597|78999533|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
44203583|NCT01806597|78999534|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
44203584|NCT01806597|78999535|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
44203585|NCT01806597|78999530|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
44203586|NCT01806597|78999531|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
44203587|NCT01806597|78999532|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
44203588|NCT01806597|78999533|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
44203589|NCT01806597|78999534|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
44203590|NCT01806597|78999535|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
44203591|NCT01806597|78999530|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
44203592|NCT01806597|78999531|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
44203593|NCT01806597|78999532|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
44203594|NCT01806597|78999533|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
44203595|NCT01806597|78999534|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
44203596|NCT01806597|78999535|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
44203597|NCT01806597|78999530|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
44203598|NCT01806597|78999531|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
44203599|NCT01806597|78999532|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
44364128|NCT00943917|79369444|FG012|Stage I|A1C elevation|0|||
44364129|NCT00943917|79369445|FG013|Stage I|A1C elevation|0|||
44364130|NCT00943917|79369446|FG014|Stage I|A1C elevation|0|||
44364131|NCT00943917|79369432|FG000|Stage I|Withdrawal by Subject|2|||
44364132|NCT00943917|79369433|FG001|Stage I|Withdrawal by Subject|1|||
44364133|NCT00943917|79369434|FG002|Stage I|Withdrawal by Subject|2|||
44364134|NCT00943917|79369435|FG003|Stage I|Withdrawal by Subject|0|||
44364135|NCT00943917|79369436|FG004|Stage I|Withdrawal by Subject|0|||
44364136|NCT00943917|79369437|FG005|Stage I|Withdrawal by Subject|0|||
44364137|NCT00943917|79369438|FG006|Stage I|Withdrawal by Subject|0|||
44364138|NCT00943917|79369439|FG007|Stage I|Withdrawal by Subject|0|||
44364139|NCT00943917|79369440|FG008|Stage I|Withdrawal by Subject|0|||
44364140|NCT00943917|79369441|FG009|Stage I|Withdrawal by Subject|0|||
44364141|NCT00943917|79369442|FG010|Stage I|Withdrawal by Subject|0|||
44364142|NCT00943917|79369443|FG011|Stage I|Withdrawal by Subject|0|||
44268877|NCT01171898|79183132|FG003|Overall Study|Lost to Follow-up|1|||
44268878|NCT01171898|79183129|FG000|Overall Study|Withdrawal by Subject|1|||
44268879|NCT01171898|79183130|FG001|Overall Study|Withdrawal by Subject|4|||
44268880|NCT01171898|79183131|FG002|Overall Study|Withdrawal by Subject|6|||
44268881|NCT01171898|79183132|FG003|Overall Study|Withdrawal by Subject|3|||
44268882|NCT01171898|79183129|FG000|Overall Study|Terminated by Sponsor|1|||
44268883|NCT01171898|79183130|FG001|Overall Study|Terminated by Sponsor|0|||
44268884|NCT01171898|79183131|FG002|Overall Study|Terminated by Sponsor|0|||
44268885|NCT01171898|79183132|FG003|Overall Study|Terminated by Sponsor|0|||
44364143|NCT00943917|79369444|FG012|Stage I|Withdrawal by Subject|0|||
44364144|NCT00943917|79369445|FG013|Stage I|Withdrawal by Subject|0|||
44364145|NCT00943917|79369446|FG014|Stage I|Withdrawal by Subject|0|||
44364146|NCT00943917|79369432|FG000|Stage II|Adverse Event|0|||
44364147|NCT00943917|79369433|FG001|Stage II|Adverse Event|0|||
44364148|NCT00943917|79369434|FG002|Stage II|Adverse Event|0|||
44364149|NCT00943917|79369435|FG003|Stage II|Adverse Event|0|||
44364150|NCT00943917|79369436|FG004|Stage II|Adverse Event|0|||
44364151|NCT00943917|79369437|FG005|Stage II|Adverse Event|1|||
44364152|NCT00943917|79369438|FG006|Stage II|Adverse Event|3|||
44364153|NCT00943917|79369439|FG007|Stage II|Adverse Event|0|||
44364154|NCT00943917|79369440|FG008|Stage II|Adverse Event|1|||
44364155|NCT00943917|79369441|FG009|Stage II|Adverse Event|0|||
44364156|NCT00943917|79369442|FG010|Stage II|Adverse Event|0|||
44364157|NCT00943917|79369443|FG011|Stage II|Adverse Event|0|||
44364158|NCT00943917|79369444|FG012|Stage II|Adverse Event|0|||
44364159|NCT00943917|79369445|FG013|Stage II|Adverse Event|0|||
44364160|NCT00943917|79369446|FG014|Stage II|Adverse Event|0|||
44364161|NCT00943917|79369432|FG000|Stage II|Withdrawal by Subject|0|||
44364162|NCT00943917|79369433|FG001|Stage II|Withdrawal by Subject|0|||
44203600|NCT01806597|78999533|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
44268886|NCT01171898|79183129|FG000|Overall Study|Ongoing|1|||
44268887|NCT01171898|79183130|FG001|Overall Study|Ongoing|9|||
44364163|NCT00943917|79369434|FG002|Stage II|Withdrawal by Subject|0|||
44364164|NCT00943917|79369435|FG003|Stage II|Withdrawal by Subject|0|||
44364165|NCT00943917|79369436|FG004|Stage II|Withdrawal by Subject|0|||
44364166|NCT00943917|79369437|FG005|Stage II|Withdrawal by Subject|1|||
44364167|NCT00943917|79369438|FG006|Stage II|Withdrawal by Subject|0|||
44364168|NCT00943917|79369439|FG007|Stage II|Withdrawal by Subject|0|||
44364169|NCT00943917|79369440|FG008|Stage II|Withdrawal by Subject|0|||
44364170|NCT00943917|79369441|FG009|Stage II|Withdrawal by Subject|0|||
44364171|NCT00943917|79369442|FG010|Stage II|Withdrawal by Subject|0|||
44364172|NCT00943917|79369443|FG011|Stage II|Withdrawal by Subject|0|||
44203601|NCT01806597|78999534|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
44203602|NCT01806597|78999535|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
44203603|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
44203604|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
44203605|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
44203606|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
44203607|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
44268888|NCT01171898|79183131|FG002|Overall Study|Ongoing|3|||
44268889|NCT01171898|79183132|FG003|Overall Study|Ongoing|0|||
44268890|NCT01171898|79183129|FG000|Overall Study|Other|1|||
44268891|NCT01171898|79183130|FG001|Overall Study|Other|5|||
44268892|NCT01171898|79183131|FG002|Overall Study|Other|0|||
44451996|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
44451997|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
44451998|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Death|8|||
44268893|NCT01171898|79183132|FG003|Overall Study|Other|2|||
44268894|NCT01005745|79183145|FG000|Overall Study|No TIL growth|1|||
44268895|NCT01005745|79183145|FG000|Overall Study|Disease progressed during TIL growth|3|||
44268896|NCT01005745|79183145|FG000|Overall Study|Death prior to treatment|1|||
44268897|NCT01005745|79183145|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
44268898|NCT00980538|79183149|FG000|Overall Study|Lost to Follow-up|20|||
44268899|NCT00980538|79183149|FG000|Overall Study|Sponsor's Decision|4|||
44268900|NCT00980538|79183149|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
44268901|NCT00980538|79183149|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
44268902|NCT00980538|79183149|FG000|Overall Study|Switch to Commercially Available Medication|25|||
44268903|NCT00980538|79183149|FG000|Overall Study|Participant Non-Compliant|9|||
44268904|NCT00980538|79183149|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
44268905|NCT00980538|79183149|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
44268906|NCT00980538|79183149|FG000|Overall Study|Other|60|||
44268907|NCT00980538|79183149|FG000|Overall Study|Other|1|||
44268908|NCT02345226|79183359|FG000|Double-Blind Phase|Adverse Event|5|||
44268909|NCT02345226|79183360|FG001|Double-Blind Phase|Adverse Event|6|||
44268910|NCT02345226|79183359|FG000|Double-Blind Phase|Death|3|||
44268911|NCT02345226|79183360|FG001|Double-Blind Phase|Death|0|||
44268912|NCT02345226|79183359|FG000|Double-Blind Phase|Pregnancy|0|||
44268913|NCT02345226|79183360|FG001|Double-Blind Phase|Pregnancy|1|||
44268914|NCT02345226|79183359|FG000|Double-Blind Phase|Lack of Efficacy|1|||
44268915|NCT02345226|79183360|FG001|Double-Blind Phase|Lack of Efficacy|0|||
44268916|NCT02345226|79183359|FG000|Double-Blind Phase|Investigator's Discretion|4|||
44268917|NCT02345226|79183360|FG001|Double-Blind Phase|Investigator's Discretion|3|||
44268918|NCT02345226|79183359|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
44268919|NCT02345226|79183360|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
44268920|NCT02345226|79183359|FG000|Double-Blind Phase|Withdrew Consent|41|||
44268921|NCT02345226|79183360|FG001|Double-Blind Phase|Withdrew Consent|39|||
44268922|NCT02345226|79183359|FG000|Double-Blind Phase|Lost to Follow-up|12|||
44268923|NCT02345226|79183360|FG001|Double-Blind Phase|Lost to Follow-up|16|||
44268924|NCT02345226|79183359|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
44268925|NCT02345226|79183360|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
44268926|NCT02345226|79183359|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
44268927|NCT02345226|79183360|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
44268928|NCT00551369|79183931|FG000|Overall Study|Protocol Violation|5|||
44268929|NCT00551369|79183931|FG000|Overall Study|Withdrawal by Subject|1|||
44268930|NCT00551369|79183931|FG000|Overall Study|Not treated per protocol and re|1|||
44268931|NCT00551291|79183944|FG000|Overall Study|Physician Decision|1|||
44451999|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Death|3|||
44364173|NCT00943917|79369444|FG012|Stage II|Withdrawal by Subject|0|||
44364174|NCT00943917|79369445|FG013|Stage II|Withdrawal by Subject|0|||
44203608|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
44203609|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
44268932|NCT00551213|79184050|FG000|Overall Study|Adverse Event|6|||
44268933|NCT00551213|79184051|FG001|Overall Study|Adverse Event|3|||
44268934|NCT00551213|79184050|FG000|Overall Study|Progressive Disease|41|||
44268935|NCT00551213|79184051|FG001|Overall Study|Progressive Disease|12|||
44268936|NCT00551213|79184050|FG000|Overall Study|Withdrawal by Subject|2|||
44364175|NCT00943917|79369446|FG014|Stage II|Withdrawal by Subject|0|||
44364176|NCT00943917|79369432|FG000|Stage II|Pregnancy|0|||
44364177|NCT00943917|79369433|FG001|Stage II|Pregnancy|0|||
44364178|NCT00943917|79369434|FG002|Stage II|Pregnancy|0|||
44364179|NCT00943917|79369435|FG003|Stage II|Pregnancy|0|||
44364180|NCT00943917|79369436|FG004|Stage II|Pregnancy|0|||
44364181|NCT00943917|79369437|FG005|Stage II|Pregnancy|1|||
44364182|NCT00943917|79369438|FG006|Stage II|Pregnancy|0|||
44452000|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
44452001|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
44268937|NCT00551213|79184051|FG001|Overall Study|Withdrawal by Subject|0|||
44268938|NCT00551213|79184050|FG000|Overall Study|Not Treated|1|||
44268939|NCT00551213|79184051|FG001|Overall Study|Not Treated|2|||
44268940|NCT00550043|79184188|FG000|Overall Study|Adverse Event|0|||
44268941|NCT00550043|79184189|FG001|Overall Study|Adverse Event|0|||
44268942|NCT00550043|79184190|FG002|Overall Study|Adverse Event|0|||
44268943|NCT00550043|79184191|FG003|Overall Study|Adverse Event|1|||
44268944|NCT00550043|79184192|FG004|Overall Study|Adverse Event|1|||
44268945|NCT00550043|79184188|FG000|Overall Study|Subject Withdrew Consent|0|||
44268946|NCT00550043|79184189|FG001|Overall Study|Subject Withdrew Consent|2|||
44268947|NCT00550043|79184190|FG002|Overall Study|Subject Withdrew Consent|1|||
44268948|NCT00550043|79184191|FG003|Overall Study|Subject Withdrew Consent|0|||
44268949|NCT00550043|79184192|FG004|Overall Study|Subject Withdrew Consent|0|||
44268950|NCT00550043|79184188|FG000|Overall Study|Other Reasons- Unspecified|0|||
44268951|NCT00550043|79184189|FG001|Overall Study|Other Reasons- Unspecified|1|||
44268952|NCT00550043|79184190|FG002|Overall Study|Other Reasons- Unspecified|0|||
44268953|NCT00550043|79184191|FG003|Overall Study|Other Reasons- Unspecified|1|||
44268954|NCT00550043|79184192|FG004|Overall Study|Other Reasons- Unspecified|0|||
44268955|NCT03188822|79184911|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
44268956|NCT03188822|79184911|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
44268957|NCT04976777|79185045|FG000|Overall Study|COVID-19 Infection|1|||
44203610|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
44203611|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
44203612|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
44203613|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
44203614|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
44203615|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
44203616|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
44203617|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
44203618|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
44203619|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
44203620|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
44203621|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
44203622|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
44203623|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
44203624|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
44203625|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
44203626|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
44203627|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
44203628|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
44203629|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
44203630|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
44203631|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
44203632|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
44203633|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
44203634|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
44203635|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
44203636|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
44203637|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
44203638|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
44203639|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
44203640|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
44203641|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
44203642|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
44203643|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
44203644|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
44203645|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
44249666|NCT01276353|79083651|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
44268958|NCT04976777|79185046|FG001|Overall Study|COVID-19 Infection|0|||
44268959|NCT00555971|79185220|FG000|Overall Study|Adverse Event|1|||
44268960|NCT00555971|79185221|FG001|Overall Study|Adverse Event|1|||
44364183|NCT00943917|79369439|FG007|Stage II|Pregnancy|0|||
44364184|NCT00943917|79369440|FG008|Stage II|Pregnancy|0|||
44364185|NCT00943917|79369441|FG009|Stage II|Pregnancy|0|||
44364186|NCT00943917|79369442|FG010|Stage II|Pregnancy|0|||
44364187|NCT00943917|79369443|FG011|Stage II|Pregnancy|0|||
44364188|NCT00943917|79369444|FG012|Stage II|Pregnancy|0|||
44364189|NCT00943917|79369445|FG013|Stage II|Pregnancy|0|||
44203646|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
44203647|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
44203648|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
44203649|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
44203650|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
44203651|NCT01806597|78999530|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
44203652|NCT01806597|78999531|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
44203653|NCT01806597|78999532|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
44203654|NCT01806597|78999533|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
44203655|NCT01806597|78999534|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
44203656|NCT01806597|78999535|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
44203657|NCT01806597|78999530|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
44203658|NCT01806597|78999531|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
44203659|NCT01806597|78999532|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
44203660|NCT01806597|78999533|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
44203661|NCT01806597|78999534|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
44203662|NCT01806597|78999535|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
44203663|NCT01806597|78999530|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
44203664|NCT01806597|78999531|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
44203665|NCT01806597|78999532|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
44203666|NCT01806597|78999533|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
44203667|NCT01806597|78999534|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
44203668|NCT01806597|78999535|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
44203669|NCT01806597|78999530|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
44203670|NCT01806597|78999531|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
44203671|NCT01806597|78999532|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
44203672|NCT01806597|78999533|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
44203673|NCT01806597|78999534|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
44203674|NCT01806597|78999535|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
44203675|NCT01806597|78999530|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
44203676|NCT01806597|78999531|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
44203677|NCT01806597|78999532|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
44203678|NCT01806597|78999533|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
44203679|NCT01806597|78999534|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
44203680|NCT01806597|78999535|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
44203681|NCT01806597|78999530|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
44203682|NCT01806597|78999531|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
44203683|NCT01806597|78999532|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
44268961|NCT02343120|79186088|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
44268962|NCT02343120|79186089|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
44268963|NCT02343120|79186090|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
44268964|NCT02343120|79186091|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
44268965|NCT02343120|79186092|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
44268966|NCT02343120|79186088|FG000|Part 1: Dose Escalation|Death|1|||
44268967|NCT02343120|79186089|FG001|Part 1: Dose Escalation|Death|2|||
44268968|NCT02343120|79186090|FG002|Part 1: Dose Escalation|Death|2|||
44268969|NCT02343120|79186091|FG003|Part 1: Dose Escalation|Death|2|||
44268970|NCT02343120|79186092|FG004|Part 1: Dose Escalation|Death|1|||
44268971|NCT02343120|79186088|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
44268972|NCT02343120|79186089|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
44268973|NCT02343120|79186090|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
44268974|NCT02343120|79186091|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
44268975|NCT02343120|79186092|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
44268976|NCT02343120|79186088|FG000|Part 2: Expansion|Sponsor decision|0|||
44268977|NCT02343120|79186089|FG001|Part 2: Expansion|Sponsor decision|0|||
44268978|NCT02343120|79186090|FG002|Part 2: Expansion|Sponsor decision|0|||
44268979|NCT02343120|79186091|FG003|Part 2: Expansion|Sponsor decision|165|||
44268980|NCT02343120|79186092|FG004|Part 2: Expansion|Sponsor decision|67|||
44364190|NCT00943917|79369446|FG014|Stage II|Pregnancy|0|||
44364191|NCT00943917|79369432|FG000|Stage II Continuation|Adverse Event|0|||
44364192|NCT00943917|79369433|FG001|Stage II Continuation|Adverse Event|0|||
44364193|NCT00943917|79369434|FG002|Stage II Continuation|Adverse Event|0|||
44364194|NCT00943917|79369435|FG003|Stage II Continuation|Adverse Event|0|||
44203684|NCT01806597|78999533|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
44203685|NCT01806597|78999534|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
44203686|NCT01806597|78999535|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
44203687|NCT02031302|78999551|FG000|Overall Study|Death|115|||
44203688|NCT02031302|78999552|FG001|Overall Study|Death|0|||
44203689|NCT02031302|78999551|FG000|Overall Study|Not treated with study valve system|18|||
44203690|NCT02031302|78999552|FG001|Overall Study|Not treated with study valve system|0|||
44203691|NCT02031302|78999551|FG000|Overall Study|Missed Follow Up|27|||
44203692|NCT02031302|78999552|FG001|Overall Study|Missed Follow Up|0|||
44203693|NCT02031302|78999551|FG000|Overall Study|Lost to Follow-up|4|||
44268981|NCT02343120|79186088|FG000|Part 2: Expansion|Death|0|||
44364195|NCT00943917|79369436|FG004|Stage II Continuation|Adverse Event|0|||
44364196|NCT00943917|79369437|FG005|Stage II Continuation|Adverse Event|0|||
44364197|NCT00943917|79369438|FG006|Stage II Continuation|Adverse Event|0|||
44364198|NCT00943917|79369439|FG007|Stage II Continuation|Adverse Event|0|||
44364199|NCT00943917|79369440|FG008|Stage II Continuation|Adverse Event|0|||
44364200|NCT00943917|79369441|FG009|Stage II Continuation|Adverse Event|0|||
44364201|NCT00943917|79369442|FG010|Stage II Continuation|Adverse Event|0|||
44364202|NCT00943917|79369443|FG011|Stage II Continuation|Adverse Event|1|||
44364203|NCT00943917|79369444|FG012|Stage II Continuation|Adverse Event|2|||
44364204|NCT00943917|79369445|FG013|Stage II Continuation|Adverse Event|1|||
44364205|NCT00943917|79369446|FG014|Stage II Continuation|Adverse Event|1|||
44364206|NCT00943917|79369432|FG000|Stage II Continuation|Withdrawal by Subject|0|||
44364207|NCT00943917|79369433|FG001|Stage II Continuation|Withdrawal by Subject|0|||
44364208|NCT00943917|79369434|FG002|Stage II Continuation|Withdrawal by Subject|0|||
44364209|NCT00943917|79369435|FG003|Stage II Continuation|Withdrawal by Subject|0|||
44364210|NCT00943917|79369436|FG004|Stage II Continuation|Withdrawal by Subject|0|||
44364211|NCT00943917|79369437|FG005|Stage II Continuation|Withdrawal by Subject|0|||
44364212|NCT00943917|79369438|FG006|Stage II Continuation|Withdrawal by Subject|0|||
44364213|NCT00943917|79369439|FG007|Stage II Continuation|Withdrawal by Subject|0|||
44364214|NCT00943917|79369440|FG008|Stage II Continuation|Withdrawal by Subject|0|||
44364215|NCT00943917|79369441|FG009|Stage II Continuation|Withdrawal by Subject|0|||
44364216|NCT00943917|79369442|FG010|Stage II Continuation|Withdrawal by Subject|0|||
44364217|NCT00943917|79369443|FG011|Stage II Continuation|Withdrawal by Subject|0|||
44364218|NCT00943917|79369444|FG012|Stage II Continuation|Withdrawal by Subject|0|||
44364219|NCT00943917|79369445|FG013|Stage II Continuation|Withdrawal by Subject|1|||
44364220|NCT00943917|79369446|FG014|Stage II Continuation|Withdrawal by Subject|3|||
44364221|NCT00943917|79369432|FG000|Stage II Continuation|Protocol Violation|0|||
44364222|NCT00943917|79369433|FG001|Stage II Continuation|Protocol Violation|0|||
44364223|NCT00943917|79369434|FG002|Stage II Continuation|Protocol Violation|0|||
44364224|NCT00943917|79369435|FG003|Stage II Continuation|Protocol Violation|0|||
44364225|NCT00943917|79369436|FG004|Stage II Continuation|Protocol Violation|0|||
44364226|NCT00943917|79369437|FG005|Stage II Continuation|Protocol Violation|0|||
44364227|NCT00943917|79369438|FG006|Stage II Continuation|Protocol Violation|0|||
44364228|NCT00943917|79369439|FG007|Stage II Continuation|Protocol Violation|0|||
44364229|NCT00943917|79369440|FG008|Stage II Continuation|Protocol Violation|0|||
44364230|NCT00943917|79369441|FG009|Stage II Continuation|Protocol Violation|1|||
44364231|NCT00943917|79369442|FG010|Stage II Continuation|Protocol Violation|0|||
44364232|NCT00943917|79369443|FG011|Stage II Continuation|Protocol Violation|1|||
44364233|NCT00943917|79369444|FG012|Stage II Continuation|Protocol Violation|0|||
44364234|NCT00943917|79369445|FG013|Stage II Continuation|Protocol Violation|0|||
44364235|NCT00943917|79369446|FG014|Stage II Continuation|Protocol Violation|0|||
44364236|NCT00943917|79369432|FG000|Stage II Continuation|hypoglycemia|0|||
44364237|NCT00943917|79369433|FG001|Stage II Continuation|hypoglycemia|0|||
44364238|NCT00943917|79369434|FG002|Stage II Continuation|hypoglycemia|0|||
44364239|NCT00943917|79369435|FG003|Stage II Continuation|hypoglycemia|0|||
44364240|NCT00943917|79369436|FG004|Stage II Continuation|hypoglycemia|0|||
44364241|NCT00943917|79369437|FG005|Stage II Continuation|hypoglycemia|0|||
44364242|NCT00943917|79369438|FG006|Stage II Continuation|hypoglycemia|0|||
44364243|NCT00943917|79369439|FG007|Stage II Continuation|hypoglycemia|0|||
44364244|NCT00943917|79369440|FG008|Stage II Continuation|hypoglycemia|0|||
44364245|NCT00943917|79369441|FG009|Stage II Continuation|hypoglycemia|0|||
44364246|NCT00943917|79369442|FG010|Stage II Continuation|hypoglycemia|0|||
44364247|NCT00943917|79369443|FG011|Stage II Continuation|hypoglycemia|0|||
44364248|NCT00943917|79369444|FG012|Stage II Continuation|hypoglycemia|1|||
44452002|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
44452003|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
44364249|NCT00943917|79369445|FG013|Stage II Continuation|hypoglycemia|0|||
44364250|NCT00943917|79369446|FG014|Stage II Continuation|hypoglycemia|0|||
44364251|NCT00943917|79369432|FG000|Stage II Continuation|A1C elevation|0|||
44364252|NCT00943917|79369433|FG001|Stage II Continuation|A1C elevation|0|||
44203694|NCT02031302|78999552|FG001|Overall Study|Lost to Follow-up|0|||
44203695|NCT01610037|78999562|FG000|All Patients|Adverse Event|27|||
44364253|NCT00943917|79369434|FG002|Stage II Continuation|A1C elevation|0|||
44364254|NCT00943917|79369435|FG003|Stage II Continuation|A1C elevation|0|||
44364255|NCT00943917|79369436|FG004|Stage II Continuation|A1C elevation|0|||
44364256|NCT00943917|79369437|FG005|Stage II Continuation|A1C elevation|0|||
44364257|NCT00943917|79369438|FG006|Stage II Continuation|A1C elevation|0|||
44364258|NCT00943917|79369439|FG007|Stage II Continuation|A1C elevation|0|||
44364259|NCT00943917|79369440|FG008|Stage II Continuation|A1C elevation|0|||
44364260|NCT00943917|79369441|FG009|Stage II Continuation|A1C elevation|0|||
44364261|NCT00943917|79369442|FG010|Stage II Continuation|A1C elevation|0|||
44364262|NCT00943917|79369443|FG011|Stage II Continuation|A1C elevation|0|||
44364263|NCT00943917|79369444|FG012|Stage II Continuation|A1C elevation|0|||
44364264|NCT00943917|79369445|FG013|Stage II Continuation|A1C elevation|1|||
44364265|NCT00943917|79369446|FG014|Stage II Continuation|A1C elevation|0|||
44364266|NCT01077024|79369481|FG000|Overall Study|Lost to Follow-up|20|||
44364267|NCT01077024|79369482|FG001|Overall Study|Lost to Follow-up|14|||
44364268|NCT01077024|79369481|FG000|Overall Study|Withdrawal by Subject|0|||
44364269|NCT01077024|79369482|FG001|Overall Study|Withdrawal by Subject|2|||
44364270|NCT01077024|79369481|FG000|Overall Study|Incarcerated|7|||
44364271|NCT01077024|79369482|FG001|Overall Study|Incarcerated|8|||
44268982|NCT02343120|79186089|FG001|Part 2: Expansion|Death|0|||
44268983|NCT02343120|79186090|FG002|Part 2: Expansion|Death|0|||
44268984|NCT02343120|79186091|FG003|Part 2: Expansion|Death|74|||
44268985|NCT02343120|79186092|FG004|Part 2: Expansion|Death|17|||
44268986|NCT02343120|79186088|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
44268987|NCT02343120|79186089|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
44268988|NCT02343120|79186090|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
44268989|NCT02343120|79186091|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
44268990|NCT02343120|79186092|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
44268991|NCT02343120|79186088|FG000|Part 2: Expansion|Lost to Follow-up|0|||
44268992|NCT02343120|79186089|FG001|Part 2: Expansion|Lost to Follow-up|0|||
44364272|NCT01077024|79369481|FG000|Overall Study|Other|4|||
44364273|NCT01077024|79369482|FG001|Overall Study|Other|4|||
44364274|NCT01089582|79369488|FG000|Overall Study|Death|2|||
44364275|NCT01089582|79369488|FG000|Overall Study|Adverse Event|15|||
44364276|NCT01089582|79369488|FG000|Overall Study|Lost to Follow-up|8|||
44364277|NCT01089582|79369488|FG000|Overall Study|Other|4|||
44268993|NCT02343120|79186090|FG002|Part 2: Expansion|Lost to Follow-up|0|||
44268994|NCT02343120|79186091|FG003|Part 2: Expansion|Lost to Follow-up|5|||
44268995|NCT02343120|79186092|FG004|Part 2: Expansion|Lost to Follow-up|2|||
44268996|NCT02343120|79186088|FG000|Part 2: Expansion|Other|0|||
44268997|NCT02343120|79186089|FG001|Part 2: Expansion|Other|0|||
44268998|NCT02343120|79186090|FG002|Part 2: Expansion|Other|0|||
44268999|NCT02343120|79186091|FG003|Part 2: Expansion|Other|1|||
44269000|NCT02343120|79186092|FG004|Part 2: Expansion|Other|5|||
44269001|NCT02343120|79186088|FG000|Part 2: Expansion|Adverse Event|0|||
44269002|NCT02343120|79186089|FG001|Part 2: Expansion|Adverse Event|0|||
44269003|NCT02343120|79186090|FG002|Part 2: Expansion|Adverse Event|0|||
44269004|NCT02343120|79186091|FG003|Part 2: Expansion|Adverse Event|1|||
44269005|NCT02343120|79186092|FG004|Part 2: Expansion|Adverse Event|1|||
44269006|NCT02342886|79186349|FG000|Overall Study|Treatment non-compliance|1|||
44269007|NCT02342886|79186350|FG001|Overall Study|Treatment non-compliance|0|||
44269008|NCT02342886|79186351|FG002|Overall Study|Treatment non-compliance|0|||
44269009|NCT02342886|79186352|FG003|Overall Study|Treatment non-compliance|1|||
44269010|NCT02342886|79186353|FG004|Overall Study|Treatment non-compliance|0|||
44269011|NCT02342886|79186349|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
44269012|NCT02342886|79186350|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
44269013|NCT02342886|79186351|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
44269014|NCT02342886|79186352|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
44269015|NCT02342886|79186353|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
44269016|NCT02342886|79186349|FG000|Overall Study|Adverse event/specific toxicity|4|||
44269017|NCT02342886|79186350|FG001|Overall Study|Adverse event/specific toxicity|3|||
44269018|NCT02342886|79186351|FG002|Overall Study|Adverse event/specific toxicity|11|||
44364278|NCT01089582|79369488|FG000|Overall Study|Withdrawal by Subject|1|||
44364279|NCT00862459|79369495|FG000|Overall Study|Lost to Follow-up|1|||
44269019|NCT02342886|79186352|FG003|Overall Study|Adverse event/specific toxicity|2|||
44364280|NCT00862459|79369496|FG001|Overall Study|Lost to Follow-up|2|||
44364281|NCT00862459|79369497|FG002|Overall Study|Lost to Follow-up|2|||
44364282|NCT00862459|79369495|FG000|Overall Study|Protocol Violation|1|||
44364283|NCT00862459|79369496|FG001|Overall Study|Protocol Violation|0|||
44269020|NCT02342886|79186353|FG004|Overall Study|Adverse event/specific toxicity|1|||
44269021|NCT02342886|79186349|FG000|Overall Study|Lost to Follow-up|1|||
44269022|NCT02342886|79186350|FG001|Overall Study|Lost to Follow-up|0|||
44269023|NCT02342886|79186351|FG002|Overall Study|Lost to Follow-up|0|||
44269024|NCT02342886|79186352|FG003|Overall Study|Lost to Follow-up|0|||
44269025|NCT02342886|79186353|FG004|Overall Study|Lost to Follow-up|0|||
44269026|NCT02342886|79186349|FG000|Overall Study|Death|1|||
44269027|NCT02342886|79186350|FG001|Overall Study|Death|2|||
44364284|NCT00862459|79369497|FG002|Overall Study|Protocol Violation|0|||
44364285|NCT00862459|79369495|FG000|Overall Study|Withdrawal by Subject|1|||
44364286|NCT00862459|79369496|FG001|Overall Study|Withdrawal by Subject|1|||
44364287|NCT00862459|79369497|FG002|Overall Study|Withdrawal by Subject|3|||
44364288|NCT00862459|79369495|FG000|Overall Study|Adverse Event|0|||
44364289|NCT00862459|79369496|FG001|Overall Study|Adverse Event|1|||
44364290|NCT00862459|79369497|FG002|Overall Study|Adverse Event|0|||
44364291|NCT00862459|79369495|FG000|Overall Study|Personal reasons|1|||
44364292|NCT00862459|79369496|FG001|Overall Study|Personal reasons|0|||
44364293|NCT00862459|79369497|FG002|Overall Study|Personal reasons|0|||
44364294|NCT00862459|79369495|FG000|Overall Study|Operation|1|||
44364295|NCT00862459|79369496|FG001|Overall Study|Operation|1|||
44364296|NCT00862459|79369497|FG002|Overall Study|Operation|0|||
44364297|NCT00862459|79369495|FG000|Overall Study|Intravenous (IV) site problems|1|||
44364298|NCT00862459|79369496|FG001|Overall Study|Intravenous (IV) site problems|0|||
44364299|NCT00862459|79369497|FG002|Overall Study|Intravenous (IV) site problems|1|||
44364300|NCT00862459|79369495|FG000|Overall Study|Unable to hold still for imaging|0|||
44364301|NCT00862459|79369496|FG001|Overall Study|Unable to hold still for imaging|1|||
44203696|NCT01610037|78999563|FG001|All Patients|Adverse Event|22|||
44364302|NCT00862459|79369497|FG002|Overall Study|Unable to hold still for imaging|0|||
44364303|NCT00862459|79369495|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
44364304|NCT00862459|79369496|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
44364305|NCT00862459|79369497|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
44203697|NCT01610037|78999564|FG002|All Patients|Adverse Event|26|||
44203698|NCT01610037|78999562|FG000|All Patients|Withdrawal by Subject|12|||
44203699|NCT01610037|78999563|FG001|All Patients|Withdrawal by Subject|10|||
44203700|NCT01610037|78999564|FG002|All Patients|Withdrawal by Subject|20|||
44203701|NCT01610037|78999562|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
44203702|NCT01610037|78999563|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
44203703|NCT01610037|78999564|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
44203704|NCT01610037|78999562|FG000|All Patients|Death|4|||
44203705|NCT01610037|78999563|FG001|All Patients|Death|2|||
44203706|NCT01610037|78999564|FG002|All Patients|Death|1|||
44203707|NCT01610037|78999562|FG000|All Patients|Protocol deviation|4|||
44203708|NCT01610037|78999563|FG001|All Patients|Protocol deviation|3|||
44203709|NCT01610037|78999564|FG002|All Patients|Protocol deviation|3|||
44203710|NCT01610037|78999562|FG000|All Patients|Abnormal laboratory value|1|||
44203711|NCT01610037|78999563|FG001|All Patients|Abnormal laboratory value|1|||
44203712|NCT01610037|78999564|FG002|All Patients|Abnormal laboratory value|0|||
44269028|NCT02342886|79186351|FG002|Overall Study|Death|1|||
44269029|NCT02342886|79186352|FG003|Overall Study|Death|0|||
44269030|NCT02342886|79186353|FG004|Overall Study|Death|1|||
44269031|NCT02342886|79186349|FG000|Overall Study|Withdrawal by Subject|0|||
44269032|NCT02342886|79186350|FG001|Overall Study|Withdrawal by Subject|1|||
44269033|NCT02342886|79186351|FG002|Overall Study|Withdrawal by Subject|0|||
44269034|NCT02342886|79186352|FG003|Overall Study|Withdrawal by Subject|1|||
44269035|NCT02342886|79186353|FG004|Overall Study|Withdrawal by Subject|0|||
44269036|NCT02342886|79186349|FG000|Overall Study|Investigator/sponsor decision|0|||
44269037|NCT02342886|79186350|FG001|Overall Study|Investigator/sponsor decision|2|||
44269038|NCT02342886|79186351|FG002|Overall Study|Investigator/sponsor decision|0|||
44269039|NCT02342886|79186352|FG003|Overall Study|Investigator/sponsor decision|3|||
44269040|NCT02342886|79186353|FG004|Overall Study|Investigator/sponsor decision|1|||
44269041|NCT02342886|79186349|FG000|Overall Study|Pregnancy|0|||
44269042|NCT02342886|79186350|FG001|Overall Study|Pregnancy|0|||
44269043|NCT02342886|79186351|FG002|Overall Study|Pregnancy|2|||
44269044|NCT02342886|79186352|FG003|Overall Study|Pregnancy|0|||
44269045|NCT02342886|79186353|FG004|Overall Study|Pregnancy|0|||
44269046|NCT02342886|79186349|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
44269047|NCT02342886|79186350|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
44269048|NCT02342886|79186351|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
44364306|NCT00862459|79369495|FG000|Overall Study|Administrative problems|0|||
44364307|NCT00862459|79369496|FG001|Overall Study|Administrative problems|1|||
44364308|NCT00862459|79369497|FG002|Overall Study|Administrative problems|0|||
44364309|NCT01074450|79369508|FG000|First Intervention|Emesis in Dosing Interval|0|||
44364310|NCT01074450|79369509|FG001|First Intervention|Emesis in Dosing Interval|2|||
44269049|NCT02342886|79186352|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
44269050|NCT02342886|79186353|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
44269051|NCT02342886|79186349|FG000|Overall Study|Protocol Violation|0|||
44269052|NCT02342886|79186350|FG001|Overall Study|Protocol Violation|0|||
44364311|NCT01074450|79369508|FG000|Second Intervention|Protocol Violation|1|||
44203713|NCT01610037|78999562|FG000|All Patients|Administrative problems|1|||
44203714|NCT01610037|78999563|FG001|All Patients|Administrative problems|4|||
44203715|NCT01610037|78999564|FG002|All Patients|Administrative problems|4|||
44203716|NCT01610037|78999562|FG000|All Patients|Lost to Follow-up|1|||
44269053|NCT02342886|79186351|FG002|Overall Study|Protocol Violation|0|||
44364312|NCT01074450|79369509|FG001|Second Intervention|Protocol Violation|0|||
44364313|NCT01074450|79369508|FG000|Second Intervention|Physician Decision|0|||
44203717|NCT01610037|78999563|FG001|All Patients|Lost to Follow-up|0|||
44203718|NCT01610037|78999564|FG002|All Patients|Lost to Follow-up|0|||
44203719|NCT01610037|78999562|FG000|All Patients|Abnormal test procedure result(s)|0|||
44203720|NCT01610037|78999563|FG001|All Patients|Abnormal test procedure result(s)|1|||
44203721|NCT01610037|78999564|FG002|All Patients|Abnormal test procedure result(s)|3|||
44203722|NCT01610037|78999562|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
44203723|NCT01610037|78999563|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
44203724|NCT01610037|78999564|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
44203725|NCT01610037|78999562|FG000|Treatment and Follow up Period|Death|10|||
44269054|NCT02342886|79186352|FG003|Overall Study|Protocol Violation|2|||
44269055|NCT02342886|79186353|FG004|Overall Study|Protocol Violation|0|||
44269056|NCT02390076|79186389|FG000|Overall Study|Lost to Follow-up|2|||
44269057|NCT02390076|79186390|FG001|Overall Study|Lost to Follow-up|1|||
44203726|NCT01610037|78999563|FG001|Treatment and Follow up Period|Death|5|||
44203727|NCT01610037|78999564|FG002|Treatment and Follow up Period|Death|4|||
44269058|NCT02390076|79186391|FG002|Overall Study|Lost to Follow-up|4|||
44269059|NCT02389998|79186410|FG000|Overall Study|car accident|1|||
44269060|NCT02389998|79186411|FG001|Overall Study|car accident|0|||
44269061|NCT02389764|79186437|FG000|Overall Study|Lack of Efficacy|9|||
44269062|NCT02366130|79186508|FG000|Overall Study|Withdrawal by Subject|3|||
44269063|NCT02366130|79186508|FG000|Overall Study|Ineligible|6|||
44269064|NCT02389452|79186570|FG000|Overall Study|Lost to Follow-up|13|||
44269065|NCT02389452|79186570|FG000|Overall Study|Adverse Event|1|||
44269066|NCT02389452|79186570|FG000|Overall Study|Withdrawal by Subject|5|||
44269067|NCT02389452|79186570|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
44269068|NCT02365584|79186608|FG000|Overall Study|Adverse Event|2|||
44269069|NCT02365584|79186609|FG001|Overall Study|Adverse Event|2|||
44269070|NCT02365584|79186608|FG000|Overall Study|Withdrawal by Subject|1|||
44269071|NCT02365584|79186609|FG001|Overall Study|Withdrawal by Subject|0|||
44269072|NCT02365584|79186608|FG000|Overall Study|Disease Progression|9|||
44269073|NCT02365584|79186609|FG001|Overall Study|Disease Progression|12|||
44269074|NCT02342418|79186621|FG000|Overall Study|Adverse Event|0|||
44269075|NCT02342418|79186622|FG001|Overall Study|Adverse Event|1|||
44269076|NCT02365506|79186663|FG000|Overall Study|Investigator's Discretion|0|||
44269077|NCT02365506|79186664|FG001|Overall Study|Investigator's Discretion|0|||
44269078|NCT02365506|79186665|FG002|Overall Study|Investigator's Discretion|1|||
44269079|NCT02312934|79186702|FG000|Overall Study|Lost to Follow-up|1|||
44269080|NCT02312934|79186703|FG001|Overall Study|Lost to Follow-up|0|||
44269081|NCT02312934|79186702|FG000|Overall Study|Physician Decision|1|||
44269082|NCT02312934|79186703|FG001|Overall Study|Physician Decision|0|||
44269083|NCT02341482|79186737|FG000|Overall Study|Adverse Event|1|||
44269084|NCT02312856|79186777|FG000|Overall Study|Death|1|||
44269085|NCT02312856|79186777|FG000|Overall Study|Lost to Follow-up|3|||
44269086|NCT01602120|79187242|FG000|Overall Study|Adverse Event|3|||
44269087|NCT01602120|79187243|FG001|Overall Study|Adverse Event|6|||
44269088|NCT01602120|79187244|FG002|Overall Study|Adverse Event|0|||
44269089|NCT01602120|79187245|FG003|Overall Study|Adverse Event|2|||
44269090|NCT01602120|79187242|FG000|Overall Study|Death|0|||
44269091|NCT01602120|79187243|FG001|Overall Study|Death|4|||
44269092|NCT01602120|79187244|FG002|Overall Study|Death|0|||
44269093|NCT01602120|79187245|FG003|Overall Study|Death|0|||
44269094|NCT01602120|79187242|FG000|Overall Study|Lost to Follow-up|0|||
44269095|NCT01602120|79187243|FG001|Overall Study|Lost to Follow-up|1|||
44269096|NCT01602120|79187244|FG002|Overall Study|Lost to Follow-up|0|||
44269097|NCT01602120|79187245|FG003|Overall Study|Lost to Follow-up|1|||
44269098|NCT01602120|79187242|FG000|Overall Study|Protocol Violation|1|||
44269099|NCT01602120|79187243|FG001|Overall Study|Protocol Violation|1|||
44269100|NCT01602120|79187244|FG002|Overall Study|Protocol Violation|0|||
44269101|NCT01602120|79187245|FG003|Overall Study|Protocol Violation|0|||
44269102|NCT01602120|79187242|FG000|Overall Study|Non-compliance|0|||
44269103|NCT01602120|79187243|FG001|Overall Study|Non-compliance|3|||
44269104|NCT01602120|79187244|FG002|Overall Study|Non-compliance|0|||
44269105|NCT01602120|79187245|FG003|Overall Study|Non-compliance|1|||
44269106|NCT01602120|79187242|FG000|Overall Study|Withdrawal by Subject|8|||
44269107|NCT01602120|79187243|FG001|Overall Study|Withdrawal by Subject|17|||
44269108|NCT01602120|79187244|FG002|Overall Study|Withdrawal by Subject|0|||
44203728|NCT01610037|78999562|FG000|Treatment and Follow up Period|Administrative problems|1|||
44269109|NCT01602120|79187245|FG003|Overall Study|Withdrawal by Subject|3|||
44269110|NCT01602120|79187242|FG000|Overall Study|Study Terminated by Sponsor|12|||
44269111|NCT01602120|79187243|FG001|Overall Study|Study Terminated by Sponsor|24|||
44269112|NCT01602120|79187244|FG002|Overall Study|Study Terminated by Sponsor|17|||
44269113|NCT01602120|79187245|FG003|Overall Study|Study Terminated by Sponsor|44|||
44269114|NCT01602120|79187242|FG000|Overall Study|Physician Decision|2|||
44269115|NCT01602120|79187243|FG001|Overall Study|Physician Decision|3|||
44269116|NCT01602120|79187244|FG002|Overall Study|Physician Decision|0|||
44269117|NCT01602120|79187245|FG003|Overall Study|Physician Decision|0|||
44269118|NCT01602120|79187242|FG000|Overall Study|Unspecified Reason|3|||
44269119|NCT01602120|79187243|FG001|Overall Study|Unspecified Reason|1|||
44269120|NCT01602120|79187244|FG002|Overall Study|Unspecified Reason|0|||
44269121|NCT01602120|79187245|FG003|Overall Study|Unspecified Reason|2|||
44269122|NCT04543955|79188052|FG000|Overall Study|Company cancelled study|1|||
44269123|NCT04543955|79188053|FG001|Overall Study|Company cancelled study|0|||
44269124|NCT04436744|79188603|FG000|Overall Study|Adverse Event|1|||
44269125|NCT04436744|79188604|FG001|Overall Study|Adverse Event|1|||
44269126|NCT04436744|79188603|FG000|Overall Study|Death|1|||
44269127|NCT04436744|79188604|FG001|Overall Study|Death|0|||
44269128|NCT04436744|79188603|FG000|Overall Study|Lost to Follow-up|0|||
44269129|NCT04436744|79188604|FG001|Overall Study|Lost to Follow-up|2|||
44269130|NCT04436744|79188603|FG000|Overall Study|Physician Decision|0|||
44269131|NCT04436744|79188604|FG001|Overall Study|Physician Decision|1|||
44269132|NCT04436744|79188603|FG000|Overall Study|Progressive Disease|0|||
44269133|NCT04436744|79188604|FG001|Overall Study|Progressive Disease|4|||
44269134|NCT04436744|79188603|FG000|Overall Study|Protocol Deviation|1|||
44269135|NCT04436744|79188604|FG001|Overall Study|Protocol Deviation|1|||
44269136|NCT04436744|79188603|FG000|Overall Study|Withdrawal by Subject|1|||
44269137|NCT04436744|79188604|FG001|Overall Study|Withdrawal by Subject|2|||
44269138|NCT02243306|79188751|FG000|Overall Study|Adverse Event|0|||
44269139|NCT02243306|79188752|FG001|Overall Study|Adverse Event|1|||
44364314|NCT01074450|79369509|FG001|Second Intervention|Physician Decision|1|||
44364315|NCT00943761|79369517|FG000|Overall Study|Lost to Follow-up|2|||
44364316|NCT00943761|79369518|FG001|Overall Study|Lost to Follow-up|0|||
44364317|NCT00943761|79369517|FG000|Overall Study|Withdrawal by Subject|2|||
44364318|NCT00943761|79369518|FG001|Overall Study|Withdrawal by Subject|1|||
44364319|NCT00949533|79369526|FG000|Overall Study|Lost to Follow-up|0|||
44364320|NCT00949533|79369527|FG001|Overall Study|Lost to Follow-up|1|||
44364321|NCT00866047|79369533|FG000|Treatment Period|Progressive disease|13|||
44364322|NCT00866047|79369533|FG000|Treatment Period|Adverse Event|16|||
44364323|NCT00866047|79369533|FG000|Treatment Period|Physician Decision|14|||
44364324|NCT00866047|79369533|FG000|Treatment Period|Withdrawal by Subject|5|||
44364325|NCT00866047|79369533|FG000|Follow-up Period|Lost to Follow-up|5|||
44364326|NCT00869323|79369537|FG000|Maintenance Therapy|concurrent illness|1|||
44364327|NCT01192022|79369545|FG000|Overall Study|Withdrawal of Consent|3|||
44364328|NCT01192022|79369546|FG001|Overall Study|Withdrawal of Consent|1|||
44364329|NCT01192022|79369547|FG002|Overall Study|Withdrawal of Consent|0|||
44364330|NCT01192022|79369548|FG003|Overall Study|Withdrawal of Consent|0|||
44364331|NCT01192022|79369549|FG004|Overall Study|Withdrawal of Consent|0|||
44364332|NCT01192022|79369545|FG000|Overall Study|Lost to Follow-up|4|||
44364333|NCT01192022|79369546|FG001|Overall Study|Lost to Follow-up|2|||
44364334|NCT01192022|79369547|FG002|Overall Study|Lost to Follow-up|1|||
44364335|NCT01192022|79369548|FG003|Overall Study|Lost to Follow-up|1|||
44364336|NCT01192022|79369549|FG004|Overall Study|Lost to Follow-up|0|||
44364337|NCT01192022|79369545|FG000|Overall Study|Adverse Event|1|||
44364338|NCT01192022|79369546|FG001|Overall Study|Adverse Event|0|||
44364339|NCT01192022|79369547|FG002|Overall Study|Adverse Event|0|||
44364340|NCT01192022|79369548|FG003|Overall Study|Adverse Event|0|||
44364341|NCT01192022|79369549|FG004|Overall Study|Adverse Event|0|||
44364342|NCT01192022|79369545|FG000|Overall Study|Fatal Adverse Event|4|||
44364343|NCT01192022|79369546|FG001|Overall Study|Fatal Adverse Event|6|||
44364344|NCT01192022|79369547|FG002|Overall Study|Fatal Adverse Event|0|||
44364345|NCT01192022|79369548|FG003|Overall Study|Fatal Adverse Event|0|||
44364346|NCT01192022|79369549|FG004|Overall Study|Fatal Adverse Event|1|||
44364347|NCT01192022|79369545|FG000|Overall Study|Physician withdrew-patient hardship|1|||
44364348|NCT01192022|79369546|FG001|Overall Study|Physician withdrew-patient hardship|0|||
44364349|NCT01192022|79369547|FG002|Overall Study|Physician withdrew-patient hardship|0|||
44364350|NCT01192022|79369548|FG003|Overall Study|Physician withdrew-patient hardship|0|||
44364351|NCT01192022|79369549|FG004|Overall Study|Physician withdrew-patient hardship|0|||
44364352|NCT01192022|79369545|FG000|Overall Study|Patient too sick from chemotherapy|0|||
44364353|NCT01192022|79369546|FG001|Overall Study|Patient too sick from chemotherapy|1|||
44364354|NCT01192022|79369547|FG002|Overall Study|Patient too sick from chemotherapy|0|||
44364355|NCT01192022|79369548|FG003|Overall Study|Patient too sick from chemotherapy|0|||
44364356|NCT01192022|79369549|FG004|Overall Study|Patient too sick from chemotherapy|0|||
44364357|NCT01192022|79369545|FG000|Overall Study|Patient needed surgery|0|||
44364358|NCT01192022|79369546|FG001|Overall Study|Patient needed surgery|1|||
44364359|NCT01192022|79369547|FG002|Overall Study|Patient needed surgery|0|||
44364360|NCT01192022|79369548|FG003|Overall Study|Patient needed surgery|0|||
44364361|NCT01192022|79369549|FG004|Overall Study|Patient needed surgery|0|||
44269140|NCT02243306|79188751|FG000|Overall Study|Other: Reached stopping criteria|0|||
44269141|NCT02243306|79188752|FG001|Overall Study|Other: Reached stopping criteria|1|||
44269142|NCT02243306|79188751|FG000|Overall Study|Physician Decision|0|||
44269143|NCT02243306|79188752|FG001|Overall Study|Physician Decision|1|||
44269144|NCT03214679|79188908|FG000|Overall Study|Lost to Follow-up|12|||
44269145|NCT03214679|79188909|FG001|Overall Study|Lost to Follow-up|14|||
44269146|NCT03214679|79188908|FG000|Overall Study|not eligible|2|||
44364362|NCT01192022|79369545|FG000|Overall Study|Parents did not allow all follow up|0|||
44364363|NCT01192022|79369546|FG001|Overall Study|Parents did not allow all follow up|0|||
44364364|NCT01192022|79369547|FG002|Overall Study|Parents did not allow all follow up|0|||
44364365|NCT01192022|79369548|FG003|Overall Study|Parents did not allow all follow up|1|||
44364366|NCT01192022|79369549|FG004|Overall Study|Parents did not allow all follow up|0|||
44364367|NCT01191944|79369562|FG000|Overall Study|Adverse Event|11|||
44364368|NCT01191944|79369563|FG001|Overall Study|Adverse Event|12|||
44364369|NCT01191944|79369562|FG000|Overall Study|Protocol Violation|1|||
44364370|NCT01191944|79369563|FG001|Overall Study|Protocol Violation|2|||
44364371|NCT01191944|79369562|FG000|Overall Study|Withdrawal by Subject|4|||
44364372|NCT01191944|79369563|FG001|Overall Study|Withdrawal by Subject|2|||
44364373|NCT01191944|79369562|FG000|Overall Study|Other|1|||
44364374|NCT01191944|79369563|FG001|Overall Study|Other|3|||
44364375|NCT01191788|79369571|FG000|Overall Study|Lost to Follow-up|21|||
44364376|NCT01191788|79369572|FG001|Overall Study|Lost to Follow-up|22|||
44364377|NCT00940875|79369581|FG000|Treatment Phase|Adverse Event|9|||
44364378|NCT00940875|79369582|FG001|Treatment Phase|Adverse Event|3|||
44364379|NCT00940875|79369581|FG000|Treatment Phase|Death|3|||
44364380|NCT00940875|79369582|FG001|Treatment Phase|Death|5|||
44364381|NCT00940875|79369581|FG000|Treatment Phase|Lack of Efficacy|1|||
44364382|NCT00940875|79369582|FG001|Treatment Phase|Lack of Efficacy|0|||
44364383|NCT00940875|79369581|FG000|Treatment Phase|Withdrawal by Subject|3|||
44364384|NCT00940875|79369582|FG001|Treatment Phase|Withdrawal by Subject|0|||
44364385|NCT00940875|79369581|FG000|Treatment Phase|Disease progression|9|||
44364386|NCT00940875|79369582|FG001|Treatment Phase|Disease progression|11|||
44364387|NCT00940875|79369581|FG000|Treatment Phase|Physician Decision|1|||
44364388|NCT00940875|79369582|FG001|Treatment Phase|Physician Decision|0|||
44364389|NCT00940875|79369581|FG000|Post-Study Treatment|Death|0|||
44364390|NCT00940875|79369582|FG001|Post-Study Treatment|Death|1|||
44364391|NCT00940875|79369581|FG000|Post-Study Treatment|Disease Progression|0|||
44364392|NCT00940875|79369582|FG001|Post-Study Treatment|Disease Progression|2|||
44364393|NCT00940485|79369591|FG000|Overall Study|HBeAb positive at Baseline|3|||
44364394|NCT00940485|79369592|FG001|Overall Study|HBeAb positive at Baseline|2|||
44364395|NCT00940485|79369591|FG000|Overall Study|Lost to Follow-up|2|||
44364396|NCT00940485|79369592|FG001|Overall Study|Lost to Follow-up|3|||
44364397|NCT00940485|79369591|FG000|Overall Study|Adverse Event|8|||
44364398|NCT00940485|79369592|FG001|Overall Study|Adverse Event|0|||
44364399|NCT00940485|79369591|FG000|Overall Study|Withdrawal by Subject|1|||
44364400|NCT00940485|79369592|FG001|Overall Study|Withdrawal by Subject|1|||
44364401|NCT00940485|79369591|FG000|Overall Study|Others|1|||
44364402|NCT00940485|79369592|FG001|Overall Study|Others|1|||
44364403|NCT00943605|79369600|FG000|Overall Study|Study termination|30|||
44364404|NCT00943605|79369601|FG001|Overall Study|Study termination|30|||
44364405|NCT01132313|79369619|FG000|Overall Study|Lack of Efficacy|1|||
44364406|NCT01132313|79369620|FG001|Overall Study|Lack of Efficacy|0|||
44364407|NCT01132313|79369621|FG002|Overall Study|Lack of Efficacy|0|||
44364408|NCT01132313|79369622|FG003|Overall Study|Lack of Efficacy|0|||
44364409|NCT01132313|79369623|FG004|Overall Study|Lack of Efficacy|0|||
44364410|NCT01132313|79369624|FG005|Overall Study|Lack of Efficacy|0|||
44364411|NCT01132313|79369625|FG006|Overall Study|Lack of Efficacy|0|||
44364412|NCT01132313|79369626|FG007|Overall Study|Lack of Efficacy|3|||
44364413|NCT01132313|79369627|FG008|Overall Study|Lack of Efficacy|14|||
44364414|NCT01132313|79369628|FG009|Overall Study|Lack of Efficacy|16|||
44364415|NCT01132313|79369629|FG010|Overall Study|Lack of Efficacy|0|||
44364416|NCT01132313|79369630|FG011|Overall Study|Lack of Efficacy|0|||
44364417|NCT01132313|79369619|FG000|Overall Study|Not treated|2|||
44364418|NCT01132313|79369620|FG001|Overall Study|Not treated|0|||
44364419|NCT01132313|79369621|FG002|Overall Study|Not treated|0|||
44364420|NCT01132313|79369622|FG003|Overall Study|Not treated|0|||
44364421|NCT01132313|79369623|FG004|Overall Study|Not treated|2|||
44364422|NCT01132313|79369624|FG005|Overall Study|Not treated|1|||
44364423|NCT01132313|79369625|FG006|Overall Study|Not treated|3|||
44269147|NCT03214679|79188909|FG001|Overall Study|not eligible|0|||
44269148|NCT01349465|79190182|FG000|Overall Study|Adverse Event|1|||
44269149|NCT01349465|79190183|FG001|Overall Study|Adverse Event|0|||
44269150|NCT01349465|79190182|FG000|Overall Study|Death|3|||
44269151|NCT01349465|79190183|FG001|Overall Study|Death|0|||
44269152|NCT01349465|79190182|FG000|Overall Study|Lost to Follow-up|10|||
44269153|NCT01349465|79190183|FG001|Overall Study|Lost to Follow-up|1|||
44364424|NCT01132313|79369626|FG007|Overall Study|Not treated|0|||
44364425|NCT01132313|79369627|FG008|Overall Study|Not treated|0|||
44364426|NCT01132313|79369628|FG009|Overall Study|Not treated|0|||
44364427|NCT01132313|79369629|FG010|Overall Study|Not treated|0|||
44269154|NCT01349465|79190182|FG000|Overall Study|Withdrawal by Subject|4|||
44269155|NCT01349465|79190183|FG001|Overall Study|Withdrawal by Subject|2|||
44269156|NCT01349465|79190182|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
44269157|NCT01349465|79190183|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
44269158|NCT01648764|79191293|FG000|Overall Study|Progressive Disease|0|||
44364428|NCT01132313|79369630|FG011|Overall Study|Not treated|0|||
44364429|NCT01132313|79369619|FG000|Overall Study|Adverse Event|0|||
44364430|NCT01132313|79369620|FG001|Overall Study|Adverse Event|0|||
44364431|NCT01132313|79369621|FG002|Overall Study|Adverse Event|4|||
44364432|NCT01132313|79369622|FG003|Overall Study|Adverse Event|10|||
44364433|NCT01132313|79369623|FG004|Overall Study|Adverse Event|19|||
44364434|NCT01132313|79369624|FG005|Overall Study|Adverse Event|6|||
44364435|NCT01132313|79369625|FG006|Overall Study|Adverse Event|5|||
44364436|NCT01132313|79369626|FG007|Overall Study|Adverse Event|3|||
44364437|NCT01132313|79369627|FG008|Overall Study|Adverse Event|7|||
44364438|NCT01132313|79369628|FG009|Overall Study|Adverse Event|2|||
44364439|NCT01132313|79369629|FG010|Overall Study|Adverse Event|0|||
44364440|NCT01132313|79369630|FG011|Overall Study|Adverse Event|0|||
44364441|NCT01132313|79369619|FG000|Overall Study|Protocol Violation|0|||
44364442|NCT01132313|79369620|FG001|Overall Study|Protocol Violation|0|||
44364443|NCT01132313|79369621|FG002|Overall Study|Protocol Violation|0|||
44364444|NCT01132313|79369622|FG003|Overall Study|Protocol Violation|1|||
44364445|NCT01132313|79369623|FG004|Overall Study|Protocol Violation|0|||
44364446|NCT01132313|79369624|FG005|Overall Study|Protocol Violation|0|||
44364447|NCT01132313|79369625|FG006|Overall Study|Protocol Violation|0|||
44364448|NCT01132313|79369626|FG007|Overall Study|Protocol Violation|0|||
44364449|NCT01132313|79369627|FG008|Overall Study|Protocol Violation|0|||
44364450|NCT01132313|79369628|FG009|Overall Study|Protocol Violation|0|||
44364451|NCT01132313|79369629|FG010|Overall Study|Protocol Violation|0|||
44364452|NCT01132313|79369630|FG011|Overall Study|Protocol Violation|0|||
44364453|NCT01132313|79369619|FG000|Overall Study|Lost to Follow-up|0|||
44364454|NCT01132313|79369620|FG001|Overall Study|Lost to Follow-up|0|||
44364455|NCT01132313|79369621|FG002|Overall Study|Lost to Follow-up|1|||
44269159|NCT01648764|79191294|FG001|Overall Study|Progressive Disease|1|||
44269160|NCT01648764|79191295|FG002|Overall Study|Progressive Disease|0|||
44269161|NCT01648764|79191296|FG003|Overall Study|Progressive Disease|0|||
44269162|NCT01648764|79191297|FG004|Overall Study|Progressive Disease|0|||
44269163|NCT01648764|79191298|FG005|Overall Study|Progressive Disease|1|||
44269164|NCT01648764|79191299|FG006|Overall Study|Progressive Disease|1|||
44269165|NCT01648764|79191300|FG007|Overall Study|Progressive Disease|0|||
44269166|NCT01648764|79191301|FG008|Overall Study|Progressive Disease|0|||
44269167|NCT01648764|79191302|FG009|Overall Study|Progressive Disease|2|||
44269168|NCT01648764|79191303|FG010|Overall Study|Progressive Disease|0|||
44269169|NCT01648764|79191304|FG011|Overall Study|Progressive Disease|1|||
44269170|NCT01648764|79191305|FG012|Overall Study|Progressive Disease|2|||
44269171|NCT01648764|79191306|FG013|Overall Study|Progressive Disease|1|||
44269172|NCT01648764|79191293|FG000|Overall Study|Adverse Event|0|||
44269173|NCT01648764|79191294|FG001|Overall Study|Adverse Event|0|||
44269174|NCT01648764|79191295|FG002|Overall Study|Adverse Event|0|||
44269175|NCT01648764|79191296|FG003|Overall Study|Adverse Event|0|||
44269176|NCT01648764|79191297|FG004|Overall Study|Adverse Event|0|||
44269177|NCT01648764|79191298|FG005|Overall Study|Adverse Event|1|||
44269178|NCT01648764|79191299|FG006|Overall Study|Adverse Event|0|||
44269179|NCT01648764|79191300|FG007|Overall Study|Adverse Event|0|||
44269180|NCT01648764|79191301|FG008|Overall Study|Adverse Event|0|||
44269181|NCT01648764|79191302|FG009|Overall Study|Adverse Event|1|||
44269182|NCT01648764|79191303|FG010|Overall Study|Adverse Event|0|||
44269183|NCT01648764|79191304|FG011|Overall Study|Adverse Event|3|||
44364456|NCT01132313|79369622|FG003|Overall Study|Lost to Follow-up|0|||
44364457|NCT01132313|79369623|FG004|Overall Study|Lost to Follow-up|0|||
44364458|NCT01132313|79369624|FG005|Overall Study|Lost to Follow-up|0|||
44364459|NCT01132313|79369625|FG006|Overall Study|Lost to Follow-up|0|||
44364460|NCT01132313|79369626|FG007|Overall Study|Lost to Follow-up|1|||
44364461|NCT01132313|79369627|FG008|Overall Study|Lost to Follow-up|0|||
44364462|NCT01132313|79369628|FG009|Overall Study|Lost to Follow-up|0|||
44364463|NCT01132313|79369629|FG010|Overall Study|Lost to Follow-up|0|||
44364464|NCT01132313|79369630|FG011|Overall Study|Lost to Follow-up|0|||
44364465|NCT01132313|79369619|FG000|Overall Study|Withdrawal by Subject|0|||
44364466|NCT01132313|79369620|FG001|Overall Study|Withdrawal by Subject|0|||
44364467|NCT01132313|79369621|FG002|Overall Study|Withdrawal by Subject|3|||
44364468|NCT01132313|79369622|FG003|Overall Study|Withdrawal by Subject|3|||
44364469|NCT01132313|79369623|FG004|Overall Study|Withdrawal by Subject|6|||
44364470|NCT01132313|79369624|FG005|Overall Study|Withdrawal by Subject|0|||
44364471|NCT01132313|79369625|FG006|Overall Study|Withdrawal by Subject|1|||
44364472|NCT01132313|79369626|FG007|Overall Study|Withdrawal by Subject|0|||
44364473|NCT01132313|79369627|FG008|Overall Study|Withdrawal by Subject|0|||
44269184|NCT01648764|79191305|FG012|Overall Study|Adverse Event|1|||
44269185|NCT01648764|79191306|FG013|Overall Study|Adverse Event|1|||
44269186|NCT01648764|79191293|FG000|Overall Study|Death|0|||
44269187|NCT01648764|79191294|FG001|Overall Study|Death|0|||
44269188|NCT01648764|79191295|FG002|Overall Study|Death|0|||
44269189|NCT01648764|79191296|FG003|Overall Study|Death|0|||
44364474|NCT01132313|79369628|FG009|Overall Study|Withdrawal by Subject|2|||
44364475|NCT01132313|79369629|FG010|Overall Study|Withdrawal by Subject|0|||
44364476|NCT01132313|79369630|FG011|Overall Study|Withdrawal by Subject|0|||
44269190|NCT01648764|79191297|FG004|Overall Study|Death|0|||
44364477|NCT01132313|79369619|FG000|Overall Study|Lack of antiviral response|0|||
44364478|NCT01132313|79369620|FG001|Overall Study|Lack of antiviral response|0|||
44364479|NCT01132313|79369621|FG002|Overall Study|Lack of antiviral response|12|||
44364480|NCT01132313|79369622|FG003|Overall Study|Lack of antiviral response|18|||
44364481|NCT01132313|79369623|FG004|Overall Study|Lack of antiviral response|18|||
44364482|NCT01132313|79369624|FG005|Overall Study|Lack of antiviral response|18|||
44364483|NCT01132313|79369625|FG006|Overall Study|Lack of antiviral response|21|||
44364484|NCT01132313|79369626|FG007|Overall Study|Lack of antiviral response|0|||
44364485|NCT01132313|79369627|FG008|Overall Study|Lack of antiviral response|0|||
44364486|NCT01132313|79369628|FG009|Overall Study|Lack of antiviral response|0|||
44364487|NCT01132313|79369629|FG010|Overall Study|Lack of antiviral response|1|||
44364488|NCT01132313|79369630|FG011|Overall Study|Lack of antiviral response|0|||
44364489|NCT01132313|79369619|FG000|Overall Study|Other reason not defined above|0|||
44364490|NCT01132313|79369620|FG001|Overall Study|Other reason not defined above|0|||
44364491|NCT01132313|79369621|FG002|Overall Study|Other reason not defined above|0|||
44364492|NCT01132313|79369622|FG003|Overall Study|Other reason not defined above|0|||
44364493|NCT01132313|79369623|FG004|Overall Study|Other reason not defined above|0|||
44364494|NCT01132313|79369624|FG005|Overall Study|Other reason not defined above|0|||
44364495|NCT01132313|79369625|FG006|Overall Study|Other reason not defined above|0|||
44364496|NCT01132313|79369626|FG007|Overall Study|Other reason not defined above|1|||
44364497|NCT01132313|79369627|FG008|Overall Study|Other reason not defined above|0|||
44364498|NCT01132313|79369628|FG009|Overall Study|Other reason not defined above|0|||
44364499|NCT01132313|79369629|FG010|Overall Study|Other reason not defined above|0|||
44364500|NCT01132313|79369630|FG011|Overall Study|Other reason not defined above|0|||
44364501|NCT00861757|79369665|FG000|Overall Study|Adverse Event|1|||
44364502|NCT00861757|79369666|FG001|Overall Study|Adverse Event|5|||
44203729|NCT01610037|78999563|FG001|Treatment and Follow up Period|Administrative problems|3|||
44203730|NCT01610037|78999564|FG002|Treatment and Follow up Period|Administrative problems|2|||
44203731|NCT01610037|78999562|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
44203732|NCT01610037|78999563|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
44203733|NCT01610037|78999564|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
44203734|NCT01806051|78999572|FG000|Overall Study|Withdrawal by Subject|6|||
44203735|NCT01837797|78999581|FG000|Period 1|Adverse Event|9|||
44203736|NCT01837797|78999582|FG001|Period 1|Adverse Event|0|||
44203737|NCT01837797|78999583|FG002|Period 1|Adverse Event|0|||
44203738|NCT01837797|78999584|FG003|Period 1|Adverse Event|0|||
44203739|NCT01837797|78999585|FG004|Period 1|Adverse Event|0|||
44203740|NCT01837797|78999581|FG000|Period 1|Withdrawal by Subject|6|||
44203741|NCT01837797|78999582|FG001|Period 1|Withdrawal by Subject|0|||
44203742|NCT01837797|78999583|FG002|Period 1|Withdrawal by Subject|0|||
44203743|NCT01837797|78999584|FG003|Period 1|Withdrawal by Subject|0|||
44203744|NCT01837797|78999585|FG004|Period 1|Withdrawal by Subject|0|||
44203745|NCT01837797|78999581|FG000|Period 1|Administrative reasons|76|||
44203746|NCT01837797|78999582|FG001|Period 1|Administrative reasons|0|||
44203747|NCT01837797|78999583|FG002|Period 1|Administrative reasons|0|||
44203748|NCT01837797|78999584|FG003|Period 1|Administrative reasons|0|||
44203749|NCT01837797|78999585|FG004|Period 1|Administrative reasons|0|||
44203750|NCT01837797|78999581|FG000|Period 1|Withdrawal of consent before treatment|1|||
44203751|NCT01837797|78999582|FG001|Period 1|Withdrawal of consent before treatment|0|||
44203752|NCT01837797|78999583|FG002|Period 1|Withdrawal of consent before treatment|0|||
44203753|NCT01837797|78999584|FG003|Period 1|Withdrawal of consent before treatment|0|||
44203754|NCT01837797|78999585|FG004|Period 1|Withdrawal of consent before treatment|0|||
44203755|NCT01837797|78999581|FG000|Period 1|Other|10|||
44203756|NCT01837797|78999582|FG001|Period 1|Other|0|||
44203757|NCT01837797|78999583|FG002|Period 1|Other|0|||
44203758|NCT01837797|78999584|FG003|Period 1|Other|0|||
44203759|NCT01837797|78999585|FG004|Period 1|Other|0|||
44203760|NCT01837797|78999581|FG000|Period 2|Administrative or other reasons|0|||
44203761|NCT01837797|78999582|FG001|Period 2|Administrative or other reasons|5|||
44203762|NCT01837797|78999583|FG002|Period 2|Administrative or other reasons|2|||
44203763|NCT01837797|78999584|FG003|Period 2|Administrative or other reasons|4|||
44269191|NCT01648764|79191298|FG005|Overall Study|Death|0|||
44269192|NCT01648764|79191299|FG006|Overall Study|Death|1|||
44269193|NCT01648764|79191300|FG007|Overall Study|Death|0|||
44269194|NCT01648764|79191301|FG008|Overall Study|Death|0|||
44269195|NCT01648764|79191302|FG009|Overall Study|Death|0|||
44269196|NCT01648764|79191303|FG010|Overall Study|Death|0|||
44269197|NCT01648764|79191304|FG011|Overall Study|Death|0|||
44269198|NCT01648764|79191305|FG012|Overall Study|Death|0|||
44364503|NCT00861757|79369667|FG002|Overall Study|Adverse Event|7|||
44203764|NCT01837797|78999585|FG004|Period 2|Administrative or other reasons|0|||
44203765|NCT01837797|78999581|FG000|Period 2|Adverse Event|0|||
44203766|NCT01837797|78999582|FG001|Period 2|Adverse Event|0|||
44203767|NCT01837797|78999583|FG002|Period 2|Adverse Event|0|||
44269199|NCT01648764|79191306|FG013|Overall Study|Death|1|||
44364504|NCT00861757|79369668|FG003|Overall Study|Adverse Event|2|||
44364505|NCT00861757|79369665|FG000|Overall Study|Entry Criteria Not Met|1|||
44203768|NCT01837797|78999584|FG003|Period 2|Adverse Event|1|||
44269200|NCT01648764|79191293|FG000|Overall Study|Withdrawal by Subject|0|||
44364506|NCT00861757|79369666|FG001|Overall Study|Entry Criteria Not Met|2|||
44364507|NCT00861757|79369667|FG002|Overall Study|Entry Criteria Not Met|1|||
44364508|NCT00861757|79369668|FG003|Overall Study|Entry Criteria Not Met|1|||
44203769|NCT01837797|78999585|FG004|Period 2|Adverse Event|0|||
44203770|NCT01837797|78999581|FG000|Period 3|Adverse Event|0|||
44203771|NCT01837797|78999582|FG001|Period 3|Adverse Event|0|||
44203772|NCT01837797|78999583|FG002|Period 3|Adverse Event|0|||
44203773|NCT01837797|78999584|FG003|Period 3|Adverse Event|0|||
44203774|NCT01837797|78999585|FG004|Period 3|Adverse Event|1|||
44203775|NCT01837797|78999581|FG000|Period 3|Administrative reasons|0|||
44203776|NCT01837797|78999582|FG001|Period 3|Administrative reasons|0|||
44269201|NCT01648764|79191294|FG001|Overall Study|Withdrawal by Subject|0|||
44269202|NCT01648764|79191295|FG002|Overall Study|Withdrawal by Subject|0|||
44364509|NCT00861757|79369665|FG000|Overall Study|Lack of Efficacy|3|||
44364510|NCT00861757|79369666|FG001|Overall Study|Lack of Efficacy|1|||
44364511|NCT00861757|79369667|FG002|Overall Study|Lack of Efficacy|0|||
44364512|NCT00861757|79369668|FG003|Overall Study|Lack of Efficacy|1|||
44364513|NCT00861757|79369665|FG000|Overall Study|Lost to Follow-up|1|||
44364514|NCT00861757|79369666|FG001|Overall Study|Lost to Follow-up|0|||
44364515|NCT00861757|79369667|FG002|Overall Study|Lost to Follow-up|1|||
44364516|NCT00861757|79369668|FG003|Overall Study|Lost to Follow-up|1|||
44364517|NCT00861757|79369665|FG000|Overall Study|Physician Decision|0|||
44364518|NCT00861757|79369666|FG001|Overall Study|Physician Decision|0|||
44364519|NCT00861757|79369667|FG002|Overall Study|Physician Decision|0|||
44364520|NCT00861757|79369668|FG003|Overall Study|Physician Decision|1|||
44364521|NCT00861757|79369665|FG000|Overall Study|Protocol Violation|2|||
44364522|NCT00861757|79369666|FG001|Overall Study|Protocol Violation|2|||
44364523|NCT00861757|79369667|FG002|Overall Study|Protocol Violation|4|||
44364524|NCT00861757|79369668|FG003|Overall Study|Protocol Violation|1|||
44364525|NCT00861757|79369665|FG000|Overall Study|Withdrawal by Subject|1|||
44364526|NCT00861757|79369666|FG001|Overall Study|Withdrawal by Subject|5|||
44364527|NCT00861757|79369667|FG002|Overall Study|Withdrawal by Subject|5|||
44364528|NCT00861757|79369668|FG003|Overall Study|Withdrawal by Subject|2|||
44364529|NCT01131455|79369685|FG000|Overall Study|Death of PI|6|||
44364530|NCT01131455|79369686|FG001|Overall Study|Death of PI|4|||
44364531|NCT01131455|79369687|FG002|Overall Study|Death of PI|0|||
44364532|NCT01138007|79369698|FG000|Overall Study|Adverse Event|4|||
44364533|NCT01138007|79369699|FG001|Overall Study|Adverse Event|12|||
44364534|NCT01138007|79369700|FG002|Overall Study|Adverse Event|9|||
44364535|NCT01138007|79369698|FG000|Overall Study|Lack of Efficacy|2|||
44364536|NCT01138007|79369699|FG001|Overall Study|Lack of Efficacy|0|||
44364537|NCT01138007|79369700|FG002|Overall Study|Lack of Efficacy|6|||
44364538|NCT01138007|79369698|FG000|Overall Study|Protocol Violation|2|||
44364539|NCT01138007|79369699|FG001|Overall Study|Protocol Violation|3|||
44364540|NCT01138007|79369700|FG002|Overall Study|Protocol Violation|2|||
44364541|NCT01138007|79369698|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
44364542|NCT01138007|79369699|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
44364543|NCT01138007|79369700|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
44364544|NCT01138007|79369698|FG000|Overall Study|Lost to Follow-up|3|||
44364545|NCT01138007|79369699|FG001|Overall Study|Lost to Follow-up|3|||
44364546|NCT01138007|79369700|FG002|Overall Study|Lost to Follow-up|5|||
44364547|NCT01138007|79369698|FG000|Overall Study|Physician Decision|0|||
44364548|NCT01138007|79369699|FG001|Overall Study|Physician Decision|5|||
44364549|NCT01138007|79369700|FG002|Overall Study|Physician Decision|3|||
44364550|NCT01138007|79369698|FG000|Overall Study|Withdrawal by Subject|5|||
44203777|NCT01837797|78999583|FG002|Period 3|Administrative reasons|0|||
44203778|NCT01837797|78999584|FG003|Period 3|Administrative reasons|0|||
44269203|NCT01648764|79191296|FG003|Overall Study|Withdrawal by Subject|0|||
44269204|NCT01648764|79191297|FG004|Overall Study|Withdrawal by Subject|0|||
44269205|NCT01648764|79191298|FG005|Overall Study|Withdrawal by Subject|0|||
44269206|NCT01648764|79191299|FG006|Overall Study|Withdrawal by Subject|2|||
44269207|NCT01648764|79191300|FG007|Overall Study|Withdrawal by Subject|0|||
44269208|NCT01648764|79191301|FG008|Overall Study|Withdrawal by Subject|0|||
44269209|NCT01648764|79191302|FG009|Overall Study|Withdrawal by Subject|0|||
44203779|NCT01837797|78999585|FG004|Period 3|Administrative reasons|20|||
44203780|NCT01837797|78999581|FG000|Period 3|Other|0|||
44269210|NCT01648764|79191303|FG010|Overall Study|Withdrawal by Subject|0|||
44269211|NCT01648764|79191304|FG011|Overall Study|Withdrawal by Subject|0|||
44269212|NCT01648764|79191305|FG012|Overall Study|Withdrawal by Subject|1|||
44364551|NCT01138007|79369699|FG001|Overall Study|Withdrawal by Subject|6|||
44364552|NCT01138007|79369700|FG002|Overall Study|Withdrawal by Subject|15|||
44364553|NCT00865345|79369710|FG000|Overall Study|Withdrawal by Subject|2|||
44364554|NCT01131299|79369714|FG000|Overall Study|Withdrawal by Subject|4|||
44364555|NCT01131299|79369715|FG001|Overall Study|Withdrawal by Subject|7|||
44364556|NCT01130831|79369720|FG000|Overall Study|Withdrawal by Subject|7|||
44364557|NCT01130831|79369720|FG000|Overall Study|Death|4|||
44364558|NCT01130831|79369720|FG000|Overall Study|Information was missing|3|||
44364559|NCT01130597|79369736|FG000|Overall Study|Protocol-specified (High K+)|1|||
44364560|NCT01130597|79369736|FG000|Overall Study|Adverse Event|4|||
44364561|NCT01130597|79369736|FG000|Overall Study|Death|1|||
44364562|NCT01130597|79369736|FG000|Overall Study|Protocol Violation|1|||
44364563|NCT00939003|79369742|FG000|Double-blind Treatment Period|Adverse Event|1|||
44364564|NCT00939003|79369743|FG001|Double-blind Treatment Period|Adverse Event|1|||
44364565|NCT00939003|79369742|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
44364566|NCT00939003|79369743|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
44364567|NCT00939003|79369742|FG000|Double-blind Treatment Period|Pregnancy|0|||
44269213|NCT01648764|79191306|FG013|Overall Study|Withdrawal by Subject|0|||
44269214|NCT01648764|79191293|FG000|Overall Study|Investigator Decision|0|||
44269215|NCT01648764|79191294|FG001|Overall Study|Investigator Decision|0|||
44364568|NCT00939003|79369743|FG001|Double-blind Treatment Period|Pregnancy|1|||
44364569|NCT00939003|79369742|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
44364570|NCT00939003|79369743|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
44364571|NCT00939003|79369742|FG000|Open-label Treatment Period|Adverse Event|4|||
44364572|NCT00939003|79369743|FG001|Open-label Treatment Period|Adverse Event|8|||
44364573|NCT00939003|79369742|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
44269216|NCT01648764|79191295|FG002|Overall Study|Investigator Decision|0|||
44269217|NCT01648764|79191296|FG003|Overall Study|Investigator Decision|0|||
44269218|NCT01648764|79191297|FG004|Overall Study|Investigator Decision|0|||
44269219|NCT01648764|79191298|FG005|Overall Study|Investigator Decision|0|||
44269220|NCT01648764|79191299|FG006|Overall Study|Investigator Decision|1|||
44269221|NCT01648764|79191300|FG007|Overall Study|Investigator Decision|0|||
44269222|NCT01648764|79191301|FG008|Overall Study|Investigator Decision|0|||
44269223|NCT01648764|79191302|FG009|Overall Study|Investigator Decision|0|||
44269224|NCT01648764|79191303|FG010|Overall Study|Investigator Decision|0|||
44269225|NCT01648764|79191304|FG011|Overall Study|Investigator Decision|1|||
44269226|NCT01648764|79191305|FG012|Overall Study|Investigator Decision|0|||
44269227|NCT01648764|79191306|FG013|Overall Study|Investigator Decision|0|||
44364574|NCT00939003|79369743|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
44364575|NCT00939003|79369742|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
44364576|NCT00939003|79369743|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
44364577|NCT00939003|79369742|FG000|Open-label Treatment Period|Pregnancy|1|||
44364578|NCT00939003|79369743|FG001|Open-label Treatment Period|Pregnancy|1|||
44364579|NCT00939003|79369742|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
44364580|NCT00939003|79369743|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
44364581|NCT00939003|79369742|FG000|Open-label Treatment Period|Site Closure|3|||
44364582|NCT00939003|79369743|FG001|Open-label Treatment Period|Site Closure|4|||
44364583|NCT01188668|79369752|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
44364584|NCT01188668|79369752|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
44364585|NCT01188668|79369752|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
44364586|NCT01130051|79369759|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
44364587|NCT01130051|79369760|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
44364588|NCT01130051|79369759|FG000|Washout Period of 14 Days|Protocol Violation|1|||
44364589|NCT01130051|79369760|FG001|Washout Period of 14 Days|Protocol Violation|1|||
44364590|NCT00865189|79369768|FG000|Overall Study|Other|1|||
44364591|NCT00865189|79369769|FG001|Overall Study|Other|2|||
44364592|NCT00865189|79369768|FG000|Overall Study|Death|4|||
44364593|NCT00865189|79369769|FG001|Overall Study|Death|11|||
44364594|NCT00865189|79369768|FG000|Overall Study|Lost to Follow-up|6|||
44364595|NCT00865189|79369769|FG001|Overall Study|Lost to Follow-up|6|||
44203781|NCT01837797|78999582|FG001|Period 3|Other|0|||
44203782|NCT01837797|78999583|FG002|Period 3|Other|0|||
44203783|NCT01837797|78999584|FG003|Period 3|Other|0|||
44203784|NCT01837797|78999585|FG004|Period 3|Other|2|||
44203785|NCT01984424|78999595|FG000|Overall Study|Withdrawal by Subject|3|||
44203786|NCT01984424|78999596|FG001|Overall Study|Withdrawal by Subject|5|||
44203787|NCT01984424|78999595|FG000|Overall Study|Sponsor Decision|0|||
44203788|NCT01984424|78999596|FG001|Overall Study|Sponsor Decision|1|||
44203789|NCT01984424|78999595|FG000|Overall Study|Lost to Follow-up|0|||
44203790|NCT01984424|78999596|FG001|Overall Study|Lost to Follow-up|1|||
44203791|NCT01837719|78999602|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
44203792|NCT01837719|78999602|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
44203793|NCT01984268|78999617|FG000|Overall Study|Study Terminated|15|||
44203794|NCT02031146|78999623|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
44203795|NCT02031146|78999624|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
44203796|NCT02031146|78999625|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
44203797|NCT02031146|78999626|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
44203798|NCT02031146|78999627|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
44203799|NCT02031146|78999628|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
44203800|NCT02031146|78999629|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
44203801|NCT02009384|78999639|FG000|Overall Study|Death|2|||
44203802|NCT01805037|78999643|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
44203803|NCT01805037|78999644|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
44203804|NCT01805037|78999643|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
44203805|NCT01805037|78999644|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
44203806|NCT01805037|78999643|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
44203807|NCT01805037|78999644|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
44203808|NCT01805037|78999643|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
44203809|NCT01805037|78999644|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
44203810|NCT01805037|78999643|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
44203811|NCT01805037|78999644|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
44203812|NCT01805037|78999643|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
44203813|NCT01805037|78999644|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
44203814|NCT01805037|78999643|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
44203815|NCT01805037|78999644|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
44203816|NCT01805037|78999643|FG000|Follow Up (up to 3 Years)|Death|0|||
44203817|NCT01805037|78999644|FG001|Follow Up (up to 3 Years)|Death|2|||
44203818|NCT01805037|78999643|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
44203819|NCT01805037|78999644|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
44203820|NCT01805037|78999643|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
44203821|NCT01805037|78999644|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
44203822|NCT01803711|78999650|FG000|Overall Study|Adverse Event|1|||
44203823|NCT01803711|78999651|FG001|Overall Study|Adverse Event|1|||
44203824|NCT01836549|78999665|FG000|Overall Study|Did not receive study drug|0|||
44203825|NCT01836549|78999666|FG001|Overall Study|Did not receive study drug|0|||
44203826|NCT01836549|78999667|FG002|Overall Study|Did not receive study drug|1|||
44203827|NCT01836549|78999668|FG003|Overall Study|Did not receive study drug|0|||
44203828|NCT01836549|78999669|FG004|Overall Study|Did not receive study drug|0|||
44203829|NCT01836549|78999670|FG005|Overall Study|Did not receive study drug|0|||
44203830|NCT01836549|78999671|FG006|Overall Study|Did not receive study drug|0|||
44203831|NCT01836549|78999665|FG000|Overall Study|Patient declared ineligible|0|||
44203832|NCT01836549|78999666|FG001|Overall Study|Patient declared ineligible|0|||
44203833|NCT01836549|78999667|FG002|Overall Study|Patient declared ineligible|0|||
44203834|NCT01836549|78999668|FG003|Overall Study|Patient declared ineligible|1|||
44203835|NCT01836549|78999669|FG004|Overall Study|Patient declared ineligible|0|||
44203836|NCT01836549|78999670|FG005|Overall Study|Patient declared ineligible|0|||
44203837|NCT01836549|78999671|FG006|Overall Study|Patient declared ineligible|0|||
44203838|NCT01836549|78999665|FG000|Overall Study|Patient inevaluable to start therapy|0|||
44203839|NCT01836549|78999666|FG001|Overall Study|Patient inevaluable to start therapy|0|||
44203840|NCT01836549|78999667|FG002|Overall Study|Patient inevaluable to start therapy|0|||
44203841|NCT01836549|78999668|FG003|Overall Study|Patient inevaluable to start therapy|0|||
44203842|NCT01836549|78999669|FG004|Overall Study|Patient inevaluable to start therapy|0|||
44203843|NCT01836549|78999670|FG005|Overall Study|Patient inevaluable to start therapy|0|||
44203844|NCT01836549|78999671|FG006|Overall Study|Patient inevaluable to start therapy|1|||
44203845|NCT01836471|78999692|FG000|Overall Study|Pregnancy|1|||
44203846|NCT01836471|78999693|FG001|Overall Study|Pregnancy|0|||
44203847|NCT01836471|78999694|FG002|Overall Study|Pregnancy|0|||
44269228|NCT02364336|79191342|FG000|Overall Study|Adverse Event|0|||
44269229|NCT02364336|79191343|FG001|Overall Study|Adverse Event|1|||
44452004|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
44203848|NCT01836471|78999695|FG003|Overall Study|Pregnancy|0|||
44203849|NCT01836471|78999696|FG004|Overall Study|Pregnancy|0|||
44203850|NCT01836471|78999692|FG000|Overall Study|Withdrawal by Subject|3|||
44203851|NCT01836471|78999693|FG001|Overall Study|Withdrawal by Subject|4|||
44203852|NCT01836471|78999694|FG002|Overall Study|Withdrawal by Subject|1|||
44203853|NCT01836471|78999695|FG003|Overall Study|Withdrawal by Subject|0|||
44203854|NCT01836471|78999696|FG004|Overall Study|Withdrawal by Subject|2|||
44203855|NCT01836471|78999692|FG000|Overall Study|Physician Decision|0|||
44203856|NCT01836471|78999693|FG001|Overall Study|Physician Decision|1|||
44269230|NCT02810951|79191574|FG000|Overall Study|Adverse Event|1|||
44364596|NCT00865189|79369768|FG000|Overall Study|Withdrawal by Subject|1|||
44364597|NCT00865189|79369769|FG001|Overall Study|Withdrawal by Subject|0|||
44364598|NCT01182194|79369777|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
44364599|NCT01182194|79369778|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
44364600|NCT01181726|79369786|FG000|First Intervention|Adverse Event|1|||
44364601|NCT01181726|79369787|FG001|First Intervention|Adverse Event|0|||
44364602|NCT01137071|79369793|FG000|Overall Study|Disease Progression|11|||
44364603|NCT01137071|79369793|FG000|Overall Study|Withdrawal by Subject|2|||
44364604|NCT01137071|79369793|FG000|Overall Study|Wrongly Included|1|||
44364605|NCT00860743|79369808|FG000|Overall Study|Withdrawal by Subject|3|||
44364606|NCT00860743|79369809|FG001|Overall Study|Withdrawal by Subject|0|||
44364607|NCT01186796|79369817|FG000|Overall Study|Adverse Event|3|||
44364608|NCT01186796|79369818|FG001|Overall Study|Adverse Event|0|||
44364609|NCT01186796|79369817|FG000|Overall Study|Withdrawal by Subject|1|||
44364610|NCT01186796|79369818|FG001|Overall Study|Withdrawal by Subject|1|||
44364611|NCT01186796|79369817|FG000|Overall Study|Protocol Violation|0|||
44364612|NCT01186796|79369818|FG001|Overall Study|Protocol Violation|1|||
44364613|NCT01136915|79369826|FG000|Overall Study|Lost to Follow-up|2|||
44364614|NCT01136915|79369827|FG001|Overall Study|Lost to Follow-up|0|||
44364615|NCT01136915|79369826|FG000|Overall Study|Exclusion criterion met|0|||
44364616|NCT01136915|79369827|FG001|Overall Study|Exclusion criterion met|1|||
44364617|NCT00940017|79369835|FG000|Overall Study|did not meet entrance criteria|3|||
44364618|NCT00940017|79369835|FG000|Overall Study|Adverse Event|1|||
44364619|NCT01129583|79369841|FG000|Overall Study|Death|1|||
44364620|NCT01129583|79369842|FG001|Overall Study|Death|0|||
44364621|NCT01129583|79369841|FG000|Overall Study|Lost to Follow-up|1|||
44364622|NCT01129583|79369842|FG001|Overall Study|Lost to Follow-up|1|||
44364623|NCT01129583|79369841|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
44364624|NCT01129583|79369842|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
44364625|NCT00848497|79369850|FG000|Overall Study|Screen failure|2|||
44364626|NCT00848497|79369851|FG001|Overall Study|Screen failure|0|||
44364627|NCT00848497|79369850|FG000|Overall Study|Withdrawal by Subject|0|||
44364628|NCT00848497|79369851|FG001|Overall Study|Withdrawal by Subject|1|||
44364629|NCT00857623|79369861|FG000|Overall Study|Adverse Event|5|||
44364630|NCT00857623|79369862|FG001|Overall Study|Adverse Event|2|||
44364631|NCT00857623|79369861|FG000|Overall Study|Study-specific discontinuation criteria|5|||
44364632|NCT00857623|79369862|FG001|Overall Study|Study-specific discontinuation criteria|3|||
44364633|NCT00857623|79369861|FG000|Overall Study|Withdrawal by Subject|2|||
44364634|NCT00857623|79369862|FG001|Overall Study|Withdrawal by Subject|1|||
44364635|NCT00857623|79369861|FG000|Overall Study|Lack of Efficacy|1|||
44269231|NCT02310906|79191670|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
44269232|NCT02310906|79191671|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
44269233|NCT02310906|79191672|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
44269234|NCT02310906|79191673|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
44269235|NCT02310906|79191670|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
44269236|NCT02310906|79191671|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
44269237|NCT02310906|79191672|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
44269238|NCT02310906|79191673|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
44269239|NCT02310906|79191670|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
44269240|NCT02310906|79191671|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
44269241|NCT02310906|79191672|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
44269242|NCT02310906|79191673|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
44269243|NCT02310906|79191670|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
44269244|NCT02310906|79191671|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
44269245|NCT02310906|79191672|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
44269246|NCT02310906|79191673|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
44364636|NCT00857623|79369862|FG001|Overall Study|Lack of Efficacy|1|||
44364637|NCT00857623|79369861|FG000|Overall Study|Severe non-compliance to protocol|1|||
44364638|NCT00857623|79369862|FG001|Overall Study|Severe non-compliance to protocol|1|||
44364639|NCT00857623|79369861|FG000|Overall Study|Intake of prohibited medication|0|||
44364640|NCT00857623|79369862|FG001|Overall Study|Intake of prohibited medication|1|||
44364641|NCT00857623|79369861|FG000|Overall Study|Positive for HEP C|0|||
44364642|NCT00857623|79369862|FG001|Overall Study|Positive for HEP C|1|||
44364643|NCT01185782|79369870|FG000|Overall Study|Adverse Event|0|||
44364644|NCT01185782|79369871|FG001|Overall Study|Adverse Event|1|||
44364645|NCT01185782|79369870|FG000|Overall Study|Protocol Violation|1|||
44364646|NCT01185782|79369871|FG001|Overall Study|Protocol Violation|0|||
44364647|NCT01185782|79369870|FG000|Overall Study|Poor Response to Treatment|3|||
44364648|NCT01185782|79369871|FG001|Overall Study|Poor Response to Treatment|1|||
44364649|NCT01185782|79369870|FG000|Overall Study|Other|2|||
44364650|NCT01185782|79369871|FG001|Overall Study|Other|5|||
44364651|NCT01185782|79369870|FG000|Overall Study|Randomized but not treated|0|||
44364652|NCT01185782|79369871|FG001|Overall Study|Randomized but not treated|4|||
44364653|NCT01129115|79369881|FG000|Overall Study|Adverse Event|1|||
44364654|NCT01129115|79369882|FG001|Overall Study|Adverse Event|2|||
44364655|NCT01129115|79369883|FG002|Overall Study|Adverse Event|3|||
44364656|NCT01129115|79369884|FG003|Overall Study|Adverse Event|3|||
44364657|NCT01129115|79369881|FG000|Overall Study|Withdrawal by Subject|1|||
44364658|NCT01129115|79369882|FG001|Overall Study|Withdrawal by Subject|3|||
44364659|NCT01129115|79369883|FG002|Overall Study|Withdrawal by Subject|1|||
44364660|NCT01129115|79369884|FG003|Overall Study|Withdrawal by Subject|4|||
44364661|NCT01129115|79369881|FG000|Overall Study|Protocol Violation|0|||
44364662|NCT01129115|79369882|FG001|Overall Study|Protocol Violation|2|||
44364663|NCT01129115|79369883|FG002|Overall Study|Protocol Violation|2|||
44364664|NCT01129115|79369884|FG003|Overall Study|Protocol Violation|2|||
44364665|NCT01185704|79369896|FG000|Overall Study|Randomized but not treated|3|||
44364666|NCT01185704|79369897|FG001|Overall Study|Randomized but not treated|3|||
44364667|NCT01185704|79369896|FG000|Overall Study|Lack of ovarian response|5|||
44364668|NCT01185704|79369897|FG001|Overall Study|Lack of ovarian response|1|||
44364669|NCT01185704|79369896|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
44364670|NCT01185704|79369897|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
44364671|NCT01185704|79369896|FG000|Overall Study|Ectopic pregnancy|0|||
44364672|NCT01185704|79369897|FG001|Overall Study|Ectopic pregnancy|1|||
44364673|NCT01128959|79369903|FG000|Lead in Period|Adverse Event|3|||
44364674|NCT01128959|79369903|FG000|Treatment Period|Adverse Event|3|||
44364675|NCT01128959|79369903|FG000|Treatment Period|Withdrawal by Subject|1|||
44364676|NCT00859573|79369911|FG000|Overall Study|Withdrawal by Subject|4|||
44364677|NCT00859573|79369912|FG001|Overall Study|Withdrawal by Subject|1|||
44364678|NCT00859573|79369911|FG000|Overall Study|Physician Decision|1|||
44364679|NCT00859573|79369912|FG001|Overall Study|Physician Decision|1|||
44364680|NCT01136291|79369920|FG000|Overall Study|Lost to Follow-up|1|||
44364681|NCT01136291|79369921|FG001|Overall Study|Lost to Follow-up|1|||
44364682|NCT01185548|79369927|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
44364683|NCT01128569|79369940|FG000|Washout Period 1|Adverse Event|0|||
44364684|NCT01128569|79369941|FG001|Washout Period 1|Adverse Event|0|||
44364685|NCT01128569|79369942|FG002|Washout Period 1|Adverse Event|1|||
44364686|NCT01128569|79369943|FG003|Washout Period 1|Adverse Event|0|||
44364687|NCT01128569|79369944|FG004|Washout Period 1|Adverse Event|0|||
44364688|NCT01128569|79369945|FG005|Washout Period 1|Adverse Event|0|||
44364689|NCT01128569|79369940|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44364690|NCT01128569|79369941|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44364691|NCT01128569|79369942|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44364692|NCT01128569|79369943|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44364693|NCT01128569|79369944|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44364694|NCT01128569|79369945|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44364695|NCT01128413|79369955|FG000|Overall Study|Withdrawal by Subject|1|||
44364696|NCT01128413|79369956|FG001|Overall Study|Withdrawal by Subject|0|||
44364697|NCT01128413|79369955|FG000|Overall Study|NICOM Monitor Problems|2|||
44364698|NCT01128413|79369956|FG001|Overall Study|NICOM Monitor Problems|1|||
44364699|NCT01128413|79369955|FG000|Overall Study|Pt made DNR|1|||
44364700|NCT01128413|79369956|FG001|Overall Study|Pt made DNR|0|||
44364701|NCT01185080|79369965|FG000|Overall Study|Adverse Event|1|||
44364702|NCT01185080|79369966|FG001|Overall Study|Adverse Event|1|||
44364703|NCT01185080|79369967|FG002|Overall Study|Adverse Event|0|||
44364704|NCT01185080|79369965|FG000|Overall Study|Personal reasons|0|||
44364705|NCT01185080|79369966|FG001|Overall Study|Personal reasons|0|||
44364706|NCT01185080|79369967|FG002|Overall Study|Personal reasons|1|||
44364707|NCT01128179|79369977|FG000|Overall Study|Death|1|||
44364708|NCT01128179|79369978|FG001|Overall Study|Death|0|||
44364709|NCT01128179|79369977|FG000|Overall Study|Protocol Violation|1|||
44364710|NCT01128179|79369978|FG001|Overall Study|Protocol Violation|0|||
44364711|NCT01181102|79369986|FG000|Overall Study|Adverse Event|28|||
44364712|NCT01181102|79369987|FG001|Overall Study|Adverse Event|26|||
44364713|NCT01181102|79369986|FG000|Overall Study|Lack of Efficacy|3|||
44364714|NCT01181102|79369987|FG001|Overall Study|Lack of Efficacy|1|||
44364715|NCT01181102|79369986|FG000|Overall Study|Lost to Follow-up|2|||
44364716|NCT01181102|79369987|FG001|Overall Study|Lost to Follow-up|0|||
44364717|NCT01181102|79369986|FG000|Overall Study|Physician Decision|3|||
44364718|NCT01181102|79369987|FG001|Overall Study|Physician Decision|1|||
44364719|NCT01181102|79369986|FG000|Overall Study|Protocol Violation|5|||
44364720|NCT01181102|79369987|FG001|Overall Study|Protocol Violation|6|||
44364721|NCT01181102|79369986|FG000|Overall Study|Withdrawal by Subject|10|||
44364722|NCT01181102|79369987|FG001|Overall Study|Withdrawal by Subject|12|||
44364723|NCT00858637|79369995|FG000|Active Comparison Phase|Adverse Event|14|||
44364724|NCT00858637|79369996|FG001|Active Comparison Phase|Adverse Event|0|||
44364725|NCT00858637|79369997|FG002|Active Comparison Phase|Adverse Event|0|||
44364726|NCT00858637|79369998|FG003|Active Comparison Phase|Adverse Event|9|||
44364727|NCT00858637|79369999|FG004|Active Comparison Phase|Adverse Event|0|||
44364728|NCT00858637|79370000|FG005|Active Comparison Phase|Adverse Event|0|||
44364729|NCT00858637|79369995|FG000|Active Comparison Phase|Death|1|||
44364730|NCT00858637|79369996|FG001|Active Comparison Phase|Death|0|||
44364731|NCT00858637|79369997|FG002|Active Comparison Phase|Death|0|||
44364732|NCT00858637|79369998|FG003|Active Comparison Phase|Death|1|||
44364733|NCT00858637|79369999|FG004|Active Comparison Phase|Death|0|||
44364734|NCT00858637|79370000|FG005|Active Comparison Phase|Death|0|||
44364735|NCT00858637|79369995|FG000|Active Comparison Phase|Physician Decision|1|||
44364736|NCT00858637|79369996|FG001|Active Comparison Phase|Physician Decision|0|||
44364737|NCT00858637|79369997|FG002|Active Comparison Phase|Physician Decision|0|||
44364738|NCT00858637|79369998|FG003|Active Comparison Phase|Physician Decision|1|||
44364739|NCT00858637|79369999|FG004|Active Comparison Phase|Physician Decision|0|||
44364740|NCT00858637|79370000|FG005|Active Comparison Phase|Physician Decision|0|||
44364741|NCT00858637|79369995|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
44364742|NCT00858637|79369996|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
44364743|NCT00858637|79369997|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
44364744|NCT00858637|79369998|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
44364745|NCT00858637|79369999|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
44364746|NCT00858637|79370000|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
44364747|NCT00858637|79369995|FG000|Active Comparison Phase|Other Reasons|1|||
44364748|NCT00858637|79369996|FG001|Active Comparison Phase|Other Reasons|0|||
44364749|NCT00858637|79369997|FG002|Active Comparison Phase|Other Reasons|0|||
44364750|NCT00858637|79369998|FG003|Active Comparison Phase|Other Reasons|1|||
44203857|NCT01836471|78999694|FG002|Overall Study|Physician Decision|0|||
44203858|NCT01836471|78999695|FG003|Overall Study|Physician Decision|0|||
44203859|NCT01836471|78999696|FG004|Overall Study|Physician Decision|0|||
44203860|NCT01836471|78999692|FG000|Overall Study|Lost to Follow-up|0|||
44203861|NCT01836471|78999693|FG001|Overall Study|Lost to Follow-up|0|||
44203862|NCT01836471|78999694|FG002|Overall Study|Lost to Follow-up|0|||
44203863|NCT01836471|78999695|FG003|Overall Study|Lost to Follow-up|1|||
44203864|NCT01836471|78999696|FG004|Overall Study|Lost to Follow-up|1|||
44203865|NCT01836471|78999692|FG000|Overall Study|Adverse Event|6|||
44203866|NCT01836471|78999693|FG001|Overall Study|Adverse Event|3|||
44203867|NCT01836471|78999694|FG002|Overall Study|Adverse Event|1|||
44203868|NCT01836471|78999695|FG003|Overall Study|Adverse Event|1|||
44203869|NCT01836471|78999696|FG004|Overall Study|Adverse Event|2|||
44203870|NCT01836471|78999692|FG000|Overall Study|Non compliance with tx|1|||
44203871|NCT01836471|78999693|FG001|Overall Study|Non compliance with tx|1|||
44203872|NCT01836471|78999694|FG002|Overall Study|Non compliance with tx|0|||
44203873|NCT01836471|78999695|FG003|Overall Study|Non compliance with tx|0|||
44203874|NCT01836471|78999696|FG004|Overall Study|Non compliance with tx|0|||
44203875|NCT02030600|78999711|FG000|Treatment Period 1|Adverse Event|5|||
44203876|NCT02030600|78999712|FG001|Treatment Period 1|Adverse Event|7|||
44203877|NCT02030600|78999711|FG000|Treatment Period 1|Lack of Efficacy|0|||
44203878|NCT02030600|78999712|FG001|Treatment Period 1|Lack of Efficacy|1|||
44203879|NCT02030600|78999711|FG000|Treatment Period 1|Lost to Follow-up|11|||
44203880|NCT02030600|78999712|FG001|Treatment Period 1|Lost to Follow-up|3|||
44203881|NCT02030600|78999711|FG000|Treatment Period 1|Protocol Violation|22|||
44203882|NCT02030600|78999712|FG001|Treatment Period 1|Protocol Violation|17|||
44269247|NCT02340078|79191723|FG000|Overall Study|Protocol Violation|1|||
44269248|NCT02340000|79191739|FG000|Time Period 1|Withdrawal by Subject|6|||
44269249|NCT02340000|79191740|FG001|Time Period 1|Withdrawal by Subject|8|||
44269250|NCT02340000|79191739|FG000|Time Period 1|Lost to Follow-up|6|||
44269251|NCT02340000|79191740|FG001|Time Period 1|Lost to Follow-up|7|||
44269252|NCT02340000|79191739|FG000|Time Period 2|Withdrawal by Subject|9|||
44269253|NCT02340000|79191740|FG001|Time Period 2|Withdrawal by Subject|7|||
44269254|NCT02340000|79191739|FG000|Time Period 2|Lost to Follow-up|10|||
44269255|NCT02340000|79191740|FG001|Time Period 2|Lost to Follow-up|8|||
44364751|NCT00858637|79369999|FG004|Active Comparison Phase|Other Reasons|0|||
44203883|NCT02030600|78999711|FG000|Treatment Period 1|Withdrawal by Subject|13|||
44203884|NCT02030600|78999712|FG001|Treatment Period 1|Withdrawal by Subject|17|||
44203885|NCT02030600|78999711|FG000|Treatment Period 1|Casebook Unsigned|1|||
44203886|NCT02030600|78999712|FG001|Treatment Period 1|Casebook Unsigned|0|||
44203887|NCT02030600|78999711|FG000|Treatment Period 1|Unclassified|1|||
44203888|NCT02030600|78999712|FG001|Treatment Period 1|Unclassified|0|||
44269256|NCT02364180|79191771|FG000|Overall Study|Screen Fail|1|||
44364752|NCT00858637|79370000|FG005|Active Comparison Phase|Other Reasons|0|||
44364753|NCT00858637|79369995|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
44364754|NCT00858637|79369996|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
44364755|NCT00858637|79369997|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
44364756|NCT00858637|79369998|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
44364757|NCT00858637|79369999|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
44364758|NCT00858637|79370000|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
44364759|NCT00858637|79369995|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
44364760|NCT00858637|79369996|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
44364761|NCT00858637|79369997|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
44364762|NCT00858637|79369998|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
44364763|NCT00858637|79369999|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
44364764|NCT00858637|79370000|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
44203889|NCT02030600|78999711|FG000|Treatment Period 2|Adverse Event|4|||
44203890|NCT02030600|78999712|FG001|Treatment Period 2|Adverse Event|4|||
44364765|NCT00858403|79370010|FG000|Overall Study|Withdrawal by Subject|1|||
44364766|NCT00858403|79370010|FG000|Overall Study|Death|3|||
44364767|NCT00858403|79370010|FG000|Overall Study|Disease Progression|1|||
44364768|NCT00858247|79370016|FG000|Baseline Assessment|Withdrawal by Subject|1|||
44364769|NCT00858247|79370017|FG001|Baseline Assessment|Withdrawal by Subject|1|||
44364770|NCT00858247|79370016|FG000|Baseline Assessment|Poor IV access|1|||
44364771|NCT00858247|79370017|FG001|Baseline Assessment|Poor IV access|0|||
44364772|NCT00858247|79370016|FG000|Baseline Assessment|Protocol Violation|0|||
44364773|NCT00858247|79370017|FG001|Baseline Assessment|Protocol Violation|1|||
44364774|NCT00858247|79370016|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
44364775|NCT00858247|79370017|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
44364776|NCT00838435|79370023|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
44364777|NCT00838435|79370023|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
44364778|NCT00838435|79370023|FG000|Part 2 (7 Years)|Adverse Event|2|||
44364779|NCT00838435|79370023|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
44364780|NCT00838435|79370023|FG000|Part 2 (7 Years)|Physician Decision|1|||
44364781|NCT00838435|79370023|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
44364782|NCT00838435|79370023|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
44364783|NCT00838201|79370032|FG000|Overall Study|Investigator decision, or other reasons|2|||
44364784|NCT00838201|79370033|FG001|Overall Study|Investigator decision, or other reasons|3|||
44364785|NCT00838201|79370032|FG000|Overall Study|Noncompliance|0|||
44364786|NCT00838201|79370033|FG001|Overall Study|Noncompliance|1|||
44364787|NCT00838201|79370032|FG000|Overall Study|Administrative decision|1|||
44364788|NCT00838201|79370033|FG001|Overall Study|Administrative decision|2|||
44364789|NCT00838201|79370032|FG000|Overall Study|Disease progression|3|||
44364790|NCT00838201|79370033|FG001|Overall Study|Disease progression|3|||
44364791|NCT00838201|79370032|FG000|Overall Study|Consent withdrawn|16|||
44364792|NCT00838201|79370033|FG001|Overall Study|Consent withdrawn|19|||
44364793|NCT00838201|79370032|FG000|Overall Study|Lost to Follow-up|4|||
44364794|NCT00838201|79370033|FG001|Overall Study|Lost to Follow-up|3|||
44364795|NCT00838201|79370032|FG000|Overall Study|Adverse Event|5|||
44364796|NCT00838201|79370033|FG001|Overall Study|Adverse Event|9|||
44364797|NCT00838201|79370032|FG000|Overall Study|Death|11|||
44364798|NCT00838201|79370033|FG001|Overall Study|Death|13|||
44364799|NCT00837967|79370039|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
44364800|NCT00837967|79370040|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
44364801|NCT02756806|79370046|FG000|Overall Study|Study terminated early|5|||
44364802|NCT00942357|79370052|FG000|Overall Study|Ineligible|37|||
44364803|NCT00942357|79370053|FG001|Overall Study|Ineligible|40|||
44364804|NCT00939783|79370059|FG000|Overall Study|Death|6|||
44364805|NCT00939783|79370059|FG000|Overall Study|Adverse Event|39|||
44364806|NCT00939783|79370059|FG000|Overall Study|Study Terminated by Sponsor|498|||
44364807|NCT00939783|79370059|FG000|Overall Study|Withdrawal by Subject|78|||
44364808|NCT00939783|79370059|FG000|Overall Study|Other|16|||
44364809|NCT00939783|79370059|FG000|Overall Study|Lost to Follow-up|8|||
44203891|NCT02030600|78999711|FG000|Treatment Period 2|Lack of Efficacy|2|||
44203892|NCT02030600|78999712|FG001|Treatment Period 2|Lack of Efficacy|1|||
44203893|NCT02030600|78999711|FG000|Treatment Period 2|Lost to Follow-up|4|||
44203894|NCT02030600|78999712|FG001|Treatment Period 2|Lost to Follow-up|2|||
44364810|NCT00939783|79370059|FG000|Overall Study|Protocol Violation|3|||
44364811|NCT00939783|79370059|FG000|Overall Study|Enrolled but not treated|1|||
44364812|NCT00939627|79370065|FG000|Overall Study|Disease Progression|16|||
44203895|NCT02030600|78999711|FG000|Treatment Period 2|Protocol Violation|1|||
44203896|NCT02030600|78999712|FG001|Treatment Period 2|Protocol Violation|2|||
44203897|NCT02030600|78999711|FG000|Treatment Period 2|Withdrawal by Subject|13|||
44203898|NCT02030600|78999712|FG001|Treatment Period 2|Withdrawal by Subject|9|||
44203899|NCT02030600|78999711|FG000|Treatment Period 2|Unclassified|1|||
44203900|NCT02030600|78999712|FG001|Treatment Period 2|Unclassified|0|||
44203901|NCT01802775|78999722|FG000|Overall Study|Death|0|||
44203902|NCT01802775|78999723|FG001|Overall Study|Death|3|||
44364813|NCT00939627|79370066|FG001|Overall Study|Disease Progression|12|||
44364814|NCT00939627|79370067|FG002|Overall Study|Disease Progression|0|||
44364815|NCT00939627|79370065|FG000|Overall Study|Adverse Event|6|||
44364816|NCT00939627|79370066|FG001|Overall Study|Adverse Event|7|||
44364817|NCT00939627|79370067|FG002|Overall Study|Adverse Event|0|||
44364818|NCT00939627|79370065|FG000|Overall Study|Death|0|||
44364819|NCT00939627|79370066|FG001|Overall Study|Death|2|||
44364820|NCT00939627|79370067|FG002|Overall Study|Death|0|||
44364821|NCT00939627|79370065|FG000|Overall Study|Withdrawal by Subject|2|||
44364822|NCT00939627|79370066|FG001|Overall Study|Withdrawal by Subject|4|||
44203903|NCT01802775|78999722|FG000|Overall Study|Reason not provided|0|||
44203904|NCT01802775|78999723|FG001|Overall Study|Reason not provided|1|||
44203905|NCT01802775|78999722|FG000|Overall Study|Physician Decision|1|||
44203906|NCT01802775|78999723|FG001|Overall Study|Physician Decision|0|||
44203907|NCT01802775|78999722|FG000|Overall Study|Adverse Event|1|||
44203908|NCT01802775|78999723|FG001|Overall Study|Adverse Event|1|||
44203909|NCT01802775|78999722|FG000|Overall Study|Withdrawal by Subject|3|||
44203910|NCT01802775|78999723|FG001|Overall Study|Withdrawal by Subject|5|||
44203911|NCT01802775|78999722|FG000|Overall Study|Lost to Follow-up|1|||
44203912|NCT01802775|78999723|FG001|Overall Study|Lost to Follow-up|2|||
44203913|NCT01802385|78999731|FG000|Overall Study|Death|106|||
44203914|NCT01802385|78999732|FG001|Overall Study|Death|120|||
44203915|NCT01773993|78999738|FG000|Overall Study|No Visit After Treatment|35|||
44203916|NCT01802073|78999744|FG000|Overall Study|Lost to Follow-up|0|||
44203917|NCT01802073|78999745|FG001|Overall Study|Lost to Follow-up|1|||
44203918|NCT01802073|78999744|FG000|Overall Study|Non-compliant|4|||
44203919|NCT01802073|78999745|FG001|Overall Study|Non-compliant|2|||
44203920|NCT01802073|78999744|FG000|Overall Study|Withdrawal by Subject|1|||
44203921|NCT01802073|78999745|FG001|Overall Study|Withdrawal by Subject|1|||
44203922|NCT01802073|78999744|FG000|Overall Study|Physician Decision|0|||
44203923|NCT01802073|78999745|FG001|Overall Study|Physician Decision|7|||
44203924|NCT01607073|78999751|FG000|Overall Study|Adverse Event|1|||
44203925|NCT01773291|78999761|FG000|Overall Study|Protocol Violation|1|||
44203926|NCT01773291|78999762|FG001|Overall Study|Protocol Violation|0|||
44203927|NCT01773291|78999763|FG002|Overall Study|Protocol Violation|0|||
44203928|NCT01773291|78999761|FG000|Overall Study|Withdrawal by Subject|0|||
44203929|NCT01773291|78999762|FG001|Overall Study|Withdrawal by Subject|0|||
44203930|NCT01773291|78999763|FG002|Overall Study|Withdrawal by Subject|1|||
44203931|NCT01801917|78999776|FG000|Period 1 - Randomized|Adverse Event|1|||
44203932|NCT01801917|78999777|FG001|Period 1 - Randomized|Adverse Event|0|||
44203933|NCT01801917|78999778|FG002|Period 1 - Randomized|Adverse Event|1|||
44203934|NCT01801917|78999779|FG003|Period 1 - Randomized|Adverse Event|0|||
44203935|NCT02008916|78999793|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
44203936|NCT02008916|78999794|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
44203937|NCT02008916|78999795|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
44203938|NCT02008916|78999793|FG000|Week 16 - 156|Adverse Event|4|||
44203939|NCT02008916|78999794|FG001|Week 16 - 156|Adverse Event|2|||
44203940|NCT02008916|78999795|FG002|Week 16 - 156|Adverse Event|3|||
44203941|NCT02008916|78999793|FG000|Week 16 - 156|Withdrawal by Subject|7|||
44203942|NCT02008916|78999794|FG001|Week 16 - 156|Withdrawal by Subject|3|||
44203943|NCT02008916|78999795|FG002|Week 16 - 156|Withdrawal by Subject|5|||
44203944|NCT02008916|78999793|FG000|Week 16 - 156|No longer requires treatment|0|||
44203945|NCT02008916|78999794|FG001|Week 16 - 156|No longer requires treatment|1|||
44203946|NCT02008916|78999795|FG002|Week 16 - 156|No longer requires treatment|0|||
44203947|NCT02008916|78999793|FG000|Week 16 - 156|Lost to Follow-up|5|||
44203948|NCT02008916|78999794|FG001|Week 16 - 156|Lost to Follow-up|0|||
44203949|NCT02008916|78999795|FG002|Week 16 - 156|Lost to Follow-up|0|||
44203950|NCT02008916|78999793|FG000|Week 16 - 156|Lack of Efficacy|3|||
44203951|NCT02008916|78999794|FG001|Week 16 - 156|Lack of Efficacy|5|||
44203952|NCT02008916|78999795|FG002|Week 16 - 156|Lack of Efficacy|2|||
44203953|NCT02008916|78999793|FG000|Week 16 - 156|Pregnancy|0|||
44203954|NCT02008916|78999794|FG001|Week 16 - 156|Pregnancy|1|||
44203955|NCT02008916|78999795|FG002|Week 16 - 156|Pregnancy|0|||
44203956|NCT02008916|78999793|FG000|Week 16 - 156|Physician Decision|0|||
44203957|NCT02008916|78999794|FG001|Week 16 - 156|Physician Decision|1|||
44203958|NCT02008916|78999795|FG002|Week 16 - 156|Physician Decision|0|||
44203959|NCT01772823|78999806|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
44203960|NCT01772823|78999807|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
44203961|NCT01772823|78999806|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
44203962|NCT01772823|78999807|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
44203963|NCT01772823|78999806|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
44203964|NCT01772823|78999807|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
44203965|NCT01772823|78999806|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
44203966|NCT01772823|78999807|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
44203967|NCT01772823|78999806|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
44203968|NCT01772823|78999807|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
44203969|NCT01772823|78999806|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
44203970|NCT01772823|78999807|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
44203971|NCT01772823|78999806|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
44203972|NCT01772823|78999807|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
44203973|NCT01772823|78999806|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
44203974|NCT01772823|78999807|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
44203975|NCT01772823|78999806|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
44203976|NCT01772823|78999807|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
44364823|NCT00939627|79370067|FG002|Overall Study|Withdrawal by Subject|0|||
44364824|NCT00939627|79370065|FG000|Overall Study|Other complicating disease|1|||
44364825|NCT00939627|79370066|FG001|Overall Study|Other complicating disease|1|||
44364826|NCT00939627|79370067|FG002|Overall Study|Other complicating disease|0|||
44364827|NCT00939627|79370065|FG000|Overall Study|Not compliant|2|||
44364828|NCT00939627|79370066|FG001|Overall Study|Not compliant|0|||
44364829|NCT00939627|79370067|FG002|Overall Study|Not compliant|0|||
44364830|NCT00939627|79370065|FG000|Overall Study|No off-tx reason given|0|||
44364831|NCT00939627|79370066|FG001|Overall Study|No off-tx reason given|2|||
44364832|NCT00939627|79370067|FG002|Overall Study|No off-tx reason given|0|||
44203977|NCT01772823|78999806|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
44203978|NCT01772823|78999807|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
44203979|NCT01772823|78999806|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
44203980|NCT01772823|78999807|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
44203981|NCT01772823|78999806|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
44203982|NCT01772823|78999807|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
44203983|NCT01772823|78999806|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
44203984|NCT01772823|78999807|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
44203985|NCT01772823|78999806|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
44203986|NCT01772823|78999807|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
44203987|NCT01772823|78999806|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
44203988|NCT01772823|78999807|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
44203989|NCT01772823|78999806|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
44203990|NCT01772823|78999807|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
44203991|NCT02029976|78999820|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
44203992|NCT02029976|78999821|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
44203993|NCT02029976|78999820|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
44203994|NCT02029976|78999821|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
44203995|NCT02029976|78999820|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
44203996|NCT02029976|78999821|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
44203997|NCT02029976|78999820|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
44203998|NCT02029976|78999821|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
44203999|NCT01983254|78999829|FG000|Overall Study|Death|6|||
44204000|NCT01983254|78999830|FG001|Overall Study|Death|6|||
44204001|NCT01983254|78999829|FG000|Overall Study|Lost to Follow-up|17|||
44204002|NCT01983254|78999830|FG001|Overall Study|Lost to Follow-up|16|||
44204003|NCT01983254|78999829|FG000|Overall Study|too ill|11|||
44204004|NCT01983254|78999830|FG001|Overall Study|too ill|8|||
44204005|NCT01771809|78999838|FG000|Overall Study|Adverse Event|4|||
44204006|NCT01771809|78999839|FG001|Overall Study|Adverse Event|12|||
44204007|NCT01771809|78999838|FG000|Overall Study|Protocol Violation|0|||
44204008|NCT01771809|78999839|FG001|Overall Study|Protocol Violation|1|||
44204009|NCT01771809|78999838|FG000|Overall Study|Withdrawal by Subject|34|||
44204010|NCT01771809|78999839|FG001|Overall Study|Withdrawal by Subject|42|||
44204011|NCT01771809|78999838|FG000|Overall Study|Lost to Follow-up|1|||
44204012|NCT01771809|78999839|FG001|Overall Study|Lost to Follow-up|3|||
44204013|NCT01771809|78999838|FG000|Overall Study|Other (Insufficient clinical response)|22|||
44204014|NCT01771809|78999839|FG001|Overall Study|Other (Insufficient clinical response)|20|||
44204015|NCT01771809|78999838|FG000|Overall Study|Death|1|||
44204016|NCT01771809|78999839|FG001|Overall Study|Death|0|||
44204017|NCT01771809|78999838|FG000|Overall Study|Other (other)|9|||
44204018|NCT01771809|78999839|FG001|Overall Study|Other (other)|5|||
44204019|NCT01771731|78999847|FG000|Overall Study|Physician Decision|1|||
44204020|NCT01771731|78999848|FG001|Overall Study|Physician Decision|0|||
44204021|NCT01771731|78999847|FG000|Overall Study|Protocol Violation|0|||
44204022|NCT01771731|78999848|FG001|Overall Study|Protocol Violation|1|||
44204023|NCT01771731|78999847|FG000|Overall Study|Adverse event: Pain Crisis|1|||
44204024|NCT01771731|78999848|FG001|Overall Study|Adverse event: Pain Crisis|1|||
44204025|NCT01982942|78999856|FG000|Overall Study|Adverse Event|10|||
44204026|NCT01982942|78999857|FG001|Overall Study|Adverse Event|5|||
44204027|NCT01982942|78999856|FG000|Overall Study|Lost to Follow-up|4|||
44204028|NCT01982942|78999857|FG001|Overall Study|Lost to Follow-up|3|||
44204029|NCT01982942|78999856|FG000|Overall Study|Multiple sclerosis progression|3|||
44204030|NCT01982942|78999857|FG001|Overall Study|Multiple sclerosis progression|2|||
44204031|NCT01982942|78999856|FG000|Overall Study|Wanted to try therapy not permitted|1|||
44204032|NCT01982942|78999857|FG001|Overall Study|Wanted to try therapy not permitted|0|||
44204033|NCT01982942|78999856|FG000|Overall Study|Subject declined future visits|0|||
44204034|NCT01982942|78999857|FG001|Overall Study|Subject declined future visits|1|||
44204035|NCT01982942|78999856|FG000|Overall Study|Left geographical area|2|||
44204036|NCT01982942|78999857|FG001|Overall Study|Left geographical area|0|||
44364833|NCT00937833|79370075|FG000|Overall Study|Protocol Violation|1|||
44364834|NCT00937833|79370076|FG001|Overall Study|Protocol Violation|2|||
44364835|NCT00937833|79370075|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
44204037|NCT01982942|78999856|FG000|Overall Study|Too many pills|1|||
44204038|NCT01982942|78999857|FG001|Overall Study|Too many pills|0|||
44204039|NCT01982942|78999856|FG000|Overall Study|MS Relapse|0|||
44204040|NCT01982942|78999857|FG001|Overall Study|MS Relapse|1|||
44204041|NCT01982942|78999856|FG000|Overall Study|Chose to join a stem cell trial|0|||
44204042|NCT01982942|78999857|FG001|Overall Study|Chose to join a stem cell trial|1|||
44204043|NCT01982942|78999856|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
44364836|NCT00937833|79370076|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
44364837|NCT00937833|79370075|FG000|Overall Study|Lost to Follow-up|10|||
44364838|NCT00937833|79370076|FG001|Overall Study|Lost to Follow-up|8|||
44364839|NCT00937833|79370075|FG000|Overall Study|Withdrawal by Subject|4|||
44364840|NCT00937833|79370076|FG001|Overall Study|Withdrawal by Subject|6|||
44364841|NCT01135511|79370091|FG000|Overall Study|Adverse Event|0|||
44364842|NCT01135511|79370092|FG001|Overall Study|Adverse Event|1|||
44364843|NCT01135511|79370093|FG002|Overall Study|Adverse Event|2|||
44364844|NCT01135511|79370094|FG003|Overall Study|Adverse Event|0|||
44364845|NCT01135511|79370095|FG004|Overall Study|Adverse Event|0|||
44364846|NCT01135511|79370096|FG005|Overall Study|Adverse Event|1|||
44364847|NCT01135511|79370097|FG006|Overall Study|Adverse Event|0|||
44364848|NCT01135511|79370098|FG007|Overall Study|Adverse Event|1|||
44364849|NCT01135511|79370099|FG008|Overall Study|Adverse Event|0|||
44364850|NCT01135511|79370091|FG000|Overall Study|Lack of Efficacy|0|||
44364851|NCT01135511|79370092|FG001|Overall Study|Lack of Efficacy|1|||
44364852|NCT01135511|79370093|FG002|Overall Study|Lack of Efficacy|1|||
44364853|NCT01135511|79370094|FG003|Overall Study|Lack of Efficacy|2|||
44364854|NCT01135511|79370095|FG004|Overall Study|Lack of Efficacy|0|||
44364855|NCT01135511|79370096|FG005|Overall Study|Lack of Efficacy|0|||
44364856|NCT01135511|79370097|FG006|Overall Study|Lack of Efficacy|0|||
44364857|NCT01135511|79370098|FG007|Overall Study|Lack of Efficacy|0|||
44364858|NCT01135511|79370099|FG008|Overall Study|Lack of Efficacy|0|||
44364859|NCT01135511|79370091|FG000|Overall Study|Protocol Violation|0|||
44364860|NCT01135511|79370092|FG001|Overall Study|Protocol Violation|0|||
44364861|NCT01135511|79370093|FG002|Overall Study|Protocol Violation|3|||
44364862|NCT01135511|79370094|FG003|Overall Study|Protocol Violation|0|||
44364863|NCT01135511|79370095|FG004|Overall Study|Protocol Violation|0|||
44364864|NCT01135511|79370096|FG005|Overall Study|Protocol Violation|0|||
44364865|NCT01135511|79370097|FG006|Overall Study|Protocol Violation|0|||
44364866|NCT01135511|79370098|FG007|Overall Study|Protocol Violation|0|||
44364867|NCT01135511|79370099|FG008|Overall Study|Protocol Violation|0|||
44364868|NCT01135511|79370091|FG000|Overall Study|Pregnancy|0|||
44204044|NCT01982942|78999857|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
44204045|NCT01769469|78999863|FG000|Overall Study|Consent Withdrawn|5|||
44204046|NCT01769469|78999863|FG000|Overall Study|Moved Out Of Area|3|||
44204047|NCT01769469|78999863|FG000|Overall Study|Lost to Follow-up|17|||
44204048|NCT01769469|78999863|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
44204049|NCT01769469|78999863|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
44204050|NCT02008526|78999872|FG000|Overall Study|Death|0|||
44204051|NCT02008526|78999873|FG001|Overall Study|Death|2|||
44204052|NCT02008526|78999874|FG002|Overall Study|Death|1|||
44204053|NCT02008526|78999872|FG000|Overall Study|Withdrawal by Subject|3|||
44204054|NCT02008526|78999873|FG001|Overall Study|Withdrawal by Subject|3|||
44204055|NCT02008526|78999874|FG002|Overall Study|Withdrawal by Subject|2|||
44204056|NCT02008526|78999872|FG000|Overall Study|Lost to Follow-up|5|||
44204057|NCT02008526|78999873|FG001|Overall Study|Lost to Follow-up|9|||
44204058|NCT02008526|78999874|FG002|Overall Study|Lost to Follow-up|6|||
44204059|NCT01769391|78999884|FG000|Overall Study|Death|10|||
44204060|NCT01769391|78999885|FG001|Overall Study|Death|1|||
44204061|NCT01769391|78999884|FG000|Overall Study|Adverse Event|0|||
44204062|NCT01769391|78999885|FG001|Overall Study|Adverse Event|3|||
44204063|NCT01769391|78999884|FG000|Overall Study|Progressive Disease|1|||
44204064|NCT01769391|78999885|FG001|Overall Study|Progressive Disease|2|||
44204065|NCT01769391|78999884|FG000|Overall Study|Withdrawal by Subject|4|||
44204066|NCT01769391|78999885|FG001|Overall Study|Withdrawal by Subject|3|||
44204067|NCT01769391|78999884|FG000|Overall Study|Investigator Decision|2|||
44204068|NCT01769391|78999885|FG001|Overall Study|Investigator Decision|0|||
44204069|NCT01800903|78999897|FG000|Second Test Period|unable to catheterise|1|||
44204070|NCT01800903|78999898|FG001|Second Test Period|unable to catheterise|0|||
44204071|NCT01800903|78999899|FG002|Second Test Period|unable to catheterise|0|||
44204072|NCT01800903|78999900|FG003|Second Test Period|unable to catheterise|0|||
44364869|NCT01135511|79370092|FG001|Overall Study|Pregnancy|0|||
44364870|NCT01135511|79370093|FG002|Overall Study|Pregnancy|0|||
44364871|NCT01135511|79370094|FG003|Overall Study|Pregnancy|1|||
44364872|NCT01135511|79370095|FG004|Overall Study|Pregnancy|0|||
44364873|NCT01135511|79370096|FG005|Overall Study|Pregnancy|0|||
44364874|NCT01135511|79370097|FG006|Overall Study|Pregnancy|0|||
44364875|NCT01135511|79370098|FG007|Overall Study|Pregnancy|0|||
44364876|NCT01135511|79370099|FG008|Overall Study|Pregnancy|0|||
44364877|NCT01135511|79370091|FG000|Overall Study|could not visit the clinic|0|||
44364878|NCT01135511|79370092|FG001|Overall Study|could not visit the clinic|1|||
44204073|NCT01800903|78999901|FG004|Second Test Period|unable to catheterise|0|||
44204074|NCT01800903|78999902|FG005|Second Test Period|unable to catheterise|0|||
44204075|NCT01767987|78999910|FG000|Overall Study|Physician Decision|4|||
44204076|NCT01767987|78999911|FG001|Overall Study|Physician Decision|1|||
44204077|NCT01800201|78999919|FG000|Overall Study|Withdrawal by Subject|2|||
44204078|NCT01800201|78999920|FG001|Overall Study|Withdrawal by Subject|0|||
44204079|NCT01800201|78999919|FG000|Overall Study|patient privacy concerns|1|||
44204080|NCT01800201|78999920|FG001|Overall Study|patient privacy concerns|1|||
44204081|NCT01800201|78999919|FG000|Overall Study|did not want to use device|0|||
44204082|NCT01800201|78999920|FG001|Overall Study|did not want to use device|1|||
44204083|NCT01800201|78999919|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
44204084|NCT01800201|78999920|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
44204085|NCT01767909|78999929|FG000|Overall Study|Withdrawal by Subject|4|||
44269257|NCT02310750|79192400|FG000|HP Period 1|Lost to Follow-up|0|||
44269258|NCT02310750|79192401|FG001|HP Period 1|Lost to Follow-up|0|||
44269259|NCT02310750|79192402|FG002|HP Period 1|Lost to Follow-up|0|||
44269260|NCT02310750|79192403|FG003|HP Period 1|Lost to Follow-up|0|||
44269261|NCT02310750|79192404|FG004|HP Period 1|Lost to Follow-up|0|||
44269262|NCT02310750|79192405|FG005|HP Period 1|Lost to Follow-up|0|||
44269263|NCT02310750|79192406|FG006|HP Period 1|Lost to Follow-up|1|||
44269264|NCT02310750|79192407|FG007|HP Period 1|Lost to Follow-up|0|||
44269265|NCT02310750|79192408|FG008|HP Period 1|Lost to Follow-up|0|||
44269266|NCT02310750|79192409|FG009|HP Period 1|Lost to Follow-up|0|||
44269267|NCT02310750|79192410|FG010|HP Period 1|Lost to Follow-up|0|||
44269268|NCT02310750|79192411|FG011|HP Period 1|Lost to Follow-up|0|||
44269269|NCT02310750|79192412|FG012|HP Period 1|Lost to Follow-up|0|||
44269270|NCT02310750|79192413|FG013|HP Period 1|Lost to Follow-up|0|||
44269271|NCT02310750|79192414|FG014|HP Period 1|Lost to Follow-up|0|||
44269272|NCT02310750|79192415|FG015|HP Period 1|Lost to Follow-up|0|||
44269273|NCT02310750|79192400|FG000|HP Period 1|Withdrawal by Subject|1|||
44269274|NCT02310750|79192401|FG001|HP Period 1|Withdrawal by Subject|0|||
44269275|NCT02310750|79192402|FG002|HP Period 1|Withdrawal by Subject|0|||
44269276|NCT02310750|79192403|FG003|HP Period 1|Withdrawal by Subject|1|||
44269277|NCT02310750|79192404|FG004|HP Period 1|Withdrawal by Subject|0|||
44269278|NCT02310750|79192405|FG005|HP Period 1|Withdrawal by Subject|0|||
44269279|NCT02310750|79192406|FG006|HP Period 1|Withdrawal by Subject|0|||
44269280|NCT02310750|79192407|FG007|HP Period 1|Withdrawal by Subject|0|||
44269281|NCT02310750|79192408|FG008|HP Period 1|Withdrawal by Subject|0|||
44269282|NCT02310750|79192409|FG009|HP Period 1|Withdrawal by Subject|0|||
44269283|NCT02310750|79192410|FG010|HP Period 1|Withdrawal by Subject|0|||
44269284|NCT02310750|79192411|FG011|HP Period 1|Withdrawal by Subject|0|||
44269285|NCT02310750|79192412|FG012|HP Period 1|Withdrawal by Subject|0|||
44269286|NCT02310750|79192413|FG013|HP Period 1|Withdrawal by Subject|0|||
44269287|NCT02310750|79192414|FG014|HP Period 1|Withdrawal by Subject|0|||
44269288|NCT02310750|79192415|FG015|HP Period 1|Withdrawal by Subject|0|||
44269289|NCT02310750|79192400|FG000|HP Washout 1|Lost to Follow-up|0|||
44269290|NCT02310750|79192401|FG001|HP Washout 1|Lost to Follow-up|0|||
44269291|NCT02310750|79192402|FG002|HP Washout 1|Lost to Follow-up|1|||
44269292|NCT02310750|79192403|FG003|HP Washout 1|Lost to Follow-up|1|||
44269293|NCT02310750|79192404|FG004|HP Washout 1|Lost to Follow-up|2|||
44269294|NCT02310750|79192405|FG005|HP Washout 1|Lost to Follow-up|2|||
44269295|NCT02310750|79192406|FG006|HP Washout 1|Lost to Follow-up|3|||
44269296|NCT02310750|79192407|FG007|HP Washout 1|Lost to Follow-up|0|||
44269297|NCT02310750|79192408|FG008|HP Washout 1|Lost to Follow-up|0|||
44269298|NCT02310750|79192409|FG009|HP Washout 1|Lost to Follow-up|0|||
44269299|NCT02310750|79192410|FG010|HP Washout 1|Lost to Follow-up|0|||
44269300|NCT02310750|79192411|FG011|HP Washout 1|Lost to Follow-up|0|||
44269301|NCT02310750|79192412|FG012|HP Washout 1|Lost to Follow-up|0|||
44364879|NCT01135511|79370093|FG002|Overall Study|could not visit the clinic|2|||
44269302|NCT02310750|79192413|FG013|HP Washout 1|Lost to Follow-up|0|||
44269303|NCT02310750|79192414|FG014|HP Washout 1|Lost to Follow-up|0|||
44269304|NCT02310750|79192415|FG015|HP Washout 1|Lost to Follow-up|0|||
44204086|NCT01767909|78999930|FG001|Overall Study|Withdrawal by Subject|7|||
44204087|NCT01767909|78999929|FG000|Overall Study|Adverse Event|3|||
44204088|NCT01767909|78999930|FG001|Overall Study|Adverse Event|1|||
44204089|NCT01767909|78999929|FG000|Overall Study|Withdrawal by Study Partner|3|||
44204090|NCT01767909|78999930|FG001|Overall Study|Withdrawal by Study Partner|1|||
44204091|NCT01767909|78999929|FG000|Overall Study|Non-Compliance|2|||
44269305|NCT02310750|79192400|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44204092|NCT01767909|78999930|FG001|Overall Study|Non-Compliance|0|||
44204093|NCT01767909|78999929|FG000|Overall Study|Perceived Lack of Efficacy|1|||
44204094|NCT01767909|78999930|FG001|Overall Study|Perceived Lack of Efficacy|0|||
44204095|NCT01767909|78999929|FG000|Overall Study|Investigator Recommendation|0|||
44269306|NCT02310750|79192401|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269307|NCT02310750|79192402|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269308|NCT02310750|79192403|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
44269309|NCT02310750|79192404|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269310|NCT02310750|79192405|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
44364880|NCT01135511|79370094|FG003|Overall Study|could not visit the clinic|0|||
44364881|NCT01135511|79370095|FG004|Overall Study|could not visit the clinic|0|||
44364882|NCT01135511|79370096|FG005|Overall Study|could not visit the clinic|0|||
44364883|NCT01135511|79370097|FG006|Overall Study|could not visit the clinic|0|||
44364884|NCT01135511|79370098|FG007|Overall Study|could not visit the clinic|0|||
44364885|NCT01135511|79370099|FG008|Overall Study|could not visit the clinic|0|||
44364886|NCT01135511|79370091|FG000|Overall Study|noncompliance with study drug taken|0|||
44364887|NCT01135511|79370092|FG001|Overall Study|noncompliance with study drug taken|0|||
44364888|NCT01135511|79370093|FG002|Overall Study|noncompliance with study drug taken|0|||
44364889|NCT01135511|79370094|FG003|Overall Study|noncompliance with study drug taken|0|||
44364890|NCT01135511|79370095|FG004|Overall Study|noncompliance with study drug taken|1|||
44364891|NCT01135511|79370096|FG005|Overall Study|noncompliance with study drug taken|0|||
44364892|NCT01135511|79370097|FG006|Overall Study|noncompliance with study drug taken|0|||
44364893|NCT01135511|79370098|FG007|Overall Study|noncompliance with study drug taken|0|||
44364894|NCT01135511|79370099|FG008|Overall Study|noncompliance with study drug taken|0|||
44364895|NCT01135511|79370091|FG000|Overall Study|Withdrawal by Subject|0|||
44364896|NCT01135511|79370092|FG001|Overall Study|Withdrawal by Subject|0|||
44364897|NCT01135511|79370093|FG002|Overall Study|Withdrawal by Subject|0|||
44364898|NCT01135511|79370094|FG003|Overall Study|Withdrawal by Subject|0|||
44364899|NCT01135511|79370095|FG004|Overall Study|Withdrawal by Subject|0|||
44364900|NCT01135511|79370096|FG005|Overall Study|Withdrawal by Subject|0|||
44364901|NCT01135511|79370097|FG006|Overall Study|Withdrawal by Subject|1|||
44364902|NCT01135511|79370098|FG007|Overall Study|Withdrawal by Subject|0|||
44364903|NCT01135511|79370099|FG008|Overall Study|Withdrawal by Subject|1|||
44364904|NCT01184846|79370128|FG000|Overall Study|Adverse Event|2|||
44364905|NCT01184846|79370128|FG000|Overall Study|Insufficient response|1|||
44364906|NCT01180400|79370136|FG000|Overall Study|Withdrawal by Subject|5|||
44364907|NCT01180400|79370137|FG001|Overall Study|Withdrawal by Subject|6|||
44364908|NCT01180400|79370136|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44364909|NCT01180400|79370137|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
44204096|NCT01767909|78999930|FG001|Overall Study|Investigator Recommendation|1|||
44204097|NCT01767909|78999929|FG000|Overall Study|Lost to Follow-up|0|||
44204098|NCT01767909|78999930|FG001|Overall Study|Lost to Follow-up|1|||
44204099|NCT01767909|78999929|FG000|Overall Study|LP uncessessful|0|||
44204100|NCT01767909|78999930|FG001|Overall Study|LP uncessessful|1|||
44204101|NCT02029274|78999942|FG000|Overall Study|Adverse Event|1|||
44204102|NCT02029274|78999943|FG001|Overall Study|Adverse Event|0|||
44204103|NCT02029274|78999944|FG002|Overall Study|Adverse Event|2|||
44204104|NCT02029274|78999945|FG003|Overall Study|Adverse Event|2|||
44204105|NCT02008370|78999959|FG000|Overall Study|Lost to Follow-up|7|||
44204106|NCT01981616|78999965|FG000|Overall Study|Adverse Event|0|||
44204107|NCT01981616|78999966|FG001|Overall Study|Adverse Event|1|||
44204108|NCT01981616|78999965|FG000|Overall Study|Protocol Violation|1|||
44204109|NCT01981616|78999966|FG001|Overall Study|Protocol Violation|0|||
44204110|NCT02104817|78999974|FG000|Overall Study|Death|363|||
44204111|NCT02104817|78999975|FG001|Overall Study|Death|330|||
44204112|NCT02104817|78999974|FG000|Overall Study|Lost to Follow-up|3|||
44204113|NCT02104817|78999975|FG001|Overall Study|Lost to Follow-up|2|||
44204114|NCT02104817|78999974|FG000|Overall Study|Protocol Violation|0|||
44204115|NCT02104817|78999975|FG001|Overall Study|Protocol Violation|1|||
44204116|NCT02104817|78999974|FG000|Overall Study|Study terminated by sponsor|5854|||
44204117|NCT02104817|78999975|FG001|Overall Study|Study terminated by sponsor|5901|||
44204118|NCT02104817|78999974|FG000|Overall Study|Withdrawal by Subject|111|||
44204119|NCT02104817|78999975|FG001|Overall Study|Withdrawal by Subject|78|||
44204120|NCT02104817|78999974|FG000|Overall Study|Other reasons|128|||
44364910|NCT01180400|79370136|FG000|Overall Study|Adverse Event|12|||
44364911|NCT01180400|79370137|FG001|Overall Study|Adverse Event|10|||
44364912|NCT01180400|79370136|FG000|Overall Study|Severe non-compliance to protocol|1|||
44452005|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
44452006|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
44204121|NCT02104817|78999975|FG001|Overall Study|Other reasons|135|||
44204122|NCT01962103|78999990|FG000|Phase 1|Adverse Event|4|||
44204123|NCT01962103|78999991|FG001|Phase 1|Adverse Event|0|||
44204124|NCT01962103|78999992|FG002|Phase 1|Adverse Event|2|||
44204125|NCT01962103|78999993|FG003|Phase 1|Adverse Event|1|||
44204126|NCT01962103|78999994|FG004|Phase 1|Adverse Event|2|||
44204127|NCT01962103|78999995|FG005|Phase 1|Adverse Event|2|||
44204128|NCT01962103|78999996|FG006|Phase 1|Adverse Event|0|||
44204129|NCT01962103|78999997|FG007|Phase 1|Adverse Event|0|||
44204130|NCT01962103|78999998|FG008|Phase 1|Adverse Event|0|||
44204131|NCT01962103|78999990|FG000|Phase 1|Progressive Disease|8|||
44204132|NCT01962103|78999991|FG001|Phase 1|Progressive Disease|6|||
44204133|NCT01962103|78999992|FG002|Phase 1|Progressive Disease|8|||
44364913|NCT01180400|79370137|FG001|Overall Study|Severe non-compliance to protocol|2|||
44364914|NCT01180400|79370136|FG000|Overall Study|Condition under investigation worsened|2|||
44364915|NCT01180400|79370137|FG001|Overall Study|Condition under investigation worsened|1|||
44364916|NCT01180400|79370136|FG000|Overall Study|Lack of Efficacy|2|||
44364917|NCT01180400|79370137|FG001|Overall Study|Lack of Efficacy|0|||
44364918|NCT01180400|79370136|FG000|Overall Study|Study-specific withdrawal criteria|1|||
44364919|NCT01180400|79370137|FG001|Overall Study|Study-specific withdrawal criteria|2|||
44364920|NCT01180400|79370136|FG000|Overall Study|Lost to Follow-up|2|||
44364921|NCT01180400|79370137|FG001|Overall Study|Lost to Follow-up|3|||
44364922|NCT01180400|79370136|FG000|Overall Study|Other|0|||
44364923|NCT01180400|79370137|FG001|Overall Study|Other|1|||
44364924|NCT01180244|79370145|FG000|Overall Study|Lack of Efficacy|0|||
44364925|NCT01180244|79370146|FG001|Overall Study|Lack of Efficacy|7|||
44364926|NCT01180244|79370145|FG000|Overall Study|Physician Decision|3|||
44364927|NCT01180244|79370146|FG001|Overall Study|Physician Decision|0|||
44364928|NCT01180244|79370145|FG000|Overall Study|Adverse Event|1|||
44364929|NCT01180244|79370146|FG001|Overall Study|Adverse Event|0|||
44364930|NCT01180244|79370145|FG000|Overall Study|Withdrawal by Subject|0|||
44364931|NCT01180244|79370146|FG001|Overall Study|Withdrawal by Subject|1|||
44364932|NCT01180244|79370145|FG000|Overall Study|Protocol Violation|1|||
44364933|NCT01180244|79370146|FG001|Overall Study|Protocol Violation|0|||
44364934|NCT01180244|79370145|FG000|Overall Study|Lost to Follow-up|1|||
44364935|NCT01180244|79370146|FG001|Overall Study|Lost to Follow-up|0|||
44364936|NCT01191086|79370152|FG000|Overall Study|Adverse Event|20|||
44364937|NCT01191086|79370152|FG000|Overall Study|Lack of Efficacy|10|||
44364938|NCT01191086|79370152|FG000|Overall Study|Lost to Follow-up|4|||
44364939|NCT01191086|79370152|FG000|Overall Study|Physician Decision|2|||
44364940|NCT01191086|79370152|FG000|Overall Study|Withdrawal by Subject|24|||
44364941|NCT01191086|79370152|FG000|Overall Study|Discontinuation criterion met|1|||
44364942|NCT01191086|79370152|FG000|Overall Study|Other|1|||
44364943|NCT01088412|79370159|FG000|Overall Study|Adverse Event|38|||
44364944|NCT01088412|79370160|FG001|Overall Study|Adverse Event|0|||
44364945|NCT01088412|79370161|FG002|Overall Study|Adverse Event|0|||
44364946|NCT01088412|79370159|FG000|Overall Study|Death|42|||
44364947|NCT01088412|79370160|FG001|Overall Study|Death|6|||
44364948|NCT01088412|79370161|FG002|Overall Study|Death|0|||
44364949|NCT01088412|79370159|FG000|Overall Study|Other Reason per Case Report Form|2089|||
44364950|NCT01088412|79370160|FG001|Overall Study|Other Reason per Case Report Form|103|||
44364951|NCT01088412|79370161|FG002|Overall Study|Other Reason per Case Report Form|9|||
44364952|NCT01088412|79370159|FG000|Overall Study|Withdrawal by Subject|1761|||
44364953|NCT01088412|79370160|FG001|Overall Study|Withdrawal by Subject|25|||
44364954|NCT01088412|79370161|FG002|Overall Study|Withdrawal by Subject|1|||
44364955|NCT01088412|79370159|FG000|Overall Study|Received Another GH Product|79|||
44364956|NCT01088412|79370160|FG001|Overall Study|Received Another GH Product|0|||
44364957|NCT01088412|79370161|FG002|Overall Study|Received Another GH Product|0|||
44364958|NCT01088412|79370159|FG000|Overall Study|Participant Moved|601|||
44364959|NCT01088412|79370160|FG001|Overall Study|Participant Moved|21|||
44364960|NCT01088412|79370161|FG002|Overall Study|Participant Moved|2|||
44364961|NCT01088412|79370159|FG000|Overall Study|Physician Decision|1041|||
44204134|NCT01962103|78999993|FG003|Phase 1|Progressive Disease|4|||
44364962|NCT01088412|79370160|FG001|Overall Study|Physician Decision|8|||
44364963|NCT01088412|79370161|FG002|Overall Study|Physician Decision|4|||
44364964|NCT01088412|79370159|FG000|Overall Study|Sponsor Decision|4467|||
44364965|NCT01088412|79370160|FG001|Overall Study|Sponsor Decision|79|||
44364966|NCT01088412|79370161|FG002|Overall Study|Sponsor Decision|23|||
44364967|NCT01088412|79370159|FG000|Overall Study|Third Party Required to Change Brand|487|||
44364968|NCT01088412|79370160|FG001|Overall Study|Third Party Required to Change Brand|0|||
44364969|NCT01088412|79370161|FG002|Overall Study|Third Party Required to Change Brand|0|||
44364970|NCT01088412|79370159|FG000|Overall Study|Lost to Follow-up|3052|||
44204135|NCT01962103|78999994|FG004|Phase 1|Progressive Disease|5|||
44204136|NCT01962103|78999995|FG005|Phase 1|Progressive Disease|4|||
44204137|NCT01962103|78999996|FG006|Phase 1|Progressive Disease|0|||
44204138|NCT01962103|78999997|FG007|Phase 1|Progressive Disease|0|||
44204139|NCT01962103|78999998|FG008|Phase 1|Progressive Disease|0|||
44204140|NCT01962103|78999990|FG000|Phase 1|Withdrawal by Subject|0|||
44204141|NCT01962103|78999991|FG001|Phase 1|Withdrawal by Subject|0|||
44204142|NCT01962103|78999992|FG002|Phase 1|Withdrawal by Subject|0|||
44204143|NCT01962103|78999993|FG003|Phase 1|Withdrawal by Subject|2|||
44204144|NCT01962103|78999994|FG004|Phase 1|Withdrawal by Subject|0|||
44204145|NCT01962103|78999995|FG005|Phase 1|Withdrawal by Subject|0|||
44364971|NCT01088412|79370160|FG001|Overall Study|Lost to Follow-up|130|||
44364972|NCT01088412|79370161|FG002|Overall Study|Lost to Follow-up|11|||
44364973|NCT01088412|79370159|FG000|Overall Study|Study Summary Not Completed|4360|||
44204146|NCT01962103|78999996|FG006|Phase 1|Withdrawal by Subject|0|||
44204147|NCT01962103|78999997|FG007|Phase 1|Withdrawal by Subject|0|||
44204148|NCT01962103|78999998|FG008|Phase 1|Withdrawal by Subject|0|||
44364974|NCT01088412|79370160|FG001|Overall Study|Study Summary Not Completed|64|||
44204149|NCT01962103|78999990|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
44364975|NCT01088412|79370161|FG002|Overall Study|Study Summary Not Completed|22|||
44364976|NCT01086384|79370174|FG000|2-week Run-in Period|Adverse Event|1|||
44364977|NCT01086384|79370175|FG001|2-week Run-in Period|Adverse Event|0|||
44364978|NCT01086384|79370176|FG002|2-week Run-in Period|Adverse Event|0|||
44364979|NCT01086384|79370174|FG000|2-week Run-in Period|Protocol Violation|1|||
44364980|NCT01086384|79370175|FG001|2-week Run-in Period|Protocol Violation|0|||
44364981|NCT01086384|79370176|FG002|2-week Run-in Period|Protocol Violation|0|||
44364982|NCT01086384|79370174|FG000|2-week Run-in Period|Lost to Follow-up|1|||
44364983|NCT01086384|79370175|FG001|2-week Run-in Period|Lost to Follow-up|0|||
44364984|NCT01086384|79370176|FG002|2-week Run-in Period|Lost to Follow-up|0|||
44364985|NCT01086384|79370174|FG000|2-week Run-in Period|Physician Decision|6|||
44364986|NCT01086384|79370175|FG001|2-week Run-in Period|Physician Decision|0|||
44364987|NCT01086384|79370176|FG002|2-week Run-in Period|Physician Decision|0|||
44364988|NCT01086384|79370174|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
44364989|NCT01086384|79370175|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44364990|NCT01086384|79370176|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44364991|NCT01086384|79370174|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
44364992|NCT01086384|79370175|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
44364993|NCT01086384|79370176|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
44364994|NCT01086384|79370174|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
44364995|NCT01086384|79370175|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
44364996|NCT01086384|79370176|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
44364997|NCT01086384|79370174|FG000|2-week Run-in Period|Randomized in Error|1|||
44364998|NCT01086384|79370175|FG001|2-week Run-in Period|Randomized in Error|0|||
44364999|NCT01086384|79370176|FG002|2-week Run-in Period|Randomized in Error|0|||
44365000|NCT01086384|79370174|FG000|Treatment Period|Withdrawal by Subject|0|||
44365001|NCT01086384|79370175|FG001|Treatment Period|Withdrawal by Subject|53|||
44365002|NCT01086384|79370176|FG002|Treatment Period|Withdrawal by Subject|55|||
44365003|NCT01086384|79370174|FG000|Treatment Period|Protocol Violation|0|||
44365004|NCT01086384|79370175|FG001|Treatment Period|Protocol Violation|26|||
44365005|NCT01086384|79370176|FG002|Treatment Period|Protocol Violation|17|||
44365006|NCT01086384|79370174|FG000|Treatment Period|Lack of Efficacy|0|||
44365007|NCT01086384|79370175|FG001|Treatment Period|Lack of Efficacy|22|||
44365008|NCT01086384|79370176|FG002|Treatment Period|Lack of Efficacy|13|||
44365009|NCT01086384|79370174|FG000|Treatment Period|Adverse Event|0|||
44365010|NCT01086384|79370175|FG001|Treatment Period|Adverse Event|19|||
44365011|NCT01086384|79370176|FG002|Treatment Period|Adverse Event|15|||
44365012|NCT01086384|79370174|FG000|Treatment Period|Lost to Follow-up|0|||
44365013|NCT01086384|79370175|FG001|Treatment Period|Lost to Follow-up|11|||
44365014|NCT01086384|79370176|FG002|Treatment Period|Lost to Follow-up|9|||
44365015|NCT01086384|79370174|FG000|Treatment Period|Physician Decision|0|||
44365016|NCT01086384|79370175|FG001|Treatment Period|Physician Decision|9|||
44365017|NCT01086384|79370176|FG002|Treatment Period|Physician Decision|6|||
44365018|NCT01086384|79370174|FG000|Treatment Period|Study Closed/Terminated|0|||
44365019|NCT01086384|79370175|FG001|Treatment Period|Study Closed/Terminated|7|||
44365020|NCT01086384|79370176|FG002|Treatment Period|Study Closed/Terminated|8|||
44365021|NCT01086384|79370174|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
44365022|NCT01086384|79370175|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
44365023|NCT01086384|79370176|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
44365024|NCT01086384|79370174|FG000|Treatment Period|Received Treatment in Error|0|||
44365025|NCT01086384|79370175|FG001|Treatment Period|Received Treatment in Error|1|||
44365026|NCT01086384|79370176|FG002|Treatment Period|Received Treatment in Error|0|||
44365027|NCT01127633|79370184|FG000|Overall Study|Adverse Event|74|||
44365028|NCT01127633|79370185|FG001|Overall Study|Adverse Event|73|||
44365029|NCT01127633|79370184|FG000|Overall Study|Death|40|||
44365030|NCT01127633|79370185|FG001|Overall Study|Death|43|||
44365031|NCT01127633|79370184|FG000|Overall Study|Lost to Follow-up|4|||
44365032|NCT01127633|79370185|FG001|Overall Study|Lost to Follow-up|0|||
44365033|NCT01127633|79370184|FG000|Overall Study|Parent/Caregiver Decision|246|||
44365034|NCT01127633|79370185|FG001|Overall Study|Parent/Caregiver Decision|228|||
44365035|NCT01127633|79370184|FG000|Overall Study|Physician Decision|60|||
44365036|NCT01127633|79370185|FG001|Overall Study|Physician Decision|45|||
44365037|NCT01127633|79370184|FG000|Overall Study|Withdrawal by Subject|57|||
44365038|NCT01127633|79370185|FG001|Overall Study|Withdrawal by Subject|72|||
44365039|NCT01127633|79370184|FG000|Overall Study|Sponsor Decision|163|||
44365040|NCT01127633|79370185|FG001|Overall Study|Sponsor Decision|195|||
44365041|NCT01127633|79370184|FG000|Overall Study|Protocol Violation|8|||
44365042|NCT01127633|79370185|FG001|Overall Study|Protocol Violation|16|||
44365043|NCT01127633|79370184|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
44365044|NCT01127633|79370185|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
44365045|NCT01127633|79370184|FG000|Overall Study|Not treated|1|||
44365046|NCT01127633|79370185|FG001|Overall Study|Not treated|0|||
44365047|NCT01122173|79370191|FG000|Overall Study|Lost to Follow-up|3|||
44365048|NCT01122173|79370191|FG000|Overall Study|Withdrawal by Subject|3|||
44365049|NCT01122173|79370191|FG000|Overall Study|Left study for other reasons|3|||
44365050|NCT01127165|79370198|FG000|Overall Study|Adverse Event|2|||
44365051|NCT01127165|79370199|FG001|Overall Study|Adverse Event|2|||
44365052|NCT01127165|79370198|FG000|Overall Study|Lack of Efficacy|10|||
44365053|NCT01127165|79370199|FG001|Overall Study|Lack of Efficacy|8|||
44204150|NCT01962103|78999991|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
44204151|NCT01962103|78999992|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
44204152|NCT01962103|78999993|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
44204153|NCT01962103|78999994|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
44204154|NCT01962103|78999995|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
44204155|NCT01962103|78999996|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
44204156|NCT01962103|78999997|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
44204157|NCT01962103|78999998|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
44204158|NCT01962103|78999990|FG000|Phase 1|Physician Decision|0|||
44204159|NCT01962103|78999991|FG001|Phase 1|Physician Decision|0|||
44204160|NCT01962103|78999992|FG002|Phase 1|Physician Decision|0|||
44204161|NCT01962103|78999993|FG003|Phase 1|Physician Decision|1|||
44204162|NCT01962103|78999994|FG004|Phase 1|Physician Decision|0|||
44204163|NCT01962103|78999995|FG005|Phase 1|Physician Decision|0|||
44204164|NCT01962103|78999996|FG006|Phase 1|Physician Decision|0|||
44204165|NCT01962103|78999997|FG007|Phase 1|Physician Decision|0|||
44204166|NCT01962103|78999998|FG008|Phase 1|Physician Decision|0|||
44204167|NCT01962103|78999990|FG000|Phase 1|Symptomatic Deterioration|3|||
44204168|NCT01962103|78999991|FG001|Phase 1|Symptomatic Deterioration|2|||
44204169|NCT01962103|78999992|FG002|Phase 1|Symptomatic Deterioration|2|||
44204170|NCT01962103|78999993|FG003|Phase 1|Symptomatic Deterioration|2|||
44204171|NCT01962103|78999994|FG004|Phase 1|Symptomatic Deterioration|1|||
44204172|NCT01962103|78999995|FG005|Phase 1|Symptomatic Deterioration|1|||
44204173|NCT01962103|78999996|FG006|Phase 1|Symptomatic Deterioration|0|||
44204174|NCT01962103|78999997|FG007|Phase 1|Symptomatic Deterioration|0|||
44204175|NCT01962103|78999998|FG008|Phase 1|Symptomatic Deterioration|0|||
44204176|NCT01962103|78999990|FG000|Phase 1|Miscellaneous|1|||
44204177|NCT01962103|78999991|FG001|Phase 1|Miscellaneous|0|||
44204178|NCT01962103|78999992|FG002|Phase 1|Miscellaneous|0|||
44204179|NCT01962103|78999993|FG003|Phase 1|Miscellaneous|0|||
44204180|NCT01962103|78999994|FG004|Phase 1|Miscellaneous|0|||
44204181|NCT01962103|78999995|FG005|Phase 1|Miscellaneous|0|||
44204182|NCT01962103|78999996|FG006|Phase 1|Miscellaneous|0|||
44204183|NCT01962103|78999997|FG007|Phase 1|Miscellaneous|0|||
44204184|NCT01962103|78999998|FG008|Phase 1|Miscellaneous|0|||
44204185|NCT01962103|78999990|FG000|Phase 2|Adverse Event|0|||
44204186|NCT01962103|78999991|FG001|Phase 2|Adverse Event|0|||
44204187|NCT01962103|78999992|FG002|Phase 2|Adverse Event|0|||
44204188|NCT01962103|78999993|FG003|Phase 2|Adverse Event|0|||
44204189|NCT01962103|78999994|FG004|Phase 2|Adverse Event|0|||
44204190|NCT01962103|78999995|FG005|Phase 2|Adverse Event|0|||
44204191|NCT01962103|78999996|FG006|Phase 2|Adverse Event|1|||
44204192|NCT01962103|78999997|FG007|Phase 2|Adverse Event|0|||
44204193|NCT01962103|78999998|FG008|Phase 2|Adverse Event|3|||
44204194|NCT01962103|78999990|FG000|Phase 2|Progressive Disease|0|||
44204195|NCT01962103|78999991|FG001|Phase 2|Progressive Disease|0|||
44204196|NCT01962103|78999992|FG002|Phase 2|Progressive Disease|0|||
44204197|NCT01962103|78999993|FG003|Phase 2|Progressive Disease|0|||
44204198|NCT01962103|78999994|FG004|Phase 2|Progressive Disease|0|||
44204199|NCT01962103|78999995|FG005|Phase 2|Progressive Disease|0|||
44204200|NCT01962103|78999996|FG006|Phase 2|Progressive Disease|11|||
44204201|NCT01962103|78999997|FG007|Phase 2|Progressive Disease|12|||
44204202|NCT01962103|78999998|FG008|Phase 2|Progressive Disease|11|||
44365054|NCT01127165|79370198|FG000|Overall Study|Lost to Follow-up|3|||
44365055|NCT01127165|79370199|FG001|Overall Study|Lost to Follow-up|5|||
44365056|NCT01127165|79370198|FG000|Overall Study|Withdrawal by Subject|1|||
44365057|NCT01127165|79370199|FG001|Overall Study|Withdrawal by Subject|3|||
44365058|NCT01127165|79370198|FG000|Overall Study|Protocol Violation|0|||
44365059|NCT01127165|79370199|FG001|Overall Study|Protocol Violation|1|||
44365060|NCT01126619|79370205|FG000|Overall Study|Not eligible for the study|2|||
44365061|NCT01126619|79370205|FG000|Overall Study|Investigator decision|4|||
44365062|NCT01126619|79370205|FG000|Overall Study|Serious adverse event|1|||
44365063|NCT01126619|79370205|FG000|Overall Study|Withdrawal by Subject|9|||
44204203|NCT01962103|78999990|FG000|Phase 2|Symptomatic Deterioration|0|||
44204204|NCT01962103|78999991|FG001|Phase 2|Symptomatic Deterioration|0|||
44204205|NCT01962103|78999992|FG002|Phase 2|Symptomatic Deterioration|0|||
44204206|NCT01962103|78999993|FG003|Phase 2|Symptomatic Deterioration|0|||
44204207|NCT01962103|78999994|FG004|Phase 2|Symptomatic Deterioration|0|||
44204208|NCT01962103|78999995|FG005|Phase 2|Symptomatic Deterioration|0|||
44204209|NCT01962103|78999996|FG006|Phase 2|Symptomatic Deterioration|2|||
44204210|NCT01962103|78999997|FG007|Phase 2|Symptomatic Deterioration|2|||
44204211|NCT01962103|78999998|FG008|Phase 2|Symptomatic Deterioration|0|||
44365064|NCT01126619|79370205|FG000|Overall Study|Non-compliance|1|||
44204212|NCT01961323|79000018|FG000|Overall Study|Withdrawal by Subject|7|||
44204213|NCT01961323|79000018|FG000|Overall Study|Lost to Follow-up|8|||
44204214|NCT01961323|79000018|FG000|Overall Study|screen failure|34|||
44204215|NCT01960855|79000027|FG000|Overall Study|Subject noncompliant|1|||
44204216|NCT01960855|79000028|FG001|Overall Study|Subject noncompliant|0|||
44204217|NCT01960855|79000029|FG002|Overall Study|Subject noncompliant|0|||
44365065|NCT00941733|79370213|FG000|Overall Study|Death|24|||
44365066|NCT00941733|79370214|FG001|Overall Study|Death|10|||
44365067|NCT00941733|79370213|FG000|Overall Study|Withdrawal by Subject|14|||
44365068|NCT00941733|79370214|FG001|Overall Study|Withdrawal by Subject|6|||
44365069|NCT00941733|79370213|FG000|Overall Study|Adverse Event|20|||
44365070|NCT00941733|79370214|FG001|Overall Study|Adverse Event|4|||
44365071|NCT00941733|79370213|FG000|Overall Study|Lost to Follow-up|1|||
44365072|NCT00941733|79370214|FG001|Overall Study|Lost to Follow-up|2|||
44365073|NCT00941733|79370213|FG000|Overall Study|Protocol Violation|15|||
44365074|NCT00941733|79370214|FG001|Overall Study|Protocol Violation|6|||
44365075|NCT00941655|79370222|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
44365076|NCT00941655|79370223|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
44365077|NCT00941655|79370222|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
44365078|NCT00941655|79370223|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
44365079|NCT00941655|79370222|FG000|Overall Study|progressed while on chemo|0|||
44365080|NCT00941655|79370223|FG001|Overall Study|progressed while on chemo|2|||
44365081|NCT00941655|79370222|FG000|Overall Study|refused further treatment|0|||
44365082|NCT00941655|79370223|FG001|Overall Study|refused further treatment|1|||
44365083|NCT00941655|79370222|FG000|Overall Study|withdrew consent|0|||
44365084|NCT00941655|79370223|FG001|Overall Study|withdrew consent|1|||
44365085|NCT00941655|79370222|FG000|Overall Study|non-compliant|0|||
44365086|NCT00941655|79370223|FG001|Overall Study|non-compliant|1|||
44365087|NCT00939393|79370232|FG000|Overall Study|Withdrawal by Subject|1|||
44365088|NCT00939393|79370233|FG001|Overall Study|Withdrawal by Subject|0|||
44365089|NCT00939393|79370232|FG000|Overall Study|Lost to Follow-up|3|||
44365090|NCT00939393|79370233|FG001|Overall Study|Lost to Follow-up|0|||
44365091|NCT00936117|79370250|FG000|Overall Study|Adverse Event|7|||
44365092|NCT00936117|79370250|FG000|Overall Study|Unable to continue oral medication|3|||
44365093|NCT04088500|79370255|FG000|Overall Study|Reason unknown|1|||
44365094|NCT04088500|79370255|FG000|Overall Study|Participant withdrew consent|1|||
44365095|NCT04088500|79370255|FG000|Overall Study|Disease progression|3|||
44365096|NCT01082874|79370263|FG000|Overall Study|Lost to Follow-up|10|||
44365097|NCT01082874|79370264|FG001|Overall Study|Lost to Follow-up|10|||
44365098|NCT01082874|79370265|FG002|Overall Study|Lost to Follow-up|6|||
44365099|NCT01082874|79370266|FG003|Overall Study|Lost to Follow-up|10|||
44365100|NCT01082874|79370263|FG000|Overall Study|Withdrawal by Subject|1|||
44365101|NCT01082874|79370264|FG001|Overall Study|Withdrawal by Subject|2|||
44365102|NCT01082874|79370265|FG002|Overall Study|Withdrawal by Subject|5|||
44365103|NCT01082874|79370266|FG003|Overall Study|Withdrawal by Subject|3|||
44365104|NCT00933543|79370278|FG000|Overall Study|Adverse Event|2|||
44365105|NCT00933543|79370279|FG001|Overall Study|Adverse Event|1|||
44365106|NCT00933543|79370278|FG000|Overall Study|Lost to Follow-up|0|||
44365107|NCT00933543|79370279|FG001|Overall Study|Lost to Follow-up|1|||
44365108|NCT00933543|79370278|FG000|Overall Study|Withdrawal by Subject|0|||
44365109|NCT00933543|79370279|FG001|Overall Study|Withdrawal by Subject|1|||
44365110|NCT00933543|79370278|FG000|Overall Study|Lack of Efficacy|0|||
44365111|NCT00933543|79370279|FG001|Overall Study|Lack of Efficacy|3|||
44365112|NCT00933543|79370278|FG000|Overall Study|Other|1|||
44365113|NCT00933543|79370279|FG001|Overall Study|Other|1|||
44365114|NCT01082328|79370285|FG000|Overall Study|Adverse Event|1|||
44365115|NCT01079988|79370294|FG000|Overall Study|Lost to Follow-up|0|||
44365116|NCT01079988|79370295|FG001|Overall Study|Lost to Follow-up|0|||
44365117|NCT01079988|79370296|FG002|Overall Study|Lost to Follow-up|0|||
44365118|NCT01079988|79370297|FG003|Overall Study|Lost to Follow-up|1|||
44452007|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
44452008|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
44204218|NCT01960855|79000030|FG003|Overall Study|Subject noncompliant|0|||
44204219|NCT01960855|79000031|FG004|Overall Study|Subject noncompliant|0|||
44204220|NCT01960855|79000027|FG000|Overall Study|Adverse Event|2|||
44204221|NCT01960855|79000028|FG001|Overall Study|Adverse Event|0|||
44204222|NCT01960855|79000029|FG002|Overall Study|Adverse Event|6|||
44204223|NCT01960855|79000030|FG003|Overall Study|Adverse Event|2|||
44204224|NCT01960855|79000031|FG004|Overall Study|Adverse Event|2|||
44204225|NCT01960855|79000027|FG000|Overall Study|Lack of Efficacy|1|||
44204226|NCT01960855|79000028|FG001|Overall Study|Lack of Efficacy|1|||
44204227|NCT01960855|79000029|FG002|Overall Study|Lack of Efficacy|0|||
44365119|NCT01079988|79370298|FG004|Overall Study|Lost to Follow-up|0|||
44365120|NCT01079988|79370294|FG000|Overall Study|Lack of Efficacy|1|||
44365121|NCT01079988|79370295|FG001|Overall Study|Lack of Efficacy|0|||
44365122|NCT01079988|79370296|FG002|Overall Study|Lack of Efficacy|0|||
44365123|NCT01079988|79370297|FG003|Overall Study|Lack of Efficacy|0|||
44365124|NCT01079988|79370298|FG004|Overall Study|Lack of Efficacy|0|||
44365125|NCT01079988|79370294|FG000|Overall Study|Other|0|||
44365126|NCT01079988|79370295|FG001|Overall Study|Other|0|||
44365127|NCT01079988|79370296|FG002|Overall Study|Other|0|||
44365128|NCT01079988|79370297|FG003|Overall Study|Other|2|||
44365129|NCT01079988|79370298|FG004|Overall Study|Other|1|||
44365130|NCT01074216|79370310|FG000|Overall Study|Physician Decision|1|||
44365131|NCT01074216|79370310|FG000|Overall Study|Not Treated|12|||
44365132|NCT01079832|79370314|FG000|Overall Study|Withdrawal by Subject|1|||
44365133|NCT01072344|79370320|FG000|Overall Study|Relasped-reached end point|7|||
44365134|NCT01072344|79370321|FG001|Overall Study|Relasped-reached end point|12|||
44365135|NCT01072344|79370320|FG000|Overall Study|Protocol Violation|1|||
44365136|NCT01072344|79370321|FG001|Overall Study|Protocol Violation|2|||
44365137|NCT01072344|79370320|FG000|Overall Study|Lost to Follow-up|3|||
44365138|NCT01072344|79370321|FG001|Overall Study|Lost to Follow-up|4|||
44365139|NCT01071954|79370327|FG000|Overall Study|Noncompliance|4|||
44365140|NCT01071954|79370327|FG000|Overall Study|Adverse Event|1|||
44365141|NCT01071954|79370327|FG000|Overall Study|Withdrawal by Subject|11|||
44365142|NCT01071954|79370327|FG000|Overall Study|Requirement for Alternative Therapy|5|||
44365143|NCT01071954|79370327|FG000|Overall Study|Administrative Decision|5|||
44365144|NCT01071954|79370327|FG000|Overall Study|Protocol Specified Criteria|1|||
44365145|NCT00837811|79370334|FG000|Overall Study|Adverse Event|4|||
44365146|NCT00837811|79370335|FG001|Overall Study|Adverse Event|6|||
44365147|NCT00837811|79370336|FG002|Overall Study|Adverse Event|0|||
44365148|NCT00837811|79370334|FG000|Overall Study|Death|1|||
44365149|NCT00837811|79370335|FG001|Overall Study|Death|1|||
44365150|NCT00837811|79370336|FG002|Overall Study|Death|0|||
44365151|NCT00837811|79370334|FG000|Overall Study|Lack of Efficacy|0|||
44365152|NCT00837811|79370335|FG001|Overall Study|Lack of Efficacy|11|||
44365153|NCT00837811|79370336|FG002|Overall Study|Lack of Efficacy|0|||
44365154|NCT00837811|79370334|FG000|Overall Study|Lost to Follow-up|1|||
44365155|NCT00837811|79370335|FG001|Overall Study|Lost to Follow-up|3|||
44365156|NCT00837811|79370336|FG002|Overall Study|Lost to Follow-up|0|||
44365157|NCT00837811|79370334|FG000|Overall Study|Physician Decision|0|||
44365158|NCT00837811|79370335|FG001|Overall Study|Physician Decision|2|||
44365159|NCT00837811|79370336|FG002|Overall Study|Physician Decision|1|||
44365160|NCT00837811|79370334|FG000|Overall Study|Withdrawal by Subject|1|||
44365161|NCT00837811|79370335|FG001|Overall Study|Withdrawal by Subject|9|||
44365162|NCT00837811|79370336|FG002|Overall Study|Withdrawal by Subject|0|||
44365163|NCT00837811|79370334|FG000|Overall Study|Sponsor Decision|0|||
44365164|NCT00837811|79370335|FG001|Overall Study|Sponsor Decision|2|||
44365165|NCT00837811|79370336|FG002|Overall Study|Sponsor Decision|0|||
44365166|NCT00857389|79370353|FG000|Overall Study|Did not proceed to transplant|2|||
44365167|NCT01071798|79370357|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
44365168|NCT01071798|79370357|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
44365169|NCT01071798|79370357|FG000|Participants Who Received One Cycle|Patient requirement|20|||
44365170|NCT01071798|79370357|FG000|Participants Who Received One Cycle|Death|5|||
44365171|NCT01071798|79370357|FG000|Participants Who Received One Cycle|Change of therapy|6|||
44365172|NCT01071798|79370357|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
44365173|NCT01071798|79370357|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
44365174|NCT01071798|79370357|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
44365175|NCT01071798|79370357|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
44365176|NCT01071798|79370357|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
44365177|NCT00857311|79370375|FG000|Overall Study|Lost to Follow-up|1|||
44365178|NCT00857311|79370376|FG001|Overall Study|Lost to Follow-up|0|||
44365179|NCT00857311|79370377|FG002|Overall Study|Lost to Follow-up|0|||
44365180|NCT00857311|79370378|FG003|Overall Study|Lost to Follow-up|0|||
44365181|NCT00857233|79370384|FG000|Overall Study|Adverse Event|24|||
44365182|NCT00857233|79370384|FG000|Overall Study|Lack of Efficacy|1|||
44365183|NCT00857233|79370384|FG000|Overall Study|Non-compliance|1|||
44365184|NCT00857233|79370384|FG000|Overall Study|Withdrawal of Consent|9|||
44365185|NCT00857233|79370384|FG000|Overall Study|Lost to Follow-up|4|||
44365186|NCT00857233|79370384|FG000|Overall Study|Nursing Home Placement|14|||
44365187|NCT00857233|79370384|FG000|Overall Study|Other Reasons|2|||
44365188|NCT00856999|79370388|FG000|Overall Study|Withdrawal by Subject|5|||
44365189|NCT01071252|79370398|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
44365190|NCT01071252|79370399|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
44365191|NCT01071252|79370400|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
44365192|NCT01071252|79370401|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
44365193|NCT01071252|79370402|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
44365194|NCT01071252|79370398|FG000|Overall Study|Withdrawal by Subject|8|||
44365195|NCT01071252|79370399|FG001|Overall Study|Withdrawal by Subject|2|||
44365196|NCT01071252|79370400|FG002|Overall Study|Withdrawal by Subject|1|||
44365197|NCT01071252|79370401|FG003|Overall Study|Withdrawal by Subject|2|||
44365198|NCT01071252|79370402|FG004|Overall Study|Withdrawal by Subject|3|||
44365199|NCT01071252|79370398|FG000|Overall Study|administrative problems|1|||
44365200|NCT01071252|79370399|FG001|Overall Study|administrative problems|1|||
44365201|NCT01071252|79370400|FG002|Overall Study|administrative problems|0|||
44365202|NCT01071252|79370401|FG003|Overall Study|administrative problems|2|||
44365203|NCT01071252|79370402|FG004|Overall Study|administrative problems|1|||
44365204|NCT01071252|79370398|FG000|Overall Study|Lost to Follow-up|1|||
44365205|NCT01071252|79370399|FG001|Overall Study|Lost to Follow-up|0|||
44365206|NCT01071252|79370400|FG002|Overall Study|Lost to Follow-up|1|||
44365207|NCT01071252|79370401|FG003|Overall Study|Lost to Follow-up|2|||
44365208|NCT01071252|79370402|FG004|Overall Study|Lost to Follow-up|0|||
44365209|NCT01071252|79370398|FG000|Overall Study|Adverse Event|1|||
44365210|NCT01071252|79370399|FG001|Overall Study|Adverse Event|1|||
44365211|NCT01071252|79370400|FG002|Overall Study|Adverse Event|0|||
44365212|NCT01071252|79370401|FG003|Overall Study|Adverse Event|1|||
44365213|NCT01071252|79370402|FG004|Overall Study|Adverse Event|0|||
44365214|NCT01071252|79370398|FG000|Overall Study|Death|0|||
44365215|NCT01071252|79370399|FG001|Overall Study|Death|0|||
44365216|NCT01071252|79370400|FG002|Overall Study|Death|0|||
44365217|NCT01071252|79370401|FG003|Overall Study|Death|0|||
44365218|NCT01071252|79370402|FG004|Overall Study|Death|1|||
44365219|NCT00856843|79370416|FG000|Overall Study|Withdrawal by Subject|1|||
44365220|NCT00856843|79370417|FG001|Overall Study|Withdrawal by Subject|5|||
44365221|NCT00856843|79370416|FG000|Overall Study|Lack of Efficacy|1|||
44365222|NCT00856843|79370417|FG001|Overall Study|Lack of Efficacy|0|||
44365223|NCT00856609|79370425|FG000|Overall Study|Adverse Event|1|||
44365224|NCT00856609|79370426|FG001|Overall Study|Adverse Event|0|||
44365225|NCT01071096|79370432|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
44365226|NCT01071096|79370433|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
44365227|NCT00856375|79370452|FG000|Overall Study|Other|0|||
44365228|NCT00856375|79370453|FG001|Overall Study|Other|1|||
44365229|NCT00856375|79370452|FG000|Overall Study|Death|32|||
44365230|NCT00856375|79370453|FG001|Overall Study|Death|30|||
44365231|NCT00856375|79370452|FG000|Overall Study|Sponsor Terminated Study|7|||
44365232|NCT00856375|79370453|FG001|Overall Study|Sponsor Terminated Study|7|||
44365233|NCT00856375|79370452|FG000|Overall Study|Withdrawal by Subject|2|||
44365234|NCT00856375|79370453|FG001|Overall Study|Withdrawal by Subject|1|||
44365235|NCT00856375|79370452|FG000|Overall Study|Lost to Follow-up|1|||
44365236|NCT00856375|79370453|FG001|Overall Study|Lost to Follow-up|2|||
44365237|NCT01070784|79370461|FG000|Overall Study|Withdrawal by Subject|6|||
44365238|NCT01070784|79370462|FG001|Overall Study|Withdrawal by Subject|9|||
44365239|NCT01070784|79370461|FG000|Overall Study|Adverse Event|14|||
44365240|NCT01070784|79370462|FG001|Overall Study|Adverse Event|9|||
44365241|NCT00837577|79370470|FG000|Double-blind Period|Clinical Adverse Event|1|||
44365242|NCT00837577|79370471|FG001|Double-blind Period|Clinical Adverse Event|0|||
44365243|NCT00837577|79370470|FG000|Double-blind Period|Withdrawal by Subject|1|||
44365244|NCT00837577|79370471|FG001|Double-blind Period|Withdrawal by Subject|0|||
44365245|NCT00837577|79370470|FG000|Open-label Period|Clinical Adverse Event|2|||
44365246|NCT00837577|79370471|FG001|Open-label Period|Clinical Adverse Event|2|||
44365247|NCT00837577|79370470|FG000|Open-label Period|Laboratory Adverse Event|0|||
44365248|NCT00837577|79370471|FG001|Open-label Period|Laboratory Adverse Event|1|||
44365249|NCT00837577|79370470|FG000|Open-label Period|Lack of Efficacy|4|||
44365250|NCT00837577|79370471|FG001|Open-label Period|Lack of Efficacy|3|||
44365251|NCT00837577|79370470|FG000|Open-label Period|Withdrawal by Subject|1|||
44365252|NCT00837577|79370471|FG001|Open-label Period|Withdrawal by Subject|2|||
44365253|NCT00837577|79370470|FG000|Open-label Period|Other Reason|1|||
44365254|NCT00837577|79370471|FG001|Open-label Period|Other Reason|1|||
44365255|NCT01070550|79370484|FG000|Overall Study|Adverse Event|43|||
44365256|NCT01070550|79370485|FG001|Overall Study|Adverse Event|1|||
44365257|NCT01070550|79370486|FG002|Overall Study|Adverse Event|3|||
44365258|NCT01070550|79370487|FG003|Overall Study|Adverse Event|0|||
44365259|NCT01070550|79370488|FG004|Overall Study|Adverse Event|0|||
44365260|NCT01070550|79370489|FG005|Overall Study|Adverse Event|0|||
44365261|NCT01070550|79370484|FG000|Overall Study|Death|20|||
44365262|NCT01070550|79370485|FG001|Overall Study|Death|4|||
44365263|NCT01070550|79370486|FG002|Overall Study|Death|3|||
44365264|NCT01070550|79370487|FG003|Overall Study|Death|0|||
44365265|NCT01070550|79370488|FG004|Overall Study|Death|0|||
44365266|NCT01070550|79370489|FG005|Overall Study|Death|0|||
44365267|NCT01070550|79370484|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
44365268|NCT01070550|79370485|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
44365269|NCT01070550|79370486|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
44365270|NCT01070550|79370487|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
44365271|NCT01070550|79370488|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
44365272|NCT01070550|79370489|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
44365273|NCT01070550|79370484|FG000|Overall Study|Early termination|3|||
44365274|NCT01070550|79370485|FG001|Overall Study|Early termination|0|||
44365275|NCT01070550|79370486|FG002|Overall Study|Early termination|0|||
44365276|NCT01070550|79370487|FG003|Overall Study|Early termination|0|||
44365277|NCT01070550|79370488|FG004|Overall Study|Early termination|0|||
44365278|NCT01070550|79370489|FG005|Overall Study|Early termination|0|||
44365279|NCT01070550|79370484|FG000|Overall Study|Failed to return|450|||
44204228|NCT01960855|79000030|FG003|Overall Study|Lack of Efficacy|0|||
44365280|NCT01070550|79370485|FG001|Overall Study|Failed to return|33|||
44365281|NCT01070550|79370486|FG002|Overall Study|Failed to return|144|||
44365282|NCT01070550|79370487|FG003|Overall Study|Failed to return|40|||
44365283|NCT01070550|79370488|FG004|Overall Study|Failed to return|1|||
44365284|NCT01070550|79370489|FG005|Overall Study|Failed to return|2|||
44365285|NCT01070550|79370484|FG000|Overall Study|Incomplete treatment|2|||
44365286|NCT01070550|79370485|FG001|Overall Study|Incomplete treatment|0|||
44365287|NCT01070550|79370486|FG002|Overall Study|Incomplete treatment|0|||
44365288|NCT01070550|79370487|FG003|Overall Study|Incomplete treatment|0|||
44365289|NCT01070550|79370488|FG004|Overall Study|Incomplete treatment|0|||
44365290|NCT01070550|79370489|FG005|Overall Study|Incomplete treatment|0|||
44365291|NCT01070550|79370484|FG000|Overall Study|Lab test not done|22|||
44365292|NCT01070550|79370485|FG001|Overall Study|Lab test not done|3|||
44365293|NCT01070550|79370486|FG002|Overall Study|Lab test not done|4|||
44365294|NCT01070550|79370487|FG003|Overall Study|Lab test not done|1|||
44365295|NCT01070550|79370488|FG004|Overall Study|Lab test not done|0|||
44204229|NCT01960855|79000031|FG004|Overall Study|Lack of Efficacy|0|||
44204230|NCT01960855|79000027|FG000|Overall Study|Other|2|||
44204231|NCT01960855|79000028|FG001|Overall Study|Other|1|||
44204232|NCT01960855|79000029|FG002|Overall Study|Other|1|||
44204233|NCT01960855|79000030|FG003|Overall Study|Other|1|||
44204234|NCT01960855|79000031|FG004|Overall Study|Other|0|||
44204235|NCT01960855|79000027|FG000|Overall Study|Consent withdrawn by subject|3|||
44204236|NCT01960855|79000028|FG001|Overall Study|Consent withdrawn by subject|1|||
44204237|NCT01960855|79000029|FG002|Overall Study|Consent withdrawn by subject|2|||
44204238|NCT01960855|79000030|FG003|Overall Study|Consent withdrawn by subject|1|||
44204239|NCT01960855|79000031|FG004|Overall Study|Consent withdrawn by subject|1|||
44204240|NCT01960855|79000027|FG000|Overall Study|Lost to Follow-up|2|||
44204241|NCT01960855|79000028|FG001|Overall Study|Lost to Follow-up|1|||
44204242|NCT01960855|79000029|FG002|Overall Study|Lost to Follow-up|0|||
44204243|NCT01960855|79000030|FG003|Overall Study|Lost to Follow-up|0|||
44204244|NCT01960855|79000031|FG004|Overall Study|Lost to Follow-up|2|||
44204245|NCT02007434|79000051|FG000|Overall Study|Lost to Follow-up|0|||
44204246|NCT02007434|79000052|FG001|Overall Study|Lost to Follow-up|1|||
44204247|NCT02007434|79000053|FG002|Overall Study|Lost to Follow-up|0|||
44204248|NCT02007434|79000054|FG003|Overall Study|Lost to Follow-up|0|||
44204249|NCT02007434|79000055|FG004|Overall Study|Lost to Follow-up|0|||
44204250|NCT02007434|79000056|FG005|Overall Study|Lost to Follow-up|0|||
44204251|NCT02007434|79000057|FG006|Overall Study|Lost to Follow-up|0|||
44204252|NCT02007434|79000058|FG007|Overall Study|Lost to Follow-up|0|||
44204253|NCT02007434|79000051|FG000|Overall Study|Non-compliance|1|||
44204254|NCT02007434|79000052|FG001|Overall Study|Non-compliance|0|||
44204255|NCT02007434|79000053|FG002|Overall Study|Non-compliance|1|||
44204256|NCT02007434|79000054|FG003|Overall Study|Non-compliance|0|||
44204257|NCT02007434|79000055|FG004|Overall Study|Non-compliance|0|||
44204258|NCT02007434|79000056|FG005|Overall Study|Non-compliance|0|||
44204259|NCT02007434|79000057|FG006|Overall Study|Non-compliance|0|||
44204260|NCT02007434|79000058|FG007|Overall Study|Non-compliance|0|||
44204261|NCT01987453|79000080|FG000|Overall Study|Death|0|||
44204262|NCT01987453|79000081|FG001|Overall Study|Death|0|||
44204263|NCT01987453|79000082|FG002|Overall Study|Death|1|||
44204264|NCT01987453|79000080|FG000|Overall Study|Lack of Efficacy|1|||
44204265|NCT01987453|79000081|FG001|Overall Study|Lack of Efficacy|12|||
44204266|NCT01987453|79000082|FG002|Overall Study|Lack of Efficacy|0|||
44204267|NCT02006641|79000097|FG000|Overall Study|Withdrawal before treatment|2|||
44204268|NCT02006641|79000098|FG001|Overall Study|Withdrawal before treatment|5|||
44204269|NCT02006641|79000099|FG002|Overall Study|Withdrawal before treatment|3|||
44204270|NCT02006641|79000097|FG000|Overall Study|Adverse Event|15|||
44204271|NCT02006641|79000098|FG001|Overall Study|Adverse Event|11|||
44204272|NCT02006641|79000099|FG002|Overall Study|Adverse Event|15|||
44204273|NCT02006641|79000097|FG000|Overall Study|Protocol Violation|0|||
44204274|NCT02006641|79000098|FG001|Overall Study|Protocol Violation|2|||
44204275|NCT02006641|79000099|FG002|Overall Study|Protocol Violation|2|||
44204276|NCT02006641|79000097|FG000|Overall Study|Lost to Follow-up|0|||
44204277|NCT02006641|79000098|FG001|Overall Study|Lost to Follow-up|1|||
44204278|NCT02006641|79000099|FG002|Overall Study|Lost to Follow-up|0|||
44204279|NCT02006641|79000097|FG000|Overall Study|Withdrawal by Subject|7|||
44204280|NCT02006641|79000098|FG001|Overall Study|Withdrawal by Subject|12|||
44204281|NCT02006641|79000099|FG002|Overall Study|Withdrawal by Subject|11|||
44204282|NCT02006641|79000097|FG000|Overall Study|Other reason: patient didn't show up|1|||
44204283|NCT02006641|79000098|FG001|Overall Study|Other reason: patient didn't show up|0|||
44204284|NCT02006641|79000099|FG002|Overall Study|Other reason: patient didn't show up|0|||
44204285|NCT02006641|79000097|FG000|Overall Study|Other reason:patient didn't want to come|0|||
44204286|NCT02006641|79000098|FG001|Overall Study|Other reason:patient didn't want to come|0|||
44204287|NCT02006641|79000099|FG002|Overall Study|Other reason:patient didn't want to come|1|||
44204288|NCT02006641|79000097|FG000|Overall Study|Other reason: patient has moved|1|||
44204289|NCT02006641|79000098|FG001|Overall Study|Other reason: patient has moved|0|||
44204290|NCT02006641|79000099|FG002|Overall Study|Other reason: patient has moved|1|||
44365296|NCT01070550|79370489|FG005|Overall Study|Lab test not done|1|||
44365297|NCT01070550|79370484|FG000|Overall Study|Lack of Efficacy|65|||
44365298|NCT01070550|79370485|FG001|Overall Study|Lack of Efficacy|1|||
44204291|NCT02006641|79000097|FG000|Overall Study|Other reason: caregiver in hospital|0|||
44365299|NCT01070550|79370486|FG002|Overall Study|Lack of Efficacy|5|||
44365300|NCT01070550|79370487|FG003|Overall Study|Lack of Efficacy|5|||
44365301|NCT01070550|79370488|FG004|Overall Study|Lack of Efficacy|0|||
44365302|NCT01070550|79370489|FG005|Overall Study|Lack of Efficacy|1|||
44365303|NCT01070550|79370484|FG000|Overall Study|Miscellaneous|12|||
44365304|NCT01070550|79370485|FG001|Overall Study|Miscellaneous|2|||
44365305|NCT01070550|79370486|FG002|Overall Study|Miscellaneous|3|||
44365306|NCT01070550|79370487|FG003|Overall Study|Miscellaneous|1|||
44365307|NCT01070550|79370488|FG004|Overall Study|Miscellaneous|0|||
44365308|NCT01070550|79370489|FG005|Overall Study|Miscellaneous|0|||
44365309|NCT01070550|79370484|FG000|Overall Study|New treatment started|3|||
44365310|NCT01070550|79370485|FG001|Overall Study|New treatment started|1|||
44365311|NCT01070550|79370486|FG002|Overall Study|New treatment started|0|||
44365312|NCT01070550|79370487|FG003|Overall Study|New treatment started|2|||
44365313|NCT01070550|79370488|FG004|Overall Study|New treatment started|0|||
44365314|NCT01070550|79370489|FG005|Overall Study|New treatment started|0|||
44365315|NCT01070550|79370484|FG000|Overall Study|Non-responders|493|||
44365316|NCT01070550|79370485|FG001|Overall Study|Non-responders|4|||
44204292|NCT02006641|79000098|FG001|Overall Study|Other reason: caregiver in hospital|1|||
44204293|NCT02006641|79000099|FG002|Overall Study|Other reason: caregiver in hospital|0|||
44204294|NCT02006641|79000097|FG000|Overall Study|Other reason: patient's wife has died|0|||
44204295|NCT02006641|79000098|FG001|Overall Study|Other reason: patient's wife has died|0|||
44204296|NCT02006641|79000099|FG002|Overall Study|Other reason: patient's wife has died|1|||
44204297|NCT02006641|79000097|FG000|Overall Study|Other reason: hospitalisation|0|||
44204298|NCT02006641|79000098|FG001|Overall Study|Other reason: hospitalisation|1|||
44204299|NCT02006641|79000099|FG002|Overall Study|Other reason: hospitalisation|0|||
44204300|NCT02006641|79000097|FG000|Overall Study|Other reason: caregiver impossibility|0|||
44204301|NCT02006641|79000098|FG001|Overall Study|Other reason: caregiver impossibility|0|||
44204302|NCT02006641|79000099|FG002|Overall Study|Other reason: caregiver impossibility|1|||
44204303|NCT02006641|79000097|FG000|Overall Study|Other reason: protocol non-compliance|0|||
44204304|NCT02006641|79000098|FG001|Overall Study|Other reason: protocol non-compliance|0|||
44204305|NCT02006641|79000099|FG002|Overall Study|Other reason: protocol non-compliance|1|||
44204306|NCT01959919|79000107|FG000|Overall Study|Did not meet the eligibility criteria|2|||
44204307|NCT01986985|79000115|FG000|Overall Study|Withdrawal by Subject|4|||
44204308|NCT01986985|79000115|FG000|Overall Study|Scan not completed due to malfunction|3|||
44204309|NCT01986907|79000119|FG000|Overall Study|Adverse Event|11|||
44204310|NCT01986907|79000119|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
44204311|NCT01986907|79000119|FG000|Overall Study|Protocol Violation|4|||
44204312|NCT01986907|79000119|FG000|Overall Study|Withdrawal by Subject|76|||
44204313|NCT01986907|79000119|FG000|Overall Study|Lost to Follow-up|38|||
44204314|NCT01986907|79000119|FG000|Overall Study|Death|9|||
44204315|NCT01959841|79000129|FG000|Overall Study|Adverse Event|1|||
44204316|NCT01959841|79000130|FG001|Overall Study|Adverse Event|3|||
44204317|NCT01959841|79000131|FG002|Overall Study|Adverse Event|2|||
44204318|NCT01959841|79000129|FG000|Overall Study|Lack of Efficacy|5|||
44204319|NCT01959841|79000130|FG001|Overall Study|Lack of Efficacy|0|||
44204320|NCT01959841|79000131|FG002|Overall Study|Lack of Efficacy|0|||
44204321|NCT01959841|79000129|FG000|Overall Study|Lost to Follow-up|1|||
44204322|NCT01959841|79000130|FG001|Overall Study|Lost to Follow-up|1|||
44204323|NCT01959841|79000131|FG002|Overall Study|Lost to Follow-up|0|||
44204324|NCT01959841|79000129|FG000|Overall Study|Physician Decision|0|||
44204325|NCT01959841|79000130|FG001|Overall Study|Physician Decision|2|||
44204326|NCT01959841|79000131|FG002|Overall Study|Physician Decision|3|||
44204327|NCT01959841|79000129|FG000|Overall Study|Protocol Violation|16|||
44204328|NCT01959841|79000130|FG001|Overall Study|Protocol Violation|23|||
44204329|NCT01959841|79000131|FG002|Overall Study|Protocol Violation|16|||
44204330|NCT01959841|79000129|FG000|Overall Study|Withdrawal by Subject|7|||
44204331|NCT01959841|79000130|FG001|Overall Study|Withdrawal by Subject|7|||
44204332|NCT01959841|79000131|FG002|Overall Study|Withdrawal by Subject|5|||
44204333|NCT01959841|79000129|FG000|Overall Study|Clinical laboratory value|2|||
44204334|NCT01959841|79000130|FG001|Overall Study|Clinical laboratory value|6|||
44204335|NCT01959841|79000131|FG002|Overall Study|Clinical laboratory value|6|||
44269311|NCT02310750|79192406|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269312|NCT02310750|79192407|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44204336|NCT01959841|79000129|FG000|Overall Study|Platelet count below on day1 or 4|11|||
44269313|NCT02310750|79192408|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
44269314|NCT02310750|79192409|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
44204337|NCT01959841|79000130|FG001|Overall Study|Platelet count below on day1 or 4|15|||
44204338|NCT01959841|79000131|FG002|Overall Study|Platelet count below on day1 or 4|11|||
44204339|NCT02005627|79000141|FG000|Overall Study|Lost to Follow-up|1|||
44204340|NCT02005627|79000142|FG001|Overall Study|Lost to Follow-up|2|||
44269315|NCT02310750|79192410|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269316|NCT02310750|79192411|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44365317|NCT01070550|79370486|FG002|Overall Study|Non-responders|21|||
44365318|NCT01070550|79370487|FG003|Overall Study|Non-responders|20|||
44365319|NCT01070550|79370488|FG004|Overall Study|Non-responders|0|||
44365320|NCT01070550|79370489|FG005|Overall Study|Non-responders|2|||
44365321|NCT01070550|79370484|FG000|Overall Study|Not categorized|33|||
44365322|NCT01070550|79370485|FG001|Overall Study|Not categorized|2|||
44365323|NCT01070550|79370486|FG002|Overall Study|Not categorized|6|||
44365324|NCT01070550|79370487|FG003|Overall Study|Not categorized|1|||
44365325|NCT01070550|79370488|FG004|Overall Study|Not categorized|0|||
44365326|NCT01070550|79370489|FG005|Overall Study|Not categorized|1|||
44365327|NCT01070550|79370484|FG000|Overall Study|Protocol Violation|15|||
44365328|NCT01070550|79370485|FG001|Overall Study|Protocol Violation|1|||
44365329|NCT01070550|79370486|FG002|Overall Study|Protocol Violation|1|||
44365330|NCT01070550|79370487|FG003|Overall Study|Protocol Violation|1|||
44365331|NCT01070550|79370488|FG004|Overall Study|Protocol Violation|0|||
44365332|NCT01070550|79370489|FG005|Overall Study|Protocol Violation|0|||
44365333|NCT01070550|79370484|FG000|Overall Study|Relapse|44|||
44365334|NCT01070550|79370485|FG001|Overall Study|Relapse|5|||
44365335|NCT01070550|79370486|FG002|Overall Study|Relapse|14|||
44365336|NCT01070550|79370487|FG003|Overall Study|Relapse|4|||
44365337|NCT01070550|79370488|FG004|Overall Study|Relapse|0|||
44365338|NCT01070550|79370489|FG005|Overall Study|Relapse|0|||
44365339|NCT01070550|79370484|FG000|Overall Study|Result not available|3|||
44365340|NCT01070550|79370485|FG001|Overall Study|Result not available|1|||
44365341|NCT01070550|79370486|FG002|Overall Study|Result not available|3|||
44365342|NCT01070550|79370487|FG003|Overall Study|Result not available|0|||
44365343|NCT01070550|79370488|FG004|Overall Study|Result not available|0|||
44365344|NCT01070550|79370489|FG005|Overall Study|Result not available|0|||
44365345|NCT01070550|79370484|FG000|Overall Study|Screen failure|1|||
44365346|NCT01070550|79370485|FG001|Overall Study|Screen failure|0|||
44365347|NCT01070550|79370486|FG002|Overall Study|Screen failure|0|||
44365348|NCT01070550|79370487|FG003|Overall Study|Screen failure|0|||
44365349|NCT01070550|79370488|FG004|Overall Study|Screen failure|0|||
44365350|NCT01070550|79370489|FG005|Overall Study|Screen failure|0|||
44365351|NCT01070550|79370484|FG000|Overall Study|Sponsor decision|1|||
44365352|NCT01070550|79370485|FG001|Overall Study|Sponsor decision|0|||
44365353|NCT01070550|79370486|FG002|Overall Study|Sponsor decision|0|||
44365354|NCT01070550|79370487|FG003|Overall Study|Sponsor decision|0|||
44365355|NCT01070550|79370488|FG004|Overall Study|Sponsor decision|0|||
44365356|NCT01070550|79370489|FG005|Overall Study|Sponsor decision|0|||
44365357|NCT01070550|79370484|FG000|Overall Study|Treatment duration shortened|1|||
44365358|NCT01070550|79370485|FG001|Overall Study|Treatment duration shortened|0|||
44365359|NCT01070550|79370486|FG002|Overall Study|Treatment duration shortened|0|||
44365360|NCT01070550|79370487|FG003|Overall Study|Treatment duration shortened|0|||
44365361|NCT01070550|79370488|FG004|Overall Study|Treatment duration shortened|0|||
44365362|NCT01070550|79370489|FG005|Overall Study|Treatment duration shortened|0|||
44365363|NCT01070550|79370484|FG000|Overall Study|Treatment interrupted|7|||
44365364|NCT01070550|79370485|FG001|Overall Study|Treatment interrupted|0|||
44365365|NCT01070550|79370486|FG002|Overall Study|Treatment interrupted|1|||
44365366|NCT01070550|79370487|FG003|Overall Study|Treatment interrupted|1|||
44365367|NCT01070550|79370488|FG004|Overall Study|Treatment interrupted|0|||
44365368|NCT01070550|79370489|FG005|Overall Study|Treatment interrupted|0|||
44365369|NCT01070550|79370484|FG000|Overall Study|Treatment not started|14|||
44365370|NCT01070550|79370485|FG001|Overall Study|Treatment not started|2|||
44365371|NCT01070550|79370486|FG002|Overall Study|Treatment not started|4|||
44365372|NCT01070550|79370487|FG003|Overall Study|Treatment not started|0|||
44365373|NCT01070550|79370488|FG004|Overall Study|Treatment not started|0|||
44365374|NCT01070550|79370489|FG005|Overall Study|Treatment not started|0|||
44365375|NCT01070550|79370484|FG000|Overall Study|Treatment restarted|0|||
44365376|NCT01070550|79370485|FG001|Overall Study|Treatment restarted|1|||
44365377|NCT01070550|79370486|FG002|Overall Study|Treatment restarted|0|||
44365378|NCT01070550|79370487|FG003|Overall Study|Treatment restarted|0|||
44365379|NCT01070550|79370488|FG004|Overall Study|Treatment restarted|0|||
44365380|NCT01070550|79370489|FG005|Overall Study|Treatment restarted|0|||
44365381|NCT01070550|79370484|FG000|Overall Study|Treatment stopped|3|||
44365382|NCT01070550|79370485|FG001|Overall Study|Treatment stopped|0|||
44365383|NCT01070550|79370486|FG002|Overall Study|Treatment stopped|0|||
44365384|NCT01070550|79370487|FG003|Overall Study|Treatment stopped|0|||
44365385|NCT01070550|79370488|FG004|Overall Study|Treatment stopped|0|||
44365386|NCT01070550|79370489|FG005|Overall Study|Treatment stopped|0|||
44365387|NCT01070550|79370484|FG000|Overall Study|Treatment unavailable|1|||
44365388|NCT01070550|79370485|FG001|Overall Study|Treatment unavailable|0|||
44365389|NCT01070550|79370486|FG002|Overall Study|Treatment unavailable|0|||
44365390|NCT01070550|79370487|FG003|Overall Study|Treatment unavailable|0|||
44365391|NCT01070550|79370488|FG004|Overall Study|Treatment unavailable|0|||
44365392|NCT01070550|79370489|FG005|Overall Study|Treatment unavailable|0|||
44365393|NCT01070550|79370484|FG000|Overall Study|Treatment was stopped early|7|||
44365394|NCT01070550|79370485|FG001|Overall Study|Treatment was stopped early|0|||
44365395|NCT01070550|79370486|FG002|Overall Study|Treatment was stopped early|0|||
44365396|NCT01070550|79370487|FG003|Overall Study|Treatment was stopped early|0|||
44365397|NCT01070550|79370488|FG004|Overall Study|Treatment was stopped early|0|||
44365398|NCT01070550|79370489|FG005|Overall Study|Treatment was stopped early|0|||
44365399|NCT01070550|79370484|FG000|Overall Study|Other|5|||
44365400|NCT01070550|79370485|FG001|Overall Study|Other|0|||
44365401|NCT01070550|79370486|FG002|Overall Study|Other|0|||
44365402|NCT01070550|79370487|FG003|Overall Study|Other|1|||
44365403|NCT01070550|79370488|FG004|Overall Study|Other|0|||
44365404|NCT01070550|79370489|FG005|Overall Study|Other|0|||
44365405|NCT01070550|79370484|FG000|Overall Study|Withdrawal by Subject|35|||
44365406|NCT01070550|79370485|FG001|Overall Study|Withdrawal by Subject|0|||
44365407|NCT01070550|79370486|FG002|Overall Study|Withdrawal by Subject|3|||
44365408|NCT01070550|79370487|FG003|Overall Study|Withdrawal by Subject|0|||
44365409|NCT01070550|79370488|FG004|Overall Study|Withdrawal by Subject|0|||
44365410|NCT01070550|79370489|FG005|Overall Study|Withdrawal by Subject|0|||
44365411|NCT00848107|79370504|FG000|Overall Study|Lost to Follow-up|2|||
44365412|NCT00848107|79370504|FG000|Overall Study|Withdrawal by Subject|8|||
44365413|NCT00848107|79370504|FG000|Overall Study|Adverse Event|9|||
44204341|NCT02005627|79000141|FG000|Overall Study|Withdrawal by Subject|1|||
44204342|NCT02005627|79000142|FG001|Overall Study|Withdrawal by Subject|2|||
44204343|NCT02104583|79000154|FG000|Overall Study|New ICD or CRT-D implanted|2|||
44204344|NCT02104583|79000155|FG001|Overall Study|New ICD or CRT-D implanted|0|||
44204345|NCT02104583|79000156|FG002|Overall Study|New ICD or CRT-D implanted|1|||
44204346|NCT02104583|79000157|FG003|Overall Study|New ICD or CRT-D implanted|0|||
44204347|NCT02104583|79000158|FG004|Overall Study|New ICD or CRT-D implanted|0|||
44204348|NCT02104583|79000154|FG000|Overall Study|Death|2|||
44204349|NCT02104583|79000155|FG001|Overall Study|Death|1|||
44204350|NCT02104583|79000156|FG002|Overall Study|Death|3|||
44204351|NCT02104583|79000157|FG003|Overall Study|Death|3|||
44365414|NCT00848107|79370504|FG000|Overall Study|Death|1|||
44365415|NCT00848107|79370504|FG000|Overall Study|Pregnancy|1|||
44365416|NCT00856297|79370513|FG000|Overall Study|Unable to classify|2|||
44365417|NCT00856297|79370514|FG001|Overall Study|Unable to classify|0|||
44365418|NCT00856297|79370515|FG002|Overall Study|Unable to classify|0|||
44365419|NCT00856297|79370516|FG003|Overall Study|Unable to classify|0|||
44365420|NCT00856297|79370517|FG004|Overall Study|Unable to classify|0|||
44365421|NCT01046136|79370536|FG000|Overall Study|Withdrawal by Subject|0|||
44365422|NCT01046136|79370537|FG001|Overall Study|Withdrawal by Subject|4|||
44365423|NCT01046136|79370536|FG000|Overall Study|Physician Decision|1|||
44365424|NCT01046136|79370537|FG001|Overall Study|Physician Decision|1|||
44365425|NCT01046136|79370536|FG000|Overall Study|Lost to Follow-up|3|||
44365426|NCT01046136|79370537|FG001|Overall Study|Lost to Follow-up|3|||
44365427|NCT01070394|79370545|FG000|Overall Study|Adverse Event|6|||
44365428|NCT01070394|79370545|FG000|Overall Study|Withdrawal by Subject|1|||
44365429|NCT00836953|79370551|FG000|Overall Study|Withdrawal by Subject|1|||
44365430|NCT00836953|79370551|FG000|Overall Study|Lost to Follow-up|1|||
44365431|NCT01070316|79370555|FG000|Extension Phase|Lack of Efficacy|3|||
44365432|NCT01070316|79370555|FG000|Extension Phase|Withdrawal by Subject|1|||
44365433|NCT01126541|79370562|FG000|Overall Study|Adverse Event|0|||
44365434|NCT01126541|79370563|FG001|Overall Study|Adverse Event|2|||
44365435|NCT01126541|79370564|FG002|Overall Study|Adverse Event|4|||
44365436|NCT01126541|79370562|FG000|Overall Study|Death|0|||
44365437|NCT01126541|79370563|FG001|Overall Study|Death|1|||
44365438|NCT01126541|79370564|FG002|Overall Study|Death|0|||
44365439|NCT01126541|79370562|FG000|Overall Study|Lack of Efficacy|6|||
44365440|NCT01126541|79370563|FG001|Overall Study|Lack of Efficacy|1|||
44365441|NCT01126541|79370564|FG002|Overall Study|Lack of Efficacy|11|||
44365442|NCT01126541|79370562|FG000|Overall Study|Lost to Follow-up|1|||
44365443|NCT01126541|79370563|FG001|Overall Study|Lost to Follow-up|2|||
44365444|NCT01126541|79370564|FG002|Overall Study|Lost to Follow-up|2|||
44452009|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
44452010|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
44452011|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
44204352|NCT02104583|79000158|FG004|Overall Study|Death|5|||
44365445|NCT01126541|79370562|FG000|Overall Study|Withdrawal by Subject|2|||
44365446|NCT01126541|79370563|FG001|Overall Study|Withdrawal by Subject|5|||
44365447|NCT01126541|79370564|FG002|Overall Study|Withdrawal by Subject|6|||
44365448|NCT01126541|79370562|FG000|Overall Study|Protocol Violation|0|||
44365449|NCT01126541|79370563|FG001|Overall Study|Protocol Violation|0|||
44365450|NCT01126541|79370564|FG002|Overall Study|Protocol Violation|1|||
44365451|NCT01126541|79370562|FG000|Overall Study|Administrative reason or other|1|||
44365452|NCT01126541|79370563|FG001|Overall Study|Administrative reason or other|1|||
44365453|NCT01126541|79370564|FG002|Overall Study|Administrative reason or other|2|||
44204353|NCT02104583|79000154|FG000|Overall Study|Subject required cardiac ablation|6|||
44204354|NCT02104583|79000155|FG001|Overall Study|Subject required cardiac ablation|4|||
44365454|NCT00836875|79370576|FG000|Overall Study|Death|3|||
44365455|NCT00836875|79370577|FG001|Overall Study|Death|2|||
44365456|NCT00836875|79370576|FG000|Overall Study|Withdrawal by Subject|0|||
44365457|NCT00836875|79370577|FG001|Overall Study|Withdrawal by Subject|1|||
44365458|NCT01125917|79370583|FG000|Overall Study|Adverse Event|43|||
44365459|NCT01125917|79370583|FG000|Overall Study|Lost to Follow-up|23|||
44365460|NCT01125917|79370583|FG000|Overall Study|Withdrawal by Subject|31|||
44365461|NCT01125917|79370583|FG000|Overall Study|Administrative|223|||
44365462|NCT01125917|79370583|FG000|Overall Study|Lack of Efficacy|19|||
44365463|NCT00847561|79370589|FG000|Overall Study|Withdrawal by Subject|4|||
44365464|NCT00847561|79370590|FG001|Overall Study|Withdrawal by Subject|3|||
44365465|NCT00847561|79370589|FG000|Overall Study|Unable to schedule|9|||
44365466|NCT00847561|79370590|FG001|Overall Study|Unable to schedule|1|||
44365467|NCT01121549|79370596|FG000|Overall Study|Adverse Event|10|||
44365468|NCT01121549|79370596|FG000|Overall Study|Lack of Efficacy|11|||
44365469|NCT01121549|79370596|FG000|Overall Study|Lost to Follow-up|12|||
44365470|NCT01121549|79370596|FG000|Overall Study|Did not meet entrance criteria|9|||
44365471|NCT01121549|79370596|FG000|Overall Study|Study terminated by sponsor|197|||
44365472|NCT01121549|79370596|FG000|Overall Study|Pregnancy|1|||
44365473|NCT01121549|79370596|FG000|Overall Study|Protocol Violation|33|||
44365474|NCT01121549|79370596|FG000|Overall Study|Withdrawal by Subject|16|||
44365475|NCT01121549|79370596|FG000|Overall Study|Other|58|||
44365476|NCT00847405|79370602|FG000|First Intervention|Adverse Event|0|||
44365477|NCT00847405|79370603|FG001|First Intervention|Adverse Event|1|||
44365478|NCT00847405|79370602|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44365479|NCT00847405|79370603|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44365480|NCT00836095|79370609|FG000|Overall Study|Physician Decision|0|||
44365481|NCT00836095|79370610|FG001|Overall Study|Physician Decision|3|||
44365482|NCT00835237|79370627|FG000|Overall Study|Lost to Follow-up|4|||
44365483|NCT00835237|79370628|FG001|Overall Study|Lost to Follow-up|0|||
44365484|NCT00835237|79370627|FG000|Overall Study|Withdrawal by Subject|2|||
44365485|NCT00835237|79370628|FG001|Overall Study|Withdrawal by Subject|0|||
44365486|NCT01072500|79370636|FG000|Overall Study|Death|2|||
44365487|NCT01072500|79370637|FG001|Overall Study|Death|2|||
44365488|NCT01072500|79370636|FG000|Overall Study|Lost to Follow-up|5|||
44365489|NCT01072500|79370637|FG001|Overall Study|Lost to Follow-up|2|||
44365490|NCT01072500|79370636|FG000|Overall Study|Withdrawal by Subject|17|||
44365491|NCT01072500|79370637|FG001|Overall Study|Withdrawal by Subject|10|||
44365492|NCT00847015|79370645|FG000|Overall Study|Withdrawal by Subject|1|||
44365493|NCT00847015|79370645|FG000|Overall Study|declined any surgery|1|||
44365494|NCT00847015|79370645|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
44365495|NCT00855595|79370651|FG000|Overall Study|Withdrawal by Subject|1|||
44365496|NCT00855595|79370652|FG001|Overall Study|Withdrawal by Subject|2|||
44365497|NCT00855595|79370651|FG000|Overall Study|Lost to Follow-up|3|||
44365498|NCT00855595|79370652|FG001|Overall Study|Lost to Follow-up|3|||
44365499|NCT00855595|79370651|FG000|Overall Study|Adverse Event|1|||
44365500|NCT00855595|79370652|FG001|Overall Study|Adverse Event|1|||
44365501|NCT00855595|79370651|FG000|Overall Study|patient moved out of state|1|||
44365502|NCT00855595|79370652|FG001|Overall Study|patient moved out of state|0|||
44365503|NCT00855595|79370651|FG000|Overall Study|patient left country|0|||
44365504|NCT00855595|79370652|FG001|Overall Study|patient left country|1|||
44365505|NCT00855439|79370660|FG000|Overall Study|Withdrawal by Subject|2|||
44365506|NCT00855439|79370661|FG001|Overall Study|Withdrawal by Subject|0|||
44365507|NCT00855439|79370660|FG000|Overall Study|Pregnancy|1|||
44365508|NCT00855439|79370661|FG001|Overall Study|Pregnancy|0|||
44365509|NCT01064856|79370669|FG000|Double-blind (DB) Period|Adverse Event|1|||
44365510|NCT01064856|79370670|FG001|Double-blind (DB) Period|Adverse Event|0|||
44365511|NCT01064856|79370671|FG002|Double-blind (DB) Period|Adverse Event|0|||
44365512|NCT01064856|79370672|FG003|Double-blind (DB) Period|Adverse Event|0|||
44269317|NCT02310750|79192412|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269318|NCT02310750|79192413|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269319|NCT02310750|79192414|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269320|NCT02310750|79192415|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
44269321|NCT02310750|79192400|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269322|NCT02310750|79192401|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269323|NCT02310750|79192402|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269324|NCT02310750|79192403|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269325|NCT02310750|79192404|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269326|NCT02310750|79192405|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44365513|NCT01064856|79370669|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
44365514|NCT01064856|79370670|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
44365515|NCT01064856|79370671|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
44365516|NCT01064856|79370672|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
44365517|NCT01064856|79370669|FG000|Open-label (OL) Period|Adverse Event|0|||
44365518|NCT01064856|79370670|FG001|Open-label (OL) Period|Adverse Event|0|||
44365519|NCT01064856|79370671|FG002|Open-label (OL) Period|Adverse Event|12|||
44365520|NCT01064856|79370672|FG003|Open-label (OL) Period|Adverse Event|6|||
44365521|NCT01064856|79370669|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
44204355|NCT02104583|79000156|FG002|Overall Study|Subject required cardiac ablation|4|||
44204356|NCT02104583|79000157|FG003|Overall Study|Subject required cardiac ablation|5|||
44204357|NCT02104583|79000158|FG004|Overall Study|Subject required cardiac ablation|4|||
44204358|NCT02104583|79000154|FG000|Overall Study|Subject required prohibited medication|0|||
44204359|NCT02104583|79000155|FG001|Overall Study|Subject required prohibited medication|1|||
44204360|NCT02104583|79000156|FG002|Overall Study|Subject required prohibited medication|1|||
44204361|NCT02104583|79000157|FG003|Overall Study|Subject required prohibited medication|0|||
44204362|NCT02104583|79000158|FG004|Overall Study|Subject required prohibited medication|1|||
44204363|NCT02104583|79000154|FG000|Overall Study|Withdrew Consent|3|||
44204364|NCT02104583|79000155|FG001|Overall Study|Withdrew Consent|2|||
44204365|NCT02104583|79000156|FG002|Overall Study|Withdrew Consent|0|||
44204366|NCT02104583|79000157|FG003|Overall Study|Withdrew Consent|2|||
44204367|NCT02104583|79000158|FG004|Overall Study|Withdrew Consent|1|||
44204368|NCT02104583|79000154|FG000|Overall Study|Investigator's Discretion|1|||
44452012|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
44204369|NCT02104583|79000155|FG001|Overall Study|Investigator's Discretion|0|||
44204370|NCT02104583|79000156|FG002|Overall Study|Investigator's Discretion|0|||
44204371|NCT02104583|79000157|FG003|Overall Study|Investigator's Discretion|0|||
44204372|NCT02104583|79000158|FG004|Overall Study|Investigator's Discretion|0|||
44204373|NCT02104583|79000154|FG000|Overall Study|Protocol Violation|0|||
44204374|NCT02104583|79000155|FG001|Overall Study|Protocol Violation|0|||
44204375|NCT02104583|79000156|FG002|Overall Study|Protocol Violation|1|||
44204376|NCT02104583|79000157|FG003|Overall Study|Protocol Violation|0|||
44204377|NCT02104583|79000158|FG004|Overall Study|Protocol Violation|0|||
44204378|NCT02104583|79000154|FG000|Overall Study|Adverse Event|3|||
44204379|NCT02104583|79000155|FG001|Overall Study|Adverse Event|3|||
44204380|NCT02104583|79000156|FG002|Overall Study|Adverse Event|6|||
44204381|NCT02104583|79000157|FG003|Overall Study|Adverse Event|6|||
44204382|NCT02104583|79000158|FG004|Overall Study|Adverse Event|1|||
44204383|NCT02104583|79000154|FG000|Overall Study|Lost to Follow-up|1|||
44204384|NCT02104583|79000155|FG001|Overall Study|Lost to Follow-up|0|||
44204385|NCT02104583|79000156|FG002|Overall Study|Lost to Follow-up|0|||
44204386|NCT02104583|79000157|FG003|Overall Study|Lost to Follow-up|0|||
44204387|NCT02104583|79000158|FG004|Overall Study|Lost to Follow-up|0|||
44204388|NCT02104583|79000154|FG000|Overall Study|Randomized but Never Treated|0|||
44204389|NCT02104583|79000155|FG001|Overall Study|Randomized but Never Treated|0|||
44204390|NCT02104583|79000156|FG002|Overall Study|Randomized but Never Treated|0|||
44204391|NCT02104583|79000157|FG003|Overall Study|Randomized but Never Treated|1|||
44204392|NCT02104583|79000158|FG004|Overall Study|Randomized but Never Treated|0|||
44204393|NCT02073929|79000181|FG000|Overall Study|Lost to Follow-up|2|||
44204394|NCT02073929|79000182|FG001|Overall Study|Lost to Follow-up|1|||
44204395|NCT02073929|79000181|FG000|Overall Study|Adverse Event|2|||
44204396|NCT02073929|79000182|FG001|Overall Study|Adverse Event|1|||
44204397|NCT02073929|79000181|FG000|Overall Study|Withdrawal by Subject|0|||
44204398|NCT02073929|79000182|FG001|Overall Study|Withdrawal by Subject|1|||
44204399|NCT02113007|79000188|FG000|Overall Study|Progressive disease|2|||
44204400|NCT02104505|79000194|FG000|First Intervention (14 Days)|Adverse Event|2|||
44204401|NCT02104505|79000195|FG001|First Intervention (14 Days)|Adverse Event|0|||
44204402|NCT02104505|79000194|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
44204403|NCT02104505|79000195|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
44204404|NCT02104505|79000194|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
44204405|NCT02104505|79000195|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
44204406|NCT02104505|79000194|FG000|First Intervention (14 Days)|exclusionary condition|0|||
44204407|NCT02104505|79000195|FG001|First Intervention (14 Days)|exclusionary condition|1|||
44204408|NCT02104505|79000194|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
44204409|NCT02104505|79000195|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
44204410|NCT02104505|79000194|FG000|Second Intervention (14 Days)|Adverse Event|2|||
44204411|NCT02104505|79000195|FG001|Second Intervention (14 Days)|Adverse Event|0|||
44204412|NCT02111993|79000204|FG000|Overall Study|Physician Decision|5|||
44204413|NCT02111993|79000205|FG001|Overall Study|Physician Decision|4|||
44204414|NCT01959607|79000215|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
44204415|NCT01959607|79000216|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
44204416|NCT01959607|79000217|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
44204417|NCT01959607|79000218|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
44204418|NCT02111603|79000227|FG000|Overall Study|Withdrawal by Subject|1|||
44365522|NCT01064856|79370670|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
44204419|NCT02102399|79000233|FG000|Overall Study|Withdrawal by Subject|6|||
44204420|NCT02102399|79000234|FG001|Overall Study|Withdrawal by Subject|4|||
44204421|NCT02111369|79000245|FG000|Overall Study|Lost to Follow-up|2|||
44204422|NCT02111369|79000245|FG000|Overall Study|Withdrawal by Subject|1|||
44204423|NCT02111213|79000251|FG000|Overall Study|Withdrawal by Subject|3|||
44365523|NCT01064856|79370671|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
44365524|NCT01064856|79370672|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
44204424|NCT02111213|79000252|FG001|Overall Study|Withdrawal by Subject|2|||
44204425|NCT02111213|79000251|FG000|Overall Study|Lost to Follow-up|3|||
44204426|NCT02111213|79000252|FG001|Overall Study|Lost to Follow-up|4|||
44365525|NCT01064856|79370669|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
44365526|NCT01064856|79370670|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
44365527|NCT01064856|79370671|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
44365528|NCT01064856|79370672|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
44365529|NCT01064856|79370669|FG000|Open-label (OL) Period|Other|0|||
44365530|NCT01064856|79370670|FG001|Open-label (OL) Period|Other|0|||
44365531|NCT01064856|79370671|FG002|Open-label (OL) Period|Other|7|||
44365532|NCT01064856|79370672|FG003|Open-label (OL) Period|Other|7|||
44204427|NCT02110901|79000260|FG000|Overall Study|Death|6|||
44204428|NCT02110901|79000261|FG001|Overall Study|Death|3|||
44204429|NCT02110901|79000260|FG000|Overall Study|Lost to Follow-up|12|||
44204430|NCT02110901|79000261|FG001|Overall Study|Lost to Follow-up|8|||
44204431|NCT02110901|79000260|FG000|Overall Study|Withdrawal by Subject|7|||
44204432|NCT02110901|79000261|FG001|Overall Study|Withdrawal by Subject|3|||
44204433|NCT02110901|79000260|FG000|Overall Study|received a kidney transplant|5|||
44204434|NCT02110901|79000261|FG001|Overall Study|received a kidney transplant|0|||
44204435|NCT02070965|79000271|FG000|Overall Study|Lost to Follow-up|0|||
44204436|NCT02070965|79000272|FG001|Overall Study|Lost to Follow-up|1|||
44204437|NCT02070965|79000273|FG002|Overall Study|Lost to Follow-up|0|||
44204438|NCT02070965|79000271|FG000|Overall Study|Withdrawal by Subject|1|||
44204439|NCT02070965|79000272|FG001|Overall Study|Withdrawal by Subject|1|||
44204440|NCT02070965|79000273|FG002|Overall Study|Withdrawal by Subject|1|||
44204441|NCT02070965|79000271|FG000|Overall Study|Subject moved|1|||
44204442|NCT02070965|79000272|FG001|Overall Study|Subject moved|0|||
44204443|NCT02070965|79000273|FG002|Overall Study|Subject moved|0|||
44204444|NCT02109107|79000281|FG000|Overall Study|Lost to Follow-up|2|||
44204445|NCT02100839|79000287|FG000|Multiple Ascending Dose|Adverse Event|2|||
44204446|NCT02100839|79000288|FG001|Multiple Ascending Dose|Adverse Event|0|||
44204447|NCT02100839|79000287|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
44204448|NCT02100839|79000288|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
44204449|NCT02069093|79000294|FG000|Overall Study|Disease progression|14|||
44204450|NCT02069093|79000294|FG000|Overall Study|New cancer therapy|1|||
44204451|NCT02069093|79000294|FG000|Overall Study|Death|1|||
44204452|NCT02069093|79000294|FG000|Overall Study|Administrative problems|1|||
44204453|NCT02069093|79000294|FG000|Overall Study|Withdrawal by Subject|2|||
44204454|NCT02069093|79000294|FG000|Overall Study|Abnormal laboratory values|1|||
44204455|NCT02069093|79000294|FG000|Overall Study|Adverse Event|10|||
44204456|NCT02109029|79000301|FG000|Part B|Adverse Event|0|||
44204457|NCT02109029|79000302|FG001|Part B|Adverse Event|0|||
44204458|NCT02109029|79000303|FG002|Part B|Adverse Event|0|||
44204459|NCT02109029|79000304|FG003|Part B|Adverse Event|0|||
44204460|NCT02109029|79000305|FG004|Part B|Adverse Event|1|||
44204461|NCT02109029|79000306|FG005|Part B|Adverse Event|1|||
44365533|NCT00846391|79370682|FG000|Overall Study|Physician Decision|0|||
44365534|NCT00846391|79370683|FG001|Overall Study|Physician Decision|0|||
44365535|NCT00846391|79370684|FG002|Overall Study|Physician Decision|1|||
44365536|NCT00846391|79370682|FG000|Overall Study|Study Terminated by Sponsor|1|||
44365537|NCT00846391|79370683|FG001|Overall Study|Study Terminated by Sponsor|2|||
44365538|NCT00846391|79370684|FG002|Overall Study|Study Terminated by Sponsor|2|||
44365539|NCT01042392|79370694|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
44365540|NCT01042392|79370695|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
44365541|NCT01042392|79370696|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
44365542|NCT01042392|79370697|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
44365543|NCT01042392|79370694|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
44365544|NCT01042392|79370695|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
44365545|NCT01042392|79370696|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
44365546|NCT01042392|79370697|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
44365547|NCT01042392|79370694|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
44365548|NCT01042392|79370695|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
44365549|NCT01042392|79370696|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
44204462|NCT02069015|79000319|FG000|Overall Study|Lost to Follow-up|39|||
44204463|NCT02069015|79000320|FG001|Overall Study|Lost to Follow-up|32|||
44204464|NCT02069015|79000319|FG000|Overall Study|Withdrawal by Subject|1|||
44204465|NCT02069015|79000320|FG001|Overall Study|Withdrawal by Subject|1|||
44204466|NCT01598129|79000327|FG000|Overall Study|Disease progression|6|||
44204467|NCT01598129|79000327|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
44204468|NCT01598129|79000327|FG000|Overall Study|Withdrawal by Subject|1|||
44204469|NCT02068547|79000334|FG000|Overall Study|Lost to Follow-up|3|||
44365550|NCT01042392|79370697|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
44365551|NCT01042392|79370694|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
44204470|NCT02068547|79000335|FG001|Overall Study|Lost to Follow-up|3|||
44365552|NCT01042392|79370695|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
44365553|NCT01042392|79370696|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
44365554|NCT01042392|79370697|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
44365555|NCT01042392|79370694|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
44365556|NCT01042392|79370695|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
44204471|NCT02068547|79000334|FG000|Overall Study|Physician Decision|1|||
44204472|NCT02068547|79000335|FG001|Overall Study|Physician Decision|0|||
44204473|NCT02108951|79000341|FG000|Overall Study|Lost to Follow-up|1|||
44204474|NCT02108951|79000341|FG000|Overall Study|Patient's/guardian's decision|1|||
44204475|NCT02108951|79000341|FG000|Overall Study|Study Terminated by Sponsor|14|||
44204476|NCT02107859|79000345|FG000|Overall Study|Withdrawal by Subject|14|||
44204477|NCT02107859|79000345|FG000|Overall Study|Adverse Event|3|||
44204478|NCT02107859|79000345|FG000|Overall Study|Study closure|41|||
44204479|NCT02107859|79000345|FG000|Overall Study|Other than specified|3|||
44204480|NCT02007278|79000351|FG000|Overall Study|Failure to comply with an eligibility|0|||
44204481|NCT02007278|79000352|FG001|Overall Study|Failure to comply with an eligibility|1|||
44204482|NCT02007278|79000351|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
44204483|NCT02007278|79000352|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
44204484|NCT02007278|79000351|FG000|Overall Study|Incorrect medication administration|1|||
44204485|NCT02007278|79000352|FG001|Overall Study|Incorrect medication administration|0|||
44204486|NCT02007278|79000351|FG000|Overall Study|Mis-randomization|1|||
44204487|NCT02007278|79000352|FG001|Overall Study|Mis-randomization|1|||
44204488|NCT02107313|79000358|FG000|Overall Study|One participant did not do the FED cohor|0|||
44204489|NCT02107313|79000359|FG001|Overall Study|One participant did not do the FED cohor|1|||
44204490|NCT02028338|79000367|FG000|Overall Study|Withdrawal by Subject|3|||
44204491|NCT02028338|79000368|FG001|Overall Study|Withdrawal by Subject|1|||
44204492|NCT02028338|79000367|FG000|Overall Study|Unable to contact participant|1|||
44204493|NCT02028338|79000368|FG001|Overall Study|Unable to contact participant|0|||
44204494|NCT01625897|79000376|FG000|Overall Study|Adverse Event|27|||
44204495|NCT01625897|79000377|FG001|Overall Study|Adverse Event|10|||
44204496|NCT01625897|79000376|FG000|Overall Study|Physician Decision|0|||
44204497|NCT01625897|79000377|FG001|Overall Study|Physician Decision|1|||
44204498|NCT01625897|79000376|FG000|Overall Study|Withdrawal by Subject|25|||
44204499|NCT01625897|79000377|FG001|Overall Study|Withdrawal by Subject|3|||
44204500|NCT02106923|79000386|FG000|Overall Study|Protocol Violation|0|||
44204501|NCT02106923|79000387|FG001|Overall Study|Protocol Violation|0|||
44204502|NCT02106923|79000388|FG002|Overall Study|Protocol Violation|0|||
44204503|NCT02106923|79000389|FG003|Overall Study|Protocol Violation|0|||
44204504|NCT02106923|79000390|FG004|Overall Study|Protocol Violation|0|||
44204505|NCT02106923|79000391|FG005|Overall Study|Protocol Violation|1|||
44204506|NCT02006732|79000409|FG000|Overall Study|Adverse Event|10|||
44204507|NCT02006732|79000410|FG001|Overall Study|Adverse Event|7|||
44204508|NCT02006732|79000411|FG002|Overall Study|Adverse Event|4|||
44204509|NCT02006732|79000412|FG003|Overall Study|Adverse Event|2|||
44204510|NCT02006732|79000409|FG000|Overall Study|Lack of Efficacy|6|||
44204511|NCT02006732|79000410|FG001|Overall Study|Lack of Efficacy|3|||
44204512|NCT02006732|79000411|FG002|Overall Study|Lack of Efficacy|1|||
44204513|NCT02006732|79000412|FG003|Overall Study|Lack of Efficacy|1|||
44204514|NCT02006732|79000409|FG000|Overall Study|Protocol Violation|1|||
44204515|NCT02006732|79000410|FG001|Overall Study|Protocol Violation|1|||
44204516|NCT02006732|79000411|FG002|Overall Study|Protocol Violation|0|||
44204517|NCT02006732|79000412|FG003|Overall Study|Protocol Violation|0|||
44204518|NCT02006732|79000409|FG000|Overall Study|Lost to Follow-up|0|||
44204519|NCT02006732|79000410|FG001|Overall Study|Lost to Follow-up|1|||
44204520|NCT02006732|79000411|FG002|Overall Study|Lost to Follow-up|0|||
44204521|NCT02006732|79000412|FG003|Overall Study|Lost to Follow-up|0|||
44204522|NCT02006732|79000409|FG000|Overall Study|Withdrawal by Subject|3|||
44204523|NCT02006732|79000410|FG001|Overall Study|Withdrawal by Subject|0|||
44204524|NCT02006732|79000411|FG002|Overall Study|Withdrawal by Subject|4|||
44204525|NCT02006732|79000412|FG003|Overall Study|Withdrawal by Subject|1|||
44204526|NCT02098733|79000422|FG000|Overall Study|Data Not Available|5|||
44204527|NCT02098733|79000422|FG000|Overall Study|Lost to Follow-up|5|||
44204528|NCT02028182|79000426|FG000|Overall Study|Protocol Violation|2|||
44365557|NCT01042392|79370696|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
44365558|NCT01042392|79370697|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
44204529|NCT02098109|79000433|FG000|Overall Study|Protocol Violation|3|||
44204530|NCT02098109|79000434|FG001|Overall Study|Protocol Violation|0|||
44204531|NCT02097719|79000442|FG000|Overall Study|Subject Withdrew Consent|1|||
44204532|NCT02097719|79000443|FG001|Overall Study|Subject Withdrew Consent|0|||
44204533|NCT02097719|79000442|FG000|Overall Study|Lost to Follow-up|0|||
44204534|NCT02097719|79000443|FG001|Overall Study|Lost to Follow-up|1|||
44204535|NCT02097719|79000442|FG000|Overall Study|Adverse Event|2|||
44204536|NCT02097719|79000443|FG001|Overall Study|Adverse Event|0|||
44204537|NCT01449370|79000474|FG000|Overall Study|Disease Progression|5|||
44204538|NCT01449370|79000475|FG001|Overall Study|Disease Progression|4|||
44204539|NCT01449370|79000476|FG002|Overall Study|Disease Progression|8|||
44204540|NCT01449370|79000477|FG003|Overall Study|Disease Progression|3|||
44365559|NCT01042392|79370694|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
44365560|NCT01042392|79370695|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
44365561|NCT01042392|79370696|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
44365562|NCT01042392|79370697|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
44365563|NCT01042392|79370694|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
44452013|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
44204541|NCT01449370|79000478|FG004|Overall Study|Disease Progression|3|||
44204542|NCT01449370|79000479|FG005|Overall Study|Disease Progression|3|||
44204543|NCT01449370|79000480|FG006|Overall Study|Disease Progression|3|||
44204544|NCT01449370|79000481|FG007|Overall Study|Disease Progression|2|||
44204545|NCT01449370|79000482|FG008|Overall Study|Disease Progression|9|||
44204546|NCT01449370|79000483|FG009|Overall Study|Disease Progression|1|||
44204547|NCT01449370|79000484|FG010|Overall Study|Disease Progression|3|||
44204548|NCT01449370|79000485|FG011|Overall Study|Disease Progression|3|||
44204549|NCT01449370|79000486|FG012|Overall Study|Disease Progression|2|||
44204550|NCT01449370|79000487|FG013|Overall Study|Disease Progression|8|||
44204551|NCT01449370|79000488|FG014|Overall Study|Disease Progression|3|||
44204552|NCT01449370|79000489|FG015|Overall Study|Disease Progression|1|||
44204553|NCT01449370|79000490|FG016|Overall Study|Disease Progression|4|||
44204554|NCT01449370|79000491|FG017|Overall Study|Disease Progression|3|||
44204555|NCT01449370|79000492|FG018|Overall Study|Disease Progression|1|||
44204556|NCT01449370|79000493|FG019|Overall Study|Disease Progression|2|||
44204557|NCT01449370|79000494|FG020|Overall Study|Disease Progression|5|||
44204558|NCT01449370|79000495|FG021|Overall Study|Disease Progression|2|||
44204559|NCT01449370|79000496|FG022|Overall Study|Disease Progression|3|||
44204560|NCT01449370|79000497|FG023|Overall Study|Disease Progression|7|||
44204561|NCT01449370|79000498|FG024|Overall Study|Disease Progression|3|||
44204562|NCT01449370|79000474|FG000|Overall Study|Adverse Event|1|||
44204563|NCT01449370|79000475|FG001|Overall Study|Adverse Event|2|||
44204564|NCT01449370|79000476|FG002|Overall Study|Adverse Event|0|||
44204565|NCT01449370|79000477|FG003|Overall Study|Adverse Event|1|||
44204566|NCT01449370|79000478|FG004|Overall Study|Adverse Event|0|||
44204567|NCT01449370|79000479|FG005|Overall Study|Adverse Event|0|||
44204568|NCT01449370|79000480|FG006|Overall Study|Adverse Event|0|||
44204569|NCT01449370|79000481|FG007|Overall Study|Adverse Event|0|||
44204570|NCT01449370|79000482|FG008|Overall Study|Adverse Event|1|||
44204571|NCT01449370|79000483|FG009|Overall Study|Adverse Event|1|||
44204572|NCT01449370|79000484|FG010|Overall Study|Adverse Event|0|||
44204573|NCT01449370|79000485|FG011|Overall Study|Adverse Event|0|||
44204574|NCT01449370|79000486|FG012|Overall Study|Adverse Event|0|||
44204575|NCT01449370|79000487|FG013|Overall Study|Adverse Event|2|||
44204576|NCT01449370|79000488|FG014|Overall Study|Adverse Event|0|||
44204577|NCT01449370|79000489|FG015|Overall Study|Adverse Event|1|||
44204578|NCT01449370|79000490|FG016|Overall Study|Adverse Event|0|||
44204579|NCT01449370|79000491|FG017|Overall Study|Adverse Event|0|||
44204580|NCT01449370|79000492|FG018|Overall Study|Adverse Event|1|||
44204581|NCT01449370|79000493|FG019|Overall Study|Adverse Event|1|||
44204582|NCT01449370|79000494|FG020|Overall Study|Adverse Event|0|||
44204583|NCT01449370|79000495|FG021|Overall Study|Adverse Event|1|||
44204584|NCT01449370|79000496|FG022|Overall Study|Adverse Event|0|||
44204585|NCT01449370|79000497|FG023|Overall Study|Adverse Event|1|||
44204586|NCT01449370|79000498|FG024|Overall Study|Adverse Event|3|||
44204587|NCT01449370|79000474|FG000|Overall Study|Participant Decision|0|||
44204588|NCT01449370|79000475|FG001|Overall Study|Participant Decision|0|||
44204589|NCT01449370|79000476|FG002|Overall Study|Participant Decision|0|||
44204590|NCT01449370|79000477|FG003|Overall Study|Participant Decision|0|||
44204591|NCT01449370|79000478|FG004|Overall Study|Participant Decision|0|||
44204592|NCT01449370|79000479|FG005|Overall Study|Participant Decision|0|||
44204593|NCT01449370|79000480|FG006|Overall Study|Participant Decision|0|||
44204594|NCT01449370|79000481|FG007|Overall Study|Participant Decision|1|||
44204595|NCT01449370|79000482|FG008|Overall Study|Participant Decision|1|||
44452014|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
44204596|NCT01449370|79000483|FG009|Overall Study|Participant Decision|0|||
44204597|NCT01449370|79000484|FG010|Overall Study|Participant Decision|0|||
44204598|NCT01449370|79000485|FG011|Overall Study|Participant Decision|0|||
44204599|NCT01449370|79000486|FG012|Overall Study|Participant Decision|1|||
44204600|NCT01449370|79000487|FG013|Overall Study|Participant Decision|1|||
44204601|NCT01449370|79000488|FG014|Overall Study|Participant Decision|0|||
44204602|NCT01449370|79000489|FG015|Overall Study|Participant Decision|1|||
44204603|NCT01449370|79000490|FG016|Overall Study|Participant Decision|3|||
44204604|NCT01449370|79000491|FG017|Overall Study|Participant Decision|0|||
44204605|NCT01449370|79000492|FG018|Overall Study|Participant Decision|1|||
44204606|NCT01449370|79000493|FG019|Overall Study|Participant Decision|0|||
44204607|NCT01449370|79000494|FG020|Overall Study|Participant Decision|0|||
44204608|NCT01449370|79000495|FG021|Overall Study|Participant Decision|1|||
44365564|NCT01042392|79370695|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
44204609|NCT01449370|79000496|FG022|Overall Study|Participant Decision|0|||
44365565|NCT01042392|79370696|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
44365566|NCT01042392|79370697|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
44365567|NCT01042392|79370694|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
44365568|NCT01042392|79370695|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
44365569|NCT01042392|79370696|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
44365570|NCT01042392|79370697|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
44365571|NCT01042392|79370694|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
44365572|NCT01042392|79370695|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
44365573|NCT01042392|79370696|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
44365574|NCT01042392|79370697|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
44365575|NCT01064310|79370711|FG000|Period 1|Adverse Event|7|||
44365576|NCT01064310|79370712|FG001|Period 1|Adverse Event|10|||
44365577|NCT01064310|79370713|FG002|Period 1|Adverse Event|0|||
44365578|NCT01064310|79370711|FG000|Period 1|Physician Decision|1|||
44365579|NCT01064310|79370712|FG001|Period 1|Physician Decision|0|||
44365580|NCT01064310|79370713|FG002|Period 1|Physician Decision|0|||
44365581|NCT01064310|79370711|FG000|Period 1|Withdrawal by Subject|2|||
44365582|NCT01064310|79370712|FG001|Period 1|Withdrawal by Subject|2|||
44365583|NCT01064310|79370713|FG002|Period 1|Withdrawal by Subject|0|||
44204610|NCT01449370|79000497|FG023|Overall Study|Participant Decision|0|||
44204611|NCT01449370|79000498|FG024|Overall Study|Participant Decision|1|||
44204612|NCT01449370|79000474|FG000|Overall Study|Lost to Follow-up|0|||
44204613|NCT01449370|79000475|FG001|Overall Study|Lost to Follow-up|0|||
44204614|NCT01449370|79000476|FG002|Overall Study|Lost to Follow-up|0|||
44204615|NCT01449370|79000477|FG003|Overall Study|Lost to Follow-up|0|||
44204616|NCT01449370|79000478|FG004|Overall Study|Lost to Follow-up|0|||
44204617|NCT01449370|79000479|FG005|Overall Study|Lost to Follow-up|0|||
44204618|NCT01449370|79000480|FG006|Overall Study|Lost to Follow-up|0|||
44204619|NCT01449370|79000481|FG007|Overall Study|Lost to Follow-up|0|||
44204620|NCT01449370|79000482|FG008|Overall Study|Lost to Follow-up|0|||
44204621|NCT01449370|79000483|FG009|Overall Study|Lost to Follow-up|0|||
44204622|NCT01449370|79000484|FG010|Overall Study|Lost to Follow-up|0|||
44204623|NCT01449370|79000485|FG011|Overall Study|Lost to Follow-up|0|||
44204624|NCT01449370|79000486|FG012|Overall Study|Lost to Follow-up|0|||
44204625|NCT01449370|79000487|FG013|Overall Study|Lost to Follow-up|0|||
44204626|NCT01449370|79000488|FG014|Overall Study|Lost to Follow-up|0|||
44204627|NCT01449370|79000489|FG015|Overall Study|Lost to Follow-up|0|||
44204628|NCT01449370|79000490|FG016|Overall Study|Lost to Follow-up|0|||
44204629|NCT01449370|79000491|FG017|Overall Study|Lost to Follow-up|0|||
44204630|NCT01449370|79000492|FG018|Overall Study|Lost to Follow-up|0|||
44204631|NCT01449370|79000493|FG019|Overall Study|Lost to Follow-up|0|||
44204632|NCT01449370|79000494|FG020|Overall Study|Lost to Follow-up|1|||
44204633|NCT01449370|79000495|FG021|Overall Study|Lost to Follow-up|0|||
44204634|NCT01449370|79000496|FG022|Overall Study|Lost to Follow-up|0|||
44204635|NCT01449370|79000497|FG023|Overall Study|Lost to Follow-up|0|||
44204636|NCT01449370|79000498|FG024|Overall Study|Lost to Follow-up|0|||
44204637|NCT01449370|79000474|FG000|Overall Study|Other|0|||
44204638|NCT01449370|79000475|FG001|Overall Study|Other|0|||
44204639|NCT01449370|79000476|FG002|Overall Study|Other|0|||
44204640|NCT01449370|79000477|FG003|Overall Study|Other|0|||
44204641|NCT01449370|79000478|FG004|Overall Study|Other|0|||
44269327|NCT02310750|79192406|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44365584|NCT01064310|79370711|FG000|Period 1|Lack of Efficacy|3|||
44365585|NCT01064310|79370712|FG001|Period 1|Lack of Efficacy|5|||
44365586|NCT01064310|79370713|FG002|Period 1|Lack of Efficacy|0|||
44365587|NCT01064310|79370711|FG000|Period 1|Entered Open-label Period|1|||
44204642|NCT01449370|79000479|FG005|Overall Study|Other|0|||
44204643|NCT01449370|79000480|FG006|Overall Study|Other|0|||
44204644|NCT01449370|79000481|FG007|Overall Study|Other|0|||
44204645|NCT01449370|79000482|FG008|Overall Study|Other|1|||
44204646|NCT01449370|79000483|FG009|Overall Study|Other|1|||
44204647|NCT01449370|79000484|FG010|Overall Study|Other|0|||
44204648|NCT01449370|79000485|FG011|Overall Study|Other|0|||
44204649|NCT01449370|79000486|FG012|Overall Study|Other|0|||
44365588|NCT01064310|79370712|FG001|Period 1|Entered Open-label Period|1|||
44365589|NCT01064310|79370713|FG002|Period 1|Entered Open-label Period|0|||
44365590|NCT01064310|79370711|FG000|Period 2|Adverse Event|2|||
44365591|NCT01064310|79370712|FG001|Period 2|Adverse Event|1|||
44365592|NCT01064310|79370713|FG002|Period 2|Adverse Event|0|||
44365593|NCT01064310|79370711|FG000|Period 2|Physician Decision|0|||
44365594|NCT01064310|79370712|FG001|Period 2|Physician Decision|1|||
44365595|NCT01064310|79370713|FG002|Period 2|Physician Decision|0|||
44365596|NCT01064310|79370711|FG000|Period 2|Entered Open-label Period|1|||
44365597|NCT01064310|79370712|FG001|Period 2|Entered Open-label Period|0|||
44365598|NCT01064310|79370713|FG002|Period 2|Entered Open-label Period|0|||
44365599|NCT01064310|79370711|FG000|Period 2|Lack of Efficacy|1|||
44365600|NCT01064310|79370712|FG001|Period 2|Lack of Efficacy|4|||
44365601|NCT01064310|79370713|FG002|Period 2|Lack of Efficacy|0|||
44365602|NCT01064310|79370711|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
44365603|NCT01064310|79370712|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
44365604|NCT01064310|79370713|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
44365605|NCT01064310|79370711|FG000|Open Label Pazopinib|Adverse Event|0|||
44365606|NCT01064310|79370712|FG001|Open Label Pazopinib|Adverse Event|0|||
44365607|NCT01064310|79370713|FG002|Open Label Pazopinib|Adverse Event|12|||
44365608|NCT01064310|79370711|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
44365609|NCT01064310|79370712|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
44365610|NCT01064310|79370713|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
44365611|NCT01064310|79370711|FG000|Open Label Pazopinib|Physician Decision|0|||
44365612|NCT01064310|79370712|FG001|Open Label Pazopinib|Physician Decision|0|||
44365613|NCT01064310|79370713|FG002|Open Label Pazopinib|Physician Decision|20|||
44365614|NCT01037244|79370726|FG000|Overall Study|Adverse Event|3|||
44365615|NCT01037244|79370727|FG001|Overall Study|Adverse Event|2|||
44365616|NCT01037244|79370728|FG002|Overall Study|Adverse Event|6|||
44365617|NCT01037244|79370729|FG003|Overall Study|Adverse Event|3|||
44365618|NCT01037244|79370726|FG000|Overall Study|Lack of Efficacy|1|||
44365619|NCT01037244|79370727|FG001|Overall Study|Lack of Efficacy|1|||
44365620|NCT01037244|79370728|FG002|Overall Study|Lack of Efficacy|0|||
44365621|NCT01037244|79370729|FG003|Overall Study|Lack of Efficacy|1|||
44365622|NCT01037244|79370726|FG000|Overall Study|Lost to Follow-up|3|||
44365623|NCT01037244|79370727|FG001|Overall Study|Lost to Follow-up|3|||
44365624|NCT01037244|79370728|FG002|Overall Study|Lost to Follow-up|4|||
44365625|NCT01037244|79370729|FG003|Overall Study|Lost to Follow-up|4|||
44365626|NCT01037244|79370726|FG000|Overall Study|Withdrawal by Subject|1|||
44365627|NCT01037244|79370727|FG001|Overall Study|Withdrawal by Subject|5|||
44365628|NCT01037244|79370728|FG002|Overall Study|Withdrawal by Subject|3|||
44365629|NCT01037244|79370729|FG003|Overall Study|Withdrawal by Subject|5|||
44365630|NCT01037244|79370726|FG000|Overall Study|Partner Withdrew Consent|2|||
44365631|NCT01037244|79370727|FG001|Overall Study|Partner Withdrew Consent|1|||
44365632|NCT01037244|79370728|FG002|Overall Study|Partner Withdrew Consent|0|||
44365633|NCT01037244|79370729|FG003|Overall Study|Partner Withdrew Consent|0|||
44365634|NCT01037244|79370726|FG000|Overall Study|Various|3|||
44365635|NCT01037244|79370727|FG001|Overall Study|Various|2|||
44365636|NCT01037244|79370728|FG002|Overall Study|Various|1|||
44365637|NCT01037244|79370729|FG003|Overall Study|Various|1|||
44365638|NCT00833989|79370743|FG000|Overall Study|Physician Decision|0|||
44365639|NCT00833989|79370744|FG001|Overall Study|Physician Decision|0|||
44365640|NCT00833989|79370745|FG002|Overall Study|Physician Decision|0|||
44365641|NCT00833989|79370746|FG003|Overall Study|Physician Decision|1|||
44365642|NCT00833989|79370743|FG000|Overall Study|Withdrawal by Subject|3|||
44365643|NCT00833989|79370744|FG001|Overall Study|Withdrawal by Subject|0|||
44365644|NCT00833989|79370745|FG002|Overall Study|Withdrawal by Subject|1|||
44365645|NCT00833989|79370746|FG003|Overall Study|Withdrawal by Subject|1|||
44365646|NCT01037088|79370759|FG000|Overall Study|Withdrawal by Subject|3|||
44365647|NCT01042236|79370768|FG000|Treatment Period 1|Adverse Event|0|||
44365648|NCT01042236|79370769|FG001|Treatment Period 1|Adverse Event|1|||
44365649|NCT01042236|79370770|FG002|Treatment Period 1|Adverse Event|0|||
44365650|NCT01042236|79370771|FG003|Treatment Period 1|Adverse Event|0|||
44204650|NCT01449370|79000487|FG013|Overall Study|Other|0|||
44365651|NCT01042236|79370772|FG004|Treatment Period 1|Adverse Event|1|||
44365652|NCT01042236|79370773|FG005|Treatment Period 1|Adverse Event|0|||
44365653|NCT01042236|79370768|FG000|Treatment Period 3|Adverse Event|0|||
44365654|NCT01042236|79370769|FG001|Treatment Period 3|Adverse Event|0|||
44365655|NCT01042236|79370770|FG002|Treatment Period 3|Adverse Event|0|||
44365656|NCT01042236|79370771|FG003|Treatment Period 3|Adverse Event|1|||
44365657|NCT01042236|79370772|FG004|Treatment Period 3|Adverse Event|0|||
44365658|NCT01042236|79370773|FG005|Treatment Period 3|Adverse Event|0|||
44365659|NCT01042236|79370768|FG000|Treatment Period 3|Protocol Violation|0|||
44204651|NCT01449370|79000488|FG014|Overall Study|Other|0|||
44365660|NCT01042236|79370769|FG001|Treatment Period 3|Protocol Violation|0|||
44365661|NCT01042236|79370770|FG002|Treatment Period 3|Protocol Violation|0|||
44365662|NCT01042236|79370771|FG003|Treatment Period 3|Protocol Violation|1|||
44365663|NCT01042236|79370772|FG004|Treatment Period 3|Protocol Violation|0|||
44365664|NCT01042236|79370773|FG005|Treatment Period 3|Protocol Violation|0|||
44365665|NCT00592501|79370781|FG000|Overall Study|Withdrawal by Subject|1|||
44365666|NCT00592501|79370781|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
44365667|NCT01040832|79370787|FG000|Overall Study|Adverse Event|4|||
44365668|NCT01040832|79370788|FG001|Overall Study|Adverse Event|5|||
44365669|NCT01040832|79370787|FG000|Overall Study|Death|4|||
44365670|NCT01040832|79370788|FG001|Overall Study|Death|6|||
44365671|NCT01040832|79370787|FG000|Overall Study|Withdrawal by Subject|2|||
44365672|NCT01040832|79370788|FG001|Overall Study|Withdrawal by Subject|3|||
44365673|NCT01040832|79370787|FG000|Overall Study|Progressive disease|32|||
44365674|NCT01040832|79370788|FG001|Overall Study|Progressive disease|17|||
44365675|NCT01040832|79370787|FG000|Overall Study|Symptomatic deterioration|2|||
44365676|NCT01040832|79370788|FG001|Overall Study|Symptomatic deterioration|5|||
44365677|NCT01040832|79370787|FG000|Overall Study|Other|2|||
44365678|NCT01040832|79370788|FG001|Overall Study|Other|1|||
44365679|NCT00854581|79370794|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
44365680|NCT00854581|79370794|FG000|Induction (Up to Day 21)|Death|1|||
44365681|NCT00854581|79370794|FG000|Induction (Up to Day 21)|Physician Decision|1|||
44365682|NCT00854581|79370794|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
44365683|NCT00833911|79370803|FG000|Titration|Adverse Event|18|||
44365684|NCT00833911|79370803|FG000|Titration|Withdrawal by Subject|3|||
44204652|NCT01449370|79000489|FG015|Overall Study|Other|0|||
44204653|NCT01449370|79000490|FG016|Overall Study|Other|0|||
44204654|NCT01449370|79000491|FG017|Overall Study|Other|0|||
44204655|NCT01449370|79000492|FG018|Overall Study|Other|0|||
44204656|NCT01449370|79000493|FG019|Overall Study|Other|0|||
44204657|NCT01449370|79000494|FG020|Overall Study|Other|0|||
44204658|NCT01449370|79000495|FG021|Overall Study|Other|0|||
44204659|NCT01449370|79000496|FG022|Overall Study|Other|1|||
44204660|NCT01449370|79000497|FG023|Overall Study|Other|1|||
44204661|NCT01449370|79000498|FG024|Overall Study|Other|0|||
44204662|NCT01449370|79000474|FG000|Overall Study|Medication Prohibited by Protocol|0|||
44204663|NCT01449370|79000475|FG001|Overall Study|Medication Prohibited by Protocol|0|||
44204664|NCT01449370|79000476|FG002|Overall Study|Medication Prohibited by Protocol|0|||
44204665|NCT01449370|79000477|FG003|Overall Study|Medication Prohibited by Protocol|0|||
44204666|NCT01449370|79000478|FG004|Overall Study|Medication Prohibited by Protocol|0|||
44204667|NCT01449370|79000479|FG005|Overall Study|Medication Prohibited by Protocol|0|||
44204668|NCT01449370|79000480|FG006|Overall Study|Medication Prohibited by Protocol|0|||
44204669|NCT01449370|79000481|FG007|Overall Study|Medication Prohibited by Protocol|0|||
44204670|NCT01449370|79000482|FG008|Overall Study|Medication Prohibited by Protocol|0|||
44204671|NCT01449370|79000483|FG009|Overall Study|Medication Prohibited by Protocol|0|||
44204672|NCT01449370|79000484|FG010|Overall Study|Medication Prohibited by Protocol|0|||
44204673|NCT01449370|79000485|FG011|Overall Study|Medication Prohibited by Protocol|0|||
44204674|NCT01449370|79000486|FG012|Overall Study|Medication Prohibited by Protocol|0|||
44204675|NCT01449370|79000487|FG013|Overall Study|Medication Prohibited by Protocol|0|||
44204676|NCT01449370|79000488|FG014|Overall Study|Medication Prohibited by Protocol|0|||
44204677|NCT01449370|79000489|FG015|Overall Study|Medication Prohibited by Protocol|0|||
44204678|NCT01449370|79000490|FG016|Overall Study|Medication Prohibited by Protocol|0|||
44204679|NCT01449370|79000491|FG017|Overall Study|Medication Prohibited by Protocol|0|||
44204680|NCT01449370|79000492|FG018|Overall Study|Medication Prohibited by Protocol|0|||
44204681|NCT01449370|79000493|FG019|Overall Study|Medication Prohibited by Protocol|0|||
44204682|NCT01449370|79000494|FG020|Overall Study|Medication Prohibited by Protocol|0|||
44204683|NCT01449370|79000495|FG021|Overall Study|Medication Prohibited by Protocol|0|||
44204684|NCT01449370|79000496|FG022|Overall Study|Medication Prohibited by Protocol|0|||
44204685|NCT01449370|79000497|FG023|Overall Study|Medication Prohibited by Protocol|1|||
44204686|NCT01449370|79000498|FG024|Overall Study|Medication Prohibited by Protocol|0|||
44204687|NCT01449370|79000474|FG000|Overall Study|Death|0|||
44204688|NCT01449370|79000475|FG001|Overall Study|Death|0|||
44204689|NCT01449370|79000476|FG002|Overall Study|Death|0|||
44204690|NCT01449370|79000477|FG003|Overall Study|Death|0|||
44204691|NCT01449370|79000478|FG004|Overall Study|Death|0|||
44365685|NCT00833911|79370803|FG000|Maintenance Phase I|Adverse Event|73|||
44365686|NCT00833911|79370803|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
44204692|NCT01449370|79000479|FG005|Overall Study|Death|0|||
44204693|NCT01449370|79000480|FG006|Overall Study|Death|0|||
44204694|NCT01449370|79000481|FG007|Overall Study|Death|0|||
44204695|NCT01449370|79000482|FG008|Overall Study|Death|0|||
44204696|NCT01449370|79000483|FG009|Overall Study|Death|0|||
44204697|NCT01449370|79000484|FG010|Overall Study|Death|0|||
44204698|NCT01449370|79000485|FG011|Overall Study|Death|0|||
44204699|NCT01449370|79000486|FG012|Overall Study|Death|0|||
44204700|NCT01449370|79000487|FG013|Overall Study|Death|0|||
44204701|NCT01449370|79000488|FG014|Overall Study|Death|0|||
44204702|NCT01449370|79000489|FG015|Overall Study|Death|0|||
44204703|NCT01449370|79000490|FG016|Overall Study|Death|0|||
44365687|NCT00833911|79370803|FG000|Maintenance Phase I|Physician Decision|10|||
44365688|NCT00833911|79370803|FG000|Maintenance Phase I|Lack of Efficacy|4|||
44365689|NCT00833911|79370803|FG000|Maintenance Phase II|Adverse Event|6|||
44365690|NCT00833911|79370803|FG000|Maintenance Phase II|Physician Decision|2|||
44365691|NCT00833911|79370803|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
44365692|NCT00833911|79370803|FG000|Maintenance Phase II|Lack of Efficacy|1|||
44365693|NCT01125293|79370817|FG000|Overall Study|Disease Progression|1|||
44365694|NCT01125293|79370818|FG001|Overall Study|Disease Progression|3|||
44365695|NCT01125293|79370819|FG002|Overall Study|Disease Progression|4|||
44365696|NCT01125293|79370820|FG003|Overall Study|Disease Progression|3|||
44365697|NCT01125293|79370821|FG004|Overall Study|Disease Progression|5|||
44204704|NCT01449370|79000491|FG017|Overall Study|Death|0|||
44204705|NCT01449370|79000492|FG018|Overall Study|Death|0|||
44204706|NCT01449370|79000493|FG019|Overall Study|Death|0|||
44204707|NCT01449370|79000494|FG020|Overall Study|Death|0|||
44204708|NCT01449370|79000495|FG021|Overall Study|Death|0|||
44204709|NCT01449370|79000496|FG022|Overall Study|Death|0|||
44204710|NCT01449370|79000497|FG023|Overall Study|Death|0|||
44204711|NCT01449370|79000498|FG024|Overall Study|Death|1|||
44204712|NCT02067533|79000573|FG000|Overall Study|Lost to Follow-up|4|||
44204713|NCT02067533|79000574|FG001|Overall Study|Lost to Follow-up|2|||
44204714|NCT02066129|79000582|FG000|Overall Study|Lost to Follow-up|13|||
44204715|NCT02066129|79000583|FG001|Overall Study|Lost to Follow-up|12|||
44204716|NCT02066129|79000582|FG000|Overall Study|Withdrawal by Subject|7|||
44204717|NCT02066129|79000583|FG001|Overall Study|Withdrawal by Subject|10|||
44204718|NCT02066129|79000582|FG000|Overall Study|Lack of Efficacy|8|||
44204719|NCT02066129|79000583|FG001|Overall Study|Lack of Efficacy|10|||
44204720|NCT02066129|79000582|FG000|Overall Study|Physician Decision|1|||
44204721|NCT02066129|79000583|FG001|Overall Study|Physician Decision|1|||
44365698|NCT01125293|79370822|FG005|Overall Study|Disease Progression|12|||
44204722|NCT02066051|79000589|FG000|Overall Study|Subject developed active GVHD|1|||
44204723|NCT01980992|79000595|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
44204724|NCT01980992|79000596|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
44204725|NCT01980992|79000595|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
44204726|NCT01980992|79000596|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
44204727|NCT01980992|79000595|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
44204728|NCT01980992|79000596|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
44204729|NCT01980992|79000595|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
44204730|NCT01980992|79000596|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
44204731|NCT01980992|79000595|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
44204732|NCT01980992|79000596|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
44204733|NCT01980992|79000595|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
44204734|NCT01980992|79000596|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
44204735|NCT02065895|79000609|FG000|Overall Study|Protocol Violation|1|||
44204736|NCT02065895|79000610|FG001|Overall Study|Protocol Violation|0|||
44204737|NCT02065895|79000611|FG002|Overall Study|Protocol Violation|0|||
44204738|NCT02065895|79000612|FG003|Overall Study|Protocol Violation|1|||
44204739|NCT02065895|79000613|FG004|Overall Study|Protocol Violation|0|||
44204740|NCT02065895|79000614|FG005|Overall Study|Protocol Violation|0|||
44204741|NCT02065895|79000609|FG000|Overall Study|Scheduling conflicts|0|||
44204742|NCT02065895|79000610|FG001|Overall Study|Scheduling conflicts|1|||
44204743|NCT02065895|79000611|FG002|Overall Study|Scheduling conflicts|0|||
44204744|NCT02065895|79000612|FG003|Overall Study|Scheduling conflicts|0|||
44204745|NCT02065895|79000613|FG004|Overall Study|Scheduling conflicts|0|||
44365699|NCT01125293|79370817|FG000|Overall Study|Adverse Event|1|||
44204746|NCT02065895|79000614|FG005|Overall Study|Scheduling conflicts|0|||
44204747|NCT02106455|79000631|FG000|Overall Study|Case Report Form Uncollected|6|||
44204748|NCT02106455|79000631|FG000|Overall Study|Protocol Deviation|2|||
44204749|NCT02006654|79000637|FG000|Overall Study|Withdrawal before treatment|4|||
44365700|NCT01125293|79370818|FG001|Overall Study|Adverse Event|0|||
44365701|NCT01125293|79370819|FG002|Overall Study|Adverse Event|0|||
44365702|NCT01125293|79370820|FG003|Overall Study|Adverse Event|0|||
44365703|NCT01125293|79370821|FG004|Overall Study|Adverse Event|2|||
44365704|NCT01125293|79370822|FG005|Overall Study|Adverse Event|8|||
44365705|NCT01125293|79370817|FG000|Overall Study|Symptomatic Deterioration|1|||
44365706|NCT01125293|79370818|FG001|Overall Study|Symptomatic Deterioration|0|||
44365707|NCT01125293|79370819|FG002|Overall Study|Symptomatic Deterioration|0|||
44365708|NCT01125293|79370820|FG003|Overall Study|Symptomatic Deterioration|0|||
44365709|NCT01125293|79370821|FG004|Overall Study|Symptomatic Deterioration|0|||
44365710|NCT01125293|79370822|FG005|Overall Study|Symptomatic Deterioration|0|||
44365711|NCT01125293|79370817|FG000|Overall Study|Death|0|||
44365712|NCT01125293|79370818|FG001|Overall Study|Death|0|||
44365713|NCT01125293|79370819|FG002|Overall Study|Death|0|||
44365714|NCT01125293|79370820|FG003|Overall Study|Death|0|||
44365715|NCT01125293|79370821|FG004|Overall Study|Death|1|||
44365716|NCT01125293|79370822|FG005|Overall Study|Death|0|||
44365717|NCT01125293|79370817|FG000|Overall Study|Withdrawal by Subject|0|||
44365718|NCT01125293|79370818|FG001|Overall Study|Withdrawal by Subject|0|||
44365719|NCT01125293|79370819|FG002|Overall Study|Withdrawal by Subject|0|||
44365720|NCT01125293|79370820|FG003|Overall Study|Withdrawal by Subject|0|||
44365721|NCT01125293|79370821|FG004|Overall Study|Withdrawal by Subject|2|||
44365722|NCT01125293|79370822|FG005|Overall Study|Withdrawal by Subject|1|||
44365723|NCT01125293|79370817|FG000|Overall Study|Physician Decision|0|||
44365724|NCT01125293|79370818|FG001|Overall Study|Physician Decision|0|||
44365725|NCT01125293|79370819|FG002|Overall Study|Physician Decision|0|||
44365726|NCT01125293|79370820|FG003|Overall Study|Physician Decision|0|||
44365727|NCT01125293|79370821|FG004|Overall Study|Physician Decision|0|||
44365728|NCT01125293|79370822|FG005|Overall Study|Physician Decision|2|||
44365729|NCT01121393|79370841|FG000|Overall Study|Progressive disease|201|||
44365730|NCT01121393|79370842|FG001|Overall Study|Progressive disease|20|||
44365731|NCT01121393|79370841|FG000|Overall Study|Other Adverse events|24|||
44365732|NCT01121393|79370842|FG001|Overall Study|Other Adverse events|45|||
44365733|NCT01121393|79370841|FG000|Overall Study|Non-compliant with protocol|0|||
44365734|NCT01121393|79370842|FG001|Overall Study|Non-compliant with protocol|3|||
44365735|NCT01121393|79370841|FG000|Overall Study|Lost to Follow-up|1|||
44365736|NCT01121393|79370842|FG001|Overall Study|Lost to Follow-up|0|||
44365737|NCT01121393|79370841|FG000|Overall Study|Refused cont. medication|7|||
44365738|NCT01121393|79370842|FG001|Overall Study|Refused cont. medication|7|||
44365739|NCT01121393|79370841|FG000|Overall Study|Not treated|3|||
44365740|NCT01121393|79370842|FG001|Overall Study|Not treated|9|||
44365741|NCT01121393|79370841|FG000|Overall Study|Other than listed|6|||
44365742|NCT01121393|79370842|FG001|Overall Study|Other than listed|0|||
44365743|NCT00937521|79370889|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
44365744|NCT00937521|79370890|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
44365745|NCT00937521|79370891|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
44365746|NCT00937521|79370892|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
44365747|NCT00937521|79370893|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
44365748|NCT00937521|79370894|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
44365749|NCT00937521|79370895|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
44365750|NCT00937521|79370896|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
44365751|NCT00937521|79370889|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
44365752|NCT00937521|79370890|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
44365753|NCT00937521|79370891|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
44365754|NCT00937521|79370892|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
44365755|NCT00937521|79370893|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
44365756|NCT00937521|79370894|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
44365757|NCT00937521|79370895|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
44365758|NCT00937521|79370896|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
44365759|NCT00937521|79370889|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
44365760|NCT00937521|79370890|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
44365761|NCT00937521|79370891|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
44365762|NCT00937521|79370892|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
44365763|NCT00937521|79370893|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
44365764|NCT00937521|79370894|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
44365765|NCT00937521|79370895|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
44365766|NCT00937521|79370896|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
44365767|NCT00937521|79370889|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
44365768|NCT00937521|79370890|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
44365769|NCT00937521|79370891|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
44365770|NCT00937521|79370892|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
44365771|NCT00937521|79370893|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
44365772|NCT00937521|79370894|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
44204750|NCT02006654|79000638|FG001|Overall Study|Withdrawal before treatment|2|||
44204751|NCT02006654|79000637|FG000|Overall Study|Adverse Event|16|||
44204752|NCT02006654|79000638|FG001|Overall Study|Adverse Event|17|||
44204753|NCT02006654|79000637|FG000|Overall Study|Death|1|||
44204754|NCT02006654|79000638|FG001|Overall Study|Death|0|||
44204755|NCT02006654|79000637|FG000|Overall Study|Withdrawal by Subject|14|||
44204756|NCT02006654|79000638|FG001|Overall Study|Withdrawal by Subject|12|||
44204757|NCT02006654|79000637|FG000|Overall Study|Protocol Violation|5|||
44204758|NCT02006654|79000638|FG001|Overall Study|Protocol Violation|8|||
44204759|NCT02006654|79000637|FG000|Overall Study|Lost to Follow-up|1|||
44204760|NCT02006654|79000638|FG001|Overall Study|Lost to Follow-up|0|||
44204761|NCT02006654|79000637|FG000|Overall Study|patient's will|2|||
44204762|NCT02006654|79000638|FG001|Overall Study|patient's will|1|||
44204763|NCT02006654|79000637|FG000|Overall Study|insufficient compliance|1|||
44204764|NCT02006654|79000638|FG001|Overall Study|insufficient compliance|0|||
44204765|NCT02006654|79000637|FG000|Overall Study|worsening cognitive condition|0|||
44204766|NCT02006654|79000638|FG001|Overall Study|worsening cognitive condition|1|||
44204767|NCT02006654|79000637|FG000|Overall Study|faecal incontinence|0|||
44204768|NCT02006654|79000638|FG001|Overall Study|faecal incontinence|1|||
44204769|NCT02006654|79000637|FG000|Overall Study|mood disorder|0|||
44204770|NCT02006654|79000638|FG001|Overall Study|mood disorder|1|||
44204771|NCT02006654|79000637|FG000|Overall Study|disallowed medication|1|||
44204772|NCT02006654|79000638|FG001|Overall Study|disallowed medication|0|||
44204773|NCT02006654|79000637|FG000|Overall Study|moving out of state|0|||
44204774|NCT02006654|79000638|FG001|Overall Study|moving out of state|1|||
44204775|NCT01980056|79000648|FG000|Overall Study|Death|1|||
44204776|NCT01980056|79000649|FG001|Overall Study|Death|1|||
44204777|NCT01980056|79000650|FG002|Overall Study|Death|0|||
44204778|NCT02027558|79000664|FG000|Overall Study|Death|0|||
44204779|NCT02027558|79000665|FG001|Overall Study|Death|1|||
44204780|NCT02027558|79000664|FG000|Overall Study|Withdrawal by Subject|2|||
44204781|NCT02027558|79000665|FG001|Overall Study|Withdrawal by Subject|0|||
44204782|NCT02027558|79000664|FG000|Overall Study|Lost to Follow-up|4|||
44204783|NCT02027558|79000665|FG001|Overall Study|Lost to Follow-up|1|||
44204784|NCT02027558|79000664|FG000|Overall Study|Refused assessment|3|||
44204785|NCT02027558|79000665|FG001|Overall Study|Refused assessment|0|||
44204786|NCT02027402|79000675|FG000|Overall Study|Withdrawal by Subject|4|||
44204787|NCT02027402|79000676|FG001|Overall Study|Withdrawal by Subject|1|||
44204788|NCT01448824|79000692|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204789|NCT01448824|79000693|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204790|NCT01448824|79000694|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204791|NCT01448824|79000695|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204792|NCT01448824|79000696|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204793|NCT01448824|79000697|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204794|NCT01448824|79000698|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
44204795|NCT01448824|79000699|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
44204796|NCT01448824|79000692|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
44204797|NCT01448824|79000693|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
44204798|NCT01448824|79000694|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
44204799|NCT01448824|79000695|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
44204800|NCT01448824|79000696|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
44269328|NCT02310750|79192407|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269329|NCT02310750|79192408|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269330|NCT02310750|79192409|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
44269331|NCT02310750|79192410|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269332|NCT02310750|79192411|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269333|NCT02310750|79192412|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269334|NCT02310750|79192413|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269335|NCT02310750|79192414|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269336|NCT02310750|79192415|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
44269337|NCT02310750|79192400|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269338|NCT02310750|79192401|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269339|NCT02310750|79192402|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269340|NCT02310750|79192403|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269341|NCT02310750|79192404|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269342|NCT02310750|79192405|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44452015|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
44204801|NCT01448824|79000697|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
44204802|NCT01448824|79000698|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
44269343|NCT02310750|79192406|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269344|NCT02310750|79192407|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
44452016|NCT00494871|79460931|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
44365773|NCT00937521|79370895|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
44365774|NCT00937521|79370896|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
44365775|NCT00937521|79370889|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
44365776|NCT00937521|79370890|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
44365777|NCT00937521|79370891|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
44365778|NCT00937521|79370892|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
44365779|NCT00937521|79370893|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
44365780|NCT00937521|79370894|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
44365781|NCT00937521|79370895|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
44365782|NCT00937521|79370896|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
44365783|NCT00937521|79370889|FG000|Booster Phase|Adverse Event|0|||
44365784|NCT00937521|79370890|FG001|Booster Phase|Adverse Event|0|||
44365785|NCT00937521|79370891|FG002|Booster Phase|Adverse Event|0|||
44365786|NCT00937521|79370892|FG003|Booster Phase|Adverse Event|0|||
44365787|NCT00937521|79370893|FG004|Booster Phase|Adverse Event|0|||
44365788|NCT00937521|79370894|FG005|Booster Phase|Adverse Event|0|||
44365789|NCT00937521|79370895|FG006|Booster Phase|Adverse Event|1|||
44365790|NCT00937521|79370896|FG007|Booster Phase|Adverse Event|0|||
44365791|NCT00937521|79370889|FG000|Booster Phase|Withdrawal by Subject|1|||
44365792|NCT00937521|79370890|FG001|Booster Phase|Withdrawal by Subject|0|||
44365793|NCT00937521|79370891|FG002|Booster Phase|Withdrawal by Subject|0|||
44365794|NCT00937521|79370892|FG003|Booster Phase|Withdrawal by Subject|1|||
44365795|NCT00937521|79370893|FG004|Booster Phase|Withdrawal by Subject|0|||
44365796|NCT00937521|79370894|FG005|Booster Phase|Withdrawal by Subject|0|||
44365797|NCT00937521|79370895|FG006|Booster Phase|Withdrawal by Subject|0|||
44365798|NCT00937521|79370896|FG007|Booster Phase|Withdrawal by Subject|2|||
44365799|NCT00937521|79370889|FG000|Booster Phase|Lost to Follow-up|2|||
44365800|NCT00937521|79370890|FG001|Booster Phase|Lost to Follow-up|2|||
44365801|NCT00937521|79370891|FG002|Booster Phase|Lost to Follow-up|4|||
44365802|NCT00937521|79370892|FG003|Booster Phase|Lost to Follow-up|2|||
44365803|NCT00937521|79370893|FG004|Booster Phase|Lost to Follow-up|4|||
44365804|NCT00937521|79370894|FG005|Booster Phase|Lost to Follow-up|4|||
44365805|NCT00937521|79370895|FG006|Booster Phase|Lost to Follow-up|3|||
44365806|NCT00937521|79370896|FG007|Booster Phase|Lost to Follow-up|0|||
44365807|NCT00937521|79370889|FG000|Booster Phase|Administrative Reason|0|||
44365808|NCT00937521|79370890|FG001|Booster Phase|Administrative Reason|0|||
44365809|NCT00937521|79370891|FG002|Booster Phase|Administrative Reason|1|||
44365810|NCT00937521|79370892|FG003|Booster Phase|Administrative Reason|0|||
44365811|NCT00937521|79370893|FG004|Booster Phase|Administrative Reason|1|||
44365812|NCT00937521|79370894|FG005|Booster Phase|Administrative Reason|1|||
44365813|NCT00937521|79370895|FG006|Booster Phase|Administrative Reason|0|||
44365814|NCT00937521|79370896|FG007|Booster Phase|Administrative Reason|0|||
44365815|NCT00937521|79370889|FG000|Booster Phase|Protocol Deviation|0|||
44365816|NCT00937521|79370890|FG001|Booster Phase|Protocol Deviation|0|||
44365817|NCT00937521|79370891|FG002|Booster Phase|Protocol Deviation|0|||
44365818|NCT00937521|79370892|FG003|Booster Phase|Protocol Deviation|0|||
44365819|NCT00937521|79370893|FG004|Booster Phase|Protocol Deviation|0|||
44365820|NCT00937521|79370894|FG005|Booster Phase|Protocol Deviation|0|||
44365821|NCT00937521|79370895|FG006|Booster Phase|Protocol Deviation|1|||
44365822|NCT00937521|79370896|FG007|Booster Phase|Protocol Deviation|0|||
44365823|NCT00935883|79370931|FG000|Treatment Period|Physician Decision|1|||
44365824|NCT00935883|79370932|FG001|Treatment Period|Physician Decision|0|||
44365825|NCT00935883|79370931|FG000|Treatment Period|Withdrawal by Subject|0|||
44365826|NCT00935883|79370932|FG001|Treatment Period|Withdrawal by Subject|2|||
44365827|NCT00936975|79370938|FG000|Overall Study|Withdrawal by Subject|1|||
44365828|NCT00936975|79370938|FG000|Overall Study|Disease progression|3|||
44365829|NCT00936975|79370938|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
44365830|NCT00936897|79370945|FG000|Overall Study|Withdrawal by Subject|9|||
44365831|NCT00936897|79370946|FG001|Overall Study|Withdrawal by Subject|19|||
44365832|NCT00936897|79370945|FG000|Overall Study|Adverse Event|4|||
44365833|NCT00936897|79370946|FG001|Overall Study|Adverse Event|13|||
44365834|NCT00936897|79370945|FG000|Overall Study|Other|3|||
44365835|NCT00936897|79370946|FG001|Overall Study|Other|9|||
44365836|NCT00936897|79370945|FG000|Overall Study|Lost to Follow-up|1|||
44365837|NCT00936897|79370946|FG001|Overall Study|Lost to Follow-up|10|||
44365838|NCT00936897|79370945|FG000|Overall Study|Administrative Decision|1|||
44365839|NCT00936897|79370946|FG001|Overall Study|Administrative Decision|2|||
44365840|NCT00936897|79370945|FG000|Overall Study|Protocol Violation|1|||
44365841|NCT00936897|79370946|FG001|Overall Study|Protocol Violation|1|||
44365842|NCT00936897|79370945|FG000|Overall Study|Ineligibility Determined|0|||
44365843|NCT00936897|79370946|FG001|Overall Study|Ineligibility Determined|3|||
44365844|NCT00936897|79370945|FG000|Overall Study|Noncompliance|0|||
44365845|NCT00936897|79370946|FG001|Overall Study|Noncompliance|2|||
44365846|NCT00936897|79370945|FG000|Overall Study|Death|0|||
44365847|NCT00936897|79370946|FG001|Overall Study|Death|1|||
44365848|NCT01120691|79370955|FG000|Overall Study|Adverse Event|59|||
44365849|NCT01120691|79370956|FG001|Overall Study|Adverse Event|67|||
44365850|NCT01120691|79370957|FG002|Overall Study|Adverse Event|47|||
44365851|NCT01120691|79370955|FG000|Overall Study|Subject withdrew consent|33|||
44365852|NCT01120691|79370956|FG001|Overall Study|Subject withdrew consent|50|||
44365853|NCT01120691|79370957|FG002|Overall Study|Subject withdrew consent|44|||
44365854|NCT01120691|79370955|FG000|Overall Study|Death|21|||
44365855|NCT01120691|79370956|FG001|Overall Study|Death|22|||
44365856|NCT01120691|79370957|FG002|Overall Study|Death|24|||
44365857|NCT01120691|79370955|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
44365858|NCT01120691|79370956|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
44365859|NCT01120691|79370957|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
44365860|NCT01120691|79370955|FG000|Overall Study|Administrative problems|15|||
44365861|NCT01120691|79370956|FG001|Overall Study|Administrative problems|8|||
44365862|NCT01120691|79370957|FG002|Overall Study|Administrative problems|9|||
44365863|NCT01120691|79370955|FG000|Overall Study|Protocol deviation|13|||
44365864|NCT01120691|79370956|FG001|Overall Study|Protocol deviation|12|||
44365865|NCT01120691|79370957|FG002|Overall Study|Protocol deviation|12|||
44365866|NCT01120691|79370955|FG000|Overall Study|Lost to Follow-up|5|||
44365867|NCT01120691|79370956|FG001|Overall Study|Lost to Follow-up|6|||
44365868|NCT01120691|79370957|FG002|Overall Study|Lost to Follow-up|4|||
44365869|NCT01120691|79370955|FG000|Overall Study|Abnormal test procedure result(s)|3|||
44365870|NCT01120691|79370956|FG001|Overall Study|Abnormal test procedure result(s)|2|||
44365871|NCT01120691|79370957|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44365872|NCT01120691|79370955|FG000|Overall Study|Patient's inability to use the device|3|||
44365873|NCT01120691|79370956|FG001|Overall Study|Patient's inability to use the device|1|||
44365874|NCT01120691|79370957|FG002|Overall Study|Patient's inability to use the device|0|||
44365875|NCT01120691|79370955|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44365876|NCT01120691|79370956|FG001|Overall Study|Abnormal laboratory value(s)|3|||
44365877|NCT01120691|79370957|FG002|Overall Study|Abnormal laboratory value(s)|4|||
44365878|NCT00935493|79370972|FG000|Overall Study|Lost to Follow-up|1|||
44365879|NCT00935493|79370973|FG001|Overall Study|Lost to Follow-up|1|||
44365880|NCT00935493|79370974|FG002|Overall Study|Lost to Follow-up|1|||
44365881|NCT00935493|79370972|FG000|Overall Study|Treatment Discontinued|0|||
44365882|NCT00935493|79370973|FG001|Overall Study|Treatment Discontinued|1|||
44365883|NCT00935493|79370974|FG002|Overall Study|Treatment Discontinued|0|||
44365884|NCT03856996|79370984|FG000|Overall Study|Withdrawal by Subject|1|||
44365885|NCT03856996|79370985|FG001|Overall Study|Withdrawal by Subject|0|||
44365886|NCT03856996|79370984|FG000|Overall Study|Lost to Follow-up|0|||
44365887|NCT03856996|79370985|FG001|Overall Study|Lost to Follow-up|1|||
44365888|NCT03856996|79370984|FG000|Overall Study|Adverse Event|1|||
44365889|NCT03856996|79370985|FG001|Overall Study|Adverse Event|1|||
44365890|NCT03856996|79370984|FG000|Overall Study|Other|1|||
44365891|NCT03856996|79370985|FG001|Overall Study|Other|0|||
44365892|NCT00935259|79370991|FG000|Period 1|Administrative (scheduling conflict)|1|||
44365893|NCT00935259|79370992|FG001|Period 1|Administrative (scheduling conflict)|1|||
44365894|NCT01120379|79371009|FG000|One Year Timepoint|Withdrawal by Subject|41|||
44365895|NCT01120379|79371009|FG000|One Year Timepoint|Lost to Follow-up|115|||
44365896|NCT01120379|79371009|FG000|One Year Timepoint|Death|108|||
44365897|NCT01120379|79371009|FG000|One Year Timepoint|Physician Decision|9|||
44365898|NCT01120379|79371009|FG000|One Year Timepoint|Any other reason for early termination|5|||
44365899|NCT01120379|79371009|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
44365900|NCT01120379|79371009|FG000|Two Year Timepoint|Lost to Follow-up|87|||
44204803|NCT01448824|79000699|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
44269345|NCT02310750|79192408|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
44269346|NCT02310750|79192409|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
44204804|NCT01448824|79000692|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204805|NCT01448824|79000693|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204806|NCT01448824|79000694|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204807|NCT01448824|79000695|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204808|NCT01448824|79000696|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204809|NCT01448824|79000697|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
44204810|NCT01448824|79000698|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204811|NCT01448824|79000699|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
44204812|NCT01448824|79000692|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
44204813|NCT01448824|79000693|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
44204814|NCT01448824|79000694|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
44204815|NCT01448824|79000695|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
44365901|NCT01120379|79371009|FG000|Two Year Timepoint|Death|123|||
44365902|NCT01120379|79371009|FG000|Two Year Timepoint|Physician Decision|12|||
44365903|NCT01120379|79371009|FG000|Two Year Timepoint|Any other reason for early termination|4|||
44365904|NCT01120379|79371009|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
44365905|NCT01120379|79371009|FG000|Three Year Timepoint|Lost to Follow-up|43|||
44365906|NCT01120379|79371009|FG000|Three Year Timepoint|Death|120|||
44269347|NCT02310750|79192410|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269348|NCT02310750|79192411|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269349|NCT02310750|79192412|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269350|NCT02310750|79192413|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269351|NCT02310750|79192414|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269352|NCT02310750|79192415|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
44269353|NCT02310750|79192400|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269354|NCT02310750|79192401|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269355|NCT02310750|79192402|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269356|NCT02310750|79192403|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269357|NCT02310750|79192404|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269358|NCT02310750|79192405|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269359|NCT02310750|79192406|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269360|NCT02310750|79192407|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
44269361|NCT02310750|79192408|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
44269362|NCT02310750|79192409|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269363|NCT02310750|79192410|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269364|NCT02310750|79192411|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269365|NCT02310750|79192412|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269366|NCT02310750|79192413|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44269367|NCT02310750|79192414|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44365907|NCT01120379|79371009|FG000|Three Year Timepoint|Physician Decision|9|||
44365908|NCT01120379|79371009|FG000|Three Year Timepoint|Any other reason for early termination|17|||
44365909|NCT01120379|79371009|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
44365910|NCT01120379|79371009|FG000|Four Year Timepoint|Lost to Follow-up|10|||
44365911|NCT01120379|79371009|FG000|Four Year Timepoint|Death|131|||
44365912|NCT01120379|79371009|FG000|Four Year Timepoint|Physician Decision|5|||
44365913|NCT01120379|79371009|FG000|Four Year Timepoint|Any other reason for early termination|217|||
44365914|NCT01120067|79371015|FG000|Overall Study|Lost to Follow-up|3|||
44365915|NCT01120067|79371016|FG001|Overall Study|Lost to Follow-up|1|||
44365916|NCT01120067|79371015|FG000|Overall Study|fail to engage >3 sessions|2|||
44365917|NCT01120067|79371016|FG001|Overall Study|fail to engage >3 sessions|0|||
44365918|NCT01124045|79371024|FG000|Overall Study|Lost to Follow-up|0|||
44365919|NCT01124045|79371025|FG001|Overall Study|Lost to Follow-up|1|||
44365920|NCT01124045|79371024|FG000|Overall Study|Physician Decision|0|||
44365921|NCT01124045|79371025|FG001|Overall Study|Physician Decision|2|||
44269368|NCT02310750|79192415|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
44365922|NCT01123889|79371033|FG000|Overall Study|Lost to Follow-up|3|||
44365923|NCT01123889|79371034|FG001|Overall Study|Lost to Follow-up|1|||
44365924|NCT00934947|79371042|FG000|Overall Study|Adverse Event|0|||
44365925|NCT00934947|79371043|FG001|Overall Study|Adverse Event|2|||
44365926|NCT01123655|79371053|FG000|Overall Study|Medication for RA had to be changed|1|||
44365927|NCT01123655|79371054|FG001|Overall Study|Medication for RA had to be changed|0|||
44365928|NCT01123655|79371055|FG002|Overall Study|Medication for RA had to be changed|0|||
44365929|NCT01123655|79371053|FG000|Overall Study|new illness|0|||
44365930|NCT01123655|79371054|FG001|Overall Study|new illness|1|||
44365931|NCT01123655|79371055|FG002|Overall Study|new illness|0|||
44365932|NCT01123655|79371053|FG000|Overall Study|began prohibitive drug|0|||
44365933|NCT01123655|79371054|FG001|Overall Study|began prohibitive drug|0|||
44365934|NCT01123655|79371055|FG002|Overall Study|began prohibitive drug|1|||
44365935|NCT00934791|79371063|FG000|Overall Study|Withdrawal by Subject|1|||
44365936|NCT00934791|79371064|FG001|Overall Study|Withdrawal by Subject|0|||
44365937|NCT01119443|79371072|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
44365938|NCT01119443|79371073|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
44365939|NCT01111019|79371082|FG000|Overall Study|Withdrew Prematurely|2|||
44452017|NCT00494871|79460932|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
44269369|NCT02310750|79192400|FG000|HP Washout 2|Lost to Follow-up|0|||
44269370|NCT02310750|79192401|FG001|HP Washout 2|Lost to Follow-up|0|||
44269371|NCT02310750|79192402|FG002|HP Washout 2|Lost to Follow-up|0|||
44269372|NCT02310750|79192403|FG003|HP Washout 2|Lost to Follow-up|0|||
44269373|NCT02310750|79192404|FG004|HP Washout 2|Lost to Follow-up|1|||
44269374|NCT02310750|79192405|FG005|HP Washout 2|Lost to Follow-up|0|||
44269375|NCT02310750|79192406|FG006|HP Washout 2|Lost to Follow-up|7|||
44365940|NCT01111019|79371082|FG000|Overall Study|Other|1|||
44365941|NCT01119287|79371101|FG000|Overall Study|Patient Decision, not related to AE|0|||
44365942|NCT01119287|79371102|FG001|Overall Study|Patient Decision, not related to AE|0|||
44365943|NCT01119287|79371103|FG002|Overall Study|Patient Decision, not related to AE|2|||
44365944|NCT01119287|79371104|FG003|Overall Study|Patient Decision, not related to AE|2|||
44365945|NCT01119287|79371105|FG004|Overall Study|Patient Decision, not related to AE|1|||
44365946|NCT01119287|79371106|FG005|Overall Study|Patient Decision, not related to AE|0|||
44365947|NCT01110707|79371120|FG000|Overall Study|Protocol Violation|0|||
44365948|NCT01110707|79371121|FG001|Overall Study|Protocol Violation|3|||
44365949|NCT01119131|79371131|FG000|Overall Study|Adverse Event|1|||
44365950|NCT01119131|79371132|FG001|Overall Study|Adverse Event|1|||
44365951|NCT01119131|79371133|FG002|Overall Study|Adverse Event|1|||
44365952|NCT01119131|79371131|FG000|Overall Study|Non-Compliance|1|||
44365953|NCT01119131|79371132|FG001|Overall Study|Non-Compliance|0|||
44365954|NCT01119131|79371133|FG002|Overall Study|Non-Compliance|4|||
44365955|NCT01119131|79371131|FG000|Overall Study|Physician Decision|0|||
44365956|NCT01119131|79371132|FG001|Overall Study|Physician Decision|0|||
44365957|NCT01119131|79371133|FG002|Overall Study|Physician Decision|1|||
44365958|NCT01118975|79371143|FG000|Overall Study|Adverse Event|0|||
44365959|NCT01118975|79371144|FG001|Overall Study|Adverse Event|1|||
44365960|NCT01110239|79371154|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
44269376|NCT02310750|79192407|FG007|HP Washout 2|Lost to Follow-up|0|||
44269377|NCT02310750|79192408|FG008|HP Washout 2|Lost to Follow-up|0|||
44269378|NCT02310750|79192409|FG009|HP Washout 2|Lost to Follow-up|0|||
44269379|NCT02310750|79192410|FG010|HP Washout 2|Lost to Follow-up|0|||
44269380|NCT02310750|79192411|FG011|HP Washout 2|Lost to Follow-up|0|||
44269381|NCT02310750|79192412|FG012|HP Washout 2|Lost to Follow-up|0|||
44269382|NCT02310750|79192413|FG013|HP Washout 2|Lost to Follow-up|0|||
44269383|NCT02310750|79192414|FG014|HP Washout 2|Lost to Follow-up|0|||
44269384|NCT02310750|79192415|FG015|HP Washout 2|Lost to Follow-up|0|||
44269385|NCT02310672|79192520|FG000|Overall Study|Death|1|||
44269386|NCT02310672|79192520|FG000|Overall Study|Lost to Follow-up|1|||
44269387|NCT02310672|79192520|FG000|Overall Study|Withdrawal by Subject|1|||
44269388|NCT02310672|79192520|FG000|Overall Study|Sponsor's decision|12|||
44269389|NCT02363946|79192666|FG000|Overall Study|Lost to Follow-up|0|||
44269390|NCT02363946|79192667|FG001|Overall Study|Lost to Follow-up|0|||
44269391|NCT02363946|79192668|FG002|Overall Study|Lost to Follow-up|0|||
44269392|NCT02363946|79192669|FG003|Overall Study|Lost to Follow-up|0|||
44269393|NCT02363946|79192670|FG004|Overall Study|Lost to Follow-up|0|||
44365961|NCT01110239|79371155|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
44365962|NCT01110239|79371156|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
44365963|NCT01110239|79371157|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
44365964|NCT01110239|79371154|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
44365965|NCT01110239|79371155|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
44365966|NCT01110239|79371156|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
44365967|NCT01110239|79371157|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
44365968|NCT01118663|79371170|FG000|Overall Study|Adverse Event|2|||
44365969|NCT01118663|79371171|FG001|Overall Study|Adverse Event|1|||
44365970|NCT01118663|79371170|FG000|Overall Study|Withdrawal by Subject|0|||
44365971|NCT01118663|79371171|FG001|Overall Study|Withdrawal by Subject|1|||
44365972|NCT01118351|79371177|FG000|Overall Study|Adverse Event|3|||
44365973|NCT01118351|79371177|FG000|Overall Study|Withdrawal by Subject|1|||
44365974|NCT01118117|79371198|FG000|Overall Study|Death|8|||
44365975|NCT01118117|79371199|FG001|Overall Study|Death|0|||
44365976|NCT01118117|79371198|FG000|Overall Study|Lost to Follow-up|6|||
44365977|NCT01118117|79371199|FG001|Overall Study|Lost to Follow-up|0|||
44365978|NCT01118117|79371198|FG000|Overall Study|Missed 12 Month Visit|7|||
44365979|NCT01118117|79371199|FG001|Overall Study|Missed 12 Month Visit|0|||
44365980|NCT01109849|79371207|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
44365981|NCT01109849|79371208|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
44365982|NCT01109849|79371209|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
44365983|NCT01109849|79371210|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
44365984|NCT01109849|79371211|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
44365985|NCT01109849|79371207|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
44365986|NCT01109849|79371208|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
44269394|NCT02363946|79192671|FG005|Overall Study|Lost to Follow-up|0|||
44269395|NCT02363946|79192672|FG006|Overall Study|Lost to Follow-up|0|||
44269396|NCT02363946|79192673|FG007|Overall Study|Lost to Follow-up|1|||
44269397|NCT02363946|79192674|FG008|Overall Study|Lost to Follow-up|0|||
44365987|NCT01109849|79371209|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
44365988|NCT01109849|79371210|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
44365989|NCT01109849|79371211|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
44365990|NCT01109849|79371207|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
44365991|NCT01109849|79371208|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
44365992|NCT01109849|79371209|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
44365993|NCT01109849|79371210|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
44365994|NCT01109849|79371211|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
44269398|NCT02363946|79192675|FG009|Overall Study|Lost to Follow-up|0|||
44269399|NCT02363946|79192676|FG010|Overall Study|Lost to Follow-up|0|||
44365995|NCT01109849|79371207|FG000|Initial Randomization: ADHD Treatment|move away|2|||
44365996|NCT01109849|79371208|FG001|Initial Randomization: ADHD Treatment|move away|7|||
44365997|NCT01109849|79371209|FG002|Initial Randomization: ADHD Treatment|move away|0|||
44365998|NCT01109849|79371210|FG003|Initial Randomization: ADHD Treatment|move away|0|||
44365999|NCT01109849|79371211|FG004|Initial Randomization: ADHD Treatment|move away|0|||
44366000|NCT01109849|79371207|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
44366001|NCT01109849|79371208|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
44366002|NCT01109849|79371209|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
44366003|NCT01109849|79371210|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
44366004|NCT01109849|79371211|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
44366005|NCT01109849|79371207|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
44366006|NCT01109849|79371208|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
44366007|NCT01109849|79371209|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
44366008|NCT01109849|79371210|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
44366009|NCT01109849|79371211|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
44366010|NCT01061736|79371241|FG000|Overall Study|Dose regimen not selected|0|||
44366011|NCT01061736|79371242|FG001|Overall Study|Dose regimen not selected|0|||
44366012|NCT01061736|79371243|FG002|Overall Study|Dose regimen not selected|0|||
44366013|NCT01061736|79371244|FG003|Overall Study|Dose regimen not selected|0|||
44366014|NCT01061736|79371245|FG004|Overall Study|Dose regimen not selected|0|||
44366015|NCT01061736|79371246|FG005|Overall Study|Dose regimen not selected|0|||
44366016|NCT01061736|79371247|FG006|Overall Study|Dose regimen not selected|79|||
44366017|NCT01061736|79371248|FG007|Overall Study|Dose regimen not selected|0|||
44366018|NCT01061736|79371249|FG008|Overall Study|Dose regimen not selected|0|||
44366019|NCT01061736|79371250|FG009|Overall Study|Dose regimen not selected|0|||
44366020|NCT01061736|79371241|FG000|Overall Study|Adverse Event|13|||
44366021|NCT01061736|79371242|FG001|Overall Study|Adverse Event|1|||
44366022|NCT01061736|79371243|FG002|Overall Study|Adverse Event|3|||
44366023|NCT01061736|79371244|FG003|Overall Study|Adverse Event|2|||
44366024|NCT01061736|79371245|FG004|Overall Study|Adverse Event|4|||
44366025|NCT01061736|79371246|FG005|Overall Study|Adverse Event|1|||
44366026|NCT01061736|79371247|FG006|Overall Study|Adverse Event|4|||
44366027|NCT01061736|79371248|FG007|Overall Study|Adverse Event|63|||
44366028|NCT01061736|79371249|FG008|Overall Study|Adverse Event|67|||
44366029|NCT01061736|79371250|FG009|Overall Study|Adverse Event|34|||
44366030|NCT01061736|79371241|FG000|Overall Study|Lack of Efficacy|0|||
44366031|NCT01061736|79371242|FG001|Overall Study|Lack of Efficacy|2|||
44366032|NCT01061736|79371243|FG002|Overall Study|Lack of Efficacy|1|||
44366033|NCT01061736|79371244|FG003|Overall Study|Lack of Efficacy|1|||
44366034|NCT01061736|79371245|FG004|Overall Study|Lack of Efficacy|1|||
44366035|NCT01061736|79371246|FG005|Overall Study|Lack of Efficacy|2|||
44366036|NCT01061736|79371247|FG006|Overall Study|Lack of Efficacy|1|||
44366037|NCT01061736|79371248|FG007|Overall Study|Lack of Efficacy|9|||
44366038|NCT01061736|79371249|FG008|Overall Study|Lack of Efficacy|9|||
44366039|NCT01061736|79371250|FG009|Overall Study|Lack of Efficacy|10|||
44366040|NCT01061736|79371241|FG000|Overall Study|Poor compliance to protocol|0|||
44366041|NCT01061736|79371242|FG001|Overall Study|Poor compliance to protocol|0|||
44366042|NCT01061736|79371243|FG002|Overall Study|Poor compliance to protocol|0|||
44366043|NCT01061736|79371244|FG003|Overall Study|Poor compliance to protocol|0|||
44366044|NCT01061736|79371245|FG004|Overall Study|Poor compliance to protocol|0|||
44366045|NCT01061736|79371246|FG005|Overall Study|Poor compliance to protocol|0|||
44366046|NCT01061736|79371247|FG006|Overall Study|Poor compliance to protocol|0|||
44366047|NCT01061736|79371248|FG007|Overall Study|Poor compliance to protocol|2|||
44366048|NCT01061736|79371249|FG008|Overall Study|Poor compliance to protocol|5|||
44366049|NCT01061736|79371250|FG009|Overall Study|Poor compliance to protocol|9|||
44366050|NCT01061736|79371241|FG000|Overall Study|Not treated|0|||
44366051|NCT01061736|79371242|FG001|Overall Study|Not treated|0|||
44366052|NCT01061736|79371243|FG002|Overall Study|Not treated|0|||
44366053|NCT01061736|79371244|FG003|Overall Study|Not treated|0|||
44366054|NCT01061736|79371245|FG004|Overall Study|Not treated|1|||
44366055|NCT01061736|79371246|FG005|Overall Study|Not treated|0|||
44366056|NCT01061736|79371247|FG006|Overall Study|Not treated|0|||
44366057|NCT01061736|79371248|FG007|Overall Study|Not treated|2|||
44366058|NCT01061736|79371249|FG008|Overall Study|Not treated|1|||
44366059|NCT01061736|79371250|FG009|Overall Study|Not treated|0|||
44366060|NCT01061736|79371241|FG000|Overall Study|Other than specified above|0|||
44366061|NCT01061736|79371242|FG001|Overall Study|Other than specified above|1|||
44366062|NCT01061736|79371243|FG002|Overall Study|Other than specified above|2|||
44366063|NCT01061736|79371244|FG003|Overall Study|Other than specified above|0|||
44366064|NCT01061736|79371245|FG004|Overall Study|Other than specified above|1|||
44366065|NCT01061736|79371246|FG005|Overall Study|Other than specified above|0|||
44366066|NCT01061736|79371247|FG006|Overall Study|Other than specified above|0|||
44366067|NCT01061736|79371248|FG007|Overall Study|Other than specified above|18|||
44366068|NCT01061736|79371249|FG008|Overall Study|Other than specified above|15|||
44366069|NCT01061736|79371250|FG009|Overall Study|Other than specified above|21|||
44366070|NCT01117337|79371277|FG000|Overall Study|Lost to Follow-up|4|||
44366071|NCT01117337|79371278|FG001|Overall Study|Lost to Follow-up|0|||
44366072|NCT01108523|79371288|FG000|Overall Study|Protocol Violation|4|||
44366073|NCT01035606|79371295|FG000|Overall Study|change in health, job demands,family|3|||
44366074|NCT01035606|79371296|FG001|Overall Study|change in health, job demands,family|3|||
44366075|NCT01035606|79371297|FG002|Overall Study|change in health, job demands,family|4|||
44366076|NCT01117181|79371307|FG000|Overall Study|Lost to Follow-up|1|||
44366077|NCT01117181|79371308|FG001|Overall Study|Lost to Follow-up|0|||
44366078|NCT01117181|79371307|FG000|Overall Study|Withdrawal by Subject|0|||
44366079|NCT01117181|79371308|FG001|Overall Study|Withdrawal by Subject|2|||
44366080|NCT01040130|79371316|FG000|Overall Study|Adverse Event|1|||
44366081|NCT01040130|79371317|FG001|Overall Study|Adverse Event|1|||
44366082|NCT01040130|79371318|FG002|Overall Study|Adverse Event|0|||
44366083|NCT01040130|79371319|FG003|Overall Study|Adverse Event|5|||
44366084|NCT01040130|79371320|FG004|Overall Study|Adverse Event|0|||
44366085|NCT01040130|79371321|FG005|Overall Study|Adverse Event|3|||
44366086|NCT01040130|79371316|FG000|Overall Study|Protocol Violation|0|||
44366087|NCT01040130|79371317|FG001|Overall Study|Protocol Violation|0|||
44366088|NCT01040130|79371318|FG002|Overall Study|Protocol Violation|2|||
44366089|NCT01040130|79371319|FG003|Overall Study|Protocol Violation|0|||
44366090|NCT01040130|79371320|FG004|Overall Study|Protocol Violation|0|||
44366091|NCT01040130|79371321|FG005|Overall Study|Protocol Violation|0|||
44366092|NCT01040130|79371316|FG000|Overall Study|Withdrawal by Subject|0|||
44366093|NCT01040130|79371317|FG001|Overall Study|Withdrawal by Subject|2|||
44366094|NCT01040130|79371318|FG002|Overall Study|Withdrawal by Subject|0|||
44366095|NCT01040130|79371319|FG003|Overall Study|Withdrawal by Subject|0|||
44366096|NCT01040130|79371320|FG004|Overall Study|Withdrawal by Subject|0|||
44366097|NCT01040130|79371321|FG005|Overall Study|Withdrawal by Subject|1|||
44366098|NCT01040130|79371316|FG000|Overall Study|Other reasons not listed above|2|||
44366099|NCT01040130|79371317|FG001|Overall Study|Other reasons not listed above|0|||
44366100|NCT01040130|79371318|FG002|Overall Study|Other reasons not listed above|0|||
44366101|NCT01040130|79371319|FG003|Overall Study|Other reasons not listed above|0|||
44366102|NCT01040130|79371320|FG004|Overall Study|Other reasons not listed above|0|||
44366103|NCT01040130|79371321|FG005|Overall Study|Other reasons not listed above|0|||
44366104|NCT00932451|79371331|FG000|Overall Study|Withdrawal by Subject|69|||
44366105|NCT00932451|79371331|FG000|Overall Study|Lost to Follow-up|22|||
44366106|NCT00932451|79371331|FG000|Overall Study|Death|726|||
44366107|NCT00932451|79371331|FG000|Overall Study|Other reasons|5|||
44366108|NCT01108055|79371339|FG000|Overall Study|Ineligible|11|||
44366109|NCT01108055|79371339|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
44366110|NCT01107899|79371346|FG000|Overall Study|Physician Decision|5|||
44366111|NCT01107899|79371347|FG001|Overall Study|Physician Decision|0|||
44204816|NCT01448824|79000696|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
44204817|NCT01448824|79000697|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
44204818|NCT01448824|79000698|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
44204819|NCT01448824|79000699|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
44204820|NCT01448824|79000692|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44204821|NCT01448824|79000693|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44366112|NCT01107899|79371348|FG002|Overall Study|Physician Decision|3|||
44366113|NCT01107899|79371346|FG000|Overall Study|Withdrawal by Subject|0|||
44366114|NCT01107899|79371347|FG001|Overall Study|Withdrawal by Subject|0|||
44366115|NCT01107899|79371348|FG002|Overall Study|Withdrawal by Subject|1|||
44366116|NCT01115933|79371359|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
44366117|NCT01107743|79371416|FG000|Overall Study|Protocol Violation|46|||
44366118|NCT01059864|79371465|FG000|Open-Label Run-In Phase|Adverse Event|7|||
44366119|NCT01059864|79371466|FG001|Open-Label Run-In Phase|Adverse Event|0|||
44366120|NCT01059864|79371467|FG002|Open-Label Run-In Phase|Adverse Event|0|||
44366121|NCT01059864|79371465|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
44366122|NCT01059864|79371466|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
44366123|NCT01059864|79371467|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
44204822|NCT01448824|79000694|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44204823|NCT01448824|79000695|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44204824|NCT01448824|79000696|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44204825|NCT01448824|79000697|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44366124|NCT01059864|79371465|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
44366125|NCT01059864|79371466|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
44366126|NCT01059864|79371467|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
44366127|NCT01059864|79371465|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
44366128|NCT01059864|79371466|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
44366129|NCT01059864|79371467|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
44366130|NCT01059864|79371465|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
44366131|NCT01059864|79371466|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
44366132|NCT01059864|79371467|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
44366133|NCT01059864|79371465|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
44366134|NCT01059864|79371466|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
44366135|NCT01059864|79371467|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
44366136|NCT01035138|79371477|FG000|Overall Study|Adverse Event|4|||
44366137|NCT01035138|79371478|FG001|Overall Study|Adverse Event|0|||
44366138|NCT01035138|79371479|FG002|Overall Study|Adverse Event|2|||
44366139|NCT01035138|79371477|FG000|Overall Study|Caregiver Decision|2|||
44366140|NCT01035138|79371478|FG001|Overall Study|Caregiver Decision|0|||
44366141|NCT01035138|79371479|FG002|Overall Study|Caregiver Decision|1|||
44366142|NCT01035138|79371477|FG000|Overall Study|Withdrawal by Subject|1|||
44366143|NCT01035138|79371478|FG001|Overall Study|Withdrawal by Subject|0|||
44204826|NCT01448824|79000698|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
44204827|NCT01448824|79000699|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
44204828|NCT01448824|79000692|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204829|NCT01448824|79000693|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204830|NCT01448824|79000694|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204831|NCT01448824|79000695|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204832|NCT01448824|79000696|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204833|NCT01448824|79000697|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204834|NCT01448824|79000698|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
44204835|NCT01448824|79000699|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
44204836|NCT01448824|79000692|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204837|NCT01448824|79000693|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204838|NCT01448824|79000694|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204839|NCT01448824|79000695|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204840|NCT01448824|79000696|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204841|NCT01448824|79000697|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204842|NCT01448824|79000698|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
44204843|NCT01448824|79000699|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
44204844|NCT01448824|79000692|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204845|NCT01448824|79000693|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204846|NCT01448824|79000694|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204847|NCT01448824|79000695|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204848|NCT01448824|79000696|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204849|NCT01448824|79000697|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204850|NCT01448824|79000698|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
44204851|NCT01448824|79000699|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
44204852|NCT02005562|79000729|FG000|Overall Study|Death|2|||
44204853|NCT02005562|79000730|FG001|Overall Study|Death|2|||
44204854|NCT02005562|79000729|FG000|Overall Study|Graft loss|7|||
44204855|NCT02005562|79000730|FG001|Overall Study|Graft loss|6|||
44204856|NCT02005562|79000729|FG000|Overall Study|Withdrawal by Subject|2|||
44204857|NCT02005562|79000730|FG001|Overall Study|Withdrawal by Subject|2|||
44204858|NCT02005562|79000729|FG000|Overall Study|No transplant|1|||
44204859|NCT02005562|79000730|FG001|Overall Study|No transplant|4|||
44204860|NCT02005562|79000729|FG000|Overall Study|Physician Decision|0|||
44204861|NCT02005562|79000730|FG001|Overall Study|Physician Decision|1|||
44204862|NCT01448044|79000738|FG000|Treatment Period|Adverse Event|4|||
44204863|NCT01448044|79000739|FG001|Treatment Period|Adverse Event|3|||
44204864|NCT01448044|79000738|FG000|Treatment Period|Lack of Efficacy|5|||
44204865|NCT01448044|79000739|FG001|Treatment Period|Lack of Efficacy|12|||
44204866|NCT01448044|79000738|FG000|Treatment Period|Subject requested discontinue study drug|1|||
44204867|NCT01448044|79000739|FG001|Treatment Period|Subject requested discontinue study drug|0|||
44204868|NCT01448044|79000738|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
44204869|NCT01448044|79000739|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
44204870|NCT01448044|79000738|FG000|Treatment Period|Participant does not meet study criteria|1|||
44204871|NCT01448044|79000739|FG001|Treatment Period|Participant does not meet study criteria|0|||
44204872|NCT01448044|79000738|FG000|Treatment Period|Lost to Follow-up|2|||
44204873|NCT01448044|79000739|FG001|Treatment Period|Lost to Follow-up|1|||
44269400|NCT02363946|79192677|FG011|Overall Study|Lost to Follow-up|0|||
44269401|NCT02363946|79192678|FG012|Overall Study|Lost to Follow-up|0|||
44269402|NCT02363478|79192706|FG000|Overall Study|Lost to Follow-up|4|||
44269403|NCT02363478|79192706|FG000|Overall Study|Adverse Event|4|||
44269404|NCT02310126|79192713|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
44269405|NCT02310126|79192714|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
44269406|NCT02310126|79192713|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
44269407|NCT02310126|79192714|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
44452018|NCT00494871|79460931|FG000|Follow-up (FU) Period|Adverse Event|1|||
44204874|NCT01448044|79000738|FG000|Treatment Period|Other reason|2|||
44204875|NCT01448044|79000739|FG001|Treatment Period|Other reason|0|||
44269408|NCT02338362|79192722|FG000|Overall Study|Withdrawal by Subject|1|||
44366144|NCT01035138|79371479|FG002|Overall Study|Withdrawal by Subject|0|||
44366145|NCT01035138|79371477|FG000|Overall Study|Physician Decision|0|||
44452019|NCT00494871|79460932|FG001|Follow-up (FU) Period|Adverse Event|1|||
44366146|NCT01035138|79371478|FG001|Overall Study|Physician Decision|0|||
44366147|NCT01035138|79371479|FG002|Overall Study|Physician Decision|1|||
44366148|NCT01035138|79371477|FG000|Overall Study|Sponsor Decision|66|||
44366149|NCT01035138|79371478|FG001|Overall Study|Sponsor Decision|60|||
44366150|NCT01035138|79371479|FG002|Overall Study|Sponsor Decision|42|||
44366151|NCT01035138|79371477|FG000|Overall Study|Lost to Follow-up|0|||
44366152|NCT01035138|79371478|FG001|Overall Study|Lost to Follow-up|0|||
44366153|NCT01035138|79371479|FG002|Overall Study|Lost to Follow-up|1|||
44366154|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
44366155|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
44366156|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
44366157|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
44366158|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
44366159|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
44366160|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
44366161|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
44366162|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
44366163|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
44366164|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
44366165|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
44366166|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
44366167|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
44366168|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
44366169|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
44366170|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Program Termination|3|||
44366171|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Program Termination|0|||
44366172|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Program Termination|1|||
44366173|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Program Termination|1|||
44366174|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
44366175|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
44366176|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
44366177|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
44366178|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
44366179|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
44366180|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
44366181|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
44366182|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
44366183|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
44366184|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
44366185|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
44366186|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
44366187|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
44366188|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
44366189|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
44366190|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
44366191|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
44366192|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
44366193|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
44366194|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
44366195|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
44366196|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
44366197|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
44366198|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
44366199|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
44366200|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
44366201|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
44366202|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
44366203|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
44366204|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
44366205|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
44366206|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
44366207|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
44366208|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
44366209|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
44366210|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
44366211|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
44366212|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
44366213|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
44366214|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
44204876|NCT01448044|79000738|FG000|Follow Up Period|Withdrawal by Subject|1|||
44366215|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
44366216|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
44366217|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
44366218|NCT03739840|79371493|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
44366219|NCT03739840|79371494|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
44366220|NCT03739840|79371495|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
44366221|NCT03739840|79371496|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
44366222|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
44366223|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
44366224|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
44366225|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
44366226|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
44366227|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
44366228|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
44366229|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
44366230|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
44366231|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
44366232|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
44366233|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
44366234|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
44366235|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
44366236|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
44366237|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
44366238|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
44366239|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
44204877|NCT01448044|79000739|FG001|Follow Up Period|Withdrawal by Subject|1|||
44204878|NCT01448044|79000738|FG000|Follow Up Period|Lost to Follow-up|6|||
44204879|NCT01448044|79000739|FG001|Follow Up Period|Lost to Follow-up|2|||
44204880|NCT01448044|79000738|FG000|Follow Up Period|Other|5|||
44204881|NCT01448044|79000739|FG001|Follow Up Period|Other|11|||
44204882|NCT02025530|79000747|FG000|Overall Study|No longer met elligibility criteria|5|||
44204883|NCT02025530|79000748|FG001|Overall Study|No longer met elligibility criteria|1|||
44204884|NCT01472380|79000754|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
44204885|NCT01472380|79000754|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
44204886|NCT01978262|79000761|FG000|Overall Study|Withdrawal by Subject|9|||
44204887|NCT01978262|79000761|FG000|Overall Study|Lost to Follow-up|2|||
44204888|NCT01447576|79000766|FG000|Overall Study|Lost to Follow-up|52|||
44204889|NCT01447576|79000766|FG000|Overall Study|Adverse Event|127|||
44204890|NCT01447576|79000766|FG000|Overall Study|Participant met withdrawal criteria|40|||
44204891|NCT01447576|79000766|FG000|Overall Study|Withdrawal by Subject|100|||
44204892|NCT01447576|79000766|FG000|Overall Study|Protocol deviation|83|||
44204893|NCT01447576|79000766|FG000|Overall Study|Lack of Efficacy|68|||
44204894|NCT01447576|79000766|FG000|Overall Study|Physician Decision|6|||
44204895|NCT01447420|79000773|FG000|Overall Study|Adverse Event|2|||
44204896|NCT01447420|79000774|FG001|Overall Study|Adverse Event|4|||
44204897|NCT01447420|79000775|FG002|Overall Study|Adverse Event|2|||
44204898|NCT01447420|79000773|FG000|Overall Study|Protocol Violation|3|||
44204899|NCT01447420|79000774|FG001|Overall Study|Protocol Violation|3|||
44204900|NCT01447420|79000775|FG002|Overall Study|Protocol Violation|0|||
44204901|NCT01447420|79000773|FG000|Overall Study|Withdrawal by Subject|4|||
44204902|NCT01447420|79000774|FG001|Overall Study|Withdrawal by Subject|1|||
44204903|NCT01447420|79000775|FG002|Overall Study|Withdrawal by Subject|0|||
44204904|NCT01447420|79000773|FG000|Overall Study|Lack of Efficacy|1|||
44204905|NCT01447420|79000774|FG001|Overall Study|Lack of Efficacy|19|||
44204906|NCT01447420|79000775|FG002|Overall Study|Lack of Efficacy|8|||
44204907|NCT01446874|79000785|FG000|Overall Study|Not eligible|1|||
44204908|NCT01446874|79000786|FG001|Overall Study|Not eligible|0|||
44204909|NCT01446874|79000787|FG002|Overall Study|Not eligible|0|||
44204910|NCT01446874|79000785|FG000|Overall Study|No surgery/No qualifying surgery|1|||
44204911|NCT01446874|79000786|FG001|Overall Study|No surgery/No qualifying surgery|0|||
44204912|NCT01446874|79000787|FG002|Overall Study|No surgery/No qualifying surgery|12|||
44204913|NCT01446874|79000785|FG000|Overall Study|Non-compliance|0|||
44204914|NCT01446874|79000786|FG001|Overall Study|Non-compliance|4|||
44204915|NCT01446874|79000787|FG002|Overall Study|Non-compliance|0|||
44204916|NCT01446874|79000785|FG000|Overall Study|Antibiotics for pre-op infection|0|||
44204917|NCT01446874|79000786|FG001|Overall Study|Antibiotics for pre-op infection|0|||
44204918|NCT01446874|79000787|FG002|Overall Study|Antibiotics for pre-op infection|2|||
44204919|NCT01446874|79000785|FG000|Overall Study|Withdrawal by Subject|0|||
44204920|NCT01446874|79000786|FG001|Overall Study|Withdrawal by Subject|0|||
44204921|NCT01446874|79000787|FG002|Overall Study|Withdrawal by Subject|4|||
44204922|NCT01446796|79000795|FG000|Overall Study|Withdrawal by Subject|1|||
44204923|NCT01446796|79000796|FG001|Overall Study|Withdrawal by Subject|0|||
44204924|NCT01439074|79000806|FG000|Overall Study|Lost to Follow-up|3|||
44204925|NCT01439074|79000807|FG001|Overall Study|Lost to Follow-up|4|||
44204926|NCT01439074|79000806|FG000|Overall Study|Subject shedding|1|||
44366240|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
44366241|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
44366242|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
44366243|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
44366244|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
44366245|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
44204927|NCT01439074|79000807|FG001|Overall Study|Subject shedding|0|||
44204928|NCT01439074|79000806|FG000|Overall Study|Withdrawal by Subject|1|||
44204929|NCT01439074|79000807|FG001|Overall Study|Withdrawal by Subject|5|||
44204930|NCT01439074|79000806|FG000|Overall Study|Other|4|||
44204931|NCT01439074|79000807|FG001|Overall Study|Other|4|||
44204932|NCT01438996|79000816|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
44204933|NCT01438996|79000817|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
44204934|NCT01438996|79000818|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
44204935|NCT01438840|79000828|FG000|Core Study|Adverse Event|0|||
44204936|NCT01438840|79000829|FG001|Core Study|Adverse Event|3|||
44204937|NCT01438840|79000830|FG002|Core Study|Adverse Event|0|||
44204938|NCT01438840|79000828|FG000|Core Study|Lack of Efficacy|15|||
44269409|NCT02338362|79192723|FG001|Overall Study|Withdrawal by Subject|1|||
44366246|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
44204939|NCT01438840|79000829|FG001|Core Study|Lack of Efficacy|7|||
44204940|NCT01438840|79000830|FG002|Core Study|Lack of Efficacy|0|||
44366247|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
44204941|NCT01438840|79000828|FG000|Core Study|Withdrawal of consent|1|||
44204942|NCT01438840|79000829|FG001|Core Study|Withdrawal of consent|0|||
44204943|NCT01438840|79000830|FG002|Core Study|Withdrawal of consent|0|||
44204944|NCT01438840|79000828|FG000|Extension Phase|Adverse Event|0|||
44204945|NCT01438840|79000829|FG001|Extension Phase|Adverse Event|0|||
44204946|NCT01438840|79000830|FG002|Extension Phase|Adverse Event|3|||
44204947|NCT01438840|79000828|FG000|Extension Phase|Lost to Follow-up|0|||
44204948|NCT01438840|79000829|FG001|Extension Phase|Lost to Follow-up|0|||
44204949|NCT01438840|79000830|FG002|Extension Phase|Lost to Follow-up|1|||
44204950|NCT01438840|79000828|FG000|Extension Phase|Withdrawal by Subject|0|||
44204951|NCT01438840|79000829|FG001|Extension Phase|Withdrawal by Subject|0|||
44204952|NCT01438840|79000830|FG002|Extension Phase|Withdrawal by Subject|3|||
44204953|NCT01438840|79000828|FG000|Extension Phase|Lack of Efficacy|0|||
44204954|NCT01438840|79000829|FG001|Extension Phase|Lack of Efficacy|0|||
44204955|NCT01438840|79000830|FG002|Extension Phase|Lack of Efficacy|2|||
44204956|NCT01438840|79000828|FG000|Extension Phase|Other|0|||
44204957|NCT01438840|79000829|FG001|Extension Phase|Other|0|||
44204958|NCT01438840|79000830|FG002|Extension Phase|Other|1|||
44204959|NCT01471054|79000839|FG000|Overall Study|Study terminated prematurely|4|||
44204960|NCT01471054|79000840|FG001|Overall Study|Study terminated prematurely|0|||
44204961|NCT01978184|79000858|FG000|Overall Study|Progressive disease|5|||
44204962|NCT01978184|79000859|FG001|Overall Study|Progressive disease|5|||
44204963|NCT01978184|79000858|FG000|Overall Study|Other than PDA|2|||
44204964|NCT01978184|79000859|FG001|Overall Study|Other than PDA|2|||
44204965|NCT01978184|79000858|FG000|Overall Study|Physician Decision|0|||
44204966|NCT01978184|79000859|FG001|Overall Study|Physician Decision|3|||
44204967|NCT01978184|79000858|FG000|Overall Study|Noncompliance|1|||
44204968|NCT01978184|79000859|FG001|Overall Study|Noncompliance|2|||
44204969|NCT01978184|79000858|FG000|Overall Study|Death|1|||
44204970|NCT01978184|79000859|FG001|Overall Study|Death|0|||
44204971|NCT01978184|79000858|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
44204972|NCT01978184|79000859|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
44204973|NCT01445548|79000865|FG000|Overall Study|Adverse Event|1|||
44204974|NCT01977794|79000871|FG000|Overall Study|Adverse Event|2|||
44204975|NCT01977794|79000872|FG001|Overall Study|Adverse Event|2|||
44204976|NCT01977794|79000871|FG000|Overall Study|Lost to Follow-up|2|||
44204977|NCT01977794|79000872|FG001|Overall Study|Lost to Follow-up|1|||
44204978|NCT01977794|79000871|FG000|Overall Study|Protocol Violation|1|||
44204979|NCT01977794|79000872|FG001|Overall Study|Protocol Violation|0|||
44204980|NCT01977794|79000871|FG000|Overall Study|Death|1|||
44204981|NCT01977794|79000872|FG001|Overall Study|Death|1|||
44204982|NCT01977794|79000871|FG000|Overall Study|Withdrew consent|2|||
44204983|NCT01977794|79000872|FG001|Overall Study|Withdrew consent|1|||
44204984|NCT01977794|79000871|FG000|Overall Study|Other|0|||
44204985|NCT01977794|79000872|FG001|Overall Study|Other|1|||
44204986|NCT02005484|79000878|FG000|Overall Study|Death|1|||
44204987|NCT02005484|79000878|FG000|Overall Study|Disease progression|1|||
44204988|NCT02005484|79000878|FG000|Overall Study|Changed to a Different Study|1|||
44204989|NCT02005484|79000878|FG000|Overall Study|Sponsor decision|1|||
44204990|NCT02005250|79000884|FG000|Overall Study|Lost to Follow-up|15|||
44204991|NCT02005250|79000885|FG001|Overall Study|Lost to Follow-up|5|||
44204992|NCT02024750|79000893|FG000|Overall Study|Withdrawal by Subject|2|||
44204993|NCT02024750|79000894|FG001|Overall Study|Withdrawal by Subject|1|||
44204994|NCT01597973|79000902|FG000|Overall Study|Found ineligible before study medication started|4|||
44204995|NCT01597973|79000903|FG001|Overall Study|Found ineligible before study medication started|2|||
44204996|NCT01597973|79000902|FG000|Overall Study|Eligible pathogen not confirmed|14|||
44204997|NCT01597973|79000903|FG001|Overall Study|Eligible pathogen not confirmed|15|||
44204998|NCT01597973|79000902|FG000|Overall Study|LAR not authorized to consent|0|||
44204999|NCT01597973|79000903|FG001|Overall Study|LAR not authorized to consent|1|||
44205000|NCT01597973|79000902|FG000|Overall Study|Ineligible due to early seizures|1|||
44205001|NCT01597973|79000903|FG001|Overall Study|Ineligible due to early seizures|0|||
44205002|NCT01597973|79000902|FG000|Overall Study|Ineligible due to non-target infection|1|||
44205003|NCT01597973|79000903|FG001|Overall Study|Ineligible due to non-target infection|1|||
44366248|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
44205004|NCT02023268|79000913|FG000|Overall Study|Lack of Efficacy|0|||
44205005|NCT02023268|79000914|FG001|Overall Study|Lack of Efficacy|1|||
44205006|NCT02023268|79000913|FG000|Overall Study|Adverse Event|0|||
44205007|NCT02023268|79000914|FG001|Overall Study|Adverse Event|2|||
44366249|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
44452020|NCT00494871|79460931|FG000|Follow-up (FU) Period|Death|13|||
44205008|NCT02023268|79000913|FG000|Overall Study|Withdrawal by Subject|0|||
44205009|NCT02023268|79000914|FG001|Overall Study|Withdrawal by Subject|1|||
44205010|NCT02047253|79000920|FG000|Overall Study|Lost to Follow-up|8|||
44205011|NCT02096705|79000926|FG000|Treatment|Adverse Event|6|||
44205012|NCT02096705|79000927|FG001|Treatment|Adverse Event|3|||
44205013|NCT02096705|79000926|FG000|Treatment|Subject request to discontinue treatment|1|||
44205014|NCT02096705|79000927|FG001|Treatment|Subject request to discontinue treatment|1|||
44205015|NCT02096705|79000926|FG000|Treatment|Withdrawal by Subject|1|||
44205016|NCT02096705|79000927|FG001|Treatment|Withdrawal by Subject|0|||
44205017|NCT02096705|79000926|FG000|Treatment|Other|1|||
44205018|NCT02096705|79000927|FG001|Treatment|Other|1|||
44205019|NCT02096705|79000926|FG000|Follow-up|Withdrawal by Subject|1|||
44205020|NCT02096705|79000927|FG001|Follow-up|Withdrawal by Subject|0|||
44205021|NCT02096705|79000926|FG000|Follow-up|Adverse Event|2|||
44205022|NCT02096705|79000927|FG001|Follow-up|Adverse Event|2|||
44205023|NCT02096705|79000926|FG000|Follow-up|Subjects not reporting status|1|||
44205024|NCT02096705|79000927|FG001|Follow-up|Subjects not reporting status|2|||
44205025|NCT02096471|79000933|FG000|Overall Study|Adverse Event|1|||
44205026|NCT02096471|79000933|FG000|Overall Study|Lack of Efficacy|7|||
44205027|NCT02096471|79000933|FG000|Overall Study|Withdrawal by Subject|3|||
44205028|NCT02096471|79000933|FG000|Overall Study|Non-Compliant|2|||
44205029|NCT02096003|79000939|FG000|Overall Study|Protocol Violation|0|||
44205030|NCT02096003|79000940|FG001|Overall Study|Protocol Violation|2|||
44205031|NCT02096003|79000939|FG000|Overall Study|additional surgery|2|||
44205032|NCT02096003|79000940|FG001|Overall Study|additional surgery|1|||
44205033|NCT02062385|79000950|FG000|Overall Study|Adverse Event|19|||
44205034|NCT02062385|79000951|FG001|Overall Study|Adverse Event|13|||
44205035|NCT02062385|79000952|FG002|Overall Study|Adverse Event|1|||
44205036|NCT02062385|79000953|FG003|Overall Study|Adverse Event|0|||
44205037|NCT02062385|79000950|FG000|Overall Study|Protocol Violation|1|||
44205038|NCT02062385|79000951|FG001|Overall Study|Protocol Violation|0|||
44205039|NCT02062385|79000952|FG002|Overall Study|Protocol Violation|0|||
44205040|NCT02062385|79000953|FG003|Overall Study|Protocol Violation|0|||
44205041|NCT02062385|79000950|FG000|Overall Study|Incomplete EPI by database lock|2|||
44205042|NCT02062385|79000951|FG001|Overall Study|Incomplete EPI by database lock|0|||
44205043|NCT02062385|79000952|FG002|Overall Study|Incomplete EPI by database lock|0|||
44205044|NCT02062385|79000953|FG003|Overall Study|Incomplete EPI by database lock|0|||
44205045|NCT02062385|79000950|FG000|Overall Study|Moved|10|||
44205046|NCT02062385|79000951|FG001|Overall Study|Moved|11|||
44205047|NCT02062385|79000952|FG002|Overall Study|Moved|1|||
44205048|NCT02062385|79000953|FG003|Overall Study|Moved|0|||
44205049|NCT02062385|79000950|FG000|Overall Study|Withdrawn by parent/guardian|46|||
44205050|NCT02062385|79000951|FG001|Overall Study|Withdrawn by parent/guardian|41|||
44205051|NCT02062385|79000952|FG002|Overall Study|Withdrawn by parent/guardian|9|||
44205052|NCT02062385|79000953|FG003|Overall Study|Withdrawn by parent/guardian|8|||
44205053|NCT02062385|79000950|FG000|Overall Study|Death|0|||
44205054|NCT02062385|79000951|FG001|Overall Study|Death|0|||
44205055|NCT02062385|79000952|FG002|Overall Study|Death|0|||
44205056|NCT02062385|79000953|FG003|Overall Study|Death|1|||
44205057|NCT02062385|79000950|FG000|Overall Study|Lost to Follow-up|0|||
44205058|NCT02062385|79000951|FG001|Overall Study|Lost to Follow-up|0|||
44205059|NCT02062385|79000952|FG002|Overall Study|Lost to Follow-up|1|||
44205060|NCT02062385|79000953|FG003|Overall Study|Lost to Follow-up|0|||
44205061|NCT02062151|79000961|FG000|Overall Study|screen failure|1|||
44205062|NCT02060903|79000967|FG000|Overall Study|Lost to Follow-up|4|||
44205063|NCT02060903|79000968|FG001|Overall Study|Lost to Follow-up|0|||
44205064|NCT02060903|79000967|FG000|Overall Study|Withdrawal by Subject|0|||
44205065|NCT02060903|79000968|FG001|Overall Study|Withdrawal by Subject|7|||
44205066|NCT02095691|79000974|FG000|Overall Study|Physician Decision|1|||
44205067|NCT02095535|79000990|FG000|Recruitment|Protocol Violation|2|||
44205068|NCT02095223|79000996|FG000|Overall Study|Withdrawal by Subject|1|||
44205069|NCT02095223|79000997|FG001|Overall Study|Withdrawal by Subject|0|||
44205070|NCT02095145|79001005|FG000|Overall Study|Withdrawal by Subject|1|||
44205071|NCT02095145|79001006|FG001|Overall Study|Withdrawal by Subject|0|||
44205072|NCT02059187|79001016|FG000|Overall Study|Adverse Event|0|||
44269410|NCT02363322|79192731|FG000|Overall Study|Lost to Follow-up|1|||
44366250|NCT03739840|79371493|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
44366251|NCT03739840|79371494|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
44366252|NCT03739840|79371495|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
44366253|NCT03739840|79371496|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
44366254|NCT01035060|79371520|FG000|Overall Study|Lost to Follow-up|0|||
44366255|NCT01035060|79371521|FG001|Overall Study|Lost to Follow-up|7|||
44366256|NCT01035060|79371520|FG000|Overall Study|Did not quality after 2nd screening|14|||
44366257|NCT01035060|79371521|FG001|Overall Study|Did not quality after 2nd screening|1|||
44366258|NCT01035060|79371520|FG000|Overall Study|Withdrawal by Subject|8|||
44205073|NCT02059187|79001017|FG001|Overall Study|Adverse Event|3|||
44205074|NCT02059187|79001016|FG000|Overall Study|Death|1|||
44205075|NCT02059187|79001017|FG001|Overall Study|Death|1|||
44205076|NCT02059187|79001016|FG000|Overall Study|Lost to Follow-up|9|||
44205077|NCT02059187|79001017|FG001|Overall Study|Lost to Follow-up|8|||
44205078|NCT02059187|79001016|FG000|Overall Study|Non-compliance with study drug|1|||
44205079|NCT02059187|79001017|FG001|Overall Study|Non-compliance with study drug|0|||
44205080|NCT02059187|79001016|FG000|Overall Study|Physician Decision|1|||
44205081|NCT02059187|79001017|FG001|Overall Study|Physician Decision|2|||
44205082|NCT02059187|79001016|FG000|Overall Study|Protocol Violation|1|||
44205083|NCT02059187|79001017|FG001|Overall Study|Protocol Violation|0|||
44205084|NCT02059187|79001016|FG000|Overall Study|Withdrawal by Subject|12|||
44205085|NCT02059187|79001017|FG001|Overall Study|Withdrawal by Subject|8|||
44366259|NCT01035060|79371521|FG001|Overall Study|Withdrawal by Subject|6|||
44366260|NCT01035060|79371520|FG000|Overall Study|Physician Decision|2|||
44366261|NCT01035060|79371521|FG001|Overall Study|Physician Decision|0|||
44366262|NCT01039428|79371529|FG000|Overall Study|Protocol Violation|1|||
44366263|NCT01039428|79371530|FG001|Overall Study|Protocol Violation|0|||
44366264|NCT01039428|79371529|FG000|Overall Study|Withdrawal by Subject|1|||
44366265|NCT01039428|79371530|FG001|Overall Study|Withdrawal by Subject|0|||
44366266|NCT01034358|79371536|FG000|Overall Study|Withdrawal by Subject|1|||
44366267|NCT01034358|79371536|FG000|Overall Study|Protocol Violation|1|||
44366268|NCT01033734|79371544|FG000|Overall Study|Withdrawal by Subject|1|||
44366269|NCT01115855|79371559|FG000|Overall Study|Adverse Event|16|||
44366270|NCT01115855|79371560|FG001|Overall Study|Adverse Event|18|||
44366271|NCT01115855|79371559|FG000|Overall Study|Death|6|||
44366272|NCT01115855|79371560|FG001|Overall Study|Death|5|||
44366273|NCT01115855|79371559|FG000|Overall Study|Lab Abnormality|1|||
44366274|NCT01115855|79371560|FG001|Overall Study|Lab Abnormality|1|||
44366275|NCT01115855|79371559|FG000|Overall Study|Protocol Violation|0|||
44366276|NCT01115855|79371560|FG001|Overall Study|Protocol Violation|1|||
44366277|NCT01115855|79371559|FG000|Overall Study|Withdrawal by Subject|5|||
44366278|NCT01115855|79371560|FG001|Overall Study|Withdrawal by Subject|5|||
44366279|NCT01115855|79371559|FG000|Overall Study|Other|8|||
44366280|NCT01115855|79371560|FG001|Overall Study|Other|6|||
44366281|NCT01115309|79371570|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
44366282|NCT01115309|79371570|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
44366283|NCT01115309|79371570|FG000|Long-term Follow-up|Lost to Follow-up|6|||
44366284|NCT03638128|79371578|FG000|Overall Study|Withdrawal by Subject|1|||
44366285|NCT03638128|79371579|FG001|Overall Study|Withdrawal by Subject|7|||
44366286|NCT03638128|79371580|FG002|Overall Study|Withdrawal by Subject|6|||
44366287|NCT03638128|79371578|FG000|Overall Study|Sponsor Decision|15|||
44366288|NCT03638128|79371579|FG001|Overall Study|Sponsor Decision|12|||
44366289|NCT03638128|79371580|FG002|Overall Study|Sponsor Decision|19|||
44366290|NCT03638128|79371578|FG000|Overall Study|Lost to Follow-up|0|||
44366291|NCT03638128|79371579|FG001|Overall Study|Lost to Follow-up|0|||
44366292|NCT03638128|79371580|FG002|Overall Study|Lost to Follow-up|1|||
44366293|NCT01059630|79371593|FG000|Overall Study|Death|100|||
44366294|NCT01059630|79371594|FG001|Overall Study|Death|84|||
44366295|NCT01059630|79371593|FG000|Overall Study|Lost to Follow-up|4|||
44366296|NCT01059630|79371594|FG001|Overall Study|Lost to Follow-up|1|||
44366297|NCT01059630|79371593|FG000|Overall Study|Physician Decision|2|||
44366298|NCT01059630|79371594|FG001|Overall Study|Physician Decision|4|||
44366299|NCT01059630|79371593|FG000|Overall Study|Withdrawal by Subject|21|||
44366300|NCT01059630|79371594|FG001|Overall Study|Withdrawal by Subject|14|||
44366301|NCT00932373|79371611|FG000|Overall Study|Progressive disease|3|||
44366302|NCT00932373|79371612|FG001|Overall Study|Progressive disease|1|||
44366303|NCT00932373|79371613|FG002|Overall Study|Progressive disease|0|||
44366304|NCT00932373|79371614|FG003|Overall Study|Progressive disease|0|||
44366305|NCT00932373|79371615|FG004|Overall Study|Progressive disease|10|||
44366306|NCT00932373|79371616|FG005|Overall Study|Progressive disease|1|||
44366307|NCT00932373|79371617|FG006|Overall Study|Progressive disease|0|||
44366308|NCT00932373|79371618|FG007|Overall Study|Progressive disease|2|||
44366309|NCT00932373|79371619|FG008|Overall Study|Progressive disease|1|||
44366310|NCT00932373|79371620|FG009|Overall Study|Progressive disease|9|||
44366311|NCT00932373|79371621|FG010|Overall Study|Progressive disease|2|||
44366312|NCT00932373|79371611|FG000|Overall Study|Adverse Event|0|||
44366313|NCT00932373|79371612|FG001|Overall Study|Adverse Event|0|||
44366314|NCT00932373|79371613|FG002|Overall Study|Adverse Event|0|||
44366315|NCT00932373|79371614|FG003|Overall Study|Adverse Event|0|||
44366316|NCT00932373|79371615|FG004|Overall Study|Adverse Event|2|||
44366317|NCT00932373|79371616|FG005|Overall Study|Adverse Event|1|||
44366318|NCT00932373|79371617|FG006|Overall Study|Adverse Event|0|||
44366319|NCT00932373|79371618|FG007|Overall Study|Adverse Event|1|||
44366320|NCT00932373|79371619|FG008|Overall Study|Adverse Event|0|||
44366321|NCT00932373|79371620|FG009|Overall Study|Adverse Event|2|||
44366322|NCT00932373|79371621|FG010|Overall Study|Adverse Event|1|||
44366323|NCT00932373|79371611|FG000|Overall Study|Physician Decision|0|||
44366324|NCT00932373|79371612|FG001|Overall Study|Physician Decision|0|||
44366325|NCT00932373|79371613|FG002|Overall Study|Physician Decision|1|||
44366326|NCT00932373|79371614|FG003|Overall Study|Physician Decision|0|||
44366327|NCT00932373|79371615|FG004|Overall Study|Physician Decision|2|||
44366328|NCT00932373|79371616|FG005|Overall Study|Physician Decision|0|||
44366329|NCT00932373|79371617|FG006|Overall Study|Physician Decision|0|||
44366330|NCT00932373|79371618|FG007|Overall Study|Physician Decision|0|||
44366331|NCT00932373|79371619|FG008|Overall Study|Physician Decision|0|||
44366332|NCT00932373|79371620|FG009|Overall Study|Physician Decision|1|||
44366333|NCT00932373|79371621|FG010|Overall Study|Physician Decision|0|||
44366334|NCT00932373|79371611|FG000|Overall Study|Dose limiting toxicity|0|||
44366335|NCT00932373|79371612|FG001|Overall Study|Dose limiting toxicity|0|||
44366336|NCT00932373|79371613|FG002|Overall Study|Dose limiting toxicity|0|||
44366337|NCT00932373|79371614|FG003|Overall Study|Dose limiting toxicity|0|||
44366338|NCT00932373|79371615|FG004|Overall Study|Dose limiting toxicity|0|||
44452021|NCT00494871|79460932|FG001|Follow-up (FU) Period|Death|12|||
44452022|NCT00494871|79460931|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
44452023|NCT00494871|79460932|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
44452024|NCT00494871|79460931|FG000|Follow-up (FU) Period|Physician Decision|0|||
44452025|NCT00494871|79460932|FG001|Follow-up (FU) Period|Physician Decision|1|||
44452026|NCT00494871|79460931|FG000|Follow-up (FU) Period|Protocol Violation|1|||
44205086|NCT02043899|79001023|FG000|Overall Study|Adverse Event|3|||
44205087|NCT02043899|79001023|FG000|Overall Study|Physician Decision|1|||
44205088|NCT02043899|79001023|FG000|Overall Study|Withdrawal by Subject|2|||
44205089|NCT02043899|79001023|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
44205090|NCT02043899|79001023|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
44205091|NCT02043899|79001023|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
44205092|NCT02043899|79001023|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
44205093|NCT02043899|79001023|FG000|Overall Study|Treatment delayed|1|||
44205094|NCT02043509|79001029|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
44205095|NCT02043509|79001030|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
44205096|NCT02043509|79001029|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
44205097|NCT02043509|79001030|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
44205098|NCT02043509|79001029|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
44205099|NCT02043509|79001030|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
44205100|NCT02043509|79001029|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
44269411|NCT02363322|79192732|FG001|Overall Study|Lost to Follow-up|0|||
44269412|NCT02361762|79192740|FG000|Overall Study|Withdrawal by Subject|0|||
44269413|NCT02361762|79192741|FG001|Overall Study|Withdrawal by Subject|1|||
44269414|NCT02361762|79192740|FG000|Overall Study|Lost to Follow-up|0|||
44269415|NCT02361762|79192741|FG001|Overall Study|Lost to Follow-up|1|||
44269416|NCT02337738|79192750|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
44269417|NCT02337738|79192751|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
44269418|NCT02337738|79192752|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
44269419|NCT02337738|79192750|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
44269420|NCT02337738|79192751|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
44269421|NCT02337738|79192752|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
44269422|NCT02337738|79192750|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
44452027|NCT00494871|79460932|FG001|Follow-up (FU) Period|Protocol Violation|0|||
44269423|NCT02337738|79192751|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
44269424|NCT02337738|79192752|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
44269425|NCT02337738|79192750|FG000|Overall Study|Voluntary Withdrawal|10|||
44205101|NCT02043509|79001030|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
44205102|NCT02058563|79001038|FG000|Overall Study|Lost to Follow-up|26|||
44205103|NCT02058563|79001039|FG001|Overall Study|Lost to Follow-up|22|||
44205104|NCT02058563|79001038|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
44205105|NCT02058563|79001039|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
44205106|NCT02058563|79001038|FG000|Overall Study|Consent Withdrawal|1|||
44205107|NCT02058563|79001039|FG001|Overall Study|Consent Withdrawal|1|||
44205108|NCT02058563|79001038|FG000|Overall Study|Other (patient incarcerated)|0|||
44205109|NCT02058563|79001039|FG001|Overall Study|Other (patient incarcerated)|1|||
44205110|NCT01622231|79001045|FG000|Overall Study|Physician Decision|1|||
44205111|NCT01622231|79001045|FG000|Overall Study|Withdrawal by Subject|1|||
44205112|NCT02042183|79001051|FG000|Overall Study|Physician Decision|7|||
44205113|NCT02042183|79001052|FG001|Overall Study|Physician Decision|2|||
44366339|NCT00932373|79371616|FG005|Overall Study|Dose limiting toxicity|1|||
44366340|NCT00932373|79371617|FG006|Overall Study|Dose limiting toxicity|0|||
44366341|NCT00932373|79371618|FG007|Overall Study|Dose limiting toxicity|0|||
44205114|NCT02042183|79001051|FG000|Overall Study|Lack of Efficacy|4|||
44205115|NCT02042183|79001052|FG001|Overall Study|Lack of Efficacy|3|||
44205116|NCT02042183|79001051|FG000|Overall Study|Non-compliance with Study Drug|2|||
44205117|NCT02042183|79001052|FG001|Overall Study|Non-compliance with Study Drug|3|||
44205118|NCT02042183|79001051|FG000|Overall Study|Adverse Event|17|||
44205119|NCT02042183|79001052|FG001|Overall Study|Adverse Event|6|||
44205120|NCT02042183|79001051|FG000|Overall Study|Other|3|||
44205121|NCT02042183|79001052|FG001|Overall Study|Other|3|||
44205122|NCT02042183|79001051|FG000|Overall Study|Withdrawal by Subject|21|||
44205123|NCT02042183|79001052|FG001|Overall Study|Withdrawal by Subject|16|||
44205124|NCT02042183|79001051|FG000|Overall Study|Site Terminated by Sponsor|2|||
44205125|NCT02042183|79001052|FG001|Overall Study|Site Terminated by Sponsor|1|||
44205126|NCT02042183|79001051|FG000|Overall Study|Lost to Follow-up|9|||
44205127|NCT02042183|79001052|FG001|Overall Study|Lost to Follow-up|2|||
44366342|NCT00932373|79371619|FG008|Overall Study|Dose limiting toxicity|0|||
44366343|NCT00932373|79371620|FG009|Overall Study|Dose limiting toxicity|0|||
44366344|NCT00932373|79371621|FG010|Overall Study|Dose limiting toxicity|0|||
44366345|NCT00932373|79371611|FG000|Overall Study|Withdrawal by Subject|0|||
44366346|NCT00932373|79371612|FG001|Overall Study|Withdrawal by Subject|0|||
44366347|NCT00932373|79371613|FG002|Overall Study|Withdrawal by Subject|0|||
44366348|NCT00932373|79371614|FG003|Overall Study|Withdrawal by Subject|0|||
44366349|NCT00932373|79371615|FG004|Overall Study|Withdrawal by Subject|0|||
44366350|NCT00932373|79371616|FG005|Overall Study|Withdrawal by Subject|0|||
44366351|NCT00932373|79371617|FG006|Overall Study|Withdrawal by Subject|0|||
44366352|NCT00932373|79371618|FG007|Overall Study|Withdrawal by Subject|0|||
44366353|NCT00932373|79371619|FG008|Overall Study|Withdrawal by Subject|1|||
44366354|NCT00932373|79371620|FG009|Overall Study|Withdrawal by Subject|0|||
44366355|NCT00932373|79371621|FG010|Overall Study|Withdrawal by Subject|0|||
44366356|NCT00932373|79371611|FG000|Overall Study|Clinical progression|0|||
44366357|NCT00932373|79371612|FG001|Overall Study|Clinical progression|0|||
44366358|NCT00932373|79371613|FG002|Overall Study|Clinical progression|0|||
44366359|NCT00932373|79371614|FG003|Overall Study|Clinical progression|0|||
44366360|NCT00932373|79371615|FG004|Overall Study|Clinical progression|0|||
44366361|NCT00932373|79371616|FG005|Overall Study|Clinical progression|0|||
44366362|NCT00932373|79371617|FG006|Overall Study|Clinical progression|1|||
44366363|NCT00932373|79371618|FG007|Overall Study|Clinical progression|0|||
44366364|NCT00932373|79371619|FG008|Overall Study|Clinical progression|0|||
44366365|NCT00932373|79371620|FG009|Overall Study|Clinical progression|0|||
44205128|NCT01977482|79001066|FG000|Overall Study|Adverse Event|0|||
44205129|NCT01977482|79001067|FG001|Overall Study|Adverse Event|1|||
44205130|NCT01977482|79001068|FG002|Overall Study|Adverse Event|1|||
44205131|NCT01977482|79001069|FG003|Overall Study|Adverse Event|0|||
44366366|NCT00932373|79371621|FG010|Overall Study|Clinical progression|0|||
44366367|NCT00932373|79371611|FG000|Overall Study|Lack of Efficacy|0|||
44205132|NCT01977482|79001070|FG004|Overall Study|Adverse Event|2|||
44205133|NCT01977482|79001071|FG005|Overall Study|Adverse Event|0|||
44205134|NCT01977482|79001066|FG000|Overall Study|Lost to Follow-up|1|||
44366368|NCT00932373|79371612|FG001|Overall Study|Lack of Efficacy|0|||
44366369|NCT00932373|79371613|FG002|Overall Study|Lack of Efficacy|0|||
44205135|NCT01977482|79001067|FG001|Overall Study|Lost to Follow-up|0|||
44205136|NCT01977482|79001068|FG002|Overall Study|Lost to Follow-up|0|||
44366370|NCT00932373|79371614|FG003|Overall Study|Lack of Efficacy|0|||
44366371|NCT00932373|79371615|FG004|Overall Study|Lack of Efficacy|0|||
44366372|NCT00932373|79371616|FG005|Overall Study|Lack of Efficacy|0|||
44366373|NCT00932373|79371617|FG006|Overall Study|Lack of Efficacy|0|||
44366374|NCT00932373|79371618|FG007|Overall Study|Lack of Efficacy|0|||
44366375|NCT00932373|79371619|FG008|Overall Study|Lack of Efficacy|0|||
44366376|NCT00932373|79371620|FG009|Overall Study|Lack of Efficacy|1|||
44366377|NCT00932373|79371621|FG010|Overall Study|Lack of Efficacy|0|||
44366378|NCT01055496|79371655|FG000|Overall Study|Withdrawal by Subject|2|||
44366379|NCT01055496|79371656|FG001|Overall Study|Withdrawal by Subject|4|||
44366380|NCT01055496|79371655|FG000|Overall Study|Death|13|||
44366381|NCT01055496|79371656|FG001|Overall Study|Death|23|||
44366382|NCT01055496|79371655|FG000|Overall Study|Lost to Follow-up|0|||
44366383|NCT01055496|79371656|FG001|Overall Study|Lost to Follow-up|2|||
44366384|NCT01055496|79371655|FG000|Overall Study|Other - Unspecified|0|||
44366385|NCT01055496|79371656|FG001|Overall Study|Other - Unspecified|1|||
44366386|NCT01055262|79371683|FG000|Overall Study|Adverse Event|5|||
44366387|NCT01055262|79371683|FG000|Overall Study|Protocol Violation|3|||
44366388|NCT01055262|79371683|FG000|Overall Study|Uncooperativeness|1|||
44366389|NCT01052844|79371689|FG000|Overall Study|Adverse Event|0|||
44366390|NCT01052844|79371690|FG001|Overall Study|Adverse Event|1|||
44366391|NCT01049412|79371698|FG000|Period I|Withdrawal by Subject|4|||
44366392|NCT01049412|79371699|FG001|Period I|Withdrawal by Subject|6|||
44366393|NCT01049412|79371698|FG000|Period I|Lost to Follow-up|2|||
44366394|NCT01049412|79371699|FG001|Period I|Lost to Follow-up|2|||
44366395|NCT01049412|79371698|FG000|Period I|Physician Decision|0|||
44366396|NCT01049412|79371699|FG001|Period I|Physician Decision|3|||
44366397|NCT01049412|79371698|FG000|Period I|Protocol Violation|1|||
44366398|NCT01049412|79371699|FG001|Period I|Protocol Violation|2|||
44366399|NCT01049412|79371698|FG000|Period I|Adverse Event|1|||
44366400|NCT01049412|79371699|FG001|Period I|Adverse Event|0|||
44366401|NCT01049412|79371698|FG000|Period II|Withdrawal by Subject|2|||
44366402|NCT01049412|79371699|FG001|Period II|Withdrawal by Subject|3|||
44366403|NCT01049412|79371698|FG000|Period II|Adverse Event|1|||
44366404|NCT01049412|79371699|FG001|Period II|Adverse Event|0|||
44366405|NCT01049412|79371698|FG000|Period II|Lost to Follow-up|1|||
44366406|NCT01049412|79371699|FG001|Period II|Lost to Follow-up|0|||
44366407|NCT00934089|79371709|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
44366408|NCT00934089|79371710|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
44366409|NCT00934089|79371709|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
44366410|NCT00934089|79371710|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
44366411|NCT01032174|79371718|FG000|Overall Study|Adverse Event|0|||
44366412|NCT01032174|79371719|FG001|Overall Study|Adverse Event|1|||
44366413|NCT00933933|79371730|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
44366414|NCT00933933|79371731|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
44366415|NCT00933933|79371732|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
44366416|NCT00933933|79371730|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
44366417|NCT00933933|79371731|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
44366418|NCT00933933|79371732|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
44366419|NCT01032018|79371750|FG000|Overall Study|Lost to Follow-up|6|||
44366420|NCT01032018|79371751|FG001|Overall Study|Lost to Follow-up|5|||
44366421|NCT01032018|79371750|FG000|Overall Study|Death|0|||
44366422|NCT01032018|79371751|FG001|Overall Study|Death|1|||
44366423|NCT01031706|79371759|FG000|Overall Study|Adverse Event|1|||
44269426|NCT02337738|79192751|FG001|Overall Study|Voluntary Withdrawal|5|||
44366424|NCT01031706|79371760|FG001|Overall Study|Adverse Event|0|||
44366425|NCT01031706|79371759|FG000|Overall Study|Withdrawal by Subject|1|||
44366426|NCT01031706|79371760|FG001|Overall Study|Withdrawal by Subject|1|||
44205137|NCT01977482|79001069|FG003|Overall Study|Lost to Follow-up|0|||
44205138|NCT01977482|79001070|FG004|Overall Study|Lost to Follow-up|0|||
44205139|NCT01977482|79001071|FG005|Overall Study|Lost to Follow-up|0|||
44205140|NCT01977482|79001066|FG000|Overall Study|Physician Decision|0|||
44205141|NCT01977482|79001067|FG001|Overall Study|Physician Decision|1|||
44205142|NCT01977482|79001068|FG002|Overall Study|Physician Decision|0|||
44205143|NCT01977482|79001069|FG003|Overall Study|Physician Decision|0|||
44205144|NCT01977482|79001070|FG004|Overall Study|Physician Decision|0|||
44205145|NCT01977482|79001071|FG005|Overall Study|Physician Decision|0|||
44366427|NCT00927069|79371768|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
44366428|NCT00927069|79371769|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
44366429|NCT00927069|79371770|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
44366430|NCT00927069|79371771|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
44366431|NCT00927069|79371768|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
44205146|NCT01977482|79001066|FG000|Overall Study|Protocol Violation|0|||
44205147|NCT01977482|79001067|FG001|Overall Study|Protocol Violation|0|||
44366432|NCT00927069|79371769|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
44366433|NCT00927069|79371770|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
44205148|NCT01977482|79001068|FG002|Overall Study|Protocol Violation|1|||
44366434|NCT00927069|79371771|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
44366435|NCT00927069|79371768|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
44366436|NCT00927069|79371769|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
44366437|NCT00927069|79371770|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
44366438|NCT00927069|79371771|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
44366439|NCT00927069|79371768|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
44366440|NCT00927069|79371769|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
44366441|NCT00927069|79371770|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
44366442|NCT00927069|79371771|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
44366443|NCT00927069|79371768|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
44366444|NCT00927069|79371769|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
44366445|NCT00927069|79371770|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
44366446|NCT00927069|79371771|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
44366447|NCT01031628|79371785|FG000|Overall Study|Study terminated early|0|||
44366448|NCT01031628|79371786|FG001|Overall Study|Study terminated early|1|||
44366449|NCT01031628|79371787|FG002|Overall Study|Study terminated early|3|||
44366450|NCT01031628|79371788|FG003|Overall Study|Study terminated early|0|||
44366451|NCT01031004|79371800|FG000|Overall Study|Protocol Violation|0|||
44366452|NCT01031004|79371801|FG001|Overall Study|Protocol Violation|1|||
44366453|NCT01031004|79371800|FG000|Overall Study|Lost to Follow-up|1|||
44366454|NCT01031004|79371801|FG001|Overall Study|Lost to Follow-up|0|||
44366455|NCT00931515|79371809|FG000|Overall Study|Lost to Follow-up|2|||
44366456|NCT00931515|79371810|FG001|Overall Study|Lost to Follow-up|5|||
44366457|NCT01028352|79371816|FG000|Overall Study|Ineligible due to baseline average pain|5|||
44366458|NCT01028352|79371816|FG000|Overall Study|Withdrawal by Subject|1|||
44366459|NCT00929643|79371833|FG000|Overall Study|Protocol Violation|2|||
44366460|NCT00926367|79371839|FG000|Overall Study|Withdrawal by Subject|0|||
44366461|NCT00926367|79371840|FG001|Overall Study|Withdrawal by Subject|1|||
44366462|NCT00926367|79371839|FG000|Overall Study|Lost to Follow-up|1|||
44366463|NCT00926367|79371840|FG001|Overall Study|Lost to Follow-up|0|||
44366464|NCT00926367|79371839|FG000|Overall Study|Skin Irritation|1|||
44366465|NCT00926367|79371840|FG001|Overall Study|Skin Irritation|2|||
44366466|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
44366467|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
44366468|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
44366469|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
44366470|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
44366471|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
44366472|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
44366473|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
44366474|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
44366475|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
44366476|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
44366477|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
44366478|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
44366479|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
44366480|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
44366481|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
44366482|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
44366483|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
44366484|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
44366485|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
44366486|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
44366487|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
44366488|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
44366489|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
44366490|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Death|2|||
44366491|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Death|1|||
44366492|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Death|2|||
44366493|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Graft loss|0|||
44366494|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Graft loss|2|||
44366495|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Graft loss|0|||
44366496|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
44366497|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
44366498|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
44366499|NCT01114529|79371851|FG000|Completed Study Medication at Month 24|Missing|2|||
44366500|NCT01114529|79371852|FG001|Completed Study Medication at Month 24|Missing|0|||
44366501|NCT01114529|79371853|FG002|Completed Study Medication at Month 24|Missing|0|||
44366502|NCT01114529|79371851|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
44366503|NCT01114529|79371852|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
44366504|NCT01114529|79371853|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
44366505|NCT01114529|79371851|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
44366506|NCT01114529|79371852|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
44366507|NCT01114529|79371853|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
44366508|NCT01114529|79371851|FG000|Completed Study Phase at Month 24|Death|8|||
44366509|NCT01114529|79371852|FG001|Completed Study Phase at Month 24|Death|5|||
44366510|NCT01114529|79371853|FG002|Completed Study Phase at Month 24|Death|4|||
44366511|NCT01114529|79371851|FG000|Completed Study Phase at Month 24|Other|2|||
44366512|NCT01114529|79371852|FG001|Completed Study Phase at Month 24|Other|0|||
44366513|NCT01114529|79371853|FG002|Completed Study Phase at Month 24|Other|0|||
44366514|NCT01114529|79371851|FG000|Completed Study Phase at Month 24|Missing|2|||
44366515|NCT01114529|79371852|FG001|Completed Study Phase at Month 24|Missing|0|||
44366516|NCT01114529|79371853|FG002|Completed Study Phase at Month 24|Missing|0|||
44366517|NCT00926289|79371865|FG000|Overall Study|Adverse Event|9|||
44366518|NCT00926289|79371866|FG001|Overall Study|Adverse Event|11|||
44366519|NCT00926289|79371865|FG000|Overall Study|Protocol Violation|8|||
44366520|NCT00926289|79371866|FG001|Overall Study|Protocol Violation|12|||
44366521|NCT00926289|79371865|FG000|Overall Study|Lost to Follow-up|3|||
44366522|NCT00926289|79371866|FG001|Overall Study|Lost to Follow-up|6|||
44366523|NCT00926289|79371865|FG000|Overall Study|Withdrawal by Subject|4|||
44366524|NCT00926289|79371866|FG001|Overall Study|Withdrawal by Subject|4|||
44366525|NCT00926289|79371865|FG000|Overall Study|Other|1|||
44366526|NCT00926289|79371866|FG001|Overall Study|Other|3|||
44366527|NCT03208036|79371891|FG000|Baseline Assessment|Withdrawal by Subject|1|||
44366528|NCT03208036|79371892|FG001|Baseline Assessment|Withdrawal by Subject|1|||
44366529|NCT03208036|79371891|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
44366530|NCT03208036|79371892|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
44366531|NCT03208036|79371891|FG000|Intervention|Withdrawal by Subject|3|||
44366532|NCT03208036|79371892|FG001|Intervention|Withdrawal by Subject|2|||
44366533|NCT03208036|79371891|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
44366534|NCT03208036|79371892|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
44366535|NCT00926211|79371898|FG000|Overall Study|Lost to Follow-up|1|||
44205149|NCT01977482|79001069|FG003|Overall Study|Protocol Violation|0|||
44205150|NCT01977482|79001070|FG004|Overall Study|Protocol Violation|0|||
44205151|NCT01977482|79001071|FG005|Overall Study|Protocol Violation|0|||
44205152|NCT01977482|79001066|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
44205153|NCT01977482|79001067|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
44205154|NCT01977482|79001068|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
44205155|NCT01977482|79001069|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
44205156|NCT01977482|79001070|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
44205157|NCT01977482|79001071|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
44205158|NCT01977482|79001066|FG000|Overall Study|Withdrawal by Subject|2|||
44205159|NCT01977482|79001067|FG001|Overall Study|Withdrawal by Subject|4|||
44205160|NCT01977482|79001068|FG002|Overall Study|Withdrawal by Subject|1|||
44205161|NCT01977482|79001069|FG003|Overall Study|Withdrawal by Subject|3|||
44205162|NCT01977482|79001070|FG004|Overall Study|Withdrawal by Subject|1|||
44205163|NCT01977482|79001071|FG005|Overall Study|Withdrawal by Subject|5|||
44205164|NCT02058095|79001092|FG000|Overall Study|Adverse Event|1|||
44205165|NCT02058095|79001093|FG001|Overall Study|Adverse Event|0|||
44205166|NCT02023112|79001101|FG000|Overall Study|Withdrawal by Subject|2|||
44205167|NCT02023112|79001102|FG001|Overall Study|Withdrawal by Subject|1|||
44205168|NCT01977092|79001112|FG000|Overall Study|Death|3|||
44269427|NCT02337738|79192752|FG002|Overall Study|Voluntary Withdrawal|2|||
44269428|NCT02337738|79192750|FG000|Overall Study|Lack of Efficacy|2|||
44269429|NCT02337738|79192751|FG001|Overall Study|Lack of Efficacy|4|||
44269430|NCT02337738|79192752|FG002|Overall Study|Lack of Efficacy|0|||
44269431|NCT02337738|79192750|FG000|Overall Study|Investigator's Judgment|1|||
44269432|NCT02337738|79192751|FG001|Overall Study|Investigator's Judgment|1|||
44366536|NCT01114373|79371903|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
44205169|NCT01977092|79001113|FG001|Overall Study|Death|4|||
44366537|NCT01114373|79371904|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
44366538|NCT01114373|79371903|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
44205170|NCT01977092|79001112|FG000|Overall Study|Lost to Follow-up|23|||
44205171|NCT01977092|79001113|FG001|Overall Study|Lost to Follow-up|14|||
44269433|NCT02337738|79192752|FG002|Overall Study|Investigator's Judgment|3|||
44269434|NCT02309112|79192763|FG000|Overall Study|Withdrawal by Subject|1|||
44366539|NCT01114373|79371904|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
44366540|NCT01114373|79371903|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
44366541|NCT01114373|79371904|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
44366542|NCT01114373|79371903|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
44366543|NCT01114373|79371904|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
44366544|NCT00925899|79371916|FG000|Part 1|Death|1|||
44366545|NCT00925899|79371917|FG001|Part 1|Death|2|||
44366546|NCT00925899|79371916|FG000|Part 1|Withdrawal by Subject|10|||
44366547|NCT00925899|79371917|FG001|Part 1|Withdrawal by Subject|9|||
44366548|NCT01114217|79371926|FG000|Overall Study|Adverse Event|5|||
44366549|NCT01114217|79371927|FG001|Overall Study|Adverse Event|3|||
44366550|NCT01114217|79371926|FG000|Overall Study|Lost to Follow-up|17|||
44366551|NCT01114217|79371927|FG001|Overall Study|Lost to Follow-up|33|||
44366552|NCT01114217|79371926|FG000|Overall Study|Withdrawal by Subject|21|||
44366553|NCT01114217|79371927|FG001|Overall Study|Withdrawal by Subject|28|||
44366554|NCT01114217|79371926|FG000|Overall Study|Other-Clerical Error|3|||
44366555|NCT01114217|79371927|FG001|Overall Study|Other-Clerical Error|0|||
44366556|NCT01114217|79371926|FG000|Overall Study|Other-Early termination|6|||
44366557|NCT01114217|79371927|FG001|Overall Study|Other-Early termination|10|||
44366558|NCT01114217|79371926|FG000|Overall Study|Other-Procedure|1|||
44366559|NCT01114217|79371927|FG001|Overall Study|Other-Procedure|1|||
44366560|NCT01114217|79371926|FG000|Overall Study|Other-Pregnancy|2|||
44366561|NCT01114217|79371927|FG001|Overall Study|Other-Pregnancy|4|||
44366562|NCT01114217|79371926|FG000|Overall Study|Other-Protocol Violation|1|||
44366563|NCT01114217|79371927|FG001|Overall Study|Other-Protocol Violation|3|||
44366564|NCT01114217|79371926|FG000|Overall Study|Other-Lack of Efficacy|1|||
44366565|NCT01114217|79371927|FG001|Overall Study|Other-Lack of Efficacy|0|||
44366566|NCT01114217|79371926|FG000|Overall Study|Other-Non Compliance|2|||
44366567|NCT01114217|79371927|FG001|Overall Study|Other-Non Compliance|0|||
44366568|NCT01114217|79371926|FG000|Overall Study|Other-Physician Decision|1|||
44366569|NCT01114217|79371927|FG001|Overall Study|Other-Physician Decision|1|||
44366570|NCT01114217|79371926|FG000|Overall Study|Other-Sponsor Decision|10|||
44366571|NCT01114217|79371927|FG001|Overall Study|Other-Sponsor Decision|12|||
44366572|NCT01114217|79371926|FG000|Overall Study|Other-Study Termination|0|||
44366573|NCT01114217|79371927|FG001|Overall Study|Other-Study Termination|1|||
44366574|NCT01114217|79371926|FG000|Overall Study|Other-Study Withdrawn|1|||
44366575|NCT01114217|79371927|FG001|Overall Study|Other-Study Withdrawn|1|||
44366576|NCT01114217|79371926|FG000|Overall Study|Other-Site Stopped Communicating|2|||
44366577|NCT01114217|79371927|FG001|Overall Study|Other-Site Stopped Communicating|0|||
44366578|NCT01114217|79371926|FG000|Overall Study|Other-Lost to Follow-up|1|||
44366579|NCT01114217|79371927|FG001|Overall Study|Other-Lost to Follow-up|0|||
44366580|NCT01114217|79371926|FG000|Overall Study|Other-Withdrawal by Subject|1|||
44366581|NCT01114217|79371927|FG001|Overall Study|Other-Withdrawal by Subject|1|||
44366582|NCT01030536|79371936|FG000|Overall Study|Withdrawal by Subject|0|||
44366583|NCT01030536|79371937|FG001|Overall Study|Withdrawal by Subject|0|||
44366584|NCT01030536|79371938|FG002|Overall Study|Withdrawal by Subject|1|||
44366585|NCT01030536|79371939|FG003|Overall Study|Withdrawal by Subject|0|||
44366586|NCT01030536|79371940|FG004|Overall Study|Withdrawal by Subject|0|||
44366587|NCT01030536|79371936|FG000|Overall Study|undefined|1|||
44366588|NCT01030536|79371937|FG001|Overall Study|undefined|0|||
44366589|NCT01030536|79371938|FG002|Overall Study|undefined|1|||
44366590|NCT01030536|79371939|FG003|Overall Study|undefined|1|||
44366591|NCT01030536|79371940|FG004|Overall Study|undefined|0|||
44205172|NCT01977092|79001112|FG000|Overall Study|Withdrawal by Subject|2|||
44205173|NCT01977092|79001113|FG001|Overall Study|Withdrawal by Subject|1|||
44366592|NCT01030536|79371936|FG000|Overall Study|Adverse Event|0|||
44366593|NCT01030536|79371937|FG001|Overall Study|Adverse Event|3|||
44366594|NCT01030536|79371938|FG002|Overall Study|Adverse Event|1|||
44366595|NCT01030536|79371939|FG003|Overall Study|Adverse Event|0|||
44366596|NCT01030536|79371940|FG004|Overall Study|Adverse Event|1|||
44366597|NCT01030536|79371936|FG000|Overall Study|Progressive disease|6|||
44366598|NCT01030536|79371937|FG001|Overall Study|Progressive disease|2|||
44366599|NCT01030536|79371938|FG002|Overall Study|Progressive disease|3|||
44366600|NCT01030536|79371939|FG003|Overall Study|Progressive disease|2|||
44366601|NCT01030536|79371940|FG004|Overall Study|Progressive disease|0|||
44366602|NCT01030536|79371936|FG000|Overall Study|Death|0|||
44366603|NCT01030536|79371937|FG001|Overall Study|Death|1|||
44366604|NCT01030536|79371938|FG002|Overall Study|Death|0|||
44366605|NCT01030536|79371939|FG003|Overall Study|Death|0|||
44366606|NCT01030536|79371940|FG004|Overall Study|Death|0|||
44205174|NCT01977092|79001112|FG000|Overall Study|In prison|3|||
44366607|NCT01030458|79371958|FG000|Overall Study|Lost to Follow-up|9|||
44366608|NCT01030458|79371959|FG001|Overall Study|Lost to Follow-up|10|||
44366609|NCT01030458|79371958|FG000|Overall Study|Withdrawal by Subject|2|||
44366610|NCT01030458|79371959|FG001|Overall Study|Withdrawal by Subject|3|||
44366611|NCT01030458|79371958|FG000|Overall Study|Logistical reasons|9|||
44366612|NCT01030458|79371959|FG001|Overall Study|Logistical reasons|5|||
44366613|NCT01030458|79371958|FG000|Overall Study|Moved or changed job|6|||
44366614|NCT01030458|79371959|FG001|Overall Study|Moved or changed job|13|||
44366615|NCT01030458|79371958|FG000|Overall Study|Side effect of medication|1|||
44366616|NCT01030458|79371959|FG001|Overall Study|Side effect of medication|1|||
44366617|NCT00930969|79371965|FG000|Overall Study|Death|5|||
44366618|NCT00930969|79371965|FG000|Overall Study|Lost to Follow-up|1|||
44366619|NCT00930969|79371965|FG000|Overall Study|Physician Decision|13|||
44366620|NCT00930969|79371965|FG000|Overall Study|Withdrawal by Subject|19|||
44366621|NCT01114139|79371971|FG000|Overall Study|Adverse Event|3|||
44366622|NCT01114139|79371972|FG001|Overall Study|Adverse Event|2|||
44366623|NCT01114139|79371971|FG000|Overall Study|Lost to Follow-up|15|||
44366624|NCT01114139|79371972|FG001|Overall Study|Lost to Follow-up|3|||
44366625|NCT01114139|79371971|FG000|Overall Study|Withdrawal by Subject|17|||
44366626|NCT01114139|79371972|FG001|Overall Study|Withdrawal by Subject|6|||
44366627|NCT01114139|79371971|FG000|Overall Study|Other-Missed 1 visit|1|||
44366628|NCT01114139|79371972|FG001|Overall Study|Other-Missed 1 visit|0|||
44366629|NCT01114139|79371971|FG000|Overall Study|Other-Protocol Violation|1|||
44366630|NCT01114139|79371972|FG001|Overall Study|Other-Protocol Violation|0|||
44366631|NCT01114139|79371971|FG000|Overall Study|Other-Out of window for study drug dose|1|||
44366632|NCT01114139|79371972|FG001|Overall Study|Other-Out of window for study drug dose|0|||
44366633|NCT01114139|79371971|FG000|Overall Study|Other-Participant falsified records|0|||
44366634|NCT01114139|79371972|FG001|Overall Study|Other-Participant falsified records|1|||
44366635|NCT01114139|79371971|FG000|Overall Study|Other-Participant went on hospice|0|||
44366636|NCT01114139|79371972|FG001|Overall Study|Other-Participant went on hospice|1|||
44366637|NCT01114139|79371971|FG000|Overall Study|Other-Physician changed treatment|1|||
44366638|NCT01114139|79371972|FG001|Overall Study|Other-Physician changed treatment|0|||
44366639|NCT01114139|79371971|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
44366640|NCT01114139|79371972|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
44366641|NCT01027884|79371980|FG000|Overall Study|Adverse Event|2|||
44366642|NCT01027884|79371981|FG001|Overall Study|Adverse Event|1|||
44366643|NCT01027884|79371980|FG000|Overall Study|Protocol Violation|1|||
44366644|NCT01027884|79371981|FG001|Overall Study|Protocol Violation|0|||
44366645|NCT01027884|79371980|FG000|Overall Study|Non-compliance|1|||
44366646|NCT01027884|79371981|FG001|Overall Study|Non-compliance|1|||
44366647|NCT01027884|79371980|FG000|Overall Study|Withdrawal by Subject|0|||
44366648|NCT01027884|79371981|FG001|Overall Study|Withdrawal by Subject|1|||
44366649|NCT01027884|79371980|FG000|Overall Study|Lost to Follow-up|0|||
44366650|NCT01027884|79371981|FG001|Overall Study|Lost to Follow-up|1|||
44366651|NCT01027884|79371980|FG000|Overall Study|Spinal fixation surgery|0|||
44366652|NCT01027884|79371981|FG001|Overall Study|Spinal fixation surgery|3|||
44366653|NCT03387514|79371989|FG000|Overall Study|Withdrawal by Subject|2|||
44366654|NCT03387514|79371989|FG000|Overall Study|Physician Decision|1|||
44366655|NCT03387514|79371989|FG000|Overall Study|Lost to Follow-up|2|||
44366656|NCT01022580|79372004|FG000|Overall Study|Death|18|||
44366657|NCT01022580|79372005|FG001|Overall Study|Death|22|||
44205175|NCT01977092|79001113|FG001|Overall Study|In prison|11|||
44205176|NCT01976624|79001119|FG000|Overall Study|Participants contraindicated|2|||
44205177|NCT01976624|79001119|FG000|Overall Study|Participants age less than 19 years|12|||
44205178|NCT02041091|79001125|FG000|Treatment|Adverse Event|3|||
44205179|NCT02041091|79001126|FG001|Treatment|Adverse Event|3|||
44205180|NCT02041091|79001125|FG000|Treatment|Withdrawal by Subject|2|||
44205181|NCT02041091|79001126|FG001|Treatment|Withdrawal by Subject|4|||
44205182|NCT02041091|79001125|FG000|Treatment|Physician Decision|1|||
44205183|NCT02041091|79001126|FG001|Treatment|Physician Decision|0|||
44205184|NCT02041091|79001125|FG000|Treatment|Sponsor Decision|15|||
44205185|NCT02041091|79001126|FG001|Treatment|Sponsor Decision|16|||
44366658|NCT01107353|79372019|FG000|Overall Study|Positive Drug Screen|1|||
44366659|NCT01107353|79372020|FG001|Overall Study|Positive Drug Screen|0|||
44366660|NCT01107197|79372028|FG000|Overall Study|Death|12|||
44366661|NCT01107197|79372029|FG001|Overall Study|Death|10|||
44205186|NCT02041091|79001125|FG000|Treatment|Lost to Follow-up|1|||
44205187|NCT02041091|79001126|FG001|Treatment|Lost to Follow-up|0|||
44205188|NCT02041091|79001125|FG000|Optional Safety Extension Period|Adverse Event|4|||
44205189|NCT02041091|79001126|FG001|Optional Safety Extension Period|Adverse Event|2|||
44205190|NCT02041091|79001125|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
44205191|NCT02041091|79001126|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
44205192|NCT02041091|79001125|FG000|Optional Safety Extension Period|Protocol Violation|2|||
44205193|NCT02041091|79001126|FG001|Optional Safety Extension Period|Protocol Violation|0|||
44205194|NCT02041091|79001125|FG000|Optional Safety Extension Period|Physician Decision|2|||
44205195|NCT02041091|79001126|FG001|Optional Safety Extension Period|Physician Decision|1|||
44205196|NCT02041091|79001125|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
44205197|NCT02041091|79001126|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
44205198|NCT02041091|79001125|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
44205199|NCT02041091|79001126|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
44205200|NCT02057549|79001140|FG000|Overall Study|Lost to Follow-up|1|||
44366662|NCT01107197|79372028|FG000|Overall Study|Lost to Follow-up|5|||
44366663|NCT01107197|79372029|FG001|Overall Study|Lost to Follow-up|8|||
44366664|NCT01107197|79372028|FG000|Overall Study|Withdrawal by Subject|3|||
44366665|NCT01107197|79372029|FG001|Overall Study|Withdrawal by Subject|5|||
44366666|NCT01112579|79372046|FG000|Overall Study|Missed Visit|1|||
44366667|NCT01112579|79372047|FG001|Overall Study|Missed Visit|1|||
44366668|NCT01112579|79372046|FG000|Overall Study|Death|0|||
44366669|NCT01112579|79372047|FG001|Overall Study|Death|2|||
44366670|NCT01112267|79372055|FG000|Overall Study|Adverse Event|24|||
44366671|NCT01112267|79372056|FG001|Overall Study|Adverse Event|6|||
44366672|NCT01112267|79372055|FG000|Overall Study|Withdrawal by Subject|3|||
44366673|NCT01112267|79372056|FG001|Overall Study|Withdrawal by Subject|5|||
44366674|NCT01112267|79372055|FG000|Overall Study|Protocol Violation|5|||
44366675|NCT01112267|79372056|FG001|Overall Study|Protocol Violation|3|||
44366676|NCT01112267|79372055|FG000|Overall Study|Participants not compliant|1|||
44366677|NCT01112267|79372056|FG001|Overall Study|Participants not compliant|2|||
44366678|NCT01112267|79372055|FG000|Overall Study|Participants not receive any study drug|1|||
44366679|NCT01112267|79372056|FG001|Overall Study|Participants not receive any study drug|2|||
44366680|NCT00925587|79372064|FG000|Overall Study|Protocol Specified Criteria|6|||
44366681|NCT00925587|79372065|FG001|Overall Study|Protocol Specified Criteria|6|||
44366682|NCT00925587|79372064|FG000|Overall Study|Physician Decision|4|||
44366683|NCT00925587|79372065|FG001|Overall Study|Physician Decision|1|||
44366684|NCT00925587|79372064|FG000|Overall Study|Protocol Violation|6|||
44366685|NCT00925587|79372065|FG001|Overall Study|Protocol Violation|4|||
44366686|NCT00925587|79372064|FG000|Overall Study|Withdrawal by Subject|9|||
44366687|NCT00925587|79372065|FG001|Overall Study|Withdrawal by Subject|6|||
44366688|NCT00925587|79372064|FG000|Overall Study|Death|5|||
44366689|NCT00925587|79372065|FG001|Overall Study|Death|5|||
44366690|NCT00925587|79372064|FG000|Overall Study|Adverse Event|6|||
44366691|NCT00925587|79372065|FG001|Overall Study|Adverse Event|2|||
44366692|NCT00925587|79372064|FG000|Overall Study|Lost to Follow-up|0|||
44366693|NCT00925587|79372065|FG001|Overall Study|Lost to Follow-up|1|||
44366694|NCT00928707|79372077|FG000|Overall Study|Protocol Violation|1|||
44366695|NCT00928707|79372078|FG001|Overall Study|Protocol Violation|0|||
44366696|NCT00930813|79372086|FG000|Overall Study|Death|4|||
44366697|NCT00930813|79372087|FG001|Overall Study|Death|5|||
44366698|NCT00930813|79372086|FG000|Overall Study|Withdrawal by Subject|2|||
44366699|NCT00930813|79372087|FG001|Overall Study|Withdrawal by Subject|5|||
44366700|NCT00930813|79372086|FG000|Overall Study|Lost to Follow-up|2|||
44366701|NCT00930813|79372087|FG001|Overall Study|Lost to Follow-up|4|||
44366702|NCT00930579|79372095|FG000|Overall Study|Withdrawal by Subject|1|||
44366703|NCT00930579|79372095|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
44366704|NCT00925353|79372099|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
44366705|NCT01106651|79372123|FG000|Overall Study|Adverse Event|17|||
44366706|NCT01106651|79372124|FG001|Overall Study|Adverse Event|9|||
44366707|NCT01106651|79372125|FG002|Overall Study|Adverse Event|23|||
44366708|NCT01106651|79372123|FG000|Overall Study|Lost to Follow-up|8|||
44366709|NCT01106651|79372124|FG001|Overall Study|Lost to Follow-up|2|||
44366710|NCT01106651|79372125|FG002|Overall Study|Lost to Follow-up|6|||
44366711|NCT01106651|79372123|FG000|Overall Study|Physician Decision|4|||
44366712|NCT01106651|79372124|FG001|Overall Study|Physician Decision|3|||
44366713|NCT01106651|79372125|FG002|Overall Study|Physician Decision|1|||
44366714|NCT01106651|79372123|FG000|Overall Study|Protocol Violation|1|||
44366715|NCT01106651|79372124|FG001|Overall Study|Protocol Violation|2|||
44366716|NCT01106651|79372125|FG002|Overall Study|Protocol Violation|1|||
44366717|NCT01106651|79372123|FG000|Overall Study|Withdrawal by Subject|14|||
44366718|NCT01106651|79372124|FG001|Overall Study|Withdrawal by Subject|7|||
44366719|NCT01106651|79372125|FG002|Overall Study|Withdrawal by Subject|4|||
44366720|NCT01106651|79372123|FG000|Overall Study|Noncompliance with study drug|1|||
44366721|NCT01106651|79372124|FG001|Overall Study|Noncompliance with study drug|0|||
44366722|NCT01106651|79372125|FG002|Overall Study|Noncompliance with study drug|2|||
44366723|NCT01106651|79372123|FG000|Overall Study|Other|34|||
44366724|NCT01106651|79372124|FG001|Overall Study|Other|31|||
44366725|NCT01106651|79372125|FG002|Overall Study|Other|21|||
44366726|NCT01106651|79372123|FG000|Overall Study|Death|0|||
44366727|NCT01106651|79372124|FG001|Overall Study|Death|3|||
44205201|NCT02057549|79001141|FG001|Overall Study|Lost to Follow-up|0|||
44366728|NCT01106651|79372125|FG002|Overall Study|Death|0|||
44366729|NCT01027650|79372144|FG000|Overall Study|Personal Reasons|0|||
44205202|NCT02057549|79001140|FG000|Overall Study|Physician Decision|1|||
44366730|NCT01027650|79372145|FG001|Overall Study|Personal Reasons|0|||
44366731|NCT01027650|79372146|FG002|Overall Study|Personal Reasons|0|||
44366732|NCT01027650|79372147|FG003|Overall Study|Personal Reasons|0|||
44366733|NCT01027650|79372148|FG004|Overall Study|Personal Reasons|2|||
44366734|NCT01027650|79372149|FG005|Overall Study|Personal Reasons|1|||
44366735|NCT01027650|79372150|FG006|Overall Study|Personal Reasons|0|||
44366736|NCT01027650|79372151|FG007|Overall Study|Personal Reasons|0|||
44366737|NCT01027650|79372144|FG000|Overall Study|Lost to Follow-up|0|||
44366738|NCT01027650|79372145|FG001|Overall Study|Lost to Follow-up|0|||
44366739|NCT01027650|79372146|FG002|Overall Study|Lost to Follow-up|0|||
44366740|NCT01027650|79372147|FG003|Overall Study|Lost to Follow-up|0|||
44366741|NCT01027650|79372148|FG004|Overall Study|Lost to Follow-up|0|||
44366742|NCT01027650|79372149|FG005|Overall Study|Lost to Follow-up|0|||
44366743|NCT01027650|79372150|FG006|Overall Study|Lost to Follow-up|1|||
44366744|NCT01027650|79372151|FG007|Overall Study|Lost to Follow-up|0|||
44366745|NCT01027650|79372144|FG000|Overall Study|Lack of Efficacy|0|||
44366746|NCT01027650|79372145|FG001|Overall Study|Lack of Efficacy|0|||
44366747|NCT01027650|79372146|FG002|Overall Study|Lack of Efficacy|0|||
44366748|NCT01027650|79372147|FG003|Overall Study|Lack of Efficacy|0|||
44366749|NCT01027650|79372148|FG004|Overall Study|Lack of Efficacy|0|||
44366750|NCT01027650|79372149|FG005|Overall Study|Lack of Efficacy|1|||
44366751|NCT01027650|79372150|FG006|Overall Study|Lack of Efficacy|0|||
44366752|NCT01027650|79372151|FG007|Overall Study|Lack of Efficacy|0|||
44366753|NCT01106027|79372169|FG000|Overall Study|Lost graft early, discontinued|1|||
44366754|NCT00927927|79372188|FG000|Overall Study|Withdrawal by Subject|0|||
44205203|NCT02057549|79001141|FG001|Overall Study|Physician Decision|0|||
44366755|NCT00927927|79372189|FG001|Overall Study|Withdrawal by Subject|0|||
44366756|NCT00927927|79372190|FG002|Overall Study|Withdrawal by Subject|0|||
44366757|NCT00927927|79372191|FG003|Overall Study|Withdrawal by Subject|0|||
44366758|NCT00927927|79372192|FG004|Overall Study|Withdrawal by Subject|0|||
44366759|NCT00927927|79372193|FG005|Overall Study|Withdrawal by Subject|0|||
44366760|NCT00927927|79372194|FG006|Overall Study|Withdrawal by Subject|0|||
44366761|NCT00927927|79372195|FG007|Overall Study|Withdrawal by Subject|2|||
44366762|NCT00927927|79372196|FG008|Overall Study|Withdrawal by Subject|0|||
44366763|NCT00927927|79372197|FG009|Overall Study|Withdrawal by Subject|0|||
44366764|NCT00927927|79372198|FG010|Overall Study|Withdrawal by Subject|0|||
44366765|NCT00927927|79372199|FG011|Overall Study|Withdrawal by Subject|2|||
44366766|NCT00927927|79372200|FG012|Overall Study|Withdrawal by Subject|0|||
44205204|NCT02057549|79001140|FG000|Overall Study|Withdrawal by Subject|1|||
44205205|NCT02057549|79001141|FG001|Overall Study|Withdrawal by Subject|0|||
44205206|NCT02057393|79001147|FG000|Overall Study|Withdrawal by Subject|1|||
44205207|NCT02057393|79001147|FG000|Overall Study|Patient did not meet criteria|1|||
44205208|NCT02040779|79001154|FG000|Overall Study|Adverse Event|1|||
44205209|NCT02040779|79001155|FG001|Overall Study|Adverse Event|0|||
44205210|NCT02040779|79001156|FG002|Overall Study|Adverse Event|0|||
44205211|NCT02040779|79001154|FG000|Overall Study|Withdrawal by Subject|4|||
44205212|NCT02040779|79001155|FG001|Overall Study|Withdrawal by Subject|1|||
44205213|NCT02040779|79001156|FG002|Overall Study|Withdrawal by Subject|3|||
44205214|NCT02040779|79001154|FG000|Overall Study|Non-compliance|0|||
44205215|NCT02040779|79001155|FG001|Overall Study|Non-compliance|1|||
44366767|NCT00927927|79372201|FG013|Overall Study|Withdrawal by Subject|0|||
44366768|NCT00927927|79372202|FG014|Overall Study|Withdrawal by Subject|0|||
44366769|NCT01027416|79372236|FG000|Overall Study|Withdrawal by Subject|0|||
44366770|NCT01027416|79372237|FG001|Overall Study|Withdrawal by Subject|1|||
44366771|NCT01027416|79372236|FG000|Overall Study|Physician Decision|1|||
44366772|NCT01027416|79372237|FG001|Overall Study|Physician Decision|4|||
44452028|NCT00494871|79460931|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
44452029|NCT00494871|79460932|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
44205216|NCT02040779|79001156|FG002|Overall Study|Non-compliance|0|||
44205217|NCT02040779|79001154|FG000|Overall Study|Protocol Violation|2|||
44366773|NCT00923559|79372245|FG000|Overall Study|Lost to Follow-up|2|||
44366774|NCT00923559|79372246|FG001|Overall Study|Lost to Follow-up|3|||
44366775|NCT01015638|79372256|FG000|Overall Study|Withdrawal by Subject|1|||
44366776|NCT01015638|79372257|FG001|Overall Study|Withdrawal by Subject|0|||
44452030|NCT00494871|79460931|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
44366777|NCT01022502|79372263|FG000|Overall Study|Adverse Event|1|||
44366778|NCT01022502|79372263|FG000|Overall Study|employment related reasons|1|||
44366779|NCT01022502|79372263|FG000|Overall Study|Withdrawal by Subject|1|||
44366780|NCT01105091|79372271|FG000|Overall Study|Death|2|||
44366781|NCT01105091|79372272|FG001|Overall Study|Death|0|||
44366782|NCT00924729|79372282|FG000|Overall Study|insufficient volume for analysis|1|||
44366783|NCT00924729|79372283|FG001|Overall Study|insufficient volume for analysis|0|||
44366784|NCT00924729|79372282|FG000|Overall Study|Protocol Violation|1|||
44366785|NCT00924729|79372283|FG001|Overall Study|Protocol Violation|0|||
44366786|NCT01099709|79372291|FG000|Period 1|Withdrawal by Subject|0|||
44366787|NCT01099709|79372292|FG001|Period 1|Withdrawal by Subject|1|||
44366788|NCT01099709|79372291|FG000|Period 1|Positive cotinine test|0|||
44366789|NCT01099709|79372292|FG001|Period 1|Positive cotinine test|1|||
44366790|NCT01099709|79372291|FG000|Period 1|Adverse Event|1|||
44366791|NCT01099709|79372292|FG001|Period 1|Adverse Event|0|||
44366792|NCT01099397|79372299|FG000|Overall Study|Lost to Follow-up|4|||
44366793|NCT01099397|79372299|FG000|Overall Study|Protocol Violation|4|||
44366794|NCT01099397|79372299|FG000|Overall Study|Withdrawal by Subject|5|||
44366795|NCT01022424|79372304|FG000|Overall Study|Adverse Event|1|||
44366796|NCT01022424|79372304|FG000|Overall Study|Physician Decision|1|||
44366797|NCT01022424|79372304|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
44366798|NCT01098851|79372314|FG000|Overall Study|Equipment failure|1|||
44366799|NCT01098851|79372315|FG001|Overall Study|Equipment failure|0|||
44366800|NCT01026948|79372321|FG000|Overall Study|Physician Decision|8|||
44366801|NCT01104779|79372329|FG000|Overall Study|Protocol Violation|1|||
44366802|NCT01104779|79372330|FG001|Overall Study|Protocol Violation|2|||
44366803|NCT01104779|79372331|FG002|Overall Study|Protocol Violation|2|||
44366804|NCT01104779|79372329|FG000|Overall Study|Lack of Efficacy|26|||
44366805|NCT01104779|79372330|FG001|Overall Study|Lack of Efficacy|12|||
44366806|NCT01104779|79372331|FG002|Overall Study|Lack of Efficacy|13|||
44366807|NCT01104779|79372329|FG000|Overall Study|Adverse Event|13|||
44366808|NCT01104779|79372330|FG001|Overall Study|Adverse Event|14|||
44366809|NCT01104779|79372331|FG002|Overall Study|Adverse Event|13|||
44366810|NCT01104779|79372329|FG000|Overall Study|Did not meet inc/exc criteria|1|||
44366811|NCT01104779|79372330|FG001|Overall Study|Did not meet inc/exc criteria|1|||
44366812|NCT01104779|79372331|FG002|Overall Study|Did not meet inc/exc criteria|1|||
44366813|NCT01104779|79372329|FG000|Overall Study|Other reasons|0|||
44366814|NCT01104779|79372330|FG001|Overall Study|Other reasons|1|||
44366815|NCT01104779|79372331|FG002|Overall Study|Other reasons|0|||
44366816|NCT01104779|79372329|FG000|Overall Study|Lost to Follow-up|2|||
44366817|NCT01104779|79372330|FG001|Overall Study|Lost to Follow-up|0|||
44366818|NCT01104779|79372331|FG002|Overall Study|Lost to Follow-up|1|||
44366819|NCT01104779|79372329|FG000|Overall Study|Withdrawal by Subject|16|||
44366820|NCT01104779|79372330|FG001|Overall Study|Withdrawal by Subject|25|||
44366821|NCT01104779|79372331|FG002|Overall Study|Withdrawal by Subject|32|||
44366822|NCT00918957|79372341|FG000|Overall Study|Adverse Event|2|||
44366823|NCT00918957|79372342|FG001|Overall Study|Adverse Event|0|||
44366824|NCT00918957|79372341|FG000|Overall Study|Withdrawal by Subject|1|||
44366825|NCT00918957|79372342|FG001|Overall Study|Withdrawal by Subject|0|||
44366826|NCT01022268|79372350|FG000|Overall Study|Withdrawal by Subject|1|||
44366827|NCT01022268|79372351|FG001|Overall Study|Withdrawal by Subject|0|||
44366828|NCT01022268|79372350|FG000|Overall Study|Withdrawal by Subject|1|||
44366829|NCT01022268|79372351|FG001|Overall Study|Withdrawal by Subject|0|||
44366830|NCT01015560|79372357|FG000|Overall Study|Adverse Event|1|||
44366831|NCT01015560|79372357|FG000|Overall Study|Not protocol specified|1|||
44366832|NCT01015560|79372357|FG000|Overall Study|Withdrawal by Subject|1|||
44366833|NCT00918879|79372363|FG000|Overall Study|Withdrawal by Subject|4|||
44366834|NCT00918879|79372364|FG001|Overall Study|Withdrawal by Subject|4|||
44366835|NCT00918879|79372363|FG000|Overall Study|Lost to Follow-up|1|||
44366836|NCT00918879|79372364|FG001|Overall Study|Lost to Follow-up|1|||
44205218|NCT02040779|79001155|FG001|Overall Study|Protocol Violation|1|||
44366837|NCT00918879|79372363|FG000|Overall Study|Severe non-compliance to protocol|1|||
44366838|NCT00918879|79372364|FG001|Overall Study|Severe non-compliance to protocol|1|||
44366839|NCT01026792|79372370|FG000|Overall Study|Protocol Violation|1|||
44366840|NCT01026324|79372377|FG000|Follow up/Survival|Withdrawal by Subject|1|||
44366841|NCT01026324|79372378|FG001|Follow up/Survival|Withdrawal by Subject|0|||
44366842|NCT01026324|79372379|FG002|Follow up/Survival|Withdrawal by Subject|0|||
44366843|NCT01098539|79372390|FG000|Overall Study|Adverse Event|26|||
44366844|NCT01098539|79372391|FG001|Overall Study|Adverse Event|26|||
44366845|NCT01098539|79372390|FG000|Overall Study|Protocol Violation|1|||
44366846|NCT01098539|79372391|FG001|Overall Study|Protocol Violation|4|||
44366847|NCT01098539|79372390|FG000|Overall Study|Noncompliance|3|||
44366848|NCT01098539|79372391|FG001|Overall Study|Noncompliance|5|||
44366849|NCT01098539|79372390|FG000|Overall Study|Lost to Follow-up|4|||
44366850|NCT01098539|79372391|FG001|Overall Study|Lost to Follow-up|4|||
44366851|NCT01098539|79372390|FG000|Overall Study|Withdrawal by Subject|12|||
44366852|NCT01098539|79372391|FG001|Overall Study|Withdrawal by Subject|26|||
44366853|NCT01098539|79372390|FG000|Overall Study|Physician Decision|5|||
44366854|NCT01098539|79372391|FG001|Overall Study|Physician Decision|3|||
44366855|NCT01098461|79372401|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
44366856|NCT01098461|79372402|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
44366857|NCT01098461|79372403|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
44366858|NCT01098461|79372404|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
44366859|NCT01098461|79372401|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
44366860|NCT01098461|79372402|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
44366861|NCT01098461|79372403|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
44366862|NCT01098461|79372404|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
44366863|NCT01098461|79372401|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
44366864|NCT01098461|79372402|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
44366865|NCT01098461|79372403|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
44366866|NCT01098461|79372404|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
44366867|NCT01098461|79372401|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
44366868|NCT01098461|79372402|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
44366869|NCT01098461|79372403|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
44366870|NCT01098461|79372404|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
44366871|NCT01098461|79372401|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
44366872|NCT01098461|79372402|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
44366873|NCT01098461|79372403|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
44366874|NCT01098461|79372404|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
44366875|NCT01098461|79372401|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
44366876|NCT01098461|79372402|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
44366877|NCT01098461|79372403|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
44366878|NCT01098461|79372404|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
44366879|NCT01098461|79372401|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
44452031|NCT00494871|79460932|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
44205219|NCT02040779|79001156|FG002|Overall Study|Protocol Violation|0|||
44205220|NCT02040779|79001154|FG000|Overall Study|Lost to Follow-up|1|||
44366880|NCT01098461|79372402|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
44366881|NCT01098461|79372403|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
44452032|NCT00420238|79460942|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
44205221|NCT02040779|79001155|FG001|Overall Study|Lost to Follow-up|2|||
44205222|NCT02040779|79001156|FG002|Overall Study|Lost to Follow-up|1|||
44205223|NCT02040779|79001154|FG000|Overall Study|Lack of Efficacy|4|||
44205224|NCT02040779|79001155|FG001|Overall Study|Lack of Efficacy|2|||
44205225|NCT02040779|79001156|FG002|Overall Study|Lack of Efficacy|0|||
44205226|NCT02056301|79001166|FG000|Overall Study|Protocol Violation|1|||
44205227|NCT02056301|79001167|FG001|Overall Study|Protocol Violation|2|||
44205228|NCT02056301|79001166|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
44205229|NCT02056301|79001167|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
44205230|NCT02056301|79001166|FG000|Overall Study|Withdrawal by Subject|0|||
44205231|NCT02056301|79001167|FG001|Overall Study|Withdrawal by Subject|1|||
44205232|NCT02056301|79001166|FG000|Overall Study|Issues with epidural|0|||
44205233|NCT02056301|79001167|FG001|Overall Study|Issues with epidural|3|||
44205234|NCT01967732|79001175|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
44366882|NCT01098461|79372404|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
44366883|NCT01098305|79372417|FG000|Overall Study|Lost to Follow-up|31|||
44366884|NCT01098305|79372418|FG001|Overall Study|Lost to Follow-up|33|||
44366885|NCT00833833|79372430|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
44366886|NCT00833833|79372431|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
44366887|NCT00833833|79372432|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
44366888|NCT00833833|79372433|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
44366889|NCT00833833|79372434|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
44366890|NCT00833833|79372435|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
44366891|NCT00833833|79372430|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
44366892|NCT00833833|79372431|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
44366893|NCT00833833|79372432|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
44366894|NCT00833833|79372433|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
44366895|NCT00833833|79372434|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
44366896|NCT00833833|79372435|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
44366897|NCT00833833|79372430|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
44366898|NCT00833833|79372431|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
44366899|NCT00833833|79372432|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
44366900|NCT00833833|79372433|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
44366901|NCT00833833|79372434|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
44366902|NCT00833833|79372435|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
44366903|NCT00833833|79372430|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
44366904|NCT00833833|79372431|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
44366905|NCT00833833|79372432|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
44366906|NCT00833833|79372433|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
44366907|NCT00833833|79372434|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
44366908|NCT00833833|79372435|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
44366909|NCT00833833|79372430|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
44366910|NCT00833833|79372431|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366911|NCT00833833|79372432|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
44366912|NCT00833833|79372433|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366913|NCT00833833|79372434|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366914|NCT00833833|79372435|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366915|NCT00833833|79372430|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
44366916|NCT00833833|79372431|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
44366917|NCT00833833|79372432|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
44366918|NCT00833833|79372433|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
44269435|NCT02309112|79192764|FG001|Overall Study|Withdrawal by Subject|0|||
44269436|NCT02309112|79192765|FG002|Overall Study|Withdrawal by Subject|1|||
44269437|NCT02309112|79192763|FG000|Overall Study|Lost to Follow-up|0|||
44269438|NCT02309112|79192764|FG001|Overall Study|Lost to Follow-up|1|||
44269439|NCT02309112|79192765|FG002|Overall Study|Lost to Follow-up|0|||
44269440|NCT02361216|79192777|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
44269441|NCT02361216|79192778|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
44269442|NCT02361216|79192777|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
44269443|NCT02361216|79192778|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
44269444|NCT02361216|79192777|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
44269445|NCT02361216|79192778|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
44269446|NCT02361216|79192777|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
44269447|NCT02361216|79192778|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
44366919|NCT00833833|79372434|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
44366920|NCT00833833|79372435|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
44366921|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
44366922|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
44366923|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
44269448|NCT02361216|79192777|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
44205235|NCT01967732|79001176|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
44205236|NCT01967732|79001177|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
44205237|NCT01967732|79001178|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
44205238|NCT01967732|79001175|FG000|First Intervention (Day 1)|Poor venous access|0|||
44205239|NCT01967732|79001176|FG001|First Intervention (Day 1)|Poor venous access|1|||
44205240|NCT01967732|79001177|FG002|First Intervention (Day 1)|Poor venous access|0|||
44205241|NCT01967732|79001178|FG003|First Intervention (Day 1)|Poor venous access|0|||
44205242|NCT01967576|79001186|FG000|Overall Study|Withdrawal by Subject|3|||
44205243|NCT01967576|79001186|FG000|Overall Study|Progressed/Removed from treatment|1|||
44205244|NCT01967576|79001186|FG000|Overall Study|Study closing at site|1|||
44205245|NCT01967576|79001186|FG000|Overall Study|Adverse Event|1|||
44205246|NCT01967576|79001186|FG000|Overall Study|Refused further treatment|1|||
44205247|NCT02039687|79001194|FG000|Overall Study|Adverse Event|0|||
44205248|NCT02039687|79001195|FG001|Overall Study|Adverse Event|0|||
44205249|NCT02039687|79001196|FG002|Overall Study|Adverse Event|1|||
44205250|NCT02039687|79001197|FG003|Overall Study|Adverse Event|0|||
44205251|NCT02039687|79001194|FG000|Overall Study|Withdrawal by Subject|0|||
44205252|NCT02039687|79001195|FG001|Overall Study|Withdrawal by Subject|1|||
44205253|NCT02039687|79001196|FG002|Overall Study|Withdrawal by Subject|0|||
44205254|NCT02039687|79001197|FG003|Overall Study|Withdrawal by Subject|0|||
44205255|NCT02039687|79001194|FG000|Overall Study|treatment assignment could not be confir|0|||
44205256|NCT02039687|79001195|FG001|Overall Study|treatment assignment could not be confir|0|||
44205257|NCT02039687|79001196|FG002|Overall Study|treatment assignment could not be confir|2|||
44205258|NCT02039687|79001197|FG003|Overall Study|treatment assignment could not be confir|0|||
44205259|NCT02003534|79001207|FG000|Overall Study|Lost to Follow-up|47|||
44205260|NCT02055365|79001211|FG000|Overall Study|Prematurely Withdrawn|1|||
44205261|NCT02039375|79001222|FG000|Overall Study|Lost to Follow-up|2|||
44205262|NCT02054897|79001229|FG000|Overall Study|Withdrawal by Subject|2|||
44205263|NCT02054897|79001230|FG001|Overall Study|Withdrawal by Subject|0|||
44205264|NCT02054897|79001231|FG002|Overall Study|Withdrawal by Subject|2|||
44205265|NCT02054897|79001229|FG000|Overall Study|Missing follow-up information|3|||
44205266|NCT02054897|79001230|FG001|Overall Study|Missing follow-up information|5|||
44205267|NCT02054897|79001231|FG002|Overall Study|Missing follow-up information|3|||
44205268|NCT02054897|79001229|FG000|Overall Study|Lost to Follow-up|4|||
44205269|NCT02054897|79001230|FG001|Overall Study|Lost to Follow-up|2|||
44205270|NCT02054897|79001231|FG002|Overall Study|Lost to Follow-up|7|||
44205271|NCT02054897|79001229|FG000|Overall Study|Randomized but not exposed|1|||
44205272|NCT02054897|79001230|FG001|Overall Study|Randomized but not exposed|0|||
44205273|NCT02054897|79001231|FG002|Overall Study|Randomized but not exposed|0|||
44205274|NCT01976312|79001241|FG000|Overall Study|Pregnancy|0|||
44205275|NCT01976312|79001242|FG001|Overall Study|Pregnancy|1|||
44205276|NCT01976312|79001241|FG000|Overall Study|Lost to Follow-up|2|||
44205277|NCT01976312|79001242|FG001|Overall Study|Lost to Follow-up|0|||
44205278|NCT01976312|79001241|FG000|Overall Study|Withdrawal by Subject|7|||
44205279|NCT01976312|79001242|FG001|Overall Study|Withdrawal by Subject|2|||
44205280|NCT01976312|79001241|FG000|Overall Study|Adverse Event|6|||
44205281|NCT01976312|79001242|FG001|Overall Study|Adverse Event|6|||
44205282|NCT01976312|79001241|FG000|Overall Study|Protocol Violation|2|||
44205283|NCT01976312|79001242|FG001|Overall Study|Protocol Violation|0|||
44205284|NCT02039219|79001251|FG000|Treatment|Withdrawal by Subject|1|||
44205285|NCT02039219|79001252|FG001|Treatment|Withdrawal by Subject|0|||
44366924|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
44366925|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
44366926|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
44366927|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
44366928|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
44366929|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
44205286|NCT02039219|79001251|FG000|Treatment|Adverse Event|0|||
44205287|NCT02039219|79001252|FG001|Treatment|Adverse Event|1|||
44205288|NCT02039219|79001251|FG000|Treatment|Physician Decision|1|||
44205289|NCT02039219|79001252|FG001|Treatment|Physician Decision|0|||
44205290|NCT02039219|79001251|FG000|Treatment|Lost to Follow-up|0|||
44205291|NCT02039219|79001252|FG001|Treatment|Lost to Follow-up|1|||
44366930|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
44452033|NCT00420238|79460943|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
44205292|NCT02039219|79001251|FG000|Treatment|Protocol Violation|1|||
44205293|NCT02039219|79001252|FG001|Treatment|Protocol Violation|0|||
44205294|NCT02039219|79001251|FG000|Treatment|Death|1|||
44366931|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
44366932|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
44366933|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
44366934|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
44366935|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
44366936|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
44366937|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
44366938|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
44366939|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44205295|NCT02039219|79001252|FG001|Treatment|Death|0|||
44205296|NCT02039219|79001251|FG000|Follow up|Adverse Event|0|||
44205297|NCT02039219|79001252|FG001|Follow up|Adverse Event|1|||
44205298|NCT02053493|79001260|FG000|Overall Study|Withdrawal by Subject|1|||
44205299|NCT02053493|79001261|FG001|Overall Study|Withdrawal by Subject|1|||
44205300|NCT02003144|79001269|FG000|Open Label Maintenance Phase|Other than specified|2|||
44205301|NCT02003144|79001270|FG001|Open Label Maintenance Phase|Other than specified|4|||
44205302|NCT02003144|79001269|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
44205303|NCT02003144|79001270|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
44205304|NCT02003144|79001269|FG000|Open Label Maintenance Phase|Pregnancy|0|||
44205305|NCT02003144|79001270|FG001|Open Label Maintenance Phase|Pregnancy|2|||
44205306|NCT02003144|79001269|FG000|Open Label Maintenance Phase|Physician Decision|1|||
44205307|NCT02003144|79001270|FG001|Open Label Maintenance Phase|Physician Decision|1|||
44205308|NCT02003144|79001269|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
44205309|NCT02003144|79001270|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
44205310|NCT02003144|79001269|FG000|Open Label Maintenance Phase|Adverse Event|2|||
44205311|NCT02003144|79001270|FG001|Open Label Maintenance Phase|Adverse Event|1|||
44205312|NCT02001194|79001281|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
44205313|NCT02001194|79001282|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
44205314|NCT02001194|79001283|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
44205315|NCT02001194|79001284|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
44205316|NCT02001194|79001281|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
44205317|NCT02001194|79001282|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
44205318|NCT02001194|79001283|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
44205319|NCT02001194|79001284|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
44205320|NCT02038907|79001308|FG000|Overall Study|Protocol Violation|0|||
44205321|NCT02038907|79001309|FG001|Overall Study|Protocol Violation|0|||
44205322|NCT02038907|79001310|FG002|Overall Study|Protocol Violation|0|||
44205323|NCT02038907|79001311|FG003|Overall Study|Protocol Violation|0|||
44205324|NCT02038907|79001312|FG004|Overall Study|Protocol Violation|0|||
44205325|NCT02038907|79001313|FG005|Overall Study|Protocol Violation|0|||
44205326|NCT02038907|79001314|FG006|Overall Study|Protocol Violation|0|||
44205327|NCT02038907|79001315|FG007|Overall Study|Protocol Violation|0|||
44205328|NCT02038907|79001316|FG008|Overall Study|Protocol Violation|0|||
44205329|NCT02038907|79001317|FG009|Overall Study|Protocol Violation|0|||
44205330|NCT02038907|79001318|FG010|Overall Study|Protocol Violation|1|||
44205331|NCT02038907|79001319|FG011|Overall Study|Protocol Violation|0|||
44205332|NCT02038907|79001320|FG012|Overall Study|Protocol Violation|0|||
44205333|NCT02038907|79001321|FG013|Overall Study|Protocol Violation|0|||
44269449|NCT02361216|79192778|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
44269450|NCT02361216|79192777|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
44269451|NCT02361216|79192778|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
44269452|NCT00559988|79193211|FG000|Overall Study|Death|147|||
44269453|NCT00559988|79193212|FG001|Overall Study|Death|140|||
44269454|NCT00559988|79193211|FG000|Overall Study|Withdrawal by Subject|152|||
44269455|NCT00559988|79193212|FG001|Overall Study|Withdrawal by Subject|139|||
44269456|NCT00559988|79193211|FG000|Overall Study|Lost to Follow-up|42|||
44269457|NCT00559988|79193212|FG001|Overall Study|Lost to Follow-up|56|||
44269458|NCT00559988|79193211|FG000|Overall Study|ICD device explanted|10|||
44269459|NCT00559988|79193212|FG001|Overall Study|ICD device explanted|17|||
44269460|NCT00559754|79193274|FG000|Overall Study|Disease progression|1|||
44269461|NCT00559754|79193274|FG000|Overall Study|Adverse Event|5|||
44366940|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366941|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366942|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
44366943|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
44205334|NCT02038907|79001308|FG000|Overall Study|Withdrawal by Subject|0|||
44269462|NCT00559754|79193274|FG000|Overall Study|Protocol Violation|1|||
44269463|NCT00559754|79193274|FG000|Overall Study|Investigator criteria|2|||
44269464|NCT00559754|79193274|FG000|Overall Study|Withdrawal by Subject|2|||
44205335|NCT02038907|79001309|FG001|Overall Study|Withdrawal by Subject|0|||
44205336|NCT02038907|79001310|FG002|Overall Study|Withdrawal by Subject|0|||
44205337|NCT02038907|79001311|FG003|Overall Study|Withdrawal by Subject|0|||
44366944|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
44366945|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
44366946|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
44366947|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
44366948|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
44366949|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
44366950|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
44366951|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
44366952|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
44366953|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
44366954|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
44366955|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
44366956|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
44366957|NCT00833833|79372430|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
44366958|NCT00833833|79372431|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
44366959|NCT00833833|79372432|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
44366960|NCT00833833|79372433|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
44366961|NCT00833833|79372434|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
44366962|NCT00833833|79372435|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
44366963|NCT01098071|79372455|FG000|Overall Study|Surgery (adenoidectomy)|2|||
44366964|NCT01098071|79372455|FG000|Overall Study|Lost to Follow-up|13|||
44366965|NCT01097057|79372459|FG000|Overall Study|Physician Decision|3|||
44366966|NCT01022112|79372468|FG000|Overall Study|Adverse Event|1|||
44366967|NCT01022112|79372469|FG001|Overall Study|Adverse Event|2|||
44366968|NCT01022112|79372470|FG002|Overall Study|Adverse Event|0|||
44366969|NCT01022112|79372471|FG003|Overall Study|Adverse Event|1|||
44366970|NCT01022112|79372472|FG004|Overall Study|Adverse Event|0|||
44366971|NCT01022112|79372468|FG000|Overall Study|Lack of Efficacy|1|||
44366972|NCT01022112|79372469|FG001|Overall Study|Lack of Efficacy|0|||
44366973|NCT01022112|79372470|FG002|Overall Study|Lack of Efficacy|0|||
44366974|NCT01022112|79372471|FG003|Overall Study|Lack of Efficacy|0|||
44366975|NCT01022112|79372472|FG004|Overall Study|Lack of Efficacy|1|||
44366976|NCT01022112|79372468|FG000|Overall Study|Physician Decision|0|||
44366977|NCT01022112|79372469|FG001|Overall Study|Physician Decision|0|||
44366978|NCT01022112|79372470|FG002|Overall Study|Physician Decision|1|||
44366979|NCT01022112|79372471|FG003|Overall Study|Physician Decision|0|||
44366980|NCT01022112|79372472|FG004|Overall Study|Physician Decision|1|||
44366981|NCT01022112|79372468|FG000|Overall Study|Withdrawal by Subject|0|||
44366982|NCT01022112|79372469|FG001|Overall Study|Withdrawal by Subject|1|||
44366983|NCT01022112|79372470|FG002|Overall Study|Withdrawal by Subject|2|||
44366984|NCT01022112|79372471|FG003|Overall Study|Withdrawal by Subject|2|||
44366985|NCT01022112|79372472|FG004|Overall Study|Withdrawal by Subject|1|||
44366986|NCT01022112|79372468|FG000|Overall Study|Fasting plasma glucose level increased|1|||
44366987|NCT01022112|79372469|FG001|Overall Study|Fasting plasma glucose level increased|0|||
44366988|NCT01022112|79372470|FG002|Overall Study|Fasting plasma glucose level increased|0|||
44366989|NCT01022112|79372471|FG003|Overall Study|Fasting plasma glucose level increased|0|||
44366990|NCT01022112|79372472|FG004|Overall Study|Fasting plasma glucose level increased|7|||
44366991|NCT01096667|79372489|FG000|Overall Study|Lost to Follow-up|1|||
44366992|NCT01096667|79372490|FG001|Overall Study|Lost to Follow-up|1|||
44366993|NCT01096667|79372491|FG002|Overall Study|Lost to Follow-up|1|||
44366994|NCT01096667|79372492|FG003|Overall Study|Lost to Follow-up|0|||
44366995|NCT01096667|79372493|FG004|Overall Study|Lost to Follow-up|0|||
44366996|NCT01096667|79372489|FG000|Overall Study|Withdrawal by Subject|1|||
44366997|NCT01096667|79372490|FG001|Overall Study|Withdrawal by Subject|0|||
44366998|NCT01096667|79372491|FG002|Overall Study|Withdrawal by Subject|0|||
44366999|NCT01096667|79372492|FG003|Overall Study|Withdrawal by Subject|1|||
44367000|NCT01096667|79372493|FG004|Overall Study|Withdrawal by Subject|0|||
44367001|NCT01096667|79372489|FG000|Overall Study|Reason not available|0|||
44367002|NCT01096667|79372490|FG001|Overall Study|Reason not available|1|||
44367003|NCT01096667|79372491|FG002|Overall Study|Reason not available|1|||
44367004|NCT01096667|79372492|FG003|Overall Study|Reason not available|1|||
44367005|NCT01096667|79372493|FG004|Overall Study|Reason not available|0|||
44367006|NCT01096667|79372489|FG000|Overall Study|Protocol Violation|0|||
44367007|NCT01096667|79372490|FG001|Overall Study|Protocol Violation|0|||
44367008|NCT01096667|79372491|FG002|Overall Study|Protocol Violation|0|||
44367009|NCT01096667|79372492|FG003|Overall Study|Protocol Violation|1|||
44367010|NCT01096667|79372493|FG004|Overall Study|Protocol Violation|0|||
44367011|NCT01096667|79372489|FG000|Overall Study|Not treated|1|||
44367012|NCT01096667|79372490|FG001|Overall Study|Not treated|0|||
44367013|NCT01096667|79372491|FG002|Overall Study|Not treated|0|||
44367014|NCT01096667|79372492|FG003|Overall Study|Not treated|0|||
44367015|NCT01096667|79372493|FG004|Overall Study|Not treated|0|||
44367016|NCT01014624|79372508|FG000|Overall Study|Adverse Event|0|||
44367017|NCT01014624|79372509|FG001|Overall Study|Adverse Event|1|||
44367018|NCT01014624|79372508|FG000|Overall Study|Protocol Violation|1|||
44367019|NCT01014624|79372509|FG001|Overall Study|Protocol Violation|0|||
44367020|NCT01014624|79372508|FG000|Overall Study|Withdrawal by Subject|1|||
44367021|NCT01014624|79372509|FG001|Overall Study|Withdrawal by Subject|0|||
44367022|NCT01021878|79372519|FG000|Overall Study|Lost to Follow-up|4|||
44367023|NCT01021878|79372520|FG001|Overall Study|Lost to Follow-up|3|||
44367024|NCT01021878|79372519|FG000|Overall Study|Death|0|||
44367025|NCT01021878|79372520|FG001|Overall Study|Death|1|||
44367026|NCT01021878|79372519|FG000|Overall Study|Adverse Event|6|||
44367027|NCT01021878|79372520|FG001|Overall Study|Adverse Event|5|||
44367028|NCT01021878|79372519|FG000|Overall Study|Transplantation|6|||
44367029|NCT01021878|79372520|FG001|Overall Study|Transplantation|1|||
44205338|NCT02038907|79001312|FG004|Overall Study|Withdrawal by Subject|0|||
44205339|NCT02038907|79001313|FG005|Overall Study|Withdrawal by Subject|0|||
44205340|NCT02038907|79001314|FG006|Overall Study|Withdrawal by Subject|0|||
44205341|NCT02038907|79001315|FG007|Overall Study|Withdrawal by Subject|0|||
44205342|NCT02038907|79001316|FG008|Overall Study|Withdrawal by Subject|0|||
44205343|NCT02038907|79001317|FG009|Overall Study|Withdrawal by Subject|0|||
44205344|NCT02038907|79001318|FG010|Overall Study|Withdrawal by Subject|1|||
44205345|NCT02038907|79001319|FG011|Overall Study|Withdrawal by Subject|0|||
44205346|NCT02038907|79001320|FG012|Overall Study|Withdrawal by Subject|0|||
44205347|NCT02038907|79001321|FG013|Overall Study|Withdrawal by Subject|0|||
44205348|NCT02038829|79001353|FG000|Washout Period 1|Death|0|||
44205349|NCT02038829|79001354|FG001|Washout Period 1|Death|0|||
44205350|NCT02038829|79001355|FG002|Washout Period 1|Death|0|||
44205351|NCT02038829|79001356|FG003|Washout Period 1|Death|0|||
44205352|NCT02038829|79001357|FG004|Washout Period 1|Death|1|||
44205353|NCT02038829|79001358|FG005|Washout Period 1|Death|0|||
44367030|NCT00854113|79372540|FG000|Overall Study|Adverse Event|0|||
44367031|NCT00854113|79372541|FG001|Overall Study|Adverse Event|0|||
44367032|NCT00854113|79372542|FG002|Overall Study|Adverse Event|0|||
44367033|NCT00854113|79372543|FG003|Overall Study|Adverse Event|0|||
44367034|NCT00854113|79372544|FG004|Overall Study|Adverse Event|0|||
44367035|NCT00854113|79372545|FG005|Overall Study|Adverse Event|0|||
44367036|NCT00854113|79372546|FG006|Overall Study|Adverse Event|0|||
44367037|NCT00854113|79372547|FG007|Overall Study|Adverse Event|2|||
44367038|NCT00854113|79372548|FG008|Overall Study|Adverse Event|0|||
44367039|NCT00854113|79372549|FG009|Overall Study|Adverse Event|0|||
44367040|NCT00854113|79372550|FG010|Overall Study|Adverse Event|0|||
44367041|NCT00854113|79372540|FG000|Overall Study|Withdrawal by Subject|0|||
44367042|NCT00854113|79372541|FG001|Overall Study|Withdrawal by Subject|0|||
44367043|NCT00854113|79372542|FG002|Overall Study|Withdrawal by Subject|0|||
44367044|NCT00854113|79372543|FG003|Overall Study|Withdrawal by Subject|0|||
44367045|NCT00854113|79372544|FG004|Overall Study|Withdrawal by Subject|0|||
44367046|NCT00854113|79372545|FG005|Overall Study|Withdrawal by Subject|0|||
44367047|NCT00854113|79372546|FG006|Overall Study|Withdrawal by Subject|0|||
44367048|NCT00854113|79372547|FG007|Overall Study|Withdrawal by Subject|1|||
44367049|NCT00854113|79372548|FG008|Overall Study|Withdrawal by Subject|1|||
44367050|NCT00854113|79372549|FG009|Overall Study|Withdrawal by Subject|0|||
44367051|NCT00854113|79372550|FG010|Overall Study|Withdrawal by Subject|0|||
44367052|NCT00845845|79372576|FG000|Overall Study|Lost to Follow-up|0|||
44367053|NCT00845845|79372577|FG001|Overall Study|Lost to Follow-up|4|||
44367054|NCT01104701|79372587|FG000|Overall Study|Withdrawal by Subject|0|||
44367055|NCT01104701|79372588|FG001|Overall Study|Withdrawal by Subject|1|||
44367056|NCT01104701|79372589|FG002|Overall Study|Withdrawal by Subject|2|||
44367057|NCT01104701|79372590|FG003|Overall Study|Withdrawal by Subject|1|||
44205354|NCT02038829|79001359|FG006|Washout Period 1|Death|0|||
44205355|NCT02038829|79001360|FG007|Washout Period 1|Death|0|||
44205356|NCT02038829|79001361|FG008|Washout Period 1|Death|0|||
44205357|NCT02038829|79001362|FG009|Washout Period 1|Death|0|||
44205358|NCT02038829|79001363|FG010|Washout Period 1|Death|0|||
44367058|NCT01104701|79372587|FG000|Overall Study|Adverse Event|0|||
44367059|NCT01104701|79372588|FG001|Overall Study|Adverse Event|0|||
44367060|NCT01104701|79372589|FG002|Overall Study|Adverse Event|0|||
44367061|NCT01104701|79372590|FG003|Overall Study|Adverse Event|1|||
44367062|NCT01104701|79372587|FG000|Overall Study|Physician Decision|0|||
44367063|NCT01104701|79372588|FG001|Overall Study|Physician Decision|2|||
44367064|NCT01104701|79372589|FG002|Overall Study|Physician Decision|0|||
44367065|NCT01104701|79372590|FG003|Overall Study|Physician Decision|0|||
44367066|NCT00833755|79372604|FG000|Overall Study|Physician Decision|4|||
44367067|NCT00833755|79372605|FG001|Overall Study|Physician Decision|4|||
44367068|NCT00833755|79372606|FG002|Overall Study|Physician Decision|2|||
44367069|NCT00833755|79372607|FG003|Overall Study|Physician Decision|6|||
44367070|NCT00833755|79372604|FG000|Overall Study|Subject had scheduling issues|0|||
44367071|NCT00833755|79372605|FG001|Overall Study|Subject had scheduling issues|1|||
44205359|NCT02038829|79001364|FG011|Washout Period 1|Death|0|||
44205360|NCT02038829|79001353|FG000|Treatment Period 2|Adverse Event|0|||
44269465|NCT00559364|79193388|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
44367072|NCT00833755|79372606|FG002|Overall Study|Subject had scheduling issues|0|||
44205361|NCT02038829|79001354|FG001|Treatment Period 2|Adverse Event|0|||
44205362|NCT02038829|79001355|FG002|Treatment Period 2|Adverse Event|0|||
44367073|NCT00833755|79372607|FG003|Overall Study|Subject had scheduling issues|0|||
44367074|NCT01021332|79372618|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
44367075|NCT01021332|79372618|FG000|Overall Study|Adverse Event|43|||
44367076|NCT01021332|79372618|FG000|Overall Study|Lack of Efficacy|19|||
44367077|NCT01021332|79372618|FG000|Overall Study|Withdrawal of Consent|23|||
44367078|NCT01021332|79372618|FG000|Overall Study|Lost to Follow-up|4|||
44367079|NCT01021332|79372618|FG000|Overall Study|Protocol Violation|9|||
44367080|NCT01021332|79372618|FG000|Overall Study|Miscellaneous|3|||
44367081|NCT00923091|79372632|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
44367082|NCT00923091|79372633|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
44367083|NCT00923091|79372634|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
44367084|NCT00923091|79372635|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
44367085|NCT00923091|79372636|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
44367086|NCT00923091|79372637|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
44367087|NCT00923091|79372638|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
44367088|NCT00923091|79372639|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
44367089|NCT00923091|79372640|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
44367090|NCT00923091|79372641|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
44367091|NCT00923091|79372642|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
44367092|NCT00923091|79372643|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
44367093|NCT00923091|79372644|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
44367094|NCT00923091|79372632|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
44367095|NCT00923091|79372633|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
44367096|NCT00923091|79372634|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
44367097|NCT00923091|79372635|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
44367098|NCT00923091|79372636|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
44367099|NCT00923091|79372637|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
44367100|NCT00923091|79372638|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
44367101|NCT00923091|79372639|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
44367102|NCT00923091|79372640|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
44367103|NCT00923091|79372641|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
44367104|NCT00923091|79372642|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
44367105|NCT00923091|79372643|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
44367106|NCT00923091|79372644|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
44367107|NCT00923091|79372632|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
44367108|NCT00923091|79372633|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
44367109|NCT00923091|79372634|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
44367110|NCT00923091|79372635|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
44367111|NCT00923091|79372636|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
44367112|NCT00923091|79372637|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
44367113|NCT00923091|79372638|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
44367114|NCT00923091|79372639|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
44367115|NCT00923091|79372640|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
44367116|NCT00923091|79372641|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
44205363|NCT02038829|79001356|FG003|Treatment Period 2|Adverse Event|0|||
44205364|NCT02038829|79001357|FG004|Treatment Period 2|Adverse Event|0|||
44205365|NCT02038829|79001358|FG005|Treatment Period 2|Adverse Event|0|||
44205366|NCT02038829|79001359|FG006|Treatment Period 2|Adverse Event|0|||
44205367|NCT02038829|79001360|FG007|Treatment Period 2|Adverse Event|0|||
44205368|NCT02038829|79001361|FG008|Treatment Period 2|Adverse Event|0|||
44205369|NCT02038829|79001362|FG009|Treatment Period 2|Adverse Event|0|||
44205370|NCT02038829|79001363|FG010|Treatment Period 2|Adverse Event|1|||
44205371|NCT02038829|79001364|FG011|Treatment Period 2|Adverse Event|0|||
44205372|NCT02038829|79001353|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44205373|NCT02038829|79001354|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44367117|NCT00923091|79372642|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
44367118|NCT00923091|79372643|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
44367119|NCT00923091|79372644|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
44367120|NCT00923091|79372632|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367121|NCT00923091|79372633|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367122|NCT00923091|79372634|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367123|NCT00923091|79372635|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367124|NCT00923091|79372636|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367125|NCT00923091|79372637|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
44205374|NCT02038829|79001355|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44205375|NCT02038829|79001356|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44205376|NCT02038829|79001357|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44205377|NCT02038829|79001358|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44367126|NCT00923091|79372638|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367127|NCT00923091|79372639|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367128|NCT00923091|79372640|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367129|NCT00923091|79372641|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367130|NCT00923091|79372642|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367131|NCT00923091|79372643|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367132|NCT00923091|79372644|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
44367133|NCT00923091|79372632|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367134|NCT00923091|79372633|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
44367135|NCT00923091|79372634|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367136|NCT00923091|79372635|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
44367137|NCT00923091|79372636|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367138|NCT00923091|79372637|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
44367139|NCT00923091|79372638|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367140|NCT00923091|79372639|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367141|NCT00923091|79372640|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367142|NCT00923091|79372641|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367143|NCT00923091|79372642|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367144|NCT00923091|79372643|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367145|NCT00923091|79372644|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
44367146|NCT00923091|79372632|FG000|Period III (Single-Blind)|Adverse Event|5|||
44367147|NCT00923091|79372633|FG001|Period III (Single-Blind)|Adverse Event|0|||
44367148|NCT00923091|79372634|FG002|Period III (Single-Blind)|Adverse Event|0|||
44367149|NCT00923091|79372635|FG003|Period III (Single-Blind)|Adverse Event|0|||
44367150|NCT00923091|79372636|FG004|Period III (Single-Blind)|Adverse Event|0|||
44367151|NCT00923091|79372637|FG005|Period III (Single-Blind)|Adverse Event|0|||
44367152|NCT00923091|79372638|FG006|Period III (Single-Blind)|Adverse Event|0|||
44367153|NCT00923091|79372639|FG007|Period III (Single-Blind)|Adverse Event|0|||
44367154|NCT00923091|79372640|FG008|Period III (Single-Blind)|Adverse Event|0|||
44367155|NCT00923091|79372641|FG009|Period III (Single-Blind)|Adverse Event|0|||
44367156|NCT00923091|79372642|FG010|Period III (Single-Blind)|Adverse Event|0|||
44367157|NCT00923091|79372643|FG011|Period III (Single-Blind)|Adverse Event|0|||
44367158|NCT00923091|79372644|FG012|Period III (Single-Blind)|Adverse Event|0|||
44367159|NCT00923091|79372632|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
44367160|NCT00923091|79372633|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367161|NCT00923091|79372634|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367162|NCT00923091|79372635|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367163|NCT00923091|79372636|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367164|NCT00923091|79372637|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367165|NCT00923091|79372638|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
44205378|NCT02038829|79001359|FG006|Treatment Period 2|Withdrawal by Subject|0|||
44205379|NCT02038829|79001360|FG007|Treatment Period 2|Withdrawal by Subject|0|||
44205380|NCT02038829|79001361|FG008|Treatment Period 2|Withdrawal by Subject|0|||
44205381|NCT02038829|79001362|FG009|Treatment Period 2|Withdrawal by Subject|0|||
44205382|NCT02038829|79001363|FG010|Treatment Period 2|Withdrawal by Subject|0|||
44205383|NCT02038829|79001364|FG011|Treatment Period 2|Withdrawal by Subject|0|||
44205384|NCT02038829|79001353|FG000|Washout Period 2|Adverse Event|0|||
44205385|NCT02038829|79001354|FG001|Washout Period 2|Adverse Event|0|||
44205386|NCT02038829|79001355|FG002|Washout Period 2|Adverse Event|0|||
44367166|NCT00923091|79372639|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367167|NCT00923091|79372640|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367168|NCT00923091|79372641|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367169|NCT00923091|79372642|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367170|NCT00923091|79372643|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367171|NCT00923091|79372644|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
44367172|NCT00923091|79372632|FG000|Period III (Single-Blind)|Protocol Violation|3|||
44367173|NCT00923091|79372633|FG001|Period III (Single-Blind)|Protocol Violation|0|||
44367174|NCT00923091|79372634|FG002|Period III (Single-Blind)|Protocol Violation|0|||
44367175|NCT00923091|79372635|FG003|Period III (Single-Blind)|Protocol Violation|0|||
44367176|NCT00923091|79372636|FG004|Period III (Single-Blind)|Protocol Violation|0|||
44367177|NCT00923091|79372637|FG005|Period III (Single-Blind)|Protocol Violation|0|||
44367178|NCT00923091|79372638|FG006|Period III (Single-Blind)|Protocol Violation|0|||
44367179|NCT00923091|79372639|FG007|Period III (Single-Blind)|Protocol Violation|0|||
44367180|NCT00923091|79372640|FG008|Period III (Single-Blind)|Protocol Violation|0|||
44367181|NCT00923091|79372641|FG009|Period III (Single-Blind)|Protocol Violation|0|||
44367182|NCT00923091|79372642|FG010|Period III (Single-Blind)|Protocol Violation|0|||
44367183|NCT00923091|79372643|FG011|Period III (Single-Blind)|Protocol Violation|0|||
44367184|NCT00923091|79372644|FG012|Period III (Single-Blind)|Protocol Violation|0|||
44367185|NCT00923091|79372632|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
44367186|NCT00923091|79372633|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
44367187|NCT00923091|79372634|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
44367188|NCT00923091|79372635|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
44367189|NCT00923091|79372636|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
44367190|NCT00923091|79372637|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
44367191|NCT00923091|79372638|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
44367192|NCT00923091|79372639|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
44367193|NCT00923091|79372640|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
44367194|NCT00923091|79372641|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
44367195|NCT00923091|79372642|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
44367196|NCT00923091|79372643|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
44367197|NCT00923091|79372644|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
44367198|NCT00923091|79372632|FG000|Period IV (Double-Blind)|Adverse Event|2|||
44367199|NCT00923091|79372633|FG001|Period IV (Double-Blind)|Adverse Event|0|||
44367200|NCT00923091|79372634|FG002|Period IV (Double-Blind)|Adverse Event|0|||
44367201|NCT00923091|79372635|FG003|Period IV (Double-Blind)|Adverse Event|0|||
44367202|NCT00923091|79372636|FG004|Period IV (Double-Blind)|Adverse Event|0|||
44367203|NCT00923091|79372637|FG005|Period IV (Double-Blind)|Adverse Event|0|||
44367204|NCT00923091|79372638|FG006|Period IV (Double-Blind)|Adverse Event|0|||
44367205|NCT00923091|79372639|FG007|Period IV (Double-Blind)|Adverse Event|0|||
44367206|NCT00923091|79372640|FG008|Period IV (Double-Blind)|Adverse Event|0|||
44367207|NCT00923091|79372641|FG009|Period IV (Double-Blind)|Adverse Event|0|||
44367208|NCT00923091|79372642|FG010|Period IV (Double-Blind)|Adverse Event|0|||
44367209|NCT00923091|79372643|FG011|Period IV (Double-Blind)|Adverse Event|0|||
44367210|NCT00923091|79372644|FG012|Period IV (Double-Blind)|Adverse Event|0|||
44367211|NCT00923091|79372632|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367212|NCT00923091|79372633|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
44367213|NCT00923091|79372634|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367214|NCT00923091|79372635|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367215|NCT00923091|79372636|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367216|NCT00923091|79372637|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367217|NCT00923091|79372638|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367218|NCT00923091|79372639|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367219|NCT00923091|79372640|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367220|NCT00923091|79372641|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367221|NCT00923091|79372642|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367222|NCT00923091|79372643|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367223|NCT00923091|79372644|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
44367224|NCT00923091|79372632|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
44367225|NCT00923091|79372633|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
44367226|NCT00923091|79372634|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
44367227|NCT00923091|79372635|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
44367228|NCT00923091|79372636|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
44367229|NCT00923091|79372637|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
44367230|NCT00923091|79372638|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
44367231|NCT00923091|79372639|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
44367232|NCT00923091|79372640|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
44367233|NCT00923091|79372641|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
44367234|NCT00923091|79372642|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
44367235|NCT00923091|79372643|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
44367236|NCT00923091|79372644|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
44367237|NCT00923091|79372632|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367238|NCT00923091|79372633|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367239|NCT00923091|79372634|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367240|NCT00923091|79372635|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367241|NCT00923091|79372636|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367242|NCT00923091|79372637|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367243|NCT00923091|79372638|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367244|NCT00923091|79372639|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367245|NCT00923091|79372640|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
44367246|NCT00923091|79372641|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367247|NCT00923091|79372642|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367248|NCT00923091|79372643|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
44367249|NCT00923091|79372644|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
44367250|NCT00923091|79372632|FG000|Period V (Double -Blind)|Protocol Violation|0|||
44367251|NCT00923091|79372633|FG001|Period V (Double -Blind)|Protocol Violation|0|||
44367252|NCT00923091|79372634|FG002|Period V (Double -Blind)|Protocol Violation|0|||
44367253|NCT00923091|79372635|FG003|Period V (Double -Blind)|Protocol Violation|0|||
44367254|NCT00923091|79372636|FG004|Period V (Double -Blind)|Protocol Violation|0|||
44367255|NCT00923091|79372637|FG005|Period V (Double -Blind)|Protocol Violation|0|||
44367256|NCT00923091|79372638|FG006|Period V (Double -Blind)|Protocol Violation|0|||
44367257|NCT00923091|79372639|FG007|Period V (Double -Blind)|Protocol Violation|0|||
44367258|NCT00923091|79372640|FG008|Period V (Double -Blind)|Protocol Violation|0|||
44367259|NCT00923091|79372641|FG009|Period V (Double -Blind)|Protocol Violation|0|||
44367260|NCT00923091|79372642|FG010|Period V (Double -Blind)|Protocol Violation|0|||
44367261|NCT00923091|79372643|FG011|Period V (Double -Blind)|Protocol Violation|0|||
44367262|NCT00923091|79372644|FG012|Period V (Double -Blind)|Protocol Violation|1|||
44367263|NCT00923091|79372632|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
44367264|NCT00923091|79372633|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
44367265|NCT00923091|79372634|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
44367266|NCT00923091|79372635|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
44367267|NCT00923091|79372636|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
44367268|NCT00923091|79372637|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
44367269|NCT00923091|79372638|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
44367270|NCT00923091|79372639|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
44367271|NCT00923091|79372640|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
44367272|NCT00923091|79372641|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
44367273|NCT00923091|79372642|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
44367274|NCT00923091|79372643|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
44367275|NCT00923091|79372644|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
44367276|NCT00923091|79372632|FG000|Period VI (Open-Label)|Adverse Event|17|||
44367277|NCT00923091|79372633|FG001|Period VI (Open-Label)|Adverse Event|0|||
44367278|NCT00923091|79372634|FG002|Period VI (Open-Label)|Adverse Event|4|||
44205387|NCT02038829|79001356|FG003|Washout Period 2|Adverse Event|0|||
44205388|NCT02038829|79001357|FG004|Washout Period 2|Adverse Event|0|||
44205389|NCT02038829|79001358|FG005|Washout Period 2|Adverse Event|0|||
44205390|NCT02038829|79001359|FG006|Washout Period 2|Adverse Event|0|||
44367279|NCT00923091|79372635|FG003|Period VI (Open-Label)|Adverse Event|1|||
44367280|NCT00923091|79372636|FG004|Period VI (Open-Label)|Adverse Event|1|||
44367281|NCT00923091|79372637|FG005|Period VI (Open-Label)|Adverse Event|0|||
44367282|NCT00923091|79372638|FG006|Period VI (Open-Label)|Adverse Event|0|||
44367283|NCT00923091|79372639|FG007|Period VI (Open-Label)|Adverse Event|0|||
44367284|NCT00923091|79372640|FG008|Period VI (Open-Label)|Adverse Event|0|||
44367285|NCT00923091|79372641|FG009|Period VI (Open-Label)|Adverse Event|0|||
44367286|NCT00923091|79372642|FG010|Period VI (Open-Label)|Adverse Event|0|||
44367287|NCT00923091|79372643|FG011|Period VI (Open-Label)|Adverse Event|0|||
44367288|NCT00923091|79372644|FG012|Period VI (Open-Label)|Adverse Event|0|||
44205391|NCT02038829|79001360|FG007|Washout Period 2|Adverse Event|0|||
44205392|NCT02038829|79001361|FG008|Washout Period 2|Adverse Event|1|||
44205393|NCT02038829|79001362|FG009|Washout Period 2|Adverse Event|0|||
44205394|NCT02038829|79001363|FG010|Washout Period 2|Adverse Event|0|||
44367289|NCT00923091|79372632|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
44452034|NCT00420238|79460942|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
44452035|NCT00420238|79460943|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
44205395|NCT02038829|79001364|FG011|Washout Period 2|Adverse Event|0|||
44205396|NCT02038829|79001353|FG000|Washout Period 2|Withdrawal by Subject|0|||
44367290|NCT00923091|79372633|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
44367291|NCT00923091|79372634|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
44367292|NCT00923091|79372635|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367293|NCT00923091|79372636|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
44367294|NCT00923091|79372637|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367295|NCT00923091|79372638|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367296|NCT00923091|79372639|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367297|NCT00923091|79372640|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367298|NCT00923091|79372641|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367299|NCT00923091|79372642|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367300|NCT00923091|79372643|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367301|NCT00923091|79372644|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
44367302|NCT00923091|79372632|FG000|Period VI (Open-Label)|Protocol Violation|6|||
44367303|NCT00923091|79372633|FG001|Period VI (Open-Label)|Protocol Violation|1|||
44367304|NCT00923091|79372634|FG002|Period VI (Open-Label)|Protocol Violation|3|||
44367305|NCT00923091|79372635|FG003|Period VI (Open-Label)|Protocol Violation|1|||
44367306|NCT00923091|79372636|FG004|Period VI (Open-Label)|Protocol Violation|4|||
44367307|NCT00923091|79372637|FG005|Period VI (Open-Label)|Protocol Violation|0|||
44367308|NCT00923091|79372638|FG006|Period VI (Open-Label)|Protocol Violation|0|||
44367309|NCT00923091|79372639|FG007|Period VI (Open-Label)|Protocol Violation|0|||
44367310|NCT00923091|79372640|FG008|Period VI (Open-Label)|Protocol Violation|0|||
44367311|NCT00923091|79372641|FG009|Period VI (Open-Label)|Protocol Violation|0|||
44367312|NCT00923091|79372642|FG010|Period VI (Open-Label)|Protocol Violation|0|||
44367313|NCT00923091|79372643|FG011|Period VI (Open-Label)|Protocol Violation|0|||
44367314|NCT00923091|79372644|FG012|Period VI (Open-Label)|Protocol Violation|0|||
44367315|NCT00923091|79372632|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
44367316|NCT00923091|79372633|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
44367317|NCT00923091|79372634|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
44367318|NCT00923091|79372635|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
44367319|NCT00923091|79372636|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
44367320|NCT00923091|79372637|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
44367321|NCT00923091|79372638|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
44367322|NCT00923091|79372639|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
44367323|NCT00923091|79372640|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
44367324|NCT00923091|79372641|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
44205397|NCT02038829|79001354|FG001|Washout Period 2|Withdrawal by Subject|0|||
44205398|NCT02038829|79001355|FG002|Washout Period 2|Withdrawal by Subject|0|||
44205399|NCT02038829|79001356|FG003|Washout Period 2|Withdrawal by Subject|0|||
44205400|NCT02038829|79001357|FG004|Washout Period 2|Withdrawal by Subject|0|||
44205401|NCT02038829|79001358|FG005|Washout Period 2|Withdrawal by Subject|1|||
44205402|NCT02038829|79001359|FG006|Washout Period 2|Withdrawal by Subject|0|||
44205403|NCT02038829|79001360|FG007|Washout Period 2|Withdrawal by Subject|0|||
44205404|NCT02038829|79001361|FG008|Washout Period 2|Withdrawal by Subject|0|||
44205405|NCT02038829|79001362|FG009|Washout Period 2|Withdrawal by Subject|0|||
44205406|NCT02038829|79001363|FG010|Washout Period 2|Withdrawal by Subject|0|||
44205407|NCT02038829|79001364|FG011|Washout Period 2|Withdrawal by Subject|0|||
44205408|NCT02038829|79001353|FG000|Treatment Period 4|Adverse Event|0|||
44205409|NCT02038829|79001354|FG001|Treatment Period 4|Adverse Event|1|||
44205410|NCT02038829|79001355|FG002|Treatment Period 4|Adverse Event|0|||
44205411|NCT02038829|79001356|FG003|Treatment Period 4|Adverse Event|0|||
44205412|NCT02038829|79001357|FG004|Treatment Period 4|Adverse Event|0|||
44205413|NCT02038829|79001358|FG005|Treatment Period 4|Adverse Event|0|||
44205414|NCT02038829|79001359|FG006|Treatment Period 4|Adverse Event|0|||
44205415|NCT02038829|79001360|FG007|Treatment Period 4|Adverse Event|0|||
44205416|NCT02038829|79001361|FG008|Treatment Period 4|Adverse Event|0|||
44205417|NCT02038829|79001362|FG009|Treatment Period 4|Adverse Event|0|||
44205418|NCT02038829|79001363|FG010|Treatment Period 4|Adverse Event|0|||
44205419|NCT02038829|79001364|FG011|Treatment Period 4|Adverse Event|0|||
44205420|NCT02038829|79001353|FG000|Washout Period 4|Adverse Event|0|||
44205421|NCT02038829|79001354|FG001|Washout Period 4|Adverse Event|0|||
44205422|NCT02038829|79001355|FG002|Washout Period 4|Adverse Event|0|||
44205423|NCT02038829|79001356|FG003|Washout Period 4|Adverse Event|0|||
44205424|NCT02038829|79001357|FG004|Washout Period 4|Adverse Event|0|||
44205425|NCT02038829|79001358|FG005|Washout Period 4|Adverse Event|0|||
44205426|NCT02038829|79001359|FG006|Washout Period 4|Adverse Event|1|||
44367325|NCT00923091|79372642|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
44367326|NCT00923091|79372643|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
44367327|NCT00923091|79372644|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
44367328|NCT00923091|79372632|FG000|Period VI (Open-Label)|Other Reason|0|||
44367329|NCT00923091|79372633|FG001|Period VI (Open-Label)|Other Reason|0|||
44367330|NCT00923091|79372634|FG002|Period VI (Open-Label)|Other Reason|0|||
44367331|NCT00923091|79372635|FG003|Period VI (Open-Label)|Other Reason|1|||
44452036|NCT00420238|79460942|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
44205427|NCT02038829|79001360|FG007|Washout Period 4|Adverse Event|0|||
44205428|NCT02038829|79001361|FG008|Washout Period 4|Adverse Event|0|||
44205429|NCT02038829|79001362|FG009|Washout Period 4|Adverse Event|0|||
44205430|NCT02038829|79001363|FG010|Washout Period 4|Adverse Event|0|||
44367332|NCT00923091|79372636|FG004|Period VI (Open-Label)|Other Reason|1|||
44205431|NCT02038829|79001364|FG011|Washout Period 4|Adverse Event|0|||
44205432|NCT02038829|79001353|FG000|Treatment Period 6|Adverse Event|0|||
44205433|NCT02038829|79001354|FG001|Treatment Period 6|Adverse Event|0|||
44205434|NCT02038829|79001355|FG002|Treatment Period 6|Adverse Event|1|||
44205435|NCT02038829|79001356|FG003|Treatment Period 6|Adverse Event|0|||
44205436|NCT02038829|79001357|FG004|Treatment Period 6|Adverse Event|0|||
44205437|NCT02038829|79001358|FG005|Treatment Period 6|Adverse Event|0|||
44205438|NCT02038829|79001359|FG006|Treatment Period 6|Adverse Event|0|||
44205439|NCT02038829|79001360|FG007|Treatment Period 6|Adverse Event|0|||
44205440|NCT02038829|79001361|FG008|Treatment Period 6|Adverse Event|0|||
44205441|NCT02038829|79001362|FG009|Treatment Period 6|Adverse Event|0|||
44205442|NCT02038829|79001363|FG010|Treatment Period 6|Adverse Event|0|||
44205443|NCT02038829|79001364|FG011|Treatment Period 6|Adverse Event|0|||
44205444|NCT02038049|79001381|FG000|Overall Study|Lost to Follow-up|1|||
44205445|NCT02038049|79001382|FG001|Overall Study|Lost to Follow-up|0|||
44205446|NCT02052011|79001394|FG000|Overall Study|Lost to Follow-up|3|||
44205447|NCT02052011|79001395|FG001|Overall Study|Lost to Follow-up|0|||
44205448|NCT02052011|79001394|FG000|Overall Study|Withdrawal by Subject|1|||
44205449|NCT02052011|79001395|FG001|Overall Study|Withdrawal by Subject|2|||
44205450|NCT02036645|79001413|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205451|NCT02036645|79001414|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205452|NCT02036645|79001415|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205453|NCT02036645|79001416|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205454|NCT02036645|79001417|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205455|NCT02036645|79001418|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205456|NCT02036645|79001419|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
44205457|NCT02036645|79001420|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205458|NCT02036645|79001421|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205459|NCT02036645|79001422|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205460|NCT02036645|79001423|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205461|NCT02036645|79001424|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
44205462|NCT02036645|79001413|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205463|NCT02036645|79001414|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205464|NCT02036645|79001415|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205465|NCT02036645|79001416|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
44205466|NCT02036645|79001417|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205467|NCT02036645|79001418|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205468|NCT02036645|79001419|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205469|NCT02036645|79001420|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205470|NCT02036645|79001421|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205471|NCT02036645|79001422|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44452037|NCT00420238|79460943|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
44452038|NCT00420238|79460942|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
44452039|NCT00420238|79460943|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
44205472|NCT02036645|79001423|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205473|NCT02036645|79001424|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
44205474|NCT02051933|79001464|FG000|Overall Study|Physician Decision|0|||
44205475|NCT02051933|79001465|FG001|Overall Study|Physician Decision|1|||
44205476|NCT02050373|79001478|FG000|Overall Study|Adverse Event|4|||
44205477|NCT02050373|79001479|FG001|Overall Study|Adverse Event|7|||
44205478|NCT02050373|79001478|FG000|Overall Study|Death|3|||
44269466|NCT00559364|79193389|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
44269467|NCT02308020|79193452|FG000|Overall Study|Lost to Follow-up|1|||
44269468|NCT02308020|79193453|FG001|Overall Study|Lost to Follow-up|7|||
44269469|NCT02308020|79193454|FG002|Overall Study|Lost to Follow-up|0|||
44269470|NCT02308020|79193455|FG003|Overall Study|Lost to Follow-up|0|||
44269471|NCT02308020|79193456|FG004|Overall Study|Lost to Follow-up|1|||
44269472|NCT02308020|79193457|FG005|Overall Study|Lost to Follow-up|2|||
44269473|NCT02308020|79193452|FG000|Overall Study|Sponsor Decision|0|||
44269474|NCT02308020|79193453|FG001|Overall Study|Sponsor Decision|8|||
44269475|NCT02308020|79193454|FG002|Overall Study|Sponsor Decision|0|||
44269476|NCT02308020|79193455|FG003|Overall Study|Sponsor Decision|2|||
44269477|NCT02308020|79193456|FG004|Overall Study|Sponsor Decision|2|||
44269478|NCT02308020|79193457|FG005|Overall Study|Sponsor Decision|1|||
44269479|NCT02308020|79193452|FG000|Overall Study|Withdrawal by Subject|3|||
44205479|NCT02050373|79001479|FG001|Overall Study|Death|3|||
44205480|NCT02049437|79001488|FG000|Period 1|Adverse Event|1|||
44205481|NCT02049437|79001489|FG001|Period 1|Adverse Event|1|||
44205482|NCT02049437|79001488|FG000|Period 1|Adverse Event|1|||
44205483|NCT02049437|79001489|FG001|Period 1|Adverse Event|0|||
44205484|NCT02035553|79001497|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
44269480|NCT02308020|79193453|FG001|Overall Study|Withdrawal by Subject|5|||
44269481|NCT02308020|79193454|FG002|Overall Study|Withdrawal by Subject|3|||
44269482|NCT02308020|79193455|FG003|Overall Study|Withdrawal by Subject|2|||
44269483|NCT02308020|79193456|FG004|Overall Study|Withdrawal by Subject|1|||
44269484|NCT02308020|79193457|FG005|Overall Study|Withdrawal by Subject|2|||
44367333|NCT00923091|79372637|FG005|Period VI (Open-Label)|Other Reason|0|||
44367334|NCT00923091|79372638|FG006|Period VI (Open-Label)|Other Reason|0|||
44367335|NCT00923091|79372639|FG007|Period VI (Open-Label)|Other Reason|0|||
44367336|NCT00923091|79372640|FG008|Period VI (Open-Label)|Other Reason|0|||
44205485|NCT02035553|79001498|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
44205486|NCT02035553|79001497|FG000|Overall Study|Adverse Event|10|||
44205487|NCT02035553|79001498|FG001|Overall Study|Adverse Event|6|||
44205488|NCT02035553|79001497|FG000|Overall Study|Physician Decision|3|||
44205489|NCT02035553|79001498|FG001|Overall Study|Physician Decision|2|||
44205490|NCT02035553|79001497|FG000|Overall Study|Lack of Efficacy|1|||
44205491|NCT02035553|79001498|FG001|Overall Study|Lack of Efficacy|1|||
44205492|NCT02035553|79001497|FG000|Overall Study|Withdrawal by Subject|4|||
44205493|NCT02035553|79001498|FG001|Overall Study|Withdrawal by Subject|7|||
44205494|NCT02035553|79001497|FG000|Overall Study|Non-compliance with Study Drug|0|||
44205495|NCT02035553|79001498|FG001|Overall Study|Non-compliance with Study Drug|1|||
44205496|NCT02035553|79001497|FG000|Overall Study|Lost to Follow-up|0|||
44205497|NCT02035553|79001498|FG001|Overall Study|Lost to Follow-up|1|||
44205498|NCT02035553|79001497|FG000|Overall Study|Other Reason|0|||
44205499|NCT02035553|79001498|FG001|Overall Study|Other Reason|4|||
44205500|NCT01445080|79001513|FG000|Overall Study|Adverse Event|5|||
44205501|NCT01445080|79001514|FG001|Overall Study|Adverse Event|3|||
44205502|NCT01445080|79001515|FG002|Overall Study|Adverse Event|11|||
44205503|NCT01445080|79001516|FG003|Overall Study|Adverse Event|6|||
44205504|NCT01445080|79001517|FG004|Overall Study|Adverse Event|2|||
44205505|NCT01445080|79001518|FG005|Overall Study|Adverse Event|3|||
44205506|NCT01445080|79001519|FG006|Overall Study|Adverse Event|0|||
44205507|NCT01445080|79001520|FG007|Overall Study|Adverse Event|3|||
44205508|NCT01445080|79001521|FG008|Overall Study|Adverse Event|10|||
44205509|NCT01445080|79001513|FG000|Overall Study|Physician Decision|0|||
44205510|NCT01445080|79001514|FG001|Overall Study|Physician Decision|0|||
44205511|NCT01445080|79001515|FG002|Overall Study|Physician Decision|1|||
44205512|NCT01445080|79001516|FG003|Overall Study|Physician Decision|0|||
44205513|NCT01445080|79001517|FG004|Overall Study|Physician Decision|0|||
44205514|NCT01445080|79001518|FG005|Overall Study|Physician Decision|3|||
44205515|NCT01445080|79001519|FG006|Overall Study|Physician Decision|2|||
44205516|NCT01445080|79001520|FG007|Overall Study|Physician Decision|2|||
44205517|NCT01445080|79001521|FG008|Overall Study|Physician Decision|0|||
44205518|NCT01445080|79001513|FG000|Overall Study|Withdrawal by Subject|1|||
44205519|NCT01445080|79001514|FG001|Overall Study|Withdrawal by Subject|0|||
44269485|NCT02359890|79193477|FG000|Overall Study|Not meeting eligibility|4|||
44269486|NCT02359890|79193477|FG000|Overall Study|Never treated with study catheter|6|||
44269487|NCT02306850|79193481|FG000|Overall Study|Lack of Efficacy|2|||
44269488|NCT02306694|79193486|FG000|Overall Study|Withdrawal by Subject|3|||
44269489|NCT02306694|79193486|FG000|Overall Study|Lost to Follow-up|1|||
44269490|NCT01648140|79193498|FG000|Overall Study|Physician Decision|1|||
44269491|NCT01648140|79193499|FG001|Overall Study|Physician Decision|0|||
44269492|NCT01648140|79193500|FG002|Overall Study|Physician Decision|0|||
44269493|NCT01648140|79193501|FG003|Overall Study|Physician Decision|0|||
44269494|NCT01648140|79193498|FG000|Overall Study|Lack of Efficacy|4|||
44269495|NCT01648140|79193499|FG001|Overall Study|Lack of Efficacy|7|||
44269496|NCT01648140|79193500|FG002|Overall Study|Lack of Efficacy|1|||
44269497|NCT01648140|79193501|FG003|Overall Study|Lack of Efficacy|0|||
44269498|NCT01648140|79193498|FG000|Overall Study|Adverse Event|3|||
44269499|NCT01648140|79193499|FG001|Overall Study|Adverse Event|1|||
44269500|NCT01648140|79193500|FG002|Overall Study|Adverse Event|2|||
44269501|NCT01648140|79193501|FG003|Overall Study|Adverse Event|0|||
44269502|NCT01648140|79193498|FG000|Overall Study|Withdrawal by Subject|2|||
44269503|NCT01648140|79193499|FG001|Overall Study|Withdrawal by Subject|3|||
44269504|NCT01648140|79193500|FG002|Overall Study|Withdrawal by Subject|3|||
44269505|NCT01648140|79193501|FG003|Overall Study|Withdrawal by Subject|2|||
44269506|NCT01648140|79193498|FG000|Overall Study|Lost to Follow-up|2|||
44269507|NCT01648140|79193499|FG001|Overall Study|Lost to Follow-up|1|||
44269508|NCT01648140|79193500|FG002|Overall Study|Lost to Follow-up|2|||
44269509|NCT01648140|79193501|FG003|Overall Study|Lost to Follow-up|0|||
44269510|NCT02336178|79193520|FG000|Overall Study|Lost to Follow-up|1|||
44269511|NCT02336178|79193520|FG000|Overall Study|Protocol Violation|1|||
44269512|NCT02336178|79193520|FG000|Overall Study|Withdrawal by Subject|1|||
44269513|NCT02336178|79193520|FG000|Overall Study|Other|1|||
44269514|NCT02357940|79193534|FG000|Overall Study|Adverse Event|0|||
44367337|NCT00923091|79372641|FG009|Period VI (Open-Label)|Other Reason|0|||
44205520|NCT01445080|79001515|FG002|Overall Study|Withdrawal by Subject|0|||
44205521|NCT01445080|79001516|FG003|Overall Study|Withdrawal by Subject|1|||
44205522|NCT01445080|79001517|FG004|Overall Study|Withdrawal by Subject|0|||
44205523|NCT01445080|79001518|FG005|Overall Study|Withdrawal by Subject|0|||
44205524|NCT01445080|79001519|FG006|Overall Study|Withdrawal by Subject|0|||
44205525|NCT01445080|79001520|FG007|Overall Study|Withdrawal by Subject|0|||
44205526|NCT01445080|79001521|FG008|Overall Study|Withdrawal by Subject|2|||
44205527|NCT01445080|79001513|FG000|Overall Study|Ineligible/Inevaluable|1|||
44269515|NCT02357940|79193535|FG001|Overall Study|Adverse Event|1|||
44367338|NCT00923091|79372642|FG010|Period VI (Open-Label)|Other Reason|0|||
44367339|NCT00923091|79372643|FG011|Period VI (Open-Label)|Other Reason|0|||
44367340|NCT00923091|79372644|FG012|Period VI (Open-Label)|Other Reason|0|||
44367341|NCT00853957|79372671|FG000|Overall Study|Adverse Event|9|||
44367342|NCT00853957|79372672|FG001|Overall Study|Adverse Event|3|||
44367343|NCT00853957|79372671|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44367344|NCT00853957|79372672|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44367345|NCT00853957|79372671|FG000|Overall Study|Subject withdrew consent|4|||
44367346|NCT00853957|79372672|FG001|Overall Study|Subject withdrew consent|5|||
44367347|NCT00853957|79372671|FG000|Overall Study|Lost to Follow-up|1|||
44367348|NCT00853957|79372672|FG001|Overall Study|Lost to Follow-up|6|||
44205528|NCT01445080|79001514|FG001|Overall Study|Ineligible/Inevaluable|2|||
44205529|NCT01445080|79001515|FG002|Overall Study|Ineligible/Inevaluable|0|||
44205530|NCT01445080|79001516|FG003|Overall Study|Ineligible/Inevaluable|1|||
44367349|NCT00853957|79372671|FG000|Overall Study|Protocol deviation|0|||
44367350|NCT00853957|79372672|FG001|Overall Study|Protocol deviation|3|||
44367351|NCT01021020|79372678|FG000|Period I|Protocol Violation|1|||
44367352|NCT01021020|79372678|FG000|Period I|Withdrawal by Subject|1|||
44367353|NCT01021020|79372678|FG000|14 Day Washout Period A|Physician Decision|1|||
44367354|NCT00833053|79372692|FG000|Overall Study|Adverse Event|4|||
44205531|NCT01445080|79001517|FG004|Overall Study|Ineligible/Inevaluable|2|||
44205532|NCT01445080|79001518|FG005|Overall Study|Ineligible/Inevaluable|3|||
44205533|NCT01445080|79001519|FG006|Overall Study|Ineligible/Inevaluable|0|||
44205534|NCT01445080|79001520|FG007|Overall Study|Ineligible/Inevaluable|0|||
44205535|NCT01445080|79001521|FG008|Overall Study|Ineligible/Inevaluable|6|||
44205536|NCT02035475|79001556|FG000|Overall Study|Withdrawal by Subject|4|||
44205537|NCT02035475|79001556|FG000|Overall Study|Physician Decision|1|||
44205538|NCT02035475|79001556|FG000|Overall Study|Equipment Error|1|||
44205539|NCT01444456|79001562|FG000|Overall Study|Withdrawal by Subject|21|||
44205540|NCT01444456|79001562|FG000|Overall Study|Physician Decision|9|||
44205541|NCT01444456|79001562|FG000|Overall Study|Lost to Follow-up|37|||
44205542|NCT01444456|79001562|FG000|Overall Study|Death|73|||
44205543|NCT01444456|79001562|FG000|Overall Study|Ineligibility determined|23|||
44205544|NCT01444456|79001562|FG000|Overall Study|Other|18|||
44205545|NCT01444456|79001562|FG000|Overall Study|Not treated|104|||
44205546|NCT01438294|79001568|FG000|Overall Study|Lost to Follow-up|3|||
44205547|NCT01438294|79001569|FG001|Overall Study|Lost to Follow-up|7|||
44205548|NCT02033759|79001577|FG000|Overall Study|Withdrawal by Subject|2|||
44205549|NCT02033759|79001578|FG001|Overall Study|Withdrawal by Subject|1|||
44205550|NCT02033759|79001577|FG000|Overall Study|Protocol Violation|1|||
44205551|NCT02033759|79001578|FG001|Overall Study|Protocol Violation|1|||
44205552|NCT01959529|79001586|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
44205553|NCT01959529|79001587|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
44205554|NCT01959529|79001586|FG000|Overall Study|Lost to Follow-up|4|||
44205555|NCT01959529|79001587|FG001|Overall Study|Lost to Follow-up|1|||
44205556|NCT01959529|79001586|FG000|Overall Study|Other|70|||
44205557|NCT01959529|79001587|FG001|Overall Study|Other|68|||
44205558|NCT01959529|79001586|FG000|Overall Study|Hypoglycaemia|1|||
44205559|NCT01959529|79001587|FG001|Overall Study|Hypoglycaemia|1|||
44367355|NCT00833053|79372693|FG001|Overall Study|Adverse Event|0|||
44367356|NCT00833053|79372692|FG000|Overall Study|Treatment Failure|3|||
44367357|NCT00833053|79372693|FG001|Overall Study|Treatment Failure|1|||
44367358|NCT00833053|79372692|FG000|Overall Study|Withdrawal by Subject|0|||
44367359|NCT00833053|79372693|FG001|Overall Study|Withdrawal by Subject|1|||
44367360|NCT00833053|79372692|FG000|Overall Study|Protocol Violation|2|||
44367361|NCT00833053|79372693|FG001|Overall Study|Protocol Violation|1|||
44367362|NCT00832975|79372699|FG000|Overall Study|Lost to Follow-up|7|||
44367363|NCT00832975|79372699|FG000|Overall Study|Protocol Violation|6|||
44367364|NCT00832975|79372699|FG000|Overall Study|Death|5|||
44367365|NCT00832975|79372699|FG000|Overall Study|Physician Decision|4|||
44367366|NCT00832975|79372699|FG000|Overall Study|Withdrawal by Subject|3|||
44367367|NCT00832975|79372699|FG000|Overall Study|Other reasons|14|||
44367368|NCT01020786|79372703|FG000|Induction Period|Entry Criteria Not Met|2|||
44367369|NCT01020786|79372703|FG000|Induction Period|Adverse Event|10|||
44205560|NCT01959529|79001586|FG000|Overall Study|Lack of glycaemic control|1|||
44205561|NCT01959529|79001587|FG001|Overall Study|Lack of glycaemic control|1|||
44205562|NCT02033369|79001595|FG000|Overall Study|Physician Decision|1|||
44205563|NCT02033369|79001596|FG001|Overall Study|Physician Decision|2|||
44205564|NCT02033369|79001595|FG000|Overall Study|Not a good demographic match|0|||
44205565|NCT02033369|79001596|FG001|Overall Study|Not a good demographic match|2|||
44205566|NCT02033369|79001595|FG000|Overall Study|Withdrawal by Subject|1|||
44205567|NCT02033369|79001596|FG001|Overall Study|Withdrawal by Subject|1|||
44367370|NCT01020786|79372703|FG000|Induction Period|Progressive Disease|31|||
44367371|NCT01020786|79372703|FG000|Induction Period|Investigator Decision|3|||
44367372|NCT01020786|79372703|FG000|Induction Period|Withdrawal by Subject|3|||
44367373|NCT01020786|79372703|FG000|Maintenance Period|Adverse Event|8|||
44367374|NCT01020786|79372703|FG000|Maintenance Period|Progressive Disease|43|||
44205568|NCT02033369|79001595|FG000|Overall Study|Lost to Follow-up|1|||
44205569|NCT02033369|79001596|FG001|Overall Study|Lost to Follow-up|0|||
44205570|NCT02033369|79001595|FG000|Overall Study|Protocol Violation|2|||
44205571|NCT02033369|79001596|FG001|Overall Study|Protocol Violation|0|||
44205572|NCT02032901|79001602|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
44205573|NCT02032901|79001603|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
44205574|NCT02032901|79001602|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
44205575|NCT02032901|79001603|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
44205576|NCT02020967|79001613|FG000|Overall Study|Withdrawal by Subject|51|||
44205577|NCT01986829|79001619|FG000|Overall Study|Death|1|||
44205578|NCT01986751|79001628|FG000|Overall Study|improperly consented|10|||
44205579|NCT01986751|79001629|FG001|Overall Study|improperly consented|2|||
44205580|NCT02004847|79001641|FG000|Overall Study|Protocol Violation|1|||
44205581|NCT02004847|79001642|FG001|Overall Study|Protocol Violation|1|||
44205582|NCT01438060|79001659|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
44205583|NCT01438060|79001660|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
44205584|NCT01438060|79001659|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
44205585|NCT01438060|79001660|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
44205586|NCT01438060|79001659|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
44205587|NCT01438060|79001660|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
44205588|NCT01438060|79001659|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
44205589|NCT01438060|79001660|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
44205590|NCT01438060|79001659|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
44205591|NCT01438060|79001660|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
44205592|NCT01438060|79001659|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
44205593|NCT01438060|79001660|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
44205594|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
44205595|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
44205596|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
44205597|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
44205598|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
44205599|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
44205600|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
44205601|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
44205602|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
44205603|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
44205604|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
44205605|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
44205606|NCT01438060|79001659|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
44205607|NCT01438060|79001660|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
44367375|NCT01020786|79372703|FG000|Maintenance Period|Withdrawal by Subject|8|||
44367376|NCT01020786|79372703|FG000|Maintenance Period|Sponsor Decision|1|||
44367377|NCT00918645|79372708|FG000|Overall Study|Withdrawal by Subject|1|||
44367378|NCT00922935|79372715|FG000|Overall Study|Protocol Violation|0|||
44367379|NCT00922935|79372716|FG001|Overall Study|Protocol Violation|3|||
44367380|NCT00922935|79372717|FG002|Overall Study|Protocol Violation|0|||
44367381|NCT00922935|79372715|FG000|Overall Study|Physician Decision|1|||
44367382|NCT00922935|79372716|FG001|Overall Study|Physician Decision|1|||
44367383|NCT00922935|79372717|FG002|Overall Study|Physician Decision|0|||
44367384|NCT00922935|79372715|FG000|Overall Study|Lost to Follow-up|0|||
44205608|NCT01438060|79001659|FG000|On Study Beyond Week 140|Adverse Event|0|||
44205609|NCT01438060|79001660|FG001|On Study Beyond Week 140|Adverse Event|2|||
44205610|NCT01438060|79001659|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
44205611|NCT01438060|79001660|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
44205612|NCT01438060|79001659|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
44205613|NCT01438060|79001660|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
44205614|NCT01438060|79001659|FG000|On Study Beyond Week 140|Death|0|||
44205615|NCT01438060|79001660|FG001|On Study Beyond Week 140|Death|1|||
44205616|NCT01438060|79001659|FG000|On Study Beyond Week 140|Other Reason|0|||
44205617|NCT01438060|79001660|FG001|On Study Beyond Week 140|Other Reason|3|||
44205618|NCT01469182|79001673|FG000|Overall Study|Adverse Event|21|||
44205619|NCT01469182|79001674|FG001|Overall Study|Adverse Event|3|||
44205620|NCT01469182|79001673|FG000|Overall Study|Lost to Follow-up|3|||
44205621|NCT01469182|79001674|FG001|Overall Study|Lost to Follow-up|0|||
44205622|NCT01469182|79001673|FG000|Overall Study|Withdrawal by Subject|4|||
44205623|NCT01469182|79001674|FG001|Overall Study|Withdrawal by Subject|1|||
44205624|NCT01469182|79001673|FG000|Overall Study|Protocol Violation|4|||
44205625|NCT01469182|79001674|FG001|Overall Study|Protocol Violation|2|||
44205626|NCT01469182|79001673|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
44205627|NCT01469182|79001674|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
44205628|NCT01444378|79001680|FG000|Overall Study|Lost to Follow-up|1|||
44205629|NCT01444378|79001680|FG000|Overall Study|Withdrawal by Subject|1|||
44205630|NCT01444378|79001680|FG000|Overall Study|Death|3|||
44205631|NCT01444378|79001680|FG000|Overall Study|Administrative Closure Of The Study|2|||
44205632|NCT01444378|79001680|FG000|Overall Study|Missed Visits|10|||
44205633|NCT02020889|79001689|FG000|Overall Study|Adverse Event|0|||
44205634|NCT02020889|79001690|FG001|Overall Study|Adverse Event|1|||
44205635|NCT02020889|79001689|FG000|Overall Study|Lack of Efficacy|1|||
44205636|NCT02020889|79001690|FG001|Overall Study|Lack of Efficacy|0|||
44205637|NCT02020889|79001689|FG000|Overall Study|Lost to Follow-up|1|||
44205638|NCT02020889|79001690|FG001|Overall Study|Lost to Follow-up|0|||
44205639|NCT02020889|79001689|FG000|Overall Study|Physician Decision|2|||
44205640|NCT02020889|79001690|FG001|Overall Study|Physician Decision|0|||
44205641|NCT02020889|79001689|FG000|Overall Study|Withdrawal by Subject|3|||
44205642|NCT02020889|79001690|FG001|Overall Study|Withdrawal by Subject|2|||
44205643|NCT01444300|79001698|FG000|Overall Study|Adverse Event|4|||
44205644|NCT01444300|79001699|FG001|Overall Study|Adverse Event|0|||
44205645|NCT01443364|79001706|FG000|Overall Study|Lack of Efficacy|14|||
44205646|NCT01443364|79001706|FG000|Overall Study|Lost to Follow-up|3|||
44205647|NCT01443364|79001706|FG000|Overall Study|Withdrawal by Subject|5|||
44205648|NCT01443364|79001706|FG000|Overall Study|Other Reason|4|||
44205649|NCT01443364|79001706|FG000|Overall Study|SAE, non-fatal|6|||
44205650|NCT01443364|79001706|FG000|Overall Study|AE, non-serious non-fatal|8|||
44367385|NCT00922935|79372716|FG001|Overall Study|Lost to Follow-up|1|||
44367386|NCT00922935|79372717|FG002|Overall Study|Lost to Follow-up|0|||
44367387|NCT01020474|79372727|FG000|Overall Study|Adverse Event|4|||
44367388|NCT01020474|79372728|FG001|Overall Study|Adverse Event|4|||
44367389|NCT01020474|79372727|FG000|Overall Study|Protocol Violation|0|||
44367390|NCT01020474|79372728|FG001|Overall Study|Protocol Violation|2|||
44367391|NCT01020474|79372727|FG000|Overall Study|Withdrawal by Subject|5|||
44367392|NCT01020474|79372728|FG001|Overall Study|Withdrawal by Subject|7|||
44367393|NCT01020474|79372727|FG000|Overall Study|Other Reasons|1|||
44367394|NCT01020474|79372728|FG001|Overall Study|Other Reasons|1|||
44367395|NCT01020474|79372727|FG000|Overall Study|Insufficient Clinical Response|0|||
44367396|NCT01020474|79372728|FG001|Overall Study|Insufficient Clinical Response|3|||
44367397|NCT00922779|79372734|FG000|Overall Study|Adverse Event|67|||
44367398|NCT00922779|79372734|FG000|Overall Study|Pregnancy|7|||
44367399|NCT00922779|79372734|FG000|Overall Study|Withdrawal by Subject|308|||
44367400|NCT00922779|79372734|FG000|Overall Study|Lost to Follow-up|44|||
44367401|NCT00922779|79372734|FG000|Overall Study|Other|27|||
44205651|NCT01443364|79001706|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44205652|NCT02020577|79001712|FG000|Overall Study|Progressive disease|3|||
44205653|NCT02020577|79001713|FG001|Overall Study|Progressive disease|38|||
44205654|NCT02020577|79001712|FG000|Overall Study|Other AE or clinical progression|0|||
44205655|NCT02020577|79001713|FG001|Overall Study|Other AE or clinical progression|15|||
44205656|NCT02020577|79001712|FG000|Overall Study|Withdrawal by Subject|0|||
44205657|NCT02020577|79001713|FG001|Overall Study|Withdrawal by Subject|1|||
44205658|NCT02020577|79001712|FG000|Overall Study|Other than stated above|0|||
44205659|NCT02020577|79001713|FG001|Overall Study|Other than stated above|1|||
44205660|NCT02020031|79001723|FG000|Overall Study|Physician Decision|1|||
44205661|NCT02020031|79001724|FG001|Overall Study|Physician Decision|1|||
44205662|NCT04179305|79001734|FG000|Overall Study|Death|1|||
44205663|NCT04179305|79001735|FG001|Overall Study|Death|1|||
44205664|NCT04179305|79001736|FG002|Overall Study|Death|0|||
44205665|NCT04179305|79001737|FG003|Overall Study|Death|0|||
44205666|NCT04179305|79001734|FG000|Overall Study|Lost to Follow-up|1|||
44205667|NCT04179305|79001735|FG001|Overall Study|Lost to Follow-up|1|||
44205668|NCT04179305|79001736|FG002|Overall Study|Lost to Follow-up|0|||
44367402|NCT00922779|79372734|FG000|Overall Study|Missing|1874|||
44205669|NCT04179305|79001737|FG003|Overall Study|Lost to Follow-up|0|||
44205670|NCT04179305|79001734|FG000|Overall Study|Withdrawal by Subject|0|||
44205671|NCT04179305|79001735|FG001|Overall Study|Withdrawal by Subject|1|||
44205672|NCT04179305|79001736|FG002|Overall Study|Withdrawal by Subject|0|||
44205673|NCT04179305|79001737|FG003|Overall Study|Withdrawal by Subject|0|||
44205674|NCT04179305|79001734|FG000|Overall Study|Did not have scan|1|||
44205675|NCT04179305|79001735|FG001|Overall Study|Did not have scan|0|||
44205676|NCT04179305|79001736|FG002|Overall Study|Did not have scan|0|||
44205677|NCT04179305|79001737|FG003|Overall Study|Did not have scan|0|||
44205678|NCT04179305|79001734|FG000|Overall Study|In hospice care|3|||
44205679|NCT04179305|79001735|FG001|Overall Study|In hospice care|0|||
44205680|NCT04179305|79001736|FG002|Overall Study|In hospice care|0|||
44205681|NCT04179305|79001737|FG003|Overall Study|In hospice care|0|||
44205682|NCT02019719|79001753|FG000|Overall Study|Adverse Event|1|||
44205683|NCT02019719|79001754|FG001|Overall Study|Adverse Event|0|||
44205684|NCT02019719|79001755|FG002|Overall Study|Adverse Event|0|||
44205685|NCT02019719|79001756|FG003|Overall Study|Adverse Event|1|||
44205686|NCT02019719|79001757|FG004|Overall Study|Adverse Event|1|||
44205687|NCT02019719|79001753|FG000|Overall Study|Protocol Violation|1|||
44205688|NCT02019719|79001754|FG001|Overall Study|Protocol Violation|1|||
44205689|NCT02019719|79001755|FG002|Overall Study|Protocol Violation|0|||
44205690|NCT02019719|79001756|FG003|Overall Study|Protocol Violation|0|||
44205691|NCT02019719|79001757|FG004|Overall Study|Protocol Violation|0|||
44205692|NCT02019719|79001753|FG000|Overall Study|Protocol defined stopping criteria|2|||
44205693|NCT02019719|79001754|FG001|Overall Study|Protocol defined stopping criteria|0|||
44205694|NCT02019719|79001755|FG002|Overall Study|Protocol defined stopping criteria|0|||
44205695|NCT02019719|79001756|FG003|Overall Study|Protocol defined stopping criteria|1|||
44205696|NCT02019719|79001757|FG004|Overall Study|Protocol defined stopping criteria|1|||
44205697|NCT02019719|79001753|FG000|Overall Study|Physician Decision|2|||
44205698|NCT02019719|79001754|FG001|Overall Study|Physician Decision|0|||
44205699|NCT02019719|79001755|FG002|Overall Study|Physician Decision|0|||
44205700|NCT02019719|79001756|FG003|Overall Study|Physician Decision|0|||
44205701|NCT02019719|79001757|FG004|Overall Study|Physician Decision|0|||
44367403|NCT00924651|79372740|FG000|Overall Study|Chemo started too soon|2|||
44367404|NCT00924651|79372741|FG001|Overall Study|Chemo started too soon|3|||
44205702|NCT02030405|79001776|FG000|Overall Study|Withdrawal by Subject|1|||
44205703|NCT02030405|79001776|FG000|Overall Study|Lost to Follow-up|1|||
44205704|NCT01975376|79001783|FG000|Overall Study|Adverse Event|5|||
44205705|NCT01975376|79001784|FG001|Overall Study|Adverse Event|5|||
44205706|NCT01975376|79001783|FG000|Overall Study|Death|65|||
44205707|NCT01975376|79001784|FG001|Overall Study|Death|72|||
44205708|NCT01975376|79001783|FG000|Overall Study|Lost to Follow-up|70|||
44205709|NCT01975376|79001784|FG001|Overall Study|Lost to Follow-up|66|||
44205710|NCT01975376|79001783|FG000|Overall Study|Withdrew consent|68|||
44205711|NCT01975376|79001784|FG001|Overall Study|Withdrew consent|62|||
44205712|NCT01975376|79001783|FG000|Overall Study|Other|2|||
44205713|NCT01975376|79001784|FG001|Overall Study|Other|4|||
44205714|NCT01975376|79001783|FG000|Overall Study|Randomized, Not Treated|16|||
44205715|NCT01975376|79001784|FG001|Overall Study|Randomized, Not Treated|8|||
44205716|NCT01443130|79001796|FG000|Overall Study|Lost to Follow-up|44|||
44205717|NCT01443130|79001797|FG001|Overall Study|Lost to Follow-up|42|||
44205718|NCT01443130|79001798|FG002|Overall Study|Lost to Follow-up|50|||
44205719|NCT01443130|79001799|FG003|Overall Study|Lost to Follow-up|23|||
44205720|NCT01443130|79001800|FG004|Overall Study|Lost to Follow-up|25|||
44205721|NCT01443130|79001801|FG005|Overall Study|Lost to Follow-up|21|||
44205722|NCT01443130|79001796|FG000|Overall Study|Death|0|||
44205723|NCT01443130|79001797|FG001|Overall Study|Death|1|||
44205724|NCT01443130|79001798|FG002|Overall Study|Death|0|||
44205725|NCT01443130|79001799|FG003|Overall Study|Death|7|||
44205726|NCT01443130|79001800|FG004|Overall Study|Death|10|||
44205727|NCT01443130|79001801|FG005|Overall Study|Death|8|||
44205728|NCT01443130|79001796|FG000|Overall Study|Adverse Event|2|||
44205729|NCT01443130|79001797|FG001|Overall Study|Adverse Event|1|||
44205730|NCT01443130|79001798|FG002|Overall Study|Adverse Event|1|||
44205731|NCT01443130|79001799|FG003|Overall Study|Adverse Event|0|||
44205732|NCT01443130|79001800|FG004|Overall Study|Adverse Event|0|||
44205733|NCT01443130|79001801|FG005|Overall Study|Adverse Event|0|||
44205734|NCT01443130|79001796|FG000|Overall Study|Protocol Violation|2|||
44205735|NCT01443130|79001797|FG001|Overall Study|Protocol Violation|1|||
44205736|NCT01443130|79001798|FG002|Overall Study|Protocol Violation|3|||
44367405|NCT00924651|79372740|FG000|Overall Study|No Reason|3|||
44367406|NCT00924651|79372741|FG001|Overall Study|No Reason|7|||
44367407|NCT00924651|79372740|FG000|Overall Study|Overwhelmed|6|||
44367408|NCT00924651|79372741|FG001|Overall Study|Overwhelmed|6|||
44367409|NCT00924651|79372740|FG000|Overall Study|Noncompliant|1|||
44367410|NCT00924651|79372741|FG001|Overall Study|Noncompliant|4|||
44205737|NCT01443130|79001799|FG003|Overall Study|Protocol Violation|2|||
44205738|NCT01443130|79001800|FG004|Overall Study|Protocol Violation|2|||
44205739|NCT01443130|79001801|FG005|Overall Study|Protocol Violation|3|||
44205740|NCT01443130|79001796|FG000|Overall Study|Withdrawal by Subject|15|||
44205741|NCT01443130|79001797|FG001|Overall Study|Withdrawal by Subject|14|||
44205742|NCT01443130|79001798|FG002|Overall Study|Withdrawal by Subject|12|||
44205743|NCT01443130|79001799|FG003|Overall Study|Withdrawal by Subject|7|||
44205744|NCT01443130|79001800|FG004|Overall Study|Withdrawal by Subject|7|||
44205745|NCT01443130|79001801|FG005|Overall Study|Withdrawal by Subject|2|||
44205746|NCT01443130|79001796|FG000|Overall Study|Death of Subject's Infant|5|||
44205747|NCT01443130|79001797|FG001|Overall Study|Death of Subject's Infant|10|||
44205748|NCT01443130|79001798|FG002|Overall Study|Death of Subject's Infant|11|||
44205749|NCT01443130|79001799|FG003|Overall Study|Death of Subject's Infant|0|||
44205750|NCT01443130|79001800|FG004|Overall Study|Death of Subject's Infant|0|||
44205751|NCT01443130|79001801|FG005|Overall Study|Death of Subject's Infant|0|||
44205752|NCT01436500|79001817|FG000|Overall Study|Death|1|||
44205753|NCT01436500|79001818|FG001|Overall Study|Death|0|||
44205754|NCT01436500|79001819|FG002|Overall Study|Death|0|||
44205755|NCT01436500|79001820|FG003|Overall Study|Death|0|||
44205756|NCT01436500|79001821|FG004|Overall Study|Death|0|||
44205757|NCT01436500|79001817|FG000|Overall Study|Adverse Event|0|||
44205758|NCT01436500|79001818|FG001|Overall Study|Adverse Event|2|||
44205759|NCT01436500|79001819|FG002|Overall Study|Adverse Event|2|||
44205760|NCT01436500|79001820|FG003|Overall Study|Adverse Event|0|||
44205761|NCT01436500|79001821|FG004|Overall Study|Adverse Event|1|||
44205762|NCT01436500|79001817|FG000|Overall Study|Withdrawal by Subject|0|||
44205763|NCT01436500|79001818|FG001|Overall Study|Withdrawal by Subject|0|||
44205764|NCT01436500|79001819|FG002|Overall Study|Withdrawal by Subject|2|||
44205765|NCT01436500|79001820|FG003|Overall Study|Withdrawal by Subject|0|||
44367411|NCT00924651|79372740|FG000|Overall Study|Medical|1|||
44367412|NCT00924651|79372741|FG001|Overall Study|Medical|3|||
44367413|NCT00924651|79372740|FG000|Overall Study|Changed Mind|10|||
44367414|NCT00924651|79372741|FG001|Overall Study|Changed Mind|1|||
44452040|NCT00420238|79460942|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
44452041|NCT00420238|79460943|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
44452042|NCT00420238|79460942|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
44452043|NCT00420238|79460943|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
44452044|NCT00420004|79460958|FG000|Overall Study|Adverse Event|4|||
44452045|NCT00420004|79460959|FG001|Overall Study|Adverse Event|1|||
44452046|NCT00420004|79460960|FG002|Overall Study|Adverse Event|1|||
44452047|NCT00420004|79460958|FG000|Overall Study|Lack of Efficacy|5|||
44452048|NCT00420004|79460959|FG001|Overall Study|Lack of Efficacy|4|||
44452049|NCT00420004|79460960|FG002|Overall Study|Lack of Efficacy|1|||
44452050|NCT00420004|79460958|FG000|Overall Study|Lost to Follow-up|31|||
44452051|NCT00420004|79460959|FG001|Overall Study|Lost to Follow-up|12|||
44452052|NCT00420004|79460960|FG002|Overall Study|Lost to Follow-up|10|||
44452053|NCT00420004|79460958|FG000|Overall Study|Entry Criteria Not Met|0|||
44452054|NCT00420004|79460959|FG001|Overall Study|Entry Criteria Not Met|1|||
44452055|NCT00420004|79460960|FG002|Overall Study|Entry Criteria Not Met|0|||
44452056|NCT00420004|79460958|FG000|Overall Study|Physician Decision|14|||
44452057|NCT00420004|79460959|FG001|Overall Study|Physician Decision|4|||
44452058|NCT00420004|79460960|FG002|Overall Study|Physician Decision|2|||
44452059|NCT00420004|79460958|FG000|Overall Study|Protocol Violation|5|||
44452060|NCT00420004|79460959|FG001|Overall Study|Protocol Violation|4|||
44452061|NCT00420004|79460960|FG002|Overall Study|Protocol Violation|3|||
44452062|NCT00420004|79460958|FG000|Overall Study|Withdrawal by Subject|67|||
44452063|NCT00420004|79460959|FG001|Overall Study|Withdrawal by Subject|42|||
44452064|NCT00420004|79460960|FG002|Overall Study|Withdrawal by Subject|14|||
44452065|NCT00420004|79460958|FG000|Overall Study|Sponsor Decision|3|||
44452066|NCT00420004|79460959|FG001|Overall Study|Sponsor Decision|3|||
44452067|NCT00420004|79460960|FG002|Overall Study|Sponsor Decision|1|||
44452068|NCT00494481|79460974|FG000|Overall Study|Condition under investigation worsened|11|||
44543049|NCT04032613|79555941|FG000|Overall Study|Did not complete post-program assessment|5|||
44543050|NCT04032613|79555942|FG001|Overall Study|Did not complete post-program assessment|2|||
44543051|NCT04000165|79555948|FG000|Overall Study|Physician Decision|1|||
44543052|NCT04000165|79555948|FG000|Overall Study|Withdrawal by Subject|1|||
44543053|NCT03187197|79555955|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
44543054|NCT03187197|79555956|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
44543055|NCT03187197|79555957|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
44543056|NCT03187197|79555955|FG000|Overall Study|Withdrawal by Subject|8|||
44543057|NCT03187197|79555956|FG001|Overall Study|Withdrawal by Subject|63|||
44543058|NCT03187197|79555957|FG002|Overall Study|Withdrawal by Subject|4|||
44543059|NCT03187197|79555955|FG000|Overall Study|Lost to Follow-up|1|||
44543060|NCT03187197|79555956|FG001|Overall Study|Lost to Follow-up|60|||
44543061|NCT03187197|79555957|FG002|Overall Study|Lost to Follow-up|7|||
44543062|NCT03187197|79555955|FG000|Overall Study|Adverse Event|6|||
44543063|NCT03187197|79555956|FG001|Overall Study|Adverse Event|29|||
44543064|NCT03187197|79555957|FG002|Overall Study|Adverse Event|0|||
44543065|NCT03187197|79555955|FG000|Overall Study|Death|0|||
44543066|NCT03187197|79555956|FG001|Overall Study|Death|11|||
44543067|NCT03187197|79555957|FG002|Overall Study|Death|0|||
44543068|NCT03187197|79555955|FG000|Overall Study|Administrative problem|1|||
44543069|NCT03187197|79555956|FG001|Overall Study|Administrative problem|1|||
44543070|NCT03187197|79555957|FG002|Overall Study|Administrative problem|0|||
44452069|NCT00494481|79460975|FG001|Overall Study|Condition under investigation worsened|13|||
44452070|NCT00494481|79460974|FG000|Overall Study|Adverse Event|15|||
44452071|NCT00494481|79460975|FG001|Overall Study|Adverse Event|11|||
44452072|NCT00494481|79460974|FG000|Overall Study|Other|1|||
44452073|NCT00494481|79460975|FG001|Overall Study|Other|0|||
44452074|NCT00494481|79460974|FG000|Overall Study|Never received IP|2|||
44452075|NCT00494481|79460975|FG001|Overall Study|Never received IP|0|||
44452076|NCT00097591|79460983|FG000|Overall Study|Withdrawal of consent|342|||
44452077|NCT00097591|79460984|FG001|Overall Study|Withdrawal of consent|323|||
44452078|NCT00097591|79460983|FG000|Overall Study|Less than 6 months on study drug|9|||
44452079|NCT00097591|79460984|FG001|Overall Study|Less than 6 months on study drug|7|||
44452080|NCT00097591|79460983|FG000|Overall Study|Unable to attend termination visit|53|||
44452081|NCT00097591|79460984|FG001|Overall Study|Unable to attend termination visit|51|||
44543071|NCT03187197|79555955|FG000|Overall Study|Reason not listed|2|||
44543072|NCT03187197|79555956|FG001|Overall Study|Reason not listed|54|||
44543073|NCT03187197|79555957|FG002|Overall Study|Reason not listed|1|||
44543074|NCT03187197|79555955|FG000|Overall Study|Missing|1|||
44543075|NCT03187197|79555956|FG001|Overall Study|Missing|32|||
44543076|NCT03187197|79555957|FG002|Overall Study|Missing|3|||
44543077|NCT03187197|79555955|FG000|Overall Study|Status missing|2|||
44543078|NCT03187197|79555956|FG001|Overall Study|Status missing|33|||
44452082|NCT00097591|79460983|FG000|Overall Study|Lost to follow up|6|||
44543079|NCT03187197|79555957|FG002|Overall Study|Status missing|3|||
44543080|NCT03187197|79555955|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
44543081|NCT03187197|79555956|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
44543082|NCT03187197|79555957|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
44543083|NCT04000009|79555965|FG000|Overall Study|Adverse Event|13|||
44543084|NCT04000009|79555965|FG000|Overall Study|Lack of Efficacy|7|||
44543085|NCT04000009|79555965|FG000|Overall Study|Lost to Follow-up|8|||
44543086|NCT04000009|79555965|FG000|Overall Study|Noncompliance with study drug|4|||
44543087|NCT04000009|79555965|FG000|Overall Study|Physician Decision|1|||
44543088|NCT04000009|79555965|FG000|Overall Study|Use of prohibited medication|3|||
44543089|NCT04000009|79555965|FG000|Overall Study|Pregnancy|1|||
44543090|NCT04000009|79555965|FG000|Overall Study|Withdrawal by Subject|22|||
44543091|NCT04000009|79555965|FG000|Overall Study|Study terminated by sponsor|98|||
44543092|NCT04000009|79555965|FG000|Overall Study|Not further specified|8|||
44543093|NCT03282240|79555972|FG000|Overall Study|Adverse Event|2|||
44543094|NCT03282240|79555973|FG001|Overall Study|Adverse Event|2|||
44543095|NCT03282240|79555974|FG002|Overall Study|Adverse Event|0|||
44543096|NCT03282240|79555972|FG000|Overall Study|Lost to Follow-up|3|||
44543097|NCT03282240|79555973|FG001|Overall Study|Lost to Follow-up|0|||
44543098|NCT03282240|79555974|FG002|Overall Study|Lost to Follow-up|0|||
44543099|NCT03282240|79555972|FG000|Overall Study|Protocol Deviation|4|||
44543100|NCT03282240|79555973|FG001|Overall Study|Protocol Deviation|1|||
44543101|NCT03282240|79555974|FG002|Overall Study|Protocol Deviation|2|||
44543102|NCT03282240|79555972|FG000|Overall Study|Withdrawal by Subject|1|||
44543103|NCT03282240|79555973|FG001|Overall Study|Withdrawal by Subject|0|||
44543104|NCT03282240|79555974|FG002|Overall Study|Withdrawal by Subject|1|||
44205766|NCT01436500|79001821|FG004|Overall Study|Withdrawal by Subject|2|||
44205767|NCT01436500|79001817|FG000|Overall Study|Physician Decision|0|||
44205768|NCT01436500|79001818|FG001|Overall Study|Physician Decision|0|||
44205769|NCT01436500|79001819|FG002|Overall Study|Physician Decision|1|||
44205770|NCT01436500|79001820|FG003|Overall Study|Physician Decision|0|||
44205771|NCT01436500|79001821|FG004|Overall Study|Physician Decision|0|||
44205772|NCT01436500|79001817|FG000|Overall Study|liver transplant|1|||
44205773|NCT01436500|79001818|FG001|Overall Study|liver transplant|0|||
44205774|NCT01436500|79001819|FG002|Overall Study|liver transplant|0|||
44205775|NCT01436500|79001820|FG003|Overall Study|liver transplant|0|||
44205776|NCT01436500|79001821|FG004|Overall Study|liver transplant|0|||
44205777|NCT01436500|79001817|FG000|Overall Study|initiation of dialysis|0|||
44205778|NCT01436500|79001818|FG001|Overall Study|initiation of dialysis|0|||
44205779|NCT01436500|79001819|FG002|Overall Study|initiation of dialysis|0|||
44205780|NCT01436500|79001820|FG003|Overall Study|initiation of dialysis|0|||
44205781|NCT01436500|79001821|FG004|Overall Study|initiation of dialysis|1|||
44205782|NCT01436500|79001817|FG000|Overall Study|discontinued study drug|1|||
44205783|NCT01436500|79001818|FG001|Overall Study|discontinued study drug|0|||
44205784|NCT01436500|79001819|FG002|Overall Study|discontinued study drug|0|||
44205785|NCT01436500|79001820|FG003|Overall Study|discontinued study drug|0|||
44205786|NCT01436500|79001821|FG004|Overall Study|discontinued study drug|0|||
44543105|NCT03185949|79555987|FG000|ITT Analysis|Withdrawal by Subject|4|||
44543106|NCT03185949|79555988|FG001|ITT Analysis|Withdrawal by Subject|3|||
44543107|NCT03185949|79555987|FG000|PP Analysis|Protocol Violation|2|||
44205787|NCT01436500|79001817|FG000|Overall Study|Other|0|||
44205788|NCT01436500|79001818|FG001|Overall Study|Other|1|||
44205789|NCT01436500|79001819|FG002|Overall Study|Other|0|||
44205790|NCT01436500|79001820|FG003|Overall Study|Other|1|||
44205791|NCT01436500|79001821|FG004|Overall Study|Other|0|||
44205792|NCT01958827|79001834|FG000|Overall Study|Adverse Event|3|||
44205793|NCT01958827|79001834|FG000|Overall Study|Lack of Efficacy|6|||
44205794|NCT01958827|79001834|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
44205795|NCT01620086|79001840|FG000|Overall Study|Withdrawal by Subject|3|||
44205796|NCT01620086|79001841|FG001|Overall Study|Withdrawal by Subject|3|||
44205797|NCT01620086|79001842|FG002|Overall Study|Withdrawal by Subject|0|||
44205798|NCT01620086|79001840|FG000|Overall Study|failed study criteria|1|||
44205799|NCT01620086|79001841|FG001|Overall Study|failed study criteria|4|||
44205800|NCT01620086|79001842|FG002|Overall Study|failed study criteria|0|||
44543108|NCT03185949|79555988|FG001|PP Analysis|Protocol Violation|2|||
44543109|NCT03185949|79555987|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
44543110|NCT03185949|79555988|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
44543111|NCT03655405|79555998|FG000|Overall Study|Death after initial data collection|4|||
44543112|NCT03655405|79555999|FG001|Overall Study|Death after initial data collection|2|||
44543113|NCT03655405|79555998|FG000|Overall Study|Died before initial data collection|1|||
44543114|NCT03655405|79555999|FG001|Overall Study|Died before initial data collection|2|||
44543115|NCT03655405|79555998|FG000|Overall Study|Protocol Violation|0|||
44543116|NCT03655405|79555999|FG001|Overall Study|Protocol Violation|1|||
44205801|NCT01620086|79001840|FG000|Overall Study|Physician Decision|1|||
44205802|NCT01620086|79001841|FG001|Overall Study|Physician Decision|0|||
44205803|NCT01620086|79001842|FG002|Overall Study|Physician Decision|0|||
44205804|NCT01436110|79001854|FG000|Overall Study|Lack of Efficacy|23|||
44205805|NCT01436110|79001855|FG001|Overall Study|Lack of Efficacy|14|||
44205806|NCT01436110|79001856|FG002|Overall Study|Lack of Efficacy|9|||
44205807|NCT01436110|79001854|FG000|Overall Study|Withdrawal by Subject|6|||
44205808|NCT01436110|79001855|FG001|Overall Study|Withdrawal by Subject|8|||
44367415|NCT00924651|79372740|FG000|Overall Study|Incomplete Form|2|||
44205809|NCT01436110|79001856|FG002|Overall Study|Withdrawal by Subject|4|||
44205810|NCT01436110|79001854|FG000|Overall Study|Adverse Event|2|||
44205811|NCT01436110|79001855|FG001|Overall Study|Adverse Event|1|||
44205812|NCT01436110|79001856|FG002|Overall Study|Adverse Event|2|||
44205813|NCT01436110|79001854|FG000|Overall Study|Physician Decision|3|||
44205814|NCT01436110|79001855|FG001|Overall Study|Physician Decision|1|||
44205815|NCT01436110|79001856|FG002|Overall Study|Physician Decision|1|||
44205816|NCT01436110|79001854|FG000|Overall Study|Lost to Follow-up|1|||
44205817|NCT01436110|79001855|FG001|Overall Study|Lost to Follow-up|1|||
44205818|NCT01436110|79001856|FG002|Overall Study|Lost to Follow-up|3|||
44205819|NCT01436110|79001854|FG000|Overall Study|Protocol Violation|3|||
44205820|NCT01436110|79001855|FG001|Overall Study|Protocol Violation|1|||
44205821|NCT01436110|79001856|FG002|Overall Study|Protocol Violation|1|||
44205822|NCT01436110|79001854|FG000|Overall Study|Did Not Receive Trial Medication|1|||
44205823|NCT01436110|79001855|FG001|Overall Study|Did Not Receive Trial Medication|0|||
44205824|NCT01436110|79001856|FG002|Overall Study|Did Not Receive Trial Medication|3|||
44205825|NCT01619852|79001866|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
44205826|NCT01619852|79001867|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
44205827|NCT01619852|79001866|FG000|3 Month Follow up|Lost to Follow-up|31|||
44205828|NCT01619852|79001867|FG001|3 Month Follow up|Lost to Follow-up|34|||
44205829|NCT02000882|79001874|FG000|Overall Study|Adverse Event|3|||
44205830|NCT02000882|79001874|FG000|Overall Study|Physician Decision|2|||
44205831|NCT02000882|79001874|FG000|Overall Study|Withdrawal by Subject|1|||
44205832|NCT01965938|79001880|FG000|Overall Study|Withdrawal by Subject|1|||
44205833|NCT01965938|79001881|FG001|Overall Study|Withdrawal by Subject|0|||
44205834|NCT01965860|79001892|FG000|Overall Study|Pregnancy|1|||
44205835|NCT01965860|79001893|FG001|Overall Study|Pregnancy|0|||
44205836|NCT01965860|79001894|FG002|Overall Study|Pregnancy|1|||
44205837|NCT01965860|79001892|FG000|Overall Study|Logistics|1|||
44205838|NCT01965860|79001893|FG001|Overall Study|Logistics|0|||
44205839|NCT01965860|79001894|FG002|Overall Study|Logistics|0|||
44205840|NCT01965704|79001915|FG000|Overall Study|Withdrawal by Subject|2|||
44205841|NCT01965704|79001916|FG001|Overall Study|Withdrawal by Subject|2|||
44205842|NCT01965704|79001917|FG002|Overall Study|Withdrawal by Subject|1|||
44205843|NCT01965704|79001918|FG003|Overall Study|Withdrawal by Subject|1|||
44205844|NCT01965704|79001915|FG000|Overall Study|Delivered at home|1|||
44205845|NCT01965704|79001916|FG001|Overall Study|Delivered at home|1|||
44205846|NCT01965704|79001917|FG002|Overall Study|Delivered at home|0|||
44205847|NCT01965704|79001918|FG003|Overall Study|Delivered at home|0|||
44543117|NCT03510598|79556005|FG000|Overall Study|Withdrawal by Subject|1|||
44543118|NCT03222141|79556009|FG000|Overall Study|Death|15|||
44543119|NCT03222141|79556009|FG000|Overall Study|Lost to Follow-up|3|||
44543120|NCT04029961|79556016|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
44543121|NCT04029961|79556017|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
44543122|NCT04029961|79556016|FG000|Overall Study|Change in Treatment Course|0|||
44543123|NCT04029961|79556017|FG001|Overall Study|Change in Treatment Course|1|||
44543124|NCT03997825|79556023|FG000|Overall Study|Death|3|||
44543125|NCT03997825|79556023|FG000|Overall Study|Lost to Follow-up|10|||
44543126|NCT03997825|79556023|FG000|Overall Study|Withdrawal by Subject|3|||
44543127|NCT03997825|79556023|FG000|Overall Study|Refused participation|1|||
44543128|NCT04024891|79556029|FG000|Overall Study|Pregnancy|0|||
44543129|NCT04024891|79556030|FG001|Overall Study|Pregnancy|1|||
44543130|NCT03250182|79556036|FG000|Overall Study|Withdrawal by Subject|1|||
44543131|NCT03993379|79556044|FG000|Overall Study|The study was terminated early due to business decision.|0|||
44543132|NCT03993379|79556045|FG001|Overall Study|The study was terminated early due to business decision.|2|||
44543133|NCT03993379|79556046|FG002|Overall Study|The study was terminated early due to business decision.|0|||
44543134|NCT03993379|79556047|FG003|Overall Study|The study was terminated early due to business decision.|0|||
44543135|NCT03993379|79556044|FG000|Overall Study|Withdrawal by Subject|0|||
44543136|NCT03993379|79556045|FG001|Overall Study|Withdrawal by Subject|1|||
44543137|NCT03993379|79556046|FG002|Overall Study|Withdrawal by Subject|0|||
44205848|NCT01965704|79001915|FG000|Overall Study|Experienced complications|0|||
44205849|NCT01965704|79001916|FG001|Overall Study|Experienced complications|0|||
44205850|NCT01965704|79001917|FG002|Overall Study|Experienced complications|2|||
44205851|NCT01965704|79001918|FG003|Overall Study|Experienced complications|2|||
44205852|NCT01965704|79001915|FG000|Overall Study|Adverse Event|0|||
44543138|NCT03993379|79556047|FG003|Overall Study|Withdrawal by Subject|0|||
44543139|NCT03370120|79556057|FG000|Overall Study|Adverse event, non-fatal|24|||
44543140|NCT03370120|79556057|FG000|Overall Study|Withdrawal by Subject|6|||
44205853|NCT01965704|79001916|FG001|Overall Study|Adverse Event|0|||
44205854|NCT01965704|79001917|FG002|Overall Study|Adverse Event|1|||
44205855|NCT01965704|79001918|FG003|Overall Study|Adverse Event|1|||
44205856|NCT01965704|79001915|FG000|Overall Study|Did not meet inclusion criteria|0|||
44205857|NCT01965704|79001916|FG001|Overall Study|Did not meet inclusion criteria|0|||
44205858|NCT01965704|79001917|FG002|Overall Study|Did not meet inclusion criteria|1|||
44367416|NCT00924651|79372741|FG001|Overall Study|Incomplete Form|1|||
44543141|NCT03370120|79556057|FG000|Overall Study|Lost to Follow-up|1|||
44543142|NCT03370120|79556057|FG000|Overall Study|Lack of Efficacy|37|||
44543143|NCT03370120|79556057|FG000|Overall Study|Per sponsor's instructions|1|||
44543144|NCT03370120|79556057|FG000|Overall Study|Study was terminated by parent company UCB|2|||
44543145|NCT03370120|79556057|FG000|Overall Study|The study was ended by the promoter|3|||
44543146|NCT03370120|79556057|FG000|Overall Study|Discontinuation of drug development|3|||
44543147|NCT03370120|79556057|FG000|Overall Study|End of project|2|||
44543148|NCT03370120|79556057|FG000|Overall Study|Premature study closure|2|||
44543149|NCT03370120|79556057|FG000|Overall Study|Premature program termination|1|||
44543150|NCT03370120|79556057|FG000|Overall Study|Premature study termination|7|||
44543151|NCT03370120|79556057|FG000|Overall Study|Trial terminated by sponsor|2|||
44543152|NCT03370120|79556057|FG000|Overall Study|Trial discontinued by sponsor|2|||
44543153|NCT03370120|79556057|FG000|Overall Study|Study ended|15|||
44543154|NCT03370120|79556057|FG000|Overall Study|Clinical trial has been cancelled|1|||
44543155|NCT03370120|79556057|FG000|Overall Study|End of study per sponsor decision|2|||
44543156|NCT03370120|79556057|FG000|Overall Study|Promoter's decision|2|||
44543157|NCT03370120|79556057|FG000|Overall Study|The trial has been suspended|3|||
44543158|NCT03370120|79556057|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
44543159|NCT03370120|79556057|FG000|Overall Study|Early termination by order of sponsor|2|||
44543160|NCT03370120|79556057|FG000|Overall Study|Discontinuation of the study|5|||
44543161|NCT03370120|79556057|FG000|Overall Study|End of clinical trial discontinuation|1|||
44543162|NCT03370120|79556057|FG000|Overall Study|Because the clinical trial ended halfway|4|||
44543163|NCT03370120|79556057|FG000|Overall Study|Development discontinued|5|||
44543164|NCT03370120|79556057|FG000|Overall Study|Padsenovil program closed|3|||
44543165|NCT03370120|79556057|FG000|Overall Study|End of project|2|||
44543166|NCT03370120|79556057|FG000|Overall Study|Termination of project|1|||
44543167|NCT03370120|79556057|FG000|Overall Study|The study was interrupted by sponsor|4|||
44543168|NCT03370120|79556057|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
44543169|NCT03370120|79556057|FG000|Overall Study|End of sponsor decision|1|||
44543170|NCT03370120|79556057|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
44543171|NCT03370120|79556057|FG000|Overall Study|Early termination of studies|5|||
44543172|NCT03370120|79556057|FG000|Overall Study|This study is ended early|1|||
44543173|NCT03370120|79556057|FG000|Overall Study|End of padsevonil program|2|||
44543174|NCT03370120|79556057|FG000|Overall Study|Decision of sponsor|6|||
44543175|NCT03370120|79556057|FG000|Overall Study|Asked by the sponsor|3|||
44543176|NCT03370120|79556057|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
44543177|NCT03370120|79556057|FG000|Overall Study|PI decision poor compliance from participant|1|||
44543178|NCT03370120|79556057|FG000|Overall Study|Promoter ended the study|3|||
44543179|NCT03370120|79556057|FG000|Overall Study|Premature study close by sponsor's decision|4|||
44543180|NCT03370120|79556057|FG000|Overall Study|Study terminated by sponsor|33|||
44543181|NCT03370120|79556057|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
44543182|NCT03370120|79556057|FG000|Overall Study|Sponsor decision to terminate study|63|||
44543183|NCT03370120|79556057|FG000|Overall Study|Program closure|3|||
44543184|NCT03370120|79556057|FG000|Overall Study|Study ended prematurely|1|||
44543185|NCT03370120|79556057|FG000|Overall Study|Study stopped by sponsor|2|||
44543186|NCT03370120|79556057|FG000|Overall Study|Program termination|55|||
44543187|NCT03370120|79556057|FG000|Overall Study|Sponsor decision|62|||
44543188|NCT03370120|79556057|FG000|Overall Study|Sponsor study closure|10|||
44543189|NCT03247686|79556065|FG000|Overall Study|Withdrawal by Subject|1|||
44543190|NCT03247686|79556066|FG001|Overall Study|Withdrawal by Subject|2|||
44543191|NCT03990649|79556077|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
44543192|NCT03990649|79556078|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
44205859|NCT01965704|79001918|FG003|Overall Study|Did not meet inclusion criteria|1|||
44205860|NCT02003365|79001929|FG000|Overall Study|Lost to Follow-up|0|||
44543193|NCT03990649|79556079|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
44543194|NCT03990649|79556077|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
44205861|NCT02003365|79001930|FG001|Overall Study|Lost to Follow-up|0|||
44543195|NCT03990649|79556078|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
44543196|NCT03990649|79556079|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
44543197|NCT03990649|79556077|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
44543198|NCT03990649|79556078|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
44543199|NCT03990649|79556079|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
44543200|NCT03990649|79556077|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
44543201|NCT03990649|79556078|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
44543202|NCT03990649|79556079|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
44543203|NCT03990649|79556077|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
44543204|NCT03990649|79556078|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
44543205|NCT03990649|79556079|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
44543206|NCT03990649|79556077|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
44543207|NCT03990649|79556078|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
44543208|NCT03990649|79556079|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
44543209|NCT03990649|79556077|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
44543210|NCT03990649|79556078|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
44543211|NCT03990649|79556079|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
44205862|NCT02003365|79001931|FG002|Overall Study|Lost to Follow-up|1|||
44205863|NCT01975220|79001942|FG000|Test Period 1|Not treated|0|||
44205864|NCT01975220|79001943|FG001|Test Period 1|Not treated|1|||
44205865|NCT01975220|79001944|FG002|Test Period 1|Not treated|0|||
44205866|NCT01975220|79001945|FG003|Test Period 1|Not treated|0|||
44205867|NCT01975220|79001946|FG004|Test Period 1|Not treated|0|||
44205868|NCT01975220|79001947|FG005|Test Period 1|Not treated|0|||
44205869|NCT01958437|79001964|FG000|Overall Study|Incidental MRI findings|0|||
44205870|NCT01958437|79001965|FG001|Overall Study|Incidental MRI findings|0|||
44205871|NCT01958437|79001966|FG002|Overall Study|Incidental MRI findings|1|||
44205872|NCT01958437|79001967|FG003|Overall Study|Incidental MRI findings|1|||
44205873|NCT01974752|79001986|FG000|Overall Study|Death|33|||
44205874|NCT01974752|79001987|FG001|Overall Study|Death|11|||
44205875|NCT01974752|79001986|FG000|Overall Study|Lost to Follow-up|2|||
44205876|NCT01974752|79001987|FG001|Overall Study|Lost to Follow-up|0|||
44205877|NCT01974752|79001986|FG000|Overall Study|Withdrawal by Subject|2|||
44205878|NCT01974752|79001987|FG001|Overall Study|Withdrawal by Subject|3|||
44205879|NCT01974752|79001986|FG000|Overall Study|Other Eligibility Criteria|0|||
44205880|NCT01974752|79001987|FG001|Overall Study|Other Eligibility Criteria|1|||
44205881|NCT01999946|79001996|FG000|Overall Study|Participant not released from jail|2|||
44205882|NCT01999946|79001997|FG001|Overall Study|Participant not released from jail|2|||
44205883|NCT01999946|79001998|FG002|Overall Study|Participant not released from jail|0|||
44205884|NCT01999946|79001996|FG000|Overall Study|Not included in primary outcome analysis|0|||
44205885|NCT01999946|79001997|FG001|Overall Study|Not included in primary outcome analysis|0|||
44205886|NCT01999946|79001998|FG002|Overall Study|Not included in primary outcome analysis|79|||
44205887|NCT01958281|79002008|FG000|Overall Study|Lack of Efficacy|5|||
44205888|NCT01958281|79002009|FG001|Overall Study|Lack of Efficacy|2|||
44543212|NCT03185481|79556086|FG000|Overall Study|Adverse Event|1|||
44543213|NCT03185481|79556086|FG000|Overall Study|Study Terminated by Sponsor|4|||
44543214|NCT03652675|79556092|FG000|Overall Study|Lost to Follow-up|4|||
44543215|NCT03652675|79556093|FG001|Overall Study|Lost to Follow-up|4|||
44543216|NCT03241368|79556099|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
44543217|NCT03241368|79556099|FG000|Overall Study|Lost to Follow-up|1|||
44543218|NCT03241368|79556099|FG000|Overall Study|Physician Decision|6|||
44543219|NCT03241368|79556099|FG000|Overall Study|Withdrawal by Subject|6|||
44543220|NCT03241368|79556099|FG000|Overall Study|Protocol Violation|1|||
44543221|NCT03220581|79556106|FG000|Overall Study|Withdrawal by Subject|0|||
44543222|NCT03220581|79556107|FG001|Overall Study|Withdrawal by Subject|1|||
44543223|NCT03220581|79556106|FG000|Overall Study|Lost to Follow-up|3|||
44543224|NCT03220581|79556107|FG001|Overall Study|Lost to Follow-up|6|||
44543225|NCT02954575|79556115|FG000|Overall Study|Withdrawal by Subject|2|||
44543226|NCT02954575|79556115|FG000|Overall Study|Adverse Event|1|||
44543227|NCT03184701|79556123|FG000|Overall Study|Death|3|||
44205889|NCT01958281|79002010|FG002|Overall Study|Lack of Efficacy|0|||
44205890|NCT01958281|79002008|FG000|Overall Study|Adverse Event|0|||
44269516|NCT02357940|79193534|FG000|Overall Study|Investigator's judgement|0|||
44269517|NCT02357940|79193535|FG001|Overall Study|Investigator's judgement|1|||
44543228|NCT03184701|79556123|FG000|Overall Study|Physician Decision|3|||
44543229|NCT03184701|79556123|FG000|Overall Study|Withdrawal by Subject|6|||
44543230|NCT03184701|79556123|FG000|Overall Study|Lost to Follow-up|5|||
44205891|NCT01958281|79002009|FG001|Overall Study|Adverse Event|2|||
44205892|NCT01958281|79002010|FG002|Overall Study|Adverse Event|0|||
44205893|NCT01958281|79002008|FG000|Overall Study|Withdrew Consent|1|||
44205894|NCT01958281|79002009|FG001|Overall Study|Withdrew Consent|0|||
44205895|NCT01958281|79002010|FG002|Overall Study|Withdrew Consent|0|||
44205896|NCT01958125|79002021|FG000|Overall Study|Missing diary data|2|||
44205897|NCT01958125|79002022|FG001|Overall Study|Missing diary data|6|||
44543231|NCT03247530|79556130|FG000|Overall Study|Withdrawal by caregiver|19|||
44543232|NCT03247530|79556131|FG001|Overall Study|Withdrawal by caregiver|8|||
44543233|NCT03247530|79556132|FG002|Overall Study|Withdrawal by caregiver|10|||
44543234|NCT03247530|79556130|FG000|Overall Study|Lost to Follow-up|3|||
44543235|NCT03247530|79556131|FG001|Overall Study|Lost to Follow-up|9|||
44543236|NCT03247530|79556132|FG002|Overall Study|Lost to Follow-up|6|||
44543237|NCT03247530|79556130|FG000|Overall Study|Adverse Event|2|||
44543238|NCT03247530|79556131|FG001|Overall Study|Adverse Event|5|||
44543239|NCT03247530|79556132|FG002|Overall Study|Adverse Event|2|||
44543240|NCT03247530|79556130|FG000|Overall Study|Failure to follow procedure|1|||
44543241|NCT03247530|79556131|FG001|Overall Study|Failure to follow procedure|1|||
44543242|NCT03247530|79556132|FG002|Overall Study|Failure to follow procedure|1|||
44543243|NCT03247530|79556130|FG000|Overall Study|Withdrawal by Subject|1|||
44543244|NCT03247530|79556131|FG001|Overall Study|Withdrawal by Subject|1|||
44543245|NCT03247530|79556132|FG002|Overall Study|Withdrawal by Subject|0|||
44543246|NCT03247530|79556130|FG000|Overall Study|Study medication misuse|0|||
44543247|NCT03247530|79556131|FG001|Overall Study|Study medication misuse|1|||
44543248|NCT03247530|79556132|FG002|Overall Study|Study medication misuse|0|||
44543249|NCT03247530|79556130|FG000|Overall Study|Other, multiple categories|1|||
44543250|NCT03247530|79556131|FG001|Overall Study|Other, multiple categories|3|||
44543251|NCT03247530|79556132|FG002|Overall Study|Other, multiple categories|1|||
44543252|NCT03246672|79556143|FG000|Overall Study|Lost to Follow-up|2|||
44543253|NCT03983317|79556147|FG000|Overall Study|Physician Decision|5|||
44543254|NCT03207243|79556153|FG000|Overall Study|Adverse Event|2|||
44543255|NCT03207243|79556154|FG001|Overall Study|Adverse Event|2|||
44543256|NCT03207243|79556153|FG000|Overall Study|Loss of Asthma Control|47|||
44543257|NCT03207243|79556154|FG001|Overall Study|Loss of Asthma Control|31|||
44543258|NCT03207243|79556153|FG000|Overall Study|Withdrawal by Subject|2|||
44543259|NCT03207243|79556154|FG001|Overall Study|Withdrawal by Subject|4|||
44543260|NCT03207243|79556153|FG000|Overall Study|Physician Decision|1|||
44543261|NCT03207243|79556154|FG001|Overall Study|Physician Decision|1|||
44543262|NCT03207243|79556153|FG000|Overall Study|Lost to Follow-up|0|||
44543263|NCT03207243|79556154|FG001|Overall Study|Lost to Follow-up|1|||
44543264|NCT03207243|79556153|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
44543265|NCT03207243|79556154|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
44543266|NCT03207243|79556153|FG000|Overall Study|Protocol Violation|0|||
44543267|NCT03207243|79556154|FG001|Overall Study|Protocol Violation|3|||
44543268|NCT03982069|79556165|FG000|Overall Study|Lost to Follow-up|5|||
44543269|NCT03982069|79556166|FG001|Overall Study|Lost to Follow-up|5|||
44543270|NCT03982069|79556167|FG002|Overall Study|Lost to Follow-up|3|||
44543271|NCT03982069|79556168|FG003|Overall Study|Lost to Follow-up|5|||
44543272|NCT03982069|79556165|FG000|Overall Study|Physician Decision|0|||
44543273|NCT03982069|79556166|FG001|Overall Study|Physician Decision|1|||
44543274|NCT03982069|79556167|FG002|Overall Study|Physician Decision|0|||
44543275|NCT03982069|79556168|FG003|Overall Study|Physician Decision|0|||
44543276|NCT03982069|79556165|FG000|Overall Study|Withdrawal by Subject|2|||
44543277|NCT03982069|79556166|FG001|Overall Study|Withdrawal by Subject|1|||
44543278|NCT03982069|79556167|FG002|Overall Study|Withdrawal by Subject|5|||
44543279|NCT03982069|79556168|FG003|Overall Study|Withdrawal by Subject|2|||
44543280|NCT03982069|79556165|FG000|Overall Study|Specimen loss|3|||
44543281|NCT03982069|79556166|FG001|Overall Study|Specimen loss|3|||
44543282|NCT03982069|79556167|FG002|Overall Study|Specimen loss|1|||
44543283|NCT03982069|79556168|FG003|Overall Study|Specimen loss|1|||
44543284|NCT02937870|79556176|FG000|Overall Study|Adverse Event|1|||
44543285|NCT02937870|79556176|FG000|Overall Study|Protocol Deviation|2|||
44543286|NCT03629041|79556190|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
44543287|NCT03629041|79556191|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
44543288|NCT03629041|79556192|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
44543289|NCT03629041|79556193|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
44205898|NCT01958125|79002021|FG000|Overall Study|No headache attacks|0|||
44205899|NCT01958125|79002022|FG001|Overall Study|No headache attacks|2|||
44205900|NCT02002975|79002028|FG000|Overall Study|Case Report Forms Uncollected|135|||
44367417|NCT00922623|79372747|FG000|Overall Study|Other|4|||
44543290|NCT03219723|79556211|FG000|Overall Study|Case Report Forms Uncollected|6|||
44543291|NCT03219723|79556211|FG000|Overall Study|Protocol Deviation|4|||
44543292|NCT03628417|79556215|FG000|Overall Study|Death|1|||
44543293|NCT03628417|79556216|FG001|Overall Study|Death|1|||
44367418|NCT00922623|79372747|FG000|Overall Study|Lost to Follow-up|1|||
44543294|NCT03184077|79556228|FG000|Overall Study|Lost to Follow-up|21|||
44543295|NCT03184077|79556229|FG001|Overall Study|Lost to Follow-up|21|||
44543296|NCT03245736|79556235|FG000|Overall Study|Adverse Event|1|||
44543297|NCT03245736|79556235|FG000|Overall Study|Progressive Disease|4|||
44543298|NCT02954887|79556239|FG000|Overall Study|Withdrawal by Subject|3|||
44543299|NCT02954887|79556239|FG000|Overall Study|Lack of Efficacy|3|||
44543300|NCT02954887|79556239|FG000|Overall Study|Other|1|||
44543301|NCT03183063|79556246|FG000|Overall Study|Withdrawal by Subject|2|||
44543302|NCT03183063|79556247|FG001|Overall Study|Withdrawal by Subject|0|||
44205901|NCT02002975|79002028|FG000|Overall Study|Protocol Deviation|437|||
44205902|NCT02001181|79002034|FG000|Overall Study|Adverse Event|0|||
44205903|NCT02001181|79002035|FG001|Overall Study|Adverse Event|2|||
44205904|NCT02001181|79002034|FG000|Overall Study|Lost to Follow-up|1|||
44205905|NCT02001181|79002035|FG001|Overall Study|Lost to Follow-up|0|||
44205906|NCT02001181|79002034|FG000|Overall Study|Withdrawal by Subject|0|||
44205907|NCT02001181|79002035|FG001|Overall Study|Withdrawal by Subject|1|||
44205908|NCT01999465|79002043|FG000|Overall Study|Lost to Follow-up|0|||
44205909|NCT01999465|79002044|FG001|Overall Study|Lost to Follow-up|2|||
44205910|NCT01999465|79002043|FG000|Overall Study|Protocol Violation|0|||
44205911|NCT01999465|79002044|FG001|Overall Study|Protocol Violation|1|||
44205912|NCT01982773|79002052|FG000|Overall Study|Withdrawal by Subject|1|||
44205913|NCT01982773|79002053|FG001|Overall Study|Withdrawal by Subject|3|||
44205914|NCT01982773|79002052|FG000|Overall Study|Lost to Follow-up|7|||
44205915|NCT01982773|79002053|FG001|Overall Study|Lost to Follow-up|1|||
44205916|NCT01974206|79002061|FG000|Overall Study|Did Not Take Study Drug|0|||
44205917|NCT01974206|79002062|FG001|Overall Study|Did Not Take Study Drug|1|||
44205918|NCT01974206|79002061|FG000|Overall Study|Physician Decision|1|||
44205919|NCT01974206|79002062|FG001|Overall Study|Physician Decision|0|||
44205920|NCT01974206|79002061|FG000|Overall Study|Withdrawal by Subject|3|||
44205921|NCT01974206|79002062|FG001|Overall Study|Withdrawal by Subject|0|||
44205922|NCT01974206|79002061|FG000|Overall Study|Lost to Follow-up|1|||
44205923|NCT01974206|79002062|FG001|Overall Study|Lost to Follow-up|0|||
44205924|NCT01974206|79002061|FG000|Overall Study|Death|1|||
44205925|NCT01974206|79002062|FG001|Overall Study|Death|0|||
44205926|NCT01999868|79002071|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
44205927|NCT01999868|79002072|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
44205928|NCT01999868|79002073|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
44205929|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
44205930|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
44205931|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
44205932|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
44205933|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
44205934|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
44205935|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
44205936|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
44452083|NCT00097591|79460984|FG001|Overall Study|Lost to follow up|10|||
44205937|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
44205938|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
44205939|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
44205940|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
44205941|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
44205942|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
44205943|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
44205944|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
44205945|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
44205946|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
44205947|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
44205948|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
44205949|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
44205950|NCT01999868|79002071|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
44205951|NCT01999868|79002072|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
44205952|NCT01999868|79002073|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
44205953|NCT01999868|79002071|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
44205954|NCT01999868|79002072|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
44205955|NCT01999868|79002073|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
44205956|NCT01999868|79002071|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
44205957|NCT01999868|79002072|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
44205958|NCT01999868|79002073|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
44205959|NCT01999868|79002071|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
44205960|NCT01999868|79002072|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
44205961|NCT01999868|79002073|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
44205962|NCT01999868|79002071|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
44205963|NCT01999868|79002072|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
44205964|NCT01999868|79002073|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
44205965|NCT01999868|79002071|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
44205966|NCT01999868|79002072|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
44269518|NCT02335242|79193543|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
44205967|NCT01999868|79002073|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
44205968|NCT01999868|79002071|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
44205969|NCT01999868|79002072|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
44205970|NCT01999868|79002073|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
44205971|NCT01957579|79002085|FG000|Overall Study|Withdrawal of concent|0|||
44205972|NCT01957579|79002086|FG001|Overall Study|Withdrawal of concent|1|||
44205973|NCT01957579|79002087|FG002|Overall Study|Withdrawal of concent|0|||
44205974|NCT01957579|79002088|FG003|Overall Study|Withdrawal of concent|0|||
44205975|NCT01957579|79002085|FG000|Overall Study|Death|0|||
44205976|NCT01957579|79002086|FG001|Overall Study|Death|0|||
44205977|NCT01957579|79002087|FG002|Overall Study|Death|2|||
44205978|NCT01957579|79002088|FG003|Overall Study|Death|0|||
44205979|NCT01999322|79002117|FG000|Overall Study|Adverse Event|1|||
44205980|NCT01999322|79002118|FG001|Overall Study|Adverse Event|0|||
44205981|NCT01996982|79002124|FG000|Overall Study|PI/team left institution|7|||
44205982|NCT01965158|79002130|FG000|Overall Study|Adverse Event|14|||
44205983|NCT01965158|79002131|FG001|Overall Study|Adverse Event|5|||
44205984|NCT01965158|79002130|FG000|Overall Study|Withdrawal by Subject|16|||
44205985|NCT01965158|79002131|FG001|Overall Study|Withdrawal by Subject|24|||
44205986|NCT01965158|79002130|FG000|Overall Study|Lost to Follow-up|7|||
44205987|NCT01965158|79002131|FG001|Overall Study|Lost to Follow-up|5|||
44205988|NCT01965158|79002130|FG000|Overall Study|Protocol Violation|1|||
44205989|NCT01965158|79002131|FG001|Overall Study|Protocol Violation|1|||
44367419|NCT01025232|79372755|FG000|Overall Study|Study drug no longer available|3|||
44367420|NCT01025232|79372756|FG001|Overall Study|Study drug no longer available|6|||
44367421|NCT01025154|79372762|FG000|Overall Study|Lost to Follow-up|1|||
44367422|NCT01025154|79372762|FG000|Overall Study|Withdrawal by Subject|1|||
44367423|NCT00832819|79372769|FG000|Overall Study|Adverse Event|0|||
44367424|NCT00832819|79372770|FG001|Overall Study|Adverse Event|1|||
44367425|NCT00832819|79372771|FG002|Overall Study|Adverse Event|0|||
44543303|NCT03183063|79556248|FG002|Overall Study|Withdrawal by Subject|0|||
44543304|NCT03183063|79556246|FG000|Overall Study|Physician Decision|3|||
44543305|NCT03183063|79556247|FG001|Overall Study|Physician Decision|4|||
44543306|NCT03183063|79556248|FG002|Overall Study|Physician Decision|4|||
44543307|NCT03182829|79556264|FG000|Overall Study|Protocol Violation|12|||
44543308|NCT03182829|79556265|FG001|Overall Study|Protocol Violation|12|||
44543309|NCT03182829|79556264|FG000|Overall Study|Other|4|||
44543310|NCT03182829|79556265|FG001|Overall Study|Other|3|||
44543311|NCT03278028|79556273|FG000|Overall Study|Lost to Follow-up|1|||
44543312|NCT03278028|79556274|FG001|Overall Study|Lost to Follow-up|0|||
44367426|NCT00832819|79372769|FG000|Overall Study|Protocol Violation|0|||
44367427|NCT00832819|79372770|FG001|Overall Study|Protocol Violation|0|||
44205990|NCT01965158|79002130|FG000|Overall Study|Other - Miscellaneous|3|||
44269519|NCT02335242|79193544|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
44367428|NCT00832819|79372771|FG002|Overall Study|Protocol Violation|1|||
44367429|NCT00853723|79372780|FG000|Overall Study|Adverse Event|3|||
44367430|NCT00853723|79372781|FG001|Overall Study|Adverse Event|4|||
44367431|NCT00853723|79372782|FG002|Overall Study|Adverse Event|1|||
44367432|NCT00853723|79372780|FG000|Overall Study|Withdrawal by Subject|2|||
44205991|NCT01965158|79002131|FG001|Overall Study|Other - Miscellaneous|0|||
44205992|NCT01964924|79002137|FG000|Trametinib Monotherapy|Progression|19|||
44205993|NCT01964924|79002138|FG001|Trametinib Monotherapy|Progression|0|||
44205994|NCT01964378|79002149|FG000|Overall Study|Disc. due to death before first dosing|0|||
44205995|NCT01964378|79002150|FG001|Overall Study|Disc. due to death before first dosing|1|||
44367433|NCT00853723|79372781|FG001|Overall Study|Withdrawal by Subject|1|||
44367434|NCT00853723|79372782|FG002|Overall Study|Withdrawal by Subject|0|||
44543313|NCT03278028|79556273|FG000|Overall Study|Withdrawal by Subject|3|||
44543314|NCT03278028|79556274|FG001|Overall Study|Withdrawal by Subject|1|||
44543315|NCT03278028|79556273|FG000|Overall Study|Pregnancy|0|||
44543316|NCT03278028|79556274|FG001|Overall Study|Pregnancy|1|||
44205996|NCT01964378|79002149|FG000|Overall Study|Disc. due to AE before first dosing|1|||
44205997|NCT01964378|79002150|FG001|Overall Study|Disc. due to AE before first dosing|0|||
44205998|NCT01964378|79002149|FG000|Overall Study|Death|3|||
44205999|NCT01964378|79002150|FG001|Overall Study|Death|2|||
44206000|NCT01964378|79002149|FG000|Overall Study|Adverse Event|12|||
44206001|NCT01964378|79002150|FG001|Overall Study|Adverse Event|5|||
44206002|NCT01964378|79002149|FG000|Overall Study|Lack of Efficacy|0|||
44206003|NCT01964378|79002150|FG001|Overall Study|Lack of Efficacy|1|||
44206004|NCT01964378|79002149|FG000|Overall Study|Protocol Violation|0|||
44206005|NCT01964378|79002150|FG001|Overall Study|Protocol Violation|1|||
44206006|NCT01964378|79002149|FG000|Overall Study|Lost to Follow-up|0|||
44206007|NCT01964378|79002150|FG001|Overall Study|Lost to Follow-up|1|||
44206008|NCT01964378|79002149|FG000|Overall Study|Withdrawal by Subject|7|||
44206009|NCT01964378|79002150|FG001|Overall Study|Withdrawal by Subject|5|||
44206010|NCT01964378|79002149|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
44206011|NCT01964378|79002150|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
44206012|NCT01964378|79002149|FG000|Overall Study|Other|1|||
44206013|NCT01964378|79002150|FG001|Overall Study|Other|2|||
44206014|NCT01442038|79002158|FG000|Overall Study|Death|35|||
44206015|NCT01442038|79002159|FG001|Overall Study|Death|29|||
44206016|NCT01442038|79002158|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
44206017|NCT01442038|79002159|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
44206018|NCT01442038|79002158|FG000|Overall Study|Participant Withdrew Consent|137|||
44206019|NCT01442038|79002159|FG001|Overall Study|Participant Withdrew Consent|102|||
44206020|NCT01442038|79002158|FG000|Overall Study|Lost to Follow-up|37|||
44206021|NCT01442038|79002159|FG001|Overall Study|Lost to Follow-up|51|||
44206022|NCT01442038|79002158|FG000|Overall Study|Adverse Event|26|||
44206023|NCT01442038|79002159|FG001|Overall Study|Adverse Event|15|||
44206024|NCT01442038|79002158|FG000|Overall Study|Protocol Deviation|9|||
44206025|NCT01442038|79002159|FG001|Overall Study|Protocol Deviation|20|||
44206026|NCT01442038|79002158|FG000|Overall Study|Investigator's Discretion|13|||
44206027|NCT01442038|79002159|FG001|Overall Study|Investigator's Discretion|16|||
44206028|NCT01442038|79002158|FG000|Overall Study|Study Terminated By Sponsor|2|||
44206029|NCT01442038|79002159|FG001|Overall Study|Study Terminated By Sponsor|3|||
44269520|NCT02335242|79193543|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
44269521|NCT02335242|79193544|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44269522|NCT02335242|79193543|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
44269523|NCT02335242|79193544|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
44269524|NCT02334384|79193556|FG000|Overall Study|Lost to Follow-up|1|||
44269525|NCT02334384|79193557|FG001|Overall Study|Lost to Follow-up|1|||
44269526|NCT02334306|79193565|FG000|Double-blind Period|Adverse Event|0|||
44269527|NCT02334306|79193566|FG001|Double-blind Period|Adverse Event|1|||
44269528|NCT02334306|79193565|FG000|Double-blind Period|Withdrawal by Subject|1|||
44269529|NCT02334306|79193566|FG001|Double-blind Period|Withdrawal by Subject|1|||
44269530|NCT02305758|79193575|FG000|Overall Study|Death|27|||
44269531|NCT02305758|79193576|FG001|Overall Study|Death|27|||
44269532|NCT02305758|79193575|FG000|Overall Study|Withdrew consent|9|||
44206030|NCT01998919|79002167|FG000|Overall Study|Death|2|||
44206031|NCT01998919|79002168|FG001|Overall Study|Death|2|||
44206032|NCT01998919|79002167|FG000|Overall Study|Adverse Event|0|||
44206033|NCT01998919|79002168|FG001|Overall Study|Adverse Event|5|||
44206034|NCT01998919|79002167|FG000|Overall Study|Disease progression|31|||
44206035|NCT01998919|79002168|FG001|Overall Study|Disease progression|22|||
44269533|NCT02305758|79193576|FG001|Overall Study|Withdrew consent|2|||
44269534|NCT02305758|79193575|FG000|Overall Study|Lost to Follow-up|6|||
44269535|NCT02305758|79193576|FG001|Overall Study|Lost to Follow-up|1|||
44269536|NCT02305758|79193575|FG000|Overall Study|Study Terminated by Sponsor|21|||
44206036|NCT01998919|79002167|FG000|Overall Study|Withdrawal by Subject|2|||
44206037|NCT01998919|79002168|FG001|Overall Study|Withdrawal by Subject|4|||
44206038|NCT01998919|79002167|FG000|Overall Study|Lost to Follow-up|2|||
44206039|NCT01998919|79002168|FG001|Overall Study|Lost to Follow-up|0|||
44206040|NCT01998919|79002167|FG000|Overall Study|Other|5|||
44206041|NCT01998919|79002168|FG001|Overall Study|Other|2|||
44206042|NCT01957111|79002176|FG000|Overall Study|Withdrawal by Subject|1|||
44269537|NCT02305758|79193576|FG001|Overall Study|Study Terminated by Sponsor|34|||
44269538|NCT02305758|79193575|FG000|Overall Study|Other, not specified|2|||
44206043|NCT01957111|79002177|FG001|Overall Study|Withdrawal by Subject|1|||
44206044|NCT01964300|79002185|FG000|Overall Study|Ineligible after enrollment|0|||
44206045|NCT01964300|79002186|FG001|Overall Study|Ineligible after enrollment|1|||
44206046|NCT01964300|79002185|FG000|Overall Study|Adverse Event|1|||
44206047|NCT01964300|79002186|FG001|Overall Study|Adverse Event|1|||
44206048|NCT01964300|79002185|FG000|Overall Study|Lack of Efficacy|3|||
44206049|NCT01964300|79002186|FG001|Overall Study|Lack of Efficacy|5|||
44206050|NCT01964300|79002185|FG000|Overall Study|Withdrawal by Subject|0|||
44206051|NCT01964300|79002186|FG001|Overall Study|Withdrawal by Subject|1|||
44206052|NCT01964300|79002185|FG000|Overall Study|To receive alternative therapy|1|||
44206053|NCT01964300|79002186|FG001|Overall Study|To receive alternative therapy|2|||
44206054|NCT01964300|79002185|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
44206055|NCT01964300|79002186|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
44206056|NCT01964300|79002185|FG000|Overall Study|Weight criteria not met|0|||
44206057|NCT01964300|79002186|FG001|Overall Study|Weight criteria not met|1|||
44206058|NCT01964222|79002194|FG000|Overall Study|Lost to Follow-up|7|||
44206059|NCT01964222|79002195|FG001|Overall Study|Lost to Follow-up|5|||
44206060|NCT01964222|79002194|FG000|Overall Study|Withdrawal by Subject|6|||
44206061|NCT01964222|79002195|FG001|Overall Study|Withdrawal by Subject|6|||
44206062|NCT01964222|79002194|FG000|Overall Study|Screening Failure|2|||
44206063|NCT01964222|79002195|FG001|Overall Study|Screening Failure|0|||
44206064|NCT01467700|79002205|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
44206065|NCT01467700|79002206|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
44206066|NCT01467700|79002207|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
44206067|NCT01467700|79002208|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
44206068|NCT01467700|79002205|FG000|Overall Study|Major Protocol Deviation|3|||
44206069|NCT01467700|79002206|FG001|Overall Study|Major Protocol Deviation|3|||
44206070|NCT01467700|79002207|FG002|Overall Study|Major Protocol Deviation|2|||
44206071|NCT01467700|79002208|FG003|Overall Study|Major Protocol Deviation|3|||
44206072|NCT01467700|79002205|FG000|Overall Study|Lost to Follow-up|6|||
44269539|NCT02305758|79193576|FG001|Overall Study|Other, not specified|1|||
44269540|NCT02305446|79193582|FG000|Overall Study|Adverse Event|1|||
44269541|NCT02303574|79193719|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269542|NCT02303574|79193720|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269543|NCT02303574|79193721|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
44269544|NCT02303574|79193722|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269545|NCT02303574|79193723|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269546|NCT02303574|79193724|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269547|NCT02303574|79193725|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269548|NCT02303574|79193726|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44206073|NCT01467700|79002206|FG001|Overall Study|Lost to Follow-up|5|||
44206074|NCT01467700|79002207|FG002|Overall Study|Lost to Follow-up|2|||
44206075|NCT01467700|79002208|FG003|Overall Study|Lost to Follow-up|3|||
44206076|NCT01467700|79002205|FG000|Overall Study|Voluntary Withdrawal|5|||
44206077|NCT01467700|79002206|FG001|Overall Study|Voluntary Withdrawal|7|||
44367435|NCT00853723|79372780|FG000|Overall Study|Protocol Violation|1|||
44367436|NCT00853723|79372781|FG001|Overall Study|Protocol Violation|2|||
44367437|NCT00853723|79372782|FG002|Overall Study|Protocol Violation|1|||
44367438|NCT01104545|79372796|FG000|Overall Study|Adverse Event|0|||
44367439|NCT01104545|79372797|FG001|Overall Study|Adverse Event|1|||
44367440|NCT01104545|79372798|FG002|Overall Study|Adverse Event|2|||
44367441|NCT00918255|79372846|FG000|Overall Study|Adverse Event|1|||
44367442|NCT00918255|79372847|FG001|Overall Study|Adverse Event|0|||
44367443|NCT00918255|79372848|FG002|Overall Study|Adverse Event|0|||
44367444|NCT00918255|79372846|FG000|Overall Study|Withdrawal by Subject|1|||
44367445|NCT00918255|79372847|FG001|Overall Study|Withdrawal by Subject|0|||
44367446|NCT00918255|79372848|FG002|Overall Study|Withdrawal by Subject|2|||
44367447|NCT00918255|79372846|FG000|Overall Study|Lack of Efficacy|1|||
44367448|NCT00918255|79372847|FG001|Overall Study|Lack of Efficacy|0|||
44367449|NCT00918255|79372848|FG002|Overall Study|Lack of Efficacy|0|||
44367450|NCT00918255|79372846|FG000|Overall Study|Lost to Follow-up|1|||
44367451|NCT00918255|79372847|FG001|Overall Study|Lost to Follow-up|0|||
44367452|NCT00918255|79372848|FG002|Overall Study|Lost to Follow-up|2|||
44367453|NCT00918255|79372846|FG000|Overall Study|Exceeded allowed number of interventions|0|||
44543317|NCT03181503|79556282|FG000|Overall Study|Adverse Event|2|||
44543318|NCT03181503|79556283|FG001|Overall Study|Adverse Event|2|||
44206078|NCT01467700|79002207|FG002|Overall Study|Voluntary Withdrawal|6|||
44206079|NCT01467700|79002208|FG003|Overall Study|Voluntary Withdrawal|2|||
44206080|NCT01467700|79002205|FG000|Overall Study|Study Termination|6|||
44206081|NCT01467700|79002206|FG001|Overall Study|Study Termination|5|||
44269549|NCT02303574|79193727|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44269550|NCT02303574|79193728|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
44367454|NCT00918255|79372847|FG001|Overall Study|Exceeded allowed number of interventions|0|||
44367455|NCT00918255|79372848|FG002|Overall Study|Exceeded allowed number of interventions|1|||
44367456|NCT00918255|79372846|FG000|Overall Study|Non-compliance|1|||
44206082|NCT01467700|79002207|FG002|Overall Study|Study Termination|10|||
44206083|NCT01467700|79002208|FG003|Overall Study|Study Termination|7|||
44206084|NCT01467700|79002205|FG000|Overall Study|Pregnancy|0|||
44206085|NCT01467700|79002206|FG001|Overall Study|Pregnancy|1|||
44206086|NCT01467700|79002207|FG002|Overall Study|Pregnancy|1|||
44367457|NCT00918255|79372847|FG001|Overall Study|Non-compliance|0|||
44367458|NCT00918255|79372848|FG002|Overall Study|Non-compliance|0|||
44367459|NCT00918255|79372846|FG000|Overall Study|Investigator discretion|1|||
44367460|NCT00918255|79372847|FG001|Overall Study|Investigator discretion|0|||
44367461|NCT00918255|79372848|FG002|Overall Study|Investigator discretion|0|||
44367462|NCT01096589|79372860|FG000|Overall Study|Adverse Event|2|||
44367463|NCT01096589|79372861|FG001|Overall Study|Adverse Event|1|||
44367464|NCT01096589|79372862|FG002|Overall Study|Adverse Event|2|||
44206087|NCT01467700|79002208|FG003|Overall Study|Pregnancy|0|||
44206088|NCT01467700|79002205|FG000|Overall Study|Lack of Efficacy|2|||
44206089|NCT01467700|79002206|FG001|Overall Study|Lack of Efficacy|0|||
44206090|NCT01467700|79002207|FG002|Overall Study|Lack of Efficacy|2|||
44206091|NCT01467700|79002208|FG003|Overall Study|Lack of Efficacy|1|||
44206092|NCT01467700|79002205|FG000|Overall Study|Reason not Specified|1|||
44206093|NCT01467700|79002206|FG001|Overall Study|Reason not Specified|3|||
44206094|NCT01467700|79002207|FG002|Overall Study|Reason not Specified|2|||
44206095|NCT01467700|79002208|FG003|Overall Study|Reason not Specified|8|||
44206096|NCT01972724|79002221|FG000|Double-Blind|Rescue Criteria Met|1|||
44206097|NCT01972724|79002222|FG001|Double-Blind|Rescue Criteria Met|0|||
44206098|NCT01972724|79002223|FG002|Double-Blind|Rescue Criteria Met|0|||
44206099|NCT01972724|79002221|FG000|Double-Blind|Adverse Event|1|||
44206100|NCT01972724|79002222|FG001|Double-Blind|Adverse Event|0|||
44206101|NCT01972724|79002223|FG002|Double-Blind|Adverse Event|0|||
44206102|NCT01972724|79002221|FG000|Double-Blind|Withdrawal of Consent|2|||
44206103|NCT01972724|79002222|FG001|Double-Blind|Withdrawal of Consent|1|||
44206104|NCT01972724|79002223|FG002|Double-Blind|Withdrawal of Consent|0|||
44206105|NCT01972724|79002221|FG000|Double-Blind|Significant Protocol Deviation|5|||
44206106|NCT01972724|79002222|FG001|Double-Blind|Significant Protocol Deviation|8|||
44206107|NCT01972724|79002223|FG002|Double-Blind|Significant Protocol Deviation|0|||
44206108|NCT01972724|79002221|FG000|Open-Label|Withdrew Consent|0|||
44206109|NCT01972724|79002222|FG001|Open-Label|Withdrew Consent|0|||
44206110|NCT01972724|79002223|FG002|Open-Label|Withdrew Consent|3|||
44206111|NCT01972724|79002221|FG000|Open-Label|Significant Protocol Deviation|0|||
44367465|NCT01096589|79372863|FG003|Overall Study|Adverse Event|1|||
44367466|NCT01096589|79372860|FG000|Overall Study|Withdrawal by Subject|2|||
44367467|NCT01096589|79372861|FG001|Overall Study|Withdrawal by Subject|1|||
44367468|NCT01096589|79372862|FG002|Overall Study|Withdrawal by Subject|1|||
44367469|NCT01096589|79372863|FG003|Overall Study|Withdrawal by Subject|1|||
44367470|NCT01096589|79372860|FG000|Overall Study|Compliance with protocol|0|||
44367471|NCT01096589|79372861|FG001|Overall Study|Compliance with protocol|0|||
44367472|NCT01096589|79372862|FG002|Overall Study|Compliance with protocol|1|||
44367473|NCT01096589|79372863|FG003|Overall Study|Compliance with protocol|0|||
44367474|NCT01096589|79372860|FG000|Overall Study|found treatment exhausting|0|||
44367475|NCT01096589|79372861|FG001|Overall Study|found treatment exhausting|0|||
44367476|NCT01096589|79372862|FG002|Overall Study|found treatment exhausting|0|||
44367477|NCT01096589|79372863|FG003|Overall Study|found treatment exhausting|1|||
44367478|NCT00845065|79372879|FG000|Overall Study|Adverse Event|3|||
44367479|NCT00845065|79372880|FG001|Overall Study|Adverse Event|23|||
44367480|NCT00845065|79372879|FG000|Overall Study|Lack of Efficacy|43|||
44367481|NCT00845065|79372880|FG001|Overall Study|Lack of Efficacy|21|||
44367482|NCT00845065|79372879|FG000|Overall Study|Non-Medical Reasons|1|||
44367483|NCT00845065|79372880|FG001|Overall Study|Non-Medical Reasons|11|||
44367484|NCT00832585|79372886|FG000|Overall Study|Withdrawal by Subject|1|||
44367485|NCT00832585|79372886|FG000|Overall Study|Lost to Follow-up|1|||
44367486|NCT00918567|79372892|FG000|Overall Study|Lack of Efficacy|3|||
44367487|NCT00918567|79372893|FG001|Overall Study|Lack of Efficacy|1|||
44367488|NCT00918567|79372892|FG000|Overall Study|Withdrawal by Subject|1|||
44367489|NCT00918567|79372893|FG001|Overall Study|Withdrawal by Subject|1|||
44367490|NCT00918567|79372892|FG000|Overall Study|Adverse Event|1|||
44367491|NCT00918567|79372893|FG001|Overall Study|Adverse Event|0|||
44367492|NCT01024920|79372901|FG000|Overall Study|Progressive disease|47|||
44367493|NCT01024920|79372902|FG001|Overall Study|Progressive disease|25|||
44367494|NCT01024920|79372901|FG000|Overall Study|Adverse Event|8|||
44206112|NCT01972724|79002222|FG001|Open-Label|Significant Protocol Deviation|0|||
44206113|NCT01972724|79002223|FG002|Open-Label|Significant Protocol Deviation|2|||
44206114|NCT01441960|79002231|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
44206115|NCT01441960|79002232|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
44367495|NCT01024920|79372902|FG001|Overall Study|Adverse Event|4|||
44367496|NCT01024920|79372901|FG000|Overall Study|Lost to Follow-up|0|||
44367497|NCT01024920|79372902|FG001|Overall Study|Lost to Follow-up|1|||
44367498|NCT01024920|79372901|FG000|Overall Study|Patient refusal to continue|4|||
44367499|NCT01024920|79372902|FG001|Overall Study|Patient refusal to continue|0|||
44206116|NCT01441960|79002231|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
44206117|NCT01441960|79002232|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
44206118|NCT01441960|79002231|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
44367500|NCT01024920|79372901|FG000|Overall Study|Other than listed|5|||
44367501|NCT01024920|79372902|FG001|Overall Study|Other than listed|1|||
44367502|NCT01024920|79372901|FG000|Overall Study|Not treated|3|||
44367503|NCT01024920|79372902|FG001|Overall Study|Not treated|0|||
44367504|NCT01024920|79372901|FG000|Overall Study|Protocol Violation|0|||
44367505|NCT01024920|79372902|FG001|Overall Study|Protocol Violation|1|||
44367506|NCT00832117|79372910|FG000|Overall Study|Death|1|||
44367507|NCT00832117|79372910|FG000|Overall Study|Disease Progression|11|||
44367508|NCT01104311|79372919|FG000|Overall Study|Withdrawal by Subject|6|||
44543319|NCT03181503|79556282|FG000|Overall Study|Protocol Violation|1|||
44543320|NCT03181503|79556283|FG001|Overall Study|Protocol Violation|0|||
44543321|NCT03181503|79556282|FG000|Overall Study|Withdrawal by Subject|3|||
44543322|NCT03181503|79556283|FG001|Overall Study|Withdrawal by Subject|0|||
44543323|NCT03181503|79556282|FG000|Overall Study|Lost to Follow-up|1|||
44543324|NCT03181503|79556283|FG001|Overall Study|Lost to Follow-up|1|||
44543325|NCT03277794|79556294|FG000|Overall Study|Lost to Follow-up|2|||
44206119|NCT01441960|79002232|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
44206120|NCT01955707|79002244|FG000|Overall Study|Adverse Event|1|||
44206121|NCT01955707|79002245|FG001|Overall Study|Adverse Event|2|||
44206122|NCT01955707|79002244|FG000|Overall Study|Lost to Follow-up|2|||
44206123|NCT01955707|79002245|FG001|Overall Study|Lost to Follow-up|1|||
44206124|NCT01955707|79002244|FG000|Overall Study|Withdrawal by Subject|0|||
44206125|NCT01955707|79002245|FG001|Overall Study|Withdrawal by Subject|3|||
44206126|NCT01955707|79002244|FG000|Overall Study|Death|13|||
44206127|NCT01955707|79002245|FG001|Overall Study|Death|14|||
44206128|NCT01955707|79002244|FG000|Overall Study|Other|4|||
44206129|NCT01955707|79002245|FG001|Overall Study|Other|2|||
44367509|NCT01104311|79372920|FG001|Overall Study|Withdrawal by Subject|6|||
44367510|NCT01104311|79372919|FG000|Overall Study|Protocol Violation|0|||
44367511|NCT01104311|79372920|FG001|Overall Study|Protocol Violation|1|||
44367512|NCT01104311|79372919|FG000|Overall Study|Physician Decision|2|||
44367513|NCT01104311|79372920|FG001|Overall Study|Physician Decision|2|||
44367514|NCT01104311|79372919|FG000|Overall Study|low compliance|1|||
44367515|NCT01104311|79372920|FG001|Overall Study|low compliance|1|||
44367516|NCT01104311|79372919|FG000|Overall Study|Adverse Event|1|||
44367517|NCT01104311|79372920|FG001|Overall Study|Adverse Event|2|||
44367518|NCT00831493|79372930|FG000|Overall Study|Intractable nausea and vomiting|1|||
44367519|NCT00853567|79372937|FG000|Overall Study|Study prematurely terminated|71|||
44367520|NCT00853489|79372947|FG000|Overall Study|Lost to Follow-up|5|||
44367521|NCT00853489|79372948|FG001|Overall Study|Lost to Follow-up|2|||
44367522|NCT01019694|79372957|FG000|Overall Study|Adverse Event|12|||
44367523|NCT01019694|79372958|FG001|Overall Study|Adverse Event|16|||
44367524|NCT01019694|79372959|FG002|Overall Study|Adverse Event|19|||
44367525|NCT01019694|79372957|FG000|Overall Study|Protocol Violation|2|||
44367526|NCT01019694|79372958|FG001|Overall Study|Protocol Violation|6|||
44367527|NCT01019694|79372959|FG002|Overall Study|Protocol Violation|4|||
44367528|NCT01019694|79372957|FG000|Overall Study|Lost to Follow-up|5|||
44367529|NCT01019694|79372958|FG001|Overall Study|Lost to Follow-up|3|||
44367530|NCT01019694|79372959|FG002|Overall Study|Lost to Follow-up|3|||
44367531|NCT01019694|79372957|FG000|Overall Study|Withdrawal by Subject|4|||
44367532|NCT01019694|79372958|FG001|Overall Study|Withdrawal by Subject|6|||
44367533|NCT01019694|79372959|FG002|Overall Study|Withdrawal by Subject|12|||
44367534|NCT01019694|79372957|FG000|Overall Study|Not treated|0|||
44367535|NCT01019694|79372958|FG001|Overall Study|Not treated|2|||
44367536|NCT01019694|79372959|FG002|Overall Study|Not treated|3|||
44367537|NCT01019694|79372957|FG000|Overall Study|Other reason (not specified)|1|||
44367538|NCT01019694|79372958|FG001|Overall Study|Other reason (not specified)|5|||
44367539|NCT01019694|79372959|FG002|Overall Study|Other reason (not specified)|6|||
44367540|NCT00831415|79372967|FG000|Overall Study|Adverse Event|14|||
44367541|NCT00831415|79372967|FG000|Overall Study|Failed to return|3|||
44367542|NCT00831415|79372967|FG000|Overall Study|Physician Decision|6|||
44367543|NCT00831415|79372967|FG000|Overall Study|Lost to Follow-up|9|||
44367544|NCT00831415|79372967|FG000|Overall Study|Protocol Violation|3|||
44367545|NCT00831415|79372967|FG000|Overall Study|Withdrawal by Subject|35|||
44367546|NCT00831415|79372967|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
44367547|NCT00831415|79372967|FG000|Overall Study|Death|1|||
44367548|NCT01095653|79372974|FG000|Overall Study|Lack of Efficacy|3|||
44367549|NCT01095653|79372975|FG001|Overall Study|Lack of Efficacy|0|||
44367550|NCT01095653|79372976|FG002|Overall Study|Lack of Efficacy|0|||
44206130|NCT01435798|79002251|FG000|Overall Study|Withdrawal by Subject|1|||
44367551|NCT01095653|79372974|FG000|Overall Study|Adverse Event|1|||
44367552|NCT01095653|79372975|FG001|Overall Study|Adverse Event|4|||
44367553|NCT01095653|79372976|FG002|Overall Study|Adverse Event|4|||
44367554|NCT01095653|79372974|FG000|Overall Study|Lost to Follow-up|1|||
44367555|NCT01095653|79372975|FG001|Overall Study|Lost to Follow-up|0|||
44367556|NCT01095653|79372976|FG002|Overall Study|Lost to Follow-up|4|||
44206131|NCT01972568|79002264|FG000|Overall Study|Other events|3|||
44206132|NCT01972568|79002265|FG001|Overall Study|Other events|0|||
44206133|NCT01972568|79002266|FG002|Overall Study|Other events|0|||
44367557|NCT01095653|79372974|FG000|Overall Study|Withdrawal by Subject|4|||
44367558|NCT01095653|79372975|FG001|Overall Study|Withdrawal by Subject|5|||
44543326|NCT03277794|79556295|FG001|Overall Study|Lost to Follow-up|4|||
44367559|NCT01095653|79372976|FG002|Overall Study|Withdrawal by Subject|3|||
44367560|NCT01095653|79372974|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
44367561|NCT01095653|79372975|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
44367562|NCT01095653|79372976|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
44206134|NCT01972568|79002264|FG000|Overall Study|Lack of Efficacy|0|||
44206135|NCT01972568|79002265|FG001|Overall Study|Lack of Efficacy|1|||
44206136|NCT01972568|79002266|FG002|Overall Study|Lack of Efficacy|2|||
44206137|NCT01972568|79002264|FG000|Overall Study|Protocol Violation|1|||
44206138|NCT01972568|79002265|FG001|Overall Study|Protocol Violation|2|||
44206139|NCT01972568|79002266|FG002|Overall Study|Protocol Violation|2|||
44206140|NCT01972568|79002264|FG000|Overall Study|Withdrawal by Subject|6|||
44206141|NCT01972568|79002265|FG001|Overall Study|Withdrawal by Subject|3|||
44206142|NCT01972568|79002266|FG002|Overall Study|Withdrawal by Subject|7|||
44206143|NCT01972568|79002264|FG000|Overall Study|Lost to Follow-up|1|||
44206144|NCT01972568|79002265|FG001|Overall Study|Lost to Follow-up|0|||
44206145|NCT01972568|79002266|FG002|Overall Study|Lost to Follow-up|0|||
44206146|NCT01972568|79002264|FG000|Overall Study|Adverse Event|5|||
44206147|NCT01972568|79002265|FG001|Overall Study|Adverse Event|6|||
44206148|NCT01972568|79002266|FG002|Overall Study|Adverse Event|5|||
44206149|NCT01955161|79002277|FG000|Overall Study|Withdrawal before treatment|2|||
44206150|NCT01955161|79002278|FG001|Overall Study|Withdrawal before treatment|0|||
44206151|NCT01955161|79002279|FG002|Overall Study|Withdrawal before treatment|1|||
44206152|NCT01955161|79002277|FG000|Overall Study|Adverse Event|10|||
44206153|NCT01955161|79002278|FG001|Overall Study|Adverse Event|14|||
44206154|NCT01955161|79002279|FG002|Overall Study|Adverse Event|15|||
44206155|NCT01955161|79002277|FG000|Overall Study|Death|1|||
44206156|NCT01955161|79002278|FG001|Overall Study|Death|1|||
44206157|NCT01955161|79002279|FG002|Overall Study|Death|3|||
44206158|NCT01955161|79002277|FG000|Overall Study|Withdrawal by Subject|9|||
44206159|NCT01955161|79002278|FG001|Overall Study|Withdrawal by Subject|8|||
44206160|NCT01955161|79002279|FG002|Overall Study|Withdrawal by Subject|12|||
44206161|NCT01955161|79002277|FG000|Overall Study|Protocol Violation|2|||
44367563|NCT00920907|79372986|FG000|Induction Period|Adverse Event|0|||
44367564|NCT00920907|79372987|FG001|Induction Period|Adverse Event|2|||
44367565|NCT00920907|79372986|FG000|Induction Period|Death|1|||
44367566|NCT00920907|79372987|FG001|Induction Period|Death|1|||
44367567|NCT00920907|79372986|FG000|Induction Period|Disease Progression|12|||
44367568|NCT00920907|79372987|FG001|Induction Period|Disease Progression|11|||
44367569|NCT00920907|79372986|FG000|Induction Period|Study Drug Toxicity|8|||
44367570|NCT00920907|79372987|FG001|Induction Period|Study Drug Toxicity|6|||
44367571|NCT00920907|79372986|FG000|Induction Period|No longer meets study criteria|0|||
44367572|NCT00920907|79372987|FG001|Induction Period|No longer meets study criteria|1|||
44367573|NCT00920907|79372986|FG000|Induction Period|Withdrawal by Subject|1|||
44367574|NCT00920907|79372987|FG001|Induction Period|Withdrawal by Subject|1|||
44367575|NCT00920907|79372986|FG000|Maintenance Period|Disease Progression|3|||
44367576|NCT00920907|79372987|FG001|Maintenance Period|Disease Progression|7|||
44367577|NCT00920907|79372986|FG000|Maintenance Period|Administrative (study closure)|7|||
44367578|NCT00920907|79372987|FG001|Maintenance Period|Administrative (study closure)|2|||
44367579|NCT00920907|79372986|FG000|Maintenance Period|Study Drug Toxicity|0|||
44367580|NCT00920907|79372987|FG001|Maintenance Period|Study Drug Toxicity|2|||
44367581|NCT00920907|79372986|FG000|Maintenance Period|Death|1|||
44367582|NCT00920907|79372987|FG001|Maintenance Period|Death|1|||
44367583|NCT00920907|79372986|FG000|Maintenance Period|Withdrawal by Subject|1|||
44367584|NCT00920907|79372987|FG001|Maintenance Period|Withdrawal by Subject|0|||
44367585|NCT00920907|79372986|FG000|Maintenance Period|Adverse Event|0|||
44367586|NCT00920907|79372987|FG001|Maintenance Period|Adverse Event|1|||
44367587|NCT01103141|79372997|FG000|Overall Study|Death|0|||
44367588|NCT01103141|79372998|FG001|Overall Study|Death|1|||
44367589|NCT01103141|79372997|FG000|Overall Study|Lost to Follow-up|2|||
44206162|NCT01955161|79002278|FG001|Overall Study|Protocol Violation|0|||
44206163|NCT01955161|79002279|FG002|Overall Study|Protocol Violation|0|||
44206164|NCT01955161|79002277|FG000|Overall Study|Other reason: physician decision|0|||
44367590|NCT01103141|79372998|FG001|Overall Study|Lost to Follow-up|1|||
44367591|NCT00844831|79373004|FG000|Overall Study|Withdrawal by Subject|4|||
44367592|NCT00844831|79373004|FG000|Overall Study|Adverse Event|1|||
44367593|NCT00844831|79373004|FG000|Overall Study|Physician Decision|1|||
44367594|NCT00920829|79373016|FG000|Allocation|No post randomization data|3|||
44367595|NCT00920829|79373017|FG001|Allocation|No post randomization data|1|||
44367596|NCT00920829|79373018|FG002|Allocation|No post randomization data|0|||
44367597|NCT00920829|79373019|FG003|Allocation|No post randomization data|2|||
44206165|NCT01955161|79002278|FG001|Overall Study|Other reason: physician decision|1|||
44206166|NCT01955161|79002279|FG002|Overall Study|Other reason: physician decision|1|||
44206167|NCT01955161|79002277|FG000|Overall Study|Other reason: disallowed medication|1|||
44206168|NCT01955161|79002278|FG001|Overall Study|Other reason: disallowed medication|0|||
44206169|NCT01955161|79002279|FG002|Overall Study|Other reason: disallowed medication|1|||
44206170|NCT01955161|79002277|FG000|Overall Study|Other reason: caregiver unavailable|1|||
44206171|NCT01955161|79002278|FG001|Overall Study|Other reason: caregiver unavailable|0|||
44367598|NCT00920829|79373016|FG000|Available for Analysis|Withdrawal by Subject|6|||
44367599|NCT00920829|79373017|FG001|Available for Analysis|Withdrawal by Subject|6|||
44367600|NCT00920829|79373018|FG002|Available for Analysis|Withdrawal by Subject|6|||
44367601|NCT00920829|79373019|FG003|Available for Analysis|Withdrawal by Subject|10|||
44367602|NCT00920829|79373016|FG000|Available for Analysis|Required Medical Treatment|0|||
44367603|NCT00920829|79373017|FG001|Available for Analysis|Required Medical Treatment|1|||
44367604|NCT00920829|79373018|FG002|Available for Analysis|Required Medical Treatment|2|||
44367605|NCT00920829|79373019|FG003|Available for Analysis|Required Medical Treatment|0|||
44367606|NCT00920829|79373016|FG000|Available for Analysis|Adverse Event|1|||
44367607|NCT00920829|79373017|FG001|Available for Analysis|Adverse Event|2|||
44367608|NCT00920829|79373018|FG002|Available for Analysis|Adverse Event|1|||
44367609|NCT00920829|79373019|FG003|Available for Analysis|Adverse Event|0|||
44367610|NCT00920829|79373016|FG000|Available for Analysis|Death|1|||
44367611|NCT00920829|79373017|FG001|Available for Analysis|Death|0|||
44367612|NCT00920829|79373018|FG002|Available for Analysis|Death|0|||
44367613|NCT00920829|79373019|FG003|Available for Analysis|Death|0|||
44367614|NCT00920829|79373016|FG000|Available for Analysis|Protocol Violation|0|||
44367615|NCT00920829|79373017|FG001|Available for Analysis|Protocol Violation|0|||
44367616|NCT00920829|79373018|FG002|Available for Analysis|Protocol Violation|1|||
44367617|NCT00920829|79373019|FG003|Available for Analysis|Protocol Violation|0|||
44367618|NCT00920829|79373016|FG000|Available for Analysis|Required more treatment|0|||
44367619|NCT00920829|79373017|FG001|Available for Analysis|Required more treatment|2|||
44367620|NCT00920829|79373018|FG002|Available for Analysis|Required more treatment|0|||
44367621|NCT00920829|79373019|FG003|Available for Analysis|Required more treatment|1|||
44367622|NCT00831181|79373029|FG000|Overall Study|Adverse Event|12|||
44367623|NCT01023672|79373034|FG000|Overall Study|Worsening disease|2|||
44367624|NCT01023672|79373034|FG000|Overall Study|Death|1|||
44367625|NCT01094171|79373038|FG000|Overall Study|Lost to Follow-up|2|||
44367626|NCT01094171|79373038|FG000|Overall Study|Informed consent withdrawal|4|||
44367627|NCT01094171|79373038|FG000|Overall Study|Migration from the study area|3|||
44367628|NCT01094171|79373038|FG000|Overall Study|Other|1|||
44367629|NCT01093625|79373044|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
44367630|NCT01093625|79373045|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
44367631|NCT01093625|79373044|FG000|2-Week Visit|Withdrawal by Subject|1|||
44367632|NCT01093625|79373045|FG001|2-Week Visit|Withdrawal by Subject|0|||
44367633|NCT01093625|79373044|FG000|1-Month Visit|Lost to Follow-up|2|||
44367634|NCT01093625|79373045|FG001|1-Month Visit|Lost to Follow-up|0|||
44367635|NCT01093625|79373044|FG000|3-Month Visit|Lost to Follow-up|2|||
44367636|NCT01093625|79373045|FG001|3-Month Visit|Lost to Follow-up|0|||
44367637|NCT01093625|79373044|FG000|6-Month Visit|Withdrawal by Subject|6|||
44367638|NCT01093625|79373045|FG001|6-Month Visit|Withdrawal by Subject|7|||
44367639|NCT01093625|79373044|FG000|6-Month Visit|Lost to Follow-up|2|||
44367640|NCT01093625|79373045|FG001|6-Month Visit|Lost to Follow-up|2|||
44367641|NCT01093625|79373044|FG000|1-Year Visit|Lost to Follow-up|5|||
44367642|NCT01093625|79373045|FG001|1-Year Visit|Lost to Follow-up|3|||
44367643|NCT01023516|79373053|FG000|Overall Study|Voluntary discontinuation|7|||
44367644|NCT01023516|79373054|FG001|Overall Study|Voluntary discontinuation|5|||
44367645|NCT01023516|79373053|FG000|Overall Study|Adverse Event|9|||
44367646|NCT01023516|79373054|FG001|Overall Study|Adverse Event|6|||
44367647|NCT01023516|79373053|FG000|Overall Study|Safety reason|0|||
44206172|NCT01955161|79002279|FG002|Overall Study|Other reason: caregiver unavailable|0|||
44206173|NCT01955161|79002277|FG000|Overall Study|Other reason: moved to nursing home|0|||
44206174|NCT01955161|79002278|FG001|Overall Study|Other reason: moved to nursing home|1|||
44206175|NCT01955161|79002279|FG002|Overall Study|Other reason: moved to nursing home|0|||
44206176|NCT01955161|79002277|FG000|Overall Study|Other reason: insufficient compliance|0|||
44206177|NCT01955161|79002278|FG001|Overall Study|Other reason: insufficient compliance|0|||
44206178|NCT01955161|79002279|FG002|Overall Study|Other reason: insufficient compliance|1|||
44206179|NCT01955161|79002277|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
44206180|NCT01955161|79002278|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
44206181|NCT01955161|79002279|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
44367648|NCT01023516|79373054|FG001|Overall Study|Safety reason|3|||
44367649|NCT01023516|79373053|FG000|Overall Study|Study-specific criteria|4|||
44367650|NCT01023516|79373054|FG001|Overall Study|Study-specific criteria|2|||
44367651|NCT01023516|79373053|FG000|Overall Study|Incorrect enrolment|4|||
44367652|NCT01023516|79373054|FG001|Overall Study|Incorrect enrolment|2|||
44367653|NCT00844753|79373064|FG000|Overall Study|Lack of Efficacy|1|||
44367654|NCT00844753|79373065|FG001|Overall Study|Lack of Efficacy|0|||
44367655|NCT00844753|79373066|FG002|Overall Study|Lack of Efficacy|2|||
44367656|NCT00844753|79373067|FG003|Overall Study|Lack of Efficacy|2|||
44367657|NCT00844753|79373064|FG000|Overall Study|Adverse Event|3|||
44367658|NCT00844753|79373065|FG001|Overall Study|Adverse Event|2|||
44206182|NCT01955161|79002277|FG000|Overall Study|Other reason: patient's will|0|||
44367659|NCT00844753|79373066|FG002|Overall Study|Adverse Event|5|||
44367660|NCT00844753|79373067|FG003|Overall Study|Adverse Event|5|||
44367661|NCT00844753|79373064|FG000|Overall Study|Lost to Follow-up|1|||
44206183|NCT01955161|79002278|FG001|Overall Study|Other reason: patient's will|0|||
44206184|NCT01955161|79002279|FG002|Overall Study|Other reason: patient's will|1|||
44206185|NCT01441414|79002287|FG000|Overall Study|Participant died|9|||
44206186|NCT01441414|79002287|FG000|Overall Study|Other reasons|3|||
44206187|NCT01441414|79002287|FG000|Overall Study|Study terminated by sponsor|2|||
44206188|NCT01441414|79002287|FG000|Overall Study|Subject refused further follow-up|1|||
44206189|NCT01971554|79002307|FG000|Overall Study|Lost to Follow-up|1|||
44206190|NCT01971554|79002308|FG001|Overall Study|Lost to Follow-up|0|||
44206191|NCT01971554|79002309|FG002|Overall Study|Lost to Follow-up|0|||
44206192|NCT01971554|79002310|FG003|Overall Study|Lost to Follow-up|0|||
44206193|NCT01955083|79002322|FG000|Overall Study|Lost to Follow-up|1|||
44206194|NCT01955083|79002323|FG001|Overall Study|Lost to Follow-up|1|||
44206195|NCT01955005|79002355|FG000|Overall Study|Withdrawal by Subject|3|||
44206196|NCT01955005|79002356|FG001|Overall Study|Withdrawal by Subject|5|||
44206197|NCT01954927|79002364|FG000|Overall Study|Withdrawal by Subject|3|||
44206198|NCT01954927|79002365|FG001|Overall Study|Withdrawal by Subject|1|||
44206199|NCT01954771|79002374|FG000|Overall Study|Missing HbA1c of end-point|1|||
44206200|NCT01954771|79002375|FG001|Overall Study|Missing HbA1c of end-point|1|||
44206201|NCT01954771|79002376|FG002|Overall Study|Missing HbA1c of end-point|0|||
44206202|NCT01954771|79002374|FG000|Overall Study|Missing CGMS of end-point|1|||
44206203|NCT01954771|79002375|FG001|Overall Study|Missing CGMS of end-point|1|||
44206204|NCT01954771|79002376|FG002|Overall Study|Missing CGMS of end-point|0|||
44206205|NCT01954771|79002374|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
44206206|NCT01954771|79002375|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
44206207|NCT01954771|79002376|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
44206208|NCT01997281|79002389|FG000|Overall Study|Withdrawal by Subject|1|||
44206209|NCT01997281|79002390|FG001|Overall Study|Withdrawal by Subject|0|||
44206210|NCT01996033|79002396|FG000|Overall Study|Death|1|||
44206211|NCT01996033|79002396|FG000|Overall Study|Physician Decision|1|||
44206212|NCT01996033|79002396|FG000|Overall Study|Withdrawal by Subject|4|||
44206213|NCT01996033|79002396|FG000|Overall Study|Lost to Follow-up|3|||
44206214|NCT01953913|79002400|FG000|Overall Study|Disease Progression|349|||
44206215|NCT01953913|79002400|FG000|Overall Study|Worsening of underlying cancer|22|||
44206216|NCT01953913|79002400|FG000|Overall Study|Adverse Event|20|||
44206217|NCT01953913|79002400|FG000|Overall Study|Protocol Violation|6|||
44206218|NCT01953913|79002400|FG000|Overall Study|Lost to Follow-up|4|||
44206219|NCT01953913|79002400|FG000|Overall Study|Withdrawal by Subject|32|||
44206220|NCT01953913|79002400|FG000|Overall Study|Other than listed|108|||
44206221|NCT01953913|79002400|FG000|Overall Study|Not Treated|1|||
44206222|NCT01971476|79002407|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
44206223|NCT01971476|79002408|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
44206224|NCT01971476|79002409|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
44206225|NCT01971476|79002407|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
44206226|NCT01971476|79002408|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
44206227|NCT01971476|79002409|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
44206228|NCT01971476|79002407|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
44206229|NCT01971476|79002408|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
44206230|NCT01971476|79002409|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
44206231|NCT01996904|79002428|FG000|Overall Study|Lost to Follow-up|38|||
44206232|NCT01996904|79002429|FG001|Overall Study|Lost to Follow-up|27|||
44206233|NCT01970540|79002438|FG000|Overall Study|Non-treatment-related AE|0|||
44206234|NCT01970540|79002439|FG001|Overall Study|Non-treatment-related AE|0|||
44206235|NCT01970540|79002440|FG002|Overall Study|Non-treatment-related AE|1|||
44206236|NCT01970540|79002438|FG000|Overall Study|Progressive disease|55|||
44206237|NCT01970540|79002439|FG001|Overall Study|Progressive disease|23|||
44206238|NCT01970540|79002440|FG002|Overall Study|Progressive disease|10|||
44206239|NCT01970540|79002438|FG000|Overall Study|Treatment delay over protocol|0|||
44206240|NCT01970540|79002439|FG001|Overall Study|Treatment delay over protocol|0|||
44206241|NCT01970540|79002440|FG002|Overall Study|Treatment delay over protocol|1|||
44206242|NCT01970540|79002438|FG000|Overall Study|Physician Decision|7|||
44206243|NCT01970540|79002439|FG001|Overall Study|Physician Decision|2|||
44206244|NCT01970540|79002440|FG002|Overall Study|Physician Decision|0|||
44206245|NCT01970540|79002438|FG000|Overall Study|Clinical progression|0|||
44206246|NCT01970540|79002439|FG001|Overall Study|Clinical progression|1|||
44206247|NCT01970540|79002440|FG002|Overall Study|Clinical progression|1|||
44269551|NCT02303574|79193719|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44269552|NCT02303574|79193720|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44269553|NCT02303574|79193721|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44206248|NCT01970540|79002438|FG000|Overall Study|End of study|2|||
44206249|NCT01970540|79002439|FG001|Overall Study|End of study|0|||
44206250|NCT01970540|79002440|FG002|Overall Study|End of study|2|||
44206251|NCT01970540|79002438|FG000|Overall Study|Adverse Event|0|||
44206252|NCT01970540|79002439|FG001|Overall Study|Adverse Event|2|||
44206253|NCT01970540|79002440|FG002|Overall Study|Adverse Event|1|||
44206254|NCT01970540|79002438|FG000|Overall Study|Treatment-related AE|4|||
44206255|NCT01970540|79002439|FG001|Overall Study|Treatment-related AE|0|||
44206256|NCT01970540|79002440|FG002|Overall Study|Treatment-related AE|2|||
44206257|NCT01970540|79002438|FG000|Overall Study|Withdrawal by Subject|4|||
44206258|NCT01970540|79002439|FG001|Overall Study|Withdrawal by Subject|0|||
44206259|NCT01970540|79002440|FG002|Overall Study|Withdrawal by Subject|1|||
44206260|NCT01970540|79002438|FG000|Overall Study|Clinical deterioration|1|||
44206261|NCT01970540|79002439|FG001|Overall Study|Clinical deterioration|0|||
44206262|NCT01970540|79002440|FG002|Overall Study|Clinical deterioration|0|||
44206263|NCT01963676|79002461|FG000|Overall Study|Withdrawal by Subject|1|||
44206264|NCT01963676|79002462|FG001|Overall Study|Withdrawal by Subject|0|||
44206265|NCT01996826|79002470|FG000|Overall Study|Lost to Follow-up|6|||
44206266|NCT01996826|79002471|FG001|Overall Study|Lost to Follow-up|2|||
44206267|NCT01996826|79002470|FG000|Overall Study|Physician Decision|1|||
44206268|NCT01996826|79002471|FG001|Overall Study|Physician Decision|1|||
44206269|NCT01996748|79002479|FG000|Overall Study|Personal reason|1|||
44206270|NCT01996748|79002480|FG001|Overall Study|Personal reason|0|||
44206271|NCT01996748|79002479|FG000|Overall Study|Physician Decision|2|||
44206272|NCT01996748|79002480|FG001|Overall Study|Physician Decision|0|||
44206273|NCT01996748|79002479|FG000|Overall Study|Adverse Event|1|||
44206274|NCT01996748|79002480|FG001|Overall Study|Adverse Event|4|||
44206275|NCT01996748|79002479|FG000|Overall Study|Withdrawal by Subject|0|||
44206276|NCT01996748|79002480|FG001|Overall Study|Withdrawal by Subject|1|||
44206277|NCT01996748|79002479|FG000|Overall Study|Lost to Follow-up|4|||
44206278|NCT01996748|79002480|FG001|Overall Study|Lost to Follow-up|1|||
44206279|NCT01621178|79002491|FG000|Overall Study|Adverse Event|5|||
44206280|NCT01621178|79002492|FG001|Overall Study|Adverse Event|2|||
44206281|NCT01621178|79002493|FG002|Overall Study|Adverse Event|8|||
44206282|NCT01621178|79002491|FG000|Overall Study|Death|6|||
44206283|NCT01621178|79002492|FG001|Overall Study|Death|7|||
44206284|NCT01621178|79002493|FG002|Overall Study|Death|2|||
44206285|NCT01621178|79002491|FG000|Overall Study|Lost to Follow-up|1|||
44206286|NCT01621178|79002492|FG001|Overall Study|Lost to Follow-up|2|||
44206287|NCT01621178|79002493|FG002|Overall Study|Lost to Follow-up|1|||
44206288|NCT01621178|79002491|FG000|Overall Study|Withdrawal by Subject|14|||
44206289|NCT01621178|79002492|FG001|Overall Study|Withdrawal by Subject|17|||
44206290|NCT01621178|79002493|FG002|Overall Study|Withdrawal by Subject|18|||
44206291|NCT01621178|79002491|FG000|Overall Study|Physician Decision|5|||
44206292|NCT01621178|79002492|FG001|Overall Study|Physician Decision|2|||
44206293|NCT01621178|79002493|FG002|Overall Study|Physician Decision|7|||
44367662|NCT00844753|79373065|FG001|Overall Study|Lost to Follow-up|1|||
44367663|NCT00844753|79373066|FG002|Overall Study|Lost to Follow-up|0|||
44367664|NCT00844753|79373067|FG003|Overall Study|Lost to Follow-up|1|||
44367665|NCT00844753|79373064|FG000|Overall Study|could not swallow medication|2|||
44367666|NCT00844753|79373065|FG001|Overall Study|could not swallow medication|0|||
44367667|NCT00844753|79373066|FG002|Overall Study|could not swallow medication|0|||
44367668|NCT00844753|79373067|FG003|Overall Study|could not swallow medication|0|||
44367669|NCT00844753|79373064|FG000|Overall Study|Withdrawal by Subject|1|||
44367670|NCT00844753|79373065|FG001|Overall Study|Withdrawal by Subject|0|||
44367671|NCT00844753|79373066|FG002|Overall Study|Withdrawal by Subject|0|||
44367672|NCT00844753|79373067|FG003|Overall Study|Withdrawal by Subject|3|||
44367673|NCT00830947|79373077|FG000|Overall Study|Lost to Follow-up|4|||
44367674|NCT00830947|79373078|FG001|Overall Study|Lost to Follow-up|4|||
44367675|NCT01018992|79373086|FG000|Overall Study|Adverse Event|8|||
44367676|NCT01018992|79373087|FG001|Overall Study|Adverse Event|3|||
44367677|NCT01018992|79373086|FG000|Overall Study|Withdrawal by Subject|3|||
44367678|NCT01018992|79373087|FG001|Overall Study|Withdrawal by Subject|8|||
44367679|NCT01018992|79373086|FG000|Overall Study|Protocol Violation|0|||
44367680|NCT01018992|79373087|FG001|Overall Study|Protocol Violation|4|||
44367681|NCT01018992|79373086|FG000|Overall Study|Lost to Follow-up|5|||
44367682|NCT01018992|79373087|FG001|Overall Study|Lost to Follow-up|1|||
44367683|NCT00917553|79373095|FG000|Overall Study|Lost to Follow-up|2|||
44206294|NCT01962974|79002505|FG000|Overall Study|Study termination|7|||
44206295|NCT01996592|79002509|FG000|Overall Study|no response to text/no diary entry|32|||
44206296|NCT01996592|79002509|FG000|Overall Study|change in surgical date|4|||
44367684|NCT00917553|79373096|FG001|Overall Study|Lost to Follow-up|1|||
44367685|NCT01018680|79373104|FG000|Overall Study|Adverse Event|23|||
44452084|NCT00097591|79460983|FG000|Overall Study|Other|0|||
44206297|NCT01996592|79002509|FG000|Overall Study|Withdrawal by Subject|5|||
44206298|NCT01996592|79002509|FG000|Overall Study|change in mode of delivery|4|||
44206299|NCT01962896|79002518|FG000|Overall Study|Lack of Efficacy|4|||
44206300|NCT01970462|79002525|FG000|Overall Study|Lost to Follow-up|0|||
44206301|NCT01970462|79002526|FG001|Overall Study|Lost to Follow-up|2|||
44206302|NCT01958671|79002535|FG000|Overall Study|Adverse Event|1|||
44206303|NCT01958671|79002536|FG001|Overall Study|Adverse Event|1|||
44206304|NCT01958671|79002537|FG002|Overall Study|Adverse Event|5|||
44206305|NCT01958671|79002535|FG000|Overall Study|Death|1|||
44367686|NCT01018680|79373105|FG001|Overall Study|Adverse Event|40|||
44367687|NCT01018680|79373104|FG000|Overall Study|Withdrawal by Subject|10|||
44367688|NCT01018680|79373105|FG001|Overall Study|Withdrawal by Subject|10|||
44367689|NCT01018680|79373104|FG000|Overall Study|Protocol Violation|5|||
44206306|NCT01958671|79002536|FG001|Overall Study|Death|0|||
44206307|NCT01958671|79002537|FG002|Overall Study|Death|0|||
44206308|NCT01958671|79002535|FG000|Overall Study|Excluded medication|0|||
44206309|NCT01958671|79002536|FG001|Overall Study|Excluded medication|0|||
44206310|NCT01958671|79002537|FG002|Overall Study|Excluded medication|1|||
44206311|NCT01958671|79002535|FG000|Overall Study|Hyperglycemia|0|||
44206312|NCT01958671|79002536|FG001|Overall Study|Hyperglycemia|0|||
44206313|NCT01958671|79002537|FG002|Overall Study|Hyperglycemia|2|||
44206314|NCT01958671|79002535|FG000|Overall Study|Lost to Follow-up|7|||
44206315|NCT01958671|79002536|FG001|Overall Study|Lost to Follow-up|11|||
44206316|NCT01958671|79002537|FG002|Overall Study|Lost to Follow-up|7|||
44206317|NCT01958671|79002535|FG000|Overall Study|Non-compliance with study drug|1|||
44206318|NCT01958671|79002536|FG001|Overall Study|Non-compliance with study drug|1|||
44206319|NCT01958671|79002537|FG002|Overall Study|Non-compliance with study drug|1|||
44206320|NCT01958671|79002535|FG000|Overall Study|Pregnancy|0|||
44206321|NCT01958671|79002536|FG001|Overall Study|Pregnancy|0|||
44206322|NCT01958671|79002537|FG002|Overall Study|Pregnancy|1|||
44206323|NCT01958671|79002535|FG000|Overall Study|Protocol Violation|0|||
44206324|NCT01958671|79002536|FG001|Overall Study|Protocol Violation|1|||
44206325|NCT01958671|79002537|FG002|Overall Study|Protocol Violation|0|||
44206326|NCT01958671|79002535|FG000|Overall Study|Study site terminated by sponsor|1|||
44206327|NCT01958671|79002536|FG001|Overall Study|Study site terminated by sponsor|0|||
44206328|NCT01958671|79002537|FG002|Overall Study|Study site terminated by sponsor|1|||
44206329|NCT01958671|79002535|FG000|Overall Study|Participant moved|0|||
44206330|NCT01958671|79002536|FG001|Overall Study|Participant moved|0|||
44206331|NCT01958671|79002537|FG002|Overall Study|Participant moved|1|||
44206332|NCT01958671|79002535|FG000|Overall Study|Withdrawal by Subject|8|||
44206333|NCT01958671|79002536|FG001|Overall Study|Withdrawal by Subject|10|||
44269554|NCT02303574|79193722|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44367690|NCT01018680|79373105|FG001|Overall Study|Protocol Violation|8|||
44367691|NCT01018680|79373104|FG000|Overall Study|Sponsor Decision|6|||
44367692|NCT01018680|79373105|FG001|Overall Study|Sponsor Decision|7|||
44367693|NCT01018680|79373104|FG000|Overall Study|Lack of Efficacy|8|||
44367694|NCT01018680|79373105|FG001|Overall Study|Lack of Efficacy|2|||
44367695|NCT01018680|79373104|FG000|Overall Study|Lost to Follow-up|5|||
44367696|NCT01018680|79373105|FG001|Overall Study|Lost to Follow-up|3|||
44367697|NCT01018680|79373104|FG000|Overall Study|Entry Criteria Not Met|1|||
44367698|NCT01018680|79373105|FG001|Overall Study|Entry Criteria Not Met|4|||
44367699|NCT01018680|79373104|FG000|Overall Study|Physician Decision|3|||
44367700|NCT01018680|79373105|FG001|Overall Study|Physician Decision|1|||
44367701|NCT01012440|79373111|FG000|Overall Study|Withdrawal by Subject|2|||
44367702|NCT00916929|79373117|FG000|Overall Study|Lost to Follow-up|1|||
44367703|NCT00916929|79373118|FG001|Overall Study|Lost to Follow-up|3|||
44367704|NCT00916929|79373117|FG000|Overall Study|Death|5|||
44367705|NCT00916929|79373118|FG001|Overall Study|Death|10|||
44367706|NCT00916929|79373117|FG000|Overall Study|Withdrawal by Subject|1|||
44367707|NCT00916929|79373118|FG001|Overall Study|Withdrawal by Subject|5|||
44367708|NCT00916929|79373117|FG000|Overall Study|Left ventricular epicardial lead|1|||
44367709|NCT00916929|79373118|FG001|Overall Study|Left ventricular epicardial lead|2|||
44367710|NCT00916929|79373117|FG000|Overall Study|Transferred to hospice care|1|||
44367711|NCT00916929|79373118|FG001|Overall Study|Transferred to hospice care|1|||
44367712|NCT00916929|79373117|FG000|Overall Study|System explant|1|||
44367713|NCT00916929|79373118|FG001|Overall Study|System explant|0|||
44367714|NCT00916929|79373117|FG000|Overall Study|Moved to another state|0|||
44367715|NCT00916929|79373118|FG001|Overall Study|Moved to another state|1|||
44367716|NCT00916929|79373117|FG000|Overall Study|Device unable to process impedance data|0|||
44367717|NCT00916929|79373118|FG001|Overall Study|Device unable to process impedance data|7|||
44367718|NCT00844597|79373132|FG000|Overall Study|Adverse Event|0|||
44367719|NCT00844597|79373133|FG001|Overall Study|Adverse Event|0|||
44367720|NCT00844597|79373134|FG002|Overall Study|Adverse Event|0|||
44367721|NCT00844597|79373135|FG003|Overall Study|Adverse Event|1|||
44367722|NCT00844597|79373136|FG004|Overall Study|Adverse Event|0|||
44367723|NCT00844597|79373137|FG005|Overall Study|Adverse Event|0|||
44367724|NCT01017120|79373155|FG000|Overall Study|Adverse Event|9|||
44206334|NCT01958671|79002537|FG002|Overall Study|Withdrawal by Subject|13|||
44367725|NCT01017120|79373156|FG001|Overall Study|Adverse Event|0|||
44206335|NCT01995266|79002549|FG000|Overall Study|Death|1|||
44206336|NCT01995266|79002549|FG000|Overall Study|Lack of Efficacy|6|||
44206337|NCT01995266|79002549|FG000|Overall Study|Adverse Event|2|||
44206338|NCT01969058|79002555|FG000|Overall Study|Withdrawal by Subject|2|||
44206339|NCT01969058|79002556|FG001|Overall Study|Withdrawal by Subject|0|||
44206340|NCT01969058|79002555|FG000|Overall Study|Adverse Event|1|||
44206341|NCT01969058|79002556|FG001|Overall Study|Adverse Event|0|||
44206342|NCT01968980|79002564|FG000|Overall Study|Death|0|||
44206343|NCT01968980|79002565|FG001|Overall Study|Death|1|||
44367726|NCT01017120|79373155|FG000|Overall Study|Lost to Follow-up|13|||
44367727|NCT01017120|79373156|FG001|Overall Study|Lost to Follow-up|11|||
44367728|NCT01017120|79373155|FG000|Overall Study|Lack of Efficacy|1|||
44367729|NCT01017120|79373156|FG001|Overall Study|Lack of Efficacy|0|||
44206344|NCT01968980|79002564|FG000|Overall Study|Adverse Event|1|||
44206345|NCT01968980|79002565|FG001|Overall Study|Adverse Event|3|||
44206346|NCT01968980|79002564|FG000|Overall Study|Does not meet entry criteria|1|||
44206347|NCT01968980|79002565|FG001|Overall Study|Does not meet entry criteria|3|||
44206348|NCT01968980|79002564|FG000|Overall Study|Withdrawal by Subject|13|||
44206349|NCT01968980|79002565|FG001|Overall Study|Withdrawal by Subject|5|||
44206350|NCT01968980|79002564|FG000|Overall Study|Other unspecified|1|||
44206351|NCT01968980|79002565|FG001|Overall Study|Other unspecified|2|||
44206352|NCT01961882|79002574|FG000|Overall Study|Adverse Event|3|||
44206353|NCT01961882|79002575|FG001|Overall Study|Adverse Event|2|||
44206354|NCT01961882|79002574|FG000|Overall Study|Physician Decision|1|||
44206355|NCT01961882|79002575|FG001|Overall Study|Physician Decision|0|||
44206356|NCT01961882|79002574|FG000|Overall Study|Withdrawal by Subject|4|||
44206357|NCT01961882|79002575|FG001|Overall Study|Withdrawal by Subject|1|||
44206358|NCT01961882|79002574|FG000|Overall Study|Relapse of AML|39|||
44206359|NCT01961882|79002575|FG001|Overall Study|Relapse of AML|37|||
44206360|NCT01961882|79002574|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
44206361|NCT01961882|79002575|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
44206362|NCT01961882|79002574|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
44206363|NCT01961882|79002575|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
44206364|NCT01968434|79002583|FG000|Overall Study|Lost to Follow-up|3|||
44206365|NCT01968434|79002584|FG001|Overall Study|Lost to Follow-up|6|||
44206366|NCT01946438|79002594|FG000|Overall Study|Adverse Event|0|||
44206367|NCT01946438|79002595|FG001|Overall Study|Adverse Event|0|||
44206368|NCT01946438|79002596|FG002|Overall Study|Adverse Event|0|||
44206369|NCT01946438|79002597|FG003|Overall Study|Adverse Event|1|||
44269555|NCT02303574|79193723|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44452085|NCT00097591|79460984|FG001|Overall Study|Other|3|||
44452086|NCT00419926|79460992|FG000|Overall Study|Withdrawal by Subject|7|||
44452087|NCT00419926|79460993|FG001|Overall Study|Withdrawal by Subject|3|||
44452088|NCT00419926|79460992|FG000|Overall Study|Administrative Problem|4|||
44452089|NCT00419926|79460993|FG001|Overall Study|Administrative Problem|4|||
44452090|NCT00419926|79460992|FG000|Overall Study|Lost to Follow-up|1|||
44543327|NCT03277794|79556294|FG000|Overall Study|Withdrew due to high acuity|1|||
44543328|NCT03277794|79556295|FG001|Overall Study|Withdrew due to high acuity|0|||
44543329|NCT03276078|79556302|FG000|Overall Study|Adverse Event|1|||
44543330|NCT03180801|79556309|FG000|Overall Study|Physician Decision|3|||
44543331|NCT03180801|79556310|FG001|Overall Study|Physician Decision|3|||
44543332|NCT03180801|79556311|FG002|Overall Study|Physician Decision|1|||
44543333|NCT03180801|79556309|FG000|Overall Study|Non-compliance|1|||
44543334|NCT03180801|79556310|FG001|Overall Study|Non-compliance|4|||
44206370|NCT01946438|79002594|FG000|Overall Study|Serious Adverse event|1|||
44206371|NCT01946438|79002595|FG001|Overall Study|Serious Adverse event|0|||
44269556|NCT02303574|79193724|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44269557|NCT02303574|79193725|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44269558|NCT02303574|79193726|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
44269559|NCT02303574|79193727|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44269560|NCT02303574|79193728|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
44269561|NCT02354976|79193764|FG000|Overall Study|Other - reason not specified|1|||
44269562|NCT02354976|79193765|FG001|Overall Study|Other - reason not specified|0|||
44269563|NCT02354976|79193766|FG002|Overall Study|Other - reason not specified|1|||
44269564|NCT02354976|79193764|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
44269565|NCT02354976|79193765|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
44269566|NCT02354976|79193766|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
44269567|NCT02354976|79193764|FG000|Overall Study|Adverse Event|1|||
44269568|NCT02354976|79193765|FG001|Overall Study|Adverse Event|0|||
44269569|NCT02354976|79193766|FG002|Overall Study|Adverse Event|2|||
44269570|NCT02303262|79193774|FG000|Overall Study|Withdrawal by Subject|2|||
44269571|NCT00558896|79193785|FG000|Overall Study|Adverse Event|1|||
44269572|NCT00558896|79193786|FG001|Overall Study|Adverse Event|1|||
44269573|NCT00558896|79193787|FG002|Overall Study|Adverse Event|1|||
44269574|NCT00558896|79193788|FG003|Overall Study|Adverse Event|3|||
44269575|NCT00558896|79193789|FG004|Overall Study|Adverse Event|4|||
44269576|NCT00558896|79193790|FG005|Overall Study|Adverse Event|10|||
44269577|NCT00558896|79193791|FG006|Overall Study|Adverse Event|3|||
44269578|NCT00558896|79193785|FG000|Overall Study|Death|3|||
44269579|NCT00558896|79193786|FG001|Overall Study|Death|0|||
44269580|NCT00558896|79193787|FG002|Overall Study|Death|2|||
44206372|NCT01946438|79002596|FG002|Overall Study|Serious Adverse event|0|||
44452091|NCT00419926|79460993|FG001|Overall Study|Lost to Follow-up|2|||
44452092|NCT00419926|79460992|FG000|Overall Study|Death|2|||
44543335|NCT03180801|79556311|FG002|Overall Study|Non-compliance|0|||
44269581|NCT00558896|79193788|FG003|Overall Study|Death|3|||
44452093|NCT00419926|79460993|FG001|Overall Study|Death|1|||
44543336|NCT03180801|79556309|FG000|Overall Study|Inoculation Target Reached|1|||
44543337|NCT03180801|79556310|FG001|Overall Study|Inoculation Target Reached|1|||
44543338|NCT03180801|79556311|FG002|Overall Study|Inoculation Target Reached|3|||
44206373|NCT01946438|79002597|FG003|Overall Study|Serious Adverse event|0|||
44206374|NCT01946438|79002594|FG000|Overall Study|Protocol Violation|0|||
44206375|NCT01946438|79002595|FG001|Overall Study|Protocol Violation|0|||
44206376|NCT01946438|79002596|FG002|Overall Study|Protocol Violation|1|||
44206377|NCT01946438|79002597|FG003|Overall Study|Protocol Violation|0|||
44206378|NCT01946438|79002594|FG000|Overall Study|Withdrawal by Subject|1|||
44206379|NCT01946438|79002595|FG001|Overall Study|Withdrawal by Subject|0|||
44206380|NCT01946438|79002596|FG002|Overall Study|Withdrawal by Subject|0|||
44206381|NCT01946438|79002597|FG003|Overall Study|Withdrawal by Subject|0|||
44206382|NCT01946282|79002616|FG000|Year 1|Did not return FIT kit|4186|||
44543339|NCT03180801|79556309|FG000|Overall Study|Adverse Event|1|||
44543340|NCT03180801|79556310|FG001|Overall Study|Adverse Event|0|||
44543341|NCT03180801|79556311|FG002|Overall Study|Adverse Event|2|||
44543342|NCT03180801|79556309|FG000|Overall Study|Withdrawal by Subject|2|||
44543343|NCT03180801|79556310|FG001|Overall Study|Withdrawal by Subject|2|||
44543344|NCT03180801|79556311|FG002|Overall Study|Withdrawal by Subject|1|||
44543345|NCT03180801|79556309|FG000|Overall Study|Lost to Follow-up|0|||
44543346|NCT03180801|79556310|FG001|Overall Study|Lost to Follow-up|2|||
44543347|NCT03180801|79556311|FG002|Overall Study|Lost to Follow-up|3|||
44206383|NCT01946282|79002617|FG001|Year 1|Did not return FIT kit|608|||
44206384|NCT01946282|79002618|FG002|Year 1|Did not return FIT kit|654|||
44206385|NCT01946282|79002616|FG000|Year 2|Did not return FIT kit|803|||
44206386|NCT01946282|79002617|FG001|Year 2|Did not return FIT kit|131|||
44206387|NCT01946282|79002618|FG002|Year 2|Did not return FIT kit|115|||
44206388|NCT01946282|79002616|FG000|Year 3|Did not return FIT kit|288|||
44206389|NCT01946282|79002617|FG001|Year 3|Did not return FIT kit|43|||
44206390|NCT01946282|79002618|FG002|Year 3|Did not return FIT kit|30|||
44367730|NCT01017120|79373155|FG000|Overall Study|Withdrawal by Subject|39|||
44367731|NCT01017120|79373156|FG001|Overall Study|Withdrawal by Subject|21|||
44206391|NCT01945580|79002630|FG000|Overall Study|Withdrawal by Subject|13|||
44206392|NCT01945580|79002631|FG001|Overall Study|Withdrawal by Subject|35|||
44206393|NCT01945580|79002630|FG000|Overall Study|Physician Decision|3|||
44206394|NCT01945580|79002631|FG001|Overall Study|Physician Decision|2|||
44367732|NCT01017120|79373155|FG000|Overall Study|Pregnancy|1|||
44367733|NCT01017120|79373156|FG001|Overall Study|Pregnancy|1|||
44367734|NCT01017120|79373155|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
44367735|NCT01017120|79373156|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
44367736|NCT01017120|79373155|FG000|Overall Study|Relocated Out of Town|0|||
44367737|NCT01017120|79373156|FG001|Overall Study|Relocated Out of Town|2|||
44367738|NCT01017120|79373155|FG000|Overall Study|Protocol Violation|1|||
44367739|NCT01017120|79373156|FG001|Overall Study|Protocol Violation|0|||
44367740|NCT01017120|79373155|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
44367741|NCT01017120|79373156|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
44367742|NCT01016964|79373164|FG000|Overall Study|Lost to Follow-up|3|||
44367743|NCT01016964|79373165|FG001|Overall Study|Lost to Follow-up|3|||
44367744|NCT02996110|79373176|FG000|Pre-Treatment|Other Reasons|0|||
44367745|NCT02996110|79373177|FG001|Pre-Treatment|Other Reasons|1|||
44367746|NCT02996110|79373178|FG002|Pre-Treatment|Other Reasons|0|||
44367747|NCT02996110|79373179|FG003|Pre-Treatment|Other Reasons|0|||
44367748|NCT02996110|79373180|FG004|Pre-Treatment|Other Reasons|1|||
44367749|NCT02996110|79373176|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
44367750|NCT02996110|79373177|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
44367751|NCT02996110|79373178|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
44367752|NCT02996110|79373179|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
44367753|NCT02996110|79373180|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
44367754|NCT02996110|79373176|FG000|Track 1|Disease Progression|15|||
44367755|NCT02996110|79373177|FG001|Track 1|Disease Progression|17|||
44367756|NCT02996110|79373178|FG002|Track 1|Disease Progression|0|||
44206395|NCT01945580|79002630|FG000|Overall Study|Lost to Follow-up|26|||
44206396|NCT01945580|79002631|FG001|Overall Study|Lost to Follow-up|39|||
44206397|NCT01945580|79002630|FG000|Overall Study|Death|7|||
44206398|NCT01945580|79002631|FG001|Overall Study|Death|2|||
44206399|NCT01945580|79002630|FG000|Overall Study|Patient moved out of state|0|||
44206400|NCT01945580|79002631|FG001|Overall Study|Patient moved out of state|1|||
44206401|NCT01945580|79002630|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
44206402|NCT01945580|79002631|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
44206403|NCT01945580|79002630|FG000|Overall Study|Family illness - unable to return|0|||
44367757|NCT02996110|79373179|FG003|Track 1|Disease Progression|0|||
44367758|NCT02996110|79373180|FG004|Track 1|Disease Progression|0|||
44367759|NCT02996110|79373176|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
44367760|NCT02996110|79373177|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
44367761|NCT02996110|79373178|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
44367762|NCT02996110|79373179|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
44543348|NCT03742271|79556322|FG000|Overall Study|Unsatisfactory Visual Response|1|||
44543349|NCT03742271|79556322|FG000|Overall Study|Withdrawal by Subject|3|||
44367763|NCT02996110|79373180|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
44367764|NCT02996110|79373176|FG000|Track 1|Study Drug Toxicity|5|||
44367765|NCT02996110|79373177|FG001|Track 1|Study Drug Toxicity|3|||
44367766|NCT02996110|79373178|FG002|Track 1|Study Drug Toxicity|0|||
44367767|NCT02996110|79373179|FG003|Track 1|Study Drug Toxicity|0|||
44367768|NCT02996110|79373180|FG004|Track 1|Study Drug Toxicity|0|||
44367769|NCT02996110|79373176|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
44367770|NCT02996110|79373177|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
44367771|NCT02996110|79373178|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
44367772|NCT02996110|79373179|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
44367773|NCT02996110|79373180|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
44367774|NCT02996110|79373176|FG000|Track 1|Administrative Reason by Sponsor|0|||
44367775|NCT02996110|79373177|FG001|Track 1|Administrative Reason by Sponsor|1|||
44367776|NCT02996110|79373178|FG002|Track 1|Administrative Reason by Sponsor|0|||
44367777|NCT02996110|79373179|FG003|Track 1|Administrative Reason by Sponsor|0|||
44367778|NCT02996110|79373180|FG004|Track 1|Administrative Reason by Sponsor|0|||
44367779|NCT02996110|79373176|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
44367780|NCT02996110|79373177|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
44367781|NCT02996110|79373178|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
44367782|NCT02996110|79373179|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
44367783|NCT02996110|79373180|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
44367784|NCT02996110|79373176|FG000|Track 2|Disease Progression|33|||
44367785|NCT02996110|79373177|FG001|Track 2|Disease Progression|26|||
44367786|NCT02996110|79373178|FG002|Track 2|Disease Progression|19|||
44367787|NCT02996110|79373179|FG003|Track 2|Disease Progression|16|||
44367788|NCT02996110|79373180|FG004|Track 2|Disease Progression|15|||
44367789|NCT02996110|79373176|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
44367790|NCT02996110|79373177|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
44367791|NCT02996110|79373178|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
44367792|NCT02996110|79373179|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
44367793|NCT02996110|79373180|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
44367794|NCT02996110|79373176|FG000|Track 2|Death|0|||
44367795|NCT02996110|79373177|FG001|Track 2|Death|0|||
44367796|NCT02996110|79373178|FG002|Track 2|Death|1|||
44367797|NCT02996110|79373179|FG003|Track 2|Death|0|||
44367798|NCT02996110|79373180|FG004|Track 2|Death|1|||
44367799|NCT02996110|79373176|FG000|Track 2|Study Drug Toxicity|4|||
44367800|NCT02996110|79373177|FG001|Track 2|Study Drug Toxicity|1|||
44367801|NCT02996110|79373178|FG002|Track 2|Study Drug Toxicity|4|||
44367802|NCT02996110|79373179|FG003|Track 2|Study Drug Toxicity|1|||
44206404|NCT01945580|79002631|FG001|Overall Study|Family illness - unable to return|1|||
44206405|NCT01945580|79002630|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
44206406|NCT01945580|79002631|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
44206407|NCT01945580|79002630|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
44206408|NCT01945580|79002631|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
44206409|NCT01945580|79002630|FG000|Overall Study|Noncompliance with 36 month visit|1|||
44269582|NCT00558896|79193789|FG004|Overall Study|Death|2|||
44367803|NCT02996110|79373180|FG004|Track 2|Study Drug Toxicity|0|||
44367804|NCT02996110|79373176|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
44367805|NCT02996110|79373177|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
44367806|NCT02996110|79373178|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
44367807|NCT02996110|79373179|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
44367808|NCT02996110|79373180|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
44367809|NCT02996110|79373176|FG000|Track 2|Participant Withdrew Consent|1|||
44367810|NCT02996110|79373177|FG001|Track 2|Participant Withdrew Consent|2|||
44367811|NCT02996110|79373178|FG002|Track 2|Participant Withdrew Consent|3|||
44367812|NCT02996110|79373179|FG003|Track 2|Participant Withdrew Consent|1|||
44367813|NCT02996110|79373180|FG004|Track 2|Participant Withdrew Consent|1|||
44367814|NCT02996110|79373176|FG000|Track 2|Other Reasons|0|||
44367815|NCT02996110|79373177|FG001|Track 2|Other Reasons|0|||
44367816|NCT02996110|79373178|FG002|Track 2|Other Reasons|1|||
44367817|NCT02996110|79373179|FG003|Track 2|Other Reasons|0|||
44367818|NCT02996110|79373180|FG004|Track 2|Other Reasons|1|||
44367819|NCT00916617|79373198|FG000|Overall Study|Adverse Event|3|||
44367820|NCT00916617|79373199|FG001|Overall Study|Adverse Event|2|||
44367821|NCT00916617|79373200|FG002|Overall Study|Adverse Event|6|||
44367822|NCT00916617|79373201|FG003|Overall Study|Adverse Event|3|||
44367823|NCT00916617|79373198|FG000|Overall Study|Withdrawal by Subject|3|||
44367824|NCT00916617|79373199|FG001|Overall Study|Withdrawal by Subject|2|||
44367825|NCT00916617|79373200|FG002|Overall Study|Withdrawal by Subject|0|||
44367826|NCT00916617|79373201|FG003|Overall Study|Withdrawal by Subject|1|||
44367827|NCT00916617|79373198|FG000|Overall Study|Caregiver Request|3|||
44543350|NCT03742271|79556322|FG000|Overall Study|Lost to Follow-up|4|||
44367828|NCT00916617|79373199|FG001|Overall Study|Caregiver Request|2|||
44367829|NCT00916617|79373200|FG002|Overall Study|Caregiver Request|1|||
44367830|NCT00916617|79373201|FG003|Overall Study|Caregiver Request|0|||
44367831|NCT00916617|79373198|FG000|Overall Study|Physician Decision|1|||
44367832|NCT00916617|79373199|FG001|Overall Study|Physician Decision|1|||
44367833|NCT00916617|79373200|FG002|Overall Study|Physician Decision|0|||
44367834|NCT00916617|79373201|FG003|Overall Study|Physician Decision|0|||
44367835|NCT00916617|79373198|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
44367836|NCT00916617|79373199|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
44367837|NCT00916617|79373200|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
44367838|NCT00916617|79373201|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
44367839|NCT00916617|79373198|FG000|Overall Study|Lost to Follow-up|2|||
44367840|NCT00916617|79373199|FG001|Overall Study|Lost to Follow-up|1|||
44367841|NCT00916617|79373200|FG002|Overall Study|Lost to Follow-up|0|||
44367842|NCT00916617|79373201|FG003|Overall Study|Lost to Follow-up|0|||
44367843|NCT00916617|79373198|FG000|Overall Study|Lack of Efficacy|1|||
44367844|NCT00916617|79373199|FG001|Overall Study|Lack of Efficacy|0|||
44367845|NCT00916617|79373200|FG002|Overall Study|Lack of Efficacy|0|||
44367846|NCT00916617|79373201|FG003|Overall Study|Lack of Efficacy|0|||
44367847|NCT00916617|79373198|FG000|Overall Study|Other|2|||
44367848|NCT00916617|79373199|FG001|Overall Study|Other|0|||
44367849|NCT00916617|79373200|FG002|Overall Study|Other|0|||
44367850|NCT00916617|79373201|FG003|Overall Study|Other|2|||
44367851|NCT01103063|79373213|FG000|Overall Study|Adverse Event|3|||
44367852|NCT01103063|79373214|FG001|Overall Study|Adverse Event|1|||
44367853|NCT01103063|79373213|FG000|Overall Study|Lost to Follow-up|68|||
44367854|NCT01103063|79373214|FG001|Overall Study|Lost to Follow-up|51|||
44367855|NCT01103063|79373213|FG000|Overall Study|Withdrawal by Subject|60|||
44367856|NCT01103063|79373214|FG001|Overall Study|Withdrawal by Subject|15|||
44367857|NCT01103063|79373213|FG000|Overall Study|Other|16|||
44367858|NCT01103063|79373214|FG001|Overall Study|Other|11|||
44367859|NCT01103063|79373213|FG000|Overall Study|Protocol Violation|1|||
44367860|NCT01103063|79373214|FG001|Overall Study|Protocol Violation|0|||
44367861|NCT01103063|79373213|FG000|Overall Study|Study terminated by Sponsor|326|||
44367862|NCT01103063|79373214|FG001|Overall Study|Study terminated by Sponsor|342|||
44367863|NCT01103063|79373213|FG000|Overall Study|Death|3|||
44367864|NCT01103063|79373214|FG001|Overall Study|Death|1|||
44367865|NCT01091675|79373222|FG000|Overall Study|Adverse Event|7|||
44367866|NCT01091675|79373222|FG000|Overall Study|Lack of Efficacy|27|||
44367867|NCT01091519|79373228|FG000|Overall Study|Adverse Event|12|||
44367868|NCT01091519|79373229|FG001|Overall Study|Adverse Event|16|||
44367869|NCT01091519|79373228|FG000|Overall Study|Death|1|||
44367870|NCT01091519|79373229|FG001|Overall Study|Death|0|||
44367871|NCT01091519|79373228|FG000|Overall Study|Lack of Efficacy|16|||
44367872|NCT01091519|79373229|FG001|Overall Study|Lack of Efficacy|19|||
44367873|NCT01091519|79373228|FG000|Overall Study|Lost to Follow-up|14|||
44367874|NCT01091519|79373229|FG001|Overall Study|Lost to Follow-up|24|||
44367875|NCT01091519|79373228|FG000|Overall Study|Withdrawal by Subject|2|||
44367876|NCT01091519|79373229|FG001|Overall Study|Withdrawal by Subject|2|||
44367877|NCT01091519|79373228|FG000|Overall Study|Other|6|||
44367878|NCT01091519|79373229|FG001|Overall Study|Other|8|||
44367879|NCT01091519|79373228|FG000|Overall Study|Randomized not treated|4|||
44206410|NCT01945580|79002631|FG001|Overall Study|Noncompliance with 36 month visit|0|||
44206411|NCT01945580|79002630|FG000|Overall Study|The patient moved.|1|||
44206412|NCT01945580|79002631|FG001|Overall Study|The patient moved.|0|||
44206413|NCT01945580|79002630|FG000|Overall Study|No data available|0|||
44206414|NCT01945580|79002631|FG001|Overall Study|No data available|2|||
44206415|NCT01945034|79002644|FG000|Overall Study|Medication Error|0|||
44206416|NCT01945034|79002645|FG001|Overall Study|Medication Error|1|||
44367880|NCT01091519|79373229|FG001|Overall Study|Randomized not treated|4|||
44367881|NCT01011738|79373238|FG000|Overall Study|Death|12|||
44452094|NCT00080119|79461003|FG000|Overall Study|Discontinued because of study closure|0|||
44206417|NCT01945034|79002646|FG002|Overall Study|Medication Error|0|||
44206418|NCT01945034|79002644|FG000|Overall Study|Withdrawal by Subject|0|||
44367882|NCT01011738|79373239|FG001|Overall Study|Death|3|||
44367883|NCT01011738|79373240|FG002|Overall Study|Death|0|||
44367884|NCT01011738|79373238|FG000|Overall Study|Unknown reasons|312|||
44367885|NCT01011738|79373239|FG001|Overall Study|Unknown reasons|291|||
44367886|NCT01011738|79373240|FG002|Overall Study|Unknown reasons|17|||
44367887|NCT00918333|79373251|FG000|Overall Study|Drug not taken per protocol|1|||
44367888|NCT00918333|79373252|FG001|Overall Study|Drug not taken per protocol|0|||
44367889|NCT00918333|79373251|FG000|Overall Study|Inadequate amount of drugs provided|1|||
44452095|NCT00080119|79461004|FG001|Overall Study|Discontinued because of study closure|0|||
44367890|NCT00918333|79373252|FG001|Overall Study|Inadequate amount of drugs provided|4|||
44367891|NCT00918333|79373251|FG000|Overall Study|Ineligible|1|||
44367892|NCT00918333|79373252|FG001|Overall Study|Ineligible|0|||
44367893|NCT00918333|79373251|FG000|Overall Study|Withdrawal by Subject|0|||
44367894|NCT00918333|79373252|FG001|Overall Study|Withdrawal by Subject|1|||
44367895|NCT01091363|79373263|FG000|Overall Study|Withdrawal by Subject|11|||
44367896|NCT01091363|79373264|FG001|Overall Study|Withdrawal by Subject|15|||
44206419|NCT01945034|79002645|FG001|Overall Study|Withdrawal by Subject|3|||
44206420|NCT01945034|79002646|FG002|Overall Study|Withdrawal by Subject|1|||
44206421|NCT01945034|79002644|FG000|Overall Study|Other|0|||
44206422|NCT01945034|79002645|FG001|Overall Study|Other|1|||
44206423|NCT01945034|79002646|FG002|Overall Study|Other|3|||
44206424|NCT01945034|79002644|FG000|Overall Study|Lost to Follow-up|0|||
44206425|NCT01945034|79002645|FG001|Overall Study|Lost to Follow-up|0|||
44206426|NCT01945034|79002646|FG002|Overall Study|Lost to Follow-up|2|||
44206427|NCT01945034|79002644|FG000|Overall Study|Protocol Violation|1|||
44206428|NCT01945034|79002645|FG001|Overall Study|Protocol Violation|0|||
44206429|NCT01945034|79002646|FG002|Overall Study|Protocol Violation|1|||
44206430|NCT01960790|79002654|FG000|Overall Study|Survey forms could not be recovered|3|||
44367897|NCT01091363|79373263|FG000|Overall Study|Lost to Follow-up|2|||
44367898|NCT01091363|79373264|FG001|Overall Study|Lost to Follow-up|2|||
44367899|NCT01090973|79373270|FG000|Overall Study|Disease progression|1|||
44367900|NCT01090739|79373274|FG000|Enrollment|Withdrawal by Subject|24|||
44367901|NCT01090739|79373274|FG000|Enrollment|Protocol Violation|14|||
44367902|NCT01090739|79373274|FG000|Enrollment|Lost to Follow-up|5|||
44367903|NCT01090739|79373274|FG000|Enrollment|Physician Decision|5|||
44367904|NCT01090739|79373274|FG000|Enrollment|Sponsor termination of site|4|||
44367905|NCT01090739|79373274|FG000|Enrollment|Study implant limit reached|2|||
44367906|NCT01090739|79373274|FG000|Enrollment|Adverse Event|1|||
44367907|NCT01090739|79373274|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
44367908|NCT01090739|79373274|FG000|12 Month Follow-up|Lost to Follow-up|1|||
44367909|NCT01090739|79373274|FG000|12 Month Follow-up|Physician Decision|1|||
44206431|NCT01960790|79002654|FG000|Overall Study|Treat with Humira outside survey period|3|||
44206432|NCT01960790|79002654|FG000|Overall Study|Transferred to another hospital|4|||
44206433|NCT01960790|79002654|FG000|Overall Study|Unevaluable for safety|1|||
44206434|NCT01618214|79002660|FG000|Overall Study|Adverse Event|3|||
44206435|NCT01618214|79002661|FG001|Overall Study|Adverse Event|1|||
44206436|NCT01618214|79002660|FG000|Overall Study|Lack of Efficacy|1|||
44206437|NCT01618214|79002661|FG001|Overall Study|Lack of Efficacy|1|||
44206438|NCT01618214|79002660|FG000|Overall Study|Protocol Violation|1|||
44206439|NCT01618214|79002661|FG001|Overall Study|Protocol Violation|4|||
44206440|NCT01618214|79002660|FG000|Overall Study|Withdrawal Criteria|1|||
44206441|NCT01618214|79002661|FG001|Overall Study|Withdrawal Criteria|2|||
44206442|NCT01618214|79002660|FG000|Overall Study|Unclassified|4|||
44206443|NCT01618214|79002661|FG001|Overall Study|Unclassified|5|||
44206444|NCT01917968|79002669|FG000|Overall Study|Death|3|||
44206445|NCT01917968|79002670|FG001|Overall Study|Death|2|||
44206446|NCT01917968|79002669|FG000|Overall Study|Lost to Follow-up|21|||
44206447|NCT01917968|79002670|FG001|Overall Study|Lost to Follow-up|39|||
44206448|NCT01917968|79002669|FG000|Overall Study|Physician Decision|1|||
44206449|NCT01917968|79002670|FG001|Overall Study|Physician Decision|2|||
44206450|NCT01917968|79002669|FG000|Overall Study|Withdrawal by Subject|20|||
44206451|NCT01917968|79002670|FG001|Overall Study|Withdrawal by Subject|35|||
44206452|NCT01917968|79002669|FG000|Overall Study|Subject Relocation|5|||
44206453|NCT01917968|79002670|FG001|Overall Study|Subject Relocation|1|||
44206454|NCT01917968|79002669|FG000|Overall Study|36M Missed Visit|3|||
44206455|NCT01917968|79002670|FG001|Overall Study|36M Missed Visit|2|||
44206456|NCT01917968|79002669|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
44206457|NCT01917968|79002670|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
44206458|NCT01917968|79002669|FG000|Overall Study|Change in Family Circumstances|0|||
44206459|NCT01917968|79002670|FG001|Overall Study|Change in Family Circumstances|1|||
44206460|NCT01917968|79002669|FG000|Overall Study|No Data Available|0|||
44206461|NCT01917968|79002670|FG001|Overall Study|No Data Available|2|||
44206462|NCT01917656|79002685|FG000|Overall Study|Adverse Event|11|||
44206463|NCT01917656|79002686|FG001|Overall Study|Adverse Event|0|||
44206464|NCT01917656|79002685|FG000|Overall Study|Withdrawal criteria|8|||
44367910|NCT01090739|79373274|FG000|12 Month Follow-up|Death|1|||
44367911|NCT01090739|79373274|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
44367912|NCT01090739|79373274|FG000|24 Month Follow-up|Lost to Follow-up|1|||
44367913|NCT01090739|79373274|FG000|24 Month Follow-up|Death|1|||
44206465|NCT01917656|79002686|FG001|Overall Study|Withdrawal criteria|14|||
44367914|NCT01090739|79373274|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
44367915|NCT01090739|79373274|FG000|36 Month Follow-up|Visit still pending|17|||
44367916|NCT00916383|79373292|FG000|Overall Study|Adverse Event|1|||
44206466|NCT01917656|79002685|FG000|Overall Study|Unclassified|0|||
44206467|NCT01917656|79002686|FG001|Overall Study|Unclassified|3|||
44206468|NCT01917656|79002685|FG000|Overall Study|Withdrawal by Subject|4|||
44206469|NCT01917656|79002686|FG001|Overall Study|Withdrawal by Subject|3|||
44206470|NCT01917656|79002685|FG000|Overall Study|Lost to Follow-up|3|||
44206471|NCT01917656|79002686|FG001|Overall Study|Lost to Follow-up|4|||
44367917|NCT00916383|79373292|FG000|Overall Study|Death|1|||
44367918|NCT00916383|79373292|FG000|Overall Study|Protocol Violation|1|||
44367919|NCT00916305|79373302|FG000|Overall Study|Lost to Follow-up|21|||
44367920|NCT00916305|79373303|FG001|Overall Study|Lost to Follow-up|27|||
44367921|NCT00916305|79373302|FG000|Overall Study|Withdrawal by Subject|0|||
44367922|NCT00916305|79373303|FG001|Overall Study|Withdrawal by Subject|1|||
44206472|NCT01944722|79002694|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
44206473|NCT01944722|79002694|FG000|Overall Study|Specimen Shipping Issues|34|||
44206474|NCT01944722|79002694|FG000|Overall Study|Improper Storage/Transport|5|||
44206475|NCT01944722|79002694|FG000|Overall Study|Insufficient Volume for Test|1|||
44206476|NCT01944722|79002694|FG000|Overall Study|Missing Specimens|3|||
44206477|NCT01944722|79002694|FG000|Overall Study|Specimens Mislabeled|2|||
44206478|NCT01944722|79002694|FG000|Overall Study|Withdrawal by Subject|8|||
44206479|NCT01944722|79002694|FG000|Overall Study|NILM Subjects <30 years old|8106|||
44206480|NCT01944722|79002694|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
44206481|NCT01944722|79002694|FG000|Overall Study|>ASCUS Cytology|1122|||
44206482|NCT01917344|79002703|FG000|Overall Study|Withdrawal by Subject|1|||
44206483|NCT02017535|79002711|FG000|Overall Study|Withdrawal by Subject|1|||
44206484|NCT02017535|79002712|FG001|Overall Study|Withdrawal by Subject|0|||
44206485|NCT02017535|79002713|FG002|Overall Study|Withdrawal by Subject|0|||
44206486|NCT02017535|79002714|FG003|Overall Study|Withdrawal by Subject|0|||
44206487|NCT01944098|79002726|FG000|Overall Study|Physician Decision|1|||
44206488|NCT01944098|79002727|FG001|Overall Study|Physician Decision|0|||
44206489|NCT02017223|79002733|FG000|Overall Study|Algorithm problems|2|||
44206490|NCT01944020|79002739|FG000|Overall Study|Withdrawal by Subject|5|||
44206491|NCT01944020|79002740|FG001|Overall Study|Withdrawal by Subject|0|||
44206492|NCT01943552|79002748|FG000|Overall Study|Adverse Event|3|||
44206493|NCT01943552|79002749|FG001|Overall Study|Adverse Event|2|||
44206494|NCT01943552|79002748|FG000|Overall Study|Withdrawal by Subject|6|||
44367923|NCT00916149|79373312|FG000|Overall Study|Lost to Follow-up|3|||
44367924|NCT00916149|79373313|FG001|Overall Study|Lost to Follow-up|2|||
44367925|NCT00916149|79373314|FG002|Overall Study|Lost to Follow-up|0|||
44367926|NCT00916149|79373312|FG000|Overall Study|Unable to place scalp EEG leads|1|||
44367927|NCT00916149|79373313|FG001|Overall Study|Unable to place scalp EEG leads|0|||
44367928|NCT00916149|79373314|FG002|Overall Study|Unable to place scalp EEG leads|0|||
44367929|NCT01090427|79373324|FG000|After Controlled Period|Death|0|||
44367930|NCT01090427|79373325|FG001|After Controlled Period|Death|0|||
44367931|NCT01090427|79373326|FG002|After Controlled Period|Death|0|||
44367932|NCT01090427|79373327|FG003|After Controlled Period|Death|0|||
44367933|NCT01090427|79373328|FG004|After Controlled Period|Death|0|||
44367934|NCT01090427|79373329|FG005|After Controlled Period|Death|1|||
44367935|NCT01090427|79373330|FG006|After Controlled Period|Death|0|||
44367936|NCT01090427|79373324|FG000|After Controlled Period|Lack of Efficacy|0|||
44367937|NCT01090427|79373325|FG001|After Controlled Period|Lack of Efficacy|0|||
44367938|NCT01090427|79373326|FG002|After Controlled Period|Lack of Efficacy|0|||
44367939|NCT01090427|79373327|FG003|After Controlled Period|Lack of Efficacy|0|||
44367940|NCT01090427|79373328|FG004|After Controlled Period|Lack of Efficacy|0|||
44367941|NCT01090427|79373329|FG005|After Controlled Period|Lack of Efficacy|3|||
44367942|NCT01090427|79373330|FG006|After Controlled Period|Lack of Efficacy|2|||
44367943|NCT01090427|79373324|FG000|After Controlled Period|Adverse Event|0|||
44367944|NCT01090427|79373325|FG001|After Controlled Period|Adverse Event|0|||
44367945|NCT01090427|79373326|FG002|After Controlled Period|Adverse Event|0|||
44367946|NCT01090427|79373327|FG003|After Controlled Period|Adverse Event|2|||
44367947|NCT01090427|79373328|FG004|After Controlled Period|Adverse Event|0|||
44367948|NCT01090427|79373329|FG005|After Controlled Period|Adverse Event|1|||
44367949|NCT01090427|79373330|FG006|After Controlled Period|Adverse Event|0|||
44367950|NCT01016262|79373354|FG000|Double-blind Phase|Adverse Event|0|||
44367951|NCT01016262|79373355|FG001|Double-blind Phase|Adverse Event|0|||
44367952|NCT01016262|79373356|FG002|Double-blind Phase|Adverse Event|1|||
44367953|NCT01016262|79373357|FG003|Double-blind Phase|Adverse Event|0|||
44367954|NCT01016262|79373358|FG004|Double-blind Phase|Adverse Event|0|||
44367955|NCT01016262|79373359|FG005|Double-blind Phase|Adverse Event|0|||
44367956|NCT01016262|79373354|FG000|Double-blind Phase|Lack of Efficacy|1|||
44367957|NCT01016262|79373355|FG001|Double-blind Phase|Lack of Efficacy|0|||
44367958|NCT01016262|79373356|FG002|Double-blind Phase|Lack of Efficacy|5|||
44367959|NCT01016262|79373357|FG003|Double-blind Phase|Lack of Efficacy|0|||
44367960|NCT01016262|79373358|FG004|Double-blind Phase|Lack of Efficacy|0|||
44367961|NCT01016262|79373359|FG005|Double-blind Phase|Lack of Efficacy|0|||
44367962|NCT01016262|79373354|FG000|Double-blind Phase|Disease Progression|0|||
44367963|NCT01016262|79373355|FG001|Double-blind Phase|Disease Progression|1|||
44367964|NCT01016262|79373356|FG002|Double-blind Phase|Disease Progression|2|||
44206495|NCT01943552|79002749|FG001|Overall Study|Withdrawal by Subject|6|||
44367965|NCT01016262|79373357|FG003|Double-blind Phase|Disease Progression|0|||
44367966|NCT01016262|79373358|FG004|Double-blind Phase|Disease Progression|0|||
44367967|NCT01016262|79373359|FG005|Double-blind Phase|Disease Progression|0|||
44206496|NCT01943552|79002748|FG000|Overall Study|Other Reasons|16|||
44206497|NCT01943552|79002749|FG001|Overall Study|Other Reasons|17|||
44206498|NCT01915940|79002757|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
44367968|NCT01016262|79373354|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
44367969|NCT01016262|79373355|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
44367970|NCT01016262|79373356|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
44367971|NCT01016262|79373357|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
44367972|NCT01016262|79373358|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
44367973|NCT01016262|79373359|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
44367974|NCT01016262|79373354|FG000|Open-Label Phase|Adverse Event|0|||
44367975|NCT01016262|79373355|FG001|Open-Label Phase|Adverse Event|0|||
44367976|NCT01016262|79373356|FG002|Open-Label Phase|Adverse Event|0|||
44367977|NCT01016262|79373357|FG003|Open-Label Phase|Adverse Event|1|||
44367978|NCT01016262|79373358|FG004|Open-Label Phase|Adverse Event|0|||
44367979|NCT01016262|79373359|FG005|Open-Label Phase|Adverse Event|0|||
44367980|NCT01016262|79373354|FG000|Open-Label Phase|Lost to Follow-up|0|||
44367981|NCT01016262|79373355|FG001|Open-Label Phase|Lost to Follow-up|0|||
44367982|NCT01016262|79373356|FG002|Open-Label Phase|Lost to Follow-up|0|||
44367983|NCT01016262|79373357|FG003|Open-Label Phase|Lost to Follow-up|0|||
44367984|NCT01016262|79373358|FG004|Open-Label Phase|Lost to Follow-up|1|||
44367985|NCT01016262|79373359|FG005|Open-Label Phase|Lost to Follow-up|0|||
44367986|NCT01016262|79373354|FG000|Open-Label Phase|Lack of Efficacy|0|||
44367987|NCT01016262|79373355|FG001|Open-Label Phase|Lack of Efficacy|0|||
44367988|NCT01016262|79373356|FG002|Open-Label Phase|Lack of Efficacy|0|||
44367989|NCT01016262|79373357|FG003|Open-Label Phase|Lack of Efficacy|1|||
44367990|NCT01016262|79373358|FG004|Open-Label Phase|Lack of Efficacy|0|||
44367991|NCT01016262|79373359|FG005|Open-Label Phase|Lack of Efficacy|0|||
44367992|NCT01016262|79373354|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
44367993|NCT01016262|79373355|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
44367994|NCT01016262|79373356|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
44367995|NCT01016262|79373357|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
44367996|NCT01016262|79373358|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
44367997|NCT01016262|79373359|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
44367999|NCT01009554|79373376|FG000|Overall Study|Adverse Event|1|||
44368000|NCT01009554|79373377|FG001|Overall Study|Adverse Event|1|||
44368001|NCT01009554|79373376|FG000|Overall Study|Withdrawal by Subject|1|||
44368002|NCT01009554|79373377|FG001|Overall Study|Withdrawal by Subject|3|||
44368003|NCT01009554|79373376|FG000|Overall Study|Noncompliant with Study Product|0|||
44368004|NCT01009554|79373377|FG001|Overall Study|Noncompliant with Study Product|3|||
44368005|NCT01006590|79373385|FG000|Overall Study|Adverse Event|2|||
44368006|NCT01006590|79373386|FG001|Overall Study|Adverse Event|3|||
44368007|NCT01006590|79373385|FG000|Overall Study|Death|1|||
44368008|NCT01006590|79373386|FG001|Overall Study|Death|1|||
44368009|NCT01006590|79373385|FG000|Overall Study|Lost to Follow-up|1|||
44206499|NCT01915940|79002758|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
44206500|NCT01915940|79002759|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
44206501|NCT01915940|79002757|FG000|Treatment Period|Decision of Participant|0|||
44206502|NCT01915940|79002758|FG001|Treatment Period|Decision of Participant|1|||
44206503|NCT01915940|79002759|FG002|Treatment Period|Decision of Participant|3|||
44206504|NCT01915940|79002757|FG000|Treatment Period|Adverse Event|0|||
44206505|NCT01915940|79002758|FG001|Treatment Period|Adverse Event|9|||
44206506|NCT01915940|79002759|FG002|Treatment Period|Adverse Event|1|||
44206507|NCT01915940|79002757|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
44206508|NCT01915940|79002758|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
44206509|NCT01915940|79002759|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
44206510|NCT01914926|79002767|FG000|Overall Study|Adverse Event|1|||
44206511|NCT01914926|79002768|FG001|Overall Study|Adverse Event|0|||
44206512|NCT01914926|79002767|FG000|Overall Study|uncooperative, agitated and removed|0|||
44206513|NCT01914926|79002768|FG001|Overall Study|uncooperative, agitated and removed|1|||
44206514|NCT02016755|79002774|FG000|Overall Study|Major amputation of index limb|2|||
44206515|NCT02016755|79002774|FG000|Overall Study|Adverse Event|2|||
44206516|NCT02016755|79002774|FG000|Overall Study|Physician Decision|1|||
44206517|NCT02016755|79002774|FG000|Overall Study|Death|2|||
44206518|NCT01942148|79002778|FG000|Overall Study|Adverse Event|4|||
44206519|NCT01942148|79002778|FG000|Overall Study|Lack of Efficacy|2|||
44206520|NCT01942148|79002778|FG000|Overall Study|Physician Decision|11|||
44206521|NCT01942148|79002778|FG000|Overall Study|Protocol Violation|1|||
44368010|NCT01006590|79373386|FG001|Overall Study|Lost to Follow-up|1|||
44368011|NCT01006590|79373385|FG000|Overall Study|Protocol Violation|1|||
44368012|NCT01006590|79373386|FG001|Overall Study|Protocol Violation|0|||
44368013|NCT01006590|79373385|FG000|Overall Study|Withdrawal by Subject|4|||
44368014|NCT01006590|79373386|FG001|Overall Study|Withdrawal by Subject|2|||
44368015|NCT01006590|79373385|FG000|Overall Study|Study specific discontinuation criteria|16|||
44206522|NCT01942148|79002778|FG000|Overall Study|Withdrawal by Subject|8|||
44206523|NCT01942148|79002778|FG000|Overall Study|Use of the prohibition medicine|1|||
44206524|NCT02030015|79002782|FG000|Overall Study|Withdrawal by Subject|3|||
44206525|NCT02030015|79002782|FG000|Overall Study|Death|13|||
44206526|NCT02029235|79002788|FG000|Overall Study|Non-compliance with study meds or diary|4|||
44368016|NCT01006590|79373386|FG001|Overall Study|Study specific discontinuation criteria|23|||
44368017|NCT01006590|79373385|FG000|Overall Study|Other|3|||
44368018|NCT01006590|79373386|FG001|Overall Study|Other|2|||
44368019|NCT01001832|79373394|FG000|Short-term Period|Adverse Event|2|||
44206527|NCT02029235|79002789|FG001|Overall Study|Non-compliance with study meds or diary|1|||
44206528|NCT01617434|79002797|FG000|Overall Study|Adverse Event|12|||
44206529|NCT01617434|79002798|FG001|Overall Study|Adverse Event|3|||
44206530|NCT01617434|79002797|FG000|Overall Study|Protocol Violation|8|||
44206531|NCT01617434|79002798|FG001|Overall Study|Protocol Violation|7|||
44206532|NCT01617434|79002797|FG000|Overall Study|Withdrawal Criteria|12|||
44206533|NCT01617434|79002798|FG001|Overall Study|Withdrawal Criteria|37|||
44206534|NCT01617434|79002797|FG000|Overall Study|Unclassified|3|||
44206535|NCT01617434|79002798|FG001|Overall Study|Unclassified|4|||
44206536|NCT01940354|79002806|FG000|Overall Study|Withdrawal by Subject|4|||
44368020|NCT01001832|79373395|FG001|Short-term Period|Adverse Event|3|||
44368021|NCT01001832|79373394|FG000|Long-term Period|Adverse Event|2|||
44368022|NCT01001832|79373395|FG001|Long-term Period|Adverse Event|1|||
44368023|NCT01001832|79373394|FG000|Long-term Period|Withdrawal by Subject|1|||
44368024|NCT01001832|79373395|FG001|Long-term Period|Withdrawal by Subject|0|||
44368025|NCT01001832|79373394|FG000|Long-term Period|Lack of Efficacy|0|||
44368026|NCT01001832|79373395|FG001|Long-term Period|Lack of Efficacy|2|||
44368027|NCT01001832|79373394|FG000|Long-term Period|Other|1|||
44368028|NCT01001832|79373395|FG001|Long-term Period|Other|2|||
44368029|NCT01001832|79373394|FG000|Follow-up Period|Withdrawal by Subject|1|||
44368030|NCT01001832|79373395|FG001|Follow-up Period|Withdrawal by Subject|0|||
44368031|NCT01001832|79373394|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
44368032|NCT01001832|79373395|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
44368033|NCT01001832|79373394|FG000|Follow-up Period|Other|2|||
44368034|NCT01001832|79373395|FG001|Follow-up Period|Other|1|||
44368035|NCT01001598|79373404|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
44543351|NCT03742271|79556322|FG000|Overall Study|Failed Insertion & removal|3|||
44368036|NCT01001598|79373404|FG000|Overall Study|Adverse Event|1|||
44368037|NCT01006356|79373408|FG000|Overall Study|Adverse Event|6|||
44368038|NCT01006356|79373408|FG000|Overall Study|Physician Decision|1|||
44368039|NCT01006356|79373408|FG000|Overall Study|Paticipants did not cooperate|6|||
44368040|NCT01006356|79373408|FG000|Overall Study|Withdrawal by Subject|1|||
44368041|NCT01006356|79373408|FG000|Overall Study|Choice by participants|2|||
44368042|NCT01006356|79373408|FG000|Overall Study|Protocol Violation|3|||
44368043|NCT01006356|79373408|FG000|Overall Study|Other|23|||
44368044|NCT01089725|79373417|FG000|Overall Study|Adverse Event|1|||
44368045|NCT01089725|79373418|FG001|Overall Study|Adverse Event|1|||
44368046|NCT01089725|79373419|FG002|Overall Study|Adverse Event|0|||
44368047|NCT01089725|79373420|FG003|Overall Study|Adverse Event|0|||
44368048|NCT01089725|79373421|FG004|Overall Study|Adverse Event|2|||
44368049|NCT01089725|79373417|FG000|Overall Study|Lack of Efficacy|4|||
44368050|NCT01089725|79373418|FG001|Overall Study|Lack of Efficacy|3|||
44368051|NCT01089725|79373419|FG002|Overall Study|Lack of Efficacy|1|||
44368052|NCT01089725|79373420|FG003|Overall Study|Lack of Efficacy|0|||
44368053|NCT01089725|79373421|FG004|Overall Study|Lack of Efficacy|4|||
44368054|NCT01089725|79373417|FG000|Overall Study|Lost to Follow-up|2|||
44368055|NCT01089725|79373418|FG001|Overall Study|Lost to Follow-up|2|||
44368056|NCT01089725|79373419|FG002|Overall Study|Lost to Follow-up|0|||
44368057|NCT01089725|79373420|FG003|Overall Study|Lost to Follow-up|3|||
44368058|NCT01089725|79373421|FG004|Overall Study|Lost to Follow-up|0|||
44368059|NCT01089725|79373417|FG000|Overall Study|Protocol Violation|0|||
44368060|NCT01089725|79373418|FG001|Overall Study|Protocol Violation|0|||
44368061|NCT01089725|79373419|FG002|Overall Study|Protocol Violation|1|||
44368062|NCT01089725|79373420|FG003|Overall Study|Protocol Violation|1|||
44368063|NCT01089725|79373421|FG004|Overall Study|Protocol Violation|0|||
44543352|NCT03742271|79556322|FG000|Overall Study|Protocol Violation|1|||
44368064|NCT01089725|79373417|FG000|Overall Study|Withdrawal by Subject|5|||
44368065|NCT01089725|79373418|FG001|Overall Study|Withdrawal by Subject|5|||
44368066|NCT01089725|79373419|FG002|Overall Study|Withdrawal by Subject|4|||
44368067|NCT01089725|79373420|FG003|Overall Study|Withdrawal by Subject|5|||
44368068|NCT01089725|79373421|FG004|Overall Study|Withdrawal by Subject|4|||
44206537|NCT01940354|79002807|FG001|Overall Study|Withdrawal by Subject|2|||
44206538|NCT01940120|79002813|FG000|Overall Study|Death|40|||
44368069|NCT01089725|79373417|FG000|Overall Study|Study Terminated by Sponsor|51|||
44368070|NCT01089725|79373418|FG001|Overall Study|Study Terminated by Sponsor|56|||
44368071|NCT01089725|79373419|FG002|Overall Study|Study Terminated by Sponsor|53|||
44368072|NCT01089725|79373420|FG003|Overall Study|Study Terminated by Sponsor|68|||
44368073|NCT01089725|79373421|FG004|Overall Study|Study Terminated by Sponsor|68|||
44368074|NCT01089725|79373417|FG000|Overall Study|Randomized, but not treated|0|||
44368075|NCT01089725|79373418|FG001|Overall Study|Randomized, but not treated|1|||
44368076|NCT01089725|79373419|FG002|Overall Study|Randomized, but not treated|2|||
44206539|NCT01940120|79002813|FG000|Overall Study|Withdrawal by Subject|8|||
44206540|NCT01911260|79002822|FG000|Supplementation Period|transference or evasion of school|7|||
44206541|NCT01911260|79002823|FG001|Supplementation Period|transference or evasion of school|9|||
44206542|NCT01911260|79002824|FG002|Supplementation Period|transference or evasion of school|7|||
44206543|NCT01911260|79002825|FG003|Supplementation Period|transference or evasion of school|6|||
44206544|NCT01911260|79002822|FG000|Supplementation Period|Adverse Event|2|||
44206545|NCT01911260|79002823|FG001|Supplementation Period|Adverse Event|0|||
44206546|NCT01911260|79002824|FG002|Supplementation Period|Adverse Event|1|||
44206547|NCT01911260|79002825|FG003|Supplementation Period|Adverse Event|0|||
44206548|NCT01911260|79002822|FG000|Supplementation Period|refused to receive supplement|1|||
44206549|NCT01911260|79002823|FG001|Supplementation Period|refused to receive supplement|0|||
44206550|NCT01911260|79002824|FG002|Supplementation Period|refused to receive supplement|1|||
44206551|NCT01911260|79002825|FG003|Supplementation Period|refused to receive supplement|0|||
44206552|NCT01911260|79002822|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
44206553|NCT01911260|79002823|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
44206554|NCT01911260|79002824|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
44206555|NCT01911260|79002825|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
44206556|NCT01911260|79002822|FG000|Follow-up Period|transference or evasion of school|13|||
44206557|NCT01911260|79002823|FG001|Follow-up Period|transference or evasion of school|20|||
44206558|NCT01911260|79002824|FG002|Follow-up Period|transference or evasion of school|15|||
44543353|NCT03214224|79556326|FG000|Overall Study|Protocol Violation|1|||
44206559|NCT01911260|79002825|FG003|Follow-up Period|transference or evasion of school|12|||
44206560|NCT02015819|79002839|FG000|Overall Study|Rickham catheter was misaligned|0|||
44206561|NCT02015819|79002840|FG001|Overall Study|Rickham catheter was misaligned|0|||
44206562|NCT02015819|79002841|FG002|Overall Study|Rickham catheter was misaligned|0|||
44206563|NCT02015819|79002842|FG003|Overall Study|Rickham catheter was misaligned|1|||
44206564|NCT01939496|79002859|FG000|Overall Study|Adverse Event|2|||
44206565|NCT01939496|79002860|FG001|Overall Study|Adverse Event|0|||
44206566|NCT01939496|79002861|FG002|Overall Study|Adverse Event|0|||
44206567|NCT01939496|79002859|FG000|Overall Study|Lost to Follow-up|1|||
44206568|NCT01939496|79002860|FG001|Overall Study|Lost to Follow-up|1|||
44206569|NCT01939496|79002861|FG002|Overall Study|Lost to Follow-up|0|||
44206570|NCT01939496|79002859|FG000|Overall Study|Physician Decision|1|||
44206571|NCT01939496|79002860|FG001|Overall Study|Physician Decision|0|||
44206572|NCT01939496|79002861|FG002|Overall Study|Physician Decision|0|||
44206573|NCT01939496|79002859|FG000|Overall Study|Protocol Violation|3|||
44206574|NCT01939496|79002860|FG001|Overall Study|Protocol Violation|0|||
44206575|NCT01939496|79002861|FG002|Overall Study|Protocol Violation|0|||
44206576|NCT01939496|79002859|FG000|Overall Study|Withdrawal by Subject|0|||
44206577|NCT01939496|79002860|FG001|Overall Study|Withdrawal by Subject|1|||
44206578|NCT01939496|79002861|FG002|Overall Study|Withdrawal by Subject|1|||
44206579|NCT01939496|79002859|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
44206580|NCT01939496|79002860|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
44206581|NCT01939496|79002861|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
44206582|NCT01939496|79002859|FG000|Overall Study|Other|2|||
44206583|NCT01939496|79002860|FG001|Overall Study|Other|0|||
44206584|NCT01939496|79002861|FG002|Overall Study|Other|1|||
44206585|NCT01939028|79002869|FG000|Overall Study|Withdrawal by Subject|5|||
44206586|NCT01939028|79002869|FG000|Overall Study|Physician Decision|7|||
44206587|NCT01938716|79002873|FG000|Overall Study|Physician Decision|2|||
44206588|NCT01938716|79002873|FG000|Overall Study|Withdrawal by Subject|2|||
44206589|NCT01937390|79002877|FG000|Overall Study|Death|2|||
44206590|NCT01937390|79002877|FG000|Overall Study|Lost to Follow-up|7|||
44368077|NCT01089725|79373420|FG003|Overall Study|Randomized, but not treated|1|||
44368078|NCT01089725|79373421|FG004|Overall Study|Randomized, but not treated|2|||
44368079|NCT01089725|79373417|FG000|Overall Study|Other|3|||
44368080|NCT01089725|79373418|FG001|Overall Study|Other|0|||
44368081|NCT01089725|79373419|FG002|Overall Study|Other|0|||
44368082|NCT01089725|79373420|FG003|Overall Study|Other|1|||
44368083|NCT01089725|79373421|FG004|Overall Study|Other|0|||
44368084|NCT01101191|79373437|FG000|Period 1|Withdrawal by Subject|1|||
44368085|NCT01101191|79373438|FG001|Period 1|Withdrawal by Subject|0|||
44368086|NCT01101191|79373437|FG000|Period 1|Adverse Event|1|||
44368087|NCT01101191|79373438|FG001|Period 1|Adverse Event|2|||
44368088|NCT01178762|79373445|FG000|Overall Study|Lost to Follow-up|15|||
44206591|NCT01937390|79002877|FG000|Overall Study|Withdrawal by Subject|5|||
44206592|NCT01937390|79002877|FG000|Overall Study|Fail to return|21|||
44206593|NCT02028767|79002881|FG000|Treatment Period 2|Non compliant with protocol|1|||
44206594|NCT02028767|79002882|FG001|Treatment Period 2|Non compliant with protocol|0|||
44368089|NCT01178294|79373449|FG000|Overall Study|Adverse Event|4|||
44368090|NCT01178294|79373449|FG000|Overall Study|Lost to Follow-up|2|||
44368091|NCT01178294|79373449|FG000|Overall Study|Lack of Efficacy|1|||
44368092|NCT01178294|79373449|FG000|Overall Study|Death|1|||
44368093|NCT01178294|79373449|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
44206595|NCT02028767|79002881|FG000|Treatment Period 2|Reason other than those specified above|1|||
44206596|NCT02028767|79002882|FG001|Treatment Period 2|Reason other than those specified above|0|||
44206597|NCT01959932|79002891|FG000|Overall Study|Withdrawal by Subject|1|||
44206598|NCT01959932|79002892|FG001|Overall Study|Withdrawal by Subject|0|||
44206599|NCT01959932|79002893|FG002|Overall Study|Withdrawal by Subject|0|||
44206600|NCT02028065|79002905|FG000|Randomization Through Start Treatment|Not treated|1|||
44206601|NCT02028065|79002906|FG001|Randomization Through Start Treatment|Not treated|3|||
44206602|NCT02028065|79002907|FG002|Randomization Through Start Treatment|Not treated|3|||
44206603|NCT02028065|79002905|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
44269583|NCT00558896|79193790|FG005|Overall Study|Death|2|||
44269584|NCT00558896|79193791|FG006|Overall Study|Death|6|||
44368094|NCT01178294|79373449|FG000|Overall Study|Subject status is terminal|1|||
44368095|NCT01178294|79373449|FG000|Overall Study|Completion status could not be verified|1|||
44206604|NCT02028065|79002906|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
44206605|NCT02028065|79002907|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
44206606|NCT02028065|79002905|FG000|Treatment Through Study Completion|Physician Decision|1|||
44368096|NCT01178138|79373453|FG000|Overall Study|Lost to Follow-up|8|||
44368097|NCT01178138|79373453|FG000|Overall Study|Withdrawal by Subject|7|||
44368098|NCT01178138|79373453|FG000|Overall Study|Physician Decision|8|||
44368099|NCT01177670|79373462|FG000|Overall Study|Study Terminated|115|||
44368100|NCT01177670|79373462|FG000|Overall Study|Physician Decision|50|||
44368101|NCT01177670|79373462|FG000|Overall Study|Withdrawal by Subject|4|||
44368102|NCT01190228|79373469|FG000|Overall Study|Protocol Violation|4|||
44206607|NCT02028065|79002906|FG001|Treatment Through Study Completion|Physician Decision|0|||
44206608|NCT02028065|79002907|FG002|Treatment Through Study Completion|Physician Decision|0|||
44206609|NCT02028065|79002905|FG000|Treatment Through Study Completion|Protocol Violation|1|||
44368103|NCT01190228|79373470|FG001|Overall Study|Protocol Violation|0|||
44206610|NCT02028065|79002906|FG001|Treatment Through Study Completion|Protocol Violation|4|||
44206611|NCT02028065|79002907|FG002|Treatment Through Study Completion|Protocol Violation|0|||
44206612|NCT02028065|79002905|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
44206613|NCT02028065|79002906|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
44206614|NCT02028065|79002907|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
44206615|NCT02028065|79002905|FG000|Treatment Through Study Completion|Adverse Event|3|||
44206616|NCT02028065|79002906|FG001|Treatment Through Study Completion|Adverse Event|3|||
44206617|NCT02028065|79002907|FG002|Treatment Through Study Completion|Adverse Event|5|||
44206618|NCT02015195|79002922|FG000|Overall Study|Adverse Event|0|||
44206619|NCT02015195|79002923|FG001|Overall Study|Adverse Event|0|||
44206620|NCT02015195|79002924|FG002|Overall Study|Adverse Event|0|||
44206621|NCT02015195|79002925|FG003|Overall Study|Adverse Event|1|||
44206622|NCT02015195|79002926|FG004|Overall Study|Adverse Event|0|||
44206623|NCT02015195|79002927|FG005|Overall Study|Adverse Event|0|||
44206624|NCT02015195|79002928|FG006|Overall Study|Adverse Event|0|||
44206625|NCT02015039|79002945|FG000|Overall Study|Not eligible|0|||
44206626|NCT02015039|79002946|FG001|Overall Study|Not eligible|1|||
44206627|NCT02025725|79002954|FG000|Overall Study|Adverse Event|5|||
44206628|NCT02025725|79002955|FG001|Overall Study|Adverse Event|0|||
44206629|NCT02025725|79002954|FG000|Overall Study|Lost to Follow-up|2|||
44206630|NCT02025725|79002955|FG001|Overall Study|Lost to Follow-up|0|||
44206631|NCT02025725|79002954|FG000|Overall Study|Protocol Violation|1|||
44206632|NCT02025725|79002955|FG001|Overall Study|Protocol Violation|1|||
44543354|NCT03214224|79556326|FG000|Overall Study|Withdrawal by Subject|2|||
44543355|NCT03214224|79556326|FG000|Overall Study|Practice controls or therapists|6|||
44206633|NCT02025725|79002954|FG000|Overall Study|Withdrawal by Subject|3|||
44206634|NCT02025725|79002955|FG001|Overall Study|Withdrawal by Subject|2|||
44368104|NCT01190228|79373471|FG002|Overall Study|Protocol Violation|0|||
44368105|NCT01190228|79373469|FG000|Overall Study|Withdrawal by Subject|1|||
44368106|NCT01190228|79373470|FG001|Overall Study|Withdrawal by Subject|0|||
44368107|NCT01190228|79373471|FG002|Overall Study|Withdrawal by Subject|0|||
44368108|NCT01009086|79373484|FG000|Overall Study|Lack of Efficacy|16|||
44368109|NCT01009086|79373485|FG001|Overall Study|Lack of Efficacy|15|||
44368110|NCT01009086|79373486|FG002|Overall Study|Lack of Efficacy|9|||
44368111|NCT01009086|79373484|FG000|Overall Study|Lost to Follow-up|4|||
44368112|NCT01009086|79373485|FG001|Overall Study|Lost to Follow-up|5|||
44368113|NCT01009086|79373486|FG002|Overall Study|Lost to Follow-up|3|||
44206635|NCT02025725|79002954|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
44206636|NCT02025725|79002955|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
44206637|NCT02025179|79002966|FG000|Overall Study|Lost to Follow-up|0|||
44206638|NCT02025179|79002967|FG001|Overall Study|Lost to Follow-up|0|||
44206639|NCT02025179|79002968|FG002|Overall Study|Lost to Follow-up|1|||
44206640|NCT02013791|79002985|FG000|Period 1|Lost to Follow-up|0|||
44206641|NCT02013791|79002986|FG001|Period 1|Lost to Follow-up|0|||
44206642|NCT02013791|79002987|FG002|Period 1|Lost to Follow-up|0|||
44206643|NCT02013791|79002988|FG003|Period 1|Lost to Follow-up|1|||
44206644|NCT02013791|79002989|FG004|Period 1|Lost to Follow-up|0|||
44206645|NCT02013791|79002990|FG005|Period 1|Lost to Follow-up|0|||
44206646|NCT02013791|79002991|FG006|Period 1|Lost to Follow-up|1|||
44206647|NCT02013791|79002992|FG007|Period 1|Lost to Follow-up|1|||
44543356|NCT03180645|79556333|FG000|Overall Study|Adverse Event|0|||
44206648|NCT02013791|79002993|FG008|Period 1|Lost to Follow-up|0|||
44206649|NCT02013791|79002985|FG000|Period 1|Other Miscellaneous Reasons|0|||
44206650|NCT02013791|79002986|FG001|Period 1|Other Miscellaneous Reasons|2|||
44206651|NCT02013791|79002987|FG002|Period 1|Other Miscellaneous Reasons|0|||
44206652|NCT02013791|79002988|FG003|Period 1|Other Miscellaneous Reasons|0|||
44368114|NCT01009086|79373484|FG000|Overall Study|Adverse Event|12|||
44368115|NCT01009086|79373485|FG001|Overall Study|Adverse Event|11|||
44368116|NCT01009086|79373486|FG002|Overall Study|Adverse Event|8|||
44206653|NCT02013791|79002989|FG004|Period 1|Other Miscellaneous Reasons|0|||
44368117|NCT01009086|79373484|FG000|Overall Study|Withdrawal by Subject|9|||
44206654|NCT02013791|79002990|FG005|Period 1|Other Miscellaneous Reasons|0|||
44206655|NCT02013791|79002991|FG006|Period 1|Other Miscellaneous Reasons|0|||
44206656|NCT02013791|79002992|FG007|Period 1|Other Miscellaneous Reasons|0|||
44206657|NCT02013791|79002993|FG008|Period 1|Other Miscellaneous Reasons|0|||
44206658|NCT02024867|79003016|FG000|Overall Study|Protocol Violation|3|||
44206659|NCT02024867|79003017|FG001|Overall Study|Protocol Violation|3|||
44206660|NCT02024867|79003016|FG000|Overall Study|Lost to Follow-up|6|||
44206661|NCT02024867|79003017|FG001|Overall Study|Lost to Follow-up|4|||
44206662|NCT01953601|79003026|FG000|Part 1 (Base Study)|Adverse Event|24|||
44206663|NCT01953601|79003027|FG001|Part 1 (Base Study)|Adverse Event|37|||
44206664|NCT01953601|79003028|FG002|Part 1 (Base Study)|Adverse Event|15|||
44368118|NCT01009086|79373485|FG001|Overall Study|Withdrawal by Subject|11|||
44368119|NCT01009086|79373486|FG002|Overall Study|Withdrawal by Subject|13|||
44368120|NCT01009086|79373484|FG000|Overall Study|Other|3|||
44368121|NCT01009086|79373485|FG001|Overall Study|Other|5|||
44368122|NCT01009086|79373486|FG002|Overall Study|Other|1|||
44368123|NCT01190150|79373501|FG000|First Treatment|Withdrawal by Subject|1|||
44368124|NCT01190150|79373502|FG001|First Treatment|Withdrawal by Subject|0|||
44368125|NCT01190150|79373501|FG000|Washout|Withdrawal by Subject|0|||
44368126|NCT01190150|79373502|FG001|Washout|Withdrawal by Subject|1|||
44368127|NCT01190150|79373501|FG000|Washout|Difficulty in adherence|0|||
44368128|NCT01190150|79373502|FG001|Washout|Difficulty in adherence|1|||
44368129|NCT01001520|79373508|FG000|Medication Period 1|Withdrawal by Subject|2|||
44368130|NCT01001520|79373509|FG001|Medication Period 1|Withdrawal by Subject|2|||
44368131|NCT01001520|79373508|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
44368132|NCT01001520|79373509|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
44368133|NCT01001520|79373508|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
44206665|NCT01953601|79003026|FG000|Part 1 (Base Study)|Death|2|||
44206666|NCT01953601|79003027|FG001|Part 1 (Base Study)|Death|0|||
44206667|NCT01953601|79003028|FG002|Part 1 (Base Study)|Death|3|||
44206668|NCT01953601|79003026|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
44206669|NCT01953601|79003027|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
44206670|NCT01953601|79003028|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
44206671|NCT01953601|79003026|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
44206672|NCT01953601|79003027|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
44206673|NCT01953601|79003028|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
44206674|NCT01953601|79003026|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
44206675|NCT01953601|79003027|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
44206676|NCT01953601|79003028|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
44206677|NCT01953601|79003026|FG000|Part 1 (Base Study)|Physician Decision|3|||
44206678|NCT01953601|79003027|FG001|Part 1 (Base Study)|Physician Decision|7|||
44206679|NCT01953601|79003028|FG002|Part 1 (Base Study)|Physician Decision|4|||
44206680|NCT01953601|79003026|FG000|Part 1 (Base Study)|Screen failure|1|||
44206681|NCT01953601|79003027|FG001|Part 1 (Base Study)|Screen failure|0|||
44368134|NCT01001520|79373509|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
44368135|NCT01001520|79373508|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
44368136|NCT01001520|79373509|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
44368137|NCT01001520|79373508|FG000|Washout Period|Withdrawal by Subject|2|||
44368138|NCT01001520|79373509|FG001|Washout Period|Withdrawal by Subject|1|||
44368139|NCT01001520|79373508|FG000|Medication Period 2|Withdrawal by Subject|0|||
44368140|NCT01001520|79373509|FG001|Medication Period 2|Withdrawal by Subject|3|||
44368141|NCT01189604|79373542|FG000|Overall Study|Impossible to visit|0|||
44368142|NCT01189604|79373543|FG001|Overall Study|Impossible to visit|0|||
44368143|NCT01189604|79373544|FG002|Overall Study|Impossible to visit|0|||
44206682|NCT01953601|79003028|FG002|Part 1 (Base Study)|Screen failure|1|||
44206683|NCT01953601|79003026|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
44206684|NCT01953601|79003027|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
44206685|NCT01953601|79003028|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
44269585|NCT00558896|79193785|FG000|Overall Study|Withdrawal by Subject|2|||
44206686|NCT01953601|79003026|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
44269586|NCT00558896|79193786|FG001|Overall Study|Withdrawal by Subject|1|||
44368144|NCT01189604|79373545|FG003|Overall Study|Impossible to visit|0|||
44368145|NCT01189604|79373546|FG004|Overall Study|Impossible to visit|0|||
44368146|NCT01189604|79373547|FG005|Overall Study|Impossible to visit|1|||
44368147|NCT01189604|79373548|FG006|Overall Study|Impossible to visit|0|||
44368148|NCT01189604|79373542|FG000|Overall Study|Adverse Event|0|||
44368149|NCT01189604|79373543|FG001|Overall Study|Adverse Event|1|||
44368150|NCT01189604|79373544|FG002|Overall Study|Adverse Event|0|||
44368151|NCT01189604|79373545|FG003|Overall Study|Adverse Event|0|||
44368152|NCT01189604|79373546|FG004|Overall Study|Adverse Event|2|||
44206687|NCT01953601|79003027|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
44206688|NCT01953601|79003028|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
44269587|NCT00558896|79193787|FG002|Overall Study|Withdrawal by Subject|1|||
44206689|NCT01953601|79003026|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
44206690|NCT01953601|79003027|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
44206691|NCT01953601|79003028|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
44206692|NCT01953601|79003026|FG000|Part 1 (Base Study)|Subject moved|2|||
44206693|NCT01953601|79003027|FG001|Part 1 (Base Study)|Subject moved|2|||
44206694|NCT01953601|79003028|FG002|Part 1 (Base Study)|Subject moved|1|||
44543357|NCT03180645|79556334|FG001|Overall Study|Adverse Event|1|||
44543358|NCT03180645|79556335|FG002|Overall Study|Adverse Event|2|||
44543359|NCT03750695|79556347|FG000|Overall Study|Lost to Follow-up|0|||
44543360|NCT03750695|79556348|FG001|Overall Study|Lost to Follow-up|1|||
44543361|NCT03231228|79556361|FG000|Overall Study|Lost to Follow-up|2|||
44543362|NCT03231228|79556362|FG001|Overall Study|Lost to Follow-up|0|||
44543363|NCT03231228|79556361|FG000|Overall Study|Physician Decision|1|||
44543364|NCT03231228|79556362|FG001|Overall Study|Physician Decision|0|||
44543365|NCT03213366|79556370|FG000|Overall Study|Lost to Follow-up|9|||
44543366|NCT03213366|79556371|FG001|Overall Study|Lost to Follow-up|4|||
44543367|NCT03213210|79556377|FG000|Overall Study|Lost to Follow-up|2|||
44543368|NCT03213210|79556377|FG000|Overall Study|Study termination|3|||
44543369|NCT02932878|79556383|FG000|Overall Study|Due to Lab Results|2|||
44543370|NCT02932878|79556384|FG001|Overall Study|Due to Lab Results|1|||
44543371|NCT03230292|79556390|FG000|Overall Study|Adverse Event|1|||
44206695|NCT01953601|79003026|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
44206696|NCT01953601|79003027|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
44206697|NCT01953601|79003028|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
44543372|NCT03230292|79556390|FG000|Overall Study|Protocol Violation|1|||
44543373|NCT03230292|79556390|FG000|Overall Study|Lost to Follow-up|1|||
44543374|NCT03230292|79556390|FG000|Overall Study|Withdrawal by Subject|3|||
44543375|NCT03228420|79556398|FG000|Overall Study|Lost to Follow-up|5|||
44543376|NCT03228420|79556399|FG001|Overall Study|Lost to Follow-up|3|||
44543377|NCT03228420|79556398|FG000|Overall Study|Withdrawal by Subject|10|||
44543378|NCT03228420|79556399|FG001|Overall Study|Withdrawal by Subject|0|||
44543379|NCT03228420|79556398|FG000|Overall Study|Adverse Event|5|||
44543380|NCT03228420|79556399|FG001|Overall Study|Adverse Event|2|||
44543381|NCT03746483|79556407|FG000|Overall Study|Adverse Event|0|||
44543382|NCT03746483|79556408|FG001|Overall Study|Adverse Event|1|||
44543383|NCT03746483|79556407|FG000|Overall Study|Lack of Efficacy|3|||
44543384|NCT03746483|79556408|FG001|Overall Study|Lack of Efficacy|2|||
44543385|NCT03746483|79556407|FG000|Overall Study|Lost to Follow-up|1|||
44543386|NCT03746483|79556408|FG001|Overall Study|Lost to Follow-up|0|||
44543387|NCT03746483|79556407|FG000|Overall Study|Protocol Violation|2|||
44543388|NCT03746483|79556408|FG001|Overall Study|Protocol Violation|0|||
44543389|NCT03746405|79556418|FG000|Overall Study|Withdrawal by Subject|3|||
44543390|NCT03746405|79556419|FG001|Overall Study|Withdrawal by Subject|0|||
44543391|NCT03746405|79556418|FG000|Overall Study|technical difficulties|0|||
44543392|NCT03746405|79556419|FG001|Overall Study|technical difficulties|2|||
44543393|NCT03226392|79556427|FG000|Overall Study|Protocol Deviation|1|||
44206698|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Adverse Event|1|||
44206699|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Adverse Event|1|||
44206700|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Adverse Event|10|||
44206701|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Death|0|||
44206702|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Death|3|||
44206703|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Death|0|||
44206704|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
44206705|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
44206706|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
44206707|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
44269588|NCT00558896|79193788|FG003|Overall Study|Withdrawal by Subject|1|||
44269589|NCT00558896|79193789|FG004|Overall Study|Withdrawal by Subject|1|||
44269590|NCT00558896|79193790|FG005|Overall Study|Withdrawal by Subject|5|||
44269591|NCT00558896|79193791|FG006|Overall Study|Withdrawal by Subject|5|||
44269592|NCT00558896|79193785|FG000|Overall Study|Alternative Treatment|2|||
44269593|NCT00558896|79193786|FG001|Overall Study|Alternative Treatment|2|||
44269594|NCT00558896|79193787|FG002|Overall Study|Alternative Treatment|0|||
44269595|NCT00558896|79193788|FG003|Overall Study|Alternative Treatment|2|||
44269596|NCT00558896|79193789|FG004|Overall Study|Alternative Treatment|6|||
44269597|NCT00558896|79193790|FG005|Overall Study|Alternative Treatment|7|||
44543394|NCT03226392|79556428|FG001|Overall Study|Protocol Deviation|0|||
44543395|NCT03226392|79556427|FG000|Overall Study|Physician Decision|1|||
44206708|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
44543396|NCT03226392|79556428|FG001|Overall Study|Physician Decision|0|||
44543397|NCT03226392|79556427|FG000|Overall Study|Lost to Follow-up|1|||
44543398|NCT03226392|79556428|FG001|Overall Study|Lost to Follow-up|0|||
44269598|NCT00558896|79193791|FG006|Overall Study|Alternative Treatment|1|||
44269599|NCT00558896|79193785|FG000|Overall Study|Physician discretion|3|||
44543399|NCT03226392|79556427|FG000|Overall Study|Adverse Event|1|||
44543400|NCT03226392|79556428|FG001|Overall Study|Adverse Event|0|||
44543401|NCT03226392|79556427|FG000|Overall Study|Technical Problems|0|||
44543402|NCT03226392|79556428|FG001|Overall Study|Technical Problems|2|||
44206709|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
44206710|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Physician Decision|2|||
44206711|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Physician Decision|0|||
44206712|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Physician Decision|2|||
44206713|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
44206714|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
44206715|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
44206716|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
44206717|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
44206718|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
44206719|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
44206720|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
44206721|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
44206722|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Subject moved|0|||
44206723|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Subject moved|0|||
44206724|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Subject moved|1|||
44206725|NCT01953601|79003026|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
44206726|NCT01953601|79003027|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
44206727|NCT01953601|79003028|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
44206728|NCT01952665|79003041|FG000|Overall Study|Physician Decision|3|||
44206729|NCT01952665|79003042|FG001|Overall Study|Physician Decision|2|||
44206730|NCT01952665|79003041|FG000|Overall Study|Lost to Follow-up|1|||
44269600|NCT00558896|79193786|FG001|Overall Study|Physician discretion|2|||
44543403|NCT03226392|79556427|FG000|Overall Study|Subject/Guardian Decision|7|||
44206731|NCT01952665|79003042|FG001|Overall Study|Lost to Follow-up|2|||
44206732|NCT01952665|79003041|FG000|Overall Study|Adverse Event|2|||
44206733|NCT01952665|79003042|FG001|Overall Study|Adverse Event|1|||
44206734|NCT01952665|79003041|FG000|Overall Study|Protocol Violation|0|||
44206735|NCT01952665|79003042|FG001|Overall Study|Protocol Violation|1|||
44269601|NCT00558896|79193787|FG002|Overall Study|Physician discretion|1|||
44269602|NCT00558896|79193788|FG003|Overall Study|Physician discretion|2|||
44269603|NCT00558896|79193789|FG004|Overall Study|Physician discretion|1|||
44269604|NCT00558896|79193790|FG005|Overall Study|Physician discretion|3|||
44269605|NCT00558896|79193791|FG006|Overall Study|Physician discretion|3|||
44269606|NCT00558896|79193785|FG000|Overall Study|Continues on treatment|10|||
44269607|NCT00558896|79193786|FG001|Overall Study|Continues on treatment|1|||
44269608|NCT00558896|79193787|FG002|Overall Study|Continues on treatment|0|||
44269609|NCT00558896|79193788|FG003|Overall Study|Continues on treatment|1|||
44269610|NCT00558896|79193789|FG004|Overall Study|Continues on treatment|9|||
44269611|NCT00558896|79193790|FG005|Overall Study|Continues on treatment|25|||
44269612|NCT00558896|79193791|FG006|Overall Study|Continues on treatment|6|||
44269613|NCT00558428|79193925|FG000|Overall Study|Adverse Event|6|||
44269614|NCT00558428|79193926|FG001|Overall Study|Adverse Event|22|||
44269615|NCT00558428|79193927|FG002|Overall Study|Adverse Event|3|||
44269616|NCT00558428|79193928|FG003|Overall Study|Adverse Event|4|||
44269617|NCT00558428|79193925|FG000|Overall Study|Lost to Follow-up|0|||
44269618|NCT00558428|79193926|FG001|Overall Study|Lost to Follow-up|1|||
44269619|NCT00558428|79193927|FG002|Overall Study|Lost to Follow-up|0|||
44269620|NCT00558428|79193928|FG003|Overall Study|Lost to Follow-up|0|||
44269621|NCT00558428|79193925|FG000|Overall Study|Lack of Efficacy|0|||
44269622|NCT00558428|79193926|FG001|Overall Study|Lack of Efficacy|0|||
44269623|NCT00558428|79193927|FG002|Overall Study|Lack of Efficacy|1|||
44452096|NCT00080119|79461005|FG002|Overall Study|Discontinued because of study closure|130|||
44269624|NCT00558428|79193928|FG003|Overall Study|Lack of Efficacy|2|||
44269625|NCT00558428|79193925|FG000|Overall Study|Non compliant with protocol|1|||
44269626|NCT00558428|79193926|FG001|Overall Study|Non compliant with protocol|0|||
44269627|NCT00558428|79193927|FG002|Overall Study|Non compliant with protocol|0|||
44269628|NCT00558428|79193928|FG003|Overall Study|Non compliant with protocol|3|||
44269629|NCT00558428|79193925|FG000|Overall Study|Consent withdrawn|2|||
44368153|NCT01189604|79373547|FG005|Overall Study|Adverse Event|0|||
44368154|NCT01189604|79373548|FG006|Overall Study|Adverse Event|1|||
44368155|NCT01189604|79373542|FG000|Overall Study|Withdrawal by Subject|1|||
44368156|NCT01189604|79373543|FG001|Overall Study|Withdrawal by Subject|0|||
44368157|NCT01189604|79373544|FG002|Overall Study|Withdrawal by Subject|0|||
44368158|NCT01189604|79373545|FG003|Overall Study|Withdrawal by Subject|0|||
44368159|NCT01189604|79373546|FG004|Overall Study|Withdrawal by Subject|0|||
44368160|NCT01189604|79373547|FG005|Overall Study|Withdrawal by Subject|0|||
44368161|NCT01189604|79373548|FG006|Overall Study|Withdrawal by Subject|0|||
44368162|NCT01008696|79373566|FG000|Overall Study|Participant's evasion of hospital visit|5|||
44368163|NCT01008696|79373567|FG001|Overall Study|Participant's evasion of hospital visit|4|||
44368164|NCT01008696|79373566|FG000|Overall Study|Withdrawal by Subject|2|||
44368165|NCT01008696|79373567|FG001|Overall Study|Withdrawal by Subject|4|||
44368166|NCT01008696|79373566|FG000|Overall Study|Physician Decision|5|||
44368167|NCT01008696|79373567|FG001|Overall Study|Physician Decision|1|||
44368168|NCT01008696|79373566|FG000|Overall Study|Adverse Event|1|||
44368169|NCT01008696|79373567|FG001|Overall Study|Adverse Event|0|||
44368170|NCT01008696|79373566|FG000|Overall Study|Participants' non-cooperation|2|||
44368171|NCT01008696|79373567|FG001|Overall Study|Participants' non-cooperation|3|||
44368172|NCT01008696|79373566|FG000|Overall Study|Other|2|||
44368173|NCT01008696|79373567|FG001|Overall Study|Other|3|||
44368174|NCT01008696|79373566|FG000|Overall Study|Other|0|||
44368175|NCT01008696|79373567|FG001|Overall Study|Other|2|||
44368176|NCT01176968|79373586|FG000|Overall Study|Adverse Event|10|||
44368177|NCT01176968|79373587|FG001|Overall Study|Adverse Event|11|||
44368178|NCT01176968|79373586|FG000|Overall Study|Death|2|||
44368179|NCT01176968|79373587|FG001|Overall Study|Death|3|||
44368180|NCT01176968|79373586|FG000|Overall Study|Lack of Efficacy|0|||
44368181|NCT01176968|79373587|FG001|Overall Study|Lack of Efficacy|1|||
44368182|NCT01176968|79373586|FG000|Overall Study|Lost to Follow-up|16|||
44368183|NCT01176968|79373587|FG001|Overall Study|Lost to Follow-up|14|||
44368184|NCT01176968|79373586|FG000|Overall Study|Withdrawal by Subject|48|||
44368185|NCT01176968|79373587|FG001|Overall Study|Withdrawal by Subject|48|||
44368186|NCT01176968|79373586|FG000|Overall Study|Protocol Violation|2|||
44368187|NCT01176968|79373587|FG001|Overall Study|Protocol Violation|1|||
44368188|NCT01176968|79373586|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
44368189|NCT01176968|79373587|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
44368190|NCT01176968|79373586|FG000|Overall Study|Study terminated by sponsor|0|||
44368191|NCT01176968|79373587|FG001|Overall Study|Study terminated by sponsor|1|||
44368192|NCT01176968|79373586|FG000|Overall Study|Reason not defined|5|||
44368193|NCT01176968|79373587|FG001|Overall Study|Reason not defined|3|||
44368194|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
44368195|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
44368196|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
44368197|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
44368198|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Pregnancy|0|||
44368199|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Pregnancy|1|||
44368200|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
44368201|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
44368202|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
44206736|NCT01952041|79003053|FG000|Overall Study|Lost to Follow-up|9|||
44206737|NCT01952041|79003054|FG001|Overall Study|Lost to Follow-up|16|||
44206738|NCT01952041|79003053|FG000|Overall Study|Withdrawal by Subject|7|||
44368203|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
44368204|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
44368205|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
44368206|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Other|3|||
44206739|NCT01952041|79003054|FG001|Overall Study|Withdrawal by Subject|5|||
44206740|NCT01952041|79003053|FG000|Overall Study|Death|1|||
44368207|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Other|0|||
44368208|NCT01006122|79373598|FG000|First Double-blind Intervention Period|Adverse Event|0|||
44368209|NCT01006122|79373599|FG001|First Double-blind Intervention Period|Adverse Event|4|||
44368210|NCT01006122|79373598|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
44368211|NCT01006122|79373599|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
44368212|NCT01006122|79373598|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
44368213|NCT01006122|79373599|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
44368214|NCT01006122|79373598|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
44368215|NCT01006122|79373599|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
44368216|NCT01006122|79373598|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
44368217|NCT01006122|79373599|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
44452097|NCT00080119|79461006|FG003|Overall Study|Discontinued because of study closure|141|||
44368218|NCT01006122|79373598|FG000|Second Double-blind Intervention Period|Death|0|||
44206741|NCT01952041|79003054|FG001|Overall Study|Death|0|||
44368219|NCT01006122|79373599|FG001|Second Double-blind Intervention Period|Death|1|||
44368220|NCT01005966|79373605|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
44368221|NCT01005966|79373606|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
44368222|NCT01005966|79373607|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
44368223|NCT01005966|79373608|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
44368224|NCT01005966|79373609|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
44368225|NCT01005966|79373605|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
44368226|NCT01005966|79373606|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
44368227|NCT01005966|79373607|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
44368228|NCT01005966|79373608|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
44368229|NCT01005966|79373609|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
44368230|NCT01005966|79373605|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
44368231|NCT01005966|79373606|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
44368232|NCT01005966|79373607|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
44368233|NCT01005966|79373608|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
44368234|NCT01005966|79373609|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
44368235|NCT01005966|79373605|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
44368236|NCT01005966|79373606|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
44368237|NCT01005966|79373607|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
44368238|NCT01005966|79373608|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
44368239|NCT01005966|79373609|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
44368240|NCT01005966|79373605|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44368241|NCT01005966|79373606|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44368242|NCT01005966|79373607|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44368243|NCT01005966|79373608|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
44368244|NCT01005966|79373609|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44368245|NCT01005966|79373605|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44368246|NCT01005966|79373606|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44368247|NCT01005966|79373607|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
44368248|NCT01005966|79373608|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44368249|NCT01005966|79373609|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
44368250|NCT01005966|79373605|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
44368251|NCT01005966|79373606|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
44368252|NCT01005966|79373607|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
44368253|NCT01005966|79373608|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
44368254|NCT01005966|79373609|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
44368255|NCT01005966|79373605|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
44368256|NCT01005966|79373606|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
44368257|NCT01005966|79373607|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
44368258|NCT01005966|79373608|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
44368259|NCT01005966|79373609|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
44368260|NCT01005966|79373605|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
44368261|NCT01005966|79373606|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
44368262|NCT01005966|79373607|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
44368263|NCT01005966|79373608|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
44368264|NCT01005966|79373609|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
44368265|NCT01005732|79373635|FG000|Overall Study|Lost to Follow-up|10|||
44368266|NCT01005732|79373635|FG000|Overall Study|Death|1|||
44368267|NCT00603382|79373649|FG000|Overall Study|Adverse Event|0|||
44368268|NCT00603382|79373650|FG001|Overall Study|Adverse Event|1|||
44368269|NCT00603382|79373651|FG002|Overall Study|Adverse Event|1|||
44368270|NCT00603382|79373652|FG003|Overall Study|Adverse Event|2|||
44368271|NCT00603382|79373653|FG004|Overall Study|Adverse Event|1|||
44368272|NCT00603382|79373654|FG005|Overall Study|Adverse Event|2|||
44368273|NCT00603382|79373649|FG000|Overall Study|Lack of Efficacy|14|||
44368274|NCT00603382|79373650|FG001|Overall Study|Lack of Efficacy|9|||
44368275|NCT00603382|79373651|FG002|Overall Study|Lack of Efficacy|3|||
44368276|NCT00603382|79373652|FG003|Overall Study|Lack of Efficacy|6|||
44368277|NCT00603382|79373653|FG004|Overall Study|Lack of Efficacy|6|||
44368278|NCT00603382|79373654|FG005|Overall Study|Lack of Efficacy|11|||
44368279|NCT00603382|79373649|FG000|Overall Study|Protocol Violation|1|||
44368280|NCT00603382|79373650|FG001|Overall Study|Protocol Violation|0|||
44368281|NCT00603382|79373651|FG002|Overall Study|Protocol Violation|1|||
44368282|NCT00603382|79373652|FG003|Overall Study|Protocol Violation|2|||
44368283|NCT00603382|79373653|FG004|Overall Study|Protocol Violation|1|||
44368284|NCT00603382|79373654|FG005|Overall Study|Protocol Violation|0|||
44368285|NCT00603382|79373649|FG000|Overall Study|Lost to Follow-up|0|||
44368286|NCT00603382|79373650|FG001|Overall Study|Lost to Follow-up|1|||
44368287|NCT00603382|79373651|FG002|Overall Study|Lost to Follow-up|1|||
44368288|NCT00603382|79373652|FG003|Overall Study|Lost to Follow-up|1|||
44368289|NCT00603382|79373653|FG004|Overall Study|Lost to Follow-up|0|||
44368290|NCT00603382|79373654|FG005|Overall Study|Lost to Follow-up|1|||
44368291|NCT00603382|79373649|FG000|Overall Study|Physician Decision|0|||
44368292|NCT00603382|79373650|FG001|Overall Study|Physician Decision|0|||
44368293|NCT00603382|79373651|FG002|Overall Study|Physician Decision|2|||
44368294|NCT00603382|79373652|FG003|Overall Study|Physician Decision|0|||
44368295|NCT00603382|79373653|FG004|Overall Study|Physician Decision|1|||
44368296|NCT00603382|79373654|FG005|Overall Study|Physician Decision|3|||
44368297|NCT00603382|79373649|FG000|Overall Study|Withdrawal by Subject|3|||
44368298|NCT00603382|79373650|FG001|Overall Study|Withdrawal by Subject|3|||
44368299|NCT00603382|79373651|FG002|Overall Study|Withdrawal by Subject|1|||
44368300|NCT00603382|79373652|FG003|Overall Study|Withdrawal by Subject|1|||
44368301|NCT00603382|79373653|FG004|Overall Study|Withdrawal by Subject|0|||
44368302|NCT00603382|79373654|FG005|Overall Study|Withdrawal by Subject|1|||
44368303|NCT01176266|79373668|FG000|Overall Study|Death|6|||
44368304|NCT01176266|79373668|FG000|Overall Study|Withdrawal by Subject|3|||
44368305|NCT01182428|79373678|FG000|Overall Study|Physician Decision|1|||
44368306|NCT01182428|79373679|FG001|Overall Study|Physician Decision|0|||
44368307|NCT01182428|79373678|FG000|Overall Study|Lost to Follow-up|9|||
44368308|NCT01182428|79373679|FG001|Overall Study|Lost to Follow-up|1|||
44368309|NCT01182428|79373678|FG000|Overall Study|Withdrawal by Subject|1|||
44368310|NCT01182428|79373679|FG001|Overall Study|Withdrawal by Subject|0|||
44368311|NCT00603304|79373687|FG000|Overall Study|Lost to Follow-up|5|||
44368312|NCT00603304|79373688|FG001|Overall Study|Lost to Follow-up|7|||
44368313|NCT00603304|79373687|FG000|Overall Study|Withdrawal by Subject|8|||
44368314|NCT00603304|79373688|FG001|Overall Study|Withdrawal by Subject|5|||
44368315|NCT00603304|79373687|FG000|Overall Study|Protocol Violation|1|||
44543404|NCT03226392|79556428|FG001|Overall Study|Subject/Guardian Decision|6|||
44543405|NCT03205371|79556446|FG000|Overall Study|Withdrawal by Subject|4|||
44543406|NCT03205371|79556447|FG001|Overall Study|Withdrawal by Subject|1|||
44206742|NCT01951573|79003060|FG000|Washout Period|Adverse Event|0|||
44206743|NCT01951573|79003061|FG001|Washout Period|Adverse Event|1|||
44206744|NCT02023697|79003070|FG000|Treatment Period|Radiological progression|13|||
44206745|NCT02023697|79003071|FG001|Treatment Period|Radiological progression|17|||
44206746|NCT02023697|79003072|FG002|Treatment Period|Radiological progression|26|||
44206747|NCT02023697|79003070|FG000|Treatment Period|Never Treated|5|||
44206748|NCT02023697|79003071|FG001|Treatment Period|Never Treated|6|||
44206749|NCT02023697|79003072|FG002|Treatment Period|Never Treated|10|||
44206750|NCT02023697|79003070|FG000|Treatment Period|Adverse Event|13|||
44206751|NCT02023697|79003071|FG001|Treatment Period|Adverse Event|25|||
44206752|NCT02023697|79003072|FG002|Treatment Period|Adverse Event|23|||
44206753|NCT02023697|79003070|FG000|Treatment Period|Logistical difficulties|1|||
44206754|NCT02023697|79003071|FG001|Treatment Period|Logistical difficulties|1|||
44206755|NCT02023697|79003072|FG002|Treatment Period|Logistical difficulties|1|||
44206756|NCT02023697|79003070|FG000|Treatment Period|Clinical progression|10|||
44206757|NCT02023697|79003071|FG001|Treatment Period|Clinical progression|8|||
44206758|NCT02023697|79003072|FG002|Treatment Period|Clinical progression|28|||
44206759|NCT02023697|79003070|FG000|Treatment Period|Withdrawal by Subject|4|||
44206760|NCT02023697|79003071|FG001|Treatment Period|Withdrawal by Subject|5|||
44206761|NCT02023697|79003072|FG002|Treatment Period|Withdrawal by Subject|13|||
44206762|NCT02023697|79003070|FG000|Treatment Period|Safety outcome reached|0|||
44206763|NCT02023697|79003071|FG001|Treatment Period|Safety outcome reached|1|||
44206764|NCT02023697|79003072|FG002|Treatment Period|Safety outcome reached|0|||
44206765|NCT02023697|79003070|FG000|Treatment Period|Physician Decision|0|||
44206766|NCT02023697|79003071|FG001|Treatment Period|Physician Decision|0|||
44206767|NCT02023697|79003072|FG002|Treatment Period|Physician Decision|1|||
44206768|NCT02023697|79003070|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
44206769|NCT02023697|79003071|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
44206770|NCT02023697|79003072|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
44206771|NCT02023697|79003070|FG000|Active Follow-up Period|Lost to Follow-up|1|||
44206772|NCT02023697|79003071|FG001|Active Follow-up Period|Lost to Follow-up|1|||
44206773|NCT02023697|79003072|FG002|Active Follow-up Period|Lost to Follow-up|1|||
44206774|NCT02023697|79003070|FG000|Active Follow-up Period|Deterioration of general condition|1|||
44543407|NCT03205371|79556448|FG002|Overall Study|Withdrawal by Subject|0|||
44543408|NCT03205371|79556449|FG003|Overall Study|Withdrawal by Subject|0|||
44543409|NCT03205371|79556450|FG004|Overall Study|Withdrawal by Subject|0|||
44543410|NCT03205371|79556451|FG005|Overall Study|Withdrawal by Subject|0|||
44543411|NCT03205371|79556452|FG006|Overall Study|Withdrawal by Subject|4|||
44543412|NCT03205371|79556453|FG007|Overall Study|Withdrawal by Subject|0|||
44543413|NCT03205371|79556454|FG008|Overall Study|Withdrawal by Subject|2|||
44543414|NCT03205371|79556455|FG009|Overall Study|Withdrawal by Subject|0|||
44206775|NCT02023697|79003071|FG001|Active Follow-up Period|Deterioration of general condition|1|||
44206776|NCT02023697|79003072|FG002|Active Follow-up Period|Deterioration of general condition|1|||
44206777|NCT02023697|79003070|FG000|Active Follow-up Period|Other unspecified|2|||
44269630|NCT00558428|79193926|FG001|Overall Study|Consent withdrawn|1|||
44368316|NCT00603304|79373688|FG001|Overall Study|Protocol Violation|0|||
44368317|NCT00603304|79373687|FG000|Overall Study|Adverse Event|4|||
44368318|NCT00603304|79373688|FG001|Overall Study|Adverse Event|2|||
44368319|NCT00603304|79373687|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
44543415|NCT03205371|79556456|FG010|Overall Study|Withdrawal by Subject|0|||
44543416|NCT03205371|79556457|FG011|Overall Study|Withdrawal by Subject|1|||
44543417|NCT03205371|79556446|FG000|Overall Study|Lost to Follow-up|0|||
44543418|NCT03205371|79556447|FG001|Overall Study|Lost to Follow-up|0|||
44543419|NCT03205371|79556448|FG002|Overall Study|Lost to Follow-up|0|||
44543420|NCT03205371|79556449|FG003|Overall Study|Lost to Follow-up|0|||
44543421|NCT03205371|79556450|FG004|Overall Study|Lost to Follow-up|0|||
44543422|NCT03205371|79556451|FG005|Overall Study|Lost to Follow-up|0|||
44543423|NCT03205371|79556452|FG006|Overall Study|Lost to Follow-up|5|||
44543424|NCT03205371|79556453|FG007|Overall Study|Lost to Follow-up|2|||
44543425|NCT03205371|79556454|FG008|Overall Study|Lost to Follow-up|3|||
44543426|NCT03205371|79556455|FG009|Overall Study|Lost to Follow-up|0|||
44543427|NCT03205371|79556456|FG010|Overall Study|Lost to Follow-up|0|||
44543428|NCT03205371|79556457|FG011|Overall Study|Lost to Follow-up|0|||
44543429|NCT03205371|79556446|FG000|Overall Study|Protocol Violation|0|||
44543430|NCT03205371|79556447|FG001|Overall Study|Protocol Violation|0|||
44543431|NCT03205371|79556448|FG002|Overall Study|Protocol Violation|0|||
44543432|NCT03205371|79556449|FG003|Overall Study|Protocol Violation|0|||
44543433|NCT03205371|79556450|FG004|Overall Study|Protocol Violation|0|||
44543434|NCT03205371|79556451|FG005|Overall Study|Protocol Violation|0|||
44543435|NCT03205371|79556452|FG006|Overall Study|Protocol Violation|1|||
44543436|NCT03205371|79556453|FG007|Overall Study|Protocol Violation|0|||
44543437|NCT03205371|79556454|FG008|Overall Study|Protocol Violation|0|||
44543438|NCT03205371|79556455|FG009|Overall Study|Protocol Violation|0|||
44543439|NCT03205371|79556456|FG010|Overall Study|Protocol Violation|0|||
44543440|NCT03205371|79556457|FG011|Overall Study|Protocol Violation|0|||
44368320|NCT00603304|79373688|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
44543441|NCT03205371|79556446|FG000|Overall Study|Adverse Event|0|||
44543442|NCT03205371|79556447|FG001|Overall Study|Adverse Event|0|||
44543443|NCT03205371|79556448|FG002|Overall Study|Adverse Event|0|||
44543444|NCT03205371|79556449|FG003|Overall Study|Adverse Event|0|||
44543445|NCT03205371|79556450|FG004|Overall Study|Adverse Event|0|||
44543446|NCT03205371|79556451|FG005|Overall Study|Adverse Event|0|||
44543447|NCT03205371|79556452|FG006|Overall Study|Adverse Event|0|||
44543448|NCT03205371|79556453|FG007|Overall Study|Adverse Event|1|||
44543449|NCT03205371|79556454|FG008|Overall Study|Adverse Event|0|||
44543450|NCT03205371|79556455|FG009|Overall Study|Adverse Event|0|||
44543451|NCT03205371|79556456|FG010|Overall Study|Adverse Event|0|||
44543452|NCT03205371|79556457|FG011|Overall Study|Adverse Event|0|||
44543453|NCT03367858|79556505|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
44543454|NCT03367858|79556506|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
44543455|NCT03367858|79556505|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
44543456|NCT03367858|79556506|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
44543457|NCT03367858|79556505|FG000|3 Month Follow Up|Lost to Follow-up|8|||
44543458|NCT03367858|79556506|FG001|3 Month Follow Up|Lost to Follow-up|3|||
44543459|NCT03367858|79556505|FG000|3 Month Follow Up|Moved out of study area|2|||
44543460|NCT03367858|79556506|FG001|3 Month Follow Up|Moved out of study area|6|||
44543461|NCT03367858|79556505|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
44543462|NCT03367858|79556506|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
44543463|NCT03367858|79556505|FG000|3 Month Follow Up|MRI contraindication|2|||
44543464|NCT03367858|79556506|FG001|3 Month Follow Up|MRI contraindication|1|||
44543465|NCT03367858|79556505|FG000|3 Month Follow Up|Incarcerated|0|||
44206778|NCT02023697|79003071|FG001|Active Follow-up Period|Other unspecified|0|||
44368321|NCT00603304|79373687|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
44368322|NCT00603304|79373688|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
44368323|NCT00603304|79373687|FG000|Overall Study|Exclusionary Medication|2|||
44368324|NCT00603304|79373688|FG001|Overall Study|Exclusionary Medication|3|||
44543466|NCT03367858|79556506|FG001|3 Month Follow Up|Incarcerated|1|||
44543467|NCT03367858|79556505|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
44543468|NCT03367858|79556506|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
44543469|NCT03367858|79556505|FG000|6 Month Follow Up|Lost to Follow-up|5|||
44543470|NCT03367858|79556506|FG001|6 Month Follow Up|Lost to Follow-up|2|||
44543471|NCT03367858|79556505|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
44543472|NCT03367858|79556506|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
44543473|NCT03367858|79556505|FG000|12 Month Follow Up|Lost to Follow-up|3|||
44543474|NCT03367858|79556506|FG001|12 Month Follow Up|Lost to Follow-up|3|||
44543475|NCT03367858|79556505|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
44543476|NCT03367858|79556506|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
44368325|NCT00603304|79373687|FG000|Overall Study|Non-Compliant|0|||
44543477|NCT03682705|79556518|FG000|Overall Study|Adverse Event|1|||
44543478|NCT03682705|79556519|FG001|Overall Study|Adverse Event|1|||
44543479|NCT03682705|79556520|FG002|Overall Study|Adverse Event|1|||
44543480|NCT03682705|79556521|FG003|Overall Study|Adverse Event|0|||
44543481|NCT03682705|79556522|FG004|Overall Study|Adverse Event|1|||
44543482|NCT03682705|79556523|FG005|Overall Study|Adverse Event|1|||
44543483|NCT03682705|79556518|FG000|Overall Study|Withdrawal by Subject|1|||
44368326|NCT00603304|79373688|FG001|Overall Study|Non-Compliant|1|||
44368327|NCT00603304|79373687|FG000|Overall Study|Moved Away|0|||
44368328|NCT00603304|79373688|FG001|Overall Study|Moved Away|2|||
44368329|NCT00603304|79373687|FG000|Overall Study|Other|2|||
44368330|NCT00603304|79373688|FG001|Overall Study|Other|0|||
44368331|NCT00603304|79373687|FG000|Overall Study|Patient Decision|2|||
44368332|NCT00603304|79373688|FG001|Overall Study|Patient Decision|0|||
44368333|NCT01176032|79373698|FG000|Overall Study|Adverse Event|1|||
44368334|NCT01176032|79373699|FG001|Overall Study|Adverse Event|0|||
44368335|NCT01176032|79373698|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44368336|NCT01176032|79373699|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44368337|NCT01176032|79373698|FG000|Overall Study|Protocol Violation|1|||
44368338|NCT01176032|79373699|FG001|Overall Study|Protocol Violation|0|||
44368339|NCT01176032|79373698|FG000|Overall Study|Informed consent withdrawn|3|||
44368340|NCT01176032|79373699|FG001|Overall Study|Informed consent withdrawn|0|||
44368341|NCT01176032|79373698|FG000|Overall Study|Other|1|||
44368342|NCT01176032|79373699|FG001|Overall Study|Other|0|||
44543484|NCT03682705|79556519|FG001|Overall Study|Withdrawal by Subject|3|||
44543485|NCT03682705|79556520|FG002|Overall Study|Withdrawal by Subject|2|||
44543486|NCT03682705|79556521|FG003|Overall Study|Withdrawal by Subject|4|||
44543487|NCT03682705|79556522|FG004|Overall Study|Withdrawal by Subject|0|||
44543488|NCT03682705|79556523|FG005|Overall Study|Withdrawal by Subject|1|||
44543489|NCT03682705|79556518|FG000|Overall Study|Other, not specified|0|||
44543490|NCT03682705|79556519|FG001|Overall Study|Other, not specified|0|||
44543491|NCT03682705|79556520|FG002|Overall Study|Other, not specified|0|||
44543492|NCT03682705|79556521|FG003|Overall Study|Other, not specified|1|||
44543493|NCT03682705|79556522|FG004|Overall Study|Other, not specified|2|||
44543494|NCT03682705|79556523|FG005|Overall Study|Other, not specified|0|||
44543495|NCT03682705|79556518|FG000|Overall Study|Lost to Follow-up|0|||
44543496|NCT03682705|79556519|FG001|Overall Study|Lost to Follow-up|0|||
44543497|NCT03682705|79556520|FG002|Overall Study|Lost to Follow-up|0|||
44543498|NCT03682705|79556521|FG003|Overall Study|Lost to Follow-up|0|||
44206779|NCT02023697|79003072|FG002|Active Follow-up Period|Other unspecified|1|||
44206780|NCT02023697|79003070|FG000|Active Follow-up Period|Clinical progression|0|||
44206781|NCT02023697|79003071|FG001|Active Follow-up Period|Clinical progression|2|||
44206782|NCT02023697|79003072|FG002|Active Follow-up Period|Clinical progression|1|||
44206783|NCT02023697|79003070|FG000|Active Follow-up Period|Radiological progression|0|||
44206784|NCT02023697|79003071|FG001|Active Follow-up Period|Radiological progression|0|||
44206785|NCT02023697|79003072|FG002|Active Follow-up Period|Radiological progression|1|||
44206786|NCT02023697|79003070|FG000|Active Follow-up Period|Death|83|||
44206787|NCT02023697|79003071|FG001|Active Follow-up Period|Death|82|||
44206788|NCT02023697|79003072|FG002|Active Follow-up Period|Death|87|||
44206789|NCT02023697|79003070|FG000|Long-term Follow-up Period|Death|9|||
44206790|NCT02023697|79003071|FG001|Long-term Follow-up Period|Death|6|||
44206791|NCT02023697|79003072|FG002|Long-term Follow-up Period|Death|4|||
44206792|NCT02023697|79003070|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
44206793|NCT02023697|79003071|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
44206794|NCT02023697|79003072|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
44206795|NCT02023697|79003070|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
44206796|NCT02023697|79003071|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
44206797|NCT02023697|79003072|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
44206798|NCT02023697|79003070|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
44206799|NCT02023697|79003071|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
44206800|NCT02023697|79003072|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
44206801|NCT02023697|79003070|FG000|Long-term Follow-up Period|Technical problems|0|||
44206802|NCT02023697|79003071|FG001|Long-term Follow-up Period|Technical problems|0|||
44206803|NCT02023697|79003072|FG002|Long-term Follow-up Period|Technical problems|1|||
44206804|NCT02023697|79003070|FG000|Long-term Follow-up Period|Other unspecified|6|||
44206805|NCT02023697|79003071|FG001|Long-term Follow-up Period|Other unspecified|3|||
44206806|NCT02023697|79003072|FG002|Long-term Follow-up Period|Other unspecified|5|||
44206807|NCT01951417|79003087|FG000|Overall Study|Withdrawal by Subject|1|||
44206808|NCT01951417|79003087|FG000|Overall Study|Protocol Violation|2|||
44206809|NCT01951417|79003087|FG000|Overall Study|Lost to Follow-up|6|||
44269631|NCT00558428|79193927|FG002|Overall Study|Consent withdrawn|0|||
44368343|NCT01008618|79373710|FG000|Period 1 (Titration Period)|Physician Decision|2|||
44368344|NCT01008618|79373711|FG001|Period 1 (Titration Period)|Physician Decision|0|||
44368345|NCT01008618|79373712|FG002|Period 1 (Titration Period)|Physician Decision|0|||
44543499|NCT03682705|79556522|FG004|Overall Study|Lost to Follow-up|3|||
44543500|NCT03682705|79556523|FG005|Overall Study|Lost to Follow-up|0|||
44543501|NCT03179787|79556537|FG000|Overall Study|Lost to Follow-up|15|||
44543502|NCT03179787|79556537|FG000|Overall Study|Case report failures|2|||
44543503|NCT03179787|79556537|FG000|Overall Study|Treatment not administered|1|||
44368346|NCT01008618|79373710|FG000|Period 1 (Titration Period)|Adverse Event|33|||
44368347|NCT01008618|79373711|FG001|Period 1 (Titration Period)|Adverse Event|0|||
44368348|NCT01008618|79373712|FG002|Period 1 (Titration Period)|Adverse Event|0|||
44368349|NCT01008618|79373710|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
44543504|NCT03745937|79556545|FG000|Overall Study|Withdrawal by Subject|0|||
44206810|NCT01951261|79003097|FG000|Overall Study|Death|1|||
44206811|NCT01951261|79003098|FG001|Overall Study|Death|0|||
44206812|NCT01951261|79003097|FG000|Overall Study|Lost to Follow-up|4|||
44206813|NCT01951261|79003098|FG001|Overall Study|Lost to Follow-up|3|||
44206814|NCT01951261|79003097|FG000|Overall Study|Protocol Violation|4|||
44206815|NCT01951261|79003098|FG001|Overall Study|Protocol Violation|3|||
44206816|NCT02023151|79003104|FG000|Overall Study|Lost to Follow-up|4|||
44206817|NCT01979185|79003110|FG000|Period 2|Other|0|||
44206818|NCT01979185|79003111|FG001|Period 2|Other|1|||
44206819|NCT01946425|79003119|FG000|Overall Study|Protocol Violation|1|||
44206820|NCT01946425|79003120|FG001|Overall Study|Protocol Violation|0|||
44206821|NCT01946425|79003119|FG000|Overall Study|Withdrawal by Subject|1|||
44206822|NCT01946425|79003120|FG001|Overall Study|Withdrawal by Subject|0|||
44206823|NCT01946191|79003129|FG000|Allocation|Did not complete orientation|1|||
44206824|NCT01946191|79003130|FG001|Allocation|Did not complete orientation|1|||
44206825|NCT01946191|79003129|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
44206826|NCT01946191|79003130|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
44206827|NCT01946191|79003129|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
44206828|NCT01946191|79003130|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
44206829|NCT01946191|79003129|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
44206830|NCT01946191|79003130|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
44206831|NCT01937312|79003139|FG000|Overall Study|Adverse Event|10|||
44206832|NCT01937312|79003140|FG001|Overall Study|Adverse Event|1|||
44206833|NCT01937312|79003139|FG000|Overall Study|Lack of Efficacy|0|||
44206834|NCT01937312|79003140|FG001|Overall Study|Lack of Efficacy|1|||
44206835|NCT01937312|79003139|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
44206836|NCT01937312|79003140|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
44206837|NCT01935128|79003147|FG000|Overall Study|Death|1|||
44206838|NCT01935128|79003147|FG000|Overall Study|Adverse Event|6|||
44206839|NCT01934972|79003153|FG000|Overall Study|Withdrawal by Subject|9|||
44206840|NCT01934972|79003154|FG001|Overall Study|Withdrawal by Subject|6|||
44206841|NCT01959230|79003162|FG000|Overall Study|Failure to follow study procedures|0|||
44206842|NCT01959230|79003163|FG001|Overall Study|Failure to follow study procedures|1|||
44206843|NCT01959230|79003162|FG000|Overall Study|Administrative reasons|2|||
44206844|NCT01959230|79003163|FG001|Overall Study|Administrative reasons|0|||
44206845|NCT01959230|79003162|FG000|Overall Study|Withdrawal by Subject|2|||
44206846|NCT01959230|79003163|FG001|Overall Study|Withdrawal by Subject|0|||
44206847|NCT01909778|79003169|FG000|Overall Study|failed screening|1|||
44206848|NCT01977937|79003177|FG000|Overall Study|Withdrawal by Subject|2|||
44206849|NCT01977937|79003178|FG001|Overall Study|Withdrawal by Subject|1|||
44206850|NCT01977937|79003177|FG000|Overall Study|Adverse Event|1|||
44206851|NCT01977937|79003178|FG001|Overall Study|Adverse Event|0|||
44206852|NCT01977937|79003177|FG000|Overall Study|Physician Decision|0|||
44206853|NCT01977937|79003178|FG001|Overall Study|Physician Decision|1|||
44206854|NCT02015663|79003186|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
44206855|NCT02015663|79003187|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
44206856|NCT02015663|79003186|FG000|Overall Study|Withdrawal by Subject|1|||
44206857|NCT02015663|79003187|FG001|Overall Study|Withdrawal by Subject|0|||
44206858|NCT02015663|79003186|FG000|Overall Study|Protocol Violation|0|||
44206859|NCT02015663|79003187|FG001|Overall Study|Protocol Violation|1|||
44206860|NCT02015663|79003186|FG000|Overall Study|Adverse Event|3|||
44206861|NCT02015663|79003187|FG001|Overall Study|Adverse Event|0|||
44206862|NCT02015663|79003186|FG000|Overall Study|Administrative problems|10|||
44206863|NCT02015663|79003187|FG001|Overall Study|Administrative problems|11|||
44206864|NCT01978093|79003196|FG000|Overall Study|Death|1|||
44206865|NCT01978093|79003197|FG001|Overall Study|Death|0|||
44206866|NCT01978093|79003196|FG000|Overall Study|Adverse Event|0|||
44206867|NCT01978093|79003197|FG001|Overall Study|Adverse Event|5|||
44206868|NCT01978093|79003196|FG000|Overall Study|Protocol Violation|8|||
44206869|NCT01978093|79003197|FG001|Overall Study|Protocol Violation|2|||
44206870|NCT01978093|79003196|FG000|Overall Study|Withdrawal by Subject|29|||
44206871|NCT01978093|79003197|FG001|Overall Study|Withdrawal by Subject|25|||
44206872|NCT01978093|79003196|FG000|Overall Study|Lost to Follow-up|11|||
44206873|NCT01978093|79003197|FG001|Overall Study|Lost to Follow-up|15|||
44206874|NCT01978093|79003196|FG000|Overall Study|Migrated/moved from study area|11|||
44206875|NCT01978093|79003197|FG001|Overall Study|Migrated/moved from study area|13|||
44206876|NCT01978093|79003196|FG000|Overall Study|Loss of kaiser coverage|4|||
44206877|NCT01978093|79003197|FG001|Overall Study|Loss of kaiser coverage|10|||
44206878|NCT01978093|79003196|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
44206879|NCT01978093|79003197|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
44206880|NCT01978093|79003196|FG000|Overall Study|Mother lost custody of child|0|||
44206881|NCT01978093|79003197|FG001|Overall Study|Mother lost custody of child|1|||
44206882|NCT01978093|79003196|FG000|Overall Study|Child was in care of grandmother|0|||
44206883|NCT01978093|79003197|FG001|Overall Study|Child was in care of grandmother|1|||
44206884|NCT01978093|79003196|FG000|Overall Study|N/A for vaccine administration|0|||
44206885|NCT01978093|79003197|FG001|Overall Study|N/A for vaccine administration|1|||
44206886|NCT01951105|79003209|FG000|Overall Study|Adverse Event|0|||
44206887|NCT01951105|79003210|FG001|Overall Study|Adverse Event|5|||
44206888|NCT01951105|79003211|FG002|Overall Study|Adverse Event|0|||
44206889|NCT01951105|79003209|FG000|Overall Study|Lost to Follow-up|0|||
44206890|NCT01951105|79003210|FG001|Overall Study|Lost to Follow-up|1|||
44206891|NCT01951105|79003211|FG002|Overall Study|Lost to Follow-up|0|||
44206892|NCT01951105|79003209|FG000|Overall Study|Protocol Violation|1|||
44206893|NCT01951105|79003210|FG001|Overall Study|Protocol Violation|1|||
44206894|NCT01951105|79003211|FG002|Overall Study|Protocol Violation|1|||
44206895|NCT01951105|79003209|FG000|Overall Study|Withdrawal by Subject|0|||
44206896|NCT01951105|79003210|FG001|Overall Study|Withdrawal by Subject|3|||
44206897|NCT01951105|79003211|FG002|Overall Study|Withdrawal by Subject|1|||
44206898|NCT01958918|79003227|FG000|Overall Study|Death|1|||
44206899|NCT01958918|79003228|FG001|Overall Study|Death|3|||
44206900|NCT01958918|79003227|FG000|Overall Study|Lost to Follow-up|4|||
44206901|NCT01958918|79003228|FG001|Overall Study|Lost to Follow-up|7|||
44206902|NCT01958918|79003227|FG000|Overall Study|Withdrawal by Subject|13|||
44206903|NCT01958918|79003228|FG001|Overall Study|Withdrawal by Subject|8|||
44206904|NCT01958918|79003227|FG000|Overall Study|Lack of Efficacy|13|||
44368350|NCT01008618|79373711|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
44368351|NCT01008618|79373712|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
44368352|NCT01008618|79373710|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
44368353|NCT01008618|79373711|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
44368354|NCT01008618|79373712|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
44368355|NCT01008618|79373710|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
44368356|NCT01008618|79373711|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
44368357|NCT01008618|79373712|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
44368358|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
44368359|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
44368360|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
44368361|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
44368362|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
44368363|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
44206905|NCT01958918|79003228|FG001|Overall Study|Lack of Efficacy|10|||
44206906|NCT01958918|79003227|FG000|Overall Study|Adverse Event|12|||
44206907|NCT01958918|79003228|FG001|Overall Study|Adverse Event|12|||
44206908|NCT01958918|79003227|FG000|Overall Study|administrative problems|0|||
44206909|NCT01958918|79003228|FG001|Overall Study|administrative problems|2|||
44206910|NCT01945489|79003236|FG000|Cycle 1|Adverse Event|2|||
44206911|NCT01945489|79003237|FG001|Cycle 1|Adverse Event|0|||
44206912|NCT01945489|79003236|FG000|Cycle 1|Lost to Follow-up|4|||
44206913|NCT01945489|79003237|FG001|Cycle 1|Lost to Follow-up|0|||
44206914|NCT01945489|79003236|FG000|Cycle 1|Personal Reasons|4|||
44206915|NCT01945489|79003237|FG001|Cycle 1|Personal Reasons|2|||
44206916|NCT01945489|79003236|FG000|Cycle 1|Protocol Violation|0|||
44206917|NCT01945489|79003237|FG001|Cycle 1|Protocol Violation|1|||
44206918|NCT01945489|79003236|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
44206919|NCT01945489|79003237|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
44206920|NCT01945489|79003236|FG000|Cycle 2|Adverse Event|1|||
44206921|NCT01945489|79003237|FG001|Cycle 2|Adverse Event|0|||
44206922|NCT01945489|79003236|FG000|Cycle 2|Lost to Follow-up|0|||
44206923|NCT01945489|79003237|FG001|Cycle 2|Lost to Follow-up|1|||
44206924|NCT01934894|79003246|FG000|Overall Study|Adverse Event|1|||
44206925|NCT01934894|79003247|FG001|Overall Study|Adverse Event|2|||
44206926|NCT01934894|79003246|FG000|Overall Study|Death|2|||
44206927|NCT01934894|79003247|FG001|Overall Study|Death|0|||
44206928|NCT01934894|79003246|FG000|Overall Study|Withdrawal by Subject|0|||
44206929|NCT01934894|79003247|FG001|Overall Study|Withdrawal by Subject|1|||
44206930|NCT01934894|79003246|FG000|Overall Study|Progressive Disease|3|||
44206931|NCT01934894|79003247|FG001|Overall Study|Progressive Disease|2|||
44368364|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
44368365|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
44206932|NCT01950169|79003259|FG000|Overall Study|Withdrawal by Subject|2|||
44206933|NCT01950169|79003260|FG001|Overall Study|Withdrawal by Subject|8|||
44206934|NCT01950169|79003261|FG002|Overall Study|Withdrawal by Subject|1|||
44368366|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
44368367|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
44206935|NCT01950169|79003259|FG000|Overall Study|Death|1|||
44206936|NCT01950169|79003260|FG001|Overall Study|Death|0|||
44206937|NCT01950169|79003261|FG002|Overall Study|Death|0|||
44206938|NCT01934504|79003274|FG000|Overall Study|Protocol Deviation|0|||
44206939|NCT01934504|79003275|FG001|Overall Study|Protocol Deviation|0|||
44206940|NCT01934504|79003276|FG002|Overall Study|Protocol Deviation|0|||
44206941|NCT01934504|79003277|FG003|Overall Study|Protocol Deviation|2|||
44368368|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
44368369|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
44368370|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
44368371|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
44368372|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
44368373|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
44368374|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
44368375|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
44368376|NCT01008618|79373710|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
44368377|NCT01008618|79373711|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
44368378|NCT01008618|79373712|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
44368379|NCT01001208|79373723|FG000|Overall Study|Adverse Event|10|||
44368380|NCT01001208|79373724|FG001|Overall Study|Adverse Event|5|||
44368381|NCT01001208|79373723|FG000|Overall Study|Lost to Follow-up|5|||
44368382|NCT01001208|79373724|FG001|Overall Study|Lost to Follow-up|9|||
44368383|NCT01001208|79373723|FG000|Overall Study|Physician Decision|1|||
44368384|NCT01001208|79373724|FG001|Overall Study|Physician Decision|0|||
44368385|NCT01001208|79373723|FG000|Overall Study|Withdrawal by Subject|4|||
44368386|NCT01001208|79373724|FG001|Overall Study|Withdrawal by Subject|5|||
44368387|NCT01001208|79373723|FG000|Overall Study|Ineligibility Determined|4|||
44368388|NCT01001208|79373724|FG001|Overall Study|Ineligibility Determined|2|||
44368389|NCT01001208|79373723|FG000|Overall Study|Noncompliance|4|||
44368390|NCT01001208|79373724|FG001|Overall Study|Noncompliance|7|||
44368391|NCT01001208|79373723|FG000|Overall Study|Disease Progression|0|||
44368392|NCT01001208|79373724|FG001|Overall Study|Disease Progression|3|||
44368393|NCT01001208|79373723|FG000|Overall Study|Other|0|||
44368394|NCT01001208|79373724|FG001|Overall Study|Other|2|||
44368395|NCT01000974|79373733|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
44368396|NCT01000974|79373734|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
44368397|NCT01000974|79373735|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
44368398|NCT01000974|79373733|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
44368399|NCT01000974|79373734|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
44206942|NCT01934504|79003274|FG000|Overall Study|Study Terminated by Sponsor|1|||
44206943|NCT01934504|79003275|FG001|Overall Study|Study Terminated by Sponsor|0|||
44206944|NCT01934504|79003276|FG002|Overall Study|Study Terminated by Sponsor|5|||
44206945|NCT01934504|79003277|FG003|Overall Study|Study Terminated by Sponsor|5|||
44206946|NCT01950013|79003290|FG000|Overall Study|Withdrawal by Subject|0|||
44206947|NCT01950013|79003291|FG001|Overall Study|Withdrawal by Subject|2|||
44206948|NCT01950013|79003292|FG002|Overall Study|Withdrawal by Subject|0|||
44206949|NCT01949155|79003302|FG000|Overall Study|Lost to Follow-up|1|||
44206950|NCT01949155|79003303|FG001|Overall Study|Lost to Follow-up|0|||
44206951|NCT01949155|79003302|FG000|Overall Study|Protocol Violation|1|||
44206952|NCT01949155|79003303|FG001|Overall Study|Protocol Violation|0|||
44206953|NCT01909466|79003310|FG000|Overall Study|Lost to Follow-up|5|||
44206954|NCT01909466|79003311|FG001|Overall Study|Lost to Follow-up|7|||
44206955|NCT01909466|79003310|FG000|Overall Study|Adverse Event|3|||
44206956|NCT01909466|79003311|FG001|Overall Study|Adverse Event|4|||
44206957|NCT01909466|79003310|FG000|Overall Study|Met Withdrawal Criteria|0|||
44206958|NCT01909466|79003311|FG001|Overall Study|Met Withdrawal Criteria|3|||
44206959|NCT01909466|79003310|FG000|Overall Study|Physician Decision|2|||
44206960|NCT01909466|79003311|FG001|Overall Study|Physician Decision|0|||
44368400|NCT01000974|79373735|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
44368401|NCT01000974|79373733|FG000|Primary Vaccination Phase|Protocol Violation|40|||
44368402|NCT01000974|79373734|FG001|Primary Vaccination Phase|Protocol Violation|3|||
44368403|NCT01000974|79373735|FG002|Primary Vaccination Phase|Protocol Violation|2|||
44543505|NCT03745937|79556546|FG001|Overall Study|Withdrawal by Subject|0|||
44206961|NCT01909466|79003310|FG000|Overall Study|Withdrawal by Subject|11|||
44269632|NCT00558428|79193928|FG003|Overall Study|Consent withdrawn|1|||
44269633|NCT00558428|79193925|FG000|Overall Study|Other|3|||
44269634|NCT00558428|79193926|FG001|Overall Study|Other|0|||
44269635|NCT00558428|79193927|FG002|Overall Study|Other|0|||
44269636|NCT00558428|79193928|FG003|Overall Study|Other|1|||
44269637|NCT00558272|79193967|FG000|Overall Study|Adverse Event|10|||
44269638|NCT00558272|79193968|FG001|Overall Study|Adverse Event|0|||
44368404|NCT01000974|79373733|FG000|Primary Vaccination Phase|Adverse Event|14|||
44368405|NCT01000974|79373734|FG001|Primary Vaccination Phase|Adverse Event|2|||
44368406|NCT01000974|79373735|FG002|Primary Vaccination Phase|Adverse Event|2|||
44368407|NCT01000974|79373733|FG000|Primary Vaccination Phase|Other|4|||
44206962|NCT01909466|79003311|FG001|Overall Study|Withdrawal by Subject|9|||
44269639|NCT00558272|79193967|FG000|Overall Study|Death|1|||
44368408|NCT01000974|79373734|FG001|Primary Vaccination Phase|Other|9|||
44543506|NCT03745937|79556547|FG002|Overall Study|Withdrawal by Subject|0|||
44206963|NCT01909466|79003310|FG000|Overall Study|Lack of Efficacy|1|||
44206964|NCT01909466|79003311|FG001|Overall Study|Lack of Efficacy|0|||
44269640|NCT00558272|79193968|FG001|Overall Study|Death|0|||
44206965|NCT01977625|79003315|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
44206966|NCT01977625|79003316|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
44206967|NCT01977625|79003315|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44206968|NCT01977625|79003316|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
44206969|NCT01944631|79003326|FG000|Overall Study|Adverse Event|1|||
44206970|NCT01944631|79003327|FG001|Overall Study|Adverse Event|0|||
44206971|NCT01944631|79003326|FG000|Overall Study|Lost to Follow-up|3|||
44206972|NCT01944631|79003327|FG001|Overall Study|Lost to Follow-up|1|||
44206973|NCT01944631|79003326|FG000|Overall Study|Withdrawal by Subject|0|||
44206974|NCT01944631|79003327|FG001|Overall Study|Withdrawal by Subject|1|||
44206975|NCT01948063|79003335|FG000|Overall Study|Boston MCI halted research protocol|0|||
44206976|NCT01948063|79003336|FG001|Overall Study|Boston MCI halted research protocol|1|||
44206977|NCT01948063|79003335|FG000|Overall Study|Discovered an enrollment in other study|0|||
44206978|NCT01948063|79003336|FG001|Overall Study|Discovered an enrollment in other study|1|||
44206979|NCT01948063|79003335|FG000|Overall Study|Blood samples were accidentally thawed|1|||
44206980|NCT01948063|79003336|FG001|Overall Study|Blood samples were accidentally thawed|0|||
44368409|NCT01000974|79373735|FG002|Primary Vaccination Phase|Other|12|||
44368410|NCT01000974|79373733|FG000|Booster Vaccination Phase|Protocol Violation|0|||
44368411|NCT01000974|79373734|FG001|Booster Vaccination Phase|Protocol Violation|0|||
44368412|NCT01000974|79373735|FG002|Booster Vaccination Phase|Protocol Violation|2|||
44368413|NCT01000974|79373733|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
44368414|NCT01000974|79373734|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
44368415|NCT01000974|79373735|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
44368416|NCT01000974|79373733|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
44368417|NCT01000974|79373734|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
44368418|NCT01000974|79373735|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
44368419|NCT01000974|79373733|FG000|Booster Vaccination Phase|Other|24|||
44368420|NCT01000974|79373734|FG001|Booster Vaccination Phase|Other|6|||
44368421|NCT01000974|79373735|FG002|Booster Vaccination Phase|Other|4|||
44368422|NCT01004406|79373748|FG000|Overall Study|Withdrawal by Subject|2|||
44368423|NCT01004406|79373749|FG001|Overall Study|Withdrawal by Subject|0|||
44206981|NCT01995071|79003354|FG000|Overall Study|Adverse Event|0|||
44206982|NCT01995071|79003355|FG001|Overall Study|Adverse Event|0|||
44206983|NCT01995071|79003356|FG002|Overall Study|Adverse Event|0|||
44206984|NCT01995071|79003357|FG003|Overall Study|Adverse Event|0|||
44206985|NCT01995071|79003358|FG004|Overall Study|Adverse Event|0|||
44206986|NCT01995071|79003359|FG005|Overall Study|Adverse Event|0|||
44206987|NCT01995071|79003360|FG006|Overall Study|Adverse Event|1|||
44206988|NCT01995071|79003361|FG007|Overall Study|Adverse Event|0|||
44206989|NCT01995071|79003362|FG008|Overall Study|Adverse Event|0|||
44206990|NCT01995071|79003363|FG009|Overall Study|Adverse Event|0|||
44206991|NCT01995071|79003364|FG010|Overall Study|Adverse Event|0|||
44206992|NCT01995071|79003365|FG011|Overall Study|Adverse Event|0|||
44206993|NCT01995071|79003354|FG000|Overall Study|Moved|0|||
44206994|NCT01995071|79003355|FG001|Overall Study|Moved|0|||
44206995|NCT01995071|79003356|FG002|Overall Study|Moved|1|||
44206996|NCT01995071|79003357|FG003|Overall Study|Moved|0|||
44206997|NCT01995071|79003358|FG004|Overall Study|Moved|1|||
44206998|NCT01995071|79003359|FG005|Overall Study|Moved|0|||
44206999|NCT01995071|79003360|FG006|Overall Study|Moved|0|||
44207000|NCT01995071|79003361|FG007|Overall Study|Moved|0|||
44207001|NCT01995071|79003362|FG008|Overall Study|Moved|0|||
44207002|NCT01995071|79003363|FG009|Overall Study|Moved|0|||
44207003|NCT01995071|79003364|FG010|Overall Study|Moved|1|||
44207004|NCT01995071|79003365|FG011|Overall Study|Moved|0|||
44207005|NCT01995071|79003354|FG000|Overall Study|Lost to Follow-up|1|||
44207006|NCT01995071|79003355|FG001|Overall Study|Lost to Follow-up|0|||
44207007|NCT01995071|79003356|FG002|Overall Study|Lost to Follow-up|0|||
44207008|NCT01995071|79003357|FG003|Overall Study|Lost to Follow-up|0|||
44207009|NCT01995071|79003358|FG004|Overall Study|Lost to Follow-up|0|||
44207010|NCT01995071|79003359|FG005|Overall Study|Lost to Follow-up|0|||
44207011|NCT01995071|79003360|FG006|Overall Study|Lost to Follow-up|0|||
44207012|NCT01995071|79003361|FG007|Overall Study|Lost to Follow-up|1|||
44368424|NCT01004406|79373748|FG000|Overall Study|Lost to Follow-up|1|||
44368425|NCT01004406|79373749|FG001|Overall Study|Lost to Follow-up|0|||
44207013|NCT01995071|79003362|FG008|Overall Study|Lost to Follow-up|1|||
44207014|NCT01995071|79003363|FG009|Overall Study|Lost to Follow-up|0|||
44207015|NCT01995071|79003364|FG010|Overall Study|Lost to Follow-up|0|||
44207016|NCT01995071|79003365|FG011|Overall Study|Lost to Follow-up|0|||
44207017|NCT01995071|79003354|FG000|Overall Study|Incarcerated|0|||
44207018|NCT01995071|79003355|FG001|Overall Study|Incarcerated|0|||
44207019|NCT01995071|79003356|FG002|Overall Study|Incarcerated|0|||
44207020|NCT01995071|79003357|FG003|Overall Study|Incarcerated|0|||
44368426|NCT01182350|79373755|FG000|Overall Study|Adverse Event|5|||
44207021|NCT01995071|79003358|FG004|Overall Study|Incarcerated|0|||
44207022|NCT01995071|79003359|FG005|Overall Study|Incarcerated|0|||
44207023|NCT01995071|79003360|FG006|Overall Study|Incarcerated|0|||
44207024|NCT01995071|79003361|FG007|Overall Study|Incarcerated|1|||
44207025|NCT01995071|79003362|FG008|Overall Study|Incarcerated|0|||
44207026|NCT01995071|79003363|FG009|Overall Study|Incarcerated|0|||
44207027|NCT01995071|79003364|FG010|Overall Study|Incarcerated|0|||
44207028|NCT01995071|79003365|FG011|Overall Study|Incarcerated|0|||
44207029|NCT01994837|79003397|FG000|Overall Study|Progressive disease per protocol|23|||
44207030|NCT01994837|79003397|FG000|Overall Study|Adv event related to progressive disease|3|||
44207031|NCT01994837|79003397|FG000|Overall Study|Fatal progressive disease|2|||
44207032|NCT01994837|79003397|FG000|Overall Study|Adverse event not related to progression|1|||
44368427|NCT01182350|79373756|FG001|Overall Study|Adverse Event|0|||
44368428|NCT01182350|79373757|FG002|Overall Study|Adverse Event|0|||
44368429|NCT01182350|79373758|FG003|Overall Study|Adverse Event|0|||
44368430|NCT01182350|79373759|FG004|Overall Study|Adverse Event|0|||
44368431|NCT01182350|79373755|FG000|Overall Study|Disease Progression|15|||
44368432|NCT01182350|79373756|FG001|Overall Study|Disease Progression|12|||
44368433|NCT01182350|79373757|FG002|Overall Study|Disease Progression|0|||
44368434|NCT01182350|79373758|FG003|Overall Study|Disease Progression|1|||
44368435|NCT01182350|79373759|FG004|Overall Study|Disease Progression|0|||
44368436|NCT01182350|79373755|FG000|Overall Study|Death|0|||
44368437|NCT01182350|79373756|FG001|Overall Study|Death|1|||
44368438|NCT01182350|79373757|FG002|Overall Study|Death|1|||
44368439|NCT01182350|79373758|FG003|Overall Study|Death|0|||
44368440|NCT01182350|79373759|FG004|Overall Study|Death|0|||
44368441|NCT01182350|79373755|FG000|Overall Study|Withdrawal by Subject|3|||
44368442|NCT01182350|79373756|FG001|Overall Study|Withdrawal by Subject|1|||
44368443|NCT01182350|79373757|FG002|Overall Study|Withdrawal by Subject|0|||
44368444|NCT01182350|79373758|FG003|Overall Study|Withdrawal by Subject|1|||
44368445|NCT01182350|79373759|FG004|Overall Study|Withdrawal by Subject|0|||
44368446|NCT01182350|79373755|FG000|Overall Study|Alternative Therapy|2|||
44368447|NCT01182350|79373756|FG001|Overall Study|Alternative Therapy|0|||
44368448|NCT01182350|79373757|FG002|Overall Study|Alternative Therapy|1|||
44368449|NCT01182350|79373758|FG003|Overall Study|Alternative Therapy|0|||
44368450|NCT01182350|79373759|FG004|Overall Study|Alternative Therapy|0|||
44368451|NCT01182350|79373755|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
44368452|NCT01182350|79373756|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
44368453|NCT01182350|79373757|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
44368454|NCT01182350|79373758|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
44368455|NCT01182350|79373759|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
44368456|NCT01182350|79373755|FG000|Overall Study|Unevaluable for Biopsy|0|||
44368457|NCT01182350|79373756|FG001|Overall Study|Unevaluable for Biopsy|0|||
44368458|NCT01182350|79373757|FG002|Overall Study|Unevaluable for Biopsy|0|||
44368459|NCT01182350|79373758|FG003|Overall Study|Unevaluable for Biopsy|0|||
44368460|NCT01182350|79373759|FG004|Overall Study|Unevaluable for Biopsy|3|||
44368461|NCT01163474|79373775|FG000|Overall Study|Withdrawal by Subject|1|||
44368462|NCT01163474|79373775|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
44368463|NCT01163474|79373775|FG000|Overall Study|Lost to Follow-up|3|||
44368464|NCT00603538|79373785|FG000|Overall Study|Adverse Event|0|||
44368465|NCT00603538|79373786|FG001|Overall Study|Adverse Event|4|||
44368466|NCT00603538|79373787|FG002|Overall Study|Adverse Event|2|||
44368467|NCT00603538|79373785|FG000|Overall Study|Objective progression or relapse|3|||
44368468|NCT00603538|79373786|FG001|Overall Study|Objective progression or relapse|0|||
44368469|NCT00603538|79373787|FG002|Overall Study|Objective progression or relapse|0|||
44368470|NCT01163318|79373798|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
44207033|NCT01994837|79003397|FG000|Overall Study|Chose palliative care|1|||
44207034|NCT01994837|79003397|FG000|Overall Study|Proceeded to transplant|1|||
44207035|NCT01994837|79003397|FG000|Overall Study|Removed from study due to no response|1|||
44207036|NCT02010593|79003403|FG000|Overall Study|Lost to Follow-up|1|||
44207037|NCT02010593|79003404|FG001|Overall Study|Lost to Follow-up|0|||
44207038|NCT02010593|79003403|FG000|Overall Study|Physician Decision|1|||
44207039|NCT02010593|79003404|FG001|Overall Study|Physician Decision|0|||
44368471|NCT01163318|79373798|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
44368472|NCT01163318|79373798|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
44368473|NCT01163318|79373798|FG000|Overall Study|Participants Without Case Report Form|7|||
44368474|NCT01163318|79373798|FG000|Overall Study|Multiple Reasons Per Participant|224|||
44368475|NCT01162304|79373802|FG000|Overall Study|Beck scale to high|11|||
44368476|NCT04515394|79373808|FG000|Overall Study|Participant did not receive treatment|1|||
44368477|NCT01175018|79373814|FG000|Overall Study|Adverse Event|3|||
44368478|NCT01175018|79373815|FG001|Overall Study|Adverse Event|1|||
44368479|NCT01174784|79373823|FG000|Overall Study|Screen fails|4|||
44368480|NCT01174550|79373830|FG000|Overall Study|Death|75|||
44368481|NCT01174550|79373831|FG001|Overall Study|Death|74|||
44368482|NCT01174550|79373830|FG000|Overall Study|Lost to Follow-up|652|||
44368483|NCT01174550|79373831|FG001|Overall Study|Lost to Follow-up|510|||
44368484|NCT01174550|79373830|FG000|Overall Study|Withdrawal by Subject|543|||
44368485|NCT01174550|79373831|FG001|Overall Study|Withdrawal by Subject|289|||
44368486|NCT01008150|79373841|FG000|Overall Study|did not receive study drug|1|||
44368487|NCT01008150|79373842|FG001|Overall Study|did not receive study drug|1|||
44368488|NCT01008150|79373843|FG002|Overall Study|did not receive study drug|1|||
44368489|NCT01008150|79373844|FG003|Overall Study|did not receive study drug|0|||
44368490|NCT01007916|79373855|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
44368491|NCT01007916|79373856|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
44368492|NCT01007916|79373855|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
44368493|NCT01007916|79373856|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
44368494|NCT01007838|79373866|FG000|Overall Study|Withdrawal by Subject|1|||
44368495|NCT01007838|79373867|FG001|Overall Study|Withdrawal by Subject|0|||
44368496|NCT01007838|79373868|FG002|Overall Study|Withdrawal by Subject|0|||
44368497|NCT01007838|79373869|FG003|Overall Study|Withdrawal by Subject|0|||
44368498|NCT01007838|79373866|FG000|Overall Study|Physician Decision|1|||
44368499|NCT01007838|79373867|FG001|Overall Study|Physician Decision|0|||
44368500|NCT01007838|79373868|FG002|Overall Study|Physician Decision|0|||
44368501|NCT01007838|79373869|FG003|Overall Study|Physician Decision|0|||
44368502|NCT01007838|79373866|FG000|Overall Study|Started home haemodialysis|1|||
44368503|NCT01007838|79373867|FG001|Overall Study|Started home haemodialysis|0|||
44368504|NCT01007838|79373868|FG002|Overall Study|Started home haemodialysis|0|||
44368505|NCT01007838|79373869|FG003|Overall Study|Started home haemodialysis|0|||
44368506|NCT01007448|79373881|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
44368507|NCT01007448|79373882|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
44368508|NCT01007448|79373881|FG000|Overall Study|Staph Skin Infection Flare|1|||
44368509|NCT01007448|79373882|FG001|Overall Study|Staph Skin Infection Flare|0|||
44368510|NCT01007448|79373881|FG000|Overall Study|Participant Leaving the Country|1|||
44368511|NCT01007448|79373882|FG001|Overall Study|Participant Leaving the Country|0|||
44368512|NCT01007448|79373881|FG000|Overall Study|Participant Given Prohibited Medication|1|||
44368513|NCT01007448|79373882|FG001|Overall Study|Participant Given Prohibited Medication|0|||
44368514|NCT01007448|79373881|FG000|Overall Study|Progressive Disease|1|||
44368515|NCT01007448|79373882|FG001|Overall Study|Progressive Disease|2|||
44207040|NCT02010593|79003403|FG000|Overall Study|Unable to adhere to visit schedule|0|||
44207041|NCT02010593|79003404|FG001|Overall Study|Unable to adhere to visit schedule|2|||
44207042|NCT01994291|79003413|FG000|Overall Study|Adverse Event|4|||
44207043|NCT01994291|79003414|FG001|Overall Study|Adverse Event|1|||
44207044|NCT01994291|79003415|FG002|Overall Study|Adverse Event|3|||
44207045|NCT01994291|79003413|FG000|Overall Study|Lost to Follow-up|1|||
44368516|NCT01007448|79373881|FG000|Overall Study|Lack of Efficacy|2|||
44368517|NCT01007448|79373882|FG001|Overall Study|Lack of Efficacy|0|||
44368518|NCT01007448|79373881|FG000|Overall Study|Withdrawal by Subject|2|||
44368519|NCT01007448|79373882|FG001|Overall Study|Withdrawal by Subject|3|||
44368520|NCT01007448|79373881|FG000|Overall Study|Adverse Event|1|||
44368521|NCT01007448|79373882|FG001|Overall Study|Adverse Event|4|||
44368522|NCT03538756|79373888|FG000|Long-Term Follow-up|Adverse Event|0|||
44368523|NCT03538756|79373889|FG001|Long-Term Follow-up|Adverse Event|0|||
44368524|NCT03538756|79373890|FG002|Long-Term Follow-up|Adverse Event|6|||
44368525|NCT03538756|79373888|FG000|Long-Term Follow-up|Death|0|||
44368526|NCT03538756|79373889|FG001|Long-Term Follow-up|Death|0|||
44368527|NCT03538756|79373890|FG002|Long-Term Follow-up|Death|1|||
44368528|NCT03538756|79373888|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
44368529|NCT03538756|79373889|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
44368530|NCT03538756|79373890|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
44368531|NCT03538756|79373888|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
44368532|NCT03538756|79373889|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
44368533|NCT03538756|79373890|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
44368534|NCT03538756|79373888|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
44368535|NCT03538756|79373889|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
44368536|NCT03538756|79373890|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
44368537|NCT01004250|79373900|FG000|Induction Therapy Period|Adverse Event|10|||
44368538|NCT01004250|79373900|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
44368539|NCT01004250|79373900|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
44368540|NCT01004250|79373900|FG000|Induction Therapy Period|Physician Decision|2|||
44368541|NCT01004250|79373900|FG000|Maintenance Therapy Period|Adverse Event|15|||
44368542|NCT01004250|79373900|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
44368543|NCT01004250|79373900|FG000|Maintenance Therapy Period|Protocol Violation|1|||
44368544|NCT01004250|79373900|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
44368545|NCT01004250|79373900|FG000|Maintenance Therapy Period|Physician Decision|4|||
44368546|NCT01004250|79373900|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
44368547|NCT01004172|79373908|FG000|Overall Study|Progressive Disease in CNS Only|16|||
44207046|NCT01994291|79003414|FG001|Overall Study|Lost to Follow-up|1|||
44368548|NCT01004172|79373908|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
44368549|NCT01004172|79373908|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
44368550|NCT01004172|79373908|FG000|Overall Study|Adverse Event|1|||
44368551|NCT01004172|79373908|FG000|Overall Study|Physician Decision|1|||
44368552|NCT01004172|79373908|FG000|Overall Study|Symptomatic Deterioration|2|||
44368553|NCT01161524|79373915|FG000|Core Study (23 Weeks)|Adverse Event|3|||
44368554|NCT01161524|79373916|FG001|Core Study (23 Weeks)|Adverse Event|0|||
44368555|NCT01161524|79373917|FG002|Core Study (23 Weeks)|Adverse Event|0|||
44368556|NCT01161524|79373915|FG000|Core Study (23 Weeks)|Other|1|||
44368557|NCT01161524|79373916|FG001|Core Study (23 Weeks)|Other|0|||
44368558|NCT01161524|79373917|FG002|Core Study (23 Weeks)|Other|0|||
44368559|NCT01161524|79373915|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
44368560|NCT01161524|79373916|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
44368561|NCT01161524|79373917|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
44368562|NCT01161524|79373915|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
44368563|NCT01161524|79373916|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
44368564|NCT01161524|79373917|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
44368565|NCT01161524|79373915|FG000|Core Study (23 Weeks)|Subject Choice|3|||
44368566|NCT01161524|79373916|FG001|Core Study (23 Weeks)|Subject Choice|2|||
44368567|NCT01161524|79373917|FG002|Core Study (23 Weeks)|Subject Choice|0|||
44368568|NCT01161524|79373915|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
44368569|NCT01161524|79373916|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
44368570|NCT01161524|79373917|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
44368571|NCT01161524|79373915|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
44368572|NCT01161524|79373916|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
44368573|NCT01161524|79373917|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
44368574|NCT01161524|79373915|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
44368575|NCT01161524|79373916|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
44368576|NCT01161524|79373917|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
44368577|NCT01161524|79373915|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
44368578|NCT01161524|79373916|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
44368579|NCT01161524|79373917|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
44368580|NCT01161524|79373915|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
44368581|NCT01161524|79373916|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
44368582|NCT01161524|79373917|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
44368583|NCT01000506|79373930|FG000|Overall Study|Adverse Event|6|||
44368584|NCT01000506|79373931|FG001|Overall Study|Adverse Event|5|||
44368585|NCT01000506|79373932|FG002|Overall Study|Adverse Event|8|||
44368586|NCT01000506|79373933|FG003|Overall Study|Adverse Event|9|||
44368587|NCT01000506|79373930|FG000|Overall Study|Lack of Efficacy|8|||
44368588|NCT01000506|79373931|FG001|Overall Study|Lack of Efficacy|6|||
44368589|NCT01000506|79373932|FG002|Overall Study|Lack of Efficacy|4|||
44368590|NCT01000506|79373933|FG003|Overall Study|Lack of Efficacy|4|||
44368591|NCT01000506|79373930|FG000|Overall Study|Protocol Violation|1|||
44368592|NCT01000506|79373931|FG001|Overall Study|Protocol Violation|1|||
44368593|NCT01000506|79373932|FG002|Overall Study|Protocol Violation|0|||
44368594|NCT01000506|79373933|FG003|Overall Study|Protocol Violation|0|||
44368595|NCT01000506|79373930|FG000|Overall Study|Lost to Follow-up|1|||
44368596|NCT01000506|79373931|FG001|Overall Study|Lost to Follow-up|1|||
44368597|NCT01000506|79373932|FG002|Overall Study|Lost to Follow-up|4|||
44368598|NCT01000506|79373933|FG003|Overall Study|Lost to Follow-up|0|||
44368599|NCT01000506|79373930|FG000|Overall Study|Physician Decision|1|||
44368600|NCT01000506|79373931|FG001|Overall Study|Physician Decision|3|||
44368601|NCT01000506|79373932|FG002|Overall Study|Physician Decision|3|||
44269641|NCT00558272|79193967|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
44269642|NCT00558272|79193968|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
44269643|NCT00558272|79193967|FG000|Overall Study|AZ study team decision|0|||
44269644|NCT00558272|79193968|FG001|Overall Study|AZ study team decision|1|||
44269645|NCT00558272|79193967|FG000|Overall Study|Incorrectly enrolled|1|||
44368602|NCT01000506|79373933|FG003|Overall Study|Physician Decision|3|||
44368603|NCT01000506|79373930|FG000|Overall Study|Withdrawal by Subject|11|||
44368604|NCT01000506|79373931|FG001|Overall Study|Withdrawal by Subject|8|||
44368605|NCT01000506|79373932|FG002|Overall Study|Withdrawal by Subject|2|||
44368606|NCT01000506|79373933|FG003|Overall Study|Withdrawal by Subject|7|||
44368607|NCT01174238|79373943|FG000|Overall Study|Lost to Follow-up|2|||
44368608|NCT01174160|79373952|FG000|Overall Study|Adverse Event|1|||
44368609|NCT01174160|79373953|FG001|Overall Study|Adverse Event|0|||
44368610|NCT01174160|79373952|FG000|Overall Study|Lost to Follow-up|1|||
44368611|NCT01174160|79373953|FG001|Overall Study|Lost to Follow-up|0|||
44368612|NCT01174160|79373952|FG000|Overall Study|Physician Decision|1|||
44368613|NCT01174160|79373953|FG001|Overall Study|Physician Decision|0|||
44368614|NCT01174160|79373952|FG000|Overall Study|Protocol Violation|4|||
44368615|NCT01174160|79373953|FG001|Overall Study|Protocol Violation|6|||
44368616|NCT01174160|79373952|FG000|Overall Study|Withdrawal by Subject|1|||
44368617|NCT01174160|79373953|FG001|Overall Study|Withdrawal by Subject|0|||
44368618|NCT01161446|79373961|FG000|Overall Study|Lost to Follow-up|18|||
44368619|NCT01161446|79373962|FG001|Overall Study|Lost to Follow-up|14|||
44368620|NCT01161446|79373961|FG000|Overall Study|Withdrawal by Subject|0|||
44368621|NCT01161446|79373962|FG001|Overall Study|Withdrawal by Subject|1|||
44368622|NCT01174004|79373970|FG000|Overall Study|Adverse Event|2|||
44368623|NCT01174004|79373971|FG001|Overall Study|Adverse Event|10|||
44368624|NCT01174004|79373970|FG000|Overall Study|Withdrawal by Subject|2|||
44368625|NCT01174004|79373971|FG001|Overall Study|Withdrawal by Subject|3|||
44368626|NCT01174004|79373970|FG000|Overall Study|At Discretion of Sponsor|2|||
44368627|NCT01174004|79373971|FG001|Overall Study|At Discretion of Sponsor|2|||
44368628|NCT01174004|79373970|FG000|Overall Study|Protocol Violation|0|||
44368629|NCT01174004|79373971|FG001|Overall Study|Protocol Violation|1|||
44368630|NCT01174004|79373970|FG000|Overall Study|Physician Decision|1|||
44368631|NCT01174004|79373971|FG001|Overall Study|Physician Decision|0|||
44368632|NCT01173692|79373979|FG000|Overall Study|Adverse Event|1|||
44368633|NCT01173692|79373980|FG001|Overall Study|Adverse Event|2|||
44368634|NCT01173692|79373979|FG000|Overall Study|Withdrawal by Subject|1|||
44368635|NCT01173692|79373980|FG001|Overall Study|Withdrawal by Subject|3|||
44368636|NCT01101035|79373988|FG000|Overall Study|Adverse Event|191|||
44368637|NCT01101035|79373989|FG001|Overall Study|Adverse Event|172|||
44368638|NCT01101035|79373988|FG000|Overall Study|Major Protocol Deviation|52|||
44368639|NCT01101035|79373989|FG001|Overall Study|Major Protocol Deviation|46|||
44368640|NCT01101035|79373988|FG000|Overall Study|Lost to Follow-up|226|||
44368641|NCT01101035|79373989|FG001|Overall Study|Lost to Follow-up|223|||
44368642|NCT01101035|79373988|FG000|Overall Study|Voluntary Withdrawal|595|||
44368643|NCT01101035|79373989|FG001|Overall Study|Voluntary Withdrawal|587|||
44368644|NCT01101035|79373988|FG000|Overall Study|Reason not Specified|333|||
44368645|NCT01101035|79373989|FG001|Overall Study|Reason not Specified|363|||
44368646|NCT01100567|79373997|FG000|Overall Study|Withdrawal by Subject|5|||
44368647|NCT01100567|79373998|FG001|Overall Study|Withdrawal by Subject|8|||
44368648|NCT01100567|79373997|FG000|Overall Study|Early Hospital Discharge|6|||
44368649|NCT01100567|79373998|FG001|Overall Study|Early Hospital Discharge|4|||
44368650|NCT01100567|79373997|FG000|Overall Study|Lost to Follow-up|1|||
44368651|NCT01100567|79373998|FG001|Overall Study|Lost to Follow-up|2|||
44368652|NCT01100567|79373997|FG000|Overall Study|Physician Decision|0|||
44368653|NCT01100567|79373998|FG001|Overall Study|Physician Decision|1|||
44368654|NCT01100567|79373997|FG000|Overall Study|Deemed ineligible after consent|0|||
44368655|NCT01100567|79373998|FG001|Overall Study|Deemed ineligible after consent|1|||
44368656|NCT01160822|79374011|FG000|Overall Study|Adverse Event|0|||
44368657|NCT01160822|79374012|FG001|Overall Study|Adverse Event|0|||
44368658|NCT01160822|79374013|FG002|Overall Study|Adverse Event|0|||
44368659|NCT01160822|79374014|FG003|Overall Study|Adverse Event|0|||
44368660|NCT01160822|79374015|FG004|Overall Study|Adverse Event|1|||
44368661|NCT01160822|79374016|FG005|Overall Study|Adverse Event|2|||
44368662|NCT01160822|79374017|FG006|Overall Study|Adverse Event|5|||
44368663|NCT01160822|79374011|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44368664|NCT01160822|79374012|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44368665|NCT01160822|79374013|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44368666|NCT01160822|79374014|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
44368667|NCT01160822|79374015|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
44368668|NCT01160822|79374016|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
44368669|NCT01160822|79374017|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
44368670|NCT01160822|79374011|FG000|Overall Study|Withdrawal by Subject|0|||
44368671|NCT01160822|79374012|FG001|Overall Study|Withdrawal by Subject|0|||
44207047|NCT01994291|79003415|FG002|Overall Study|Lost to Follow-up|0|||
44207048|NCT01994291|79003413|FG000|Overall Study|Does not meet entrance criteria|1|||
44207049|NCT01994291|79003414|FG001|Overall Study|Does not meet entrance criteria|0|||
44207050|NCT01994291|79003415|FG002|Overall Study|Does not meet entrance criteria|0|||
44207051|NCT01994291|79003413|FG000|Overall Study|Medication error without associated AE|1|||
44207052|NCT01994291|79003414|FG001|Overall Study|Medication error without associated AE|0|||
44207053|NCT01994291|79003415|FG002|Overall Study|Medication error without associated AE|1|||
44207054|NCT01994291|79003413|FG000|Overall Study|Protocol Violation|1|||
44207055|NCT01994291|79003414|FG001|Overall Study|Protocol Violation|0|||
44207056|NCT01994291|79003415|FG002|Overall Study|Protocol Violation|0|||
44207057|NCT01994291|79003413|FG000|Overall Study|Withdrawal by Subject|6|||
44207058|NCT01994291|79003414|FG001|Overall Study|Withdrawal by Subject|3|||
44207059|NCT01994291|79003415|FG002|Overall Study|Withdrawal by Subject|5|||
44207060|NCT01994291|79003413|FG000|Overall Study|Other|1|||
44207061|NCT01994291|79003414|FG001|Overall Study|Other|2|||
44368672|NCT01160822|79374013|FG002|Overall Study|Withdrawal by Subject|0|||
44368673|NCT01160822|79374014|FG003|Overall Study|Withdrawal by Subject|0|||
44368674|NCT01160822|79374015|FG004|Overall Study|Withdrawal by Subject|0|||
44207062|NCT01994291|79003415|FG002|Overall Study|Other|0|||
44368675|NCT01160822|79374016|FG005|Overall Study|Withdrawal by Subject|0|||
44368676|NCT01160822|79374017|FG006|Overall Study|Withdrawal by Subject|1|||
44368677|NCT01160822|79374011|FG000|Overall Study|Lost to Follow-up|0|||
44368678|NCT01160822|79374012|FG001|Overall Study|Lost to Follow-up|0|||
44368679|NCT01160822|79374013|FG002|Overall Study|Lost to Follow-up|0|||
44207063|NCT02094677|79003426|FG000|Overall Study|Screening|3|||
44207064|NCT02094677|79003427|FG001|Overall Study|Screening|1|||
44207065|NCT01993823|79003442|FG000|Overall Study|Requested by the patient|6|||
44207066|NCT01993823|79003443|FG001|Overall Study|Requested by the patient|11|||
44207067|NCT01993823|79003442|FG000|Overall Study|Protocol Violation|0|||
44207068|NCT01993823|79003443|FG001|Overall Study|Protocol Violation|1|||
44207069|NCT01993823|79003442|FG000|Overall Study|Lost to Follow-up|1|||
44207070|NCT01993823|79003443|FG001|Overall Study|Lost to Follow-up|4|||
44207071|NCT01993667|79003451|FG000|Overall Study|Insufficient data to analyze|16|||
44207072|NCT01993667|79003452|FG001|Overall Study|Insufficient data to analyze|16|||
44207073|NCT01993667|79003451|FG000|Overall Study|Insufficient altitude reached|3|||
44207074|NCT01993667|79003452|FG001|Overall Study|Insufficient altitude reached|1|||
44207075|NCT01993667|79003451|FG000|Overall Study|Lost to Follow-up|2|||
44207076|NCT01993667|79003452|FG001|Overall Study|Lost to Follow-up|2|||
44207077|NCT01992107|79003461|FG000|Overall Study|Administrative reasons|2|||
44207078|NCT01992107|79003462|FG001|Overall Study|Administrative reasons|0|||
44207079|NCT01992107|79003463|FG002|Overall Study|Administrative reasons|0|||
44207080|NCT01992107|79003461|FG000|Overall Study|Adverse Event|0|||
44207081|NCT01992107|79003462|FG001|Overall Study|Adverse Event|1|||
44368680|NCT01160822|79374014|FG003|Overall Study|Lost to Follow-up|0|||
44368681|NCT01160822|79374015|FG004|Overall Study|Lost to Follow-up|1|||
44207082|NCT01992107|79003463|FG002|Overall Study|Adverse Event|0|||
44207083|NCT01992107|79003461|FG000|Overall Study|Lost to Follow-up|46|||
44207084|NCT01992107|79003462|FG001|Overall Study|Lost to Follow-up|22|||
44207085|NCT01992107|79003463|FG002|Overall Study|Lost to Follow-up|26|||
44207086|NCT01992107|79003461|FG000|Overall Study|noncompliance and were unavailable|7|||
44207087|NCT01992107|79003462|FG001|Overall Study|noncompliance and were unavailable|3|||
44207088|NCT01992107|79003463|FG002|Overall Study|noncompliance and were unavailable|2|||
44207089|NCT01992107|79003461|FG000|Overall Study|Withdrawal by Subject|13|||
44207090|NCT01992107|79003462|FG001|Overall Study|Withdrawal by Subject|7|||
44207091|NCT01992107|79003463|FG002|Overall Study|Withdrawal by Subject|8|||
44207092|NCT01934192|79003492|FG000|Overall Study|Protocol Violation|0|||
44207093|NCT01934192|79003493|FG001|Overall Study|Protocol Violation|0|||
44207094|NCT01934192|79003494|FG002|Overall Study|Protocol Violation|0|||
44207095|NCT01934192|79003495|FG003|Overall Study|Protocol Violation|1|||
44207096|NCT01934192|79003492|FG000|Overall Study|Other: reached stopping criteria|6|||
44207097|NCT01934192|79003493|FG001|Overall Study|Other: reached stopping criteria|5|||
44207098|NCT01934192|79003494|FG002|Overall Study|Other: reached stopping criteria|1|||
44207099|NCT01934192|79003495|FG003|Overall Study|Other: reached stopping criteria|0|||
44207100|NCT01934192|79003492|FG000|Overall Study|Physician Decision|3|||
44207101|NCT01934192|79003493|FG001|Overall Study|Physician Decision|2|||
44207102|NCT01934192|79003494|FG002|Overall Study|Physician Decision|0|||
44207103|NCT01934192|79003495|FG003|Overall Study|Physician Decision|0|||
44207104|NCT01933880|79003518|FG000|Overall Study|Withdrawal by Subject|5|||
44207105|NCT01933880|79003519|FG001|Overall Study|Withdrawal by Subject|0|||
44207106|NCT01933880|79003518|FG000|Overall Study|Lack of Efficacy|1|||
44207107|NCT01933880|79003519|FG001|Overall Study|Lack of Efficacy|0|||
44207108|NCT01933880|79003518|FG000|Overall Study|Concomitant medication Interference|0|||
44207109|NCT01933880|79003519|FG001|Overall Study|Concomitant medication Interference|1|||
44207110|NCT01933880|79003518|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
44207111|NCT01933880|79003519|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
44207112|NCT01933880|79003518|FG000|Overall Study|Other|4|||
44207113|NCT01933880|79003519|FG001|Overall Study|Other|0|||
44207114|NCT01933880|79003518|FG000|Overall Study|Protocol Violation|1|||
44207115|NCT01933880|79003519|FG001|Overall Study|Protocol Violation|0|||
44207116|NCT02008877|79003530|FG000|Overall Study|Inevaluable|0|||
44207117|NCT02008877|79003531|FG001|Overall Study|Inevaluable|1|||
44207118|NCT02008877|79003532|FG002|Overall Study|Inevaluable|0|||
44207119|NCT01933334|79003543|FG000|Overall Study|Adverse Event|5|||
44207120|NCT01933334|79003544|FG001|Overall Study|Adverse Event|1|||
44207121|NCT01933334|79003543|FG000|Overall Study|Withdrawal by Subject|0|||
44207122|NCT01933334|79003544|FG001|Overall Study|Withdrawal by Subject|1|||
44207123|NCT01908140|79003552|FG000|Overall Study|Other or Progressive Disease|5|||
44207124|NCT01908140|79003553|FG001|Overall Study|Other or Progressive Disease|12|||
44368682|NCT01160822|79374016|FG005|Overall Study|Lost to Follow-up|0|||
44207125|NCT01908140|79003552|FG000|Overall Study|Lack of Efficacy|7|||
44207126|NCT01908140|79003553|FG001|Overall Study|Lack of Efficacy|5|||
44207127|NCT01908140|79003552|FG000|Overall Study|Withdrawal by Subject|23|||
44368683|NCT01160822|79374017|FG006|Overall Study|Lost to Follow-up|0|||
44368684|NCT01160822|79374011|FG000|Overall Study|Administrative problems|0|||
44207128|NCT01908140|79003553|FG001|Overall Study|Withdrawal by Subject|24|||
44368685|NCT01160822|79374012|FG001|Overall Study|Administrative problems|0|||
44207129|NCT01908140|79003552|FG000|Overall Study|Lost to Follow-up|1|||
44207130|NCT01908140|79003553|FG001|Overall Study|Lost to Follow-up|6|||
44207131|NCT01908140|79003552|FG000|Overall Study|Protocol Violation|8|||
44207132|NCT01908140|79003553|FG001|Overall Study|Protocol Violation|9|||
44207133|NCT01908140|79003552|FG000|Overall Study|Adverse Event|22|||
44207134|NCT01908140|79003553|FG001|Overall Study|Adverse Event|23|||
44368686|NCT01160822|79374013|FG002|Overall Study|Administrative problems|0|||
44207135|NCT02008565|79003563|FG000|Overall Study|Protocol Violation|1|||
44207136|NCT02008565|79003564|FG001|Overall Study|Protocol Violation|1|||
44207137|NCT02008565|79003565|FG002|Overall Study|Protocol Violation|2|||
44207138|NCT02008565|79003566|FG003|Overall Study|Protocol Violation|0|||
44207139|NCT01907906|79003580|FG000|Overall Study|Withdrawal by Subject|1|||
44368687|NCT01160822|79374014|FG003|Overall Study|Administrative problems|0|||
44368688|NCT01160822|79374015|FG004|Overall Study|Administrative problems|1|||
44368689|NCT01160822|79374016|FG005|Overall Study|Administrative problems|0|||
44368690|NCT01160822|79374017|FG006|Overall Study|Administrative problems|0|||
44368691|NCT01160822|79374011|FG000|Overall Study|Protocol deviation|0|||
44368692|NCT01160822|79374012|FG001|Overall Study|Protocol deviation|0|||
44368693|NCT01160822|79374013|FG002|Overall Study|Protocol deviation|0|||
44368694|NCT01160822|79374014|FG003|Overall Study|Protocol deviation|0|||
44368695|NCT01160822|79374015|FG004|Overall Study|Protocol deviation|2|||
44368696|NCT01160822|79374016|FG005|Overall Study|Protocol deviation|0|||
44368697|NCT01160822|79374017|FG006|Overall Study|Protocol deviation|0|||
44207140|NCT01907906|79003581|FG001|Overall Study|Withdrawal by Subject|0|||
44207141|NCT01907906|79003580|FG000|Overall Study|Physician Decision|3|||
44207142|NCT01907906|79003581|FG001|Overall Study|Physician Decision|1|||
44207143|NCT01907828|79003591|FG000|Overall Study|Exclusion criteria not met|0|||
44207144|NCT01907828|79003592|FG001|Overall Study|Exclusion criteria not met|1|||
44207145|NCT01907828|79003591|FG000|Overall Study|Withdrawal by Subject|3|||
44207146|NCT01907828|79003592|FG001|Overall Study|Withdrawal by Subject|4|||
44207147|NCT01907828|79003591|FG000|Overall Study|Lost to Follow-up|3|||
44207148|NCT01907828|79003592|FG001|Overall Study|Lost to Follow-up|0|||
44207149|NCT01907828|79003591|FG000|Overall Study|Participant refused 24-month follow-up|1|||
44207150|NCT01907828|79003592|FG001|Overall Study|Participant refused 24-month follow-up|0|||
44207151|NCT01907828|79003591|FG000|Overall Study|Participant met exclusion criteria|0|||
44207152|NCT01907828|79003592|FG001|Overall Study|Participant met exclusion criteria|1|||
44207153|NCT01907516|79003600|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
44207154|NCT01907516|79003601|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
44207155|NCT01907516|79003600|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
44207156|NCT01907516|79003601|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
44207157|NCT01907516|79003600|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
44368698|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
44368699|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
44368700|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
44368701|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
44368702|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Death|13|||
44368703|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Death|12|||
44368704|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Progression|257|||
44368705|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Progression|218|||
44368706|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
44368707|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
44368708|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
44368709|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
44368710|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
44368711|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
44368712|NCT01006980|79374036|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
44368713|NCT01006980|79374037|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
44368714|NCT01006980|79374036|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
44368715|NCT01006980|79374037|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
44368716|NCT01006980|79374036|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
44368717|NCT01006980|79374037|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
44368718|NCT01006980|79374036|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
44368719|NCT01006980|79374037|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
44368720|NCT01006980|79374036|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
44368721|NCT01006980|79374037|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
44368722|NCT01006980|79374036|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
44368723|NCT01006980|79374037|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
44368724|NCT00887926|79374048|FG000|Overall Study|Withdrawal by Subject|0|||
44368725|NCT00887926|79374049|FG001|Overall Study|Withdrawal by Subject|1|||
44368726|NCT00887926|79374050|FG002|Overall Study|Withdrawal by Subject|0|||
44207158|NCT01907516|79003601|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
44368727|NCT00887926|79374051|FG003|Overall Study|Withdrawal by Subject|0|||
44368728|NCT00998400|79374065|FG000|Overall Study|Lack of interest/motivation|1|||
44207159|NCT01907516|79003600|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
44207160|NCT01907516|79003601|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
44207161|NCT01931462|79003608|FG000|Overall Study|Withdrawal by Subject|1|||
44207162|NCT01931150|79003614|FG000|Overall Study|Withdrawal by Subject|1|||
44368729|NCT00998400|79374066|FG001|Overall Study|Lack of interest/motivation|2|||
44368730|NCT00998400|79374065|FG000|Overall Study|Logistical problems|1|||
44368731|NCT00998400|79374066|FG001|Overall Study|Logistical problems|0|||
44368732|NCT00997386|79374073|FG000|Overall Study|Death|7|||
44368733|NCT00996996|79374077|FG000|Overall Study|Progressive Disease|10|||
44368734|NCT00996996|79374077|FG000|Overall Study|Non-compliance|8|||
44368735|NCT00996996|79374077|FG000|Overall Study|Lost to Follow-up|9|||
44368736|NCT00996996|79374077|FG000|Overall Study|Death|5|||
44368737|NCT00996996|79374077|FG000|Overall Study|Did Not Receive Study Medications|1|||
44368738|NCT00996918|79374086|FG000|Overall Study|Lack of Efficacy|1|||
44368739|NCT00996918|79374087|FG001|Overall Study|Lack of Efficacy|1|||
44368740|NCT00996918|79374088|FG002|Overall Study|Lack of Efficacy|2|||
44368741|NCT00996918|79374089|FG003|Overall Study|Lack of Efficacy|2|||
44368742|NCT00996918|79374090|FG004|Overall Study|Lack of Efficacy|0|||
44368743|NCT00996918|79374086|FG000|Overall Study|Adverse Event|2|||
44368744|NCT00996918|79374087|FG001|Overall Study|Adverse Event|5|||
44368745|NCT00996918|79374088|FG002|Overall Study|Adverse Event|2|||
44368746|NCT00996918|79374089|FG003|Overall Study|Adverse Event|6|||
44207163|NCT01931150|79003615|FG001|Overall Study|Withdrawal by Subject|2|||
44207164|NCT01930214|79003624|FG000|Overall Study|Death|4|||
44207165|NCT01930214|79003625|FG001|Overall Study|Death|4|||
44207166|NCT01930214|79003626|FG002|Overall Study|Death|11|||
44207167|NCT01930214|79003624|FG000|Overall Study|Lost to Follow-up|12|||
44207168|NCT01930214|79003625|FG001|Overall Study|Lost to Follow-up|13|||
44207169|NCT01930214|79003626|FG002|Overall Study|Lost to Follow-up|12|||
44207170|NCT01930214|79003624|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
44207171|NCT01930214|79003625|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
44207172|NCT01930214|79003626|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
44207173|NCT01930214|79003624|FG000|Overall Study|Physician Decision|2|||
44207174|NCT01930214|79003625|FG001|Overall Study|Physician Decision|0|||
44207175|NCT01930214|79003626|FG002|Overall Study|Physician Decision|0|||
44207176|NCT01958294|79003634|FG000|Overall Study|Clinical Circumstances|2|||
44368747|NCT00996918|79374090|FG004|Overall Study|Adverse Event|0|||
44368748|NCT00996918|79374086|FG000|Overall Study|Withdrawal by Subject|1|||
44368749|NCT00996918|79374087|FG001|Overall Study|Withdrawal by Subject|4|||
44368750|NCT00996918|79374088|FG002|Overall Study|Withdrawal by Subject|3|||
44368751|NCT00996918|79374089|FG003|Overall Study|Withdrawal by Subject|3|||
44368752|NCT00996918|79374090|FG004|Overall Study|Withdrawal by Subject|2|||
44368753|NCT00996918|79374086|FG000|Overall Study|Physician Decision|1|||
44368754|NCT00996918|79374087|FG001|Overall Study|Physician Decision|0|||
44368755|NCT00996918|79374088|FG002|Overall Study|Physician Decision|0|||
44368756|NCT00996918|79374089|FG003|Overall Study|Physician Decision|0|||
44368757|NCT00996918|79374090|FG004|Overall Study|Physician Decision|0|||
44368758|NCT00996918|79374086|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
44368759|NCT00996918|79374087|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
44368760|NCT00996918|79374088|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
44368761|NCT00996918|79374089|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
44368762|NCT00996918|79374090|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
44368763|NCT00996918|79374086|FG000|Overall Study|Loss of Caregiver|0|||
44368764|NCT00996918|79374087|FG001|Overall Study|Loss of Caregiver|1|||
44368765|NCT00996918|79374088|FG002|Overall Study|Loss of Caregiver|0|||
44368766|NCT00996918|79374089|FG003|Overall Study|Loss of Caregiver|0|||
44368767|NCT00996918|79374090|FG004|Overall Study|Loss of Caregiver|0|||
44368768|NCT00996918|79374086|FG000|Overall Study|Other|3|||
44368769|NCT00996918|79374087|FG001|Overall Study|Other|1|||
44368770|NCT00996918|79374088|FG002|Overall Study|Other|0|||
44368771|NCT00996918|79374089|FG003|Overall Study|Other|0|||
44368772|NCT00996918|79374090|FG004|Overall Study|Other|0|||
44368773|NCT01160744|79374106|FG000|Overall Study|Withdrawal by Subject|11|||
44368774|NCT01160744|79374107|FG001|Overall Study|Withdrawal by Subject|5|||
44368775|NCT01160744|79374108|FG002|Overall Study|Withdrawal by Subject|6|||
44368776|NCT01160744|79374109|FG003|Overall Study|Withdrawal by Subject|4|||
44368777|NCT01160744|79374106|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
44207177|NCT01906346|79003638|FG000|Overall Study|AEs|1|||
44207178|NCT01958060|79003650|FG000|Overall Study|Not treated|2|||
44207179|NCT01958060|79003651|FG001|Overall Study|Not treated|0|||
44269646|NCT00558272|79193968|FG001|Overall Study|Incorrectly enrolled|0|||
44269647|NCT00558272|79193967|FG000|Overall Study|Withdrawal by Subject|0|||
44368778|NCT01160744|79374107|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
44368779|NCT01160744|79374108|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
44368780|NCT01160744|79374109|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
44368781|NCT01160354|79374124|FG000|Overall Study|Death|0|||
44368782|NCT01160354|79374125|FG001|Overall Study|Death|1|||
44368783|NCT01160354|79374126|FG002|Overall Study|Death|1|||
44368784|NCT01160198|79374137|FG000|Overall Study|Withdrawal by Subject|2|||
44368785|NCT01160198|79374138|FG001|Overall Study|Withdrawal by Subject|1|||
44368786|NCT01160198|79374139|FG002|Overall Study|Withdrawal by Subject|0|||
44368787|NCT01160198|79374137|FG000|Overall Study|Adverse Event|0|||
44368788|NCT01160198|79374138|FG001|Overall Study|Adverse Event|1|||
44207180|NCT01958060|79003652|FG002|Overall Study|Not treated|0|||
44207181|NCT01958060|79003653|FG003|Overall Study|Not treated|0|||
44368789|NCT01160198|79374139|FG002|Overall Study|Adverse Event|0|||
44368790|NCT01160198|79374137|FG000|Overall Study|Lost to Follow-up|0|||
44207182|NCT01958060|79003654|FG004|Overall Study|Not treated|1|||
44207183|NCT01958060|79003655|FG005|Overall Study|Not treated|0|||
44207184|NCT01929980|79003674|FG000|Overall Study|Physician Decision|1|||
44207185|NCT01363076|79003680|FG000|Overall Study|Withdrawal by Subject|0|||
44207186|NCT01363076|79003681|FG001|Overall Study|Withdrawal by Subject|1|||
44207187|NCT01929044|79003689|FG000|Overall Study|Adverse Event|1|||
44207188|NCT01929044|79003690|FG001|Overall Study|Adverse Event|0|||
44207189|NCT01929044|79003689|FG000|Overall Study|Protocol Violation|9|||
44207190|NCT01929044|79003690|FG001|Overall Study|Protocol Violation|14|||
44207191|NCT01929044|79003689|FG000|Overall Study|Not Treated|1|||
44207192|NCT01929044|79003690|FG001|Overall Study|Not Treated|3|||
44207193|NCT01903460|79003700|FG000|Overall Study|Adverse Event|0|||
44207194|NCT01903460|79003701|FG001|Overall Study|Adverse Event|0|||
44207195|NCT01903460|79003702|FG002|Overall Study|Adverse Event|0|||
44207196|NCT01903460|79003703|FG003|Overall Study|Adverse Event|1|||
44207197|NCT01957202|79003712|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207198|NCT01957202|79003713|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
44207199|NCT01957202|79003714|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207200|NCT01957202|79003715|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207201|NCT01957202|79003716|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207202|NCT01957202|79003717|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207203|NCT01957202|79003718|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207204|NCT01957202|79003719|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207205|NCT01957202|79003720|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207206|NCT01957202|79003721|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207207|NCT01957202|79003722|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207208|NCT01957202|79003723|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207209|NCT01957202|79003724|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207210|NCT01957202|79003725|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207211|NCT01957202|79003726|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207212|NCT01957202|79003727|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207213|NCT01957202|79003728|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
44207214|NCT01957202|79003729|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
44207215|NCT01957202|79003712|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207216|NCT01957202|79003713|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207217|NCT01957202|79003714|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207218|NCT01957202|79003715|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207219|NCT01957202|79003716|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207220|NCT01957202|79003717|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207221|NCT01957202|79003718|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207222|NCT01957202|79003719|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207223|NCT01957202|79003720|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
44368791|NCT01160198|79374138|FG001|Overall Study|Lost to Follow-up|1|||
44207224|NCT01957202|79003721|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207225|NCT01957202|79003722|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207226|NCT01957202|79003723|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207227|NCT01957202|79003724|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207228|NCT01957202|79003725|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
44368792|NCT01160198|79374139|FG002|Overall Study|Lost to Follow-up|0|||
44207229|NCT01957202|79003726|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207230|NCT01957202|79003727|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
44207231|NCT01957202|79003728|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
44207232|NCT01957202|79003729|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
44249667|NCT01276353|79083652|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
44249668|NCT01276353|79083651|FG000|Extension|Physician Decision|1|||
44249669|NCT01276353|79083652|FG001|Extension|Physician Decision|0|||
44249670|NCT01276353|79083651|FG000|Extension|Prohibited concomitant medications|0|||
44249671|NCT01276353|79083652|FG001|Extension|Prohibited concomitant medications|1|||
44249672|NCT02536794|79083687|FG000|Reached 1st Response Assessment|Adverse Event|2|||
44249673|NCT02536794|79083687|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
44249674|NCT02536794|79083687|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
44249675|NCT02536794|79083687|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
44249676|NCT02536794|79083687|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
44249677|NCT02536794|79083687|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
44249678|NCT01480076|79083757|FG000|Overall Study|Run-in Failure|52|||
44249679|NCT01480076|79083757|FG000|Overall Study|Adverse Event|39|||
44269648|NCT00558272|79193968|FG001|Overall Study|Withdrawal by Subject|1|||
44269649|NCT00557492|79194113|FG000|Overall Study|Change in health insurance|1|||
44269650|NCT02354586|79194216|FG000|Overall Study|Death|230|||
44269651|NCT02354586|79194216|FG000|Overall Study|Withdrawal by Subject|59|||
44269652|NCT02354586|79194216|FG000|Overall Study|Lost to Follow-up|11|||
44269653|NCT02354586|79194216|FG000|Overall Study|Sponsor decision|51|||
44368793|NCT01160198|79374137|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
44249680|NCT01480076|79083757|FG000|Overall Study|Death|2|||
44249681|NCT01480076|79083757|FG000|Overall Study|Disease Progression|5|||
44249682|NCT01480076|79083757|FG000|Overall Study|Non-compliance With Study Protocol|15|||
44249683|NCT01480076|79083757|FG000|Overall Study|Withdrawal by Subject|105|||
44249684|NCT01480076|79083757|FG000|Overall Study|Lost to Follow-up|7|||
44249685|NCT01480076|79083757|FG000|Overall Study|Investigator Decision|13|||
44249686|NCT01480076|79083757|FG000|Overall Study|Other|52|||
44249687|NCT02650128|79083845|FG000|Overall Study|Death|2|||
44249688|NCT01362270|79083860|FG000|Overall Study|Withdrawal by Subject|1|||
44249689|NCT01362270|79083861|FG001|Overall Study|Withdrawal by Subject|0|||
44249690|NCT01362270|79083860|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
44249691|NCT01362270|79083861|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
44249692|NCT01362270|79083860|FG000|Overall Study|Met excl. criteria before 1st session|1|||
44249693|NCT01362270|79083861|FG001|Overall Study|Met excl. criteria before 1st session|1|||
44249694|NCT00089479|79083882|FG000|Overall Study|Death|108|||
44249695|NCT00089479|79083883|FG001|Overall Study|Death|75|||
44249696|NCT00089479|79083882|FG000|Overall Study|Withdrawal by Subject|86|||
44249697|NCT00089479|79083883|FG001|Overall Study|Withdrawal by Subject|107|||
44249698|NCT00089479|79083882|FG000|Overall Study|Lost to Follow-up|137|||
44249699|NCT00089479|79083883|FG001|Overall Study|Lost to Follow-up|107|||
44249700|NCT01463306|79083892|FG000|Overall Study|Adverse Event|6|||
44249701|NCT01463306|79083893|FG001|Overall Study|Adverse Event|9|||
44249702|NCT01463306|79083894|FG002|Overall Study|Adverse Event|3|||
44249703|NCT01463306|79083892|FG000|Overall Study|Death|3|||
44249704|NCT01463306|79083893|FG001|Overall Study|Death|3|||
44249705|NCT01463306|79083894|FG002|Overall Study|Death|0|||
44249706|NCT01463306|79083892|FG000|Overall Study|Lack of Efficacy|22|||
44249707|NCT01463306|79083893|FG001|Overall Study|Lack of Efficacy|16|||
44249708|NCT01463306|79083894|FG002|Overall Study|Lack of Efficacy|1|||
44249709|NCT01463306|79083892|FG000|Overall Study|Lost to Follow-up|5|||
44249710|NCT01463306|79083893|FG001|Overall Study|Lost to Follow-up|2|||
44249711|NCT01463306|79083894|FG002|Overall Study|Lost to Follow-up|0|||
44249712|NCT01463306|79083892|FG000|Overall Study|Protocol Violation|4|||
44368794|NCT01160198|79374138|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
44368795|NCT01160198|79374139|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
44368796|NCT01159574|79374147|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
44249713|NCT01463306|79083893|FG001|Overall Study|Protocol Violation|0|||
44249714|NCT01463306|79083894|FG002|Overall Study|Protocol Violation|0|||
44269654|NCT02354586|79194216|FG000|Overall Study|Site closure|2|||
44249715|NCT01463306|79083892|FG000|Overall Study|Withdrawal by Subject|19|||
44249716|NCT01463306|79083893|FG001|Overall Study|Withdrawal by Subject|9|||
44249717|NCT01463306|79083894|FG002|Overall Study|Withdrawal by Subject|1|||
44249718|NCT01463306|79083892|FG000|Overall Study|Other|26|||
44249719|NCT01463306|79083893|FG001|Overall Study|Other|13|||
44249720|NCT01463306|79083894|FG002|Overall Study|Other|0|||
44269655|NCT02354586|79194216|FG000|Overall Study|Intercurrent illness|1|||
44207233|NCT01616654|79003744|FG000|Overall Study|Lack of Efficacy|1|||
44207234|NCT01616654|79003745|FG001|Overall Study|Lack of Efficacy|0|||
44368797|NCT01159574|79374147|FG000|Treatment Phase|Adverse Event|3|||
44368798|NCT01159574|79374147|FG000|Treatment Phase|Death|6|||
44368799|NCT01159574|79374147|FG000|Treatment Phase|Physician Decision|2|||
44368800|NCT01159574|79374147|FG000|Treatment Phase|Withdrawal by Subject|7|||
44368801|NCT01159574|79374147|FG000|Treatment Phase|still on treatment|2|||
44207235|NCT01616654|79003746|FG002|Overall Study|Lack of Efficacy|0|||
44207236|NCT01616654|79003747|FG003|Overall Study|Lack of Efficacy|0|||
44207237|NCT01616654|79003748|FG004|Overall Study|Lack of Efficacy|1|||
44207238|NCT01616654|79003744|FG000|Overall Study|Adverse Event|0|||
44207239|NCT01616654|79003745|FG001|Overall Study|Adverse Event|1|||
44207240|NCT01616654|79003746|FG002|Overall Study|Adverse Event|2|||
44207241|NCT01616654|79003747|FG003|Overall Study|Adverse Event|1|||
44207242|NCT01616654|79003748|FG004|Overall Study|Adverse Event|0|||
44207243|NCT01616654|79003744|FG000|Overall Study|Withdrawal by Subject|2|||
44207244|NCT01616654|79003745|FG001|Overall Study|Withdrawal by Subject|2|||
44207245|NCT01616654|79003746|FG002|Overall Study|Withdrawal by Subject|3|||
44207246|NCT01616654|79003747|FG003|Overall Study|Withdrawal by Subject|1|||
44207247|NCT01616654|79003748|FG004|Overall Study|Withdrawal by Subject|5|||
44207248|NCT01616654|79003744|FG000|Overall Study|Protocol Violation|0|||
44207249|NCT01616654|79003745|FG001|Overall Study|Protocol Violation|5|||
44207250|NCT01616654|79003746|FG002|Overall Study|Protocol Violation|2|||
44207251|NCT01616654|79003747|FG003|Overall Study|Protocol Violation|4|||
44207252|NCT01616654|79003748|FG004|Overall Study|Protocol Violation|4|||
44207253|NCT01616654|79003744|FG000|Overall Study|Lost to Follow-up|1|||
44207254|NCT01616654|79003745|FG001|Overall Study|Lost to Follow-up|0|||
44207255|NCT01616654|79003746|FG002|Overall Study|Lost to Follow-up|3|||
44207256|NCT01616654|79003747|FG003|Overall Study|Lost to Follow-up|2|||
44207257|NCT01616654|79003748|FG004|Overall Study|Lost to Follow-up|1|||
44207258|NCT01616654|79003744|FG000|Overall Study|Pregnancy|1|||
44207259|NCT01616654|79003745|FG001|Overall Study|Pregnancy|0|||
44207260|NCT01616654|79003746|FG002|Overall Study|Pregnancy|0|||
44207261|NCT01616654|79003747|FG003|Overall Study|Pregnancy|0|||
44207262|NCT01616654|79003748|FG004|Overall Study|Pregnancy|1|||
44207263|NCT01902290|79003763|FG000|Overall Study|Withdrawal by Subject|19|||
44207264|NCT01902290|79003764|FG001|Overall Study|Withdrawal by Subject|27|||
44207265|NCT01902290|79003763|FG000|Overall Study|Lost to Follow-up|2|||
44207266|NCT01902290|79003764|FG001|Overall Study|Lost to Follow-up|2|||
44207267|NCT01902290|79003763|FG000|Overall Study|Death|1|||
44207268|NCT01902290|79003764|FG001|Overall Study|Death|0|||
44207269|NCT01902290|79003763|FG000|Overall Study|Sponsor Decision|26|||
44207270|NCT01902290|79003764|FG001|Overall Study|Sponsor Decision|24|||
44207271|NCT01467466|79003775|FG000|Overall Study|Withdrawal by Subject|15|||
44207272|NCT01467466|79003776|FG001|Overall Study|Withdrawal by Subject|18|||
44207273|NCT01467466|79003777|FG002|Overall Study|Withdrawal by Subject|13|||
44207274|NCT01467466|79003778|FG003|Overall Study|Withdrawal by Subject|11|||
44207275|NCT01467466|79003775|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
44207276|NCT01467466|79003776|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
44207277|NCT01467466|79003777|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
44207278|NCT01467466|79003778|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
44207279|NCT01467466|79003775|FG000|Overall Study|Procedure Cancelled|46|||
44207280|NCT01467466|79003776|FG001|Overall Study|Procedure Cancelled|45|||
44207281|NCT01467466|79003777|FG002|Overall Study|Procedure Cancelled|25|||
44207282|NCT01467466|79003778|FG003|Overall Study|Procedure Cancelled|29|||
44207283|NCT01467466|79003775|FG000|Overall Study|No Endpoint Blood Draw|38|||
44207284|NCT01467466|79003776|FG001|Overall Study|No Endpoint Blood Draw|32|||
44207285|NCT01467466|79003777|FG002|Overall Study|No Endpoint Blood Draw|51|||
44207286|NCT01467466|79003778|FG003|Overall Study|No Endpoint Blood Draw|43|||
44207287|NCT01441180|79003791|FG000|Overall Study|Lost to Follow-up|1|||
44207288|NCT01441180|79003792|FG001|Overall Study|Lost to Follow-up|1|||
44207289|NCT01441180|79003793|FG002|Overall Study|Lost to Follow-up|1|||
44207290|NCT01441180|79003791|FG000|Overall Study|Discontinued|0|||
44207291|NCT01441180|79003792|FG001|Overall Study|Discontinued|0|||
44207292|NCT01441180|79003793|FG002|Overall Study|Discontinued|2|||
44207293|NCT01441102|79003804|FG000|Overall Study|Adverse Event|1|||
44207294|NCT01441102|79003804|FG000|Overall Study|Withdrawal by Subject|2|||
44207295|NCT01467076|79003811|FG000|Overall Study|Lost to Follow-up|1|||
44207296|NCT01467076|79003812|FG001|Overall Study|Lost to Follow-up|0|||
44207297|NCT01467076|79003813|FG002|Overall Study|Lost to Follow-up|0|||
44207298|NCT01466062|79003821|FG000|Overall Study|Adverse Event|1|||
44207299|NCT01466062|79003821|FG000|Overall Study|Withdrawal by Subject|1|||
44207300|NCT01435018|79003828|FG000|Overall Study|Death|37|||
44368802|NCT01159574|79374147|FG000|Follow Up Phase|Lost to Follow-up|2|||
44207301|NCT01435018|79003829|FG001|Overall Study|Death|18|||
44207302|NCT01435018|79003830|FG002|Overall Study|Death|25|||
44207303|NCT01435018|79003828|FG000|Overall Study|Site is closing|4|||
44207304|NCT01435018|79003829|FG001|Overall Study|Site is closing|9|||
44207305|NCT01435018|79003830|FG002|Overall Study|Site is closing|7|||
44207306|NCT01435018|79003828|FG000|Overall Study|Withdrew consent|0|||
44207307|NCT01435018|79003829|FG001|Overall Study|Withdrew consent|3|||
44207308|NCT01435018|79003830|FG002|Overall Study|Withdrew consent|1|||
44207309|NCT01435018|79003828|FG000|Overall Study|Not willing to adhere to requirements|0|||
44207310|NCT01435018|79003829|FG001|Overall Study|Not willing to adhere to requirements|2|||
44207311|NCT01435018|79003830|FG002|Overall Study|Not willing to adhere to requirements|3|||
44207312|NCT01435018|79003828|FG000|Overall Study|Not able to get to clinic|2|||
44207313|NCT01435018|79003829|FG001|Overall Study|Not able to get to clinic|0|||
44207314|NCT01435018|79003830|FG002|Overall Study|Not able to get to clinic|2|||
44207315|NCT01435018|79003828|FG000|Overall Study|Severe debilitation, unable to continue|0|||
44207316|NCT01435018|79003829|FG001|Overall Study|Severe debilitation, unable to continue|0|||
44207317|NCT01435018|79003830|FG002|Overall Study|Severe debilitation, unable to continue|1|||
44207318|NCT01435018|79003828|FG000|Overall Study|Unable to contact participant/parent|1|||
44207319|NCT01435018|79003829|FG001|Overall Study|Unable to contact participant/parent|1|||
44207320|NCT01435018|79003830|FG002|Overall Study|Unable to contact participant/parent|1|||
44207321|NCT01435018|79003828|FG000|Overall Study|Enrollment Violation|0|||
44207322|NCT01435018|79003829|FG001|Overall Study|Enrollment Violation|1|||
44207323|NCT01435018|79003830|FG002|Overall Study|Enrollment Violation|0|||
44207324|NCT01435018|79003828|FG000|Overall Study|Never started chemotherapy|3|||
44207325|NCT01435018|79003829|FG001|Overall Study|Never started chemotherapy|0|||
44207326|NCT01435018|79003830|FG002|Overall Study|Never started chemotherapy|1|||
44207327|NCT01419184|79003842|FG000|Overall Study|Site data not available|3|||
44207328|NCT01419184|79003843|FG001|Overall Study|Site data not available|2|||
44207329|NCT01419184|79003842|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
44207330|NCT01419184|79003843|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
44207331|NCT01419184|79003842|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
44207332|NCT01419184|79003843|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
44207333|NCT01419184|79003842|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
44207334|NCT01419184|79003843|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
44207335|NCT01419184|79003842|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
44207336|NCT01419184|79003843|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
44207337|NCT01419184|79003842|FG000|Overall Study|Participant randomized, not treated|1|||
44207338|NCT01419184|79003843|FG001|Overall Study|Participant randomized, not treated|0|||
44207339|NCT01417234|79003849|FG000|Overall Study|Subject non-compliant|3|||
44207340|NCT01417156|79003853|FG000|Overall Study|Adverse Event|12|||
44207341|NCT01417156|79003853|FG000|Overall Study|Protocol Violation|2|||
44207342|NCT01417078|79003857|FG000|Overall Study|Withdrawal by Subject|1|||
44207343|NCT01954394|79003865|FG000|Overall Study|Enrolled but not treated|1|||
44207344|NCT01954394|79003866|FG001|Overall Study|Enrolled but not treated|0|||
44207345|NCT01954394|79003865|FG000|Overall Study|Adverse Event|10|||
44207346|NCT01954394|79003866|FG001|Overall Study|Adverse Event|23|||
44207347|NCT01954394|79003865|FG000|Overall Study|Poor compliance to protocol|7|||
44207348|NCT01954394|79003866|FG001|Overall Study|Poor compliance to protocol|7|||
44207349|NCT01954394|79003865|FG000|Overall Study|Participant Moved|0|||
44207350|NCT01954394|79003866|FG001|Overall Study|Participant Moved|4|||
44207351|NCT01954394|79003865|FG000|Overall Study|Related to Study Drug administration|2|||
44207352|NCT01954394|79003866|FG001|Overall Study|Related to Study Drug administration|2|||
44207353|NCT01954394|79003865|FG000|Overall Study|Other than specified above|10|||
44207354|NCT01954394|79003866|FG001|Overall Study|Other than specified above|21|||
44207355|NCT01464424|79003874|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
44207356|NCT01464424|79003875|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
44207357|NCT01902134|79003887|FG000|Overall Study|Adverse Event|3|||
44207358|NCT01902134|79003888|FG001|Overall Study|Adverse Event|1|||
44207359|NCT01902134|79003889|FG002|Overall Study|Adverse Event|2|||
44207360|NCT01902134|79003890|FG003|Overall Study|Adverse Event|1|||
44207361|NCT01902134|79003891|FG004|Overall Study|Adverse Event|1|||
44207362|NCT01902134|79003892|FG005|Overall Study|Adverse Event|3|||
44269656|NCT02354586|79194216|FG000|Overall Study|Protocol Violation|3|||
44269657|NCT02354586|79194216|FG000|Overall Study|Physician Decision|13|||
44269658|NCT02354586|79194216|FG000|Overall Study|Lack of Efficacy|86|||
44207363|NCT01902134|79003887|FG000|Overall Study|Lack of Efficacy|0|||
44207364|NCT01902134|79003888|FG001|Overall Study|Lack of Efficacy|0|||
44207365|NCT01902134|79003889|FG002|Overall Study|Lack of Efficacy|2|||
44368803|NCT01159574|79374147|FG000|Follow Up Phase|still being followed for overall surviva|18|||
44368804|NCT01158950|79374151|FG000|1st Intervention (1 Day)|Physician Decision|1|||
44368805|NCT01158950|79374152|FG001|1st Intervention (1 Day)|Physician Decision|2|||
44368806|NCT01172288|79374159|FG000|Overall Study|Adverse Event|1|||
44207366|NCT01902134|79003890|FG003|Overall Study|Lack of Efficacy|0|||
44207367|NCT01902134|79003891|FG004|Overall Study|Lack of Efficacy|0|||
44207368|NCT01902134|79003892|FG005|Overall Study|Lack of Efficacy|1|||
44207369|NCT01902134|79003887|FG000|Overall Study|Physician Decision|0|||
44207370|NCT01902134|79003888|FG001|Overall Study|Physician Decision|1|||
44207371|NCT01902134|79003889|FG002|Overall Study|Physician Decision|0|||
44207372|NCT01902134|79003890|FG003|Overall Study|Physician Decision|0|||
44207373|NCT01902134|79003891|FG004|Overall Study|Physician Decision|0|||
44207374|NCT01902134|79003892|FG005|Overall Study|Physician Decision|0|||
44207375|NCT01902134|79003887|FG000|Overall Study|Protocol Violation|0|||
44207376|NCT01902134|79003888|FG001|Overall Study|Protocol Violation|0|||
44207377|NCT01902134|79003889|FG002|Overall Study|Protocol Violation|0|||
44207378|NCT01902134|79003890|FG003|Overall Study|Protocol Violation|0|||
44207379|NCT01902134|79003891|FG004|Overall Study|Protocol Violation|0|||
44207380|NCT01902134|79003892|FG005|Overall Study|Protocol Violation|1|||
44207381|NCT01902134|79003887|FG000|Overall Study|Withdrawal by Subject|4|||
44207382|NCT01902134|79003888|FG001|Overall Study|Withdrawal by Subject|8|||
44207383|NCT01902134|79003889|FG002|Overall Study|Withdrawal by Subject|9|||
44207384|NCT01902134|79003890|FG003|Overall Study|Withdrawal by Subject|1|||
44207385|NCT01902134|79003891|FG004|Overall Study|Withdrawal by Subject|5|||
44207386|NCT01902134|79003892|FG005|Overall Study|Withdrawal by Subject|4|||
44207387|NCT01902134|79003887|FG000|Overall Study|no compliance|1|||
44207388|NCT01902134|79003888|FG001|Overall Study|no compliance|0|||
44207389|NCT01902134|79003889|FG002|Overall Study|no compliance|0|||
44207390|NCT01902134|79003890|FG003|Overall Study|no compliance|0|||
44207391|NCT01902134|79003891|FG004|Overall Study|no compliance|0|||
44207392|NCT01902134|79003892|FG005|Overall Study|no compliance|0|||
44207393|NCT01902134|79003887|FG000|Overall Study|Other|0|||
44207394|NCT01902134|79003888|FG001|Overall Study|Other|1|||
44207395|NCT01902134|79003889|FG002|Overall Study|Other|2|||
44207396|NCT01902134|79003890|FG003|Overall Study|Other|0|||
44207397|NCT01902134|79003891|FG004|Overall Study|Other|1|||
44207398|NCT01902134|79003892|FG005|Overall Study|Other|0|||
44207399|NCT01954082|79003910|FG000|Overall Study|Study Suspension|42|||
44207400|NCT01954082|79003911|FG001|Overall Study|Study Suspension|36|||
44207401|NCT01954082|79003910|FG000|Overall Study|Adverse Event|10|||
44207402|NCT01954082|79003911|FG001|Overall Study|Adverse Event|4|||
44207403|NCT01954082|79003910|FG000|Overall Study|Intolerance|0|||
44207404|NCT01954082|79003911|FG001|Overall Study|Intolerance|1|||
44207405|NCT01954082|79003910|FG000|Overall Study|Non-compliance|6|||
44207406|NCT01954082|79003911|FG001|Overall Study|Non-compliance|4|||
44207407|NCT01954082|79003910|FG000|Overall Study|Physician Decision|2|||
44207408|NCT01954082|79003911|FG001|Overall Study|Physician Decision|0|||
44207409|NCT01954082|79003910|FG000|Overall Study|Parent Decision|1|||
44207410|NCT01954082|79003911|FG001|Overall Study|Parent Decision|0|||
44207411|NCT01954082|79003910|FG000|Overall Study|Withdrawal by Subject|0|||
44207412|NCT01954082|79003911|FG001|Overall Study|Withdrawal by Subject|1|||
44207413|NCT01954082|79003910|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
44207414|NCT01954082|79003911|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
44207415|NCT01954082|79003910|FG000|Overall Study|Redirection of Care|0|||
44207416|NCT01954082|79003911|FG001|Overall Study|Redirection of Care|2|||
44207417|NCT01954082|79003910|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
44207418|NCT01954082|79003911|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
44207419|NCT01954082|79003910|FG000|Overall Study|Comfort Care|0|||
44207420|NCT01954082|79003911|FG001|Overall Study|Comfort Care|1|||
44207421|NCT01954082|79003910|FG000|Overall Study|Infant Moved|0|||
44207422|NCT01954082|79003911|FG001|Overall Study|Infant Moved|1|||
44207423|NCT01954082|79003910|FG000|Overall Study|Randomized not Treated|4|||
44207424|NCT01954082|79003911|FG001|Overall Study|Randomized not Treated|2|||
44207425|NCT01417000|79003919|FG000|Overall Study|Death|59|||
44207426|NCT01417000|79003920|FG001|Overall Study|Death|28|||
44207427|NCT01417000|79003919|FG000|Overall Study|Lost to Follow-up|1|||
44207428|NCT01417000|79003920|FG001|Overall Study|Lost to Follow-up|0|||
44368807|NCT01172288|79374160|FG001|Overall Study|Adverse Event|0|||
44368808|NCT01172288|79374159|FG000|Overall Study|Protocol Violation|0|||
44368809|NCT01172288|79374160|FG001|Overall Study|Protocol Violation|1|||
44368810|NCT00996840|79374171|FG000|Overall Study|Adverse Event|0|||
44368811|NCT00996840|79374172|FG001|Overall Study|Adverse Event|1|||
44207429|NCT01417000|79003919|FG000|Overall Study|Study Terminated by Sponsor|1|||
44207430|NCT01417000|79003920|FG001|Overall Study|Study Terminated by Sponsor|1|||
44207431|NCT01416610|79003926|FG000|Overall Study|Adverse Event|4|||
44207432|NCT01416610|79003926|FG000|Overall Study|Adverse Event -Patient decision|3|||
44207433|NCT01416610|79003926|FG000|Overall Study|Lack of Efficacy|4|||
44368812|NCT00996840|79374173|FG002|Overall Study|Adverse Event|0|||
44368813|NCT00996840|79374174|FG003|Overall Study|Adverse Event|0|||
44207434|NCT01416610|79003926|FG000|Overall Study|No reason given|5|||
44368814|NCT00996840|79374175|FG004|Overall Study|Adverse Event|0|||
44207435|NCT01416610|79003926|FG000|Overall Study|Withdrawal by Subject|13|||
44207436|NCT01416610|79003926|FG000|Overall Study|Lost to Follow-up|7|||
44207437|NCT01416610|79003926|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
44207438|NCT01416142|79003934|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
44207439|NCT01416142|79003935|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
44207440|NCT01416142|79003936|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
44368815|NCT00996840|79374171|FG000|Overall Study|Physician Decision|0|||
44207441|NCT01415986|79003944|FG000|Overall Study|Lost to Follow-up|1|||
44207442|NCT01415908|79003951|FG000|Overall Study|Withdrawal by Subject|1|||
44207443|NCT01415908|79003952|FG001|Overall Study|Withdrawal by Subject|0|||
44207444|NCT01415518|79003960|FG000|Overall Study|Withdrawal by Subject|2|||
44207445|NCT01415518|79003961|FG001|Overall Study|Withdrawal by Subject|12|||
44207446|NCT01415518|79003960|FG000|Overall Study|Protocol Violation|6|||
44207447|NCT01415518|79003961|FG001|Overall Study|Protocol Violation|8|||
44207448|NCT01415518|79003960|FG000|Overall Study|Lost to Follow-up|3|||
44207449|NCT01415518|79003961|FG001|Overall Study|Lost to Follow-up|5|||
44207450|NCT01415518|79003960|FG000|Overall Study|Adverse Event|3|||
44207451|NCT01415518|79003961|FG001|Overall Study|Adverse Event|4|||
44207452|NCT01415518|79003960|FG000|Overall Study|Death|1|||
44207453|NCT01415518|79003961|FG001|Overall Study|Death|1|||
44207454|NCT01415518|79003960|FG000|Overall Study|Condition under Investigation Worsened|1|||
44207455|NCT01415518|79003961|FG001|Overall Study|Condition under Investigation Worsened|1|||
44207456|NCT01393600|79003967|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
44207457|NCT01393600|79003968|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
44207458|NCT01393600|79003969|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
44207459|NCT01393600|79003970|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
44207460|NCT01393600|79003967|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
44207461|NCT01393600|79003968|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
44207462|NCT01393600|79003969|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
44207463|NCT01393600|79003970|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
44207464|NCT01393600|79003967|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
44207465|NCT01393600|79003968|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
44207466|NCT01393600|79003969|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
44207467|NCT01393600|79003970|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
44207468|NCT01393600|79003967|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
44207469|NCT01393600|79003968|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
44207470|NCT01393600|79003969|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
44207471|NCT01393600|79003970|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
44207472|NCT01393600|79003967|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
44207473|NCT01393600|79003968|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
44207474|NCT01393600|79003969|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
44207475|NCT01393600|79003970|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
44207476|NCT01393600|79003967|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
44207477|NCT01393600|79003968|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
44207478|NCT01393600|79003969|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
44207479|NCT01393600|79003970|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
44207480|NCT01393600|79003967|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
44368816|NCT00996840|79374172|FG001|Overall Study|Physician Decision|0|||
44368817|NCT00996840|79374173|FG002|Overall Study|Physician Decision|1|||
44368818|NCT00996840|79374174|FG003|Overall Study|Physician Decision|1|||
44368819|NCT00996840|79374175|FG004|Overall Study|Physician Decision|2|||
44207481|NCT01393600|79003968|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
44207482|NCT01393600|79003969|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
44207483|NCT01393600|79003970|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
44207484|NCT01432756|79003986|FG000|Overall Study|Lost to Follow-up|1|||
44368820|NCT00996840|79374171|FG000|Overall Study|Withdrawal by Subject|1|||
44368821|NCT00996840|79374172|FG001|Overall Study|Withdrawal by Subject|1|||
44368822|NCT00996840|79374173|FG002|Overall Study|Withdrawal by Subject|0|||
44368823|NCT00996840|79374174|FG003|Overall Study|Withdrawal by Subject|0|||
44368824|NCT00996840|79374175|FG004|Overall Study|Withdrawal by Subject|0|||
44368825|NCT00998946|79374191|FG000|Overall Study|Lost to Follow-up|1|||
44269659|NCT02354586|79194216|FG000|Overall Study|Adverse Event|7|||
44269660|NCT02332824|79194241|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
44269661|NCT02332824|79194242|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
44269662|NCT02332824|79194243|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
44269663|NCT02332824|79194244|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
44269664|NCT02332824|79194245|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
44269665|NCT02332824|79194246|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
44368826|NCT00998946|79374191|FG000|Overall Study|Withdrawal by Subject|1|||
44368827|NCT00998946|79374191|FG000|Overall Study|Death|2|||
44207485|NCT01432756|79003987|FG001|Overall Study|Lost to Follow-up|0|||
44207486|NCT01432756|79003988|FG002|Overall Study|Lost to Follow-up|2|||
44207487|NCT01432756|79003989|FG003|Overall Study|Lost to Follow-up|1|||
44207488|NCT01432600|79004000|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
44207489|NCT01432600|79004001|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
44269666|NCT02332824|79194241|FG000|Overall Study|Voluntary Withdrawal|1|||
44269667|NCT02332824|79194242|FG001|Overall Study|Voluntary Withdrawal|0|||
44452098|NCT00080119|79461003|FG000|Overall Study|Unable to get to clinic|24|||
44368828|NCT00998946|79374191|FG000|Overall Study|Reason Unspecified|3|||
44368829|NCT00998946|79374191|FG000|Overall Study|Enrolled but not Dosed|2|||
44368830|NCT01158404|79374203|FG000|Overall Study|Withdrawal by Subject|0|||
44368831|NCT01158404|79374204|FG001|Overall Study|Withdrawal by Subject|1|||
44368832|NCT01158404|79374205|FG002|Overall Study|Withdrawal by Subject|0|||
44368833|NCT01158404|79374206|FG003|Overall Study|Withdrawal by Subject|0|||
44368834|NCT01158404|79374207|FG004|Overall Study|Withdrawal by Subject|3|||
44368835|NCT01158404|79374208|FG005|Overall Study|Withdrawal by Subject|1|||
44368836|NCT01158404|79374209|FG006|Overall Study|Withdrawal by Subject|0|||
44368837|NCT01158404|79374210|FG007|Overall Study|Withdrawal by Subject|1|||
44207490|NCT01432600|79004002|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
44207491|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
44207492|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
44207493|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
44207494|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
44207495|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
44207496|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
44207497|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
44207498|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
44207499|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
44207500|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
44207501|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
44207502|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
44207503|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
44207504|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
44207505|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
44207506|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
44207507|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
44207508|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
44207509|NCT01432444|79004012|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
44207510|NCT01432444|79004013|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
44207511|NCT01432444|79004014|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
44207512|NCT01432444|79004012|FG000|Treatment Phase|Lost to Follow-up|0|||
44207513|NCT01432444|79004013|FG001|Treatment Phase|Lost to Follow-up|33|||
44207514|NCT01432444|79004014|FG002|Treatment Phase|Lost to Follow-up|0|||
44207515|NCT01432444|79004012|FG000|Treatment Phase|Adverse Event|0|||
44207516|NCT01432444|79004013|FG001|Treatment Phase|Adverse Event|37|||
44207517|NCT01432444|79004014|FG002|Treatment Phase|Adverse Event|0|||
44207518|NCT01432444|79004012|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
44207519|NCT01432444|79004013|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
44207520|NCT01432444|79004014|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
44207521|NCT01432444|79004012|FG000|Treatment Phase|Physician Decision|0|||
44207522|NCT01432444|79004013|FG001|Treatment Phase|Physician Decision|5|||
44368838|NCT01158404|79374203|FG000|Overall Study|Physician Decision|0|||
44368839|NCT01158404|79374204|FG001|Overall Study|Physician Decision|0|||
44368840|NCT01158404|79374205|FG002|Overall Study|Physician Decision|0|||
44368841|NCT01158404|79374206|FG003|Overall Study|Physician Decision|0|||
44368842|NCT01158404|79374207|FG004|Overall Study|Physician Decision|0|||
44368843|NCT01158404|79374208|FG005|Overall Study|Physician Decision|0|||
44368844|NCT01158404|79374209|FG006|Overall Study|Physician Decision|0|||
44368845|NCT01158404|79374210|FG007|Overall Study|Physician Decision|1|||
44368846|NCT01158404|79374203|FG000|Overall Study|Progressive Disease|0|||
44368847|NCT01158404|79374204|FG001|Overall Study|Progressive Disease|0|||
44368848|NCT01158404|79374205|FG002|Overall Study|Progressive Disease|0|||
44368849|NCT01158404|79374206|FG003|Overall Study|Progressive Disease|0|||
44368850|NCT01158404|79374207|FG004|Overall Study|Progressive Disease|0|||
44368851|NCT01158404|79374208|FG005|Overall Study|Progressive Disease|0|||
44368852|NCT01158404|79374209|FG006|Overall Study|Progressive Disease|1|||
44368853|NCT01158404|79374210|FG007|Overall Study|Progressive Disease|0|||
44368854|NCT00998790|79374230|FG000|Overall Study|Withdrawal by Subject|21|||
44368855|NCT01001988|79374234|FG000|Overall Study|Protocol Violation|84|||
44368856|NCT01001988|79374234|FG000|Overall Study|Withdrawal by Subject|18|||
44368857|NCT01001988|79374234|FG000|Overall Study|Lost to Follow-up|15|||
44368858|NCT00996606|79374238|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
44368859|NCT00996606|79374238|FG000|Overall Study|Insufficient Therapeutic Response|2|||
44207523|NCT01432444|79004014|FG002|Treatment Phase|Physician Decision|0|||
44207524|NCT01432444|79004012|FG000|Treatment Phase|Withdrawal by Subject|0|||
44207525|NCT01432444|79004013|FG001|Treatment Phase|Withdrawal by Subject|41|||
44207526|NCT01432444|79004014|FG002|Treatment Phase|Withdrawal by Subject|0|||
44207527|NCT01432444|79004012|FG000|Treatment Phase|Protocol Deviation|0|||
44368860|NCT00996606|79374238|FG000|Overall Study|Protocol Violation|1|||
44368861|NCT00996606|79374238|FG000|Overall Study|Withdrawal by Subject|3|||
44368862|NCT00995436|79374245|FG000|Overall Study|Withdrawal by Subject|2|||
44368863|NCT00995436|79374246|FG001|Overall Study|Withdrawal by Subject|5|||
44368864|NCT00995436|79374247|FG002|Overall Study|Withdrawal by Subject|0|||
44368865|NCT00994890|79374258|FG000|Overall Study|Adverse Event|13|||
44368866|NCT00994890|79374259|FG001|Overall Study|Adverse Event|9|||
44368867|NCT00994890|79374260|FG002|Overall Study|Adverse Event|11|||
44368868|NCT00994890|79374258|FG000|Overall Study|Lack of Efficacy|0|||
44368869|NCT00994890|79374259|FG001|Overall Study|Lack of Efficacy|0|||
44368870|NCT00994890|79374260|FG002|Overall Study|Lack of Efficacy|1|||
44368871|NCT00994890|79374258|FG000|Overall Study|Lost to Follow-up|6|||
44368872|NCT00994890|79374259|FG001|Overall Study|Lost to Follow-up|1|||
44368873|NCT00994890|79374260|FG002|Overall Study|Lost to Follow-up|3|||
44368874|NCT00994890|79374258|FG000|Overall Study|No longer willing to participate|8|||
44368875|NCT00994890|79374259|FG001|Overall Study|No longer willing to participate|5|||
44368876|NCT00994890|79374260|FG002|Overall Study|No longer willing to participate|13|||
44368877|NCT00994890|79374258|FG000|Overall Study|Protocol Violation|2|||
44368878|NCT00994890|79374259|FG001|Overall Study|Protocol Violation|4|||
44368879|NCT00994890|79374260|FG002|Overall Study|Protocol Violation|0|||
44207528|NCT01432444|79004013|FG001|Treatment Phase|Protocol Deviation|3|||
44207529|NCT01432444|79004014|FG002|Treatment Phase|Protocol Deviation|0|||
44207530|NCT01432444|79004012|FG000|Treatment Phase|Lack of Efficacy|0|||
44207531|NCT01432444|79004013|FG001|Treatment Phase|Lack of Efficacy|10|||
44207532|NCT01432444|79004014|FG002|Treatment Phase|Lack of Efficacy|0|||
44207533|NCT01432444|79004012|FG000|Extension Phase|Lost to Follow-up|0|||
44207534|NCT01432444|79004013|FG001|Extension Phase|Lost to Follow-up|0|||
44207535|NCT01432444|79004014|FG002|Extension Phase|Lost to Follow-up|17|||
44207536|NCT01432444|79004012|FG000|Extension Phase|Adverse Event|0|||
44207537|NCT01432444|79004013|FG001|Extension Phase|Adverse Event|0|||
44207538|NCT01432444|79004014|FG002|Extension Phase|Adverse Event|10|||
44207539|NCT01432444|79004012|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
44207540|NCT01432444|79004013|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
44207541|NCT01432444|79004014|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
44207542|NCT01432444|79004012|FG000|Extension Phase|Met Withdrawal Criteria|0|||
44207543|NCT01432444|79004013|FG001|Extension Phase|Met Withdrawal Criteria|0|||
44207544|NCT01432444|79004014|FG002|Extension Phase|Met Withdrawal Criteria|144|||
44207545|NCT01432444|79004012|FG000|Extension Phase|Physician Decision|0|||
44207546|NCT01432444|79004013|FG001|Extension Phase|Physician Decision|0|||
44207547|NCT01432444|79004014|FG002|Extension Phase|Physician Decision|1|||
44207548|NCT01432444|79004012|FG000|Extension Phase|Withdrawal by Subject|0|||
44207549|NCT01432444|79004013|FG001|Extension Phase|Withdrawal by Subject|0|||
44207550|NCT01432444|79004014|FG002|Extension Phase|Withdrawal by Subject|13|||
44207551|NCT01432366|79004019|FG000|Overall Study|Non-Responder|7|||
44207552|NCT01432366|79004019|FG000|Overall Study|Adverse Event|8|||
44207553|NCT01432366|79004019|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
44207554|NCT01432366|79004019|FG000|Overall Study|Pregnancy|1|||
44207555|NCT01432366|79004019|FG000|Overall Study|Lost to Follow-up|13|||
44207556|NCT01432366|79004019|FG000|Overall Study|Lack of Efficacy|1|||
44368880|NCT00994890|79374258|FG000|Overall Study|Study terminated by sponsor|199|||
44368881|NCT00994890|79374259|FG001|Overall Study|Study terminated by sponsor|201|||
44368882|NCT00994890|79374260|FG002|Overall Study|Study terminated by sponsor|197|||
44368883|NCT00994890|79374258|FG000|Overall Study|Randomized, but not treated|1|||
44368884|NCT00994890|79374259|FG001|Overall Study|Randomized, but not treated|0|||
44368885|NCT00994890|79374260|FG002|Overall Study|Randomized, but not treated|0|||
44368886|NCT00994890|79374258|FG000|Overall Study|Other|2|||
44368887|NCT00994890|79374259|FG001|Overall Study|Other|2|||
44368888|NCT00994890|79374260|FG002|Overall Study|Other|1|||
44368889|NCT00994422|79374270|FG000|Overall Study|Lost to Follow-up|7|||
44368890|NCT00994422|79374271|FG001|Overall Study|Lost to Follow-up|1|||
44368891|NCT01171976|79374282|FG000|Overall Study|Protocol Violation|0|||
44368892|NCT01171976|79374283|FG001|Overall Study|Protocol Violation|0|||
44368893|NCT01171976|79374284|FG002|Overall Study|Protocol Violation|1|||
44368894|NCT01171976|79374282|FG000|Overall Study|Death|2|||
44368895|NCT01171976|79374283|FG001|Overall Study|Death|4|||
44368896|NCT01171976|79374284|FG002|Overall Study|Death|1|||
44368897|NCT01171976|79374282|FG000|Overall Study|Lost to Follow-up|4|||
44368898|NCT01171976|79374283|FG001|Overall Study|Lost to Follow-up|0|||
44368899|NCT01171976|79374284|FG002|Overall Study|Lost to Follow-up|2|||
44368900|NCT01171976|79374282|FG000|Overall Study|Withdrawal by Subject|1|||
44368901|NCT01171976|79374283|FG001|Overall Study|Withdrawal by Subject|5|||
44368902|NCT01171976|79374284|FG002|Overall Study|Withdrawal by Subject|6|||
44368903|NCT01171976|79374282|FG000|Overall Study|Abnormal test result|1|||
44368904|NCT01171976|79374283|FG001|Overall Study|Abnormal test result|0|||
44368905|NCT01171976|79374284|FG002|Overall Study|Abnormal test result|0|||
44368906|NCT01171976|79374282|FG000|Overall Study|Adverse Event|6|||
44368907|NCT01171976|79374283|FG001|Overall Study|Adverse Event|2|||
44207557|NCT01432366|79004019|FG000|Overall Study|Site Closed|20|||
44207558|NCT01432366|79004019|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
44207559|NCT01432366|79004019|FG000|Overall Study|Other|14|||
44207560|NCT01415440|79004026|FG000|Overall Study|Lost to Follow-up|0|||
44207561|NCT01415440|79004027|FG001|Overall Study|Lost to Follow-up|1|||
44207562|NCT01415440|79004028|FG002|Overall Study|Lost to Follow-up|2|||
44368908|NCT01171976|79374284|FG002|Overall Study|Adverse Event|5|||
44452099|NCT00080119|79461004|FG001|Overall Study|Unable to get to clinic|24|||
44368909|NCT00996216|79374292|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
44368910|NCT00996216|79374292|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
44368911|NCT00996216|79374292|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
44368912|NCT00830869|79374309|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
44368913|NCT00830869|79374310|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
44368914|NCT00830869|79374311|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
44368915|NCT00830869|79374312|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
44368916|NCT00830869|79374313|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
44543507|NCT03745937|79556548|FG003|Overall Study|Withdrawal by Subject|1|||
44207563|NCT01415440|79004026|FG000|Overall Study|Physician Decision|3|||
44207564|NCT01415440|79004027|FG001|Overall Study|Physician Decision|0|||
44207565|NCT01415440|79004028|FG002|Overall Study|Physician Decision|0|||
44207566|NCT01415440|79004026|FG000|Overall Study|Withdrawal by Subject|1|||
44207567|NCT01415440|79004027|FG001|Overall Study|Withdrawal by Subject|0|||
44207568|NCT01415440|79004028|FG002|Overall Study|Withdrawal by Subject|0|||
44207569|NCT01932788|79004046|FG000|Overall Study|Protocol Violation|18|||
44207570|NCT01932788|79004047|FG001|Overall Study|Protocol Violation|0|||
44207571|NCT01932788|79004046|FG000|Overall Study|Lost to Follow-up|18|||
44207572|NCT01932788|79004047|FG001|Overall Study|Lost to Follow-up|46|||
44207573|NCT01932788|79004046|FG000|Overall Study|Lack of Efficacy|2|||
44207574|NCT01932788|79004047|FG001|Overall Study|Lack of Efficacy|0|||
44207575|NCT01932788|79004046|FG000|Overall Study|Withdrawal by Subject|0|||
44207576|NCT01932788|79004047|FG001|Overall Study|Withdrawal by Subject|5|||
44207577|NCT01414738|79004053|FG000|Overall Study|Death|26|||
44207578|NCT01414738|79004053|FG000|Overall Study|Refused testing|5|||
44207579|NCT01414738|79004053|FG000|Overall Study|Lost to Follow-up|2|||
44207580|NCT01414738|79004053|FG000|Overall Study|Refused, disease progression|8|||
44207581|NCT01414738|79004053|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
44207582|NCT01414114|79004057|FG000|Overall Study|Adverse Event|2|||
44207583|NCT01414114|79004057|FG000|Overall Study|Withdrawal by Subject|1|||
44207584|NCT01414114|79004057|FG000|Overall Study|Other|2|||
44207585|NCT01393444|79004063|FG000|Overall Study|Withdrawal by Subject|1|||
44207586|NCT01393444|79004063|FG000|Overall Study|Determined ineligible during screening.|2|||
44207587|NCT01431976|79004067|FG000|Overall Study|Adverse Event|6|||
44207588|NCT01431976|79004067|FG000|Overall Study|Lack of Efficacy|2|||
44207589|NCT01431976|79004067|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
44207590|NCT01431976|79004067|FG000|Overall Study|Physician Decision|1|||
44207591|NCT01431976|79004067|FG000|Overall Study|Withdrawal by Subject|1|||
44207592|NCT01392742|79004071|FG000|Overall Study|Premature study termination|42|||
44207593|NCT01392742|79004071|FG000|Overall Study|Failure to return|35|||
44207594|NCT01392742|79004071|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
44207595|NCT01392742|79004071|FG000|Overall Study|Lost to Follow-up|34|||
44207596|NCT01392742|79004071|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
44207597|NCT01392742|79004071|FG000|Overall Study|ITR and Protocol deviation|1|||
44207598|NCT01392742|79004071|FG000|Overall Study|Adverse event/intercurrent illness|17|||
44207599|NCT01392742|79004071|FG000|Overall Study|Protocol Violation|14|||
44207600|NCT01392742|79004071|FG000|Overall Study|Other|3|||
44207601|NCT01392742|79004071|FG000|Overall Study|Missing information|13|||
44207602|NCT01413958|79004077|FG000|Overall Study|Lost to Follow-up|0|||
44207603|NCT01413958|79004078|FG001|Overall Study|Lost to Follow-up|1|||
44207604|NCT01413178|79004087|FG000|Overall Study|Toxicity|1|||
44207605|NCT01413178|79004088|FG001|Overall Study|Toxicity|0|||
44207606|NCT01413178|79004087|FG000|Overall Study|Ineligible|0|||
44207607|NCT01413178|79004088|FG001|Overall Study|Ineligible|2|||
44207608|NCT01799889|79004106|FG000|Overall Study|Adverse Event|4|||
44207609|NCT01799889|79004107|FG001|Overall Study|Adverse Event|4|||
44207610|NCT01799889|79004108|FG002|Overall Study|Adverse Event|5|||
44207611|NCT01799889|79004109|FG003|Overall Study|Adverse Event|1|||
44207612|NCT01799889|79004110|FG004|Overall Study|Adverse Event|11|||
44207613|NCT01799889|79004111|FG005|Overall Study|Adverse Event|1|||
44207614|NCT01799889|79004112|FG006|Overall Study|Adverse Event|5|||
44207615|NCT01799889|79004113|FG007|Overall Study|Adverse Event|2|||
44207616|NCT01799889|79004114|FG008|Overall Study|Adverse Event|3|||
44207617|NCT01799889|79004115|FG009|Overall Study|Adverse Event|1|||
44207618|NCT01799889|79004116|FG010|Overall Study|Adverse Event|1|||
44269668|NCT02332824|79194243|FG002|Overall Study|Voluntary Withdrawal|0|||
44269669|NCT02332824|79194244|FG003|Overall Study|Voluntary Withdrawal|0|||
44269670|NCT02332824|79194245|FG004|Overall Study|Voluntary Withdrawal|0|||
44543508|NCT03745937|79556545|FG000|Overall Study|Not-specifed|0|||
44269671|NCT02332824|79194246|FG005|Overall Study|Voluntary Withdrawal|0|||
44269672|NCT02332824|79194241|FG000|Overall Study|Inconvenient schedule|1|||
44207619|NCT01799889|79004117|FG011|Overall Study|Adverse Event|0|||
44207620|NCT01799889|79004106|FG000|Overall Study|Death|1|||
44207621|NCT01799889|79004107|FG001|Overall Study|Death|0|||
44207622|NCT01799889|79004108|FG002|Overall Study|Death|5|||
44207623|NCT01799889|79004109|FG003|Overall Study|Death|3|||
44543509|NCT03745937|79556546|FG001|Overall Study|Not-specifed|1|||
44207624|NCT01799889|79004110|FG004|Overall Study|Death|1|||
44207625|NCT01799889|79004111|FG005|Overall Study|Death|0|||
44207626|NCT01799889|79004112|FG006|Overall Study|Death|0|||
44207627|NCT01799889|79004113|FG007|Overall Study|Death|0|||
44207628|NCT01799889|79004114|FG008|Overall Study|Death|1|||
44207629|NCT01799889|79004115|FG009|Overall Study|Death|0|||
44207630|NCT01799889|79004116|FG010|Overall Study|Death|1|||
44207631|NCT01799889|79004117|FG011|Overall Study|Death|0|||
44207632|NCT01799889|79004106|FG000|Overall Study|Lack of Efficacy|1|||
44207633|NCT01799889|79004107|FG001|Overall Study|Lack of Efficacy|1|||
44207634|NCT01799889|79004108|FG002|Overall Study|Lack of Efficacy|0|||
44207635|NCT01799889|79004109|FG003|Overall Study|Lack of Efficacy|1|||
44207636|NCT01799889|79004110|FG004|Overall Study|Lack of Efficacy|2|||
44207637|NCT01799889|79004111|FG005|Overall Study|Lack of Efficacy|2|||
44207638|NCT01799889|79004112|FG006|Overall Study|Lack of Efficacy|0|||
44207639|NCT01799889|79004113|FG007|Overall Study|Lack of Efficacy|0|||
44207640|NCT01799889|79004114|FG008|Overall Study|Lack of Efficacy|2|||
44207641|NCT01799889|79004115|FG009|Overall Study|Lack of Efficacy|0|||
44207642|NCT01799889|79004116|FG010|Overall Study|Lack of Efficacy|1|||
44207643|NCT01799889|79004117|FG011|Overall Study|Lack of Efficacy|0|||
44207644|NCT01799889|79004106|FG000|Overall Study|Lost to Follow-up|0|||
44207645|NCT01799889|79004107|FG001|Overall Study|Lost to Follow-up|1|||
44368917|NCT00830869|79374314|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
44368918|NCT00830869|79374315|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
44368919|NCT00830869|79374316|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
44368920|NCT00830869|79374317|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
44368921|NCT00830869|79374318|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
44368922|NCT00830869|79374319|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
44368923|NCT00830869|79374320|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
44368924|NCT00830869|79374309|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
44368925|NCT00830869|79374310|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
44368926|NCT00830869|79374311|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
44368927|NCT00830869|79374312|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
44368928|NCT00830869|79374313|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
44368929|NCT00830869|79374314|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
44368930|NCT00830869|79374315|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
44368931|NCT00830869|79374316|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
44368932|NCT00830869|79374317|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
44368933|NCT00830869|79374318|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
44368934|NCT00830869|79374319|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
44368935|NCT00830869|79374320|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
44368936|NCT00830869|79374309|FG000|Period 1: Part 1|Adverse Event|0|||
44368937|NCT00830869|79374310|FG001|Period 1: Part 1|Adverse Event|0|||
44368938|NCT00830869|79374311|FG002|Period 1: Part 1|Adverse Event|0|||
44368939|NCT00830869|79374312|FG003|Period 1: Part 1|Adverse Event|0|||
44368940|NCT00830869|79374313|FG004|Period 1: Part 1|Adverse Event|0|||
44368941|NCT00830869|79374314|FG005|Period 1: Part 1|Adverse Event|1|||
44368942|NCT00830869|79374315|FG006|Period 1: Part 1|Adverse Event|1|||
44368943|NCT00830869|79374316|FG007|Period 1: Part 1|Adverse Event|0|||
44368944|NCT00830869|79374317|FG008|Period 1: Part 1|Adverse Event|0|||
44368945|NCT00830869|79374318|FG009|Period 1: Part 1|Adverse Event|0|||
44368946|NCT00830869|79374319|FG010|Period 1: Part 1|Adverse Event|0|||
44368947|NCT00830869|79374320|FG011|Period 1: Part 1|Adverse Event|0|||
44368948|NCT00830869|79374309|FG000|Period 1: Part 1|Progressive disease|1|||
44368949|NCT00830869|79374310|FG001|Period 1: Part 1|Progressive disease|0|||
44368950|NCT00830869|79374311|FG002|Period 1: Part 1|Progressive disease|1|||
44368951|NCT00830869|79374312|FG003|Period 1: Part 1|Progressive disease|6|||
44368952|NCT00830869|79374313|FG004|Period 1: Part 1|Progressive disease|4|||
44368953|NCT00830869|79374314|FG005|Period 1: Part 1|Progressive disease|4|||
44368954|NCT00830869|79374315|FG006|Period 1: Part 1|Progressive disease|1|||
44368955|NCT00830869|79374316|FG007|Period 1: Part 1|Progressive disease|0|||
44368956|NCT00830869|79374317|FG008|Period 1: Part 1|Progressive disease|0|||
44368957|NCT00830869|79374318|FG009|Period 1: Part 1|Progressive disease|0|||
44368958|NCT00830869|79374319|FG010|Period 1: Part 1|Progressive disease|0|||
44368959|NCT00830869|79374320|FG011|Period 1: Part 1|Progressive disease|0|||
44368960|NCT00830869|79374309|FG000|Period 2: Part 2|Protocol Violation|0|||
44368961|NCT00830869|79374310|FG001|Period 2: Part 2|Protocol Violation|0|||
44368962|NCT00830869|79374311|FG002|Period 2: Part 2|Protocol Violation|0|||
44543510|NCT03745937|79556547|FG002|Overall Study|Not-specifed|0|||
44207646|NCT01799889|79004108|FG002|Overall Study|Lost to Follow-up|0|||
44368963|NCT00830869|79374312|FG003|Period 2: Part 2|Protocol Violation|0|||
44368964|NCT00830869|79374313|FG004|Period 2: Part 2|Protocol Violation|0|||
44368965|NCT00830869|79374314|FG005|Period 2: Part 2|Protocol Violation|0|||
44368966|NCT00830869|79374315|FG006|Period 2: Part 2|Protocol Violation|0|||
44368967|NCT00830869|79374316|FG007|Period 2: Part 2|Protocol Violation|1|||
44543511|NCT03745937|79556548|FG003|Overall Study|Not-specifed|1|||
44207647|NCT01799889|79004109|FG003|Overall Study|Lost to Follow-up|0|||
44207648|NCT01799889|79004110|FG004|Overall Study|Lost to Follow-up|0|||
44207649|NCT01799889|79004111|FG005|Overall Study|Lost to Follow-up|0|||
44207650|NCT01799889|79004112|FG006|Overall Study|Lost to Follow-up|0|||
44207651|NCT01799889|79004113|FG007|Overall Study|Lost to Follow-up|0|||
44207652|NCT01799889|79004114|FG008|Overall Study|Lost to Follow-up|0|||
44368968|NCT00830869|79374317|FG008|Period 2: Part 2|Protocol Violation|0|||
44368969|NCT00830869|79374318|FG009|Period 2: Part 2|Protocol Violation|1|||
44368970|NCT00830869|79374319|FG010|Period 2: Part 2|Protocol Violation|0|||
44368971|NCT00830869|79374320|FG011|Period 2: Part 2|Protocol Violation|0|||
44368972|NCT00830869|79374309|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
44368973|NCT00830869|79374310|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
44368974|NCT00830869|79374311|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
44368975|NCT00830869|79374312|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
44368976|NCT00830869|79374313|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
44368977|NCT00830869|79374314|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
44207653|NCT01799889|79004115|FG009|Overall Study|Lost to Follow-up|0|||
44207654|NCT01799889|79004116|FG010|Overall Study|Lost to Follow-up|0|||
44207655|NCT01799889|79004117|FG011|Overall Study|Lost to Follow-up|0|||
44207656|NCT01799889|79004106|FG000|Overall Study|Physician Decision|3|||
44207657|NCT01799889|79004107|FG001|Overall Study|Physician Decision|2|||
44207658|NCT01799889|79004108|FG002|Overall Study|Physician Decision|4|||
44207659|NCT01799889|79004109|FG003|Overall Study|Physician Decision|4|||
44207660|NCT01799889|79004110|FG004|Overall Study|Physician Decision|5|||
44207661|NCT01799889|79004111|FG005|Overall Study|Physician Decision|5|||
44207662|NCT01799889|79004112|FG006|Overall Study|Physician Decision|5|||
44207663|NCT01799889|79004113|FG007|Overall Study|Physician Decision|2|||
44207664|NCT01799889|79004114|FG008|Overall Study|Physician Decision|6|||
44207665|NCT01799889|79004115|FG009|Overall Study|Physician Decision|0|||
44207666|NCT01799889|79004116|FG010|Overall Study|Physician Decision|0|||
44207667|NCT01799889|79004117|FG011|Overall Study|Physician Decision|1|||
44207668|NCT01799889|79004106|FG000|Overall Study|Progressive Disease|30|||
44207669|NCT01799889|79004107|FG001|Overall Study|Progressive Disease|26|||
44207670|NCT01799889|79004108|FG002|Overall Study|Progressive Disease|25|||
44207671|NCT01799889|79004109|FG003|Overall Study|Progressive Disease|30|||
44207672|NCT01799889|79004110|FG004|Overall Study|Progressive Disease|23|||
44207673|NCT01799889|79004111|FG005|Overall Study|Progressive Disease|9|||
44207674|NCT01799889|79004112|FG006|Overall Study|Progressive Disease|8|||
44207675|NCT01799889|79004113|FG007|Overall Study|Progressive Disease|13|||
44207676|NCT01799889|79004114|FG008|Overall Study|Progressive Disease|18|||
44207677|NCT01799889|79004115|FG009|Overall Study|Progressive Disease|5|||
44207678|NCT01799889|79004116|FG010|Overall Study|Progressive Disease|3|||
44207679|NCT01799889|79004117|FG011|Overall Study|Progressive Disease|1|||
44207680|NCT01799889|79004106|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
44368978|NCT00830869|79374315|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
44368979|NCT00830869|79374316|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
44368980|NCT00830869|79374317|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
44368981|NCT00830869|79374318|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
44368982|NCT00830869|79374319|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
44368983|NCT00830869|79374320|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
44368984|NCT00830869|79374309|FG000|Period 2: Part 2|Adverse Event|0|||
44368985|NCT00830869|79374310|FG001|Period 2: Part 2|Adverse Event|0|||
44368986|NCT00830869|79374311|FG002|Period 2: Part 2|Adverse Event|0|||
44368987|NCT00830869|79374312|FG003|Period 2: Part 2|Adverse Event|0|||
44368988|NCT00830869|79374313|FG004|Period 2: Part 2|Adverse Event|0|||
44368989|NCT00830869|79374314|FG005|Period 2: Part 2|Adverse Event|0|||
44368990|NCT00830869|79374315|FG006|Period 2: Part 2|Adverse Event|0|||
44368991|NCT00830869|79374316|FG007|Period 2: Part 2|Adverse Event|4|||
44368992|NCT00830869|79374317|FG008|Period 2: Part 2|Adverse Event|3|||
44368993|NCT00830869|79374318|FG009|Period 2: Part 2|Adverse Event|2|||
44368994|NCT00830869|79374319|FG010|Period 2: Part 2|Adverse Event|2|||
44368995|NCT00830869|79374320|FG011|Period 2: Part 2|Adverse Event|0|||
44368996|NCT00830869|79374309|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
44368997|NCT00830869|79374310|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
44368998|NCT00830869|79374311|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
44368999|NCT00830869|79374312|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
44207681|NCT01799889|79004107|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
44207682|NCT01799889|79004108|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
44207683|NCT01799889|79004109|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
44207684|NCT01799889|79004110|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
44207685|NCT01799889|79004111|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
44369000|NCT00830869|79374313|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
44369001|NCT00830869|79374314|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
44369002|NCT00830869|79374315|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
44369003|NCT00830869|79374316|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
44369004|NCT00830869|79374317|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
44207686|NCT01799889|79004112|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
44207687|NCT01799889|79004113|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
44207688|NCT01799889|79004114|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
44207689|NCT01799889|79004115|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
44207690|NCT01799889|79004116|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
44369005|NCT00830869|79374318|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
44369006|NCT00830869|79374319|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
44369007|NCT00830869|79374320|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
44369008|NCT00830869|79374309|FG000|Period 2: Part 2|Progressive disease|0|||
44369009|NCT00830869|79374310|FG001|Period 2: Part 2|Progressive disease|0|||
44369010|NCT00830869|79374311|FG002|Period 2: Part 2|Progressive disease|0|||
44369011|NCT00830869|79374312|FG003|Period 2: Part 2|Progressive disease|0|||
44369012|NCT00830869|79374313|FG004|Period 2: Part 2|Progressive disease|0|||
44369013|NCT00830869|79374314|FG005|Period 2: Part 2|Progressive disease|0|||
44207691|NCT01799889|79004117|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
44207692|NCT01799889|79004106|FG000|Overall Study|Study Terminated By Sponsor|1|||
44207693|NCT01799889|79004107|FG001|Overall Study|Study Terminated By Sponsor|0|||
44207694|NCT01799889|79004108|FG002|Overall Study|Study Terminated By Sponsor|0|||
44207695|NCT01799889|79004109|FG003|Overall Study|Study Terminated By Sponsor|0|||
44207696|NCT01799889|79004110|FG004|Overall Study|Study Terminated By Sponsor|2|||
44207697|NCT01799889|79004111|FG005|Overall Study|Study Terminated By Sponsor|1|||
44207698|NCT01799889|79004112|FG006|Overall Study|Study Terminated By Sponsor|0|||
44207699|NCT01799889|79004113|FG007|Overall Study|Study Terminated By Sponsor|2|||
44207700|NCT01799889|79004114|FG008|Overall Study|Study Terminated By Sponsor|1|||
44207701|NCT01799889|79004115|FG009|Overall Study|Study Terminated By Sponsor|1|||
44207702|NCT01799889|79004116|FG010|Overall Study|Study Terminated By Sponsor|0|||
44207703|NCT01799889|79004117|FG011|Overall Study|Study Terminated By Sponsor|0|||
44207704|NCT01799889|79004106|FG000|Overall Study|Withdrawal by Subject|1|||
44207705|NCT01799889|79004107|FG001|Overall Study|Withdrawal by Subject|6|||
44207706|NCT01799889|79004108|FG002|Overall Study|Withdrawal by Subject|4|||
44207707|NCT01799889|79004109|FG003|Overall Study|Withdrawal by Subject|0|||
44207708|NCT01799889|79004110|FG004|Overall Study|Withdrawal by Subject|5|||
44207709|NCT01799889|79004111|FG005|Overall Study|Withdrawal by Subject|1|||
44369014|NCT00830869|79374315|FG006|Period 2: Part 2|Progressive disease|0|||
44369015|NCT00830869|79374316|FG007|Period 2: Part 2|Progressive disease|14|||
44369016|NCT00830869|79374317|FG008|Period 2: Part 2|Progressive disease|11|||
44369017|NCT00830869|79374318|FG009|Period 2: Part 2|Progressive disease|12|||
44369018|NCT00830869|79374319|FG010|Period 2: Part 2|Progressive disease|8|||
44369019|NCT00830869|79374320|FG011|Period 2: Part 2|Progressive disease|15|||
44369020|NCT00830869|79374309|FG000|Period 2: Part 2|Other|0|||
44369021|NCT00830869|79374310|FG001|Period 2: Part 2|Other|0|||
44369022|NCT00830869|79374311|FG002|Period 2: Part 2|Other|0|||
44369023|NCT00830869|79374312|FG003|Period 2: Part 2|Other|0|||
44369024|NCT00830869|79374313|FG004|Period 2: Part 2|Other|0|||
44207710|NCT01799889|79004112|FG006|Overall Study|Withdrawal by Subject|3|||
44207711|NCT01799889|79004113|FG007|Overall Study|Withdrawal by Subject|1|||
44207712|NCT01799889|79004114|FG008|Overall Study|Withdrawal by Subject|2|||
44207713|NCT01799889|79004115|FG009|Overall Study|Withdrawal by Subject|1|||
44207714|NCT01799889|79004116|FG010|Overall Study|Withdrawal by Subject|1|||
44207715|NCT01799889|79004117|FG011|Overall Study|Withdrawal by Subject|1|||
44207716|NCT01799889|79004106|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44207717|NCT01799889|79004107|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44207718|NCT01799889|79004108|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44207719|NCT01799889|79004109|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44207720|NCT01799889|79004110|FG004|Overall Study|Non-Compliance With Study Drug|0|||
44207721|NCT01799889|79004111|FG005|Overall Study|Non-Compliance With Study Drug|1|||
44369025|NCT00830869|79374314|FG005|Period 2: Part 2|Other|0|||
44369026|NCT00830869|79374315|FG006|Period 2: Part 2|Other|0|||
44369027|NCT00830869|79374316|FG007|Period 2: Part 2|Other|0|||
44369028|NCT00830869|79374317|FG008|Period 2: Part 2|Other|0|||
44369029|NCT00830869|79374318|FG009|Period 2: Part 2|Other|1|||
44369030|NCT00830869|79374319|FG010|Period 2: Part 2|Other|0|||
44369031|NCT00830869|79374320|FG011|Period 2: Part 2|Other|0|||
44369032|NCT00844519|79374349|FG000|Overall Study|Withdrawal by Subject|1|||
44369033|NCT00844519|79374350|FG001|Overall Study|Withdrawal by Subject|1|||
44369034|NCT00844519|79374349|FG000|Overall Study|Adverse Event|1|||
44369035|NCT00844519|79374350|FG001|Overall Study|Adverse Event|0|||
44369036|NCT01171820|79374358|FG000|Overall Study|Death|3|||
44369037|NCT01171820|79374359|FG001|Overall Study|Death|3|||
44369038|NCT01171820|79374358|FG000|Overall Study|Lost to Follow-up|0|||
44369039|NCT01171820|79374359|FG001|Overall Study|Lost to Follow-up|1|||
44369040|NCT01171820|79374358|FG000|Overall Study|Withdrawal by Subject|2|||
44369041|NCT01171820|79374359|FG001|Overall Study|Withdrawal by Subject|0|||
44207722|NCT01799889|79004112|FG006|Overall Study|Non-Compliance With Study Drug|0|||
44207723|NCT01799889|79004113|FG007|Overall Study|Non-Compliance With Study Drug|0|||
44207724|NCT01799889|79004114|FG008|Overall Study|Non-Compliance With Study Drug|0|||
44207725|NCT01799889|79004115|FG009|Overall Study|Non-Compliance With Study Drug|0|||
44207726|NCT01799889|79004116|FG010|Overall Study|Non-Compliance With Study Drug|0|||
44369042|NCT01171820|79374358|FG000|Overall Study|Physician Decision|0|||
44369043|NCT01171820|79374359|FG001|Overall Study|Physician Decision|1|||
44369044|NCT01171820|79374358|FG000|Overall Study|1-Year Missed Visit|1|||
44369045|NCT01171820|79374359|FG001|Overall Study|1-Year Missed Visit|1|||
44369046|NCT00994110|79374367|FG000|Overall Study|Withdrawal by Subject|9|||
44369047|NCT00994110|79374368|FG001|Overall Study|Withdrawal by Subject|9|||
44369048|NCT00994110|79374367|FG000|Overall Study|Not Treated|4|||
44369049|NCT00994110|79374368|FG001|Overall Study|Not Treated|8|||
44369050|NCT00994110|79374367|FG000|Overall Study|Adverse Event|1|||
44369051|NCT00994110|79374368|FG001|Overall Study|Adverse Event|0|||
44207727|NCT01799889|79004117|FG011|Overall Study|Non-Compliance With Study Drug|0|||
44207728|NCT01412944|79004156|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
44207729|NCT01412944|79004157|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
44207730|NCT01412944|79004158|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
44207731|NCT01412944|79004159|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
44207732|NCT01412944|79004160|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
44207733|NCT01412944|79004161|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
44207734|NCT01412944|79004156|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
44207735|NCT01412944|79004157|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
44207736|NCT01412944|79004158|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
44207737|NCT01412944|79004159|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
44207738|NCT01412944|79004160|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
44207739|NCT01412944|79004161|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
44207740|NCT01412944|79004156|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
44207741|NCT01412944|79004157|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
44207742|NCT01412944|79004158|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
44207743|NCT01412944|79004159|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
44207744|NCT01412944|79004160|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
44207745|NCT01412944|79004161|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
44207746|NCT01412944|79004156|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
44207747|NCT01412944|79004157|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
44207748|NCT01412944|79004158|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
44207749|NCT01412944|79004159|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
44207750|NCT01412944|79004160|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
44207751|NCT01412944|79004161|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
44207752|NCT01412944|79004156|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
44207753|NCT01412944|79004157|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
44207754|NCT01412944|79004158|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
44207755|NCT01412944|79004159|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
44207756|NCT01412944|79004160|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
44207757|NCT01412944|79004161|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
44207758|NCT01412944|79004156|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
44207759|NCT01412944|79004157|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
44207760|NCT01412944|79004158|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
44207761|NCT01412944|79004159|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
44207762|NCT01412944|79004160|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
44207763|NCT01412944|79004161|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
44207764|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207765|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207766|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
44207767|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
44207768|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
44207769|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207770|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Adverse Event|0|||
44207771|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Adverse Event|0|||
44207772|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Adverse Event|0|||
44207773|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Adverse Event|0|||
44207774|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Adverse Event|1|||
44207775|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Adverse Event|0|||
44207776|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
44207777|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
44207778|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
44207779|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
44369052|NCT00994110|79374367|FG000|Overall Study|Patient not resected|41|||
44369053|NCT00994110|79374368|FG001|Overall Study|Patient not resected|52|||
44369054|NCT00994110|79374367|FG000|Overall Study|Pt not eligible|10|||
44369055|NCT00994110|79374368|FG001|Overall Study|Pt not eligible|5|||
44369056|NCT00993954|79374376|FG000|Overall Study|Protocol Violation|21|||
44369057|NCT00993954|79374377|FG001|Overall Study|Protocol Violation|2|||
44369058|NCT01157234|79374385|FG000|Overall Study|Withdrawal by Subject|1|||
44207780|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
44207781|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
44369059|NCT01157234|79374386|FG001|Overall Study|Withdrawal by Subject|0|||
44369060|NCT00991302|79374401|FG000|Overall Study|Death|0|||
44369061|NCT00991302|79374402|FG001|Overall Study|Death|1|||
44207782|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207783|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207784|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207785|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207786|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207787|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
44207788|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207789|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207790|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207791|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207792|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
44207793|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207794|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
44207795|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
44207796|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207797|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207798|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207799|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
44207800|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
44207801|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
44207802|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
44207803|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
44207804|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
44207805|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
44207806|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207807|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
44207808|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207809|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207810|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207811|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
44207812|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207813|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
44207814|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207815|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207816|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207817|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
44207818|NCT01412944|79004156|FG000|Entire: IV + Maintenance|Adverse Event|0|||
44207819|NCT01412944|79004157|FG001|Entire: IV + Maintenance|Adverse Event|1|||
44207820|NCT01412944|79004158|FG002|Entire: IV + Maintenance|Adverse Event|0|||
44207821|NCT01412944|79004159|FG003|Entire: IV + Maintenance|Adverse Event|0|||
44207822|NCT01412944|79004160|FG004|Entire: IV + Maintenance|Adverse Event|0|||
44207823|NCT01412944|79004161|FG005|Entire: IV + Maintenance|Adverse Event|0|||
44207824|NCT01798485|79004179|FG000|Overall Study|Adverse Event|32|||
44207825|NCT01798485|79004180|FG001|Overall Study|Adverse Event|40|||
44207826|NCT01798485|79004179|FG000|Overall Study|Withdrawal by Subject|27|||
44207827|NCT01798485|79004180|FG001|Overall Study|Withdrawal by Subject|31|||
44207828|NCT01798485|79004179|FG000|Overall Study|Lost to Follow-up|0|||
44207829|NCT01798485|79004180|FG001|Overall Study|Lost to Follow-up|3|||
44207830|NCT01798485|79004179|FG000|Overall Study|Physician Decision|14|||
44207831|NCT01798485|79004180|FG001|Overall Study|Physician Decision|10|||
44207832|NCT01798485|79004179|FG000|Overall Study|Objective Disease Progression|152|||
44207833|NCT01798485|79004180|FG001|Overall Study|Objective Disease Progression|106|||
44207834|NCT01798485|79004179|FG000|Overall Study|Death|25|||
44207835|NCT01798485|79004180|FG001|Overall Study|Death|22|||
44207836|NCT01798485|79004179|FG000|Overall Study|Sponsor Decision|61|||
44207837|NCT01798485|79004180|FG001|Overall Study|Sponsor Decision|54|||
44269673|NCT02332824|79194242|FG001|Overall Study|Inconvenient schedule|1|||
44269674|NCT02332824|79194243|FG002|Overall Study|Inconvenient schedule|0|||
44269675|NCT02332824|79194244|FG003|Overall Study|Inconvenient schedule|0|||
44269676|NCT02332824|79194245|FG004|Overall Study|Inconvenient schedule|0|||
44269677|NCT02332824|79194246|FG005|Overall Study|Inconvenient schedule|0|||
44207838|NCT01798485|79004179|FG000|Overall Study|Clinical Progression|35|||
44269678|NCT02332824|79194241|FG000|Overall Study|Transfer|0|||
44269679|NCT02332824|79194242|FG001|Overall Study|Transfer|0|||
44207839|NCT01798485|79004180|FG001|Overall Study|Clinical Progression|24|||
44207840|NCT01767597|79004188|FG000|Overall Study|Incomplete intervention|3|||
44207841|NCT01767597|79004189|FG001|Overall Study|Incomplete intervention|1|||
44207842|NCT01767597|79004188|FG000|Overall Study|Withdrawal by Subject|1|||
44207843|NCT01767597|79004189|FG001|Overall Study|Withdrawal by Subject|0|||
44207844|NCT01767519|79004198|FG000|Overall Study|Other Reasons|4|||
44207845|NCT01767519|79004199|FG001|Overall Study|Other Reasons|4|||
44207846|NCT01767519|79004200|FG002|Overall Study|Other Reasons|2|||
44207847|NCT01767519|79004198|FG000|Overall Study|Protocol Violation|0|||
44207848|NCT01767519|79004199|FG001|Overall Study|Protocol Violation|3|||
44207849|NCT01767519|79004200|FG002|Overall Study|Protocol Violation|0|||
44207850|NCT01767519|79004198|FG000|Overall Study|Personal Reasons|1|||
44207851|NCT01767519|79004199|FG001|Overall Study|Personal Reasons|0|||
44207852|NCT01767519|79004200|FG002|Overall Study|Personal Reasons|0|||
44207853|NCT01767519|79004198|FG000|Overall Study|Lost to Follow-up|3|||
44207854|NCT01767519|79004199|FG001|Overall Study|Lost to Follow-up|1|||
44207855|NCT01767519|79004200|FG002|Overall Study|Lost to Follow-up|2|||
44207856|NCT01767519|79004198|FG000|Overall Study|Lack of Efficacy|1|||
44207857|NCT01767519|79004199|FG001|Overall Study|Lack of Efficacy|0|||
44207858|NCT01767519|79004200|FG002|Overall Study|Lack of Efficacy|0|||
44207859|NCT01767519|79004198|FG000|Overall Study|Adverse Event|5|||
44207860|NCT01767519|79004199|FG001|Overall Study|Adverse Event|5|||
44207861|NCT01767519|79004200|FG002|Overall Study|Adverse Event|1|||
44207862|NCT01797783|79004210|FG000|Overall Study|Adverse Event|1|||
44207863|NCT01797783|79004211|FG001|Overall Study|Adverse Event|1|||
44207864|NCT01797783|79004210|FG000|Overall Study|Withdrawal by Subject|1|||
44207865|NCT01797783|79004211|FG001|Overall Study|Withdrawal by Subject|0|||
44207866|NCT01766817|79004228|FG000|Overall Study|Drug-related adverse event|1|||
44207867|NCT01766817|79004229|FG001|Overall Study|Drug-related adverse event|2|||
44207868|NCT01766817|79004230|FG002|Overall Study|Drug-related adverse event|1|||
44207869|NCT01766817|79004228|FG000|Overall Study|Drug-unrelated adverse event|3|||
44207870|NCT01766817|79004229|FG001|Overall Study|Drug-unrelated adverse event|3|||
44207871|NCT01766817|79004230|FG002|Overall Study|Drug-unrelated adverse event|3|||
44207872|NCT01766817|79004228|FG000|Overall Study|Death|1|||
44207873|NCT01766817|79004229|FG001|Overall Study|Death|1|||
44207874|NCT01766817|79004230|FG002|Overall Study|Death|0|||
44207875|NCT01766817|79004228|FG000|Overall Study|Unable to take study drug|0|||
44207876|NCT01766817|79004229|FG001|Overall Study|Unable to take study drug|1|||
44207877|NCT01766817|79004230|FG002|Overall Study|Unable to take study drug|0|||
44207878|NCT01766817|79004228|FG000|Overall Study|Withdrawal by Subject|2|||
44207879|NCT01766817|79004229|FG001|Overall Study|Withdrawal by Subject|0|||
44207880|NCT01766817|79004230|FG002|Overall Study|Withdrawal by Subject|3|||
44207881|NCT01766817|79004228|FG000|Overall Study|Subject non-compliance|0|||
44207882|NCT01766817|79004229|FG001|Overall Study|Subject non-compliance|1|||
44207883|NCT01766817|79004230|FG002|Overall Study|Subject non-compliance|2|||
44207884|NCT01766817|79004228|FG000|Overall Study|Physician Decision|3|||
44207885|NCT01766817|79004229|FG001|Overall Study|Physician Decision|3|||
44207886|NCT01766817|79004230|FG002|Overall Study|Physician Decision|4|||
44207887|NCT01766817|79004228|FG000|Overall Study|Other|1|||
44207888|NCT01766817|79004229|FG001|Overall Study|Other|0|||
44207889|NCT01766817|79004230|FG002|Overall Study|Other|0|||
44207890|NCT01797705|79004238|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
44207891|NCT01797705|79004238|FG000|Overall Study|Withdrawal by Subject|1|||
44207892|NCT01797081|79004246|FG000|Overall Study|Adverse Event|1|||
44207893|NCT01797081|79004247|FG001|Overall Study|Adverse Event|0|||
44207894|NCT01797081|79004248|FG002|Overall Study|Adverse Event|1|||
44207895|NCT01797081|79004249|FG003|Overall Study|Adverse Event|0|||
44207896|NCT01797081|79004246|FG000|Overall Study|Pregnancy|1|||
44207897|NCT01797081|79004247|FG001|Overall Study|Pregnancy|0|||
44207898|NCT01797081|79004248|FG002|Overall Study|Pregnancy|0|||
44207899|NCT01797081|79004249|FG003|Overall Study|Pregnancy|0|||
44207900|NCT01797081|79004246|FG000|Overall Study|Personal Reasons|12|||
44207901|NCT01797081|79004247|FG001|Overall Study|Personal Reasons|4|||
44369062|NCT00991302|79374401|FG000|Overall Study|Lost to Follow-up|14|||
44369063|NCT00991302|79374402|FG001|Overall Study|Lost to Follow-up|12|||
44369064|NCT00995670|79374411|FG000|Overall Study|Failed arterial cannulation|1|||
44369065|NCT00995670|79374412|FG001|Overall Study|Failed arterial cannulation|0|||
44369066|NCT00995670|79374413|FG002|Overall Study|Failed arterial cannulation|3|||
44369067|NCT00601354|79374423|FG000|Overall Study|Lost to Follow-up|4|||
44369068|NCT00601354|79374424|FG001|Overall Study|Lost to Follow-up|5|||
44207902|NCT01797081|79004248|FG002|Overall Study|Personal Reasons|4|||
44207903|NCT01797081|79004249|FG003|Overall Study|Personal Reasons|8|||
44207904|NCT01797081|79004246|FG000|Overall Study|Protocol Violation|0|||
44207905|NCT01797081|79004247|FG001|Overall Study|Protocol Violation|0|||
44369069|NCT00853099|79374433|FG000|Double-blind Period|Adverse Event|7|||
44369070|NCT00853099|79374434|FG001|Double-blind Period|Adverse Event|9|||
44207906|NCT01797081|79004248|FG002|Overall Study|Protocol Violation|0|||
44207907|NCT01797081|79004249|FG003|Overall Study|Protocol Violation|1|||
44207908|NCT01794117|79004261|FG000|Overall Study|Adverse Event|1|||
44207909|NCT01794117|79004262|FG001|Overall Study|Adverse Event|0|||
44207910|NCT01794117|79004263|FG002|Overall Study|Adverse Event|0|||
44207911|NCT01794117|79004264|FG003|Overall Study|Adverse Event|0|||
44207912|NCT01794117|79004261|FG000|Overall Study|Participant noncompliance|0|||
44207913|NCT01794117|79004262|FG001|Overall Study|Participant noncompliance|1|||
44207914|NCT01794117|79004263|FG002|Overall Study|Participant noncompliance|0|||
44207915|NCT01794117|79004264|FG003|Overall Study|Participant noncompliance|0|||
44369071|NCT00853099|79374435|FG002|Double-blind Period|Adverse Event|13|||
44207916|NCT01794117|79004261|FG000|Overall Study|Refused further treatment|0|||
44207917|NCT01794117|79004262|FG001|Overall Study|Refused further treatment|2|||
44369072|NCT00853099|79374436|FG003|Double-blind Period|Adverse Event|0|||
44369073|NCT00853099|79374433|FG000|Double-blind Period|Withdrawal by Subject|2|||
44369074|NCT00853099|79374434|FG001|Double-blind Period|Withdrawal by Subject|3|||
44369075|NCT00853099|79374435|FG002|Double-blind Period|Withdrawal by Subject|0|||
44369076|NCT00853099|79374436|FG003|Double-blind Period|Withdrawal by Subject|0|||
44369077|NCT00853099|79374433|FG000|Double-blind Period|Lack of Efficacy|14|||
44369078|NCT00853099|79374434|FG001|Double-blind Period|Lack of Efficacy|17|||
44369079|NCT00853099|79374435|FG002|Double-blind Period|Lack of Efficacy|16|||
44369080|NCT00853099|79374436|FG003|Double-blind Period|Lack of Efficacy|0|||
44369081|NCT00853099|79374433|FG000|Double-blind Period|Other|0|||
44207918|NCT01794117|79004263|FG002|Overall Study|Refused further treatment|0|||
44207919|NCT01794117|79004264|FG003|Overall Study|Refused further treatment|0|||
44207920|NCT01766037|79004277|FG000|Overall Study|Adverse Event|1|||
44207921|NCT01766037|79004278|FG001|Overall Study|Adverse Event|0|||
44207922|NCT01766037|79004277|FG000|Overall Study|Lack of Efficacy|1|||
44207923|NCT01766037|79004278|FG001|Overall Study|Lack of Efficacy|0|||
44207924|NCT01766037|79004277|FG000|Overall Study|Lost to Follow-up|0|||
44369082|NCT00853099|79374434|FG001|Double-blind Period|Other|0|||
44369083|NCT00853099|79374435|FG002|Double-blind Period|Other|1|||
44369084|NCT00853099|79374436|FG003|Double-blind Period|Other|0|||
44369085|NCT00853099|79374433|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
44369086|NCT00853099|79374434|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
44369087|NCT00853099|79374435|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
44369088|NCT00853099|79374436|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
44369089|NCT00853099|79374433|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
44369090|NCT00853099|79374434|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
44369091|NCT00853099|79374435|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
44369092|NCT00853099|79374436|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
44369093|NCT00853099|79374433|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
44369094|NCT00853099|79374434|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
44369095|NCT00853099|79374435|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
44369096|NCT00853099|79374436|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
44369097|NCT00853099|79374433|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
44369098|NCT00853099|79374434|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
44369099|NCT00853099|79374435|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
44369100|NCT00853099|79374436|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
44369101|NCT00853099|79374433|FG000|Double-blind + Open-label Periods|Other|0|||
44369102|NCT00853099|79374434|FG001|Double-blind + Open-label Periods|Other|0|||
44369103|NCT00853099|79374435|FG002|Double-blind + Open-label Periods|Other|0|||
44369104|NCT00853099|79374436|FG003|Double-blind + Open-label Periods|Other|6|||
44369105|NCT00992784|79374449|FG000|Overall Study|Adverse Event|2|||
44369106|NCT00992784|79374450|FG001|Overall Study|Adverse Event|1|||
44369107|NCT00992784|79374451|FG002|Overall Study|Adverse Event|0|||
44369108|NCT00992784|79374449|FG000|Overall Study|Withdrawal by Subject|1|||
44369109|NCT00992784|79374450|FG001|Overall Study|Withdrawal by Subject|1|||
44369110|NCT00992784|79374451|FG002|Overall Study|Withdrawal by Subject|1|||
44369111|NCT00830167|79374461|FG000|Overall Study|Lack of Efficacy|26|||
44369112|NCT00830167|79374462|FG001|Overall Study|Lack of Efficacy|10|||
44369113|NCT00830167|79374461|FG000|Overall Study|Adverse Event|8|||
44369114|NCT00830167|79374462|FG001|Overall Study|Adverse Event|24|||
44369115|NCT00830167|79374461|FG000|Overall Study|Not meeting entrance criteria|2|||
44369116|NCT00830167|79374462|FG001|Overall Study|Not meeting entrance criteria|5|||
44369117|NCT00830167|79374461|FG000|Overall Study|Withdrawal by Subject|2|||
44369118|NCT00830167|79374462|FG001|Overall Study|Withdrawal by Subject|0|||
44369119|NCT00830167|79374461|FG000|Overall Study|Lost to Follow-up|0|||
44369120|NCT00830167|79374462|FG001|Overall Study|Lost to Follow-up|1|||
44369121|NCT00830167|79374461|FG000|Overall Study|Protocol Violation|0|||
44369122|NCT00830167|79374462|FG001|Overall Study|Protocol Violation|1|||
44369123|NCT00830167|79374461|FG000|Overall Study|Other|2|||
44369124|NCT00830167|79374462|FG001|Overall Study|Other|2|||
44369125|NCT00992394|79374470|FG000|Overall Study|Lack of Efficacy|6|||
44369126|NCT00992394|79374471|FG001|Overall Study|Lack of Efficacy|3|||
44369127|NCT00992394|79374470|FG000|Overall Study|Adverse Event|4|||
44207925|NCT01766037|79004278|FG001|Overall Study|Lost to Follow-up|10|||
44369128|NCT00992394|79374471|FG001|Overall Study|Adverse Event|5|||
44369129|NCT00992394|79374470|FG000|Overall Study|Withdrawal by Subject|8|||
44369130|NCT00992394|79374471|FG001|Overall Study|Withdrawal by Subject|2|||
44369131|NCT00992394|79374470|FG000|Overall Study|Physician Decision|1|||
44369132|NCT00992394|79374471|FG001|Overall Study|Physician Decision|0|||
44369133|NCT00992394|79374470|FG000|Overall Study|Protocol Violation|2|||
44369134|NCT00992394|79374471|FG001|Overall Study|Protocol Violation|4|||
44369135|NCT00992394|79374470|FG000|Overall Study|Lost to Follow-up|2|||
44207926|NCT01766037|79004277|FG000|Overall Study|Physician Decision|0|||
44207927|NCT01766037|79004278|FG001|Overall Study|Physician Decision|1|||
44369136|NCT00992394|79374471|FG001|Overall Study|Lost to Follow-up|0|||
44369137|NCT00992394|79374470|FG000|Overall Study|Other event|1|||
44369138|NCT00992394|79374471|FG001|Overall Study|Other event|0|||
44369139|NCT00829933|79374481|FG000|Overall Study|Adverse Event|2|||
44369140|NCT00829933|79374482|FG001|Overall Study|Adverse Event|3|||
44369141|NCT00829933|79374483|FG002|Overall Study|Adverse Event|2|||
44369142|NCT00829933|79374484|FG003|Overall Study|Adverse Event|1|||
44369143|NCT00829933|79374481|FG000|Overall Study|Death|0|||
44369144|NCT00829933|79374482|FG001|Overall Study|Death|0|||
44207928|NCT01766037|79004277|FG000|Overall Study|Withdrawal by Subject|18|||
44207929|NCT01766037|79004278|FG001|Overall Study|Withdrawal by Subject|16|||
44207930|NCT01766037|79004277|FG000|Overall Study|Moved from area|5|||
44207931|NCT01766037|79004278|FG001|Overall Study|Moved from area|0|||
44207932|NCT01766037|79004277|FG000|Overall Study|medical - unrelated|1|||
44207933|NCT01766037|79004278|FG001|Overall Study|medical - unrelated|2|||
44207934|NCT01766037|79004277|FG000|Overall Study|nausea / discomfort|3|||
44207935|NCT01766037|79004278|FG001|Overall Study|nausea / discomfort|0|||
44207936|NCT01765569|79004284|FG000|Period B|Withdrawal by Subject|1|||
44207937|NCT01765569|79004284|FG000|Period C|Death|1|||
44207938|NCT01609257|79004293|FG000|Overall Study|Lost to Follow-up|2|||
44207939|NCT01609257|79004294|FG001|Overall Study|Lost to Follow-up|1|||
44207940|NCT01609257|79004293|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
44207941|NCT01609257|79004294|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
44207942|NCT01609257|79004293|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
44207943|NCT01609257|79004294|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
44207944|NCT01609023|79004303|FG000|Overall Study|Lack of Efficacy|3|||
44207945|NCT01609023|79004303|FG000|Overall Study|Withdrawal by Subject|4|||
44207946|NCT01609023|79004303|FG000|Overall Study|Lost to Follow-up|8|||
44207947|NCT01609023|79004303|FG000|Overall Study|Toxicity|3|||
44207948|NCT01609023|79004303|FG000|Overall Study|Disease progression|10|||
44207949|NCT01609023|79004303|FG000|Overall Study|Physician Decision|2|||
44207950|NCT01609023|79004303|FG000|Overall Study|Death|2|||
44207951|NCT01609023|79004303|FG000|Overall Study|Personal reasons|1|||
44207952|NCT01765179|79004307|FG000|Overall Study|Adverse Event|3|||
44207953|NCT01765179|79004307|FG000|Overall Study|Lost to Follow-up|5|||
44207954|NCT01765179|79004307|FG000|Overall Study|Non-compliance with study drug|2|||
44207955|NCT01765179|79004307|FG000|Overall Study|Protocol Violation|1|||
44207956|NCT01765179|79004307|FG000|Overall Study|Withdrawal by Subject|8|||
44207957|NCT01765179|79004307|FG000|Overall Study|Hematocrit >54%|3|||
44207958|NCT01765179|79004307|FG000|Overall Study|prohibited med|1|||
44207959|NCT01765179|79004307|FG000|Overall Study|Out of country unable to finish study|1|||
44207960|NCT01765179|79004307|FG000|Overall Study|lack of venous access|1|||
44207961|NCT01765179|79004307|FG000|Overall Study|work conflict|1|||
44207962|NCT01765179|79004307|FG000|Overall Study|Ca elevated 10.6|1|||
44207963|NCT01764945|79004319|FG000|Overall Study|Adverse Event|0|||
44207964|NCT01764945|79004320|FG001|Overall Study|Adverse Event|1|||
44207965|NCT01764945|79004321|FG002|Overall Study|Adverse Event|0|||
44207966|NCT01764945|79004322|FG003|Overall Study|Adverse Event|0|||
44207967|NCT01764945|79004323|FG004|Overall Study|Adverse Event|0|||
44207968|NCT01764945|79004324|FG005|Overall Study|Adverse Event|0|||
44207969|NCT01764945|79004325|FG006|Overall Study|Adverse Event|1|||
44207970|NCT01764945|79004326|FG007|Overall Study|Adverse Event|0|||
44207971|NCT01793883|79004347|FG000|Overall Study|Withdrawal by Subject|3|||
44207972|NCT01793883|79004348|FG001|Overall Study|Withdrawal by Subject|7|||
44369145|NCT00829933|79374483|FG002|Overall Study|Death|1|||
44207973|NCT01793883|79004349|FG002|Overall Study|Withdrawal by Subject|3|||
44207974|NCT01793883|79004347|FG000|Overall Study|Subject noncompliance|0|||
44207975|NCT01793883|79004348|FG001|Overall Study|Subject noncompliance|1|||
44207976|NCT01793883|79004349|FG002|Overall Study|Subject noncompliance|1|||
44207977|NCT01793883|79004347|FG000|Overall Study|Lost to Follow-up|5|||
44207978|NCT01793883|79004348|FG001|Overall Study|Lost to Follow-up|1|||
44207979|NCT01793883|79004349|FG002|Overall Study|Lost to Follow-up|3|||
44207980|NCT01793883|79004347|FG000|Overall Study|Randomized in error|1|||
44207981|NCT01793883|79004348|FG001|Overall Study|Randomized in error|0|||
44207982|NCT01793883|79004349|FG002|Overall Study|Randomized in error|0|||
44207983|NCT01793883|79004347|FG000|Overall Study|Unable to complete spriometry|1|||
44207984|NCT01793883|79004348|FG001|Overall Study|Unable to complete spriometry|0|||
44207985|NCT01793883|79004349|FG002|Overall Study|Unable to complete spriometry|0|||
44207986|NCT01793883|79004347|FG000|Overall Study|Unable to complete measurements|1|||
44369146|NCT00829933|79374484|FG003|Overall Study|Death|1|||
44369147|NCT00829933|79374481|FG000|Overall Study|Lack of Efficacy|0|||
44369148|NCT00829933|79374482|FG001|Overall Study|Lack of Efficacy|1|||
44369149|NCT00829933|79374483|FG002|Overall Study|Lack of Efficacy|0|||
44207987|NCT01793883|79004348|FG001|Overall Study|Unable to complete measurements|0|||
44207988|NCT01793883|79004349|FG002|Overall Study|Unable to complete measurements|0|||
44207989|NCT01793883|79004347|FG000|Overall Study|Met exclusion criteria|1|||
44207990|NCT01793883|79004348|FG001|Overall Study|Met exclusion criteria|0|||
44207991|NCT01793883|79004349|FG002|Overall Study|Met exclusion criteria|0|||
44207992|NCT01793883|79004347|FG000|Overall Study|Dosing error|0|||
44207993|NCT01793883|79004348|FG001|Overall Study|Dosing error|1|||
44207994|NCT01793883|79004349|FG002|Overall Study|Dosing error|0|||
44369150|NCT00829933|79374484|FG003|Overall Study|Lack of Efficacy|0|||
44207995|NCT01793883|79004347|FG000|Overall Study|Respiratory distress during spirometry|0|||
44207996|NCT01793883|79004348|FG001|Overall Study|Respiratory distress during spirometry|0|||
44207997|NCT01793883|79004349|FG002|Overall Study|Respiratory distress during spirometry|1|||
44207998|NCT01792635|79004360|FG000|Part B|Adverse Event|0|||
44207999|NCT01792635|79004361|FG001|Part B|Adverse Event|0|||
44208000|NCT01792635|79004362|FG002|Part B|Adverse Event|1|||
44208001|NCT01792635|79004360|FG000|Part B|Study terminated|0|||
44208002|NCT01792635|79004361|FG001|Part B|Study terminated|4|||
44208003|NCT01792635|79004362|FG002|Part B|Study terminated|3|||
44208004|NCT01953692|79004380|FG000|Overall Study|Adverse Event|5|||
44208005|NCT01953692|79004381|FG001|Overall Study|Adverse Event|2|||
44208006|NCT01953692|79004382|FG002|Overall Study|Adverse Event|4|||
44208007|NCT01953692|79004383|FG003|Overall Study|Adverse Event|2|||
44369151|NCT00829933|79374481|FG000|Overall Study|Physician Decision|5|||
44369152|NCT00829933|79374482|FG001|Overall Study|Physician Decision|7|||
44369153|NCT00829933|79374483|FG002|Overall Study|Physician Decision|8|||
44369154|NCT00829933|79374484|FG003|Overall Study|Physician Decision|1|||
44369155|NCT00829933|79374481|FG000|Overall Study|Pregnancy|0|||
44369156|NCT00829933|79374482|FG001|Overall Study|Pregnancy|0|||
44369157|NCT00829933|79374483|FG002|Overall Study|Pregnancy|0|||
44369158|NCT00829933|79374484|FG003|Overall Study|Pregnancy|2|||
44369159|NCT00829933|79374481|FG000|Overall Study|Protocol Violation|2|||
44369160|NCT00829933|79374482|FG001|Overall Study|Protocol Violation|1|||
44369161|NCT00829933|79374483|FG002|Overall Study|Protocol Violation|0|||
44369162|NCT00829933|79374484|FG003|Overall Study|Protocol Violation|0|||
44369163|NCT00829933|79374481|FG000|Overall Study|withdrew before treatment started|5|||
44369164|NCT00829933|79374482|FG001|Overall Study|withdrew before treatment started|1|||
44369165|NCT00829933|79374483|FG002|Overall Study|withdrew before treatment started|2|||
44369166|NCT00829933|79374484|FG003|Overall Study|withdrew before treatment started|9|||
44369167|NCT01170962|79374497|FG000|Treatment Period|Lack of Efficacy|96|||
44369168|NCT01170962|79374498|FG001|Treatment Period|Lack of Efficacy|91|||
44369169|NCT01170962|79374499|FG002|Treatment Period|Lack of Efficacy|7|||
44369170|NCT01170962|79374497|FG000|Treatment Period|Adverse Event|11|||
44369171|NCT01170962|79374498|FG001|Treatment Period|Adverse Event|12|||
44369172|NCT01170962|79374499|FG002|Treatment Period|Adverse Event|3|||
44369173|NCT01170962|79374497|FG000|Treatment Period|Withdrawal by Subject|2|||
44369174|NCT01170962|79374498|FG001|Treatment Period|Withdrawal by Subject|1|||
44369175|NCT01170962|79374499|FG002|Treatment Period|Withdrawal by Subject|0|||
44369176|NCT01170962|79374497|FG000|Treatment Period|Lost to Follow-up|1|||
44369177|NCT01170962|79374498|FG001|Treatment Period|Lost to Follow-up|1|||
44369178|NCT01170962|79374499|FG002|Treatment Period|Lost to Follow-up|1|||
44369179|NCT01170962|79374497|FG000|Treatment Period|Participant no longer meets criteria|0|||
44369180|NCT01170962|79374498|FG001|Treatment Period|Participant no longer meets criteria|1|||
44369181|NCT01170962|79374499|FG002|Treatment Period|Participant no longer meets criteria|0|||
44369182|NCT01170962|79374497|FG000|Treatment Period|Request to discontinue treatment|7|||
44369183|NCT01170962|79374498|FG001|Treatment Period|Request to discontinue treatment|3|||
44369184|NCT01170962|79374499|FG002|Treatment Period|Request to discontinue treatment|1|||
44369185|NCT01170962|79374497|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
44369186|NCT01170962|79374498|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
44369187|NCT01170962|79374499|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
44208008|NCT01953692|79004384|FG004|Overall Study|Adverse Event|1|||
44208009|NCT01953692|79004385|FG005|Overall Study|Adverse Event|2|||
44208010|NCT01953692|79004386|FG006|Overall Study|Adverse Event|0|||
44208011|NCT01953692|79004387|FG007|Overall Study|Adverse Event|0|||
44208012|NCT01953692|79004388|FG008|Overall Study|Adverse Event|0|||
44369188|NCT01170962|79374497|FG000|Follow up Period|Withdrawal by Subject|14|||
44369189|NCT01170962|79374498|FG001|Follow up Period|Withdrawal by Subject|10|||
44369190|NCT01170962|79374499|FG002|Follow up Period|Withdrawal by Subject|2|||
44369191|NCT01170962|79374497|FG000|Follow up Period|Lost to Follow-up|13|||
44369192|NCT01170962|79374498|FG001|Follow up Period|Lost to Follow-up|8|||
44208013|NCT01953692|79004380|FG000|Overall Study|Clinical Progression|0|||
44208014|NCT01953692|79004381|FG001|Overall Study|Clinical Progression|15|||
44208015|NCT01953692|79004382|FG002|Overall Study|Clinical Progression|7|||
44369193|NCT01170962|79374499|FG002|Follow up Period|Lost to Follow-up|1|||
44369194|NCT01170962|79374497|FG000|Follow up Period|Death|2|||
44369195|NCT01170962|79374498|FG001|Follow up Period|Death|2|||
44369196|NCT01170962|79374499|FG002|Follow up Period|Death|0|||
44208016|NCT01953692|79004383|FG003|Overall Study|Clinical Progression|5|||
44208017|NCT01953692|79004384|FG004|Overall Study|Clinical Progression|0|||
44208018|NCT01953692|79004385|FG005|Overall Study|Clinical Progression|7|||
44208019|NCT01953692|79004386|FG006|Overall Study|Clinical Progression|20|||
44208020|NCT01953692|79004387|FG007|Overall Study|Clinical Progression|3|||
44208021|NCT01953692|79004388|FG008|Overall Study|Clinical Progression|3|||
44208022|NCT01953692|79004380|FG000|Overall Study|Death|5|||
44208023|NCT01953692|79004381|FG001|Overall Study|Death|0|||
44369197|NCT01170962|79374497|FG000|Follow up Period|Others|10|||
44369198|NCT01170962|79374498|FG001|Follow up Period|Others|7|||
44369199|NCT01170962|79374499|FG002|Follow up Period|Others|3|||
44208024|NCT01953692|79004382|FG002|Overall Study|Death|2|||
44208025|NCT01953692|79004383|FG003|Overall Study|Death|2|||
44208026|NCT01953692|79004384|FG004|Overall Study|Death|1|||
44208027|NCT01953692|79004385|FG005|Overall Study|Death|3|||
44208028|NCT01953692|79004386|FG006|Overall Study|Death|6|||
44208029|NCT01953692|79004387|FG007|Overall Study|Death|2|||
44208030|NCT01953692|79004388|FG008|Overall Study|Death|1|||
44208031|NCT01953692|79004380|FG000|Overall Study|Excluded Medication|1|||
44208032|NCT01953692|79004381|FG001|Overall Study|Excluded Medication|0|||
44208033|NCT01953692|79004382|FG002|Overall Study|Excluded Medication|0|||
44208034|NCT01953692|79004383|FG003|Overall Study|Excluded Medication|0|||
44208035|NCT01953692|79004384|FG004|Overall Study|Excluded Medication|0|||
44208036|NCT01953692|79004385|FG005|Overall Study|Excluded Medication|0|||
44208037|NCT01953692|79004386|FG006|Overall Study|Excluded Medication|0|||
44208038|NCT01953692|79004387|FG007|Overall Study|Excluded Medication|0|||
44208039|NCT01953692|79004388|FG008|Overall Study|Excluded Medication|0|||
44208040|NCT01953692|79004380|FG000|Overall Study|Lost to Follow-up|1|||
44208041|NCT01953692|79004381|FG001|Overall Study|Lost to Follow-up|0|||
44208042|NCT01953692|79004382|FG002|Overall Study|Lost to Follow-up|3|||
44208043|NCT01953692|79004383|FG003|Overall Study|Lost to Follow-up|1|||
44208044|NCT01953692|79004384|FG004|Overall Study|Lost to Follow-up|0|||
44208045|NCT01953692|79004385|FG005|Overall Study|Lost to Follow-up|1|||
44208046|NCT01953692|79004386|FG006|Overall Study|Lost to Follow-up|0|||
44208047|NCT01953692|79004387|FG007|Overall Study|Lost to Follow-up|0|||
44208048|NCT01953692|79004388|FG008|Overall Study|Lost to Follow-up|0|||
44208049|NCT01953692|79004380|FG000|Overall Study|Physician Decision|11|||
44208050|NCT01953692|79004381|FG001|Overall Study|Physician Decision|4|||
44369200|NCT00843193|79374518|FG000|Overall Study|Adverse Event|2|||
44369201|NCT00843193|79374519|FG001|Overall Study|Adverse Event|4|||
44369202|NCT00843193|79374518|FG000|Overall Study|Lack of Efficacy|1|||
44369203|NCT00843193|79374519|FG001|Overall Study|Lack of Efficacy|1|||
44369204|NCT00843193|79374518|FG000|Overall Study|Protocol Violation|1|||
44369205|NCT00843193|79374519|FG001|Overall Study|Protocol Violation|2|||
44369206|NCT00843193|79374518|FG000|Overall Study|Lost to Follow-up|1|||
44369207|NCT00843193|79374519|FG001|Overall Study|Lost to Follow-up|0|||
44369208|NCT00843193|79374518|FG000|Overall Study|Physician Decision|0|||
44369209|NCT00843193|79374519|FG001|Overall Study|Physician Decision|1|||
44369210|NCT00843193|79374518|FG000|Overall Study|Withdrawal by Subject|3|||
44369211|NCT00843193|79374519|FG001|Overall Study|Withdrawal by Subject|3|||
44369212|NCT00829621|79374528|FG000|Overall Study|Death|1|||
44369213|NCT00829621|79374529|FG001|Overall Study|Death|0|||
44369214|NCT00829621|79374528|FG000|Overall Study|Lost to Follow-up|3|||
44369215|NCT00829621|79374529|FG001|Overall Study|Lost to Follow-up|4|||
44369216|NCT01157078|79374537|FG000|Overall Study|Withdrawal by Subject|12|||
44369217|NCT01157078|79374538|FG001|Overall Study|Withdrawal by Subject|14|||
44369218|NCT01157078|79374537|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44369219|NCT01157078|79374538|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44369220|NCT01157078|79374537|FG000|Overall Study|Adverse Event|6|||
44369221|NCT01157078|79374538|FG001|Overall Study|Adverse Event|6|||
44369222|NCT01157078|79374537|FG000|Overall Study|Severe non-compliance to protocol|2|||
44369223|NCT01157078|79374538|FG001|Overall Study|Severe non-compliance to protocol|4|||
44369224|NCT01157078|79374537|FG000|Overall Study|Condition under investigation worsened|0|||
44369225|NCT01157078|79374538|FG001|Overall Study|Condition under investigation worsened|1|||
44369226|NCT01157078|79374537|FG000|Overall Study|Lack of Efficacy|2|||
44208051|NCT01953692|79004382|FG002|Overall Study|Physician Decision|2|||
44208052|NCT01953692|79004383|FG003|Overall Study|Physician Decision|2|||
44208053|NCT01953692|79004384|FG004|Overall Study|Physician Decision|1|||
44208054|NCT01953692|79004385|FG005|Overall Study|Physician Decision|2|||
44208055|NCT01953692|79004386|FG006|Overall Study|Physician Decision|4|||
44208056|NCT01953692|79004387|FG007|Overall Study|Physician Decision|1|||
44369227|NCT01157078|79374538|FG001|Overall Study|Lack of Efficacy|0|||
44369228|NCT01157078|79374537|FG000|Overall Study|Study-specific withdrawal criteria|2|||
44369229|NCT01157078|79374538|FG001|Overall Study|Study-specific withdrawal criteria|2|||
44369230|NCT01157078|79374537|FG000|Overall Study|Lost to Follow-up|7|||
44369231|NCT01157078|79374538|FG001|Overall Study|Lost to Follow-up|5|||
44208057|NCT01953692|79004388|FG008|Overall Study|Physician Decision|0|||
44208058|NCT01953692|79004380|FG000|Overall Study|Protocol Violation|0|||
44208059|NCT01953692|79004381|FG001|Overall Study|Protocol Violation|2|||
44208060|NCT01953692|79004382|FG002|Overall Study|Protocol Violation|1|||
44208061|NCT01953692|79004383|FG003|Overall Study|Protocol Violation|0|||
44208062|NCT01953692|79004384|FG004|Overall Study|Protocol Violation|0|||
44208063|NCT01953692|79004385|FG005|Overall Study|Protocol Violation|0|||
44208064|NCT01953692|79004386|FG006|Overall Study|Protocol Violation|0|||
44208065|NCT01953692|79004387|FG007|Overall Study|Protocol Violation|1|||
44208066|NCT01953692|79004388|FG008|Overall Study|Protocol Violation|0|||
44208067|NCT01953692|79004380|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208068|NCT01953692|79004381|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208069|NCT01953692|79004382|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208070|NCT01953692|79004383|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208071|NCT01953692|79004384|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208072|NCT01953692|79004385|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208073|NCT01953692|79004386|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208074|NCT01953692|79004387|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
44208075|NCT01953692|79004388|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
44208076|NCT01953692|79004380|FG000|Overall Study|Withdrawal by Subject|4|||
44208077|NCT01953692|79004381|FG001|Overall Study|Withdrawal by Subject|2|||
44208078|NCT01953692|79004382|FG002|Overall Study|Withdrawal by Subject|1|||
44208079|NCT01953692|79004383|FG003|Overall Study|Withdrawal by Subject|2|||
44208080|NCT01953692|79004384|FG004|Overall Study|Withdrawal by Subject|0|||
44208081|NCT01953692|79004385|FG005|Overall Study|Withdrawal by Subject|3|||
44208082|NCT01953692|79004386|FG006|Overall Study|Withdrawal by Subject|2|||
44208083|NCT01953692|79004387|FG007|Overall Study|Withdrawal by Subject|1|||
44208084|NCT01953692|79004388|FG008|Overall Study|Withdrawal by Subject|1|||
44208085|NCT01791153|79004422|FG000|Part 1: Blinded Period|Adverse Event|7|||
44208086|NCT01791153|79004423|FG001|Part 1: Blinded Period|Adverse Event|3|||
44208087|NCT01791153|79004424|FG002|Part 1: Blinded Period|Adverse Event|2|||
44208088|NCT01791153|79004425|FG003|Part 1: Blinded Period|Adverse Event|0|||
44208089|NCT01791153|79004426|FG004|Part 1: Blinded Period|Adverse Event|0|||
44208090|NCT01791153|79004427|FG005|Part 1: Blinded Period|Adverse Event|0|||
44208091|NCT01791153|79004428|FG006|Part 1: Blinded Period|Adverse Event|0|||
44208092|NCT01791153|79004429|FG007|Part 1: Blinded Period|Adverse Event|0|||
44208093|NCT01791153|79004422|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
44208094|NCT01791153|79004423|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
44208095|NCT01791153|79004424|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
44208096|NCT01791153|79004425|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
44208097|NCT01791153|79004426|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
44208098|NCT01791153|79004427|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
44208099|NCT01791153|79004428|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
44208100|NCT01791153|79004429|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
44208101|NCT01791153|79004422|FG000|Part 1: Blinded Period|Non-Compliance|1|||
44208102|NCT01791153|79004423|FG001|Part 1: Blinded Period|Non-Compliance|0|||
44208103|NCT01791153|79004424|FG002|Part 1: Blinded Period|Non-Compliance|0|||
44208104|NCT01791153|79004425|FG003|Part 1: Blinded Period|Non-Compliance|0|||
44208105|NCT01791153|79004426|FG004|Part 1: Blinded Period|Non-Compliance|0|||
44208106|NCT01791153|79004427|FG005|Part 1: Blinded Period|Non-Compliance|0|||
44208107|NCT01791153|79004428|FG006|Part 1: Blinded Period|Non-Compliance|0|||
44208108|NCT01791153|79004429|FG007|Part 1: Blinded Period|Non-Compliance|0|||
44208109|NCT01791153|79004422|FG000|Part 1: Blinded Period|Physician Decision|0|||
44208110|NCT01791153|79004423|FG001|Part 1: Blinded Period|Physician Decision|0|||
44208111|NCT01791153|79004424|FG002|Part 1: Blinded Period|Physician Decision|0|||
44208112|NCT01791153|79004425|FG003|Part 1: Blinded Period|Physician Decision|1|||
44208113|NCT01791153|79004426|FG004|Part 1: Blinded Period|Physician Decision|0|||
44208114|NCT01791153|79004427|FG005|Part 1: Blinded Period|Physician Decision|0|||
44369232|NCT01157078|79374537|FG000|Overall Study|Other|2|||
44369233|NCT01157078|79374538|FG001|Overall Study|Other|4|||
44369234|NCT00591721|79374546|FG000|Overall Study|Withdrawal by Subject|10|||
44208115|NCT01791153|79004428|FG006|Part 1: Blinded Period|Physician Decision|0|||
44208116|NCT01791153|79004429|FG007|Part 1: Blinded Period|Physician Decision|0|||
44208117|NCT01791153|79004422|FG000|Part 1: Blinded Period|Protocol Violation|0|||
44208118|NCT01791153|79004423|FG001|Part 1: Blinded Period|Protocol Violation|0|||
44208119|NCT01791153|79004424|FG002|Part 1: Blinded Period|Protocol Violation|0|||
44208120|NCT01791153|79004425|FG003|Part 1: Blinded Period|Protocol Violation|1|||
44208121|NCT01791153|79004426|FG004|Part 1: Blinded Period|Protocol Violation|0|||
44208122|NCT01791153|79004427|FG005|Part 1: Blinded Period|Protocol Violation|0|||
44269680|NCT02332824|79194243|FG002|Overall Study|Transfer|1|||
44208123|NCT01791153|79004428|FG006|Part 1: Blinded Period|Protocol Violation|0|||
44269681|NCT02332824|79194244|FG003|Overall Study|Transfer|1|||
44269682|NCT02332824|79194245|FG004|Overall Study|Transfer|0|||
44269683|NCT02332824|79194246|FG005|Overall Study|Transfer|0|||
44269684|NCT00556712|79194393|FG000|Overall Study|Adverse Event|7|||
44269685|NCT00556712|79194394|FG001|Overall Study|Adverse Event|19|||
44269686|NCT00556712|79194393|FG000|Overall Study|Death|5|||
44269687|NCT00556712|79194394|FG001|Overall Study|Death|10|||
44269688|NCT00556712|79194393|FG000|Overall Study|Progressive Disease|383|||
44269689|NCT00556712|79194394|FG001|Overall Study|Progressive Disease|320|||
44269690|NCT00556712|79194393|FG000|Overall Study|Protocol Violation|3|||
44269691|NCT00556712|79194394|FG001|Overall Study|Protocol Violation|2|||
44208124|NCT01791153|79004429|FG007|Part 1: Blinded Period|Protocol Violation|0|||
44208125|NCT01791153|79004422|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
44208126|NCT01791153|79004423|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
44208127|NCT01791153|79004424|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
44208128|NCT01791153|79004425|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
44208129|NCT01791153|79004426|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
44208130|NCT01791153|79004427|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
44208131|NCT01791153|79004428|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
44208132|NCT01791153|79004429|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
44208133|NCT01791153|79004422|FG000|Part 2: Open-label Period|Adverse Event|0|||
44208134|NCT01791153|79004423|FG001|Part 2: Open-label Period|Adverse Event|0|||
44208135|NCT01791153|79004424|FG002|Part 2: Open-label Period|Adverse Event|0|||
44208136|NCT01791153|79004425|FG003|Part 2: Open-label Period|Adverse Event|0|||
44208137|NCT01791153|79004426|FG004|Part 2: Open-label Period|Adverse Event|0|||
44208138|NCT01791153|79004427|FG005|Part 2: Open-label Period|Adverse Event|1|||
44208139|NCT01791153|79004428|FG006|Part 2: Open-label Period|Adverse Event|1|||
44208140|NCT01791153|79004429|FG007|Part 2: Open-label Period|Adverse Event|2|||
44208141|NCT01791153|79004422|FG000|Part 2: Open-label Period|Death|0|||
44208142|NCT01791153|79004423|FG001|Part 2: Open-label Period|Death|0|||
44208143|NCT01791153|79004424|FG002|Part 2: Open-label Period|Death|0|||
44208144|NCT01791153|79004425|FG003|Part 2: Open-label Period|Death|0|||
44208145|NCT01791153|79004426|FG004|Part 2: Open-label Period|Death|0|||
44208146|NCT01791153|79004427|FG005|Part 2: Open-label Period|Death|1|||
44208147|NCT01791153|79004428|FG006|Part 2: Open-label Period|Death|1|||
44208148|NCT01791153|79004429|FG007|Part 2: Open-label Period|Death|1|||
44208149|NCT01791153|79004422|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
44208150|NCT01791153|79004423|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
44208151|NCT01791153|79004424|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
44208152|NCT01791153|79004425|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
44208153|NCT01791153|79004426|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
44208154|NCT01791153|79004427|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
44208155|NCT01791153|79004428|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
44208156|NCT01791153|79004429|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
44208157|NCT01791153|79004422|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
44208158|NCT01791153|79004423|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
44208159|NCT01791153|79004424|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
44208160|NCT01791153|79004425|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
44208161|NCT01791153|79004426|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
44208162|NCT01791153|79004427|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
44208163|NCT01791153|79004428|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
44208164|NCT01791153|79004429|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
44208165|NCT01791153|79004422|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
44208166|NCT01791153|79004423|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
44208167|NCT01791153|79004424|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
44208168|NCT01791153|79004425|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
44208169|NCT01791153|79004426|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
44208170|NCT01791153|79004427|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
44269692|NCT00556712|79194393|FG000|Overall Study|Refused Treatment|17|||
44269693|NCT00556712|79194394|FG001|Overall Study|Refused Treatment|16|||
44269694|NCT00556712|79194393|FG000|Overall Study|Failure to Return|2|||
44269695|NCT00556712|79194394|FG001|Overall Study|Failure to Return|3|||
44208171|NCT01791153|79004428|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
44269696|NCT00556712|79194393|FG000|Overall Study|Other|2|||
44543512|NCT02956057|79556565|FG000|Overall Study|Discontinued intervention|14|||
44208172|NCT01791153|79004429|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
44208173|NCT01791153|79004422|FG000|Part 2: Open-label Period|Physician Decision|0|||
44208174|NCT01791153|79004423|FG001|Part 2: Open-label Period|Physician Decision|0|||
44208175|NCT01791153|79004424|FG002|Part 2: Open-label Period|Physician Decision|0|||
44208176|NCT01791153|79004425|FG003|Part 2: Open-label Period|Physician Decision|0|||
44208177|NCT01791153|79004426|FG004|Part 2: Open-label Period|Physician Decision|1|||
44208178|NCT01791153|79004427|FG005|Part 2: Open-label Period|Physician Decision|1|||
44269697|NCT00556712|79194394|FG001|Overall Study|Other|2|||
44269698|NCT00556712|79194393|FG000|Overall Study|Ongoing at Data Cutoff|32|||
44543513|NCT02956057|79556566|FG001|Overall Study|Discontinued intervention|10|||
44208179|NCT01791153|79004428|FG006|Part 2: Open-label Period|Physician Decision|0|||
44208180|NCT01791153|79004429|FG007|Part 2: Open-label Period|Physician Decision|0|||
44208181|NCT01926782|79004450|FG000|Overall Study|Participant moved|2|||
44208182|NCT01926782|79004451|FG001|Overall Study|Participant moved|0|||
44208183|NCT01926782|79004452|FG002|Overall Study|Participant moved|1|||
44208184|NCT01926782|79004453|FG003|Overall Study|Participant moved|1|||
44208185|NCT01926782|79004454|FG004|Overall Study|Participant moved|0|||
44208186|NCT01926782|79004455|FG005|Overall Study|Participant moved|3|||
44208187|NCT01926782|79004450|FG000|Overall Study|Physician Decision|0|||
44208188|NCT01926782|79004451|FG001|Overall Study|Physician Decision|2|||
44208189|NCT01926782|79004452|FG002|Overall Study|Physician Decision|1|||
44208190|NCT01926782|79004453|FG003|Overall Study|Physician Decision|1|||
44208191|NCT01926782|79004454|FG004|Overall Study|Physician Decision|0|||
44369235|NCT00591721|79374547|FG001|Overall Study|Withdrawal by Subject|10|||
44369236|NCT00591721|79374546|FG000|Overall Study|Lost to Follow-up|1|||
44369237|NCT00591721|79374547|FG001|Overall Study|Lost to Follow-up|4|||
44369238|NCT00591721|79374546|FG000|Overall Study|Intervention not received|10|||
44369239|NCT00591721|79374547|FG001|Overall Study|Intervention not received|8|||
44208192|NCT01926782|79004455|FG005|Overall Study|Physician Decision|0|||
44208193|NCT01926782|79004450|FG000|Overall Study|Other than specified|2|||
44208194|NCT01926782|79004451|FG001|Overall Study|Other than specified|3|||
44208195|NCT01926782|79004452|FG002|Overall Study|Other than specified|5|||
44208196|NCT01926782|79004453|FG003|Overall Study|Other than specified|12|||
44369240|NCT01156844|79374557|FG000|Overall Study|Adverse Event|0|||
44369241|NCT01156844|79374558|FG001|Overall Study|Adverse Event|0|||
44369242|NCT01156844|79374559|FG002|Overall Study|Adverse Event|1|||
44369243|NCT01156844|79374560|FG003|Overall Study|Adverse Event|1|||
44369244|NCT01156844|79374557|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44369245|NCT01156844|79374558|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44369246|NCT01156844|79374559|FG002|Overall Study|Abnormal test procedure result(s)|2|||
44369247|NCT01156844|79374560|FG003|Overall Study|Abnormal test procedure result(s)|2|||
44369248|NCT01156844|79374557|FG000|Overall Study|Withdrawal by Subject|0|||
44208197|NCT01926782|79004454|FG004|Overall Study|Other than specified|4|||
44208198|NCT01926782|79004455|FG005|Overall Study|Other than specified|11|||
44208199|NCT01926782|79004450|FG000|Overall Study|Adverse Event|13|||
44208200|NCT01926782|79004451|FG001|Overall Study|Adverse Event|4|||
44208201|NCT01926782|79004452|FG002|Overall Study|Adverse Event|17|||
44208202|NCT01926782|79004453|FG003|Overall Study|Adverse Event|4|||
44208203|NCT01926782|79004454|FG004|Overall Study|Adverse Event|3|||
44208204|NCT01926782|79004455|FG005|Overall Study|Adverse Event|14|||
44208205|NCT01926782|79004450|FG000|Overall Study|Poor compliance to protocol|5|||
44208206|NCT01926782|79004451|FG001|Overall Study|Poor compliance to protocol|3|||
44208207|NCT01926782|79004452|FG002|Overall Study|Poor compliance to protocol|8|||
44208208|NCT01926782|79004453|FG003|Overall Study|Poor compliance to protocol|0|||
44208209|NCT01926782|79004454|FG004|Overall Study|Poor compliance to protocol|1|||
44208210|NCT01926782|79004455|FG005|Overall Study|Poor compliance to protocol|6|||
44208211|NCT01926782|79004450|FG000|Overall Study|Randomized and not treated|0|||
44208212|NCT01926782|79004451|FG001|Overall Study|Randomized and not treated|0|||
44208213|NCT01926782|79004452|FG002|Overall Study|Randomized and not treated|0|||
44208214|NCT01926782|79004453|FG003|Overall Study|Randomized and not treated|1|||
44208215|NCT01926782|79004454|FG004|Overall Study|Randomized and not treated|0|||
44208216|NCT01926782|79004455|FG005|Overall Study|Randomized and not treated|0|||
44208217|NCT01926782|79004450|FG000|Overall Study|Withdrawal by Subject|6|||
44208218|NCT01926782|79004451|FG001|Overall Study|Withdrawal by Subject|1|||
44208219|NCT01926782|79004452|FG002|Overall Study|Withdrawal by Subject|8|||
44369249|NCT01156844|79374558|FG001|Overall Study|Withdrawal by Subject|0|||
44369250|NCT01156844|79374559|FG002|Overall Study|Withdrawal by Subject|2|||
44369251|NCT01156844|79374560|FG003|Overall Study|Withdrawal by Subject|2|||
44369252|NCT01156844|79374557|FG000|Overall Study|Lost to Follow-up|0|||
44369253|NCT01156844|79374558|FG001|Overall Study|Lost to Follow-up|0|||
44369254|NCT01156844|79374559|FG002|Overall Study|Lost to Follow-up|1|||
44208220|NCT01926782|79004453|FG003|Overall Study|Withdrawal by Subject|1|||
44208221|NCT01926782|79004454|FG004|Overall Study|Withdrawal by Subject|0|||
44208222|NCT01926782|79004455|FG005|Overall Study|Withdrawal by Subject|5|||
44208223|NCT01926782|79004450|FG000|Overall Study|Related to study drug administration|0|||
44208224|NCT01926782|79004451|FG001|Overall Study|Related to study drug administration|0|||
44208225|NCT01926782|79004452|FG002|Overall Study|Related to study drug administration|0|||
44208226|NCT01926782|79004453|FG003|Overall Study|Related to study drug administration|0|||
44369255|NCT01156844|79374560|FG003|Overall Study|Lost to Follow-up|0|||
44369256|NCT01156844|79374557|FG000|Overall Study|Administrative problems|0|||
44369257|NCT01156844|79374558|FG001|Overall Study|Administrative problems|1|||
44208227|NCT01926782|79004454|FG004|Overall Study|Related to study drug administration|0|||
44208228|NCT01926782|79004455|FG005|Overall Study|Related to study drug administration|2|||
44208229|NCT01926626|79004470|FG000|Overall Study|Withdrawal by Subject|15|||
44208230|NCT01926626|79004470|FG000|Overall Study|Lost to Follow-up|7|||
44208231|NCT01953224|79004476|FG000|Overall Study|Lost to Follow-up|1|||
44369258|NCT01156844|79374559|FG002|Overall Study|Administrative problems|0|||
44208232|NCT01953224|79004477|FG001|Overall Study|Lost to Follow-up|1|||
44208233|NCT01953224|79004476|FG000|Overall Study|Withdrawal by Subject|1|||
44208234|NCT01953224|79004477|FG001|Overall Study|Withdrawal by Subject|2|||
44269699|NCT00556712|79194394|FG001|Overall Study|Ongoing at Data Cutoff|66|||
44269700|NCT00556322|79194468|FG000|Overall Study|Insufficient therapeutic response|158|||
44369259|NCT01156844|79374560|FG003|Overall Study|Administrative problems|1|||
44208235|NCT01900730|79004485|FG000|Overall Study|Withdrawal by Subject|1|||
44208236|NCT01900730|79004486|FG001|Overall Study|Withdrawal by Subject|0|||
44208237|NCT01900730|79004485|FG000|Overall Study|Screen Failure|1|||
44208238|NCT01900730|79004486|FG001|Overall Study|Screen Failure|0|||
44208239|NCT01952834|79004492|FG000|Overall Study|Adverse Event|1|||
44208240|NCT01952054|79004497|FG000|Overall Study|Physician Decision|1|||
44208241|NCT01925768|79004503|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
44208242|NCT01925768|79004504|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44208243|NCT01925768|79004503|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
44208244|NCT01925768|79004504|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
44208245|NCT01925768|79004503|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
44208246|NCT01925768|79004504|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
44208247|NCT01925768|79004503|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
44208248|NCT01925768|79004504|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
44208249|NCT01925768|79004503|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
44208250|NCT01925768|79004504|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
44208251|NCT01925768|79004503|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
44208252|NCT01925768|79004504|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
44208253|NCT01925768|79004503|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
44208254|NCT01925768|79004504|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
44208255|NCT01925768|79004503|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
44208256|NCT01925768|79004504|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
44208257|NCT01925768|79004503|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
44208258|NCT01925768|79004504|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
44208259|NCT01925768|79004503|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
44208260|NCT01925768|79004504|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
44208261|NCT01925768|79004503|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
44208262|NCT01925768|79004504|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
44208263|NCT01431274|79004519|FG000|Overall Study|Adverse Event|51|||
44208264|NCT01431274|79004520|FG001|Overall Study|Adverse Event|37|||
44208265|NCT01431274|79004521|FG002|Overall Study|Adverse Event|43|||
44208266|NCT01431274|79004522|FG003|Overall Study|Adverse Event|30|||
44208267|NCT01431274|79004523|FG004|Overall Study|Adverse Event|37|||
44208268|NCT01431274|79004519|FG000|Overall Study|Consent withdrawn not due to AE|29|||
44208269|NCT01431274|79004520|FG001|Overall Study|Consent withdrawn not due to AE|20|||
44208270|NCT01431274|79004521|FG002|Overall Study|Consent withdrawn not due to AE|17|||
44208271|NCT01431274|79004522|FG003|Overall Study|Consent withdrawn not due to AE|20|||
44208272|NCT01431274|79004523|FG004|Overall Study|Consent withdrawn not due to AE|11|||
44208273|NCT01431274|79004519|FG000|Overall Study|Non compliant with protocol|5|||
44208274|NCT01431274|79004520|FG001|Overall Study|Non compliant with protocol|8|||
44208275|NCT01431274|79004521|FG002|Overall Study|Non compliant with protocol|4|||
44208276|NCT01431274|79004522|FG003|Overall Study|Non compliant with protocol|4|||
44208277|NCT01431274|79004523|FG004|Overall Study|Non compliant with protocol|4|||
44208278|NCT01431274|79004519|FG000|Overall Study|Lost to Follow-up|6|||
44208279|NCT01431274|79004520|FG001|Overall Study|Lost to Follow-up|7|||
44208280|NCT01431274|79004521|FG002|Overall Study|Lost to Follow-up|1|||
44208281|NCT01431274|79004522|FG003|Overall Study|Lost to Follow-up|4|||
44208282|NCT01431274|79004523|FG004|Overall Study|Lost to Follow-up|0|||
44208283|NCT01431274|79004519|FG000|Overall Study|Other reason not stated above|6|||
44208284|NCT01431274|79004520|FG001|Overall Study|Other reason not stated above|5|||
44208285|NCT01431274|79004521|FG002|Overall Study|Other reason not stated above|7|||
44208286|NCT01431274|79004522|FG003|Overall Study|Other reason not stated above|2|||
44208287|NCT01431274|79004523|FG004|Overall Study|Other reason not stated above|4|||
44208288|NCT01991795|79004537|FG000|Overall Study|Lost to Follow-up|6|||
44369260|NCT01156844|79374557|FG000|Overall Study|Protocol deviation|2|||
44369261|NCT01156844|79374558|FG001|Overall Study|Protocol deviation|0|||
44369262|NCT01156844|79374559|FG002|Overall Study|Protocol deviation|0|||
44369263|NCT01156844|79374560|FG003|Overall Study|Protocol deviation|0|||
44208289|NCT01991795|79004538|FG001|Overall Study|Lost to Follow-up|4|||
44208290|NCT01991795|79004537|FG000|Overall Study|Withdrawal by Subject|117|||
44208291|NCT01991795|79004538|FG001|Overall Study|Withdrawal by Subject|94|||
44208292|NCT01991795|79004537|FG000|Overall Study|Site prematurely closed by sponsor|26|||
44369264|NCT00853021|79374573|FG000|Overall Study|Adverse Event|2|||
44543514|NCT02956057|79556567|FG002|Overall Study|Discontinued intervention|7|||
44208293|NCT01991795|79004538|FG001|Overall Study|Site prematurely closed by sponsor|25|||
44208294|NCT01411852|79004579|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
44208295|NCT01411852|79004580|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
44208296|NCT01411852|79004579|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
44208297|NCT01411852|79004580|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
44208298|NCT01411852|79004579|FG000|Prehospital Intervention Phase|Found to be under age|0|||
44208299|NCT01411852|79004580|FG001|Prehospital Intervention Phase|Found to be under age|1|||
44208300|NCT01411852|79004579|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
44208301|NCT01411852|79004580|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
44208302|NCT01411852|79004579|FG000|Hospital Intervention Phase|Severe head injury|5|||
44208303|NCT01411852|79004580|FG001|Hospital Intervention Phase|Severe head injury|4|||
44208304|NCT01411852|79004579|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
44208305|NCT01411852|79004580|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
44208306|NCT01411852|79004579|FG000|Hospital Intervention Phase|Miscommunication error|1|||
44208307|NCT01411852|79004580|FG001|Hospital Intervention Phase|Miscommunication error|2|||
44208308|NCT01411852|79004579|FG000|Hospital Intervention Phase|CPR administered|3|||
44208309|NCT01411852|79004580|FG001|Hospital Intervention Phase|CPR administered|1|||
44208310|NCT01411852|79004579|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
44208311|NCT01411852|79004580|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
44208312|NCT01411852|79004579|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
44208313|NCT01411852|79004580|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
44208314|NCT01411852|79004579|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
44208315|NCT01411852|79004580|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
44208316|NCT01411852|79004579|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
44208317|NCT01411852|79004580|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
44208318|NCT01411852|79004579|FG000|Hospital Intervention Phase|Other ineligible|2|||
44208319|NCT01411852|79004580|FG001|Hospital Intervention Phase|Other ineligible|2|||
44208320|NCT01411852|79004579|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
44208321|NCT01411852|79004580|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
44208322|NCT01411852|79004579|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
44208323|NCT01411852|79004580|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
44208324|NCT01411852|79004579|FG000|Hospital Intervention Phase|Vascular access failed|1|||
44208325|NCT01411852|79004580|FG001|Hospital Intervention Phase|Vascular access failed|0|||
44208326|NCT01411774|79004590|FG000|Overall Study|Withdrawal by Subject|0|||
44208327|NCT01411774|79004591|FG001|Overall Study|Withdrawal by Subject|3|||
44208328|NCT01411228|79004600|FG000|Overall Study|Lost to Follow-up|0|||
44208329|NCT01411228|79004601|FG001|Overall Study|Lost to Follow-up|0|||
44208330|NCT01411228|79004602|FG002|Overall Study|Lost to Follow-up|1|||
44208331|NCT01411228|79004600|FG000|Overall Study|Withdrawal by Subject|1|||
44208332|NCT01411228|79004601|FG001|Overall Study|Withdrawal by Subject|0|||
44208333|NCT01411228|79004602|FG002|Overall Study|Withdrawal by Subject|0|||
44208334|NCT01410604|79004612|FG000|Overall Study|Adverse Event|2|||
44208335|NCT01410604|79004613|FG001|Overall Study|Adverse Event|1|||
44208336|NCT01410604|79004612|FG000|Overall Study|Lost to Follow-up|1|||
44208337|NCT01410604|79004613|FG001|Overall Study|Lost to Follow-up|0|||
44208338|NCT01410604|79004612|FG000|Overall Study|Physician Decision|0|||
44208339|NCT01410604|79004613|FG001|Overall Study|Physician Decision|1|||
44208340|NCT01991483|79004623|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
44208341|NCT01991483|79004624|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
44208342|NCT01991483|79004625|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
44208343|NCT01991483|79004626|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
44208344|NCT01991483|79004623|FG000|Dose Level 600 mg|Physician Decision|0|||
44208345|NCT01991483|79004624|FG001|Dose Level 600 mg|Physician Decision|0|||
44208346|NCT01991483|79004625|FG002|Dose Level 600 mg|Physician Decision|1|||
44208347|NCT01991483|79004626|FG003|Dose Level 600 mg|Physician Decision|0|||
44208348|NCT01991483|79004623|FG000|Dose Level 1000 mg|Protocol Violation|0|||
44208349|NCT01991483|79004624|FG001|Dose Level 1000 mg|Protocol Violation|0|||
44208350|NCT01991483|79004625|FG002|Dose Level 1000 mg|Protocol Violation|0|||
44208351|NCT01991483|79004626|FG003|Dose Level 1000 mg|Protocol Violation|1|||
44208352|NCT01410448|79004641|FG000|Overall Study|No conversion to everolimus|0|||
44208353|NCT01410448|79004642|FG001|Overall Study|No conversion to everolimus|24|||
44208354|NCT01410448|79004641|FG000|Overall Study|Graft loss|4|||
44208355|NCT01410448|79004642|FG001|Overall Study|Graft loss|1|||
44208356|NCT01410448|79004641|FG000|Overall Study|Administrative issues|2|||
44208357|NCT01410448|79004642|FG001|Overall Study|Administrative issues|1|||
44208358|NCT01410448|79004641|FG000|Overall Study|Lost to Follow-up|1|||
44208359|NCT01410448|79004642|FG001|Overall Study|Lost to Follow-up|0|||
44208360|NCT01410448|79004641|FG000|Overall Study|Withdrawal by Subject|3|||
44208361|NCT01410448|79004642|FG001|Overall Study|Withdrawal by Subject|2|||
44208362|NCT01410448|79004641|FG000|Overall Study|Protocol Violation|0|||
44208363|NCT01410448|79004642|FG001|Overall Study|Protocol Violation|4|||
44208364|NCT01410448|79004641|FG000|Overall Study|Death|2|||
44208365|NCT01410448|79004642|FG001|Overall Study|Death|3|||
44208366|NCT01943851|79004666|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208367|NCT01943851|79004667|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208368|NCT01943851|79004668|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208369|NCT01943851|79004669|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
44208370|NCT01943851|79004670|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208371|NCT01943851|79004671|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208372|NCT01943851|79004672|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
44208373|NCT01943851|79004673|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
44208374|NCT01943851|79004674|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
44208375|NCT01943851|79004675|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208376|NCT01943851|79004676|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208377|NCT01943851|79004677|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208378|NCT01943851|79004678|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208379|NCT01943851|79004679|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208380|NCT01943851|79004680|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208381|NCT01943851|79004681|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208382|NCT01943851|79004682|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44208383|NCT01943851|79004683|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
44369265|NCT00853021|79374573|FG000|Overall Study|Withdrawal by Subject|2|||
44369266|NCT00853021|79374573|FG000|Overall Study|Death|1|||
44369267|NCT01156532|79374577|FG000|Overall Study|Family Reasons|1|||
44369268|NCT01156532|79374577|FG000|Overall Study|Lost to Follow-up|1|||
44369269|NCT00843115|79374581|FG000|Overall Study|Death|4|||
44369270|NCT00843115|79374581|FG000|Overall Study|Adverse Event|30|||
44369271|NCT00843115|79374581|FG000|Overall Study|Lost to Follow-up|4|||
44369272|NCT00843115|79374581|FG000|Overall Study|Withdrawal by Subject|17|||
44369273|NCT00843115|79374581|FG000|Overall Study|Family wanted meds stopped|1|||
44369274|NCT00843115|79374581|FG000|Overall Study|Family does not want continuation|1|||
44369275|NCT00843115|79374581|FG000|Overall Study|Patient forgot to take meds|1|||
44369276|NCT00843115|79374581|FG000|Overall Study|Does not meet entrance criteria|1|||
44369277|NCT00843115|79374581|FG000|Overall Study|Physician Decision|1|||
44369278|NCT00843115|79374581|FG000|Overall Study|Family discontinued meds|1|||
44369279|NCT00843115|79374581|FG000|Overall Study|patient took for 2 days then stopped|1|||
44369280|NCT00843115|79374581|FG000|Overall Study|patient never took the medication|1|||
44369281|NCT00843115|79374581|FG000|Overall Study|hospitalized due to deterioration|1|||
44369282|NCT00843115|79374581|FG000|Overall Study|week 12 not done|1|||
44369283|NCT00843115|79374581|FG000|Overall Study|Syndrome De Glissement|1|||
44369284|NCT01156376|79374588|FG000|Overall Study|Adverse Event|1|||
44369285|NCT01156376|79374589|FG001|Overall Study|Adverse Event|0|||
44369286|NCT01156376|79374590|FG002|Overall Study|Adverse Event|1|||
44369287|NCT01156376|79374588|FG000|Overall Study|Withdrawal by Subject|0|||
44369288|NCT01156376|79374589|FG001|Overall Study|Withdrawal by Subject|0|||
44369289|NCT01156376|79374590|FG002|Overall Study|Withdrawal by Subject|3|||
44369290|NCT00829387|79374600|FG000|Overall Study|Withdrawal by Subject|2|||
44369291|NCT00829387|79374601|FG001|Overall Study|Withdrawal by Subject|3|||
44369292|NCT00829387|79374600|FG000|Overall Study|Disqualified by PI|1|||
44369293|NCT00829387|79374601|FG001|Overall Study|Disqualified by PI|0|||
44369294|NCT01156142|79374609|FG000|Overall Study|Withdrawal by Subject|8|||
44369295|NCT01156142|79374610|FG001|Overall Study|Withdrawal by Subject|6|||
44369296|NCT01156142|79374609|FG000|Overall Study|Ineligible|0|||
44369297|NCT01156142|79374610|FG001|Overall Study|Ineligible|1|||
44369298|NCT00842257|79374616|FG000|Overall Study|Adverse Event|1|||
44369299|NCT00852475|79374622|FG000|Overall Study|Lost to Follow-up|3|||
44369300|NCT00852475|79374623|FG001|Overall Study|Lost to Follow-up|4|||
44369301|NCT01155284|79374633|FG000|Overall Study|Withdrawal by Subject|4|||
44369302|NCT01155284|79374634|FG001|Overall Study|Withdrawal by Subject|3|||
44369303|NCT01155284|79374633|FG000|Overall Study|Lost to Follow-up|1|||
44208384|NCT01943851|79004666|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208385|NCT01943851|79004667|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208386|NCT01943851|79004668|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208387|NCT01943851|79004669|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208388|NCT01943851|79004670|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
44208389|NCT01943851|79004671|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208390|NCT01943851|79004672|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44369304|NCT01155284|79374634|FG001|Overall Study|Lost to Follow-up|2|||
44369305|NCT01155284|79374633|FG000|Overall Study|Physician Decision|1|||
44543515|NCT02956057|79556568|FG003|Overall Study|Discontinued intervention|14|||
44208391|NCT01943851|79004673|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
44369306|NCT01155284|79374634|FG001|Overall Study|Physician Decision|0|||
44369307|NCT01155284|79374633|FG000|Overall Study|Adverse Event|1|||
44369308|NCT01155284|79374634|FG001|Overall Study|Adverse Event|0|||
44369309|NCT00852397|79374645|FG000|Overall Study|Adverse Event|4|||
44369310|NCT00852397|79374646|FG001|Overall Study|Adverse Event|6|||
44369311|NCT00852397|79374647|FG002|Overall Study|Adverse Event|4|||
44369312|NCT00852397|79374645|FG000|Overall Study|Death|0|||
44208392|NCT01943851|79004674|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208393|NCT01943851|79004675|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208394|NCT01943851|79004676|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208395|NCT01943851|79004677|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208396|NCT01943851|79004678|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208397|NCT01943851|79004679|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208398|NCT01943851|79004680|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208399|NCT01943851|79004681|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208400|NCT01943851|79004682|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208401|NCT01943851|79004683|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
44208402|NCT01943851|79004666|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208403|NCT01943851|79004667|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208404|NCT01943851|79004668|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208405|NCT01943851|79004669|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208406|NCT01943851|79004670|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208407|NCT01943851|79004671|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208408|NCT01943851|79004672|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208409|NCT01943851|79004673|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208410|NCT01943851|79004674|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208411|NCT01943851|79004675|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208412|NCT01943851|79004676|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208413|NCT01943851|79004677|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208414|NCT01943851|79004678|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208415|NCT01943851|79004679|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
44208416|NCT01943851|79004680|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208417|NCT01943851|79004681|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208418|NCT01943851|79004682|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208419|NCT01943851|79004683|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
44208420|NCT01943851|79004666|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208421|NCT01943851|79004667|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208422|NCT01943851|79004668|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208423|NCT01943851|79004669|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208424|NCT01943851|79004670|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208425|NCT01943851|79004671|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208426|NCT01943851|79004672|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208427|NCT01943851|79004673|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208428|NCT01943851|79004674|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208429|NCT01943851|79004675|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208430|NCT01943851|79004676|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208431|NCT01943851|79004677|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208432|NCT01943851|79004678|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208433|NCT01943851|79004679|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208434|NCT01943851|79004680|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208435|NCT01943851|79004681|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
44208436|NCT01943851|79004682|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208437|NCT01943851|79004683|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
44208438|NCT01943851|79004666|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208439|NCT01943851|79004667|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44369313|NCT00852397|79374646|FG001|Overall Study|Death|0|||
44369314|NCT00852397|79374647|FG002|Overall Study|Death|1|||
44369315|NCT00852397|79374645|FG000|Overall Study|Withdrawal by Subject|4|||
44369316|NCT00852397|79374646|FG001|Overall Study|Withdrawal by Subject|1|||
44369317|NCT00852397|79374647|FG002|Overall Study|Withdrawal by Subject|2|||
44369318|NCT00852397|79374645|FG000|Overall Study|Study terminated by sponsor|2|||
44369319|NCT00852397|79374646|FG001|Overall Study|Study terminated by sponsor|1|||
44369320|NCT00852397|79374647|FG002|Overall Study|Study terminated by sponsor|6|||
44369321|NCT00852397|79374645|FG000|Overall Study|Difficulty in study site visit|1|||
44369322|NCT00852397|79374646|FG001|Overall Study|Difficulty in study site visit|0|||
44369323|NCT00852397|79374647|FG002|Overall Study|Difficulty in study site visit|0|||
44208440|NCT01943851|79004668|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208441|NCT01943851|79004669|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44369324|NCT00852397|79374645|FG000|Overall Study|Protocol Violation|0|||
44369325|NCT00852397|79374646|FG001|Overall Study|Protocol Violation|0|||
44369326|NCT00852397|79374647|FG002|Overall Study|Protocol Violation|1|||
44208442|NCT01943851|79004670|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208443|NCT01943851|79004671|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208444|NCT01943851|79004672|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208445|NCT01943851|79004673|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208446|NCT01943851|79004674|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44369327|NCT00841321|79374657|FG000|Overall Study|Lost to Follow-up|1|||
44369328|NCT00841321|79374658|FG001|Overall Study|Lost to Follow-up|1|||
44208447|NCT01943851|79004675|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208448|NCT01943851|79004676|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208449|NCT01943851|79004677|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208450|NCT01943851|79004678|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208451|NCT01943851|79004679|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208452|NCT01943851|79004680|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
44208453|NCT01943851|79004681|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
44208454|NCT01943851|79004682|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
44208455|NCT01943851|79004683|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
44208456|NCT01430104|79004724|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
44208457|NCT01990859|79004731|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
44208458|NCT01990859|79004731|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
44369329|NCT00841321|79374657|FG000|Overall Study|Adverse Event|0|||
44208459|NCT02093897|79004736|FG000|Overall Study|Physician Decision|1|||
44208460|NCT02093897|79004736|FG000|Overall Study|Planned age group closure - no's reached|17|||
44208461|NCT02093897|79004736|FG000|Overall Study|Adverse event, non-fatal|1|||
44369330|NCT00841321|79374658|FG001|Overall Study|Adverse Event|2|||
44369331|NCT00986232|79374670|FG000|Overall Study|Adverse Event|1|||
44369332|NCT00986232|79374671|FG001|Overall Study|Adverse Event|2|||
44369333|NCT00986232|79374672|FG002|Overall Study|Adverse Event|3|||
44369334|NCT00986232|79374673|FG003|Overall Study|Adverse Event|0|||
44369335|NCT00986232|79374670|FG000|Overall Study|Lost to Follow-up|19|||
44369336|NCT00986232|79374671|FG001|Overall Study|Lost to Follow-up|12|||
44369337|NCT00986232|79374672|FG002|Overall Study|Lost to Follow-up|12|||
44369338|NCT00986232|79374673|FG003|Overall Study|Lost to Follow-up|7|||
44369339|NCT00986232|79374670|FG000|Overall Study|Protocol Violation|2|||
44369340|NCT00986232|79374671|FG001|Overall Study|Protocol Violation|3|||
44369341|NCT00986232|79374672|FG002|Overall Study|Protocol Violation|0|||
44369342|NCT00986232|79374673|FG003|Overall Study|Protocol Violation|1|||
44208462|NCT01990313|79004747|FG000|Overall Study|Lost to Follow-up|1|||
44369343|NCT00986232|79374670|FG000|Overall Study|Withdrawal by Subject|13|||
44208463|NCT01947517|79004753|FG000|Overall Study|Withdrawal by Subject|1|||
44208464|NCT01947517|79004754|FG001|Overall Study|Withdrawal by Subject|1|||
44369344|NCT00986232|79374671|FG001|Overall Study|Withdrawal by Subject|16|||
44369345|NCT00986232|79374672|FG002|Overall Study|Withdrawal by Subject|12|||
44208465|NCT02006927|79004760|FG000|Overall Study|Adverse Event|2|||
44208466|NCT02006927|79004760|FG000|Overall Study|Withdrawal by Subject|1|||
44208467|NCT01947283|79004771|FG000|Overall Study|Death|1|||
44208468|NCT01947283|79004772|FG001|Overall Study|Death|1|||
44208469|NCT01947283|79004773|FG002|Overall Study|Death|1|||
44208470|NCT01947283|79004774|FG003|Overall Study|Death|0|||
44208471|NCT01947283|79004775|FG004|Overall Study|Death|0|||
44208472|NCT01947283|79004776|FG005|Overall Study|Death|0|||
44208473|NCT01947283|79004777|FG006|Overall Study|Death|0|||
44208474|NCT01947283|79004771|FG000|Overall Study|Lost to Follow-up|4|||
44208475|NCT01947283|79004772|FG001|Overall Study|Lost to Follow-up|6|||
44208476|NCT01947283|79004773|FG002|Overall Study|Lost to Follow-up|5|||
44208477|NCT01947283|79004774|FG003|Overall Study|Lost to Follow-up|5|||
44208478|NCT01947283|79004775|FG004|Overall Study|Lost to Follow-up|0|||
44208479|NCT01947283|79004776|FG005|Overall Study|Lost to Follow-up|2|||
44208480|NCT01947283|79004777|FG006|Overall Study|Lost to Follow-up|5|||
44208481|NCT01947283|79004771|FG000|Overall Study|Withdrawal by Subject|10|||
44208482|NCT01947283|79004772|FG001|Overall Study|Withdrawal by Subject|8|||
44208483|NCT01947283|79004773|FG002|Overall Study|Withdrawal by Subject|4|||
44208484|NCT01947283|79004774|FG003|Overall Study|Withdrawal by Subject|1|||
44208485|NCT01947283|79004775|FG004|Overall Study|Withdrawal by Subject|0|||
44208486|NCT01947283|79004776|FG005|Overall Study|Withdrawal by Subject|0|||
44208487|NCT01947283|79004777|FG006|Overall Study|Withdrawal by Subject|2|||
44208488|NCT01947283|79004771|FG000|Overall Study|No Clinical Recording|12|||
44208489|NCT01947283|79004772|FG001|Overall Study|No Clinical Recording|6|||
44208490|NCT01947283|79004773|FG002|Overall Study|No Clinical Recording|8|||
44208491|NCT01947283|79004774|FG003|Overall Study|No Clinical Recording|10|||
44208492|NCT01947283|79004775|FG004|Overall Study|No Clinical Recording|0|||
44208493|NCT01947283|79004776|FG005|Overall Study|No Clinical Recording|0|||
44208494|NCT01947283|79004777|FG006|Overall Study|No Clinical Recording|0|||
44208495|NCT01947283|79004771|FG000|Overall Study|Non-coding Clinical Recording language|0|||
44208496|NCT01947283|79004772|FG001|Overall Study|Non-coding Clinical Recording language|0|||
44208497|NCT01947283|79004773|FG002|Overall Study|Non-coding Clinical Recording language|0|||
44208498|NCT01947283|79004774|FG003|Overall Study|Non-coding Clinical Recording language|1|||
44208499|NCT01947283|79004775|FG004|Overall Study|Non-coding Clinical Recording language|0|||
44208500|NCT01947283|79004776|FG005|Overall Study|Non-coding Clinical Recording language|0|||
44208501|NCT01947283|79004777|FG006|Overall Study|Non-coding Clinical Recording language|0|||
44208502|NCT01947283|79004771|FG000|Overall Study|Missing Follow-up Assessment|2|||
44208503|NCT01947283|79004772|FG001|Overall Study|Missing Follow-up Assessment|2|||
44208504|NCT01947283|79004773|FG002|Overall Study|Missing Follow-up Assessment|3|||
44208505|NCT01947283|79004774|FG003|Overall Study|Missing Follow-up Assessment|0|||
44208506|NCT01947283|79004775|FG004|Overall Study|Missing Follow-up Assessment|0|||
44208507|NCT01947283|79004776|FG005|Overall Study|Missing Follow-up Assessment|2|||
44208508|NCT01947283|79004777|FG006|Overall Study|Missing Follow-up Assessment|0|||
44208509|NCT01947283|79004771|FG000|Overall Study|No patients were enrolled in study|0|||
44208510|NCT01947283|79004772|FG001|Overall Study|No patients were enrolled in study|0|||
44208511|NCT01947283|79004773|FG002|Overall Study|No patients were enrolled in study|0|||
44208512|NCT01947283|79004774|FG003|Overall Study|No patients were enrolled in study|0|||
44208513|NCT01947283|79004775|FG004|Overall Study|No patients were enrolled in study|0|||
44208514|NCT01947283|79004776|FG005|Overall Study|No patients were enrolled in study|3|||
44208515|NCT01947283|79004777|FG006|Overall Study|No patients were enrolled in study|1|||
44208516|NCT02006693|79004796|FG000|Overall Study|No Reason Specified|6|||
44208517|NCT02006693|79004797|FG001|Overall Study|No Reason Specified|8|||
44208518|NCT02006693|79004796|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
44208519|NCT02006693|79004797|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
44208520|NCT02006693|79004796|FG000|Overall Study|XEN Implant Explantation|0|||
44208521|NCT02006693|79004797|FG001|Overall Study|XEN Implant Explantation|1|||
44208522|NCT02006693|79004796|FG000|Overall Study|Death|2|||
44208523|NCT02006693|79004797|FG001|Overall Study|Death|2|||
44208524|NCT02006693|79004796|FG000|Overall Study|Lost to Follow-up|4|||
44208525|NCT02006693|79004797|FG001|Overall Study|Lost to Follow-up|1|||
44208526|NCT02006693|79004796|FG000|Overall Study|Patient Decision|4|||
44208527|NCT02006693|79004797|FG001|Overall Study|Patient Decision|0|||
44208528|NCT01947127|79004805|FG000|Overall Study|Protocol Violation|18|||
44208529|NCT01947127|79004806|FG001|Overall Study|Protocol Violation|38|||
44208530|NCT01947127|79004805|FG000|Overall Study|Withdrawal by Subject|1|||
44208531|NCT01947127|79004806|FG001|Overall Study|Withdrawal by Subject|1|||
44208532|NCT01947127|79004805|FG000|Overall Study|Data loss|4|||
44208533|NCT01947127|79004806|FG001|Overall Study|Data loss|4|||
44208534|NCT01976845|79004815|FG000|Overall Study|Physician Decision|8|||
44208535|NCT01976845|79004816|FG001|Overall Study|Physician Decision|8|||
44208536|NCT01976845|79004817|FG002|Overall Study|Physician Decision|3|||
44208537|NCT01989689|79004827|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
44208538|NCT01989689|79004828|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
44208539|NCT01989689|79004827|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
44208540|NCT01989689|79004828|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
44208541|NCT01943539|79004836|FG000|Overall Study|Non-compliance with at-home intervention|4|||
44208542|NCT01943539|79004837|FG001|Overall Study|Non-compliance with at-home intervention|0|||
44208543|NCT01942993|79004844|FG000|Overall Study|Lost to Follow-up|1|||
44208544|NCT01942993|79004844|FG000|Overall Study|Physician Decision|1|||
44208545|NCT01989455|79004853|FG000|Overall Study|Adverse Event|0|||
44208546|NCT01989455|79004854|FG001|Overall Study|Adverse Event|1|||
44208547|NCT01989455|79004855|FG002|Overall Study|Adverse Event|0|||
44208548|NCT01989455|79004856|FG003|Overall Study|Adverse Event|0|||
44208549|NCT01989455|79004857|FG004|Overall Study|Adverse Event|0|||
44208550|NCT01989455|79004853|FG000|Overall Study|Withdrawal by Subject|0|||
44208551|NCT01989455|79004854|FG001|Overall Study|Withdrawal by Subject|1|||
44208552|NCT01989455|79004855|FG002|Overall Study|Withdrawal by Subject|0|||
44208553|NCT01989455|79004856|FG003|Overall Study|Withdrawal by Subject|0|||
44208554|NCT01989455|79004857|FG004|Overall Study|Withdrawal by Subject|0|||
44208555|NCT01989455|79004853|FG000|Overall Study|Technical problems with infusion|0|||
44208556|NCT01989455|79004854|FG001|Overall Study|Technical problems with infusion|0|||
44208557|NCT01989455|79004855|FG002|Overall Study|Technical problems with infusion|1|||
44208558|NCT01989455|79004856|FG003|Overall Study|Technical problems with infusion|0|||
44208559|NCT01989455|79004857|FG004|Overall Study|Technical problems with infusion|1|||
44208560|NCT01942837|79004873|FG000|Overall Study|Death|1|||
44208561|NCT01942837|79004873|FG000|Overall Study|Symptomatic or radiographic progression|49|||
44208562|NCT01942837|79004873|FG000|Overall Study|Adverse Event|6|||
44208563|NCT01942837|79004873|FG000|Overall Study|Physician Decision|3|||
44208564|NCT01942837|79004873|FG000|Overall Study|Withdrawal by Subject|2|||
44208565|NCT01942837|79004873|FG000|Overall Study|Intercurrent Illness|1|||
44208566|NCT01942837|79004873|FG000|Overall Study|On treatment|3|||
44208567|NCT01942837|79004873|FG000|Overall Study|Never initiate the treatment|2|||
44208568|NCT01987895|79004880|FG000|Overall Study|Withdrawal by Subject|12|||
44208569|NCT01987895|79004881|FG001|Overall Study|Withdrawal by Subject|7|||
44208570|NCT01987895|79004880|FG000|Overall Study|Physician Decision|8|||
44208571|NCT01987895|79004881|FG001|Overall Study|Physician Decision|10|||
44208572|NCT01987895|79004880|FG000|Overall Study|Death|7|||
44208573|NCT01987895|79004881|FG001|Overall Study|Death|7|||
44208574|NCT01987895|79004880|FG000|Overall Study|Lost to Follow-up|3|||
44208575|NCT01987895|79004881|FG001|Overall Study|Lost to Follow-up|5|||
44208576|NCT01987895|79004880|FG000|Overall Study|randomized before giving IC|0|||
44208577|NCT01987895|79004881|FG001|Overall Study|randomized before giving IC|1|||
44208578|NCT02005445|79004889|FG000|Overall Study|Dual study enrollment|0|||
44208579|NCT02005445|79004890|FG001|Overall Study|Dual study enrollment|1|||
44208580|NCT01618669|79004898|FG000|Overall Study|Lost to Follow-up|1|||
44208581|NCT01618669|79004899|FG001|Overall Study|Lost to Follow-up|1|||
44208582|NCT01618669|79004898|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
44208583|NCT01618669|79004899|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
44208584|NCT01618669|79004898|FG000|Overall Study|Adverse Event|16|||
44208585|NCT01618669|79004899|FG001|Overall Study|Adverse Event|7|||
44208586|NCT01618669|79004898|FG000|Overall Study|Protocol Violation|5|||
44208587|NCT01618669|79004899|FG001|Overall Study|Protocol Violation|3|||
44208588|NCT01618669|79004898|FG000|Overall Study|Withdrawal by Subject|9|||
44208589|NCT01618669|79004899|FG001|Overall Study|Withdrawal by Subject|9|||
44208590|NCT01618669|79004898|FG000|Overall Study|Miscellaneous Reason|0|||
44208591|NCT01618669|79004899|FG001|Overall Study|Miscellaneous Reason|1|||
44369346|NCT00986232|79374673|FG003|Overall Study|Withdrawal by Subject|3|||
44369347|NCT00986232|79374670|FG000|Overall Study|Missed one or more bleeds|13|||
44369348|NCT00986232|79374671|FG001|Overall Study|Missed one or more bleeds|10|||
44369349|NCT00986232|79374672|FG002|Overall Study|Missed one or more bleeds|6|||
44369350|NCT00986232|79374673|FG003|Overall Study|Missed one or more bleeds|7|||
44369351|NCT00986232|79374670|FG000|Overall Study|Incomplete safety follow-up|3|||
44369352|NCT00986232|79374671|FG001|Overall Study|Incomplete safety follow-up|7|||
44208592|NCT01390948|79004920|FG000|Overall Study|End of Study|1|||
44208593|NCT01390948|79004921|FG001|Overall Study|End of Study|0|||
44208594|NCT01390948|79004922|FG002|Overall Study|End of Study|0|||
44208595|NCT01390948|79004920|FG000|Overall Study|Withdrew consent|2|||
44208596|NCT01390948|79004921|FG001|Overall Study|Withdrew consent|2|||
44208597|NCT01390948|79004922|FG002|Overall Study|Withdrew consent|0|||
44369353|NCT00986232|79374672|FG002|Overall Study|Incomplete safety follow-up|2|||
44208598|NCT01390948|79004920|FG000|Overall Study|Progressive Disease|2|||
44208599|NCT01390948|79004921|FG001|Overall Study|Progressive Disease|5|||
44208600|NCT01390948|79004922|FG002|Overall Study|Progressive Disease|0|||
44208601|NCT01390948|79004920|FG000|Overall Study|Death during follow-up|10|||
44208602|NCT01390948|79004921|FG001|Overall Study|Death during follow-up|11|||
44369354|NCT00986232|79374673|FG003|Overall Study|Incomplete safety follow-up|2|||
44369355|NCT00852241|79374689|FG000|Overall Study|Physician Decision|18|||
44208603|NCT01390948|79004922|FG002|Overall Study|Death during follow-up|1|||
44208604|NCT02005211|79004936|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
44208605|NCT02005211|79004937|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
44208606|NCT02005211|79004938|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
44208607|NCT02005211|79004939|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
44208608|NCT02005211|79004940|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
44208609|NCT02005211|79004941|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
44208610|NCT02005211|79004942|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
44208611|NCT01429792|79004965|FG000|Overall Study|Other Reasons|67|||
44208612|NCT01429792|79004965|FG000|Overall Study|Unknown Disposition|94|||
44208613|NCT01429792|79004965|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
44208614|NCT01429792|79004965|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
44208615|NCT01429792|79004965|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
44208616|NCT01429792|79004965|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
44208617|NCT01429792|79004965|FG000|Overall Study|Withdrawal by Subject|70|||
44208618|NCT01429792|79004965|FG000|Overall Study|Lost to Follow-up|88|||
44208619|NCT01409434|79004969|FG000|Overall Study|Protocol Violation|4|||
44208620|NCT01925612|79004978|FG000|Overall Study|Progressive Disease|1|||
44208621|NCT01925612|79004979|FG001|Overall Study|Progressive Disease|1|||
44208622|NCT01925612|79004980|FG002|Overall Study|Progressive Disease|1|||
44208623|NCT01925612|79004981|FG003|Overall Study|Progressive Disease|0|||
44208624|NCT01925612|79004982|FG004|Overall Study|Progressive Disease|0|||
44208625|NCT01925612|79004978|FG000|Overall Study|Adverse Event|3|||
44208626|NCT01925612|79004979|FG001|Overall Study|Adverse Event|3|||
44208627|NCT01925612|79004980|FG002|Overall Study|Adverse Event|0|||
44208628|NCT01925612|79004981|FG003|Overall Study|Adverse Event|1|||
44208629|NCT01925612|79004982|FG004|Overall Study|Adverse Event|2|||
44208630|NCT02093663|79004994|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
44208631|NCT02093663|79004995|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
44208632|NCT02093663|79004996|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
44208633|NCT02093663|79004997|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
44208634|NCT02093663|79004998|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
44208635|NCT02093663|79004994|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
44269701|NCT00556322|79194469|FG001|Overall Study|Insufficient therapeutic response|168|||
44369356|NCT01169636|79374698|FG000|Overall Study|Adverse Event|0|||
44369357|NCT01169636|79374699|FG001|Overall Study|Adverse Event|0|||
44369358|NCT01169636|79374700|FG002|Overall Study|Adverse Event|1|||
44369359|NCT01169636|79374701|FG003|Overall Study|Adverse Event|1|||
44369360|NCT01169636|79374702|FG004|Overall Study|Adverse Event|0|||
44369361|NCT01169636|79374698|FG000|Overall Study|Screen failure|0|||
44369362|NCT01169636|79374699|FG001|Overall Study|Screen failure|0|||
44369363|NCT01169636|79374700|FG002|Overall Study|Screen failure|2|||
44369364|NCT01169636|79374701|FG003|Overall Study|Screen failure|0|||
44369365|NCT01169636|79374702|FG004|Overall Study|Screen failure|0|||
44369366|NCT01169636|79374698|FG000|Overall Study|Withdrawal by Subject|0|||
44369367|NCT01169636|79374699|FG001|Overall Study|Withdrawal by Subject|0|||
44369368|NCT01169636|79374700|FG002|Overall Study|Withdrawal by Subject|0|||
44369369|NCT01169636|79374701|FG003|Overall Study|Withdrawal by Subject|0|||
44369370|NCT01169636|79374702|FG004|Overall Study|Withdrawal by Subject|3|||
44369371|NCT01169558|79374712|FG000|Overall Study|Disease progression|98|||
44369372|NCT01169558|79374712|FG000|Overall Study|Adverse Event|25|||
44369373|NCT01169558|79374712|FG000|Overall Study|Withdrawal of Consent|8|||
44369374|NCT01169558|79374712|FG000|Overall Study|Medical Decision|7|||
44369375|NCT01169558|79374712|FG000|Overall Study|Stable Disease|4|||
44369376|NCT01169558|79374712|FG000|Overall Study|Lost to Follow-up|4|||
44369377|NCT01169558|79374712|FG000|Overall Study|Need for Surgery|4|||
44369378|NCT01169558|79374712|FG000|Overall Study|Non-compliance|2|||
44369379|NCT01169558|79374712|FG000|Overall Study|Protocol Violation|2|||
44369380|NCT01169558|79374712|FG000|Overall Study|Partial response|2|||
44369381|NCT00840463|79374718|FG000|Overall Study|Adverse Event|1|||
44369382|NCT00840463|79374719|FG001|Overall Study|Adverse Event|0|||
44369383|NCT01168856|79374727|FG000|Overall Study|Lost to Follow-up|4|||
44369384|NCT01168856|79374728|FG001|Overall Study|Lost to Follow-up|34|||
44369385|NCT01168856|79374727|FG000|Overall Study|Withdrawal by Subject|6|||
44269702|NCT00556322|79194468|FG000|Overall Study|Adverse Event|7|||
44369386|NCT01168856|79374728|FG001|Overall Study|Withdrawal by Subject|8|||
44369387|NCT01168856|79374727|FG000|Overall Study|Physician Decision|2|||
44369388|NCT01168856|79374728|FG001|Overall Study|Physician Decision|1|||
44208636|NCT02093663|79004995|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208637|NCT02093663|79004996|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208638|NCT02093663|79004997|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208639|NCT02093663|79004998|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208640|NCT02093663|79004994|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
44208641|NCT02093663|79004995|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
44269703|NCT00556322|79194469|FG001|Overall Study|Adverse Event|4|||
44369389|NCT01168856|79374727|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
44369390|NCT01168856|79374728|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
44369391|NCT01168856|79374727|FG000|Overall Study|Participant received anti-HCV treatment|1|||
44369392|NCT01168856|79374728|FG001|Overall Study|Participant received anti-HCV treatment|0|||
44208642|NCT02093663|79004996|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
44208643|NCT02093663|79004997|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
44208644|NCT02093663|79004998|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
44208645|NCT02093663|79004994|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
44208646|NCT02093663|79004995|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
44208647|NCT02093663|79004996|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
44369393|NCT01168856|79374727|FG000|Overall Study|Death|0|||
44369394|NCT01168856|79374728|FG001|Overall Study|Death|2|||
44369395|NCT01168856|79374727|FG000|Overall Study|Other|1|||
44369396|NCT01168856|79374728|FG001|Overall Study|Other|291|||
44369397|NCT01168856|79374727|FG000|Overall Study|Protocol Violation|4|||
44369398|NCT01168856|79374728|FG001|Overall Study|Protocol Violation|6|||
44369399|NCT00828451|79374739|FG000|Overall Study|Death|2|||
44369400|NCT00828451|79374739|FG000|Overall Study|Lack of intravenous line|7|||
44369401|NCT00828451|79374739|FG000|Overall Study|Withdrawal by Subject|1|||
44369402|NCT00828451|79374739|FG000|Overall Study|Deterioration in clinical status|1|||
44369403|NCT00839917|79374745|FG000|Overall Study|Lost to Follow-up|1|||
44369404|NCT00839917|79374746|FG001|Overall Study|Lost to Follow-up|0|||
44369405|NCT00839917|79374745|FG000|Overall Study|Did not receive vaccine|0|||
44369406|NCT00839917|79374746|FG001|Overall Study|Did not receive vaccine|1|||
44369407|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
44369408|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
44369409|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
44369410|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
44369411|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
44369412|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
44369413|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
44369414|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
44369415|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
44369416|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
44369417|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
44369418|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
44369419|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
44369420|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
44369421|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
44369422|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
44369423|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
44369424|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
44369425|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
44369426|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
44369427|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
44369428|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
44369429|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
44369430|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
44369431|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
44369432|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
44369433|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
44369434|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
44369435|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
44369436|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
44369437|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
44369438|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
44369439|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
44369440|NCT00839527|79374755|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
44369441|NCT00839527|79374756|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
44369442|NCT00839527|79374757|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
44369443|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
44208648|NCT02093663|79004997|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
44208649|NCT02093663|79004998|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
44208650|NCT02093663|79004994|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208651|NCT02093663|79004995|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208652|NCT02093663|79004996|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
44208653|NCT02093663|79004997|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208654|NCT02093663|79004998|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
44208655|NCT02093663|79004994|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
44208656|NCT02093663|79004995|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
44208657|NCT02093663|79004996|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
44369444|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
44369445|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
44208658|NCT02093663|79004997|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
44208659|NCT02093663|79004998|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
44208660|NCT02093663|79004994|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
44208661|NCT02093663|79004995|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
44208662|NCT02093663|79004996|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
44208663|NCT02093663|79004997|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
44208664|NCT02093663|79004998|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
44208665|NCT02093663|79004994|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
44208666|NCT02093663|79004995|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
44208667|NCT02093663|79004996|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
44208668|NCT02093663|79004997|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
44208669|NCT02093663|79004998|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
44208670|NCT02093663|79004994|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
44208671|NCT02093663|79004995|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
44208672|NCT02093663|79004996|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
44208673|NCT02093663|79004997|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
44208674|NCT02093663|79004998|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
44208675|NCT01408888|79005015|FG000|First Intervention|Adverse Event|0|||
44208676|NCT01408888|79005016|FG001|First Intervention|Adverse Event|1|||
44208677|NCT01408888|79005015|FG000|First Intervention|Withdrawal by Subject|0|||
44208678|NCT01408888|79005016|FG001|First Intervention|Withdrawal by Subject|2|||
44208679|NCT01408888|79005015|FG000|Second Intervention|Withdrawal by Subject|1|||
44208680|NCT01408888|79005016|FG001|Second Intervention|Withdrawal by Subject|0|||
44208681|NCT01408888|79005015|FG000|Second Intervention|Adverse Event|1|||
44208682|NCT01408888|79005016|FG001|Second Intervention|Adverse Event|0|||
44208683|NCT01918033|79005035|FG000|Overall Study|Adverse Event|1|||
44208684|NCT01918033|79005036|FG001|Overall Study|Adverse Event|0|||
44208685|NCT01918033|79005037|FG002|Overall Study|Adverse Event|2|||
44208686|NCT01918033|79005035|FG000|Overall Study|Lost to Follow-up|0|||
44208687|NCT01918033|79005036|FG001|Overall Study|Lost to Follow-up|1|||
44208688|NCT01918033|79005037|FG002|Overall Study|Lost to Follow-up|0|||
44208689|NCT01918033|79005035|FG000|Overall Study|Protocol Violation|2|||
44208690|NCT01918033|79005036|FG001|Overall Study|Protocol Violation|0|||
44208691|NCT01918033|79005037|FG002|Overall Study|Protocol Violation|1|||
44208692|NCT01918033|79005035|FG000|Overall Study|Withdrawal by Subject|2|||
44208693|NCT01918033|79005036|FG001|Overall Study|Withdrawal by Subject|1|||
44208694|NCT01918033|79005037|FG002|Overall Study|Withdrawal by Subject|0|||
44208695|NCT01408732|79005045|FG000|Overall Study|Withdrawal by Subject|2|||
44208696|NCT01408732|79005046|FG001|Overall Study|Withdrawal by Subject|2|||
44208697|NCT01390402|79005052|FG000|Overall Study|Death|1|||
44208698|NCT01390402|79005052|FG000|Overall Study|Disease Progression|4|||
44208699|NCT01976299|79005058|FG000|Overall Study|Withdrawal by Subject|3|||
44208700|NCT01976299|79005059|FG001|Overall Study|Withdrawal by Subject|1|||
44208701|NCT01976299|79005058|FG000|Overall Study|Death|4|||
44208702|NCT01976299|79005059|FG001|Overall Study|Death|2|||
44208703|NCT01976299|79005058|FG000|Overall Study|Lost to Follow-up|7|||
44208704|NCT01976299|79005059|FG001|Overall Study|Lost to Follow-up|1|||
44208705|NCT01976299|79005058|FG000|Overall Study|See clarification above in comments|9|||
44208706|NCT01976299|79005059|FG001|Overall Study|See clarification above in comments|2|||
44208707|NCT01428076|79005067|FG000|Overall Study|Adverse Event|0|||
44208708|NCT01428076|79005068|FG001|Overall Study|Adverse Event|1|||
44208709|NCT01900652|79005078|FG000|Overall Study|Progressive Disease|1|||
44208710|NCT01900652|79005079|FG001|Overall Study|Progressive Disease|0|||
44208711|NCT01900652|79005078|FG000|Overall Study|Consent withdrawn by subject|1|||
44208712|NCT01900652|79005079|FG001|Overall Study|Consent withdrawn by subject|1|||
44208713|NCT01900652|79005078|FG000|Overall Study|Death|3|||
44208714|NCT01900652|79005079|FG001|Overall Study|Death|0|||
44208715|NCT01900652|79005078|FG000|Overall Study|Adverse Event|2|||
44208716|NCT01900652|79005079|FG001|Overall Study|Adverse Event|1|||
44208717|NCT01900652|79005078|FG000|Overall Study|Physician Decision|1|||
44208718|NCT01900652|79005079|FG001|Overall Study|Physician Decision|1|||
44208719|NCT02093351|79005093|FG000|Part A|Adverse Event|0|||
44369446|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
44543516|NCT02956057|79556569|FG004|Overall Study|Discontinued intervention|4|||
44208720|NCT02093351|79005094|FG001|Part A|Adverse Event|1|||
44208721|NCT02093351|79005095|FG002|Part A|Adverse Event|1|||
44208722|NCT02093351|79005096|FG003|Part A|Adverse Event|0|||
44269704|NCT00556322|79194468|FG000|Overall Study|Other|4|||
44208723|NCT02093351|79005093|FG000|Part A|Condition under investigation worsened|2|||
44208724|NCT02093351|79005094|FG001|Part A|Condition under investigation worsened|0|||
44208725|NCT02093351|79005095|FG002|Part A|Condition under investigation worsened|2|||
44208726|NCT02093351|79005096|FG003|Part A|Condition under investigation worsened|0|||
44208727|NCT02093351|79005093|FG000|Part A|Death|0|||
44208728|NCT02093351|79005094|FG001|Part A|Death|1|||
44269705|NCT00556322|79194469|FG001|Overall Study|Other|1|||
44208729|NCT02093351|79005095|FG002|Part A|Death|0|||
44208730|NCT02093351|79005096|FG003|Part A|Death|0|||
44208731|NCT02093351|79005093|FG000|Part B|Patient decision|0|||
44208732|NCT02093351|79005094|FG001|Part B|Patient decision|0|||
44208733|NCT02093351|79005095|FG002|Part B|Patient decision|0|||
44208734|NCT02093351|79005096|FG003|Part B|Patient decision|3|||
44208735|NCT02093351|79005093|FG000|Part B|Disease progression|0|||
44208736|NCT02093351|79005094|FG001|Part B|Disease progression|0|||
44208737|NCT02093351|79005095|FG002|Part B|Disease progression|0|||
44208738|NCT02093351|79005096|FG003|Part B|Disease progression|4|||
44369447|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
44369448|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
44369449|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
44369450|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
44369451|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
44369452|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
44369453|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
44369454|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
44369455|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
44369456|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
44369457|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
44369458|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
44369459|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
44369460|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
44369461|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
44369462|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
44369463|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
44369464|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
44369465|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
44369466|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
44369467|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
44369468|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
44369469|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
44369470|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
44369471|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
44369472|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
44369473|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
44369474|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
44369475|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
44369476|NCT00839527|79374755|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
44369477|NCT00839527|79374756|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
44369478|NCT00839527|79374757|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
44369479|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
44369480|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
44369481|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
44369482|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
44369483|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
44369484|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
44369485|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
44369486|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
44369487|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
44369488|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
44369489|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
44369490|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
44369491|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
44369492|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
44369493|NCT00600886|79374769|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
44369494|NCT00600886|79374770|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
44543517|NCT02956057|79556570|FG005|Overall Study|Discontinued intervention|17|||
44543518|NCT02956057|79556565|FG000|Overall Study|Lost to Follow-up|0|||
44543519|NCT02956057|79556566|FG001|Overall Study|Lost to Follow-up|2|||
44208739|NCT02093351|79005093|FG000|Part B|Complete response|0|||
44208740|NCT02093351|79005094|FG001|Part B|Complete response|0|||
44208741|NCT02093351|79005095|FG002|Part B|Complete response|0|||
44208742|NCT02093351|79005096|FG003|Part B|Complete response|1|||
44208743|NCT02093351|79005093|FG000|Part B|Adverse event + disease progression|0|||
44208744|NCT02093351|79005094|FG001|Part B|Adverse event + disease progression|0|||
44208745|NCT02093351|79005095|FG002|Part B|Adverse event + disease progression|0|||
44208746|NCT02093351|79005096|FG003|Part B|Adverse event + disease progression|1|||
44369495|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
44369496|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
44369497|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
44369498|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
44369499|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
44369500|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
44369501|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
44369502|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
44369503|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
44369504|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
44369505|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
44369506|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
44369507|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Death|1|||
44369508|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Death|1|||
44369509|NCT00600886|79374769|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
44369510|NCT00600886|79374770|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
44369511|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
44369512|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
44369513|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
44369514|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
44369515|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
44369516|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
44369517|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
44369518|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
44369519|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
44369520|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
44369521|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
44369522|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
44369523|NCT00600886|79374769|FG000|Extension - After Crossover (CAS)|Death|1|||
44369524|NCT00600886|79374770|FG001|Extension - After Crossover (CAS)|Death|0|||
44369525|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
44369526|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
44369527|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
44369528|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
44369529|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
44369530|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
44369531|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
44369532|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
44369533|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
44369534|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
44369535|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
44369536|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
44369537|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
44369538|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
44369539|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
44369540|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
44369541|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
44369542|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
44369543|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
44369544|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
44369545|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
44369546|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
44369547|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
44369548|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
44369549|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
44369550|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
44369551|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
44369552|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
44369553|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
44369554|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
44369555|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
44369556|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
44369557|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
44369558|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
44369559|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
44452100|NCT00080119|79461005|FG002|Overall Study|Unable to get to clinic|7|||
44369560|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
44369561|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
44369562|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
44369563|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
44369564|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
44369565|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
44369566|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
44369567|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
44369568|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
44369569|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
44369570|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
44369571|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
44369572|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
44369573|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
44369574|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
44369575|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
44369576|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
44369577|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Site closed|0|||
44369578|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Site closed|0|||
44369579|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Site closed|1|||
44369580|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Site closed|0|||
44369581|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
44208747|NCT02093351|79005093|FG000|Part B|Lack of therapeutic response|0|||
44208748|NCT02093351|79005094|FG001|Part B|Lack of therapeutic response|0|||
44208749|NCT02093351|79005095|FG002|Part B|Lack of therapeutic response|0|||
44208750|NCT02093351|79005096|FG003|Part B|Lack of therapeutic response|12|||
44208751|NCT02093351|79005093|FG000|Part B|Condition under investigation worsened|0|||
44208752|NCT02093351|79005094|FG001|Part B|Condition under investigation worsened|0|||
44208753|NCT02093351|79005095|FG002|Part B|Condition under investigation worsened|0|||
44208754|NCT02093351|79005096|FG003|Part B|Condition under investigation worsened|39|||
44208755|NCT02093351|79005093|FG000|Part B|Adverse Event|0|||
44208756|NCT02093351|79005094|FG001|Part B|Adverse Event|0|||
44208757|NCT02093351|79005095|FG002|Part B|Adverse Event|0|||
44208758|NCT02093351|79005096|FG003|Part B|Adverse Event|2|||
44208759|NCT02093351|79005093|FG000|Part B|Death|0|||
44208760|NCT02093351|79005094|FG001|Part B|Death|0|||
44208761|NCT02093351|79005095|FG002|Part B|Death|0|||
44208762|NCT02093351|79005096|FG003|Part B|Death|1|||
44208763|NCT02092961|79005135|FG000|Overall Study|Not reported|1|||
44208764|NCT02092961|79005136|FG001|Overall Study|Not reported|0|||
44208765|NCT02092961|79005137|FG002|Overall Study|Not reported|1|||
44208766|NCT02092961|79005135|FG000|Overall Study|Study stopped|13|||
44369582|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
44369583|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
44369584|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
44369585|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
44369586|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
44369587|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
44208767|NCT02092961|79005136|FG001|Overall Study|Study stopped|9|||
44269706|NCT00556322|79194468|FG000|Overall Study|Lost to Follow-up|5|||
44269707|NCT00556322|79194469|FG001|Overall Study|Lost to Follow-up|3|||
44269708|NCT00556322|79194468|FG000|Overall Study|Withdrawal by Subject|19|||
44269709|NCT00556322|79194469|FG001|Overall Study|Withdrawal by Subject|7|||
44269710|NCT00556322|79194468|FG000|Overall Study|Protocol Violation|5|||
44269711|NCT00556322|79194469|FG001|Overall Study|Protocol Violation|1|||
44269712|NCT00556322|79194468|FG000|Overall Study|Ongoing at data cutoff|3|||
44269713|NCT00556322|79194469|FG001|Overall Study|Ongoing at data cutoff|5|||
44208768|NCT02092961|79005137|FG002|Overall Study|Study stopped|12|||
44208769|NCT02092961|79005135|FG000|Overall Study|Lack of therapeutic response|2|||
44208770|NCT02092961|79005136|FG001|Overall Study|Lack of therapeutic response|1|||
44269714|NCT00556322|79194468|FG000|Overall Study|Death|20|||
44369588|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
44208771|NCT02092961|79005137|FG002|Overall Study|Lack of therapeutic response|3|||
44208772|NCT02092961|79005135|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
44208773|NCT02092961|79005136|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
44208774|NCT02092961|79005137|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
44208775|NCT02092961|79005135|FG000|Overall Study|Adverse Event|2|||
44208776|NCT02092961|79005136|FG001|Overall Study|Adverse Event|4|||
44208777|NCT02092961|79005137|FG002|Overall Study|Adverse Event|0|||
44208778|NCT01898078|79005148|FG000|Overall Study|Progressive Disease|1|||
44208779|NCT01898078|79005149|FG001|Overall Study|Progressive Disease|5|||
44208780|NCT01898078|79005148|FG000|Overall Study|Adverse Event|2|||
44543520|NCT02956057|79556567|FG002|Overall Study|Lost to Follow-up|1|||
44208781|NCT01898078|79005149|FG001|Overall Study|Adverse Event|1|||
44208782|NCT01898078|79005148|FG000|Overall Study|Withdrawal by Subject|1|||
44208783|NCT01898078|79005149|FG001|Overall Study|Withdrawal by Subject|1|||
44208784|NCT01898078|79005148|FG000|Overall Study|Symptomatic Deterioration|2|||
44208785|NCT01898078|79005149|FG001|Overall Study|Symptomatic Deterioration|0|||
44208786|NCT01898078|79005148|FG000|Overall Study|Reason not Specified|0|||
44208787|NCT01898078|79005149|FG001|Overall Study|Reason not Specified|1|||
44208788|NCT01987817|79005159|FG000|Overall Study|Adverse Event|4|||
44208789|NCT01987817|79005160|FG001|Overall Study|Adverse Event|0|||
44208790|NCT01987817|79005159|FG000|Overall Study|Withdrawal by Subject|1|||
44208791|NCT01987817|79005160|FG001|Overall Study|Withdrawal by Subject|1|||
44208792|NCT01987817|79005159|FG000|Overall Study|Physician Decision|1|||
44208793|NCT01987817|79005160|FG001|Overall Study|Physician Decision|0|||
44208794|NCT01940497|79005169|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
44208795|NCT01940497|79005170|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
44208796|NCT01940497|79005169|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
44208797|NCT01940497|79005170|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
44208798|NCT01940497|79005169|FG000|Overall Study|Violation of Entry Criteria|1|||
44208799|NCT01940497|79005170|FG001|Overall Study|Violation of Entry Criteria|1|||
44208800|NCT01940497|79005169|FG000|Overall Study|Refused Treatment|1|||
44208801|NCT01940497|79005170|FG001|Overall Study|Refused Treatment|3|||
44208802|NCT01940497|79005169|FG000|Overall Study|Withdrew Consent|6|||
44208803|NCT01940497|79005170|FG001|Overall Study|Withdrew Consent|2|||
44208804|NCT01940497|79005169|FG000|Overall Study|Administrative/Other|1|||
44208805|NCT01940497|79005170|FG001|Overall Study|Administrative/Other|1|||
44208806|NCT01924754|79005190|FG000|Overall Study|Lost to Follow-up|1|||
44208807|NCT01924754|79005191|FG001|Overall Study|Lost to Follow-up|2|||
44208808|NCT01924754|79005192|FG002|Overall Study|Lost to Follow-up|1|||
44208809|NCT01924754|79005190|FG000|Overall Study|Pregnancy|0|||
44208810|NCT01924754|79005191|FG001|Overall Study|Pregnancy|1|||
44208811|NCT01924754|79005192|FG002|Overall Study|Pregnancy|2|||
44208812|NCT01924364|79005203|FG000|Overall Study|Physician Decision|3|||
44208813|NCT01987505|79005220|FG000|Overall Study|Other|9|||
44208814|NCT01987505|79005220|FG000|Overall Study|Withdrawal by Subject|2|||
44208815|NCT01987505|79005220|FG000|Overall Study|Other Reason|2|||
44208816|NCT01987505|79005220|FG000|Overall Study|Lost to Follow-up|15|||
44208817|NCT01987505|79005220|FG000|Overall Study|Investigator Decision|2|||
44208818|NCT01987505|79005220|FG000|Overall Study|Death|4|||
44208819|NCT01923896|79005228|FG000|Overall Study|Adverse Event|1|||
44208820|NCT01923896|79005229|FG001|Overall Study|Adverse Event|0|||
44208821|NCT02004353|79005235|FG000|Overall Study|Voluntary participation|1334|||
44208822|NCT01938625|79005241|FG000|Overall Study|Withdrawal by Subject|0|||
44208823|NCT01938625|79005242|FG001|Overall Study|Withdrawal by Subject|1|||
44208824|NCT01938625|79005241|FG000|Overall Study|Adverse Event|0|||
44208825|NCT01938625|79005242|FG001|Overall Study|Adverse Event|1|||
44208826|NCT01975675|79005252|FG000|Overall Study|Death|0|||
44208827|NCT01975675|79005253|FG001|Overall Study|Death|1|||
44208828|NCT01975675|79005254|FG002|Overall Study|Death|0|||
44208829|NCT01975675|79005255|FG003|Overall Study|Death|0|||
44208830|NCT01975285|79005267|FG000|Overall Study|Failed Block and follow up|2|||
44208831|NCT01975285|79005268|FG001|Overall Study|Failed Block and follow up|2|||
44208832|NCT01974895|79005276|FG000|Overall Study|Protocol Violation|1|||
44208833|NCT01974895|79005277|FG001|Overall Study|Protocol Violation|0|||
44208834|NCT01974895|79005276|FG000|Overall Study|Lost to Follow-up|4|||
44208835|NCT01974895|79005277|FG001|Overall Study|Lost to Follow-up|6|||
44208836|NCT01974895|79005276|FG000|Overall Study|Withdrawal by Subject|0|||
44208837|NCT01974895|79005277|FG001|Overall Study|Withdrawal by Subject|1|||
44208838|NCT01974895|79005276|FG000|Overall Study|Other (Missed Visit)|1|||
44208839|NCT01974895|79005277|FG001|Overall Study|Other (Missed Visit)|0|||
44208840|NCT01974895|79005276|FG000|Overall Study|Other (Reason unknown)|9|||
44208841|NCT01974895|79005277|FG001|Overall Study|Other (Reason unknown)|8|||
44208842|NCT01974817|79005283|FG000|Overall Study|Death|4|||
44208843|NCT01974817|79005283|FG000|Overall Study|Lost to Follow-up|2|||
44208844|NCT01974817|79005283|FG000|Overall Study|Protocol Violation|2|||
44208845|NCT01915849|79005291|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
44208846|NCT01915849|79005292|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
44208847|NCT01915849|79005293|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
44208848|NCT01915849|79005294|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
44208849|NCT01915849|79005291|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
44208850|NCT01915849|79005292|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44208851|NCT01915849|79005293|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44208852|NCT01915849|79005294|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44208853|NCT01915771|79005304|FG000|Day 1|Withdrawal by Subject|1|||
44208854|NCT01915771|79005304|FG000|Day 15|Withdrawal by Subject|1|||
44208855|NCT01938391|79005312|FG000|6 Month Follow up|Withdrawal by Subject|1|||
44208856|NCT01938391|79005312|FG000|12 Month Follow up|Physician Decision|1|||
44208857|NCT01938391|79005312|FG000|12 Month Follow up|Withdrawal by Subject|1|||
44208858|NCT01915303|79005316|FG000|Core Phase|Adverse Event|7|||
44208859|NCT01915303|79005316|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
44208860|NCT01915303|79005316|FG000|Core Phase|Death|2|||
44208861|NCT01915303|79005316|FG000|Core Phase|Protocol Violation|2|||
44208862|NCT01915303|79005316|FG000|Core Phase|Abnormal lab value|1|||
44208863|NCT01915303|79005316|FG000|Core Phase|Withdrawal by Subject|1|||
44208864|NCT01915303|79005316|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
44208865|NCT01915303|79005316|FG000|Extension Phase|Withdrawal by Subject|4|||
44208866|NCT01915303|79005316|FG000|Extension Phase|Adverse Event|3|||
44208867|NCT01915303|79005316|FG000|Extension Phase|Death|1|||
44208868|NCT01915303|79005316|FG000|Extension Phase|Protocol Violation|1|||
44269715|NCT00556322|79194469|FG001|Overall Study|Death|14|||
44269716|NCT00556166|79194487|FG000|Overall Study|Withdrawal by Subject|1|||
44269717|NCT02332590|79194647|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
44269718|NCT02332590|79194648|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
44269719|NCT02332590|79194647|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
44269720|NCT02332590|79194648|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
44208869|NCT01987427|79005323|FG000|Overall Study|Adverse Event|4|||
44208870|NCT01987427|79005324|FG001|Overall Study|Adverse Event|2|||
44208871|NCT01987427|79005325|FG002|Overall Study|Adverse Event|8|||
44208872|NCT01987427|79005323|FG000|Overall Study|Lost to Follow-up|6|||
44208873|NCT01987427|79005324|FG001|Overall Study|Lost to Follow-up|6|||
44208874|NCT01987427|79005325|FG002|Overall Study|Lost to Follow-up|9|||
44208875|NCT01987427|79005323|FG000|Overall Study|Withdrawal by Subject|2|||
44208876|NCT01987427|79005324|FG001|Overall Study|Withdrawal by Subject|1|||
44208877|NCT01987427|79005325|FG002|Overall Study|Withdrawal by Subject|3|||
44208878|NCT01987427|79005323|FG000|Overall Study|Lack of Efficacy|1|||
44208879|NCT01987427|79005324|FG001|Overall Study|Lack of Efficacy|0|||
44208880|NCT01987427|79005325|FG002|Overall Study|Lack of Efficacy|0|||
44208881|NCT01987427|79005323|FG000|Overall Study|Other|1|||
44208882|NCT01987427|79005324|FG001|Overall Study|Other|1|||
44208883|NCT01987427|79005325|FG002|Overall Study|Other|0|||
44208884|NCT01937299|79005335|FG000|Overall Study|Adverse Event|13|||
44208885|NCT01937299|79005336|FG001|Overall Study|Adverse Event|0|||
44208886|NCT01937299|79005335|FG000|Overall Study|Lack of Efficacy|0|||
44208887|NCT01937299|79005336|FG001|Overall Study|Lack of Efficacy|4|||
44208888|NCT01937299|79005335|FG000|Overall Study|Withdrawal by Subject|1|||
44208889|NCT01937299|79005336|FG001|Overall Study|Withdrawal by Subject|0|||
44208890|NCT02003963|79005345|FG000|Overall Study|Lost to Follow-up|2|||
44208891|NCT02003963|79005346|FG001|Overall Study|Lost to Follow-up|1|||
44208892|NCT01606761|79005357|FG000|Prior to Week 24|Lost to Follow-up|0|||
44208893|NCT01606761|79005358|FG001|Prior to Week 24|Lost to Follow-up|3|||
44208894|NCT01606761|79005359|FG002|Prior to Week 24|Lost to Follow-up|2|||
44208895|NCT01606761|79005360|FG003|Prior to Week 24|Lost to Follow-up|0|||
44208896|NCT01606761|79005361|FG004|Prior to Week 24|Lost to Follow-up|0|||
44208897|NCT01606761|79005357|FG000|Prior to Week 24|Withdrawal by Subject|12|||
44208898|NCT01606761|79005358|FG001|Prior to Week 24|Withdrawal by Subject|10|||
44208899|NCT01606761|79005359|FG002|Prior to Week 24|Withdrawal by Subject|9|||
44208900|NCT01606761|79005360|FG003|Prior to Week 24|Withdrawal by Subject|0|||
44208901|NCT01606761|79005361|FG004|Prior to Week 24|Withdrawal by Subject|0|||
44208902|NCT01606761|79005357|FG000|Prior to Week 24|Adverse Event|11|||
44208903|NCT01606761|79005358|FG001|Prior to Week 24|Adverse Event|18|||
44208904|NCT01606761|79005359|FG002|Prior to Week 24|Adverse Event|22|||
44208905|NCT01606761|79005360|FG003|Prior to Week 24|Adverse Event|0|||
44208906|NCT01606761|79005361|FG004|Prior to Week 24|Adverse Event|0|||
44208907|NCT01606761|79005357|FG000|Prior to Week 24|Lack of Efficacy|15|||
44208908|NCT01606761|79005358|FG001|Prior to Week 24|Lack of Efficacy|14|||
44208909|NCT01606761|79005359|FG002|Prior to Week 24|Lack of Efficacy|8|||
44208910|NCT01606761|79005360|FG003|Prior to Week 24|Lack of Efficacy|0|||
44208911|NCT01606761|79005361|FG004|Prior to Week 24|Lack of Efficacy|0|||
44208912|NCT01606761|79005357|FG000|Prior to Week 24|Physician Decision|0|||
44208913|NCT01606761|79005358|FG001|Prior to Week 24|Physician Decision|3|||
44208914|NCT01606761|79005359|FG002|Prior to Week 24|Physician Decision|1|||
44208915|NCT01606761|79005360|FG003|Prior to Week 24|Physician Decision|0|||
44208916|NCT01606761|79005361|FG004|Prior to Week 24|Physician Decision|0|||
44208917|NCT01606761|79005357|FG000|Prior to Week 24|Other|4|||
44208918|NCT01606761|79005358|FG001|Prior to Week 24|Other|7|||
44208919|NCT01606761|79005359|FG002|Prior to Week 24|Other|5|||
44208920|NCT01606761|79005360|FG003|Prior to Week 24|Other|0|||
44269721|NCT02332590|79194647|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
44208921|NCT01606761|79005361|FG004|Prior to Week 24|Other|0|||
44369589|NCT00838903|79374794|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
44369590|NCT00838903|79374795|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
44208922|NCT01606761|79005357|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
44208923|NCT01606761|79005358|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
44208924|NCT01606761|79005359|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
44208925|NCT01606761|79005360|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
44208926|NCT01606761|79005361|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
44208927|NCT01606761|79005357|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
44208928|NCT01606761|79005358|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
44208929|NCT01606761|79005359|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
44208930|NCT01606761|79005360|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
44208931|NCT01606761|79005361|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
44208932|NCT01606761|79005357|FG000|Week 24 to Week 52|Adverse Event|0|||
44208933|NCT01606761|79005358|FG001|Week 24 to Week 52|Adverse Event|11|||
44208934|NCT01606761|79005359|FG002|Week 24 to Week 52|Adverse Event|14|||
44208935|NCT01606761|79005360|FG003|Week 24 to Week 52|Adverse Event|3|||
44208936|NCT01606761|79005361|FG004|Week 24 to Week 52|Adverse Event|15|||
44208937|NCT01606761|79005357|FG000|Week 24 to Week 52|Death|0|||
44208938|NCT01606761|79005358|FG001|Week 24 to Week 52|Death|0|||
44208939|NCT01606761|79005359|FG002|Week 24 to Week 52|Death|2|||
44208940|NCT01606761|79005360|FG003|Week 24 to Week 52|Death|1|||
44208941|NCT01606761|79005361|FG004|Week 24 to Week 52|Death|0|||
44208942|NCT01606761|79005357|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
44208943|NCT01606761|79005358|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
44208944|NCT01606761|79005359|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
44208945|NCT01606761|79005360|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
44208946|NCT01606761|79005361|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
44208947|NCT01606761|79005357|FG000|Week 24 to Week 52|Physician Decision|0|||
44208948|NCT01606761|79005358|FG001|Week 24 to Week 52|Physician Decision|1|||
44208949|NCT01606761|79005359|FG002|Week 24 to Week 52|Physician Decision|1|||
44208950|NCT01606761|79005360|FG003|Week 24 to Week 52|Physician Decision|0|||
44208951|NCT01606761|79005361|FG004|Week 24 to Week 52|Physician Decision|0|||
44208952|NCT01606761|79005357|FG000|Week 24 to Week 52|Other|0|||
44208953|NCT01606761|79005358|FG001|Week 24 to Week 52|Other|1|||
44208954|NCT01606761|79005359|FG002|Week 24 to Week 52|Other|5|||
44208955|NCT01606761|79005360|FG003|Week 24 to Week 52|Other|2|||
44208956|NCT01606761|79005361|FG004|Week 24 to Week 52|Other|2|||
44208957|NCT01606761|79005357|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
44208958|NCT01606761|79005358|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
44208959|NCT01606761|79005359|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
44208960|NCT01606761|79005360|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
44208961|NCT01606761|79005361|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
44208962|NCT01606761|79005357|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
44208963|NCT01606761|79005358|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
44208964|NCT01606761|79005359|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
44208965|NCT01606761|79005360|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
44208966|NCT01606761|79005361|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
44208967|NCT01606761|79005357|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
44208968|NCT01606761|79005358|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
44208969|NCT01606761|79005359|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
44208970|NCT01606761|79005360|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
44208971|NCT01606761|79005361|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
44208972|NCT01606761|79005357|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
44208973|NCT01606761|79005358|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
44208974|NCT01606761|79005359|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
44208975|NCT01606761|79005360|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
44208976|NCT01606761|79005361|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
44208977|NCT01790295|79005376|FG000|Overall Study|Adverse Event|1|||
44208978|NCT01790295|79005376|FG000|Overall Study|Death|4|||
44208979|NCT01790295|79005376|FG000|Overall Study|Lack of Efficacy|2|||
44208980|NCT01790295|79005376|FG000|Overall Study|Study closure|4|||
44208981|NCT01597557|79005383|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
44208982|NCT01597557|79005384|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
44208983|NCT01760733|79005390|FG000|Waiting List|Death|18|||
44208984|NCT01760733|79005390|FG000|Waiting List|Removed from waiting list|41|||
44208985|NCT01760733|79005390|FG000|Waiting List|Not received a transplant yet|13|||
44208986|NCT01760733|79005390|FG000|Transplanted|Not reached 10 years post transplant|184|||
44208987|NCT01760733|79005390|FG000|Transplanted|Death|26|||
44208988|NCT01760733|79005390|FG000|Transplanted|Graft loss|7|||
44208989|NCT01914757|79005398|FG000|Overall Study|Severe non-compliance to protocol|3|||
44208990|NCT01914757|79005399|FG001|Overall Study|Severe non-compliance to protocol|1|||
44208991|NCT01914757|79005400|FG002|Overall Study|Severe non-compliance to protocol|2|||
44208992|NCT01914757|79005398|FG000|Overall Study|Lost to Follow-up|5|||
44208993|NCT01914757|79005399|FG001|Overall Study|Lost to Follow-up|8|||
44208994|NCT01914757|79005400|FG002|Overall Study|Lost to Follow-up|6|||
44208995|NCT01914757|79005398|FG000|Overall Study|Withdrawal by Subject|15|||
44208996|NCT01914757|79005399|FG001|Overall Study|Withdrawal by Subject|27|||
44208997|NCT01914757|79005400|FG002|Overall Study|Withdrawal by Subject|19|||
44208998|NCT01914757|79005398|FG000|Overall Study|Death|2|||
44208999|NCT01914757|79005399|FG001|Overall Study|Death|2|||
44209000|NCT01914757|79005400|FG002|Overall Study|Death|1|||
44209001|NCT01914757|79005398|FG000|Overall Study|Adverse Event|4|||
44209002|NCT01914757|79005399|FG001|Overall Study|Adverse Event|3|||
44209003|NCT01914757|79005400|FG002|Overall Study|Adverse Event|4|||
44209004|NCT01914757|79005398|FG000|Overall Study|Study specific withdrawal criteria|0|||
44209005|NCT01914757|79005399|FG001|Overall Study|Study specific withdrawal criteria|1|||
44209006|NCT01914757|79005400|FG002|Overall Study|Study specific withdrawal criteria|0|||
44209007|NCT01914757|79005398|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44209008|NCT01914757|79005399|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44209009|NCT01914757|79005400|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
44209010|NCT01914757|79005398|FG000|Overall Study|Other reasons|5|||
44209011|NCT01914757|79005399|FG001|Overall Study|Other reasons|9|||
44209012|NCT01914757|79005400|FG002|Overall Study|Other reasons|4|||
44209013|NCT02003573|79005411|FG000|Overall Study|Progressive disease|2|||
44209014|NCT02003573|79005412|FG001|Overall Study|Progressive disease|0|||
44209015|NCT02003573|79005413|FG002|Overall Study|Progressive disease|1|||
44209016|NCT02003573|79005411|FG000|Overall Study|Other Adverse event|0|||
44209017|NCT02003573|79005412|FG001|Overall Study|Other Adverse event|1|||
44209018|NCT02003573|79005413|FG002|Overall Study|Other Adverse event|1|||
44209019|NCT02003573|79005411|FG000|Overall Study|Refuse to take trial medication|0|||
44209020|NCT02003573|79005412|FG001|Overall Study|Refuse to take trial medication|1|||
44209021|NCT02003573|79005413|FG002|Overall Study|Refuse to take trial medication|1|||
44209022|NCT02003573|79005411|FG000|Overall Study|Other than specified|1|||
44209023|NCT02003573|79005412|FG001|Overall Study|Other than specified|2|||
44209024|NCT02003573|79005413|FG002|Overall Study|Other than specified|3|||
44209025|NCT01914679|79005423|FG000|Overall Study|Lack of Efficacy|1|||
44209026|NCT01914679|79005423|FG000|Overall Study|Sponsor terminated study|4|||
44209027|NCT01789281|79005429|FG000|Overall Study|Disease progression|15|||
44209028|NCT01789281|79005430|FG001|Overall Study|Disease progression|4|||
44209029|NCT01789281|79005429|FG000|Overall Study|Adverse Event|5|||
44209030|NCT01789281|79005430|FG001|Overall Study|Adverse Event|5|||
44209031|NCT01789281|79005429|FG000|Overall Study|Withdrawal by Subject|1|||
44209032|NCT01789281|79005430|FG001|Overall Study|Withdrawal by Subject|0|||
44209033|NCT01789281|79005429|FG000|Overall Study|Lost to Follow-up|1|||
44209034|NCT01789281|79005430|FG001|Overall Study|Lost to Follow-up|0|||
44209035|NCT01789281|79005429|FG000|Overall Study|Administrative problems|0|||
44209036|NCT01789281|79005430|FG001|Overall Study|Administrative problems|1|||
44209037|NCT01923740|79005439|FG000|Overall Study|Lost to Follow-up|4|||
44209038|NCT01923740|79005440|FG001|Overall Study|Lost to Follow-up|9|||
44209039|NCT01923740|79005439|FG000|Overall Study|Withdrawal by Subject|2|||
44209040|NCT01923740|79005440|FG001|Overall Study|Withdrawal by Subject|0|||
44209041|NCT01789203|79005448|FG000|Overall Study|Adverse Event|2|||
44209042|NCT01789203|79005449|FG001|Overall Study|Adverse Event|2|||
44269722|NCT02332590|79194648|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
44369591|NCT00838903|79374796|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
44369592|NCT00838903|79374797|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
44369593|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
44369594|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
44369595|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
44369596|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
44369597|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
44369598|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
44369599|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
44369600|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
44369601|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
44369602|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
44369603|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
44369604|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
44369605|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
44369606|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
44369607|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
44369608|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
44269723|NCT02332590|79194647|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
44269724|NCT02332590|79194648|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
44269725|NCT02332590|79194647|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
44369609|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
44369610|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
44369611|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
44369612|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
44369613|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
44369614|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
44369615|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
44209043|NCT01789203|79005448|FG000|Overall Study|Withdrawal by Subject|1|||
44209044|NCT01789203|79005449|FG001|Overall Study|Withdrawal by Subject|0|||
44209045|NCT01789203|79005448|FG000|Overall Study|Death|1|||
44269726|NCT02332590|79194648|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
44369616|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
44369617|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
44369618|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
44369619|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
44369620|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
44369621|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
44369622|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
44369623|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
44369624|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
44369625|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
44369626|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
44369627|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
44369628|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
44369629|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
44369630|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
44369631|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
44369632|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
44369633|NCT00838903|79374794|FG000|Follow-up Period (8 Weeks)|Missing|1|||
44369634|NCT00838903|79374795|FG001|Follow-up Period (8 Weeks)|Missing|2|||
44369635|NCT00838903|79374796|FG002|Follow-up Period (8 Weeks)|Missing|1|||
44369636|NCT00838903|79374797|FG003|Follow-up Period (8 Weeks)|Missing|1|||
44369637|NCT00828139|79374811|FG000|Overall Study|Adverse Event|8|||
44369638|NCT00828139|79374812|FG001|Overall Study|Adverse Event|1|||
44369639|NCT00828139|79374813|FG002|Overall Study|Adverse Event|10|||
44369640|NCT00828139|79374814|FG003|Overall Study|Adverse Event|5|||
44369641|NCT00828139|79374811|FG000|Overall Study|Death|2|||
44369642|NCT00828139|79374812|FG001|Overall Study|Death|1|||
44369643|NCT00828139|79374813|FG002|Overall Study|Death|0|||
44369644|NCT00828139|79374814|FG003|Overall Study|Death|2|||
44369645|NCT00828139|79374811|FG000|Overall Study|Refusal unrelated to toxicity|3|||
44369646|NCT00828139|79374812|FG001|Overall Study|Refusal unrelated to toxicity|4|||
44369647|NCT00828139|79374813|FG002|Overall Study|Refusal unrelated to toxicity|5|||
44369648|NCT00828139|79374814|FG003|Overall Study|Refusal unrelated to toxicity|3|||
44369649|NCT00828139|79374811|FG000|Overall Study|Disease Progression|24|||
44369650|NCT00828139|79374812|FG001|Overall Study|Disease Progression|33|||
44369651|NCT00828139|79374813|FG002|Overall Study|Disease Progression|35|||
44369652|NCT00828139|79374814|FG003|Overall Study|Disease Progression|39|||
44369653|NCT00828139|79374811|FG000|Overall Study|Other|4|||
44369654|NCT00828139|79374812|FG001|Overall Study|Other|2|||
44369655|NCT00828139|79374813|FG002|Overall Study|Other|5|||
44369656|NCT00828139|79374814|FG003|Overall Study|Other|2|||
44369657|NCT00838513|79374824|FG000|Screening Period|Screen Failure|3|||
44369658|NCT00838513|79374824|FG000|Extension Treatment Period|Death|1|||
44369659|NCT00838513|79374824|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
44369660|NCT00600106|79374830|FG000|Overall Study|Withdrawal by Subject|1|||
44209046|NCT01789203|79005449|FG001|Overall Study|Death|0|||
44209047|NCT01789203|79005448|FG000|Overall Study|Protocol Violation|2|||
44209048|NCT01789203|79005449|FG001|Overall Study|Protocol Violation|1|||
44209049|NCT01789203|79005448|FG000|Overall Study|Other|1|||
44209050|NCT01789203|79005449|FG001|Overall Study|Other|1|||
44209051|NCT01789203|79005448|FG000|Overall Study|patient non-adherent|2|||
44209052|NCT01789203|79005449|FG001|Overall Study|patient non-adherent|0|||
44209053|NCT01789047|79005459|FG000|Overall Study|Adverse Event|3|||
44209054|NCT01789047|79005460|FG001|Overall Study|Adverse Event|2|||
44209055|NCT01789047|79005459|FG000|Overall Study|Withdrawal by Subject|1|||
44209056|NCT01789047|79005460|FG001|Overall Study|Withdrawal by Subject|2|||
44209057|NCT01788423|79005469|FG000|Overall Study|See Comments in Completed (above)|0|||
44209058|NCT01788423|79005470|FG001|Overall Study|See Comments in Completed (above)|4|||
44209059|NCT01788423|79005471|FG002|Overall Study|See Comments in Completed (above)|5|||
44209060|NCT01617187|79005483|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
44209061|NCT01617187|79005484|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
44209062|NCT01617187|79005485|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
44209063|NCT01617187|79005486|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
44269727|NCT02332590|79194647|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
44269728|NCT02332590|79194648|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
44269729|NCT02332590|79194647|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
44269730|NCT02332590|79194648|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
44369661|NCT00600106|79374831|FG001|Overall Study|Withdrawal by Subject|1|||
44369662|NCT00850993|79374841|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
44369663|NCT00850993|79374842|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
44369664|NCT00850993|79374843|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
44369665|NCT00850993|79374844|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
44369666|NCT00818779|79374856|FG000|Overall Study|Protocol Violation|1|||
44209064|NCT01617187|79005483|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
44209065|NCT01617187|79005484|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
44209066|NCT01617187|79005485|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
44209067|NCT01617187|79005486|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
44209068|NCT01617187|79005483|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
44209069|NCT01617187|79005484|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
44209070|NCT01617187|79005485|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
44209071|NCT01617187|79005486|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
44209072|NCT01617187|79005483|FG000|Treatment Through Study Completion|Adverse Event|1|||
44209073|NCT01617187|79005484|FG001|Treatment Through Study Completion|Adverse Event|1|||
44209074|NCT01617187|79005485|FG002|Treatment Through Study Completion|Adverse Event|0|||
44209075|NCT01617187|79005486|FG003|Treatment Through Study Completion|Adverse Event|1|||
44209076|NCT01617187|79005483|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
44209077|NCT01617187|79005484|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
44209078|NCT01617187|79005485|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
44209079|NCT01617187|79005486|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
44209080|NCT01617187|79005483|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
44209081|NCT01617187|79005484|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
44209082|NCT01617187|79005485|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
44209083|NCT01617187|79005486|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
44209084|NCT01617187|79005483|FG000|Treatment Through Study Completion|Protocol Violation|1|||
44209085|NCT01617187|79005484|FG001|Treatment Through Study Completion|Protocol Violation|0|||
44209086|NCT01617187|79005485|FG002|Treatment Through Study Completion|Protocol Violation|0|||
44209087|NCT01617187|79005486|FG003|Treatment Through Study Completion|Protocol Violation|1|||
44209088|NCT01759407|79005498|FG000|Overall Study|Protocol Violation|0|||
44209089|NCT01759407|79005499|FG001|Overall Study|Protocol Violation|2|||
44209090|NCT01787331|79005505|FG000|Overall Study|Physician Decision|1|||
44209091|NCT01787331|79005505|FG000|Overall Study|Withdrawal by Subject|1|||
44209092|NCT01757847|79005511|FG000|Overall Study|Withdrawal by Subject|3|||
44209093|NCT01757847|79005512|FG001|Overall Study|Withdrawal by Subject|4|||
44209094|NCT01787097|79005518|FG000|Overall Study|Withdrawal by Subject|1|||
44209095|NCT01787097|79005519|FG001|Overall Study|Withdrawal by Subject|0|||
44209096|NCT01787097|79005520|FG002|Overall Study|Withdrawal by Subject|0|||
44209097|NCT01787097|79005521|FG003|Overall Study|Withdrawal by Subject|0|||
44209098|NCT01757691|79005541|FG000|Overall Study|Administrative problems|2|||
44209099|NCT01757691|79005542|FG001|Overall Study|Administrative problems|0|||
44209100|NCT01786707|79005550|FG000|Overall Study|Lost to Follow-up|1|||
44209101|NCT01786707|79005551|FG001|Overall Study|Lost to Follow-up|1|||
44209102|NCT01786629|79005559|FG000|Overall Study|Lack of Efficacy|0|||
44209103|NCT01786629|79005560|FG001|Overall Study|Lack of Efficacy|4|||
44209104|NCT01786629|79005559|FG000|Overall Study|Adverse Event|0|||
44209105|NCT01786629|79005560|FG001|Overall Study|Adverse Event|1|||
44209106|NCT01786551|79005566|FG000|Overall Study|Participant withdrew consent|2|||
44209107|NCT01973569|79005573|FG000|Overall Study|Adverse Event|9|||
44209108|NCT01973569|79005574|FG001|Overall Study|Adverse Event|2|||
44209109|NCT01973569|79005575|FG002|Overall Study|Adverse Event|4|||
44209110|NCT01973569|79005573|FG000|Overall Study|Protocol Violation|2|||
44209111|NCT01973569|79005574|FG001|Overall Study|Protocol Violation|1|||
44209112|NCT01973569|79005575|FG002|Overall Study|Protocol Violation|3|||
44209113|NCT01973569|79005573|FG000|Overall Study|Withdrawal by Subject|7|||
44209114|NCT01973569|79005574|FG001|Overall Study|Withdrawal by Subject|5|||
44209115|NCT01973569|79005575|FG002|Overall Study|Withdrawal by Subject|2|||
44209116|NCT01973569|79005573|FG000|Overall Study|Invasive dental treatment|3|||
44209117|NCT01973569|79005574|FG001|Overall Study|Invasive dental treatment|5|||
44209118|NCT01973569|79005575|FG002|Overall Study|Invasive dental treatment|6|||
44209119|NCT01973569|79005573|FG000|Overall Study|Prohibited concomitant d|1|||
44209120|NCT01973569|79005574|FG001|Overall Study|Prohibited concomitant d|5|||
44209121|NCT01973569|79005575|FG002|Overall Study|Prohibited concomitant d|0|||
44209122|NCT01973569|79005573|FG000|Overall Study|Disease progression|0|||
44209123|NCT01973569|79005574|FG001|Overall Study|Disease progression|3|||
44209124|NCT01973569|79005575|FG002|Overall Study|Disease progression|0|||
44209125|NCT01973569|79005573|FG000|Overall Study|Other|1|||
44209126|NCT01973569|79005574|FG001|Overall Study|Other|1|||
44209127|NCT01973569|79005575|FG002|Overall Study|Other|0|||
44209128|NCT01973569|79005573|FG000|Overall Study|Did not receive study drug|6|||
44209129|NCT01973569|79005574|FG001|Overall Study|Did not receive study drug|3|||
44209130|NCT01973569|79005575|FG002|Overall Study|Did not receive study drug|3|||
44209131|NCT01973491|79005583|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
44209132|NCT01973491|79005583|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
44209133|NCT01973491|79005583|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
44209134|NCT01951586|79005589|FG000|Overall Study|Death|61|||
44209135|NCT01951586|79005590|FG001|Overall Study|Death|120|||
44209136|NCT01951586|79005589|FG000|Overall Study|Withdrawal by Subject|8|||
44209137|NCT01951586|79005590|FG001|Overall Study|Withdrawal by Subject|17|||
44209138|NCT01951586|79005589|FG000|Overall Study|Lost to Follow-up|0|||
44543521|NCT02956057|79556568|FG003|Overall Study|Lost to Follow-up|1|||
44543522|NCT02956057|79556569|FG004|Overall Study|Lost to Follow-up|1|||
44209139|NCT01951586|79005590|FG001|Overall Study|Lost to Follow-up|1|||
44209140|NCT01951586|79005589|FG000|Overall Study|Sponsor Decision|9|||
44209141|NCT01951586|79005590|FG001|Overall Study|Sponsor Decision|10|||
44209142|NCT01785849|79005599|FG000|Overall Study|Death|7|||
44209143|NCT01785849|79005600|FG001|Overall Study|Death|9|||
44209144|NCT01785849|79005599|FG000|Overall Study|Protocol Specified Criteria|29|||
44209145|NCT01785849|79005600|FG001|Overall Study|Protocol Specified Criteria|1|||
44209146|NCT01785849|79005599|FG000|Overall Study|Withdrawal by Subject|15|||
44209147|NCT01785849|79005600|FG001|Overall Study|Withdrawal by Subject|12|||
44209148|NCT01785849|79005599|FG000|Overall Study|Sponsor Decision|0|||
44209149|NCT01785849|79005600|FG001|Overall Study|Sponsor Decision|1|||
44209150|NCT01785849|79005599|FG000|Overall Study|Lost to Follow-up|10|||
44209151|NCT01785849|79005600|FG001|Overall Study|Lost to Follow-up|11|||
44209152|NCT01756833|79005608|FG000|Overall Study|Withdrawal by Subject|4|||
44209153|NCT01756833|79005609|FG001|Overall Study|Withdrawal by Subject|3|||
44209154|NCT01617967|79005621|FG000|Overall Study|Protocol Violation|0|||
44209155|NCT01617967|79005622|FG001|Overall Study|Protocol Violation|0|||
44209156|NCT01617967|79005623|FG002|Overall Study|Protocol Violation|0|||
44209157|NCT01617967|79005624|FG003|Overall Study|Protocol Violation|1|||
44209158|NCT01617967|79005625|FG004|Overall Study|Protocol Violation|0|||
44209159|NCT01617967|79005626|FG005|Overall Study|Protocol Violation|0|||
44209160|NCT01617967|79005621|FG000|Overall Study|Withdrawal by Subject|0|||
44209161|NCT01617967|79005622|FG001|Overall Study|Withdrawal by Subject|0|||
44209162|NCT01617967|79005623|FG002|Overall Study|Withdrawal by Subject|0|||
44209163|NCT01617967|79005624|FG003|Overall Study|Withdrawal by Subject|0|||
44209164|NCT01617967|79005625|FG004|Overall Study|Withdrawal by Subject|0|||
44209165|NCT01617967|79005626|FG005|Overall Study|Withdrawal by Subject|1|||
44209166|NCT01617967|79005621|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
44209167|NCT01617967|79005622|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
44209168|NCT01617967|79005623|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
44209169|NCT01617967|79005624|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
44209170|NCT01617967|79005625|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
44209171|NCT01617967|79005626|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
44209172|NCT01785615|79005644|FG000|Dietary Phase|Lost to Follow-up|0|||
44209173|NCT01785615|79005645|FG001|Dietary Phase|Lost to Follow-up|0|||
44209174|NCT01785615|79005646|FG002|Dietary Phase|Lost to Follow-up|0|||
44209175|NCT01785615|79005647|FG003|Dietary Phase|Lost to Follow-up|24|||
44209176|NCT01913041|79005659|FG000|Overall Study|Protocol Violation|35|||
44209177|NCT01913041|79005659|FG000|Overall Study|Withdrawal by Subject|3|||
44209178|NCT01913041|79005659|FG000|Overall Study|Physician Decision|1|||
44209179|NCT01756053|79005663|FG000|Period 1 (10 Days)|Protocol Violation|1|||
44209180|NCT01756053|79005664|FG001|Period 1 (10 Days)|Protocol Violation|1|||
44209181|NCT01756053|79005663|FG000|Period 2 (10 Days)|Protocol Violation|0|||
44209182|NCT01756053|79005664|FG001|Period 2 (10 Days)|Protocol Violation|2|||
44209183|NCT01785069|79005674|FG000|Overall Study|Implanted with nonstudy device|1|||
44209184|NCT01785069|79005675|FG001|Overall Study|Implanted with nonstudy device|2|||
44209185|NCT01785069|79005676|FG002|Overall Study|Implanted with nonstudy device|1|||
44209186|NCT01785069|79005677|FG003|Overall Study|Implanted with nonstudy device|0|||
44209187|NCT01785069|79005674|FG000|Overall Study|Death|0|||
44543523|NCT02956057|79556570|FG005|Overall Study|Lost to Follow-up|0|||
44543524|NCT03179319|79556586|FG000|Overall Study|Lost to Follow-up|6|||
44543525|NCT03179319|79556587|FG001|Overall Study|Lost to Follow-up|0|||
44543526|NCT03627091|79556596|FG000|Overall Study|Adverse Event|0|||
44543527|NCT03627091|79556597|FG001|Overall Study|Adverse Event|0|||
44543528|NCT03627091|79556598|FG002|Overall Study|Adverse Event|2|||
44543529|NCT03627091|79556596|FG000|Overall Study|Withdrawal by Subject|2|||
44543530|NCT03627091|79556597|FG001|Overall Study|Withdrawal by Subject|0|||
44543531|NCT03627091|79556598|FG002|Overall Study|Withdrawal by Subject|2|||
44543532|NCT03627091|79556596|FG000|Overall Study|Physician Decision|2|||
44543533|NCT03627091|79556597|FG001|Overall Study|Physician Decision|0|||
44209188|NCT01785069|79005675|FG001|Overall Study|Death|0|||
44209189|NCT01785069|79005676|FG002|Overall Study|Death|2|||
44209190|NCT01785069|79005677|FG003|Overall Study|Death|0|||
44209191|NCT01785069|79005674|FG000|Overall Study|Subject choice|2|||
44209192|NCT01785069|79005675|FG001|Overall Study|Subject choice|2|||
44209193|NCT01785069|79005676|FG002|Overall Study|Subject choice|0|||
44209194|NCT01785069|79005677|FG003|Overall Study|Subject choice|1|||
44209195|NCT01785069|79005674|FG000|Overall Study|Lost to Follow-up|1|||
44209196|NCT01785069|79005675|FG001|Overall Study|Lost to Follow-up|2|||
44209197|NCT01785069|79005676|FG002|Overall Study|Lost to Follow-up|4|||
44209198|NCT01785069|79005677|FG003|Overall Study|Lost to Follow-up|1|||
44543534|NCT03627091|79556598|FG002|Overall Study|Physician Decision|0|||
44543535|NCT03627091|79556596|FG000|Overall Study|Site terminated by sponsor|0|||
44543536|NCT03627091|79556597|FG001|Overall Study|Site terminated by sponsor|1|||
44209199|NCT01785069|79005674|FG000|Overall Study|Reason not Specified|1|||
44209200|NCT01785069|79005675|FG001|Overall Study|Reason not Specified|2|||
44209201|NCT01785069|79005676|FG002|Overall Study|Reason not Specified|1|||
44209202|NCT01785069|79005677|FG003|Overall Study|Reason not Specified|4|||
44209203|NCT01785069|79005674|FG000|Overall Study|Not evaluable|7|||
44209204|NCT01785069|79005675|FG001|Overall Study|Not evaluable|4|||
44209205|NCT01785069|79005676|FG002|Overall Study|Not evaluable|5|||
44209206|NCT01785069|79005677|FG003|Overall Study|Not evaluable|8|||
44209207|NCT01784523|79005689|FG000|Overall Study|Study closed early|7|||
44209208|NCT01784523|79005690|FG001|Overall Study|Study closed early|4|||
44209209|NCT01784211|79005698|FG000|Part A (Days 1-15)|Adverse Event|1|||
44209210|NCT01784211|79005699|FG001|Part A (Days 1-15)|Adverse Event|1|||
44209211|NCT01784211|79005700|FG002|Part A (Days 1-15)|Adverse Event|0|||
44209212|NCT01784211|79005701|FG003|Part A (Days 1-15)|Adverse Event|0|||
44209213|NCT01784211|79005702|FG004|Part A (Days 1-15)|Adverse Event|0|||
44209214|NCT01784211|79005703|FG005|Part A (Days 1-15)|Adverse Event|0|||
44209215|NCT01784211|79005698|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
44209216|NCT01784211|79005699|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
44209217|NCT01784211|79005700|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
44209218|NCT01784211|79005701|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
44209219|NCT01784211|79005702|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
44209220|NCT01784211|79005703|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
44209221|NCT01783821|79005717|FG000|Overall Study|Screen Failure|1|||
44209222|NCT01783821|79005718|FG001|Overall Study|Screen Failure|1|||
44209223|NCT01783743|79005726|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
44209224|NCT01783743|79005727|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
44209225|NCT01783743|79005726|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
44209226|NCT01783743|79005727|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
44209227|NCT01783743|79005726|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
44209228|NCT01783743|79005727|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
44209229|NCT01608321|79005735|FG000|Overall Study|Withdrawal by Subject|1|||
44209230|NCT01608321|79005736|FG001|Overall Study|Withdrawal by Subject|0|||
44209231|NCT01608087|79005745|FG000|Overall Study|Lost to Follow-up|0|||
44209232|NCT01608087|79005746|FG001|Overall Study|Lost to Follow-up|1|||
44209233|NCT01608087|79005747|FG002|Overall Study|Lost to Follow-up|0|||
44209234|NCT01608087|79005745|FG000|Overall Study|Other Reason|0|||
44209235|NCT01608087|79005746|FG001|Overall Study|Other Reason|1|||
44209236|NCT01608087|79005747|FG002|Overall Study|Other Reason|0|||
44209237|NCT01912963|79005758|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
44209238|NCT01912963|79005759|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
44209239|NCT01912963|79005760|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
44209240|NCT01912963|79005758|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
44209241|NCT01912963|79005759|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
44209242|NCT01912963|79005760|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
44209243|NCT01912963|79005758|FG000|Overall Study|Adverse Event|0|||
44209244|NCT01912963|79005759|FG001|Overall Study|Adverse Event|1|||
44209245|NCT01912963|79005760|FG002|Overall Study|Adverse Event|1|||
44209246|NCT01912963|79005758|FG000|Overall Study|Withdrawal by Subject|0|||
44209247|NCT01912963|79005759|FG001|Overall Study|Withdrawal by Subject|1|||
44209248|NCT01912963|79005760|FG002|Overall Study|Withdrawal by Subject|0|||
44209249|NCT01912963|79005758|FG000|Overall Study|Sought treatment locally|0|||
44209250|NCT01912963|79005759|FG001|Overall Study|Sought treatment locally|1|||
44209251|NCT01912963|79005760|FG002|Overall Study|Sought treatment locally|0|||
44209252|NCT01754727|79005768|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
44209253|NCT01912807|79005774|FG000|Overall Study|Did not meet elegibility criteria|6|||
44209254|NCT01912807|79005775|FG001|Overall Study|Did not meet elegibility criteria|4|||
44209255|NCT01912807|79005774|FG000|Overall Study|Lost to Follow-up|36|||
44209256|NCT01912807|79005775|FG001|Overall Study|Lost to Follow-up|37|||
44209257|NCT01782885|79005783|FG000|Overall Study|Lost to Follow-up|4|||
44209258|NCT01782885|79005784|FG001|Overall Study|Lost to Follow-up|6|||
44209259|NCT01912729|79005792|FG000|Overall Study|Withdrawal by Subject|0|||
44209260|NCT01912729|79005793|FG001|Overall Study|Withdrawal by Subject|1|||
44369667|NCT00818779|79374857|FG001|Overall Study|Protocol Violation|0|||
44369668|NCT00818779|79374856|FG000|Overall Study|Lost to Follow-up|1|||
44209261|NCT01754493|79005799|FG000|Overall Study|Adverse Event|1|||
44209262|NCT01754493|79005799|FG000|Overall Study|Lost to Follow-up|3|||
44209263|NCT01754493|79005799|FG000|Overall Study|Withdrawal by Subject|1|||
44209264|NCT01754493|79005799|FG000|Overall Study|Moved out of town|1|||
44209265|NCT01754493|79005799|FG000|Overall Study|Scheduling conflict|1|||
44209266|NCT01972789|79005805|FG000|Overall Study|Adverse Event|11|||
44209267|NCT01972789|79005806|FG001|Overall Study|Adverse Event|4|||
44209268|NCT01972789|79005805|FG000|Overall Study|Subject withdrew consent|14|||
44209269|NCT01972789|79005806|FG001|Overall Study|Subject withdrew consent|12|||
44209270|NCT01972789|79005805|FG000|Overall Study|Lost to Follow-up|4|||
44209271|NCT01972789|79005806|FG001|Overall Study|Lost to Follow-up|7|||
44369669|NCT00818779|79374857|FG001|Overall Study|Lost to Follow-up|0|||
44209272|NCT01972789|79005805|FG000|Overall Study|Death|7|||
44209273|NCT01972789|79005806|FG001|Overall Study|Death|5|||
44209274|NCT01972789|79005805|FG000|Overall Study|Protocol deviation|1|||
44209275|NCT01972789|79005806|FG001|Overall Study|Protocol deviation|0|||
44209276|NCT01972789|79005805|FG000|Overall Study|Physician Decision|3|||
44209277|NCT01972789|79005806|FG001|Overall Study|Physician Decision|2|||
44209278|NCT01934335|79005814|FG000|Overall Study|Withdrawal by Subject|1|||
44269731|NCT02332590|79194647|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
44269732|NCT02332590|79194648|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
44269733|NCT02332590|79194647|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
44269734|NCT02332590|79194648|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
44269735|NCT00554840|79194719|FG000|Overall Study|Physician Decision|0|||
44269736|NCT00554840|79194720|FG001|Overall Study|Physician Decision|1|||
44269737|NCT02302716|79194745|FG000|Overall Study|Adverse Event|1|||
44269738|NCT02302716|79194746|FG001|Overall Study|Adverse Event|1|||
44269739|NCT02302716|79194745|FG000|Overall Study|Death|0|||
44269740|NCT02302716|79194746|FG001|Overall Study|Death|1|||
44209279|NCT01934335|79005815|FG001|Overall Study|Withdrawal by Subject|1|||
44209280|NCT01912339|79005823|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
44209281|NCT01912339|79005824|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
44209282|NCT01912339|79005825|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
44209283|NCT01912339|79005823|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
44209284|NCT01912339|79005824|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
44209285|NCT01912339|79005825|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
44209286|NCT01912339|79005823|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
44209287|NCT01912339|79005824|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
44209288|NCT01912339|79005825|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
44209289|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
44209290|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
44209291|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
44209292|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
44209293|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
44209294|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
44209295|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
44209296|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
44209297|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
44209298|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
44209299|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
44209300|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
44209301|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
44209302|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
44209303|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
44209304|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
44209305|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
44209306|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
44209307|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
44209308|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
44369670|NCT00818779|79374856|FG000|Overall Study|Adverse Event|4|||
44543537|NCT03627091|79556598|FG002|Overall Study|Site terminated by sponsor|0|||
44543538|NCT03627091|79556596|FG000|Overall Study|Disease relapse|7|||
44209309|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
44209310|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
44209311|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
44269741|NCT02302716|79194745|FG000|Overall Study|Lack of Efficacy|0|||
44209312|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
44209313|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
44209314|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
44209315|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
44209316|NCT01912339|79005823|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
44209317|NCT01912339|79005824|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
44209318|NCT01912339|79005825|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
44209319|NCT01911793|79005833|FG000|Overall Study|Physician Decision|1|||
44209320|NCT01911793|79005834|FG001|Overall Study|Physician Decision|5|||
44209321|NCT01933789|79005849|FG000|Overall Study|Death|0|||
44209322|NCT01933789|79005850|FG001|Overall Study|Death|0|||
44209323|NCT01933789|79005851|FG002|Overall Study|Death|0|||
44209324|NCT01933789|79005852|FG003|Overall Study|Death|0|||
44209325|NCT01933789|79005853|FG004|Overall Study|Death|21|||
44209326|NCT01933789|79005854|FG005|Overall Study|Death|32|||
44209327|NCT01933789|79005855|FG006|Overall Study|Death|0|||
44209328|NCT01933789|79005856|FG007|Overall Study|Death|0|||
44209329|NCT01933789|79005857|FG008|Overall Study|Death|0|||
44209330|NCT01933789|79005849|FG000|Overall Study|Lost to Follow-up|0|||
44209331|NCT01933789|79005850|FG001|Overall Study|Lost to Follow-up|0|||
44209332|NCT01933789|79005851|FG002|Overall Study|Lost to Follow-up|0|||
44209333|NCT01933789|79005852|FG003|Overall Study|Lost to Follow-up|1|||
44209334|NCT01933789|79005853|FG004|Overall Study|Lost to Follow-up|8|||
44209335|NCT01933789|79005854|FG005|Overall Study|Lost to Follow-up|9|||
44209336|NCT01933789|79005855|FG006|Overall Study|Lost to Follow-up|1|||
44209337|NCT01933789|79005856|FG007|Overall Study|Lost to Follow-up|4|||
44209338|NCT01933789|79005857|FG008|Overall Study|Lost to Follow-up|0|||
44209339|NCT01933789|79005849|FG000|Overall Study|Withdrawal by Subject|2|||
44209340|NCT01933789|79005850|FG001|Overall Study|Withdrawal by Subject|1|||
44209341|NCT01933789|79005851|FG002|Overall Study|Withdrawal by Subject|0|||
44209342|NCT01933789|79005852|FG003|Overall Study|Withdrawal by Subject|0|||
44209343|NCT01933789|79005853|FG004|Overall Study|Withdrawal by Subject|17|||
44209344|NCT01933789|79005854|FG005|Overall Study|Withdrawal by Subject|16|||
44209345|NCT01933789|79005855|FG006|Overall Study|Withdrawal by Subject|1|||
44209346|NCT01933789|79005856|FG007|Overall Study|Withdrawal by Subject|4|||
44209347|NCT01933789|79005857|FG008|Overall Study|Withdrawal by Subject|0|||
44209348|NCT01933789|79005849|FG000|Overall Study|Became Ineligible|4|||
44209349|NCT01933789|79005850|FG001|Overall Study|Became Ineligible|0|||
44209350|NCT01933789|79005851|FG002|Overall Study|Became Ineligible|0|||
44209351|NCT01933789|79005852|FG003|Overall Study|Became Ineligible|0|||
44209352|NCT01933789|79005853|FG004|Overall Study|Became Ineligible|13|||
44209353|NCT01933789|79005854|FG005|Overall Study|Became Ineligible|10|||
44209354|NCT01933789|79005855|FG006|Overall Study|Became Ineligible|13|||
44209355|NCT01933789|79005856|FG007|Overall Study|Became Ineligible|6|||
44209356|NCT01933789|79005857|FG008|Overall Study|Became Ineligible|0|||
44209357|NCT01910389|79005879|FG000|Overall Study|Withdrawal by Subject|2|||
44209358|NCT01910389|79005880|FG001|Overall Study|Withdrawal by Subject|0|||
44209359|NCT01910389|79005879|FG000|Overall Study|Study Closed|13|||
44209360|NCT01910389|79005880|FG001|Overall Study|Study Closed|8|||
44209361|NCT01970995|79005889|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
44209362|NCT01970995|79005890|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
44209363|NCT01970995|79005891|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
44209364|NCT01970995|79005889|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
44209365|NCT01970995|79005890|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
44209366|NCT01970995|79005891|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
44209367|NCT01970527|79005901|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
44209368|NCT01970527|79005902|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
44209369|NCT01970527|79005901|FG000|Treatment|Disease progression|0|||
44209370|NCT01970527|79005902|FG001|Treatment|Disease progression|1|||
44209371|NCT01970527|79005901|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
44209372|NCT01970527|79005902|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
44209373|NCT01970527|79005901|FG000|Treatment|Death|0|||
44209374|NCT01970527|79005902|FG001|Treatment|Death|1|||
44209375|NCT01970527|79005901|FG000|Follow-up Clinic Visit|Disease progression|1|||
44209376|NCT01970527|79005902|FG001|Follow-up Clinic Visit|Disease progression|1|||
44209377|NCT01970527|79005901|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
44209378|NCT01970527|79005902|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
44209379|NCT01970527|79005901|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
44209380|NCT01970527|79005902|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
44209381|NCT01931995|79005913|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
44209382|NCT01931995|79005914|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
44209383|NCT01931995|79005913|FG000|First Intervention (1 Day)|Physician Decision|1|||
44209384|NCT01931995|79005914|FG001|First Intervention (1 Day)|Physician Decision|1|||
44209385|NCT01931995|79005913|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
44209386|NCT01931995|79005914|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
44209387|NCT01408576|79005923|FG000|Overall Study|Lack of Efficacy|17|||
44209388|NCT01408576|79005924|FG001|Overall Study|Lack of Efficacy|30|||
44209389|NCT01408576|79005925|FG002|Overall Study|Lack of Efficacy|48|||
44209390|NCT01408576|79005923|FG000|Overall Study|Protocol Violation|1|||
44209391|NCT01408576|79005924|FG001|Overall Study|Protocol Violation|2|||
44209392|NCT01408576|79005925|FG002|Overall Study|Protocol Violation|2|||
44209393|NCT01408576|79005923|FG000|Overall Study|Lost to Follow-up|10|||
44209394|NCT01408576|79005924|FG001|Overall Study|Lost to Follow-up|9|||
44209395|NCT01408576|79005925|FG002|Overall Study|Lost to Follow-up|17|||
44209396|NCT01408576|79005923|FG000|Overall Study|Withdrawal by Subject|34|||
44209397|NCT01408576|79005924|FG001|Overall Study|Withdrawal by Subject|60|||
44209398|NCT01408576|79005925|FG002|Overall Study|Withdrawal by Subject|66|||
44209399|NCT01408576|79005923|FG000|Overall Study|Sponsor terminated study|89|||
44209400|NCT01408576|79005924|FG001|Overall Study|Sponsor terminated study|333|||
44209401|NCT01408576|79005925|FG002|Overall Study|Sponsor terminated study|330|||
44209402|NCT01408576|79005923|FG000|Overall Study|AE, serious fatal|4|||
44209403|NCT01408576|79005924|FG001|Overall Study|AE, serious fatal|4|||
44209404|NCT01408576|79005925|FG002|Overall Study|AE, serious fatal|1|||
44209405|NCT01408576|79005923|FG000|Overall Study|SAE, non-fatal|11|||
44209406|NCT01408576|79005924|FG001|Overall Study|SAE, non-fatal|23|||
44209407|NCT01408576|79005925|FG002|Overall Study|SAE, non-fatal|14|||
44209408|NCT01408576|79005923|FG000|Overall Study|AE, non-serious non-fatal|12|||
44209409|NCT01408576|79005924|FG001|Overall Study|AE, non-serious non-fatal|19|||
44209410|NCT01408576|79005925|FG002|Overall Study|AE, non-serious non-fatal|11|||
44209411|NCT01408576|79005923|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
44209412|NCT01408576|79005924|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44209413|NCT01408576|79005925|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44209414|NCT01408576|79005923|FG000|Overall Study|AE, unknown type|0|||
44543539|NCT03627091|79556597|FG001|Overall Study|Disease relapse|5|||
44543540|NCT03627091|79556598|FG002|Overall Study|Disease relapse|1|||
44543541|NCT03627091|79556596|FG000|Overall Study|Other|1|||
44543542|NCT03627091|79556597|FG001|Overall Study|Other|0|||
44543543|NCT03627091|79556598|FG002|Overall Study|Other|0|||
44543544|NCT04237584|79556611|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
44543545|NCT04237584|79556612|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
44543546|NCT04237584|79556613|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
44543547|NCT04237584|79556614|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
44209415|NCT01408576|79005924|FG001|Overall Study|AE, unknown type|1|||
44209416|NCT01408576|79005925|FG002|Overall Study|AE, unknown type|0|||
44209417|NCT01408576|79005923|FG000|Overall Study|Other|10|||
44209418|NCT01408576|79005924|FG001|Overall Study|Other|16|||
44209419|NCT01408576|79005925|FG002|Overall Study|Other|18|||
44209420|NCT01427920|79005947|FG000|Overall Study|Adverse Event|1|||
44209421|NCT01427920|79005948|FG001|Overall Study|Adverse Event|2|||
44209422|NCT01427920|79005947|FG000|Overall Study|Lack of Efficacy|1|||
44209423|NCT01427920|79005948|FG001|Overall Study|Lack of Efficacy|0|||
44209424|NCT01427920|79005947|FG000|Overall Study|Protocol Violation|1|||
44209425|NCT01427920|79005948|FG001|Overall Study|Protocol Violation|3|||
44209426|NCT01427920|79005947|FG000|Overall Study|Withdrawal Criteria|4|||
44209427|NCT01427920|79005948|FG001|Overall Study|Withdrawal Criteria|4|||
44209428|NCT01427920|79005947|FG000|Overall Study|Unclassified|2|||
44209429|NCT01427920|79005948|FG001|Overall Study|Unclassified|8|||
44209430|NCT01427608|79005956|FG000|Overall Study|Death|1|||
44209431|NCT01427608|79005957|FG001|Overall Study|Death|0|||
44209432|NCT01427608|79005956|FG000|Overall Study|Withdrawal by Subject|7|||
44209433|NCT01427608|79005957|FG001|Overall Study|Withdrawal by Subject|3|||
44209434|NCT01427608|79005956|FG000|Overall Study|Relapsed-all cause|13|||
44209435|NCT01427608|79005957|FG001|Overall Study|Relapsed-all cause|34|||
44209436|NCT01427608|79005956|FG000|Overall Study|Events not attributed to study meds|0|||
44209437|NCT01427608|79005957|FG001|Overall Study|Events not attributed to study meds|1|||
44209438|NCT01408030|79005969|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
44209439|NCT01408030|79005970|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
44209440|NCT01408030|79005971|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
44209441|NCT01408030|79005972|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
44209442|NCT01408030|79005969|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
44209443|NCT01408030|79005970|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
44209444|NCT01408030|79005971|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
44209445|NCT01408030|79005972|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
44209446|NCT01408030|79005969|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
44209447|NCT01408030|79005970|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
44209448|NCT01408030|79005971|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
44209449|NCT01408030|79005972|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
44209450|NCT01408030|79005969|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
44209451|NCT01408030|79005970|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
44209452|NCT01408030|79005971|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
44209453|NCT01408030|79005972|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
44209454|NCT01408030|79005969|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
44209455|NCT01408030|79005970|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
44209456|NCT01408030|79005971|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
44209457|NCT01408030|79005972|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
44209458|NCT01408030|79005969|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
44209459|NCT01408030|79005970|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
44209460|NCT01408030|79005971|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
44209461|NCT01408030|79005972|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
44209462|NCT01408030|79005969|FG000|Observation Phase (Off Drug)|Other|1|||
44369671|NCT00818779|79374857|FG001|Overall Study|Adverse Event|1|||
44369672|NCT00850759|79374867|FG000|Overall Study|Lost to Follow-up|7|||
44543548|NCT04237584|79556611|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
44209463|NCT01408030|79005970|FG001|Observation Phase (Off Drug)|Other|1|||
44209464|NCT01408030|79005971|FG002|Observation Phase (Off Drug)|Other|1|||
44209465|NCT01408030|79005972|FG003|Observation Phase (Off Drug)|Other|1|||
44209466|NCT01897532|79005984|FG000|Discontinuation From Treatment|Not Treated|7|||
44209467|NCT01897532|79005985|FG001|Discontinuation From Treatment|Not Treated|5|||
44209468|NCT01897532|79005984|FG000|Discontinuation From Treatment|Other reason than specified|196|||
44209469|NCT01897532|79005985|FG001|Discontinuation From Treatment|Other reason than specified|176|||
44209470|NCT01897532|79005984|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
44209471|NCT01897532|79005985|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
44209472|NCT01897532|79005984|FG000|Discontinuation From Treatment|Non compliance|24|||
44209473|NCT01897532|79005985|FG001|Discontinuation From Treatment|Non compliance|15|||
44209474|NCT01897532|79005984|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
44209475|NCT01897532|79005985|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
44209476|NCT01897532|79005984|FG000|Discontinuation From Trial|Not Treated|7|||
44209477|NCT01897532|79005985|FG001|Discontinuation From Trial|Not Treated|5|||
44209478|NCT01897532|79005984|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
44209479|NCT01897532|79005985|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
44209480|NCT01923428|79005995|FG000|Overall Study|Adverse Event|8|||
44209481|NCT01923428|79005996|FG001|Overall Study|Adverse Event|6|||
44209482|NCT01923428|79005997|FG002|Overall Study|Adverse Event|3|||
44209483|NCT01923428|79005998|FG003|Overall Study|Adverse Event|3|||
44209484|NCT01923428|79005995|FG000|Overall Study|Withdrawal by Subject|5|||
44209485|NCT01923428|79005996|FG001|Overall Study|Withdrawal by Subject|3|||
44209486|NCT01923428|79005997|FG002|Overall Study|Withdrawal by Subject|0|||
44209487|NCT01923428|79005998|FG003|Overall Study|Withdrawal by Subject|4|||
44209488|NCT01923428|79005995|FG000|Overall Study|Lost to Follow-up|2|||
44209489|NCT01923428|79005996|FG001|Overall Study|Lost to Follow-up|1|||
44209490|NCT01923428|79005997|FG002|Overall Study|Lost to Follow-up|5|||
44209491|NCT01923428|79005998|FG003|Overall Study|Lost to Follow-up|0|||
44209492|NCT01923428|79005995|FG000|Overall Study|Protocol Violation|3|||
44209493|NCT01923428|79005996|FG001|Overall Study|Protocol Violation|0|||
44209494|NCT01923428|79005997|FG002|Overall Study|Protocol Violation|2|||
44369673|NCT00850759|79374868|FG001|Overall Study|Lost to Follow-up|5|||
44369674|NCT00850759|79374869|FG002|Overall Study|Lost to Follow-up|5|||
44369675|NCT00850759|79374870|FG003|Overall Study|Lost to Follow-up|3|||
44369676|NCT00827827|79374882|FG000|Overall Study|Lost to Follow-up|3|||
44369677|NCT00827827|79374883|FG001|Overall Study|Lost to Follow-up|0|||
44369678|NCT00827827|79374882|FG000|Overall Study|Fall at home- hospitalization|1|||
44369679|NCT00827827|79374883|FG001|Overall Study|Fall at home- hospitalization|0|||
44369680|NCT00827827|79374882|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
44369681|NCT00827827|79374883|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
44369682|NCT00827827|79374882|FG000|Overall Study|Gout|1|||
44543549|NCT04237584|79556612|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
44209495|NCT01923428|79005998|FG003|Overall Study|Protocol Violation|1|||
44209496|NCT01923428|79005995|FG000|Overall Study|Non Compliance to treatment|1|||
44209497|NCT01923428|79005996|FG001|Overall Study|Non Compliance to treatment|2|||
44209498|NCT01923428|79005997|FG002|Overall Study|Non Compliance to treatment|0|||
44209499|NCT01923428|79005998|FG003|Overall Study|Non Compliance to treatment|1|||
44209500|NCT01923428|79005995|FG000|Overall Study|Lack of Efficacy|0|||
44209501|NCT01923428|79005996|FG001|Overall Study|Lack of Efficacy|0|||
44369683|NCT00827827|79374883|FG001|Overall Study|Gout|0|||
44369684|NCT00827827|79374882|FG000|Overall Study|Transportation issues|1|||
44369685|NCT00827827|79374883|FG001|Overall Study|Transportation issues|0|||
44209502|NCT01923428|79005997|FG002|Overall Study|Lack of Efficacy|1|||
44209503|NCT01923428|79005998|FG003|Overall Study|Lack of Efficacy|1|||
44209504|NCT01896986|79006010|FG000|Overall Study|samples lost|14|||
44209505|NCT01896986|79006011|FG001|Overall Study|samples lost|23|||
44209506|NCT01896128|79006019|FG000|Overall Study|Withdrawal by Subject|3|||
44209507|NCT01896128|79006020|FG001|Overall Study|Withdrawal by Subject|3|||
44209508|NCT01949870|79006026|FG000|Overall Study|Lack of Efficacy|2|||
44209509|NCT01949870|79006026|FG000|Overall Study|Adverse Event|1|||
44209510|NCT01949870|79006026|FG000|Overall Study|Study termination|1|||
44209511|NCT01949870|79006026|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
44209512|NCT01949480|79006032|FG000|Overall Study|Physician Decision|5|||
44209513|NCT01949480|79006033|FG001|Overall Study|Physician Decision|8|||
44209514|NCT01949090|79006044|FG000|Overall Study|Serious Adverse Event|0|||
44209515|NCT01949090|79006045|FG001|Overall Study|Serious Adverse Event|1|||
44209516|NCT01949090|79006046|FG002|Overall Study|Serious Adverse Event|2|||
44209517|NCT01949090|79006047|FG003|Overall Study|Serious Adverse Event|0|||
44209518|NCT01949090|79006048|FG004|Overall Study|Serious Adverse Event|1|||
44209519|NCT01949090|79006044|FG000|Overall Study|Withdrawal by Subject|2|||
44209520|NCT01949090|79006045|FG001|Overall Study|Withdrawal by Subject|0|||
44209521|NCT01949090|79006046|FG002|Overall Study|Withdrawal by Subject|0|||
44209522|NCT01949090|79006047|FG003|Overall Study|Withdrawal by Subject|0|||
44209523|NCT01949090|79006048|FG004|Overall Study|Withdrawal by Subject|1|||
44209524|NCT01949090|79006044|FG000|Overall Study|Protocol non-compliance|0|||
44209525|NCT01949090|79006045|FG001|Overall Study|Protocol non-compliance|0|||
44209526|NCT01949090|79006046|FG002|Overall Study|Protocol non-compliance|0|||
44209527|NCT01949090|79006047|FG003|Overall Study|Protocol non-compliance|0|||
44209528|NCT01949090|79006048|FG004|Overall Study|Protocol non-compliance|1|||
44209529|NCT01949090|79006044|FG000|Overall Study|Lost to Follow-up|2|||
44209530|NCT01949090|79006045|FG001|Overall Study|Lost to Follow-up|1|||
44209531|NCT01949090|79006046|FG002|Overall Study|Lost to Follow-up|0|||
44209532|NCT01949090|79006047|FG003|Overall Study|Lost to Follow-up|1|||
44209533|NCT01949090|79006048|FG004|Overall Study|Lost to Follow-up|1|||
44209534|NCT01948076|79006063|FG000|Overall Study|Withdrawal by Subject|0|||
44209535|NCT01948076|79006064|FG001|Overall Study|Withdrawal by Subject|1|||
44209536|NCT01922258|79006074|FG000|Overall Study|Lost to Follow-up|1|||
44209537|NCT01922258|79006075|FG001|Overall Study|Lost to Follow-up|1|||
44209538|NCT01922258|79006074|FG000|Overall Study|Adverse Event|9|||
44209539|NCT01922258|79006075|FG001|Overall Study|Adverse Event|2|||
44209540|NCT01922258|79006074|FG000|Overall Study|Met Withdrawal Criteria|0|||
44209541|NCT01922258|79006075|FG001|Overall Study|Met Withdrawal Criteria|4|||
44209542|NCT01922258|79006074|FG000|Overall Study|Withdrawn by the Investigator|1|||
44543550|NCT04237584|79556613|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
44543551|NCT04237584|79556614|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
44543552|NCT04237584|79556611|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
44543553|NCT04237584|79556612|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
44543554|NCT04237584|79556613|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
44543555|NCT04237584|79556614|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
44209543|NCT01922258|79006075|FG001|Overall Study|Withdrawn by the Investigator|4|||
44209544|NCT01922258|79006074|FG000|Overall Study|Withdrawal by participant|5|||
44209545|NCT01922258|79006075|FG001|Overall Study|Withdrawal by participant|5|||
44369686|NCT00827827|79374882|FG000|Overall Study|Burned with water at home|1|||
44369687|NCT00827827|79374883|FG001|Overall Study|Burned with water at home|0|||
44369688|NCT00600028|79374892|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
44369689|NCT00600028|79374893|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
44369690|NCT00600028|79374892|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
44369691|NCT00600028|79374893|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
44369692|NCT00600028|79374892|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
44369693|NCT00600028|79374893|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
44369694|NCT03542266|79374902|FG000|Treatment Phase|Withdrawal by Subject|1|||
44369695|NCT03542266|79374902|FG000|Treatment Phase|Adverse Event|1|||
44209546|NCT01406938|79006083|FG000|Induction Period|Subject/guardian decision|6|||
44209547|NCT01406938|79006084|FG001|Induction Period|Subject/guardian decision|8|||
44209548|NCT01406938|79006085|FG002|Induction Period|Subject/guardian decision|0|||
44369696|NCT03542266|79374902|FG000|Treatment Phase|PD|1|||
44209549|NCT01406938|79006086|FG003|Induction Period|Subject/guardian decision|0|||
44209550|NCT01406938|79006087|FG004|Induction Period|Subject/guardian decision|0|||
44209551|NCT01406938|79006088|FG005|Induction Period|Subject/guardian decision|0|||
44209552|NCT01406938|79006083|FG000|Induction Period|Protocol deviation|1|||
44209553|NCT01406938|79006084|FG001|Induction Period|Protocol deviation|0|||
44209554|NCT01406938|79006085|FG002|Induction Period|Protocol deviation|0|||
44209555|NCT01406938|79006086|FG003|Induction Period|Protocol deviation|0|||
44209556|NCT01406938|79006087|FG004|Induction Period|Protocol deviation|0|||
44269742|NCT02302716|79194746|FG001|Overall Study|Lack of Efficacy|1|||
44369697|NCT00827359|79374906|FG000|Overall Study|Progressive Diseas|19|||
44209557|NCT01406938|79006088|FG005|Induction Period|Protocol deviation|0|||
44209558|NCT01406938|79006083|FG000|Induction Period|Adverse Event|8|||
44209559|NCT01406938|79006084|FG001|Induction Period|Adverse Event|9|||
44209560|NCT01406938|79006085|FG002|Induction Period|Adverse Event|0|||
44209561|NCT01406938|79006086|FG003|Induction Period|Adverse Event|0|||
44209562|NCT01406938|79006087|FG004|Induction Period|Adverse Event|0|||
44209563|NCT01406938|79006088|FG005|Induction Period|Adverse Event|0|||
44209564|NCT01406938|79006083|FG000|Induction Period|Lack of Efficacy|1|||
44209565|NCT01406938|79006084|FG001|Induction Period|Lack of Efficacy|0|||
44209566|NCT01406938|79006085|FG002|Induction Period|Lack of Efficacy|0|||
44209567|NCT01406938|79006086|FG003|Induction Period|Lack of Efficacy|0|||
44209568|NCT01406938|79006087|FG004|Induction Period|Lack of Efficacy|0|||
44209569|NCT01406938|79006088|FG005|Induction Period|Lack of Efficacy|0|||
44209570|NCT01406938|79006083|FG000|Induction Period|Lost to Follow-up|2|||
44209571|NCT01406938|79006084|FG001|Induction Period|Lost to Follow-up|3|||
44209572|NCT01406938|79006085|FG002|Induction Period|Lost to Follow-up|0|||
44209573|NCT01406938|79006086|FG003|Induction Period|Lost to Follow-up|0|||
44209574|NCT01406938|79006087|FG004|Induction Period|Lost to Follow-up|0|||
44209575|NCT01406938|79006088|FG005|Induction Period|Lost to Follow-up|0|||
44209576|NCT01406938|79006083|FG000|Maintenance Period|Adverse Event|0|||
44209577|NCT01406938|79006084|FG001|Maintenance Period|Adverse Event|0|||
44209578|NCT01406938|79006085|FG002|Maintenance Period|Adverse Event|2|||
44209579|NCT01406938|79006086|FG003|Maintenance Period|Adverse Event|8|||
44209580|NCT01406938|79006087|FG004|Maintenance Period|Adverse Event|4|||
44209581|NCT01406938|79006088|FG005|Maintenance Period|Adverse Event|2|||
44209582|NCT01406938|79006083|FG000|Maintenance Period|Death|0|||
44369698|NCT00827359|79374906|FG000|Overall Study|Unacceptable Toxicity|5|||
44369699|NCT00827359|79374906|FG000|Overall Study|Ineligible|1|||
44369700|NCT00818389|79374912|FG000|Overall Study|Death|1|||
44369701|NCT00818389|79374913|FG001|Overall Study|Death|3|||
44369702|NCT00818389|79374912|FG000|Overall Study|ALS Disease Progression|1|||
44369703|NCT00818389|79374913|FG001|Overall Study|ALS Disease Progression|0|||
44369704|NCT00818389|79374912|FG000|Overall Study|Withdrawal by Subject|2|||
44369705|NCT00818389|79374913|FG001|Overall Study|Withdrawal by Subject|2|||
44369706|NCT00818389|79374912|FG000|Overall Study|Adverse Event|0|||
44369707|NCT00818389|79374913|FG001|Overall Study|Adverse Event|1|||
44369708|NCT00850135|79374919|FG000|Overall Study|Physician Decision|1|||
44369709|NCT01154816|79374937|FG000|Overall Study|Withdrawal by Subject|1|||
44369710|NCT01154816|79374938|FG001|Overall Study|Withdrawal by Subject|0|||
44369711|NCT01154816|79374939|FG002|Overall Study|Withdrawal by Subject|0|||
44543556|NCT04237584|79556611|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
44209583|NCT01406938|79006084|FG001|Maintenance Period|Death|0|||
44209584|NCT01406938|79006085|FG002|Maintenance Period|Death|0|||
44209585|NCT01406938|79006086|FG003|Maintenance Period|Death|0|||
44209586|NCT01406938|79006087|FG004|Maintenance Period|Death|1|||
44209587|NCT01406938|79006088|FG005|Maintenance Period|Death|0|||
44269743|NCT02302716|79194745|FG000|Overall Study|Lost to Follow-up|2|||
44269744|NCT02302716|79194746|FG001|Overall Study|Lost to Follow-up|4|||
44269745|NCT02302716|79194745|FG000|Overall Study|Physician Decision|3|||
44269746|NCT02302716|79194746|FG001|Overall Study|Physician Decision|4|||
44269747|NCT02302716|79194745|FG000|Overall Study|Withdrawal by Subject|13|||
44269748|NCT02302716|79194746|FG001|Overall Study|Withdrawal by Subject|7|||
44269749|NCT02302716|79194745|FG000|Overall Study|Protocol Violation|0|||
44269750|NCT02302716|79194746|FG001|Overall Study|Protocol Violation|1|||
44209588|NCT01406938|79006083|FG000|Maintenance Period|Subject/guardian decision|0|||
44269751|NCT00554606|79194775|FG000|Overall Study|Adverse Event|3|||
44209589|NCT01406938|79006084|FG001|Maintenance Period|Subject/guardian decision|0|||
44269752|NCT00554606|79194775|FG000|Overall Study|Abnormal laboratory values|1|||
44269753|NCT00554606|79194775|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
44269754|NCT00554606|79194775|FG000|Overall Study|Subject withdrew consent|2|||
44209590|NCT01406938|79006085|FG002|Maintenance Period|Subject/guardian decision|11|||
44209591|NCT01406938|79006086|FG003|Maintenance Period|Subject/guardian decision|7|||
44209592|NCT01406938|79006087|FG004|Maintenance Period|Subject/guardian decision|10|||
44209593|NCT01406938|79006088|FG005|Maintenance Period|Subject/guardian decision|7|||
44209594|NCT01406938|79006083|FG000|Maintenance Period|Protocol Violation|0|||
44209595|NCT01406938|79006084|FG001|Maintenance Period|Protocol Violation|0|||
44269755|NCT00554606|79194775|FG000|Overall Study|Lost to Follow-up|2|||
44209596|NCT01406938|79006085|FG002|Maintenance Period|Protocol Violation|2|||
44209597|NCT01406938|79006086|FG003|Maintenance Period|Protocol Violation|2|||
44269756|NCT00554606|79194775|FG000|Overall Study|Administrative problems|60|||
44209598|NCT01406938|79006087|FG004|Maintenance Period|Protocol Violation|2|||
44269757|NCT00554606|79194775|FG000|Overall Study|Death|1|||
44269758|NCT00554606|79194775|FG000|Overall Study|Protocol deviation|2|||
44369712|NCT01154816|79374940|FG003|Overall Study|Withdrawal by Subject|1|||
44369713|NCT01154816|79374941|FG004|Overall Study|Withdrawal by Subject|0|||
44369714|NCT01154816|79374942|FG005|Overall Study|Withdrawal by Subject|0|||
44369715|NCT01154816|79374943|FG006|Overall Study|Withdrawal by Subject|0|||
44369716|NCT01154816|79374944|FG007|Overall Study|Withdrawal by Subject|0|||
44209599|NCT01406938|79006088|FG005|Maintenance Period|Protocol Violation|2|||
44209600|NCT01406938|79006083|FG000|Maintenance Period|Pregnancy|0|||
44209601|NCT01406938|79006084|FG001|Maintenance Period|Pregnancy|0|||
44209602|NCT01406938|79006085|FG002|Maintenance Period|Pregnancy|0|||
44209603|NCT01406938|79006086|FG003|Maintenance Period|Pregnancy|0|||
44209604|NCT01406938|79006087|FG004|Maintenance Period|Pregnancy|1|||
44209605|NCT01406938|79006088|FG005|Maintenance Period|Pregnancy|0|||
44209606|NCT01406938|79006083|FG000|Maintenance Period|Lost to Follow-up|0|||
44209607|NCT01406938|79006084|FG001|Maintenance Period|Lost to Follow-up|0|||
44209608|NCT01406938|79006085|FG002|Maintenance Period|Lost to Follow-up|0|||
44209609|NCT01406938|79006086|FG003|Maintenance Period|Lost to Follow-up|0|||
44209610|NCT01406938|79006087|FG004|Maintenance Period|Lost to Follow-up|4|||
44209611|NCT01406938|79006088|FG005|Maintenance Period|Lost to Follow-up|0|||
44209612|NCT01406938|79006083|FG000|Maintenance Period|Lack of Efficacy|0|||
44209613|NCT01406938|79006084|FG001|Maintenance Period|Lack of Efficacy|0|||
44209614|NCT01406938|79006085|FG002|Maintenance Period|Lack of Efficacy|2|||
44209615|NCT01406938|79006086|FG003|Maintenance Period|Lack of Efficacy|1|||
44209616|NCT01406938|79006087|FG004|Maintenance Period|Lack of Efficacy|3|||
44209617|NCT01406938|79006088|FG005|Maintenance Period|Lack of Efficacy|5|||
44209618|NCT01406938|79006083|FG000|Follow up|Lack of Efficacy|3|||
44209619|NCT01406938|79006084|FG001|Follow up|Lack of Efficacy|2|||
44209620|NCT01406938|79006085|FG002|Follow up|Lack of Efficacy|1|||
44209621|NCT01406938|79006086|FG003|Follow up|Lack of Efficacy|0|||
44209622|NCT01406938|79006087|FG004|Follow up|Lack of Efficacy|0|||
44209623|NCT01406938|79006088|FG005|Follow up|Lack of Efficacy|0|||
44209624|NCT01406938|79006083|FG000|Follow up|Patient/guardian decision|4|||
44209625|NCT01406938|79006084|FG001|Follow up|Patient/guardian decision|2|||
44209626|NCT01406938|79006085|FG002|Follow up|Patient/guardian decision|4|||
44209627|NCT01406938|79006086|FG003|Follow up|Patient/guardian decision|2|||
44209628|NCT01406938|79006087|FG004|Follow up|Patient/guardian decision|4|||
44209629|NCT01406938|79006088|FG005|Follow up|Patient/guardian decision|1|||
44209630|NCT01406938|79006083|FG000|Follow up|Protocol Violation|0|||
44209631|NCT01406938|79006084|FG001|Follow up|Protocol Violation|0|||
44209632|NCT01406938|79006085|FG002|Follow up|Protocol Violation|1|||
44209633|NCT01406938|79006086|FG003|Follow up|Protocol Violation|0|||
44209634|NCT01406938|79006087|FG004|Follow up|Protocol Violation|0|||
44209635|NCT01406938|79006088|FG005|Follow up|Protocol Violation|0|||
44209636|NCT01406938|79006083|FG000|Follow up|Physician Decision|0|||
44209637|NCT01406938|79006084|FG001|Follow up|Physician Decision|0|||
44209638|NCT01406938|79006085|FG002|Follow up|Physician Decision|2|||
44209639|NCT01406938|79006086|FG003|Follow up|Physician Decision|0|||
44209640|NCT01406938|79006087|FG004|Follow up|Physician Decision|3|||
44209641|NCT01406938|79006088|FG005|Follow up|Physician Decision|1|||
44209642|NCT01406938|79006083|FG000|Follow up|Lost to Follow-up|1|||
44209643|NCT01406938|79006084|FG001|Follow up|Lost to Follow-up|1|||
44209644|NCT01406938|79006085|FG002|Follow up|Lost to Follow-up|0|||
44209645|NCT01406938|79006086|FG003|Follow up|Lost to Follow-up|1|||
44209646|NCT01406938|79006087|FG004|Follow up|Lost to Follow-up|2|||
44209647|NCT01406938|79006088|FG005|Follow up|Lost to Follow-up|1|||
44209648|NCT01405924|79006108|FG000|Overall Study|Protocol Violation|8|||
44209649|NCT01405924|79006108|FG000|Overall Study|Missing/Incomplete Data|2|||
44209650|NCT01426438|79006116|FG000|Overall Study|Lost to Follow-up|1|||
44209651|NCT01426438|79006117|FG001|Overall Study|Lost to Follow-up|3|||
44209652|NCT01426438|79006116|FG000|Overall Study|Off study Treatment|9|||
44209653|NCT01426438|79006117|FG001|Overall Study|Off study Treatment|3|||
44209654|NCT01426438|79006116|FG000|Overall Study|Poor scan quality|3|||
44209655|NCT01426438|79006117|FG001|Overall Study|Poor scan quality|2|||
44209656|NCT01426438|79006116|FG000|Overall Study|Missed Scan|2|||
44209657|NCT01426438|79006117|FG001|Overall Study|Missed Scan|2|||
44209658|NCT01425814|79006123|FG000|Period 1|Stability criteria not fulfilled|0|||
44209659|NCT01425814|79006124|FG001|Period 1|Stability criteria not fulfilled|1|||
44209660|NCT01425814|79006125|FG002|Period 1|Stability criteria not fulfilled|0|||
44209661|NCT01425814|79006126|FG003|Period 1|Stability criteria not fulfilled|0|||
44209662|NCT01425814|79006127|FG004|Period 1|Stability criteria not fulfilled|0|||
44209663|NCT01425814|79006128|FG005|Period 1|Stability criteria not fulfilled|0|||
44543557|NCT04237584|79556612|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
44209664|NCT01425814|79006123|FG000|Period 2|Stability criteria not fulfilled|0|||
44209665|NCT01425814|79006124|FG001|Period 2|Stability criteria not fulfilled|1|||
44209666|NCT01425814|79006125|FG002|Period 2|Stability criteria not fulfilled|0|||
44209667|NCT01425814|79006126|FG003|Period 2|Stability criteria not fulfilled|0|||
44209668|NCT01425814|79006127|FG004|Period 2|Stability criteria not fulfilled|0|||
44269759|NCT02354508|79194811|FG000|Period 1: Core Phase|Adverse Event|1|||
44209669|NCT01425814|79006128|FG005|Period 2|Stability criteria not fulfilled|0|||
44209670|NCT01425814|79006123|FG000|Period 3|Adverse Event|0|||
44209671|NCT01425814|79006124|FG001|Period 3|Adverse Event|0|||
44209672|NCT01425814|79006125|FG002|Period 3|Adverse Event|0|||
44209673|NCT01425814|79006126|FG003|Period 3|Adverse Event|0|||
44209674|NCT01425814|79006127|FG004|Period 3|Adverse Event|0|||
44209675|NCT01425814|79006128|FG005|Period 3|Adverse Event|1|||
44209676|NCT01425814|79006123|FG000|Period 4|Adverse Event|1|||
44209677|NCT01425814|79006124|FG001|Period 4|Adverse Event|0|||
44209678|NCT01425814|79006125|FG002|Period 4|Adverse Event|1|||
44209679|NCT01425814|79006126|FG003|Period 4|Adverse Event|0|||
44209680|NCT01425814|79006127|FG004|Period 4|Adverse Event|0|||
44209681|NCT01425814|79006128|FG005|Period 4|Adverse Event|0|||
44209682|NCT01425814|79006123|FG000|Period 5|Stability criteria not fulfilled|0|||
44209683|NCT01425814|79006124|FG001|Period 5|Stability criteria not fulfilled|0|||
44209684|NCT01425814|79006125|FG002|Period 5|Stability criteria not fulfilled|1|||
44209685|NCT01425814|79006126|FG003|Period 5|Stability criteria not fulfilled|0|||
44209686|NCT01425814|79006127|FG004|Period 5|Stability criteria not fulfilled|0|||
44209687|NCT01425814|79006128|FG005|Period 5|Stability criteria not fulfilled|1|||
44209688|NCT01782495|79006153|FG000|Overall Study|Adverse Event|0|||
44209689|NCT01782495|79006154|FG001|Overall Study|Adverse Event|0|||
44209690|NCT01782495|79006155|FG002|Overall Study|Adverse Event|0|||
44209691|NCT01782495|79006156|FG003|Overall Study|Adverse Event|0|||
44209692|NCT01782495|79006157|FG004|Overall Study|Adverse Event|0|||
44209693|NCT01782495|79006158|FG005|Overall Study|Adverse Event|0|||
44209694|NCT01782495|79006159|FG006|Overall Study|Adverse Event|0|||
44209695|NCT01782495|79006160|FG007|Overall Study|Adverse Event|2|||
44209696|NCT01782495|79006161|FG008|Overall Study|Adverse Event|0|||
44209697|NCT01782495|79006162|FG009|Overall Study|Adverse Event|0|||
44209698|NCT01782495|79006163|FG010|Overall Study|Adverse Event|0|||
44209699|NCT01782495|79006153|FG000|Overall Study|Withdrew Consent|0|||
44209700|NCT01782495|79006154|FG001|Overall Study|Withdrew Consent|1|||
44209701|NCT01782495|79006155|FG002|Overall Study|Withdrew Consent|0|||
44209702|NCT01782495|79006156|FG003|Overall Study|Withdrew Consent|0|||
44209703|NCT01782495|79006157|FG004|Overall Study|Withdrew Consent|0|||
44209704|NCT01782495|79006158|FG005|Overall Study|Withdrew Consent|0|||
44209705|NCT01782495|79006159|FG006|Overall Study|Withdrew Consent|0|||
44209706|NCT01782495|79006160|FG007|Overall Study|Withdrew Consent|1|||
44209707|NCT01782495|79006161|FG008|Overall Study|Withdrew Consent|0|||
44209708|NCT01782495|79006162|FG009|Overall Study|Withdrew Consent|0|||
44209709|NCT01782495|79006163|FG010|Overall Study|Withdrew Consent|0|||
44209710|NCT01922102|79006190|FG000|Overall Study|Withdrawal by Subject|7|||
44209711|NCT01922102|79006191|FG001|Overall Study|Withdrawal by Subject|3|||
44209712|NCT01922102|79006192|FG002|Overall Study|Withdrawal by Subject|7|||
44209713|NCT01922102|79006190|FG000|Overall Study|Physician Decision|0|||
44209714|NCT01922102|79006191|FG001|Overall Study|Physician Decision|2|||
44209715|NCT01922102|79006192|FG002|Overall Study|Physician Decision|1|||
44209716|NCT01922102|79006190|FG000|Overall Study|Adverse Event|1|||
44209717|NCT01922102|79006191|FG001|Overall Study|Adverse Event|2|||
44209718|NCT01922102|79006192|FG002|Overall Study|Adverse Event|0|||
44209719|NCT01922102|79006190|FG000|Overall Study|Lost to Follow-up|1|||
44209720|NCT01922102|79006191|FG001|Overall Study|Lost to Follow-up|0|||
44369717|NCT01154816|79374945|FG008|Overall Study|Withdrawal by Subject|1|||
44209721|NCT01922102|79006192|FG002|Overall Study|Lost to Follow-up|0|||
44209722|NCT01922102|79006190|FG000|Overall Study|Administrative problems|0|||
44209723|NCT01922102|79006191|FG001|Overall Study|Administrative problems|2|||
44209724|NCT01922102|79006192|FG002|Overall Study|Administrative problems|0|||
44209725|NCT01405768|79006206|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
44209726|NCT01405768|79006207|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
44209727|NCT01913353|79006215|FG000|Overall Study|Adverse Event|2|||
44209728|NCT01913353|79006216|FG001|Overall Study|Adverse Event|0|||
44209729|NCT01913353|79006215|FG000|Overall Study|Physician Decision|0|||
44209730|NCT01913353|79006216|FG001|Overall Study|Physician Decision|2|||
44209731|NCT01913353|79006215|FG000|Overall Study|Withdrawal by Subject|20|||
44209732|NCT01913353|79006216|FG001|Overall Study|Withdrawal by Subject|6|||
44209733|NCT01913353|79006215|FG000|Overall Study|multiple reasons|10|||
44209734|NCT01913353|79006216|FG001|Overall Study|multiple reasons|7|||
44209735|NCT01754259|79006231|FG000|Overall Study|Withdrawal by Subject|2|||
44209736|NCT01754259|79006232|FG001|Overall Study|Withdrawal by Subject|4|||
44209737|NCT01754259|79006231|FG000|Overall Study|Adverse Event|3|||
44209738|NCT01754259|79006232|FG001|Overall Study|Adverse Event|1|||
44209739|NCT01754259|79006231|FG000|Overall Study|Lost to Follow-up|0|||
44209740|NCT01754259|79006232|FG001|Overall Study|Lost to Follow-up|1|||
44209741|NCT01405456|79006240|FG000|Overall Study|Lost to Follow-up|2|||
44209742|NCT01405456|79006241|FG001|Overall Study|Lost to Follow-up|1|||
44209743|NCT01405456|79006240|FG000|Overall Study|Physician Decision|1|||
44209744|NCT01405456|79006241|FG001|Overall Study|Physician Decision|0|||
44209745|NCT01404988|79006250|FG000|Overall Study|Death|2|||
44209746|NCT01404988|79006251|FG001|Overall Study|Death|0|||
44209747|NCT01404988|79006252|FG002|Overall Study|Death|2|||
44209748|NCT01404988|79006250|FG000|Overall Study|Adverse Event|1|||
44209749|NCT01404988|79006251|FG001|Overall Study|Adverse Event|0|||
44209750|NCT01404988|79006252|FG002|Overall Study|Adverse Event|0|||
44209751|NCT01404988|79006250|FG000|Overall Study|Withdrawal by Subject|2|||
44209752|NCT01404988|79006251|FG001|Overall Study|Withdrawal by Subject|2|||
44209753|NCT01404988|79006252|FG002|Overall Study|Withdrawal by Subject|0|||
44209754|NCT01404988|79006250|FG000|Overall Study|Lost to Follow-up|1|||
44209755|NCT01404988|79006251|FG001|Overall Study|Lost to Follow-up|2|||
44209756|NCT01404988|79006252|FG002|Overall Study|Lost to Follow-up|1|||
44209757|NCT01389232|79006263|FG000|Overall Study|Had scaffold removed|15|||
44209758|NCT01389232|79006263|FG000|Overall Study|Personal reasons|2|||
44209759|NCT01389232|79006263|FG000|Overall Study|Adverse Event|1|||
44209760|NCT01389232|79006263|FG000|Overall Study|Death|1|||
44209761|NCT01404208|79006279|FG000|Overall Study|Discontinued|3|||
44209762|NCT01404208|79006280|FG001|Overall Study|Discontinued|0|||
44209763|NCT01617668|79006288|FG000|Overall Study|Adverse Event|7|||
44209764|NCT01617668|79006289|FG001|Overall Study|Adverse Event|0|||
44209765|NCT01617668|79006290|FG002|Overall Study|Adverse Event|12|||
44209766|NCT01617668|79006291|FG003|Overall Study|Adverse Event|5|||
44209767|NCT01617668|79006288|FG000|Overall Study|Physician Decision|1|||
44209768|NCT01617668|79006289|FG001|Overall Study|Physician Decision|2|||
44209769|NCT01617668|79006290|FG002|Overall Study|Physician Decision|3|||
44209770|NCT01617668|79006291|FG003|Overall Study|Physician Decision|0|||
44209771|NCT01617668|79006288|FG000|Overall Study|Progressive Disease|4|||
44209772|NCT01617668|79006289|FG001|Overall Study|Progressive Disease|4|||
44209773|NCT01617668|79006290|FG002|Overall Study|Progressive Disease|6|||
44209774|NCT01617668|79006291|FG003|Overall Study|Progressive Disease|9|||
44209775|NCT01617668|79006288|FG000|Overall Study|Subject/guardian decision|1|||
44209776|NCT01617668|79006289|FG001|Overall Study|Subject/guardian decision|3|||
44209777|NCT01617668|79006290|FG002|Overall Study|Subject/guardian decision|2|||
44209778|NCT01617668|79006291|FG003|Overall Study|Subject/guardian decision|1|||
44209779|NCT01425268|79006307|FG000|Overall Study|Withdrawal by Subject|2|||
44209780|NCT01425268|79006308|FG001|Overall Study|Withdrawal by Subject|0|||
44209781|NCT01425268|79006307|FG000|Overall Study|Sponsor Decision|5|||
44209782|NCT01425268|79006308|FG001|Overall Study|Sponsor Decision|0|||
44209783|NCT01425268|79006307|FG000|Overall Study|Physician Decision|1|||
44209784|NCT01425268|79006308|FG001|Overall Study|Physician Decision|0|||
44209785|NCT01425190|79006317|FG000|Overall Study|Full dose not consumed.|1|||
44209786|NCT01425190|79006318|FG001|Overall Study|Full dose not consumed.|0|||
44209787|NCT01425190|79006319|FG002|Overall Study|Full dose not consumed.|0|||
44209788|NCT01388530|79006327|FG000|Overall Study|Lost to Follow-up|5|||
44209789|NCT01895270|79006333|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
44209790|NCT01895270|79006334|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
44369718|NCT01154816|79374946|FG009|Overall Study|Withdrawal by Subject|3|||
44369719|NCT01154816|79374947|FG010|Overall Study|Withdrawal by Subject|0|||
44369720|NCT01154816|79374948|FG011|Overall Study|Withdrawal by Subject|0|||
44369721|NCT01154816|79374937|FG000|Overall Study|Progressive Disease|13|||
44369722|NCT01154816|79374938|FG001|Overall Study|Progressive Disease|8|||
44209791|NCT01895270|79006333|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
44209792|NCT01895270|79006334|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
44209793|NCT01895270|79006333|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
44543558|NCT04237584|79556613|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
44209794|NCT01895270|79006334|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
44209795|NCT01895270|79006333|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
44209796|NCT01895270|79006334|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
44209797|NCT01895270|79006333|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
44209798|NCT01895270|79006334|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
44209799|NCT01895270|79006333|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
44369723|NCT01154816|79374939|FG002|Overall Study|Progressive Disease|9|||
44369724|NCT01154816|79374940|FG003|Overall Study|Progressive Disease|9|||
44209800|NCT01895270|79006334|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
44209801|NCT01895270|79006333|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
44209802|NCT01895270|79006334|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
44209803|NCT01424722|79006340|FG000|Overall Study|Sponsor terminated investigation|2258|||
44209804|NCT01424644|79006346|FG000|Overall Study|Adverse Event|2|||
44209805|NCT01424644|79006347|FG001|Overall Study|Adverse Event|0|||
44209806|NCT01424644|79006346|FG000|Overall Study|Withdrawal by Subject|9|||
44209807|NCT01424644|79006347|FG001|Overall Study|Withdrawal by Subject|12|||
44209808|NCT01424644|79006346|FG000|Overall Study|Lost to Follow-up|16|||
44209809|NCT01424644|79006347|FG001|Overall Study|Lost to Follow-up|12|||
44209810|NCT01424644|79006346|FG000|Overall Study|Protocol Violation|4|||
44209811|NCT01424644|79006347|FG001|Overall Study|Protocol Violation|3|||
44209812|NCT01424644|79006346|FG000|Overall Study|Administrative Reason|1|||
44209813|NCT01424644|79006347|FG001|Overall Study|Administrative Reason|0|||
44209814|NCT01424644|79006346|FG000|Overall Study|Unable to Classify|1|||
44209815|NCT01424644|79006347|FG001|Overall Study|Unable to Classify|0|||
44209816|NCT01920854|79006360|FG000|Overall Study|Withdrawal by Subject|1|||
44209817|NCT01920854|79006361|FG001|Overall Study|Withdrawal by Subject|0|||
44209818|NCT01920854|79006362|FG002|Overall Study|Withdrawal by Subject|0|||
44369725|NCT01154816|79374941|FG004|Overall Study|Progressive Disease|8|||
44369726|NCT01154816|79374942|FG005|Overall Study|Progressive Disease|8|||
44369727|NCT01154816|79374943|FG006|Overall Study|Progressive Disease|5|||
44369728|NCT01154816|79374944|FG007|Overall Study|Progressive Disease|6|||
44369729|NCT01154816|79374945|FG008|Overall Study|Progressive Disease|8|||
44369730|NCT01154816|79374946|FG009|Overall Study|Progressive Disease|6|||
44369731|NCT01154816|79374947|FG010|Overall Study|Progressive Disease|10|||
44369732|NCT01154816|79374948|FG011|Overall Study|Progressive Disease|3|||
44369733|NCT01154816|79374937|FG000|Overall Study|Physician Decision|1|||
44369734|NCT01154816|79374938|FG001|Overall Study|Physician Decision|0|||
44369735|NCT01154816|79374939|FG002|Overall Study|Physician Decision|1|||
44369736|NCT01154816|79374940|FG003|Overall Study|Physician Decision|0|||
44369737|NCT01154816|79374941|FG004|Overall Study|Physician Decision|2|||
44369738|NCT01154816|79374942|FG005|Overall Study|Physician Decision|0|||
44369739|NCT01154816|79374943|FG006|Overall Study|Physician Decision|0|||
44369740|NCT01154816|79374944|FG007|Overall Study|Physician Decision|0|||
44369741|NCT01154816|79374945|FG008|Overall Study|Physician Decision|0|||
44369742|NCT01154816|79374946|FG009|Overall Study|Physician Decision|1|||
44369743|NCT01154816|79374947|FG010|Overall Study|Physician Decision|1|||
44369744|NCT01154816|79374948|FG011|Overall Study|Physician Decision|1|||
44369745|NCT01154816|79374937|FG000|Overall Study|Adverse Event|5|||
44369746|NCT01154816|79374938|FG001|Overall Study|Adverse Event|2|||
44369747|NCT01154816|79374939|FG002|Overall Study|Adverse Event|0|||
44369748|NCT01154816|79374940|FG003|Overall Study|Adverse Event|0|||
44369749|NCT01154816|79374941|FG004|Overall Study|Adverse Event|0|||
44369750|NCT01154816|79374942|FG005|Overall Study|Adverse Event|0|||
44209819|NCT01920854|79006363|FG003|Overall Study|Withdrawal by Subject|0|||
44209820|NCT01920854|79006364|FG004|Overall Study|Withdrawal by Subject|1|||
44543559|NCT04237584|79556614|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
44209821|NCT01920854|79006365|FG005|Overall Study|Withdrawal by Subject|0|||
44209822|NCT01920854|79006366|FG006|Overall Study|Withdrawal by Subject|1|||
44209823|NCT01403194|79006401|FG000|Overall Study|Screen Failure|2|||
44209824|NCT01403194|79006401|FG000|Overall Study|Lost to Follow-up|8|||
44209825|NCT01403116|79006407|FG000|Overall Study|Adverse Event|7|||
44209826|NCT01403116|79006408|FG001|Overall Study|Adverse Event|4|||
44209827|NCT01403116|79006407|FG000|Overall Study|Lost to Follow-up|7|||
44209828|NCT01403116|79006408|FG001|Overall Study|Lost to Follow-up|5|||
44209829|NCT01403116|79006407|FG000|Overall Study|Withdrawal by Subject|12|||
44209830|NCT01403116|79006408|FG001|Overall Study|Withdrawal by Subject|15|||
44209831|NCT01403116|79006407|FG000|Overall Study|Non-compliance of study drug|3|||
44209832|NCT01403116|79006408|FG001|Overall Study|Non-compliance of study drug|0|||
44209833|NCT01403116|79006407|FG000|Overall Study|Protocol Violation|0|||
44209834|NCT01403116|79006408|FG001|Overall Study|Protocol Violation|1|||
44209835|NCT01403116|79006407|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
44209836|NCT01403116|79006408|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
44209837|NCT01403116|79006407|FG000|Overall Study|Hct >54%|2|||
44209838|NCT01403116|79006408|FG001|Overall Study|Hct >54%|0|||
44209839|NCT01403116|79006407|FG000|Overall Study|unable to keep appointments|0|||
44209840|NCT01403116|79006408|FG001|Overall Study|unable to keep appointments|2|||
44209841|NCT01402570|79006414|FG000|Overall Study|Adverse Event|1|||
44209842|NCT01753401|79006421|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
44209843|NCT01753401|79006422|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
44209844|NCT01753401|79006423|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
44369751|NCT01154816|79374943|FG006|Overall Study|Adverse Event|1|||
44369752|NCT01154816|79374944|FG007|Overall Study|Adverse Event|1|||
44369753|NCT01154816|79374945|FG008|Overall Study|Adverse Event|0|||
44369754|NCT01154816|79374946|FG009|Overall Study|Adverse Event|0|||
44369755|NCT01154816|79374947|FG010|Overall Study|Adverse Event|0|||
44369756|NCT01154816|79374948|FG011|Overall Study|Adverse Event|0|||
44209845|NCT01753401|79006424|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
44209846|NCT01753401|79006421|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
44209847|NCT01753401|79006422|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
44209848|NCT01753401|79006423|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
44209849|NCT01753401|79006424|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
44209850|NCT01753401|79006421|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
44209851|NCT01753401|79006422|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
44209852|NCT01753401|79006423|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
44209853|NCT01753401|79006424|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
44209854|NCT01753401|79006421|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
44209855|NCT01753401|79006422|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
44209856|NCT01753401|79006423|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
44209857|NCT01753401|79006424|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
44209858|NCT01753401|79006421|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
44209859|NCT01753401|79006422|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
44209860|NCT01753401|79006423|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
44209861|NCT01753401|79006424|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
44209862|NCT01753401|79006421|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
44209863|NCT01753401|79006422|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
44209864|NCT01753401|79006423|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
44209865|NCT01753401|79006424|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
44209866|NCT01753401|79006421|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
44209867|NCT01753401|79006422|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
44209868|NCT01753401|79006423|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
44209869|NCT01753401|79006424|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
44209870|NCT01618916|79006440|FG000|Overall Study|Adverse Event|1|||
44209871|NCT01618916|79006441|FG001|Overall Study|Adverse Event|0|||
44209872|NCT01618916|79006442|FG002|Overall Study|Adverse Event|0|||
44209873|NCT01618916|79006443|FG003|Overall Study|Adverse Event|0|||
44209874|NCT01618916|79006444|FG004|Overall Study|Adverse Event|0|||
44209875|NCT01618916|79006445|FG005|Overall Study|Adverse Event|0|||
44209876|NCT01618916|79006440|FG000|Overall Study|Withdrawal by Subject|0|||
44209877|NCT01618916|79006441|FG001|Overall Study|Withdrawal by Subject|1|||
44209878|NCT01618916|79006442|FG002|Overall Study|Withdrawal by Subject|1|||
44209879|NCT01618916|79006443|FG003|Overall Study|Withdrawal by Subject|0|||
44209880|NCT01618916|79006444|FG004|Overall Study|Withdrawal by Subject|1|||
44209881|NCT01618916|79006445|FG005|Overall Study|Withdrawal by Subject|0|||
44209882|NCT01618916|79006440|FG000|Overall Study|Lost to Follow-up|1|||
44209883|NCT01618916|79006441|FG001|Overall Study|Lost to Follow-up|0|||
44209884|NCT01618916|79006442|FG002|Overall Study|Lost to Follow-up|0|||
44209885|NCT01618916|79006443|FG003|Overall Study|Lost to Follow-up|2|||
44209886|NCT01618916|79006444|FG004|Overall Study|Lost to Follow-up|0|||
44209887|NCT01618916|79006445|FG005|Overall Study|Lost to Follow-up|0|||
44209888|NCT01753323|79006461|FG000|Overall Study|Lack of Efficacy|0|||
44209889|NCT01753323|79006462|FG001|Overall Study|Lack of Efficacy|0|||
44209890|NCT01753323|79006463|FG002|Overall Study|Lack of Efficacy|8|||
44209891|NCT01753323|79006461|FG000|Overall Study|Protocol deviation|1|||
44209892|NCT01753323|79006462|FG001|Overall Study|Protocol deviation|0|||
44209893|NCT01753323|79006463|FG002|Overall Study|Protocol deviation|0|||
44209894|NCT01753323|79006461|FG000|Overall Study|Adverse Event|0|||
44209895|NCT01753323|79006462|FG001|Overall Study|Adverse Event|0|||
44209896|NCT01753323|79006463|FG002|Overall Study|Adverse Event|1|||
44209897|NCT01894568|79006474|FG000|Overall Study|Adverse Event|2|||
44209898|NCT01894568|79006475|FG001|Overall Study|Adverse Event|3|||
44209899|NCT01894568|79006474|FG000|Overall Study|Protocol required discontinuation|2|||
44209900|NCT01894568|79006475|FG001|Overall Study|Protocol required discontinuation|1|||
44209901|NCT01894568|79006474|FG000|Overall Study|Withdrawal by Subject|5|||
44209902|NCT01894568|79006475|FG001|Overall Study|Withdrawal by Subject|5|||
44209903|NCT01894568|79006474|FG000|Overall Study|Physician Decision|1|||
44209904|NCT01894568|79006475|FG001|Overall Study|Physician Decision|0|||
44209905|NCT01894568|79006474|FG000|Overall Study|Lost to Follow-up|0|||
44209906|NCT01894568|79006475|FG001|Overall Study|Lost to Follow-up|1|||
44209907|NCT01618838|79006482|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
44269760|NCT02354508|79194812|FG001|Period 1: Core Phase|Adverse Event|1|||
44269761|NCT02354508|79194813|FG002|Period 1: Core Phase|Adverse Event|2|||
44269762|NCT02354508|79194811|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
44543560|NCT04237584|79556611|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
44543561|NCT04237584|79556612|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
44543562|NCT04237584|79556613|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
44543563|NCT04237584|79556614|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
44209908|NCT01920152|79006489|FG000|Overall Study|Withdrawal by Subject|1|||
44543564|NCT03224598|79556631|FG000|Overall Study|Lost to Follow-up|0|||
44209909|NCT01920152|79006490|FG001|Overall Study|Withdrawal by Subject|2|||
44209910|NCT01752933|79006498|FG000|Treatment|Disease Progression|3|||
44209911|NCT01752933|79006499|FG001|Treatment|Disease Progression|29|||
44209912|NCT01752933|79006498|FG000|Treatment|Withdrawal by Subject|0|||
44543565|NCT03224598|79556632|FG001|Overall Study|Lost to Follow-up|2|||
44543566|NCT03224598|79556633|FG002|Overall Study|Lost to Follow-up|0|||
44209913|NCT01752933|79006499|FG001|Treatment|Withdrawal by Subject|5|||
44209914|NCT01752933|79006498|FG000|Treatment|Adverse Event|1|||
44209915|NCT01752933|79006499|FG001|Treatment|Adverse Event|4|||
44209916|NCT01752933|79006498|FG000|Treatment|Physician Decision|0|||
44209917|NCT01752933|79006499|FG001|Treatment|Physician Decision|3|||
44209918|NCT01752933|79006498|FG000|Treatment|Death|0|||
44209919|NCT01752933|79006499|FG001|Treatment|Death|2|||
44209920|NCT01752933|79006498|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
44209921|NCT01752933|79006499|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
44209922|NCT01752933|79006498|FG000|Treatment|Patient noncompliant|0|||
44209923|NCT01752933|79006499|FG001|Treatment|Patient noncompliant|1|||
44209924|NCT01752933|79006498|FG000|Treatment|Patient unable to travel to appointments|0|||
44209925|NCT01752933|79006499|FG001|Treatment|Patient unable to travel to appointments|1|||
44209926|NCT01752933|79006498|FG000|Overall Study and Follow-up|Death|4|||
44209927|NCT01752933|79006499|FG001|Overall Study and Follow-up|Death|34|||
44209928|NCT01752933|79006498|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
44209929|NCT01752933|79006499|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
44209930|NCT01752933|79006498|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
44209931|NCT01752933|79006499|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
44209932|NCT01752933|79006498|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
44209933|NCT01752933|79006499|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
44209934|NCT01752855|79006508|FG000|Overall Study|Adverse Event|1|||
44209935|NCT01752855|79006509|FG001|Overall Study|Adverse Event|0|||
44209936|NCT01752855|79006508|FG000|Overall Study|Withdrew Consent|0|||
44209937|NCT01752855|79006509|FG001|Overall Study|Withdrew Consent|2|||
44209938|NCT01752855|79006508|FG000|Overall Study|Lack of Efficacy|0|||
44209939|NCT01752855|79006509|FG001|Overall Study|Lack of Efficacy|2|||
44209940|NCT01402492|79006518|FG000|Overall Study|Withdrawal by Subject|17|||
44209941|NCT01402492|79006519|FG001|Overall Study|Withdrawal by Subject|11|||
44209942|NCT01402492|79006520|FG002|Overall Study|Withdrawal by Subject|11|||
44209943|NCT01402492|79006518|FG000|Overall Study|Adverse Event|2|||
44209944|NCT01402492|79006519|FG001|Overall Study|Adverse Event|3|||
44209945|NCT01402492|79006520|FG002|Overall Study|Adverse Event|4|||
44209946|NCT01402492|79006518|FG000|Overall Study|Physician Decision|0|||
44209947|NCT01402492|79006519|FG001|Overall Study|Physician Decision|3|||
44209948|NCT01402492|79006520|FG002|Overall Study|Physician Decision|0|||
44209949|NCT01402492|79006518|FG000|Overall Study|Incarcerated (N=3)|2|||
44209950|NCT01402492|79006519|FG001|Overall Study|Incarcerated (N=3)|0|||
44209951|NCT01402492|79006520|FG002|Overall Study|Incarcerated (N=3)|1|||
44209952|NCT01402102|79006530|FG000|Overall Study|Protocol Violation|1|||
44209953|NCT01402102|79006531|FG001|Overall Study|Protocol Violation|0|||
44209954|NCT01402102|79006530|FG000|Overall Study|Insufficiency of compliance|1|||
44209955|NCT01402102|79006531|FG001|Overall Study|Insufficiency of compliance|1|||
44209956|NCT01402102|79006530|FG000|Overall Study|Withdrawal by Subject|0|||
44209957|NCT01402102|79006531|FG001|Overall Study|Withdrawal by Subject|2|||
44209958|NCT01423084|79006541|FG000|Overall Study|Adverse Event|0|||
44209959|NCT01423084|79006542|FG001|Overall Study|Adverse Event|1|||
44209960|NCT01423084|79006541|FG000|Overall Study|Withdrawal by Subject|2|||
44209961|NCT01423084|79006542|FG001|Overall Study|Withdrawal by Subject|3|||
44209962|NCT01894256|79006552|FG000|Part A|Adverse Event|0|||
44209963|NCT01894256|79006553|FG001|Part A|Adverse Event|1|||
44209964|NCT01894256|79006554|FG002|Part A|Adverse Event|0|||
44209965|NCT01894256|79006552|FG000|Part B|Death|0|||
44209966|NCT01894256|79006553|FG001|Part B|Death|1|||
44369757|NCT00849901|79374994|FG000|Acute Treatment Phase|Adverse Event|9|||
44369758|NCT00849901|79374995|FG001|Acute Treatment Phase|Adverse Event|1|||
44369759|NCT00849901|79374996|FG002|Acute Treatment Phase|Adverse Event|3|||
44369760|NCT00849901|79374994|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
44369761|NCT00849901|79374995|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
44369762|NCT00849901|79374996|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
44369763|NCT00849901|79374994|FG000|Acute Treatment Phase|Protocol Violation|0|||
44369764|NCT00849901|79374995|FG001|Acute Treatment Phase|Protocol Violation|2|||
44209967|NCT01894256|79006554|FG002|Part B|Death|1|||
44209968|NCT01894256|79006552|FG000|Part B|Withdrawal by Subject|0|||
44209969|NCT01894256|79006553|FG001|Part B|Withdrawal by Subject|1|||
44209970|NCT01894256|79006554|FG002|Part B|Withdrawal by Subject|0|||
44209971|NCT01894256|79006552|FG000|Part B|Lack of Efficacy|15|||
44209972|NCT01894256|79006553|FG001|Part B|Lack of Efficacy|12|||
44209973|NCT01894256|79006554|FG002|Part B|Lack of Efficacy|13|||
44209974|NCT01780935|79006567|FG000|Overall Study|Admin problems due to early termination|321|||
44209975|NCT01780935|79006568|FG001|Overall Study|Admin problems due to early termination|309|||
44209976|NCT01780935|79006567|FG000|Overall Study|Adverse Event|2|||
44209977|NCT01780935|79006568|FG001|Overall Study|Adverse Event|4|||
44209978|NCT01780935|79006567|FG000|Overall Study|Death|1|||
44209979|NCT01780935|79006568|FG001|Overall Study|Death|6|||
44209980|NCT01780935|79006567|FG000|Overall Study|Lost to Follow-up|2|||
44369765|NCT00849901|79374996|FG002|Acute Treatment Phase|Protocol Violation|1|||
44369766|NCT00849901|79374994|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
44369767|NCT00849901|79374995|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
44369768|NCT00849901|79374996|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
44369769|NCT00849901|79374994|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
44369770|NCT00849901|79374995|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
44369771|NCT00849901|79374996|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
44369772|NCT00849901|79374994|FG000|Acute Treatment Phase|Physician Decision|1|||
44369773|NCT00849901|79374995|FG001|Acute Treatment Phase|Physician Decision|1|||
44369774|NCT00849901|79374996|FG002|Acute Treatment Phase|Physician Decision|1|||
44369775|NCT00849901|79374994|FG000|Acute Treatment Phase|Sponsor Decision|1|||
44369776|NCT00849901|79374995|FG001|Acute Treatment Phase|Sponsor Decision|0|||
44369777|NCT00849901|79374996|FG002|Acute Treatment Phase|Sponsor Decision|0|||
44369778|NCT00849901|79374994|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
44369779|NCT00849901|79374995|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
44369780|NCT00849901|79374996|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
44369781|NCT00849901|79374994|FG000|Extension Phase|Adverse Event|2|||
44369782|NCT00849901|79374995|FG001|Extension Phase|Adverse Event|8|||
44369783|NCT00849901|79374996|FG002|Extension Phase|Adverse Event|4|||
44369784|NCT00849901|79374994|FG000|Extension Phase|Lost to Follow-up|3|||
44369785|NCT00849901|79374995|FG001|Extension Phase|Lost to Follow-up|0|||
44369786|NCT00849901|79374996|FG002|Extension Phase|Lost to Follow-up|1|||
44369787|NCT00849901|79374994|FG000|Extension Phase|Protocol Violation|2|||
44369788|NCT00849901|79374995|FG001|Extension Phase|Protocol Violation|2|||
44369789|NCT00849901|79374996|FG002|Extension Phase|Protocol Violation|4|||
44369790|NCT00849901|79374994|FG000|Extension Phase|Withdrawal by Subject|7|||
44369791|NCT00849901|79374995|FG001|Extension Phase|Withdrawal by Subject|6|||
44369792|NCT00849901|79374996|FG002|Extension Phase|Withdrawal by Subject|3|||
44369793|NCT00849901|79374994|FG000|Extension Phase|Parent or Caregiver Decision|10|||
44369794|NCT00849901|79374995|FG001|Extension Phase|Parent or Caregiver Decision|4|||
44369795|NCT00849901|79374996|FG002|Extension Phase|Parent or Caregiver Decision|4|||
44369796|NCT00849901|79374994|FG000|Extension Phase|Physician Decision|1|||
44369797|NCT00849901|79374995|FG001|Extension Phase|Physician Decision|2|||
44369798|NCT00849901|79374996|FG002|Extension Phase|Physician Decision|0|||
44369799|NCT00849901|79374994|FG000|Extension Phase|Lack of Efficacy|2|||
44369800|NCT00849901|79374995|FG001|Extension Phase|Lack of Efficacy|4|||
44369801|NCT00849901|79374996|FG002|Extension Phase|Lack of Efficacy|1|||
44369802|NCT01168232|79375010|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
44369803|NCT01168232|79375010|FG000|Overall Study|Ineligible- Wrong cell type|6|||
44369804|NCT01168232|79375010|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
44369805|NCT00817531|79375014|FG000|Overall Study|Adverse Event|1|||
44369806|NCT00817531|79375014|FG000|Overall Study|Lack of Efficacy|1|||
44369807|NCT00817063|79375020|FG000|Overall Study|Adverse Event|32|||
44369808|NCT00817063|79375021|FG001|Overall Study|Adverse Event|13|||
44369809|NCT00817063|79375020|FG000|Overall Study|Death|1|||
44369810|NCT00817063|79375021|FG001|Overall Study|Death|1|||
44369811|NCT00817063|79375020|FG000|Overall Study|Lack of Efficacy|33|||
44369812|NCT00817063|79375021|FG001|Overall Study|Lack of Efficacy|86|||
44209981|NCT01780935|79006568|FG001|Overall Study|Lost to Follow-up|6|||
44209982|NCT01780935|79006567|FG000|Overall Study|Physician Decision|1|||
44209983|NCT01780935|79006568|FG001|Overall Study|Physician Decision|1|||
44209984|NCT01780935|79006567|FG000|Overall Study|Protocol deviation|0|||
44209985|NCT01780935|79006568|FG001|Overall Study|Protocol deviation|1|||
44209986|NCT01780935|79006567|FG000|Overall Study|Patient withdrew consent|8|||
44209987|NCT01780935|79006568|FG001|Overall Study|Patient withdrew consent|9|||
44209988|NCT01894100|79006576|FG000|Overall Study|Lost to Follow-up|0|||
44369813|NCT00817063|79375020|FG000|Overall Study|Failure to Return|13|||
44369814|NCT00817063|79375021|FG001|Overall Study|Failure to Return|12|||
44369815|NCT00817063|79375020|FG000|Overall Study|Violation of Selection at Entry|7|||
44369816|NCT00817063|79375021|FG001|Overall Study|Violation of Selection at Entry|4|||
44209989|NCT01894100|79006577|FG001|Overall Study|Lost to Follow-up|1|||
44209990|NCT01894100|79006576|FG000|Overall Study|Withdrawal by Subject|3|||
44209991|NCT01894100|79006577|FG001|Overall Study|Withdrawal by Subject|0|||
44369817|NCT00817063|79375020|FG000|Overall Study|Protocol Violation|3|||
44369818|NCT00817063|79375021|FG001|Overall Study|Protocol Violation|8|||
44369819|NCT00817063|79375020|FG000|Overall Study|Withdrawal by Subject|17|||
44369820|NCT00817063|79375021|FG001|Overall Study|Withdrawal by Subject|37|||
44369821|NCT00817063|79375020|FG000|Overall Study|Early Improvement|19|||
44369822|NCT00817063|79375021|FG001|Overall Study|Early Improvement|4|||
44369823|NCT00817063|79375020|FG000|Overall Study|Administrative|10|||
44369824|NCT00817063|79375021|FG001|Overall Study|Administrative|4|||
44369825|NCT00817063|79375020|FG000|Overall Study|Abnormality of Laboratory Test|2|||
44209992|NCT01401478|79006623|FG000|Overall Study|Study drug not available|6|||
44209993|NCT01401478|79006623|FG000|Overall Study|Adverse Event|5|||
44369826|NCT00817063|79375021|FG001|Overall Study|Abnormality of Laboratory Test|1|||
44369827|NCT01166750|79375029|FG000|Overall Study|Lost to Follow-up|1|||
44369828|NCT01166750|79375030|FG001|Overall Study|Lost to Follow-up|0|||
44369829|NCT00826267|79375039|FG000|Overall Study|Other Adverse Event|1|||
44369830|NCT00826267|79375040|FG001|Overall Study|Other Adverse Event|0|||
44369831|NCT00826267|79375041|FG002|Overall Study|Other Adverse Event|0|||
44369832|NCT00986154|79375052|FG000|Overall Study|Death|136|||
44369833|NCT00986154|79375053|FG001|Overall Study|Death|127|||
44369834|NCT00986154|79375052|FG000|Overall Study|Lost to Follow-up|7|||
44369835|NCT00986154|79375053|FG001|Overall Study|Lost to Follow-up|4|||
44369836|NCT00986154|79375052|FG000|Overall Study|Withdrawal by Subject|32|||
44369837|NCT00986154|79375053|FG001|Overall Study|Withdrawal by Subject|33|||
44369838|NCT00986154|79375052|FG000|Overall Study|investigator/subject decide not continue|6|||
44369839|NCT00986154|79375053|FG001|Overall Study|investigator/subject decide not continue|3|||
44369840|NCT00986154|79375052|FG000|Overall Study|never received study drug|25|||
44369841|NCT00986154|79375053|FG001|Overall Study|never received study drug|27|||
44369842|NCT00848965|79375059|FG000|Overall Study|Adverse Event|1|||
44369843|NCT00848965|79375059|FG000|Overall Study|Withdrawal by Subject|1|||
44369844|NCT01154036|79375078|FG000|Phase I|Physician Decision|0|||
44369845|NCT01154036|79375079|FG001|Phase I|Physician Decision|1|||
44369846|NCT01154036|79375080|FG002|Phase I|Physician Decision|0|||
44369847|NCT01154036|79375081|FG003|Phase I|Physician Decision|0|||
44369848|NCT01154036|79375082|FG004|Phase I|Physician Decision|0|||
44369849|NCT01154036|79375083|FG005|Phase I|Physician Decision|0|||
44369850|NCT01154036|79375084|FG006|Phase I|Physician Decision|0|||
44369851|NCT01154036|79375085|FG007|Phase I|Physician Decision|0|||
44369852|NCT01154036|79375078|FG000|Phase I|Lost to Follow-up|0|||
44369853|NCT01154036|79375079|FG001|Phase I|Lost to Follow-up|3|||
44369854|NCT01154036|79375080|FG002|Phase I|Lost to Follow-up|6|||
44369855|NCT01154036|79375081|FG003|Phase I|Lost to Follow-up|0|||
44369856|NCT01154036|79375082|FG004|Phase I|Lost to Follow-up|0|||
44369857|NCT01154036|79375083|FG005|Phase I|Lost to Follow-up|0|||
44369858|NCT01154036|79375084|FG006|Phase I|Lost to Follow-up|0|||
44369859|NCT01154036|79375085|FG007|Phase I|Lost to Follow-up|0|||
44369860|NCT01154036|79375078|FG000|Phase I|Protocol Violation|0|||
44369861|NCT01154036|79375079|FG001|Phase I|Protocol Violation|3|||
44369862|NCT01154036|79375080|FG002|Phase I|Protocol Violation|9|||
44369863|NCT01154036|79375081|FG003|Phase I|Protocol Violation|0|||
44369864|NCT01154036|79375082|FG004|Phase I|Protocol Violation|0|||
44369865|NCT01154036|79375083|FG005|Phase I|Protocol Violation|0|||
44369866|NCT01154036|79375084|FG006|Phase I|Protocol Violation|0|||
44369867|NCT01154036|79375085|FG007|Phase I|Protocol Violation|0|||
44369868|NCT01154036|79375078|FG000|Phase I|Withdrawal by Subject|2|||
44369869|NCT01154036|79375079|FG001|Phase I|Withdrawal by Subject|10|||
44369870|NCT01154036|79375080|FG002|Phase I|Withdrawal by Subject|29|||
44369871|NCT01154036|79375081|FG003|Phase I|Withdrawal by Subject|0|||
44369872|NCT01154036|79375082|FG004|Phase I|Withdrawal by Subject|0|||
44209994|NCT01401478|79006623|FG000|Overall Study|Hyperphosphatemia|5|||
44209995|NCT01401478|79006623|FG000|Overall Study|Lost to Follow-up|5|||
44209996|NCT01401478|79006623|FG000|Overall Study|Kidney transplantation|3|||
44209997|NCT01401478|79006623|FG000|Overall Study|Withdrawal by Subject|3|||
44209998|NCT01401478|79006623|FG000|Overall Study|Blood samples not available|1|||
44209999|NCT01401478|79006623|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
44210000|NCT01401478|79006623|FG000|Overall Study|Low intact parathyroid hormone|1|||
44210001|NCT01401478|79006623|FG000|Overall Study|Serious adverse event|1|||
44210002|NCT01422850|79006627|FG000|Overall Study|Physician Decision|3|||
44210003|NCT01422538|79006636|FG000|Overall Study|Lost to Follow-up|0|||
44210004|NCT01422538|79006637|FG001|Overall Study|Lost to Follow-up|1|||
44210005|NCT01422538|79006638|FG002|Overall Study|Lost to Follow-up|1|||
44210006|NCT01422538|79006636|FG000|Overall Study|Missed visit|0|||
44210007|NCT01422538|79006637|FG001|Overall Study|Missed visit|1|||
44210008|NCT01422538|79006638|FG002|Overall Study|Missed visit|1|||
44210009|NCT01422382|79006647|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
44210010|NCT01401322|79006651|FG000|Overall Study|Withdrawal by Subject|1|||
44210011|NCT01401322|79006651|FG000|Overall Study|Physician Decision|1|||
44210012|NCT01387594|79006657|FG000|Overall Study|Withdrawal by Subject|0|||
44369873|NCT01154036|79375083|FG005|Phase I|Withdrawal by Subject|0|||
44369874|NCT01154036|79375084|FG006|Phase I|Withdrawal by Subject|0|||
44369875|NCT01154036|79375085|FG007|Phase I|Withdrawal by Subject|0|||
44369876|NCT01154036|79375078|FG000|Phase I|Adverse Event|1|||
44369877|NCT01154036|79375079|FG001|Phase I|Adverse Event|11|||
44369878|NCT01154036|79375080|FG002|Phase I|Adverse Event|12|||
44369879|NCT01154036|79375081|FG003|Phase I|Adverse Event|0|||
44369880|NCT01154036|79375082|FG004|Phase I|Adverse Event|0|||
44369881|NCT01154036|79375083|FG005|Phase I|Adverse Event|0|||
44369882|NCT01154036|79375084|FG006|Phase I|Adverse Event|0|||
44369883|NCT01154036|79375085|FG007|Phase I|Adverse Event|0|||
44210013|NCT01387594|79006658|FG001|Overall Study|Withdrawal by Subject|2|||
44210014|NCT01387594|79006657|FG000|Overall Study|Lost to Follow-up|0|||
44210015|NCT01387594|79006658|FG001|Overall Study|Lost to Follow-up|1|||
44210016|NCT01401010|79006669|FG000|Overall Study|Could not interpret assay results|1|||
44210017|NCT01401010|79006670|FG001|Overall Study|Could not interpret assay results|0|||
44210018|NCT01400932|79006683|FG000|Overall Study|Adverse Event|10|||
44210019|NCT01400932|79006684|FG001|Overall Study|Adverse Event|5|||
44210020|NCT01400932|79006683|FG000|Overall Study|Lack of Efficacy|0|||
44210021|NCT01400932|79006684|FG001|Overall Study|Lack of Efficacy|3|||
44210022|NCT01400932|79006683|FG000|Overall Study|Withdrawal by Subject|2|||
44369884|NCT01154036|79375078|FG000|Phase II|Adverse Event|0|||
44369885|NCT01154036|79375079|FG001|Phase II|Adverse Event|0|||
44369886|NCT01154036|79375080|FG002|Phase II|Adverse Event|0|||
44369887|NCT01154036|79375081|FG003|Phase II|Adverse Event|0|||
44369888|NCT01154036|79375082|FG004|Phase II|Adverse Event|1|||
44369889|NCT01154036|79375083|FG005|Phase II|Adverse Event|1|||
44369890|NCT01154036|79375084|FG006|Phase II|Adverse Event|1|||
44369891|NCT01154036|79375085|FG007|Phase II|Adverse Event|1|||
44369892|NCT01154036|79375078|FG000|Phase II|Physician Decision|0|||
44369893|NCT01154036|79375079|FG001|Phase II|Physician Decision|0|||
44369894|NCT01154036|79375080|FG002|Phase II|Physician Decision|0|||
44369895|NCT01154036|79375081|FG003|Phase II|Physician Decision|0|||
44369896|NCT01154036|79375082|FG004|Phase II|Physician Decision|0|||
44369897|NCT01154036|79375083|FG005|Phase II|Physician Decision|0|||
44210023|NCT01400932|79006684|FG001|Overall Study|Withdrawal by Subject|6|||
44210024|NCT01400932|79006683|FG000|Overall Study|Lost to Follow-up|1|||
44210025|NCT01400932|79006684|FG001|Overall Study|Lost to Follow-up|0|||
44210026|NCT01400932|79006683|FG000|Overall Study|Protocol Deviation|0|||
44369898|NCT01154036|79375084|FG006|Phase II|Physician Decision|1|||
44369899|NCT01154036|79375085|FG007|Phase II|Physician Decision|0|||
44369900|NCT01154036|79375078|FG000|Phase II|Lost to Follow-up|0|||
44369901|NCT01154036|79375079|FG001|Phase II|Lost to Follow-up|0|||
44369902|NCT01154036|79375080|FG002|Phase II|Lost to Follow-up|0|||
44369903|NCT01154036|79375081|FG003|Phase II|Lost to Follow-up|1|||
44369904|NCT01154036|79375082|FG004|Phase II|Lost to Follow-up|2|||
44369905|NCT01154036|79375083|FG005|Phase II|Lost to Follow-up|0|||
44369906|NCT01154036|79375084|FG006|Phase II|Lost to Follow-up|2|||
44369907|NCT01154036|79375085|FG007|Phase II|Lost to Follow-up|1|||
44369908|NCT01154036|79375078|FG000|Phase II|Protocol Violation|0|||
44369909|NCT01154036|79375079|FG001|Phase II|Protocol Violation|0|||
44369910|NCT01154036|79375080|FG002|Phase II|Protocol Violation|0|||
44369911|NCT01154036|79375081|FG003|Phase II|Protocol Violation|0|||
44369912|NCT01154036|79375082|FG004|Phase II|Protocol Violation|1|||
44369913|NCT01154036|79375083|FG005|Phase II|Protocol Violation|2|||
44210027|NCT01400932|79006684|FG001|Overall Study|Protocol Deviation|1|||
44210028|NCT01400932|79006683|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44210029|NCT01400932|79006684|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44210030|NCT01400698|79006694|FG000|Overall Study|Lost to Follow-up|2|||
44210031|NCT01400698|79006695|FG001|Overall Study|Lost to Follow-up|5|||
44210032|NCT01400698|79006696|FG002|Overall Study|Lost to Follow-up|2|||
44210033|NCT01400698|79006697|FG003|Overall Study|Lost to Follow-up|1|||
44210034|NCT01400698|79006698|FG004|Overall Study|Lost to Follow-up|4|||
44210035|NCT01400698|79006699|FG005|Overall Study|Lost to Follow-up|3|||
44210036|NCT01400698|79006694|FG000|Overall Study|Withdrawal by Subject|8|||
44210037|NCT01400698|79006695|FG001|Overall Study|Withdrawal by Subject|2|||
44210038|NCT01400698|79006696|FG002|Overall Study|Withdrawal by Subject|0|||
44210039|NCT01400698|79006697|FG003|Overall Study|Withdrawal by Subject|4|||
44210040|NCT01400698|79006698|FG004|Overall Study|Withdrawal by Subject|1|||
44210041|NCT01400698|79006699|FG005|Overall Study|Withdrawal by Subject|3|||
44210042|NCT01400698|79006694|FG000|Overall Study|Protocol Violation|0|||
44210043|NCT01400698|79006695|FG001|Overall Study|Protocol Violation|1|||
44210044|NCT01400698|79006696|FG002|Overall Study|Protocol Violation|0|||
44369914|NCT01154036|79375084|FG006|Phase II|Protocol Violation|0|||
44369915|NCT01154036|79375085|FG007|Phase II|Protocol Violation|0|||
44369916|NCT01154036|79375078|FG000|Phase II|Withdrawal by Subject|0|||
44210045|NCT01400698|79006697|FG003|Overall Study|Protocol Violation|0|||
44210046|NCT01400698|79006698|FG004|Overall Study|Protocol Violation|1|||
44210047|NCT01400698|79006699|FG005|Overall Study|Protocol Violation|0|||
44369917|NCT01154036|79375079|FG001|Phase II|Withdrawal by Subject|0|||
44369918|NCT01154036|79375080|FG002|Phase II|Withdrawal by Subject|0|||
44369919|NCT01154036|79375081|FG003|Phase II|Withdrawal by Subject|0|||
44210048|NCT01400698|79006694|FG000|Overall Study|Non-compliance|0|||
44210049|NCT01400698|79006695|FG001|Overall Study|Non-compliance|1|||
44210050|NCT01400698|79006696|FG002|Overall Study|Non-compliance|0|||
44210051|NCT01400698|79006697|FG003|Overall Study|Non-compliance|1|||
44210052|NCT01400698|79006698|FG004|Overall Study|Non-compliance|0|||
44210053|NCT01400698|79006699|FG005|Overall Study|Non-compliance|0|||
44369920|NCT01154036|79375082|FG004|Phase II|Withdrawal by Subject|4|||
44543567|NCT03224598|79556631|FG000|Overall Study|Other|0|||
44369921|NCT01154036|79375083|FG005|Phase II|Withdrawal by Subject|2|||
44369922|NCT01154036|79375084|FG006|Phase II|Withdrawal by Subject|5|||
44369923|NCT01154036|79375085|FG007|Phase II|Withdrawal by Subject|4|||
44369924|NCT00816595|79375107|FG000|Overall Study|Withdrawal by Subject|2|||
44369925|NCT00816595|79375108|FG001|Overall Study|Withdrawal by Subject|0|||
44369926|NCT01166438|79375118|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
44369927|NCT01166438|79375119|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
44369928|NCT01166438|79375118|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
44369929|NCT01166438|79375119|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
44369930|NCT01166438|79375118|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
44369931|NCT01166438|79375119|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
44369932|NCT01166438|79375118|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
44369933|NCT01166438|79375119|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
44369934|NCT01166438|79375118|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
44369935|NCT01166438|79375119|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
44369936|NCT01166438|79375118|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
44369937|NCT01166438|79375119|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
44369938|NCT01153958|79375128|FG000|Overall Study|Study Terminated|36|||
44369939|NCT01153958|79375129|FG001|Overall Study|Study Terminated|32|||
44369940|NCT00599638|79375139|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
44369941|NCT00599638|79375140|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
44369942|NCT00599638|79375141|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
44369943|NCT00599638|79375142|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
44369944|NCT00599638|79375139|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
44369945|NCT00599638|79375140|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
44369946|NCT00599638|79375141|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
44369947|NCT00599638|79375142|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
44369948|NCT00599638|79375139|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
44369949|NCT00599638|79375140|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
44369950|NCT00599638|79375141|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
44369951|NCT00599638|79375142|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
44369952|NCT00599638|79375139|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
44369953|NCT00599638|79375140|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
44369954|NCT00599638|79375141|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
44369955|NCT00599638|79375142|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
44369956|NCT00599638|79375139|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
44369957|NCT00599638|79375140|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
44369958|NCT00599638|79375141|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
44369959|NCT00599638|79375142|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
44369960|NCT00599638|79375139|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
44543568|NCT03224598|79556632|FG001|Overall Study|Other|1|||
44210054|NCT01400698|79006694|FG000|Overall Study|Adverse Event|1|||
44210055|NCT01400698|79006695|FG001|Overall Study|Adverse Event|0|||
44210056|NCT01400698|79006696|FG002|Overall Study|Adverse Event|0|||
44210057|NCT01400698|79006697|FG003|Overall Study|Adverse Event|0|||
44210058|NCT01400698|79006698|FG004|Overall Study|Adverse Event|0|||
44210059|NCT01400698|79006699|FG005|Overall Study|Adverse Event|0|||
44210060|NCT01400698|79006694|FG000|Overall Study|Other|4|||
44210061|NCT01400698|79006695|FG001|Overall Study|Other|2|||
44210062|NCT01400698|79006696|FG002|Overall Study|Other|0|||
44210063|NCT01400698|79006697|FG003|Overall Study|Other|2|||
44210064|NCT01400698|79006698|FG004|Overall Study|Other|1|||
44210065|NCT01400698|79006699|FG005|Overall Study|Other|0|||
44210066|NCT01890746|79006711|FG000|Overall Study|Death|39|||
44210067|NCT01890746|79006712|FG001|Overall Study|Death|30|||
44210068|NCT01890746|79006711|FG000|Overall Study|Adverse Event|1|||
44210069|NCT01890746|79006712|FG001|Overall Study|Adverse Event|0|||
44210070|NCT01890746|79006711|FG000|Overall Study|Lost to Follow-up|4|||
44210071|NCT01890746|79006712|FG001|Overall Study|Lost to Follow-up|1|||
44210072|NCT01890746|79006711|FG000|Overall Study|Physician Decision|3|||
44210073|NCT01890746|79006712|FG001|Overall Study|Physician Decision|2|||
44210074|NCT01890746|79006711|FG000|Overall Study|Withdrawal by Subject|5|||
44210075|NCT01890746|79006712|FG001|Overall Study|Withdrawal by Subject|8|||
44210076|NCT01422304|79006720|FG000|Overall Study|Adverse Event|0|||
44210077|NCT01422304|79006721|FG001|Overall Study|Adverse Event|1|||
44210078|NCT01422304|79006720|FG000|Overall Study|Lost to Follow-up|14|||
44369961|NCT00599638|79375140|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
44210079|NCT01422304|79006721|FG001|Overall Study|Lost to Follow-up|20|||
44210080|NCT01422304|79006720|FG000|Overall Study|Never Entered Follow-up|2|||
44210081|NCT01422304|79006721|FG001|Overall Study|Never Entered Follow-up|1|||
44210082|NCT01422304|79006720|FG000|Overall Study|Protocol Violation|1|||
44210083|NCT01422304|79006721|FG001|Overall Study|Protocol Violation|0|||
44369962|NCT00599638|79375141|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
44369963|NCT00599638|79375142|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
44210084|NCT01422304|79006720|FG000|Overall Study|Withdrawal by Subject|4|||
44210085|NCT01422304|79006721|FG001|Overall Study|Withdrawal by Subject|2|||
44210086|NCT01422304|79006720|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
44210087|NCT01422304|79006721|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
44210088|NCT01422304|79006720|FG000|Overall Study|Not Treated|3|||
44210089|NCT01422304|79006721|FG001|Overall Study|Not Treated|11|||
44210090|NCT01387516|79006731|FG000|Overall Study|Lost to Follow-up|4|||
44369964|NCT00599638|79375139|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
44369965|NCT00599638|79375140|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
44369966|NCT00599638|79375141|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
44369967|NCT00599638|79375142|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
44369968|NCT00599638|79375139|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
44369969|NCT00599638|79375140|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
44369970|NCT00599638|79375141|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
44210091|NCT01387516|79006732|FG001|Overall Study|Lost to Follow-up|4|||
44210092|NCT01387516|79006733|FG002|Overall Study|Lost to Follow-up|2|||
44210093|NCT01387516|79006734|FG003|Overall Study|Lost to Follow-up|3|||
44210094|NCT01387516|79006731|FG000|Overall Study|Withdrawal by Subject|1|||
44210095|NCT01387516|79006732|FG001|Overall Study|Withdrawal by Subject|1|||
44210096|NCT01387516|79006733|FG002|Overall Study|Withdrawal by Subject|2|||
44210097|NCT01387516|79006734|FG003|Overall Study|Withdrawal by Subject|0|||
44210098|NCT01387516|79006731|FG000|Overall Study|Death|0|||
44210099|NCT01387516|79006732|FG001|Overall Study|Death|0|||
44210100|NCT01387516|79006733|FG002|Overall Study|Death|0|||
44210101|NCT01387516|79006734|FG003|Overall Study|Death|1|||
44210102|NCT01421134|79006755|FG000|Overall Study|Adverse Event|3|||
44210103|NCT01421134|79006756|FG001|Overall Study|Adverse Event|5|||
44210104|NCT01421134|79006755|FG000|Overall Study|Lack of Efficacy|2|||
44210105|NCT01421134|79006756|FG001|Overall Study|Lack of Efficacy|4|||
44210106|NCT01421134|79006755|FG000|Overall Study|Protocol Violation|0|||
44210107|NCT01421134|79006756|FG001|Overall Study|Protocol Violation|3|||
44210108|NCT01421134|79006755|FG000|Overall Study|Withdrawal by Subject|1|||
44210109|NCT01421134|79006756|FG001|Overall Study|Withdrawal by Subject|1|||
44210110|NCT01421134|79006755|FG000|Overall Study|Administrative|0|||
44369971|NCT00599638|79375142|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
44369972|NCT00599638|79375139|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
44369973|NCT00599638|79375140|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
44369974|NCT00599638|79375141|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
44369975|NCT00599638|79375142|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
44369976|NCT01166282|79375152|FG000|Open-label Period|Adverse Event|0|||
44369977|NCT01166282|79375153|FG001|Open-label Period|Adverse Event|0|||
44369978|NCT01166282|79375154|FG002|Open-label Period|Adverse Event|6|||
44369979|NCT01166282|79375152|FG000|Open-label Period|Withdrawal by Subject|0|||
44369980|NCT01166282|79375153|FG001|Open-label Period|Withdrawal by Subject|0|||
44369981|NCT01166282|79375154|FG002|Open-label Period|Withdrawal by Subject|4|||
44369982|NCT01166282|79375152|FG000|Open-label Period|Lack of Efficacy|0|||
44369983|NCT01166282|79375153|FG001|Open-label Period|Lack of Efficacy|0|||
44210111|NCT01421134|79006756|FG001|Overall Study|Administrative|1|||
44210112|NCT01421134|79006755|FG000|Overall Study|Lost to Follow-up|1|||
44210113|NCT01421134|79006756|FG001|Overall Study|Lost to Follow-up|1|||
44210114|NCT01894022|79006764|FG000|Overall Study|Death|1|||
44210115|NCT01894022|79006765|FG001|Overall Study|Death|0|||
44210116|NCT01894022|79006764|FG000|Overall Study|Adverse Event, non-fatal|1|||
44210117|NCT01894022|79006765|FG001|Overall Study|Adverse Event, non-fatal|0|||
44210118|NCT01894022|79006764|FG000|Overall Study|Study Closed/terminated|7|||
44210119|NCT01894022|79006765|FG001|Overall Study|Study Closed/terminated|10|||
44210120|NCT01615328|79006774|FG000|Overall Study|Lost to Follow-up|3|||
44210121|NCT01615328|79006775|FG001|Overall Study|Lost to Follow-up|5|||
44210122|NCT01890512|79006785|FG000|Overall Study|Physician Decision|1|||
44369984|NCT01166282|79375154|FG002|Open-label Period|Lack of Efficacy|2|||
44369985|NCT01166282|79375152|FG000|Open-label Period|Remission|0|||
44369986|NCT01166282|79375153|FG001|Open-label Period|Remission|0|||
44369987|NCT01166282|79375154|FG002|Open-label Period|Remission|4|||
44369988|NCT01166282|79375152|FG000|Open-label Period|Irregular Compliance|0|||
44369989|NCT01166282|79375153|FG001|Open-label Period|Irregular Compliance|0|||
44210123|NCT01890512|79006785|FG000|Overall Study|Withdrawal by Subject|1|||
44210124|NCT01890512|79006785|FG000|Overall Study|Protocol Violation|1|||
44210125|NCT01387282|79006791|FG000|Overall Study|Death|47|||
44210126|NCT01387282|79006792|FG001|Overall Study|Death|16|||
44369990|NCT01166282|79375154|FG002|Open-label Period|Irregular Compliance|1|||
44210127|NCT01387282|79006791|FG000|Overall Study|Other|5|||
44210128|NCT01387282|79006792|FG001|Overall Study|Other|1|||
44543569|NCT03224598|79556633|FG002|Overall Study|Other|0|||
44210129|NCT01387282|79006791|FG000|Overall Study|Unrelated AE|6|||
44210130|NCT01387282|79006792|FG001|Overall Study|Unrelated AE|4|||
44210131|NCT01387282|79006791|FG000|Overall Study|Withdrawal by patient|33|||
44210132|NCT01387282|79006792|FG001|Overall Study|Withdrawal by patient|23|||
44210133|NCT01387282|79006791|FG000|Overall Study|Study drug-related AE|2|||
44210134|NCT01387282|79006792|FG001|Overall Study|Study drug-related AE|2|||
44210135|NCT01387282|79006791|FG000|Overall Study|Lost to Follow-up|4|||
44210136|NCT01387282|79006792|FG001|Overall Study|Lost to Follow-up|1|||
44210137|NCT01386970|79006800|FG000|Overall Study|Withdrawal by Subject|0|||
44210138|NCT01386970|79006801|FG001|Overall Study|Withdrawal by Subject|1|||
44210139|NCT01386970|79006800|FG000|Overall Study|Adverse Event|4|||
44210140|NCT01386970|79006801|FG001|Overall Study|Adverse Event|1|||
44210141|NCT01890434|79006809|FG000|Overall Study|Adverse Event|8|||
44210142|NCT01890434|79006809|FG000|Overall Study|PCI at external hospital|1|||
44210143|NCT01890434|79006809|FG000|Overall Study|Assessment discrepancy|1|||
44210144|NCT01890434|79006809|FG000|Overall Study|CRC didn't contact participant for FU|1|||
44210145|NCT01890434|79006809|FG000|Overall Study|Could not get whole set of images|1|||
44210146|NCT01890434|79006809|FG000|Overall Study|Decline to return for GSPECT|1|||
44210147|NCT01890434|79006809|FG000|Overall Study|GSPECT at rest was not done|1|||
44210148|NCT01890434|79006809|FG000|Overall Study|Participant didn't complete MRI|1|||
44210149|NCT01890434|79006809|FG000|Overall Study|Uncontactable by phone|1|||
44210150|NCT01890434|79006809|FG000|Overall Study|Moved out of position|1|||
44210151|NCT01890434|79006809|FG000|Overall Study|Unable to contact|1|||
44210152|NCT01890434|79006809|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
44210153|NCT01385566|79006819|FG000|Overall Study|Lost to Follow-up|1|||
44210154|NCT01385566|79006820|FG001|Overall Study|Lost to Follow-up|0|||
44210155|NCT01385566|79006821|FG002|Overall Study|Lost to Follow-up|0|||
44369991|NCT01153724|79375162|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44369992|NCT01153724|79375162|FG000|Treatment Period 2|Adverse Event|1|||
44210156|NCT01385566|79006822|FG003|Overall Study|Lost to Follow-up|0|||
44210157|NCT01385566|79006823|FG004|Overall Study|Lost to Follow-up|0|||
44210158|NCT01385566|79006824|FG005|Overall Study|Lost to Follow-up|0|||
44210159|NCT01385566|79006819|FG000|Overall Study|Withdrawal by Subject|0|||
44210160|NCT01385566|79006820|FG001|Overall Study|Withdrawal by Subject|0|||
44210161|NCT01385566|79006821|FG002|Overall Study|Withdrawal by Subject|0|||
44210162|NCT01385566|79006822|FG003|Overall Study|Withdrawal by Subject|1|||
44210163|NCT01385566|79006823|FG004|Overall Study|Withdrawal by Subject|0|||
44210164|NCT01385566|79006824|FG005|Overall Study|Withdrawal by Subject|0|||
44210165|NCT01780545|79006842|FG000|Overall Study|Withdrawal by Subject|3|||
44210166|NCT01780545|79006843|FG001|Overall Study|Withdrawal by Subject|1|||
44210167|NCT01780545|79006842|FG000|Overall Study|Lost to Follow-up|1|||
44210168|NCT01780545|79006843|FG001|Overall Study|Lost to Follow-up|1|||
44210169|NCT01780389|79006852|FG000|Overall Study|Adverse Event|1|||
44210170|NCT01778985|79006859|FG000|Overall Study|Lost to Follow-up|1|||
44210171|NCT01778985|79006860|FG001|Overall Study|Lost to Follow-up|0|||
44210172|NCT01778985|79006859|FG000|Overall Study|Physician Decision|2|||
44210173|NCT01778985|79006860|FG001|Overall Study|Physician Decision|2|||
44210174|NCT01778985|79006859|FG000|Overall Study|Protocol Violation|4|||
44210175|NCT01778985|79006860|FG001|Overall Study|Protocol Violation|1|||
44210176|NCT01778751|79006868|FG000|Overall Study|Lost to Follow-up|1|||
44210177|NCT01778751|79006869|FG001|Overall Study|Lost to Follow-up|0|||
44210178|NCT01778751|79006868|FG000|Overall Study|Withdrawal by Subject|0|||
44210179|NCT01778751|79006869|FG001|Overall Study|Withdrawal by Subject|2|||
44369993|NCT01153724|79375162|FG000|Treatment Period 2|Other reason not defined above|1|||
44369994|NCT01152788|79375170|FG000|Overall Study|Withdrawal by Subject|0|||
44369995|NCT01152788|79375171|FG001|Overall Study|Withdrawal by Subject|3|||
44210180|NCT01778751|79006868|FG000|Overall Study|Transfered care|1|||
44210181|NCT01778751|79006869|FG001|Overall Study|Transfered care|0|||
44210182|NCT01865084|79006878|FG000|Double Blind Period (DB)|Adverse Event|2|||
44210183|NCT01865084|79006879|FG001|Double Blind Period (DB)|Adverse Event|2|||
44210184|NCT01865084|79006880|FG002|Double Blind Period (DB)|Adverse Event|1|||
44210185|NCT01865084|79006878|FG000|Double Blind Period (DB)|Protocol Violation|0|||
44210186|NCT01865084|79006879|FG001|Double Blind Period (DB)|Protocol Violation|0|||
44210187|NCT01865084|79006880|FG002|Double Blind Period (DB)|Protocol Violation|1|||
44210188|NCT01865084|79006878|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
44210189|NCT01865084|79006879|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
44210190|NCT01865084|79006880|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
44210191|NCT01865084|79006878|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
44210192|NCT01865084|79006879|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
44210193|NCT01865084|79006880|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
44369996|NCT01152788|79375170|FG000|Overall Study|No treatment|0|||
44369997|NCT01152788|79375171|FG001|Overall Study|No treatment|1|||
44369998|NCT01165424|79375177|FG000|Overall Study|Clinical adverse experiences|1|||
44369999|NCT01165424|79375177|FG000|Overall Study|Laboratory adverse experiences|1|||
44210194|NCT01865084|79006878|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
44210195|NCT01865084|79006879|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
44210196|NCT01865084|79006880|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
44210197|NCT01865084|79006878|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
44210198|NCT01865084|79006879|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
44210199|NCT01865084|79006880|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
44210200|NCT01865084|79006878|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
44210201|NCT01865084|79006879|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
44210202|NCT01865084|79006880|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
44210203|NCT01865084|79006878|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
44210204|NCT01865084|79006879|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
44210205|NCT01865084|79006880|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
44210206|NCT01865084|79006878|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
44210207|NCT01865084|79006879|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
44210208|NCT01865084|79006880|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
44210209|NCT01778127|79006895|FG000|Overall Study|Lost to Follow-up|5|||
44210210|NCT01778127|79006896|FG001|Overall Study|Lost to Follow-up|1|||
44370000|NCT01165424|79375177|FG000|Overall Study|Did not meet entry criteria|1|||
44370001|NCT01165424|79375177|FG000|Overall Study|Participant moved (relocated)|1|||
44370002|NCT01152554|79375183|FG000|Overall Study|Withdrawal by Subject|73|||
44370003|NCT01152554|79375184|FG001|Overall Study|Withdrawal by Subject|28|||
44370004|NCT01152554|79375183|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
44370005|NCT01152554|79375184|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
44370006|NCT01152554|79375183|FG000|Overall Study|Adverse Event|67|||
44370007|NCT01152554|79375184|FG001|Overall Study|Adverse Event|14|||
44370008|NCT01152554|79375183|FG000|Overall Study|Severe non-compliance to protocol|36|||
44370009|NCT01152554|79375184|FG001|Overall Study|Severe non-compliance to protocol|14|||
44370010|NCT01152554|79375183|FG000|Overall Study|Condition under investigation worsened|5|||
44370011|NCT01152554|79375184|FG001|Overall Study|Condition under investigation worsened|2|||
44370012|NCT01152554|79375183|FG000|Overall Study|Lack of Efficacy|20|||
44370013|NCT01152554|79375184|FG001|Overall Study|Lack of Efficacy|3|||
44370014|NCT01152554|79375183|FG000|Overall Study|Study-specific withdrawal criteria|17|||
44370015|NCT01152554|79375184|FG001|Overall Study|Study-specific withdrawal criteria|8|||
44370016|NCT01152554|79375183|FG000|Overall Study|Lost to Follow-up|87|||
44370017|NCT01152554|79375184|FG001|Overall Study|Lost to Follow-up|32|||
44370018|NCT01152554|79375183|FG000|Overall Study|Other|28|||
44370019|NCT01152554|79375184|FG001|Overall Study|Other|8|||
44370020|NCT01152554|79375183|FG000|Overall Study|Death|1|||
44370021|NCT01152554|79375184|FG001|Overall Study|Death|1|||
44370022|NCT00598702|79375198|FG000|Overall Study|Other|0|||
44370023|NCT00598702|79375199|FG001|Overall Study|Other|2|||
44370024|NCT00598702|79375200|FG002|Overall Study|Other|0|||
44370025|NCT00598702|79375201|FG003|Overall Study|Other|0|||
44370026|NCT00598702|79375202|FG004|Overall Study|Other|0|||
44370027|NCT00598702|79375203|FG005|Overall Study|Other|1|||
44370028|NCT00598702|79375204|FG006|Overall Study|Other|0|||
44370029|NCT00598702|79375205|FG007|Overall Study|Other|0|||
44370030|NCT00598702|79375198|FG000|Overall Study|Early discharge from hospital|0|||
44370031|NCT00598702|79375199|FG001|Overall Study|Early discharge from hospital|0|||
44210211|NCT01778127|79006897|FG002|Overall Study|Lost to Follow-up|2|||
44210212|NCT01778127|79006895|FG000|Overall Study|Withdrawal by Subject|3|||
44210213|NCT01778127|79006896|FG001|Overall Study|Withdrawal by Subject|1|||
44210214|NCT01778127|79006897|FG002|Overall Study|Withdrawal by Subject|4|||
44210215|NCT01892540|79006908|FG000|Overall Study|Did not complete PET/MRI|0|||
44210216|NCT01892540|79006909|FG001|Overall Study|Did not complete PET/MRI|0|||
44210217|NCT01892540|79006910|FG002|Overall Study|Did not complete PET/MRI|2|||
44210218|NCT01892540|79006908|FG000|Overall Study|Did not fit in scanner|0|||
44210219|NCT01892540|79006909|FG001|Overall Study|Did not fit in scanner|0|||
44210220|NCT01892540|79006910|FG002|Overall Study|Did not fit in scanner|1|||
44210221|NCT01385098|79006918|FG000|Overall Study|Adverse Event|10|||
44210222|NCT01385098|79006918|FG000|Overall Study|Lost to Follow-up|4|||
44210223|NCT01398514|79006926|FG000|Overall Study|Adverse Event|1|||
44210224|NCT01398514|79006927|FG001|Overall Study|Adverse Event|0|||
44370032|NCT00598702|79375200|FG002|Overall Study|Early discharge from hospital|2|||
44370033|NCT00598702|79375201|FG003|Overall Study|Early discharge from hospital|5|||
44370034|NCT00598702|79375202|FG004|Overall Study|Early discharge from hospital|0|||
44370035|NCT00598702|79375203|FG005|Overall Study|Early discharge from hospital|10|||
44370036|NCT00598702|79375204|FG006|Overall Study|Early discharge from hospital|1|||
44370037|NCT00598702|79375205|FG007|Overall Study|Early discharge from hospital|0|||
44370038|NCT00598702|79375198|FG000|Overall Study|Adverse Event|0|||
44210225|NCT01398514|79006926|FG000|Overall Study|Non-compliance with study procedures|2|||
44210226|NCT01398514|79006927|FG001|Overall Study|Non-compliance with study procedures|0|||
44210227|NCT01398514|79006926|FG000|Overall Study|Physiologic non-responsiveness|1|||
44210228|NCT01398514|79006927|FG001|Overall Study|Physiologic non-responsiveness|3|||
44370039|NCT00598702|79375199|FG001|Overall Study|Adverse Event|0|||
44370040|NCT00598702|79375200|FG002|Overall Study|Adverse Event|0|||
44370041|NCT00598702|79375201|FG003|Overall Study|Adverse Event|1|||
44370042|NCT00598702|79375202|FG004|Overall Study|Adverse Event|0|||
44370043|NCT00598702|79375203|FG005|Overall Study|Adverse Event|0|||
44210229|NCT01398514|79006926|FG000|Overall Study|Failure to show a conditioned response|4|||
44210230|NCT01398514|79006927|FG001|Overall Study|Failure to show a conditioned response|3|||
44210231|NCT01398358|79006938|FG000|Overall Study|Lost to Follow-up|11|||
44210232|NCT01398358|79006939|FG001|Overall Study|Lost to Follow-up|21|||
44210233|NCT01398358|79006940|FG002|Overall Study|Lost to Follow-up|18|||
44210234|NCT01398358|79006938|FG000|Overall Study|Withdrawal by Subject|3|||
44210235|NCT01398358|79006939|FG001|Overall Study|Withdrawal by Subject|2|||
44210236|NCT01398358|79006940|FG002|Overall Study|Withdrawal by Subject|2|||
44210237|NCT01398358|79006938|FG000|Overall Study|no longer eligible|1|||
44210238|NCT01398358|79006939|FG001|Overall Study|no longer eligible|0|||
44210239|NCT01398358|79006940|FG002|Overall Study|no longer eligible|1|||
44210240|NCT01778049|79006950|FG000|Open Label Treatment Period|Adverse Event|5|||
44210241|NCT01778049|79006951|FG001|Open Label Treatment Period|Adverse Event|15|||
44210242|NCT01778049|79006952|FG002|Open Label Treatment Period|Adverse Event|0|||
44210243|NCT01778049|79006953|FG003|Open Label Treatment Period|Adverse Event|0|||
44210244|NCT01778049|79006954|FG004|Open Label Treatment Period|Adverse Event|0|||
44210245|NCT01778049|79006955|FG005|Open Label Treatment Period|Adverse Event|0|||
44210246|NCT01778049|79006950|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
44210247|NCT01778049|79006951|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
44210248|NCT01778049|79006952|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
44210249|NCT01778049|79006953|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
44210250|NCT01778049|79006954|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
44210251|NCT01778049|79006955|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
44210252|NCT01778049|79006950|FG000|Open Label Treatment Period|Protocol Violation|5|||
44210253|NCT01778049|79006951|FG001|Open Label Treatment Period|Protocol Violation|5|||
44210254|NCT01778049|79006952|FG002|Open Label Treatment Period|Protocol Violation|0|||
44210255|NCT01778049|79006953|FG003|Open Label Treatment Period|Protocol Violation|0|||
44210256|NCT01778049|79006954|FG004|Open Label Treatment Period|Protocol Violation|0|||
44210257|NCT01778049|79006955|FG005|Open Label Treatment Period|Protocol Violation|0|||
44210258|NCT01778049|79006950|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
44210259|NCT01778049|79006951|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
44210260|NCT01778049|79006952|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
44210261|NCT01778049|79006953|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
44210262|NCT01778049|79006954|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
44210263|NCT01778049|79006955|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
44210264|NCT01778049|79006950|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
44210265|NCT01778049|79006951|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
44210266|NCT01778049|79006952|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
44210267|NCT01778049|79006953|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
44210268|NCT01778049|79006954|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
44370044|NCT00598702|79375204|FG006|Overall Study|Adverse Event|0|||
44370045|NCT00598702|79375205|FG007|Overall Study|Adverse Event|0|||
44210269|NCT01778049|79006955|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
44210270|NCT01778049|79006950|FG000|Open Label Treatment Period|Not treated|2|||
44210271|NCT01778049|79006951|FG001|Open Label Treatment Period|Not treated|1|||
44210272|NCT01778049|79006952|FG002|Open Label Treatment Period|Not treated|0|||
44210273|NCT01778049|79006953|FG003|Open Label Treatment Period|Not treated|0|||
44210274|NCT01778049|79006954|FG004|Open Label Treatment Period|Not treated|0|||
44210275|NCT01778049|79006955|FG005|Open Label Treatment Period|Not treated|0|||
44210276|NCT01778049|79006950|FG000|Open Label Treatment Period|Other reason not defined above|77|||
44210277|NCT01778049|79006951|FG001|Open Label Treatment Period|Other reason not defined above|94|||
44210278|NCT01778049|79006952|FG002|Open Label Treatment Period|Other reason not defined above|0|||
44210279|NCT01778049|79006953|FG003|Open Label Treatment Period|Other reason not defined above|0|||
44210280|NCT01778049|79006954|FG004|Open Label Treatment Period|Other reason not defined above|0|||
44210281|NCT01778049|79006955|FG005|Open Label Treatment Period|Other reason not defined above|0|||
44210282|NCT01778049|79006950|FG000|Double Blind Treatment Period|Adverse Event|0|||
44210283|NCT01778049|79006951|FG001|Double Blind Treatment Period|Adverse Event|0|||
44210284|NCT01778049|79006952|FG002|Double Blind Treatment Period|Adverse Event|4|||
44210285|NCT01778049|79006953|FG003|Double Blind Treatment Period|Adverse Event|5|||
44370046|NCT00598702|79375198|FG000|Overall Study|Withdrawal by Subject|0|||
44370047|NCT00598702|79375199|FG001|Overall Study|Withdrawal by Subject|0|||
44370048|NCT00598702|79375200|FG002|Overall Study|Withdrawal by Subject|0|||
44210286|NCT01778049|79006954|FG004|Double Blind Treatment Period|Adverse Event|3|||
44210287|NCT01778049|79006955|FG005|Double Blind Treatment Period|Adverse Event|2|||
44210288|NCT01778049|79006950|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
44370049|NCT00598702|79375201|FG003|Overall Study|Withdrawal by Subject|1|||
44210289|NCT01778049|79006951|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
44210290|NCT01778049|79006952|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
44210291|NCT01778049|79006953|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
44210292|NCT01778049|79006954|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
44210293|NCT01778049|79006955|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
44210294|NCT01778049|79006950|FG000|Double Blind Treatment Period|Protocol Violation|0|||
44210295|NCT01778049|79006951|FG001|Double Blind Treatment Period|Protocol Violation|0|||
44210296|NCT01778049|79006952|FG002|Double Blind Treatment Period|Protocol Violation|2|||
44210297|NCT01778049|79006953|FG003|Double Blind Treatment Period|Protocol Violation|0|||
44210298|NCT01778049|79006954|FG004|Double Blind Treatment Period|Protocol Violation|0|||
44210299|NCT01778049|79006955|FG005|Double Blind Treatment Period|Protocol Violation|0|||
44210300|NCT01778049|79006950|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
44210301|NCT01778049|79006951|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
44210302|NCT01778049|79006952|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
44210303|NCT01778049|79006953|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
44210304|NCT01778049|79006954|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
44210305|NCT01778049|79006955|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
44210306|NCT01778049|79006950|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
44210307|NCT01778049|79006951|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
44210308|NCT01778049|79006952|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
44210309|NCT01778049|79006953|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
44210310|NCT01778049|79006954|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
44210311|NCT01778049|79006955|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
44210312|NCT01778049|79006950|FG000|Double Blind Treatment Period|Not treated|0|||
44210313|NCT01778049|79006951|FG001|Double Blind Treatment Period|Not treated|0|||
44210314|NCT01778049|79006952|FG002|Double Blind Treatment Period|Not treated|0|||
44210315|NCT01778049|79006953|FG003|Double Blind Treatment Period|Not treated|2|||
44210316|NCT01778049|79006954|FG004|Double Blind Treatment Period|Not treated|2|||
44210317|NCT01778049|79006955|FG005|Double Blind Treatment Period|Not treated|0|||
44210318|NCT01778049|79006950|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
44210319|NCT01778049|79006951|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
44210320|NCT01778049|79006952|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
44210321|NCT01778049|79006953|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
44210322|NCT01778049|79006954|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
44210323|NCT01778049|79006955|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
44210324|NCT01777581|79006969|FG000|Overall Study|Lost to Follow-up|1|||
44210325|NCT01777581|79006970|FG001|Overall Study|Lost to Follow-up|1|||
44210326|NCT01777581|79006969|FG000|Overall Study|Adverse Event|2|||
44210327|NCT01777581|79006970|FG001|Overall Study|Adverse Event|0|||
44210328|NCT01777581|79006969|FG000|Overall Study|Lack of Efficacy|0|||
44210329|NCT01777581|79006970|FG001|Overall Study|Lack of Efficacy|1|||
44210330|NCT01864148|79006981|FG000|Overall Study|Other|2|||
44210331|NCT01864148|79006982|FG001|Overall Study|Other|1|||
44210332|NCT01864148|79006983|FG002|Overall Study|Other|1|||
44210333|NCT01864148|79006984|FG003|Overall Study|Other|3|||
44210334|NCT01864148|79006985|FG004|Overall Study|Other|1|||
44210335|NCT01864148|79006981|FG000|Overall Study|Death|0|||
44210336|NCT01864148|79006982|FG001|Overall Study|Death|0|||
44210337|NCT01864148|79006983|FG002|Overall Study|Death|0|||
44210338|NCT01864148|79006984|FG003|Overall Study|Death|1|||
44370050|NCT00598702|79375202|FG004|Overall Study|Withdrawal by Subject|1|||
44370051|NCT00598702|79375203|FG005|Overall Study|Withdrawal by Subject|0|||
44370052|NCT00598702|79375204|FG006|Overall Study|Withdrawal by Subject|0|||
44370053|NCT00598702|79375205|FG007|Overall Study|Withdrawal by Subject|0|||
44370054|NCT00598702|79375198|FG000|Overall Study|Physician Decision|0|||
44370055|NCT00598702|79375199|FG001|Overall Study|Physician Decision|0|||
44370056|NCT00598702|79375200|FG002|Overall Study|Physician Decision|0|||
44210339|NCT01864148|79006985|FG004|Overall Study|Death|0|||
44210340|NCT01864148|79006981|FG000|Overall Study|Investigator Decision|5|||
44210341|NCT01864148|79006982|FG001|Overall Study|Investigator Decision|0|||
44210342|NCT01864148|79006983|FG002|Overall Study|Investigator Decision|0|||
44210343|NCT01864148|79006984|FG003|Overall Study|Investigator Decision|4|||
44210344|NCT01864148|79006985|FG004|Overall Study|Investigator Decision|6|||
44210345|NCT01864148|79006981|FG000|Overall Study|Withdrawal by Subject|9|||
44210346|NCT01864148|79006982|FG001|Overall Study|Withdrawal by Subject|2|||
44370057|NCT00598702|79375201|FG003|Overall Study|Physician Decision|0|||
44370058|NCT00598702|79375202|FG004|Overall Study|Physician Decision|1|||
44543570|NCT03681691|79556643|FG000|Overall Study|COVID|1|||
44210347|NCT01864148|79006983|FG002|Overall Study|Withdrawal by Subject|6|||
44210348|NCT01864148|79006984|FG003|Overall Study|Withdrawal by Subject|8|||
44210349|NCT01864148|79006985|FG004|Overall Study|Withdrawal by Subject|8|||
44210350|NCT01864148|79006981|FG000|Overall Study|Lost to Follow-up|0|||
44210351|NCT01864148|79006982|FG001|Overall Study|Lost to Follow-up|0|||
44370059|NCT00598702|79375203|FG005|Overall Study|Physician Decision|0|||
44210352|NCT01864148|79006983|FG002|Overall Study|Lost to Follow-up|0|||
44210353|NCT01864148|79006984|FG003|Overall Study|Lost to Follow-up|2|||
44210354|NCT01864148|79006985|FG004|Overall Study|Lost to Follow-up|1|||
44210355|NCT01864148|79006981|FG000|Overall Study|Adverse Event|4|||
44210356|NCT01864148|79006982|FG001|Overall Study|Adverse Event|2|||
44210357|NCT01864148|79006983|FG002|Overall Study|Adverse Event|4|||
44210358|NCT01864148|79006984|FG003|Overall Study|Adverse Event|7|||
44210359|NCT01864148|79006985|FG004|Overall Study|Adverse Event|7|||
44210360|NCT01864148|79006981|FG000|Overall Study|Not Dosed|0|||
44210361|NCT01864148|79006982|FG001|Overall Study|Not Dosed|0|||
44210362|NCT01864148|79006983|FG002|Overall Study|Not Dosed|0|||
44210363|NCT01864148|79006984|FG003|Overall Study|Not Dosed|1|||
44210364|NCT01864148|79006985|FG004|Overall Study|Not Dosed|0|||
44210365|NCT01751139|79007002|FG000|Overall Study|Other|135|||
44210366|NCT01751139|79007002|FG000|Overall Study|Sponsor study termination|1609|||
44210367|NCT01751139|79007002|FG000|Overall Study|Lost to Follow-up|240|||
44210368|NCT01751139|79007002|FG000|Overall Study|Withdrawal by Subject|251|||
44210369|NCT01751139|79007002|FG000|Overall Study|Adverse Event|1|||
44210370|NCT01751139|79007002|FG000|Overall Study|Death|31|||
44210371|NCT01890122|79007010|FG000|Overall Study|Adverse Event|1|||
44210372|NCT01890122|79007011|FG001|Overall Study|Adverse Event|1|||
44210373|NCT01890122|79007012|FG002|Overall Study|Adverse Event|1|||
44210374|NCT01890122|79007013|FG003|Overall Study|Adverse Event|2|||
44210375|NCT01890122|79007010|FG000|Overall Study|Major Protocol Deviation|3|||
44210376|NCT01890122|79007011|FG001|Overall Study|Major Protocol Deviation|1|||
44210377|NCT01890122|79007012|FG002|Overall Study|Major Protocol Deviation|0|||
44210378|NCT01890122|79007013|FG003|Overall Study|Major Protocol Deviation|1|||
44210379|NCT01890122|79007010|FG000|Overall Study|Lost to Follow-up|0|||
44210380|NCT01890122|79007011|FG001|Overall Study|Lost to Follow-up|1|||
44210381|NCT01890122|79007012|FG002|Overall Study|Lost to Follow-up|2|||
44210382|NCT01890122|79007013|FG003|Overall Study|Lost to Follow-up|2|||
44210383|NCT01890122|79007010|FG000|Overall Study|Voluntary Withdrawal|8|||
44210384|NCT01890122|79007011|FG001|Overall Study|Voluntary Withdrawal|8|||
44210385|NCT01890122|79007012|FG002|Overall Study|Voluntary Withdrawal|2|||
44210386|NCT01890122|79007013|FG003|Overall Study|Voluntary Withdrawal|11|||
44210387|NCT01890122|79007010|FG000|Overall Study|Lack of Efficacy|14|||
44210388|NCT01890122|79007011|FG001|Overall Study|Lack of Efficacy|24|||
44210389|NCT01890122|79007012|FG002|Overall Study|Lack of Efficacy|7|||
44210390|NCT01890122|79007013|FG003|Overall Study|Lack of Efficacy|41|||
44210391|NCT01890122|79007010|FG000|Overall Study|Reason not Specified|0|||
44210392|NCT01890122|79007011|FG001|Overall Study|Reason not Specified|1|||
44210393|NCT01890122|79007012|FG002|Overall Study|Reason not Specified|1|||
44210394|NCT01890122|79007013|FG003|Overall Study|Reason not Specified|2|||
44210395|NCT01890122|79007010|FG000|Overall Study|Randomized but not Treated|1|||
44210396|NCT01890122|79007011|FG001|Overall Study|Randomized but not Treated|1|||
44210397|NCT01890122|79007012|FG002|Overall Study|Randomized but not Treated|0|||
44210398|NCT01890122|79007013|FG003|Overall Study|Randomized but not Treated|0|||
44210399|NCT01397890|79007025|FG000|Overall Study|Withdrawal by Subject|7|||
44210400|NCT01397890|79007026|FG001|Overall Study|Withdrawal by Subject|11|||
44210401|NCT01397890|79007025|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
44210402|NCT01397890|79007026|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
44210403|NCT01397890|79007025|FG000|Overall Study|Death|2|||
44210404|NCT01397890|79007026|FG001|Overall Study|Death|3|||
44210405|NCT01397890|79007025|FG000|Overall Study|Lost to Follow-up|1|||
44210406|NCT01397890|79007026|FG001|Overall Study|Lost to Follow-up|4|||
44210407|NCT01397890|79007025|FG000|Overall Study|Condition under Investigation Worsened|1|||
44210408|NCT01397890|79007026|FG001|Overall Study|Condition under Investigation Worsened|3|||
44210409|NCT01397890|79007025|FG000|Overall Study|Adverse Event|1|||
44210410|NCT01397890|79007026|FG001|Overall Study|Adverse Event|2|||
44210411|NCT01397890|79007025|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
44210412|NCT01397890|79007026|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
44370060|NCT00598702|79375204|FG006|Overall Study|Physician Decision|0|||
44210413|NCT01397890|79007025|FG000|Overall Study|Others|2|||
44210414|NCT01397890|79007026|FG001|Overall Study|Others|1|||
44210415|NCT01777269|79007034|FG000|Overall Study|Adverse Event|24|||
44210416|NCT01777269|79007035|FG001|Overall Study|Adverse Event|33|||
44210417|NCT01777269|79007034|FG000|Overall Study|Lack of Efficacy|8|||
44210418|NCT01777269|79007035|FG001|Overall Study|Lack of Efficacy|10|||
44370061|NCT00598702|79375205|FG007|Overall Study|Physician Decision|0|||
44543571|NCT03681691|79556644|FG001|Overall Study|COVID|0|||
44269763|NCT02354508|79194812|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
44269764|NCT02354508|79194813|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
44210419|NCT01777269|79007034|FG000|Overall Study|Protocol Violation|4|||
44210420|NCT01777269|79007035|FG001|Overall Study|Protocol Violation|4|||
44269765|NCT02354508|79194811|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
44210421|NCT01777269|79007034|FG000|Overall Study|Participants reached stopping criteria|1|||
44210422|NCT01777269|79007035|FG001|Overall Study|Participants reached stopping criteria|1|||
44210423|NCT01777269|79007034|FG000|Overall Study|Lost to Follow-up|4|||
44210424|NCT01777269|79007035|FG001|Overall Study|Lost to Follow-up|0|||
44210425|NCT01777269|79007034|FG000|Overall Study|Physician Decision|5|||
44210426|NCT01777269|79007035|FG001|Overall Study|Physician Decision|2|||
44210427|NCT01777269|79007034|FG000|Overall Study|Withdrawal by Subject|9|||
44210428|NCT01777269|79007035|FG001|Overall Study|Withdrawal by Subject|9|||
44210429|NCT04016272|79007043|FG000|Overall Study|Withdrawal by Subject|1|||
44210430|NCT04016272|79007044|FG001|Overall Study|Withdrawal by Subject|2|||
44210431|NCT01751061|79007052|FG000|Overall Study|Death|1|||
44210432|NCT01751061|79007053|FG001|Overall Study|Death|0|||
44210433|NCT01751061|79007052|FG000|Overall Study|patient death|5|||
44210434|NCT01751061|79007053|FG001|Overall Study|patient death|0|||
44210435|NCT01751061|79007052|FG000|Overall Study|Lost to Follow-up|40|||
44210436|NCT01751061|79007053|FG001|Overall Study|Lost to Follow-up|25|||
44210437|NCT01751061|79007052|FG000|Overall Study|patient regained decisional capacity|4|||
44210438|NCT01751061|79007053|FG001|Overall Study|patient regained decisional capacity|8|||
44210439|NCT01751061|79007052|FG000|Overall Study|Withdrawal by Subject|4|||
44210440|NCT01751061|79007053|FG001|Overall Study|Withdrawal by Subject|1|||
44210441|NCT01751061|79007052|FG000|Overall Study|Physician Decision|2|||
44210442|NCT01751061|79007053|FG001|Overall Study|Physician Decision|0|||
44210443|NCT01777191|79007061|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
44269766|NCT02354508|79194812|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
44269767|NCT02354508|79194813|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
44370062|NCT00598702|79375198|FG000|Overall Study|Dose limiting toxicity|0|||
44269768|NCT02354508|79194811|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
44269769|NCT02354508|79194812|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
44269770|NCT02354508|79194813|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
44370063|NCT00598702|79375199|FG001|Overall Study|Dose limiting toxicity|0|||
44370064|NCT00598702|79375200|FG002|Overall Study|Dose limiting toxicity|0|||
44370065|NCT00598702|79375201|FG003|Overall Study|Dose limiting toxicity|1|||
44210444|NCT01777191|79007062|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
44269771|NCT02354508|79194811|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
44269772|NCT02354508|79194812|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
44370066|NCT00598702|79375202|FG004|Overall Study|Dose limiting toxicity|1|||
44370067|NCT00598702|79375203|FG005|Overall Study|Dose limiting toxicity|1|||
44370068|NCT00598702|79375204|FG006|Overall Study|Dose limiting toxicity|0|||
44210445|NCT01777191|79007061|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
44210446|NCT01777191|79007062|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
44210447|NCT01777191|79007061|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
44210448|NCT01777191|79007062|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
44210449|NCT01777191|79007061|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
44210450|NCT01777191|79007062|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
44210451|NCT01777191|79007061|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
44210452|NCT01777191|79007062|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
44210453|NCT01777191|79007061|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
44210454|NCT01777191|79007062|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
44210455|NCT01777191|79007061|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
44210456|NCT01777191|79007062|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
44210457|NCT01777191|79007061|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
44210458|NCT01777191|79007062|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
44210459|NCT01777191|79007061|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
44210460|NCT01777191|79007062|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
44210461|NCT01777191|79007061|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
44210462|NCT01777191|79007062|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
44210463|NCT01777191|79007061|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
44210464|NCT01777191|79007062|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
44210465|NCT01896050|79007073|FG000|Overall Study|Adverse Event|37|||
44210466|NCT01896050|79007074|FG001|Overall Study|Adverse Event|2|||
44210467|NCT01896050|79007073|FG000|Overall Study|Death|1|||
44210468|NCT01896050|79007074|FG001|Overall Study|Death|0|||
44210469|NCT01775787|79007082|FG000|First 7-10 Days|Adverse Event|0|||
44210470|NCT01775787|79007083|FG001|First 7-10 Days|Adverse Event|1|||
44210471|NCT01775787|79007082|FG000|First 7-10 Days|family emergency|0|||
44210472|NCT01775787|79007083|FG001|First 7-10 Days|family emergency|1|||
44370069|NCT00598702|79375205|FG007|Overall Study|Dose limiting toxicity|0|||
44370070|NCT01148810|79375225|FG000|Overall Study|Adverse Event|0|||
44370071|NCT01148810|79375226|FG001|Overall Study|Adverse Event|2|||
44370072|NCT01148810|79375225|FG000|Overall Study|Lack of Efficacy|0|||
44370073|NCT01148810|79375226|FG001|Overall Study|Lack of Efficacy|1|||
44370074|NCT01148810|79375225|FG000|Overall Study|Withdrawal by Subject|0|||
44370075|NCT01148810|79375226|FG001|Overall Study|Withdrawal by Subject|2|||
44370076|NCT01148810|79375225|FG000|Overall Study|Protocol Violation|1|||
44370077|NCT01148810|79375226|FG001|Overall Study|Protocol Violation|0|||
44370078|NCT01151618|79375233|FG000|Overall Study|Adverse Event|2|||
44370079|NCT01151618|79375233|FG000|Overall Study|Withdrawal by Subject|7|||
44370080|NCT01164956|79375237|FG000|Overall Study|Side Effects|1|||
44370081|NCT01164956|79375238|FG001|Overall Study|Side Effects|0|||
44370082|NCT01164956|79375239|FG002|Overall Study|Side Effects|1|||
44370083|NCT01164722|79375249|FG000|Overall Study|Adverse Event|0|||
44370084|NCT01164722|79375250|FG001|Overall Study|Adverse Event|1|||
44370085|NCT01164722|79375249|FG000|Overall Study|Withdrawal by Subject|3|||
44370086|NCT01164722|79375250|FG001|Overall Study|Withdrawal by Subject|4|||
44370087|NCT01164722|79375249|FG000|Overall Study|Lost to Follow-up|3|||
44370088|NCT01164722|79375250|FG001|Overall Study|Lost to Follow-up|6|||
44370089|NCT01164722|79375249|FG000|Overall Study|met protocol criteria for non-treatment|11|||
44370090|NCT01164722|79375250|FG001|Overall Study|met protocol criteria for non-treatment|1|||
44370091|NCT01164722|79375249|FG000|Overall Study|enrolled on other study, concomitant med|1|||
44370092|NCT01164722|79375250|FG001|Overall Study|enrolled on other study, concomitant med|3|||
44370093|NCT01151540|79375256|FG000|Overall Study|Other|2|||
44210473|NCT01775787|79007082|FG000|First 7-10 Days|time commitment|0|||
44210474|NCT01775787|79007083|FG001|First 7-10 Days|time commitment|2|||
44210475|NCT01775787|79007082|FG000|First 7-10 Days|concerns with using IV|1|||
44210476|NCT01775787|79007083|FG001|First 7-10 Days|concerns with using IV|2|||
44210477|NCT01775787|79007082|FG000|Second 7-10 Days|time commitment|0|||
44210478|NCT01775787|79007083|FG001|Second 7-10 Days|time commitment|1|||
44210479|NCT01775787|79007082|FG000|Second 7-10 Days|concerns with using IV|0|||
44370094|NCT01151540|79375256|FG000|Overall Study|Adverse event, non-fatal|4|||
44543572|NCT03681691|79556643|FG000|Overall Study|prolonged bleeding|1|||
44543573|NCT03681691|79556644|FG001|Overall Study|prolonged bleeding|0|||
44210480|NCT01775787|79007083|FG001|Second 7-10 Days|concerns with using IV|1|||
44210481|NCT01775553|79007091|FG000|Overall Study|Adverse Event|1|||
44210482|NCT01775553|79007091|FG000|Overall Study|Disease Progression|12|||
44210483|NCT01775475|79007097|FG000|Overall Study|Death|3|||
44210484|NCT01775475|79007098|FG001|Overall Study|Death|3|||
44370095|NCT01151540|79375256|FG000|Overall Study|Withdrawal by Subject|7|||
44370096|NCT01163786|79375260|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
44370097|NCT01163786|79375260|FG000|Treatment With Bortezomib|Adverse Event|2|||
44370098|NCT01163786|79375260|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
44370099|NCT00984282|79375266|FG000|Double Blind Treatment|Adverse Event|40|||
44543574|NCT03681691|79556643|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
44370100|NCT00984282|79375267|FG001|Double Blind Treatment|Adverse Event|6|||
44210485|NCT01774929|79007104|FG000|Overall Study|Adverse Event|3|||
44210486|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
44210487|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
44210488|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
44210489|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
44210490|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
44210491|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
44210492|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
44210493|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
44210494|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
44210495|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
44210496|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
44210497|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
44210498|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
44210499|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
44210500|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
44210501|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
44210502|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
44210503|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
44210504|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
44210505|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
44210506|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
44210507|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
44210508|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
44210509|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
44210510|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
44210511|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
44210512|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
44210513|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
44210514|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44210515|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44210516|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44210517|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44210518|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
44210519|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44210520|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
44210521|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
44210522|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
44210523|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
44210524|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
44210525|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
44210526|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
44210527|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
44210528|NCT01888874|79007115|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
44210529|NCT01888874|79007116|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
44210530|NCT01888874|79007117|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
44210531|NCT01888874|79007118|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
44210532|NCT01888874|79007119|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
44210533|NCT01888874|79007120|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
44210534|NCT01888874|79007121|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
44210535|NCT01888874|79007115|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
44210536|NCT01888874|79007116|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
44210537|NCT01888874|79007117|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
44210538|NCT01888874|79007118|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
44210539|NCT01888874|79007119|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
44210540|NCT01888874|79007120|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
44210541|NCT01888874|79007121|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
44210542|NCT01888874|79007115|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
44210543|NCT01888874|79007116|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
44210544|NCT01888874|79007117|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
44210545|NCT01888874|79007118|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
44370101|NCT00984282|79375266|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
44370102|NCT00984282|79375267|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
44370103|NCT00984282|79375266|FG000|Double Blind Treatment|Physician Decision|1|||
44269773|NCT02354508|79194813|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
44269774|NCT02354508|79194811|FG000|Period 2: Extension Phase|Physician Decision|5|||
44269775|NCT02354508|79194812|FG001|Period 2: Extension Phase|Physician Decision|0|||
44269776|NCT02354508|79194813|FG002|Period 2: Extension Phase|Physician Decision|1|||
44269777|NCT02354508|79194811|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
44269778|NCT02354508|79194812|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
44370104|NCT00984282|79375267|FG001|Double Blind Treatment|Physician Decision|2|||
44370105|NCT00984282|79375266|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
44370106|NCT00984282|79375267|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
44370107|NCT00984282|79375266|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
44370108|NCT00984282|79375267|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
44370109|NCT00984282|79375266|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
44370110|NCT00984282|79375267|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
44370111|NCT00984282|79375266|FG000|Double Blind Treatment|Lost to Follow-up|3|||
44370112|NCT00984282|79375267|FG001|Double Blind Treatment|Lost to Follow-up|0|||
44543575|NCT03681691|79556644|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
44543576|NCT02935842|79556656|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
44543577|NCT02935842|79556657|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
44543578|NCT02935842|79556658|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
44543579|NCT02935842|79556659|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
44543580|NCT02935842|79556656|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
44543581|NCT02935842|79556657|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
44543582|NCT02935842|79556658|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
44210546|NCT01888874|79007119|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
44210547|NCT01888874|79007120|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
44370113|NCT00984282|79375266|FG000|Double Blind Treatment|Death|8|||
44370114|NCT00984282|79375267|FG001|Double Blind Treatment|Death|4|||
44210548|NCT01888874|79007121|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
44210549|NCT01888874|79007115|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
44210550|NCT01888874|79007116|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
44210551|NCT01888874|79007117|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
44210552|NCT01888874|79007118|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
44210553|NCT01888874|79007119|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
44210554|NCT01888874|79007120|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
44210555|NCT01888874|79007121|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
44210556|NCT01888874|79007115|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
44210557|NCT01888874|79007116|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
44210558|NCT01888874|79007117|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
44210559|NCT01888874|79007118|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
44210560|NCT01888874|79007119|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
44210561|NCT01888874|79007120|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
44210562|NCT01888874|79007121|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
44210563|NCT01888874|79007115|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
44210564|NCT01888874|79007116|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
44210565|NCT01888874|79007117|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
44210566|NCT01888874|79007118|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
44210567|NCT01888874|79007119|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
44210568|NCT01888874|79007120|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
44210569|NCT01888874|79007121|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
44210570|NCT01888874|79007115|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
44210571|NCT01888874|79007116|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
44210572|NCT01888874|79007117|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
44269779|NCT02354508|79194813|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
44269780|NCT02354508|79194811|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
44370115|NCT00984282|79375266|FG000|Double Blind Treatment|Not treated|0|||
44210573|NCT01888874|79007118|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
44210574|NCT01888874|79007119|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
44210575|NCT01888874|79007120|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
44210576|NCT01888874|79007121|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
44210577|NCT01749735|79007140|FG000|Overall Study|Withdrawal by Subject|1|||
44210578|NCT01749735|79007141|FG001|Overall Study|Withdrawal by Subject|0|||
44210579|NCT01749033|79007150|FG000|Overall Study|Did not receive allocated intervention|3|||
44210580|NCT01749033|79007151|FG001|Overall Study|Did not receive allocated intervention|3|||
44210581|NCT01749033|79007152|FG002|Overall Study|Did not receive allocated intervention|0|||
44210582|NCT01749033|79007150|FG000|Overall Study|Lost to Follow-up|0|||
44210583|NCT01749033|79007151|FG001|Overall Study|Lost to Follow-up|2|||
44210584|NCT01749033|79007152|FG002|Overall Study|Lost to Follow-up|1|||
44210585|NCT01774305|79007163|FG000|Overall Study|Physician Decision|1|||
44210586|NCT01774305|79007164|FG001|Overall Study|Physician Decision|0|||
44210587|NCT01737021|79007172|FG000|Overall Study|Lost to Follow-up|5|||
44210588|NCT01737021|79007173|FG001|Overall Study|Lost to Follow-up|3|||
44210589|NCT01397422|79007183|FG000|Overall Study|Adverse Event|0|||
44210590|NCT01397422|79007184|FG001|Overall Study|Adverse Event|3|||
44210591|NCT01397422|79007185|FG002|Overall Study|Adverse Event|3|||
44210592|NCT01397422|79007186|FG003|Overall Study|Adverse Event|8|||
44210593|NCT01397422|79007183|FG000|Overall Study|Withdrawal by Subject|1|||
44210594|NCT01397422|79007184|FG001|Overall Study|Withdrawal by Subject|0|||
44210595|NCT01397422|79007185|FG002|Overall Study|Withdrawal by Subject|0|||
44370116|NCT00984282|79375267|FG001|Double Blind Treatment|Not treated|1|||
44370117|NCT00984282|79375266|FG000|Double Blind Treatment|Switched to commercial drug|6|||
44370118|NCT00984282|79375267|FG001|Double Blind Treatment|Switched to commercial drug|1|||
44370119|NCT00984282|79375266|FG000|Double Blind Treatment|protocol driven decision point|1|||
44370120|NCT00984282|79375267|FG001|Double Blind Treatment|protocol driven decision point|1|||
44370121|NCT00984282|79375266|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
44370122|NCT00984282|79375267|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
44370123|NCT00984282|79375266|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
44370124|NCT00984282|79375267|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
44370125|NCT00984282|79375266|FG000|Open-label Treatment|Adverse Event|20|||
44370126|NCT00984282|79375267|FG001|Open-label Treatment|Adverse Event|30|||
44370127|NCT00984282|79375266|FG000|Open-label Treatment|Withdrawal by Subject|6|||
44370128|NCT00984282|79375267|FG001|Open-label Treatment|Withdrawal by Subject|21|||
44370129|NCT00984282|79375266|FG000|Open-label Treatment|Death|7|||
44370130|NCT00984282|79375267|FG001|Open-label Treatment|Death|15|||
44370131|NCT00984282|79375266|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
44370132|NCT00984282|79375267|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
44370133|NCT00984282|79375266|FG000|Open-label Treatment|Lost to Follow-up|1|||
44370134|NCT00984282|79375267|FG001|Open-label Treatment|Lost to Follow-up|1|||
44370135|NCT00984282|79375266|FG000|Open-label Treatment|Patient convenience|1|||
44210596|NCT01397422|79007186|FG003|Overall Study|Withdrawal by Subject|0|||
44210597|NCT01397422|79007183|FG000|Overall Study|Increased bradykinesia related to PD|1|||
44210598|NCT01397422|79007184|FG001|Overall Study|Increased bradykinesia related to PD|0|||
44210599|NCT01397422|79007185|FG002|Overall Study|Increased bradykinesia related to PD|0|||
44210600|NCT01397422|79007186|FG003|Overall Study|Increased bradykinesia related to PD|0|||
44210601|NCT01736553|79007200|FG000|Overall Study|Death|12|||
44370136|NCT00984282|79375267|FG001|Open-label Treatment|Patient convenience|0|||
44370137|NCT00984282|79375266|FG000|Open-label Treatment|Non-compliant with study medication|1|||
44370138|NCT00984282|79375267|FG001|Open-label Treatment|Non-compliant with study medication|0|||
44370139|NCT00984282|79375266|FG000|Open-label Treatment|Target lesion removed|0|||
44370140|NCT00984282|79375267|FG001|Open-label Treatment|Target lesion removed|1|||
44370141|NCT00984282|79375266|FG000|Open-label Treatment|Protocol driven decision point|1|||
44370142|NCT00984282|79375267|FG001|Open-label Treatment|Protocol driven decision point|1|||
44370143|NCT00984282|79375266|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
44370144|NCT00984282|79375267|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
44370145|NCT00984282|79375266|FG000|Open-label Treatment|Switched to commercial drug|6|||
44370146|NCT00984282|79375267|FG001|Open-label Treatment|Switched to commercial drug|7|||
44370147|NCT00984282|79375266|FG000|Open-label Treatment|Physician Decision|1|||
44370148|NCT00984282|79375267|FG001|Open-label Treatment|Physician Decision|0|||
44370149|NCT00984282|79375266|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
44210602|NCT01736553|79007201|FG001|Overall Study|Death|0|||
44210603|NCT01736553|79007200|FG000|Overall Study|Withdrawal by Subject|5|||
44210604|NCT01736553|79007201|FG001|Overall Study|Withdrawal by Subject|2|||
44210605|NCT01736553|79007200|FG000|Overall Study|Lost to Follow-up|2|||
44370150|NCT00984282|79375267|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
44210606|NCT01736553|79007201|FG001|Overall Study|Lost to Follow-up|2|||
44210607|NCT01888640|79007228|FG000|Overall Study|Lost to Follow-up|1|||
44210608|NCT01888640|79007229|FG001|Overall Study|Lost to Follow-up|2|||
44210609|NCT01888640|79007230|FG002|Overall Study|Lost to Follow-up|0|||
44370151|NCT00984282|79375266|FG000|Long Term Follow-up|Death|27|||
44370152|NCT00984282|79375267|FG001|Long Term Follow-up|Death|68|||
44370153|NCT00984282|79375266|FG000|Long Term Follow-up|Lost to Follow-up|3|||
44370154|NCT00984282|79375267|FG001|Long Term Follow-up|Lost to Follow-up|6|||
44370155|NCT00984282|79375266|FG000|Long Term Follow-up|Protocol driven decision point|25|||
44370156|NCT00984282|79375267|FG001|Long Term Follow-up|Protocol driven decision point|26|||
44370157|NCT00984282|79375266|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
44370158|NCT00984282|79375267|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
44370159|NCT00984282|79375266|FG000|Long Term Follow-up|Switched to commercial drug|4|||
44370160|NCT00984282|79375267|FG001|Long Term Follow-up|Switched to commercial drug|2|||
44370161|NCT00984282|79375266|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
44370162|NCT00984282|79375267|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
44370163|NCT01147874|79375275|FG000|Overall Study|Adverse Event|5|||
44370164|NCT01147874|79375275|FG000|Overall Study|Investigator's Request|1|||
44370165|NCT01147874|79375275|FG000|Overall Study|Lost to Follow-up|25|||
44370166|NCT01147874|79375275|FG000|Overall Study|Other|5|||
44210610|NCT01888640|79007228|FG000|Overall Study|Withdrawal by Subject|15|||
44210611|NCT01888640|79007229|FG001|Overall Study|Withdrawal by Subject|11|||
44370167|NCT01147874|79375275|FG000|Overall Study|Protocol Violation|5|||
44370168|NCT01147874|79375275|FG000|Overall Study|Sponsor's Decision|2|||
44370169|NCT01147874|79375275|FG000|Overall Study|Withdrawal by Subject|24|||
44370170|NCT01147640|79375281|FG000|Overall Study|Adverse Event|2|||
44370171|NCT01147640|79375282|FG001|Overall Study|Adverse Event|0|||
44370172|NCT01147640|79375281|FG000|Overall Study|Physician Decision|1|||
44370173|NCT01147640|79375282|FG001|Overall Study|Physician Decision|0|||
44370174|NCT01147640|79375281|FG000|Overall Study|Withdrawal by Subject|1|||
44370175|NCT01147640|79375282|FG001|Overall Study|Withdrawal by Subject|0|||
44370176|NCT01147640|79375281|FG000|Overall Study|Lost to Follow-up|0|||
44370177|NCT01147640|79375282|FG001|Overall Study|Lost to Follow-up|1|||
44370178|NCT01147640|79375281|FG000|Overall Study|Didn't meet eligibility criteria|1|||
44370179|NCT01147640|79375282|FG001|Overall Study|Didn't meet eligibility criteria|0|||
44370180|NCT01121900|79375288|FG000|First Intervention Period|Adverse Event|1|||
44370181|NCT01121900|79375289|FG001|First Intervention Period|Adverse Event|1|||
44370182|NCT01121900|79375288|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
44370183|NCT01121900|79375289|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44370184|NCT01121666|79375297|FG000|Overall Study|Protocol Violation|29|||
44370185|NCT01121666|79375298|FG001|Overall Study|Protocol Violation|10|||
44370186|NCT00984126|79375308|FG000|Overall Study|Protocol Violation|0|||
44210612|NCT01888640|79007230|FG002|Overall Study|Withdrawal by Subject|4|||
44210613|NCT01888640|79007228|FG000|Overall Study|Minimum dose not met|10|||
44210614|NCT01888640|79007229|FG001|Overall Study|Minimum dose not met|16|||
44210615|NCT01888640|79007230|FG002|Overall Study|Minimum dose not met|0|||
44210616|NCT01888640|79007228|FG000|Overall Study|Given wrong unit (placebo)|1|||
44210617|NCT01888640|79007229|FG001|Overall Study|Given wrong unit (placebo)|0|||
44210618|NCT01888640|79007230|FG002|Overall Study|Given wrong unit (placebo)|0|||
44210619|NCT01888640|79007228|FG000|Overall Study|Excluded for prior TENS|0|||
44210620|NCT01888640|79007229|FG001|Overall Study|Excluded for prior TENS|1|||
44210621|NCT01888640|79007230|FG002|Overall Study|Excluded for prior TENS|0|||
44210622|NCT01888640|79007228|FG000|Overall Study|Researcher Termination of Participant|0|||
44210623|NCT01888640|79007229|FG001|Overall Study|Researcher Termination of Participant|1|||
44370187|NCT00984126|79375309|FG001|Overall Study|Protocol Violation|0|||
44370188|NCT00984126|79375310|FG002|Overall Study|Protocol Violation|1|||
44370189|NCT00984126|79375311|FG003|Overall Study|Protocol Violation|2|||
44370190|NCT00984126|79375308|FG000|Overall Study|Adverse Event|0|||
44370191|NCT00984126|79375309|FG001|Overall Study|Adverse Event|0|||
44210624|NCT01888640|79007230|FG002|Overall Study|Researcher Termination of Participant|1|||
44210625|NCT01736475|79007243|FG000|Overall Study|Adverse Event|4|||
44210626|NCT01736475|79007244|FG001|Overall Study|Adverse Event|0|||
44210627|NCT01736475|79007243|FG000|Overall Study|Withdrawal by Subject|2|||
44210628|NCT01736475|79007244|FG001|Overall Study|Withdrawal by Subject|0|||
44370192|NCT00984126|79375310|FG002|Overall Study|Adverse Event|0|||
44370193|NCT00984126|79375311|FG003|Overall Study|Adverse Event|2|||
44370194|NCT00984126|79375308|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
44370195|NCT00984126|79375309|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
44370196|NCT00984126|79375310|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
44370197|NCT00984126|79375311|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
44543583|NCT02935842|79556659|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
44370198|NCT00984126|79375308|FG000|Overall Study|Withdrawal criteria|0|||
44370199|NCT00984126|79375309|FG001|Overall Study|Withdrawal criteria|1|||
44370200|NCT00984126|79375310|FG002|Overall Study|Withdrawal criteria|3|||
44370201|NCT00984126|79375311|FG003|Overall Study|Withdrawal criteria|9|||
44370202|NCT00979602|79375332|FG000|Overall Study|Serious Adverse Event|5|||
44370203|NCT00979602|79375333|FG001|Overall Study|Serious Adverse Event|3|||
44210629|NCT01736475|79007243|FG000|Overall Study|Protocol Violation|4|||
44210630|NCT01736475|79007244|FG001|Overall Study|Protocol Violation|0|||
44210631|NCT01736475|79007243|FG000|Overall Study|Other - Screen failure|1|||
44210632|NCT01736475|79007244|FG001|Overall Study|Other - Screen failure|0|||
44210633|NCT01736475|79007243|FG000|Overall Study|Other - Surgical procedure|1|||
44210634|NCT01736475|79007244|FG001|Overall Study|Other - Surgical procedure|0|||
44210635|NCT01863758|79007261|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
44210636|NCT01863758|79007261|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
44210637|NCT01863680|79007265|FG000|Overall Study|Adverse Event|17|||
44210638|NCT01863680|79007265|FG000|Overall Study|Risk of OHSS|17|||
44210639|NCT01863680|79007265|FG000|Overall Study|Spontaneous pregnancy|2|||
44210640|NCT01863680|79007265|FG000|Overall Study|Withdrawal by Subject|1|||
44210641|NCT01863680|79007265|FG000|Overall Study|Did not undergo IVF/ET|14|||
44210642|NCT01863680|79007265|FG000|Overall Study|Other|6|||
44210643|NCT01747629|79007271|FG000|Overall Study|Adverse Event|1|||
44210644|NCT01747629|79007272|FG001|Overall Study|Adverse Event|2|||
44210645|NCT01747629|79007271|FG000|Overall Study|Withdrawal by Subject|2|||
44210646|NCT01747629|79007272|FG001|Overall Study|Withdrawal by Subject|2|||
44210647|NCT01747629|79007271|FG000|Overall Study|Noncompliance|1|||
44210648|NCT01747629|79007272|FG001|Overall Study|Noncompliance|1|||
44210649|NCT01747629|79007271|FG000|Overall Study|Inclusion criteria not met|1|||
44370204|NCT00979602|79375332|FG000|Overall Study|Protocol Violation|3|||
44370205|NCT00979602|79375333|FG001|Overall Study|Protocol Violation|0|||
44370206|NCT00979602|79375332|FG000|Overall Study|Withdrawal by Subject|31|||
44370207|NCT00979602|79375333|FG001|Overall Study|Withdrawal by Subject|25|||
44370208|NCT00979602|79375332|FG000|Overall Study|Lost to Follow-up|100|||
44370209|NCT00979602|79375333|FG001|Overall Study|Lost to Follow-up|96|||
44370210|NCT00979602|79375332|FG000|Overall Study|Migrated/moved from study area|3|||
44370211|NCT00979602|79375333|FG001|Overall Study|Migrated/moved from study area|6|||
44370212|NCT00979602|79375332|FG000|Overall Study|Others|3|||
44370213|NCT00979602|79375333|FG001|Overall Study|Others|3|||
44370214|NCT00816361|79375358|FG000|Overall Study|Withdrawal by Subject|0|||
44370215|NCT00816361|79375359|FG001|Overall Study|Withdrawal by Subject|0|||
44370216|NCT00816361|79375360|FG002|Overall Study|Withdrawal by Subject|0|||
44370217|NCT00816361|79375361|FG003|Overall Study|Withdrawal by Subject|0|||
44370218|NCT00816361|79375362|FG004|Overall Study|Withdrawal by Subject|1|||
44370219|NCT00816361|79375363|FG005|Overall Study|Withdrawal by Subject|2|||
44370220|NCT00816361|79375364|FG006|Overall Study|Withdrawal by Subject|0|||
44370221|NCT00816361|79375365|FG007|Overall Study|Withdrawal by Subject|2|||
44210650|NCT01747629|79007272|FG001|Overall Study|Inclusion criteria not met|0|||
44210651|NCT01747629|79007271|FG000|Overall Study|Not treated|1|||
44210652|NCT01747629|79007272|FG001|Overall Study|Not treated|0|||
44210653|NCT01747629|79007271|FG000|Overall Study|Other|2|||
44210654|NCT01747629|79007272|FG001|Overall Study|Other|1|||
44210655|NCT01863368|79007280|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
44210656|NCT01863368|79007281|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
44210657|NCT01863368|79007280|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
44210658|NCT01863368|79007281|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
44210659|NCT01863368|79007280|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
44210660|NCT01863368|79007281|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
44210661|NCT01863368|79007280|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
44210662|NCT01863368|79007281|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
44210663|NCT01863368|79007280|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
44210664|NCT01863368|79007281|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
44210665|NCT01863368|79007280|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
44210666|NCT01863368|79007281|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
44210667|NCT01886690|79007290|FG000|Overall Study|Protocol Violation|0|||
44210668|NCT01886690|79007291|FG001|Overall Study|Protocol Violation|1|||
44210669|NCT01886690|79007290|FG000|Overall Study|Personal Reasons|0|||
44210670|NCT01886690|79007291|FG001|Overall Study|Personal Reasons|1|||
44370222|NCT00816361|79375366|FG008|Overall Study|Withdrawal by Subject|1|||
44370223|NCT00816361|79375358|FG000|Overall Study|Death|4|||
44210671|NCT01886378|79007297|FG000|Overall Study|Adverse Event|1|||
44210672|NCT01886378|79007297|FG000|Overall Study|Withdrawal by Subject|4|||
44210673|NCT01886300|79007301|FG000|Overall Study|Trial terminated by sponsor|16|||
44210674|NCT01885208|79007307|FG000|Overall Study|Unclassified|32|||
44210675|NCT01885208|79007308|FG001|Overall Study|Unclassified|38|||
44210676|NCT01859702|79007314|FG000|Overall Study|Protocol deviation|3|||
44210677|NCT01859702|79007314|FG000|Overall Study|Adverse Event|2|||
44210678|NCT01835132|79007318|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
44210679|NCT01747551|79007324|FG000|Overall Study|Progressive Disease|24|||
44370224|NCT00816361|79375359|FG001|Overall Study|Death|3|||
44210680|NCT01747551|79007325|FG001|Overall Study|Progressive Disease|17|||
44210681|NCT01747551|79007324|FG000|Overall Study|Death|3|||
44370225|NCT00816361|79375360|FG002|Overall Study|Death|3|||
44370226|NCT00816361|79375361|FG003|Overall Study|Death|3|||
44370227|NCT00816361|79375362|FG004|Overall Study|Death|1|||
44210682|NCT01747551|79007325|FG001|Overall Study|Death|1|||
44370228|NCT00816361|79375363|FG005|Overall Study|Death|1|||
44370229|NCT00816361|79375364|FG006|Overall Study|Death|3|||
44210683|NCT01747551|79007324|FG000|Overall Study|Adverse Event|7|||
44210684|NCT01747551|79007325|FG001|Overall Study|Adverse Event|1|||
44210685|NCT01747551|79007324|FG000|Overall Study|Prolonged Treatment Delay|2|||
44210686|NCT01747551|79007325|FG001|Overall Study|Prolonged Treatment Delay|0|||
44210687|NCT01747551|79007324|FG000|Overall Study|Withdrawal by Subject|3|||
44210688|NCT01747551|79007325|FG001|Overall Study|Withdrawal by Subject|1|||
44210689|NCT01747551|79007324|FG000|Overall Study|Physician Decision|2|||
44210690|NCT01747551|79007325|FG001|Overall Study|Physician Decision|1|||
44210691|NCT01747551|79007324|FG000|Overall Study|Other|2|||
44210692|NCT01747551|79007325|FG001|Overall Study|Other|0|||
44210693|NCT01736397|79007333|FG000|Overall Study|Lack of Efficacy|1|||
44210694|NCT01736397|79007334|FG001|Overall Study|Lack of Efficacy|11|||
44210695|NCT01736397|79007333|FG000|Overall Study|Withdrawal by Subject|6|||
44210696|NCT01736397|79007334|FG001|Overall Study|Withdrawal by Subject|5|||
44210697|NCT01736397|79007333|FG000|Overall Study|Lost to Follow-up|0|||
44210698|NCT01736397|79007334|FG001|Overall Study|Lost to Follow-up|1|||
44210699|NCT01736397|79007333|FG000|Overall Study|Adverse Event|6|||
44210700|NCT01736397|79007334|FG001|Overall Study|Adverse Event|3|||
44210701|NCT01736397|79007333|FG000|Overall Study|Not stated|1|||
44210702|NCT01736397|79007334|FG001|Overall Study|Not stated|4|||
44210703|NCT01859390|79007342|FG000|Overall Study|Insufficient Sputum Collected|1|||
44210704|NCT01859390|79007343|FG001|Overall Study|Insufficient Sputum Collected|3|||
44210705|NCT01859390|79007342|FG000|Overall Study|Sample Missing Collection Date|0|||
44210706|NCT01859390|79007343|FG001|Overall Study|Sample Missing Collection Date|1|||
44210707|NCT01859390|79007342|FG000|Overall Study|Tube Cracked|0|||
44210708|NCT01859390|79007343|FG001|Overall Study|Tube Cracked|2|||
44210709|NCT01859390|79007342|FG000|Overall Study|Shipment Error|0|||
44210710|NCT01859390|79007343|FG001|Overall Study|Shipment Error|1|||
44210711|NCT01858766|79007368|FG000|Overall Study|Randomized but Never Treated|0|||
44269781|NCT02354508|79194812|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
44269782|NCT02354508|79194813|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
44269783|NCT02354508|79194811|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
44269784|NCT02354508|79194812|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
44269785|NCT02354508|79194813|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
44269786|NCT00554216|79194865|FG000|Overall Study|Lost to Follow-up|92|||
44269787|NCT00554216|79194866|FG001|Overall Study|Lost to Follow-up|31|||
44269788|NCT00554216|79194867|FG002|Overall Study|Lost to Follow-up|63|||
44210712|NCT01858766|79007369|FG001|Overall Study|Randomized but Never Treated|0|||
44210713|NCT01858766|79007370|FG002|Overall Study|Randomized but Never Treated|0|||
44210714|NCT01858766|79007371|FG003|Overall Study|Randomized but Never Treated|0|||
44210715|NCT01858766|79007372|FG004|Overall Study|Randomized but Never Treated|0|||
44210716|NCT01858766|79007373|FG005|Overall Study|Randomized but Never Treated|1|||
44210717|NCT01858766|79007374|FG006|Overall Study|Randomized but Never Treated|0|||
44210718|NCT01858766|79007375|FG007|Overall Study|Randomized but Never Treated|0|||
44210719|NCT01858766|79007376|FG008|Overall Study|Randomized but Never Treated|0|||
44210720|NCT01858766|79007377|FG009|Overall Study|Randomized but Never Treated|0|||
44210721|NCT01858766|79007378|FG010|Overall Study|Randomized but Never Treated|0|||
44210722|NCT01858766|79007379|FG011|Overall Study|Randomized but Never Treated|0|||
44210723|NCT01858766|79007380|FG012|Overall Study|Randomized but Never Treated|0|||
44269789|NCT00554216|79194865|FG000|Overall Study|Adverse Event|16|||
44269790|NCT00554216|79194866|FG001|Overall Study|Adverse Event|16|||
44269791|NCT00554216|79194867|FG002|Overall Study|Adverse Event|36|||
44370230|NCT00816361|79375365|FG007|Overall Study|Death|7|||
44269792|NCT00554216|79194865|FG000|Overall Study|Withdrawal by Subject|92|||
44269793|NCT00554216|79194866|FG001|Overall Study|Withdrawal by Subject|31|||
44269794|NCT00554216|79194867|FG002|Overall Study|Withdrawal by Subject|43|||
44210724|NCT01858766|79007381|FG013|Overall Study|Randomized but Never Treated|0|||
44210725|NCT01858766|79007382|FG014|Overall Study|Randomized but Never Treated|0|||
44210726|NCT01858766|79007383|FG015|Overall Study|Randomized but Never Treated|0|||
44210727|NCT01858766|79007384|FG016|Overall Study|Randomized but Never Treated|0|||
44210728|NCT01858766|79007385|FG017|Overall Study|Randomized but Never Treated|1|||
44210729|NCT01858766|79007386|FG018|Overall Study|Randomized but Never Treated|0|||
44210730|NCT01858766|79007368|FG000|Overall Study|Death|0|||
44210731|NCT01858766|79007369|FG001|Overall Study|Death|0|||
44210732|NCT01858766|79007370|FG002|Overall Study|Death|1|||
44210733|NCT01858766|79007371|FG003|Overall Study|Death|0|||
44210734|NCT01858766|79007372|FG004|Overall Study|Death|0|||
44210735|NCT01858766|79007373|FG005|Overall Study|Death|0|||
44210736|NCT01858766|79007374|FG006|Overall Study|Death|0|||
44210737|NCT01858766|79007375|FG007|Overall Study|Death|0|||
44210738|NCT01858766|79007376|FG008|Overall Study|Death|0|||
44210739|NCT01858766|79007377|FG009|Overall Study|Death|0|||
44210740|NCT01858766|79007378|FG010|Overall Study|Death|0|||
44210741|NCT01858766|79007379|FG011|Overall Study|Death|0|||
44210742|NCT01858766|79007380|FG012|Overall Study|Death|0|||
44210743|NCT01858766|79007381|FG013|Overall Study|Death|0|||
44210744|NCT01858766|79007382|FG014|Overall Study|Death|0|||
44210745|NCT01858766|79007383|FG015|Overall Study|Death|0|||
44210746|NCT01858766|79007384|FG016|Overall Study|Death|0|||
44210747|NCT01858766|79007385|FG017|Overall Study|Death|0|||
44210748|NCT01858766|79007386|FG018|Overall Study|Death|0|||
44210749|NCT01858766|79007368|FG000|Overall Study|Lack of Efficacy|1|||
44210750|NCT01858766|79007369|FG001|Overall Study|Lack of Efficacy|0|||
44210751|NCT01858766|79007370|FG002|Overall Study|Lack of Efficacy|0|||
44210752|NCT01858766|79007371|FG003|Overall Study|Lack of Efficacy|0|||
44210753|NCT01858766|79007372|FG004|Overall Study|Lack of Efficacy|1|||
44210754|NCT01858766|79007373|FG005|Overall Study|Lack of Efficacy|2|||
44210755|NCT01858766|79007374|FG006|Overall Study|Lack of Efficacy|0|||
44210756|NCT01858766|79007375|FG007|Overall Study|Lack of Efficacy|0|||
44210757|NCT01858766|79007376|FG008|Overall Study|Lack of Efficacy|0|||
44210758|NCT01858766|79007377|FG009|Overall Study|Lack of Efficacy|0|||
44210759|NCT01858766|79007378|FG010|Overall Study|Lack of Efficacy|0|||
44210760|NCT01858766|79007379|FG011|Overall Study|Lack of Efficacy|3|||
44210761|NCT01858766|79007380|FG012|Overall Study|Lack of Efficacy|5|||
44210762|NCT01858766|79007381|FG013|Overall Study|Lack of Efficacy|3|||
44210763|NCT01858766|79007382|FG014|Overall Study|Lack of Efficacy|5|||
44210764|NCT01858766|79007383|FG015|Overall Study|Lack of Efficacy|5|||
44210765|NCT01858766|79007384|FG016|Overall Study|Lack of Efficacy|2|||
44210766|NCT01858766|79007385|FG017|Overall Study|Lack of Efficacy|3|||
44210767|NCT01858766|79007386|FG018|Overall Study|Lack of Efficacy|3|||
44210768|NCT01858766|79007368|FG000|Overall Study|Lost to Follow-up|0|||
44210769|NCT01858766|79007369|FG001|Overall Study|Lost to Follow-up|0|||
44210770|NCT01858766|79007370|FG002|Overall Study|Lost to Follow-up|0|||
44210771|NCT01858766|79007371|FG003|Overall Study|Lost to Follow-up|0|||
44210772|NCT01858766|79007372|FG004|Overall Study|Lost to Follow-up|0|||
44210773|NCT01858766|79007373|FG005|Overall Study|Lost to Follow-up|1|||
44210774|NCT01858766|79007374|FG006|Overall Study|Lost to Follow-up|0|||
44210775|NCT01858766|79007375|FG007|Overall Study|Lost to Follow-up|2|||
44210776|NCT01858766|79007376|FG008|Overall Study|Lost to Follow-up|0|||
44210777|NCT01858766|79007377|FG009|Overall Study|Lost to Follow-up|0|||
44210778|NCT01858766|79007378|FG010|Overall Study|Lost to Follow-up|0|||
44210779|NCT01858766|79007379|FG011|Overall Study|Lost to Follow-up|1|||
44210780|NCT01858766|79007380|FG012|Overall Study|Lost to Follow-up|0|||
44210781|NCT01858766|79007381|FG013|Overall Study|Lost to Follow-up|0|||
44210782|NCT01858766|79007382|FG014|Overall Study|Lost to Follow-up|3|||
44210783|NCT01858766|79007383|FG015|Overall Study|Lost to Follow-up|1|||
44210784|NCT01858766|79007384|FG016|Overall Study|Lost to Follow-up|1|||
44210785|NCT01858766|79007385|FG017|Overall Study|Lost to Follow-up|0|||
44210786|NCT01858766|79007386|FG018|Overall Study|Lost to Follow-up|1|||
44210787|NCT01858766|79007368|FG000|Overall Study|Withdrew Consent|0|||
44210788|NCT01858766|79007369|FG001|Overall Study|Withdrew Consent|0|||
44210789|NCT01858766|79007370|FG002|Overall Study|Withdrew Consent|0|||
44210790|NCT01858766|79007371|FG003|Overall Study|Withdrew Consent|0|||
44210791|NCT01858766|79007372|FG004|Overall Study|Withdrew Consent|0|||
44210792|NCT01858766|79007373|FG005|Overall Study|Withdrew Consent|0|||
44210793|NCT01858766|79007374|FG006|Overall Study|Withdrew Consent|0|||
44210794|NCT01858766|79007375|FG007|Overall Study|Withdrew Consent|0|||
44210795|NCT01858766|79007376|FG008|Overall Study|Withdrew Consent|0|||
44210796|NCT01858766|79007377|FG009|Overall Study|Withdrew Consent|0|||
44210797|NCT01858766|79007378|FG010|Overall Study|Withdrew Consent|0|||
44210798|NCT01858766|79007379|FG011|Overall Study|Withdrew Consent|1|||
44210799|NCT01858766|79007380|FG012|Overall Study|Withdrew Consent|0|||
44210800|NCT01858766|79007381|FG013|Overall Study|Withdrew Consent|0|||
44210801|NCT01858766|79007382|FG014|Overall Study|Withdrew Consent|0|||
44210802|NCT01858766|79007383|FG015|Overall Study|Withdrew Consent|0|||
44210803|NCT01858766|79007384|FG016|Overall Study|Withdrew Consent|0|||
44210804|NCT01858766|79007385|FG017|Overall Study|Withdrew Consent|0|||
44210805|NCT01858766|79007386|FG018|Overall Study|Withdrew Consent|0|||
44210806|NCT01734993|79007419|FG000|Overall Study|Adverse Event|1|||
44210807|NCT01734993|79007419|FG000|Overall Study|Lack of Efficacy|1|||
44210808|NCT01745367|79007426|FG000|Overall Study|Death|1|||
44210809|NCT01745367|79007427|FG001|Overall Study|Death|0|||
44210810|NCT01745367|79007426|FG000|Overall Study|Withdrawal by Subject|1|||
44210811|NCT01745367|79007427|FG001|Overall Study|Withdrawal by Subject|2|||
44210812|NCT01745367|79007426|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
44210813|NCT01745367|79007427|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
44210814|NCT01745367|79007426|FG000|Overall Study|Other Reasons Unspecified|0|||
44210815|NCT01745367|79007427|FG001|Overall Study|Other Reasons Unspecified|2|||
44210816|NCT01733121|79007435|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
44210817|NCT01733121|79007436|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
44210818|NCT01733121|79007435|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
44210819|NCT01733121|79007436|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
44210820|NCT01733121|79007435|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
44210821|NCT01733121|79007436|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
44210822|NCT01733121|79007435|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
44210823|NCT01733121|79007436|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
44210824|NCT01744977|79007446|FG000|Overall Study|Withdrawal by Subject|1|||
44210825|NCT01744977|79007447|FG001|Overall Study|Withdrawal by Subject|2|||
44210826|NCT01744977|79007446|FG000|Overall Study|Death|2|||
44210827|NCT01744977|79007447|FG001|Overall Study|Death|3|||
44210828|NCT01744977|79007446|FG000|Overall Study|Lost to Follow-up|2|||
44210829|NCT01744977|79007447|FG001|Overall Study|Lost to Follow-up|0|||
44210830|NCT01744977|79007446|FG000|Overall Study|No longer meets inclusion|6|||
44210831|NCT01744977|79007447|FG001|Overall Study|No longer meets inclusion|0|||
44210832|NCT01383928|79007456|FG000|Overall Study|Initiation of ASCT|2|||
44210833|NCT01383928|79007457|FG001|Overall Study|Initiation of ASCT|1|||
44210834|NCT01383928|79007458|FG002|Overall Study|Initiation of ASCT|18|||
44210835|NCT01383928|79007456|FG000|Overall Study|Adverse Event|1|||
44210836|NCT01383928|79007457|FG001|Overall Study|Adverse Event|2|||
44210837|NCT01383928|79007458|FG002|Overall Study|Adverse Event|8|||
44210838|NCT01383928|79007456|FG000|Overall Study|Other|1|||
44210839|NCT01383928|79007457|FG001|Overall Study|Other|3|||
44210840|NCT01383928|79007458|FG002|Overall Study|Other|4|||
44210841|NCT01383928|79007456|FG000|Overall Study|Progressive Disease|1|||
44210842|NCT01383928|79007457|FG001|Overall Study|Progressive Disease|1|||
44210843|NCT01383928|79007458|FG002|Overall Study|Progressive Disease|5|||
44210844|NCT01383928|79007456|FG000|Overall Study|Withdrawal by Subject|0|||
44210845|NCT01383928|79007457|FG001|Overall Study|Withdrawal by Subject|0|||
44210846|NCT01383928|79007458|FG002|Overall Study|Withdrawal by Subject|4|||
44210847|NCT01383928|79007456|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
44210848|NCT01383928|79007457|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
44210849|NCT01383928|79007458|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
44210850|NCT01382602|79007470|FG000|Overall Study|Protocol Violation|0|||
44269795|NCT00554216|79194865|FG000|Overall Study|Non compliance|10|||
44269796|NCT00554216|79194866|FG001|Overall Study|Non compliance|4|||
44210851|NCT01382602|79007471|FG001|Overall Study|Protocol Violation|3|||
44210852|NCT01382602|79007470|FG000|Overall Study|Withdrawal by Subject|0|||
44210853|NCT01382602|79007471|FG001|Overall Study|Withdrawal by Subject|1|||
44210854|NCT04801420|79007480|FG000|Overall Study|Other|1|||
44210855|NCT04801420|79007481|FG001|Overall Study|Other|2|||
44210856|NCT04801420|79007482|FG002|Overall Study|Other|1|||
44210857|NCT04801420|79007480|FG000|Overall Study|Lost to Follow-up|7|||
44210858|NCT04801420|79007481|FG001|Overall Study|Lost to Follow-up|9|||
44210859|NCT04801420|79007482|FG002|Overall Study|Lost to Follow-up|10|||
44210860|NCT04801420|79007480|FG000|Overall Study|Moved from study area|0|||
44210861|NCT04801420|79007481|FG001|Overall Study|Moved from study area|1|||
44210862|NCT04801420|79007482|FG002|Overall Study|Moved from study area|1|||
44210863|NCT04801420|79007480|FG000|Overall Study|Withdrawal by Subject|5|||
44210864|NCT04801420|79007481|FG001|Overall Study|Withdrawal by Subject|1|||
44210865|NCT04801420|79007482|FG002|Overall Study|Withdrawal by Subject|4|||
44210866|NCT04801420|79007480|FG000|Overall Study|Individual stopping criteria reached|0|||
44210867|NCT04801420|79007481|FG001|Overall Study|Individual stopping criteria reached|1|||
44210868|NCT04801420|79007482|FG002|Overall Study|Individual stopping criteria reached|0|||
44269797|NCT00554216|79194867|FG002|Overall Study|Non compliance|5|||
44210869|NCT04801420|79007480|FG000|Overall Study|Ongoing in the study|195|||
44210870|NCT04801420|79007481|FG001|Overall Study|Ongoing in the study|195|||
44210871|NCT04801420|79007482|FG002|Overall Study|Ongoing in the study|192|||
44210872|NCT04294472|79007497|FG000|Overall Study|Adverse Event|0|||
44210873|NCT04294472|79007498|FG001|Overall Study|Adverse Event|1|||
44210874|NCT04294472|79007499|FG002|Overall Study|Adverse Event|1|||
44210875|NCT04294472|79007497|FG000|Overall Study|Randomized but not treated|0|||
44210876|NCT04294472|79007498|FG001|Overall Study|Randomized but not treated|1|||
44210877|NCT04294472|79007499|FG002|Overall Study|Randomized but not treated|1|||
44210878|NCT04233918|79007509|FG000|Part C (Extension Period)|Ongoing in study|0|||
44210879|NCT04233918|79007510|FG001|Part C (Extension Period)|Ongoing in study|0|||
44210880|NCT04233918|79007511|FG002|Part C (Extension Period)|Ongoing in study|15|||
44210881|NCT04060251|79007523|FG000|Overall Study|Study terminated due to low enrollment.|7|||
44269798|NCT00554216|79194865|FG000|Overall Study|Pregnancy|2|||
44269799|NCT00554216|79194866|FG001|Overall Study|Pregnancy|1|||
44269800|NCT00554216|79194867|FG002|Overall Study|Pregnancy|14|||
44269801|NCT00554216|79194865|FG000|Overall Study|Restricted med|3|||
44269802|NCT00554216|79194866|FG001|Overall Study|Restricted med|1|||
44269803|NCT00554216|79194867|FG002|Overall Study|Restricted med|1|||
44269804|NCT00554216|79194865|FG000|Overall Study|Other|12|||
44269805|NCT00554216|79194866|FG001|Overall Study|Other|7|||
44269806|NCT00554216|79194867|FG002|Overall Study|Other|10|||
44269807|NCT00554216|79194865|FG000|Overall Study|Lack of Efficacy|15|||
44370231|NCT00816361|79375366|FG008|Overall Study|Death|8|||
44370232|NCT00816361|79375358|FG000|Overall Study|Other|0|||
44370233|NCT00816361|79375359|FG001|Overall Study|Other|0|||
44269808|NCT00554216|79194866|FG001|Overall Study|Lack of Efficacy|3|||
44269809|NCT00554216|79194867|FG002|Overall Study|Lack of Efficacy|0|||
44269810|NCT02353572|79194892|FG000|Overall Study|Withdrawal by Subject|1|||
44269811|NCT02353572|79194892|FG000|Overall Study|Study terminated|2|||
44370234|NCT00816361|79375360|FG002|Overall Study|Other|0|||
44370235|NCT00816361|79375361|FG003|Overall Study|Other|0|||
44370236|NCT00816361|79375362|FG004|Overall Study|Other|0|||
44370237|NCT00816361|79375363|FG005|Overall Study|Other|0|||
44210882|NCT04060251|79007524|FG001|Overall Study|Study terminated due to low enrollment.|5|||
44210883|NCT04060251|79007525|FG002|Overall Study|Study terminated due to low enrollment.|7|||
44210884|NCT04060251|79007523|FG000|Overall Study|Adverse Event|1|||
44210885|NCT04060251|79007524|FG001|Overall Study|Adverse Event|1|||
44210886|NCT04060251|79007525|FG002|Overall Study|Adverse Event|0|||
44210887|NCT04048876|79007537|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
44210888|NCT04048876|79007538|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
44210889|NCT04048876|79007539|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
44210890|NCT04048876|79007540|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
44210891|NCT04048876|79007537|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
44210892|NCT04048876|79007538|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
44210893|NCT04048876|79007539|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
44210894|NCT04048876|79007540|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
44210895|NCT04048876|79007537|FG000|Placebo Controlled Phase|Adverse Event|0|||
44210896|NCT04048876|79007538|FG001|Placebo Controlled Phase|Adverse Event|1|||
44210897|NCT04048876|79007539|FG002|Placebo Controlled Phase|Adverse Event|0|||
44210898|NCT04048876|79007540|FG003|Placebo Controlled Phase|Adverse Event|0|||
44210899|NCT04048876|79007537|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
44210900|NCT04048876|79007538|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
44210901|NCT04048876|79007539|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
44210902|NCT04048876|79007540|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
44210903|NCT03921424|79007567|FG000|Overall Study|Lost to Follow-up|0|||
44210904|NCT03921424|79007568|FG001|Overall Study|Lost to Follow-up|1|||
44210905|NCT03921424|79007567|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
44210906|NCT03921424|79007568|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
44210907|NCT03852628|79007591|FG000|Overall Study|Lost to Follow-up|7|||
44210908|NCT03852628|79007592|FG001|Overall Study|Lost to Follow-up|6|||
44210909|NCT03852628|79007591|FG000|Overall Study|Lack of Efficacy|6|||
44210910|NCT03852628|79007592|FG001|Overall Study|Lack of Efficacy|6|||
44370238|NCT00816361|79375364|FG006|Overall Study|Other|0|||
44370239|NCT00816361|79375365|FG007|Overall Study|Other|0|||
44370240|NCT00816361|79375366|FG008|Overall Study|Other|1|||
44370241|NCT00826111|79375389|FG000|Overall Study|Lost to Follow-up|0|||
44370242|NCT00826111|79375390|FG001|Overall Study|Lost to Follow-up|1|||
44370243|NCT00826111|79375389|FG000|Overall Study|Protocol Violation|1|||
44370244|NCT00826111|79375390|FG001|Overall Study|Protocol Violation|0|||
44370245|NCT00826111|79375389|FG000|Overall Study|Withdrawal by Subject|5|||
44370246|NCT00826111|79375390|FG001|Overall Study|Withdrawal by Subject|0|||
44370247|NCT00826111|79375389|FG000|Overall Study|Physician Decision|1|||
44370248|NCT00826111|79375390|FG001|Overall Study|Physician Decision|1|||
44370249|NCT00982644|79375401|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
44210911|NCT03602976|79007598|FG000|Overall Study|Withdrawal by Subject|1|||
44210912|NCT03278106|79007614|FG000|Overall Study|No protocol treatment|1|||
44269812|NCT00552578|79194904|FG000|Overall Study|Lost to Follow-up|1|||
44269813|NCT00552578|79194905|FG001|Overall Study|Lost to Follow-up|1|||
44210913|NCT03214198|79007618|FG000|Overall Study|Case Report Forms Uncollected|18|||
44210914|NCT03214198|79007618|FG000|Overall Study|Protocol Deviation|18|||
44269814|NCT02301936|79194913|FG000|Overall Study|Lost to Follow-up|1|||
44269815|NCT02301936|79194914|FG001|Overall Study|Lost to Follow-up|0|||
44370250|NCT00982644|79375402|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
44370251|NCT00982644|79375401|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
44269816|NCT00552344|79194953|FG000|Overall Study|Lack of Efficacy|55|||
44370252|NCT00982644|79375402|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
44210915|NCT02914639|79007624|FG000|Overall Study|Withdrawal by Subject|0|||
44210916|NCT02914639|79007625|FG001|Overall Study|Withdrawal by Subject|2|||
44210917|NCT02865018|79007632|FG000|Overall Study|Withdrawal by Subject|1|||
44210918|NCT02704208|79007647|FG000|Overall Study|Lost to Follow-up|42|||
44210919|NCT02704208|79007648|FG001|Overall Study|Lost to Follow-up|37|||
44210920|NCT02315898|79007667|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
44210921|NCT02315898|79007668|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
44210922|NCT02315898|79007669|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
44210923|NCT02315898|79007670|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
44210924|NCT02157883|79007677|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
44210925|NCT02157883|79007677|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
44210926|NCT02157883|79007677|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
44210927|NCT02157883|79007677|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
44210928|NCT02157883|79007677|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
44210929|NCT02071290|79007686|FG000|Overall Study|Death|1|||
44210930|NCT02071290|79007687|FG001|Overall Study|Death|0|||
44210931|NCT02071290|79007686|FG000|Overall Study|Withdrawal by Subject|0|||
44210932|NCT02071290|79007687|FG001|Overall Study|Withdrawal by Subject|1|||
44210933|NCT02071290|79007686|FG000|Overall Study|Protocol Violation|3|||
44210934|NCT02071290|79007687|FG001|Overall Study|Protocol Violation|5|||
44210935|NCT02071290|79007686|FG000|Overall Study|Physician Decision|0|||
44210936|NCT02071290|79007687|FG001|Overall Study|Physician Decision|1|||
44210937|NCT02066181|79007695|FG000|Overall Study|Withdrawal by Subject|1|||
44210938|NCT02066181|79007696|FG001|Overall Study|Withdrawal by Subject|1|||
44210939|NCT01970865|79007722|FG000|Overall Study|Death|3|||
44210940|NCT01970865|79007723|FG001|Overall Study|Death|1|||
44210941|NCT01970865|79007724|FG002|Overall Study|Death|3|||
44210942|NCT01970865|79007725|FG003|Overall Study|Death|4|||
44210943|NCT01970865|79007726|FG004|Overall Study|Death|6|||
44210944|NCT01970865|79007727|FG005|Overall Study|Death|3|||
44210945|NCT01970865|79007728|FG006|Overall Study|Death|1|||
44210946|NCT01970865|79007729|FG007|Overall Study|Death|3|||
44210947|NCT01970865|79007730|FG008|Overall Study|Death|2|||
44210948|NCT01970865|79007731|FG009|Overall Study|Death|1|||
44210949|NCT01970865|79007732|FG010|Overall Study|Death|1|||
44210950|NCT01970865|79007733|FG011|Overall Study|Death|4|||
44210951|NCT01970865|79007734|FG012|Overall Study|Death|14|||
44210952|NCT01970865|79007735|FG013|Overall Study|Death|19|||
44210953|NCT01970865|79007736|FG014|Overall Study|Death|15|||
44210954|NCT01970865|79007737|FG015|Overall Study|Death|10|||
44210955|NCT01970865|79007738|FG016|Overall Study|Death|1|||
44210956|NCT01970865|79007722|FG000|Overall Study|Lost to Follow-up|0|||
44210957|NCT01970865|79007723|FG001|Overall Study|Lost to Follow-up|0|||
44210958|NCT01970865|79007724|FG002|Overall Study|Lost to Follow-up|0|||
44210959|NCT01970865|79007725|FG003|Overall Study|Lost to Follow-up|1|||
44210960|NCT01970865|79007726|FG004|Overall Study|Lost to Follow-up|1|||
44210961|NCT01970865|79007727|FG005|Overall Study|Lost to Follow-up|0|||
44210962|NCT01970865|79007728|FG006|Overall Study|Lost to Follow-up|0|||
44210963|NCT01970865|79007729|FG007|Overall Study|Lost to Follow-up|0|||
44210964|NCT01970865|79007730|FG008|Overall Study|Lost to Follow-up|0|||
44210965|NCT01970865|79007731|FG009|Overall Study|Lost to Follow-up|0|||
44210966|NCT01970865|79007732|FG010|Overall Study|Lost to Follow-up|0|||
44210967|NCT01970865|79007733|FG011|Overall Study|Lost to Follow-up|0|||
44210968|NCT01970865|79007734|FG012|Overall Study|Lost to Follow-up|1|||
44210969|NCT01970865|79007735|FG013|Overall Study|Lost to Follow-up|0|||
44210970|NCT01970865|79007736|FG014|Overall Study|Lost to Follow-up|0|||
44210971|NCT01970865|79007737|FG015|Overall Study|Lost to Follow-up|0|||
44210972|NCT01970865|79007738|FG016|Overall Study|Lost to Follow-up|0|||
44210973|NCT01970865|79007722|FG000|Overall Study|Withdrawal by Subject|0|||
44210974|NCT01970865|79007723|FG001|Overall Study|Withdrawal by Subject|0|||
44210975|NCT01970865|79007724|FG002|Overall Study|Withdrawal by Subject|0|||
44210976|NCT01970865|79007725|FG003|Overall Study|Withdrawal by Subject|1|||
44210977|NCT01970865|79007726|FG004|Overall Study|Withdrawal by Subject|2|||
44210978|NCT01970865|79007727|FG005|Overall Study|Withdrawal by Subject|0|||
44210979|NCT01970865|79007728|FG006|Overall Study|Withdrawal by Subject|0|||
44210980|NCT01970865|79007729|FG007|Overall Study|Withdrawal by Subject|0|||
44210981|NCT01970865|79007730|FG008|Overall Study|Withdrawal by Subject|0|||
44210982|NCT01970865|79007731|FG009|Overall Study|Withdrawal by Subject|0|||
44210983|NCT01970865|79007732|FG010|Overall Study|Withdrawal by Subject|0|||
44210984|NCT01970865|79007733|FG011|Overall Study|Withdrawal by Subject|1|||
44210985|NCT01970865|79007734|FG012|Overall Study|Withdrawal by Subject|2|||
44210986|NCT01970865|79007735|FG013|Overall Study|Withdrawal by Subject|5|||
44210987|NCT01970865|79007736|FG014|Overall Study|Withdrawal by Subject|2|||
44210988|NCT01970865|79007737|FG015|Overall Study|Withdrawal by Subject|7|||
44210989|NCT01970865|79007738|FG016|Overall Study|Withdrawal by Subject|0|||
44210990|NCT01970865|79007722|FG000|Overall Study|Other|0|||
44210991|NCT01970865|79007723|FG001|Overall Study|Other|0|||
44210992|NCT01970865|79007724|FG002|Overall Study|Other|0|||
44210993|NCT01970865|79007725|FG003|Overall Study|Other|1|||
44210994|NCT01970865|79007726|FG004|Overall Study|Other|0|||
44210995|NCT01970865|79007727|FG005|Overall Study|Other|0|||
44210996|NCT01970865|79007728|FG006|Overall Study|Other|0|||
44210997|NCT01970865|79007729|FG007|Overall Study|Other|0|||
44269817|NCT00552344|79194953|FG000|Overall Study|Loss of efficacy|75|||
44370253|NCT00982644|79375401|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
44370254|NCT00982644|79375402|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
44370255|NCT00982644|79375401|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
44370256|NCT00982644|79375402|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
44370257|NCT00982644|79375401|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
44370258|NCT00982644|79375402|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
44370259|NCT00982644|79375401|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
44370260|NCT00982644|79375402|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
44370261|NCT00982644|79375401|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
44370262|NCT00982644|79375402|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
44370263|NCT00982644|79375401|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
44370264|NCT00982644|79375402|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
44370265|NCT00982644|79375401|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
44370266|NCT00982644|79375402|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
44370267|NCT00982644|79375401|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
44370268|NCT00982644|79375402|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
44370269|NCT00815659|79375408|FG000|Overall Study|Adverse Event|9|||
44370270|NCT00815659|79375408|FG000|Overall Study|Withdrawal by Subject|9|||
44370271|NCT00815659|79375408|FG000|Overall Study|Lost to Follow-up|4|||
44370272|NCT00815659|79375408|FG000|Overall Study|Protocol Violation|1|||
44370273|NCT00825175|79375414|FG000|Overall Study|Withdrawal by Subject|0|||
44370274|NCT00825175|79375415|FG001|Overall Study|Withdrawal by Subject|5|||
44370275|NCT00824473|79375423|FG000|Overall Study|Adverse Event|4|||
44370276|NCT00824473|79375424|FG001|Overall Study|Adverse Event|5|||
44370277|NCT00824473|79375423|FG000|Overall Study|Lack of Efficacy|2|||
44370278|NCT00824473|79375424|FG001|Overall Study|Lack of Efficacy|2|||
44370279|NCT00824473|79375423|FG000|Overall Study|Protocol Violation|2|||
44370280|NCT00824473|79375424|FG001|Overall Study|Protocol Violation|0|||
44370281|NCT00824473|79375423|FG000|Overall Study|Non-Compliance|4|||
44269818|NCT00552344|79194953|FG000|Overall Study|Lost to Follow-up|8|||
44370282|NCT00824473|79375424|FG001|Overall Study|Non-Compliance|2|||
44370283|NCT00824473|79375423|FG000|Overall Study|Withdrawal by Subject|2|||
44370284|NCT00824473|79375424|FG001|Overall Study|Withdrawal by Subject|3|||
44370285|NCT00824473|79375423|FG000|Overall Study|Other|1|||
44370286|NCT00824473|79375424|FG001|Overall Study|Other|1|||
44370287|NCT00815191|79375436|FG000|Overall Study|Protocol Violation|1|||
44370288|NCT00815191|79375437|FG001|Overall Study|Protocol Violation|1|||
44210998|NCT01970865|79007730|FG008|Overall Study|Other|0|||
44210999|NCT01970865|79007731|FG009|Overall Study|Other|0|||
44211000|NCT01970865|79007732|FG010|Overall Study|Other|0|||
44211001|NCT01970865|79007733|FG011|Overall Study|Other|0|||
44211002|NCT01970865|79007734|FG012|Overall Study|Other|0|||
44211003|NCT01970865|79007735|FG013|Overall Study|Other|1|||
44211004|NCT01970865|79007736|FG014|Overall Study|Other|0|||
44211005|NCT01970865|79007737|FG015|Overall Study|Other|1|||
44211006|NCT01970865|79007738|FG016|Overall Study|Other|0|||
44211007|NCT01970865|79007722|FG000|Overall Study|Study ongoing|0|||
44211008|NCT01970865|79007723|FG001|Overall Study|Study ongoing|2|||
44211009|NCT01970865|79007724|FG002|Overall Study|Study ongoing|0|||
44370289|NCT00812929|79375443|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
44370290|NCT00812929|79375444|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
44370291|NCT00812929|79375445|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
44370292|NCT00812929|79375446|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
44370293|NCT00812929|79375447|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
44370294|NCT00812929|79375448|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
44370295|NCT00812929|79375449|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
44370296|NCT00812929|79375450|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
44370297|NCT00812929|79375451|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
44370298|NCT00812929|79375452|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
44370299|NCT00812929|79375443|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
44370300|NCT00812929|79375444|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
44370301|NCT00812929|79375445|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
44370302|NCT00812929|79375446|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
44370303|NCT00812929|79375447|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
44370304|NCT00812929|79375448|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
44370305|NCT00812929|79375449|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
44370306|NCT00812929|79375450|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
44370307|NCT00812929|79375451|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
44370308|NCT00812929|79375452|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
44370309|NCT00812929|79375443|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
44452101|NCT00080119|79461006|FG003|Overall Study|Unable to get to clinic|1|||
44452102|NCT00080119|79461003|FG000|Overall Study|Consent withdrawn|13|||
44452103|NCT00080119|79461004|FG001|Overall Study|Consent withdrawn|17|||
44452104|NCT00080119|79461005|FG002|Overall Study|Consent withdrawn|4|||
44452105|NCT00080119|79461006|FG003|Overall Study|Consent withdrawn|6|||
44452106|NCT00080119|79461003|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
44452107|NCT00080119|79461004|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
44452108|NCT00080119|79461005|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
44452109|NCT00080119|79461006|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
44452110|NCT00080119|79461003|FG000|Overall Study|Lost to Follow-up|16|||
44452111|NCT00080119|79461004|FG001|Overall Study|Lost to Follow-up|19|||
44452112|NCT00080119|79461005|FG002|Overall Study|Lost to Follow-up|19|||
44211010|NCT01970865|79007725|FG003|Overall Study|Study ongoing|6|||
44211011|NCT01970865|79007726|FG004|Overall Study|Study ongoing|8|||
44211012|NCT01970865|79007727|FG005|Overall Study|Study ongoing|0|||
44211013|NCT01970865|79007728|FG006|Overall Study|Study ongoing|2|||
44211014|NCT01970865|79007729|FG007|Overall Study|Study ongoing|0|||
44211015|NCT01970865|79007730|FG008|Overall Study|Study ongoing|1|||
44370310|NCT00812929|79375444|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
44370311|NCT00812929|79375445|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
44370312|NCT00812929|79375446|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
44370313|NCT00812929|79375447|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
44370314|NCT00812929|79375448|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
44370315|NCT00812929|79375449|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
44370316|NCT00812929|79375450|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
44370317|NCT00812929|79375451|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
44370318|NCT00812929|79375452|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
44370319|NCT00824161|79375469|FG000|Overall Study|Withdrawal by Subject|1|||
44370320|NCT00824161|79375469|FG000|Overall Study|Screen Failure|1|||
44370321|NCT00979134|79375478|FG000|Overall Study|Disease progression|18|||
44370322|NCT00979134|79375479|FG001|Overall Study|Disease progression|2|||
44370323|NCT00979134|79375480|FG002|Overall Study|Disease progression|5|||
44370324|NCT00979134|79375478|FG000|Overall Study|Adverse Event|0|||
44370325|NCT00979134|79375479|FG001|Overall Study|Adverse Event|0|||
44370326|NCT00979134|79375480|FG002|Overall Study|Adverse Event|2|||
44370327|NCT00979134|79375478|FG000|Overall Study|Withdrawal by Subject|1|||
44452113|NCT00080119|79461006|FG003|Overall Study|Lost to Follow-up|14|||
44452114|NCT00419380|79461020|FG000|Overall Study|Lack of Efficacy|1|||
44452115|NCT00419380|79461021|FG001|Overall Study|Lack of Efficacy|7|||
44452116|NCT00419380|79461020|FG000|Overall Study|Physician Decision|0|||
44452117|NCT00419380|79461021|FG001|Overall Study|Physician Decision|1|||
44452118|NCT00419380|79461020|FG000|Overall Study|Lost to Follow-up|0|||
44211016|NCT01970865|79007731|FG009|Overall Study|Study ongoing|3|||
44370328|NCT00979134|79375479|FG001|Overall Study|Withdrawal by Subject|1|||
44370329|NCT00979134|79375480|FG002|Overall Study|Withdrawal by Subject|2|||
44370330|NCT00979134|79375478|FG000|Overall Study|Lost to Follow-up|2|||
44370331|NCT00979134|79375479|FG001|Overall Study|Lost to Follow-up|2|||
44452119|NCT00419380|79461021|FG001|Overall Study|Lost to Follow-up|1|||
44452120|NCT00419380|79461020|FG000|Overall Study|Withdrawal by Subject|0|||
44211017|NCT01970865|79007732|FG010|Overall Study|Study ongoing|29|||
44211018|NCT01970865|79007733|FG011|Overall Study|Study ongoing|22|||
44370332|NCT00979134|79375480|FG002|Overall Study|Lost to Follow-up|0|||
44370333|NCT00979134|79375478|FG000|Overall Study|Death|4|||
44211019|NCT01970865|79007734|FG012|Overall Study|Study ongoing|43|||
44452121|NCT00419380|79461021|FG001|Overall Study|Withdrawal by Subject|1|||
44452122|NCT00413062|79461029|FG000|Overall Study|Adverse event/serious adverse event|289|||
44452123|NCT00413062|79461030|FG001|Overall Study|Adverse event/serious adverse event|56|||
44452124|NCT00413062|79461029|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
44452125|NCT00413062|79461030|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
44452126|NCT00413062|79461029|FG000|Overall Study|Withdrawal of informed consent|111|||
44452127|NCT00413062|79461030|FG001|Overall Study|Withdrawal of informed consent|36|||
44452128|NCT00413062|79461029|FG000|Overall Study|Pregnancy|15|||
44452129|NCT00413062|79461030|FG001|Overall Study|Pregnancy|5|||
44452130|NCT00413062|79461029|FG000|Overall Study|Pregnancy wish|17|||
44452131|NCT00413062|79461030|FG001|Overall Study|Pregnancy wish|6|||
44452132|NCT00413062|79461029|FG000|Overall Study|Lost to Follow-up|175|||
44452133|NCT00413062|79461030|FG001|Overall Study|Lost to Follow-up|73|||
44452134|NCT00413062|79461029|FG000|Overall Study|Other reason|70|||
44452135|NCT00413062|79461030|FG001|Overall Study|Other reason|34|||
44452136|NCT00494091|79461040|FG000|Overall Study|Death|5|||
44452137|NCT00494091|79461041|FG001|Overall Study|Death|54|||
44452138|NCT00494091|79461040|FG000|Overall Study|Lost to Follow-up|0|||
44452139|NCT00494091|79461041|FG001|Overall Study|Lost to Follow-up|4|||
44452140|NCT00494091|79461040|FG000|Overall Study|Other|1|||
44452141|NCT00494091|79461041|FG001|Overall Study|Other|11|||
44452142|NCT00494091|79461040|FG000|Overall Study|Withdrawal by Subject|0|||
44452143|NCT00494091|79461041|FG001|Overall Study|Withdrawal by Subject|7|||
44452144|NCT00494013|79461050|FG000|Overall Study|Adverse Event|0|||
44452145|NCT00494013|79461051|FG001|Overall Study|Adverse Event|1|||
44452146|NCT00494013|79461050|FG000|Overall Study|Entry Criteria Not Met|1|||
44452147|NCT00494013|79461051|FG001|Overall Study|Entry Criteria Not Met|4|||
44452148|NCT00494013|79461050|FG000|Overall Study|Lost to Follow-up|5|||
44452149|NCT00494013|79461051|FG001|Overall Study|Lost to Follow-up|6|||
44452150|NCT00494013|79461050|FG000|Overall Study|Physician Decision|3|||
44452151|NCT00494013|79461051|FG001|Overall Study|Physician Decision|5|||
44452152|NCT00494013|79461050|FG000|Overall Study|Protocol Violation|8|||
44452153|NCT00494013|79461051|FG001|Overall Study|Protocol Violation|5|||
44452154|NCT00494013|79461050|FG000|Overall Study|Withdrawal by Subject|13|||
44452155|NCT00494013|79461051|FG001|Overall Study|Withdrawal by Subject|14|||
44452156|NCT00494013|79461050|FG000|Overall Study|Sponsor Decision|0|||
44211020|NCT01970865|79007735|FG013|Overall Study|Study ongoing|41|||
44211021|NCT01970865|79007736|FG014|Overall Study|Study ongoing|29|||
44211022|NCT01970865|79007737|FG015|Overall Study|Study ongoing|29|||
44211023|NCT01970865|79007738|FG016|Overall Study|Study ongoing|2|||
44211024|NCT01711541|79007813|FG000|Overall Study|Cancel prior to treatment|0|||
44211025|NCT01711541|79007814|FG001|Overall Study|Cancel prior to treatment|0|||
44211026|NCT01711541|79007815|FG002|Overall Study|Cancel prior to treatment|0|||
44211027|NCT01711541|79007816|FG003|Overall Study|Cancel prior to treatment|1|||
44211028|NCT01711541|79007817|FG004|Overall Study|Cancel prior to treatment|0|||
44211029|NCT01711541|79007813|FG000|Overall Study|Ineligible|0|||
44211030|NCT01711541|79007814|FG001|Overall Study|Ineligible|1|||
44211031|NCT01711541|79007815|FG002|Overall Study|Ineligible|0|||
44211032|NCT01711541|79007816|FG003|Overall Study|Ineligible|0|||
44211033|NCT01711541|79007817|FG004|Overall Study|Ineligible|0|||
44211034|NCT01382446|79007853|FG000|Overall Study|Withdrawal by Subject|0|||
44370334|NCT00979134|79375479|FG001|Overall Study|Death|0|||
44370335|NCT00979134|79375480|FG002|Overall Study|Death|26|||
44370336|NCT00979134|79375478|FG000|Overall Study|Other|8|||
44370337|NCT00979134|79375479|FG001|Overall Study|Other|1|||
44370338|NCT00979134|79375480|FG002|Overall Study|Other|5|||
44370339|NCT00824005|79375495|FG000|Overall Study|Death|0|||
44370340|NCT00824005|79375496|FG001|Overall Study|Death|1|||
44370341|NCT00824005|79375495|FG000|Overall Study|Lost to Follow-up|0|||
44370342|NCT00824005|79375496|FG001|Overall Study|Lost to Follow-up|1|||
44370343|NCT00814879|79375504|FG000|By Week 24|Cancer Diagnosis|1|||
44370344|NCT00814879|79375505|FG001|By Week 24|Cancer Diagnosis|0|||
44370345|NCT00814879|79375504|FG000|By Week 24|Incarceration|0|||
44452157|NCT00494013|79461051|FG001|Overall Study|Sponsor Decision|1|||
44370346|NCT00814879|79375505|FG001|By Week 24|Incarceration|1|||
44370347|NCT00814879|79375504|FG000|By Week 48|Lost to Follow-up|2|||
44452158|NCT00079339|79461060|FG000|Overall Study|Adverse Event|1|||
44452159|NCT00079339|79461061|FG001|Overall Study|Adverse Event|7|||
44370348|NCT00814879|79375505|FG001|By Week 48|Lost to Follow-up|2|||
44452160|NCT00079339|79461062|FG002|Overall Study|Adverse Event|2|||
44452161|NCT00079339|79461060|FG000|Overall Study|Death|1|||
44452162|NCT00079339|79461061|FG001|Overall Study|Death|0|||
44211035|NCT01382446|79007854|FG001|Overall Study|Withdrawal by Subject|1|||
44211036|NCT01382446|79007853|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
44452163|NCT00079339|79461062|FG002|Overall Study|Death|0|||
44211037|NCT01382446|79007854|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
44211038|NCT01382212|79007860|FG000|Overall Study|Kidney transplant|1|||
44370349|NCT00814879|79375504|FG000|By Week 48|Death|0|||
44370350|NCT00814879|79375505|FG001|By Week 48|Death|1|||
44370351|NCT03347422|79375514|FG000|Part A (26 Weeks)|Adverse Event|3|||
44452164|NCT00079339|79461060|FG000|Overall Study|Non-compliance|0|||
44452165|NCT00079339|79461061|FG001|Overall Study|Non-compliance|0|||
44452166|NCT00079339|79461062|FG002|Overall Study|Non-compliance|1|||
44452167|NCT00079339|79461060|FG000|Overall Study|Withdrawal by Subject|0|||
44452168|NCT00079339|79461061|FG001|Overall Study|Withdrawal by Subject|4|||
44452169|NCT00079339|79461062|FG002|Overall Study|Withdrawal by Subject|1|||
44452170|NCT00079339|79461060|FG000|Overall Study|Disease progression|3|||
44452171|NCT00079339|79461061|FG001|Overall Study|Disease progression|28|||
44452172|NCT00079339|79461062|FG002|Overall Study|Disease progression|2|||
44452173|NCT00493779|79461075|FG000|Overall Study|Logistical issue at site|1|||
44452174|NCT00541866|79461085|FG000|Overall Study|Adverse Event|3|||
44452175|NCT00541866|79461086|FG001|Overall Study|Adverse Event|0|||
44452176|NCT00541866|79461087|FG002|Overall Study|Adverse Event|0|||
44452177|NCT00541866|79461088|FG003|Overall Study|Adverse Event|0|||
44452178|NCT00541866|79461089|FG004|Overall Study|Adverse Event|0|||
44452179|NCT00541866|79461085|FG000|Overall Study|Death|1|||
44452180|NCT00541866|79461086|FG001|Overall Study|Death|0|||
44452181|NCT00541866|79461087|FG002|Overall Study|Death|0|||
44452182|NCT00541866|79461088|FG003|Overall Study|Death|0|||
44452183|NCT00541866|79461089|FG004|Overall Study|Death|0|||
44452184|NCT00541866|79461085|FG000|Overall Study|Lack of Efficacy|19|||
44452185|NCT00541866|79461086|FG001|Overall Study|Lack of Efficacy|15|||
44452186|NCT00541866|79461087|FG002|Overall Study|Lack of Efficacy|10|||
44452187|NCT00541866|79461088|FG003|Overall Study|Lack of Efficacy|12|||
44452188|NCT00541866|79461089|FG004|Overall Study|Lack of Efficacy|14|||
44452189|NCT00541866|79461085|FG000|Overall Study|Not Reported or Other|11|||
44452190|NCT00541866|79461086|FG001|Overall Study|Not Reported or Other|3|||
44452191|NCT00541866|79461087|FG002|Overall Study|Not Reported or Other|3|||
44452192|NCT00541866|79461088|FG003|Overall Study|Not Reported or Other|3|||
44452193|NCT00541866|79461089|FG004|Overall Study|Not Reported or Other|1|||
44452194|NCT00541866|79461085|FG000|Overall Study|Physician Decision|0|||
44452195|NCT00541866|79461086|FG001|Overall Study|Physician Decision|0|||
44452196|NCT00541866|79461087|FG002|Overall Study|Physician Decision|2|||
44452197|NCT00541866|79461088|FG003|Overall Study|Physician Decision|1|||
44452198|NCT00541866|79461089|FG004|Overall Study|Physician Decision|0|||
44452199|NCT00493467|79461117|FG000|Overall Study|Death|1|||
44452200|NCT00090493|79461121|FG000|Overall Study|Physician Decision|2|||
44452201|NCT04329702|79461128|FG000|Overall Study|illness|3|||
44452202|NCT04329702|79461129|FG001|Overall Study|illness|4|||
44452203|NCT04329702|79461130|FG002|Overall Study|illness|0|||
44452204|NCT04329702|79461128|FG000|Overall Study|Lost to Follow-up|0|||
44452205|NCT04329702|79461129|FG001|Overall Study|Lost to Follow-up|0|||
44452206|NCT04329702|79461130|FG002|Overall Study|Lost to Follow-up|2|||
44452207|NCT04329702|79461128|FG000|Overall Study|Death|0|||
44452208|NCT04329702|79461129|FG001|Overall Study|Death|2|||
44211039|NCT01382212|79007860|FG000|Overall Study|Withdrew consent|1|||
44211040|NCT01381900|79007867|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
44211041|NCT01381900|79007868|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
44211042|NCT01381900|79007869|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
44211043|NCT01381900|79007867|FG000|Overall Study|Adverse Event|4|||
44211044|NCT01381900|79007868|FG001|Overall Study|Adverse Event|6|||
44211045|NCT01381900|79007869|FG002|Overall Study|Adverse Event|7|||
44211046|NCT01381900|79007867|FG000|Overall Study|Noncompliance with study drug|0|||
44211047|NCT01381900|79007868|FG001|Overall Study|Noncompliance with study drug|0|||
44211048|NCT01381900|79007869|FG002|Overall Study|Noncompliance with study drug|1|||
44211049|NCT01381900|79007867|FG000|Overall Study|Physician Decision|0|||
44211050|NCT01381900|79007868|FG001|Overall Study|Physician Decision|1|||
44370352|NCT03347422|79375515|FG001|Part A (26 Weeks)|Adverse Event|0|||
44370353|NCT03347422|79375514|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
44370354|NCT03347422|79375515|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
44370355|NCT03347422|79375514|FG000|Part B (149 Weeks)|Adverse Event|0|||
44370356|NCT03347422|79375515|FG001|Part B (149 Weeks)|Adverse Event|1|||
44370357|NCT03347422|79375514|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
44370358|NCT03347422|79375515|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
44370359|NCT03347422|79375514|FG000|Part B (149 Weeks)|Other|1|||
44370360|NCT03347422|79375515|FG001|Part B (149 Weeks)|Other|0|||
44370361|NCT00814801|79375531|FG000|Overall Study|Adverse Event|15|||
44370362|NCT00814801|79375532|FG001|Overall Study|Adverse Event|16|||
44370363|NCT00814801|79375533|FG002|Overall Study|Adverse Event|19|||
44370364|NCT00814801|79375531|FG000|Overall Study|Withdrawal by Subject|9|||
44452209|NCT04329702|79461130|FG002|Overall Study|Death|0|||
44452210|NCT00481065|79461151|FG000|Overall Study|Adverse event or death|1|||
44452211|NCT00481065|79461152|FG001|Overall Study|Adverse event or death|1|||
44452212|NCT00481065|79461153|FG002|Overall Study|Adverse event or death|3|||
44452213|NCT00481065|79461154|FG003|Overall Study|Adverse event or death|0|||
44452214|NCT00481065|79461155|FG004|Overall Study|Adverse event or death|2|||
44452215|NCT00481065|79461156|FG005|Overall Study|Adverse event or death|0|||
44452216|NCT00481065|79461157|FG006|Overall Study|Adverse event or death|1|||
44452217|NCT00481065|79461158|FG007|Overall Study|Adverse event or death|1|||
44452218|NCT00481065|79461151|FG000|Overall Study|Withdrawal by Subject|11|||
44452219|NCT00481065|79461152|FG001|Overall Study|Withdrawal by Subject|12|||
44452220|NCT00481065|79461153|FG002|Overall Study|Withdrawal by Subject|7|||
44452221|NCT00481065|79461154|FG003|Overall Study|Withdrawal by Subject|11|||
44452222|NCT00481065|79461155|FG004|Overall Study|Withdrawal by Subject|13|||
44452223|NCT00481065|79461156|FG005|Overall Study|Withdrawal by Subject|12|||
44452224|NCT00481065|79461157|FG006|Overall Study|Withdrawal by Subject|9|||
44452225|NCT00481065|79461158|FG007|Overall Study|Withdrawal by Subject|10|||
44452226|NCT00481065|79461151|FG000|Overall Study|Lost to Follow-up|4|||
44452227|NCT00481065|79461152|FG001|Overall Study|Lost to Follow-up|2|||
44452228|NCT00481065|79461153|FG002|Overall Study|Lost to Follow-up|4|||
44452229|NCT00481065|79461154|FG003|Overall Study|Lost to Follow-up|3|||
44452230|NCT00481065|79461155|FG004|Overall Study|Lost to Follow-up|3|||
44452231|NCT00481065|79461156|FG005|Overall Study|Lost to Follow-up|3|||
44452232|NCT00481065|79461157|FG006|Overall Study|Lost to Follow-up|2|||
44452233|NCT00481065|79461158|FG007|Overall Study|Lost to Follow-up|5|||
44452234|NCT00481065|79461151|FG000|Overall Study|Inappropriate enrollment|4|||
44452235|NCT00481065|79461152|FG001|Overall Study|Inappropriate enrollment|0|||
44452236|NCT00481065|79461153|FG002|Overall Study|Inappropriate enrollment|2|||
44452237|NCT00481065|79461154|FG003|Overall Study|Inappropriate enrollment|0|||
44452238|NCT00481065|79461155|FG004|Overall Study|Inappropriate enrollment|2|||
44452239|NCT00481065|79461156|FG005|Overall Study|Inappropriate enrollment|1|||
44452240|NCT00481065|79461157|FG006|Overall Study|Inappropriate enrollment|0|||
44452241|NCT00481065|79461158|FG007|Overall Study|Inappropriate enrollment|1|||
44452242|NCT00481065|79461151|FG000|Overall Study|Administrative reason|0|||
44452243|NCT00481065|79461152|FG001|Overall Study|Administrative reason|0|||
44452244|NCT00481065|79461153|FG002|Overall Study|Administrative reason|0|||
44452245|NCT00481065|79461154|FG003|Overall Study|Administrative reason|0|||
44452246|NCT00481065|79461155|FG004|Overall Study|Administrative reason|0|||
44452247|NCT00481065|79461156|FG005|Overall Study|Administrative reason|2|||
44452248|NCT00481065|79461157|FG006|Overall Study|Administrative reason|1|||
44452249|NCT00481065|79461158|FG007|Overall Study|Administrative reason|0|||
44452250|NCT00481065|79461151|FG000|Overall Study|Protocol Violation|2|||
44452251|NCT00481065|79461152|FG001|Overall Study|Protocol Violation|1|||
44452252|NCT00481065|79461153|FG002|Overall Study|Protocol Violation|1|||
44452253|NCT00481065|79461154|FG003|Overall Study|Protocol Violation|1|||
44211051|NCT01381900|79007869|FG002|Overall Study|Physician Decision|1|||
44211052|NCT01381900|79007867|FG000|Overall Study|Protocol Violation|0|||
44211053|NCT01381900|79007868|FG001|Overall Study|Protocol Violation|1|||
44211054|NCT01381900|79007869|FG002|Overall Study|Protocol Violation|1|||
44211055|NCT01381900|79007867|FG000|Overall Study|Withdrawal by Subject|0|||
44211056|NCT01381900|79007868|FG001|Overall Study|Withdrawal by Subject|0|||
44211057|NCT01381900|79007869|FG002|Overall Study|Withdrawal by Subject|1|||
44211058|NCT01381900|79007867|FG000|Overall Study|Early withdraw|3|||
44211059|NCT01381900|79007868|FG001|Overall Study|Early withdraw|1|||
44211060|NCT01381900|79007869|FG002|Overall Study|Early withdraw|1|||
44211061|NCT01744665|79007877|FG000|Monitoring Phase|Adverse Event|4|||
44211062|NCT01744665|79007877|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
44370365|NCT00814801|79375532|FG001|Overall Study|Withdrawal by Subject|11|||
44370366|NCT00814801|79375533|FG002|Overall Study|Withdrawal by Subject|14|||
44370367|NCT00814801|79375531|FG000|Overall Study|Inappropriate as a subject|1|||
44370368|NCT00814801|79375532|FG001|Overall Study|Inappropriate as a subject|1|||
44370369|NCT00814801|79375533|FG002|Overall Study|Inappropriate as a subject|1|||
44370370|NCT00814801|79375531|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
44370371|NCT00814801|79375532|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
44370372|NCT00814801|79375533|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
44370373|NCT00814801|79375531|FG000|Overall Study|Missing or change of caregiver|6|||
44370374|NCT00814801|79375532|FG001|Overall Study|Missing or change of caregiver|2|||
44370375|NCT00814801|79375533|FG002|Overall Study|Missing or change of caregiver|4|||
44370376|NCT00814801|79375531|FG000|Overall Study|Non-compliance|0|||
44370377|NCT00814801|79375532|FG001|Overall Study|Non-compliance|1|||
44370378|NCT00814801|79375533|FG002|Overall Study|Non-compliance|1|||
44370379|NCT00814801|79375531|FG000|Overall Study|Other|2|||
44370380|NCT00814801|79375532|FG001|Overall Study|Other|6|||
44370381|NCT00814801|79375533|FG002|Overall Study|Other|4|||
44211063|NCT01744665|79007877|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
44211064|NCT01744665|79007877|FG000|Monitoring Phase|Withdrawal by Subject|5|||
44370382|NCT00823615|79375541|FG000|Period 2|Lost to Follow-up|2|||
44370383|NCT00823615|79375542|FG001|Period 2|Lost to Follow-up|0|||
44452254|NCT00481065|79461155|FG004|Overall Study|Protocol Violation|2|||
44452255|NCT00481065|79461156|FG005|Overall Study|Protocol Violation|6|||
44452256|NCT00481065|79461157|FG006|Overall Study|Protocol Violation|3|||
44452257|NCT00481065|79461158|FG007|Overall Study|Protocol Violation|2|||
44211065|NCT01744665|79007877|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
44211066|NCT01744665|79007877|FG000|Consolidation Phase|Adverse Event|2|||
44452258|NCT00481065|79461151|FG000|Overall Study|Unable to classify|0|||
44452259|NCT00481065|79461152|FG001|Overall Study|Unable to classify|1|||
44452260|NCT00481065|79461153|FG002|Overall Study|Unable to classify|2|||
44452261|NCT00481065|79461154|FG003|Overall Study|Unable to classify|0|||
44452262|NCT00481065|79461155|FG004|Overall Study|Unable to classify|1|||
44452263|NCT00481065|79461156|FG005|Overall Study|Unable to classify|0|||
44452264|NCT00481065|79461157|FG006|Overall Study|Unable to classify|0|||
44452265|NCT00481065|79461158|FG007|Overall Study|Unable to classify|0|||
44452266|NCT00493311|79461180|FG000|Overall Study|Need for rescue medication|2|||
44452267|NCT00493311|79461181|FG001|Overall Study|Need for rescue medication|2|||
44452268|NCT00571649|79461189|FG000|Treatment Period|Adverse Event|438|||
44452269|NCT00571649|79461190|FG001|Treatment Period|Adverse Event|385|||
44452270|NCT00571649|79461189|FG000|Treatment Period|Clinical endpoint reached|50|||
44452271|NCT00571649|79461190|FG001|Treatment Period|Clinical endpoint reached|56|||
44211067|NCT01744665|79007877|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
44211068|NCT01744665|79007877|FG000|Consolidation Phase|Withdrawal by Subject|4|||
44211069|NCT01744665|79007877|FG000|Consolidation Phase|Administrative problems|9|||
44211070|NCT01744665|79007877|FG000|Re-initiation Phase|Administrative problems|10|||
44211071|NCT01744665|79007877|FG000|Re-initiation Phase|Adverse Event|1|||
44211072|NCT01744665|79007877|FG000|Re-initiation Phase|No longer required treatment|1|||
44211073|NCT01744665|79007877|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
44211074|NCT01744197|79007886|FG000|Overall Study|Received 1 patch|2|||
44211075|NCT01744197|79007887|FG001|Overall Study|Received 1 patch|1|||
44211076|NCT01744197|79007886|FG000|Overall Study|No patch received|2|||
44211077|NCT01744197|79007887|FG001|Overall Study|No patch received|2|||
44211078|NCT01732107|79007893|FG000|Overall Study|Adverse Event|2|||
44211079|NCT01732107|79007893|FG000|Overall Study|Disease Progression|8|||
44211080|NCT01732107|79007893|FG000|Overall Study|Physician Decision|1|||
44211081|NCT01732107|79007893|FG000|Overall Study|Withdrawal by Subject|2|||
44211082|NCT01743027|79007901|FG000|Overall Study|Adverse Event|2|||
44211083|NCT01743027|79007902|FG001|Overall Study|Adverse Event|0|||
44211084|NCT01743027|79007903|FG002|Overall Study|Adverse Event|0|||
44211085|NCT01743027|79007904|FG003|Overall Study|Adverse Event|0|||
44211086|NCT01743027|79007901|FG000|Overall Study|Lost to Follow-up|0|||
44211087|NCT01743027|79007902|FG001|Overall Study|Lost to Follow-up|0|||
44211088|NCT01743027|79007903|FG002|Overall Study|Lost to Follow-up|2|||
44211089|NCT01743027|79007904|FG003|Overall Study|Lost to Follow-up|0|||
44211090|NCT01743027|79007901|FG000|Overall Study|Progressive Disease|1|||
44211091|NCT01743027|79007902|FG001|Overall Study|Progressive Disease|4|||
44211092|NCT01743027|79007903|FG002|Overall Study|Progressive Disease|3|||
44211093|NCT01743027|79007904|FG003|Overall Study|Progressive Disease|0|||
44211094|NCT01743027|79007901|FG000|Overall Study|Protocol Violation|1|||
44211095|NCT01743027|79007902|FG001|Overall Study|Protocol Violation|1|||
44211096|NCT01743027|79007903|FG002|Overall Study|Protocol Violation|1|||
44211097|NCT01743027|79007904|FG003|Overall Study|Protocol Violation|0|||
44211098|NCT01743027|79007901|FG000|Overall Study|Withdrawal by Subject|1|||
44211099|NCT01743027|79007902|FG001|Overall Study|Withdrawal by Subject|0|||
44211100|NCT01743027|79007903|FG002|Overall Study|Withdrawal by Subject|3|||
44211101|NCT01743027|79007904|FG003|Overall Study|Withdrawal by Subject|1|||
44211102|NCT01380730|79007922|FG000|Overall Study|Death|0|||
44211103|NCT01380730|79007923|FG001|Overall Study|Death|0|||
44211104|NCT01380730|79007924|FG002|Overall Study|Death|0|||
44211105|NCT01380730|79007925|FG003|Overall Study|Death|0|||
44211106|NCT01380730|79007926|FG004|Overall Study|Death|1|||
44211107|NCT01380730|79007927|FG005|Overall Study|Death|0|||
44211108|NCT01380730|79007928|FG006|Overall Study|Death|0|||
44211109|NCT01380730|79007929|FG007|Overall Study|Death|0|||
44211110|NCT01395784|79007947|FG000|Overall Study|Lost to Follow-up|7|||
44211111|NCT01395784|79007947|FG000|Overall Study|Withdrawal by Subject|3|||
44211112|NCT01395784|79007947|FG000|Overall Study|Physician Decision|5|||
44211113|NCT01380184|79007951|FG000|Part 1 (19 Days)|Adverse Event|1|||
44211114|NCT01380184|79007951|FG000|Part 2|Adverse Event|5|||
44211115|NCT01380184|79007951|FG000|Part 2|Disease Progression|8|||
44211116|NCT01380184|79007951|FG000|Part 2|Lost to Follow-up|1|||
44211117|NCT01395394|79007958|FG000|Baseline Study Visit|Protocol Violation|1|||
44452272|NCT00571649|79461189|FG000|Treatment Period|Withdrawal by Subject|285|||
44452273|NCT00571649|79461190|FG001|Treatment Period|Withdrawal by Subject|255|||
44211118|NCT01395394|79007959|FG001|Baseline Study Visit|Protocol Violation|0|||
44452274|NCT00571649|79461189|FG000|Treatment Period|Death|76|||
44211119|NCT01395394|79007960|FG002|Baseline Study Visit|Protocol Violation|0|||
44452275|NCT00571649|79461190|FG001|Treatment Period|Death|59|||
44452276|NCT00571649|79461189|FG000|Treatment Period|Physician Decision|8|||
44452277|NCT00571649|79461190|FG001|Treatment Period|Physician Decision|9|||
44452278|NCT00571649|79461189|FG000|Treatment Period|Lost to Follow-up|43|||
44452279|NCT00571649|79461190|FG001|Treatment Period|Lost to Follow-up|41|||
44211120|NCT01395316|79007968|FG000|Overall Study|Lost to Follow-up|2|||
44211121|NCT01395316|79007968|FG000|Overall Study|poor MRI quality|1|||
44211122|NCT01742091|79007978|FG000|Overall Study|Adverse Event|0|||
44211123|NCT01742091|79007979|FG001|Overall Study|Adverse Event|0|||
44211124|NCT01742091|79007980|FG002|Overall Study|Adverse Event|0|||
44211125|NCT01742091|79007981|FG003|Overall Study|Adverse Event|0|||
44211126|NCT01742091|79007982|FG004|Overall Study|Adverse Event|1|||
44211127|NCT01742091|79007983|FG005|Overall Study|Adverse Event|0|||
44211128|NCT01742091|79007978|FG000|Overall Study|Physician Decision|0|||
44211129|NCT01742091|79007979|FG001|Overall Study|Physician Decision|0|||
44211130|NCT01742091|79007980|FG002|Overall Study|Physician Decision|0|||
44211131|NCT01742091|79007981|FG003|Overall Study|Physician Decision|0|||
44211132|NCT01742091|79007982|FG004|Overall Study|Physician Decision|0|||
44211133|NCT01742091|79007983|FG005|Overall Study|Physician Decision|1|||
44211134|NCT01742091|79007978|FG000|Overall Study|Withdrawal by Subject|0|||
44211135|NCT01742091|79007979|FG001|Overall Study|Withdrawal by Subject|0|||
44211136|NCT01742091|79007980|FG002|Overall Study|Withdrawal by Subject|0|||
44211137|NCT01742091|79007981|FG003|Overall Study|Withdrawal by Subject|1|||
44211138|NCT01742091|79007982|FG004|Overall Study|Withdrawal by Subject|0|||
44211139|NCT01742091|79007983|FG005|Overall Study|Withdrawal by Subject|0|||
44211140|NCT01742091|79007978|FG000|Overall Study|Lost to Follow-up|0|||
44211141|NCT01742091|79007979|FG001|Overall Study|Lost to Follow-up|0|||
44211142|NCT01742091|79007980|FG002|Overall Study|Lost to Follow-up|0|||
44211143|NCT01742091|79007981|FG003|Overall Study|Lost to Follow-up|0|||
44211144|NCT01742091|79007982|FG004|Overall Study|Lost to Follow-up|0|||
44211145|NCT01742091|79007983|FG005|Overall Study|Lost to Follow-up|1|||
44211146|NCT01731951|79008003|FG000|Overall Study|Documented Disease Progression|1|||
44211147|NCT01731951|79008004|FG001|Overall Study|Documented Disease Progression|0|||
44211148|NCT01731951|79008005|FG002|Overall Study|Documented Disease Progression|0|||
44211149|NCT01731951|79008006|FG003|Overall Study|Documented Disease Progression|0|||
44211150|NCT01731951|79008007|FG004|Overall Study|Documented Disease Progression|0|||
44211151|NCT01731951|79008008|FG005|Overall Study|Documented Disease Progression|0|||
44211152|NCT01731951|79008003|FG000|Overall Study|Lost to Follow-up|2|||
44211153|NCT01731951|79008004|FG001|Overall Study|Lost to Follow-up|0|||
44211154|NCT01731951|79008005|FG002|Overall Study|Lost to Follow-up|0|||
44211155|NCT01731951|79008006|FG003|Overall Study|Lost to Follow-up|1|||
44211156|NCT01731951|79008007|FG004|Overall Study|Lost to Follow-up|3|||
44211157|NCT01731951|79008008|FG005|Overall Study|Lost to Follow-up|1|||
44211158|NCT01731951|79008003|FG000|Overall Study|Withdrawal of Consent|1|||
44211159|NCT01731951|79008004|FG001|Overall Study|Withdrawal of Consent|0|||
44211160|NCT01731951|79008005|FG002|Overall Study|Withdrawal of Consent|0|||
44211161|NCT01731951|79008006|FG003|Overall Study|Withdrawal of Consent|0|||
44211162|NCT01731951|79008007|FG004|Overall Study|Withdrawal of Consent|0|||
44211163|NCT01731951|79008008|FG005|Overall Study|Withdrawal of Consent|2|||
44211164|NCT01731951|79008003|FG000|Overall Study|Death|13|||
44211165|NCT01731951|79008004|FG001|Overall Study|Death|15|||
44211166|NCT01731951|79008005|FG002|Overall Study|Death|9|||
44211167|NCT01731951|79008006|FG003|Overall Study|Death|8|||
44211168|NCT01731951|79008007|FG004|Overall Study|Death|9|||
44211169|NCT01731951|79008008|FG005|Overall Study|Death|6|||
44211170|NCT01731171|79008028|FG000|Overall Study|Withdrawal by Subject|4|||
44211171|NCT01731171|79008029|FG001|Overall Study|Withdrawal by Subject|1|||
44211172|NCT01731171|79008028|FG000|Overall Study|Lost to Follow-up|3|||
44211173|NCT01731171|79008029|FG001|Overall Study|Lost to Follow-up|2|||
44211174|NCT01731171|79008028|FG000|Overall Study|Moved out of Area|0|||
44211175|NCT01731171|79008029|FG001|Overall Study|Moved out of Area|2|||
44211176|NCT01731171|79008028|FG000|Overall Study|Terminated for Lack of Adherence|0|||
44370384|NCT00823615|79375541|FG000|Period 2|Time/Job Conflict|1|||
44370385|NCT00823615|79375542|FG001|Period 2|Time/Job Conflict|2|||
44370386|NCT00812461|79375550|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
44370387|NCT00812461|79375551|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
44370388|NCT00812461|79375550|FG000|All Treated Patients|Adverse Event|8|||
44370389|NCT00812461|79375551|FG001|All Treated Patients|Adverse Event|15|||
44370390|NCT00812461|79375550|FG000|All Treated Patients|Lack of Efficacy|13|||
44370391|NCT00812461|79375551|FG001|All Treated Patients|Lack of Efficacy|7|||
44370392|NCT00812461|79375550|FG000|All Treated Patients|Non-compliance|6|||
44370393|NCT00812461|79375551|FG001|All Treated Patients|Non-compliance|9|||
44370394|NCT00812461|79375550|FG000|All Treated Patients|Protocol Violation|36|||
44370395|NCT00812461|79375551|FG001|All Treated Patients|Protocol Violation|27|||
44370396|NCT00812461|79375550|FG000|All Treated Patients|Withdrawal by Subject|45|||
44370397|NCT00812461|79375551|FG001|All Treated Patients|Withdrawal by Subject|54|||
44452280|NCT00571649|79461189|FG000|Treatment Period|Non-compliant with study medication|88|||
44211177|NCT01731171|79008029|FG001|Overall Study|Terminated for Lack of Adherence|1|||
44211178|NCT01731171|79008028|FG000|Overall Study|Terminated for Safety Reasons|0|||
44211179|NCT01731171|79008029|FG001|Overall Study|Terminated for Safety Reasons|1|||
44211180|NCT01741701|79008037|FG000|Overall Study|Adverse Event|5|||
44211181|NCT01741701|79008038|FG001|Overall Study|Adverse Event|1|||
44211182|NCT01741701|79008037|FG000|Overall Study|Withdrawal by Subject|0|||
44211183|NCT01741701|79008038|FG001|Overall Study|Withdrawal by Subject|1|||
44211184|NCT01741545|79008046|FG000|Treatment Period|Lack of Efficacy|0|||
44211185|NCT01741545|79008047|FG001|Treatment Period|Lack of Efficacy|1|||
44211186|NCT01741545|79008046|FG000|Treatment Period|Adverse event, non-fatal|1|||
44211187|NCT01741545|79008047|FG001|Treatment Period|Adverse event, non-fatal|3|||
44211188|NCT01741545|79008046|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
44211189|NCT01741545|79008047|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
44211190|NCT01741545|79008046|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
44211191|NCT01741545|79008047|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
44211192|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
44211193|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
44211194|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
44211195|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
44211196|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
44211197|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
44211198|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
44211199|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
44211200|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
44211201|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
44211202|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
44211203|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
44211204|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
44211205|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
44211206|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
44211207|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
44211208|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
44211209|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
44211210|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
44211211|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
44211212|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
44211213|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
44211214|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
44211215|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
44211216|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
44211217|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
44211218|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
44211219|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
44211220|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
44211221|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
44211222|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
44211223|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
44211224|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
44211225|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
44211226|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
44211227|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
44211228|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
44211229|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
44211230|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
44211231|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
44211232|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
44211233|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
44211234|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
44211235|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
44211236|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
44211237|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
44211238|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
44211239|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
44211240|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
44211241|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
44211242|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
44211243|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
44211244|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
44211245|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
44211246|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
44211247|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
44211248|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
44211249|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
44211250|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
44211251|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
44211252|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
44211253|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
44211254|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
44211255|NCT01884350|79008055|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
44211256|NCT01884350|79008056|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
44211257|NCT01884350|79008057|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
44211258|NCT01614795|79008071|FG000|Overall Study|Adverse Event|0|||
44211259|NCT01614795|79008072|FG001|Overall Study|Adverse Event|0|||
44211260|NCT01614795|79008073|FG002|Overall Study|Adverse Event|1|||
44211261|NCT01614795|79008074|FG003|Overall Study|Adverse Event|1|||
44211262|NCT01614795|79008071|FG000|Overall Study|Lack of Efficacy|10|||
44211263|NCT01614795|79008072|FG001|Overall Study|Lack of Efficacy|10|||
44211264|NCT01614795|79008073|FG002|Overall Study|Lack of Efficacy|9|||
44211265|NCT01614795|79008074|FG003|Overall Study|Lack of Efficacy|8|||
44211266|NCT01614795|79008071|FG000|Overall Study|Physician Decision|1|||
44211267|NCT01614795|79008072|FG001|Overall Study|Physician Decision|0|||
44211268|NCT01614795|79008073|FG002|Overall Study|Physician Decision|1|||
44211269|NCT01614795|79008074|FG003|Overall Study|Physician Decision|1|||
44211270|NCT01614795|79008071|FG000|Overall Study|Withdrawal by Subject|0|||
44211271|NCT01614795|79008072|FG001|Overall Study|Withdrawal by Subject|1|||
44211272|NCT01614795|79008073|FG002|Overall Study|Withdrawal by Subject|0|||
44211273|NCT01614795|79008074|FG003|Overall Study|Withdrawal by Subject|2|||
44211274|NCT01614795|79008071|FG000|Overall Study|Ineligible|0|||
44211275|NCT01614795|79008072|FG001|Overall Study|Ineligible|1|||
44211276|NCT01614795|79008073|FG002|Overall Study|Ineligible|0|||
44211277|NCT01614795|79008074|FG003|Overall Study|Ineligible|0|||
44211278|NCT01834586|79008085|FG000|Overall Study|Adverse Event|1|||
44211279|NCT01614249|79008091|FG000|Overall Study|Lost to Follow-up|11|||
44211280|NCT01614249|79008092|FG001|Overall Study|Lost to Follow-up|23|||
44211281|NCT01597778|79008100|FG000|Overall Study|Death|7|||
44211282|NCT01597778|79008101|FG001|Overall Study|Death|10|||
44211283|NCT01597778|79008100|FG000|Overall Study|Withdrawal by Subject|3|||
44211284|NCT01597778|79008101|FG001|Overall Study|Withdrawal by Subject|4|||
44211285|NCT01597778|79008100|FG000|Overall Study|Adverse Event|1|||
44211286|NCT01597778|79008101|FG001|Overall Study|Adverse Event|1|||
44211287|NCT01597778|79008100|FG000|Overall Study|Protocol Violation|1|||
44211288|NCT01597778|79008101|FG001|Overall Study|Protocol Violation|11|||
44211289|NCT01597778|79008100|FG000|Overall Study|Transplanted off protocol|2|||
44211290|NCT01597778|79008101|FG001|Overall Study|Transplanted off protocol|3|||
44211291|NCT01614093|79008107|FG000|Overall Study|Withdrawal by Subject|1|||
44211292|NCT01834274|79008114|FG000|Overall Study|Study Termination|41|||
44211293|NCT01834274|79008115|FG001|Overall Study|Study Termination|38|||
44211294|NCT01834274|79008114|FG000|Overall Study|Withdrawal by Subject|1|||
44211295|NCT01834274|79008115|FG001|Overall Study|Withdrawal by Subject|1|||
44211296|NCT01834274|79008114|FG000|Overall Study|Lost to Follow-up|3|||
44211297|NCT01834274|79008115|FG001|Overall Study|Lost to Follow-up|1|||
44211298|NCT01834274|79008114|FG000|Overall Study|Other|2|||
44211299|NCT01834274|79008115|FG001|Overall Study|Other|1|||
44370398|NCT00812461|79375550|FG000|All Treated Patients|Lost to Follow-up|11|||
44370399|NCT00812461|79375551|FG001|All Treated Patients|Lost to Follow-up|14|||
44370400|NCT00812461|79375550|FG000|All Treated Patients|Other Reason|13|||
44211300|NCT01739595|79008124|FG000|Overall Study|Adverse Event|3|||
44211301|NCT01739595|79008125|FG001|Overall Study|Adverse Event|0|||
44211302|NCT01739595|79008126|FG002|Overall Study|Adverse Event|0|||
44211303|NCT01739595|79008124|FG000|Overall Study|Lost to Follow-up|2|||
44211304|NCT01739595|79008125|FG001|Overall Study|Lost to Follow-up|0|||
44211305|NCT01739595|79008126|FG002|Overall Study|Lost to Follow-up|0|||
44211306|NCT01739595|79008124|FG000|Overall Study|Withdrawal by Subject|2|||
44211307|NCT01739595|79008125|FG001|Overall Study|Withdrawal by Subject|1|||
44211308|NCT01739595|79008126|FG002|Overall Study|Withdrawal by Subject|2|||
44211309|NCT01739595|79008124|FG000|Overall Study|Eligibility issue|3|||
44211310|NCT01739595|79008125|FG001|Overall Study|Eligibility issue|0|||
44211311|NCT01739595|79008126|FG002|Overall Study|Eligibility issue|0|||
44211312|NCT01739595|79008124|FG000|Overall Study|Protocol Violation|1|||
44211313|NCT01739595|79008125|FG001|Overall Study|Protocol Violation|0|||
44211314|NCT01739595|79008126|FG002|Overall Study|Protocol Violation|0|||
44452281|NCT00571649|79461190|FG001|Treatment Period|Non-compliant with study medication|89|||
44452282|NCT00571649|79461189|FG000|Treatment Period|Patient convenience|11|||
44452283|NCT00571649|79461190|FG001|Treatment Period|Patient convenience|13|||
44452284|NCT00571649|79461189|FG000|Treatment Period|Protocol Violation|90|||
44452285|NCT00571649|79461190|FG001|Treatment Period|Protocol Violation|92|||
44452286|NCT00571649|79461189|FG000|Treatment Period|Technical problems|3|||
44452287|NCT00571649|79461190|FG001|Treatment Period|Technical problems|5|||
44452288|NCT00571649|79461189|FG000|Follow-up Period|Adverse Event|46|||
44452289|NCT00571649|79461190|FG001|Follow-up Period|Adverse Event|40|||
44452290|NCT00571649|79461189|FG000|Follow-up Period|Clinical endpoint reached|5|||
44211315|NCT01739595|79008124|FG000|Overall Study|Lab assessment|1|||
44211316|NCT01739595|79008125|FG001|Overall Study|Lab assessment|0|||
44211317|NCT01739595|79008126|FG002|Overall Study|Lab assessment|0|||
44211318|NCT01739595|79008124|FG000|Overall Study|Drug discrepancy|1|||
44211319|NCT01739595|79008125|FG001|Overall Study|Drug discrepancy|0|||
44211320|NCT01739595|79008126|FG002|Overall Study|Drug discrepancy|0|||
44211321|NCT01833494|79008133|FG000|Overall Study|Adverse Event|24|||
44211322|NCT01833494|79008133|FG000|Overall Study|Physician Decision|6|||
44211323|NCT01833494|79008133|FG000|Overall Study|Withdrawal by Subject|6|||
44211324|NCT01833494|79008133|FG000|Overall Study|Decrease in serum phosphorus|4|||
44211325|NCT01833494|79008133|FG000|Overall Study|Decrease in serum calcium|4|||
44211326|NCT01833494|79008133|FG000|Overall Study|Increase in serum ferritin|1|||
44211327|NCT01738971|79008140|FG000|Overall Study|Lost to Follow-up|19|||
44211328|NCT01738971|79008141|FG001|Overall Study|Lost to Follow-up|30|||
44211329|NCT01738971|79008142|FG002|Overall Study|Lost to Follow-up|17|||
44211330|NCT01738581|79008152|FG000|Overall Study|Lost to Follow-up|1|||
44211331|NCT01738581|79008153|FG001|Overall Study|Lost to Follow-up|0|||
44211332|NCT01738503|79008165|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
44211333|NCT01738503|79008166|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
44211334|NCT01738503|79008167|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
44211335|NCT01738503|79008168|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
44211336|NCT01738503|79008169|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
44211337|NCT01738503|79008170|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
44211338|NCT01738503|79008171|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
44211339|NCT01738503|79008165|FG000|Treatment Period|Adverse Event|0|||
44211340|NCT01738503|79008166|FG001|Treatment Period|Adverse Event|1|||
44211341|NCT01738503|79008167|FG002|Treatment Period|Adverse Event|0|||
44211342|NCT01738503|79008168|FG003|Treatment Period|Adverse Event|1|||
44211343|NCT01738503|79008169|FG004|Treatment Period|Adverse Event|2|||
44452291|NCT00571649|79461190|FG001|Follow-up Period|Clinical endpoint reached|2|||
44452292|NCT00571649|79461189|FG000|Follow-up Period|Withdrawal by Subject|119|||
44452293|NCT00571649|79461190|FG001|Follow-up Period|Withdrawal by Subject|115|||
44452294|NCT00571649|79461189|FG000|Follow-up Period|Death|132|||
44452295|NCT00571649|79461190|FG001|Follow-up Period|Death|133|||
44452296|NCT00571649|79461189|FG000|Follow-up Period|Physician Decision|7|||
44452297|NCT00571649|79461190|FG001|Follow-up Period|Physician Decision|13|||
44452298|NCT00571649|79461189|FG000|Follow-up Period|Lost to Follow-up|95|||
44452299|NCT00571649|79461190|FG001|Follow-up Period|Lost to Follow-up|92|||
44452300|NCT00571649|79461189|FG000|Follow-up Period|Patient convenience|136|||
44452301|NCT00571649|79461190|FG001|Follow-up Period|Patient convenience|121|||
44452302|NCT00571649|79461189|FG000|Follow-up Period|Protocol Violation|5|||
44370401|NCT00812461|79375551|FG001|All Treated Patients|Other Reason|21|||
44370402|NCT00599326|79375557|FG000|Overall Study|Lost to Follow-up|1|||
44370403|NCT00599326|79375557|FG000|Overall Study|Noncompliant|1|||
44370404|NCT00978432|79375564|FG000|Overall Study|Withdrawal by Subject|0|||
44370405|NCT00978432|79375565|FG001|Overall Study|Withdrawal by Subject|0|||
44370406|NCT00978432|79375566|FG002|Overall Study|Withdrawal by Subject|1|||
44370407|NCT00978432|79375564|FG000|Overall Study|Lack of Efficacy|1|||
44370408|NCT00978432|79375565|FG001|Overall Study|Lack of Efficacy|1|||
44370409|NCT00978432|79375566|FG002|Overall Study|Lack of Efficacy|3|||
44370410|NCT00978432|79375564|FG000|Overall Study|Adverse Event|2|||
44370411|NCT00978432|79375565|FG001|Overall Study|Adverse Event|0|||
44370412|NCT00978432|79375566|FG002|Overall Study|Adverse Event|1|||
44370413|NCT00975780|79375576|FG000|Follow Up|Death|88|||
44370414|NCT00975780|79375577|FG001|Follow Up|Death|122|||
44452303|NCT00571649|79461190|FG001|Follow-up Period|Protocol Violation|12|||
44543584|NCT02935842|79556656|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
44543585|NCT02935842|79556657|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
44452304|NCT00546572|79461198|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
44452305|NCT00546572|79461199|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
44452306|NCT00546572|79461198|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
44211344|NCT01738503|79008170|FG005|Treatment Period|Adverse Event|2|||
44211345|NCT01738503|79008171|FG006|Treatment Period|Adverse Event|2|||
44211346|NCT01738503|79008165|FG000|Treatment Period|Lost to Follow-up|0|||
44452307|NCT00546572|79461199|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
44543586|NCT02935842|79556658|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
44370415|NCT00975780|79375576|FG000|Follow Up|Facility Withdrawal|7|||
44452308|NCT00546572|79461198|FG000|Vax 1 / Year 0|Protocol Violation|3|||
44452309|NCT00546572|79461199|FG001|Vax 1 / Year 0|Protocol Violation|4|||
44452310|NCT00546572|79461198|FG000|Vax 1 / Year 0|Death|2|||
44452311|NCT00546572|79461199|FG001|Vax 1 / Year 0|Death|2|||
44452312|NCT00546572|79461198|FG000|Vax 1 / Year 0|Adverse Event|0|||
44452313|NCT00546572|79461199|FG001|Vax 1 / Year 0|Adverse Event|1|||
44452314|NCT00546572|79461198|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
44452315|NCT00546572|79461199|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
44452316|NCT00546572|79461198|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
44452317|NCT00546572|79461199|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
44452318|NCT00546572|79461198|FG000|Vax 2 / Year 1|Other|1|||
44452319|NCT00546572|79461199|FG001|Vax 2 / Year 1|Other|1|||
44452320|NCT00546572|79461198|FG000|Vax 2 / Year 1|Adverse Event|1|||
44452321|NCT00546572|79461199|FG001|Vax 2 / Year 1|Adverse Event|0|||
44452322|NCT00546572|79461198|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
44452323|NCT00546572|79461199|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
44452324|NCT03917472|79461218|FG000|Overall Study|Physician Decision|4|||
44452325|NCT03917472|79461219|FG001|Overall Study|Physician Decision|0|||
44452326|NCT03917472|79461218|FG000|Overall Study|Adverse Event|3|||
44452327|NCT03917472|79461219|FG001|Overall Study|Adverse Event|1|||
44452328|NCT03917472|79461218|FG000|Overall Study|Death|7|||
44452329|NCT03917472|79461219|FG001|Overall Study|Death|5|||
44452330|NCT03917472|79461218|FG000|Overall Study|Withdrawal by Subject|11|||
44452331|NCT03917472|79461219|FG001|Overall Study|Withdrawal by Subject|4|||
44452332|NCT03917472|79461218|FG000|Overall Study|Lost to Follow-up|10|||
44543587|NCT02935842|79556659|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
44370416|NCT00975780|79375577|FG001|Follow Up|Facility Withdrawal|23|||
44370417|NCT00975780|79375576|FG000|Follow Up|Discharged from Facility|7|||
44370418|NCT00975780|79375577|FG001|Follow Up|Discharged from Facility|12|||
44370419|NCT00814489|79375586|FG000|Overall Study|Other|2|||
44370420|NCT00814489|79375587|FG001|Overall Study|Other|0|||
44370421|NCT00814489|79375588|FG002|Overall Study|Other|1|||
44370422|NCT00814333|79375600|FG000|Enrollment|Lost to Follow-up|1|||
44370423|NCT00814333|79375601|FG001|Enrollment|Lost to Follow-up|0|||
44370424|NCT01147250|79375609|FG000|Overall Study|Lost to Follow-up|14|||
44370425|NCT01147250|79375610|FG001|Overall Study|Lost to Follow-up|11|||
44370426|NCT01147250|79375609|FG000|Overall Study|Withdrawal by Subject|83|||
44370427|NCT01147250|79375610|FG001|Overall Study|Withdrawal by Subject|88|||
44370428|NCT01147250|79375609|FG000|Overall Study|Site termination by sponsor|13|||
44370429|NCT01147250|79375610|FG001|Overall Study|Site termination by sponsor|5|||
44370430|NCT01147250|79375609|FG000|Overall Study|Other than specified|0|||
44370431|NCT01147250|79375610|FG001|Overall Study|Other than specified|1|||
44370432|NCT00813943|79375619|FG000|Overall Study|Ongoing at cut-off date|5|||
44370433|NCT00813943|79375620|FG001|Overall Study|Ongoing at cut-off date|5|||
44370434|NCT00813943|79375621|FG002|Overall Study|Ongoing at cut-off date|3|||
44370435|NCT00821509|79375633|FG000|Overall Study|Withdrawal by Subject|12|||
44370436|NCT00821509|79375634|FG001|Overall Study|Withdrawal by Subject|11|||
44452333|NCT03917472|79461219|FG001|Overall Study|Lost to Follow-up|5|||
44211347|NCT01738503|79008166|FG001|Treatment Period|Lost to Follow-up|0|||
44370437|NCT00821509|79375635|FG002|Overall Study|Withdrawal by Subject|34|||
44370438|NCT00821431|79375645|FG000|Overall Study|Adverse Event|6|||
44211348|NCT01738503|79008167|FG002|Treatment Period|Lost to Follow-up|3|||
44370439|NCT00821431|79375646|FG001|Overall Study|Adverse Event|3|||
44370440|NCT00821431|79375645|FG000|Overall Study|Withdrawal by Subject|5|||
44452334|NCT00681863|79461226|FG000|Overall Study|Adverse Event|1|||
44452335|NCT00681863|79461226|FG000|Overall Study|Lost to Follow-up|2|||
44452336|NCT00681863|79461226|FG000|Overall Study|Lack of Efficacy|2|||
44452337|NCT00681863|79461226|FG000|Overall Study|Other|18|||
44370441|NCT00821431|79375646|FG001|Overall Study|Withdrawal by Subject|0|||
44370442|NCT00821431|79375645|FG000|Overall Study|Lost to Follow-up|1|||
44452338|NCT00681629|79461232|FG000|Overall Study|Study termination|4|||
44452339|NCT00681629|79461233|FG001|Overall Study|Study termination|2|||
44452340|NCT00681629|79461232|FG000|Overall Study|Adverse Event|1|||
44211349|NCT01738503|79008168|FG003|Treatment Period|Lost to Follow-up|4|||
44211350|NCT01738503|79008169|FG004|Treatment Period|Lost to Follow-up|1|||
44211351|NCT01738503|79008170|FG005|Treatment Period|Lost to Follow-up|1|||
44211352|NCT01738503|79008171|FG006|Treatment Period|Lost to Follow-up|5|||
44211353|NCT01738503|79008165|FG000|Treatment Period|Withdrawal by Subject|0|||
44211354|NCT01738503|79008166|FG001|Treatment Period|Withdrawal by Subject|1|||
44211355|NCT01738503|79008167|FG002|Treatment Period|Withdrawal by Subject|0|||
44370443|NCT00821431|79375646|FG001|Overall Study|Lost to Follow-up|0|||
44370444|NCT00821431|79375645|FG000|Overall Study|Protocol Violation|3|||
44370445|NCT00821431|79375646|FG001|Overall Study|Protocol Violation|1|||
44370446|NCT00821431|79375645|FG000|Overall Study|Physician Decision|0|||
44370447|NCT00821431|79375646|FG001|Overall Study|Physician Decision|1|||
44370448|NCT00813865|79375652|FG000|Overall Study|Failure to Respond|3|||
44370449|NCT00813865|79375652|FG000|Overall Study|Lost to Follow-up|3|||
44370450|NCT00813865|79375652|FG000|Overall Study|Withdrawal by Subject|1|||
44370451|NCT01147172|79375656|FG000|Overall Study|Withdrawal by Subject|2|||
44370452|NCT01147172|79375656|FG000|Overall Study|Lost to Follow-up|2|||
44370453|NCT01120964|79375664|FG000|Overall Study|Did not receive full treatment|1|||
44370454|NCT01120964|79375665|FG001|Overall Study|Did not receive full treatment|0|||
44370455|NCT01146860|79375673|FG000|Overall Study|Withdrawal by Subject|0|||
44370456|NCT01146860|79375674|FG001|Overall Study|Withdrawal by Subject|1|||
44370457|NCT00591565|79375680|FG000|Overall Study|lost follow up, withdrawn|5|||
44370458|NCT01146782|79375684|FG000|Screening Cohort|Screen Failure|187|||
44370459|NCT01146782|79375684|FG000|Screening Cohort|Lost to Follow-up|4|||
44370460|NCT01146782|79375684|FG000|Screening Cohort|Physician Decision|1|||
44370461|NCT01146782|79375684|FG000|Screening Cohort|Withdrawal by Subject|29|||
44370462|NCT01146782|79375684|FG000|Safety Cohort|Screen Failure|61|||
44370463|NCT01146782|79375684|FG000|Safety Cohort|Withdrawal by Subject|4|||
44370464|NCT01146782|79375684|FG000|Safety Cohort|Control AHI <5|4|||
44370465|NCT01146782|79375684|FG000|Safety Cohort|TST <4 hrs|14|||
44370466|NCT01146782|79375684|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
44370467|NCT01146782|79375684|FG000|Primary Endpoint Cohort|Physician Decision|1|||
44370468|NCT00978120|79375693|FG000|Overall Study|Death|0|||
44370469|NCT00978120|79375694|FG001|Overall Study|Death|0|||
44370470|NCT00978120|79375695|FG002|Overall Study|Death|0|||
44370471|NCT00978120|79375696|FG003|Overall Study|Death|1|||
44370472|NCT00978120|79375693|FG000|Overall Study|Lost to Follow-up|0|||
44370473|NCT00978120|79375694|FG001|Overall Study|Lost to Follow-up|0|||
44370474|NCT00978120|79375695|FG002|Overall Study|Lost to Follow-up|3|||
44370475|NCT00978120|79375696|FG003|Overall Study|Lost to Follow-up|0|||
44370476|NCT00978120|79375693|FG000|Overall Study|Withdrawal by Subject|2|||
44370477|NCT00978120|79375694|FG001|Overall Study|Withdrawal by Subject|0|||
44370478|NCT00978120|79375695|FG002|Overall Study|Withdrawal by Subject|0|||
44370479|NCT00978120|79375696|FG003|Overall Study|Withdrawal by Subject|0|||
44370480|NCT00978120|79375693|FG000|Overall Study|Moved out of state|0|||
44370481|NCT00978120|79375694|FG001|Overall Study|Moved out of state|0|||
44370482|NCT00978120|79375695|FG002|Overall Study|Moved out of state|0|||
44370483|NCT00978120|79375696|FG003|Overall Study|Moved out of state|1|||
44370484|NCT00978042|79375712|FG000|Initial Treatment Period|Treated in Error|0|||
44370485|NCT00978042|79375713|FG001|Initial Treatment Period|Treated in Error|3|||
44370486|NCT00978042|79375712|FG000|Initial Treatment Period|Ineligibility|1|||
44370487|NCT00978042|79375713|FG001|Initial Treatment Period|Ineligibility|0|||
44370488|NCT00978042|79375712|FG000|Initial Treatment Period|Lost to Follow-up|21|||
44370489|NCT00978042|79375713|FG001|Initial Treatment Period|Lost to Follow-up|3|||
44370490|NCT00978042|79375712|FG000|Initial Treatment Period|Adverse Event|2|||
44370491|NCT00978042|79375713|FG001|Initial Treatment Period|Adverse Event|0|||
44370492|NCT00978042|79375712|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
44370493|NCT00978042|79375713|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
44370494|NCT00978042|79375712|FG000|Initial Treatment Period|Consent withdrawn|22|||
44370495|NCT00978042|79375713|FG001|Initial Treatment Period|Consent withdrawn|9|||
44370496|NCT00978042|79375712|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
44370497|NCT00978042|79375713|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
44370498|NCT01133678|79375721|FG000|Overall Study|Death|1|||
44370499|NCT01133678|79375722|FG001|Overall Study|Death|1|||
44370500|NCT01133522|79375738|FG000|Overall Study|Withdrawal by Subject|0|||
44370501|NCT01133522|79375739|FG001|Overall Study|Withdrawal by Subject|1|||
44370502|NCT01133522|79375740|FG002|Overall Study|Withdrawal by Subject|0|||
44370503|NCT01133522|79375741|FG003|Overall Study|Withdrawal by Subject|1|||
44370504|NCT01133522|79375742|FG004|Overall Study|Withdrawal by Subject|0|||
44370505|NCT01133522|79375743|FG005|Overall Study|Withdrawal by Subject|0|||
44370506|NCT01133522|79375744|FG006|Overall Study|Withdrawal by Subject|0|||
44211356|NCT01738503|79008168|FG003|Treatment Period|Withdrawal by Subject|1|||
44211357|NCT01738503|79008169|FG004|Treatment Period|Withdrawal by Subject|1|||
44370507|NCT01133522|79375745|FG007|Overall Study|Withdrawal by Subject|0|||
44370508|NCT01133522|79375746|FG008|Overall Study|Withdrawal by Subject|0|||
44370509|NCT01133522|79375747|FG009|Overall Study|Withdrawal by Subject|0|||
44452341|NCT00681629|79461233|FG001|Overall Study|Adverse Event|0|||
44452342|NCT00679367|79461239|FG000|Overall Study|Adverse Event|7|||
44452343|NCT00679367|79461239|FG000|Overall Study|inability to swallow oral drugs|1|||
44452344|NCT00679367|79461239|FG000|Overall Study|Lack of Efficacy|3|||
44452345|NCT00679367|79461239|FG000|Overall Study|Withdrawal by Subject|1|||
44452346|NCT03937778|79461244|FG000|Overall Study|Withdrawal by Subject|1|||
44452347|NCT03937778|79461244|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
44452348|NCT03935126|79461248|FG000|Overall Study|Study termination by sponsor|3|||
44452349|NCT00545714|79461252|FG000|Induction Phase (6 Months)|Physician Decision|3|||
44211358|NCT01738503|79008170|FG005|Treatment Period|Withdrawal by Subject|1|||
44211359|NCT01738503|79008171|FG006|Treatment Period|Withdrawal by Subject|1|||
44211360|NCT01738503|79008165|FG000|Treatment Period|Protocol Violation|0|||
44211361|NCT01738503|79008166|FG001|Treatment Period|Protocol Violation|3|||
44211362|NCT01738503|79008167|FG002|Treatment Period|Protocol Violation|1|||
44211363|NCT01738503|79008168|FG003|Treatment Period|Protocol Violation|0|||
44211364|NCT01738503|79008169|FG004|Treatment Period|Protocol Violation|4|||
44211365|NCT01738503|79008170|FG005|Treatment Period|Protocol Violation|2|||
44211366|NCT01738503|79008171|FG006|Treatment Period|Protocol Violation|0|||
44211367|NCT01738503|79008165|FG000|Treatment Period|Other|0|||
44211368|NCT01738503|79008166|FG001|Treatment Period|Other|0|||
44211369|NCT01738503|79008167|FG002|Treatment Period|Other|1|||
44211370|NCT01738503|79008168|FG003|Treatment Period|Other|0|||
44211371|NCT01738503|79008169|FG004|Treatment Period|Other|0|||
44211372|NCT01738503|79008170|FG005|Treatment Period|Other|0|||
44211373|NCT01738503|79008171|FG006|Treatment Period|Other|0|||
44211374|NCT01738503|79008165|FG000|PET Imaging Sub-study|Adverse Event|0|||
44211375|NCT01738503|79008166|FG001|PET Imaging Sub-study|Adverse Event|0|||
44211376|NCT01738503|79008167|FG002|PET Imaging Sub-study|Adverse Event|0|||
44370510|NCT01133522|79375738|FG000|Overall Study|Physician Decision|0|||
44370511|NCT01133522|79375739|FG001|Overall Study|Physician Decision|0|||
44370512|NCT01133522|79375740|FG002|Overall Study|Physician Decision|0|||
44370513|NCT01133522|79375741|FG003|Overall Study|Physician Decision|0|||
44370514|NCT01133522|79375742|FG004|Overall Study|Physician Decision|1|||
44370515|NCT01133522|79375743|FG005|Overall Study|Physician Decision|0|||
44370516|NCT01133522|79375744|FG006|Overall Study|Physician Decision|0|||
44452350|NCT00545714|79461252|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
44452351|NCT00545714|79461252|FG000|Induction Phase (6 Months)|Disease Progression|1|||
44452352|NCT00545714|79461252|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
44452353|NCT00545714|79461252|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
44543588|NCT02935842|79556656|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
44543589|NCT02935842|79556657|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
44211377|NCT01738503|79008168|FG003|PET Imaging Sub-study|Adverse Event|0|||
44211378|NCT01738503|79008169|FG004|PET Imaging Sub-study|Adverse Event|0|||
44370517|NCT01133522|79375745|FG007|Overall Study|Physician Decision|0|||
44370518|NCT01133522|79375746|FG008|Overall Study|Physician Decision|0|||
44370519|NCT01133522|79375747|FG009|Overall Study|Physician Decision|0|||
44370520|NCT01133288|79375776|FG000|Eligibility Assessment|met exclusion criteria|5|||
44370521|NCT01133288|79375776|FG000|Intervention Allocation|study terminated|2|||
44370522|NCT00883090|79375784|FG000|Overall Study|Sponsor's decision|1|||
44370523|NCT00883090|79375784|FG000|Overall Study|Withdrawal by Subject|1|||
44370524|NCT01132820|79375788|FG000|Overall Study|Ineligible: wrong cell type|1|||
44370525|NCT01132820|79375788|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
44370526|NCT01132820|79375788|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
44370527|NCT01132820|79375788|FG000|Overall Study|Never treated|1|||
44452354|NCT00545714|79461252|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
44452355|NCT00545714|79461252|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
44452356|NCT00545714|79461252|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
44452357|NCT00545714|79461252|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
44211379|NCT01738503|79008170|FG005|PET Imaging Sub-study|Adverse Event|1|||
44211380|NCT01738503|79008171|FG006|PET Imaging Sub-study|Adverse Event|0|||
44370528|NCT01132820|79375788|FG000|Overall Study|Inadequate data|1|||
44370529|NCT00885352|79375807|FG000|Overall Study|Adverse Event|2|||
44370530|NCT00885352|79375808|FG001|Overall Study|Adverse Event|3|||
44211381|NCT01738503|79008165|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
44211382|NCT01738503|79008166|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
44211383|NCT01738503|79008167|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
44211384|NCT01738503|79008168|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
44211385|NCT01738503|79008169|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
44211386|NCT01738503|79008170|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
44211387|NCT01738503|79008171|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
44211388|NCT01738191|79008195|FG000|Overall Study|Withdrawal by Subject|4|||
44211389|NCT01738191|79008196|FG001|Overall Study|Withdrawal by Subject|1|||
44211390|NCT01737879|79008202|FG000|Overall Study|Death|1|||
44370531|NCT00885352|79375807|FG000|Overall Study|Lost to Follow-up|2|||
44370532|NCT00885352|79375808|FG001|Overall Study|Lost to Follow-up|2|||
44370533|NCT00885352|79375807|FG000|Overall Study|Physician Decision|0|||
44370534|NCT00885352|79375808|FG001|Overall Study|Physician Decision|3|||
44211391|NCT01737879|79008202|FG000|Overall Study|Sponsor decision|40|||
44211392|NCT01879683|79008206|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
44211393|NCT01605825|79008212|FG000|Overall Study|Adverse Event|4|||
44211394|NCT01605825|79008213|FG001|Overall Study|Adverse Event|2|||
44211395|NCT01605825|79008212|FG000|Overall Study|Withdrawal by Subject|0|||
44211396|NCT01605825|79008213|FG001|Overall Study|Withdrawal by Subject|1|||
44211397|NCT01605825|79008212|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
44211398|NCT01605825|79008213|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
44211399|NCT01605825|79008212|FG000|Overall Study|Non-Compliance with Protocol|3|||
44211400|NCT01605825|79008213|FG001|Overall Study|Non-Compliance with Protocol|0|||
44211401|NCT01727505|79008219|FG000|First 24 Hours|Adverse Event|0|||
44211402|NCT01727505|79008220|FG001|First 24 Hours|Adverse Event|1|||
44211403|NCT01727505|79008219|FG000|Second 24 Hours|Missing data|0|||
44211404|NCT01727505|79008220|FG001|Second 24 Hours|Missing data|1|||
44211405|NCT01726803|79008228|FG000|Overall Study|Lost to Follow-up|6|||
44211406|NCT01726803|79008229|FG001|Overall Study|Lost to Follow-up|1|||
44211407|NCT01726803|79008228|FG000|Overall Study|Withdrawal by Subject|1|||
44211408|NCT01726803|79008229|FG001|Overall Study|Withdrawal by Subject|0|||
44211409|NCT01726335|79008235|FG000|Overall Study|Lost to Follow-up|2|||
44211410|NCT01726335|79008235|FG000|Overall Study|Withdrawal by Subject|15|||
44211411|NCT01726335|79008235|FG000|Overall Study|Adverse Event|4|||
44211412|NCT01726335|79008235|FG000|Overall Study|Lost to Follow-up|2|||
44211413|NCT01726335|79008235|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
44211414|NCT01877421|79008271|FG000|Phase 2|Lost to Follow-up|0|||
44211415|NCT01877421|79008272|FG001|Phase 2|Lost to Follow-up|0|||
44211416|NCT01877421|79008273|FG002|Phase 2|Lost to Follow-up|0|||
44211417|NCT01877421|79008274|FG003|Phase 2|Lost to Follow-up|0|||
44211418|NCT01877421|79008275|FG004|Phase 2|Lost to Follow-up|0|||
44211419|NCT01877421|79008276|FG005|Phase 2|Lost to Follow-up|0|||
44211420|NCT01877421|79008277|FG006|Phase 2|Lost to Follow-up|1|||
44211421|NCT01877421|79008278|FG007|Phase 2|Lost to Follow-up|0|||
44211422|NCT01877421|79008279|FG008|Phase 2|Lost to Follow-up|0|||
44211423|NCT01877421|79008280|FG009|Phase 2|Lost to Follow-up|0|||
44211424|NCT01877421|79008281|FG010|Phase 2|Lost to Follow-up|0|||
44211425|NCT01877421|79008282|FG011|Phase 2|Lost to Follow-up|0|||
44211426|NCT01877421|79008283|FG012|Phase 2|Lost to Follow-up|0|||
44211427|NCT01877421|79008284|FG013|Phase 2|Lost to Follow-up|0|||
44211428|NCT01877421|79008285|FG014|Phase 2|Lost to Follow-up|0|||
44211429|NCT01877421|79008286|FG015|Phase 2|Lost to Follow-up|0|||
44211430|NCT01877421|79008287|FG016|Phase 2|Lost to Follow-up|0|||
44211431|NCT01877421|79008288|FG017|Phase 2|Lost to Follow-up|0|||
44211432|NCT01877421|79008271|FG000|Phase 2|Withdrawal by Subject|0|||
44211433|NCT01877421|79008272|FG001|Phase 2|Withdrawal by Subject|0|||
44211434|NCT01877421|79008273|FG002|Phase 2|Withdrawal by Subject|0|||
44211435|NCT01877421|79008274|FG003|Phase 2|Withdrawal by Subject|0|||
44211436|NCT01877421|79008275|FG004|Phase 2|Withdrawal by Subject|0|||
44211437|NCT01877421|79008276|FG005|Phase 2|Withdrawal by Subject|0|||
44211438|NCT01877421|79008277|FG006|Phase 2|Withdrawal by Subject|0|||
44211439|NCT01877421|79008278|FG007|Phase 2|Withdrawal by Subject|0|||
44211440|NCT01877421|79008279|FG008|Phase 2|Withdrawal by Subject|1|||
44211441|NCT01877421|79008280|FG009|Phase 2|Withdrawal by Subject|0|||
44211442|NCT01877421|79008281|FG010|Phase 2|Withdrawal by Subject|1|||
44211443|NCT01877421|79008282|FG011|Phase 2|Withdrawal by Subject|0|||
44211444|NCT01877421|79008283|FG012|Phase 2|Withdrawal by Subject|1|||
44211445|NCT01877421|79008284|FG013|Phase 2|Withdrawal by Subject|0|||
44211446|NCT01877421|79008285|FG014|Phase 2|Withdrawal by Subject|0|||
44211447|NCT01877421|79008286|FG015|Phase 2|Withdrawal by Subject|1|||
44211448|NCT01877421|79008287|FG016|Phase 2|Withdrawal by Subject|0|||
44211449|NCT01877421|79008288|FG017|Phase 2|Withdrawal by Subject|0|||
44211450|NCT01877421|79008271|FG000|Phase 2|Protocol Violation|0|||
44211451|NCT01877421|79008272|FG001|Phase 2|Protocol Violation|0|||
44370535|NCT00885352|79375807|FG000|Overall Study|Protocol Violation|0|||
44370536|NCT00885352|79375808|FG001|Overall Study|Protocol Violation|2|||
44211452|NCT01877421|79008273|FG002|Phase 2|Protocol Violation|0|||
44370537|NCT00885352|79375807|FG000|Overall Study|Withdrawal by Subject|1|||
44452358|NCT00545714|79461252|FG000|Maintenance Phase (36 Months)|Death|2|||
44452359|NCT00539838|79461259|FG000|Overall Study|Fail to return|2|||
44452360|NCT00539838|79461260|FG001|Overall Study|Fail to return|0|||
44452361|NCT00539838|79461261|FG002|Overall Study|Fail to return|0|||
44452362|NCT00539838|79461259|FG000|Overall Study|Withdrawal by Subject|0|||
44452363|NCT00539838|79461260|FG001|Overall Study|Withdrawal by Subject|4|||
44452364|NCT00539838|79461261|FG002|Overall Study|Withdrawal by Subject|0|||
44452365|NCT00539838|79461259|FG000|Overall Study|Death|0|||
44452366|NCT00539838|79461260|FG001|Overall Study|Death|2|||
44452367|NCT00539838|79461261|FG002|Overall Study|Death|0|||
44543590|NCT02935842|79556658|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
44543591|NCT02935842|79556659|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
44543592|NCT02935842|79556656|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
44543593|NCT02935842|79556657|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
44543594|NCT02935842|79556658|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
44543595|NCT02935842|79556659|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
44543596|NCT03680911|79556678|FG000|At Home Treatment|Study Termination|3|||
44211453|NCT01877421|79008274|FG003|Phase 2|Protocol Violation|0|||
44211454|NCT01877421|79008275|FG004|Phase 2|Protocol Violation|0|||
44211455|NCT01877421|79008276|FG005|Phase 2|Protocol Violation|0|||
44211456|NCT01877421|79008277|FG006|Phase 2|Protocol Violation|0|||
44211457|NCT01877421|79008278|FG007|Phase 2|Protocol Violation|0|||
44211458|NCT01877421|79008279|FG008|Phase 2|Protocol Violation|0|||
44211459|NCT01877421|79008280|FG009|Phase 2|Protocol Violation|0|||
44211460|NCT01877421|79008281|FG010|Phase 2|Protocol Violation|1|||
44211461|NCT01877421|79008282|FG011|Phase 2|Protocol Violation|0|||
44211462|NCT01877421|79008283|FG012|Phase 2|Protocol Violation|0|||
44211463|NCT01877421|79008284|FG013|Phase 2|Protocol Violation|0|||
44211464|NCT01877421|79008285|FG014|Phase 2|Protocol Violation|0|||
44211465|NCT01877421|79008286|FG015|Phase 2|Protocol Violation|0|||
44211466|NCT01877421|79008287|FG016|Phase 2|Protocol Violation|0|||
44211467|NCT01877421|79008288|FG017|Phase 2|Protocol Violation|0|||
44211468|NCT01726023|79008370|FG000|Overall Study|Death|1|||
44211469|NCT01726023|79008371|FG001|Overall Study|Death|1|||
44211470|NCT01726023|79008370|FG000|Overall Study|Lost to Follow-up|5|||
44211471|NCT01726023|79008371|FG001|Overall Study|Lost to Follow-up|10|||
44211472|NCT01726023|79008370|FG000|Overall Study|Other Eligibility criteria|7|||
44211473|NCT01726023|79008371|FG001|Overall Study|Other Eligibility criteria|7|||
44211474|NCT01726023|79008370|FG000|Overall Study|Withdrawal by Subject|16|||
44211475|NCT01726023|79008371|FG001|Overall Study|Withdrawal by Subject|8|||
44211476|NCT01877265|79008384|FG000|Treatment Period 1|Sponsor Decision|0|||
44211477|NCT01877265|79008385|FG001|Treatment Period 1|Sponsor Decision|0|||
44211478|NCT01877265|79008386|FG002|Treatment Period 1|Sponsor Decision|1|||
44211479|NCT01877265|79008387|FG003|Treatment Period 1|Sponsor Decision|0|||
44211480|NCT01877265|79008388|FG004|Treatment Period 1|Sponsor Decision|0|||
44211481|NCT01877265|79008389|FG005|Treatment Period 1|Sponsor Decision|0|||
44211482|NCT01877265|79008384|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
44211483|NCT01877265|79008385|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
44211484|NCT01877265|79008386|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
44370538|NCT00885352|79375808|FG001|Overall Study|Withdrawal by Subject|5|||
44370539|NCT00885352|79375807|FG000|Overall Study|Contradiction to study medication|0|||
44370540|NCT00885352|79375808|FG001|Overall Study|Contradiction to study medication|2|||
44370541|NCT00885352|79375807|FG000|Overall Study|Excluded medication|2|||
44370542|NCT00885352|79375808|FG001|Overall Study|Excluded medication|2|||
44370543|NCT00885352|79375807|FG000|Overall Study|Lab abnormalities|1|||
44370544|NCT00885352|79375808|FG001|Overall Study|Lab abnormalities|1|||
44370545|NCT00885118|79375819|FG000|Overall Study|Adverse Event|1|||
44370546|NCT00885118|79375820|FG001|Overall Study|Adverse Event|0|||
44370547|NCT00885118|79375821|FG002|Overall Study|Adverse Event|0|||
44370548|NCT00885118|79375822|FG003|Overall Study|Adverse Event|0|||
44370549|NCT00885118|79375823|FG004|Overall Study|Adverse Event|0|||
44370550|NCT00885118|79375819|FG000|Overall Study|Withdrawal by Subject|0|||
44370551|NCT00885118|79375820|FG001|Overall Study|Withdrawal by Subject|0|||
44370552|NCT00885118|79375821|FG002|Overall Study|Withdrawal by Subject|0|||
44452368|NCT00539838|79461259|FG000|Overall Study|Did not cooperate|1|||
44452369|NCT00539838|79461260|FG001|Overall Study|Did not cooperate|0|||
44452370|NCT00539838|79461261|FG002|Overall Study|Did not cooperate|1|||
44543597|NCT03680911|79556679|FG001|At Home Treatment|Study Termination|0|||
44543598|NCT03680911|79556678|FG000|At Home Treatment|Lost to Follow-up|0|||
44211485|NCT01877265|79008387|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
44211486|NCT01877265|79008388|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
44211487|NCT01877265|79008389|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
44211488|NCT01877265|79008384|FG000|Treatment Period 3|Lost to Follow-up|1|||
44211489|NCT01877265|79008385|FG001|Treatment Period 3|Lost to Follow-up|0|||
44211490|NCT01877265|79008386|FG002|Treatment Period 3|Lost to Follow-up|0|||
44211491|NCT01877265|79008387|FG003|Treatment Period 3|Lost to Follow-up|0|||
44211492|NCT01877265|79008388|FG004|Treatment Period 3|Lost to Follow-up|0|||
44211493|NCT01877265|79008389|FG005|Treatment Period 3|Lost to Follow-up|0|||
44211494|NCT01877187|79008400|FG000|Overall Study|Death|2|||
44211495|NCT01877187|79008400|FG000|Overall Study|Withdrawal by Subject|4|||
44211496|NCT01877187|79008400|FG000|Overall Study|Lost to Follow-up|3|||
44211497|NCT01877187|79008400|FG000|Overall Study|Declining clinical status|11|||
44211498|NCT01877187|79008400|FG000|Overall Study|Liver transplant|2|||
44211499|NCT01858532|79008411|FG000|Overall Study|Adverse Event|58|||
44211500|NCT01858532|79008412|FG001|Overall Study|Adverse Event|50|||
44211501|NCT01858532|79008413|FG002|Overall Study|Adverse Event|23|||
44211502|NCT01858532|79008414|FG003|Overall Study|Adverse Event|28|||
44211503|NCT01858532|79008411|FG000|Overall Study|Withdrew consent|71|||
44211504|NCT01858532|79008412|FG001|Overall Study|Withdrew consent|93|||
44211505|NCT01858532|79008413|FG002|Overall Study|Withdrew consent|46|||
44211506|NCT01858532|79008414|FG003|Overall Study|Withdrew consent|27|||
44211507|NCT01858532|79008411|FG000|Overall Study|Lost to Follow-up|17|||
44211508|NCT01858532|79008412|FG001|Overall Study|Lost to Follow-up|26|||
44211509|NCT01858532|79008413|FG002|Overall Study|Lost to Follow-up|11|||
44211510|NCT01858532|79008414|FG003|Overall Study|Lost to Follow-up|14|||
44211511|NCT01858532|79008411|FG000|Overall Study|Deterioration of medical status|3|||
44211512|NCT01858532|79008412|FG001|Overall Study|Deterioration of medical status|4|||
44211513|NCT01858532|79008413|FG002|Overall Study|Deterioration of medical status|3|||
44211514|NCT01858532|79008414|FG003|Overall Study|Deterioration of medical status|7|||
44211515|NCT01858532|79008411|FG000|Overall Study|Investigator request|3|||
44211516|NCT01858532|79008412|FG001|Overall Study|Investigator request|4|||
44211517|NCT01858532|79008413|FG002|Overall Study|Investigator request|2|||
44211518|NCT01858532|79008414|FG003|Overall Study|Investigator request|6|||
44211519|NCT01858532|79008411|FG000|Overall Study|Other, not specified|29|||
44211520|NCT01858532|79008412|FG001|Overall Study|Other, not specified|15|||
44211521|NCT01858532|79008413|FG002|Overall Study|Other, not specified|13|||
44211522|NCT01858532|79008414|FG003|Overall Study|Other, not specified|11|||
44211523|NCT01883492|79008426|FG000|Overall Study|Lost to Follow-up|3|||
44211524|NCT01883492|79008427|FG001|Overall Study|Lost to Follow-up|4|||
44211525|NCT01883492|79008426|FG000|Overall Study|Surgery on contra-lateral hip|0|||
44211526|NCT01883492|79008427|FG001|Overall Study|Surgery on contra-lateral hip|1|||
44211527|NCT01883492|79008426|FG000|Overall Study|Poor X-ray quality|7|||
44211528|NCT01883492|79008427|FG001|Overall Study|Poor X-ray quality|4|||
44211529|NCT01883492|79008426|FG000|Overall Study|Withdrawal by Subject|1|||
44211530|NCT01883492|79008427|FG001|Overall Study|Withdrawal by Subject|0|||
44211531|NCT01883492|79008426|FG000|Overall Study|inappropriate implant used|1|||
44211532|NCT01883492|79008427|FG001|Overall Study|inappropriate implant used|1|||
44211533|NCT01883492|79008426|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
44211534|NCT01883492|79008427|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
44211535|NCT01832480|79008435|FG000|Overall Study|Lost to Follow-up|33|||
44211536|NCT01832480|79008436|FG001|Overall Study|Lost to Follow-up|30|||
44211537|NCT01832480|79008435|FG000|Overall Study|Withdrawal by Subject|0|||
44211538|NCT01832480|79008436|FG001|Overall Study|Withdrawal by Subject|2|||
44211539|NCT01832480|79008435|FG000|Overall Study|post randomization ineligible|8|||
44211540|NCT01832480|79008436|FG001|Overall Study|post randomization ineligible|10|||
44211541|NCT01858376|79008442|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
44211542|NCT01831856|79008448|FG000|Overall Study|Adverse Event|5|||
44211543|NCT01831856|79008449|FG001|Overall Study|Adverse Event|8|||
44211544|NCT01831856|79008448|FG000|Overall Study|Lack of Efficacy|13|||
44211545|NCT01831856|79008449|FG001|Overall Study|Lack of Efficacy|11|||
44211546|NCT01831856|79008448|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
44211547|NCT01831856|79008449|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
44211548|NCT01831544|79008455|FG000|Overall Study|Death|1|||
44211549|NCT01831544|79008455|FG000|Overall Study|Still on original MVAD device|2|||
44211550|NCT01857206|79008461|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
44211551|NCT01857206|79008462|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
44211552|NCT01857206|79008461|FG000|Overall Study|Lost to Follow-up|9|||
44211553|NCT01857206|79008462|FG001|Overall Study|Lost to Follow-up|6|||
44211554|NCT01857206|79008461|FG000|Overall Study|Unclassified|3|||
44211555|NCT01857206|79008462|FG001|Overall Study|Unclassified|3|||
44211556|NCT01857206|79008461|FG000|Overall Study|Withdrawal by Subject|1|||
44211557|NCT01857206|79008462|FG001|Overall Study|Withdrawal by Subject|0|||
44452371|NCT00539838|79461259|FG000|Overall Study|Administrative|4|||
44211558|NCT01882088|79008472|FG000|Overall Study|Intolerance of esophageal manometry|1|||
44211559|NCT01882088|79008472|FG000|Overall Study|no possibility to place the catheter|1|||
44211560|NCT01882088|79008472|FG000|Overall Study|Protocol Violation|1|||
44211561|NCT01882088|79008472|FG000|Overall Study|inadequate pH-impedance tracings|2|||
44211562|NCT01881776|79008479|FG000|Overall Study|Lost to Follow-up|1|||
44452372|NCT00539838|79461260|FG001|Overall Study|Administrative|0|||
44452373|NCT00539838|79461261|FG002|Overall Study|Administrative|8|||
44452374|NCT00679289|79461274|FG000|Overall Study|Progressive disease|4|||
44452375|NCT00679289|79461275|FG001|Overall Study|Progressive disease|5|||
44452376|NCT00679289|79461276|FG002|Overall Study|Progressive disease|18|||
44452377|NCT00679289|79461274|FG000|Overall Study|Withdrawal by Subject|0|||
44452378|NCT00679289|79461275|FG001|Overall Study|Withdrawal by Subject|1|||
44452379|NCT00679289|79461276|FG002|Overall Study|Withdrawal by Subject|1|||
44452380|NCT00679289|79461274|FG000|Overall Study|Adverse Event|0|||
44452381|NCT00679289|79461275|FG001|Overall Study|Adverse Event|0|||
44452382|NCT00679289|79461276|FG002|Overall Study|Adverse Event|3|||
44452383|NCT00679289|79461274|FG000|Overall Study|Physician Decision|1|||
44452384|NCT00679289|79461275|FG001|Overall Study|Physician Decision|0|||
44452385|NCT00679289|79461276|FG002|Overall Study|Physician Decision|1|||
44452386|NCT00679211|79461286|FG000|Overall Study|Progressive disease|82|||
44452387|NCT00679211|79461286|FG000|Overall Study|Adverse Event|7|||
44452388|NCT00679211|79461286|FG000|Overall Study|Withdrawal by Subject|2|||
44452389|NCT00679211|79461286|FG000|Overall Study|Physician Decision|5|||
44452390|NCT00679211|79461286|FG000|Overall Study|Refused to undergo protocol procedures|1|||
44452391|NCT00679211|79461286|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
44211563|NCT01881776|79008480|FG001|Overall Study|Lost to Follow-up|2|||
44211564|NCT01881776|79008481|FG002|Overall Study|Lost to Follow-up|1|||
44211565|NCT01881776|79008479|FG000|Overall Study|Protocol Violation|0|||
44211566|NCT01881776|79008480|FG001|Overall Study|Protocol Violation|2|||
44211567|NCT01881776|79008481|FG002|Overall Study|Protocol Violation|1|||
44211568|NCT01708161|79008495|FG000|Overall Study|Adverse Event|1|||
44211569|NCT01708161|79008496|FG001|Overall Study|Adverse Event|3|||
44211570|NCT01708161|79008497|FG002|Overall Study|Adverse Event|4|||
44211571|NCT01708161|79008498|FG003|Overall Study|Adverse Event|2|||
44211572|NCT01708161|79008499|FG004|Overall Study|Adverse Event|3|||
44211573|NCT01708161|79008500|FG005|Overall Study|Adverse Event|0|||
44211574|NCT01708161|79008495|FG000|Overall Study|Death|0|||
44211575|NCT01708161|79008496|FG001|Overall Study|Death|0|||
44211576|NCT01708161|79008497|FG002|Overall Study|Death|0|||
44211577|NCT01708161|79008498|FG003|Overall Study|Death|1|||
44211578|NCT01708161|79008499|FG004|Overall Study|Death|0|||
44211579|NCT01708161|79008500|FG005|Overall Study|Death|1|||
44211580|NCT01708161|79008495|FG000|Overall Study|Withdrawal by Subject|0|||
44211581|NCT01708161|79008496|FG001|Overall Study|Withdrawal by Subject|1|||
44211582|NCT01708161|79008497|FG002|Overall Study|Withdrawal by Subject|1|||
44211583|NCT01708161|79008498|FG003|Overall Study|Withdrawal by Subject|0|||
44211584|NCT01708161|79008499|FG004|Overall Study|Withdrawal by Subject|0|||
44211585|NCT01708161|79008500|FG005|Overall Study|Withdrawal by Subject|0|||
44211586|NCT01708161|79008495|FG000|Overall Study|Administrative problems|0|||
44211587|NCT01708161|79008496|FG001|Overall Study|Administrative problems|1|||
44211588|NCT01708161|79008497|FG002|Overall Study|Administrative problems|0|||
44211589|NCT01708161|79008498|FG003|Overall Study|Administrative problems|0|||
44211590|NCT01708161|79008499|FG004|Overall Study|Administrative problems|0|||
44211591|NCT01708161|79008500|FG005|Overall Study|Administrative problems|0|||
44211592|NCT01708161|79008495|FG000|Overall Study|Disease progression|3|||
44211593|NCT01708161|79008496|FG001|Overall Study|Disease progression|5|||
44211594|NCT01708161|79008497|FG002|Overall Study|Disease progression|5|||
44211595|NCT01708161|79008498|FG003|Overall Study|Disease progression|13|||
44211596|NCT01708161|79008499|FG004|Overall Study|Disease progression|3|||
44211597|NCT01708161|79008500|FG005|Overall Study|Disease progression|0|||
44211598|NCT01707693|79008516|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
44211599|NCT01707693|79008517|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
44211600|NCT01707693|79008516|FG000|Overall Study Allocation|Protocol Violation|4|||
44211601|NCT01707693|79008517|FG001|Overall Study Allocation|Protocol Violation|3|||
44211602|NCT01707693|79008516|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
44211603|NCT01707693|79008517|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
44211604|NCT01707693|79008516|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
44211605|NCT01707693|79008517|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
44269819|NCT00552344|79194953|FG000|Overall Study|Withdrawal by Subject|48|||
44269820|NCT00552344|79194953|FG000|Overall Study|SAE, non-fatal|6|||
44452392|NCT00679211|79461286|FG000|Overall Study|Other|1|||
44543599|NCT03680911|79556679|FG001|At Home Treatment|Lost to Follow-up|1|||
44543600|NCT03680911|79556678|FG000|At Home Treatment|Withdrawal by Subject|0|||
44211606|NCT01722669|79008530|FG000|Overall Study|Withdrawal by Subject|0|||
44211607|NCT01722669|79008531|FG001|Overall Study|Withdrawal by Subject|0|||
44211608|NCT01722669|79008532|FG002|Overall Study|Withdrawal by Subject|0|||
44211609|NCT01722669|79008533|FG003|Overall Study|Withdrawal by Subject|0|||
44452393|NCT00545948|79461295|FG000|Overall Study|Not Treated|1|||
44452394|NCT00545948|79461296|FG001|Overall Study|Not Treated|1|||
44452395|NCT00545948|79461297|FG002|Overall Study|Not Treated|7|||
44211610|NCT01722669|79008534|FG004|Overall Study|Withdrawal by Subject|0|||
44269821|NCT00552344|79194953|FG000|Overall Study|AE, non-serious non-fatal|38|||
44543601|NCT03680911|79556679|FG001|At Home Treatment|Withdrawal by Subject|2|||
44543602|NCT03680911|79556678|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
44543603|NCT03680911|79556679|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
44543604|NCT03224130|79556687|FG000|Overall Study|consent issue|0|||
44543605|NCT03224130|79556688|FG001|Overall Study|consent issue|1|||
44543606|NCT03679741|79556694|FG000|Period 1|No longer meet eligibility criteria|1|||
44543607|NCT03679741|79556695|FG001|Period 1|No longer meet eligibility criteria|0|||
44543608|NCT03679741|79556694|FG000|Period 1|Lost to Follow-up|0|||
44543609|NCT03679741|79556695|FG001|Period 1|Lost to Follow-up|1|||
44543610|NCT03679741|79556694|FG000|Period 1|Adverse Event|1|||
44543611|NCT03679741|79556695|FG001|Period 1|Adverse Event|1|||
44543612|NCT03679741|79556694|FG000|Period 1|Withdrawal by Subject|0|||
44211611|NCT01722669|79008535|FG005|Overall Study|Withdrawal by Subject|2|||
44211612|NCT01707147|79008555|FG000|Overall Study|Administered Trajenta prior to contract|5|||
44211613|NCT01707147|79008555|FG000|Overall Study|Patients who have not taken Trajenta|1|||
44211614|NCT01707147|79008555|FG000|Overall Study|Follow-up failure|17|||
44211615|NCT01707147|79008555|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
44211616|NCT01876251|79008562|FG000|Overall Study|Clinical progression|1|||
44211617|NCT01876251|79008563|FG001|Overall Study|Clinical progression|0|||
44211618|NCT01876251|79008564|FG002|Overall Study|Clinical progression|0|||
44211619|NCT01876251|79008562|FG000|Overall Study|Death|2|||
44211620|NCT01876251|79008563|FG001|Overall Study|Death|0|||
44211621|NCT01876251|79008564|FG002|Overall Study|Death|1|||
44211622|NCT01876251|79008562|FG000|Overall Study|Participant started new treatment|1|||
44211623|NCT01876251|79008563|FG001|Overall Study|Participant started new treatment|0|||
44211624|NCT01876251|79008564|FG002|Overall Study|Participant started new treatment|1|||
44211625|NCT01876251|79008562|FG000|Overall Study|Participant refused further follow-up|0|||
44211626|NCT01876251|79008563|FG001|Overall Study|Participant refused further follow-up|0|||
44211627|NCT01876251|79008564|FG002|Overall Study|Participant refused further follow-up|1|||
44211628|NCT01876251|79008562|FG000|Overall Study|Study terminated|1|||
44211629|NCT01876251|79008563|FG001|Overall Study|Study terminated|0|||
44211630|NCT01876251|79008564|FG002|Overall Study|Study terminated|0|||
44211631|NCT01876251|79008562|FG000|Overall Study|Objective progression or relapse|10|||
44211632|NCT01876251|79008563|FG001|Overall Study|Objective progression or relapse|3|||
44211633|NCT01876251|79008564|FG002|Overall Study|Objective progression or relapse|8|||
44211634|NCT01875471|79008575|FG000|Overall Study|Adverse Event|0|||
44211635|NCT01875471|79008576|FG001|Overall Study|Adverse Event|1|||
44211636|NCT01875471|79008575|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
44211637|NCT01875471|79008576|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
44211638|NCT01875237|79008584|FG000|Overall Study|GVDH before DLI|1|||
44211639|NCT01875237|79008585|FG001|Overall Study|GVDH before DLI|0|||
44211640|NCT01875237|79008584|FG000|Overall Study|DLI cells could not be produced|1|||
44211641|NCT01875237|79008585|FG001|Overall Study|DLI cells could not be produced|0|||
44211642|NCT01874535|79008595|FG000|Overall Study|Lost to Follow-up|10|||
44211643|NCT01874535|79008596|FG001|Overall Study|Lost to Follow-up|9|||
44211644|NCT01874535|79008595|FG000|Overall Study|incomplete symptom resolution|45|||
44211645|NCT01874535|79008596|FG001|Overall Study|incomplete symptom resolution|35|||
44211646|NCT01722045|79008602|FG000|Overall Study|Adverse Event|8|||
44211647|NCT01722045|79008602|FG000|Overall Study|Death|3|||
44211648|NCT01722045|79008602|FG000|Overall Study|Withdrawal by Subject|8|||
44211649|NCT01722045|79008602|FG000|Overall Study|Lost to Follow-up|4|||
44452396|NCT00679055|79461308|FG000|Overall Study|Adverse Event|0|||
44452397|NCT00679055|79461309|FG001|Overall Study|Adverse Event|1|||
44452398|NCT00679055|79461308|FG000|Overall Study|Other|0|||
44452399|NCT00679055|79461309|FG001|Overall Study|Other|3|||
44452400|NCT00679055|79461308|FG000|Overall Study|Study Terminated|2|||
44452401|NCT00679055|79461309|FG001|Overall Study|Study Terminated|1|||
44452402|NCT03927950|79461315|FG000|Overall Study|Adverse Event|9|||
44452403|NCT00678899|79461320|FG000|Overall Study|Adverse Event|1|||
44452404|NCT00678587|79461327|FG000|Overall Study|Adverse Event|3|||
44452405|NCT00678587|79461328|FG001|Overall Study|Adverse Event|3|||
44452406|NCT00678587|79461327|FG000|Overall Study|Lack of Efficacy|1|||
44452407|NCT00678587|79461328|FG001|Overall Study|Lack of Efficacy|0|||
44452408|NCT00678587|79461327|FG000|Overall Study|Protocol Violation|2|||
44452409|NCT00678587|79461328|FG001|Overall Study|Protocol Violation|1|||
44543613|NCT03679741|79556695|FG001|Period 1|Withdrawal by Subject|1|||
44211650|NCT01722045|79008602|FG000|Overall Study|Protocol Deviation|1|||
44211651|NCT01722045|79008602|FG000|Overall Study|Physician Decision|3|||
44211652|NCT01722045|79008602|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
44211653|NCT01721109|79008606|FG000|Overall Study|Lack of Efficacy|1|||
44211654|NCT01721109|79008606|FG000|Overall Study|Non- Compliance with Study Drug|3|||
44211655|NCT01721109|79008606|FG000|Overall Study|Withdrew Consent|1|||
44211656|NCT01721109|79008606|FG000|Overall Study|Lost to Follow-up|2|||
44211657|NCT01874145|79008612|FG000|Core Period|Non-compliance|1|||
44211658|NCT01874145|79008613|FG001|Core Period|Non-compliance|0|||
44211659|NCT01874145|79008612|FG000|Core Period|Protocol Violation|1|||
44211660|NCT01874145|79008613|FG001|Core Period|Protocol Violation|1|||
44211661|NCT01874145|79008612|FG000|Core Period|Physician Decision|1|||
44211662|NCT01874145|79008613|FG001|Core Period|Physician Decision|1|||
44211663|NCT01874145|79008612|FG000|Core Period|Adverse Event|0|||
44211664|NCT01874145|79008613|FG001|Core Period|Adverse Event|1|||
44211665|NCT01874145|79008612|FG000|Core Period|Withdrawal by Subject|0|||
44211666|NCT01874145|79008613|FG001|Core Period|Withdrawal by Subject|4|||
44211667|NCT01874145|79008612|FG000|Extension Period|Adverse Event|3|||
44211668|NCT01874145|79008613|FG001|Extension Period|Adverse Event|2|||
44211669|NCT01874145|79008612|FG000|Extension Period|Withdrawal by Subject|2|||
44211670|NCT01874145|79008613|FG001|Extension Period|Withdrawal by Subject|1|||
44211671|NCT01874145|79008612|FG000|Extension Period|Lost to Follow-up|1|||
44211672|NCT01874145|79008613|FG001|Extension Period|Lost to Follow-up|1|||
44211673|NCT01720797|79008625|FG000|Overall Study|Withdrawal by Subject|3|||
44211674|NCT01720797|79008626|FG001|Overall Study|Withdrawal by Subject|0|||
44211675|NCT01831466|79008644|FG000|Overall Study|Protocol Violation|1|||
44211676|NCT01831466|79008645|FG001|Overall Study|Protocol Violation|1|||
44211677|NCT01831466|79008646|FG002|Overall Study|Protocol Violation|2|||
44211678|NCT01831466|79008647|FG003|Overall Study|Protocol Violation|0|||
44211679|NCT01831466|79008648|FG004|Overall Study|Protocol Violation|0|||
44211680|NCT01831466|79008649|FG005|Overall Study|Protocol Violation|1|||
44211681|NCT01831466|79008650|FG006|Overall Study|Protocol Violation|0|||
44211682|NCT01831466|79008651|FG007|Overall Study|Protocol Violation|0|||
44211683|NCT01831466|79008652|FG008|Overall Study|Protocol Violation|0|||
44211684|NCT01831466|79008653|FG009|Overall Study|Protocol Violation|0|||
44211685|NCT01831466|79008654|FG010|Overall Study|Protocol Violation|0|||
44211686|NCT01831466|79008655|FG011|Overall Study|Protocol Violation|0|||
44211687|NCT01831466|79008644|FG000|Overall Study|Other|2|||
44211688|NCT01831466|79008645|FG001|Overall Study|Other|3|||
44211689|NCT01831466|79008646|FG002|Overall Study|Other|2|||
44211690|NCT01831466|79008647|FG003|Overall Study|Other|2|||
44211691|NCT01831466|79008648|FG004|Overall Study|Other|2|||
44211692|NCT01831466|79008649|FG005|Overall Study|Other|1|||
44211693|NCT01831466|79008650|FG006|Overall Study|Other|0|||
44211694|NCT01831466|79008651|FG007|Overall Study|Other|0|||
44211695|NCT01831466|79008652|FG008|Overall Study|Other|0|||
44211696|NCT01831466|79008653|FG009|Overall Study|Other|0|||
44211697|NCT01831466|79008654|FG010|Overall Study|Other|0|||
44211698|NCT01831466|79008655|FG011|Overall Study|Other|0|||
44211699|NCT01831466|79008644|FG000|Overall Study|Non-compliance with study treatment|2|||
44211700|NCT01831466|79008645|FG001|Overall Study|Non-compliance with study treatment|1|||
44452410|NCT00678587|79461327|FG000|Overall Study|Study Closed/Terminated|1|||
44452411|NCT00678587|79461328|FG001|Overall Study|Study Closed/Terminated|0|||
44452412|NCT00678587|79461327|FG000|Overall Study|Lost to Follow-up|3|||
44211701|NCT01831466|79008646|FG002|Overall Study|Non-compliance with study treatment|1|||
44211702|NCT01831466|79008647|FG003|Overall Study|Non-compliance with study treatment|0|||
44211703|NCT01831466|79008648|FG004|Overall Study|Non-compliance with study treatment|0|||
44211704|NCT01831466|79008649|FG005|Overall Study|Non-compliance with study treatment|1|||
44211705|NCT01831466|79008650|FG006|Overall Study|Non-compliance with study treatment|0|||
44211706|NCT01831466|79008651|FG007|Overall Study|Non-compliance with study treatment|0|||
44211707|NCT01831466|79008652|FG008|Overall Study|Non-compliance with study treatment|0|||
44370553|NCT00885118|79375822|FG003|Overall Study|Withdrawal by Subject|0|||
44370554|NCT00885118|79375823|FG004|Overall Study|Withdrawal by Subject|1|||
44370555|NCT00885118|79375819|FG000|Overall Study|Other reason not defined above|0|||
44370556|NCT00885118|79375820|FG001|Overall Study|Other reason not defined above|0|||
44370557|NCT00885118|79375821|FG002|Overall Study|Other reason not defined above|1|||
44370558|NCT00885118|79375822|FG003|Overall Study|Other reason not defined above|0|||
44370559|NCT00885118|79375823|FG004|Overall Study|Other reason not defined above|0|||
44370560|NCT00880906|79375841|FG000|Overall Study|Lost to Follow-up|0|||
44370561|NCT00880906|79375842|FG001|Overall Study|Lost to Follow-up|1|||
44211708|NCT01831466|79008653|FG009|Overall Study|Non-compliance with study treatment|0|||
44211709|NCT01831466|79008654|FG010|Overall Study|Non-compliance with study treatment|0|||
44370562|NCT00880906|79375841|FG000|Overall Study|Did not meet criteria following patholog|12|||
44211710|NCT01831466|79008655|FG011|Overall Study|Non-compliance with study treatment|0|||
44211711|NCT01831466|79008644|FG000|Overall Study|Death|0|||
44211712|NCT01831466|79008645|FG001|Overall Study|Death|1|||
44211713|NCT01831466|79008646|FG002|Overall Study|Death|0|||
44211714|NCT01831466|79008647|FG003|Overall Study|Death|0|||
44211715|NCT01831466|79008648|FG004|Overall Study|Death|0|||
44211716|NCT01831466|79008649|FG005|Overall Study|Death|0|||
44211717|NCT01831466|79008650|FG006|Overall Study|Death|0|||
44211718|NCT01831466|79008651|FG007|Overall Study|Death|0|||
44211719|NCT01831466|79008652|FG008|Overall Study|Death|0|||
44211720|NCT01831466|79008653|FG009|Overall Study|Death|0|||
44211721|NCT01831466|79008654|FG010|Overall Study|Death|0|||
44211722|NCT01831466|79008655|FG011|Overall Study|Death|0|||
44211723|NCT01831466|79008644|FG000|Overall Study|Withdrawal by Subject|6|||
44211724|NCT01831466|79008645|FG001|Overall Study|Withdrawal by Subject|3|||
44211725|NCT01831466|79008646|FG002|Overall Study|Withdrawal by Subject|3|||
44211726|NCT01831466|79008647|FG003|Overall Study|Withdrawal by Subject|3|||
44211727|NCT01831466|79008648|FG004|Overall Study|Withdrawal by Subject|3|||
44211728|NCT01831466|79008649|FG005|Overall Study|Withdrawal by Subject|5|||
44211729|NCT01831466|79008650|FG006|Overall Study|Withdrawal by Subject|0|||
44211730|NCT01831466|79008651|FG007|Overall Study|Withdrawal by Subject|0|||
44211731|NCT01831466|79008652|FG008|Overall Study|Withdrawal by Subject|0|||
44211732|NCT01831466|79008653|FG009|Overall Study|Withdrawal by Subject|1|||
44211733|NCT01831466|79008654|FG010|Overall Study|Withdrawal by Subject|0|||
44211734|NCT01831466|79008655|FG011|Overall Study|Withdrawal by Subject|1|||
44211735|NCT01831466|79008644|FG000|Overall Study|Lost to Follow-up|0|||
44211736|NCT01831466|79008645|FG001|Overall Study|Lost to Follow-up|1|||
44211737|NCT01831466|79008646|FG002|Overall Study|Lost to Follow-up|4|||
44211738|NCT01831466|79008647|FG003|Overall Study|Lost to Follow-up|2|||
44211739|NCT01831466|79008648|FG004|Overall Study|Lost to Follow-up|0|||
44211740|NCT01831466|79008649|FG005|Overall Study|Lost to Follow-up|3|||
44211741|NCT01831466|79008650|FG006|Overall Study|Lost to Follow-up|0|||
44211742|NCT01831466|79008651|FG007|Overall Study|Lost to Follow-up|0|||
44211743|NCT01831466|79008652|FG008|Overall Study|Lost to Follow-up|0|||
44211744|NCT01831466|79008653|FG009|Overall Study|Lost to Follow-up|1|||
44211745|NCT01831466|79008654|FG010|Overall Study|Lost to Follow-up|0|||
44211746|NCT01831466|79008655|FG011|Overall Study|Lost to Follow-up|1|||
44211747|NCT01831466|79008644|FG000|Overall Study|Lack of Efficacy|5|||
44211748|NCT01831466|79008645|FG001|Overall Study|Lack of Efficacy|8|||
44211749|NCT01831466|79008646|FG002|Overall Study|Lack of Efficacy|7|||
44211750|NCT01831466|79008647|FG003|Overall Study|Lack of Efficacy|6|||
44211751|NCT01831466|79008648|FG004|Overall Study|Lack of Efficacy|9|||
44211752|NCT01831466|79008649|FG005|Overall Study|Lack of Efficacy|8|||
44211753|NCT01831466|79008650|FG006|Overall Study|Lack of Efficacy|1|||
44211754|NCT01831466|79008651|FG007|Overall Study|Lack of Efficacy|1|||
44211755|NCT01831466|79008652|FG008|Overall Study|Lack of Efficacy|2|||
44211756|NCT01831466|79008653|FG009|Overall Study|Lack of Efficacy|2|||
44211757|NCT01831466|79008654|FG010|Overall Study|Lack of Efficacy|2|||
44211758|NCT01831466|79008655|FG011|Overall Study|Lack of Efficacy|0|||
44211759|NCT01831466|79008644|FG000|Overall Study|Adverse Event|0|||
44211760|NCT01831466|79008645|FG001|Overall Study|Adverse Event|0|||
44211761|NCT01831466|79008646|FG002|Overall Study|Adverse Event|4|||
44211762|NCT01831466|79008647|FG003|Overall Study|Adverse Event|6|||
44211763|NCT01831466|79008648|FG004|Overall Study|Adverse Event|3|||
44211764|NCT01831466|79008649|FG005|Overall Study|Adverse Event|7|||
44211765|NCT01831466|79008650|FG006|Overall Study|Adverse Event|0|||
44211766|NCT01831466|79008651|FG007|Overall Study|Adverse Event|1|||
44211767|NCT01831466|79008652|FG008|Overall Study|Adverse Event|1|||
44211768|NCT01831466|79008653|FG009|Overall Study|Adverse Event|1|||
44211769|NCT01831466|79008654|FG010|Overall Study|Adverse Event|0|||
44211770|NCT01831466|79008655|FG011|Overall Study|Adverse Event|2|||
44211771|NCT01881620|79008675|FG000|Overall Study|Protocol Violation|4|||
44211772|NCT01830920|79008684|FG000|Overall Study|Adverse Event|1|||
44211773|NCT01830920|79008685|FG001|Overall Study|Adverse Event|0|||
44211774|NCT01830920|79008686|FG002|Overall Study|Adverse Event|1|||
44211775|NCT01830920|79008687|FG003|Overall Study|Adverse Event|0|||
44211776|NCT01830920|79008688|FG004|Overall Study|Adverse Event|0|||
44211777|NCT01830920|79008684|FG000|Overall Study|Withdrawal by Subject|2|||
44211778|NCT01830920|79008685|FG001|Overall Study|Withdrawal by Subject|2|||
44452413|NCT00678587|79461328|FG001|Overall Study|Lost to Follow-up|5|||
44543614|NCT03679741|79556694|FG000|Period 2|Adverse Event|2|||
44211779|NCT01830920|79008686|FG002|Overall Study|Withdrawal by Subject|1|||
44211780|NCT01830920|79008687|FG003|Overall Study|Withdrawal by Subject|7|||
44211781|NCT01830920|79008688|FG004|Overall Study|Withdrawal by Subject|1|||
44211782|NCT01830920|79008684|FG000|Overall Study|Death|3|||
44211783|NCT01830920|79008685|FG001|Overall Study|Death|3|||
44211784|NCT01830920|79008686|FG002|Overall Study|Death|5|||
44370563|NCT00880906|79375842|FG001|Overall Study|Did not meet criteria following patholog|6|||
44211785|NCT01830920|79008687|FG003|Overall Study|Death|4|||
44211786|NCT01830920|79008688|FG004|Overall Study|Death|4|||
44211787|NCT01830920|79008684|FG000|Overall Study|Other|15|||
44211788|NCT01830920|79008685|FG001|Overall Study|Other|1|||
44211789|NCT01830920|79008686|FG002|Overall Study|Other|1|||
44211790|NCT01830920|79008687|FG003|Overall Study|Other|5|||
44211791|NCT01830920|79008688|FG004|Overall Study|Other|3|||
44370564|NCT00882310|79375848|FG000|Overall Study|Screen Failure|10|||
44211792|NCT01881230|79008703|FG000|Overall Study|Death|2|||
44211793|NCT01881230|79008704|FG001|Overall Study|Death|0|||
44211794|NCT01881230|79008705|FG002|Overall Study|Death|1|||
44211795|NCT01881230|79008703|FG000|Overall Study|Adverse Event|9|||
44211796|NCT01881230|79008704|FG001|Overall Study|Adverse Event|13|||
44211797|NCT01881230|79008705|FG002|Overall Study|Adverse Event|12|||
44211798|NCT01881230|79008703|FG000|Overall Study|Progressive Disease|31|||
44211799|NCT01881230|79008704|FG001|Overall Study|Progressive Disease|35|||
44211800|NCT01881230|79008705|FG002|Overall Study|Progressive Disease|36|||
44211801|NCT01881230|79008703|FG000|Overall Study|Symptomatic Deterioration|3|||
44211802|NCT01881230|79008704|FG001|Overall Study|Symptomatic Deterioration|3|||
44211803|NCT01881230|79008705|FG002|Overall Study|Symptomatic Deterioration|1|||
44211804|NCT01881230|79008703|FG000|Overall Study|Withdrawal by Subject|6|||
44211805|NCT01881230|79008704|FG001|Overall Study|Withdrawal by Subject|4|||
44211806|NCT01881230|79008705|FG002|Overall Study|Withdrawal by Subject|6|||
44211807|NCT01881230|79008703|FG000|Overall Study|Physician Decision|4|||
44211808|NCT01881230|79008704|FG001|Overall Study|Physician Decision|3|||
44211809|NCT01881230|79008705|FG002|Overall Study|Physician Decision|6|||
44211810|NCT01881230|79008703|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44211811|NCT01881230|79008704|FG001|Overall Study|Non-Compliance with Study Drug|2|||
44211812|NCT01881230|79008705|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44211813|NCT01881230|79008703|FG000|Overall Study|Given Commercially Available Drug|0|||
44211814|NCT01881230|79008704|FG001|Overall Study|Given Commercially Available Drug|0|||
44211815|NCT01881230|79008705|FG002|Overall Study|Given Commercially Available Drug|2|||
44211816|NCT01881230|79008703|FG000|Overall Study|Protocol Violation|1|||
44211817|NCT01881230|79008704|FG001|Overall Study|Protocol Violation|1|||
44452414|NCT00678587|79461327|FG000|Overall Study|Investigator Discretion|2|||
44211818|NCT01881230|79008705|FG002|Overall Study|Protocol Violation|0|||
44370565|NCT00882310|79375848|FG000|Overall Study|Never received treatment|1|||
44370566|NCT00882310|79375848|FG000|Overall Study|Death|6|||
44370567|NCT00882310|79375848|FG000|Overall Study|Progression of disease|4|||
44452415|NCT00678587|79461328|FG001|Overall Study|Investigator Discretion|6|||
44452416|NCT00678587|79461327|FG000|Overall Study|Withdrew Consent|8|||
44452417|NCT00678587|79461328|FG001|Overall Study|Withdrew Consent|3|||
44452418|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Adverse Event|2|||
44452419|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Adverse Event|2|||
44452420|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Adverse Event|4|||
44452421|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Adverse Event|0|||
44452422|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Adverse Event|0|||
44452423|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Progressive disease|0|||
44452424|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Progressive disease|0|||
44452425|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Progressive disease|1|||
44452426|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Progressive disease|0|||
44452427|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Progressive disease|0|||
44452428|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
44452429|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
44452430|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
44452431|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
44452432|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
44452433|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
44452434|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
44452435|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
44452436|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
44452437|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
44370568|NCT00882310|79375848|FG000|Overall Study|Adverse Event|1|||
44370569|NCT00884650|79375854|FG000|Overall Study|Did not return complete pain diaries|7|||
44370570|NCT00884650|79375855|FG001|Overall Study|Did not return complete pain diaries|7|||
44452438|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
44452439|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
44211819|NCT01881230|79008703|FG000|Overall Study|Miscellaneous|3|||
44370571|NCT00884650|79375854|FG000|Overall Study|Admitted Post-Op|1|||
44370572|NCT00884650|79375855|FG001|Overall Study|Admitted Post-Op|0|||
44370573|NCT00884650|79375854|FG000|Overall Study|Femoral Stress Fracture|1|||
44370574|NCT00884650|79375855|FG001|Overall Study|Femoral Stress Fracture|0|||
44452440|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
44211820|NCT01881230|79008704|FG001|Overall Study|Miscellaneous|3|||
44211821|NCT01881230|79008705|FG002|Overall Study|Miscellaneous|0|||
44211822|NCT01881230|79008703|FG000|Overall Study|Untreated: Other|0|||
44370575|NCT00884650|79375854|FG000|Overall Study|Pain Pump Complication|0|||
44452441|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
44452442|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
44452443|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
44452444|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
44452445|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
44211823|NCT01881230|79008704|FG001|Overall Study|Untreated: Other|0|||
44211824|NCT01881230|79008705|FG002|Overall Study|Untreated: Other|1|||
44452446|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
44452447|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
44452448|NCT03523728|79461340|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
44452449|NCT03523728|79461341|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
44452450|NCT03523728|79461342|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
44452451|NCT03523728|79461343|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
44452452|NCT03523728|79461344|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
44452453|NCT03523728|79461340|FG000|Stage 2 (24 Months)|Adverse Event|0|||
44452454|NCT03523728|79461341|FG001|Stage 2 (24 Months)|Adverse Event|0|||
44211825|NCT01881230|79008703|FG000|Overall Study|Untreated: Death|0|||
44211826|NCT01881230|79008704|FG001|Overall Study|Untreated: Death|0|||
44211827|NCT01881230|79008705|FG002|Overall Study|Untreated: Death|1|||
44211828|NCT01881230|79008703|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
44211829|NCT01881230|79008704|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
44211830|NCT01881230|79008705|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
44211831|NCT01856582|79008713|FG000|Overall Study|Died prior to Boost infusion|1|||
44211832|NCT01829360|79008721|FG000|Overall Study|Protocol Violation|0|||
44211833|NCT01829360|79008722|FG001|Overall Study|Protocol Violation|0|||
44211834|NCT01829360|79008723|FG002|Overall Study|Protocol Violation|1|||
44211835|NCT01829360|79008724|FG003|Overall Study|Protocol Violation|0|||
44211836|NCT01856114|79008740|FG000|Overall Study|Withdrawal by Subject|1|||
44211837|NCT01856114|79008741|FG001|Overall Study|Withdrawal by Subject|0|||
44211838|NCT01856114|79008740|FG000|Overall Study|Adverse Event|1|||
44211839|NCT01856114|79008741|FG001|Overall Study|Adverse Event|0|||
44211840|NCT01855958|79008749|FG000|Overall Study|Withdrawal by Subject|1|||
44211841|NCT01855958|79008750|FG001|Overall Study|Withdrawal by Subject|0|||
44211842|NCT01855412|79008761|FG000|Overall Study|Death|77|||
44211843|NCT01855412|79008762|FG001|Overall Study|Death|123|||
44211844|NCT01855412|79008763|FG002|Overall Study|Death|30|||
44211845|NCT01855412|79008761|FG000|Overall Study|Lost to Follow-up|28|||
44211846|NCT01855412|79008762|FG001|Overall Study|Lost to Follow-up|46|||
44211847|NCT01855412|79008763|FG002|Overall Study|Lost to Follow-up|15|||
44269822|NCT00552344|79194953|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
44452455|NCT03523728|79461342|FG002|Stage 2 (24 Months)|Adverse Event|0|||
44452456|NCT03523728|79461343|FG003|Stage 2 (24 Months)|Adverse Event|1|||
44452457|NCT03523728|79461344|FG004|Stage 2 (24 Months)|Adverse Event|2|||
44452458|NCT03523728|79461340|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
44452459|NCT03523728|79461341|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
44452460|NCT03523728|79461342|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
44452461|NCT03523728|79461343|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
44452462|NCT03523728|79461344|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
44452463|NCT03523728|79461340|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
44452464|NCT03523728|79461341|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
44452465|NCT03523728|79461342|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
44452466|NCT03523728|79461343|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
44452467|NCT03523728|79461344|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
44452468|NCT03523728|79461340|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
44452469|NCT03523728|79461341|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
44452470|NCT03523728|79461342|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
44269823|NCT00552344|79194953|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
44269824|NCT00552344|79194953|FG000|Overall Study|Other Reason|22|||
44269825|NCT00553514|79194990|FG000|Overall Study|Protocol deviation|0|||
44370576|NCT00884650|79375855|FG001|Overall Study|Pain Pump Complication|1|||
44269826|NCT00553514|79194991|FG001|Overall Study|Protocol deviation|0|||
44370577|NCT00881608|79375867|FG000|Overall Study|Study prematurely terminated|11|||
44370578|NCT01088399|79375882|FG000|Overall Study|Adverse Event|211|||
44370579|NCT01088399|79375883|FG001|Overall Study|Adverse Event|16|||
44370580|NCT01088399|79375884|FG002|Overall Study|Adverse Event|0|||
44370581|NCT01088399|79375882|FG000|Overall Study|Death|204|||
44370582|NCT01088399|79375883|FG001|Overall Study|Death|45|||
44370583|NCT01088399|79375884|FG002|Overall Study|Death|0|||
44370584|NCT01088399|79375882|FG000|Overall Study|Lack of Efficacy|298|||
44452471|NCT03523728|79461343|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
44452472|NCT03523728|79461344|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
44452473|NCT03523728|79461340|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
44452474|NCT03523728|79461341|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
44452475|NCT03523728|79461342|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
44211848|NCT01855412|79008761|FG000|Overall Study|Withdrawal by Subject|77|||
44211849|NCT01855412|79008762|FG001|Overall Study|Withdrawal by Subject|123|||
44211850|NCT01855412|79008763|FG002|Overall Study|Withdrawal by Subject|24|||
44211851|NCT01855412|79008761|FG000|Overall Study|Physician Decision|25|||
44269827|NCT00553514|79194992|FG002|Overall Study|Protocol deviation|0|||
44370585|NCT01088399|79375883|FG001|Overall Study|Lack of Efficacy|7|||
44543615|NCT03679741|79556695|FG001|Period 2|Adverse Event|1|||
44543616|NCT03679741|79556694|FG000|Period 2|Withdrawal by Subject|1|||
44370586|NCT01088399|79375884|FG002|Overall Study|Lack of Efficacy|5|||
44370587|NCT01088399|79375882|FG000|Overall Study|Lost to Follow-up|1070|||
44370588|NCT01088399|79375883|FG001|Overall Study|Lost to Follow-up|278|||
44370589|NCT01088399|79375884|FG002|Overall Study|Lost to Follow-up|58|||
44370590|NCT01088399|79375882|FG000|Overall Study|Physician Decision|531|||
44370591|NCT01088399|79375883|FG001|Overall Study|Physician Decision|88|||
44370592|NCT01088399|79375884|FG002|Overall Study|Physician Decision|16|||
44370593|NCT01088399|79375882|FG000|Overall Study|Withdrawal by Subject|544|||
44370594|NCT01088399|79375883|FG001|Overall Study|Withdrawal by Subject|195|||
44370595|NCT01088399|79375884|FG002|Overall Study|Withdrawal by Subject|33|||
44370596|NCT01088399|79375882|FG000|Overall Study|Change to or start of somatropin therapy|234|||
44370597|NCT01088399|79375883|FG001|Overall Study|Change to or start of somatropin therapy|17|||
44370598|NCT01088399|79375884|FG002|Overall Study|Change to or start of somatropin therapy|12|||
44370599|NCT01088399|79375882|FG000|Overall Study|Sponsor decision|1573|||
44370600|NCT01088399|79375883|FG001|Overall Study|Sponsor decision|298|||
44211852|NCT01855412|79008762|FG001|Overall Study|Physician Decision|31|||
44211853|NCT01855412|79008763|FG002|Overall Study|Physician Decision|3|||
44211854|NCT01855412|79008761|FG000|Overall Study|Site Closure|4|||
44211855|NCT01855412|79008762|FG001|Overall Study|Site Closure|18|||
44211856|NCT01855412|79008763|FG002|Overall Study|Site Closure|1|||
44211857|NCT01855412|79008761|FG000|Overall Study|Reason not Specified|1|||
44211858|NCT01855412|79008762|FG001|Overall Study|Reason not Specified|2|||
44211859|NCT01855412|79008763|FG002|Overall Study|Reason not Specified|3|||
44211860|NCT01614470|79008779|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
44211861|NCT01614470|79008780|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44211862|NCT01614470|79008781|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44211863|NCT01614470|79008779|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
44211864|NCT01614470|79008780|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
44211865|NCT01614470|79008781|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
44211866|NCT01880528|79008792|FG000|Overall Study|Other|1|||
44211867|NCT01880528|79008793|FG001|Overall Study|Other|1|||
44211868|NCT01854944|79008802|FG000|Overall Study|Withdrawal by Subject|0|||
44211869|NCT01854944|79008803|FG001|Overall Study|Withdrawal by Subject|0|||
44211870|NCT01854944|79008804|FG002|Overall Study|Withdrawal by Subject|1|||
44211871|NCT01829048|79008831|FG000|Overall Study|Withdrawal by Subject|0|||
44211872|NCT01829048|79008832|FG001|Overall Study|Withdrawal by Subject|0|||
44370601|NCT01088399|79375884|FG002|Overall Study|Sponsor decision|7|||
44370602|NCT01088399|79375882|FG000|Overall Study|Protocol Violation|10|||
44370603|NCT01088399|79375883|FG001|Overall Study|Protocol Violation|1|||
44452476|NCT03523728|79461343|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
44452477|NCT03523728|79461344|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
44452478|NCT00538590|79461363|FG000|Overall Study|Death|1|||
44452479|NCT00538590|79461364|FG001|Overall Study|Death|0|||
44452480|NCT00466947|79461372|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
44452481|NCT00466947|79461373|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
44452482|NCT00466947|79461372|FG000|Study End Analysis Period|Adverse Event|35|||
44452483|NCT00466947|79461373|FG001|Study End Analysis Period|Adverse Event|43|||
44452484|NCT00466947|79461372|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
44452485|NCT00466947|79461373|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
44452486|NCT00466947|79461372|FG000|Study End Analysis Period|Physician Decision|29|||
44452487|NCT00466947|79461373|FG001|Study End Analysis Period|Physician Decision|29|||
44211873|NCT01829048|79008833|FG002|Overall Study|Withdrawal by Subject|0|||
44370604|NCT01088399|79375884|FG002|Overall Study|Protocol Violation|0|||
44370605|NCT01088399|79375882|FG000|Overall Study|Enrollment criteria not met|48|||
44370606|NCT01088399|79375883|FG001|Overall Study|Enrollment criteria not met|119|||
44370607|NCT01088399|79375884|FG002|Overall Study|Enrollment criteria not met|70|||
44370608|NCT01088399|79375882|FG000|Overall Study|Study summary visit not completed|2398|||
44370609|NCT01088399|79375883|FG001|Overall Study|Study summary visit not completed|283|||
44370610|NCT01088399|79375884|FG002|Overall Study|Study summary visit not completed|80|||
44370611|NCT00598078|79375892|FG000|Period 2 (Day 2)|Adverse Event|1|||
44211874|NCT01829048|79008834|FG003|Overall Study|Withdrawal by Subject|2|||
44269828|NCT00553514|79194993|FG003|Overall Study|Protocol deviation|1|||
44370612|NCT00598078|79375893|FG001|Period 2 (Day 2)|Adverse Event|0|||
44370613|NCT01079195|79375901|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
44452488|NCT00466947|79461372|FG000|Study End Analysis Period|Protocol Violation|9|||
44452489|NCT00466947|79461373|FG001|Study End Analysis Period|Protocol Violation|17|||
44211875|NCT01829048|79008835|FG004|Overall Study|Withdrawal by Subject|0|||
44211876|NCT01854710|79008848|FG000|Overall Study|Withdrawal by Subject|2|||
44211877|NCT01854710|79008849|FG001|Overall Study|Withdrawal by Subject|1|||
44211878|NCT01854710|79008850|FG002|Overall Study|Withdrawal by Subject|0|||
44211879|NCT01854710|79008851|FG003|Overall Study|Withdrawal by Subject|0|||
44211880|NCT01854710|79008852|FG004|Overall Study|Withdrawal by Subject|0|||
44211881|NCT01854710|79008853|FG005|Overall Study|Withdrawal by Subject|0|||
44211882|NCT01854710|79008848|FG000|Overall Study|CRI procedural error|2|||
44211883|NCT01854710|79008849|FG001|Overall Study|CRI procedural error|2|||
44211884|NCT01854710|79008850|FG002|Overall Study|CRI procedural error|2|||
44211885|NCT01854710|79008851|FG003|Overall Study|CRI procedural error|2|||
44211886|NCT01854710|79008852|FG004|Overall Study|CRI procedural error|2|||
44211887|NCT01854710|79008853|FG005|Overall Study|CRI procedural error|2|||
44211888|NCT01828034|79008867|FG000|Overall Study|Withdrawal by Subject|0|||
44211889|NCT01828034|79008868|FG001|Overall Study|Withdrawal by Subject|0|||
44211890|NCT01828034|79008869|FG002|Overall Study|Withdrawal by Subject|0|||
44211891|NCT01828034|79008870|FG003|Overall Study|Withdrawal by Subject|1|||
44211892|NCT01853696|79008879|FG000|Overall Study|Withdrawal by Subject|1|||
44211893|NCT01853696|79008880|FG001|Overall Study|Withdrawal by Subject|1|||
44211894|NCT01853696|79008879|FG000|Overall Study|Lost to Follow-up|5|||
44211895|NCT01853696|79008880|FG001|Overall Study|Lost to Follow-up|4|||
44211896|NCT01871805|79008892|FG000|Phase I|Death|7|||
44211897|NCT01871805|79008893|FG001|Phase I|Death|4|||
44211898|NCT01871805|79008894|FG002|Phase I|Death|6|||
44211899|NCT01871805|79008895|FG003|Phase I|Death|2|||
44211900|NCT01871805|79008896|FG004|Phase I|Death|9|||
44211901|NCT01871805|79008897|FG005|Phase I|Death|0|||
44211902|NCT01871805|79008892|FG000|Phase I|Alive in Survival Follow-up|0|||
44211903|NCT01871805|79008893|FG001|Phase I|Alive in Survival Follow-up|2|||
44211904|NCT01871805|79008894|FG002|Phase I|Alive in Survival Follow-up|4|||
44211905|NCT01871805|79008895|FG003|Phase I|Alive in Survival Follow-up|5|||
44211906|NCT01871805|79008896|FG004|Phase I|Alive in Survival Follow-up|4|||
44211907|NCT01871805|79008897|FG005|Phase I|Alive in Survival Follow-up|0|||
44211908|NCT01871805|79008892|FG000|Phase I|Lost to Follow-up|0|||
44211909|NCT01871805|79008893|FG001|Phase I|Lost to Follow-up|1|||
44211910|NCT01871805|79008894|FG002|Phase I|Lost to Follow-up|3|||
44211911|NCT01871805|79008895|FG003|Phase I|Lost to Follow-up|0|||
44211912|NCT01871805|79008896|FG004|Phase I|Lost to Follow-up|0|||
44211913|NCT01871805|79008897|FG005|Phase I|Lost to Follow-up|0|||
44211914|NCT01871805|79008892|FG000|Phase II|Death|0|||
44211915|NCT01871805|79008893|FG001|Phase II|Death|0|||
44211916|NCT01871805|79008894|FG002|Phase II|Death|0|||
44211917|NCT01871805|79008895|FG003|Phase II|Death|0|||
44211918|NCT01871805|79008896|FG004|Phase II|Death|0|||
44211919|NCT01871805|79008897|FG005|Phase II|Death|45|||
44211920|NCT01871805|79008892|FG000|Phase II|Alive in Survival Follow-up|0|||
44211921|NCT01871805|79008893|FG001|Phase II|Alive in Survival Follow-up|0|||
44211922|NCT01871805|79008894|FG002|Phase II|Alive in Survival Follow-up|0|||
44211923|NCT01871805|79008895|FG003|Phase II|Alive in Survival Follow-up|0|||
44211924|NCT01871805|79008896|FG004|Phase II|Alive in Survival Follow-up|0|||
44211925|NCT01871805|79008897|FG005|Phase II|Alive in Survival Follow-up|29|||
44211926|NCT01871805|79008892|FG000|Phase II|Lost to Follow-up|0|||
44211927|NCT01871805|79008893|FG001|Phase II|Lost to Follow-up|0|||
44370614|NCT01079195|79375901|FG000|Overall Study|No Documentation Available|437|||
44370615|NCT01079195|79375901|FG000|Overall Study|Adverse Event|157|||
44370616|NCT01079195|79375901|FG000|Overall Study|Reason Unknown|39|||
44211928|NCT01871805|79008894|FG002|Phase II|Lost to Follow-up|0|||
44452490|NCT00466947|79461372|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
44211929|NCT01871805|79008895|FG003|Phase II|Lost to Follow-up|0|||
44211930|NCT01871805|79008896|FG004|Phase II|Lost to Follow-up|0|||
44211931|NCT01871805|79008897|FG005|Phase II|Lost to Follow-up|13|||
44211932|NCT01719861|79008928|FG000|Cycle 1|Death|4|||
44211933|NCT01719861|79008928|FG000|Cycle 2|Death|1|||
44211934|NCT01853618|79008938|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
44211935|NCT01853618|79008939|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
44211936|NCT01853618|79008940|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
44211937|NCT01853618|79008941|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
44211938|NCT01853618|79008942|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
44211939|NCT01853618|79008938|FG000|Overall Study|Progressive disease|1|||
44211940|NCT01853618|79008939|FG001|Overall Study|Progressive disease|1|||
44211941|NCT01853618|79008940|FG002|Overall Study|Progressive disease|1|||
44211942|NCT01853618|79008941|FG003|Overall Study|Progressive disease|1|||
44211943|NCT01853618|79008942|FG004|Overall Study|Progressive disease|2|||
44211944|NCT01853618|79008938|FG000|Overall Study|Physician Decision|0|||
44211945|NCT01853618|79008939|FG001|Overall Study|Physician Decision|1|||
44211946|NCT01853618|79008940|FG002|Overall Study|Physician Decision|1|||
44211947|NCT01853618|79008941|FG003|Overall Study|Physician Decision|0|||
44211948|NCT01853618|79008942|FG004|Overall Study|Physician Decision|0|||
44211949|NCT01853618|79008938|FG000|Overall Study|Refused further treatment|0|||
44211950|NCT01853618|79008939|FG001|Overall Study|Refused further treatment|0|||
44211951|NCT01853618|79008940|FG002|Overall Study|Refused further treatment|0|||
44211952|NCT01853618|79008941|FG003|Overall Study|Refused further treatment|0|||
44370617|NCT01079195|79375901|FG000|Overall Study|Withdrawal by Subject|18|||
44370618|NCT01079195|79375901|FG000|Overall Study|Financial Reasons|15|||
44452491|NCT00466947|79461373|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
44452492|NCT00466947|79461372|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
44452493|NCT00466947|79461373|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
44452494|NCT00466947|79461372|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
44452495|NCT00466947|79461373|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
44452496|NCT00466947|79461372|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
44452497|NCT00466947|79461373|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
44452498|NCT00537810|79461384|FG000|Overall Study|Withdrawal by Subject|4|||
44452499|NCT00537810|79461385|FG001|Overall Study|Withdrawal by Subject|11|||
44452500|NCT00537810|79461386|FG002|Overall Study|Withdrawal by Subject|4|||
44452501|NCT00537810|79461387|FG003|Overall Study|Withdrawal by Subject|3|||
44452502|NCT00537810|79461384|FG000|Overall Study|Medically withdrawn|2|||
44452503|NCT00537810|79461385|FG001|Overall Study|Medically withdrawn|2|||
44452504|NCT00537810|79461386|FG002|Overall Study|Medically withdrawn|0|||
44452505|NCT00537810|79461387|FG003|Overall Study|Medically withdrawn|1|||
44452506|NCT01287936|79461400|FG000|Overall Study|Lost to Follow-up|0|||
44452507|NCT01287936|79461401|FG001|Overall Study|Lost to Follow-up|1|||
44452508|NCT01287936|79461402|FG002|Overall Study|Lost to Follow-up|1|||
44452509|NCT00090259|79461412|FG000|Overall Study|Lost to Follow-up|30|||
44452510|NCT00090259|79461413|FG001|Overall Study|Lost to Follow-up|26|||
44370619|NCT01079195|79375901|FG000|Overall Study|Lack of Effectiveness|12|||
44370620|NCT01079195|79375901|FG000|Overall Study|Physician Decision|4|||
44370621|NCT01079195|79375901|FG000|Overall Study|Improved Status of Participant|4|||
44370622|NCT01079195|79375901|FG000|Overall Study|No Follow-up Documentation Available|4|||
44370623|NCT01079195|79375901|FG000|Overall Study|Non-compliance|2|||
44370624|NCT00883558|79375905|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
44370625|NCT00883558|79375906|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
44370626|NCT00883558|79375907|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
44370627|NCT00883558|79375905|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
44370628|NCT00883558|79375906|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
44370629|NCT00883558|79375907|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
44370630|NCT00883558|79375905|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
44452511|NCT00090259|79461412|FG000|Overall Study|Withdrawal by Subject|21|||
44452512|NCT00090259|79461413|FG001|Overall Study|Withdrawal by Subject|15|||
44452513|NCT00090259|79461412|FG000|Overall Study|Investigator site closed|11|||
44211953|NCT01853618|79008942|FG004|Overall Study|Refused further treatment|1|||
44211954|NCT01853462|79008957|FG000|Overall Study|Withdrawal by Subject|1|||
44211955|NCT01853462|79008958|FG001|Overall Study|Withdrawal by Subject|1|||
44211956|NCT01719783|79008968|FG000|Dose 2|Physician Decision|1|||
44452514|NCT00090259|79461413|FG001|Overall Study|Investigator site closed|7|||
44452515|NCT00079183|79461419|FG000|Overall Study|Withdrawal by Subject|4|||
44543617|NCT03679741|79556695|FG001|Period 2|Withdrawal by Subject|1|||
44211957|NCT01719783|79008969|FG001|Dose 2|Physician Decision|0|||
44211958|NCT01853384|79008997|FG000|Randomized|Adverse Event|5|||
44211959|NCT01853384|79008998|FG001|Randomized|Adverse Event|3|||
44211960|NCT01853384|79008997|FG000|Randomized|Death|1|||
44211961|NCT01853384|79008998|FG001|Randomized|Death|2|||
44211962|NCT01853384|79008997|FG000|Randomized|Lost to Follow-up|1|||
44211963|NCT01853384|79008998|FG001|Randomized|Lost to Follow-up|1|||
44211964|NCT01853384|79008997|FG000|Randomized|Withdrawal by Subject|5|||
44211965|NCT01853384|79008998|FG001|Randomized|Withdrawal by Subject|3|||
44211966|NCT01853384|79008997|FG000|Randomized|Sponsor Decision|47|||
44211967|NCT01853384|79008998|FG001|Randomized|Sponsor Decision|34|||
44211968|NCT01853384|79008997|FG000|Randomized|Other|3|||
44211969|NCT01853384|79008998|FG001|Randomized|Other|3|||
44211970|NCT01853384|79008997|FG000|Completed Follow up Visit 1|Early Termination|13|||
44211971|NCT01853384|79008998|FG001|Completed Follow up Visit 1|Early Termination|9|||
44211972|NCT01853384|79008997|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
44211973|NCT01853384|79008998|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
44211974|NCT01853384|79008997|FG000|Completed Follow up Visit 2|Adverse Event|1|||
44211975|NCT01853384|79008998|FG001|Completed Follow up Visit 2|Adverse Event|0|||
44211976|NCT01853384|79008997|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
44211977|NCT01853384|79008998|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
44211978|NCT01853384|79008997|FG000|Completed Follow up Visit 2|Death|1|||
44211979|NCT01853384|79008998|FG001|Completed Follow up Visit 2|Death|0|||
44211980|NCT01853384|79008997|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
44211981|NCT01853384|79008998|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
44211982|NCT01878890|79009008|FG000|Overall Study|Protocol Violation|0|||
44211983|NCT01878890|79009009|FG001|Overall Study|Protocol Violation|1|||
44211984|NCT01878890|79009010|FG002|Overall Study|Protocol Violation|0|||
44211985|NCT01878890|79009011|FG003|Overall Study|Protocol Violation|0|||
44211986|NCT01827332|79009024|FG000|Overall Study|Lost to Follow-up|2|||
44211987|NCT01827332|79009025|FG001|Overall Study|Lost to Follow-up|1|||
44211988|NCT01719003|79009039|FG000|Overall Study|Non compliant with protocol|1|||
44211989|NCT01719003|79009040|FG001|Overall Study|Non compliant with protocol|1|||
44211990|NCT01719003|79009041|FG002|Overall Study|Non compliant with protocol|0|||
44211991|NCT01719003|79009042|FG003|Overall Study|Non compliant with protocol|1|||
44211992|NCT01719003|79009043|FG004|Overall Study|Non compliant with protocol|2|||
44211993|NCT01719003|79009044|FG005|Overall Study|Non compliant with protocol|1|||
44211994|NCT01719003|79009045|FG006|Overall Study|Non compliant with protocol|2|||
44211995|NCT01719003|79009046|FG007|Overall Study|Non compliant with protocol|3|||
44211996|NCT01719003|79009047|FG008|Overall Study|Non compliant with protocol|0|||
44211997|NCT01719003|79009039|FG000|Overall Study|Adverse Event|6|||
44211998|NCT01719003|79009040|FG001|Overall Study|Adverse Event|5|||
44211999|NCT01719003|79009041|FG002|Overall Study|Adverse Event|4|||
44212000|NCT01719003|79009042|FG003|Overall Study|Adverse Event|3|||
44212001|NCT01719003|79009043|FG004|Overall Study|Adverse Event|4|||
44212002|NCT01719003|79009044|FG005|Overall Study|Adverse Event|3|||
44212003|NCT01719003|79009045|FG006|Overall Study|Adverse Event|6|||
44212004|NCT01719003|79009046|FG007|Overall Study|Adverse Event|5|||
44212005|NCT01719003|79009047|FG008|Overall Study|Adverse Event|0|||
44212006|NCT01719003|79009039|FG000|Overall Study|Lost to Follow-up|0|||
44212007|NCT01719003|79009040|FG001|Overall Study|Lost to Follow-up|6|||
44212008|NCT01719003|79009041|FG002|Overall Study|Lost to Follow-up|7|||
44212009|NCT01719003|79009042|FG003|Overall Study|Lost to Follow-up|2|||
44212010|NCT01719003|79009043|FG004|Overall Study|Lost to Follow-up|3|||
44212011|NCT01719003|79009044|FG005|Overall Study|Lost to Follow-up|4|||
44212012|NCT01719003|79009045|FG006|Overall Study|Lost to Follow-up|3|||
44212013|NCT01719003|79009046|FG007|Overall Study|Lost to Follow-up|2|||
44212014|NCT01719003|79009047|FG008|Overall Study|Lost to Follow-up|2|||
44212015|NCT01719003|79009039|FG000|Overall Study|Refusal to continue, not due to AE|2|||
44212016|NCT01719003|79009040|FG001|Overall Study|Refusal to continue, not due to AE|5|||
44212017|NCT01719003|79009041|FG002|Overall Study|Refusal to continue, not due to AE|4|||
44212018|NCT01719003|79009042|FG003|Overall Study|Refusal to continue, not due to AE|4|||
44212019|NCT01719003|79009043|FG004|Overall Study|Refusal to continue, not due to AE|4|||
44212020|NCT01719003|79009044|FG005|Overall Study|Refusal to continue, not due to AE|3|||
44212021|NCT01719003|79009045|FG006|Overall Study|Refusal to continue, not due to AE|8|||
44212022|NCT01719003|79009046|FG007|Overall Study|Refusal to continue, not due to AE|7|||
44269829|NCT00553514|79194994|FG004|Overall Study|Protocol deviation|0|||
44370631|NCT00883558|79375906|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
44370632|NCT00883558|79375907|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
44370633|NCT00883558|79375905|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
44212023|NCT01719003|79009047|FG008|Overall Study|Refusal to continue, not due to AE|1|||
44212024|NCT01719003|79009039|FG000|Overall Study|Reason other than those specified|0|||
44212025|NCT01719003|79009040|FG001|Overall Study|Reason other than those specified|0|||
44212026|NCT01719003|79009041|FG002|Overall Study|Reason other than those specified|2|||
44212027|NCT01719003|79009042|FG003|Overall Study|Reason other than those specified|3|||
44212028|NCT01719003|79009043|FG004|Overall Study|Reason other than those specified|4|||
44212029|NCT01719003|79009044|FG005|Overall Study|Reason other than those specified|1|||
44212030|NCT01719003|79009045|FG006|Overall Study|Reason other than those specified|0|||
44212031|NCT01719003|79009046|FG007|Overall Study|Reason other than those specified|3|||
44269830|NCT00553514|79194990|FG000|Overall Study|Lack of ovarian response|4|||
44212032|NCT01719003|79009047|FG008|Overall Study|Reason other than those specified|1|||
44212033|NCT01719003|79009039|FG000|Overall Study|Lack of Efficacy|0|||
44212034|NCT01719003|79009040|FG001|Overall Study|Lack of Efficacy|0|||
44212035|NCT01719003|79009041|FG002|Overall Study|Lack of Efficacy|0|||
44212036|NCT01719003|79009042|FG003|Overall Study|Lack of Efficacy|0|||
44212037|NCT01719003|79009043|FG004|Overall Study|Lack of Efficacy|0|||
44212038|NCT01719003|79009044|FG005|Overall Study|Lack of Efficacy|0|||
44212039|NCT01719003|79009045|FG006|Overall Study|Lack of Efficacy|1|||
44212040|NCT01719003|79009046|FG007|Overall Study|Lack of Efficacy|0|||
44212041|NCT01719003|79009047|FG008|Overall Study|Lack of Efficacy|0|||
44212042|NCT01853228|79009066|FG000|Phase 1|Lack of Efficacy|8|||
44212043|NCT01853228|79009067|FG001|Phase 1|Lack of Efficacy|0|||
44212044|NCT01853228|79009066|FG000|Phase 1|Other|1|||
44212045|NCT01853228|79009067|FG001|Phase 1|Other|0|||
44212046|NCT01853228|79009066|FG000|Phase 2|Physician Decision|0|||
44212047|NCT01853228|79009067|FG001|Phase 2|Physician Decision|1|||
44212048|NCT01853228|79009066|FG000|Phase 2|Proceed To Transplant|0|||
44212049|NCT01853228|79009067|FG001|Phase 2|Proceed To Transplant|3|||
44212050|NCT01853228|79009066|FG000|Phase 2|Lack of Efficacy|0|||
44212051|NCT01853228|79009067|FG001|Phase 2|Lack of Efficacy|4|||
44212052|NCT01705587|79009074|FG000|Overall Study|Withdrawal by Subject|0|||
44212053|NCT01705587|79009075|FG001|Overall Study|Withdrawal by Subject|1|||
44212054|NCT01718535|79009091|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
44212055|NCT01718535|79009092|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
44212056|NCT01718535|79009093|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
44212057|NCT01718535|79009094|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
44212058|NCT01718535|79009095|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
44212059|NCT01718535|79009096|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
44212060|NCT01718535|79009097|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
44212061|NCT01718535|79009098|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
44212062|NCT01718535|79009099|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
44212063|NCT01718535|79009100|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
44212064|NCT01717989|79009122|FG000|Overall Study|Ineligibility determined|6|||
44212065|NCT01717989|79009122|FG000|Overall Study|Protocol deviation|6|||
44212066|NCT01717989|79009122|FG000|Overall Study|Withdrawal by Subject|11|||
44212067|NCT01717989|79009122|FG000|Overall Study|Physician Decision|2|||
44212068|NCT01717989|79009122|FG000|Overall Study|Lost to Follow-up|11|||
44212069|NCT01717989|79009122|FG000|Overall Study|Death|439|||
44212070|NCT01717989|79009122|FG000|Overall Study|Protocol-specified criteria|551|||
44212071|NCT01717989|79009122|FG000|Overall Study|Other|40|||
44212072|NCT01705509|79009141|FG000|Inclusion CPET|Screen Failure|5|||
44212073|NCT01705509|79009141|FG000|Inclusion CPET|Withdrawal by Subject|2|||
44212074|NCT01705509|79009141|FG000|CPET w/ Ranexa|Screen Failure|2|||
44212075|NCT01853072|79009147|FG000|Overall Study|Adverse event prior to treatment|0|||
44212076|NCT01853072|79009148|FG001|Overall Study|Adverse event prior to treatment|1|||
44212077|NCT01853072|79009147|FG000|Overall Study|Adverse Event|0|||
44212078|NCT01853072|79009148|FG001|Overall Study|Adverse Event|3|||
44212079|NCT01853072|79009147|FG000|Overall Study|Death|1|||
44212080|NCT01853072|79009148|FG001|Overall Study|Death|4|||
44212081|NCT01853072|79009147|FG000|Overall Study|Lost to Follow-up|0|||
44212082|NCT01853072|79009148|FG001|Overall Study|Lost to Follow-up|3|||
44212083|NCT01853072|79009147|FG000|Overall Study|Non-compliance with study drug|0|||
44212084|NCT01853072|79009148|FG001|Overall Study|Non-compliance with study drug|1|||
44212085|NCT01853072|79009147|FG000|Overall Study|Physician Decision|1|||
44212086|NCT01853072|79009148|FG001|Overall Study|Physician Decision|1|||
44212087|NCT01853072|79009147|FG000|Overall Study|Withdrawal by Subject|1|||
44212088|NCT01853072|79009148|FG001|Overall Study|Withdrawal by Subject|2|||
44212089|NCT01853072|79009147|FG000|Overall Study|Reason not specified|9|||
44212090|NCT01853072|79009148|FG001|Overall Study|Reason not specified|6|||
44212091|NCT01877720|79009156|FG000|Overall Study|Adverse Event|1|||
44212092|NCT01877720|79009157|FG001|Overall Study|Adverse Event|0|||
44212093|NCT01870869|79009167|FG000|Overall Study|Implanted with nonstudy device|1|||
44212094|NCT01870869|79009168|FG001|Overall Study|Implanted with nonstudy device|3|||
44212095|NCT01870869|79009169|FG002|Overall Study|Implanted with nonstudy device|14|||
44212096|NCT01870869|79009170|FG003|Overall Study|Implanted with nonstudy device|4|||
44212097|NCT01870869|79009167|FG000|Overall Study|Death|0|||
44212098|NCT01870869|79009168|FG001|Overall Study|Death|0|||
44212099|NCT01870869|79009169|FG002|Overall Study|Death|7|||
44212100|NCT01870869|79009170|FG003|Overall Study|Death|1|||
44212101|NCT01870869|79009167|FG000|Overall Study|Subject choice|6|||
44212102|NCT01870869|79009168|FG001|Overall Study|Subject choice|2|||
44212103|NCT01870869|79009169|FG002|Overall Study|Subject choice|22|||
44212104|NCT01870869|79009170|FG003|Overall Study|Subject choice|8|||
44212105|NCT01870869|79009167|FG000|Overall Study|Lost to Follow-up|10|||
44212106|NCT01870869|79009168|FG001|Overall Study|Lost to Follow-up|2|||
44212107|NCT01870869|79009169|FG002|Overall Study|Lost to Follow-up|25|||
44212108|NCT01870869|79009170|FG003|Overall Study|Lost to Follow-up|3|||
44212109|NCT01870869|79009167|FG000|Overall Study|Reason not Specified|1|||
44212110|NCT01870869|79009168|FG001|Overall Study|Reason not Specified|2|||
44212111|NCT01870869|79009169|FG002|Overall Study|Reason not Specified|20|||
44212112|NCT01870869|79009170|FG003|Overall Study|Reason not Specified|4|||
44212113|NCT01870869|79009167|FG000|Overall Study|Not evaluable|10|||
44212114|NCT01870869|79009168|FG001|Overall Study|Not evaluable|5|||
44212115|NCT01870869|79009169|FG002|Overall Study|Not evaluable|42|||
44212116|NCT01870869|79009170|FG003|Overall Study|Not evaluable|10|||
44212117|NCT01877408|79009182|FG000|Overall Study|Lost to Follow-up|0|||
44212118|NCT01877408|79009183|FG001|Overall Study|Lost to Follow-up|2|||
44212119|NCT01717287|79009192|FG000|Overall Study|Lost to Follow-up|0|||
44212120|NCT01717287|79009193|FG001|Overall Study|Lost to Follow-up|2|||
44212121|NCT01717287|79009192|FG000|Overall Study|Protocol Violation|0|||
44212122|NCT01717287|79009193|FG001|Overall Study|Protocol Violation|1|||
44212123|NCT01827254|79009199|FG000|Overall Study|Death|10|||
44212124|NCT01827254|79009199|FG000|Overall Study|Case report form not completed|4|||
44212125|NCT01827254|79009199|FG000|Overall Study|Invalidated centre|3|||
44212126|NCT01827254|79009199|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
44212127|NCT01827254|79009199|FG000|Overall Study|Did not complete re-challenge|1|||
44212128|NCT01827254|79009199|FG000|Overall Study|Disease progression|36|||
44212129|NCT01827254|79009199|FG000|Overall Study|Intolerance to treatment|4|||
44370634|NCT00883558|79375906|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
44370635|NCT00883558|79375907|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
44370636|NCT00883558|79375905|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
44212130|NCT01824602|79009211|FG000|Overall Study|Withdrawal by Subject|0|||
44212131|NCT01824602|79009212|FG001|Overall Study|Withdrawal by Subject|0|||
44212132|NCT01824602|79009213|FG002|Overall Study|Withdrawal by Subject|1|||
44212133|NCT01824602|79009214|FG003|Overall Study|Withdrawal by Subject|2|||
44212134|NCT01824602|79009211|FG000|Overall Study|Patient non-compliance|0|||
44212135|NCT01824602|79009212|FG001|Overall Study|Patient non-compliance|0|||
44212136|NCT01824602|79009213|FG002|Overall Study|Patient non-compliance|1|||
44212137|NCT01824602|79009214|FG003|Overall Study|Patient non-compliance|0|||
44212138|NCT01824602|79009211|FG000|Overall Study|Adverse Event|1|||
44212139|NCT01824602|79009212|FG001|Overall Study|Adverse Event|0|||
44212140|NCT01824602|79009213|FG002|Overall Study|Adverse Event|2|||
44212141|NCT01824602|79009214|FG003|Overall Study|Adverse Event|2|||
44212142|NCT01824602|79009211|FG000|Overall Study|Treatment failure|0|||
44212143|NCT01824602|79009212|FG001|Overall Study|Treatment failure|0|||
44212144|NCT01824602|79009213|FG002|Overall Study|Treatment failure|0|||
44212145|NCT01824602|79009214|FG003|Overall Study|Treatment failure|1|||
44212146|NCT01704651|79009226|FG000|Overall Study|Pre-op withdrawal by subject|1|||
44212147|NCT01704651|79009227|FG001|Overall Study|Pre-op withdrawal by subject|1|||
44212148|NCT01704651|79009226|FG000|Overall Study|Pre-op change in treatment plan|1|||
44212149|NCT01704651|79009227|FG001|Overall Study|Pre-op change in treatment plan|4|||
44212150|NCT01704651|79009226|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
44212151|NCT01704651|79009227|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
44212152|NCT01704651|79009226|FG000|Overall Study|Post-op did not have laparotomy|2|||
44212153|NCT01704651|79009227|FG001|Overall Study|Post-op did not have laparotomy|1|||
44269831|NCT00553514|79194991|FG001|Overall Study|Lack of ovarian response|5|||
44269832|NCT00553514|79194992|FG002|Overall Study|Lack of ovarian response|5|||
44269833|NCT00553514|79194993|FG003|Overall Study|Lack of ovarian response|5|||
44269834|NCT00553514|79194994|FG004|Overall Study|Lack of ovarian response|6|||
44269835|NCT00553514|79194990|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
44269836|NCT00553514|79194991|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
44370637|NCT00883558|79375906|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
44212154|NCT01876706|79009233|FG000|Overall Study|BPH Intervention|9|||
44212155|NCT01876706|79009233|FG000|Overall Study|Lost to Follow-up|7|||
44269837|NCT00553514|79194992|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
44269838|NCT00553514|79194993|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
44370638|NCT00883558|79375907|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
44212156|NCT01876706|79009233|FG000|Overall Study|Withdrawals|6|||
44212157|NCT01876706|79009233|FG000|Overall Study|Death|3|||
44212158|NCT01876082|79009239|FG000|Overall Study|Withdrawal by Subject|0|||
44212159|NCT01876082|79009240|FG001|Overall Study|Withdrawal by Subject|2|||
44212160|NCT01876082|79009239|FG000|Overall Study|Protocol Violation|1|||
44212161|NCT01876082|79009240|FG001|Overall Study|Protocol Violation|0|||
44212162|NCT01876082|79009239|FG000|Overall Study|Adverse Event|1|||
44212163|NCT01876082|79009240|FG001|Overall Study|Adverse Event|1|||
44212164|NCT01876082|79009239|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
44212165|NCT01876082|79009240|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
44212166|NCT01704495|79009250|FG000|Subjects Randomized|Other Reason|3|||
44212167|NCT01704495|79009251|FG001|Subjects Randomized|Other Reason|2|||
44212168|NCT01704495|79009252|FG002|Subjects Randomized|Other Reason|3|||
44212169|NCT01704495|79009253|FG003|Subjects Randomized|Other Reason|2|||
44212170|NCT01704495|79009250|FG000|Subjects Randomized|Discontinuation criteria met|4|||
44212171|NCT01704495|79009251|FG001|Subjects Randomized|Discontinuation criteria met|2|||
44212172|NCT01704495|79009252|FG002|Subjects Randomized|Discontinuation criteria met|2|||
44212173|NCT01704495|79009253|FG003|Subjects Randomized|Discontinuation criteria met|0|||
44212174|NCT01704495|79009250|FG000|Subjects Randomized|Adverse Event|8|||
44212175|NCT01704495|79009251|FG001|Subjects Randomized|Adverse Event|2|||
44212176|NCT01704495|79009252|FG002|Subjects Randomized|Adverse Event|0|||
44212177|NCT01704495|79009253|FG003|Subjects Randomized|Adverse Event|7|||
44212178|NCT01704495|79009250|FG000|Subjects Randomized|Withdrawal by Subject|5|||
44370639|NCT00880750|79375915|FG000|First Intervention|Adverse Event|1|||
44370640|NCT00880750|79375916|FG001|First Intervention|Adverse Event|0|||
44370641|NCT00880750|79375915|FG000|First Intervention|Unable to collect urine|4|||
44370642|NCT00880750|79375916|FG001|First Intervention|Unable to collect urine|0|||
44370643|NCT00880750|79375915|FG000|First Intervention|Non-compliance with meals|0|||
44370644|NCT00880750|79375916|FG001|First Intervention|Non-compliance with meals|1|||
44370645|NCT00880750|79375915|FG000|First Intervention|Withdrawal by Subject|2|||
44452516|NCT00079183|79461419|FG000|Overall Study|Study medication non-compliance|2|||
44452517|NCT00079183|79461419|FG000|Overall Study|Specimen collection non-compliance|1|||
44212179|NCT01704495|79009251|FG001|Subjects Randomized|Withdrawal by Subject|5|||
44370646|NCT00880750|79375916|FG001|First Intervention|Withdrawal by Subject|0|||
44212180|NCT01704495|79009252|FG002|Subjects Randomized|Withdrawal by Subject|5|||
44269839|NCT00553514|79194994|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
44452518|NCT00676403|79461430|FG000|Overall Study|Adverse Event|1|||
44212181|NCT01704495|79009253|FG003|Subjects Randomized|Withdrawal by Subject|5|||
44212182|NCT01704495|79009250|FG000|Subjects Randomized|Protocol Violation|1|||
44212183|NCT01704495|79009251|FG001|Subjects Randomized|Protocol Violation|1|||
44212184|NCT01704495|79009252|FG002|Subjects Randomized|Protocol Violation|2|||
44212185|NCT01704495|79009253|FG003|Subjects Randomized|Protocol Violation|0|||
44212186|NCT01704495|79009250|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
44212187|NCT01704495|79009251|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
44212188|NCT01704495|79009252|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
44212189|NCT01704495|79009253|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
44212190|NCT01704495|79009250|FG000|Optional Safety Extension|Adverse Event|0|||
44212191|NCT01704495|79009251|FG001|Optional Safety Extension|Adverse Event|4|||
44212192|NCT01704495|79009252|FG002|Optional Safety Extension|Adverse Event|0|||
44212193|NCT01704495|79009253|FG003|Optional Safety Extension|Adverse Event|1|||
44212194|NCT01704495|79009250|FG000|Optional Safety Extension|Other reason|27|||
44212195|NCT01704495|79009251|FG001|Optional Safety Extension|Other reason|29|||
44212196|NCT01704495|79009252|FG002|Optional Safety Extension|Other reason|30|||
44212197|NCT01704495|79009253|FG003|Optional Safety Extension|Other reason|28|||
44212198|NCT01704495|79009250|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
44212199|NCT01704495|79009251|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
44212200|NCT01704495|79009252|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
44212201|NCT01704495|79009253|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
44212202|NCT01716663|79009263|FG000|Overall Study|Withdrawn prior to procedure|4|||
44212203|NCT01716663|79009263|FG000|Overall Study|Treated with non-study catheter|2|||
44212204|NCT01716585|79009269|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
44212205|NCT01716585|79009270|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
44212206|NCT01716585|79009269|FG000|Double-blind Treatment|Adverse Event|2|||
44212207|NCT01716585|79009270|FG001|Double-blind Treatment|Adverse Event|1|||
44212208|NCT01716585|79009269|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
44212209|NCT01716585|79009270|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
44212210|NCT01716585|79009269|FG000|Double-blind Treatment|Lost to Follow-up|2|||
44212211|NCT01716585|79009270|FG001|Double-blind Treatment|Lost to Follow-up|0|||
44212212|NCT01716585|79009269|FG000|Double-blind Treatment|Subject Noncompliant|1|||
44212213|NCT01716585|79009270|FG001|Double-blind Treatment|Subject Noncompliant|0|||
44212214|NCT01716585|79009269|FG000|Double-blind Treatment|Other|1|||
44269840|NCT00553514|79194990|FG000|Overall Study|Risk of multiple pregnancy|0|||
44212215|NCT01716585|79009270|FG001|Double-blind Treatment|Other|0|||
44212216|NCT01716585|79009269|FG000|Open-label Treatment|Adverse Event|0|||
44212217|NCT01716585|79009270|FG001|Open-label Treatment|Adverse Event|2|||
44370647|NCT00880750|79375915|FG000|First Intervention|Lost to Follow-up|2|||
44370648|NCT00880750|79375916|FG001|First Intervention|Lost to Follow-up|0|||
44370649|NCT00880750|79375915|FG000|Second Intervention|Withdrawal by Subject|2|||
44370650|NCT00880750|79375916|FG001|Second Intervention|Withdrawal by Subject|2|||
44370651|NCT00880750|79375915|FG000|Second Intervention|Protocol Violation|1|||
44370652|NCT00880750|79375916|FG001|Second Intervention|Protocol Violation|0|||
44452519|NCT00676403|79461431|FG001|Overall Study|Adverse Event|2|||
44452520|NCT00676403|79461432|FG002|Overall Study|Adverse Event|0|||
44370653|NCT00880750|79375915|FG000|Second Intervention|Unable to collect urine|1|||
44212218|NCT01716585|79009269|FG000|Open-label Treatment|Virologic Failure|0|||
44212219|NCT01716585|79009270|FG001|Open-label Treatment|Virologic Failure|2|||
44212220|NCT01716585|79009269|FG000|Open-label Treatment|Withdrawal by Subject|0|||
44212221|NCT01716585|79009270|FG001|Open-label Treatment|Withdrawal by Subject|3|||
44212222|NCT01852292|79009279|FG000|Overall Study|Untreated - did not receive study drug|3|||
44212223|NCT01852292|79009280|FG001|Overall Study|Untreated - did not receive study drug|1|||
44212224|NCT01852292|79009279|FG000|Overall Study|Death|9|||
44212225|NCT01852292|79009280|FG001|Overall Study|Death|8|||
44212226|NCT01852292|79009279|FG000|Overall Study|Patient/guardian decision|8|||
44212227|NCT01852292|79009280|FG001|Overall Study|Patient/guardian decision|4|||
44212228|NCT01852292|79009279|FG000|Overall Study|Adverse Event|8|||
44212229|NCT01852292|79009280|FG001|Overall Study|Adverse Event|11|||
44212230|NCT01852292|79009279|FG000|Overall Study|Physician Decision|6|||
44212231|NCT01852292|79009280|FG001|Overall Study|Physician Decision|2|||
44370654|NCT00880750|79375916|FG001|Second Intervention|Unable to collect urine|0|||
44370655|NCT00597766|79375925|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
44370656|NCT00597766|79375926|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
44370657|NCT00597766|79375927|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
44370658|NCT00597766|79375925|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
44370659|NCT00597766|79375926|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
44212232|NCT01852292|79009279|FG000|Overall Study|Protocol Violation|2|||
44212233|NCT01852292|79009280|FG001|Overall Study|Protocol Violation|0|||
44212234|NCT01852292|79009279|FG000|Overall Study|Non-compliance with study treatment|1|||
44212235|NCT01852292|79009280|FG001|Overall Study|Non-compliance with study treatment|0|||
44452521|NCT00676403|79461433|FG003|Overall Study|Adverse Event|5|||
44212236|NCT01852292|79009279|FG000|Overall Study|Study terminated by Sponsor|0|||
44212237|NCT01852292|79009280|FG001|Overall Study|Study terminated by Sponsor|1|||
44212238|NCT01852292|79009279|FG000|Overall Study|Progressive disease|42|||
44212239|NCT01852292|79009280|FG001|Overall Study|Progressive disease|52|||
44212240|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
44212241|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
44212242|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
44212243|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
44212244|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
44212245|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
44212246|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
44212247|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
44212248|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
44212249|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
44212250|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
44212251|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
44212252|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
44212253|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
44212254|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
44212255|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
44370660|NCT00597766|79375927|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
44370661|NCT00979992|79375935|FG000|Overall Study|Ineligible - inadequate pathology|1|||
44370662|NCT00979992|79375935|FG000|Overall Study|Ineligible - wrong cell type|2|||
44452522|NCT00676403|79461434|FG004|Overall Study|Adverse Event|1|||
44452523|NCT00676403|79461435|FG005|Overall Study|Adverse Event|2|||
44452524|NCT00676403|79461430|FG000|Overall Study|Lost to Follow-up|0|||
44452525|NCT00676403|79461431|FG001|Overall Study|Lost to Follow-up|0|||
44452526|NCT00676403|79461432|FG002|Overall Study|Lost to Follow-up|0|||
44452527|NCT00676403|79461433|FG003|Overall Study|Lost to Follow-up|0|||
44452528|NCT00676403|79461434|FG004|Overall Study|Lost to Follow-up|0|||
44452529|NCT00676403|79461435|FG005|Overall Study|Lost to Follow-up|1|||
44452530|NCT00676403|79461430|FG000|Overall Study|Reason Unspecified|1|||
44452531|NCT00676403|79461431|FG001|Overall Study|Reason Unspecified|0|||
44452532|NCT00676403|79461432|FG002|Overall Study|Reason Unspecified|1|||
44452533|NCT00676403|79461433|FG003|Overall Study|Reason Unspecified|0|||
44452534|NCT00676403|79461434|FG004|Overall Study|Reason Unspecified|0|||
44452535|NCT00676403|79461435|FG005|Overall Study|Reason Unspecified|1|||
44370663|NCT00979992|79375935|FG000|Overall Study|Refused - Never Treated|2|||
44370664|NCT01079741|79375944|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
44370665|NCT01079741|79375945|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
44370666|NCT01079741|79375946|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
44370667|NCT01079741|79375947|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
44370668|NCT01079741|79375948|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
44370669|NCT01079741|79375944|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
44370670|NCT01079741|79375945|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
44370671|NCT01079741|79375946|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
44370672|NCT01079741|79375947|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
44370673|NCT01079741|79375948|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
44370674|NCT01079663|79375962|FG000|Overall Study|Adverse Event|0|||
44370675|NCT01079663|79375963|FG001|Overall Study|Adverse Event|2|||
44370676|NCT01079663|79375962|FG000|Overall Study|Protocol Violation|0|||
44370677|NCT01079663|79375963|FG001|Overall Study|Protocol Violation|2|||
44370678|NCT00879814|79375973|FG000|Overall Study|Adverse Event|0|||
44370679|NCT00879814|79375974|FG001|Overall Study|Adverse Event|1|||
44370680|NCT00879814|79375975|FG002|Overall Study|Adverse Event|0|||
44370681|NCT00879814|79375976|FG003|Overall Study|Adverse Event|0|||
44370682|NCT00879814|79375973|FG000|Overall Study|Lost to Follow-up|1|||
44370683|NCT00879814|79375974|FG001|Overall Study|Lost to Follow-up|0|||
44370684|NCT00879814|79375975|FG002|Overall Study|Lost to Follow-up|0|||
44370685|NCT00879814|79375976|FG003|Overall Study|Lost to Follow-up|2|||
44370686|NCT00879814|79375973|FG000|Overall Study|Participant Failed to Return|0|||
44370687|NCT00879814|79375974|FG001|Overall Study|Participant Failed to Return|0|||
44370688|NCT00879814|79375975|FG002|Overall Study|Participant Failed to Return|0|||
44452536|NCT00676403|79461430|FG000|Overall Study|Withdrawal by Subject|0|||
44452537|NCT00676403|79461431|FG001|Overall Study|Withdrawal by Subject|0|||
44452538|NCT00676403|79461432|FG002|Overall Study|Withdrawal by Subject|0|||
44212256|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
44370689|NCT00879814|79375976|FG003|Overall Study|Participant Failed to Return|1|||
44212257|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
44370690|NCT00879814|79375973|FG000|Overall Study|Withdrawal by Subject|3|||
44452539|NCT00676403|79461433|FG003|Overall Study|Withdrawal by Subject|0|||
44452540|NCT00676403|79461434|FG004|Overall Study|Withdrawal by Subject|0|||
44370691|NCT00879814|79375974|FG001|Overall Study|Withdrawal by Subject|1|||
44212258|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
44212259|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
44212260|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
44212261|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
44212262|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
44212263|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
44212264|NCT01715805|79009286|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
44212265|NCT01715805|79009287|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
44212266|NCT01715805|79009288|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
44212267|NCT01715805|79009289|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
44212268|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
44212269|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
44212270|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
44212271|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
44212272|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
44212273|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
44212274|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
44212275|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
44212276|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
44212277|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
44212278|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
44212279|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
44212280|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
44212281|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
44212282|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
44212283|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
44212284|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
44212285|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
44212286|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
44212287|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
44212288|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
44212289|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
44212290|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
44212291|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
44212292|NCT01715805|79009286|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
44212293|NCT01715805|79009287|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
44212294|NCT01715805|79009288|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
44212295|NCT01715805|79009289|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
44212296|NCT01852214|79009297|FG000|Period 1|Adverse Event|1|||
44212297|NCT01852214|79009298|FG001|Period 1|Adverse Event|2|||
44212298|NCT01852214|79009297|FG000|Period 1|Withdrawal by Subject|0|||
44212299|NCT01852214|79009298|FG001|Period 1|Withdrawal by Subject|1|||
44212300|NCT01852214|79009297|FG000|Washout Period|Withdrawal by Subject|0|||
44212301|NCT01852214|79009298|FG001|Washout Period|Withdrawal by Subject|1|||
44212302|NCT01393990|79009323|FG000|Overall Study|Adverse Event|0|||
44212303|NCT01393990|79009324|FG001|Overall Study|Adverse Event|0|||
44212304|NCT01393990|79009325|FG002|Overall Study|Adverse Event|0|||
44212305|NCT01393990|79009326|FG003|Overall Study|Adverse Event|0|||
44212306|NCT01393990|79009327|FG004|Overall Study|Adverse Event|0|||
44212307|NCT01393990|79009328|FG005|Overall Study|Adverse Event|0|||
44212308|NCT01393990|79009329|FG006|Overall Study|Adverse Event|0|||
44370692|NCT00879814|79375975|FG002|Overall Study|Withdrawal by Subject|1|||
44370693|NCT00879814|79375976|FG003|Overall Study|Withdrawal by Subject|2|||
44370694|NCT00879814|79375973|FG000|Overall Study|Physician Decision|0|||
44370695|NCT00879814|79375974|FG001|Overall Study|Physician Decision|0|||
44370696|NCT00879814|79375975|FG002|Overall Study|Physician Decision|1|||
44370697|NCT00879814|79375976|FG003|Overall Study|Physician Decision|0|||
44370698|NCT00879814|79375973|FG000|Overall Study|Other|0|||
44370699|NCT00879814|79375974|FG001|Overall Study|Other|0|||
44370700|NCT00879814|79375975|FG002|Overall Study|Other|1|||
44212309|NCT01393990|79009330|FG007|Overall Study|Adverse Event|0|||
44212310|NCT01393990|79009331|FG008|Overall Study|Adverse Event|0|||
44212311|NCT01393990|79009332|FG009|Overall Study|Adverse Event|0|||
44212312|NCT01393990|79009333|FG010|Overall Study|Adverse Event|0|||
44212313|NCT01393990|79009334|FG011|Overall Study|Adverse Event|0|||
44370701|NCT00879814|79375976|FG003|Overall Study|Other|0|||
44370702|NCT01132664|79375991|FG000|Phase lb|Adverse Event|0|||
44370703|NCT01132664|79375992|FG001|Phase lb|Adverse Event|1|||
44370704|NCT01132664|79375993|FG002|Phase lb|Adverse Event|0|||
44212314|NCT01393990|79009335|FG012|Overall Study|Adverse Event|0|||
44370705|NCT01132664|79375994|FG003|Phase lb|Adverse Event|0|||
44212315|NCT01393990|79009336|FG013|Overall Study|Adverse Event|0|||
44212316|NCT01393990|79009337|FG014|Overall Study|Adverse Event|1|||
44212317|NCT01393990|79009338|FG015|Overall Study|Adverse Event|1|||
44212318|NCT01393990|79009339|FG016|Overall Study|Adverse Event|0|||
44212319|NCT01393990|79009340|FG017|Overall Study|Adverse Event|0|||
44212320|NCT01393990|79009323|FG000|Overall Study|Progressive Disease|1|||
44212321|NCT01393990|79009324|FG001|Overall Study|Progressive Disease|0|||
44212322|NCT01393990|79009325|FG002|Overall Study|Progressive Disease|0|||
44212323|NCT01393990|79009326|FG003|Overall Study|Progressive Disease|1|||
44212324|NCT01393990|79009327|FG004|Overall Study|Progressive Disease|1|||
44212325|NCT01393990|79009328|FG005|Overall Study|Progressive Disease|1|||
44212326|NCT01393990|79009329|FG006|Overall Study|Progressive Disease|1|||
44212327|NCT01393990|79009330|FG007|Overall Study|Progressive Disease|1|||
44212328|NCT01393990|79009331|FG008|Overall Study|Progressive Disease|3|||
44212329|NCT01393990|79009332|FG009|Overall Study|Progressive Disease|1|||
44212330|NCT01393990|79009333|FG010|Overall Study|Progressive Disease|0|||
44212331|NCT01393990|79009334|FG011|Overall Study|Progressive Disease|0|||
44212332|NCT01393990|79009335|FG012|Overall Study|Progressive Disease|0|||
44212333|NCT01393990|79009336|FG013|Overall Study|Progressive Disease|1|||
44212334|NCT01393990|79009337|FG014|Overall Study|Progressive Disease|6|||
44212335|NCT01393990|79009338|FG015|Overall Study|Progressive Disease|1|||
44212336|NCT01393990|79009339|FG016|Overall Study|Progressive Disease|0|||
44212337|NCT01393990|79009340|FG017|Overall Study|Progressive Disease|0|||
44212338|NCT01393990|79009323|FG000|Overall Study|Death|0|||
44212339|NCT01393990|79009324|FG001|Overall Study|Death|0|||
44212340|NCT01393990|79009325|FG002|Overall Study|Death|0|||
44212341|NCT01393990|79009326|FG003|Overall Study|Death|0|||
44212342|NCT01393990|79009327|FG004|Overall Study|Death|1|||
44212343|NCT01393990|79009328|FG005|Overall Study|Death|0|||
44212344|NCT01393990|79009329|FG006|Overall Study|Death|0|||
44212345|NCT01393990|79009330|FG007|Overall Study|Death|0|||
44212346|NCT01393990|79009331|FG008|Overall Study|Death|0|||
44212347|NCT01393990|79009332|FG009|Overall Study|Death|0|||
44212348|NCT01393990|79009333|FG010|Overall Study|Death|0|||
44212349|NCT01393990|79009334|FG011|Overall Study|Death|0|||
44212350|NCT01393990|79009335|FG012|Overall Study|Death|0|||
44212351|NCT01393990|79009336|FG013|Overall Study|Death|1|||
44212352|NCT01393990|79009337|FG014|Overall Study|Death|1|||
44212353|NCT01393990|79009338|FG015|Overall Study|Death|0|||
44212354|NCT01393990|79009339|FG016|Overall Study|Death|0|||
44212355|NCT01393990|79009340|FG017|Overall Study|Death|0|||
44370706|NCT01132664|79375995|FG004|Phase lb|Adverse Event|0|||
44370707|NCT01132664|79375991|FG000|Phase lb|Withdrawal by Subject|1|||
44370708|NCT01132664|79375992|FG001|Phase lb|Withdrawal by Subject|2|||
44370709|NCT01132664|79375993|FG002|Phase lb|Withdrawal by Subject|0|||
44370710|NCT01132664|79375994|FG003|Phase lb|Withdrawal by Subject|0|||
44370711|NCT01132664|79375995|FG004|Phase lb|Withdrawal by Subject|0|||
44370712|NCT01132664|79375991|FG000|Phase lb|Disease Progression|4|||
44370713|NCT01132664|79375992|FG001|Phase lb|Disease Progression|9|||
44370714|NCT01132664|79375993|FG002|Phase lb|Disease Progression|0|||
44370715|NCT01132664|79375994|FG003|Phase lb|Disease Progression|0|||
44370716|NCT01132664|79375995|FG004|Phase lb|Disease Progression|0|||
44370717|NCT01132664|79375991|FG000|Phase ll|Death|0|||
44370718|NCT01132664|79375992|FG001|Phase ll|Death|0|||
44370719|NCT01132664|79375993|FG002|Phase ll|Death|2|||
44543618|NCT03678103|79556701|FG000|Overall Study|Withdrawn prior to completion|4|||
44212356|NCT01393990|79009323|FG000|Overall Study|Withdrawal by Subject|0|||
44212357|NCT01393990|79009324|FG001|Overall Study|Withdrawal by Subject|0|||
44212358|NCT01393990|79009325|FG002|Overall Study|Withdrawal by Subject|0|||
44212359|NCT01393990|79009326|FG003|Overall Study|Withdrawal by Subject|0|||
44212360|NCT01393990|79009327|FG004|Overall Study|Withdrawal by Subject|0|||
44212361|NCT01393990|79009328|FG005|Overall Study|Withdrawal by Subject|0|||
44212362|NCT01393990|79009329|FG006|Overall Study|Withdrawal by Subject|0|||
44212363|NCT01393990|79009330|FG007|Overall Study|Withdrawal by Subject|0|||
44370720|NCT01132664|79375994|FG003|Phase ll|Death|0|||
44543619|NCT03649477|79556708|FG000|Overall Study|Adverse Event|2|||
44212364|NCT01393990|79009331|FG008|Overall Study|Withdrawal by Subject|0|||
44212365|NCT01393990|79009332|FG009|Overall Study|Withdrawal by Subject|0|||
44212366|NCT01393990|79009333|FG010|Overall Study|Withdrawal by Subject|0|||
44212367|NCT01393990|79009334|FG011|Overall Study|Withdrawal by Subject|0|||
44370721|NCT01132664|79375995|FG004|Phase ll|Death|0|||
44370722|NCT01132664|79375991|FG000|Phase ll|Adverse Event|0|||
44212368|NCT01393990|79009335|FG012|Overall Study|Withdrawal by Subject|0|||
44212369|NCT01393990|79009336|FG013|Overall Study|Withdrawal by Subject|0|||
44212370|NCT01393990|79009337|FG014|Overall Study|Withdrawal by Subject|1|||
44212371|NCT01393990|79009338|FG015|Overall Study|Withdrawal by Subject|1|||
44212372|NCT01393990|79009339|FG016|Overall Study|Withdrawal by Subject|0|||
44370723|NCT01132664|79375992|FG001|Phase ll|Adverse Event|0|||
44370724|NCT01132664|79375993|FG002|Phase ll|Adverse Event|10|||
44212373|NCT01393990|79009340|FG017|Overall Study|Withdrawal by Subject|0|||
44212374|NCT00210184|79009389|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
44370725|NCT01132664|79375994|FG003|Phase ll|Adverse Event|0|||
44452541|NCT00676403|79461435|FG005|Overall Study|Withdrawal by Subject|1|||
44452542|NCT00078325|79461458|FG000|Overall Study|Adverse Event|15|||
44452543|NCT00078325|79461459|FG001|Overall Study|Adverse Event|10|||
44452544|NCT00078325|79461460|FG002|Overall Study|Adverse Event|5|||
44452545|NCT00078325|79461458|FG000|Overall Study|Protocol Violation|2|||
44452546|NCT00078325|79461459|FG001|Overall Study|Protocol Violation|2|||
44452547|NCT00078325|79461460|FG002|Overall Study|Protocol Violation|0|||
44452548|NCT00078325|79461458|FG000|Overall Study|Withdrawal by Subject|1|||
44452549|NCT00078325|79461459|FG001|Overall Study|Withdrawal by Subject|5|||
44452550|NCT00078325|79461460|FG002|Overall Study|Withdrawal by Subject|3|||
44452551|NCT00078325|79461458|FG000|Overall Study|Lost to Follow-up|0|||
44452552|NCT00078325|79461459|FG001|Overall Study|Lost to Follow-up|1|||
44452553|NCT00078325|79461460|FG002|Overall Study|Lost to Follow-up|1|||
44452554|NCT00078325|79461458|FG000|Overall Study|Physician Decision|2|||
44212375|NCT00210106|79009393|FG000|Overall Study|Death|1|||
44212376|NCT00210106|79009393|FG000|Overall Study|Protocol Violation|13|||
44212377|NCT01851590|79009401|FG000|Overall Study|Withdrawal by Subject|0|||
44212378|NCT01851590|79009402|FG001|Overall Study|Withdrawal by Subject|0|||
44212379|NCT01851590|79009403|FG002|Overall Study|Withdrawal by Subject|1|||
44212380|NCT01851590|79009401|FG000|Overall Study|Adverse Event|0|||
44212381|NCT01851590|79009402|FG001|Overall Study|Adverse Event|0|||
44452555|NCT00078325|79461459|FG001|Overall Study|Physician Decision|0|||
44452556|NCT00078325|79461460|FG002|Overall Study|Physician Decision|1|||
44452557|NCT00078325|79461458|FG000|Overall Study|Miscellaneous|1|||
44452558|NCT00078325|79461459|FG001|Overall Study|Miscellaneous|1|||
44452559|NCT00078325|79461460|FG002|Overall Study|Miscellaneous|1|||
44452560|NCT00077857|79461470|FG000|Overall Study|Adverse Event|30|||
44452561|NCT00077857|79461471|FG001|Overall Study|Adverse Event|32|||
44452562|NCT00077857|79461470|FG000|Overall Study|Death|7|||
44452563|NCT00077857|79461471|FG001|Overall Study|Death|3|||
44452564|NCT00077857|79461470|FG000|Overall Study|Insufficient therapeutic response|112|||
44452565|NCT00077857|79461471|FG001|Overall Study|Insufficient therapeutic response|128|||
44452566|NCT00077857|79461470|FG000|Overall Study|Violation of selection criteria at entry|3|||
44452567|NCT00077857|79461471|FG001|Overall Study|Violation of selection criteria at entry|1|||
44452568|NCT00077857|79461470|FG000|Overall Study|Other protocol violation|0|||
44452569|NCT00077857|79461471|FG001|Overall Study|Other protocol violation|1|||
44452570|NCT00077857|79461470|FG000|Overall Study|Refused treatment|29|||
44452571|NCT00077857|79461471|FG001|Overall Study|Refused treatment|21|||
44452572|NCT00077857|79461470|FG000|Overall Study|Failure to return|5|||
44452573|NCT00077857|79461471|FG001|Overall Study|Failure to return|5|||
44452574|NCT00077857|79461470|FG000|Overall Study|Other|15|||
44452575|NCT00077857|79461471|FG001|Overall Study|Other|13|||
44452576|NCT00545402|79461479|FG000|Overall Study|Discontinuation of treatment|17|||
44452577|NCT00545402|79461480|FG001|Overall Study|Discontinuation of treatment|9|||
44370726|NCT01132664|79375995|FG004|Phase ll|Adverse Event|0|||
44370727|NCT01132664|79375991|FG000|Phase ll|Withdrawal by Subject|0|||
44370728|NCT01132664|79375992|FG001|Phase ll|Withdrawal by Subject|0|||
44370729|NCT01132664|79375993|FG002|Phase ll|Withdrawal by Subject|3|||
44452578|NCT00545402|79461479|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
44452579|NCT00545402|79461480|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
44452580|NCT00545402|79461479|FG000|Overall Study|Death|5|||
44452581|NCT00545402|79461480|FG001|Overall Study|Death|7|||
44452582|NCT00545402|79461479|FG000|Overall Study|Graft loss|2|||
44452583|NCT00545402|79461480|FG001|Overall Study|Graft loss|4|||
44452584|NCT00545402|79461479|FG000|Overall Study|Withdrawal by Subject|0|||
44452585|NCT00545402|79461480|FG001|Overall Study|Withdrawal by Subject|1|||
44212382|NCT01851590|79009403|FG002|Overall Study|Adverse Event|2|||
44370730|NCT01132664|79375994|FG003|Phase ll|Withdrawal by Subject|0|||
44370731|NCT01132664|79375995|FG004|Phase ll|Withdrawal by Subject|0|||
44370732|NCT01132664|79375991|FG000|Phase ll|Disease progression|0|||
44370733|NCT01132664|79375992|FG001|Phase ll|Disease progression|0|||
44370734|NCT01132664|79375993|FG002|Phase ll|Disease progression|35|||
44452586|NCT00545402|79461479|FG000|Overall Study|Protocol Violation|1|||
44452587|NCT00545402|79461480|FG001|Overall Study|Protocol Violation|0|||
44212383|NCT01851590|79009401|FG000|Overall Study|Lack of Efficacy|0|||
44212384|NCT01851590|79009402|FG001|Overall Study|Lack of Efficacy|1|||
44212385|NCT01851590|79009403|FG002|Overall Study|Lack of Efficacy|0|||
44212386|NCT01852058|79009418|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
44212387|NCT01852058|79009419|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212388|NCT01852058|79009420|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44452588|NCT00545402|79461479|FG000|Overall Study|Reason not specified|1|||
44452589|NCT00545402|79461480|FG001|Overall Study|Reason not specified|1|||
44452590|NCT00545792|79461486|FG000|Overall Study|Withdrawal by Subject|1|||
44212389|NCT01852058|79009421|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44370735|NCT01132664|79375994|FG003|Phase ll|Disease progression|0|||
44370736|NCT01132664|79375995|FG004|Phase ll|Disease progression|0|||
44370737|NCT01132664|79375991|FG000|BM Cohort|Disease progression|0|||
44452591|NCT00545168|79461493|FG000|Overall Study|Lost to Follow-up|5|||
44212390|NCT01852058|79009422|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212391|NCT01852058|79009423|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212392|NCT01852058|79009424|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212393|NCT01852058|79009425|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212394|NCT01852058|79009426|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212395|NCT01852058|79009427|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212396|NCT01852058|79009428|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212397|NCT01852058|79009429|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
44212398|NCT01852058|79009418|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212399|NCT01852058|79009419|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212400|NCT01852058|79009420|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212401|NCT01852058|79009421|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212402|NCT01852058|79009422|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
44212403|NCT01852058|79009423|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212404|NCT01852058|79009424|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212405|NCT01852058|79009425|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212406|NCT01852058|79009426|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212407|NCT01852058|79009427|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212408|NCT01852058|79009428|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212409|NCT01852058|79009429|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
44212410|NCT01852058|79009418|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212411|NCT01852058|79009419|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212412|NCT01852058|79009420|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212413|NCT01852058|79009421|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212414|NCT01852058|79009422|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
44212415|NCT01852058|79009423|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
44212416|NCT01852058|79009424|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212417|NCT01852058|79009425|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212418|NCT01852058|79009426|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212419|NCT01852058|79009427|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212420|NCT01852058|79009428|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212421|NCT01852058|79009429|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
44212422|NCT01852058|79009418|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212423|NCT01852058|79009419|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212424|NCT01852058|79009420|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212425|NCT01852058|79009421|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212426|NCT01852058|79009422|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
44212427|NCT01852058|79009423|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212428|NCT01852058|79009424|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212429|NCT01852058|79009425|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212430|NCT01852058|79009426|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212431|NCT01852058|79009427|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212432|NCT01852058|79009428|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44212433|NCT01852058|79009429|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
44370738|NCT01132664|79375992|FG001|BM Cohort|Disease progression|0|||
44370739|NCT01132664|79375993|FG002|BM Cohort|Disease progression|0|||
44370740|NCT01132664|79375994|FG003|BM Cohort|Disease progression|3|||
44370741|NCT01132664|79375995|FG004|BM Cohort|Disease progression|4|||
44370742|NCT01132664|79375991|FG000|BM Cohort|Adverse Event|0|||
44370743|NCT01132664|79375992|FG001|BM Cohort|Adverse Event|0|||
44370744|NCT01132664|79375993|FG002|BM Cohort|Adverse Event|0|||
44370745|NCT01132664|79375994|FG003|BM Cohort|Adverse Event|0|||
44370746|NCT01132664|79375995|FG004|BM Cohort|Adverse Event|1|||
44370747|NCT01132664|79375991|FG000|BM Cohort|Withdrawal by Subject|0|||
44370748|NCT01132664|79375992|FG001|BM Cohort|Withdrawal by Subject|0|||
44370749|NCT01132664|79375993|FG002|BM Cohort|Withdrawal by Subject|0|||
44370750|NCT01132664|79375994|FG003|BM Cohort|Withdrawal by Subject|0|||
44370751|NCT01132664|79375995|FG004|BM Cohort|Withdrawal by Subject|1|||
44370752|NCT00591409|79376017|FG000|Overall Study|Not Treated|0|||
44370753|NCT00591409|79376018|FG001|Overall Study|Not Treated|0|||
44212434|NCT01852058|79009418|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212435|NCT01852058|79009419|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212436|NCT01852058|79009420|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212437|NCT01852058|79009421|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212438|NCT01852058|79009422|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
44212439|NCT01852058|79009423|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
44212440|NCT01852058|79009424|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212441|NCT01852058|79009425|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212442|NCT01852058|79009426|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44370754|NCT00591409|79376019|FG002|Overall Study|Not Treated|0|||
44370755|NCT00591409|79376020|FG003|Overall Study|Not Treated|0|||
44370756|NCT00591409|79376021|FG004|Overall Study|Not Treated|1|||
44370757|NCT00591409|79376022|FG005|Overall Study|Not Treated|0|||
44452592|NCT00545168|79461494|FG001|Overall Study|Lost to Follow-up|5|||
44452593|NCT00545168|79461495|FG002|Overall Study|Lost to Follow-up|5|||
44452594|NCT00545168|79461493|FG000|Overall Study|Withdrawal by Subject|9|||
44452595|NCT00545168|79461494|FG001|Overall Study|Withdrawal by Subject|0|||
44452596|NCT00545168|79461495|FG002|Overall Study|Withdrawal by Subject|13|||
44452597|NCT00545168|79461493|FG000|Overall Study|Protocol Violation|1|||
44452598|NCT00545168|79461494|FG001|Overall Study|Protocol Violation|0|||
44452599|NCT00545168|79461495|FG002|Overall Study|Protocol Violation|1|||
44452600|NCT00545168|79461493|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
44452601|NCT00545168|79461494|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
44452602|NCT00545168|79461495|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
44452603|NCT00544544|79461504|FG000|Overall Study|Withdrawal by Subject|1|||
44452604|NCT00544544|79461504|FG000|Overall Study|Adverse Event|1|||
44452605|NCT00544544|79461504|FG000|Overall Study|Lost to Follow-up|1|||
44452606|NCT00541346|79461508|FG000|Follow-up|Adverse Event|1|||
44452607|NCT00077623|79461515|FG000|Overall Study|Adverse Event|1|||
44452608|NCT00077623|79461516|FG001|Overall Study|Adverse Event|0|||
44452609|NCT00077623|79461517|FG002|Overall Study|Adverse Event|1|||
44452610|NCT00077623|79461515|FG000|Overall Study|Withdrawal by Subject|2|||
44452611|NCT00077623|79461516|FG001|Overall Study|Withdrawal by Subject|10|||
44452612|NCT00077623|79461517|FG002|Overall Study|Withdrawal by Subject|1|||
44452613|NCT00077623|79461515|FG000|Overall Study|Other-Non safety reason|18|||
44452614|NCT00077623|79461516|FG001|Overall Study|Other-Non safety reason|15|||
44452615|NCT00077623|79461517|FG002|Overall Study|Other-Non safety reason|19|||
44452616|NCT00077623|79461515|FG000|Overall Study|Insufficient therapeutic response|2|||
44452617|NCT00077623|79461516|FG001|Overall Study|Insufficient therapeutic response|0|||
44370758|NCT00591409|79376023|FG006|Overall Study|Not Treated|0|||
44370759|NCT00591409|79376024|FG007|Overall Study|Not Treated|0|||
44370760|NCT00591409|79376025|FG008|Overall Study|Not Treated|0|||
44370761|NCT00591409|79376026|FG009|Overall Study|Not Treated|1|||
44370762|NCT01078805|79376048|FG000|Overall Study|Clinically significant abnormal lab|5|||
44370763|NCT01078805|79376048|FG000|Overall Study|Death|134|||
44370764|NCT01078805|79376048|FG000|Overall Study|Lost to Follow-up|676|||
44370765|NCT01078805|79376048|FG000|Overall Study|Physician Decision|169|||
44370766|NCT01078805|79376048|FG000|Overall Study|Serious adverse event|26|||
44370767|NCT01078805|79376048|FG000|Overall Study|Sponsor decision|46|||
44370768|NCT01078805|79376048|FG000|Overall Study|Withdrawal by Subject|739|||
44452618|NCT00077623|79461517|FG002|Overall Study|Insufficient therapeutic response|0|||
44452619|NCT00077623|79461515|FG000|Overall Study|Death|12|||
44452620|NCT00077623|79461516|FG001|Overall Study|Death|18|||
44452621|NCT00077623|79461517|FG002|Overall Study|Death|11|||
44452622|NCT00077623|79461515|FG000|Overall Study|Failure to return|1|||
44452623|NCT00077623|79461516|FG001|Overall Study|Failure to return|0|||
44452624|NCT00077623|79461517|FG002|Overall Study|Failure to return|0|||
44452625|NCT00541034|79461525|FG000|Overall Study|Non-Compliance|3|||
44452626|NCT00540644|79461531|FG000|Overall Study|Adverse Event|3|||
44452627|NCT00540644|79461532|FG001|Overall Study|Adverse Event|1|||
44452628|NCT00540644|79461531|FG000|Overall Study|Disease Progression|3|||
44452629|NCT00540644|79461532|FG001|Overall Study|Disease Progression|1|||
44452630|NCT00540644|79461531|FG000|Overall Study|Physician Decision|0|||
44452631|NCT00540644|79461532|FG001|Overall Study|Physician Decision|5|||
44452632|NCT00540644|79461531|FG000|Overall Study|Withdrawal by Subject|2|||
44452633|NCT00540644|79461532|FG001|Overall Study|Withdrawal by Subject|2|||
44452634|NCT00540644|79461531|FG000|Overall Study|Noncomplilance|1|||
44452635|NCT00540644|79461532|FG001|Overall Study|Noncomplilance|0|||
44452636|NCT00543296|79461538|FG000|Overall Study|Physician Decision|7|||
44370769|NCT01078805|79376048|FG000|Overall Study|Other|173|||
44370770|NCT01078805|79376048|FG000|Overall Study|Didn't take study drug|82|||
44370771|NCT00820027|79376056|FG000|Overall Study|Adverse Event|15|||
44370772|NCT00820027|79376057|FG001|Overall Study|Adverse Event|8|||
44452637|NCT00543140|79461542|FG000|Overall Study|Lost to Follow-up|33|||
44452638|NCT00543140|79461542|FG000|Overall Study|Withdrawal by Subject|13|||
44452639|NCT00543140|79461542|FG000|Overall Study|Protocol Violation|10|||
44452640|NCT00543140|79461542|FG000|Overall Study|Insufficient weight loss|10|||
44452641|NCT00543140|79461542|FG000|Overall Study|SAE leading to explant of SAGB|3|||
44452642|NCT00543140|79461542|FG000|Overall Study|Death|1|||
44452643|NCT00543140|79461542|FG000|Overall Study|Subject moved|1|||
44452644|NCT00543140|79461542|FG000|Overall Study|Conversion to different procedure|1|||
44452645|NCT00543062|79461546|FG000|Overall Study|Withdrawal by Subject|1|||
44452646|NCT00543062|79461547|FG001|Overall Study|Withdrawal by Subject|0|||
44452647|NCT00543062|79461548|FG002|Overall Study|Withdrawal by Subject|2|||
44212443|NCT01852058|79009427|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212444|NCT01852058|79009428|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44212445|NCT01852058|79009429|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
44452648|NCT00543062|79461549|FG003|Overall Study|Withdrawal by Subject|0|||
44452649|NCT00543062|79461546|FG000|Overall Study|Adverse Event|0|||
44452650|NCT00543062|79461547|FG001|Overall Study|Adverse Event|1|||
44452651|NCT00543062|79461548|FG002|Overall Study|Adverse Event|1|||
44452652|NCT00543062|79461549|FG003|Overall Study|Adverse Event|1|||
44452653|NCT00543062|79461546|FG000|Overall Study|Protocol Violation|1|||
44452654|NCT00543062|79461547|FG001|Overall Study|Protocol Violation|0|||
44452655|NCT00543062|79461548|FG002|Overall Study|Protocol Violation|0|||
44452656|NCT00543062|79461549|FG003|Overall Study|Protocol Violation|0|||
44452657|NCT03911960|79461569|FG000|Overall Study|Lost to Follow-up|5|||
44452658|NCT03911960|79461570|FG001|Overall Study|Lost to Follow-up|3|||
44452659|NCT00676091|79461579|FG000|Infant Series|Parent or legal guardian request|10|||
44452660|NCT00676091|79461580|FG001|Infant Series|Parent or legal guardian request|8|||
44212446|NCT01852058|79009418|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212447|NCT01852058|79009419|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212448|NCT01852058|79009420|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212449|NCT01852058|79009421|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
44212450|NCT01852058|79009422|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212451|NCT01852058|79009423|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212452|NCT01852058|79009424|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212453|NCT01852058|79009425|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212454|NCT01852058|79009426|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212455|NCT01852058|79009427|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212456|NCT01852058|79009428|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212457|NCT01852058|79009429|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
44212458|NCT01852058|79009418|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212459|NCT01852058|79009419|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212460|NCT01852058|79009420|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212461|NCT01852058|79009421|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212462|NCT01852058|79009422|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
44212463|NCT01852058|79009423|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
44212464|NCT01852058|79009424|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212465|NCT01852058|79009425|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212466|NCT01852058|79009426|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212467|NCT01852058|79009427|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212468|NCT01852058|79009428|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212469|NCT01852058|79009429|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
44212470|NCT01852058|79009418|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212471|NCT01852058|79009419|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212472|NCT01852058|79009420|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212473|NCT01852058|79009421|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212474|NCT01852058|79009422|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212475|NCT01852058|79009423|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212476|NCT01852058|79009424|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212477|NCT01852058|79009425|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
44212478|NCT01852058|79009426|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212479|NCT01852058|79009427|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212480|NCT01852058|79009428|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44212481|NCT01852058|79009429|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
44452661|NCT00676091|79461579|FG000|Infant Series|Protocol Violation|6|||
44452662|NCT00676091|79461580|FG001|Infant Series|Protocol Violation|3|||
44452663|NCT00676091|79461579|FG000|Infant Series|Adverse Event|2|||
44452664|NCT00676091|79461580|FG001|Infant Series|Adverse Event|3|||
44452665|NCT00676091|79461579|FG000|Infant Series|Failed to return|1|||
44452666|NCT00676091|79461580|FG001|Infant Series|Failed to return|3|||
44452667|NCT00676091|79461579|FG000|Infant Series|Lost to Follow-up|1|||
44452668|NCT00676091|79461580|FG001|Infant Series|Lost to Follow-up|0|||
44452669|NCT00676091|79461579|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
44212482|NCT01852058|79009418|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212483|NCT01852058|79009419|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212484|NCT01852058|79009420|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212485|NCT01852058|79009421|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212486|NCT01852058|79009422|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212487|NCT01852058|79009423|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212488|NCT01852058|79009424|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212489|NCT01852058|79009425|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212490|NCT01852058|79009426|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
44212491|NCT01852058|79009427|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212492|NCT01852058|79009428|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212493|NCT01852058|79009429|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
44212494|NCT00218296|79009466|FG000|Overall Study|Lost to Follow-up|9|||
44212495|NCT00218296|79009467|FG001|Overall Study|Lost to Follow-up|7|||
44212496|NCT00218296|79009466|FG000|Overall Study|Withdrawal by Subject|36|||
44212497|NCT00218296|79009467|FG001|Overall Study|Withdrawal by Subject|47|||
44212498|NCT00218296|79009466|FG000|Overall Study|Randomized but did not enter treatment|66|||
44212499|NCT00218296|79009467|FG001|Overall Study|Randomized but did not enter treatment|67|||
44212500|NCT00217672|79009475|FG000|Allocation|Ineligible|2|||
44212501|NCT00217672|79009476|FG001|Allocation|Ineligible|0|||
44212502|NCT00217672|79009475|FG000|Treatment|disease progression|33|||
44212503|NCT00217672|79009476|FG001|Treatment|disease progression|4|||
44212504|NCT00217672|79009475|FG000|Treatment|Adverse Event|18|||
44212505|NCT00217672|79009476|FG001|Treatment|Adverse Event|2|||
44212506|NCT00217672|79009475|FG000|Treatment|reqd treatment not permitted by protocol|6|||
44212507|NCT00217672|79009476|FG001|Treatment|reqd treatment not permitted by protocol|0|||
44212508|NCT00217672|79009475|FG000|Treatment|Physician Decision|6|||
44212509|NCT00217672|79009476|FG001|Treatment|Physician Decision|0|||
44212510|NCT00217672|79009475|FG000|Treatment|insurance issues|1|||
44212511|NCT00217672|79009476|FG001|Treatment|insurance issues|1|||
44212512|NCT00217672|79009475|FG000|Treatment|Death|2|||
44212513|NCT00217672|79009476|FG001|Treatment|Death|0|||
44212514|NCT00217672|79009475|FG000|Treatment|secondary malignancy|1|||
44212515|NCT00217672|79009476|FG001|Treatment|secondary malignancy|0|||
44212516|NCT00217672|79009475|FG000|Follow-up|Withdrawal by Subject|4|||
44212517|NCT00217672|79009476|FG001|Follow-up|Withdrawal by Subject|0|||
44212518|NCT00217672|79009475|FG000|Follow-up|Lost to Follow-up|1|||
44212519|NCT00217672|79009476|FG001|Follow-up|Lost to Follow-up|0|||
44212520|NCT00216736|79009482|FG000|Overall Study|Lost to Follow-up|1|||
44212521|NCT00216736|79009483|FG001|Overall Study|Lost to Follow-up|1|||
44212522|NCT01850030|79009491|FG000|Overall Study|Adverse Event|64|||
44212523|NCT01850030|79009492|FG001|Overall Study|Adverse Event|82|||
44212524|NCT01850030|79009491|FG000|Overall Study|Lack of Efficacy|3|||
44212525|NCT01850030|79009492|FG001|Overall Study|Lack of Efficacy|1|||
44212526|NCT01850030|79009491|FG000|Overall Study|Lost to Follow-up|5|||
44212527|NCT01850030|79009492|FG001|Overall Study|Lost to Follow-up|5|||
44212528|NCT01850030|79009491|FG000|Overall Study|Withdrawal by Subject|3|||
44212529|NCT01850030|79009492|FG001|Overall Study|Withdrawal by Subject|4|||
44212530|NCT01850030|79009491|FG000|Overall Study|Protocol Violation|24|||
44212531|NCT01850030|79009492|FG001|Overall Study|Protocol Violation|28|||
44212532|NCT01850030|79009491|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
44212533|NCT01850030|79009492|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
44212534|NCT00215644|79009500|FG000|Overall Study|Disease Progression|28|||
44212535|NCT00215644|79009501|FG001|Overall Study|Disease Progression|10|||
44212536|NCT00215644|79009500|FG000|Overall Study|Adverse Event|2|||
44212537|NCT00215644|79009501|FG001|Overall Study|Adverse Event|9|||
44212538|NCT00215644|79009500|FG000|Overall Study|Death|1|||
44212539|NCT00215644|79009501|FG001|Overall Study|Death|2|||
44212540|NCT00215644|79009500|FG000|Overall Study|Withdrawal by Subject|1|||
44212541|NCT00215644|79009501|FG001|Overall Study|Withdrawal by Subject|0|||
44212542|NCT00215644|79009500|FG000|Overall Study|Other|3|||
44212543|NCT00215644|79009501|FG001|Overall Study|Other|15|||
44212544|NCT00215644|79009500|FG000|Overall Study|Randomized but Not Treated|1|||
44212545|NCT00215644|79009501|FG001|Overall Study|Randomized but Not Treated|0|||
44212546|NCT01870401|79009509|FG000|Overall Study|Death|48|||
44212547|NCT01870401|79009510|FG001|Overall Study|Death|24|||
44212548|NCT01870401|79009509|FG000|Overall Study|Withdrawal by Subject|39|||
44212549|NCT01870401|79009510|FG001|Overall Study|Withdrawal by Subject|26|||
44212550|NCT01870401|79009509|FG000|Overall Study|Lost to Follow-up|19|||
44212551|NCT01870401|79009510|FG001|Overall Study|Lost to Follow-up|14|||
44212552|NCT01870401|79009509|FG000|Overall Study|Other|9|||
44212553|NCT01870401|79009510|FG001|Overall Study|Other|7|||
44212554|NCT01870401|79009509|FG000|Overall Study|On-going in the Study|35|||
44212555|NCT01870401|79009510|FG001|Overall Study|On-going in the Study|25|||
44212556|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
44212557|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
44212558|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
44212559|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
44212560|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
44212561|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
44212562|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
44212563|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
44212564|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
44212565|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
44212566|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
44212567|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
44212568|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
44212569|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
44212570|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
44212571|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
44212572|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
44212573|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
44212574|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
44212575|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
44212576|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Other|3|||
44212577|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Other|0|||
44212578|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Other|2|||
44212579|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Other|2|||
44212580|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Other|7|||
44212581|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212582|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212583|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212584|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
44212585|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212586|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212587|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212588|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212589|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212590|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
44212591|NCT00213148|79009522|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
44212592|NCT00213148|79009523|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
44212593|NCT00213148|79009524|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
44212594|NCT00213148|79009525|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
44212595|NCT00213148|79009526|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
44212596|NCT00213148|79009522|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
44212597|NCT00213148|79009523|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
44212598|NCT00213148|79009524|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
44212599|NCT00213148|79009525|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
44212600|NCT00213148|79009526|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
44212601|NCT00213148|79009522|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
44212602|NCT00213148|79009523|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
44212603|NCT00213148|79009524|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
44212604|NCT00213148|79009525|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
44212605|NCT00213148|79009526|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
44212606|NCT00213148|79009522|FG000|Cycle 2 (1 Month)|Other|2|||
44212607|NCT00213148|79009523|FG001|Cycle 2 (1 Month)|Other|1|||
44212608|NCT00213148|79009524|FG002|Cycle 2 (1 Month)|Other|2|||
44212609|NCT00213148|79009525|FG003|Cycle 2 (1 Month)|Other|8|||
44212610|NCT00213148|79009526|FG004|Cycle 2 (1 Month)|Other|7|||
44212611|NCT00213148|79009522|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212612|NCT00213148|79009523|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
44212613|NCT00213148|79009524|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212614|NCT00213148|79009525|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212615|NCT00213148|79009526|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
44212616|NCT00213148|79009522|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
44212617|NCT00213148|79009523|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212618|NCT00213148|79009524|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212619|NCT00213148|79009525|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
44452670|NCT00676091|79461580|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
44452671|NCT00676091|79461579|FG000|After Infant Series|Adverse Event|0|||
44212620|NCT00213148|79009526|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
44212621|NCT00213148|79009522|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
44212622|NCT00213148|79009523|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
44452672|NCT00676091|79461580|FG001|After Infant Series|Adverse Event|1|||
44212623|NCT00213148|79009524|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
44212624|NCT00213148|79009525|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
44212625|NCT00213148|79009526|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
44212626|NCT00213148|79009522|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
44212627|NCT00213148|79009523|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
44452673|NCT00676091|79461579|FG000|After Infant Series|Protocol Violation|0|||
44212628|NCT00213148|79009524|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
44212629|NCT00213148|79009525|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
44212630|NCT00213148|79009526|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
44212631|NCT00213148|79009522|FG000|Cycle 3 (1 Month)|Other|0|||
44212632|NCT00213148|79009523|FG001|Cycle 3 (1 Month)|Other|0|||
44452674|NCT00676091|79461580|FG001|After Infant Series|Protocol Violation|1|||
44452675|NCT00676091|79461579|FG000|After Infant Series|Failed to return|1|||
44452676|NCT00676091|79461580|FG001|After Infant Series|Failed to return|1|||
44452677|NCT00676091|79461579|FG000|Toddler Dose|Failed to return|2|||
44452678|NCT00676091|79461580|FG001|Toddler Dose|Failed to return|0|||
44452679|NCT00676091|79461579|FG000|Toddler Dose|Parent or legal guardian request|1|||
44452680|NCT00676091|79461580|FG001|Toddler Dose|Parent or legal guardian request|0|||
44452681|NCT00678041|79461592|FG000|Overall Study|Physician Decision|5|||
44452682|NCT00678041|79461593|FG001|Overall Study|Physician Decision|5|||
44452683|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
44452684|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
44452685|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
44212633|NCT00213148|79009524|FG002|Cycle 3 (1 Month)|Other|1|||
44212634|NCT00213148|79009525|FG003|Cycle 3 (1 Month)|Other|1|||
44212635|NCT00213148|79009526|FG004|Cycle 3 (1 Month)|Other|0|||
44212636|NCT01704261|79009548|FG000|Overall Study|Withdrawal by Subject|12|||
44212637|NCT01704261|79009549|FG001|Overall Study|Withdrawal by Subject|15|||
44212638|NCT01704261|79009548|FG000|Overall Study|Lost to Follow-up|1|||
44212639|NCT01704261|79009549|FG001|Overall Study|Lost to Follow-up|0|||
44212640|NCT01715571|79009555|FG000|Overall Study|Lost to Follow-up|8|||
44212641|NCT00212758|79009559|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
44212642|NCT00212758|79009560|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
44212643|NCT00212758|79009559|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
44212644|NCT00212758|79009560|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
44212645|NCT01824290|79009568|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
44212646|NCT01824290|79009569|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
44212647|NCT01824290|79009570|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
44212648|NCT01824290|79009571|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
44212649|NCT01824290|79009568|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
44212650|NCT01824290|79009569|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
44212651|NCT01824290|79009570|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
44212652|NCT01824290|79009571|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
44212653|NCT01824290|79009568|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
44212654|NCT01824290|79009569|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
44212655|NCT01824290|79009570|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
44212656|NCT01824290|79009571|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
44212657|NCT01824290|79009568|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
44212658|NCT01824290|79009569|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
44212659|NCT01824290|79009570|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
44212660|NCT01824290|79009571|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
44212661|NCT01824290|79009568|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
44212662|NCT01824290|79009569|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
44212663|NCT01824290|79009570|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
44212664|NCT01824290|79009571|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
44212665|NCT01824290|79009568|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
44212666|NCT01824290|79009569|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
44212667|NCT01824290|79009570|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
44212668|NCT01824290|79009571|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
44212669|NCT01715415|79009585|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
44212670|NCT01715415|79009586|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
44212671|NCT01715415|79009585|FG000|Double-blind Treatment|Adverse Event|3|||
44212672|NCT01715415|79009586|FG001|Double-blind Treatment|Adverse Event|0|||
44212673|NCT01715415|79009585|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
44212674|NCT01715415|79009586|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
44212675|NCT01715415|79009585|FG000|Double-blind Treatment|Other|1|||
44212676|NCT01715415|79009586|FG001|Double-blind Treatment|Other|0|||
44212677|NCT01715415|79009585|FG000|Open-label Treatment|Adverse Event|0|||
44212678|NCT01715415|79009586|FG001|Open-label Treatment|Adverse Event|1|||
44212679|NCT01715415|79009585|FG000|Open-label Treatment|Subject Noncompliant|0|||
44212680|NCT01715415|79009586|FG001|Open-label Treatment|Subject Noncompliant|1|||
44212681|NCT00211510|79009595|FG000|Overall Study|Physician Decision|3|||
44452686|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
44452687|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
44452688|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
44452689|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
44452690|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
44452691|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
44452692|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
44452693|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
44452694|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
44452695|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
44212682|NCT00211510|79009596|FG001|Overall Study|Physician Decision|1|||
44452696|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
44212683|NCT00211510|79009595|FG000|Overall Study|Withdrawal by Subject|3|||
44212684|NCT00211510|79009596|FG001|Overall Study|Withdrawal by Subject|1|||
44452697|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
44212685|NCT01869777|79009605|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
44452698|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
44452699|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
44452700|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
44452701|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
44452702|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
44452703|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
44452704|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
44452705|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
44212686|NCT01714947|79009609|FG000|Part B|Progressive Disease|3|||
44212687|NCT01869699|79009615|FG000|Overall Study|Withdrawal by Subject|1|||
44212688|NCT01869699|79009616|FG001|Overall Study|Withdrawal by Subject|0|||
44212689|NCT01714635|79009625|FG000|Overall Study|Discontinued|1|||
44212690|NCT01714635|79009626|FG001|Overall Study|Discontinued|0|||
44212691|NCT01714635|79009627|FG002|Overall Study|Discontinued|2|||
44212692|NCT01714635|79009625|FG000|Overall Study|Missed 6-month exam|1|||
44212693|NCT01714635|79009626|FG001|Overall Study|Missed 6-month exam|0|||
44212694|NCT01714635|79009627|FG002|Overall Study|Missed 6-month exam|0|||
44212695|NCT01713933|79009635|FG000|Overall Study|Lost to Follow-up|2|||
44212696|NCT01713933|79009635|FG000|Overall Study|Withdrawal by Subject|3|||
44212697|NCT01713933|79009635|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
44452706|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
44452707|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452708|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
44452709|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452710|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452711|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452712|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452713|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452714|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
44452715|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
44452716|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
44452717|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
44452718|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
44452719|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
44452720|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
44452721|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
44452722|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
44452723|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452724|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452725|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452726|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
44452727|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452728|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452729|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452730|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
44452731|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
44452732|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
44452733|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
44452734|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
44452735|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
44452736|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
44452737|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
44452738|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
44452739|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
44452740|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
44452741|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
44452742|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
44452743|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
44452744|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
44452745|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
44452746|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
44452747|NCT03903822|79461608|FG000|Treatment Phase (6 Weeks)|Other|2|||
44452748|NCT03903822|79461609|FG001|Treatment Phase (6 Weeks)|Other|1|||
44452749|NCT03903822|79461610|FG002|Treatment Phase (6 Weeks)|Other|0|||
44212698|NCT01868997|79009641|FG000|Overall Study|Adverse Event|2|||
44452750|NCT03903822|79461611|FG003|Treatment Phase (6 Weeks)|Other|0|||
44452751|NCT03903822|79461612|FG004|Treatment Phase (6 Weeks)|Other|1|||
44452752|NCT03903822|79461613|FG005|Treatment Phase (6 Weeks)|Other|1|||
44452753|NCT03903822|79461614|FG006|Treatment Phase (6 Weeks)|Other|0|||
44452754|NCT03903822|79461615|FG007|Treatment Phase (6 Weeks)|Other|0|||
44452755|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
44452756|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
44212699|NCT01868997|79009642|FG001|Overall Study|Adverse Event|5|||
44212700|NCT01868997|79009641|FG000|Overall Study|Lack of Efficacy|2|||
44212701|NCT01868997|79009642|FG001|Overall Study|Lack of Efficacy|0|||
44452757|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
44452758|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
44452759|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
44452760|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
44452761|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
44452762|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
44452763|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44212702|NCT01868997|79009641|FG000|Overall Study|Other|3|||
44212703|NCT01868997|79009642|FG001|Overall Study|Other|1|||
44452764|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44212704|NCT01875848|79009650|FG000|Overall Study|Withdrawal by Subject|2|||
44212705|NCT01875848|79009651|FG001|Overall Study|Withdrawal by Subject|0|||
44212706|NCT04191382|79009660|FG000|Overall Study|Withdrawal by Subject|1|||
44212707|NCT04191382|79009661|FG001|Overall Study|Withdrawal by Subject|0|||
44212708|NCT04191382|79009662|FG002|Overall Study|Withdrawal by Subject|0|||
44212709|NCT01703091|79009672|FG000|Overall Study|Adverse Event|5|||
44212710|NCT01703091|79009673|FG001|Overall Study|Adverse Event|3|||
44212711|NCT01703091|79009672|FG000|Overall Study|Physician Decision|2|||
44212712|NCT01703091|79009673|FG001|Overall Study|Physician Decision|1|||
44212713|NCT01703091|79009672|FG000|Overall Study|Withdrawal by Subject|1|||
44212714|NCT01703091|79009673|FG001|Overall Study|Withdrawal by Subject|0|||
44212715|NCT01703091|79009672|FG000|Overall Study|Sponsor Decision|1|||
44212716|NCT01703091|79009673|FG001|Overall Study|Sponsor Decision|0|||
44212717|NCT01712685|79009679|FG000|Overall Study|pt declined to participate before trmt|1|||
44212718|NCT01867671|79009685|FG000|Overall Study|Adverse Event|5|||
44212719|NCT01867671|79009686|FG001|Overall Study|Adverse Event|3|||
44212720|NCT01867671|79009685|FG000|Overall Study|Anaphylaxis|0|||
44212721|NCT01867671|79009686|FG001|Overall Study|Anaphylaxis|1|||
44212722|NCT01867671|79009685|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
44212723|NCT01867671|79009686|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
44212724|NCT01867671|79009685|FG000|Overall Study|Lost to Follow-up|0|||
44212725|NCT01867671|79009686|FG001|Overall Study|Lost to Follow-up|1|||
44212726|NCT01867671|79009685|FG000|Overall Study|Non-compliance with Study Drug|1|||
44212727|NCT01867671|79009686|FG001|Overall Study|Non-compliance with Study Drug|2|||
44212728|NCT01867671|79009685|FG000|Overall Study|Withdrawal by Subject|21|||
44212729|NCT01867671|79009686|FG001|Overall Study|Withdrawal by Subject|21|||
44212730|NCT01702311|79009694|FG000|Overall Study|Withdrawal by Subject|3|||
44212731|NCT01702311|79009695|FG001|Overall Study|Withdrawal by Subject|2|||
44212732|NCT01702311|79009694|FG000|Overall Study|Discharge less than 24 hours|10|||
44212733|NCT01702311|79009695|FG001|Overall Study|Discharge less than 24 hours|7|||
44212734|NCT01702311|79009694|FG000|Overall Study|Physician Decision|3|||
44212735|NCT01702311|79009695|FG001|Overall Study|Physician Decision|4|||
44212736|NCT01712061|79009711|FG000|Overall Study|Adverse Event|4|||
44212737|NCT01712061|79009712|FG001|Overall Study|Adverse Event|9|||
44212738|NCT01712061|79009713|FG002|Overall Study|Adverse Event|5|||
44212739|NCT01712061|79009711|FG000|Overall Study|Death|0|||
44212740|NCT01712061|79009712|FG001|Overall Study|Death|0|||
44212741|NCT01712061|79009713|FG002|Overall Study|Death|1|||
44212742|NCT01712061|79009711|FG000|Overall Study|Lost to Follow-up|1|||
44212743|NCT01712061|79009712|FG001|Overall Study|Lost to Follow-up|0|||
44212744|NCT01712061|79009713|FG002|Overall Study|Lost to Follow-up|1|||
44370773|NCT00820027|79376058|FG002|Overall Study|Adverse Event|10|||
44452765|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44370774|NCT00820027|79376059|FG003|Overall Study|Adverse Event|5|||
44370775|NCT00820027|79376056|FG000|Overall Study|Lack of Efficacy|2|||
44370776|NCT00820027|79376057|FG001|Overall Study|Lack of Efficacy|1|||
44370777|NCT00820027|79376058|FG002|Overall Study|Lack of Efficacy|2|||
44370778|NCT00820027|79376059|FG003|Overall Study|Lack of Efficacy|2|||
44370779|NCT00820027|79376056|FG000|Overall Study|Physician Decision|0|||
44370780|NCT00820027|79376057|FG001|Overall Study|Physician Decision|1|||
44452766|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44452767|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
44452768|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44452769|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44452770|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
44452771|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
44212745|NCT01712061|79009711|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
44212746|NCT01712061|79009712|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
44212747|NCT01712061|79009713|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
44212748|NCT01712061|79009711|FG000|Overall Study|Medication Error Without Associated AE|0|||
44370781|NCT00820027|79376058|FG002|Overall Study|Physician Decision|1|||
44212749|NCT01712061|79009712|FG001|Overall Study|Medication Error Without Associated AE|1|||
44212750|NCT01712061|79009713|FG002|Overall Study|Medication Error Without Associated AE|0|||
44212751|NCT01712061|79009711|FG000|Overall Study|Withdrawal by Subject|1|||
44370782|NCT00820027|79376059|FG003|Overall Study|Physician Decision|0|||
44370783|NCT00820027|79376056|FG000|Overall Study|Protocol Violation|3|||
44212752|NCT01712061|79009712|FG001|Overall Study|Withdrawal by Subject|7|||
44212753|NCT01712061|79009713|FG002|Overall Study|Withdrawal by Subject|1|||
44212754|NCT01712061|79009711|FG000|Overall Study|Other|0|||
44212755|NCT01712061|79009712|FG001|Overall Study|Other|3|||
44212756|NCT01712061|79009713|FG002|Overall Study|Other|0|||
44212757|NCT03592186|79009724|FG000|Overall Study|Withdrawal by Subject|1|||
44212758|NCT03592186|79009725|FG001|Overall Study|Withdrawal by Subject|0|||
44452772|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
44452773|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
44452774|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
44452775|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
44452776|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
44452777|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
44452778|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
44452779|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
44452780|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
44452781|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
44452782|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
44452783|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
44452784|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
44452785|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
44452786|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
44452787|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
44452788|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
44212759|NCT03592186|79009724|FG000|Overall Study|Lost to Follow-up|16|||
44212760|NCT03592186|79009725|FG001|Overall Study|Lost to Follow-up|11|||
44212761|NCT03598114|79009733|FG000|Overall Study|Staff turnover/left the program|3|||
44212762|NCT03598114|79009734|FG001|Overall Study|Staff turnover/left the program|39|||
44452789|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
44452790|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
44452791|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
44452792|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
44452793|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
44452794|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
44452795|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452796|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452797|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452798|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452799|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452800|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
44212763|NCT01711983|79009761|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
44212764|NCT01711983|79009761|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
44212765|NCT01711983|79009761|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
44212766|NCT01711983|79009761|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
44212767|NCT01874288|79009775|FG000|Overall Study|Withdrawal by Subject|1|||
44212768|NCT01874288|79009776|FG001|Overall Study|Withdrawal by Subject|0|||
44212769|NCT01874288|79009777|FG002|Overall Study|Withdrawal by Subject|2|||
44212770|NCT01874288|79009778|FG003|Overall Study|Withdrawal by Subject|1|||
44212771|NCT01874288|79009779|FG004|Overall Study|Withdrawal by Subject|1|||
44212772|NCT01874288|79009775|FG000|Overall Study|Physician Decision|0|||
44212773|NCT01874288|79009776|FG001|Overall Study|Physician Decision|0|||
44212774|NCT01874288|79009777|FG002|Overall Study|Physician Decision|0|||
44212775|NCT01874288|79009778|FG003|Overall Study|Physician Decision|1|||
44212776|NCT01874288|79009779|FG004|Overall Study|Physician Decision|0|||
44212777|NCT01874288|79009775|FG000|Overall Study|Progressive disease|2|||
44212778|NCT01874288|79009776|FG001|Overall Study|Progressive disease|0|||
44212779|NCT01874288|79009777|FG002|Overall Study|Progressive disease|3|||
44212780|NCT01874288|79009778|FG003|Overall Study|Progressive disease|5|||
44212781|NCT01874288|79009779|FG004|Overall Study|Progressive disease|1|||
44212782|NCT01874054|79009808|FG000|Overall Study|Withdrawal by Subject|3|||
44212783|NCT01874054|79009808|FG000|Overall Study|Study Termination by Sponsor|42|||
44212784|NCT01874054|79009808|FG000|Overall Study|Lost to Follow-up|5|||
44212785|NCT01874054|79009808|FG000|Overall Study|Death|5|||
44370784|NCT00820027|79376057|FG001|Overall Study|Protocol Violation|0|||
44370785|NCT00820027|79376058|FG002|Overall Study|Protocol Violation|4|||
44370786|NCT00820027|79376059|FG003|Overall Study|Protocol Violation|0|||
44370787|NCT00820027|79376056|FG000|Overall Study|Withdrawal by Subject|6|||
44370788|NCT00820027|79376057|FG001|Overall Study|Withdrawal by Subject|4|||
44370789|NCT00820027|79376058|FG002|Overall Study|Withdrawal by Subject|4|||
44370790|NCT00820027|79376059|FG003|Overall Study|Withdrawal by Subject|6|||
44452801|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452802|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
44452803|NCT03903822|79461608|FG000|Follow up Phase (4 Weeks)|Other|1|||
44452804|NCT03903822|79461609|FG001|Follow up Phase (4 Weeks)|Other|1|||
44452805|NCT03903822|79461610|FG002|Follow up Phase (4 Weeks)|Other|0|||
44452806|NCT03903822|79461611|FG003|Follow up Phase (4 Weeks)|Other|0|||
44452807|NCT03903822|79461612|FG004|Follow up Phase (4 Weeks)|Other|0|||
44452808|NCT03903822|79461613|FG005|Follow up Phase (4 Weeks)|Other|0|||
44452809|NCT03903822|79461614|FG006|Follow up Phase (4 Weeks)|Other|0|||
44452810|NCT03903822|79461615|FG007|Follow up Phase (4 Weeks)|Other|0|||
44452811|NCT00677807|79461636|FG000|Overall Study|Adverse Event|4|||
44452812|NCT00677807|79461637|FG001|Overall Study|Adverse Event|1|||
44452813|NCT00677807|79461638|FG002|Overall Study|Adverse Event|6|||
44452814|NCT00677807|79461636|FG000|Overall Study|Lack of Efficacy|0|||
44452815|NCT00677807|79461637|FG001|Overall Study|Lack of Efficacy|0|||
44452816|NCT00677807|79461638|FG002|Overall Study|Lack of Efficacy|2|||
44452817|NCT00677807|79461636|FG000|Overall Study|Participant no longer needs study drug|0|||
44452818|NCT00677807|79461637|FG001|Overall Study|Participant no longer needs study drug|0|||
44452819|NCT00677807|79461638|FG002|Overall Study|Participant no longer needs study drug|1|||
44452820|NCT00677807|79461636|FG000|Overall Study|Withdrawal by Subject|10|||
44452821|NCT00677807|79461637|FG001|Overall Study|Withdrawal by Subject|3|||
44452822|NCT00677807|79461638|FG002|Overall Study|Withdrawal by Subject|6|||
44452823|NCT00677807|79461636|FG000|Overall Study|Lost to Follow-up|2|||
44452824|NCT00677807|79461637|FG001|Overall Study|Lost to Follow-up|2|||
44452825|NCT00677807|79461638|FG002|Overall Study|Lost to Follow-up|2|||
44370791|NCT01076153|79376070|FG000|Overall Study|Symptoms improved/resolved|10|||
44370792|NCT01076153|79376070|FG000|Overall Study|Adverse Event|1|||
44370793|NCT01076075|79376080|FG000|Overall Study|Adverse Event|3|||
44370794|NCT01076075|79376081|FG001|Overall Study|Adverse Event|9|||
44370795|NCT01076075|79376080|FG000|Overall Study|Lack of Efficacy|5|||
44452826|NCT00677807|79461636|FG000|Overall Study|Administrative problems|1|||
44452827|NCT00677807|79461637|FG001|Overall Study|Administrative problems|1|||
44452828|NCT00677807|79461638|FG002|Overall Study|Administrative problems|2|||
44212786|NCT01873742|79009814|FG000|Overall Study|Lost to Follow-up|68|||
44212787|NCT01873742|79009815|FG001|Overall Study|Lost to Follow-up|76|||
44212788|NCT01873586|79009821|FG000|Overall Study|Lost to Follow-up|3|||
44370796|NCT01076075|79376081|FG001|Overall Study|Lack of Efficacy|4|||
44370797|NCT01076075|79376080|FG000|Overall Study|Lost to Follow-up|6|||
44370798|NCT01076075|79376081|FG001|Overall Study|Lost to Follow-up|5|||
44370799|NCT01076075|79376080|FG000|Overall Study|other|19|||
44370800|NCT01076075|79376081|FG001|Overall Study|other|9|||
44370801|NCT01076075|79376080|FG000|Overall Study|Protocol Violation|0|||
44370802|NCT01076075|79376081|FG001|Overall Study|Protocol Violation|1|||
44212789|NCT04027348|79009855|FG000|Overall Study|Adverse Event|2|||
44212790|NCT04196686|79009868|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
44212791|NCT04196686|79009869|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
44212792|NCT02708680|79009878|FG000|Overall Study|Withdrawal by Subject|4|||
44370803|NCT01076075|79376080|FG000|Overall Study|Withdrawal by Subject|8|||
44212793|NCT02708680|79009879|FG001|Overall Study|Withdrawal by Subject|12|||
44212794|NCT02708680|79009880|FG002|Overall Study|Withdrawal by Subject|12|||
44212795|NCT02708680|79009878|FG000|Overall Study|Death|4|||
44212796|NCT02708680|79009879|FG001|Overall Study|Death|19|||
44212797|NCT02708680|79009880|FG002|Overall Study|Death|21|||
44212798|NCT02708680|79009878|FG000|Overall Study|Lost to Follow-up|0|||
44212799|NCT02708680|79009879|FG001|Overall Study|Lost to Follow-up|3|||
44212800|NCT02708680|79009880|FG002|Overall Study|Lost to Follow-up|3|||
44212801|NCT02708680|79009878|FG000|Overall Study|Study Terminated By Sponsor|0|||
44212802|NCT02708680|79009879|FG001|Overall Study|Study Terminated By Sponsor|5|||
44212803|NCT02708680|79009880|FG002|Overall Study|Study Terminated By Sponsor|4|||
44212804|NCT02708680|79009878|FG000|Overall Study|Other than Specified|0|||
44212805|NCT02708680|79009879|FG001|Overall Study|Other than Specified|0|||
44212806|NCT02708680|79009880|FG002|Overall Study|Other than Specified|1|||
44212807|NCT02708680|79009878|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
44212808|NCT02708680|79009879|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
44212809|NCT02708680|79009880|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
44212810|NCT01611974|79009894|FG000|Overall Study|Death|10|||
44212811|NCT01611974|79009895|FG001|Overall Study|Death|12|||
44212812|NCT01611974|79009896|FG002|Overall Study|Death|10|||
44212813|NCT01611974|79009894|FG000|Overall Study|Lost to Follow-up|0|||
44212814|NCT01611974|79009895|FG001|Overall Study|Lost to Follow-up|1|||
44212815|NCT01611974|79009896|FG002|Overall Study|Lost to Follow-up|0|||
44212816|NCT01611974|79009894|FG000|Overall Study|Physician Decision|5|||
44212817|NCT01611974|79009895|FG001|Overall Study|Physician Decision|1|||
44212818|NCT01611974|79009896|FG002|Overall Study|Physician Decision|2|||
44212819|NCT01611974|79009894|FG000|Overall Study|Withdrawal by Subject|0|||
44212820|NCT01611974|79009895|FG001|Overall Study|Withdrawal by Subject|1|||
44212821|NCT01611974|79009896|FG002|Overall Study|Withdrawal by Subject|4|||
44212822|NCT01848938|79009906|FG000|Overall Study|Lost to Follow-up|1|||
44212823|NCT01848938|79009907|FG001|Overall Study|Lost to Follow-up|1|||
44212824|NCT01871870|79009913|FG000|Overall Study|Hardware issues|7|||
44212825|NCT01871870|79009913|FG000|Overall Study|hyperglycemia|2|||
44212826|NCT01871558|79009926|FG000|Overall Study|Other reason|0|||
44212827|NCT01871558|79009927|FG001|Overall Study|Other reason|1|||
44212828|NCT01871558|79009926|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
44212829|NCT01871558|79009927|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
44212830|NCT01871558|79009926|FG000|Overall Study|Withdrawal by Subject|2|||
44212831|NCT01871558|79009927|FG001|Overall Study|Withdrawal by Subject|0|||
44212832|NCT01711359|79009936|FG000|Treatment Period|Withdrawal by Subject|18|||
44212833|NCT01711359|79009937|FG001|Treatment Period|Withdrawal by Subject|7|||
44212834|NCT01711359|79009938|FG002|Treatment Period|Withdrawal by Subject|13|||
44212835|NCT01711359|79009936|FG000|Treatment Period|Lack of Efficacy|13|||
44212836|NCT01711359|79009937|FG001|Treatment Period|Lack of Efficacy|2|||
44212837|NCT01711359|79009938|FG002|Treatment Period|Lack of Efficacy|2|||
44212838|NCT01711359|79009936|FG000|Treatment Period|Adverse Event|8|||
44212839|NCT01711359|79009937|FG001|Treatment Period|Adverse Event|10|||
44212840|NCT01711359|79009938|FG002|Treatment Period|Adverse Event|24|||
44212841|NCT01711359|79009936|FG000|Treatment Period|Physician Decision|4|||
44212842|NCT01711359|79009937|FG001|Treatment Period|Physician Decision|3|||
44212843|NCT01711359|79009938|FG002|Treatment Period|Physician Decision|2|||
44212844|NCT01711359|79009936|FG000|Treatment Period|Death|3|||
44212845|NCT01711359|79009937|FG001|Treatment Period|Death|0|||
44212846|NCT01711359|79009938|FG002|Treatment Period|Death|0|||
44212847|NCT01711359|79009936|FG000|Treatment Period|Entry Criteria Not Met|1|||
44370804|NCT01076075|79376081|FG001|Overall Study|Withdrawal by Subject|19|||
44370805|NCT01075763|79376092|FG000|Overall Study|Lost to Follow-up|2|||
44370806|NCT01075763|79376093|FG001|Overall Study|Lost to Follow-up|1|||
44370807|NCT01075763|79376092|FG000|Overall Study|Lack of Efficacy|0|||
44370808|NCT01075763|79376093|FG001|Overall Study|Lack of Efficacy|1|||
44370809|NCT01075763|79376092|FG000|Overall Study|Withdrawal by Subject|2|||
44452829|NCT00677807|79461636|FG000|Overall Study|Death|0|||
44452830|NCT00677807|79461637|FG001|Overall Study|Death|1|||
44212848|NCT01711359|79009937|FG001|Treatment Period|Entry Criteria Not Met|0|||
44212849|NCT01711359|79009938|FG002|Treatment Period|Entry Criteria Not Met|0|||
44212850|NCT01711359|79009936|FG000|Treatment Period|Sponsor Decision|1|||
44212851|NCT01711359|79009937|FG001|Treatment Period|Sponsor Decision|0|||
44212852|NCT01711359|79009938|FG002|Treatment Period|Sponsor Decision|0|||
44212853|NCT01711359|79009936|FG000|Treatment Period|Lost to Follow-up|1|||
44212854|NCT01711359|79009937|FG001|Treatment Period|Lost to Follow-up|1|||
44212855|NCT01711359|79009938|FG002|Treatment Period|Lost to Follow-up|1|||
44212856|NCT01711359|79009936|FG000|Treatment Period|Randomized, Not Treated|3|||
44212857|NCT01711359|79009937|FG001|Treatment Period|Randomized, Not Treated|1|||
44370810|NCT01075763|79376093|FG001|Overall Study|Withdrawal by Subject|2|||
44452831|NCT00677807|79461638|FG002|Overall Study|Death|1|||
44452832|NCT00677807|79461636|FG000|Overall Study|Protocol Deviation|1|||
44212858|NCT01711359|79009938|FG002|Treatment Period|Randomized, Not Treated|0|||
44370811|NCT00881530|79376105|FG000|Overall Study|Adverse Event|5|||
44212859|NCT01710657|79009965|FG000|Overall Study|Lost to Follow-up|2|||
44212860|NCT01710657|79009966|FG001|Overall Study|Lost to Follow-up|0|||
44212861|NCT01710657|79009967|FG002|Overall Study|Lost to Follow-up|1|||
44212862|NCT01710657|79009965|FG000|Overall Study|Protocol Violation|2|||
44212863|NCT01710657|79009966|FG001|Overall Study|Protocol Violation|2|||
44212864|NCT01710657|79009967|FG002|Overall Study|Protocol Violation|0|||
44212865|NCT01710657|79009965|FG000|Overall Study|Adverse Event|14|||
44370812|NCT00881530|79376106|FG001|Overall Study|Adverse Event|1|||
44370813|NCT00881530|79376107|FG002|Overall Study|Adverse Event|1|||
44452833|NCT00677807|79461637|FG001|Overall Study|Protocol Deviation|3|||
44452834|NCT00677807|79461638|FG002|Overall Study|Protocol Deviation|0|||
44452835|NCT00687401|79461646|FG000|Overall Study|Protocol Violation|7|||
44452836|NCT00687401|79461646|FG000|Overall Study|Adverse Event|6|||
44452837|NCT00687401|79461646|FG000|Overall Study|Lack of Efficacy|6|||
44452838|NCT00687401|79461646|FG000|Overall Study|Withdrawal by Subject|4|||
44452839|NCT00687401|79461646|FG000|Overall Study|Did not return for visit|3|||
44452840|NCT00687401|79461646|FG000|Overall Study|For reasons different from those above|4|||
44452841|NCT00538902|79461666|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
44452842|NCT00538902|79461667|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
44452843|NCT00538902|79461668|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
44452844|NCT00538902|79461666|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
44452845|NCT00538902|79461667|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
44452846|NCT00538902|79461668|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
44452847|NCT00538902|79461666|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
44452848|NCT00538902|79461667|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
44452849|NCT00538902|79461668|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
44452850|NCT00538902|79461666|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
44452851|NCT00538902|79461667|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
44452852|NCT00538902|79461668|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
44452853|NCT00538902|79461666|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
44452854|NCT00538902|79461667|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
44452855|NCT00538902|79461668|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
44452856|NCT00538902|79461666|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
44452857|NCT00538902|79461667|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
44452858|NCT00538902|79461668|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
44452859|NCT00538902|79461666|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
44452860|NCT00538902|79461667|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
44452861|NCT00538902|79461668|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
44452862|NCT00538902|79461666|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
44452863|NCT00538902|79461667|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
44452864|NCT00538902|79461668|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
44452865|NCT00541970|79461682|FG000|Month 7|Protocol Violation|9|||
44452866|NCT00541970|79461683|FG001|Month 7|Protocol Violation|13|||
44452867|NCT00541970|79461684|FG002|Month 7|Protocol Violation|11|||
44452868|NCT00541970|79461685|FG003|Month 7|Protocol Violation|5|||
44452869|NCT00541970|79461682|FG000|Month 12|Adverse Event|0|||
44452870|NCT00541970|79461683|FG001|Month 12|Adverse Event|1|||
44452871|NCT00541970|79461684|FG002|Month 12|Adverse Event|1|||
44452872|NCT00541970|79461685|FG003|Month 12|Adverse Event|1|||
44452873|NCT00541970|79461682|FG000|Month 12|Protocol Violation|12|||
44452874|NCT00541970|79461683|FG001|Month 12|Protocol Violation|21|||
44452875|NCT00541970|79461684|FG002|Month 12|Protocol Violation|20|||
44452876|NCT00541970|79461685|FG003|Month 12|Protocol Violation|15|||
44370814|NCT00881530|79376108|FG003|Overall Study|Adverse Event|4|||
44370815|NCT00881530|79376109|FG004|Overall Study|Adverse Event|10|||
44370816|NCT00881530|79376110|FG005|Overall Study|Adverse Event|2|||
44370817|NCT00881530|79376105|FG000|Overall Study|Lack of Efficacy|1|||
44370818|NCT00881530|79376106|FG001|Overall Study|Lack of Efficacy|0|||
44370819|NCT00881530|79376107|FG002|Overall Study|Lack of Efficacy|0|||
44370820|NCT00881530|79376108|FG003|Overall Study|Lack of Efficacy|0|||
44370821|NCT00881530|79376109|FG004|Overall Study|Lack of Efficacy|1|||
44370822|NCT00881530|79376110|FG005|Overall Study|Lack of Efficacy|1|||
44452877|NCT00541970|79461682|FG000|Month 18|Adverse Event|0|||
44452878|NCT00541970|79461683|FG001|Month 18|Adverse Event|1|||
44452879|NCT00541970|79461684|FG002|Month 18|Adverse Event|1|||
44452880|NCT00541970|79461685|FG003|Month 18|Adverse Event|1|||
44452881|NCT00541970|79461682|FG000|Month 18|Protocol Violation|14|||
44452882|NCT00541970|79461683|FG001|Month 18|Protocol Violation|23|||
44452883|NCT00541970|79461684|FG002|Month 18|Protocol Violation|24|||
44212866|NCT01710657|79009966|FG001|Overall Study|Adverse Event|8|||
44370823|NCT00881530|79376105|FG000|Overall Study|Not compliant with the protocol|0|||
44370824|NCT00881530|79376106|FG001|Overall Study|Not compliant with the protocol|0|||
44370825|NCT00881530|79376107|FG002|Overall Study|Not compliant with the protocol|0|||
44452884|NCT00541970|79461685|FG003|Month 18|Protocol Violation|16|||
44212867|NCT01710657|79009967|FG002|Overall Study|Adverse Event|28|||
44452885|NCT00541970|79461682|FG000|Month 24|Adverse Event|0|||
44452886|NCT00541970|79461683|FG001|Month 24|Adverse Event|1|||
44452887|NCT00541970|79461684|FG002|Month 24|Adverse Event|1|||
44452888|NCT00541970|79461685|FG003|Month 24|Adverse Event|1|||
44452889|NCT00541970|79461682|FG000|Month 24|Protocol Violation|29|||
44452890|NCT00541970|79461683|FG001|Month 24|Protocol Violation|31|||
44452891|NCT00541970|79461684|FG002|Month 24|Protocol Violation|31|||
44452892|NCT00541970|79461685|FG003|Month 24|Protocol Violation|21|||
44452893|NCT00541970|79461682|FG000|Month 36|Protocol Violation|61|||
44452894|NCT00541970|79461683|FG001|Month 36|Protocol Violation|66|||
44452895|NCT00541970|79461684|FG002|Month 36|Protocol Violation|66|||
44452896|NCT00541970|79461685|FG003|Month 36|Protocol Violation|60|||
44452897|NCT00541970|79461682|FG000|Month 48|Withdrawal by Subject|2|||
44452898|NCT00541970|79461683|FG001|Month 48|Withdrawal by Subject|4|||
44212868|NCT01710657|79009965|FG000|Overall Study|Withdrawal by Subject|0|||
44212869|NCT01710657|79009966|FG001|Overall Study|Withdrawal by Subject|1|||
44212870|NCT01710657|79009967|FG002|Overall Study|Withdrawal by Subject|2|||
44212871|NCT01710657|79009965|FG000|Overall Study|Lack of Efficacy|0|||
44212872|NCT01710657|79009966|FG001|Overall Study|Lack of Efficacy|1|||
44212873|NCT01710657|79009967|FG002|Overall Study|Lack of Efficacy|1|||
44212874|NCT01701063|79009978|FG000|Overall Study|Lost to Follow-up|0|||
44212875|NCT01701063|79009979|FG001|Overall Study|Lost to Follow-up|1|||
44212876|NCT01701063|79009980|FG002|Overall Study|Lost to Follow-up|0|||
44212877|NCT01701063|79009978|FG000|Overall Study|Withdrawal by Subject|0|||
44212878|NCT01701063|79009979|FG001|Overall Study|Withdrawal by Subject|0|||
44212879|NCT01701063|79009980|FG002|Overall Study|Withdrawal by Subject|1|||
44212880|NCT01701063|79009978|FG000|Overall Study|Other|0|||
44212881|NCT01701063|79009979|FG001|Overall Study|Other|0|||
44212882|NCT01701063|79009980|FG002|Overall Study|Other|1|||
44212883|NCT01700985|79009991|FG000|Overall Study|Incarcerated|0|||
44212884|NCT01700985|79009992|FG001|Overall Study|Incarcerated|1|||
44212885|NCT01710501|79010001|FG000|Overall Study|Lost to Follow-up|2|||
44212886|NCT01710501|79010002|FG001|Overall Study|Lost to Follow-up|0|||
44212887|NCT01710501|79010003|FG002|Overall Study|Lost to Follow-up|0|||
44212888|NCT01700829|79010013|FG000|Overall Study|Withdrawal by Subject|1|||
44212889|NCT01700829|79010014|FG001|Overall Study|Withdrawal by Subject|1|||
44212890|NCT01710345|79010023|FG000|Overall Study|Adverse Event|0|||
44212891|NCT01710345|79010024|FG001|Overall Study|Adverse Event|2|||
44212892|NCT01710345|79010025|FG002|Overall Study|Adverse Event|0|||
44212893|NCT01710345|79010023|FG000|Overall Study|Lack of Efficacy|2|||
44212894|NCT01710345|79010024|FG001|Overall Study|Lack of Efficacy|3|||
44212895|NCT01710345|79010025|FG002|Overall Study|Lack of Efficacy|1|||
44212896|NCT01710345|79010023|FG000|Overall Study|Drug Dosing Error|1|||
44212897|NCT01710345|79010024|FG001|Overall Study|Drug Dosing Error|0|||
44370826|NCT00881530|79376108|FG003|Overall Study|Not compliant with the protocol|0|||
44370827|NCT00881530|79376109|FG004|Overall Study|Not compliant with the protocol|2|||
44370828|NCT00881530|79376110|FG005|Overall Study|Not compliant with the protocol|0|||
44370829|NCT00881530|79376105|FG000|Overall Study|Lost to Follow-up|0|||
44370830|NCT00881530|79376106|FG001|Overall Study|Lost to Follow-up|1|||
44370831|NCT00881530|79376107|FG002|Overall Study|Lost to Follow-up|1|||
44370832|NCT00881530|79376108|FG003|Overall Study|Lost to Follow-up|3|||
44370833|NCT00881530|79376109|FG004|Overall Study|Lost to Follow-up|1|||
44370834|NCT00881530|79376110|FG005|Overall Study|Lost to Follow-up|0|||
44370835|NCT00881530|79376105|FG000|Overall Study|Refused to continue medication|7|||
44370836|NCT00881530|79376106|FG001|Overall Study|Refused to continue medication|2|||
44370837|NCT00881530|79376107|FG002|Overall Study|Refused to continue medication|1|||
44370838|NCT00881530|79376108|FG003|Overall Study|Refused to continue medication|2|||
44370839|NCT00881530|79376109|FG004|Overall Study|Refused to continue medication|0|||
44370840|NCT00881530|79376110|FG005|Overall Study|Refused to continue medication|0|||
44370841|NCT00881530|79376105|FG000|Overall Study|Other reason not defined above|1|||
44212898|NCT01710345|79010025|FG002|Overall Study|Drug Dosing Error|0|||
44212899|NCT01710033|79010041|FG000|Stage 2|Adverse Event|0|||
44212900|NCT01710033|79010042|FG001|Stage 2|Adverse Event|0|||
44370842|NCT00881530|79376106|FG001|Overall Study|Other reason not defined above|1|||
44452899|NCT00541970|79461684|FG002|Month 48|Withdrawal by Subject|4|||
44452900|NCT00541970|79461685|FG003|Month 48|Withdrawal by Subject|2|||
44452901|NCT00541970|79461682|FG000|Month 48|Other|3|||
44452902|NCT00541970|79461683|FG001|Month 48|Other|1|||
44212901|NCT01710033|79010043|FG002|Stage 2|Adverse Event|0|||
44212902|NCT01710033|79010044|FG003|Stage 2|Adverse Event|0|||
44212903|NCT01710033|79010045|FG004|Stage 2|Adverse Event|1|||
44370843|NCT00881530|79376107|FG002|Overall Study|Other reason not defined above|2|||
44370844|NCT00881530|79376108|FG003|Overall Study|Other reason not defined above|0|||
44212904|NCT01822496|79010062|FG000|Overall Study|Protocol Violation|2|||
44212905|NCT01822496|79010063|FG001|Overall Study|Protocol Violation|2|||
44212906|NCT01822496|79010064|FG002|Overall Study|Protocol Violation|0|||
44212907|NCT01822496|79010065|FG003|Overall Study|Protocol Violation|1|||
44452903|NCT00541970|79461684|FG002|Month 48|Other|1|||
44452904|NCT00541970|79461685|FG003|Month 48|Other|0|||
44452905|NCT00541970|79461682|FG000|Month 48|Lost to Follow-up|66|||
44212908|NCT01822496|79010062|FG000|Overall Study|Withdrawal by Subject|0|||
44212909|NCT01822496|79010063|FG001|Overall Study|Withdrawal by Subject|0|||
44212910|NCT01822496|79010064|FG002|Overall Study|Withdrawal by Subject|0|||
44212911|NCT01822496|79010065|FG003|Overall Study|Withdrawal by Subject|3|||
44212912|NCT01867047|79010077|FG000|Overall Study|Lost to Follow-up|3|||
44212913|NCT01867047|79010078|FG001|Overall Study|Lost to Follow-up|3|||
44212914|NCT01867047|79010077|FG000|Overall Study|Withdrawal by Subject|2|||
44212915|NCT01867047|79010078|FG001|Overall Study|Withdrawal by Subject|0|||
44212916|NCT01867047|79010077|FG000|Overall Study|Physician Decision|2|||
44212917|NCT01867047|79010078|FG001|Overall Study|Physician Decision|0|||
44212918|NCT01867047|79010077|FG000|Overall Study|surgery not indicated in protocol|1|||
44212919|NCT01867047|79010078|FG001|Overall Study|surgery not indicated in protocol|2|||
44212920|NCT01821560|79010090|FG000|Overall Study|Lost to Follow-up|5|||
44212921|NCT01821560|79010091|FG001|Overall Study|Lost to Follow-up|5|||
44212922|NCT01821560|79010090|FG000|Overall Study|Withdrawal by Subject|1|||
44212923|NCT01821560|79010091|FG001|Overall Study|Withdrawal by Subject|1|||
44212924|NCT01821560|79010090|FG000|Overall Study|Protocol Violation|0|||
44212925|NCT01821560|79010091|FG001|Overall Study|Protocol Violation|1|||
44212926|NCT01871402|79010099|FG000|Overall Study|Lost to Follow-up|1|||
44212927|NCT01871402|79010100|FG001|Overall Study|Lost to Follow-up|0|||
44212928|NCT01871402|79010099|FG000|Overall Study|Withdrawal by Subject|0|||
44212929|NCT01871402|79010100|FG001|Overall Study|Withdrawal by Subject|2|||
44212930|NCT01871402|79010099|FG000|Overall Study|Non-compliance|0|||
44212931|NCT01871402|79010100|FG001|Overall Study|Non-compliance|1|||
44212932|NCT01846442|79010119|FG000|Overall Study|Adverse Event|2|||
44212933|NCT01846442|79010120|FG001|Overall Study|Adverse Event|4|||
44212934|NCT01846442|79010121|FG002|Overall Study|Adverse Event|2|||
44212935|NCT01846442|79010122|FG003|Overall Study|Adverse Event|1|||
44212936|NCT01846442|79010119|FG000|Overall Study|Lost to Follow-up|0|||
44212937|NCT01846442|79010120|FG001|Overall Study|Lost to Follow-up|0|||
44212938|NCT01846442|79010121|FG002|Overall Study|Lost to Follow-up|1|||
44212939|NCT01846442|79010122|FG003|Overall Study|Lost to Follow-up|0|||
44212940|NCT01846442|79010119|FG000|Overall Study|Withdrawal by Subject|3|||
44212941|NCT01846442|79010120|FG001|Overall Study|Withdrawal by Subject|2|||
44212942|NCT01846442|79010121|FG002|Overall Study|Withdrawal by Subject|0|||
44212943|NCT01846442|79010122|FG003|Overall Study|Withdrawal by Subject|1|||
44212944|NCT01846442|79010119|FG000|Overall Study|Left the city/Lost medication|1|||
44212945|NCT01846442|79010120|FG001|Overall Study|Left the city/Lost medication|0|||
44212946|NCT01846442|79010121|FG002|Overall Study|Left the city/Lost medication|1|||
44212947|NCT01846442|79010122|FG003|Overall Study|Left the city/Lost medication|1|||
44212948|NCT01709721|79010135|FG000|Open Label Phase|Withdrawal by Subject|0|||
44212949|NCT01709721|79010136|FG001|Open Label Phase|Withdrawal by Subject|0|||
44212950|NCT01709721|79010137|FG002|Open Label Phase|Withdrawal by Subject|5|||
44212951|NCT01709721|79010135|FG000|Open Label Phase|Adverse Event|0|||
44212952|NCT01709721|79010136|FG001|Open Label Phase|Adverse Event|0|||
44212953|NCT01709721|79010137|FG002|Open Label Phase|Adverse Event|8|||
44212954|NCT01709721|79010135|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
44212955|NCT01709721|79010136|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
44212956|NCT01709721|79010137|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
44212957|NCT01709721|79010135|FG000|Open Label Phase|Investigator Decision|0|||
44212958|NCT01709721|79010136|FG001|Open Label Phase|Investigator Decision|0|||
44212959|NCT01709721|79010137|FG002|Open Label Phase|Investigator Decision|1|||
44212960|NCT01709721|79010135|FG000|Open Label Phase|Sponsor Decision|0|||
44212961|NCT01709721|79010136|FG001|Open Label Phase|Sponsor Decision|0|||
44212962|NCT01709721|79010137|FG002|Open Label Phase|Sponsor Decision|2|||
44212963|NCT01709721|79010135|FG000|Open Label Phase|Protocol Violation|0|||
44212964|NCT01709721|79010136|FG001|Open Label Phase|Protocol Violation|0|||
44212965|NCT01709721|79010137|FG002|Open Label Phase|Protocol Violation|1|||
44212966|NCT01709721|79010135|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
44212967|NCT01709721|79010136|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
44212968|NCT01709721|79010137|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
44212969|NCT01709721|79010135|FG000|Open Label Phase|Inadequate Pain Control|0|||
44212970|NCT01709721|79010136|FG001|Open Label Phase|Inadequate Pain Control|0|||
44212971|NCT01709721|79010137|FG002|Open Label Phase|Inadequate Pain Control|37|||
44212972|NCT01709721|79010135|FG000|Open Label Phase|Other, Specify in text field in database|0|||
44452906|NCT00541970|79461683|FG001|Month 48|Lost to Follow-up|68|||
44212973|NCT01709721|79010136|FG001|Open Label Phase|Other, Specify in text field in database|0|||
44452907|NCT00541970|79461684|FG002|Month 48|Lost to Follow-up|68|||
44212974|NCT01709721|79010137|FG002|Open Label Phase|Other, Specify in text field in database|14|||
44212975|NCT01709721|79010135|FG000|Randomized Phase|Adverse Event|0|||
44212976|NCT01709721|79010136|FG001|Randomized Phase|Adverse Event|1|||
44212977|NCT01709721|79010137|FG002|Randomized Phase|Adverse Event|0|||
44452908|NCT00541970|79461685|FG003|Month 48|Lost to Follow-up|73|||
44452909|NCT00541970|79461682|FG000|Month 60|Protocol Violation|78|||
44452910|NCT00541970|79461683|FG001|Month 60|Protocol Violation|77|||
44212978|NCT01709721|79010135|FG000|Randomized Phase|Lost to Follow-up|1|||
44212979|NCT01709721|79010136|FG001|Randomized Phase|Lost to Follow-up|0|||
44212980|NCT01709721|79010137|FG002|Randomized Phase|Lost to Follow-up|0|||
44212981|NCT01709721|79010135|FG000|Randomized Phase|Inadequate Pain Control|1|||
44212982|NCT01709721|79010136|FG001|Randomized Phase|Inadequate Pain Control|2|||
44212983|NCT01709721|79010137|FG002|Randomized Phase|Inadequate Pain Control|0|||
44212984|NCT01709721|79010135|FG000|Randomized Phase|Other, Specify text field in database|1|||
44212985|NCT01709721|79010136|FG001|Randomized Phase|Other, Specify text field in database|3|||
44212986|NCT01709721|79010137|FG002|Randomized Phase|Other, Specify text field in database|0|||
44212987|NCT01866657|79010147|FG000|Overall Study|Surgery canceled|2|||
44212988|NCT01866657|79010148|FG001|Overall Study|Surgery canceled|0|||
44212989|NCT01700205|79010156|FG000|Overall Study|Withdrawal by Subject|13|||
44212990|NCT01700205|79010157|FG001|Overall Study|Withdrawal by Subject|13|||
44212991|NCT01700205|79010156|FG000|Overall Study|Protocol Violation|2|||
44212992|NCT01700205|79010157|FG001|Overall Study|Protocol Violation|2|||
44212993|NCT01700049|79010163|FG000|Overall Study|Withdrawal by Subject|1|||
44212994|NCT01699815|79010170|FG000|Overall Study|Protocol Violation|4|||
44212995|NCT01699815|79010171|FG001|Overall Study|Protocol Violation|7|||
44212996|NCT01699815|79010170|FG000|Overall Study|record could not be located|1|||
44212997|NCT01699815|79010171|FG001|Overall Study|record could not be located|0|||
44212998|NCT01699815|79010170|FG000|Overall Study|Adverse Event|0|||
44212999|NCT01699815|79010171|FG001|Overall Study|Adverse Event|1|||
44213000|NCT01866423|79010177|FG000|Overall Study|Lack of Efficacy|3|||
44213001|NCT01866423|79010177|FG000|Overall Study|Sponsor Decision|1|||
44213002|NCT01846208|79010184|FG000|Overall Study|Withdrew prior to treatment|1|||
44213003|NCT01846208|79010185|FG001|Overall Study|Withdrew prior to treatment|1|||
44213004|NCT01846208|79010186|FG002|Overall Study|Withdrew prior to treatment|1|||
44213005|NCT01846208|79010184|FG000|Overall Study|Dosing Symptoms|1|||
44213006|NCT01846208|79010185|FG001|Overall Study|Dosing Symptoms|2|||
44213007|NCT01846208|79010186|FG002|Overall Study|Dosing Symptoms|6|||
44213008|NCT01846208|79010184|FG000|Overall Study|Withdrawal by Subject|5|||
44213009|NCT01846208|79010185|FG001|Overall Study|Withdrawal by Subject|0|||
44213010|NCT01846208|79010186|FG002|Overall Study|Withdrawal by Subject|0|||
44213011|NCT01846208|79010184|FG000|Overall Study|Non-compliance|1|||
44213012|NCT01846208|79010185|FG001|Overall Study|Non-compliance|1|||
44213013|NCT01846208|79010186|FG002|Overall Study|Non-compliance|0|||
44213014|NCT01846208|79010184|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
44213015|NCT01846208|79010185|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
44213016|NCT01846208|79010186|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
44213017|NCT01846208|79010184|FG000|Overall Study|Refused SU OFC|0|||
44213018|NCT01846208|79010185|FG001|Overall Study|Refused SU OFC|0|||
44213019|NCT01846208|79010186|FG002|Overall Study|Refused SU OFC|1|||
44213020|NCT01845974|79010196|FG000|Overall Study|screen failure|1|||
44213021|NCT01845974|79010197|FG001|Overall Study|screen failure|0|||
44213022|NCT01865487|79010209|FG000|Overall Study|Lost to Follow-up|0|||
44213023|NCT01865487|79010210|FG001|Overall Study|Lost to Follow-up|0|||
44213024|NCT01865487|79010211|FG002|Overall Study|Lost to Follow-up|0|||
44213025|NCT01865487|79010212|FG003|Overall Study|Lost to Follow-up|1|||
44452911|NCT00541970|79461684|FG002|Month 60|Protocol Violation|82|||
44452912|NCT00541970|79461685|FG003|Month 60|Protocol Violation|72|||
44452913|NCT00687323|79461695|FG000|Overall Study|Death|25|||
44452914|NCT00687323|79461695|FG000|Overall Study|Withdrawal by Subject|1|||
44452915|NCT00687323|79461695|FG000|Overall Study|Excluded from efficacy evaluations|6|||
44213026|NCT01865487|79010213|FG004|Overall Study|Lost to Follow-up|0|||
44213027|NCT01865487|79010214|FG005|Overall Study|Lost to Follow-up|0|||
44452916|NCT00687323|79461695|FG000|Overall Study|Screen failure|148|||
44452917|NCT03899064|79461712|FG000|Overall Study|Lost to Follow-up|1|||
44452918|NCT03899064|79461712|FG000|Overall Study|Protocol Violation|2|||
44213028|NCT01865487|79010215|FG006|Overall Study|Lost to Follow-up|1|||
44213029|NCT01865487|79010216|FG007|Overall Study|Lost to Follow-up|0|||
44213030|NCT01865487|79010217|FG008|Overall Study|Lost to Follow-up|0|||
44213031|NCT01865487|79010218|FG009|Overall Study|Lost to Follow-up|0|||
44213032|NCT01865487|79010209|FG000|Overall Study|Withdrawal by Subject|0|||
44213033|NCT01865487|79010210|FG001|Overall Study|Withdrawal by Subject|0|||
44452919|NCT03899064|79461712|FG000|Overall Study|Withdrawal by Subject|2|||
44452920|NCT03899064|79461712|FG000|Overall Study|Other|2|||
44452921|NCT03902574|79461719|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
44452922|NCT03902574|79461720|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
44213034|NCT01865487|79010211|FG002|Overall Study|Withdrawal by Subject|0|||
44213035|NCT01865487|79010212|FG003|Overall Study|Withdrawal by Subject|0|||
44213036|NCT01865487|79010213|FG004|Overall Study|Withdrawal by Subject|1|||
44213037|NCT01865487|79010214|FG005|Overall Study|Withdrawal by Subject|0|||
44213038|NCT01865487|79010215|FG006|Overall Study|Withdrawal by Subject|0|||
44213039|NCT01865487|79010216|FG007|Overall Study|Withdrawal by Subject|0|||
44452923|NCT03902574|79461721|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
44213040|NCT01865487|79010217|FG008|Overall Study|Withdrawal by Subject|0|||
44213041|NCT01865487|79010218|FG009|Overall Study|Withdrawal by Subject|0|||
44452924|NCT00542828|79461733|FG000|Overall Study|Physician Decision|1|||
44452925|NCT00542828|79461733|FG000|Overall Study|Need for Prohibited Treatment|3|||
44213042|NCT01699503|79010248|FG000|Overall Study|Death|31|||
44213043|NCT01699503|79010249|FG001|Overall Study|Death|40|||
44213044|NCT01699503|79010248|FG000|Overall Study|Withdrawal by Subject|65|||
44213045|NCT01699503|79010249|FG001|Overall Study|Withdrawal by Subject|57|||
44213046|NCT01699503|79010248|FG000|Overall Study|Lost to Follow-up|121|||
44213047|NCT01699503|79010249|FG001|Overall Study|Lost to Follow-up|117|||
44213048|NCT01699503|79010248|FG000|Overall Study|Excluded due to quality|783|||
44213049|NCT01699503|79010249|FG001|Overall Study|Excluded due to quality|791|||
44213050|NCT01709409|79010257|FG000|Overall Study|Protocol Violation|1|||
44213051|NCT01709409|79010258|FG001|Overall Study|Protocol Violation|0|||
44213052|NCT01698879|79010267|FG000|Overall Study|Withdrawal by Subject|1|||
44213053|NCT01698879|79010268|FG001|Overall Study|Withdrawal by Subject|0|||
44213054|NCT01698879|79010269|FG002|Overall Study|Withdrawal by Subject|0|||
44213055|NCT01698801|79010308|FG000|Treatment Phase|Adverse Event|4|||
44213056|NCT01698801|79010308|FG000|Treatment Phase|Protocol Violation|1|||
44213057|NCT01698801|79010308|FG000|Treatment Phase|Other|4|||
44213058|NCT01698801|79010308|FG000|Treatment Phase|Withdrawal by Subject|1|||
44213059|NCT01698801|79010308|FG000|Treatment Phase|Disease progression|1|||
44213060|NCT01698801|79010308|FG000|Follow Up Phase|Withdrawal by Subject|1|||
44213061|NCT01698801|79010308|FG000|Follow Up Phase|Death|4|||
44213062|NCT01682811|79010320|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
44213063|NCT01682811|79010321|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
44213064|NCT01682811|79010322|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
44213065|NCT01682811|79010323|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
44213066|NCT01682811|79010324|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
44213067|NCT01682811|79010325|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
44213068|NCT01682811|79010326|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
44370845|NCT00881530|79376109|FG004|Overall Study|Other reason not defined above|0|||
44370846|NCT00881530|79376110|FG005|Overall Study|Other reason not defined above|2|||
44452926|NCT00542828|79461733|FG000|Overall Study|Study Prematurely Discontinued|7|||
44452927|NCT00542828|79461733|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
44213069|NCT01682811|79010320|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
44370847|NCT01075685|79376126|FG000|Overall Study|Protocol Violation|9|||
44370848|NCT01075685|79376127|FG001|Overall Study|Protocol Violation|1|||
44370849|NCT01075685|79376126|FG000|Overall Study|Withdrawal by Subject|20|||
44370850|NCT01075685|79376127|FG001|Overall Study|Withdrawal by Subject|5|||
44370851|NCT01075685|79376126|FG000|Overall Study|Lost to Follow-up|563|||
44370852|NCT01075685|79376127|FG001|Overall Study|Lost to Follow-up|220|||
44370853|NCT01075217|79376135|FG000|Overall Study|Adverse Event|1|||
44370854|NCT01075217|79376136|FG001|Overall Study|Adverse Event|1|||
44370855|NCT01075217|79376135|FG000|Overall Study|Physician Decision|1|||
44370856|NCT01075217|79376136|FG001|Overall Study|Physician Decision|0|||
44370857|NCT01078571|79376150|FG000|Overall Study|Adverse Event|36|||
44370858|NCT01078571|79376150|FG000|Overall Study|Lack of effectiveness|36|||
44370859|NCT01078571|79376150|FG000|Overall Study|Reason not reported|21|||
44370860|NCT01078571|79376150|FG000|Overall Study|Withdrawal by Subject|12|||
44370861|NCT01078571|79376150|FG000|Overall Study|Lost to Follow-up|8|||
44370862|NCT01078571|79376150|FG000|Overall Study|Protocol Violation|2|||
44370863|NCT00977106|79376161|FG000|Overall Study|Adverse Event|5|||
44370864|NCT00977106|79376162|FG001|Overall Study|Adverse Event|6|||
44370865|NCT00977106|79376161|FG000|Overall Study|Withdrawal by Subject|2|||
44370866|NCT00977106|79376162|FG001|Overall Study|Withdrawal by Subject|2|||
44370867|NCT00977106|79376161|FG000|Overall Study|Lack of Efficacy|2|||
44370868|NCT00977106|79376162|FG001|Overall Study|Lack of Efficacy|2|||
44370869|NCT00977106|79376161|FG000|Overall Study|Protocol Violation|0|||
44370870|NCT00977106|79376162|FG001|Overall Study|Protocol Violation|1|||
44370871|NCT00977106|79376161|FG000|Overall Study|Other|1|||
44370872|NCT00977106|79376162|FG001|Overall Study|Other|0|||
44370873|NCT01077713|79376172|FG000|Overall Study|Withdrawal by Subject|1|||
44370874|NCT01077713|79376173|FG001|Overall Study|Withdrawal by Subject|2|||
44370875|NCT01077713|79376172|FG000|Overall Study|Progressive Disease (PD)|0|||
44370876|NCT01077713|79376173|FG001|Overall Study|Progressive Disease (PD)|1|||
44370877|NCT01077713|79376172|FG000|Overall Study|Death|28|||
44370878|NCT01077713|79376173|FG001|Overall Study|Death|29|||
44370879|NCT01077713|79376172|FG000|Overall Study|Lost to Follow-up|1|||
44370880|NCT01077713|79376173|FG001|Overall Study|Lost to Follow-up|1|||
44370881|NCT01077713|79376172|FG000|Overall Study|Adverse Event|2|||
44213070|NCT01682811|79010321|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
44370882|NCT01077713|79376173|FG001|Overall Study|Adverse Event|1|||
44370883|NCT01077713|79376172|FG000|Overall Study|Other|4|||
44213071|NCT01682811|79010322|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
44213072|NCT01682811|79010323|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
44213073|NCT01682811|79010324|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
44213074|NCT01682811|79010325|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
44213075|NCT01682811|79010326|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
44213076|NCT01682811|79010320|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
44452928|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
44213077|NCT01682811|79010321|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
44213078|NCT01682811|79010322|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
44452929|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
44452930|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
44452931|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
44452932|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
44452933|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
44452934|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
44452935|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
44452936|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
44452937|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
44452938|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
44452939|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
44452940|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
44452941|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
44452942|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
44452943|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
44452944|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
44452945|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
44452946|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
44452947|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
44452948|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
44213079|NCT01682811|79010323|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
44213080|NCT01682811|79010324|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
44213081|NCT01682811|79010325|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
44213082|NCT01682811|79010326|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
44213083|NCT01682811|79010320|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
44213084|NCT01682811|79010321|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
44213085|NCT01682811|79010322|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
44213086|NCT01682811|79010323|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
44370884|NCT01077713|79376173|FG001|Overall Study|Other|2|||
44370885|NCT00813709|79376182|FG000|Double Blind Period|Adverse Event|4|||
44370886|NCT00813709|79376183|FG001|Double Blind Period|Adverse Event|1|||
44370887|NCT00813709|79376184|FG002|Double Blind Period|Adverse Event|4|||
44370888|NCT00813709|79376185|FG003|Double Blind Period|Adverse Event|0|||
44370889|NCT00813709|79376186|FG004|Double Blind Period|Adverse Event|0|||
44370890|NCT00813709|79376187|FG005|Double Blind Period|Adverse Event|0|||
44370891|NCT00813709|79376182|FG000|Double Blind Period|Lost to Follow-up|3|||
44370892|NCT00813709|79376183|FG001|Double Blind Period|Lost to Follow-up|2|||
44370893|NCT00813709|79376184|FG002|Double Blind Period|Lost to Follow-up|2|||
44370894|NCT00813709|79376185|FG003|Double Blind Period|Lost to Follow-up|0|||
44370895|NCT00813709|79376186|FG004|Double Blind Period|Lost to Follow-up|0|||
44370896|NCT00813709|79376187|FG005|Double Blind Period|Lost to Follow-up|0|||
44370897|NCT00813709|79376182|FG000|Double Blind Period|Switched to open label phase|9|||
44370898|NCT00813709|79376183|FG001|Double Blind Period|Switched to open label phase|26|||
44370899|NCT00813709|79376184|FG002|Double Blind Period|Switched to open label phase|18|||
44370900|NCT00813709|79376185|FG003|Double Blind Period|Switched to open label phase|0|||
44370901|NCT00813709|79376186|FG004|Double Blind Period|Switched to open label phase|0|||
44370902|NCT00813709|79376187|FG005|Double Blind Period|Switched to open label phase|0|||
44370903|NCT00813709|79376182|FG000|Double Blind Period|Randomized but not treated|1|||
44370904|NCT00813709|79376183|FG001|Double Blind Period|Randomized but not treated|3|||
44370905|NCT00813709|79376184|FG002|Double Blind Period|Randomized but not treated|1|||
44370906|NCT00813709|79376185|FG003|Double Blind Period|Randomized but not treated|0|||
44370907|NCT00813709|79376186|FG004|Double Blind Period|Randomized but not treated|0|||
44370908|NCT00813709|79376187|FG005|Double Blind Period|Randomized but not treated|0|||
44370909|NCT00813709|79376182|FG000|Double Blind Period|Other|14|||
44370910|NCT00813709|79376183|FG001|Double Blind Period|Other|9|||
44370911|NCT00813709|79376184|FG002|Double Blind Period|Other|6|||
44543620|NCT03649477|79556709|FG001|Overall Study|Adverse Event|0|||
44213087|NCT01682811|79010324|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
44213088|NCT01682811|79010325|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
44370912|NCT00813709|79376185|FG003|Double Blind Period|Other|0|||
44370913|NCT00813709|79376186|FG004|Double Blind Period|Other|0|||
44370914|NCT00813709|79376187|FG005|Double Blind Period|Other|0|||
44370915|NCT00813709|79376182|FG000|Open Label Period|Adverse Event|0|||
44213089|NCT01682811|79010326|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
44370916|NCT00813709|79376183|FG001|Open Label Period|Adverse Event|0|||
44370917|NCT00813709|79376184|FG002|Open Label Period|Adverse Event|0|||
44370918|NCT00813709|79376185|FG003|Open Label Period|Adverse Event|5|||
44213090|NCT01682031|79010347|FG000|Overall Study|Withdrawal by Subject|0|||
44213091|NCT01682031|79010348|FG001|Overall Study|Withdrawal by Subject|1|||
44213092|NCT01682031|79010347|FG000|Overall Study|Adverse Event|0|||
44213093|NCT01682031|79010348|FG001|Overall Study|Adverse Event|2|||
44213094|NCT01682031|79010347|FG000|Overall Study|MRI results indicate increased nodul|0|||
44213095|NCT01682031|79010348|FG001|Overall Study|MRI results indicate increased nodul|1|||
44213096|NCT01682031|79010347|FG000|Overall Study|Patient could not swallow tablets|1|||
44213097|NCT01682031|79010348|FG001|Overall Study|Patient could not swallow tablets|0|||
44213098|NCT01682031|79010347|FG000|Overall Study|Patient stopped selenium on his own|0|||
44213099|NCT01682031|79010348|FG001|Overall Study|Patient stopped selenium on his own|1|||
44213100|NCT01567527|79010369|FG000|Conversion Phase.|Protocol deviation|3|||
44213101|NCT01567527|79010370|FG001|Conversion Phase.|Protocol deviation|0|||
44213102|NCT01567527|79010371|FG002|Conversion Phase.|Protocol deviation|0|||
44213103|NCT01567527|79010372|FG003|Conversion Phase.|Protocol deviation|0|||
44213104|NCT01567527|79010373|FG004|Conversion Phase.|Protocol deviation|0|||
44213105|NCT01567527|79010369|FG000|Conversion Phase.|Met withdrawal criteria|10|||
44213106|NCT01567527|79010370|FG001|Conversion Phase.|Met withdrawal criteria|0|||
44213107|NCT01567527|79010371|FG002|Conversion Phase.|Met withdrawal criteria|0|||
44213108|NCT01567527|79010372|FG003|Conversion Phase.|Met withdrawal criteria|0|||
44213109|NCT01567527|79010373|FG004|Conversion Phase.|Met withdrawal criteria|0|||
44213110|NCT01567527|79010369|FG000|Conversion Phase.|Withdrawal by Subject|32|||
44213111|NCT01567527|79010370|FG001|Conversion Phase.|Withdrawal by Subject|0|||
44213112|NCT01567527|79010371|FG002|Conversion Phase.|Withdrawal by Subject|0|||
44213113|NCT01567527|79010372|FG003|Conversion Phase.|Withdrawal by Subject|0|||
44213114|NCT01567527|79010373|FG004|Conversion Phase.|Withdrawal by Subject|0|||
44213115|NCT01567527|79010369|FG000|Conversion Phase.|Lost to Follow-up|16|||
44213116|NCT01567527|79010370|FG001|Conversion Phase.|Lost to Follow-up|0|||
44213117|NCT01567527|79010371|FG002|Conversion Phase.|Lost to Follow-up|0|||
44213118|NCT01567527|79010372|FG003|Conversion Phase.|Lost to Follow-up|0|||
44213119|NCT01567527|79010373|FG004|Conversion Phase.|Lost to Follow-up|0|||
44213120|NCT01567527|79010369|FG000|Conversion Phase.|Lack of Efficacy|2|||
44213121|NCT01567527|79010370|FG001|Conversion Phase.|Lack of Efficacy|0|||
44213122|NCT01567527|79010371|FG002|Conversion Phase.|Lack of Efficacy|0|||
44213123|NCT01567527|79010372|FG003|Conversion Phase.|Lack of Efficacy|0|||
44213124|NCT01567527|79010373|FG004|Conversion Phase.|Lack of Efficacy|0|||
44213125|NCT01567527|79010369|FG000|Conversion Phase.|Adverse Event|33|||
44213126|NCT01567527|79010370|FG001|Conversion Phase.|Adverse Event|0|||
44213127|NCT01567527|79010371|FG002|Conversion Phase.|Adverse Event|0|||
44213128|NCT01567527|79010372|FG003|Conversion Phase.|Adverse Event|0|||
44213129|NCT01567527|79010373|FG004|Conversion Phase.|Adverse Event|0|||
44213130|NCT01567527|79010369|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
44213131|NCT01567527|79010370|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
44213132|NCT01567527|79010371|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
44213133|NCT01567527|79010372|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
44213134|NCT01567527|79010373|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
44213135|NCT01567527|79010369|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
44213136|NCT01567527|79010370|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
44213137|NCT01567527|79010371|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
44213138|NCT01567527|79010372|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
44213139|NCT01567527|79010373|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
44213140|NCT01567527|79010369|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
44213141|NCT01567527|79010370|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
44213142|NCT01567527|79010371|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
44213143|NCT01567527|79010372|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
44213144|NCT01567527|79010373|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
44213145|NCT01567527|79010369|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
44213146|NCT01567527|79010370|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
44213147|NCT01567527|79010371|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
44370919|NCT00813709|79376186|FG004|Open Label Period|Adverse Event|4|||
44370920|NCT00813709|79376187|FG005|Open Label Period|Adverse Event|3|||
44370921|NCT00813709|79376182|FG000|Open Label Period|Lack of Efficacy|0|||
44370922|NCT00813709|79376183|FG001|Open Label Period|Lack of Efficacy|0|||
44370923|NCT00813709|79376184|FG002|Open Label Period|Lack of Efficacy|0|||
44370924|NCT00813709|79376185|FG003|Open Label Period|Lack of Efficacy|3|||
44370925|NCT00813709|79376186|FG004|Open Label Period|Lack of Efficacy|1|||
44370926|NCT00813709|79376187|FG005|Open Label Period|Lack of Efficacy|1|||
44370927|NCT00813709|79376182|FG000|Open Label Period|Randomized but not treated|0|||
44370928|NCT00813709|79376183|FG001|Open Label Period|Randomized but not treated|0|||
44213148|NCT01567527|79010372|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
44213149|NCT01567527|79010373|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
44213150|NCT01567527|79010369|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
44370929|NCT00813709|79376184|FG002|Open Label Period|Randomized but not treated|0|||
44370930|NCT00813709|79376185|FG003|Open Label Period|Randomized but not treated|1|||
44543621|NCT03649477|79556710|FG002|Overall Study|Adverse Event|0|||
44213151|NCT01567527|79010370|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
44452949|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
44452950|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
44452951|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
44452952|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
44452953|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
44452954|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
44452955|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
44452956|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
44452957|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
44452958|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
44452959|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
44452960|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
44452961|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
44452962|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
44452963|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
44452964|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
44452965|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
44452966|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
44452967|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
44452968|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
44452969|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
44452970|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
44452971|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
44452972|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
44452973|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
44452974|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
44452975|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
44452976|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
44452977|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
44543622|NCT03677869|79556718|FG000|Overall Study|Withdrawal by Subject|1|||
44543623|NCT03677401|79556724|FG000|Overall Study|Adverse Event|4|||
44543624|NCT03677401|79556725|FG001|Overall Study|Adverse Event|14|||
44543625|NCT03677401|79556724|FG000|Overall Study|Lack of Efficacy|3|||
44543626|NCT03677401|79556725|FG001|Overall Study|Lack of Efficacy|1|||
44543627|NCT03677401|79556724|FG000|Overall Study|Withdrawal by Subject|2|||
44543628|NCT03677401|79556725|FG001|Overall Study|Withdrawal by Subject|2|||
44543629|NCT03677401|79556724|FG000|Overall Study|Sponsor decision|0|||
44543630|NCT03677401|79556725|FG001|Overall Study|Sponsor decision|1|||
44543631|NCT03677401|79556724|FG000|Overall Study|Reason Unspecified|1|||
44543632|NCT03677401|79556725|FG001|Overall Study|Reason Unspecified|0|||
44543633|NCT03218787|79556731|FG000|Overall Study|Lost to Follow-up|12|||
44543634|NCT03218787|79556731|FG000|Overall Study|Withdrawal by Subject|72|||
44543635|NCT03218787|79556731|FG000|Overall Study|Physician Decision|11|||
44543636|NCT03218787|79556731|FG000|Overall Study|Death|111|||
44543637|NCT01348087|79556735|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
44543638|NCT01348087|79556735|FG000|Overall Study|Administrative problems|79|||
44543639|NCT01348087|79556735|FG000|Overall Study|protocol deviation|1|||
44213152|NCT01567527|79010371|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
44213153|NCT01567527|79010372|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
44213154|NCT01567527|79010373|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
44213155|NCT01567527|79010369|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
44213156|NCT01567527|79010370|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
44370931|NCT00813709|79376186|FG004|Open Label Period|Randomized but not treated|0|||
44370932|NCT00813709|79376187|FG005|Open Label Period|Randomized but not treated|1|||
44370933|NCT00813709|79376182|FG000|Open Label Period|Other|0|||
44370934|NCT00813709|79376183|FG001|Open Label Period|Other|0|||
44370935|NCT00813709|79376184|FG002|Open Label Period|Other|0|||
44370936|NCT00813709|79376185|FG003|Open Label Period|Other|11|||
44370937|NCT00813709|79376186|FG004|Open Label Period|Other|5|||
44213157|NCT01567527|79010371|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
44213158|NCT01567527|79010372|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
44370938|NCT00813709|79376187|FG005|Open Label Period|Other|6|||
44370939|NCT01077323|79376219|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
44370940|NCT01077323|79376220|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
44370941|NCT01077323|79376221|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
44370942|NCT01077323|79376219|FG000|Overall Study|Dispensing of drug in baseline period|0|||
44213159|NCT01567527|79010373|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
44213160|NCT01567527|79010369|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
44213161|NCT01567527|79010370|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
44213162|NCT01567527|79010371|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
44213163|NCT01567527|79010372|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
44213164|NCT01567527|79010373|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
44213165|NCT01567527|79010369|FG000|IM Depot Stabilization.|Protocol deviation|0|||
44213166|NCT01567527|79010370|FG001|IM Depot Stabilization.|Protocol deviation|0|||
44213167|NCT01567527|79010371|FG002|IM Depot Stabilization.|Protocol deviation|5|||
44213168|NCT01567527|79010372|FG003|IM Depot Stabilization.|Protocol deviation|0|||
44213169|NCT01567527|79010373|FG004|IM Depot Stabilization.|Protocol deviation|0|||
44213170|NCT01567527|79010369|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
44213171|NCT01567527|79010370|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
44213172|NCT01567527|79010371|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
44213173|NCT01567527|79010372|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
44213174|NCT01567527|79010373|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
44213175|NCT01567527|79010369|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
44213176|NCT01567527|79010370|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
44213177|NCT01567527|79010371|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
44213178|NCT01567527|79010372|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
44213179|NCT01567527|79010373|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
44213180|NCT01567527|79010369|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
44543640|NCT01348087|79556735|FG000|Overall Study|Lost to Follow-up|1|||
44543641|NCT01348087|79556735|FG000|Overall Study|Subject withdrew consent|7|||
44543642|NCT01348087|79556735|FG000|Overall Study|Adverse Event|25|||
44543643|NCT01347931|79556749|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
44543644|NCT03645421|79556759|FG000|Overall Study|Adverse Event|0|||
44543645|NCT03645421|79556760|FG001|Overall Study|Adverse Event|0|||
44543646|NCT03645421|79556761|FG002|Overall Study|Adverse Event|4|||
44543647|NCT03645421|79556762|FG003|Overall Study|Adverse Event|1|||
44543648|NCT03645421|79556759|FG000|Overall Study|Withdrawal by patient|0|||
44543649|NCT03645421|79556760|FG001|Overall Study|Withdrawal by patient|0|||
44543650|NCT03645421|79556761|FG002|Overall Study|Withdrawal by patient|0|||
44543651|NCT03645421|79556762|FG003|Overall Study|Withdrawal by patient|3|||
44543652|NCT03645421|79556759|FG000|Overall Study|Study specific withdrawal criteria|0|||
44452978|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
44452979|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
44452980|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
44452981|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
44452982|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
44452983|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
44452984|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
44452985|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
44452986|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
44452987|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
44452988|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
44452989|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
44543653|NCT03645421|79556760|FG001|Overall Study|Study specific withdrawal criteria|0|||
44543654|NCT03645421|79556761|FG002|Overall Study|Study specific withdrawal criteria|1|||
44543655|NCT03645421|79556762|FG003|Overall Study|Study specific withdrawal criteria|0|||
44543656|NCT03207750|79556777|FG000|Overall Study|Adverse Event|3|||
44213181|NCT01567527|79010370|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
44213182|NCT01567527|79010371|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
44213183|NCT01567527|79010372|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
44213184|NCT01567527|79010373|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
44213185|NCT01567527|79010369|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
44213186|NCT01567527|79010370|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
44370943|NCT01077323|79376220|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
44370944|NCT01077323|79376221|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
44370945|NCT01077323|79376219|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
44370946|NCT01077323|79376220|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
44370947|NCT01077323|79376221|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
44370948|NCT00976950|79376229|FG000|Overall Study|Adverse Event|3|||
44370949|NCT00976950|79376229|FG000|Overall Study|Events with no relationship to Aptivus|3|||
44370950|NCT05570500|79376250|FG000|Overall Study|Lost to Follow-up|7|||
44370951|NCT05570500|79376251|FG001|Overall Study|Lost to Follow-up|5|||
44370952|NCT05466682|79376259|FG000|Overall Study|Withdrawal by Subject|0|||
44370953|NCT05466682|79376260|FG001|Overall Study|Withdrawal by Subject|2|||
44370954|NCT05466682|79376259|FG000|Overall Study|Lost to Follow-up|2|||
44213187|NCT01567527|79010371|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
44213188|NCT01567527|79010372|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
44213189|NCT01567527|79010373|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
44213190|NCT01567527|79010369|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
44213191|NCT01567527|79010370|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
44213192|NCT01567527|79010371|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
44213193|NCT01567527|79010372|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
44213194|NCT01567527|79010373|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
44213195|NCT01567527|79010369|FG000|IM Depot Stabilization.|Adverse Event|0|||
44213196|NCT01567527|79010370|FG001|IM Depot Stabilization.|Adverse Event|0|||
44213197|NCT01567527|79010371|FG002|IM Depot Stabilization.|Adverse Event|37|||
44213198|NCT01567527|79010372|FG003|IM Depot Stabilization.|Adverse Event|0|||
44213199|NCT01567527|79010373|FG004|IM Depot Stabilization.|Adverse Event|0|||
44213200|NCT01567527|79010369|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
44213201|NCT01567527|79010370|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
44213202|NCT01567527|79010371|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
44213203|NCT01567527|79010372|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
44213204|NCT01567527|79010373|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
44213205|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
44213206|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
44452990|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
44452991|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
44452992|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
44452993|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
44452994|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
44452995|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
44452996|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
44452997|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
44452998|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
44452999|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
44453000|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
44453001|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
44453002|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
44453003|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
44453004|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
44453005|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
44453006|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
44453007|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
44453008|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
44453009|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
44453010|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
44453011|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
44453012|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
44453013|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
44453014|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
44453015|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
44453016|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
44213207|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
44213208|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
44213209|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
44370955|NCT05466682|79376260|FG001|Overall Study|Lost to Follow-up|1|||
44370956|NCT05099640|79376273|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
44370957|NCT05099640|79376274|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
44370958|NCT05099640|79376275|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
44370959|NCT05099640|79376273|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
44370960|NCT05099640|79376274|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
44370961|NCT05099640|79376275|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
44370962|NCT05099640|79376273|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
44370963|NCT05099640|79376274|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
44370964|NCT05099640|79376275|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
44370965|NCT05099640|79376273|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
44370966|NCT05099640|79376274|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
44370967|NCT05099640|79376275|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
44543657|NCT03207750|79556778|FG001|Overall Study|Adverse Event|2|||
44213210|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
44213211|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
44213212|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
44213213|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
44213214|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
44213215|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
44213216|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
44213217|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
44213218|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
44213219|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
44213220|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
44213221|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
44213222|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
44213223|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
44213224|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
44213225|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44213226|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44213227|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44269841|NCT00553514|79194991|FG001|Overall Study|Risk of multiple pregnancy|2|||
44269842|NCT00553514|79194992|FG002|Overall Study|Risk of multiple pregnancy|0|||
44213228|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
44213229|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
44213230|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
44213231|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
44269843|NCT00553514|79194993|FG003|Overall Study|Risk of multiple pregnancy|1|||
44370968|NCT05099640|79376273|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
44370969|NCT05099640|79376274|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
44370970|NCT05099640|79376275|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
44370971|NCT05099640|79376273|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
44370972|NCT05099640|79376274|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
44370973|NCT05099640|79376275|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
44453017|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
44453018|NCT00090103|79461740|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
44453019|NCT00090103|79461741|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
44453020|NCT00090103|79461742|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
44453021|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
44453022|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
44453023|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
44453024|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
44453025|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
44453026|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
44453027|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
44453028|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
44453029|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
44453030|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
44453031|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
44453032|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
44453033|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
44453034|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
44453035|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
44453036|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
44453037|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
44453038|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
44453039|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
44453040|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
44453041|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
44370974|NCT05020665|79376287|FG000|Overall Study|Study terminated by Sponsor|5|||
44370975|NCT05020665|79376288|FG001|Overall Study|Study terminated by Sponsor|4|||
44370976|NCT05020665|79376287|FG000|Overall Study|Death|2|||
44370977|NCT05020665|79376288|FG001|Overall Study|Death|1|||
44453042|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
44453043|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
44453044|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
44453045|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
44453046|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
44543658|NCT03207750|79556777|FG000|Overall Study|Lost to Follow-up|21|||
44213232|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
44213233|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
44213234|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
44213235|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
44213236|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
44213237|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
44213238|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
44213239|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
44213240|NCT01567527|79010369|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44213241|NCT01567527|79010370|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44213242|NCT01567527|79010371|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44213243|NCT01567527|79010372|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
44213244|NCT01567527|79010373|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
44213245|NCT01818752|79010384|FG000|Overall Study|Adverse Event|64|||
44213246|NCT01818752|79010385|FG001|Overall Study|Adverse Event|74|||
44453047|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
44453048|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
44453049|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
44453050|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
44453051|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
44453052|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
44453053|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
44453054|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
44453055|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
44453056|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
44453057|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
44453058|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
44453059|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
44453060|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
44453061|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
44453062|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
44453063|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
44453064|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
44453065|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
44453066|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
44453067|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
44453068|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
44453069|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Death|1|||
44453070|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Death|0|||
44453071|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Death|1|||
44453072|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
44453073|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
44453074|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
44453075|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
44453076|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
44453077|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
44453078|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
44453079|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
44453080|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
44453081|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
44453082|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
44453083|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
44453084|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
44453085|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
44453086|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
44453087|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
44453088|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
44453089|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
44453090|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
44453091|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
44453092|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
44453093|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Depression|0|||
44543659|NCT03207750|79556778|FG001|Overall Study|Lost to Follow-up|29|||
44543660|NCT03207750|79556777|FG000|Overall Study|Protocol Violation|0|||
44543661|NCT03207750|79556778|FG001|Overall Study|Protocol Violation|1|||
44453094|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Depression|1|||
44213247|NCT01818752|79010384|FG000|Overall Study|Death|14|||
44213248|NCT01818752|79010385|FG001|Overall Study|Death|18|||
44213249|NCT01818752|79010384|FG000|Overall Study|Non-compliance|16|||
44213250|NCT01818752|79010385|FG001|Overall Study|Non-compliance|20|||
44213251|NCT01818752|79010384|FG000|Overall Study|Withdrawal by Subject|15|||
44213252|NCT01818752|79010385|FG001|Overall Study|Withdrawal by Subject|14|||
44213253|NCT01818752|79010384|FG000|Overall Study|Physician Decision|9|||
44213254|NCT01818752|79010385|FG001|Overall Study|Physician Decision|8|||
44213255|NCT01818752|79010384|FG000|Overall Study|Disease Progression|54|||
44213256|NCT01818752|79010385|FG001|Overall Study|Disease Progression|48|||
44213257|NCT01818752|79010384|FG000|Overall Study|Other|7|||
44213258|NCT01818752|79010385|FG001|Overall Study|Other|8|||
44213259|NCT01818752|79010384|FG000|Overall Study|Continuing Treatment|1|||
44213260|NCT01818752|79010385|FG001|Overall Study|Continuing Treatment|4|||
44213261|NCT01818752|79010384|FG000|Overall Study|Randomized but not Dosed|7|||
44213262|NCT01818752|79010385|FG001|Overall Study|Randomized but not Dosed|4|||
44213263|NCT01845818|79010393|FG000|Overall Study|Withdrawal by Subject|0|||
44213264|NCT01845818|79010394|FG001|Overall Study|Withdrawal by Subject|1|||
44213265|NCT01845818|79010393|FG000|Overall Study|Lost to Follow-up|7|||
44213266|NCT01845818|79010394|FG001|Overall Study|Lost to Follow-up|5|||
44213267|NCT01845818|79010393|FG000|Overall Study|Administrative Reasons|3|||
44213268|NCT01845818|79010394|FG001|Overall Study|Administrative Reasons|1|||
44213269|NCT01845818|79010393|FG000|Overall Study|Serious Adverse Event|1|||
44213270|NCT01845818|79010394|FG001|Overall Study|Serious Adverse Event|1|||
44213271|NCT01845818|79010393|FG000|Overall Study|Other|25|||
44213272|NCT01845818|79010394|FG001|Overall Study|Other|8|||
44213273|NCT01845818|79010393|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
44213274|NCT01845818|79010394|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
44213275|NCT01845818|79010393|FG000|Overall Study|No Follow-Up Data Available|4|||
44213276|NCT01845818|79010394|FG001|Overall Study|No Follow-Up Data Available|1|||
44213277|NCT01362608|79010404|FG000|Overall Study|Protocol Violation|0|||
44213278|NCT01362608|79010405|FG001|Overall Study|Protocol Violation|1|||
44213279|NCT01362608|79010404|FG000|Overall Study|Lost to Follow-up|3|||
44213280|NCT01362608|79010405|FG001|Overall Study|Lost to Follow-up|1|||
44213281|NCT01362608|79010404|FG000|Overall Study|Withdrawal by Subject|1|||
44213282|NCT01362608|79010405|FG001|Overall Study|Withdrawal by Subject|2|||
44453095|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Depression|0|||
44453096|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
44453097|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
44453098|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
44453099|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Jailed|0|||
44453100|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Jailed|1|||
44453101|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Jailed|0|||
44453102|NCT00090103|79461740|FG000|16-Week Safety Follow-up Period|Other|0|||
44453103|NCT00090103|79461741|FG001|16-Week Safety Follow-up Period|Other|1|||
44213283|NCT01362608|79010404|FG000|Overall Study|Lack of Efficacy|0|||
44213284|NCT01362608|79010405|FG001|Overall Study|Lack of Efficacy|2|||
44213285|NCT01362608|79010404|FG000|Overall Study|Adverse Event|0|||
44213286|NCT01362608|79010405|FG001|Overall Study|Adverse Event|2|||
44213287|NCT01871090|79010413|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
44213288|NCT01871090|79010414|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
44213289|NCT01871090|79010413|FG000|Overall Study|Interrogation not completed correctly|1|||
44370978|NCT05020665|79376287|FG000|Overall Study|Physician Decision|0|||
44370979|NCT05020665|79376288|FG001|Overall Study|Physician Decision|1|||
44370980|NCT05020665|79376287|FG000|Overall Study|Withdrawal by Subject|0|||
44370981|NCT05020665|79376288|FG001|Overall Study|Withdrawal by Subject|1|||
44370982|NCT05020665|79376287|FG000|Overall Study|Reason not specified|1|||
44370983|NCT05020665|79376288|FG001|Overall Study|Reason not specified|0|||
44370984|NCT04869787|79376297|FG000|Screening|Physician Decision|1|||
44370985|NCT04869787|79376297|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
44213290|NCT01871090|79010414|FG001|Overall Study|Interrogation not completed correctly|0|||
44213291|NCT01871090|79010413|FG000|Overall Study|Subject Non-Compliance|0|||
44213292|NCT01871090|79010414|FG001|Overall Study|Subject Non-Compliance|1|||
44213293|NCT01818596|79010422|FG000|Overall Study|Enrolled but Not Treated|4|||
44453104|NCT00090103|79461742|FG002|16-Week Safety Follow-up Period|Other|0|||
44453105|NCT00087607|79461752|FG000|Overall Study|Adverse Event|14|||
44453106|NCT00087607|79461753|FG001|Overall Study|Adverse Event|24|||
44453107|NCT00087607|79461752|FG000|Overall Study|Death|0|||
44213294|NCT01818596|79010423|FG001|Overall Study|Enrolled but Not Treated|0|||
44213295|NCT01818596|79010422|FG000|Overall Study|Adverse Event|7|||
44213296|NCT01818596|79010423|FG001|Overall Study|Adverse Event|0|||
44213297|NCT01818596|79010422|FG000|Overall Study|Death|3|||
44370986|NCT04854057|79376303|FG000|Overall Study|Adverse Event|0|||
44370987|NCT04854057|79376304|FG001|Overall Study|Adverse Event|1|||
44370988|NCT04639258|79376333|FG000|Overall Study|Screen failure|5|||
44370989|NCT04639258|79376333|FG000|Overall Study|Physician Decision|2|||
44213298|NCT01818596|79010423|FG001|Overall Study|Death|0|||
44213299|NCT01818596|79010422|FG000|Overall Study|Investigator's Discretion|4|||
44213300|NCT01818596|79010423|FG001|Overall Study|Investigator's Discretion|0|||
44213301|NCT01818596|79010422|FG000|Overall Study|Protocol Violation|1|||
44213302|NCT01818596|79010423|FG001|Overall Study|Protocol Violation|0|||
44213303|NCT01818596|79010422|FG000|Overall Study|Withdrew Consent|5|||
44213304|NCT01818596|79010423|FG001|Overall Study|Withdrew Consent|0|||
44213305|NCT01818596|79010422|FG000|Overall Study|Lost to Follow-up|7|||
44213306|NCT01818596|79010423|FG001|Overall Study|Lost to Follow-up|0|||
44213307|NCT04577794|79010436|FG000|Overall Study|Adverse Event|1|||
44213308|NCT04577794|79010437|FG001|Overall Study|Adverse Event|1|||
44453108|NCT00087607|79461753|FG001|Overall Study|Death|1|||
44453109|NCT00087607|79461752|FG000|Overall Study|Insufficient Therapeutic Response|53|||
44453110|NCT00087607|79461753|FG001|Overall Study|Insufficient Therapeutic Response|42|||
44453111|NCT00087607|79461752|FG000|Overall Study|Failure to return|21|||
44453112|NCT00087607|79461753|FG001|Overall Study|Failure to return|17|||
44453113|NCT00087607|79461752|FG000|Overall Study|Withdrew Consent|12|||
44453114|NCT00087607|79461753|FG001|Overall Study|Withdrew Consent|16|||
44453115|NCT00087607|79461752|FG000|Overall Study|Administrative|12|||
44453116|NCT00087607|79461753|FG001|Overall Study|Administrative|12|||
44453117|NCT00087607|79461752|FG000|Overall Study|Refused Treatment|5|||
44453118|NCT00087607|79461753|FG001|Overall Study|Refused Treatment|7|||
44453119|NCT00087607|79461752|FG000|Overall Study|Other Protocol Violation|5|||
44453120|NCT00087607|79461753|FG001|Overall Study|Other Protocol Violation|2|||
44453121|NCT00087607|79461752|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
44453122|NCT00087607|79461753|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
44453123|NCT00069823|79461765|FG000|Overall Study|Did not have follow-up diary cards|6|||
44453124|NCT00069823|79461766|FG001|Overall Study|Did not have follow-up diary cards|3|||
44453125|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
44453126|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
44453127|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
44453128|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
44453129|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
44453130|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
44453131|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
44453132|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
44453133|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
44453134|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
44453135|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
44453136|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
44453137|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
44453138|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
44453139|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
44453140|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
44453141|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
44453142|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
44453143|NCT00086515|79461778|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
44453144|NCT00086515|79461779|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
44213309|NCT01594281|79010454|FG000|Interventional Core Phase|Protocol Deviation|1|||
44269844|NCT00553514|79194994|FG004|Overall Study|Risk of multiple pregnancy|0|||
44269845|NCT00553514|79194990|FG000|Overall Study|Other|1|||
44269846|NCT00553514|79194991|FG001|Overall Study|Other|1|||
44269847|NCT00553514|79194992|FG002|Overall Study|Other|0|||
44269848|NCT00553514|79194993|FG003|Overall Study|Other|0|||
44269849|NCT00553514|79194994|FG004|Overall Study|Other|1|||
44269850|NCT00553436|79195018|FG000|Overall Study|Conversion to another procedure|1|||
44269851|NCT00553202|79195049|FG000|Overall Study|Death|16|||
44269852|NCT00553202|79195049|FG000|Overall Study|Lost to Follow-up|1|||
44269853|NCT00553202|79195049|FG000|Overall Study|Physician Decision|28|||
44269854|NCT00553202|79195049|FG000|Overall Study|Withdrawal by Subject|1|||
44269855|NCT00553202|79195049|FG000|Overall Study|No donor identified|16|||
44269856|NCT00553202|79195049|FG000|Overall Study|Fails to meet organ function|6|||
44269857|NCT00552188|79195073|FG000|Overall Study|Adverse Event|0|||
44269858|NCT00552188|79195074|FG001|Overall Study|Adverse Event|2|||
44269859|NCT00552188|79195073|FG000|Overall Study|Lost to Follow-up|2|||
44269860|NCT00552188|79195074|FG001|Overall Study|Lost to Follow-up|1|||
44269861|NCT00552188|79195073|FG000|Overall Study|Withdrawal of consent|0|||
44269862|NCT00552188|79195074|FG001|Overall Study|Withdrawal of consent|1|||
44269863|NCT00552188|79195073|FG000|Overall Study|Subject returned to home country|0|||
44213310|NCT01594281|79010455|FG001|Interventional Core Phase|Protocol Deviation|0|||
44213311|NCT01594281|79010456|FG002|Interventional Core Phase|Protocol Deviation|0|||
44269864|NCT00552188|79195074|FG001|Overall Study|Subject returned to home country|1|||
44269865|NCT00552110|79195094|FG000|Overall Study|Serious or Life-Threatening AE|0|||
44269866|NCT00552110|79195095|FG001|Overall Study|Serious or Life-Threatening AE|0|||
44453145|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
44453146|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
44453147|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
44453148|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
44453149|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
44453150|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
44453151|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
44453152|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
44453153|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
44453154|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
44453155|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
44453156|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
44453157|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
44453158|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
44453159|NCT00086515|79461778|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
44453160|NCT00086515|79461779|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
44453161|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
44453162|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
44453163|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
44213312|NCT01594281|79010454|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
44213313|NCT01594281|79010455|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
44370990|NCT04639258|79376333|FG000|Overall Study|Early study termination|3|||
44370991|NCT04639258|79376333|FG000|Overall Study|Withdrawal by Subject|1|||
44370992|NCT04568122|79376355|FG000|Overall Study|Lost to Follow-up|48|||
44370993|NCT04568122|79376356|FG001|Overall Study|Lost to Follow-up|44|||
44370994|NCT04568122|79376357|FG002|Overall Study|Lost to Follow-up|4|||
44370995|NCT04568122|79376358|FG003|Overall Study|Lost to Follow-up|0|||
44370996|NCT04568122|79376359|FG004|Overall Study|Lost to Follow-up|0|||
44370997|NCT04533815|79376375|FG000|Overall Study|Adverse Event|2|||
44370998|NCT04533815|79376375|FG000|Overall Study|Site withdrew|5|||
44370999|NCT04447755|79376386|FG000|Overall Study|Death|8|||
44371000|NCT04447755|79376387|FG001|Overall Study|Death|14|||
44453164|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
44453165|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
44453166|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
44453167|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
44453168|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
44453169|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
44213314|NCT01594281|79010456|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
44213315|NCT01594281|79010454|FG000|Interventional Core Phase|Death|1|||
44213316|NCT01594281|79010455|FG001|Interventional Core Phase|Death|1|||
44213317|NCT01594281|79010456|FG002|Interventional Core Phase|Death|2|||
44213318|NCT01594281|79010454|FG000|Interventional Core Phase|Lost to Follow-up|1|||
44213319|NCT01594281|79010455|FG001|Interventional Core Phase|Lost to Follow-up|4|||
44213320|NCT01594281|79010456|FG002|Interventional Core Phase|Lost to Follow-up|1|||
44213321|NCT01594281|79010454|FG000|Interventional Core Phase|Adverse Event|4|||
44213322|NCT01594281|79010455|FG001|Interventional Core Phase|Adverse Event|4|||
44213323|NCT01594281|79010456|FG002|Interventional Core Phase|Adverse Event|4|||
44213324|NCT01594281|79010454|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
44213325|NCT01594281|79010455|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
44213326|NCT01594281|79010456|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
44213327|NCT01594281|79010454|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
44213328|NCT01594281|79010455|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
44213329|NCT01594281|79010456|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
44213330|NCT01594281|79010454|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
44213331|NCT01594281|79010455|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
44213332|NCT01594281|79010456|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
44213333|NCT01566981|79010469|FG000|Overall Study|Lost to Follow-up|5|||
44213334|NCT01566981|79010470|FG001|Overall Study|Lost to Follow-up|8|||
44213335|NCT01870778|79010480|FG000|Overall Study|Withdrawal by Subject|8|||
44213336|NCT01870778|79010481|FG001|Overall Study|Withdrawal by Subject|7|||
44213337|NCT01870778|79010480|FG000|Overall Study|Lost to Follow-up|0|||
44213338|NCT01870778|79010481|FG001|Overall Study|Lost to Follow-up|2|||
44213339|NCT01818284|79010494|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
44213340|NCT01818284|79010495|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
44269867|NCT00552110|79195096|FG002|Overall Study|Serious or Life-Threatening AE|1|||
44213341|NCT01818284|79010494|FG000|Overall Study|Death|0|||
44371001|NCT04447755|79376388|FG002|Overall Study|Death|8|||
44371002|NCT04447755|79376389|FG003|Overall Study|Death|9|||
44371003|NCT04447755|79376390|FG004|Overall Study|Death|7|||
44371004|NCT04447755|79376391|FG005|Overall Study|Death|7|||
44371005|NCT04447755|79376392|FG006|Overall Study|Death|40|||
44371006|NCT04447755|79376386|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44213342|NCT01818284|79010495|FG001|Overall Study|Death|2|||
44213343|NCT01610492|79010531|FG000|Overall Study|Adverse Event|1|||
44213344|NCT01610492|79010531|FG000|Overall Study|Lack of Efficacy|3|||
44213345|NCT01610492|79010531|FG000|Overall Study|Other: Reached stopping criteria|1|||
44213346|NCT01610492|79010531|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
44213347|NCT01817582|79010538|FG000|Overall Study|Withdrawal by Subject|0|||
44213348|NCT01817582|79010539|FG001|Overall Study|Withdrawal by Subject|1|||
44213349|NCT01817582|79010540|FG002|Overall Study|Withdrawal by Subject|0|||
44213350|NCT01817582|79010538|FG000|Overall Study|Participant revealed masked treatment|1|||
44213351|NCT01817582|79010539|FG001|Overall Study|Participant revealed masked treatment|0|||
44213352|NCT01817582|79010540|FG002|Overall Study|Participant revealed masked treatment|0|||
44213353|NCT01817582|79010538|FG000|Overall Study|Randomized but exclusion criteria met|1|||
44213354|NCT01817582|79010539|FG001|Overall Study|Randomized but exclusion criteria met|0|||
44213355|NCT01817582|79010540|FG002|Overall Study|Randomized but exclusion criteria met|0|||
44213356|NCT01594125|79010553|FG000|Overall Study|Withdrawal by Subject|1|||
44213357|NCT01594125|79010554|FG001|Overall Study|Withdrawal by Subject|0|||
44213358|NCT01594125|79010555|FG002|Overall Study|Withdrawal by Subject|0|||
44213359|NCT01594125|79010556|FG003|Overall Study|Withdrawal by Subject|1|||
44213360|NCT01594125|79010557|FG004|Overall Study|Withdrawal by Subject|0|||
44213361|NCT01594125|79010553|FG000|Overall Study|Progressive Disease|3|||
44213362|NCT01594125|79010554|FG001|Overall Study|Progressive Disease|12|||
44213363|NCT01594125|79010555|FG002|Overall Study|Progressive Disease|3|||
44213364|NCT01594125|79010556|FG003|Overall Study|Progressive Disease|3|||
44213365|NCT01594125|79010557|FG004|Overall Study|Progressive Disease|7|||
44213366|NCT01870076|79010573|FG000|Overall Study|Withdrawal by Subject|1|||
44213367|NCT01870076|79010574|FG001|Overall Study|Withdrawal by Subject|0|||
44213368|NCT01870076|79010575|FG002|Overall Study|Withdrawal by Subject|1|||
44213369|NCT01870076|79010576|FG003|Overall Study|Withdrawal by Subject|0|||
44213370|NCT01592721|79010586|FG000|Long-term Follow-up|Death|1|||
44213371|NCT01613378|79010590|FG000|Overall Study|Lack of Efficacy|13|||
44213372|NCT01613378|79010590|FG000|Overall Study|Adverse Event|11|||
44213373|NCT01613378|79010590|FG000|Overall Study|Withdrawal by Subject|8|||
44213374|NCT01613378|79010590|FG000|Overall Study|Death|2|||
44213375|NCT01613378|79010590|FG000|Overall Study|Lost to Follow-up|1|||
44213376|NCT01613378|79010590|FG000|Overall Study|Other Reason|4|||
44213377|NCT01592409|79010596|FG000|Overall Study|Withdrawal by Subject|0|||
44213378|NCT01592409|79010597|FG001|Overall Study|Withdrawal by Subject|1|||
44213379|NCT01697319|79010616|FG000|Primary Phase|Withdrawal by Subject|1|||
44213380|NCT01697319|79010616|FG000|Extension Phase|Terminated by Sponsor|15|||
44213381|NCT01566435|79010631|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
44213382|NCT01696929|79010639|FG000|Overall Study|Physician Decision|1|||
44213383|NCT01696773|79010649|FG000|Days 15-27, Washout|Adverse Event|1|||
44213384|NCT01696773|79010650|FG001|Days 15-27, Washout|Adverse Event|0|||
44213385|NCT01696695|79010665|FG000|Overall Study|Disease progression|373|||
44213386|NCT01696695|79010665|FG000|Overall Study|Death|29|||
44213387|NCT01696695|79010665|FG000|Overall Study|Adverse Event|74|||
44213388|NCT01696695|79010665|FG000|Overall Study|Withdrawal by Subject|92|||
44213389|NCT01696695|79010665|FG000|Overall Study|Lost to Follow-up|48|||
44213390|NCT01696695|79010665|FG000|Overall Study|Other|74|||
44213391|NCT01696695|79010665|FG000|Overall Study|Major Protocol Violation|192|||
44213392|NCT01565889|79010697|FG000|Part A|Withdrawal by Subject|1|||
44213393|NCT01565889|79010698|FG001|Part A|Withdrawal by Subject|0|||
44213394|NCT01565889|79010699|FG002|Part A|Withdrawal by Subject|0|||
44213395|NCT01565889|79010700|FG003|Part A|Withdrawal by Subject|0|||
44213396|NCT01565889|79010701|FG004|Part A|Withdrawal by Subject|0|||
44213397|NCT01565889|79010702|FG005|Part A|Withdrawal by Subject|0|||
44213398|NCT01565889|79010697|FG000|Part B|Withdrawal by Subject|0|||
44213399|NCT01565889|79010698|FG001|Part B|Withdrawal by Subject|0|||
44269868|NCT00552110|79195097|FG003|Overall Study|Serious or Life-Threatening AE|0|||
44371007|NCT04447755|79376387|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44371008|NCT04447755|79376388|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44371009|NCT04447755|79376389|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
44371010|NCT04447755|79376390|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
44213400|NCT01565889|79010699|FG002|Part B|Withdrawal by Subject|0|||
44213401|NCT01565889|79010700|FG003|Part B|Withdrawal by Subject|0|||
44213402|NCT01565889|79010701|FG004|Part B|Withdrawal by Subject|0|||
44213403|NCT01565889|79010702|FG005|Part B|Withdrawal by Subject|1|||
44213404|NCT01565889|79010697|FG000|Part B|Lack of Efficacy|0|||
44213405|NCT01565889|79010698|FG001|Part B|Lack of Efficacy|0|||
44213406|NCT01565889|79010699|FG002|Part B|Lack of Efficacy|0|||
44213407|NCT01565889|79010700|FG003|Part B|Lack of Efficacy|0|||
44213408|NCT01565889|79010701|FG004|Part B|Lack of Efficacy|0|||
44213409|NCT01565889|79010702|FG005|Part B|Lack of Efficacy|2|||
44213410|NCT01565889|79010697|FG000|Part B|Lost to Follow-up|0|||
44213411|NCT01565889|79010698|FG001|Part B|Lost to Follow-up|0|||
44371011|NCT04447755|79376391|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
44213412|NCT01565889|79010699|FG002|Part B|Lost to Follow-up|0|||
44213413|NCT01565889|79010700|FG003|Part B|Lost to Follow-up|0|||
44269869|NCT00552110|79195098|FG004|Overall Study|Serious or Life-Threatening AE|0|||
44269870|NCT00552110|79195094|FG000|Overall Study|Lack of Efficacy|1|||
44269871|NCT00552110|79195095|FG001|Overall Study|Lack of Efficacy|0|||
44453170|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
44453171|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
44453172|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
44213414|NCT01565889|79010701|FG004|Part B|Lost to Follow-up|0|||
44213415|NCT01565889|79010702|FG005|Part B|Lost to Follow-up|1|||
44213416|NCT01696071|79010717|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
44213417|NCT01696071|79010718|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
44213418|NCT01591863|79010729|FG000|Overall Study|Adverse Event|3|||
44213419|NCT01591863|79010729|FG000|Overall Study|Withdrawal by Subject|1|||
44213420|NCT01591863|79010729|FG000|Overall Study|recurrence|9|||
44213421|NCT01591863|79010729|FG000|Overall Study|Lack of Efficacy|1|||
44213422|NCT01591785|79010735|FG000|Overall Study|worsening condition|1|||
44213423|NCT01591785|79010736|FG001|Overall Study|worsening condition|2|||
44213424|NCT01591785|79010735|FG000|Overall Study|Protocol Violation|2|||
44213425|NCT01591785|79010736|FG001|Overall Study|Protocol Violation|0|||
44213426|NCT01591785|79010735|FG000|Overall Study|Lost to Follow-up|1|||
44213427|NCT01591785|79010736|FG001|Overall Study|Lost to Follow-up|0|||
44213428|NCT01695993|79010745|FG000|Overall Study|Lost to Follow-up|2|||
44213429|NCT01695993|79010746|FG001|Overall Study|Lost to Follow-up|1|||
44213430|NCT01695993|79010747|FG002|Overall Study|Lost to Follow-up|3|||
44213431|NCT01695993|79010745|FG000|Overall Study|Withdrawal by Subject|2|||
44213432|NCT01695993|79010746|FG001|Overall Study|Withdrawal by Subject|2|||
44213433|NCT01695993|79010747|FG002|Overall Study|Withdrawal by Subject|2|||
44213434|NCT01695993|79010745|FG000|Overall Study|To ill to continue|1|||
44213435|NCT01695993|79010746|FG001|Overall Study|To ill to continue|2|||
44213436|NCT01695993|79010747|FG002|Overall Study|To ill to continue|0|||
44213437|NCT01695993|79010745|FG000|Overall Study|Changed Medical Facility|0|||
44213438|NCT01695993|79010746|FG001|Overall Study|Changed Medical Facility|0|||
44213439|NCT01695993|79010747|FG002|Overall Study|Changed Medical Facility|1|||
44213440|NCT01565343|79010758|FG000|Overall Study|Administrative decision/technical issues|1|||
44213441|NCT01565343|79010759|FG001|Overall Study|Administrative decision/technical issues|0|||
44213442|NCT01565343|79010760|FG002|Overall Study|Administrative decision/technical issues|0|||
44213443|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Progressive disease|50|||
44213444|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Progressive disease|110|||
44213445|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Progressive disease|0|||
44213446|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Progressive disease|0|||
44213447|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
44213448|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
44213449|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44213450|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44213451|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Adverse Event|7|||
44213452|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Adverse Event|7|||
44213453|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Adverse Event|0|||
44213454|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Adverse Event|0|||
44213455|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Other|1|||
44213456|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Other|3|||
44213457|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Other|0|||
44213458|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Other|0|||
44213459|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Physician Decision|6|||
44213460|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Physician Decision|3|||
44213461|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Physician Decision|0|||
44213462|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Physician Decision|0|||
44213463|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Death|1|||
44453173|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
44453174|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
44453175|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
44453176|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
44453177|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
44453178|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
44213464|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Death|1|||
44213465|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Death|0|||
44269872|NCT00552110|79195096|FG002|Overall Study|Lack of Efficacy|0|||
44269873|NCT00552110|79195097|FG003|Overall Study|Lack of Efficacy|1|||
44269874|NCT00552110|79195098|FG004|Overall Study|Lack of Efficacy|4|||
44453179|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
44453180|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
44453181|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
44213466|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Death|0|||
44213467|NCT01695135|79010785|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
44543662|NCT03207750|79556777|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
44543663|NCT03207750|79556778|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
44543664|NCT03207750|79556777|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
44543665|NCT03207750|79556778|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
44213468|NCT01695135|79010786|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
44213469|NCT01695135|79010787|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
44213470|NCT01695135|79010788|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
44213471|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
44213472|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
44213473|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
44213474|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
44213475|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
44213476|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
44371012|NCT04447755|79376392|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
44371013|NCT04447755|79376386|FG000|Overall Study|Ongoing in Study|1|||
44371014|NCT04447755|79376387|FG001|Overall Study|Ongoing in Study|2|||
44371015|NCT04447755|79376388|FG002|Overall Study|Ongoing in Study|0|||
44371016|NCT04447755|79376389|FG003|Overall Study|Ongoing in Study|0|||
44371017|NCT04447755|79376390|FG004|Overall Study|Ongoing in Study|2|||
44371018|NCT04447755|79376391|FG005|Overall Study|Ongoing in Study|2|||
44371019|NCT04447755|79376392|FG006|Overall Study|Ongoing in Study|26|||
44371020|NCT04060680|79376427|FG000|Overall Study|Unsuccessful implant|17|||
44371021|NCT04060680|79376427|FG000|Overall Study|Adverse Event|3|||
44371022|NCT04060680|79376427|FG000|Overall Study|Death|2|||
44371023|NCT04060680|79376427|FG000|Overall Study|Study product no longer in use|1|||
44371024|NCT04060680|79376427|FG000|Overall Study|Withdrawal by Subject|1|||
44381498|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
44381499|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
44381500|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
44381501|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
44381502|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
44381503|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
44381504|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
44381505|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
44381506|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
44381507|NCT01026818|79387582|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
44381508|NCT01026818|79387583|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
44381509|NCT01026818|79387584|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
44381510|NCT01026818|79387585|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
44381511|NCT01026818|79387582|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
44381512|NCT01026818|79387583|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
44381513|NCT01026818|79387584|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
44381514|NCT01026818|79387585|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
44381515|NCT01026818|79387582|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
44381516|NCT01026818|79387583|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
44381517|NCT01026818|79387584|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
44381518|NCT01026818|79387585|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
44381519|NCT01026818|79387582|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
44381520|NCT01026818|79387583|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
44381521|NCT01026818|79387584|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
44381522|NCT01026818|79387585|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
44381523|NCT01026818|79387582|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
44381524|NCT01026818|79387583|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
44381525|NCT01026818|79387584|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
44381526|NCT01026818|79387585|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
44381527|NCT00735397|79387597|FG000|Overall Study|Adverse Event|194|||
44381528|NCT00735397|79387597|FG000|Overall Study|Lost to Follow-up|33|||
44381529|NCT00735397|79387597|FG000|Overall Study|Participant choice|252|||
44381530|NCT00735397|79387597|FG000|Overall Study|Inadequate therapeutic effect|202|||
44381531|NCT00735397|79387597|FG000|Overall Study|Administrative/Other|502|||
44381532|NCT00735007|79387604|FG000|Overall Study|Adverse Event|4|||
44381533|NCT00735007|79387604|FG000|Overall Study|Protocol Violation|1|||
44381534|NCT00743509|79387608|FG000|Overall Study|Withdrawal by Subject|2|||
44381535|NCT00734929|79387614|FG000|Overall Study|Lost to Follow-up|1|||
44381536|NCT00734929|79387615|FG001|Overall Study|Lost to Follow-up|2|||
44381537|NCT00734929|79387614|FG000|Overall Study|No intervention/ screen fail|5|||
44381538|NCT00734929|79387615|FG001|Overall Study|No intervention/ screen fail|3|||
44453182|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
44453183|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
44453184|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
44453185|NCT00086515|79461778|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
44453186|NCT00086515|79461779|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
44453187|NCT00541658|79461788|FG000|Overall Study|Adverse Event|28|||
44453188|NCT00541658|79461789|FG001|Overall Study|Adverse Event|37|||
44453189|NCT00541658|79461790|FG002|Overall Study|Adverse Event|25|||
44453190|NCT00541658|79461788|FG000|Overall Study|Physician Decision|0|||
44453191|NCT00541658|79461789|FG001|Overall Study|Physician Decision|0|||
44453192|NCT00541658|79461790|FG002|Overall Study|Physician Decision|4|||
44453193|NCT00541658|79461788|FG000|Overall Study|Lost to Follow-up|3|||
44453194|NCT00541658|79461789|FG001|Overall Study|Lost to Follow-up|3|||
44453195|NCT00541658|79461790|FG002|Overall Study|Lost to Follow-up|6|||
44453196|NCT00541658|79461788|FG000|Overall Study|Protocol Violation|0|||
44453197|NCT00541658|79461789|FG001|Overall Study|Protocol Violation|1|||
44453198|NCT00541658|79461790|FG002|Overall Study|Protocol Violation|1|||
44453199|NCT00541658|79461788|FG000|Overall Study|Withdrawal by Subject|28|||
44453200|NCT00541658|79461789|FG001|Overall Study|Withdrawal by Subject|32|||
44453201|NCT00541658|79461790|FG002|Overall Study|Withdrawal by Subject|32|||
44453202|NCT00541658|79461788|FG000|Overall Study|Took No Study Drug|1|||
44453203|NCT00541658|79461789|FG001|Overall Study|Took No Study Drug|0|||
44453204|NCT00541658|79461790|FG002|Overall Study|Took No Study Drug|0|||
44453205|NCT03907280|79461814|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
44453206|NCT03907280|79461815|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
44453207|NCT03907280|79461816|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
44213477|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
44213478|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
44213479|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
44213480|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
44213481|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
44213482|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
44213483|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Other|0|||
44213484|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Other|0|||
44213485|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Other|4|||
44213486|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Other|7|||
44213487|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
44213488|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
44213489|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
44213490|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
44213491|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Death|0|||
44213492|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Death|0|||
44213493|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Death|2|||
44213494|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Death|7|||
44213495|NCT01695135|79010785|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
44213496|NCT01695135|79010786|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
44213497|NCT01695135|79010787|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
44213498|NCT01695135|79010788|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
44213499|NCT01610414|79010798|FG000|Study Start - Month 13|Serious Adverse Event|65|||
44213500|NCT01610414|79010799|FG001|Study Start - Month 13|Serious Adverse Event|67|||
44213501|NCT01610414|79010798|FG000|Study Start - Month 13|Adverse Event|14|||
44213502|NCT01610414|79010799|FG001|Study Start - Month 13|Adverse Event|14|||
44213503|NCT01610414|79010798|FG000|Study Start - Month 13|Protocol Violation|3|||
44213504|NCT01610414|79010799|FG001|Study Start - Month 13|Protocol Violation|1|||
44371025|NCT03981614|79376435|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
44371026|NCT03981614|79376436|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
44371027|NCT03981614|79376437|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
44371028|NCT03965689|79376448|FG000|Overall Study|Too sick to get study intervention|2|||
44371029|NCT03918629|79376467|FG000|Overall Study|Adverse Event|19|||
44371030|NCT03918629|79376468|FG001|Overall Study|Adverse Event|20|||
44371031|NCT03918629|79376467|FG000|Overall Study|Death|14|||
44453208|NCT04120376|79461828|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
44453209|NCT04120376|79461829|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
44543666|NCT03207750|79556777|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
44213505|NCT01610414|79010798|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
44371032|NCT03918629|79376468|FG001|Overall Study|Death|7|||
44371033|NCT03918629|79376467|FG000|Overall Study|Lost to Follow-up|36|||
44371034|NCT03918629|79376468|FG001|Overall Study|Lost to Follow-up|28|||
44453210|NCT03905642|79461836|FG000|Overall Study|Withdrawal by Subject|3|||
44453211|NCT03905642|79461836|FG000|Overall Study|Pregnancy|1|||
44453212|NCT03905642|79461836|FG000|Overall Study|Adverse Event|1|||
44453213|NCT03905642|79461836|FG000|Overall Study|Lack of Efficacy|1|||
44453214|NCT03905642|79461836|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
44453215|NCT00412984|79461876|FG000|Overall Study|Death|331|||
44453216|NCT00412984|79461877|FG001|Overall Study|Death|349|||
44453217|NCT00412984|79461876|FG000|Overall Study|Adverse Event|679|||
44453218|NCT00412984|79461877|FG001|Overall Study|Adverse Event|738|||
44453219|NCT00412984|79461876|FG000|Overall Study|Withdrawal by Subject|921|||
44213506|NCT01610414|79010799|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
44213507|NCT01610414|79010798|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
44213508|NCT01610414|79010799|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
44213509|NCT01610414|79010798|FG000|Study Start - Month 13|Lost to Follow-up|4|||
44213510|NCT01610414|79010799|FG001|Study Start - Month 13|Lost to Follow-up|6|||
44213511|NCT01610414|79010798|FG000|Study Start - Month 13|Suspected HZ episode|1|||
44213512|NCT01610414|79010799|FG001|Study Start - Month 13|Suspected HZ episode|3|||
44213513|NCT01610414|79010798|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
44213514|NCT01610414|79010799|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
44213515|NCT01610414|79010798|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
44213516|NCT01610414|79010799|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
44213517|NCT01610414|79010798|FG000|Month 13 - Month 25|Adverse Event|8|||
44213518|NCT01610414|79010799|FG001|Month 13 - Month 25|Adverse Event|4|||
44213519|NCT01610414|79010798|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
44213520|NCT01610414|79010799|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
44213521|NCT01610414|79010798|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
44213522|NCT01610414|79010799|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
44213523|NCT01610414|79010798|FG000|Month 13 - Month 25|Protocol Violation|0|||
44213524|NCT01610414|79010799|FG001|Month 13 - Month 25|Protocol Violation|2|||
44213525|NCT01610414|79010798|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
44213526|NCT01610414|79010799|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
44213527|NCT01610414|79010798|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
44213528|NCT01610414|79010799|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
44213529|NCT01610414|79010798|FG000|After Month 25|Study end not reached|48|||
44213530|NCT01610414|79010799|FG001|After Month 25|Study end not reached|53|||
44213531|NCT01564407|79010835|FG000|Overall Study|Lost to Follow-up|0|||
44213532|NCT01564407|79010836|FG001|Overall Study|Lost to Follow-up|1|||
44213533|NCT01564407|79010837|FG002|Overall Study|Lost to Follow-up|0|||
44213534|NCT01564407|79010838|FG003|Overall Study|Lost to Follow-up|0|||
44213535|NCT01564407|79010839|FG004|Overall Study|Lost to Follow-up|0|||
44213536|NCT01564407|79010835|FG000|Overall Study|Withdrawal by Subject|0|||
44213537|NCT01564407|79010836|FG001|Overall Study|Withdrawal by Subject|1|||
44213538|NCT01564407|79010837|FG002|Overall Study|Withdrawal by Subject|0|||
44213539|NCT01564407|79010838|FG003|Overall Study|Withdrawal by Subject|0|||
44213540|NCT01564407|79010839|FG004|Overall Study|Withdrawal by Subject|0|||
44213541|NCT01564407|79010835|FG000|Overall Study|funding lost, study ended|0|||
44213542|NCT01564407|79010836|FG001|Overall Study|funding lost, study ended|0|||
44213543|NCT01564407|79010837|FG002|Overall Study|funding lost, study ended|0|||
44213544|NCT01564407|79010838|FG003|Overall Study|funding lost, study ended|1|||
44213545|NCT01564407|79010839|FG004|Overall Study|funding lost, study ended|0|||
44371035|NCT03918629|79376467|FG000|Overall Study|Physician Decision|1|||
44371036|NCT03918629|79376468|FG001|Overall Study|Physician Decision|0|||
44371037|NCT03918629|79376467|FG000|Overall Study|Protocol Violation|7|||
44371038|NCT03918629|79376468|FG001|Overall Study|Protocol Violation|4|||
44371039|NCT03918629|79376467|FG000|Overall Study|Withdrawal by Subject|47|||
44371040|NCT03918629|79376468|FG001|Overall Study|Withdrawal by Subject|47|||
44371041|NCT03918629|79376467|FG000|Overall Study|Other|7|||
44371042|NCT03918629|79376468|FG001|Overall Study|Other|11|||
44371043|NCT03918629|79376467|FG000|Overall Study|Randomized but not vaccinated|2|||
44371044|NCT03918629|79376468|FG001|Overall Study|Randomized but not vaccinated|1|||
44371045|NCT03713593|79376480|FG000|Overall Study|Participants Ongoing|140|||
44371046|NCT03713593|79376481|FG001|Overall Study|Participants Ongoing|114|||
44371047|NCT03713593|79376480|FG000|Overall Study|Withdrawal by Subject|3|||
44371048|NCT03713593|79376481|FG001|Overall Study|Withdrawal by Subject|6|||
44453220|NCT00412984|79461877|FG001|Overall Study|Withdrawal by Subject|989|||
44453221|NCT00412984|79461876|FG000|Overall Study|Lost to Follow-up|51|||
44213546|NCT01590771|79010862|FG000|Overall Study|Other Protocol Specified Criteria|5|||
44213547|NCT01590771|79010863|FG001|Overall Study|Other Protocol Specified Criteria|14|||
44213548|NCT01590771|79010862|FG000|Overall Study|Withdrawal by Subject|8|||
44213549|NCT01590771|79010863|FG001|Overall Study|Withdrawal by Subject|15|||
44371049|NCT03713593|79376480|FG000|Overall Study|Death|252|||
44371050|NCT03713593|79376481|FG001|Overall Study|Death|279|||
44371051|NCT03585270|79376489|FG000|Overall Study|Withdrawal by Subject|2|||
44371052|NCT03585270|79376490|FG001|Overall Study|Withdrawal by Subject|6|||
44371053|NCT03585270|79376489|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
44453222|NCT00412984|79461877|FG001|Overall Study|Lost to Follow-up|39|||
44213550|NCT01590771|79010862|FG000|Overall Study|Protocol Violation|1|||
44213551|NCT01590771|79010863|FG001|Overall Study|Protocol Violation|2|||
44213552|NCT01590771|79010862|FG000|Overall Study|Lost to Follow-up|1|||
44453223|NCT00412984|79461876|FG000|Overall Study|Poor/Noncompliance|57|||
44453224|NCT00412984|79461877|FG001|Overall Study|Poor/Noncompliance|77|||
44453225|NCT00412984|79461876|FG000|Overall Study|Pregnancy|1|||
44453226|NCT00412984|79461877|FG001|Overall Study|Pregnancy|0|||
44453227|NCT00412984|79461876|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
44453228|NCT00412984|79461877|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
44453229|NCT00412984|79461876|FG000|Overall Study|Administrative Reason by Sponsor|11|||
44453230|NCT00412984|79461877|FG001|Overall Study|Administrative Reason by Sponsor|8|||
44453231|NCT00412984|79461876|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
44453232|NCT00412984|79461877|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
44453233|NCT00412984|79461876|FG000|Overall Study|Other Reason|80|||
44453234|NCT00412984|79461877|FG001|Overall Study|Other Reason|92|||
44453235|NCT00412984|79461876|FG000|Overall Study|Not Reported|11|||
44453236|NCT00412984|79461877|FG001|Overall Study|Not Reported|12|||
44453237|NCT00539864|79461885|FG000|Overall Study|Lost to Follow-up|0|||
44453238|NCT00539864|79461886|FG001|Overall Study|Lost to Follow-up|1|||
44453239|NCT00539864|79461885|FG000|Overall Study|Withdrawal by Subject|1|||
44453240|NCT00539864|79461886|FG001|Overall Study|Withdrawal by Subject|1|||
44453241|NCT00673049|79461894|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
44453242|NCT00673049|79461895|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
44453243|NCT00673049|79461896|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
44543667|NCT03207750|79556778|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
44213553|NCT01590771|79010863|FG001|Overall Study|Lost to Follow-up|1|||
44213554|NCT01590771|79010862|FG000|Overall Study|Lack of Efficacy|1|||
44213555|NCT01590771|79010863|FG001|Overall Study|Lack of Efficacy|0|||
44213556|NCT01590771|79010862|FG000|Overall Study|Adverse Event|3|||
44213557|NCT01590771|79010863|FG001|Overall Study|Adverse Event|7|||
44213558|NCT01563237|79010869|FG000|Overall Study|Lost to Follow-up|6|||
44213559|NCT01563237|79010870|FG001|Overall Study|Lost to Follow-up|0|||
44213560|NCT01563237|79010869|FG000|Overall Study|Withdrawal by Subject|1|||
44213561|NCT01563237|79010870|FG001|Overall Study|Withdrawal by Subject|0|||
44213562|NCT01563237|79010869|FG000|Overall Study|Adverse Event|1|||
44213563|NCT01563237|79010870|FG001|Overall Study|Adverse Event|0|||
44213564|NCT01563237|79010869|FG000|Overall Study|Medical Reasons|1|||
44213565|NCT01563237|79010870|FG001|Overall Study|Medical Reasons|0|||
44543668|NCT03207750|79556777|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
44543669|NCT03207750|79556778|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
44543670|NCT03207750|79556777|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
44543671|NCT03207750|79556778|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
44543672|NCT03674281|79556787|FG000|Overall Study|screen failure|2|||
44543673|NCT03674281|79556788|FG001|Overall Study|screen failure|0|||
44543674|NCT03674281|79556789|FG002|Overall Study|screen failure|0|||
44543675|NCT03674281|79556787|FG000|Overall Study|Withdrawal by Subject|1|||
44543676|NCT03674281|79556788|FG001|Overall Study|Withdrawal by Subject|3|||
44543677|NCT03674281|79556789|FG002|Overall Study|Withdrawal by Subject|3|||
44543678|NCT03673345|79556813|FG000|Overall Study|Lost to Follow-up|1|||
44543679|NCT03673345|79556814|FG001|Overall Study|Lost to Follow-up|0|||
44543680|NCT03673345|79556815|FG002|Overall Study|Lost to Follow-up|3|||
44543681|NCT03673345|79556816|FG003|Overall Study|Lost to Follow-up|3|||
44543682|NCT03673345|79556817|FG004|Overall Study|Lost to Follow-up|2|||
44543683|NCT03673345|79556818|FG005|Overall Study|Lost to Follow-up|1|||
44543684|NCT03673345|79556819|FG006|Overall Study|Lost to Follow-up|0|||
44543685|NCT03673345|79556820|FG007|Overall Study|Lost to Follow-up|0|||
44543686|NCT03673345|79556813|FG000|Overall Study|Withdrawal by Subject|1|||
44543687|NCT03673345|79556814|FG001|Overall Study|Withdrawal by Subject|0|||
44543688|NCT03673345|79556815|FG002|Overall Study|Withdrawal by Subject|4|||
44543689|NCT03673345|79556816|FG003|Overall Study|Withdrawal by Subject|2|||
44213566|NCT01563237|79010869|FG000|Overall Study|Death|1|||
44213567|NCT01563237|79010870|FG001|Overall Study|Death|0|||
44543690|NCT03673345|79556817|FG004|Overall Study|Withdrawal by Subject|0|||
44453244|NCT00673049|79461897|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
44453245|NCT00673049|79461894|FG000|Before Progression on Erlotinib|Death|235|||
44213568|NCT01694433|79010886|FG000|Overall Study|Adverse Event|7|||
44213569|NCT01694433|79010887|FG001|Overall Study|Adverse Event|0|||
44213570|NCT01694433|79010886|FG000|Overall Study|Physician Decision|1|||
44213571|NCT01694433|79010887|FG001|Overall Study|Physician Decision|0|||
44213572|NCT01694433|79010886|FG000|Overall Study|Withdrawal by Subject|3|||
44213573|NCT01694433|79010887|FG001|Overall Study|Withdrawal by Subject|4|||
44213574|NCT01694121|79010895|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
44213575|NCT01694121|79010896|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
44213576|NCT01562613|79010902|FG000|Overall Study|Lost to Follow-up|2|||
44213577|NCT01562613|79010902|FG000|Overall Study|Withdrawal by Subject|2|||
44213578|NCT01693185|79010908|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
44213579|NCT01693185|79010909|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
44213580|NCT01693029|79010949|FG000|Overall Study|Withdrawal by Subject|15|||
44213581|NCT01693029|79010950|FG001|Overall Study|Withdrawal by Subject|22|||
44213582|NCT01693029|79010949|FG000|Overall Study|Kidney transplantation|7|||
44213583|NCT01693029|79010950|FG001|Overall Study|Kidney transplantation|7|||
44213584|NCT01693029|79010949|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
44213585|NCT01693029|79010950|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
44213586|NCT01693029|79010949|FG000|Overall Study|Protocol Violation|6|||
44213587|NCT01693029|79010950|FG001|Overall Study|Protocol Violation|7|||
44213588|NCT01693029|79010949|FG000|Overall Study|Change in dialysis modality|2|||
44213589|NCT01693029|79010950|FG001|Overall Study|Change in dialysis modality|1|||
44213590|NCT01693029|79010949|FG000|Overall Study|Physician Decision|0|||
44213591|NCT01693029|79010950|FG001|Overall Study|Physician Decision|2|||
44213592|NCT01693029|79010949|FG000|Overall Study|Lost to Follow-up|0|||
44213593|NCT01693029|79010950|FG001|Overall Study|Lost to Follow-up|1|||
44213594|NCT01693029|79010949|FG000|Overall Study|Adverse Event|1|||
44213595|NCT01693029|79010950|FG001|Overall Study|Adverse Event|6|||
44213596|NCT01693029|79010949|FG000|Overall Study|Death|5|||
44213597|NCT01693029|79010950|FG001|Overall Study|Death|8|||
44213598|NCT01693029|79010949|FG000|Overall Study|Non-compliance|2|||
44213599|NCT01693029|79010950|FG001|Overall Study|Non-compliance|1|||
44213600|NCT01589445|79010956|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
44213601|NCT01589445|79010956|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
44213602|NCT01589445|79010956|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
44213603|NCT01589445|79010956|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
44213604|NCT01589445|79010956|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
44213605|NCT01589445|79010956|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
44213606|NCT01589445|79010956|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
44213607|NCT01589445|79010956|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
44213608|NCT01589445|79010956|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
44213609|NCT01589445|79010956|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
44371054|NCT03585270|79376490|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
44371055|NCT03585270|79376489|FG000|Overall Study|Adverse Event|5|||
44371056|NCT03585270|79376490|FG001|Overall Study|Adverse Event|2|||
44371057|NCT03585270|79376489|FG000|Overall Study|Lost to Follow-up|1|||
44371058|NCT03585270|79376490|FG001|Overall Study|Lost to Follow-up|4|||
44371059|NCT03585270|79376489|FG000|Overall Study|Death|5|||
44453246|NCT00673049|79461895|FG001|Before Progression on Erlotinib|Death|167|||
44453247|NCT00673049|79461896|FG002|Before Progression on Erlotinib|Death|1|||
44453248|NCT00673049|79461897|FG003|Before Progression on Erlotinib|Death|0|||
44453249|NCT00673049|79461894|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
44453250|NCT00673049|79461895|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
44453251|NCT00673049|79461896|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
44453252|NCT00673049|79461897|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
44453253|NCT00673049|79461894|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
44371060|NCT03585270|79376490|FG001|Overall Study|Death|3|||
44371061|NCT03585270|79376489|FG000|Overall Study|Other reasons|2|||
44371062|NCT03585270|79376490|FG001|Overall Study|Other reasons|2|||
44453254|NCT00673049|79461895|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
44453255|NCT00673049|79461896|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
44453256|NCT00673049|79461897|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
44453257|NCT00673049|79461894|FG000|Before Progression on Erlotinib|Other|1|||
44453258|NCT00673049|79461895|FG001|Before Progression on Erlotinib|Other|2|||
44453259|NCT00673049|79461896|FG002|Before Progression on Erlotinib|Other|0|||
44453260|NCT00673049|79461897|FG003|Before Progression on Erlotinib|Other|0|||
44213610|NCT01588509|79010966|FG000|Overall Study|Lost to Follow-up|1|||
44213611|NCT01588509|79010967|FG001|Overall Study|Lost to Follow-up|0|||
44213612|NCT01588353|79010976|FG000|Step2|Withdrawal by Subject|0|||
44213613|NCT01588353|79010977|FG001|Step2|Withdrawal by Subject|1|||
44213614|NCT01588353|79010978|FG002|Step2|Withdrawal by Subject|0|||
44213615|NCT01588353|79010976|FG000|Step3|Adverse Event|0|||
44371063|NCT03499249|79376498|FG000|Overall Study|Physician Decision|1|||
44371064|NCT03138499|79376504|FG000|Overall Study|Lost to Follow-up|1|||
44371065|NCT03138499|79376505|FG001|Overall Study|Lost to Follow-up|0|||
44213616|NCT01588353|79010977|FG001|Step3|Adverse Event|0|||
44213617|NCT01588353|79010978|FG002|Step3|Adverse Event|2|||
44213618|NCT01588197|79010987|FG000|Overall Study|Lack of Efficacy|0|||
44213619|NCT01588197|79010988|FG001|Overall Study|Lack of Efficacy|1|||
44213620|NCT01588197|79010987|FG000|Overall Study|No MRI|1|||
44213621|NCT01588197|79010988|FG001|Overall Study|No MRI|0|||
44213622|NCT01561989|79010996|FG000|Overall Study|accural target not met.|5|||
44213623|NCT01561989|79010997|FG001|Overall Study|accural target not met.|6|||
44213624|NCT01587885|79011012|FG000|Treatment Period 1|Failure to Return|0|||
44213625|NCT01587885|79011013|FG001|Treatment Period 1|Failure to Return|1|||
44213626|NCT01587885|79011012|FG000|Treatment Period 1|Protocol Violation|0|||
44213627|NCT01587885|79011013|FG001|Treatment Period 1|Protocol Violation|2|||
44213628|NCT01587651|79011023|FG000|Overall Study|Adverse Event|0|||
44213629|NCT01587651|79011024|FG001|Overall Study|Adverse Event|1|||
44213630|NCT01587651|79011025|FG002|Overall Study|Adverse Event|0|||
44213631|NCT01587651|79011023|FG000|Overall Study|Protocol Violation|0|||
44213632|NCT01587651|79011024|FG001|Overall Study|Protocol Violation|1|||
44213633|NCT01587651|79011025|FG002|Overall Study|Protocol Violation|1|||
44213634|NCT01587651|79011023|FG000|Overall Study|Withdrawal by Subject|0|||
44213635|NCT01587651|79011024|FG001|Overall Study|Withdrawal by Subject|1|||
44213636|NCT01587651|79011025|FG002|Overall Study|Withdrawal by Subject|0|||
44213637|NCT01691859|79011047|FG000|Overall Study|Adverse Event|19|||
44213638|NCT01691859|79011047|FG000|Overall Study|Lack of Efficacy|11|||
44213639|NCT01691859|79011047|FG000|Overall Study|Protocol Violation|4|||
44213640|NCT01691859|79011047|FG000|Overall Study|Product commercially available|221|||
44213641|NCT01691859|79011047|FG000|Overall Study|Study closed/terminated|50|||
44213642|NCT01691859|79011047|FG000|Overall Study|Lost to Follow-up|5|||
44213643|NCT01691859|79011047|FG000|Overall Study|Physician Decision|6|||
44213644|NCT01691859|79011047|FG000|Overall Study|Withdrawal by Subject|31|||
44213645|NCT01691781|79011091|FG000|Overall Study|Withdrawal by Subject|4|||
44213646|NCT01691781|79011092|FG001|Overall Study|Withdrawal by Subject|3|||
44213647|NCT01691781|79011091|FG000|Overall Study|Physician Decision|1|||
44213648|NCT01691781|79011092|FG001|Overall Study|Physician Decision|1|||
44213649|NCT01691781|79011091|FG000|Overall Study|Protocol Violation|2|||
44213650|NCT01691781|79011092|FG001|Overall Study|Protocol Violation|2|||
44213651|NCT01691781|79011091|FG000|Overall Study|Adverse Event|0|||
44213652|NCT01691781|79011092|FG001|Overall Study|Adverse Event|1|||
44213653|NCT01561755|79011100|FG000|Overall Study|Lost to Follow-up|0|||
44213654|NCT01561755|79011101|FG001|Overall Study|Lost to Follow-up|1|||
44213655|NCT01585155|79011121|FG000|Overall Study|Adverse Event|1|||
44213656|NCT01585155|79011121|FG000|Overall Study|Lack of Efficacy|2|||
44213657|NCT01585155|79011121|FG000|Overall Study|Worsening ulcerative colitis|2|||
44213658|NCT01560507|79011128|FG000|Overall Study|Lost to Follow-up|3|||
44213659|NCT01560507|79011129|FG001|Overall Study|Lost to Follow-up|1|||
44213660|NCT01560507|79011130|FG002|Overall Study|Lost to Follow-up|2|||
44213661|NCT01560507|79011128|FG000|Overall Study|Withdrawal by Subject|1|||
44213662|NCT01560507|79011129|FG001|Overall Study|Withdrawal by Subject|1|||
44213663|NCT01560507|79011130|FG002|Overall Study|Withdrawal by Subject|0|||
44213664|NCT01584843|79011145|FG000|First Treatment Period|Adverse Event|0|||
44213665|NCT01584843|79011146|FG001|First Treatment Period|Adverse Event|0|||
44213666|NCT01584843|79011147|FG002|First Treatment Period|Adverse Event|1|||
44213667|NCT01584843|79011148|FG003|First Treatment Period|Adverse Event|0|||
44371066|NCT03138499|79376504|FG000|Overall Study|Participants withdrew consent|1|||
44371067|NCT03138499|79376505|FG001|Overall Study|Participants withdrew consent|0|||
44371068|NCT03138499|79376504|FG000|Overall Study|Participant discontinued study before treatment|0|||
44371069|NCT03138499|79376505|FG001|Overall Study|Participant discontinued study before treatment|1|||
44371070|NCT03138499|79376504|FG000|Overall Study|Disease Progression|2|||
44371071|NCT03138499|79376505|FG001|Overall Study|Disease Progression|6|||
44213668|NCT01584843|79011149|FG004|First Treatment Period|Adverse Event|0|||
44213669|NCT01584843|79011150|FG005|First Treatment Period|Adverse Event|0|||
44213670|NCT01584843|79011145|FG000|First Treatment Period|Protocol Violation|0|||
44213671|NCT01584843|79011146|FG001|First Treatment Period|Protocol Violation|0|||
44213672|NCT01584843|79011147|FG002|First Treatment Period|Protocol Violation|0|||
44213673|NCT01584843|79011148|FG003|First Treatment Period|Protocol Violation|0|||
44213674|NCT01584843|79011149|FG004|First Treatment Period|Protocol Violation|0|||
44213675|NCT01584843|79011150|FG005|First Treatment Period|Protocol Violation|1|||
44213676|NCT01584843|79011145|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
44213677|NCT01584843|79011146|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
44213678|NCT01584843|79011147|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
44213679|NCT01584843|79011148|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
44213680|NCT01584843|79011149|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
44213681|NCT01584843|79011150|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
44213682|NCT01584843|79011145|FG000|Second Treatment Period|Withdrawal by Subject|0|||
44213683|NCT01584843|79011146|FG001|Second Treatment Period|Withdrawal by Subject|0|||
44371072|NCT03138499|79376504|FG000|Overall Study|Study drug toxicity|2|||
44371073|NCT03138499|79376505|FG001|Overall Study|Study drug toxicity|2|||
44453261|NCT00673049|79461894|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
44453262|NCT00673049|79461895|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
44453263|NCT00673049|79461896|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
44213684|NCT01584843|79011147|FG002|Second Treatment Period|Withdrawal by Subject|0|||
44213685|NCT01584843|79011148|FG003|Second Treatment Period|Withdrawal by Subject|0|||
44213686|NCT01584843|79011149|FG004|Second Treatment Period|Withdrawal by Subject|0|||
44213687|NCT01584843|79011150|FG005|Second Treatment Period|Withdrawal by Subject|1|||
44213688|NCT01560429|79011168|FG000|Overall Study|Protocol Violation|3|||
44213689|NCT01560429|79011169|FG001|Overall Study|Protocol Violation|6|||
44213690|NCT01582971|79011179|FG000|Overall Study|Death|2|||
44213691|NCT01582971|79011180|FG001|Overall Study|Death|1|||
44213692|NCT01582971|79011179|FG000|Overall Study|Lost to Follow-up|18|||
44213693|NCT01582971|79011180|FG001|Overall Study|Lost to Follow-up|21|||
44213694|NCT01582971|79011179|FG000|Overall Study|Withdrawal by Subject|4|||
44213695|NCT01582971|79011180|FG001|Overall Study|Withdrawal by Subject|2|||
44213696|NCT01582971|79011179|FG000|Overall Study|Other|15|||
44213697|NCT01582971|79011180|FG001|Overall Study|Other|13|||
44213698|NCT01690299|79011195|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
44213699|NCT01690299|79011196|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
44213700|NCT01690299|79011197|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
44213701|NCT01690299|79011198|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
44213702|NCT01690299|79011199|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
44213703|NCT01690299|79011200|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
44213704|NCT01690299|79011195|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
44213705|NCT01690299|79011196|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44213706|NCT01690299|79011197|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44213707|NCT01690299|79011198|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44213708|NCT01690299|79011199|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44213709|NCT01690299|79011200|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44213710|NCT01690299|79011195|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
44213711|NCT01690299|79011196|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
44213712|NCT01690299|79011197|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44213713|NCT01690299|79011198|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44213714|NCT01690299|79011199|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44213715|NCT01690299|79011200|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44213716|NCT01690299|79011195|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
44213717|NCT01690299|79011196|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
44213718|NCT01690299|79011197|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
44213719|NCT01690299|79011198|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
44213720|NCT01690299|79011199|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
44213721|NCT01690299|79011200|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
44213722|NCT01690299|79011195|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
44213723|NCT01690299|79011196|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
44213724|NCT01690299|79011197|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
44213725|NCT01690299|79011198|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
44213726|NCT01690299|79011199|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
44213727|NCT01690299|79011200|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
44213728|NCT01690299|79011195|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
44213729|NCT01690299|79011196|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
44213730|NCT01690299|79011197|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
44213731|NCT01690299|79011198|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
44213732|NCT01690299|79011199|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
44213733|NCT01690299|79011200|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
44213734|NCT01690299|79011195|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
44213735|NCT01690299|79011196|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
44249721|NCT01463306|79083892|FG000|Overall Study|Approval expiry at site|1|||
44371074|NCT03138499|79376504|FG000|Overall Study|Participant request to discontinue study treatment|1|||
44371075|NCT03138499|79376505|FG001|Overall Study|Participant request to discontinue study treatment|1|||
44371076|NCT03138499|79376504|FG000|Overall Study|Other reasons|2|||
44371077|NCT03138499|79376505|FG001|Overall Study|Other reasons|0|||
44371078|NCT03136185|79376521|FG000|Overall Study|Adverse Event|0|||
44371079|NCT03136185|79376522|FG001|Overall Study|Adverse Event|1|||
44371080|NCT03136185|79376523|FG002|Overall Study|Adverse Event|3|||
44371081|NCT03136185|79376524|FG003|Overall Study|Adverse Event|1|||
44371082|NCT03136185|79376525|FG004|Overall Study|Adverse Event|2|||
44371083|NCT03136185|79376526|FG005|Overall Study|Adverse Event|2|||
44371084|NCT03136185|79376527|FG006|Overall Study|Adverse Event|5|||
44453264|NCT00673049|79461897|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
44453265|NCT00673049|79461894|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
44453266|NCT00673049|79461895|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
44453267|NCT00673049|79461896|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
44453268|NCT00673049|79461897|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
44453269|NCT00673049|79461894|FG000|After Progression on Erlotinib|Death|0|||
44453270|NCT00673049|79461895|FG001|After Progression on Erlotinib|Death|0|||
44453271|NCT00673049|79461896|FG002|After Progression on Erlotinib|Death|0|||
44453272|NCT00673049|79461897|FG003|After Progression on Erlotinib|Death|71|||
44453273|NCT00673049|79461894|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
44453274|NCT00673049|79461895|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
44453275|NCT00673049|79461896|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
44453276|NCT00673049|79461897|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
44453277|NCT00673049|79461894|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
44453278|NCT00673049|79461895|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
44453279|NCT00673049|79461896|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
44453280|NCT00673049|79461897|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
44213736|NCT01690299|79011197|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
44213737|NCT01690299|79011198|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
44213738|NCT01690299|79011199|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
44213739|NCT01690299|79011200|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
44213740|NCT01690299|79011195|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
44213741|NCT01690299|79011196|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
44213742|NCT01690299|79011197|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
44213743|NCT01690299|79011198|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
44213744|NCT01690299|79011199|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
44213745|NCT01690299|79011200|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
44213746|NCT01690299|79011195|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
44213747|NCT01690299|79011196|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
44269875|NCT00552110|79195094|FG000|Overall Study|Withdrawal by Subject|0|||
44269876|NCT00552110|79195095|FG001|Overall Study|Withdrawal by Subject|2|||
44371085|NCT03136185|79376528|FG007|Overall Study|Adverse Event|1|||
44371086|NCT03136185|79376529|FG008|Overall Study|Adverse Event|1|||
44371087|NCT03136185|79376521|FG000|Overall Study|Death|0|||
44371088|NCT03136185|79376522|FG001|Overall Study|Death|0|||
44213748|NCT01690299|79011197|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
44213749|NCT01690299|79011198|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
44269877|NCT00552110|79195096|FG002|Overall Study|Withdrawal by Subject|0|||
44371089|NCT03136185|79376523|FG002|Overall Study|Death|0|||
44371090|NCT03136185|79376524|FG003|Overall Study|Death|1|||
44371091|NCT03136185|79376525|FG004|Overall Study|Death|1|||
44371092|NCT03136185|79376526|FG005|Overall Study|Death|0|||
44371093|NCT03136185|79376527|FG006|Overall Study|Death|1|||
44371094|NCT03136185|79376528|FG007|Overall Study|Death|0|||
44371095|NCT03136185|79376529|FG008|Overall Study|Death|0|||
44371096|NCT03136185|79376521|FG000|Overall Study|Physician Decision|3|||
44371097|NCT03136185|79376522|FG001|Overall Study|Physician Decision|1|||
44371098|NCT03136185|79376523|FG002|Overall Study|Physician Decision|1|||
44371099|NCT03136185|79376524|FG003|Overall Study|Physician Decision|2|||
44371100|NCT03136185|79376525|FG004|Overall Study|Physician Decision|1|||
44371101|NCT03136185|79376526|FG005|Overall Study|Physician Decision|2|||
44371102|NCT03136185|79376527|FG006|Overall Study|Physician Decision|1|||
44371103|NCT03136185|79376528|FG007|Overall Study|Physician Decision|0|||
44371104|NCT03136185|79376529|FG008|Overall Study|Physician Decision|1|||
44371105|NCT03136185|79376521|FG000|Overall Study|Protocol Defined Disease Progression|0|||
44371106|NCT03136185|79376522|FG001|Overall Study|Protocol Defined Disease Progression|0|||
44371107|NCT03136185|79376523|FG002|Overall Study|Protocol Defined Disease Progression|1|||
44371108|NCT03136185|79376524|FG003|Overall Study|Protocol Defined Disease Progression|0|||
44371109|NCT03136185|79376525|FG004|Overall Study|Protocol Defined Disease Progression|0|||
44371110|NCT03136185|79376526|FG005|Overall Study|Protocol Defined Disease Progression|1|||
44371111|NCT03136185|79376527|FG006|Overall Study|Protocol Defined Disease Progression|0|||
44371112|NCT03136185|79376528|FG007|Overall Study|Protocol Defined Disease Progression|1|||
44371113|NCT03136185|79376529|FG008|Overall Study|Protocol Defined Disease Progression|1|||
44371114|NCT03136185|79376521|FG000|Overall Study|Withdrawal by Subject|1|||
44371115|NCT03136185|79376522|FG001|Overall Study|Withdrawal by Subject|0|||
44371116|NCT03136185|79376523|FG002|Overall Study|Withdrawal by Subject|1|||
44453281|NCT00673049|79461894|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
44371117|NCT03136185|79376524|FG003|Overall Study|Withdrawal by Subject|1|||
44371118|NCT03136185|79376525|FG004|Overall Study|Withdrawal by Subject|1|||
44371119|NCT03136185|79376526|FG005|Overall Study|Withdrawal by Subject|1|||
44371120|NCT03136185|79376527|FG006|Overall Study|Withdrawal by Subject|2|||
44371121|NCT03136185|79376528|FG007|Overall Study|Withdrawal by Subject|3|||
44371122|NCT03136185|79376529|FG008|Overall Study|Withdrawal by Subject|3|||
44213750|NCT01690299|79011199|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
44213751|NCT01690299|79011200|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
44213752|NCT01690299|79011195|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
44213753|NCT01690299|79011196|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
44213754|NCT01690299|79011197|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
44213755|NCT01690299|79011198|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
44213756|NCT01690299|79011199|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
44213757|NCT01690299|79011200|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
44213758|NCT01690143|79011229|FG000|Overall Study|Withdrawal by Subject|1|||
44213759|NCT01559259|79011248|FG000|Overall Study|Withdrawal by Subject|0|||
44213760|NCT01559259|79011249|FG001|Overall Study|Withdrawal by Subject|0|||
44213761|NCT01559259|79011250|FG002|Overall Study|Withdrawal by Subject|0|||
44213762|NCT01559259|79011251|FG003|Overall Study|Withdrawal by Subject|1|||
44213763|NCT01559259|79011252|FG004|Overall Study|Withdrawal by Subject|0|||
44213764|NCT01559259|79011248|FG000|Overall Study|Adverse Event|0|||
44213765|NCT01559259|79011249|FG001|Overall Study|Adverse Event|1|||
44213766|NCT01559259|79011250|FG002|Overall Study|Adverse Event|1|||
44213767|NCT01559259|79011251|FG003|Overall Study|Adverse Event|0|||
44213768|NCT01559259|79011252|FG004|Overall Study|Adverse Event|0|||
44213769|NCT01670500|79011276|FG000|Overall Study|Withdrawal by Subject|1|||
44213770|NCT01670500|79011277|FG001|Overall Study|Withdrawal by Subject|0|||
44213771|NCT02400736|79011285|FG000|Overall Study|Lost to Follow-up|6|||
44213772|NCT02400736|79011286|FG001|Overall Study|Lost to Follow-up|6|||
44213773|NCT02400736|79011285|FG000|Overall Study|Withdrawal by Subject|2|||
44213774|NCT02400736|79011286|FG001|Overall Study|Withdrawal by Subject|1|||
44213775|NCT02400736|79011285|FG000|Overall Study|Moved from the area|3|||
44213776|NCT02400736|79011286|FG001|Overall Study|Moved from the area|1|||
44213777|NCT01689519|79011298|FG000|Intent to Treat|Death|157|||
44213778|NCT01689519|79011299|FG001|Intent to Treat|Death|167|||
44213779|NCT01689519|79011298|FG000|Intent to Treat|Lost to Follow-up|4|||
44213780|NCT01689519|79011299|FG001|Intent to Treat|Lost to Follow-up|8|||
44213781|NCT01689519|79011298|FG000|Intent to Treat|Other|2|||
44213782|NCT01689519|79011299|FG001|Intent to Treat|Other|4|||
44213783|NCT01689519|79011298|FG000|Intent to Treat|Physician Decision|4|||
44213784|NCT01689519|79011299|FG001|Intent to Treat|Physician Decision|1|||
44213785|NCT01689519|79011298|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
44213786|NCT01689519|79011299|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
44213787|NCT01689519|79011298|FG000|Intent to Treat|Withdrawal by Subject|21|||
44213788|NCT01689519|79011299|FG001|Intent to Treat|Withdrawal by Subject|20|||
44213789|NCT01689519|79011298|FG000|Safety Population|Death|158|||
44213790|NCT01689519|79011299|FG001|Safety Population|Death|165|||
44213791|NCT01689519|79011298|FG000|Safety Population|Lost to Follow-up|4|||
44213792|NCT01689519|79011299|FG001|Safety Population|Lost to Follow-up|8|||
44213793|NCT01689519|79011298|FG000|Safety Population|Other|2|||
44213794|NCT01689519|79011299|FG001|Safety Population|Other|4|||
44213795|NCT01689519|79011298|FG000|Safety Population|Physician Decision|4|||
44213796|NCT01689519|79011299|FG001|Safety Population|Physician Decision|1|||
44213797|NCT01689519|79011298|FG000|Safety Population|Study Terminated By Sponsor|60|||
44213798|NCT01689519|79011299|FG001|Safety Population|Study Terminated By Sponsor|47|||
44213799|NCT01689519|79011298|FG000|Safety Population|Withdrawal by Subject|20|||
44213800|NCT01689519|79011299|FG001|Safety Population|Withdrawal by Subject|20|||
44213801|NCT01689363|79011305|FG000|Overall Study|Protocol Violation|0|||
44213802|NCT01689363|79011306|FG001|Overall Study|Protocol Violation|1|||
44213803|NCT01689363|79011307|FG002|Overall Study|Protocol Violation|0|||
44213804|NCT01689363|79011308|FG003|Overall Study|Protocol Violation|0|||
44213805|NCT01689363|79011309|FG004|Overall Study|Protocol Violation|0|||
44213806|NCT01689363|79011310|FG005|Overall Study|Protocol Violation|0|||
44213807|NCT01689363|79011311|FG006|Overall Study|Protocol Violation|0|||
44213808|NCT01689363|79011312|FG007|Overall Study|Protocol Violation|0|||
44213809|NCT01558635|79011328|FG000|Overall Study|Death|1|||
44213810|NCT01558635|79011328|FG000|Overall Study|Withdrawal by Subject|2|||
44213811|NCT01558635|79011328|FG000|Overall Study|Physician Decision|1|||
44213812|NCT01558635|79011328|FG000|Overall Study|Subject received other treatment|1|||
44213813|NCT01558635|79011328|FG000|Overall Study|Reveal XT was explanted|1|||
44213814|NCT00089986|79011342|FG000|Overall Study|Adverse Event|6|||
44269878|NCT00552110|79195097|FG003|Overall Study|Withdrawal by Subject|3|||
44213815|NCT00089986|79011343|FG001|Overall Study|Adverse Event|9|||
44213816|NCT00089986|79011344|FG002|Overall Study|Adverse Event|6|||
44213817|NCT00089986|79011342|FG000|Overall Study|Lost to Follow-up|3|||
44213818|NCT00089986|79011343|FG001|Overall Study|Lost to Follow-up|1|||
44213819|NCT00089986|79011344|FG002|Overall Study|Lost to Follow-up|1|||
44213820|NCT00089986|79011342|FG000|Overall Study|Protocol Violation|0|||
44213821|NCT00089986|79011343|FG001|Overall Study|Protocol Violation|1|||
44213822|NCT00089986|79011344|FG002|Overall Study|Protocol Violation|0|||
44269879|NCT00552110|79195098|FG004|Overall Study|Withdrawal by Subject|2|||
44453282|NCT00673049|79461895|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
44453283|NCT00673049|79461896|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
44453284|NCT00673049|79461897|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
44453285|NCT00412750|79461908|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44453286|NCT00412750|79461909|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44453287|NCT00412750|79461910|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44453288|NCT00412750|79461908|FG000|Overall Study|Administrative problems|21|||
44453289|NCT00412750|79461909|FG001|Overall Study|Administrative problems|17|||
44453290|NCT00412750|79461910|FG002|Overall Study|Administrative problems|14|||
44453291|NCT00412750|79461908|FG000|Overall Study|Adverse Event|8|||
44453292|NCT00412750|79461909|FG001|Overall Study|Adverse Event|3|||
44453293|NCT00412750|79461910|FG002|Overall Study|Adverse Event|3|||
44453294|NCT00412750|79461908|FG000|Overall Study|Lost to Follow-up|1|||
44453295|NCT00412750|79461909|FG001|Overall Study|Lost to Follow-up|0|||
44453296|NCT00412750|79461910|FG002|Overall Study|Lost to Follow-up|1|||
44453297|NCT00412750|79461908|FG000|Overall Study|Withdrawal by Subject|0|||
44453298|NCT00412750|79461909|FG001|Overall Study|Withdrawal by Subject|1|||
44453299|NCT00412750|79461910|FG002|Overall Study|Withdrawal by Subject|2|||
44453300|NCT00412750|79461908|FG000|Overall Study|Lack of Efficacy|0|||
44453301|NCT00412750|79461909|FG001|Overall Study|Lack of Efficacy|0|||
44453302|NCT00412750|79461910|FG002|Overall Study|Lack of Efficacy|3|||
44453303|NCT00076999|79461924|FG000|Overall Study|Adverse Event|2|||
44213823|NCT00089986|79011342|FG000|Overall Study|Patient transferred to another hospital|2|||
44213824|NCT00089986|79011343|FG001|Overall Study|Patient transferred to another hospital|1|||
44213825|NCT00089986|79011344|FG002|Overall Study|Patient transferred to another hospital|0|||
44213826|NCT00089986|79011342|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
44213827|NCT00089986|79011343|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
44213828|NCT00089986|79011344|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
44213829|NCT00089986|79011342|FG000|Overall Study|Hemohlobin stopping rule|0|||
44213830|NCT00089986|79011343|FG001|Overall Study|Hemohlobin stopping rule|1|||
44213831|NCT00089986|79011344|FG002|Overall Study|Hemohlobin stopping rule|0|||
44213832|NCT00089986|79011342|FG000|Overall Study|Investigator decision to withdrew|0|||
44213833|NCT00089986|79011343|FG001|Overall Study|Investigator decision to withdrew|1|||
44213834|NCT00089986|79011344|FG002|Overall Study|Investigator decision to withdrew|0|||
44213835|NCT00089986|79011342|FG000|Overall Study|Enrollment in another study|0|||
44213836|NCT00089986|79011343|FG001|Overall Study|Enrollment in another study|1|||
44213837|NCT00089986|79011344|FG002|Overall Study|Enrollment in another study|0|||
44213838|NCT00089986|79011342|FG000|Overall Study|Family decision|0|||
44213839|NCT00089986|79011343|FG001|Overall Study|Family decision|1|||
44213840|NCT00089986|79011344|FG002|Overall Study|Family decision|0|||
44213841|NCT00089986|79011342|FG000|Overall Study|Do not resuscitate (DNR)|0|||
44213842|NCT00089986|79011343|FG001|Overall Study|Do not resuscitate (DNR)|0|||
44213843|NCT00089986|79011344|FG002|Overall Study|Do not resuscitate (DNR)|1|||
44213844|NCT00089986|79011342|FG000|Overall Study|Withdrawal by Subject|3|||
44213845|NCT00089986|79011343|FG001|Overall Study|Withdrawal by Subject|6|||
44213846|NCT00089986|79011344|FG002|Overall Study|Withdrawal by Subject|2|||
44213847|NCT01689207|79011367|FG000|Overall Study|Adverse Event|0|||
44213848|NCT01689207|79011368|FG001|Overall Study|Adverse Event|1|||
44213849|NCT01689207|79011369|FG002|Overall Study|Adverse Event|0|||
44213850|NCT01689207|79011370|FG003|Overall Study|Adverse Event|0|||
44213851|NCT01689207|79011371|FG004|Overall Study|Adverse Event|2|||
44213852|NCT01689207|79011372|FG005|Overall Study|Adverse Event|1|||
44213853|NCT01689207|79011373|FG006|Overall Study|Adverse Event|0|||
44213854|NCT01689207|79011374|FG007|Overall Study|Adverse Event|0|||
44213855|NCT01689207|79011375|FG008|Overall Study|Adverse Event|1|||
44213856|NCT01689207|79011376|FG009|Overall Study|Adverse Event|0|||
44213857|NCT01689207|79011377|FG010|Overall Study|Adverse Event|0|||
44213858|NCT00089284|79011412|FG000|Overall Study|Adverse event before starting treatment|0|||
44213859|NCT00089284|79011413|FG001|Overall Study|Adverse event before starting treatment|0|||
44269880|NCT00552110|79195094|FG000|Overall Study|Lost to Follow-up|0|||
44453304|NCT00076999|79461925|FG001|Overall Study|Adverse Event|8|||
44453305|NCT00076999|79461926|FG002|Overall Study|Adverse Event|6|||
44453306|NCT00076999|79461927|FG003|Overall Study|Adverse Event|0|||
44453307|NCT00076999|79461928|FG004|Overall Study|Adverse Event|2|||
44453308|NCT00076999|79461924|FG000|Overall Study|Protocol Violation|0|||
44453309|NCT00076999|79461925|FG001|Overall Study|Protocol Violation|3|||
44213860|NCT00089284|79011414|FG002|Overall Study|Adverse event before starting treatment|0|||
44213861|NCT00089284|79011415|FG003|Overall Study|Adverse event before starting treatment|0|||
44213862|NCT00089284|79011416|FG004|Overall Study|Adverse event before starting treatment|0|||
44213863|NCT00089284|79011417|FG005|Overall Study|Adverse event before starting treatment|0|||
44213864|NCT00089284|79011418|FG006|Overall Study|Adverse event before starting treatment|1|||
44213865|NCT01688973|79011442|FG000|Overall Study|Ineligible|2|||
44269881|NCT00552110|79195095|FG001|Overall Study|Lost to Follow-up|0|||
44213866|NCT01688973|79011443|FG001|Overall Study|Ineligible|3|||
44269882|NCT00552110|79195096|FG002|Overall Study|Lost to Follow-up|0|||
44213867|NCT00087646|79011454|FG000|Overall Study|Adverse Event|37|||
44213868|NCT00087646|79011455|FG001|Overall Study|Adverse Event|6|||
44213869|NCT00087646|79011456|FG002|Overall Study|Adverse Event|18|||
44213870|NCT00087646|79011457|FG003|Overall Study|Adverse Event|20|||
44213871|NCT00087646|79011454|FG000|Overall Study|Death|0|||
44213872|NCT00087646|79011455|FG001|Overall Study|Death|1|||
44213873|NCT00087646|79011456|FG002|Overall Study|Death|0|||
44213874|NCT00087646|79011457|FG003|Overall Study|Death|0|||
44213875|NCT00087646|79011454|FG000|Overall Study|Withdrawal by Subject|6|||
44213876|NCT00087646|79011455|FG001|Overall Study|Withdrawal by Subject|1|||
44213877|NCT00087646|79011456|FG002|Overall Study|Withdrawal by Subject|2|||
44213878|NCT00087646|79011457|FG003|Overall Study|Withdrawal by Subject|2|||
44213879|NCT00087646|79011454|FG000|Overall Study|Insufficient therapeutic response|64|||
44213880|NCT00087646|79011455|FG001|Overall Study|Insufficient therapeutic response|24|||
44213881|NCT00087646|79011456|FG002|Overall Study|Insufficient therapeutic response|38|||
44213882|NCT00087646|79011457|FG003|Overall Study|Insufficient therapeutic response|51|||
44213883|NCT00087646|79011454|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
44213884|NCT00087646|79011455|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
44213885|NCT00087646|79011456|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
44213886|NCT00087646|79011457|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
44213887|NCT00087646|79011454|FG000|Overall Study|Failure to Return|5|||
44213888|NCT00087646|79011455|FG001|Overall Study|Failure to Return|2|||
44213889|NCT00087646|79011456|FG002|Overall Study|Failure to Return|2|||
44453310|NCT00076999|79461926|FG002|Overall Study|Protocol Violation|4|||
44453311|NCT00076999|79461927|FG003|Overall Study|Protocol Violation|0|||
44453312|NCT00076999|79461928|FG004|Overall Study|Protocol Violation|9|||
44453313|NCT00076999|79461924|FG000|Overall Study|Lost to Follow-up|2|||
44453314|NCT00076999|79461925|FG001|Overall Study|Lost to Follow-up|1|||
44453315|NCT00076999|79461926|FG002|Overall Study|Lost to Follow-up|0|||
44453316|NCT00076999|79461927|FG003|Overall Study|Lost to Follow-up|0|||
44453317|NCT00076999|79461928|FG004|Overall Study|Lost to Follow-up|0|||
44453318|NCT00076999|79461924|FG000|Overall Study|Withdrawal by Subject|0|||
44453319|NCT00076999|79461925|FG001|Overall Study|Withdrawal by Subject|4|||
44453320|NCT00076999|79461926|FG002|Overall Study|Withdrawal by Subject|3|||
44453321|NCT00076999|79461927|FG003|Overall Study|Withdrawal by Subject|0|||
44453322|NCT00076999|79461928|FG004|Overall Study|Withdrawal by Subject|1|||
44453323|NCT00076999|79461924|FG000|Overall Study|Other reason (not specified)|8|||
44453324|NCT00076999|79461925|FG001|Overall Study|Other reason (not specified)|8|||
44453325|NCT00076999|79461926|FG002|Overall Study|Other reason (not specified)|4|||
44453326|NCT00076999|79461927|FG003|Overall Study|Other reason (not specified)|1|||
44453327|NCT00076999|79461928|FG004|Overall Study|Other reason (not specified)|13|||
44453328|NCT03905096|79461943|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
44453329|NCT03905096|79461944|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
44453330|NCT00412360|79461959|FG000|Overall Study|Lost to Follow-up|0|||
44453331|NCT00412360|79461960|FG001|Overall Study|Lost to Follow-up|1|||
44453332|NCT00412360|79461959|FG000|Overall Study|Not Transplanted|1|||
44453333|NCT00412360|79461960|FG001|Overall Study|Not Transplanted|2|||
44453334|NCT00571103|79461966|FG000|Overall Study|Withdrawal by Subject|1|||
44453335|NCT00571103|79461966|FG000|Overall Study|Lost to Follow-up|1|||
44453336|NCT00069277|79461970|FG000|Overall Study|Adverse Event|3|||
44453337|NCT00069277|79461970|FG000|Overall Study|Withdrawal by Subject|1|||
44453338|NCT00069277|79461970|FG000|Overall Study|Progressive Disease|15|||
44453339|NCT00069277|79461970|FG000|Overall Study|Physician Decision|2|||
44213890|NCT00087646|79011457|FG003|Overall Study|Failure to Return|3|||
44213891|NCT00087646|79011454|FG000|Overall Study|Administrative/Other|6|||
44213892|NCT00087646|79011455|FG001|Overall Study|Administrative/Other|1|||
44213893|NCT00087646|79011456|FG002|Overall Study|Administrative/Other|1|||
44213894|NCT00087646|79011457|FG003|Overall Study|Administrative/Other|2|||
44213895|NCT00087646|79011454|FG000|Overall Study|Other Protocol Violation|3|||
44213896|NCT00087646|79011455|FG001|Overall Study|Other Protocol Violation|1|||
44213897|NCT00087646|79011456|FG002|Overall Study|Other Protocol Violation|0|||
44453340|NCT00418522|79461976|FG000|Overall Study|Adverse Event|7|||
44453341|NCT00418522|79461977|FG001|Overall Study|Adverse Event|1|||
44453342|NCT00418522|79461976|FG000|Overall Study|Lack of Efficacy|1|||
44453343|NCT00418522|79461977|FG001|Overall Study|Lack of Efficacy|3|||
44453344|NCT00418522|79461976|FG000|Overall Study|Lost to Follow-up|10|||
44213898|NCT00087646|79011457|FG003|Overall Study|Other Protocol Violation|0|||
44213899|NCT00087646|79011454|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
44213900|NCT00087646|79011455|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
44213901|NCT00087646|79011456|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
44213902|NCT00087646|79011457|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
44213903|NCT00087568|79011474|FG000|Overall Study|Adverse Event|4|||
44213904|NCT00087568|79011475|FG001|Overall Study|Adverse Event|0|||
44453345|NCT00418522|79461977|FG001|Overall Study|Lost to Follow-up|4|||
44213905|NCT00087568|79011474|FG000|Overall Study|Withdrawal by Subject|1|||
44213906|NCT00087568|79011475|FG001|Overall Study|Withdrawal by Subject|1|||
44213907|NCT00087568|79011474|FG000|Overall Study|Lost to Follow-up|1|||
44213908|NCT00087568|79011475|FG001|Overall Study|Lost to Follow-up|0|||
44213909|NCT00087568|79011474|FG000|Overall Study|Lack of Efficacy|24|||
44213910|NCT00087568|79011475|FG001|Overall Study|Lack of Efficacy|1|||
44213911|NCT00085540|79011483|FG000|Overall Study|Withdrawal by Subject|0|||
44213912|NCT00085540|79011484|FG001|Overall Study|Withdrawal by Subject|1|||
44213913|NCT00085540|79011483|FG000|Overall Study|Protocol Violation|0|||
44213914|NCT00085540|79011484|FG001|Overall Study|Protocol Violation|1|||
44213915|NCT01688739|79011500|FG000|Overall Study|Administrative Decision|1|||
44213916|NCT01688739|79011501|FG001|Overall Study|Administrative Decision|0|||
44213917|NCT01688739|79011502|FG002|Overall Study|Administrative Decision|0|||
44213918|NCT01688739|79011503|FG003|Overall Study|Administrative Decision|0|||
44213919|NCT01688739|79011504|FG004|Overall Study|Administrative Decision|0|||
44213920|NCT01688739|79011505|FG005|Overall Study|Administrative Decision|0|||
44213921|NCT01688739|79011506|FG006|Overall Study|Administrative Decision|0|||
44213922|NCT01688739|79011507|FG007|Overall Study|Administrative Decision|0|||
44213923|NCT01688739|79011508|FG008|Overall Study|Administrative Decision|0|||
44213924|NCT01688739|79011509|FG009|Overall Study|Administrative Decision|0|||
44213925|NCT00084838|79011539|FG000|Overall Study|Death|1|||
44213926|NCT00084838|79011539|FG000|Overall Study|Adverse Event|2|||
44213927|NCT00084838|79011539|FG000|Overall Study|Withdrawal by Subject|1|||
44213928|NCT00084838|79011539|FG000|Overall Study|Progressive Disease|4|||
44213929|NCT00084838|79011539|FG000|Overall Study|Pt Non-Compliance|1|||
44213930|NCT00084838|79011539|FG000|Overall Study|Ineligible|4|||
44213931|NCT01558089|79011545|FG000|Overall Study|Adverse Event|1|||
44213932|NCT01558089|79011545|FG000|Overall Study|Lack of Efficacy|1|||
44213933|NCT01558089|79011545|FG000|Overall Study|Lost to Follow-up|5|||
44213934|NCT01558089|79011545|FG000|Overall Study|Withdrawal by Subject|6|||
44213935|NCT01581021|79011551|FG000|Overall Study|Lost to Follow-up|4|||
44213936|NCT01581021|79011552|FG001|Overall Study|Lost to Follow-up|6|||
44213937|NCT01581021|79011551|FG000|Overall Study|More than 2 hooks in thoracic|3|||
44213938|NCT01581021|79011552|FG001|Overall Study|More than 2 hooks in thoracic|0|||
44213939|NCT01581021|79011551|FG000|Overall Study|Neuromuscular|2|||
44213940|NCT01581021|79011552|FG001|Overall Study|Neuromuscular|1|||
44213941|NCT01581021|79011551|FG000|Overall Study|Not Randomized|1|||
44213942|NCT01581021|79011552|FG001|Overall Study|Not Randomized|2|||
44213943|NCT01581021|79011551|FG000|Overall Study|Lenke 6 Classification|0|||
44213944|NCT01581021|79011552|FG001|Overall Study|Lenke 6 Classification|1|||
44453346|NCT00418522|79461976|FG000|Overall Study|Withdrawal by Subject|31|||
44453347|NCT00418522|79461977|FG001|Overall Study|Withdrawal by Subject|7|||
44453348|NCT00418522|79461976|FG000|Overall Study|Other|27|||
44453349|NCT00418522|79461977|FG001|Overall Study|Other|23|||
44453350|NCT00418522|79461976|FG000|Overall Study|Randomized but did not receive treatment|7|||
44453351|NCT00418522|79461977|FG001|Overall Study|Randomized but did not receive treatment|4|||
44453352|NCT00403546|79461985|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
44453353|NCT00403546|79461986|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
44453354|NCT00403546|79461987|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
44453355|NCT00403546|79461985|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
44453356|NCT00403546|79461986|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
44453357|NCT00403546|79461987|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
44453358|NCT00403546|79461985|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
44453359|NCT00403546|79461986|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
44453360|NCT00403546|79461987|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
44453361|NCT00403546|79461985|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
44453362|NCT00403546|79461986|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
44453363|NCT00403546|79461987|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
44453364|NCT00403546|79461985|FG000|Screening Phase|Screening Failure|22|||
44453365|NCT00403546|79461986|FG001|Screening Phase|Screening Failure|0|||
44453366|NCT00403546|79461987|FG002|Screening Phase|Screening Failure|0|||
44453367|NCT00403546|79461985|FG000|Screening Phase|Adverse Event|1|||
44453368|NCT00403546|79461986|FG001|Screening Phase|Adverse Event|0|||
44453369|NCT00403546|79461987|FG002|Screening Phase|Adverse Event|0|||
44213945|NCT01581021|79011551|FG000|Overall Study|Lack of Efficacy|0|||
44213946|NCT01581021|79011552|FG001|Overall Study|Lack of Efficacy|1|||
44213947|NCT00084682|79011558|FG000|Overall Study|Withdrawal by Subject|1|||
44453370|NCT00403546|79461985|FG000|Screening Phase|Terminated Prior to Randomization|5|||
44453371|NCT00403546|79461986|FG001|Screening Phase|Terminated Prior to Randomization|0|||
44213948|NCT01556997|79011566|FG000|Overall Study|Adverse Event|10|||
44213949|NCT01556997|79011567|FG001|Overall Study|Adverse Event|12|||
44453372|NCT00403546|79461987|FG002|Screening Phase|Terminated Prior to Randomization|0|||
44213950|NCT01556997|79011568|FG002|Overall Study|Adverse Event|12|||
44453373|NCT00403546|79461985|FG000|Randomized Trial|Early Terminations|0|||
44213951|NCT01556997|79011566|FG000|Overall Study|Lost to Follow-up|6|||
44213952|NCT01556997|79011567|FG001|Overall Study|Lost to Follow-up|6|||
44453374|NCT00403546|79461986|FG001|Randomized Trial|Early Terminations|17|||
44453375|NCT00403546|79461987|FG002|Randomized Trial|Early Terminations|16|||
44453376|NCT00403390|79461998|FG000|Overall Study|Withdrawal by Subject|1|||
44453377|NCT00403390|79461999|FG001|Overall Study|Withdrawal by Subject|0|||
44453378|NCT00403390|79461998|FG000|Overall Study|samples lost|1|||
44453379|NCT00403390|79461999|FG001|Overall Study|samples lost|0|||
44453380|NCT00403390|79461998|FG000|Overall Study|non-compliant|1|||
44453381|NCT00403390|79461999|FG001|Overall Study|non-compliant|0|||
44453382|NCT00403234|79462009|FG000|Overall Study|Withdrawal by Subject|0|||
44453383|NCT00403234|79462010|FG001|Overall Study|Withdrawal by Subject|1|||
44453384|NCT00403234|79462011|FG002|Overall Study|Withdrawal by Subject|0|||
44453385|NCT00403234|79462012|FG003|Overall Study|Withdrawal by Subject|0|||
44453386|NCT00403234|79462009|FG000|Overall Study|Adverse Event|1|||
44453387|NCT00403234|79462010|FG001|Overall Study|Adverse Event|0|||
44453388|NCT00403234|79462011|FG002|Overall Study|Adverse Event|1|||
44453389|NCT00403234|79462012|FG003|Overall Study|Adverse Event|0|||
44453390|NCT00402688|79462025|FG000|Overall Study|Adverse Event|12|||
44453391|NCT00402688|79462026|FG001|Overall Study|Adverse Event|9|||
44453392|NCT00402688|79462027|FG002|Overall Study|Adverse Event|3|||
44453393|NCT00402688|79462025|FG000|Overall Study|Withdrawal by Subject|3|||
44453394|NCT00402688|79462026|FG001|Overall Study|Withdrawal by Subject|1|||
44453395|NCT00402688|79462027|FG002|Overall Study|Withdrawal by Subject|1|||
44453396|NCT00402688|79462025|FG000|Overall Study|Physician Decision|0|||
44453397|NCT00402688|79462026|FG001|Overall Study|Physician Decision|0|||
44453398|NCT00402688|79462027|FG002|Overall Study|Physician Decision|1|||
44453399|NCT00402688|79462025|FG000|Overall Study|Lack of Efficacy|4|||
44453400|NCT00402688|79462026|FG001|Overall Study|Lack of Efficacy|4|||
44453401|NCT00402688|79462027|FG002|Overall Study|Lack of Efficacy|5|||
44453402|NCT00402688|79462025|FG000|Overall Study|Protocol Violation|1|||
44453403|NCT00402688|79462026|FG001|Overall Study|Protocol Violation|1|||
44453404|NCT00402688|79462027|FG002|Overall Study|Protocol Violation|1|||
44213953|NCT01556997|79011568|FG002|Overall Study|Lost to Follow-up|4|||
44213954|NCT01556997|79011566|FG000|Overall Study|Physician Decision|1|||
44213955|NCT01556997|79011567|FG001|Overall Study|Physician Decision|1|||
44213956|NCT01556997|79011568|FG002|Overall Study|Physician Decision|1|||
44213957|NCT01556997|79011566|FG000|Overall Study|Withdrawal by Subject|7|||
44213958|NCT01556997|79011567|FG001|Overall Study|Withdrawal by Subject|6|||
44213959|NCT01556997|79011568|FG002|Overall Study|Withdrawal by Subject|8|||
44213960|NCT01556997|79011566|FG000|Overall Study|Other|2|||
44213961|NCT01556997|79011567|FG001|Overall Study|Other|3|||
44213962|NCT01556997|79011568|FG002|Overall Study|Other|7|||
44213963|NCT00082888|79011579|FG000|Overall Study|Ineligible|1|||
44213964|NCT00082888|79011580|FG001|Overall Study|Ineligible|0|||
44453405|NCT00402688|79462025|FG000|Overall Study|Lost to Follow-up|1|||
44453406|NCT00402688|79462026|FG001|Overall Study|Lost to Follow-up|0|||
44453407|NCT00402688|79462027|FG002|Overall Study|Lost to Follow-up|2|||
44453408|NCT00402688|79462025|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
44213965|NCT00082888|79011581|FG002|Overall Study|Ineligible|0|||
44213966|NCT00082810|79011590|FG000|Overall Study|Adverse Event|3|||
44213967|NCT00082810|79011590|FG000|Overall Study|Progressive disease|24|||
44269883|NCT00552110|79195097|FG003|Overall Study|Lost to Follow-up|1|||
44453409|NCT00402688|79462026|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
44453410|NCT00402688|79462027|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
44453411|NCT00402688|79462025|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
44453412|NCT00402688|79462026|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
44453413|NCT00402688|79462027|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
44453414|NCT00402688|79462025|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
44453415|NCT00402688|79462026|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
44453416|NCT00402688|79462027|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
44213968|NCT00082810|79011590|FG000|Overall Study|Withdrawal by Subject|4|||
44269884|NCT00552110|79195098|FG004|Overall Study|Lost to Follow-up|1|||
44213969|NCT01577745|79011601|FG000|Overall Study|Withdrawal by Subject|0|||
44213970|NCT01577745|79011602|FG001|Overall Study|Withdrawal by Subject|1|||
44213971|NCT01577745|79011603|FG002|Overall Study|Withdrawal by Subject|0|||
44213972|NCT01577745|79011604|FG003|Overall Study|Withdrawal by Subject|3|||
44213973|NCT01577745|79011605|FG004|Overall Study|Withdrawal by Subject|2|||
44213974|NCT01577745|79011606|FG005|Overall Study|Withdrawal by Subject|0|||
44213975|NCT01577745|79011601|FG000|Overall Study|Death|3|||
44213976|NCT01577745|79011602|FG001|Overall Study|Death|2|||
44213977|NCT01577745|79011603|FG002|Overall Study|Death|2|||
44213978|NCT01577745|79011604|FG003|Overall Study|Death|1|||
44213979|NCT01577745|79011605|FG004|Overall Study|Death|1|||
44213980|NCT01577745|79011606|FG005|Overall Study|Death|3|||
44213981|NCT01577745|79011601|FG000|Overall Study|Physician Decision|0|||
44213982|NCT01577745|79011602|FG001|Overall Study|Physician Decision|0|||
44213983|NCT01577745|79011603|FG002|Overall Study|Physician Decision|0|||
44213984|NCT01577745|79011604|FG003|Overall Study|Physician Decision|1|||
44213985|NCT01577745|79011605|FG004|Overall Study|Physician Decision|1|||
44213986|NCT01577745|79011606|FG005|Overall Study|Physician Decision|0|||
44213987|NCT01577745|79011601|FG000|Overall Study|Lost to Follow-up|0|||
44213988|NCT01577745|79011602|FG001|Overall Study|Lost to Follow-up|0|||
44213989|NCT01577745|79011603|FG002|Overall Study|Lost to Follow-up|0|||
44213990|NCT01577745|79011604|FG003|Overall Study|Lost to Follow-up|0|||
44213991|NCT01577745|79011605|FG004|Overall Study|Lost to Follow-up|0|||
44213992|NCT01577745|79011606|FG005|Overall Study|Lost to Follow-up|1|||
44213993|NCT01577745|79011601|FG000|Overall Study|Alternative Therapy|0|||
44213994|NCT01577745|79011602|FG001|Overall Study|Alternative Therapy|0|||
44213995|NCT01577745|79011603|FG002|Overall Study|Alternative Therapy|0|||
44213996|NCT01577745|79011604|FG003|Overall Study|Alternative Therapy|1|||
44213997|NCT01577745|79011605|FG004|Overall Study|Alternative Therapy|1|||
44213998|NCT01577745|79011606|FG005|Overall Study|Alternative Therapy|0|||
44213999|NCT01688037|79011628|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
44214000|NCT01688037|79011629|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
44214001|NCT01688037|79011630|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
44214002|NCT01688037|79011628|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
44214003|NCT01688037|79011629|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
44214004|NCT01688037|79011630|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
44214005|NCT01688037|79011628|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
44214006|NCT01688037|79011629|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
44214007|NCT01688037|79011630|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
44214008|NCT01688037|79011628|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
44214009|NCT01688037|79011629|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
44214010|NCT01688037|79011630|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
44214011|NCT01688037|79011628|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
44214012|NCT01688037|79011629|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
44214013|NCT01688037|79011630|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
44214014|NCT01688037|79011628|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
44214015|NCT01688037|79011629|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
44214016|NCT01688037|79011630|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
44214017|NCT01688037|79011628|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
44214018|NCT01688037|79011629|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
44214019|NCT01688037|79011630|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
44214020|NCT01688037|79011628|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
44214021|NCT01688037|79011629|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
44214022|NCT01688037|79011630|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
44214023|NCT01688037|79011628|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
44214024|NCT01688037|79011629|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
44214025|NCT01688037|79011630|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
44371123|NCT03136185|79376521|FG000|Overall Study|Not Reported|4|||
44371124|NCT03136185|79376522|FG001|Overall Study|Not Reported|1|||
44371125|NCT03136185|79376523|FG002|Overall Study|Not Reported|0|||
44371126|NCT03136185|79376524|FG003|Overall Study|Not Reported|1|||
44371127|NCT03136185|79376525|FG004|Overall Study|Not Reported|0|||
44371128|NCT03136185|79376526|FG005|Overall Study|Not Reported|2|||
44371129|NCT03136185|79376527|FG006|Overall Study|Not Reported|1|||
44371130|NCT03136185|79376528|FG007|Overall Study|Not Reported|1|||
44371131|NCT03136185|79376529|FG008|Overall Study|Not Reported|0|||
44214026|NCT01688037|79011628|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
44214027|NCT01688037|79011629|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
44371132|NCT03125902|79376558|FG000|Overall Study|Death|52|||
44371133|NCT03125902|79376559|FG001|Overall Study|Death|123|||
44371134|NCT03125902|79376558|FG000|Overall Study|Lost to Follow-up|1|||
44214028|NCT01688037|79011630|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
44214029|NCT01610336|79011653|FG000|Overall Study|Progressive Disease|4|||
44214030|NCT01610336|79011654|FG001|Overall Study|Progressive Disease|6|||
44371135|NCT03125902|79376559|FG001|Overall Study|Lost to Follow-up|0|||
44453417|NCT00671879|79462038|FG000|Overall Study|Withdrawal by Subject|0|||
44453418|NCT00671879|79462039|FG001|Overall Study|Withdrawal by Subject|4|||
44453419|NCT00671879|79462040|FG002|Overall Study|Withdrawal by Subject|6|||
44453420|NCT00401830|79462051|FG000|Overall Study|Adverse Event|10|||
44453421|NCT00401830|79462052|FG001|Overall Study|Adverse Event|18|||
44453422|NCT00401830|79462051|FG000|Overall Study|Lack of Efficacy|11|||
44453423|NCT00401830|79462052|FG001|Overall Study|Lack of Efficacy|5|||
44453424|NCT00401830|79462051|FG000|Overall Study|Withdrawal by Subject|4|||
44453425|NCT00401830|79462052|FG001|Overall Study|Withdrawal by Subject|3|||
44453426|NCT00401830|79462051|FG000|Overall Study|Protocol Violation|3|||
44453427|NCT00401830|79462052|FG001|Overall Study|Protocol Violation|3|||
44453428|NCT00401830|79462051|FG000|Overall Study|Non-compliance with drug study|1|||
44453429|NCT00401830|79462052|FG001|Overall Study|Non-compliance with drug study|0|||
44453430|NCT00401830|79462051|FG000|Overall Study|Lost to Follow-up|1|||
44453431|NCT00401830|79462052|FG001|Overall Study|Lost to Follow-up|3|||
44453432|NCT00401830|79462051|FG000|Overall Study|Other: Personal / Family problems|1|||
44453433|NCT00401830|79462052|FG001|Overall Study|Other: Personal / Family problems|0|||
44453434|NCT00401752|79462060|FG000|Overall Study|Adverse Event|2|||
44453435|NCT00401752|79462061|FG001|Overall Study|Adverse Event|5|||
44453436|NCT00401752|79462060|FG000|Overall Study|Withdrawal by Subject|2|||
44453437|NCT00401752|79462061|FG001|Overall Study|Withdrawal by Subject|6|||
44453438|NCT00401752|79462060|FG000|Overall Study|Lost to Follow-up|1|||
44453439|NCT00401752|79462061|FG001|Overall Study|Lost to Follow-up|4|||
44453440|NCT00401752|79462060|FG000|Overall Study|Development of any exclusion criteria|4|||
44453441|NCT00401752|79462061|FG001|Overall Study|Development of any exclusion criteria|2|||
44453442|NCT00401752|79462060|FG000|Overall Study|Physician Decision|1|||
44453443|NCT00401752|79462061|FG001|Overall Study|Physician Decision|1|||
44453444|NCT00539240|79462070|FG000|Overall Study|Withdrawal by Subject|0|||
44453445|NCT00539240|79462071|FG001|Overall Study|Withdrawal by Subject|2|||
44453446|NCT00539240|79462072|FG002|Overall Study|Withdrawal by Subject|0|||
44453447|NCT00539240|79462070|FG000|Overall Study|Protocol Violation|1|||
44214031|NCT01610336|79011655|FG002|Overall Study|Progressive Disease|6|||
44214032|NCT01610336|79011656|FG003|Overall Study|Progressive Disease|5|||
44214033|NCT01610336|79011657|FG004|Overall Study|Progressive Disease|3|||
44214034|NCT01610336|79011658|FG005|Overall Study|Progressive Disease|10|||
44214035|NCT01610336|79011659|FG006|Overall Study|Progressive Disease|1|||
44214036|NCT01610336|79011660|FG007|Overall Study|Progressive Disease|6|||
44214037|NCT01610336|79011661|FG008|Overall Study|Progressive Disease|6|||
44214038|NCT01610336|79011662|FG009|Overall Study|Progressive Disease|40|||
44214039|NCT01610336|79011663|FG010|Overall Study|Progressive Disease|36|||
44214040|NCT01610336|79011653|FG000|Overall Study|Adverse Event|0|||
44214041|NCT01610336|79011654|FG001|Overall Study|Adverse Event|0|||
44214042|NCT01610336|79011655|FG002|Overall Study|Adverse Event|0|||
44214043|NCT01610336|79011656|FG003|Overall Study|Adverse Event|1|||
44214044|NCT01610336|79011657|FG004|Overall Study|Adverse Event|1|||
44214045|NCT01610336|79011658|FG005|Overall Study|Adverse Event|1|||
44214046|NCT01610336|79011659|FG006|Overall Study|Adverse Event|0|||
44214047|NCT01610336|79011660|FG007|Overall Study|Adverse Event|0|||
44214048|NCT01610336|79011661|FG008|Overall Study|Adverse Event|2|||
44214049|NCT01610336|79011662|FG009|Overall Study|Adverse Event|8|||
44214050|NCT01610336|79011663|FG010|Overall Study|Adverse Event|6|||
44214051|NCT01610336|79011653|FG000|Overall Study|Subject/Guardian decision|1|||
44214052|NCT01610336|79011654|FG001|Overall Study|Subject/Guardian decision|1|||
44214053|NCT01610336|79011655|FG002|Overall Study|Subject/Guardian decision|0|||
44214054|NCT01610336|79011656|FG003|Overall Study|Subject/Guardian decision|1|||
44214055|NCT01610336|79011657|FG004|Overall Study|Subject/Guardian decision|0|||
44214056|NCT01610336|79011658|FG005|Overall Study|Subject/Guardian decision|0|||
44453448|NCT00539240|79462071|FG001|Overall Study|Protocol Violation|1|||
44453449|NCT00539240|79462072|FG002|Overall Study|Protocol Violation|4|||
44453450|NCT00539240|79462070|FG000|Overall Study|Lost to Follow-up|2|||
44453451|NCT00539240|79462071|FG001|Overall Study|Lost to Follow-up|3|||
44453452|NCT00539240|79462072|FG002|Overall Study|Lost to Follow-up|1|||
44453453|NCT00539240|79462070|FG000|Overall Study|Adverse Event|3|||
44453454|NCT00539240|79462071|FG001|Overall Study|Adverse Event|1|||
44453455|NCT00539240|79462072|FG002|Overall Study|Adverse Event|10|||
44453456|NCT00417976|79462080|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
44453457|NCT00417976|79462080|FG000|Overall Study|Treatment -related toxicity|2|||
44453458|NCT00673673|79462085|FG000|Overall Study|Progressive disease|27|||
44453459|NCT00673673|79462085|FG000|Overall Study|Adverse Event|4|||
44214057|NCT01610336|79011659|FG006|Overall Study|Subject/Guardian decision|0|||
44214058|NCT01610336|79011660|FG007|Overall Study|Subject/Guardian decision|1|||
44214059|NCT01610336|79011661|FG008|Overall Study|Subject/Guardian decision|0|||
44214060|NCT01610336|79011662|FG009|Overall Study|Subject/Guardian decision|2|||
44214061|NCT01610336|79011663|FG010|Overall Study|Subject/Guardian decision|2|||
44214062|NCT01610336|79011653|FG000|Overall Study|Death|0|||
44214063|NCT01610336|79011654|FG001|Overall Study|Death|0|||
44453460|NCT00673673|79462085|FG000|Overall Study|Withdrawal by Subject|3|||
44453461|NCT00673673|79462085|FG000|Overall Study|Investigators' discretion|2|||
44453462|NCT00069121|79462091|FG000|Overall Study|Death|286|||
44453463|NCT00069121|79462092|FG001|Overall Study|Death|242|||
44453464|NCT00069121|79462091|FG000|Overall Study|Withdrawal by Subject|18|||
44453465|NCT00069121|79462092|FG001|Overall Study|Withdrawal by Subject|20|||
44453466|NCT00069121|79462091|FG000|Overall Study|Lost to Follow-up|63|||
44214064|NCT01610336|79011655|FG002|Overall Study|Death|0|||
44214065|NCT01610336|79011656|FG003|Overall Study|Death|0|||
44214066|NCT01610336|79011657|FG004|Overall Study|Death|0|||
44214067|NCT01610336|79011658|FG005|Overall Study|Death|1|||
44214068|NCT01610336|79011659|FG006|Overall Study|Death|3|||
44214069|NCT01610336|79011660|FG007|Overall Study|Death|0|||
44214070|NCT01610336|79011661|FG008|Overall Study|Death|0|||
44214071|NCT01610336|79011662|FG009|Overall Study|Death|1|||
44214072|NCT01610336|79011663|FG010|Overall Study|Death|2|||
44214073|NCT01610336|79011653|FG000|Overall Study|Non-Compliance with study treatment|0|||
44214074|NCT01610336|79011654|FG001|Overall Study|Non-Compliance with study treatment|0|||
44214075|NCT01610336|79011655|FG002|Overall Study|Non-Compliance with study treatment|0|||
44214076|NCT01610336|79011656|FG003|Overall Study|Non-Compliance with study treatment|0|||
44214077|NCT01610336|79011657|FG004|Overall Study|Non-Compliance with study treatment|0|||
44214078|NCT01610336|79011658|FG005|Overall Study|Non-Compliance with study treatment|0|||
44214079|NCT01610336|79011659|FG006|Overall Study|Non-Compliance with study treatment|0|||
44214080|NCT01610336|79011660|FG007|Overall Study|Non-Compliance with study treatment|0|||
44214081|NCT01610336|79011661|FG008|Overall Study|Non-Compliance with study treatment|0|||
44214082|NCT01610336|79011662|FG009|Overall Study|Non-Compliance with study treatment|1|||
44214083|NCT01610336|79011663|FG010|Overall Study|Non-Compliance with study treatment|0|||
44453467|NCT00069121|79462092|FG001|Overall Study|Lost to Follow-up|63|||
44453468|NCT00399802|79462104|FG000|Overall Study|Adverse Event|0|||
44453469|NCT00399802|79462105|FG001|Overall Study|Adverse Event|2|||
44453470|NCT00399802|79462104|FG000|Overall Study|Participant discontinued by mistake|0|||
44453471|NCT00399802|79462105|FG001|Overall Study|Participant discontinued by mistake|1|||
44453472|NCT00399568|79462113|FG000|Overall Study|Adverse Event|1|||
44453473|NCT00399568|79462114|FG001|Overall Study|Adverse Event|2|||
44453474|NCT00399568|79462113|FG000|Overall Study|Withdrawal by Subject|7|||
44453475|NCT00399568|79462114|FG001|Overall Study|Withdrawal by Subject|3|||
44453476|NCT00399568|79462113|FG000|Overall Study|Protocol non-compliance|2|||
44453477|NCT00399568|79462114|FG001|Overall Study|Protocol non-compliance|2|||
44453478|NCT00399568|79462113|FG000|Overall Study|Lost to Follow-up|2|||
44453479|NCT00399568|79462114|FG001|Overall Study|Lost to Follow-up|2|||
44453480|NCT03900728|79462125|FG000|Overall Study|No text responses|0|||
44453481|NCT03900728|79462126|FG001|Overall Study|No text responses|0|||
44453482|NCT03900728|79462127|FG002|Overall Study|No text responses|4|||
44453483|NCT00068419|79462135|FG000|Overall Study|Adverse Event|3|||
44453484|NCT00068419|79462135|FG000|Overall Study|Lack of Efficacy|24|||
44453485|NCT00068419|79462135|FG000|Overall Study|Lost to Follow-up|1|||
44453486|NCT00068419|79462135|FG000|Overall Study|Physician Decision|7|||
44453487|NCT00068419|79462135|FG000|Overall Study|Withdrawal by Subject|14|||
44453488|NCT00068419|79462135|FG000|Overall Study|Ineligible|11|||
44453489|NCT00068107|79462139|FG000|Overall Study|end-stage renal disease|6|||
44453490|NCT00068107|79462139|FG000|Overall Study|Death|2|||
44453491|NCT00068107|79462139|FG000|Overall Study|Withdrawal by Subject|1|||
44453492|NCT00394654|79462148|FG000|Overall Study|Lost to Follow-up|1|||
44453493|NCT00394654|79462149|FG001|Overall Study|Lost to Follow-up|0|||
44453494|NCT00394654|79462148|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
44214084|NCT01610336|79011653|FG000|Overall Study|Physician Decision|0|||
44371136|NCT03125902|79376558|FG000|Overall Study|Mastectomy|0|||
44371137|NCT03125902|79376559|FG001|Overall Study|Mastectomy|1|||
44371138|NCT03125902|79376558|FG000|Overall Study|Physician Decision|1|||
44371139|NCT03125902|79376559|FG001|Overall Study|Physician Decision|0|||
44371140|NCT03125902|79376558|FG000|Overall Study|Withdrawal by Subject|13|||
44371141|NCT03125902|79376559|FG001|Overall Study|Withdrawal by Subject|25|||
44371142|NCT03125902|79376558|FG000|Overall Study|Study is ongoing|153|||
44371143|NCT03125902|79376559|FG001|Overall Study|Study is ongoing|282|||
44371144|NCT02985957|79376582|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44371145|NCT02985957|79376583|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44371146|NCT02985957|79376584|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44453495|NCT00394654|79462149|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
44453496|NCT03900416|79462157|FG000|Six Week Follow-up|Lost to Follow-up|1|||
44453497|NCT03900416|79462158|FG001|Six Week Follow-up|Lost to Follow-up|0|||
44453498|NCT03900416|79462157|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
44453499|NCT03900416|79462158|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
44453500|NCT03900416|79462157|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
44214085|NCT01610336|79011654|FG001|Overall Study|Physician Decision|0|||
44214086|NCT01610336|79011655|FG002|Overall Study|Physician Decision|0|||
44214087|NCT01610336|79011656|FG003|Overall Study|Physician Decision|0|||
44453501|NCT03900416|79462158|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
44214088|NCT01610336|79011657|FG004|Overall Study|Physician Decision|0|||
44214089|NCT01610336|79011658|FG005|Overall Study|Physician Decision|0|||
44453502|NCT03900416|79462157|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
44453503|NCT03900416|79462158|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
44214090|NCT01610336|79011659|FG006|Overall Study|Physician Decision|1|||
44214091|NCT01610336|79011660|FG007|Overall Study|Physician Decision|0|||
44214092|NCT01610336|79011661|FG008|Overall Study|Physician Decision|0|||
44214093|NCT01610336|79011662|FG009|Overall Study|Physician Decision|0|||
44214094|NCT01610336|79011663|FG010|Overall Study|Physician Decision|0|||
44214095|NCT01610336|79011653|FG000|Overall Study|Protocol Deviation|0|||
44214096|NCT01610336|79011654|FG001|Overall Study|Protocol Deviation|0|||
44214097|NCT01610336|79011655|FG002|Overall Study|Protocol Deviation|0|||
44214098|NCT01610336|79011656|FG003|Overall Study|Protocol Deviation|0|||
44214099|NCT01610336|79011657|FG004|Overall Study|Protocol Deviation|0|||
44214100|NCT01610336|79011658|FG005|Overall Study|Protocol Deviation|0|||
44214101|NCT01610336|79011659|FG006|Overall Study|Protocol Deviation|0|||
44214102|NCT01610336|79011660|FG007|Overall Study|Protocol Deviation|0|||
44214103|NCT01610336|79011661|FG008|Overall Study|Protocol Deviation|0|||
44214104|NCT01610336|79011662|FG009|Overall Study|Protocol Deviation|1|||
44214105|NCT01610336|79011663|FG010|Overall Study|Protocol Deviation|0|||
44214106|NCT01610336|79011653|FG000|Overall Study|Transfer to another trial|0|||
44214107|NCT01610336|79011654|FG001|Overall Study|Transfer to another trial|0|||
44214108|NCT01610336|79011655|FG002|Overall Study|Transfer to another trial|0|||
44214109|NCT01610336|79011656|FG003|Overall Study|Transfer to another trial|0|||
44453504|NCT03900416|79462157|FG000|Twelve Week Follow-up|Adverse Event|1|||
44453505|NCT03900416|79462158|FG001|Twelve Week Follow-up|Adverse Event|1|||
44453506|NCT03900416|79462157|FG000|Six Month Follow-up|Lost to Follow-up|4|||
44453507|NCT03900416|79462158|FG001|Six Month Follow-up|Lost to Follow-up|3|||
44453508|NCT03900416|79462157|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
44453509|NCT03900416|79462158|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
44453510|NCT00399490|79462164|FG000|Overall Study|Adverse Event|19|||
44453511|NCT00399490|79462164|FG000|Overall Study|Lack of Efficacy|31|||
44453512|NCT00399490|79462164|FG000|Overall Study|Lost to Follow-up|5|||
44453513|NCT00399490|79462164|FG000|Overall Study|Withdrawal by Subject|18|||
44453514|NCT00399490|79462164|FG000|Overall Study|Other|25|||
44453515|NCT00398866|79462173|FG000|Overall Study|Adverse Event|1|||
44453516|NCT00398866|79462174|FG001|Overall Study|Adverse Event|0|||
44453517|NCT00398866|79462175|FG002|Overall Study|Adverse Event|0|||
44453518|NCT00398866|79462173|FG000|Overall Study|Lack of Efficacy|0|||
44453519|NCT00398866|79462174|FG001|Overall Study|Lack of Efficacy|0|||
44453520|NCT00398866|79462175|FG002|Overall Study|Lack of Efficacy|1|||
44453521|NCT00398866|79462173|FG000|Overall Study|Lost to Follow-up|7|||
44453522|NCT00398866|79462174|FG001|Overall Study|Lost to Follow-up|6|||
44453523|NCT00398866|79462175|FG002|Overall Study|Lost to Follow-up|4|||
44453524|NCT00398866|79462173|FG000|Overall Study|Withdrawal by Subject|5|||
44453525|NCT00398866|79462174|FG001|Overall Study|Withdrawal by Subject|1|||
44453526|NCT00398866|79462175|FG002|Overall Study|Withdrawal by Subject|2|||
44453527|NCT00398866|79462173|FG000|Overall Study|Unable to complete requirements of study|1|||
44453528|NCT00398866|79462174|FG001|Overall Study|Unable to complete requirements of study|1|||
44453529|NCT00398866|79462175|FG002|Overall Study|Unable to complete requirements of study|1|||
44453530|NCT00398632|79462184|FG000|Overall Study|Withdrawal by Subject|1|||
44214110|NCT01610336|79011657|FG004|Overall Study|Transfer to another trial|0|||
44214111|NCT01610336|79011658|FG005|Overall Study|Transfer to another trial|0|||
44214112|NCT01610336|79011659|FG006|Overall Study|Transfer to another trial|0|||
44214113|NCT01610336|79011660|FG007|Overall Study|Transfer to another trial|0|||
44214114|NCT01610336|79011661|FG008|Overall Study|Transfer to another trial|0|||
44214115|NCT01610336|79011662|FG009|Overall Study|Transfer to another trial|0|||
44214116|NCT01610336|79011663|FG010|Overall Study|Transfer to another trial|1|||
44214117|NCT01613222|79011691|FG000|Overall Study|Physician Decision|1|||
44214118|NCT01613222|79011691|FG000|Overall Study|Unable to place arterial line|1|||
44214119|NCT01613222|79011691|FG000|Overall Study|Reused disposable sensors|10|||
44214120|NCT01612676|79011738|FG000|Overall Study|Adverse Event|2|||
44214121|NCT01612676|79011739|FG001|Overall Study|Adverse Event|3|||
44214122|NCT01612676|79011740|FG002|Overall Study|Adverse Event|1|||
44214123|NCT01612676|79011741|FG003|Overall Study|Adverse Event|3|||
44453531|NCT00398632|79462184|FG000|Overall Study|Lack of Efficacy|1|||
44453532|NCT00673361|79462189|FG000|Overall Study|Screen Failure|2|||
44214124|NCT01612676|79011738|FG000|Overall Study|Protocol Violation|0|||
44269885|NCT00552110|79195094|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
44453533|NCT00393718|79462195|FG000|Overall Study|Adverse Event|20|||
44214125|NCT01612676|79011739|FG001|Overall Study|Protocol Violation|1|||
44214126|NCT01612676|79011740|FG002|Overall Study|Protocol Violation|0|||
44214127|NCT01612676|79011741|FG003|Overall Study|Protocol Violation|0|||
44214128|NCT01869764|79011755|FG000|Overall Study|Withdrawal by Subject|0|||
44214129|NCT01869764|79011756|FG001|Overall Study|Withdrawal by Subject|2|||
44453534|NCT00393718|79462196|FG001|Overall Study|Adverse Event|8|||
44453535|NCT00393718|79462195|FG000|Overall Study|Protocol Violation|1|||
44453536|NCT00393718|79462196|FG001|Overall Study|Protocol Violation|2|||
44453537|NCT00393718|79462195|FG000|Overall Study|Lack of Efficacy|10|||
44214130|NCT01842620|79011762|FG000|Period 1|Withdrawal by Subject|1|||
44214131|NCT01842620|79011763|FG001|Period 1|Withdrawal by Subject|0|||
44453538|NCT00393718|79462196|FG001|Overall Study|Lack of Efficacy|9|||
44453539|NCT00393718|79462195|FG000|Overall Study|Hypoglycaemia|3|||
44453540|NCT00393718|79462196|FG001|Overall Study|Hypoglycaemia|2|||
44453541|NCT00393718|79462195|FG000|Overall Study|Subject decision|5|||
44453542|NCT00393718|79462196|FG001|Overall Study|Subject decision|0|||
44453543|NCT00393718|79462195|FG000|Overall Study|Withdrawal of consent|2|||
44453544|NCT00393718|79462196|FG001|Overall Study|Withdrawal of consent|1|||
44453545|NCT00393718|79462195|FG000|Overall Study|Missed measurement|1|||
44453546|NCT00393718|79462196|FG001|Overall Study|Missed measurement|0|||
44453547|NCT00393718|79462195|FG000|Overall Study|Move|1|||
44453548|NCT00393718|79462196|FG001|Overall Study|Move|0|||
44453549|NCT00669071|79462202|FG000|Overall Study|Lost to Follow-up|3|||
44453550|NCT00669071|79462202|FG000|Overall Study|Final visit 40 days out of window|1|||
44453551|NCT00398320|79462208|FG000|Overall Study|Death|1|||
44453552|NCT00398320|79462208|FG000|Overall Study|Adverse Event|4|||
44453553|NCT00398320|79462208|FG000|Overall Study|Physician Decision|1|||
44453554|NCT00670007|79462212|FG000|Overall Study|Drug abuse|1|||
44453555|NCT00670007|79462212|FG000|Overall Study|Lung transplant|1|||
44453556|NCT00670007|79462212|FG000|Overall Study|Travel/Vacation|1|||
44453557|NCT00670007|79462212|FG000|Overall Study|Adverse event, serious fatal|1|||
44453558|NCT00670007|79462212|FG000|Overall Study|Adverse Event|1|||
44453559|NCT00670007|79462212|FG000|Overall Study|Withdrawal by Subject|4|||
44453560|NCT00535496|79462219|FG000|Overall Study|Lost to Follow-up|0|||
44453561|NCT00535496|79462220|FG001|Overall Study|Lost to Follow-up|1|||
44453562|NCT00535496|79462221|FG002|Overall Study|Lost to Follow-up|0|||
44453563|NCT00535496|79462222|FG003|Overall Study|Lost to Follow-up|0|||
44453564|NCT00535496|79462219|FG000|Overall Study|Not treated with sugammadex|0|||
44214132|NCT01931839|79011789|FG000|Overall Study|Death|0|||
44214133|NCT01931839|79011790|FG001|Overall Study|Death|1|||
44214134|NCT01931839|79011791|FG002|Overall Study|Death|2|||
44214135|NCT01931839|79011792|FG003|Overall Study|Death|0|||
44214136|NCT01931839|79011793|FG004|Overall Study|Death|0|||
44214137|NCT01931839|79011794|FG005|Overall Study|Death|0|||
44214138|NCT01931839|79011795|FG006|Overall Study|Death|0|||
44214139|NCT01931839|79011789|FG000|Overall Study|Physician Decision|1|||
44214140|NCT01931839|79011790|FG001|Overall Study|Physician Decision|0|||
44214141|NCT01931839|79011791|FG002|Overall Study|Physician Decision|1|||
44214142|NCT01931839|79011792|FG003|Overall Study|Physician Decision|0|||
44214143|NCT01931839|79011793|FG004|Overall Study|Physician Decision|0|||
44214144|NCT01931839|79011794|FG005|Overall Study|Physician Decision|0|||
44214145|NCT01931839|79011795|FG006|Overall Study|Physician Decision|1|||
44371147|NCT02985957|79376585|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44371148|NCT02985957|79376586|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44371149|NCT02985957|79376587|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44371150|NCT02985957|79376588|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44371151|NCT02985957|79376582|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
44371152|NCT02985957|79376583|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
44371153|NCT02985957|79376584|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
44371154|NCT02985957|79376585|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
44371155|NCT02985957|79376586|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
44371156|NCT02985957|79376587|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
44371157|NCT02985957|79376588|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
44371158|NCT02985957|79376582|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44371159|NCT02985957|79376583|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44371160|NCT02985957|79376584|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44371161|NCT02985957|79376585|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44371162|NCT02985957|79376586|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44371163|NCT02985957|79376587|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44371164|NCT02985957|79376588|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
44371165|NCT02985957|79376582|FG000|Treatment Period|Death|0|||
44371166|NCT02985957|79376583|FG001|Treatment Period|Death|0|||
44371167|NCT02985957|79376584|FG002|Treatment Period|Death|0|||
44371168|NCT02985957|79376585|FG003|Treatment Period|Death|0|||
44371169|NCT02985957|79376586|FG004|Treatment Period|Death|1|||
44371170|NCT02985957|79376587|FG005|Treatment Period|Death|0|||
44371171|NCT02985957|79376588|FG006|Treatment Period|Death|0|||
44371172|NCT02985957|79376582|FG000|Treatment Period|Participant withdrew consent|0|||
44453565|NCT00535496|79462220|FG001|Overall Study|Not treated with sugammadex|1|||
44453566|NCT00535496|79462221|FG002|Overall Study|Not treated with sugammadex|0|||
44453567|NCT00535496|79462222|FG003|Overall Study|Not treated with sugammadex|0|||
44453568|NCT00539006|79462233|FG000|Pre-treatment|Other|0|||
44453569|NCT00539006|79462234|FG001|Pre-treatment|Other|1|||
44453570|NCT00539006|79462235|FG002|Pre-treatment|Other|0|||
44214146|NCT01931839|79011789|FG000|Overall Study|Withdrawal of consent|0|||
44214147|NCT01931839|79011790|FG001|Overall Study|Withdrawal of consent|0|||
44214148|NCT01931839|79011791|FG002|Overall Study|Withdrawal of consent|0|||
44214149|NCT01931839|79011792|FG003|Overall Study|Withdrawal of consent|0|||
44214150|NCT01931839|79011793|FG004|Overall Study|Withdrawal of consent|1|||
44214151|NCT01931839|79011794|FG005|Overall Study|Withdrawal of consent|0|||
44214152|NCT01931839|79011795|FG006|Overall Study|Withdrawal of consent|0|||
44214153|NCT01931839|79011789|FG000|Overall Study|Adverse Event|9|||
44214154|NCT01931839|79011790|FG001|Overall Study|Adverse Event|4|||
44214155|NCT01931839|79011791|FG002|Overall Study|Adverse Event|1|||
44214156|NCT01931839|79011792|FG003|Overall Study|Adverse Event|3|||
44214157|NCT01931839|79011793|FG004|Overall Study|Adverse Event|0|||
44453571|NCT00539006|79462236|FG003|Pre-treatment|Other|0|||
44453572|NCT00539006|79462233|FG000|Treatment Period 1|Lost to Follow-up|0|||
44453573|NCT00539006|79462234|FG001|Treatment Period 1|Lost to Follow-up|0|||
44453574|NCT00539006|79462235|FG002|Treatment Period 1|Lost to Follow-up|1|||
44453575|NCT00539006|79462236|FG003|Treatment Period 1|Lost to Follow-up|0|||
44453576|NCT00539006|79462233|FG000|Treatment Period 1|Protocol Violation|0|||
44453577|NCT00539006|79462234|FG001|Treatment Period 1|Protocol Violation|0|||
44453578|NCT00539006|79462235|FG002|Treatment Period 1|Protocol Violation|1|||
44453579|NCT00539006|79462236|FG003|Treatment Period 1|Protocol Violation|0|||
44453580|NCT00539006|79462233|FG000|Treatment Period 1|Lack of Efficacy|0|||
44214158|NCT01931839|79011794|FG005|Overall Study|Adverse Event|0|||
44214159|NCT01931839|79011795|FG006|Overall Study|Adverse Event|1|||
44214160|NCT01931839|79011789|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
44214161|NCT01931839|79011790|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
44214162|NCT01931839|79011791|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
44214163|NCT01931839|79011792|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
44214164|NCT01931839|79011793|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
44214165|NCT01931839|79011794|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
44453581|NCT00539006|79462234|FG001|Treatment Period 1|Lack of Efficacy|0|||
44453582|NCT00539006|79462235|FG002|Treatment Period 1|Lack of Efficacy|0|||
44453583|NCT00539006|79462236|FG003|Treatment Period 1|Lack of Efficacy|1|||
44453584|NCT00539006|79462233|FG000|Washout|Adverse Event|2|||
44214166|NCT01931839|79011795|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
44214167|NCT01931839|79011789|FG000|Overall Study|Other non-compliance|15|||
44214168|NCT01931839|79011790|FG001|Overall Study|Other non-compliance|9|||
44269886|NCT00552110|79195095|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
44269887|NCT00552110|79195096|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
44371173|NCT02985957|79376583|FG001|Treatment Period|Participant withdrew consent|0|||
44371174|NCT02985957|79376584|FG002|Treatment Period|Participant withdrew consent|0|||
44371175|NCT02985957|79376585|FG003|Treatment Period|Participant withdrew consent|1|||
44371176|NCT02985957|79376586|FG004|Treatment Period|Participant withdrew consent|3|||
44371177|NCT02985957|79376587|FG005|Treatment Period|Participant withdrew consent|0|||
44371178|NCT02985957|79376588|FG006|Treatment Period|Participant withdrew consent|1|||
44371179|NCT02985957|79376582|FG000|Treatment Period|Lost to Follow-up|0|||
44371180|NCT02985957|79376583|FG001|Treatment Period|Lost to Follow-up|0|||
44371181|NCT02985957|79376584|FG002|Treatment Period|Lost to Follow-up|0|||
44371182|NCT02985957|79376585|FG003|Treatment Period|Lost to Follow-up|0|||
44371183|NCT02985957|79376586|FG004|Treatment Period|Lost to Follow-up|1|||
44371184|NCT02985957|79376587|FG005|Treatment Period|Lost to Follow-up|0|||
44371185|NCT02985957|79376588|FG006|Treatment Period|Lost to Follow-up|0|||
44371186|NCT02985957|79376582|FG000|Treatment Period|Other reasons|0|||
44371187|NCT02985957|79376583|FG001|Treatment Period|Other reasons|0|||
44371188|NCT02985957|79376584|FG002|Treatment Period|Other reasons|1|||
44371189|NCT02985957|79376585|FG003|Treatment Period|Other reasons|3|||
44371190|NCT02985957|79376586|FG004|Treatment Period|Other reasons|6|||
44371191|NCT02985957|79376587|FG005|Treatment Period|Other reasons|0|||
44371192|NCT02985957|79376588|FG006|Treatment Period|Other reasons|1|||
44371193|NCT02985957|79376582|FG000|Treatment Period|Not reported|0|||
44371194|NCT02985957|79376583|FG001|Treatment Period|Not reported|1|||
44371195|NCT02985957|79376584|FG002|Treatment Period|Not reported|2|||
44371196|NCT02985957|79376585|FG003|Treatment Period|Not reported|5|||
44453585|NCT00539006|79462234|FG001|Washout|Adverse Event|1|||
44453586|NCT00539006|79462235|FG002|Washout|Adverse Event|0|||
44453587|NCT00539006|79462236|FG003|Washout|Adverse Event|0|||
44214169|NCT01931839|79011791|FG002|Overall Study|Other non-compliance|12|||
44214170|NCT01931839|79011792|FG003|Overall Study|Other non-compliance|3|||
44214171|NCT01931839|79011793|FG004|Overall Study|Other non-compliance|0|||
44371197|NCT02985957|79376586|FG004|Treatment Period|Not reported|0|||
44371198|NCT02985957|79376587|FG005|Treatment Period|Not reported|0|||
44371199|NCT02985957|79376588|FG006|Treatment Period|Not reported|0|||
44371200|NCT02985957|79376582|FG000|Treatment Period|Maximum clinical benefit|0|||
44453588|NCT00539006|79462233|FG000|Washout|Protocol Violation|1|||
44453589|NCT00539006|79462234|FG001|Washout|Protocol Violation|1|||
44453590|NCT00539006|79462235|FG002|Washout|Protocol Violation|0|||
44453591|NCT00539006|79462236|FG003|Washout|Protocol Violation|0|||
44453592|NCT00539006|79462233|FG000|Washout|Withdrawal by Subject|0|||
44453593|NCT00539006|79462234|FG001|Washout|Withdrawal by Subject|2|||
44453594|NCT00539006|79462235|FG002|Washout|Withdrawal by Subject|0|||
44453595|NCT00539006|79462236|FG003|Washout|Withdrawal by Subject|0|||
44453596|NCT00539006|79462233|FG000|Washout|Failed to meet continuation criteria|16|||
44453597|NCT00539006|79462234|FG001|Washout|Failed to meet continuation criteria|5|||
44453598|NCT00539006|79462235|FG002|Washout|Failed to meet continuation criteria|14|||
44453599|NCT00539006|79462236|FG003|Washout|Failed to meet continuation criteria|6|||
44453600|NCT00539006|79462233|FG000|Washout|Other|1|||
44453601|NCT00539006|79462234|FG001|Washout|Other|1|||
44453602|NCT00539006|79462235|FG002|Washout|Other|2|||
44453603|NCT00539006|79462236|FG003|Washout|Other|3|||
44453604|NCT00539006|79462233|FG000|Treatment Period 2|Protocol Violation|1|||
44453605|NCT00539006|79462234|FG001|Treatment Period 2|Protocol Violation|0|||
44453606|NCT00539006|79462235|FG002|Treatment Period 2|Protocol Violation|0|||
44453607|NCT00539006|79462236|FG003|Treatment Period 2|Protocol Violation|0|||
44453608|NCT00539006|79462233|FG000|Treatment Period 2|Other|0|||
44453609|NCT00539006|79462234|FG001|Treatment Period 2|Other|1|||
44453610|NCT00539006|79462235|FG002|Treatment Period 2|Other|0|||
44214172|NCT01931839|79011794|FG005|Overall Study|Other non-compliance|3|||
44214173|NCT01931839|79011795|FG006|Overall Study|Other non-compliance|0|||
44214174|NCT01931839|79011789|FG000|Overall Study|Lost to Follow-up|1|||
44214175|NCT01931839|79011790|FG001|Overall Study|Lost to Follow-up|2|||
44214176|NCT01931839|79011791|FG002|Overall Study|Lost to Follow-up|4|||
44214177|NCT01931839|79011792|FG003|Overall Study|Lost to Follow-up|5|||
44214178|NCT01931839|79011793|FG004|Overall Study|Lost to Follow-up|0|||
44214179|NCT01931839|79011794|FG005|Overall Study|Lost to Follow-up|0|||
44214180|NCT01931839|79011795|FG006|Overall Study|Lost to Follow-up|0|||
44214181|NCT01931839|79011789|FG000|Overall Study|Other|4|||
44214182|NCT01931839|79011790|FG001|Overall Study|Other|2|||
44214183|NCT01931839|79011791|FG002|Overall Study|Other|6|||
44214184|NCT01931839|79011792|FG003|Overall Study|Other|0|||
44214185|NCT01931839|79011793|FG004|Overall Study|Other|0|||
44214186|NCT01931839|79011794|FG005|Overall Study|Other|0|||
44214187|NCT01931839|79011795|FG006|Overall Study|Other|0|||
44214188|NCT01842308|79011820|FG000|Overall Study|Withdrawal by Subject|0|||
44371201|NCT02985957|79376583|FG001|Treatment Period|Maximum clinical benefit|0|||
44371202|NCT02985957|79376584|FG002|Treatment Period|Maximum clinical benefit|1|||
44371203|NCT02985957|79376585|FG003|Treatment Period|Maximum clinical benefit|1|||
44371204|NCT02985957|79376586|FG004|Treatment Period|Maximum clinical benefit|0|||
44371205|NCT02985957|79376587|FG005|Treatment Period|Maximum clinical benefit|0|||
44371206|NCT02985957|79376588|FG006|Treatment Period|Maximum clinical benefit|2|||
44371207|NCT02985957|79376582|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
44371208|NCT02985957|79376583|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
44371209|NCT02985957|79376584|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
44371210|NCT02985957|79376585|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
44371211|NCT02985957|79376586|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
44371212|NCT02985957|79376587|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
44371213|NCT02985957|79376588|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
44371214|NCT02985957|79376582|FG000|Treatment Period|Study drug toxicity|1|||
44371215|NCT02985957|79376583|FG001|Treatment Period|Study drug toxicity|23|||
44371216|NCT02985957|79376584|FG002|Treatment Period|Study drug toxicity|20|||
44371217|NCT02985957|79376585|FG003|Treatment Period|Study drug toxicity|11|||
44371218|NCT02985957|79376586|FG004|Treatment Period|Study drug toxicity|19|||
44453611|NCT00539006|79462236|FG003|Treatment Period 2|Other|0|||
44453612|NCT00537056|79462252|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
44453613|NCT00535262|79462258|FG000|Overall Study|No funding|3|||
44453614|NCT00074581|79462264|FG000|Overall Study|Death|15|||
44214189|NCT01842308|79011821|FG001|Overall Study|Withdrawal by Subject|0|||
44214190|NCT01842308|79011822|FG002|Overall Study|Withdrawal by Subject|0|||
44214191|NCT01842308|79011823|FG003|Overall Study|Withdrawal by Subject|0|||
44214192|NCT01842308|79011824|FG004|Overall Study|Withdrawal by Subject|1|||
44371219|NCT02985957|79376587|FG005|Treatment Period|Study drug toxicity|3|||
44371220|NCT02985957|79376588|FG006|Treatment Period|Study drug toxicity|5|||
44371221|NCT02985957|79376582|FG000|Treatment Period|Disease progression|0|||
44371222|NCT02985957|79376583|FG001|Treatment Period|Disease progression|16|||
44371223|NCT02985957|79376584|FG002|Treatment Period|Disease progression|20|||
44453615|NCT00074581|79462265|FG001|Overall Study|Death|16|||
44453616|NCT00074581|79462264|FG000|Overall Study|Withdrawal by Subject|50|||
44453617|NCT00074581|79462265|FG001|Overall Study|Withdrawal by Subject|49|||
44453618|NCT00074581|79462264|FG000|Overall Study|Unable to adhere to visit schedule|13|||
44453619|NCT00074581|79462265|FG001|Overall Study|Unable to adhere to visit schedule|14|||
44453620|NCT00074581|79462264|FG000|Overall Study|Relocated|14|||
44453621|NCT00074581|79462265|FG001|Overall Study|Relocated|9|||
44453622|NCT00074581|79462264|FG000|Overall Study|Were withdrawn by investigator|5|||
44453623|NCT00074581|79462265|FG001|Overall Study|Were withdrawn by investigator|2|||
44453624|NCT00074581|79462264|FG000|Overall Study|Lost to Follow-up|16|||
44453625|NCT00074581|79462265|FG001|Overall Study|Lost to Follow-up|11|||
44453626|NCT00074581|79462264|FG000|Overall Study|Ended relationship w. index participant|117|||
44453627|NCT00074581|79462265|FG001|Overall Study|Ended relationship w. index participant|106|||
44453628|NCT00074581|79462264|FG000|Overall Study|Other|14|||
44453629|NCT00074581|79462265|FG001|Overall Study|Other|19|||
44453630|NCT03895034|79462271|FG000|Overall Study|Lost to Follow-up|2|||
44453631|NCT00536978|79462275|FG000|Overall Study|Not eligible for Adback Infusion|22|||
44453632|NCT03809611|79462281|FG000|Overall Study|Withdrawal by Subject|1|||
44453633|NCT03809611|79462282|FG001|Overall Study|Withdrawal by Subject|1|||
44453634|NCT03807739|79462293|FG000|Overall Study|Adverse Event|1|||
44453635|NCT03807739|79462294|FG001|Overall Study|Adverse Event|0|||
44453636|NCT03807739|79462295|FG002|Overall Study|Adverse Event|0|||
44453637|NCT03807739|79462296|FG003|Overall Study|Adverse Event|0|||
44453638|NCT03807739|79462293|FG000|Overall Study|Withdrawal by Subject|1|||
44214193|NCT01931059|79011839|FG000|Day 1|Pregnancy|0|||
44214194|NCT01931059|79011840|FG001|Day 1|Pregnancy|1|||
44214195|NCT01931059|79011839|FG000|Day3|Lost to Follow-up|1|||
44214196|NCT01931059|79011840|FG001|Day3|Lost to Follow-up|0|||
44214197|NCT01841762|79011852|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
44214198|NCT01841762|79011852|FG000|Treatment Period|Adverse Event|16|||
44214199|NCT01841762|79011852|FG000|Treatment Period|Death|1|||
44214200|NCT01841762|79011852|FG000|Treatment Period|Withdrawal by Subject|7|||
44214201|NCT01841762|79011852|FG000|Treatment Period|Lost to Follow-up|1|||
44214202|NCT01841762|79011852|FG000|Treatment Period|Physician Decision|2|||
44214203|NCT01841762|79011852|FG000|Treatment Period|Other, including non-compliance|5|||
44214204|NCT01841762|79011852|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
44214205|NCT01841762|79011852|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
44214206|NCT01841762|79011852|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
44214207|NCT01841762|79011852|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
44214208|NCT01841060|79011869|FG000|Overall Study|Protocol Violation|10|||
44214209|NCT01814696|79011875|FG000|Overall Study|Withdrawal by Subject|1|||
44214210|NCT01814696|79011876|FG001|Overall Study|Withdrawal by Subject|0|||
44214211|NCT01814696|79011875|FG000|Overall Study|Randomized to wrong group|1|||
44214212|NCT01814696|79011876|FG001|Overall Study|Randomized to wrong group|0|||
44453639|NCT03807739|79462294|FG001|Overall Study|Withdrawal by Subject|0|||
44453640|NCT03807739|79462295|FG002|Overall Study|Withdrawal by Subject|0|||
44453641|NCT03807739|79462296|FG003|Overall Study|Withdrawal by Subject|0|||
44453642|NCT00536744|79462308|FG000|Overall Study|Adverse Event|13|||
44453643|NCT00536744|79462309|FG001|Overall Study|Adverse Event|10|||
44453644|NCT00536744|79462308|FG000|Overall Study|Death|2|||
44453645|NCT00536744|79462309|FG001|Overall Study|Death|1|||
44453646|NCT00536744|79462308|FG000|Overall Study|Physician Decision|3|||
44453647|NCT00536744|79462309|FG001|Overall Study|Physician Decision|1|||
44453648|NCT00536744|79462308|FG000|Overall Study|Lost to Follow-up|3|||
44453649|NCT00536744|79462309|FG001|Overall Study|Lost to Follow-up|5|||
44453650|NCT00536744|79462308|FG000|Overall Study|Withdrawal by Subject|7|||
44453651|NCT00536744|79462309|FG001|Overall Study|Withdrawal by Subject|8|||
44453652|NCT00536744|79462308|FG000|Overall Study|PI tried alternative treatment|1|||
44453653|NCT00536744|79462309|FG001|Overall Study|PI tried alternative treatment|3|||
44453654|NCT00536510|79462326|FG000|Overall Study|Adverse Event|27|||
44453655|NCT00536510|79462327|FG001|Overall Study|Adverse Event|4|||
44453656|NCT00536510|79462326|FG000|Overall Study|Lost to Follow-up|11|||
44453657|NCT00536510|79462327|FG001|Overall Study|Lost to Follow-up|8|||
44453658|NCT00536510|79462326|FG000|Overall Study|Protocol Violation|4|||
44453659|NCT00536510|79462327|FG001|Overall Study|Protocol Violation|5|||
44453660|NCT00536510|79462326|FG000|Overall Study|Withdrawal by Subject|16|||
44453661|NCT00536510|79462327|FG001|Overall Study|Withdrawal by Subject|9|||
44453662|NCT00536510|79462326|FG000|Overall Study|Flushing with Product|20|||
44214213|NCT01970371|79011885|FG000|Overall Study|Death|8|||
44214214|NCT01970371|79011886|FG001|Overall Study|Death|13|||
44214215|NCT01970371|79011887|FG002|Overall Study|Death|12|||
44214216|NCT01970371|79011885|FG000|Overall Study|Lost to Follow-up|0|||
44214217|NCT01970371|79011886|FG001|Overall Study|Lost to Follow-up|0|||
44453663|NCT00536510|79462327|FG001|Overall Study|Flushing with Product|0|||
44453664|NCT00536510|79462326|FG000|Overall Study|Laboratory Adverse Event|2|||
44453665|NCT00536510|79462327|FG001|Overall Study|Laboratory Adverse Event|1|||
44453666|NCT00536510|79462326|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
44453667|NCT00536510|79462327|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
44214218|NCT01970371|79011887|FG002|Overall Study|Lost to Follow-up|1|||
44453668|NCT00398086|79462336|FG000|Overall Study|Unacceptable Toxicity|2|||
44453669|NCT00398086|79462337|FG001|Overall Study|Unacceptable Toxicity|8|||
44453670|NCT00398086|79462338|FG002|Overall Study|Unacceptable Toxicity|2|||
44453671|NCT00398086|79462336|FG000|Overall Study|Adverse Event|1|||
44453672|NCT00398086|79462337|FG001|Overall Study|Adverse Event|4|||
44453673|NCT00398086|79462338|FG002|Overall Study|Adverse Event|0|||
44453674|NCT00398086|79462336|FG000|Overall Study|Physician Decision|1|||
44453675|NCT00398086|79462337|FG001|Overall Study|Physician Decision|4|||
44453676|NCT00398086|79462338|FG002|Overall Study|Physician Decision|0|||
44453677|NCT00398086|79462336|FG000|Overall Study|Withdrawal by Subject|5|||
44453678|NCT00398086|79462337|FG001|Overall Study|Withdrawal by Subject|7|||
44453679|NCT00398086|79462338|FG002|Overall Study|Withdrawal by Subject|0|||
44453680|NCT00536198|79462348|FG000|Overall Study|Lost to Follow-up|15|||
44453681|NCT00536198|79462349|FG001|Overall Study|Lost to Follow-up|14|||
44453682|NCT00536198|79462348|FG000|Overall Study|Withdrawal by Subject|16|||
44453683|NCT00536198|79462349|FG001|Overall Study|Withdrawal by Subject|12|||
44214219|NCT01868594|79011908|FG000|Overall Study|Do not meet inclusion criteria|4|||
44453684|NCT00536198|79462348|FG000|Overall Study|Adverse Event|2|||
44453685|NCT00536198|79462349|FG001|Overall Study|Adverse Event|2|||
44453686|NCT00536198|79462348|FG000|Overall Study|Rescue|3|||
44453687|NCT00536198|79462349|FG001|Overall Study|Rescue|9|||
44453688|NCT00536198|79462348|FG000|Overall Study|Pregnancy|1|||
44453689|NCT00536198|79462349|FG001|Overall Study|Pregnancy|1|||
44453690|NCT00536198|79462348|FG000|Overall Study|Protocol Violation|0|||
44453691|NCT00536198|79462349|FG001|Overall Study|Protocol Violation|1|||
44453692|NCT00393484|79462359|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
44453693|NCT00393484|79462360|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
44453694|NCT00393484|79462359|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
44453695|NCT00393484|79462360|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
44453696|NCT00393484|79462359|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
44453697|NCT00393484|79462360|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
44453698|NCT00393484|79462359|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
44453699|NCT00393484|79462360|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
44453700|NCT00393484|79462359|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
44453701|NCT00393484|79462360|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
44453702|NCT00393484|79462359|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
44453703|NCT00393484|79462360|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
44453704|NCT00393484|79462359|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
44453705|NCT00393484|79462360|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
44453706|NCT00393484|79462359|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
44214220|NCT01868594|79011909|FG001|Overall Study|Do not meet inclusion criteria|3|||
44214221|NCT01616953|79011919|FG000|Overall Study|Lost to Follow-up|1|||
44214222|NCT01616953|79011920|FG001|Overall Study|Lost to Follow-up|0|||
44214223|NCT01616953|79011919|FG000|Overall Study|lack of bone and soft tissue|1|||
44214224|NCT01616953|79011920|FG001|Overall Study|lack of bone and soft tissue|0|||
44214225|NCT01867658|79011926|FG000|Overall Study|Withdrawal by Subject|6|||
44214226|NCT01867658|79011926|FG000|Overall Study|Death|2|||
44214227|NCT01867658|79011926|FG000|Overall Study|Subject could not be contacted|1|||
44214228|NCT01867580|79011932|FG000|Overall Study|Withdrawal by Subject|2|||
44214229|NCT01867580|79011933|FG001|Overall Study|Withdrawal by Subject|3|||
44214230|NCT01867580|79011932|FG000|Overall Study|Physician Decision|17|||
44269888|NCT00552110|79195097|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
44371224|NCT02985957|79376585|FG003|Treatment Period|Disease progression|39|||
44371225|NCT02985957|79376586|FG004|Treatment Period|Disease progression|29|||
44371226|NCT02985957|79376587|FG005|Treatment Period|Disease progression|11|||
44371227|NCT02985957|79376588|FG006|Treatment Period|Disease progression|28|||
44371228|NCT02985957|79376582|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
44371229|NCT02985957|79376583|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
44371230|NCT02985957|79376584|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
44371231|NCT02985957|79376585|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
44371232|NCT02985957|79376586|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
44371233|NCT02985957|79376587|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
44371234|NCT02985957|79376588|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
44453707|NCT00393484|79462360|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
44453708|NCT00393484|79462359|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
44453709|NCT00393484|79462360|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
44214231|NCT01867580|79011933|FG001|Overall Study|Physician Decision|12|||
44214232|NCT01867580|79011932|FG000|Overall Study|Lost to Follow-up|3|||
44214233|NCT01867580|79011933|FG001|Overall Study|Lost to Follow-up|5|||
44214234|NCT01867580|79011932|FG000|Overall Study|Sponsor terminated study|1|||
44543691|NCT03673345|79556818|FG005|Overall Study|Withdrawal by Subject|0|||
44543692|NCT03673345|79556819|FG006|Overall Study|Withdrawal by Subject|0|||
44543693|NCT03673345|79556820|FG007|Overall Study|Withdrawal by Subject|0|||
44543694|NCT03673345|79556813|FG000|Overall Study|Physician Decision|0|||
44543695|NCT03673345|79556814|FG001|Overall Study|Physician Decision|0|||
44543696|NCT03673345|79556815|FG002|Overall Study|Physician Decision|2|||
44543697|NCT03673345|79556816|FG003|Overall Study|Physician Decision|0|||
44543698|NCT03673345|79556817|FG004|Overall Study|Physician Decision|0|||
44543699|NCT03673345|79556818|FG005|Overall Study|Physician Decision|0|||
44543700|NCT03673345|79556819|FG006|Overall Study|Physician Decision|0|||
44543701|NCT03673345|79556820|FG007|Overall Study|Physician Decision|0|||
44543702|NCT03223662|79556838|FG000|Overall Study|Physician Decision|1|||
44543703|NCT03223662|79556838|FG000|Overall Study|Study closure|1|||
44543704|NCT03672097|79556842|FG000|Period 1|Withdrawal by Subject|2|||
44543705|NCT03672097|79556842|FG000|Period 1|Adverse Event|1|||
44543706|NCT03672097|79556842|FG000|Period 1|Did not receive treatment|1|||
44543707|NCT03672097|79556842|FG000|Period 2|Withdrawal by Subject|3|||
44543708|NCT03672097|79556842|FG000|Period 2|Other|1|||
44543709|NCT03847896|79556851|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
44543710|NCT03847896|79556852|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
44214235|NCT01867580|79011933|FG001|Overall Study|Sponsor terminated study|0|||
44214236|NCT01867580|79011932|FG000|Overall Study|Missed follow-up assessment|2|||
44214237|NCT01867580|79011933|FG001|Overall Study|Missed follow-up assessment|1|||
44214238|NCT01867580|79011932|FG000|Overall Study|Interruption to therapy|3|||
44214239|NCT01867580|79011933|FG001|Overall Study|Interruption to therapy|0|||
44214240|NCT01867580|79011932|FG000|Overall Study|Osteomyelitis|0|||
44214241|NCT01867580|79011933|FG001|Overall Study|Osteomyelitis|1|||
44214242|NCT01867580|79011932|FG000|Overall Study|Continuation of therapy|0|||
44214243|NCT01867580|79011933|FG001|Overall Study|Continuation of therapy|1|||
44214244|NCT01867580|79011932|FG000|Overall Study|Wound recurrence|0|||
44214245|NCT01867580|79011933|FG001|Overall Study|Wound recurrence|1|||
44214246|NCT01839656|79011947|FG000|Overall Study|Withdrawal by Subject|1|||
44453710|NCT00393484|79462359|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
44453711|NCT00393484|79462360|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
44453712|NCT00667823|79462368|FG000|Overall Study|Lost to Follow-up|5|||
44453713|NCT00667823|79462368|FG000|Overall Study|Adverse Event|7|||
44453714|NCT00667823|79462368|FG000|Overall Study|Death|182|||
44453715|NCT00667823|79462368|FG000|Overall Study|Withdrawal by Subject|12|||
44453716|NCT00667823|79462368|FG000|Overall Study|Other|8|||
44453717|NCT00667823|79462368|FG000|Overall Study|Missing (completion page missing)|2|||
44453718|NCT00397930|79462374|FG000|Overall Study|Personal reasons|14|||
44453719|NCT00397930|79462375|FG001|Overall Study|Personal reasons|8|||
44453720|NCT00397930|79462374|FG000|Overall Study|Other medical|9|||
44453721|NCT00397930|79462375|FG001|Overall Study|Other medical|4|||
44453722|NCT00397930|79462374|FG000|Overall Study|Unknown reasons|9|||
44453723|NCT00397930|79462375|FG001|Overall Study|Unknown reasons|14|||
44453724|NCT00397930|79462374|FG000|Overall Study|Noncompliant|3|||
44453725|NCT00397930|79462375|FG001|Overall Study|Noncompliant|2|||
44453726|NCT00397930|79462374|FG000|Overall Study|Too time-consuming|2|||
44453727|NCT00397930|79462375|FG001|Overall Study|Too time-consuming|9|||
44453728|NCT00397930|79462374|FG000|Overall Study|Started own yoga program|1|||
44214247|NCT01839656|79011948|FG001|Overall Study|Withdrawal by Subject|1|||
44214248|NCT01839656|79011947|FG000|Overall Study|Adverse event, serious fatal|1|||
44214249|NCT01839656|79011948|FG001|Overall Study|Adverse event, serious fatal|4|||
44214250|NCT01839656|79011947|FG000|Overall Study|Early study closure|0|||
44214251|NCT01839656|79011948|FG001|Overall Study|Early study closure|11|||
44214252|NCT01839656|79011947|FG000|Overall Study|Adverse Event|1|||
44453729|NCT00397930|79462375|FG001|Overall Study|Started own yoga program|1|||
44453730|NCT00397930|79462374|FG000|Overall Study|Did not want to be in control group|0|||
44453731|NCT00397930|79462375|FG001|Overall Study|Did not want to be in control group|1|||
44453732|NCT00397930|79462374|FG000|Overall Study|Withdrawal by Subject|0|||
44453733|NCT00397930|79462375|FG001|Overall Study|Withdrawal by Subject|8|||
44453734|NCT00397930|79462374|FG000|Overall Study|Missing data|0|||
44453735|NCT00397930|79462375|FG001|Overall Study|Missing data|4|||
44453736|NCT00397540|79462383|FG000|Overall Study|short follow-up duration < 12 months|1|||
44453737|NCT00397540|79462384|FG001|Overall Study|short follow-up duration < 12 months|0|||
44543711|NCT03847896|79556853|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
44214253|NCT01839656|79011948|FG001|Overall Study|Adverse Event|0|||
44214254|NCT01839188|79011954|FG000|Overall Study|Withdrawal by Subject|1|||
44214255|NCT01838876|79011963|FG000|Overall Study|Adverse Event|49|||
44453738|NCT00536120|79462393|FG000|Overall Study|Lost to Follow-up|1|||
44453739|NCT00536120|79462394|FG001|Overall Study|Lost to Follow-up|0|||
44453740|NCT00536120|79462393|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
44453741|NCT00536120|79462394|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
44214256|NCT01838876|79011963|FG000|Overall Study|Insufficient Therapeutic Response|10|||
44214257|NCT01838876|79011963|FG000|Overall Study|Protocol Violation|34|||
44214258|NCT01838876|79011963|FG000|Overall Study|Withdrawal of Consent|33|||
44214259|NCT01838876|79011963|FG000|Overall Study|Lost to Follow-up|21|||
44214260|NCT01838876|79011963|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
44214261|NCT01838876|79011963|FG000|Overall Study|Reason not Specified|7|||
44214262|NCT01838876|79011963|FG000|Overall Study|Did not meet eligibility criteria|78|||
44214263|NCT01838642|79011978|FG000|Overall Study|Died on study|1|||
44214264|NCT01611194|79011985|FG000|Overall Study|Lost to Follow-up|0|||
44214265|NCT01611194|79011986|FG001|Overall Study|Lost to Follow-up|1|||
44453742|NCT00536120|79462393|FG000|Overall Study|Non-compliance|1|||
44453743|NCT00536120|79462394|FG001|Overall Study|Non-compliance|0|||
44453744|NCT00536120|79462393|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
44269889|NCT00552110|79195098|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
44269890|NCT00552110|79195094|FG000|Overall Study|Withdrawn per Sponsor|0|||
44269891|NCT00552110|79195095|FG001|Overall Study|Withdrawn per Sponsor|1|||
44269892|NCT00552110|79195096|FG002|Overall Study|Withdrawn per Sponsor|0|||
44269893|NCT00552110|79195097|FG003|Overall Study|Withdrawn per Sponsor|0|||
44269894|NCT00552110|79195098|FG004|Overall Study|Withdrawn per Sponsor|1|||
44269895|NCT00552110|79195094|FG000|Overall Study|Use of Prohibited Medication|1|||
44269896|NCT00552110|79195095|FG001|Overall Study|Use of Prohibited Medication|1|||
44453745|NCT00536120|79462394|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
44453746|NCT00536120|79462393|FG000|Overall Study|Steroid Use|0|||
44453747|NCT00536120|79462394|FG001|Overall Study|Steroid Use|2|||
44453748|NCT00536120|79462393|FG000|Overall Study|Missed Study Visit|0|||
44453749|NCT00536120|79462394|FG001|Overall Study|Missed Study Visit|1|||
44453750|NCT00057811|79462402|FG000|Overall Study|Lack of Efficacy|1|||
44453751|NCT00057811|79462403|FG001|Overall Study|Lack of Efficacy|4|||
44453752|NCT00057811|79462402|FG000|Overall Study|Physician Decision|1|||
44214266|NCT01611194|79011985|FG000|Overall Study|Withdrawal by Subject|0|||
44214267|NCT01611194|79011986|FG001|Overall Study|Withdrawal by Subject|1|||
44214268|NCT01611194|79011985|FG000|Overall Study|drug use|0|||
44214269|NCT01611194|79011986|FG001|Overall Study|drug use|1|||
44214270|NCT01813058|79011994|FG000|Overall Study|Withdrawal by Subject|5|||
44214271|NCT01813058|79011995|FG001|Overall Study|Withdrawal by Subject|4|||
44214272|NCT01867424|79012003|FG000|Overall Study|Patient noncompliance|2|||
44214273|NCT01867424|79012004|FG001|Overall Study|Patient noncompliance|1|||
44214274|NCT01811732|79012012|FG000|Overall Study|Lost to Follow-up|24|||
44214275|NCT01811732|79012013|FG001|Overall Study|Lost to Follow-up|30|||
44214276|NCT01811732|79012012|FG000|Overall Study|Withdrawal by Subject|16|||
44214277|NCT01811732|79012013|FG001|Overall Study|Withdrawal by Subject|10|||
44214278|NCT01811732|79012012|FG000|Overall Study|Adverse Event|3|||
44214279|NCT01811732|79012013|FG001|Overall Study|Adverse Event|9|||
44214280|NCT01811732|79012012|FG000|Overall Study|Lack of Efficacy|3|||
44214281|NCT01811732|79012013|FG001|Overall Study|Lack of Efficacy|1|||
44214282|NCT01811732|79012012|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
44371235|NCT02985957|79376582|FG000|Treatment Period|Poor/Non-Compliance|0|||
44371236|NCT02985957|79376583|FG001|Treatment Period|Poor/Non-Compliance|0|||
44371237|NCT02985957|79376584|FG002|Treatment Period|Poor/Non-Compliance|0|||
44371238|NCT02985957|79376585|FG003|Treatment Period|Poor/Non-Compliance|0|||
44371239|NCT02985957|79376586|FG004|Treatment Period|Poor/Non-Compliance|1|||
44371240|NCT02985957|79376587|FG005|Treatment Period|Poor/Non-Compliance|1|||
44371241|NCT02985957|79376588|FG006|Treatment Period|Poor/Non-Compliance|0|||
44371242|NCT02985957|79376582|FG000|Treatment Period|Continuing in Treatment Period|0|||
44371243|NCT02985957|79376583|FG001|Treatment Period|Continuing in Treatment Period|1|||
44371244|NCT02985957|79376584|FG002|Treatment Period|Continuing in Treatment Period|0|||
44371245|NCT02985957|79376585|FG003|Treatment Period|Continuing in Treatment Period|4|||
44371246|NCT02985957|79376586|FG004|Treatment Period|Continuing in Treatment Period|4|||
44453753|NCT00057811|79462403|FG001|Overall Study|Physician Decision|0|||
44453754|NCT00057811|79462402|FG000|Overall Study|Withdrawal by Subject|3|||
44214283|NCT01811732|79012013|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
44214284|NCT01811732|79012012|FG000|Overall Study|Physician Decision|2|||
44214285|NCT01811732|79012013|FG001|Overall Study|Physician Decision|0|||
44269897|NCT00552110|79195096|FG002|Overall Study|Use of Prohibited Medication|0|||
44543712|NCT03847896|79556854|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
44214286|NCT01811732|79012012|FG000|Overall Study|Death|1|||
44371247|NCT02985957|79376587|FG005|Treatment Period|Continuing in Treatment Period|0|||
44371248|NCT02985957|79376588|FG006|Treatment Period|Continuing in Treatment Period|0|||
44214287|NCT01811732|79012013|FG001|Overall Study|Death|1|||
44214288|NCT01811732|79012012|FG000|Overall Study|Insufficient venous access|0|||
44214289|NCT01811732|79012013|FG001|Overall Study|Insufficient venous access|1|||
44214290|NCT01811732|79012012|FG000|Overall Study|Protocol Violation|0|||
44214291|NCT01811732|79012013|FG001|Overall Study|Protocol Violation|1|||
44214292|NCT01811732|79012012|FG000|Overall Study|Subject incarcerated|1|||
44214293|NCT01811732|79012013|FG001|Overall Study|Subject incarcerated|2|||
44214294|NCT01811732|79012012|FG000|Overall Study|Admitted to another facility|1|||
44214295|NCT01811732|79012013|FG001|Overall Study|Admitted to another facility|0|||
44214296|NCT01811732|79012012|FG000|Overall Study|Correct study drug not available on site|1|||
44214297|NCT01811732|79012013|FG001|Overall Study|Correct study drug not available on site|0|||
44214298|NCT01836458|79012024|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
44214299|NCT01836458|79012025|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44214300|NCT01836458|79012026|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
44214301|NCT01836458|79012027|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
44214302|NCT01811186|79012039|FG000|Overall Study|Adverse Event|54|||
44214303|NCT01811186|79012040|FG001|Overall Study|Adverse Event|38|||
44214304|NCT01811186|79012039|FG000|Overall Study|Protocol Violation|5|||
44214305|NCT01811186|79012040|FG001|Overall Study|Protocol Violation|6|||
44214306|NCT01811186|79012039|FG000|Overall Study|Withdrawal by Subject|5|||
44214307|NCT01811186|79012040|FG001|Overall Study|Withdrawal by Subject|10|||
44214308|NCT01811186|79012039|FG000|Overall Study|Lack of Efficacy|3|||
44214309|NCT01811186|79012040|FG001|Overall Study|Lack of Efficacy|6|||
44214310|NCT01811186|79012039|FG000|Overall Study|Lost to Follow-up|4|||
44214311|NCT01811186|79012040|FG001|Overall Study|Lost to Follow-up|2|||
44214312|NCT01866098|79012053|FG000|Overall Study|Lost to Follow-up|11|||
44214313|NCT01866098|79012054|FG001|Overall Study|Lost to Follow-up|18|||
44214314|NCT01866098|79012055|FG002|Overall Study|Lost to Follow-up|13|||
44214315|NCT01866098|79012053|FG000|Overall Study|Physician Decision|0|||
44214316|NCT01866098|79012054|FG001|Overall Study|Physician Decision|1|||
44214317|NCT01866098|79012055|FG002|Overall Study|Physician Decision|2|||
44214318|NCT01866098|79012053|FG000|Overall Study|Adverse Event|1|||
44214319|NCT01866098|79012054|FG001|Overall Study|Adverse Event|5|||
44214320|NCT01866098|79012055|FG002|Overall Study|Adverse Event|4|||
44214321|NCT01866098|79012053|FG000|Overall Study|Protocol Violation|1|||
44214322|NCT01866098|79012054|FG001|Overall Study|Protocol Violation|0|||
44214323|NCT01866098|79012055|FG002|Overall Study|Protocol Violation|0|||
44214324|NCT01866098|79012053|FG000|Overall Study|Withdrawal by Subject|1|||
44214325|NCT01866098|79012054|FG001|Overall Study|Withdrawal by Subject|2|||
44214326|NCT01866098|79012055|FG002|Overall Study|Withdrawal by Subject|0|||
44214327|NCT01866098|79012053|FG000|Overall Study|Unrelated Hospitalization|2|||
44214328|NCT01866098|79012054|FG001|Overall Study|Unrelated Hospitalization|0|||
44214329|NCT01866098|79012055|FG002|Overall Study|Unrelated Hospitalization|1|||
44214330|NCT01866098|79012053|FG000|Overall Study|Non-compliance|1|||
44214331|NCT01866098|79012054|FG001|Overall Study|Non-compliance|0|||
44214332|NCT01866098|79012055|FG002|Overall Study|Non-compliance|1|||
44214333|NCT01866098|79012053|FG000|Overall Study|Pregnancy|2|||
44214334|NCT01866098|79012054|FG001|Overall Study|Pregnancy|0|||
44371249|NCT02915523|79376614|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
44371250|NCT02915523|79376615|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
44371251|NCT02915523|79376616|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
44371252|NCT02915523|79376617|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
44371253|NCT02915523|79376614|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
44371254|NCT02915523|79376615|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
44371255|NCT02915523|79376616|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
44371256|NCT02915523|79376617|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
44214335|NCT01866098|79012055|FG002|Overall Study|Pregnancy|0|||
44214336|NCT01866098|79012053|FG000|Overall Study|Death|0|||
44214337|NCT01866098|79012054|FG001|Overall Study|Death|1|||
44214338|NCT01866098|79012055|FG002|Overall Study|Death|0|||
44214339|NCT01865552|79012069|FG000|Period 1|Adverse Event|1|||
44214340|NCT01865552|79012070|FG001|Period 1|Adverse Event|0|||
44371257|NCT02915523|79376614|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
44371258|NCT02915523|79376615|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
44371259|NCT02915523|79376616|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
44214341|NCT01865552|79012071|FG002|Period 1|Adverse Event|0|||
44214342|NCT01865552|79012072|FG003|Period 1|Adverse Event|1|||
44214343|NCT01865552|79012073|FG004|Period 1|Adverse Event|1|||
44214344|NCT01865552|79012074|FG005|Period 1|Adverse Event|1|||
44214345|NCT01865552|79012069|FG000|Period 1|Pathological lab|0|||
44214346|NCT01865552|79012070|FG001|Period 1|Pathological lab|0|||
44214347|NCT01865552|79012071|FG002|Period 1|Pathological lab|0|||
44214348|NCT01865552|79012072|FG003|Period 1|Pathological lab|0|||
44214349|NCT01865552|79012073|FG004|Period 1|Pathological lab|1|||
44214350|NCT01865552|79012074|FG005|Period 1|Pathological lab|0|||
44214351|NCT01865552|79012069|FG000|Period 1|Other|0|||
44214352|NCT01865552|79012070|FG001|Period 1|Other|0|||
44214353|NCT01865552|79012071|FG002|Period 1|Other|0|||
44371260|NCT02915523|79376617|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
44453755|NCT00057811|79462403|FG001|Overall Study|Withdrawal by Subject|4|||
44453756|NCT00057811|79462402|FG000|Overall Study|Ineligible|4|||
44453757|NCT00057811|79462403|FG001|Overall Study|Ineligible|2|||
44453758|NCT00057811|79462402|FG000|Overall Study|Inevaluable|1|||
44453759|NCT00057811|79462403|FG001|Overall Study|Inevaluable|2|||
44453760|NCT02866682|79462416|FG000|Overall Study|Death|0|||
44453761|NCT02866682|79462417|FG001|Overall Study|Death|1|||
44453762|NCT02866682|79462416|FG000|Overall Study|Lost to Follow-up|0|||
44453763|NCT02866682|79462417|FG001|Overall Study|Lost to Follow-up|4|||
44453764|NCT02866682|79462416|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
44453765|NCT02866682|79462417|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
44453766|NCT02866682|79462416|FG000|Overall Study|Other|0|||
44453767|NCT02866682|79462417|FG001|Overall Study|Other|1|||
44453768|NCT00570713|79462434|FG000|Overall Study|Adverse Event|16|||
44453769|NCT00570713|79462435|FG001|Overall Study|Adverse Event|9|||
44453770|NCT00570713|79462434|FG000|Overall Study|Death|7|||
44453771|NCT00570713|79462435|FG001|Overall Study|Death|7|||
44453772|NCT00570713|79462434|FG000|Overall Study|Lack of Efficacy|40|||
44453773|NCT00570713|79462435|FG001|Overall Study|Lack of Efficacy|49|||
44453774|NCT00570713|79462434|FG000|Overall Study|Physician Decision|2|||
44453775|NCT00570713|79462435|FG001|Overall Study|Physician Decision|2|||
44453776|NCT00570713|79462434|FG000|Overall Study|Withdrawal by Subject|3|||
44453777|NCT00570713|79462435|FG001|Overall Study|Withdrawal by Subject|3|||
44453778|NCT00570713|79462434|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
44214354|NCT01865552|79012072|FG003|Period 1|Other|0|||
44214355|NCT01865552|79012073|FG004|Period 1|Other|1|||
44214356|NCT01865552|79012074|FG005|Period 1|Other|0|||
44214357|NCT01809314|79012088|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
44214358|NCT01809314|79012088|FG000|Overall Study|Adverse Event|6|||
44214359|NCT01809314|79012088|FG000|Overall Study|Insufficient Therapeutic Response|14|||
44214360|NCT01809314|79012088|FG000|Overall Study|Lost to Follow-up|724|||
44214361|NCT01803464|79012096|FG000|Overall Study|Incomplete data|0|||
44214362|NCT01803464|79012097|FG001|Overall Study|Incomplete data|0|||
44214363|NCT01803464|79012098|FG002|Overall Study|Incomplete data|4|||
44214364|NCT01803464|79012099|FG003|Overall Study|Incomplete data|0|||
44214365|NCT01803464|79012096|FG000|Overall Study|Withdrawal by Subject|1|||
44214366|NCT01803464|79012097|FG001|Overall Study|Withdrawal by Subject|0|||
44214367|NCT01803464|79012098|FG002|Overall Study|Withdrawal by Subject|0|||
44214368|NCT01803464|79012099|FG003|Overall Study|Withdrawal by Subject|0|||
44214369|NCT01808690|79012115|FG000|Overall Study|Withdrawal by Subject|1|||
44214370|NCT01808690|79012116|FG001|Overall Study|Withdrawal by Subject|2|||
44214371|NCT01363297|79012127|FG000|Overall Study|Other|0|||
44214372|NCT01363297|79012128|FG001|Overall Study|Other|0|||
44214373|NCT01363297|79012129|FG002|Overall Study|Other|0|||
44214374|NCT01363297|79012130|FG003|Overall Study|Other|0|||
44214375|NCT01363297|79012131|FG004|Overall Study|Other|1|||
44214376|NCT01363297|79012127|FG000|Overall Study|Death|3|||
44214377|NCT01363297|79012128|FG001|Overall Study|Death|6|||
44214378|NCT01363297|79012129|FG002|Overall Study|Death|6|||
44371261|NCT02915523|79376614|FG000|Expansion Phase (Phase 2)|Death|0|||
44371262|NCT02915523|79376615|FG001|Expansion Phase (Phase 2)|Death|0|||
44371263|NCT02915523|79376616|FG002|Expansion Phase (Phase 2)|Death|26|||
44371264|NCT02915523|79376617|FG003|Expansion Phase (Phase 2)|Death|53|||
44371265|NCT02915523|79376614|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
44371266|NCT02915523|79376615|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
44371267|NCT02915523|79376616|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
44371268|NCT02915523|79376617|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
44371269|NCT02915523|79376614|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
44371270|NCT02915523|79376615|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
44371271|NCT02915523|79376616|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
44453779|NCT00570713|79462435|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
44453780|NCT00669617|79462445|FG000|Period 1|Withdrawal by Subject|0|||
44453781|NCT00669617|79462446|FG001|Period 1|Withdrawal by Subject|0|||
44453782|NCT00669617|79462447|FG002|Period 1|Withdrawal by Subject|1|||
44214379|NCT01363297|79012130|FG003|Overall Study|Death|10|||
44214380|NCT01363297|79012131|FG004|Overall Study|Death|30|||
44214381|NCT01908907|79012150|FG000|Overall Study|Physician Decision|1|||
44214382|NCT01908907|79012151|FG001|Overall Study|Physician Decision|0|||
44214383|NCT01908907|79012150|FG000|Overall Study|Protocol Violation|1|||
44214384|NCT01908907|79012151|FG001|Overall Study|Protocol Violation|0|||
44214385|NCT01808612|79012164|FG000|Treatment Period|Adverse Event|8|||
44214386|NCT01808612|79012165|FG001|Treatment Period|Adverse Event|4|||
44371272|NCT02915523|79376617|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
44371273|NCT02915523|79376614|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
44371274|NCT02915523|79376615|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
44371275|NCT02915523|79376616|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
44453783|NCT00669617|79462448|FG003|Period 1|Withdrawal by Subject|0|||
44453784|NCT00669617|79462449|FG004|Period 1|Withdrawal by Subject|0|||
44453785|NCT00669617|79462445|FG000|Period 1|Protocol Deviation|0|||
44453786|NCT00669617|79462446|FG001|Period 1|Protocol Deviation|0|||
44453787|NCT00669617|79462447|FG002|Period 1|Protocol Deviation|0|||
44453788|NCT00669617|79462448|FG003|Period 1|Protocol Deviation|0|||
44453789|NCT00669617|79462449|FG004|Period 1|Protocol Deviation|1|||
44214387|NCT01808612|79012166|FG002|Treatment Period|Adverse Event|3|||
44214388|NCT01808612|79012164|FG000|Treatment Period|Lost to Follow-up|2|||
44214389|NCT01808612|79012165|FG001|Treatment Period|Lost to Follow-up|2|||
44214390|NCT01808612|79012166|FG002|Treatment Period|Lost to Follow-up|1|||
44214391|NCT01808612|79012164|FG000|Treatment Period|Protocol Violation|1|||
44214392|NCT01808612|79012165|FG001|Treatment Period|Protocol Violation|0|||
44214393|NCT01808612|79012166|FG002|Treatment Period|Protocol Violation|0|||
44214394|NCT01808612|79012164|FG000|Treatment Period|Withdrawal by Subject|1|||
44214395|NCT01808612|79012165|FG001|Treatment Period|Withdrawal by Subject|0|||
44214396|NCT01808612|79012166|FG002|Treatment Period|Withdrawal by Subject|4|||
44214397|NCT01808612|79012164|FG000|Treatment Period|Physician Decision|1|||
44214398|NCT01808612|79012165|FG001|Treatment Period|Physician Decision|0|||
44214399|NCT01808612|79012166|FG002|Treatment Period|Physician Decision|4|||
44214400|NCT01808612|79012164|FG000|Treatment Period|Sponsor Decision|1|||
44214401|NCT01808612|79012165|FG001|Treatment Period|Sponsor Decision|0|||
44214402|NCT01808612|79012166|FG002|Treatment Period|Sponsor Decision|0|||
44214403|NCT01808612|79012164|FG000|Treatment Period|Lack of Efficacy|1|||
44214404|NCT01808612|79012165|FG001|Treatment Period|Lack of Efficacy|1|||
44214405|NCT01808612|79012166|FG002|Treatment Period|Lack of Efficacy|2|||
44214406|NCT01808612|79012164|FG000|Discontinuation Period|Adverse Event|1|||
44214407|NCT01808612|79012165|FG001|Discontinuation Period|Adverse Event|0|||
44214408|NCT01808612|79012166|FG002|Discontinuation Period|Adverse Event|0|||
44214409|NCT01808612|79012164|FG000|Discontinuation Period|Physician Decision|1|||
44214410|NCT01808612|79012165|FG001|Discontinuation Period|Physician Decision|0|||
44214411|NCT01808612|79012166|FG002|Discontinuation Period|Physician Decision|0|||
44453790|NCT00669617|79462445|FG000|Period 3|Lost to Follow-up|1|||
44214412|NCT01808612|79012164|FG000|Discontinuation Period|Lost to Follow-up|0|||
44214413|NCT01808612|79012165|FG001|Discontinuation Period|Lost to Follow-up|1|||
44214414|NCT01808612|79012166|FG002|Discontinuation Period|Lost to Follow-up|0|||
44453791|NCT00669617|79462446|FG001|Period 3|Lost to Follow-up|0|||
44214415|NCT01908829|79012180|FG000|Overall Study|Adverse Event|13|||
44214416|NCT01908829|79012181|FG001|Overall Study|Adverse Event|11|||
44214417|NCT01908829|79012182|FG002|Overall Study|Adverse Event|13|||
44214418|NCT01908829|79012180|FG000|Overall Study|Lost to Follow-up|4|||
44214419|NCT01908829|79012181|FG001|Overall Study|Lost to Follow-up|2|||
44214420|NCT01908829|79012182|FG002|Overall Study|Lost to Follow-up|1|||
44214421|NCT01908829|79012180|FG000|Overall Study|Randomized no double-blind drug received|1|||
44214422|NCT01908829|79012181|FG001|Overall Study|Randomized no double-blind drug received|0|||
44214423|NCT01908829|79012182|FG002|Overall Study|Randomized no double-blind drug received|1|||
44214424|NCT01908829|79012180|FG000|Overall Study|Discontinued (no EoT page)|2|||
44214425|NCT01908829|79012181|FG001|Overall Study|Discontinued (no EoT page)|0|||
44214426|NCT01908829|79012182|FG002|Overall Study|Discontinued (no EoT page)|0|||
44214427|NCT01908829|79012180|FG000|Overall Study|Miscellaneous|0|||
44214428|NCT01908829|79012181|FG001|Overall Study|Miscellaneous|2|||
44214429|NCT01908829|79012182|FG002|Overall Study|Miscellaneous|0|||
44453792|NCT00669617|79462447|FG002|Period 3|Lost to Follow-up|0|||
44453793|NCT00669617|79462448|FG003|Period 3|Lost to Follow-up|0|||
44453794|NCT00669617|79462449|FG004|Period 3|Lost to Follow-up|0|||
44453795|NCT00535730|79462463|FG000|Overall Study|Adverse Event|1|||
44453796|NCT00535730|79462464|FG001|Overall Study|Adverse Event|1|||
44214430|NCT01908829|79012180|FG000|Overall Study|Protocol Violation|2|||
44214431|NCT01908829|79012181|FG001|Overall Study|Protocol Violation|2|||
44214432|NCT01908829|79012182|FG002|Overall Study|Protocol Violation|0|||
44214433|NCT01908829|79012180|FG000|Overall Study|Lack of Efficacy|1|||
44453797|NCT00535730|79462463|FG000|Overall Study|Lost to Follow-up|0|||
44453798|NCT00535730|79462464|FG001|Overall Study|Lost to Follow-up|1|||
44453799|NCT00535730|79462463|FG000|Overall Study|Physician Decision|0|||
44453800|NCT00535730|79462464|FG001|Overall Study|Physician Decision|1|||
44453801|NCT00535730|79462463|FG000|Overall Study|Protocol Violation|1|||
44453802|NCT00535730|79462464|FG001|Overall Study|Protocol Violation|0|||
44453803|NCT00535730|79462463|FG000|Overall Study|Withdrawal by Subject|0|||
44453804|NCT00535730|79462464|FG001|Overall Study|Withdrawal by Subject|4|||
44453805|NCT00666965|79462475|FG000|Overall Study|Adverse Event|0|||
44453806|NCT00666965|79462476|FG001|Overall Study|Adverse Event|2|||
44453807|NCT00666965|79462477|FG002|Overall Study|Adverse Event|1|||
44453808|NCT00666965|79462478|FG003|Overall Study|Adverse Event|9|||
44269898|NCT00552110|79195097|FG003|Overall Study|Use of Prohibited Medication|0|||
44269899|NCT00552110|79195098|FG004|Overall Study|Use of Prohibited Medication|0|||
44269900|NCT00552110|79195094|FG000|Overall Study|Delay of Study due to Relabeling|0|||
44269901|NCT00552110|79195095|FG001|Overall Study|Delay of Study due to Relabeling|0|||
44453809|NCT00666965|79462475|FG000|Overall Study|Lack of Efficacy|1|||
44453810|NCT00666965|79462476|FG001|Overall Study|Lack of Efficacy|1|||
44453811|NCT00666965|79462477|FG002|Overall Study|Lack of Efficacy|0|||
44453812|NCT00666965|79462478|FG003|Overall Study|Lack of Efficacy|0|||
44453813|NCT00666965|79462475|FG000|Overall Study|Protocol Violation|0|||
44453814|NCT00666965|79462476|FG001|Overall Study|Protocol Violation|0|||
44453815|NCT00666965|79462477|FG002|Overall Study|Protocol Violation|0|||
44453816|NCT00666965|79462478|FG003|Overall Study|Protocol Violation|2|||
44453817|NCT00666965|79462475|FG000|Overall Study|Discontinuation criteria|2|||
44453818|NCT00666965|79462476|FG001|Overall Study|Discontinuation criteria|1|||
44453819|NCT00666965|79462477|FG002|Overall Study|Discontinuation criteria|1|||
44453820|NCT00666965|79462478|FG003|Overall Study|Discontinuation criteria|2|||
44214434|NCT01908829|79012181|FG001|Overall Study|Lack of Efficacy|3|||
44214435|NCT01908829|79012182|FG002|Overall Study|Lack of Efficacy|2|||
44214436|NCT01908829|79012180|FG000|Overall Study|Withdrawal by Subject|26|||
44214437|NCT01908829|79012181|FG001|Overall Study|Withdrawal by Subject|29|||
44214438|NCT01908829|79012182|FG002|Overall Study|Withdrawal by Subject|22|||
44214439|NCT01773122|79012194|FG000|Overall Study|Due to amended age eligibility criteria|3|||
44214440|NCT01773122|79012195|FG001|Overall Study|Due to amended age eligibility criteria|1|||
44214441|NCT01773122|79012196|FG002|Overall Study|Due to amended age eligibility criteria|0|||
44214442|NCT01773122|79012197|FG003|Overall Study|Due to amended age eligibility criteria|1|||
44214443|NCT01808534|79012207|FG000|Overall Study|Disease progression|3|||
44214444|NCT01808534|79012207|FG000|Overall Study|Physician Decision|1|||
44214445|NCT01808222|79012211|FG000|Overall Study|mpMR scan was not performed|1|||
44269902|NCT00552110|79195096|FG002|Overall Study|Delay of Study due to Relabeling|0|||
44269903|NCT00552110|79195097|FG003|Overall Study|Delay of Study due to Relabeling|1|||
44269904|NCT00552110|79195098|FG004|Overall Study|Delay of Study due to Relabeling|0|||
44269905|NCT00552110|79195094|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
44269906|NCT00552110|79195095|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
44269907|NCT00552110|79195096|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
44269908|NCT00552110|79195097|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
44269909|NCT00552110|79195098|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
44453821|NCT00666965|79462475|FG000|Overall Study|Withdrawal by Subject|0|||
44453822|NCT00666965|79462476|FG001|Overall Study|Withdrawal by Subject|0|||
44453823|NCT00666965|79462477|FG002|Overall Study|Withdrawal by Subject|0|||
44453824|NCT00666965|79462478|FG003|Overall Study|Withdrawal by Subject|2|||
44453825|NCT03889886|79462492|FG000|Overall Study|Other|0|||
44453826|NCT03889886|79462493|FG001|Overall Study|Other|1|||
44453827|NCT03889886|79462494|FG002|Overall Study|Other|0|||
44453828|NCT03889886|79462495|FG003|Overall Study|Other|1|||
44214446|NCT01772576|79012215|FG000|Overall Study|Death|15|||
44214447|NCT01772576|79012215|FG000|Overall Study|Protocol Violation|1|||
44453829|NCT03889886|79462492|FG000|Overall Study|Withdrawal by Subject|0|||
44453830|NCT03889886|79462493|FG001|Overall Study|Withdrawal by Subject|0|||
44269910|NCT00552110|79195094|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
44269911|NCT00552110|79195095|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
44453831|NCT03889886|79462494|FG002|Overall Study|Withdrawal by Subject|1|||
44453832|NCT03889886|79462495|FG003|Overall Study|Withdrawal by Subject|0|||
44453833|NCT03889886|79462492|FG000|Overall Study|Adverse Event|0|||
44453834|NCT03889886|79462493|FG001|Overall Study|Adverse Event|0|||
44453835|NCT03889886|79462494|FG002|Overall Study|Adverse Event|0|||
44214448|NCT01772576|79012215|FG000|Overall Study|Lost to Follow-up|3|||
44214449|NCT01772576|79012215|FG000|Overall Study|Study device not used|3|||
44214450|NCT01772576|79012215|FG000|Overall Study|Adverse Event|6|||
44453836|NCT03889886|79462495|FG003|Overall Study|Adverse Event|6|||
44453837|NCT03888482|79462507|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
44453838|NCT03888482|79462508|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
44453839|NCT03888482|79462507|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
44453840|NCT03888482|79462508|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
44453841|NCT00667355|79462516|FG000|Overall Study|Adverse Event|5|||
44214451|NCT01772576|79012215|FG000|Overall Study|Withdrawal by Subject|6|||
44214452|NCT01802216|79012242|FG000|4 Month Visit|Participant did not show to visit|3|||
44453842|NCT00667355|79462516|FG000|Overall Study|Lost to Follow-up|1|||
44453843|NCT00667355|79462516|FG000|Overall Study|Other reason was not specified|5|||
44453844|NCT00532844|79462522|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
44453845|NCT00532844|79462523|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
44453846|NCT00532844|79462522|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
44453847|NCT00532844|79462523|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
44453848|NCT00532844|79462522|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
44453849|NCT00532844|79462523|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
44453850|NCT00532844|79462522|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
44453851|NCT00532844|79462523|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
44453852|NCT00532844|79462522|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
44214453|NCT01802216|79012243|FG001|4 Month Visit|Participant did not show to visit|4|||
44453853|NCT00532844|79462523|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
44453854|NCT00666263|79462551|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
44453855|NCT00666263|79462552|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
44453856|NCT00666263|79462551|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
44453857|NCT00666263|79462552|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
44453858|NCT00666263|79462551|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
44453859|NCT00666263|79462552|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
44453860|NCT00667277|79462597|FG000|Overall Study|Withdrawal by Subject|2|||
44453861|NCT00534638|79462603|FG000|Overall Study|Withdrawal by Subject|3|||
44453862|NCT00534638|79462604|FG001|Overall Study|Withdrawal by Subject|4|||
44453863|NCT00534638|79462603|FG000|Overall Study|Migrated/moved from study area|13|||
44453864|NCT00534638|79462604|FG001|Overall Study|Migrated/moved from study area|11|||
44214454|NCT01802216|79012242|FG000|8 Month Visit|Participant did not show to visit|3|||
44214455|NCT01802216|79012243|FG001|8 Month Visit|Participant did not show to visit|5|||
44214456|NCT01802216|79012242|FG000|12 Month Visit|Participant did not show to visit|3|||
44214457|NCT01802216|79012243|FG001|12 Month Visit|Participant did not show to visit|4|||
44214458|NCT01808144|79012251|FG000|Overall Study|Death|1|||
44214459|NCT01808144|79012252|FG001|Overall Study|Death|0|||
44214460|NCT01808144|79012251|FG000|Overall Study|Withdrawal by Subject|16|||
44214461|NCT01808144|79012252|FG001|Overall Study|Withdrawal by Subject|23|||
44214462|NCT01808144|79012251|FG000|Overall Study|Lost to Follow-up|6|||
44214463|NCT01808144|79012252|FG001|Overall Study|Lost to Follow-up|3|||
44214464|NCT01808144|79012251|FG000|Overall Study|Protocol Violation|6|||
44453865|NCT00534638|79462603|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
44214465|NCT01808144|79012252|FG001|Overall Study|Protocol Violation|6|||
44214466|NCT01808144|79012251|FG000|Overall Study|Gout flare|0|||
44214467|NCT01808144|79012252|FG001|Overall Study|Gout flare|1|||
44269912|NCT00552110|79195096|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
44371276|NCT02915523|79376617|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
44371277|NCT02890355|79376631|FG000|Overall Study|Adverse Event|5|||
44371278|NCT02890355|79376632|FG001|Overall Study|Adverse Event|5|||
44371279|NCT02890355|79376631|FG000|Overall Study|Refusal unrelated to adverse event|5|||
44371280|NCT02890355|79376632|FG001|Overall Study|Refusal unrelated to adverse event|10|||
44371281|NCT02890355|79376631|FG000|Overall Study|Progression/relapse|46|||
44371282|NCT02890355|79376632|FG001|Overall Study|Progression/relapse|39|||
44453866|NCT00534638|79462604|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
44214468|NCT01808144|79012251|FG000|Overall Study|Adverse Event|11|||
44214469|NCT01808144|79012252|FG001|Overall Study|Adverse Event|15|||
44214470|NCT01801982|79012258|FG000|Overall Study|Lost to Follow-up|1|||
44214471|NCT01808066|79012271|FG000|Overall Study|Withdrawal by Subject|15|||
44269913|NCT00552110|79195097|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
44371283|NCT02890355|79376631|FG000|Overall Study|Not protocol specified|3|||
44371284|NCT02890355|79376632|FG001|Overall Study|Not protocol specified|4|||
44453867|NCT00534638|79462603|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
44453868|NCT00534638|79462604|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
44453869|NCT00534638|79462603|FG000|Overall Study|Other|1685|||
44453870|NCT00534638|79462604|FG001|Overall Study|Other|902|||
44453871|NCT00662129|79462615|FG000|Overall Study|Protocol Violation|1|||
44453872|NCT00662129|79462615|FG000|Overall Study|Cancel prior to beginning treatment|1|||
44453873|NCT00662129|79462615|FG000|Overall Study|Ineligible|1|||
44453874|NCT00664859|79462622|FG000|Overall Study|Adverse Event|2|||
44453875|NCT00664859|79462623|FG001|Overall Study|Adverse Event|1|||
44453876|NCT00664859|79462624|FG002|Overall Study|Adverse Event|3|||
44453877|NCT00664859|79462622|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
44453878|NCT00664859|79462623|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
44453879|NCT00664859|79462624|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
44453880|NCT00664859|79462622|FG000|Overall Study|Noncompliance with protocol|1|||
44453881|NCT00664859|79462623|FG001|Overall Study|Noncompliance with protocol|0|||
44453882|NCT00664859|79462624|FG002|Overall Study|Noncompliance with protocol|4|||
44453883|NCT00664859|79462622|FG000|Overall Study|Laboratory abnormality|2|||
44453884|NCT00664859|79462623|FG001|Overall Study|Laboratory abnormality|1|||
44453885|NCT00664859|79462624|FG002|Overall Study|Laboratory abnormality|4|||
44453886|NCT00664859|79462622|FG000|Overall Study|Withdrawal by Subject|4|||
44453887|NCT00664859|79462623|FG001|Overall Study|Withdrawal by Subject|1|||
44453888|NCT00664859|79462624|FG002|Overall Study|Withdrawal by Subject|3|||
44453889|NCT00664859|79462622|FG000|Overall Study|Lost to Follow-up|2|||
44453890|NCT00664859|79462623|FG001|Overall Study|Lost to Follow-up|2|||
44453891|NCT00664859|79462624|FG002|Overall Study|Lost to Follow-up|1|||
44453892|NCT00664859|79462622|FG000|Overall Study|Other|0|||
44453893|NCT00664859|79462623|FG001|Overall Study|Other|1|||
44453894|NCT00664859|79462624|FG002|Overall Study|Other|2|||
44453895|NCT00570401|79462632|FG000|Overall Study|Adverse Event|2|||
44453896|NCT00532298|79462642|FG000|Overall Study|Adverse Event|1|||
44453897|NCT00532298|79462643|FG001|Overall Study|Adverse Event|0|||
44453898|NCT00532298|79462644|FG002|Overall Study|Adverse Event|0|||
44453899|NCT00532298|79462645|FG003|Overall Study|Adverse Event|0|||
44453900|NCT00532298|79462646|FG004|Overall Study|Adverse Event|1|||
44453901|NCT00532298|79462647|FG005|Overall Study|Adverse Event|1|||
44453902|NCT00532298|79462642|FG000|Overall Study|Lost to Follow-up|1|||
44453903|NCT00532298|79462643|FG001|Overall Study|Lost to Follow-up|1|||
44453904|NCT00532298|79462644|FG002|Overall Study|Lost to Follow-up|1|||
44453905|NCT00532298|79462645|FG003|Overall Study|Lost to Follow-up|0|||
44453906|NCT00532298|79462646|FG004|Overall Study|Lost to Follow-up|0|||
44453907|NCT00532298|79462647|FG005|Overall Study|Lost to Follow-up|1|||
44453908|NCT00410410|79462667|FG000|Induction Period (IP)|Death|1|||
44453909|NCT00410410|79462668|FG001|Induction Period (IP)|Death|0|||
44453910|NCT00410410|79462669|FG002|Induction Period (IP)|Death|0|||
44453911|NCT00410410|79462670|FG003|Induction Period (IP)|Death|0|||
44453912|NCT00410410|79462671|FG004|Induction Period (IP)|Death|0|||
44453913|NCT00410410|79462672|FG005|Induction Period (IP)|Death|0|||
44453914|NCT00410410|79462673|FG006|Induction Period (IP)|Death|0|||
44214472|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
44214473|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
44214474|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
44214475|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
44214476|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
44214477|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
44214478|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
44453915|NCT00410410|79462674|FG007|Induction Period (IP)|Death|0|||
44214479|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
44214480|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
44371285|NCT02844816|79376642|FG000|Overall Study|No protocol treatment received|5|||
44371286|NCT02844816|79376643|FG001|Overall Study|No protocol treatment received|1|||
44371287|NCT02844816|79376642|FG000|Overall Study|Ineligible|22|||
44371288|NCT02844816|79376643|FG001|Overall Study|Ineligible|15|||
44371289|NCT02844816|79376642|FG000|Overall Study|Participant refusal|5|||
44371290|NCT02844816|79376643|FG001|Overall Study|Participant refusal|5|||
44371291|NCT02844816|79376642|FG000|Overall Study|Adverse Event|5|||
44371292|NCT02844816|79376643|FG001|Overall Study|Adverse Event|4|||
44453916|NCT00410410|79462675|FG008|Induction Period (IP)|Death|0|||
44453917|NCT00410410|79462667|FG000|Induction Period (IP)|Adverse Event|3|||
44453918|NCT00410410|79462668|FG001|Induction Period (IP)|Adverse Event|4|||
44453919|NCT00410410|79462669|FG002|Induction Period (IP)|Adverse Event|2|||
44453920|NCT00410410|79462670|FG003|Induction Period (IP)|Adverse Event|4|||
44453921|NCT00410410|79462671|FG004|Induction Period (IP)|Adverse Event|1|||
44453922|NCT00410410|79462672|FG005|Induction Period (IP)|Adverse Event|0|||
44453923|NCT00410410|79462673|FG006|Induction Period (IP)|Adverse Event|0|||
44371293|NCT02844816|79376642|FG000|Overall Study|Death|0|||
44453924|NCT00410410|79462674|FG007|Induction Period (IP)|Adverse Event|0|||
44453925|NCT00410410|79462675|FG008|Induction Period (IP)|Adverse Event|0|||
44214481|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
44214482|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
44214483|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
44214484|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
44453926|NCT00410410|79462667|FG000|Induction Period (IP)|Lack of Efficacy|26|||
44214485|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
44214486|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
44214487|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Death|5|||
44214488|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Death|0|||
44214489|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Death|2|||
44269914|NCT00552110|79195098|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
44269915|NCT02301624|79195121|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
44269916|NCT02301624|79195122|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
44453927|NCT00410410|79462668|FG001|Induction Period (IP)|Lack of Efficacy|24|||
44453928|NCT00410410|79462669|FG002|Induction Period (IP)|Lack of Efficacy|8|||
44453929|NCT00410410|79462670|FG003|Induction Period (IP)|Lack of Efficacy|8|||
44453930|NCT00410410|79462671|FG004|Induction Period (IP)|Lack of Efficacy|7|||
44453931|NCT00410410|79462672|FG005|Induction Period (IP)|Lack of Efficacy|7|||
44269917|NCT02301624|79195121|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
44269918|NCT02301624|79195122|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
44269919|NCT02301624|79195121|FG000|Open-label Maintenance Phase|Adverse Event|2|||
44269920|NCT02301624|79195122|FG001|Open-label Maintenance Phase|Adverse Event|5|||
44269921|NCT02301624|79195121|FG000|Open-label Maintenance Phase|Physician Decision|3|||
44269922|NCT02301624|79195122|FG001|Open-label Maintenance Phase|Physician Decision|3|||
44269923|NCT02301624|79195121|FG000|Open-label Maintenance Phase|Death|2|||
44269924|NCT02301624|79195122|FG001|Open-label Maintenance Phase|Death|1|||
44269925|NCT02301624|79195121|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
44269926|NCT02301624|79195122|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
44269927|NCT02301546|79195163|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
44269928|NCT02301546|79195164|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
44269929|NCT02301546|79195163|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
44269930|NCT02301546|79195164|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
44269931|NCT02301546|79195163|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
44269932|NCT02301546|79195164|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
44371294|NCT02844816|79376643|FG001|Overall Study|Death|1|||
44371295|NCT02844816|79376642|FG000|Overall Study|Disease progression/recurrence|50|||
44371296|NCT02844816|79376643|FG001|Overall Study|Disease progression/recurrence|24|||
44371297|NCT02844816|79376642|FG000|Overall Study|Physician Decision|1|||
44371298|NCT02844816|79376643|FG001|Overall Study|Physician Decision|1|||
44269933|NCT02301546|79195163|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
44269934|NCT02301546|79195164|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
44269935|NCT02301546|79195163|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
44269936|NCT02301546|79195164|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
44269937|NCT02301546|79195163|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
44269938|NCT02301546|79195164|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
44269939|NCT02301546|79195163|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
44214490|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Death|0|||
44214491|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Death|4|||
44214492|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
44214493|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
44371299|NCT02581930|79376659|FG000|Overall Study|Withdrawal by Subject|1|||
44371300|NCT02581930|79376659|FG000|Overall Study|patient declined further treatment|1|||
44371301|NCT02513563|79376672|FG000|Overall Study|Death|4|||
44371302|NCT02513563|79376672|FG000|Overall Study|Withdrawal by Subject|4|||
44371303|NCT02513563|79376672|FG000|Overall Study|Physician Decision|1|||
44371304|NCT02466971|79376678|FG000|Overall Study|eligible and never treated|14|||
44371305|NCT02466971|79376679|FG001|Overall Study|eligible and never treated|20|||
44371306|NCT02466971|79376678|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
44371307|NCT02466971|79376679|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
44371308|NCT02466971|79376678|FG000|Overall Study|ineligible and treated|1|||
44371309|NCT02466971|79376679|FG001|Overall Study|ineligible and treated|0|||
44371310|NCT02466971|79376678|FG000|Overall Study|ineligible and never treated|0|||
44371311|NCT02466971|79376679|FG001|Overall Study|ineligible and never treated|1|||
44371312|NCT02443545|79376685|FG000|Overall Study|Adverse Event|1|||
44269940|NCT02301546|79195164|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
44371313|NCT02443545|79376686|FG001|Overall Study|Adverse Event|1|||
44371314|NCT02443545|79376685|FG000|Overall Study|Lost to Follow-up|0|||
44371315|NCT02443545|79376686|FG001|Overall Study|Lost to Follow-up|2|||
44453932|NCT00410410|79462673|FG006|Induction Period (IP)|Lack of Efficacy|0|||
44371316|NCT02443545|79376685|FG000|Overall Study|Physician Decision|3|||
44453933|NCT00410410|79462674|FG007|Induction Period (IP)|Lack of Efficacy|0|||
44453934|NCT00410410|79462675|FG008|Induction Period (IP)|Lack of Efficacy|0|||
44453935|NCT00410410|79462667|FG000|Induction Period (IP)|Lost to Follow-up|2|||
44453936|NCT00410410|79462668|FG001|Induction Period (IP)|Lost to Follow-up|2|||
44453937|NCT00410410|79462669|FG002|Induction Period (IP)|Lost to Follow-up|2|||
44453938|NCT00410410|79462670|FG003|Induction Period (IP)|Lost to Follow-up|3|||
44453939|NCT00410410|79462671|FG004|Induction Period (IP)|Lost to Follow-up|0|||
44453940|NCT00410410|79462672|FG005|Induction Period (IP)|Lost to Follow-up|1|||
44453941|NCT00410410|79462673|FG006|Induction Period (IP)|Lost to Follow-up|0|||
44453942|NCT00410410|79462674|FG007|Induction Period (IP)|Lost to Follow-up|0|||
44453943|NCT00410410|79462675|FG008|Induction Period (IP)|Lost to Follow-up|0|||
44453944|NCT00410410|79462667|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
44453945|NCT00410410|79462668|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
44453946|NCT00410410|79462669|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
44453947|NCT00410410|79462670|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
44453948|NCT00410410|79462671|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
44453949|NCT00410410|79462672|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
44453950|NCT00410410|79462673|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
44453951|NCT00410410|79462674|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
44453952|NCT00410410|79462675|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
44214494|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
44214495|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
44214496|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
44214497|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
44214498|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
44214499|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
44214500|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
44214501|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
44214502|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
44214503|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
44269941|NCT02351934|79195188|FG000|Allocation|POD weight<pre-op weight|3|||
44269942|NCT02351934|79195189|FG001|Allocation|POD weight<pre-op weight|0|||
44269943|NCT02351934|79195188|FG000|Allocation|Hypotension preventing administration|2|||
44269944|NCT02351934|79195189|FG001|Allocation|Hypotension preventing administration|0|||
44269945|NCT02351934|79195188|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
44269946|NCT02351934|79195189|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
44269947|NCT02351934|79195188|FG000|Follow-Up|POD weight<pre-op weight|3|||
44269948|NCT02351934|79195189|FG001|Follow-Up|POD weight<pre-op weight|0|||
44269949|NCT02351934|79195188|FG000|Follow-Up|Acute Kidney Injury|1|||
44269950|NCT02351934|79195189|FG001|Follow-Up|Acute Kidney Injury|0|||
44269951|NCT02351934|79195188|FG000|Follow-Up|Early dismissal|3|||
44269952|NCT02351934|79195189|FG001|Follow-Up|Early dismissal|0|||
44269953|NCT02351934|79195188|FG000|Follow-Up|Hypotension|3|||
44269954|NCT02351934|79195189|FG001|Follow-Up|Hypotension|0|||
44269955|NCT02351934|79195188|FG000|Follow-Up|No documentation|2|||
44269956|NCT02351934|79195189|FG001|Follow-Up|No documentation|0|||
44269957|NCT02351934|79195188|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
44371317|NCT02443545|79376686|FG001|Overall Study|Physician Decision|0|||
44371318|NCT02443545|79376685|FG000|Overall Study|Protocol Violation|8|||
44371319|NCT02443545|79376686|FG001|Overall Study|Protocol Violation|1|||
44371320|NCT02443545|79376685|FG000|Overall Study|Pregnancy|1|||
44371321|NCT02443545|79376686|FG001|Overall Study|Pregnancy|1|||
44371322|NCT02443545|79376685|FG000|Overall Study|Withdrawal by Subject|6|||
44371323|NCT02443545|79376686|FG001|Overall Study|Withdrawal by Subject|3|||
44371324|NCT02443545|79376685|FG000|Overall Study|Termination of study|20|||
44371325|NCT02443545|79376686|FG001|Overall Study|Termination of study|11|||
44371326|NCT02388906|79376709|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
44371327|NCT02388906|79376710|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
44371328|NCT02388906|79376709|FG000|Treatment Period|Disease progression|121|||
44371329|NCT02388906|79376710|FG001|Treatment Period|Disease progression|101|||
44371330|NCT02388906|79376709|FG000|Treatment Period|Study drug toxicity|41|||
44371331|NCT02388906|79376710|FG001|Treatment Period|Study drug toxicity|208|||
44371332|NCT02388906|79376709|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
44371333|NCT02388906|79376710|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
44371334|NCT02388906|79376709|FG000|Treatment Period|Participant request to stop treatment|5|||
44371335|NCT02388906|79376710|FG001|Treatment Period|Participant request to stop treatment|9|||
44371336|NCT02388906|79376709|FG000|Treatment Period|Participant withdrew consent|2|||
44453953|NCT00410410|79462667|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44371337|NCT02388906|79376710|FG001|Treatment Period|Participant withdrew consent|3|||
44371338|NCT02388906|79376709|FG000|Treatment Period|Poor/non-compliance|0|||
44371339|NCT02388906|79376710|FG001|Treatment Period|Poor/non-compliance|1|||
44453954|NCT00410410|79462668|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453955|NCT00410410|79462669|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
44453956|NCT00410410|79462670|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453957|NCT00410410|79462671|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453958|NCT00410410|79462672|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453959|NCT00410410|79462673|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453960|NCT00410410|79462674|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453961|NCT00410410|79462675|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
44453962|NCT00410410|79462667|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453963|NCT00410410|79462668|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453964|NCT00410410|79462669|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453965|NCT00410410|79462670|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453966|NCT00410410|79462671|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
44453967|NCT00410410|79462672|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
44453968|NCT00410410|79462673|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453969|NCT00410410|79462674|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453970|NCT00410410|79462675|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
44453971|NCT00410410|79462667|FG000|Induction Period (IP)|Other|0|||
44543713|NCT03847896|79556855|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
44214504|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
44214505|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
44214506|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
44214507|NCT01604343|79012279|FG000|Prior to W52 Administration(Through W52)|Other|15|||
44214508|NCT01604343|79012280|FG001|Prior to W52 Administration(Through W52)|Other|0|||
44214509|NCT01604343|79012281|FG002|Prior to W52 Administration(Through W52)|Other|10|||
44214510|NCT01604343|79012282|FG003|Prior to W52 Administration(Through W52)|Other|0|||
44214511|NCT01604343|79012283|FG004|Prior to W52 Administration(Through W52)|Other|6|||
44214512|NCT01604343|79012279|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
44214513|NCT01604343|79012280|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
44214514|NCT01604343|79012281|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
44214515|NCT01604343|79012282|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
44214516|NCT01604343|79012283|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
44214517|NCT01604343|79012279|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
44214518|NCT01604343|79012280|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
44214519|NCT01604343|79012281|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
44214520|NCT01604343|79012282|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
44214521|NCT01604343|79012283|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
44214522|NCT01604343|79012279|FG000|Week 52 to Week 104|Adverse Event|0|||
44269958|NCT02351934|79195189|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
44269959|NCT02351934|79195188|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
44269960|NCT02351934|79195189|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
44214523|NCT01604343|79012280|FG001|Week 52 to Week 104|Adverse Event|12|||
44214524|NCT01604343|79012281|FG002|Week 52 to Week 104|Adverse Event|26|||
44214525|NCT01604343|79012282|FG003|Week 52 to Week 104|Adverse Event|21|||
44214526|NCT01604343|79012283|FG004|Week 52 to Week 104|Adverse Event|27|||
44214527|NCT01604343|79012279|FG000|Week 52 to Week 104|Death|0|||
44371340|NCT02388906|79376709|FG000|Treatment Period|Participant no longer meets study criteria|0|||
44371341|NCT02388906|79376710|FG001|Treatment Period|Participant no longer meets study criteria|1|||
44371342|NCT02388906|79376709|FG000|Treatment Period|Other reasons|3|||
44371343|NCT02388906|79376710|FG001|Treatment Period|Other reasons|3|||
44371344|NCT02375555|79376716|FG000|Induction Period|Adverse Event|7|||
44371345|NCT02375555|79376716|FG000|Induction Period|Withdrawal by Subject|2|||
44371346|NCT02375555|79376716|FG000|Induction Period|Other|1|||
44371347|NCT02375555|79376716|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
44371348|NCT02375555|79376716|FG000|Maintenance Period|Adverse Event|2|||
44371349|NCT02375555|79376716|FG000|Maintenance Period|Withdrawal by Subject|4|||
44371350|NCT02375555|79376716|FG000|Maintenance Period|Death|1|||
44371351|NCT02375555|79376716|FG000|Maintenance Period|Disease Progression|5|||
44371352|NCT02375555|79376716|FG000|Maintenance Period|Patient Non-compliance|1|||
44371353|NCT02375555|79376716|FG000|Maintenance Period|Still on maintenance|16|||
44214528|NCT01604343|79012280|FG001|Week 52 to Week 104|Death|4|||
44214529|NCT01604343|79012281|FG002|Week 52 to Week 104|Death|2|||
44269961|NCT02351856|79195229|FG000|Overall Study|Adverse Event|2|||
44269962|NCT02351856|79195229|FG000|Overall Study|Physician Decision|5|||
44371354|NCT02306161|79376733|FG000|Overall Study|Death|1|||
44371355|NCT02306161|79376734|FG001|Overall Study|Death|3|||
44371356|NCT02306161|79376733|FG000|Overall Study|Lack of Efficacy|20|||
44371357|NCT02306161|79376734|FG001|Overall Study|Lack of Efficacy|43|||
44453972|NCT00410410|79462668|FG001|Induction Period (IP)|Other|0|||
44543714|NCT03847896|79556851|FG000|Overall Study|Withdrawal by Subject|2|||
44371358|NCT02306161|79376733|FG000|Overall Study|Physician Decision|30|||
44214530|NCT01604343|79012282|FG003|Week 52 to Week 104|Death|5|||
44453973|NCT00410410|79462669|FG002|Induction Period (IP)|Other|1|||
44453974|NCT00410410|79462670|FG003|Induction Period (IP)|Other|0|||
44453975|NCT00410410|79462671|FG004|Induction Period (IP)|Other|0|||
44453976|NCT00410410|79462672|FG005|Induction Period (IP)|Other|0|||
44453977|NCT00410410|79462673|FG006|Induction Period (IP)|Other|0|||
44453978|NCT00410410|79462674|FG007|Induction Period (IP)|Other|0|||
44453979|NCT00410410|79462675|FG008|Induction Period (IP)|Other|0|||
44453980|NCT00410410|79462667|FG000|Maintenance Period (MP)|Death|0|||
44453981|NCT00410410|79462668|FG001|Maintenance Period (MP)|Death|0|||
44453982|NCT00410410|79462669|FG002|Maintenance Period (MP)|Death|0|||
44453983|NCT00410410|79462670|FG003|Maintenance Period (MP)|Death|0|||
44453984|NCT00410410|79462671|FG004|Maintenance Period (MP)|Death|0|||
44453985|NCT00410410|79462672|FG005|Maintenance Period (MP)|Death|0|||
44453986|NCT00410410|79462673|FG006|Maintenance Period (MP)|Death|1|||
44453987|NCT00410410|79462674|FG007|Maintenance Period (MP)|Death|0|||
44453988|NCT00410410|79462675|FG008|Maintenance Period (MP)|Death|0|||
44453989|NCT00410410|79462667|FG000|Maintenance Period (MP)|Adverse Event|0|||
44453990|NCT00410410|79462668|FG001|Maintenance Period (MP)|Adverse Event|0|||
44543715|NCT03847896|79556852|FG001|Overall Study|Withdrawal by Subject|10|||
44543716|NCT03847896|79556853|FG002|Overall Study|Withdrawal by Subject|5|||
44214531|NCT01604343|79012283|FG004|Week 52 to Week 104|Death|0|||
44214532|NCT01604343|79012279|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
44214533|NCT01604343|79012280|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
44214534|NCT01604343|79012281|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
44214535|NCT01604343|79012282|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
44214536|NCT01604343|79012283|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
44214537|NCT01604343|79012279|FG000|Week 52 to Week 104|Physician Decision|0|||
44214538|NCT01604343|79012280|FG001|Week 52 to Week 104|Physician Decision|1|||
44214539|NCT01604343|79012281|FG002|Week 52 to Week 104|Physician Decision|0|||
44214540|NCT01604343|79012282|FG003|Week 52 to Week 104|Physician Decision|0|||
44214541|NCT01604343|79012283|FG004|Week 52 to Week 104|Physician Decision|2|||
44214542|NCT01604343|79012279|FG000|Week 52 to Week 104|Pregnancy|0|||
44269963|NCT02351856|79195229|FG000|Overall Study|Study terminated by sponsor|1|||
44269964|NCT02349360|79195269|FG000|Overall Study|Withdrawal by Subject|0|||
44269965|NCT02349360|79195270|FG001|Overall Study|Withdrawal by Subject|1|||
44269966|NCT00551642|79195295|FG000|Treatment Period|Protocol Deviation|6|||
44269967|NCT00551642|79195296|FG001|Treatment Period|Protocol Deviation|11|||
44269968|NCT00551642|79195295|FG000|Treatment Period|Delivery device failure|1|||
44269969|NCT00551642|79195296|FG001|Treatment Period|Delivery device failure|3|||
44269970|NCT00551642|79195295|FG000|Treatment Period|Physician Decision|0|||
44269971|NCT00551642|79195296|FG001|Treatment Period|Physician Decision|1|||
44269972|NCT00551642|79195295|FG000|Treatment Period|Death|33|||
44269973|NCT00551642|79195296|FG001|Treatment Period|Death|31|||
44269974|NCT00551642|79195295|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
44269975|NCT00551642|79195296|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
44269976|NCT00551642|79195295|FG000|Treatment Period|Adverse Event|15|||
44269977|NCT00551642|79195296|FG001|Treatment Period|Adverse Event|12|||
44269978|NCT00551642|79195295|FG000|Treatment Period|Withdrawal by Subject|2|||
44269979|NCT00551642|79195296|FG001|Treatment Period|Withdrawal by Subject|1|||
44269980|NCT00550550|79195381|FG000|Overall Study|Adverse Event|13|||
44269981|NCT00550550|79195382|FG001|Overall Study|Adverse Event|5|||
44214543|NCT01604343|79012280|FG001|Week 52 to Week 104|Pregnancy|0|||
44269982|NCT00550550|79195381|FG000|Overall Study|Treatment Failure|0|||
44269983|NCT00550550|79195382|FG001|Overall Study|Treatment Failure|1|||
44269984|NCT00550550|79195381|FG000|Overall Study|Lost to Follow-up|4|||
44269985|NCT00550550|79195382|FG001|Overall Study|Lost to Follow-up|0|||
44269986|NCT00550550|79195381|FG000|Overall Study|Withdrawal by Subject|10|||
44269987|NCT00550550|79195382|FG001|Overall Study|Withdrawal by Subject|8|||
44269988|NCT00550550|79195381|FG000|Overall Study|Protocol Violation|5|||
44371359|NCT02306161|79376734|FG001|Overall Study|Physician Decision|18|||
44371360|NCT02306161|79376733|FG000|Overall Study|Withdrawal by Subject|4|||
44371361|NCT02306161|79376734|FG001|Overall Study|Withdrawal by Subject|0|||
44371362|NCT02306161|79376733|FG000|Overall Study|Ineligible|9|||
44371363|NCT02306161|79376734|FG001|Overall Study|Ineligible|5|||
44371364|NCT02152982|79376749|FG000|Overall Study|Ineligible|4|||
44371365|NCT02152982|79376750|FG001|Overall Study|Ineligible|4|||
44371366|NCT02152982|79376749|FG000|Overall Study|Did not start treatment|12|||
44371367|NCT02152982|79376750|FG001|Overall Study|Did not start treatment|6|||
44371368|NCT01928394|79376842|FG000|Treatment Period|Disease progression|17|||
44371369|NCT01928394|79376843|FG001|Treatment Period|Disease progression|2|||
44371370|NCT01928394|79376844|FG002|Treatment Period|Disease progression|12|||
44371371|NCT01928394|79376845|FG003|Treatment Period|Disease progression|48|||
44371372|NCT01928394|79376846|FG004|Treatment Period|Disease progression|3|||
44453991|NCT00410410|79462669|FG002|Maintenance Period (MP)|Adverse Event|0|||
44453992|NCT00410410|79462670|FG003|Maintenance Period (MP)|Adverse Event|0|||
44214544|NCT01604343|79012281|FG002|Week 52 to Week 104|Pregnancy|1|||
44269989|NCT00550550|79195382|FG001|Overall Study|Protocol Violation|14|||
44453993|NCT00410410|79462671|FG004|Maintenance Period (MP)|Adverse Event|0|||
44453994|NCT00410410|79462672|FG005|Maintenance Period (MP)|Adverse Event|0|||
44453995|NCT00410410|79462673|FG006|Maintenance Period (MP)|Adverse Event|1|||
44453996|NCT00410410|79462674|FG007|Maintenance Period (MP)|Adverse Event|3|||
44453997|NCT00410410|79462675|FG008|Maintenance Period (MP)|Adverse Event|0|||
44269990|NCT00550550|79195381|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
44269991|NCT00550550|79195382|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
44269992|NCT00550550|79195381|FG000|Overall Study|Randomized But Not Treated|1|||
44269993|NCT00550550|79195382|FG001|Overall Study|Randomized But Not Treated|0|||
44269994|NCT02301156|79195433|FG000|Overall Study|Adverse Event|13|||
44269995|NCT02301156|79195434|FG001|Overall Study|Adverse Event|14|||
44269996|NCT02301156|79195433|FG000|Overall Study|Death|1|||
44269997|NCT02301156|79195434|FG001|Overall Study|Death|5|||
44269998|NCT02301156|79195433|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
44269999|NCT02301156|79195434|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
44270000|NCT02301156|79195433|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
44270001|NCT02301156|79195434|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
44270002|NCT02301156|79195433|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
44270003|NCT02301156|79195434|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
44270004|NCT02301156|79195433|FG000|Overall Study|Reason not Specified|6|||
44270005|NCT02301156|79195434|FG001|Overall Study|Reason not Specified|3|||
44371373|NCT01928394|79376847|FG005|Treatment Period|Disease progression|25|||
44371374|NCT01928394|79376848|FG006|Treatment Period|Disease progression|38|||
44371375|NCT01928394|79376849|FG007|Treatment Period|Disease progression|16|||
44214545|NCT01604343|79012282|FG003|Week 52 to Week 104|Pregnancy|2|||
44214546|NCT01604343|79012283|FG004|Week 52 to Week 104|Pregnancy|1|||
44214547|NCT01604343|79012279|FG000|Week 52 to Week 104|Other|0|||
44214548|NCT01604343|79012280|FG001|Week 52 to Week 104|Other|11|||
44214549|NCT01604343|79012281|FG002|Week 52 to Week 104|Other|11|||
44214550|NCT01604343|79012282|FG003|Week 52 to Week 104|Other|6|||
44214551|NCT01604343|79012283|FG004|Week 52 to Week 104|Other|3|||
44214552|NCT01604343|79012279|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
44214553|NCT01604343|79012280|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
44214554|NCT01604343|79012281|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
44214555|NCT01604343|79012282|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
44214556|NCT01604343|79012283|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
44214557|NCT01604343|79012279|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
44214558|NCT01604343|79012280|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
44214559|NCT01604343|79012281|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
44214560|NCT01604343|79012282|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
44214561|NCT01604343|79012283|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
44214562|NCT01604343|79012279|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
44214563|NCT01604343|79012280|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
44214564|NCT01604343|79012281|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
44214565|NCT01604343|79012282|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
44214566|NCT01604343|79012283|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
44214567|NCT01801436|79012293|FG000|Overall Study|Withdrawal by Subject|3|||
44214568|NCT01801436|79012293|FG000|Overall Study|Adverse Event|2|||
44371376|NCT01928394|79376850|FG008|Treatment Period|Disease progression|3|||
44453998|NCT00410410|79462667|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
44453999|NCT00410410|79462668|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
44454000|NCT00410410|79462669|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
44454001|NCT00410410|79462670|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
44454002|NCT00410410|79462671|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
44454003|NCT00410410|79462672|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
44454004|NCT00410410|79462673|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
44454005|NCT00410410|79462674|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
44454006|NCT00410410|79462675|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
44454007|NCT00410410|79462667|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
44454008|NCT00410410|79462668|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
44454009|NCT00410410|79462669|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
44454010|NCT00410410|79462670|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
44454011|NCT00410410|79462671|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
44214569|NCT01801436|79012293|FG000|Overall Study|Progressive disease|4|||
44214570|NCT01771250|79012297|FG000|Period 1|Met exclusion criteria|1|||
44214571|NCT01771250|79012298|FG001|Period 1|Met exclusion criteria|0|||
44371377|NCT01928394|79376851|FG009|Treatment Period|Disease progression|11|||
44371378|NCT01928394|79376852|FG010|Treatment Period|Disease progression|22|||
44371379|NCT01928394|79376853|FG011|Treatment Period|Disease progression|73|||
44371380|NCT01928394|79376854|FG012|Treatment Period|Disease progression|38|||
44371381|NCT01928394|79376855|FG013|Treatment Period|Disease progression|118|||
44371382|NCT01928394|79376856|FG014|Treatment Period|Disease progression|59|||
44371383|NCT01928394|79376857|FG015|Treatment Period|Disease progression|1|||
44454012|NCT00410410|79462672|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
44454013|NCT00410410|79462673|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
44454014|NCT00410410|79462674|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
44454015|NCT00410410|79462675|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
44454016|NCT00410410|79462667|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454017|NCT00410410|79462668|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454018|NCT00410410|79462669|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454019|NCT00410410|79462670|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454020|NCT00410410|79462671|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454021|NCT00410410|79462672|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454022|NCT00410410|79462673|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
44454023|NCT00410410|79462674|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
44454024|NCT00410410|79462675|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
44454025|NCT00410410|79462667|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454026|NCT00410410|79462668|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454027|NCT00410410|79462669|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454028|NCT00410410|79462670|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454029|NCT00410410|79462671|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454030|NCT00410410|79462672|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454031|NCT00410410|79462673|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
44454032|NCT00410410|79462674|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
44454033|NCT00410410|79462675|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
44454034|NCT00410410|79462667|FG000|Open-Label Period (OL)|Death|0|||
44454035|NCT00410410|79462668|FG001|Open-Label Period (OL)|Death|0|||
44454036|NCT00410410|79462669|FG002|Open-Label Period (OL)|Death|0|||
44454037|NCT00410410|79462670|FG003|Open-Label Period (OL)|Death|0|||
44454038|NCT00410410|79462671|FG004|Open-Label Period (OL)|Death|0|||
44454039|NCT00410410|79462672|FG005|Open-Label Period (OL)|Death|0|||
44454040|NCT00410410|79462673|FG006|Open-Label Period (OL)|Death|0|||
44214572|NCT01770860|79012304|FG000|Overall Study|Withdrawal by Subject|4|||
44214573|NCT01770860|79012304|FG000|Overall Study|Lost to Follow-up|1|||
44214574|NCT01770860|79012304|FG000|Overall Study|Administrative decision made by the PI|1|||
44214575|NCT01603875|79012315|FG000|Overall Study|Preexisting rabies antibody|3|||
44214576|NCT01603875|79012316|FG001|Overall Study|Preexisting rabies antibody|4|||
44214577|NCT01603875|79012317|FG002|Overall Study|Preexisting rabies antibody|3|||
44214578|NCT01603875|79012315|FG000|Overall Study|Lost to Follow-up|4|||
44214579|NCT01603875|79012316|FG001|Overall Study|Lost to Follow-up|3|||
44214580|NCT01603875|79012317|FG002|Overall Study|Lost to Follow-up|6|||
44454041|NCT00410410|79462674|FG007|Open-Label Period (OL)|Death|0|||
44454042|NCT00410410|79462675|FG008|Open-Label Period (OL)|Death|1|||
44454043|NCT00410410|79462667|FG000|Open-Label Period (OL)|Adverse Event|0|||
44454044|NCT00410410|79462668|FG001|Open-Label Period (OL)|Adverse Event|0|||
44454045|NCT00410410|79462669|FG002|Open-Label Period (OL)|Adverse Event|0|||
44454046|NCT00410410|79462670|FG003|Open-Label Period (OL)|Adverse Event|0|||
44454047|NCT00410410|79462671|FG004|Open-Label Period (OL)|Adverse Event|0|||
44454048|NCT00410410|79462672|FG005|Open-Label Period (OL)|Adverse Event|0|||
44454049|NCT00410410|79462673|FG006|Open-Label Period (OL)|Adverse Event|0|||
44454050|NCT00410410|79462674|FG007|Open-Label Period (OL)|Adverse Event|0|||
44454051|NCT00410410|79462675|FG008|Open-Label Period (OL)|Adverse Event|10|||
44454052|NCT00410410|79462667|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
44454053|NCT00410410|79462668|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
44454054|NCT00410410|79462669|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
44454055|NCT00410410|79462670|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
44454056|NCT00410410|79462671|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
44543717|NCT03847896|79556854|FG003|Overall Study|Withdrawal by Subject|9|||
44543718|NCT03847896|79556855|FG004|Overall Study|Withdrawal by Subject|8|||
44214581|NCT01603875|79012315|FG000|Overall Study|Protocol Violation|0|||
44270006|NCT02301390|79195515|FG000|Overall Study|Withdrawal by Subject|3|||
44270007|NCT02301390|79195516|FG001|Overall Study|Withdrawal by Subject|5|||
44270008|NCT02301390|79195515|FG000|Overall Study|Protocol Violation|1|||
44270009|NCT02301390|79195516|FG001|Overall Study|Protocol Violation|0|||
44270010|NCT02301390|79195515|FG000|Overall Study|Physician Decision|1|||
44270011|NCT02301390|79195516|FG001|Overall Study|Physician Decision|0|||
44270012|NCT02301390|79195515|FG000|Overall Study|Lost to Follow-up|0|||
44270013|NCT02301390|79195516|FG001|Overall Study|Lost to Follow-up|1|||
44270014|NCT02301390|79195515|FG000|Overall Study|Death|2|||
44214582|NCT01603875|79012316|FG001|Overall Study|Protocol Violation|1|||
44214583|NCT01603875|79012317|FG002|Overall Study|Protocol Violation|0|||
44270015|NCT02301390|79195516|FG001|Overall Study|Death|2|||
44270016|NCT02301390|79195515|FG000|Overall Study|Procedure not completed|0|||
44270017|NCT02301390|79195516|FG001|Overall Study|Procedure not completed|4|||
44270018|NCT02301390|79195515|FG000|Overall Study|Missed multiple visits|1|||
44454057|NCT00410410|79462672|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
44454058|NCT00410410|79462673|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
44454059|NCT00410410|79462674|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
44270019|NCT02301390|79195516|FG001|Overall Study|Missed multiple visits|1|||
44270020|NCT02301390|79195515|FG000|Overall Study|study terminated|2|||
44454060|NCT00410410|79462675|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
44454061|NCT00410410|79462667|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
44454062|NCT00410410|79462668|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
44454063|NCT00410410|79462669|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
44454064|NCT00410410|79462670|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
44454065|NCT00410410|79462671|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
44454066|NCT00410410|79462672|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
44454067|NCT00410410|79462673|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
44454068|NCT00410410|79462674|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
44454069|NCT00410410|79462675|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
44454070|NCT00410410|79462667|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454071|NCT00410410|79462668|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454072|NCT00410410|79462669|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454073|NCT00410410|79462670|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454074|NCT00410410|79462671|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454075|NCT00410410|79462672|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454076|NCT00410410|79462673|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454077|NCT00410410|79462674|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
44454078|NCT00410410|79462675|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
44454079|NCT00410410|79462667|FG000|Open-Label Period (OL)|Pregnancy|0|||
44454080|NCT00410410|79462668|FG001|Open-Label Period (OL)|Pregnancy|0|||
44454081|NCT00410410|79462669|FG002|Open-Label Period (OL)|Pregnancy|0|||
44454082|NCT00410410|79462670|FG003|Open-Label Period (OL)|Pregnancy|0|||
44214584|NCT01770392|79012325|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
44214585|NCT01603641|79012335|FG000|Overall Study|Did not Receive Treatment|3|||
44214586|NCT01603641|79012335|FG000|Overall Study|Adverse Event|1|||
44214587|NCT01603641|79012335|FG000|Overall Study|Lack of Efficacy|1|||
44214588|NCT01603641|79012335|FG000|Overall Study|Lost to Follow-up|6|||
44214589|NCT01603641|79012335|FG000|Overall Study|Personal Reasons|18|||
44214590|NCT01603641|79012335|FG000|Overall Study|Other Miscellaneous Reasons|6|||
44214591|NCT01556763|79012342|FG000|Overall Study|Withdrawal by Subject|0|||
44214592|NCT01556763|79012343|FG001|Overall Study|Withdrawal by Subject|1|||
44214593|NCT01556763|79012344|FG002|Overall Study|Withdrawal by Subject|0|||
44214594|NCT01576575|79012354|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
44214595|NCT01576575|79012354|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
44214596|NCT01576575|79012354|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
44214597|NCT01555983|79012364|FG000|Overall Study|Withdrawal by Subject|1|||
44214598|NCT01555983|79012365|FG001|Overall Study|Withdrawal by Subject|0|||
44454083|NCT00410410|79462671|FG004|Open-Label Period (OL)|Pregnancy|0|||
44454084|NCT00410410|79462672|FG005|Open-Label Period (OL)|Pregnancy|0|||
44454085|NCT00410410|79462673|FG006|Open-Label Period (OL)|Pregnancy|0|||
44454086|NCT00410410|79462674|FG007|Open-Label Period (OL)|Pregnancy|0|||
44454087|NCT00410410|79462675|FG008|Open-Label Period (OL)|Pregnancy|1|||
44454088|NCT00410410|79462667|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454089|NCT00410410|79462668|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454090|NCT00410410|79462669|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454091|NCT00410410|79462670|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454092|NCT00410410|79462671|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454093|NCT00410410|79462672|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454094|NCT00410410|79462673|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454095|NCT00410410|79462674|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
44454096|NCT00410410|79462675|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
44454097|NCT00410410|79462667|FG000|Open-Label Period (OL)|Other|0|||
44454098|NCT00410410|79462668|FG001|Open-Label Period (OL)|Other|0|||
44454099|NCT00410410|79462669|FG002|Open-Label Period (OL)|Other|0|||
44454100|NCT00410410|79462670|FG003|Open-Label Period (OL)|Other|0|||
44454101|NCT00410410|79462671|FG004|Open-Label Period (OL)|Other|0|||
44454102|NCT00410410|79462672|FG005|Open-Label Period (OL)|Other|0|||
44454103|NCT00410410|79462673|FG006|Open-Label Period (OL)|Other|0|||
44454104|NCT00410410|79462674|FG007|Open-Label Period (OL)|Other|0|||
44454105|NCT00410410|79462675|FG008|Open-Label Period (OL)|Other|7|||
44454106|NCT00534404|79462713|FG000|Overall Study|Death|0|||
44454107|NCT00534404|79462714|FG001|Overall Study|Death|0|||
44454108|NCT00534404|79462715|FG002|Overall Study|Death|2|||
44214599|NCT01555983|79012366|FG002|Overall Study|Withdrawal by Subject|0|||
44214600|NCT01555983|79012367|FG003|Overall Study|Withdrawal by Subject|0|||
44454109|NCT00534404|79462713|FG000|Overall Study|Withdrawal by Subject|8|||
44454110|NCT00534404|79462714|FG001|Overall Study|Withdrawal by Subject|2|||
44454111|NCT00534404|79462715|FG002|Overall Study|Withdrawal by Subject|38|||
44454112|NCT00534404|79462713|FG000|Overall Study|Removed by study staff|2|||
44454113|NCT00534404|79462714|FG001|Overall Study|Removed by study staff|3|||
44454114|NCT00534404|79462715|FG002|Overall Study|Removed by study staff|1|||
44454115|NCT00534404|79462713|FG000|Overall Study|Lost to Follow-up|170|||
44454116|NCT00534404|79462714|FG001|Overall Study|Lost to Follow-up|138|||
44454117|NCT00534404|79462715|FG002|Overall Study|Lost to Follow-up|201|||
44454118|NCT00393094|79462723|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
44454119|NCT00393094|79462723|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
44454120|NCT00409786|79462729|FG000|Overall Study|Withdrawal by Subject|3|||
44454121|NCT00409708|79462735|FG000|Treatment|Abnormal test procedure result(s)|1|||
44454122|NCT00409708|79462736|FG001|Treatment|Abnormal test procedure result(s)|0|||
44454123|NCT00409708|79462735|FG000|Treatment|Lack of Efficacy|0|||
44454124|NCT00409708|79462736|FG001|Treatment|Lack of Efficacy|1|||
44454125|NCT00409708|79462735|FG000|Treatment|Protocol Violation|6|||
44454126|NCT00409708|79462736|FG001|Treatment|Protocol Violation|2|||
44454127|NCT00409708|79462735|FG000|Treatment|Withdrawal by Subject|3|||
44454128|NCT00409708|79462736|FG001|Treatment|Withdrawal by Subject|8|||
44454129|NCT00409708|79462735|FG000|Treatment|Lost to Follow-up|0|||
44454130|NCT00409708|79462736|FG001|Treatment|Lost to Follow-up|6|||
44454131|NCT00409708|79462735|FG000|Treatment|Administrative problems|5|||
44454132|NCT00409708|79462736|FG001|Treatment|Administrative problems|0|||
44454133|NCT00409708|79462735|FG000|Washout|Lack of Efficacy|9|||
44454134|NCT00409708|79462736|FG001|Washout|Lack of Efficacy|1|||
44454135|NCT00409708|79462735|FG000|Washout|Protocol Violation|0|||
44454136|NCT00409708|79462736|FG001|Washout|Protocol Violation|1|||
44454137|NCT00409708|79462735|FG000|Washout|Withdrawal by Subject|11|||
44454138|NCT00409708|79462736|FG001|Washout|Withdrawal by Subject|5|||
44454139|NCT00409708|79462735|FG000|Washout|Lost to Follow-up|1|||
44454140|NCT00409708|79462736|FG001|Washout|Lost to Follow-up|3|||
44454141|NCT00391846|79462753|FG000|Overall Study|Adverse Event|4|||
44454142|NCT00391846|79462754|FG001|Overall Study|Adverse Event|1|||
44454143|NCT00391846|79462753|FG000|Overall Study|Did not meet the required elig. crit|2|||
44454144|NCT00391846|79462754|FG001|Overall Study|Did not meet the required elig. crit|2|||
44454145|NCT00391846|79462753|FG000|Overall Study|Withdrawal by Subject|2|||
44454146|NCT00391846|79462754|FG001|Overall Study|Withdrawal by Subject|3|||
44454147|NCT00391846|79462753|FG000|Overall Study|Developed study specific DC criteria|0|||
44454148|NCT00391846|79462754|FG001|Overall Study|Developed study specific DC criteria|1|||
44454149|NCT00534248|79462779|FG000|Overall Study|Adverse Event|19|||
44454150|NCT00534248|79462780|FG001|Overall Study|Adverse Event|29|||
44454151|NCT00534248|79462779|FG000|Overall Study|Lost to Follow-up|353|||
44454152|NCT00534248|79462780|FG001|Overall Study|Lost to Follow-up|375|||
44454153|NCT00534248|79462779|FG000|Overall Study|Other protocol specified criteria|13|||
44454154|NCT00534248|79462780|FG001|Overall Study|Other protocol specified criteria|3|||
44454155|NCT00534248|79462779|FG000|Overall Study|Physician Decision|10|||
44454156|NCT00534248|79462780|FG001|Overall Study|Physician Decision|7|||
44454157|NCT00534248|79462779|FG000|Overall Study|Protocol Violation|3|||
44454158|NCT00534248|79462780|FG001|Overall Study|Protocol Violation|4|||
44454159|NCT00534248|79462779|FG000|Overall Study|Withdrawal by Subject|263|||
44454160|NCT00534248|79462780|FG001|Overall Study|Withdrawal by Subject|255|||
44454161|NCT00391768|79462793|FG000|Overall Study|Withdrawal by Subject|0|||
44454162|NCT00391768|79462794|FG001|Overall Study|Withdrawal by Subject|0|||
44454163|NCT00391768|79462795|FG002|Overall Study|Withdrawal by Subject|1|||
44454164|NCT00391768|79462796|FG003|Overall Study|Withdrawal by Subject|0|||
44454165|NCT00391768|79462797|FG004|Overall Study|Withdrawal by Subject|0|||
44454166|NCT00391768|79462798|FG005|Overall Study|Withdrawal by Subject|1|||
44454167|NCT00391768|79462799|FG006|Overall Study|Withdrawal by Subject|1|||
44454168|NCT00391768|79462793|FG000|Overall Study|Lost to Follow-up|0|||
44454169|NCT00391768|79462794|FG001|Overall Study|Lost to Follow-up|0|||
44454170|NCT00391768|79462795|FG002|Overall Study|Lost to Follow-up|0|||
44454171|NCT00391768|79462796|FG003|Overall Study|Lost to Follow-up|1|||
44454172|NCT00391768|79462797|FG004|Overall Study|Lost to Follow-up|2|||
44454173|NCT00391768|79462798|FG005|Overall Study|Lost to Follow-up|2|||
44454174|NCT00391768|79462799|FG006|Overall Study|Lost to Follow-up|3|||
44454175|NCT00391222|79462836|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
44454176|NCT00391222|79462837|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
44214601|NCT01555983|79012368|FG004|Overall Study|Withdrawal by Subject|1|||
44214602|NCT01555983|79012369|FG005|Overall Study|Withdrawal by Subject|1|||
44214603|NCT01576341|79012377|FG000|Overall Study|Withdrawal by Subject|24|||
44454177|NCT00391222|79462838|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
44454178|NCT00391222|79462839|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
44454179|NCT00391222|79462836|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
44454180|NCT00391222|79462837|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
44454181|NCT00391222|79462838|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
44214604|NCT01576341|79012377|FG000|Overall Study|Adverse Event|10|||
44270021|NCT02301390|79195516|FG001|Overall Study|study terminated|0|||
44454182|NCT00391222|79462839|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
44454183|NCT00391222|79462836|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
44454184|NCT00391222|79462837|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
44214605|NCT01576341|79012377|FG000|Overall Study|Death|21|||
44214606|NCT01576341|79012377|FG000|Overall Study|Physician Decision|2|||
44214607|NCT01576341|79012377|FG000|Overall Study|Lost to Follow-up|2|||
44454185|NCT00391222|79462838|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
44454186|NCT00391222|79462839|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
44454187|NCT00391222|79462836|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
44454188|NCT00391222|79462837|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
44454189|NCT00391222|79462838|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
44454190|NCT00391222|79462839|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
44454191|NCT00391222|79462836|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
44454192|NCT00391222|79462837|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
44454193|NCT00391222|79462838|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
44454194|NCT00391222|79462839|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
44454195|NCT00391222|79462836|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
44454196|NCT00391222|79462837|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
44454197|NCT00391222|79462838|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
44454198|NCT00391222|79462839|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
44454199|NCT00391222|79462836|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
44454200|NCT00391222|79462837|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
44454201|NCT00391222|79462838|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
44454202|NCT00391222|79462839|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
44454203|NCT00391222|79462836|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
44454204|NCT00391222|79462837|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
44454205|NCT00391222|79462838|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
44454206|NCT00391222|79462839|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
44454207|NCT00391222|79462836|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
44454208|NCT00391222|79462837|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
44454209|NCT00391222|79462838|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
44454210|NCT00391222|79462839|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
44454211|NCT00391222|79462836|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
44454212|NCT00391222|79462837|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
44454213|NCT00391222|79462838|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
44454214|NCT00391222|79462839|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
44454215|NCT00391222|79462836|FG000|Period III (Double-Blind Treatment)|Other|6|||
44454216|NCT00391222|79462837|FG001|Period III (Double-Blind Treatment)|Other|1|||
44454217|NCT00391222|79462838|FG002|Period III (Double-Blind Treatment)|Other|6|||
44454218|NCT00391222|79462839|FG003|Period III (Double-Blind Treatment)|Other|0|||
44454219|NCT00409006|79462851|FG000|Overall Study|Death|15|||
44454220|NCT00409006|79462852|FG001|Overall Study|Death|6|||
44454221|NCT00409006|79462851|FG000|Overall Study|Lost to Follow-up|1|||
44454222|NCT00409006|79462852|FG001|Overall Study|Lost to Follow-up|2|||
44454223|NCT00409006|79462851|FG000|Overall Study|Withdrawal by Subject|3|||
44454224|NCT00409006|79462852|FG001|Overall Study|Withdrawal by Subject|2|||
44454225|NCT00409006|79462851|FG000|Overall Study|Physician Decision|1|||
44214608|NCT01576341|79012377|FG000|Overall Study|Kidney transplantation|10|||
44214609|NCT01576341|79012377|FG000|Overall Study|Protocol Violation|12|||
44214610|NCT01576341|79012377|FG000|Overall Study|Other|12|||
44214611|NCT01687413|79012395|FG000|Overall Study|Withdrawal by Subject|0|||
44214612|NCT01687413|79012396|FG001|Overall Study|Withdrawal by Subject|2|||
44214613|NCT01687413|79012395|FG000|Overall Study|Not eligible|0|||
44214614|NCT01687413|79012396|FG001|Overall Study|Not eligible|2|||
44214615|NCT01687413|79012395|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
44214616|NCT01687413|79012396|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
44214617|NCT01555671|79012422|FG000|Overall Study|Physician Decision|20|||
44214618|NCT01555671|79012423|FG001|Overall Study|Physician Decision|25|||
44454226|NCT00409006|79462852|FG001|Overall Study|Physician Decision|2|||
44454227|NCT00534092|79462860|FG000|Overall Study|Lost to Follow-up|1|||
44454228|NCT00534092|79462861|FG001|Overall Study|Lost to Follow-up|0|||
44454229|NCT00534092|79462860|FG000|Overall Study|personal reasons/family concerns|1|||
44454230|NCT00534092|79462861|FG001|Overall Study|personal reasons/family concerns|0|||
44270022|NCT02300610|79195633|FG000|Overall Study|Withdrawal by Subject|1|||
44270023|NCT02300610|79195634|FG001|Overall Study|Withdrawal by Subject|0|||
44270024|NCT02300610|79195635|FG002|Overall Study|Withdrawal by Subject|1|||
44270025|NCT02300298|79195680|FG000|Disposition for Nintedanib|Progressive disease|10|||
44454231|NCT00408928|79462869|FG000|Overall Study|Withdrawal by Subject|1|||
44454232|NCT00408928|79462869|FG000|Overall Study|Death|1|||
44454233|NCT00408928|79462869|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
44454234|NCT00390910|79462876|FG000|Overall Study|Adverse Event|1|||
44454235|NCT00390910|79462877|FG001|Overall Study|Adverse Event|0|||
44454236|NCT00390910|79462878|FG002|Overall Study|Adverse Event|0|||
44454237|NCT00390910|79462876|FG000|Overall Study|Lost to Follow-up|0|||
44270026|NCT02300298|79195681|FG001|Disposition for Nintedanib|Progressive disease|0|||
44214619|NCT01801358|79012437|FG000|Overall Study|Adverse Event|0|||
44454238|NCT00390910|79462877|FG001|Overall Study|Lost to Follow-up|1|||
44454239|NCT00390910|79462878|FG002|Overall Study|Lost to Follow-up|5|||
44454240|NCT00390910|79462876|FG000|Overall Study|Withdrawal by Subject|1|||
44454241|NCT00390910|79462877|FG001|Overall Study|Withdrawal by Subject|3|||
44454242|NCT00390910|79462878|FG002|Overall Study|Withdrawal by Subject|2|||
44454243|NCT00390910|79462876|FG000|Overall Study|Migrated/moved from study area|0|||
44454244|NCT00390910|79462877|FG001|Overall Study|Migrated/moved from study area|0|||
44454245|NCT00390910|79462878|FG002|Overall Study|Migrated/moved from study area|3|||
44454246|NCT00533702|79462890|FG000|Overall Study|Withdrawal by Subject|3|||
44454247|NCT00533702|79462891|FG001|Overall Study|Withdrawal by Subject|1|||
44454248|NCT00533702|79462890|FG000|Overall Study|Found ineligible after randomization|2|||
44454249|NCT00533702|79462891|FG001|Overall Study|Found ineligible after randomization|1|||
44454250|NCT00408694|79462897|FG000|Overall Study|Ineligible|1|||
44454251|NCT00408694|79462897|FG000|Overall Study|No protocol treatment|1|||
44454252|NCT00396136|79462901|FG000|Overall Study|Death|43|||
44454253|NCT00396136|79462901|FG000|Overall Study|Withdrawal by Subject|59|||
44454254|NCT00396136|79462901|FG000|Overall Study|Lost to Follow-up|15|||
44454255|NCT00396136|79462901|FG000|Overall Study|Study device explanted|8|||
44454256|NCT00530894|79462909|FG000|Overall Study|Death|84|||
44454257|NCT00530894|79462910|FG001|Overall Study|Death|89|||
44454258|NCT00530894|79462911|FG002|Overall Study|Death|55|||
44454259|NCT00530894|79462912|FG003|Overall Study|Death|89|||
44454260|NCT00530894|79462909|FG000|Overall Study|Lost to Follow-up|1|||
44454261|NCT00530894|79462910|FG001|Overall Study|Lost to Follow-up|3|||
44454262|NCT00530894|79462911|FG002|Overall Study|Lost to Follow-up|0|||
44454263|NCT00530894|79462912|FG003|Overall Study|Lost to Follow-up|0|||
44454264|NCT00530894|79462909|FG000|Overall Study|Withdrawal by Subject|1|||
44454265|NCT00530894|79462910|FG001|Overall Study|Withdrawal by Subject|23|||
44454266|NCT00530894|79462911|FG002|Overall Study|Withdrawal by Subject|0|||
44454267|NCT00530894|79462912|FG003|Overall Study|Withdrawal by Subject|5|||
44454268|NCT00530894|79462909|FG000|Overall Study|Alive and censored prior to 1 year|2|||
44454269|NCT00530894|79462910|FG001|Overall Study|Alive and censored prior to 1 year|0|||
44454270|NCT00530894|79462911|FG002|Overall Study|Alive and censored prior to 1 year|0|||
44454271|NCT00530894|79462912|FG003|Overall Study|Alive and censored prior to 1 year|0|||
44454272|NCT00056407|79462926|FG000|Overall Study|Adverse Event|282|||
44454273|NCT00056407|79462927|FG001|Overall Study|Adverse Event|364|||
44454274|NCT00056407|79462926|FG000|Overall Study|Withdrawal by Subject|377|||
44454275|NCT00056407|79462927|FG001|Overall Study|Withdrawal by Subject|361|||
44454276|NCT00056407|79462926|FG000|Overall Study|Lost to Follow-up|123|||
44454277|NCT00056407|79462927|FG001|Overall Study|Lost to Follow-up|113|||
44454278|NCT00056407|79462926|FG000|Overall Study|Protocol Violation|104|||
44454279|NCT00056407|79462927|FG001|Overall Study|Protocol Violation|95|||
44454280|NCT00056407|79462926|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
44454281|NCT00056407|79462927|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
44454282|NCT00056407|79462926|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
44454283|NCT00056407|79462927|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
44454284|NCT00056407|79462926|FG000|Overall Study|Missing|25|||
44454285|NCT00056407|79462927|FG001|Overall Study|Missing|34|||
44454286|NCT00388726|79462935|FG000|Overall Study|Adverse Event|50|||
44454287|NCT00388726|79462936|FG001|Overall Study|Adverse Event|24|||
44454288|NCT00388726|79462935|FG000|Overall Study|Progressive Disease|336|||
44214620|NCT01801358|79012438|FG001|Overall Study|Adverse Event|2|||
44214621|NCT01801358|79012439|FG002|Overall Study|Adverse Event|1|||
44214622|NCT01801358|79012440|FG003|Overall Study|Adverse Event|0|||
44214623|NCT01801358|79012441|FG004|Overall Study|Adverse Event|0|||
44214624|NCT01801358|79012442|FG005|Overall Study|Adverse Event|1|||
44214625|NCT01801358|79012437|FG000|Overall Study|Physician Decision|0|||
44214626|NCT01801358|79012438|FG001|Overall Study|Physician Decision|0|||
44214627|NCT01801358|79012439|FG002|Overall Study|Physician Decision|1|||
44214628|NCT01801358|79012440|FG003|Overall Study|Physician Decision|0|||
44214629|NCT01801358|79012441|FG004|Overall Study|Physician Decision|0|||
44214630|NCT01801358|79012442|FG005|Overall Study|Physician Decision|0|||
44454289|NCT00388726|79462936|FG001|Overall Study|Progressive Disease|153|||
44214631|NCT01801358|79012437|FG000|Overall Study|Progressive Disease|6|||
44214632|NCT01801358|79012438|FG001|Overall Study|Progressive Disease|4|||
44214633|NCT01801358|79012439|FG002|Overall Study|Progressive Disease|4|||
44214634|NCT01801358|79012440|FG003|Overall Study|Progressive Disease|5|||
44454290|NCT00388726|79462935|FG000|Overall Study|Clinical Progression|61|||
44454291|NCT00388726|79462936|FG001|Overall Study|Clinical Progression|36|||
44454292|NCT00388726|79462935|FG000|Overall Study|Withdrawal by Subject|10|||
44454293|NCT00388726|79462936|FG001|Overall Study|Withdrawal by Subject|7|||
44454294|NCT00388726|79462935|FG000|Overall Study|Administrative|6|||
44214635|NCT01801358|79012441|FG004|Overall Study|Progressive Disease|6|||
44214636|NCT01801358|79012442|FG005|Overall Study|Progressive Disease|5|||
44214637|NCT01801358|79012437|FG000|Overall Study|Withdrawal by Subject|0|||
44214638|NCT01801358|79012438|FG001|Overall Study|Withdrawal by Subject|0|||
44454295|NCT00388726|79462936|FG001|Overall Study|Administrative|9|||
44454296|NCT00388726|79462935|FG000|Overall Study|Physician Decision|18|||
44214639|NCT01801358|79012439|FG002|Overall Study|Withdrawal by Subject|0|||
44214640|NCT01801358|79012440|FG003|Overall Study|Withdrawal by Subject|1|||
44214641|NCT01801358|79012441|FG004|Overall Study|Withdrawal by Subject|0|||
44214642|NCT01801358|79012442|FG005|Overall Study|Withdrawal by Subject|2|||
44214643|NCT01807598|79012477|FG000|Overall Study|Withdrawal by Subject|4|||
44214644|NCT01807598|79012477|FG000|Overall Study|Adverse Event|1|||
44214645|NCT01807598|79012477|FG000|Overall Study|Other Physician Decision|1|||
44214646|NCT01801280|79012485|FG000|Period 1|Withdrawal by Subject|0|||
44214647|NCT01801280|79012486|FG001|Period 1|Withdrawal by Subject|1|||
44214648|NCT01801280|79012487|FG002|Period 1|Withdrawal by Subject|0|||
44214649|NCT01801280|79012488|FG003|Period 1|Withdrawal by Subject|0|||
44214650|NCT01801280|79012485|FG000|Period 2|Withdrawal by Subject|1|||
44214651|NCT01801280|79012486|FG001|Period 2|Withdrawal by Subject|0|||
44214652|NCT01801280|79012487|FG002|Period 2|Withdrawal by Subject|0|||
44214653|NCT01801280|79012488|FG003|Period 2|Withdrawal by Subject|0|||
44214654|NCT01801280|79012485|FG000|Period 4|Protocol Violation|0|||
44214655|NCT01801280|79012486|FG001|Period 4|Protocol Violation|0|||
44214656|NCT01801280|79012487|FG002|Period 4|Protocol Violation|1|||
44214657|NCT01801280|79012488|FG003|Period 4|Protocol Violation|0|||
44214658|NCT01769456|79012498|FG000|Overall Study|Lost to Follow-up|19|||
44214659|NCT01769456|79012498|FG000|Overall Study|Withdrawal by Subject|3|||
44214660|NCT01769456|79012498|FG000|Overall Study|Did not receive PCC intervention|6|||
44214661|NCT01769456|79012498|FG000|Overall Study|Moved out of the area|3|||
44214662|NCT01769456|79012498|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
44214663|NCT01769456|79012498|FG000|Overall Study|Parental request to youth to withdraw|1|||
44214664|NCT01769378|79012505|FG000|Overall Study|Adverse Event|10|||
44214665|NCT01769378|79012506|FG001|Overall Study|Adverse Event|0|||
44214666|NCT01769378|79012505|FG000|Overall Study|Entry criteria not met|1|||
44214667|NCT01769378|79012506|FG001|Overall Study|Entry criteria not met|0|||
44214668|NCT01769378|79012505|FG000|Overall Study|Protocol Violation|1|||
44214669|NCT01769378|79012506|FG001|Overall Study|Protocol Violation|1|||
44214670|NCT01769378|79012505|FG000|Overall Study|Withdrawal by Subject|10|||
44214671|NCT01769378|79012506|FG001|Overall Study|Withdrawal by Subject|3|||
44214672|NCT01769378|79012505|FG000|Overall Study|Sponsor Decision|1|||
44214673|NCT01769378|79012506|FG001|Overall Study|Sponsor Decision|0|||
44454297|NCT00388726|79462936|FG001|Overall Study|Physician Decision|13|||
44454298|NCT00388726|79462935|FG000|Overall Study|Death|3|||
44454299|NCT00388726|79462936|FG001|Overall Study|Death|2|||
44454300|NCT00387790|79462942|FG000|Overall Study|Adverse Event|5|||
44454301|NCT00387790|79462942|FG000|Overall Study|Lack of Efficacy|2|||
44454302|NCT00387790|79462942|FG000|Overall Study|Physician Decision|2|||
44454303|NCT00387790|79462942|FG000|Overall Study|Withdrawal by Subject|3|||
44454304|NCT00387790|79462942|FG000|Overall Study|Ineligible for study|2|||
44454305|NCT00073021|79462948|FG000|Overall Study|Protocol Violation|2|||
44454306|NCT00073021|79462949|FG001|Overall Study|Protocol Violation|1|||
44454307|NCT00073021|79462948|FG000|Overall Study|Adverse Event|4|||
44454308|NCT00073021|79462949|FG001|Overall Study|Adverse Event|4|||
44454309|NCT00073021|79462948|FG000|Overall Study|Withdrawal by Subject|6|||
44454310|NCT00073021|79462949|FG001|Overall Study|Withdrawal by Subject|5|||
44454311|NCT00073021|79462948|FG000|Overall Study|Physician Decision|3|||
44454312|NCT00073021|79462949|FG001|Overall Study|Physician Decision|1|||
44454313|NCT00073021|79462948|FG000|Overall Study|Lack of Efficacy|11|||
44454314|NCT00073021|79462949|FG001|Overall Study|Lack of Efficacy|5|||
44454315|NCT00407758|79462955|FG000|Overall Study|ineligible -improper prior treatment|1|||
44454316|NCT00531752|79462963|FG000|First Double-blind Intervention Period|Adverse Event|2|||
44454317|NCT00531752|79462964|FG001|First Double-blind Intervention Period|Adverse Event|0|||
44454318|NCT00531752|79462965|FG002|First Double-blind Intervention Period|Adverse Event|1|||
44454319|NCT00531752|79462966|FG003|First Double-blind Intervention Period|Adverse Event|1|||
44454320|NCT00531752|79462963|FG000|First Double-blind Intervention Period|Other|1|||
44454321|NCT00531752|79462964|FG001|First Double-blind Intervention Period|Other|4|||
44454322|NCT00531752|79462965|FG002|First Double-blind Intervention Period|Other|4|||
44214674|NCT01769378|79012505|FG000|Overall Study|Lost to Follow-up|2|||
44454323|NCT00531752|79462966|FG003|First Double-blind Intervention Period|Other|0|||
44454324|NCT00531752|79462963|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
44454325|NCT00531752|79462964|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
44454326|NCT00531752|79462965|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
44454327|NCT00531752|79462966|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
44214675|NCT01769378|79012506|FG001|Overall Study|Lost to Follow-up|0|||
44214676|NCT01807520|79012515|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
44214677|NCT01807520|79012516|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
44214678|NCT01807520|79012517|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
44214679|NCT01807520|79012518|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
44214680|NCT01807520|79012519|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
44214681|NCT01807520|79012520|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
44454328|NCT00531752|79462963|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
44454329|NCT00531752|79462964|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
44454330|NCT00531752|79462965|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
44454331|NCT00531752|79462966|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
44454332|NCT00531752|79462963|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
44454333|NCT00531752|79462964|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
44454334|NCT00531752|79462965|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
44454335|NCT00531752|79462966|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
44454336|NCT00531752|79462963|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
44454337|NCT00531752|79462964|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
44454338|NCT00531752|79462965|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
44454339|NCT00531752|79462966|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
44454340|NCT00531752|79462963|FG000|Second Double-blind Intervention Period|Other|1|||
44454341|NCT00531752|79462964|FG001|Second Double-blind Intervention Period|Other|1|||
44454342|NCT00531752|79462965|FG002|Second Double-blind Intervention Period|Other|0|||
44454343|NCT00531752|79462966|FG003|Second Double-blind Intervention Period|Other|0|||
44454344|NCT00531752|79462963|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
44454345|NCT00531752|79462964|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
44454346|NCT00531752|79462965|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
44454347|NCT00531752|79462966|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
44454348|NCT00531752|79462963|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
44454349|NCT00531752|79462964|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
44454350|NCT00531752|79462965|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
44454351|NCT00531752|79462966|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
44454352|NCT00395746|79462977|FG000|Overall Study|Adverse Event|5|||
44454353|NCT00395746|79462978|FG001|Overall Study|Adverse Event|2|||
44454354|NCT00395746|79462979|FG002|Overall Study|Adverse Event|2|||
44454355|NCT00395746|79462977|FG000|Overall Study|Protocol Violation|0|||
44214682|NCT01807520|79012521|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
44214683|NCT01807520|79012515|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
44214684|NCT01807520|79012516|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
44454356|NCT00395746|79462978|FG001|Overall Study|Protocol Violation|1|||
44454357|NCT00395746|79462979|FG002|Overall Study|Protocol Violation|0|||
44454358|NCT00395746|79462977|FG000|Overall Study|Lack of Efficacy|2|||
44454359|NCT00395746|79462978|FG001|Overall Study|Lack of Efficacy|0|||
44454360|NCT00395746|79462979|FG002|Overall Study|Lack of Efficacy|17|||
44454361|NCT00395746|79462977|FG000|Overall Study|Hypoglycaemia|2|||
44454362|NCT00395746|79462978|FG001|Overall Study|Hypoglycaemia|1|||
44454363|NCT00395746|79462979|FG002|Overall Study|Hypoglycaemia|0|||
44454364|NCT00395746|79462977|FG000|Overall Study|Subject decision|0|||
44454365|NCT00395746|79462978|FG001|Overall Study|Subject decision|0|||
44454366|NCT00395746|79462979|FG002|Overall Study|Subject decision|1|||
44454367|NCT00395746|79462977|FG000|Overall Study|Withdrawal of consent|0|||
44454368|NCT00395746|79462978|FG001|Overall Study|Withdrawal of consent|0|||
44454369|NCT00395746|79462979|FG002|Overall Study|Withdrawal of consent|1|||
44454370|NCT00395746|79462977|FG000|Overall Study|Difficultulty in use of device|0|||
44454371|NCT00395746|79462978|FG001|Overall Study|Difficultulty in use of device|0|||
44454372|NCT00395746|79462979|FG002|Overall Study|Difficultulty in use of device|1|||
44454373|NCT00395746|79462977|FG000|Overall Study|Unable to visit site on schedule|1|||
44454374|NCT00395746|79462978|FG001|Overall Study|Unable to visit site on schedule|0|||
44454375|NCT00395746|79462979|FG002|Overall Study|Unable to visit site on schedule|0|||
44454376|NCT00055471|79462990|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
44454377|NCT00055471|79462991|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
44454378|NCT00055471|79462992|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
44454379|NCT00055471|79462990|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
44454380|NCT00055471|79462991|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
44454381|NCT00055471|79462992|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
44454382|NCT00055471|79462990|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
44454383|NCT00055471|79462991|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
44454384|NCT00055471|79462992|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
44454385|NCT00395512|79463004|FG000|Overall Study|Adverse Event|3|||
44543719|NCT03847896|79556851|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44543720|NCT03847896|79556852|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44214685|NCT01807520|79012517|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
44454386|NCT00395512|79463005|FG001|Overall Study|Adverse Event|8|||
44454387|NCT00395512|79463006|FG002|Overall Study|Adverse Event|6|||
44454388|NCT00395512|79463007|FG003|Overall Study|Adverse Event|6|||
44454389|NCT00395512|79463004|FG000|Overall Study|Protocol Violation|2|||
44543721|NCT03847896|79556853|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44543722|NCT03847896|79556854|FG003|Overall Study|Withdrawal by parent/guardian|0|||
44454390|NCT00395512|79463005|FG001|Overall Study|Protocol Violation|3|||
44214686|NCT01807520|79012518|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
44214687|NCT01807520|79012519|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
44214688|NCT01807520|79012520|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
44214689|NCT01807520|79012521|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
44214690|NCT01807520|79012515|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
44214691|NCT01807520|79012516|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
44214692|NCT01807520|79012517|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
44214693|NCT01807520|79012518|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
44214694|NCT01807520|79012519|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
44454391|NCT00395512|79463006|FG002|Overall Study|Protocol Violation|6|||
44454392|NCT00395512|79463007|FG003|Overall Study|Protocol Violation|7|||
44454393|NCT00395512|79463004|FG000|Overall Study|Lost to Follow-up|2|||
44454394|NCT00395512|79463005|FG001|Overall Study|Lost to Follow-up|6|||
44454395|NCT00395512|79463006|FG002|Overall Study|Lost to Follow-up|5|||
44454396|NCT00395512|79463007|FG003|Overall Study|Lost to Follow-up|5|||
44543723|NCT03847896|79556855|FG004|Overall Study|Withdrawal by parent/guardian|0|||
44270027|NCT02300298|79195680|FG000|Disposition for Docetaxel|Progressive disease|0|||
44270028|NCT02300298|79195681|FG001|Disposition for Docetaxel|Progressive disease|6|||
44270029|NCT02300298|79195680|FG000|Disposition for Docetaxel|other adverse event|0|||
44270030|NCT02300298|79195681|FG001|Disposition for Docetaxel|other adverse event|4|||
44270031|NCT02300220|79195687|FG000|Overall Study|Lost to Follow-up|1|||
44270032|NCT02300220|79195688|FG001|Overall Study|Lost to Follow-up|2|||
44270033|NCT02300220|79195687|FG000|Overall Study|Death|1|||
44270034|NCT02300220|79195688|FG001|Overall Study|Death|1|||
44270035|NCT02300220|79195687|FG000|Overall Study|Adverse Event|1|||
44270036|NCT02300220|79195688|FG001|Overall Study|Adverse Event|1|||
44270037|NCT02300220|79195687|FG000|Overall Study|Protocol Violation|1|||
44270038|NCT02300220|79195688|FG001|Overall Study|Protocol Violation|0|||
44270039|NCT02300220|79195687|FG000|Overall Study|Withdrawal by Subject|0|||
44270040|NCT02300220|79195688|FG001|Overall Study|Withdrawal by Subject|2|||
44270041|NCT02300220|79195687|FG000|Overall Study|Did not tolerate IMP|0|||
44270042|NCT02300220|79195688|FG001|Overall Study|Did not tolerate IMP|1|||
44270043|NCT02327130|79195712|FG000|Overall Study|Discharged in less than 5 days|5|||
44270044|NCT02327130|79195712|FG000|Overall Study|Physician Decision|2|||
44270045|NCT02327130|79195712|FG000|Overall Study|Unable to provide breath sample|1|||
44270046|NCT02327130|79195712|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
44270047|NCT02327130|79195712|FG000|Overall Study|Met exclusion criteria|3|||
44270048|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270049|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
44270050|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
44270051|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270052|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270053|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270054|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270055|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270056|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270057|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270058|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270059|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270060|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270061|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270062|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44270063|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
44270064|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
44270065|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44214695|NCT01807520|79012520|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
44214696|NCT01807520|79012521|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
44214697|NCT01807520|79012515|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
44214698|NCT01807520|79012516|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
44543724|NCT03847896|79556851|FG000|Overall Study|Adverse Event|2|||
44543725|NCT03847896|79556852|FG001|Overall Study|Adverse Event|1|||
44543726|NCT03847896|79556853|FG002|Overall Study|Adverse Event|3|||
44543727|NCT03847896|79556854|FG003|Overall Study|Adverse Event|2|||
44270066|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270067|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44543728|NCT03847896|79556855|FG004|Overall Study|Adverse Event|4|||
44214699|NCT01807520|79012517|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
44214700|NCT01807520|79012518|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
44270068|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44454397|NCT00395512|79463004|FG000|Overall Study|Withdrawal by Subject|6|||
44454398|NCT00395512|79463005|FG001|Overall Study|Withdrawal by Subject|5|||
44270069|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270070|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270071|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270072|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270073|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270074|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270075|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270076|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270077|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
44270078|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
44270079|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
44270080|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
44270081|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270082|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270083|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270084|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270085|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270086|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270087|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270088|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270089|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270090|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270091|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270092|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44270093|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270094|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270095|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
44270096|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270097|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270098|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270099|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270100|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270101|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270102|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270103|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270104|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270105|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270106|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270107|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
44270108|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270109|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270110|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
44270111|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270112|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270113|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270114|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44454399|NCT00395512|79463006|FG002|Overall Study|Withdrawal by Subject|5|||
44454400|NCT00395512|79463007|FG003|Overall Study|Withdrawal by Subject|12|||
44454401|NCT00395512|79463004|FG000|Overall Study|Physician Decision|6|||
44454402|NCT00395512|79463005|FG001|Overall Study|Physician Decision|4|||
44454403|NCT00395512|79463006|FG002|Overall Study|Physician Decision|2|||
44454404|NCT00395512|79463007|FG003|Overall Study|Physician Decision|2|||
44454405|NCT00395512|79463004|FG000|Overall Study|Other|1|||
44454406|NCT00395512|79463005|FG001|Overall Study|Other|1|||
44454407|NCT00395512|79463006|FG002|Overall Study|Other|0|||
44454408|NCT00395512|79463007|FG003|Overall Study|Other|0|||
44454409|NCT00395512|79463004|FG000|Overall Study|Hyperglycemic Rescue|18|||
44543729|NCT03847896|79556851|FG000|Overall Study|A severe exacerbation event|0|||
44214701|NCT01807520|79012519|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
44214702|NCT01807520|79012520|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
44214703|NCT01807520|79012521|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
44214704|NCT01807520|79012515|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
44214705|NCT01807520|79012516|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
44214706|NCT01807520|79012517|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
44214707|NCT01807520|79012518|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
44214708|NCT01807520|79012519|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
44214709|NCT01807520|79012520|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
44454410|NCT00395512|79463005|FG001|Overall Study|Hyperglycemic Rescue|10|||
44454411|NCT00395512|79463006|FG002|Overall Study|Hyperglycemic Rescue|4|||
44454412|NCT00395512|79463007|FG003|Overall Study|Hyperglycemic Rescue|6|||
44454413|NCT00054691|79463017|FG000|Overall Study|Unmeasurable Disease|2|||
44454414|NCT00054691|79463017|FG000|Overall Study|Noncompliant|1|||
44454415|NCT00387712|79463023|FG000|Overall Study|Physician Decision|6|||
44454416|NCT00387712|79463024|FG001|Overall Study|Physician Decision|4|||
44454417|NCT00387712|79463023|FG000|Overall Study|Lost to Follow-up|17|||
44454418|NCT00387712|79463024|FG001|Overall Study|Lost to Follow-up|20|||
44454419|NCT00387712|79463023|FG000|Overall Study|Withdrawal by Subject|6|||
44454420|NCT00387712|79463024|FG001|Overall Study|Withdrawal by Subject|12|||
44454421|NCT00072475|79463030|FG000|Overall Study|Adverse Event|44|||
44454422|NCT00072475|79463030|FG000|Overall Study|Death|3|||
44454423|NCT00072475|79463030|FG000|Overall Study|Withdrawal by Subject|46|||
44454424|NCT00072475|79463030|FG000|Overall Study|Patient/Investigator Decision|4|||
44454425|NCT00066469|79463034|FG000|Overall Study|Death|3|||
44454426|NCT00066469|79463034|FG000|Overall Study|Lack of Efficacy|9|||
44454427|NCT00066469|79463034|FG000|Overall Study|Lost to Follow-up|1|||
44454428|NCT00066469|79463034|FG000|Overall Study|Physician Decision|1|||
44454429|NCT00066469|79463034|FG000|Overall Study|Withdrawal by Subject|1|||
44454430|NCT00066469|79463034|FG000|Overall Study|ineligible|1|||
44454431|NCT00387088|79463040|FG000|Overall Study|Adverse Event|143|||
44454432|NCT00387088|79463041|FG001|Overall Study|Adverse Event|156|||
44454433|NCT00387088|79463040|FG000|Overall Study|Protocol Violation|47|||
44454434|NCT00387088|79463041|FG001|Overall Study|Protocol Violation|35|||
44454435|NCT00387088|79463040|FG000|Overall Study|Withdrawal by Subject|20|||
44454436|NCT00387088|79463041|FG001|Overall Study|Withdrawal by Subject|35|||
44454437|NCT00387088|79463040|FG000|Overall Study|Lack of Efficacy|28|||
44454438|NCT00387088|79463041|FG001|Overall Study|Lack of Efficacy|67|||
44454439|NCT00387088|79463040|FG000|Overall Study|Lost to Follow-up|22|||
44454440|NCT00387088|79463041|FG001|Overall Study|Lost to Follow-up|28|||
44454441|NCT00387088|79463040|FG000|Overall Study|Other|58|||
44454442|NCT00387088|79463041|FG001|Overall Study|Other|52|||
44454443|NCT00053365|79463047|FG000|Overall Study|Incorrect cell type|1|||
44454444|NCT00053365|79463047|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
44454445|NCT00053365|79463047|FG000|Overall Study|Never treated|4|||
44454446|NCT00387010|79463053|FG000|Dose Titration Period|Adverse Event|12|||
44543730|NCT03847896|79556852|FG001|Overall Study|A severe exacerbation event|0|||
44214710|NCT01807520|79012521|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
44214711|NCT01807520|79012515|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
44214712|NCT01807520|79012516|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
44214713|NCT01807520|79012517|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
44214714|NCT01807520|79012518|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
44371384|NCT01928394|79376858|FG016|Treatment Period|Disease progression|43|||
44371385|NCT01928394|79376859|FG017|Treatment Period|Disease progression|56|||
44371386|NCT01928394|79376860|FG018|Treatment Period|Disease progression|50|||
44371387|NCT01928394|79376861|FG019|Treatment Period|Disease progression|71|||
44371388|NCT01928394|79376862|FG020|Treatment Period|Disease progression|30|||
44371389|NCT01928394|79376863|FG021|Treatment Period|Disease progression|31|||
44371390|NCT01928394|79376864|FG022|Treatment Period|Disease progression|31|||
44371391|NCT01928394|79376842|FG000|Treatment Period|Study drug toxicity|1|||
44371392|NCT01928394|79376843|FG001|Treatment Period|Study drug toxicity|1|||
44371393|NCT01928394|79376844|FG002|Treatment Period|Study drug toxicity|3|||
44371394|NCT01928394|79376845|FG003|Treatment Period|Study drug toxicity|3|||
44371395|NCT01928394|79376846|FG004|Treatment Period|Study drug toxicity|0|||
44371396|NCT01928394|79376847|FG005|Treatment Period|Study drug toxicity|9|||
44371397|NCT01928394|79376848|FG006|Treatment Period|Study drug toxicity|7|||
44371398|NCT01928394|79376849|FG007|Treatment Period|Study drug toxicity|1|||
44371399|NCT01928394|79376850|FG008|Treatment Period|Study drug toxicity|0|||
44371400|NCT01928394|79376851|FG009|Treatment Period|Study drug toxicity|5|||
44371401|NCT01928394|79376852|FG010|Treatment Period|Study drug toxicity|2|||
44371402|NCT01928394|79376853|FG011|Treatment Period|Study drug toxicity|3|||
44371403|NCT01928394|79376854|FG012|Treatment Period|Study drug toxicity|7|||
44371404|NCT01928394|79376855|FG013|Treatment Period|Study drug toxicity|5|||
44371405|NCT01928394|79376856|FG014|Treatment Period|Study drug toxicity|12|||
44371406|NCT01928394|79376857|FG015|Treatment Period|Study drug toxicity|0|||
44371407|NCT01928394|79376858|FG016|Treatment Period|Study drug toxicity|3|||
44371408|NCT01928394|79376859|FG017|Treatment Period|Study drug toxicity|3|||
44371409|NCT01928394|79376860|FG018|Treatment Period|Study drug toxicity|12|||
44454447|NCT00387010|79463053|FG000|Dose Titration Period|Lack of Efficacy|5|||
44454448|NCT00387010|79463053|FG000|Dose Titration Period|Withdrawal by Subject|3|||
44454449|NCT00387010|79463053|FG000|Dose Titration Period|Protocol Violation|1|||
44454450|NCT00387010|79463053|FG000|Dose Titration Period|Lost to Follow-up|2|||
44454451|NCT00387010|79463053|FG000|Dose Titration Period|Noncompliance with study medication|8|||
44454452|NCT00387010|79463053|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
44454453|NCT00387010|79463053|FG000|Treatment Period|Adverse Event|4|||
44454454|NCT00387010|79463053|FG000|Treatment Period|Withdrawal by Subject|1|||
44454455|NCT00387010|79463053|FG000|Treatment Period|Noncompliance with study medication|2|||
44454456|NCT00387010|79463053|FG000|Treatment Period|Noncompliance with study procedures|3|||
44454457|NCT00387010|79463053|FG000|Treatment Period|Participant reported study drug stolen|1|||
44454458|NCT00386776|79463057|FG000|Overall Study|Withdrawal by Subject|8|||
44454459|NCT00065065|79463065|FG000|Overall Study|Adverse Event|3|||
44454460|NCT00065065|79463066|FG001|Overall Study|Adverse Event|2|||
44454461|NCT00065065|79463065|FG000|Overall Study|Withdrawal by Subject|1|||
44454462|NCT00065065|79463066|FG001|Overall Study|Withdrawal by Subject|5|||
44454463|NCT00065065|79463065|FG000|Overall Study|Lack of Efficacy|4|||
44454464|NCT00065065|79463066|FG001|Overall Study|Lack of Efficacy|11|||
44454465|NCT00065065|79463065|FG000|Overall Study|Other|2|||
44454466|NCT00065065|79463066|FG001|Overall Study|Other|2|||
44454467|NCT00386308|79463076|FG000|Overall Study|Adverse Event|3|||
44454468|NCT00386308|79463077|FG001|Overall Study|Adverse Event|3|||
44454469|NCT00386308|79463076|FG000|Overall Study|Protocol Violation|2|||
44454470|NCT00386308|79463077|FG001|Overall Study|Protocol Violation|5|||
44454471|NCT00386308|79463076|FG000|Overall Study|Lack of Efficacy|0|||
44454472|NCT00386308|79463077|FG001|Overall Study|Lack of Efficacy|2|||
44454473|NCT00386308|79463076|FG000|Overall Study|Lost to Follow-up|10|||
44454474|NCT00386308|79463077|FG001|Overall Study|Lost to Follow-up|6|||
44454475|NCT00386308|79463076|FG000|Overall Study|Withdrawal by Subject|6|||
44454476|NCT00386308|79463077|FG001|Overall Study|Withdrawal by Subject|2|||
44454477|NCT00386308|79463076|FG000|Overall Study|Other Event|8|||
44454478|NCT00386308|79463077|FG001|Overall Study|Other Event|1|||
44454479|NCT00064987|79463085|FG000|Overall Study|Physician Decision|3|||
44454480|NCT00064987|79463086|FG001|Overall Study|Physician Decision|0|||
44454481|NCT00374452|79463094|FG000|Overall Study|Left clinic before intervention started|4|||
44454482|NCT00374452|79463095|FG001|Overall Study|Left clinic before intervention started|1|||
44454483|NCT00374452|79463094|FG000|Overall Study|Change in job role before intervention|0|||
44454484|NCT00374452|79463095|FG001|Overall Study|Change in job role before intervention|1|||
44454485|NCT00374452|79463094|FG000|Overall Study|Left clinic after intervention started|1|||
44454486|NCT00374452|79463095|FG001|Overall Study|Left clinic after intervention started|1|||
44454487|NCT00374452|79463094|FG000|Overall Study|Withdrawal by Subject|0|||
44454488|NCT00374452|79463095|FG001|Overall Study|Withdrawal by Subject|2|||
44454489|NCT00064753|79463103|FG000|Overall Study|Death|251|||
44454490|NCT00064753|79463104|FG001|Overall Study|Death|242|||
44454491|NCT00064753|79463103|FG000|Overall Study|Withdrawal by Subject|198|||
44454492|NCT00064753|79463104|FG001|Overall Study|Withdrawal by Subject|171|||
44454493|NCT00064753|79463103|FG000|Overall Study|Lost to Follow-up|225|||
44454494|NCT00064753|79463104|FG001|Overall Study|Lost to Follow-up|235|||
44454495|NCT00374140|79463110|FG000|Overall Study|Lost to Follow-up|1|||
44454496|NCT00374140|79463110|FG000|Overall Study|Protocol Violation|1|||
44454497|NCT00665561|79463116|FG000|Overall Study|Death recorded on subject summary pages|75|||
44454498|NCT00665561|79463117|FG001|Overall Study|Death recorded on subject summary pages|75|||
44454499|NCT00665561|79463116|FG000|Overall Study|Does not meet entrance criteria|19|||
44454500|NCT00665561|79463117|FG001|Overall Study|Does not meet entrance criteria|21|||
44454501|NCT00665561|79463116|FG000|Overall Study|Lost to Follow-up|203|||
44454502|NCT00665561|79463117|FG001|Overall Study|Lost to Follow-up|264|||
44454503|NCT00665561|79463116|FG000|Overall Study|Withdrawal by Subject|74|||
44454504|NCT00665561|79463117|FG001|Overall Study|Withdrawal by Subject|65|||
44454505|NCT00665561|79463116|FG000|Overall Study|Other|123|||
44454506|NCT00665561|79463117|FG001|Overall Study|Other|108|||
44454507|NCT00665561|79463116|FG000|Overall Study|Site closed|8|||
44454508|NCT00665561|79463117|FG001|Overall Study|Site closed|0|||
44454509|NCT00665561|79463116|FG000|Overall Study|Withdrawn due to pregnancy|0|||
44454510|NCT00665561|79463117|FG001|Overall Study|Withdrawn due to pregnancy|1|||
44454511|NCT00663923|79463123|FG000|Overall Study|Lost to Follow-up|2|||
44454512|NCT00386152|79463132|FG000|Overall Study|Adverse Event|6|||
44454513|NCT00386152|79463133|FG001|Overall Study|Adverse Event|5|||
44454514|NCT00386152|79463134|FG002|Overall Study|Adverse Event|4|||
44454515|NCT00386152|79463132|FG000|Overall Study|Chang from original chemo stratification|4|||
44454516|NCT00386152|79463133|FG001|Overall Study|Chang from original chemo stratification|5|||
44454517|NCT00386152|79463134|FG002|Overall Study|Chang from original chemo stratification|6|||
44454518|NCT00386152|79463132|FG000|Overall Study|Death|3|||
44454519|NCT00386152|79463133|FG001|Overall Study|Death|0|||
44454520|NCT00386152|79463134|FG002|Overall Study|Death|1|||
44454521|NCT00386152|79463132|FG000|Overall Study|Disease progression|7|||
44454522|NCT00386152|79463133|FG001|Overall Study|Disease progression|4|||
44454523|NCT00386152|79463134|FG002|Overall Study|Disease progression|5|||
44454524|NCT00386152|79463132|FG000|Overall Study|Physician Decision|13|||
44454525|NCT00386152|79463133|FG001|Overall Study|Physician Decision|10|||
44454526|NCT00386152|79463134|FG002|Overall Study|Physician Decision|4|||
44454527|NCT00386152|79463132|FG000|Overall Study|Lost to Follow-up|1|||
44454528|NCT00386152|79463133|FG001|Overall Study|Lost to Follow-up|0|||
44454529|NCT00386152|79463134|FG002|Overall Study|Lost to Follow-up|0|||
44454530|NCT00386152|79463132|FG000|Overall Study|Completed chemotherapy|4|||
44454531|NCT00386152|79463133|FG001|Overall Study|Completed chemotherapy|5|||
44454532|NCT00386152|79463134|FG002|Overall Study|Completed chemotherapy|1|||
44454533|NCT00386152|79463132|FG000|Overall Study|Protocol Violation|3|||
44454534|NCT00386152|79463133|FG001|Overall Study|Protocol Violation|5|||
44454535|NCT00386152|79463134|FG002|Overall Study|Protocol Violation|2|||
44454536|NCT00386152|79463132|FG000|Overall Study|Withdrawal by Subject|3|||
44454537|NCT00386152|79463133|FG001|Overall Study|Withdrawal by Subject|6|||
44454538|NCT00386152|79463134|FG002|Overall Study|Withdrawal by Subject|10|||
44454539|NCT00385918|79463144|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
44454540|NCT00385918|79463145|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
44454541|NCT00385918|79463146|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
44454542|NCT00385918|79463144|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
44454543|NCT00385918|79463145|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
44454544|NCT00385918|79463146|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
44454545|NCT00385918|79463144|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
44454546|NCT00385918|79463145|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
44454547|NCT00385918|79463146|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
44454548|NCT00385918|79463144|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
44454549|NCT00385918|79463145|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
44454550|NCT00385918|79463146|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
44454551|NCT00385918|79463144|FG000|Intervention Phase After Randomization|Physician Decision|1|||
44454552|NCT00385918|79463145|FG001|Intervention Phase After Randomization|Physician Decision|0|||
44454553|NCT00385918|79463146|FG002|Intervention Phase After Randomization|Physician Decision|0|||
44454554|NCT00385918|79463144|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
44454555|NCT00385918|79463145|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
44454556|NCT00385918|79463146|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
44454557|NCT00385840|79463155|FG000|Overall Study|Adverse Event|1|||
44454558|NCT00385840|79463156|FG001|Overall Study|Adverse Event|1|||
44454559|NCT00385840|79463155|FG000|Overall Study|Lost to Follow-up|3|||
44454560|NCT00385840|79463156|FG001|Overall Study|Lost to Follow-up|13|||
44454561|NCT00385762|79463162|FG000|Overall Study|Adverse Event|1|||
44454562|NCT00385762|79463162|FG000|Overall Study|Lost to Follow-up|1|||
44454563|NCT00385684|79463166|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
44454564|NCT00385684|79463167|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
44454565|NCT00385684|79463166|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
44454566|NCT00385684|79463167|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
44454567|NCT00385684|79463166|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
44454568|NCT00385684|79463167|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
44454569|NCT00661661|79463175|FG000|Overall Study|Adverse Event|99|||
44454570|NCT00661661|79463176|FG001|Overall Study|Adverse Event|24|||
44454571|NCT00661661|79463175|FG000|Overall Study|Lack of Efficacy|3|||
44454572|NCT00661661|79463176|FG001|Overall Study|Lack of Efficacy|2|||
44454573|NCT00661661|79463175|FG000|Overall Study|Lost to Follow-up|0|||
44454574|NCT00661661|79463176|FG001|Overall Study|Lost to Follow-up|1|||
44454575|NCT00661661|79463175|FG000|Overall Study|Withdrawal by Subject|15|||
44454576|NCT00661661|79463176|FG001|Overall Study|Withdrawal by Subject|5|||
44454577|NCT00661661|79463175|FG000|Overall Study|Other|22|||
44454578|NCT00661661|79463176|FG001|Overall Study|Other|7|||
44454579|NCT00661661|79463175|FG000|Overall Study|Not assigned treatment|1|||
44454580|NCT00661661|79463176|FG001|Overall Study|Not assigned treatment|0|||
44454581|NCT00038467|79463186|FG000|Overall Study|Adverse Event|170|||
44454582|NCT00038467|79463187|FG001|Overall Study|Adverse Event|145|||
44454583|NCT00038467|79463186|FG000|Overall Study|Withdrawal by Subject|150|||
44214715|NCT01807520|79012519|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
44214716|NCT01807520|79012520|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
44214717|NCT01807520|79012521|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
44214718|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
44214719|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
44214720|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
44214721|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
44214722|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
44214723|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
44214724|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
44214725|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
44214726|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
44214727|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
44454584|NCT00038467|79463187|FG001|Overall Study|Withdrawal by Subject|107|||
44454585|NCT00038467|79463186|FG000|Overall Study|Protocol Violation|19|||
44454586|NCT00038467|79463187|FG001|Overall Study|Protocol Violation|22|||
44454587|NCT00038467|79463186|FG000|Overall Study|Death|22|||
44454588|NCT00038467|79463187|FG001|Overall Study|Death|16|||
44454589|NCT00038467|79463186|FG000|Overall Study|Lost to Follow-up|15|||
44454590|NCT00038467|79463187|FG001|Overall Study|Lost to Follow-up|10|||
44454591|NCT00038467|79463186|FG000|Overall Study|Recurrence|109|||
44454592|NCT00038467|79463187|FG001|Overall Study|Recurrence|179|||
44454593|NCT00038467|79463186|FG000|Overall Study|Randomized, but not treated|31|||
44454594|NCT00038467|79463187|FG001|Overall Study|Randomized, but not treated|35|||
44454595|NCT00038467|79463186|FG000|Overall Study|Other|26|||
44454596|NCT00038467|79463187|FG001|Overall Study|Other|28|||
44454597|NCT00051025|79463195|FG000|Overall Study|Progressive Disease|1|||
44454598|NCT00051025|79463196|FG001|Overall Study|Progressive Disease|1|||
44454599|NCT00051025|79463195|FG000|Overall Study|Adverse Event|1|||
44454600|NCT00051025|79463196|FG001|Overall Study|Adverse Event|1|||
44454601|NCT00051025|79463195|FG000|Overall Study|Withdrawal by Subject|0|||
44454602|NCT00051025|79463196|FG001|Overall Study|Withdrawal by Subject|1|||
44454603|NCT00051025|79463195|FG000|Overall Study|Death|0|||
44454604|NCT00051025|79463196|FG001|Overall Study|Death|1|||
44454605|NCT00660179|79463205|FG000|Overall Study|Death|44|||
44454606|NCT00660179|79463206|FG001|Overall Study|Death|47|||
44454607|NCT00660179|79463207|FG002|Overall Study|Death|34|||
44454608|NCT00660179|79463205|FG000|Overall Study|Withdrawal of consent|4|||
44454609|NCT00660179|79463206|FG001|Overall Study|Withdrawal of consent|6|||
44454610|NCT00660179|79463207|FG002|Overall Study|Withdrawal of consent|4|||
44454611|NCT00660179|79463205|FG000|Overall Study|Lost to Follow-up|7|||
44454612|NCT00660179|79463206|FG001|Overall Study|Lost to Follow-up|5|||
44454613|NCT00660179|79463207|FG002|Overall Study|Lost to Follow-up|2|||
44454614|NCT00660179|79463205|FG000|Overall Study|Administrative reason|0|||
44454615|NCT00660179|79463206|FG001|Overall Study|Administrative reason|0|||
44454616|NCT00660179|79463207|FG002|Overall Study|Administrative reason|1|||
44454617|NCT00660179|79463205|FG000|Overall Study|Incorrect randomization|1|||
44454618|NCT00660179|79463206|FG001|Overall Study|Incorrect randomization|0|||
44454619|NCT00660179|79463207|FG002|Overall Study|Incorrect randomization|0|||
44454620|NCT00050167|79463217|FG000|Overall Study|not eligible not invasive|1|||
44454621|NCT00050167|79463218|FG001|Overall Study|not eligible not invasive|1|||
44454622|NCT00660023|79463224|FG000|Overall Study|Adverse Event|2|||
44454623|NCT00660023|79463224|FG000|Overall Study|Death|8|||
44454624|NCT00660023|79463224|FG000|Overall Study|Blood Transfusion|5|||
44454625|NCT00660023|79463224|FG000|Overall Study|Renal Transplantation|3|||
44454626|NCT00660023|79463224|FG000|Overall Study|Withdrawal by Subject|1|||
44454627|NCT00660023|79463224|FG000|Overall Study|Missed Pregnancy Test|1|||
44454628|NCT00660023|79463224|FG000|Overall Study|Other Screening Failure|9|||
44454629|NCT00062647|79463230|FG000|Overall Study|Death|2|||
44454630|NCT00062647|79463231|FG001|Overall Study|Death|2|||
44543731|NCT03847896|79556853|FG002|Overall Study|A severe exacerbation event|0|||
44214728|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
44214729|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
44214730|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
44214731|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
44214732|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
44214733|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
44214734|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
44214735|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
44214736|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
44214737|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
44214738|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
44214739|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
44214740|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
44214741|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
44214742|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
44214743|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
44214744|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
44214745|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
44214746|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
44454631|NCT00062647|79463230|FG000|Overall Study|Adverse Event|1|||
44454632|NCT00062647|79463231|FG001|Overall Study|Adverse Event|1|||
44454633|NCT00062647|79463230|FG000|Overall Study|Withdrawal by Subject|2|||
44454634|NCT00062647|79463231|FG001|Overall Study|Withdrawal by Subject|1|||
44454635|NCT00062647|79463230|FG000|Overall Study|Protocol Violation|1|||
44454636|NCT00062647|79463231|FG001|Overall Study|Protocol Violation|0|||
44454637|NCT00062647|79463230|FG000|Overall Study|Lost to Follow-up|1|||
44454638|NCT00062647|79463231|FG001|Overall Study|Lost to Follow-up|2|||
44454639|NCT00062647|79463230|FG000|Overall Study|Failed continuation criteria|4|||
44454640|NCT00062647|79463231|FG001|Overall Study|Failed continuation criteria|2|||
44454641|NCT00062647|79463230|FG000|Overall Study|Other|4|||
44454642|NCT00062647|79463231|FG001|Overall Study|Other|4|||
44454643|NCT00062647|79463230|FG000|Overall Study|Never received study treatment|1|||
44454644|NCT00062647|79463231|FG001|Overall Study|Never received study treatment|1|||
44454645|NCT00570323|79463239|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
44454646|NCT00570323|79463240|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
44454647|NCT00570323|79463239|FG000|Started Treatment After Randomization|Protocol Violation|1|||
44454648|NCT00570323|79463240|FG001|Started Treatment After Randomization|Protocol Violation|0|||
44454649|NCT00570323|79463239|FG000|Started Treatment After Randomization|Physician Decision|1|||
44454650|NCT00570323|79463240|FG001|Started Treatment After Randomization|Physician Decision|0|||
44454651|NCT00570323|79463239|FG000|Complete Study After Start|Lost to Follow-up|0|||
44454652|NCT00570323|79463240|FG001|Complete Study After Start|Lost to Follow-up|1|||
44454653|NCT00570323|79463239|FG000|Complete Study After Start|Withdrawal by Subject|2|||
44454654|NCT00570323|79463240|FG001|Complete Study After Start|Withdrawal by Subject|0|||
44454655|NCT00570323|79463239|FG000|Complete Study After Start|Physician Decision|1|||
44454656|NCT00570323|79463240|FG001|Complete Study After Start|Physician Decision|0|||
44454657|NCT00661505|79463248|FG000|Overall Study|Adverse Event|3|||
44454658|NCT00661505|79463248|FG000|Overall Study|Protocol Violation|14|||
44454659|NCT00661505|79463248|FG000|Overall Study|Withdrawal by Subject|8|||
44454660|NCT00661505|79463248|FG000|Overall Study|Lost to Follow-up|3|||
44454661|NCT00661505|79463248|FG000|Overall Study|Other|2|||
44454662|NCT00662909|79463256|FG000|Overall Study|Adverse Event|17|||
44454663|NCT00662909|79463257|FG001|Overall Study|Adverse Event|18|||
44454664|NCT00662909|79463258|FG002|Overall Study|Adverse Event|19|||
44454665|NCT00662909|79463256|FG000|Overall Study|Lack of Efficacy|9|||
44454666|NCT00662909|79463257|FG001|Overall Study|Lack of Efficacy|1|||
44454667|NCT00662909|79463258|FG002|Overall Study|Lack of Efficacy|5|||
44454668|NCT00662909|79463256|FG000|Overall Study|Withdrawal by Subject|29|||
44454669|NCT00662909|79463257|FG001|Overall Study|Withdrawal by Subject|22|||
44454670|NCT00662909|79463258|FG002|Overall Study|Withdrawal by Subject|16|||
44454671|NCT00662909|79463256|FG000|Overall Study|Lost to Follow-up|2|||
44454672|NCT00662909|79463257|FG001|Overall Study|Lost to Follow-up|9|||
44454673|NCT00662909|79463258|FG002|Overall Study|Lost to Follow-up|3|||
44454674|NCT00662909|79463256|FG000|Overall Study|Protocol Violation|7|||
44454675|NCT00662909|79463257|FG001|Overall Study|Protocol Violation|4|||
44454676|NCT00662909|79463258|FG002|Overall Study|Protocol Violation|5|||
44454677|NCT00662909|79463256|FG000|Overall Study|Randomized- never received study drug|1|||
44454678|NCT00662909|79463257|FG001|Overall Study|Randomized- never received study drug|0|||
44454679|NCT00662909|79463258|FG002|Overall Study|Randomized- never received study drug|0|||
44454680|NCT00662909|79463256|FG000|Overall Study|Non-compliance with study procedures|3|||
44454681|NCT00662909|79463257|FG001|Overall Study|Non-compliance with study procedures|3|||
44454682|NCT00662909|79463258|FG002|Overall Study|Non-compliance with study procedures|2|||
44454683|NCT00662909|79463256|FG000|Overall Study|Physician Decision|1|||
44454684|NCT00662909|79463257|FG001|Overall Study|Physician Decision|1|||
44454685|NCT00662909|79463258|FG002|Overall Study|Physician Decision|2|||
44454686|NCT00662909|79463256|FG000|Overall Study|Eligibility criterion not met|0|||
44454687|NCT00662909|79463257|FG001|Overall Study|Eligibility criterion not met|1|||
44454688|NCT00662909|79463258|FG002|Overall Study|Eligibility criterion not met|1|||
44454689|NCT00050011|79463268|FG000|Overall Study|Adverse Event|41|||
44454690|NCT00050011|79463269|FG001|Overall Study|Adverse Event|46|||
44454691|NCT00050011|79463268|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44454692|NCT00050011|79463269|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44454693|NCT00050011|79463268|FG000|Overall Study|Abnormal test procedure results|0|||
44454694|NCT00050011|79463269|FG001|Overall Study|Abnormal test procedure results|1|||
44454695|NCT00050011|79463268|FG000|Overall Study|Lack of Efficacy|16|||
44454696|NCT00050011|79463269|FG001|Overall Study|Lack of Efficacy|21|||
44454697|NCT00050011|79463268|FG000|Overall Study|Participant condition no longer required|1|||
44454698|NCT00050011|79463269|FG001|Overall Study|Participant condition no longer required|0|||
44454699|NCT00050011|79463268|FG000|Overall Study|Protocol Violation|4|||
44454700|NCT00050011|79463269|FG001|Overall Study|Protocol Violation|10|||
44454701|NCT00050011|79463268|FG000|Overall Study|Withdrawal by Subject|34|||
44454702|NCT00050011|79463269|FG001|Overall Study|Withdrawal by Subject|26|||
44454703|NCT00050011|79463268|FG000|Overall Study|Lost to Follow-up|7|||
44454704|NCT00050011|79463269|FG001|Overall Study|Lost to Follow-up|9|||
44454705|NCT00050011|79463268|FG000|Overall Study|Administrative problems|10|||
44454706|NCT00050011|79463269|FG001|Overall Study|Administrative problems|6|||
44454707|NCT00050011|79463268|FG000|Overall Study|Death|7|||
44454708|NCT00050011|79463269|FG001|Overall Study|Death|4|||
44454709|NCT00050011|79463268|FG000|Overall Study|Unknown - Reason is missing|0|||
44454710|NCT00050011|79463269|FG001|Overall Study|Unknown - Reason is missing|2|||
44454711|NCT00661427|79463278|FG000|Overall Study|Adverse Event|5|||
44454712|NCT00661427|79463279|FG001|Overall Study|Adverse Event|5|||
44454713|NCT00661427|79463278|FG000|Overall Study|Patient not treated|0|||
44454714|NCT00661427|79463279|FG001|Overall Study|Patient not treated|2|||
44454715|NCT00049543|79463287|FG000|Overall Study|still on treatment|2|||
44454716|NCT00049543|79463288|FG001|Overall Study|still on treatment|9|||
44454717|NCT00048997|79463296|FG000|Overall Study|Protocol Violation|7|||
44454718|NCT00048997|79463297|FG001|Overall Study|Protocol Violation|2|||
44454719|NCT00048997|79463296|FG000|Overall Study|Withdrawal by Subject|6|||
44454720|NCT00048997|79463297|FG001|Overall Study|Withdrawal by Subject|1|||
44454721|NCT00035815|79463304|FG000|Overall Study|Withdrawal by Subject|17|||
44454722|NCT00035815|79463305|FG001|Overall Study|Withdrawal by Subject|11|||
44454723|NCT00662831|79463313|FG000|Overall Study|Death|4|||
44454724|NCT00662831|79463314|FG001|Overall Study|Death|1|||
44454725|NCT00662831|79463313|FG000|Overall Study|Lack of Efficacy|6|||
44454726|NCT00662831|79463314|FG001|Overall Study|Lack of Efficacy|6|||
44454727|NCT00662831|79463313|FG000|Overall Study|Lost to Follow-up|1|||
44454728|NCT00662831|79463314|FG001|Overall Study|Lost to Follow-up|0|||
44454729|NCT00662831|79463313|FG000|Overall Study|Withdrawal by Subject|2|||
44454730|NCT00662831|79463314|FG001|Overall Study|Withdrawal by Subject|1|||
44454731|NCT00662831|79463313|FG000|Overall Study|Other|62|||
44454732|NCT00662831|79463314|FG001|Overall Study|Other|31|||
44454733|NCT00662831|79463313|FG000|Overall Study|Protocol Violation|8|||
44454734|NCT00662831|79463314|FG001|Overall Study|Protocol Violation|4|||
44454735|NCT00662831|79463313|FG000|Overall Study|Adverse Event|23|||
44454736|NCT00662831|79463314|FG001|Overall Study|Adverse Event|16|||
44454737|NCT00662363|79463322|FG000|Overall Study|Withdrawal by Subject|6|||
44454738|NCT00662363|79463323|FG001|Overall Study|Withdrawal by Subject|5|||
44454739|NCT00662363|79463322|FG000|Overall Study|Adverse Event|0|||
44454740|NCT00662363|79463323|FG001|Overall Study|Adverse Event|3|||
44454741|NCT00662363|79463322|FG000|Overall Study|Discharged early from rehab|4|||
44454742|NCT00662363|79463323|FG001|Overall Study|Discharged early from rehab|1|||
44454743|NCT00662363|79463322|FG000|Overall Study|Protocol Violation|1|||
44454744|NCT00662363|79463323|FG001|Overall Study|Protocol Violation|1|||
44454745|NCT00661271|79463333|FG000|Overall Study|Lost to Follow-up|28|||
44454746|NCT00661271|79463334|FG001|Overall Study|Lost to Follow-up|25|||
44454747|NCT00661193|79463342|FG000|Overall Study|Adverse Event|2|||
44454748|NCT00661193|79463343|FG001|Overall Study|Adverse Event|1|||
44454749|NCT00661193|79463342|FG000|Overall Study|Withdrawal by Subject|3|||
44454750|NCT00661193|79463343|FG001|Overall Study|Withdrawal by Subject|1|||
44454751|NCT00661193|79463342|FG000|Overall Study|Progression|27|||
44454752|NCT00661193|79463343|FG001|Overall Study|Progression|24|||
44454753|NCT00661193|79463342|FG000|Overall Study|Not protocol specified|1|||
44454754|NCT00661193|79463343|FG001|Overall Study|Not protocol specified|0|||
44454755|NCT00658541|79463349|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
44454756|NCT00658541|79463350|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44454757|NCT00658541|79463349|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
44454758|NCT00658541|79463350|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44454759|NCT00048061|79463360|FG000|Overall Study|Adverse Event|41|||
44454760|NCT00048061|79463361|FG001|Overall Study|Adverse Event|32|||
44454761|NCT00048061|79463362|FG002|Overall Study|Adverse Event|44|||
44454762|NCT00048061|79463363|FG003|Overall Study|Adverse Event|37|||
44214747|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
44214748|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
44214749|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
44371410|NCT01928394|79376861|FG019|Treatment Period|Study drug toxicity|15|||
44371411|NCT01928394|79376862|FG020|Treatment Period|Study drug toxicity|4|||
44371412|NCT01928394|79376863|FG021|Treatment Period|Study drug toxicity|7|||
44371413|NCT01928394|79376864|FG022|Treatment Period|Study drug toxicity|4|||
44371414|NCT01928394|79376842|FG000|Treatment Period|AE unrelated to study drug|0|||
44371415|NCT01928394|79376843|FG001|Treatment Period|AE unrelated to study drug|0|||
44371416|NCT01928394|79376844|FG002|Treatment Period|AE unrelated to study drug|2|||
44371417|NCT01928394|79376845|FG003|Treatment Period|AE unrelated to study drug|3|||
44371418|NCT01928394|79376846|FG004|Treatment Period|AE unrelated to study drug|0|||
44371419|NCT01928394|79376847|FG005|Treatment Period|AE unrelated to study drug|5|||
44371420|NCT01928394|79376848|FG006|Treatment Period|AE unrelated to study drug|1|||
44371421|NCT01928394|79376849|FG007|Treatment Period|AE unrelated to study drug|0|||
44371422|NCT01928394|79376850|FG008|Treatment Period|AE unrelated to study drug|0|||
44371423|NCT01928394|79376851|FG009|Treatment Period|AE unrelated to study drug|2|||
44454763|NCT00048061|79463360|FG000|Overall Study|Lost to Follow-up|3|||
44454764|NCT00048061|79463361|FG001|Overall Study|Lost to Follow-up|2|||
44371424|NCT01928394|79376852|FG010|Treatment Period|AE unrelated to study drug|0|||
44454765|NCT00048061|79463362|FG002|Overall Study|Lost to Follow-up|4|||
44454766|NCT00048061|79463363|FG003|Overall Study|Lost to Follow-up|5|||
44454767|NCT00048061|79463360|FG000|Overall Study|Withdrawal by Subject|20|||
44454768|NCT00048061|79463361|FG001|Overall Study|Withdrawal by Subject|29|||
44454769|NCT00048061|79463362|FG002|Overall Study|Withdrawal by Subject|29|||
44454770|NCT00048061|79463363|FG003|Overall Study|Withdrawal by Subject|32|||
44454771|NCT00048061|79463360|FG000|Overall Study|Did not follow-up|5|||
44454772|NCT00048061|79463361|FG001|Overall Study|Did not follow-up|5|||
44454773|NCT00048061|79463362|FG002|Overall Study|Did not follow-up|4|||
44454774|NCT00048061|79463363|FG003|Overall Study|Did not follow-up|5|||
44454775|NCT00048061|79463360|FG000|Overall Study|Early improvement|6|||
44454776|NCT00048061|79463361|FG001|Overall Study|Early improvement|5|||
44454777|NCT00048061|79463362|FG002|Overall Study|Early improvement|3|||
44454778|NCT00048061|79463363|FG003|Overall Study|Early improvement|0|||
44454779|NCT00656513|79463376|FG000|Overall Study|Protocol Violation|1|||
44454780|NCT00656513|79463377|FG001|Overall Study|Protocol Violation|0|||
44454781|NCT00656513|79463378|FG002|Overall Study|Protocol Violation|2|||
44454782|NCT00656513|79463376|FG000|Overall Study|Withdrawal by Subject|0|||
44454783|NCT00656513|79463377|FG001|Overall Study|Withdrawal by Subject|11|||
44454784|NCT00656513|79463378|FG002|Overall Study|Withdrawal by Subject|4|||
44454785|NCT00656513|79463376|FG000|Overall Study|Death|0|||
44454786|NCT00656513|79463377|FG001|Overall Study|Death|0|||
44454787|NCT00656513|79463378|FG002|Overall Study|Death|1|||
44454788|NCT00656513|79463376|FG000|Overall Study|Missing data|0|||
44454789|NCT00656513|79463377|FG001|Overall Study|Missing data|11|||
44454790|NCT00656513|79463378|FG002|Overall Study|Missing data|9|||
44454791|NCT00656513|79463376|FG000|Overall Study|Incomplete treatment|3|||
44454792|NCT00656513|79463377|FG001|Overall Study|Incomplete treatment|0|||
44454793|NCT00656513|79463378|FG002|Overall Study|Incomplete treatment|0|||
44454794|NCT00656513|79463376|FG000|Overall Study|Treatment completed outside of timeframe|0|||
44454795|NCT00656513|79463377|FG001|Overall Study|Treatment completed outside of timeframe|3|||
44454796|NCT00656513|79463378|FG002|Overall Study|Treatment completed outside of timeframe|1|||
44454797|NCT00656513|79463376|FG000|Overall Study|Missing baseline form|0|||
44454798|NCT00656513|79463377|FG001|Overall Study|Missing baseline form|5|||
44454799|NCT00656513|79463378|FG002|Overall Study|Missing baseline form|5|||
44454800|NCT00655889|79463386|FG000|Overall Study|Inadequate cell growth|1|||
44454801|NCT00655889|79463386|FG000|Overall Study|Protocol Violation|1|||
44454802|NCT00655733|79463392|FG000|Overall Study|Lost to Follow-up|2|||
44454803|NCT00655733|79463393|FG001|Overall Study|Lost to Follow-up|2|||
44454804|NCT00655733|79463392|FG000|Overall Study|Adverse Event|2|||
44454805|NCT00655733|79463393|FG001|Overall Study|Adverse Event|2|||
44454806|NCT00655733|79463392|FG000|Overall Study|Withdrawal by Subject|3|||
44454807|NCT00655733|79463393|FG001|Overall Study|Withdrawal by Subject|3|||
44454808|NCT00655733|79463392|FG000|Overall Study|Physician Decision|0|||
44454809|NCT00655733|79463393|FG001|Overall Study|Physician Decision|1|||
44454810|NCT00657371|79463401|FG000|Overall Study|Poor bowel preparation|15|||
44454811|NCT00657371|79463401|FG000|Overall Study|Unable to intubate the cecum|5|||
44454812|NCT00657371|79463401|FG000|Overall Study|Protocol Violation|2|||
44454813|NCT00657371|79463401|FG000|Overall Study|Device- related reasons|13|||
44454814|NCT00657371|79463401|FG000|Overall Study|Pre-existing medical condition|4|||
44454815|NCT00658775|79463407|FG000|Overall Study|Adverse Event|4|||
44454816|NCT00658775|79463408|FG001|Overall Study|Adverse Event|6|||
44454817|NCT00658775|79463407|FG000|Overall Study|Lost to Follow-up|17|||
44454818|NCT00658775|79463408|FG001|Overall Study|Lost to Follow-up|18|||
44454819|NCT00658775|79463407|FG000|Overall Study|Withdrawal by Subject|6|||
44454820|NCT00658775|79463408|FG001|Overall Study|Withdrawal by Subject|4|||
44454821|NCT00658775|79463407|FG000|Overall Study|Withdrawal of consent|8|||
44454822|NCT00658775|79463408|FG001|Overall Study|Withdrawal of consent|7|||
44454823|NCT00658775|79463407|FG000|Overall Study|Other|7|||
44454824|NCT00658775|79463408|FG001|Overall Study|Other|8|||
44454825|NCT00488631|79463420|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
44454826|NCT00488631|79463421|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
44454827|NCT00488631|79463422|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
44454828|NCT00488631|79463423|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
44454829|NCT00488631|79463424|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
44454830|NCT00488631|79463425|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
44371425|NCT01928394|79376853|FG011|Treatment Period|AE unrelated to study drug|12|||
44371426|NCT01928394|79376854|FG012|Treatment Period|AE unrelated to study drug|6|||
44371427|NCT01928394|79376855|FG013|Treatment Period|AE unrelated to study drug|13|||
44371428|NCT01928394|79376856|FG014|Treatment Period|AE unrelated to study drug|6|||
44371429|NCT01928394|79376857|FG015|Treatment Period|AE unrelated to study drug|1|||
44371430|NCT01928394|79376858|FG016|Treatment Period|AE unrelated to study drug|1|||
44371431|NCT01928394|79376859|FG017|Treatment Period|AE unrelated to study drug|6|||
44371432|NCT01928394|79376860|FG018|Treatment Period|AE unrelated to study drug|3|||
44454831|NCT00488631|79463426|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
44454832|NCT00488631|79463427|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
44454833|NCT00488631|79463428|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
44454834|NCT00488631|79463429|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
44454835|NCT00488631|79463420|FG000|Double Blind Period (Week 0-54)|Death|0|||
44454836|NCT00488631|79463421|FG001|Double Blind Period (Week 0-54)|Death|0|||
44454837|NCT00488631|79463422|FG002|Double Blind Period (Week 0-54)|Death|0|||
44454838|NCT00488631|79463423|FG003|Double Blind Period (Week 0-54)|Death|0|||
44454839|NCT00488631|79463424|FG004|Double Blind Period (Week 0-54)|Death|0|||
44454840|NCT00488631|79463425|FG005|Double Blind Period (Week 0-54)|Death|1|||
44454841|NCT00488631|79463426|FG006|Double Blind Period (Week 0-54)|Death|0|||
44454842|NCT00488631|79463427|FG007|Double Blind Period (Week 0-54)|Death|0|||
44454843|NCT00488631|79463428|FG008|Double Blind Period (Week 0-54)|Death|0|||
44454844|NCT00488631|79463429|FG009|Double Blind Period (Week 0-54)|Death|0|||
44454845|NCT00488631|79463420|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
44454846|NCT00488631|79463421|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
44454847|NCT00488631|79463422|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
44454848|NCT00488631|79463423|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
44454849|NCT00488631|79463424|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
44454850|NCT00488631|79463425|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
44454851|NCT00488631|79463426|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
44454852|NCT00488631|79463427|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
44454853|NCT00488631|79463428|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
44454854|NCT00488631|79463429|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
44454855|NCT00488631|79463420|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
44454856|NCT00488631|79463421|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
44454857|NCT00488631|79463422|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
44454858|NCT00488631|79463423|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
44454859|NCT00488631|79463424|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
44454860|NCT00488631|79463425|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
44454861|NCT00488631|79463426|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
44454862|NCT00488631|79463427|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
44454863|NCT00488631|79463428|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
44454864|NCT00488631|79463429|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
44454865|NCT00488631|79463420|FG000|Double Blind Period (Week 0-54)|Other|6|||
44454866|NCT00488631|79463421|FG001|Double Blind Period (Week 0-54)|Other|12|||
44454867|NCT00488631|79463422|FG002|Double Blind Period (Week 0-54)|Other|10|||
44454868|NCT00488631|79463423|FG003|Double Blind Period (Week 0-54)|Other|11|||
44454869|NCT00488631|79463424|FG004|Double Blind Period (Week 0-54)|Other|14|||
44454870|NCT00488631|79463425|FG005|Double Blind Period (Week 0-54)|Other|34|||
44454871|NCT00488631|79463426|FG006|Double Blind Period (Week 0-54)|Other|0|||
44454872|NCT00488631|79463427|FG007|Double Blind Period (Week 0-54)|Other|0|||
44454873|NCT00488631|79463428|FG008|Double Blind Period (Week 0-54)|Other|0|||
44454874|NCT00488631|79463429|FG009|Double Blind Period (Week 0-54)|Other|0|||
44454875|NCT00488631|79463420|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454876|NCT00488631|79463421|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454877|NCT00488631|79463422|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454878|NCT00488631|79463423|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454879|NCT00488631|79463424|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454880|NCT00488631|79463425|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454881|NCT00488631|79463426|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
44454882|NCT00488631|79463427|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
44454883|NCT00488631|79463428|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
44454884|NCT00488631|79463429|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
44454885|NCT00488631|79463420|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
44454886|NCT00488631|79463421|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
44454887|NCT00488631|79463422|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
44454888|NCT00488631|79463423|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
44454889|NCT00488631|79463424|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
44454890|NCT00488631|79463425|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
44454891|NCT00488631|79463426|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
44454892|NCT00488631|79463427|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
44454893|NCT00488631|79463428|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
44543732|NCT03847896|79556854|FG003|Overall Study|A severe exacerbation event|0|||
44454894|NCT00488631|79463429|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
44454895|NCT00488631|79463420|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
44454896|NCT00488631|79463421|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
44454897|NCT00488631|79463422|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
44454898|NCT00488631|79463423|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
44454899|NCT00488631|79463424|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
44454900|NCT00488631|79463425|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
44454901|NCT00488631|79463426|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
44454902|NCT00488631|79463427|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
44543733|NCT03847896|79556855|FG004|Overall Study|A severe exacerbation event|3|||
44543734|NCT03847896|79556851|FG000|Overall Study|Protocol Violation|0|||
44543735|NCT03847896|79556852|FG001|Overall Study|Protocol Violation|2|||
44454903|NCT00488631|79463428|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
44454904|NCT00488631|79463429|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
44454905|NCT00488631|79463420|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454906|NCT00488631|79463421|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454907|NCT00488631|79463422|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454908|NCT00488631|79463423|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454909|NCT00488631|79463424|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454910|NCT00488631|79463425|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454911|NCT00488631|79463426|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
44454912|NCT00488631|79463427|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454913|NCT00488631|79463428|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
44454914|NCT00488631|79463429|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
44454915|NCT00488631|79463420|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454916|NCT00488631|79463421|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454917|NCT00488631|79463422|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454918|NCT00488631|79463423|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454919|NCT00488631|79463424|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454920|NCT00488631|79463425|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454921|NCT00488631|79463426|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
44454922|NCT00488631|79463427|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
44454923|NCT00488631|79463428|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
44454924|NCT00488631|79463429|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
44454925|NCT00655499|79463452|FG000|Overall Study|not eligible|4|||
44454926|NCT00654875|79463459|FG000|Overall Study|Adverse Event|5|||
44454927|NCT00654875|79463460|FG001|Overall Study|Adverse Event|5|||
44454928|NCT00654875|79463459|FG000|Overall Study|Withdrawal by Subject|4|||
44454929|NCT00654875|79463460|FG001|Overall Study|Withdrawal by Subject|4|||
44454930|NCT00654875|79463459|FG000|Overall Study|Protocol Violation|3|||
44454931|NCT00654875|79463460|FG001|Overall Study|Protocol Violation|3|||
44454932|NCT00654875|79463459|FG000|Overall Study|Lack of Efficacy|2|||
44454933|NCT00654875|79463460|FG001|Overall Study|Lack of Efficacy|2|||
44454934|NCT00654875|79463459|FG000|Overall Study|Lost to Follow-up|1|||
44454935|NCT00654875|79463460|FG001|Overall Study|Lost to Follow-up|3|||
44454936|NCT00654875|79463459|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
44454937|NCT00654875|79463460|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
44454938|NCT00654875|79463459|FG000|Overall Study|Administrative Problems|1|||
44454939|NCT00654875|79463460|FG001|Overall Study|Administrative Problems|0|||
44454940|NCT00651755|79463466|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
44454941|NCT00651755|79463467|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
44454942|NCT00651755|79463466|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
44454943|NCT00651755|79463467|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
44454944|NCT00654641|79463476|FG000|Overall Study|Lost to Follow-up|2|||
44454945|NCT00654641|79463477|FG001|Overall Study|Lost to Follow-up|3|||
44454946|NCT00569777|79463485|FG000|Overall Study|Withdrawal by Subject|4|||
44454947|NCT00569777|79463486|FG001|Overall Study|Withdrawal by Subject|0|||
44454948|NCT00569777|79463485|FG000|Overall Study|Adverse Event|3|||
44454949|NCT00569777|79463486|FG001|Overall Study|Adverse Event|0|||
44454950|NCT00569777|79463485|FG000|Overall Study|Lost to Follow-up|1|||
44454951|NCT00569777|79463486|FG001|Overall Study|Lost to Follow-up|0|||
44454952|NCT00569777|79463485|FG000|Overall Study|scheduled eye surgery|0|||
44454953|NCT00569777|79463486|FG001|Overall Study|scheduled eye surgery|1|||
44454954|NCT00569777|79463485|FG000|Overall Study|did not meet exclusion criteria|1|||
44454955|NCT00569777|79463486|FG001|Overall Study|did not meet exclusion criteria|2|||
44454956|NCT00569777|79463485|FG000|Overall Study|pregnant|1|||
44454957|NCT00569777|79463486|FG001|Overall Study|pregnant|0|||
44454958|NCT00569231|79463492|FG000|Overall Study|Study unrelated surgery|1|||
44454959|NCT00569231|79463492|FG000|Overall Study|Airfare expense|2|||
44454960|NCT00569231|79463492|FG000|Overall Study|Withdrawal by Subject|1|||
44454961|NCT00569231|79463492|FG000|Overall Study|Car accident injury|1|||
44454962|NCT00569231|79463492|FG000|Overall Study|Non-compliance|2|||
44454963|NCT00654095|79463496|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
44454964|NCT00654095|79463496|FG000|Overall Study|Elevated triglyceride level (2)|1|||
44454965|NCT00654095|79463496|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
44454966|NCT00654095|79463496|FG000|Overall Study|Adverse Event|11|||
44454967|NCT00654095|79463496|FG000|Overall Study|Withdrawal by Subject|5|||
44454968|NCT00654095|79463496|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
44454969|NCT00654095|79463496|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
44454970|NCT00654095|79463496|FG000|Overall Study|Did not meet inclusion criteria|1|||
44454971|NCT00650585|79463502|FG000|Overall Study|Lost to Follow-up|505|||
44454972|NCT00650585|79463503|FG001|Overall Study|Lost to Follow-up|482|||
44454973|NCT00650585|79463502|FG000|Overall Study|No parental consent|935|||
44454974|NCT00650585|79463503|FG001|Overall Study|No parental consent|866|||
44454975|NCT00650585|79463502|FG000|Overall Study|Excluded/ruled ineligible|357|||
44454976|NCT00650585|79463503|FG001|Overall Study|Excluded/ruled ineligible|129|||
44454977|NCT00653939|79463511|FG000|Overall Study|Adverse Event|1|||
44454978|NCT00653939|79463512|FG001|Overall Study|Adverse Event|3|||
44454979|NCT00653939|79463511|FG000|Overall Study|Withdrawal by Subject|3|||
44454980|NCT00653939|79463512|FG001|Overall Study|Withdrawal by Subject|3|||
44454981|NCT00653939|79463511|FG000|Overall Study|Physician Decision|4|||
44454982|NCT00653939|79463512|FG001|Overall Study|Physician Decision|0|||
44454983|NCT00653939|79463511|FG000|Overall Study|Disease Progression|2|||
44454984|NCT00653939|79463512|FG001|Overall Study|Disease Progression|3|||
44454985|NCT00653939|79463511|FG000|Overall Study|Other|2|||
44454986|NCT00653939|79463512|FG001|Overall Study|Other|6|||
44454987|NCT00646451|79463520|FG000|Overall Study|Adverse Event|3|||
44454988|NCT00646451|79463521|FG001|Overall Study|Adverse Event|0|||
44454989|NCT00646451|79463520|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
44454990|NCT00646451|79463521|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
44454991|NCT00642707|79463533|FG000|Overall Study|Adverse Event|0|||
44454992|NCT00642707|79463534|FG001|Overall Study|Adverse Event|0|||
44454993|NCT00642707|79463535|FG002|Overall Study|Adverse Event|0|||
44454994|NCT00642707|79463536|FG003|Overall Study|Adverse Event|2|||
44454995|NCT00642707|79463533|FG000|Overall Study|Withdrawal by Subject|1|||
44454996|NCT00642707|79463534|FG001|Overall Study|Withdrawal by Subject|0|||
44454997|NCT00642707|79463535|FG002|Overall Study|Withdrawal by Subject|0|||
44454998|NCT00642707|79463536|FG003|Overall Study|Withdrawal by Subject|0|||
44454999|NCT00568685|79463549|FG000|Overall Study|Adverse Event|2|||
44455000|NCT00568685|79463550|FG001|Overall Study|Adverse Event|3|||
44455001|NCT00568685|79463551|FG002|Overall Study|Adverse Event|3|||
44455002|NCT00568685|79463549|FG000|Overall Study|Withdrawal by Subject|7|||
44543736|NCT03847896|79556853|FG002|Overall Study|Protocol Violation|1|||
44543737|NCT03847896|79556854|FG003|Overall Study|Protocol Violation|0|||
44214750|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
44214751|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
44214752|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
44214753|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
44214754|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
44214755|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
44214756|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
44214757|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
44214758|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
44214759|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
44214760|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
44214761|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
44214762|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
44214763|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
44214764|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
44214765|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
44214766|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
44214767|NCT01807520|79012515|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
44270115|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270116|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270117|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270118|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270119|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270120|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44371433|NCT01928394|79376861|FG019|Treatment Period|AE unrelated to study drug|5|||
44371434|NCT01928394|79376862|FG020|Treatment Period|AE unrelated to study drug|1|||
44371435|NCT01928394|79376863|FG021|Treatment Period|AE unrelated to study drug|1|||
44371436|NCT01928394|79376864|FG022|Treatment Period|AE unrelated to study drug|0|||
44371437|NCT01928394|79376842|FG000|Treatment Period|Participant request to stop therapy|0|||
44371438|NCT01928394|79376843|FG001|Treatment Period|Participant request to stop therapy|0|||
44371439|NCT01928394|79376844|FG002|Treatment Period|Participant request to stop therapy|0|||
44371440|NCT01928394|79376845|FG003|Treatment Period|Participant request to stop therapy|0|||
44371441|NCT01928394|79376846|FG004|Treatment Period|Participant request to stop therapy|0|||
44371442|NCT01928394|79376847|FG005|Treatment Period|Participant request to stop therapy|3|||
44371443|NCT01928394|79376848|FG006|Treatment Period|Participant request to stop therapy|3|||
44371444|NCT01928394|79376849|FG007|Treatment Period|Participant request to stop therapy|0|||
44455003|NCT00568685|79463550|FG001|Overall Study|Withdrawal by Subject|2|||
44455004|NCT00568685|79463551|FG002|Overall Study|Withdrawal by Subject|2|||
44543738|NCT03847896|79556855|FG004|Overall Study|Protocol Violation|2|||
44543739|NCT03847896|79556851|FG000|Overall Study|Lost to Follow-up|0|||
44543740|NCT03847896|79556852|FG001|Overall Study|Lost to Follow-up|0|||
44543741|NCT03847896|79556853|FG002|Overall Study|Lost to Follow-up|0|||
44543742|NCT03847896|79556854|FG003|Overall Study|Lost to Follow-up|1|||
44543743|NCT03847896|79556855|FG004|Overall Study|Lost to Follow-up|0|||
44543744|NCT03847896|79556851|FG000|Overall Study|Condition under investigation worsened|0|||
44543745|NCT03847896|79556852|FG001|Overall Study|Condition under investigation worsened|0|||
44543746|NCT03847896|79556853|FG002|Overall Study|Condition under investigation worsened|0|||
44543747|NCT03847896|79556854|FG003|Overall Study|Condition under investigation worsened|1|||
44543748|NCT03847896|79556855|FG004|Overall Study|Condition under investigation worsened|1|||
44543749|NCT03847896|79556851|FG000|Overall Study|Lack of Efficacy|0|||
44543750|NCT03847896|79556852|FG001|Overall Study|Lack of Efficacy|0|||
44543751|NCT03847896|79556853|FG002|Overall Study|Lack of Efficacy|0|||
44543752|NCT03847896|79556854|FG003|Overall Study|Lack of Efficacy|2|||
44543753|NCT03847896|79556855|FG004|Overall Study|Lack of Efficacy|2|||
44455005|NCT00568685|79463549|FG000|Overall Study|Protocol Violation|1|||
44455006|NCT00568685|79463550|FG001|Overall Study|Protocol Violation|0|||
44455007|NCT00568685|79463551|FG002|Overall Study|Protocol Violation|0|||
44455008|NCT00061945|79463565|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
44455009|NCT00061945|79463566|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
44455010|NCT00061945|79463565|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
44455011|NCT00061945|79463566|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
44455012|NCT00061945|79463565|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
44455013|NCT00061945|79463566|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
44455014|NCT00061945|79463565|FG000|Course IV: Alemtuzumab|Early exits|6|||
44455015|NCT00061945|79463566|FG001|Course IV: Alemtuzumab|Early exits|15|||
44455016|NCT00642473|79463577|FG000|Overall Study|Withdrawal by Subject|0|||
44455017|NCT00642473|79463578|FG001|Overall Study|Withdrawal by Subject|5|||
44455018|NCT00642473|79463577|FG000|Overall Study|Progression or death|2|||
44455019|NCT00642473|79463578|FG001|Overall Study|Progression or death|4|||
44455020|NCT00642473|79463577|FG000|Overall Study|Other|2|||
44455021|NCT00642473|79463578|FG001|Overall Study|Other|2|||
44455022|NCT00645671|79463589|FG000|Overall Study|Protocol Violation|1|||
44455023|NCT00645671|79463590|FG001|Overall Study|Protocol Violation|0|||
44455024|NCT00645671|79463589|FG000|Overall Study|Withdrawal by Subject|0|||
44455025|NCT00645671|79463590|FG001|Overall Study|Withdrawal by Subject|4|||
44455026|NCT00645671|79463589|FG000|Overall Study|Adverse Event|0|||
44455027|NCT00645671|79463590|FG001|Overall Study|Adverse Event|1|||
44455028|NCT00645671|79463589|FG000|Overall Study|Physician Decision|0|||
44455029|NCT00645671|79463590|FG001|Overall Study|Physician Decision|1|||
44455030|NCT00366340|79463598|FG000|Infant Series|Protocol Violation|3|||
44455031|NCT00366340|79463599|FG001|Infant Series|Protocol Violation|4|||
44455032|NCT00366340|79463598|FG000|Infant Series|Withdrawal by Subject|3|||
44455033|NCT00366340|79463599|FG001|Infant Series|Withdrawal by Subject|3|||
44455034|NCT00366340|79463598|FG000|Infant Series|Adverse Event|0|||
44455035|NCT00366340|79463599|FG001|Infant Series|Adverse Event|2|||
44455036|NCT00366340|79463598|FG000|Infant Series|Lost to Follow-up|1|||
44214768|NCT01807520|79012516|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
44455037|NCT00366340|79463599|FG001|Infant Series|Lost to Follow-up|1|||
44455038|NCT00366340|79463598|FG000|Infant Series|Failure to return|1|||
44455039|NCT00366340|79463599|FG001|Infant Series|Failure to return|0|||
44455040|NCT00366340|79463598|FG000|After the Infant Series|Parent/legal guardian request|1|||
44455041|NCT00366340|79463599|FG001|After the Infant Series|Parent/legal guardian request|1|||
44455042|NCT00366340|79463598|FG000|After the Infant Series|Failed to return|0|||
44455043|NCT00366340|79463599|FG001|After the Infant Series|Failed to return|1|||
44455044|NCT00366340|79463598|FG000|After the Infant Series|Protocol Violation|2|||
44455045|NCT00366340|79463599|FG001|After the Infant Series|Protocol Violation|2|||
44455046|NCT00366340|79463598|FG000|After the Infant Series|Adverse Event|0|||
44214769|NCT01807520|79012517|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
44214770|NCT01807520|79012518|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
44214771|NCT01807520|79012519|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
44214772|NCT01807520|79012520|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
44214773|NCT01807520|79012521|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
44214774|NCT01807520|79012515|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
44455047|NCT00366340|79463599|FG001|After the Infant Series|Adverse Event|1|||
44543754|NCT03847896|79556851|FG000|Overall Study|Other reasons|3|||
44214775|NCT01807520|79012516|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
44455048|NCT00366340|79463598|FG000|After the Infant Series|Lost to Follow-up|0|||
44455049|NCT00366340|79463599|FG001|After the Infant Series|Lost to Follow-up|1|||
44455050|NCT00366340|79463598|FG000|Toddler Dose|Failed to return|1|||
44455051|NCT00366340|79463599|FG001|Toddler Dose|Failed to return|0|||
44455052|NCT00366340|79463598|FG000|Toddler Dose|Parent/legal guardian request|0|||
44455053|NCT00366340|79463599|FG001|Toddler Dose|Parent/legal guardian request|1|||
44455054|NCT00061633|79463631|FG000|Overall Study|Adverse Event|1|||
44455055|NCT00061633|79463632|FG001|Overall Study|Adverse Event|2|||
44543755|NCT03847896|79556852|FG001|Overall Study|Other reasons|3|||
44214776|NCT01807520|79012517|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
44214777|NCT01807520|79012518|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
44214778|NCT01807520|79012519|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
44214779|NCT01807520|79012520|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
44214780|NCT01807520|79012521|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
44214781|NCT01807520|79012515|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
44214782|NCT01807520|79012516|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
44214783|NCT01807520|79012517|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
44214784|NCT01807520|79012518|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
44214785|NCT01807520|79012519|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
44214786|NCT01807520|79012520|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
44214787|NCT01807520|79012521|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
44214788|NCT01807520|79012515|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
44214789|NCT01807520|79012516|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
44214790|NCT01807520|79012517|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
44214791|NCT01807520|79012518|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
44214792|NCT01807520|79012519|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
44214793|NCT01807520|79012520|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
44214794|NCT01807520|79012521|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
44214795|NCT01806896|79012534|FG000|Overall Study|Adverse Event|2|||
44214796|NCT01806896|79012535|FG001|Overall Study|Adverse Event|0|||
44214797|NCT01806896|79012534|FG000|Overall Study|Other|1|||
44214798|NCT01806896|79012535|FG001|Overall Study|Other|0|||
44214799|NCT01768676|79012543|FG000|Overall Study|Adverse Event|3|||
44214800|NCT01768676|79012544|FG001|Overall Study|Adverse Event|3|||
44214801|NCT01768676|79012543|FG000|Overall Study|Lost to Follow-up|13|||
44214802|NCT01768676|79012544|FG001|Overall Study|Lost to Follow-up|16|||
44214803|NCT01768676|79012543|FG000|Overall Study|Protocol Violation|1|||
44214804|NCT01768676|79012544|FG001|Overall Study|Protocol Violation|1|||
44214805|NCT01768676|79012543|FG000|Overall Study|Physician Decision|4|||
44214806|NCT01768676|79012544|FG001|Overall Study|Physician Decision|1|||
44214807|NCT01768676|79012543|FG000|Overall Study|Withdrawal by Subject|3|||
44214808|NCT01768676|79012544|FG001|Overall Study|Withdrawal by Subject|10|||
44214809|NCT01555125|79012553|FG000|Induction Period|Lost to Follow-up|0|||
44214810|NCT01555125|79012554|FG001|Induction Period|Lost to Follow-up|2|||
44214811|NCT01555125|79012555|FG002|Induction Period|Lost to Follow-up|0|||
44214812|NCT01555125|79012556|FG003|Induction Period|Lost to Follow-up|0|||
44214813|NCT01555125|79012557|FG004|Induction Period|Lost to Follow-up|0|||
44214814|NCT01555125|79012553|FG000|Induction Period|Adverse Event|0|||
44214815|NCT01555125|79012554|FG001|Induction Period|Adverse Event|1|||
44214816|NCT01555125|79012555|FG002|Induction Period|Adverse Event|0|||
44214817|NCT01555125|79012556|FG003|Induction Period|Adverse Event|0|||
44214818|NCT01555125|79012557|FG004|Induction Period|Adverse Event|1|||
44214819|NCT01555125|79012553|FG000|Induction Period|Subject / guardian decision|0|||
44214820|NCT01555125|79012554|FG001|Induction Period|Subject / guardian decision|0|||
44214821|NCT01555125|79012555|FG002|Induction Period|Subject / guardian decision|0|||
44214822|NCT01555125|79012556|FG003|Induction Period|Subject / guardian decision|0|||
44214823|NCT01555125|79012557|FG004|Induction Period|Subject / guardian decision|2|||
44214824|NCT01555125|79012553|FG000|Induction Period|Death|1|||
44214825|NCT01555125|79012554|FG001|Induction Period|Death|0|||
44214826|NCT01555125|79012555|FG002|Induction Period|Death|0|||
44214827|NCT01555125|79012556|FG003|Induction Period|Death|0|||
44214828|NCT01555125|79012557|FG004|Induction Period|Death|0|||
44214829|NCT01555125|79012553|FG000|Maintenance Period|Adverse Event|1|||
44214830|NCT01555125|79012554|FG001|Maintenance Period|Adverse Event|1|||
44214831|NCT01555125|79012555|FG002|Maintenance Period|Adverse Event|0|||
44214832|NCT01555125|79012556|FG003|Maintenance Period|Adverse Event|0|||
44214833|NCT01555125|79012557|FG004|Maintenance Period|Adverse Event|0|||
44214834|NCT01555125|79012553|FG000|Maintenance Period|Subject / guardian decision|1|||
44214835|NCT01555125|79012554|FG001|Maintenance Period|Subject / guardian decision|2|||
44214836|NCT01555125|79012555|FG002|Maintenance Period|Subject / guardian decision|0|||
44214837|NCT01555125|79012556|FG003|Maintenance Period|Subject / guardian decision|0|||
44214838|NCT01555125|79012557|FG004|Maintenance Period|Subject / guardian decision|0|||
44214839|NCT01555125|79012553|FG000|Maintenance Period|Lost to Follow-up|2|||
44455056|NCT00061633|79463631|FG000|Overall Study|Withdrawal by Subject|2|||
44455057|NCT00061633|79463632|FG001|Overall Study|Withdrawal by Subject|2|||
44455058|NCT00061633|79463631|FG000|Overall Study|Lost to Follow-up|1|||
44214840|NCT01555125|79012554|FG001|Maintenance Period|Lost to Follow-up|0|||
44214841|NCT01555125|79012555|FG002|Maintenance Period|Lost to Follow-up|0|||
44214842|NCT01555125|79012556|FG003|Maintenance Period|Lost to Follow-up|1|||
44455059|NCT00061633|79463632|FG001|Overall Study|Lost to Follow-up|4|||
44214843|NCT01555125|79012557|FG004|Maintenance Period|Lost to Follow-up|0|||
44214844|NCT01555125|79012553|FG000|Maintenance Period|Lack of Efficacy|6|||
44214845|NCT01555125|79012554|FG001|Maintenance Period|Lack of Efficacy|1|||
44214846|NCT01555125|79012555|FG002|Maintenance Period|Lack of Efficacy|3|||
44455060|NCT00061633|79463631|FG000|Overall Study|Other|1|||
44455061|NCT00061633|79463632|FG001|Overall Study|Other|1|||
44455062|NCT00061633|79463631|FG000|Overall Study|Never received study treatment|0|||
44455063|NCT00061633|79463632|FG001|Overall Study|Never received study treatment|2|||
44455064|NCT00645593|79463640|FG000|Overall Study|Later found to be ineligible|1|||
44455065|NCT00645593|79463641|FG001|Overall Study|Later found to be ineligible|0|||
44455066|NCT03832738|79463650|FG000|Overall Study|Withdrawal by Subject|6|||
44455067|NCT03832738|79463651|FG001|Overall Study|Withdrawal by Subject|7|||
44455068|NCT03832738|79463652|FG002|Overall Study|Withdrawal by Subject|16|||
44455069|NCT03832738|79463650|FG000|Overall Study|Physician Decision|0|||
44455070|NCT03832738|79463651|FG001|Overall Study|Physician Decision|1|||
44455071|NCT03832738|79463652|FG002|Overall Study|Physician Decision|2|||
44455072|NCT03832738|79463650|FG000|Overall Study|Adverse Event|2|||
44455073|NCT03832738|79463651|FG001|Overall Study|Adverse Event|3|||
44455074|NCT03832738|79463652|FG002|Overall Study|Adverse Event|1|||
44455075|NCT03832738|79463650|FG000|Overall Study|Pregnancy|0|||
44455076|NCT03832738|79463651|FG001|Overall Study|Pregnancy|1|||
44214847|NCT01555125|79012556|FG003|Maintenance Period|Lack of Efficacy|0|||
44214848|NCT01555125|79012557|FG004|Maintenance Period|Lack of Efficacy|0|||
44214849|NCT01555125|79012553|FG000|Maintenance Period|Physician Decision|0|||
44214850|NCT01555125|79012554|FG001|Maintenance Period|Physician Decision|0|||
44214851|NCT01555125|79012555|FG002|Maintenance Period|Physician Decision|1|||
44214852|NCT01555125|79012556|FG003|Maintenance Period|Physician Decision|0|||
44214853|NCT01555125|79012557|FG004|Maintenance Period|Physician Decision|0|||
44214854|NCT01555125|79012553|FG000|Maintenance Period|Death|0|||
44214855|NCT01555125|79012554|FG001|Maintenance Period|Death|0|||
44214856|NCT01555125|79012555|FG002|Maintenance Period|Death|0|||
44214857|NCT01555125|79012556|FG003|Maintenance Period|Death|1|||
44214858|NCT01555125|79012557|FG004|Maintenance Period|Death|0|||
44214859|NCT01555125|79012553|FG000|Extension|Adverse Event|1|||
44214860|NCT01555125|79012554|FG001|Extension|Adverse Event|2|||
44214861|NCT01555125|79012555|FG002|Extension|Adverse Event|1|||
44214862|NCT01555125|79012556|FG003|Extension|Adverse Event|1|||
44214863|NCT01555125|79012557|FG004|Extension|Adverse Event|0|||
44214864|NCT01555125|79012553|FG000|Extension|Protocol deviation|1|||
44214865|NCT01555125|79012554|FG001|Extension|Protocol deviation|0|||
44214866|NCT01555125|79012555|FG002|Extension|Protocol deviation|0|||
44214867|NCT01555125|79012556|FG003|Extension|Protocol deviation|0|||
44214868|NCT01555125|79012557|FG004|Extension|Protocol deviation|0|||
44214869|NCT01555125|79012553|FG000|Extension|Lack of Efficacy|7|||
44214870|NCT01555125|79012554|FG001|Extension|Lack of Efficacy|6|||
44214871|NCT01555125|79012555|FG002|Extension|Lack of Efficacy|3|||
44214872|NCT01555125|79012556|FG003|Extension|Lack of Efficacy|0|||
44214873|NCT01555125|79012557|FG004|Extension|Lack of Efficacy|0|||
44214874|NCT01555125|79012553|FG000|Extension|Lost to Follow-up|2|||
44214875|NCT01555125|79012554|FG001|Extension|Lost to Follow-up|1|||
44214876|NCT01555125|79012555|FG002|Extension|Lost to Follow-up|2|||
44214877|NCT01555125|79012556|FG003|Extension|Lost to Follow-up|0|||
44455077|NCT03832738|79463652|FG002|Overall Study|Pregnancy|0|||
44214878|NCT01555125|79012557|FG004|Extension|Lost to Follow-up|0|||
44371445|NCT01928394|79376850|FG008|Treatment Period|Participant request to stop therapy|0|||
44214879|NCT01555125|79012553|FG000|Extension|Study terminated by sponsor|32|||
44214880|NCT01555125|79012554|FG001|Extension|Study terminated by sponsor|33|||
44214881|NCT01555125|79012555|FG002|Extension|Study terminated by sponsor|16|||
44371446|NCT01928394|79376851|FG009|Treatment Period|Participant request to stop therapy|0|||
44371447|NCT01928394|79376852|FG010|Treatment Period|Participant request to stop therapy|3|||
44371448|NCT01928394|79376853|FG011|Treatment Period|Participant request to stop therapy|2|||
44371449|NCT01928394|79376854|FG012|Treatment Period|Participant request to stop therapy|1|||
44371450|NCT01928394|79376855|FG013|Treatment Period|Participant request to stop therapy|2|||
44371451|NCT01928394|79376856|FG014|Treatment Period|Participant request to stop therapy|4|||
44455078|NCT00046891|79463662|FG000|Overall Study|Cancels|5|||
44455079|NCT00046891|79463663|FG001|Overall Study|Cancels|9|||
44455080|NCT00046891|79463662|FG000|Overall Study|Ineligible|1|||
44455081|NCT00046891|79463663|FG001|Overall Study|Ineligible|1|||
44455082|NCT00046891|79463662|FG000|Overall Study|Withdrawal by Subject|18|||
44455083|NCT00046891|79463663|FG001|Overall Study|Withdrawal by Subject|15|||
44455084|NCT00046891|79463662|FG000|Overall Study|Adverse Event|5|||
44214882|NCT01555125|79012556|FG003|Extension|Study terminated by sponsor|20|||
44214883|NCT01555125|79012557|FG004|Extension|Study terminated by sponsor|0|||
44214884|NCT01555125|79012553|FG000|Extension|Subject/guardian decision|1|||
44455085|NCT00046891|79463663|FG001|Overall Study|Adverse Event|5|||
44455086|NCT00365794|79463677|FG000|Overall Study|Withdrawal by Subject|2|||
44455087|NCT00383500|79463685|FG000|Overall Study|Withdrawal by Subject|8|||
44455088|NCT00383500|79463686|FG001|Overall Study|Withdrawal by Subject|3|||
44455089|NCT00383500|79463687|FG002|Overall Study|Withdrawal by Subject|0|||
44455090|NCT00383500|79463685|FG000|Overall Study|Lost to Follow-up|0|||
44455091|NCT00383500|79463686|FG001|Overall Study|Lost to Follow-up|0|||
44455092|NCT00383500|79463687|FG002|Overall Study|Lost to Follow-up|2|||
44455093|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
44455094|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
44455095|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
44455096|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
44455097|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
44455098|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
44455099|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
44455100|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
44455101|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
44214885|NCT01555125|79012554|FG001|Extension|Subject/guardian decision|9|||
44455102|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
44455103|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
44455104|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
44214886|NCT01555125|79012555|FG002|Extension|Subject/guardian decision|1|||
44214887|NCT01555125|79012556|FG003|Extension|Subject/guardian decision|0|||
44214888|NCT01555125|79012557|FG004|Extension|Subject/guardian decision|0|||
44214889|NCT01555125|79012553|FG000|Extension|Technical Problems|1|||
44214890|NCT01555125|79012554|FG001|Extension|Technical Problems|0|||
44214891|NCT01555125|79012555|FG002|Extension|Technical Problems|0|||
44214892|NCT01555125|79012556|FG003|Extension|Technical Problems|1|||
44214893|NCT01555125|79012557|FG004|Extension|Technical Problems|0|||
44214894|NCT01555125|79012553|FG000|Follow-Up Period|Lost to Follow-up|1|||
44214895|NCT01555125|79012554|FG001|Follow-Up Period|Lost to Follow-up|0|||
44214896|NCT01555125|79012555|FG002|Follow-Up Period|Lost to Follow-up|0|||
44214897|NCT01555125|79012556|FG003|Follow-Up Period|Lost to Follow-up|0|||
44214898|NCT01555125|79012557|FG004|Follow-Up Period|Lost to Follow-up|0|||
44214899|NCT01555125|79012553|FG000|Follow-Up Period|Subject / guardian decision|3|||
44214900|NCT01555125|79012554|FG001|Follow-Up Period|Subject / guardian decision|1|||
44214901|NCT01555125|79012555|FG002|Follow-Up Period|Subject / guardian decision|1|||
44214902|NCT01555125|79012556|FG003|Follow-Up Period|Subject / guardian decision|1|||
44214903|NCT01555125|79012557|FG004|Follow-Up Period|Subject / guardian decision|0|||
44214904|NCT01768286|79012576|FG000|Overall Study|Randomized But Not Treated|0|||
44214905|NCT01768286|79012577|FG001|Overall Study|Randomized But Not Treated|0|||
44214906|NCT01768286|79012578|FG002|Overall Study|Randomized But Not Treated|1|||
44214907|NCT01768286|79012579|FG003|Overall Study|Randomized But Not Treated|0|||
44214908|NCT01768286|79012576|FG000|Overall Study|Lack of Efficacy|7|||
44214909|NCT01768286|79012577|FG001|Overall Study|Lack of Efficacy|4|||
44214910|NCT01768286|79012578|FG002|Overall Study|Lack of Efficacy|0|||
44214911|NCT01768286|79012579|FG003|Overall Study|Lack of Efficacy|1|||
44214912|NCT01768286|79012576|FG000|Overall Study|Withdrew Consent|0|||
44214913|NCT01768286|79012577|FG001|Overall Study|Withdrew Consent|0|||
44214914|NCT01768286|79012578|FG002|Overall Study|Withdrew Consent|1|||
44214915|NCT01768286|79012579|FG003|Overall Study|Withdrew Consent|0|||
44214916|NCT01800968|79012591|FG000|Overall Study|Death|23|||
44214917|NCT01800968|79012592|FG001|Overall Study|Death|16|||
44214918|NCT01800968|79012591|FG000|Overall Study|Lost to Follow-up|5|||
44214919|NCT01800968|79012592|FG001|Overall Study|Lost to Follow-up|7|||
44214920|NCT01800968|79012591|FG000|Overall Study|Withdrawal by Subject|7|||
44214921|NCT01800968|79012592|FG001|Overall Study|Withdrawal by Subject|9|||
44214922|NCT01800968|79012591|FG000|Overall Study|Physician Decision|1|||
44214923|NCT01800968|79012592|FG001|Overall Study|Physician Decision|0|||
44214924|NCT01799720|79012601|FG000|Overall Study|Withdrawal by Subject|3|||
44214925|NCT01799720|79012602|FG001|Overall Study|Withdrawal by Subject|0|||
44455105|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
44455106|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
44455107|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
44455108|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
44455109|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
44455110|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
44455111|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
44214926|NCT01799720|79012603|FG002|Overall Study|Withdrawal by Subject|0|||
44214927|NCT01799720|79012601|FG000|Overall Study|Protocol Violation|0|||
44214928|NCT01799720|79012602|FG001|Overall Study|Protocol Violation|1|||
44214929|NCT01799720|79012603|FG002|Overall Study|Protocol Violation|0|||
44214930|NCT01799720|79012601|FG000|Overall Study|Pregnancy|0|||
44455112|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
44455113|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
44214931|NCT01799720|79012602|FG001|Overall Study|Pregnancy|0|||
44214932|NCT01799720|79012603|FG002|Overall Study|Pregnancy|1|||
44214933|NCT01687257|79012613|FG000|Overall Study|Efficacy Failure|6|||
44214934|NCT01687257|79012614|FG001|Overall Study|Efficacy Failure|0|||
44214935|NCT01687257|79012615|FG002|Overall Study|Efficacy Failure|5|||
44214936|NCT01687257|79012613|FG000|Overall Study|Subject Withdrew Consent|1|||
44214937|NCT01687257|79012614|FG001|Overall Study|Subject Withdrew Consent|1|||
44214938|NCT01687257|79012615|FG002|Overall Study|Subject Withdrew Consent|1|||
44214939|NCT01687257|79012613|FG000|Overall Study|Adverse Event|1|||
44214940|NCT01687257|79012614|FG001|Overall Study|Adverse Event|0|||
44214941|NCT01687257|79012615|FG002|Overall Study|Adverse Event|0|||
44214942|NCT01687257|79012613|FG000|Overall Study|Investigator's Discretion|0|||
44214943|NCT01687257|79012614|FG001|Overall Study|Investigator's Discretion|3|||
44214944|NCT01687257|79012615|FG002|Overall Study|Investigator's Discretion|0|||
44214945|NCT01806740|79012629|FG000|Overall Study|Withdrawal by Subject|4|||
44214946|NCT01806740|79012629|FG000|Overall Study|Physician Decision|1|||
44214947|NCT01806740|79012629|FG000|Overall Study|Patient's refusal of treatment|1|||
44214948|NCT01687101|79012636|FG000|Overall Study|Lost to Follow-up|7|||
44214949|NCT01968967|79012642|FG000|Treatment Period|Other|22|||
44214950|NCT01968967|79012643|FG001|Treatment Period|Other|22|||
44214951|NCT01968967|79012644|FG002|Treatment Period|Other|0|||
44214952|NCT01968967|79012645|FG003|Treatment Period|Other|0|||
44543756|NCT03847896|79556853|FG002|Overall Study|Other reasons|1|||
44214953|NCT01968967|79012646|FG004|Treatment Period|Other|0|||
44214954|NCT01968967|79012642|FG000|Treatment Period|Withdrawal by Subject|71|||
44214955|NCT01968967|79012643|FG001|Treatment Period|Withdrawal by Subject|61|||
44214956|NCT01968967|79012644|FG002|Treatment Period|Withdrawal by Subject|0|||
44214957|NCT01968967|79012645|FG003|Treatment Period|Withdrawal by Subject|0|||
44214958|NCT01968967|79012646|FG004|Treatment Period|Withdrawal by Subject|0|||
44214959|NCT01968967|79012642|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
44214960|NCT01968967|79012643|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
44214961|NCT01968967|79012644|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
44214962|NCT01968967|79012645|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
44214963|NCT01968967|79012646|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
44214964|NCT01968967|79012642|FG000|Treatment Period|Lost to Follow-up|26|||
44214965|NCT01968967|79012643|FG001|Treatment Period|Lost to Follow-up|31|||
44214966|NCT01968967|79012644|FG002|Treatment Period|Lost to Follow-up|0|||
44214967|NCT01968967|79012645|FG003|Treatment Period|Lost to Follow-up|0|||
44214968|NCT01968967|79012646|FG004|Treatment Period|Lost to Follow-up|0|||
44214969|NCT01968967|79012642|FG000|Treatment Period|Protocol Violation|1|||
44214970|NCT01968967|79012643|FG001|Treatment Period|Protocol Violation|2|||
44214971|NCT01968967|79012644|FG002|Treatment Period|Protocol Violation|0|||
44214972|NCT01968967|79012645|FG003|Treatment Period|Protocol Violation|0|||
44214973|NCT01968967|79012646|FG004|Treatment Period|Protocol Violation|0|||
44214974|NCT01968967|79012642|FG000|Treatment Period|Adverse Event|9|||
44214975|NCT01968967|79012643|FG001|Treatment Period|Adverse Event|8|||
44214976|NCT01968967|79012644|FG002|Treatment Period|Adverse Event|0|||
44214977|NCT01968967|79012645|FG003|Treatment Period|Adverse Event|0|||
44214978|NCT01968967|79012646|FG004|Treatment Period|Adverse Event|0|||
44214979|NCT01968967|79012642|FG000|Treatment Period|Death|9|||
44214980|NCT01968967|79012643|FG001|Treatment Period|Death|2|||
44214981|NCT01968967|79012644|FG002|Treatment Period|Death|0|||
44214982|NCT01968967|79012645|FG003|Treatment Period|Death|0|||
44214983|NCT01968967|79012646|FG004|Treatment Period|Death|0|||
44214984|NCT01968967|79012642|FG000|Treatment Period|Randomized Not Treated|6|||
44214985|NCT01968967|79012643|FG001|Treatment Period|Randomized Not Treated|5|||
44214986|NCT01968967|79012644|FG002|Treatment Period|Randomized Not Treated|0|||
44214987|NCT01968967|79012645|FG003|Treatment Period|Randomized Not Treated|0|||
44214988|NCT01968967|79012646|FG004|Treatment Period|Randomized Not Treated|0|||
44214989|NCT01968967|79012642|FG000|Extension Period|Withdrew Consent|0|||
44214990|NCT01968967|79012643|FG001|Extension Period|Withdrew Consent|0|||
44214991|NCT01968967|79012644|FG002|Extension Period|Withdrew Consent|2|||
44214992|NCT01968967|79012645|FG003|Extension Period|Withdrew Consent|0|||
44270121|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44371452|NCT01928394|79376857|FG015|Treatment Period|Participant request to stop therapy|0|||
44371453|NCT01928394|79376858|FG016|Treatment Period|Participant request to stop therapy|1|||
44371454|NCT01928394|79376859|FG017|Treatment Period|Participant request to stop therapy|3|||
44543757|NCT03847896|79556854|FG003|Overall Study|Other reasons|2|||
44214993|NCT01968967|79012646|FG004|Extension Period|Withdrew Consent|5|||
44214994|NCT01554579|79012662|FG000|Overall Study|Adverse Event|6|||
44214995|NCT01554579|79012663|FG001|Overall Study|Adverse Event|25|||
44214996|NCT01554579|79012662|FG000|Overall Study|Lack of Efficacy|2|||
44214997|NCT01554579|79012663|FG001|Overall Study|Lack of Efficacy|1|||
44214998|NCT01554579|79012662|FG000|Overall Study|Withdrawal by Subject|2|||
44214999|NCT01554579|79012663|FG001|Overall Study|Withdrawal by Subject|1|||
44215000|NCT01806662|79012670|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
44215001|NCT01806662|79012671|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
44215002|NCT01806662|79012670|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
44215003|NCT01806662|79012671|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
44215004|NCT01806662|79012670|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
44215005|NCT01806662|79012671|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
44215006|NCT01806662|79012670|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
44215007|NCT01806662|79012671|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
44215008|NCT01930123|79012679|FG000|Overall Study|Adverse Event|1|||
44215009|NCT01930123|79012680|FG001|Overall Study|Adverse Event|0|||
44215010|NCT01930123|79012679|FG000|Overall Study|Physician Decision|21|||
44215011|NCT01930123|79012680|FG001|Overall Study|Physician Decision|8|||
44215012|NCT01930123|79012679|FG000|Overall Study|Withdrawal by Subject|1|||
44215013|NCT01930123|79012680|FG001|Overall Study|Withdrawal by Subject|0|||
44215014|NCT01930045|79012686|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
44215015|NCT01930045|79012687|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
44215016|NCT01930045|79012688|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
44215017|NCT01930045|79012689|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
44215018|NCT01930045|79012690|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
44215019|NCT01930045|79012691|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
44215020|NCT01930045|79012686|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
44215021|NCT01930045|79012687|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
44215022|NCT01930045|79012688|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
44455114|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Other|0|||
44455115|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Other|1|||
44455116|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Other|0|||
44455117|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Other|0|||
44455118|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Other|0|||
44455119|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Other|0|||
44455120|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Other|0|||
44455121|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
44455122|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
44455123|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
44455124|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
44455125|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
44455126|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
44455127|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
44455128|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
44455129|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
44455130|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
44455131|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
44455132|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
44455133|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
44455134|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
44455135|NCT00365716|79463701|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
44455136|NCT00365716|79463702|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
44455137|NCT00365716|79463703|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
44455138|NCT00365716|79463704|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
44455139|NCT00365716|79463705|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
44455140|NCT00365716|79463706|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
44455141|NCT00365716|79463707|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
44455142|NCT00365716|79463701|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
44455143|NCT00365716|79463702|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
44455144|NCT00365716|79463703|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
44455145|NCT00365716|79463704|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
44455146|NCT00365716|79463705|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
44215023|NCT01930045|79012689|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
44215024|NCT01930045|79012690|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
44455147|NCT00365716|79463706|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
44455148|NCT00365716|79463707|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
44215025|NCT01930045|79012691|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
44215026|NCT01929343|79012706|FG000|Overall Study|Physician Decision|0|||
44215027|NCT01929343|79012707|FG001|Overall Study|Physician Decision|2|||
44455149|NCT00365716|79463701|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
44455150|NCT00365716|79463702|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
44543758|NCT03847896|79556855|FG004|Overall Study|Other reasons|1|||
44215028|NCT01929343|79012708|FG002|Overall Study|Physician Decision|0|||
44455151|NCT00365716|79463703|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
44455152|NCT00365716|79463704|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
44455153|NCT00365716|79463705|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
44455154|NCT00365716|79463706|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
44455155|NCT00365716|79463707|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
44455156|NCT00365716|79463701|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
44455157|NCT00365716|79463702|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
44455158|NCT00365716|79463703|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
44455159|NCT00365716|79463704|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
44455160|NCT00365716|79463705|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
44455161|NCT00365716|79463706|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
44455162|NCT00365716|79463707|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
44455163|NCT00365716|79463701|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
44455164|NCT00365716|79463702|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
44455165|NCT00365716|79463703|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
44455166|NCT00365716|79463704|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
44455167|NCT00365716|79463705|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
44455168|NCT00365716|79463706|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
44455169|NCT00365716|79463707|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
44455170|NCT00365716|79463701|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
44455171|NCT00365716|79463702|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
44455172|NCT00365716|79463703|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
44455173|NCT00365716|79463704|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
44455174|NCT00365716|79463705|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
44455175|NCT00365716|79463706|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
44455176|NCT00365716|79463707|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
44455177|NCT00365716|79463701|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
44455178|NCT00365716|79463702|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
44455179|NCT00365716|79463703|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
44455180|NCT00365716|79463704|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
44455181|NCT00365716|79463705|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
44455182|NCT00365716|79463706|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
44455183|NCT00365716|79463707|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
44455184|NCT00365716|79463701|FG000|Extension 1|Lost to Follow-up|0|||
44455185|NCT00365716|79463702|FG001|Extension 1|Lost to Follow-up|0|||
44455186|NCT00365716|79463703|FG002|Extension 1|Lost to Follow-up|0|||
44455187|NCT00365716|79463704|FG003|Extension 1|Lost to Follow-up|0|||
44455188|NCT00365716|79463705|FG004|Extension 1|Lost to Follow-up|0|||
44455189|NCT00365716|79463706|FG005|Extension 1|Lost to Follow-up|1|||
44455190|NCT00365716|79463707|FG006|Extension 1|Lost to Follow-up|0|||
44455191|NCT00365716|79463701|FG000|Extension 1|Other|0|||
44455192|NCT00365716|79463702|FG001|Extension 1|Other|0|||
44455193|NCT00365716|79463703|FG002|Extension 1|Other|0|||
44455194|NCT00365716|79463704|FG003|Extension 1|Other|0|||
44455195|NCT00365716|79463705|FG004|Extension 1|Other|0|||
44455196|NCT00365716|79463706|FG005|Extension 1|Other|9|||
44455197|NCT00365716|79463707|FG006|Extension 1|Other|0|||
44455198|NCT00365716|79463701|FG000|Extension 1|Moved|0|||
44455199|NCT00365716|79463702|FG001|Extension 1|Moved|0|||
44455200|NCT00365716|79463703|FG002|Extension 1|Moved|0|||
44455201|NCT00365716|79463704|FG003|Extension 1|Moved|0|||
44455202|NCT00365716|79463705|FG004|Extension 1|Moved|0|||
44455203|NCT00365716|79463706|FG005|Extension 1|Moved|4|||
44455204|NCT00365716|79463707|FG006|Extension 1|Moved|0|||
44455205|NCT00365716|79463701|FG000|Extension 1|Withdrawal by Subject|0|||
44455206|NCT00365716|79463702|FG001|Extension 1|Withdrawal by Subject|0|||
44455207|NCT00365716|79463703|FG002|Extension 1|Withdrawal by Subject|0|||
44455208|NCT00365716|79463704|FG003|Extension 1|Withdrawal by Subject|0|||
44455209|NCT00365716|79463705|FG004|Extension 1|Withdrawal by Subject|0|||
44455210|NCT00365716|79463706|FG005|Extension 1|Withdrawal by Subject|3|||
44455211|NCT00365716|79463707|FG006|Extension 1|Withdrawal by Subject|0|||
44455212|NCT00365716|79463701|FG000|Extension 1|Pregnancy|0|||
44455213|NCT00365716|79463702|FG001|Extension 1|Pregnancy|0|||
44455214|NCT00365716|79463703|FG002|Extension 1|Pregnancy|0|||
44455215|NCT00365716|79463704|FG003|Extension 1|Pregnancy|0|||
44455216|NCT00365716|79463705|FG004|Extension 1|Pregnancy|0|||
44455217|NCT00365716|79463706|FG005|Extension 1|Pregnancy|4|||
44455218|NCT00365716|79463707|FG006|Extension 1|Pregnancy|0|||
44455219|NCT00365716|79463701|FG000|Extension 1|Protocol Violation|0|||
44455220|NCT00365716|79463702|FG001|Extension 1|Protocol Violation|0|||
44455221|NCT00365716|79463703|FG002|Extension 1|Protocol Violation|0|||
44455222|NCT00365716|79463704|FG003|Extension 1|Protocol Violation|0|||
44455223|NCT00365716|79463705|FG004|Extension 1|Protocol Violation|0|||
44455224|NCT00365716|79463706|FG005|Extension 1|Protocol Violation|1|||
44455225|NCT00365716|79463707|FG006|Extension 1|Protocol Violation|0|||
44455226|NCT00365716|79463701|FG000|Extension 2|Lost to Follow-up|0|||
44455227|NCT00365716|79463702|FG001|Extension 2|Lost to Follow-up|0|||
44455228|NCT00365716|79463703|FG002|Extension 2|Lost to Follow-up|0|||
44455229|NCT00365716|79463704|FG003|Extension 2|Lost to Follow-up|0|||
44455230|NCT00365716|79463705|FG004|Extension 2|Lost to Follow-up|0|||
44455231|NCT00365716|79463706|FG005|Extension 2|Lost to Follow-up|0|||
44455232|NCT00365716|79463707|FG006|Extension 2|Lost to Follow-up|2|||
44455233|NCT00365716|79463701|FG000|Extension 2|Other|0|||
44455234|NCT00365716|79463702|FG001|Extension 2|Other|0|||
44455235|NCT00365716|79463703|FG002|Extension 2|Other|0|||
44455236|NCT00365716|79463704|FG003|Extension 2|Other|0|||
44455237|NCT00365716|79463705|FG004|Extension 2|Other|0|||
44455238|NCT00365716|79463706|FG005|Extension 2|Other|0|||
44455239|NCT00365716|79463707|FG006|Extension 2|Other|3|||
44455240|NCT00365716|79463701|FG000|Extension 2|Withdrawal by Subject|0|||
44455241|NCT00365716|79463702|FG001|Extension 2|Withdrawal by Subject|0|||
44455242|NCT00365716|79463703|FG002|Extension 2|Withdrawal by Subject|0|||
44455243|NCT00365716|79463704|FG003|Extension 2|Withdrawal by Subject|0|||
44455244|NCT00365716|79463705|FG004|Extension 2|Withdrawal by Subject|0|||
44455245|NCT00365716|79463706|FG005|Extension 2|Withdrawal by Subject|0|||
44455246|NCT00365716|79463707|FG006|Extension 2|Withdrawal by Subject|5|||
44455247|NCT00059839|79463723|FG000|Overall Study|Death|1|||
44455248|NCT00059839|79463724|FG001|Overall Study|Death|1|||
44455249|NCT00059839|79463723|FG000|Overall Study|Lack of Efficacy|6|||
44455250|NCT00059839|79463724|FG001|Overall Study|Lack of Efficacy|5|||
44455251|NCT00059839|79463723|FG000|Overall Study|Lost to Follow-up|2|||
44455252|NCT00059839|79463724|FG001|Overall Study|Lost to Follow-up|0|||
44455253|NCT00059839|79463723|FG000|Overall Study|Physician Decision|1|||
44455254|NCT00059839|79463724|FG001|Overall Study|Physician Decision|2|||
44455255|NCT00059839|79463723|FG000|Overall Study|Withdrawal by Subject|1|||
44455256|NCT00059839|79463724|FG001|Overall Study|Withdrawal by Subject|6|||
44215029|NCT01929343|79012706|FG000|Overall Study|Withdrawal by Subject|1|||
44215030|NCT01929343|79012707|FG001|Overall Study|Withdrawal by Subject|0|||
44215031|NCT01929343|79012708|FG002|Overall Study|Withdrawal by Subject|0|||
44215032|NCT01968811|79012716|FG000|Overall Study|Protocol Violation|4|||
44215033|NCT01968811|79012716|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
44215034|NCT01806584|79012722|FG000|Overall Study|Adverse Event|2|||
44215035|NCT01806584|79012723|FG001|Overall Study|Adverse Event|1|||
44215036|NCT01806584|79012722|FG000|Overall Study|Death|1|||
44215037|NCT01806584|79012723|FG001|Overall Study|Death|0|||
44215038|NCT01806584|79012722|FG000|Overall Study|Lost to Follow-up|0|||
44215039|NCT01806584|79012723|FG001|Overall Study|Lost to Follow-up|2|||
44215040|NCT01806584|79012722|FG000|Overall Study|Study terminated by sponsor|9|||
44455257|NCT00059839|79463723|FG000|Overall Study|Ineligible|1|||
44455258|NCT00059839|79463724|FG001|Overall Study|Ineligible|3|||
44455259|NCT00059215|79463734|FG000|Overall Study|Adverse Event|5|||
44455260|NCT00059215|79463735|FG001|Overall Study|Adverse Event|5|||
44455261|NCT00059215|79463736|FG002|Overall Study|Adverse Event|9|||
44455262|NCT00059215|79463737|FG003|Overall Study|Adverse Event|9|||
44455263|NCT00059215|79463734|FG000|Overall Study|Death|0|||
44455264|NCT00059215|79463735|FG001|Overall Study|Death|0|||
44455265|NCT00059215|79463736|FG002|Overall Study|Death|3|||
44455266|NCT00059215|79463737|FG003|Overall Study|Death|0|||
44455267|NCT00059215|79463734|FG000|Overall Study|Lost to Follow-up|1|||
44215041|NCT01806584|79012723|FG001|Overall Study|Study terminated by sponsor|14|||
44455268|NCT00059215|79463735|FG001|Overall Study|Lost to Follow-up|2|||
44455269|NCT00059215|79463736|FG002|Overall Study|Lost to Follow-up|0|||
44455270|NCT00059215|79463737|FG003|Overall Study|Lost to Follow-up|0|||
44455271|NCT00059215|79463734|FG000|Overall Study|Withdrawal by Subject|4|||
44455272|NCT00059215|79463735|FG001|Overall Study|Withdrawal by Subject|4|||
44455273|NCT00059215|79463736|FG002|Overall Study|Withdrawal by Subject|1|||
44455274|NCT00059215|79463737|FG003|Overall Study|Withdrawal by Subject|3|||
44215042|NCT01806584|79012722|FG000|Overall Study|Withdrawal by Subject|1|||
44215043|NCT01806584|79012723|FG001|Overall Study|Withdrawal by Subject|1|||
44215044|NCT01806584|79012722|FG000|Overall Study|Other unspecified|1|||
44215045|NCT01806584|79012723|FG001|Overall Study|Other unspecified|0|||
44215046|NCT01798706|79012731|FG000|Overall Study|Adverse Event|15|||
44215047|NCT01798706|79012732|FG001|Overall Study|Adverse Event|10|||
44215048|NCT01798706|79012731|FG000|Overall Study|Lack of Efficacy|0|||
44215049|NCT01798706|79012732|FG001|Overall Study|Lack of Efficacy|2|||
44215050|NCT01798706|79012731|FG000|Overall Study|Poor compliance to protocol|1|||
44215051|NCT01798706|79012732|FG001|Overall Study|Poor compliance to protocol|0|||
44215052|NCT01798706|79012731|FG000|Overall Study|Other than specified above|5|||
44215053|NCT01798706|79012732|FG001|Overall Study|Other than specified above|9|||
44371455|NCT01928394|79376860|FG018|Treatment Period|Participant request to stop therapy|1|||
44371456|NCT01928394|79376861|FG019|Treatment Period|Participant request to stop therapy|1|||
44371457|NCT01928394|79376862|FG020|Treatment Period|Participant request to stop therapy|3|||
44455275|NCT00059215|79463734|FG000|Overall Study|Protocol Violation|1|||
44455276|NCT00059215|79463735|FG001|Overall Study|Protocol Violation|0|||
44455277|NCT00059215|79463736|FG002|Overall Study|Protocol Violation|1|||
44455278|NCT00059215|79463737|FG003|Overall Study|Protocol Violation|0|||
44455279|NCT00059215|79463734|FG000|Overall Study|Protocol entry criteria not met|1|||
44455280|NCT00059215|79463735|FG001|Overall Study|Protocol entry criteria not met|1|||
44455281|NCT00059215|79463736|FG002|Overall Study|Protocol entry criteria not met|0|||
44455282|NCT00059215|79463737|FG003|Overall Study|Protocol entry criteria not met|2|||
44455283|NCT00059215|79463734|FG000|Overall Study|Physician Decision|1|||
44455284|NCT00059215|79463735|FG001|Overall Study|Physician Decision|2|||
44455285|NCT00059215|79463736|FG002|Overall Study|Physician Decision|1|||
44455286|NCT00059215|79463737|FG003|Overall Study|Physician Decision|1|||
44455287|NCT00058825|79463748|FG000|Overall Study|Relapse|9|||
44455288|NCT00058825|79463748|FG000|Overall Study|Progressive Disease|5|||
44455289|NCT00058825|79463748|FG000|Overall Study|Graft Failure|5|||
44455290|NCT00058825|79463748|FG000|Overall Study|Death|3|||
44455291|NCT00364858|79463756|FG000|Overall Study|Adverse Event|1|||
44455292|NCT00364858|79463757|FG001|Overall Study|Adverse Event|5|||
44455293|NCT00364858|79463756|FG000|Overall Study|Withdrawal by Subject|1|||
44455294|NCT00364858|79463757|FG001|Overall Study|Withdrawal by Subject|1|||
44455295|NCT00364858|79463756|FG000|Overall Study|Pregnancy|1|||
44455296|NCT00364858|79463757|FG001|Overall Study|Pregnancy|1|||
44455297|NCT00364858|79463756|FG000|Overall Study|Clinical failure|2|||
44455298|NCT00364858|79463757|FG001|Overall Study|Clinical failure|13|||
44455299|NCT00364858|79463756|FG000|Overall Study|Discontinuation at baseline|1|||
44455300|NCT00364858|79463757|FG001|Overall Study|Discontinuation at baseline|0|||
44455301|NCT00364858|79463756|FG000|Overall Study|Non-compliant|1|||
44455302|NCT00364858|79463757|FG001|Overall Study|Non-compliant|0|||
44455303|NCT00364858|79463756|FG000|Overall Study|Return to Q2 regimen|0|||
44455304|NCT00364858|79463757|FG001|Overall Study|Return to Q2 regimen|1|||
44455305|NCT00364858|79463756|FG000|Overall Study|Clinical baseline issue|0|||
44455306|NCT00364858|79463757|FG001|Overall Study|Clinical baseline issue|1|||
44455307|NCT03803059|79463764|FG000|Overall Study|Protocol Violation|2|||
44455308|NCT03803059|79463764|FG000|Overall Study|Lost to Follow-up|1|||
44455309|NCT00372424|79463769|FG000|Overall Study|Adverse Event|2|||
44455310|NCT00372424|79463769|FG000|Overall Study|Withdrawal by Subject|1|||
44455311|NCT00372424|79463769|FG000|Overall Study|Death|1|||
44455312|NCT00372424|79463769|FG000|Overall Study|Objective Progression or Relapse|14|||
44455313|NCT00372424|79463769|FG000|Overall Study|Other|7|||
44455314|NCT00372424|79463769|FG000|Overall Study|Enrolled, Not Treated|1|||
44455315|NCT00372190|79463775|FG000|Overall Study|Lost to Follow-up|3|||
44455316|NCT00372190|79463776|FG001|Overall Study|Lost to Follow-up|1|||
44455317|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
44455318|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
44455319|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
44455320|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
44215054|NCT01767194|79012740|FG000|Overall Study|Adverse Event|1|||
44371458|NCT01928394|79376863|FG021|Treatment Period|Participant request to stop therapy|1|||
44371459|NCT01928394|79376864|FG022|Treatment Period|Participant request to stop therapy|3|||
44371460|NCT01928394|79376842|FG000|Treatment Period|Participant withdrew consent|0|||
44371461|NCT01928394|79376843|FG001|Treatment Period|Participant withdrew consent|0|||
44455321|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
44455322|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
44215055|NCT01767194|79012741|FG001|Overall Study|Adverse Event|1|||
44215056|NCT01767194|79012740|FG000|Overall Study|Death|0|||
44215057|NCT01767194|79012741|FG001|Overall Study|Death|1|||
44215058|NCT01767194|79012740|FG000|Overall Study|Lack of Efficacy|12|||
44215059|NCT01767194|79012741|FG001|Overall Study|Lack of Efficacy|11|||
44455323|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
44455324|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
44215060|NCT01767194|79012740|FG000|Overall Study|Physician Decision|2|||
44215061|NCT01767194|79012741|FG001|Overall Study|Physician Decision|23|||
44455325|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
44455326|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
44455327|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
44455328|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
44455329|NCT00044083|79463786|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
44455330|NCT00044083|79463787|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
44455331|NCT00044083|79463786|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
44455332|NCT00044083|79463787|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
44455333|NCT00044083|79463786|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
44215062|NCT01767194|79012740|FG000|Overall Study|Withdrawal by Subject|0|||
44215063|NCT01767194|79012741|FG001|Overall Study|Withdrawal by Subject|1|||
44215064|NCT01767194|79012740|FG000|Overall Study|Ineligible|1|||
44215065|NCT01767194|79012741|FG001|Overall Study|Ineligible|1|||
44215066|NCT01767194|79012740|FG000|Overall Study|Refusal by patient/parent|2|||
44215067|NCT01767194|79012741|FG001|Overall Study|Refusal by patient/parent|4|||
44215068|NCT01767194|79012740|FG000|Overall Study|Criteria not met on time for next cycle|0|||
44215069|NCT01767194|79012741|FG001|Overall Study|Criteria not met on time for next cycle|1|||
44215070|NCT01575873|79012752|FG000|Overall Study|Withdrawal by Subject|15|||
44215071|NCT01575873|79012753|FG001|Overall Study|Withdrawal by Subject|20|||
44455334|NCT00044083|79463787|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
44455335|NCT00044083|79463786|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
44455336|NCT00044083|79463787|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
44455337|NCT00058123|79463820|FG000|Overall Study|Wrong histology|9|||
44455338|NCT00058123|79463820|FG000|Overall Study|Received >3 prior treatments|1|||
44455339|NCT00022633|79463827|FG000|Overall Study|Adverse Event|11|||
44455340|NCT00022633|79463828|FG001|Overall Study|Adverse Event|1|||
44455341|NCT00022633|79463827|FG000|Overall Study|Refusal unrelated to adverse event|1|||
44455342|NCT00022633|79463828|FG001|Overall Study|Refusal unrelated to adverse event|0|||
44455343|NCT00022633|79463827|FG000|Overall Study|Progression/relapse|9|||
44455344|NCT00022633|79463828|FG001|Overall Study|Progression/relapse|2|||
44455345|NCT00022633|79463827|FG000|Overall Study|Death|4|||
44455346|NCT00022633|79463828|FG001|Overall Study|Death|0|||
44455347|NCT00022633|79463827|FG000|Overall Study|Other - not protocol specified|3|||
44455348|NCT00022633|79463828|FG001|Overall Study|Other - not protocol specified|2|||
44455349|NCT00022633|79463827|FG000|Overall Study|Ineligible|4|||
44455350|NCT00022633|79463828|FG001|Overall Study|Ineligible|0|||
44455351|NCT00021541|79463835|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
44455352|NCT00021541|79463836|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
44455353|NCT00021541|79463835|FG000|Period 1-First Treatment|Adverse Event|2|||
44455354|NCT00021541|79463836|FG001|Period 1-First Treatment|Adverse Event|1|||
44455355|NCT00021541|79463835|FG000|Period 1-First Treatment|non-adherence|3|||
44455356|NCT00021541|79463836|FG001|Period 1-First Treatment|non-adherence|0|||
44455357|NCT00021541|79463835|FG000|Period 1-First Treatment|Death|1|||
44455358|NCT00021541|79463836|FG001|Period 1-First Treatment|Death|0|||
44455359|NCT00021541|79463835|FG000|Period 1-First Treatment|Pts that did not progress|2|||
44455360|NCT00021541|79463836|FG001|Period 1-First Treatment|Pts that did not progress|2|||
44455361|NCT00021541|79463835|FG000|Period 1-First Treatment|Ineligible|0|||
44455362|NCT00021541|79463836|FG001|Period 1-First Treatment|Ineligible|2|||
44215072|NCT01575873|79012754|FG002|Overall Study|Withdrawal by Subject|34|||
44215073|NCT01575873|79012755|FG003|Overall Study|Withdrawal by Subject|34|||
44215074|NCT01575873|79012752|FG000|Overall Study|Adverse Event|7|||
44371462|NCT01928394|79376844|FG002|Treatment Period|Participant withdrew consent|1|||
44371463|NCT01928394|79376845|FG003|Treatment Period|Participant withdrew consent|1|||
44371464|NCT01928394|79376846|FG004|Treatment Period|Participant withdrew consent|0|||
44371465|NCT01928394|79376847|FG005|Treatment Period|Participant withdrew consent|1|||
44371466|NCT01928394|79376848|FG006|Treatment Period|Participant withdrew consent|0|||
44371467|NCT01928394|79376849|FG007|Treatment Period|Participant withdrew consent|1|||
44371468|NCT01928394|79376850|FG008|Treatment Period|Participant withdrew consent|0|||
44371469|NCT01928394|79376851|FG009|Treatment Period|Participant withdrew consent|0|||
44371470|NCT01928394|79376852|FG010|Treatment Period|Participant withdrew consent|1|||
44371471|NCT01928394|79376853|FG011|Treatment Period|Participant withdrew consent|1|||
44371472|NCT01928394|79376854|FG012|Treatment Period|Participant withdrew consent|1|||
44371473|NCT01928394|79376855|FG013|Treatment Period|Participant withdrew consent|0|||
44371474|NCT01928394|79376856|FG014|Treatment Period|Participant withdrew consent|2|||
44455363|NCT00021541|79463835|FG000|Period 2-crossover|refused phase B|2|||
44455364|NCT00021541|79463836|FG001|Period 2-crossover|refused phase B|2|||
44455365|NCT00021541|79463835|FG000|Period 2-crossover|Withdrawal by Subject|3|||
44455366|NCT00021541|79463836|FG001|Period 2-crossover|Withdrawal by Subject|4|||
44215075|NCT01575873|79012753|FG001|Overall Study|Adverse Event|7|||
44215076|NCT01575873|79012754|FG002|Overall Study|Adverse Event|9|||
44215077|NCT01575873|79012755|FG003|Overall Study|Adverse Event|12|||
44371475|NCT01928394|79376857|FG015|Treatment Period|Participant withdrew consent|0|||
44455367|NCT00021541|79463835|FG000|Period 2-crossover|Adverse Event|2|||
44215078|NCT01575873|79012752|FG000|Overall Study|Lost to Follow-up|1|||
44215079|NCT01575873|79012753|FG001|Overall Study|Lost to Follow-up|3|||
44215080|NCT01575873|79012754|FG002|Overall Study|Lost to Follow-up|13|||
44215081|NCT01575873|79012755|FG003|Overall Study|Lost to Follow-up|5|||
44215082|NCT01575873|79012752|FG000|Overall Study|Death|3|||
44215083|NCT01575873|79012753|FG001|Overall Study|Death|2|||
44215084|NCT01575873|79012754|FG002|Overall Study|Death|8|||
44215085|NCT01575873|79012755|FG003|Overall Study|Death|9|||
44215086|NCT01575873|79012752|FG000|Overall Study|Noncompliance|1|||
44215087|NCT01575873|79012753|FG001|Overall Study|Noncompliance|2|||
44215088|NCT01575873|79012754|FG002|Overall Study|Noncompliance|4|||
44215089|NCT01575873|79012755|FG003|Overall Study|Noncompliance|3|||
44215090|NCT01575873|79012752|FG000|Overall Study|Administrative decision|1|||
44215091|NCT01575873|79012753|FG001|Overall Study|Administrative decision|1|||
44455368|NCT00021541|79463836|FG001|Period 2-crossover|Adverse Event|2|||
44455369|NCT00021541|79463835|FG000|Period 2-crossover|non-adherence|1|||
44455370|NCT00021541|79463836|FG001|Period 2-crossover|non-adherence|0|||
44455371|NCT00021541|79463835|FG000|Period 2-crossover|Pts that did not progress|2|||
44455372|NCT00021541|79463836|FG001|Period 2-crossover|Pts that did not progress|3|||
44455373|NCT00021229|79463847|FG000|Overall Study|Adverse Event|10|||
44455374|NCT00021229|79463848|FG001|Overall Study|Adverse Event|5|||
44455375|NCT00021229|79463849|FG002|Overall Study|Adverse Event|2|||
44215092|NCT01575873|79012754|FG002|Overall Study|Administrative decision|1|||
44215093|NCT01575873|79012755|FG003|Overall Study|Administrative decision|0|||
44455376|NCT00021229|79463847|FG000|Overall Study|Death|0|||
44455377|NCT00021229|79463848|FG001|Overall Study|Death|1|||
44455378|NCT00021229|79463849|FG002|Overall Study|Death|0|||
44455379|NCT00021229|79463847|FG000|Overall Study|Withdrawal by Subject|7|||
44455380|NCT00021229|79463848|FG001|Overall Study|Withdrawal by Subject|7|||
44455381|NCT00021229|79463849|FG002|Overall Study|Withdrawal by Subject|1|||
44455382|NCT00021229|79463847|FG000|Overall Study|Progressive Disease|15|||
44455383|NCT00021229|79463848|FG001|Overall Study|Progressive Disease|19|||
44455384|NCT00021229|79463849|FG002|Overall Study|Progressive Disease|12|||
44455385|NCT00021229|79463847|FG000|Overall Study|Protocol Violation|1|||
44455386|NCT00021229|79463848|FG001|Overall Study|Protocol Violation|1|||
44455387|NCT00021229|79463849|FG002|Overall Study|Protocol Violation|0|||
44455388|NCT00021229|79463847|FG000|Overall Study|Physician Decision|0|||
44455389|NCT00021229|79463848|FG001|Overall Study|Physician Decision|0|||
44455390|NCT00021229|79463849|FG002|Overall Study|Physician Decision|1|||
44455391|NCT00021229|79463847|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
44455392|NCT00021229|79463848|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
44455393|NCT00021229|79463849|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
44215094|NCT01575873|79012752|FG000|Overall Study|Protocol deviation|0|||
44371476|NCT01928394|79376858|FG016|Treatment Period|Participant withdrew consent|2|||
44371477|NCT01928394|79376859|FG017|Treatment Period|Participant withdrew consent|1|||
44371478|NCT01928394|79376860|FG018|Treatment Period|Participant withdrew consent|1|||
44371479|NCT01928394|79376861|FG019|Treatment Period|Participant withdrew consent|1|||
44371480|NCT01928394|79376862|FG020|Treatment Period|Participant withdrew consent|0|||
44371481|NCT01928394|79376863|FG021|Treatment Period|Participant withdrew consent|2|||
44371482|NCT01928394|79376864|FG022|Treatment Period|Participant withdrew consent|0|||
44371483|NCT01928394|79376842|FG000|Treatment Period|Poor/non-compliance|0|||
44371484|NCT01928394|79376843|FG001|Treatment Period|Poor/non-compliance|0|||
44371485|NCT01928394|79376844|FG002|Treatment Period|Poor/non-compliance|0|||
44371486|NCT01928394|79376845|FG003|Treatment Period|Poor/non-compliance|1|||
44371487|NCT01928394|79376846|FG004|Treatment Period|Poor/non-compliance|0|||
44371488|NCT01928394|79376847|FG005|Treatment Period|Poor/non-compliance|0|||
44371489|NCT01928394|79376848|FG006|Treatment Period|Poor/non-compliance|0|||
44371490|NCT01928394|79376849|FG007|Treatment Period|Poor/non-compliance|0|||
44371491|NCT01928394|79376850|FG008|Treatment Period|Poor/non-compliance|0|||
44371492|NCT01928394|79376851|FG009|Treatment Period|Poor/non-compliance|0|||
44371493|NCT01928394|79376852|FG010|Treatment Period|Poor/non-compliance|0|||
44371494|NCT01928394|79376853|FG011|Treatment Period|Poor/non-compliance|0|||
44371495|NCT01928394|79376854|FG012|Treatment Period|Poor/non-compliance|1|||
44371496|NCT01928394|79376855|FG013|Treatment Period|Poor/non-compliance|0|||
44371497|NCT01928394|79376856|FG014|Treatment Period|Poor/non-compliance|1|||
44371498|NCT01928394|79376857|FG015|Treatment Period|Poor/non-compliance|0|||
44455394|NCT00372112|79463863|FG000|Overall Study|Adverse Event|0|||
44371499|NCT01928394|79376858|FG016|Treatment Period|Poor/non-compliance|0|||
44215095|NCT01575873|79012753|FG001|Overall Study|Protocol deviation|1|||
44215096|NCT01575873|79012754|FG002|Overall Study|Protocol deviation|0|||
44215097|NCT01575873|79012755|FG003|Overall Study|Protocol deviation|1|||
44371500|NCT01928394|79376859|FG017|Treatment Period|Poor/non-compliance|1|||
44215098|NCT01575873|79012752|FG000|Overall Study|Requirement for Alternative Therapy|0|||
44215099|NCT01575873|79012753|FG001|Overall Study|Requirement for Alternative Therapy|0|||
44455395|NCT00372112|79463864|FG001|Overall Study|Adverse Event|1|||
44455396|NCT00372112|79463865|FG002|Overall Study|Adverse Event|1|||
44215100|NCT01575873|79012754|FG002|Overall Study|Requirement for Alternative Therapy|1|||
44455397|NCT00372112|79463866|FG003|Overall Study|Adverse Event|1|||
44455398|NCT00372112|79463863|FG000|Overall Study|Withdrawal by Subject|0|||
44455399|NCT00372112|79463864|FG001|Overall Study|Withdrawal by Subject|0|||
44455400|NCT00372112|79463865|FG002|Overall Study|Withdrawal by Subject|2|||
44455401|NCT00372112|79463866|FG003|Overall Study|Withdrawal by Subject|1|||
44455402|NCT00372112|79463863|FG000|Overall Study|Exacerbation|0|||
44455403|NCT00372112|79463864|FG001|Overall Study|Exacerbation|0|||
44455404|NCT00372112|79463865|FG002|Overall Study|Exacerbation|0|||
44215101|NCT01575873|79012755|FG003|Overall Study|Requirement for Alternative Therapy|1|||
44215102|NCT01575873|79012752|FG000|Overall Study|Other|0|||
44215103|NCT01575873|79012753|FG001|Overall Study|Other|0|||
44215104|NCT01575873|79012754|FG002|Overall Study|Other|4|||
44215105|NCT01575873|79012755|FG003|Overall Study|Other|2|||
44215106|NCT01575561|79012763|FG000|Overall Study|Adverse Event|9|||
44215107|NCT01575561|79012763|FG000|Overall Study|Lack of Efficacy|8|||
44215108|NCT01575561|79012763|FG000|Overall Study|Lost to Follow-up|6|||
44215109|NCT01575561|79012763|FG000|Overall Study|Protocol Violation|4|||
44215110|NCT01575561|79012763|FG000|Overall Study|Withdrawal by Subject|11|||
44215111|NCT01575561|79012763|FG000|Overall Study|administration|1|||
44215112|NCT01609790|79012770|FG000|Overall Study|Protocol Violation|1|||
44215113|NCT01609790|79012771|FG001|Overall Study|Protocol Violation|7|||
44215114|NCT01609790|79012772|FG002|Overall Study|Protocol Violation|8|||
44215115|NCT01767116|79012782|FG000|Overall Study|Lost to Follow-up|2|||
44215116|NCT01767116|79012783|FG001|Overall Study|Lost to Follow-up|2|||
44215117|NCT01574703|79012793|FG000|Overall Study|Adverse Event|0|||
44215118|NCT01574703|79012794|FG001|Overall Study|Adverse Event|2|||
44215119|NCT01574703|79012795|FG002|Overall Study|Adverse Event|1|||
44215120|NCT01574703|79012796|FG003|Overall Study|Adverse Event|1|||
44215121|NCT01574703|79012793|FG000|Overall Study|Protocol Violation|0|||
44215122|NCT01574703|79012794|FG001|Overall Study|Protocol Violation|0|||
44215123|NCT01574703|79012795|FG002|Overall Study|Protocol Violation|0|||
44215124|NCT01574703|79012796|FG003|Overall Study|Protocol Violation|1|||
44215125|NCT01574703|79012793|FG000|Overall Study|Unspecified Reason|27|||
44215126|NCT01574703|79012794|FG001|Overall Study|Unspecified Reason|15|||
44215127|NCT01574703|79012795|FG002|Overall Study|Unspecified Reason|20|||
44215128|NCT01574703|79012796|FG003|Overall Study|Unspecified Reason|16|||
44215129|NCT01574703|79012793|FG000|Overall Study|Withdrawal by Subject|53|||
44215130|NCT01574703|79012794|FG001|Overall Study|Withdrawal by Subject|52|||
44215131|NCT01574703|79012795|FG002|Overall Study|Withdrawal by Subject|36|||
44215132|NCT01574703|79012796|FG003|Overall Study|Withdrawal by Subject|61|||
44215133|NCT01574703|79012793|FG000|Overall Study|Met Withdrawal Criteria|0|||
44215134|NCT01574703|79012794|FG001|Overall Study|Met Withdrawal Criteria|1|||
44215135|NCT01574703|79012795|FG002|Overall Study|Met Withdrawal Criteria|1|||
44215136|NCT01574703|79012796|FG003|Overall Study|Met Withdrawal Criteria|0|||
44215137|NCT01574703|79012793|FG000|Overall Study|Lost to Follow-up|43|||
44215138|NCT01574703|79012794|FG001|Overall Study|Lost to Follow-up|41|||
44215139|NCT01574703|79012795|FG002|Overall Study|Lost to Follow-up|46|||
44215140|NCT01574703|79012796|FG003|Overall Study|Lost to Follow-up|35|||
44215141|NCT01574703|79012793|FG000|Overall Study|Death|2|||
44215142|NCT01574703|79012794|FG001|Overall Study|Death|1|||
44215143|NCT01574703|79012795|FG002|Overall Study|Death|1|||
44215144|NCT01574703|79012796|FG003|Overall Study|Death|0|||
44215145|NCT01686633|79012809|FG000|Overall Study|Lack of Efficacy|33|||
44215146|NCT01686633|79012810|FG001|Overall Study|Lack of Efficacy|13|||
44215147|NCT01686633|79012811|FG002|Overall Study|Lack of Efficacy|11|||
44371501|NCT01928394|79376860|FG018|Treatment Period|Poor/non-compliance|0|||
44371502|NCT01928394|79376861|FG019|Treatment Period|Poor/non-compliance|1|||
44371503|NCT01928394|79376862|FG020|Treatment Period|Poor/non-compliance|0|||
44371504|NCT01928394|79376863|FG021|Treatment Period|Poor/non-compliance|0|||
44371505|NCT01928394|79376864|FG022|Treatment Period|Poor/non-compliance|0|||
44371506|NCT01928394|79376842|FG000|Treatment Period|other reason|0|||
44371507|NCT01928394|79376843|FG001|Treatment Period|other reason|0|||
44371508|NCT01928394|79376844|FG002|Treatment Period|other reason|0|||
44371509|NCT01928394|79376845|FG003|Treatment Period|other reason|0|||
44371510|NCT01928394|79376846|FG004|Treatment Period|other reason|0|||
44215148|NCT01686633|79012809|FG000|Overall Study|Withdrawal by Subject|8|||
44215149|NCT01686633|79012810|FG001|Overall Study|Withdrawal by Subject|8|||
44215150|NCT01686633|79012811|FG002|Overall Study|Withdrawal by Subject|5|||
44215151|NCT01686633|79012809|FG000|Overall Study|Physician Decision|3|||
44215152|NCT01686633|79012810|FG001|Overall Study|Physician Decision|4|||
44215153|NCT01686633|79012811|FG002|Overall Study|Physician Decision|4|||
44371511|NCT01928394|79376847|FG005|Treatment Period|other reason|0|||
44455405|NCT00372112|79463866|FG003|Overall Study|Exacerbation|1|||
44455406|NCT00372112|79463863|FG000|Overall Study|PR >240 at Visit 3|0|||
44215154|NCT01686633|79012809|FG000|Overall Study|Adverse Event|4|||
44215155|NCT01686633|79012810|FG001|Overall Study|Adverse Event|3|||
44215156|NCT01686633|79012811|FG002|Overall Study|Adverse Event|3|||
44215157|NCT01686633|79012809|FG000|Overall Study|Protocol Violation|2|||
44215158|NCT01686633|79012810|FG001|Overall Study|Protocol Violation|3|||
44215159|NCT01686633|79012811|FG002|Overall Study|Protocol Violation|0|||
44455407|NCT00372112|79463864|FG001|Overall Study|PR >240 at Visit 3|0|||
44455408|NCT00372112|79463865|FG002|Overall Study|PR >240 at Visit 3|0|||
44455409|NCT00372112|79463866|FG003|Overall Study|PR >240 at Visit 3|1|||
44455410|NCT00372112|79463863|FG000|Overall Study|Hepatitis B|1|||
44455411|NCT00372112|79463864|FG001|Overall Study|Hepatitis B|0|||
44455412|NCT00372112|79463865|FG002|Overall Study|Hepatitis B|0|||
44455413|NCT00372112|79463866|FG003|Overall Study|Hepatitis B|0|||
44455414|NCT00372112|79463863|FG000|Overall Study|Other-protocol violation|0|||
44455415|NCT00372112|79463864|FG001|Overall Study|Other-protocol violation|0|||
44455416|NCT00372112|79463865|FG002|Overall Study|Other-protocol violation|1|||
44455417|NCT00372112|79463866|FG003|Overall Study|Other-protocol violation|0|||
44455418|NCT00488475|79463879|FG000|Overall Study|Other|1754|||
44455419|NCT00042991|79463890|FG000|Overall Study|Adverse Event|1|||
44455420|NCT00042991|79463891|FG001|Overall Study|Adverse Event|4|||
44455421|NCT00042991|79463892|FG002|Overall Study|Adverse Event|2|||
44455422|NCT00042991|79463893|FG003|Overall Study|Adverse Event|0|||
44455423|NCT00042991|79463894|FG004|Overall Study|Adverse Event|0|||
44455424|NCT00042991|79463895|FG005|Overall Study|Adverse Event|1|||
44455425|NCT00042991|79463896|FG006|Overall Study|Adverse Event|0|||
44455426|NCT00042991|79463890|FG000|Overall Study|Withdrawal by Subject|0|||
44455427|NCT00042991|79463891|FG001|Overall Study|Withdrawal by Subject|7|||
44455428|NCT00042991|79463892|FG002|Overall Study|Withdrawal by Subject|2|||
44455429|NCT00042991|79463893|FG003|Overall Study|Withdrawal by Subject|0|||
44455430|NCT00042991|79463894|FG004|Overall Study|Withdrawal by Subject|1|||
44455431|NCT00042991|79463895|FG005|Overall Study|Withdrawal by Subject|0|||
44455432|NCT00042991|79463896|FG006|Overall Study|Withdrawal by Subject|0|||
44455433|NCT00042991|79463890|FG000|Overall Study|Disease Progression|5|||
44455434|NCT00042991|79463891|FG001|Overall Study|Disease Progression|29|||
44455435|NCT00042991|79463892|FG002|Overall Study|Disease Progression|2|||
44455436|NCT00042991|79463893|FG003|Overall Study|Disease Progression|2|||
44455437|NCT00042991|79463894|FG004|Overall Study|Disease Progression|1|||
44215160|NCT01686633|79012809|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
44215161|NCT01686633|79012810|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
44215162|NCT01686633|79012811|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
44215163|NCT01686633|79012809|FG000|Overall Study|Lost to Follow-up|0|||
44215164|NCT01686633|79012810|FG001|Overall Study|Lost to Follow-up|1|||
44215165|NCT01686633|79012811|FG002|Overall Study|Lost to Follow-up|1|||
44215166|NCT01685697|79012821|FG000|Overall Study|Protocol Violation|3|||
44215167|NCT01685697|79012822|FG001|Overall Study|Protocol Violation|3|||
44215168|NCT02395120|79012833|FG000|Overall Study|Missed follow-up dental exam|57|||
44215169|NCT02395120|79012834|FG001|Overall Study|Missed follow-up dental exam|62|||
44215170|NCT02395120|79012835|FG002|Overall Study|Missed follow-up dental exam|6|||
44215171|NCT02395120|79012836|FG003|Overall Study|Missed follow-up dental exam|6|||
44215172|NCT02395120|79012837|FG004|Overall Study|Missed follow-up dental exam|51|||
44215173|NCT01685229|79012851|FG000|Overall Study|Subjects missing Study Exit form|3|||
44215174|NCT01685229|79012852|FG001|Overall Study|Subjects missing Study Exit form|1|||
44455438|NCT00042991|79463895|FG005|Overall Study|Disease Progression|4|||
44455439|NCT00042991|79463896|FG006|Overall Study|Disease Progression|2|||
44455440|NCT00042991|79463890|FG000|Overall Study|Alternative Therapy|0|||
44455441|NCT00042991|79463891|FG001|Overall Study|Alternative Therapy|0|||
44455442|NCT00042991|79463892|FG002|Overall Study|Alternative Therapy|0|||
44455443|NCT00042991|79463893|FG003|Overall Study|Alternative Therapy|0|||
44455444|NCT00042991|79463894|FG004|Overall Study|Alternative Therapy|1|||
44455445|NCT00042991|79463895|FG005|Overall Study|Alternative Therapy|0|||
44455446|NCT00042991|79463896|FG006|Overall Study|Alternative Therapy|0|||
44455447|NCT00466167|79463917|FG000|Overall Study|Adverse Event|8|||
44455448|NCT00466167|79463918|FG001|Overall Study|Adverse Event|8|||
44455449|NCT00466167|79463919|FG002|Overall Study|Adverse Event|7|||
44455450|NCT00466167|79463917|FG000|Overall Study|Lack of Efficacy|2|||
44455451|NCT00466167|79463918|FG001|Overall Study|Lack of Efficacy|0|||
44455452|NCT00466167|79463919|FG002|Overall Study|Lack of Efficacy|3|||
44455453|NCT00466167|79463917|FG000|Overall Study|Protocol Violation|1|||
44455454|NCT00466167|79463918|FG001|Overall Study|Protocol Violation|1|||
44455455|NCT00466167|79463919|FG002|Overall Study|Protocol Violation|2|||
44455456|NCT00466167|79463917|FG000|Overall Study|Lost to Follow-up|3|||
44455457|NCT00466167|79463918|FG001|Overall Study|Lost to Follow-up|2|||
44455458|NCT00466167|79463919|FG002|Overall Study|Lost to Follow-up|2|||
44455459|NCT00466167|79463917|FG000|Overall Study|Withdrawal by Subject|4|||
44455460|NCT00466167|79463918|FG001|Overall Study|Withdrawal by Subject|1|||
44455461|NCT00466167|79463919|FG002|Overall Study|Withdrawal by Subject|6|||
44455462|NCT00466167|79463917|FG000|Overall Study|patient did not meet inclusion criteria|1|||
44455463|NCT00466167|79463918|FG001|Overall Study|patient did not meet inclusion criteria|0|||
44455464|NCT00466167|79463919|FG002|Overall Study|patient did not meet inclusion criteria|1|||
44455465|NCT00466167|79463917|FG000|Overall Study|Not treated|1|||
44455466|NCT00466167|79463918|FG001|Overall Study|Not treated|0|||
44455467|NCT00466167|79463919|FG002|Overall Study|Not treated|0|||
44455468|NCT00480441|79463929|FG000|Screening|Not Eligible|37|||
44455469|NCT00480441|79463930|FG001|Screening|Not Eligible|0|||
44455470|NCT00480441|79463931|FG002|Screening|Not Eligible|0|||
44455471|NCT00480441|79463929|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
44455472|NCT00480441|79463930|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
44455473|NCT00480441|79463931|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
44455474|NCT00480441|79463929|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
44455475|NCT00480441|79463930|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
44455476|NCT00480441|79463931|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
44455477|NCT00480441|79463929|FG000|Baseline Functional MRI|physical contraindication|4|||
44455478|NCT00480441|79463930|FG001|Baseline Functional MRI|physical contraindication|0|||
44455479|NCT00480441|79463931|FG002|Baseline Functional MRI|physical contraindication|0|||
44455480|NCT00480441|79463929|FG000|Randomization|Lost to Follow-up|0|||
44455481|NCT00480441|79463930|FG001|Randomization|Lost to Follow-up|7|||
44455482|NCT00480441|79463931|FG002|Randomization|Lost to Follow-up|2|||
44455483|NCT00488319|79463941|FG000|Overall Study|Adverse Event|1|||
44455484|NCT00488319|79463942|FG001|Overall Study|Adverse Event|2|||
44455485|NCT00488319|79463943|FG002|Overall Study|Adverse Event|23|||
44455486|NCT00488319|79463941|FG000|Overall Study|Lack of Efficacy|6|||
44455487|NCT00488319|79463942|FG001|Overall Study|Lack of Efficacy|12|||
44455488|NCT00488319|79463943|FG002|Overall Study|Lack of Efficacy|27|||
44455489|NCT00488319|79463941|FG000|Overall Study|Lost to Follow-up|3|||
44455490|NCT00488319|79463942|FG001|Overall Study|Lost to Follow-up|5|||
44455491|NCT00488319|79463943|FG002|Overall Study|Lost to Follow-up|16|||
44455492|NCT00488319|79463941|FG000|Overall Study|Withdrawal by Subject|5|||
44455493|NCT00488319|79463942|FG001|Overall Study|Withdrawal by Subject|20|||
44455494|NCT00488319|79463943|FG002|Overall Study|Withdrawal by Subject|44|||
44455495|NCT00488319|79463941|FG000|Overall Study|Other reasons for withdrawal|0|||
44455496|NCT00488319|79463942|FG001|Overall Study|Other reasons for withdrawal|4|||
44455497|NCT00488319|79463943|FG002|Overall Study|Other reasons for withdrawal|12|||
44455498|NCT00463047|79463952|FG000|Titration Period 1|Adverse Event|10|||
44455499|NCT00463047|79463953|FG001|Titration Period 1|Adverse Event|8|||
44455500|NCT00463047|79463952|FG000|Titration Period 1|Lack of Efficacy|10|||
44455501|NCT00463047|79463953|FG001|Titration Period 1|Lack of Efficacy|4|||
44455502|NCT00463047|79463952|FG000|Titration Period 1|Lost to Follow-up|2|||
44455503|NCT00463047|79463953|FG001|Titration Period 1|Lost to Follow-up|0|||
44455504|NCT00463047|79463952|FG000|Titration Period 1|Non-compliance with study medication|3|||
44455505|NCT00463047|79463953|FG001|Titration Period 1|Non-compliance with study medication|5|||
44455506|NCT00463047|79463952|FG000|Titration Period 1|Protocol Violation|5|||
44455507|NCT00463047|79463953|FG001|Titration Period 1|Protocol Violation|5|||
44455508|NCT00463047|79463952|FG000|Titration Period 1|Withdrawal by Subject|3|||
44455509|NCT00463047|79463953|FG001|Titration Period 1|Withdrawal by Subject|5|||
44455510|NCT00463047|79463952|FG000|Titration Period 1|Non-compliance procedures|4|||
44455511|NCT00463047|79463953|FG001|Titration Period 1|Non-compliance procedures|10|||
44455512|NCT00463047|79463952|FG000|Titration Period 1|Other|0|||
44455513|NCT00463047|79463953|FG001|Titration Period 1|Other|2|||
44543759|NCT03670537|79556867|FG000|Overall Study|Protocol Violation|1|||
44543760|NCT03619837|79556871|FG000|Screening|received organs from HCV-negative donors|47|||
44215175|NCT01685229|79012851|FG000|Overall Study|Lost to Follow-up|16|||
44455514|NCT00463047|79463952|FG000|Titration Period 2|Adverse Event|9|||
44455515|NCT00463047|79463953|FG001|Titration Period 2|Adverse Event|9|||
44455516|NCT00463047|79463952|FG000|Titration Period 2|Lack of Efficacy|6|||
44455517|NCT00463047|79463953|FG001|Titration Period 2|Lack of Efficacy|4|||
44455518|NCT00463047|79463952|FG000|Titration Period 2|Withdrawal by Subject|1|||
44455519|NCT00463047|79463953|FG001|Titration Period 2|Withdrawal by Subject|0|||
44455520|NCT00463047|79463952|FG000|Titration Period 2|Protocol Violation|2|||
44455521|NCT00463047|79463953|FG001|Titration Period 2|Protocol Violation|3|||
44455522|NCT00463047|79463952|FG000|Titration Period 2|Lost to Follow-up|1|||
44455523|NCT00463047|79463953|FG001|Titration Period 2|Lost to Follow-up|2|||
44455524|NCT00463047|79463952|FG000|Titration Period 2|Non-compliance study medication|4|||
44455525|NCT00463047|79463953|FG001|Titration Period 2|Non-compliance study medication|2|||
44455526|NCT00463047|79463952|FG000|Titration Period 2|Non-compliance procedures|4|||
44143706|NCT02006147|78933052|FG000|Overall Study|Withdrawal by Sponsor|1|||
44143707|NCT02006147|78933053|FG001|Overall Study|Withdrawal by Sponsor|0|||
44215176|NCT01685229|79012852|FG001|Overall Study|Lost to Follow-up|10|||
44215177|NCT01685229|79012851|FG000|Overall Study|Withdrawal by Subject|6|||
44215178|NCT01685229|79012852|FG001|Overall Study|Withdrawal by Subject|5|||
44215179|NCT01685229|79012851|FG000|Overall Study|Death|1|||
44215180|NCT01685229|79012852|FG001|Overall Study|Death|0|||
44215181|NCT01551693|79012863|FG000|Overall Study|Disease Progression|1|||
44215182|NCT01551693|79012864|FG001|Overall Study|Disease Progression|0|||
44215183|NCT01551693|79012863|FG000|Overall Study|Adverse Event|0|||
44215184|NCT01551693|79012864|FG001|Overall Study|Adverse Event|1|||
44215185|NCT01551693|79012863|FG000|Overall Study|Withdrawal by Subject|0|||
44215186|NCT01551693|79012864|FG001|Overall Study|Withdrawal by Subject|1|||
44215187|NCT01574157|79012872|FG000|Overall Study|Withdrawal by Subject|4|||
44215188|NCT01574157|79012873|FG001|Overall Study|Withdrawal by Subject|5|||
44215189|NCT01574157|79012872|FG000|Overall Study|Lost to Follow-up|0|||
44215190|NCT01574157|79012873|FG001|Overall Study|Lost to Follow-up|3|||
44215191|NCT01574079|79012885|FG000|Overall Study|Physician Decision|0|||
44215192|NCT01574079|79012886|FG001|Overall Study|Physician Decision|2|||
44215193|NCT01574079|79012885|FG000|Overall Study|Lost to Follow-up|1|||
44215194|NCT01574079|79012886|FG001|Overall Study|Lost to Follow-up|0|||
44215195|NCT01573767|79012896|FG000|Overall Study|Adverse Event|0|||
44215196|NCT01573767|79012897|FG001|Overall Study|Adverse Event|1|||
44270122|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
44270123|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270124|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270125|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
44270126|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270127|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270128|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270129|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44371512|NCT01928394|79376848|FG006|Treatment Period|other reason|0|||
44371513|NCT01928394|79376849|FG007|Treatment Period|other reason|0|||
44371514|NCT01928394|79376850|FG008|Treatment Period|other reason|0|||
44371515|NCT01928394|79376851|FG009|Treatment Period|other reason|0|||
44215197|NCT01573767|79012898|FG002|Overall Study|Adverse Event|0|||
44215198|NCT01573767|79012899|FG003|Overall Study|Adverse Event|1|||
44215199|NCT01573767|79012896|FG000|Overall Study|Lack of Efficacy|18|||
44215200|NCT01573767|79012897|FG001|Overall Study|Lack of Efficacy|15|||
44215201|NCT01573767|79012898|FG002|Overall Study|Lack of Efficacy|12|||
44215202|NCT01573767|79012899|FG003|Overall Study|Lack of Efficacy|17|||
44371516|NCT01928394|79376852|FG010|Treatment Period|other reason|1|||
44371517|NCT01928394|79376853|FG011|Treatment Period|other reason|1|||
44371518|NCT01928394|79376854|FG012|Treatment Period|other reason|1|||
44371519|NCT01928394|79376855|FG013|Treatment Period|other reason|0|||
44371520|NCT01928394|79376856|FG014|Treatment Period|other reason|1|||
44371521|NCT01928394|79376857|FG015|Treatment Period|other reason|0|||
44371522|NCT01928394|79376858|FG016|Treatment Period|other reason|0|||
44371523|NCT01928394|79376859|FG017|Treatment Period|other reason|0|||
44371524|NCT01928394|79376860|FG018|Treatment Period|other reason|2|||
44455527|NCT00463047|79463953|FG001|Titration Period 2|Non-compliance procedures|1|||
44215203|NCT01573767|79012896|FG000|Overall Study|Protocol Violation|3|||
44215204|NCT01573767|79012897|FG001|Overall Study|Protocol Violation|1|||
44270130|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44371525|NCT01928394|79376861|FG019|Treatment Period|other reason|2|||
44371526|NCT01928394|79376862|FG020|Treatment Period|other reason|0|||
44371527|NCT01928394|79376863|FG021|Treatment Period|other reason|0|||
44371528|NCT01928394|79376864|FG022|Treatment Period|other reason|0|||
44455528|NCT00463047|79463952|FG000|Titration Period 2|Other|3|||
44455529|NCT00463047|79463953|FG001|Titration Period 2|Other|2|||
44455530|NCT00463047|79463952|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
44143708|NCT02006147|78933054|FG002|Overall Study|Withdrawal by Sponsor|0|||
44215205|NCT01573767|79012898|FG002|Overall Study|Protocol Violation|1|||
44215206|NCT01573767|79012899|FG003|Overall Study|Protocol Violation|3|||
44455531|NCT00463047|79463953|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
44455532|NCT00463047|79463952|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
44455533|NCT00463047|79463953|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
44455534|NCT00463047|79463952|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
44455535|NCT00463047|79463953|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
44455536|NCT00463047|79463952|FG000|Double-Blind Treatment Period 1|Other|1|||
44455537|NCT00463047|79463953|FG001|Double-Blind Treatment Period 1|Other|0|||
44455538|NCT00463047|79463952|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
44455539|NCT00463047|79463953|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
44455540|NCT00463047|79463952|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
44455541|NCT00463047|79463953|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
44455542|NCT00463047|79463952|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
44455543|NCT00463047|79463953|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
44455544|NCT00487695|79463960|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
44455545|NCT00487695|79463961|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
44455546|NCT00487695|79463960|FG000|First Procedure|active wheezing (did not have procedure)|1|||
44455547|NCT00487695|79463961|FG001|First Procedure|active wheezing (did not have procedure)|0|||
44455548|NCT00487695|79463960|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
44455549|NCT00487695|79463961|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
44455550|NCT00487695|79463960|FG000|Second Procedure|active wheezing|0|||
44455551|NCT00487695|79463961|FG001|Second Procedure|active wheezing|1|||
44455552|NCT00487695|79463960|FG000|Second Procedure|Withdrawal by Subject|1|||
44455553|NCT00487695|79463961|FG001|Second Procedure|Withdrawal by Subject|2|||
44455554|NCT00487539|79463971|FG000|Overall Study|Adverse Event|3|||
44455555|NCT00487539|79463972|FG001|Overall Study|Adverse Event|2|||
44455556|NCT00487539|79463973|FG002|Overall Study|Adverse Event|1|||
44455557|NCT00487539|79463974|FG003|Overall Study|Adverse Event|1|||
44455558|NCT00487539|79463971|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44455559|NCT00487539|79463972|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44455560|NCT00487539|79463973|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44455561|NCT00487539|79463974|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
44455562|NCT00487539|79463971|FG000|Overall Study|Other|3|||
44455563|NCT00487539|79463972|FG001|Overall Study|Other|1|||
44455564|NCT00487539|79463973|FG002|Overall Study|Other|2|||
44455565|NCT00487539|79463974|FG003|Overall Study|Other|2|||
44455566|NCT00486837|79463985|FG000|Overall Study|Withdrawal by Subject|1|||
44455567|NCT00486837|79463986|FG001|Overall Study|Withdrawal by Subject|0|||
44455568|NCT00486837|79463985|FG000|Overall Study|Adverse Event|1|||
44455569|NCT00486837|79463986|FG001|Overall Study|Adverse Event|1|||
44455570|NCT00486837|79463985|FG000|Overall Study|Protocol Violation|4|||
44455571|NCT00486837|79463986|FG001|Overall Study|Protocol Violation|2|||
44215207|NCT01573767|79012896|FG000|Overall Study|Lost to Follow-up|0|||
44215208|NCT01573767|79012897|FG001|Overall Study|Lost to Follow-up|1|||
44215209|NCT01573767|79012898|FG002|Overall Study|Lost to Follow-up|1|||
44215210|NCT01573767|79012899|FG003|Overall Study|Lost to Follow-up|1|||
44215211|NCT01573767|79012896|FG000|Overall Study|Physician Decision|1|||
44215212|NCT01573767|79012897|FG001|Overall Study|Physician Decision|2|||
44215213|NCT01573767|79012898|FG002|Overall Study|Physician Decision|0|||
44215214|NCT01573767|79012899|FG003|Overall Study|Physician Decision|2|||
44215215|NCT01573767|79012896|FG000|Overall Study|Withdrawal by Subject|0|||
44215216|NCT01573767|79012897|FG001|Overall Study|Withdrawal by Subject|1|||
44215217|NCT01573767|79012898|FG002|Overall Study|Withdrawal by Subject|0|||
44215218|NCT01573767|79012899|FG003|Overall Study|Withdrawal by Subject|0|||
44455572|NCT00486837|79463985|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
44455573|NCT00486837|79463986|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
44455574|NCT00486759|79463996|FG000|Treatment|Adverse event/intercurrent illness|86|||
44455575|NCT00486759|79463997|FG001|Treatment|Adverse event/intercurrent illness|39|||
44455576|NCT00486759|79463996|FG000|Treatment|Insufficient therapeutic response|37|||
44455577|NCT00486759|79463997|FG001|Treatment|Insufficient therapeutic response|39|||
44455578|NCT00486759|79463996|FG000|Treatment|Death|17|||
44455579|NCT00486759|79463997|FG001|Treatment|Death|10|||
44455580|NCT00486759|79463996|FG000|Treatment|Withdrew consent|15|||
44215219|NCT01551303|79012911|FG000|Overall Study|failed awareness check on vision test|4|||
44215220|NCT01551303|79012912|FG001|Overall Study|failed awareness check on vision test|7|||
44215221|NCT00638404|79012920|FG000|Overall Study|Physician Decision|8|||
44215222|NCT00638404|79012921|FG001|Overall Study|Physician Decision|0|||
44215223|NCT01550757|79012935|FG000|Overall Study|Lost to Follow-up|21|||
44215224|NCT01550757|79012936|FG001|Overall Study|Lost to Follow-up|14|||
44215225|NCT01550757|79012937|FG002|Overall Study|Lost to Follow-up|42|||
44215226|NCT01550757|79012938|FG003|Overall Study|Lost to Follow-up|53|||
44215227|NCT01550757|79012935|FG000|Overall Study|Withdrawal by Subject|2|||
44215228|NCT01550757|79012936|FG001|Overall Study|Withdrawal by Subject|0|||
44215229|NCT01550757|79012937|FG002|Overall Study|Withdrawal by Subject|3|||
44455581|NCT00486759|79463997|FG001|Treatment|Withdrew consent|12|||
44455582|NCT00486759|79463996|FG000|Treatment|Administrative/reason not specified|17|||
44455583|NCT00486759|79463997|FG001|Treatment|Administrative/reason not specified|21|||
44455584|NCT00486759|79463996|FG000|Treatment|Refused treatment|10|||
44455585|NCT00486759|79463997|FG001|Treatment|Refused treatment|7|||
44455586|NCT00486759|79463996|FG000|Treatment|Violation of selection criteria at entry|3|||
44455587|NCT00486759|79463997|FG001|Treatment|Violation of selection criteria at entry|3|||
44455588|NCT00486759|79463996|FG000|Treatment|Other protocol violation|1|||
44455589|NCT00486759|79463997|FG001|Treatment|Other protocol violation|5|||
44455590|NCT00486759|79463996|FG000|Treatment|Failure to return|1|||
44455591|NCT00486759|79463997|FG001|Treatment|Failure to return|1|||
44455592|NCT00486759|79463996|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
44455593|NCT00486759|79463997|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
44455594|NCT00486759|79463996|FG000|Safety Follow-up|Death|40|||
44455595|NCT00486759|79463997|FG001|Safety Follow-up|Death|29|||
44455596|NCT00486759|79463996|FG000|Safety Follow-up|Withdrew consent|32|||
44455597|NCT00486759|79463997|FG001|Safety Follow-up|Withdrew consent|23|||
44455598|NCT00486759|79463996|FG000|Safety Follow-up|Failure to return|9|||
44455599|NCT00486759|79463997|FG001|Safety Follow-up|Failure to return|6|||
44455600|NCT00486759|79463996|FG000|Safety Follow-up|Administrative/not specified|8|||
44455601|NCT00486759|79463997|FG001|Safety Follow-up|Administrative/not specified|6|||
44455602|NCT00486759|79463996|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
44455603|NCT00486759|79463997|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
44455604|NCT00486759|79463996|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
44543761|NCT03619837|79556871|FG000|Screening|died on the wait-list|2|||
44543762|NCT03619837|79556871|FG000|Screening|remained on the wait list|40|||
44543763|NCT03619837|79556871|FG000|Screening|didn't meet eligibility criteria|3|||
44215230|NCT01550757|79012938|FG003|Overall Study|Withdrawal by Subject|1|||
44371529|NCT01928394|79376842|FG000|Treatment Period|Maximum clinical benefit|0|||
44371530|NCT01928394|79376843|FG001|Treatment Period|Maximum clinical benefit|0|||
44371531|NCT01928394|79376844|FG002|Treatment Period|Maximum clinical benefit|0|||
44371532|NCT01928394|79376845|FG003|Treatment Period|Maximum clinical benefit|0|||
44371533|NCT01928394|79376846|FG004|Treatment Period|Maximum clinical benefit|0|||
44371534|NCT01928394|79376847|FG005|Treatment Period|Maximum clinical benefit|0|||
44371535|NCT01928394|79376848|FG006|Treatment Period|Maximum clinical benefit|0|||
44371536|NCT01928394|79376849|FG007|Treatment Period|Maximum clinical benefit|0|||
44371537|NCT01928394|79376850|FG008|Treatment Period|Maximum clinical benefit|0|||
44371538|NCT01928394|79376851|FG009|Treatment Period|Maximum clinical benefit|0|||
44371539|NCT01928394|79376852|FG010|Treatment Period|Maximum clinical benefit|1|||
44371540|NCT01928394|79376853|FG011|Treatment Period|Maximum clinical benefit|1|||
44371541|NCT01928394|79376854|FG012|Treatment Period|Maximum clinical benefit|0|||
44371542|NCT01928394|79376855|FG013|Treatment Period|Maximum clinical benefit|0|||
44371543|NCT01928394|79376856|FG014|Treatment Period|Maximum clinical benefit|1|||
44371544|NCT01928394|79376857|FG015|Treatment Period|Maximum clinical benefit|0|||
44371545|NCT01928394|79376858|FG016|Treatment Period|Maximum clinical benefit|0|||
44371546|NCT01928394|79376859|FG017|Treatment Period|Maximum clinical benefit|1|||
44371547|NCT01928394|79376860|FG018|Treatment Period|Maximum clinical benefit|1|||
44371548|NCT01928394|79376861|FG019|Treatment Period|Maximum clinical benefit|0|||
44371549|NCT01928394|79376862|FG020|Treatment Period|Maximum clinical benefit|2|||
44371550|NCT01928394|79376863|FG021|Treatment Period|Maximum clinical benefit|0|||
44371551|NCT01928394|79376864|FG022|Treatment Period|Maximum clinical benefit|0|||
44371552|NCT01928394|79376842|FG000|Treatment Period|Lost to Follow-up|0|||
44371553|NCT01928394|79376843|FG001|Treatment Period|Lost to Follow-up|0|||
44371554|NCT01928394|79376844|FG002|Treatment Period|Lost to Follow-up|0|||
44371555|NCT01928394|79376845|FG003|Treatment Period|Lost to Follow-up|0|||
44371556|NCT01928394|79376846|FG004|Treatment Period|Lost to Follow-up|0|||
44371557|NCT01928394|79376847|FG005|Treatment Period|Lost to Follow-up|0|||
44371558|NCT01928394|79376848|FG006|Treatment Period|Lost to Follow-up|0|||
44371559|NCT01928394|79376849|FG007|Treatment Period|Lost to Follow-up|0|||
44371560|NCT01928394|79376850|FG008|Treatment Period|Lost to Follow-up|0|||
44371561|NCT01928394|79376851|FG009|Treatment Period|Lost to Follow-up|0|||
44371562|NCT01928394|79376852|FG010|Treatment Period|Lost to Follow-up|0|||
44371563|NCT01928394|79376853|FG011|Treatment Period|Lost to Follow-up|0|||
44371564|NCT01928394|79376854|FG012|Treatment Period|Lost to Follow-up|0|||
44371565|NCT01928394|79376855|FG013|Treatment Period|Lost to Follow-up|0|||
44371566|NCT01928394|79376856|FG014|Treatment Period|Lost to Follow-up|0|||
44371567|NCT01928394|79376857|FG015|Treatment Period|Lost to Follow-up|0|||
44371568|NCT01928394|79376858|FG016|Treatment Period|Lost to Follow-up|0|||
44371569|NCT01928394|79376859|FG017|Treatment Period|Lost to Follow-up|0|||
44455605|NCT00486759|79463997|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
44455606|NCT00486603|79464005|FG000|Overall Study|Withdrawal by Subject|1|||
44371570|NCT01928394|79376860|FG018|Treatment Period|Lost to Follow-up|0|||
44371571|NCT01928394|79376861|FG019|Treatment Period|Lost to Follow-up|0|||
44371572|NCT01928394|79376862|FG020|Treatment Period|Lost to Follow-up|0|||
44455607|NCT00486603|79464006|FG001|Overall Study|Withdrawal by Subject|0|||
44543764|NCT03619837|79556871|FG000|Screening|withdrew consent|2|||
44543765|NCT03619837|79556871|FG000|Screening|never listed for HCV-viremic donor|1|||
44543766|NCT03619837|79556871|FG000|Screening|developed exclusion criteria|2|||
44215231|NCT01685073|79012950|FG000|Overall Study|Lost to Follow-up|6|||
44215232|NCT01685073|79012951|FG001|Overall Study|Lost to Follow-up|8|||
44215233|NCT01685073|79012950|FG000|Overall Study|Withdrawal by Subject|24|||
44215234|NCT01685073|79012951|FG001|Overall Study|Withdrawal by Subject|24|||
44215235|NCT01572909|79012959|FG000|Overall Study|Adverse Event|7|||
44215236|NCT01572909|79012960|FG001|Overall Study|Adverse Event|2|||
44215237|NCT01572909|79012959|FG000|Overall Study|Death|3|||
44215238|NCT01572909|79012960|FG001|Overall Study|Death|1|||
44215239|NCT01572909|79012959|FG000|Overall Study|Lost to Follow-up|8|||
44215240|NCT01572909|79012960|FG001|Overall Study|Lost to Follow-up|7|||
44215241|NCT01572909|79012959|FG000|Overall Study|Physician Decision|1|||
44215242|NCT01572909|79012960|FG001|Overall Study|Physician Decision|1|||
44215243|NCT01572909|79012959|FG000|Overall Study|Technical Issues|1|||
44215244|NCT01572909|79012960|FG001|Overall Study|Technical Issues|0|||
44371573|NCT01928394|79376863|FG021|Treatment Period|Lost to Follow-up|0|||
44371574|NCT01928394|79376864|FG022|Treatment Period|Lost to Follow-up|1|||
44371575|NCT01928394|79376842|FG000|Treatment Period|Death|0|||
44371576|NCT01928394|79376843|FG001|Treatment Period|Death|0|||
44371577|NCT01928394|79376844|FG002|Treatment Period|Death|0|||
44371578|NCT01928394|79376845|FG003|Treatment Period|Death|0|||
44371579|NCT01928394|79376846|FG004|Treatment Period|Death|0|||
44371580|NCT01928394|79376847|FG005|Treatment Period|Death|0|||
44371581|NCT01928394|79376848|FG006|Treatment Period|Death|0|||
44371582|NCT01928394|79376849|FG007|Treatment Period|Death|0|||
44371583|NCT01928394|79376850|FG008|Treatment Period|Death|0|||
44371584|NCT01928394|79376851|FG009|Treatment Period|Death|0|||
44371585|NCT01928394|79376852|FG010|Treatment Period|Death|0|||
44371586|NCT01928394|79376853|FG011|Treatment Period|Death|0|||
44371587|NCT01928394|79376854|FG012|Treatment Period|Death|0|||
44371588|NCT01928394|79376855|FG013|Treatment Period|Death|1|||
44371589|NCT01928394|79376856|FG014|Treatment Period|Death|2|||
44371590|NCT01928394|79376857|FG015|Treatment Period|Death|0|||
44371591|NCT01928394|79376858|FG016|Treatment Period|Death|0|||
44371592|NCT01928394|79376859|FG017|Treatment Period|Death|0|||
44371593|NCT01928394|79376860|FG018|Treatment Period|Death|0|||
44371594|NCT01928394|79376861|FG019|Treatment Period|Death|0|||
44371595|NCT01928394|79376862|FG020|Treatment Period|Death|0|||
44371596|NCT01928394|79376863|FG021|Treatment Period|Death|0|||
44371597|NCT01928394|79376864|FG022|Treatment Period|Death|0|||
44371598|NCT01928394|79376842|FG000|Follow-up Period|Participant withdrew consent|3|||
44371599|NCT01928394|79376843|FG001|Follow-up Period|Participant withdrew consent|0|||
44371600|NCT01928394|79376844|FG002|Follow-up Period|Participant withdrew consent|1|||
44371601|NCT01928394|79376845|FG003|Follow-up Period|Participant withdrew consent|4|||
44371602|NCT01928394|79376846|FG004|Follow-up Period|Participant withdrew consent|0|||
44371603|NCT01928394|79376847|FG005|Follow-up Period|Participant withdrew consent|2|||
44371604|NCT01928394|79376848|FG006|Follow-up Period|Participant withdrew consent|5|||
44371605|NCT01928394|79376849|FG007|Follow-up Period|Participant withdrew consent|1|||
44371606|NCT01928394|79376850|FG008|Follow-up Period|Participant withdrew consent|0|||
44371607|NCT01928394|79376851|FG009|Follow-up Period|Participant withdrew consent|0|||
44371608|NCT01928394|79376852|FG010|Follow-up Period|Participant withdrew consent|5|||
44371609|NCT01928394|79376853|FG011|Follow-up Period|Participant withdrew consent|8|||
44371610|NCT01928394|79376854|FG012|Follow-up Period|Participant withdrew consent|2|||
44371611|NCT01928394|79376855|FG013|Follow-up Period|Participant withdrew consent|12|||
44371612|NCT01928394|79376856|FG014|Follow-up Period|Participant withdrew consent|7|||
44371613|NCT01928394|79376857|FG015|Follow-up Period|Participant withdrew consent|0|||
44371614|NCT01928394|79376858|FG016|Follow-up Period|Participant withdrew consent|5|||
44371615|NCT01928394|79376859|FG017|Follow-up Period|Participant withdrew consent|3|||
44371616|NCT01928394|79376860|FG018|Follow-up Period|Participant withdrew consent|2|||
44371617|NCT01928394|79376861|FG019|Follow-up Period|Participant withdrew consent|7|||
44371618|NCT01928394|79376862|FG020|Follow-up Period|Participant withdrew consent|4|||
44371619|NCT01928394|79376863|FG021|Follow-up Period|Participant withdrew consent|6|||
44371620|NCT01928394|79376864|FG022|Follow-up Period|Participant withdrew consent|2|||
44371621|NCT01928394|79376842|FG000|Follow-up Period|Death|0|||
44371622|NCT01928394|79376843|FG001|Follow-up Period|Death|0|||
44371623|NCT01928394|79376844|FG002|Follow-up Period|Death|2|||
44371624|NCT01928394|79376845|FG003|Follow-up Period|Death|6|||
44371625|NCT01928394|79376846|FG004|Follow-up Period|Death|0|||
44371626|NCT01928394|79376847|FG005|Follow-up Period|Death|6|||
44215245|NCT01572909|79012959|FG000|Overall Study|Withdrawal by Subject|12|||
44215246|NCT01572909|79012960|FG001|Overall Study|Withdrawal by Subject|11|||
44215247|NCT01572909|79012959|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
44215248|NCT01572909|79012960|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
44371627|NCT01928394|79376848|FG006|Follow-up Period|Death|6|||
44371628|NCT01928394|79376849|FG007|Follow-up Period|Death|2|||
44371629|NCT01928394|79376850|FG008|Follow-up Period|Death|1|||
44371630|NCT01928394|79376851|FG009|Follow-up Period|Death|2|||
44455608|NCT00486603|79464007|FG002|Overall Study|Withdrawal by Subject|0|||
44455609|NCT00486603|79464008|FG003|Overall Study|Withdrawal by Subject|0|||
44455610|NCT00486603|79464009|FG004|Overall Study|Withdrawal by Subject|0|||
44455611|NCT00486603|79464005|FG000|Overall Study|Physician Decision|0|||
44455612|NCT00486603|79464006|FG001|Overall Study|Physician Decision|1|||
44455613|NCT00486603|79464007|FG002|Overall Study|Physician Decision|0|||
44455614|NCT00486603|79464008|FG003|Overall Study|Physician Decision|0|||
44455615|NCT00486603|79464009|FG004|Overall Study|Physician Decision|0|||
44455616|NCT00486291|79464026|FG000|Overall Study|Adverse Event|3|||
44455617|NCT00486291|79464027|FG001|Overall Study|Adverse Event|4|||
44455618|NCT00486291|79464026|FG000|Overall Study|Lost to Follow-up|3|||
44455619|NCT00486291|79464027|FG001|Overall Study|Lost to Follow-up|7|||
44455620|NCT00486291|79464026|FG000|Overall Study|protocol non-compliance|10|||
44455621|NCT00486291|79464027|FG001|Overall Study|protocol non-compliance|15|||
44455622|NCT00486291|79464026|FG000|Overall Study|requirement for restricted medication|0|||
44455623|NCT00486291|79464027|FG001|Overall Study|requirement for restricted medication|3|||
44455624|NCT00474045|79464035|FG000|Overall Study|Adverse Event|18|||
44455625|NCT00474045|79464036|FG001|Overall Study|Adverse Event|8|||
44455626|NCT00474045|79464035|FG000|Overall Study|Unclassified|1|||
44455627|NCT00474045|79464036|FG001|Overall Study|Unclassified|3|||
44455628|NCT00474045|79464035|FG000|Overall Study|Lack of Efficacy|0|||
44455629|NCT00474045|79464036|FG001|Overall Study|Lack of Efficacy|9|||
44455630|NCT00474045|79464035|FG000|Overall Study|Lost to Follow-up|1|||
44455631|NCT00474045|79464036|FG001|Overall Study|Lost to Follow-up|1|||
44455632|NCT00474045|79464035|FG000|Overall Study|Protocol Violation|10|||
44455633|NCT00474045|79464036|FG001|Overall Study|Protocol Violation|12|||
44455634|NCT00474045|79464035|FG000|Overall Study|Withdrawal by Subject|16|||
44455635|NCT00474045|79464036|FG001|Overall Study|Withdrawal by Subject|18|||
44455636|NCT00474045|79464035|FG000|Overall Study|Withdrawal criteria|60|||
44455637|NCT00474045|79464036|FG001|Overall Study|Withdrawal criteria|50|||
44455638|NCT00462501|79464042|FG000|Overall Study|Not treated|3|||
44455639|NCT00462501|79464042|FG000|Overall Study|Adverse Event|2|||
44455640|NCT00383188|79464051|FG000|Overall Study|Adverse Event|4|||
44455641|NCT00383188|79464052|FG001|Overall Study|Adverse Event|7|||
44455642|NCT00383188|79464053|FG002|Overall Study|Adverse Event|9|||
44455643|NCT00383188|79464054|FG003|Overall Study|Adverse Event|8|||
44455644|NCT00383188|79464055|FG004|Overall Study|Adverse Event|8|||
44455645|NCT00383188|79464051|FG000|Overall Study|Lack of Efficacy|9|||
44455646|NCT00383188|79464052|FG001|Overall Study|Lack of Efficacy|3|||
44455647|NCT00383188|79464053|FG002|Overall Study|Lack of Efficacy|3|||
44215249|NCT01572675|79012970|FG000|Overall Study|End of prescribed treatment|140|||
44215250|NCT01572675|79012971|FG001|Overall Study|End of prescribed treatment|118|||
44543767|NCT03619837|79556871|FG000|Screening|excluded by the investigator due to non-compliance|1|||
44215251|NCT01572675|79012970|FG000|Overall Study|Recovery|16|||
44455648|NCT00383188|79464054|FG003|Overall Study|Lack of Efficacy|2|||
44455649|NCT00383188|79464055|FG004|Overall Study|Lack of Efficacy|6|||
44455650|NCT00383188|79464051|FG000|Overall Study|Other|3|||
44455651|NCT00383188|79464052|FG001|Overall Study|Other|1|||
44455652|NCT00383188|79464053|FG002|Overall Study|Other|0|||
44455653|NCT00383188|79464054|FG003|Overall Study|Other|2|||
44455654|NCT00383188|79464055|FG004|Overall Study|Other|6|||
44455655|NCT00383188|79464051|FG000|Overall Study|No longer willing to participate|1|||
44215252|NCT01572675|79012971|FG001|Overall Study|Recovery|23|||
44215253|NCT01572675|79012970|FG000|Overall Study|Lack of Efficacy|31|||
44215254|NCT01572675|79012971|FG001|Overall Study|Lack of Efficacy|31|||
44215255|NCT01572675|79012970|FG000|Overall Study|Intolerance|6|||
44215256|NCT01572675|79012971|FG001|Overall Study|Intolerance|5|||
44215257|NCT01572675|79012970|FG000|Overall Study|Improved symptoms|8|||
44215258|NCT01572675|79012971|FG001|Overall Study|Improved symptoms|2|||
44215259|NCT01572675|79012970|FG000|Overall Study|Surgical intervention|3|||
44215260|NCT01572675|79012971|FG001|Overall Study|Surgical intervention|6|||
44215261|NCT01572675|79012970|FG000|Overall Study|Withdrawal by Subject|5|||
44215262|NCT01572675|79012971|FG001|Overall Study|Withdrawal by Subject|1|||
44215263|NCT01572675|79012970|FG000|Overall Study|Physician Decision|2|||
44215264|NCT01572675|79012971|FG001|Overall Study|Physician Decision|2|||
44215265|NCT01572675|79012970|FG000|Overall Study|Death unrelated to coxibs|1|||
44215266|NCT01572675|79012971|FG001|Overall Study|Death unrelated to coxibs|1|||
44215267|NCT01572675|79012970|FG000|Overall Study|Other disease detected|1|||
44215268|NCT01572675|79012971|FG001|Overall Study|Other disease detected|1|||
44371631|NCT01928394|79376852|FG010|Follow-up Period|Death|4|||
44371632|NCT01928394|79376853|FG011|Follow-up Period|Death|12|||
44371633|NCT01928394|79376854|FG012|Follow-up Period|Death|11|||
44371634|NCT01928394|79376855|FG013|Follow-up Period|Death|25|||
44371635|NCT01928394|79376856|FG014|Follow-up Period|Death|18|||
44371636|NCT01928394|79376857|FG015|Follow-up Period|Death|0|||
44371637|NCT01928394|79376858|FG016|Follow-up Period|Death|6|||
44371638|NCT01928394|79376859|FG017|Follow-up Period|Death|5|||
44371639|NCT01928394|79376860|FG018|Follow-up Period|Death|13|||
44371640|NCT01928394|79376861|FG019|Follow-up Period|Death|13|||
44371641|NCT01928394|79376862|FG020|Follow-up Period|Death|5|||
44371642|NCT01928394|79376863|FG021|Follow-up Period|Death|3|||
44371643|NCT01928394|79376864|FG022|Follow-up Period|Death|2|||
44371644|NCT01928394|79376842|FG000|Follow-up Period|other reason|0|||
44371645|NCT01928394|79376843|FG001|Follow-up Period|other reason|0|||
44371646|NCT01928394|79376844|FG002|Follow-up Period|other reason|0|||
44371647|NCT01928394|79376845|FG003|Follow-up Period|other reason|0|||
44371648|NCT01928394|79376846|FG004|Follow-up Period|other reason|0|||
44371649|NCT01928394|79376847|FG005|Follow-up Period|other reason|0|||
44371650|NCT01928394|79376848|FG006|Follow-up Period|other reason|1|||
44371651|NCT01928394|79376849|FG007|Follow-up Period|other reason|3|||
44371652|NCT01928394|79376850|FG008|Follow-up Period|other reason|0|||
44371653|NCT01928394|79376851|FG009|Follow-up Period|other reason|0|||
44371654|NCT01928394|79376852|FG010|Follow-up Period|other reason|2|||
44371655|NCT01928394|79376853|FG011|Follow-up Period|other reason|1|||
44371656|NCT01928394|79376854|FG012|Follow-up Period|other reason|0|||
44371657|NCT01928394|79376855|FG013|Follow-up Period|other reason|1|||
44371658|NCT01928394|79376856|FG014|Follow-up Period|other reason|4|||
44371659|NCT01928394|79376857|FG015|Follow-up Period|other reason|0|||
44455656|NCT00383188|79464052|FG001|Overall Study|No longer willing to participate|0|||
44455657|NCT00383188|79464053|FG002|Overall Study|No longer willing to participate|1|||
44371660|NCT01928394|79376858|FG016|Follow-up Period|other reason|2|||
44215269|NCT01572675|79012970|FG000|Overall Study|Unknown reason|1|||
44215270|NCT01572675|79012971|FG001|Overall Study|Unknown reason|1|||
44215271|NCT01572675|79012970|FG000|Overall Study|Rheumatologist new evaluation|0|||
44371661|NCT01928394|79376859|FG017|Follow-up Period|other reason|0|||
44371662|NCT01928394|79376860|FG018|Follow-up Period|other reason|1|||
44371663|NCT01928394|79376861|FG019|Follow-up Period|other reason|1|||
44215272|NCT01572675|79012971|FG001|Overall Study|Rheumatologist new evaluation|1|||
44215273|NCT01572675|79012970|FG000|Overall Study|Missing data|1|||
44215274|NCT01572675|79012971|FG001|Overall Study|Missing data|4|||
44215275|NCT01572675|79012970|FG000|Overall Study|Lost to Follow-up|22|||
44215276|NCT01572675|79012971|FG001|Overall Study|Lost to Follow-up|27|||
44215277|NCT05065983|79012990|FG000|Overall Study|Lost to Follow-up|2|||
44215278|NCT04797650|79012997|FG000|Overall Study|Reason Not Specified|5|||
44215279|NCT04797650|79012998|FG001|Overall Study|Reason Not Specified|12|||
44215280|NCT04797650|79012999|FG002|Overall Study|Reason Not Specified|5|||
44215281|NCT04797650|79012997|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
44215282|NCT04797650|79012998|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
44215283|NCT04797650|79012999|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
44215284|NCT04797650|79012997|FG000|Overall Study|Lack of Efficacy|1|||
44215285|NCT04797650|79012998|FG001|Overall Study|Lack of Efficacy|0|||
44215286|NCT04797650|79012999|FG002|Overall Study|Lack of Efficacy|1|||
44215287|NCT04797650|79012997|FG000|Overall Study|Non-compliance with Study Drug|0|||
44215288|NCT04797650|79012998|FG001|Overall Study|Non-compliance with Study Drug|0|||
44215289|NCT04797650|79012999|FG002|Overall Study|Non-compliance with Study Drug|2|||
44215290|NCT04797650|79012997|FG000|Overall Study|Lost to Follow-up|4|||
44215291|NCT04797650|79012998|FG001|Overall Study|Lost to Follow-up|6|||
44215292|NCT04797650|79012999|FG002|Overall Study|Lost to Follow-up|1|||
44215293|NCT04705597|79013011|FG000|Overall Study|Death|16|||
44215294|NCT04705597|79013012|FG001|Overall Study|Death|9|||
44215295|NCT04705597|79013011|FG000|Overall Study|Lost to Follow-up|1|||
44215296|NCT04705597|79013012|FG001|Overall Study|Lost to Follow-up|0|||
44215297|NCT04705597|79013011|FG000|Overall Study|Withdrawal by Subject|1|||
44215298|NCT04705597|79013012|FG001|Overall Study|Withdrawal by Subject|2|||
44215299|NCT04534114|79013022|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
44215300|NCT04534114|79013023|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
44215301|NCT04534114|79013024|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
44215302|NCT04534114|79013025|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
44215303|NCT04534114|79013022|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
44215304|NCT04534114|79013023|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
44215305|NCT04534114|79013024|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
44215306|NCT04534114|79013025|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
44215307|NCT04534114|79013022|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
44215308|NCT04534114|79013023|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
44215309|NCT04534114|79013024|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
44215310|NCT04534114|79013025|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
44215311|NCT04534114|79013022|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
44215312|NCT04534114|79013023|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
44215313|NCT04534114|79013024|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
44215314|NCT04534114|79013025|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
44215315|NCT04534114|79013022|FG000|Main Treatment Period|Physician Decision|0|||
44215316|NCT04534114|79013023|FG001|Main Treatment Period|Physician Decision|0|||
44215317|NCT04534114|79013024|FG002|Main Treatment Period|Physician Decision|0|||
44371664|NCT01928394|79376862|FG020|Follow-up Period|other reason|0|||
44371665|NCT01928394|79376863|FG021|Follow-up Period|other reason|0|||
44371666|NCT01928394|79376864|FG022|Follow-up Period|other reason|1|||
44371667|NCT01928394|79376842|FG000|Follow-up Period|Lost to Follow-up|0|||
44371668|NCT01928394|79376843|FG001|Follow-up Period|Lost to Follow-up|0|||
44371669|NCT01928394|79376844|FG002|Follow-up Period|Lost to Follow-up|0|||
44371670|NCT01928394|79376845|FG003|Follow-up Period|Lost to Follow-up|0|||
44455658|NCT00383188|79464054|FG003|Overall Study|No longer willing to participate|0|||
44455659|NCT00383188|79464055|FG004|Overall Study|No longer willing to participate|2|||
44215318|NCT04534114|79013025|FG003|Main Treatment Period|Physician Decision|1|||
44215319|NCT04534114|79013022|FG000|Main Treatment Period|Death|1|||
44215320|NCT04534114|79013023|FG001|Main Treatment Period|Death|0|||
44371671|NCT01928394|79376846|FG004|Follow-up Period|Lost to Follow-up|0|||
44270131|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44371672|NCT01928394|79376847|FG005|Follow-up Period|Lost to Follow-up|0|||
44455660|NCT00383188|79464051|FG000|Overall Study|Lost to Follow-up|0|||
44455661|NCT00383188|79464052|FG001|Overall Study|Lost to Follow-up|0|||
44455662|NCT00383188|79464053|FG002|Overall Study|Lost to Follow-up|0|||
44215321|NCT04534114|79013024|FG002|Main Treatment Period|Death|0|||
44215322|NCT04534114|79013025|FG003|Main Treatment Period|Death|1|||
44215323|NCT04534114|79013022|FG000|Main Treatment Period|Other reason|1|||
44215324|NCT04534114|79013023|FG001|Main Treatment Period|Other reason|1|||
44215325|NCT04534114|79013024|FG002|Main Treatment Period|Other reason|0|||
44215326|NCT04534114|79013025|FG003|Main Treatment Period|Other reason|0|||
44455663|NCT00383188|79464054|FG003|Overall Study|Lost to Follow-up|0|||
44455664|NCT00383188|79464055|FG004|Overall Study|Lost to Follow-up|1|||
44455665|NCT00462345|79464069|FG000|Overall Study|Withdrawal by Subject|2|||
44215327|NCT04534114|79013022|FG000|Main Treatment Period|Participant decision|1|||
44215328|NCT04534114|79013023|FG001|Main Treatment Period|Participant decision|3|||
44215329|NCT04534114|79013024|FG002|Main Treatment Period|Participant decision|3|||
44215330|NCT04534114|79013025|FG003|Main Treatment Period|Participant decision|1|||
44215331|NCT04534114|79013022|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
44215332|NCT04534114|79013023|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
44455666|NCT00462345|79464069|FG000|Overall Study|Did not complete second course|1|||
44455667|NCT00453999|79464076|FG000|Overall Study|Adverse Event|1|||
44455668|NCT00453999|79464077|FG001|Overall Study|Adverse Event|2|||
44455669|NCT00453999|79464078|FG002|Overall Study|Adverse Event|1|||
44455670|NCT00453999|79464076|FG000|Overall Study|Lost to Follow-up|0|||
44455671|NCT00453999|79464077|FG001|Overall Study|Lost to Follow-up|1|||
44455672|NCT00453999|79464078|FG002|Overall Study|Lost to Follow-up|1|||
44455673|NCT00453999|79464076|FG000|Overall Study|Withdrawal by Subject|2|||
44455674|NCT00453999|79464077|FG001|Overall Study|Withdrawal by Subject|1|||
44455675|NCT00453999|79464078|FG002|Overall Study|Withdrawal by Subject|1|||
44455676|NCT00453999|79464076|FG000|Overall Study|Subject Request|2|||
44455677|NCT00453999|79464077|FG001|Overall Study|Subject Request|1|||
44455678|NCT00453999|79464078|FG002|Overall Study|Subject Request|0|||
44455679|NCT00453921|79464091|FG000|Overall Study|Withdrawal by Subject|1|||
44455680|NCT00453921|79464092|FG001|Overall Study|Withdrawal by Subject|1|||
44455681|NCT00453921|79464093|FG002|Overall Study|Withdrawal by Subject|1|||
44455682|NCT00453921|79464094|FG003|Overall Study|Withdrawal by Subject|1|||
44455683|NCT00453921|79464091|FG000|Overall Study|Lost to Follow-up|0|||
44455684|NCT00453921|79464092|FG001|Overall Study|Lost to Follow-up|0|||
44455685|NCT00453921|79464093|FG002|Overall Study|Lost to Follow-up|1|||
44455686|NCT00453921|79464094|FG003|Overall Study|Lost to Follow-up|0|||
44455687|NCT00382720|79464111|FG000|Overall Study|Adverse Event|21|||
44455688|NCT00382720|79464112|FG001|Overall Study|Adverse Event|23|||
44455689|NCT00382720|79464113|FG002|Overall Study|Adverse Event|15|||
44455690|NCT00382720|79464111|FG000|Overall Study|Protocol Violation|2|||
44455691|NCT00382720|79464112|FG001|Overall Study|Protocol Violation|5|||
44455692|NCT00382720|79464113|FG002|Overall Study|Protocol Violation|1|||
44543768|NCT03206970|79556875|FG000|Overall Study|Death|21|||
44543769|NCT03206970|79556875|FG000|Overall Study|Withdrawal by Subject|13|||
44543770|NCT03206970|79556875|FG000|Overall Study|Lost to Follow-up|3|||
44543771|NCT03206970|79556875|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
44543772|NCT03644173|79556879|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
44543773|NCT03644173|79556879|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
44215333|NCT04534114|79013024|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
44215334|NCT04534114|79013025|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
44215335|NCT04534114|79013022|FG000|Main Treatment Period|Adverse Event|4|||
44215336|NCT04534114|79013023|FG001|Main Treatment Period|Adverse Event|2|||
44215337|NCT04534114|79013024|FG002|Main Treatment Period|Adverse Event|1|||
44455693|NCT00382720|79464111|FG000|Overall Study|Death|0|||
44543774|NCT03644173|79556879|FG000|Participants at the 1-month Follow up|Death|2|||
44543775|NCT03644173|79556879|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
44543776|NCT03178851|79556887|FG000|Overall Study|Death|48|||
44543777|NCT03178851|79556888|FG001|Overall Study|Death|2|||
44543778|NCT03178851|79556889|FG002|Overall Study|Death|25|||
44543779|NCT03178851|79556887|FG000|Overall Study|Withdrawal by Subject|8|||
44543780|NCT03178851|79556888|FG001|Overall Study|Withdrawal by Subject|0|||
44543781|NCT03178851|79556889|FG002|Overall Study|Withdrawal by Subject|0|||
44543782|NCT03178851|79556887|FG000|Overall Study|Lost to Follow-up|5|||
44543783|NCT03178851|79556888|FG001|Overall Study|Lost to Follow-up|2|||
44543784|NCT03178851|79556889|FG002|Overall Study|Lost to Follow-up|0|||
44215338|NCT04534114|79013025|FG003|Main Treatment Period|Adverse Event|2|||
44455694|NCT00382720|79464112|FG001|Overall Study|Death|1|||
44455695|NCT00382720|79464113|FG002|Overall Study|Death|2|||
44543785|NCT03178851|79556887|FG000|Overall Study|Adverse Event|0|||
44543786|NCT03178851|79556888|FG001|Overall Study|Adverse Event|0|||
44455696|NCT00382720|79464111|FG000|Overall Study|Progressive disease|37|||
44455697|NCT00382720|79464112|FG001|Overall Study|Progressive disease|28|||
44455698|NCT00382720|79464113|FG002|Overall Study|Progressive disease|38|||
44455699|NCT00382720|79464111|FG000|Overall Study|Withdrew consent|1|||
44455700|NCT00382720|79464112|FG001|Overall Study|Withdrew consent|1|||
44455701|NCT00382720|79464113|FG002|Overall Study|Withdrew consent|2|||
44215339|NCT04534114|79013022|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
44371673|NCT01928394|79376848|FG006|Follow-up Period|Lost to Follow-up|0|||
44371674|NCT01928394|79376849|FG007|Follow-up Period|Lost to Follow-up|0|||
44371675|NCT01928394|79376850|FG008|Follow-up Period|Lost to Follow-up|0|||
44371676|NCT01928394|79376851|FG009|Follow-up Period|Lost to Follow-up|0|||
44371677|NCT01928394|79376852|FG010|Follow-up Period|Lost to Follow-up|0|||
44371678|NCT01928394|79376853|FG011|Follow-up Period|Lost to Follow-up|1|||
44371679|NCT01928394|79376854|FG012|Follow-up Period|Lost to Follow-up|1|||
44371680|NCT01928394|79376855|FG013|Follow-up Period|Lost to Follow-up|0|||
44371681|NCT01928394|79376856|FG014|Follow-up Period|Lost to Follow-up|1|||
44371682|NCT01928394|79376857|FG015|Follow-up Period|Lost to Follow-up|0|||
44371683|NCT01928394|79376858|FG016|Follow-up Period|Lost to Follow-up|1|||
44371684|NCT01928394|79376859|FG017|Follow-up Period|Lost to Follow-up|0|||
44371685|NCT01928394|79376860|FG018|Follow-up Period|Lost to Follow-up|0|||
44371686|NCT01928394|79376861|FG019|Follow-up Period|Lost to Follow-up|0|||
44371687|NCT01928394|79376862|FG020|Follow-up Period|Lost to Follow-up|0|||
44371688|NCT01928394|79376863|FG021|Follow-up Period|Lost to Follow-up|0|||
44371689|NCT01928394|79376864|FG022|Follow-up Period|Lost to Follow-up|1|||
44371693|NCT01864018|79376928|FG000|Overall Study|Ineligible|3|||
44371694|NCT01864018|79376929|FG001|Overall Study|Ineligible|1|||
44371695|NCT01850108|79376940|FG000|Overall Study|Lost to Follow-up|4|||
44371696|NCT01850108|79376940|FG000|Overall Study|Not eligible|1|||
44371697|NCT01850108|79376940|FG000|Overall Study|Failed engraftment|2|||
44371698|NCT01850108|79376940|FG000|Overall Study|Physician Decision|1|||
44371699|NCT01844505|79376949|FG000|Overall Study|Disease progression|170|||
44371700|NCT01844505|79376950|FG001|Overall Study|Disease progression|88|||
44371701|NCT01844505|79376951|FG002|Overall Study|Disease progression|224|||
44371702|NCT01844505|79376949|FG000|Overall Study|Study drug toxicity|40|||
44371703|NCT01844505|79376950|FG001|Overall Study|Study drug toxicity|131|||
44371704|NCT01844505|79376951|FG002|Overall Study|Study drug toxicity|50|||
44215340|NCT04534114|79013023|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
44215341|NCT04534114|79013024|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
44215342|NCT04534114|79013025|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
44215343|NCT04534114|79013022|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
44215344|NCT04534114|79013023|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
44215345|NCT04534114|79013024|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
44371705|NCT01844505|79376949|FG000|Overall Study|Death|1|||
44371706|NCT01844505|79376950|FG001|Overall Study|Death|3|||
44371707|NCT01844505|79376951|FG002|Overall Study|Death|1|||
44371708|NCT01844505|79376949|FG000|Overall Study|Adverse event unrelated to study drug|7|||
44371709|NCT01844505|79376950|FG001|Overall Study|Adverse event unrelated to study drug|15|||
44371710|NCT01844505|79376951|FG002|Overall Study|Adverse event unrelated to study drug|6|||
44270132|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270133|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270134|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270135|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270136|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270137|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
44270138|NCT02326272|79195767|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270139|NCT02326272|79195768|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270140|NCT02326272|79195769|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
44270141|NCT02326272|79195770|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270142|NCT02326272|79195771|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270143|NCT02326272|79195772|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44371711|NCT01844505|79376949|FG000|Overall Study|Subject request discontinue treatment|17|||
44543787|NCT03178851|79556889|FG002|Overall Study|Adverse Event|1|||
44543788|NCT03178851|79556887|FG000|Overall Study|Study Termination by Sponsor|31|||
44215346|NCT04534114|79013025|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
44215347|NCT04534114|79013022|FG000|Extension Treatment Period|Other reason|0|||
44215348|NCT04534114|79013023|FG001|Extension Treatment Period|Other reason|1|||
44215349|NCT04534114|79013024|FG002|Extension Treatment Period|Other reason|0|||
44215350|NCT04534114|79013025|FG003|Extension Treatment Period|Other reason|0|||
44215351|NCT04534114|79013022|FG000|Extension Treatment Period|Death|0|||
44215352|NCT04534114|79013023|FG001|Extension Treatment Period|Death|0|||
44215353|NCT04534114|79013024|FG002|Extension Treatment Period|Death|1|||
44215354|NCT04534114|79013025|FG003|Extension Treatment Period|Death|2|||
44215355|NCT04534114|79013022|FG000|Extension Treatment Period|Adverse Event|0|||
44215356|NCT04534114|79013023|FG001|Extension Treatment Period|Adverse Event|1|||
44215357|NCT04534114|79013024|FG002|Extension Treatment Period|Adverse Event|0|||
44215358|NCT04534114|79013025|FG003|Extension Treatment Period|Adverse Event|1|||
44215359|NCT04534114|79013022|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
44215360|NCT04534114|79013023|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
44215361|NCT04534114|79013024|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
44215362|NCT04534114|79013025|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
44215363|NCT04474366|79013046|FG000|Overall Study|Lost to Follow-up|2|||
44215364|NCT04474366|79013047|FG001|Overall Study|Lost to Follow-up|5|||
44215365|NCT04422431|79013053|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
44215366|NCT04422431|79013053|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
44215367|NCT04422431|79013053|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
44215368|NCT04422431|79013053|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
44215369|NCT04115488|79013064|FG000|Overall Study|Adverse Event|8|||
44215370|NCT04115488|79013065|FG001|Overall Study|Adverse Event|4|||
44215371|NCT04115488|79013064|FG000|Overall Study|Withdrawal by Subject|3|||
44215372|NCT04115488|79013065|FG001|Overall Study|Withdrawal by Subject|6|||
44215373|NCT04115488|79013064|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
44215374|NCT04115488|79013065|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
44215375|NCT04115488|79013064|FG000|Overall Study|Patient 's location change|1|||
44215376|NCT04115488|79013065|FG001|Overall Study|Patient 's location change|0|||
44215377|NCT04115488|79013064|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
44215378|NCT04115488|79013065|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
44215379|NCT04080752|79013089|FG000|Overall Study|Adverse Event|2|||
44371712|NCT01844505|79376950|FG001|Overall Study|Subject request discontinue treatment|14|||
44371713|NCT01844505|79376951|FG002|Overall Study|Subject request discontinue treatment|8|||
44371714|NCT01844505|79376949|FG000|Overall Study|Withdrawal by Subject|0|||
44371715|NCT01844505|79376950|FG001|Overall Study|Withdrawal by Subject|3|||
44371716|NCT01844505|79376951|FG002|Overall Study|Withdrawal by Subject|0|||
44371717|NCT01844505|79376949|FG000|Overall Study|Lost to Follow-up|1|||
44371718|NCT01844505|79376950|FG001|Overall Study|Lost to Follow-up|0|||
44543789|NCT03178851|79556888|FG001|Overall Study|Study Termination by Sponsor|7|||
44543790|NCT03178851|79556889|FG002|Overall Study|Study Termination by Sponsor|26|||
44215380|NCT04080752|79013090|FG001|Overall Study|Adverse Event|3|||
44215381|NCT04080752|79013089|FG000|Overall Study|Lack of Efficacy|1|||
44215382|NCT04080752|79013090|FG001|Overall Study|Lack of Efficacy|0|||
44215383|NCT04080752|79013089|FG000|Overall Study|Lost to Follow-up|1|||
44215384|NCT04080752|79013090|FG001|Overall Study|Lost to Follow-up|0|||
44215385|NCT04080752|79013089|FG000|Overall Study|Pregnancy|0|||
44215386|NCT04080752|79013090|FG001|Overall Study|Pregnancy|1|||
44543791|NCT03643159|79556900|FG000|Overall Study|Adverse Event|1|||
44215387|NCT04080752|79013089|FG000|Overall Study|Withdrawal by Subject|7|||
44215388|NCT04080752|79013090|FG001|Overall Study|Withdrawal by Subject|0|||
44215389|NCT04080752|79013089|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44371719|NCT01844505|79376951|FG002|Overall Study|Lost to Follow-up|0|||
44371720|NCT01844505|79376949|FG000|Overall Study|Maximum clinical benefit|8|||
44371721|NCT01844505|79376950|FG001|Overall Study|Maximum clinical benefit|11|||
44371722|NCT01844505|79376951|FG002|Overall Study|Maximum clinical benefit|2|||
44371723|NCT01844505|79376949|FG000|Overall Study|Poor/non-compliance|1|||
44371724|NCT01844505|79376950|FG001|Overall Study|Poor/non-compliance|1|||
44371725|NCT01844505|79376951|FG002|Overall Study|Poor/non-compliance|1|||
44371726|NCT01844505|79376949|FG000|Overall Study|Subject no longer meets criteria|0|||
44371727|NCT01844505|79376950|FG001|Overall Study|Subject no longer meets criteria|1|||
44371728|NCT01844505|79376951|FG002|Overall Study|Subject no longer meets criteria|0|||
44371729|NCT01844505|79376949|FG000|Overall Study|Other Reasons|4|||
44371730|NCT01844505|79376950|FG001|Overall Study|Other Reasons|2|||
44371731|NCT01844505|79376951|FG002|Overall Study|Other Reasons|2|||
44371732|NCT01844505|79376949|FG000|Overall Study|Not Reported|0|||
44371733|NCT01844505|79376950|FG001|Overall Study|Not Reported|0|||
44371734|NCT01844505|79376951|FG002|Overall Study|Not Reported|1|||
44371735|NCT01796171|79376973|FG000|Enrolled|Death|0|||
44371736|NCT01796171|79376974|FG001|Enrolled|Death|0|||
44371737|NCT01796171|79376975|FG002|Enrolled|Death|0|||
44371738|NCT01796171|79376976|FG003|Enrolled|Death|0|||
44371739|NCT01796171|79376977|FG004|Enrolled|Death|0|||
44371740|NCT01796171|79376978|FG005|Enrolled|Death|0|||
44371741|NCT01796171|79376979|FG006|Enrolled|Death|0|||
44371742|NCT01796171|79376980|FG007|Enrolled|Death|0|||
44371743|NCT01796171|79376981|FG008|Enrolled|Death|0|||
44371744|NCT01796171|79376982|FG009|Enrolled|Death|0|||
44371745|NCT01796171|79376983|FG010|Enrolled|Death|0|||
44371746|NCT01796171|79376984|FG011|Enrolled|Death|0|||
44371747|NCT01796171|79376985|FG012|Enrolled|Death|0|||
44371748|NCT01796171|79376986|FG013|Enrolled|Death|0|||
44371749|NCT01796171|79376987|FG014|Enrolled|Death|1|||
44371750|NCT01796171|79376973|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
44371751|NCT01796171|79376974|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
44371752|NCT01796171|79376975|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
44371753|NCT01796171|79376976|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
44371754|NCT01796171|79376977|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
44371755|NCT01796171|79376978|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
44371756|NCT01796171|79376979|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
44371757|NCT01796171|79376980|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
44371758|NCT01796171|79376981|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
44371759|NCT01796171|79376982|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
44371760|NCT01796171|79376983|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
44371761|NCT01796171|79376984|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
44371762|NCT01796171|79376985|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
44371763|NCT01796171|79376986|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
44371764|NCT01796171|79376987|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
44371765|NCT01796171|79376973|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371766|NCT01796171|79376974|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44215390|NCT04080752|79013090|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44215391|NCT04080752|79013089|FG000|Overall Study|Other|2|||
44215392|NCT04080752|79013090|FG001|Overall Study|Other|1|||
44371767|NCT01796171|79376975|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371768|NCT01796171|79376976|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371769|NCT01796171|79376977|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371770|NCT01796171|79376978|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371771|NCT01796171|79376979|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44455702|NCT00382720|79464111|FG000|Overall Study|Withdrawal by Subject|11|||
44455703|NCT00382720|79464112|FG001|Overall Study|Withdrawal by Subject|20|||
44455704|NCT00382720|79464113|FG002|Overall Study|Withdrawal by Subject|12|||
44455705|NCT00382720|79464111|FG000|Overall Study|Surgery|1|||
44455706|NCT00382720|79464112|FG001|Overall Study|Surgery|1|||
44455707|NCT00382720|79464113|FG002|Overall Study|Surgery|4|||
44455708|NCT00382720|79464111|FG000|Overall Study|Patient did not receive study medication|1|||
44455709|NCT00382720|79464112|FG001|Overall Study|Patient did not receive study medication|1|||
44455710|NCT00382720|79464113|FG002|Overall Study|Patient did not receive study medication|4|||
44455711|NCT00382720|79464111|FG000|Overall Study|Clinically progressive disease|0|||
44455712|NCT00382720|79464112|FG001|Overall Study|Clinically progressive disease|1|||
44455713|NCT00382720|79464113|FG002|Overall Study|Clinically progressive disease|0|||
44455714|NCT00382720|79464111|FG000|Overall Study|Good prognosis|0|||
44455715|NCT00382720|79464112|FG001|Overall Study|Good prognosis|1|||
44455716|NCT00382720|79464113|FG002|Overall Study|Good prognosis|0|||
44455717|NCT00382720|79464111|FG000|Overall Study|Investigator/Clinical decision|5|||
44543792|NCT03643159|79556900|FG000|Overall Study|Withdrawal by Subject|1|||
44543793|NCT03205566|79556907|FG000|Phase 1|Protocol Violation|1|||
44543794|NCT03205566|79556908|FG001|Phase 1|Protocol Violation|1|||
44543795|NCT02935452|79556920|FG000|Overall Study|work and life commintment|3|||
44543796|NCT02935452|79556921|FG001|Overall Study|work and life commintment|1|||
44543797|NCT03178773|79556929|FG000|Overall Study|Death|0|||
44543798|NCT03178773|79556930|FG001|Overall Study|Death|1|||
44543799|NCT03178773|79556929|FG000|Overall Study|Lost to Follow-up|29|||
44543800|NCT03178773|79556930|FG001|Overall Study|Lost to Follow-up|25|||
44543801|NCT03178773|79556929|FG000|Overall Study|Withdrawal by Subject|10|||
44543802|NCT03178773|79556930|FG001|Overall Study|Withdrawal by Subject|14|||
44543803|NCT03218397|79556939|FG000|Overall Study|Prior positive blood culture|8|||
44543804|NCT03218397|79556940|FG001|Overall Study|Prior positive blood culture|13|||
44543805|NCT03218397|79556939|FG000|Overall Study|Comfort care|8|||
44543806|NCT03218397|79556940|FG001|Overall Study|Comfort care|5|||
44543807|NCT03218397|79556939|FG000|Overall Study|Comfort care and positive blood culture|1|||
44543808|NCT03218397|79556940|FG001|Overall Study|Comfort care and positive blood culture|0|||
44543809|NCT03218397|79556939|FG000|Overall Study|Comfort care and mixed culture|0|||
44543810|NCT03218397|79556940|FG001|Overall Study|Comfort care and mixed culture|1|||
44543811|NCT03218397|79556939|FG000|Overall Study|Mixed culture|2|||
44543812|NCT03218397|79556940|FG001|Overall Study|Mixed culture|2|||
44543813|NCT03218397|79556939|FG000|Overall Study|Inaccessible hospital records|2|||
44543814|NCT03218397|79556940|FG001|Overall Study|Inaccessible hospital records|5|||
44543815|NCT03218397|79556939|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
44543816|NCT03218397|79556940|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
44543817|NCT03218397|79556939|FG000|Overall Study|Randomized during laboratory off hours|2|||
44543818|NCT03218397|79556940|FG001|Overall Study|Randomized during laboratory off hours|1|||
44543819|NCT03618823|79556948|FG000|Overall Study|Lost to Follow-up|63|||
44455718|NCT00382720|79464112|FG001|Overall Study|Investigator/Clinical decision|6|||
44455719|NCT00382720|79464113|FG002|Overall Study|Investigator/Clinical decision|6|||
44543820|NCT03618823|79556949|FG001|Overall Study|Lost to Follow-up|61|||
44543821|NCT03640507|79556961|FG000|Overall Study|Withdrawal by Subject|0|||
44543822|NCT03640507|79556962|FG001|Overall Study|Withdrawal by Subject|0|||
44543823|NCT03640507|79556963|FG002|Overall Study|Withdrawal by Subject|1|||
44543824|NCT02937636|79556973|FG000|Overall Study|Other (Not specified)|3|||
44215393|NCT03968419|79013100|FG000|Treatment Period|Adverse Event|0|||
44215394|NCT03968419|79013101|FG001|Treatment Period|Adverse Event|0|||
44455720|NCT00382720|79464111|FG000|Overall Study|Discontinued at end of study|0|||
44455721|NCT00382720|79464112|FG001|Overall Study|Discontinued at end of study|1|||
44455722|NCT00382720|79464113|FG002|Overall Study|Discontinued at end of study|2|||
44455723|NCT00453063|79464123|FG000|Overall Study|Adverse Event|1|||
44455724|NCT00453063|79464124|FG001|Overall Study|Adverse Event|2|||
44455725|NCT00453063|79464123|FG000|Overall Study|Withdrawal by Subject|1|||
44455726|NCT00453063|79464124|FG001|Overall Study|Withdrawal by Subject|1|||
44455727|NCT00453063|79464123|FG000|Overall Study|Protocol Violation|1|||
44455728|NCT00453063|79464124|FG001|Overall Study|Protocol Violation|0|||
44455729|NCT00371566|79464132|FG000|Treatment Phase|Withdrawal by Subject|0|||
44455730|NCT00371566|79464133|FG001|Treatment Phase|Withdrawal by Subject|1|||
44455731|NCT00371566|79464132|FG000|Treatment Phase|Adverse Event|0|||
44455732|NCT00371566|79464133|FG001|Treatment Phase|Adverse Event|1|||
44455733|NCT00371566|79464132|FG000|Treatment Phase|Protocol Violation|0|||
44455734|NCT00371566|79464133|FG001|Treatment Phase|Protocol Violation|1|||
44455735|NCT00371566|79464132|FG000|Chemoradiation Phase|Physician Decision|2|||
44455736|NCT00371566|79464133|FG001|Chemoradiation Phase|Physician Decision|0|||
44455737|NCT00371566|79464132|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
44455738|NCT00371566|79464133|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
44455739|NCT00371566|79464132|FG000|Chemoradiation Phase|Non compliant|0|||
44455740|NCT00371566|79464133|FG001|Chemoradiation Phase|Non compliant|1|||
44455741|NCT00371566|79464132|FG000|Chemoradiation Phase|Progressive Disease|1|||
44455742|NCT00371566|79464133|FG001|Chemoradiation Phase|Progressive Disease|1|||
44455743|NCT00371566|79464132|FG000|Chemoradiation Phase|Death|2|||
44455744|NCT00371566|79464133|FG001|Chemoradiation Phase|Death|0|||
44455745|NCT00371566|79464132|FG000|Follow Up Phase|Death|0|||
44455746|NCT00371566|79464133|FG001|Follow Up Phase|Death|5|||
44455747|NCT00371566|79464132|FG000|Follow Up Phase|Disease progression|1|||
44455748|NCT00371566|79464133|FG001|Follow Up Phase|Disease progression|0|||
44455749|NCT00371566|79464132|FG000|Follow Up Phase|Withdrawal by Subject|0|||
44455750|NCT00371566|79464133|FG001|Follow Up Phase|Withdrawal by Subject|1|||
44455751|NCT00371566|79464132|FG000|Follow Up Phase|Physician Decision|1|||
44455752|NCT00371566|79464133|FG001|Follow Up Phase|Physician Decision|1|||
44455753|NCT00371566|79464132|FG000|Follow Up Phase|Lost to Follow-up|1|||
44455754|NCT00371566|79464133|FG001|Follow Up Phase|Lost to Follow-up|0|||
44455755|NCT00382408|79464141|FG000|Overall Study|Did not meet protocol requirement|3|||
44455756|NCT00382408|79464142|FG001|Overall Study|Did not meet protocol requirement|3|||
44455757|NCT00382408|79464141|FG000|Overall Study|Protocol Violation|2|||
44455758|NCT00382408|79464142|FG001|Overall Study|Protocol Violation|2|||
44455759|NCT00382408|79464141|FG000|Overall Study|Physician Decision|1|||
44455760|NCT00382408|79464142|FG001|Overall Study|Physician Decision|0|||
44455761|NCT00382408|79464141|FG000|Overall Study|Withdrawal by Subject|17|||
44455762|NCT00382408|79464142|FG001|Overall Study|Withdrawal by Subject|6|||
44455763|NCT00382408|79464141|FG000|Overall Study|Pregnancy|2|||
44455764|NCT00382408|79464142|FG001|Overall Study|Pregnancy|0|||
44455765|NCT00382408|79464141|FG000|Overall Study|Lost to Follow-up|19|||
44455766|NCT00382408|79464142|FG001|Overall Study|Lost to Follow-up|8|||
44455767|NCT00382408|79464141|FG000|Overall Study|Other|100|||
44455768|NCT00382408|79464142|FG001|Overall Study|Other|35|||
44455769|NCT00371254|79464150|FG000|Overall Study|Disease progression|13|||
44543825|NCT02937636|79556974|FG001|Overall Study|Other (Not specified)|2|||
44215395|NCT03968419|79013102|FG002|Treatment Period|Adverse Event|1|||
44371772|NCT01796171|79376980|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371773|NCT01796171|79376981|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371774|NCT01796171|79376982|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371775|NCT01796171|79376983|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371776|NCT01796171|79376984|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371777|NCT01796171|79376985|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371778|NCT01796171|79376986|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
44371779|NCT01796171|79376987|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
44371780|NCT01796171|79376973|FG000|Treatment Period With Betalutin|Progressive disease|0|||
44371781|NCT01796171|79376974|FG001|Treatment Period With Betalutin|Progressive disease|1|||
44371782|NCT01796171|79376975|FG002|Treatment Period With Betalutin|Progressive disease|0|||
44371783|NCT01796171|79376976|FG003|Treatment Period With Betalutin|Progressive disease|0|||
44371784|NCT01796171|79376977|FG004|Treatment Period With Betalutin|Progressive disease|0|||
44371785|NCT01796171|79376978|FG005|Treatment Period With Betalutin|Progressive disease|0|||
44371786|NCT01796171|79376979|FG006|Treatment Period With Betalutin|Progressive disease|0|||
44371787|NCT01796171|79376980|FG007|Treatment Period With Betalutin|Progressive disease|0|||
44455770|NCT00371254|79464151|FG001|Overall Study|Disease progression|13|||
44455771|NCT00371254|79464150|FG000|Overall Study|Study drug toxicity|3|||
44455772|NCT00371254|79464151|FG001|Overall Study|Study drug toxicity|5|||
44455773|NCT00371254|79464150|FG000|Overall Study|Subject request|5|||
44455774|NCT00371254|79464151|FG001|Overall Study|Subject request|0|||
44455775|NCT00371254|79464150|FG000|Overall Study|Investigator Decision|2|||
44455776|NCT00371254|79464151|FG001|Overall Study|Investigator Decision|0|||
44455777|NCT00371254|79464150|FG000|Overall Study|Adverse event unrelated to study drug|0|||
44455778|NCT00371254|79464151|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44455779|NCT00371254|79464150|FG000|Overall Study|Lost to Follow-up|0|||
44455780|NCT00371254|79464151|FG001|Overall Study|Lost to Follow-up|1|||
44455781|NCT00371254|79464150|FG000|Overall Study|Withdrawal by Subject|0|||
44455782|NCT00371254|79464151|FG001|Overall Study|Withdrawal by Subject|1|||
44455783|NCT00452673|79464161|FG000|Dose Escalation Period|Disease Progression|6|||
44455784|NCT00452673|79464162|FG001|Dose Escalation Period|Disease Progression|6|||
44455785|NCT00452673|79464163|FG002|Dose Escalation Period|Disease Progression|2|||
44455786|NCT00452673|79464164|FG003|Dose Escalation Period|Disease Progression|6|||
44455787|NCT00452673|79464165|FG004|Dose Escalation Period|Disease Progression|0|||
44455788|NCT00452673|79464161|FG000|Dose Escalation Period|study drug toxicity|1|||
44455789|NCT00452673|79464162|FG001|Dose Escalation Period|study drug toxicity|3|||
44455790|NCT00452673|79464163|FG002|Dose Escalation Period|study drug toxicity|3|||
44455791|NCT00452673|79464164|FG003|Dose Escalation Period|study drug toxicity|1|||
44455792|NCT00452673|79464165|FG004|Dose Escalation Period|study drug toxicity|0|||
44455793|NCT00452673|79464161|FG000|Dose Escalation Period|Other|0|||
44455794|NCT00452673|79464162|FG001|Dose Escalation Period|Other|0|||
44455795|NCT00452673|79464163|FG002|Dose Escalation Period|Other|1|||
44455796|NCT00452673|79464164|FG003|Dose Escalation Period|Other|0|||
44455797|NCT00452673|79464165|FG004|Dose Escalation Period|Other|0|||
44455798|NCT00452673|79464161|FG000|Dose Escalation Period|Adverse Event|0|||
44455799|NCT00452673|79464162|FG001|Dose Escalation Period|Adverse Event|0|||
44455800|NCT00452673|79464163|FG002|Dose Escalation Period|Adverse Event|0|||
44455801|NCT00452673|79464164|FG003|Dose Escalation Period|Adverse Event|1|||
44455802|NCT00452673|79464165|FG004|Dose Escalation Period|Adverse Event|0|||
44455803|NCT00452673|79464161|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
44455804|NCT00452673|79464162|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
44455805|NCT00452673|79464163|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
44455806|NCT00452673|79464164|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
44455807|NCT00452673|79464165|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
44455808|NCT00452673|79464161|FG000|Dose Expansion Period|Disease Progression|0|||
44455809|NCT00452673|79464162|FG001|Dose Expansion Period|Disease Progression|0|||
44455810|NCT00452673|79464163|FG002|Dose Expansion Period|Disease Progression|0|||
44455811|NCT00452673|79464164|FG003|Dose Expansion Period|Disease Progression|0|||
44455812|NCT00452673|79464165|FG004|Dose Expansion Period|Disease Progression|19|||
44455813|NCT00452673|79464161|FG000|Dose Expansion Period|Other|0|||
44455814|NCT00452673|79464162|FG001|Dose Expansion Period|Other|0|||
44455815|NCT00452673|79464163|FG002|Dose Expansion Period|Other|0|||
44455816|NCT00452673|79464164|FG003|Dose Expansion Period|Other|0|||
44455817|NCT00452673|79464165|FG004|Dose Expansion Period|Other|2|||
44455818|NCT00461253|79464178|FG000|Overall Study|Death|985|||
44455819|NCT00461253|79464179|FG001|Overall Study|Death|0|||
44455820|NCT00461253|79464178|FG000|Overall Study|Protocol Violation|613|||
44455821|NCT00461253|79464179|FG001|Overall Study|Protocol Violation|236|||
44455822|NCT00461253|79464178|FG000|Overall Study|no response|2609|||
44455823|NCT00461253|79464179|FG001|Overall Study|no response|11789|||
44455824|NCT00461253|79464178|FG000|Overall Study|administrative|773|||
44455825|NCT00461253|79464179|FG001|Overall Study|administrative|7773|||
44455826|NCT00469833|79464185|FG000|Overall Study|No IV access|2|||
44455827|NCT00382174|79464197|FG000|Overall Study|Lost to Follow-up|1|||
44455828|NCT00382174|79464198|FG001|Overall Study|Lost to Follow-up|4|||
44455829|NCT00382174|79464199|FG002|Overall Study|Lost to Follow-up|5|||
44455830|NCT00382174|79464197|FG000|Overall Study|Adverse Event|1|||
44455831|NCT00382174|79464198|FG001|Overall Study|Adverse Event|4|||
44455832|NCT00382174|79464199|FG002|Overall Study|Adverse Event|5|||
44455833|NCT00382174|79464197|FG000|Overall Study|Withdrawal by Subject|1|||
44455834|NCT00382174|79464198|FG001|Overall Study|Withdrawal by Subject|4|||
44455835|NCT00382174|79464199|FG002|Overall Study|Withdrawal by Subject|5|||
44455836|NCT00382174|79464197|FG000|Overall Study|Non compliance|1|||
44455837|NCT00382174|79464198|FG001|Overall Study|Non compliance|0|||
44455838|NCT00382174|79464199|FG002|Overall Study|Non compliance|1|||
44455839|NCT00382174|79464197|FG000|Overall Study|Physician Decision|0|||
44455840|NCT00382174|79464198|FG001|Overall Study|Physician Decision|2|||
44455841|NCT00382174|79464199|FG002|Overall Study|Physician Decision|2|||
44455842|NCT00382174|79464197|FG000|Overall Study|Failed to meet criteria|0|||
44455843|NCT00382174|79464198|FG001|Overall Study|Failed to meet criteria|1|||
44455844|NCT00382174|79464199|FG002|Overall Study|Failed to meet criteria|1|||
44455845|NCT00382174|79464197|FG000|Overall Study|Wounds merged|0|||
44455846|NCT00382174|79464198|FG001|Overall Study|Wounds merged|2|||
44455847|NCT00382174|79464199|FG002|Overall Study|Wounds merged|2|||
44455848|NCT00641537|79464212|FG000|96-week Period|Adverse Event|0|||
44455849|NCT00641537|79464213|FG001|96-week Period|Adverse Event|1|||
44455850|NCT00641537|79464214|FG002|96-week Period|Adverse Event|3|||
44455851|NCT00641537|79464215|FG003|96-week Period|Adverse Event|0|||
44455852|NCT00641537|79464216|FG004|96-week Period|Adverse Event|2|||
44455853|NCT00641537|79464217|FG005|96-week Period|Adverse Event|0|||
44215396|NCT03968419|79013100|FG000|Safety Follow-up Period|Death|3|||
44215397|NCT03968419|79013101|FG001|Safety Follow-up Period|Death|2|||
44215398|NCT03968419|79013102|FG002|Safety Follow-up Period|Death|1|||
44215399|NCT03968419|79013100|FG000|Safety Follow-up Period|Subject Decision|2|||
44215400|NCT03968419|79013101|FG001|Safety Follow-up Period|Subject Decision|1|||
44215401|NCT03968419|79013102|FG002|Safety Follow-up Period|Subject Decision|0|||
44215402|NCT03784846|79013116|FG000|Pre-COVID Study|Lost to Follow-up|3|||
44215403|NCT03784846|79013117|FG001|Pre-COVID Study|Lost to Follow-up|3|||
44215404|NCT03784846|79013118|FG002|Pre-COVID Study|Lost to Follow-up|2|||
44215405|NCT03784846|79013116|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
44215406|NCT03784846|79013117|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
44215407|NCT03784846|79013118|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
44215408|NCT03784846|79013116|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
44215409|NCT03784846|79013117|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
44371788|NCT01796171|79376981|FG008|Treatment Period With Betalutin|Progressive disease|0|||
44371789|NCT01796171|79376982|FG009|Treatment Period With Betalutin|Progressive disease|0|||
44371790|NCT01796171|79376983|FG010|Treatment Period With Betalutin|Progressive disease|0|||
44455854|NCT00641537|79464218|FG006|96-week Period|Adverse Event|0|||
44455855|NCT00641537|79464219|FG007|96-week Period|Adverse Event|0|||
44455856|NCT00641537|79464212|FG000|96-week Period|Lost to Follow-up|3|||
44455857|NCT00641537|79464213|FG001|96-week Period|Lost to Follow-up|1|||
44455858|NCT00641537|79464214|FG002|96-week Period|Lost to Follow-up|2|||
44455859|NCT00641537|79464215|FG003|96-week Period|Lost to Follow-up|2|||
44455860|NCT00641537|79464216|FG004|96-week Period|Lost to Follow-up|4|||
44455861|NCT00641537|79464217|FG005|96-week Period|Lost to Follow-up|0|||
44455862|NCT00641537|79464218|FG006|96-week Period|Lost to Follow-up|1|||
44455863|NCT00641537|79464219|FG007|96-week Period|Lost to Follow-up|0|||
44455864|NCT00641537|79464212|FG000|96-week Period|Protocol Violation|0|||
44455865|NCT00641537|79464213|FG001|96-week Period|Protocol Violation|1|||
44455866|NCT00641537|79464214|FG002|96-week Period|Protocol Violation|0|||
44455867|NCT00641537|79464215|FG003|96-week Period|Protocol Violation|1|||
44455868|NCT00641537|79464216|FG004|96-week Period|Protocol Violation|0|||
44455869|NCT00641537|79464217|FG005|96-week Period|Protocol Violation|1|||
44455870|NCT00641537|79464218|FG006|96-week Period|Protocol Violation|0|||
44455871|NCT00641537|79464219|FG007|96-week Period|Protocol Violation|0|||
44371791|NCT01796171|79376984|FG011|Treatment Period With Betalutin|Progressive disease|0|||
44371792|NCT01796171|79376985|FG012|Treatment Period With Betalutin|Progressive disease|0|||
44371793|NCT01796171|79376986|FG013|Treatment Period With Betalutin|Progressive disease|0|||
44215410|NCT03784846|79013118|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
44215411|NCT03784846|79013116|FG000|Post-COVID Study|Lost to Follow-up|3|||
44371794|NCT01796171|79376987|FG014|Treatment Period With Betalutin|Progressive disease|0|||
44371795|NCT01796171|79376973|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44455872|NCT00641537|79464212|FG000|96-week Period|Death|2|||
44455873|NCT00641537|79464213|FG001|96-week Period|Death|0|||
44455874|NCT00641537|79464214|FG002|96-week Period|Death|1|||
44455875|NCT00641537|79464215|FG003|96-week Period|Death|0|||
44455876|NCT00641537|79464216|FG004|96-week Period|Death|0|||
44455877|NCT00641537|79464217|FG005|96-week Period|Death|0|||
44455878|NCT00641537|79464218|FG006|96-week Period|Death|0|||
44455879|NCT00641537|79464219|FG007|96-week Period|Death|0|||
44455880|NCT00641537|79464212|FG000|96-week Period|Other|4|||
44455881|NCT00641537|79464213|FG001|96-week Period|Other|7|||
44455882|NCT00641537|79464214|FG002|96-week Period|Other|14|||
44455883|NCT00641537|79464215|FG003|96-week Period|Other|9|||
44215412|NCT03784846|79013117|FG001|Post-COVID Study|Lost to Follow-up|5|||
44455884|NCT00641537|79464216|FG004|96-week Period|Other|11|||
44455885|NCT00641537|79464217|FG005|96-week Period|Other|6|||
44455886|NCT00641537|79464218|FG006|96-week Period|Other|4|||
44455887|NCT00641537|79464219|FG007|96-week Period|Other|6|||
44455888|NCT00641537|79464212|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
44455889|NCT00641537|79464213|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
44455890|NCT00641537|79464214|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
44455891|NCT00641537|79464215|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
44455892|NCT00641537|79464216|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
44455893|NCT00641537|79464217|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
44455894|NCT00641537|79464218|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
44455895|NCT00641537|79464219|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
44455896|NCT00641537|79464212|FG000|24-Week Supplemental Follow-up Period|Other|0|||
44455897|NCT00641537|79464213|FG001|24-Week Supplemental Follow-up Period|Other|2|||
44455898|NCT00641537|79464214|FG002|24-Week Supplemental Follow-up Period|Other|2|||
44455899|NCT00641537|79464215|FG003|24-Week Supplemental Follow-up Period|Other|1|||
44455900|NCT00641537|79464216|FG004|24-Week Supplemental Follow-up Period|Other|3|||
44455901|NCT00641537|79464217|FG005|24-Week Supplemental Follow-up Period|Other|0|||
44455902|NCT00641537|79464218|FG006|24-Week Supplemental Follow-up Period|Other|1|||
44215413|NCT03784846|79013118|FG002|Post-COVID Study|Lost to Follow-up|1|||
44215414|NCT03784846|79013116|FG000|Post-COVID Study|Withdrawal by Subject|1|||
44215415|NCT03784846|79013117|FG001|Post-COVID Study|Withdrawal by Subject|2|||
44215416|NCT03784846|79013118|FG002|Post-COVID Study|Withdrawal by Subject|0|||
44215417|NCT03756350|79013126|FG000|Overall Study|Lost to Follow-up|1|||
44215418|NCT03648996|79013148|FG000|Overall Study|Withdrawal by Subject|0|||
44215419|NCT03648996|79013149|FG001|Overall Study|Withdrawal by Subject|2|||
44215420|NCT03648996|79013150|FG002|Overall Study|Withdrawal by Subject|2|||
44215421|NCT03648996|79013148|FG000|Overall Study|Physician Decision|2|||
44215422|NCT03648996|79013149|FG001|Overall Study|Physician Decision|0|||
44215423|NCT03648996|79013150|FG002|Overall Study|Physician Decision|0|||
44215424|NCT03483961|79013175|FG000|Overall Study|Lost to Follow-up|7|||
44215425|NCT03483961|79013176|FG001|Overall Study|Lost to Follow-up|6|||
44215426|NCT03483961|79013177|FG002|Overall Study|Lost to Follow-up|6|||
44215427|NCT03483961|79013178|FG003|Overall Study|Lost to Follow-up|6|||
44215428|NCT03483961|79013179|FG004|Overall Study|Lost to Follow-up|6|||
44215429|NCT03483961|79013180|FG005|Overall Study|Lost to Follow-up|4|||
44215430|NCT03483961|79013181|FG006|Overall Study|Lost to Follow-up|4|||
44215431|NCT03483961|79013182|FG007|Overall Study|Lost to Follow-up|11|||
44215432|NCT03483961|79013183|FG008|Overall Study|Lost to Follow-up|1|||
44455903|NCT00641537|79464219|FG007|24-Week Supplemental Follow-up Period|Other|1|||
44455904|NCT03840135|79464239|FG000|Overall Study|Protocol Violation|6|||
44215433|NCT03483961|79013184|FG009|Overall Study|Lost to Follow-up|0|||
44455905|NCT03840135|79464240|FG001|Overall Study|Protocol Violation|1|||
44455906|NCT03840135|79464239|FG000|Overall Study|Withdrawal by Subject|1|||
44455907|NCT03840135|79464240|FG001|Overall Study|Withdrawal by Subject|0|||
44455908|NCT00461175|79464252|FG000|Overall Study|Protocol Violation|522|||
44215434|NCT03483961|79013175|FG000|Overall Study|Withdrawal by Subject|3|||
44215435|NCT03483961|79013176|FG001|Overall Study|Withdrawal by Subject|4|||
44215436|NCT03483961|79013177|FG002|Overall Study|Withdrawal by Subject|5|||
44215437|NCT03483961|79013178|FG003|Overall Study|Withdrawal by Subject|3|||
44215438|NCT03483961|79013179|FG004|Overall Study|Withdrawal by Subject|4|||
44215439|NCT03483961|79013180|FG005|Overall Study|Withdrawal by Subject|2|||
44215440|NCT03483961|79013181|FG006|Overall Study|Withdrawal by Subject|1|||
44371796|NCT01796171|79376974|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371797|NCT01796171|79376975|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371798|NCT01796171|79376976|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371799|NCT01796171|79376977|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371800|NCT01796171|79376978|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371801|NCT01796171|79376979|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371802|NCT01796171|79376980|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371803|NCT01796171|79376981|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
44371804|NCT01796171|79376982|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371805|NCT01796171|79376983|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
44371806|NCT01796171|79376984|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
44371807|NCT01796171|79376985|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371808|NCT01796171|79376986|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44371809|NCT01796171|79376987|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
44455909|NCT00461175|79464253|FG001|Overall Study|Protocol Violation|365|||
44455910|NCT00641147|79464261|FG000|Completed 4 Months.|Physician Decision|1|||
44455911|NCT00641147|79464262|FG001|Completed 4 Months.|Physician Decision|0|||
44455912|NCT00641147|79464261|FG000|Completed 4 Months.|Adverse Event|1|||
44215441|NCT03483961|79013182|FG007|Overall Study|Withdrawal by Subject|2|||
44455913|NCT00641147|79464262|FG001|Completed 4 Months.|Adverse Event|0|||
44455914|NCT00641147|79464261|FG000|Completed 8 Months.|Physician Decision|2|||
44455915|NCT00641147|79464262|FG001|Completed 8 Months.|Physician Decision|1|||
44455916|NCT00641147|79464261|FG000|Completed 8 Months.|non compliance|1|||
44455917|NCT00641147|79464262|FG001|Completed 8 Months.|non compliance|0|||
44455918|NCT00641147|79464261|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
44455919|NCT00641147|79464262|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
44455920|NCT00641147|79464261|FG000|Completed 12 Months.|Physician Decision|1|||
44543826|NCT03638635|79556983|FG000|Initial Hospitalization|Study terminated prematurely|0|||
44543827|NCT03638635|79556984|FG001|Initial Hospitalization|Study terminated prematurely|1|||
44455921|NCT00641147|79464262|FG001|Completed 12 Months.|Physician Decision|1|||
44455922|NCT00641147|79464261|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
44215442|NCT03483961|79013183|FG008|Overall Study|Withdrawal by Subject|1|||
44215443|NCT03483961|79013184|FG009|Overall Study|Withdrawal by Subject|0|||
44215444|NCT03483961|79013175|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
44215445|NCT03483961|79013176|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44277770|NCT02138916|79238745|FG000|Overall Study|Severe non-compliance|1|||
44277771|NCT02138916|79238746|FG001|Overall Study|Severe non-compliance|2|||
44371810|NCT01796171|79376973|FG000|Treatment Period With Betalutin|Physician Decision|0|||
44371811|NCT01796171|79376974|FG001|Treatment Period With Betalutin|Physician Decision|0|||
44371812|NCT01796171|79376975|FG002|Treatment Period With Betalutin|Physician Decision|0|||
44371813|NCT01796171|79376976|FG003|Treatment Period With Betalutin|Physician Decision|0|||
44371814|NCT01796171|79376977|FG004|Treatment Period With Betalutin|Physician Decision|0|||
44371815|NCT01796171|79376978|FG005|Treatment Period With Betalutin|Physician Decision|0|||
44371816|NCT01796171|79376979|FG006|Treatment Period With Betalutin|Physician Decision|0|||
44371817|NCT01796171|79376980|FG007|Treatment Period With Betalutin|Physician Decision|0|||
44371818|NCT01796171|79376981|FG008|Treatment Period With Betalutin|Physician Decision|0|||
44371819|NCT01796171|79376982|FG009|Treatment Period With Betalutin|Physician Decision|0|||
44455923|NCT00641147|79464262|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
44455924|NCT00641147|79464261|FG000|Completed 16 Months.|Physician Decision|1|||
44277772|NCT02138916|79238747|FG002|Overall Study|Severe non-compliance|1|||
44277773|NCT02138916|79238745|FG000|Overall Study|Lost to Follow-up|4|||
44277774|NCT02138916|79238746|FG001|Overall Study|Lost to Follow-up|2|||
44277775|NCT02138916|79238747|FG002|Overall Study|Lost to Follow-up|3|||
44277776|NCT02138916|79238745|FG000|Overall Study|Adverse Event|4|||
44277777|NCT02138916|79238746|FG001|Overall Study|Adverse Event|4|||
44277778|NCT02138916|79238747|FG002|Overall Study|Adverse Event|3|||
44277779|NCT02118012|79238757|FG000|Overall Study|Adverse Event|0|||
44277780|NCT02118012|79238758|FG001|Overall Study|Adverse Event|1|||
44277781|NCT02118012|79238757|FG000|Overall Study|Physician Decision|0|||
44277782|NCT02118012|79238758|FG001|Overall Study|Physician Decision|1|||
44277783|NCT02093520|79238766|FG000|Overall Study|Not treated|6|||
44277784|NCT02093520|79238767|FG001|Overall Study|Not treated|22|||
44277785|NCT02138838|79238775|FG000|Overall Study|Study Closure|7|||
44277786|NCT02138838|79238776|FG001|Overall Study|Study Closure|6|||
44455925|NCT00641147|79464262|FG001|Completed 16 Months.|Physician Decision|0|||
44455926|NCT00641147|79464261|FG000|Completed 16 Months.|Lost to Follow-up|1|||
44455927|NCT00641147|79464262|FG001|Completed 16 Months.|Lost to Follow-up|0|||
44455928|NCT00460239|79464272|FG000|Overall Study|Physician Decision|0|||
44455929|NCT00460239|79464273|FG001|Overall Study|Physician Decision|1|||
44455930|NCT00460239|79464274|FG002|Overall Study|Physician Decision|0|||
44455931|NCT00460239|79464275|FG003|Overall Study|Physician Decision|0|||
44455932|NCT00460239|79464276|FG004|Overall Study|Physician Decision|0|||
44455933|NCT00460239|79464277|FG005|Overall Study|Physician Decision|2|||
44455934|NCT00460239|79464278|FG006|Overall Study|Physician Decision|0|||
44455935|NCT00460239|79464279|FG007|Overall Study|Physician Decision|0|||
44455936|NCT00460239|79464280|FG008|Overall Study|Physician Decision|0|||
44455937|NCT00460239|79464272|FG000|Overall Study|Withdrawal by Subject|0|||
44455938|NCT00460239|79464273|FG001|Overall Study|Withdrawal by Subject|0|||
44455939|NCT00460239|79464274|FG002|Overall Study|Withdrawal by Subject|0|||
44455940|NCT00460239|79464275|FG003|Overall Study|Withdrawal by Subject|0|||
44455941|NCT00460239|79464276|FG004|Overall Study|Withdrawal by Subject|0|||
44455942|NCT00460239|79464277|FG005|Overall Study|Withdrawal by Subject|1|||
44455943|NCT00460239|79464278|FG006|Overall Study|Withdrawal by Subject|0|||
44455944|NCT00460239|79464279|FG007|Overall Study|Withdrawal by Subject|0|||
44455945|NCT00460239|79464280|FG008|Overall Study|Withdrawal by Subject|0|||
44455946|NCT00640835|79464295|FG000|Overall Study|Adverse Event|5|||
44455947|NCT00640835|79464296|FG001|Overall Study|Adverse Event|3|||
44455948|NCT00640835|79464295|FG000|Overall Study|Withdrawal by Subject|12|||
44455949|NCT00640835|79464296|FG001|Overall Study|Withdrawal by Subject|14|||
44455950|NCT00640835|79464295|FG000|Overall Study|Physician Decision|10|||
44455951|NCT00640835|79464296|FG001|Overall Study|Physician Decision|14|||
44455952|NCT00640835|79464295|FG000|Overall Study|Sponsor's Decision|11|||
44455953|NCT00640835|79464296|FG001|Overall Study|Sponsor's Decision|7|||
44455954|NCT00640835|79464295|FG000|Overall Study|Protocol Violation|2|||
44455955|NCT00640835|79464296|FG001|Overall Study|Protocol Violation|2|||
44455956|NCT00640835|79464295|FG000|Overall Study|Lost to Follow-up|17|||
44455957|NCT00640835|79464296|FG001|Overall Study|Lost to Follow-up|13|||
44455958|NCT00640835|79464295|FG000|Overall Study|Other Reason|19|||
44455959|NCT00640835|79464296|FG001|Overall Study|Other Reason|4|||
44455960|NCT03839355|79464304|FG000|Overall Study|Withdrawal by Subject|1|||
44455961|NCT03839355|79464305|FG001|Overall Study|Withdrawal by Subject|0|||
44455962|NCT00382018|79464315|FG000|Overall Study|Progression|0|||
44455963|NCT00382018|79464316|FG001|Overall Study|Progression|136|||
44455964|NCT00382018|79464317|FG002|Overall Study|Progression|51|||
44455965|NCT00382018|79464318|FG003|Overall Study|Progression|43|||
44455966|NCT00382018|79464315|FG000|Overall Study|Death|0|||
44455967|NCT00382018|79464316|FG001|Overall Study|Death|9|||
44543828|NCT03638635|79556983|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
44371820|NCT01796171|79376983|FG010|Treatment Period With Betalutin|Physician Decision|5|||
44371821|NCT01796171|79376984|FG011|Treatment Period With Betalutin|Physician Decision|1|||
44371822|NCT01796171|79376985|FG012|Treatment Period With Betalutin|Physician Decision|1|||
44371823|NCT01796171|79376986|FG013|Treatment Period With Betalutin|Physician Decision|0|||
44371824|NCT01796171|79376987|FG014|Treatment Period With Betalutin|Physician Decision|0|||
44371825|NCT01796171|79376973|FG000|Treatment Period With Betalutin|Death|0|||
44371826|NCT01796171|79376974|FG001|Treatment Period With Betalutin|Death|0|||
44371827|NCT01796171|79376975|FG002|Treatment Period With Betalutin|Death|0|||
44371828|NCT01796171|79376976|FG003|Treatment Period With Betalutin|Death|0|||
44371829|NCT01796171|79376977|FG004|Treatment Period With Betalutin|Death|0|||
44371830|NCT01796171|79376978|FG005|Treatment Period With Betalutin|Death|0|||
44371831|NCT01796171|79376979|FG006|Treatment Period With Betalutin|Death|0|||
44455968|NCT00382018|79464317|FG002|Overall Study|Death|7|||
44455969|NCT00382018|79464318|FG003|Overall Study|Death|11|||
44455970|NCT00382018|79464315|FG000|Overall Study|Withdrawal by Subject|0|||
44455971|NCT00382018|79464316|FG001|Overall Study|Withdrawal by Subject|4|||
44455972|NCT00382018|79464317|FG002|Overall Study|Withdrawal by Subject|3|||
44455973|NCT00382018|79464318|FG003|Overall Study|Withdrawal by Subject|4|||
44455974|NCT00382018|79464315|FG000|Overall Study|Other, not protocol specified|0|||
44455975|NCT00382018|79464316|FG001|Overall Study|Other, not protocol specified|16|||
44455976|NCT00382018|79464317|FG002|Overall Study|Other, not protocol specified|3|||
44455977|NCT00382018|79464318|FG003|Overall Study|Other, not protocol specified|1|||
44455978|NCT00640601|79464331|FG000|Overall Study|Adverse Event|43|||
44455979|NCT00640601|79464331|FG000|Overall Study|Withdrawal by Subject|20|||
44455980|NCT00640601|79464331|FG000|Overall Study|Protocol Violation|6|||
44455981|NCT00640601|79464331|FG000|Overall Study|Lack of Efficacy|16|||
44455982|NCT00640601|79464331|FG000|Overall Study|Lost to Follow-up|9|||
44455983|NCT00640601|79464331|FG000|Overall Study|Physician Decision|8|||
44455984|NCT00640601|79464331|FG000|Overall Study|treatment naive, combination therapy|10|||
44455985|NCT03838731|79464337|FG000|Overall Study|Pregnancy|0|||
44455986|NCT03838731|79464338|FG001|Overall Study|Pregnancy|1|||
44455987|NCT03838731|79464337|FG000|Overall Study|Withdrawal of consent|1|||
44455988|NCT03838731|79464338|FG001|Overall Study|Withdrawal of consent|0|||
44455989|NCT00452439|79464346|FG000|Overall Study|Lost to Follow-up|1|||
44455990|NCT00452439|79464347|FG001|Overall Study|Lost to Follow-up|1|||
44455991|NCT00452439|79464346|FG000|Overall Study|Refused Treatment|4|||
44455992|NCT00452439|79464347|FG001|Overall Study|Refused Treatment|3|||
44455993|NCT00452439|79464346|FG000|Overall Study|Death|3|||
44455994|NCT00452439|79464347|FG001|Overall Study|Death|1|||
44455995|NCT00452439|79464346|FG000|Overall Study|Bone Marrow Transplant|0|||
44455996|NCT00452439|79464347|FG001|Overall Study|Bone Marrow Transplant|1|||
44455997|NCT00452439|79464346|FG000|Overall Study|Too Ill to Continue|0|||
44455998|NCT00452439|79464347|FG001|Overall Study|Too Ill to Continue|1|||
44455999|NCT00452439|79464346|FG000|Overall Study|Failed to achieve complete response|2|||
44456000|NCT00452439|79464347|FG001|Overall Study|Failed to achieve complete response|0|||
44456001|NCT00452439|79464346|FG000|Overall Study|Relapse|3|||
44456002|NCT00452439|79464347|FG001|Overall Study|Relapse|0|||
44456003|NCT00452439|79464346|FG000|Overall Study|Fracture|1|||
44215446|NCT03483961|79013177|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215447|NCT03483961|79013178|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215448|NCT03483961|79013179|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215449|NCT03483961|79013180|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215450|NCT03483961|79013181|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215451|NCT03483961|79013182|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215452|NCT03483961|79013183|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215453|NCT03483961|79013184|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
44215454|NCT03483961|79013175|FG000|Overall Study|Adverse Event|0|||
44215455|NCT03483961|79013176|FG001|Overall Study|Adverse Event|0|||
44215456|NCT03483961|79013177|FG002|Overall Study|Adverse Event|1|||
44215457|NCT03483961|79013178|FG003|Overall Study|Adverse Event|0|||
44215458|NCT03483961|79013179|FG004|Overall Study|Adverse Event|0|||
44215459|NCT03483961|79013180|FG005|Overall Study|Adverse Event|0|||
44215460|NCT03483961|79013181|FG006|Overall Study|Adverse Event|0|||
44215461|NCT03483961|79013182|FG007|Overall Study|Adverse Event|0|||
44215462|NCT03483961|79013183|FG008|Overall Study|Adverse Event|0|||
44215463|NCT03483961|79013184|FG009|Overall Study|Adverse Event|0|||
44215464|NCT03459807|79013207|FG000|Overall Study|Withdrawal due to transplant|0|||
44215465|NCT03459807|79013208|FG001|Overall Study|Withdrawal due to transplant|1|||
44215466|NCT03439293|79013221|FG000|Overall Study|Ongoing on Treatment|15|||
44215467|NCT03439293|79013221|FG000|Overall Study|Ongoing off Treatment|19|||
44215468|NCT03439293|79013221|FG000|Overall Study|Death|18|||
44215469|NCT03439293|79013221|FG000|Overall Study|Withdrawal by Subject|7|||
44215470|NCT03439293|79013221|FG000|Overall Study|Lost to Follow-up|2|||
44215471|NCT03423979|79013226|FG000|Overall Study|Death|1|||
44215472|NCT03239210|79013232|FG000|Overall Study|Lost to Follow-up|2|||
44215473|NCT03239210|79013233|FG001|Overall Study|Lost to Follow-up|2|||
44215474|NCT03239210|79013232|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
44215475|NCT03239210|79013233|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
44215476|NCT03239210|79013232|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
44215477|NCT03239210|79013233|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
44215478|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
44215479|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
44215480|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
44215481|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
44215482|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
44215483|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
44215484|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
44215485|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
44215486|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
44456004|NCT00452439|79464347|FG001|Overall Study|Fracture|0|||
44456005|NCT00381940|79464353|FG000|Overall Study|Lack of Efficacy|3|||
44456006|NCT00381940|79464353|FG000|Overall Study|Protocol Violation|1|||
44456007|NCT00381940|79464353|FG000|Overall Study|Ineligible|1|||
44456008|NCT00364156|79464359|FG000|Overall Study|Withdrawal by Subject|73|||
44456009|NCT00364156|79464360|FG001|Overall Study|Withdrawal by Subject|80|||
44456010|NCT00364156|79464359|FG000|Overall Study|Protocol Violation|6|||
44456011|NCT00364156|79464360|FG001|Overall Study|Protocol Violation|1|||
44456012|NCT00452361|79464368|FG000|Overall Study|Adverse Event|8|||
44215487|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
44215488|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
44215489|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
44456013|NCT00452361|79464369|FG001|Overall Study|Adverse Event|0|||
44456014|NCT00452361|79464368|FG000|Overall Study|Withdrawal by Subject|0|||
44456015|NCT00452361|79464369|FG001|Overall Study|Withdrawal by Subject|1|||
44456016|NCT00452361|79464368|FG000|Overall Study|Premature termination|13|||
44456017|NCT00452361|79464369|FG001|Overall Study|Premature termination|9|||
44456018|NCT00640289|79464375|FG000|Overall Study|Death|3|||
44456019|NCT00640289|79464375|FG000|Overall Study|Withdrawal by Subject|1|||
44456020|NCT00640289|79464375|FG000|Overall Study|Lost to Follow-up|1|||
44456021|NCT00640289|79464375|FG000|Overall Study|Data collected under different amendment|2|||
44456022|NCT00640289|79464375|FG000|Overall Study|Transferred to another center|1|||
44456023|NCT00640289|79464375|FG000|Overall Study|Missing status|5|||
44456024|NCT00568451|79464383|FG000|Overall Study|Disease Progression|0|||
44456025|NCT00568451|79464384|FG001|Overall Study|Disease Progression|0|||
44456026|NCT00568451|79464385|FG002|Overall Study|Disease Progression|2|||
44456027|NCT00568451|79464386|FG003|Overall Study|Disease Progression|7|||
44456028|NCT00459537|79464399|FG000|Overall Study|Adverse Event|1|||
44456029|NCT00459537|79464400|FG001|Overall Study|Adverse Event|6|||
44456030|NCT00459537|79464399|FG000|Overall Study|Lack of Efficacy|10|||
44456031|NCT00459537|79464400|FG001|Overall Study|Lack of Efficacy|11|||
44456032|NCT00459537|79464399|FG000|Overall Study|Withdrawal by Subject|20|||
44456033|NCT00459537|79464400|FG001|Overall Study|Withdrawal by Subject|26|||
44456034|NCT00459537|79464399|FG000|Overall Study|Lost to Follow-up|27|||
44456035|NCT00459537|79464400|FG001|Overall Study|Lost to Follow-up|30|||
44456036|NCT00459537|79464399|FG000|Overall Study|Administrative problems|3|||
44456037|NCT00459537|79464400|FG001|Overall Study|Administrative problems|0|||
44456038|NCT00459537|79464399|FG000|Overall Study|Protocol Violation|4|||
44456039|NCT00459537|79464400|FG001|Overall Study|Protocol Violation|3|||
44456040|NCT00459537|79464399|FG000|Overall Study|Missing|1|||
44456041|NCT00459537|79464400|FG001|Overall Study|Missing|0|||
44456042|NCT03850509|79464408|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
44215490|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
44215491|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44456043|NCT03850509|79464409|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
44456044|NCT00635999|79464418|FG000|Overall Study|Withdrawal by Subject|4|||
44456045|NCT00635999|79464419|FG001|Overall Study|Withdrawal by Subject|2|||
44456046|NCT00635999|79464420|FG002|Overall Study|Withdrawal by Subject|1|||
44456047|NCT00469209|79464431|FG000|Overall Study|Adverse Event|1|||
44456048|NCT00469209|79464432|FG001|Overall Study|Adverse Event|0|||
44456049|NCT00469209|79464433|FG002|Overall Study|Adverse Event|1|||
44456050|NCT00635219|79464446|FG000|Overall Study|Adverse Event|12|||
44215492|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44215493|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44215494|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
44215495|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
44215496|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
44215497|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
44215498|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
44215499|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
44215500|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
44215501|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
44215502|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
44215503|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
44215504|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
44215505|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
44215506|NCT03227224|79013243|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
44215507|NCT03227224|79013244|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
44215508|NCT03227224|79013245|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
44215509|NCT03227224|79013246|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
44215510|NCT03227224|79013243|FG000|Follow-up Phase (2 Weeks)|Other|4|||
44215511|NCT03227224|79013244|FG001|Follow-up Phase (2 Weeks)|Other|4|||
44215512|NCT03227224|79013245|FG002|Follow-up Phase (2 Weeks)|Other|6|||
44215513|NCT03227224|79013246|FG003|Follow-up Phase (2 Weeks)|Other|3|||
44215514|NCT03086343|79013265|FG000|Overall Study|Adverse Event|7|||
44215515|NCT03086343|79013266|FG001|Overall Study|Adverse Event|7|||
44215516|NCT03086343|79013265|FG000|Overall Study|Withdrawal by Subject|10|||
44215517|NCT03086343|79013266|FG001|Overall Study|Withdrawal by Subject|6|||
44215518|NCT03086343|79013265|FG000|Overall Study|Lost to Follow-up|3|||
44215519|NCT03086343|79013266|FG001|Overall Study|Lost to Follow-up|1|||
44215520|NCT03086343|79013265|FG000|Overall Study|Lack of Efficacy|4|||
44215521|NCT03086343|79013266|FG001|Overall Study|Lack of Efficacy|6|||
44215522|NCT03086343|79013265|FG000|Overall Study|Other, not specified|8|||
44215523|NCT03086343|79013266|FG001|Overall Study|Other, not specified|4|||
44215524|NCT03086343|79013265|FG000|Overall Study|Missing|0|||
44215525|NCT03086343|79013266|FG001|Overall Study|Missing|1|||
44215526|NCT02788045|79013310|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
44215527|NCT02788045|79013311|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
44215528|NCT02788045|79013312|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
44215529|NCT02788045|79013310|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
44215530|NCT02788045|79013311|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
44215531|NCT02788045|79013312|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
44215532|NCT02788045|79013310|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
44215533|NCT02788045|79013311|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
44215534|NCT02788045|79013312|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
44215535|NCT02788045|79013310|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
44215536|NCT02788045|79013311|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
44215537|NCT02788045|79013312|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
44215538|NCT02788045|79013310|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
44215539|NCT02788045|79013311|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
44215540|NCT02788045|79013312|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
44215541|NCT02788045|79013310|FG000|Main Study (Up to Week 72)|Other|3|||
44215542|NCT02788045|79013311|FG001|Main Study (Up to Week 72)|Other|0|||
44215543|NCT02788045|79013312|FG002|Main Study (Up to Week 72)|Other|0|||
44215544|NCT02788045|79013310|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
44215545|NCT02788045|79013311|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
44215546|NCT02788045|79013312|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
44215547|NCT02788045|79013310|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
44215548|NCT02788045|79013311|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
44215549|NCT02788045|79013312|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
44215550|NCT02788045|79013310|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
44215551|NCT02788045|79013311|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
44456051|NCT00635219|79464447|FG001|Overall Study|Adverse Event|10|||
44456052|NCT00635219|79464448|FG002|Overall Study|Adverse Event|18|||
44456053|NCT00635219|79464449|FG003|Overall Study|Adverse Event|15|||
44456054|NCT00635219|79464450|FG004|Overall Study|Adverse Event|19|||
44456055|NCT00635219|79464446|FG000|Overall Study|Lack of Efficacy|5|||
44270144|NCT02326272|79195773|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270145|NCT02326272|79195774|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44456056|NCT00635219|79464447|FG001|Overall Study|Lack of Efficacy|6|||
44456057|NCT00635219|79464448|FG002|Overall Study|Lack of Efficacy|3|||
44543829|NCT03638635|79556984|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
44456058|NCT00635219|79464449|FG003|Overall Study|Lack of Efficacy|4|||
44456059|NCT00635219|79464450|FG004|Overall Study|Lack of Efficacy|6|||
44456060|NCT00635219|79464446|FG000|Overall Study|Non-compliance With Study Product|0|||
44456061|NCT00635219|79464447|FG001|Overall Study|Non-compliance With Study Product|0|||
44456062|NCT00635219|79464448|FG002|Overall Study|Non-compliance With Study Product|0|||
44456063|NCT00635219|79464449|FG003|Overall Study|Non-compliance With Study Product|2|||
44456064|NCT00635219|79464450|FG004|Overall Study|Non-compliance With Study Product|1|||
44456065|NCT00635219|79464446|FG000|Overall Study|Protocol Violation|0|||
44456066|NCT00635219|79464447|FG001|Overall Study|Protocol Violation|2|||
44456067|NCT00635219|79464448|FG002|Overall Study|Protocol Violation|3|||
44456068|NCT00635219|79464449|FG003|Overall Study|Protocol Violation|2|||
44456069|NCT00635219|79464450|FG004|Overall Study|Protocol Violation|4|||
44456070|NCT00635219|79464446|FG000|Overall Study|Withdrawal of Consent|8|||
44456071|NCT00635219|79464447|FG001|Overall Study|Withdrawal of Consent|6|||
44456072|NCT00635219|79464448|FG002|Overall Study|Withdrawal of Consent|8|||
44456073|NCT00635219|79464449|FG003|Overall Study|Withdrawal of Consent|11|||
44456074|NCT00635219|79464450|FG004|Overall Study|Withdrawal of Consent|8|||
44456075|NCT00635219|79464446|FG000|Overall Study|Lost to Follow-up|0|||
44456076|NCT00635219|79464447|FG001|Overall Study|Lost to Follow-up|0|||
44456077|NCT00635219|79464448|FG002|Overall Study|Lost to Follow-up|2|||
44456078|NCT00635219|79464449|FG003|Overall Study|Lost to Follow-up|0|||
44456079|NCT00635219|79464450|FG004|Overall Study|Lost to Follow-up|3|||
44456080|NCT00635219|79464446|FG000|Overall Study|Administrative or Other Reasons|0|||
44371832|NCT01796171|79376980|FG007|Treatment Period With Betalutin|Death|0|||
44371833|NCT01796171|79376981|FG008|Treatment Period With Betalutin|Death|0|||
44371834|NCT01796171|79376982|FG009|Treatment Period With Betalutin|Death|0|||
44371835|NCT01796171|79376983|FG010|Treatment Period With Betalutin|Death|2|||
44371836|NCT01796171|79376984|FG011|Treatment Period With Betalutin|Death|0|||
44371837|NCT01796171|79376985|FG012|Treatment Period With Betalutin|Death|0|||
44456081|NCT00635219|79464447|FG001|Overall Study|Administrative or Other Reasons|1|||
44456082|NCT00635219|79464448|FG002|Overall Study|Administrative or Other Reasons|1|||
44456083|NCT00635219|79464449|FG003|Overall Study|Administrative or Other Reasons|0|||
44456084|NCT00635219|79464450|FG004|Overall Study|Administrative or Other Reasons|1|||
44456085|NCT00363766|79464464|FG000|Overall Study|Progressive Disease|15|||
44456086|NCT00363766|79464465|FG001|Overall Study|Progressive Disease|9|||
44456087|NCT00363766|79464464|FG000|Overall Study|Adverse Event|10|||
44456088|NCT00363766|79464465|FG001|Overall Study|Adverse Event|2|||
44456089|NCT00363766|79464464|FG000|Overall Study|Disease Related Death|1|||
44456090|NCT00363766|79464465|FG001|Overall Study|Disease Related Death|3|||
44456091|NCT00363766|79464464|FG000|Overall Study|Not Disease Related Death|3|||
44456092|NCT00363766|79464465|FG001|Overall Study|Not Disease Related Death|4|||
44456093|NCT00363766|79464464|FG000|Overall Study|Withdrawal by Subject|2|||
44215552|NCT02788045|79013312|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
44215553|NCT02315703|79013346|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
44215554|NCT02315703|79013347|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
44215555|NCT02315703|79013348|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
44215556|NCT02315703|79013349|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
44215557|NCT02315703|79013350|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
44215558|NCT02315703|79013351|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
44371838|NCT01796171|79376986|FG013|Treatment Period With Betalutin|Death|0|||
44371839|NCT01796171|79376987|FG014|Treatment Period With Betalutin|Death|0|||
44371840|NCT01796171|79376973|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
44371841|NCT01796171|79376974|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
44371842|NCT01796171|79376975|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
44371843|NCT01796171|79376976|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
44371844|NCT01796171|79376977|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
44456094|NCT00363766|79464465|FG001|Overall Study|Withdrawal by Subject|0|||
44371845|NCT01796171|79376978|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
44456095|NCT00363766|79464464|FG000|Overall Study|Physician Decision|1|||
44456096|NCT00363766|79464465|FG001|Overall Study|Physician Decision|2|||
44456097|NCT00468819|79464475|FG000|Overall Study|Withdrawal by Subject|4|||
44456098|NCT00468819|79464476|FG001|Overall Study|Withdrawal by Subject|0|||
44456099|NCT00468819|79464477|FG002|Overall Study|Withdrawal by Subject|1|||
44456100|NCT00468819|79464475|FG000|Overall Study|Lost to Follow-up|0|||
44456101|NCT00468819|79464476|FG001|Overall Study|Lost to Follow-up|0|||
44456102|NCT00468819|79464477|FG002|Overall Study|Lost to Follow-up|1|||
44456103|NCT00468819|79464475|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
44456104|NCT00468819|79464476|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
44456105|NCT00468819|79464477|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
44456106|NCT00451191|79464489|FG000|Overall Study|withdrawal or received alternate tx|15|||
44215559|NCT02315703|79013352|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
44456107|NCT00451191|79464490|FG001|Overall Study|withdrawal or received alternate tx|11|||
44456108|NCT00451035|79464496|FG000|Overall Study|Disease progression|11|||
44456109|NCT00451035|79464496|FG000|Overall Study|Death|3|||
44456110|NCT00451035|79464496|FG000|Overall Study|New anti-neoplastic therapy|3|||
44456111|NCT00468585|79464505|FG000|Overall Study|Patient not treated|1|||
44456112|NCT00468585|79464506|FG001|Overall Study|Patient not treated|0|||
44456113|NCT00468585|79464507|FG002|Overall Study|Patient not treated|1|||
44456114|NCT00468585|79464508|FG003|Overall Study|Patient not treated|0|||
44456115|NCT00468585|79464505|FG000|Overall Study|Patient found to be ineligible|0|||
44456116|NCT00468585|79464506|FG001|Overall Study|Patient found to be ineligible|0|||
44456117|NCT00468585|79464507|FG002|Overall Study|Patient found to be ineligible|1|||
44456118|NCT00468585|79464508|FG003|Overall Study|Patient found to be ineligible|0|||
44456119|NCT00468585|79464505|FG000|Overall Study|Adverse Event|0|||
44456120|NCT00468585|79464506|FG001|Overall Study|Adverse Event|0|||
44456121|NCT00468585|79464507|FG002|Overall Study|Adverse Event|1|||
44456122|NCT00468585|79464508|FG003|Overall Study|Adverse Event|0|||
44456123|NCT00468585|79464505|FG000|Overall Study|Withdrawal by Subject|0|||
44456124|NCT00468585|79464506|FG001|Overall Study|Withdrawal by Subject|0|||
44456125|NCT00468585|79464507|FG002|Overall Study|Withdrawal by Subject|2|||
44456126|NCT00468585|79464508|FG003|Overall Study|Withdrawal by Subject|1|||
44456127|NCT00450801|79464518|FG000|Overall Study|Death|1|||
44456128|NCT00458211|79464527|FG000|Overall Study|Lack of Efficacy|12|||
44456129|NCT00458211|79464527|FG000|Overall Study|Withdrawal by Subject|2|||
44215560|NCT02315703|79013353|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
44215561|NCT02315703|79013346|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
44215562|NCT02315703|79013347|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
44215563|NCT02315703|79013348|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
44215564|NCT02315703|79013349|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
44456130|NCT00458211|79464527|FG000|Overall Study|Protocol Violation|2|||
44456131|NCT00450723|79464535|FG000|Overall Study|Physician Decision|5|||
44456132|NCT00467961|79464540|FG000|Overall Study|Technical Failures|5|||
44456133|NCT00467961|79464540|FG000|Overall Study|Disease Progression|2|||
44456134|NCT00457821|79464552|FG000|Part 2|Withdrawal by Subject|0|||
44456135|NCT00457821|79464553|FG001|Part 2|Withdrawal by Subject|0|||
44456136|NCT00457821|79464554|FG002|Part 2|Withdrawal by Subject|0|||
44456137|NCT00457821|79464555|FG003|Part 2|Withdrawal by Subject|0|||
44456138|NCT00457821|79464556|FG004|Part 2|Withdrawal by Subject|0|||
44456139|NCT00457821|79464557|FG005|Part 2|Withdrawal by Subject|0|||
44456140|NCT00457821|79464558|FG006|Part 2|Withdrawal by Subject|0|||
44215565|NCT02315703|79013350|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
44215566|NCT02315703|79013351|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
44371846|NCT01796171|79376979|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
44371847|NCT01796171|79376980|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
44371848|NCT01796171|79376981|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
44371849|NCT01796171|79376982|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
44371850|NCT01796171|79376983|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
44371851|NCT01796171|79376984|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
44371852|NCT01796171|79376985|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
44371853|NCT01796171|79376986|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
44371854|NCT01796171|79376987|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
44371855|NCT01796171|79376973|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371856|NCT01796171|79376974|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371857|NCT01796171|79376975|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44543830|NCT03638635|79556983|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
44456141|NCT00457821|79464559|FG007|Part 2|Withdrawal by Subject|1|||
44456142|NCT00633893|79464579|FG000|Overall Study|Death|1|||
44456143|NCT00633893|79464580|FG001|Overall Study|Death|3|||
44456144|NCT00633893|79464581|FG002|Overall Study|Death|9|||
44456145|NCT00633893|79464579|FG000|Overall Study|Adverse Event|65|||
44456146|NCT00633893|79464580|FG001|Overall Study|Adverse Event|58|||
44456147|NCT00633893|79464581|FG002|Overall Study|Adverse Event|126|||
44456148|NCT00633893|79464579|FG000|Overall Study|Withdrawal by Subject|7|||
44456149|NCT00633893|79464580|FG001|Overall Study|Withdrawal by Subject|12|||
44456150|NCT00633893|79464581|FG002|Overall Study|Withdrawal by Subject|6|||
44456151|NCT00633893|79464579|FG000|Overall Study|Lost to Follow-up|2|||
44456152|NCT00633893|79464580|FG001|Overall Study|Lost to Follow-up|4|||
44456153|NCT00633893|79464581|FG002|Overall Study|Lost to Follow-up|8|||
44456154|NCT00633893|79464579|FG000|Overall Study|Poor/non-compliance|5|||
44456155|NCT00633893|79464580|FG001|Overall Study|Poor/non-compliance|12|||
44456156|NCT00633893|79464581|FG002|Overall Study|Poor/non-compliance|3|||
44456157|NCT00633893|79464579|FG000|Overall Study|Pregnancy|2|||
44456158|NCT00633893|79464580|FG001|Overall Study|Pregnancy|1|||
44456159|NCT00633893|79464581|FG002|Overall Study|Pregnancy|1|||
44456160|NCT00633893|79464579|FG000|Overall Study|Not meet/no longer meets criteria|4|||
44456161|NCT00633893|79464580|FG001|Overall Study|Not meet/no longer meets criteria|6|||
44456162|NCT00633893|79464581|FG002|Overall Study|Not meet/no longer meets criteria|4|||
44456163|NCT00633893|79464579|FG000|Overall Study|Other|28|||
44456164|NCT00633893|79464580|FG001|Overall Study|Other|33|||
44456165|NCT00633893|79464581|FG002|Overall Study|Other|31|||
44456166|NCT00457743|79464592|FG000|Overall Study|Adverse Event|0|||
44456167|NCT00457743|79464593|FG001|Overall Study|Adverse Event|4|||
44456168|NCT00457743|79464594|FG002|Overall Study|Adverse Event|0|||
44456169|NCT00457743|79464592|FG000|Overall Study|Lack of Efficacy|3|||
44456170|NCT00457743|79464593|FG001|Overall Study|Lack of Efficacy|23|||
44456171|NCT00457743|79464594|FG002|Overall Study|Lack of Efficacy|3|||
44456172|NCT00450411|79464603|FG000|Overall Study|Protocol Violation|6|||
44456173|NCT00450411|79464603|FG000|Overall Study|No protocol treatment|2|||
44456174|NCT00644969|79464609|FG000|Treatment Phase|Randomized, not treated|1|||
44456175|NCT00644969|79464610|FG001|Treatment Phase|Randomized, not treated|0|||
44456176|NCT00644969|79464609|FG000|Treatment Phase|Adverse Event|3|||
44456177|NCT00644969|79464610|FG001|Treatment Phase|Adverse Event|0|||
44456178|NCT00644969|79464609|FG000|Treatment Phase|Withdrawal by Subject|4|||
44456179|NCT00644969|79464610|FG001|Treatment Phase|Withdrawal by Subject|0|||
44456180|NCT00644969|79464609|FG000|Treatment Phase|Lost to Follow-up|2|||
44456181|NCT00644969|79464610|FG001|Treatment Phase|Lost to Follow-up|2|||
44456182|NCT00644969|79464609|FG000|Treatment Phase|Other|4|||
44456183|NCT00644969|79464610|FG001|Treatment Phase|Other|1|||
44456184|NCT00644969|79464609|FG000|Post Treatment Phase|Death|1|||
44456185|NCT00644969|79464610|FG001|Post Treatment Phase|Death|0|||
44456186|NCT00644969|79464609|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
44371858|NCT01796171|79376976|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371859|NCT01796171|79376977|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371860|NCT01796171|79376978|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371861|NCT01796171|79376979|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371862|NCT01796171|79376980|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371863|NCT01796171|79376981|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371864|NCT01796171|79376982|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371865|NCT01796171|79376983|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
44371866|NCT01796171|79376984|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
44371867|NCT01796171|79376985|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371868|NCT01796171|79376986|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371869|NCT01796171|79376987|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
44371870|NCT01796171|79376973|FG000|Follow-up Period|Start of further anticancer therapy|4|||
44371871|NCT01796171|79376974|FG001|Follow-up Period|Start of further anticancer therapy|25|||
44371872|NCT01796171|79376975|FG002|Follow-up Period|Start of further anticancer therapy|2|||
44371873|NCT01796171|79376976|FG003|Follow-up Period|Start of further anticancer therapy|1|||
44371874|NCT01796171|79376977|FG004|Follow-up Period|Start of further anticancer therapy|2|||
44456187|NCT00644969|79464610|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
44371875|NCT01796171|79376978|FG005|Follow-up Period|Start of further anticancer therapy|2|||
44456188|NCT00644969|79464609|FG000|Post Treatment Phase|Lost to Follow-up|4|||
44456189|NCT00644969|79464610|FG001|Post Treatment Phase|Lost to Follow-up|1|||
44456190|NCT00644969|79464609|FG000|Post Treatment Phase|Other|1|||
44456191|NCT00644969|79464610|FG001|Post Treatment Phase|Other|0|||
44456192|NCT00644423|79464618|FG000|Overall Study|Lost to Follow-up|1|||
44456193|NCT00644423|79464619|FG001|Overall Study|Lost to Follow-up|1|||
44456194|NCT00628355|79464627|FG000|Overall Study|Withdrawal by Subject|1|||
44456195|NCT00628355|79464628|FG001|Overall Study|Withdrawal by Subject|1|||
44456196|NCT00627497|79464639|FG000|Overall Study|Lost to Follow-up|1|||
44456197|NCT00627497|79464640|FG001|Overall Study|Lost to Follow-up|1|||
44456198|NCT00627497|79464641|FG002|Overall Study|Lost to Follow-up|0|||
44456199|NCT00627497|79464642|FG003|Overall Study|Lost to Follow-up|0|||
44456200|NCT00648167|79464652|FG000|Overall Study|Adverse Event|6|||
44456201|NCT00648167|79464652|FG000|Overall Study|unable to swallow tablets|1|||
44456202|NCT00647699|79464686|FG000|Overall Study|Lost to Follow-up|5|||
44456203|NCT00647699|79464687|FG001|Overall Study|Lost to Follow-up|4|||
44456204|NCT00647699|79464686|FG000|Overall Study|Withdrawal by Subject|3|||
44456205|NCT00647699|79464687|FG001|Overall Study|Withdrawal by Subject|8|||
44456206|NCT00467649|79464695|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
44456207|NCT00467649|79464696|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
44456208|NCT00467649|79464697|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
44456209|NCT00467649|79464698|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
44456210|NCT00467649|79464699|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
44456211|NCT00467649|79464700|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
44456212|NCT00467649|79464695|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
44456213|NCT00467649|79464696|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
44456214|NCT00467649|79464697|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
44456215|NCT00467649|79464698|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
44456216|NCT00467649|79464699|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
44456217|NCT00467649|79464700|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
44456218|NCT00467649|79464695|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
44456219|NCT00467649|79464696|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
44456220|NCT00467649|79464697|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
44456221|NCT00467649|79464698|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
44456222|NCT00467649|79464699|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
44456223|NCT00467649|79464700|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
44456224|NCT00467649|79464695|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
44456225|NCT00467649|79464696|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
44456226|NCT00467649|79464697|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
44456227|NCT00467649|79464698|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
44456228|NCT00467649|79464699|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
44456229|NCT00467649|79464700|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
44456230|NCT00467649|79464695|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
44456231|NCT00467649|79464696|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
44456232|NCT00467649|79464697|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
44456233|NCT00467649|79464698|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
44456234|NCT00467649|79464699|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
44456235|NCT00467649|79464700|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
44456236|NCT00467649|79464695|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
44456237|NCT00467649|79464696|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
44456238|NCT00467649|79464697|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
44456239|NCT00467649|79464698|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
44456240|NCT00467649|79464699|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
44456241|NCT00467649|79464700|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
44215567|NCT02315703|79013352|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
44371876|NCT01796171|79376979|FG006|Follow-up Period|Start of further anticancer therapy|1|||
44371877|NCT01796171|79376980|FG007|Follow-up Period|Start of further anticancer therapy|15|||
44371878|NCT01796171|79376981|FG008|Follow-up Period|Start of further anticancer therapy|2|||
44371879|NCT01796171|79376982|FG009|Follow-up Period|Start of further anticancer therapy|0|||
44371880|NCT01796171|79376983|FG010|Follow-up Period|Start of further anticancer therapy|0|||
44371881|NCT01796171|79376984|FG011|Follow-up Period|Start of further anticancer therapy|0|||
44371882|NCT01796171|79376985|FG012|Follow-up Period|Start of further anticancer therapy|0|||
44371883|NCT01796171|79376986|FG013|Follow-up Period|Start of further anticancer therapy|0|||
44456242|NCT00467649|79464695|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
44456243|NCT00467649|79464696|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
44456244|NCT00467649|79464697|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
44456245|NCT00467649|79464698|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
44456246|NCT00467649|79464699|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
44456247|NCT00467649|79464700|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
44456248|NCT00450333|79464722|FG000|Overall Study|Study terminated|47|||
44456249|NCT00450333|79464723|FG001|Overall Study|Study terminated|54|||
44456250|NCT00450333|79464724|FG002|Overall Study|Study terminated|16|||
44456251|NCT00450333|79464725|FG003|Overall Study|Study terminated|21|||
44215568|NCT02315703|79013353|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
44456252|NCT00450333|79464722|FG000|Overall Study|Adverse Event|1|||
44456253|NCT00450333|79464723|FG001|Overall Study|Adverse Event|7|||
44456254|NCT00450333|79464724|FG002|Overall Study|Adverse Event|2|||
44456255|NCT00450333|79464725|FG003|Overall Study|Adverse Event|2|||
44456256|NCT00450333|79464722|FG000|Overall Study|Protocol Violation|1|||
44371884|NCT01796171|79376987|FG014|Follow-up Period|Start of further anticancer therapy|0|||
44371885|NCT01796171|79376973|FG000|Follow-up Period|Progressive disease|0|||
44371886|NCT01796171|79376974|FG001|Follow-up Period|Progressive disease|1|||
44371887|NCT01796171|79376975|FG002|Follow-up Period|Progressive disease|0|||
44371888|NCT01796171|79376976|FG003|Follow-up Period|Progressive disease|0|||
44371889|NCT01796171|79376977|FG004|Follow-up Period|Progressive disease|0|||
44371890|NCT01796171|79376978|FG005|Follow-up Period|Progressive disease|0|||
44371891|NCT01796171|79376979|FG006|Follow-up Period|Progressive disease|0|||
44371892|NCT01796171|79376980|FG007|Follow-up Period|Progressive disease|3|||
44371893|NCT01796171|79376981|FG008|Follow-up Period|Progressive disease|0|||
44371894|NCT01796171|79376982|FG009|Follow-up Period|Progressive disease|0|||
44371895|NCT01796171|79376983|FG010|Follow-up Period|Progressive disease|0|||
44371896|NCT01796171|79376984|FG011|Follow-up Period|Progressive disease|0|||
44371897|NCT01796171|79376985|FG012|Follow-up Period|Progressive disease|0|||
44371898|NCT01796171|79376986|FG013|Follow-up Period|Progressive disease|0|||
44371899|NCT01796171|79376987|FG014|Follow-up Period|Progressive disease|0|||
44371900|NCT01796171|79376973|FG000|Follow-up Period|Physician Decision|0|||
44371901|NCT01796171|79376974|FG001|Follow-up Period|Physician Decision|2|||
44371902|NCT01796171|79376975|FG002|Follow-up Period|Physician Decision|0|||
44371903|NCT01796171|79376976|FG003|Follow-up Period|Physician Decision|0|||
44456257|NCT00450333|79464723|FG001|Overall Study|Protocol Violation|0|||
44215569|NCT02315703|79013346|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
44456258|NCT00450333|79464724|FG002|Overall Study|Protocol Violation|1|||
44456259|NCT00450333|79464725|FG003|Overall Study|Protocol Violation|0|||
44456260|NCT00450333|79464722|FG000|Overall Study|Withdrawal by Subject|1|||
44456261|NCT00450333|79464723|FG001|Overall Study|Withdrawal by Subject|0|||
44456262|NCT00450333|79464724|FG002|Overall Study|Withdrawal by Subject|3|||
44456263|NCT00450333|79464725|FG003|Overall Study|Withdrawal by Subject|0|||
44456264|NCT00450333|79464722|FG000|Overall Study|Kidney transplant|1|||
44215570|NCT02315703|79013347|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
44215571|NCT02315703|79013348|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
44215572|NCT02315703|79013349|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
44215573|NCT02315703|79013350|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
44215574|NCT02315703|79013351|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
44215575|NCT02315703|79013352|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
44215576|NCT02315703|79013353|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
44215577|NCT02315703|79013346|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44215578|NCT02315703|79013347|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44371904|NCT01796171|79376977|FG004|Follow-up Period|Physician Decision|0|||
44456265|NCT00450333|79464723|FG001|Overall Study|Kidney transplant|0|||
44456266|NCT00450333|79464724|FG002|Overall Study|Kidney transplant|1|||
44456267|NCT00450333|79464725|FG003|Overall Study|Kidney transplant|3|||
44456268|NCT00450333|79464722|FG000|Overall Study|Death|3|||
44456269|NCT00450333|79464723|FG001|Overall Study|Death|2|||
44456270|NCT00450333|79464724|FG002|Overall Study|Death|2|||
44456271|NCT00450333|79464725|FG003|Overall Study|Death|2|||
44371905|NCT01796171|79376978|FG005|Follow-up Period|Physician Decision|0|||
44371906|NCT01796171|79376979|FG006|Follow-up Period|Physician Decision|0|||
44371907|NCT01796171|79376980|FG007|Follow-up Period|Physician Decision|0|||
44371908|NCT01796171|79376981|FG008|Follow-up Period|Physician Decision|0|||
44456272|NCT00643565|79464737|FG000|Overall Study|Death|12|||
44456273|NCT00643565|79464738|FG001|Overall Study|Death|11|||
44456274|NCT00643565|79464737|FG000|Overall Study|Withdrawal by Subject|4|||
44456275|NCT00643565|79464738|FG001|Overall Study|Withdrawal by Subject|1|||
44215579|NCT02315703|79013348|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44215580|NCT02315703|79013349|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44215581|NCT02315703|79013350|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44215582|NCT02315703|79013351|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44456276|NCT00643565|79464737|FG000|Overall Study|Lost to Follow-up|0|||
44456277|NCT00643565|79464738|FG001|Overall Study|Lost to Follow-up|6|||
44456278|NCT00643565|79464737|FG000|Overall Study|Other|7|||
44456279|NCT00643565|79464738|FG001|Overall Study|Other|8|||
44456280|NCT00643565|79464737|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
44456281|NCT00643565|79464738|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
44456282|NCT00643565|79464737|FG000|Overall Study|Recurrence of Disease|2|||
44456283|NCT00643565|79464738|FG001|Overall Study|Recurrence of Disease|1|||
44456284|NCT00643565|79464737|FG000|Overall Study|Progression of Disease|18|||
44456285|NCT00643565|79464738|FG001|Overall Study|Progression of Disease|14|||
44456286|NCT00643565|79464737|FG000|Overall Study|Protocol Violation|3|||
44456287|NCT00643565|79464738|FG001|Overall Study|Protocol Violation|0|||
44456288|NCT00643565|79464737|FG000|Overall Study|Did Not Cooperate|0|||
44456289|NCT00643565|79464738|FG001|Overall Study|Did Not Cooperate|1|||
44456290|NCT00643565|79464737|FG000|Overall Study|Administrative|22|||
44456291|NCT00643565|79464738|FG001|Overall Study|Administrative|16|||
44215583|NCT02315703|79013352|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
44215584|NCT02315703|79013353|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
44215585|NCT02315703|79013346|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
44215586|NCT02315703|79013347|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
44215587|NCT02315703|79013348|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
44215588|NCT02315703|79013349|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
44371909|NCT01796171|79376982|FG009|Follow-up Period|Physician Decision|0|||
44371910|NCT01796171|79376983|FG010|Follow-up Period|Physician Decision|5|||
44371911|NCT01796171|79376984|FG011|Follow-up Period|Physician Decision|0|||
44371912|NCT01796171|79376985|FG012|Follow-up Period|Physician Decision|0|||
44371913|NCT01796171|79376986|FG013|Follow-up Period|Physician Decision|0|||
44456292|NCT00643565|79464737|FG000|Overall Study|Adverse Event|5|||
44456293|NCT00643565|79464738|FG001|Overall Study|Adverse Event|8|||
44456294|NCT00643487|79464745|FG000|Overall Study|Technical difficulty|3|||
44456295|NCT00450255|79464749|FG000|Overall Study|Prior RFA ablation of liver|1|||
44456296|NCT00450177|79464756|FG000|Overall Study|Adverse Event|7|||
44456297|NCT00450177|79464757|FG001|Overall Study|Adverse Event|4|||
44456298|NCT00450177|79464756|FG000|Overall Study|Withdrawal by Subject|1|||
44456299|NCT00450177|79464757|FG001|Overall Study|Withdrawal by Subject|6|||
44456300|NCT00450177|79464756|FG000|Overall Study|Withdrawal by Primary Team|1|||
44456301|NCT00450177|79464757|FG001|Overall Study|Withdrawal by Primary Team|1|||
44456302|NCT03848949|79464765|FG000|Overall Study|Lost to Follow-up|5|||
44456303|NCT03848949|79464766|FG001|Overall Study|Lost to Follow-up|7|||
44456304|NCT00467259|79464774|FG000|Overall Study|Adverse Event|24|||
44456305|NCT00467259|79464775|FG001|Overall Study|Adverse Event|90|||
44456306|NCT00467259|79464774|FG000|Overall Study|Protocol Violation|1|||
44456307|NCT00467259|79464775|FG001|Overall Study|Protocol Violation|7|||
44456308|NCT00467259|79464774|FG000|Overall Study|Withdrawal by Subject|34|||
44456309|NCT00467259|79464775|FG001|Overall Study|Withdrawal by Subject|108|||
44456310|NCT00467259|79464774|FG000|Overall Study|Physician Decision|0|||
44456311|NCT00467259|79464775|FG001|Overall Study|Physician Decision|2|||
44456312|NCT00467259|79464774|FG000|Overall Study|Lost to Follow-up|14|||
44456313|NCT00467259|79464775|FG001|Overall Study|Lost to Follow-up|34|||
44456314|NCT00467259|79464774|FG000|Overall Study|Site Closed|2|||
44543831|NCT03638635|79556984|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
44215589|NCT02315703|79013350|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
44371914|NCT01796171|79376987|FG014|Follow-up Period|Physician Decision|0|||
44371915|NCT01796171|79376973|FG000|Follow-up Period|Withdrawal by Subject|0|||
44371916|NCT01796171|79376974|FG001|Follow-up Period|Withdrawal by Subject|1|||
44371917|NCT01796171|79376975|FG002|Follow-up Period|Withdrawal by Subject|0|||
44371918|NCT01796171|79376976|FG003|Follow-up Period|Withdrawal by Subject|0|||
44215590|NCT02315703|79013351|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
44371919|NCT01796171|79376977|FG004|Follow-up Period|Withdrawal by Subject|0|||
44371920|NCT01796171|79376978|FG005|Follow-up Period|Withdrawal by Subject|1|||
44371921|NCT01796171|79376979|FG006|Follow-up Period|Withdrawal by Subject|0|||
44456315|NCT00467259|79464775|FG001|Overall Study|Site Closed|1|||
44456316|NCT00449865|79464783|FG000|Overall Study|Withdrawal by Subject|110|||
44456317|NCT00449865|79464784|FG001|Overall Study|Withdrawal by Subject|110|||
44456318|NCT00449865|79464783|FG000|Overall Study|Lost to Follow-up|36|||
44456319|NCT00449865|79464784|FG001|Overall Study|Lost to Follow-up|37|||
44456320|NCT00449865|79464783|FG000|Overall Study|Physician Decision|13|||
44543832|NCT03204981|79556990|FG000|Overall Study|Physician Decision|2|||
44456321|NCT00449865|79464784|FG001|Overall Study|Physician Decision|12|||
44456322|NCT00449865|79464783|FG000|Overall Study|Death|31|||
44456323|NCT00449865|79464784|FG001|Overall Study|Death|40|||
44456324|NCT00449865|79464783|FG000|Overall Study|Protocol Violation|8|||
44456325|NCT00449865|79464784|FG001|Overall Study|Protocol Violation|7|||
44456326|NCT00449865|79464783|FG000|Overall Study|Study was stopped|324|||
44456327|NCT00449865|79464784|FG001|Overall Study|Study was stopped|328|||
44456328|NCT00449787|79464792|FG000|Overall Study|Lost to Follow-up|10|||
44456329|NCT00449787|79464793|FG001|Overall Study|Lost to Follow-up|8|||
44456330|NCT00449787|79464792|FG000|Overall Study|Did not require medication|95|||
44456331|NCT00449787|79464793|FG001|Overall Study|Did not require medication|92|||
44456332|NCT00449163|79464801|FG000|Overall Study|Physician Decision|3|||
44456333|NCT00448539|79464807|FG000|Overall Study|Medication non-compliance|4|||
44456334|NCT00448539|79464808|FG001|Overall Study|Medication non-compliance|1|||
44456335|NCT00448539|79464807|FG000|Overall Study|Protocol Violation|1|||
44456336|NCT00448539|79464808|FG001|Overall Study|Protocol Violation|0|||
44456337|NCT00448539|79464807|FG000|Overall Study|Request of the investigator or sponsor|67|||
44456338|NCT00448539|79464808|FG001|Overall Study|Request of the investigator or sponsor|54|||
44456339|NCT00448539|79464807|FG000|Overall Study|Withdrawal by Subject|20|||
44456340|NCT00448539|79464808|FG001|Overall Study|Withdrawal by Subject|24|||
44456341|NCT00448539|79464807|FG000|Overall Study|Diary non-compliance|1|||
44456342|NCT00448539|79464808|FG001|Overall Study|Diary non-compliance|0|||
44456343|NCT00448539|79464807|FG000|Overall Study|Adverse Event|9|||
44456344|NCT00448539|79464808|FG001|Overall Study|Adverse Event|26|||
44456345|NCT00448539|79464807|FG000|Overall Study|Lack of Efficacy|27|||
44456346|NCT00448539|79464808|FG001|Overall Study|Lack of Efficacy|40|||
44456347|NCT00448539|79464807|FG000|Overall Study|Miscellaneous|2|||
44456348|NCT00448539|79464808|FG001|Overall Study|Miscellaneous|1|||
44456349|NCT00448539|79464807|FG000|Overall Study|Change of meds|2|||
44456350|NCT00448539|79464808|FG001|Overall Study|Change of meds|3|||
44456351|NCT00448539|79464807|FG000|Overall Study|Lost to Follow-up|1|||
44456352|NCT00448539|79464808|FG001|Overall Study|Lost to Follow-up|3|||
44456353|NCT00457665|79464816|FG000|12 Months|Drug allergy|1|||
44456354|NCT00457665|79464817|FG001|12 Months|Drug allergy|1|||
44456355|NCT00457665|79464816|FG000|12 Months|High HIV viral load|5|||
44456356|NCT00457665|79464817|FG001|12 Months|High HIV viral load|1|||
44456357|NCT00457665|79464816|FG000|12 Months|Lipodystrophy|2|||
44456358|NCT00457665|79464817|FG001|12 Months|Lipodystrophy|0|||
44456359|NCT00457665|79464816|FG000|12 Months|Withdrawal by Subject|0|||
44456360|NCT00457665|79464817|FG001|12 Months|Withdrawal by Subject|2|||
44456361|NCT00457665|79464816|FG000|12 Months|Abnormal Liver function tests|0|||
44456362|NCT00457665|79464817|FG001|12 Months|Abnormal Liver function tests|5|||
44456363|NCT00457665|79464816|FG000|24 Months|Withdrawal by Subject|3|||
44456364|NCT00457665|79464817|FG001|24 Months|Withdrawal by Subject|2|||
44456365|NCT00457665|79464816|FG000|24 Months|Lipodystrophy|1|||
44456366|NCT00457665|79464817|FG001|24 Months|Lipodystrophy|1|||
44456367|NCT00457665|79464816|FG000|24 Months|Abnormal liver function tests|1|||
44456368|NCT00457665|79464817|FG001|24 Months|Abnormal liver function tests|5|||
44456369|NCT00447603|79464823|FG000|Screening|Withdrawal by Subject|1|||
44456370|NCT00447603|79464824|FG001|Screening|Withdrawal by Subject|0|||
44456371|NCT00447603|79464825|FG002|Screening|Withdrawal by Subject|0|||
44456372|NCT00447603|79464823|FG000|Screening|Protocol Violation|1|||
44456373|NCT00447603|79464824|FG001|Screening|Protocol Violation|0|||
44456374|NCT00447603|79464825|FG002|Screening|Protocol Violation|0|||
44456375|NCT00447603|79464823|FG000|Screening|Screen Failure|4|||
44456376|NCT00447603|79464824|FG001|Screening|Screen Failure|0|||
44456377|NCT00447603|79464825|FG002|Screening|Screen Failure|0|||
44456378|NCT00447603|79464823|FG000|Screening|Study Terminated by Sponsor|15|||
44456379|NCT00447603|79464824|FG001|Screening|Study Terminated by Sponsor|0|||
44456380|NCT00447603|79464825|FG002|Screening|Study Terminated by Sponsor|0|||
44456381|NCT00447603|79464823|FG000|Filter Period|Adverse Event|0|||
44456382|NCT00447603|79464824|FG001|Filter Period|Adverse Event|0|||
44456383|NCT00447603|79464825|FG002|Filter Period|Adverse Event|1|||
44456384|NCT00447603|79464823|FG000|Filter Period|Screen Failure|0|||
44456385|NCT00447603|79464824|FG001|Filter Period|Screen Failure|3|||
44456386|NCT00447603|79464825|FG002|Filter Period|Screen Failure|4|||
44456387|NCT00447603|79464823|FG000|Filter Period|Study terminated by Sponsor|0|||
44456388|NCT00447603|79464824|FG001|Filter Period|Study terminated by Sponsor|1|||
44456389|NCT00447603|79464825|FG002|Filter Period|Study terminated by Sponsor|10|||
44456390|NCT00447057|79464837|FG000|Overall Study|Adverse Event|4|||
44456391|NCT00447057|79464838|FG001|Overall Study|Adverse Event|10|||
44215591|NCT02315703|79013352|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
44456392|NCT00447057|79464839|FG002|Overall Study|Adverse Event|0|||
44456393|NCT00447057|79464840|FG003|Overall Study|Adverse Event|3|||
44456394|NCT00447057|79464837|FG000|Overall Study|Death due to study disease|6|||
44456395|NCT00447057|79464838|FG001|Overall Study|Death due to study disease|4|||
44456396|NCT00447057|79464839|FG002|Overall Study|Death due to study disease|1|||
44456397|NCT00447057|79464840|FG003|Overall Study|Death due to study disease|1|||
44456398|NCT00447057|79464837|FG000|Overall Study|Lost to Follow-up|0|||
44456399|NCT00447057|79464838|FG001|Overall Study|Lost to Follow-up|1|||
44456400|NCT00447057|79464839|FG002|Overall Study|Lost to Follow-up|0|||
44456401|NCT00447057|79464840|FG003|Overall Study|Lost to Follow-up|0|||
44456402|NCT00447057|79464837|FG000|Overall Study|Entry criteria not met|1|||
44456403|NCT00447057|79464838|FG001|Overall Study|Entry criteria not met|1|||
44456404|NCT00447057|79464839|FG002|Overall Study|Entry criteria not met|0|||
44456405|NCT00447057|79464840|FG003|Overall Study|Entry criteria not met|0|||
44456406|NCT00447057|79464837|FG000|Overall Study|Protocol Violation|0|||
44456407|NCT00447057|79464838|FG001|Overall Study|Protocol Violation|1|||
44456408|NCT00447057|79464839|FG002|Overall Study|Protocol Violation|0|||
44456409|NCT00447057|79464840|FG003|Overall Study|Protocol Violation|0|||
44456410|NCT00447057|79464837|FG000|Overall Study|Withdrawal by Subject|4|||
44456411|NCT00447057|79464838|FG001|Overall Study|Withdrawal by Subject|5|||
44456412|NCT00447057|79464839|FG002|Overall Study|Withdrawal by Subject|1|||
44456413|NCT00447057|79464840|FG003|Overall Study|Withdrawal by Subject|1|||
44456414|NCT00447057|79464837|FG000|Overall Study|Physician Decision|9|||
44456415|NCT00447057|79464838|FG001|Overall Study|Physician Decision|6|||
44456416|NCT00447057|79464839|FG002|Overall Study|Physician Decision|3|||
44456417|NCT00447057|79464840|FG003|Overall Study|Physician Decision|1|||
44456418|NCT00447057|79464837|FG000|Overall Study|Sponsor decision|1|||
44456419|NCT00447057|79464838|FG001|Overall Study|Sponsor decision|1|||
44456420|NCT00447057|79464839|FG002|Overall Study|Sponsor decision|0|||
44456421|NCT00447057|79464840|FG003|Overall Study|Sponsor decision|0|||
44215592|NCT02315703|79013353|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
44215593|NCT02315703|79013346|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
44456422|NCT00447057|79464837|FG000|Overall Study|Progressive disease|58|||
44456423|NCT00447057|79464838|FG001|Overall Study|Progressive disease|43|||
44456424|NCT00447057|79464839|FG002|Overall Study|Progressive disease|13|||
44215594|NCT02315703|79013347|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
44215595|NCT02315703|79013348|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
44215596|NCT02315703|79013349|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
44215597|NCT02315703|79013350|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
44215598|NCT02315703|79013351|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
44215599|NCT02315703|79013352|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
44215600|NCT02315703|79013353|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
44215601|NCT02315703|79013346|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
44215602|NCT02315703|79013347|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
44215603|NCT02315703|79013348|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
44215604|NCT02315703|79013349|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
44215605|NCT02315703|79013350|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
44215606|NCT02315703|79013351|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
44215607|NCT02315703|79013352|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
44215608|NCT02315703|79013353|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
44215609|NCT02315703|79013346|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44215610|NCT02315703|79013347|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
44215611|NCT02315703|79013348|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44456425|NCT00447057|79464840|FG003|Overall Study|Progressive disease|18|||
44456426|NCT00447057|79464837|FG000|Overall Study|Death due to adverse event|0|||
44456427|NCT00447057|79464838|FG001|Overall Study|Death due to adverse event|0|||
44456428|NCT00447057|79464839|FG002|Overall Study|Death due to adverse event|1|||
44456429|NCT00447057|79464840|FG003|Overall Study|Death due to adverse event|2|||
44456430|NCT00447057|79464837|FG000|Overall Study|Death, study drug related|0|||
44456431|NCT00447057|79464838|FG001|Overall Study|Death, study drug related|1|||
44456432|NCT00447057|79464839|FG002|Overall Study|Death, study drug related|0|||
44215612|NCT02315703|79013349|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44215613|NCT02315703|79013350|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44215614|NCT02315703|79013351|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44456433|NCT00447057|79464840|FG003|Overall Study|Death, study drug related|0|||
44456434|NCT00446511|79464852|FG000|Overall Study|Adverse Event|7|||
44215615|NCT02315703|79013352|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44215616|NCT02315703|79013353|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
44215617|NCT02315703|79013346|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
44456435|NCT00446511|79464853|FG001|Overall Study|Adverse Event|2|||
44456436|NCT00446511|79464854|FG002|Overall Study|Adverse Event|3|||
44456437|NCT00446511|79464855|FG003|Overall Study|Adverse Event|1|||
44456438|NCT00446511|79464852|FG000|Overall Study|Protocol Violation|0|||
44456439|NCT00446511|79464853|FG001|Overall Study|Protocol Violation|0|||
44456440|NCT00446511|79464854|FG002|Overall Study|Protocol Violation|0|||
44456441|NCT00446511|79464855|FG003|Overall Study|Protocol Violation|1|||
44456442|NCT00446511|79464852|FG000|Overall Study|Withdrawal by Subject|0|||
44456443|NCT00446511|79464853|FG001|Overall Study|Withdrawal by Subject|0|||
44456444|NCT00446511|79464854|FG002|Overall Study|Withdrawal by Subject|0|||
44456445|NCT00446511|79464855|FG003|Overall Study|Withdrawal by Subject|3|||
44456446|NCT00446511|79464852|FG000|Overall Study|Administrative Problems|3|||
44456447|NCT00446511|79464853|FG001|Overall Study|Administrative Problems|0|||
44456448|NCT00446511|79464854|FG002|Overall Study|Administrative Problems|4|||
44456449|NCT00446511|79464855|FG003|Overall Study|Administrative Problems|1|||
44456450|NCT00446199|79464871|FG000|Overall Study|Adverse Event|7|||
44456451|NCT00446199|79464872|FG001|Overall Study|Adverse Event|4|||
44456452|NCT00446199|79464873|FG002|Overall Study|Adverse Event|6|||
44456453|NCT00446199|79464874|FG003|Overall Study|Adverse Event|4|||
44456454|NCT00446199|79464871|FG000|Overall Study|Lost to Follow-up|4|||
44456455|NCT00446199|79464872|FG001|Overall Study|Lost to Follow-up|5|||
44456456|NCT00446199|79464873|FG002|Overall Study|Lost to Follow-up|2|||
44456457|NCT00446199|79464874|FG003|Overall Study|Lost to Follow-up|6|||
44456458|NCT00446199|79464871|FG000|Overall Study|Protocol Violation|1|||
44456459|NCT00446199|79464872|FG001|Overall Study|Protocol Violation|2|||
44456460|NCT00446199|79464873|FG002|Overall Study|Protocol Violation|1|||
44456461|NCT00446199|79464874|FG003|Overall Study|Protocol Violation|3|||
44456462|NCT00446199|79464871|FG000|Overall Study|Withdrawal by Subject|2|||
44456463|NCT00446199|79464872|FG001|Overall Study|Withdrawal by Subject|5|||
44456464|NCT00446199|79464873|FG002|Overall Study|Withdrawal by Subject|9|||
44456465|NCT00446199|79464874|FG003|Overall Study|Withdrawal by Subject|10|||
44456466|NCT00446199|79464871|FG000|Overall Study|Site termination|2|||
44456467|NCT00446199|79464872|FG001|Overall Study|Site termination|0|||
44456468|NCT00446199|79464873|FG002|Overall Study|Site termination|0|||
44456469|NCT00446199|79464874|FG003|Overall Study|Site termination|1|||
44456470|NCT00446199|79464871|FG000|Overall Study|Randomization in Error|2|||
44456471|NCT00446199|79464872|FG001|Overall Study|Randomization in Error|0|||
44456472|NCT00446199|79464873|FG002|Overall Study|Randomization in Error|1|||
44456473|NCT00446199|79464874|FG003|Overall Study|Randomization in Error|1|||
44456474|NCT00446199|79464871|FG000|Overall Study|Lack of Efficacy|1|||
44456475|NCT00446199|79464872|FG001|Overall Study|Lack of Efficacy|0|||
44456476|NCT00446199|79464873|FG002|Overall Study|Lack of Efficacy|0|||
44456477|NCT00446199|79464874|FG003|Overall Study|Lack of Efficacy|1|||
44371922|NCT01796171|79376980|FG007|Follow-up Period|Withdrawal by Subject|0|||
44371923|NCT01796171|79376981|FG008|Follow-up Period|Withdrawal by Subject|0|||
44371924|NCT01796171|79376982|FG009|Follow-up Period|Withdrawal by Subject|0|||
44371925|NCT01796171|79376983|FG010|Follow-up Period|Withdrawal by Subject|3|||
44371926|NCT01796171|79376984|FG011|Follow-up Period|Withdrawal by Subject|1|||
44371927|NCT01796171|79376985|FG012|Follow-up Period|Withdrawal by Subject|0|||
44371928|NCT01796171|79376986|FG013|Follow-up Period|Withdrawal by Subject|0|||
44371929|NCT01796171|79376987|FG014|Follow-up Period|Withdrawal by Subject|0|||
44371930|NCT01796171|79376973|FG000|Follow-up Period|Death|0|||
44371931|NCT01796171|79376974|FG001|Follow-up Period|Death|0|||
44371932|NCT01796171|79376975|FG002|Follow-up Period|Death|0|||
44371933|NCT01796171|79376976|FG003|Follow-up Period|Death|0|||
44371934|NCT01796171|79376977|FG004|Follow-up Period|Death|0|||
44371935|NCT01796171|79376978|FG005|Follow-up Period|Death|0|||
44371936|NCT01796171|79376979|FG006|Follow-up Period|Death|1|||
44371937|NCT01796171|79376980|FG007|Follow-up Period|Death|0|||
44371938|NCT01796171|79376981|FG008|Follow-up Period|Death|0|||
44371939|NCT01796171|79376982|FG009|Follow-up Period|Death|0|||
44371940|NCT01796171|79376983|FG010|Follow-up Period|Death|17|||
44371941|NCT01796171|79376984|FG011|Follow-up Period|Death|9|||
44456478|NCT00446199|79464871|FG000|Overall Study|Non-compliant with study drug|1|||
44456479|NCT00446199|79464872|FG001|Overall Study|Non-compliant with study drug|0|||
44456480|NCT00446199|79464873|FG002|Overall Study|Non-compliant with study drug|5|||
44456481|NCT00446199|79464874|FG003|Overall Study|Non-compliant with study drug|0|||
44456482|NCT00446199|79464871|FG000|Overall Study|Non-compliant with visit schedule|1|||
44456483|NCT00446199|79464872|FG001|Overall Study|Non-compliant with visit schedule|1|||
44456484|NCT00446199|79464873|FG002|Overall Study|Non-compliant with visit schedule|1|||
44456485|NCT00446199|79464874|FG003|Overall Study|Non-compliant with visit schedule|2|||
44456486|NCT00446199|79464871|FG000|Overall Study|Hormone fear|0|||
44456487|NCT00446199|79464872|FG001|Overall Study|Hormone fear|0|||
44456488|NCT00446199|79464873|FG002|Overall Study|Hormone fear|0|||
44215618|NCT02315703|79013347|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
44215619|NCT02315703|79013348|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
44215620|NCT02315703|79013349|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
44215621|NCT02315703|79013350|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
44215622|NCT02315703|79013351|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
44371942|NCT01796171|79376985|FG012|Follow-up Period|Death|1|||
44371943|NCT01796171|79376986|FG013|Follow-up Period|Death|0|||
44456489|NCT00446199|79464874|FG003|Overall Study|Hormone fear|1|||
44456490|NCT00446199|79464871|FG000|Overall Study|Lost interest in study participation|0|||
44456491|NCT00446199|79464872|FG001|Overall Study|Lost interest in study participation|1|||
44456492|NCT00446199|79464873|FG002|Overall Study|Lost interest in study participation|0|||
44456493|NCT00446199|79464874|FG003|Overall Study|Lost interest in study participation|0|||
44456494|NCT00446199|79464871|FG000|Overall Study|In-/Exclusion criterion violated|2|||
44456495|NCT00446199|79464872|FG001|Overall Study|In-/Exclusion criterion violated|1|||
44456496|NCT00446199|79464873|FG002|Overall Study|In-/Exclusion criterion violated|2|||
44456497|NCT00446199|79464874|FG003|Overall Study|In-/Exclusion criterion violated|1|||
44456498|NCT00446199|79464871|FG000|Overall Study|Move|0|||
44456499|NCT00446199|79464872|FG001|Overall Study|Move|1|||
44456500|NCT00446199|79464873|FG002|Overall Study|Move|0|||
44456501|NCT00446199|79464874|FG003|Overall Study|Move|0|||
44456502|NCT00456495|79464884|FG000|Overall Study|Physician Decision|2|||
44456503|NCT00445341|79464889|FG000|Overall Study|refused further treatment|1|||
44456504|NCT00445341|79464889|FG000|Overall Study|taken off treatment too early|1|||
44456505|NCT03846453|79464895|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
44456506|NCT03846453|79464896|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
44371944|NCT01796171|79376987|FG014|Follow-up Period|Death|0|||
44371945|NCT01796171|79376973|FG000|Follow-up Period|Patient transferred to other hospital|0|||
44371946|NCT01796171|79376974|FG001|Follow-up Period|Patient transferred to other hospital|1|||
44456507|NCT03846453|79464897|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
44456508|NCT03846453|79464895|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
44456509|NCT03846453|79464896|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
44456510|NCT03846453|79464897|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
44456511|NCT03846453|79464895|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
44456512|NCT03846453|79464896|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
44456513|NCT03846453|79464897|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
44456514|NCT03846453|79464895|FG000|Placebo Run-in (14 Days)|Other|2|||
44456515|NCT03846453|79464896|FG001|Placebo Run-in (14 Days)|Other|0|||
44371947|NCT01796171|79376975|FG002|Follow-up Period|Patient transferred to other hospital|0|||
44371948|NCT01796171|79376976|FG003|Follow-up Period|Patient transferred to other hospital|0|||
44371949|NCT01796171|79376977|FG004|Follow-up Period|Patient transferred to other hospital|0|||
44371950|NCT01796171|79376978|FG005|Follow-up Period|Patient transferred to other hospital|0|||
44371951|NCT01796171|79376979|FG006|Follow-up Period|Patient transferred to other hospital|0|||
44371952|NCT01796171|79376980|FG007|Follow-up Period|Patient transferred to other hospital|0|||
44371953|NCT01796171|79376981|FG008|Follow-up Period|Patient transferred to other hospital|0|||
44371954|NCT01796171|79376982|FG009|Follow-up Period|Patient transferred to other hospital|0|||
44371955|NCT01796171|79376983|FG010|Follow-up Period|Patient transferred to other hospital|0|||
44371956|NCT01796171|79376984|FG011|Follow-up Period|Patient transferred to other hospital|0|||
44371957|NCT01796171|79376985|FG012|Follow-up Period|Patient transferred to other hospital|0|||
44371958|NCT01796171|79376986|FG013|Follow-up Period|Patient transferred to other hospital|0|||
44371959|NCT01796171|79376987|FG014|Follow-up Period|Patient transferred to other hospital|0|||
44371960|NCT01796171|79376973|FG000|Follow-up Period|Sponsor Decision|0|||
44371961|NCT01796171|79376974|FG001|Follow-up Period|Sponsor Decision|0|||
44371962|NCT01796171|79376975|FG002|Follow-up Period|Sponsor Decision|0|||
44371963|NCT01796171|79376976|FG003|Follow-up Period|Sponsor Decision|0|||
44371964|NCT01796171|79376977|FG004|Follow-up Period|Sponsor Decision|0|||
44371965|NCT01796171|79376978|FG005|Follow-up Period|Sponsor Decision|0|||
44371966|NCT01796171|79376979|FG006|Follow-up Period|Sponsor Decision|0|||
44371967|NCT01796171|79376980|FG007|Follow-up Period|Sponsor Decision|0|||
44456516|NCT03846453|79464897|FG002|Placebo Run-in (14 Days)|Other|0|||
44456517|NCT03846453|79464895|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
44215623|NCT02315703|79013352|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
44456518|NCT03846453|79464896|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
44456519|NCT03846453|79464897|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
44456520|NCT03846453|79464895|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
44456521|NCT03846453|79464896|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
44456522|NCT03846453|79464897|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
44456523|NCT03846453|79464895|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
44456524|NCT03846453|79464896|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
44456525|NCT03846453|79464897|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
44456526|NCT03846453|79464895|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
44456527|NCT03846453|79464896|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
44456528|NCT03846453|79464897|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
44456529|NCT03846453|79464895|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
44456530|NCT03846453|79464896|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
44456531|NCT03846453|79464897|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
44456532|NCT00444951|79464908|FG000|Overall Study|Lost to Follow-up|1|||
44456533|NCT00444951|79464909|FG001|Overall Study|Lost to Follow-up|1|||
44456534|NCT00444951|79464910|FG002|Overall Study|Lost to Follow-up|0|||
44456535|NCT00444951|79464908|FG000|Overall Study|Withdrawal by Subject|4|||
44456536|NCT00444951|79464909|FG001|Overall Study|Withdrawal by Subject|5|||
44456537|NCT00444951|79464910|FG002|Overall Study|Withdrawal by Subject|3|||
44456538|NCT00444795|79464918|FG000|Overall Study|Not Treated|1|||
44456539|NCT00444795|79464918|FG000|Overall Study|Treated Prior to the Contract Date|2|||
44456540|NCT03846219|79464925|FG000|Overall Study|Withdrawal by Subject|3|||
44456541|NCT03846219|79464926|FG001|Overall Study|Withdrawal by Subject|2|||
44456542|NCT03846219|79464927|FG002|Overall Study|Withdrawal by Subject|2|||
44456543|NCT03846219|79464925|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
44456544|NCT03846219|79464926|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
44456545|NCT03846219|79464927|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
44456546|NCT03846219|79464925|FG000|Overall Study|Physician Decision|0|||
44456547|NCT03846219|79464926|FG001|Overall Study|Physician Decision|0|||
44456548|NCT03846219|79464927|FG002|Overall Study|Physician Decision|2|||
44456549|NCT00455325|79464943|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
44456550|NCT00455325|79464944|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
44456551|NCT00455325|79464945|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
44456552|NCT00455325|79464946|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
44456553|NCT00455325|79464943|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
44456554|NCT00455325|79464944|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
44456555|NCT00455325|79464945|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
44456556|NCT00455325|79464946|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
44456557|NCT00455325|79464943|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
44456558|NCT00455325|79464944|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
44456559|NCT00455325|79464945|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
44456560|NCT00455325|79464946|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
44215624|NCT02315703|79013353|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
44215625|NCT02049359|79013373|FG000|Overall Study|Lost to Follow-up|26|||
44215626|NCT02049359|79013374|FG001|Overall Study|Lost to Follow-up|19|||
44215627|NCT01698905|79013404|FG000|Overall Study|Adverse Event|4|||
44215628|NCT01698905|79013404|FG000|Overall Study|Physician Decision|2|||
44215629|NCT01698905|79013404|FG000|Overall Study|Pregnancy|1|||
44215630|NCT01698905|79013404|FG000|Overall Study|Protocol Violation|1|||
44215631|NCT01698905|79013404|FG000|Overall Study|Subject/guardian decision|2|||
44270146|NCT02326272|79195775|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44371968|NCT01796171|79376981|FG008|Follow-up Period|Sponsor Decision|0|||
44371969|NCT01796171|79376982|FG009|Follow-up Period|Sponsor Decision|0|||
44371970|NCT01796171|79376983|FG010|Follow-up Period|Sponsor Decision|40|||
44371971|NCT01796171|79376984|FG011|Follow-up Period|Sponsor Decision|15|||
44371972|NCT01796171|79376985|FG012|Follow-up Period|Sponsor Decision|7|||
44371973|NCT01796171|79376986|FG013|Follow-up Period|Sponsor Decision|0|||
44371974|NCT01796171|79376987|FG014|Follow-up Period|Sponsor Decision|0|||
44371975|NCT01620944|79377020|FG000|Overall Study|Early termination of Study|2|||
44371976|NCT01620944|79377021|FG001|Overall Study|Early termination of Study|1|||
44371977|NCT01522976|79377030|FG000|Overall Study|Ineligible|4|||
44371978|NCT01522976|79377031|FG001|Overall Study|Ineligible|0|||
44371979|NCT01522976|79377032|FG002|Overall Study|Ineligible|1|||
44371980|NCT01522976|79377030|FG000|Overall Study|Death|7|||
44371981|NCT01522976|79377031|FG001|Overall Study|Death|6|||
44371982|NCT01522976|79377032|FG002|Overall Study|Death|2|||
44371983|NCT01522976|79377030|FG000|Overall Study|Still on treatment|9|||
44371984|NCT01522976|79377031|FG001|Overall Study|Still on treatment|9|||
44371985|NCT01522976|79377032|FG002|Overall Study|Still on treatment|6|||
44215632|NCT01698905|79013404|FG000|Overall Study|Death|1|||
44371986|NCT01522976|79377030|FG000|Overall Study|Disease progression|28|||
44215633|NCT01466686|79013415|FG000|Overall Study|Withdrawal by Subject|1|||
44371987|NCT01522976|79377031|FG001|Overall Study|Disease progression|30|||
44456561|NCT00455325|79464943|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
44456562|NCT00455325|79464944|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
44456563|NCT00455325|79464945|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
44456564|NCT00455325|79464946|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
44456565|NCT00455325|79464943|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
44215634|NCT01550289|79013421|FG000|Overall Study|Protocol Violation|1|||
44215635|NCT01550289|79013422|FG001|Overall Study|Protocol Violation|0|||
44456566|NCT00455325|79464944|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
44456567|NCT00455325|79464945|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
44456568|NCT00455325|79464946|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
44456569|NCT00455325|79464943|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
44456570|NCT00455325|79464944|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
44456571|NCT00455325|79464945|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
44456572|NCT00455325|79464946|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
44456573|NCT00455325|79464943|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
44456574|NCT00455325|79464944|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
44456575|NCT00455325|79464945|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
44456576|NCT00455325|79464946|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
44215636|NCT01550289|79013421|FG000|Overall Study|Lost to Follow-up|1|||
44215637|NCT01550289|79013422|FG001|Overall Study|Lost to Follow-up|1|||
44215638|NCT01550289|79013421|FG000|Overall Study|Withdrawal by Subject|11|||
44215639|NCT01550289|79013422|FG001|Overall Study|Withdrawal by Subject|3|||
44215640|NCT01968031|79013433|FG000|Overall Study|Adverse Event|13|||
44215641|NCT01968031|79013434|FG001|Overall Study|Adverse Event|10|||
44215642|NCT01968031|79013435|FG002|Overall Study|Adverse Event|22|||
44215643|NCT01968031|79013433|FG000|Overall Study|Withdrawal by Subject|3|||
44456577|NCT00443781|79464957|FG000|Overall Study|Lost to Follow-up|10|||
44215644|NCT01968031|79013434|FG001|Overall Study|Withdrawal by Subject|7|||
44215645|NCT01968031|79013435|FG002|Overall Study|Withdrawal by Subject|3|||
44215646|NCT01968031|79013433|FG000|Overall Study|Did not meet entry criteria|1|||
44215647|NCT01968031|79013434|FG001|Overall Study|Did not meet entry criteria|1|||
44215648|NCT01968031|79013435|FG002|Overall Study|Did not meet entry criteria|1|||
44215649|NCT01968031|79013433|FG000|Overall Study|Noncompliance|0|||
44215650|NCT01968031|79013434|FG001|Overall Study|Noncompliance|0|||
44215651|NCT01968031|79013435|FG002|Overall Study|Noncompliance|2|||
44215652|NCT01968031|79013433|FG000|Overall Study|Failed inclusion criteria|0|||
44215653|NCT01968031|79013434|FG001|Overall Study|Failed inclusion criteria|2|||
44215654|NCT01968031|79013435|FG002|Overall Study|Failed inclusion criteria|0|||
44215655|NCT01968031|79013433|FG000|Overall Study|Death|0|||
44215656|NCT01968031|79013434|FG001|Overall Study|Death|0|||
44215657|NCT01968031|79013435|FG002|Overall Study|Death|1|||
44215658|NCT01968031|79013433|FG000|Overall Study|Prohibited concomitant medication|1|||
44215659|NCT01968031|79013434|FG001|Overall Study|Prohibited concomitant medication|0|||
44215660|NCT01968031|79013435|FG002|Overall Study|Prohibited concomitant medication|0|||
44215661|NCT01684215|79013447|FG000|Phase 1, Part 1|Adverse Event|1|||
44215662|NCT01684215|79013448|FG001|Phase 1, Part 1|Adverse Event|0|||
44215663|NCT01684215|79013449|FG002|Phase 1, Part 1|Adverse Event|0|||
44215664|NCT01684215|79013450|FG003|Phase 1, Part 1|Adverse Event|0|||
44215665|NCT01684215|79013447|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
44215666|NCT01684215|79013448|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
44215667|NCT01684215|79013449|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
44215668|NCT01684215|79013450|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
44215669|NCT01684215|79013447|FG000|Phase 1, Part 2|Adverse Event|0|||
44215670|NCT01684215|79013448|FG001|Phase 1, Part 2|Adverse Event|0|||
44215671|NCT01684215|79013449|FG002|Phase 1, Part 2|Adverse Event|1|||
44215672|NCT01684215|79013450|FG003|Phase 1, Part 2|Adverse Event|0|||
44215673|NCT01684215|79013447|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
44215674|NCT01684215|79013448|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
44215675|NCT01684215|79013449|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
44215676|NCT01684215|79013450|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
44215677|NCT01684215|79013447|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
44215678|NCT01684215|79013448|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
44215679|NCT01684215|79013449|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
44215680|NCT01684215|79013450|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
44456578|NCT00443781|79464957|FG000|Overall Study|Physician Decision|2|||
44456579|NCT00443781|79464957|FG000|Overall Study|Protocol Violation|1|||
44456580|NCT00443781|79464957|FG000|Overall Study|Withdrawal by Subject|6|||
44456581|NCT00443781|79464957|FG000|Overall Study|Unable to comply with study follow up|2|||
44215681|NCT01684215|79013447|FG000|Phase 2|Death|0|||
44215682|NCT01684215|79013448|FG001|Phase 2|Death|0|||
44215683|NCT01684215|79013449|FG002|Phase 2|Death|0|||
44215684|NCT01684215|79013450|FG003|Phase 2|Death|8|||
44215685|NCT01684215|79013447|FG000|Phase 2|Study terminated by sponsor|0|||
44215686|NCT01684215|79013448|FG001|Phase 2|Study terminated by sponsor|0|||
44215687|NCT01684215|79013449|FG002|Phase 2|Study terminated by sponsor|0|||
44543833|NCT03204981|79556990|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
44543834|NCT03205488|79556999|FG000|Overall Study|Adverse Event|1|||
44543835|NCT03205488|79557000|FG001|Overall Study|Adverse Event|2|||
44543836|NCT03205488|79557001|FG002|Overall Study|Adverse Event|4|||
44543837|NCT03205488|79556999|FG000|Overall Study|Protocol Violation|0|||
44543838|NCT03205488|79557000|FG001|Overall Study|Protocol Violation|0|||
44543839|NCT03205488|79557001|FG002|Overall Study|Protocol Violation|1|||
44371988|NCT01522976|79377032|FG002|Overall Study|Disease progression|25|||
44371989|NCT01522976|79377030|FG000|Overall Study|Adverse Event|17|||
44371990|NCT01522976|79377031|FG001|Overall Study|Adverse Event|7|||
44371991|NCT01522976|79377032|FG002|Overall Study|Adverse Event|18|||
44371992|NCT01522976|79377030|FG000|Overall Study|Refusal unrelated to adverse event|10|||
44371993|NCT01522976|79377031|FG001|Overall Study|Refusal unrelated to adverse event|13|||
44371994|NCT01522976|79377032|FG002|Overall Study|Refusal unrelated to adverse event|14|||
44371995|NCT01522976|79377030|FG000|Overall Study|Not protocol specified|22|||
44371996|NCT01522976|79377031|FG001|Overall Study|Not protocol specified|27|||
44371997|NCT01522976|79377032|FG002|Overall Study|Not protocol specified|27|||
44371998|NCT01371981|79377049|FG000|Overall Study|Adverse Event|12|||
44371999|NCT01371981|79377050|FG001|Overall Study|Adverse Event|17|||
44372000|NCT01371981|79377051|FG002|Overall Study|Adverse Event|0|||
44372001|NCT01371981|79377052|FG003|Overall Study|Adverse Event|4|||
44372002|NCT01371981|79377053|FG004|Overall Study|Adverse Event|1|||
44372003|NCT01371981|79377054|FG005|Overall Study|Adverse Event|0|||
44372004|NCT01371981|79377049|FG000|Overall Study|Death|22|||
44372005|NCT01371981|79377050|FG001|Overall Study|Death|16|||
44372006|NCT01371981|79377051|FG002|Overall Study|Death|0|||
44372007|NCT01371981|79377052|FG003|Overall Study|Death|0|||
44372008|NCT01371981|79377053|FG004|Overall Study|Death|2|||
44372009|NCT01371981|79377054|FG005|Overall Study|Death|2|||
44372010|NCT01371981|79377049|FG000|Overall Study|Lack of Efficacy|69|||
44372011|NCT01371981|79377050|FG001|Overall Study|Lack of Efficacy|61|||
44372012|NCT01371981|79377051|FG002|Overall Study|Lack of Efficacy|4|||
44372013|NCT01371981|79377052|FG003|Overall Study|Lack of Efficacy|8|||
44372014|NCT01371981|79377053|FG004|Overall Study|Lack of Efficacy|5|||
44372015|NCT01371981|79377054|FG005|Overall Study|Lack of Efficacy|0|||
44270147|NCT02326272|79195776|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44372016|NCT01371981|79377049|FG000|Overall Study|Physician Decision|48|||
44372017|NCT01371981|79377050|FG001|Overall Study|Physician Decision|63|||
44372018|NCT01371981|79377051|FG002|Overall Study|Physician Decision|1|||
44372019|NCT01371981|79377052|FG003|Overall Study|Physician Decision|7|||
44543840|NCT03204279|79557015|FG000|Overall Study|Withdrawal by Subject|0|||
44543841|NCT03204279|79557016|FG001|Overall Study|Withdrawal by Subject|1|||
44456582|NCT00443781|79464957|FG000|Overall Study|Investigator terminated participation|1|||
44456583|NCT00443781|79464957|FG000|Overall Study|Insurance not covered|2|||
44456584|NCT00443781|79464957|FG000|Overall Study|PD/FAD not done|1|||
44456585|NCT00443703|79464963|FG000|Overall Study|Never Treated|3|||
44456586|NCT00443703|79464964|FG001|Overall Study|Never Treated|1|||
44456587|NCT00443703|79464963|FG000|Overall Study|Adverse Event|7|||
44456588|NCT00443703|79464964|FG001|Overall Study|Adverse Event|3|||
44456589|NCT00443703|79464963|FG000|Overall Study|Lack of Efficacy|3|||
44456590|NCT00443703|79464964|FG001|Overall Study|Lack of Efficacy|1|||
44456591|NCT00443703|79464963|FG000|Overall Study|Lost to Follow-up|0|||
44456592|NCT00443703|79464964|FG001|Overall Study|Lost to Follow-up|4|||
44456593|NCT00443703|79464963|FG000|Overall Study|Physician Decision|4|||
44456594|NCT00443703|79464964|FG001|Overall Study|Physician Decision|2|||
44456595|NCT00443703|79464963|FG000|Overall Study|Protocol Violation|1|||
44456596|NCT00443703|79464964|FG001|Overall Study|Protocol Violation|1|||
44456597|NCT00443703|79464963|FG000|Overall Study|Withdrawal by Subject|9|||
44456598|NCT00443703|79464964|FG001|Overall Study|Withdrawal by Subject|6|||
44456599|NCT00443703|79464963|FG000|Overall Study|Progressive Disease|1|||
44456600|NCT00443703|79464964|FG001|Overall Study|Progressive Disease|0|||
44456601|NCT00381706|79464976|FG000|Overall Study|Never treated|7|||
44215688|NCT01684215|79013450|FG003|Phase 2|Study terminated by sponsor|30|||
44456602|NCT00381706|79464977|FG001|Overall Study|Never treated|2|||
44215689|NCT01684215|79013447|FG000|Phase 2|Enrolled but not treated|0|||
44215690|NCT01684215|79013448|FG001|Phase 2|Enrolled but not treated|0|||
44215691|NCT01684215|79013449|FG002|Phase 2|Enrolled but not treated|0|||
44215692|NCT01684215|79013450|FG003|Phase 2|Enrolled but not treated|1|||
44215693|NCT01684215|79013447|FG000|Phase 2|Lost to Follow-up|0|||
44215694|NCT01684215|79013448|FG001|Phase 2|Lost to Follow-up|0|||
44215695|NCT01684215|79013449|FG002|Phase 2|Lost to Follow-up|0|||
44215696|NCT01684215|79013450|FG003|Phase 2|Lost to Follow-up|4|||
44215697|NCT01549275|79013465|FG000|Overall Study|Lost to Follow-up|1|||
44215698|NCT01549275|79013466|FG001|Overall Study|Lost to Follow-up|0|||
44215699|NCT01908205|79013478|FG000|Overall Study|Lost to Follow-up|2|||
44215700|NCT01908205|79013479|FG001|Overall Study|Lost to Follow-up|0|||
44215701|NCT01908205|79013478|FG000|Overall Study|Withdrawal by Subject|3|||
44215702|NCT01908205|79013479|FG001|Overall Study|Withdrawal by Subject|1|||
44215703|NCT01549041|79013500|FG000|Overall Study|Lack of Efficacy|2|||
44215704|NCT01549041|79013501|FG001|Overall Study|Lack of Efficacy|4|||
44215705|NCT01549041|79013500|FG000|Overall Study|Adverse Event|0|||
44215706|NCT01549041|79013501|FG001|Overall Study|Adverse Event|4|||
44215707|NCT01907815|79013509|FG000|Overall Study|Withdrawal by Subject|1|||
44215708|NCT01907815|79013510|FG001|Overall Study|Withdrawal by Subject|0|||
44215709|NCT01548573|79013518|FG000|Overall Study|Death|3|||
44215710|NCT01548573|79013518|FG000|Overall Study|Withdrawal by Subject|2|||
44215711|NCT01907737|79013523|FG000|Overall Study|Withdrawal by Subject|1|||
44215712|NCT01570491|79013535|FG000|Overall Study|Lost to Follow-up|3|||
44215713|NCT01570491|79013536|FG001|Overall Study|Lost to Follow-up|1|||
44215714|NCT01570491|79013535|FG000|Overall Study|treatment: not given or discontinued|2|||
44215715|NCT01570491|79013536|FG001|Overall Study|treatment: not given or discontinued|0|||
44215716|NCT01929109|79013547|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
44215717|NCT01929109|79013548|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
44456603|NCT00381706|79464978|FG002|Overall Study|Never treated|1|||
44456604|NCT00535236|79465002|FG000|Overall Study|Adverse Event|1|||
44543842|NCT03173547|79557025|FG000|Overall Study|Adverse Event|2|||
44543843|NCT03173547|79557026|FG001|Overall Study|Adverse Event|0|||
44543844|NCT03173547|79557025|FG000|Overall Study|Withdrawal by Subject|2|||
44543845|NCT03173547|79557026|FG001|Overall Study|Withdrawal by Subject|2|||
44543846|NCT02954653|79557034|FG000|Overall Study|Death|3|||
44543847|NCT02954653|79557035|FG001|Overall Study|Death|1|||
44543848|NCT02954653|79557036|FG002|Overall Study|Death|0|||
44543849|NCT02954653|79557037|FG003|Overall Study|Death|0|||
44543850|NCT02954653|79557038|FG004|Overall Study|Death|0|||
44543851|NCT02954653|79557039|FG005|Overall Study|Death|0|||
44456605|NCT00535236|79465003|FG001|Overall Study|Adverse Event|0|||
44215718|NCT01929109|79013549|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
44456606|NCT00535236|79465004|FG002|Overall Study|Adverse Event|9|||
44215719|NCT01929109|79013550|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
44215720|NCT01929109|79013551|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
44215721|NCT01518153|79013566|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
44215722|NCT01518153|79013567|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
44215723|NCT01518153|79013568|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
44456607|NCT00535236|79465005|FG003|Overall Study|Adverse Event|3|||
44456608|NCT00535236|79465006|FG004|Overall Study|Adverse Event|3|||
44543852|NCT02954653|79557040|FG006|Overall Study|Death|0|||
44543853|NCT02954653|79557041|FG007|Overall Study|Death|0|||
44543854|NCT02954653|79557042|FG008|Overall Study|Death|0|||
44543855|NCT02954653|79557034|FG000|Overall Study|Randomized but did not receive treatment|1|||
44456609|NCT00535236|79465007|FG005|Overall Study|Adverse Event|0|||
44456610|NCT00535236|79465008|FG006|Overall Study|Adverse Event|5|||
44456611|NCT00535236|79465009|FG007|Overall Study|Adverse Event|1|||
44456612|NCT00535236|79465010|FG008|Overall Study|Adverse Event|2|||
44456613|NCT00535236|79465011|FG009|Overall Study|Adverse Event|1|||
44456614|NCT00535236|79465002|FG000|Overall Study|Lost to Follow-up|1|||
44456615|NCT00535236|79465003|FG001|Overall Study|Lost to Follow-up|2|||
44456616|NCT00535236|79465004|FG002|Overall Study|Lost to Follow-up|0|||
44456617|NCT00535236|79465005|FG003|Overall Study|Lost to Follow-up|0|||
44456618|NCT00535236|79465006|FG004|Overall Study|Lost to Follow-up|2|||
44456619|NCT00535236|79465007|FG005|Overall Study|Lost to Follow-up|0|||
44456620|NCT00535236|79465008|FG006|Overall Study|Lost to Follow-up|0|||
44456621|NCT00535236|79465009|FG007|Overall Study|Lost to Follow-up|0|||
44456622|NCT00535236|79465010|FG008|Overall Study|Lost to Follow-up|6|||
44456623|NCT00535236|79465011|FG009|Overall Study|Lost to Follow-up|1|||
44456624|NCT00535236|79465002|FG000|Overall Study|Physician Decision|0|||
44456625|NCT00535236|79465003|FG001|Overall Study|Physician Decision|0|||
44456626|NCT00535236|79465004|FG002|Overall Study|Physician Decision|0|||
44456627|NCT00535236|79465005|FG003|Overall Study|Physician Decision|0|||
44456628|NCT00535236|79465006|FG004|Overall Study|Physician Decision|1|||
44456629|NCT00535236|79465007|FG005|Overall Study|Physician Decision|0|||
44456630|NCT00535236|79465008|FG006|Overall Study|Physician Decision|1|||
44456631|NCT00535236|79465009|FG007|Overall Study|Physician Decision|0|||
44456632|NCT00535236|79465010|FG008|Overall Study|Physician Decision|0|||
44456633|NCT00535236|79465011|FG009|Overall Study|Physician Decision|0|||
44456634|NCT00535236|79465002|FG000|Overall Study|Protocol Violation|2|||
44456635|NCT00535236|79465003|FG001|Overall Study|Protocol Violation|0|||
44456636|NCT00535236|79465004|FG002|Overall Study|Protocol Violation|1|||
44456637|NCT00535236|79465005|FG003|Overall Study|Protocol Violation|0|||
44456638|NCT00535236|79465006|FG004|Overall Study|Protocol Violation|0|||
44456639|NCT00535236|79465007|FG005|Overall Study|Protocol Violation|0|||
44456640|NCT00535236|79465008|FG006|Overall Study|Protocol Violation|0|||
44456641|NCT00535236|79465009|FG007|Overall Study|Protocol Violation|0|||
44456642|NCT00535236|79465010|FG008|Overall Study|Protocol Violation|1|||
44456643|NCT00535236|79465011|FG009|Overall Study|Protocol Violation|0|||
44456644|NCT00535236|79465002|FG000|Overall Study|Withdrawal by Subject|3|||
44456645|NCT00535236|79465003|FG001|Overall Study|Withdrawal by Subject|0|||
44456646|NCT00535236|79465004|FG002|Overall Study|Withdrawal by Subject|2|||
44456647|NCT00535236|79465005|FG003|Overall Study|Withdrawal by Subject|1|||
44456648|NCT00535236|79465006|FG004|Overall Study|Withdrawal by Subject|6|||
44456649|NCT00535236|79465007|FG005|Overall Study|Withdrawal by Subject|1|||
44456650|NCT00535236|79465008|FG006|Overall Study|Withdrawal by Subject|5|||
44456651|NCT00535236|79465009|FG007|Overall Study|Withdrawal by Subject|0|||
44456652|NCT00535236|79465010|FG008|Overall Study|Withdrawal by Subject|4|||
44456653|NCT00535236|79465011|FG009|Overall Study|Withdrawal by Subject|2|||
44456654|NCT00370552|79465039|FG000|Overall Study|Adverse Event|2|||
44456655|NCT00370552|79465040|FG001|Overall Study|Adverse Event|2|||
44456656|NCT00370552|79465041|FG002|Overall Study|Adverse Event|2|||
44456657|NCT00370552|79465039|FG000|Overall Study|Disease progression|23|||
44456658|NCT00370552|79465040|FG001|Overall Study|Disease progression|23|||
44456659|NCT00370552|79465041|FG002|Overall Study|Disease progression|15|||
44456660|NCT00370552|79465039|FG000|Overall Study|Maximum clinical benefit|3|||
44456661|NCT00370552|79465040|FG001|Overall Study|Maximum clinical benefit|5|||
44456662|NCT00370552|79465041|FG002|Overall Study|Maximum clinical benefit|5|||
44215724|NCT01518153|79013566|FG000|Stem Cell Transplant|Death|2|||
44215725|NCT01518153|79013567|FG001|Stem Cell Transplant|Death|0|||
44215726|NCT01518153|79013568|FG002|Stem Cell Transplant|Death|0|||
44215727|NCT01518153|79013566|FG000|Stem Cell Transplant|Secondary graft failure|1|||
44215728|NCT01518153|79013567|FG001|Stem Cell Transplant|Secondary graft failure|0|||
44215729|NCT01518153|79013568|FG002|Stem Cell Transplant|Secondary graft failure|0|||
44215730|NCT01518153|79013566|FG000|Stem Cell Transplant|Adverse Event|1|||
44215731|NCT01518153|79013567|FG001|Stem Cell Transplant|Adverse Event|0|||
44456663|NCT00370552|79465039|FG000|Overall Study|Poor or noncompliance|0|||
44456664|NCT00370552|79465040|FG001|Overall Study|Poor or noncompliance|0|||
44456665|NCT00370552|79465041|FG002|Overall Study|Poor or noncompliance|1|||
44456666|NCT00370552|79465039|FG000|Overall Study|Study drug toxicity|11|||
44456667|NCT00370552|79465040|FG001|Overall Study|Study drug toxicity|8|||
44456668|NCT00370552|79465041|FG002|Overall Study|Study drug toxicity|6|||
44456669|NCT00370552|79465039|FG000|Overall Study|Withdrawal by Subject|2|||
44543856|NCT02954653|79557035|FG001|Overall Study|Randomized but did not receive treatment|0|||
44543857|NCT02954653|79557036|FG002|Overall Study|Randomized but did not receive treatment|0|||
44215732|NCT01518153|79013568|FG002|Stem Cell Transplant|Adverse Event|0|||
44215733|NCT01518153|79013566|FG000|Donor Lymphocyte Infusion|Death|0|||
44456670|NCT00370552|79465040|FG001|Overall Study|Withdrawal by Subject|0|||
44456671|NCT00370552|79465041|FG002|Overall Study|Withdrawal by Subject|1|||
44456672|NCT00370552|79465039|FG000|Overall Study|Still on treatment|1|||
44456673|NCT00370552|79465040|FG001|Overall Study|Still on treatment|3|||
44456674|NCT00370552|79465041|FG002|Overall Study|Still on treatment|2|||
44456675|NCT00370552|79465039|FG000|Overall Study|Never treated|1|||
44456676|NCT00370552|79465040|FG001|Overall Study|Never treated|0|||
44456677|NCT00370552|79465041|FG002|Overall Study|Never treated|0|||
44456678|NCT00370552|79465039|FG000|Overall Study|Physician Decision|1|||
44456679|NCT00370552|79465040|FG001|Overall Study|Physician Decision|1|||
44456680|NCT00370552|79465041|FG002|Overall Study|Physician Decision|0|||
44456681|NCT00370552|79465039|FG000|Overall Study|Investigator decision|2|||
44456682|NCT00370552|79465040|FG001|Overall Study|Investigator decision|1|||
44456683|NCT00370552|79465041|FG002|Overall Study|Investigator decision|0|||
44543858|NCT02954653|79557037|FG003|Overall Study|Randomized but did not receive treatment|0|||
44543859|NCT02954653|79557038|FG004|Overall Study|Randomized but did not receive treatment|0|||
44543860|NCT02954653|79557039|FG005|Overall Study|Randomized but did not receive treatment|0|||
44543861|NCT02954653|79557040|FG006|Overall Study|Randomized but did not receive treatment|0|||
44543862|NCT02954653|79557041|FG007|Overall Study|Randomized but did not receive treatment|0|||
44543863|NCT02954653|79557042|FG008|Overall Study|Randomized but did not receive treatment|0|||
44543864|NCT02954653|79557034|FG000|Overall Study|Started another anti-cancer therapy|0|||
44543865|NCT02954653|79557035|FG001|Overall Study|Started another anti-cancer therapy|1|||
44543866|NCT02954653|79557036|FG002|Overall Study|Started another anti-cancer therapy|0|||
44543867|NCT02954653|79557037|FG003|Overall Study|Started another anti-cancer therapy|0|||
44543868|NCT02954653|79557038|FG004|Overall Study|Started another anti-cancer therapy|0|||
44543869|NCT02954653|79557039|FG005|Overall Study|Started another anti-cancer therapy|0|||
44543870|NCT02954653|79557040|FG006|Overall Study|Started another anti-cancer therapy|0|||
44543871|NCT02954653|79557041|FG007|Overall Study|Started another anti-cancer therapy|0|||
44543872|NCT02954653|79557042|FG008|Overall Study|Started another anti-cancer therapy|0|||
44543873|NCT02954653|79557034|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
44543874|NCT02954653|79557035|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
44543875|NCT02954653|79557036|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
44543876|NCT02954653|79557037|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
44456684|NCT00370552|79465039|FG000|Overall Study|High risk of allergic reaction|0|||
44456685|NCT00370552|79465040|FG001|Overall Study|High risk of allergic reaction|1|||
44456686|NCT00370552|79465041|FG002|Overall Study|High risk of allergic reaction|0|||
44456687|NCT00370552|79465039|FG000|Overall Study|Planned radiation for palliation|0|||
44456688|NCT00370552|79465040|FG001|Overall Study|Planned radiation for palliation|1|||
44456689|NCT00370552|79465041|FG002|Overall Study|Planned radiation for palliation|0|||
44456690|NCT00537030|79465049|FG000|Overall Study|Physician Decision|2|||
44456691|NCT00537030|79465049|FG000|Overall Study|Withdrawal by Subject|2|||
44456692|NCT00537030|79465049|FG000|Overall Study|≥ Grade 2 allergy|7|||
44456693|NCT00537030|79465049|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
44456694|NCT00537030|79465049|FG000|Overall Study|Ineligible|2|||
44456695|NCT00537030|79465049|FG000|Overall Study|Inevaluable|2|||
44456696|NCT00381238|79465053|FG000|Overall Study|Adverse Event|3|||
44456697|NCT00381238|79465053|FG000|Overall Study|Protocol Violation|1|||
44270148|NCT02326272|79195777|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270149|NCT02326272|79195778|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44372020|NCT01371981|79377053|FG004|Overall Study|Physician Decision|14|||
44372021|NCT01371981|79377054|FG005|Overall Study|Physician Decision|3|||
44372022|NCT01371981|79377049|FG000|Overall Study|Withdrawal by Subject|12|||
44372023|NCT01371981|79377050|FG001|Overall Study|Withdrawal by Subject|19|||
44372024|NCT01371981|79377051|FG002|Overall Study|Withdrawal by Subject|1|||
44372025|NCT01371981|79377052|FG003|Overall Study|Withdrawal by Subject|2|||
44372026|NCT01371981|79377053|FG004|Overall Study|Withdrawal by Subject|10|||
44372027|NCT01371981|79377054|FG005|Overall Study|Withdrawal by Subject|3|||
44372028|NCT01371981|79377049|FG000|Overall Study|Ineligible|19|||
44372029|NCT01371981|79377050|FG001|Overall Study|Ineligible|13|||
44372030|NCT01371981|79377051|FG002|Overall Study|Ineligible|0|||
44456698|NCT00381238|79465053|FG000|Overall Study|Withdrawal by Subject|4|||
44456699|NCT00381238|79465053|FG000|Overall Study|Lack of Efficacy|2|||
44456700|NCT00381238|79465053|FG000|Overall Study|Withdrew by physician|1|||
44456701|NCT00381238|79465053|FG000|Overall Study|Disease progression|1|||
44456702|NCT03896022|79465060|FG000|Overall Study|Withdrawal by Subject|1|||
44456703|NCT03896022|79465061|FG001|Overall Study|Withdrawal by Subject|0|||
44456704|NCT03896022|79465062|FG002|Overall Study|Withdrawal by Subject|0|||
44456705|NCT03896022|79465060|FG000|Overall Study|Did not have procedure|3|||
44456706|NCT03896022|79465061|FG001|Overall Study|Did not have procedure|0|||
44456707|NCT03896022|79465062|FG002|Overall Study|Did not have procedure|0|||
44456708|NCT03831880|79465074|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
44456709|NCT03831880|79465075|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
44456710|NCT03831880|79465074|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
44456711|NCT03831880|79465075|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
44456712|NCT00380692|79465098|FG000|Study Period II - Double Blind|Adverse Event|1|||
44215734|NCT01518153|79013567|FG001|Donor Lymphocyte Infusion|Death|2|||
44215735|NCT01518153|79013568|FG002|Donor Lymphocyte Infusion|Death|1|||
44215736|NCT01906489|79013578|FG000|Overall Study|Adverse Event|10|||
44215737|NCT01906489|79013579|FG001|Overall Study|Adverse Event|3|||
44215738|NCT01906489|79013578|FG000|Overall Study|Worsening of CKD|6|||
44215739|NCT01906489|79013579|FG001|Overall Study|Worsening of CKD|4|||
44215740|NCT01906489|79013578|FG000|Overall Study|Withdrawal by Subject|5|||
44215741|NCT01906489|79013579|FG001|Overall Study|Withdrawal by Subject|0|||
44215742|NCT01906489|79013578|FG000|Overall Study|Worsening of Anemia|1|||
44215743|NCT01906489|79013579|FG001|Overall Study|Worsening of Anemia|0|||
44456713|NCT00380692|79465099|FG001|Study Period II - Double Blind|Adverse Event|0|||
44456714|NCT00380692|79465098|FG000|Study Period II - Double Blind|Protocol Violation|2|||
44456715|NCT00380692|79465099|FG001|Study Period II - Double Blind|Protocol Violation|2|||
44456716|NCT00380692|79465098|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
44456717|NCT00380692|79465099|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
44456718|NCT00380692|79465098|FG000|Study Period II - Double Blind|Physician Decision|0|||
44456719|NCT00380692|79465099|FG001|Study Period II - Double Blind|Physician Decision|1|||
44456720|NCT00380692|79465098|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
44456721|NCT00380692|79465099|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
44456722|NCT00380692|79465098|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
44215744|NCT01906489|79013578|FG000|Overall Study|Protocol Violation|0|||
44215745|NCT01906489|79013579|FG001|Overall Study|Protocol Violation|1|||
44215746|NCT01906489|79013578|FG000|Overall Study|Non- Compliance|1|||
44215747|NCT01906489|79013579|FG001|Overall Study|Non- Compliance|0|||
44215748|NCT01906489|79013578|FG000|Overall Study|Sponsor Decision|1|||
44215749|NCT01906489|79013579|FG001|Overall Study|Sponsor Decision|0|||
44215750|NCT01906489|79013578|FG000|Overall Study|Lost to Follow-up|1|||
44215751|NCT01906489|79013579|FG001|Overall Study|Lost to Follow-up|1|||
44215752|NCT01906489|79013578|FG000|Overall Study|Other|1|||
44215753|NCT01906489|79013579|FG001|Overall Study|Other|0|||
44215754|NCT01517373|79013590|FG000|Run-in Period|Death|1|||
44215755|NCT01517373|79013591|FG001|Run-in Period|Death|0|||
44215756|NCT01517373|79013592|FG002|Run-in Period|Death|0|||
44215757|NCT01517373|79013593|FG003|Run-in Period|Death|0|||
44215758|NCT01517373|79013594|FG004|Run-in Period|Death|0|||
44215759|NCT01517373|79013595|FG005|Run-in Period|Death|0|||
44215760|NCT01517373|79013590|FG000|Run-in Period|Adverse Event|5|||
44215761|NCT01517373|79013591|FG001|Run-in Period|Adverse Event|0|||
44215762|NCT01517373|79013592|FG002|Run-in Period|Adverse Event|0|||
44215763|NCT01517373|79013593|FG003|Run-in Period|Adverse Event|0|||
44372031|NCT01371981|79377052|FG003|Overall Study|Ineligible|0|||
44372032|NCT01371981|79377053|FG004|Overall Study|Ineligible|0|||
44372033|NCT01371981|79377054|FG005|Overall Study|Ineligible|4|||
44372034|NCT01371981|79377049|FG000|Overall Study|Did not start treatment|2|||
44372035|NCT01371981|79377050|FG001|Overall Study|Did not start treatment|3|||
44372036|NCT01371981|79377051|FG002|Overall Study|Did not start treatment|0|||
44372037|NCT01371981|79377052|FG003|Overall Study|Did not start treatment|0|||
44372038|NCT01371981|79377053|FG004|Overall Study|Did not start treatment|0|||
44372039|NCT01371981|79377054|FG005|Overall Study|Did not start treatment|2|||
44372040|NCT01274338|79377079|FG000|Overall Study|Lack of Efficacy|72|||
44372041|NCT01274338|79377080|FG001|Overall Study|Lack of Efficacy|108|||
44372042|NCT01274338|79377081|FG002|Overall Study|Lack of Efficacy|116|||
44215764|NCT01517373|79013594|FG004|Run-in Period|Adverse Event|0|||
44215765|NCT01517373|79013595|FG005|Run-in Period|Adverse Event|0|||
44215766|NCT01517373|79013590|FG000|Run-in Period|Did not meet eligibility criteria|34|||
44215767|NCT01517373|79013591|FG001|Run-in Period|Did not meet eligibility criteria|0|||
44215768|NCT01517373|79013592|FG002|Run-in Period|Did not meet eligibility criteria|0|||
44215769|NCT01517373|79013593|FG003|Run-in Period|Did not meet eligibility criteria|0|||
44215770|NCT01517373|79013594|FG004|Run-in Period|Did not meet eligibility criteria|0|||
44215771|NCT01517373|79013595|FG005|Run-in Period|Did not meet eligibility criteria|0|||
44215772|NCT01517373|79013590|FG000|Run-in Period|Lost to Follow-up|1|||
44372043|NCT01274338|79377082|FG003|Overall Study|Lack of Efficacy|0|||
44372044|NCT01274338|79377083|FG004|Overall Study|Lack of Efficacy|0|||
44456723|NCT00380692|79465099|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
44456724|NCT00380692|79465098|FG000|Study Period III - Open Label|Adverse Event|5|||
44456725|NCT00380692|79465099|FG001|Study Period III - Open Label|Adverse Event|3|||
44456726|NCT00380692|79465098|FG000|Study Period III - Open Label|Protocol Violation|0|||
44456727|NCT00380692|79465099|FG001|Study Period III - Open Label|Protocol Violation|0|||
44456728|NCT00380692|79465098|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
44456729|NCT00380692|79465099|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
44456730|NCT00380692|79465098|FG000|Study Period III - Open Label|Physician Decision|0|||
44456731|NCT00380692|79465099|FG001|Study Period III - Open Label|Physician Decision|3|||
44456732|NCT00380692|79465098|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
44456733|NCT00380692|79465099|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
44456734|NCT00380692|79465098|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
44456735|NCT00380692|79465099|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
44456736|NCT00536874|79465105|FG000|Overall Study|Adverse Event|1|||
44456737|NCT00536874|79465105|FG000|Overall Study|Death|2|||
44456738|NCT00536874|79465105|FG000|Overall Study|Withdrawal by Subject|1|||
44456739|NCT00380068|79465109|FG000|Overall Study|Adverse Event|40|||
44456740|NCT00380068|79465109|FG000|Overall Study|Withdrawal by Subject|10|||
44456741|NCT00380068|79465109|FG000|Overall Study|Not compliant|6|||
44456742|NCT00380068|79465109|FG000|Overall Study|Lost to Follow-up|1|||
44456743|NCT00380068|79465109|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
44456744|NCT00380068|79465109|FG000|Overall Study|Lung transplant|3|||
44456745|NCT00380068|79465109|FG000|Overall Study|Physician Decision|2|||
44456746|NCT00380068|79465109|FG000|Overall Study|Partipant moved away|1|||
44456747|NCT00380068|79465109|FG000|Overall Study|Lack of Efficacy|5|||
44456748|NCT00536484|79465115|FG000|Overall Study|Adverse Event|21|||
44456749|NCT00536484|79465116|FG001|Overall Study|Adverse Event|34|||
44456750|NCT00536484|79465115|FG000|Overall Study|Withdrawal by Subject|11|||
44456751|NCT00536484|79465116|FG001|Overall Study|Withdrawal by Subject|11|||
44456752|NCT00536484|79465115|FG000|Overall Study|Lost to Follow-up|8|||
44456753|NCT00536484|79465116|FG001|Overall Study|Lost to Follow-up|6|||
44456754|NCT00536484|79465115|FG000|Overall Study|Lack of Efficacy|16|||
44456755|NCT00536484|79465116|FG001|Overall Study|Lack of Efficacy|5|||
44456756|NCT00536484|79465115|FG000|Overall Study|Other|4|||
44456757|NCT00536484|79465116|FG001|Overall Study|Other|0|||
44456758|NCT00370396|79465125|FG000|Overall Study|Withdrawal by Subject|0|||
44456759|NCT00370396|79465126|FG001|Overall Study|Withdrawal by Subject|0|||
44456760|NCT00370396|79465127|FG002|Overall Study|Withdrawal by Subject|1|||
44456761|NCT00370396|79465125|FG000|Overall Study|Lost to Follow-up|11|||
44456762|NCT00370396|79465126|FG001|Overall Study|Lost to Follow-up|1|||
44456763|NCT00370396|79465127|FG002|Overall Study|Lost to Follow-up|0|||
44456764|NCT00455013|79465138|FG000|Short Term Period|Adverse Event|2|||
44456765|NCT00455013|79465139|FG001|Short Term Period|Adverse Event|5|||
44456766|NCT00455013|79465140|FG002|Short Term Period|Adverse Event|0|||
44456767|NCT00455013|79465138|FG000|Short Term Period|Withdrawal by Subject|0|||
44456768|NCT00455013|79465139|FG001|Short Term Period|Withdrawal by Subject|0|||
44456769|NCT00455013|79465140|FG002|Short Term Period|Withdrawal by Subject|1|||
44456770|NCT00455013|79465138|FG000|Short Term Period|Lack of Efficacy|4|||
44456771|NCT00455013|79465139|FG001|Short Term Period|Lack of Efficacy|0|||
44456772|NCT00455013|79465140|FG002|Short Term Period|Lack of Efficacy|0|||
44456773|NCT00455013|79465138|FG000|Short Term Period|Other|0|||
44456774|NCT00455013|79465139|FG001|Short Term Period|Other|0|||
44456775|NCT00455013|79465140|FG002|Short Term Period|Other|1|||
44456776|NCT00455013|79465138|FG000|Long Term Extension (LTE)|Adverse Event|0|||
44456777|NCT00455013|79465139|FG001|Long Term Extension (LTE)|Adverse Event|1|||
44456778|NCT00455013|79465140|FG002|Long Term Extension (LTE)|Adverse Event|1|||
44456779|NCT00455013|79465138|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
44456780|NCT00455013|79465139|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
44456781|NCT00455013|79465140|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
44456782|NCT00455013|79465138|FG000|Long Term Extension (LTE)|Death|1|||
44456783|NCT00455013|79465139|FG001|Long Term Extension (LTE)|Death|1|||
44456784|NCT00455013|79465140|FG002|Long Term Extension (LTE)|Death|0|||
44456785|NCT00455013|79465138|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
44456786|NCT00455013|79465139|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
44215773|NCT01517373|79013591|FG001|Run-in Period|Lost to Follow-up|0|||
44456787|NCT00455013|79465140|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
44456788|NCT00455013|79465138|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
44456789|NCT00455013|79465139|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
44456790|NCT00455013|79465140|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
44456791|NCT00455013|79465138|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
44215774|NCT01517373|79013592|FG002|Run-in Period|Lost to Follow-up|0|||
44456792|NCT00455013|79465139|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
44456793|NCT00455013|79465140|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
44456794|NCT00455013|79465138|FG000|Long Term Extension (LTE)|non-specified|0|||
44456795|NCT00455013|79465139|FG001|Long Term Extension (LTE)|non-specified|0|||
44456796|NCT00455013|79465140|FG002|Long Term Extension (LTE)|non-specified|1|||
44456797|NCT00363298|79465150|FG000|First Study Week|Lack of Efficacy|6|||
44456798|NCT00363298|79465151|FG001|First Study Week|Lack of Efficacy|5|||
44456799|NCT00363298|79465150|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
44456800|NCT00363298|79465151|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
44456801|NCT00363142|79465160|FG000|Overall Study|Adverse Event|2|||
44456802|NCT00363142|79465161|FG001|Overall Study|Adverse Event|0|||
44456803|NCT00363142|79465160|FG000|Overall Study|Lack of Efficacy|0|||
44456804|NCT00363142|79465161|FG001|Overall Study|Lack of Efficacy|1|||
44456805|NCT00363142|79465160|FG000|Overall Study|Lost to Follow-up|1|||
44456806|NCT00363142|79465161|FG001|Overall Study|Lost to Follow-up|0|||
44456807|NCT00363142|79465160|FG000|Overall Study|Non-compliance|1|||
44456808|NCT00363142|79465161|FG001|Overall Study|Non-compliance|1|||
44456809|NCT00363142|79465160|FG000|Overall Study|Withdrawal by Subject|3|||
44456810|NCT00363142|79465161|FG001|Overall Study|Withdrawal by Subject|1|||
44456811|NCT00454857|79465170|FG000|Overall Study|Withdrawal by Subject|15|||
44456812|NCT00454857|79465170|FG000|Overall Study|Lost to Follow-up|16|||
44456813|NCT00454857|79465170|FG000|Overall Study|Noncompliance|6|||
44456814|NCT00454857|79465170|FG000|Overall Study|Death|5|||
44456815|NCT00454857|79465170|FG000|Overall Study|Other|11|||
44456816|NCT00454857|79465170|FG000|Overall Study|Reason unknown|1|||
44456817|NCT00379912|79465176|FG000|Overall Study|Lack of Efficacy|1|||
44456818|NCT00379912|79465177|FG001|Overall Study|Lack of Efficacy|0|||
44456819|NCT00379834|79465189|FG000|Overall Study|Time constraints|2|||
44456820|NCT00379210|79465195|FG000|Overall Study|Withdrawal by Subject|10|||
44456821|NCT00379210|79465196|FG001|Overall Study|Withdrawal by Subject|7|||
44456822|NCT00378898|79465204|FG000|Overall Study|Withdrawal by Subject|10|||
44456823|NCT00378898|79465205|FG001|Overall Study|Withdrawal by Subject|5|||
44456824|NCT00378898|79465204|FG000|Overall Study|Protocol Violation|1|||
44456825|NCT00378898|79465205|FG001|Overall Study|Protocol Violation|1|||
44456826|NCT00378508|79465215|FG000|Overall Study|Withdrawal by Subject|1|||
44456827|NCT00378508|79465216|FG001|Overall Study|Withdrawal by Subject|3|||
44456828|NCT00378508|79465215|FG000|Overall Study|Lost to Follow-up|1|||
44456829|NCT00378508|79465216|FG001|Overall Study|Lost to Follow-up|0|||
44456830|NCT00454779|79465225|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
44456831|NCT00454779|79465226|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
44456832|NCT00454779|79465225|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
44456833|NCT00454779|79465226|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
44456834|NCT00454779|79465225|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
44456835|NCT00454779|79465226|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
44456836|NCT00454779|79465225|FG000|First-line Treatment Phase|Protocol Violation|0|||
44456837|NCT00454779|79465226|FG001|First-line Treatment Phase|Protocol Violation|1|||
44456838|NCT00454779|79465225|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
44456839|NCT00454779|79465226|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
44456840|NCT00454779|79465225|FG000|First-line Treatment Phase|Ongoing|1|||
44456841|NCT00454779|79465226|FG001|First-line Treatment Phase|Ongoing|0|||
44456842|NCT00454779|79465225|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
44456843|NCT00454779|79465226|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
44456844|NCT00454779|79465225|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
44456845|NCT00454779|79465226|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
44456846|NCT00454779|79465225|FG000|Second-line Treatment Phase|Ongoing|0|||
44456847|NCT00454779|79465226|FG001|Second-line Treatment Phase|Ongoing|1|||
44456848|NCT00439569|79465236|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
44456849|NCT00439569|79465236|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
44456850|NCT00439569|79465236|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
44456851|NCT00443079|79465242|FG000|Overall Study|Lost to Follow-up|0|||
44456852|NCT00443079|79465243|FG001|Overall Study|Lost to Follow-up|1|||
44456853|NCT00427635|79465279|FG000|Treatment Phase|Withdrawal by Subject|1|||
44456854|NCT00427635|79465280|FG001|Treatment Phase|Withdrawal by Subject|0|||
44456855|NCT00427635|79465279|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
44456856|NCT00427635|79465280|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
44215775|NCT01517373|79013593|FG003|Run-in Period|Lost to Follow-up|0|||
44215776|NCT01517373|79013594|FG004|Run-in Period|Lost to Follow-up|0|||
44215777|NCT01517373|79013595|FG005|Run-in Period|Lost to Follow-up|0|||
44215778|NCT01517373|79013590|FG000|Run-in Period|Withdrawal by Subject|12|||
44456857|NCT00427011|79465286|FG000|Overall Study|Adverse Event|10|||
44456858|NCT00427011|79465286|FG000|Overall Study|Withdrawal by Subject|1|||
44456859|NCT00427011|79465286|FG000|Overall Study|Lack of Efficacy|2|||
44456860|NCT00427011|79465286|FG000|Overall Study|Other|12|||
44456861|NCT03891264|79465291|FG000|Overall Study|Adverse Event|1|||
44456862|NCT03891264|79465291|FG000|Overall Study|Withdrawal by Subject|2|||
44456863|NCT03891264|79465291|FG000|Overall Study|Physician Decision|2|||
44456864|NCT00439179|79465299|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
44215779|NCT01517373|79013591|FG001|Run-in Period|Withdrawal by Subject|0|||
44215780|NCT01517373|79013592|FG002|Run-in Period|Withdrawal by Subject|0|||
44456865|NCT00439179|79465300|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
44456866|NCT00439179|79465301|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
44215781|NCT01517373|79013593|FG003|Run-in Period|Withdrawal by Subject|0|||
44215782|NCT01517373|79013594|FG004|Run-in Period|Withdrawal by Subject|0|||
44215783|NCT01517373|79013595|FG005|Run-in Period|Withdrawal by Subject|0|||
44215784|NCT01517373|79013590|FG000|Run-in Period|Sponsor Decision|3|||
44456867|NCT00439179|79465302|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
44456868|NCT00438633|79465317|FG000|Overall Study|Withdrawal by Subject|1|||
44456869|NCT00438633|79465318|FG001|Overall Study|Withdrawal by Subject|0|||
44456870|NCT00438633|79465317|FG000|Overall Study|Lost to Follow-up|15|||
44456871|NCT00438633|79465318|FG001|Overall Study|Lost to Follow-up|17|||
44456872|NCT00438399|79465327|FG000|Overall Study|Lost to Follow-up|2|||
44456873|NCT00438399|79465328|FG001|Overall Study|Lost to Follow-up|2|||
44456874|NCT00438399|79465329|FG002|Overall Study|Lost to Follow-up|1|||
44456875|NCT00438399|79465330|FG003|Overall Study|Lost to Follow-up|1|||
44456876|NCT00438399|79465331|FG004|Overall Study|Lost to Follow-up|1|||
44456877|NCT00438399|79465332|FG005|Overall Study|Lost to Follow-up|1|||
44456878|NCT00438399|79465327|FG000|Overall Study|Adverse Event|0|||
44456879|NCT00438399|79465328|FG001|Overall Study|Adverse Event|0|||
44456880|NCT00438399|79465329|FG002|Overall Study|Adverse Event|1|||
44456881|NCT00438399|79465330|FG003|Overall Study|Adverse Event|1|||
44456882|NCT00438399|79465331|FG004|Overall Study|Adverse Event|0|||
44456883|NCT00438399|79465332|FG005|Overall Study|Adverse Event|1|||
44456884|NCT00438399|79465327|FG000|Overall Study|Withdrawal by Subject|5|||
44456885|NCT00438399|79465328|FG001|Overall Study|Withdrawal by Subject|6|||
44456886|NCT00438399|79465329|FG002|Overall Study|Withdrawal by Subject|3|||
44456887|NCT00438399|79465330|FG003|Overall Study|Withdrawal by Subject|2|||
44456888|NCT00438399|79465331|FG004|Overall Study|Withdrawal by Subject|2|||
44456889|NCT00438399|79465332|FG005|Overall Study|Withdrawal by Subject|2|||
44456890|NCT00438399|79465327|FG000|Overall Study|Protocol Violation|0|||
44456891|NCT00438399|79465328|FG001|Overall Study|Protocol Violation|0|||
44456892|NCT00438399|79465329|FG002|Overall Study|Protocol Violation|1|||
44456893|NCT00438399|79465330|FG003|Overall Study|Protocol Violation|0|||
44456894|NCT00438399|79465331|FG004|Overall Study|Protocol Violation|0|||
44456895|NCT00438399|79465332|FG005|Overall Study|Protocol Violation|1|||
44456896|NCT00438399|79465327|FG000|Overall Study|Subje stopped study|0|||
44456897|NCT00438399|79465328|FG001|Overall Study|Subje stopped study|0|||
44456898|NCT00438399|79465329|FG002|Overall Study|Subje stopped study|1|||
44456899|NCT00438399|79465330|FG003|Overall Study|Subje stopped study|0|||
44456900|NCT00438399|79465331|FG004|Overall Study|Subje stopped study|0|||
44456901|NCT00438399|79465332|FG005|Overall Study|Subje stopped study|0|||
44456902|NCT00438399|79465327|FG000|Overall Study|Pregnancy|0|||
44456903|NCT00438399|79465328|FG001|Overall Study|Pregnancy|0|||
44456904|NCT00438399|79465329|FG002|Overall Study|Pregnancy|0|||
44456905|NCT00438399|79465330|FG003|Overall Study|Pregnancy|0|||
44456906|NCT00438399|79465331|FG004|Overall Study|Pregnancy|0|||
44456907|NCT00438399|79465332|FG005|Overall Study|Pregnancy|1|||
44456908|NCT00438399|79465327|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
44456909|NCT00438399|79465328|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
44456910|NCT00438399|79465329|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
44456911|NCT00438399|79465330|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
44456912|NCT00438399|79465331|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
44456913|NCT00438399|79465332|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
44456914|NCT00426231|79465343|FG000|Overall Study|Withdrawal by Subject|9|||
44456915|NCT00426231|79465344|FG001|Overall Study|Withdrawal by Subject|12|||
44456916|NCT00425607|79465350|FG000|Overall Study|Death|1|||
44456917|NCT00425607|79465350|FG000|Overall Study|Withdrawal by Subject|1|||
44456918|NCT00437073|79465356|FG000|Overall Study|Sponsor Terminated Study|1|||
44456919|NCT00437073|79465357|FG001|Overall Study|Sponsor Terminated Study|0|||
44456920|NCT00437073|79465356|FG000|Overall Study|Physician Decision|0|||
44456921|NCT00437073|79465357|FG001|Overall Study|Physician Decision|1|||
44456922|NCT00425373|79465372|FG000|Overall Study|Adverse Event|2|||
44456923|NCT00425373|79465373|FG001|Overall Study|Adverse Event|2|||
44456924|NCT00425373|79465374|FG002|Overall Study|Adverse Event|0|||
44456925|NCT00425373|79465375|FG003|Overall Study|Adverse Event|1|||
44456926|NCT00425373|79465376|FG004|Overall Study|Adverse Event|4|||
44456927|NCT00425373|79465377|FG005|Overall Study|Adverse Event|6|||
44456928|NCT00425373|79465378|FG006|Overall Study|Adverse Event|2|||
44215785|NCT01517373|79013591|FG001|Run-in Period|Sponsor Decision|0|||
44215786|NCT01517373|79013592|FG002|Run-in Period|Sponsor Decision|0|||
44215787|NCT01517373|79013593|FG003|Run-in Period|Sponsor Decision|0|||
44456929|NCT00425373|79465379|FG007|Overall Study|Adverse Event|3|||
44456930|NCT00425373|79465380|FG008|Overall Study|Adverse Event|8|||
44456931|NCT00425373|79465372|FG000|Overall Study|Lost to Follow-up|0|||
44456932|NCT00425373|79465373|FG001|Overall Study|Lost to Follow-up|1|||
44456933|NCT00425373|79465374|FG002|Overall Study|Lost to Follow-up|0|||
44456934|NCT00425373|79465375|FG003|Overall Study|Lost to Follow-up|0|||
44456935|NCT00425373|79465376|FG004|Overall Study|Lost to Follow-up|1|||
44456936|NCT00425373|79465377|FG005|Overall Study|Lost to Follow-up|0|||
44456937|NCT00425373|79465378|FG006|Overall Study|Lost to Follow-up|0|||
44456938|NCT00425373|79465379|FG007|Overall Study|Lost to Follow-up|0|||
44456939|NCT00425373|79465380|FG008|Overall Study|Lost to Follow-up|0|||
44456940|NCT00425373|79465372|FG000|Overall Study|Protocol Violation|1|||
44456941|NCT00425373|79465373|FG001|Overall Study|Protocol Violation|0|||
44456942|NCT00425373|79465374|FG002|Overall Study|Protocol Violation|1|||
44456943|NCT00425373|79465375|FG003|Overall Study|Protocol Violation|0|||
44456944|NCT00425373|79465376|FG004|Overall Study|Protocol Violation|0|||
44456945|NCT00425373|79465377|FG005|Overall Study|Protocol Violation|0|||
44456946|NCT00425373|79465378|FG006|Overall Study|Protocol Violation|0|||
44456947|NCT00425373|79465379|FG007|Overall Study|Protocol Violation|5|||
44456948|NCT00425373|79465380|FG008|Overall Study|Protocol Violation|3|||
44456949|NCT00425373|79465372|FG000|Overall Study|Withdrawal by Subject|2|||
44456950|NCT00425373|79465373|FG001|Overall Study|Withdrawal by Subject|0|||
44456951|NCT00425373|79465374|FG002|Overall Study|Withdrawal by Subject|2|||
44456952|NCT00425373|79465375|FG003|Overall Study|Withdrawal by Subject|1|||
44456953|NCT00425373|79465376|FG004|Overall Study|Withdrawal by Subject|4|||
44456954|NCT00425373|79465377|FG005|Overall Study|Withdrawal by Subject|0|||
44456955|NCT00425373|79465378|FG006|Overall Study|Withdrawal by Subject|2|||
44456956|NCT00425373|79465379|FG007|Overall Study|Withdrawal by Subject|2|||
44456957|NCT00425373|79465380|FG008|Overall Study|Withdrawal by Subject|2|||
44456958|NCT00425373|79465372|FG000|Overall Study|Lack of Efficacy|0|||
44456959|NCT00425373|79465373|FG001|Overall Study|Lack of Efficacy|0|||
44456960|NCT00425373|79465374|FG002|Overall Study|Lack of Efficacy|0|||
44456961|NCT00425373|79465375|FG003|Overall Study|Lack of Efficacy|0|||
44456962|NCT00425373|79465376|FG004|Overall Study|Lack of Efficacy|1|||
44456963|NCT00425373|79465377|FG005|Overall Study|Lack of Efficacy|3|||
44456964|NCT00425373|79465378|FG006|Overall Study|Lack of Efficacy|3|||
44456965|NCT00425373|79465379|FG007|Overall Study|Lack of Efficacy|0|||
44456966|NCT00425373|79465380|FG008|Overall Study|Lack of Efficacy|5|||
44456967|NCT03894540|79465406|FG000|Overall Study|Adverse Event|0|||
44456968|NCT03894540|79465407|FG001|Overall Study|Adverse Event|0|||
44456969|NCT03894540|79465408|FG002|Overall Study|Adverse Event|0|||
44456970|NCT03894540|79465409|FG003|Overall Study|Adverse Event|0|||
44456971|NCT03894540|79465410|FG004|Overall Study|Adverse Event|1|||
44456972|NCT03894540|79465411|FG005|Overall Study|Adverse Event|0|||
44456973|NCT03894540|79465406|FG000|Overall Study|Withdrawal by Subject|0|||
44456974|NCT03894540|79465407|FG001|Overall Study|Withdrawal by Subject|0|||
44215788|NCT01517373|79013594|FG004|Run-in Period|Sponsor Decision|0|||
44215789|NCT01517373|79013595|FG005|Run-in Period|Sponsor Decision|0|||
44215790|NCT01517373|79013590|FG000|Run-in Period|Other|1|||
44215791|NCT01517373|79013591|FG001|Run-in Period|Other|0|||
44215792|NCT01517373|79013592|FG002|Run-in Period|Other|0|||
44215793|NCT01517373|79013593|FG003|Run-in Period|Other|0|||
44215794|NCT01517373|79013594|FG004|Run-in Period|Other|0|||
44215795|NCT01517373|79013595|FG005|Run-in Period|Other|0|||
44215796|NCT01517373|79013590|FG000|Treatment Period|Adverse Event|0|||
44215797|NCT01517373|79013591|FG001|Treatment Period|Adverse Event|0|||
44215798|NCT01517373|79013592|FG002|Treatment Period|Adverse Event|0|||
44215799|NCT01517373|79013593|FG003|Treatment Period|Adverse Event|0|||
44270150|NCT02326272|79195779|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270151|NCT02326272|79195780|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44372045|NCT01274338|79377084|FG005|Overall Study|Lack of Efficacy|0|||
44372046|NCT01274338|79377079|FG000|Overall Study|Adverse Event|272|||
44372047|NCT01274338|79377080|FG001|Overall Study|Adverse Event|105|||
44372048|NCT01274338|79377081|FG002|Overall Study|Adverse Event|180|||
44372049|NCT01274338|79377082|FG003|Overall Study|Adverse Event|1|||
44372050|NCT01274338|79377083|FG004|Overall Study|Adverse Event|0|||
44372051|NCT01274338|79377084|FG005|Overall Study|Adverse Event|0|||
44372052|NCT01274338|79377079|FG000|Overall Study|Death|8|||
44372053|NCT01274338|79377080|FG001|Overall Study|Death|1|||
44372054|NCT01274338|79377081|FG002|Overall Study|Death|0|||
44372055|NCT01274338|79377082|FG003|Overall Study|Death|0|||
44372056|NCT01274338|79377083|FG004|Overall Study|Death|0|||
44456975|NCT03894540|79465408|FG002|Overall Study|Withdrawal by Subject|0|||
44456976|NCT03894540|79465409|FG003|Overall Study|Withdrawal by Subject|0|||
44456977|NCT03894540|79465410|FG004|Overall Study|Withdrawal by Subject|1|||
44456978|NCT03894540|79465411|FG005|Overall Study|Withdrawal by Subject|0|||
44456979|NCT03894540|79465406|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
44456980|NCT03894540|79465407|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
44456981|NCT03894540|79465408|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
44372057|NCT01274338|79377084|FG005|Overall Study|Death|0|||
44456982|NCT03894540|79465409|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
44456983|NCT03894540|79465410|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
44456984|NCT03894540|79465411|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
44215800|NCT01517373|79013594|FG004|Treatment Period|Adverse Event|0|||
44215801|NCT01517373|79013595|FG005|Treatment Period|Adverse Event|2|||
44215802|NCT01517373|79013590|FG000|Treatment Period|Lost to Follow-up|0|||
44456985|NCT03894540|79465406|FG000|Overall Study|Progressive Disease Clinical|1|||
44456986|NCT03894540|79465407|FG001|Overall Study|Progressive Disease Clinical|1|||
44456987|NCT03894540|79465408|FG002|Overall Study|Progressive Disease Clinical|0|||
44456988|NCT03894540|79465409|FG003|Overall Study|Progressive Disease Clinical|1|||
44456989|NCT03894540|79465410|FG004|Overall Study|Progressive Disease Clinical|5|||
44456990|NCT03894540|79465411|FG005|Overall Study|Progressive Disease Clinical|1|||
44456991|NCT03894540|79465406|FG000|Overall Study|Study termination by sponsor|0|||
44456992|NCT03894540|79465407|FG001|Overall Study|Study termination by sponsor|0|||
44456993|NCT03894540|79465408|FG002|Overall Study|Study termination by sponsor|0|||
44456994|NCT03894540|79465409|FG003|Overall Study|Study termination by sponsor|0|||
44456995|NCT03894540|79465410|FG004|Overall Study|Study termination by sponsor|2|||
44456996|NCT03894540|79465411|FG005|Overall Study|Study termination by sponsor|0|||
44456997|NCT00535626|79465429|FG000|Overall Study|Death|15|||
44456998|NCT00535626|79465429|FG000|Overall Study|Lost to Follow-up|29|||
44456999|NCT00535626|79465429|FG000|Overall Study|Withdrawal by Subject|20|||
44457000|NCT00535626|79465429|FG000|Overall Study|Removal/revision of study component|8|||
44457001|NCT00535626|79465429|FG000|Overall Study|Subject terminated|31|||
44457002|NCT00535626|79465429|FG000|Overall Study|Unable to return|2|||
44457003|NCT03889704|79465452|FG000|Overall Study|Study terminated due to pandemic|1|||
44457004|NCT03887442|79465458|FG000|Overall Study|Adverse Event|1|||
44457005|NCT03887442|79465459|FG001|Overall Study|Adverse Event|0|||
44457006|NCT00425061|79465474|FG000|Overall Study|Adverse Event|1|||
44457007|NCT00425061|79465475|FG001|Overall Study|Adverse Event|0|||
44457008|NCT00425061|79465476|FG002|Overall Study|Adverse Event|0|||
44457009|NCT00425061|79465477|FG003|Overall Study|Adverse Event|2|||
44457010|NCT00425061|79465478|FG004|Overall Study|Adverse Event|2|||
44457011|NCT00425061|79465479|FG005|Overall Study|Adverse Event|0|||
44457012|NCT00425061|79465480|FG006|Overall Study|Adverse Event|0|||
44457013|NCT00425061|79465474|FG000|Overall Study|Lost to Follow-up|0|||
44457014|NCT00425061|79465475|FG001|Overall Study|Lost to Follow-up|1|||
44457015|NCT00425061|79465476|FG002|Overall Study|Lost to Follow-up|0|||
44457016|NCT00425061|79465477|FG003|Overall Study|Lost to Follow-up|0|||
44457017|NCT00425061|79465478|FG004|Overall Study|Lost to Follow-up|0|||
44457018|NCT00425061|79465479|FG005|Overall Study|Lost to Follow-up|0|||
44457019|NCT00425061|79465480|FG006|Overall Study|Lost to Follow-up|0|||
44457020|NCT00425061|79465474|FG000|Overall Study|Protocol Violation|1|||
44457021|NCT00425061|79465475|FG001|Overall Study|Protocol Violation|0|||
44457022|NCT00425061|79465476|FG002|Overall Study|Protocol Violation|0|||
44457023|NCT00425061|79465477|FG003|Overall Study|Protocol Violation|0|||
44457024|NCT00425061|79465478|FG004|Overall Study|Protocol Violation|0|||
44457025|NCT00425061|79465479|FG005|Overall Study|Protocol Violation|0|||
44457026|NCT00425061|79465480|FG006|Overall Study|Protocol Violation|0|||
44457027|NCT00425061|79465474|FG000|Overall Study|Withdrawal by Subject|0|||
44215803|NCT01517373|79013591|FG001|Treatment Period|Lost to Follow-up|0|||
44457028|NCT00425061|79465475|FG001|Overall Study|Withdrawal by Subject|1|||
44457029|NCT00425061|79465476|FG002|Overall Study|Withdrawal by Subject|0|||
44457030|NCT00425061|79465477|FG003|Overall Study|Withdrawal by Subject|0|||
44457031|NCT00425061|79465478|FG004|Overall Study|Withdrawal by Subject|1|||
44457032|NCT00425061|79465479|FG005|Overall Study|Withdrawal by Subject|0|||
44215804|NCT01517373|79013592|FG002|Treatment Period|Lost to Follow-up|1|||
44215805|NCT01517373|79013593|FG003|Treatment Period|Lost to Follow-up|1|||
44215806|NCT01517373|79013594|FG004|Treatment Period|Lost to Follow-up|0|||
44215807|NCT01517373|79013595|FG005|Treatment Period|Lost to Follow-up|0|||
44215808|NCT01517373|79013590|FG000|Treatment Period|Withdrawal by Subject|0|||
44215809|NCT01517373|79013591|FG001|Treatment Period|Withdrawal by Subject|3|||
44215810|NCT01517373|79013592|FG002|Treatment Period|Withdrawal by Subject|2|||
44215811|NCT01517373|79013593|FG003|Treatment Period|Withdrawal by Subject|2|||
44215812|NCT01517373|79013594|FG004|Treatment Period|Withdrawal by Subject|2|||
44457033|NCT00425061|79465480|FG006|Overall Study|Withdrawal by Subject|3|||
44457034|NCT00425061|79465474|FG000|Overall Study|Sponsor's request|0|||
44457035|NCT00425061|79465475|FG001|Overall Study|Sponsor's request|0|||
44457036|NCT00425061|79465476|FG002|Overall Study|Sponsor's request|0|||
44457037|NCT00425061|79465477|FG003|Overall Study|Sponsor's request|0|||
44457038|NCT00425061|79465478|FG004|Overall Study|Sponsor's request|19|||
44457039|NCT00425061|79465479|FG005|Overall Study|Sponsor's request|4|||
44457040|NCT00425061|79465480|FG006|Overall Study|Sponsor's request|15|||
44457041|NCT00425061|79465474|FG000|Overall Study|Physician Decision|0|||
44215813|NCT01517373|79013595|FG005|Treatment Period|Withdrawal by Subject|3|||
44215814|NCT01517373|79013590|FG000|Treatment Period|Other|0|||
44457042|NCT00425061|79465475|FG001|Overall Study|Physician Decision|0|||
44457043|NCT00425061|79465476|FG002|Overall Study|Physician Decision|0|||
44457044|NCT00425061|79465477|FG003|Overall Study|Physician Decision|0|||
44457045|NCT00425061|79465478|FG004|Overall Study|Physician Decision|1|||
44215815|NCT01517373|79013591|FG001|Treatment Period|Other|0|||
44457046|NCT00425061|79465479|FG005|Overall Study|Physician Decision|0|||
44457047|NCT00425061|79465480|FG006|Overall Study|Physician Decision|0|||
44215816|NCT01517373|79013592|FG002|Treatment Period|Other|0|||
44215817|NCT01517373|79013593|FG003|Treatment Period|Other|0|||
44457048|NCT00425061|79465474|FG000|Overall Study|Other|0|||
44457049|NCT00425061|79465475|FG001|Overall Study|Other|0|||
44457050|NCT00425061|79465476|FG002|Overall Study|Other|0|||
44457051|NCT00425061|79465477|FG003|Overall Study|Other|0|||
44457052|NCT00425061|79465478|FG004|Overall Study|Other|3|||
44457053|NCT00425061|79465479|FG005|Overall Study|Other|0|||
44457054|NCT00425061|79465480|FG006|Overall Study|Other|1|||
44457055|NCT00424827|79465498|FG000|Overall Study|Adverse Event|1|||
44457056|NCT03885726|79465503|FG000|Overall Study|Staffing issues/lost interest|1|||
44457057|NCT03885726|79465503|FG000|Overall Study|Early discharge from hospital|3|||
44457058|NCT00377962|79465513|FG000|Core Study: 0-12 Months|Adverse Event|18|||
44457059|NCT00377962|79465514|FG001|Core Study: 0-12 Months|Adverse Event|2|||
44457060|NCT00377962|79465513|FG000|Core Study: 0-12 Months|Death|3|||
44457061|NCT00377962|79465514|FG001|Core Study: 0-12 Months|Death|0|||
44457062|NCT00377962|79465513|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
44457063|NCT00377962|79465514|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
44457064|NCT00377962|79465513|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
44457065|NCT00377962|79465514|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
44457066|NCT00377962|79465513|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
44457067|NCT00377962|79465514|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
44457068|NCT00377962|79465513|FG000|Extension Study: 12-24 Months|Death|1|||
44457069|NCT00377962|79465514|FG001|Extension Study: 12-24 Months|Death|1|||
44457070|NCT00377962|79465513|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
44457071|NCT00377962|79465514|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
44457072|NCT00377962|79465513|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
44215818|NCT01517373|79013594|FG004|Treatment Period|Other|1|||
44215819|NCT01517373|79013595|FG005|Treatment Period|Other|0|||
44457073|NCT00377962|79465514|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
44457074|NCT00377962|79465513|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
44457075|NCT00377962|79465514|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
44457076|NCT00424749|79465526|FG000|Overall Study|Withdrawal by Subject|1|||
44457077|NCT00424593|79465532|FG000|Acute Double-Blind Period|Adverse Event|16|||
44457078|NCT00424593|79465533|FG001|Acute Double-Blind Period|Adverse Event|7|||
44457079|NCT00424593|79465532|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
44457080|NCT00424593|79465533|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
44457081|NCT00424593|79465532|FG000|Acute Double-Blind Period|Protocol Violation|2|||
44457082|NCT00424593|79465533|FG001|Acute Double-Blind Period|Protocol Violation|2|||
44457083|NCT00424593|79465532|FG000|Acute Double-Blind Period|Physician Decision|1|||
44457084|NCT00424593|79465533|FG001|Acute Double-Blind Period|Physician Decision|2|||
44457085|NCT00424593|79465532|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
44457086|NCT00424593|79465533|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
44457087|NCT00424593|79465532|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
44457088|NCT00424593|79465533|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
44457089|NCT00424593|79465532|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
44457090|NCT00424593|79465533|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
44457091|NCT00424593|79465532|FG000|Dose-Blind Extension Period|Adverse Event|18|||
44457092|NCT00424593|79465533|FG001|Dose-Blind Extension Period|Adverse Event|0|||
44457093|NCT00424593|79465532|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
44457094|NCT00424593|79465533|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
44457095|NCT00424593|79465532|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
44457096|NCT00424593|79465533|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
44457097|NCT00424593|79465532|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
44457098|NCT00424593|79465533|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
44457099|NCT00424593|79465532|FG000|Dose-Blind Extension Period|Physician Decision|3|||
44457100|NCT00424593|79465533|FG001|Dose-Blind Extension Period|Physician Decision|0|||
44457101|NCT00369382|79465541|FG000|Overall Study|Death|0|||
44457102|NCT00369382|79465542|FG001|Overall Study|Death|2|||
44457103|NCT00369382|79465541|FG000|Overall Study|Physician Decision|2|||
44457104|NCT00369382|79465542|FG001|Overall Study|Physician Decision|1|||
44457105|NCT00369382|79465541|FG000|Overall Study|Withdrawal by Subject|5|||
44457106|NCT00369382|79465542|FG001|Overall Study|Withdrawal by Subject|0|||
44457107|NCT00369382|79465541|FG000|Overall Study|Randomized, not treated|2|||
44457108|NCT00369382|79465542|FG001|Overall Study|Randomized, not treated|0|||
44457109|NCT00369382|79465541|FG000|Overall Study|Other|1|||
44457110|NCT00369382|79465542|FG001|Overall Study|Other|0|||
44457111|NCT00424515|79465551|FG000|Overall Study|Progressive Disease|10|||
44457112|NCT00424515|79465552|FG001|Overall Study|Progressive Disease|11|||
44457113|NCT00424515|79465551|FG000|Overall Study|Adverse Event|0|||
44457114|NCT00424515|79465552|FG001|Overall Study|Adverse Event|1|||
44457115|NCT00424515|79465551|FG000|Overall Study|Intercurrent Illness|0|||
44457116|NCT00424515|79465552|FG001|Overall Study|Intercurrent Illness|1|||
44457117|NCT00424515|79465551|FG000|Overall Study|Withdrawal by Subject|1|||
44457118|NCT00424515|79465552|FG001|Overall Study|Withdrawal by Subject|0|||
44457119|NCT00377260|79465560|FG000|Overall Study|Lost to Follow-up|0|||
44457120|NCT00377260|79465561|FG001|Overall Study|Lost to Follow-up|1|||
44457121|NCT00377260|79465560|FG000|Overall Study|Withdrawal by Subject|2|||
44457122|NCT00377260|79465561|FG001|Overall Study|Withdrawal by Subject|4|||
44457123|NCT00441441|79465569|FG000|Overall Study|Adverse Event|2|||
44457124|NCT00441441|79465570|FG001|Overall Study|Adverse Event|1|||
44457125|NCT00441441|79465569|FG000|Overall Study|Protocol Violation|4|||
44457126|NCT00441441|79465570|FG001|Overall Study|Protocol Violation|6|||
44457127|NCT00441441|79465569|FG000|Overall Study|Exacerbation of asthma|1|||
44457128|NCT00441441|79465570|FG001|Overall Study|Exacerbation of asthma|2|||
44457129|NCT00441441|79465569|FG000|Overall Study|Withdrawal by Subject|1|||
44457130|NCT00441441|79465570|FG001|Overall Study|Withdrawal by Subject|2|||
44457131|NCT00441441|79465569|FG000|Overall Study|Other|3|||
44457132|NCT00441441|79465570|FG001|Overall Study|Other|3|||
44457133|NCT00436917|79465590|FG000|Overall Study|Withdrawal by Subject|13|||
44457134|NCT00436917|79465590|FG000|Overall Study|Adverse Event|2|||
44457135|NCT00436917|79465590|FG000|Overall Study|Physician Decision|1|||
44457136|NCT00436917|79465590|FG000|Overall Study|Death|1|||
44457137|NCT00436917|79465590|FG000|Overall Study|Lost to Follow-up|1|||
44457138|NCT00436917|79465590|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
44457139|NCT00436917|79465590|FG000|Overall Study|Increased creatinine|1|||
44457140|NCT00436917|79465590|FG000|Overall Study|Personal conflicts of patient|1|||
44457141|NCT00436605|79465594|FG000|Overall Study|Protocol Violation|3|||
44457142|NCT00368992|79465598|FG000|Overall Study|Ineligible|5|||
44457143|NCT00368992|79465598|FG000|Overall Study|Refused treatment|3|||
44457144|NCT00368992|79465598|FG000|Overall Study|Lack of Efficacy|63|||
44457145|NCT00368992|79465598|FG000|Overall Study|Adverse Event|26|||
44457146|NCT00368992|79465598|FG000|Overall Study|Death|4|||
44457147|NCT00368992|79465598|FG000|Overall Study|Other|9|||
44457148|NCT00376246|79465603|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
44457149|NCT00376246|79465604|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
44457150|NCT00376246|79465603|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
44457151|NCT00376246|79465604|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
44457152|NCT00376246|79465603|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
44457153|NCT00376246|79465604|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
44457154|NCT00368836|79465614|FG000|Phase II|Screen Failure|1|||
44457155|NCT00368836|79465614|FG000|Phase II|Withdrawal by Subject|1|||
44457156|NCT00368836|79465614|FG000|Phase II|unable to collect blood and/or breath|17|||
44457157|NCT00368836|79465614|FG000|Phase II|Protocol Violation|2|||
44457158|NCT00376168|79465623|FG000|Overall Study|Adverse Event|1|||
44457159|NCT00376168|79465624|FG001|Overall Study|Adverse Event|1|||
44457160|NCT00376168|79465623|FG000|Overall Study|Pregnancy|1|||
44457161|NCT00376168|79465624|FG001|Overall Study|Pregnancy|0|||
44457162|NCT00375934|79465632|FG000|Overall Study|Adverse Event|1|||
44457163|NCT00375934|79465633|FG001|Overall Study|Adverse Event|1|||
44215820|NCT01517373|79013590|FG000|Treatment Period|Protocol Violation|0|||
44215821|NCT01517373|79013591|FG001|Treatment Period|Protocol Violation|0|||
44457164|NCT00375934|79465632|FG000|Overall Study|Withdrawal by Subject|2|||
44457165|NCT00375934|79465633|FG001|Overall Study|Withdrawal by Subject|2|||
44457166|NCT00375934|79465632|FG000|Overall Study|Lack of Efficacy|0|||
44457167|NCT00375934|79465633|FG001|Overall Study|Lack of Efficacy|2|||
44457168|NCT00375934|79465632|FG000|Overall Study|Physician Decision|0|||
44457169|NCT00375934|79465633|FG001|Overall Study|Physician Decision|1|||
44457170|NCT00642941|79465651|FG000|Overall Study|Physician Decision|3|||
44457171|NCT00642941|79465652|FG001|Overall Study|Physician Decision|1|||
44457172|NCT00642941|79465653|FG002|Overall Study|Physician Decision|0|||
44457173|NCT00642941|79465654|FG003|Overall Study|Physician Decision|0|||
44457174|NCT00642941|79465655|FG004|Overall Study|Physician Decision|0|||
44457175|NCT00642941|79465656|FG005|Overall Study|Physician Decision|0|||
44457176|NCT00642941|79465657|FG006|Overall Study|Physician Decision|1|||
44457177|NCT00642941|79465658|FG007|Overall Study|Physician Decision|0|||
44457178|NCT00642941|79465659|FG008|Overall Study|Physician Decision|0|||
44457179|NCT00642941|79465660|FG009|Overall Study|Physician Decision|1|||
44457180|NCT00642941|79465661|FG010|Overall Study|Physician Decision|0|||
44457181|NCT00642941|79465662|FG011|Overall Study|Physician Decision|1|||
44457182|NCT00642941|79465651|FG000|Overall Study|Death|4|||
44457183|NCT00642941|79465652|FG001|Overall Study|Death|0|||
44457184|NCT00642941|79465653|FG002|Overall Study|Death|1|||
44457185|NCT00642941|79465654|FG003|Overall Study|Death|1|||
44457186|NCT00642941|79465655|FG004|Overall Study|Death|2|||
44457187|NCT00642941|79465656|FG005|Overall Study|Death|1|||
44215822|NCT01517373|79013592|FG002|Treatment Period|Protocol Violation|0|||
44215823|NCT01517373|79013593|FG003|Treatment Period|Protocol Violation|0|||
44215824|NCT01517373|79013594|FG004|Treatment Period|Protocol Violation|1|||
44215825|NCT01517373|79013595|FG005|Treatment Period|Protocol Violation|0|||
44215826|NCT01517373|79013590|FG000|Treatment Period|Lack of Efficacy|0|||
44215827|NCT01517373|79013591|FG001|Treatment Period|Lack of Efficacy|1|||
44215828|NCT01517373|79013592|FG002|Treatment Period|Lack of Efficacy|1|||
44270152|NCT02326272|79195781|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
44270153|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44270154|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44270155|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44372058|NCT01274338|79377079|FG000|Overall Study|Withdrawal by Subject|27|||
44372059|NCT01274338|79377080|FG001|Overall Study|Withdrawal by Subject|99|||
44372060|NCT01274338|79377081|FG002|Overall Study|Withdrawal by Subject|17|||
44372061|NCT01274338|79377082|FG003|Overall Study|Withdrawal by Subject|0|||
44372062|NCT01274338|79377083|FG004|Overall Study|Withdrawal by Subject|0|||
44372063|NCT01274338|79377084|FG005|Overall Study|Withdrawal by Subject|0|||
44372064|NCT01274338|79377079|FG000|Overall Study|Did not start treatment|8|||
44457188|NCT00642941|79465657|FG006|Overall Study|Death|0|||
44457189|NCT00642941|79465658|FG007|Overall Study|Death|0|||
44457190|NCT00642941|79465659|FG008|Overall Study|Death|0|||
44457191|NCT00642941|79465660|FG009|Overall Study|Death|0|||
44457192|NCT00642941|79465661|FG010|Overall Study|Death|0|||
44457193|NCT00642941|79465662|FG011|Overall Study|Death|1|||
44215829|NCT01517373|79013593|FG003|Treatment Period|Lack of Efficacy|3|||
44457194|NCT00642941|79465651|FG000|Overall Study|Study closed by Sponsor|0|||
44457195|NCT00642941|79465652|FG001|Overall Study|Study closed by Sponsor|1|||
44457196|NCT00642941|79465653|FG002|Overall Study|Study closed by Sponsor|0|||
44457197|NCT00642941|79465654|FG003|Overall Study|Study closed by Sponsor|0|||
44457198|NCT00642941|79465655|FG004|Overall Study|Study closed by Sponsor|0|||
44457199|NCT00642941|79465656|FG005|Overall Study|Study closed by Sponsor|0|||
44457200|NCT00642941|79465657|FG006|Overall Study|Study closed by Sponsor|0|||
44457201|NCT00642941|79465658|FG007|Overall Study|Study closed by Sponsor|0|||
44457202|NCT00642941|79465659|FG008|Overall Study|Study closed by Sponsor|0|||
44457203|NCT00642941|79465660|FG009|Overall Study|Study closed by Sponsor|0|||
44215830|NCT01517373|79013594|FG004|Treatment Period|Lack of Efficacy|2|||
44372065|NCT01274338|79377080|FG001|Overall Study|Did not start treatment|116|||
44457204|NCT00642941|79465661|FG010|Overall Study|Study closed by Sponsor|0|||
44457205|NCT00642941|79465662|FG011|Overall Study|Study closed by Sponsor|0|||
44457206|NCT00642941|79465651|FG000|Overall Study|Withdrawal by Subject|1|||
44457207|NCT00642941|79465652|FG001|Overall Study|Withdrawal by Subject|0|||
44457208|NCT00642941|79465653|FG002|Overall Study|Withdrawal by Subject|0|||
44457209|NCT00642941|79465654|FG003|Overall Study|Withdrawal by Subject|2|||
44457210|NCT00642941|79465655|FG004|Overall Study|Withdrawal by Subject|0|||
44457211|NCT00642941|79465656|FG005|Overall Study|Withdrawal by Subject|0|||
44457212|NCT00642941|79465657|FG006|Overall Study|Withdrawal by Subject|2|||
44457213|NCT00642941|79465658|FG007|Overall Study|Withdrawal by Subject|0|||
44457214|NCT00642941|79465659|FG008|Overall Study|Withdrawal by Subject|1|||
44457215|NCT00642941|79465660|FG009|Overall Study|Withdrawal by Subject|0|||
44457216|NCT00642941|79465661|FG010|Overall Study|Withdrawal by Subject|0|||
44457217|NCT00642941|79465662|FG011|Overall Study|Withdrawal by Subject|1|||
44457218|NCT00642941|79465651|FG000|Overall Study|Protocol Violation|0|||
44457219|NCT00642941|79465652|FG001|Overall Study|Protocol Violation|0|||
44457220|NCT00642941|79465653|FG002|Overall Study|Protocol Violation|0|||
44457221|NCT00642941|79465654|FG003|Overall Study|Protocol Violation|0|||
44457222|NCT00642941|79465655|FG004|Overall Study|Protocol Violation|0|||
44457223|NCT00642941|79465656|FG005|Overall Study|Protocol Violation|0|||
44457224|NCT00642941|79465657|FG006|Overall Study|Protocol Violation|1|||
44457225|NCT00642941|79465658|FG007|Overall Study|Protocol Violation|0|||
44457226|NCT00642941|79465659|FG008|Overall Study|Protocol Violation|0|||
44457227|NCT00642941|79465660|FG009|Overall Study|Protocol Violation|0|||
44457228|NCT00642941|79465661|FG010|Overall Study|Protocol Violation|0|||
44457229|NCT00642941|79465662|FG011|Overall Study|Protocol Violation|0|||
44457230|NCT00642941|79465651|FG000|Overall Study|Adverse Event|1|||
44457231|NCT00642941|79465652|FG001|Overall Study|Adverse Event|1|||
44457232|NCT00642941|79465653|FG002|Overall Study|Adverse Event|0|||
44457233|NCT00642941|79465654|FG003|Overall Study|Adverse Event|0|||
44457234|NCT00642941|79465655|FG004|Overall Study|Adverse Event|0|||
44457235|NCT00642941|79465656|FG005|Overall Study|Adverse Event|0|||
44457236|NCT00642941|79465657|FG006|Overall Study|Adverse Event|1|||
44457237|NCT00642941|79465658|FG007|Overall Study|Adverse Event|1|||
44457238|NCT00642941|79465659|FG008|Overall Study|Adverse Event|0|||
44457239|NCT00642941|79465660|FG009|Overall Study|Adverse Event|1|||
44457240|NCT00642941|79465661|FG010|Overall Study|Adverse Event|0|||
44457241|NCT00642941|79465662|FG011|Overall Study|Adverse Event|0|||
44457242|NCT00642941|79465651|FG000|Overall Study|Other|1|||
44457243|NCT00642941|79465652|FG001|Overall Study|Other|1|||
44457244|NCT00642941|79465653|FG002|Overall Study|Other|1|||
44457245|NCT00642941|79465654|FG003|Overall Study|Other|1|||
44457246|NCT00642941|79465655|FG004|Overall Study|Other|0|||
44457247|NCT00642941|79465656|FG005|Overall Study|Other|1|||
44457248|NCT00642941|79465657|FG006|Overall Study|Other|0|||
44457249|NCT00642941|79465658|FG007|Overall Study|Other|1|||
44457250|NCT00642941|79465659|FG008|Overall Study|Other|0|||
44457251|NCT00642941|79465660|FG009|Overall Study|Other|0|||
44457252|NCT00642941|79465661|FG010|Overall Study|Other|0|||
44457253|NCT00642941|79465662|FG011|Overall Study|Other|1|||
44457254|NCT00642941|79465651|FG000|Overall Study|Disease progression|60|||
44457255|NCT00642941|79465652|FG001|Overall Study|Disease progression|50|||
44457256|NCT00642941|79465653|FG002|Overall Study|Disease progression|5|||
44457257|NCT00642941|79465654|FG003|Overall Study|Disease progression|36|||
44457258|NCT00642941|79465655|FG004|Overall Study|Disease progression|23|||
44457259|NCT00642941|79465656|FG005|Overall Study|Disease progression|39|||
44457260|NCT00642941|79465657|FG006|Overall Study|Disease progression|18|||
44457261|NCT00642941|79465658|FG007|Overall Study|Disease progression|12|||
44457262|NCT00642941|79465659|FG008|Overall Study|Disease progression|10|||
44457263|NCT00642941|79465660|FG009|Overall Study|Disease progression|7|||
44457264|NCT00642941|79465661|FG010|Overall Study|Disease progression|12|||
44457265|NCT00642941|79465662|FG011|Overall Study|Disease progression|7|||
44457266|NCT00531960|79465711|FG000|Overall Study|Adverse Event|5|||
44457267|NCT00531960|79465712|FG001|Overall Study|Adverse Event|4|||
44457268|NCT00531960|79465711|FG000|Overall Study|Death|3|||
44457269|NCT00531960|79465712|FG001|Overall Study|Death|2|||
44457270|NCT00531960|79465711|FG000|Overall Study|Lack of Efficacy|42|||
44457271|NCT00531960|79465712|FG001|Overall Study|Lack of Efficacy|41|||
44457272|NCT00531960|79465711|FG000|Overall Study|Violation of Selection Criteria|2|||
44457273|NCT00531960|79465712|FG001|Overall Study|Violation of Selection Criteria|0|||
44215831|NCT01517373|79013595|FG005|Treatment Period|Lack of Efficacy|0|||
44215832|NCT01517373|79013590|FG000|Treatment Period|Medication error without AEs|0|||
44215833|NCT01517373|79013591|FG001|Treatment Period|Medication error without AEs|0|||
44215834|NCT01517373|79013592|FG002|Treatment Period|Medication error without AEs|2|||
44215835|NCT01517373|79013593|FG003|Treatment Period|Medication error without AEs|1|||
44215836|NCT01517373|79013594|FG004|Treatment Period|Medication error without AEs|0|||
44457274|NCT00531960|79465711|FG000|Overall Study|Refused Treatment|5|||
44457275|NCT00531960|79465712|FG001|Overall Study|Refused Treatment|6|||
44457276|NCT00531960|79465711|FG000|Overall Study|Other|4|||
44457277|NCT00531960|79465712|FG001|Overall Study|Other|10|||
44457278|NCT00361504|79465720|FG000|Overall Study|Withdrawal by Subject|94|||
44457279|NCT00361504|79465721|FG001|Overall Study|Withdrawal by Subject|31|||
44457280|NCT00361504|79465720|FG000|Overall Study|Lost to Follow-up|40|||
44457281|NCT00361504|79465721|FG001|Overall Study|Lost to Follow-up|7|||
44457282|NCT00361504|79465720|FG000|Overall Study|Adverse Event|203|||
44457283|NCT00361504|79465721|FG001|Overall Study|Adverse Event|82|||
44457284|NCT00361504|79465720|FG000|Overall Study|Lack of Efficacy|72|||
44457285|NCT00361504|79465721|FG001|Overall Study|Lack of Efficacy|7|||
44457286|NCT00361504|79465720|FG000|Overall Study|Resolution of Pain|2|||
44457287|NCT00361504|79465721|FG001|Overall Study|Resolution of Pain|0|||
44457288|NCT00361504|79465720|FG000|Overall Study|Study medication non compliant|42|||
44457289|NCT00361504|79465721|FG001|Overall Study|Study medication non compliant|15|||
44457290|NCT00361504|79465720|FG000|Overall Study|All other|28|||
44457291|NCT00361504|79465721|FG001|Overall Study|All other|3|||
44457292|NCT00361270|79465731|FG000|Overall Study|Death|0|||
44457293|NCT00361270|79465732|FG001|Overall Study|Death|0|||
44457294|NCT00361270|79465733|FG002|Overall Study|Death|0|||
44457295|NCT00361270|79465734|FG003|Overall Study|Death|2|||
44457296|NCT00361270|79465731|FG000|Overall Study|Lost to Follow-up|4|||
44457297|NCT00361270|79465732|FG001|Overall Study|Lost to Follow-up|1|||
44457298|NCT00361270|79465733|FG002|Overall Study|Lost to Follow-up|0|||
44457299|NCT00361270|79465734|FG003|Overall Study|Lost to Follow-up|0|||
44457300|NCT00361270|79465731|FG000|Overall Study|Physician Decision|0|||
44457301|NCT00361270|79465732|FG001|Overall Study|Physician Decision|0|||
44457302|NCT00361270|79465733|FG002|Overall Study|Physician Decision|1|||
44457303|NCT00361270|79465734|FG003|Overall Study|Physician Decision|0|||
44457304|NCT00361270|79465731|FG000|Overall Study|Protocol Violation|9|||
44457305|NCT00361270|79465732|FG001|Overall Study|Protocol Violation|4|||
44457306|NCT00361270|79465733|FG002|Overall Study|Protocol Violation|5|||
44457307|NCT00361270|79465734|FG003|Overall Study|Protocol Violation|4|||
44457308|NCT00361270|79465731|FG000|Overall Study|Withdrawal by Subject|6|||
44457309|NCT00361270|79465732|FG001|Overall Study|Withdrawal by Subject|6|||
44457310|NCT00361270|79465733|FG002|Overall Study|Withdrawal by Subject|3|||
44457311|NCT00361270|79465734|FG003|Overall Study|Withdrawal by Subject|7|||
44457312|NCT00361270|79465731|FG000|Overall Study|Afraid of Hypnosis|1|||
44457313|NCT00361270|79465732|FG001|Overall Study|Afraid of Hypnosis|2|||
44457314|NCT00361270|79465733|FG002|Overall Study|Afraid of Hypnosis|0|||
44457315|NCT00361270|79465734|FG003|Overall Study|Afraid of Hypnosis|0|||
44457316|NCT00361270|79465731|FG000|Overall Study|Problems with Transportation|4|||
44457317|NCT00361270|79465732|FG001|Overall Study|Problems with Transportation|0|||
44457318|NCT00361270|79465733|FG002|Overall Study|Problems with Transportation|0|||
44457319|NCT00361270|79465734|FG003|Overall Study|Problems with Transportation|0|||
44457320|NCT00361270|79465731|FG000|Overall Study|Adverse Event|0|||
44457321|NCT00361270|79465732|FG001|Overall Study|Adverse Event|1|||
44457322|NCT00361270|79465733|FG002|Overall Study|Adverse Event|1|||
44457323|NCT00361270|79465734|FG003|Overall Study|Adverse Event|0|||
44457324|NCT00367744|79465753|FG000|Overall Study|Lost to Follow-up|4|||
44457325|NCT00367744|79465754|FG001|Overall Study|Lost to Follow-up|5|||
44457326|NCT03883386|79465763|FG000|First Assignment|Lost to Follow-up|1|||
44457327|NCT03883386|79465764|FG001|First Assignment|Lost to Follow-up|0|||
44457328|NCT03883386|79465763|FG000|First Assignment|Withdrawal by Subject|1|||
44457329|NCT03883386|79465764|FG001|First Assignment|Withdrawal by Subject|1|||
44457330|NCT00530946|79465774|FG000|Overall Study|Adverse Event|1|||
44457331|NCT00530946|79465775|FG001|Overall Study|Adverse Event|2|||
44457332|NCT00530946|79465776|FG002|Overall Study|Adverse Event|1|||
44457333|NCT00530946|79465777|FG003|Overall Study|Adverse Event|1|||
44457334|NCT00530946|79465774|FG000|Overall Study|Protocol Violation|0|||
44457335|NCT00530946|79465775|FG001|Overall Study|Protocol Violation|0|||
44457336|NCT00530946|79465776|FG002|Overall Study|Protocol Violation|0|||
44457337|NCT00530946|79465777|FG003|Overall Study|Protocol Violation|1|||
44457338|NCT00530946|79465774|FG000|Overall Study|Noncompliance|1|||
44457339|NCT00530946|79465775|FG001|Overall Study|Noncompliance|0|||
44457340|NCT00530946|79465776|FG002|Overall Study|Noncompliance|0|||
44457341|NCT00530946|79465777|FG003|Overall Study|Noncompliance|0|||
44457342|NCT00424047|79465789|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
44457343|NCT00424047|79465790|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
44457344|NCT00424047|79465789|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
44457345|NCT00424047|79465790|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
44457346|NCT00424047|79465789|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
44457347|NCT00424047|79465790|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
44457348|NCT00424047|79465789|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
44457349|NCT00424047|79465790|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
44457350|NCT00424047|79465789|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
44457351|NCT00424047|79465790|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
44457352|NCT00424047|79465789|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
44457353|NCT00424047|79465790|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
44457354|NCT00424047|79465789|FG000|On Study at Time of Unblinding|Adverse Event|22|||
44457355|NCT00424047|79465790|FG001|On Study at Time of Unblinding|Adverse Event|12|||
44457356|NCT00424047|79465789|FG000|On Study at Time of Unblinding|Progression of disease|92|||
44457357|NCT00424047|79465790|FG001|On Study at Time of Unblinding|Progression of disease|128|||
44457358|NCT00424047|79465789|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
44457359|NCT00424047|79465790|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
44457360|NCT00424047|79465789|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
44457361|NCT00424047|79465790|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
44457362|NCT00424047|79465789|FG000|On Study at Time of Unblinding|Death|11|||
44457363|NCT00424047|79465790|FG001|On Study at Time of Unblinding|Death|11|||
44457364|NCT00424047|79465789|FG000|On Study at Time of Unblinding|Other|5|||
44457365|NCT00424047|79465790|FG001|On Study at Time of Unblinding|Other|4|||
44457366|NCT00424047|79465789|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
44457367|NCT00424047|79465790|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
44457368|NCT00424047|79465789|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
44457369|NCT00424047|79465790|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
44457370|NCT00424047|79465789|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
44215837|NCT01517373|79013595|FG005|Treatment Period|Medication error without AEs|2|||
44215838|NCT01517295|79013610|FG000|Overall Study|Physician Decision|1|||
44215839|NCT01517295|79013611|FG001|Overall Study|Physician Decision|0|||
44215840|NCT01541865|79013617|FG000|Overall Study|Lost to Follow-up|11|||
44215841|NCT01541865|79013617|FG000|Overall Study|Withdrawal by Subject|9|||
44215842|NCT01541865|79013617|FG000|Overall Study|Adverse Event|1|||
44215843|NCT01541865|79013617|FG000|Overall Study|Protocol Violation|1|||
44270156|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44372066|NCT01274338|79377081|FG002|Overall Study|Did not start treatment|7|||
44372067|NCT01274338|79377082|FG003|Overall Study|Did not start treatment|0|||
44372068|NCT01274338|79377083|FG004|Overall Study|Did not start treatment|0|||
44372069|NCT01274338|79377084|FG005|Overall Study|Did not start treatment|0|||
44372070|NCT01274338|79377079|FG000|Overall Study|Alternative therapy|0|||
44372071|NCT01274338|79377080|FG001|Overall Study|Alternative therapy|1|||
44372072|NCT01274338|79377081|FG002|Overall Study|Alternative therapy|0|||
44457371|NCT00424047|79465790|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
44457372|NCT00424047|79465789|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
44457373|NCT00424047|79465790|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
44457374|NCT00424047|79465789|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
44457375|NCT00424047|79465790|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
44457376|NCT00530790|79465801|FG000|Overall Study|Adverse Event|2|||
44457377|NCT00530790|79465801|FG000|Overall Study|Withdrawal by Subject|2|||
44215844|NCT01541397|79013623|FG000|Overall Study|Study ended prior to data collection|4|||
44215845|NCT01541397|79013624|FG001|Overall Study|Study ended prior to data collection|2|||
44270157|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
44372073|NCT01274338|79377082|FG003|Overall Study|Alternative therapy|0|||
44372074|NCT01274338|79377083|FG004|Overall Study|Alternative therapy|0|||
44457378|NCT00530790|79465801|FG000|Overall Study|Physician Decision|1|||
44215846|NCT01548417|79013632|FG000|Overall Study|Withdrawal by Subject|0|||
44215847|NCT01548417|79013633|FG001|Overall Study|Withdrawal by Subject|2|||
44215848|NCT01546857|79013641|FG000|Overall Study|Withdrawal by Subject|2|||
44215849|NCT01546857|79013642|FG001|Overall Study|Withdrawal by Subject|3|||
44215850|NCT01540851|79013651|FG000|Overall Study|Lost to Follow-up|14|||
44215851|NCT01540851|79013652|FG001|Overall Study|Lost to Follow-up|15|||
44215852|NCT01540851|79013651|FG000|Overall Study|Withdrawal by Subject|7|||
44215853|NCT01540851|79013652|FG001|Overall Study|Withdrawal by Subject|3|||
44215854|NCT01516749|79013660|FG000|Active Therapy|Lost to Follow-up|1|||
44215855|NCT01516749|79013660|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
44215856|NCT01516437|79013668|FG000|Overall Study|Reason not specified|0|||
44215857|NCT01516437|79013669|FG001|Overall Study|Reason not specified|0|||
44215858|NCT01516437|79013670|FG002|Overall Study|Reason not specified|1|||
44215859|NCT01516437|79013671|FG003|Overall Study|Reason not specified|1|||
44215860|NCT01515423|79013685|FG000|Open Label Phase|Adverse Event|57|||
44215861|NCT01515423|79013686|FG001|Open Label Phase|Adverse Event|0|||
44215862|NCT01515423|79013687|FG002|Open Label Phase|Adverse Event|0|||
44215863|NCT01515423|79013685|FG000|Open Label Phase|Death|2|||
44215864|NCT01515423|79013686|FG001|Open Label Phase|Death|0|||
44215865|NCT01515423|79013687|FG002|Open Label Phase|Death|0|||
44215866|NCT01515423|79013685|FG000|Open Label Phase|Lack of Efficacy|117|||
44215867|NCT01515423|79013686|FG001|Open Label Phase|Lack of Efficacy|0|||
44215868|NCT01515423|79013687|FG002|Open Label Phase|Lack of Efficacy|0|||
44215869|NCT01515423|79013685|FG000|Open Label Phase|Lost to Follow-up|21|||
44215870|NCT01515423|79013686|FG001|Open Label Phase|Lost to Follow-up|0|||
44215871|NCT01515423|79013687|FG002|Open Label Phase|Lost to Follow-up|0|||
44215872|NCT01515423|79013685|FG000|Open Label Phase|Withdrawal by Subject|118|||
44215873|NCT01515423|79013686|FG001|Open Label Phase|Withdrawal by Subject|0|||
44215874|NCT01515423|79013687|FG002|Open Label Phase|Withdrawal by Subject|0|||
44215875|NCT01515423|79013685|FG000|Open Label Phase|excluded from DB Phase|70|||
44215876|NCT01515423|79013686|FG001|Open Label Phase|excluded from DB Phase|0|||
44215877|NCT01515423|79013687|FG002|Open Label Phase|excluded from DB Phase|0|||
44215878|NCT01515423|79013685|FG000|Open Label Phase|Other|28|||
44215879|NCT01515423|79013686|FG001|Open Label Phase|Other|0|||
44215880|NCT01515423|79013687|FG002|Open Label Phase|Other|0|||
44215881|NCT01515423|79013685|FG000|DOUBLE BLIND|Adverse Event|0|||
44215882|NCT01515423|79013686|FG001|DOUBLE BLIND|Adverse Event|15|||
44215883|NCT01515423|79013687|FG002|DOUBLE BLIND|Adverse Event|13|||
44215884|NCT01515423|79013685|FG000|DOUBLE BLIND|Death|0|||
44215885|NCT01515423|79013686|FG001|DOUBLE BLIND|Death|1|||
44215886|NCT01515423|79013687|FG002|DOUBLE BLIND|Death|2|||
44270158|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
44270159|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
44270160|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
44372075|NCT01274338|79377084|FG005|Overall Study|Alternative therapy|0|||
44270161|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
44372076|NCT01274338|79377079|FG000|Overall Study|Other complicating diseases|0|||
44372077|NCT01274338|79377080|FG001|Overall Study|Other complicating diseases|3|||
44372078|NCT01274338|79377081|FG002|Overall Study|Other complicating diseases|1|||
44372079|NCT01274338|79377082|FG003|Overall Study|Other complicating diseases|0|||
44372080|NCT01274338|79377083|FG004|Overall Study|Other complicating diseases|0|||
44372081|NCT01274338|79377084|FG005|Overall Study|Other complicating diseases|0|||
44372082|NCT01274338|79377079|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
44215887|NCT01515423|79013685|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
44215888|NCT01515423|79013686|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
44215889|NCT01515423|79013687|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
44215890|NCT01515423|79013685|FG000|DOUBLE BLIND|Pregnancy|0|||
44215891|NCT01515423|79013686|FG001|DOUBLE BLIND|Pregnancy|2|||
44215892|NCT01515423|79013687|FG002|DOUBLE BLIND|Pregnancy|0|||
44457379|NCT00530088|79465805|FG000|Overall Study|Disease Progression|4|||
44215893|NCT01515423|79013685|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
44215894|NCT01515423|79013686|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
44215895|NCT01515423|79013687|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
44372083|NCT01274338|79377080|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
44215896|NCT01515423|79013685|FG000|DOUBLE BLIND|Other|0|||
44215897|NCT01515423|79013686|FG001|DOUBLE BLIND|Other|6|||
44215898|NCT01515423|79013687|FG002|DOUBLE BLIND|Other|12|||
44215899|NCT01515423|79013685|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
44215900|NCT01515423|79013686|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
44215901|NCT01515423|79013687|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
44215902|NCT00637156|79013696|FG000|Overall Study|Withdrawal by Subject|0|||
44215903|NCT00637156|79013697|FG001|Overall Study|Withdrawal by Subject|7|||
44215904|NCT00637156|79013696|FG000|Overall Study|Death|0|||
44372084|NCT01274338|79377081|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
44372085|NCT01274338|79377082|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
44372086|NCT01274338|79377083|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
44372087|NCT01274338|79377084|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
44372088|NCT01274338|79377079|FG000|Overall Study|Pregnancy|0|||
44372089|NCT01274338|79377080|FG001|Overall Study|Pregnancy|0|||
44372090|NCT01274338|79377081|FG002|Overall Study|Pregnancy|1|||
44372091|NCT01274338|79377082|FG003|Overall Study|Pregnancy|0|||
44372092|NCT01274338|79377083|FG004|Overall Study|Pregnancy|0|||
44215905|NCT00637156|79013697|FG001|Overall Study|Death|1|||
44215906|NCT00637156|79013696|FG000|Overall Study|Lost to Follow-up|10|||
44372093|NCT01274338|79377084|FG005|Overall Study|Pregnancy|0|||
44372094|NCT01274338|79377079|FG000|Overall Study|Reason not reported|12|||
44372095|NCT01274338|79377080|FG001|Overall Study|Reason not reported|21|||
44372096|NCT01274338|79377081|FG002|Overall Study|Reason not reported|3|||
44215907|NCT00637156|79013697|FG001|Overall Study|Lost to Follow-up|16|||
44372097|NCT01274338|79377082|FG003|Overall Study|Reason not reported|0|||
44215908|NCT00637000|79013705|FG000|Overall Study|Withdrawal by Subject|4|||
44215909|NCT00637000|79013706|FG001|Overall Study|Withdrawal by Subject|3|||
44215910|NCT01515189|79013714|FG000|Induction|Disease Progression|109|||
44215911|NCT01515189|79013715|FG001|Induction|Disease Progression|155|||
44215912|NCT01515189|79013714|FG000|Induction|Study drug toxicity|86|||
44215913|NCT01515189|79013715|FG001|Induction|Study drug toxicity|36|||
44372098|NCT01274338|79377083|FG004|Overall Study|Reason not reported|1|||
44372099|NCT01274338|79377084|FG005|Overall Study|Reason not reported|0|||
44372100|NCT01272037|79377099|FG000|Overall Study|Death|25|||
44372101|NCT01272037|79377100|FG001|Overall Study|Death|28|||
44372102|NCT01272037|79377099|FG000|Overall Study|Adverse Event|12|||
44372103|NCT01272037|79377100|FG001|Overall Study|Adverse Event|7|||
44372104|NCT01272037|79377099|FG000|Overall Study|Withdrawal by Subject|175|||
44457380|NCT00530088|79465805|FG000|Overall Study|Physician Decision|4|||
44457381|NCT00530088|79465805|FG000|Overall Study|Other Not Specified|2|||
44215914|NCT01515189|79013714|FG000|Induction|Death|24|||
44215915|NCT01515189|79013715|FG001|Induction|Death|17|||
44457382|NCT00360568|79465811|FG000|Overall Study|Adverse Event|1|||
44215916|NCT01515189|79013714|FG000|Induction|Adverse Event|14|||
44215917|NCT01515189|79013715|FG001|Induction|Adverse Event|9|||
44215918|NCT01515189|79013714|FG000|Induction|Withdrawal by Subject|3|||
44372105|NCT01272037|79377100|FG001|Overall Study|Withdrawal by Subject|93|||
44457383|NCT00360568|79465812|FG001|Overall Study|Adverse Event|2|||
44457384|NCT00360568|79465811|FG000|Overall Study|Lack of Efficacy|1|||
44457385|NCT00360568|79465812|FG001|Overall Study|Lack of Efficacy|0|||
44457386|NCT00360568|79465811|FG000|Overall Study|Withdrawal by Subject|0|||
44457387|NCT00360568|79465812|FG001|Overall Study|Withdrawal by Subject|3|||
44457388|NCT00436215|79465820|FG000|Overall Study|Refused further treatment|3|||
44457389|NCT00436215|79465820|FG000|Overall Study|Small bowel obstruction|1|||
44457390|NCT00441363|79465826|FG000|Overall Study|Adverse Event|4|||
44457391|NCT00441363|79465827|FG001|Overall Study|Adverse Event|2|||
44457392|NCT00441363|79465826|FG000|Overall Study|Withdrawal by Subject|3|||
44457393|NCT00441363|79465827|FG001|Overall Study|Withdrawal by Subject|4|||
44457394|NCT00441363|79465826|FG000|Overall Study|Physician Decision|6|||
44457395|NCT00441363|79465827|FG001|Overall Study|Physician Decision|7|||
44457396|NCT00441363|79465826|FG000|Overall Study|Lost to Follow-up|2|||
44457397|NCT00441363|79465827|FG001|Overall Study|Lost to Follow-up|2|||
44457398|NCT00441363|79465826|FG000|Overall Study|Other|2|||
44457399|NCT00441363|79465827|FG001|Overall Study|Other|0|||
44457400|NCT00530712|79465833|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
44457401|NCT00530712|79465833|FG000|30 Day Follow-up Visit|Missed Visit|5|||
44457402|NCT00530712|79465833|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
44457403|NCT00530712|79465833|FG000|6 Month Follow-up Visit|Missed Visit|3|||
44457404|NCT00530712|79465833|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
44457405|NCT00530712|79465833|FG000|6 Month Follow-up Visit|Death|2|||
44215919|NCT01515189|79013715|FG001|Induction|Withdrawal by Subject|9|||
44215920|NCT01515189|79013714|FG000|Induction|No longer meets study criteria|0|||
44215921|NCT01515189|79013715|FG001|Induction|No longer meets study criteria|2|||
44215922|NCT01515189|79013714|FG000|Induction|Lost to Follow-up|1|||
44215923|NCT01515189|79013715|FG001|Induction|Lost to Follow-up|0|||
44215924|NCT01515189|79013714|FG000|Induction|Other|0|||
44215925|NCT01515189|79013715|FG001|Induction|Other|4|||
44457406|NCT00530712|79465833|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
44457407|NCT00530712|79465833|FG000|12 Month Follow-up Visit|Missed Visit|3|||
44457408|NCT00530712|79465833|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
44457409|NCT00530712|79465833|FG000|12 Month Follow-up Visit|Death|9|||
44457410|NCT00626795|79465841|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
44215926|NCT01515189|79013714|FG000|First Re-Induction Phase|Disease progression|6|||
44215927|NCT01515189|79013715|FG001|First Re-Induction Phase|Disease progression|14|||
44457411|NCT00626795|79465842|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
44457412|NCT00626795|79465843|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
44215928|NCT01515189|79013714|FG000|First Re-Induction Phase|Study drug toxicity|5|||
44215929|NCT01515189|79013715|FG001|First Re-Induction Phase|Study drug toxicity|0|||
44215930|NCT01515189|79013714|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
44215931|NCT01515189|79013715|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
44215932|NCT01515189|79013714|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
44215933|NCT01515189|79013715|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
44215934|NCT01515189|79013714|FG000|First Re-Induction Phase|Other|1|||
44215935|NCT01515189|79013715|FG001|First Re-Induction Phase|Other|0|||
44215936|NCT01546623|79013723|FG000|Overall Study|Adverse Event|2|||
44215937|NCT01546623|79013724|FG001|Overall Study|Adverse Event|3|||
44372106|NCT01272037|79377099|FG000|Overall Study|Disease progression|70|||
44372107|NCT01272037|79377100|FG001|Overall Study|Disease progression|111|||
44372108|NCT01272037|79377099|FG000|Overall Study|Other reason|42|||
44372109|NCT01272037|79377100|FG001|Overall Study|Other reason|41|||
44372110|NCT01272037|79377099|FG000|Overall Study|Delinquent data|24|||
44372111|NCT01272037|79377100|FG001|Overall Study|Delinquent data|19|||
44372112|NCT01272037|79377099|FG000|Overall Study|Reason under review|33|||
44372113|NCT01272037|79377100|FG001|Overall Study|Reason under review|29|||
44372114|NCT01272037|79377099|FG000|Overall Study|On treatment|626|||
44372115|NCT01272037|79377100|FG001|Overall Study|On treatment|632|||
44372116|NCT01199575|79377106|FG000|Overall Study|Withdrawal by Subject|5|||
44372117|NCT01194570|79377113|FG000|Overall Study|Adverse Event|22|||
44372118|NCT01194570|79377114|FG001|Overall Study|Adverse Event|40|||
44372119|NCT01194570|79377113|FG000|Overall Study|Death|6|||
44372120|NCT01194570|79377114|FG001|Overall Study|Death|20|||
44457413|NCT00626795|79465841|FG000|Blinded Treatment|Lack of Efficacy|2|||
44457414|NCT00626795|79465842|FG001|Blinded Treatment|Lack of Efficacy|0|||
44457415|NCT00626795|79465843|FG002|Blinded Treatment|Lack of Efficacy|0|||
44457416|NCT00626795|79465841|FG000|Blinded Treatment|Unacceptable adverse event|0|||
44457417|NCT00626795|79465842|FG001|Blinded Treatment|Unacceptable adverse event|0|||
44457418|NCT00626795|79465843|FG002|Blinded Treatment|Unacceptable adverse event|1|||
44215938|NCT01546623|79013723|FG000|Overall Study|Major Protocol Deviation|1|||
44543877|NCT02954653|79557038|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
44215939|NCT01546623|79013724|FG001|Overall Study|Major Protocol Deviation|1|||
44215940|NCT01546623|79013723|FG000|Overall Study|High Prostate specific antigen|2|||
44372121|NCT01194570|79377113|FG000|Overall Study|Lack of Efficacy|32|||
44372122|NCT01194570|79377114|FG001|Overall Study|Lack of Efficacy|33|||
44372123|NCT01194570|79377113|FG000|Overall Study|Lost to Follow-up|4|||
44215941|NCT01546623|79013724|FG001|Overall Study|High Prostate specific antigen|1|||
44215942|NCT01546623|79013723|FG000|Overall Study|Did Not Receive Study Drug|1|||
44215943|NCT01546623|79013724|FG001|Overall Study|Did Not Receive Study Drug|1|||
44215944|NCT01546155|79013730|FG000|Overall Study|could not tolerate long scan duration|3|||
44215945|NCT00636610|79013736|FG000|Overall Study|Adverse Event|4|||
44215946|NCT00636610|79013737|FG001|Overall Study|Adverse Event|4|||
44215947|NCT00636610|79013736|FG000|Overall Study|Death|6|||
44215948|NCT00636610|79013737|FG001|Overall Study|Death|3|||
44215949|NCT00636610|79013736|FG000|Overall Study|Physician decision to withdraw patient|15|||
44215950|NCT00636610|79013737|FG001|Overall Study|Physician decision to withdraw patient|9|||
44215951|NCT00636610|79013736|FG000|Overall Study|Subject decision to withdraw|15|||
44215952|NCT00636610|79013737|FG001|Overall Study|Subject decision to withdraw|11|||
44215953|NCT00636610|79013736|FG000|Overall Study|Disease progression - radiographic|41|||
44215954|NCT00636610|79013737|FG001|Overall Study|Disease progression - radiographic|51|||
44215955|NCT00636610|79013736|FG000|Overall Study|Disease progression - clinical|8|||
44215956|NCT00636610|79013737|FG001|Overall Study|Disease progression - clinical|3|||
44215957|NCT00636610|79013736|FG000|Overall Study|Reason for discontinuation not available|3|||
44215958|NCT00636610|79013737|FG001|Overall Study|Reason for discontinuation not available|2|||
44215959|NCT00635050|79013745|FG000|Overall Study|Withdrawal by Subject|1|||
44457419|NCT00626795|79465841|FG000|Blinded Treatment|Protocol Violation|0|||
44457420|NCT00626795|79465842|FG001|Blinded Treatment|Protocol Violation|1|||
44457421|NCT00626795|79465843|FG002|Blinded Treatment|Protocol Violation|1|||
44457422|NCT00626795|79465841|FG000|Blinded Treatment|Withdrawal by Subject|1|||
44457423|NCT00626795|79465842|FG001|Blinded Treatment|Withdrawal by Subject|1|||
44457424|NCT00626795|79465843|FG002|Blinded Treatment|Withdrawal by Subject|0|||
44457425|NCT00626795|79465841|FG000|Blinded Treatment|Other reasons|2|||
44457426|NCT00626795|79465842|FG001|Blinded Treatment|Other reasons|0|||
44457427|NCT00626795|79465843|FG002|Blinded Treatment|Other reasons|2|||
44457428|NCT00626795|79465841|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
44457429|NCT00626795|79465842|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
44457430|NCT00626795|79465843|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
44457431|NCT00626639|79465857|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
44457432|NCT00626639|79465858|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
44457433|NCT00626561|79465866|FG000|Overall Study|Withdrawal by Subject|2|||
44457434|NCT00626561|79465866|FG000|Overall Study|Disease Progression|2|||
44457435|NCT03880266|79465878|FG000|Overall Study|Withdrawal by Subject|0|||
44457436|NCT03880266|79465879|FG001|Overall Study|Withdrawal by Subject|1|||
44457437|NCT03880266|79465880|FG002|Overall Study|Withdrawal by Subject|1|||
44457438|NCT03880266|79465881|FG003|Overall Study|Withdrawal by Subject|0|||
44457439|NCT03880266|79465882|FG004|Overall Study|Withdrawal by Subject|0|||
44457440|NCT03880266|79465883|FG005|Overall Study|Withdrawal by Subject|0|||
44543878|NCT02954653|79557039|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
44543879|NCT02954653|79557040|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
44543880|NCT02954653|79557041|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
44543881|NCT02954653|79557042|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
44543882|NCT03173313|79557056|FG000|Overall Study|Lost to Follow-up|2|||
44543883|NCT03173313|79557057|FG001|Overall Study|Lost to Follow-up|3|||
44543884|NCT03173313|79557056|FG000|Overall Study|Withdrawal by Subject|0|||
44543885|NCT03173313|79557057|FG001|Overall Study|Withdrawal by Subject|1|||
44543886|NCT03173313|79557056|FG000|Overall Study|Death|5|||
44215960|NCT00634504|79013754|FG000|Overall Study|Protocol Violation|1|||
44215961|NCT00634504|79013755|FG001|Overall Study|Protocol Violation|0|||
44215962|NCT00634114|79013764|FG000|Overall Study|Adverse Event|6|||
44457441|NCT03880266|79465884|FG006|Overall Study|Withdrawal by Subject|0|||
44457442|NCT03880266|79465885|FG007|Overall Study|Withdrawal by Subject|0|||
44457443|NCT00423891|79465906|FG000|Enrolled|Withdrawal by Subject|0|||
44215963|NCT00634114|79013765|FG001|Overall Study|Adverse Event|8|||
44215964|NCT00634114|79013766|FG002|Overall Study|Adverse Event|3|||
44215965|NCT00634114|79013764|FG000|Overall Study|Withdrawal by Subject|9|||
44215966|NCT00634114|79013765|FG001|Overall Study|Withdrawal by Subject|6|||
44215967|NCT00634114|79013766|FG002|Overall Study|Withdrawal by Subject|11|||
44215968|NCT00634114|79013764|FG000|Overall Study|Lost to Follow-up|0|||
44215969|NCT00634114|79013765|FG001|Overall Study|Lost to Follow-up|0|||
44215970|NCT00634114|79013766|FG002|Overall Study|Lost to Follow-up|1|||
44215971|NCT00634114|79013764|FG000|Overall Study|Protocol Violation|3|||
44215972|NCT00634114|79013765|FG001|Overall Study|Protocol Violation|3|||
44215973|NCT00634114|79013766|FG002|Overall Study|Protocol Violation|1|||
44215974|NCT00634114|79013764|FG000|Overall Study|Pregnancy|1|||
44215975|NCT00634114|79013765|FG001|Overall Study|Pregnancy|0|||
44215976|NCT00634114|79013766|FG002|Overall Study|Pregnancy|0|||
44215977|NCT00634114|79013764|FG000|Overall Study|Incorrect enrolment|0|||
44215978|NCT00634114|79013765|FG001|Overall Study|Incorrect enrolment|1|||
44215979|NCT00634114|79013766|FG002|Overall Study|Incorrect enrolment|0|||
44215980|NCT00634114|79013764|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
44215981|NCT00634114|79013765|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
44215982|NCT00634114|79013766|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
44215983|NCT00634114|79013764|FG000|Overall Study|Difficult to continue|3|||
44215984|NCT00634114|79013765|FG001|Overall Study|Difficult to continue|1|||
44215985|NCT00634114|79013766|FG002|Overall Study|Difficult to continue|1|||
44215986|NCT00634114|79013764|FG000|Overall Study|Other reason|1|||
44215987|NCT00634114|79013765|FG001|Overall Study|Other reason|1|||
44215988|NCT00634114|79013766|FG002|Overall Study|Other reason|1|||
44215989|NCT00634036|79013776|FG000|Overall Study|Lost to Follow-up|1|||
44215990|NCT00634036|79013777|FG001|Overall Study|Lost to Follow-up|1|||
44215991|NCT00634036|79013776|FG000|Overall Study|Withdrawal by Subject|1|||
44215992|NCT00634036|79013777|FG001|Overall Study|Withdrawal by Subject|1|||
44215993|NCT01545375|79013785|FG000|Overall Study|Adverse Event|2|||
44215994|NCT01545375|79013786|FG001|Overall Study|Adverse Event|1|||
44215995|NCT01545375|79013785|FG000|Overall Study|Lost to Follow-up|34|||
44215996|NCT01545375|79013786|FG001|Overall Study|Lost to Follow-up|31|||
44215997|NCT01545375|79013785|FG000|Overall Study|Protocol Violation|3|||
44215998|NCT01545375|79013786|FG001|Overall Study|Protocol Violation|3|||
44215999|NCT01545375|79013785|FG000|Overall Study|Withdrawal by Subject|58|||
44216000|NCT01545375|79013786|FG001|Overall Study|Withdrawal by Subject|55|||
44216001|NCT01539837|79013795|FG000|Overall Study|reduce neutrophil level|0|||
44216002|NCT01539837|79013796|FG001|Overall Study|reduce neutrophil level|1|||
44216003|NCT01539837|79013797|FG002|Overall Study|reduce neutrophil level|1|||
44216004|NCT01539837|79013795|FG000|Overall Study|bad compliance|0|||
44216005|NCT01539837|79013796|FG001|Overall Study|bad compliance|0|||
44216006|NCT01539837|79013797|FG002|Overall Study|bad compliance|1|||
44216007|NCT01539759|79013807|FG000|Overall Study|Lost to Follow-up|6|||
44216008|NCT01539759|79013808|FG001|Overall Study|Lost to Follow-up|8|||
44216009|NCT00633022|79013817|FG000|Overall Study|Adverse Event|1|||
44216010|NCT00633022|79013818|FG001|Overall Study|Adverse Event|0|||
44216011|NCT00633022|79013819|FG002|Overall Study|Adverse Event|5|||
44216012|NCT00633022|79013817|FG000|Overall Study|Physician Decision|0|||
44216013|NCT00633022|79013818|FG001|Overall Study|Physician Decision|1|||
44216014|NCT00633022|79013819|FG002|Overall Study|Physician Decision|0|||
44216015|NCT00630994|79013827|FG000|Overall Study|Adverse Event|1|||
44216016|NCT00630994|79013827|FG000|Overall Study|Disease Progression|1|||
44216017|NCT00630994|79013827|FG000|Overall Study|Lack of Efficacy|1|||
44216018|NCT00630994|79013827|FG000|Overall Study|Other|1|||
44216019|NCT00630838|79013833|FG000|Overall Study|Death|0|||
44216020|NCT00630838|79013834|FG001|Overall Study|Death|1|||
44216021|NCT00630838|79013833|FG000|Overall Study|Lost to Follow-up|0|||
44216022|NCT00630838|79013834|FG001|Overall Study|Lost to Follow-up|1|||
44216023|NCT00630058|79013844|FG000|Overall Study|Adverse Event|1|||
44216024|NCT00630058|79013845|FG001|Overall Study|Adverse Event|1|||
44457444|NCT00423891|79465907|FG001|Enrolled|Withdrawal by Subject|0|||
44216025|NCT00630058|79013844|FG000|Overall Study|Withdrawal by Subject|0|||
44216026|NCT00630058|79013845|FG001|Overall Study|Withdrawal by Subject|1|||
44216027|NCT00630058|79013844|FG000|Overall Study|stopping criteria|3|||
44216028|NCT00630058|79013845|FG001|Overall Study|stopping criteria|2|||
44216029|NCT01925794|79013851|FG000|180 Days|Death|2|||
44216030|NCT01925794|79013851|FG000|180 Days|Withdrawal by Subject|2|||
44216031|NCT01925794|79013851|FG000|270 Days|Death|2|||
44216032|NCT01925794|79013851|FG000|270 Days|Protocol Violation|3|||
44216033|NCT00989950|79013863|FG000|Randomized Phase|Protocol Violation|1|||
44216034|NCT00989950|79013864|FG001|Randomized Phase|Protocol Violation|0|||
44216035|NCT00989950|79013865|FG002|Randomized Phase|Protocol Violation|0|||
44216036|NCT00989950|79013866|FG003|Randomized Phase|Protocol Violation|0|||
44216037|NCT00989950|79013863|FG000|Randomized Phase|Adverse Event|0|||
44216038|NCT00989950|79013864|FG001|Randomized Phase|Adverse Event|1|||
44216039|NCT00989950|79013865|FG002|Randomized Phase|Adverse Event|0|||
44216040|NCT00989950|79013866|FG003|Randomized Phase|Adverse Event|0|||
44216041|NCT01905943|79013876|FG000|Overall Study|Withdrawal of consent|90|||
44216042|NCT01905943|79013876|FG000|Overall Study|Lost to Follow-up|16|||
44216043|NCT01905943|79013876|FG000|Overall Study|Investigator discretion|7|||
44216044|NCT01905943|79013876|FG000|Overall Study|Death|186|||
44216045|NCT01905943|79013876|FG000|Overall Study|Adverse Event|3|||
44457445|NCT00423891|79465908|FG002|Enrolled|Withdrawal by Subject|1|||
44457446|NCT00423891|79465906|FG000|Enrolled|Lost to Follow-up|0|||
44457447|NCT00423891|79465907|FG001|Enrolled|Lost to Follow-up|0|||
44457448|NCT00423891|79465908|FG002|Enrolled|Lost to Follow-up|1|||
44457449|NCT00423891|79465906|FG000|Enrolled|No longer met criteria|11|||
44457450|NCT00423891|79465907|FG001|Enrolled|No longer met criteria|2|||
44457451|NCT00423891|79465908|FG002|Enrolled|No longer met criteria|1|||
44457452|NCT00423891|79465906|FG000|Treatment|Withdrawal by Subject|1|||
44457453|NCT00423891|79465907|FG001|Treatment|Withdrawal by Subject|0|||
44457454|NCT00423891|79465908|FG002|Treatment|Withdrawal by Subject|0|||
44457455|NCT00423891|79465906|FG000|Treatment|Lost to Follow-up|1|||
44457456|NCT00423891|79465907|FG001|Treatment|Lost to Follow-up|0|||
44457457|NCT00423891|79465908|FG002|Treatment|Lost to Follow-up|0|||
44457458|NCT00423891|79465906|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
44457459|NCT00423891|79465907|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
44457460|NCT00423891|79465908|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
44457461|NCT00423891|79465906|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
44216046|NCT01905943|79013876|FG000|Overall Study|Other|12|||
44457462|NCT00423891|79465907|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
44457463|NCT00423891|79465908|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
44216047|NCT01905553|79013897|FG000|Period 2|Adverse Event|1|||
44216048|NCT01905553|79013898|FG001|Period 2|Adverse Event|0|||
44216049|NCT01929031|79013908|FG000|Overall Study|Adverse Event|3|||
44216050|NCT01929031|79013909|FG001|Overall Study|Adverse Event|1|||
44216051|NCT01929031|79013910|FG002|Overall Study|Adverse Event|1|||
44216052|NCT01929031|79013911|FG003|Overall Study|Adverse Event|0|||
44216053|NCT01929031|79013912|FG004|Overall Study|Adverse Event|0|||
44216054|NCT01929031|79013913|FG005|Overall Study|Adverse Event|0|||
44216055|NCT01929031|79013908|FG000|Overall Study|Protocol Violation|1|||
44216056|NCT01929031|79013909|FG001|Overall Study|Protocol Violation|0|||
44216057|NCT01929031|79013910|FG002|Overall Study|Protocol Violation|0|||
44216058|NCT01929031|79013911|FG003|Overall Study|Protocol Violation|0|||
44216059|NCT01929031|79013912|FG004|Overall Study|Protocol Violation|0|||
44216060|NCT01929031|79013913|FG005|Overall Study|Protocol Violation|1|||
44372124|NCT01194570|79377114|FG001|Overall Study|Lost to Follow-up|15|||
44372125|NCT01194570|79377113|FG000|Overall Study|Non-Compliance|2|||
44372126|NCT01194570|79377114|FG001|Overall Study|Non-Compliance|2|||
44372127|NCT01194570|79377113|FG000|Overall Study|Non-Compliance With Study Drug|2|||
44372128|NCT01194570|79377114|FG001|Overall Study|Non-Compliance With Study Drug|2|||
44372129|NCT01194570|79377113|FG000|Overall Study|Other|18|||
44372130|NCT01194570|79377114|FG001|Overall Study|Other|47|||
44372131|NCT01194570|79377113|FG000|Overall Study|Physician Decision|10|||
44372132|NCT01194570|79377114|FG001|Overall Study|Physician Decision|25|||
44372133|NCT01194570|79377113|FG000|Overall Study|Protocol Violation|1|||
44372134|NCT01194570|79377114|FG001|Overall Study|Protocol Violation|2|||
44372135|NCT01194570|79377113|FG000|Overall Study|Study Terminated By Sponsor|0|||
44372136|NCT01194570|79377114|FG001|Overall Study|Study Terminated By Sponsor|1|||
44372137|NCT01194570|79377113|FG000|Overall Study|Withdrawal by Subject|57|||
44372138|NCT01194570|79377114|FG001|Overall Study|Withdrawal by Subject|82|||
44372139|NCT01194570|79377113|FG000|Overall Study|Pregnancy|1|||
44372140|NCT01194570|79377114|FG001|Overall Study|Pregnancy|1|||
44372141|NCT01169337|79377127|FG000|Overall Study|Lack of Efficacy|5|||
44372142|NCT01169337|79377128|FG001|Overall Study|Lack of Efficacy|7|||
44457464|NCT00423813|79465921|FG000|Overall Study|Adverse Event|11|||
44457465|NCT00423813|79465922|FG001|Overall Study|Adverse Event|30|||
44457466|NCT00423813|79465923|FG002|Overall Study|Adverse Event|40|||
44372143|NCT01169337|79377129|FG002|Overall Study|Lack of Efficacy|0|||
44372144|NCT01169337|79377127|FG000|Overall Study|Adverse Event|12|||
44372145|NCT01169337|79377128|FG001|Overall Study|Adverse Event|18|||
44216061|NCT01929031|79013908|FG000|Overall Study|Reason other than specified above|0|||
44216062|NCT01929031|79013909|FG001|Overall Study|Reason other than specified above|1|||
44216063|NCT01929031|79013910|FG002|Overall Study|Reason other than specified above|0|||
44372146|NCT01169337|79377129|FG002|Overall Study|Adverse Event|0|||
44372147|NCT01169337|79377127|FG000|Overall Study|Death|2|||
44216064|NCT01929031|79013911|FG003|Overall Study|Reason other than specified above|0|||
44372148|NCT01169337|79377128|FG001|Overall Study|Death|0|||
44457467|NCT00423813|79465921|FG000|Overall Study|Withdrawal by Subject|6|||
44457468|NCT00423813|79465922|FG001|Overall Study|Withdrawal by Subject|8|||
44216065|NCT01929031|79013912|FG004|Overall Study|Reason other than specified above|1|||
44216066|NCT01929031|79013913|FG005|Overall Study|Reason other than specified above|0|||
44216067|NCT00989092|79013925|FG000|Overall Study|Physician Decision|9|||
44216068|NCT00989092|79013926|FG001|Overall Study|Physician Decision|6|||
44216069|NCT00989092|79013925|FG000|Overall Study|Adverse Event|20|||
44216070|NCT00989092|79013926|FG001|Overall Study|Adverse Event|1|||
44216071|NCT00989092|79013925|FG000|Overall Study|Chemotherapy initiated|12|||
44270162|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44270163|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44270164|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44270165|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44457469|NCT00423813|79465923|FG002|Overall Study|Withdrawal by Subject|5|||
44457470|NCT00423813|79465921|FG000|Overall Study|Lost to Follow-up|5|||
44457471|NCT00423813|79465922|FG001|Overall Study|Lost to Follow-up|4|||
44457472|NCT00423813|79465923|FG002|Overall Study|Lost to Follow-up|4|||
44457473|NCT00423813|79465921|FG000|Overall Study|Lack of Efficacy|23|||
44270166|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44457474|NCT00423813|79465922|FG001|Overall Study|Lack of Efficacy|18|||
44457475|NCT00423813|79465923|FG002|Overall Study|Lack of Efficacy|19|||
44457476|NCT00423813|79465921|FG000|Overall Study|Physician Decision|2|||
44457477|NCT00423813|79465922|FG001|Overall Study|Physician Decision|0|||
44457478|NCT00423813|79465923|FG002|Overall Study|Physician Decision|0|||
44457479|NCT00423813|79465921|FG000|Overall Study|Sponsor Decision|0|||
44457480|NCT00423813|79465922|FG001|Overall Study|Sponsor Decision|1|||
44457481|NCT00423813|79465923|FG002|Overall Study|Sponsor Decision|0|||
44457482|NCT00423813|79465921|FG000|Overall Study|Protocol Violation|9|||
44457483|NCT00423813|79465922|FG001|Overall Study|Protocol Violation|4|||
44457484|NCT00423813|79465923|FG002|Overall Study|Protocol Violation|4|||
44457485|NCT00423813|79465921|FG000|Overall Study|Pregnancy|0|||
44457486|NCT00423813|79465922|FG001|Overall Study|Pregnancy|0|||
44457487|NCT00423813|79465923|FG002|Overall Study|Pregnancy|1|||
44457488|NCT00423813|79465921|FG000|Overall Study|Subject started night shift work|1|||
44457489|NCT00423813|79465922|FG001|Overall Study|Subject started night shift work|0|||
44457490|NCT00423813|79465923|FG002|Overall Study|Subject started night shift work|0|||
44457491|NCT00423813|79465921|FG000|Overall Study|Will start exclusionary medications|0|||
44457492|NCT00423813|79465922|FG001|Overall Study|Will start exclusionary medications|1|||
44457493|NCT00423813|79465923|FG002|Overall Study|Will start exclusionary medications|0|||
44457494|NCT00423813|79465921|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
44457495|NCT00423813|79465922|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
44457496|NCT00423813|79465923|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
44457497|NCT03687372|79465933|FG000|Overall Study|Lost to Follow-up|12|||
44457498|NCT03687372|79465934|FG001|Overall Study|Lost to Follow-up|21|||
44457499|NCT03687372|79465933|FG000|Overall Study|Withdrawal by Subject|4|||
44457500|NCT03687372|79465934|FG001|Overall Study|Withdrawal by Subject|17|||
44457501|NCT03687372|79465933|FG000|Overall Study|Investigator Decision|1|||
44457502|NCT03687372|79465934|FG001|Overall Study|Investigator Decision|1|||
44457503|NCT00626405|79465944|FG000|Overall Study|Deemed Ineligible|1|||
44457504|NCT00626405|79465945|FG001|Overall Study|Deemed Ineligible|0|||
44457505|NCT00626405|79465944|FG000|Overall Study|Withdrawal by Subject|0|||
44457506|NCT00626405|79465945|FG001|Overall Study|Withdrawal by Subject|1|||
44457507|NCT00358150|79465951|FG000|Overall Study|Adverse Event|3|||
44457508|NCT00358150|79465951|FG000|Overall Study|Withdrawal by Subject|1|||
44457509|NCT00358150|79465951|FG000|Overall Study|Undefined|3|||
44457510|NCT05061966|79465978|FG000|Overall Study|Lost to Follow-up|13|||
44457511|NCT05061966|79465979|FG001|Overall Study|Lost to Follow-up|13|||
44543887|NCT03173313|79557057|FG001|Overall Study|Death|0|||
44543888|NCT03173313|79557056|FG000|Overall Study|Physician Decision|1|||
44457512|NCT05027815|79465987|FG000|Overall Study|Death|2|||
44457513|NCT05027815|79465988|FG001|Overall Study|Death|1|||
44457514|NCT04827134|79465998|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
44457515|NCT04827134|79465999|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
44457516|NCT04827134|79466000|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
44216072|NCT00989092|79013926|FG001|Overall Study|Chemotherapy initiated|4|||
44543889|NCT03173313|79557057|FG001|Overall Study|Physician Decision|0|||
44543890|NCT03173313|79557056|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
44543891|NCT03173313|79557057|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
44543892|NCT03173313|79557056|FG000|Overall Study|Bone Fracture|1|||
44543893|NCT03173313|79557057|FG001|Overall Study|Bone Fracture|0|||
44543894|NCT03215667|79557063|FG000|Overall Study|Physician Decision|4|||
44216073|NCT00989092|79013925|FG000|Overall Study|Withdrawal by Subject|17|||
44216074|NCT00989092|79013926|FG001|Overall Study|Withdrawal by Subject|9|||
44216075|NCT00989092|79013925|FG000|Overall Study|Death|14|||
44216076|NCT00989092|79013926|FG001|Overall Study|Death|2|||
44457517|NCT04827134|79466001|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
44457518|NCT04818593|79466015|FG000|Overall Study|Low Oocyte Yield|8|||
44457519|NCT04818593|79466016|FG001|Overall Study|Low Oocyte Yield|8|||
44457520|NCT04818593|79466015|FG000|Overall Study|Not ICSI Insemination|7|||
44457521|NCT04818593|79466016|FG001|Overall Study|Not ICSI Insemination|7|||
44457522|NCT04818593|79466015|FG000|Overall Study|Poor Sperm Quality|2|||
44457523|NCT04818593|79466016|FG001|Overall Study|Poor Sperm Quality|2|||
44216077|NCT00989092|79013925|FG000|Overall Study|Ineligibility determined|3|||
44216078|NCT00989092|79013926|FG001|Overall Study|Ineligibility determined|3|||
44457524|NCT04818593|79466015|FG000|Overall Study|Withdrawal by Subject|2|||
44457525|NCT04818593|79466016|FG001|Overall Study|Withdrawal by Subject|2|||
44457526|NCT04818593|79466015|FG000|Overall Study|Conversion to IUI due to low response|1|||
44457527|NCT04818593|79466016|FG001|Overall Study|Conversion to IUI due to low response|1|||
44457528|NCT04680975|79466022|FG000|Overall Study|Adverse Event|3|||
44457529|NCT04680975|79466022|FG000|Overall Study|Death|1|||
44457530|NCT04680975|79466022|FG000|Overall Study|Progressive Disease|1|||
44457531|NCT04680975|79466022|FG000|Overall Study|Withdrawal by Subject|1|||
44457532|NCT04673786|79466028|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
44457533|NCT04673786|79466029|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
44457534|NCT04673786|79466030|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
44457535|NCT04673786|79466028|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
44457536|NCT04673786|79466029|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
44457537|NCT04673786|79466030|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
44457538|NCT04673786|79466028|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
44457539|NCT04673786|79466029|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
44457540|NCT04673786|79466030|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
44543895|NCT03634579|79557067|FG000|Overall Study|study termination|9|||
44543896|NCT02730208|79557073|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
44543897|NCT02730208|79557074|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
44543898|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
44543899|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
44543900|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
44543901|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
44543902|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
44543903|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
44543904|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
44543905|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
44543906|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
44216079|NCT00989092|79013925|FG000|Overall Study|Lost to Follow-up|6|||
44457541|NCT04673786|79466028|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
44457542|NCT04673786|79466029|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
44216080|NCT00989092|79013926|FG001|Overall Study|Lost to Follow-up|2|||
44216081|NCT00989092|79013925|FG000|Overall Study|Other|3|||
44216082|NCT00989092|79013926|FG001|Overall Study|Other|1|||
44457543|NCT04673786|79466030|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
44457544|NCT04673786|79466028|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
44457545|NCT04673786|79466029|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
44457546|NCT04673786|79466030|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
44457547|NCT04673786|79466028|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
44457548|NCT04673786|79466029|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
44457549|NCT04673786|79466030|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
44457550|NCT04583969|79466054|FG000|Overall Study|Death|31|||
44457551|NCT04583969|79466055|FG001|Overall Study|Death|38|||
44457552|NCT04583969|79466054|FG000|Overall Study|Lost to Follow-up|16|||
44457553|NCT04583969|79466055|FG001|Overall Study|Lost to Follow-up|13|||
44457554|NCT04583969|79466054|FG000|Overall Study|Protocol Violation|1|||
44457555|NCT04583969|79466055|FG001|Overall Study|Protocol Violation|0|||
44457556|NCT04583969|79466054|FG000|Overall Study|Withdrawal by Subject|3|||
44457557|NCT04583969|79466055|FG001|Overall Study|Withdrawal by Subject|3|||
44457558|NCT04583969|79466054|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
44457559|NCT04583969|79466055|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
44457560|NCT04583969|79466054|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
44457561|NCT04583969|79466055|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
44457562|NCT04583969|79466054|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
44457563|NCT04583969|79466055|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
44457564|NCT04583969|79466054|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
44457565|NCT04583969|79466055|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
44216083|NCT00989092|79013925|FG000|Overall Study|Protocol deviation|2|||
44216084|NCT00989092|79013926|FG001|Overall Study|Protocol deviation|0|||
44216085|NCT00989092|79013925|FG000|Overall Study|Erythropoietin therapy initiated|2|||
44457566|NCT04583969|79466054|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
44457567|NCT04583969|79466055|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
44457568|NCT04561115|79466061|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
44457569|NCT04561115|79466062|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
44457570|NCT04561115|79466061|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
44457571|NCT04561115|79466062|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
44216086|NCT00989092|79013926|FG001|Overall Study|Erythropoietin therapy initiated|0|||
44216087|NCT00989092|79013925|FG000|Overall Study|Did not receive study drug|2|||
44216088|NCT00989092|79013926|FG001|Overall Study|Did not receive study drug|0|||
44216089|NCT00988858|79013933|FG000|Overall Study|Adverse Event|7|||
44216090|NCT00988858|79013933|FG000|Overall Study|Death|1|||
44216091|NCT00988858|79013933|FG000|Overall Study|Physician Decision|1|||
44216092|NCT00988858|79013933|FG000|Overall Study|Sponsor Decision|1|||
44216093|NCT00986986|79013939|FG000|Overall Study|Lost to Follow-up|0|||
44216094|NCT00986986|79013940|FG001|Overall Study|Lost to Follow-up|1|||
44216095|NCT01904773|79013947|FG000|Screen|Screen failure|3|||
44216096|NCT01904773|79013948|FG001|Screen|Screen failure|0|||
44216097|NCT01904773|79013949|FG002|Screen|Screen failure|0|||
44216098|NCT01904773|79013950|FG003|Screen|Screen failure|0|||
44216099|NCT01904773|79013951|FG004|Screen|Screen failure|0|||
44216100|NCT01904773|79013952|FG005|Screen|Screen failure|0|||
44216101|NCT01904773|79013953|FG006|Screen|Screen failure|0|||
44216102|NCT01904773|79013954|FG007|Screen|Screen failure|0|||
44216103|NCT01904773|79013955|FG008|Screen|Screen failure|0|||
44216104|NCT01904773|79013947|FG000|Screen|Withdrawal by Subject|1|||
44216105|NCT01904773|79013948|FG001|Screen|Withdrawal by Subject|0|||
44270167|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
44270168|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44457572|NCT04561115|79466061|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
44457573|NCT04561115|79466062|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
44216106|NCT01904773|79013949|FG002|Screen|Withdrawal by Subject|0|||
44270169|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44216107|NCT01904773|79013950|FG003|Screen|Withdrawal by Subject|0|||
44216108|NCT01904773|79013951|FG004|Screen|Withdrawal by Subject|0|||
44216109|NCT01904773|79013952|FG005|Screen|Withdrawal by Subject|0|||
44216110|NCT01904773|79013953|FG006|Screen|Withdrawal by Subject|0|||
44216111|NCT01904773|79013954|FG007|Screen|Withdrawal by Subject|0|||
44216112|NCT01904773|79013955|FG008|Screen|Withdrawal by Subject|0|||
44216113|NCT01904773|79013947|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
44216114|NCT01904773|79013948|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216115|NCT01904773|79013949|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216116|NCT01904773|79013950|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216117|NCT01904773|79013951|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216118|NCT01904773|79013952|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216119|NCT01904773|79013953|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216120|NCT01904773|79013954|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44372149|NCT01169337|79377129|FG002|Overall Study|Death|0|||
44457574|NCT04366258|79466068|FG000|Baseline Assessments|Screen Failure|21|||
44372150|NCT01169337|79377127|FG000|Overall Study|Withdrawal by Subject|11|||
44372151|NCT01169337|79377128|FG001|Overall Study|Withdrawal by Subject|11|||
44457575|NCT04366258|79466068|FG000|Baseline Assessments|Early Termination|3|||
44457576|NCT03891667|79466118|FG000|Overall Study|Physician Decision|1|||
44457577|NCT03891667|79466119|FG001|Overall Study|Physician Decision|0|||
44457578|NCT03891667|79466118|FG000|Overall Study|COVID related pause|1|||
44457579|NCT03891667|79466119|FG001|Overall Study|COVID related pause|1|||
44457580|NCT03891667|79466118|FG000|Overall Study|Withdrawal by Subject|0|||
44457581|NCT03891667|79466119|FG001|Overall Study|Withdrawal by Subject|1|||
44457582|NCT03891667|79466118|FG000|Overall Study|Adverse Event|0|||
44457583|NCT03891667|79466119|FG001|Overall Study|Adverse Event|1|||
44457584|NCT03715153|79466143|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
44457585|NCT03715153|79466144|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
44457586|NCT03715153|79466143|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
44457587|NCT03715153|79466144|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
44457588|NCT03715153|79466143|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
44457589|NCT03715153|79466144|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
44457590|NCT03715153|79466143|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
44457591|NCT03715153|79466144|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
44457592|NCT03715153|79466143|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
44457593|NCT03715153|79466144|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
44457594|NCT03715153|79466143|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
44457595|NCT03715153|79466144|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
44457596|NCT03569293|79466173|FG000|Overall Study|Adverse Event|4|||
44216121|NCT01904773|79013955|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
44216122|NCT01904773|79013947|FG000|First Intervention|Adverse Event|0|||
44372152|NCT01169337|79377129|FG002|Overall Study|Withdrawal by Subject|6|||
44372153|NCT01169337|79377127|FG000|Overall Study|Noncompliance|2|||
44372154|NCT01169337|79377128|FG001|Overall Study|Noncompliance|0|||
44372155|NCT01169337|79377129|FG002|Overall Study|Noncompliance|0|||
44457597|NCT03569293|79466174|FG001|Overall Study|Adverse Event|1|||
44457598|NCT03569293|79466175|FG002|Overall Study|Adverse Event|5|||
44216123|NCT01904773|79013948|FG001|First Intervention|Adverse Event|0|||
44457599|NCT03569293|79466176|FG003|Overall Study|Adverse Event|1|||
44457600|NCT03569293|79466177|FG004|Overall Study|Adverse Event|0|||
44457601|NCT03569293|79466178|FG005|Overall Study|Adverse Event|0|||
44457602|NCT03569293|79466173|FG000|Overall Study|Withdrawal by Subject|16|||
44216124|NCT01904773|79013949|FG002|First Intervention|Adverse Event|0|||
44270170|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44372156|NCT01169337|79377127|FG000|Overall Study|Other complicating disease|1|||
44216125|NCT01904773|79013950|FG003|First Intervention|Adverse Event|0|||
44216126|NCT01904773|79013951|FG004|First Intervention|Adverse Event|0|||
44216127|NCT01904773|79013952|FG005|First Intervention|Adverse Event|0|||
44216128|NCT01904773|79013953|FG006|First Intervention|Adverse Event|1|||
44216129|NCT01904773|79013954|FG007|First Intervention|Adverse Event|0|||
44216130|NCT01904773|79013955|FG008|First Intervention|Adverse Event|0|||
44457603|NCT03569293|79466174|FG001|Overall Study|Withdrawal by Subject|2|||
44457604|NCT03569293|79466175|FG002|Overall Study|Withdrawal by Subject|4|||
44457605|NCT03569293|79466176|FG003|Overall Study|Withdrawal by Subject|1|||
44457606|NCT03569293|79466177|FG004|Overall Study|Withdrawal by Subject|0|||
44457607|NCT03569293|79466178|FG005|Overall Study|Withdrawal by Subject|0|||
44457608|NCT03569293|79466173|FG000|Overall Study|Lost to Follow-up|1|||
44457609|NCT03569293|79466174|FG001|Overall Study|Lost to Follow-up|3|||
44457610|NCT03569293|79466175|FG002|Overall Study|Lost to Follow-up|1|||
44457611|NCT03569293|79466176|FG003|Overall Study|Lost to Follow-up|1|||
44457612|NCT03569293|79466177|FG004|Overall Study|Lost to Follow-up|0|||
44457613|NCT03569293|79466178|FG005|Overall Study|Lost to Follow-up|0|||
44457614|NCT03569293|79466173|FG000|Overall Study|Other|8|||
44457615|NCT03569293|79466174|FG001|Overall Study|Other|2|||
44457616|NCT03569293|79466175|FG002|Overall Study|Other|1|||
44457617|NCT03569293|79466176|FG003|Overall Study|Other|1|||
44457618|NCT03569293|79466177|FG004|Overall Study|Other|0|||
44457619|NCT03569293|79466178|FG005|Overall Study|Other|0|||
44457620|NCT03569293|79466173|FG000|Overall Study|Ongoing at Time of Analysis|8|||
44457621|NCT03569293|79466174|FG001|Overall Study|Ongoing at Time of Analysis|1|||
44457622|NCT03569293|79466175|FG002|Overall Study|Ongoing at Time of Analysis|3|||
44457623|NCT03569293|79466176|FG003|Overall Study|Ongoing at Time of Analysis|0|||
44457624|NCT03569293|79466177|FG004|Overall Study|Ongoing at Time of Analysis|0|||
44457625|NCT03569293|79466178|FG005|Overall Study|Ongoing at Time of Analysis|0|||
44457626|NCT03464136|79466194|FG000|Overall Study|Lost to Follow-up|5|||
44457627|NCT03464136|79466195|FG001|Overall Study|Lost to Follow-up|8|||
44457628|NCT03464136|79466194|FG000|Overall Study|Withdrawal by Subject|16|||
44457629|NCT03464136|79466195|FG001|Overall Study|Withdrawal by Subject|13|||
44457630|NCT03464136|79466194|FG000|Overall Study|Death|1|||
44457631|NCT03464136|79466195|FG001|Overall Study|Death|0|||
44457632|NCT03464136|79466194|FG000|Overall Study|Other|8|||
44216131|NCT01904773|79013947|FG000|Placebo Washout First Intervention|Condition worsened|0|||
44372157|NCT01169337|79377128|FG001|Overall Study|Other complicating disease|1|||
44457633|NCT03464136|79466195|FG001|Overall Study|Other|4|||
44457634|NCT03020823|79466219|FG000|Overall Study|Physician Decision|4|||
44457635|NCT03020823|79466219|FG000|Overall Study|Lack of Efficacy|4|||
44457636|NCT03020823|79466219|FG000|Overall Study|Adverse Event|2|||
44372158|NCT01169337|79377129|FG002|Overall Study|Other complicating disease|0|||
44372159|NCT01169337|79377127|FG000|Overall Study|Physician Decision|1|||
44372160|NCT01169337|79377128|FG001|Overall Study|Physician Decision|5|||
44372161|NCT01169337|79377129|FG002|Overall Study|Physician Decision|0|||
44216132|NCT01904773|79013948|FG001|Placebo Washout First Intervention|Condition worsened|1|||
44216133|NCT01904773|79013949|FG002|Placebo Washout First Intervention|Condition worsened|0|||
44372162|NCT01169337|79377127|FG000|Overall Study|Alternative therapy|0|||
44372163|NCT01169337|79377128|FG001|Overall Study|Alternative therapy|2|||
44457637|NCT02969369|79466227|FG000|Study|Adverse Event|1|||
44457638|NCT02969369|79466228|FG001|Study|Adverse Event|6|||
44216134|NCT01904773|79013950|FG003|Placebo Washout First Intervention|Condition worsened|0|||
44372164|NCT01169337|79377129|FG002|Overall Study|Alternative therapy|0|||
44457639|NCT02969369|79466227|FG000|Study|Lack of Efficacy|0|||
44457640|NCT02969369|79466228|FG001|Study|Lack of Efficacy|1|||
44457641|NCT02969369|79466227|FG000|Study|Lost to Follow-up|0|||
44216135|NCT01904773|79013951|FG004|Placebo Washout First Intervention|Condition worsened|0|||
44457642|NCT02969369|79466228|FG001|Study|Lost to Follow-up|1|||
44457643|NCT02969369|79466227|FG000|Study|Withdrawal by Subject|3|||
44457644|NCT02969369|79466228|FG001|Study|Withdrawal by Subject|5|||
44457645|NCT02969369|79466227|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
44457646|NCT02969369|79466228|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
44457647|NCT02969369|79466227|FG000|Double-blind Period|Adverse Event|1|||
44457648|NCT02969369|79466228|FG001|Double-blind Period|Adverse Event|5|||
44457649|NCT02969369|79466227|FG000|Double-blind Period|Lost to Follow-up|0|||
44457650|NCT02969369|79466228|FG001|Double-blind Period|Lost to Follow-up|1|||
44457651|NCT02969369|79466227|FG000|Double-blind Period|Withdrawal by Subject|2|||
44457652|NCT02969369|79466228|FG001|Double-blind Period|Withdrawal by Subject|3|||
44457653|NCT02969369|79466227|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
44457654|NCT02969369|79466228|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
44457655|NCT02969369|79466227|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
44457656|NCT02969369|79466228|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
44457657|NCT02969369|79466227|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
44457658|NCT02969369|79466228|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
44457659|NCT02969369|79466227|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
44457660|NCT02969369|79466228|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
44457661|NCT02583269|79466248|FG000|Overall Study|Patient hospitalized prior to start|1|||
44457662|NCT02583269|79466249|FG001|Overall Study|Patient hospitalized prior to start|0|||
44457663|NCT02583269|79466250|FG002|Overall Study|Patient hospitalized prior to start|0|||
44457664|NCT02583269|79466251|FG003|Overall Study|Patient hospitalized prior to start|0|||
44457665|NCT02583269|79466252|FG004|Overall Study|Patient hospitalized prior to start|0|||
44457666|NCT02546921|79466272|FG000|Overall Study|Adverse Event|0|||
44457667|NCT02546921|79466273|FG001|Overall Study|Adverse Event|5|||
44457668|NCT02546921|79466274|FG002|Overall Study|Adverse Event|2|||
44457669|NCT02546921|79466275|FG003|Overall Study|Adverse Event|0|||
44457670|NCT02546921|79466276|FG004|Overall Study|Adverse Event|0|||
44457671|NCT02546921|79466277|FG005|Overall Study|Adverse Event|0|||
44457672|NCT02546921|79466278|FG006|Overall Study|Adverse Event|0|||
44372165|NCT01169337|79377127|FG000|Overall Study|Changed hospital|0|||
44372166|NCT01169337|79377128|FG001|Overall Study|Changed hospital|1|||
44372167|NCT01169337|79377129|FG002|Overall Study|Changed hospital|0|||
44457673|NCT02546921|79466272|FG000|Overall Study|Evidence of Disease Progression|1|||
44457674|NCT02546921|79466273|FG001|Overall Study|Evidence of Disease Progression|0|||
44457675|NCT02546921|79466274|FG002|Overall Study|Evidence of Disease Progression|0|||
44457676|NCT02546921|79466275|FG003|Overall Study|Evidence of Disease Progression|0|||
44457677|NCT02546921|79466276|FG004|Overall Study|Evidence of Disease Progression|1|||
44457678|NCT02546921|79466277|FG005|Overall Study|Evidence of Disease Progression|0|||
44457679|NCT02546921|79466278|FG006|Overall Study|Evidence of Disease Progression|0|||
44457680|NCT02546921|79466272|FG000|Overall Study|Patient Choice|0|||
44457681|NCT02546921|79466273|FG001|Overall Study|Patient Choice|1|||
44457682|NCT02546921|79466274|FG002|Overall Study|Patient Choice|0|||
44457683|NCT02546921|79466275|FG003|Overall Study|Patient Choice|0|||
44457684|NCT02546921|79466276|FG004|Overall Study|Patient Choice|0|||
44457685|NCT02546921|79466277|FG005|Overall Study|Patient Choice|1|||
44457686|NCT02546921|79466278|FG006|Overall Study|Patient Choice|0|||
44457687|NCT02513329|79466312|FG000|Overall Study|Lost to Follow-up|5|||
44216136|NCT01904773|79013952|FG005|Placebo Washout First Intervention|Condition worsened|0|||
44216137|NCT01904773|79013953|FG006|Placebo Washout First Intervention|Condition worsened|0|||
44216138|NCT01904773|79013954|FG007|Placebo Washout First Intervention|Condition worsened|0|||
44372168|NCT01169337|79377127|FG000|Overall Study|Never started treatment|0|||
44372169|NCT01169337|79377128|FG001|Overall Study|Never started treatment|2|||
44372170|NCT01169337|79377129|FG002|Overall Study|Never started treatment|0|||
44372171|NCT01169337|79377127|FG000|Overall Study|Reason not reported|1|||
44372172|NCT01169337|79377128|FG001|Overall Study|Reason not reported|0|||
44457688|NCT02513329|79466313|FG001|Overall Study|Lost to Follow-up|2|||
44457689|NCT02425826|79466323|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
44457690|NCT02425826|79466324|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
44216139|NCT01904773|79013955|FG008|Placebo Washout First Intervention|Condition worsened|0|||
44216140|NCT01904773|79013947|FG000|Fifth Intervention|Adverse Event|0|||
44216141|NCT01904773|79013948|FG001|Fifth Intervention|Adverse Event|0|||
44216142|NCT01904773|79013949|FG002|Fifth Intervention|Adverse Event|0|||
44372173|NCT01169337|79377129|FG002|Overall Study|Reason not reported|0|||
44457691|NCT02425826|79466325|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
44457692|NCT02425826|79466323|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
44457693|NCT02425826|79466324|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
44457694|NCT02425826|79466325|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
44216143|NCT01904773|79013950|FG003|Fifth Intervention|Adverse Event|0|||
44216144|NCT01904773|79013951|FG004|Fifth Intervention|Adverse Event|0|||
44216145|NCT01904773|79013952|FG005|Fifth Intervention|Adverse Event|0|||
44216146|NCT01904773|79013953|FG006|Fifth Intervention|Adverse Event|0|||
44216147|NCT01904773|79013954|FG007|Fifth Intervention|Adverse Event|1|||
44372174|NCT01169337|79377127|FG000|Overall Study|Continuing lenalidomide|9|||
44372175|NCT01169337|79377128|FG001|Overall Study|Continuing lenalidomide|43|||
44372176|NCT01169337|79377129|FG002|Overall Study|Continuing lenalidomide|0|||
44216148|NCT01904773|79013955|FG008|Fifth Intervention|Adverse Event|0|||
44216149|NCT01904773|79013947|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216150|NCT01904773|79013948|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
44216151|NCT01904773|79013949|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216152|NCT01904773|79013950|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216153|NCT01904773|79013951|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216154|NCT01904773|79013952|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216155|NCT01904773|79013953|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216156|NCT01904773|79013954|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216157|NCT01904773|79013955|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
44216158|NCT01928719|79013969|FG000|Overall Study|Lost to Follow-up|26|||
44216159|NCT01928719|79013970|FG001|Overall Study|Lost to Follow-up|11|||
44216160|NCT01928719|79013969|FG000|Overall Study|Withdrawal by Subject|22|||
44216161|NCT01928719|79013970|FG001|Overall Study|Withdrawal by Subject|7|||
44216162|NCT01928719|79013969|FG000|Overall Study|Protocol Violation|3|||
44216163|NCT01928719|79013970|FG001|Overall Study|Protocol Violation|1|||
44216164|NCT01928719|79013969|FG000|Overall Study|Adverse Event|1|||
44216165|NCT01928719|79013970|FG001|Overall Study|Adverse Event|0|||
44216166|NCT00986674|79013981|FG000|Overall Study|Lack of Efficacy|28|||
44216167|NCT00986674|79013982|FG001|Overall Study|Lack of Efficacy|25|||
44216168|NCT00986674|79013983|FG002|Overall Study|Lack of Efficacy|23|||
44216169|NCT00986674|79013981|FG000|Overall Study|Adverse Event|4|||
44216170|NCT00986674|79013982|FG001|Overall Study|Adverse Event|8|||
44216171|NCT00986674|79013983|FG002|Overall Study|Adverse Event|9|||
44216172|NCT00986674|79013981|FG000|Overall Study|Death|5|||
44216173|NCT00986674|79013982|FG001|Overall Study|Death|0|||
44216174|NCT00986674|79013983|FG002|Overall Study|Death|4|||
44216175|NCT00986674|79013981|FG000|Overall Study|Withdrawal by Subject|6|||
44372177|NCT01064648|79377140|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
44372178|NCT01064648|79377141|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
44372179|NCT01064648|79377142|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
44372180|NCT01064648|79377143|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
44543907|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
44216176|NCT00986674|79013982|FG001|Overall Study|Withdrawal by Subject|2|||
44216177|NCT00986674|79013983|FG002|Overall Study|Withdrawal by Subject|1|||
44216178|NCT00986674|79013981|FG000|Overall Study|alternative therapy|0|||
44216179|NCT00986674|79013982|FG001|Overall Study|alternative therapy|0|||
44216180|NCT00986674|79013983|FG002|Overall Study|alternative therapy|1|||
44216181|NCT00986674|79013981|FG000|Overall Study|not start protocol therapy|4|||
44457695|NCT02425826|79466323|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
44457696|NCT02425826|79466324|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
44216182|NCT00986674|79013982|FG001|Overall Study|not start protocol therapy|3|||
44216183|NCT00986674|79013983|FG002|Overall Study|not start protocol therapy|1|||
44216184|NCT00986674|79013981|FG000|Overall Study|unknown/not specify|0|||
44216185|NCT00986674|79013982|FG001|Overall Study|unknown/not specify|7|||
44216186|NCT00986674|79013983|FG002|Overall Study|unknown/not specify|9|||
44216187|NCT00986440|79013993|FG000|Overall Study|Progressive disease|27|||
44216188|NCT00986440|79013994|FG001|Overall Study|Progressive disease|37|||
44457697|NCT02425826|79466325|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
44457698|NCT02425826|79466323|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
44457699|NCT02425826|79466324|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
44457700|NCT02425826|79466325|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
44457701|NCT02425826|79466323|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
44457702|NCT02425826|79466324|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
44457703|NCT02425826|79466325|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
44457704|NCT02425826|79466323|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
44457705|NCT02425826|79466324|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
44457706|NCT02425826|79466325|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
44457707|NCT02425826|79466323|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
44457708|NCT02425826|79466324|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
44457709|NCT02425826|79466325|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
44457710|NCT02425826|79466323|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
44457711|NCT02425826|79466324|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
44457712|NCT02425826|79466325|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
44457713|NCT02425826|79466323|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
44457714|NCT02425826|79466324|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
44457715|NCT02425826|79466325|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
44457716|NCT02425826|79466323|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
44457717|NCT02425826|79466324|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
44457718|NCT02425826|79466325|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
44457719|NCT02406027|79466338|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
44457720|NCT02406027|79466339|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
44457721|NCT02406027|79466340|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
44457722|NCT02406027|79466341|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
44457723|NCT02406027|79466342|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
44457724|NCT02406027|79466343|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
44457725|NCT02406027|79466344|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
44457726|NCT02406027|79466338|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
44457727|NCT02406027|79466339|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
44457728|NCT02406027|79466340|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
44457729|NCT02406027|79466341|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
44457730|NCT02406027|79466342|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
44457731|NCT02406027|79466343|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
44457732|NCT02406027|79466344|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
44457733|NCT02406027|79466338|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
44457734|NCT02406027|79466339|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
44457735|NCT02406027|79466340|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
44457736|NCT02406027|79466341|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
44457737|NCT02406027|79466342|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
44457738|NCT02406027|79466343|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
44457739|NCT02406027|79466344|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
44457740|NCT02406027|79466338|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
44457741|NCT02406027|79466339|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
44457742|NCT02406027|79466340|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
44457743|NCT02406027|79466341|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
44457744|NCT02406027|79466342|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
44457745|NCT02406027|79466343|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
44457746|NCT02406027|79466344|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
44543908|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
44216189|NCT00986440|79013993|FG000|Overall Study|Serious adverse event or adverse event|9|||
44216190|NCT00986440|79013994|FG001|Overall Study|Serious adverse event or adverse event|2|||
44457747|NCT02406027|79466338|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
44457748|NCT02406027|79466339|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
44457749|NCT02406027|79466340|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
44457750|NCT02406027|79466341|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
44457751|NCT02406027|79466342|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
44457752|NCT02406027|79466343|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
44457753|NCT02406027|79466344|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
44457754|NCT02406027|79466338|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
44457755|NCT02406027|79466339|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
44457756|NCT02406027|79466340|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
44457757|NCT02406027|79466341|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
44457758|NCT02406027|79466342|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
44457759|NCT02406027|79466343|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
44457760|NCT02406027|79466344|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
44457761|NCT02406027|79466338|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
44457762|NCT02406027|79466339|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
44457763|NCT02406027|79466340|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
44457764|NCT02406027|79466341|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
44457765|NCT02406027|79466342|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
44270171|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44457766|NCT02406027|79466343|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
44457767|NCT02406027|79466344|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
44457768|NCT02406027|79466338|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
44543909|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
44216191|NCT00986440|79013993|FG000|Overall Study|Withdrawal by Subject|1|||
44216192|NCT00986440|79013994|FG001|Overall Study|Withdrawal by Subject|2|||
44216193|NCT00986440|79013993|FG000|Overall Study|Screen failure (not dosed)|4|||
44216194|NCT00986440|79013994|FG001|Overall Study|Screen failure (not dosed)|2|||
44216195|NCT01904383|79014000|FG000|Overall Study|CRF not collected|117|||
44216196|NCT01904383|79014000|FG000|Overall Study|Reason not listed|147|||
44216197|NCT01904383|79014000|FG000|Overall Study|Lost to Follow-up|674|||
44216198|NCT01904383|79014000|FG000|Overall Study|Lack of Efficacy|370|||
44216199|NCT01904383|79014000|FG000|Overall Study|Improvement|141|||
44216200|NCT01904383|79014000|FG000|Overall Study|Adverse Event|271|||
44216201|NCT01904383|79014000|FG000|Overall Study|No patient visit after entry|54|||
44216202|NCT01904149|79014010|FG000|Overall Study|Adverse Event|3|||
44216203|NCT01904149|79014011|FG001|Overall Study|Adverse Event|4|||
44216204|NCT01904149|79014012|FG002|Overall Study|Adverse Event|0|||
44216205|NCT01904149|79014013|FG003|Overall Study|Adverse Event|1|||
44216206|NCT01904149|79014014|FG004|Overall Study|Adverse Event|1|||
44216207|NCT01904149|79014015|FG005|Overall Study|Adverse Event|2|||
44216208|NCT01904149|79014010|FG000|Overall Study|Lack of Efficacy|0|||
44216209|NCT01904149|79014011|FG001|Overall Study|Lack of Efficacy|3|||
44216210|NCT01904149|79014012|FG002|Overall Study|Lack of Efficacy|1|||
44216211|NCT01904149|79014013|FG003|Overall Study|Lack of Efficacy|3|||
44216212|NCT01904149|79014014|FG004|Overall Study|Lack of Efficacy|3|||
44216213|NCT01904149|79014015|FG005|Overall Study|Lack of Efficacy|1|||
44216214|NCT01904149|79014010|FG000|Overall Study|Withdrawal by Subject|1|||
44216215|NCT01904149|79014011|FG001|Overall Study|Withdrawal by Subject|3|||
44216216|NCT01904149|79014012|FG002|Overall Study|Withdrawal by Subject|1|||
44216217|NCT01904149|79014013|FG003|Overall Study|Withdrawal by Subject|0|||
44216218|NCT01904149|79014014|FG004|Overall Study|Withdrawal by Subject|1|||
44216219|NCT01904149|79014015|FG005|Overall Study|Withdrawal by Subject|0|||
44216220|NCT01904149|79014010|FG000|Overall Study|Protocol Violation|0|||
44216221|NCT01904149|79014011|FG001|Overall Study|Protocol Violation|1|||
44216222|NCT01904149|79014012|FG002|Overall Study|Protocol Violation|0|||
44216223|NCT01904149|79014013|FG003|Overall Study|Protocol Violation|0|||
44216224|NCT01904149|79014014|FG004|Overall Study|Protocol Violation|0|||
44216225|NCT01904149|79014015|FG005|Overall Study|Protocol Violation|0|||
44216226|NCT01904149|79014010|FG000|Overall Study|non compliance with study drug|1|||
44216227|NCT01904149|79014011|FG001|Overall Study|non compliance with study drug|0|||
44216228|NCT01904149|79014012|FG002|Overall Study|non compliance with study drug|0|||
44216229|NCT01904149|79014013|FG003|Overall Study|non compliance with study drug|0|||
44216230|NCT01904149|79014014|FG004|Overall Study|non compliance with study drug|0|||
44216231|NCT01904149|79014015|FG005|Overall Study|non compliance with study drug|0|||
44216232|NCT00986362|79014033|FG000|Overall Study|Death|2|||
44216233|NCT00986362|79014034|FG001|Overall Study|Death|0|||
44216234|NCT00986362|79014033|FG000|Overall Study|Lost to Follow-up|0|||
44216235|NCT00986362|79014034|FG001|Overall Study|Lost to Follow-up|1|||
44216236|NCT01890421|79014040|FG000|Overall Study|Adverse Event|1|||
44216237|NCT01890421|79014040|FG000|Overall Study|Other reason|10|||
44216238|NCT00985738|79014046|FG000|Overall Study|Study closed prematurely|8|||
44216239|NCT00985738|79014047|FG001|Overall Study|Study closed prematurely|8|||
44216240|NCT01928485|79014055|FG000|Overall Study|Physician Decision|0|||
44216241|NCT01928485|79014056|FG001|Overall Study|Physician Decision|1|||
44216242|NCT00985504|79014064|FG000|Acute Treatment Period|Adverse Event|3|||
44216243|NCT00985504|79014065|FG001|Acute Treatment Period|Adverse Event|4|||
44216244|NCT00985504|79014064|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
44216245|NCT00985504|79014065|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
44216246|NCT00985504|79014064|FG000|Acute Treatment Period|Protocol Violation|2|||
44216247|NCT00985504|79014065|FG001|Acute Treatment Period|Protocol Violation|0|||
44216248|NCT00985504|79014064|FG000|Acute Treatment Period|Sponsor Decision|0|||
44216249|NCT00985504|79014065|FG001|Acute Treatment Period|Sponsor Decision|1|||
44216250|NCT00985504|79014064|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
44216251|NCT00985504|79014065|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
44216252|NCT00985504|79014064|FG000|Optimization Period|Adverse Event|7|||
44216253|NCT00985504|79014065|FG001|Optimization Period|Adverse Event|9|||
44216254|NCT00985504|79014064|FG000|Optimization Period|Death|0|||
44216255|NCT00985504|79014065|FG001|Optimization Period|Death|1|||
44216256|NCT00985504|79014064|FG000|Optimization Period|Lack of Efficacy|5|||
44216257|NCT00985504|79014065|FG001|Optimization Period|Lack of Efficacy|3|||
44216258|NCT00985504|79014064|FG000|Optimization Period|Lost to Follow-up|0|||
44216259|NCT00985504|79014065|FG001|Optimization Period|Lost to Follow-up|1|||
44216260|NCT00985504|79014064|FG000|Optimization Period|Physician Decision|1|||
44216261|NCT00985504|79014065|FG001|Optimization Period|Physician Decision|0|||
44216262|NCT00985504|79014064|FG000|Optimization Period|Protocol Violation|3|||
44216263|NCT00985504|79014065|FG001|Optimization Period|Protocol Violation|1|||
44216264|NCT00985504|79014064|FG000|Optimization Period|Withdrawal by Subject|10|||
44216265|NCT00985504|79014065|FG001|Optimization Period|Withdrawal by Subject|8|||
44216266|NCT00985426|79014073|FG000|Overall Study|Adverse Event|0|||
44216267|NCT00985426|79014074|FG001|Overall Study|Adverse Event|1|||
44216268|NCT00985426|79014073|FG000|Overall Study|Subject Non-Compliance|3|||
44216269|NCT00985426|79014074|FG001|Overall Study|Subject Non-Compliance|3|||
44216270|NCT00985426|79014073|FG000|Overall Study|Withdrawal by Subject|12|||
44216271|NCT00985426|79014074|FG001|Overall Study|Withdrawal by Subject|16|||
44216272|NCT00985426|79014073|FG000|Overall Study|Lost to Follow-up|8|||
44216273|NCT00985426|79014074|FG001|Overall Study|Lost to Follow-up|10|||
44216274|NCT00985426|79014073|FG000|Overall Study|Death|7|||
44216275|NCT00985426|79014074|FG001|Overall Study|Death|3|||
44216276|NCT00985426|79014073|FG000|Overall Study|Protocol Violation|2|||
44216277|NCT00985426|79014074|FG001|Overall Study|Protocol Violation|0|||
44216278|NCT00985426|79014073|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
44372181|NCT01064648|79377140|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
44372182|NCT01064648|79377141|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
44372183|NCT01064648|79377142|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
44457769|NCT02406027|79466339|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
44457770|NCT02406027|79466340|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
44457771|NCT02406027|79466341|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
44457772|NCT02406027|79466342|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
44457773|NCT02406027|79466343|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
44457774|NCT02406027|79466344|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
44457775|NCT02406027|79466338|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
44457776|NCT02406027|79466339|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
44457777|NCT02406027|79466340|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
44457778|NCT02406027|79466341|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
44457779|NCT02406027|79466342|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
44457780|NCT02406027|79466343|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
44457781|NCT02406027|79466344|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
44457782|NCT02406027|79466338|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
44457783|NCT02406027|79466339|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
44457784|NCT02406027|79466340|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
44457785|NCT02406027|79466341|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
44457786|NCT02406027|79466342|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
44457787|NCT02406027|79466343|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
44457788|NCT02406027|79466344|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
44457789|NCT02278120|79466362|FG000|Overall Study|Progressive disease|122|||
44457790|NCT02278120|79466363|FG001|Overall Study|Progressive disease|174|||
44457791|NCT02278120|79466362|FG000|Overall Study|Patient/guardian decision|14|||
44543910|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
44543911|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
44543912|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
44543913|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
44543914|NCT01291511|79557082|FG000|Cross-Titration and Stabilization Phase|Death|1|||
44543915|NCT01291511|79557083|FG001|Cross-Titration and Stabilization Phase|Death|0|||
44543916|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
44543917|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
44543918|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
44543919|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
44543920|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
44543921|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
44216279|NCT00985426|79014074|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
44216280|NCT00985192|79014080|FG000|Overall Study|Withdrawal by Subject|1|||
44216281|NCT00985192|79014080|FG000|Overall Study|Disease Progression|1|||
44216282|NCT00985192|79014080|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
44372184|NCT01064648|79377143|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
44372185|NCT01064648|79377140|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
44372186|NCT01064648|79377141|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
44372187|NCT01064648|79377142|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
44372188|NCT01064648|79377143|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
44372189|NCT01064648|79377140|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
44216283|NCT00985114|79014086|FG000|Overall Study|Adverse Event|1|||
44216284|NCT00985114|79014087|FG001|Overall Study|Adverse Event|0|||
44457792|NCT02278120|79466363|FG001|Overall Study|Patient/guardian decision|8|||
44457793|NCT02278120|79466362|FG000|Overall Study|Adverse Event|12|||
44457794|NCT02278120|79466363|FG001|Overall Study|Adverse Event|10|||
44216285|NCT00985114|79014086|FG000|Overall Study|Withdrawal by Subject|0|||
44216286|NCT00985114|79014087|FG001|Overall Study|Withdrawal by Subject|2|||
44457795|NCT02278120|79466362|FG000|Overall Study|Physician Decision|8|||
44457796|NCT02278120|79466363|FG001|Overall Study|Physician Decision|19|||
44457797|NCT02278120|79466362|FG000|Overall Study|Death|3|||
44457798|NCT02278120|79466363|FG001|Overall Study|Death|3|||
44457799|NCT02278120|79466362|FG000|Overall Study|Lost to Follow-up|2|||
44457800|NCT02278120|79466363|FG001|Overall Study|Lost to Follow-up|0|||
44457801|NCT02278120|79466362|FG000|Overall Study|Protocol Violation|0|||
44457802|NCT02278120|79466363|FG001|Overall Study|Protocol Violation|2|||
44457803|NCT02255357|79466371|FG000|Overall Study|Physician Decision|10|||
44457804|NCT02255357|79466372|FG001|Overall Study|Physician Decision|24|||
44457805|NCT02211131|79466380|FG000|Overall Study|Death|26|||
44457806|NCT02211131|79466381|FG001|Overall Study|Death|16|||
44457807|NCT02211131|79466380|FG000|Overall Study|Lost to Follow-up|4|||
44457808|NCT02211131|79466381|FG001|Overall Study|Lost to Follow-up|3|||
44457809|NCT02211131|79466380|FG000|Overall Study|Decision by Sponsor|1|||
44457810|NCT02211131|79466381|FG001|Overall Study|Decision by Sponsor|1|||
44457811|NCT02211131|79466380|FG000|Overall Study|Withdrawal by Subject|3|||
44457812|NCT02211131|79466381|FG001|Overall Study|Withdrawal by Subject|8|||
44457813|NCT02155647|79466396|FG000|Overall Study|Still on Treatment|26|||
44457814|NCT02155647|79466397|FG001|Overall Study|Still on Treatment|26|||
44216287|NCT00984568|79014095|FG000|Overall Study|Withdrawal by Subject|1|||
44216288|NCT00984568|79014096|FG001|Overall Study|Withdrawal by Subject|2|||
44216289|NCT00984568|79014095|FG000|Overall Study|Lack of Efficacy|2|||
44216290|NCT00984568|79014096|FG001|Overall Study|Lack of Efficacy|0|||
44216291|NCT00984568|79014095|FG000|Overall Study|Adverse Event|2|||
44216292|NCT00984568|79014096|FG001|Overall Study|Adverse Event|0|||
44216293|NCT00984568|79014095|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
44216294|NCT00984568|79014096|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
44216295|NCT00984568|79014095|FG000|Overall Study|Lost to Follow-up|0|||
44216296|NCT00984568|79014096|FG001|Overall Study|Lost to Follow-up|1|||
44216297|NCT00984568|79014095|FG000|Overall Study|Opportunistic Infection|1|||
44216298|NCT00984568|79014096|FG001|Overall Study|Opportunistic Infection|0|||
44216299|NCT00984568|79014095|FG000|Overall Study|Unknown Reason|1|||
44216300|NCT00984568|79014096|FG001|Overall Study|Unknown Reason|3|||
44216301|NCT00984256|79014104|FG000|Overall Study|Withdrawal by Subject|0|||
44216302|NCT00984256|79014105|FG001|Overall Study|Withdrawal by Subject|1|||
44216303|NCT00984022|79014122|FG000|Overall Study|Lost to Follow-up|10|||
44270172|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44270173|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
44270174|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
44457815|NCT02155647|79466396|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
44543922|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
44543923|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
44543924|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
44543925|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
44543926|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
44543927|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
44543928|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
44543929|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
44543930|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
44543931|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
44543932|NCT01291511|79557082|FG000|Double-blind Relapse Prevention Phase|Death|1|||
44543933|NCT01291511|79557083|FG001|Double-blind Relapse Prevention Phase|Death|0|||
44543934|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
44457816|NCT02155647|79466397|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
44457817|NCT02134587|79466407|FG000|Overall Study|Did not completed all meetings|30|||
44216304|NCT00984022|79014123|FG001|Overall Study|Lost to Follow-up|14|||
44216305|NCT01890265|79014135|FG000|Overall Study|Other (Unspecified reason)|0|||
44216306|NCT01890265|79014136|FG001|Overall Study|Other (Unspecified reason)|1|||
44216307|NCT01890265|79014137|FG002|Overall Study|Other (Unspecified reason)|0|||
44216308|NCT01890265|79014138|FG003|Overall Study|Other (Unspecified reason)|0|||
44457818|NCT01752920|79466420|FG000|Overall Study|Adverse Event|1|||
44457819|NCT01752920|79466421|FG001|Overall Study|Adverse Event|0|||
44216309|NCT01890265|79014139|FG004|Overall Study|Other (Unspecified reason)|0|||
44216310|NCT01890265|79014140|FG005|Overall Study|Other (Unspecified reason)|0|||
44216311|NCT01890265|79014135|FG000|Overall Study|Progressive disease|6|||
44216312|NCT01890265|79014136|FG001|Overall Study|Progressive disease|6|||
44216313|NCT01890265|79014137|FG002|Overall Study|Progressive disease|0|||
44216314|NCT01890265|79014138|FG003|Overall Study|Progressive disease|0|||
44216315|NCT01890265|79014139|FG004|Overall Study|Progressive disease|0|||
44457820|NCT01752920|79466422|FG002|Overall Study|Adverse Event|5|||
44457821|NCT01752920|79466423|FG003|Overall Study|Adverse Event|10|||
44216316|NCT01890265|79014140|FG005|Overall Study|Progressive disease|0|||
44216317|NCT01890265|79014135|FG000|Overall Study|Adverse Event|2|||
44216318|NCT01890265|79014136|FG001|Overall Study|Adverse Event|1|||
44457822|NCT01752920|79466420|FG000|Overall Study|Clinical Disease Progression|6|||
44457823|NCT01752920|79466421|FG001|Overall Study|Clinical Disease Progression|4|||
44457824|NCT01752920|79466422|FG002|Overall Study|Clinical Disease Progression|1|||
44457825|NCT01752920|79466423|FG003|Overall Study|Clinical Disease Progression|13|||
44457826|NCT01752920|79466420|FG000|Overall Study|Physician Decision|1|||
44457827|NCT01752920|79466421|FG001|Overall Study|Physician Decision|0|||
44457828|NCT01752920|79466422|FG002|Overall Study|Physician Decision|0|||
44457829|NCT01752920|79466423|FG003|Overall Study|Physician Decision|3|||
44457830|NCT01752920|79466420|FG000|Overall Study|Radiographic Disease Progression|20|||
44457831|NCT01752920|79466421|FG001|Overall Study|Radiographic Disease Progression|7|||
44457832|NCT01752920|79466422|FG002|Overall Study|Radiographic Disease Progression|12|||
44457833|NCT01752920|79466423|FG003|Overall Study|Radiographic Disease Progression|29|||
44457834|NCT01752920|79466420|FG000|Overall Study|Study Terminated by Sponsor|0|||
44457835|NCT01752920|79466421|FG001|Overall Study|Study Terminated by Sponsor|0|||
44457836|NCT01752920|79466422|FG002|Overall Study|Study Terminated by Sponsor|0|||
44457837|NCT01752920|79466423|FG003|Overall Study|Study Terminated by Sponsor|1|||
44457838|NCT01752920|79466420|FG000|Overall Study|Withdrawal by Subject|0|||
44457839|NCT01752920|79466421|FG001|Overall Study|Withdrawal by Subject|1|||
44457840|NCT01752920|79466422|FG002|Overall Study|Withdrawal by Subject|0|||
44457841|NCT01752920|79466423|FG003|Overall Study|Withdrawal by Subject|1|||
44457842|NCT01752920|79466420|FG000|Overall Study|Lack of clinical benefit|1|||
44457843|NCT01752920|79466421|FG001|Overall Study|Lack of clinical benefit|1|||
44457844|NCT01752920|79466422|FG002|Overall Study|Lack of clinical benefit|1|||
44457845|NCT01752920|79466423|FG003|Overall Study|Lack of clinical benefit|1|||
44457846|NCT00976963|79466437|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
44457847|NCT00976963|79466438|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
44457848|NCT00976963|79466437|FG000|Overall Study|administrative error|1|||
44270175|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44457849|NCT00976963|79466438|FG001|Overall Study|administrative error|0|||
44457850|NCT00976963|79466437|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
44457851|NCT00976963|79466438|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
44216319|NCT01890265|79014137|FG002|Overall Study|Adverse Event|0|||
44216320|NCT01890265|79014138|FG003|Overall Study|Adverse Event|0|||
44216321|NCT01890265|79014139|FG004|Overall Study|Adverse Event|0|||
44216322|NCT01890265|79014140|FG005|Overall Study|Adverse Event|0|||
44216323|NCT01890265|79014135|FG000|Overall Study|Death|2|||
44216324|NCT01890265|79014136|FG001|Overall Study|Death|3|||
44457852|NCT00423735|79466455|FG000|Overall Study|Ineligible / No protocol treatment|8|||
44457853|NCT00423735|79466456|FG001|Overall Study|Ineligible / No protocol treatment|6|||
44457854|NCT00423735|79466457|FG002|Overall Study|Ineligible / No protocol treatment|0|||
44457855|NCT00626327|79466470|FG000|Overall Study|Withdrawal by Subject|21|||
44457856|NCT00626327|79466471|FG001|Overall Study|Withdrawal by Subject|29|||
44457857|NCT00626327|79466472|FG002|Overall Study|Withdrawal by Subject|30|||
44457858|NCT00626327|79466470|FG000|Overall Study|Adverse Event|1|||
44457859|NCT00626327|79466471|FG001|Overall Study|Adverse Event|0|||
44457860|NCT00626327|79466472|FG002|Overall Study|Adverse Event|0|||
44457861|NCT00626327|79466470|FG000|Overall Study|Lost to Follow-up|24|||
44457862|NCT00626327|79466471|FG001|Overall Study|Lost to Follow-up|21|||
44457863|NCT00626327|79466472|FG002|Overall Study|Lost to Follow-up|23|||
44457864|NCT00626327|79466470|FG000|Overall Study|Inappropriate enrollment|4|||
44457865|NCT00626327|79466471|FG001|Overall Study|Inappropriate enrollment|5|||
44457866|NCT00626327|79466472|FG002|Overall Study|Inappropriate enrollment|3|||
44457867|NCT00626327|79466470|FG000|Overall Study|Administrative Reason|2|||
44457868|NCT00626327|79466471|FG001|Overall Study|Administrative Reason|0|||
44457869|NCT00626327|79466472|FG002|Overall Study|Administrative Reason|6|||
44457870|NCT00626327|79466470|FG000|Overall Study|Protocol Violation|26|||
44457871|NCT00626327|79466471|FG001|Overall Study|Protocol Violation|4|||
44457872|NCT00626327|79466472|FG002|Overall Study|Protocol Violation|26|||
44457873|NCT00357994|79466490|FG000|Overall Study|Adverse Event|1|||
44457874|NCT00357994|79466491|FG001|Overall Study|Adverse Event|2|||
44457875|NCT00357994|79466490|FG000|Overall Study|Lack of Efficacy|0|||
44457876|NCT00357994|79466491|FG001|Overall Study|Lack of Efficacy|1|||
44457877|NCT00357994|79466490|FG000|Overall Study|Protocol Violation|1|||
44457878|NCT00357994|79466491|FG001|Overall Study|Protocol Violation|0|||
44457879|NCT00423657|79466499|FG000|Overall Study|Withdrew consent|10|||
44457880|NCT00423657|79466500|FG001|Overall Study|Withdrew consent|8|||
44457881|NCT00423657|79466499|FG000|Overall Study|Non-compliance|0|||
44457882|NCT00423657|79466500|FG001|Overall Study|Non-compliance|1|||
44457883|NCT00423657|79466499|FG000|Overall Study|Other|15|||
44457884|NCT00423657|79466500|FG001|Overall Study|Other|16|||
44457885|NCT00423657|79466499|FG000|Overall Study|Request of sponsor/investigator|1|||
44457886|NCT00423657|79466500|FG001|Overall Study|Request of sponsor/investigator|0|||
44457887|NCT00367432|79466506|FG000|First Period (16 Weeks)|Adverse Event|6|||
44457888|NCT00367432|79466507|FG001|First Period (16 Weeks)|Adverse Event|0|||
44457889|NCT00367432|79466506|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
44457890|NCT00367432|79466507|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
44457891|NCT00367432|79466506|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
44216325|NCT01890265|79014137|FG002|Overall Study|Death|1|||
44216326|NCT01890265|79014138|FG003|Overall Study|Death|0|||
44216327|NCT01890265|79014139|FG004|Overall Study|Death|0|||
44216328|NCT01890265|79014140|FG005|Overall Study|Death|0|||
44216329|NCT01890265|79014135|FG000|Overall Study|Withdrawal by Subject|0|||
44216330|NCT01890265|79014136|FG001|Overall Study|Withdrawal by Subject|2|||
44216331|NCT01890265|79014137|FG002|Overall Study|Withdrawal by Subject|3|||
44216332|NCT01890265|79014138|FG003|Overall Study|Withdrawal by Subject|0|||
44457892|NCT00367432|79466507|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
44457893|NCT00367432|79466506|FG000|First Period (16 Weeks)|Other Reason|2|||
44457894|NCT00367432|79466507|FG001|First Period (16 Weeks)|Other Reason|0|||
44216333|NCT01890265|79014139|FG004|Overall Study|Withdrawal by Subject|2|||
44457895|NCT00367432|79466506|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
44457896|NCT00367432|79466507|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
44457897|NCT00367432|79466506|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
44457898|NCT00367432|79466507|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
44457899|NCT00367432|79466506|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
44457900|NCT00367432|79466507|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
44457901|NCT00367432|79466506|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
44457902|NCT00367432|79466507|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
44216334|NCT01890265|79014140|FG005|Overall Study|Withdrawal by Subject|0|||
44216335|NCT01928329|79014161|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
44216336|NCT01928329|79014162|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
44216337|NCT01928329|79014161|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
44216338|NCT01928329|79014162|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
44216339|NCT01928329|79014161|FG000|Overall Study|Adverse Event|5|||
44216340|NCT01928329|79014162|FG001|Overall Study|Adverse Event|3|||
44216341|NCT01928329|79014161|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
44216342|NCT01928329|79014162|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
44216343|NCT01928329|79014161|FG000|Overall Study|Withdrawal by Subject|1|||
44216344|NCT01928329|79014162|FG001|Overall Study|Withdrawal by Subject|5|||
44216345|NCT01928329|79014161|FG000|Overall Study|Physician Decision|1|||
44216346|NCT01928329|79014162|FG001|Overall Study|Physician Decision|1|||
44216347|NCT01890109|79014170|FG000|Overall Study|Withdrawal by Subject|0|||
44216348|NCT01890109|79014171|FG001|Overall Study|Withdrawal by Subject|3|||
44216349|NCT01890109|79014170|FG000|Overall Study|Lost to Follow-up|1|||
44216350|NCT01890109|79014171|FG001|Overall Study|Lost to Follow-up|2|||
44216351|NCT00982930|79014178|FG000|Overall Study|Adverse Event|1|||
44216352|NCT00982930|79014178|FG000|Overall Study|Withdrawal by Subject|1|||
44216353|NCT00982930|79014178|FG000|Overall Study|Administrative Problems|2|||
44216354|NCT00981682|79014182|FG000|Overall Study|Adverse Event|48|||
44216355|NCT00981682|79014182|FG000|Overall Study|Withdrawal by Subject|52|||
44216356|NCT00981682|79014182|FG000|Overall Study|Lost to Follow-up|14|||
44216357|NCT00981682|79014182|FG000|Overall Study|Lack of Efficacy|13|||
44216358|NCT00981682|79014182|FG000|Overall Study|Protocol Violation|6|||
44216359|NCT00981682|79014182|FG000|Overall Study|administrative|9|||
44216360|NCT01903993|79014188|FG000|Overall Study|Death|118|||
44216361|NCT01903993|79014189|FG001|Overall Study|Death|121|||
44216362|NCT01903993|79014188|FG000|Overall Study|Withdrawal by Subject|15|||
44216363|NCT01903993|79014189|FG001|Overall Study|Withdrawal by Subject|4|||
44216364|NCT01903993|79014188|FG000|Overall Study|Lost to Follow-up|2|||
44216365|NCT01903993|79014189|FG001|Overall Study|Lost to Follow-up|3|||
44216366|NCT01903993|79014188|FG000|Overall Study|Study Terminated by Sponsor|8|||
44216367|NCT01903993|79014189|FG001|Overall Study|Study Terminated by Sponsor|14|||
44216368|NCT01903993|79014188|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
44216369|NCT01903993|79014189|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
44216370|NCT00981292|79014202|FG000|Day 1|Protocol Violation|1|||
44216371|NCT00981292|79014203|FG001|Day 1|Protocol Violation|0|||
44216372|NCT00981292|79014204|FG002|Day 1|Protocol Violation|0|||
44216373|NCT00981292|79014205|FG003|Day 1|Protocol Violation|0|||
44216374|NCT00981292|79014206|FG004|Day 1|Protocol Violation|0|||
44216375|NCT00981292|79014207|FG005|Day 1|Protocol Violation|2|||
44216376|NCT00981292|79014202|FG000|Day 2|Protocol Violation|2|||
44216377|NCT00981292|79014203|FG001|Day 2|Protocol Violation|0|||
44216378|NCT00981292|79014204|FG002|Day 2|Protocol Violation|0|||
44216379|NCT00981292|79014205|FG003|Day 2|Protocol Violation|0|||
44216380|NCT00981292|79014206|FG004|Day 2|Protocol Violation|0|||
44216381|NCT00981292|79014207|FG005|Day 2|Protocol Violation|0|||
44216382|NCT00981292|79014202|FG000|Day 3|Protocol Violation|0|||
44216383|NCT00981292|79014203|FG001|Day 3|Protocol Violation|0|||
44216384|NCT00981292|79014204|FG002|Day 3|Protocol Violation|0|||
44216385|NCT00981292|79014205|FG003|Day 3|Protocol Violation|0|||
44216386|NCT00981292|79014206|FG004|Day 3|Protocol Violation|0|||
44216387|NCT00981292|79014207|FG005|Day 3|Protocol Violation|1|||
44216388|NCT00980044|79014222|FG000|Overall Study|Withdrawal by Subject|5|||
44216389|NCT00980044|79014223|FG001|Overall Study|Withdrawal by Subject|7|||
44216390|NCT00980044|79014224|FG002|Overall Study|Withdrawal by Subject|3|||
44216391|NCT00980044|79014222|FG000|Overall Study|Protocol Violation|0|||
44216392|NCT00980044|79014223|FG001|Overall Study|Protocol Violation|0|||
44216393|NCT00980044|79014224|FG002|Overall Study|Protocol Violation|2|||
44216394|NCT01903837|79014239|FG000|Part A|Withdrawal by Subject|4|||
44372190|NCT01064648|79377141|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
44216395|NCT01903837|79014240|FG001|Part A|Withdrawal by Subject|9|||
44216396|NCT01903837|79014241|FG002|Part A|Withdrawal by Subject|8|||
44216397|NCT01903837|79014242|FG003|Part A|Withdrawal by Subject|5|||
44216398|NCT01903837|79014239|FG000|Part A|Adverse Event|3|||
44216399|NCT01903837|79014240|FG001|Part A|Adverse Event|6|||
44216400|NCT01903837|79014241|FG002|Part A|Adverse Event|9|||
44216401|NCT01903837|79014242|FG003|Part A|Adverse Event|6|||
44216402|NCT01903837|79014239|FG000|Part A|Lost to Follow-up|9|||
44216403|NCT01903837|79014240|FG001|Part A|Lost to Follow-up|7|||
44216404|NCT01903837|79014241|FG002|Part A|Lost to Follow-up|7|||
44216405|NCT01903837|79014242|FG003|Part A|Lost to Follow-up|2|||
44216406|NCT01903837|79014239|FG000|Part A|Non-compliance with study drug|1|||
44216407|NCT01903837|79014240|FG001|Part A|Non-compliance with study drug|4|||
44216408|NCT01903837|79014241|FG002|Part A|Non-compliance with study drug|4|||
44216409|NCT01903837|79014242|FG003|Part A|Non-compliance with study drug|0|||
44216410|NCT01903837|79014239|FG000|Part A|Physician Decision|1|||
44216411|NCT01903837|79014240|FG001|Part A|Physician Decision|1|||
44216412|NCT01903837|79014241|FG002|Part A|Physician Decision|0|||
44216413|NCT01903837|79014242|FG003|Part A|Physician Decision|0|||
44216414|NCT01903837|79014239|FG000|Part A|Protocol Violation|1|||
44216415|NCT01903837|79014240|FG001|Part A|Protocol Violation|1|||
44372191|NCT01064648|79377142|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
44372192|NCT01064648|79377143|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
44372193|NCT01064648|79377140|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
44457903|NCT00367432|79466506|FG000|Second Period (up to 54 Months)|Other Reason|6|||
44457904|NCT00367432|79466507|FG001|Second Period (up to 54 Months)|Other Reason|2|||
44457905|NCT00623363|79466513|FG000|Overall Study|Adverse Event|2|||
44457906|NCT00623363|79466514|FG001|Overall Study|Adverse Event|2|||
44457907|NCT00423267|79466523|FG000|Period A|Withdrawal by Subject|0|||
44457908|NCT00423267|79466524|FG001|Period A|Withdrawal by Subject|1|||
44457909|NCT00423267|79466523|FG000|Period A|Non-compliance with protocol|1|||
44457910|NCT00423267|79466524|FG001|Period A|Non-compliance with protocol|0|||
44457911|NCT00423267|79466523|FG000|Period A|Administrative|1|||
44457912|NCT00423267|79466524|FG001|Period A|Administrative|0|||
44457913|NCT00626093|79466532|FG000|Overall Study|Lost to Follow-up|5|||
44457914|NCT00626093|79466532|FG000|Overall Study|Death|1|||
44457915|NCT00626093|79466532|FG000|Overall Study|Physician Decision|4|||
44457916|NCT00626093|79466532|FG000|Overall Study|Withdrawal by Subject|6|||
44457917|NCT00626093|79466532|FG000|Overall Study|Protocol Violation|1|||
44457918|NCT00626093|79466532|FG000|Overall Study|One of the required devices not implante|6|||
44457919|NCT00357760|79466538|FG000|Overall Study|Disease progression|44|||
44457920|NCT00357760|79466539|FG001|Overall Study|Disease progression|17|||
44457921|NCT00357760|79466538|FG000|Overall Study|Adverse Event|10|||
44457922|NCT00357760|79466539|FG001|Overall Study|Adverse Event|7|||
44457923|NCT00357760|79466538|FG000|Overall Study|Death|0|||
44457924|NCT00357760|79466539|FG001|Overall Study|Death|3|||
44457925|NCT00357760|79466538|FG000|Overall Study|Alternative therapy|1|||
44457926|NCT00357760|79466539|FG001|Overall Study|Alternative therapy|0|||
44457927|NCT00357760|79466538|FG000|Overall Study|Withdrawal by Subject|0|||
44457928|NCT00357760|79466539|FG001|Overall Study|Withdrawal by Subject|2|||
44457929|NCT00357760|79466538|FG000|Overall Study|Never started treatment|2|||
44457930|NCT00357760|79466539|FG001|Overall Study|Never started treatment|1|||
44457931|NCT00357760|79466538|FG000|Overall Study|Ineligible|0|||
44457932|NCT00357760|79466539|FG001|Overall Study|Ineligible|2|||
44457933|NCT00357760|79466538|FG000|Overall Study|Physician Decision|2|||
44457934|NCT00357760|79466539|FG001|Overall Study|Physician Decision|1|||
44457935|NCT00357760|79466538|FG000|Overall Study|Protocol Violation|0|||
44457936|NCT00357760|79466539|FG001|Overall Study|Protocol Violation|1|||
44457937|NCT00357760|79466538|FG000|Overall Study|To receive hospice care|0|||
44457938|NCT00357760|79466539|FG001|Overall Study|To receive hospice care|1|||
44457939|NCT00622739|79466547|FG000|Overall Study|Physician Decision|1|||
44457940|NCT00622739|79466548|FG001|Overall Study|Physician Decision|0|||
44457941|NCT00622739|79466547|FG000|Overall Study|Adverse Event|1|||
44457942|NCT00622739|79466548|FG001|Overall Study|Adverse Event|2|||
44457943|NCT00622739|79466547|FG000|Overall Study|Lack of Efficacy|0|||
44457944|NCT00622739|79466548|FG001|Overall Study|Lack of Efficacy|2|||
44457945|NCT00622739|79466547|FG000|Overall Study|Withdrawal by Subject|0|||
44457946|NCT00622739|79466548|FG001|Overall Study|Withdrawal by Subject|1|||
44457947|NCT00622739|79466547|FG000|Overall Study|Lost to Follow-up|0|||
44457948|NCT00622739|79466548|FG001|Overall Study|Lost to Follow-up|1|||
44457949|NCT00435825|79466560|FG000|Overall Study|Abnormality of Laboratory Test|0|||
44457950|NCT00435825|79466561|FG001|Overall Study|Abnormality of Laboratory Test|1|||
44216416|NCT01903837|79014241|FG002|Part A|Protocol Violation|0|||
44216417|NCT01903837|79014242|FG003|Part A|Protocol Violation|0|||
44216418|NCT01903837|79014239|FG000|Part B|Lost to Follow-up|0|||
44216419|NCT01903837|79014240|FG001|Part B|Lost to Follow-up|3|||
44216420|NCT01903837|79014241|FG002|Part B|Lost to Follow-up|3|||
44372194|NCT01064648|79377141|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
44372195|NCT01064648|79377142|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
44372196|NCT01064648|79377143|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
44372197|NCT01064648|79377140|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
44372198|NCT01064648|79377141|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
44372199|NCT01064648|79377142|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
44372200|NCT01064648|79377143|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
44372201|NCT01064648|79377140|FG000|Phase II|Adverse Event|0|||
44372202|NCT01064648|79377141|FG001|Phase II|Adverse Event|0|||
44372203|NCT01064648|79377142|FG002|Phase II|Adverse Event|15|||
44372204|NCT01064648|79377143|FG003|Phase II|Adverse Event|8|||
44372205|NCT01064648|79377140|FG000|Phase II|Death|0|||
44372206|NCT01064648|79377141|FG001|Phase II|Death|0|||
44457951|NCT00435825|79466562|FG002|Overall Study|Abnormality of Laboratory Test|0|||
44457952|NCT00435825|79466563|FG003|Overall Study|Abnormality of Laboratory Test|0|||
44457953|NCT00435825|79466560|FG000|Overall Study|Insufficient Therapeutic Response|3|||
44457954|NCT00435825|79466561|FG001|Overall Study|Insufficient Therapeutic Response|1|||
44216421|NCT01903837|79014242|FG003|Part B|Lost to Follow-up|4|||
44216422|NCT01903837|79014239|FG000|Part B|Withdrawal by Subject|1|||
44216423|NCT01903837|79014240|FG001|Part B|Withdrawal by Subject|2|||
44216424|NCT01903837|79014241|FG002|Part B|Withdrawal by Subject|0|||
44216425|NCT01903837|79014242|FG003|Part B|Withdrawal by Subject|3|||
44216426|NCT01903837|79014239|FG000|Part B|Adverse Event|3|||
44216427|NCT01903837|79014240|FG001|Part B|Adverse Event|0|||
44216428|NCT01903837|79014241|FG002|Part B|Adverse Event|2|||
44216429|NCT01903837|79014242|FG003|Part B|Adverse Event|0|||
44216430|NCT01903837|79014239|FG000|Part B|Non-compliance with study drug|2|||
44216431|NCT01903837|79014240|FG001|Part B|Non-compliance with study drug|0|||
44216432|NCT01903837|79014241|FG002|Part B|Non-compliance with study drug|0|||
44216433|NCT01903837|79014242|FG003|Part B|Non-compliance with study drug|1|||
44216434|NCT01903837|79014239|FG000|Part B|Incarceration|2|||
44216435|NCT01903837|79014240|FG001|Part B|Incarceration|0|||
44216436|NCT01903837|79014241|FG002|Part B|Incarceration|0|||
44216437|NCT01903837|79014242|FG003|Part B|Incarceration|1|||
44216438|NCT01903837|79014239|FG000|Part B|Physician Decision|1|||
44216439|NCT01903837|79014240|FG001|Part B|Physician Decision|0|||
44216440|NCT01903837|79014241|FG002|Part B|Physician Decision|0|||
44216441|NCT01903837|79014242|FG003|Part B|Physician Decision|2|||
44216442|NCT01903837|79014239|FG000|Part B|Lack of Efficacy|0|||
44216443|NCT01903837|79014240|FG001|Part B|Lack of Efficacy|1|||
44216444|NCT01903837|79014241|FG002|Part B|Lack of Efficacy|0|||
44216445|NCT01903837|79014242|FG003|Part B|Lack of Efficacy|0|||
44216446|NCT01903525|79014275|FG000|Overall Study|Lost to Follow-up|5|||
44216447|NCT01903525|79014276|FG001|Overall Study|Lost to Follow-up|9|||
44216448|NCT01903525|79014275|FG000|Overall Study|Adverse Event|0|||
44216449|NCT01903525|79014276|FG001|Overall Study|Adverse Event|1|||
44216450|NCT00981526|79014284|FG000|Overall Study|Withdrawal by Subject|0|||
44216451|NCT00981526|79014285|FG001|Overall Study|Withdrawal by Subject|2|||
44216452|NCT00981526|79014284|FG000|Overall Study|Physician Decision|4|||
44216453|NCT00981526|79014285|FG001|Overall Study|Physician Decision|4|||
44216454|NCT01927861|79014295|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
44216455|NCT01927861|79014296|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
44216456|NCT01927861|79014295|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
44216457|NCT01927861|79014296|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
44216458|NCT01927627|79014302|FG000|Overall Study|Adverse Event|3|||
44216459|NCT01927627|79014302|FG000|Overall Study|Lack of Efficacy|1|||
44216460|NCT01927627|79014302|FG000|Overall Study|Financial Concerns|1|||
44216461|NCT01889251|79014308|FG000|Overall Study|Adverse Event|1|||
44216462|NCT01889251|79014309|FG001|Overall Study|Adverse Event|0|||
44216463|NCT01616563|79014315|FG000|Overall Study|Lost to Follow-up|40|||
44216464|NCT01616173|79014323|FG000|Overall Study|Lost to Follow-up|0|||
44216465|NCT01616173|79014324|FG001|Overall Study|Lost to Follow-up|2|||
44216466|NCT01616173|79014325|FG002|Overall Study|Lost to Follow-up|0|||
44216467|NCT01544595|79014339|FG000|Status at Week 68|Adverse Event|3|||
44216468|NCT01544595|79014340|FG001|Status at Week 68|Adverse Event|2|||
44216469|NCT01544595|79014341|FG002|Status at Week 68|Adverse Event|1|||
44216470|NCT01544595|79014342|FG003|Status at Week 68|Adverse Event|0|||
44216471|NCT01544595|79014343|FG004|Status at Week 68|Adverse Event|0|||
44216472|NCT01544595|79014344|FG005|Status at Week 68|Adverse Event|0|||
44216473|NCT01544595|79014339|FG000|Status at Week 68|Lack of Efficacy|1|||
44216474|NCT01544595|79014340|FG001|Status at Week 68|Lack of Efficacy|0|||
44216475|NCT01544595|79014341|FG002|Status at Week 68|Lack of Efficacy|0|||
44216476|NCT01544595|79014342|FG003|Status at Week 68|Lack of Efficacy|0|||
44216477|NCT01544595|79014343|FG004|Status at Week 68|Lack of Efficacy|0|||
44216478|NCT01544595|79014344|FG005|Status at Week 68|Lack of Efficacy|0|||
44216479|NCT01544595|79014339|FG000|Status at Week 68|Lost to Follow-up|1|||
44216480|NCT01544595|79014340|FG001|Status at Week 68|Lost to Follow-up|1|||
44216481|NCT01544595|79014341|FG002|Status at Week 68|Lost to Follow-up|0|||
44216482|NCT01544595|79014342|FG003|Status at Week 68|Lost to Follow-up|0|||
44372207|NCT01064648|79377142|FG002|Phase II|Death|4|||
44216483|NCT01544595|79014343|FG004|Status at Week 68|Lost to Follow-up|0|||
44216484|NCT01544595|79014344|FG005|Status at Week 68|Lost to Follow-up|0|||
44216485|NCT01544595|79014339|FG000|Status at Week 68|Non-compliance with study treatment|1|||
44216486|NCT01544595|79014340|FG001|Status at Week 68|Non-compliance with study treatment|0|||
44216487|NCT01544595|79014341|FG002|Status at Week 68|Non-compliance with study treatment|0|||
44216488|NCT01544595|79014342|FG003|Status at Week 68|Non-compliance with study treatment|1|||
44216489|NCT01544595|79014343|FG004|Status at Week 68|Non-compliance with study treatment|0|||
44216490|NCT01544595|79014344|FG005|Status at Week 68|Non-compliance with study treatment|0|||
44216491|NCT01544595|79014339|FG000|Status at Week 68|Protocol Violation|2|||
44216492|NCT01544595|79014340|FG001|Status at Week 68|Protocol Violation|0|||
44216493|NCT01544595|79014341|FG002|Status at Week 68|Protocol Violation|1|||
44216494|NCT01544595|79014342|FG003|Status at Week 68|Protocol Violation|1|||
44216495|NCT01544595|79014343|FG004|Status at Week 68|Protocol Violation|0|||
44216496|NCT01544595|79014344|FG005|Status at Week 68|Protocol Violation|0|||
44216497|NCT01544595|79014339|FG000|Status at Week 68|Technical problems|1|||
44216498|NCT01544595|79014340|FG001|Status at Week 68|Technical problems|0|||
44216499|NCT01544595|79014341|FG002|Status at Week 68|Technical problems|0|||
44216500|NCT01544595|79014342|FG003|Status at Week 68|Technical problems|1|||
44372208|NCT01064648|79377143|FG003|Phase II|Death|5|||
44543935|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
44543936|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
44543937|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
44543938|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
44543939|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
44543940|NCT03201900|79557090|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
44543941|NCT03201900|79557090|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
44543942|NCT03201900|79557090|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
44543943|NCT03201900|79557090|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
44543944|NCT03201900|79557090|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
44457955|NCT00435825|79466562|FG002|Overall Study|Insufficient Therapeutic Response|0|||
44457956|NCT00435825|79466563|FG003|Overall Study|Insufficient Therapeutic Response|3|||
44457957|NCT00435825|79466560|FG000|Overall Study|Other Protocol Violation|1|||
44457958|NCT00435825|79466561|FG001|Overall Study|Other Protocol Violation|0|||
44543945|NCT03201900|79557090|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
44543946|NCT03201900|79557090|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
44543947|NCT03170271|79557105|FG000|Overall Study|Adverse Event|7|||
44543948|NCT03170271|79557106|FG001|Overall Study|Adverse Event|2|||
44543949|NCT03170271|79557105|FG000|Overall Study|Lost to Follow-up|0|||
44457959|NCT00435825|79466562|FG002|Overall Study|Other Protocol Violation|0|||
44457960|NCT00435825|79466563|FG003|Overall Study|Other Protocol Violation|0|||
44457961|NCT00435825|79466560|FG000|Overall Study|Refused treatment|2|||
44457962|NCT00435825|79466561|FG001|Overall Study|Refused treatment|0|||
44457963|NCT00435825|79466562|FG002|Overall Study|Refused treatment|0|||
44457964|NCT00435825|79466563|FG003|Overall Study|Refused treatment|5|||
44457965|NCT00435825|79466560|FG000|Overall Study|Failure to return|5|||
44457966|NCT00435825|79466561|FG001|Overall Study|Failure to return|0|||
44457967|NCT00435825|79466562|FG002|Overall Study|Failure to return|4|||
44372209|NCT01064648|79377140|FG000|Phase II|Withdrawal by Subject|0|||
44543950|NCT03170271|79557106|FG001|Overall Study|Lost to Follow-up|1|||
44543951|NCT03170271|79557105|FG000|Overall Study|Physician Decision|1|||
44543952|NCT03170271|79557106|FG001|Overall Study|Physician Decision|0|||
44543953|NCT03170271|79557105|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
44543954|NCT03170271|79557106|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
44543955|NCT03170271|79557105|FG000|Overall Study|Withdrawal by Subject|17|||
44372210|NCT01064648|79377141|FG001|Phase II|Withdrawal by Subject|0|||
44372211|NCT01064648|79377142|FG002|Phase II|Withdrawal by Subject|2|||
44372212|NCT01064648|79377143|FG003|Phase II|Withdrawal by Subject|5|||
44372213|NCT01064648|79377140|FG000|Phase II|Progression|0|||
44372214|NCT01064648|79377141|FG001|Phase II|Progression|0|||
44372215|NCT01064648|79377142|FG002|Phase II|Progression|21|||
44372216|NCT01064648|79377143|FG003|Phase II|Progression|27|||
44372217|NCT01064648|79377140|FG000|Phase II|Non-protocol specified|0|||
44372218|NCT01064648|79377141|FG001|Phase II|Non-protocol specified|0|||
44372219|NCT01064648|79377142|FG002|Phase II|Non-protocol specified|5|||
44372220|NCT01064648|79377143|FG003|Phase II|Non-protocol specified|3|||
44372221|NCT01064648|79377140|FG000|Phase II|Under Review|0|||
44372222|NCT01064648|79377141|FG001|Phase II|Under Review|0|||
44372223|NCT01064648|79377142|FG002|Phase II|Under Review|2|||
44372224|NCT01064648|79377143|FG003|Phase II|Under Review|0|||
44372225|NCT00980460|79377161|FG000|Overall Study|Death|0|||
44372226|NCT00980460|79377162|FG001|Overall Study|Death|0|||
44372227|NCT00980460|79377163|FG002|Overall Study|Death|1|||
44372228|NCT00980460|79377164|FG003|Overall Study|Death|2|||
44372229|NCT00980460|79377165|FG004|Overall Study|Death|1|||
44457968|NCT00435825|79466563|FG003|Overall Study|Failure to return|0|||
44457969|NCT00435825|79466560|FG000|Overall Study|Did not receive study drug|1|||
44457970|NCT00435825|79466561|FG001|Overall Study|Did not receive study drug|0|||
44457971|NCT00435825|79466562|FG002|Overall Study|Did not receive study drug|2|||
44457972|NCT00435825|79466563|FG003|Overall Study|Did not receive study drug|0|||
44543956|NCT03170271|79557106|FG001|Overall Study|Withdrawal by Subject|5|||
44543957|NCT03170271|79557105|FG000|Overall Study|Other|2|||
44372230|NCT00980460|79377161|FG000|Overall Study|Lack of Efficacy|0|||
44457973|NCT00435825|79466560|FG000|Overall Study|Did not enter follow-up|0|||
44543958|NCT03170271|79557106|FG001|Overall Study|Other|2|||
44543959|NCT03170271|79557105|FG000|Overall Study|Randomized in error|4|||
44372231|NCT00980460|79377162|FG001|Overall Study|Lack of Efficacy|0|||
44372232|NCT00980460|79377163|FG002|Overall Study|Lack of Efficacy|10|||
44216501|NCT01544595|79014343|FG004|Status at Week 68|Technical problems|0|||
44372233|NCT00980460|79377164|FG003|Overall Study|Lack of Efficacy|6|||
44457974|NCT00435825|79466561|FG001|Overall Study|Did not enter follow-up|4|||
44372234|NCT00980460|79377165|FG004|Overall Study|Lack of Efficacy|8|||
44372235|NCT00980460|79377161|FG000|Overall Study|Lost to Follow-up|0|||
44372236|NCT00980460|79377162|FG001|Overall Study|Lost to Follow-up|0|||
44372237|NCT00980460|79377163|FG002|Overall Study|Lost to Follow-up|0|||
44372238|NCT00980460|79377164|FG003|Overall Study|Lost to Follow-up|1|||
44372239|NCT00980460|79377165|FG004|Overall Study|Lost to Follow-up|0|||
44372240|NCT00980460|79377161|FG000|Overall Study|Physician Decision|0|||
44372241|NCT00980460|79377162|FG001|Overall Study|Physician Decision|0|||
44372242|NCT00980460|79377163|FG002|Overall Study|Physician Decision|11|||
44372243|NCT00980460|79377164|FG003|Overall Study|Physician Decision|5|||
44372244|NCT00980460|79377165|FG004|Overall Study|Physician Decision|3|||
44372245|NCT00980460|79377161|FG000|Overall Study|Withdrawal by Subject|0|||
44457975|NCT00435825|79466562|FG002|Overall Study|Did not enter follow-up|1|||
44457976|NCT00435825|79466563|FG003|Overall Study|Did not enter follow-up|3|||
44457977|NCT00435825|79466560|FG000|Overall Study|Did not complete full follow-up period|6|||
44216502|NCT01544595|79014344|FG005|Status at Week 68|Technical problems|0|||
44372246|NCT00980460|79377162|FG001|Overall Study|Withdrawal by Subject|0|||
44372247|NCT00980460|79377163|FG002|Overall Study|Withdrawal by Subject|1|||
44372248|NCT00980460|79377164|FG003|Overall Study|Withdrawal by Subject|0|||
44372249|NCT00980460|79377165|FG004|Overall Study|Withdrawal by Subject|0|||
44372250|NCT00980460|79377161|FG000|Overall Study|Ineligible|0|||
44372251|NCT00980460|79377162|FG001|Overall Study|Ineligible|2|||
44372252|NCT00980460|79377163|FG002|Overall Study|Ineligible|3|||
44372253|NCT00980460|79377164|FG003|Overall Study|Ineligible|1|||
44372254|NCT00980460|79377165|FG004|Overall Study|Ineligible|4|||
44372255|NCT00980460|79377161|FG000|Overall Study|Refusal of further therapy|0|||
44372256|NCT00980460|79377162|FG001|Overall Study|Refusal of further therapy|2|||
44216503|NCT01544595|79014339|FG000|Status at Week 68|Withdrawal by Subject|0|||
44216504|NCT01544595|79014340|FG001|Status at Week 68|Withdrawal by Subject|1|||
44372257|NCT00980460|79377163|FG002|Overall Study|Refusal of further therapy|3|||
44372258|NCT00980460|79377164|FG003|Overall Study|Refusal of further therapy|2|||
44372259|NCT00980460|79377165|FG004|Overall Study|Refusal of further therapy|0|||
44372260|NCT00980460|79377161|FG000|Overall Study|No therapy within 42 days of resection|0|||
44372261|NCT00980460|79377162|FG001|Overall Study|No therapy within 42 days of resection|0|||
44372262|NCT00980460|79377163|FG002|Overall Study|No therapy within 42 days of resection|3|||
44372263|NCT00980460|79377164|FG003|Overall Study|No therapy within 42 days of resection|1|||
44372264|NCT00980460|79377165|FG004|Overall Study|No therapy within 42 days of resection|0|||
44372265|NCT00980460|79377161|FG000|Overall Study|No transplant by protocol timepoints|0|||
44372266|NCT00980460|79377162|FG001|Overall Study|No transplant by protocol timepoints|0|||
44372267|NCT00980460|79377163|FG002|Overall Study|No transplant by protocol timepoints|3|||
44372268|NCT00980460|79377164|FG003|Overall Study|No transplant by protocol timepoints|0|||
44372269|NCT00980460|79377165|FG004|Overall Study|No transplant by protocol timepoints|0|||
44372270|NCT00977574|79377187|FG000|Overall Study|Never Treated|4|||
44372271|NCT00977574|79377188|FG001|Overall Study|Never Treated|2|||
44372272|NCT00977574|79377189|FG002|Overall Study|Never Treated|4|||
44372273|NCT00972478|79377199|FG000|Overall Study|Adverse Event|3|||
44372274|NCT00972478|79377200|FG001|Overall Study|Adverse Event|16|||
44372275|NCT00972478|79377199|FG000|Overall Study|Withdrawal by Subject|1|||
44372276|NCT00972478|79377200|FG001|Overall Study|Withdrawal by Subject|8|||
44372277|NCT00972478|79377199|FG000|Overall Study|Progression/Relapse|0|||
44372278|NCT00972478|79377200|FG001|Overall Study|Progression/Relapse|2|||
44372279|NCT00972478|79377199|FG000|Overall Study|Death|0|||
44372280|NCT00972478|79377200|FG001|Overall Study|Death|2|||
44372281|NCT00972478|79377199|FG000|Overall Study|Not protocol specified|1|||
44372282|NCT00972478|79377200|FG001|Overall Study|Not protocol specified|1|||
44372283|NCT00972478|79377199|FG000|Overall Study|Ineligible|1|||
44372284|NCT00972478|79377200|FG001|Overall Study|Ineligible|7|||
44372285|NCT00972478|79377199|FG000|Overall Study|Not start protocol treatment|1|||
44372286|NCT00972478|79377200|FG001|Overall Study|Not start protocol treatment|2|||
44372287|NCT00861705|79377211|FG000|Overall Study|Never Began Treatment|7|||
44372288|NCT00861705|79377212|FG001|Overall Study|Never Began Treatment|3|||
44372289|NCT00861705|79377213|FG002|Overall Study|Never Began Treatment|0|||
44216505|NCT01544595|79014341|FG002|Status at Week 68|Withdrawal by Subject|1|||
44216506|NCT01544595|79014342|FG003|Status at Week 68|Withdrawal by Subject|2|||
44372290|NCT00861705|79377214|FG003|Overall Study|Never Began Treatment|1|||
44372291|NCT00843882|79377235|FG000|Step 1|Lack of Efficacy|14|||
44372292|NCT00843882|79377236|FG001|Step 1|Lack of Efficacy|10|||
44372293|NCT00843882|79377237|FG002|Step 1|Lack of Efficacy|21|||
44372294|NCT00843882|79377235|FG000|Step 1|Adverse Event|8|||
44216507|NCT01544595|79014343|FG004|Status at Week 68|Withdrawal by Subject|0|||
44372295|NCT00843882|79377236|FG001|Step 1|Adverse Event|17|||
44372296|NCT00843882|79377237|FG002|Step 1|Adverse Event|20|||
44372297|NCT00843882|79377235|FG000|Step 1|Death|1|||
44372298|NCT00843882|79377236|FG001|Step 1|Death|2|||
44372299|NCT00843882|79377237|FG002|Step 1|Death|4|||
44372300|NCT00843882|79377235|FG000|Step 1|Withdrawal by Subject|6|||
44372301|NCT00843882|79377236|FG001|Step 1|Withdrawal by Subject|12|||
44372302|NCT00843882|79377237|FG002|Step 1|Withdrawal by Subject|9|||
44216508|NCT01544595|79014344|FG005|Status at Week 68|Withdrawal by Subject|0|||
44216509|NCT01544595|79014339|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
44216510|NCT01544595|79014340|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
44216511|NCT01544595|79014341|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
44216512|NCT01544595|79014342|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
44216513|NCT01544595|79014343|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
44216514|NCT01544595|79014344|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
44216515|NCT01544595|79014339|FG000|Status at Week 156|Withdrawal by Subject|9|||
44216516|NCT01544595|79014340|FG001|Status at Week 156|Withdrawal by Subject|10|||
44216517|NCT01544595|79014341|FG002|Status at Week 156|Withdrawal by Subject|4|||
44216518|NCT01544595|79014342|FG003|Status at Week 156|Withdrawal by Subject|9|||
44216519|NCT01544595|79014343|FG004|Status at Week 156|Withdrawal by Subject|20|||
44216520|NCT01544595|79014344|FG005|Status at Week 156|Withdrawal by Subject|6|||
44216521|NCT01544595|79014339|FG000|Status at Week 156|Adverse Event|9|||
44372303|NCT00843882|79377235|FG000|Step 1|Physician Decision|0|||
44457978|NCT00435825|79466561|FG001|Overall Study|Did not complete full follow-up period|6|||
44457979|NCT00435825|79466562|FG002|Overall Study|Did not complete full follow-up period|4|||
44457980|NCT00435825|79466563|FG003|Overall Study|Did not complete full follow-up period|5|||
44457981|NCT00574145|79466575|FG000|Overall Study|Withdrawal by Subject|2|||
44457982|NCT00574145|79466576|FG001|Overall Study|Withdrawal by Subject|1|||
44457983|NCT00423189|79466585|FG000|Overall Study|Death|0|||
44457984|NCT00423189|79466586|FG001|Overall Study|Death|1|||
44457985|NCT00423189|79466587|FG002|Overall Study|Death|0|||
44457986|NCT00422799|79466600|FG000|Overall Study|Withdrawal by Subject|6|||
44457987|NCT00422799|79466600|FG000|Overall Study|Adverse Event|7|||
44457988|NCT00435045|79466606|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
44457989|NCT00435045|79466607|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
44457990|NCT00435045|79466606|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
44457991|NCT00435045|79466607|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
44457992|NCT00435045|79466606|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
44457993|NCT00435045|79466607|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
44457994|NCT00435045|79466606|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
44457995|NCT00435045|79466607|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
44457996|NCT00435045|79466606|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
44457997|NCT00435045|79466607|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
44457998|NCT00435045|79466606|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
44457999|NCT00435045|79466607|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
44458000|NCT00435045|79466606|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
44458001|NCT00435045|79466607|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
44458002|NCT00435045|79466606|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
44458003|NCT00435045|79466607|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
44458004|NCT00435045|79466606|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
44458005|NCT00435045|79466607|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
44458006|NCT00435045|79466606|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
44458007|NCT00435045|79466607|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
44458008|NCT00435045|79466606|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
44458009|NCT00435045|79466607|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
44458010|NCT00441129|79466615|FG000|Overall Study|Withdrawal by Subject|6|||
44458011|NCT00441129|79466616|FG001|Overall Study|Withdrawal by Subject|14|||
44458012|NCT00622505|79466624|FG000|Overall Study|Adverse Event|9|||
44458013|NCT00622505|79466625|FG001|Overall Study|Adverse Event|7|||
44458014|NCT00622505|79466624|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
44458015|NCT00622505|79466625|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
44458016|NCT00622505|79466624|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
44543960|NCT03170271|79557106|FG001|Overall Study|Randomized in error|0|||
44216522|NCT01544595|79014340|FG001|Status at Week 156|Adverse Event|11|||
44216523|NCT01544595|79014341|FG002|Status at Week 156|Adverse Event|1|||
44372304|NCT00843882|79377236|FG001|Step 1|Physician Decision|5|||
44372305|NCT00843882|79377237|FG002|Step 1|Physician Decision|1|||
44372306|NCT00843882|79377235|FG000|Step 1|Patient and physician's decision|0|||
44372307|NCT00843882|79377236|FG001|Step 1|Patient and physician's decision|0|||
44372308|NCT00843882|79377237|FG002|Step 1|Patient and physician's decision|1|||
44372309|NCT00843882|79377235|FG000|Step 1|Other complicating disease|1|||
44372310|NCT00843882|79377236|FG001|Step 1|Other complicating disease|3|||
44372311|NCT00843882|79377237|FG002|Step 1|Other complicating disease|4|||
44458017|NCT00622505|79466625|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
44458018|NCT00622505|79466624|FG000|Overall Study|Withdrawal by Subject|12|||
44543961|NCT03613129|79557116|FG000|Pre-treatment Assessment|Protocol Violation|2|||
44216524|NCT01544595|79014342|FG003|Status at Week 156|Adverse Event|3|||
44216525|NCT01544595|79014343|FG004|Status at Week 156|Adverse Event|4|||
44270176|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
44372312|NCT00843882|79377235|FG000|Step 1|Alternative therapy|0|||
44216526|NCT01544595|79014344|FG005|Status at Week 156|Adverse Event|2|||
44216527|NCT01544595|79014339|FG000|Status at Week 156|Lost to Follow-up|4|||
44216528|NCT01544595|79014340|FG001|Status at Week 156|Lost to Follow-up|4|||
44216529|NCT01544595|79014341|FG002|Status at Week 156|Lost to Follow-up|0|||
44216530|NCT01544595|79014342|FG003|Status at Week 156|Lost to Follow-up|1|||
44216531|NCT01544595|79014343|FG004|Status at Week 156|Lost to Follow-up|4|||
44216532|NCT01544595|79014344|FG005|Status at Week 156|Lost to Follow-up|1|||
44216533|NCT01544595|79014339|FG000|Status at Week 156|Non-compliance with study treatement|0|||
44458019|NCT00622505|79466625|FG001|Overall Study|Withdrawal by Subject|5|||
44458020|NCT00622505|79466624|FG000|Overall Study|Administrative Problems|2|||
44458021|NCT00622505|79466625|FG001|Overall Study|Administrative Problems|4|||
44458022|NCT00622505|79466624|FG000|Overall Study|Death|2|||
44458023|NCT00622505|79466625|FG001|Overall Study|Death|2|||
44458024|NCT00357370|79466634|FG000|Cohort 2|Lack of Efficacy|0|||
44458025|NCT00357370|79466635|FG001|Cohort 2|Lack of Efficacy|2|||
44458026|NCT00357370|79466636|FG002|Cohort 2|Lack of Efficacy|1|||
44458027|NCT00357370|79466634|FG000|Cohort 2|Adverse Event|1|||
44458028|NCT00357370|79466635|FG001|Cohort 2|Adverse Event|1|||
44458029|NCT00357370|79466636|FG002|Cohort 2|Adverse Event|1|||
44458030|NCT00357370|79466634|FG000|Cohort 2|Lost to Follow-up|0|||
44458031|NCT00357370|79466635|FG001|Cohort 2|Lost to Follow-up|1|||
44458032|NCT00357370|79466636|FG002|Cohort 2|Lost to Follow-up|0|||
44458033|NCT00357370|79466634|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
44458034|NCT00357370|79466635|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
44458035|NCT00357370|79466636|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
44458036|NCT00357370|79466634|FG000|Cohort 2|Withdrawal by Subject|0|||
44458037|NCT00357370|79466635|FG001|Cohort 2|Withdrawal by Subject|2|||
44458038|NCT00357370|79466636|FG002|Cohort 2|Withdrawal by Subject|0|||
44458039|NCT00574847|79466646|FG000|Overall Study|Adverse Event|2|||
44458040|NCT00574847|79466647|FG001|Overall Study|Adverse Event|0|||
44458041|NCT00574847|79466646|FG000|Overall Study|Death|1|||
44458042|NCT00574847|79466647|FG001|Overall Study|Death|0|||
44458043|NCT00574847|79466646|FG000|Overall Study|Withdrawal by Subject|2|||
44458044|NCT00574847|79466647|FG001|Overall Study|Withdrawal by Subject|2|||
44458045|NCT00574847|79466646|FG000|Overall Study|Physician Decision|1|||
44458046|NCT00574847|79466647|FG001|Overall Study|Physician Decision|0|||
44458047|NCT00574847|79466646|FG000|Overall Study|Did not receive medication (declined)|2|||
44458048|NCT00574847|79466647|FG001|Overall Study|Did not receive medication (declined)|5|||
44458049|NCT00348790|79466653|FG000|Completed Treatment|Withdrawal by Subject|4|||
44458050|NCT00348790|79466653|FG000|Completed Treatment|Disease progression|14|||
44458051|NCT00348790|79466653|FG000|Completed Treatment|Adverse Event|4|||
44458052|NCT00348790|79466653|FG000|Completed Treatment|Required surgery|2|||
44458053|NCT00348790|79466653|FG000|Completed Treatment|Unable to travel to study site|1|||
44458054|NCT00360490|79466660|FG000|Overall Study|Adverse Event|4|||
44458055|NCT00360490|79466661|FG001|Overall Study|Adverse Event|2|||
44458056|NCT00360490|79466660|FG000|Overall Study|Lost to Follow-up|2|||
44543962|NCT03613129|79557117|FG001|Pre-treatment Assessment|Protocol Violation|0|||
44216534|NCT01544595|79014340|FG001|Status at Week 156|Non-compliance with study treatement|1|||
44216535|NCT01544595|79014341|FG002|Status at Week 156|Non-compliance with study treatement|0|||
44372313|NCT00843882|79377236|FG001|Step 1|Alternative therapy|1|||
44372314|NCT00843882|79377237|FG002|Step 1|Alternative therapy|1|||
44372315|NCT00843882|79377235|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
44372316|NCT00843882|79377236|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
44372317|NCT00843882|79377237|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
44372318|NCT00843882|79377235|FG000|Step 1|Off treatment reason unknown|0|||
44372319|NCT00843882|79377236|FG001|Step 1|Off treatment reason unknown|1|||
44372320|NCT00843882|79377237|FG002|Step 1|Off treatment reason unknown|4|||
44372321|NCT00843882|79377235|FG000|Step 1|Never started treatment|2|||
44372322|NCT00843882|79377236|FG001|Step 1|Never started treatment|0|||
44372323|NCT00843882|79377237|FG002|Step 1|Never started treatment|0|||
44372324|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
44372325|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
44372326|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
44372327|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
44372328|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
44372329|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
44458057|NCT00360490|79466661|FG001|Overall Study|Lost to Follow-up|1|||
44458058|NCT00360490|79466660|FG000|Overall Study|Physician Decision|2|||
44458059|NCT00360490|79466661|FG001|Overall Study|Physician Decision|1|||
44458060|NCT00360490|79466660|FG000|Overall Study|Protocol Violation|0|||
44458061|NCT00360490|79466661|FG001|Overall Study|Protocol Violation|4|||
44216536|NCT01544595|79014342|FG003|Status at Week 156|Non-compliance with study treatement|1|||
44216537|NCT01544595|79014343|FG004|Status at Week 156|Non-compliance with study treatement|0|||
44458062|NCT00360490|79466660|FG000|Overall Study|Withdrawal by Subject|1|||
44458063|NCT00360490|79466661|FG001|Overall Study|Withdrawal by Subject|3|||
44458064|NCT00624377|79466667|FG000|Overall Study|Lost to Follow-up|355|||
44458065|NCT00624377|79466667|FG000|Overall Study|Withdrawal by Subject|100|||
44458066|NCT00624377|79466667|FG000|Overall Study|Adverse Event|14|||
44458067|NCT00624377|79466667|FG000|Overall Study|Other|91|||
44458068|NCT00624377|79466667|FG000|Overall Study|Non-evaluable population|84|||
44458069|NCT00624065|79466673|FG000|Overall Study|Adverse Event|5|||
44458070|NCT00624065|79466674|FG001|Overall Study|Adverse Event|6|||
44458071|NCT00624065|79466673|FG000|Overall Study|Lost to Follow-up|4|||
44458072|NCT00624065|79466674|FG001|Overall Study|Lost to Follow-up|1|||
44458073|NCT00624065|79466673|FG000|Overall Study|Consent withdrawn|6|||
44458074|NCT00624065|79466674|FG001|Overall Study|Consent withdrawn|5|||
44458075|NCT00624065|79466673|FG000|Overall Study|Lack of Efficacy|0|||
44458076|NCT00624065|79466674|FG001|Overall Study|Lack of Efficacy|3|||
44216538|NCT01544595|79014344|FG005|Status at Week 156|Non-compliance with study treatement|1|||
44216539|NCT01544595|79014339|FG000|Status at Week 156|Physician Decision|0|||
44216540|NCT01544595|79014340|FG001|Status at Week 156|Physician Decision|3|||
44458077|NCT00624065|79466673|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
44458078|NCT00624065|79466674|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
44458079|NCT00360412|79466682|FG000|Overall Study|Adverse Event|37|||
44458080|NCT00360412|79466683|FG001|Overall Study|Adverse Event|65|||
44458081|NCT00360412|79466682|FG000|Overall Study|Protocol Violation|2|||
44458082|NCT00360412|79466683|FG001|Overall Study|Protocol Violation|5|||
44458083|NCT00360412|79466682|FG000|Overall Study|Patient withdrew consent|27|||
44458084|NCT00360412|79466683|FG001|Overall Study|Patient withdrew consent|52|||
44458085|NCT00360412|79466682|FG000|Overall Study|Lack of therapeutic efficacy|46|||
44458086|NCT00360412|79466683|FG001|Overall Study|Lack of therapeutic efficacy|61|||
44458087|NCT00360412|79466682|FG000|Overall Study|Physician Decision|2|||
44458088|NCT00360412|79466683|FG001|Overall Study|Physician Decision|4|||
44458089|NCT00360412|79466682|FG000|Overall Study|Other|5|||
44458090|NCT00360412|79466683|FG001|Overall Study|Other|6|||
44458091|NCT00360412|79466682|FG000|Overall Study|Study termination by Sponsor|214|||
44458092|NCT00360412|79466683|FG001|Overall Study|Study termination by Sponsor|469|||
44458093|NCT00623831|79466691|FG000|Overall Study|Withdrawal by Subject|1|||
44458094|NCT00623831|79466692|FG001|Overall Study|Withdrawal by Subject|0|||
44458095|NCT00623831|79466691|FG000|Overall Study|Progressive Disease|0|||
44458096|NCT00623831|79466692|FG001|Overall Study|Progressive Disease|1|||
44458097|NCT00360334|79466703|FG000|Overall Study|Adverse Event|7|||
44458098|NCT00360334|79466704|FG001|Overall Study|Adverse Event|4|||
44458099|NCT00360334|79466703|FG000|Overall Study|Protocol Violation|1|||
44458100|NCT00360334|79466704|FG001|Overall Study|Protocol Violation|1|||
44458101|NCT00360334|79466703|FG000|Overall Study|Physician Decision|2|||
44458102|NCT00360334|79466704|FG001|Overall Study|Physician Decision|3|||
44458103|NCT00360334|79466703|FG000|Overall Study|Lack of Efficacy|0|||
44458104|NCT00360334|79466704|FG001|Overall Study|Lack of Efficacy|1|||
44458105|NCT00360334|79466703|FG000|Overall Study|Entry criterion not met|1|||
44458106|NCT00360334|79466704|FG001|Overall Study|Entry criterion not met|2|||
44458107|NCT00360334|79466703|FG000|Overall Study|Subject decision|8|||
44458108|NCT00360334|79466704|FG001|Overall Study|Subject decision|2|||
44458109|NCT00422097|79466716|FG000|Dose Level 2|Still on treatment|0|||
44216541|NCT01544595|79014341|FG002|Status at Week 156|Physician Decision|1|||
44458110|NCT00422097|79466717|FG001|Dose Level 2|Still on treatment|1|||
44458111|NCT00422097|79466718|FG002|Dose Level 2|Still on treatment|0|||
44216542|NCT01544595|79014342|FG003|Status at Week 156|Physician Decision|0|||
44458112|NCT00422097|79466719|FG003|Dose Level 2|Still on treatment|0|||
44216543|NCT01544595|79014343|FG004|Status at Week 156|Physician Decision|0|||
44458113|NCT00422097|79466720|FG004|Dose Level 2|Still on treatment|0|||
44458114|NCT00422097|79466721|FG005|Dose Level 2|Still on treatment|0|||
44458115|NCT00422097|79466722|FG006|Dose Level 2|Still on treatment|0|||
44458116|NCT00422097|79466723|FG007|Dose Level 2|Still on treatment|0|||
44458117|NCT00348556|79466747|FG000|Overall Study|Adverse Event|1|||
44458118|NCT00434967|79466755|FG000|Overall Study|Adverse Event|2|||
44216544|NCT01544595|79014344|FG005|Status at Week 156|Physician Decision|0|||
44216545|NCT01544595|79014339|FG000|Status at Week 156|Pregnancy|2|||
44270177|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
44458119|NCT00434967|79466756|FG001|Overall Study|Adverse Event|4|||
44458120|NCT00434967|79466757|FG002|Overall Study|Adverse Event|3|||
44458121|NCT00434967|79466758|FG003|Overall Study|Adverse Event|3|||
44458122|NCT00434967|79466755|FG000|Overall Study|Lost to Follow-up|0|||
44458123|NCT00434967|79466756|FG001|Overall Study|Lost to Follow-up|0|||
44216546|NCT01544595|79014340|FG001|Status at Week 156|Pregnancy|3|||
44216547|NCT01544595|79014341|FG002|Status at Week 156|Pregnancy|0|||
44216548|NCT01544595|79014342|FG003|Status at Week 156|Pregnancy|0|||
44216549|NCT01544595|79014343|FG004|Status at Week 156|Pregnancy|0|||
44216550|NCT01544595|79014344|FG005|Status at Week 156|Pregnancy|0|||
44458124|NCT00434967|79466757|FG002|Overall Study|Lost to Follow-up|1|||
44458125|NCT00434967|79466758|FG003|Overall Study|Lost to Follow-up|0|||
44458126|NCT00434967|79466755|FG000|Overall Study|Withdrawal by Subject|2|||
44458127|NCT00434967|79466756|FG001|Overall Study|Withdrawal by Subject|2|||
44458128|NCT00434967|79466757|FG002|Overall Study|Withdrawal by Subject|4|||
44458129|NCT00434967|79466758|FG003|Overall Study|Withdrawal by Subject|6|||
44372330|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
44372331|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
44216551|NCT01544595|79014339|FG000|Status at Week 156|Protocol Violation|3|||
44216552|NCT01544595|79014340|FG001|Status at Week 156|Protocol Violation|1|||
44216553|NCT01544595|79014341|FG002|Status at Week 156|Protocol Violation|2|||
44216554|NCT01544595|79014342|FG003|Status at Week 156|Protocol Violation|2|||
44216555|NCT01544595|79014343|FG004|Status at Week 156|Protocol Violation|0|||
44216556|NCT01544595|79014344|FG005|Status at Week 156|Protocol Violation|0|||
44216557|NCT01544595|79014339|FG000|Status at Week 156|Technical problems|3|||
44216558|NCT01544595|79014340|FG001|Status at Week 156|Technical problems|1|||
44216559|NCT01544595|79014341|FG002|Status at Week 156|Technical problems|0|||
44216560|NCT01544595|79014342|FG003|Status at Week 156|Technical problems|1|||
44216561|NCT01544595|79014343|FG004|Status at Week 156|Technical problems|0|||
44216562|NCT01544595|79014344|FG005|Status at Week 156|Technical problems|0|||
44216563|NCT01544595|79014339|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
44216564|NCT01544595|79014340|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
44216565|NCT01544595|79014341|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
44216566|NCT01544595|79014342|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
44372332|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
44372333|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
44372334|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
44372335|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
44372336|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
44372337|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
44372338|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
44372339|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
44372340|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
44372341|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
44372342|NCT00843882|79377235|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
44372343|NCT00843882|79377236|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
44372344|NCT00843882|79377237|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
44372345|NCT00769379|79377252|FG000|Overall Study|No follow up data mapped to Other.|3|||
44372346|NCT00769379|79377253|FG001|Overall Study|No follow up data mapped to Other.|13|||
44372347|NCT00658814|79377261|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
44372348|NCT00658814|79377262|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
44372349|NCT00658814|79377261|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
44372350|NCT00658814|79377262|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
44372351|NCT00658814|79377261|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
44372352|NCT00658814|79377262|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
44372353|NCT00658814|79377261|FG000|Remission Induction Chemotherapy|Death|1|||
44372354|NCT00658814|79377262|FG001|Remission Induction Chemotherapy|Death|4|||
44372355|NCT00658814|79377261|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
44372356|NCT00658814|79377262|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
44372357|NCT00658814|79377261|FG000|Remission Induction Chemotherapy|Not eligible|1|||
44372358|NCT00658814|79377262|FG001|Remission Induction Chemotherapy|Not eligible|2|||
44372359|NCT00658814|79377261|FG000|Consolidation Therapy|Not protocol specified|0|||
44372360|NCT00658814|79377262|FG001|Consolidation Therapy|Not protocol specified|1|||
44372361|NCT00658814|79377261|FG000|Consolidation Therapy|Not eligible|2|||
44372362|NCT00658814|79377262|FG001|Consolidation Therapy|Not eligible|2|||
44372363|NCT00658814|79377261|FG000|Maintenance Therapy|Adverse Event|1|||
44372364|NCT00658814|79377262|FG001|Maintenance Therapy|Adverse Event|1|||
44372365|NCT00658814|79377261|FG000|Maintenance Therapy|Not protocol specified|1|||
44372366|NCT00658814|79377262|FG001|Maintenance Therapy|Not protocol specified|0|||
44372367|NCT00658814|79377261|FG000|Maintenance Therapy|Not eligible|1|||
44372368|NCT00658814|79377262|FG001|Maintenance Therapy|Not eligible|0|||
44458130|NCT00434967|79466755|FG000|Overall Study|Randomized in error|0|||
44458131|NCT00434967|79466756|FG001|Overall Study|Randomized in error|0|||
44372369|NCT00644228|79377274|FG000|Randomization & Eligibility|Ineligible|31|||
44372370|NCT00644228|79377275|FG001|Randomization & Eligibility|Ineligible|21|||
44372371|NCT00644228|79377274|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
44372372|NCT00644228|79377275|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
44372373|NCT00644228|79377274|FG000|Randomization & Eligibility|Invalid Consent|0|||
44458132|NCT00434967|79466757|FG002|Overall Study|Randomized in error|0|||
44216567|NCT01544595|79014343|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
44216568|NCT01544595|79014344|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
44216569|NCT01544595|79014339|FG000|Status at Week 156|Lack of Efficacy|1|||
44216570|NCT01544595|79014340|FG001|Status at Week 156|Lack of Efficacy|0|||
44458133|NCT00434967|79466758|FG003|Overall Study|Randomized in error|1|||
44458134|NCT00434967|79466755|FG000|Overall Study|Protocol Violation|0|||
44216571|NCT01544595|79014341|FG002|Status at Week 156|Lack of Efficacy|1|||
44458135|NCT00434967|79466756|FG001|Overall Study|Protocol Violation|1|||
44458136|NCT00434967|79466757|FG002|Overall Study|Protocol Violation|0|||
44458137|NCT00434967|79466758|FG003|Overall Study|Protocol Violation|1|||
44372374|NCT00644228|79377275|FG001|Randomization & Eligibility|Invalid Consent|1|||
44372375|NCT00644228|79377274|FG000|Induction Therapy|Adverse Event|22|||
44372376|NCT00644228|79377275|FG001|Induction Therapy|Adverse Event|55|||
44372377|NCT00644228|79377274|FG000|Induction Therapy|Withdrawal by Subject|10|||
44372378|NCT00644228|79377275|FG001|Induction Therapy|Withdrawal by Subject|3|||
44372379|NCT00644228|79377274|FG000|Induction Therapy|Progression/Relapse|24|||
44372380|NCT00644228|79377275|FG001|Induction Therapy|Progression/Relapse|12|||
44372381|NCT00644228|79377274|FG000|Induction Therapy|Death|3|||
44372382|NCT00644228|79377275|FG001|Induction Therapy|Death|7|||
44372383|NCT00644228|79377274|FG000|Induction Therapy|Not Protocol-Specified|24|||
44372384|NCT00644228|79377275|FG001|Induction Therapy|Not Protocol-Specified|28|||
44372385|NCT00644228|79377274|FG000|Maintenance|Adverse Event|27|||
44372386|NCT00644228|79377275|FG001|Maintenance|Adverse Event|31|||
44372387|NCT00644228|79377274|FG000|Maintenance|Withdrawal by Subject|6|||
44372388|NCT00644228|79377275|FG001|Maintenance|Withdrawal by Subject|4|||
44372389|NCT00644228|79377274|FG000|Maintenance|Progression/Relapse|67|||
44372390|NCT00644228|79377275|FG001|Maintenance|Progression/Relapse|42|||
44372391|NCT00644228|79377274|FG000|Maintenance|Death|3|||
44372392|NCT00644228|79377275|FG001|Maintenance|Death|3|||
44372393|NCT00644228|79377274|FG000|Maintenance|Not Protocol-Specified|14|||
44372394|NCT00644228|79377275|FG001|Maintenance|Not Protocol-Specified|15|||
44372395|NCT00644228|79377274|FG000|Maintenance|On Treatment|26|||
44372396|NCT00644228|79377275|FG001|Maintenance|On Treatment|40|||
44372397|NCT00588770|79377283|FG000|Overall Study|Disease progression|85|||
44543963|NCT03613129|79557118|FG002|Pre-treatment Assessment|Protocol Violation|0|||
44543964|NCT03613129|79557119|FG003|Pre-treatment Assessment|Protocol Violation|0|||
44543965|NCT03613129|79557120|FG004|Pre-treatment Assessment|Protocol Violation|0|||
44543966|NCT03613129|79557116|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
44543967|NCT03613129|79557117|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
44543968|NCT03613129|79557118|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
44543969|NCT03613129|79557119|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
44543970|NCT03613129|79557120|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
44543971|NCT03235284|79557135|FG000|Overall Study|Adverse Event|1|||
44543972|NCT03235284|79557136|FG001|Overall Study|Adverse Event|2|||
44543973|NCT03235284|79557137|FG002|Overall Study|Adverse Event|1|||
44543974|NCT03170193|79557152|FG000|Overall Study|Withdrawal by Subject|0|||
44543975|NCT03170193|79557153|FG001|Overall Study|Withdrawal by Subject|0|||
44372398|NCT00588770|79377284|FG001|Overall Study|Disease progression|68|||
44372399|NCT00588770|79377283|FG000|Overall Study|Adverse Event|29|||
44372400|NCT00588770|79377284|FG001|Overall Study|Adverse Event|58|||
44372401|NCT00588770|79377283|FG000|Overall Study|Death|13|||
44372402|NCT00588770|79377284|FG001|Overall Study|Death|22|||
44372403|NCT00588770|79377283|FG000|Overall Study|Withdrawal by Subject|15|||
44372404|NCT00588770|79377284|FG001|Overall Study|Withdrawal by Subject|25|||
44458138|NCT00434967|79466755|FG000|Overall Study|Physician Decision|1|||
44458139|NCT00434967|79466756|FG001|Overall Study|Physician Decision|1|||
44458140|NCT00434967|79466757|FG002|Overall Study|Physician Decision|1|||
44458141|NCT00434967|79466758|FG003|Overall Study|Physician Decision|0|||
44458142|NCT00434967|79466755|FG000|Overall Study|Patient Disposition Challenges|2|||
44458143|NCT00434967|79466756|FG001|Overall Study|Patient Disposition Challenges|0|||
44458144|NCT00434967|79466757|FG002|Overall Study|Patient Disposition Challenges|0|||
44458145|NCT00434967|79466758|FG003|Overall Study|Patient Disposition Challenges|3|||
44458146|NCT00356590|79466768|FG000|Overall Study|Adverse Event|54|||
44458147|NCT00356590|79466768|FG000|Overall Study|Death|10|||
44458148|NCT00356590|79466768|FG000|Overall Study|Lost to Follow-up|35|||
44458149|NCT00356590|79466768|FG000|Overall Study|Physician Decision|46|||
44458150|NCT00356590|79466768|FG000|Overall Study|Withdrawal by Subject|41|||
44458151|NCT00356590|79466768|FG000|Overall Study|Completed month 12 only|2|||
44458152|NCT00356590|79466768|FG000|Overall Study|Protocol issues|6|||
44543976|NCT03170193|79557154|FG002|Overall Study|Withdrawal by Subject|0|||
44543977|NCT03170193|79557155|FG003|Overall Study|Withdrawal by Subject|1|||
44543978|NCT03170193|79557156|FG004|Overall Study|Withdrawal by Subject|0|||
44372405|NCT00588770|79377283|FG000|Overall Study|Alternative therapy|2|||
44372406|NCT00588770|79377284|FG001|Overall Study|Alternative therapy|4|||
44372407|NCT00588770|79377283|FG000|Overall Study|Other complicating disease|3|||
44372408|NCT00588770|79377284|FG001|Overall Study|Other complicating disease|2|||
44372409|NCT00588770|79377283|FG000|Overall Study|Not start protocol therapy|0|||
44372410|NCT00588770|79377284|FG001|Overall Study|Not start protocol therapy|9|||
44458153|NCT00356590|79466768|FG000|Overall Study|Response status|28|||
44458154|NCT00356590|79466768|FG000|Overall Study|Other|52|||
44458155|NCT00356278|79466775|FG000|Overall Study|Withdrawal by Subject|25|||
44458156|NCT00356278|79466776|FG001|Overall Study|Withdrawal by Subject|15|||
44458157|NCT00356278|79466777|FG002|Overall Study|Withdrawal by Subject|19|||
44543979|NCT03170193|79557157|FG005|Overall Study|Withdrawal by Subject|0|||
44458158|NCT00356200|79466787|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
44543980|NCT03170193|79557158|FG006|Overall Study|Withdrawal by Subject|0|||
44543981|NCT03170193|79557152|FG000|Overall Study|Lost to Follow-up|1|||
44543982|NCT03170193|79557153|FG001|Overall Study|Lost to Follow-up|1|||
44543983|NCT03170193|79557154|FG002|Overall Study|Lost to Follow-up|0|||
44543984|NCT03170193|79557155|FG003|Overall Study|Lost to Follow-up|0|||
44543985|NCT03170193|79557156|FG004|Overall Study|Lost to Follow-up|0|||
44543986|NCT03170193|79557157|FG005|Overall Study|Lost to Follow-up|0|||
44458159|NCT00356200|79466788|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
44458160|NCT00356200|79466787|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
44458161|NCT00356200|79466788|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
44458162|NCT00356122|79466800|FG000|TREATMENT|Lack of Efficacy|26|||
44458163|NCT00356122|79466800|FG000|TREATMENT|Adverse Event|10|||
44458164|NCT00356122|79466800|FG000|TREATMENT|Subject's request|4|||
44458165|NCT00356122|79466800|FG000|TREATMENT|Other|4|||
44458166|NCT00356122|79466800|FG000|TREATMENT|Did not receive study medication|1|||
44458167|NCT00356122|79466800|FG000|FOLLOW-UP|Death|37|||
44458168|NCT00356122|79466800|FG000|FOLLOW-UP|Lost to Follow-up|2|||
44458169|NCT00356122|79466800|FG000|FOLLOW-UP|Other|2|||
44458170|NCT00347932|79466806|FG000|Overall Study|Adverse Event|4|||
44458171|NCT00347932|79466807|FG001|Overall Study|Adverse Event|5|||
44458172|NCT00347932|79466806|FG000|Overall Study|Lack of Efficacy|3|||
44458173|NCT00347932|79466807|FG001|Overall Study|Lack of Efficacy|14|||
44458174|NCT00347932|79466806|FG000|Overall Study|Lost to Follow-up|10|||
44458175|NCT00347932|79466807|FG001|Overall Study|Lost to Follow-up|9|||
44458176|NCT00347932|79466806|FG000|Overall Study|Withdrawal by Subject|10|||
44458177|NCT00347932|79466807|FG001|Overall Study|Withdrawal by Subject|16|||
44458178|NCT00347932|79466806|FG000|Overall Study|Did not meet inclusion criteria|4|||
44458179|NCT00347932|79466807|FG001|Overall Study|Did not meet inclusion criteria|8|||
44458180|NCT00528996|79466818|FG000|Overall Study|Other reasons than listing|6|||
44458181|NCT00528996|79466819|FG001|Overall Study|Other reasons than listing|7|||
44458182|NCT00528996|79466820|FG002|Overall Study|Other reasons than listing|14|||
44458183|NCT00528996|79466821|FG003|Overall Study|Other reasons than listing|11|||
44458184|NCT00528996|79466822|FG004|Overall Study|Other reasons than listing|5|||
44458185|NCT00528996|79466818|FG000|Overall Study|Refused continue medication|16|||
44458186|NCT00528996|79466819|FG001|Overall Study|Refused continue medication|0|||
44458187|NCT00528996|79466820|FG002|Overall Study|Refused continue medication|3|||
44458188|NCT00528996|79466821|FG003|Overall Study|Refused continue medication|3|||
44458189|NCT00528996|79466822|FG004|Overall Study|Refused continue medication|6|||
44458190|NCT00528996|79466818|FG000|Overall Study|Lost to Follow-up|2|||
44458191|NCT00528996|79466819|FG001|Overall Study|Lost to Follow-up|0|||
44458192|NCT00528996|79466820|FG002|Overall Study|Lost to Follow-up|4|||
44458193|NCT00528996|79466821|FG003|Overall Study|Lost to Follow-up|1|||
44458194|NCT00528996|79466822|FG004|Overall Study|Lost to Follow-up|3|||
44458195|NCT00528996|79466818|FG000|Overall Study|Protocol Violation|1|||
44458196|NCT00528996|79466819|FG001|Overall Study|Protocol Violation|2|||
44458197|NCT00528996|79466820|FG002|Overall Study|Protocol Violation|3|||
44543987|NCT03170193|79557158|FG006|Overall Study|Lost to Follow-up|0|||
44543988|NCT03633331|79557180|FG000|Overall Study|Withdrawal by Subject|1|||
44543989|NCT03201003|79557186|FG000|Overall Study|Adverse Event|14|||
44543990|NCT03201003|79557187|FG001|Overall Study|Adverse Event|1|||
44543991|NCT03201003|79557186|FG000|Overall Study|Other reasons|5|||
44543992|NCT03201003|79557187|FG001|Overall Study|Other reasons|1|||
44543993|NCT03201003|79557186|FG000|Overall Study|Withdrawal by Subject|4|||
44543994|NCT03201003|79557187|FG001|Overall Study|Withdrawal by Subject|1|||
44543995|NCT03201003|79557186|FG000|Overall Study|Lost to Follow-up|2|||
44543996|NCT03201003|79557187|FG001|Overall Study|Lost to Follow-up|0|||
44543997|NCT03201003|79557186|FG000|Overall Study|Protocol Violation|1|||
44543998|NCT03201003|79557187|FG001|Overall Study|Protocol Violation|0|||
44543999|NCT03166215|79557195|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
44544000|NCT03166215|79557196|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
44544001|NCT03166215|79557197|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
44544002|NCT03166215|79557195|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
44458198|NCT00528996|79466821|FG003|Overall Study|Protocol Violation|3|||
44544003|NCT03166215|79557196|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
44544004|NCT03166215|79557197|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
44458199|NCT00528996|79466822|FG004|Overall Study|Protocol Violation|2|||
44458200|NCT00528996|79466818|FG000|Overall Study|Lack of Efficacy|7|||
44458201|NCT00528996|79466819|FG001|Overall Study|Lack of Efficacy|2|||
44458202|NCT00528996|79466820|FG002|Overall Study|Lack of Efficacy|1|||
44458203|NCT00528996|79466821|FG003|Overall Study|Lack of Efficacy|3|||
44458204|NCT00528996|79466822|FG004|Overall Study|Lack of Efficacy|3|||
44544005|NCT03168711|79557219|FG000|Overall Study|Adverse Event|2|||
44458205|NCT00528996|79466818|FG000|Overall Study|Adverse Event|32|||
44458206|NCT00528996|79466819|FG001|Overall Study|Adverse Event|13|||
44458207|NCT00528996|79466820|FG002|Overall Study|Adverse Event|18|||
44544006|NCT03168711|79557220|FG001|Overall Study|Adverse Event|0|||
44544007|NCT03168711|79557219|FG000|Overall Study|Withdrawal by Subject|0|||
44544008|NCT03168711|79557220|FG001|Overall Study|Withdrawal by Subject|1|||
44544009|NCT03168711|79557219|FG000|Overall Study|Death|0|||
44544010|NCT03168711|79557220|FG001|Overall Study|Death|1|||
44544011|NCT03738215|79557229|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
44544012|NCT03738215|79557230|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
44544013|NCT03738215|79557231|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
44544014|NCT03738215|79557229|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
44544015|NCT03738215|79557230|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
44544016|NCT03738215|79557231|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44544017|NCT03738215|79557229|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
44544018|NCT03738215|79557230|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
44458208|NCT00528996|79466821|FG003|Overall Study|Adverse Event|29|||
44458209|NCT00528996|79466822|FG004|Overall Study|Adverse Event|18|||
44458210|NCT00359788|79466839|FG000|Overall Study|Adverse Event|11|||
44458211|NCT00359788|79466840|FG001|Overall Study|Adverse Event|10|||
44458212|NCT00359788|79466839|FG000|Overall Study|Lack of Efficacy|1|||
44458213|NCT00359788|79466840|FG001|Overall Study|Lack of Efficacy|2|||
44458214|NCT00359788|79466839|FG000|Overall Study|Lost to Follow-up|3|||
44458215|NCT00359788|79466840|FG001|Overall Study|Lost to Follow-up|2|||
44458216|NCT00359788|79466839|FG000|Overall Study|Withdrawal by Subject|4|||
44458217|NCT00359788|79466840|FG001|Overall Study|Withdrawal by Subject|1|||
44458218|NCT00359788|79466839|FG000|Overall Study|Protocol Violation|4|||
44458219|NCT00359788|79466840|FG001|Overall Study|Protocol Violation|2|||
44458220|NCT03878160|79466849|FG000|Overall Study|Lost to Follow-up|1|||
44458221|NCT03878160|79466850|FG001|Overall Study|Lost to Follow-up|1|||
44458222|NCT03878160|79466851|FG002|Overall Study|Lost to Follow-up|1|||
44458223|NCT03878160|79466849|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
44458224|NCT03878160|79466850|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
44458225|NCT03878160|79466851|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
44458226|NCT00623597|79466861|FG000|Overall Study|Failed to return|1|||
44458227|NCT00623597|79466862|FG001|Overall Study|Failed to return|0|||
44458228|NCT00347776|79466873|FG000|1.5 Month Follow-up|Death|2|||
44544019|NCT03738215|79557231|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
44544020|NCT03738215|79557229|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
44544021|NCT03738215|79557230|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
44544022|NCT03738215|79557231|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
44544023|NCT03738215|79557229|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
44372411|NCT00588770|79377283|FG000|Overall Study|Lack of Efficacy|8|||
44372412|NCT00588770|79377284|FG001|Overall Study|Lack of Efficacy|10|||
44372413|NCT00588770|79377283|FG000|Overall Study|Physician discretion|2|||
44372414|NCT00588770|79377284|FG001|Overall Study|Physician discretion|0|||
44372415|NCT00588770|79377283|FG000|Overall Study|Patient non-compliance|2|||
44372416|NCT00588770|79377284|FG001|Overall Study|Patient non-compliance|2|||
44372417|NCT00433511|79377293|FG000|Step 1|Adverse Event|50|||
44372418|NCT00433511|79377294|FG001|Step 1|Adverse Event|157|||
44372419|NCT00433511|79377295|FG002|Step 1|Adverse Event|153|||
44372420|NCT00433511|79377293|FG000|Step 1|Withdrawal by Subject|45|||
44372421|NCT00433511|79377294|FG001|Step 1|Withdrawal by Subject|143|||
44372422|NCT00433511|79377295|FG002|Step 1|Withdrawal by Subject|154|||
44372423|NCT00433511|79377293|FG000|Step 1|Death|3|||
44372424|NCT00433511|79377294|FG001|Step 1|Death|1|||
44372425|NCT00433511|79377295|FG002|Step 1|Death|1|||
44372426|NCT00433511|79377293|FG000|Step 1|Physician Decision|1|||
44372427|NCT00433511|79377294|FG001|Step 1|Physician Decision|4|||
44372428|NCT00433511|79377295|FG002|Step 1|Physician Decision|3|||
44372429|NCT00433511|79377293|FG000|Step 1|Never started protocol therapy|28|||
44372430|NCT00433511|79377294|FG001|Step 1|Never started protocol therapy|64|||
44372431|NCT00433511|79377295|FG002|Step 1|Never started protocol therapy|66|||
44372432|NCT00433511|79377293|FG000|Step 1|Alternative therapy|2|||
44372433|NCT00433511|79377294|FG001|Step 1|Alternative therapy|1|||
44372434|NCT00433511|79377295|FG002|Step 1|Alternative therapy|3|||
44372435|NCT00433511|79377293|FG000|Step 1|Disease progression, relapse|5|||
44372436|NCT00433511|79377294|FG001|Step 1|Disease progression, relapse|3|||
44372437|NCT00433511|79377295|FG002|Step 1|Disease progression, relapse|3|||
44372438|NCT00433511|79377293|FG000|Step 1|Other complicating disease|2|||
44372439|NCT00433511|79377294|FG001|Step 1|Other complicating disease|6|||
44372440|NCT00433511|79377295|FG002|Step 1|Other complicating disease|3|||
44372441|NCT00433511|79377293|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
44372442|NCT00433511|79377294|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
44372443|NCT00433511|79377295|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
44372444|NCT00433511|79377293|FG000|Step 1|Suspected recurrence|0|||
44458229|NCT00347776|79466874|FG001|1.5 Month Follow-up|Death|0|||
44458230|NCT00347776|79466875|FG002|1.5 Month Follow-up|Death|0|||
44458231|NCT00347776|79466873|FG000|1.5 Month Follow-up|reached the endpoint|12|||
44458232|NCT00347776|79466874|FG001|1.5 Month Follow-up|reached the endpoint|8|||
44458233|NCT00347776|79466875|FG002|1.5 Month Follow-up|reached the endpoint|12|||
44458234|NCT00347776|79466873|FG000|6 Month Follow-up|Death|2|||
44458235|NCT00347776|79466874|FG001|6 Month Follow-up|Death|1|||
44458236|NCT00347776|79466875|FG002|6 Month Follow-up|Death|3|||
44458237|NCT00347776|79466873|FG000|6 Month Follow-up|reached endpont|20|||
44458238|NCT00347776|79466874|FG001|6 Month Follow-up|reached endpont|12|||
44458239|NCT00347776|79466875|FG002|6 Month Follow-up|reached endpont|15|||
44458240|NCT00347776|79466873|FG000|12 Month Follow-up|Lost to Follow-up|7|||
44458241|NCT00347776|79466874|FG001|12 Month Follow-up|Lost to Follow-up|6|||
44544024|NCT03738215|79557230|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
44544025|NCT03738215|79557231|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
44544026|NCT03738215|79557229|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
44544027|NCT03738215|79557230|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
44544028|NCT03738215|79557231|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
44544029|NCT03738215|79557229|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
44544030|NCT03738215|79557230|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
44544031|NCT03738215|79557231|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
44544032|NCT03738215|79557229|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
44458242|NCT00347776|79466875|FG002|12 Month Follow-up|Lost to Follow-up|6|||
44458243|NCT00347776|79466873|FG000|12 Month Follow-up|Death|3|||
44458244|NCT00347776|79466874|FG001|12 Month Follow-up|Death|4|||
44458245|NCT00347776|79466875|FG002|12 Month Follow-up|Death|4|||
44458246|NCT00347776|79466873|FG000|12 Month Follow-up|Reached endpoint|13|||
44458247|NCT00347776|79466874|FG001|12 Month Follow-up|Reached endpoint|6|||
44458248|NCT00347776|79466875|FG002|12 Month Follow-up|Reached endpoint|9|||
44458249|NCT03829228|79466883|FG000|Overall Study|Protocol Violation|1|||
44458250|NCT00529542|79466889|FG000|Overall Study|Withdrawal by Subject|1|||
44458251|NCT00529542|79466890|FG001|Overall Study|Withdrawal by Subject|0|||
44458252|NCT00529542|79466889|FG000|Overall Study|Lost to Follow-up|0|||
44458253|NCT00529542|79466890|FG001|Overall Study|Lost to Follow-up|1|||
44458254|NCT00621959|79466898|FG000|Overall Study|Adverse Event|4|||
44458255|NCT00621959|79466899|FG001|Overall Study|Adverse Event|2|||
44458256|NCT00621959|79466898|FG000|Overall Study|Lack of Efficacy|1|||
44458257|NCT00621959|79466899|FG001|Overall Study|Lack of Efficacy|1|||
44458258|NCT00621959|79466898|FG000|Overall Study|Lost to Follow-up|0|||
44458259|NCT00621959|79466899|FG001|Overall Study|Lost to Follow-up|2|||
44458260|NCT00621959|79466898|FG000|Overall Study|Withdrawal by Subject|1|||
44458261|NCT00621959|79466899|FG001|Overall Study|Withdrawal by Subject|1|||
44458262|NCT00621959|79466898|FG000|Overall Study|Other|1|||
44458263|NCT00621959|79466899|FG001|Overall Study|Other|3|||
44458264|NCT03877224|79466907|FG000|Overall Study|Death|3|||
44458265|NCT03877224|79466908|FG001|Overall Study|Death|2|||
44544033|NCT03738215|79557230|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
44544034|NCT03738215|79557231|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
44270178|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44270179|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44270180|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44270181|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44372445|NCT00433511|79377294|FG001|Step 1|Suspected recurrence|1|||
44372446|NCT00433511|79377295|FG002|Step 1|Suspected recurrence|0|||
44372447|NCT00433511|79377293|FG000|Step 1|Insurance/drug distribution issues|0|||
44372448|NCT00433511|79377294|FG001|Step 1|Insurance/drug distribution issues|1|||
44372449|NCT00433511|79377295|FG002|Step 1|Insurance/drug distribution issues|2|||
44372450|NCT00433511|79377293|FG000|Step 1|Patient moved|0|||
44372451|NCT00433511|79377294|FG001|Step 1|Patient moved|0|||
44372452|NCT00433511|79377295|FG002|Step 1|Patient moved|1|||
44372453|NCT00433511|79377293|FG000|Step 2 (Arm D)|Adverse Event|0|||
44372454|NCT00433511|79377294|FG001|Step 2 (Arm D)|Adverse Event|0|||
44372455|NCT00433511|79377295|FG002|Step 2 (Arm D)|Adverse Event|135|||
44372456|NCT00433511|79377293|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
44372457|NCT00433511|79377294|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
44372458|NCT00433511|79377295|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
44372459|NCT00433511|79377293|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
44372460|NCT00433511|79377294|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
44372461|NCT00433511|79377295|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
44372462|NCT00433511|79377293|FG000|Step 2 (Arm D)|Physician Decision|0|||
44372463|NCT00433511|79377294|FG001|Step 2 (Arm D)|Physician Decision|0|||
44372464|NCT00433511|79377295|FG002|Step 2 (Arm D)|Physician Decision|9|||
44372465|NCT00433511|79377293|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
44372466|NCT00433511|79377294|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
44458266|NCT03877224|79466907|FG000|Overall Study|Withdrawal by Subject|1|||
44458267|NCT03877224|79466908|FG001|Overall Study|Withdrawal by Subject|6|||
44458268|NCT03877224|79466907|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
44458269|NCT03877224|79466908|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
44458270|NCT00528606|79466916|FG000|Overall Study|Withdrew consent|4|||
44458271|NCT00528606|79466917|FG001|Overall Study|Withdrew consent|3|||
44458272|NCT00528606|79466916|FG000|Overall Study|Lost to Follow-up|4|||
44458273|NCT00528606|79466917|FG001|Overall Study|Lost to Follow-up|1|||
44458274|NCT00528606|79466916|FG000|Overall Study|Adverse Event|3|||
44458275|NCT00528606|79466917|FG001|Overall Study|Adverse Event|0|||
44458276|NCT00528606|79466916|FG000|Overall Study|Other|2|||
44458277|NCT00528606|79466917|FG001|Overall Study|Other|0|||
44458278|NCT00621257|79466928|FG000|Overall Study|Lost to Follow-up|4|||
44458279|NCT00621257|79466929|FG001|Overall Study|Lost to Follow-up|0|||
44458280|NCT00621257|79466930|FG002|Overall Study|Lost to Follow-up|2|||
44458281|NCT00621257|79466931|FG003|Overall Study|Lost to Follow-up|4|||
44458282|NCT00621257|79466932|FG004|Overall Study|Lost to Follow-up|7|||
44458283|NCT00621257|79466928|FG000|Overall Study|Adverse Event|0|||
44458284|NCT00621257|79466929|FG001|Overall Study|Adverse Event|1|||
44458285|NCT00621257|79466930|FG002|Overall Study|Adverse Event|1|||
44458286|NCT00621257|79466931|FG003|Overall Study|Adverse Event|0|||
44458287|NCT00621257|79466932|FG004|Overall Study|Adverse Event|0|||
44458288|NCT00621257|79466928|FG000|Overall Study|Physician Decision|0|||
44458289|NCT00621257|79466929|FG001|Overall Study|Physician Decision|2|||
44458290|NCT00621257|79466930|FG002|Overall Study|Physician Decision|0|||
44458291|NCT00621257|79466931|FG003|Overall Study|Physician Decision|1|||
44458292|NCT00621257|79466932|FG004|Overall Study|Physician Decision|1|||
44458293|NCT00621257|79466928|FG000|Overall Study|Withdrawal by Subject|0|||
44458294|NCT00621257|79466929|FG001|Overall Study|Withdrawal by Subject|0|||
44458295|NCT00621257|79466930|FG002|Overall Study|Withdrawal by Subject|0|||
44458296|NCT00621257|79466931|FG003|Overall Study|Withdrawal by Subject|1|||
44458297|NCT00621257|79466932|FG004|Overall Study|Withdrawal by Subject|1|||
44458298|NCT00528840|79466944|FG000|Overall Study|Lost to Follow-up|10|||
44458299|NCT00528840|79466944|FG000|Overall Study|Adverse Event|1|||
44458300|NCT00528840|79466944|FG000|Overall Study|Withdrawal by Subject|17|||
44458301|NCT00528840|79466944|FG000|Overall Study|Death|2|||
44458302|NCT00528840|79466944|FG000|Overall Study|Administrative Reasons|1|||
44458303|NCT00528840|79466944|FG000|Overall Study|Other|2|||
44458304|NCT00528528|79466952|FG000|Overall Study|Lost to Follow-up|0|||
44458305|NCT00528528|79466953|FG001|Overall Study|Lost to Follow-up|0|||
44458306|NCT00528528|79466954|FG002|Overall Study|Lost to Follow-up|1|||
44458307|NCT00528528|79466955|FG003|Overall Study|Lost to Follow-up|1|||
44458308|NCT00528528|79466952|FG000|Overall Study|Ineligible to continue the trial|0|||
44544035|NCT03738215|79557229|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
44458309|NCT00528528|79466953|FG001|Overall Study|Ineligible to continue the trial|0|||
44544036|NCT03738215|79557230|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
44544037|NCT03738215|79557231|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
44544038|NCT03738215|79557229|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
44544039|NCT03738215|79557230|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
44544040|NCT03738215|79557231|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
44544041|NCT03199911|79557241|FG000|Overall Study|Lost to Follow-up|5|||
44544042|NCT03199911|79557242|FG001|Overall Study|Lost to Follow-up|5|||
44544043|NCT03199911|79557241|FG000|Overall Study|Did not proceed with surgery|2|||
44544044|NCT03199911|79557242|FG001|Overall Study|Did not proceed with surgery|1|||
44544045|NCT03736967|79557252|FG000|Overall Study|Withdrawal by Subject|26|||
44544046|NCT03736967|79557253|FG001|Overall Study|Withdrawal by Subject|25|||
44544047|NCT03736967|79557254|FG002|Overall Study|Withdrawal by Subject|23|||
44216572|NCT01544595|79014342|FG003|Status at Week 156|Lack of Efficacy|4|||
44458310|NCT00528528|79466954|FG002|Overall Study|Ineligible to continue the trial|0|||
44544048|NCT03736967|79557255|FG003|Overall Study|Withdrawal by Subject|26|||
44216573|NCT01544595|79014343|FG004|Status at Week 156|Lack of Efficacy|10|||
44216574|NCT01544595|79014344|FG005|Status at Week 156|Lack of Efficacy|5|||
44216575|NCT01539525|79014365|FG000|Overall Study|Lost to Follow-up|19|||
44216576|NCT01539525|79014366|FG001|Overall Study|Lost to Follow-up|12|||
44216577|NCT01539525|79014367|FG002|Overall Study|Lost to Follow-up|11|||
44216578|NCT01539525|79014365|FG000|Overall Study|Withdrawal by Subject|0|||
44458311|NCT00528528|79466955|FG003|Overall Study|Ineligible to continue the trial|1|||
44458312|NCT00528528|79466952|FG000|Overall Study|Other|0|||
44458313|NCT00528528|79466953|FG001|Overall Study|Other|1|||
44458314|NCT00528528|79466954|FG002|Overall Study|Other|0|||
44458315|NCT00528528|79466955|FG003|Overall Study|Other|0|||
44458316|NCT00528528|79466952|FG000|Overall Study|Withdrawal by Subject|3|||
44458317|NCT00528528|79466953|FG001|Overall Study|Withdrawal by Subject|2|||
44458318|NCT00528528|79466954|FG002|Overall Study|Withdrawal by Subject|1|||
44544049|NCT03736967|79557252|FG000|Overall Study|Lost to Follow-up|3|||
44544050|NCT03736967|79557253|FG001|Overall Study|Lost to Follow-up|2|||
44458319|NCT00528528|79466955|FG003|Overall Study|Withdrawal by Subject|1|||
44216579|NCT01539525|79014366|FG001|Overall Study|Withdrawal by Subject|3|||
44216580|NCT01539525|79014367|FG002|Overall Study|Withdrawal by Subject|2|||
44458320|NCT00528528|79466952|FG000|Overall Study|Ongoing participant|0|||
44458321|NCT00528528|79466953|FG001|Overall Study|Ongoing participant|0|||
44458322|NCT00528528|79466954|FG002|Overall Study|Ongoing participant|1|||
44458323|NCT00528528|79466955|FG003|Overall Study|Ongoing participant|0|||
44458324|NCT00620555|79466967|FG000|Overall Study|Adverse Event|4|||
44458325|NCT00620555|79466967|FG000|Overall Study|Protocol Violation|2|||
44458326|NCT00620555|79466967|FG000|Overall Study|Lack of Efficacy|12|||
44458327|NCT00620555|79466967|FG000|Overall Study|Withdrawal by Subject|1|||
44458328|NCT00620555|79466967|FG000|Overall Study|Choice of other treatment|1|||
44458329|NCT00620555|79466967|FG000|Overall Study|Visit failure against planned|1|||
44458330|NCT00529386|79466971|FG000|Overall Study|Lost to Follow-up|1|||
44458331|NCT03875118|79466977|FG000|Overall Study|Withdrawal by Subject|4|||
44458332|NCT03875118|79466978|FG001|Overall Study|Withdrawal by Subject|4|||
44458333|NCT00529308|79466986|FG000|Overall Study|Withdrawal by Subject|1|||
44458334|NCT00529308|79466987|FG001|Overall Study|Withdrawal by Subject|1|||
44458335|NCT03875508|79466993|FG000|Overall Study|Adverse Event|1|||
44458336|NCT03875508|79466993|FG000|Overall Study|Lost to Follow-up|8|||
44458337|NCT03875508|79466993|FG000|Overall Study|Lack of Efficacy|1|||
44458338|NCT03875508|79466993|FG000|Overall Study|Other, not specified|2|||
44458339|NCT00620321|79466999|FG000|Overall Study|Adverse Event|1|||
44458340|NCT00620321|79467000|FG001|Overall Study|Adverse Event|1|||
44216581|NCT01539525|79014365|FG000|Overall Study|Protocol Violation|1|||
44216582|NCT01539525|79014366|FG001|Overall Study|Protocol Violation|1|||
44216583|NCT01539525|79014367|FG002|Overall Study|Protocol Violation|4|||
44216584|NCT01513551|79014381|FG000|Overall Study|Death|0|||
44216585|NCT01513551|79014382|FG001|Overall Study|Death|1|||
44216586|NCT01513551|79014383|FG002|Overall Study|Death|0|||
44216587|NCT01513551|79014381|FG000|Overall Study|Lost to Follow-up|3|||
44216588|NCT01513551|79014382|FG001|Overall Study|Lost to Follow-up|5|||
44216589|NCT01513551|79014383|FG002|Overall Study|Lost to Follow-up|2|||
44216590|NCT01513551|79014381|FG000|Overall Study|Withdrawal by Subject|1|||
44216591|NCT01513551|79014382|FG001|Overall Study|Withdrawal by Subject|0|||
44216592|NCT01513551|79014383|FG002|Overall Study|Withdrawal by Subject|2|||
44216593|NCT01513551|79014381|FG000|Overall Study|Randomized but not vaccinated|0|||
44216594|NCT01513551|79014382|FG001|Overall Study|Randomized but not vaccinated|0|||
44216595|NCT01513551|79014383|FG002|Overall Study|Randomized but not vaccinated|1|||
44216596|NCT01513473|79014393|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
44216597|NCT01513473|79014394|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
44216598|NCT01513473|79014393|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
44216599|NCT01513473|79014394|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
44216600|NCT01513473|79014393|FG000|Main Trial (26 Weeks)|Unclassified|0|||
44216601|NCT01513473|79014394|FG001|Main Trial (26 Weeks)|Unclassified|2|||
44216602|NCT01513473|79014393|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
44216603|NCT01513473|79014394|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
44216604|NCT01513473|79014393|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
44216605|NCT01513473|79014394|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
44216606|NCT01513317|79014402|FG000|Overall Study|Withdrawal by Subject|15|||
44216607|NCT01513317|79014403|FG001|Overall Study|Withdrawal by Subject|4|||
44216608|NCT01513317|79014402|FG000|Overall Study|Death|1|||
44216609|NCT01513317|79014403|FG001|Overall Study|Death|1|||
44216610|NCT01513317|79014402|FG000|Overall Study|Study terminated by sponsor|18|||
44216611|NCT01513317|79014403|FG001|Overall Study|Study terminated by sponsor|18|||
44216612|NCT01513317|79014402|FG000|Overall Study|Other|0|||
44216613|NCT01513317|79014403|FG001|Overall Study|Other|1|||
44216614|NCT03824392|79014413|FG000|Overall Study|Adverse Event|1|||
44216615|NCT03824392|79014414|FG001|Overall Study|Adverse Event|0|||
44270182|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
44458341|NCT00620321|79466999|FG000|Overall Study|Death|1|||
44458342|NCT00620321|79467000|FG001|Overall Study|Death|1|||
44458343|NCT00620321|79466999|FG000|Overall Study|Physician Decision|0|||
44458344|NCT00620321|79467000|FG001|Overall Study|Physician Decision|7|||
44458345|NCT00620321|79466999|FG000|Overall Study|Progressive Disease|5|||
44458346|NCT00620321|79467000|FG001|Overall Study|Progressive Disease|5|||
44458347|NCT00620321|79466999|FG000|Overall Study|Sponsor Decision|0|||
44458348|NCT00620321|79467000|FG001|Overall Study|Sponsor Decision|1|||
44458349|NCT00620321|79466999|FG000|Overall Study|Withdrawal by Subject|1|||
44216616|NCT03824392|79014415|FG002|Overall Study|Adverse Event|0|||
44216617|NCT03824392|79014416|FG003|Overall Study|Adverse Event|0|||
44216618|NCT03824392|79014413|FG000|Overall Study|Investigator Decision|0|||
44216619|NCT03824392|79014414|FG001|Overall Study|Investigator Decision|1|||
44216620|NCT03824392|79014415|FG002|Overall Study|Investigator Decision|0|||
44216621|NCT03824392|79014416|FG003|Overall Study|Investigator Decision|0|||
44458350|NCT00620321|79467000|FG001|Overall Study|Withdrawal by Subject|1|||
44216622|NCT03824392|79014413|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
44216623|NCT03824392|79014414|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
44458351|NCT00621023|79467006|FG000|Overall Study|Death|5|||
44458352|NCT00621023|79467006|FG000|Overall Study|Follow up discontinued|1|||
44458353|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
44458354|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458355|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458356|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458357|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458358|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458359|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458360|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458361|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
44458362|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
44458363|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
44458364|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
44458365|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
44458366|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
44458367|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
44458368|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
44458369|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
44458370|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
44458371|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
44458372|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
44458373|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
44458374|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
44458375|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
44458376|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
44458377|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
44458378|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
44458379|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
44458380|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
44458381|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
44458382|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
44458383|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
44458384|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
44458385|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
44458386|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
44458387|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
44458388|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
44458389|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44216624|NCT03824392|79014415|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
44216625|NCT03824392|79014416|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
44216626|NCT01901653|79014439|FG000|Overall Study|Death|2|||
44216627|NCT01901653|79014440|FG001|Overall Study|Death|1|||
44216628|NCT01901653|79014441|FG002|Overall Study|Death|8|||
44216629|NCT01901653|79014442|FG003|Overall Study|Death|3|||
44216630|NCT01901653|79014443|FG004|Overall Study|Death|2|||
44216631|NCT01901653|79014444|FG005|Overall Study|Death|2|||
44216632|NCT01901653|79014445|FG006|Overall Study|Death|6|||
44216633|NCT01901653|79014446|FG007|Overall Study|Death|9|||
44216634|NCT01901653|79014447|FG008|Overall Study|Death|1|||
44216635|NCT01901653|79014448|FG009|Overall Study|Death|16|||
44216636|NCT01901653|79014449|FG010|Overall Study|Death|2|||
44216637|NCT01901653|79014450|FG011|Overall Study|Death|15|||
44216638|NCT01901653|79014451|FG012|Overall Study|Death|4|||
44372467|NCT00433511|79377295|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
44372468|NCT00433511|79377293|FG000|Step 2 (Arm D)|Other complicating disease|0|||
44372469|NCT00433511|79377294|FG001|Step 2 (Arm D)|Other complicating disease|0|||
44372470|NCT00433511|79377295|FG002|Step 2 (Arm D)|Other complicating disease|3|||
44372471|NCT00433511|79377293|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
44372472|NCT00433511|79377294|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
44372473|NCT00433511|79377295|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
44372474|NCT00433511|79377293|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
44372475|NCT00433511|79377294|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
44372476|NCT00433511|79377295|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
44458390|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44216639|NCT01901653|79014439|FG000|Overall Study|Lost to Follow-up|1|||
44216640|NCT01901653|79014440|FG001|Overall Study|Lost to Follow-up|0|||
44216641|NCT01901653|79014441|FG002|Overall Study|Lost to Follow-up|2|||
44216642|NCT01901653|79014442|FG003|Overall Study|Lost to Follow-up|0|||
44216643|NCT01901653|79014443|FG004|Overall Study|Lost to Follow-up|0|||
44216644|NCT01901653|79014444|FG005|Overall Study|Lost to Follow-up|1|||
44216645|NCT01901653|79014445|FG006|Overall Study|Lost to Follow-up|0|||
44216646|NCT01901653|79014446|FG007|Overall Study|Lost to Follow-up|1|||
44216647|NCT01901653|79014447|FG008|Overall Study|Lost to Follow-up|0|||
44216648|NCT01901653|79014448|FG009|Overall Study|Lost to Follow-up|0|||
44216649|NCT01901653|79014449|FG010|Overall Study|Lost to Follow-up|0|||
44216650|NCT01901653|79014450|FG011|Overall Study|Lost to Follow-up|0|||
44458391|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44458392|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
44458393|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44458394|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
44458395|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44458396|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44458397|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
44458398|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
44458399|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
44458400|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
44458401|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
44458402|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
44458403|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
44458404|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
44458405|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
44458406|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
44458407|NCT00528372|79467019|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
44458408|NCT00528372|79467020|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
44458409|NCT00528372|79467021|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
44458410|NCT00528372|79467022|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
44458411|NCT00528372|79467023|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
44458412|NCT00528372|79467024|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
44458413|NCT00528372|79467025|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
44458414|NCT00528372|79467026|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
44458415|NCT00528372|79467027|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
44458416|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
44458417|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
44458418|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
44458419|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
44458420|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
44458421|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
44458422|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
44544051|NCT03736967|79557254|FG002|Overall Study|Lost to Follow-up|1|||
44544052|NCT03736967|79557255|FG003|Overall Study|Lost to Follow-up|1|||
44544053|NCT03736967|79557252|FG000|Overall Study|Physician Decision|1|||
44544054|NCT03736967|79557253|FG001|Overall Study|Physician Decision|0|||
44216651|NCT01901653|79014451|FG012|Overall Study|Lost to Follow-up|0|||
44216652|NCT01901653|79014439|FG000|Overall Study|Withdrawal by Subject|0|||
44216653|NCT01901653|79014440|FG001|Overall Study|Withdrawal by Subject|0|||
44216654|NCT01901653|79014441|FG002|Overall Study|Withdrawal by Subject|0|||
44216655|NCT01901653|79014442|FG003|Overall Study|Withdrawal by Subject|0|||
44216656|NCT01901653|79014443|FG004|Overall Study|Withdrawal by Subject|0|||
44216657|NCT01901653|79014444|FG005|Overall Study|Withdrawal by Subject|0|||
44270183|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270184|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270185|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270186|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270187|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270188|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
44270189|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270190|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
44270191|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270192|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270193|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270194|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44216658|NCT01901653|79014445|FG006|Overall Study|Withdrawal by Subject|1|||
44216659|NCT01901653|79014446|FG007|Overall Study|Withdrawal by Subject|0|||
44216660|NCT01901653|79014447|FG008|Overall Study|Withdrawal by Subject|0|||
44216661|NCT01901653|79014448|FG009|Overall Study|Withdrawal by Subject|0|||
44270195|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44458423|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
44544055|NCT03736967|79557254|FG002|Overall Study|Physician Decision|0|||
44458424|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
44458425|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
44458426|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
44458427|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
44458428|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
44458429|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
44458430|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
44458431|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
44458432|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
44458433|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
44458434|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
44458435|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
44458436|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
44458437|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
44458438|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
44458439|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
44458440|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
44458441|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
44458442|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
44458443|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
44458444|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
44458445|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
44458446|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
44458447|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
44458448|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
44458449|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
44458450|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
44458451|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
44458452|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
44458453|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
44458454|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
44458455|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
44458456|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
44458457|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
44458458|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
44458459|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
44458460|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
44458461|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458462|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458463|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458464|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458465|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
44458466|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
44458467|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458468|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458469|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
44458470|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
44458471|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
44458472|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
44458473|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
44458474|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
44458475|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
44458476|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
44458477|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
44372477|NCT00433511|79377293|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
44372478|NCT00433511|79377294|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
44372479|NCT00433511|79377295|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
44372480|NCT00433511|79377293|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
44372481|NCT00433511|79377294|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
44372482|NCT00433511|79377295|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
44372483|NCT00324805|79377308|FG000|Overall Study|Adverse Event|62|||
44372484|NCT00324805|79377309|FG001|Overall Study|Adverse Event|203|||
44372485|NCT00324805|79377308|FG000|Overall Study|Progression|7|||
44458478|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
44458479|NCT00528372|79467019|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
44458480|NCT00528372|79467020|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
44458481|NCT00528372|79467021|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
44458482|NCT00528372|79467022|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
44458483|NCT00528372|79467023|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
44458484|NCT00528372|79467024|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
44458485|NCT00528372|79467025|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
44458486|NCT00528372|79467026|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
44458487|NCT00528372|79467027|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
44458488|NCT00527982|79467075|FG000|Overall Study|Physician Decision|1|||
44458489|NCT00527982|79467076|FG001|Overall Study|Physician Decision|0|||
44458490|NCT00527904|79467082|FG000|Overall Study|Adverse Event|45|||
44458491|NCT00527904|79467082|FG000|Overall Study|Withdrawal by Subject|21|||
44458492|NCT00527904|79467082|FG000|Overall Study|Lost to Follow-up|8|||
44458493|NCT00527904|79467082|FG000|Overall Study|misc|22|||
44458494|NCT00619619|79467094|FG000|Overall Study|Physician Decision|0|||
44458495|NCT00619619|79467095|FG001|Overall Study|Physician Decision|0|||
44216662|NCT01901653|79014449|FG010|Overall Study|Withdrawal by Subject|0|||
44216663|NCT01901653|79014450|FG011|Overall Study|Withdrawal by Subject|0|||
44216664|NCT01901653|79014451|FG012|Overall Study|Withdrawal by Subject|0|||
44216665|NCT01901653|79014439|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
44216666|NCT01901653|79014440|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
44216667|NCT01901653|79014441|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
44372486|NCT00324805|79377309|FG001|Overall Study|Progression|35|||
44372487|NCT00324805|79377308|FG000|Overall Study|Withdrawal by Subject|51|||
44372488|NCT00324805|79377309|FG001|Overall Study|Withdrawal by Subject|174|||
44372489|NCT00324805|79377308|FG000|Overall Study|Death|6|||
44372490|NCT00324805|79377309|FG001|Overall Study|Death|9|||
44372491|NCT00324805|79377308|FG000|Overall Study|Alternative therapy|4|||
44372492|NCT00324805|79377309|FG001|Overall Study|Alternative therapy|8|||
44372493|NCT00324805|79377308|FG000|Overall Study|Other complicating disease|1|||
44372494|NCT00324805|79377309|FG001|Overall Study|Other complicating disease|9|||
44372495|NCT00324805|79377308|FG000|Overall Study|Other reasons|7|||
44372496|NCT00324805|79377309|FG001|Overall Study|Other reasons|26|||
44372497|NCT00324805|79377308|FG000|Overall Study|Other|0|||
44372498|NCT00324805|79377309|FG001|Overall Study|Other|2|||
44372499|NCT00324805|79377308|FG000|Overall Study|Did not start therapy|12|||
44372500|NCT00324805|79377309|FG001|Overall Study|Did not start therapy|17|||
44372501|NCT00248040|79377335|FG000|Overall Study|transplantectomy|2|||
44372502|NCT00248040|79377336|FG001|Overall Study|transplantectomy|1|||
44372503|NCT00248040|79377337|FG002|Overall Study|transplantectomy|3|||
44372504|NCT00248040|79377335|FG000|Overall Study|transplant cancelled post treat start|1|||
44372505|NCT00248040|79377336|FG001|Overall Study|transplant cancelled post treat start|0|||
44372506|NCT00248040|79377337|FG002|Overall Study|transplant cancelled post treat start|0|||
44372507|NCT00248040|79377335|FG000|Overall Study|Death|0|||
44372508|NCT00248040|79377336|FG001|Overall Study|Death|0|||
44372509|NCT00248040|79377337|FG002|Overall Study|Death|1|||
44372510|NCT00976716|79377346|FG000|Overall Study|Adverse Event|1|||
44372511|NCT00973674|79377353|FG000|Overall Study|Protocol Violation|2|||
44372512|NCT00973674|79377354|FG001|Overall Study|Protocol Violation|0|||
44372513|NCT00819091|79377363|FG000|Overall Study|Adverse Event|3|||
44372514|NCT00819091|79377364|FG001|Overall Study|Adverse Event|5|||
44372515|NCT00819091|79377363|FG000|Overall Study|Protocol Violation|0|||
44458496|NCT00619619|79467096|FG002|Overall Study|Physician Decision|1|||
44458497|NCT00619619|79467097|FG003|Overall Study|Physician Decision|0|||
44458498|NCT00619619|79467098|FG004|Overall Study|Physician Decision|0|||
44216668|NCT01901653|79014442|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
44216669|NCT01901653|79014443|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
44216670|NCT01901653|79014444|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
44216671|NCT01901653|79014445|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
44216672|NCT01901653|79014446|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
44372516|NCT00819091|79377364|FG001|Overall Study|Protocol Violation|1|||
44372517|NCT00819091|79377363|FG000|Overall Study|Lost to Follow-up|2|||
44372518|NCT00819091|79377364|FG001|Overall Study|Lost to Follow-up|0|||
44372519|NCT00819091|79377363|FG000|Overall Study|Withdrawal by Subject|1|||
44372520|NCT00819091|79377364|FG001|Overall Study|Withdrawal by Subject|2|||
44372521|NCT00819091|79377363|FG000|Overall Study|Other|1|||
44372522|NCT00819091|79377364|FG001|Overall Study|Other|2|||
44372523|NCT00973362|79377372|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
44372524|NCT00973362|79377373|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
44372525|NCT00973362|79377372|FG000|Baseline Evaluation|No colposcopy visit|62|||
44458499|NCT00619619|79467099|FG005|Overall Study|Physician Decision|0|||
44458500|NCT00619619|79467100|FG006|Overall Study|Physician Decision|0|||
44458501|NCT00619619|79467101|FG007|Overall Study|Physician Decision|0|||
44458502|NCT00619619|79467094|FG000|Overall Study|Protocol Violation|0|||
44216673|NCT01901653|79014447|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
44216674|NCT01901653|79014448|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
44216675|NCT01901653|79014449|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
44216676|NCT01901653|79014450|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
44216677|NCT01901653|79014451|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
44216678|NCT01925989|79014479|FG000|Period 1|Sponsor Decision|1|||
44216679|NCT01925989|79014480|FG001|Period 1|Sponsor Decision|1|||
44216680|NCT01925989|79014481|FG002|Period 1|Sponsor Decision|0|||
44216681|NCT01925989|79014479|FG000|Period 1|Withdrawal by Subject|0|||
44216682|NCT01925989|79014480|FG001|Period 1|Withdrawal by Subject|1|||
44216683|NCT01925989|79014481|FG002|Period 1|Withdrawal by Subject|0|||
44216684|NCT01901419|79014495|FG000|Overall Study|Protocol Violation|2|||
44216685|NCT01901419|79014496|FG001|Overall Study|Protocol Violation|6|||
44216686|NCT01901419|79014495|FG000|Overall Study|unavailable researchers|6|||
44216687|NCT01901419|79014496|FG001|Overall Study|unavailable researchers|3|||
44216688|NCT01901341|79014523|FG000|Overall Study|Adverse Event|4|||
44458503|NCT00619619|79467095|FG001|Overall Study|Protocol Violation|0|||
44458504|NCT00619619|79467096|FG002|Overall Study|Protocol Violation|0|||
44458505|NCT00619619|79467097|FG003|Overall Study|Protocol Violation|1|||
44458506|NCT00619619|79467098|FG004|Overall Study|Protocol Violation|0|||
44458507|NCT00619619|79467099|FG005|Overall Study|Protocol Violation|0|||
44458508|NCT00619619|79467100|FG006|Overall Study|Protocol Violation|1|||
44458509|NCT00619619|79467101|FG007|Overall Study|Protocol Violation|1|||
44458510|NCT00619619|79467094|FG000|Overall Study|Adverse Event|0|||
44458511|NCT00619619|79467095|FG001|Overall Study|Adverse Event|0|||
44458512|NCT00619619|79467096|FG002|Overall Study|Adverse Event|0|||
44458513|NCT00619619|79467097|FG003|Overall Study|Adverse Event|0|||
44458514|NCT00619619|79467098|FG004|Overall Study|Adverse Event|2|||
44458515|NCT00619619|79467099|FG005|Overall Study|Adverse Event|0|||
44458516|NCT00619619|79467100|FG006|Overall Study|Adverse Event|0|||
44458517|NCT00619619|79467101|FG007|Overall Study|Adverse Event|2|||
44458518|NCT00527826|79467124|FG000|Overall Study|Adverse Event|10|||
44458519|NCT00527826|79467125|FG001|Overall Study|Adverse Event|10|||
44458520|NCT00527826|79467124|FG000|Overall Study|Lost to Follow-up|3|||
44216689|NCT01901341|79014524|FG001|Overall Study|Adverse Event|2|||
44458521|NCT00527826|79467125|FG001|Overall Study|Lost to Follow-up|2|||
44458522|NCT00527826|79467124|FG000|Overall Study|Withdrawal by Subject|5|||
44458523|NCT00527826|79467125|FG001|Overall Study|Withdrawal by Subject|8|||
44458524|NCT00527826|79467124|FG000|Overall Study|Inclusion Criteria Not Met|3|||
44458525|NCT00527826|79467125|FG001|Overall Study|Inclusion Criteria Not Met|3|||
44458526|NCT00527826|79467124|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
44458527|NCT00527826|79467125|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
44458528|NCT00527826|79467124|FG000|Overall Study|Additional Intake of Viani forte|0|||
44458529|NCT00527826|79467125|FG001|Overall Study|Additional Intake of Viani forte|1|||
44458530|NCT00527826|79467124|FG000|Overall Study|Participant moved away|0|||
44458531|NCT00527826|79467125|FG001|Overall Study|Participant moved away|1|||
44216690|NCT01901341|79014523|FG000|Overall Study|Lack of Efficacy|0|||
44216691|NCT01901341|79014524|FG001|Overall Study|Lack of Efficacy|2|||
44216692|NCT01901341|79014523|FG000|Overall Study|Lost to Follow-up|0|||
44216693|NCT01901341|79014524|FG001|Overall Study|Lost to Follow-up|1|||
44372526|NCT00973362|79377373|FG001|Baseline Evaluation|No colposcopy visit|0|||
44372527|NCT00973362|79377372|FG000|Baseline Evaluation|Inevaluable|686|||
44372528|NCT00973362|79377373|FG001|Baseline Evaluation|Inevaluable|223|||
44372529|NCT00973362|79377372|FG000|3-Year Follow-up|Lost to Follow-up|17|||
44372530|NCT00973362|79377373|FG001|3-Year Follow-up|Lost to Follow-up|0|||
44372531|NCT00819013|79377386|FG000|Overall Study|Not meeting continuing study eligibility|2|||
44372532|NCT00819013|79377387|FG001|Overall Study|Not meeting continuing study eligibility|1|||
44372533|NCT00819013|79377388|FG002|Overall Study|Not meeting continuing study eligibility|2|||
44372534|NCT00819013|79377389|FG003|Overall Study|Not meeting continuing study eligibility|1|||
44372535|NCT00819013|79377386|FG000|Overall Study|Adverse Event|0|||
44372536|NCT00819013|79377387|FG001|Overall Study|Adverse Event|0|||
44372537|NCT00819013|79377388|FG002|Overall Study|Adverse Event|1|||
44372538|NCT00819013|79377389|FG003|Overall Study|Adverse Event|0|||
44216694|NCT01901341|79014523|FG000|Overall Study|Protocol Violation|2|||
44216695|NCT01901341|79014524|FG001|Overall Study|Protocol Violation|0|||
44372539|NCT00819013|79377386|FG000|Overall Study|Withdrawal by Subject|1|||
44372540|NCT00819013|79377387|FG001|Overall Study|Withdrawal by Subject|0|||
44372541|NCT00819013|79377388|FG002|Overall Study|Withdrawal by Subject|1|||
44458532|NCT00527748|79467134|FG000|Overall Study|Other|3|||
44458533|NCT00619385|79467141|FG000|Overall Study|Adverse Event|0|||
44458534|NCT00619385|79467142|FG001|Overall Study|Adverse Event|0|||
44458535|NCT00619385|79467143|FG002|Overall Study|Adverse Event|3|||
44458536|NCT00619385|79467141|FG000|Overall Study|Other|1|||
44458537|NCT00619385|79467142|FG001|Overall Study|Other|2|||
44458538|NCT00619385|79467143|FG002|Overall Study|Other|1|||
44458539|NCT00619307|79467156|FG000|Overall Study|Adverse Event|0|||
44216696|NCT01901341|79014523|FG000|Overall Study|Study Terminated by Sponsor|13|||
44372542|NCT00819013|79377389|FG003|Overall Study|Withdrawal by Subject|0|||
44458540|NCT00619307|79467157|FG001|Overall Study|Adverse Event|1|||
44458541|NCT00619307|79467156|FG000|Overall Study|Lost to Follow-up|0|||
44458542|NCT00619307|79467157|FG001|Overall Study|Lost to Follow-up|1|||
44458543|NCT00619307|79467156|FG000|Overall Study|Protocol Violation|3|||
44458544|NCT00619307|79467157|FG001|Overall Study|Protocol Violation|0|||
44458545|NCT00619307|79467156|FG000|Overall Study|Withdrew consent|1|||
44458546|NCT00619307|79467157|FG001|Overall Study|Withdrew consent|0|||
44458547|NCT00619307|79467156|FG000|Overall Study|Severe migraine|0|||
44458548|NCT00619307|79467157|FG001|Overall Study|Severe migraine|1|||
44458549|NCT00619307|79467156|FG000|Overall Study|MS attack plus steroids|0|||
44458550|NCT00619307|79467157|FG001|Overall Study|MS attack plus steroids|1|||
44458551|NCT00619229|79467165|FG000|Overall Study|Withdrawal by Subject|1|||
44458552|NCT00619229|79467166|FG001|Overall Study|Withdrawal by Subject|1|||
44458553|NCT00619229|79467165|FG000|Overall Study|Lost to Follow-up|1|||
44458554|NCT00619229|79467166|FG001|Overall Study|Lost to Follow-up|0|||
44458555|NCT00619229|79467165|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
44458556|NCT00619229|79467166|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
44458557|NCT00619229|79467165|FG000|Overall Study|Investigator planned Cataract Operation|1|||
44458558|NCT00619229|79467166|FG001|Overall Study|Investigator planned Cataract Operation|0|||
44458559|NCT00619151|79467174|FG000|Overall Study|Study terminated prior to followup|1|||
44458560|NCT00619151|79467175|FG001|Overall Study|Study terminated prior to followup|0|||
44458561|NCT00618995|79467181|FG000|Period 1|Adverse Event|0|||
44458562|NCT00618995|79467182|FG001|Period 1|Adverse Event|0|||
44458563|NCT00618995|79467183|FG002|Period 1|Adverse Event|1|||
44458564|NCT00618995|79467184|FG003|Period 1|Adverse Event|0|||
44458565|NCT00618995|79467181|FG000|Period 1|Protocol Violation|0|||
44458566|NCT00618995|79467182|FG001|Period 1|Protocol Violation|1|||
44458567|NCT00618995|79467183|FG002|Period 1|Protocol Violation|1|||
44458568|NCT00618995|79467184|FG003|Period 1|Protocol Violation|0|||
44458569|NCT00618995|79467181|FG000|Period 2|Protocol Violation|0|||
44458570|NCT00618995|79467182|FG001|Period 2|Protocol Violation|0|||
44458571|NCT00618995|79467183|FG002|Period 2|Protocol Violation|1|||
44458572|NCT00618995|79467184|FG003|Period 2|Protocol Violation|0|||
44458573|NCT00618995|79467181|FG000|Period 4|Adverse Event|1|||
44458574|NCT00618995|79467182|FG001|Period 4|Adverse Event|0|||
44458575|NCT00618995|79467183|FG002|Period 4|Adverse Event|0|||
44458576|NCT00618995|79467184|FG003|Period 4|Adverse Event|0|||
44458577|NCT03685344|79467198|FG000|Overall Study|Withdrawal by Subject|1|||
44458578|NCT03685344|79467199|FG001|Overall Study|Withdrawal by Subject|1|||
44458579|NCT03685344|79467200|FG002|Overall Study|Withdrawal by Subject|2|||
44458580|NCT03685344|79467201|FG003|Overall Study|Withdrawal by Subject|0|||
44458581|NCT03685344|79467198|FG000|Overall Study|Physician Decision|1|||
44458582|NCT03685344|79467199|FG001|Overall Study|Physician Decision|1|||
44458583|NCT03685344|79467200|FG002|Overall Study|Physician Decision|5|||
44458584|NCT03685344|79467201|FG003|Overall Study|Physician Decision|0|||
44458585|NCT03685344|79467198|FG000|Overall Study|Death|1|||
44458586|NCT03685344|79467199|FG001|Overall Study|Death|1|||
44458587|NCT03685344|79467200|FG002|Overall Study|Death|0|||
44458588|NCT03685344|79467201|FG003|Overall Study|Death|0|||
44458589|NCT00520572|79467217|FG000|Overall Study|Adverse Event|9|||
44458590|NCT00520572|79467218|FG001|Overall Study|Adverse Event|3|||
44458591|NCT00520572|79467219|FG002|Overall Study|Adverse Event|6|||
44458592|NCT00520572|79467220|FG003|Overall Study|Adverse Event|9|||
44458593|NCT00520572|79467221|FG004|Overall Study|Adverse Event|7|||
44458594|NCT00520572|79467222|FG005|Overall Study|Adverse Event|2|||
44458595|NCT00520572|79467217|FG000|Overall Study|Withdrawal by Subject|0|||
44458596|NCT00520572|79467218|FG001|Overall Study|Withdrawal by Subject|9|||
44270196|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270197|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
44270198|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44458597|NCT00520572|79467219|FG002|Overall Study|Withdrawal by Subject|5|||
44458598|NCT00520572|79467220|FG003|Overall Study|Withdrawal by Subject|2|||
44458599|NCT00520572|79467221|FG004|Overall Study|Withdrawal by Subject|2|||
44458600|NCT00520572|79467222|FG005|Overall Study|Withdrawal by Subject|0|||
44458601|NCT00520572|79467217|FG000|Overall Study|Protocol Violation|0|||
44458602|NCT00520572|79467218|FG001|Overall Study|Protocol Violation|0|||
44458603|NCT00520572|79467219|FG002|Overall Study|Protocol Violation|1|||
44458604|NCT00520572|79467220|FG003|Overall Study|Protocol Violation|0|||
44458605|NCT00520572|79467221|FG004|Overall Study|Protocol Violation|0|||
44458606|NCT00520572|79467222|FG005|Overall Study|Protocol Violation|0|||
44458607|NCT00520572|79467217|FG000|Overall Study|Lack of Efficacy|1|||
44458608|NCT00520572|79467218|FG001|Overall Study|Lack of Efficacy|1|||
44458609|NCT00520572|79467219|FG002|Overall Study|Lack of Efficacy|1|||
44458610|NCT00520572|79467220|FG003|Overall Study|Lack of Efficacy|2|||
44458611|NCT00520572|79467221|FG004|Overall Study|Lack of Efficacy|1|||
44458612|NCT00520572|79467222|FG005|Overall Study|Lack of Efficacy|0|||
44458613|NCT00520572|79467217|FG000|Overall Study|Lost to Follow-up|0|||
44458614|NCT00520572|79467218|FG001|Overall Study|Lost to Follow-up|0|||
44458615|NCT00520572|79467219|FG002|Overall Study|Lost to Follow-up|0|||
44458616|NCT00520572|79467220|FG003|Overall Study|Lost to Follow-up|0|||
44458617|NCT00520572|79467221|FG004|Overall Study|Lost to Follow-up|1|||
44458618|NCT00520572|79467222|FG005|Overall Study|Lost to Follow-up|0|||
44458619|NCT00520572|79467217|FG000|Overall Study|Incorrect enrollment|1|||
44458620|NCT00520572|79467218|FG001|Overall Study|Incorrect enrollment|0|||
44458621|NCT00520572|79467219|FG002|Overall Study|Incorrect enrollment|1|||
44458622|NCT00520572|79467220|FG003|Overall Study|Incorrect enrollment|0|||
44458623|NCT00520572|79467221|FG004|Overall Study|Incorrect enrollment|1|||
44458624|NCT00520572|79467222|FG005|Overall Study|Incorrect enrollment|0|||
44458625|NCT00520572|79467217|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
44458626|NCT00520572|79467218|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
44458627|NCT00520572|79467219|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
44458628|NCT00520572|79467220|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
44458629|NCT00520572|79467221|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
44458630|NCT00520572|79467222|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
44458631|NCT00520572|79467217|FG000|Overall Study|Long break in taking Medication|0|||
44458632|NCT00520572|79467218|FG001|Overall Study|Long break in taking Medication|0|||
44458633|NCT00520572|79467219|FG002|Overall Study|Long break in taking Medication|0|||
44458634|NCT00520572|79467220|FG003|Overall Study|Long break in taking Medication|1|||
44458635|NCT00520572|79467221|FG004|Overall Study|Long break in taking Medication|0|||
44458636|NCT00520572|79467222|FG005|Overall Study|Long break in taking Medication|0|||
44216697|NCT01901341|79014524|FG001|Overall Study|Study Terminated by Sponsor|15|||
44216698|NCT01901341|79014523|FG000|Overall Study|Withdrawal by Subject|1|||
44458637|NCT00520572|79467217|FG000|Overall Study|Did not receive Treatment|1|||
44216699|NCT01901341|79014524|FG001|Overall Study|Withdrawal by Subject|1|||
44216700|NCT01615939|79014533|FG000|Overall Study|Lost to Follow-up|5|||
44216701|NCT01615939|79014534|FG001|Overall Study|Lost to Follow-up|0|||
44216702|NCT01901185|79014540|FG000|Overall Study|Withdrawal by Subject|2|||
44216703|NCT01888003|79014547|FG000|Overall Study|Study Terminated|5|||
44216704|NCT01888003|79014548|FG001|Overall Study|Study Terminated|6|||
44216705|NCT01888003|79014549|FG002|Overall Study|Study Terminated|40|||
44216706|NCT02775214|79014559|FG000|Overall Study|Withdrawal by Subject|2|||
44216707|NCT02775214|79014560|FG001|Overall Study|Withdrawal by Subject|0|||
44216708|NCT01925209|79014615|FG000|Treatment Epoch|Physician Decision|1|||
44216709|NCT01925209|79014616|FG001|Treatment Epoch|Physician Decision|0|||
44216710|NCT01925209|79014617|FG002|Treatment Epoch|Physician Decision|0|||
44216711|NCT01925209|79014618|FG003|Treatment Epoch|Physician Decision|0|||
44216712|NCT01925209|79014615|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
44216713|NCT01925209|79014616|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
44216714|NCT01925209|79014617|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
44216715|NCT01925209|79014618|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
44216716|NCT01925209|79014615|FG000|Treatment Epoch|Death|1|||
44216717|NCT01925209|79014616|FG001|Treatment Epoch|Death|0|||
44216718|NCT01925209|79014617|FG002|Treatment Epoch|Death|0|||
44458638|NCT00520572|79467218|FG001|Overall Study|Did not receive Treatment|0|||
44458639|NCT00520572|79467219|FG002|Overall Study|Did not receive Treatment|1|||
44458640|NCT00520572|79467220|FG003|Overall Study|Did not receive Treatment|0|||
44458641|NCT00520572|79467221|FG004|Overall Study|Did not receive Treatment|0|||
44458642|NCT00520572|79467222|FG005|Overall Study|Did not receive Treatment|0|||
44458643|NCT00573833|79467236|FG000|Overall Study|Not Treated|2|||
44458644|NCT00520494|79467240|FG000|Overall Study|Withdrawal by Subject|1|||
44458645|NCT00527514|79467244|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
44458646|NCT00527514|79467244|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
44458647|NCT00527514|79467244|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
44458648|NCT00527514|79467244|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
44458649|NCT00527514|79467244|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
44458650|NCT00527514|79467244|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
44458651|NCT00527514|79467244|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
44270199|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44270200|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44458652|NCT00618449|79467257|FG000|Overall Study|Lost to Follow-up|98|||
44458653|NCT00618449|79467258|FG001|Overall Study|Lost to Follow-up|110|||
44458654|NCT03684642|79467267|FG000|Overall Study|Adverse Event|6|||
44216719|NCT01925209|79014618|FG003|Treatment Epoch|Death|0|||
44458655|NCT03684642|79467268|FG001|Overall Study|Adverse Event|15|||
44458656|NCT03684642|79467269|FG002|Overall Study|Adverse Event|11|||
44458657|NCT03684642|79467267|FG000|Overall Study|Withdrawal by Subject|35|||
44458658|NCT03684642|79467268|FG001|Overall Study|Withdrawal by Subject|53|||
44216720|NCT01925209|79014615|FG000|Treatment Epoch|Protocol deviation|0|||
44216721|NCT01925209|79014616|FG001|Treatment Epoch|Protocol deviation|0|||
44458659|NCT03684642|79467269|FG002|Overall Study|Withdrawal by Subject|23|||
44458660|NCT03684642|79467267|FG000|Overall Study|Lack of Efficacy|0|||
44458661|NCT03684642|79467268|FG001|Overall Study|Lack of Efficacy|0|||
44458662|NCT03684642|79467269|FG002|Overall Study|Lack of Efficacy|1|||
44458663|NCT03684642|79467267|FG000|Overall Study|Poor compliance to protocol|0|||
44458664|NCT03684642|79467268|FG001|Overall Study|Poor compliance to protocol|4|||
44458665|NCT03684642|79467269|FG002|Overall Study|Poor compliance to protocol|1|||
44458666|NCT03684642|79467267|FG000|Overall Study|Other than specified|62|||
44458667|NCT03684642|79467268|FG001|Overall Study|Other than specified|60|||
44458668|NCT03684642|79467269|FG002|Overall Study|Other than specified|67|||
44458669|NCT03684642|79467267|FG000|Overall Study|Randomized and not treated|0|||
44458670|NCT03684642|79467268|FG001|Overall Study|Randomized and not treated|0|||
44458671|NCT03684642|79467269|FG002|Overall Study|Randomized and not treated|1|||
44458672|NCT03684642|79467267|FG000|Overall Study|Missing completion status but alive at last contact|0|||
44458673|NCT03684642|79467268|FG001|Overall Study|Missing completion status but alive at last contact|1|||
44458674|NCT03684642|79467269|FG002|Overall Study|Missing completion status but alive at last contact|2|||
44458675|NCT00519636|79467281|FG000|Treatment Period 1|Adverse Event|1|||
44458676|NCT00519636|79467282|FG001|Treatment Period 1|Adverse Event|0|||
44458677|NCT00519636|79467283|FG002|Treatment Period 1|Adverse Event|1|||
44458678|NCT00519636|79467284|FG003|Treatment Period 1|Adverse Event|0|||
44458679|NCT00519636|79467281|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
44458680|NCT00519636|79467282|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
44458681|NCT00519636|79467283|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
44458682|NCT00519636|79467284|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
44458683|NCT00519636|79467281|FG000|Washout Period|Adverse Event|2|||
44458684|NCT00519636|79467282|FG001|Washout Period|Adverse Event|1|||
44458685|NCT00519636|79467283|FG002|Washout Period|Adverse Event|1|||
44458686|NCT00519636|79467284|FG003|Washout Period|Adverse Event|0|||
44458687|NCT00519636|79467281|FG000|Washout Period|Lost to Follow-up|1|||
44458688|NCT00519636|79467282|FG001|Washout Period|Lost to Follow-up|0|||
44458689|NCT00519636|79467283|FG002|Washout Period|Lost to Follow-up|0|||
44458690|NCT00519636|79467284|FG003|Washout Period|Lost to Follow-up|0|||
44458691|NCT00519636|79467281|FG000|Washout Period|Protocol Violation|0|||
44458692|NCT00519636|79467282|FG001|Washout Period|Protocol Violation|0|||
44458693|NCT00519636|79467283|FG002|Washout Period|Protocol Violation|1|||
44458694|NCT00519636|79467284|FG003|Washout Period|Protocol Violation|2|||
44458695|NCT00519636|79467281|FG000|Washout Period|Withdrawal by Subject|1|||
44458696|NCT00519636|79467282|FG001|Washout Period|Withdrawal by Subject|0|||
44458697|NCT00519636|79467283|FG002|Washout Period|Withdrawal by Subject|1|||
44372543|NCT00819013|79377386|FG000|Overall Study|Lost to Follow-up|0|||
44372544|NCT00819013|79377387|FG001|Overall Study|Lost to Follow-up|0|||
44372545|NCT00819013|79377388|FG002|Overall Study|Lost to Follow-up|1|||
44372546|NCT00819013|79377389|FG003|Overall Study|Lost to Follow-up|2|||
44372547|NCT00819013|79377386|FG000|Overall Study|Death|0|||
44372548|NCT00819013|79377387|FG001|Overall Study|Death|0|||
44372549|NCT00819013|79377388|FG002|Overall Study|Death|0|||
44372550|NCT00819013|79377389|FG003|Overall Study|Death|1|||
44372551|NCT00976560|79377401|FG000|Overall Study|Adverse Event|5|||
44372552|NCT00976560|79377402|FG001|Overall Study|Adverse Event|5|||
44372553|NCT00976560|79377401|FG000|Overall Study|Lack of Efficacy|3|||
44372554|NCT00976560|79377402|FG001|Overall Study|Lack of Efficacy|5|||
44372555|NCT00976560|79377401|FG000|Overall Study|Protocol Violation|1|||
44372556|NCT00976560|79377402|FG001|Overall Study|Protocol Violation|0|||
44372557|NCT00976560|79377401|FG000|Overall Study|Lost to Follow-up|1|||
44372558|NCT00976560|79377402|FG001|Overall Study|Lost to Follow-up|0|||
44372559|NCT00976560|79377401|FG000|Overall Study|Physician Decision|2|||
44372560|NCT00976560|79377402|FG001|Overall Study|Physician Decision|0|||
44458698|NCT00519636|79467284|FG003|Washout Period|Withdrawal by Subject|0|||
44458699|NCT00519636|79467281|FG000|Washout Period|Failed to meet continuation criteria|14|||
44458700|NCT00519636|79467282|FG001|Washout Period|Failed to meet continuation criteria|11|||
44458701|NCT00519636|79467283|FG002|Washout Period|Failed to meet continuation criteria|9|||
44458702|NCT00519636|79467284|FG003|Washout Period|Failed to meet continuation criteria|3|||
44458703|NCT00519636|79467281|FG000|Washout Period|Out of pollen area > 48 hours|1|||
44458704|NCT00519636|79467282|FG001|Washout Period|Out of pollen area > 48 hours|0|||
44372561|NCT00976560|79377401|FG000|Overall Study|Withdrawal by Subject|2|||
44372562|NCT00976560|79377402|FG001|Overall Study|Withdrawal by Subject|3|||
44458705|NCT00519636|79467283|FG002|Washout Period|Out of pollen area > 48 hours|0|||
44458706|NCT00519636|79467284|FG003|Washout Period|Out of pollen area > 48 hours|0|||
44458707|NCT00519636|79467281|FG000|Washout Period|Participating in study at another site|1|||
44458708|NCT00519636|79467282|FG001|Washout Period|Participating in study at another site|0|||
44458709|NCT00519636|79467283|FG002|Washout Period|Participating in study at another site|0|||
44458710|NCT00519636|79467284|FG003|Washout Period|Participating in study at another site|0|||
44458711|NCT00519636|79467281|FG000|Washout Period|Non-compliant|0|||
44372563|NCT00976482|79377408|FG000|Overall Study|Death|208|||
44372564|NCT00976482|79377408|FG000|Overall Study|Withdrawal by Subject|45|||
44372565|NCT00976482|79377408|FG000|Overall Study|Center terminated|1|||
44458712|NCT00519636|79467282|FG001|Washout Period|Non-compliant|1|||
44458713|NCT00519636|79467283|FG002|Washout Period|Non-compliant|0|||
44458714|NCT00519636|79467284|FG003|Washout Period|Non-compliant|0|||
44458715|NCT00519636|79467281|FG000|Washout Period|Per doctors request|0|||
44458716|NCT00519636|79467282|FG001|Washout Period|Per doctors request|1|||
44458717|NCT00519636|79467283|FG002|Washout Period|Per doctors request|0|||
44458718|NCT00519636|79467284|FG003|Washout Period|Per doctors request|0|||
44458719|NCT00519636|79467281|FG000|Washout Period|Subject randomized in error|0|||
44458720|NCT00519636|79467282|FG001|Washout Period|Subject randomized in error|0|||
44458721|NCT00519636|79467283|FG002|Washout Period|Subject randomized in error|1|||
44458722|NCT00519636|79467284|FG003|Washout Period|Subject randomized in error|0|||
44458723|NCT00519636|79467281|FG000|Washout Period|Prohibited medications|0|||
44458724|NCT00519636|79467282|FG001|Washout Period|Prohibited medications|0|||
44458725|NCT00519636|79467283|FG002|Washout Period|Prohibited medications|1|||
44458726|NCT00519636|79467284|FG003|Washout Period|Prohibited medications|0|||
44458727|NCT00519636|79467281|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
44458728|NCT00519636|79467282|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
44458729|NCT00519636|79467283|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
44458730|NCT00519636|79467284|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
44458731|NCT00519636|79467281|FG000|Treatment Period 2|Subject randomized in error|0|||
44458732|NCT00519636|79467282|FG001|Treatment Period 2|Subject randomized in error|1|||
44458733|NCT00519636|79467283|FG002|Treatment Period 2|Subject randomized in error|0|||
44458734|NCT00519636|79467284|FG003|Treatment Period 2|Subject randomized in error|0|||
44458735|NCT00519636|79467281|FG000|Treatment Period 2|Per doctors request|0|||
44458736|NCT00519636|79467282|FG001|Treatment Period 2|Per doctors request|0|||
44458737|NCT00519636|79467283|FG002|Treatment Period 2|Per doctors request|1|||
44458738|NCT00519636|79467284|FG003|Treatment Period 2|Per doctors request|0|||
44458739|NCT00519636|79467281|FG000|Treatment Period 2|Subject misrandomized|0|||
44458740|NCT00519636|79467282|FG001|Treatment Period 2|Subject misrandomized|0|||
44458741|NCT00519636|79467283|FG002|Treatment Period 2|Subject misrandomized|0|||
44458742|NCT00519636|79467284|FG003|Treatment Period 2|Subject misrandomized|1|||
44216722|NCT01925209|79014617|FG002|Treatment Epoch|Protocol deviation|1|||
44216723|NCT01925209|79014618|FG003|Treatment Epoch|Protocol deviation|1|||
44216724|NCT01925209|79014615|FG000|Treatment Epoch|Withdrawal by Subject|4|||
44216725|NCT01925209|79014616|FG001|Treatment Epoch|Withdrawal by Subject|3|||
44216726|NCT01925209|79014617|FG002|Treatment Epoch|Withdrawal by Subject|3|||
44372566|NCT00976482|79377408|FG000|Overall Study|Protocol Violation|5|||
44372567|NCT00975156|79377414|FG000|Overall Study|Protocol Violation|0|||
44372568|NCT00975156|79377415|FG001|Overall Study|Protocol Violation|1|||
44372569|NCT00810043|79377427|FG000|Overall Study|Withdrawal by Subject|1|||
44372570|NCT00810043|79377428|FG001|Overall Study|Withdrawal by Subject|0|||
44372571|NCT00810043|79377429|FG002|Overall Study|Withdrawal by Subject|2|||
44372572|NCT00810043|79377427|FG000|Overall Study|Lost to Follow-up|1|||
44458743|NCT00519636|79467281|FG000|Post Study Period|Subject randomized in error|0|||
44458744|NCT00519636|79467282|FG001|Post Study Period|Subject randomized in error|0|||
44216727|NCT01925209|79014618|FG003|Treatment Epoch|Withdrawal by Subject|2|||
44216728|NCT01925209|79014615|FG000|Treatment Epoch|Adverse Event|3|||
44372573|NCT00810043|79377428|FG001|Overall Study|Lost to Follow-up|0|||
44372574|NCT00810043|79377429|FG002|Overall Study|Lost to Follow-up|0|||
44458745|NCT00519636|79467283|FG002|Post Study Period|Subject randomized in error|0|||
44458746|NCT00519636|79467284|FG003|Post Study Period|Subject randomized in error|1|||
44458747|NCT00618371|79467298|FG000|Overall Study|Withdrawal by Subject|2|||
44458748|NCT00526890|79467303|FG000|Overall Study|Adverse Event|2|||
44458749|NCT03864900|79467309|FG000|Overall Study|Withdrawal by Subject|1|||
44458750|NCT03864900|79467310|FG001|Overall Study|Withdrawal by Subject|1|||
44514766|NCT03107026|79520594|FG000|Overall Study|Withdrawal by Subject|13|||
44458751|NCT03864900|79467309|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
44458752|NCT03864900|79467310|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
44458753|NCT00526656|79467316|FG000|Overall Study|Death|1|||
44458754|NCT00526656|79467316|FG000|Overall Study|Refused surgery|1|||
44458755|NCT00617903|79467323|FG000|Overall Study|Withdrawal by Subject|2|||
44458756|NCT00617903|79467324|FG001|Overall Study|Withdrawal by Subject|3|||
44270201|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44372575|NCT00810043|79377427|FG000|Overall Study|Physician Decision|0|||
44372576|NCT00810043|79377428|FG001|Overall Study|Physician Decision|0|||
44372577|NCT00810043|79377429|FG002|Overall Study|Physician Decision|2|||
44372578|NCT00810043|79377427|FG000|Overall Study|Death|2|||
44372579|NCT00810043|79377428|FG001|Overall Study|Death|0|||
44372580|NCT00810043|79377429|FG002|Overall Study|Death|0|||
44372581|NCT00810043|79377427|FG000|Overall Study|Unrelated medical problem|0|||
44372582|NCT00810043|79377428|FG001|Overall Study|Unrelated medical problem|1|||
44458757|NCT00617903|79467323|FG000|Overall Study|Lost to Follow-up|1|||
44458758|NCT00617903|79467324|FG001|Overall Study|Lost to Follow-up|1|||
44458759|NCT00617903|79467323|FG000|Overall Study|Lack of Efficacy|0|||
44458760|NCT00617903|79467324|FG001|Overall Study|Lack of Efficacy|1|||
44544056|NCT03736967|79557255|FG003|Overall Study|Physician Decision|1|||
44216729|NCT01925209|79014616|FG001|Treatment Epoch|Adverse Event|5|||
44216730|NCT01925209|79014617|FG002|Treatment Epoch|Adverse Event|3|||
44216731|NCT01925209|79014618|FG003|Treatment Epoch|Adverse Event|1|||
44216732|NCT01925209|79014615|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
44216733|NCT01925209|79014616|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
44216734|NCT01925209|79014617|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
44216735|NCT01925209|79014618|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
44216736|NCT01925209|79014615|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
44216737|NCT01925209|79014616|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
44372583|NCT00810043|79377429|FG002|Overall Study|Unrelated medical problem|0|||
44372584|NCT00810043|79377427|FG000|Overall Study|Non-medical problem|0|||
44458761|NCT00617903|79467323|FG000|Overall Study|Adverse Event|0|||
44372585|NCT00810043|79377428|FG001|Overall Study|Non-medical problem|0|||
44372586|NCT00810043|79377429|FG002|Overall Study|Non-medical problem|1|||
44458762|NCT00617903|79467324|FG001|Overall Study|Adverse Event|1|||
44458763|NCT00617903|79467323|FG000|Overall Study|noncompliance|0|||
44458764|NCT00617903|79467324|FG001|Overall Study|noncompliance|1|||
44458765|NCT00526110|79467332|FG000|Overall Study|Adverse Event|2|||
44458766|NCT00526110|79467333|FG001|Overall Study|Adverse Event|9|||
44458767|NCT00526110|79467332|FG000|Overall Study|Disease Progression|0|||
44458768|NCT00526110|79467333|FG001|Overall Study|Disease Progression|19|||
44458769|NCT00526110|79467332|FG000|Overall Study|Maximal Response|0|||
44458770|NCT00526110|79467333|FG001|Overall Study|Maximal Response|6|||
44458771|NCT00526110|79467332|FG000|Overall Study|Withdrawal by Subject|0|||
44458772|NCT00526110|79467333|FG001|Overall Study|Withdrawal by Subject|2|||
44458773|NCT00526110|79467332|FG000|Overall Study|Poor Tolerance|0|||
44458774|NCT00526110|79467333|FG001|Overall Study|Poor Tolerance|5|||
44458775|NCT00512148|79467339|FG000|Primay Study Period|Withdrawal by Subject|1|||
44458776|NCT00511836|79467347|FG000|Double-blind Period|Lost to Follow-up|1|||
44458777|NCT00511836|79467348|FG001|Double-blind Period|Lost to Follow-up|0|||
44458778|NCT00573755|79467370|FG000|Overall Study|Still receiving treatment|1|||
44458779|NCT00573755|79467371|FG001|Overall Study|Still receiving treatment|0|||
44458780|NCT00524316|79467377|FG000|Overall Study|Withdrawal by Subject|2|||
44458781|NCT00524316|79467377|FG000|Overall Study|Adverse Event|7|||
44458782|NCT00524316|79467377|FG000|Overall Study|Disease Progression|7|||
44458783|NCT03861936|79467394|FG000|Overall Study|Withdrawal by Subject|4|||
44458784|NCT03861936|79467395|FG001|Overall Study|Withdrawal by Subject|1|||
44458785|NCT03861936|79467396|FG002|Overall Study|Withdrawal by Subject|3|||
44458786|NCT03861936|79467394|FG000|Overall Study|Lost to Follow-up|5|||
44458787|NCT03861936|79467395|FG001|Overall Study|Lost to Follow-up|3|||
44458788|NCT03861936|79467396|FG002|Overall Study|Lost to Follow-up|3|||
44458789|NCT03861936|79467394|FG000|Overall Study|Physician Decision|0|||
44458790|NCT03861936|79467395|FG001|Overall Study|Physician Decision|1|||
44458791|NCT03861936|79467396|FG002|Overall Study|Physician Decision|0|||
44458792|NCT03861936|79467394|FG000|Overall Study|Protocol Deviation|0|||
44458793|NCT03861936|79467395|FG001|Overall Study|Protocol Deviation|0|||
44458794|NCT03861936|79467396|FG002|Overall Study|Protocol Deviation|1|||
44458795|NCT03861936|79467394|FG000|Overall Study|Reason not Specified|5|||
44458796|NCT03861936|79467395|FG001|Overall Study|Reason not Specified|5|||
44458797|NCT03861936|79467396|FG002|Overall Study|Reason not Specified|3|||
44458798|NCT00434577|79467409|FG000|Months 0-3|Serious Adverse Event|0|||
44458799|NCT00434577|79467410|FG001|Months 0-3|Serious Adverse Event|0|||
44458800|NCT00434577|79467411|FG002|Months 0-3|Serious Adverse Event|1|||
44458801|NCT00434577|79467412|FG003|Months 0-3|Serious Adverse Event|0|||
44458802|NCT00434577|79467413|FG004|Months 0-3|Serious Adverse Event|0|||
44458803|NCT00434577|79467409|FG000|Months 0-3|Adverse Event|0|||
44458804|NCT00434577|79467410|FG001|Months 0-3|Adverse Event|1|||
44458805|NCT00434577|79467411|FG002|Months 0-3|Adverse Event|1|||
44458806|NCT00434577|79467412|FG003|Months 0-3|Adverse Event|0|||
44458807|NCT00434577|79467413|FG004|Months 0-3|Adverse Event|0|||
44458808|NCT00434577|79467409|FG000|Months 0-3|Lost to Follow-up|0|||
44458809|NCT00434577|79467410|FG001|Months 0-3|Lost to Follow-up|0|||
44458810|NCT00434577|79467411|FG002|Months 0-3|Lost to Follow-up|0|||
44458811|NCT00434577|79467412|FG003|Months 0-3|Lost to Follow-up|0|||
44458812|NCT00434577|79467413|FG004|Months 0-3|Lost to Follow-up|2|||
44458813|NCT00434577|79467409|FG000|Months 0-3|Protocol Violation|1|||
44458814|NCT00434577|79467410|FG001|Months 0-3|Protocol Violation|0|||
44216738|NCT01925209|79014617|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
44216739|NCT01925209|79014618|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
44216740|NCT01925209|79014615|FG000|Follow-up|Adverse Event|1|||
44458815|NCT00434577|79467411|FG002|Months 0-3|Protocol Violation|1|||
44216741|NCT01925209|79014616|FG001|Follow-up|Adverse Event|4|||
44216742|NCT01925209|79014617|FG002|Follow-up|Adverse Event|0|||
44216743|NCT01925209|79014618|FG003|Follow-up|Adverse Event|1|||
44372587|NCT00810043|79377427|FG000|Overall Study|No longer met enrollment criteria|0|||
44372588|NCT00810043|79377428|FG001|Overall Study|No longer met enrollment criteria|0|||
44372589|NCT00810043|79377429|FG002|Overall Study|No longer met enrollment criteria|3|||
44372590|NCT01120184|79377441|FG000|Overall Study|Adverse Event|0|||
44372591|NCT01120184|79377442|FG001|Overall Study|Adverse Event|1|||
44372592|NCT01120184|79377443|FG002|Overall Study|Adverse Event|0|||
44372593|NCT01120184|79377441|FG000|Overall Study|Lost to Follow-up|13|||
44372594|NCT01120184|79377442|FG001|Overall Study|Lost to Follow-up|13|||
44372595|NCT01120184|79377443|FG002|Overall Study|Lost to Follow-up|11|||
44372596|NCT01120184|79377441|FG000|Overall Study|Physician Decision|9|||
44372597|NCT01120184|79377442|FG001|Overall Study|Physician Decision|1|||
44372598|NCT01120184|79377443|FG002|Overall Study|Physician Decision|3|||
44372599|NCT01120184|79377441|FG000|Overall Study|Reason not Specified|8|||
44372600|NCT01120184|79377442|FG001|Overall Study|Reason not Specified|3|||
44372601|NCT01120184|79377443|FG002|Overall Study|Reason not Specified|12|||
44372602|NCT01120184|79377441|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
44458816|NCT00434577|79467412|FG003|Months 0-3|Protocol Violation|0|||
44458817|NCT00434577|79467413|FG004|Months 0-3|Protocol Violation|0|||
44458818|NCT00434577|79467409|FG000|Months 0-3|Withdrawal by Subject|2|||
44458819|NCT00434577|79467410|FG001|Months 0-3|Withdrawal by Subject|1|||
44458820|NCT00434577|79467411|FG002|Months 0-3|Withdrawal by Subject|1|||
44458821|NCT00434577|79467412|FG003|Months 0-3|Withdrawal by Subject|1|||
44458822|NCT00434577|79467413|FG004|Months 0-3|Withdrawal by Subject|1|||
44458823|NCT00434421|79467425|FG000|Overall Study|Withdrawal by Subject|1|||
44458824|NCT00434421|79467425|FG000|Overall Study|Non-compliance with study treatment|1|||
44458825|NCT00421707|79467431|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
44458826|NCT00421707|79467432|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
44458827|NCT00421707|79467431|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
44458828|NCT00421707|79467432|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
44458829|NCT00421707|79467431|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
44458830|NCT00421707|79467432|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
44458831|NCT00421707|79467431|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
44458832|NCT00421707|79467432|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
44458833|NCT00421707|79467431|FG000|Period 2: Washout|Adverse Event|1|||
44458834|NCT00421707|79467432|FG001|Period 2: Washout|Adverse Event|1|||
44458835|NCT00421707|79467431|FG000|Period 2: Washout|Withdrawal by Subject|0|||
44458836|NCT00421707|79467432|FG001|Period 2: Washout|Withdrawal by Subject|1|||
44458837|NCT00421707|79467431|FG000|Period 2: Washout|Lost to Follow-up|0|||
44458838|NCT00421707|79467432|FG001|Period 2: Washout|Lost to Follow-up|1|||
44458839|NCT00421707|79467431|FG000|Period 2: Washout|Other: Pregnancy|0|||
44458840|NCT00421707|79467432|FG001|Period 2: Washout|Other: Pregnancy|1|||
44458841|NCT00421707|79467431|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
44458842|NCT00421707|79467432|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
44458843|NCT00421707|79467431|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
44458844|NCT00421707|79467432|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
44458845|NCT00421707|79467431|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
44458846|NCT00421707|79467432|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
44458847|NCT00518622|79467458|FG000|Overall Study|Lost to Follow-up|0|||
44458848|NCT00518622|79467459|FG001|Overall Study|Lost to Follow-up|0|||
44458849|NCT00518622|79467460|FG002|Overall Study|Lost to Follow-up|1|||
44458850|NCT00518622|79467461|FG003|Overall Study|Lost to Follow-up|0|||
44458851|NCT00518622|79467462|FG004|Overall Study|Lost to Follow-up|0|||
44458852|NCT00518622|79467463|FG005|Overall Study|Lost to Follow-up|0|||
44458853|NCT00518622|79467464|FG006|Overall Study|Lost to Follow-up|0|||
44458854|NCT00518622|79467465|FG007|Overall Study|Lost to Follow-up|0|||
44458855|NCT00518622|79467458|FG000|Overall Study|Study medication taken incorrectly|0|||
44458856|NCT00518622|79467459|FG001|Overall Study|Study medication taken incorrectly|1|||
44458857|NCT00518622|79467460|FG002|Overall Study|Study medication taken incorrectly|0|||
44458858|NCT00518622|79467461|FG003|Overall Study|Study medication taken incorrectly|0|||
44458859|NCT00518622|79467462|FG004|Overall Study|Study medication taken incorrectly|0|||
44458860|NCT00518622|79467463|FG005|Overall Study|Study medication taken incorrectly|0|||
44458861|NCT00518622|79467464|FG006|Overall Study|Study medication taken incorrectly|0|||
44458862|NCT00518622|79467465|FG007|Overall Study|Study medication taken incorrectly|0|||
44458863|NCT00517296|79467485|FG000|Overall Study|Withdrawal by Subject|1|||
44458864|NCT00517296|79467486|FG001|Overall Study|Withdrawal by Subject|0|||
44458865|NCT00516906|79467494|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
44458866|NCT00516906|79467495|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
44458867|NCT00523848|79467501|FG000|Overall Study|Adverse Event|11|||
44458868|NCT00523848|79467501|FG000|Overall Study|Withdrawal by Subject|2|||
44270202|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44270203|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
44372603|NCT01120184|79377442|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
44372604|NCT01120184|79377443|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
44372605|NCT01120184|79377441|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
44372606|NCT01120184|79377442|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
44372607|NCT01120184|79377443|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
44372608|NCT01120184|79377441|FG000|Overall Study|Death|170|||
44372609|NCT01120184|79377442|FG001|Overall Study|Death|176|||
44372610|NCT01120184|79377443|FG002|Overall Study|Death|169|||
44372611|NCT01120028|79377455|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
44458869|NCT00523848|79467501|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
44458870|NCT00523848|79467501|FG000|Overall Study|Disease Progression|5|||
44458871|NCT00523848|79467501|FG000|Overall Study|Other, unspecified|4|||
44458872|NCT00617669|79467507|FG000|Overall Study|Withdrawal by Subject|71|||
44458873|NCT00617669|79467508|FG001|Overall Study|Withdrawal by Subject|77|||
44458874|NCT00617669|79467507|FG000|Overall Study|Lost to Follow-up|3|||
44458875|NCT00617669|79467508|FG001|Overall Study|Lost to Follow-up|2|||
44458876|NCT00617669|79467507|FG000|Overall Study|Adverse Event|87|||
44372612|NCT01120028|79377456|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
44372613|NCT01120028|79377457|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
44372614|NCT01120028|79377458|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
44372615|NCT01120028|79377455|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
44458877|NCT00617669|79467508|FG001|Overall Study|Adverse Event|76|||
44458878|NCT00617669|79467507|FG000|Overall Study|Protocol Violation|2|||
44458879|NCT00617669|79467508|FG001|Overall Study|Protocol Violation|3|||
44458880|NCT00617669|79467507|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
44458881|NCT00617669|79467508|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
44458882|NCT00617669|79467507|FG000|Overall Study|Patients randomized but not treated|2|||
44458883|NCT00617669|79467508|FG001|Overall Study|Patients randomized but not treated|3|||
44458884|NCT00510510|79467517|FG000|Overall Study|Adverse Event|4|||
44458885|NCT00510510|79467518|FG001|Overall Study|Adverse Event|3|||
44458886|NCT00510510|79467519|FG002|Overall Study|Adverse Event|6|||
44458887|NCT00510510|79467517|FG000|Overall Study|Lack of Efficacy|0|||
44458888|NCT00510510|79467518|FG001|Overall Study|Lack of Efficacy|1|||
44458889|NCT00510510|79467519|FG002|Overall Study|Lack of Efficacy|1|||
44458890|NCT00510510|79467517|FG000|Overall Study|Subjects no longer requires study drug|0|||
44458891|NCT00510510|79467518|FG001|Overall Study|Subjects no longer requires study drug|0|||
44458892|NCT00510510|79467519|FG002|Overall Study|Subjects no longer requires study drug|2|||
44458893|NCT00510510|79467517|FG000|Overall Study|Withdrawal by Subject|1|||
44458894|NCT00510510|79467518|FG001|Overall Study|Withdrawal by Subject|2|||
44458895|NCT00510510|79467519|FG002|Overall Study|Withdrawal by Subject|3|||
44458896|NCT00510510|79467517|FG000|Overall Study|Lost to Follow-up|0|||
44458897|NCT00510510|79467518|FG001|Overall Study|Lost to Follow-up|0|||
44458898|NCT00510510|79467519|FG002|Overall Study|Lost to Follow-up|1|||
44458899|NCT00510510|79467517|FG000|Overall Study|Protocol Violation|0|||
44458900|NCT00510510|79467518|FG001|Overall Study|Protocol Violation|3|||
44458901|NCT00510510|79467519|FG002|Overall Study|Protocol Violation|4|||
44458902|NCT00617591|79467527|FG000|Overall Study|Withdrew consent during Induction|4|||
44458903|NCT00617591|79467527|FG000|Overall Study|Withdrew consent during Maintenance|6|||
44458904|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Adverse Event|21|||
44458905|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Adverse Event|6|||
44458906|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
44458907|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
44458908|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
44458909|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
44458910|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
44458911|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
44458912|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Physician Decision|0|||
44458913|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Physician Decision|3|||
44458914|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
44458915|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
44458916|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
44458917|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
44458918|NCT00510276|79467534|FG000|Acute Double-Blind Phase|Subject Decision|26|||
44458919|NCT00510276|79467535|FG001|Acute Double-Blind Phase|Subject Decision|28|||
44458920|NCT00510276|79467534|FG000|Extension Open-Label Phase|Adverse Event|9|||
44458921|NCT00510276|79467535|FG001|Extension Open-Label Phase|Adverse Event|18|||
44458922|NCT00510276|79467534|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
44458923|NCT00510276|79467535|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
44458924|NCT00510276|79467534|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
44458925|NCT00510276|79467535|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
44458926|NCT00510276|79467534|FG000|Extension Open-Label Phase|Physician Decision|2|||
44458927|NCT00510276|79467535|FG001|Extension Open-Label Phase|Physician Decision|3|||
44372616|NCT01120028|79377456|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
44372617|NCT01120028|79377457|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
44372618|NCT01120028|79377458|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
44372619|NCT00878800|79377474|FG000|Overall Study|Adverse Event|0|||
44372620|NCT00878800|79377475|FG001|Overall Study|Adverse Event|0|||
44372621|NCT00878800|79377476|FG002|Overall Study|Adverse Event|2|||
44372622|NCT00878800|79377477|FG003|Overall Study|Adverse Event|0|||
44372623|NCT00878800|79377478|FG004|Overall Study|Adverse Event|1|||
44372624|NCT00878800|79377474|FG000|Overall Study|Progressive disease|1|||
44372625|NCT00878800|79377475|FG001|Overall Study|Progressive disease|5|||
44216744|NCT01925209|79014615|FG000|Follow-up|Physician Decision|0|||
44458928|NCT00510276|79467534|FG000|Extension Open-Label Phase|Protocol Violation|0|||
44458929|NCT00510276|79467535|FG001|Extension Open-Label Phase|Protocol Violation|1|||
44458930|NCT00510276|79467534|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
44458931|NCT00510276|79467535|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
44458932|NCT00510276|79467534|FG000|Extension Open-Label Phase|Subject Decision|7|||
44458933|NCT00510276|79467535|FG001|Extension Open-Label Phase|Subject Decision|9|||
44458934|NCT00616655|79467551|FG000|Overall Study|Adverse Event|10|||
44458935|NCT00616655|79467552|FG001|Overall Study|Adverse Event|7|||
44458936|NCT00616655|79467553|FG002|Overall Study|Adverse Event|12|||
44458937|NCT00616655|79467551|FG000|Overall Study|Lack of Efficacy|5|||
44458938|NCT00616655|79467552|FG001|Overall Study|Lack of Efficacy|5|||
44458939|NCT00616655|79467553|FG002|Overall Study|Lack of Efficacy|5|||
44458940|NCT00616655|79467551|FG000|Overall Study|Lost to Follow-up|3|||
44458941|NCT00616655|79467552|FG001|Overall Study|Lost to Follow-up|12|||
44458942|NCT00616655|79467553|FG002|Overall Study|Lost to Follow-up|10|||
44458943|NCT00616655|79467551|FG000|Overall Study|Protocol Violation|2|||
44458944|NCT00616655|79467552|FG001|Overall Study|Protocol Violation|4|||
44458945|NCT00616655|79467553|FG002|Overall Study|Protocol Violation|3|||
44458946|NCT00616655|79467551|FG000|Overall Study|Withdrawal by Subject|9|||
44458947|NCT00616655|79467552|FG001|Overall Study|Withdrawal by Subject|7|||
44458948|NCT00616655|79467553|FG002|Overall Study|Withdrawal by Subject|11|||
44458949|NCT00616655|79467551|FG000|Overall Study|Does not meet in/ex criteria|0|||
44458950|NCT00616655|79467552|FG001|Overall Study|Does not meet in/ex criteria|0|||
44458951|NCT00616655|79467553|FG002|Overall Study|Does not meet in/ex criteria|2|||
44458952|NCT00616655|79467551|FG000|Overall Study|Other|6|||
44458953|NCT00616655|79467552|FG001|Overall Study|Other|6|||
44458954|NCT00616655|79467553|FG002|Overall Study|Other|5|||
44458955|NCT00510198|79467563|FG000|Overall Study|Withdrawal by Subject|5|||
44458956|NCT00510198|79467564|FG001|Overall Study|Withdrawal by Subject|4|||
44458957|NCT00516048|79467574|FG000|Overall Study|Death|0|||
44458958|NCT00516048|79467575|FG001|Overall Study|Death|0|||
44458959|NCT00516048|79467576|FG002|Overall Study|Death|1|||
44458960|NCT00516048|79467574|FG000|Overall Study|Subject Decision|0|||
44458961|NCT00516048|79467575|FG001|Overall Study|Subject Decision|2|||
44458962|NCT00516048|79467576|FG002|Overall Study|Subject Decision|0|||
44458963|NCT00617357|79467584|FG000|Overall Study|Lost to Follow-up|7|||
44458964|NCT00617357|79467584|FG000|Overall Study|Death|5|||
44458965|NCT00617357|79467584|FG000|Overall Study|insurance concerns|2|||
44458966|NCT00617357|79467584|FG000|Overall Study|Withdrawal by Subject|1|||
44458967|NCT00617357|79467584|FG000|Overall Study|Physician Decision|1|||
44458968|NCT00420927|79467596|FG000|Period 1|Adverse Event|19|||
44458969|NCT00420927|79467597|FG001|Period 1|Adverse Event|15|||
44458970|NCT00420927|79467598|FG002|Period 1|Adverse Event|0|||
44458971|NCT00420927|79467599|FG003|Period 1|Adverse Event|0|||
44458972|NCT00420927|79467600|FG004|Period 1|Adverse Event|0|||
44458973|NCT00420927|79467601|FG005|Period 1|Adverse Event|0|||
44458974|NCT00420927|79467602|FG006|Period 1|Adverse Event|0|||
44458975|NCT00420927|79467596|FG000|Period 1|Withdrawal by Subject|7|||
44458976|NCT00420927|79467597|FG001|Period 1|Withdrawal by Subject|12|||
44458977|NCT00420927|79467598|FG002|Period 1|Withdrawal by Subject|0|||
44458978|NCT00420927|79467599|FG003|Period 1|Withdrawal by Subject|0|||
44458979|NCT00420927|79467600|FG004|Period 1|Withdrawal by Subject|0|||
44458980|NCT00420927|79467601|FG005|Period 1|Withdrawal by Subject|0|||
44458981|NCT00420927|79467602|FG006|Period 1|Withdrawal by Subject|0|||
44458982|NCT00420927|79467596|FG000|Period 1|Lost to Follow-up|8|||
44458983|NCT00420927|79467597|FG001|Period 1|Lost to Follow-up|6|||
44458984|NCT00420927|79467598|FG002|Period 1|Lost to Follow-up|0|||
44458985|NCT00420927|79467599|FG003|Period 1|Lost to Follow-up|0|||
44458986|NCT00420927|79467600|FG004|Period 1|Lost to Follow-up|0|||
44458987|NCT00420927|79467601|FG005|Period 1|Lost to Follow-up|0|||
44458988|NCT00420927|79467602|FG006|Period 1|Lost to Follow-up|0|||
44458989|NCT00420927|79467596|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
44458990|NCT00420927|79467597|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
44458991|NCT00420927|79467598|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
44458992|NCT00420927|79467599|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
44458993|NCT00420927|79467600|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
44458994|NCT00420927|79467601|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
44458995|NCT00420927|79467602|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
44372626|NCT00878800|79377476|FG002|Overall Study|Progressive disease|6|||
44372627|NCT00878800|79377477|FG003|Overall Study|Progressive disease|5|||
44372628|NCT00878800|79377478|FG004|Overall Study|Progressive disease|13|||
44372629|NCT00878800|79377474|FG000|Overall Study|Withdrew consent|1|||
44372630|NCT00878800|79377475|FG001|Overall Study|Withdrew consent|1|||
44372631|NCT00878800|79377476|FG002|Overall Study|Withdrew consent|0|||
44372632|NCT00878800|79377477|FG003|Overall Study|Withdrew consent|1|||
44372633|NCT00878800|79377478|FG004|Overall Study|Withdrew consent|1|||
44372634|NCT00878800|79377474|FG000|Overall Study|Death|0|||
44372635|NCT00878800|79377475|FG001|Overall Study|Death|0|||
44372636|NCT00878800|79377476|FG002|Overall Study|Death|1|||
44372637|NCT00878800|79377477|FG003|Overall Study|Death|0|||
44372638|NCT00878800|79377478|FG004|Overall Study|Death|0|||
44372639|NCT00878800|79377474|FG000|Overall Study|Other|1|||
44372640|NCT00878800|79377475|FG001|Overall Study|Other|1|||
44372641|NCT00878800|79377476|FG002|Overall Study|Other|0|||
44372642|NCT00878800|79377477|FG003|Overall Study|Other|0|||
44372643|NCT00878800|79377478|FG004|Overall Study|Other|1|||
44372644|NCT01119950|79377489|FG000|Overall Study|Adverse Event|25|||
44372645|NCT01119950|79377489|FG000|Overall Study|Withdrawal by Subject|9|||
44372646|NCT01119950|79377489|FG000|Overall Study|Protocol Violation|5|||
44372647|NCT01119950|79377489|FG000|Overall Study|Lost to Follow-up|4|||
44372648|NCT01119950|79377489|FG000|Overall Study|Administrative|2|||
44372649|NCT01119950|79377489|FG000|Overall Study|Abnormal lab value|1|||
44372650|NCT01119950|79377489|FG000|Overall Study|Death|1|||
44372651|NCT01145222|79377519|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
44372652|NCT01145222|79377520|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
44372653|NCT01145222|79377521|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
44372654|NCT01145222|79377522|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
44372655|NCT01145222|79377519|FG000|Overall Study|Poor bowel preparation|0|||
44372656|NCT01145222|79377520|FG001|Overall Study|Poor bowel preparation|0|||
44372657|NCT01145222|79377521|FG002|Overall Study|Poor bowel preparation|0|||
44372658|NCT01145222|79377522|FG003|Overall Study|Poor bowel preparation|1|||
44372659|NCT01145066|79377535|FG000|Overall Study|To resume NSAIDs|2|||
44372660|NCT01145066|79377536|FG001|Overall Study|To resume NSAIDs|2|||
44372661|NCT01145066|79377537|FG002|Overall Study|To resume NSAIDs|1|||
44372662|NCT01145066|79377535|FG000|Overall Study|Non-related surgery|0|||
44372663|NCT01145066|79377536|FG001|Overall Study|Non-related surgery|0|||
44372664|NCT01145066|79377537|FG002|Overall Study|Non-related surgery|1|||
44372665|NCT01145066|79377535|FG000|Overall Study|Withdrawal by Subject|0|||
44372666|NCT01145066|79377536|FG001|Overall Study|Withdrawal by Subject|0|||
44372667|NCT01145066|79377537|FG002|Overall Study|Withdrawal by Subject|2|||
44372668|NCT01145066|79377535|FG000|Overall Study|To start new med|1|||
44372669|NCT01145066|79377536|FG001|Overall Study|To start new med|0|||
44372670|NCT01145066|79377537|FG002|Overall Study|To start new med|0|||
44372671|NCT01145066|79377535|FG000|Overall Study|problems swallowing capsule|1|||
44372672|NCT01145066|79377536|FG001|Overall Study|problems swallowing capsule|0|||
44372673|NCT01145066|79377537|FG002|Overall Study|problems swallowing capsule|0|||
44372674|NCT01145066|79377535|FG000|Overall Study|Abdominal discomfort|0|||
44372675|NCT01145066|79377536|FG001|Overall Study|Abdominal discomfort|1|||
44372676|NCT01145066|79377537|FG002|Overall Study|Abdominal discomfort|0|||
44372677|NCT01145066|79377535|FG000|Overall Study|Low platelet count|0|||
44372678|NCT01145066|79377536|FG001|Overall Study|Low platelet count|1|||
44372679|NCT01145066|79377537|FG002|Overall Study|Low platelet count|0|||
44372680|NCT01132118|79377547|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
44372681|NCT01132118|79377548|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
44372682|NCT01132118|79377547|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
44458996|NCT00420927|79467596|FG000|Period 1|Death|2|||
44458997|NCT00420927|79467597|FG001|Period 1|Death|0|||
44458998|NCT00420927|79467598|FG002|Period 1|Death|0|||
44458999|NCT00420927|79467599|FG003|Period 1|Death|0|||
44372683|NCT01132118|79377548|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
44372684|NCT01132118|79377547|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
44372685|NCT01132118|79377548|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
44372686|NCT00972816|79377562|FG000|Overall Study|Adverse Event|0|||
44372687|NCT00972816|79377563|FG001|Overall Study|Adverse Event|0|||
44372688|NCT00972816|79377564|FG002|Overall Study|Adverse Event|1|||
44372689|NCT00972816|79377565|FG003|Overall Study|Adverse Event|0|||
44372690|NCT00972816|79377566|FG004|Overall Study|Adverse Event|0|||
44372691|NCT00972816|79377567|FG005|Overall Study|Adverse Event|0|||
44372692|NCT00972816|79377568|FG006|Overall Study|Adverse Event|0|||
44372693|NCT00972816|79377569|FG007|Overall Study|Adverse Event|0|||
44372694|NCT00972816|79377562|FG000|Overall Study|Withdrawal by Subject|4|||
44372695|NCT00972816|79377563|FG001|Overall Study|Withdrawal by Subject|2|||
44372696|NCT00972816|79377564|FG002|Overall Study|Withdrawal by Subject|1|||
44372697|NCT00972816|79377565|FG003|Overall Study|Withdrawal by Subject|3|||
44459000|NCT00420927|79467600|FG004|Period 1|Death|0|||
44459001|NCT00420927|79467601|FG005|Period 1|Death|0|||
44459002|NCT00420927|79467602|FG006|Period 1|Death|0|||
44459003|NCT00420927|79467596|FG000|Period 1|Subject moved/relocated|0|||
44459004|NCT00420927|79467597|FG001|Period 1|Subject moved/relocated|2|||
44459005|NCT00420927|79467598|FG002|Period 1|Subject moved/relocated|0|||
44459006|NCT00420927|79467599|FG003|Period 1|Subject moved/relocated|0|||
44459007|NCT00420927|79467600|FG004|Period 1|Subject moved/relocated|0|||
44459008|NCT00420927|79467601|FG005|Period 1|Subject moved/relocated|0|||
44459009|NCT00420927|79467602|FG006|Period 1|Subject moved/relocated|0|||
44459010|NCT00420927|79467596|FG000|Period 1|Noncompliant with study drug|1|||
44459011|NCT00420927|79467597|FG001|Period 1|Noncompliant with study drug|1|||
44459012|NCT00420927|79467598|FG002|Period 1|Noncompliant with study drug|0|||
44459013|NCT00420927|79467599|FG003|Period 1|Noncompliant with study drug|0|||
44459014|NCT00420927|79467600|FG004|Period 1|Noncompliant with study drug|0|||
44459015|NCT00420927|79467601|FG005|Period 1|Noncompliant with study drug|0|||
44459016|NCT00420927|79467602|FG006|Period 1|Noncompliant with study drug|0|||
44459017|NCT00420927|79467596|FG000|Period 1|Randomization error|1|||
44459018|NCT00420927|79467597|FG001|Period 1|Randomization error|0|||
44459019|NCT00420927|79467598|FG002|Period 1|Randomization error|0|||
44459020|NCT00420927|79467599|FG003|Period 1|Randomization error|0|||
44459021|NCT00420927|79467600|FG004|Period 1|Randomization error|0|||
44459022|NCT00420927|79467601|FG005|Period 1|Randomization error|0|||
44459023|NCT00420927|79467602|FG006|Period 1|Randomization error|0|||
44459024|NCT00420927|79467596|FG000|Period 1|Suspected tuberculosis/positive test|1|||
44459025|NCT00420927|79467597|FG001|Period 1|Suspected tuberculosis/positive test|1|||
44459026|NCT00420927|79467598|FG002|Period 1|Suspected tuberculosis/positive test|0|||
44459027|NCT00420927|79467599|FG003|Period 1|Suspected tuberculosis/positive test|0|||
44459028|NCT00420927|79467600|FG004|Period 1|Suspected tuberculosis/positive test|0|||
44459029|NCT00420927|79467601|FG005|Period 1|Suspected tuberculosis/positive test|0|||
44459030|NCT00420927|79467602|FG006|Period 1|Suspected tuberculosis/positive test|0|||
44459031|NCT00420927|79467596|FG000|Period 1|Study site closure|0|||
44459032|NCT00420927|79467597|FG001|Period 1|Study site closure|1|||
44459033|NCT00420927|79467598|FG002|Period 1|Study site closure|0|||
44459034|NCT00420927|79467599|FG003|Period 1|Study site closure|0|||
44459035|NCT00420927|79467600|FG004|Period 1|Study site closure|0|||
44459036|NCT00420927|79467601|FG005|Period 1|Study site closure|0|||
44459037|NCT00420927|79467602|FG006|Period 1|Study site closure|0|||
44459038|NCT00420927|79467596|FG000|Period 1|Subject received new diagnosis|0|||
44459039|NCT00420927|79467597|FG001|Period 1|Subject received new diagnosis|2|||
44216745|NCT01925209|79014616|FG001|Follow-up|Physician Decision|0|||
44216746|NCT01925209|79014617|FG002|Follow-up|Physician Decision|1|||
44216747|NCT01925209|79014618|FG003|Follow-up|Physician Decision|0|||
44216748|NCT01925209|79014615|FG000|Follow-up|Non-compliance with study treatment|0|||
44216749|NCT01925209|79014616|FG001|Follow-up|Non-compliance with study treatment|0|||
44216750|NCT01925209|79014617|FG002|Follow-up|Non-compliance with study treatment|0|||
44216751|NCT01925209|79014618|FG003|Follow-up|Non-compliance with study treatment|1|||
44216752|NCT01925209|79014615|FG000|Follow-up|Withdrawal by Subject|0|||
44216753|NCT01925209|79014616|FG001|Follow-up|Withdrawal by Subject|2|||
44216754|NCT01925209|79014617|FG002|Follow-up|Withdrawal by Subject|0|||
44216755|NCT01925209|79014618|FG003|Follow-up|Withdrawal by Subject|2|||
44216756|NCT01614925|79014630|FG000|Overall Study|Withdrawal by Subject|1|||
44216757|NCT01614925|79014631|FG001|Overall Study|Withdrawal by Subject|0|||
44216758|NCT01614925|79014630|FG000|Overall Study|Protocol Violation|3|||
44216759|NCT01614925|79014631|FG001|Overall Study|Protocol Violation|2|||
44216760|NCT01886833|79014637|FG000|Overall Study|IgA not available from both periods|204|||
44216761|NCT01898923|79014646|FG000|Overall Study|Lack of Efficacy|5|||
44216762|NCT01898923|79014647|FG001|Overall Study|Lack of Efficacy|6|||
44216763|NCT01898923|79014646|FG000|Overall Study|Adverse Event|3|||
44459040|NCT00420927|79467598|FG002|Period 1|Subject received new diagnosis|0|||
44459041|NCT00420927|79467599|FG003|Period 1|Subject received new diagnosis|0|||
44459042|NCT00420927|79467600|FG004|Period 1|Subject received new diagnosis|0|||
44459043|NCT00420927|79467601|FG005|Period 1|Subject received new diagnosis|0|||
44216764|NCT01898923|79014647|FG001|Overall Study|Adverse Event|1|||
44216765|NCT01898923|79014646|FG000|Overall Study|Lost to Follow-up|0|||
44216766|NCT01898923|79014647|FG001|Overall Study|Lost to Follow-up|1|||
44216767|NCT01898923|79014646|FG000|Overall Study|Withdrawal by Subject|4|||
44459044|NCT00420927|79467602|FG006|Period 1|Subject received new diagnosis|0|||
44459045|NCT00420927|79467596|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
44459046|NCT00420927|79467597|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
44459047|NCT00420927|79467598|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
44544057|NCT03736967|79557252|FG000|Overall Study|Adverse Event|0|||
44459048|NCT00420927|79467599|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
44459049|NCT00420927|79467600|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
44459050|NCT00420927|79467601|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
44459051|NCT00420927|79467602|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
44459052|NCT00420927|79467596|FG000|Period 1|Failed to meet entry criteria|8|||
44459053|NCT00420927|79467597|FG001|Period 1|Failed to meet entry criteria|7|||
44459054|NCT00420927|79467598|FG002|Period 1|Failed to meet entry criteria|0|||
44459055|NCT00420927|79467599|FG003|Period 1|Failed to meet entry criteria|0|||
44459056|NCT00420927|79467600|FG004|Period 1|Failed to meet entry criteria|0|||
44459057|NCT00420927|79467601|FG005|Period 1|Failed to meet entry criteria|0|||
44459058|NCT00420927|79467602|FG006|Period 1|Failed to meet entry criteria|0|||
44459059|NCT00420927|79467596|FG000|Period 1|Took prohibited medication|1|||
44459060|NCT00420927|79467597|FG001|Period 1|Took prohibited medication|3|||
44459061|NCT00420927|79467598|FG002|Period 1|Took prohibited medication|0|||
44459062|NCT00420927|79467599|FG003|Period 1|Took prohibited medication|0|||
44459063|NCT00420927|79467600|FG004|Period 1|Took prohibited medication|0|||
44459064|NCT00420927|79467601|FG005|Period 1|Took prohibited medication|0|||
44459065|NCT00420927|79467602|FG006|Period 1|Took prohibited medication|0|||
44459066|NCT00420927|79467596|FG000|Period 2|Adverse Event|0|||
44459067|NCT00420927|79467597|FG001|Period 2|Adverse Event|0|||
44459068|NCT00420927|79467598|FG002|Period 2|Adverse Event|7|||
44459069|NCT00420927|79467599|FG003|Period 2|Adverse Event|3|||
44459070|NCT00420927|79467600|FG004|Period 2|Adverse Event|17|||
44459071|NCT00420927|79467601|FG005|Period 2|Adverse Event|6|||
44459072|NCT00420927|79467602|FG006|Period 2|Adverse Event|20|||
44459073|NCT00420927|79467596|FG000|Period 2|Withdrawal by Subject|0|||
44459074|NCT00420927|79467597|FG001|Period 2|Withdrawal by Subject|0|||
44459075|NCT00420927|79467598|FG002|Period 2|Withdrawal by Subject|1|||
44459076|NCT00420927|79467599|FG003|Period 2|Withdrawal by Subject|3|||
44459077|NCT00420927|79467600|FG004|Period 2|Withdrawal by Subject|11|||
44459078|NCT00420927|79467601|FG005|Period 2|Withdrawal by Subject|2|||
44459079|NCT00420927|79467602|FG006|Period 2|Withdrawal by Subject|12|||
44459080|NCT00420927|79467596|FG000|Period 2|Lost to Follow-up|0|||
44216768|NCT01898923|79014647|FG001|Overall Study|Withdrawal by Subject|7|||
44216769|NCT01898923|79014646|FG000|Overall Study|Physician Decision|3|||
44459081|NCT00420927|79467597|FG001|Period 2|Lost to Follow-up|0|||
44459082|NCT00420927|79467598|FG002|Period 2|Lost to Follow-up|2|||
44459083|NCT00420927|79467599|FG003|Period 2|Lost to Follow-up|2|||
44459084|NCT00420927|79467600|FG004|Period 2|Lost to Follow-up|6|||
44459085|NCT00420927|79467601|FG005|Period 2|Lost to Follow-up|3|||
44459086|NCT00420927|79467602|FG006|Period 2|Lost to Follow-up|9|||
44216770|NCT01898923|79014647|FG001|Overall Study|Physician Decision|4|||
44216771|NCT01898923|79014646|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
44216772|NCT01898923|79014647|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
44216773|NCT01924429|79014655|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
44216774|NCT01924429|79014656|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
44216775|NCT01898299|79014666|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
44216776|NCT01898299|79014667|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
44216777|NCT01886287|79014673|FG000|Overall Study|Radiographic disease progression|1|||
44216778|NCT01886287|79014673|FG000|Overall Study|Clinical progression due to disease|1|||
44216779|NCT01885195|79014677|FG000|Overall Study|Adverse Event|29|||
44216780|NCT01885195|79014677|FG000|Overall Study|Death|1|||
44216781|NCT01885195|79014677|FG000|Overall Study|Disease Progression|67|||
44216782|NCT01885195|79014677|FG000|Overall Study|Protocol Deviation|2|||
44270204|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44270205|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44270206|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44372698|NCT00972816|79377566|FG004|Overall Study|Withdrawal by Subject|0|||
44372699|NCT00972816|79377567|FG005|Overall Study|Withdrawal by Subject|1|||
44372700|NCT00972816|79377568|FG006|Overall Study|Withdrawal by Subject|1|||
44372701|NCT00972816|79377569|FG007|Overall Study|Withdrawal by Subject|2|||
44372702|NCT00972816|79377562|FG000|Overall Study|Lost to Follow-up|11|||
44372703|NCT00972816|79377563|FG001|Overall Study|Lost to Follow-up|9|||
44372704|NCT00972816|79377564|FG002|Overall Study|Lost to Follow-up|7|||
44372705|NCT00972816|79377565|FG003|Overall Study|Lost to Follow-up|5|||
44459087|NCT00420927|79467596|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
44459088|NCT00420927|79467597|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
44459089|NCT00420927|79467598|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
44459090|NCT00420927|79467599|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
44459091|NCT00420927|79467600|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
44459092|NCT00420927|79467601|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
44216783|NCT01885195|79014677|FG000|Overall Study|Physician Decision|3|||
44216784|NCT01885195|79014677|FG000|Overall Study|Patient/guardian decision|8|||
44216785|NCT01896895|79014684|FG000|Double-blind MP|Physician Decision|0|||
44372706|NCT00972816|79377566|FG004|Overall Study|Lost to Follow-up|11|||
44459093|NCT00420927|79467602|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
44459094|NCT00420927|79467596|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
44459095|NCT00420927|79467597|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
44459096|NCT00420927|79467598|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
44459097|NCT00420927|79467599|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
44459098|NCT00420927|79467600|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
44459099|NCT00420927|79467601|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
44459100|NCT00420927|79467602|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
44459101|NCT00420927|79467596|FG000|Period 2|Subject unable to find transportation|0|||
44459102|NCT00420927|79467597|FG001|Period 2|Subject unable to find transportation|0|||
44459103|NCT00420927|79467598|FG002|Period 2|Subject unable to find transportation|0|||
44459104|NCT00420927|79467599|FG003|Period 2|Subject unable to find transportation|0|||
44459105|NCT00420927|79467600|FG004|Period 2|Subject unable to find transportation|0|||
44459106|NCT00420927|79467601|FG005|Period 2|Subject unable to find transportation|0|||
44459107|NCT00420927|79467602|FG006|Period 2|Subject unable to find transportation|1|||
44459108|NCT00420927|79467596|FG000|Period 2|Physician Decision|0|||
44459109|NCT00420927|79467597|FG001|Period 2|Physician Decision|0|||
44459110|NCT00420927|79467598|FG002|Period 2|Physician Decision|0|||
44459111|NCT00420927|79467599|FG003|Period 2|Physician Decision|0|||
44459112|NCT00420927|79467600|FG004|Period 2|Physician Decision|1|||
44459113|NCT00420927|79467601|FG005|Period 2|Physician Decision|1|||
44459114|NCT00420927|79467602|FG006|Period 2|Physician Decision|0|||
44459115|NCT00420927|79467596|FG000|Period 2|Sponsor decision|0|||
44459116|NCT00420927|79467597|FG001|Period 2|Sponsor decision|0|||
44459117|NCT00420927|79467598|FG002|Period 2|Sponsor decision|1|||
44459118|NCT00420927|79467599|FG003|Period 2|Sponsor decision|0|||
44459119|NCT00420927|79467600|FG004|Period 2|Sponsor decision|0|||
44459120|NCT00420927|79467601|FG005|Period 2|Sponsor decision|0|||
44459121|NCT00420927|79467602|FG006|Period 2|Sponsor decision|1|||
44459122|NCT00420927|79467596|FG000|Period 2|Randomization error|0|||
44459123|NCT00420927|79467597|FG001|Period 2|Randomization error|0|||
44459124|NCT00420927|79467598|FG002|Period 2|Randomization error|0|||
44459125|NCT00420927|79467599|FG003|Period 2|Randomization error|0|||
44544058|NCT03736967|79557253|FG001|Overall Study|Adverse Event|1|||
44544059|NCT03736967|79557254|FG002|Overall Study|Adverse Event|0|||
44544060|NCT03736967|79557255|FG003|Overall Study|Adverse Event|1|||
44544061|NCT03736967|79557252|FG000|Overall Study|Death|0|||
44216786|NCT01896895|79014685|FG001|Double-blind MP|Physician Decision|0|||
44216787|NCT01896895|79014686|FG002|Double-blind MP|Physician Decision|1|||
44216788|NCT01896895|79014687|FG003|Double-blind MP|Physician Decision|0|||
44216789|NCT01896895|79014684|FG000|Double-blind MP|Withdrawal by Subject|0|||
44216790|NCT01896895|79014685|FG001|Double-blind MP|Withdrawal by Subject|2|||
44216791|NCT01896895|79014686|FG002|Double-blind MP|Withdrawal by Subject|1|||
44216792|NCT01896895|79014687|FG003|Double-blind MP|Withdrawal by Subject|0|||
44216793|NCT01896895|79014684|FG000|Double-blind MP|Lost to Follow-up|1|||
44216794|NCT01896895|79014685|FG001|Double-blind MP|Lost to Follow-up|0|||
44216795|NCT01896895|79014686|FG002|Double-blind MP|Lost to Follow-up|1|||
44216796|NCT01896895|79014687|FG003|Double-blind MP|Lost to Follow-up|0|||
44216797|NCT01923181|79014723|FG000|Overall Study|Protocol Violation|2|||
44216798|NCT01923181|79014724|FG001|Overall Study|Protocol Violation|2|||
44216799|NCT01923181|79014725|FG002|Overall Study|Protocol Violation|0|||
44216800|NCT01923181|79014726|FG003|Overall Study|Protocol Violation|2|||
44216801|NCT01923181|79014727|FG004|Overall Study|Protocol Violation|2|||
44216802|NCT01923181|79014728|FG005|Overall Study|Protocol Violation|1|||
44216803|NCT01923181|79014729|FG006|Overall Study|Protocol Violation|1|||
44270207|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
44372707|NCT00972816|79377567|FG005|Overall Study|Lost to Follow-up|10|||
44372708|NCT00972816|79377568|FG006|Overall Study|Lost to Follow-up|7|||
44372709|NCT00972816|79377569|FG007|Overall Study|Lost to Follow-up|7|||
44372710|NCT00972816|79377562|FG000|Overall Study|Inappropriate enrolment|0|||
44372711|NCT00972816|79377563|FG001|Overall Study|Inappropriate enrolment|0|||
44372712|NCT00972816|79377564|FG002|Overall Study|Inappropriate enrolment|0|||
44372713|NCT00972816|79377565|FG003|Overall Study|Inappropriate enrolment|0|||
44372714|NCT00972816|79377566|FG004|Overall Study|Inappropriate enrolment|0|||
44372715|NCT00972816|79377567|FG005|Overall Study|Inappropriate enrolment|0|||
44372716|NCT00972816|79377568|FG006|Overall Study|Inappropriate enrolment|2|||
44372717|NCT00972816|79377569|FG007|Overall Study|Inappropriate enrolment|0|||
44372718|NCT00972816|79377562|FG000|Overall Study|Unable to classify|2|||
44372719|NCT00972816|79377563|FG001|Overall Study|Unable to classify|0|||
44459126|NCT00420927|79467600|FG004|Period 2|Randomization error|1|||
44459127|NCT00420927|79467601|FG005|Period 2|Randomization error|1|||
44459128|NCT00420927|79467602|FG006|Period 2|Randomization error|0|||
44459129|NCT00420927|79467596|FG000|Period 2|Noncompliant with study drug|0|||
44459130|NCT00420927|79467597|FG001|Period 2|Noncompliant with study drug|0|||
44459131|NCT00420927|79467598|FG002|Period 2|Noncompliant with study drug|0|||
44544062|NCT03736967|79557253|FG001|Overall Study|Death|0|||
44216804|NCT01923181|79014730|FG007|Overall Study|Protocol Violation|2|||
44216805|NCT01923181|79014731|FG008|Overall Study|Protocol Violation|1|||
44459132|NCT00420927|79467599|FG003|Period 2|Noncompliant with study drug|1|||
44459133|NCT00420927|79467600|FG004|Period 2|Noncompliant with study drug|0|||
44459134|NCT00420927|79467601|FG005|Period 2|Noncompliant with study drug|0|||
44459135|NCT00420927|79467602|FG006|Period 2|Noncompliant with study drug|2|||
44459136|NCT00420927|79467596|FG000|Period 2|Methotrexate intolerance|0|||
44459137|NCT00420927|79467597|FG001|Period 2|Methotrexate intolerance|0|||
44459138|NCT00420927|79467598|FG002|Period 2|Methotrexate intolerance|0|||
44459139|NCT00420927|79467599|FG003|Period 2|Methotrexate intolerance|0|||
44459140|NCT00420927|79467600|FG004|Period 2|Methotrexate intolerance|0|||
44459141|NCT00420927|79467601|FG005|Period 2|Methotrexate intolerance|0|||
44459142|NCT00420927|79467602|FG006|Period 2|Methotrexate intolerance|1|||
44459143|NCT00420927|79467596|FG000|Period 2|Took prohibited medication|0|||
44459144|NCT00420927|79467597|FG001|Period 2|Took prohibited medication|0|||
44459145|NCT00420927|79467598|FG002|Period 2|Took prohibited medication|0|||
44459146|NCT00420927|79467599|FG003|Period 2|Took prohibited medication|0|||
44459147|NCT00420927|79467600|FG004|Period 2|Took prohibited medication|1|||
44459148|NCT00420927|79467601|FG005|Period 2|Took prohibited medication|0|||
44459149|NCT00420927|79467602|FG006|Period 2|Took prohibited medication|0|||
44459150|NCT00573443|79467619|FG000|Double-Blind Phase|Lost to Follow-up|1|||
44459151|NCT00573443|79467620|FG001|Double-Blind Phase|Lost to Follow-up|3|||
44459152|NCT00573443|79467621|FG002|Double-Blind Phase|Lost to Follow-up|2|||
44459153|NCT00573443|79467619|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
44459154|NCT00573443|79467620|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
44459155|NCT00573443|79467621|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
44459156|NCT00573443|79467619|FG000|Double-Blind Phase|Adverse Event|1|||
44459157|NCT00573443|79467620|FG001|Double-Blind Phase|Adverse Event|5|||
44459158|NCT00573443|79467621|FG002|Double-Blind Phase|Adverse Event|0|||
44459159|NCT00573443|79467619|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
44459160|NCT00573443|79467620|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
44459161|NCT00573443|79467621|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
44459162|NCT00573443|79467619|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
44216806|NCT01923181|79014723|FG000|Overall Study|Withdrawal by Subject|0|||
44216807|NCT01923181|79014724|FG001|Overall Study|Withdrawal by Subject|1|||
44216808|NCT01923181|79014725|FG002|Overall Study|Withdrawal by Subject|0|||
44216809|NCT01923181|79014726|FG003|Overall Study|Withdrawal by Subject|1|||
44216810|NCT01923181|79014727|FG004|Overall Study|Withdrawal by Subject|4|||
44372720|NCT00972816|79377564|FG002|Overall Study|Unable to classify|0|||
44372721|NCT00972816|79377565|FG003|Overall Study|Unable to classify|0|||
44372722|NCT00972816|79377566|FG004|Overall Study|Unable to classify|1|||
44372723|NCT00972816|79377567|FG005|Overall Study|Unable to classify|0|||
44372724|NCT00972816|79377568|FG006|Overall Study|Unable to classify|0|||
44372725|NCT00972816|79377569|FG007|Overall Study|Unable to classify|0|||
44372726|NCT00969618|79377587|FG000|Overall Study|Adverse Event|29|||
44372727|NCT00969618|79377587|FG000|Overall Study|Entry Criteria Not Met|3|||
44372728|NCT00969618|79377587|FG000|Overall Study|Lack of Efficacy|2|||
44372729|NCT00969618|79377587|FG000|Overall Study|Lost to Follow-up|7|||
44372730|NCT00969618|79377587|FG000|Overall Study|Physician Decision|1|||
44372731|NCT00969618|79377587|FG000|Overall Study|Protocol Violation|9|||
44372732|NCT00969618|79377587|FG000|Overall Study|Withdrawal by Subject|27|||
44372733|NCT00969540|79377593|FG000|Overall Study|Lost to Follow-up|1|||
44372734|NCT00969540|79377594|FG001|Overall Study|Lost to Follow-up|1|||
44372735|NCT00975000|79377614|FG000|Overall Study|Other|1|||
44372736|NCT00975000|79377615|FG001|Overall Study|Other|0|||
44372737|NCT00975000|79377614|FG000|Overall Study|Adverse Event|1|||
44372738|NCT00975000|79377615|FG001|Overall Study|Adverse Event|1|||
44372739|NCT00975000|79377614|FG000|Overall Study|Withdrawal by Subject|2|||
44372740|NCT00975000|79377615|FG001|Overall Study|Withdrawal by Subject|2|||
44372741|NCT00975000|79377614|FG000|Overall Study|Lost to Follow-up|0|||
44372742|NCT00975000|79377615|FG001|Overall Study|Lost to Follow-up|1|||
44372743|NCT00975000|79377614|FG000|Overall Study|Protocol-specified Criteria|1|||
44372744|NCT00975000|79377615|FG001|Overall Study|Protocol-specified Criteria|0|||
44372745|NCT00975000|79377614|FG000|Overall Study|Non-compliance|0|||
44372746|NCT00975000|79377615|FG001|Overall Study|Non-compliance|1|||
44372747|NCT00974922|79377621|FG000|Overall Study|study terminated|24|||
44372748|NCT00972504|79377625|FG000|Overall Study|Adverse Event|2|||
44372749|NCT00972504|79377625|FG000|Overall Study|Investigator discretion|1|||
44372750|NCT00969228|79377637|FG000|Overall Study|Adverse Event|1|||
44372751|NCT00969228|79377638|FG001|Overall Study|Adverse Event|0|||
44459163|NCT00573443|79467620|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
44459164|NCT00573443|79467621|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
44459165|NCT00573443|79467619|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
44459166|NCT00573443|79467620|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
44459167|NCT00573443|79467621|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
44372752|NCT00969228|79377637|FG000|Overall Study|Withdrawal by Subject|4|||
44372753|NCT00969228|79377638|FG001|Overall Study|Withdrawal by Subject|0|||
44459168|NCT00573443|79467619|FG000|Double-Blind Phase|Protocol Violation|0|||
44459169|NCT00573443|79467620|FG001|Double-Blind Phase|Protocol Violation|2|||
44459170|NCT00573443|79467621|FG002|Double-Blind Phase|Protocol Violation|1|||
44459171|NCT00573443|79467619|FG000|Double-Blind Phase|Other|0|||
44459172|NCT00573443|79467620|FG001|Double-Blind Phase|Other|2|||
44459173|NCT00573443|79467621|FG002|Double-Blind Phase|Other|3|||
44459174|NCT00573443|79467619|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
44459175|NCT00573443|79467620|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
44459176|NCT00573443|79467621|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
44459177|NCT00573443|79467619|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
44459178|NCT00573443|79467620|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
44459179|NCT00573443|79467621|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
44459180|NCT00573443|79467619|FG000|Open-Label Extension Phase|Adverse Event|3|||
44459181|NCT00573443|79467620|FG001|Open-Label Extension Phase|Adverse Event|0|||
44459182|NCT00573443|79467621|FG002|Open-Label Extension Phase|Adverse Event|0|||
44459183|NCT00573443|79467619|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
44459184|NCT00573443|79467620|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
44459185|NCT00573443|79467621|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
44459186|NCT00573443|79467619|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
44459187|NCT00573443|79467620|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
44459188|NCT00573443|79467621|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
44459189|NCT00573443|79467619|FG000|Open-Label Extension Phase|Protocol Violation|2|||
44459190|NCT00573443|79467620|FG001|Open-Label Extension Phase|Protocol Violation|0|||
44459191|NCT00573443|79467621|FG002|Open-Label Extension Phase|Protocol Violation|0|||
44459192|NCT00573443|79467619|FG000|Open-Label Extension Phase|Other|2|||
44459193|NCT00573443|79467620|FG001|Open-Label Extension Phase|Other|0|||
44216811|NCT01923181|79014728|FG005|Overall Study|Withdrawal by Subject|2|||
44216812|NCT01923181|79014729|FG006|Overall Study|Withdrawal by Subject|4|||
44216813|NCT01923181|79014730|FG007|Overall Study|Withdrawal by Subject|3|||
44216814|NCT01923181|79014731|FG008|Overall Study|Withdrawal by Subject|1|||
44216815|NCT01923181|79014723|FG000|Overall Study|Other|1|||
44216816|NCT01923181|79014724|FG001|Overall Study|Other|0|||
44216817|NCT01923181|79014725|FG002|Overall Study|Other|0|||
44216818|NCT01923181|79014726|FG003|Overall Study|Other|1|||
44216819|NCT01923181|79014727|FG004|Overall Study|Other|0|||
44216820|NCT01923181|79014728|FG005|Overall Study|Other|0|||
44216821|NCT01923181|79014729|FG006|Overall Study|Other|0|||
44216822|NCT01923181|79014730|FG007|Overall Study|Other|0|||
44216823|NCT01923181|79014731|FG008|Overall Study|Other|0|||
44216824|NCT01923181|79014723|FG000|Overall Study|Lost to Follow-up|0|||
44216825|NCT01923181|79014724|FG001|Overall Study|Lost to Follow-up|3|||
44216826|NCT01923181|79014725|FG002|Overall Study|Lost to Follow-up|2|||
44216827|NCT01923181|79014726|FG003|Overall Study|Lost to Follow-up|1|||
44216828|NCT01923181|79014727|FG004|Overall Study|Lost to Follow-up|2|||
44216829|NCT01923181|79014728|FG005|Overall Study|Lost to Follow-up|1|||
44216830|NCT01923181|79014729|FG006|Overall Study|Lost to Follow-up|3|||
44216831|NCT01923181|79014730|FG007|Overall Study|Lost to Follow-up|3|||
44216832|NCT01923181|79014731|FG008|Overall Study|Lost to Follow-up|1|||
44216833|NCT01896271|79014754|FG000|Overall Study|Physician Decision|10|||
44216834|NCT01884571|79014758|FG000|Overall Study|Adverse Event|1|||
44216835|NCT01884571|79014758|FG000|Overall Study|Death|2|||
44216836|NCT01884571|79014758|FG000|Overall Study|Withdrawal by Subject|2|||
44216837|NCT01884571|79014758|FG000|Overall Study|Disease progression|3|||
44216838|NCT01884337|79014764|FG000|Treatment|Adverse Event|2|||
44216839|NCT01884337|79014765|FG001|Treatment|Adverse Event|2|||
44216840|NCT01884337|79014764|FG000|Treatment|Subj. request to discont. treatment|2|||
44216841|NCT01884337|79014765|FG001|Treatment|Subj. request to discont. treatment|0|||
44216842|NCT01884337|79014764|FG000|Follow-up Period|Lost to Follow-up|1|||
44216843|NCT01884337|79014765|FG001|Follow-up Period|Lost to Follow-up|1|||
44216844|NCT01922089|79014773|FG000|Overall Study|Adverse Event|18|||
44216845|NCT01922089|79014774|FG001|Overall Study|Adverse Event|13|||
44216846|NCT01922089|79014773|FG000|Overall Study|Protocol Deviation|10|||
44216847|NCT01922089|79014774|FG001|Overall Study|Protocol Deviation|7|||
44216848|NCT01922089|79014773|FG000|Overall Study|Withdrawal by Subject|3|||
44216849|NCT01922089|79014774|FG001|Overall Study|Withdrawal by Subject|4|||
44216850|NCT01922089|79014773|FG000|Overall Study|administrative problems|4|||
44216851|NCT01922089|79014774|FG001|Overall Study|administrative problems|1|||
44216852|NCT01922089|79014773|FG000|Overall Study|Physician Decision|2|||
44216853|NCT01922089|79014774|FG001|Overall Study|Physician Decision|3|||
44459194|NCT00573443|79467621|FG002|Open-Label Extension Phase|Other|0|||
44459195|NCT00420849|79467630|FG000|Overall Study|Lack of Efficacy|154|||
44459196|NCT00420849|79467630|FG000|Overall Study|Adverse Event|107|||
44216854|NCT01922089|79014773|FG000|Overall Study|Death|2|||
44216855|NCT01922089|79014774|FG001|Overall Study|Death|1|||
44216856|NCT01922089|79014773|FG000|Overall Study|Lost to Follow-up|0|||
44216857|NCT01922089|79014774|FG001|Overall Study|Lost to Follow-up|1|||
44216858|NCT01884025|79014782|FG000|Overall Study|Lost to Follow-up|3|||
44216859|NCT01884025|79014783|FG001|Overall Study|Lost to Follow-up|4|||
44216860|NCT01896193|79014793|FG000|Overall Study|Lack of Efficacy|20|||
44216861|NCT01896193|79014794|FG001|Overall Study|Lack of Efficacy|11|||
44216862|NCT01896193|79014793|FG000|Overall Study|Protocol Violation|0|||
44216863|NCT01896193|79014794|FG001|Overall Study|Protocol Violation|1|||
44216864|NCT01896193|79014793|FG000|Overall Study|Withdrew Consent|1|||
44216865|NCT01896193|79014794|FG001|Overall Study|Withdrew Consent|0|||
44216866|NCT01922011|79014804|FG000|Overall Study|Protocol Violation|0|||
44216867|NCT01922011|79014805|FG001|Overall Study|Protocol Violation|1|||
44216868|NCT01922011|79014804|FG000|Overall Study|Physician Decision|0|||
44216869|NCT01922011|79014805|FG001|Overall Study|Physician Decision|1|||
44216870|NCT01922011|79014804|FG000|Overall Study|Parent/Guardian Decision|3|||
44216871|NCT01922011|79014805|FG001|Overall Study|Parent/Guardian Decision|0|||
44216872|NCT01922011|79014804|FG000|Overall Study|Lost to Follow-up|0|||
44216873|NCT01922011|79014805|FG001|Overall Study|Lost to Follow-up|1|||
44216874|NCT01922011|79014804|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
44216875|NCT01922011|79014805|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
44216876|NCT01922011|79014804|FG000|Overall Study|Not Treated|1|||
44216877|NCT01922011|79014805|FG001|Overall Study|Not Treated|0|||
44216878|NCT01922011|79014804|FG000|Overall Study|Lack of willing home health agency|1|||
44216879|NCT01922011|79014805|FG001|Overall Study|Lack of willing home health agency|0|||
44216880|NCT01922011|79014804|FG000|Overall Study|Randomized in error|1|||
44216881|NCT01922011|79014805|FG001|Overall Study|Randomized in error|0|||
44216882|NCT01883635|79014819|FG000|Overall Study|Withdrawal by Subject|4|||
44216883|NCT01883635|79014820|FG001|Overall Study|Withdrawal by Subject|0|||
44216884|NCT01921387|79014828|FG000|Overall Study|Adverse Event|1|||
44459197|NCT00420849|79467630|FG000|Overall Study|Withdrawal by Subject|28|||
44459198|NCT00420849|79467630|FG000|Overall Study|Death|18|||
44459199|NCT00420849|79467630|FG000|Overall Study|Other|14|||
44459200|NCT00420849|79467630|FG000|Overall Study|Transplant|8|||
44459201|NCT00420849|79467630|FG000|Overall Study|Protocol Violation|1|||
44459202|NCT00420849|79467630|FG000|Overall Study|Lost to Follow-up|1|||
44459203|NCT00617279|79467639|FG000|Overall Study|Study terminated by Sponsor|10|||
44459204|NCT00617279|79467640|FG001|Overall Study|Study terminated by Sponsor|15|||
44216885|NCT01895335|79014832|FG000|Overall Study|Adverse Event|106|||
44216886|NCT01895335|79014832|FG000|Overall Study|Lack of Efficacy|53|||
44216887|NCT01895335|79014832|FG000|Overall Study|Poor Compliance to Protocol|11|||
44216888|NCT01895335|79014832|FG000|Overall Study|Included But Not treated|1|||
44216889|NCT01895335|79014832|FG000|Overall Study|Other than Specified Above|44|||
44216890|NCT01617655|79014838|FG000|Overall Study|Adverse Event|2|||
44216891|NCT01617655|79014839|FG001|Overall Study|Adverse Event|3|||
44216892|NCT01617655|79014838|FG000|Overall Study|Poor compliance to protocol|1|||
44216893|NCT01617655|79014839|FG001|Overall Study|Poor compliance to protocol|4|||
44216894|NCT01617655|79014838|FG000|Overall Study|Participants moved|0|||
44216895|NCT01617655|79014839|FG001|Overall Study|Participants moved|4|||
44216896|NCT01617655|79014838|FG000|Overall Study|Consent withdrawn by participant|1|||
44216897|NCT01617655|79014839|FG001|Overall Study|Consent withdrawn by participant|1|||
44216898|NCT01617655|79014838|FG000|Overall Study|Last visit outside protocol visit window|1|||
44459205|NCT00617279|79467639|FG000|Overall Study|Graft abandonment|2|||
44459206|NCT00617279|79467640|FG001|Overall Study|Graft abandonment|0|||
44459207|NCT00617279|79467639|FG000|Overall Study|Lost to Follow-up|1|||
44459208|NCT00617279|79467640|FG001|Overall Study|Lost to Follow-up|0|||
44459209|NCT00617279|79467639|FG000|Overall Study|Death|1|||
44459210|NCT00617279|79467640|FG001|Overall Study|Death|2|||
44459211|NCT00420381|79467646|FG000|Overall Study|Protocol Violation|1|||
44459212|NCT00617201|79467652|FG000|Overall Study|Lost to Follow-up|9|||
44216899|NCT01617655|79014839|FG001|Overall Study|Last visit outside protocol visit window|10|||
44216900|NCT01617655|79014838|FG000|Overall Study|Site closure|3|||
44216901|NCT01617655|79014839|FG001|Overall Study|Site closure|5|||
44216902|NCT01617655|79014838|FG000|Overall Study|Other than specified above|1|||
44216903|NCT01617655|79014839|FG001|Overall Study|Other than specified above|2|||
44216904|NCT01895101|79014850|FG000|Overall Study|OPCAB procedure|1|||
44216905|NCT01895101|79014851|FG001|Overall Study|OPCAB procedure|1|||
44216906|NCT01895101|79014852|FG002|Overall Study|OPCAB procedure|3|||
44216907|NCT01895101|79014850|FG000|Overall Study|Withdrawal by Subject|0|||
44216908|NCT01895101|79014851|FG001|Overall Study|Withdrawal by Subject|1|||
44216909|NCT01895101|79014852|FG002|Overall Study|Withdrawal by Subject|2|||
44216910|NCT01895101|79014850|FG000|Overall Study|another study, enrolled in other study|0|||
44372754|NCT00969228|79377637|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
44372755|NCT00969228|79377638|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
44372756|NCT00969150|79377646|FG000|Overall Study|Adverse Event|4|||
44372757|NCT00969150|79377647|FG001|Overall Study|Adverse Event|14|||
44372758|NCT00969150|79377646|FG000|Overall Study|Lack of Efficacy|1|||
44372759|NCT00969150|79377647|FG001|Overall Study|Lack of Efficacy|1|||
44372760|NCT00969150|79377646|FG000|Overall Study|Protocol Violation|9|||
44372761|NCT00969150|79377647|FG001|Overall Study|Protocol Violation|12|||
44216911|NCT01895101|79014851|FG001|Overall Study|another study, enrolled in other study|1|||
44216912|NCT01895101|79014852|FG002|Overall Study|another study, enrolled in other study|0|||
44216913|NCT01895101|79014850|FG000|Overall Study|Death|0|||
44459213|NCT00617201|79467653|FG001|Overall Study|Lost to Follow-up|13|||
44459214|NCT00420303|79467663|FG000|Overall Study|Serious Adverse Event|1|||
44459215|NCT00420303|79467664|FG001|Overall Study|Serious Adverse Event|0|||
44459216|NCT00420303|79467663|FG000|Overall Study|Lack of Efficacy|0|||
44459217|NCT00420303|79467664|FG001|Overall Study|Lack of Efficacy|3|||
44459218|NCT00420303|79467663|FG000|Overall Study|Physician Decision|0|||
44459219|NCT00420303|79467664|FG001|Overall Study|Physician Decision|1|||
44459220|NCT00617123|79467672|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
44459221|NCT00617123|79467673|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
44459222|NCT00617123|79467672|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
44459223|NCT00617123|79467673|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
44459224|NCT00617123|79467672|FG000|Referral Screening Period|Adverse Event|0|||
44459225|NCT00617123|79467673|FG001|Referral Screening Period|Adverse Event|1|||
44459226|NCT00617123|79467672|FG000|Study Treatment Period|Withdrawal by Subject|8|||
44459227|NCT00617123|79467673|FG001|Study Treatment Period|Withdrawal by Subject|12|||
44459228|NCT00617123|79467672|FG000|Study Treatment Period|Adverse Event|7|||
44459229|NCT00617123|79467673|FG001|Study Treatment Period|Adverse Event|3|||
44459230|NCT00617123|79467672|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
44459231|NCT00617123|79467673|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
44459232|NCT00617123|79467672|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
44459233|NCT00617123|79467673|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
44459234|NCT00419757|79467681|FG000|Overall Study|Adverse Event|1|||
44459235|NCT00419757|79467682|FG001|Overall Study|Adverse Event|4|||
44459236|NCT00419757|79467681|FG000|Overall Study|Lost to Follow-up|1|||
44459237|NCT00419757|79467682|FG001|Overall Study|Lost to Follow-up|4|||
44459238|NCT00419757|79467681|FG000|Overall Study|Withdrawal by Subject|7|||
44459239|NCT00419757|79467682|FG001|Overall Study|Withdrawal by Subject|1|||
44459240|NCT00419757|79467681|FG000|Overall Study|Protocol Violation|2|||
44459241|NCT00419757|79467682|FG001|Overall Study|Protocol Violation|3|||
44459242|NCT00419757|79467681|FG000|Overall Study|Study specific discontinuation criteria|4|||
44459243|NCT00419757|79467682|FG001|Overall Study|Study specific discontinuation criteria|8|||
44459244|NCT00419757|79467681|FG000|Overall Study|Multiple reasons|3|||
44459245|NCT00419757|79467682|FG001|Overall Study|Multiple reasons|1|||
44459246|NCT00434109|79467690|FG000|Overall Study|Physician Decision|9|||
44459247|NCT00434109|79467690|FG000|Overall Study|Adverse Event|5|||
44459248|NCT00434109|79467690|FG000|Overall Study|Protocol Violation|1|||
44459249|NCT00434109|79467690|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
44459250|NCT00433329|79467694|FG000|Overall Study|Adverse Event|9|||
44459251|NCT00433329|79467694|FG000|Overall Study|Death|4|||
44459252|NCT00433329|79467694|FG000|Overall Study|Withdrew consent|3|||
44459253|NCT00433329|79467694|FG000|Overall Study|Discontinued sildenafil|2|||
44459254|NCT00433329|79467694|FG000|Overall Study|Moved out of state|1|||
44459255|NCT00433329|79467694|FG000|Overall Study|Lost to Follow-up|1|||
44459256|NCT00433329|79467694|FG000|Overall Study|Physician Decision|1|||
44459257|NCT00616421|79467701|FG000|Overall Study|Withdrawal by Subject|9|||
44459258|NCT00616421|79467702|FG001|Overall Study|Withdrawal by Subject|11|||
44459259|NCT00616421|79467703|FG002|Overall Study|Withdrawal by Subject|8|||
44459260|NCT00616421|79467701|FG000|Overall Study|Lost to Follow-up|12|||
44459261|NCT00616421|79467702|FG001|Overall Study|Lost to Follow-up|26|||
44459262|NCT00616421|79467703|FG002|Overall Study|Lost to Follow-up|30|||
44459263|NCT00616421|79467701|FG000|Overall Study|Inappropriate enrollment|3|||
44459264|NCT00616421|79467702|FG001|Overall Study|Inappropriate enrollment|0|||
44459265|NCT00616421|79467703|FG002|Overall Study|Inappropriate enrollment|1|||
44459266|NCT00616421|79467701|FG000|Overall Study|Administrative reason|1|||
44459267|NCT00616421|79467702|FG001|Overall Study|Administrative reason|0|||
44459268|NCT00616421|79467703|FG002|Overall Study|Administrative reason|0|||
44459269|NCT00616421|79467701|FG000|Overall Study|Protocol Violation|0|||
44459270|NCT00616421|79467702|FG001|Overall Study|Protocol Violation|1|||
44459271|NCT00616421|79467703|FG002|Overall Study|Protocol Violation|2|||
44459272|NCT00616421|79467701|FG000|Overall Study|Unable to classify|1|||
44459273|NCT00616421|79467702|FG001|Overall Study|Unable to classify|0|||
44459274|NCT00616421|79467703|FG002|Overall Study|Unable to classify|0|||
44459275|NCT00433017|79467727|FG000|Overall Study|Adverse Event|5|||
44459276|NCT00433017|79467728|FG001|Overall Study|Adverse Event|3|||
44459277|NCT00433017|79467727|FG000|Overall Study|Withdrawal by Subject|4|||
44459278|NCT00433017|79467728|FG001|Overall Study|Withdrawal by Subject|5|||
44459279|NCT00433017|79467727|FG000|Overall Study|Lost to Follow-up|3|||
44459280|NCT00433017|79467728|FG001|Overall Study|Lost to Follow-up|4|||
44459281|NCT00433017|79467727|FG000|Overall Study|Administrative problems|80|||
44459282|NCT00433017|79467728|FG001|Overall Study|Administrative problems|86|||
44459283|NCT00433017|79467727|FG000|Overall Study|Protocol Violation|1|||
44459284|NCT00433017|79467728|FG001|Overall Study|Protocol Violation|0|||
44459285|NCT00433017|79467727|FG000|Overall Study|Death|2|||
44459286|NCT00433017|79467728|FG001|Overall Study|Death|2|||
44459287|NCT00433017|79467727|FG000|Overall Study|Subject no longer requires study drug|1|||
44459288|NCT00433017|79467728|FG001|Overall Study|Subject no longer requires study drug|1|||
44459289|NCT00615719|79467760|FG000|Overall Study|Physician Decision|5|||
44459290|NCT00418665|79467767|FG000|Treatment Period|Ineligibility determined|1|||
44459291|NCT00418665|79467768|FG001|Treatment Period|Ineligibility determined|1|||
44459292|NCT00418665|79467769|FG002|Treatment Period|Ineligibility determined|0|||
44216914|NCT01895101|79014851|FG001|Overall Study|Death|1|||
44216915|NCT01895101|79014852|FG002|Overall Study|Death|0|||
44216916|NCT01895101|79014850|FG000|Overall Study|coagulation disorder|0|||
44216917|NCT01895101|79014851|FG001|Overall Study|coagulation disorder|1|||
44216918|NCT01895101|79014852|FG002|Overall Study|coagulation disorder|0|||
44216919|NCT01894477|79014862|FG000|Overall Study|Protocol Violation|0|||
44216920|NCT01894477|79014863|FG001|Overall Study|Protocol Violation|1|||
44216921|NCT01894477|79014862|FG000|Overall Study|protocol changed due SC changed to cord|0|||
44216922|NCT01894477|79014863|FG001|Overall Study|protocol changed due SC changed to cord|1|||
44216923|NCT01894243|79014872|FG000|Overall Study|Adverse Event|0|||
44216924|NCT01894243|79014873|FG001|Overall Study|Adverse Event|1|||
44216925|NCT01894243|79014874|FG002|Overall Study|Adverse Event|2|||
44216926|NCT01894243|79014872|FG000|Overall Study|Death|0|||
44216927|NCT01894243|79014873|FG001|Overall Study|Death|0|||
44216928|NCT01894243|79014874|FG002|Overall Study|Death|3|||
44216929|NCT01894243|79014872|FG000|Overall Study|Lack of Efficacy|3|||
44216930|NCT01894243|79014873|FG001|Overall Study|Lack of Efficacy|3|||
44216931|NCT01894243|79014874|FG002|Overall Study|Lack of Efficacy|1|||
44216932|NCT01894243|79014872|FG000|Overall Study|Condition under investigation worsened|8|||
44216933|NCT01894243|79014873|FG001|Overall Study|Condition under investigation worsened|6|||
44216934|NCT01894243|79014874|FG002|Overall Study|Condition under investigation worsened|2|||
44216935|NCT01894243|79014872|FG000|Overall Study|Subject decision|1|||
44216936|NCT01894243|79014873|FG001|Overall Study|Subject decision|0|||
44216937|NCT01894243|79014874|FG002|Overall Study|Subject decision|0|||
44216938|NCT01894243|79014872|FG000|Overall Study|Other|1|||
44216939|NCT01894243|79014873|FG001|Overall Study|Other|0|||
44216940|NCT01894243|79014874|FG002|Overall Study|Other|0|||
44216941|NCT03822832|79014891|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
44216942|NCT03822832|79014892|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
44216943|NCT03822832|79014891|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
44216944|NCT03822832|79014892|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
44216945|NCT03822832|79014891|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
44216946|NCT03822832|79014892|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
44216947|NCT03822832|79014891|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
44216948|NCT03822832|79014892|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
44216949|NCT03822832|79014891|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
44216950|NCT03822832|79014892|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
44216951|NCT03822832|79014891|FG000|Re-allocation|Not re-allocated to open label period|2|||
44216952|NCT03822832|79014892|FG001|Re-allocation|Not re-allocated to open label period|6|||
44216953|NCT03822832|79014891|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
44216954|NCT03822832|79014892|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
44216955|NCT03822832|79014891|FG000|Period 2 - Open Label Period|Adverse Event|0|||
44216956|NCT03822832|79014892|FG001|Period 2 - Open Label Period|Adverse Event|3|||
44372762|NCT00969150|79377646|FG000|Overall Study|Withdrawal by Subject|13|||
44372763|NCT00969150|79377647|FG001|Overall Study|Withdrawal by Subject|9|||
44372764|NCT00969150|79377646|FG000|Overall Study|Lost to Follow-up|5|||
44372765|NCT00969150|79377647|FG001|Overall Study|Lost to Follow-up|4|||
44372766|NCT00969150|79377646|FG000|Overall Study|Other reasons|1|||
44372767|NCT00969150|79377647|FG001|Overall Study|Other reasons|0|||
44372768|NCT00974220|79377655|FG000|Treatment Period 1|Adverse Event|2|||
44372769|NCT00974220|79377656|FG001|Treatment Period 1|Adverse Event|1|||
44372770|NCT00974220|79377655|FG000|Treatment Period 1|noncompliant subjects|0|||
44372771|NCT00974220|79377656|FG001|Treatment Period 1|noncompliant subjects|1|||
44372772|NCT00971178|79377665|FG000|Overall Study|Lost to Follow-up|2|||
44372773|NCT00971178|79377666|FG001|Overall Study|Lost to Follow-up|2|||
44372774|NCT00971178|79377667|FG002|Overall Study|Lost to Follow-up|2|||
44459293|NCT00418665|79467767|FG000|Treatment Period|Adverse Event|2|||
44216957|NCT01513239|79014902|FG000|Period 1: Main Phase|Adverse Event|1|||
44216958|NCT01513239|79014903|FG001|Period 1: Main Phase|Adverse Event|1|||
44216959|NCT01513239|79014904|FG002|Period 1: Main Phase|Adverse Event|2|||
44216960|NCT01513239|79014905|FG003|Period 1: Main Phase|Adverse Event|0|||
44216961|NCT01513239|79014906|FG004|Period 1: Main Phase|Adverse Event|0|||
44216962|NCT01513239|79014907|FG005|Period 1: Main Phase|Adverse Event|0|||
44216963|NCT01513239|79014902|FG000|Period 1: Main Phase|Death|29|||
44216964|NCT01513239|79014903|FG001|Period 1: Main Phase|Death|22|||
44216965|NCT01513239|79014904|FG002|Period 1: Main Phase|Death|32|||
44216966|NCT01513239|79014905|FG003|Period 1: Main Phase|Death|0|||
44372775|NCT03670602|79377677|FG000|Overall Study|Lost to Follow-up|1|||
44372776|NCT03670602|79377678|FG001|Overall Study|Lost to Follow-up|0|||
44372777|NCT03670602|79377677|FG000|Overall Study|Withdrawal by Subject|0|||
44372778|NCT03670602|79377678|FG001|Overall Study|Withdrawal by Subject|3|||
44459294|NCT00418665|79467768|FG001|Treatment Period|Adverse Event|2|||
44459295|NCT00418665|79467769|FG002|Treatment Period|Adverse Event|0|||
44459296|NCT00418665|79467767|FG000|Treatment Period|Withdrawal by Subject|0|||
44459297|NCT00418665|79467768|FG001|Treatment Period|Withdrawal by Subject|3|||
44459298|NCT00418665|79467769|FG002|Treatment Period|Withdrawal by Subject|1|||
44459299|NCT00418665|79467767|FG000|Treatment Period|Requirement for alternative therapy|1|||
44459300|NCT00418665|79467768|FG001|Treatment Period|Requirement for alternative therapy|0|||
44459301|NCT00418665|79467769|FG002|Treatment Period|Requirement for alternative therapy|0|||
44459302|NCT00418665|79467767|FG000|Treatment Period|Physician Decision|1|||
44459303|NCT00418665|79467768|FG001|Treatment Period|Physician Decision|0|||
44459304|NCT00418665|79467769|FG002|Treatment Period|Physician Decision|3|||
44459305|NCT00418665|79467767|FG000|Treatment Extension|Adverse Event|1|||
44459306|NCT00418665|79467768|FG001|Treatment Extension|Adverse Event|0|||
44459307|NCT00418665|79467769|FG002|Treatment Extension|Adverse Event|0|||
44459308|NCT00418665|79467767|FG000|Treatment Extension|Withdrawal by Subject|1|||
44459309|NCT00418665|79467768|FG001|Treatment Extension|Withdrawal by Subject|0|||
44459310|NCT00418665|79467769|FG002|Treatment Extension|Withdrawal by Subject|0|||
44459311|NCT00418665|79467767|FG000|Treatment Extension|Requirement for alternative therapy|2|||
44459312|NCT00418665|79467768|FG001|Treatment Extension|Requirement for alternative therapy|2|||
44459313|NCT00418665|79467769|FG002|Treatment Extension|Requirement for alternative therapy|0|||
44459314|NCT00418665|79467767|FG000|Treatment Extension|Physician Decision|2|||
44459315|NCT00418665|79467768|FG001|Treatment Extension|Physician Decision|2|||
44459316|NCT00418665|79467769|FG002|Treatment Extension|Physician Decision|1|||
44459317|NCT00418665|79467767|FG000|Treatment Extension|Death|0|||
44459318|NCT00418665|79467768|FG001|Treatment Extension|Death|0|||
44459319|NCT00418665|79467769|FG002|Treatment Extension|Death|1|||
44459320|NCT00432237|79467781|FG000|Overall Study|Adverse Event|0|||
44459321|NCT00432237|79467782|FG001|Overall Study|Adverse Event|0|||
44459322|NCT00432237|79467783|FG002|Overall Study|Adverse Event|0|||
44459323|NCT00432237|79467784|FG003|Overall Study|Adverse Event|1|||
44459324|NCT00432237|79467781|FG000|Overall Study|Lack of Efficacy|0|||
44459325|NCT00432237|79467782|FG001|Overall Study|Lack of Efficacy|0|||
44459326|NCT00432237|79467783|FG002|Overall Study|Lack of Efficacy|0|||
44459327|NCT00432237|79467784|FG003|Overall Study|Lack of Efficacy|1|||
44459328|NCT00432237|79467781|FG000|Overall Study|Lost to Follow-up|10|||
44459329|NCT00432237|79467782|FG001|Overall Study|Lost to Follow-up|10|||
44216967|NCT01513239|79014906|FG004|Period 1: Main Phase|Death|0|||
44459330|NCT00432237|79467783|FG002|Overall Study|Lost to Follow-up|18|||
44459331|NCT00432237|79467784|FG003|Overall Study|Lost to Follow-up|18|||
44459332|NCT00432237|79467781|FG000|Overall Study|Physician Decision|1|||
44459333|NCT00432237|79467782|FG001|Overall Study|Physician Decision|3|||
44459334|NCT00432237|79467783|FG002|Overall Study|Physician Decision|2|||
44459335|NCT00432237|79467784|FG003|Overall Study|Physician Decision|1|||
44459336|NCT00432237|79467781|FG000|Overall Study|Pregnancy|0|||
44459337|NCT00432237|79467782|FG001|Overall Study|Pregnancy|1|||
44459338|NCT00432237|79467783|FG002|Overall Study|Pregnancy|0|||
44459339|NCT00432237|79467784|FG003|Overall Study|Pregnancy|0|||
44459340|NCT00432237|79467781|FG000|Overall Study|Protocol Violation|13|||
44459341|NCT00432237|79467782|FG001|Overall Study|Protocol Violation|10|||
44459342|NCT00432237|79467783|FG002|Overall Study|Protocol Violation|11|||
44459343|NCT00432237|79467784|FG003|Overall Study|Protocol Violation|8|||
44459344|NCT00432237|79467781|FG000|Overall Study|Withdrawal by Subject|5|||
44459345|NCT00432237|79467782|FG001|Overall Study|Withdrawal by Subject|6|||
44459346|NCT00432237|79467783|FG002|Overall Study|Withdrawal by Subject|9|||
44459347|NCT00432237|79467784|FG003|Overall Study|Withdrawal by Subject|11|||
44459348|NCT00432237|79467781|FG000|Overall Study|Lack of Qualifying Event|38|||
44216968|NCT01513239|79014907|FG005|Period 1: Main Phase|Death|0|||
44216969|NCT01513239|79014902|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
44372779|NCT00968526|79377686|FG000|Overall Study|Adverse Event|2|||
44372780|NCT00968526|79377687|FG001|Overall Study|Adverse Event|0|||
44372781|NCT00968526|79377686|FG000|Overall Study|Migrated/moved from study area|1|||
44372782|NCT00968526|79377687|FG001|Overall Study|Migrated/moved from study area|0|||
44372783|NCT03664674|79377704|FG000|Overall Study|Adverse Event|1|||
44372784|NCT03664674|79377705|FG001|Overall Study|Adverse Event|1|||
44372785|NCT03664674|79377704|FG000|Overall Study|Physician Decision|0|||
44372786|NCT03664674|79377705|FG001|Overall Study|Physician Decision|1|||
44372787|NCT03664674|79377704|FG000|Overall Study|Withdrawal by Subject|2|||
44459349|NCT00432237|79467782|FG001|Overall Study|Lack of Qualifying Event|71|||
44459350|NCT00432237|79467783|FG002|Overall Study|Lack of Qualifying Event|69|||
44459351|NCT00432237|79467784|FG003|Overall Study|Lack of Qualifying Event|84|||
44459352|NCT00531284|79467811|FG000|Overall Study|Progressive Disease|1|||
44372788|NCT03664674|79377705|FG001|Overall Study|Withdrawal by Subject|0|||
44459353|NCT00531284|79467812|FG001|Overall Study|Progressive Disease|3|||
44459354|NCT00531284|79467813|FG002|Overall Study|Progressive Disease|5|||
44459355|NCT00531284|79467814|FG003|Overall Study|Progressive Disease|42|||
44459356|NCT00531284|79467815|FG004|Overall Study|Progressive Disease|4|||
44459357|NCT00531284|79467816|FG005|Overall Study|Progressive Disease|4|||
44459358|NCT00531284|79467817|FG006|Overall Study|Progressive Disease|3|||
44459359|NCT00531284|79467818|FG007|Overall Study|Progressive Disease|8|||
44459360|NCT00531284|79467819|FG008|Overall Study|Progressive Disease|6|||
44459361|NCT00531284|79467820|FG009|Overall Study|Progressive Disease|3|||
44459362|NCT00531284|79467821|FG010|Overall Study|Progressive Disease|3|||
44459363|NCT00531284|79467822|FG011|Overall Study|Progressive Disease|14|||
44459364|NCT00531284|79467823|FG012|Overall Study|Progressive Disease|2|||
44459365|NCT00531284|79467824|FG013|Overall Study|Progressive Disease|1|||
44459366|NCT00531284|79467825|FG014|Overall Study|Progressive Disease|2|||
44216970|NCT01513239|79014903|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
44216971|NCT01513239|79014904|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
44216972|NCT01513239|79014905|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
44216973|NCT01513239|79014906|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
44459367|NCT00531284|79467826|FG015|Overall Study|Progressive Disease|11|||
44459368|NCT00531284|79467827|FG016|Overall Study|Progressive Disease|5|||
44459369|NCT00531284|79467811|FG000|Overall Study|Adverse Event|0|||
44459370|NCT00531284|79467812|FG001|Overall Study|Adverse Event|1|||
44459371|NCT00531284|79467813|FG002|Overall Study|Adverse Event|1|||
44459372|NCT00531284|79467814|FG003|Overall Study|Adverse Event|7|||
44459373|NCT00531284|79467815|FG004|Overall Study|Adverse Event|0|||
44459374|NCT00531284|79467816|FG005|Overall Study|Adverse Event|2|||
44459375|NCT00531284|79467817|FG006|Overall Study|Adverse Event|3|||
44459376|NCT00531284|79467818|FG007|Overall Study|Adverse Event|2|||
44459377|NCT00531284|79467819|FG008|Overall Study|Adverse Event|3|||
44216974|NCT01513239|79014907|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
44216975|NCT01513239|79014902|FG000|Period 1: Main Phase|Physician Decision|4|||
44459378|NCT00531284|79467820|FG009|Overall Study|Adverse Event|0|||
44459379|NCT00531284|79467821|FG010|Overall Study|Adverse Event|0|||
44459380|NCT00531284|79467822|FG011|Overall Study|Adverse Event|5|||
44459381|NCT00531284|79467823|FG012|Overall Study|Adverse Event|0|||
44459382|NCT00531284|79467824|FG013|Overall Study|Adverse Event|1|||
44459383|NCT00531284|79467825|FG014|Overall Study|Adverse Event|1|||
44459384|NCT00531284|79467826|FG015|Overall Study|Adverse Event|0|||
44459385|NCT00531284|79467827|FG016|Overall Study|Adverse Event|2|||
44459386|NCT00531284|79467811|FG000|Overall Study|Withdrawal by Subject|1|||
44459387|NCT00531284|79467812|FG001|Overall Study|Withdrawal by Subject|0|||
44459388|NCT00531284|79467813|FG002|Overall Study|Withdrawal by Subject|0|||
44459389|NCT00531284|79467814|FG003|Overall Study|Withdrawal by Subject|4|||
44459390|NCT00531284|79467815|FG004|Overall Study|Withdrawal by Subject|0|||
44459391|NCT00531284|79467816|FG005|Overall Study|Withdrawal by Subject|0|||
44459392|NCT00531284|79467817|FG006|Overall Study|Withdrawal by Subject|0|||
44216976|NCT01513239|79014903|FG001|Period 1: Main Phase|Physician Decision|4|||
44216977|NCT01513239|79014904|FG002|Period 1: Main Phase|Physician Decision|4|||
44216978|NCT01513239|79014905|FG003|Period 1: Main Phase|Physician Decision|0|||
44216979|NCT01513239|79014906|FG004|Period 1: Main Phase|Physician Decision|0|||
44216980|NCT01513239|79014907|FG005|Period 1: Main Phase|Physician Decision|0|||
44459393|NCT00531284|79467818|FG007|Overall Study|Withdrawal by Subject|0|||
44459394|NCT00531284|79467819|FG008|Overall Study|Withdrawal by Subject|0|||
44459395|NCT00531284|79467820|FG009|Overall Study|Withdrawal by Subject|0|||
44459396|NCT00531284|79467821|FG010|Overall Study|Withdrawal by Subject|0|||
44459397|NCT00531284|79467822|FG011|Overall Study|Withdrawal by Subject|3|||
44459398|NCT00531284|79467823|FG012|Overall Study|Withdrawal by Subject|0|||
44459399|NCT00531284|79467824|FG013|Overall Study|Withdrawal by Subject|1|||
44459400|NCT00531284|79467825|FG014|Overall Study|Withdrawal by Subject|0|||
44459401|NCT00531284|79467826|FG015|Overall Study|Withdrawal by Subject|1|||
44459402|NCT00531284|79467827|FG016|Overall Study|Withdrawal by Subject|1|||
44459403|NCT00531284|79467811|FG000|Overall Study|Other|1|||
44216981|NCT01513239|79014902|FG000|Period 1: Main Phase|Protocol Violation|2|||
44216982|NCT01513239|79014903|FG001|Period 1: Main Phase|Protocol Violation|2|||
44216983|NCT01513239|79014904|FG002|Period 1: Main Phase|Protocol Violation|2|||
44216984|NCT01513239|79014905|FG003|Period 1: Main Phase|Protocol Violation|0|||
44216985|NCT01513239|79014906|FG004|Period 1: Main Phase|Protocol Violation|0|||
44216986|NCT01513239|79014907|FG005|Period 1: Main Phase|Protocol Violation|0|||
44216987|NCT01513239|79014902|FG000|Period 1: Main Phase|Technical Problems|1|||
44544063|NCT03736967|79557254|FG002|Overall Study|Death|0|||
44544064|NCT03736967|79557255|FG003|Overall Study|Death|1|||
44216988|NCT01513239|79014903|FG001|Period 1: Main Phase|Technical Problems|2|||
44216989|NCT01513239|79014904|FG002|Period 1: Main Phase|Technical Problems|0|||
44216990|NCT01513239|79014905|FG003|Period 1: Main Phase|Technical Problems|0|||
44216991|NCT01513239|79014906|FG004|Period 1: Main Phase|Technical Problems|0|||
44270208|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44459404|NCT00531284|79467812|FG001|Overall Study|Other|0|||
44459405|NCT00531284|79467813|FG002|Overall Study|Other|0|||
44459406|NCT00531284|79467814|FG003|Overall Study|Other|10|||
44459407|NCT00531284|79467815|FG004|Overall Study|Other|2|||
44459408|NCT00531284|79467816|FG005|Overall Study|Other|1|||
44459409|NCT00531284|79467817|FG006|Overall Study|Other|0|||
44459410|NCT00531284|79467818|FG007|Overall Study|Other|0|||
44459411|NCT00531284|79467819|FG008|Overall Study|Other|2|||
44459412|NCT00531284|79467820|FG009|Overall Study|Other|1|||
44544065|NCT03736967|79557252|FG000|Overall Study|Randomized but never treated|1|||
44459413|NCT00531284|79467821|FG010|Overall Study|Other|0|||
44459414|NCT00531284|79467822|FG011|Overall Study|Other|2|||
44459415|NCT00531284|79467823|FG012|Overall Study|Other|0|||
44459416|NCT00531284|79467824|FG013|Overall Study|Other|0|||
44459417|NCT00531284|79467825|FG014|Overall Study|Other|1|||
44459418|NCT00531284|79467826|FG015|Overall Study|Other|0|||
44459419|NCT00531284|79467827|FG016|Overall Study|Other|0|||
44459420|NCT00531206|79467883|FG000|Overall Study|Adverse Event related|5|||
44459421|NCT00531206|79467883|FG000|Overall Study|Lack of Efficacy|2|||
44459422|NCT00531206|79467883|FG000|Overall Study|Lost to Follow-up|5|||
44459423|NCT00531206|79467883|FG000|Overall Study|including non-related adverse events|8|||
44459424|NCT00530816|79467890|FG000|Overall Study|Progressive Disease|16|||
44459425|NCT00530816|79467891|FG001|Overall Study|Progressive Disease|24|||
44459426|NCT00530816|79467892|FG002|Overall Study|Progressive Disease|24|||
44459427|NCT00530816|79467890|FG000|Overall Study|Adverse Event|6|||
44459428|NCT00530816|79467891|FG001|Overall Study|Adverse Event|13|||
44459429|NCT00530816|79467892|FG002|Overall Study|Adverse Event|7|||
44459430|NCT00530816|79467890|FG000|Overall Study|Other|3|||
44459431|NCT00530816|79467891|FG001|Overall Study|Other|3|||
44459432|NCT00530816|79467892|FG002|Overall Study|Other|4|||
44459433|NCT00530816|79467890|FG000|Overall Study|Withdrawal by Subject|1|||
44459434|NCT00530816|79467891|FG001|Overall Study|Withdrawal by Subject|2|||
44459435|NCT00530816|79467892|FG002|Overall Study|Withdrawal by Subject|6|||
44459436|NCT00615017|79467906|FG000|Overall Study|Adverse Event|0|||
44216992|NCT01513239|79014907|FG005|Period 1: Main Phase|Technical Problems|0|||
44216993|NCT01513239|79014902|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
44216994|NCT01513239|79014903|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
44372789|NCT00967668|79377716|FG000|Overall Study|Withdrawal by Subject|13|||
44372790|NCT00967668|79377717|FG001|Overall Study|Withdrawal by Subject|8|||
44372791|NCT00967668|79377718|FG002|Overall Study|Withdrawal by Subject|8|||
44372792|NCT00967668|79377716|FG000|Overall Study|Death|0|||
44372793|NCT00967668|79377717|FG001|Overall Study|Death|2|||
44372794|NCT00967668|79377718|FG002|Overall Study|Death|4|||
44372795|NCT00967668|79377716|FG000|Overall Study|Removed due to behavior|1|||
44372796|NCT00967668|79377717|FG001|Overall Study|Removed due to behavior|1|||
44372797|NCT00967668|79377718|FG002|Overall Study|Removed due to behavior|2|||
44372798|NCT00967668|79377716|FG000|Overall Study|Refused Year 2|11|||
44372799|NCT00967668|79377717|FG001|Overall Study|Refused Year 2|6|||
44372800|NCT00967668|79377718|FG002|Overall Study|Refused Year 2|4|||
44372801|NCT00967668|79377716|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
44372802|NCT00967668|79377717|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
44372803|NCT00967668|79377718|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
44372804|NCT00967668|79377716|FG000|Overall Study|Lost to Follow-up|15|||
44372805|NCT00967668|79377717|FG001|Overall Study|Lost to Follow-up|9|||
44372806|NCT00967668|79377718|FG002|Overall Study|Lost to Follow-up|16|||
44372807|NCT00967668|79377716|FG000|Overall Study|Refused 12-mo assessment|3|||
44372808|NCT00967668|79377717|FG001|Overall Study|Refused 12-mo assessment|1|||
44372809|NCT00967668|79377718|FG002|Overall Study|Refused 12-mo assessment|9|||
44372810|NCT00967668|79377716|FG000|Overall Study|Pregnancy|1|||
44372811|NCT00967668|79377717|FG001|Overall Study|Pregnancy|0|||
44372812|NCT00967668|79377718|FG002|Overall Study|Pregnancy|0|||
44372813|NCT00970944|79377731|FG000|Overall Study|Death|1|||
44372814|NCT00970944|79377732|FG001|Overall Study|Death|0|||
44372815|NCT00970944|79377731|FG000|Overall Study|Physician Decision|0|||
44372816|NCT00970944|79377732|FG001|Overall Study|Physician Decision|2|||
44372817|NCT04892147|79377741|FG000|Overall Study|Withdrawal by Subject|2|||
44372818|NCT04892147|79377742|FG001|Overall Study|Withdrawal by Subject|0|||
44372819|NCT04839289|79377751|FG000|Overall Study|Withdrawal by Subject|1|||
44372820|NCT04839289|79377752|FG001|Overall Study|Withdrawal by Subject|0|||
44459437|NCT00615017|79467907|FG001|Overall Study|Adverse Event|1|||
44216995|NCT01513239|79014904|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
44459438|NCT00615017|79467908|FG002|Overall Study|Adverse Event|2|||
44459439|NCT00615017|79467909|FG003|Overall Study|Adverse Event|0|||
44216996|NCT01513239|79014905|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
44216997|NCT01513239|79014906|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
44372821|NCT04544865|79377760|FG000|Overall Study|Death|0|||
44372822|NCT04544865|79377761|FG001|Overall Study|Death|2|||
44372823|NCT04544865|79377760|FG000|Overall Study|Lost to Follow-up|11|||
44459440|NCT00615017|79467910|FG004|Overall Study|Adverse Event|0|||
44459441|NCT00615017|79467911|FG005|Overall Study|Adverse Event|1|||
44372824|NCT04544865|79377761|FG001|Overall Study|Lost to Follow-up|7|||
44459442|NCT00615017|79467906|FG000|Overall Study|Death|0|||
44459443|NCT00615017|79467907|FG001|Overall Study|Death|0|||
44459444|NCT00615017|79467908|FG002|Overall Study|Death|2|||
44459445|NCT00615017|79467909|FG003|Overall Study|Death|0|||
44459446|NCT00615017|79467910|FG004|Overall Study|Death|1|||
44459447|NCT00615017|79467911|FG005|Overall Study|Death|1|||
44459448|NCT00615017|79467906|FG000|Overall Study|Sepsis resolved|0|||
44459449|NCT00615017|79467907|FG001|Overall Study|Sepsis resolved|0|||
44216998|NCT01513239|79014907|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
44216999|NCT01513239|79014902|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
44217000|NCT01513239|79014903|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
44217001|NCT01513239|79014904|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
44217002|NCT01513239|79014905|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
44217003|NCT01513239|79014906|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
44217004|NCT01513239|79014907|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
44459450|NCT00615017|79467908|FG002|Overall Study|Sepsis resolved|1|||
44459451|NCT00615017|79467909|FG003|Overall Study|Sepsis resolved|0|||
44459452|NCT00615017|79467910|FG004|Overall Study|Sepsis resolved|0|||
44459453|NCT00615017|79467911|FG005|Overall Study|Sepsis resolved|0|||
44459454|NCT00615017|79467906|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
44459455|NCT00615017|79467907|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
44459456|NCT00615017|79467908|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
44459457|NCT00615017|79467909|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
44459458|NCT00615017|79467910|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
44459459|NCT00615017|79467911|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
44459460|NCT00615017|79467906|FG000|Overall Study|Physician discontinued drug|0|||
44459461|NCT00615017|79467907|FG001|Overall Study|Physician discontinued drug|0|||
44459462|NCT00615017|79467908|FG002|Overall Study|Physician discontinued drug|0|||
44459463|NCT00615017|79467909|FG003|Overall Study|Physician discontinued drug|0|||
44459464|NCT00615017|79467910|FG004|Overall Study|Physician discontinued drug|0|||
44459465|NCT00615017|79467911|FG005|Overall Study|Physician discontinued drug|1|||
44270209|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44270210|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44372825|NCT04544865|79377760|FG000|Overall Study|Withdrawal by Subject|0|||
44372826|NCT04544865|79377761|FG001|Overall Study|Withdrawal by Subject|1|||
44372827|NCT04544865|79377760|FG000|Overall Study|Other|0|||
44372828|NCT04544865|79377761|FG001|Overall Study|Other|1|||
44372829|NCT04440813|79377770|FG000|Overall Study|Lost to Follow-up|5|||
44372830|NCT04440813|79377771|FG001|Overall Study|Lost to Follow-up|5|||
44372831|NCT04233073|79377785|FG000|Overall Study|Death|5|||
44372832|NCT04120116|79377793|FG000|Overall Study|Lost to Follow-up|0|||
44372833|NCT04120116|79377794|FG001|Overall Study|Lost to Follow-up|1|||
44372834|NCT04120116|79377795|FG002|Overall Study|Lost to Follow-up|0|||
44372835|NCT04120116|79377796|FG003|Overall Study|Lost to Follow-up|2|||
44372836|NCT04120116|79377793|FG000|Overall Study|Withdrawal by Subject|1|||
44372837|NCT04120116|79377794|FG001|Overall Study|Withdrawal by Subject|0|||
44372838|NCT04120116|79377795|FG002|Overall Study|Withdrawal by Subject|1|||
44372839|NCT04120116|79377796|FG003|Overall Study|Withdrawal by Subject|1|||
44372840|NCT04120116|79377793|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
44372841|NCT04120116|79377794|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
44372842|NCT04120116|79377795|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
44372843|NCT04120116|79377796|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
44372844|NCT03657810|79377819|FG000|Overall Study|Adverse Event|0|||
44372845|NCT03657810|79377820|FG001|Overall Study|Adverse Event|1|||
44372846|NCT03657810|79377821|FG002|Overall Study|Adverse Event|0|||
44372847|NCT03657810|79377819|FG000|Overall Study|Lack of Efficacy|4|||
44372848|NCT03657810|79377820|FG001|Overall Study|Lack of Efficacy|1|||
44372849|NCT03657810|79377821|FG002|Overall Study|Lack of Efficacy|3|||
44372850|NCT03657810|79377819|FG000|Overall Study|Protocol Violation|1|||
44372851|NCT03657810|79377820|FG001|Overall Study|Protocol Violation|0|||
44372852|NCT03657810|79377821|FG002|Overall Study|Protocol Violation|0|||
44372853|NCT03657810|79377819|FG000|Overall Study|Lost to Follow-up|0|||
44372854|NCT03657810|79377820|FG001|Overall Study|Lost to Follow-up|1|||
44372855|NCT03657810|79377821|FG002|Overall Study|Lost to Follow-up|0|||
44372856|NCT03657810|79377819|FG000|Overall Study|Not provided|0|||
44372857|NCT03657810|79377820|FG001|Overall Study|Not provided|1|||
44372858|NCT03657810|79377821|FG002|Overall Study|Not provided|0|||
44372859|NCT03370341|79377843|FG000|Overall Study|Lost to Follow-up|0|||
44459466|NCT00614939|79467927|FG000|Overall Study|Withdrawal by Subject|10|||
44372860|NCT03370341|79377844|FG001|Overall Study|Lost to Follow-up|1|||
44459467|NCT00614939|79467928|FG001|Overall Study|Withdrawal by Subject|17|||
44459468|NCT00614939|79467927|FG000|Overall Study|Study specific discontinuation criteris|13|||
44459469|NCT00614939|79467928|FG001|Overall Study|Study specific discontinuation criteris|16|||
44372861|NCT02544074|79377913|FG000|Overall Study|Withdrawal by Subject|0|||
44372862|NCT02544074|79377914|FG001|Overall Study|Withdrawal by Subject|1|||
44459470|NCT00614939|79467927|FG000|Overall Study|Adverse Event|2|||
44459471|NCT00614939|79467928|FG001|Overall Study|Adverse Event|5|||
44459472|NCT00614939|79467927|FG000|Overall Study|Incorrect enrollment|1|||
44459473|NCT00614939|79467928|FG001|Overall Study|Incorrect enrollment|2|||
44459474|NCT00614939|79467927|FG000|Overall Study|Death|4|||
44459475|NCT00614939|79467928|FG001|Overall Study|Death|3|||
44459476|NCT00614939|79467927|FG000|Overall Study|Poor/non-compliance|4|||
44459477|NCT00614939|79467928|FG001|Overall Study|Poor/non-compliance|0|||
44459478|NCT00614939|79467927|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
44459479|NCT00614939|79467928|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
44459480|NCT00530504|79467934|FG000|Overall Study|Death|54|||
44459481|NCT00530504|79467934|FG000|Overall Study|Lost to Follow-up|26|||
44459482|NCT00530504|79467934|FG000|Overall Study|Withdrawal by Subject|39|||
44459483|NCT00530504|79467934|FG000|Overall Study|Exited study due to other reasons|33|||
44459484|NCT04720664|79467964|FG000|Overall Study|Adverse Event|2|||
44459485|NCT04720664|79467964|FG000|Overall Study|Lack of Efficacy|9|||
44459486|NCT04371198|79467977|FG000|Overall Study|inadequate sample|4|||
44459487|NCT04288154|79467983|FG000|Overall Study|Withdrawal by Subject|9|||
44459488|NCT04288154|79467984|FG001|Overall Study|Withdrawal by Subject|9|||
44459489|NCT04258579|79467990|FG000|Overall Study|Withdrawal by Subject|7|||
44459490|NCT04258579|79467990|FG000|Overall Study|Lost to Follow-up|3|||
44459491|NCT04258579|79467990|FG000|Overall Study|Protocol Violation|2|||
44459492|NCT04258579|79467990|FG000|Overall Study|Adverse Event|1|||
44459493|NCT03945214|79467998|FG000|Overall Study|Lost to Follow-up|3|||
44459494|NCT03945214|79467999|FG001|Overall Study|Lost to Follow-up|4|||
44459495|NCT03945214|79468000|FG002|Overall Study|Lost to Follow-up|7|||
44459496|NCT03945214|79468001|FG003|Overall Study|Lost to Follow-up|4|||
44459497|NCT03829683|79468013|FG000|Overall Study|Lost to Follow-up|1|||
44459498|NCT03829683|79468014|FG001|Overall Study|Lost to Follow-up|0|||
44459499|NCT03829683|79468013|FG000|Overall Study|Physician Decision|3|||
44459500|NCT03829683|79468014|FG001|Overall Study|Physician Decision|1|||
44459501|NCT03829683|79468013|FG000|Overall Study|Withdrawal by Subject|0|||
44459502|NCT03829683|79468014|FG001|Overall Study|Withdrawal by Subject|1|||
44459503|NCT03829683|79468013|FG000|Overall Study|Discharge from hospital|1|||
44459504|NCT03829683|79468014|FG001|Overall Study|Discharge from hospital|0|||
44459505|NCT03810456|79468023|FG000|Treatment|Urgent Family Matters|3|||
44459506|NCT03810456|79468024|FG001|Treatment|Urgent Family Matters|0|||
44459507|NCT03810456|79468025|FG002|Treatment|Urgent Family Matters|0|||
44459508|NCT03810456|79468023|FG000|Treatment|Scheduling Conflicts|0|||
44459509|NCT03810456|79468024|FG001|Treatment|Scheduling Conflicts|11|||
44459510|NCT03810456|79468025|FG002|Treatment|Scheduling Conflicts|0|||
44459511|NCT03810456|79468023|FG000|Treatment|No Longer Interested|0|||
44459512|NCT03810456|79468024|FG001|Treatment|No Longer Interested|12|||
44459513|NCT03810456|79468025|FG002|Treatment|No Longer Interested|0|||
44459514|NCT03810456|79468023|FG000|Treatment|Transportation Issues|0|||
44459515|NCT03810456|79468024|FG001|Treatment|Transportation Issues|1|||
44459516|NCT03810456|79468025|FG002|Treatment|Transportation Issues|0|||
44459517|NCT03810456|79468023|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
44459518|NCT03810456|79468024|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
44459519|NCT03810456|79468025|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
44459520|NCT03810456|79468023|FG000|1 Month Follow-Up|Relocated to Different State|1|||
44459521|NCT03810456|79468024|FG001|1 Month Follow-Up|Relocated to Different State|0|||
44459522|NCT03810456|79468025|FG002|1 Month Follow-Up|Relocated to Different State|1|||
44459523|NCT03810456|79468023|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
44459524|NCT03810456|79468024|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
44459525|NCT03810456|79468025|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
44459526|NCT03810456|79468023|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
44459527|NCT03810456|79468024|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
44459528|NCT03810456|79468025|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
44459529|NCT03810456|79468023|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
44459530|NCT03810456|79468024|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
44459531|NCT03810456|79468025|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
44459532|NCT03810456|79468023|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
44459533|NCT03810456|79468024|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
44459534|NCT03810456|79468025|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
44459535|NCT03810456|79468023|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
44459536|NCT03810456|79468024|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
44217005|NCT01513239|79014902|FG000|Period 2: 9 Month Extension Phase|Death|0|||
44217006|NCT01513239|79014903|FG001|Period 2: 9 Month Extension Phase|Death|0|||
44459537|NCT03810456|79468025|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
44459538|NCT03450057|79468037|FG000|Overall Study|Death|17|||
44459539|NCT03450057|79468037|FG000|Overall Study|ICF withdrawal|4|||
44459540|NCT03450057|79468037|FG000|Overall Study|Lost to Follow-up|2|||
44459541|NCT03353415|79468050|FG000|Masked CGM Wear|Lost to Follow-up|2|||
44459542|NCT03353415|79468050|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
44459543|NCT02658890|79468092|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459544|NCT02658890|79468093|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459545|NCT02658890|79468094|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459546|NCT02658890|79468095|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459547|NCT02658890|79468096|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459548|NCT02658890|79468097|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459549|NCT02658890|79468098|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459550|NCT02658890|79468099|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459551|NCT02658890|79468100|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
44459552|NCT02658890|79468101|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459553|NCT02658890|79468102|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459554|NCT02658890|79468103|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459555|NCT02658890|79468104|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459556|NCT02658890|79468105|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459557|NCT02658890|79468106|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459558|NCT02658890|79468107|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459559|NCT02658890|79468108|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459560|NCT02658890|79468109|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459561|NCT02658890|79468110|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459562|NCT02658890|79468111|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459563|NCT02658890|79468112|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459564|NCT02658890|79468113|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459565|NCT02658890|79468114|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459566|NCT02658890|79468115|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459567|NCT02658890|79468116|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459568|NCT02658890|79468117|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44217007|NCT01513239|79014904|FG002|Period 2: 9 Month Extension Phase|Death|0|||
44459569|NCT02658890|79468118|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459570|NCT02658890|79468092|FG000|Treatment Phase|Adverse Event|0|||
44459571|NCT02658890|79468093|FG001|Treatment Phase|Adverse Event|1|||
44459572|NCT02658890|79468094|FG002|Treatment Phase|Adverse Event|2|||
44459573|NCT02658890|79468095|FG003|Treatment Phase|Adverse Event|2|||
44459574|NCT02658890|79468096|FG004|Treatment Phase|Adverse Event|1|||
44459575|NCT02658890|79468097|FG005|Treatment Phase|Adverse Event|0|||
44459576|NCT02658890|79468098|FG006|Treatment Phase|Adverse Event|0|||
44459577|NCT02658890|79468099|FG007|Treatment Phase|Adverse Event|2|||
44459578|NCT02658890|79468100|FG008|Treatment Phase|Adverse Event|1|||
44459579|NCT02658890|79468101|FG009|Treatment Phase|Adverse Event|2|||
44459580|NCT02658890|79468102|FG010|Treatment Phase|Adverse Event|3|||
44459581|NCT02658890|79468103|FG011|Treatment Phase|Adverse Event|0|||
44459582|NCT02658890|79468104|FG012|Treatment Phase|Adverse Event|1|||
44459583|NCT02658890|79468105|FG013|Treatment Phase|Adverse Event|4|||
44459584|NCT02658890|79468106|FG014|Treatment Phase|Adverse Event|0|||
44459585|NCT02658890|79468107|FG015|Treatment Phase|Adverse Event|0|||
44459586|NCT02658890|79468108|FG016|Treatment Phase|Adverse Event|0|||
44459587|NCT02658890|79468109|FG017|Treatment Phase|Adverse Event|0|||
44459588|NCT02658890|79468110|FG018|Treatment Phase|Adverse Event|5|||
44459589|NCT02658890|79468111|FG019|Treatment Phase|Adverse Event|1|||
44459590|NCT02658890|79468112|FG020|Treatment Phase|Adverse Event|3|||
44459591|NCT02658890|79468113|FG021|Treatment Phase|Adverse Event|0|||
44459592|NCT02658890|79468114|FG022|Treatment Phase|Adverse Event|5|||
44459593|NCT02658890|79468115|FG023|Treatment Phase|Adverse Event|0|||
44459594|NCT02658890|79468116|FG024|Treatment Phase|Adverse Event|0|||
44459595|NCT02658890|79468117|FG025|Treatment Phase|Adverse Event|2|||
44459596|NCT02658890|79468118|FG026|Treatment Phase|Adverse Event|1|||
44459597|NCT02658890|79468092|FG000|Treatment Phase|Death|0|||
44459598|NCT02658890|79468093|FG001|Treatment Phase|Death|0|||
44459599|NCT02658890|79468094|FG002|Treatment Phase|Death|0|||
44459600|NCT02658890|79468095|FG003|Treatment Phase|Death|0|||
44459601|NCT02658890|79468096|FG004|Treatment Phase|Death|0|||
44459602|NCT02658890|79468097|FG005|Treatment Phase|Death|0|||
44459603|NCT02658890|79468098|FG006|Treatment Phase|Death|0|||
44459604|NCT02658890|79468099|FG007|Treatment Phase|Death|0|||
44459605|NCT02658890|79468100|FG008|Treatment Phase|Death|0|||
44270211|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44270212|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
44459606|NCT02658890|79468101|FG009|Treatment Phase|Death|0|||
44459607|NCT02658890|79468102|FG010|Treatment Phase|Death|0|||
44459608|NCT02658890|79468103|FG011|Treatment Phase|Death|0|||
44372863|NCT02544074|79377915|FG002|Overall Study|Withdrawal by Subject|0|||
44372864|NCT02544074|79377916|FG003|Overall Study|Withdrawal by Subject|0|||
44372865|NCT02544074|79377917|FG004|Overall Study|Withdrawal by Subject|0|||
44372866|NCT02544074|79377918|FG005|Overall Study|Withdrawal by Subject|0|||
44372867|NCT02544074|79377919|FG006|Overall Study|Withdrawal by Subject|0|||
44372868|NCT02544074|79377920|FG007|Overall Study|Withdrawal by Subject|0|||
44372869|NCT02544074|79377921|FG008|Overall Study|Withdrawal by Subject|0|||
44372870|NCT02544074|79377922|FG009|Overall Study|Withdrawal by Subject|0|||
44459609|NCT02658890|79468104|FG012|Treatment Phase|Death|0|||
44459610|NCT02658890|79468105|FG013|Treatment Phase|Death|0|||
44459611|NCT02658890|79468106|FG014|Treatment Phase|Death|0|||
44459612|NCT02658890|79468107|FG015|Treatment Phase|Death|0|||
44459613|NCT02658890|79468108|FG016|Treatment Phase|Death|0|||
44372871|NCT02544074|79377923|FG010|Overall Study|Withdrawal by Subject|0|||
44459614|NCT02658890|79468109|FG017|Treatment Phase|Death|0|||
44459615|NCT02658890|79468110|FG018|Treatment Phase|Death|1|||
44372872|NCT02544074|79377924|FG011|Overall Study|Withdrawal by Subject|0|||
44459616|NCT02658890|79468111|FG019|Treatment Phase|Death|0|||
44459617|NCT02658890|79468112|FG020|Treatment Phase|Death|0|||
44459618|NCT02658890|79468113|FG021|Treatment Phase|Death|0|||
44459619|NCT02658890|79468114|FG022|Treatment Phase|Death|0|||
44459620|NCT02658890|79468115|FG023|Treatment Phase|Death|0|||
44459621|NCT02658890|79468116|FG024|Treatment Phase|Death|0|||
44459622|NCT02658890|79468117|FG025|Treatment Phase|Death|0|||
44459623|NCT02658890|79468118|FG026|Treatment Phase|Death|0|||
44459624|NCT02658890|79468092|FG000|Treatment Phase|Lost to Follow-up|0|||
44459625|NCT02658890|79468093|FG001|Treatment Phase|Lost to Follow-up|0|||
44459626|NCT02658890|79468094|FG002|Treatment Phase|Lost to Follow-up|0|||
44459627|NCT02658890|79468095|FG003|Treatment Phase|Lost to Follow-up|0|||
44459628|NCT02658890|79468096|FG004|Treatment Phase|Lost to Follow-up|0|||
44459629|NCT02658890|79468097|FG005|Treatment Phase|Lost to Follow-up|0|||
44372873|NCT02544074|79377925|FG012|Overall Study|Withdrawal by Subject|0|||
44372874|NCT02544074|79377926|FG013|Overall Study|Withdrawal by Subject|0|||
44372875|NCT02544074|79377927|FG014|Overall Study|Withdrawal by Subject|0|||
44372876|NCT02544074|79377928|FG015|Overall Study|Withdrawal by Subject|0|||
44372877|NCT02544074|79377929|FG016|Overall Study|Withdrawal by Subject|0|||
44372878|NCT02544074|79377930|FG017|Overall Study|Withdrawal by Subject|0|||
44372879|NCT02544074|79377931|FG018|Overall Study|Withdrawal by Subject|0|||
44372880|NCT02544074|79377932|FG019|Overall Study|Withdrawal by Subject|0|||
44372881|NCT02544074|79377933|FG020|Overall Study|Withdrawal by Subject|0|||
44372882|NCT02544074|79377913|FG000|Overall Study|Tablet error|0|||
44372883|NCT02544074|79377914|FG001|Overall Study|Tablet error|0|||
44372884|NCT02544074|79377915|FG002|Overall Study|Tablet error|0|||
44372885|NCT02544074|79377916|FG003|Overall Study|Tablet error|0|||
44372886|NCT02544074|79377917|FG004|Overall Study|Tablet error|0|||
44372887|NCT02544074|79377918|FG005|Overall Study|Tablet error|1|||
44372888|NCT02544074|79377919|FG006|Overall Study|Tablet error|0|||
44372889|NCT02544074|79377920|FG007|Overall Study|Tablet error|0|||
44372890|NCT02544074|79377921|FG008|Overall Study|Tablet error|0|||
44372891|NCT02544074|79377922|FG009|Overall Study|Tablet error|1|||
44372892|NCT02544074|79377923|FG010|Overall Study|Tablet error|0|||
44372893|NCT02544074|79377924|FG011|Overall Study|Tablet error|0|||
44372894|NCT02544074|79377925|FG012|Overall Study|Tablet error|0|||
44372895|NCT02544074|79377926|FG013|Overall Study|Tablet error|0|||
44372896|NCT02544074|79377927|FG014|Overall Study|Tablet error|0|||
44372897|NCT02544074|79377928|FG015|Overall Study|Tablet error|0|||
44372898|NCT02544074|79377929|FG016|Overall Study|Tablet error|0|||
44372899|NCT02544074|79377930|FG017|Overall Study|Tablet error|0|||
44372900|NCT02544074|79377931|FG018|Overall Study|Tablet error|0|||
44372901|NCT02544074|79377932|FG019|Overall Study|Tablet error|0|||
44372902|NCT02544074|79377933|FG020|Overall Study|Tablet error|0|||
44372903|NCT02502799|79377971|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
44372904|NCT02502799|79377972|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
44372905|NCT02502799|79377973|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
44372906|NCT02502799|79377974|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
44372907|NCT02502799|79377971|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
44459630|NCT02658890|79468098|FG006|Treatment Phase|Lost to Follow-up|1|||
44372908|NCT02502799|79377972|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
44372909|NCT02502799|79377973|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
44459631|NCT02658890|79468099|FG007|Treatment Phase|Lost to Follow-up|0|||
44217008|NCT01513239|79014905|FG003|Period 2: 9 Month Extension Phase|Death|2|||
44217009|NCT01513239|79014906|FG004|Period 2: 9 Month Extension Phase|Death|5|||
44459632|NCT02658890|79468100|FG008|Treatment Phase|Lost to Follow-up|0|||
44459633|NCT02658890|79468101|FG009|Treatment Phase|Lost to Follow-up|0|||
44459634|NCT02658890|79468102|FG010|Treatment Phase|Lost to Follow-up|0|||
44459635|NCT02658890|79468103|FG011|Treatment Phase|Lost to Follow-up|0|||
44459636|NCT02658890|79468104|FG012|Treatment Phase|Lost to Follow-up|0|||
44459637|NCT02658890|79468105|FG013|Treatment Phase|Lost to Follow-up|0|||
44459638|NCT02658890|79468106|FG014|Treatment Phase|Lost to Follow-up|0|||
44459639|NCT02658890|79468107|FG015|Treatment Phase|Lost to Follow-up|0|||
44459640|NCT02658890|79468108|FG016|Treatment Phase|Lost to Follow-up|0|||
44459641|NCT02658890|79468109|FG017|Treatment Phase|Lost to Follow-up|0|||
44459642|NCT02658890|79468110|FG018|Treatment Phase|Lost to Follow-up|0|||
44459643|NCT02658890|79468111|FG019|Treatment Phase|Lost to Follow-up|0|||
44459644|NCT02658890|79468112|FG020|Treatment Phase|Lost to Follow-up|0|||
44459645|NCT02658890|79468113|FG021|Treatment Phase|Lost to Follow-up|0|||
44459646|NCT02658890|79468114|FG022|Treatment Phase|Lost to Follow-up|0|||
44459647|NCT02658890|79468115|FG023|Treatment Phase|Lost to Follow-up|0|||
44459648|NCT02658890|79468116|FG024|Treatment Phase|Lost to Follow-up|0|||
44459649|NCT02658890|79468117|FG025|Treatment Phase|Lost to Follow-up|0|||
44459650|NCT02658890|79468118|FG026|Treatment Phase|Lost to Follow-up|0|||
44459651|NCT02658890|79468092|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
44459652|NCT02658890|79468093|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
44459653|NCT02658890|79468094|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
44459654|NCT02658890|79468095|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
44459655|NCT02658890|79468096|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
44459656|NCT02658890|79468097|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
44459657|NCT02658890|79468098|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
44459658|NCT02658890|79468099|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
44459659|NCT02658890|79468100|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
44459660|NCT02658890|79468101|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
44459661|NCT02658890|79468102|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
44459662|NCT02658890|79468103|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
44459663|NCT02658890|79468104|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
44459664|NCT02658890|79468105|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
44459665|NCT02658890|79468106|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
44459666|NCT02658890|79468107|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
44459667|NCT02658890|79468108|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
44459668|NCT02658890|79468109|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
44544066|NCT03736967|79557253|FG001|Overall Study|Randomized but never treated|0|||
44544067|NCT03736967|79557254|FG002|Overall Study|Randomized but never treated|0|||
44544068|NCT03736967|79557255|FG003|Overall Study|Randomized but never treated|0|||
44544069|NCT03168555|79557268|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
44544070|NCT03168555|79557268|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
44544071|NCT03168555|79557268|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
44544072|NCT03168555|79557268|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
44544073|NCT03235050|79557280|FG000|Overall Study|Adverse Event|0|||
44544074|NCT03235050|79557281|FG001|Overall Study|Adverse Event|0|||
44544075|NCT03235050|79557282|FG002|Overall Study|Adverse Event|1|||
44544076|NCT03235050|79557283|FG003|Overall Study|Adverse Event|4|||
44544077|NCT03235050|79557284|FG004|Overall Study|Adverse Event|1|||
44217010|NCT01513239|79014907|FG005|Period 2: 9 Month Extension Phase|Death|2|||
44217011|NCT01513239|79014902|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
44459669|NCT02658890|79468110|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
44459670|NCT02658890|79468111|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
44459671|NCT02658890|79468112|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
44459672|NCT02658890|79468113|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
44459673|NCT02658890|79468114|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
44459674|NCT02658890|79468115|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
44544078|NCT03235050|79557280|FG000|Overall Study|Death|0|||
44217012|NCT01513239|79014903|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
44217013|NCT01513239|79014904|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
44270213|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270214|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270215|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270216|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270217|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270218|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270219|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270220|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
44270221|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270222|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270223|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270224|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44217014|NCT01513239|79014905|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
44217015|NCT01513239|79014906|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
44217016|NCT01513239|79014907|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
44217017|NCT01513239|79014902|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
44217018|NCT01513239|79014903|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
44217019|NCT01513239|79014904|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
44217020|NCT01513239|79014905|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
44270225|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270226|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270227|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
44270228|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270229|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270230|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270231|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270232|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270233|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270234|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
44270235|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44217021|NCT01513239|79014906|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
44217022|NCT01513239|79014907|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
44217023|NCT01513239|79014902|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
44217024|NCT01513239|79014903|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
44217025|NCT01513239|79014904|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
44217026|NCT01513239|79014905|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
44217027|NCT01513239|79014906|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
44217028|NCT01513239|79014907|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
44217029|NCT01544127|79014922|FG000|Overall Study|Lost to Follow-up|4|||
44217030|NCT01544127|79014923|FG001|Overall Study|Lost to Follow-up|2|||
44217031|NCT01544127|79014924|FG002|Overall Study|Lost to Follow-up|9|||
44217032|NCT01544127|79014922|FG000|Overall Study|Withdrawal by Subject|2|||
44217033|NCT01544127|79014923|FG001|Overall Study|Withdrawal by Subject|2|||
44217034|NCT01544127|79014924|FG002|Overall Study|Withdrawal by Subject|1|||
44217035|NCT01544127|79014922|FG000|Overall Study|Discharged out of catchment area|1|||
44217036|NCT01544127|79014923|FG001|Overall Study|Discharged out of catchment area|1|||
44217037|NCT01544127|79014924|FG002|Overall Study|Discharged out of catchment area|1|||
44217038|NCT01544127|79014922|FG000|Overall Study|Death|1|||
44217039|NCT01544127|79014923|FG001|Overall Study|Death|0|||
44217040|NCT01544127|79014924|FG002|Overall Study|Death|0|||
44217041|NCT01544127|79014922|FG000|Overall Study|Jail or Prison|1|||
44217042|NCT01544127|79014923|FG001|Overall Study|Jail or Prison|1|||
44217043|NCT01544127|79014924|FG002|Overall Study|Jail or Prison|2|||
44217044|NCT01544127|79014922|FG000|Overall Study|Became Psychotic|1|||
44217045|NCT01544127|79014923|FG001|Overall Study|Became Psychotic|0|||
44217046|NCT01544127|79014924|FG002|Overall Study|Became Psychotic|0|||
44217047|NCT01544127|79014922|FG000|Overall Study|Researcher withdrew|1|||
44217048|NCT01544127|79014923|FG001|Overall Study|Researcher withdrew|0|||
44217049|NCT01544127|79014924|FG002|Overall Study|Researcher withdrew|0|||
44217050|NCT01544127|79014922|FG000|Overall Study|Went active duty|0|||
44217051|NCT01544127|79014923|FG001|Overall Study|Went active duty|0|||
44217052|NCT01544127|79014924|FG002|Overall Study|Went active duty|1|||
44217053|NCT01512693|79014935|FG000|Overall Study|Withdrawal by Subject|0|||
44217054|NCT01512693|79014936|FG001|Overall Study|Withdrawal by Subject|1|||
44217055|NCT01458340|79014945|FG000|Overall Study|Adverse Event|5|||
44217056|NCT01458340|79014946|FG001|Overall Study|Adverse Event|4|||
44217057|NCT01458340|79014947|FG002|Overall Study|Adverse Event|2|||
44217058|NCT01458340|79014945|FG000|Overall Study|Lost to Follow-up|3|||
44217059|NCT01458340|79014946|FG001|Overall Study|Lost to Follow-up|3|||
44217060|NCT01458340|79014947|FG002|Overall Study|Lost to Follow-up|10|||
44217061|NCT01458340|79014945|FG000|Overall Study|Miscellaneous|0|||
44217062|NCT01458340|79014946|FG001|Overall Study|Miscellaneous|1|||
44217063|NCT01458340|79014947|FG002|Overall Study|Miscellaneous|0|||
44217064|NCT01458340|79014945|FG000|Overall Study|Physician Decision|1|||
44217065|NCT01458340|79014946|FG001|Overall Study|Physician Decision|1|||
44217066|NCT01458340|79014947|FG002|Overall Study|Physician Decision|2|||
44217067|NCT01458340|79014945|FG000|Overall Study|Protocol Violation|6|||
44217068|NCT01458340|79014946|FG001|Overall Study|Protocol Violation|6|||
44217069|NCT01458340|79014947|FG002|Overall Study|Protocol Violation|5|||
44217070|NCT01458340|79014945|FG000|Overall Study|Withdrawal by Subject|12|||
44217071|NCT01458340|79014946|FG001|Overall Study|Withdrawal by Subject|6|||
44217072|NCT01458340|79014947|FG002|Overall Study|Withdrawal by Subject|4|||
44217073|NCT01539291|79014993|FG000|Study GS-US-312-0116|Adverse Event|9|||
44217074|NCT01539291|79014994|FG001|Study GS-US-312-0116|Adverse Event|0|||
44217075|NCT01539291|79014995|FG002|Study GS-US-312-0116|Adverse Event|0|||
44217076|NCT01539291|79014996|FG003|Study GS-US-312-0116|Adverse Event|0|||
44217077|NCT01539291|79014993|FG000|Study GS-US-312-0116|Physician Decision|1|||
44217078|NCT01539291|79014994|FG001|Study GS-US-312-0116|Physician Decision|0|||
44217079|NCT01539291|79014995|FG002|Study GS-US-312-0116|Physician Decision|0|||
44217080|NCT01539291|79014996|FG003|Study GS-US-312-0116|Physician Decision|0|||
44217081|NCT01539291|79014993|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
44217082|NCT01539291|79014994|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
44217083|NCT01539291|79014995|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
44217084|NCT01539291|79014996|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
44217085|NCT01539291|79014993|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
44217086|NCT01539291|79014994|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
44217087|NCT01539291|79014995|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
44217088|NCT01539291|79014996|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
44217089|NCT01539291|79014993|FG000|Study GS-US-312-0116|Other|1|||
44217090|NCT01539291|79014994|FG001|Study GS-US-312-0116|Other|0|||
44217091|NCT01539291|79014995|FG002|Study GS-US-312-0116|Other|0|||
44217092|NCT01539291|79014996|FG003|Study GS-US-312-0116|Other|0|||
44217093|NCT01539291|79014993|FG000|Study GS-US-312-0117|Adverse Event|22|||
44217094|NCT01539291|79014994|FG001|Study GS-US-312-0117|Adverse Event|1|||
44217095|NCT01539291|79014995|FG002|Study GS-US-312-0117|Adverse Event|9|||
44217096|NCT01539291|79014996|FG003|Study GS-US-312-0117|Adverse Event|12|||
44217097|NCT01539291|79014993|FG000|Study GS-US-312-0117|Physician Decision|9|||
44217098|NCT01539291|79014994|FG001|Study GS-US-312-0117|Physician Decision|0|||
44217099|NCT01539291|79014995|FG002|Study GS-US-312-0117|Physician Decision|6|||
44217100|NCT01539291|79014996|FG003|Study GS-US-312-0117|Physician Decision|4|||
44217101|NCT01539291|79014993|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
44270236|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44372910|NCT02502799|79377974|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
44372911|NCT02502799|79377971|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
44372912|NCT02502799|79377972|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
44372913|NCT02502799|79377973|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
44372914|NCT02502799|79377974|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
44217102|NCT01539291|79014994|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
44217103|NCT01539291|79014995|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
44217104|NCT01539291|79014996|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
44217105|NCT01539291|79014993|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
44217106|NCT01539291|79014994|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
44217107|NCT01539291|79014995|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
44217108|NCT01539291|79014996|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
44217109|NCT01539291|79014993|FG000|Study GS-US-312-0117|Other|2|||
44217110|NCT01539291|79014994|FG001|Study GS-US-312-0117|Other|1|||
44217111|NCT01539291|79014995|FG002|Study GS-US-312-0117|Other|1|||
44217112|NCT01539291|79014996|FG003|Study GS-US-312-0117|Other|1|||
44217113|NCT01538199|79015019|FG000|Overall Study|Lost to Follow-up|1|||
44217114|NCT01538199|79015020|FG001|Overall Study|Lost to Follow-up|2|||
44217115|NCT01538199|79015021|FG002|Overall Study|Lost to Follow-up|1|||
44372915|NCT02502799|79377971|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
44372916|NCT02502799|79377972|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
44217116|NCT01538199|79015022|FG003|Overall Study|Lost to Follow-up|0|||
44270237|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44217117|NCT01538199|79015019|FG000|Overall Study|participant did not have time|1|||
44217118|NCT01538199|79015020|FG001|Overall Study|participant did not have time|0|||
44217119|NCT01538199|79015021|FG002|Overall Study|participant did not have time|0|||
44217120|NCT01538199|79015022|FG003|Overall Study|participant did not have time|2|||
44217121|NCT01538199|79015019|FG000|Overall Study|Lack of Efficacy|0|||
44372917|NCT02502799|79377973|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
44459675|NCT02658890|79468116|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
44459676|NCT02658890|79468117|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
44459677|NCT02658890|79468118|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
44459678|NCT02658890|79468092|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
44459679|NCT02658890|79468093|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
44459680|NCT02658890|79468094|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
44459681|NCT02658890|79468095|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
44459682|NCT02658890|79468096|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
44459683|NCT02658890|79468097|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
44459684|NCT02658890|79468098|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
44459685|NCT02658890|79468099|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
44459686|NCT02658890|79468100|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
44459687|NCT02658890|79468101|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
44459688|NCT02658890|79468102|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
44459689|NCT02658890|79468103|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
44459690|NCT02658890|79468104|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
44459691|NCT02658890|79468105|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
44459692|NCT02658890|79468106|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
44459693|NCT02658890|79468107|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
44459694|NCT02658890|79468108|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
44459695|NCT02658890|79468109|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
44459696|NCT02658890|79468110|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
44459697|NCT02658890|79468111|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
44459698|NCT02658890|79468112|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
44459699|NCT02658890|79468113|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
44459700|NCT02658890|79468114|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
44459701|NCT02658890|79468115|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
44459702|NCT02658890|79468116|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
44459703|NCT02658890|79468117|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
44459704|NCT02658890|79468118|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
44459705|NCT02658890|79468092|FG000|Treatment Phase|Other Reasons|0|||
44459706|NCT02658890|79468093|FG001|Treatment Phase|Other Reasons|0|||
44459707|NCT02658890|79468094|FG002|Treatment Phase|Other Reasons|0|||
44459708|NCT02658890|79468095|FG003|Treatment Phase|Other Reasons|0|||
44459709|NCT02658890|79468096|FG004|Treatment Phase|Other Reasons|0|||
44459710|NCT02658890|79468097|FG005|Treatment Phase|Other Reasons|0|||
44459711|NCT02658890|79468098|FG006|Treatment Phase|Other Reasons|1|||
44459712|NCT02658890|79468099|FG007|Treatment Phase|Other Reasons|0|||
44459713|NCT02658890|79468100|FG008|Treatment Phase|Other Reasons|1|||
44459714|NCT02658890|79468101|FG009|Treatment Phase|Other Reasons|0|||
44459715|NCT02658890|79468102|FG010|Treatment Phase|Other Reasons|0|||
44459716|NCT02658890|79468103|FG011|Treatment Phase|Other Reasons|0|||
44459717|NCT02658890|79468104|FG012|Treatment Phase|Other Reasons|0|||
44459718|NCT02658890|79468105|FG013|Treatment Phase|Other Reasons|2|||
44217122|NCT01538199|79015020|FG001|Overall Study|Lack of Efficacy|1|||
44372918|NCT02502799|79377974|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
44372919|NCT02502799|79377971|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
44372920|NCT02502799|79377972|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
44372921|NCT02502799|79377973|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
44372922|NCT02502799|79377974|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
44372923|NCT02086448|79377987|FG000|Overall Study|Withdrawal by Subject|1|||
44372924|NCT02086448|79377988|FG001|Overall Study|Withdrawal by Subject|0|||
44372925|NCT02086448|79377989|FG002|Overall Study|Withdrawal by Subject|0|||
44372926|NCT02086448|79377990|FG003|Overall Study|Withdrawal by Subject|2|||
44372927|NCT01993836|79378003|FG000|Overall Study|Surgery Cancelled|3|||
44372928|NCT01993836|79378004|FG001|Overall Study|Surgery Cancelled|0|||
44372929|NCT01993836|79378005|FG002|Overall Study|Surgery Cancelled|0|||
44459719|NCT02658890|79468106|FG014|Treatment Phase|Other Reasons|0|||
44459720|NCT02658890|79468107|FG015|Treatment Phase|Other Reasons|0|||
44459721|NCT02658890|79468108|FG016|Treatment Phase|Other Reasons|0|||
44459722|NCT02658890|79468109|FG017|Treatment Phase|Other Reasons|0|||
44459723|NCT02658890|79468110|FG018|Treatment Phase|Other Reasons|1|||
44459724|NCT02658890|79468111|FG019|Treatment Phase|Other Reasons|0|||
44459725|NCT02658890|79468112|FG020|Treatment Phase|Other Reasons|0|||
44459726|NCT02658890|79468113|FG021|Treatment Phase|Other Reasons|0|||
44459727|NCT02658890|79468114|FG022|Treatment Phase|Other Reasons|0|||
44459728|NCT02658890|79468115|FG023|Treatment Phase|Other Reasons|0|||
44459729|NCT02658890|79468116|FG024|Treatment Phase|Other Reasons|1|||
44459730|NCT02658890|79468117|FG025|Treatment Phase|Other Reasons|0|||
44459731|NCT02658890|79468118|FG026|Treatment Phase|Other Reasons|1|||
44459732|NCT02658890|79468092|FG000|Treatment Phase|Progressive Disease|6|||
44459733|NCT02658890|79468093|FG001|Treatment Phase|Progressive Disease|7|||
44459734|NCT02658890|79468094|FG002|Treatment Phase|Progressive Disease|6|||
44459735|NCT02658890|79468095|FG003|Treatment Phase|Progressive Disease|12|||
44459736|NCT02658890|79468096|FG004|Treatment Phase|Progressive Disease|6|||
44459737|NCT02658890|79468097|FG005|Treatment Phase|Progressive Disease|18|||
44459738|NCT02658890|79468098|FG006|Treatment Phase|Progressive Disease|12|||
44459739|NCT02658890|79468099|FG007|Treatment Phase|Progressive Disease|19|||
44459740|NCT02658890|79468100|FG008|Treatment Phase|Progressive Disease|26|||
44459741|NCT02658890|79468101|FG009|Treatment Phase|Progressive Disease|8|||
44459742|NCT02658890|79468102|FG010|Treatment Phase|Progressive Disease|7|||
44459743|NCT02658890|79468103|FG011|Treatment Phase|Progressive Disease|9|||
44459744|NCT02658890|79468104|FG012|Treatment Phase|Progressive Disease|8|||
44459745|NCT02658890|79468105|FG013|Treatment Phase|Progressive Disease|29|||
44459746|NCT02658890|79468106|FG014|Treatment Phase|Progressive Disease|6|||
44459747|NCT02658890|79468107|FG015|Treatment Phase|Progressive Disease|2|||
44459748|NCT02658890|79468108|FG016|Treatment Phase|Progressive Disease|32|||
44459749|NCT02658890|79468109|FG017|Treatment Phase|Progressive Disease|14|||
44459750|NCT02658890|79468110|FG018|Treatment Phase|Progressive Disease|40|||
44372930|NCT01993836|79378003|FG000|Overall Study|Physician Decision|2|||
44372931|NCT01993836|79378004|FG001|Overall Study|Physician Decision|1|||
44459751|NCT02658890|79468111|FG019|Treatment Phase|Progressive Disease|32|||
44459752|NCT02658890|79468112|FG020|Treatment Phase|Progressive Disease|19|||
44459753|NCT02658890|79468113|FG021|Treatment Phase|Progressive Disease|30|||
44459754|NCT02658890|79468114|FG022|Treatment Phase|Progressive Disease|15|||
44459755|NCT02658890|79468115|FG023|Treatment Phase|Progressive Disease|0|||
44459756|NCT02658890|79468116|FG024|Treatment Phase|Progressive Disease|0|||
44459757|NCT02658890|79468117|FG025|Treatment Phase|Progressive Disease|14|||
44459758|NCT02658890|79468118|FG026|Treatment Phase|Progressive Disease|11|||
44459759|NCT02658890|79468092|FG000|Treatment Phase|Study Drug Toxicity|0|||
44459760|NCT02658890|79468093|FG001|Treatment Phase|Study Drug Toxicity|0|||
44459761|NCT02658890|79468094|FG002|Treatment Phase|Study Drug Toxicity|2|||
44459762|NCT02658890|79468095|FG003|Treatment Phase|Study Drug Toxicity|0|||
44459763|NCT02658890|79468096|FG004|Treatment Phase|Study Drug Toxicity|0|||
44459764|NCT02658890|79468097|FG005|Treatment Phase|Study Drug Toxicity|0|||
44459765|NCT02658890|79468098|FG006|Treatment Phase|Study Drug Toxicity|0|||
44459766|NCT02658890|79468099|FG007|Treatment Phase|Study Drug Toxicity|0|||
44459767|NCT02658890|79468100|FG008|Treatment Phase|Study Drug Toxicity|3|||
44459768|NCT02658890|79468101|FG009|Treatment Phase|Study Drug Toxicity|0|||
44459769|NCT02658890|79468102|FG010|Treatment Phase|Study Drug Toxicity|1|||
44459770|NCT02658890|79468103|FG011|Treatment Phase|Study Drug Toxicity|1|||
44459771|NCT02658890|79468104|FG012|Treatment Phase|Study Drug Toxicity|2|||
44459772|NCT02658890|79468105|FG013|Treatment Phase|Study Drug Toxicity|9|||
44459773|NCT02658890|79468106|FG014|Treatment Phase|Study Drug Toxicity|0|||
44459774|NCT02658890|79468107|FG015|Treatment Phase|Study Drug Toxicity|1|||
44459775|NCT02658890|79468108|FG016|Treatment Phase|Study Drug Toxicity|1|||
44459776|NCT02658890|79468109|FG017|Treatment Phase|Study Drug Toxicity|0|||
44459777|NCT02658890|79468110|FG018|Treatment Phase|Study Drug Toxicity|8|||
44459778|NCT02658890|79468111|FG019|Treatment Phase|Study Drug Toxicity|3|||
44459779|NCT02658890|79468112|FG020|Treatment Phase|Study Drug Toxicity|2|||
44372932|NCT01993836|79378005|FG002|Overall Study|Physician Decision|0|||
44372933|NCT01993836|79378003|FG000|Overall Study|Death|0|||
44372934|NCT01993836|79378004|FG001|Overall Study|Death|2|||
44372935|NCT01993836|79378005|FG002|Overall Study|Death|0|||
44372936|NCT01993836|79378003|FG000|Overall Study|Withdrawal by Subject|12|||
44372937|NCT01993836|79378004|FG001|Overall Study|Withdrawal by Subject|10|||
44372938|NCT01993836|79378005|FG002|Overall Study|Withdrawal by Subject|5|||
44372939|NCT00753545|79378020|FG000|Overall Study|Death|98|||
44372940|NCT00753545|79378021|FG001|Overall Study|Death|112|||
44372941|NCT00753545|79378020|FG000|Overall Study|Lost to Follow-up|2|||
44372942|NCT00753545|79378021|FG001|Overall Study|Lost to Follow-up|3|||
44459780|NCT02658890|79468113|FG021|Treatment Phase|Study Drug Toxicity|0|||
44459781|NCT02658890|79468114|FG022|Treatment Phase|Study Drug Toxicity|8|||
44459782|NCT02658890|79468115|FG023|Treatment Phase|Study Drug Toxicity|0|||
44459783|NCT02658890|79468116|FG024|Treatment Phase|Study Drug Toxicity|0|||
44459784|NCT02658890|79468117|FG025|Treatment Phase|Study Drug Toxicity|2|||
44459785|NCT02658890|79468118|FG026|Treatment Phase|Study Drug Toxicity|0|||
44544079|NCT03235050|79557281|FG001|Overall Study|Death|0|||
44459786|NCT02658890|79468092|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459787|NCT02658890|79468093|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459788|NCT02658890|79468094|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459789|NCT02658890|79468095|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
44459790|NCT02658890|79468096|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44544080|NCT03235050|79557282|FG002|Overall Study|Death|0|||
44459791|NCT02658890|79468097|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459792|NCT02658890|79468098|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459793|NCT02658890|79468099|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459794|NCT02658890|79468100|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459795|NCT02658890|79468101|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
44459796|NCT02658890|79468102|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459797|NCT02658890|79468103|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459798|NCT02658890|79468104|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459799|NCT02658890|79468105|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459800|NCT02658890|79468106|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459801|NCT02658890|79468107|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459802|NCT02658890|79468108|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459803|NCT02658890|79468109|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459804|NCT02658890|79468110|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
44459805|NCT02658890|79468111|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459806|NCT02658890|79468112|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459807|NCT02658890|79468113|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459808|NCT02658890|79468114|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
44459809|NCT02658890|79468115|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459810|NCT02658890|79468116|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459811|NCT02658890|79468117|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459812|NCT02658890|79468118|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
44459813|NCT02658890|79468092|FG000|Treatment Phase|Withdrawal by Subject|0|||
44459814|NCT02658890|79468093|FG001|Treatment Phase|Withdrawal by Subject|1|||
44459815|NCT02658890|79468094|FG002|Treatment Phase|Withdrawal by Subject|0|||
44459816|NCT02658890|79468095|FG003|Treatment Phase|Withdrawal by Subject|0|||
44459817|NCT02658890|79468096|FG004|Treatment Phase|Withdrawal by Subject|0|||
44459818|NCT02658890|79468097|FG005|Treatment Phase|Withdrawal by Subject|0|||
44459819|NCT02658890|79468098|FG006|Treatment Phase|Withdrawal by Subject|1|||
44459820|NCT02658890|79468099|FG007|Treatment Phase|Withdrawal by Subject|0|||
44459821|NCT02658890|79468100|FG008|Treatment Phase|Withdrawal by Subject|0|||
44459822|NCT02658890|79468101|FG009|Treatment Phase|Withdrawal by Subject|1|||
44459823|NCT02658890|79468102|FG010|Treatment Phase|Withdrawal by Subject|0|||
44459824|NCT02658890|79468103|FG011|Treatment Phase|Withdrawal by Subject|0|||
44459825|NCT02658890|79468104|FG012|Treatment Phase|Withdrawal by Subject|1|||
44459826|NCT02658890|79468105|FG013|Treatment Phase|Withdrawal by Subject|3|||
44459827|NCT02658890|79468106|FG014|Treatment Phase|Withdrawal by Subject|0|||
44459828|NCT02658890|79468107|FG015|Treatment Phase|Withdrawal by Subject|0|||
44459829|NCT02658890|79468108|FG016|Treatment Phase|Withdrawal by Subject|1|||
44459830|NCT02658890|79468109|FG017|Treatment Phase|Withdrawal by Subject|0|||
44459831|NCT02658890|79468110|FG018|Treatment Phase|Withdrawal by Subject|4|||
44372943|NCT00753545|79378020|FG000|Overall Study|Protocol Violation|1|||
44372944|NCT00753545|79378021|FG001|Overall Study|Protocol Violation|0|||
44372945|NCT00753545|79378020|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
44372946|NCT00753545|79378021|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
44372947|NCT00278915|79378036|FG000|Overall Study|Lack of Efficacy|1|||
44372948|NCT00970632|79378043|FG000|Overall Study|Adverse Event|2|||
44372949|NCT00970632|79378044|FG001|Overall Study|Adverse Event|2|||
44372950|NCT00970632|79378045|FG002|Overall Study|Adverse Event|1|||
44372951|NCT00970632|79378043|FG000|Overall Study|Lack of Efficacy|3|||
44372952|NCT00970632|79378044|FG001|Overall Study|Lack of Efficacy|0|||
44459832|NCT02658890|79468111|FG019|Treatment Phase|Withdrawal by Subject|3|||
44459833|NCT02658890|79468112|FG020|Treatment Phase|Withdrawal by Subject|0|||
44459834|NCT02658890|79468113|FG021|Treatment Phase|Withdrawal by Subject|4|||
44372953|NCT00970632|79378045|FG002|Overall Study|Lack of Efficacy|0|||
44459835|NCT02658890|79468114|FG022|Treatment Phase|Withdrawal by Subject|1|||
44459836|NCT02658890|79468115|FG023|Treatment Phase|Withdrawal by Subject|1|||
44459837|NCT02658890|79468116|FG024|Treatment Phase|Withdrawal by Subject|0|||
44459838|NCT02658890|79468117|FG025|Treatment Phase|Withdrawal by Subject|0|||
44459839|NCT02658890|79468118|FG026|Treatment Phase|Withdrawal by Subject|0|||
44459840|NCT02597062|79468210|FG000|Overall Study|Ineligible|1|||
44459841|NCT05159362|79468260|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
44459842|NCT05159362|79468261|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
44459843|NCT05159362|79468262|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
44459844|NCT04975191|79468277|FG000|Overall Study|Protocol Violation|1|||
44459845|NCT04975191|79468278|FG001|Overall Study|Protocol Violation|2|||
44217123|NCT01538199|79015021|FG002|Overall Study|Lack of Efficacy|0|||
44217124|NCT01538199|79015022|FG003|Overall Study|Lack of Efficacy|0|||
44217125|NCT01511445|79015041|FG000|Overall Study|Lost to Follow-up|3|||
44217126|NCT01511445|79015042|FG001|Overall Study|Lost to Follow-up|1|||
44217127|NCT01511445|79015041|FG000|Overall Study|Protocol Violation|1|||
44217128|NCT01511445|79015042|FG001|Overall Study|Protocol Violation|3|||
44217129|NCT01511445|79015041|FG000|Overall Study|Protocol Violation|1|||
44217130|NCT01511445|79015042|FG001|Overall Study|Protocol Violation|0|||
44217131|NCT01543503|79015050|FG000|Overall Study|Lost to Follow-up|32|||
44217132|NCT01543503|79015051|FG001|Overall Study|Lost to Follow-up|36|||
44217133|NCT01543503|79015050|FG000|Overall Study|Adverse Event|9|||
44217134|NCT01543503|79015051|FG001|Overall Study|Adverse Event|13|||
44217135|NCT01543503|79015050|FG000|Overall Study|Lack of Efficacy|4|||
44217136|NCT01543503|79015051|FG001|Overall Study|Lack of Efficacy|16|||
44217137|NCT01543503|79015050|FG000|Overall Study|Participant withdrew informed consent|8|||
44217138|NCT01543503|79015051|FG001|Overall Study|Participant withdrew informed consent|10|||
44217139|NCT01543503|79015050|FG000|Overall Study|Change of jobs|0|||
44217140|NCT01543503|79015051|FG001|Overall Study|Change of jobs|1|||
44217141|NCT01543503|79015050|FG000|Overall Study|Intolerance to the biologic treatment|0|||
44217142|NCT01543503|79015051|FG001|Overall Study|Intolerance to the biologic treatment|1|||
44217143|NCT01543503|79015050|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
44217144|NCT01543503|79015051|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
44217145|NCT01543503|79015050|FG000|Overall Study|Participant did not complete last visit|0|||
44217146|NCT01543503|79015051|FG001|Overall Study|Participant did not complete last visit|2|||
44217147|NCT01543503|79015050|FG000|Overall Study|Refused to continue treatment|7|||
44217148|NCT01543503|79015051|FG001|Overall Study|Refused to continue treatment|0|||
44217149|NCT01543503|79015050|FG000|Overall Study|Incorrect medication received|1|||
44217150|NCT01543503|79015051|FG001|Overall Study|Incorrect medication received|0|||
44217151|NCT01543503|79015050|FG000|Overall Study|Participant moved to another city|2|||
44217152|NCT01543503|79015051|FG001|Overall Study|Participant moved to another city|0|||
44217153|NCT01543503|79015050|FG000|Overall Study|Participant will not return for visits|0|||
44217154|NCT01543503|79015051|FG001|Overall Study|Participant will not return for visits|2|||
44217155|NCT01543503|79015050|FG000|Overall Study|Participant transferred to another city|1|||
44217156|NCT01543503|79015051|FG001|Overall Study|Participant transferred to another city|0|||
44217157|NCT01543503|79015050|FG000|Overall Study|Participant moved to Scotland|1|||
44217158|NCT01543503|79015051|FG001|Overall Study|Participant moved to Scotland|0|||
44217159|NCT01543503|79015050|FG000|Overall Study|Participant decision to stop treatment|1|||
44217160|NCT01543503|79015051|FG001|Overall Study|Participant decision to stop treatment|0|||
44372954|NCT00970632|79378043|FG000|Overall Study|Lost to Follow-up|3|||
44372955|NCT00970632|79378044|FG001|Overall Study|Lost to Follow-up|0|||
44372956|NCT00970632|79378045|FG002|Overall Study|Lost to Follow-up|2|||
44372957|NCT00970632|79378043|FG000|Overall Study|Protocol Violation|8|||
44372958|NCT00970632|79378044|FG001|Overall Study|Protocol Violation|5|||
44372959|NCT00970632|79378045|FG002|Overall Study|Protocol Violation|8|||
44372960|NCT00970632|79378043|FG000|Overall Study|Withdrawal by Subject|7|||
44372961|NCT00970632|79378044|FG001|Overall Study|Withdrawal by Subject|6|||
44372962|NCT00970632|79378045|FG002|Overall Study|Withdrawal by Subject|4|||
44372963|NCT00970632|79378043|FG000|Overall Study|Entry criteria not met|0|||
44372964|NCT00970632|79378044|FG001|Overall Study|Entry criteria not met|2|||
44372965|NCT00970632|79378045|FG002|Overall Study|Entry criteria not met|2|||
44459846|NCT04975191|79468279|FG002|Overall Study|Protocol Violation|2|||
44372966|NCT00970632|79378043|FG000|Overall Study|Sponsor decision|1|||
44372967|NCT00970632|79378044|FG001|Overall Study|Sponsor decision|0|||
44217161|NCT01543503|79015050|FG000|Overall Study|Investigator did not wish to participate|1|||
44217162|NCT01543503|79015051|FG001|Overall Study|Investigator did not wish to participate|1|||
44217163|NCT01543503|79015050|FG000|Overall Study|Participant recruited after closing date|0|||
44217164|NCT01543503|79015051|FG001|Overall Study|Participant recruited after closing date|1|||
44217165|NCT01543503|79015050|FG000|Overall Study|Site stopped participation|5|||
44459847|NCT04975191|79468280|FG003|Overall Study|Protocol Violation|2|||
44459848|NCT04975191|79468277|FG000|Overall Study|Lost to Follow-up|13|||
44544081|NCT03235050|79557283|FG003|Overall Study|Death|2|||
44217166|NCT01543503|79015051|FG001|Overall Study|Site stopped participation|1|||
44372968|NCT00970632|79378045|FG002|Overall Study|Sponsor decision|1|||
44217167|NCT01543503|79015050|FG000|Overall Study|Participant did not attend a visit|1|||
44217168|NCT01543503|79015051|FG001|Overall Study|Participant did not attend a visit|0|||
44217169|NCT01543503|79015050|FG000|Overall Study|Moved to other rheumatologic site|0|||
44217170|NCT01543503|79015051|FG001|Overall Study|Moved to other rheumatologic site|1|||
44217171|NCT01543503|79015050|FG000|Overall Study|Participant consented to another study|0|||
44217172|NCT01543503|79015051|FG001|Overall Study|Participant consented to another study|2|||
44217173|NCT01543503|79015050|FG000|Overall Study|Participant went to United States|1|||
44217174|NCT01543503|79015051|FG001|Overall Study|Participant went to United States|0|||
44217175|NCT01543503|79015050|FG000|Overall Study|Screen failure|1|||
44217176|NCT01543503|79015051|FG001|Overall Study|Screen failure|0|||
44217177|NCT01511055|79015057|FG000|Overall Study|Withdrawal by Subject|6|||
44217178|NCT01537887|79015061|FG000|Period 1|Physician Decision|0|||
44217179|NCT01537887|79015062|FG001|Period 1|Physician Decision|0|||
44217180|NCT01537887|79015063|FG002|Period 1|Physician Decision|0|||
44217181|NCT01537887|79015064|FG003|Period 1|Physician Decision|0|||
44217182|NCT01537887|79015065|FG004|Period 1|Physician Decision|1|||
44217183|NCT01537887|79015066|FG005|Period 1|Physician Decision|1|||
44217184|NCT01537887|79015061|FG000|Period 1|Did not receive treatment|0|||
44217185|NCT01537887|79015062|FG001|Period 1|Did not receive treatment|0|||
44217186|NCT01537887|79015063|FG002|Period 1|Did not receive treatment|1|||
44217187|NCT01537887|79015064|FG003|Period 1|Did not receive treatment|0|||
44217188|NCT01537887|79015065|FG004|Period 1|Did not receive treatment|0|||
44217189|NCT01537887|79015066|FG005|Period 1|Did not receive treatment|0|||
44372969|NCT01144364|79378055|FG000|Induction Phase|Disease progression|14|||
44459849|NCT04975191|79468278|FG001|Overall Study|Lost to Follow-up|3|||
44459850|NCT04975191|79468279|FG002|Overall Study|Lost to Follow-up|8|||
44459851|NCT04975191|79468280|FG003|Overall Study|Lost to Follow-up|8|||
44459852|NCT04492020|79468306|FG000|Overall Study|Adverse Event|1|||
44459853|NCT04492020|79468307|FG001|Overall Study|Adverse Event|3|||
44459854|NCT04492020|79468306|FG000|Overall Study|Withdrawal by Subject|4|||
44459855|NCT04492020|79468307|FG001|Overall Study|Withdrawal by Subject|3|||
44459856|NCT04492020|79468306|FG000|Overall Study|Lost to Follow-up|4|||
44459857|NCT04492020|79468307|FG001|Overall Study|Lost to Follow-up|3|||
44459858|NCT04492020|79468306|FG000|Overall Study|Protocol Violation|5|||
44459859|NCT04492020|79468307|FG001|Overall Study|Protocol Violation|2|||
44459860|NCT04492020|79468306|FG000|Overall Study|Lack of Qualifying Event|25|||
44459861|NCT04492020|79468307|FG001|Overall Study|Lack of Qualifying Event|27|||
44459862|NCT04492020|79468306|FG000|Overall Study|Non-compliance with Study Drug|2|||
44459863|NCT04492020|79468307|FG001|Overall Study|Non-compliance with Study Drug|1|||
44459864|NCT04382911|79468313|FG000|Overall Study|unable to be imaged prior to surgery|2|||
44459865|NCT04072575|79468321|FG000|Overall Study|Physician Decision|1|||
44459866|NCT04072575|79468321|FG000|Overall Study|Adverse Event|7|||
44459867|NCT04072575|79468321|FG000|Overall Study|Withdrawal by Subject|14|||
44459868|NCT04072575|79468321|FG000|Overall Study|Other|2|||
44459869|NCT03911869|79468327|FG000|Safety Lead-in Phase|Death|7|||
44459870|NCT03911869|79468328|FG001|Safety Lead-in Phase|Death|0|||
44459871|NCT03911869|79468329|FG002|Safety Lead-in Phase|Death|0|||
44459872|NCT03911869|79468327|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
44459873|NCT03911869|79468328|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
44459874|NCT03911869|79468329|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
44459875|NCT03911869|79468327|FG000|Safety Lead-in Phase|Other|1|||
44459876|NCT03911869|79468328|FG001|Safety Lead-in Phase|Other|0|||
44459877|NCT03911869|79468329|FG002|Safety Lead-in Phase|Other|0|||
44459878|NCT03911869|79468327|FG000|Phase 2|Death|0|||
44372970|NCT01144364|79378056|FG001|Induction Phase|Disease progression|0|||
44372971|NCT01144364|79378057|FG002|Induction Phase|Disease progression|0|||
44372972|NCT01144364|79378055|FG000|Induction Phase|Adverse Event|9|||
44372973|NCT01144364|79378056|FG001|Induction Phase|Adverse Event|0|||
44372974|NCT01144364|79378057|FG002|Induction Phase|Adverse Event|0|||
44372975|NCT01144364|79378055|FG000|Induction Phase|Death|1|||
44372976|NCT01144364|79378056|FG001|Induction Phase|Death|0|||
44372977|NCT01144364|79378057|FG002|Induction Phase|Death|0|||
44372978|NCT01144364|79378055|FG000|Induction Phase|Withdrawal by Subject|1|||
44459879|NCT03911869|79468328|FG001|Phase 2|Death|3|||
44459880|NCT03911869|79468329|FG002|Phase 2|Death|0|||
44372979|NCT01144364|79378056|FG001|Induction Phase|Withdrawal by Subject|0|||
44372980|NCT01144364|79378057|FG002|Induction Phase|Withdrawal by Subject|0|||
44217190|NCT01537887|79015061|FG000|Period 2|Withdrawal by Subject|0|||
44217191|NCT01537887|79015062|FG001|Period 2|Withdrawal by Subject|1|||
44372981|NCT01144364|79378055|FG000|Induction Phase|Lost to Follow-up|2|||
44459881|NCT03897088|79468338|FG000|Overall Study|Withdrawal by Subject|12|||
44459882|NCT03897088|79468339|FG001|Overall Study|Withdrawal by Subject|12|||
44459883|NCT03897088|79468338|FG000|Overall Study|Lost to Follow-up|7|||
44459884|NCT03897088|79468339|FG001|Overall Study|Lost to Follow-up|15|||
44459885|NCT03897088|79468338|FG000|Overall Study|Sponsor Decision|1|||
44459886|NCT03897088|79468339|FG001|Overall Study|Sponsor Decision|2|||
44459887|NCT03897088|79468338|FG000|Overall Study|COVID-19|2|||
44217192|NCT01537887|79015063|FG002|Period 2|Withdrawal by Subject|0|||
44217193|NCT01537887|79015064|FG003|Period 2|Withdrawal by Subject|0|||
44217194|NCT01537887|79015065|FG004|Period 2|Withdrawal by Subject|0|||
44217195|NCT01537887|79015066|FG005|Period 2|Withdrawal by Subject|0|||
44217196|NCT01537887|79015061|FG000|Period 3|Adverse Event|0|||
44217197|NCT01537887|79015062|FG001|Period 3|Adverse Event|0|||
44217198|NCT01537887|79015063|FG002|Period 3|Adverse Event|1|||
44217199|NCT01537887|79015064|FG003|Period 3|Adverse Event|0|||
44217200|NCT01537887|79015065|FG004|Period 3|Adverse Event|0|||
44217201|NCT01537887|79015066|FG005|Period 3|Adverse Event|0|||
44217202|NCT01537887|79015061|FG000|Period 3|Withdrawal by Subject|0|||
44217203|NCT01537887|79015062|FG001|Period 3|Withdrawal by Subject|1|||
44217204|NCT01537887|79015063|FG002|Period 3|Withdrawal by Subject|0|||
44217205|NCT01537887|79015064|FG003|Period 3|Withdrawal by Subject|0|||
44217206|NCT01537887|79015065|FG004|Period 3|Withdrawal by Subject|0|||
44217207|NCT01537887|79015066|FG005|Period 3|Withdrawal by Subject|0|||
44217208|NCT01489527|79015076|FG000|Overall Study|Pregnancy|9|||
44217209|NCT01489527|79015077|FG001|Overall Study|Pregnancy|14|||
44270238|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270239|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270240|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270241|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270242|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
44270243|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44372982|NCT01144364|79378056|FG001|Induction Phase|Lost to Follow-up|0|||
44544082|NCT03235050|79557284|FG004|Overall Study|Death|1|||
44372983|NCT01144364|79378057|FG002|Induction Phase|Lost to Follow-up|0|||
44372984|NCT01144364|79378055|FG000|Induction Phase|Physician Decision|1|||
44372985|NCT01144364|79378056|FG001|Induction Phase|Physician Decision|0|||
44372986|NCT01144364|79378057|FG002|Induction Phase|Physician Decision|0|||
44544083|NCT03235050|79557280|FG000|Overall Study|Lost to Follow-up|1|||
44544084|NCT03235050|79557281|FG001|Overall Study|Lost to Follow-up|2|||
44217210|NCT01489527|79015076|FG000|Overall Study|Participant moved|6|||
44217211|NCT01489527|79015077|FG001|Overall Study|Participant moved|7|||
44217212|NCT01489527|79015076|FG000|Overall Study|Withdrawal by Subject|0|||
44217213|NCT01489527|79015077|FG001|Overall Study|Withdrawal by Subject|4|||
44217214|NCT01489527|79015076|FG000|Overall Study|Lost to Follow-up|5|||
44217215|NCT01489527|79015077|FG001|Overall Study|Lost to Follow-up|1|||
44217216|NCT01489527|79015076|FG000|Overall Study|Procedures|1|||
44270244|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44372987|NCT01144364|79378055|FG000|Induction Phase|Stable disease|2|||
44372988|NCT01144364|79378056|FG001|Induction Phase|Stable disease|0|||
44372989|NCT01144364|79378057|FG002|Induction Phase|Stable disease|0|||
44372990|NCT01144364|79378055|FG000|Induction Phase|Secondary neoplasia|1|||
44372991|NCT01144364|79378056|FG001|Induction Phase|Secondary neoplasia|0|||
44217217|NCT01489527|79015077|FG001|Overall Study|Procedures|0|||
44217218|NCT01489527|79015076|FG000|Overall Study|Not compliant|1|||
44217219|NCT01489527|79015077|FG001|Overall Study|Not compliant|0|||
44217220|NCT01487577|79015090|FG000|Overall Study|Became ineligible after signing consent|1|||
44217221|NCT01536951|79015096|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217222|NCT01536951|79015097|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217223|NCT01536951|79015098|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
44217224|NCT01536951|79015099|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217225|NCT01536951|79015100|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217226|NCT01536951|79015101|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217227|NCT01536951|79015102|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217228|NCT01536951|79015103|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217229|NCT01536951|79015104|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
44217230|NCT01536951|79015096|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
44217231|NCT01536951|79015097|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
44217232|NCT01536951|79015098|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
44217233|NCT01536951|79015099|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
44217234|NCT01536951|79015100|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
44217235|NCT01536951|79015101|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
44217236|NCT01536951|79015102|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
44217237|NCT01536951|79015103|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
44217238|NCT01536951|79015104|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
44217239|NCT01536795|79015129|FG000|Overall Study|Lost to Follow-up|0|||
44217240|NCT01536795|79015130|FG001|Overall Study|Lost to Follow-up|2|||
44217241|NCT01536795|79015129|FG000|Overall Study|Lack of Efficacy|1|||
44217242|NCT01536795|79015130|FG001|Overall Study|Lack of Efficacy|0|||
44217243|NCT01536561|79015140|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
44217244|NCT01536561|79015140|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
44217245|NCT01536561|79015140|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
44217246|NCT01536561|79015140|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
44217247|NCT01536561|79015140|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
44217248|NCT01536561|79015140|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
44217249|NCT01536405|79015158|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
44217250|NCT01536405|79015159|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
44217251|NCT01536405|79015158|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
44217252|NCT01536405|79015159|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
44217253|NCT01536405|79015158|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
44217254|NCT01536405|79015159|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
44217255|NCT01536405|79015158|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
44217256|NCT01536405|79015159|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
44217257|NCT01536405|79015158|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
44217258|NCT01536405|79015159|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
44217259|NCT01536405|79015158|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
44217260|NCT01536405|79015159|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
44217261|NCT01536405|79015158|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
44217262|NCT01536405|79015159|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
44217263|NCT01536405|79015158|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
44217264|NCT01536405|79015159|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
44217265|NCT01536405|79015158|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
44217266|NCT01536405|79015159|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
44217267|NCT01536405|79015158|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
44217268|NCT01536405|79015159|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
44217269|NCT01536405|79015158|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
44217270|NCT01536405|79015159|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
44217271|NCT01536405|79015158|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
44217272|NCT01536405|79015159|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
44217273|NCT01536405|79015158|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
44459888|NCT03897088|79468339|FG001|Overall Study|COVID-19|0|||
44217274|NCT01536405|79015159|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
44217275|NCT01487265|79015165|FG000|Overall Study|Adverse Event|8|||
44217276|NCT01487265|79015165|FG000|Overall Study|Withdrawal by Subject|5|||
44217277|NCT01487265|79015165|FG000|Overall Study|Disease Progression|21|||
44217278|NCT01487265|79015165|FG000|Overall Study|Death|2|||
44217279|NCT01487265|79015165|FG000|Overall Study|Still on Treatment|1|||
44217280|NCT01485627|79015171|FG000|Overall Study|Patient withdrew|6|||
44217281|NCT01485627|79015172|FG001|Overall Study|Patient withdrew|5|||
44217282|NCT01485627|79015171|FG000|Overall Study|Patient died|3|||
44217283|NCT01485627|79015172|FG001|Overall Study|Patient died|1|||
44217284|NCT01485627|79015171|FG000|Overall Study|Patient lost to followup|0|||
44217285|NCT01485627|79015172|FG001|Overall Study|Patient lost to followup|1|||
44217286|NCT01485627|79015171|FG000|Overall Study|Caregiver withdrew|3|||
44217287|NCT01485627|79015172|FG001|Overall Study|Caregiver withdrew|3|||
44217288|NCT01485627|79015171|FG000|Overall Study|Caregiver lost to follow up|11|||
44217289|NCT01485627|79015172|FG001|Overall Study|Caregiver lost to follow up|12|||
44217290|NCT01485627|79015171|FG000|Overall Study|Caregiver died|1|||
44217291|NCT01485627|79015172|FG001|Overall Study|Caregiver died|0|||
44217292|NCT01485627|79015171|FG000|Overall Study|caregiver was not bereaved|42|||
44217293|NCT01485627|79015172|FG001|Overall Study|caregiver was not bereaved|35|||
44217294|NCT01508325|79015195|FG000|Overall Study|Withdrawal by Subject|8|||
44217295|NCT01508325|79015196|FG001|Overall Study|Withdrawal by Subject|9|||
44217296|NCT01508325|79015195|FG000|Overall Study|Protocol Violation|0|||
44217297|NCT01508325|79015196|FG001|Overall Study|Protocol Violation|3|||
44217298|NCT01508325|79015195|FG000|Overall Study|Physician Decision|2|||
44372992|NCT01144364|79378057|FG002|Induction Phase|Secondary neoplasia|0|||
44459889|NCT03897088|79468338|FG000|Overall Study|Other|3|||
44459890|NCT03897088|79468339|FG001|Overall Study|Other|0|||
44217299|NCT01508325|79015196|FG001|Overall Study|Physician Decision|1|||
44217300|NCT01508325|79015195|FG000|Overall Study|Adverse Event|1|||
44217301|NCT01508325|79015196|FG001|Overall Study|Adverse Event|0|||
44217302|NCT01508325|79015195|FG000|Overall Study|Lost to Follow-up|5|||
44217303|NCT01508325|79015196|FG001|Overall Study|Lost to Follow-up|6|||
44217304|NCT01508325|79015195|FG000|Overall Study|Other|2|||
44217305|NCT01508325|79015196|FG001|Overall Study|Other|2|||
44217306|NCT01508169|79015204|FG000|Overall Study|Adverse Event|1|||
44217307|NCT01508169|79015205|FG001|Overall Study|Adverse Event|0|||
44217308|NCT01508169|79015204|FG000|Overall Study|Withdrawal by Subject|1|||
44217309|NCT01508169|79015205|FG001|Overall Study|Withdrawal by Subject|0|||
44217310|NCT01508169|79015204|FG000|Overall Study|Lost to Follow-up|1|||
44217311|NCT01508169|79015205|FG001|Overall Study|Lost to Follow-up|2|||
44459891|NCT03897088|79468338|FG000|Overall Study|Non-compliance with Study Drug|1|||
44459892|NCT03897088|79468339|FG001|Overall Study|Non-compliance with Study Drug|1|||
44459893|NCT03897088|79468338|FG000|Overall Study|Pregnancy|0|||
44459894|NCT03897088|79468339|FG001|Overall Study|Pregnancy|1|||
44459895|NCT03700684|79468367|FG000|Overall Study|COVID-19|0|||
44459896|NCT03700684|79468368|FG001|Overall Study|COVID-19|0|||
44459897|NCT03700684|79468369|FG002|Overall Study|COVID-19|2|||
44459898|NCT03659136|79468379|FG000|Overall Study|Not treated|2|||
44459899|NCT03659136|79468380|FG001|Overall Study|Not treated|0|||
44459900|NCT03659136|79468379|FG000|Overall Study|Covid-19 related|1|||
44217312|NCT01536171|79015217|FG000|Overall Study|Withdrawal by Subject|1|||
44372993|NCT01144364|79378055|FG000|Induction Phase|Protocol Violation|1|||
44372994|NCT01144364|79378056|FG001|Induction Phase|Protocol Violation|0|||
44372995|NCT01144364|79378057|FG002|Induction Phase|Protocol Violation|0|||
44372996|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
44372997|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
44372998|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
44372999|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
44373000|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
44373001|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
44217313|NCT01536093|79015224|FG000|Overall Study|Death|1|||
44217314|NCT01536093|79015225|FG001|Overall Study|Death|2|||
44217315|NCT01536093|79015224|FG000|Overall Study|absence of maternal colostrum|2|||
44373002|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Death|0|||
44373003|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Death|2|||
44373004|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Death|0|||
44459901|NCT03659136|79468380|FG001|Overall Study|Covid-19 related|1|||
44459902|NCT03659136|79468379|FG000|Overall Study|Withdrawal by Subject|1|||
44459903|NCT03659136|79468380|FG001|Overall Study|Withdrawal by Subject|6|||
44459904|NCT03659136|79468379|FG000|Overall Study|Adverse Event|4|||
44217316|NCT01536093|79015225|FG001|Overall Study|absence of maternal colostrum|0|||
44217317|NCT01536093|79015224|FG000|Overall Study|Withdrawal by Subject|0|||
44217318|NCT01536093|79015225|FG001|Overall Study|Withdrawal by Subject|1|||
44217319|NCT01536015|79015233|FG000|Overall Study|Adverse Event|1|||
44217320|NCT01536015|79015234|FG001|Overall Study|Adverse Event|4|||
44217321|NCT01536015|79015233|FG000|Overall Study|Lost to Follow-up|0|||
44217322|NCT01536015|79015234|FG001|Overall Study|Lost to Follow-up|1|||
44217323|NCT01536015|79015233|FG000|Overall Study|Inclusion Criterion not met|2|||
44217324|NCT01536015|79015234|FG001|Overall Study|Inclusion Criterion not met|0|||
44217325|NCT01536015|79015233|FG000|Overall Study|Study closure|5|||
44217326|NCT01536015|79015234|FG001|Overall Study|Study closure|5|||
44217327|NCT01484691|79015243|FG000|Overall Study|Withdrawal by Subject|1|||
44217328|NCT01484691|79015244|FG001|Overall Study|Withdrawal by Subject|1|||
44217329|NCT01484691|79015245|FG002|Overall Study|Withdrawal by Subject|1|||
44217330|NCT01484691|79015243|FG000|Overall Study|Physician Decision|0|||
44217331|NCT01484691|79015244|FG001|Overall Study|Physician Decision|2|||
44217332|NCT01484691|79015245|FG002|Overall Study|Physician Decision|1|||
44217333|NCT01535235|79015256|FG000|Overall Study|Adverse Event|1|||
44217334|NCT01535235|79015257|FG001|Overall Study|Adverse Event|0|||
44217335|NCT01483599|79015301|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
44217336|NCT01483599|79015302|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217337|NCT01483599|79015303|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217338|NCT01483599|79015304|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
44217339|NCT01483599|79015305|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
44217340|NCT01483599|79015306|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
44217341|NCT01483599|79015307|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
44217342|NCT01483599|79015308|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217343|NCT01483599|79015309|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217344|NCT01483599|79015310|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217345|NCT01483599|79015311|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217346|NCT01483599|79015312|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217347|NCT01483599|79015313|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217348|NCT01483599|79015314|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
44217349|NCT01483599|79015301|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217350|NCT01483599|79015302|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
44217351|NCT01483599|79015303|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217352|NCT01483599|79015304|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
44217353|NCT01483599|79015305|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217354|NCT01483599|79015306|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217355|NCT01483599|79015307|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
44217356|NCT01483599|79015308|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217357|NCT01483599|79015309|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217358|NCT01483599|79015310|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217359|NCT01483599|79015311|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217360|NCT01483599|79015312|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217361|NCT01483599|79015313|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217362|NCT01483599|79015314|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
44217363|NCT01483599|79015301|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
44217364|NCT01483599|79015302|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217365|NCT01483599|79015303|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217366|NCT01483599|79015304|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217367|NCT01483599|79015305|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217368|NCT01483599|79015306|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217369|NCT01483599|79015307|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217370|NCT01483599|79015308|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217371|NCT01483599|79015309|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217372|NCT01483599|79015310|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217373|NCT01483599|79015311|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217374|NCT01483599|79015312|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217375|NCT01483599|79015313|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217376|NCT01483599|79015314|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
44217377|NCT01483599|79015301|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
44217378|NCT01483599|79015302|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
44217379|NCT01483599|79015303|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
44217380|NCT01483599|79015304|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
44217381|NCT01483599|79015305|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
44217382|NCT01483599|79015306|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
44217383|NCT01483599|79015307|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
44217384|NCT01483599|79015308|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
44459905|NCT03659136|79468380|FG001|Overall Study|Adverse Event|6|||
44459906|NCT03659136|79468379|FG000|Overall Study|Progressive disease|37|||
44459907|NCT03659136|79468380|FG001|Overall Study|Progressive disease|31|||
44217385|NCT01483599|79015309|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
44217386|NCT01483599|79015310|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
44459908|NCT03659136|79468379|FG000|Overall Study|Study closure|2|||
44459909|NCT03659136|79468380|FG001|Overall Study|Study closure|2|||
44459910|NCT03659136|79468379|FG000|Overall Study|Sponsor decision/recommendation|3|||
44217387|NCT01483599|79015311|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
44217388|NCT01483599|79015312|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
44217389|NCT01483599|79015313|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
44217390|NCT01483599|79015314|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
44217391|NCT01483599|79015301|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
44217392|NCT01483599|79015302|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
44217393|NCT01483599|79015303|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
44217394|NCT01483599|79015304|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
44217395|NCT01483599|79015305|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
44217396|NCT01483599|79015306|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
44217397|NCT01483599|79015307|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
44217398|NCT01483599|79015308|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
44217399|NCT01483599|79015309|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
44217400|NCT01483599|79015310|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
44217401|NCT01483599|79015311|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
44217402|NCT01483599|79015312|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
44217403|NCT01483599|79015313|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
44217404|NCT01483599|79015314|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
44217405|NCT01483599|79015301|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217406|NCT01483599|79015302|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217407|NCT01483599|79015303|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44459911|NCT03659136|79468380|FG001|Overall Study|Sponsor decision/recommendation|2|||
44459912|NCT03659136|79468379|FG000|Overall Study|Switched to other drug/therapy|2|||
44459913|NCT03659136|79468380|FG001|Overall Study|Switched to other drug/therapy|2|||
44459914|NCT03659136|79468379|FG000|Overall Study|Lack of clinical benefit|0|||
44459915|NCT03659136|79468380|FG001|Overall Study|Lack of clinical benefit|1|||
44459916|NCT03390036|79468415|FG000|Overall Study|Lost to Follow-up|1|||
44217408|NCT01483599|79015304|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217409|NCT01483599|79015305|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217410|NCT01483599|79015306|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217411|NCT01483599|79015307|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217412|NCT01483599|79015308|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
44217413|NCT01483599|79015309|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
44217414|NCT01483599|79015310|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217415|NCT01483599|79015311|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217416|NCT01483599|79015312|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
44217417|NCT01483599|79015313|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
44217418|NCT01483599|79015314|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
44217419|NCT01483599|79015301|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217420|NCT01483599|79015302|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217421|NCT01483599|79015303|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217422|NCT01483599|79015304|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217423|NCT01483599|79015305|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44459917|NCT03390036|79468416|FG001|Overall Study|Lost to Follow-up|0|||
44459918|NCT03390036|79468417|FG002|Overall Study|Lost to Follow-up|0|||
44217424|NCT01483599|79015306|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217425|NCT01483599|79015307|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44459919|NCT03390036|79468415|FG000|Overall Study|Lack of Efficacy|1|||
44217426|NCT01483599|79015308|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217427|NCT01483599|79015309|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
44217428|NCT01483599|79015310|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217429|NCT01483599|79015311|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217430|NCT01483599|79015312|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
44217431|NCT01483599|79015313|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
44217432|NCT01483599|79015314|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
44217433|NCT01483599|79015301|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217434|NCT01483599|79015302|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217435|NCT01483599|79015303|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217436|NCT01483599|79015304|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217437|NCT01483599|79015305|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217438|NCT01483599|79015306|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217439|NCT01483599|79015307|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217440|NCT01483599|79015308|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217441|NCT01483599|79015309|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
44217442|NCT01483599|79015310|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217443|NCT01483599|79015311|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
44217444|NCT01483599|79015312|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217445|NCT01483599|79015313|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
44217446|NCT01483599|79015314|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
44217447|NCT01483599|79015301|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217448|NCT01483599|79015302|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44373005|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
44373006|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
44373007|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
44373008|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
44373009|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
44544085|NCT03235050|79557282|FG002|Overall Study|Lost to Follow-up|1|||
44217449|NCT01483599|79015303|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217450|NCT01483599|79015304|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217451|NCT01483599|79015305|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217452|NCT01483599|79015306|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217453|NCT01483599|79015307|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217454|NCT01483599|79015308|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217455|NCT01483599|79015309|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
44217456|NCT01483599|79015310|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217457|NCT01483599|79015311|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217458|NCT01483599|79015312|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
44217459|NCT01483599|79015313|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
44217460|NCT01483599|79015314|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
44217461|NCT01483599|79015301|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
44217462|NCT01483599|79015302|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
44217463|NCT01483599|79015303|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
44217464|NCT01483599|79015304|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
44217465|NCT01483599|79015305|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
44217466|NCT01483599|79015306|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
44217467|NCT01483599|79015307|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
44217468|NCT01483599|79015308|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
44217469|NCT01483599|79015309|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
44217470|NCT01483599|79015310|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
44217471|NCT01483599|79015311|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
44217472|NCT01483599|79015312|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
44217473|NCT01483599|79015313|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
44217474|NCT01483599|79015314|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
44217475|NCT01507545|79015390|FG000|Overall Study|Withdrawal by Subject|6|||
44217476|NCT01507545|79015391|FG001|Overall Study|Withdrawal by Subject|2|||
44217477|NCT01507545|79015390|FG000|Overall Study|Lost to Follow-up|1|||
44217478|NCT01507545|79015391|FG001|Overall Study|Lost to Follow-up|0|||
44217479|NCT01507545|79015390|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
44217480|NCT01507545|79015391|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
44217481|NCT01507545|79015390|FG000|Overall Study|Progressive disease|60|||
44217482|NCT01507545|79015391|FG001|Overall Study|Progressive disease|27|||
44217483|NCT01507545|79015390|FG000|Overall Study|Other|6|||
44217484|NCT01507545|79015391|FG001|Overall Study|Other|4|||
44217485|NCT01482819|79015397|FG000|Overall Study|Lost to Follow-up|2|||
44217486|NCT01534533|79015409|FG000|Overall Study|Lost to Follow-up|3|||
44217487|NCT01534533|79015410|FG001|Overall Study|Lost to Follow-up|0|||
44217488|NCT01534533|79015411|FG002|Overall Study|Lost to Follow-up|4|||
44217489|NCT01534533|79015412|FG003|Overall Study|Lost to Follow-up|3|||
44217490|NCT01534533|79015409|FG000|Overall Study|Withdrawal by Subject|5|||
44217491|NCT01534533|79015410|FG001|Overall Study|Withdrawal by Subject|3|||
44217492|NCT01534533|79015411|FG002|Overall Study|Withdrawal by Subject|4|||
44217493|NCT01534533|79015412|FG003|Overall Study|Withdrawal by Subject|1|||
44217494|NCT01506609|79015546|FG000|Overall Study|Adverse Event Related to Progression|0|||
44217495|NCT01506609|79015547|FG001|Overall Study|Adverse Event Related to Progression|0|||
44217496|NCT01506609|79015548|FG002|Overall Study|Adverse Event Related to Progression|0|||
44217497|NCT01506609|79015549|FG003|Overall Study|Adverse Event Related to Progression|3|||
44217498|NCT01506609|79015550|FG004|Overall Study|Adverse Event Related to Progression|7|||
44217499|NCT01506609|79015551|FG005|Overall Study|Adverse Event Related to Progression|3|||
44217500|NCT01506609|79015546|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
44217501|NCT01506609|79015547|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
44217502|NCT01506609|79015548|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
44217503|NCT01506609|79015549|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
44217504|NCT01506609|79015550|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
44217505|NCT01506609|79015551|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
44217506|NCT01506609|79015546|FG000|Overall Study|Withdrawal by Subject|0|||
44217507|NCT01506609|79015547|FG001|Overall Study|Withdrawal by Subject|0|||
44373010|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
44217508|NCT01506609|79015548|FG002|Overall Study|Withdrawal by Subject|0|||
44217509|NCT01506609|79015549|FG003|Overall Study|Withdrawal by Subject|9|||
44217510|NCT01506609|79015550|FG004|Overall Study|Withdrawal by Subject|7|||
44217511|NCT01506609|79015551|FG005|Overall Study|Withdrawal by Subject|7|||
44217512|NCT01506609|79015546|FG000|Overall Study|Lost to Follow-up|0|||
44217513|NCT01506609|79015547|FG001|Overall Study|Lost to Follow-up|0|||
44217514|NCT01506609|79015548|FG002|Overall Study|Lost to Follow-up|0|||
44217515|NCT01506609|79015549|FG003|Overall Study|Lost to Follow-up|1|||
44217516|NCT01506609|79015550|FG004|Overall Study|Lost to Follow-up|2|||
44217517|NCT01506609|79015551|FG005|Overall Study|Lost to Follow-up|0|||
44217518|NCT01506609|79015546|FG000|Overall Study|Sponsor Discontinued Study|0|||
44373011|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
44217519|NCT01506609|79015547|FG001|Overall Study|Sponsor Discontinued Study|0|||
44217520|NCT01506609|79015548|FG002|Overall Study|Sponsor Discontinued Study|0|||
44217521|NCT01506609|79015549|FG003|Overall Study|Sponsor Discontinued Study|2|||
44217522|NCT01506609|79015550|FG004|Overall Study|Sponsor Discontinued Study|2|||
44217523|NCT01506609|79015551|FG005|Overall Study|Sponsor Discontinued Study|0|||
44217524|NCT01506609|79015546|FG000|Overall Study|Progressive Disease per Protocol|1|||
44217525|NCT01506609|79015547|FG001|Overall Study|Progressive Disease per Protocol|0|||
44217526|NCT01506609|79015548|FG002|Overall Study|Progressive Disease per Protocol|0|||
44217527|NCT01506609|79015549|FG003|Overall Study|Progressive Disease per Protocol|64|||
44217528|NCT01506609|79015550|FG004|Overall Study|Progressive Disease per Protocol|57|||
44217529|NCT01506609|79015551|FG005|Overall Study|Progressive Disease per Protocol|74|||
44217530|NCT01506609|79015546|FG000|Overall Study|Other, Not Specified|0|||
44217531|NCT01506609|79015547|FG001|Overall Study|Other, Not Specified|0|||
44217532|NCT01506609|79015548|FG002|Overall Study|Other, Not Specified|0|||
44217533|NCT01506609|79015549|FG003|Overall Study|Other, Not Specified|10|||
44217534|NCT01506609|79015550|FG004|Overall Study|Other, Not Specified|7|||
44217535|NCT01506609|79015551|FG005|Overall Study|Other, Not Specified|3|||
44217536|NCT01506609|79015546|FG000|Overall Study|Missing / Unknown Reason|1|||
44217537|NCT01506609|79015547|FG001|Overall Study|Missing / Unknown Reason|0|||
44217538|NCT01506609|79015548|FG002|Overall Study|Missing / Unknown Reason|1|||
44217539|NCT01506609|79015549|FG003|Overall Study|Missing / Unknown Reason|4|||
44217540|NCT01506609|79015550|FG004|Overall Study|Missing / Unknown Reason|4|||
44217541|NCT01506609|79015551|FG005|Overall Study|Missing / Unknown Reason|2|||
44459920|NCT03390036|79468416|FG001|Overall Study|Lack of Efficacy|0|||
44459921|NCT03390036|79468417|FG002|Overall Study|Lack of Efficacy|0|||
44459922|NCT03341936|79468442|FG000|Overall Study|Ineligible|1|||
44373012|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
44373013|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
44373014|NCT01144364|79378055|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
44373015|NCT01144364|79378056|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
44373016|NCT01144364|79378057|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
44373017|NCT01119248|79378067|FG000|Overall Study|Physician Decision|5|||
44373018|NCT01131494|79378072|FG000|Overall Study|Withdrawal by Subject|2|||
44373019|NCT01131260|79378079|FG000|Overall Study|Randomization error|5|||
44373020|NCT01131260|79378080|FG001|Overall Study|Randomization error|1|||
44373021|NCT01131260|79378079|FG000|Overall Study|Declined to continue participation|8|||
44373022|NCT01131260|79378080|FG001|Overall Study|Declined to continue participation|13|||
44373023|NCT01131260|79378079|FG000|Overall Study|Physician Decision|22|||
44373024|NCT01131260|79378080|FG001|Overall Study|Physician Decision|24|||
44373025|NCT01131260|79378079|FG000|Overall Study|Technical problems|7|||
44373026|NCT01131260|79378080|FG001|Overall Study|Technical problems|6|||
44373027|NCT01131260|79378079|FG000|Overall Study|Staff error|2|||
44373028|NCT01131260|79378080|FG001|Overall Study|Staff error|1|||
44373029|NCT01131260|79378079|FG000|Overall Study|Ineligible|0|||
44373030|NCT01131260|79378080|FG001|Overall Study|Ineligible|2|||
44373031|NCT00965094|79378090|FG000|Overall Study|Adverse Event|5|||
44373032|NCT00965094|79378091|FG001|Overall Study|Adverse Event|0|||
44373033|NCT00965094|79378090|FG000|Overall Study|Lost to Follow-up|0|||
44373034|NCT00965094|79378091|FG001|Overall Study|Lost to Follow-up|1|||
44373035|NCT01131182|79378100|FG000|Overall Study|Withdrawal by Subject|1|||
44373036|NCT01131182|79378101|FG001|Overall Study|Withdrawal by Subject|1|||
44373037|NCT01131182|79378100|FG000|Overall Study|Lost to Follow-up|14|||
44373038|NCT01131182|79378101|FG001|Overall Study|Lost to Follow-up|15|||
44373039|NCT01131182|79378100|FG000|Overall Study|Other Reason|1|||
44373040|NCT01131182|79378101|FG001|Overall Study|Other Reason|0|||
44373041|NCT00964860|79378109|FG000|Overall Study|Withdrawal by Subject|0|||
44459923|NCT03341936|79468442|FG000|Overall Study|Disease Progression|2|||
44373042|NCT00964860|79378110|FG001|Overall Study|Withdrawal by Subject|1|||
44373043|NCT01131104|79378116|FG000|Overall Study|Withdrawal by Subject|3|||
44373044|NCT01131104|79378116|FG000|Overall Study|Physician Decision|4|||
44373045|NCT01131104|79378116|FG000|Overall Study|Information Not Available|5|||
44373046|NCT01131104|79378116|FG000|Overall Study|No Information on Index Date of Onset|1|||
44373047|NCT01118780|79378122|FG000|Overall Study|Adverse Event|15|||
44373048|NCT01118780|79378123|FG001|Overall Study|Adverse Event|15|||
44373049|NCT01118780|79378122|FG000|Overall Study|Death|1|||
44373050|NCT01118780|79378123|FG001|Overall Study|Death|0|||
44373051|NCT01118780|79378122|FG000|Overall Study|Lack of Efficacy|2|||
44373052|NCT01118780|79378123|FG001|Overall Study|Lack of Efficacy|6|||
44373053|NCT01118780|79378122|FG000|Overall Study|Physician Decision|2|||
44373054|NCT01118780|79378123|FG001|Overall Study|Physician Decision|0|||
44373055|NCT01118780|79378122|FG000|Overall Study|Protocol Violation|3|||
44270245|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44459924|NCT03341936|79468442|FG000|Overall Study|Withdrew Consent|4|||
44459925|NCT03341936|79468442|FG000|Overall Study|Non-Compliance|1|||
44373056|NCT01118780|79378123|FG001|Overall Study|Protocol Violation|6|||
44373057|NCT01118780|79378122|FG000|Overall Study|Withdrawal by Subject|13|||
44373058|NCT01118780|79378123|FG001|Overall Study|Withdrawal by Subject|8|||
44373059|NCT00964782|79378134|FG000|Overall Study|Lost to Follow-up|1|||
44373060|NCT00964782|79378135|FG001|Overall Study|Lost to Follow-up|0|||
44373061|NCT00966654|79378143|FG000|Overall Study|Study was terminated,PI left institution|12|||
44373062|NCT03262116|79378155|FG000|Overall Study|Physician Decision|0|||
44373063|NCT03262116|79378156|FG001|Overall Study|Physician Decision|2|||
44373064|NCT03262116|79378157|FG002|Overall Study|Physician Decision|1|||
44373065|NCT03262116|79378158|FG003|Overall Study|Physician Decision|1|||
44373066|NCT03262116|79378159|FG004|Overall Study|Physician Decision|1|||
44373067|NCT03262116|79378160|FG005|Overall Study|Physician Decision|2|||
44373068|NCT01130168|79378168|FG000|Period 1|Withdrawal by Subject|0|||
44373069|NCT01130168|79378169|FG001|Period 1|Withdrawal by Subject|1|||
44373070|NCT01130168|79378170|FG002|Period 1|Withdrawal by Subject|0|||
44373071|NCT01130168|79378171|FG003|Period 1|Withdrawal by Subject|1|||
44373072|NCT01130168|79378172|FG004|Period 1|Withdrawal by Subject|0|||
44373073|NCT01130168|79378173|FG005|Period 1|Withdrawal by Subject|0|||
44373074|NCT01130168|79378168|FG000|Period 1|Discontinued For Other Reason|0|||
44373075|NCT01130168|79378169|FG001|Period 1|Discontinued For Other Reason|0|||
44373076|NCT01130168|79378170|FG002|Period 1|Discontinued For Other Reason|1|||
44373077|NCT01130168|79378171|FG003|Period 1|Discontinued For Other Reason|1|||
44373078|NCT01130168|79378172|FG004|Period 1|Discontinued For Other Reason|0|||
44373079|NCT01130168|79378173|FG005|Period 1|Discontinued For Other Reason|0|||
44373080|NCT01130168|79378168|FG000|Period 1|Adverse Event|0|||
44373081|NCT01130168|79378169|FG001|Period 1|Adverse Event|0|||
44373082|NCT01130168|79378170|FG002|Period 1|Adverse Event|0|||
44373083|NCT01130168|79378171|FG003|Period 1|Adverse Event|1|||
44373084|NCT01130168|79378172|FG004|Period 1|Adverse Event|0|||
44373085|NCT01130168|79378173|FG005|Period 1|Adverse Event|0|||
44373086|NCT01144052|79378184|FG000|Overall Study|Withdrawal by Subject|1|||
44373087|NCT01144052|79378185|FG001|Overall Study|Withdrawal by Subject|1|||
44373088|NCT01143896|79378195|FG000|Overall Study|Did not complete Baseline Interview|5|||
44373089|NCT01143896|79378196|FG001|Overall Study|Did not complete Baseline Interview|4|||
44373090|NCT01143896|79378195|FG000|Overall Study|Lost to Follow-up|18|||
44373091|NCT01143896|79378196|FG001|Overall Study|Lost to Follow-up|13|||
44373092|NCT01143896|79378195|FG000|Overall Study|Withdrawal by Subject|13|||
44373093|NCT01143896|79378196|FG001|Overall Study|Withdrawal by Subject|5|||
44373094|NCT01143896|79378195|FG000|Overall Study|Death|6|||
44373095|NCT01143896|79378196|FG001|Overall Study|Death|3|||
44373096|NCT01118312|79378205|FG000|Overall Study|Lost to Follow-up|33|||
44373097|NCT01118312|79378206|FG001|Overall Study|Lost to Follow-up|32|||
44373098|NCT01118312|79378205|FG000|Overall Study|Withdrawal by Subject|1|||
44373099|NCT01118312|79378206|FG001|Overall Study|Withdrawal by Subject|3|||
44373100|NCT01117766|79378212|FG000|First Intervention|Adverse Event|0|||
44373101|NCT01117766|79378213|FG001|First Intervention|Adverse Event|1|||
44373102|NCT01117766|79378212|FG000|First Intervention|Protocol Violation|1|||
44373103|NCT01117766|79378213|FG001|First Intervention|Protocol Violation|0|||
44373104|NCT01117766|79378212|FG000|Washout Period|Protocol Violation|0|||
44373105|NCT01117766|79378213|FG001|Washout Period|Protocol Violation|2|||
44373106|NCT01117766|79378212|FG000|Second Intervention|Lost to Follow-up|1|||
44373107|NCT01117766|79378213|FG001|Second Intervention|Lost to Follow-up|0|||
44373108|NCT01117766|79378212|FG000|Second Intervention|Other|1|||
44459926|NCT03341936|79468442|FG000|Overall Study|Physician Decision|1|||
44373109|NCT01117766|79378213|FG001|Second Intervention|Other|2|||
44373110|NCT01117766|79378212|FG000|Second Intervention|Adverse Event|0|||
44373111|NCT01117766|79378213|FG001|Second Intervention|Adverse Event|2|||
44373112|NCT01117766|79378212|FG000|Second Intervention|Withdrawal by Subject|0|||
44544086|NCT03235050|79557283|FG003|Overall Study|Lost to Follow-up|2|||
44459927|NCT03341936|79468442|FG000|Overall Study|Withdrawal by Subject|1|||
44459928|NCT03341936|79468442|FG000|Overall Study|Other|1|||
44373113|NCT01117766|79378213|FG001|Second Intervention|Withdrawal by Subject|1|||
44373114|NCT01117454|79378221|FG000|Overall Study|Pregnancy|0|||
44373115|NCT01117454|79378222|FG001|Overall Study|Pregnancy|1|||
44373116|NCT01116440|79378230|FG000|Treatment|Withdrawal by Subject|2|||
44373117|NCT01116440|79378231|FG001|Treatment|Withdrawal by Subject|2|||
44373118|NCT01116440|79378230|FG000|Treatment|Lost to Follow-up|1|||
44373119|NCT01116440|79378231|FG001|Treatment|Lost to Follow-up|1|||
44373120|NCT01116440|79378230|FG000|Treatment|Protocol Violation|0|||
44373121|NCT01116440|79378231|FG001|Treatment|Protocol Violation|2|||
44373122|NCT01116440|79378230|FG000|Treatment|Lack of Efficacy|0|||
44373123|NCT01116440|79378231|FG001|Treatment|Lack of Efficacy|1|||
44373124|NCT01116440|79378230|FG000|Treatment|Adverse Event|0|||
44373125|NCT01116440|79378231|FG001|Treatment|Adverse Event|1|||
44373126|NCT01116440|79378230|FG000|Withdrawal|Withdrawal by Subject|0|||
44373127|NCT01116440|79378231|FG001|Withdrawal|Withdrawal by Subject|1|||
44373128|NCT01116440|79378230|FG000|Withdrawal|Lost to Follow-up|0|||
44373129|NCT01116440|79378231|FG001|Withdrawal|Lost to Follow-up|1|||
44459929|NCT03284203|79468446|FG000|Overall Study|Lost to Follow-up|3|||
44373130|NCT01116440|79378230|FG000|Follow-up|Lost to Follow-up|0|||
44373131|NCT01116440|79378231|FG001|Follow-up|Lost to Follow-up|1|||
44373132|NCT01116440|79378230|FG000|Follow-up|Withdrawal by Subject|0|||
44373133|NCT01116440|79378231|FG001|Follow-up|Withdrawal by Subject|1|||
44217542|NCT01506453|79015575|FG000|Overall Study|Withdrawal prior to treatment|0|||
44217543|NCT01506453|79015576|FG001|Overall Study|Withdrawal prior to treatment|2|||
44373134|NCT01129622|79378239|FG000|Overall Study|Withdrawal by Subject|2|||
44217544|NCT01482429|79015584|FG000|Care Usual|Protocol Violation|0|||
44373135|NCT01128842|79378244|FG000|Overall Study|Adverse Event|1|||
44459930|NCT03233724|79468455|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
44459931|NCT03233724|79468456|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
44459932|NCT03233724|79468457|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
44459933|NCT03233724|79468458|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
44459934|NCT03233724|79468459|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
44459935|NCT03233724|79468455|FG000|Phase I Dose Escalation|Best interest of participant|1|||
44459936|NCT03233724|79468456|FG001|Phase I Dose Escalation|Best interest of participant|1|||
44459937|NCT03233724|79468457|FG002|Phase I Dose Escalation|Best interest of participant|1|||
44459938|NCT03233724|79468458|FG003|Phase I Dose Escalation|Best interest of participant|0|||
44459939|NCT03233724|79468459|FG004|Phase I Dose Escalation|Best interest of participant|0|||
44459940|NCT03233724|79468455|FG000|Phase I Dose Escalation|Physician Decision|0|||
44459941|NCT03233724|79468456|FG001|Phase I Dose Escalation|Physician Decision|0|||
44459942|NCT03233724|79468457|FG002|Phase I Dose Escalation|Physician Decision|1|||
44217545|NCT01482429|79015585|FG001|Care Usual|Protocol Violation|172|||
44217546|NCT01482429|79015584|FG000|Care Usual|Lost to Follow-up|0|||
44217547|NCT01482429|79015585|FG001|Care Usual|Lost to Follow-up|1|||
44217548|NCT01482429|79015584|FG000|Protocol|Protocol Violation|275|||
44217549|NCT01482429|79015585|FG001|Protocol|Protocol Violation|0|||
44217550|NCT01504971|79015591|FG000|Overall Study|Physician Decision|13|||
44217551|NCT01479777|79015599|FG000|Overall Study|Physician Decision|2|||
44217552|NCT01479621|79015609|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
44217553|NCT01479621|79015610|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44217554|NCT01479621|79015611|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44217555|NCT01479621|79015612|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44217556|NCT01479621|79015613|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44217557|NCT01479621|79015614|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44217558|NCT01479621|79015615|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44217559|NCT01479621|79015609|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
44217560|NCT01479621|79015610|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44217561|NCT01479621|79015611|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44217562|NCT01479621|79015612|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44217563|NCT01479621|79015613|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44217564|NCT01479621|79015614|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44217565|NCT01479621|79015615|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44217566|NCT01479621|79015609|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
44217567|NCT01479621|79015610|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44217568|NCT01479621|79015611|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44217569|NCT01479621|79015612|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44217570|NCT01479621|79015613|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44217571|NCT01479621|79015614|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44217572|NCT01479621|79015615|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44217573|NCT01479621|79015609|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
44217574|NCT01479621|79015610|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44217575|NCT01479621|79015611|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44217576|NCT01479621|79015612|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44217577|NCT01479621|79015613|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44217578|NCT01479621|79015614|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44373136|NCT01128842|79378244|FG000|Overall Study|Disease Progression|6|||
44373137|NCT01143038|79378249|FG000|Overall Study|Withdrawal by Subject|4|||
44373138|NCT01143038|79378249|FG000|Overall Study|Requirement for alternative therapy|5|||
44373139|NCT01143038|79378249|FG000|Overall Study|Adverse Event|3|||
44373140|NCT01143038|79378249|FG000|Overall Study|Lost to Follow-up|2|||
44373141|NCT01143038|79378249|FG000|Overall Study|Protocol Deviation|1|||
44373142|NCT01143038|79378249|FG000|Overall Study|Death|1|||
44373143|NCT00966264|79378255|FG000|Overall Study|Lost to Follow-up|4|||
44373144|NCT00966264|79378256|FG001|Overall Study|Lost to Follow-up|3|||
44373145|NCT00915525|79378264|FG000|Overall Study|Protocol Violation|9|||
44373146|NCT00915525|79378265|FG001|Overall Study|Protocol Violation|4|||
44373147|NCT00915525|79378264|FG000|Overall Study|Withdrawal by Subject|59|||
44373148|NCT00915525|79378265|FG001|Overall Study|Withdrawal by Subject|21|||
44373149|NCT00915525|79378264|FG000|Overall Study|Lost to Follow-up|27|||
44373150|NCT00915525|79378265|FG001|Overall Study|Lost to Follow-up|16|||
44373151|NCT00915525|79378264|FG000|Overall Study|Pregnancy|2|||
44373152|NCT00915525|79378265|FG001|Overall Study|Pregnancy|0|||
44373153|NCT00915525|79378264|FG000|Overall Study|Lack of Efficacy|15|||
44373154|NCT00915525|79378265|FG001|Overall Study|Lack of Efficacy|32|||
44373155|NCT00915525|79378264|FG000|Overall Study|Adverse Event|29|||
44373156|NCT00915525|79378265|FG001|Overall Study|Adverse Event|13|||
44373157|NCT00915525|79378264|FG000|Overall Study|Missing|12|||
44373158|NCT00915525|79378265|FG001|Overall Study|Missing|1|||
44373159|NCT00915525|79378264|FG000|Overall Study|Other Reason|35|||
44373160|NCT00915525|79378265|FG001|Overall Study|Other Reason|12|||
44373161|NCT00915525|79378264|FG000|Overall Study|Site Closed|27|||
44373162|NCT00915525|79378265|FG001|Overall Study|Site Closed|9|||
44373163|NCT00915525|79378264|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
44373164|NCT00915525|79378265|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
44459943|NCT03233724|79468458|FG003|Phase I Dose Escalation|Physician Decision|0|||
44459944|NCT03233724|79468459|FG004|Phase I Dose Escalation|Physician Decision|0|||
44459945|NCT03233724|79468455|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
44544087|NCT03235050|79557284|FG004|Overall Study|Lost to Follow-up|0|||
44459946|NCT03233724|79468456|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
44459947|NCT03233724|79468457|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
44459948|NCT03233724|79468458|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
44459949|NCT03233724|79468459|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
44544088|NCT03235050|79557280|FG000|Overall Study|Withdrawal by Subject|3|||
44544089|NCT03235050|79557281|FG001|Overall Study|Withdrawal by Subject|2|||
44544090|NCT03235050|79557282|FG002|Overall Study|Withdrawal by Subject|2|||
44544091|NCT03235050|79557283|FG003|Overall Study|Withdrawal by Subject|5|||
44544092|NCT03235050|79557284|FG004|Overall Study|Withdrawal by Subject|7|||
44373165|NCT00915525|79378264|FG000|Overall Study|Study Burden|28|||
44373166|NCT00915525|79378265|FG001|Overall Study|Study Burden|12|||
44459950|NCT03026283|79468473|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
44544093|NCT03235050|79557280|FG000|Overall Study|Other reasons|0|||
44373167|NCT00915525|79378264|FG000|Overall Study|Non-Compliance|3|||
44373168|NCT00915525|79378265|FG001|Overall Study|Non-Compliance|1|||
44373169|NCT00915525|79378264|FG000|Overall Study|Patient Moved|15|||
44373170|NCT00915525|79378265|FG001|Overall Study|Patient Moved|9|||
44373171|NCT01074047|79378293|FG000|Treatment Phase|Adverse Event|89|||
44373172|NCT01074047|79378294|FG001|Treatment Phase|Adverse Event|66|||
44373173|NCT01074047|79378293|FG000|Treatment Phase|Disease Progression|16|||
44373174|NCT01074047|79378294|FG001|Treatment Phase|Disease Progression|21|||
44373175|NCT01074047|79378293|FG000|Treatment Phase|Withdrawal by Subject|27|||
44373176|NCT01074047|79378294|FG001|Treatment Phase|Withdrawal by Subject|48|||
44373177|NCT01074047|79378293|FG000|Treatment Phase|Death|53|||
44373178|NCT01074047|79378294|FG001|Treatment Phase|Death|58|||
44373179|NCT01074047|79378293|FG000|Treatment Phase|Lost to Follow-up|0|||
44373180|NCT01074047|79378294|FG001|Treatment Phase|Lost to Follow-up|1|||
44373181|NCT01074047|79378293|FG000|Treatment Phase|Protocol Violation|0|||
44459951|NCT03026283|79468474|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
44459952|NCT03026283|79468475|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
44459953|NCT03026283|79468476|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
44459954|NCT03026283|79468477|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
44373182|NCT01074047|79378294|FG001|Treatment Phase|Protocol Violation|1|||
44373183|NCT01074047|79378293|FG000|Treatment Phase|Miscellaneous|32|||
44373184|NCT01074047|79378294|FG001|Treatment Phase|Miscellaneous|39|||
44373185|NCT01074047|79378293|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
44373186|NCT01074047|79378294|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
44217579|NCT01479621|79015615|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44217580|NCT01479621|79015609|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
44217581|NCT01479621|79015610|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44217582|NCT01479621|79015611|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44217583|NCT01479621|79015612|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44217584|NCT01479621|79015613|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44217585|NCT01479621|79015614|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44217586|NCT01479621|79015615|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44217587|NCT01479621|79015609|FG000|Treatment Period|Adverse Event|0|||
44217588|NCT01479621|79015610|FG001|Treatment Period|Adverse Event|0|||
44217589|NCT01479621|79015611|FG002|Treatment Period|Adverse Event|0|||
44217590|NCT01479621|79015612|FG003|Treatment Period|Adverse Event|0|||
44217591|NCT01479621|79015613|FG004|Treatment Period|Adverse Event|1|||
44217592|NCT01479621|79015614|FG005|Treatment Period|Adverse Event|2|||
44217593|NCT01479621|79015615|FG006|Treatment Period|Adverse Event|2|||
44217594|NCT01479621|79015609|FG000|Treatment Period|Withdrawal by Subject|0|||
44217595|NCT01479621|79015610|FG001|Treatment Period|Withdrawal by Subject|4|||
44217596|NCT01479621|79015611|FG002|Treatment Period|Withdrawal by Subject|2|||
44217597|NCT01479621|79015612|FG003|Treatment Period|Withdrawal by Subject|2|||
44217598|NCT01479621|79015613|FG004|Treatment Period|Withdrawal by Subject|5|||
44217599|NCT01479621|79015614|FG005|Treatment Period|Withdrawal by Subject|5|||
44217600|NCT01479621|79015615|FG006|Treatment Period|Withdrawal by Subject|1|||
44217601|NCT01479621|79015609|FG000|Treatment Period|Physician Decision|0|||
44217602|NCT01479621|79015610|FG001|Treatment Period|Physician Decision|0|||
44373187|NCT01074047|79378293|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
44373188|NCT01074047|79378294|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
44217603|NCT01479621|79015611|FG002|Treatment Period|Physician Decision|0|||
44217604|NCT01479621|79015612|FG003|Treatment Period|Physician Decision|0|||
44373189|NCT01074047|79378293|FG000|Survival Follow-Up Phase|Death|116|||
44217605|NCT01479621|79015613|FG004|Treatment Period|Physician Decision|1|||
44217606|NCT01479621|79015614|FG005|Treatment Period|Physician Decision|1|||
44217607|NCT01479621|79015615|FG006|Treatment Period|Physician Decision|0|||
44217608|NCT01479621|79015609|FG000|Treatment Period|Non-compliance to study drug|0|||
44373190|NCT01074047|79378294|FG001|Survival Follow-Up Phase|Death|124|||
44217609|NCT01479621|79015610|FG001|Treatment Period|Non-compliance to study drug|1|||
44217610|NCT01479621|79015611|FG002|Treatment Period|Non-compliance to study drug|0|||
44217611|NCT01479621|79015612|FG003|Treatment Period|Non-compliance to study drug|0|||
44217612|NCT01479621|79015613|FG004|Treatment Period|Non-compliance to study drug|0|||
44217613|NCT01479621|79015614|FG005|Treatment Period|Non-compliance to study drug|0|||
44217614|NCT01479621|79015615|FG006|Treatment Period|Non-compliance to study drug|1|||
44217615|NCT01479621|79015609|FG000|Treatment Period|Protocol Violation|0|||
44217616|NCT01479621|79015610|FG001|Treatment Period|Protocol Violation|9|||
44217617|NCT01479621|79015611|FG002|Treatment Period|Protocol Violation|6|||
44217618|NCT01479621|79015612|FG003|Treatment Period|Protocol Violation|5|||
44217619|NCT01479621|79015613|FG004|Treatment Period|Protocol Violation|2|||
44217620|NCT01479621|79015614|FG005|Treatment Period|Protocol Violation|10|||
44217621|NCT01479621|79015615|FG006|Treatment Period|Protocol Violation|6|||
44459955|NCT03026283|79468478|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
44459956|NCT03026283|79468479|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
44459957|NCT03026283|79468480|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
44459958|NCT03026283|79468473|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
44459959|NCT03026283|79468474|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
44459960|NCT03026283|79468475|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
44459961|NCT03026283|79468476|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
44459962|NCT03026283|79468477|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
44459963|NCT03026283|79468478|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
44459964|NCT03026283|79468479|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
44459965|NCT03026283|79468480|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
44217622|NCT01479621|79015609|FG000|Treatment Period|Pregnancy|0|||
44459966|NCT03026283|79468473|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44459967|NCT03026283|79468474|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
44459968|NCT03026283|79468475|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44459969|NCT03026283|79468476|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44217623|NCT01479621|79015610|FG001|Treatment Period|Pregnancy|0|||
44217624|NCT01479621|79015611|FG002|Treatment Period|Pregnancy|2|||
44217625|NCT01479621|79015612|FG003|Treatment Period|Pregnancy|0|||
44217626|NCT01479621|79015613|FG004|Treatment Period|Pregnancy|0|||
44217627|NCT01479621|79015614|FG005|Treatment Period|Pregnancy|0|||
44217628|NCT01479621|79015615|FG006|Treatment Period|Pregnancy|0|||
44217629|NCT01479621|79015609|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
44217630|NCT01479621|79015610|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
44217631|NCT01479621|79015611|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
44217632|NCT01479621|79015612|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
44217633|NCT01479621|79015613|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
44217634|NCT01479621|79015614|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
44217635|NCT01479621|79015615|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
44217636|NCT01479621|79015609|FG000|Treatment Period|Lost to Follow-up|0|||
44217637|NCT01479621|79015610|FG001|Treatment Period|Lost to Follow-up|0|||
44217638|NCT01479621|79015611|FG002|Treatment Period|Lost to Follow-up|1|||
44270246|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270247|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270248|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270249|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44373191|NCT01074047|79378293|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
44373192|NCT01074047|79378294|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
44373193|NCT01074047|79378293|FG000|Extension Phase|Physician Decision|1|||
44373194|NCT01074047|79378294|FG001|Extension Phase|Physician Decision|0|||
44373195|NCT01074047|79378293|FG000|Extension Phase|Adverse Event|5|||
44373196|NCT01074047|79378294|FG001|Extension Phase|Adverse Event|0|||
44373197|NCT01074047|79378293|FG000|Extension Phase|Disease Progression|9|||
44373198|NCT01074047|79378294|FG001|Extension Phase|Disease Progression|0|||
44373199|NCT01074047|79378293|FG000|Extension Phase|Withdrawal by Subject|2|||
44373200|NCT01074047|79378294|FG001|Extension Phase|Withdrawal by Subject|0|||
44373201|NCT01074047|79378293|FG000|Extension Phase|Death|5|||
44373202|NCT01074047|79378294|FG001|Extension Phase|Death|0|||
44217639|NCT01479621|79015612|FG003|Treatment Period|Lost to Follow-up|0|||
44217640|NCT01479621|79015613|FG004|Treatment Period|Lost to Follow-up|2|||
44217641|NCT01479621|79015614|FG005|Treatment Period|Lost to Follow-up|2|||
44373203|NCT01142726|79378310|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
44459970|NCT03026283|79468477|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44217642|NCT01479621|79015615|FG006|Treatment Period|Lost to Follow-up|1|||
44217643|NCT01479621|79015609|FG000|Treatment Period|Met stopping criteria|0|||
44217644|NCT01479621|79015610|FG001|Treatment Period|Met stopping criteria|8|||
44217645|NCT01479621|79015611|FG002|Treatment Period|Met stopping criteria|7|||
44217646|NCT01479621|79015612|FG003|Treatment Period|Met stopping criteria|4|||
44217647|NCT01479621|79015613|FG004|Treatment Period|Met stopping criteria|9|||
44217648|NCT01479621|79015614|FG005|Treatment Period|Met stopping criteria|20|||
44217649|NCT01479621|79015615|FG006|Treatment Period|Met stopping criteria|6|||
44217650|NCT01479465|79015663|FG000|Overall Study|Disease Progression|9|||
44217651|NCT01479465|79015664|FG001|Overall Study|Disease Progression|61|||
44217652|NCT01479465|79015665|FG002|Overall Study|Disease Progression|65|||
44217653|NCT01479465|79015666|FG003|Overall Study|Disease Progression|70|||
44217654|NCT01479465|79015663|FG000|Overall Study|Study Discontinued by Sponsor|0|||
44217655|NCT01479465|79015664|FG001|Overall Study|Study Discontinued by Sponsor|7|||
44217656|NCT01479465|79015665|FG002|Overall Study|Study Discontinued by Sponsor|5|||
44217657|NCT01479465|79015666|FG003|Overall Study|Study Discontinued by Sponsor|3|||
44217658|NCT01479465|79015663|FG000|Overall Study|Adverse Event|0|||
44217659|NCT01479465|79015664|FG001|Overall Study|Adverse Event|3|||
44217660|NCT01479465|79015665|FG002|Overall Study|Adverse Event|6|||
44217661|NCT01479465|79015666|FG003|Overall Study|Adverse Event|4|||
44217662|NCT01479465|79015663|FG000|Overall Study|Investigator Discretion|1|||
44217663|NCT01479465|79015664|FG001|Overall Study|Investigator Discretion|4|||
44217664|NCT01479465|79015665|FG002|Overall Study|Investigator Discretion|2|||
44217665|NCT01479465|79015666|FG003|Overall Study|Investigator Discretion|4|||
44217666|NCT01479465|79015663|FG000|Overall Study|Subject Request|1|||
44217667|NCT01479465|79015664|FG001|Overall Study|Subject Request|3|||
44217668|NCT01479465|79015665|FG002|Overall Study|Subject Request|4|||
44217669|NCT01479465|79015666|FG003|Overall Study|Subject Request|2|||
44217670|NCT01479465|79015663|FG000|Overall Study|Subject Withdrew Consent|0|||
44217671|NCT01479465|79015664|FG001|Overall Study|Subject Withdrew Consent|5|||
44217672|NCT01479465|79015665|FG002|Overall Study|Subject Withdrew Consent|2|||
44217673|NCT01479465|79015666|FG003|Overall Study|Subject Withdrew Consent|1|||
44217674|NCT01479465|79015663|FG000|Overall Study|Protocol Violation|0|||
44217675|NCT01479465|79015664|FG001|Overall Study|Protocol Violation|1|||
44217676|NCT01479465|79015665|FG002|Overall Study|Protocol Violation|1|||
44217677|NCT01479465|79015666|FG003|Overall Study|Protocol Violation|0|||
44217678|NCT01479465|79015663|FG000|Overall Study|Death|0|||
44217679|NCT01479465|79015664|FG001|Overall Study|Death|0|||
44217680|NCT01479465|79015665|FG002|Overall Study|Death|0|||
44217681|NCT01479465|79015666|FG003|Overall Study|Death|1|||
44217682|NCT01479465|79015663|FG000|Overall Study|Lost to Follow-up|0|||
44217683|NCT01479465|79015664|FG001|Overall Study|Lost to Follow-up|0|||
44373204|NCT01142726|79378311|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
44373205|NCT01142726|79378312|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
44217684|NCT01479465|79015665|FG002|Overall Study|Lost to Follow-up|1|||
44217685|NCT01479465|79015666|FG003|Overall Study|Lost to Follow-up|0|||
44217686|NCT01503021|79015720|FG000|Overall Study|Adverse Event|7|||
44217687|NCT01503021|79015721|FG001|Overall Study|Adverse Event|6|||
44217688|NCT01503021|79015720|FG000|Overall Study|Death|0|||
44217689|NCT01503021|79015721|FG001|Overall Study|Death|2|||
44217690|NCT01503021|79015720|FG000|Overall Study|Lost to Follow-up|2|||
44217691|NCT01503021|79015721|FG001|Overall Study|Lost to Follow-up|0|||
44217692|NCT01503021|79015720|FG000|Overall Study|Physician Decision|3|||
44217693|NCT01503021|79015721|FG001|Overall Study|Physician Decision|0|||
44217694|NCT01503021|79015720|FG000|Overall Study|Protocol Violation|1|||
44217695|NCT01503021|79015721|FG001|Overall Study|Protocol Violation|3|||
44217696|NCT01503021|79015720|FG000|Overall Study|Withdrawal by Subject|9|||
44217697|NCT01503021|79015721|FG001|Overall Study|Withdrawal by Subject|8|||
44217698|NCT01503021|79015720|FG000|Overall Study|Moved, received transplant, etc.|5|||
44217699|NCT01503021|79015721|FG001|Overall Study|Moved, received transplant, etc.|7|||
44217700|NCT01531725|79015732|FG000|Overall Study|Protocol Violation|5|||
44459971|NCT03026283|79468478|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44217701|NCT01478373|79015736|FG000|Treatment Phase|Protocol Violation|1|||
44217702|NCT01478373|79015736|FG000|Survival Phase|Adverse Event|8|||
44373206|NCT01142726|79378310|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
44373207|NCT01142726|79378311|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
44459972|NCT03026283|79468479|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44459973|NCT03026283|79468480|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
44459974|NCT03026283|79468473|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459975|NCT03026283|79468474|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459976|NCT03026283|79468475|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
44459977|NCT03026283|79468476|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459978|NCT03026283|79468477|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459979|NCT03026283|79468478|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459980|NCT03026283|79468479|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459981|NCT03026283|79468480|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
44459982|NCT03026283|79468473|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
44459983|NCT03026283|79468474|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
44459984|NCT03026283|79468475|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
44459985|NCT03026283|79468476|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
44459986|NCT03026283|79468477|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
44459987|NCT03026283|79468478|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
44459988|NCT03026283|79468479|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
44459989|NCT03026283|79468480|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
44459990|NCT03026283|79468473|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
44459991|NCT03026283|79468474|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
44459992|NCT03026283|79468475|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
44459993|NCT03026283|79468476|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
44459994|NCT03026283|79468477|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
44459995|NCT03026283|79468478|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
44459996|NCT03026283|79468479|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
44459997|NCT03026283|79468480|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
44459998|NCT03026283|79468473|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
44459999|NCT03026283|79468474|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
44460000|NCT03026283|79468475|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
44460001|NCT03026283|79468476|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
44460002|NCT03026283|79468477|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
44460003|NCT03026283|79468478|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
44373208|NCT01142726|79378312|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
44373209|NCT01142726|79378310|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
44373210|NCT01142726|79378311|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
44373211|NCT01142726|79378312|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
44373212|NCT01142726|79378310|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
44373213|NCT01142726|79378311|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
44460004|NCT03026283|79468479|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
44460005|NCT03026283|79468480|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
44460006|NCT03026283|79468473|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44460007|NCT03026283|79468474|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44460008|NCT03026283|79468475|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44460009|NCT03026283|79468476|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
44460010|NCT03026283|79468477|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44460011|NCT03026283|79468478|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44460012|NCT03026283|79468479|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44460013|NCT03026283|79468480|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
44217703|NCT01478373|79015736|FG000|Survival Phase|Protocol Violation|1|||
44217704|NCT01478373|79015736|FG000|Survival Phase|crossover to another study|2|||
44217705|NCT01478373|79015736|FG000|Survival Phase|Progressive Disease|27|||
44217706|NCT01502709|79015742|FG000|Overall Study|Lost to Follow-up|4|||
44217707|NCT01502709|79015743|FG001|Overall Study|Lost to Follow-up|0|||
44373214|NCT01142726|79378312|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
44217708|NCT01477749|79015750|FG000|Overall Study|Physician Decision|4|||
44217709|NCT01502631|79015780|FG000|Overall Study|Adverse Event|5|||
44217710|NCT01502631|79015781|FG001|Overall Study|Adverse Event|8|||
44373215|NCT01142726|79378310|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
44217711|NCT01502631|79015780|FG000|Overall Study|Lost to Follow-up|2|||
44217712|NCT01502631|79015781|FG001|Overall Study|Lost to Follow-up|2|||
44217713|NCT01502631|79015780|FG000|Overall Study|Participant withdrew consent|2|||
44217714|NCT01502631|79015781|FG001|Overall Study|Participant withdrew consent|4|||
44217715|NCT01502631|79015780|FG000|Overall Study|Participant non-compliant|1|||
44217716|NCT01502631|79015781|FG001|Overall Study|Participant non-compliant|0|||
44217717|NCT01502631|79015780|FG000|Overall Study|Investigator's decision|0|||
44217718|NCT01502631|79015781|FG001|Overall Study|Investigator's decision|1|||
44217719|NCT01502631|79015780|FG000|Overall Study|Other|10|||
44217720|NCT01502631|79015781|FG001|Overall Study|Other|5|||
44217721|NCT01475721|79015837|FG000|Overall Study|Death|3|||
44217722|NCT01475721|79015838|FG001|Overall Study|Death|6|||
44217723|NCT01475721|79015837|FG000|Overall Study|Withdrawal by Subject|8|||
44217724|NCT01475721|79015838|FG001|Overall Study|Withdrawal by Subject|8|||
44217725|NCT01530087|79015862|FG000|Overall Study|Physician Decision|2|||
44217726|NCT01475487|79015880|FG000|Overall Study|had to leave early for personal reasons|2|||
44460014|NCT03026283|79468473|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
44460015|NCT03026283|79468474|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
44460016|NCT03026283|79468475|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
44460017|NCT03026283|79468476|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
44460018|NCT03026283|79468477|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
44460019|NCT03026283|79468478|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
44217727|NCT01475487|79015881|FG001|Overall Study|had to leave early for personal reasons|1|||
44460020|NCT03026283|79468479|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
44460021|NCT03026283|79468480|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
44460022|NCT01994954|79468547|FG000|Overall Study|Death|1|||
44460023|NCT01994954|79468548|FG001|Overall Study|Death|0|||
44460024|NCT01994954|79468547|FG000|Overall Study|Withdrawal by Subject|9|||
44460025|NCT01994954|79468548|FG001|Overall Study|Withdrawal by Subject|14|||
44460026|NCT01994954|79468547|FG000|Overall Study|Physician Decision|2|||
44460027|NCT01994954|79468548|FG001|Overall Study|Physician Decision|2|||
44460028|NCT01994954|79468547|FG000|Overall Study|Lost to Follow-up|8|||
44460029|NCT01994954|79468548|FG001|Overall Study|Lost to Follow-up|10|||
44460030|NCT01994954|79468547|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
44460031|NCT01994954|79468548|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
44460032|NCT00380367|79468625|FG000|Overall Study|Lost to Follow-up|1|||
44460033|NCT00380367|79468625|FG000|Overall Study|Withdrawal by Subject|1|||
44460034|NCT00531050|79468635|FG000|Part 1: Period 1|Adverse Event|0|||
44460035|NCT00531050|79468636|FG001|Part 1: Period 1|Adverse Event|1|||
44460036|NCT00531050|79468637|FG002|Part 1: Period 1|Adverse Event|0|||
44460037|NCT00531050|79468638|FG003|Part 1: Period 1|Adverse Event|0|||
44460038|NCT00531050|79468639|FG004|Part 1: Period 1|Adverse Event|0|||
44460039|NCT00531050|79468640|FG005|Part 1: Period 1|Adverse Event|0|||
44460040|NCT00531050|79468635|FG000|Part 1: Period 1|Protocol Deviation|0|||
44460041|NCT00531050|79468636|FG001|Part 1: Period 1|Protocol Deviation|0|||
44460042|NCT00531050|79468637|FG002|Part 1: Period 1|Protocol Deviation|0|||
44460043|NCT00531050|79468638|FG003|Part 1: Period 1|Protocol Deviation|1|||
44460044|NCT00531050|79468639|FG004|Part 1: Period 1|Protocol Deviation|0|||
44217728|NCT01475331|79015889|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
44217729|NCT01475331|79015890|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
44217730|NCT01475331|79015889|FG000|Overall Study|excessive main duct communication|1|||
44217731|NCT01475331|79015890|FG001|Overall Study|excessive main duct communication|1|||
44217732|NCT01475331|79015889|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
44217733|NCT01475331|79015890|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
44217734|NCT01475331|79015889|FG000|Overall Study|Sign of malignancy during the procedure|2|||
44217735|NCT01475331|79015890|FG001|Overall Study|Sign of malignancy during the procedure|0|||
44217736|NCT01475331|79015889|FG000|Overall Study|cyst found to be prohibitively small|0|||
44217737|NCT01475331|79015890|FG001|Overall Study|cyst found to be prohibitively small|1|||
44217738|NCT01500213|79015898|FG000|Overall Study|Adverse Event|35|||
44217739|NCT01500213|79015899|FG001|Overall Study|Adverse Event|35|||
44217740|NCT01500213|79015898|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
44460045|NCT00531050|79468640|FG005|Part 1: Period 1|Protocol Deviation|0|||
44460046|NCT00531050|79468635|FG000|Part 1: Period 3|Adverse Event|1|||
44460047|NCT00531050|79468636|FG001|Part 1: Period 3|Adverse Event|0|||
44460048|NCT00531050|79468637|FG002|Part 1: Period 3|Adverse Event|0|||
44217741|NCT01500213|79015899|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
44217742|NCT01500213|79015898|FG000|Overall Study|Withdrawal by Subject|28|||
44217743|NCT01500213|79015899|FG001|Overall Study|Withdrawal by Subject|37|||
44217744|NCT01500213|79015898|FG000|Overall Study|Death|7|||
44217745|NCT01500213|79015899|FG001|Overall Study|Death|3|||
44217746|NCT01500213|79015898|FG000|Overall Study|Disease Progression|13|||
44217747|NCT01500213|79015899|FG001|Overall Study|Disease Progression|21|||
44217748|NCT01500213|79015898|FG000|Overall Study|Protocol Violation|19|||
44217749|NCT01500213|79015899|FG001|Overall Study|Protocol Violation|19|||
44217750|NCT01500213|79015898|FG000|Overall Study|Physician Decision|12|||
44217751|NCT01500213|79015899|FG001|Overall Study|Physician Decision|10|||
44217752|NCT01500213|79015898|FG000|Overall Study|Lack of Efficacy|9|||
44217753|NCT01500213|79015899|FG001|Overall Study|Lack of Efficacy|7|||
44217754|NCT01500213|79015898|FG000|Overall Study|Lost to Follow-up|3|||
44217755|NCT01500213|79015899|FG001|Overall Study|Lost to Follow-up|6|||
44217756|NCT01500213|79015898|FG000|Overall Study|Other Reasons|7|||
44217757|NCT01500213|79015899|FG001|Overall Study|Other Reasons|5|||
44217758|NCT01475253|79015929|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
44217759|NCT01475253|79015930|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
44217760|NCT01475253|79015931|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
44217761|NCT01475253|79015932|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
44217762|NCT01475253|79015929|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
44217763|NCT01475253|79015930|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
44460049|NCT00531050|79468638|FG003|Part 1: Period 3|Adverse Event|0|||
44217764|NCT01475253|79015931|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
44217765|NCT01475253|79015932|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
44217766|NCT01500135|79015990|FG000|Overall Study|Withdrawal of Consent|4|||
44217767|NCT01500135|79015991|FG001|Overall Study|Withdrawal of Consent|0|||
44373216|NCT01142726|79378311|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
44373217|NCT01142726|79378312|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
44217768|NCT01500135|79015990|FG000|Overall Study|Lost to Follow-up|6|||
44217769|NCT01500135|79015991|FG001|Overall Study|Lost to Follow-up|4|||
44217770|NCT01500135|79015990|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
44217771|NCT01500135|79015991|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
44217772|NCT01500135|79015990|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
44217773|NCT01500135|79015991|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
44217774|NCT01500135|79015990|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
44217775|NCT01500135|79015991|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
44217776|NCT01500135|79015990|FG000|Overall Study|Participant was a Safety Concern|1|||
44217777|NCT01500135|79015991|FG001|Overall Study|Participant was a Safety Concern|0|||
44217778|NCT01500135|79015990|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
44217779|NCT01500135|79015991|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
44217780|NCT01475097|79016003|FG000|Overall Study|Protocol Violation|1|||
44217781|NCT01475097|79016004|FG001|Overall Study|Protocol Violation|1|||
44217782|NCT01529385|79016012|FG000|Overall Study|Lost to Follow-up|2|||
44217783|NCT01529385|79016013|FG001|Overall Study|Lost to Follow-up|1|||
44217784|NCT01474551|79016019|FG000|Overall Study|Death|1|||
44217785|NCT01500057|79016054|FG000|Overall Study|Lost to Follow-up|6|||
44217786|NCT01500057|79016055|FG001|Overall Study|Lost to Follow-up|4|||
44460050|NCT00531050|79468639|FG004|Part 1: Period 3|Adverse Event|0|||
44544094|NCT03235050|79557281|FG001|Overall Study|Other reasons|1|||
44544095|NCT03235050|79557282|FG002|Overall Study|Other reasons|0|||
44217787|NCT01499667|79016073|FG000|Overall Study|administrative problems|4|||
44217788|NCT01499667|79016074|FG001|Overall Study|administrative problems|5|||
44217789|NCT01499667|79016075|FG002|Overall Study|administrative problems|5|||
44217790|NCT01499667|79016073|FG000|Overall Study|Protocol Violation|1|||
44217791|NCT01499667|79016074|FG001|Overall Study|Protocol Violation|3|||
44217792|NCT01499667|79016075|FG002|Overall Study|Protocol Violation|2|||
44217793|NCT01499667|79016073|FG000|Overall Study|Adverse Event|0|||
44373218|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
44217794|NCT01499667|79016074|FG001|Overall Study|Adverse Event|2|||
44217795|NCT01499667|79016075|FG002|Overall Study|Adverse Event|2|||
44217796|NCT01499667|79016073|FG000|Overall Study|Withdrawal by Subject|2|||
44460051|NCT00531050|79468640|FG005|Part 1: Period 3|Adverse Event|0|||
44460052|NCT00531050|79468635|FG000|Part 2: Period 1|Adverse Event|0|||
44460053|NCT00531050|79468636|FG001|Part 2: Period 1|Adverse Event|0|||
44460054|NCT00531050|79468637|FG002|Part 2: Period 1|Adverse Event|0|||
44460055|NCT00531050|79468638|FG003|Part 2: Period 1|Adverse Event|0|||
44460056|NCT00531050|79468639|FG004|Part 2: Period 1|Adverse Event|0|||
44460057|NCT00531050|79468640|FG005|Part 2: Period 1|Adverse Event|1|||
44460058|NCT00531050|79468635|FG000|Part 2: Period 3|Abnormal test procedure|1|||
44460059|NCT00531050|79468636|FG001|Part 2: Period 3|Abnormal test procedure|0|||
44460060|NCT00531050|79468637|FG002|Part 2: Period 3|Abnormal test procedure|0|||
44460061|NCT00531050|79468638|FG003|Part 2: Period 3|Abnormal test procedure|0|||
44460062|NCT00531050|79468639|FG004|Part 2: Period 3|Abnormal test procedure|0|||
44460063|NCT00531050|79468640|FG005|Part 2: Period 3|Abnormal test procedure|1|||
44460064|NCT00530348|79468659|FG000|Overall Study|Adverse Event|5|||
44460065|NCT00530348|79468660|FG001|Overall Study|Adverse Event|1|||
44460066|NCT00530348|79468659|FG000|Overall Study|Death|0|||
44460067|NCT00530348|79468660|FG001|Overall Study|Death|1|||
44460068|NCT00530348|79468659|FG000|Overall Study|Lack of Efficacy|2|||
44460069|NCT00530348|79468660|FG001|Overall Study|Lack of Efficacy|0|||
44460070|NCT00530348|79468659|FG000|Overall Study|Lost to Follow-up|0|||
44373219|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
44373220|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
44373221|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
44373222|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
44373223|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
44373224|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
44373225|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
44373226|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
44373227|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
44373228|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
44373229|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
44373230|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
44373231|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
44373232|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
44373233|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
44373234|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
44373235|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
44373236|NCT01142726|79378310|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
44373237|NCT01142726|79378311|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
44373238|NCT01142726|79378312|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
44373239|NCT01142726|79378310|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
44373240|NCT01142726|79378311|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
44373241|NCT01142726|79378312|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
44373242|NCT01142726|79378310|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
44373243|NCT01142726|79378311|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
44373244|NCT01142726|79378312|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
44373245|NCT01142726|79378310|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
44217797|NCT01499667|79016074|FG001|Overall Study|Withdrawal by Subject|1|||
44217798|NCT01499667|79016075|FG002|Overall Study|Withdrawal by Subject|1|||
44373246|NCT01142726|79378311|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
44373247|NCT01142726|79378312|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
44373248|NCT01142726|79378310|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
44460071|NCT00530348|79468660|FG001|Overall Study|Lost to Follow-up|2|||
44460072|NCT00530348|79468659|FG000|Overall Study|Physician Decision|1|||
44460073|NCT00530348|79468660|FG001|Overall Study|Physician Decision|2|||
44460074|NCT00530348|79468659|FG000|Overall Study|Pregnancy|1|||
44460075|NCT00530348|79468660|FG001|Overall Study|Pregnancy|0|||
44460076|NCT00530348|79468659|FG000|Overall Study|Withdrawal by Subject|12|||
44217799|NCT01499667|79016073|FG000|Overall Study|Lack of Efficacy|2|||
44373249|NCT01142726|79378311|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
44217800|NCT01499667|79016074|FG001|Overall Study|Lack of Efficacy|0|||
44217801|NCT01499667|79016075|FG002|Overall Study|Lack of Efficacy|0|||
44217802|NCT01499511|79016085|FG000|Overall Study|Death|1|||
44217803|NCT01499511|79016086|FG001|Overall Study|Death|0|||
44217804|NCT01474317|79016106|FG000|Overall Study|Adverse Event|1|||
44217805|NCT01474317|79016106|FG000|Overall Study|Subject ineligible for study|1|||
44217806|NCT01499355|79016202|FG000|Run-In Period|Study Termination|15|||
44217807|NCT01499355|79016203|FG001|Run-In Period|Study Termination|0|||
44217808|NCT01499355|79016204|FG002|Run-In Period|Study Termination|0|||
44217809|NCT01499355|79016205|FG003|Run-In Period|Study Termination|0|||
44460077|NCT00530348|79468660|FG001|Overall Study|Withdrawal by Subject|12|||
44460078|NCT00530348|79468659|FG000|Overall Study|Randomised in error|1|||
44460079|NCT00530348|79468660|FG001|Overall Study|Randomised in error|0|||
44460080|NCT00530348|79468659|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
44460081|NCT00530348|79468660|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
44460082|NCT03886220|79468668|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
44460083|NCT03886220|79468669|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
44544096|NCT03235050|79557283|FG003|Overall Study|Other reasons|1|||
44460084|NCT03886220|79468668|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
44270250|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270251|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
44270252|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270253|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270254|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270255|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270256|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270257|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
44270258|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270259|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270260|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270261|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270262|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270263|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
44270264|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
44270265|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
44270266|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
44270267|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44460085|NCT03886220|79468669|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44460086|NCT03886220|79468668|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
44460087|NCT03886220|79468669|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
44460088|NCT00530270|79468677|FG000|Overall Study|Protocol Violation|1|||
44217810|NCT01499355|79016202|FG000|Run-In Period|Other|3|||
44217811|NCT01499355|79016203|FG001|Run-In Period|Other|0|||
44217812|NCT01499355|79016204|FG002|Run-In Period|Other|0|||
44217813|NCT01499355|79016205|FG003|Run-In Period|Other|0|||
44217814|NCT01499355|79016202|FG000|Run-In Period|Death|2|||
44217815|NCT01499355|79016203|FG001|Run-In Period|Death|0|||
44217816|NCT01499355|79016204|FG002|Run-In Period|Death|0|||
44217817|NCT01499355|79016205|FG003|Run-In Period|Death|0|||
44217818|NCT01499355|79016202|FG000|Run-In Period|Investigator Decision|2|||
44217819|NCT01499355|79016203|FG001|Run-In Period|Investigator Decision|0|||
44217820|NCT01499355|79016204|FG002|Run-In Period|Investigator Decision|0|||
44217821|NCT01499355|79016205|FG003|Run-In Period|Investigator Decision|0|||
44217822|NCT01499355|79016202|FG000|Run-In Period|Consent Withdrawn|1|||
44217823|NCT01499355|79016203|FG001|Run-In Period|Consent Withdrawn|0|||
44217824|NCT01499355|79016204|FG002|Run-In Period|Consent Withdrawn|0|||
44217825|NCT01499355|79016205|FG003|Run-In Period|Consent Withdrawn|0|||
44217826|NCT01499355|79016202|FG000|Run-In Period|Adverse Event|8|||
44217827|NCT01499355|79016203|FG001|Run-In Period|Adverse Event|0|||
44217828|NCT01499355|79016204|FG002|Run-In Period|Adverse Event|0|||
44217829|NCT01499355|79016205|FG003|Run-In Period|Adverse Event|0|||
44217830|NCT01499355|79016202|FG000|Double-Blind Period|Adverse Event|0|||
44217831|NCT01499355|79016203|FG001|Double-Blind Period|Adverse Event|2|||
44217832|NCT01499355|79016204|FG002|Double-Blind Period|Adverse Event|3|||
44217833|NCT01499355|79016205|FG003|Double-Blind Period|Adverse Event|2|||
44217834|NCT01499355|79016202|FG000|Double-Blind Period|Study Termination|0|||
44217835|NCT01499355|79016203|FG001|Double-Blind Period|Study Termination|18|||
44217836|NCT01499355|79016204|FG002|Double-Blind Period|Study Termination|16|||
44217837|NCT01499355|79016205|FG003|Double-Blind Period|Study Termination|14|||
44217838|NCT01499355|79016202|FG000|Double-Blind Period|Other|0|||
44217839|NCT01499355|79016203|FG001|Double-Blind Period|Other|1|||
44217840|NCT01499355|79016204|FG002|Double-Blind Period|Other|2|||
44217841|NCT01499355|79016205|FG003|Double-Blind Period|Other|2|||
44217842|NCT01499355|79016202|FG000|Double-Blind Period|Death|0|||
44217843|NCT01499355|79016203|FG001|Double-Blind Period|Death|1|||
44217844|NCT01499355|79016204|FG002|Double-Blind Period|Death|0|||
44217845|NCT01499355|79016205|FG003|Double-Blind Period|Death|0|||
44217846|NCT01499355|79016202|FG000|Double-Blind Period|Investigator Decision|0|||
44217847|NCT01499355|79016203|FG001|Double-Blind Period|Investigator Decision|0|||
44217848|NCT01499355|79016204|FG002|Double-Blind Period|Investigator Decision|3|||
44217849|NCT01499355|79016205|FG003|Double-Blind Period|Investigator Decision|3|||
44217850|NCT01499355|79016202|FG000|Double-Blind Period|Consent Withdrawn|0|||
44217851|NCT01499355|79016203|FG001|Double-Blind Period|Consent Withdrawn|0|||
44217852|NCT01499355|79016204|FG002|Double-Blind Period|Consent Withdrawn|1|||
44217853|NCT01499355|79016205|FG003|Double-Blind Period|Consent Withdrawn|2|||
44460089|NCT00530270|79468678|FG001|Overall Study|Protocol Violation|0|||
44217854|NCT01499355|79016202|FG000|Double-Blind Period|Lost to Follow-up|0|||
44217855|NCT01499355|79016203|FG001|Double-Blind Period|Lost to Follow-up|1|||
44217856|NCT01499355|79016204|FG002|Double-Blind Period|Lost to Follow-up|0|||
44217857|NCT01499355|79016205|FG003|Double-Blind Period|Lost to Follow-up|0|||
44217858|NCT01474239|79016226|FG000|Overall Study|Disease Progression|37|||
44217859|NCT01474239|79016227|FG001|Overall Study|Disease Progression|25|||
44217860|NCT01474239|79016226|FG000|Overall Study|Adverse Event|12|||
44217861|NCT01474239|79016227|FG001|Overall Study|Adverse Event|3|||
44217862|NCT01474239|79016226|FG000|Overall Study|Withdrawal by Subject|1|||
44217863|NCT01474239|79016227|FG001|Overall Study|Withdrawal by Subject|2|||
44217864|NCT01474239|79016226|FG000|Overall Study|Death|1|||
44217865|NCT01474239|79016227|FG001|Overall Study|Death|1|||
44460090|NCT03885596|79468688|FG000|Overall Study|Withdrawal by Subject|2|||
44460091|NCT03885596|79468689|FG001|Overall Study|Withdrawal by Subject|1|||
44460092|NCT03885596|79468690|FG002|Overall Study|Withdrawal by Subject|0|||
44460093|NCT03885596|79468691|FG003|Overall Study|Withdrawal by Subject|0|||
44460094|NCT00529100|79468707|FG000|Overall Study|Adverse Event|0|||
44460095|NCT00529100|79468708|FG001|Overall Study|Adverse Event|5|||
44460096|NCT00529100|79468707|FG000|Overall Study|Protocol Violation|0|||
44460097|NCT00529100|79468708|FG001|Overall Study|Protocol Violation|1|||
44460098|NCT00529100|79468707|FG000|Overall Study|Progressive Disease|0|||
44460099|NCT00529100|79468708|FG001|Overall Study|Progressive Disease|1|||
44460100|NCT00529100|79468707|FG000|Overall Study|Withdrawal by Subject|0|||
44460101|NCT00529100|79468708|FG001|Overall Study|Withdrawal by Subject|1|||
44460102|NCT00529100|79468707|FG000|Overall Study|Participant Ineligibility|0|||
44460103|NCT00529100|79468708|FG001|Overall Study|Participant Ineligibility|1|||
44460104|NCT03878108|79468720|FG000|Overall Study|Adverse Event|1|||
44460105|NCT03878108|79468721|FG001|Overall Study|Adverse Event|0|||
44460106|NCT00529958|79468730|FG000|2-Year Follow-up|Lost to Follow-up|1|||
44460107|NCT00529958|79468731|FG001|2-Year Follow-up|Lost to Follow-up|2|||
44460108|NCT00529958|79468732|FG002|2-Year Follow-up|Lost to Follow-up|2|||
44217866|NCT01474239|79016226|FG000|Overall Study|Clinical Disease Progression|7|||
44460109|NCT00529958|79468730|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
44460110|NCT00529958|79468731|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
44460111|NCT00529958|79468732|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
44460112|NCT00529958|79468730|FG000|5-Year Follow-up|Lost to Follow-up|2|||
44460113|NCT00529958|79468731|FG001|5-Year Follow-up|Lost to Follow-up|3|||
44217867|NCT01474239|79016227|FG001|Overall Study|Clinical Disease Progression|1|||
44217868|NCT01474239|79016226|FG000|Overall Study|Withdrawal for Economic Reason|1|||
44217869|NCT01474239|79016227|FG001|Overall Study|Withdrawal for Economic Reason|0|||
44217870|NCT01473381|79016237|FG000|Overall Study|Adverse Event|8|||
44217871|NCT01473381|79016238|FG001|Overall Study|Adverse Event|20|||
44217872|NCT01473381|79016239|FG002|Overall Study|Adverse Event|25|||
44217873|NCT01473381|79016240|FG003|Overall Study|Adverse Event|17|||
44217874|NCT01473381|79016237|FG000|Overall Study|Insufficient Therapeutic Response|10|||
44217875|NCT01473381|79016238|FG001|Overall Study|Insufficient Therapeutic Response|1|||
44217876|NCT01473381|79016239|FG002|Overall Study|Insufficient Therapeutic Response|2|||
44217877|NCT01473381|79016240|FG003|Overall Study|Insufficient Therapeutic Response|3|||
44217878|NCT01473381|79016237|FG000|Overall Study|Protocol Violation|17|||
44217879|NCT01473381|79016238|FG001|Overall Study|Protocol Violation|23|||
44217880|NCT01473381|79016239|FG002|Overall Study|Protocol Violation|19|||
44217881|NCT01473381|79016240|FG003|Overall Study|Protocol Violation|17|||
44270268|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44460114|NCT00529958|79468732|FG002|5-Year Follow-up|Lost to Follow-up|1|||
44460115|NCT00529958|79468730|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
44460116|NCT00529958|79468731|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
44460117|NCT00529958|79468732|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
44460118|NCT00529802|79468740|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
44217882|NCT01473381|79016237|FG000|Overall Study|Withdrawal of Consent|20|||
44270269|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270270|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44270271|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44460119|NCT00529802|79468740|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
44460120|NCT00529802|79468740|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
44460121|NCT00529802|79468740|FG000|Evaluable for Primary Endpoint|Death|1|||
44460122|NCT00529802|79468740|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
44460123|NCT00529802|79468740|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
44460124|NCT00529802|79468740|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
44460125|NCT00528866|79468746|FG000|Overall Study|Protocol Violation|6|||
44460126|NCT00614393|79468756|FG000|Overall Study|Adverse Event|20|||
44460127|NCT00614393|79468757|FG001|Overall Study|Adverse Event|2|||
44460128|NCT00614393|79468758|FG002|Overall Study|Adverse Event|3|||
44217883|NCT01473381|79016238|FG001|Overall Study|Withdrawal of Consent|21|||
44217884|NCT01473381|79016239|FG002|Overall Study|Withdrawal of Consent|20|||
44217885|NCT01473381|79016240|FG003|Overall Study|Withdrawal of Consent|26|||
44217886|NCT01473381|79016237|FG000|Overall Study|Lost to Follow-up|25|||
44217887|NCT01473381|79016238|FG001|Overall Study|Lost to Follow-up|28|||
44217888|NCT01473381|79016239|FG002|Overall Study|Lost to Follow-up|35|||
44217889|NCT01473381|79016240|FG003|Overall Study|Lost to Follow-up|23|||
44217890|NCT01473381|79016237|FG000|Overall Study|Other Reasons|0|||
44217891|NCT01473381|79016238|FG001|Overall Study|Other Reasons|0|||
44217892|NCT01473381|79016239|FG002|Overall Study|Other Reasons|1|||
44217893|NCT01473381|79016240|FG003|Overall Study|Other Reasons|3|||
44217894|NCT01499277|79016282|FG000|Overall Study|Adverse Event|3|||
44217895|NCT01499277|79016283|FG001|Overall Study|Adverse Event|6|||
44217896|NCT01499277|79016282|FG000|Overall Study|Death|3|||
44217897|NCT01499277|79016283|FG001|Overall Study|Death|2|||
44217898|NCT01499277|79016282|FG000|Overall Study|Lost to Follow-up|15|||
44217899|NCT01499277|79016283|FG001|Overall Study|Lost to Follow-up|8|||
44217900|NCT01499277|79016282|FG000|Overall Study|Protocol Violation|2|||
44217901|NCT01499277|79016283|FG001|Overall Study|Protocol Violation|3|||
44217902|NCT01499277|79016282|FG000|Overall Study|Withdrawal by Subject|16|||
44217903|NCT01499277|79016283|FG001|Overall Study|Withdrawal by Subject|6|||
44217904|NCT01499277|79016282|FG000|Overall Study|Lack of therapeutic response and other|8|||
44217905|NCT01499277|79016283|FG001|Overall Study|Lack of therapeutic response and other|7|||
44217906|NCT01499199|79016308|FG000|Overall Study|Adverse Event|1|||
44217907|NCT01499199|79016308|FG000|Overall Study|Lack of Efficacy|1|||
44217908|NCT01499043|79016312|FG000|Overall Study|Progressive disease (radiographic)|2|||
44217909|NCT01499043|79016312|FG000|Overall Study|Progressive disease (clinical)|1|||
44217910|NCT01499043|79016312|FG000|Overall Study|Withdrawal by Subject|2|||
44217911|NCT01499043|79016312|FG000|Overall Study|Adverse Event|1|||
44217912|NCT01498887|79016386|FG000|Overall Study|Administrative problems|1|||
44217913|NCT01498887|79016387|FG001|Overall Study|Administrative problems|0|||
44217914|NCT01498887|79016386|FG000|Overall Study|Lost to Follow-up|1|||
44217915|NCT01498887|79016387|FG001|Overall Study|Lost to Follow-up|1|||
44217916|NCT01498887|79016386|FG000|Overall Study|Withdrawal by Subject|1|||
44217917|NCT01498887|79016387|FG001|Overall Study|Withdrawal by Subject|0|||
44217918|NCT01498887|79016386|FG000|Overall Study|Protocol Violation|1|||
44217919|NCT01498887|79016387|FG001|Overall Study|Protocol Violation|3|||
44217920|NCT01498887|79016386|FG000|Overall Study|Lack of Efficacy|5|||
44217921|NCT01498887|79016387|FG001|Overall Study|Lack of Efficacy|3|||
44217922|NCT01498887|79016386|FG000|Overall Study|Abnormal result from test procedure|1|||
44217923|NCT01498887|79016387|FG001|Overall Study|Abnormal result from test procedure|1|||
44217924|NCT01498887|79016386|FG000|Overall Study|Abnormal laboratory value|2|||
44217925|NCT01498887|79016387|FG001|Overall Study|Abnormal laboratory value|2|||
44217926|NCT01498887|79016386|FG000|Overall Study|Adverse Event|4|||
44217927|NCT01498887|79016387|FG001|Overall Study|Adverse Event|1|||
44217928|NCT01498653|79016396|FG000|Overall Study|Adverse Event|2|||
44217929|NCT01498653|79016397|FG001|Overall Study|Adverse Event|2|||
44217930|NCT01498653|79016396|FG000|Overall Study|Lack of Efficacy|12|||
44217931|NCT01498653|79016397|FG001|Overall Study|Lack of Efficacy|26|||
44217932|NCT01498653|79016396|FG000|Overall Study|Protocol Violation|0|||
44217933|NCT01498653|79016397|FG001|Overall Study|Protocol Violation|4|||
44217934|NCT01498653|79016396|FG000|Overall Study|Lost to Follow-up|1|||
44217935|NCT01498653|79016397|FG001|Overall Study|Lost to Follow-up|0|||
44217936|NCT01498653|79016396|FG000|Overall Study|Physician Decision|2|||
44217937|NCT01498653|79016397|FG001|Overall Study|Physician Decision|0|||
44217938|NCT01498653|79016396|FG000|Overall Study|Withdrawal by Subject|2|||
44217939|NCT01498653|79016397|FG001|Overall Study|Withdrawal by Subject|3|||
44217940|NCT01498575|79016405|FG000|Overall Sample|Withdrawal by Subject|60|||
44217941|NCT01498575|79016406|FG001|Overall Sample|Withdrawal by Subject|14|||
44217942|NCT01498575|79016405|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
44217943|NCT01498575|79016406|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
44217944|NCT01498575|79016405|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
44217945|NCT01498575|79016406|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
44217946|NCT01498185|79016417|FG000|Overall Study|Adverse Event|0|||
44217947|NCT01498185|79016418|FG001|Overall Study|Adverse Event|0|||
44217948|NCT01498185|79016419|FG002|Overall Study|Adverse Event|0|||
44217949|NCT01498185|79016420|FG003|Overall Study|Adverse Event|1|||
44217950|NCT01498185|79016421|FG004|Overall Study|Adverse Event|0|||
44217951|NCT01498185|79016417|FG000|Overall Study|Withdrawal by Subject|1|||
44217952|NCT01498185|79016418|FG001|Overall Study|Withdrawal by Subject|1|||
44460129|NCT00614393|79468759|FG003|Overall Study|Adverse Event|13|||
44460130|NCT00614393|79468760|FG004|Overall Study|Adverse Event|21|||
44460131|NCT00614393|79468756|FG000|Overall Study|Lost to Follow-up|0|||
44460132|NCT00614393|79468757|FG001|Overall Study|Lost to Follow-up|0|||
44460133|NCT00614393|79468758|FG002|Overall Study|Lost to Follow-up|0|||
44460134|NCT00614393|79468759|FG003|Overall Study|Lost to Follow-up|1|||
44460135|NCT00614393|79468760|FG004|Overall Study|Lost to Follow-up|2|||
44460136|NCT00614393|79468756|FG000|Overall Study|Physician Decision|17|||
44460137|NCT00614393|79468757|FG001|Overall Study|Physician Decision|0|||
44460138|NCT00614393|79468758|FG002|Overall Study|Physician Decision|1|||
44460139|NCT00614393|79468759|FG003|Overall Study|Physician Decision|8|||
44544097|NCT03235050|79557284|FG004|Overall Study|Other reasons|2|||
44217953|NCT01498185|79016419|FG002|Overall Study|Withdrawal by Subject|0|||
44217954|NCT01498185|79016420|FG003|Overall Study|Withdrawal by Subject|2|||
44217955|NCT01498185|79016421|FG004|Overall Study|Withdrawal by Subject|1|||
44217956|NCT01498185|79016417|FG000|Overall Study|No longer met criteria, etc|0|||
44217957|NCT01498185|79016418|FG001|Overall Study|No longer met criteria, etc|0|||
44217958|NCT01498185|79016419|FG002|Overall Study|No longer met criteria, etc|0|||
44373250|NCT01142726|79378312|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
44373251|NCT01073267|79378328|FG000|Overall Study|Disease Progression|3|||
44373252|NCT01142336|79378334|FG000|Overall Study|Adverse Event|1|||
44373253|NCT01142336|79378335|FG001|Overall Study|Adverse Event|1|||
44373254|NCT01142336|79378334|FG000|Overall Study|Lost to Follow-up|0|||
44373255|NCT01142336|79378335|FG001|Overall Study|Lost to Follow-up|1|||
44373256|NCT00915681|79378344|FG000|Overall Study|Screening failures|46|||
44373257|NCT01128296|79378348|FG000|Overall Study|Physician Decision|0|||
44373258|NCT01128296|79378349|FG001|Overall Study|Physician Decision|0|||
44373259|NCT01128296|79378350|FG002|Overall Study|Physician Decision|0|||
44373260|NCT01128296|79378351|FG003|Overall Study|Physician Decision|0|||
44373261|NCT01128296|79378352|FG004|Overall Study|Physician Decision|0|||
44373262|NCT01128296|79378353|FG005|Overall Study|Physician Decision|3|||
44460140|NCT00614393|79468760|FG004|Overall Study|Physician Decision|9|||
44544098|NCT04502212|79557313|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
44217959|NCT01498185|79016420|FG003|Overall Study|No longer met criteria, etc|0|||
44217960|NCT01498185|79016421|FG004|Overall Study|No longer met criteria, etc|2|||
44373263|NCT01128296|79378348|FG000|Overall Study|Withdrawal by Subject|0|||
44460141|NCT00614393|79468756|FG000|Overall Study|Progressive Disease|118|||
44460142|NCT00614393|79468757|FG001|Overall Study|Progressive Disease|5|||
44217961|NCT01528605|79016443|FG000|Overall Study|Lost to Follow-up|1|||
44217962|NCT01528605|79016444|FG001|Overall Study|Lost to Follow-up|0|||
44217963|NCT01528605|79016445|FG002|Overall Study|Lost to Follow-up|1|||
44217964|NCT01528605|79016446|FG003|Overall Study|Lost to Follow-up|1|||
44373264|NCT01128296|79378349|FG001|Overall Study|Withdrawal by Subject|0|||
44373265|NCT01128296|79378350|FG002|Overall Study|Withdrawal by Subject|0|||
44217965|NCT01528605|79016447|FG004|Overall Study|Lost to Follow-up|0|||
44217966|NCT01528605|79016448|FG005|Overall Study|Lost to Follow-up|0|||
44217967|NCT01528605|79016443|FG000|Overall Study|Death|1|||
44217968|NCT01528605|79016444|FG001|Overall Study|Death|0|||
44217969|NCT01528605|79016445|FG002|Overall Study|Death|0|||
44217970|NCT01528605|79016446|FG003|Overall Study|Death|0|||
44217971|NCT01528605|79016447|FG004|Overall Study|Death|0|||
44217972|NCT01528605|79016448|FG005|Overall Study|Death|0|||
44217973|NCT01528215|79016464|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
44217974|NCT01528215|79016465|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
44217975|NCT01528215|79016464|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
44270272|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
44217976|NCT01528215|79016465|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
44217977|NCT01528215|79016464|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
44217978|NCT01528215|79016465|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
44217979|NCT01528215|79016464|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
44217980|NCT01528215|79016465|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
44217981|NCT01527357|79016473|FG000|Overall Study|Death|8|||
44217982|NCT01527357|79016474|FG001|Overall Study|Death|2|||
44217983|NCT01527357|79016473|FG000|Overall Study|Lost to Follow-up|6|||
44217984|NCT01527357|79016474|FG001|Overall Study|Lost to Follow-up|4|||
44217985|NCT01527357|79016473|FG000|Overall Study|Withdrew Consent|1|||
44217986|NCT01527357|79016474|FG001|Overall Study|Withdrew Consent|1|||
44217987|NCT01527357|79016473|FG000|Overall Study|Non-compliance|0|||
44217988|NCT01527357|79016474|FG001|Overall Study|Non-compliance|1|||
44217989|NCT01527357|79016473|FG000|Overall Study|No Day 29 Visit|0|||
44217990|NCT01527357|79016474|FG001|Overall Study|No Day 29 Visit|1|||
44217991|NCT01527357|79016473|FG000|Overall Study|Did Not Receive Treatment|2|||
44217992|NCT01527357|79016474|FG001|Overall Study|Did Not Receive Treatment|0|||
44217993|NCT01526889|79016493|FG000|Treatment Period|Adverse Event|2|||
44217994|NCT01526889|79016494|FG001|Treatment Period|Adverse Event|0|||
44217995|NCT01526889|79016493|FG000|Treatment Extension Period|Administrative problems|1|||
44217996|NCT01526889|79016494|FG001|Treatment Extension Period|Administrative problems|0|||
44217997|NCT01472835|79016506|FG000|Overall Study|Lost to Follow-up|2|||
44217998|NCT01472835|79016507|FG001|Overall Study|Lost to Follow-up|0|||
44217999|NCT01526733|79016520|FG000|Phase 1|Protocol Violation|1|||
44218000|NCT01526733|79016521|FG001|Phase 1|Protocol Violation|0|||
44218001|NCT01526733|79016520|FG000|Phase 1|Withdrawal by Subject|1|||
44218002|NCT01526733|79016521|FG001|Phase 1|Withdrawal by Subject|1|||
44373266|NCT01128296|79378351|FG003|Overall Study|Withdrawal by Subject|0|||
44373267|NCT01128296|79378352|FG004|Overall Study|Withdrawal by Subject|0|||
44373268|NCT01128296|79378353|FG005|Overall Study|Withdrawal by Subject|2|||
44373269|NCT01115738|79378367|FG000|Overall Study|Death|1|||
44218003|NCT01472757|79016566|FG000|Overall Study|Withdrawal by Subject|1|||
44218004|NCT01472757|79016567|FG001|Overall Study|Withdrawal by Subject|2|||
44218005|NCT01472757|79016568|FG002|Overall Study|Withdrawal by Subject|2|||
44460143|NCT00614393|79468758|FG002|Overall Study|Progressive Disease|5|||
44218006|NCT01472757|79016569|FG003|Overall Study|Withdrawal by Subject|0|||
44218007|NCT01472757|79016566|FG000|Overall Study|Asthma exacerbation|4|||
44218008|NCT01472757|79016567|FG001|Overall Study|Asthma exacerbation|1|||
44218009|NCT01472757|79016568|FG002|Overall Study|Asthma exacerbation|2|||
44218010|NCT01472757|79016569|FG003|Overall Study|Asthma exacerbation|1|||
44218011|NCT01472757|79016566|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
44218012|NCT01472757|79016567|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
44218013|NCT01472757|79016568|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
44218014|NCT01472757|79016569|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
44218015|NCT01472757|79016566|FG000|Overall Study|Protocol Violation|3|||
44218016|NCT01472757|79016567|FG001|Overall Study|Protocol Violation|2|||
44218017|NCT01472757|79016568|FG002|Overall Study|Protocol Violation|4|||
44218018|NCT01472757|79016569|FG003|Overall Study|Protocol Violation|4|||
44218019|NCT01472757|79016566|FG000|Overall Study|Other reasons|1|||
44218020|NCT01472757|79016567|FG001|Overall Study|Other reasons|0|||
44218021|NCT01472757|79016568|FG002|Overall Study|Other reasons|2|||
44218022|NCT01472757|79016569|FG003|Overall Study|Other reasons|2|||
44218023|NCT01472289|79016588|FG000|Overall Study|Death|2|||
44218024|NCT01525875|79016607|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
44218025|NCT01525875|79016608|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
44218026|NCT01525875|79016607|FG000|Open-label Period|Lost to Follow-up|0|||
44218027|NCT01525875|79016608|FG001|Open-label Period|Lost to Follow-up|2|||
44218028|NCT01525641|79016614|FG000|Overall Study|Case report form not collected|25|||
44218029|NCT01525641|79016614|FG000|Overall Study|No visit since the first visit|16|||
44218030|NCT01525641|79016614|FG000|Overall Study|Adverse Event|73|||
44218031|NCT01525641|79016614|FG000|Overall Study|Lack of Efficacy|24|||
44218032|NCT01525641|79016614|FG000|Overall Study|Improvement|5|||
44218033|NCT01525641|79016614|FG000|Overall Study|Lost to follow-up (relocation)|1|||
44218034|NCT01525641|79016614|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
44460144|NCT00614393|79468759|FG003|Overall Study|Progressive Disease|138|||
44460145|NCT00614393|79468760|FG004|Overall Study|Progressive Disease|130|||
44218035|NCT01525641|79016614|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
44218036|NCT01525641|79016614|FG000|Overall Study|Other than stated above|7|||
44218037|NCT01496469|79016629|FG000|Overall Study|Adverse Event|1|||
44218038|NCT01496469|79016630|FG001|Overall Study|Adverse Event|0|||
44460146|NCT00614393|79468756|FG000|Overall Study|Protocol Violation|1|||
44460147|NCT00614393|79468757|FG001|Overall Study|Protocol Violation|0|||
44460148|NCT00614393|79468758|FG002|Overall Study|Protocol Violation|0|||
44460149|NCT00614393|79468759|FG003|Overall Study|Protocol Violation|0|||
44460150|NCT00614393|79468760|FG004|Overall Study|Protocol Violation|0|||
44460151|NCT00614393|79468756|FG000|Overall Study|Terminated by Sponsor|0|||
44460152|NCT00614393|79468757|FG001|Overall Study|Terminated by Sponsor|0|||
44460153|NCT00614393|79468758|FG002|Overall Study|Terminated by Sponsor|0|||
44460154|NCT00614393|79468759|FG003|Overall Study|Terminated by Sponsor|0|||
44460155|NCT00614393|79468760|FG004|Overall Study|Terminated by Sponsor|1|||
44460156|NCT00614393|79468756|FG000|Overall Study|Withdrawal by Subject|20|||
44460157|NCT00614393|79468757|FG001|Overall Study|Withdrawal by Subject|1|||
44460158|NCT00614393|79468758|FG002|Overall Study|Withdrawal by Subject|1|||
44460159|NCT00614393|79468759|FG003|Overall Study|Withdrawal by Subject|16|||
44460160|NCT00614393|79468760|FG004|Overall Study|Withdrawal by Subject|13|||
44460161|NCT00614393|79468756|FG000|Overall Study|Other|4|||
44460162|NCT00614393|79468757|FG001|Overall Study|Other|0|||
44460163|NCT00614393|79468758|FG002|Overall Study|Other|0|||
44460164|NCT00614393|79468759|FG003|Overall Study|Other|4|||
44460165|NCT00614393|79468760|FG004|Overall Study|Other|2|||
44460166|NCT00614393|79468756|FG000|Overall Study|Not Treated|0|||
44460167|NCT00614393|79468757|FG001|Overall Study|Not Treated|0|||
44460168|NCT00614393|79468758|FG002|Overall Study|Not Treated|0|||
44460169|NCT00614393|79468759|FG003|Overall Study|Not Treated|0|||
44460170|NCT00614393|79468760|FG004|Overall Study|Not Treated|2|||
44460171|NCT00612677|79468772|FG000|Overall Study|study closed before treatment started|1|||
44460172|NCT00613925|79468778|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
44460173|NCT00613925|79468779|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
44460174|NCT00613301|79468785|FG000|Overall Study|Adverse Event|49|||
44460175|NCT00613301|79468785|FG000|Overall Study|Lost to Follow-up|88|||
44460176|NCT00613301|79468785|FG000|Overall Study|Withdrawal by Subject|5|||
44460177|NCT00613301|79468785|FG000|Overall Study|Death|6|||
44460178|NCT00613301|79468785|FG000|Overall Study|Lack of Efficacy|13|||
44460179|NCT00613301|79468785|FG000|Overall Study|Physician Decision|2|||
44460180|NCT00613301|79468785|FG000|Overall Study|No data was collected|53|||
44460181|NCT00613301|79468785|FG000|Overall Study|Irregularly enrolled patients|12|||
44460182|NCT00609947|79468790|FG000|Overall Study|Death|1|||
44460183|NCT00609869|79468795|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
44460184|NCT00609869|79468795|FG000|Overall Study|Severe hematologic toxicity|1|||
44460185|NCT00609869|79468795|FG000|Overall Study|Withdrawal by Subject|1|||
44460186|NCT00609869|79468795|FG000|Overall Study|Seizures|1|||
44460187|NCT00609869|79468795|FG000|Overall Study|Severe tumor flare reaction|1|||
44460188|NCT00609869|79468795|FG000|Overall Study|Hepatitis B infection|1|||
44460189|NCT00609869|79468795|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
44460190|NCT00609869|79468795|FG000|Overall Study|Mantle cell: not evaluable|4|||
44460191|NCT00529568|79468801|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
44460192|NCT00529568|79468802|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
44460193|NCT00529568|79468803|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
44460194|NCT00529568|79468801|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
44460195|NCT00529568|79468802|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
44460196|NCT00529568|79468803|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
44460197|NCT00529568|79468801|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
44460198|NCT00529568|79468802|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
44460199|NCT00529568|79468803|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
44460200|NCT00529568|79468801|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
44460201|NCT00529568|79468802|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
44460202|NCT00529568|79468803|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
44460203|NCT00529568|79468801|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
44544099|NCT04502212|79557313|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
44544100|NCT03167619|79557320|FG000|Overall Study|Death|11|||
44544101|NCT03167619|79557321|FG001|Overall Study|Death|8|||
44460204|NCT00529568|79468802|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
44460205|NCT00529568|79468803|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
44460206|NCT00529568|79468801|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
44460207|NCT00529568|79468802|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
44460208|NCT00529568|79468803|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
44460209|NCT00529568|79468801|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
44460210|NCT00529568|79468802|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
44373270|NCT01115738|79378368|FG001|Overall Study|Death|0|||
44373271|NCT01115738|79378369|FG002|Overall Study|Death|0|||
44373272|NCT01115738|79378367|FG000|Overall Study|Lost to Follow-up|0|||
44460211|NCT00529568|79468803|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
44373273|NCT01115738|79378368|FG001|Overall Study|Lost to Follow-up|0|||
44373274|NCT01115738|79378369|FG002|Overall Study|Lost to Follow-up|1|||
44373275|NCT01115738|79378367|FG000|Overall Study|Physician Decision|18|||
44460212|NCT00529568|79468801|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
44218039|NCT01496469|79016629|FG000|Overall Study|Protocol Violation|2|||
44373276|NCT01115738|79378368|FG001|Overall Study|Physician Decision|15|||
44218040|NCT01496469|79016630|FG001|Overall Study|Protocol Violation|0|||
44373277|NCT01115738|79378369|FG002|Overall Study|Physician Decision|17|||
44544102|NCT03167619|79557320|FG000|Overall Study|Withdrawal by Subject|1|||
44544103|NCT03167619|79557321|FG001|Overall Study|Withdrawal by Subject|2|||
44544104|NCT03167619|79557320|FG000|Overall Study|Physician Decision|0|||
44544105|NCT03167619|79557321|FG001|Overall Study|Physician Decision|1|||
44544106|NCT03578809|79557331|FG000|Overall Study|Death|0|||
44544107|NCT03578809|79557332|FG001|Overall Study|Death|2|||
44544108|NCT03578809|79557333|FG002|Overall Study|Death|0|||
44544109|NCT03578809|79557334|FG003|Overall Study|Death|1|||
44544110|NCT03578809|79557331|FG000|Overall Study|Lost to Follow-up|0|||
44544111|NCT03578809|79557332|FG001|Overall Study|Lost to Follow-up|1|||
44544112|NCT03578809|79557333|FG002|Overall Study|Lost to Follow-up|0|||
44544113|NCT03578809|79557334|FG003|Overall Study|Lost to Follow-up|0|||
44544114|NCT03578809|79557331|FG000|Overall Study|Withdrawal by Subject|3|||
44544115|NCT03578809|79557332|FG001|Overall Study|Withdrawal by Subject|5|||
44544116|NCT03578809|79557333|FG002|Overall Study|Withdrawal by Subject|2|||
44544117|NCT03578809|79557334|FG003|Overall Study|Withdrawal by Subject|0|||
44544118|NCT03578809|79557331|FG000|Overall Study|Other|3|||
44544119|NCT03578809|79557332|FG001|Overall Study|Other|6|||
44544120|NCT03578809|79557333|FG002|Overall Study|Other|2|||
44544121|NCT03578809|79557334|FG003|Overall Study|Other|8|||
44544122|NCT03198507|79557349|FG000|Overall Study|Withdrawal by Subject|1|||
44544123|NCT03198507|79557350|FG001|Overall Study|Withdrawal by Subject|0|||
44460213|NCT00529568|79468802|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
44460214|NCT00529568|79468803|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
44460215|NCT00529568|79468801|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
44460216|NCT00529568|79468802|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
44460217|NCT00529568|79468803|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
44460218|NCT00529568|79468801|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
44460219|NCT00529568|79468802|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
44460220|NCT00529568|79468803|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
44460221|NCT00529568|79468801|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
44544124|NCT03610165|79557358|FG000|Overall Study|Device didn't work|0|||
44544125|NCT03610165|79557359|FG001|Overall Study|Device didn't work|1|||
44373278|NCT01115738|79378367|FG000|Overall Study|Withdrawal by Subject|6|||
44373279|NCT01115738|79378368|FG001|Overall Study|Withdrawal by Subject|6|||
44373280|NCT01115738|79378369|FG002|Overall Study|Withdrawal by Subject|9|||
44373281|NCT01141478|79378387|FG000|Overall Study|Withdrawal by Subject|1|||
44373282|NCT01141478|79378388|FG001|Overall Study|Withdrawal by Subject|1|||
44373283|NCT01114880|79378396|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
44373284|NCT01114880|79378397|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
44460222|NCT00529568|79468802|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
44544126|NCT03609619|79557367|FG000|Overall Study|Adverse Event|1|||
44544127|NCT03609619|79557368|FG001|Overall Study|Adverse Event|0|||
44544128|NCT03609619|79557367|FG000|Overall Study|Lack of Efficacy|1|||
44544129|NCT03609619|79557368|FG001|Overall Study|Lack of Efficacy|2|||
44544130|NCT03609619|79557367|FG000|Overall Study|Protocol Violation|5|||
44544131|NCT03609619|79557368|FG001|Overall Study|Protocol Violation|0|||
44544132|NCT03609619|79557367|FG000|Overall Study|Withdrawal by Subject|2|||
44544133|NCT03609619|79557368|FG001|Overall Study|Withdrawal by Subject|3|||
44544134|NCT03609619|79557367|FG000|Overall Study|Lost to Follow-up|1|||
44544135|NCT03609619|79557368|FG001|Overall Study|Lost to Follow-up|1|||
44460223|NCT00529568|79468803|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
44460224|NCT00611975|79468814|FG000|Overall Study|Withdrawal by Subject|3|||
44460225|NCT00611975|79468815|FG001|Overall Study|Withdrawal by Subject|7|||
44460226|NCT00611975|79468814|FG000|Overall Study|Pregnancy|2|||
44460227|NCT00611975|79468815|FG001|Overall Study|Pregnancy|1|||
44460228|NCT00573131|79468823|FG000|Overall Study|Withdrawal by Subject|10|||
44460229|NCT00573131|79468824|FG001|Overall Study|Withdrawal by Subject|8|||
44460230|NCT00521144|79468835|FG000|Overall Study|Not Treated|0|||
44460231|NCT00521144|79468836|FG001|Overall Study|Not Treated|0|||
44460232|NCT00521144|79468837|FG002|Overall Study|Not Treated|0|||
44460233|NCT00521144|79468838|FG003|Overall Study|Not Treated|1|||
44460234|NCT00521144|79468839|FG004|Overall Study|Not Treated|0|||
44460235|NCT00521144|79468835|FG000|Overall Study|Adverse Event|0|||
44460236|NCT00521144|79468836|FG001|Overall Study|Adverse Event|1|||
44460237|NCT00521144|79468837|FG002|Overall Study|Adverse Event|0|||
44460238|NCT00521144|79468838|FG003|Overall Study|Adverse Event|0|||
44460239|NCT00521144|79468839|FG004|Overall Study|Adverse Event|1|||
44460240|NCT00521144|79468835|FG000|Overall Study|Progressive Disease|4|||
44460241|NCT00521144|79468836|FG001|Overall Study|Progressive Disease|2|||
44460242|NCT00521144|79468837|FG002|Overall Study|Progressive Disease|2|||
44460243|NCT00521144|79468838|FG003|Overall Study|Progressive Disease|0|||
44460244|NCT00521144|79468839|FG004|Overall Study|Progressive Disease|6|||
44460245|NCT00520676|79468853|FG000|Overall Study|Death|84|||
44460246|NCT00520676|79468854|FG001|Overall Study|Death|81|||
44460247|NCT00520676|79468853|FG000|Overall Study|Lost to Follow-up|6|||
44460248|NCT00520676|79468854|FG001|Overall Study|Lost to Follow-up|10|||
44460249|NCT00520676|79468853|FG000|Overall Study|Physician Decision|4|||
44460250|NCT00520676|79468854|FG001|Overall Study|Physician Decision|1|||
44460251|NCT00520676|79468853|FG000|Overall Study|Withdrawal by Subject|7|||
44460252|NCT00520676|79468854|FG001|Overall Study|Withdrawal by Subject|11|||
44460253|NCT00610649|79468871|FG000|Overall Study|Adverse Event|1|||
44460254|NCT00610649|79468872|FG001|Overall Study|Adverse Event|0|||
44460255|NCT00610649|79468873|FG002|Overall Study|Adverse Event|0|||
44460256|NCT00610649|79468874|FG003|Overall Study|Adverse Event|0|||
44460257|NCT00610649|79468875|FG004|Overall Study|Adverse Event|0|||
44460258|NCT00610649|79468876|FG005|Overall Study|Adverse Event|0|||
44460259|NCT00610649|79468877|FG006|Overall Study|Adverse Event|0|||
44460260|NCT00610649|79468878|FG007|Overall Study|Adverse Event|0|||
44544136|NCT03167151|79557377|FG000|Overall Study|Withdrawal by Subject|1|||
44544137|NCT03167151|79557378|FG001|Overall Study|Withdrawal by Subject|0|||
44544138|NCT03167151|79557379|FG002|Overall Study|Withdrawal by Subject|0|||
44218041|NCT01496469|79016629|FG000|Overall Study|Lost to Follow-up|1|||
44218042|NCT01496469|79016630|FG001|Overall Study|Lost to Follow-up|1|||
44218043|NCT01496469|79016629|FG000|Overall Study|Withdrawal by Subject|4|||
44218044|NCT01496469|79016630|FG001|Overall Study|Withdrawal by Subject|4|||
44544139|NCT03167151|79557377|FG000|Overall Study|No evidence of tumour at surgery|0|||
44544140|NCT03167151|79557378|FG001|Overall Study|No evidence of tumour at surgery|1|||
44544141|NCT03167151|79557379|FG002|Overall Study|No evidence of tumour at surgery|1|||
44544142|NCT03660943|79557389|FG000|Overall Study|Adverse Event|5|||
44544143|NCT03660943|79557390|FG001|Overall Study|Adverse Event|3|||
44544144|NCT03660943|79557389|FG000|Overall Study|Death|0|||
44544145|NCT03660943|79557390|FG001|Overall Study|Death|2|||
44544146|NCT03660943|79557389|FG000|Overall Study|Lost to Follow-up|7|||
44544147|NCT03660943|79557390|FG001|Overall Study|Lost to Follow-up|3|||
44544148|NCT03660943|79557389|FG000|Overall Study|Protocol Violation|3|||
44544149|NCT03660943|79557390|FG001|Overall Study|Protocol Violation|5|||
44544150|NCT03660943|79557389|FG000|Overall Study|Withdrawal by Subject|8|||
44544151|NCT03660943|79557390|FG001|Overall Study|Withdrawal by Subject|15|||
44218045|NCT01496469|79016629|FG000|Overall Study|BP exceeds protocol limits|1|||
44544152|NCT03660943|79557389|FG000|Overall Study|Lack of Efficacy|9|||
44218046|NCT01496469|79016630|FG001|Overall Study|BP exceeds protocol limits|2|||
44460261|NCT00610649|79468879|FG008|Overall Study|Adverse Event|0|||
44460262|NCT00610649|79468880|FG009|Overall Study|Adverse Event|0|||
44460263|NCT00610649|79468881|FG010|Overall Study|Adverse Event|1|||
44460264|NCT00610649|79468871|FG000|Overall Study|Family Emergency|0|||
44460265|NCT00610649|79468872|FG001|Overall Study|Family Emergency|1|||
44460266|NCT00610649|79468873|FG002|Overall Study|Family Emergency|0|||
44460267|NCT00610649|79468874|FG003|Overall Study|Family Emergency|0|||
44460268|NCT00610649|79468875|FG004|Overall Study|Family Emergency|0|||
44218047|NCT01496469|79016629|FG000|Overall Study|Other|1|||
44460269|NCT00610649|79468876|FG005|Overall Study|Family Emergency|0|||
44218048|NCT01496469|79016630|FG001|Overall Study|Other|1|||
44460270|NCT00610649|79468877|FG006|Overall Study|Family Emergency|0|||
44460271|NCT00610649|79468878|FG007|Overall Study|Family Emergency|0|||
44460272|NCT00610649|79468879|FG008|Overall Study|Family Emergency|0|||
44460273|NCT00610649|79468880|FG009|Overall Study|Family Emergency|0|||
44544153|NCT03660943|79557390|FG001|Overall Study|Lack of Efficacy|12|||
44218049|NCT01471353|79016645|FG000|Overall Study|remain on study|3|||
44218050|NCT01525407|79016651|FG000|Overall Study|Change in recipient treatment plan|2|||
44218051|NCT01525407|79016652|FG001|Overall Study|Change in recipient treatment plan|2|||
44373285|NCT01114880|79378396|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
44373286|NCT01114880|79378397|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
44373287|NCT01114880|79378396|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
44373288|NCT01114880|79378397|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
44373289|NCT01114880|79378396|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
44373290|NCT01114880|79378397|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
44373291|NCT01114880|79378396|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
44373292|NCT01114880|79378397|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
44373293|NCT01114880|79378396|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
44373294|NCT01114880|79378397|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
44373295|NCT01114724|79378405|FG000|Overall Study|Death|8|||
44373296|NCT01114724|79378405|FG000|Overall Study|Lost to Follow-up|1|||
44373297|NCT01114724|79378405|FG000|Overall Study|Withdrawal by Subject|1|||
44460274|NCT00610649|79468881|FG010|Overall Study|Family Emergency|0|||
44460275|NCT00610649|79468871|FG000|Overall Study|Withdrawal by Subject|0|||
44460276|NCT00610649|79468872|FG001|Overall Study|Withdrawal by Subject|0|||
44460277|NCT00610649|79468873|FG002|Overall Study|Withdrawal by Subject|0|||
44460278|NCT00610649|79468874|FG003|Overall Study|Withdrawal by Subject|0|||
44460279|NCT00610649|79468875|FG004|Overall Study|Withdrawal by Subject|0|||
44460280|NCT00610649|79468876|FG005|Overall Study|Withdrawal by Subject|0|||
44460281|NCT00610649|79468877|FG006|Overall Study|Withdrawal by Subject|0|||
44460282|NCT00610649|79468878|FG007|Overall Study|Withdrawal by Subject|0|||
44460283|NCT00610649|79468879|FG008|Overall Study|Withdrawal by Subject|0|||
44460284|NCT00610649|79468880|FG009|Overall Study|Withdrawal by Subject|1|||
44460285|NCT00610649|79468881|FG010|Overall Study|Withdrawal by Subject|0|||
44460286|NCT00608543|79468905|FG000|Overall Study|Adverse Event|4|||
44460287|NCT00520130|79468912|FG000|Overall Study|Disease progression on study|4|||
44460288|NCT00520130|79468913|FG001|Overall Study|Disease progression on study|0|||
44460289|NCT00520130|79468912|FG000|Overall Study|Physician Decision|1|||
44218052|NCT01525407|79016651|FG000|Overall Study|Withdrawal by Subject|0|||
44218053|NCT01525407|79016652|FG001|Overall Study|Withdrawal by Subject|1|||
44218054|NCT01525407|79016651|FG000|Overall Study|Transplant was delayed|0|||
44218055|NCT01525407|79016652|FG001|Overall Study|Transplant was delayed|1|||
44218056|NCT01525407|79016651|FG000|Overall Study|Delay in Transplant|1|||
44218057|NCT01525407|79016652|FG001|Overall Study|Delay in Transplant|0|||
44218058|NCT01471197|79016660|FG000|Overall Study|Disease Progression|4|||
44373298|NCT00964392|79378412|FG000|Overall Study|Withdrawal by Subject|4|||
44460290|NCT00520130|79468913|FG001|Overall Study|Physician Decision|1|||
44460291|NCT00519896|79468923|FG000|Overall Study|Protocol Violation|1|||
44218059|NCT01471197|79016661|FG001|Overall Study|Disease Progression|2|||
44218060|NCT01471197|79016660|FG000|Overall Study|Death|1|||
44218061|NCT01471197|79016661|FG001|Overall Study|Death|0|||
44460292|NCT00519896|79468923|FG000|Overall Study|Adverse Event|1|||
44460293|NCT00527618|79468936|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
44460294|NCT00527618|79468937|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
44460295|NCT00527618|79468936|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
44218062|NCT01471197|79016660|FG000|Overall Study|Study Drug Toxicity|1|||
44218063|NCT01471197|79016661|FG001|Overall Study|Study Drug Toxicity|0|||
44218064|NCT01524783|79016695|FG000|Blinded Period|Adverse Event|64|||
44218065|NCT01524783|79016696|FG001|Blinded Period|Adverse Event|7|||
44218066|NCT01524783|79016697|FG002|Blinded Period|Adverse Event|0|||
44218067|NCT01524783|79016695|FG000|Blinded Period|Disease Progression|89|||
44218068|NCT01524783|79016696|FG001|Blinded Period|Disease Progression|75|||
44218069|NCT01524783|79016697|FG002|Blinded Period|Disease Progression|0|||
44218070|NCT01524783|79016695|FG000|Blinded Period|Withdrawal by Subject|19|||
44218071|NCT01524783|79016696|FG001|Blinded Period|Withdrawal by Subject|6|||
44218072|NCT01524783|79016697|FG002|Blinded Period|Withdrawal by Subject|0|||
44218073|NCT01524783|79016695|FG000|Blinded Period|Protocol deviation|2|||
44218074|NCT01524783|79016696|FG001|Blinded Period|Protocol deviation|1|||
44218075|NCT01524783|79016697|FG002|Blinded Period|Protocol deviation|0|||
44218076|NCT01524783|79016695|FG000|Blinded Period|Death|5|||
44218077|NCT01524783|79016696|FG001|Blinded Period|Death|2|||
44218078|NCT01524783|79016697|FG002|Blinded Period|Death|0|||
44218079|NCT01524783|79016695|FG000|Open-label Period|Disease progression|13|||
44218080|NCT01524783|79016696|FG001|Open-label Period|Disease progression|0|||
44218081|NCT01524783|79016697|FG002|Open-label Period|Disease progression|2|||
44218082|NCT01524783|79016695|FG000|Open-label Period|Administrative problems|5|||
44218083|NCT01524783|79016696|FG001|Open-label Period|Administrative problems|0|||
44218084|NCT01524783|79016697|FG002|Open-label Period|Administrative problems|2|||
44218085|NCT01524783|79016695|FG000|Open-label Period|Adverse Event|5|||
44218086|NCT01524783|79016696|FG001|Open-label Period|Adverse Event|0|||
44218087|NCT01524783|79016697|FG002|Open-label Period|Adverse Event|1|||
44218088|NCT01524783|79016695|FG000|Open-label Period|Withdrawal by Subject|2|||
44218089|NCT01524783|79016696|FG001|Open-label Period|Withdrawal by Subject|0|||
44218090|NCT01524783|79016697|FG002|Open-label Period|Withdrawal by Subject|1|||
44218091|NCT01524783|79016695|FG000|Open-label Period|Protocol deviation|1|||
44218092|NCT01524783|79016696|FG001|Open-label Period|Protocol deviation|0|||
44218093|NCT01524783|79016697|FG002|Open-label Period|Protocol deviation|0|||
44218094|NCT01494987|79016711|FG000|Overall Study|Adverse Event|6|||
44218095|NCT01494987|79016712|FG001|Overall Study|Adverse Event|5|||
44218096|NCT01494987|79016711|FG000|Overall Study|Hyperglycemia|6|||
44218097|NCT01494987|79016712|FG001|Overall Study|Hyperglycemia|4|||
44218098|NCT01494987|79016711|FG000|Overall Study|Investigator's Discretion|1|||
44218099|NCT01494987|79016712|FG001|Overall Study|Investigator's Discretion|2|||
44218100|NCT01494987|79016711|FG000|Overall Study|Lost to Follow-up|1|||
44218101|NCT01494987|79016712|FG001|Overall Study|Lost to Follow-up|1|||
44218102|NCT01494987|79016711|FG000|Overall Study|Protocol Violation|3|||
44218103|NCT01494987|79016712|FG001|Overall Study|Protocol Violation|3|||
44218104|NCT01494987|79016711|FG000|Overall Study|Subject Non-Compliance|9|||
44460296|NCT00527618|79468937|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
44460297|NCT00527618|79468936|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
44460298|NCT00527618|79468937|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
44460299|NCT00527618|79468936|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
44460300|NCT00527618|79468937|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
44373299|NCT00964392|79378413|FG001|Overall Study|Withdrawal by Subject|6|||
44460301|NCT00527618|79468936|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
44460302|NCT00527618|79468937|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
44460303|NCT00527618|79468936|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
44460304|NCT00527618|79468937|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
44460305|NCT00527072|79468944|FG000|Overall Study|Adverse Event|13|||
44460306|NCT00527072|79468944|FG000|Overall Study|Lack of Efficacy|11|||
44218105|NCT01494987|79016712|FG001|Overall Study|Subject Non-Compliance|10|||
44218106|NCT01494987|79016711|FG000|Overall Study|Subject Withdrew Consent|2|||
44460307|NCT00527072|79468944|FG000|Overall Study|Lost to Follow-up|3|||
44460308|NCT00527072|79468944|FG000|Overall Study|Protocol Violation|2|||
44460309|NCT00527072|79468944|FG000|Overall Study|Withdrawal by Subject|7|||
44460310|NCT00526994|79468952|FG000|Overall Study|Lost to Follow-up|98|||
44460311|NCT00526994|79468953|FG001|Overall Study|Lost to Follow-up|108|||
44460312|NCT00526994|79468954|FG002|Overall Study|Lost to Follow-up|96|||
44460313|NCT00526994|79468952|FG000|Overall Study|Death|4|||
44460314|NCT00526994|79468953|FG001|Overall Study|Death|3|||
44460315|NCT00526994|79468954|FG002|Overall Study|Death|3|||
44460316|NCT00526994|79468952|FG000|Overall Study|Withdrawal by Subject|2|||
44460317|NCT00526994|79468953|FG001|Overall Study|Withdrawal by Subject|7|||
44460318|NCT00526994|79468954|FG002|Overall Study|Withdrawal by Subject|5|||
44460319|NCT00526994|79468952|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
44460320|NCT00526994|79468953|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
44460321|NCT00526994|79468954|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
44460322|NCT00519428|79468965|FG000|Overall Study|Adverse Event|5|||
44460323|NCT00519428|79468966|FG001|Overall Study|Adverse Event|2|||
44460324|NCT00519428|79468967|FG002|Overall Study|Adverse Event|10|||
44460325|NCT00519428|79468965|FG000|Overall Study|Lost to Follow-up|7|||
44460326|NCT00519428|79468966|FG001|Overall Study|Lost to Follow-up|7|||
44460327|NCT00519428|79468967|FG002|Overall Study|Lost to Follow-up|6|||
44460328|NCT00519428|79468965|FG000|Overall Study|Withdrawal by Subject|8|||
44460329|NCT00519428|79468966|FG001|Overall Study|Withdrawal by Subject|3|||
44460330|NCT00519428|79468967|FG002|Overall Study|Withdrawal by Subject|7|||
44460331|NCT00519428|79468965|FG000|Overall Study|unstated|1|||
44460332|NCT00519428|79468966|FG001|Overall Study|unstated|3|||
44460333|NCT00519428|79468967|FG002|Overall Study|unstated|2|||
44460334|NCT00432159|79468983|FG000|Overall Study|Death|0|||
44460335|NCT00432159|79468984|FG001|Overall Study|Death|1|||
44460336|NCT00432159|79468985|FG002|Overall Study|Death|0|||
44460337|NCT00432159|79468986|FG003|Overall Study|Death|0|||
44460338|NCT00432159|79468987|FG004|Overall Study|Death|0|||
44460339|NCT00432159|79468983|FG000|Overall Study|Failure|9|||
44460340|NCT00432159|79468984|FG001|Overall Study|Failure|5|||
44460341|NCT00432159|79468985|FG002|Overall Study|Failure|3|||
44460342|NCT00432159|79468986|FG003|Overall Study|Failure|2|||
44460343|NCT00432159|79468987|FG004|Overall Study|Failure|3|||
44460344|NCT00432159|79468983|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
44460345|NCT00432159|79468984|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
44460346|NCT00432159|79468985|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
44460347|NCT00432159|79468986|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
44460348|NCT00432159|79468987|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
44544154|NCT03660943|79557389|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
44218107|NCT01494987|79016712|FG001|Overall Study|Subject Withdrew Consent|3|||
44373300|NCT00964392|79378412|FG000|Overall Study|Lost to Follow-up|4|||
44373301|NCT00964392|79378413|FG001|Overall Study|Lost to Follow-up|10|||
44373302|NCT00964392|79378412|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
44373303|NCT00964392|79378413|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
44373304|NCT00964392|79378412|FG000|Overall Study|Not completed|44|||
44373305|NCT00964392|79378413|FG001|Overall Study|Not completed|168|||
44373306|NCT00914589|79378422|FG000|Overall Study|Adverse Event|1|||
44373307|NCT00914589|79378423|FG001|Overall Study|Adverse Event|0|||
44373308|NCT00914589|79378424|FG002|Overall Study|Adverse Event|1|||
44373309|NCT00914589|79378422|FG000|Overall Study|Protocol Violation|8|||
44460349|NCT00519194|79468999|FG000|Overall Study|Withdrawal by Subject|9|||
44460350|NCT00519194|79468999|FG000|Overall Study|Death|9|||
44218108|NCT01524627|79016720|FG000|Overall Study|Physician Decision|0|||
44460351|NCT00519194|79468999|FG000|Overall Study|Lost to Follow-up|3|||
44460352|NCT00431847|79469007|FG000|Overall Study|completion of less than two study visits|6|||
44460353|NCT00431847|79469008|FG001|Overall Study|completion of less than two study visits|3|||
44460354|NCT00431847|79469009|FG002|Overall Study|completion of less than two study visits|4|||
44460355|NCT00431847|79469010|FG003|Overall Study|completion of less than two study visits|14|||
44373310|NCT00914589|79378423|FG001|Overall Study|Protocol Violation|6|||
44460356|NCT00431847|79469011|FG004|Overall Study|completion of less than two study visits|0|||
44218109|NCT01524627|79016721|FG001|Overall Study|Physician Decision|1|||
44460357|NCT00431847|79469007|FG000|Overall Study|Protocol Violation|0|||
44460358|NCT00431847|79469008|FG001|Overall Study|Protocol Violation|0|||
44460359|NCT00431847|79469009|FG002|Overall Study|Protocol Violation|0|||
44460360|NCT00431847|79469010|FG003|Overall Study|Protocol Violation|0|||
44460361|NCT00431847|79469011|FG004|Overall Study|Protocol Violation|1|||
44218110|NCT01524627|79016720|FG000|Overall Study|Lost to Follow-up|1|||
44218111|NCT01524627|79016721|FG001|Overall Study|Lost to Follow-up|1|||
44218112|NCT01469637|79016729|FG000|First Intervention|Unacceptable behavior|0|||
44218113|NCT01469637|79016730|FG001|First Intervention|Unacceptable behavior|1|||
44218114|NCT01469637|79016729|FG000|Second Intervention|Incarcerated|1|||
44218115|NCT01469637|79016730|FG001|Second Intervention|Incarcerated|0|||
44218116|NCT04842747|79017150|FG000|Overall Study|Withdrawal by Subject|6|||
44218117|NCT04842747|79017151|FG001|Overall Study|Withdrawal by Subject|2|||
44218118|NCT04842747|79017150|FG000|Overall Study|Lost to Follow-up|1|||
44218119|NCT04842747|79017151|FG001|Overall Study|Lost to Follow-up|2|||
44218120|NCT04842747|79017150|FG000|Overall Study|Physician Decision|1|||
44218121|NCT04842747|79017151|FG001|Overall Study|Physician Decision|0|||
44218122|NCT04842747|79017150|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
44218123|NCT04842747|79017151|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
44218124|NCT04810481|79017159|FG000|Overall Study|Disqualified data sets|10|||
44218125|NCT04810481|79017160|FG001|Overall Study|Disqualified data sets|28|||
44218126|NCT04755231|79017179|FG000|Overall Study|Lost to Follow-up|5|||
44218127|NCT04755231|79017179|FG000|Overall Study|Withdrawal by Subject|5|||
44373311|NCT00914589|79378424|FG002|Overall Study|Protocol Violation|3|||
44373312|NCT00914589|79378422|FG000|Overall Study|unclassified|16|||
44460362|NCT00431067|79469021|FG000|Overall Study|Other Adverse Event|9|||
44218128|NCT04664400|79017192|FG000|Overall Study|Withdrawal by Subject|2|||
44373313|NCT00914589|79378423|FG001|Overall Study|unclassified|9|||
44218129|NCT04657770|79017197|FG000|Overall Study|Withdrawal by Subject|3|||
44460363|NCT00431067|79469021|FG000|Overall Study|Progressive disease|30|||
44218130|NCT04657770|79017197|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
44218131|NCT04496453|79017201|FG000|Overall Study|Lost to Follow-up|6|||
44218132|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
44218133|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
44218134|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
44218135|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
44218136|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
44218137|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
44218138|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
44218139|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
44218140|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
44218141|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
44218142|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
44460364|NCT00431067|79469021|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
44460365|NCT00430989|79469027|FG000|Overall Study|Lost to Follow-up|2|||
44460366|NCT00430989|79469028|FG001|Overall Study|Lost to Follow-up|3|||
44460367|NCT00430989|79469027|FG000|Overall Study|Withdrawal by Subject|15|||
44460368|NCT00430989|79469028|FG001|Overall Study|Withdrawal by Subject|14|||
44460369|NCT00430989|79469027|FG000|Overall Study|Protocol Violation|30|||
44460370|NCT00430989|79469028|FG001|Overall Study|Protocol Violation|37|||
44460371|NCT00430989|79469027|FG000|Overall Study|Not eligible|13|||
44460372|NCT00430989|79469028|FG001|Overall Study|Not eligible|6|||
44460373|NCT00430755|79469036|FG000|Overall Study|Withdrawal by Subject|53|||
44460374|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
44460375|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
44460376|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
44460377|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
44544155|NCT03660943|79557390|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
44218143|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
44218144|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
44373314|NCT00914589|79378424|FG002|Overall Study|unclassified|7|||
44249722|NCT01463306|79083893|FG001|Overall Study|Approval expiry at site|0|||
44373315|NCT00914589|79378422|FG000|Overall Study|Death|0|||
44460378|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
44218145|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
44460379|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
44460380|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
44460381|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
44460382|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
44460383|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
44460384|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Subject decision|1|||
44460385|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Subject decision|1|||
44460386|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
44460387|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
44460388|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
44460389|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
44460390|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
44460391|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
44460392|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
44460393|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
44460394|NCT00518882|79469042|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
44460395|NCT00518882|79469043|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
44460396|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
44460397|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
44460398|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
44460399|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
44460400|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
44460401|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
44460402|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
44460403|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
44460404|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
44460405|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
44460406|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
44460407|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
44460408|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
44460409|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
44249723|NCT01463306|79083894|FG002|Overall Study|Approval expiry at site|0|||
44460410|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
44460411|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
44460412|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
44460413|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
44460414|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
44460415|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
44218146|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
44218147|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
44218148|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
44218149|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
44218150|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
44218151|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
44218152|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
44218153|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
44218154|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
44218155|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
44218156|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
44218157|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
44218158|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
44218159|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
44218160|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
44218161|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
44218162|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
44218163|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
44218164|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
44460416|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
44460417|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
44460418|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
44460419|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
44218165|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
44460420|NCT00518882|79469042|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
44460421|NCT00518882|79469043|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
44460422|NCT00518336|79469051|FG000|Year 7|Lost to Follow-up|2|||
44460423|NCT00518336|79469052|FG001|Year 7|Lost to Follow-up|0|||
44460424|NCT00518336|79469051|FG000|Year 7|Could not attend in time|0|||
44460425|NCT00518336|79469052|FG001|Year 7|Could not attend in time|3|||
44460426|NCT00518336|79469051|FG000|Year 8|Lost to Follow-up|1|||
44460427|NCT00518336|79469052|FG001|Year 8|Lost to Follow-up|1|||
44460428|NCT00518336|79469051|FG000|Year 8|Could not attend in time|0|||
44460429|NCT00518336|79469052|FG001|Year 8|Could not attend in time|1|||
44460430|NCT00518336|79469051|FG000|Year 9|Migrated/moved from study area|1|||
44460431|NCT00518336|79469052|FG001|Year 9|Migrated/moved from study area|1|||
44460432|NCT00518336|79469051|FG000|Year 9|Lost to Follow-up|3|||
44460433|NCT00518336|79469052|FG001|Year 9|Lost to Follow-up|0|||
44460434|NCT00518336|79469051|FG000|Year 9|Personal reasons|1|||
44460435|NCT00518336|79469052|FG001|Year 9|Personal reasons|0|||
44460436|NCT00518180|79469061|FG000|Overall Study|Withdrawal by Subject|29|||
44460437|NCT00518180|79469062|FG001|Overall Study|Withdrawal by Subject|30|||
44460438|NCT00518180|79469063|FG002|Overall Study|Withdrawal by Subject|42|||
44460439|NCT00518180|79469061|FG000|Overall Study|Lost to Follow-up|30|||
44460440|NCT00518180|79469062|FG001|Overall Study|Lost to Follow-up|28|||
44460441|NCT00518180|79469063|FG002|Overall Study|Lost to Follow-up|34|||
44460442|NCT00518180|79469061|FG000|Overall Study|Administrative reason|0|||
44460443|NCT00518180|79469062|FG001|Overall Study|Administrative reason|2|||
44460444|NCT00518180|79469063|FG002|Overall Study|Administrative reason|2|||
44460445|NCT00518180|79469061|FG000|Overall Study|Protocol Violation|5|||
44460446|NCT00518180|79469062|FG001|Overall Study|Protocol Violation|7|||
44460447|NCT00518180|79469063|FG002|Overall Study|Protocol Violation|4|||
44460448|NCT00518180|79469061|FG000|Overall Study|Unable to classify|0|||
44460449|NCT00518180|79469062|FG001|Overall Study|Unable to classify|2|||
44218166|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
44218167|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
44218168|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
44218169|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
44218170|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
44218171|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
44218172|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
44218173|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
44218174|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
44218175|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
44218176|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
44218177|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
44218178|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
44218179|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
44218180|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
44218181|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
44218182|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
44218183|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
44218184|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
44218185|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
44218186|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
44373316|NCT00914589|79378423|FG001|Overall Study|Death|1|||
44373317|NCT00914589|79378424|FG002|Overall Study|Death|1|||
44373318|NCT00912405|79378432|FG000|Overall Study|Lost to Follow-up|5|||
44373319|NCT00878722|79378444|FG000|Overall Study|Progressive disease|3|||
44373320|NCT00878722|79378445|FG001|Overall Study|Progressive disease|3|||
44373321|NCT00878722|79378446|FG002|Overall Study|Progressive disease|3|||
44373322|NCT00878722|79378447|FG003|Overall Study|Progressive disease|7|||
44373323|NCT00878722|79378448|FG004|Overall Study|Progressive disease|7|||
44373324|NCT00878722|79378449|FG005|Overall Study|Progressive disease|1|||
44460450|NCT00518180|79469063|FG002|Overall Study|Unable to classify|0|||
44460451|NCT00518180|79469061|FG000|Overall Study|Adverse Event|1|||
44460452|NCT00518180|79469062|FG001|Overall Study|Adverse Event|0|||
44460453|NCT00518180|79469063|FG002|Overall Study|Adverse Event|0|||
44460454|NCT00525902|79469080|FG000|Overall Study|Lack of Efficacy|1|||
44460455|NCT00525824|79469088|FG000|Overall Study|Adverse Event|7|||
44460456|NCT00525824|79469089|FG001|Overall Study|Adverse Event|11|||
44460457|NCT00525824|79469090|FG002|Overall Study|Adverse Event|6|||
44460458|NCT00525824|79469091|FG003|Overall Study|Adverse Event|7|||
44460459|NCT00525824|79469088|FG000|Overall Study|Withdrawal by Subject|5|||
44373325|NCT00878722|79378450|FG006|Overall Study|Progressive disease|4|||
44373326|NCT00878722|79378451|FG007|Overall Study|Progressive disease|3|||
44460460|NCT00525824|79469089|FG001|Overall Study|Withdrawal by Subject|9|||
44460461|NCT00525824|79469090|FG002|Overall Study|Withdrawal by Subject|3|||
44460462|NCT00525824|79469091|FG003|Overall Study|Withdrawal by Subject|4|||
44218187|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
44218188|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
44218189|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
44460463|NCT00525824|79469088|FG000|Overall Study|Lost to Follow-up|4|||
44460464|NCT00525824|79469089|FG001|Overall Study|Lost to Follow-up|2|||
44218190|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
44218191|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
44218192|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
44218193|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
44277787|NCT02138838|79238775|FG000|Overall Study|Withdrawal by Subject|1|||
44460465|NCT00525824|79469090|FG002|Overall Study|Lost to Follow-up|4|||
44460466|NCT00525824|79469091|FG003|Overall Study|Lost to Follow-up|0|||
44460467|NCT00525824|79469088|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
44460468|NCT00525824|79469089|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
44373327|NCT00878722|79378444|FG000|Overall Study|Death|0|||
44373328|NCT00878722|79378445|FG001|Overall Study|Death|0|||
44373329|NCT00878722|79378446|FG002|Overall Study|Death|0|||
44373330|NCT00878722|79378447|FG003|Overall Study|Death|1|||
44373331|NCT00878722|79378448|FG004|Overall Study|Death|0|||
44373332|NCT00878722|79378449|FG005|Overall Study|Death|1|||
44373333|NCT00878722|79378450|FG006|Overall Study|Death|0|||
44373334|NCT00878722|79378451|FG007|Overall Study|Death|2|||
44373335|NCT00878722|79378444|FG000|Overall Study|Adverse Event|0|||
44460469|NCT00525824|79469090|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
44460470|NCT00525824|79469091|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
44270273|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44373336|NCT00878722|79378445|FG001|Overall Study|Adverse Event|0|||
44373337|NCT00878722|79378446|FG002|Overall Study|Adverse Event|0|||
44460471|NCT00525824|79469088|FG000|Overall Study|Severe non-compliance|0|||
44460472|NCT00525824|79469089|FG001|Overall Study|Severe non-compliance|1|||
44460473|NCT00525824|79469090|FG002|Overall Study|Severe non-compliance|1|||
44460474|NCT00525824|79469091|FG003|Overall Study|Severe non-compliance|1|||
44460475|NCT00525824|79469088|FG000|Overall Study|Safety reasons|1|||
44460476|NCT00525824|79469089|FG001|Overall Study|Safety reasons|0|||
44218194|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
44218195|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
44218196|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
44218197|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
44218198|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
44218199|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
44218200|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
44218201|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
44218202|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
44218203|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
44277788|NCT02138838|79238776|FG001|Overall Study|Withdrawal by Subject|5|||
44460477|NCT00525824|79469090|FG002|Overall Study|Safety reasons|1|||
44460478|NCT00525824|79469091|FG003|Overall Study|Safety reasons|0|||
44544156|NCT03167073|79557398|FG000|Overall Study|Stillbirth|1|||
44218204|NCT04440163|79017213|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
44218205|NCT04440163|79017214|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
44218206|NCT04440163|79017215|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
44218207|NCT04440163|79017216|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
44218208|NCT04440163|79017217|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
44460479|NCT00525824|79469088|FG000|Overall Study|Other|1|||
44460480|NCT00525824|79469089|FG001|Overall Study|Other|3|||
44460481|NCT00525824|79469090|FG002|Overall Study|Other|3|||
44460482|NCT00525824|79469091|FG003|Overall Study|Other|1|||
44460483|NCT00525590|79469105|FG000|Overall Study|Adverse Event|3|||
44460484|NCT00525590|79469105|FG000|Overall Study|Physician Decision|3|||
44460485|NCT00525590|79469105|FG000|Overall Study|Withdrawal by Subject|16|||
44460486|NCT00525590|79469105|FG000|Overall Study|Lost to Follow-up|1|||
44460487|NCT00525590|79469105|FG000|Overall Study|Death|9|||
44460488|NCT00525590|79469105|FG000|Overall Study|Other|13|||
44460489|NCT00430677|79469112|FG000|Short-term Period|Death|1|||
44460490|NCT00430677|79469113|FG001|Short-term Period|Death|1|||
44460491|NCT00430677|79469114|FG002|Short-term Period|Death|5|||
44460492|NCT00430677|79469112|FG000|Short-term Period|Adverse Event|15|||
44460493|NCT00430677|79469113|FG001|Short-term Period|Adverse Event|13|||
44460494|NCT00430677|79469114|FG002|Short-term Period|Adverse Event|9|||
44460495|NCT00430677|79469112|FG000|Short-term Period|Lack of Efficacy|5|||
44460496|NCT00430677|79469113|FG001|Short-term Period|Lack of Efficacy|6|||
44218209|NCT04440163|79017218|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
44218210|NCT04440163|79017219|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
44373338|NCT00878722|79378447|FG003|Overall Study|Adverse Event|0|||
44373339|NCT00878722|79378448|FG004|Overall Study|Adverse Event|0|||
44373340|NCT00878722|79378449|FG005|Overall Study|Adverse Event|0|||
44373341|NCT00878722|79378450|FG006|Overall Study|Adverse Event|2|||
44373342|NCT00878722|79378451|FG007|Overall Study|Adverse Event|0|||
44373343|NCT00878722|79378444|FG000|Overall Study|Withdrawal by Subject|0|||
44373344|NCT00878722|79378445|FG001|Overall Study|Withdrawal by Subject|0|||
44373345|NCT00878722|79378446|FG002|Overall Study|Withdrawal by Subject|0|||
44373346|NCT00878722|79378447|FG003|Overall Study|Withdrawal by Subject|0|||
44373347|NCT00878722|79378448|FG004|Overall Study|Withdrawal by Subject|0|||
44373348|NCT00878722|79378449|FG005|Overall Study|Withdrawal by Subject|0|||
44373349|NCT00878722|79378450|FG006|Overall Study|Withdrawal by Subject|0|||
44373350|NCT00878722|79378451|FG007|Overall Study|Withdrawal by Subject|2|||
44373351|NCT00878722|79378444|FG000|Overall Study|Relapse|0|||
44373352|NCT00878722|79378445|FG001|Overall Study|Relapse|0|||
44373353|NCT00878722|79378446|FG002|Overall Study|Relapse|0|||
44373354|NCT00878722|79378447|FG003|Overall Study|Relapse|1|||
44373355|NCT00878722|79378448|FG004|Overall Study|Relapse|0|||
44373356|NCT00878722|79378449|FG005|Overall Study|Relapse|0|||
44373357|NCT00878722|79378450|FG006|Overall Study|Relapse|0|||
44373358|NCT00878722|79378451|FG007|Overall Study|Relapse|0|||
44373359|NCT00964158|79378479|FG000|Overall Study|Lost to Follow-up|0|||
44373360|NCT00964158|79378480|FG001|Overall Study|Lost to Follow-up|1|||
44373361|NCT00964158|79378481|FG002|Overall Study|Lost to Follow-up|2|||
44373362|NCT00964158|79378479|FG000|Overall Study|Withdrawal by Subject|0|||
44460497|NCT00430677|79469114|FG002|Short-term Period|Lack of Efficacy|4|||
44460498|NCT00430677|79469112|FG000|Short-term Period|Withdrawal by Subject|1|||
44218211|NCT04440163|79017220|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
44373363|NCT00964158|79378480|FG001|Overall Study|Withdrawal by Subject|0|||
44373364|NCT00964158|79378481|FG002|Overall Study|Withdrawal by Subject|6|||
44460499|NCT00430677|79469113|FG001|Short-term Period|Withdrawal by Subject|1|||
44373365|NCT00961350|79378494|FG000|Overall Study|Adverse Event|18|||
44460500|NCT00430677|79469114|FG002|Short-term Period|Withdrawal by Subject|2|||
44218212|NCT04440163|79017213|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
44218213|NCT04440163|79017214|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
44218214|NCT04440163|79017215|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
44218215|NCT04440163|79017216|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
44218216|NCT04440163|79017217|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
44218217|NCT04440163|79017218|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
44218218|NCT04440163|79017219|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
44218219|NCT04440163|79017220|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
44218220|NCT04440163|79017213|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218221|NCT04440163|79017214|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218222|NCT04440163|79017215|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218223|NCT04440163|79017216|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
44218224|NCT04440163|79017217|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218225|NCT04440163|79017218|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218226|NCT04440163|79017219|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218227|NCT04440163|79017220|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
44218228|NCT04304508|79017251|FG000|Overall Study|Subject Decision|29|||
44218229|NCT04304508|79017252|FG001|Overall Study|Subject Decision|39|||
44218230|NCT04304508|79017253|FG002|Overall Study|Subject Decision|37|||
44218231|NCT04304508|79017254|FG003|Overall Study|Subject Decision|48|||
44218232|NCT04304508|79017251|FG000|Overall Study|Death|6|||
44544157|NCT03167073|79557399|FG001|Overall Study|Stillbirth|0|||
44544158|NCT03657277|79557405|FG000|Overall Study|Physician Decision|2|||
44544159|NCT03657277|79557405|FG000|Overall Study|Lost to Follow-up|1|||
44218233|NCT04304508|79017252|FG001|Overall Study|Death|1|||
44218234|NCT04304508|79017253|FG002|Overall Study|Death|8|||
44218235|NCT04304508|79017254|FG003|Overall Study|Death|5|||
44218236|NCT04304508|79017251|FG000|Overall Study|Non-compliance With Study Drug|3|||
44218237|NCT04304508|79017252|FG001|Overall Study|Non-compliance With Study Drug|1|||
44218238|NCT04304508|79017253|FG002|Overall Study|Non-compliance With Study Drug|2|||
44544160|NCT03657277|79557405|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
44544161|NCT03197883|79557411|FG000|Overall Study|Adverse Event|1|||
44460501|NCT00430677|79469112|FG000|Short-term Period|Participant no longer met study criteria|1|||
44460502|NCT00430677|79469113|FG001|Short-term Period|Participant no longer met study criteria|1|||
44460503|NCT00430677|79469114|FG002|Short-term Period|Participant no longer met study criteria|2|||
44460504|NCT00430677|79469112|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
44460505|NCT00430677|79469113|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
44460506|NCT00430677|79469114|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
44460507|NCT00430677|79469112|FG000|Short-term Period|Pregnancy|0|||
44460508|NCT00430677|79469113|FG001|Short-term Period|Pregnancy|2|||
44460509|NCT00430677|79469114|FG002|Short-term Period|Pregnancy|0|||
44460510|NCT00430677|79469112|FG000|Long-term Extension Period|Death|1|||
44460511|NCT00430677|79469113|FG001|Long-term Extension Period|Death|0|||
44460512|NCT00430677|79469114|FG002|Long-term Extension Period|Death|0|||
44460513|NCT00430677|79469112|FG000|Long-term Extension Period|Adverse Event|3|||
44460514|NCT00430677|79469113|FG001|Long-term Extension Period|Adverse Event|2|||
44460515|NCT00430677|79469114|FG002|Long-term Extension Period|Adverse Event|5|||
44460516|NCT00430677|79469112|FG000|Long-term Extension Period|Lack of Efficacy|5|||
44460517|NCT00430677|79469113|FG001|Long-term Extension Period|Lack of Efficacy|3|||
44460518|NCT00430677|79469114|FG002|Long-term Extension Period|Lack of Efficacy|8|||
44460519|NCT00430677|79469112|FG000|Long-term Extension Period|Lost to Follow-up|1|||
44460520|NCT00430677|79469113|FG001|Long-term Extension Period|Lost to Follow-up|1|||
44460521|NCT00430677|79469114|FG002|Long-term Extension Period|Lost to Follow-up|1|||
44460522|NCT00430677|79469112|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
44460523|NCT00430677|79469113|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
44373366|NCT00961350|79378495|FG001|Overall Study|Adverse Event|33|||
44373367|NCT00961350|79378494|FG000|Overall Study|Withdrawal by Subject|10|||
44373368|NCT00961350|79378495|FG001|Overall Study|Withdrawal by Subject|10|||
44373369|NCT00961350|79378494|FG000|Overall Study|Lost to Follow-up|3|||
44373370|NCT00961350|79378495|FG001|Overall Study|Lost to Follow-up|3|||
44373371|NCT00961350|79378494|FG000|Overall Study|Misc|16|||
44373372|NCT00961350|79378495|FG001|Overall Study|Misc|21|||
44373373|NCT00963924|79378503|FG000|Overall Study|Adverse Event|1|||
44373374|NCT00963924|79378504|FG001|Overall Study|Adverse Event|0|||
44373375|NCT00963924|79378503|FG000|Overall Study|Withdrawal by Subject|0|||
44373376|NCT00963924|79378504|FG001|Overall Study|Withdrawal by Subject|1|||
44373377|NCT00963924|79378503|FG000|Overall Study|Changed antipsychotic|0|||
44373378|NCT00963924|79378504|FG001|Overall Study|Changed antipsychotic|1|||
44373379|NCT00963924|79378503|FG000|Overall Study|Lost to Follow-up|0|||
44373380|NCT00963924|79378504|FG001|Overall Study|Lost to Follow-up|1|||
44373381|NCT03265665|79378514|FG000|24-week Data Collection|Withdrawal by Subject|2|||
44373382|NCT03265665|79378515|FG001|24-week Data Collection|Withdrawal by Subject|2|||
44373383|NCT03265665|79378514|FG000|24-week Data Collection|Lost to Follow-up|4|||
44373384|NCT03265665|79378515|FG001|24-week Data Collection|Lost to Follow-up|5|||
44373385|NCT03265665|79378514|FG000|36-week Data Collection|Lost to Follow-up|6|||
44373386|NCT03265665|79378515|FG001|36-week Data Collection|Lost to Follow-up|8|||
44373387|NCT01114646|79378525|FG000|Overall Study|Withdrawal by Subject|3|||
44373388|NCT01114646|79378526|FG001|Overall Study|Withdrawal by Subject|2|||
44373389|NCT00965562|79378535|FG000|Overall Study|Lost to Follow-up|1|||
44373390|NCT00965562|79378536|FG001|Overall Study|Lost to Follow-up|2|||
44373391|NCT00965562|79378537|FG002|Overall Study|Lost to Follow-up|3|||
44373392|NCT00965562|79378535|FG000|Overall Study|Withdrawal by Subject|2|||
44373393|NCT00965562|79378536|FG001|Overall Study|Withdrawal by Subject|2|||
44218239|NCT04304508|79017254|FG003|Overall Study|Non-compliance With Study Drug|0|||
44218240|NCT04304508|79017251|FG000|Overall Study|Switching To Other Therapy|1|||
44218241|NCT04304508|79017252|FG001|Overall Study|Switching To Other Therapy|1|||
44218242|NCT04304508|79017253|FG002|Overall Study|Switching To Other Therapy|1|||
44218243|NCT04304508|79017254|FG003|Overall Study|Switching To Other Therapy|2|||
44218244|NCT04304508|79017251|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
44218245|NCT04304508|79017252|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
44218246|NCT04304508|79017253|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
44218247|NCT04304508|79017254|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
44218248|NCT04304508|79017251|FG000|Overall Study|Withdrawal by Subject|7|||
44218249|NCT04304508|79017252|FG001|Overall Study|Withdrawal by Subject|5|||
44218250|NCT04304508|79017253|FG002|Overall Study|Withdrawal by Subject|11|||
44218251|NCT04304508|79017254|FG003|Overall Study|Withdrawal by Subject|6|||
44218252|NCT04304508|79017251|FG000|Overall Study|Logistical Difficulties|2|||
44218253|NCT04304508|79017252|FG001|Overall Study|Logistical Difficulties|2|||
44218254|NCT04304508|79017253|FG002|Overall Study|Logistical Difficulties|3|||
44218255|NCT04304508|79017254|FG003|Overall Study|Logistical Difficulties|2|||
44218256|NCT04304508|79017251|FG000|Overall Study|Missing Information|1|||
44218257|NCT04304508|79017252|FG001|Overall Study|Missing Information|2|||
44218258|NCT04304508|79017253|FG002|Overall Study|Missing Information|1|||
44218259|NCT04304508|79017254|FG003|Overall Study|Missing Information|3|||
44218260|NCT04304508|79017251|FG000|Overall Study|Other|7|||
44218261|NCT04304508|79017252|FG001|Overall Study|Other|6|||
44218262|NCT04304508|79017253|FG002|Overall Study|Other|5|||
44218263|NCT04304508|79017254|FG003|Overall Study|Other|4|||
44218264|NCT04304508|79017251|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
44218265|NCT04304508|79017252|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
44218266|NCT04304508|79017253|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
44218267|NCT04304508|79017254|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
44218268|NCT04304508|79017251|FG000|Overall Study|Physician Decision|3|||
44218269|NCT04304508|79017252|FG001|Overall Study|Physician Decision|4|||
44218270|NCT04304508|79017253|FG002|Overall Study|Physician Decision|9|||
44218271|NCT04304508|79017254|FG003|Overall Study|Physician Decision|7|||
44218272|NCT04304508|79017251|FG000|Overall Study|Study drug never administered|10|||
44218273|NCT04304508|79017252|FG001|Overall Study|Study drug never administered|4|||
44218274|NCT04304508|79017253|FG002|Overall Study|Study drug never administered|4|||
44218275|NCT04304508|79017254|FG003|Overall Study|Study drug never administered|4|||
44218276|NCT04304508|79017251|FG000|Overall Study|Adverse Event|49|||
44218277|NCT04304508|79017252|FG001|Overall Study|Adverse Event|50|||
44218278|NCT04304508|79017253|FG002|Overall Study|Adverse Event|51|||
44218279|NCT04304508|79017254|FG003|Overall Study|Adverse Event|56|||
44218280|NCT04304508|79017251|FG000|Overall Study|Lost to Follow-up|1|||
44218281|NCT04304508|79017252|FG001|Overall Study|Lost to Follow-up|5|||
44218282|NCT04304508|79017253|FG002|Overall Study|Lost to Follow-up|2|||
44218283|NCT04304508|79017254|FG003|Overall Study|Lost to Follow-up|3|||
44218284|NCT04206332|79017283|FG000|Part A|Lost to Follow-up|0|||
44544162|NCT03197883|79557412|FG001|Overall Study|Adverse Event|1|||
44218285|NCT04206332|79017284|FG001|Part A|Lost to Follow-up|1|||
44218286|NCT04206332|79017285|FG002|Part A|Lost to Follow-up|0|||
44218287|NCT04206332|79017286|FG003|Part A|Lost to Follow-up|0|||
44218288|NCT04206332|79017287|FG004|Part A|Lost to Follow-up|0|||
44218289|NCT04206332|79017288|FG005|Part A|Lost to Follow-up|0|||
44218290|NCT04206332|79017289|FG006|Part A|Lost to Follow-up|0|||
44218291|NCT04206332|79017290|FG007|Part A|Lost to Follow-up|0|||
44373394|NCT00965562|79378537|FG002|Overall Study|Withdrawal by Subject|0|||
44460524|NCT00430677|79469114|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
44460525|NCT00430677|79469112|FG000|Long-term Extension Period|Pregnancy|1|||
44460526|NCT00430677|79469113|FG001|Long-term Extension Period|Pregnancy|1|||
44460527|NCT00430677|79469114|FG002|Long-term Extension Period|Pregnancy|0|||
44460528|NCT00430677|79469112|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
44460529|NCT00430677|79469113|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
44460530|NCT00430677|79469114|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
44460531|NCT00430677|79469112|FG000|Long-term Extension Period|Other|2|||
44460532|NCT00430677|79469113|FG001|Long-term Extension Period|Other|1|||
44460533|NCT00430677|79469114|FG002|Long-term Extension Period|Other|1|||
44460534|NCT00430677|79469112|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
44460535|NCT00430677|79469113|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
44460536|NCT00430677|79469114|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
44460537|NCT00525512|79469142|FG000|Double-Blind Phase|Adverse Event|48|||
44460538|NCT00525512|79469143|FG001|Double-Blind Phase|Adverse Event|28|||
44460539|NCT00525512|79469144|FG002|Double-Blind Phase|Adverse Event|0|||
44460540|NCT00525512|79469145|FG003|Double-Blind Phase|Adverse Event|0|||
44460541|NCT00525512|79469142|FG000|Double-Blind Phase|Protocol Violation|3|||
44460542|NCT00525512|79469143|FG001|Double-Blind Phase|Protocol Violation|1|||
44460543|NCT00525512|79469144|FG002|Double-Blind Phase|Protocol Violation|0|||
44460544|NCT00525512|79469145|FG003|Double-Blind Phase|Protocol Violation|0|||
44460545|NCT00525512|79469142|FG000|Double-Blind Phase|Lost to Follow-up|3|||
44460546|NCT00525512|79469143|FG001|Double-Blind Phase|Lost to Follow-up|7|||
44460547|NCT00525512|79469144|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44460548|NCT00525512|79469145|FG003|Double-Blind Phase|Lost to Follow-up|0|||
44460549|NCT00525512|79469142|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
44460550|NCT00525512|79469143|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
44460551|NCT00525512|79469144|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
44460552|NCT00525512|79469145|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44460553|NCT00525512|79469142|FG000|Double-Blind Phase|Lack of Efficacy|13|||
44460554|NCT00525512|79469143|FG001|Double-Blind Phase|Lack of Efficacy|5|||
44460555|NCT00525512|79469144|FG002|Double-Blind Phase|Lack of Efficacy|0|||
44460556|NCT00525512|79469145|FG003|Double-Blind Phase|Lack of Efficacy|0|||
44460557|NCT00525512|79469142|FG000|Double-Blind Phase|Other reason (not specified)|12|||
44460558|NCT00525512|79469143|FG001|Double-Blind Phase|Other reason (not specified)|13|||
44460559|NCT00525512|79469144|FG002|Double-Blind Phase|Other reason (not specified)|0|||
44460560|NCT00525512|79469145|FG003|Double-Blind Phase|Other reason (not specified)|0|||
44460561|NCT00525512|79469142|FG000|Open-Label Phase|Adverse Event|0|||
44460562|NCT00525512|79469143|FG001|Open-Label Phase|Adverse Event|0|||
44460563|NCT00525512|79469144|FG002|Open-Label Phase|Adverse Event|1|||
44460564|NCT00525512|79469145|FG003|Open-Label Phase|Adverse Event|0|||
44460565|NCT00525512|79469142|FG000|Open-Label Phase|Lost to Follow-up|0|||
44460566|NCT00525512|79469143|FG001|Open-Label Phase|Lost to Follow-up|0|||
44460567|NCT00525512|79469144|FG002|Open-Label Phase|Lost to Follow-up|1|||
44460568|NCT00525512|79469145|FG003|Open-Label Phase|Lost to Follow-up|0|||
44218292|NCT04206332|79017291|FG008|Part A|Lost to Follow-up|0|||
44218293|NCT04206332|79017292|FG009|Part A|Lost to Follow-up|0|||
44218294|NCT04206332|79017293|FG010|Part A|Lost to Follow-up|0|||
44218295|NCT04206332|79017294|FG011|Part A|Lost to Follow-up|0|||
44218296|NCT04206332|79017295|FG012|Part A|Lost to Follow-up|0|||
44218297|NCT04206332|79017296|FG013|Part A|Lost to Follow-up|0|||
44218298|NCT04206332|79017297|FG014|Part A|Lost to Follow-up|0|||
44218299|NCT04206332|79017298|FG015|Part A|Lost to Follow-up|0|||
44218300|NCT04206332|79017299|FG016|Part A|Lost to Follow-up|0|||
44218301|NCT04206332|79017283|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218302|NCT04206332|79017284|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218303|NCT04206332|79017285|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218304|NCT04206332|79017286|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218305|NCT04206332|79017287|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218306|NCT04206332|79017288|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
44218307|NCT04206332|79017289|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44373395|NCT00912093|79378551|FG000|The Controlled Phase|Death|0|||
44218308|NCT04206332|79017290|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218309|NCT04206332|79017291|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218310|NCT04206332|79017292|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218311|NCT04206332|79017293|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218312|NCT04206332|79017294|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218313|NCT04206332|79017295|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218314|NCT04206332|79017296|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218315|NCT04206332|79017297|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218316|NCT04206332|79017298|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218317|NCT04206332|79017299|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
44218318|NCT04206332|79017283|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218319|NCT04206332|79017284|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218320|NCT04206332|79017285|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218321|NCT04206332|79017286|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44460569|NCT00525512|79469142|FG000|Open-Label Phase|Other reason (not specified)|0|||
44460570|NCT00525512|79469143|FG001|Open-Label Phase|Other reason (not specified)|0|||
44460571|NCT00525512|79469144|FG002|Open-Label Phase|Other reason (not specified)|4|||
44460572|NCT00525512|79469145|FG003|Open-Label Phase|Other reason (not specified)|5|||
44460573|NCT00517634|79469157|FG000|Second Treatment Period|Withdrawal by Subject|0|||
44460574|NCT00517634|79469158|FG001|Second Treatment Period|Withdrawal by Subject|0|||
44460575|NCT00517634|79469159|FG002|Second Treatment Period|Withdrawal by Subject|0|||
44460576|NCT00517634|79469160|FG003|Second Treatment Period|Withdrawal by Subject|0|||
44460577|NCT00517634|79469161|FG004|Second Treatment Period|Withdrawal by Subject|1|||
44460578|NCT00517634|79469162|FG005|Second Treatment Period|Withdrawal by Subject|0|||
44460579|NCT03683576|79469174|FG000|Overall Study|Withdrawal by Subject|2|||
44460580|NCT03683576|79469175|FG001|Overall Study|Withdrawal by Subject|0|||
44460581|NCT03683576|79469176|FG002|Overall Study|Withdrawal by Subject|8|||
44460582|NCT03683576|79469177|FG003|Overall Study|Withdrawal by Subject|3|||
44460583|NCT03683576|79469174|FG000|Overall Study|Adverse Event|3|||
44460584|NCT03683576|79469175|FG001|Overall Study|Adverse Event|0|||
44460585|NCT03683576|79469176|FG002|Overall Study|Adverse Event|0|||
44460586|NCT03683576|79469177|FG003|Overall Study|Adverse Event|4|||
44460587|NCT03683576|79469174|FG000|Overall Study|Lack of Efficacy|1|||
44460588|NCT03683576|79469175|FG001|Overall Study|Lack of Efficacy|0|||
44460589|NCT03683576|79469176|FG002|Overall Study|Lack of Efficacy|1|||
44460590|NCT03683576|79469177|FG003|Overall Study|Lack of Efficacy|1|||
44460591|NCT03683576|79469174|FG000|Overall Study|Lost to Follow-up|0|||
44460592|NCT03683576|79469175|FG001|Overall Study|Lost to Follow-up|1|||
44460593|NCT03683576|79469176|FG002|Overall Study|Lost to Follow-up|2|||
44460594|NCT03683576|79469177|FG003|Overall Study|Lost to Follow-up|0|||
44460595|NCT03683576|79469174|FG000|Overall Study|Other, Not Specified|0|||
44460596|NCT03683576|79469175|FG001|Overall Study|Other, Not Specified|2|||
44460597|NCT03683576|79469176|FG002|Overall Study|Other, Not Specified|0|||
44460598|NCT03683576|79469177|FG003|Overall Study|Other, Not Specified|0|||
44460599|NCT03683576|79469174|FG000|Overall Study|Protocol Violation|0|||
44460600|NCT03683576|79469175|FG001|Overall Study|Protocol Violation|1|||
44460601|NCT03683576|79469176|FG002|Overall Study|Protocol Violation|1|||
44460602|NCT03683576|79469177|FG003|Overall Study|Protocol Violation|0|||
44460603|NCT03863834|79469187|FG000|Overall Study|Lost to Follow-up|3|||
44460604|NCT00430521|79469199|FG000|Overall Study|Adverse Event|0|||
44460605|NCT00430521|79469200|FG001|Overall Study|Adverse Event|0|||
44460606|NCT00430521|79469201|FG002|Overall Study|Adverse Event|0|||
44460607|NCT00430521|79469202|FG003|Overall Study|Adverse Event|0|||
44460608|NCT00430521|79469203|FG004|Overall Study|Adverse Event|0|||
44460609|NCT00430521|79469204|FG005|Overall Study|Adverse Event|2|||
44544163|NCT03197883|79557411|FG000|Overall Study|Lost to Follow-up|1|||
44544164|NCT03197883|79557412|FG001|Overall Study|Lost to Follow-up|0|||
44544165|NCT03197883|79557411|FG000|Overall Study|Protocol Violation|1|||
44218322|NCT04206332|79017287|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44373396|NCT00912093|79378552|FG001|The Controlled Phase|Death|1|||
44373397|NCT00912093|79378553|FG002|The Controlled Phase|Death|0|||
44373398|NCT00912093|79378554|FG003|The Controlled Phase|Death|0|||
44373399|NCT00912093|79378555|FG004|The Controlled Phase|Death|0|||
44373400|NCT00912093|79378551|FG000|The Controlled Phase|Medical Condition|0|||
44373401|NCT00912093|79378552|FG001|The Controlled Phase|Medical Condition|1|||
44373402|NCT00912093|79378553|FG002|The Controlled Phase|Medical Condition|0|||
44373403|NCT00912093|79378554|FG003|The Controlled Phase|Medical Condition|0|||
44373404|NCT00912093|79378555|FG004|The Controlled Phase|Medical Condition|0|||
44373405|NCT00912093|79378551|FG000|The Controlled Phase|Lost to Follow-up|0|||
44373406|NCT00912093|79378552|FG001|The Controlled Phase|Lost to Follow-up|0|||
44373407|NCT00912093|79378553|FG002|The Controlled Phase|Lost to Follow-up|0|||
44373408|NCT00912093|79378554|FG003|The Controlled Phase|Lost to Follow-up|0|||
44373409|NCT00912093|79378555|FG004|The Controlled Phase|Lost to Follow-up|1|||
44460610|NCT00430521|79469205|FG006|Overall Study|Adverse Event|1|||
44373410|NCT00965484|79378563|FG000|Overall Study|Protocol Violation|1|||
44460611|NCT00430521|79469206|FG007|Overall Study|Adverse Event|0|||
44460612|NCT00430521|79469199|FG000|Overall Study|Lost to Follow-up|7|||
44460613|NCT00430521|79469200|FG001|Overall Study|Lost to Follow-up|8|||
44460614|NCT00430521|79469201|FG002|Overall Study|Lost to Follow-up|3|||
44460615|NCT00430521|79469202|FG003|Overall Study|Lost to Follow-up|5|||
44460616|NCT00430521|79469203|FG004|Overall Study|Lost to Follow-up|5|||
44460617|NCT00430521|79469204|FG005|Overall Study|Lost to Follow-up|2|||
44460618|NCT00430521|79469205|FG006|Overall Study|Lost to Follow-up|8|||
44460619|NCT00430521|79469206|FG007|Overall Study|Lost to Follow-up|10|||
44460620|NCT00430521|79469199|FG000|Overall Study|Pregnancy|0|||
44544166|NCT03197883|79557412|FG001|Overall Study|Protocol Violation|0|||
44373411|NCT00965484|79378563|FG000|Overall Study|Withdrawal by Subject|1|||
44373412|NCT00961116|79378567|FG000|Washout Period of 7 Days|Adverse Event|1|||
44373413|NCT00961116|79378568|FG001|Washout Period of 7 Days|Adverse Event|1|||
44460621|NCT00430521|79469200|FG001|Overall Study|Pregnancy|0|||
44373414|NCT00961116|79378567|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
44373415|NCT00961116|79378568|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44373416|NCT00961116|79378567|FG000|Washout Period of 7 Days|Protocol Violation|0|||
44460622|NCT00430521|79469201|FG002|Overall Study|Pregnancy|0|||
44460623|NCT00430521|79469202|FG003|Overall Study|Pregnancy|0|||
44460624|NCT00430521|79469203|FG004|Overall Study|Pregnancy|0|||
44270274|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44270275|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44460625|NCT00430521|79469204|FG005|Overall Study|Pregnancy|0|||
44218323|NCT04206332|79017288|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218324|NCT04206332|79017289|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218325|NCT04206332|79017290|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
44218326|NCT04206332|79017291|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218327|NCT04206332|79017292|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218328|NCT04206332|79017293|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
44218329|NCT04206332|79017294|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218330|NCT04206332|79017295|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218331|NCT04206332|79017296|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218332|NCT04206332|79017297|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218333|NCT04206332|79017298|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44249724|NCT01504412|79083923|FG000|Overall Study|Adverse Event|1|||
44460626|NCT00430521|79469205|FG006|Overall Study|Pregnancy|1|||
44460627|NCT00430521|79469206|FG007|Overall Study|Pregnancy|0|||
44460628|NCT00430521|79469199|FG000|Overall Study|Vaccine Expired|0|||
44460629|NCT00430521|79469200|FG001|Overall Study|Vaccine Expired|0|||
44460630|NCT00430521|79469201|FG002|Overall Study|Vaccine Expired|0|||
44460631|NCT00430521|79469202|FG003|Overall Study|Vaccine Expired|0|||
44460632|NCT00430521|79469203|FG004|Overall Study|Vaccine Expired|0|||
44460633|NCT00430521|79469204|FG005|Overall Study|Vaccine Expired|1|||
44460634|NCT00430521|79469205|FG006|Overall Study|Vaccine Expired|0|||
44460635|NCT00430521|79469206|FG007|Overall Study|Vaccine Expired|0|||
44460636|NCT00430521|79469199|FG000|Overall Study|Protocol Violation|1|||
44460637|NCT00430521|79469200|FG001|Overall Study|Protocol Violation|0|||
44460638|NCT00430521|79469201|FG002|Overall Study|Protocol Violation|0|||
44460639|NCT00430521|79469202|FG003|Overall Study|Protocol Violation|0|||
44460640|NCT00430521|79469203|FG004|Overall Study|Protocol Violation|0|||
44460641|NCT00430521|79469204|FG005|Overall Study|Protocol Violation|0|||
44460642|NCT00430521|79469205|FG006|Overall Study|Protocol Violation|0|||
44460643|NCT00430521|79469206|FG007|Overall Study|Protocol Violation|0|||
44460644|NCT00430521|79469199|FG000|Overall Study|Withdrawal by Subject|3|||
44460645|NCT00430521|79469200|FG001|Overall Study|Withdrawal by Subject|1|||
44460646|NCT00430521|79469201|FG002|Overall Study|Withdrawal by Subject|0|||
44460647|NCT00430521|79469202|FG003|Overall Study|Withdrawal by Subject|3|||
44460648|NCT00430521|79469203|FG004|Overall Study|Withdrawal by Subject|0|||
44460649|NCT00430521|79469204|FG005|Overall Study|Withdrawal by Subject|0|||
44460650|NCT00430521|79469205|FG006|Overall Study|Withdrawal by Subject|0|||
44460651|NCT00430521|79469206|FG007|Overall Study|Withdrawal by Subject|2|||
44460652|NCT00429663|79469239|FG000|Overall Study|Lost to Follow-up|24|||
44460653|NCT00429663|79469240|FG001|Overall Study|Lost to Follow-up|31|||
44460654|NCT00429663|79469239|FG000|Overall Study|Physician Decision|6|||
44460655|NCT00429663|79469240|FG001|Overall Study|Physician Decision|3|||
44460656|NCT00429663|79469239|FG000|Overall Study|Withdrawal by Subject|2|||
44460657|NCT00429663|79469240|FG001|Overall Study|Withdrawal by Subject|5|||
44218334|NCT04206332|79017299|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218335|NCT04206332|79017283|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218336|NCT04206332|79017284|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218337|NCT04206332|79017285|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218338|NCT04206332|79017286|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218339|NCT04206332|79017287|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44143709|NCT02006147|78933055|FG003|Overall Study|Withdrawal by Sponsor|0|||
44143710|NCT02732119|78933066|FG000|Phase I|Adverse Event|1|||
44143711|NCT02732119|78933067|FG001|Phase I|Adverse Event|3|||
44143712|NCT02732119|78933068|FG002|Phase I|Adverse Event|1|||
44143713|NCT02732119|78933069|FG003|Phase I|Adverse Event|0|||
44143714|NCT02732119|78933070|FG004|Phase I|Adverse Event|0|||
44143715|NCT02732119|78933066|FG000|Phase I|Progressive disease|7|||
44143716|NCT02732119|78933067|FG001|Phase I|Progressive disease|3|||
44143717|NCT02732119|78933068|FG002|Phase I|Progressive disease|2|||
44143718|NCT02732119|78933069|FG003|Phase I|Progressive disease|0|||
44270276|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44270277|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44218340|NCT04206332|79017288|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218341|NCT04206332|79017289|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218342|NCT04206332|79017290|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218343|NCT04206332|79017291|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218344|NCT04206332|79017292|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218345|NCT04206332|79017293|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218346|NCT04206332|79017294|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218347|NCT04206332|79017295|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218348|NCT04206332|79017296|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218349|NCT04206332|79017297|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44218350|NCT04206332|79017298|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
44270278|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
44270279|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44460658|NCT00429663|79469239|FG000|Overall Study|Death|4|||
44218351|NCT04206332|79017299|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
44373417|NCT00961116|79378568|FG001|Washout Period of 7 Days|Protocol Violation|1|||
44373418|NCT00912015|79378579|FG000|Overall Study|Lack of Efficacy|1|||
44373419|NCT00912015|79378580|FG001|Overall Study|Lack of Efficacy|0|||
44373420|NCT00912015|79378581|FG002|Overall Study|Lack of Efficacy|0|||
44218352|NCT04206332|79017283|FG000|Part C|Withdrawal by Subject|0|||
44218353|NCT04206332|79017284|FG001|Part C|Withdrawal by Subject|0|||
44218354|NCT04206332|79017285|FG002|Part C|Withdrawal by Subject|0|||
44218355|NCT04206332|79017286|FG003|Part C|Withdrawal by Subject|0|||
44218356|NCT04206332|79017287|FG004|Part C|Withdrawal by Subject|0|||
44218357|NCT04206332|79017288|FG005|Part C|Withdrawal by Subject|0|||
44218358|NCT04206332|79017289|FG006|Part C|Withdrawal by Subject|0|||
44373421|NCT00912015|79378582|FG003|Overall Study|Lack of Efficacy|0|||
44373422|NCT00912015|79378579|FG000|Overall Study|Withdrawal by Subject|8|||
44373423|NCT00912015|79378580|FG001|Overall Study|Withdrawal by Subject|8|||
44460659|NCT00429663|79469240|FG001|Overall Study|Death|0|||
44460660|NCT00429585|79469248|FG000|Overall Study|Death|1|||
44373424|NCT00912015|79378581|FG002|Overall Study|Withdrawal by Subject|3|||
44373425|NCT00912015|79378582|FG003|Overall Study|Withdrawal by Subject|0|||
44373426|NCT00912015|79378579|FG000|Overall Study|Protocol Violation|1|||
44373427|NCT00912015|79378580|FG001|Overall Study|Protocol Violation|0|||
44373428|NCT00912015|79378581|FG002|Overall Study|Protocol Violation|0|||
44373429|NCT00912015|79378582|FG003|Overall Study|Protocol Violation|1|||
44373430|NCT00912015|79378579|FG000|Overall Study|Adverse Event|6|||
44373431|NCT00912015|79378580|FG001|Overall Study|Adverse Event|0|||
44460661|NCT00429585|79469249|FG001|Overall Study|Death|0|||
44460662|NCT00429585|79469248|FG000|Overall Study|Lost to Follow-up|27|||
44460663|NCT00429585|79469249|FG001|Overall Study|Lost to Follow-up|20|||
44460664|NCT00429585|79469248|FG000|Overall Study|Physician Decision|2|||
44218359|NCT04206332|79017290|FG007|Part C|Withdrawal by Subject|0|||
44218360|NCT04206332|79017291|FG008|Part C|Withdrawal by Subject|0|||
44218361|NCT04206332|79017292|FG009|Part C|Withdrawal by Subject|0|||
44373432|NCT00912015|79378581|FG002|Overall Study|Adverse Event|0|||
44460665|NCT00429585|79469249|FG001|Overall Study|Physician Decision|0|||
44218362|NCT04206332|79017293|FG010|Part C|Withdrawal by Subject|0|||
44218363|NCT04206332|79017294|FG011|Part C|Withdrawal by Subject|0|||
44218364|NCT04206332|79017295|FG012|Part C|Withdrawal by Subject|0|||
44218365|NCT04206332|79017296|FG013|Part C|Withdrawal by Subject|0|||
44218366|NCT04206332|79017297|FG014|Part C|Withdrawal by Subject|2|||
44277789|NCT02138214|79238785|FG000|Overall Study|Withdrawal by Subject|0|||
44460666|NCT05822921|79469257|FG000|Overall Study|Lost to Follow-up|1|||
44218367|NCT04206332|79017298|FG015|Part C|Withdrawal by Subject|0|||
44460667|NCT05822921|79469258|FG001|Overall Study|Lost to Follow-up|1|||
44460668|NCT05094154|79469270|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
44460669|NCT05094154|79469271|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
44460670|NCT05094154|79469270|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
44460671|NCT05094154|79469271|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
44460672|NCT04530448|79469300|FG000|Overall Study|Physician Decision|3|||
44460673|NCT04530448|79469301|FG001|Overall Study|Physician Decision|0|||
44460674|NCT04476030|79469309|FG000|Overall Study|Withdrawal by Subject|20|||
44460675|NCT04476030|79469310|FG001|Overall Study|Withdrawal by Subject|16|||
44460676|NCT04476030|79469309|FG000|Overall Study|Adverse Event|10|||
44460677|NCT04476030|79469310|FG001|Overall Study|Adverse Event|11|||
44460678|NCT04476030|79469309|FG000|Overall Study|Lost to Follow-up|7|||
44460679|NCT04476030|79469310|FG001|Overall Study|Lost to Follow-up|4|||
44460680|NCT04476030|79469309|FG000|Overall Study|Physician Decision|1|||
44460681|NCT04476030|79469310|FG001|Overall Study|Physician Decision|1|||
44460682|NCT04476030|79469309|FG000|Overall Study|Protocol Deviation|2|||
44460683|NCT04476030|79469310|FG001|Overall Study|Protocol Deviation|0|||
44460684|NCT04476030|79469309|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
44460685|NCT04476030|79469310|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
44460686|NCT04476030|79469309|FG000|Overall Study|Randomized but not Dosed|2|||
44460687|NCT04476030|79469310|FG001|Overall Study|Randomized but not Dosed|8|||
44460688|NCT04382612|79469331|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
44460689|NCT04158687|79469343|FG000|Overall Study|Adverse Event|2|||
44460690|NCT04158687|79469344|FG001|Overall Study|Adverse Event|3|||
44460691|NCT04158687|79469345|FG002|Overall Study|Adverse Event|0|||
44460692|NCT04158687|79469346|FG003|Overall Study|Adverse Event|3|||
44460693|NCT04158687|79469343|FG000|Overall Study|Lost to Follow-up|5|||
44460694|NCT04158687|79469344|FG001|Overall Study|Lost to Follow-up|12|||
44460695|NCT04158687|79469345|FG002|Overall Study|Lost to Follow-up|4|||
44460696|NCT04158687|79469346|FG003|Overall Study|Lost to Follow-up|5|||
44218368|NCT04206332|79017299|FG016|Part C|Withdrawal by Subject|0|||
44218369|NCT03790111|79017382|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
44218370|NCT03780543|79017389|FG000|Overall Study|Adverse Event|1|||
44218371|NCT03780543|79017390|FG001|Overall Study|Adverse Event|0|||
44218372|NCT03780543|79017391|FG002|Overall Study|Adverse Event|2|||
44218373|NCT03780543|79017389|FG000|Overall Study|Lost to Follow-up|2|||
44218374|NCT03780543|79017390|FG001|Overall Study|Lost to Follow-up|0|||
44218375|NCT03780543|79017391|FG002|Overall Study|Lost to Follow-up|1|||
44218376|NCT03780543|79017389|FG000|Overall Study|Study terminated by Sponsor|8|||
44218377|NCT03780543|79017390|FG001|Overall Study|Study terminated by Sponsor|7|||
44218378|NCT03780543|79017391|FG002|Overall Study|Study terminated by Sponsor|13|||
44218379|NCT03780543|79017389|FG000|Overall Study|Withdrawal by Subject|1|||
44218380|NCT03780543|79017390|FG001|Overall Study|Withdrawal by Subject|8|||
44460697|NCT04158687|79469343|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
44460698|NCT04158687|79469344|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
44460699|NCT04158687|79469345|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
44218381|NCT03780543|79017391|FG002|Overall Study|Withdrawal by Subject|1|||
44218382|NCT03780543|79017389|FG000|Overall Study|Noncompliance with study drug|1|||
44218383|NCT03780543|79017390|FG001|Overall Study|Noncompliance with study drug|0|||
44218384|NCT03780543|79017391|FG002|Overall Study|Noncompliance with study drug|0|||
44218385|NCT03745820|79017404|FG000|Overall Study|Adverse Event|0|||
44218386|NCT03745820|79017405|FG001|Overall Study|Adverse Event|3|||
44218387|NCT03745820|79017406|FG002|Overall Study|Adverse Event|2|||
44218388|NCT03745820|79017404|FG000|Overall Study|Non-Compliance with Study Drug|4|||
44218389|NCT03745820|79017405|FG001|Overall Study|Non-Compliance with Study Drug|3|||
44218390|NCT03745820|79017406|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44373433|NCT00912015|79378582|FG003|Overall Study|Adverse Event|1|||
44373434|NCT00960804|79378595|FG000|Overall Study|Adverse Event|1|||
44218391|NCT03745820|79017404|FG000|Overall Study|Withdrawal by Subject|4|||
44373435|NCT00960804|79378596|FG001|Overall Study|Adverse Event|0|||
44143719|NCT02732119|78933070|FG004|Phase I|Progressive disease|0|||
44218392|NCT03745820|79017405|FG001|Overall Study|Withdrawal by Subject|4|||
44218393|NCT03745820|79017406|FG002|Overall Study|Withdrawal by Subject|4|||
44218394|NCT03745820|79017404|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
44218395|NCT03745820|79017405|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
44218396|NCT03745820|79017406|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
44218397|NCT03745820|79017404|FG000|Overall Study|Lost to Follow-up|2|||
44218398|NCT03745820|79017405|FG001|Overall Study|Lost to Follow-up|0|||
44218399|NCT03745820|79017406|FG002|Overall Study|Lost to Follow-up|3|||
44218400|NCT03745820|79017404|FG000|Overall Study|Reason not Specified|2|||
44218401|NCT03745820|79017405|FG001|Overall Study|Reason not Specified|4|||
44218402|NCT03745820|79017406|FG002|Overall Study|Reason not Specified|1|||
44218403|NCT03699631|79017414|FG000|Overall Study|Adverse Event|3|||
44218404|NCT03686150|79017424|FG000|Overall Study|Withdrawal by Subject|1|||
44218405|NCT03686150|79017425|FG001|Overall Study|Withdrawal by Subject|1|||
44218406|NCT03686150|79017426|FG002|Overall Study|Withdrawal by Subject|1|||
44218407|NCT03686150|79017427|FG003|Overall Study|Withdrawal by Subject|0|||
44218408|NCT03686150|79017428|FG004|Overall Study|Withdrawal by Subject|1|||
44218409|NCT03686150|79017429|FG005|Overall Study|Withdrawal by Subject|2|||
44218410|NCT03686150|79017424|FG000|Overall Study|Physician Decision|1|||
44218411|NCT03686150|79017425|FG001|Overall Study|Physician Decision|0|||
44218412|NCT03686150|79017426|FG002|Overall Study|Physician Decision|0|||
44218413|NCT03686150|79017427|FG003|Overall Study|Physician Decision|0|||
44218414|NCT03686150|79017428|FG004|Overall Study|Physician Decision|0|||
44373436|NCT00960804|79378597|FG002|Overall Study|Adverse Event|0|||
44218415|NCT03686150|79017429|FG005|Overall Study|Physician Decision|1|||
44218416|NCT03686150|79017424|FG000|Overall Study|Lost to Follow-up|0|||
44218417|NCT03686150|79017425|FG001|Overall Study|Lost to Follow-up|1|||
44218418|NCT03686150|79017426|FG002|Overall Study|Lost to Follow-up|0|||
44544167|NCT03197883|79557411|FG000|Overall Study|Other (Not Specified)|0|||
44544168|NCT03197883|79557412|FG001|Overall Study|Other (Not Specified)|5|||
44544169|NCT03234036|79557421|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
44544170|NCT03234036|79557422|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
44544171|NCT03234036|79557423|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
44218419|NCT03686150|79017427|FG003|Overall Study|Lost to Follow-up|0|||
44218420|NCT03686150|79017428|FG004|Overall Study|Lost to Follow-up|0|||
44218421|NCT03686150|79017429|FG005|Overall Study|Lost to Follow-up|0|||
44218422|NCT03604172|79017442|FG000|Overall Study|Lost to Follow-up|1|||
44218423|NCT03604172|79017443|FG001|Overall Study|Lost to Follow-up|2|||
44218424|NCT03496207|79017452|FG000|Base Study|Adverse Event|0|||
44218425|NCT03496207|79017453|FG001|Base Study|Adverse Event|0|||
44218426|NCT03496207|79017454|FG002|Base Study|Adverse Event|1|||
44218427|NCT03496207|79017455|FG003|Base Study|Adverse Event|1|||
44218428|NCT03496207|79017456|FG004|Base Study|Adverse Event|4|||
44218429|NCT03496207|79017452|FG000|Base Study|Death|0|||
44218430|NCT03496207|79017453|FG001|Base Study|Death|0|||
44218431|NCT03496207|79017454|FG002|Base Study|Death|0|||
44218432|NCT03496207|79017455|FG003|Base Study|Death|0|||
44218433|NCT03496207|79017456|FG004|Base Study|Death|1|||
44218434|NCT03496207|79017452|FG000|Base Study|Withdrawal by Subject|0|||
44218435|NCT03496207|79017453|FG001|Base Study|Withdrawal by Subject|0|||
44218436|NCT03496207|79017454|FG002|Base Study|Withdrawal by Subject|1|||
44218437|NCT03496207|79017455|FG003|Base Study|Withdrawal by Subject|0|||
44218438|NCT03496207|79017456|FG004|Base Study|Withdrawal by Subject|1|||
44218439|NCT03496207|79017452|FG000|Extension Period|Adverse Event|0|||
44218440|NCT03496207|79017453|FG001|Extension Period|Adverse Event|0|||
44218441|NCT03496207|79017454|FG002|Extension Period|Adverse Event|0|||
44218442|NCT03496207|79017455|FG003|Extension Period|Adverse Event|1|||
44218443|NCT03496207|79017456|FG004|Extension Period|Adverse Event|1|||
44218444|NCT03496207|79017452|FG000|Extension Period|Death|1|||
44218445|NCT03496207|79017453|FG001|Extension Period|Death|0|||
44218446|NCT03496207|79017454|FG002|Extension Period|Death|0|||
44218447|NCT03496207|79017455|FG003|Extension Period|Death|1|||
44218448|NCT03496207|79017456|FG004|Extension Period|Death|2|||
44218449|NCT03496207|79017452|FG000|Extension Period|Withdrawal by Subject|1|||
44218450|NCT03496207|79017453|FG001|Extension Period|Withdrawal by Subject|0|||
44218451|NCT03496207|79017454|FG002|Extension Period|Withdrawal by Subject|0|||
44218452|NCT03496207|79017455|FG003|Extension Period|Withdrawal by Subject|1|||
44218453|NCT03496207|79017456|FG004|Extension Period|Withdrawal by Subject|1|||
44218454|NCT03496207|79017452|FG000|Extension Period|Elevated hemoglobin levels|0|||
44218455|NCT03496207|79017453|FG001|Extension Period|Elevated hemoglobin levels|0|||
44373437|NCT00960804|79378595|FG000|Overall Study|Withdrawal by Subject|1|||
44218456|NCT03496207|79017454|FG002|Extension Period|Elevated hemoglobin levels|0|||
44218457|NCT03496207|79017455|FG003|Extension Period|Elevated hemoglobin levels|0|||
44218458|NCT03496207|79017456|FG004|Extension Period|Elevated hemoglobin levels|1|||
44544172|NCT03234036|79557424|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
44218459|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
44218460|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
44218461|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
44218462|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
44218463|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
44218464|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
44460700|NCT04158687|79469346|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
44460701|NCT04158687|79469343|FG000|Overall Study|Non-Compliance with Study Medication|2|||
44460702|NCT04158687|79469344|FG001|Overall Study|Non-Compliance with Study Medication|2|||
44460703|NCT04158687|79469345|FG002|Overall Study|Non-Compliance with Study Medication|3|||
44460704|NCT04158687|79469346|FG003|Overall Study|Non-Compliance with Study Medication|0|||
44460705|NCT04158687|79469343|FG000|Overall Study|Investigator Decision|0|||
44460706|NCT04158687|79469344|FG001|Overall Study|Investigator Decision|0|||
44460707|NCT04158687|79469345|FG002|Overall Study|Investigator Decision|2|||
44460708|NCT04158687|79469346|FG003|Overall Study|Investigator Decision|0|||
44460709|NCT04158687|79469343|FG000|Overall Study|Protocol Violation|0|||
44460710|NCT04158687|79469344|FG001|Overall Study|Protocol Violation|2|||
44460711|NCT04158687|79469345|FG002|Overall Study|Protocol Violation|1|||
44460712|NCT04158687|79469346|FG003|Overall Study|Protocol Violation|0|||
44460713|NCT04158687|79469343|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
44460714|NCT04158687|79469344|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
44460715|NCT04158687|79469345|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
44460716|NCT04158687|79469346|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
44460717|NCT04158687|79469343|FG000|Overall Study|Reason not Specified|3|||
44460718|NCT04158687|79469344|FG001|Overall Study|Reason not Specified|2|||
44460719|NCT04158687|79469345|FG002|Overall Study|Reason not Specified|4|||
44460720|NCT04158687|79469346|FG003|Overall Study|Reason not Specified|4|||
44460721|NCT04090749|79469359|FG000|Open Label Pilot|Lost to Follow-up|1|||
44460722|NCT04090749|79469360|FG001|Open Label Pilot|Lost to Follow-up|0|||
44460723|NCT04090749|79469361|FG002|Open Label Pilot|Lost to Follow-up|0|||
44460724|NCT04090749|79469359|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
44460725|NCT04090749|79469360|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
44460726|NCT04090749|79469361|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
44460727|NCT04090749|79469359|FG000|Pilot Trial|Lost to Follow-up|0|||
44460728|NCT04090749|79469360|FG001|Pilot Trial|Lost to Follow-up|1|||
44460729|NCT04090749|79469361|FG002|Pilot Trial|Lost to Follow-up|1|||
44460730|NCT04076059|79469371|FG000|Double Blind Phase|Progressive disease|22|||
44460731|NCT04076059|79469372|FG001|Double Blind Phase|Progressive disease|26|||
44460732|NCT04076059|79469373|FG002|Double Blind Phase|Progressive disease|0|||
44460733|NCT04076059|79469371|FG000|Double Blind Phase|Withdrawal by Subject|4|||
44460734|NCT04076059|79469372|FG001|Double Blind Phase|Withdrawal by Subject|11|||
44460735|NCT04076059|79469373|FG002|Double Blind Phase|Withdrawal by Subject|0|||
44460736|NCT04076059|79469371|FG000|Double Blind Phase|Death|1|||
44460737|NCT04076059|79469372|FG001|Double Blind Phase|Death|1|||
44460738|NCT04076059|79469373|FG002|Double Blind Phase|Death|0|||
44460739|NCT04076059|79469371|FG000|Double Blind Phase|Lost to Follow-up|1|||
44460740|NCT04076059|79469372|FG001|Double Blind Phase|Lost to Follow-up|0|||
44460741|NCT04076059|79469373|FG002|Double Blind Phase|Lost to Follow-up|0|||
44460742|NCT04076059|79469371|FG000|Double Blind Phase|Adverse Event|5|||
44460743|NCT04076059|79469372|FG001|Double Blind Phase|Adverse Event|1|||
44460744|NCT04076059|79469373|FG002|Double Blind Phase|Adverse Event|0|||
44460745|NCT04076059|79469371|FG000|Double Blind Phase|Ongoing Participants|82|||
44460746|NCT04076059|79469372|FG001|Double Blind Phase|Ongoing Participants|18|||
44460747|NCT04076059|79469373|FG002|Double Blind Phase|Ongoing Participants|0|||
44460748|NCT04076059|79469371|FG000|Double Blind Phase|Miscellaneous|3|||
44460749|NCT04076059|79469372|FG001|Double Blind Phase|Miscellaneous|1|||
44460750|NCT04076059|79469373|FG002|Double Blind Phase|Miscellaneous|0|||
44460751|NCT04076059|79469371|FG000|Double Blind Phase|Protocol Deviation|1|||
44460752|NCT04076059|79469372|FG001|Double Blind Phase|Protocol Deviation|1|||
44460753|NCT04076059|79469373|FG002|Double Blind Phase|Protocol Deviation|0|||
44460754|NCT04076059|79469371|FG000|Double Blind Phase|Did not take study drug|1|||
44460755|NCT04076059|79469372|FG001|Double Blind Phase|Did not take study drug|1|||
44460756|NCT04076059|79469373|FG002|Double Blind Phase|Did not take study drug|0|||
44460757|NCT04076059|79469371|FG000|Open Label Phase|Progressive disease|0|||
44460758|NCT04076059|79469372|FG001|Open Label Phase|Progressive disease|0|||
44460759|NCT04076059|79469373|FG002|Open Label Phase|Progressive disease|7|||
44218465|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
44218466|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
44249725|NCT01504412|79083924|FG001|Overall Study|Adverse Event|8|||
44460760|NCT04076059|79469371|FG000|Open Label Phase|Withdrawal by Subject|0|||
44460761|NCT04076059|79469372|FG001|Open Label Phase|Withdrawal by Subject|0|||
44460762|NCT04076059|79469373|FG002|Open Label Phase|Withdrawal by Subject|3|||
44460763|NCT04076059|79469371|FG000|Open Label Phase|Death|0|||
44460764|NCT04076059|79469372|FG001|Open Label Phase|Death|0|||
44460765|NCT04076059|79469373|FG002|Open Label Phase|Death|2|||
44544173|NCT03606109|79557442|FG000|Overall Study|Lost to Follow-up|2|||
44544174|NCT03606109|79557443|FG001|Overall Study|Lost to Follow-up|1|||
44460766|NCT04076059|79469371|FG000|Open Label Phase|Ongoing Participants|0|||
44460767|NCT04076059|79469372|FG001|Open Label Phase|Ongoing Participants|0|||
44460768|NCT04076059|79469373|FG002|Open Label Phase|Ongoing Participants|11|||
44460769|NCT04047420|79469380|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
44460770|NCT04047420|79469380|FG000|Washout Period|Refused Participation|2|||
44460771|NCT04003636|79469389|FG000|Overall Study|Death|409|||
44460772|NCT04003636|79469390|FG001|Overall Study|Death|443|||
44460773|NCT04003636|79469389|FG000|Overall Study|Lost to Follow-up|0|||
44460774|NCT04003636|79469390|FG001|Overall Study|Lost to Follow-up|1|||
44460775|NCT04003636|79469389|FG000|Overall Study|Withdrawal by Subject|5|||
44460776|NCT04003636|79469390|FG001|Overall Study|Withdrawal by Subject|2|||
44460777|NCT04003636|79469389|FG000|Overall Study|Participant On-going|119|||
44460778|NCT04003636|79469390|FG001|Overall Study|Participant On-going|90|||
44460779|NCT03958045|79469397|FG000|Overall Study|Withdrawal by Subject|1|||
44460780|NCT03806179|79469403|FG000|Overall Study|Progressive disease|0|||
44460781|NCT03806179|79469404|FG001|Overall Study|Progressive disease|2|||
44460782|NCT03759587|79469410|FG000|Overall Study|Adverse Event|5|||
44460783|NCT03759587|79469410|FG000|Overall Study|Progressive Disease|10|||
44460784|NCT03759587|79469410|FG000|Overall Study|Site Terminated by Sponsor|3|||
44460785|NCT03759587|79469410|FG000|Overall Study|Withdrawal by Subject|1|||
44460786|NCT03735121|79469432|FG000|Overall Study|Death|3|||
44460787|NCT03735121|79469433|FG001|Overall Study|Death|6|||
44460788|NCT03735121|79469434|FG002|Overall Study|Death|8|||
44460789|NCT03735121|79469435|FG003|Overall Study|Death|37|||
44544175|NCT02729896|79557452|FG000|Overall Study|Death|0|||
44544176|NCT02729896|79557453|FG001|Overall Study|Death|2|||
44460790|NCT03735121|79469436|FG004|Overall Study|Death|86|||
44460791|NCT03735121|79469432|FG000|Overall Study|Withdrawal by Subject|1|||
44460792|NCT03735121|79469433|FG001|Overall Study|Withdrawal by Subject|1|||
44460793|NCT03735121|79469434|FG002|Overall Study|Withdrawal by Subject|3|||
44460794|NCT03735121|79469435|FG003|Overall Study|Withdrawal by Subject|4|||
44544177|NCT02729896|79557454|FG002|Overall Study|Death|13|||
44143720|NCT02732119|78933066|FG000|Phase I|Protocol deviation|0|||
44460795|NCT03735121|79469436|FG004|Overall Study|Withdrawal by Subject|2|||
44460796|NCT03735121|79469432|FG000|Overall Study|Progressive Disease|0|||
44544178|NCT02729896|79557452|FG000|Overall Study|Lost to Follow-up|0|||
44460797|NCT03735121|79469433|FG001|Overall Study|Progressive Disease|0|||
44460798|NCT03735121|79469434|FG002|Overall Study|Progressive Disease|1|||
44460799|NCT03735121|79469435|FG003|Overall Study|Progressive Disease|0|||
44460800|NCT03735121|79469436|FG004|Overall Study|Progressive Disease|0|||
44460801|NCT03735121|79469432|FG000|Overall Study|Lost to Follow-up|0|||
44460802|NCT03735121|79469433|FG001|Overall Study|Lost to Follow-up|0|||
44460803|NCT03735121|79469434|FG002|Overall Study|Lost to Follow-up|0|||
44460804|NCT03735121|79469435|FG003|Overall Study|Lost to Follow-up|0|||
44373438|NCT00960804|79378596|FG001|Overall Study|Withdrawal by Subject|0|||
44373439|NCT00960804|79378597|FG002|Overall Study|Withdrawal by Subject|0|||
44373440|NCT00960804|79378595|FG000|Overall Study|Study terminated by the sponsor|5|||
44218467|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
44218468|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
44218469|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
44218470|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
44218471|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
44218472|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
44218473|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
44218474|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44218475|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44218476|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44218477|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
44218478|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
44218479|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
44218480|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
44218481|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
44218482|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
44218483|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
44218484|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
44270280|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44218485|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
44270281|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44270282|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44270283|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44460805|NCT03735121|79469436|FG004|Overall Study|Lost to Follow-up|1|||
44460806|NCT03735121|79469432|FG000|Overall Study|Ongoing|3|||
44460807|NCT03735121|79469433|FG001|Overall Study|Ongoing|3|||
44460808|NCT03735121|79469434|FG002|Overall Study|Ongoing|26|||
44460809|NCT03735121|79469435|FG003|Overall Study|Ongoing|83|||
44460810|NCT03735121|79469436|FG004|Overall Study|Ongoing|158|||
44460811|NCT03730194|79469462|FG000|First Stage Treatment|Withdrawal by Subject|1|||
44460812|NCT03730194|79469463|FG001|First Stage Treatment|Withdrawal by Subject|1|||
44218486|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
44218487|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
44218488|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
44218489|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
44218490|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
44218491|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
44218492|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
44218493|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
44218494|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
44218495|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
44218496|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
44460813|NCT03730194|79469464|FG002|First Stage Treatment|Withdrawal by Subject|0|||
44460814|NCT03730194|79469465|FG003|First Stage Treatment|Withdrawal by Subject|0|||
44460815|NCT03730194|79469466|FG004|First Stage Treatment|Withdrawal by Subject|0|||
44218497|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
44460816|NCT03730194|79469467|FG005|First Stage Treatment|Withdrawal by Subject|0|||
44460817|NCT03730194|79469462|FG000|First Stage Treatment|Protocol Violation|3|||
44460818|NCT03730194|79469463|FG001|First Stage Treatment|Protocol Violation|3|||
44460819|NCT03730194|79469464|FG002|First Stage Treatment|Protocol Violation|0|||
44460820|NCT03730194|79469465|FG003|First Stage Treatment|Protocol Violation|0|||
44460821|NCT03730194|79469466|FG004|First Stage Treatment|Protocol Violation|0|||
44460822|NCT03730194|79469467|FG005|First Stage Treatment|Protocol Violation|0|||
44460823|NCT03559400|79469476|FG000|Overall Study|Lost to Follow-up|9|||
44460824|NCT03559400|79469477|FG001|Overall Study|Lost to Follow-up|7|||
44460825|NCT03559400|79469476|FG000|Overall Study|Death|0|||
44460826|NCT03559400|79469477|FG001|Overall Study|Death|2|||
44460827|NCT03483012|79469484|FG000|Overall Study|Lack of Efficacy|6|||
44218498|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
44218499|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
44218500|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
44218501|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
44373441|NCT00960804|79378596|FG001|Overall Study|Study terminated by the sponsor|4|||
44373442|NCT00960804|79378597|FG002|Overall Study|Study terminated by the sponsor|10|||
44373443|NCT01126580|79378608|FG000|Overall Study|Adverse Event|14|||
44460828|NCT03231709|79469494|FG000|Treatment Period 1|Reason not Specified|0|||
44460829|NCT03231709|79469495|FG001|Treatment Period 1|Reason not Specified|1|||
44460830|NCT03231709|79469494|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
44544179|NCT02729896|79557453|FG001|Overall Study|Lost to Follow-up|2|||
44544180|NCT02729896|79557454|FG002|Overall Study|Lost to Follow-up|3|||
44544181|NCT02729896|79557452|FG000|Overall Study|Other|0|||
44218502|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
44218503|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
44373444|NCT01126580|79378609|FG001|Overall Study|Adverse Event|8|||
44373445|NCT01126580|79378610|FG002|Overall Study|Adverse Event|12|||
44373446|NCT01126580|79378608|FG000|Overall Study|Withdrawal by Subject|11|||
44373447|NCT01126580|79378609|FG001|Overall Study|Withdrawal by Subject|19|||
44373448|NCT01126580|79378610|FG002|Overall Study|Withdrawal by Subject|14|||
44373449|NCT01126580|79378608|FG000|Overall Study|Sponsor Decision|5|||
44373450|NCT01126580|79378609|FG001|Overall Study|Sponsor Decision|4|||
44373451|NCT01126580|79378610|FG002|Overall Study|Sponsor Decision|7|||
44373452|NCT01126580|79378608|FG000|Overall Study|Physician Decision|1|||
44373453|NCT01126580|79378609|FG001|Overall Study|Physician Decision|1|||
44373454|NCT01126580|79378610|FG002|Overall Study|Physician Decision|2|||
44373455|NCT01126580|79378608|FG000|Overall Study|Entry Criteria Not Met|1|||
44218504|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
44373456|NCT01126580|79378609|FG001|Overall Study|Entry Criteria Not Met|1|||
44460831|NCT03231709|79469495|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
44460832|NCT03014479|79469507|FG000|Overall Study|Adverse Event|0|||
44460833|NCT03014479|79469508|FG001|Overall Study|Adverse Event|1|||
44460834|NCT03014479|79469507|FG000|Overall Study|Voluntary Withdrawal|0|||
44460835|NCT03014479|79469508|FG001|Overall Study|Voluntary Withdrawal|2|||
44460836|NCT03014479|79469507|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
44460837|NCT03014479|79469508|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
44373457|NCT01126580|79378610|FG002|Overall Study|Entry Criteria Not Met|2|||
44373458|NCT01126580|79378608|FG000|Overall Study|Lack of Efficacy|2|||
44373459|NCT01126580|79378609|FG001|Overall Study|Lack of Efficacy|3|||
44544182|NCT02729896|79557453|FG001|Overall Study|Other|2|||
44218505|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
44218506|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
44218507|NCT03444870|79017481|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
44218508|NCT03444870|79017482|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
44218509|NCT03444870|79017483|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
44218510|NCT03444870|79017484|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
44218511|NCT03444870|79017485|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
44218512|NCT03444870|79017486|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
44218513|NCT03444870|79017481|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
44218514|NCT03444870|79017482|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
44218515|NCT03444870|79017483|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
44218516|NCT03444870|79017484|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
44218517|NCT03444870|79017485|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
44218518|NCT03444870|79017486|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
44218519|NCT03444870|79017481|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
44218520|NCT03444870|79017482|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
44218521|NCT03444870|79017483|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
44460838|NCT02937818|79469518|FG000|Overall Study|Participants decision|1|||
44460839|NCT02937818|79469519|FG001|Overall Study|Participants decision|0|||
44460840|NCT02937818|79469520|FG002|Overall Study|Participants decision|1|||
44460841|NCT02937818|79469521|FG003|Overall Study|Participants decision|1|||
44460842|NCT02937818|79469518|FG000|Overall Study|Adverse Event|2|||
44460843|NCT02937818|79469519|FG001|Overall Study|Adverse Event|4|||
44460844|NCT02937818|79469520|FG002|Overall Study|Adverse Event|1|||
44460845|NCT02937818|79469521|FG003|Overall Study|Adverse Event|1|||
44460846|NCT02937818|79469518|FG000|Overall Study|Disease progression|17|||
44460847|NCT02937818|79469519|FG001|Overall Study|Disease progression|14|||
44460848|NCT02937818|79469520|FG002|Overall Study|Disease progression|7|||
44460849|NCT02937818|79469521|FG003|Overall Study|Disease progression|18|||
44460850|NCT02937818|79469518|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
44460851|NCT02937818|79469519|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
44460852|NCT02937818|79469520|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
44460853|NCT02937818|79469521|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
44460854|NCT02937818|79469518|FG000|Overall Study|Condition under investigation worsened|0|||
44460855|NCT02937818|79469519|FG001|Overall Study|Condition under investigation worsened|0|||
44460856|NCT02937818|79469520|FG002|Overall Study|Condition under investigation worsened|1|||
44460857|NCT02937818|79469521|FG003|Overall Study|Condition under investigation worsened|0|||
44460858|NCT02937818|79469518|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
44460859|NCT02937818|79469519|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
44460860|NCT02937818|79469520|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
44218522|NCT03444870|79017484|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
44460861|NCT02937818|79469521|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
44460862|NCT02864394|79469545|FG000|Overall Study|Death|184|||
44460863|NCT02864394|79469546|FG001|Overall Study|Death|189|||
44218523|NCT03444870|79017485|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
44218524|NCT03444870|79017486|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
44218525|NCT03444870|79017481|FG000|Open-Label Extension (OLE) Period|Death|0|||
44218526|NCT03444870|79017482|FG001|Open-Label Extension (OLE) Period|Death|0|||
44218527|NCT03444870|79017483|FG002|Open-Label Extension (OLE) Period|Death|0|||
44218528|NCT03444870|79017484|FG003|Open-Label Extension (OLE) Period|Death|0|||
44277790|NCT02138214|79238786|FG001|Overall Study|Withdrawal by Subject|1|||
44544183|NCT02729896|79557454|FG002|Overall Study|Other|0|||
44143721|NCT02732119|78933067|FG001|Phase I|Protocol deviation|1|||
44143722|NCT02732119|78933068|FG002|Phase I|Protocol deviation|0|||
44143723|NCT02732119|78933069|FG003|Phase I|Protocol deviation|0|||
44143724|NCT02732119|78933070|FG004|Phase I|Protocol deviation|0|||
44143725|NCT02732119|78933066|FG000|Phase I|Physician Decision|0|||
44143726|NCT02732119|78933067|FG001|Phase I|Physician Decision|3|||
44143727|NCT02732119|78933068|FG002|Phase I|Physician Decision|4|||
44143728|NCT02732119|78933069|FG003|Phase I|Physician Decision|0|||
44143729|NCT02732119|78933070|FG004|Phase I|Physician Decision|0|||
44143730|NCT02732119|78933066|FG000|Phase II|Adverse Event|0|||
44143731|NCT02732119|78933067|FG001|Phase II|Adverse Event|0|||
44143732|NCT02732119|78933068|FG002|Phase II|Adverse Event|0|||
44143733|NCT02732119|78933069|FG003|Phase II|Adverse Event|3|||
44143734|NCT02732119|78933070|FG004|Phase II|Adverse Event|3|||
44143735|NCT02732119|78933066|FG000|Phase II|Death|0|||
44143736|NCT02732119|78933067|FG001|Phase II|Death|0|||
44143737|NCT02732119|78933068|FG002|Phase II|Death|0|||
44143738|NCT02732119|78933069|FG003|Phase II|Death|1|||
44143739|NCT02732119|78933070|FG004|Phase II|Death|0|||
44143740|NCT02732119|78933066|FG000|Phase II|Progressive dissease|0|||
44143741|NCT02732119|78933067|FG001|Phase II|Progressive dissease|0|||
44270284|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44270285|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44218529|NCT03444870|79017485|FG004|Open-Label Extension (OLE) Period|Death|1|||
44218530|NCT03444870|79017486|FG005|Open-Label Extension (OLE) Period|Death|0|||
44218531|NCT03112590|79017514|FG000|Overall Study|Adverse Event|0|||
44218532|NCT03112590|79017515|FG001|Overall Study|Adverse Event|1|||
44218533|NCT03112590|79017516|FG002|Overall Study|Adverse Event|0|||
44218534|NCT03060629|79017526|FG000|Overall Study|Death|4|||
44218535|NCT03060629|79017527|FG001|Overall Study|Death|5|||
44218536|NCT03060629|79017526|FG000|Overall Study|Withdrawal by Subject|50|||
44218537|NCT03060629|79017527|FG001|Overall Study|Withdrawal by Subject|35|||
44218538|NCT03060629|79017526|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
44218539|NCT03060629|79017527|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
44218540|NCT03060629|79017526|FG000|Overall Study|Participant Relocate|15|||
44218541|NCT03060629|79017527|FG001|Overall Study|Participant Relocate|15|||
44218542|NCT03060629|79017526|FG000|Overall Study|Unable to Contact Participant|34|||
44218543|NCT03060629|79017527|FG001|Overall Study|Unable to Contact Participant|23|||
44218544|NCT03060629|79017526|FG000|Overall Study|Investigator Decision|7|||
44218545|NCT03060629|79017527|FG001|Overall Study|Investigator Decision|7|||
44218546|NCT03060629|79017526|FG000|Overall Study|Study Terminated by Sponsor|1100|||
44218547|NCT03060629|79017527|FG001|Overall Study|Study Terminated by Sponsor|1123|||
44218548|NCT03060629|79017526|FG000|Overall Study|Other|4|||
44218549|NCT03060629|79017527|FG001|Overall Study|Other|4|||
44373460|NCT01126580|79378610|FG002|Overall Study|Lack of Efficacy|4|||
44373461|NCT01126580|79378608|FG000|Overall Study|Protocol Violation|0|||
44373462|NCT01126580|79378609|FG001|Overall Study|Protocol Violation|1|||
44373463|NCT01126580|79378610|FG002|Overall Study|Protocol Violation|2|||
44373464|NCT01126580|79378608|FG000|Overall Study|Lost to Follow-up|15|||
44143742|NCT02732119|78933068|FG002|Phase II|Progressive dissease|0|||
44143743|NCT02732119|78933069|FG003|Phase II|Progressive dissease|30|||
44143744|NCT02732119|78933070|FG004|Phase II|Progressive dissease|23|||
44143745|NCT02732119|78933066|FG000|Phase II|Study terminated by sponsor|0|||
44143746|NCT02732119|78933067|FG001|Phase II|Study terminated by sponsor|0|||
44143747|NCT02732119|78933068|FG002|Phase II|Study terminated by sponsor|0|||
44143748|NCT02732119|78933069|FG003|Phase II|Study terminated by sponsor|2|||
44218550|NCT03021486|79017536|FG000|Overall Study|Withdrawal by Subject|1|||
44218551|NCT03021486|79017537|FG001|Overall Study|Withdrawal by Subject|1|||
44218552|NCT03021486|79017538|FG002|Overall Study|Withdrawal by Subject|3|||
44218553|NCT03021486|79017536|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
44218554|NCT03021486|79017537|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
44218555|NCT03021486|79017538|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
44218556|NCT02999789|79017550|FG000|Overall Study|Withdrawal by Subject|0|||
44218557|NCT02999789|79017551|FG001|Overall Study|Withdrawal by Subject|1|||
44218558|NCT02999789|79017550|FG000|Overall Study|Became ineligible|1|||
44218559|NCT02999789|79017551|FG001|Overall Study|Became ineligible|2|||
44218560|NCT02923115|79017564|FG000|Overall Study|Lost to Follow-up|0|||
44218561|NCT02923115|79017565|FG001|Overall Study|Lost to Follow-up|0|||
44218562|NCT02923115|79017566|FG002|Overall Study|Lost to Follow-up|0|||
44218563|NCT02923115|79017567|FG003|Overall Study|Lost to Follow-up|1|||
44218564|NCT02923115|79017568|FG004|Overall Study|Lost to Follow-up|0|||
44218565|NCT02923115|79017569|FG005|Overall Study|Lost to Follow-up|0|||
44218566|NCT02923115|79017564|FG000|Overall Study|Withdrawal by Subject|0|||
44218567|NCT02923115|79017565|FG001|Overall Study|Withdrawal by Subject|1|||
44218568|NCT02923115|79017566|FG002|Overall Study|Withdrawal by Subject|0|||
44218569|NCT02923115|79017567|FG003|Overall Study|Withdrawal by Subject|0|||
44218570|NCT02923115|79017568|FG004|Overall Study|Withdrawal by Subject|0|||
44218571|NCT02923115|79017569|FG005|Overall Study|Withdrawal by Subject|0|||
44218572|NCT02923115|79017564|FG000|Overall Study|Randomized, but not dosed|0|||
44218573|NCT02923115|79017565|FG001|Overall Study|Randomized, but not dosed|0|||
44218574|NCT02923115|79017566|FG002|Overall Study|Randomized, but not dosed|3|||
44218575|NCT02923115|79017567|FG003|Overall Study|Randomized, but not dosed|1|||
44218576|NCT02923115|79017568|FG004|Overall Study|Randomized, but not dosed|5|||
44218577|NCT02923115|79017569|FG005|Overall Study|Randomized, but not dosed|0|||
44218578|NCT02910583|79017585|FG000|Overall Study|Withdrawal by Subject|6|||
44218579|NCT02910583|79017586|FG001|Overall Study|Withdrawal by Subject|7|||
44218580|NCT02910583|79017585|FG000|Overall Study|Other, Not Specified|1|||
44218581|NCT02910583|79017586|FG001|Overall Study|Other, Not Specified|0|||
44218582|NCT02487394|79017631|FG000|Phase 1|Withdrawal by Subject|0|||
44218583|NCT02487394|79017632|FG001|Phase 1|Withdrawal by Subject|1|||
44544184|NCT02729896|79557452|FG000|Overall Study|Physician Decision|1|||
44218584|NCT02029846|79017653|FG000|Overall Study|n=1 each arm|1|||
44218585|NCT02029846|79017654|FG001|Overall Study|n=1 each arm|1|||
44218586|NCT05889039|79017664|FG000|Overall Study|error in completing survey|0|||
44218587|NCT05889039|79017665|FG001|Overall Study|error in completing survey|2|||
44218588|NCT05889039|79017666|FG002|Overall Study|error in completing survey|0|||
44218589|NCT05889039|79017667|FG003|Overall Study|error in completing survey|0|||
44218590|NCT05889039|79017664|FG000|Overall Study|Lost to Follow-up|4|||
44218591|NCT05889039|79017665|FG001|Overall Study|Lost to Follow-up|0|||
44218592|NCT05889039|79017666|FG002|Overall Study|Lost to Follow-up|0|||
44218593|NCT05889039|79017667|FG003|Overall Study|Lost to Follow-up|0|||
44218594|NCT05790408|79017677|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
44218595|NCT04944992|79017726|FG000|Overall Study|Lost to Follow-up|1|||
44218596|NCT04944992|79017727|FG001|Overall Study|Lost to Follow-up|1|||
44218597|NCT04944992|79017726|FG000|Overall Study|Physician Decision|1|||
44218598|NCT04944992|79017727|FG001|Overall Study|Physician Decision|0|||
44218599|NCT04944992|79017726|FG000|Overall Study|Withdrawal by Subject|6|||
44218600|NCT04944992|79017727|FG001|Overall Study|Withdrawal by Subject|1|||
44218601|NCT04820530|79017733|FG000|Extension Treatment Period|Ongoing at the time of the data cut-off date 2022-11-02|32|||
44218602|NCT04535583|79017754|FG000|Overall Study|Lost to Follow-up|1|||
44218603|NCT04535583|79017754|FG000|Overall Study|Physician Decision|1|||
44373465|NCT01126580|79378609|FG001|Overall Study|Lost to Follow-up|13|||
44218604|NCT04535583|79017754|FG000|Overall Study|Withdrawal by Subject|1|||
44218605|NCT04484935|79017769|FG000|Overall Study|Other|0|||
44218606|NCT04484935|79017770|FG001|Overall Study|Other|1|||
44218607|NCT04484935|79017769|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44373466|NCT01126580|79378610|FG002|Overall Study|Lost to Follow-up|9|||
44460864|NCT02864394|79469545|FG000|Overall Study|Lost to Follow-up|0|||
44218608|NCT04484935|79017770|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44218609|NCT04484935|79017769|FG000|Overall Study|Lost to Follow-up|1|||
44218610|NCT04484935|79017770|FG001|Overall Study|Lost to Follow-up|0|||
44218611|NCT04484935|79017769|FG000|Overall Study|Death|2|||
44218612|NCT04484935|79017770|FG001|Overall Study|Death|1|||
44373467|NCT01126580|79378608|FG000|Overall Study|Treatment Non-compliance|0|||
44218613|NCT04262882|79017779|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
44218614|NCT04262882|79017780|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
44218615|NCT04262882|79017779|FG000|Overall Study|Lost to Follow-up|1|||
44218616|NCT04262882|79017780|FG001|Overall Study|Lost to Follow-up|0|||
44218617|NCT04135859|79017788|FG000|Overall Study|Withdrawal by Subject|1|||
44218618|NCT04135859|79017789|FG001|Overall Study|Withdrawal by Subject|0|||
44218619|NCT04135859|79017788|FG000|Overall Study|Withdrawal due to screening failure|1|||
44270286|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44544185|NCT02729896|79557453|FG001|Overall Study|Physician Decision|2|||
44218620|NCT04135859|79017789|FG001|Overall Study|Withdrawal due to screening failure|2|||
44218621|NCT04135859|79017788|FG000|Overall Study|Did not complete stress test|3|||
44218622|NCT04135859|79017789|FG001|Overall Study|Did not complete stress test|3|||
44218623|NCT04135859|79017788|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
44218624|NCT04135859|79017789|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
44218625|NCT04068610|79017798|FG000|Overall Study|Death|4|||
44218626|NCT04068610|79017799|FG001|Overall Study|Death|8|||
44544186|NCT02729896|79557454|FG002|Overall Study|Physician Decision|3|||
44218627|NCT04068610|79017800|FG002|Overall Study|Death|13|||
44218628|NCT04068610|79017798|FG000|Overall Study|Lost to Follow-up|0|||
44218629|NCT04068610|79017799|FG001|Overall Study|Lost to Follow-up|2|||
44218630|NCT04068610|79017800|FG002|Overall Study|Lost to Follow-up|0|||
44218631|NCT04068610|79017798|FG000|Overall Study|Withdrawal by Subject|0|||
44218632|NCT04068610|79017799|FG001|Overall Study|Withdrawal by Subject|4|||
44218633|NCT04068610|79017800|FG002|Overall Study|Withdrawal by Subject|2|||
44218634|NCT04068610|79017798|FG000|Overall Study|Other|3|||
44218635|NCT04068610|79017799|FG001|Overall Study|Other|12|||
44218636|NCT04068610|79017800|FG002|Overall Study|Other|11|||
44218637|NCT03860844|79017811|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
44373468|NCT01126580|79378609|FG001|Overall Study|Treatment Non-compliance|2|||
44373469|NCT01126580|79378610|FG002|Overall Study|Treatment Non-compliance|3|||
44373470|NCT00911157|79378621|FG000|Overall Study|Adverse Event|4|||
44373471|NCT00911157|79378622|FG001|Overall Study|Adverse Event|1|||
44373472|NCT00911157|79378621|FG000|Overall Study|Withdrawal by Subject|1|||
44373473|NCT00911157|79378622|FG001|Overall Study|Withdrawal by Subject|1|||
44373474|NCT00911157|79378621|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
44218638|NCT03860844|79017812|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
44218639|NCT03860844|79017813|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
44373475|NCT00911157|79378622|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
44373476|NCT00911157|79378621|FG000|Overall Study|Need to treat for lung cancer|1|||
44373477|NCT00911157|79378622|FG001|Overall Study|Need to treat for lung cancer|0|||
44373478|NCT00960570|79378628|FG000|21 Day Washout Period|Adverse Event|1|||
44373479|NCT00960570|79378628|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
44373480|NCT00960570|79378628|FG000|1 Day Period Between Dosing|Adverse Event|2|||
44373481|NCT00960570|79378628|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
44373482|NCT01126424|79378641|FG000|Overall Study|Adverse Event|0|||
44373483|NCT01126424|79378642|FG001|Overall Study|Adverse Event|0|||
44373484|NCT01126424|79378643|FG002|Overall Study|Adverse Event|0|||
44373485|NCT01126424|79378644|FG003|Overall Study|Adverse Event|0|||
44373486|NCT01126424|79378645|FG004|Overall Study|Adverse Event|1|||
44373487|NCT01126424|79378646|FG005|Overall Study|Adverse Event|0|||
44373488|NCT01126424|79378641|FG000|Overall Study|Withdrawal by Subject|0|||
44373489|NCT01126424|79378642|FG001|Overall Study|Withdrawal by Subject|0|||
44373490|NCT01126424|79378643|FG002|Overall Study|Withdrawal by Subject|1|||
44373491|NCT01126424|79378644|FG003|Overall Study|Withdrawal by Subject|3|||
44373492|NCT01126424|79378645|FG004|Overall Study|Withdrawal by Subject|1|||
44373493|NCT01126424|79378646|FG005|Overall Study|Withdrawal by Subject|0|||
44373494|NCT01126268|79378654|FG000|Overall Study|Adverse Event|1|||
44373495|NCT00879658|79378665|FG000|Overall Study|Abnormal laboratory value(s)|3|||
44373496|NCT00879658|79378666|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44373497|NCT00879658|79378667|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44373498|NCT00879658|79378668|FG003|Overall Study|Abnormal laboratory value(s)|1|||
44373499|NCT00879658|79378669|FG004|Overall Study|Abnormal laboratory value(s)|0|||
44373500|NCT00879658|79378670|FG005|Overall Study|Abnormal laboratory value(s)|0|||
44373501|NCT00879658|79378671|FG006|Overall Study|Abnormal laboratory value(s)|0|||
44373502|NCT00879658|79378665|FG000|Overall Study|Administrative problems|2|||
44373503|NCT00879658|79378666|FG001|Overall Study|Administrative problems|1|||
44373504|NCT00879658|79378667|FG002|Overall Study|Administrative problems|0|||
44373505|NCT00879658|79378668|FG003|Overall Study|Administrative problems|1|||
44373506|NCT00879658|79378669|FG004|Overall Study|Administrative problems|0|||
44373507|NCT00879658|79378670|FG005|Overall Study|Administrative problems|0|||
44218640|NCT03860844|79017811|FG000|Overall Study|Progressive disease|5|||
44218641|NCT03860844|79017812|FG001|Overall Study|Progressive disease|3|||
44218642|NCT03860844|79017813|FG002|Overall Study|Progressive disease|4|||
44218643|NCT03860844|79017811|FG000|Overall Study|Other, Not related to COVID-19|0|||
44218644|NCT03860844|79017812|FG001|Overall Study|Other, Not related to COVID-19|1|||
44218645|NCT03860844|79017813|FG002|Overall Study|Other, Not related to COVID-19|0|||
44218646|NCT03459846|79017825|FG000|Overall Study|Death|52|||
44218647|NCT03459846|79017826|FG001|Overall Study|Death|46|||
44218648|NCT03459846|79017825|FG000|Overall Study|Study terminated by sponsor|24|||
44218649|NCT03459846|79017826|FG001|Overall Study|Study terminated by sponsor|28|||
44218650|NCT03459846|79017825|FG000|Overall Study|Withdrawal by Subject|2|||
44218651|NCT03459846|79017826|FG001|Overall Study|Withdrawal by Subject|2|||
44373508|NCT00879658|79378671|FG006|Overall Study|Administrative problems|0|||
44373509|NCT00879658|79378665|FG000|Overall Study|Adverse Event|6|||
44373510|NCT00879658|79378666|FG001|Overall Study|Adverse Event|4|||
44373511|NCT00879658|79378667|FG002|Overall Study|Adverse Event|3|||
44373512|NCT00879658|79378668|FG003|Overall Study|Adverse Event|1|||
44373513|NCT00879658|79378669|FG004|Overall Study|Adverse Event|2|||
44373514|NCT00879658|79378670|FG005|Overall Study|Adverse Event|0|||
44218652|NCT03298984|79017836|FG000|Overall Study|Physician Decision|1|||
44218653|NCT03298984|79017837|FG001|Overall Study|Physician Decision|0|||
44218654|NCT03298984|79017838|FG002|Overall Study|Physician Decision|0|||
44218655|NCT03298984|79017839|FG003|Overall Study|Physician Decision|6|||
44218656|NCT03298984|79017836|FG000|Overall Study|Lack of Efficacy|0|||
44218657|NCT03298984|79017837|FG001|Overall Study|Lack of Efficacy|1|||
44218658|NCT03298984|79017838|FG002|Overall Study|Lack of Efficacy|1|||
44218659|NCT03298984|79017839|FG003|Overall Study|Lack of Efficacy|4|||
44218660|NCT03298984|79017836|FG000|Overall Study|Relapsed disease (following remission)|0|||
44218661|NCT03298984|79017837|FG001|Overall Study|Relapsed disease (following remission)|0|||
44218662|NCT03298984|79017838|FG002|Overall Study|Relapsed disease (following remission)|1|||
44218663|NCT03298984|79017839|FG003|Overall Study|Relapsed disease (following remission)|1|||
44218664|NCT03298984|79017836|FG000|Overall Study|Adverse Event|0|||
44218665|NCT03298984|79017837|FG001|Overall Study|Adverse Event|0|||
44218666|NCT03298984|79017838|FG002|Overall Study|Adverse Event|0|||
44218667|NCT03298984|79017839|FG003|Overall Study|Adverse Event|1|||
44218668|NCT03298984|79017836|FG000|Overall Study|Death|0|||
44218669|NCT03298984|79017837|FG001|Overall Study|Death|0|||
44218670|NCT03298984|79017838|FG002|Overall Study|Death|0|||
44218671|NCT03298984|79017839|FG003|Overall Study|Death|2|||
44218672|NCT03298984|79017836|FG000|Overall Study|Insurance Company Decision|0|||
44218673|NCT03298984|79017837|FG001|Overall Study|Insurance Company Decision|0|||
44218674|NCT03298984|79017838|FG002|Overall Study|Insurance Company Decision|0|||
44218675|NCT03298984|79017839|FG003|Overall Study|Insurance Company Decision|1|||
44218676|NCT03248492|79017855|FG000|Overall Study|Ongoing|23|||
44218677|NCT03248492|79017856|FG001|Overall Study|Ongoing|26|||
44218678|NCT03248492|79017857|FG002|Overall Study|Ongoing|3|||
44218679|NCT03248492|79017858|FG003|Overall Study|Ongoing|85|||
44218680|NCT03248492|79017859|FG004|Overall Study|Ongoing|2|||
44218681|NCT03248492|79017855|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
44218682|NCT03248492|79017856|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
44218683|NCT03248492|79017857|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
44218684|NCT03248492|79017858|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
44218685|NCT03248492|79017859|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
44218686|NCT03248492|79017855|FG000|Overall Study|Adverse Event|6|||
44218687|NCT03248492|79017856|FG001|Overall Study|Adverse Event|6|||
44218688|NCT03248492|79017857|FG002|Overall Study|Adverse Event|8|||
44544187|NCT02729896|79557452|FG000|Overall Study|Progressive Disease|0|||
44218689|NCT03248492|79017858|FG003|Overall Study|Adverse Event|8|||
44218690|NCT03248492|79017859|FG004|Overall Study|Adverse Event|1|||
44218691|NCT03248492|79017855|FG000|Overall Study|Withdrawal by Subject|3|||
44218692|NCT03248492|79017856|FG001|Overall Study|Withdrawal by Subject|3|||
44218693|NCT03248492|79017857|FG002|Overall Study|Withdrawal by Subject|0|||
44218694|NCT03248492|79017858|FG003|Overall Study|Withdrawal by Subject|3|||
44218695|NCT03248492|79017859|FG004|Overall Study|Withdrawal by Subject|1|||
44218696|NCT03248492|79017855|FG000|Overall Study|Physician Decision|1|||
44460865|NCT02864394|79469546|FG001|Overall Study|Lost to Follow-up|2|||
44460866|NCT02864394|79469545|FG000|Overall Study|Sponsor Decision|26|||
44460867|NCT02864394|79469546|FG001|Overall Study|Sponsor Decision|11|||
44460868|NCT02864394|79469545|FG000|Overall Study|Withdrawal by Subject|3|||
44373515|NCT00879658|79378671|FG006|Overall Study|Adverse Event|0|||
44373516|NCT00879658|79378665|FG000|Overall Study|Protocol Violation|1|||
44373517|NCT00879658|79378666|FG001|Overall Study|Protocol Violation|0|||
44373518|NCT00879658|79378667|FG002|Overall Study|Protocol Violation|0|||
44373519|NCT00879658|79378668|FG003|Overall Study|Protocol Violation|0|||
44373520|NCT00879658|79378669|FG004|Overall Study|Protocol Violation|0|||
44373521|NCT00879658|79378670|FG005|Overall Study|Protocol Violation|0|||
44373522|NCT00879658|79378671|FG006|Overall Study|Protocol Violation|0|||
44373523|NCT00879658|79378665|FG000|Overall Study|Withdrawal by Subject|3|||
44373524|NCT00879658|79378666|FG001|Overall Study|Withdrawal by Subject|0|||
44373525|NCT00879658|79378667|FG002|Overall Study|Withdrawal by Subject|2|||
44373526|NCT00879658|79378668|FG003|Overall Study|Withdrawal by Subject|0|||
44373527|NCT00879658|79378669|FG004|Overall Study|Withdrawal by Subject|0|||
44373528|NCT00879658|79378670|FG005|Overall Study|Withdrawal by Subject|1|||
44373529|NCT00879658|79378671|FG006|Overall Study|Withdrawal by Subject|0|||
44373530|NCT00879658|79378665|FG000|Overall Study|Lack of Efficacy|0|||
44373531|NCT00879658|79378666|FG001|Overall Study|Lack of Efficacy|0|||
44373532|NCT00879658|79378667|FG002|Overall Study|Lack of Efficacy|2|||
44373533|NCT00879658|79378668|FG003|Overall Study|Lack of Efficacy|0|||
44373534|NCT00879658|79378669|FG004|Overall Study|Lack of Efficacy|0|||
44373535|NCT00879658|79378670|FG005|Overall Study|Lack of Efficacy|0|||
44373536|NCT00879658|79378671|FG006|Overall Study|Lack of Efficacy|0|||
44373537|NCT00879658|79378665|FG000|Overall Study|misrandomized (never received study med)|0|||
44373538|NCT00879658|79378666|FG001|Overall Study|misrandomized (never received study med)|0|||
44373539|NCT00879658|79378667|FG002|Overall Study|misrandomized (never received study med)|0|||
44373540|NCT00879658|79378668|FG003|Overall Study|misrandomized (never received study med)|1|||
44373541|NCT00879658|79378669|FG004|Overall Study|misrandomized (never received study med)|0|||
44373542|NCT00879658|79378670|FG005|Overall Study|misrandomized (never received study med)|0|||
44373543|NCT00879658|79378671|FG006|Overall Study|misrandomized (never received study med)|0|||
44373544|NCT00959946|79378701|FG000|Overall Study|Adverse Event|0|||
44373545|NCT00959946|79378702|FG001|Overall Study|Adverse Event|0|||
44373546|NCT00959946|79378703|FG002|Overall Study|Adverse Event|2|||
44373547|NCT00959946|79378704|FG003|Overall Study|Adverse Event|1|||
44373548|NCT00959946|79378705|FG004|Overall Study|Adverse Event|0|||
44373549|NCT00959946|79378706|FG005|Overall Study|Adverse Event|1|||
44460869|NCT02864394|79469546|FG001|Overall Study|Withdrawal by Subject|10|||
44460870|NCT02773849|79469559|FG000|Overall Study|Adverse Event|3|||
44460871|NCT02773849|79469559|FG000|Overall Study|Lack of Efficacy|89|||
44460872|NCT02773849|79469559|FG000|Overall Study|Withdrawal by Subject|1|||
44373550|NCT00959946|79378707|FG006|Overall Study|Adverse Event|0|||
44373551|NCT00959946|79378708|FG007|Overall Study|Adverse Event|0|||
44373552|NCT00959946|79378701|FG000|Overall Study|Death|0|||
44373553|NCT00959946|79378702|FG001|Overall Study|Death|0|||
44373554|NCT00959946|79378703|FG002|Overall Study|Death|0|||
44373555|NCT00959946|79378704|FG003|Overall Study|Death|0|||
44373556|NCT00959946|79378705|FG004|Overall Study|Death|0|||
44373557|NCT00959946|79378706|FG005|Overall Study|Death|1|||
44218697|NCT03248492|79017856|FG001|Overall Study|Physician Decision|0|||
44218698|NCT03248492|79017857|FG002|Overall Study|Physician Decision|1|||
44218699|NCT03248492|79017858|FG003|Overall Study|Physician Decision|2|||
44218700|NCT03248492|79017859|FG004|Overall Study|Physician Decision|0|||
44218701|NCT03248492|79017855|FG000|Overall Study|Death|1|||
44218702|NCT03248492|79017856|FG001|Overall Study|Death|0|||
44218703|NCT03248492|79017857|FG002|Overall Study|Death|0|||
44218704|NCT03248492|79017858|FG003|Overall Study|Death|6|||
44218705|NCT03248492|79017859|FG004|Overall Study|Death|0|||
44218706|NCT03248492|79017855|FG000|Overall Study|Other|0|||
44218707|NCT03248492|79017856|FG001|Overall Study|Other|1|||
44218708|NCT03248492|79017857|FG002|Overall Study|Other|0|||
44218709|NCT03248492|79017858|FG003|Overall Study|Other|4|||
44218710|NCT03248492|79017859|FG004|Overall Study|Other|0|||
44218711|NCT03224468|79017881|FG000|Overall Study|Did not obtain MM card|53|||
44218712|NCT03224468|79017882|FG001|Overall Study|Did not obtain MM card|0|||
44218713|NCT03224468|79017881|FG000|Overall Study|Lost to Follow-up|4|||
44218714|NCT03224468|79017882|FG001|Overall Study|Lost to Follow-up|11|||
44218715|NCT03224468|79017881|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
44218716|NCT03224468|79017882|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
44218717|NCT03149003|79017891|FG000|Overall Study|Randomized but not treated|0|||
44218718|NCT03149003|79017892|FG001|Overall Study|Randomized but not treated|1|||
44218719|NCT03149003|79017893|FG002|Overall Study|Randomized but not treated|18|||
44218720|NCT03093974|79017907|FG000|Overall Study|Withdrawal by Subject|32|||
44218721|NCT03093974|79017908|FG001|Overall Study|Withdrawal by Subject|27|||
44218722|NCT03093974|79017907|FG000|Overall Study|Adverse Event|17|||
44218723|NCT03093974|79017908|FG001|Overall Study|Adverse Event|24|||
44218724|NCT03093974|79017907|FG000|Overall Study|Death|0|||
44218725|NCT03093974|79017908|FG001|Overall Study|Death|1|||
44218726|NCT03093974|79017907|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44218727|NCT03093974|79017908|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44218728|NCT03093974|79017907|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
44218729|NCT03093974|79017908|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
44218730|NCT03093974|79017907|FG000|Overall Study|Lost to Follow-up|0|||
44218731|NCT03093974|79017908|FG001|Overall Study|Lost to Follow-up|1|||
44218732|NCT03093974|79017907|FG000|Overall Study|Other|1|||
44218733|NCT03093974|79017908|FG001|Overall Study|Other|2|||
44218734|NCT03089606|79017914|FG000|Overall Study|Progression after Cycle 1|1|||
44218735|NCT03023332|79017930|FG000|Overall Study|Withdrawal by Subject|10|||
44218736|NCT03023332|79017931|FG001|Overall Study|Withdrawal by Subject|5|||
44218737|NCT03023332|79017932|FG002|Overall Study|Withdrawal by Subject|4|||
44218738|NCT03023332|79017933|FG003|Overall Study|Withdrawal by Subject|7|||
44218739|NCT03023332|79017930|FG000|Overall Study|Lost to Follow-up|13|||
44218740|NCT03023332|79017931|FG001|Overall Study|Lost to Follow-up|16|||
44218741|NCT03023332|79017932|FG002|Overall Study|Lost to Follow-up|8|||
44218742|NCT03023332|79017933|FG003|Overall Study|Lost to Follow-up|13|||
44218743|NCT03023332|79017930|FG000|Overall Study|Death|1|||
44218744|NCT03023332|79017931|FG001|Overall Study|Death|0|||
44218745|NCT03023332|79017932|FG002|Overall Study|Death|0|||
44218746|NCT03023332|79017933|FG003|Overall Study|Death|0|||
44218747|NCT02993731|79017962|FG000|Overall Study|Study Termination|101|||
44218748|NCT02993731|79017963|FG001|Overall Study|Study Termination|105|||
44218749|NCT02903368|79017981|FG000|Part 1|Adverse Event|3|||
44218750|NCT02903368|79017982|FG001|Part 1|Adverse Event|0|||
44218751|NCT02903368|79017983|FG002|Part 1|Adverse Event|0|||
44218752|NCT02903368|79017984|FG003|Part 1|Adverse Event|0|||
44373558|NCT00959946|79378707|FG006|Overall Study|Death|0|||
44373559|NCT00959946|79378708|FG007|Overall Study|Death|0|||
44373560|NCT00959946|79378701|FG000|Overall Study|Disease Progression|2|||
44373561|NCT00959946|79378702|FG001|Overall Study|Disease Progression|4|||
44373562|NCT00959946|79378703|FG002|Overall Study|Disease Progression|2|||
44373563|NCT00959946|79378704|FG003|Overall Study|Disease Progression|4|||
44373564|NCT00959946|79378705|FG004|Overall Study|Disease Progression|4|||
44373565|NCT00959946|79378706|FG005|Overall Study|Disease Progression|6|||
44373566|NCT00959946|79378707|FG006|Overall Study|Disease Progression|2|||
44373567|NCT00959946|79378708|FG007|Overall Study|Disease Progression|2|||
44373568|NCT00959946|79378701|FG000|Overall Study|Withdrawal by Subject|0|||
44373569|NCT00959946|79378702|FG001|Overall Study|Withdrawal by Subject|0|||
44218753|NCT02903368|79017981|FG000|Part 1|Withdrawal by Subject|1|||
44218754|NCT02903368|79017982|FG001|Part 1|Withdrawal by Subject|0|||
44218755|NCT02903368|79017983|FG002|Part 1|Withdrawal by Subject|0|||
44218756|NCT02903368|79017984|FG003|Part 1|Withdrawal by Subject|0|||
44218757|NCT02903368|79017981|FG000|Part 2|Adverse Event|0|||
44373570|NCT00959946|79378703|FG002|Overall Study|Withdrawal by Subject|0|||
44218758|NCT02903368|79017982|FG001|Part 2|Adverse Event|0|||
44218759|NCT02903368|79017983|FG002|Part 2|Adverse Event|5|||
44218760|NCT02903368|79017984|FG003|Part 2|Adverse Event|0|||
44218761|NCT02903368|79017981|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
44218762|NCT02903368|79017982|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
44373571|NCT00959946|79378704|FG003|Overall Study|Withdrawal by Subject|0|||
44218763|NCT02903368|79017983|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
44218764|NCT02903368|79017984|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
44218765|NCT02903368|79017981|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
44218766|NCT02903368|79017982|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
44218767|NCT02903368|79017983|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
44218768|NCT02903368|79017984|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
44218769|NCT02903368|79017981|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
44218770|NCT02903368|79017982|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
44218771|NCT02903368|79017983|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
44218772|NCT02903368|79017984|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
44218773|NCT02753127|79018004|FG000|Overall Study|Lost to Follow-up|13|||
44218774|NCT02753127|79018005|FG001|Overall Study|Lost to Follow-up|11|||
44218775|NCT02753127|79018004|FG000|Overall Study|Withdrawal by Subject|37|||
44218776|NCT02753127|79018005|FG001|Overall Study|Withdrawal by Subject|47|||
44373572|NCT00959946|79378705|FG004|Overall Study|Withdrawal by Subject|0|||
44373573|NCT00959946|79378706|FG005|Overall Study|Withdrawal by Subject|1|||
44373574|NCT00959946|79378707|FG006|Overall Study|Withdrawal by Subject|0|||
44460873|NCT02773849|79469559|FG000|Overall Study|Withdrawal of Consent|1|||
44460874|NCT02516241|79469581|FG000|Overall Study|Death|255|||
44373575|NCT00959946|79378708|FG007|Overall Study|Withdrawal by Subject|0|||
44460875|NCT02516241|79469582|FG001|Overall Study|Death|262|||
44460876|NCT02516241|79469583|FG002|Overall Study|Death|270|||
44460877|NCT02516241|79469581|FG000|Overall Study|Lost to Follow-up|1|||
44460878|NCT02516241|79469582|FG001|Overall Study|Lost to Follow-up|1|||
44460879|NCT02516241|79469583|FG002|Overall Study|Lost to Follow-up|3|||
44460880|NCT02516241|79469581|FG000|Overall Study|Withdrawal by Subject|2|||
44460881|NCT02516241|79469582|FG001|Overall Study|Withdrawal by Subject|7|||
44460882|NCT02516241|79469583|FG002|Overall Study|Withdrawal by Subject|12|||
44460883|NCT02516241|79469581|FG000|Overall Study|participants ongoing at data cut-off|84|||
44460884|NCT02516241|79469582|FG001|Overall Study|participants ongoing at data cut-off|76|||
44460885|NCT02516241|79469583|FG002|Overall Study|participants ongoing at data cut-off|59|||
44460886|NCT02162810|79469611|FG000|Overall Study|Protocol Violation|1|||
44460887|NCT02162810|79469612|FG001|Overall Study|Protocol Violation|0|||
44460888|NCT02162810|79469611|FG000|Overall Study|patients did not report compliance|4|||
44460889|NCT02162810|79469612|FG001|Overall Study|patients did not report compliance|1|||
44460890|NCT01709435|79469624|FG000|Overall Study|Adverse Event|1|||
44460891|NCT01709435|79469625|FG001|Overall Study|Adverse Event|1|||
44460892|NCT01709435|79469626|FG002|Overall Study|Adverse Event|1|||
44460893|NCT01709435|79469627|FG003|Overall Study|Adverse Event|0|||
44460894|NCT01709435|79469628|FG004|Overall Study|Adverse Event|0|||
44460895|NCT01709435|79469629|FG005|Overall Study|Adverse Event|1|||
44460896|NCT01709435|79469624|FG000|Overall Study|Lack of Efficacy|5|||
44460897|NCT01709435|79469625|FG001|Overall Study|Lack of Efficacy|7|||
44460898|NCT01709435|79469626|FG002|Overall Study|Lack of Efficacy|2|||
44460899|NCT01709435|79469627|FG003|Overall Study|Lack of Efficacy|2|||
44460900|NCT01709435|79469628|FG004|Overall Study|Lack of Efficacy|6|||
44460901|NCT01709435|79469629|FG005|Overall Study|Lack of Efficacy|3|||
44460902|NCT01709435|79469624|FG000|Overall Study|Physician Decision|0|||
44460903|NCT01709435|79469625|FG001|Overall Study|Physician Decision|1|||
44460904|NCT01709435|79469626|FG002|Overall Study|Physician Decision|0|||
44460905|NCT01709435|79469627|FG003|Overall Study|Physician Decision|1|||
44460906|NCT01709435|79469628|FG004|Overall Study|Physician Decision|2|||
44460907|NCT01709435|79469629|FG005|Overall Study|Physician Decision|0|||
44460908|NCT01709435|79469624|FG000|Overall Study|Withdrawal by Subject|0|||
44460909|NCT01709435|79469625|FG001|Overall Study|Withdrawal by Subject|0|||
44460910|NCT01709435|79469626|FG002|Overall Study|Withdrawal by Subject|3|||
44373576|NCT00911937|79378733|FG000|Overall Study|Death|1|||
44373577|NCT00911937|79378734|FG001|Overall Study|Death|0|||
44373578|NCT00911937|79378733|FG000|Overall Study|Lost to Follow-up|8|||
44373579|NCT00911937|79378734|FG001|Overall Study|Lost to Follow-up|5|||
44373580|NCT00911937|79378733|FG000|Overall Study|Withdrawal by Subject|10|||
44460911|NCT01709435|79469627|FG003|Overall Study|Withdrawal by Subject|0|||
44460912|NCT01709435|79469628|FG004|Overall Study|Withdrawal by Subject|2|||
44460913|NCT01709435|79469629|FG005|Overall Study|Withdrawal by Subject|2|||
44460914|NCT01358877|79469647|FG000|Overall Study|Death|80|||
44460915|NCT01358877|79469648|FG001|Overall Study|Death|89|||
44460916|NCT01358877|79469647|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
44373581|NCT00911937|79378734|FG001|Overall Study|Withdrawal by Subject|7|||
44460917|NCT01358877|79469648|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
44460918|NCT01358877|79469647|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
44460919|NCT01358877|79469648|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
44544188|NCT02729896|79557453|FG001|Overall Study|Progressive Disease|1|||
44460920|NCT01358877|79469647|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
44460921|NCT01358877|79469648|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
44460922|NCT01358877|79469647|FG000|Overall Study|Other|142|||
44460923|NCT01358877|79469648|FG001|Overall Study|Other|129|||
44460924|NCT00643279|79469680|FG000|Overall Study|Death|13|||
44460925|NCT00643279|79469681|FG001|Overall Study|Death|11|||
44460926|NCT00643279|79469680|FG000|Overall Study|Withdrawal by Subject|3|||
44460927|NCT00643279|79469681|FG001|Overall Study|Withdrawal by Subject|0|||
44460928|NCT00643279|79469680|FG000|Overall Study|Lost to Follow-up|0|||
44460929|NCT00643279|79469681|FG001|Overall Study|Lost to Follow-up|1|||
44460930|NCT00643279|79469680|FG000|Overall Study|Physician Decision|0|||
44460931|NCT00643279|79469681|FG001|Overall Study|Physician Decision|1|||
44460932|NCT05607043|79469701|FG000|Overall Study|Lost to Follow-up|2|||
44460933|NCT04550221|79469728|FG000|Overall Study|Lost to Follow-up|0|||
44460934|NCT04550221|79469729|FG001|Overall Study|Lost to Follow-up|4|||
44218777|NCT02753127|79018004|FG000|Overall Study|Other|3|||
44218778|NCT02753127|79018005|FG001|Overall Study|Other|8|||
44218779|NCT02753127|79018004|FG000|Overall Study|Hospice|0|||
44218780|NCT02753127|79018005|FG001|Overall Study|Hospice|2|||
44218781|NCT02657551|79018019|FG000|Overall Study|Adverse Event|2|||
44218782|NCT02657551|79018019|FG000|Overall Study|Withdrawal by Subject|1|||
44218783|NCT02657551|79018019|FG000|Overall Study|Non-Compliance|1|||
44218784|NCT02657551|79018019|FG000|Overall Study|Progression / Relapse|4|||
44218785|NCT02527434|79018026|FG000|Overall Study|Lost to Follow-up|2|||
44218786|NCT02527434|79018027|FG001|Overall Study|Lost to Follow-up|2|||
44218787|NCT02527434|79018028|FG002|Overall Study|Lost to Follow-up|0|||
44218788|NCT02527434|79018026|FG000|Overall Study|Death|19|||
44218789|NCT02527434|79018027|FG001|Overall Study|Death|6|||
44218790|NCT02527434|79018028|FG002|Overall Study|Death|17|||
44218791|NCT02527434|79018026|FG000|Overall Study|Withdrawal by Subject|5|||
44218792|NCT02527434|79018027|FG001|Overall Study|Withdrawal by Subject|3|||
44218793|NCT02527434|79018028|FG002|Overall Study|Withdrawal by Subject|3|||
44218794|NCT02527434|79018026|FG000|Overall Study|Reason Not Specified|1|||
44218795|NCT02527434|79018027|FG001|Overall Study|Reason Not Specified|0|||
44218796|NCT02527434|79018028|FG002|Overall Study|Reason Not Specified|0|||
44218797|NCT02527434|79018026|FG000|Overall Study|Site closure|1|||
44218798|NCT02527434|79018027|FG001|Overall Study|Site closure|0|||
44218799|NCT02527434|79018028|FG002|Overall Study|Site closure|0|||
44218800|NCT02460835|79018046|FG000|Overall Study|Disease progression prior to treatment|3|||
44218801|NCT02460835|79018046|FG000|Overall Study|Unable to complete planning scans|2|||
44218802|NCT02460835|79018046|FG000|Overall Study|Decrease in performance status|1|||
44218803|NCT02460835|79018046|FG000|Overall Study|Withdrawal by Subject|3|||
44218804|NCT02460835|79018046|FG000|Overall Study|Underwent fractionated RT|10|||
44218805|NCT02460835|79018046|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
44218806|NCT02231749|79018082|FG000|Overall Study|Disease progression|229|||
44218807|NCT02231749|79018083|FG001|Overall Study|Disease progression|297|||
44218808|NCT02231749|79018082|FG000|Overall Study|Study Drug Toxicity|134|||
44218809|NCT02231749|79018083|FG001|Overall Study|Study Drug Toxicity|63|||
44218810|NCT02231749|79018082|FG000|Overall Study|Death|1|||
44218811|NCT02231749|79018083|FG001|Overall Study|Death|1|||
44218812|NCT02231749|79018082|FG000|Overall Study|AE unrelated to Study drug|32|||
44218813|NCT02231749|79018083|FG001|Overall Study|AE unrelated to Study drug|31|||
44373582|NCT00911937|79378733|FG000|Overall Study|Withdrawn due to pregnancy|1|||
44373583|NCT00911937|79378734|FG001|Overall Study|Withdrawn due to pregnancy|0|||
44373584|NCT00911937|79378733|FG000|Overall Study|Adverse Event|11|||
44373585|NCT00911937|79378734|FG001|Overall Study|Adverse Event|25|||
44373586|NCT00911937|79378733|FG000|Overall Study|Lack of Efficacy|11|||
44373587|NCT00911937|79378734|FG001|Overall Study|Lack of Efficacy|6|||
44373588|NCT00911937|79378733|FG000|Overall Study|Did not meet inclusion criteria|9|||
44373589|NCT00911937|79378734|FG001|Overall Study|Did not meet inclusion criteria|11|||
44218814|NCT02231749|79018082|FG000|Overall Study|Participant's request to discontinue|10|||
44218815|NCT02231749|79018083|FG001|Overall Study|Participant's request to discontinue|21|||
44218816|NCT02231749|79018082|FG000|Overall Study|Participant withdrew Consent|8|||
44218817|NCT02231749|79018083|FG001|Overall Study|Participant withdrew Consent|15|||
44218818|NCT02231749|79018082|FG000|Overall Study|Lost to Follow-up|1|||
44218819|NCT02231749|79018083|FG001|Overall Study|Lost to Follow-up|2|||
44373590|NCT00911937|79378733|FG000|Overall Study|Protocol Violation|14|||
44460935|NCT04550221|79469728|FG000|Overall Study|Withdrawn|3|||
44373591|NCT00911937|79378734|FG001|Overall Study|Protocol Violation|23|||
44373592|NCT00911937|79378733|FG000|Overall Study|Randomized but not treated|13|||
44460936|NCT04550221|79469729|FG001|Overall Study|Withdrawn|0|||
44460937|NCT04550221|79469728|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
44460938|NCT04550221|79469729|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
44218820|NCT02231749|79018082|FG000|Overall Study|Maximum Clinical Benefit|5|||
44218821|NCT02231749|79018083|FG001|Overall Study|Maximum Clinical Benefit|8|||
44218822|NCT02231749|79018082|FG000|Overall Study|Poor/Non-Compliance|0|||
44218823|NCT02231749|79018083|FG001|Overall Study|Poor/Non-Compliance|3|||
44218824|NCT02231749|79018082|FG000|Overall Study|Pregnancy|1|||
44218825|NCT02231749|79018083|FG001|Overall Study|Pregnancy|0|||
44218826|NCT02231749|79018082|FG000|Overall Study|other|0|||
44218827|NCT02231749|79018083|FG001|Overall Study|other|8|||
44218828|NCT02231749|79018082|FG000|Overall Study|No longer meets Study Criteria|1|||
44218829|NCT02231749|79018083|FG001|Overall Study|No longer meets Study Criteria|0|||
44218830|NCT01776307|79018148|FG000|Overall Study|Not dosed|0|||
44218831|NCT01776307|79018149|FG001|Overall Study|Not dosed|0|||
44218832|NCT01776307|79018150|FG002|Overall Study|Not dosed|1|||
44218833|NCT05419908|79018212|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
44218834|NCT05419908|79018213|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
44218835|NCT05419908|79018212|FG000|Overall Study|Serious Adverse Event|0|||
44218836|NCT05419908|79018213|FG001|Overall Study|Serious Adverse Event|2|||
44218837|NCT05419908|79018212|FG000|Overall Study|Withdrawal by Subject|2|||
44218838|NCT05419908|79018213|FG001|Overall Study|Withdrawal by Subject|0|||
44218839|NCT05419908|79018212|FG000|Overall Study|Miscellaneous|1|||
44218840|NCT05419908|79018213|FG001|Overall Study|Miscellaneous|1|||
44218841|NCT05091060|79018219|FG000|Overall Study|Lost to Follow-up|1|||
44218842|NCT05056311|79018223|FG000|Overall Study|Lost to Follow-up|14|||
44218843|NCT05056311|79018223|FG000|Overall Study|Withdrawal by Subject|1|||
44218844|NCT05056311|79018223|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
44218845|NCT05020899|79018230|FG000|8 Week Follow-up|Lost to Follow-up|3|||
44218846|NCT05020899|79018231|FG001|8 Week Follow-up|Lost to Follow-up|6|||
44218847|NCT05020899|79018230|FG000|12 Week Follow-up|Lost to Follow-up|1|||
44218848|NCT05020899|79018231|FG001|12 Week Follow-up|Lost to Follow-up|0|||
44218849|NCT05020899|79018230|FG000|12 Week Follow-up|Death|0|||
44218850|NCT05020899|79018231|FG001|12 Week Follow-up|Death|1|||
44218851|NCT04806503|79018261|FG000|Overall Study|Lost to Follow-up|0|||
44218852|NCT04806503|79018262|FG001|Overall Study|Lost to Follow-up|0|||
44218853|NCT04806503|79018263|FG002|Overall Study|Lost to Follow-up|1|||
44218854|NCT04806503|79018264|FG003|Overall Study|Lost to Follow-up|0|||
44218855|NCT04806503|79018265|FG004|Overall Study|Lost to Follow-up|0|||
44218856|NCT04806503|79018261|FG000|Overall Study|Withdrawal by Subject|1|||
44218857|NCT04806503|79018262|FG001|Overall Study|Withdrawal by Subject|0|||
44218858|NCT04806503|79018263|FG002|Overall Study|Withdrawal by Subject|1|||
44218859|NCT04806503|79018264|FG003|Overall Study|Withdrawal by Subject|1|||
44218860|NCT04806503|79018265|FG004|Overall Study|Withdrawal by Subject|1|||
44373593|NCT00911937|79378734|FG001|Overall Study|Randomized but not treated|13|||
44373594|NCT00911937|79378733|FG000|Overall Study|Other|9|||
44373595|NCT00911937|79378734|FG001|Overall Study|Other|5|||
44460939|NCT04193176|79469750|FG000|Overall Study|Withdrawal by Subject|6|||
44460940|NCT04193176|79469751|FG001|Overall Study|Withdrawal by Subject|10|||
44460941|NCT05384834|79469757|FG000|Overall Study|Lost to Follow-up|43|||
44460942|NCT05384834|79469757|FG000|Overall Study|Withdrawal by Subject|5|||
44460943|NCT05101486|79469764|FG000|Overall Study|Death|1|||
44460944|NCT05101486|79469765|FG001|Overall Study|Death|0|||
44460945|NCT05101486|79469766|FG002|Overall Study|Death|1|||
44460946|NCT05101486|79469764|FG000|Overall Study|Lost to Follow-up|12|||
44460947|NCT05101486|79469765|FG001|Overall Study|Lost to Follow-up|8|||
44460948|NCT05101486|79469766|FG002|Overall Study|Lost to Follow-up|17|||
44460949|NCT05101486|79469764|FG000|Overall Study|Physician Decision|1|||
44460950|NCT05101486|79469765|FG001|Overall Study|Physician Decision|0|||
44460951|NCT05101486|79469766|FG002|Overall Study|Physician Decision|0|||
44460952|NCT05101486|79469764|FG000|Overall Study|Protocol Violation|0|||
44373596|NCT00880048|79378743|FG000|Overall Study|Adverse Event|2|||
44373597|NCT00880048|79378744|FG001|Overall Study|Adverse Event|3|||
44373598|NCT00880048|79378745|FG002|Overall Study|Adverse Event|5|||
44373599|NCT00880048|79378743|FG000|Overall Study|Lack of Efficacy|1|||
44373600|NCT00880048|79378744|FG001|Overall Study|Lack of Efficacy|2|||
44218861|NCT04806503|79018261|FG000|Overall Study|Adverse Event|1|||
44218862|NCT04806503|79018262|FG001|Overall Study|Adverse Event|1|||
44218863|NCT04806503|79018263|FG002|Overall Study|Adverse Event|0|||
44218864|NCT04806503|79018264|FG003|Overall Study|Adverse Event|1|||
44218865|NCT04806503|79018265|FG004|Overall Study|Adverse Event|0|||
44218866|NCT04508751|79018281|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
44218867|NCT04508751|79018282|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
44218868|NCT04508751|79018283|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
44373601|NCT00880048|79378745|FG002|Overall Study|Lack of Efficacy|2|||
44373602|NCT00880048|79378743|FG000|Overall Study|Protocol Violation|4|||
44373603|NCT00880048|79378744|FG001|Overall Study|Protocol Violation|6|||
44460953|NCT05101486|79469765|FG001|Overall Study|Protocol Violation|0|||
44460954|NCT05101486|79469766|FG002|Overall Study|Protocol Violation|1|||
44460955|NCT05101486|79469764|FG000|Overall Study|Withdrawal by Subject|5|||
44218869|NCT04473482|79018293|FG000|Overall Study|Death|0|||
44218870|NCT04473482|79018294|FG001|Overall Study|Death|3|||
44218871|NCT04473482|79018293|FG000|Overall Study|Lost to Follow-up|9|||
44218872|NCT04473482|79018294|FG001|Overall Study|Lost to Follow-up|7|||
44218873|NCT04473482|79018293|FG000|Overall Study|Withdrawal by Subject|2|||
44218874|NCT04473482|79018294|FG001|Overall Study|Withdrawal by Subject|1|||
44218875|NCT03919799|79018304|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
44218876|NCT03919799|79018305|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
44218877|NCT03919799|79018306|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
44218878|NCT03919799|79018307|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
44218879|NCT03919799|79018308|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
44218880|NCT03919799|79018304|FG000|DB Period (28 Weeks)|Adverse Event|1|||
44218881|NCT03919799|79018305|FG001|DB Period (28 Weeks)|Adverse Event|1|||
44218882|NCT03919799|79018306|FG002|DB Period (28 Weeks)|Adverse Event|1|||
44218883|NCT03919799|79018307|FG003|DB Period (28 Weeks)|Adverse Event|0|||
44218884|NCT03919799|79018308|FG004|DB Period (28 Weeks)|Adverse Event|0|||
44218885|NCT03919799|79018304|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
44218886|NCT03919799|79018305|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
44218887|NCT03919799|79018306|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
44218888|NCT03919799|79018307|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
44218889|NCT03919799|79018308|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
44218890|NCT03919799|79018304|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
44218891|NCT03919799|79018305|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
44218892|NCT03919799|79018306|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
44218893|NCT03919799|79018307|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
44218894|NCT03919799|79018308|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
44218895|NCT03919799|79018304|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
44218896|NCT03919799|79018305|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
44218897|NCT03919799|79018306|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
44218898|NCT03919799|79018307|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
44218899|NCT03919799|79018308|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
44218900|NCT03621735|79018353|FG000|Overall Study|Withdrawal by Subject|13|||
44218901|NCT03621735|79018354|FG001|Overall Study|Withdrawal by Subject|13|||
44218902|NCT03245151|79018414|FG000|Overall Study|Withdrawal by Subject|2|||
44218903|NCT03245151|79018415|FG001|Overall Study|Withdrawal by Subject|0|||
44218904|NCT03245151|79018416|FG002|Overall Study|Withdrawal by Subject|0|||
44218905|NCT03245151|79018417|FG003|Overall Study|Withdrawal by Subject|2|||
44218906|NCT03245151|79018418|FG004|Overall Study|Withdrawal by Subject|1|||
44218907|NCT03245151|79018414|FG000|Overall Study|Death|3|||
44218908|NCT03245151|79018415|FG001|Overall Study|Death|14|||
44218909|NCT03245151|79018416|FG002|Overall Study|Death|9|||
44218910|NCT03245151|79018417|FG003|Overall Study|Death|16|||
44218911|NCT03245151|79018418|FG004|Overall Study|Death|7|||
44218912|NCT03245151|79018414|FG000|Overall Study|Sponsor's decision|0|||
44218913|NCT03245151|79018415|FG001|Overall Study|Sponsor's decision|1|||
44218914|NCT03245151|79018416|FG002|Overall Study|Sponsor's decision|0|||
44218915|NCT03245151|79018417|FG003|Overall Study|Sponsor's decision|0|||
44218916|NCT03245151|79018418|FG004|Overall Study|Sponsor's decision|0|||
44277791|NCT02138214|79238787|FG002|Overall Study|Withdrawal by Subject|0|||
44218917|NCT02087865|79018452|FG000|Overall Study|Withdrawal by Subject|6|||
44218918|NCT02087865|79018453|FG001|Overall Study|Withdrawal by Subject|0|||
44218919|NCT02087865|79018454|FG002|Overall Study|Withdrawal by Subject|1|||
44218920|NCT02087865|79018452|FG000|Overall Study|Lost to Follow-up|0|||
44218921|NCT02087865|79018453|FG001|Overall Study|Lost to Follow-up|0|||
44218922|NCT02087865|79018454|FG002|Overall Study|Lost to Follow-up|1|||
44218923|NCT02087865|79018452|FG000|Overall Study|Drug Non-compliance|0|||
44218924|NCT02087865|79018453|FG001|Overall Study|Drug Non-compliance|2|||
44218925|NCT02087865|79018454|FG002|Overall Study|Drug Non-compliance|0|||
44218926|NCT02087865|79018452|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
44218927|NCT02087865|79018453|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
44218928|NCT02087865|79018454|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
44218929|NCT01682083|79018474|FG000|Overall Study|Lost to Follow-up|11|||
44218930|NCT01682083|79018475|FG001|Overall Study|Lost to Follow-up|18|||
44218931|NCT01682083|79018474|FG000|Overall Study|Withdrawal by Subject|31|||
44218932|NCT01682083|79018475|FG001|Overall Study|Withdrawal by Subject|40|||
44218933|NCT01682083|79018474|FG000|Overall Study|Death|60|||
44218934|NCT01682083|79018475|FG001|Overall Study|Death|93|||
44218935|NCT01682083|79018474|FG000|Overall Study|Physician Decision|5|||
44218936|NCT01682083|79018475|FG001|Overall Study|Physician Decision|4|||
44218937|NCT01180790|79018492|FG000|Overall Study|Adverse Event|1|||
44218938|NCT01180790|79018493|FG001|Overall Study|Adverse Event|1|||
44218939|NCT01180790|79018494|FG002|Overall Study|Adverse Event|2|||
44218940|NCT01180790|79018495|FG003|Overall Study|Adverse Event|0|||
44218941|NCT01180790|79018496|FG004|Overall Study|Adverse Event|1|||
44218942|NCT01180790|79018497|FG005|Overall Study|Adverse Event|3|||
44218943|NCT01180790|79018498|FG006|Overall Study|Adverse Event|0|||
44218944|NCT01180790|79018492|FG000|Overall Study|Withdrawal by Subject|3|||
44218945|NCT01180790|79018493|FG001|Overall Study|Withdrawal by Subject|0|||
44218946|NCT01180790|79018494|FG002|Overall Study|Withdrawal by Subject|5|||
44218947|NCT01180790|79018495|FG003|Overall Study|Withdrawal by Subject|0|||
44218948|NCT01180790|79018496|FG004|Overall Study|Withdrawal by Subject|2|||
44218949|NCT01180790|79018497|FG005|Overall Study|Withdrawal by Subject|1|||
44218950|NCT01180790|79018498|FG006|Overall Study|Withdrawal by Subject|0|||
44218951|NCT01180790|79018492|FG000|Overall Study|Lost to Follow-up|3|||
44218952|NCT01180790|79018493|FG001|Overall Study|Lost to Follow-up|1|||
44218953|NCT01180790|79018494|FG002|Overall Study|Lost to Follow-up|0|||
44218954|NCT01180790|79018495|FG003|Overall Study|Lost to Follow-up|2|||
44218955|NCT01180790|79018496|FG004|Overall Study|Lost to Follow-up|1|||
44218956|NCT01180790|79018497|FG005|Overall Study|Lost to Follow-up|0|||
44218957|NCT01180790|79018498|FG006|Overall Study|Lost to Follow-up|1|||
44218958|NCT01180790|79018492|FG000|Overall Study|Physician Decision|1|||
44218959|NCT01180790|79018493|FG001|Overall Study|Physician Decision|0|||
44218960|NCT01180790|79018494|FG002|Overall Study|Physician Decision|0|||
44218961|NCT01180790|79018495|FG003|Overall Study|Physician Decision|1|||
44218962|NCT01180790|79018496|FG004|Overall Study|Physician Decision|0|||
44218963|NCT01180790|79018497|FG005|Overall Study|Physician Decision|0|||
44218964|NCT01180790|79018498|FG006|Overall Study|Physician Decision|0|||
44218965|NCT01180790|79018492|FG000|Overall Study|Lack of Efficacy|1|||
44218966|NCT01180790|79018493|FG001|Overall Study|Lack of Efficacy|2|||
44218967|NCT01180790|79018494|FG002|Overall Study|Lack of Efficacy|5|||
44460956|NCT05101486|79469765|FG001|Overall Study|Withdrawal by Subject|2|||
44460957|NCT05101486|79469766|FG002|Overall Study|Withdrawal by Subject|4|||
44460958|NCT05101486|79469764|FG000|Overall Study|Randomized but not vaccinated|1|||
44460959|NCT05101486|79469765|FG001|Overall Study|Randomized but not vaccinated|1|||
44460960|NCT05101486|79469766|FG002|Overall Study|Randomized but not vaccinated|1|||
44460961|NCT05083585|79469776|FG000|Overall Study|Death|1|||
44460962|NCT05083585|79469777|FG001|Overall Study|Death|1|||
44218968|NCT01180790|79018495|FG003|Overall Study|Lack of Efficacy|6|||
44373604|NCT00880048|79378745|FG002|Overall Study|Protocol Violation|5|||
44373605|NCT00880048|79378743|FG000|Overall Study|Lost to Follow-up|6|||
44373606|NCT00880048|79378744|FG001|Overall Study|Lost to Follow-up|6|||
44373607|NCT00880048|79378745|FG002|Overall Study|Lost to Follow-up|5|||
44373608|NCT00880048|79378743|FG000|Overall Study|Physician Decision|1|||
44373609|NCT00880048|79378744|FG001|Overall Study|Physician Decision|1|||
44373610|NCT00880048|79378745|FG002|Overall Study|Physician Decision|7|||
44373611|NCT00880048|79378743|FG000|Overall Study|Withdrawal by Subject|5|||
44373612|NCT00880048|79378744|FG001|Overall Study|Withdrawal by Subject|8|||
44373613|NCT00880048|79378745|FG002|Overall Study|Withdrawal by Subject|5|||
44373614|NCT00880048|79378743|FG000|Overall Study|Study closed/terminated|9|||
44373615|NCT00880048|79378744|FG001|Overall Study|Study closed/terminated|7|||
44373616|NCT00880048|79378745|FG002|Overall Study|Study closed/terminated|6|||
44218969|NCT01180790|79018496|FG004|Overall Study|Lack of Efficacy|1|||
44218970|NCT01180790|79018497|FG005|Overall Study|Lack of Efficacy|3|||
44218971|NCT01180790|79018498|FG006|Overall Study|Lack of Efficacy|0|||
44218972|NCT01180790|79018492|FG000|Overall Study|compliance|0|||
44373617|NCT00962208|79378755|FG000|Overall Study|Could not achieve good vision|9|||
44373618|NCT00962208|79378756|FG001|Overall Study|Could not achieve good vision|0|||
44373619|NCT00962208|79378755|FG000|Overall Study|Contraindicated to continue study|5|||
44373620|NCT00962208|79378756|FG001|Overall Study|Contraindicated to continue study|1|||
44460963|NCT05083585|79469776|FG000|Overall Study|Lost to Follow-up|1|||
44544189|NCT02729896|79557454|FG002|Overall Study|Progressive Disease|0|||
44218973|NCT01180790|79018493|FG001|Overall Study|compliance|1|||
44218974|NCT01180790|79018494|FG002|Overall Study|compliance|0|||
44218975|NCT01180790|79018495|FG003|Overall Study|compliance|0|||
44218976|NCT01180790|79018496|FG004|Overall Study|compliance|0|||
44218977|NCT01180790|79018497|FG005|Overall Study|compliance|0|||
44218978|NCT01180790|79018498|FG006|Overall Study|compliance|0|||
44218979|NCT01180790|79018492|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
44218980|NCT01180790|79018493|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
44218981|NCT01180790|79018494|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
44218982|NCT01180790|79018495|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
44218983|NCT01180790|79018496|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
44218984|NCT01180790|79018497|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
44218985|NCT01180790|79018498|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
44218986|NCT00679042|79018547|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
44218987|NCT00679042|79018547|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
44218988|NCT00679042|79018547|FG000|5-Year Follow Up|Death|1|||
44218989|NCT00679042|79018547|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
44218990|NCT00679042|79018547|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
44218991|NCT00350272|79018553|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
44218992|NCT00350272|79018554|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
44218993|NCT00350272|79018553|FG000|Blinded 12-Week Treatment|Death|1|||
44218994|NCT00350272|79018554|FG001|Blinded 12-Week Treatment|Death|0|||
44218995|NCT00350272|79018553|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
44218996|NCT00350272|79018554|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
44218997|NCT00350272|79018553|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
44218998|NCT00350272|79018554|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
44218999|NCT00350272|79018553|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
44219000|NCT00350272|79018554|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
44219001|NCT00350272|79018553|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
44219002|NCT00350272|79018554|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
44219003|NCT00350272|79018553|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
44219004|NCT00350272|79018554|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
44219005|NCT00350272|79018553|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
44219006|NCT00350272|79018554|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
44219007|NCT00350272|79018553|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
44219008|NCT00350272|79018554|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
44219009|NCT00350272|79018553|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
44219010|NCT00350272|79018554|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
44219011|NCT00350272|79018553|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
44219012|NCT00350272|79018554|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
44219013|NCT02028884|79018565|FG000|Double-blind Period|Adverse Event|5|||
44219014|NCT02028884|79018566|FG001|Double-blind Period|Adverse Event|3|||
44219015|NCT02028884|79018567|FG002|Double-blind Period|Adverse Event|0|||
44219016|NCT02028884|79018565|FG000|Double-blind Period|Eligibility Violation|1|||
44219017|NCT02028884|79018566|FG001|Double-blind Period|Eligibility Violation|0|||
44219018|NCT02028884|79018567|FG002|Double-blind Period|Eligibility Violation|0|||
44219019|NCT02028884|79018565|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
44219020|NCT02028884|79018566|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
44219021|NCT02028884|79018567|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
44219022|NCT02028884|79018565|FG000|Double-blind Period|Withdrawal by Subject|2|||
44219023|NCT02028884|79018566|FG001|Double-blind Period|Withdrawal by Subject|0|||
44219024|NCT02028884|79018567|FG002|Double-blind Period|Withdrawal by Subject|0|||
44219025|NCT02028884|79018565|FG000|Open-label Extension Period|Adverse Event|3|||
44219026|NCT02028884|79018566|FG001|Open-label Extension Period|Adverse Event|1|||
44219027|NCT02028884|79018567|FG002|Open-label Extension Period|Adverse Event|0|||
44219028|NCT02028884|79018565|FG000|Open-label Extension Period|Lack of Efficacy|3|||
44219029|NCT02028884|79018566|FG001|Open-label Extension Period|Lack of Efficacy|0|||
44219030|NCT02028884|79018567|FG002|Open-label Extension Period|Lack of Efficacy|0|||
44219031|NCT02028884|79018565|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
44219032|NCT02028884|79018566|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
44373621|NCT00962208|79378755|FG000|Overall Study|Lost to Follow-up|0|||
44373622|NCT00962208|79378756|FG001|Overall Study|Lost to Follow-up|9|||
44219033|NCT02028884|79018567|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
44219034|NCT02028884|79018565|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
44219035|NCT02028884|79018566|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
44219036|NCT02028884|79018567|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
44219037|NCT02028884|79018565|FG000|Open-label Extension Period|Switched to another treatment option|3|||
44219038|NCT02028884|79018566|FG001|Open-label Extension Period|Switched to another treatment option|0|||
44219039|NCT02028884|79018567|FG002|Open-label Extension Period|Switched to another treatment option|0|||
44373623|NCT01076543|79378768|FG000|Overall Study|Withdrawal by Subject|2|||
44460964|NCT05083585|79469777|FG001|Overall Study|Lost to Follow-up|1|||
44373624|NCT01076543|79378769|FG001|Overall Study|Withdrawal by Subject|0|||
44219040|NCT01422187|79018620|FG000|Overall Study|Personal reason|1|||
44219041|NCT01422187|79018621|FG001|Overall Study|Personal reason|0|||
44219042|NCT01422187|79018622|FG002|Overall Study|Personal reason|0|||
44219043|NCT01422187|79018620|FG000|Overall Study|Lost to Follow-up|0|||
44219044|NCT01422187|79018621|FG001|Overall Study|Lost to Follow-up|1|||
44219045|NCT01422187|79018622|FG002|Overall Study|Lost to Follow-up|0|||
44219046|NCT00472212|79018632|FG000|Overall Study|Lost to Follow-up|6|||
44219047|NCT00472212|79018633|FG001|Overall Study|Lost to Follow-up|4|||
44219048|NCT00139477|79018641|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
44219049|NCT00139477|79018642|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
44219050|NCT00139477|79018641|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
44219051|NCT00139477|79018642|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
44219052|NCT00139477|79018641|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
44219053|NCT00139477|79018642|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
44219054|NCT00139477|79018641|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
44219055|NCT00139477|79018642|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
44219056|NCT00139477|79018641|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
44219057|NCT00139477|79018642|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
44219058|NCT00139477|79018641|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
44219059|NCT00139477|79018642|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
44219060|NCT00139477|79018641|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
44219061|NCT00139477|79018642|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
44219062|NCT01469013|79018962|FG000|Part A (Treatment Period)|Adverse Event|1|||
44219063|NCT01469013|79018963|FG001|Part A (Treatment Period)|Adverse Event|0|||
44219064|NCT01469013|79018964|FG002|Part A (Treatment Period)|Adverse Event|0|||
44219065|NCT01469013|79018965|FG003|Part A (Treatment Period)|Adverse Event|0|||
44219066|NCT01469013|79018966|FG004|Part A (Treatment Period)|Adverse Event|1|||
44219067|NCT01469013|79018967|FG005|Part A (Treatment Period)|Adverse Event|0|||
44219068|NCT01469013|79018968|FG006|Part A (Treatment Period)|Adverse Event|0|||
44219069|NCT01469013|79018969|FG007|Part A (Treatment Period)|Adverse Event|0|||
44219070|NCT01469013|79018970|FG008|Part A (Treatment Period)|Adverse Event|0|||
44219071|NCT01469013|79018971|FG009|Part A (Treatment Period)|Adverse Event|0|||
44219072|NCT01469013|79018972|FG010|Part A (Treatment Period)|Adverse Event|0|||
44219073|NCT01469013|79018973|FG011|Part A (Treatment Period)|Adverse Event|0|||
44219074|NCT01469013|79018974|FG012|Part A (Treatment Period)|Adverse Event|0|||
44219075|NCT01469013|79018962|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219076|NCT01469013|79018963|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219077|NCT01469013|79018964|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
44219078|NCT01469013|79018965|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219079|NCT01469013|79018966|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219080|NCT01469013|79018967|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219081|NCT01469013|79018968|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219082|NCT01469013|79018969|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219083|NCT01469013|79018970|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219084|NCT01469013|79018971|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219085|NCT01469013|79018972|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219086|NCT01469013|79018973|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219087|NCT01469013|79018974|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
44219088|NCT01469013|79018962|FG000|Part B (Extension Period)|Adverse Event|0|||
44219089|NCT01469013|79018963|FG001|Part B (Extension Period)|Adverse Event|0|||
44219090|NCT01469013|79018964|FG002|Part B (Extension Period)|Adverse Event|0|||
44219091|NCT01469013|79018965|FG003|Part B (Extension Period)|Adverse Event|0|||
44219092|NCT01469013|79018966|FG004|Part B (Extension Period)|Adverse Event|0|||
44219093|NCT01469013|79018967|FG005|Part B (Extension Period)|Adverse Event|2|||
44219094|NCT01469013|79018968|FG006|Part B (Extension Period)|Adverse Event|5|||
44460965|NCT05083585|79469776|FG000|Overall Study|Withdrawal by Subject|2|||
44219095|NCT01469013|79018969|FG007|Part B (Extension Period)|Adverse Event|5|||
44219096|NCT01469013|79018970|FG008|Part B (Extension Period)|Adverse Event|3|||
44460966|NCT05083585|79469777|FG001|Overall Study|Withdrawal by Subject|0|||
44460967|NCT05083585|79469776|FG000|Overall Study|Randomized but not vaccinated|2|||
44460968|NCT05083585|79469777|FG001|Overall Study|Randomized but not vaccinated|0|||
44460969|NCT05071313|79469785|FG000|Overall Study|Lost to Follow-up|17|||
44219097|NCT01469013|79018971|FG009|Part B (Extension Period)|Adverse Event|3|||
44219098|NCT01469013|79018972|FG010|Part B (Extension Period)|Adverse Event|1|||
44219099|NCT01469013|79018973|FG011|Part B (Extension Period)|Adverse Event|6|||
44219100|NCT01469013|79018974|FG012|Part B (Extension Period)|Adverse Event|3|||
44219101|NCT01469013|79018962|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
44219102|NCT01469013|79018963|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
44219103|NCT01469013|79018964|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
44460970|NCT05071313|79469786|FG001|Overall Study|Lost to Follow-up|10|||
44219104|NCT01469013|79018965|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
44460971|NCT05071313|79469785|FG000|Overall Study|Physician Decision|1|||
44219105|NCT01469013|79018966|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
44219106|NCT01469013|79018967|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
44219107|NCT01469013|79018968|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
44219108|NCT01469013|79018969|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
44219109|NCT01469013|79018970|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
44219110|NCT01469013|79018971|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
44219111|NCT01469013|79018972|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
44219112|NCT01469013|79018973|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
44219113|NCT01469013|79018974|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
44219114|NCT01493427|79019001|FG000|Overall Study|Adverse Event|10|||
44219115|NCT01493427|79019001|FG000|Overall Study|Personal Reasons|4|||
44219116|NCT01493427|79019001|FG000|Overall Study|Lost to Follow-up|2|||
44219117|NCT01493427|79019001|FG000|Overall Study|Inability to Follow Instructions|2|||
44219118|NCT01493427|79019001|FG000|Overall Study|Other|2|||
44219119|NCT01523457|79019007|FG000|Overall Study|Withdrawal by Subject|7|||
44219120|NCT01523457|79019008|FG001|Overall Study|Withdrawal by Subject|2|||
44219121|NCT01523301|79019016|FG000|Overall Study|Adverse Event|25|||
44219122|NCT01523301|79019017|FG001|Overall Study|Adverse Event|16|||
44270287|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
44270288|NCT02326272|79195767|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44460972|NCT05071313|79469786|FG001|Overall Study|Physician Decision|6|||
44460973|NCT05071313|79469785|FG000|Overall Study|Death|1|||
44460974|NCT05071313|79469786|FG001|Overall Study|Death|0|||
44460975|NCT05071313|79469785|FG000|Overall Study|Withdrawal by Subject|10|||
44460976|NCT05071313|79469786|FG001|Overall Study|Withdrawal by Subject|15|||
44270289|NCT02326272|79195768|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270290|NCT02326272|79195769|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44373625|NCT01076543|79378770|FG002|Overall Study|Withdrawal by Subject|0|||
44373626|NCT01076543|79378771|FG003|Overall Study|Withdrawal by Subject|0|||
44460977|NCT05071313|79469785|FG000|Overall Study|Other|1|||
44460978|NCT05071313|79469786|FG001|Overall Study|Other|0|||
44460979|NCT05071313|79469785|FG000|Overall Study|Randomized but not vaccinated|4|||
44460980|NCT05071313|79469786|FG001|Overall Study|Randomized but not vaccinated|2|||
44460981|NCT05019729|79469814|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
44460982|NCT05019729|79469815|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
44460983|NCT05019729|79469816|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
44460984|NCT05019729|79469817|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
44460985|NCT05019729|79469818|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
44460986|NCT05019729|79469819|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
44460987|NCT04544475|79469867|FG000|Overall Study|Withdrawal by Subject|1|||
44460988|NCT04544475|79469868|FG001|Overall Study|Withdrawal by Subject|3|||
44460989|NCT04045613|79469899|FG000|Overall Study|Adverse Event|2|||
44460990|NCT04045613|79469900|FG001|Overall Study|Adverse Event|2|||
44460991|NCT04045613|79469901|FG002|Overall Study|Adverse Event|1|||
44460992|NCT04045613|79469902|FG003|Overall Study|Adverse Event|1|||
44460993|NCT04045613|79469903|FG004|Overall Study|Adverse Event|0|||
44460994|NCT04045613|79469904|FG005|Overall Study|Adverse Event|0|||
44460995|NCT04045613|79469905|FG006|Overall Study|Adverse Event|1|||
44460996|NCT04045613|79469899|FG000|Overall Study|Withdrawal by Subject|0|||
44460997|NCT04045613|79469900|FG001|Overall Study|Withdrawal by Subject|5|||
44460998|NCT04045613|79469901|FG002|Overall Study|Withdrawal by Subject|0|||
44460999|NCT04045613|79469902|FG003|Overall Study|Withdrawal by Subject|0|||
44461000|NCT04045613|79469903|FG004|Overall Study|Withdrawal by Subject|0|||
44461001|NCT04045613|79469904|FG005|Overall Study|Withdrawal by Subject|1|||
44461002|NCT04045613|79469905|FG006|Overall Study|Withdrawal by Subject|0|||
44373627|NCT01076543|79378772|FG004|Overall Study|Withdrawal by Subject|0|||
44373628|NCT01076543|79378773|FG005|Overall Study|Withdrawal by Subject|0|||
44373629|NCT01072877|79378793|FG000|Overall Study|Lost to Follow-up|1|||
44373630|NCT01072877|79378794|FG001|Overall Study|Lost to Follow-up|1|||
44373631|NCT01072877|79378795|FG002|Overall Study|Lost to Follow-up|0|||
44373632|NCT01072877|79378796|FG003|Overall Study|Lost to Follow-up|2|||
44373633|NCT01072877|79378797|FG004|Overall Study|Lost to Follow-up|0|||
44373634|NCT00961896|79378814|FG000|Overall Study|Abnormal laboratory value|0|||
44373635|NCT00961896|79378815|FG001|Overall Study|Abnormal laboratory value|0|||
44373636|NCT00961896|79378816|FG002|Overall Study|Abnormal laboratory value|1|||
44461003|NCT04045613|79469899|FG000|Overall Study|Physician Decision|2|||
44461004|NCT04045613|79469900|FG001|Overall Study|Physician Decision|0|||
44461005|NCT04045613|79469901|FG002|Overall Study|Physician Decision|0|||
44461006|NCT04045613|79469902|FG003|Overall Study|Physician Decision|0|||
44461007|NCT04045613|79469903|FG004|Overall Study|Physician Decision|1|||
44219123|NCT01523301|79019016|FG000|Overall Study|Lack of Efficacy|0|||
44219124|NCT01523301|79019017|FG001|Overall Study|Lack of Efficacy|2|||
44461008|NCT04045613|79469904|FG005|Overall Study|Physician Decision|0|||
44461009|NCT04045613|79469905|FG006|Overall Study|Physician Decision|0|||
44219125|NCT01523301|79019016|FG000|Overall Study|Protocol Violation|3|||
44461010|NCT04045613|79469899|FG000|Overall Study|Death|3|||
44461011|NCT04045613|79469900|FG001|Overall Study|Death|0|||
44461012|NCT04045613|79469901|FG002|Overall Study|Death|0|||
44219126|NCT01523301|79019017|FG001|Overall Study|Protocol Violation|4|||
44219127|NCT01523301|79019016|FG000|Overall Study|Lost to Follow-up|1|||
44219128|NCT01523301|79019017|FG001|Overall Study|Lost to Follow-up|0|||
44219129|NCT01523301|79019016|FG000|Overall Study|Withdrawal by Subject|6|||
44219130|NCT01523301|79019017|FG001|Overall Study|Withdrawal by Subject|8|||
44219131|NCT01523301|79019016|FG000|Overall Study|Other Reason|0|||
44219132|NCT01523301|79019017|FG001|Overall Study|Other Reason|2|||
44219133|NCT01806506|79019025|FG000|Overall Study|Lost to Follow-up|2|||
44219134|NCT01806506|79019026|FG001|Overall Study|Lost to Follow-up|1|||
44219135|NCT01766336|79019034|FG000|Overall Study|Adverse Event|11|||
44219136|NCT01766336|79019035|FG001|Overall Study|Adverse Event|8|||
44219137|NCT01766336|79019034|FG000|Overall Study|Death|4|||
44219138|NCT01766336|79019035|FG001|Overall Study|Death|3|||
44219139|NCT01766336|79019034|FG000|Overall Study|Lost to Follow-up|1|||
44219140|NCT01766336|79019035|FG001|Overall Study|Lost to Follow-up|3|||
44219141|NCT01766336|79019034|FG000|Overall Study|Physician Decision|4|||
44219142|NCT01766336|79019035|FG001|Overall Study|Physician Decision|2|||
44219143|NCT01766336|79019034|FG000|Overall Study|Protocol Violation|0|||
44219144|NCT01766336|79019035|FG001|Overall Study|Protocol Violation|1|||
44219145|NCT01766336|79019034|FG000|Overall Study|Sponsor Decision|52|||
44219146|NCT01766336|79019035|FG001|Overall Study|Sponsor Decision|43|||
44219147|NCT01766336|79019034|FG000|Overall Study|Withdrawal by Subject|18|||
44219148|NCT01766336|79019035|FG001|Overall Study|Withdrawal by Subject|15|||
44219149|NCT01797536|79019045|FG000|Overall Study|Adverse Event|0|||
44219150|NCT01797536|79019046|FG001|Overall Study|Adverse Event|1|||
44219151|NCT01797536|79019047|FG002|Overall Study|Adverse Event|0|||
44219152|NCT01797536|79019048|FG003|Overall Study|Adverse Event|0|||
44219153|NCT01797302|79019061|FG000|Overall Study|Lost to Follow-up|16|||
44219154|NCT01797302|79019062|FG001|Overall Study|Lost to Follow-up|23|||
44219155|NCT01797302|79019063|FG002|Overall Study|Lost to Follow-up|22|||
44219156|NCT01797302|79019061|FG000|Overall Study|Withdrawal by Subject|1|||
44219157|NCT01797302|79019062|FG001|Overall Study|Withdrawal by Subject|3|||
44219158|NCT01797302|79019063|FG002|Overall Study|Withdrawal by Subject|4|||
44219159|NCT01805180|79019073|FG000|Lead-in Donor Phase|screen failure|1|||
44219160|NCT01805180|79019074|FG001|Lead-in Donor Phase|screen failure|0|||
44219161|NCT01805180|79019075|FG002|Lead-in Donor Phase|screen failure|0|||
44219162|NCT01804946|79019085|FG000|Overall Study|Protocol Violation|1|||
44219163|NCT01804946|79019086|FG001|Overall Study|Protocol Violation|0|||
44219164|NCT01804946|79019085|FG000|Overall Study|Adverse Event|0|||
44219165|NCT01804946|79019086|FG001|Overall Study|Adverse Event|1|||
44219166|NCT01804946|79019085|FG000|Overall Study|Insufficient data available|0|||
44219167|NCT01804946|79019086|FG001|Overall Study|Insufficient data available|1|||
44219168|NCT01804946|79019085|FG000|Overall Study|Do not meet inclusion criteria|1|||
44219169|NCT01804946|79019086|FG001|Overall Study|Do not meet inclusion criteria|2|||
44219170|NCT01737398|79019096|FG000|Overall Study|Adverse event or SAE|16|||
44219171|NCT01737398|79019097|FG001|Overall Study|Adverse event or SAE|1|||
44219172|NCT01737398|79019096|FG000|Overall Study|Stopping rule met|2|||
44219173|NCT01737398|79019097|FG001|Overall Study|Stopping rule met|1|||
44219174|NCT01737398|79019096|FG000|Overall Study|Voluntary withdrawal|2|||
44219175|NCT01737398|79019097|FG001|Overall Study|Voluntary withdrawal|3|||
44219176|NCT01737398|79019096|FG000|Overall Study|Ineligibility|1|||
44219177|NCT01737398|79019097|FG001|Overall Study|Ineligibility|0|||
44219178|NCT01737398|79019096|FG000|Overall Study|Liver transplant|1|||
44219179|NCT01737398|79019097|FG001|Overall Study|Liver transplant|0|||
44219180|NCT01737398|79019096|FG000|Overall Study|Disease progression|2|||
44219181|NCT01737398|79019097|FG001|Overall Study|Disease progression|3|||
44219182|NCT01737398|79019096|FG000|Overall Study|Sponsor's decision|2|||
44219183|NCT01737398|79019097|FG001|Overall Study|Sponsor's decision|0|||
44461013|NCT04045613|79469902|FG003|Overall Study|Death|0|||
44219184|NCT01795898|79019106|FG000|Overall Study|Adverse Event|27|||
44219185|NCT01795898|79019106|FG000|Overall Study|Lost to Follow-up|20|||
44219186|NCT01795898|79019106|FG000|Overall Study|Withdrawal of consent|6|||
44461014|NCT04045613|79469903|FG004|Overall Study|Death|0|||
44219187|NCT01795898|79019106|FG000|Overall Study|Diagnosed with metastasis|1|||
44219188|NCT01795898|79019106|FG000|Overall Study|No pain|1|||
44219189|NCT01795898|79019106|FG000|Overall Study|Death|1|||
44219190|NCT01795898|79019106|FG000|Overall Study|Withdrew consent & had adverse events|3|||
44219191|NCT01795898|79019106|FG000|Overall Study|Physician Decision|1|||
44219192|NCT01736696|79019117|FG000|Overall Study|Withdrawal by Subject|0|||
44461015|NCT04045613|79469904|FG005|Overall Study|Death|0|||
44219193|NCT01736696|79019118|FG001|Overall Study|Withdrawal by Subject|0|||
44219194|NCT01736696|79019119|FG002|Overall Study|Withdrawal by Subject|1|||
44219195|NCT01736696|79019120|FG003|Overall Study|Withdrawal by Subject|0|||
44219196|NCT01736696|79019121|FG004|Overall Study|Withdrawal by Subject|0|||
44219197|NCT01736696|79019122|FG005|Overall Study|Withdrawal by Subject|0|||
44219198|NCT01736696|79019123|FG006|Overall Study|Withdrawal by Subject|0|||
44219199|NCT01736540|79019147|FG000|Overall Study|Did not complete scan within 45 days|2|||
44219200|NCT01736540|79019147|FG000|Overall Study|Death|1|||
44219201|NCT01736540|79019147|FG000|Overall Study|Abnormal test procedure|1|||
44219202|NCT01736540|79019147|FG000|Overall Study|Withdrawal by Subject|5|||
44219203|NCT01736540|79019147|FG000|Overall Study|Protocol Violation|1|||
44219204|NCT01736540|79019147|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
44219205|NCT01736540|79019147|FG000|Overall Study|No show for MRI appointment|1|||
44219206|NCT01736540|79019147|FG000|Overall Study|Unable to make MRI appointment|3|||
44219207|NCT01794338|79019160|FG000|Overall Study|Death|2|||
44219208|NCT01794338|79019161|FG001|Overall Study|Death|0|||
44219209|NCT01794338|79019160|FG000|Overall Study|Lost to Follow-up|6|||
44219210|NCT01794338|79019161|FG001|Overall Study|Lost to Follow-up|9|||
44219211|NCT01609478|79019170|FG000|Overall Study|Adverse Event|3|||
44219212|NCT01609478|79019171|FG001|Overall Study|Adverse Event|1|||
44219213|NCT01609478|79019172|FG002|Overall Study|Adverse Event|5|||
44219214|NCT01609478|79019170|FG000|Overall Study|Protocol Deviation|0|||
44219215|NCT01609478|79019171|FG001|Overall Study|Protocol Deviation|1|||
44219216|NCT01609478|79019172|FG002|Overall Study|Protocol Deviation|1|||
44219217|NCT01609478|79019170|FG000|Overall Study|Non-Compliance with study treatment|1|||
44219218|NCT01609478|79019171|FG001|Overall Study|Non-Compliance with study treatment|0|||
44219219|NCT01609478|79019172|FG002|Overall Study|Non-Compliance with study treatment|0|||
44219220|NCT01609478|79019170|FG000|Overall Study|Physician Decision|1|||
44219221|NCT01609478|79019171|FG001|Overall Study|Physician Decision|0|||
44219222|NCT01609478|79019172|FG002|Overall Study|Physician Decision|1|||
44219223|NCT01609478|79019170|FG000|Overall Study|Withdrawal by Subject|2|||
44219224|NCT01609478|79019171|FG001|Overall Study|Withdrawal by Subject|0|||
44219225|NCT01609478|79019172|FG002|Overall Study|Withdrawal by Subject|2|||
44219226|NCT01764854|79019184|FG000|Overall Study|Adverse Event|0|||
44219227|NCT01764854|79019185|FG001|Overall Study|Adverse Event|0|||
44219228|NCT01764854|79019186|FG002|Overall Study|Adverse Event|2|||
44219229|NCT01764854|79019187|FG003|Overall Study|Adverse Event|0|||
44219230|NCT01764854|79019184|FG000|Overall Study|Withdrawal by Subject|0|||
44219231|NCT01764854|79019185|FG001|Overall Study|Withdrawal by Subject|0|||
44219232|NCT01764854|79019186|FG002|Overall Study|Withdrawal by Subject|1|||
44219233|NCT01764854|79019187|FG003|Overall Study|Withdrawal by Subject|0|||
44219234|NCT01764854|79019184|FG000|Overall Study|relocation|0|||
44219235|NCT01764854|79019185|FG001|Overall Study|relocation|0|||
44219236|NCT01764854|79019186|FG002|Overall Study|relocation|2|||
44219237|NCT01764854|79019187|FG003|Overall Study|relocation|0|||
44219238|NCT01764854|79019184|FG000|Overall Study|Protocol Violation|0|||
44219239|NCT01764854|79019185|FG001|Overall Study|Protocol Violation|0|||
44219240|NCT01764854|79019186|FG002|Overall Study|Protocol Violation|1|||
44219241|NCT01764854|79019187|FG003|Overall Study|Protocol Violation|2|||
44219242|NCT01764464|79019199|FG000|First Intervention|Withdrawal by Subject|1|||
44219243|NCT01764464|79019200|FG001|First Intervention|Withdrawal by Subject|0|||
44219244|NCT01764464|79019199|FG000|First Intervention|Lost to Follow-up|1|||
44219245|NCT01764464|79019200|FG001|First Intervention|Lost to Follow-up|0|||
44219246|NCT01764464|79019199|FG000|First Intervention|Adverse Event|0|||
44219247|NCT01764464|79019200|FG001|First Intervention|Adverse Event|2|||
44219248|NCT01764464|79019199|FG000|First Intervention|did not receive study drug|0|||
44219249|NCT01764464|79019200|FG001|First Intervention|did not receive study drug|1|||
44219250|NCT01764464|79019199|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
44219251|NCT01764464|79019200|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
44219252|NCT01764386|79019208|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
44219253|NCT01764386|79019209|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
44219254|NCT01764386|79019208|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
44219255|NCT01764386|79019209|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
44373637|NCT00957528|79378830|FG000|Overall Study|Protocol Violation|0|||
44219256|NCT01764386|79019208|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
44219257|NCT01764386|79019209|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
44219258|NCT01764386|79019208|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
44219259|NCT01764386|79019209|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
44219260|NCT01764386|79019208|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
44219261|NCT01764386|79019209|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
44219262|NCT01764386|79019208|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
44373638|NCT00957528|79378831|FG001|Overall Study|Protocol Violation|1|||
44373639|NCT00957528|79378832|FG002|Overall Study|Protocol Violation|0|||
44373640|NCT00957528|79378830|FG000|Overall Study|Withdrawal by Subject|0|||
44373641|NCT00957528|79378831|FG001|Overall Study|Withdrawal by Subject|0|||
44219263|NCT01764386|79019209|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
44219264|NCT01764386|79019208|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
44219265|NCT01764386|79019209|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
44219266|NCT01764386|79019208|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
44219267|NCT01764386|79019209|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
44219268|NCT01763918|79019220|FG000|Overall Study|Withdrawal by Subject|2|||
44219269|NCT01763918|79019221|FG001|Overall Study|Withdrawal by Subject|1|||
44219270|NCT01763918|79019222|FG002|Overall Study|Withdrawal by Subject|1|||
44219271|NCT01763918|79019223|FG003|Overall Study|Withdrawal by Subject|2|||
44219272|NCT01763918|79019220|FG000|Overall Study|Sponsor Decision|4|||
44219273|NCT01763918|79019221|FG001|Overall Study|Sponsor Decision|0|||
44219274|NCT01763918|79019222|FG002|Overall Study|Sponsor Decision|9|||
44219275|NCT01763918|79019223|FG003|Overall Study|Sponsor Decision|0|||
44219276|NCT01763684|79019235|FG000|Overall Study|Study terminated early due to low enrollment|126|||
44219277|NCT01763684|79019236|FG001|Overall Study|Study terminated early due to low enrollment|127|||
44219278|NCT01763684|79019235|FG000|Overall Study|Study surgery not performed|7|||
44219279|NCT01763684|79019236|FG001|Overall Study|Study surgery not performed|6|||
44219280|NCT01606748|79019244|FG000|Overall Study|Adverse Event|1|||
44219281|NCT01606748|79019245|FG001|Overall Study|Adverse Event|0|||
44219282|NCT01606748|79019244|FG000|Overall Study|Progressive Disease|1|||
44219283|NCT01606748|79019245|FG001|Overall Study|Progressive Disease|0|||
44219284|NCT01606748|79019244|FG000|Overall Study|Withdrawal by Subject|1|||
44219285|NCT01606748|79019245|FG001|Overall Study|Withdrawal by Subject|0|||
44219286|NCT01597622|79019263|FG000|Overall Study|Adverse Event|7|||
44219287|NCT01597622|79019263|FG000|Overall Study|Lack of Efficacy|3|||
44219288|NCT01597622|79019263|FG000|Overall Study|Protocol Violation|1|||
44219289|NCT01597622|79019263|FG000|Overall Study|Lost to Follow-up|1|||
44219290|NCT01597622|79019263|FG000|Overall Study|Investigator Discretion|5|||
44219291|NCT01597622|79019263|FG000|Overall Study|Withdrawal by Subject|20|||
44219292|NCT01597622|79019263|FG000|Overall Study|Death|1|||
44219293|NCT01761266|79019269|FG000|Overall Study|Death|415|||
44219294|NCT01761266|79019270|FG001|Overall Study|Death|402|||
44219295|NCT01761266|79019269|FG000|Overall Study|Lost to Follow-up|8|||
44219296|NCT01761266|79019270|FG001|Overall Study|Lost to Follow-up|12|||
44219297|NCT01761266|79019269|FG000|Overall Study|Withdrawal by Subject|14|||
44219298|NCT01761266|79019270|FG001|Overall Study|Withdrawal by Subject|10|||
44219299|NCT01761266|79019269|FG000|Overall Study|Sponsor Decision|41|||
44219300|NCT01761266|79019270|FG001|Overall Study|Sponsor Decision|52|||
44219301|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
44219302|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
44219303|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
44219304|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
44219305|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Adverse Event|5|||
44219306|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Adverse Event|3|||
44219307|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Adverse Event|4|||
44219308|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Adverse Event|10|||
44219309|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
44219310|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
44219311|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
44219312|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
44219313|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
44219314|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
44219315|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
44219316|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
44219317|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Pregnancy|5|||
44219318|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Pregnancy|0|||
44219319|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Pregnancy|3|||
44219320|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Pregnancy|2|||
44219321|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Non-compliance|1|||
44219322|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Non-compliance|4|||
44219323|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Non-compliance|0|||
44219324|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Non-compliance|3|||
44219325|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Other|0|||
44373642|NCT00957528|79378832|FG002|Overall Study|Withdrawal by Subject|1|||
44219326|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Other|3|||
44219327|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Other|3|||
44219328|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Other|1|||
44373643|NCT00958776|79378842|FG000|Overall Study|Adverse Event|0|||
44219329|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
44219330|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
44219331|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
44219332|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
44219333|NCT01760954|79019283|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
44219334|NCT01760954|79019284|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
44219335|NCT01760954|79019285|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
44219336|NCT01760954|79019286|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
44219337|NCT01760954|79019283|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
44219338|NCT01760954|79019284|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
44219339|NCT01760954|79019285|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
44219340|NCT01760954|79019286|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
44219341|NCT01760954|79019283|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
44219342|NCT01760954|79019284|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
44219343|NCT01760954|79019285|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
44219344|NCT01760954|79019286|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
44461016|NCT04045613|79469905|FG006|Overall Study|Death|1|||
44461017|NCT04045613|79469899|FG000|Overall Study|Other reasons|0|||
44461018|NCT04045613|79469900|FG001|Overall Study|Other reasons|1|||
44461019|NCT04045613|79469901|FG002|Overall Study|Other reasons|0|||
44461020|NCT04045613|79469902|FG003|Overall Study|Other reasons|0|||
44461021|NCT04045613|79469903|FG004|Overall Study|Other reasons|0|||
44461022|NCT04045613|79469904|FG005|Overall Study|Other reasons|0|||
44461023|NCT04045613|79469905|FG006|Overall Study|Other reasons|1|||
44461024|NCT04045613|79469899|FG000|Overall Study|Progressive disease: Clinical progression|1|||
44461025|NCT04045613|79469900|FG001|Overall Study|Progressive disease: Clinical progression|0|||
44461026|NCT04045613|79469901|FG002|Overall Study|Progressive disease: Clinical progression|3|||
44461027|NCT04045613|79469902|FG003|Overall Study|Progressive disease: Clinical progression|1|||
44461028|NCT04045613|79469903|FG004|Overall Study|Progressive disease: Clinical progression|1|||
44461029|NCT04045613|79469904|FG005|Overall Study|Progressive disease: Clinical progression|3|||
44461030|NCT04045613|79469905|FG006|Overall Study|Progressive disease: Clinical progression|3|||
44461031|NCT04045613|79469899|FG000|Overall Study|Progressive disease: Radiological progression|24|||
44461032|NCT04045613|79469900|FG001|Overall Study|Progressive disease: Radiological progression|6|||
44219345|NCT01760954|79019283|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
44219346|NCT01760954|79019284|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
44219347|NCT01760954|79019285|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
44219348|NCT01760954|79019286|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
44219349|NCT01760954|79019283|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
44219350|NCT01760954|79019284|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
44219351|NCT01760954|79019285|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
44219352|NCT01760954|79019286|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
44219353|NCT01760954|79019283|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
44219354|NCT01760954|79019284|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
44219355|NCT01760954|79019285|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
44219356|NCT01760954|79019286|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
44219357|NCT01760954|79019283|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
44219358|NCT01760954|79019284|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
44219359|NCT01760954|79019285|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
44219360|NCT01760954|79019286|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
44219361|NCT01760876|79019296|FG000|Overall Study|Non-cardiac death (head injury)|1|||
44373644|NCT00958776|79378843|FG001|Overall Study|Adverse Event|1|||
44373645|NCT00958776|79378842|FG000|Overall Study|Physician Decision|1|||
44373646|NCT00958776|79378843|FG001|Overall Study|Physician Decision|0|||
44373647|NCT00958776|79378842|FG000|Overall Study|Lost to Follow-up|2|||
44373648|NCT00958776|79378843|FG001|Overall Study|Lost to Follow-up|6|||
44373649|NCT00958776|79378842|FG000|Overall Study|Withdrawal by Subject|7|||
44373650|NCT00958776|79378843|FG001|Overall Study|Withdrawal by Subject|16|||
44373651|NCT00958776|79378842|FG000|Overall Study|Protocol Violation|1|||
44373652|NCT00958776|79378843|FG001|Overall Study|Protocol Violation|1|||
44373653|NCT00958776|79378842|FG000|Overall Study|Death|2|||
44373654|NCT00958776|79378843|FG001|Overall Study|Death|1|||
44373655|NCT00958776|79378842|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
44373656|NCT00958776|79378843|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
44373657|NCT00958776|79378842|FG000|Overall Study|Missing|1|||
44461033|NCT04045613|79469901|FG002|Overall Study|Progressive disease: Radiological progression|8|||
44461034|NCT04045613|79469902|FG003|Overall Study|Progressive disease: Radiological progression|0|||
44373658|NCT00958776|79378843|FG001|Overall Study|Missing|1|||
44373659|NCT00596830|79378852|FG000|Overall Study|Death|258|||
44373660|NCT00596830|79378853|FG001|Overall Study|Death|247|||
44373661|NCT00596830|79378852|FG000|Overall Study|Lost to Follow-up|7|||
44219362|NCT01760876|79019296|FG000|Overall Study|Carcinoma of prostate|1|||
44219363|NCT01760876|79019296|FG000|Overall Study|Impaired renal function|1|||
44219364|NCT01760876|79019296|FG000|Overall Study|Major depression|1|||
44219365|NCT01760876|79019296|FG000|Overall Study|Very poor baseline OCT quality|2|||
44219366|NCT01759862|79019302|FG000|Overall Study|Physician Decision|3|||
44219367|NCT01759862|79019303|FG001|Overall Study|Physician Decision|1|||
44219368|NCT01759862|79019302|FG000|Overall Study|Adverse Event|0|||
44219369|NCT01759862|79019303|FG001|Overall Study|Adverse Event|1|||
44219370|NCT01606670|79019309|FG000|Overall Study|Adverse Event|6|||
44219371|NCT01606670|79019309|FG000|Overall Study|Lack of Efficacy|2|||
44219372|NCT01606670|79019309|FG000|Overall Study|Lost to Follow-up|3|||
44219373|NCT01606670|79019309|FG000|Overall Study|Withdrawal by Subject|3|||
44219374|NCT01606670|79019309|FG000|Overall Study|Other Reason|2|||
44219375|NCT01793792|79019313|FG000|Overall Study|Death|5|||
44219376|NCT01793792|79019313|FG000|Overall Study|Lost to Follow-up|5|||
44219377|NCT01793792|79019313|FG000|Overall Study|Withdrawal by Subject|1|||
44219378|NCT01793792|79019313|FG000|Overall Study|Device Not Implanted|1|||
44219379|NCT01790984|79019319|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
44219380|NCT01790984|79019320|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
44219381|NCT01790984|79019321|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
44219382|NCT01790984|79019322|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
44219383|NCT01735994|79019347|FG000|Overall Study|Withdrawal by Subject|6|||
44219384|NCT01735994|79019348|FG001|Overall Study|Withdrawal by Subject|4|||
44219385|NCT01735994|79019347|FG000|Overall Study|Injury|2|||
44219386|NCT01735994|79019348|FG001|Overall Study|Injury|0|||
44219387|NCT01735994|79019347|FG000|Overall Study|Kicked off team|5|||
44219388|NCT01735994|79019348|FG001|Overall Study|Kicked off team|0|||
44219389|NCT01735994|79019347|FG000|Overall Study|Lost to Follow-up|50|||
44219390|NCT01735994|79019348|FG001|Overall Study|Lost to Follow-up|62|||
44219391|NCT01790828|79019354|FG000|Overall Study|Other|34|||
44219392|NCT01790594|79019360|FG000|Overall Study|Death|1|||
44219393|NCT01790594|79019361|FG001|Overall Study|Death|0|||
44219394|NCT01790594|79019362|FG002|Overall Study|Death|0|||
44219395|NCT01790594|79019360|FG000|Overall Study|Physician Decision|2|||
44219396|NCT01790594|79019361|FG001|Overall Study|Physician Decision|1|||
44219397|NCT01790594|79019362|FG002|Overall Study|Physician Decision|0|||
44219398|NCT01790594|79019360|FG000|Overall Study|Withdrawal by Subject|2|||
44219399|NCT01790594|79019361|FG001|Overall Study|Withdrawal by Subject|0|||
44219400|NCT01790594|79019362|FG002|Overall Study|Withdrawal by Subject|0|||
44219401|NCT01790594|79019360|FG000|Overall Study|Transplant was not done|0|||
44219402|NCT01790594|79019361|FG001|Overall Study|Transplant was not done|0|||
44219403|NCT01790594|79019362|FG002|Overall Study|Transplant was not done|3|||
44219404|NCT01790594|79019360|FG000|Overall Study|Terminated prior to week 76|0|||
44219405|NCT01790594|79019361|FG001|Overall Study|Terminated prior to week 76|2|||
44219406|NCT01790594|79019362|FG002|Overall Study|Terminated prior to week 76|0|||
44219407|NCT01790516|79019371|FG000|Overall Study|Physician Decision|1|||
44219408|NCT01790516|79019372|FG001|Overall Study|Physician Decision|0|||
44219409|NCT01790438|79019380|FG000|Overall Study|Adverse Event|3|||
44219410|NCT01790438|79019381|FG001|Overall Study|Adverse Event|2|||
44219411|NCT01790438|79019380|FG000|Overall Study|Death|4|||
44219412|NCT01790438|79019381|FG001|Overall Study|Death|0|||
44219413|NCT01790438|79019380|FG000|Overall Study|Lost to Follow-up|5|||
44219414|NCT01790438|79019381|FG001|Overall Study|Lost to Follow-up|2|||
44219415|NCT01790438|79019380|FG000|Overall Study|Withdrawal by Subject|13|||
44219416|NCT01790438|79019381|FG001|Overall Study|Withdrawal by Subject|2|||
44219417|NCT01790438|79019380|FG000|Overall Study|Physician Decision|3|||
44219418|NCT01790438|79019381|FG001|Overall Study|Physician Decision|1|||
44219419|NCT01790438|79019380|FG000|Overall Study|Sponsor Decision|0|||
44270291|NCT02326272|79195770|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44219420|NCT01790438|79019381|FG001|Overall Study|Sponsor Decision|3|||
44219421|NCT01790438|79019380|FG000|Overall Study|Protocol Required Discontinuation|7|||
44270292|NCT02326272|79195771|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270293|NCT02326272|79195772|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44277792|NCT02138214|79238785|FG000|Overall Study|Lost to Follow-up|0|||
44219422|NCT01790438|79019381|FG001|Overall Study|Protocol Required Discontinuation|1|||
44219423|NCT01735916|79019392|FG000|Overall Study|Subject not eligible to be randomized|11|||
44219424|NCT01735916|79019393|FG001|Overall Study|Subject not eligible to be randomized|0|||
44219425|NCT01735916|79019394|FG002|Overall Study|Subject not eligible to be randomized|0|||
44219426|NCT01735916|79019392|FG000|Overall Study|Early termination of study by sponsor|4|||
44219427|NCT01735916|79019393|FG001|Overall Study|Early termination of study by sponsor|19|||
44219428|NCT01735916|79019394|FG002|Overall Study|Early termination of study by sponsor|7|||
44219429|NCT01735916|79019392|FG000|Overall Study|Withdrawal by Subject|3|||
44219430|NCT01735916|79019393|FG001|Overall Study|Withdrawal by Subject|0|||
44219431|NCT01735916|79019394|FG002|Overall Study|Withdrawal by Subject|0|||
44219432|NCT01790126|79019404|FG000|Overall Study|PSA Progression|12|||
44219433|NCT01790126|79019405|FG001|Overall Study|PSA Progression|16|||
44219434|NCT01790126|79019406|FG002|Overall Study|PSA Progression|16|||
44219435|NCT01790126|79019404|FG000|Overall Study|Other|5|||
44219436|NCT01790126|79019405|FG001|Overall Study|Other|4|||
44219437|NCT01790126|79019406|FG002|Overall Study|Other|8|||
44219438|NCT01790126|79019404|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
44219439|NCT01790126|79019405|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
44219440|NCT01790126|79019406|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
44219441|NCT01790126|79019404|FG000|Overall Study|Withdrawal by Physician|1|||
44219442|NCT01790126|79019405|FG001|Overall Study|Withdrawal by Physician|1|||
44219443|NCT01790126|79019406|FG002|Overall Study|Withdrawal by Physician|2|||
44219444|NCT01790126|79019404|FG000|Overall Study|Withdrawal by Subject|3|||
44219445|NCT01790126|79019405|FG001|Overall Study|Withdrawal by Subject|1|||
44219446|NCT01790126|79019406|FG002|Overall Study|Withdrawal by Subject|2|||
44219447|NCT01790126|79019404|FG000|Overall Study|Lost to Follow-up|1|||
44219448|NCT01790126|79019405|FG001|Overall Study|Lost to Follow-up|0|||
44219449|NCT01790126|79019406|FG002|Overall Study|Lost to Follow-up|1|||
44219450|NCT01790126|79019404|FG000|Overall Study|Adverse Event|0|||
44219451|NCT01790126|79019405|FG001|Overall Study|Adverse Event|2|||
44219452|NCT01790126|79019406|FG002|Overall Study|Adverse Event|0|||
44219453|NCT01790126|79019404|FG000|Overall Study|Death|2|||
44219454|NCT01790126|79019405|FG001|Overall Study|Death|0|||
44219455|NCT01790126|79019406|FG002|Overall Study|Death|0|||
44219456|NCT01790126|79019404|FG000|Overall Study|Radiographic Progression|3|||
44219457|NCT01790126|79019405|FG001|Overall Study|Radiographic Progression|1|||
44219458|NCT01790126|79019406|FG002|Overall Study|Radiographic Progression|0|||
44219459|NCT01734902|79019417|FG000|Overall Study|Other than listed|0|||
44219460|NCT01734902|79019418|FG001|Overall Study|Other than listed|2|||
44219461|NCT01790048|79019426|FG000|Overall Study|Incorrect Age|9|||
44219462|NCT01790048|79019427|FG001|Overall Study|Incorrect Age|14|||
44219463|NCT01790048|79019426|FG000|Overall Study|data entry error|0|||
44373662|NCT00596830|79378853|FG001|Overall Study|Lost to Follow-up|11|||
44373663|NCT00596830|79378852|FG000|Overall Study|Withdrawal by Subject|22|||
44373664|NCT00596830|79378853|FG001|Overall Study|Withdrawal by Subject|12|||
44373665|NCT00596830|79378852|FG000|Overall Study|Study terminated by sponsor|51|||
44373666|NCT00596830|79378853|FG001|Overall Study|Study terminated by sponsor|62|||
44461035|NCT04045613|79469903|FG004|Overall Study|Progressive disease: Radiological progression|6|||
44461036|NCT04045613|79469904|FG005|Overall Study|Progressive disease: Radiological progression|6|||
44373667|NCT00596830|79378852|FG000|Overall Study|Follow-up was discontinued|1|||
44373668|NCT00596830|79378853|FG001|Overall Study|Follow-up was discontinued|0|||
44373669|NCT00596830|79378852|FG000|Overall Study|Randomized but not treated|3|||
44373670|NCT00596830|79378853|FG001|Overall Study|Randomized but not treated|7|||
44373671|NCT00957372|79378862|FG000|PART I|Lost to Follow-up|0|||
44373672|NCT00957372|79378863|FG001|PART I|Lost to Follow-up|0|||
44373673|NCT00957372|79378864|FG002|PART I|Lost to Follow-up|1|||
44373674|NCT00957372|79378865|FG003|PART I|Lost to Follow-up|0|||
44373675|NCT00957372|79378862|FG000|PART II|Withdrawal by Subject|0|||
44373676|NCT00957372|79378863|FG001|PART II|Withdrawal by Subject|0|||
44373677|NCT00957372|79378864|FG002|PART II|Withdrawal by Subject|0|||
44373678|NCT00957372|79378865|FG003|PART II|Withdrawal by Subject|8|||
44373679|NCT00957372|79378862|FG000|PART II|Physician Decision|0|||
44373680|NCT00957372|79378863|FG001|PART II|Physician Decision|0|||
44373681|NCT00957372|79378864|FG002|PART II|Physician Decision|0|||
44373682|NCT00957372|79378865|FG003|PART II|Physician Decision|1|||
44219464|NCT01790048|79019427|FG001|Overall Study|data entry error|1|||
44219465|NCT01790048|79019426|FG000|Overall Study|Other|0|||
44219466|NCT01790048|79019427|FG001|Overall Study|Other|2|||
44219467|NCT01790048|79019426|FG000|Overall Study|SAM at Enrollment|2|||
44219468|NCT01790048|79019427|FG001|Overall Study|SAM at Enrollment|0|||
44219469|NCT01790048|79019426|FG000|Overall Study|Measurement error|1|||
44219470|NCT01790048|79019427|FG001|Overall Study|Measurement error|0|||
44219471|NCT01789970|79019437|FG000|Open-label Titration Period|Adverse Event|68|||
44219472|NCT01789970|79019438|FG001|Open-label Titration Period|Adverse Event|0|||
44219473|NCT01789970|79019439|FG002|Open-label Titration Period|Adverse Event|0|||
44373683|NCT00957372|79378862|FG000|PART II|Pregnancy|0|||
44373684|NCT00957372|79378863|FG001|PART II|Pregnancy|0|||
44373685|NCT00957372|79378864|FG002|PART II|Pregnancy|0|||
44373686|NCT00957372|79378865|FG003|PART II|Pregnancy|1|||
44544190|NCT02729896|79557452|FG000|Overall Study|Withdrawal by Subject|1|||
44373687|NCT00957372|79378862|FG000|PART II|Not Know|0|||
44219474|NCT01789970|79019437|FG000|Open-label Titration Period|Lack of Efficacy|31|||
44219475|NCT01789970|79019438|FG001|Open-label Titration Period|Lack of Efficacy|0|||
44219476|NCT01789970|79019439|FG002|Open-label Titration Period|Lack of Efficacy|0|||
44219477|NCT01789970|79019437|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
44219478|NCT01789970|79019438|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
44219479|NCT01789970|79019439|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
44219480|NCT01789970|79019437|FG000|Open-label Titration Period|Protocol Violation|18|||
44219481|NCT01789970|79019438|FG001|Open-label Titration Period|Protocol Violation|0|||
44219482|NCT01789970|79019439|FG002|Open-label Titration Period|Protocol Violation|0|||
44219483|NCT01789970|79019437|FG000|Open-label Titration Period|Lost to Follow-up|5|||
44219484|NCT01789970|79019438|FG001|Open-label Titration Period|Lost to Follow-up|0|||
44219485|NCT01789970|79019439|FG002|Open-label Titration Period|Lost to Follow-up|0|||
44219486|NCT01789970|79019437|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
44219487|NCT01789970|79019438|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
44219488|NCT01789970|79019439|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
44219489|NCT01789970|79019437|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
44219490|NCT01789970|79019438|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
44219491|NCT01789970|79019439|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
44219492|NCT01789970|79019437|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
44219493|NCT01789970|79019438|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
44219494|NCT01789970|79019439|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
44219495|NCT01789970|79019437|FG000|Open-label Titration Period|Pregnancy|2|||
44219496|NCT01789970|79019438|FG001|Open-label Titration Period|Pregnancy|0|||
44219497|NCT01789970|79019439|FG002|Open-label Titration Period|Pregnancy|0|||
44219498|NCT01789970|79019437|FG000|Open-label Titration Period|Other|76|||
44219499|NCT01789970|79019438|FG001|Open-label Titration Period|Other|0|||
44219500|NCT01789970|79019439|FG002|Open-label Titration Period|Other|0|||
44219501|NCT01789970|79019437|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
44219502|NCT01789970|79019438|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
44219503|NCT01789970|79019439|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
44219504|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
44219505|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
44219506|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
44219507|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
44219508|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
44219509|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
44219510|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
44219511|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
44219512|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
44219513|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
44219514|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
44219515|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
44219516|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
44219517|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
44219518|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
44219519|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
44219520|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
44219521|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
44219522|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
44219523|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
44219524|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
44219525|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
44219526|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
44219527|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
44219528|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
44219529|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
44219530|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
44219531|NCT01789970|79019437|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
44219532|NCT01789970|79019438|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
44219533|NCT01789970|79019439|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
44373688|NCT00957372|79378863|FG001|PART II|Not Know|0|||
44373689|NCT00957372|79378864|FG002|PART II|Not Know|0|||
44219534|NCT01734434|79019457|FG000|Overall Study|Death Infant|3|||
44219535|NCT01734434|79019458|FG001|Overall Study|Death Infant|1|||
44219536|NCT01734434|79019459|FG002|Overall Study|Death Infant|17|||
44219537|NCT01734434|79019460|FG003|Overall Study|Death Infant|5|||
44219538|NCT01734434|79019457|FG000|Overall Study|Lost to Follow-up|2|||
44219539|NCT01734434|79019458|FG001|Overall Study|Lost to Follow-up|9|||
44219540|NCT01734434|79019459|FG002|Overall Study|Lost to Follow-up|67|||
44219541|NCT01734434|79019460|FG003|Overall Study|Lost to Follow-up|11|||
44219542|NCT01734434|79019457|FG000|Overall Study|No Live Birth|1|||
44219543|NCT01734434|79019458|FG001|Overall Study|No Live Birth|2|||
44219544|NCT01734434|79019459|FG002|Overall Study|No Live Birth|32|||
44219545|NCT01734434|79019460|FG003|Overall Study|No Live Birth|6|||
44219546|NCT01734434|79019457|FG000|Overall Study|Withdrawal by Subject|4|||
44219547|NCT01734434|79019458|FG001|Overall Study|Withdrawal by Subject|0|||
44219548|NCT01734434|79019459|FG002|Overall Study|Withdrawal by Subject|8|||
44219549|NCT01734434|79019460|FG003|Overall Study|Withdrawal by Subject|1|||
44219550|NCT01734434|79019457|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
44219551|NCT01734434|79019458|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
44219552|NCT01734434|79019459|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
44219553|NCT01734434|79019460|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
44219554|NCT01734434|79019457|FG000|Overall Study|Subject Not Reachable|0|||
44219555|NCT01734434|79019458|FG001|Overall Study|Subject Not Reachable|0|||
44219556|NCT01734434|79019459|FG002|Overall Study|Subject Not Reachable|1|||
44219557|NCT01734434|79019460|FG003|Overall Study|Subject Not Reachable|0|||
44461037|NCT04045613|79469905|FG006|Overall Study|Progressive disease: Radiological progression|11|||
44461038|NCT03964207|79469935|FG000|First Treatment|Withdrawal by Subject|1|||
44461039|NCT03964207|79469936|FG001|First Treatment|Withdrawal by Subject|2|||
44461040|NCT03964207|79469935|FG000|First Treatment|Protocol Violation|1|||
44461041|NCT03964207|79469936|FG001|First Treatment|Protocol Violation|0|||
44461042|NCT03964207|79469935|FG000|First Treatment|Lost to Follow-up|1|||
44461043|NCT03964207|79469936|FG001|First Treatment|Lost to Follow-up|0|||
44461044|NCT03964207|79469935|FG000|Second Treatment|Lost to Follow-up|0|||
44461045|NCT03964207|79469936|FG001|Second Treatment|Lost to Follow-up|1|||
44461046|NCT03964207|79469935|FG000|Second Treatment|Adverse Event|1|||
44461047|NCT03964207|79469936|FG001|Second Treatment|Adverse Event|2|||
44461048|NCT03947255|79469945|FG000|Overall Study|Study Closure by Sponsor|2|||
44461049|NCT03947255|79469946|FG001|Overall Study|Study Closure by Sponsor|2|||
44461050|NCT03947255|79469945|FG000|Overall Study|Withdrawal by Subject|2|||
44461051|NCT03947255|79469946|FG001|Overall Study|Withdrawal by Subject|2|||
44461052|NCT03947255|79469945|FG000|Overall Study|Lost to Follow-up|2|||
44461053|NCT03947255|79469946|FG001|Overall Study|Lost to Follow-up|0|||
44461054|NCT03947255|79469945|FG000|Overall Study|Death|0|||
44461055|NCT03947255|79469946|FG001|Overall Study|Death|2|||
44461056|NCT03929757|79469954|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
44461057|NCT03929757|79469955|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
44461058|NCT03929757|79469956|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
44461059|NCT03929757|79469954|FG000|Main Study: Up to Day 365|Other|1|||
44461060|NCT03929757|79469955|FG001|Main Study: Up to Day 365|Other|0|||
44461061|NCT03929757|79469956|FG002|Main Study: Up to Day 365|Other|0|||
44461062|NCT03929757|79469954|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
44461063|NCT03929757|79469955|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
44461064|NCT03929757|79469956|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
44219558|NCT01734434|79019457|FG000|Overall Study|Treatment Defaulter|0|||
44219559|NCT01734434|79019458|FG001|Overall Study|Treatment Defaulter|0|||
44219560|NCT01734434|79019459|FG002|Overall Study|Treatment Defaulter|1|||
44219561|NCT01734434|79019460|FG003|Overall Study|Treatment Defaulter|0|||
44219562|NCT01734434|79019457|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
44219563|NCT01734434|79019458|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
44219564|NCT01734434|79019459|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
44219565|NCT01734434|79019460|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
44219566|NCT01734434|79019457|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
44219567|NCT01734434|79019458|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
44461065|NCT03748823|79469965|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
44461066|NCT03748823|79469966|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
44219568|NCT01734434|79019459|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
44219569|NCT01734434|79019460|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
44461067|NCT03748823|79469965|FG000|Extension Period|Withdrawal by Subject|1|||
44461068|NCT03748823|79469966|FG001|Extension Period|Withdrawal by Subject|2|||
44219570|NCT01788566|79019478|FG000|Overall Study|Death|4|||
44219571|NCT01788566|79019478|FG000|Overall Study|Adverse Event|1|||
44219572|NCT01788566|79019478|FG000|Overall Study|Clinical Progressive Disease|3|||
44219573|NCT01733732|79019484|FG000|Overall Study|Adverse Event|1|||
44219574|NCT01733732|79019485|FG001|Overall Study|Adverse Event|0|||
44461069|NCT03748823|79469965|FG000|Extension Period|Death|0|||
44461070|NCT03748823|79469966|FG001|Extension Period|Death|1|||
44219575|NCT01733732|79019484|FG000|Overall Study|Did not attend all study visits|1|||
44219576|NCT01733732|79019485|FG001|Overall Study|Did not attend all study visits|0|||
44219577|NCT01732874|79019503|FG000|Overall Study|Withdrawal by Subject|5|||
44219578|NCT01732874|79019504|FG001|Overall Study|Withdrawal by Subject|1|||
44219579|NCT01732874|79019503|FG000|Overall Study|Death of Infant|3|||
44219580|NCT01732874|79019504|FG001|Overall Study|Death of Infant|2|||
44219581|NCT01732796|79019513|FG000|Overall Study|Adverse Event|16|||
44219582|NCT01732796|79019514|FG001|Overall Study|Adverse Event|16|||
44219583|NCT01732796|79019515|FG002|Overall Study|Adverse Event|4|||
44219584|NCT01732796|79019513|FG000|Overall Study|Lack of Efficacy|21|||
44219585|NCT01732796|79019514|FG001|Overall Study|Lack of Efficacy|18|||
44219586|NCT01732796|79019515|FG002|Overall Study|Lack of Efficacy|5|||
44219587|NCT01732796|79019513|FG000|Overall Study|Lost to Follow-up|2|||
44219588|NCT01732796|79019514|FG001|Overall Study|Lost to Follow-up|0|||
44219589|NCT01732796|79019515|FG002|Overall Study|Lost to Follow-up|0|||
44219590|NCT01732796|79019513|FG000|Overall Study|Withdrawal by Subject|6|||
44219591|NCT01732796|79019514|FG001|Overall Study|Withdrawal by Subject|8|||
44219592|NCT01732796|79019515|FG002|Overall Study|Withdrawal by Subject|2|||
44219593|NCT01732796|79019513|FG000|Overall Study|Other reason not defined above|1|||
44219594|NCT01732796|79019514|FG001|Overall Study|Other reason not defined above|0|||
44219595|NCT01732796|79019515|FG002|Overall Study|Other reason not defined above|2|||
44219596|NCT01732640|79019525|FG000|Overall Study|Adverse Event|0|||
44219597|NCT01732640|79019526|FG001|Overall Study|Adverse Event|1|||
44219598|NCT01732640|79019525|FG000|Overall Study|Death|0|||
44219599|NCT01732640|79019526|FG001|Overall Study|Death|1|||
44219600|NCT01732484|79019536|FG000|Overall Study|Death|7|||
44219601|NCT01732484|79019536|FG000|Overall Study|Lost to Follow-up|14|||
44219602|NCT01732484|79019536|FG000|Overall Study|chronical illness|5|||
44219603|NCT01786148|79019544|FG000|Overall Study|Lost to Follow-up|21|||
44219604|NCT01786148|79019545|FG001|Overall Study|Lost to Follow-up|13|||
44219605|NCT01786148|79019544|FG000|Overall Study|Death|0|||
44219606|NCT01786148|79019545|FG001|Overall Study|Death|1|||
44219607|NCT01786148|79019544|FG000|Overall Study|Withdrawal by Subject|0|||
44219608|NCT01786148|79019545|FG001|Overall Study|Withdrawal by Subject|7|||
44219609|NCT01786148|79019544|FG000|Overall Study|Incarceration|1|||
44219610|NCT01786148|79019545|FG001|Overall Study|Incarceration|1|||
44219611|NCT01785602|79019557|FG000|Overall Study|Withdrawal by Subject|2|||
44219612|NCT01785602|79019558|FG001|Overall Study|Withdrawal by Subject|0|||
44219613|NCT01785602|79019557|FG000|Overall Study|Lost to Follow-up|1|||
44219614|NCT01785602|79019558|FG001|Overall Study|Lost to Follow-up|1|||
44219615|NCT01785602|79019557|FG000|Overall Study|Adverse Event|3|||
44219616|NCT01785602|79019558|FG001|Overall Study|Adverse Event|5|||
44219617|NCT01785602|79019557|FG000|Overall Study|Administrative problems|7|||
44219618|NCT01785602|79019558|FG001|Overall Study|Administrative problems|3|||
44219619|NCT01785524|79019566|FG000|Overall Study|Withdrawal by Subject|2|||
44219620|NCT01785524|79019567|FG001|Overall Study|Withdrawal by Subject|2|||
44219621|NCT01757288|79019576|FG000|Overall Study|Consent withdrawal|0|||
44544191|NCT02729896|79557453|FG001|Overall Study|Withdrawal by Subject|0|||
44219622|NCT01757288|79019577|FG001|Overall Study|Consent withdrawal|4|||
44219623|NCT01757288|79019578|FG002|Overall Study|Consent withdrawal|4|||
44219624|NCT01757288|79019576|FG000|Overall Study|Patient off study, IRB hold.|0|||
44219625|NCT01757288|79019577|FG001|Overall Study|Patient off study, IRB hold.|0|||
44219626|NCT01757288|79019578|FG002|Overall Study|Patient off study, IRB hold.|1|||
44219627|NCT01757288|79019576|FG000|Overall Study|Patient death prior to starting treatment|0|||
44373690|NCT00957372|79378865|FG003|PART II|Not Know|20|||
44373691|NCT00957372|79378862|FG000|PART II|Adverse Event|0|||
44373692|NCT00957372|79378863|FG001|PART II|Adverse Event|0|||
44373693|NCT00957372|79378864|FG002|PART II|Adverse Event|0|||
44373694|NCT00957372|79378865|FG003|PART II|Adverse Event|10|||
44373695|NCT00957372|79378862|FG000|PART II|Patient non-compliance|0|||
44373696|NCT00957372|79378863|FG001|PART II|Patient non-compliance|0|||
44373697|NCT00957372|79378864|FG002|PART II|Patient non-compliance|0|||
44373698|NCT00957372|79378865|FG003|PART II|Patient non-compliance|4|||
44373699|NCT00952848|79378881|FG000|Overall Study|Withdrawal by Subject|4|||
44219628|NCT01757288|79019577|FG001|Overall Study|Patient death prior to starting treatment|0|||
44219629|NCT01757288|79019578|FG002|Overall Study|Patient death prior to starting treatment|1|||
44219630|NCT01757288|79019576|FG000|Overall Study|Wrong medication administered|0|||
44219631|NCT01757288|79019577|FG001|Overall Study|Wrong medication administered|1|||
44219632|NCT01757288|79019578|FG002|Overall Study|Wrong medication administered|0|||
44219633|NCT01757288|79019576|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
44219634|NCT01757288|79019577|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
44219635|NCT01757288|79019578|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
44219636|NCT01757288|79019576|FG000|Overall Study|Not meeting protocol constraints|0|||
44219637|NCT01757288|79019577|FG001|Overall Study|Not meeting protocol constraints|1|||
44373700|NCT00952614|79378885|FG000|Overall Study|Death|3|||
44373701|NCT00952614|79378885|FG000|Overall Study|Lost to Follow-up|3|||
44373702|NCT00952614|79378885|FG000|Overall Study|other reason|1|||
44219638|NCT01757288|79019578|FG002|Overall Study|Not meeting protocol constraints|1|||
44219639|NCT01757288|79019576|FG000|Overall Study|Multiple missed appointments|0|||
44219640|NCT01757288|79019577|FG001|Overall Study|Multiple missed appointments|1|||
44219641|NCT01757288|79019578|FG002|Overall Study|Multiple missed appointments|0|||
44219642|NCT01757288|79019576|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
44219643|NCT01757288|79019577|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
44219644|NCT01757288|79019578|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
44219645|NCT01757288|79019576|FG000|Overall Study|>2 weeks treatment break|0|||
44219646|NCT01757288|79019577|FG001|Overall Study|>2 weeks treatment break|0|||
44219647|NCT01757288|79019578|FG002|Overall Study|>2 weeks treatment break|1|||
44219648|NCT01756898|79019591|FG000|Overall Study|Adverse Event|7|||
44219649|NCT01756898|79019592|FG001|Overall Study|Adverse Event|1|||
44461071|NCT03748823|79469965|FG000|Extension Period|Protocol Violation|1|||
44461072|NCT03748823|79469966|FG001|Extension Period|Protocol Violation|0|||
44461073|NCT03748823|79469965|FG000|Extension Period|Ongoing in the Extension Period|41|||
44461074|NCT03748823|79469966|FG001|Extension Period|Ongoing in the Extension Period|84|||
44461075|NCT03548558|79469989|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
44461076|NCT03548558|79469990|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
44461077|NCT03548558|79469991|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
44461078|NCT03548558|79469992|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
44461079|NCT03548558|79469993|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
44461080|NCT03548558|79469994|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
44461081|NCT03548558|79469995|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
44461082|NCT03548558|79469989|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
44461083|NCT03548558|79469990|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
44461084|NCT03548558|79469991|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
44219650|NCT01756898|79019593|FG002|Overall Study|Adverse Event|0|||
44219651|NCT01756898|79019594|FG003|Overall Study|Adverse Event|0|||
44219652|NCT01756898|79019591|FG000|Overall Study|Lack of Efficacy|4|||
44219653|NCT01756898|79019592|FG001|Overall Study|Lack of Efficacy|7|||
44219654|NCT01756898|79019593|FG002|Overall Study|Lack of Efficacy|6|||
44219655|NCT01756898|79019594|FG003|Overall Study|Lack of Efficacy|6|||
44461085|NCT03548558|79469992|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
44461086|NCT03548558|79469993|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
44461087|NCT03548558|79469994|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
44461088|NCT03548558|79469995|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
44461089|NCT03548558|79469989|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
44461090|NCT03548558|79469990|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
44461091|NCT03548558|79469991|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
44461092|NCT03548558|79469992|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
44461093|NCT03548558|79469993|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
44461094|NCT03548558|79469994|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
44461095|NCT03548558|79469995|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
44461096|NCT03548558|79469989|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
44461097|NCT03548558|79469990|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
44461098|NCT03548558|79469991|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
44461099|NCT03548558|79469992|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
44461100|NCT03548558|79469993|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
44461101|NCT03548558|79469994|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
44461102|NCT03548558|79469995|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
44461103|NCT03548558|79469989|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
44461104|NCT03548558|79469990|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
44461105|NCT03548558|79469991|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
44461106|NCT03548558|79469992|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
44461107|NCT03548558|79469993|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
44461108|NCT03548558|79469994|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
44461109|NCT03548558|79469995|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
44461110|NCT03548558|79469989|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
44461111|NCT03548558|79469990|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
44461112|NCT03548558|79469991|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
44461113|NCT03548558|79469992|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
44461114|NCT03548558|79469993|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
44219656|NCT01756898|79019591|FG000|Overall Study|Lost to Follow-up|2|||
44219657|NCT01756898|79019592|FG001|Overall Study|Lost to Follow-up|4|||
44270294|NCT02326272|79195773|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
44461115|NCT03548558|79469994|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
44219658|NCT01756898|79019593|FG002|Overall Study|Lost to Follow-up|2|||
44219659|NCT01756898|79019594|FG003|Overall Study|Lost to Follow-up|3|||
44219660|NCT01756898|79019591|FG000|Overall Study|Protocol Violation|1|||
44219661|NCT01756898|79019592|FG001|Overall Study|Protocol Violation|2|||
44219662|NCT01756898|79019593|FG002|Overall Study|Protocol Violation|2|||
44219663|NCT01756898|79019594|FG003|Overall Study|Protocol Violation|1|||
44219664|NCT01756898|79019591|FG000|Overall Study|Withdrew Consent|5|||
44219665|NCT01756898|79019592|FG001|Overall Study|Withdrew Consent|3|||
44219666|NCT01756898|79019593|FG002|Overall Study|Withdrew Consent|5|||
44219667|NCT01756898|79019594|FG003|Overall Study|Withdrew Consent|6|||
44219668|NCT01756898|79019591|FG000|Overall Study|Other|0|||
44219669|NCT01756898|79019592|FG001|Overall Study|Other|2|||
44219670|NCT01756898|79019593|FG002|Overall Study|Other|2|||
44219671|NCT01756898|79019594|FG003|Overall Study|Other|0|||
44219672|NCT01731938|79019611|FG000|Preliminary Part I|Withdrawal by Subject|2|||
44219673|NCT01731938|79019612|FG001|Preliminary Part I|Withdrawal by Subject|2|||
44219674|NCT01731938|79019611|FG000|Preliminary Part I|Physician Decision|1|||
44219675|NCT01731938|79019612|FG001|Preliminary Part I|Physician Decision|0|||
44219676|NCT01731938|79019611|FG000|Preliminary Part I|Lost to Follow-up|0|||
44219677|NCT01731938|79019612|FG001|Preliminary Part I|Lost to Follow-up|3|||
44219678|NCT01731938|79019611|FG000|Preliminary Part I|Missed Week 6 visit|0|||
44219679|NCT01731938|79019612|FG001|Preliminary Part I|Missed Week 6 visit|3|||
44219680|NCT01731938|79019611|FG000|Primary Part II|Withdrawal by Subject|5|||
44219681|NCT01731938|79019612|FG001|Primary Part II|Withdrawal by Subject|4|||
44219682|NCT01731938|79019611|FG000|Primary Part II|Lost to Follow-up|4|||
44219683|NCT01731938|79019612|FG001|Primary Part II|Lost to Follow-up|5|||
44219684|NCT01731938|79019611|FG000|Primary Part II|Death|2|||
44219685|NCT01731938|79019612|FG001|Primary Part II|Death|1|||
44219686|NCT01731938|79019611|FG000|Primary Part II|Missed Week 6 visit|2|||
44219687|NCT01731938|79019612|FG001|Primary Part II|Missed Week 6 visit|3|||
44219688|NCT01731470|79019619|FG000|Overall Study|Withdrawal by Subject|1|||
44219689|NCT01731470|79019619|FG000|Overall Study|Did not meet study criteria|1|||
44219690|NCT01756352|79019623|FG000|Overall Study|moved away and lost to followup|1|||
44219691|NCT01756274|79019627|FG000|Overall Study|Protocol Violation|2|||
44219692|NCT01756274|79019627|FG000|Overall Study|Laboratory error|1|||
44219693|NCT01731002|79019635|FG000|Overall Study|Adverse Event|0|||
44219694|NCT01731002|79019636|FG001|Overall Study|Adverse Event|2|||
44219695|NCT01731002|79019637|FG002|Overall Study|Adverse Event|2|||
44219696|NCT01731002|79019635|FG000|Overall Study|Non-Compliant|0|||
44219697|NCT01731002|79019636|FG001|Overall Study|Non-Compliant|1|||
44219698|NCT01731002|79019637|FG002|Overall Study|Non-Compliant|0|||
44219699|NCT01731002|79019635|FG000|Overall Study|Lost to Follow-up|1|||
44219700|NCT01731002|79019636|FG001|Overall Study|Lost to Follow-up|0|||
44219701|NCT01731002|79019637|FG002|Overall Study|Lost to Follow-up|0|||
44219702|NCT01731002|79019635|FG000|Overall Study|Test Agent Discontinuation|0|||
44219703|NCT01731002|79019636|FG001|Overall Study|Test Agent Discontinuation|1|||
44219704|NCT01731002|79019637|FG002|Overall Study|Test Agent Discontinuation|0|||
44219705|NCT01731002|79019635|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
44219706|NCT01731002|79019636|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
44219707|NCT01731002|79019637|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
44219708|NCT01731002|79019635|FG000|Overall Study|Elevated IOP|1|||
44219709|NCT01731002|79019636|FG001|Overall Study|Elevated IOP|0|||
44219710|NCT01731002|79019637|FG002|Overall Study|Elevated IOP|0|||
44219711|NCT01731002|79019635|FG000|Overall Study|Inappropriate use of study medications|0|||
44219712|NCT01731002|79019636|FG001|Overall Study|Inappropriate use of study medications|0|||
44219713|NCT01731002|79019637|FG002|Overall Study|Inappropriate use of study medications|1|||
44219714|NCT01783886|79019648|FG000|Overall Study|Lost to Follow-up|0|||
44219715|NCT01783886|79019649|FG001|Overall Study|Lost to Follow-up|3|||
44219716|NCT01783886|79019650|FG002|Overall Study|Lost to Follow-up|0|||
44219717|NCT01783886|79019648|FG000|Overall Study|Protocol deviation|0|||
44219718|NCT01783886|79019649|FG001|Overall Study|Protocol deviation|0|||
44219719|NCT01783886|79019650|FG002|Overall Study|Protocol deviation|2|||
44219720|NCT01783886|79019648|FG000|Overall Study|Withdrawal of consent by participant|1|||
44219721|NCT01783886|79019649|FG001|Overall Study|Withdrawal of consent by participant|3|||
44219722|NCT01783886|79019650|FG002|Overall Study|Withdrawal of consent by participant|4|||
44219723|NCT01783886|79019648|FG000|Overall Study|Adverse Event|4|||
44219724|NCT01783886|79019649|FG001|Overall Study|Adverse Event|5|||
44461116|NCT03548558|79469995|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
44461117|NCT03364673|79470057|FG000|Overall Study|Withdrawal by Subject|2|||
44461118|NCT03364673|79470057|FG000|Overall Study|Injury unrelated to study|3|||
44219725|NCT01783886|79019650|FG002|Overall Study|Adverse Event|4|||
44219726|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219727|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219728|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219729|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219730|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
44219731|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219732|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219733|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
44219734|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
44219735|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219736|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
44219737|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
44219738|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219739|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219740|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219741|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
44219742|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
44219743|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
44219744|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
44219745|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
44219746|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
44219747|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
44219748|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
44219749|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
44219750|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
44219751|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
44219752|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
44219753|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
44219754|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
44219755|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
44219756|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
44219757|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
44219758|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219759|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219760|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219761|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44461119|NCT03330405|79470072|FG000|Overall Study|Other|1|||
44461120|NCT03330405|79470073|FG001|Overall Study|Other|3|||
44461121|NCT03330405|79470074|FG002|Overall Study|Other|1|||
44461122|NCT03330405|79470075|FG003|Overall Study|Other|0|||
44461123|NCT03330405|79470076|FG004|Overall Study|Other|2|||
44461124|NCT03330405|79470077|FG005|Overall Study|Other|0|||
44461125|NCT03330405|79470078|FG006|Overall Study|Other|1|||
44461126|NCT03330405|79470079|FG007|Overall Study|Other|0|||
44461127|NCT03330405|79470080|FG008|Overall Study|Other|0|||
44461128|NCT03330405|79470081|FG009|Overall Study|Other|0|||
44461129|NCT03330405|79470082|FG010|Overall Study|Other|0|||
44461130|NCT03330405|79470072|FG000|Overall Study|Progressive disease|8|||
44219762|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219763|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
44219764|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
44219765|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219766|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219767|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
44219768|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
44219769|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
44219770|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44270295|NCT02326272|79195774|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44461131|NCT03330405|79470073|FG001|Overall Study|Progressive disease|27|||
44461132|NCT03330405|79470074|FG002|Overall Study|Progressive disease|4|||
44461133|NCT03330405|79470075|FG003|Overall Study|Progressive disease|18|||
44461134|NCT03330405|79470076|FG004|Overall Study|Progressive disease|16|||
44461135|NCT03330405|79470077|FG005|Overall Study|Progressive disease|14|||
44461136|NCT03330405|79470078|FG006|Overall Study|Progressive disease|7|||
44219771|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219772|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219773|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
44219774|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219775|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219776|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219777|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219778|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219779|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
44219780|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219781|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219782|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219783|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219784|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44544192|NCT02729896|79557454|FG002|Overall Study|Withdrawal by Subject|3|||
44544193|NCT03575065|79557465|FG000|Overall Study|Death|31|||
44461137|NCT03330405|79470079|FG007|Overall Study|Progressive disease|29|||
44461138|NCT03330405|79470080|FG008|Overall Study|Progressive disease|9|||
44461139|NCT03330405|79470081|FG009|Overall Study|Progressive disease|11|||
44461140|NCT03330405|79470082|FG010|Overall Study|Progressive disease|5|||
44461141|NCT03330405|79470072|FG000|Overall Study|Withdrawal by Subject|1|||
44461142|NCT03330405|79470073|FG001|Overall Study|Withdrawal by Subject|4|||
44461143|NCT03330405|79470074|FG002|Overall Study|Withdrawal by Subject|0|||
44461144|NCT03330405|79470075|FG003|Overall Study|Withdrawal by Subject|1|||
44461145|NCT03330405|79470076|FG004|Overall Study|Withdrawal by Subject|1|||
44461146|NCT03330405|79470077|FG005|Overall Study|Withdrawal by Subject|1|||
44461147|NCT03330405|79470078|FG006|Overall Study|Withdrawal by Subject|0|||
44461148|NCT03330405|79470079|FG007|Overall Study|Withdrawal by Subject|2|||
44461149|NCT03330405|79470080|FG008|Overall Study|Withdrawal by Subject|2|||
44461150|NCT03330405|79470081|FG009|Overall Study|Withdrawal by Subject|1|||
44461151|NCT03330405|79470082|FG010|Overall Study|Withdrawal by Subject|1|||
44461152|NCT03330405|79470072|FG000|Overall Study|Global deterioration of health status|2|||
44461153|NCT03330405|79470073|FG001|Overall Study|Global deterioration of health status|3|||
44461154|NCT03330405|79470074|FG002|Overall Study|Global deterioration of health status|0|||
44461155|NCT03330405|79470075|FG003|Overall Study|Global deterioration of health status|2|||
44461156|NCT03330405|79470076|FG004|Overall Study|Global deterioration of health status|3|||
44461157|NCT03330405|79470077|FG005|Overall Study|Global deterioration of health status|3|||
44461158|NCT03330405|79470078|FG006|Overall Study|Global deterioration of health status|0|||
44461159|NCT03330405|79470079|FG007|Overall Study|Global deterioration of health status|2|||
44461160|NCT03330405|79470080|FG008|Overall Study|Global deterioration of health status|8|||
44461161|NCT03330405|79470081|FG009|Overall Study|Global deterioration of health status|4|||
44461162|NCT03330405|79470082|FG010|Overall Study|Global deterioration of health status|1|||
44461163|NCT03330405|79470072|FG000|Overall Study|Adverse Event|0|||
44461164|NCT03330405|79470073|FG001|Overall Study|Adverse Event|1|||
44461165|NCT03330405|79470074|FG002|Overall Study|Adverse Event|0|||
44461166|NCT03330405|79470075|FG003|Overall Study|Adverse Event|1|||
44461167|NCT03330405|79470076|FG004|Overall Study|Adverse Event|1|||
44461168|NCT03330405|79470077|FG005|Overall Study|Adverse Event|1|||
44461169|NCT03330405|79470078|FG006|Overall Study|Adverse Event|3|||
44461170|NCT03330405|79470079|FG007|Overall Study|Adverse Event|4|||
44461171|NCT03330405|79470080|FG008|Overall Study|Adverse Event|2|||
44461172|NCT03330405|79470081|FG009|Overall Study|Adverse Event|2|||
44461173|NCT03330405|79470082|FG010|Overall Study|Adverse Event|2|||
44461174|NCT03330405|79470072|FG000|Overall Study|Death|0|||
44461175|NCT03330405|79470073|FG001|Overall Study|Death|4|||
44461176|NCT03330405|79470074|FG002|Overall Study|Death|0|||
44461177|NCT03330405|79470075|FG003|Overall Study|Death|0|||
44461178|NCT03330405|79470076|FG004|Overall Study|Death|0|||
44461179|NCT03330405|79470077|FG005|Overall Study|Death|1|||
44461180|NCT03330405|79470078|FG006|Overall Study|Death|0|||
44461181|NCT03330405|79470079|FG007|Overall Study|Death|2|||
44461182|NCT03330405|79470080|FG008|Overall Study|Death|0|||
44461183|NCT03330405|79470081|FG009|Overall Study|Death|0|||
44544194|NCT03575065|79557466|FG001|Overall Study|Death|12|||
44219785|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
44461184|NCT03330405|79470082|FG010|Overall Study|Death|0|||
44461185|NCT03330405|79470072|FG000|Overall Study|Physician Decision|0|||
44461186|NCT03330405|79470073|FG001|Overall Study|Physician Decision|0|||
44461187|NCT03330405|79470074|FG002|Overall Study|Physician Decision|0|||
44461188|NCT03330405|79470075|FG003|Overall Study|Physician Decision|0|||
44461189|NCT03330405|79470076|FG004|Overall Study|Physician Decision|0|||
44219786|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219787|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219788|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219789|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
44219790|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219791|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219792|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219793|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219794|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219795|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
44219796|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219797|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219798|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219799|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219800|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219801|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219802|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219803|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219804|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219805|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
44219806|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219807|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219808|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219809|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219810|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219811|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219812|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219813|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219814|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
44219815|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219816|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219817|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219818|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219819|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219820|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219821|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
44219822|NCT01609556|79019674|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
44219823|NCT01609556|79019675|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219824|NCT01609556|79019676|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219825|NCT01609556|79019677|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219826|NCT01609556|79019678|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219827|NCT01609556|79019679|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
44219828|NCT01609556|79019680|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219829|NCT01609556|79019681|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219830|NCT01609556|79019682|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219831|NCT01609556|79019683|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219832|NCT01609556|79019684|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
44219833|NCT01609556|79019685|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219834|NCT01609556|79019686|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219835|NCT01609556|79019687|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219836|NCT01609556|79019688|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219837|NCT01609556|79019689|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
44219838|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219839|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219840|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219841|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219842|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219843|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219844|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44544195|NCT03575065|79557465|FG000|Overall Study|Sponsor's Decision|28|||
44544196|NCT03575065|79557466|FG001|Overall Study|Sponsor's Decision|13|||
44544197|NCT03575065|79557465|FG000|Overall Study|Withdrawal by Subject|2|||
44219845|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219846|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44544198|NCT03575065|79557466|FG001|Overall Study|Withdrawal by Subject|1|||
44544199|NCT03575065|79557465|FG000|Overall Study|Lost to Follow-up|1|||
44219847|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219848|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219849|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
44219850|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
44219851|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
44219852|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
44219853|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
44219854|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219855|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219856|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219857|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219858|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219859|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219860|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219861|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219862|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219863|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219864|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219865|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
44219866|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
44219867|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
44219868|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
44219869|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
44219870|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219871|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219872|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219873|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219874|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219875|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219876|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219877|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219878|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219879|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219880|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219881|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
44219882|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
44219883|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
44219884|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
44219885|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
44219886|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219887|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219888|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219889|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219890|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219891|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219892|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219893|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219894|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219895|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219896|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219897|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219898|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
44219899|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219900|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219901|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
44219902|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219903|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219904|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219905|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219906|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44249726|NCT01504412|79083925|FG002|Overall Study|Adverse Event|1|||
44461190|NCT03330405|79470077|FG005|Overall Study|Physician Decision|0|||
44461191|NCT03330405|79470078|FG006|Overall Study|Physician Decision|0|||
44461192|NCT03330405|79470079|FG007|Overall Study|Physician Decision|1|||
44461193|NCT03330405|79470080|FG008|Overall Study|Physician Decision|0|||
44461194|NCT03330405|79470081|FG009|Overall Study|Physician Decision|0|||
44461195|NCT03330405|79470082|FG010|Overall Study|Physician Decision|0|||
44461196|NCT02683239|79470223|FG000|Overall Study|Protocol Violation|35|||
44461197|NCT02683239|79470224|FG001|Overall Study|Protocol Violation|23|||
44461198|NCT02683239|79470225|FG002|Overall Study|Protocol Violation|26|||
44461199|NCT02683239|79470226|FG003|Overall Study|Protocol Violation|4|||
44461200|NCT02683239|79470227|FG004|Overall Study|Protocol Violation|35|||
44461201|NCT02683239|79470228|FG005|Overall Study|Protocol Violation|4|||
44461202|NCT02683239|79470229|FG006|Overall Study|Protocol Violation|5|||
44461203|NCT02683239|79470223|FG000|Overall Study|Adverse Event|64|||
44461204|NCT02683239|79470224|FG001|Overall Study|Adverse Event|39|||
44461205|NCT02683239|79470225|FG002|Overall Study|Adverse Event|42|||
44461206|NCT02683239|79470226|FG003|Overall Study|Adverse Event|16|||
44461207|NCT02683239|79470227|FG004|Overall Study|Adverse Event|189|||
44461208|NCT02683239|79470228|FG005|Overall Study|Adverse Event|9|||
44461209|NCT02683239|79470229|FG006|Overall Study|Adverse Event|9|||
44461210|NCT02683239|79470223|FG000|Overall Study|Physician Decision|38|||
44461211|NCT02683239|79470224|FG001|Overall Study|Physician Decision|19|||
44461212|NCT02683239|79470225|FG002|Overall Study|Physician Decision|14|||
44461213|NCT02683239|79470226|FG003|Overall Study|Physician Decision|73|||
44461214|NCT02683239|79470227|FG004|Overall Study|Physician Decision|143|||
44461215|NCT02683239|79470228|FG005|Overall Study|Physician Decision|14|||
44461216|NCT02683239|79470229|FG006|Overall Study|Physician Decision|15|||
44461217|NCT02683239|79470223|FG000|Overall Study|Withdrawal by Subject|187|||
44461218|NCT02683239|79470224|FG001|Overall Study|Withdrawal by Subject|99|||
44461219|NCT02683239|79470225|FG002|Overall Study|Withdrawal by Subject|91|||
44461220|NCT02683239|79470226|FG003|Overall Study|Withdrawal by Subject|18|||
44461221|NCT02683239|79470227|FG004|Overall Study|Withdrawal by Subject|248|||
44461222|NCT02683239|79470228|FG005|Overall Study|Withdrawal by Subject|22|||
44461223|NCT02683239|79470229|FG006|Overall Study|Withdrawal by Subject|28|||
44461224|NCT02683239|79470223|FG000|Overall Study|Lost to Follow-up|77|||
44461225|NCT02683239|79470224|FG001|Overall Study|Lost to Follow-up|24|||
44461226|NCT02683239|79470225|FG002|Overall Study|Lost to Follow-up|25|||
44461227|NCT02683239|79470226|FG003|Overall Study|Lost to Follow-up|7|||
44461228|NCT02683239|79470227|FG004|Overall Study|Lost to Follow-up|88|||
44461229|NCT02683239|79470228|FG005|Overall Study|Lost to Follow-up|8|||
44461230|NCT02683239|79470229|FG006|Overall Study|Lost to Follow-up|11|||
44461231|NCT02683239|79470223|FG000|Overall Study|Death|9|||
44461232|NCT02683239|79470224|FG001|Overall Study|Death|5|||
44461233|NCT02683239|79470225|FG002|Overall Study|Death|8|||
44461234|NCT02683239|79470226|FG003|Overall Study|Death|0|||
44461235|NCT02683239|79470227|FG004|Overall Study|Death|12|||
44461236|NCT02683239|79470228|FG005|Overall Study|Death|1|||
44461237|NCT02683239|79470229|FG006|Overall Study|Death|0|||
44461238|NCT02683239|79470223|FG000|Overall Study|Lack of Efficacy|50|||
44461239|NCT02683239|79470224|FG001|Overall Study|Lack of Efficacy|23|||
44461240|NCT02683239|79470225|FG002|Overall Study|Lack of Efficacy|12|||
44461241|NCT02683239|79470226|FG003|Overall Study|Lack of Efficacy|2|||
44373703|NCT00911859|79378893|FG000|Treatment Period|Adverse Event|3|||
44373704|NCT00911859|79378894|FG001|Treatment Period|Adverse Event|3|||
44373705|NCT00911859|79378895|FG002|Treatment Period|Adverse Event|7|||
44373706|NCT00911859|79378893|FG000|Treatment Period|Death|1|||
44373707|NCT00911859|79378894|FG001|Treatment Period|Death|3|||
44373708|NCT00911859|79378895|FG002|Treatment Period|Death|5|||
44373709|NCT00911859|79378893|FG000|Treatment Period|Lack of Efficacy|1|||
44373710|NCT00911859|79378894|FG001|Treatment Period|Lack of Efficacy|7|||
44373711|NCT00911859|79378895|FG002|Treatment Period|Lack of Efficacy|5|||
44373712|NCT00911859|79378893|FG000|Treatment Period|Physician Decision|3|||
44373713|NCT00911859|79378894|FG001|Treatment Period|Physician Decision|3|||
44373714|NCT00911859|79378895|FG002|Treatment Period|Physician Decision|3|||
44373715|NCT00911859|79378893|FG000|Treatment Period|Withdrawal by Subject|0|||
44461242|NCT02683239|79470227|FG004|Overall Study|Lack of Efficacy|29|||
44461243|NCT02683239|79470228|FG005|Overall Study|Lack of Efficacy|2|||
44461244|NCT02683239|79470229|FG006|Overall Study|Lack of Efficacy|3|||
44461245|NCT02683239|79470223|FG000|Overall Study|Missing data|0|||
44461246|NCT02683239|79470224|FG001|Overall Study|Missing data|1|||
44461247|NCT02683239|79470225|FG002|Overall Study|Missing data|1|||
44461248|NCT02683239|79470226|FG003|Overall Study|Missing data|0|||
44461249|NCT02683239|79470227|FG004|Overall Study|Missing data|1|||
44461250|NCT02683239|79470228|FG005|Overall Study|Missing data|0|||
44461251|NCT02683239|79470229|FG006|Overall Study|Missing data|0|||
44373716|NCT00911859|79378894|FG001|Treatment Period|Withdrawal by Subject|4|||
44373717|NCT00911859|79378895|FG002|Treatment Period|Withdrawal by Subject|5|||
44373718|NCT00911859|79378893|FG000|Treatment Period|Did not receive study treatment|0|||
44219907|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219908|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219909|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219910|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219911|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219912|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219913|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
44219914|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
44219915|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
44219916|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
44219917|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
44219918|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219919|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219920|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44270296|NCT02326272|79195775|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270297|NCT02326272|79195776|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270298|NCT02326272|79195777|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270299|NCT02326272|79195778|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270300|NCT02326272|79195779|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270301|NCT02326272|79195780|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44219921|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219922|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219923|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219924|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219925|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219926|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219927|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44270302|NCT02326272|79195781|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
44270303|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
44270304|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
44270305|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
44270306|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
44270307|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
44270308|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
44270309|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
44270310|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
44270311|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
44270312|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
44270313|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
44270314|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
44270315|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
44270316|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
44219928|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44270317|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
44270318|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270319|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270320|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270321|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270322|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270323|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270324|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270325|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44544200|NCT03575065|79557466|FG001|Overall Study|Lost to Follow-up|0|||
44544201|NCT03514134|79557475|FG000|Overall Study|Lost to Follow-up|0|||
44219929|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44249727|NCT01504412|79083926|FG003|Overall Study|Adverse Event|7|||
44270326|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270327|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270328|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
44270329|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
44270330|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
44270331|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
44270332|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
44219930|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219931|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219932|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
44219933|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
44219934|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219935|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219936|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219937|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219938|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219939|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219940|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219941|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
44270333|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44219942|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219943|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219944|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219945|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219946|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
44219947|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
44219948|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
44219949|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
44219950|NCT01609556|79019674|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219951|NCT01609556|79019675|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219952|NCT01609556|79019676|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219953|NCT01609556|79019677|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219954|NCT01609556|79019678|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219955|NCT01609556|79019679|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219956|NCT01609556|79019680|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219957|NCT01609556|79019681|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219958|NCT01609556|79019682|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219959|NCT01609556|79019683|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44270334|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270335|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270336|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270337|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270338|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270339|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270340|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270341|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270342|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270343|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
44270344|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270345|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
44270346|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270347|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
44270348|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270349|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44219960|NCT01609556|79019684|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219961|NCT01609556|79019685|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219962|NCT01609556|79019686|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
44219963|NCT01609556|79019687|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219964|NCT01609556|79019688|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44219965|NCT01609556|79019689|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
44373719|NCT00911859|79378894|FG001|Treatment Period|Did not receive study treatment|1|||
44373720|NCT00911859|79378895|FG002|Treatment Period|Did not receive study treatment|0|||
44219966|NCT01763996|79020063|FG000|Treatment Period 2|Adverse Event|0|||
44219967|NCT01763996|79020064|FG001|Treatment Period 2|Adverse Event|1|||
44219968|NCT01468701|79020496|FG000|Overall Study|Not eligible|91|||
44219969|NCT01468701|79020497|FG001|Overall Study|Not eligible|140|||
44219970|NCT01468701|79020498|FG002|Overall Study|Not eligible|29|||
44219971|NCT01468701|79020499|FG003|Overall Study|Not eligible|12|||
44219972|NCT01468701|79020500|FG004|Overall Study|Not eligible|22|||
44219973|NCT01468701|79020501|FG005|Overall Study|Not eligible|2|||
44219974|NCT01468701|79020502|FG006|Overall Study|Not eligible|39|||
44219975|NCT01468701|79020503|FG007|Overall Study|Not eligible|1|||
44219976|NCT01468701|79020504|FG008|Overall Study|Not eligible|40|||
44219977|NCT01468701|79020505|FG009|Overall Study|Not eligible|126|||
44219978|NCT01468701|79020506|FG010|Overall Study|Not eligible|39|||
44219979|NCT01468701|79020507|FG011|Overall Study|Not eligible|33|||
44219980|NCT01468701|79020508|FG012|Overall Study|Not eligible|1|||
44219981|NCT01468701|79020509|FG013|Overall Study|Not eligible|19|||
44219982|NCT01468701|79020510|FG014|Overall Study|Not eligible|1|||
44219983|NCT01468701|79020511|FG015|Overall Study|Not eligible|32|||
44270350|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270351|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270352|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270353|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270354|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270355|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270356|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270357|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270358|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270359|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
44270360|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270361|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270362|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
44270363|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270364|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270365|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270366|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270367|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270368|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270369|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270370|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270371|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270372|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270373|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
44270374|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270375|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
44270376|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
44270377|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
44270378|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270379|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270380|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270381|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270382|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270383|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270384|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270385|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44219984|NCT01468701|79020512|FG016|Overall Study|Not eligible|0|||
44219985|NCT01468701|79020496|FG000|Overall Study|Lost to Follow-up|306|||
44219986|NCT01468701|79020497|FG001|Overall Study|Lost to Follow-up|0|||
44219987|NCT01468701|79020498|FG002|Overall Study|Lost to Follow-up|0|||
44219988|NCT01468701|79020499|FG003|Overall Study|Lost to Follow-up|0|||
44270386|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270387|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270388|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44219989|NCT01468701|79020500|FG004|Overall Study|Lost to Follow-up|0|||
44219990|NCT01468701|79020501|FG005|Overall Study|Lost to Follow-up|0|||
44219991|NCT01468701|79020502|FG006|Overall Study|Lost to Follow-up|0|||
44219992|NCT01468701|79020503|FG007|Overall Study|Lost to Follow-up|0|||
44219993|NCT01468701|79020504|FG008|Overall Study|Lost to Follow-up|215|||
44219994|NCT01468701|79020505|FG009|Overall Study|Lost to Follow-up|309|||
44219995|NCT01468701|79020506|FG010|Overall Study|Lost to Follow-up|224|||
44219996|NCT01468701|79020507|FG011|Overall Study|Lost to Follow-up|212|||
44270389|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
44270390|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270391|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
44270392|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
44270393|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270394|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270395|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270396|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270397|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270398|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270399|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270400|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270401|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270402|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270403|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44373721|NCT00911859|79378893|FG000|Maintainance Period|Lack of Efficacy|0|||
44219997|NCT01468701|79020508|FG012|Overall Study|Lost to Follow-up|11|||
44219998|NCT01468701|79020509|FG013|Overall Study|Lost to Follow-up|164|||
44219999|NCT01468701|79020510|FG014|Overall Study|Lost to Follow-up|17|||
44220000|NCT01468701|79020511|FG015|Overall Study|Lost to Follow-up|127|||
44220001|NCT01468701|79020512|FG016|Overall Study|Lost to Follow-up|1|||
44220002|NCT01468701|79020496|FG000|Overall Study|Withdrawal by Subject|165|||
44220003|NCT01468701|79020497|FG001|Overall Study|Withdrawal by Subject|0|||
44220004|NCT01468701|79020498|FG002|Overall Study|Withdrawal by Subject|0|||
44220005|NCT01468701|79020499|FG003|Overall Study|Withdrawal by Subject|0|||
44270404|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
44373722|NCT00911859|79378894|FG001|Maintainance Period|Lack of Efficacy|0|||
44270405|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
44373723|NCT00911859|79378895|FG002|Maintainance Period|Lack of Efficacy|9|||
44373724|NCT00911859|79378893|FG000|Maintainance Period|Physician Decision|0|||
44373725|NCT00911859|79378894|FG001|Maintainance Period|Physician Decision|0|||
44373726|NCT00911859|79378895|FG002|Maintainance Period|Physician Decision|9|||
44373727|NCT00911859|79378893|FG000|Maintainance Period|Withdrawal by Subject|0|||
44270406|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
44270407|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
44270408|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270409|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270410|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270411|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270412|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270413|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270414|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270415|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270416|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270417|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270418|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270419|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
44270420|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270421|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270422|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
44270423|NCT02326272|79195767|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270424|NCT02326272|79195768|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270425|NCT02326272|79195769|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270426|NCT02326272|79195770|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270427|NCT02326272|79195771|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270428|NCT02326272|79195772|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270429|NCT02326272|79195773|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270430|NCT02326272|79195774|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270431|NCT02326272|79195775|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270432|NCT02326272|79195776|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270433|NCT02326272|79195777|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270434|NCT02326272|79195778|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270435|NCT02326272|79195779|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
44270436|NCT02326272|79195780|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270437|NCT02326272|79195781|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
44270438|NCT02325414|79195818|FG000|Overall Study|Withdrawal by Subject|3|||
44270439|NCT02325414|79195819|FG001|Overall Study|Withdrawal by Subject|1|||
44270440|NCT02325414|79195818|FG000|Overall Study|Lost to Follow-up|5|||
44270441|NCT02325414|79195819|FG001|Overall Study|Lost to Follow-up|5|||
44270442|NCT02349048|79195837|FG000|Overall Study|Withdrawal by Subject|4|||
44270443|NCT02349048|79195838|FG001|Overall Study|Withdrawal by Subject|0|||
44373728|NCT00911859|79378894|FG001|Maintainance Period|Withdrawal by Subject|0|||
44373729|NCT00911859|79378895|FG002|Maintainance Period|Withdrawal by Subject|3|||
44373730|NCT00911859|79378893|FG000|Follow-up Period|Death|5|||
44220006|NCT01468701|79020500|FG004|Overall Study|Withdrawal by Subject|0|||
44220007|NCT01468701|79020501|FG005|Overall Study|Withdrawal by Subject|0|||
44220008|NCT01468701|79020502|FG006|Overall Study|Withdrawal by Subject|0|||
44220009|NCT01468701|79020503|FG007|Overall Study|Withdrawal by Subject|0|||
44220010|NCT01468701|79020504|FG008|Overall Study|Withdrawal by Subject|83|||
44220011|NCT01468701|79020505|FG009|Overall Study|Withdrawal by Subject|88|||
44220012|NCT01468701|79020506|FG010|Overall Study|Withdrawal by Subject|100|||
44220013|NCT01468701|79020507|FG011|Overall Study|Withdrawal by Subject|114|||
44220014|NCT01468701|79020508|FG012|Overall Study|Withdrawal by Subject|9|||
44220015|NCT01468701|79020509|FG013|Overall Study|Withdrawal by Subject|47|||
44220016|NCT01468701|79020510|FG014|Overall Study|Withdrawal by Subject|6|||
44220017|NCT01468701|79020511|FG015|Overall Study|Withdrawal by Subject|31|||
44270444|NCT02349048|79195837|FG000|Overall Study|Lost to Follow-up|1|||
44270445|NCT02349048|79195838|FG001|Overall Study|Lost to Follow-up|0|||
44270446|NCT02299206|79195885|FG000|Overall Study|Lost to Follow-up|1|||
44373731|NCT00911859|79378894|FG001|Follow-up Period|Death|8|||
44220018|NCT01468701|79020512|FG016|Overall Study|Withdrawal by Subject|0|||
44220019|NCT01468701|79020496|FG000|Overall Study|Other reasons than listed|437|||
44249728|NCT01504412|79083927|FG004|Overall Study|Adverse Event|10|||
44270447|NCT02299206|79195885|FG000|Overall Study|Withdrawal by Subject|1|||
44270448|NCT02298192|79195904|FG000|Overall Study|Unclassified|3|||
44270449|NCT02298192|79195905|FG001|Overall Study|Unclassified|2|||
44270450|NCT02298192|79195904|FG000|Overall Study|Withdrawal criteria|2|||
44270451|NCT02298192|79195905|FG001|Overall Study|Withdrawal criteria|0|||
44270452|NCT02298192|79195904|FG000|Overall Study|Withdrawal by Subject|6|||
44270453|NCT02298192|79195905|FG001|Overall Study|Withdrawal by Subject|1|||
44270454|NCT02298192|79195904|FG000|Overall Study|Lost to Follow-up|2|||
44270455|NCT02298192|79195905|FG001|Overall Study|Lost to Follow-up|1|||
44270456|NCT02298192|79195904|FG000|Overall Study|Adverse Event|6|||
44270457|NCT02298192|79195905|FG001|Overall Study|Adverse Event|2|||
44270458|NCT02280408|79196031|FG000|Overall Study|Lost to Follow-up|0|||
44373732|NCT00911859|79378895|FG002|Follow-up Period|Death|10|||
44373733|NCT00911859|79378893|FG000|Follow-up Period|Lost to Follow-up|1|||
44461252|NCT02097134|79470245|FG000|Overall Study|Physician Decision|4|||
44461253|NCT02097134|79470245|FG000|Overall Study|Non-Protocol Therapy|1|||
44220020|NCT01468701|79020497|FG001|Overall Study|Other reasons than listed|0|||
44220021|NCT01468701|79020498|FG002|Overall Study|Other reasons than listed|0|||
44220022|NCT01468701|79020499|FG003|Overall Study|Other reasons than listed|0|||
44220023|NCT01468701|79020500|FG004|Overall Study|Other reasons than listed|0|||
44220024|NCT01468701|79020501|FG005|Overall Study|Other reasons than listed|0|||
44220025|NCT01468701|79020502|FG006|Overall Study|Other reasons than listed|0|||
44220026|NCT01468701|79020503|FG007|Overall Study|Other reasons than listed|0|||
44220027|NCT01468701|79020504|FG008|Overall Study|Other reasons than listed|318|||
44220028|NCT01468701|79020505|FG009|Overall Study|Other reasons than listed|658|||
44220029|NCT01468701|79020506|FG010|Overall Study|Other reasons than listed|433|||
44220030|NCT01468701|79020507|FG011|Overall Study|Other reasons than listed|504|||
44220031|NCT01468701|79020508|FG012|Overall Study|Other reasons than listed|28|||
44220032|NCT01468701|79020509|FG013|Overall Study|Other reasons than listed|239|||
44220033|NCT01468701|79020510|FG014|Overall Study|Other reasons than listed|39|||
44220034|NCT01468701|79020511|FG015|Overall Study|Other reasons than listed|172|||
44220035|NCT01468701|79020512|FG016|Overall Study|Other reasons than listed|0|||
44220036|NCT01468701|79020496|FG000|Overall Study|No end of study case report form|0|||
44220037|NCT01468701|79020497|FG001|Overall Study|No end of study case report form|0|||
44220038|NCT01468701|79020498|FG002|Overall Study|No end of study case report form|0|||
44220039|NCT01468701|79020499|FG003|Overall Study|No end of study case report form|0|||
44220040|NCT01468701|79020500|FG004|Overall Study|No end of study case report form|0|||
44220041|NCT01468701|79020501|FG005|Overall Study|No end of study case report form|0|||
44220042|NCT01468701|79020502|FG006|Overall Study|No end of study case report form|0|||
44220043|NCT01468701|79020503|FG007|Overall Study|No end of study case report form|0|||
44220044|NCT01468701|79020504|FG008|Overall Study|No end of study case report form|4|||
44220045|NCT01468701|79020505|FG009|Overall Study|No end of study case report form|1|||
44220046|NCT01468701|79020506|FG010|Overall Study|No end of study case report form|2|||
44220047|NCT01468701|79020507|FG011|Overall Study|No end of study case report form|3|||
44220048|NCT01468701|79020508|FG012|Overall Study|No end of study case report form|0|||
44220049|NCT01468701|79020509|FG013|Overall Study|No end of study case report form|1|||
44220050|NCT01468701|79020510|FG014|Overall Study|No end of study case report form|0|||
44220051|NCT01468701|79020511|FG015|Overall Study|No end of study case report form|0|||
44220052|NCT01468701|79020512|FG016|Overall Study|No end of study case report form|0|||
44220053|NCT01468701|79020496|FG000|Overall Study|Not being followed up|0|||
44220054|NCT01468701|79020497|FG001|Overall Study|Not being followed up|4963|||
44220055|NCT01468701|79020498|FG002|Overall Study|Not being followed up|1755|||
44220056|NCT01468701|79020499|FG003|Overall Study|Not being followed up|703|||
44220057|NCT01468701|79020500|FG004|Overall Study|Not being followed up|1714|||
44220058|NCT01468701|79020501|FG005|Overall Study|Not being followed up|126|||
44220059|NCT01468701|79020502|FG006|Overall Study|Not being followed up|1170|||
44220060|NCT01468701|79020503|FG007|Overall Study|Not being followed up|4|||
44220061|NCT01468701|79020504|FG008|Overall Study|Not being followed up|0|||
44220062|NCT01468701|79020505|FG009|Overall Study|Not being followed up|0|||
44220063|NCT01468701|79020506|FG010|Overall Study|Not being followed up|0|||
44220064|NCT01468701|79020507|FG011|Overall Study|Not being followed up|0|||
44220065|NCT01468701|79020508|FG012|Overall Study|Not being followed up|0|||
44220066|NCT01468701|79020509|FG013|Overall Study|Not being followed up|0|||
44220067|NCT01468701|79020510|FG014|Overall Study|Not being followed up|0|||
44220068|NCT01468701|79020511|FG015|Overall Study|Not being followed up|0|||
44220069|NCT01468701|79020512|FG016|Overall Study|Not being followed up|0|||
44220070|NCT01492101|79020527|FG000|Overall Study|Death|323|||
44220071|NCT01492101|79020528|FG001|Overall Study|Death|322|||
44220072|NCT01492101|79020527|FG000|Overall Study|Withdrawal by Subject|14|||
44220073|NCT01492101|79020528|FG001|Overall Study|Withdrawal by Subject|18|||
44220074|NCT01492101|79020527|FG000|Overall Study|Lost to Follow-up|0|||
44220075|NCT01492101|79020528|FG001|Overall Study|Lost to Follow-up|2|||
44270459|NCT02280408|79196032|FG001|Overall Study|Lost to Follow-up|2|||
44270460|NCT02280408|79196033|FG002|Overall Study|Lost to Follow-up|0|||
44270461|NCT02280408|79196034|FG003|Overall Study|Lost to Follow-up|0|||
44461254|NCT02097134|79470245|FG000|Overall Study|Progressive Disease|3|||
44270462|NCT02296476|79196101|FG000|Overall Study|Disease Progression|6|||
44270463|NCT02296476|79196102|FG001|Overall Study|Disease Progression|4|||
44270464|NCT02296476|79196103|FG002|Overall Study|Disease Progression|2|||
44270465|NCT00552032|79196144|FG000|Overall Study|Withdrawal by Subject|2|||
44270466|NCT00552032|79196145|FG001|Overall Study|Withdrawal by Subject|2|||
44270467|NCT00552032|79196144|FG000|Overall Study|Protocol Violation|7|||
44270468|NCT00552032|79196145|FG001|Overall Study|Protocol Violation|12|||
44270469|NCT00552032|79196144|FG000|Overall Study|Lost to Follow-up|8|||
44270470|NCT00552032|79196145|FG001|Overall Study|Lost to Follow-up|5|||
44270471|NCT03312530|79196931|FG000|Overall Study|Death|5|||
44270472|NCT03312530|79196932|FG001|Overall Study|Death|5|||
44270473|NCT03312530|79196933|FG002|Overall Study|Death|4|||
44270474|NCT03312530|79196934|FG003|Overall Study|Death|10|||
44270475|NCT03312530|79196935|FG004|Overall Study|Death|8|||
44270476|NCT03312530|79196931|FG000|Overall Study|Lost to Follow-up|0|||
44270477|NCT03312530|79196932|FG001|Overall Study|Lost to Follow-up|0|||
44270478|NCT03312530|79196933|FG002|Overall Study|Lost to Follow-up|0|||
44270479|NCT03312530|79196934|FG003|Overall Study|Lost to Follow-up|1|||
44270480|NCT03312530|79196935|FG004|Overall Study|Lost to Follow-up|0|||
44270481|NCT03312530|79196931|FG000|Overall Study|Participant in another sponsor study.|0|||
44270482|NCT03312530|79196932|FG001|Overall Study|Participant in another sponsor study.|0|||
44270483|NCT03312530|79196933|FG002|Overall Study|Participant in another sponsor study.|0|||
44270484|NCT03312530|79196934|FG003|Overall Study|Participant in another sponsor study.|1|||
44220076|NCT01468311|79020534|FG000|Overall Study|mobilization failure|1|||
44220077|NCT01468311|79020534|FG000|Overall Study|Withdrawal by Subject|1|||
44220078|NCT01730534|79020645|FG000|Overall Study|Withdrawal by Subject|97|||
44270485|NCT03312530|79196935|FG004|Overall Study|Participant in another sponsor study.|0|||
44270486|NCT03312530|79196931|FG000|Overall Study|Study terminated by sponsor|1|||
44270487|NCT03312530|79196932|FG001|Overall Study|Study terminated by sponsor|0|||
44270488|NCT03312530|79196933|FG002|Overall Study|Study terminated by sponsor|2|||
44270489|NCT03312530|79196934|FG003|Overall Study|Study terminated by sponsor|3|||
44270490|NCT03312530|79196935|FG004|Overall Study|Study terminated by sponsor|7|||
44270491|NCT03312530|79196931|FG000|Overall Study|Withdrawal by Subject|0|||
44270492|NCT03312530|79196932|FG001|Overall Study|Withdrawal by Subject|1|||
44270493|NCT03312530|79196933|FG002|Overall Study|Withdrawal by Subject|0|||
44270494|NCT03312530|79196934|FG003|Overall Study|Withdrawal by Subject|0|||
44270495|NCT03312530|79196935|FG004|Overall Study|Withdrawal by Subject|0|||
44270496|NCT03312530|79196931|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
44270497|NCT03312530|79196932|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
44270498|NCT03312530|79196933|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
44270499|NCT03312530|79196934|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
44270500|NCT03312530|79196935|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
44270501|NCT02296320|79197053|FG000|Overall Study|Withdrawal by Subject|4|||
44270502|NCT02296320|79197054|FG001|Overall Study|Withdrawal by Subject|0|||
44270503|NCT02296320|79197055|FG002|Overall Study|Withdrawal by Subject|2|||
44270504|NCT02296320|79197053|FG000|Overall Study|Death|24|||
44270505|NCT02296320|79197054|FG001|Overall Study|Death|3|||
44270506|NCT02296320|79197055|FG002|Overall Study|Death|27|||
44270507|NCT02296320|79197053|FG000|Overall Study|Lost to Follow-up|5|||
44270508|NCT02296320|79197054|FG001|Overall Study|Lost to Follow-up|2|||
44270509|NCT02296320|79197055|FG002|Overall Study|Lost to Follow-up|7|||
44270510|NCT02296320|79197053|FG000|Overall Study|Not treated|2|||
44220079|NCT01730534|79020646|FG001|Overall Study|Withdrawal by Subject|127|||
44220080|NCT01730534|79020645|FG000|Overall Study|Lost to Follow-up|12|||
44220081|NCT01730534|79020646|FG001|Overall Study|Lost to Follow-up|18|||
44220082|NCT01783730|79020666|FG000|Overall Study|Failed to meet inclusion criteria|6|||
44220083|NCT01730378|79020672|FG000|Overall Study|Lost to Follow-up|1|||
44220084|NCT01730378|79020673|FG001|Overall Study|Lost to Follow-up|0|||
44220085|NCT01783496|79020686|FG000|Overall Study|Lost to Follow-up|0|||
44220086|NCT01783496|79020687|FG001|Overall Study|Lost to Follow-up|0|||
44220087|NCT01783496|79020688|FG002|Overall Study|Lost to Follow-up|0|||
44220088|NCT01783496|79020689|FG003|Overall Study|Lost to Follow-up|2|||
44270511|NCT02296320|79197054|FG001|Overall Study|Not treated|0|||
44270512|NCT02296320|79197055|FG002|Overall Study|Not treated|0|||
44270513|NCT02296320|79197053|FG000|Overall Study|Not - specified|0|||
44270514|NCT02296320|79197054|FG001|Overall Study|Not - specified|0|||
44270515|NCT02296320|79197055|FG002|Overall Study|Not - specified|1|||
44270516|NCT02296242|79197094|FG000|Overall Study|Death|1|||
44270517|NCT02296242|79197095|FG001|Overall Study|Death|1|||
44270518|NCT02296242|79197096|FG002|Overall Study|Death|1|||
44270519|NCT02296242|79197097|FG003|Overall Study|Death|1|||
44220089|NCT01783496|79020690|FG004|Overall Study|Lost to Follow-up|0|||
44220090|NCT01783496|79020691|FG005|Overall Study|Lost to Follow-up|1|||
44270520|NCT02296242|79197098|FG004|Overall Study|Death|1|||
44220091|NCT01783496|79020686|FG000|Overall Study|Withdrawal by Subject|1|||
44270521|NCT02296242|79197094|FG000|Overall Study|Withdrawal by Subject|0|||
44270522|NCT02296242|79197095|FG001|Overall Study|Withdrawal by Subject|0|||
44270523|NCT02296242|79197096|FG002|Overall Study|Withdrawal by Subject|1|||
44270524|NCT02296242|79197097|FG003|Overall Study|Withdrawal by Subject|1|||
44270525|NCT02296242|79197098|FG004|Overall Study|Withdrawal by Subject|3|||
44270526|NCT02296242|79197094|FG000|Overall Study|Disease Progression|1|||
44270527|NCT02296242|79197095|FG001|Overall Study|Disease Progression|3|||
44270528|NCT02296242|79197096|FG002|Overall Study|Disease Progression|2|||
44270529|NCT02296242|79197097|FG003|Overall Study|Disease Progression|8|||
44270530|NCT02296242|79197098|FG004|Overall Study|Disease Progression|11|||
44270531|NCT02296242|79197094|FG000|Overall Study|Unacceptable Toxicity|0|||
44270532|NCT02296242|79197095|FG001|Overall Study|Unacceptable Toxicity|0|||
44270533|NCT02296242|79197096|FG002|Overall Study|Unacceptable Toxicity|0|||
44270534|NCT02296242|79197097|FG003|Overall Study|Unacceptable Toxicity|0|||
44270535|NCT02296242|79197098|FG004|Overall Study|Unacceptable Toxicity|1|||
44270536|NCT02296242|79197094|FG000|Overall Study|Patient Condition Changed|0|||
44270537|NCT02296242|79197095|FG001|Overall Study|Patient Condition Changed|0|||
44270538|NCT02296242|79197096|FG002|Overall Study|Patient Condition Changed|2|||
44270539|NCT02296242|79197097|FG003|Overall Study|Patient Condition Changed|0|||
44270540|NCT02296242|79197098|FG004|Overall Study|Patient Condition Changed|1|||
44270541|NCT02296242|79197094|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
44270542|NCT02296242|79197095|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
44270543|NCT02296242|79197096|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
44270544|NCT02296242|79197097|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
44270545|NCT02296242|79197098|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
44270546|NCT02296242|79197094|FG000|Overall Study|Lost to Follow-up|1|||
44270547|NCT02296242|79197095|FG001|Overall Study|Lost to Follow-up|0|||
44270548|NCT02296242|79197096|FG002|Overall Study|Lost to Follow-up|0|||
44270549|NCT02296242|79197097|FG003|Overall Study|Lost to Follow-up|0|||
44270550|NCT02296242|79197098|FG004|Overall Study|Lost to Follow-up|0|||
44270551|NCT02296242|79197094|FG000|Overall Study|Need for Hydroxyurea|2|||
44270552|NCT02296242|79197095|FG001|Overall Study|Need for Hydroxyurea|0|||
44270553|NCT02296242|79197096|FG002|Overall Study|Need for Hydroxyurea|0|||
44270554|NCT02296242|79197097|FG003|Overall Study|Need for Hydroxyurea|0|||
44461255|NCT02097134|79470245|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
44461256|NCT01859130|79470250|FG000|Overall Study|Death|4|||
44461257|NCT01859130|79470250|FG000|Overall Study|Lost to Follow-up|16|||
44461258|NCT01859130|79470250|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
44220092|NCT01783496|79020687|FG001|Overall Study|Withdrawal by Subject|0|||
44220093|NCT01783496|79020688|FG002|Overall Study|Withdrawal by Subject|0|||
44220094|NCT01783496|79020689|FG003|Overall Study|Withdrawal by Subject|0|||
44220095|NCT01783496|79020690|FG004|Overall Study|Withdrawal by Subject|0|||
44220096|NCT01783496|79020691|FG005|Overall Study|Withdrawal by Subject|0|||
44220097|NCT01729208|79020716|FG000|Baseline|Physician Decision|5|||
44220098|NCT01729208|79020717|FG001|Baseline|Physician Decision|4|||
44220099|NCT01729208|79020716|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
44220100|NCT01729208|79020717|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
44220101|NCT01729208|79020716|FG000|12 Months Follow-up|Lost to Follow-up|3|||
44220102|NCT01729208|79020717|FG001|12 Months Follow-up|Lost to Follow-up|3|||
44220103|NCT01729208|79020716|FG000|24 Months Follow-up|Lost to Follow-up|3|||
44220104|NCT01729208|79020717|FG001|24 Months Follow-up|Lost to Follow-up|0|||
44270555|NCT02296242|79197098|FG004|Overall Study|Need for Hydroxyurea|0|||
44270556|NCT02296242|79197094|FG000|Overall Study|Screened for Other Protocol|0|||
44270557|NCT02296242|79197095|FG001|Overall Study|Screened for Other Protocol|1|||
44373734|NCT00911859|79378894|FG001|Follow-up Period|Lost to Follow-up|1|||
44373735|NCT00911859|79378895|FG002|Follow-up Period|Lost to Follow-up|0|||
44373736|NCT00911859|79378893|FG000|Follow-up Period|Withdrawal by Subject|0|||
44373737|NCT00911859|79378894|FG001|Follow-up Period|Withdrawal by Subject|4|||
44373738|NCT00911859|79378895|FG002|Follow-up Period|Withdrawal by Subject|4|||
44373739|NCT00911859|79378893|FG000|Follow-up Period|Study terminated by sponsor|5|||
44373740|NCT00911859|79378894|FG001|Follow-up Period|Study terminated by sponsor|33|||
44373741|NCT00911859|79378895|FG002|Follow-up Period|Study terminated by sponsor|27|||
44373742|NCT00956592|79378905|FG000|Overall Study|Protocol Violation|1|||
44373743|NCT00956592|79378906|FG001|Overall Study|Protocol Violation|3|||
44373744|NCT02725593|79378916|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
44373745|NCT02725593|79378917|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
44373746|NCT02725593|79378916|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
44373747|NCT02725593|79378917|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
44461259|NCT01859130|79470250|FG000|Overall Study|Physician Decision|6|||
44220105|NCT01729208|79020716|FG000|36 Months Follow-up|Physician Decision|1|||
44270558|NCT02296242|79197096|FG002|Overall Study|Screened for Other Protocol|0|||
44270559|NCT02296242|79197097|FG003|Overall Study|Screened for Other Protocol|0|||
44270560|NCT02296242|79197098|FG004|Overall Study|Screened for Other Protocol|0|||
44270561|NCT02296242|79197094|FG000|Overall Study|Physician Decision|0|||
44270562|NCT02296242|79197095|FG001|Overall Study|Physician Decision|1|||
44461260|NCT01859130|79470250|FG000|Overall Study|Withdrawal by Subject|17|||
44461261|NCT01859130|79470250|FG000|Overall Study|Adverse Event|11|||
44461262|NCT01174043|79470267|FG000|Overall Study|Disease progression|5|||
44461263|NCT01174043|79470267|FG000|Overall Study|Adverse Event|3|||
44461264|NCT01174043|79470267|FG000|Overall Study|Death|1|||
44461265|NCT01174043|79470267|FG000|Overall Study|Withdrawal by Subject|2|||
44461266|NCT04050982|79470273|FG000|Overall Study|Did not meet eligibility criteria|0|||
44461267|NCT04050982|79470274|FG001|Overall Study|Did not meet eligibility criteria|1|||
44461268|NCT04050982|79470275|FG002|Overall Study|Did not meet eligibility criteria|0|||
44461269|NCT04050982|79470273|FG000|Overall Study|Withdrawal by Subject|1|||
44461270|NCT04050982|79470274|FG001|Overall Study|Withdrawal by Subject|0|||
44461271|NCT04050982|79470275|FG002|Overall Study|Withdrawal by Subject|0|||
44461272|NCT04050982|79470273|FG000|Overall Study|Unable to enroll on platform|1|||
44461273|NCT04050982|79470274|FG001|Overall Study|Unable to enroll on platform|0|||
44461274|NCT04050982|79470275|FG002|Overall Study|Unable to enroll on platform|0|||
44461275|NCT03905265|79470285|FG000|Overall Study|Withdrawal by Subject|1|||
44461276|NCT03905265|79470286|FG001|Overall Study|Withdrawal by Subject|1|||
44461277|NCT03905265|79470287|FG002|Overall Study|Withdrawal by Subject|0|||
44270563|NCT02296242|79197096|FG002|Overall Study|Physician Decision|0|||
44270564|NCT02296242|79197097|FG003|Overall Study|Physician Decision|1|||
44270565|NCT02296242|79197098|FG004|Overall Study|Physician Decision|0|||
44270566|NCT02296242|79197094|FG000|Overall Study|Alternative Treatment|0|||
44270567|NCT02296242|79197095|FG001|Overall Study|Alternative Treatment|0|||
44270568|NCT02296242|79197096|FG002|Overall Study|Alternative Treatment|0|||
44270569|NCT02296242|79197097|FG003|Overall Study|Alternative Treatment|1|||
44270570|NCT02296242|79197098|FG004|Overall Study|Alternative Treatment|0|||
44270571|NCT02296242|79197094|FG000|Overall Study|Adverse Event|0|||
44270572|NCT02296242|79197095|FG001|Overall Study|Adverse Event|0|||
44461278|NCT03905265|79470288|FG003|Overall Study|Withdrawal by Subject|0|||
44461279|NCT03848845|79470301|FG000|Overall Study|Lost to Follow-up|0|||
44461280|NCT03848845|79470302|FG001|Overall Study|Lost to Follow-up|1|||
44461281|NCT03848845|79470303|FG002|Overall Study|Lost to Follow-up|0|||
44461282|NCT03848845|79470301|FG000|Overall Study|Withdrawal by Subject|3|||
44461283|NCT03848845|79470302|FG001|Overall Study|Withdrawal by Subject|2|||
44461284|NCT03848845|79470303|FG002|Overall Study|Withdrawal by Subject|6|||
44461285|NCT03848845|79470301|FG000|Overall Study|In Follow-up|0|||
44461286|NCT03848845|79470302|FG001|Overall Study|In Follow-up|1|||
44461287|NCT03848845|79470303|FG002|Overall Study|In Follow-up|12|||
44220106|NCT01729208|79020717|FG001|36 Months Follow-up|Physician Decision|0|||
44220107|NCT01729208|79020716|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
44220108|NCT01729208|79020717|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
44220109|NCT01609010|79020734|FG000|Overall Study|Stable disease (SD)|22|||
44220110|NCT01609010|79020735|FG001|Overall Study|Stable disease (SD)|16|||
44220111|NCT01609010|79020734|FG000|Overall Study|Progressive disease (PD)|8|||
44220112|NCT01609010|79020735|FG001|Overall Study|Progressive disease (PD)|10|||
44220113|NCT01609010|79020734|FG000|Overall Study|Adverse Event|3|||
44270573|NCT02296242|79197096|FG002|Overall Study|Adverse Event|0|||
44270574|NCT02296242|79197097|FG003|Overall Study|Adverse Event|1|||
44270575|NCT02296242|79197098|FG004|Overall Study|Adverse Event|0|||
44270576|NCT02296242|79197094|FG000|Overall Study|Lack of Efficacy|0|||
44270577|NCT02296242|79197095|FG001|Overall Study|Lack of Efficacy|0|||
44270578|NCT02296242|79197096|FG002|Overall Study|Lack of Efficacy|0|||
44270579|NCT02296242|79197097|FG003|Overall Study|Lack of Efficacy|0|||
44270580|NCT02296242|79197098|FG004|Overall Study|Lack of Efficacy|3|||
44270581|NCT02295774|79197118|FG000|Overall Study|Physician Decision|1|||
44270582|NCT02295774|79197118|FG000|Overall Study|Withdrawal by Subject|2|||
44270583|NCT02294682|79197133|FG000|Overall Study|Could not swallow pills|1|||
44461288|NCT03848845|79470301|FG000|Overall Study|On Study Treatment|0|||
44461289|NCT03848845|79470302|FG001|Overall Study|On Study Treatment|0|||
44220114|NCT01609010|79020735|FG001|Overall Study|Adverse Event|6|||
44220115|NCT01609010|79020734|FG000|Overall Study|Withdrawal by Subject|2|||
44461290|NCT03848845|79470303|FG002|Overall Study|On Study Treatment|4|||
44461291|NCT03848845|79470301|FG000|Overall Study|Physician Decision|0|||
44461292|NCT03848845|79470302|FG001|Overall Study|Physician Decision|0|||
44461293|NCT03848845|79470303|FG002|Overall Study|Physician Decision|1|||
44461294|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
44220116|NCT01609010|79020735|FG001|Overall Study|Withdrawal by Subject|2|||
44270584|NCT02294682|79197134|FG001|Overall Study|Could not swallow pills|0|||
44270585|NCT02294604|79197143|FG000|Overall Study|Did not provide samples for culture|0|||
44461295|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
44220117|NCT01609010|79020734|FG000|Overall Study|Other|2|||
44270586|NCT02294604|79197144|FG001|Overall Study|Did not provide samples for culture|1|||
44270587|NCT02294604|79197145|FG002|Overall Study|Did not provide samples for culture|0|||
44270588|NCT02294604|79197143|FG000|Overall Study|Culture contamination|1|||
44270589|NCT02294604|79197144|FG001|Overall Study|Culture contamination|2|||
44270590|NCT02294604|79197145|FG002|Overall Study|Culture contamination|0|||
44270591|NCT01645176|79197164|FG000|Overall Study|Lack of Efficacy|4|||
44270592|NCT01645176|79197164|FG000|Overall Study|did not complete final MRI|1|||
44270593|NCT02322216|79197179|FG000|Overall Study|Adverse Event|1|||
44270594|NCT02322216|79197180|FG001|Overall Study|Adverse Event|0|||
44270595|NCT02322216|79197179|FG000|Overall Study|Withdrawal by Subject|1|||
44461296|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
44461297|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
44461298|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
44461299|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
44220118|NCT01609010|79020735|FG001|Overall Study|Other|0|||
44220119|NCT01609010|79020734|FG000|Overall Study|Other malignancy|1|||
44220120|NCT01609010|79020735|FG001|Overall Study|Other malignancy|0|||
44220121|NCT01609010|79020734|FG000|Overall Study|Pathology review|2|||
44220122|NCT01609010|79020735|FG001|Overall Study|Pathology review|1|||
44220123|NCT01609010|79020734|FG000|Overall Study|Protocol Violation|1|||
44220124|NCT01609010|79020735|FG001|Overall Study|Protocol Violation|1|||
44220125|NCT01609010|79020734|FG000|Overall Study|New cancer|1|||
44220126|NCT01609010|79020735|FG001|Overall Study|New cancer|0|||
44220127|NCT01609010|79020734|FG000|Overall Study|Lost to Follow-up|1|||
44220128|NCT01609010|79020735|FG001|Overall Study|Lost to Follow-up|1|||
44220129|NCT01608308|79020743|FG000|Overall Study|pretreatment medical and billing reasons|0|||
44220130|NCT01608308|79020744|FG001|Overall Study|pretreatment medical and billing reasons|2|||
44220131|NCT01755416|79020775|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
44220132|NCT01755416|79020776|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
44220133|NCT01755026|79020784|FG000|Overall Study|Adverse Event|1|||
44220134|NCT01755026|79020785|FG001|Overall Study|Adverse Event|0|||
44220135|NCT01755026|79020784|FG000|Overall Study|Withdrawal by Subject|1|||
44220136|NCT01755026|79020785|FG001|Overall Study|Withdrawal by Subject|1|||
44220137|NCT01491945|79020800|FG000|Overall Study|Death|30|||
44220138|NCT01491945|79020800|FG000|Overall Study|Withdrwan/LTF|16|||
44220139|NCT01491945|79020800|FG000|Overall Study|Conversion|4|||
44220140|NCT01491945|79020800|FG000|Overall Study|Missed Visit|1|||
44220141|NCT01728584|79020822|FG000|Overall Study|Adverse Event|1|||
44270596|NCT02322216|79197180|FG001|Overall Study|Withdrawal by Subject|4|||
44270597|NCT01647516|79197221|FG000|Induction Period (IP)|Physician Decision|2|||
44270598|NCT01647516|79197222|FG001|Induction Period (IP)|Physician Decision|0|||
44270599|NCT01647516|79197223|FG002|Induction Period (IP)|Physician Decision|0|||
44270600|NCT01647516|79197224|FG003|Induction Period (IP)|Physician Decision|0|||
44270601|NCT01647516|79197225|FG004|Induction Period (IP)|Physician Decision|0|||
44373748|NCT02725593|79378916|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
44373749|NCT02725593|79378917|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
44373750|NCT02725593|79378916|FG000|Long Term Extension|Withdrawal by Subject|1|||
44373751|NCT02725593|79378917|FG001|Long Term Extension|Withdrawal by Subject|3|||
44373752|NCT00911625|79378925|FG000|Overall Study|Lost to Follow-up|7|||
44373753|NCT00911625|79378926|FG001|Overall Study|Lost to Follow-up|0|||
44373754|NCT00596752|79378934|FG000|Overall Study|Other Reason|44|||
44373755|NCT00596752|79378935|FG001|Overall Study|Other Reason|49|||
44373756|NCT00596752|79378934|FG000|Overall Study|Adverse Event|34|||
44373757|NCT00596752|79378935|FG001|Overall Study|Adverse Event|34|||
44373758|NCT00596752|79378934|FG000|Overall Study|Lost to Follow-up|22|||
44373759|NCT00596752|79378935|FG001|Overall Study|Lost to Follow-up|38|||
44373760|NCT00596752|79378934|FG000|Overall Study|Withdrawal by Subject|12|||
44373761|NCT00596752|79378935|FG001|Overall Study|Withdrawal by Subject|9|||
44373762|NCT00596752|79378934|FG000|Overall Study|Unsatisfactory Compliance|9|||
44373763|NCT00596752|79378935|FG001|Overall Study|Unsatisfactory Compliance|6|||
44373764|NCT00596752|79378934|FG000|Overall Study|Lack of Efficacy|4|||
44373765|NCT00596752|79378935|FG001|Overall Study|Lack of Efficacy|7|||
44373766|NCT00596752|79378934|FG000|Overall Study|Protocol Violation|1|||
44373767|NCT00596752|79378935|FG001|Overall Study|Protocol Violation|0|||
44373768|NCT00958074|79378943|FG000|Overall Study|Withdrawal by Subject|0|||
44373769|NCT00958074|79378944|FG001|Overall Study|Withdrawal by Subject|1|||
44373770|NCT00809965|79378953|FG000|Overall Study|Death|194|||
44373771|NCT00809965|79378954|FG001|Overall Study|Death|147|||
44373772|NCT00809965|79378955|FG002|Overall Study|Death|196|||
44373773|NCT00809965|79378953|FG000|Overall Study|Lost to Follow-up|17|||
44373774|NCT00809965|79378954|FG001|Overall Study|Lost to Follow-up|10|||
44373775|NCT00809965|79378955|FG002|Overall Study|Lost to Follow-up|18|||
44373776|NCT00809965|79378953|FG000|Overall Study|Withdrawal by Subject|405|||
44461300|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
44220142|NCT01728584|79020823|FG001|Overall Study|Adverse Event|0|||
44220143|NCT01728584|79020824|FG002|Overall Study|Adverse Event|0|||
44220144|NCT01728584|79020825|FG003|Overall Study|Adverse Event|0|||
44220145|NCT01728584|79020822|FG000|Overall Study|Physician Decision|4|||
44270602|NCT01647516|79197226|FG005|Induction Period (IP)|Physician Decision|0|||
44270603|NCT01647516|79197221|FG000|Induction Period (IP)|Adverse Event|1|||
44373777|NCT00809965|79378954|FG001|Overall Study|Withdrawal by Subject|448|||
44373778|NCT00809965|79378955|FG002|Overall Study|Withdrawal by Subject|441|||
44220146|NCT01728584|79020823|FG001|Overall Study|Physician Decision|0|||
44220147|NCT01728584|79020824|FG002|Overall Study|Physician Decision|1|||
44220148|NCT01728584|79020825|FG003|Overall Study|Physician Decision|0|||
44220149|NCT01728584|79020822|FG000|Overall Study|Withdrawal by Subject|1|||
44220150|NCT01728584|79020823|FG001|Overall Study|Withdrawal by Subject|0|||
44220151|NCT01728584|79020824|FG002|Overall Study|Withdrawal by Subject|0|||
44220152|NCT01728584|79020825|FG003|Overall Study|Withdrawal by Subject|0|||
44220153|NCT01728584|79020822|FG000|Overall Study|Screen failure|1|||
44220154|NCT01728584|79020823|FG001|Overall Study|Screen failure|0|||
44220155|NCT01728584|79020824|FG002|Overall Study|Screen failure|0|||
44220156|NCT01728584|79020825|FG003|Overall Study|Screen failure|0|||
44220157|NCT01728584|79020822|FG000|Overall Study|Other reason (not specified)|1|||
44220158|NCT01728584|79020823|FG001|Overall Study|Other reason (not specified)|0|||
44220159|NCT01728584|79020824|FG002|Overall Study|Other reason (not specified)|0|||
44220160|NCT01728584|79020825|FG003|Overall Study|Other reason (not specified)|1|||
44220161|NCT01522443|79020858|FG000|Overall Study|No longer receiving clinical benefit|36|||
44220162|NCT01522443|79020859|FG001|Overall Study|No longer receiving clinical benefit|28|||
44220163|NCT01522443|79020858|FG000|Overall Study|Adverse Event|10|||
44220164|NCT01522443|79020859|FG001|Overall Study|Adverse Event|15|||
44220165|NCT01522443|79020858|FG000|Overall Study|Withdrawal by Subject|5|||
44220166|NCT01522443|79020859|FG001|Overall Study|Withdrawal by Subject|8|||
44220167|NCT01522443|79020858|FG000|Overall Study|No study treatment given|1|||
44220168|NCT01522443|79020859|FG001|Overall Study|No study treatment given|1|||
44220169|NCT01522443|79020858|FG000|Overall Study|Other|1|||
44220170|NCT01522443|79020859|FG001|Overall Study|Other|3|||
44220171|NCT01468233|79020876|FG000|Treatment Period 1|Adverse Event|5|||
44220172|NCT01468233|79020877|FG001|Treatment Period 1|Adverse Event|3|||
44220173|NCT01468233|79020878|FG002|Treatment Period 1|Adverse Event|0|||
44220174|NCT01468233|79020879|FG003|Treatment Period 1|Adverse Event|0|||
44220175|NCT01468233|79020880|FG004|Treatment Period 1|Adverse Event|0|||
44220176|NCT01468233|79020881|FG005|Treatment Period 1|Adverse Event|0|||
44220177|NCT01468233|79020876|FG000|Treatment Period 1|Withdrawal by Subject|3|||
44220178|NCT01468233|79020877|FG001|Treatment Period 1|Withdrawal by Subject|4|||
44220179|NCT01468233|79020878|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44220180|NCT01468233|79020879|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44220181|NCT01468233|79020880|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44220182|NCT01468233|79020881|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44220183|NCT01468233|79020876|FG000|Treatment Period 1|Lost to Follow-up|3|||
44220184|NCT01468233|79020877|FG001|Treatment Period 1|Lost to Follow-up|0|||
44220185|NCT01468233|79020878|FG002|Treatment Period 1|Lost to Follow-up|0|||
44220186|NCT01468233|79020879|FG003|Treatment Period 1|Lost to Follow-up|0|||
44220187|NCT01468233|79020880|FG004|Treatment Period 1|Lost to Follow-up|0|||
44220188|NCT01468233|79020881|FG005|Treatment Period 1|Lost to Follow-up|0|||
44220189|NCT01468233|79020876|FG000|Treatment Period 1|Other|1|||
44220190|NCT01468233|79020877|FG001|Treatment Period 1|Other|1|||
44220191|NCT01468233|79020878|FG002|Treatment Period 1|Other|0|||
44220192|NCT01468233|79020879|FG003|Treatment Period 1|Other|0|||
44220193|NCT01468233|79020880|FG004|Treatment Period 1|Other|0|||
44220194|NCT01468233|79020881|FG005|Treatment Period 1|Other|0|||
44220195|NCT01468233|79020876|FG000|Treatment Period 2|Adverse Event|0|||
44220196|NCT01468233|79020877|FG001|Treatment Period 2|Adverse Event|0|||
44220197|NCT01468233|79020878|FG002|Treatment Period 2|Adverse Event|3|||
44220198|NCT01468233|79020879|FG003|Treatment Period 2|Adverse Event|0|||
44220199|NCT01468233|79020880|FG004|Treatment Period 2|Adverse Event|2|||
44220200|NCT01468233|79020881|FG005|Treatment Period 2|Adverse Event|1|||
44220201|NCT01468233|79020876|FG000|Treatment Period 2|Lack of Efficacy|0|||
44220202|NCT01468233|79020877|FG001|Treatment Period 2|Lack of Efficacy|0|||
44220203|NCT01468233|79020878|FG002|Treatment Period 2|Lack of Efficacy|9|||
44373779|NCT00809965|79378953|FG000|Overall Study|Other Reason|167|||
44373780|NCT00809965|79378954|FG001|Overall Study|Other Reason|170|||
44373781|NCT00809965|79378955|FG002|Overall Study|Other Reason|189|||
44220204|NCT01468233|79020879|FG003|Treatment Period 2|Lack of Efficacy|2|||
44220205|NCT01468233|79020880|FG004|Treatment Period 2|Lack of Efficacy|0|||
44270604|NCT01647516|79197222|FG001|Induction Period (IP)|Adverse Event|2|||
44373782|NCT00597376|79378965|FG000|Overall Study|Withdrawal by Subject|4|||
44373783|NCT00597376|79378966|FG001|Overall Study|Withdrawal by Subject|3|||
44220206|NCT01468233|79020881|FG005|Treatment Period 2|Lack of Efficacy|1|||
44220207|NCT01468233|79020876|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44220208|NCT01468233|79020877|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44220209|NCT01468233|79020878|FG002|Treatment Period 2|Withdrawal by Subject|9|||
44220210|NCT01468233|79020879|FG003|Treatment Period 2|Withdrawal by Subject|1|||
44220211|NCT01468233|79020880|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44220212|NCT01468233|79020881|FG005|Treatment Period 2|Withdrawal by Subject|1|||
44220213|NCT01468233|79020876|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
44220214|NCT01468233|79020877|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
44373784|NCT00597376|79378965|FG000|Overall Study|Adverse Event|4|||
44220215|NCT01468233|79020878|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
44220216|NCT01468233|79020879|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
44220217|NCT01468233|79020880|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
44220218|NCT01468233|79020881|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
44220219|NCT01468233|79020876|FG000|Treatment Period 2|Lost to Follow-up|0|||
44220220|NCT01468233|79020877|FG001|Treatment Period 2|Lost to Follow-up|0|||
44220221|NCT01468233|79020878|FG002|Treatment Period 2|Lost to Follow-up|3|||
44220222|NCT01468233|79020879|FG003|Treatment Period 2|Lost to Follow-up|0|||
44373785|NCT00597376|79378966|FG001|Overall Study|Adverse Event|1|||
44461301|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
44461302|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
44461303|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
44461304|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
44220223|NCT01468233|79020880|FG004|Treatment Period 2|Lost to Follow-up|2|||
44220224|NCT01468233|79020881|FG005|Treatment Period 2|Lost to Follow-up|0|||
44220225|NCT01468233|79020876|FG000|Treatment Period 2|Other|0|||
44220226|NCT01468233|79020877|FG001|Treatment Period 2|Other|0|||
44220227|NCT01468233|79020878|FG002|Treatment Period 2|Other|3|||
44220228|NCT01468233|79020879|FG003|Treatment Period 2|Other|0|||
44220229|NCT01468233|79020880|FG004|Treatment Period 2|Other|1|||
44220230|NCT01468233|79020881|FG005|Treatment Period 2|Other|0|||
44220231|NCT01468077|79020901|FG000|Overall Study|Adverse Event|2|||
44220232|NCT01468077|79020902|FG001|Overall Study|Adverse Event|2|||
44220233|NCT01468077|79020901|FG000|Overall Study|Lack of Efficacy|1|||
44220234|NCT01468077|79020902|FG001|Overall Study|Lack of Efficacy|1|||
44220235|NCT01468077|79020901|FG000|Overall Study|Physician Decision|1|||
44220236|NCT01468077|79020902|FG001|Overall Study|Physician Decision|0|||
44220237|NCT01522365|79020910|FG000|Overall Study|Withdrawal by Subject|1|||
44220238|NCT01522365|79020911|FG001|Overall Study|Withdrawal by Subject|1|||
44220239|NCT01522365|79020910|FG000|Overall Study|Lost to Follow-up|1|||
44220240|NCT01522365|79020911|FG001|Overall Study|Lost to Follow-up|1|||
44220241|NCT01783418|79020920|FG000|Overall Study|Withdrawal by Subject|1|||
44220242|NCT01783418|79020921|FG001|Overall Study|Withdrawal by Subject|0|||
44220243|NCT01521897|79020927|FG000|Overall Study|Protocol Violation|18|||
44220244|NCT01521897|79020927|FG000|Overall Study|Lost to Follow-up|5|||
44220245|NCT01782872|79020935|FG000|Overall Study|Protocol Violation|0|||
44220246|NCT01782872|79020936|FG001|Overall Study|Protocol Violation|0|||
44220247|NCT01782872|79020937|FG002|Overall Study|Protocol Violation|0|||
44220248|NCT01782872|79020938|FG003|Overall Study|Protocol Violation|1|||
44220249|NCT01782872|79020935|FG000|Overall Study|Withdrawal by Subject|0|||
44220250|NCT01782872|79020936|FG001|Overall Study|Withdrawal by Subject|1|||
44220251|NCT01782872|79020937|FG002|Overall Study|Withdrawal by Subject|0|||
44220252|NCT01782872|79020938|FG003|Overall Study|Withdrawal by Subject|0|||
44220253|NCT01490697|79020950|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
44270605|NCT01647516|79197223|FG002|Induction Period (IP)|Adverse Event|0|||
44373786|NCT00910689|79379002|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
44373787|NCT00910689|79379003|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
44373788|NCT00910689|79379004|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
44373789|NCT00910689|79379005|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
44373790|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
44373791|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
44373792|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
44373793|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
44373794|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
44373795|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
44373796|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
44373797|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
44373798|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
44373799|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
44373800|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
44220254|NCT01490697|79020951|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
44220255|NCT01728194|79020959|FG000|Overall Study|Lost to Follow-up|4|||
44220256|NCT01728194|79020960|FG001|Overall Study|Lost to Follow-up|3|||
44220257|NCT01728194|79020959|FG000|Overall Study|Physician Decision|4|||
44220258|NCT01728194|79020960|FG001|Overall Study|Physician Decision|0|||
44220259|NCT01728194|79020959|FG000|Overall Study|Withdrawal by Subject|7|||
44373801|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
44373802|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
44461305|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
44461306|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
44461307|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
44461308|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
44461309|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
44461310|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
44461311|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
44461312|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
44461313|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
44461314|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
44461315|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
44461316|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
44461317|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
44461318|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
44461319|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
44461320|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
44461321|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
44461322|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
44461323|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
44461324|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
44220260|NCT01728194|79020960|FG001|Overall Study|Withdrawal by Subject|3|||
44220261|NCT01728194|79020959|FG000|Overall Study|Perceived Medication Side Effects|4|||
44220262|NCT01728194|79020960|FG001|Overall Study|Perceived Medication Side Effects|0|||
44220263|NCT01728194|79020959|FG000|Overall Study|Family Member Request|1|||
44220264|NCT01728194|79020960|FG001|Overall Study|Family Member Request|0|||
44220265|NCT01782482|79020968|FG000|Overall Study|Adverse Event|2|||
44220266|NCT01782482|79020969|FG001|Overall Study|Adverse Event|1|||
44220267|NCT01782482|79020968|FG000|Overall Study|Lost to Follow-up|2|||
44220268|NCT01782482|79020969|FG001|Overall Study|Lost to Follow-up|3|||
44220269|NCT01782482|79020968|FG000|Overall Study|Physician Decision|1|||
44220270|NCT01782482|79020969|FG001|Overall Study|Physician Decision|0|||
44220271|NCT01782482|79020968|FG000|Overall Study|Protocol Violation|1|||
44220272|NCT01782482|79020969|FG001|Overall Study|Protocol Violation|0|||
44220273|NCT01782482|79020968|FG000|Overall Study|Withdrawal by Subject|2|||
44220274|NCT01782482|79020969|FG001|Overall Study|Withdrawal by Subject|3|||
44220275|NCT01782482|79020968|FG000|Overall Study|Randomized in Error|2|||
44461325|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
44220276|NCT01782482|79020969|FG001|Overall Study|Randomized in Error|2|||
44220277|NCT01782482|79020968|FG000|Overall Study|Habitually wearing toric lens OS|0|||
44220278|NCT01782482|79020969|FG001|Overall Study|Habitually wearing toric lens OS|1|||
44220279|NCT01466673|79020977|FG000|Overall Study|Non-compliance with study treatment|2|||
44220280|NCT01466673|79020978|FG001|Overall Study|Non-compliance with study treatment|0|||
44220281|NCT01466673|79020977|FG000|Overall Study|Lost to Follow-up|3|||
44220282|NCT01466673|79020978|FG001|Overall Study|Lost to Follow-up|5|||
44220283|NCT01466673|79020977|FG000|Overall Study|Adverse Event|2|||
44220284|NCT01466673|79020978|FG001|Overall Study|Adverse Event|1|||
44220285|NCT01753856|79020986|FG000|Overall Study|Adverse Event|1|||
44220286|NCT01753856|79020987|FG001|Overall Study|Adverse Event|0|||
44220287|NCT01753856|79020986|FG000|Overall Study|Withdrawal by Subject|0|||
44220288|NCT01753856|79020987|FG001|Overall Study|Withdrawal by Subject|2|||
44220289|NCT01753856|79020986|FG000|Overall Study|Sponsor Decision|2|||
44220290|NCT01753856|79020987|FG001|Overall Study|Sponsor Decision|0|||
44220291|NCT01464333|79020996|FG000|Overall Study|Adverse Event|34|||
44373803|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
44373804|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
44373805|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
44373806|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
44373807|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
44373808|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
44373809|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
44373810|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
44461326|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
44220292|NCT01464333|79020996|FG000|Overall Study|Lack of Efficacy|72|||
44220293|NCT01464333|79020996|FG000|Overall Study|Withdrawal by Subject|11|||
44220294|NCT01464333|79020996|FG000|Overall Study|Other|4|||
44220295|NCT01464333|79020996|FG000|Overall Study|No Hospital Visit|42|||
44220296|NCT01464255|79021002|FG000|Overall Study|unresolve corneal staining|0|||
44220297|NCT01464255|79021003|FG001|Overall Study|unresolve corneal staining|1|||
44220298|NCT01464021|79021010|FG000|Overall Study|Withdrawal by Subject|13|||
44220299|NCT01464021|79021010|FG000|Overall Study|Lost to Follow-up|1|||
44220300|NCT01464021|79021010|FG000|Overall Study|Lack of Efficacy|1|||
44220301|NCT01464021|79021010|FG000|Overall Study|various|11|||
44461327|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
44461328|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
44461329|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
44461330|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
44461331|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
44461332|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
44461333|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
44461334|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
44461335|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
44461336|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
44220302|NCT01753310|79021016|FG000|Overall Study|Entered into open label extension study|25|||
44220303|NCT01753310|79021017|FG001|Overall Study|Entered into open label extension study|22|||
44461337|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
44461338|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
44220304|NCT01753310|79021016|FG000|Overall Study|Adverse Event|1|||
44220305|NCT01753310|79021017|FG001|Overall Study|Adverse Event|0|||
44220306|NCT01753310|79021016|FG000|Overall Study|Lost to Follow-up|2|||
44220307|NCT01753310|79021017|FG001|Overall Study|Lost to Follow-up|0|||
44461339|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
44461340|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
44461341|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
44461342|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
44461343|NCT03742037|79470316|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
44461344|NCT03742037|79470317|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
44461345|NCT03742037|79470318|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
44544202|NCT03514134|79557476|FG001|Overall Study|Lost to Follow-up|1|||
44220308|NCT01753310|79021016|FG000|Overall Study|Subject decision|2|||
44220309|NCT01753310|79021017|FG001|Overall Study|Subject decision|2|||
44220310|NCT01753310|79021016|FG000|Overall Study|Sponsor decision|1|||
44220311|NCT01753310|79021017|FG001|Overall Study|Sponsor decision|0|||
44220312|NCT01753310|79021016|FG000|Overall Study|Withdrawal by Subject|1|||
44270606|NCT01647516|79197224|FG003|Induction Period (IP)|Adverse Event|0|||
44373811|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
44373812|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
44373813|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
44373814|NCT00910689|79379002|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
44373815|NCT00910689|79379003|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
44373816|NCT00910689|79379004|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
44373817|NCT00910689|79379005|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
44373818|NCT00910689|79379002|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
44373819|NCT00910689|79379003|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
44373820|NCT00910689|79379004|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
44373821|NCT00910689|79379005|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
44373822|NCT00910689|79379002|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
44373823|NCT00910689|79379003|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
44373824|NCT00910689|79379004|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
44373825|NCT00910689|79379005|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
44373826|NCT00910689|79379002|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
44373827|NCT00910689|79379003|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
44373828|NCT00910689|79379004|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
44373829|NCT00910689|79379005|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
44373830|NCT00910689|79379002|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
44373831|NCT00910689|79379003|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
44373832|NCT00910689|79379004|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
44373833|NCT00910689|79379005|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
44373834|NCT00910689|79379002|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
44373835|NCT00910689|79379003|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
44373836|NCT00910689|79379004|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
44373837|NCT00910689|79379005|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
44373838|NCT00910689|79379002|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
44373839|NCT00910689|79379003|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
44373840|NCT00910689|79379004|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
44270607|NCT01647516|79197225|FG004|Induction Period (IP)|Adverse Event|0|||
44270608|NCT01647516|79197226|FG005|Induction Period (IP)|Adverse Event|0|||
44220313|NCT01753310|79021017|FG001|Overall Study|Withdrawal by Subject|0|||
44373841|NCT00910689|79379005|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
44220314|NCT01463631|79021027|FG000|Overall Study|Withdrawal by Subject|0|||
44270609|NCT01647516|79197221|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
44461346|NCT03742037|79470319|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
44461347|NCT03742037|79470320|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
44461348|NCT03742037|79470321|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
44461349|NCT03742037|79470322|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
44461350|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
44461351|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
44461352|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
44461353|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
44461354|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
44461355|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
44461356|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
44461357|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
44461358|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
44461359|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
44461360|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
44461361|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
44461362|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
44461363|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
44461364|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
44461365|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
44461366|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
44461367|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
44461368|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
44461369|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
44461370|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
44461371|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
44461372|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
44461373|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
44461374|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
44461375|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
44461376|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
44461377|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
44461378|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
44461379|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
44461380|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
44461381|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
44461382|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
44461383|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
44461384|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
44461385|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
44461386|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
44461387|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
44461388|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
44461389|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
44461390|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
44461391|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
44461392|NCT03742037|79470316|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
44461393|NCT03742037|79470317|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
44461394|NCT03742037|79470318|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
44461395|NCT03742037|79470319|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
44461396|NCT03742037|79470320|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
44461397|NCT03742037|79470321|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
44461398|NCT03742037|79470322|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
44461399|NCT03714815|79470339|FG000|Overall Study|Physician Decision|2|||
44461400|NCT03714815|79470339|FG000|Overall Study|Withdrawal by Subject|2|||
44461401|NCT03714815|79470339|FG000|Overall Study|Death|11|||
44461402|NCT03640312|79470349|FG000|Overall Study|Lost to Follow-up|3|||
44461403|NCT03640312|79470350|FG001|Overall Study|Lost to Follow-up|6|||
44461404|NCT02254278|79470362|FG000|Overall Study|Protocol Violation|1|||
44270610|NCT01647516|79197222|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
44220315|NCT01463631|79021028|FG001|Overall Study|Withdrawal by Subject|0|||
44220316|NCT01463631|79021029|FG002|Overall Study|Withdrawal by Subject|0|||
44220317|NCT01463631|79021030|FG003|Overall Study|Withdrawal by Subject|1|||
44461405|NCT02254278|79470363|FG001|Overall Study|Protocol Violation|1|||
44461406|NCT01998841|79470375|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
44461407|NCT01998841|79470376|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
44461408|NCT01998841|79470377|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
44461409|NCT01998841|79470378|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
44461410|NCT01998841|79470379|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
44461411|NCT01998841|79470375|FG000|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
44461412|NCT01998841|79470376|FG001|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
44461413|NCT01998841|79470377|FG002|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
44461414|NCT01998841|79470378|FG003|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|147|||
44461415|NCT01998841|79470379|FG004|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|72|||
44461416|NCT01607879|79470389|FG000|Overall Study|Death|1|||
44461417|NCT01607879|79470390|FG001|Overall Study|Death|0|||
44461418|NCT00352027|79470401|FG000|Overall Study|Progressive disease|3|||
44461419|NCT00440271|79470443|FG000|Overall Study|Protocol Violation|1|||
44461420|NCT00440271|79470444|FG001|Overall Study|Protocol Violation|1|||
44461421|NCT00440271|79470443|FG000|Overall Study|Adverse Event|0|||
44461422|NCT00440271|79470444|FG001|Overall Study|Adverse Event|1|||
44461423|NCT00440271|79470443|FG000|Overall Study|Lost to Follow-up|1|||
44461424|NCT00440271|79470444|FG001|Overall Study|Lost to Follow-up|0|||
44461425|NCT00440271|79470443|FG000|Overall Study|Withdrawal by Subject|0|||
44461426|NCT00440271|79470444|FG001|Overall Study|Withdrawal by Subject|2|||
44461427|NCT00440271|79470443|FG000|Overall Study|Lack of Efficacy|0|||
44461428|NCT00440271|79470444|FG001|Overall Study|Lack of Efficacy|1|||
44220318|NCT01463631|79021027|FG000|Overall Study|Death|0|||
44220319|NCT01463631|79021028|FG001|Overall Study|Death|0|||
44220320|NCT01463631|79021029|FG002|Overall Study|Death|1|||
44220321|NCT01463631|79021030|FG003|Overall Study|Death|0|||
44220322|NCT01463631|79021027|FG000|Overall Study|Progressive Disease|0|||
44220323|NCT01463631|79021028|FG001|Overall Study|Progressive Disease|0|||
44220324|NCT01463631|79021029|FG002|Overall Study|Progressive Disease|0|||
44220325|NCT01463631|79021030|FG003|Overall Study|Progressive Disease|5|||
44220326|NCT01521507|79021044|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
44220327|NCT01521507|79021045|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
44220328|NCT01521507|79021044|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
44373842|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
44373843|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
44373844|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
44373845|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
44373846|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
44373847|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
44373848|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
44373849|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
44373850|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
44373851|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
44373852|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
44373853|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
44373854|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
44373855|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
44373856|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
44373857|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
44373858|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
44373859|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
44461429|NCT00440271|79470443|FG000|Overall Study|Due to closure of trial|8|||
44461430|NCT00440271|79470444|FG001|Overall Study|Due to closure of trial|10|||
44220329|NCT01521507|79021045|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
44461431|NCT00440271|79470443|FG000|Overall Study|Other|2|||
44220330|NCT01521507|79021044|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
44220331|NCT01521507|79021045|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
44373860|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
44373861|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
44461432|NCT00440271|79470444|FG001|Overall Study|Other|0|||
44461433|NCT00346216|79470453|FG000|Overall Study|Other|181|||
44461434|NCT00346216|79470454|FG001|Overall Study|Other|231|||
44461435|NCT00346216|79470455|FG002|Overall Study|Other|205|||
44461436|NCT00346216|79470453|FG000|Overall Study|No longer willing to participate|600|||
44461437|NCT00346216|79470454|FG001|Overall Study|No longer willing to participate|606|||
44461438|NCT00346216|79470455|FG002|Overall Study|No longer willing to participate|585|||
44461439|NCT00346216|79470453|FG000|Overall Study|Withdrawal by Subject|661|||
44461440|NCT00346216|79470454|FG001|Overall Study|Withdrawal by Subject|692|||
44544203|NCT03188718|79557482|FG000|Overall Study|Participant noncompliance|4|||
44220332|NCT01521507|79021044|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
44220333|NCT01521507|79021045|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
44220334|NCT01521507|79021044|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
44220335|NCT01521507|79021045|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
44220336|NCT01521507|79021044|FG000|Stage 2: Observational Design|Physician Decision|1|||
44220337|NCT01521507|79021045|FG001|Stage 2: Observational Design|Physician Decision|0|||
44220338|NCT01521117|79021058|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
44220339|NCT01521117|79021059|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
44220340|NCT01521117|79021058|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
44220341|NCT01521117|79021059|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
44220342|NCT01521117|79021058|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
44220343|NCT01521117|79021059|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
44220344|NCT01466595|79021067|FG000|Overall Study|Withdrawal by Subject|0|||
44220345|NCT01466595|79021068|FG001|Overall Study|Withdrawal by Subject|1|||
44220346|NCT01728116|79021085|FG000|Overall Study|Sponsor Terminated Study|106|||
44220347|NCT01728116|79021086|FG001|Overall Study|Sponsor Terminated Study|35|||
44220348|NCT01728116|79021085|FG000|Overall Study|Withdrawal by Subject|16|||
44220349|NCT01728116|79021086|FG001|Overall Study|Withdrawal by Subject|9|||
44220350|NCT01728116|79021085|FG000|Overall Study|Adverse Event|13|||
44220351|NCT01728116|79021086|FG001|Overall Study|Adverse Event|0|||
44220352|NCT01728116|79021085|FG000|Overall Study|Procedure/device failure|7|||
44220353|NCT01728116|79021086|FG001|Overall Study|Procedure/device failure|0|||
44220354|NCT01728116|79021085|FG000|Overall Study|Lost to Follow-up|9|||
44220355|NCT01728116|79021086|FG001|Overall Study|Lost to Follow-up|2|||
44220356|NCT01728116|79021085|FG000|Overall Study|Physician Decision|2|||
44220357|NCT01728116|79021086|FG001|Overall Study|Physician Decision|0|||
44220358|NCT01728116|79021085|FG000|Overall Study|Subject Non-Compliance|2|||
44220359|NCT01728116|79021086|FG001|Overall Study|Subject Non-Compliance|0|||
44220360|NCT01728116|79021085|FG000|Overall Study|Inter-current finding at procedure|1|||
44220361|NCT01728116|79021086|FG001|Overall Study|Inter-current finding at procedure|0|||
44220362|NCT01728116|79021085|FG000|Overall Study|Incorrectly enrolled in Study|0|||
44220363|NCT01728116|79021086|FG001|Overall Study|Incorrectly enrolled in Study|1|||
44220364|NCT01728116|79021085|FG000|Overall Study|various not noted previously|5|||
44220365|NCT01728116|79021086|FG001|Overall Study|various not noted previously|0|||
44220366|NCT01465659|79021097|FG000|Completed 1 Cycle of Treatment|Death|0|||
44220367|NCT01465659|79021098|FG001|Completed 1 Cycle of Treatment|Death|1|||
44220368|NCT01465659|79021099|FG002|Completed 1 Cycle of Treatment|Death|0|||
44220369|NCT01465659|79021100|FG003|Completed 1 Cycle of Treatment|Death|0|||
44220370|NCT01465659|79021097|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
44220371|NCT01465659|79021098|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
44220372|NCT01465659|79021099|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
44220373|NCT01465659|79021100|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
44220374|NCT01465659|79021097|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
44220375|NCT01465659|79021098|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
44220376|NCT01465659|79021099|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
44220377|NCT01465659|79021100|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
44373862|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
44373863|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
44373864|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
44373865|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
44220378|NCT01465659|79021097|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
44373866|NCT00910689|79379002|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
44373867|NCT00910689|79379003|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
44373868|NCT00910689|79379004|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
44373869|NCT00910689|79379005|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
44220379|NCT01465659|79021098|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
44220380|NCT01465659|79021099|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
44220381|NCT01465659|79021100|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
44220382|NCT01465659|79021097|FG000|Completed Follow for 1 Year|Death|6|||
44220383|NCT01465659|79021098|FG001|Completed Follow for 1 Year|Death|3|||
44461441|NCT00346216|79470455|FG002|Overall Study|Withdrawal by Subject|651|||
44220384|NCT01465659|79021099|FG002|Completed Follow for 1 Year|Death|2|||
44220385|NCT01465659|79021100|FG003|Completed Follow for 1 Year|Death|4|||
44220386|NCT01753076|79021115|FG000|Overall Study|Adverse Event|17|||
44220387|NCT01753076|79021116|FG001|Overall Study|Adverse Event|18|||
44220388|NCT01753076|79021115|FG000|Overall Study|Lack of Efficacy|3|||
44220389|NCT01753076|79021116|FG001|Overall Study|Lack of Efficacy|1|||
44220390|NCT01753076|79021115|FG000|Overall Study|Lost to Follow-up|2|||
44220391|NCT01753076|79021116|FG001|Overall Study|Lost to Follow-up|1|||
44220392|NCT01753076|79021115|FG000|Overall Study|Physician Decision|4|||
44220393|NCT01753076|79021116|FG001|Overall Study|Physician Decision|2|||
44220394|NCT01753076|79021115|FG000|Overall Study|Withdrawal by Subject|14|||
44373870|NCT00807001|79379020|FG000|Overall Study|Non-compliance|0|||
44373871|NCT00807001|79379021|FG001|Overall Study|Non-compliance|1|||
44373872|NCT00807001|79379022|FG002|Overall Study|Non-compliance|0|||
44373873|NCT00807001|79379023|FG003|Overall Study|Non-compliance|0|||
44373874|NCT00807001|79379024|FG004|Overall Study|Non-compliance|0|||
44373875|NCT00809341|79379038|FG000|Overall Study|Physician Decision|0|||
44373876|NCT00809341|79379039|FG001|Overall Study|Physician Decision|1|||
44461442|NCT00346216|79470453|FG000|Overall Study|Lost to Follow-up|611|||
44461443|NCT00346216|79470454|FG001|Overall Study|Lost to Follow-up|588|||
44461444|NCT00346216|79470455|FG002|Overall Study|Lost to Follow-up|542|||
44461445|NCT00346216|79470453|FG000|Overall Study|Physician Decision|80|||
44461446|NCT00346216|79470454|FG001|Overall Study|Physician Decision|76|||
44461447|NCT00346216|79470455|FG002|Overall Study|Physician Decision|59|||
44373877|NCT01125800|79379050|FG000|Phase I|Protocol Violation|0|||
44373878|NCT01125800|79379051|FG001|Phase I|Protocol Violation|3|||
44373879|NCT01125800|79379052|FG002|Phase I|Protocol Violation|1|||
44373880|NCT01125800|79379053|FG003|Phase I|Protocol Violation|1|||
44373881|NCT01125800|79379054|FG004|Phase I|Protocol Violation|0|||
44373882|NCT01125800|79379050|FG000|Phase I|Adverse Event|2|||
44373883|NCT01125800|79379051|FG001|Phase I|Adverse Event|2|||
44373884|NCT01125800|79379052|FG002|Phase I|Adverse Event|1|||
44373885|NCT01125800|79379053|FG003|Phase I|Adverse Event|7|||
44373886|NCT01125800|79379054|FG004|Phase I|Adverse Event|0|||
44461448|NCT00346216|79470453|FG000|Overall Study|Does not meet entrance criteria|13|||
44461449|NCT00346216|79470454|FG001|Overall Study|Does not meet entrance criteria|10|||
44461450|NCT00346216|79470455|FG002|Overall Study|Does not meet entrance criteria|8|||
44461451|NCT00346216|79470453|FG000|Overall Study|Death|189|||
44461452|NCT00346216|79470454|FG001|Overall Study|Death|192|||
44461453|NCT00346216|79470455|FG002|Overall Study|Death|228|||
44461454|NCT00346216|79470453|FG000|Overall Study|Study terminated by sponsor|11|||
44461455|NCT00346216|79470454|FG001|Overall Study|Study terminated by sponsor|4|||
44461456|NCT00346216|79470455|FG002|Overall Study|Study terminated by sponsor|8|||
44461457|NCT00346216|79470453|FG000|Overall Study|Missing Subject Summary Status|62|||
44461458|NCT00346216|79470454|FG001|Overall Study|Missing Subject Summary Status|61|||
44461459|NCT00346216|79470455|FG002|Overall Study|Missing Subject Summary Status|62|||
44461460|NCT00417963|79470463|FG000|Overall Study|Lost to Follow-up|3|||
44461461|NCT00417963|79470463|FG000|Overall Study|Withdrawal by Subject|18|||
44461462|NCT00417963|79470463|FG000|Overall Study|Death|17|||
44461463|NCT00417963|79470463|FG000|Overall Study|Study device could not be deployed|3|||
44461464|NCT00429273|79470475|FG000|Overall Study|Lost to Follow-up|1|||
44461465|NCT00429273|79470476|FG001|Overall Study|Lost to Follow-up|2|||
44461466|NCT00429273|79470477|FG002|Overall Study|Lost to Follow-up|2|||
44461467|NCT00429273|79470475|FG000|Overall Study|Physician Decision|6|||
44461468|NCT00429273|79470476|FG001|Overall Study|Physician Decision|5|||
44461469|NCT00429273|79470477|FG002|Overall Study|Physician Decision|5|||
44461470|NCT00429273|79470475|FG000|Overall Study|Adverse Event|1|||
44461471|NCT00429273|79470476|FG001|Overall Study|Adverse Event|1|||
44461472|NCT00429273|79470477|FG002|Overall Study|Adverse Event|2|||
44461473|NCT00359632|79470487|FG000|Overall Study|Death|2|||
44461474|NCT00359632|79470488|FG001|Overall Study|Death|0|||
44461475|NCT00359632|79470487|FG000|Overall Study|Adverse Event|1|||
44461476|NCT00359632|79470488|FG001|Overall Study|Adverse Event|0|||
44461477|NCT00359632|79470487|FG000|Overall Study|Non-compliance with visit schedule|1|||
44461478|NCT00359632|79470488|FG001|Overall Study|Non-compliance with visit schedule|0|||
44461479|NCT00417885|79470494|FG000|Overall Study|Adverse Event|1|||
44461480|NCT00417885|79470494|FG000|Overall Study|Objective Progression or Relapse|3|||
44461481|NCT00417885|79470494|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
44461482|NCT04488770|79470511|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44373887|NCT01125800|79379050|FG000|Phase I|Administrative problems|1|||
44461483|NCT04488770|79470512|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461484|NCT04488770|79470513|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461485|NCT04488770|79470514|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
44220395|NCT01753076|79021116|FG001|Overall Study|Withdrawal by Subject|24|||
44220396|NCT01753076|79021115|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
44373888|NCT01125800|79379051|FG001|Phase I|Administrative problems|0|||
44373889|NCT01125800|79379052|FG002|Phase I|Administrative problems|0|||
44373890|NCT01125800|79379053|FG003|Phase I|Administrative problems|0|||
44220397|NCT01753076|79021116|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
44220398|NCT01463007|79021124|FG000|Overall Study|Physician Decision|1|||
44220399|NCT01462929|79021132|FG000|Overall Study|Adverse Event|3|||
44220400|NCT01462929|79021133|FG001|Overall Study|Adverse Event|3|||
44220401|NCT01462929|79021134|FG002|Overall Study|Adverse Event|4|||
44220402|NCT01462929|79021132|FG000|Overall Study|Withdrawal by Subject|2|||
44220403|NCT01462929|79021133|FG001|Overall Study|Withdrawal by Subject|1|||
44220404|NCT01462929|79021134|FG002|Overall Study|Withdrawal by Subject|0|||
44220405|NCT01462929|79021132|FG000|Overall Study|Lack of Efficacy|0|||
44220406|NCT01462929|79021133|FG001|Overall Study|Lack of Efficacy|0|||
44220407|NCT01462929|79021134|FG002|Overall Study|Lack of Efficacy|1|||
44220408|NCT01462695|79021144|FG000|Overall Study|Adverse Event|1|||
44220409|NCT01462695|79021145|FG001|Overall Study|Adverse Event|1|||
44220410|NCT01462695|79021144|FG000|Overall Study|Death|2|||
44220411|NCT01462695|79021145|FG001|Overall Study|Death|0|||
44220412|NCT01462695|79021144|FG000|Overall Study|Lack of Efficacy|6|||
44220413|NCT01462695|79021145|FG001|Overall Study|Lack of Efficacy|12|||
44220414|NCT01462695|79021144|FG000|Overall Study|Physician Decision|5|||
44220415|NCT01462695|79021145|FG001|Overall Study|Physician Decision|0|||
44220416|NCT01462695|79021144|FG000|Overall Study|Withdrawal by Subject|2|||
44220417|NCT01462695|79021145|FG001|Overall Study|Withdrawal by Subject|0|||
44220418|NCT01462695|79021144|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
44220419|NCT01462695|79021145|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
44220420|NCT01465347|79021151|FG000|Overall Study|Withdrawal by Subject|1|||
44220421|NCT01465347|79021152|FG001|Overall Study|Withdrawal by Subject|1|||
44220422|NCT01465347|79021151|FG000|Overall Study|Physician Decision|0|||
44220423|NCT01465347|79021152|FG001|Overall Study|Physician Decision|1|||
44220424|NCT01465347|79021151|FG000|Overall Study|Admitted to hospice|0|||
44220425|NCT01465347|79021152|FG001|Overall Study|Admitted to hospice|1|||
44220426|NCT01465191|79021164|FG000|Overall Study|Protocol Violation|6|||
44220427|NCT01465191|79021165|FG001|Overall Study|Protocol Violation|3|||
44220428|NCT01465191|79021166|FG002|Overall Study|Protocol Violation|3|||
44220429|NCT01465191|79021164|FG000|Overall Study|Lost to Follow-up|3|||
44220430|NCT01465191|79021165|FG001|Overall Study|Lost to Follow-up|6|||
44220431|NCT01465191|79021166|FG002|Overall Study|Lost to Follow-up|4|||
44220432|NCT01519947|79021181|FG000|Overall Study|Death|0|||
44220433|NCT01519947|79021182|FG001|Overall Study|Death|0|||
44220434|NCT01519947|79021183|FG002|Overall Study|Death|0|||
44220435|NCT01519947|79021184|FG003|Overall Study|Death|1|||
44220436|NCT01519947|79021181|FG000|Overall Study|Protocol Violation|0|||
44220437|NCT01519947|79021182|FG001|Overall Study|Protocol Violation|0|||
44220438|NCT01519947|79021183|FG002|Overall Study|Protocol Violation|2|||
44220439|NCT01519947|79021184|FG003|Overall Study|Protocol Violation|1|||
44220440|NCT01519947|79021181|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
44220441|NCT01519947|79021182|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
44220442|NCT01519947|79021183|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
44220443|NCT01519947|79021184|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
44220444|NCT01519947|79021181|FG000|Overall Study|Development of Anemia|0|||
44220445|NCT01519947|79021182|FG001|Overall Study|Development of Anemia|1|||
44220446|NCT01519947|79021183|FG002|Overall Study|Development of Anemia|0|||
44220447|NCT01519947|79021184|FG003|Overall Study|Development of Anemia|1|||
44220448|NCT01519947|79021181|FG000|Overall Study|Blood Transfusion|0|||
44220449|NCT01519947|79021182|FG001|Overall Study|Blood Transfusion|1|||
44220450|NCT01519947|79021183|FG002|Overall Study|Blood Transfusion|1|||
44220451|NCT01519947|79021184|FG003|Overall Study|Blood Transfusion|0|||
44220452|NCT01519947|79021181|FG000|Overall Study|Withdrawal by Subject|0|||
44220453|NCT01519947|79021182|FG001|Overall Study|Withdrawal by Subject|1|||
44220454|NCT01519947|79021183|FG002|Overall Study|Withdrawal by Subject|0|||
44220455|NCT01519947|79021184|FG003|Overall Study|Withdrawal by Subject|1|||
44220456|NCT01519947|79021181|FG000|Overall Study|Lost to Follow-up|0|||
44461486|NCT04488770|79470515|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461487|NCT04488770|79470516|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461488|NCT04488770|79470517|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461489|NCT04488770|79470518|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461490|NCT04488770|79470519|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461491|NCT04488770|79470520|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461492|NCT04488770|79470521|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461493|NCT04488770|79470522|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44220457|NCT01519947|79021182|FG001|Overall Study|Lost to Follow-up|0|||
44220458|NCT01519947|79021183|FG002|Overall Study|Lost to Follow-up|3|||
44461494|NCT04488770|79470523|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
44461495|NCT04488770|79470511|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
44461496|NCT04488770|79470512|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461497|NCT04488770|79470513|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461498|NCT04488770|79470514|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461499|NCT04488770|79470515|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461500|NCT04488770|79470516|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44220459|NCT01519947|79021184|FG003|Overall Study|Lost to Follow-up|2|||
44220460|NCT01519947|79021181|FG000|Overall Study|Poor Response|1|||
44220461|NCT01519947|79021182|FG001|Overall Study|Poor Response|0|||
44220462|NCT01519947|79021183|FG002|Overall Study|Poor Response|0|||
44220463|NCT01519947|79021184|FG003|Overall Study|Poor Response|1|||
44461501|NCT04488770|79470517|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461502|NCT04488770|79470518|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461503|NCT04488770|79470519|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461504|NCT04488770|79470520|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461505|NCT04488770|79470521|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461506|NCT04488770|79470522|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461507|NCT04488770|79470523|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
44461508|NCT04488770|79470511|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461509|NCT04488770|79470512|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461510|NCT04488770|79470513|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461511|NCT04488770|79470514|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461512|NCT04488770|79470515|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461513|NCT04488770|79470516|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
44461514|NCT04488770|79470517|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
44461515|NCT04488770|79470518|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461516|NCT04488770|79470519|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461517|NCT04488770|79470520|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461518|NCT04488770|79470521|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461519|NCT04488770|79470522|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44461520|NCT04488770|79470523|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44220464|NCT01519947|79021181|FG000|Overall Study|Adverse Event|1|||
44270611|NCT01647516|79197223|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
44270612|NCT01647516|79197224|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
44270613|NCT01647516|79197225|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
44270614|NCT01647516|79197226|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
44270615|NCT01647516|79197221|FG000|Induction Period (IP)|Participant Choice|0|||
44270616|NCT01647516|79197222|FG001|Induction Period (IP)|Participant Choice|0|||
44270617|NCT01647516|79197223|FG002|Induction Period (IP)|Participant Choice|1|||
44270618|NCT01647516|79197224|FG003|Induction Period (IP)|Participant Choice|0|||
44270619|NCT01647516|79197225|FG004|Induction Period (IP)|Participant Choice|0|||
44270620|NCT01647516|79197226|FG005|Induction Period (IP)|Participant Choice|0|||
44270621|NCT01647516|79197221|FG000|Induction Period (IP)|Lack of Efficacy|1|||
44270622|NCT01647516|79197222|FG001|Induction Period (IP)|Lack of Efficacy|0|||
44270623|NCT01647516|79197223|FG002|Induction Period (IP)|Lack of Efficacy|0|||
44270624|NCT01647516|79197224|FG003|Induction Period (IP)|Lack of Efficacy|0|||
44270625|NCT01647516|79197225|FG004|Induction Period (IP)|Lack of Efficacy|0|||
44270626|NCT01647516|79197226|FG005|Induction Period (IP)|Lack of Efficacy|0|||
44270627|NCT01647516|79197221|FG000|Induction Period (IP)|No study drug received|1|||
44270628|NCT01647516|79197222|FG001|Induction Period (IP)|No study drug received|1|||
44270629|NCT01647516|79197223|FG002|Induction Period (IP)|No study drug received|0|||
44220465|NCT01519947|79021182|FG001|Overall Study|Adverse Event|0|||
44270630|NCT01647516|79197224|FG003|Induction Period (IP)|No study drug received|0|||
44270631|NCT01647516|79197225|FG004|Induction Period (IP)|No study drug received|0|||
44270632|NCT01647516|79197226|FG005|Induction Period (IP)|No study drug received|0|||
44270633|NCT01647516|79197221|FG000|Maintenance Period (MP)|Adverse Event|2|||
44270634|NCT01647516|79197222|FG001|Maintenance Period (MP)|Adverse Event|1|||
44270635|NCT01647516|79197223|FG002|Maintenance Period (MP)|Adverse Event|0|||
44270636|NCT01647516|79197224|FG003|Maintenance Period (MP)|Adverse Event|0|||
44270637|NCT01647516|79197225|FG004|Maintenance Period (MP)|Adverse Event|0|||
44270638|NCT01647516|79197226|FG005|Maintenance Period (MP)|Adverse Event|0|||
44270639|NCT01647516|79197221|FG000|Maintenance Period (MP)|Non-compliance|1|||
44270640|NCT01647516|79197222|FG001|Maintenance Period (MP)|Non-compliance|0|||
44270641|NCT01647516|79197223|FG002|Maintenance Period (MP)|Non-compliance|0|||
44270642|NCT01647516|79197224|FG003|Maintenance Period (MP)|Non-compliance|0|||
44220466|NCT01519947|79021183|FG002|Overall Study|Adverse Event|1|||
44220467|NCT01519947|79021184|FG003|Overall Study|Adverse Event|1|||
44270643|NCT01647516|79197225|FG004|Maintenance Period (MP)|Non-compliance|0|||
44270644|NCT01647516|79197226|FG005|Maintenance Period (MP)|Non-compliance|0|||
44270645|NCT01647516|79197221|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
44270646|NCT01647516|79197222|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
44270647|NCT01647516|79197223|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
44270648|NCT01647516|79197224|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
44270649|NCT01647516|79197225|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
44270650|NCT01647516|79197226|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
44270651|NCT01647516|79197221|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
44270652|NCT01647516|79197222|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
44270653|NCT01647516|79197223|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
44270654|NCT01647516|79197224|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
44270655|NCT01647516|79197225|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
44270656|NCT01647516|79197226|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
44220468|NCT01462227|79021196|FG000|Second Assignment|Lost to Follow-up|1|||
44220469|NCT01462227|79021197|FG001|Second Assignment|Lost to Follow-up|0|||
44220470|NCT01462227|79021198|FG002|Second Assignment|Lost to Follow-up|0|||
44220471|NCT01462227|79021199|FG003|Second Assignment|Lost to Follow-up|0|||
44220472|NCT01462227|79021196|FG000|Second Assignment|Protocol Violation|0|||
44220473|NCT01462227|79021197|FG001|Second Assignment|Protocol Violation|1|||
44220474|NCT01462227|79021198|FG002|Second Assignment|Protocol Violation|1|||
44220475|NCT01462227|79021199|FG003|Second Assignment|Protocol Violation|0|||
44220476|NCT01464879|79021207|FG000|Overall Study|Physician Decision|1|||
44220477|NCT01464879|79021207|FG000|Overall Study|Non-compliance|1|||
44220478|NCT01519869|79021217|FG000|Overall Study|Lost to Follow-up|1|||
44220479|NCT01519791|79021223|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
44220480|NCT01519791|79021224|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
44220481|NCT01519791|79021223|FG000|Overall Study|Protocol Violation|6|||
44220482|NCT01519791|79021224|FG001|Overall Study|Protocol Violation|19|||
44220483|NCT01519791|79021223|FG000|Overall Study|Other Reason|87|||
44220484|NCT01519791|79021224|FG001|Overall Study|Other Reason|222|||
44220485|NCT01519791|79021223|FG000|Overall Study|subjects randomized in error|2|||
44220486|NCT01519791|79021224|FG001|Overall Study|subjects randomized in error|0|||
44220487|NCT01519791|79021223|FG000|Overall Study|Lack of Efficacy|16|||
44270657|NCT01647516|79197221|FG000|Open-Label Period|Adverse Event|0|||
44270658|NCT01647516|79197222|FG001|Open-Label Period|Adverse Event|0|||
44270659|NCT01647516|79197223|FG002|Open-Label Period|Adverse Event|0|||
44270660|NCT01647516|79197224|FG003|Open-Label Period|Adverse Event|5|||
44270661|NCT01647516|79197225|FG004|Open-Label Period|Adverse Event|6|||
44373891|NCT01125800|79379054|FG004|Phase I|Administrative problems|0|||
44373892|NCT01125800|79379050|FG000|Phase I|Withdrawal by Subject|0|||
44373893|NCT01125800|79379051|FG001|Phase I|Withdrawal by Subject|0|||
44220488|NCT01519791|79021224|FG001|Overall Study|Lack of Efficacy|20|||
44220489|NCT01519791|79021223|FG000|Overall Study|SAE, non-fatal|6|||
44220490|NCT01519791|79021224|FG001|Overall Study|SAE, non-fatal|22|||
44220491|NCT01519791|79021223|FG000|Overall Study|AE, serious fatal|0|||
44220492|NCT01519791|79021224|FG001|Overall Study|AE, serious fatal|1|||
44220493|NCT01519791|79021223|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
44373894|NCT01125800|79379052|FG002|Phase I|Withdrawal by Subject|1|||
44373895|NCT01125800|79379053|FG003|Phase I|Withdrawal by Subject|0|||
44373896|NCT01125800|79379054|FG004|Phase I|Withdrawal by Subject|0|||
44373897|NCT01125800|79379050|FG000|Phase I|Disease progression|5|||
44220494|NCT01519791|79021224|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
44220495|NCT01519791|79021223|FG000|Overall Study|AE, non-serious non-fatal|12|||
44220496|NCT01519791|79021224|FG001|Overall Study|AE, non-serious non-fatal|31|||
44220497|NCT01519791|79021223|FG000|Overall Study|Withdrawal by Subject|15|||
44220498|NCT01519791|79021224|FG001|Overall Study|Withdrawal by Subject|37|||
44220499|NCT01519791|79021223|FG000|Overall Study|Lost to Follow-up|6|||
44220500|NCT01519791|79021224|FG001|Overall Study|Lost to Follow-up|14|||
44270662|NCT01647516|79197226|FG005|Open-Label Period|Adverse Event|3|||
44270663|NCT01647516|79197221|FG000|Open-Label Period|Pregnancy|0|||
44270664|NCT01647516|79197222|FG001|Open-Label Period|Pregnancy|0|||
44270665|NCT01647516|79197223|FG002|Open-Label Period|Pregnancy|0|||
44270666|NCT01647516|79197224|FG003|Open-Label Period|Pregnancy|0|||
44270667|NCT01647516|79197225|FG004|Open-Label Period|Pregnancy|0|||
44270668|NCT01647516|79197226|FG005|Open-Label Period|Pregnancy|1|||
44270669|NCT01647516|79197221|FG000|Open-Label Period|Non-compliance|0|||
44373898|NCT01125800|79379051|FG001|Phase I|Disease progression|4|||
44220501|NCT01461993|79021235|FG000|Overall Study|Withdrawal by Subject|60|||
44220502|NCT01461993|79021236|FG001|Overall Study|Withdrawal by Subject|53|||
44220503|NCT01461993|79021237|FG002|Overall Study|Withdrawal by Subject|16|||
44220504|NCT01461993|79021235|FG000|Overall Study|Lost to Follow-up|44|||
44220505|NCT01461993|79021236|FG001|Overall Study|Lost to Follow-up|48|||
44220506|NCT01461993|79021237|FG002|Overall Study|Lost to Follow-up|22|||
44220507|NCT01461993|79021235|FG000|Overall Study|Protocol Violation|10|||
44220508|NCT01461993|79021236|FG001|Overall Study|Protocol Violation|9|||
44220509|NCT01461993|79021237|FG002|Overall Study|Protocol Violation|7|||
44270670|NCT01647516|79197222|FG001|Open-Label Period|Non-compliance|0|||
44270671|NCT01647516|79197223|FG002|Open-Label Period|Non-compliance|0|||
44270672|NCT01647516|79197224|FG003|Open-Label Period|Non-compliance|1|||
44270673|NCT01647516|79197225|FG004|Open-Label Period|Non-compliance|0|||
44270674|NCT01647516|79197226|FG005|Open-Label Period|Non-compliance|1|||
44270675|NCT01647516|79197221|FG000|Open-Label Period|Physician Decision|0|||
44270676|NCT01647516|79197222|FG001|Open-Label Period|Physician Decision|0|||
44270677|NCT01647516|79197223|FG002|Open-Label Period|Physician Decision|0|||
44270678|NCT01647516|79197224|FG003|Open-Label Period|Physician Decision|1|||
44373899|NCT01125800|79379052|FG002|Phase I|Disease progression|1|||
44373900|NCT01125800|79379053|FG003|Phase I|Disease progression|3|||
44461521|NCT04488770|79470511|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461522|NCT04488770|79470512|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461523|NCT04488770|79470513|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461524|NCT04488770|79470514|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461525|NCT04488770|79470515|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
44461526|NCT04488770|79470516|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461527|NCT04488770|79470517|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461528|NCT04488770|79470518|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461529|NCT04488770|79470519|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461530|NCT04488770|79470520|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461531|NCT04488770|79470521|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461532|NCT04488770|79470522|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461533|NCT04488770|79470523|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
44461534|NCT00525044|79470569|FG000|Overall Study|Lost to Follow-up|0|||
44461535|NCT00525044|79470570|FG001|Overall Study|Lost to Follow-up|1|||
44461536|NCT00355342|79470578|FG000|Overall Study|Adverse Event|13|||
44461537|NCT00355342|79470579|FG001|Overall Study|Adverse Event|15|||
44461538|NCT00355342|79470578|FG000|Overall Study|Lost to Follow-up|4|||
44461539|NCT00355342|79470579|FG001|Overall Study|Lost to Follow-up|2|||
44461540|NCT00355342|79470578|FG000|Overall Study|Withdrawal by Subject|14|||
44461541|NCT00355342|79470579|FG001|Overall Study|Withdrawal by Subject|11|||
44461542|NCT00355342|79470578|FG000|Overall Study|Sponsor terminated study|2|||
44461543|NCT00355342|79470579|FG001|Overall Study|Sponsor terminated study|2|||
44461544|NCT00355342|79470578|FG000|Overall Study|Overcompliant-PI discretion|1|||
44461545|NCT00355342|79470579|FG001|Overall Study|Overcompliant-PI discretion|0|||
44461546|NCT00355342|79470578|FG000|Overall Study|Use of prohibited medication|1|||
44461547|NCT00355342|79470579|FG001|Overall Study|Use of prohibited medication|0|||
44461548|NCT00355342|79470578|FG000|Overall Study|COPD exacerbation|1|||
44461549|NCT00355342|79470579|FG001|Overall Study|COPD exacerbation|1|||
44461550|NCT00355342|79470578|FG000|Overall Study|Dispensed wrong study drug kit|1|||
44220510|NCT01461993|79021235|FG000|Overall Study|Adverse Event|9|||
44220511|NCT01461993|79021236|FG001|Overall Study|Adverse Event|11|||
44270679|NCT01647516|79197225|FG004|Open-Label Period|Physician Decision|1|||
44373901|NCT01125800|79379054|FG004|Phase I|Disease progression|0|||
44373902|NCT01125800|79379050|FG000|Phase II|Protocol Violation|0|||
44373903|NCT01125800|79379051|FG001|Phase II|Protocol Violation|0|||
44373904|NCT01125800|79379052|FG002|Phase II|Protocol Violation|0|||
44373905|NCT01125800|79379053|FG003|Phase II|Protocol Violation|0|||
44373906|NCT01125800|79379054|FG004|Phase II|Protocol Violation|1|||
44373907|NCT01125800|79379050|FG000|Phase II|Adverse Event|0|||
44373908|NCT01125800|79379051|FG001|Phase II|Adverse Event|0|||
44373909|NCT01125800|79379052|FG002|Phase II|Adverse Event|0|||
44373910|NCT01125800|79379053|FG003|Phase II|Adverse Event|0|||
44373911|NCT01125800|79379054|FG004|Phase II|Adverse Event|2|||
44373912|NCT01125800|79379050|FG000|Phase II|Disease progression|0|||
44373913|NCT01125800|79379051|FG001|Phase II|Disease progression|0|||
44373914|NCT01125800|79379052|FG002|Phase II|Disease progression|0|||
44220512|NCT01461993|79021237|FG002|Overall Study|Adverse Event|3|||
44220513|NCT01461993|79021235|FG000|Overall Study|No longer met eligibility criteria|13|||
44373915|NCT01125800|79379053|FG003|Phase II|Disease progression|1|||
44220514|NCT01461993|79021236|FG001|Overall Study|No longer met eligibility criteria|18|||
44270680|NCT01647516|79197226|FG005|Open-Label Period|Physician Decision|0|||
44270681|NCT01647516|79197221|FG000|Open-Label Period|Withdrawal by Subject|0|||
44270682|NCT01647516|79197222|FG001|Open-Label Period|Withdrawal by Subject|0|||
44373916|NCT01125800|79379054|FG004|Phase II|Disease progression|8|||
44220515|NCT01461993|79021237|FG002|Overall Study|No longer met eligibility criteria|10|||
44220516|NCT01461993|79021235|FG000|Overall Study|Did not meet entrance criteria|2|||
44220517|NCT01461993|79021236|FG001|Overall Study|Did not meet entrance criteria|3|||
44220518|NCT01461993|79021237|FG002|Overall Study|Did not meet entrance criteria|0|||
44220519|NCT01461993|79021235|FG000|Overall Study|Other|13|||
44220520|NCT01461993|79021236|FG001|Overall Study|Other|15|||
44220521|NCT01461993|79021237|FG002|Overall Study|Other|6|||
44373917|NCT01125722|79379071|FG000|Overall Study|Withdrawal by Subject|2|||
44373918|NCT01125722|79379072|FG001|Overall Study|Withdrawal by Subject|1|||
44270683|NCT01647516|79197223|FG002|Open-Label Period|Withdrawal by Subject|0|||
44270684|NCT01647516|79197224|FG003|Open-Label Period|Withdrawal by Subject|9|||
44270685|NCT01647516|79197225|FG004|Open-Label Period|Withdrawal by Subject|11|||
44373919|NCT01125722|79379071|FG000|Overall Study|Lost to Follow-up|1|||
44373920|NCT01125722|79379072|FG001|Overall Study|Lost to Follow-up|0|||
44373921|NCT00811135|79379078|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
44373922|NCT00811135|79379078|FG000|Overall Study|Death|3|||
44373923|NCT00811135|79379078|FG000|Overall Study|Protocol Violation|2|||
44373924|NCT00811135|79379078|FG000|Overall Study|Violation of Selection Criteria|1|||
44373925|NCT00811135|79379078|FG000|Overall Study|Refused Treatment|1|||
44373926|NCT00811135|79379078|FG000|Overall Study|Withdrawal by Subject|3|||
44373927|NCT00811135|79379078|FG000|Overall Study|Administrative/Other Unspecified|11|||
44373928|NCT00811135|79379078|FG000|Overall Study|Ongoing|59|||
44373929|NCT00811057|79379085|FG000|Overall Study|Protocol Violation|5|||
44373930|NCT00811057|79379086|FG001|Overall Study|Protocol Violation|10|||
44373931|NCT00811057|79379087|FG002|Overall Study|Protocol Violation|10|||
44373932|NCT00879970|79379098|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
44373933|NCT00879970|79379099|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
44373934|NCT00879970|79379100|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
44373935|NCT00879970|79379101|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
44373936|NCT00879970|79379102|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
44373937|NCT00879970|79379098|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
44373938|NCT00879970|79379099|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
44270686|NCT01647516|79197226|FG005|Open-Label Period|Withdrawal by Subject|6|||
44270687|NCT01647516|79197221|FG000|Open-Label Period|Lost to Follow-up|0|||
44270688|NCT01647516|79197222|FG001|Open-Label Period|Lost to Follow-up|0|||
44270689|NCT01647516|79197223|FG002|Open-Label Period|Lost to Follow-up|0|||
44270690|NCT01647516|79197224|FG003|Open-Label Period|Lost to Follow-up|1|||
44270691|NCT01647516|79197225|FG004|Open-Label Period|Lost to Follow-up|0|||
44270692|NCT01647516|79197226|FG005|Open-Label Period|Lost to Follow-up|1|||
44270693|NCT01647516|79197221|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
44270694|NCT01647516|79197222|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
44270695|NCT01647516|79197223|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
44270696|NCT01647516|79197224|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
44220522|NCT01782326|79021248|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
44373939|NCT00879970|79379100|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
44373940|NCT00879970|79379101|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
44373941|NCT00879970|79379102|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
44373942|NCT00879970|79379098|FG000|Period 1 TZD Randomization|Death|2|||
44373943|NCT00879970|79379099|FG001|Period 1 TZD Randomization|Death|1|||
44373944|NCT00879970|79379100|FG002|Period 1 TZD Randomization|Death|0|||
44461551|NCT00355342|79470579|FG001|Overall Study|Dispensed wrong study drug kit|0|||
44220523|NCT01782326|79021249|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
44270697|NCT01647516|79197225|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
44220524|NCT01782326|79021248|FG000|Planned Treatment Epoch|Death|29|||
44220525|NCT01782326|79021249|FG001|Planned Treatment Epoch|Death|30|||
44373945|NCT00879970|79379101|FG003|Period 1 TZD Randomization|Death|0|||
44373946|NCT00879970|79379102|FG004|Period 1 TZD Randomization|Death|0|||
44373947|NCT00879970|79379098|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
44270698|NCT01647516|79197226|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
44220526|NCT01782326|79021248|FG000|Planned Treatment Epoch|Physician Decision|18|||
44220527|NCT01782326|79021249|FG001|Planned Treatment Epoch|Physician Decision|16|||
44270699|NCT01647516|79197221|FG000|Open-Label Period|Lack of Efficacy|0|||
44270700|NCT01647516|79197222|FG001|Open-Label Period|Lack of Efficacy|0|||
44270701|NCT01647516|79197223|FG002|Open-Label Period|Lack of Efficacy|0|||
44270702|NCT01647516|79197224|FG003|Open-Label Period|Lack of Efficacy|7|||
44270703|NCT01647516|79197225|FG004|Open-Label Period|Lack of Efficacy|9|||
44270704|NCT01647516|79197226|FG005|Open-Label Period|Lack of Efficacy|10|||
44270705|NCT01647516|79197221|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
44270706|NCT01647516|79197222|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
44270707|NCT01647516|79197223|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
44270708|NCT01647516|79197224|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
44270709|NCT01647516|79197225|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
44270710|NCT01647516|79197226|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
44270711|NCT01647516|79197221|FG000|Open-Label Period|No completion / discontinuation visit|0|||
44270712|NCT01647516|79197222|FG001|Open-Label Period|No completion / discontinuation visit|0|||
44270713|NCT01647516|79197223|FG002|Open-Label Period|No completion / discontinuation visit|0|||
44270714|NCT01647516|79197224|FG003|Open-Label Period|No completion / discontinuation visit|0|||
44270715|NCT01647516|79197225|FG004|Open-Label Period|No completion / discontinuation visit|2|||
44270716|NCT01647516|79197226|FG005|Open-Label Period|No completion / discontinuation visit|1|||
44270717|NCT01647282|79197243|FG000|Overall Study|Physician Decision|7|||
44270718|NCT01647282|79197244|FG001|Overall Study|Physician Decision|5|||
44270719|NCT02321436|79197252|FG000|Overall Study|Withdrawal by Subject|1|||
44461552|NCT00355342|79470578|FG000|Overall Study|Non-compliance with Dexa scans|1|||
44461553|NCT00355342|79470579|FG001|Overall Study|Non-compliance with Dexa scans|0|||
44461554|NCT00355342|79470578|FG000|Overall Study|Withdrawal by participant and physician|1|||
44461555|NCT00355342|79470579|FG001|Overall Study|Withdrawal by participant and physician|0|||
44461556|NCT00355342|79470578|FG000|Overall Study|Participant relocated|0|||
44461557|NCT00355342|79470579|FG001|Overall Study|Participant relocated|1|||
44461558|NCT00355342|79470578|FG000|Overall Study|Participant discontinued study drug|0|||
44461559|NCT00355342|79470579|FG001|Overall Study|Participant discontinued study drug|1|||
44461560|NCT00355342|79470578|FG000|Overall Study|Study management|0|||
44461561|NCT00355342|79470579|FG001|Overall Study|Study management|1|||
44461562|NCT00355342|79470578|FG000|Overall Study|Protocol Violation|0|||
44461563|NCT00355342|79470579|FG001|Overall Study|Protocol Violation|1|||
44461564|NCT00355342|79470578|FG000|Overall Study|Use of protocol excluded medication|0|||
44461565|NCT00355342|79470579|FG001|Overall Study|Use of protocol excluded medication|1|||
44461566|NCT01573754|79470587|FG000|Overall Study|Noncompliance or remission not achieved|3|||
44461567|NCT01573754|79470588|FG001|Overall Study|Noncompliance or remission not achieved|15|||
44461568|NCT00355264|79470594|FG000|Extension (Variable Duration)|Adverse Event|1|||
44461569|NCT00355264|79470594|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
44461570|NCT00355030|79470605|FG000|Study Period 1 Treatment|Adverse Event|1|||
44461571|NCT00355030|79470606|FG001|Study Period 1 Treatment|Adverse Event|1|||
44461572|NCT00355030|79470605|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
44461573|NCT00355030|79470606|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
44461574|NCT00355030|79470605|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
44461575|NCT00355030|79470606|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
44220528|NCT01782326|79021248|FG000|Planned Treatment Epoch|Protocol deviation|2|||
44220529|NCT01782326|79021249|FG001|Planned Treatment Epoch|Protocol deviation|3|||
44220530|NCT01782326|79021248|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
44220531|NCT01782326|79021249|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
44220532|NCT01782326|79021248|FG000|Planned Treatment Epoch|Technical problems|0|||
44220533|NCT01782326|79021249|FG001|Planned Treatment Epoch|Technical problems|4|||
44220534|NCT01782326|79021248|FG000|Double-blind Treatment|Adverse Event|129|||
44220535|NCT01782326|79021249|FG001|Double-blind Treatment|Adverse Event|145|||
44220536|NCT01782326|79021248|FG000|Double-blind Treatment|Subject/guardian decision|111|||
44270720|NCT02321436|79197253|FG001|Overall Study|Withdrawal by Subject|0|||
44270721|NCT02321436|79197252|FG000|Overall Study|Lost to Follow-up|0|||
44461576|NCT00355030|79470605|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
44461577|NCT00355030|79470606|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
44461578|NCT00355030|79470605|FG000|Study Period 1 Treatment|Physician Decision|0|||
44461579|NCT00355030|79470606|FG001|Study Period 1 Treatment|Physician Decision|1|||
44461580|NCT00355030|79470605|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
44270722|NCT02321436|79197253|FG001|Overall Study|Lost to Follow-up|1|||
44461581|NCT00355030|79470606|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
44220537|NCT01782326|79021249|FG001|Double-blind Treatment|Subject/guardian decision|125|||
44220538|NCT01782326|79021248|FG000|Double-blind Treatment|Lack of Efficacy|17|||
44270723|NCT02319642|79197262|FG000|Overall Study|Adverse Event|2|||
44270724|NCT02319642|79197263|FG001|Overall Study|Adverse Event|4|||
44270725|NCT02319642|79197262|FG000|Overall Study|Lack of Efficacy|1|||
44270726|NCT02319642|79197263|FG001|Overall Study|Lack of Efficacy|1|||
44270727|NCT02319642|79197262|FG000|Overall Study|Withdrawal by Subject|1|||
44270728|NCT02319642|79197263|FG001|Overall Study|Withdrawal by Subject|1|||
44270729|NCT02280096|79197273|FG000|Overall Study|Pregnancy|1|||
44270730|NCT02280096|79197274|FG001|Overall Study|Pregnancy|0|||
44270731|NCT02280096|79197273|FG000|Overall Study|Functional neurological disorder|1|||
44270732|NCT02280096|79197274|FG001|Overall Study|Functional neurological disorder|0|||
44270733|NCT02280096|79197273|FG000|Overall Study|Lack of attachment|0|||
44270734|NCT02280096|79197274|FG001|Overall Study|Lack of attachment|1|||
44270735|NCT02279862|79197291|FG000|Overall Study|Study drug toxicity|3|||
44270736|NCT02279862|79197292|FG001|Overall Study|Study drug toxicity|6|||
44270737|NCT02279862|79197291|FG000|Overall Study|No longer meets criteria|0|||
44270738|NCT02279862|79197292|FG001|Overall Study|No longer meets criteria|1|||
44270739|NCT02279862|79197291|FG000|Overall Study|Administrative reason by sponsor|0|||
44270740|NCT02279862|79197292|FG001|Overall Study|Administrative reason by sponsor|1|||
44270741|NCT02279862|79197291|FG000|Overall Study|Disease progression|5|||
44270742|NCT02279862|79197292|FG001|Overall Study|Disease progression|2|||
44270743|NCT02279862|79197291|FG000|Overall Study|Study closed by sponsor|16|||
44270744|NCT02279862|79197292|FG001|Overall Study|Study closed by sponsor|13|||
44270745|NCT02279862|79197291|FG000|Overall Study|Other|1|||
44270746|NCT02279862|79197292|FG001|Overall Study|Other|2|||
44270747|NCT02279862|79197291|FG000|Overall Study|Withdrawal by Subject|1|||
44270748|NCT02279862|79197292|FG001|Overall Study|Withdrawal by Subject|0|||
44270749|NCT02318940|79197300|FG000|Overall Study|lost the record|1|||
44270750|NCT02318940|79197301|FG001|Overall Study|lost the record|0|||
44270751|NCT02294058|79197310|FG000|Overall Study|Adverse Event|16|||
44270752|NCT02294058|79197311|FG001|Overall Study|Adverse Event|7|||
44270753|NCT02294058|79197312|FG002|Overall Study|Adverse Event|13|||
44270754|NCT02294058|79197310|FG000|Overall Study|Lack of Efficacy|3|||
44270755|NCT02294058|79197311|FG001|Overall Study|Lack of Efficacy|3|||
44270756|NCT02294058|79197312|FG002|Overall Study|Lack of Efficacy|0|||
44270757|NCT02294058|79197310|FG000|Overall Study|Lost to Follow-up|1|||
44270758|NCT02294058|79197311|FG001|Overall Study|Lost to Follow-up|0|||
44270759|NCT02294058|79197312|FG002|Overall Study|Lost to Follow-up|2|||
44270760|NCT02294058|79197310|FG000|Overall Study|Withdrawal by Subject|10|||
44270761|NCT02294058|79197311|FG001|Overall Study|Withdrawal by Subject|14|||
44270762|NCT02294058|79197312|FG002|Overall Study|Withdrawal by Subject|13|||
44270763|NCT02294058|79197310|FG000|Overall Study|Physician Decision|2|||
44270764|NCT02294058|79197311|FG001|Overall Study|Physician Decision|1|||
44270765|NCT02294058|79197312|FG002|Overall Study|Physician Decision|0|||
44270766|NCT02294058|79197310|FG000|Overall Study|Miscellaneous|4|||
44270767|NCT02294058|79197311|FG001|Overall Study|Miscellaneous|1|||
44270768|NCT02294058|79197312|FG002|Overall Study|Miscellaneous|1|||
44270769|NCT02293902|79197324|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
44270770|NCT02293902|79197325|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
44270771|NCT02293902|79197326|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
44373948|NCT00879970|79379099|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
44220539|NCT01782326|79021249|FG001|Double-blind Treatment|Lack of Efficacy|22|||
44220540|NCT01782326|79021248|FG000|Double-blind Treatment|Physician Decision|13|||
44220541|NCT01782326|79021249|FG001|Double-blind Treatment|Physician Decision|16|||
44220542|NCT01782326|79021248|FG000|Double-blind Treatment|Protocol deviation|8|||
44220543|NCT01782326|79021249|FG001|Double-blind Treatment|Protocol deviation|7|||
44220544|NCT01782326|79021248|FG000|Double-blind Treatment|Technical problems|0|||
44220545|NCT01782326|79021249|FG001|Double-blind Treatment|Technical problems|5|||
44220546|NCT01439373|79021257|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
44220547|NCT01439373|79021258|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
44220548|NCT01439373|79021257|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
44220549|NCT01439373|79021258|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
44220550|NCT01461369|79021271|FG000|Overall Study|Lack of Efficacy|2|||
44220551|NCT01461369|79021272|FG001|Overall Study|Lack of Efficacy|0|||
44270772|NCT02293902|79197327|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
44373949|NCT00879970|79379100|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
44220552|NCT01461369|79021273|FG002|Overall Study|Lack of Efficacy|6|||
44220553|NCT01461369|79021271|FG000|Overall Study|Lost to Follow-up|0|||
44220554|NCT01461369|79021272|FG001|Overall Study|Lost to Follow-up|0|||
44270773|NCT02293902|79197328|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
44270774|NCT02293902|79197324|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
44270775|NCT02293902|79197325|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
44270776|NCT02293902|79197326|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
44270777|NCT02293902|79197327|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
44270778|NCT02293902|79197328|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
44270779|NCT02293902|79197324|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
44270780|NCT02293902|79197325|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
44270781|NCT02293902|79197326|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
44277793|NCT02138214|79238786|FG001|Overall Study|Lost to Follow-up|2|||
44461582|NCT00355030|79470605|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
44461583|NCT00355030|79470606|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
44461584|NCT00355030|79470605|FG000|Study Period 1 Treatment|Other|2|||
44461585|NCT00355030|79470606|FG001|Study Period 1 Treatment|Other|6|||
44220555|NCT01461369|79021273|FG002|Overall Study|Lost to Follow-up|3|||
44220556|NCT01461369|79021271|FG000|Overall Study|Adverse Event|9|||
44220557|NCT01461369|79021272|FG001|Overall Study|Adverse Event|12|||
44220558|NCT01461369|79021273|FG002|Overall Study|Adverse Event|4|||
44461586|NCT00355030|79470605|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
44461587|NCT00355030|79470606|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
44461588|NCT00355030|79470605|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
44461589|NCT00355030|79470606|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
44461590|NCT00354172|79470612|FG000|Overall Study|Did not receive transplant|1|||
44461591|NCT00345592|79470618|FG000|Overall Study|Death|14|||
44461592|NCT00345592|79470619|FG001|Overall Study|Death|16|||
44461593|NCT00345592|79470618|FG000|Overall Study|Withdrawal by Subject|11|||
44461594|NCT00345592|79470619|FG001|Overall Study|Withdrawal by Subject|8|||
44461595|NCT00353704|79470627|FG000|Overall Study|Protocol Violation|3|||
44461596|NCT00353704|79470628|FG001|Overall Study|Protocol Violation|1|||
44461597|NCT00512252|79470637|FG000|Overall Study|Lost to Follow-up|0|||
44461598|NCT00512252|79470638|FG001|Overall Study|Lost to Follow-up|0|||
44461599|NCT00512252|79470639|FG002|Overall Study|Lost to Follow-up|1|||
44461600|NCT00512252|79470637|FG000|Overall Study|Protocol Violation|0|||
44461601|NCT00512252|79470638|FG001|Overall Study|Protocol Violation|0|||
44461602|NCT00512252|79470639|FG002|Overall Study|Protocol Violation|1|||
44461603|NCT00512252|79470637|FG000|Overall Study|Death|0|||
44461604|NCT00512252|79470638|FG001|Overall Study|Death|0|||
44461605|NCT00512252|79470639|FG002|Overall Study|Death|1|||
44461606|NCT00516386|79470654|FG000|Overall Study|not interested in the study|4|||
44461607|NCT00516386|79470654|FG000|Overall Study|Lost to Follow-up|2|||
44461608|NCT00524420|79470660|FG000|Overall Study|Lack of Efficacy|1|||
44220559|NCT01461369|79021271|FG000|Overall Study|Protocol Violation|1|||
44220560|NCT01461369|79021272|FG001|Overall Study|Protocol Violation|2|||
44220561|NCT01461369|79021273|FG002|Overall Study|Protocol Violation|2|||
44220562|NCT01461369|79021271|FG000|Overall Study|Withdrawal by Subject|1|||
44220563|NCT01461369|79021272|FG001|Overall Study|Withdrawal by Subject|3|||
44220564|NCT01461369|79021273|FG002|Overall Study|Withdrawal by Subject|2|||
44220565|NCT01727258|79021284|FG000|Overall Study|Adverse Event|0|||
44270782|NCT02293902|79197327|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
44373950|NCT00879970|79379101|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
44373951|NCT00879970|79379102|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
44373952|NCT00879970|79379098|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
44373953|NCT00879970|79379099|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
44373954|NCT00879970|79379100|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
44373955|NCT00879970|79379101|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
44373956|NCT00879970|79379102|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
44373957|NCT00879970|79379098|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
44373958|NCT00879970|79379099|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
44373959|NCT00879970|79379100|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
44373960|NCT00879970|79379101|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
44373961|NCT00879970|79379102|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
44373962|NCT00879970|79379098|FG000|Period 2 Vitamin D Randomization|Death|0|||
44373963|NCT00879970|79379099|FG001|Period 2 Vitamin D Randomization|Death|0|||
44373964|NCT00879970|79379100|FG002|Period 2 Vitamin D Randomization|Death|0|||
44373965|NCT00879970|79379101|FG003|Period 2 Vitamin D Randomization|Death|2|||
44373966|NCT00879970|79379102|FG004|Period 2 Vitamin D Randomization|Death|0|||
44373967|NCT00808639|79379120|FG000|Overall Study|Disease progression before surgery.|1|||
44373968|NCT00810901|79379126|FG000|Overall Study|Lost to Follow-up|88|||
44373969|NCT00810901|79379127|FG001|Overall Study|Lost to Follow-up|58|||
44373970|NCT00910299|79379135|FG000|Overall Study|Withdrawal by Subject|16|||
44373971|NCT00910299|79379136|FG001|Overall Study|Withdrawal by Subject|13|||
44373972|NCT00910299|79379135|FG000|Overall Study|Sponsor Decision|58|||
44373973|NCT00910299|79379136|FG001|Overall Study|Sponsor Decision|60|||
44373974|NCT00910299|79379135|FG000|Overall Study|Didn't receive any study drug|2|||
44461609|NCT00524420|79470661|FG001|Overall Study|Lack of Efficacy|0|||
44461610|NCT00512096|79470669|FG000|Overall Study|Adverse Event|2|||
44461611|NCT00512096|79470669|FG000|Overall Study|Withdrawal by Subject|2|||
44220566|NCT01727258|79021285|FG001|Overall Study|Adverse Event|2|||
44373975|NCT00910299|79379136|FG001|Overall Study|Didn't receive any study drug|1|||
44461612|NCT00512096|79470669|FG000|Overall Study|Lack of Efficacy|3|||
44461613|NCT00524030|79470675|FG000|Overall Study|Lack of Efficacy|10|||
44461614|NCT00524030|79470676|FG001|Overall Study|Lack of Efficacy|24|||
44220567|NCT01727258|79021286|FG002|Overall Study|Adverse Event|0|||
44220568|NCT01727258|79021284|FG000|Overall Study|Noncompliance with Study Drug|0|||
44220569|NCT01727258|79021285|FG001|Overall Study|Noncompliance with Study Drug|0|||
44220570|NCT01727258|79021286|FG002|Overall Study|Noncompliance with Study Drug|1|||
44220571|NCT01727258|79021284|FG000|Overall Study|Withdrawal by Subject|1|||
44220572|NCT01727258|79021285|FG001|Overall Study|Withdrawal by Subject|1|||
44220573|NCT01727258|79021286|FG002|Overall Study|Withdrawal by Subject|0|||
44220574|NCT01727258|79021284|FG000|Overall Study|Lost to Follow-up|1|||
44220575|NCT01727258|79021285|FG001|Overall Study|Lost to Follow-up|0|||
44220576|NCT01727258|79021286|FG002|Overall Study|Lost to Follow-up|0|||
44220577|NCT01781390|79021297|FG000|Overall Study|Withdrawal of Consent|0|||
44220578|NCT01781390|79021298|FG001|Overall Study|Withdrawal of Consent|3|||
44220579|NCT01781390|79021299|FG002|Overall Study|Withdrawal of Consent|1|||
44220580|NCT01781390|79021297|FG000|Overall Study|Lost to Follow-up|1|||
44220581|NCT01781390|79021298|FG001|Overall Study|Lost to Follow-up|1|||
44220582|NCT01781390|79021299|FG002|Overall Study|Lost to Follow-up|1|||
44220583|NCT01781390|79021297|FG000|Overall Study|Adverse Event|1|||
44220584|NCT01781390|79021298|FG001|Overall Study|Adverse Event|2|||
44220585|NCT01781390|79021299|FG002|Overall Study|Adverse Event|1|||
44220586|NCT01781390|79021297|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
44220587|NCT01781390|79021298|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
44220588|NCT01781390|79021299|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
44220589|NCT01781234|79021309|FG000|Overall Study|Adverse Event|2|||
44220590|NCT01781234|79021310|FG001|Overall Study|Adverse Event|0|||
44220591|NCT01781234|79021309|FG000|Overall Study|Protocol Violation|3|||
44220592|NCT01781234|79021310|FG001|Overall Study|Protocol Violation|0|||
44220593|NCT01781234|79021309|FG000|Overall Study|Withdrawal by Subject|4|||
44220594|NCT01781234|79021310|FG001|Overall Study|Withdrawal by Subject|3|||
44220595|NCT01752842|79021320|FG000|Overall Study|Adverse Event|3|||
44220596|NCT01752842|79021321|FG001|Overall Study|Adverse Event|0|||
44220597|NCT01752842|79021320|FG000|Overall Study|Withdrawal by Subject|0|||
44220598|NCT01752842|79021321|FG001|Overall Study|Withdrawal by Subject|2|||
44220599|NCT01461057|79021329|FG000|Overall Study|Death|10|||
44220600|NCT01461057|79021330|FG001|Overall Study|Death|9|||
44220601|NCT01461057|79021329|FG000|Overall Study|Withdrawal by Subject|2|||
44220602|NCT01461057|79021330|FG001|Overall Study|Withdrawal by Subject|3|||
44220603|NCT01461057|79021329|FG000|Overall Study|Physician Decision|0|||
44220604|NCT01461057|79021330|FG001|Overall Study|Physician Decision|2|||
44220605|NCT01461057|79021329|FG000|Overall Study|Adverse Event|0|||
44220606|NCT01461057|79021330|FG001|Overall Study|Adverse Event|1|||
44220607|NCT01461057|79021329|FG000|Overall Study|Progression of Disease|1|||
44220608|NCT01461057|79021330|FG001|Overall Study|Progression of Disease|0|||
44220609|NCT01461057|79021329|FG000|Overall Study|Study Terminated by Sponsor|2|||
44220610|NCT01461057|79021330|FG001|Overall Study|Study Terminated by Sponsor|0|||
44220611|NCT01460901|79021336|FG000|Overall Study|Withdrawal by Subject|2|||
44220612|NCT01519635|79021345|FG000|Overall Study|Withdrawal by Subject|0|||
44220613|NCT01519635|79021346|FG001|Overall Study|Withdrawal by Subject|1|||
44220614|NCT01519635|79021345|FG000|Overall Study|No possibility to put a catheter|1|||
44220615|NCT01519635|79021346|FG001|Overall Study|No possibility to put a catheter|2|||
44220616|NCT01519323|79021352|FG000|Overall Study|Death|3|||
44220617|NCT01519323|79021353|FG001|Overall Study|Death|2|||
44220618|NCT01519323|79021352|FG000|Overall Study|Study terminated by sponsor|0|||
44220619|NCT01519323|79021353|FG001|Overall Study|Study terminated by sponsor|1|||
44220620|NCT01519245|79021361|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
44220621|NCT01519245|79021362|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
44220622|NCT01519167|79021372|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
44220623|NCT01519167|79021373|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
44220624|NCT01519167|79021372|FG000|Overall Study|Adverse Event|0|||
44220625|NCT01519167|79021373|FG001|Overall Study|Adverse Event|1|||
44220626|NCT01519167|79021372|FG000|Overall Study|Lack of Efficacy|0|||
44220627|NCT01519167|79021373|FG001|Overall Study|Lack of Efficacy|1|||
44220628|NCT01519167|79021372|FG000|Overall Study|Medical condition changes&deep sedation|0|||
44220629|NCT01519167|79021373|FG001|Overall Study|Medical condition changes&deep sedation|2|||
44220630|NCT01519167|79021372|FG000|Overall Study|Physician Decision|0|||
44220631|NCT01519167|79021373|FG001|Overall Study|Physician Decision|1|||
44220632|NCT01519089|79021614|FG000|Overall Study|Adverse Event|4|||
44220633|NCT01519089|79021615|FG001|Overall Study|Adverse Event|4|||
44220634|NCT01519089|79021614|FG000|Overall Study|Lack of Efficacy|0|||
44220635|NCT01519089|79021615|FG001|Overall Study|Lack of Efficacy|2|||
44220636|NCT01519089|79021614|FG000|Overall Study|Lost to Follow-up|1|||
44220637|NCT01519089|79021615|FG001|Overall Study|Lost to Follow-up|0|||
44220638|NCT01519089|79021614|FG000|Overall Study|Withdrawal by Subject|0|||
44220639|NCT01519089|79021615|FG001|Overall Study|Withdrawal by Subject|2|||
44220640|NCT01519089|79021614|FG000|Overall Study|Other|2|||
44220641|NCT01519089|79021615|FG001|Overall Study|Other|6|||
44220642|NCT01519089|79021614|FG000|Overall Study|Not received study drug|0|||
44277794|NCT02138214|79238787|FG002|Overall Study|Lost to Follow-up|4|||
44220643|NCT01519089|79021615|FG001|Overall Study|Not received study drug|1|||
44220644|NCT01518699|79021637|FG000|Period 2|Protocol Violation|1|||
44220645|NCT01518699|79021638|FG001|Period 2|Protocol Violation|1|||
44220646|NCT01518699|79021639|FG002|Period 2|Protocol Violation|0|||
44220647|NCT01518699|79021640|FG003|Period 2|Protocol Violation|0|||
44220648|NCT01518699|79021641|FG004|Period 2|Protocol Violation|0|||
44220649|NCT01518699|79021642|FG005|Period 2|Protocol Violation|0|||
44220650|NCT01518699|79021637|FG000|Period 2|Lost to Follow-up|0|||
44220651|NCT01518699|79021638|FG001|Period 2|Lost to Follow-up|1|||
44220652|NCT01518699|79021639|FG002|Period 2|Lost to Follow-up|0|||
44220653|NCT01518699|79021640|FG003|Period 2|Lost to Follow-up|0|||
44220654|NCT01518699|79021641|FG004|Period 2|Lost to Follow-up|0|||
44220655|NCT01518699|79021642|FG005|Period 2|Lost to Follow-up|0|||
44220656|NCT01518699|79021637|FG000|Period 2|Adverse Event|1|||
44220657|NCT01518699|79021638|FG001|Period 2|Adverse Event|0|||
44220658|NCT01518699|79021639|FG002|Period 2|Adverse Event|0|||
44220659|NCT01518699|79021640|FG003|Period 2|Adverse Event|0|||
44220660|NCT01518699|79021641|FG004|Period 2|Adverse Event|0|||
44220661|NCT01518699|79021642|FG005|Period 2|Adverse Event|0|||
44220662|NCT01518309|79021650|FG000|Overall Study|Adverse Event|6|||
44220663|NCT01518309|79021650|FG000|Overall Study|Death|6|||
44220664|NCT01518309|79021650|FG000|Overall Study|Lack of Efficacy|7|||
44220665|NCT01518309|79021650|FG000|Overall Study|Withdrawal by Subject|6|||
44220666|NCT01518309|79021650|FG000|Overall Study|Physician Decision|3|||
44220667|NCT01518309|79021650|FG000|Overall Study|Sponsor Decision|2|||
44220668|NCT01518309|79021650|FG000|Overall Study|Not in Predefined Categories|9|||
44220669|NCT01419717|79021654|FG000|Overall Study|Protocol-specified Criteria|62|||
44220670|NCT01419717|79021654|FG000|Overall Study|Adverse Event|19|||
44220671|NCT01419717|79021654|FG000|Overall Study|Death|17|||
44220672|NCT01419717|79021654|FG000|Overall Study|Withdrawal by Subject|10|||
44220673|NCT01419717|79021654|FG000|Overall Study|Disease Progression|9|||
44220674|NCT01419717|79021654|FG000|Overall Study|Other|4|||
44220675|NCT01419717|79021654|FG000|Overall Study|Lost to Follow-up|2|||
44220676|NCT01419717|79021654|FG000|Overall Study|Administrative Decision|1|||
44220677|NCT01419717|79021654|FG000|Overall Study|Noncompliance|1|||
44220678|NCT01458951|79021661|FG000|Overall Study|Other|1|||
44220679|NCT01458951|79021662|FG001|Overall Study|Other|0|||
44220680|NCT01458951|79021663|FG002|Overall Study|Other|0|||
44220681|NCT01458951|79021661|FG000|Overall Study|Protocol Violation|5|||
44220682|NCT01458951|79021662|FG001|Overall Study|Protocol Violation|1|||
44220683|NCT01458951|79021663|FG002|Overall Study|Protocol Violation|0|||
44220684|NCT01458951|79021661|FG000|Overall Study|Withdrawal by Subject|2|||
44220685|NCT01458951|79021662|FG001|Overall Study|Withdrawal by Subject|0|||
44220686|NCT01458951|79021663|FG002|Overall Study|Withdrawal by Subject|2|||
44220687|NCT01458951|79021661|FG000|Overall Study|Adverse Event|7|||
44220688|NCT01458951|79021662|FG001|Overall Study|Adverse Event|0|||
44220689|NCT01458951|79021663|FG002|Overall Study|Adverse Event|2|||
44220690|NCT01458951|79021661|FG000|Overall Study|Insufficient Clinical Response|17|||
44220691|NCT01458951|79021662|FG001|Overall Study|Insufficient Clinical Response|0|||
44220692|NCT01458951|79021663|FG002|Overall Study|Insufficient Clinical Response|11|||
44220693|NCT01458639|79021670|FG000|Overall Study|Physician Decision|4|||
44220694|NCT01458639|79021670|FG000|Overall Study|Equipment issue|1|||
44220695|NCT01458639|79021670|FG000|Overall Study|Inability to obtain subject blood sample|1|||
44220696|NCT01437423|79021674|FG000|Overall Study|Lost to Follow-up|12|||
44220697|NCT01437423|79021674|FG000|Overall Study|Off label usage|3|||
44220698|NCT01458249|79021705|FG000|Overall Study|Not treated|1|||
44220699|NCT01458249|79021705|FG000|Overall Study|Adverse Event|4|||
44220700|NCT01458249|79021705|FG000|Overall Study|Other|2|||
44220701|NCT01458249|79021705|FG000|Overall Study|Ongoing|1|||
44220702|NCT01458171|79021721|FG000|Overall Study|Adverse Event|1|||
44220703|NCT01457703|79021738|FG000|Overall Study|Screen Failure|5|||
44220704|NCT01457703|79021739|FG001|Overall Study|Screen Failure|7|||
44220705|NCT01457703|79021738|FG000|Overall Study|Withdrawal by Subject|1|||
44220706|NCT01457703|79021739|FG001|Overall Study|Withdrawal by Subject|4|||
44220707|NCT01419015|79021757|FG000|Overall Study|Death|2|||
44220708|NCT01418937|79021778|FG000|Overall Study|Lost to Follow-up|5|||
44220709|NCT01418937|79021778|FG000|Overall Study|Protocol Violation|1|||
44220710|NCT01418937|79021778|FG000|Overall Study|Pregnancy|1|||
44220711|NCT01418937|79021778|FG000|Overall Study|Withdrawal by Subject|1|||
44220712|NCT01417377|79021791|FG000|Overall Study|Lost to Follow-up|12|||
44220713|NCT01417377|79021791|FG000|Overall Study|Enrolled, but not treated|1|||
44220714|NCT01437267|79021838|FG000|Overall Study|Withdrawal by Subject|0|||
44220715|NCT01437267|79021839|FG001|Overall Study|Withdrawal by Subject|0|||
44220716|NCT01437267|79021840|FG002|Overall Study|Withdrawal by Subject|0|||
44220717|NCT01437267|79021841|FG003|Overall Study|Withdrawal by Subject|1|||
44220718|NCT01437267|79021842|FG004|Overall Study|Withdrawal by Subject|0|||
44220719|NCT01437267|79021843|FG005|Overall Study|Withdrawal by Subject|0|||
44220720|NCT01437267|79021838|FG000|Overall Study|Protocol Violation|0|||
44220721|NCT01437267|79021839|FG001|Overall Study|Protocol Violation|1|||
44220722|NCT01437267|79021840|FG002|Overall Study|Protocol Violation|0|||
44220723|NCT01437267|79021841|FG003|Overall Study|Protocol Violation|0|||
44220724|NCT01437267|79021842|FG004|Overall Study|Protocol Violation|0|||
44220725|NCT01437267|79021843|FG005|Overall Study|Protocol Violation|0|||
44220726|NCT01437111|79021870|FG000|Overall Study|Adverse Event|2|||
44220727|NCT01437111|79021870|FG000|Overall Study|Withdrawal by Subject|4|||
44220728|NCT01437111|79021870|FG000|Overall Study|Not reported|5|||
44220729|NCT01437111|79021870|FG000|Overall Study|Physician Decision|1|||
44220730|NCT01437111|79021870|FG000|Overall Study|Lost to Follow-up|5|||
44220731|NCT01437111|79021870|FG000|Overall Study|Protocol Violation|1|||
44220732|NCT01436643|79021918|FG000|2-week Pre-treatment|Abnormal test result|0|||
44220733|NCT01436643|79021919|FG001|2-week Pre-treatment|Abnormal test result|0|||
44220734|NCT01436643|79021920|FG002|2-week Pre-treatment|Abnormal test result|0|||
44220735|NCT01436643|79021921|FG003|2-week Pre-treatment|Abnormal test result|1|||
44220736|NCT01436643|79021918|FG000|2-week Pre-treatment|Adverse Event|0|||
44220737|NCT01436643|79021919|FG001|2-week Pre-treatment|Adverse Event|0|||
44220738|NCT01436643|79021920|FG002|2-week Pre-treatment|Adverse Event|0|||
44220739|NCT01436643|79021921|FG003|2-week Pre-treatment|Adverse Event|5|||
44220740|NCT01436643|79021918|FG000|2-week Pre-treatment|Protocol Violation|0|||
44220741|NCT01436643|79021919|FG001|2-week Pre-treatment|Protocol Violation|0|||
44220742|NCT01436643|79021920|FG002|2-week Pre-treatment|Protocol Violation|0|||
44220743|NCT01436643|79021921|FG003|2-week Pre-treatment|Protocol Violation|4|||
44220744|NCT01436643|79021918|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
44220745|NCT01436643|79021919|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
44220746|NCT01436643|79021920|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
44220747|NCT01436643|79021921|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
44220748|NCT01436643|79021918|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
44220749|NCT01436643|79021919|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
44220750|NCT01436643|79021920|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
44220751|NCT01436643|79021921|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
44220752|NCT01436643|79021918|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
44220753|NCT01436643|79021919|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
44220754|NCT01436643|79021920|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
44220755|NCT01436643|79021921|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
44220756|NCT01454739|79022019|FG000|Overall Study|Protocol Violation|2|||
44220757|NCT01454739|79022020|FG001|Overall Study|Protocol Violation|3|||
44220758|NCT01454739|79022019|FG000|Overall Study|Withdrawal by Subject|2|||
44220759|NCT01454739|79022020|FG001|Overall Study|Withdrawal by Subject|6|||
44220760|NCT01454739|79022019|FG000|Overall Study|Other|3|||
44220761|NCT01454739|79022020|FG001|Overall Study|Other|5|||
44220762|NCT01454739|79022019|FG000|Overall Study|Physician Decision|0|||
44220763|NCT01454739|79022020|FG001|Overall Study|Physician Decision|5|||
44220764|NCT01454739|79022019|FG000|Overall Study|Lost to Follow-up|0|||
44220765|NCT01454739|79022020|FG001|Overall Study|Lost to Follow-up|1|||
44220766|NCT01454739|79022019|FG000|Overall Study|Adverse Event|0|||
44220767|NCT01454739|79022020|FG001|Overall Study|Adverse Event|1|||
44220768|NCT01416441|79022058|FG000|Overall Study|Lost to Follow-up|5|||
44220769|NCT01416441|79022058|FG000|Overall Study|Adverse Event|6|||
44220770|NCT01416441|79022058|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
44220771|NCT01416441|79022058|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
44220772|NCT01416441|79022058|FG000|Overall Study|Investigator Withdrew Subject|2|||
44220773|NCT01416441|79022058|FG000|Overall Study|Subject Withdrew Consent|12|||
44220774|NCT01416441|79022058|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
44220775|NCT01436253|79022067|FG000|Overall Study|Lost to Follow-up|182|||
44220776|NCT01436253|79022067|FG000|Overall Study|Not meeting all eligibility criteria|117|||
44220777|NCT01454583|79022980|FG000|1st Year|Lost to Follow-up|1057|||
44220778|NCT01454583|79022981|FG001|1st Year|Lost to Follow-up|318|||
44220779|NCT01454583|79022982|FG002|1st Year|Lost to Follow-up|180|||
44220780|NCT01454583|79022980|FG000|2nd Year|Lost to Follow-up|3965|||
44220781|NCT01454583|79022981|FG001|2nd Year|Lost to Follow-up|1049|||
44220782|NCT01454583|79022982|FG002|2nd Year|Lost to Follow-up|737|||
44220783|NCT01454583|79022980|FG000|3rd Year|Lost to Follow-up|1959|||
44220784|NCT01454583|79022981|FG001|3rd Year|Lost to Follow-up|512|||
44220785|NCT01454583|79022982|FG002|3rd Year|Lost to Follow-up|297|||
44220786|NCT01436175|79023005|FG000|Overall Study|Adverse Event|111|||
44220787|NCT01436175|79023005|FG000|Overall Study|Protocol Violation|49|||
44220788|NCT01436175|79023005|FG000|Overall Study|Withdrawal by Subject|108|||
44220789|NCT01436175|79023005|FG000|Overall Study|Lost to Follow-up|89|||
44220790|NCT01436175|79023005|FG000|Overall Study|Lack of Efficacy|24|||
44220791|NCT01436175|79023005|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
44220792|NCT01436175|79023005|FG000|Overall Study|Other|826|||
44220793|NCT01453725|79023033|FG000|Overall Study|Adverse Event|3|||
44220794|NCT01453725|79023034|FG001|Overall Study|Adverse Event|3|||
44220795|NCT01453725|79023033|FG000|Overall Study|Lost to Follow-up|4|||
44220796|NCT01453725|79023034|FG001|Overall Study|Lost to Follow-up|0|||
44220797|NCT01453725|79023033|FG000|Overall Study|Non-compliance With Protocol|1|||
44220798|NCT01453725|79023034|FG001|Overall Study|Non-compliance With Protocol|2|||
44220799|NCT01453725|79023033|FG000|Overall Study|Protocol Violation|1|||
44220800|NCT01453725|79023034|FG001|Overall Study|Protocol Violation|0|||
44220801|NCT01453725|79023033|FG000|Overall Study|Withdrawal by Subject|2|||
44220802|NCT01453725|79023034|FG001|Overall Study|Withdrawal by Subject|3|||
44220803|NCT01453725|79023033|FG000|Overall Study|Pregnancy Wish|0|||
44220804|NCT01453725|79023034|FG001|Overall Study|Pregnancy Wish|2|||
44220805|NCT01453725|79023033|FG000|Overall Study|Pregnancy|1|||
44220806|NCT01453725|79023034|FG001|Overall Study|Pregnancy|0|||
44220807|NCT01453725|79023033|FG000|Overall Study|Physician Decision|1|||
44220808|NCT01453725|79023034|FG001|Overall Study|Physician Decision|1|||
44220809|NCT01415349|79023073|FG000|Treatment Period 1|Adverse Event|0|||
44220810|NCT01415349|79023074|FG001|Treatment Period 1|Adverse Event|1|||
44220811|NCT01415349|79023073|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44220812|NCT01415349|79023074|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44220813|NCT01453023|79023128|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
44220814|NCT01453023|79023129|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
44220815|NCT01453023|79023128|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
44220816|NCT01453023|79023129|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
44220817|NCT01453023|79023128|FG000|Treatment Period 2|Protocol Violation|0|||
44220818|NCT01453023|79023129|FG001|Treatment Period 2|Protocol Violation|1|||
44220819|NCT01452789|79023137|FG000|Overall Study|Withdrawal by Subject|3|||
44220820|NCT01452789|79023138|FG001|Overall Study|Withdrawal by Subject|2|||
44220821|NCT01451931|79023147|FG000|Overall Study|Lost to Follow-up|17|||
44220822|NCT01451931|79023148|FG001|Overall Study|Lost to Follow-up|36|||
44220823|NCT01451931|79023149|FG002|Overall Study|Lost to Follow-up|21|||
44220824|NCT01451931|79023147|FG000|Overall Study|Withdrawal by Subject|16|||
44220825|NCT01451931|79023148|FG001|Overall Study|Withdrawal by Subject|22|||
44220826|NCT01451931|79023149|FG002|Overall Study|Withdrawal by Subject|22|||
44220827|NCT01414257|79023172|FG000|Overall Study|No Visit After First Day of Treatment|12|||
44220828|NCT01414257|79023172|FG000|Overall Study|Protocol Violation|10|||
44220829|NCT01434693|79023215|FG000|Overall Study|Adverse Event|1|||
44220830|NCT01434693|79023216|FG001|Overall Study|Adverse Event|0|||
44220831|NCT01434693|79023217|FG002|Overall Study|Adverse Event|0|||
44220832|NCT01434693|79023218|FG003|Overall Study|Adverse Event|0|||
44220833|NCT01434693|79023215|FG000|Overall Study|Withdrawal by Subject|1|||
44220834|NCT01434693|79023216|FG001|Overall Study|Withdrawal by Subject|0|||
44220835|NCT01434693|79023217|FG002|Overall Study|Withdrawal by Subject|1|||
44220836|NCT01434693|79023218|FG003|Overall Study|Withdrawal by Subject|1|||
44220837|NCT01434693|79023215|FG000|Overall Study|Lost to Follow-up|1|||
44220838|NCT01434693|79023216|FG001|Overall Study|Lost to Follow-up|0|||
44220839|NCT01434693|79023217|FG002|Overall Study|Lost to Follow-up|0|||
44220840|NCT01434693|79023218|FG003|Overall Study|Lost to Follow-up|0|||
44220841|NCT01451541|79023235|FG000|Overall Study|Adverse Event|4|||
44220842|NCT01451541|79023236|FG001|Overall Study|Adverse Event|3|||
44220843|NCT01451541|79023237|FG002|Overall Study|Adverse Event|6|||
44220844|NCT01451541|79023235|FG000|Overall Study|Lack of Efficacy|2|||
44220845|NCT01451541|79023236|FG001|Overall Study|Lack of Efficacy|0|||
44220846|NCT01451541|79023237|FG002|Overall Study|Lack of Efficacy|0|||
44220847|NCT01451541|79023235|FG000|Overall Study|Lost to Follow-up|4|||
44220848|NCT01451541|79023236|FG001|Overall Study|Lost to Follow-up|4|||
44220849|NCT01451541|79023237|FG002|Overall Study|Lost to Follow-up|7|||
44220850|NCT01451541|79023235|FG000|Overall Study|Withdrawal by Subject|15|||
44220851|NCT01451541|79023236|FG001|Overall Study|Withdrawal by Subject|8|||
44220852|NCT01451541|79023237|FG002|Overall Study|Withdrawal by Subject|6|||
44220853|NCT01451541|79023235|FG000|Overall Study|randomization error, noncompliance|11|||
44220854|NCT01451541|79023236|FG001|Overall Study|randomization error, noncompliance|10|||
44220855|NCT01451541|79023237|FG002|Overall Study|randomization error, noncompliance|8|||
44220856|NCT01450761|79023365|FG000|Randomization|Subject no longer meets study criteria|1|||
44220857|NCT01450761|79023366|FG001|Randomization|Subject no longer meets study criteria|2|||
44220858|NCT01450761|79023365|FG000|Randomization|Withdrawal by Subject|2|||
44220859|NCT01450761|79023366|FG001|Randomization|Withdrawal by Subject|0|||
44220860|NCT01450761|79023365|FG000|Randomization|Disease progression|0|||
44220861|NCT01450761|79023366|FG001|Randomization|Disease progression|2|||
44220862|NCT01450761|79023365|FG000|Randomization|Adverse Event unrelated to study drug|1|||
44220863|NCT01450761|79023366|FG001|Randomization|Adverse Event unrelated to study drug|0|||
44220864|NCT01450761|79023365|FG000|Randomization|Other|0|||
44220865|NCT01450761|79023366|FG001|Randomization|Other|1|||
44220866|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Disease progression|33|||
44220867|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Disease progression|32|||
44220868|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
44220869|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
44220870|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
44220871|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
44220872|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
44220873|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
44220874|NCT01450761|79023365|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
44220875|NCT01450761|79023366|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
44220876|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Death|3|||
44220877|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Death|3|||
44220878|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Other|2|||
44220879|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Other|2|||
44220880|NCT01450761|79023365|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
44220881|NCT01450761|79023366|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
44220882|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
44220883|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
44220884|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
44220885|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
44220886|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
44220887|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
44220888|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
44220889|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
44220890|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
44220891|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
44220892|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Death|5|||
44220893|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Death|6|||
44220894|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
44220895|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
44220896|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
44220897|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
44220898|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
44220899|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
44220900|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
44220901|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
44220902|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
44220903|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
44220904|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
44220905|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
44220906|NCT01450761|79023365|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
44220907|NCT01450761|79023366|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
44220908|NCT01433991|79023416|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
44220909|NCT01433991|79023417|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
44220910|NCT01433991|79023418|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
44220911|NCT01433991|79023419|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
44220912|NCT01433991|79023416|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
44220913|NCT01433991|79023417|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
44220914|NCT01433991|79023418|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
44220915|NCT01433991|79023419|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
44220916|NCT01433991|79023416|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
44220917|NCT01433991|79023417|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
44220918|NCT01433991|79023418|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
44220919|NCT01433991|79023419|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
44373976|NCT00595504|79379144|FG000|Overall Study|Withdrawal by Subject|1|||
44373977|NCT00595504|79379145|FG001|Overall Study|Withdrawal by Subject|3|||
44220920|NCT01433991|79023416|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
44220921|NCT01433991|79023417|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
44220922|NCT01433991|79023418|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
44220923|NCT01433991|79023419|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
44220924|NCT01433991|79023416|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
44220925|NCT01433991|79023417|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
44373978|NCT00595504|79379144|FG000|Overall Study|Physician Decision|1|||
44373979|NCT00595504|79379145|FG001|Overall Study|Physician Decision|0|||
44461615|NCT00524030|79470675|FG000|Overall Study|Lost to Follow-up|0|||
44461616|NCT00524030|79470676|FG001|Overall Study|Lost to Follow-up|2|||
44220926|NCT01433991|79023418|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
44373980|NCT00808483|79379153|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
44461617|NCT00524030|79470675|FG000|Overall Study|Withdrawal by Subject|3|||
44220927|NCT01433991|79023419|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
44220928|NCT01433991|79023416|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
44220929|NCT01433991|79023417|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
44220930|NCT01433991|79023418|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
44220931|NCT01433991|79023419|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
44220932|NCT01433991|79023416|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
44220933|NCT01433991|79023417|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
44220934|NCT01433991|79023418|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
44220935|NCT01433991|79023419|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
44220936|NCT01450683|79023435|FG000|Overall Study|Adverse Event|2|||
44220937|NCT01433055|79023441|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
44220938|NCT01433055|79023442|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
44220939|NCT01433055|79023441|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
44220940|NCT01433055|79023442|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
44220941|NCT01450137|79023450|FG000|Up to Week 12|Adverse Event|2|||
44220942|NCT01450137|79023451|FG001|Up to Week 12|Adverse Event|1|||
44220943|NCT01450137|79023450|FG000|Up to Week 12|Withdrawal by Subject|0|||
44220944|NCT01450137|79023451|FG001|Up to Week 12|Withdrawal by Subject|2|||
44220945|NCT01450137|79023450|FG000|Week 12 to Study End|Death|0|||
44220946|NCT01450137|79023451|FG001|Week 12 to Study End|Death|1|||
44220947|NCT01450137|79023450|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
44220948|NCT01450137|79023451|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
44220949|NCT01412229|79023457|FG000|Overall Study|Physician Decision|1|||
44220950|NCT01412151|79023462|FG000|Week 0 - 306 - Treatment Period|Death|1|||
44220951|NCT01412151|79023462|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
44220952|NCT01412151|79023462|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
44220953|NCT01412151|79023462|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
44220954|NCT01432275|79023468|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
44220955|NCT01432275|79023469|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
44220956|NCT01432275|79023468|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
44220957|NCT01432275|79023469|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
44220958|NCT01432275|79023468|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
44220959|NCT01432275|79023469|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
44220960|NCT01432275|79023468|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
44220961|NCT01432275|79023469|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
44220962|NCT01432275|79023468|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
44220963|NCT01432275|79023469|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
44220964|NCT01432275|79023468|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
44220965|NCT01432275|79023469|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
44220966|NCT01432275|79023468|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
44220967|NCT01432275|79023469|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
44220968|NCT01432275|79023468|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
44220969|NCT01432275|79023469|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
44220970|NCT01432275|79023468|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
44220971|NCT01432275|79023469|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
44220972|NCT01411995|79023477|FG000|Overall Study|Failed IUD insertion|0|||
44220973|NCT01411995|79023478|FG001|Overall Study|Failed IUD insertion|1|||
44220974|NCT01411917|79023486|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
44220975|NCT01411917|79023487|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
44220976|NCT01411839|79023495|FG000|Overall Study|Lost to Follow-up|4|||
44220977|NCT01411839|79023496|FG001|Overall Study|Lost to Follow-up|3|||
44220978|NCT01411215|79023504|FG000|Overall Study|Adverse Event|1|||
44220979|NCT01411215|79023505|FG001|Overall Study|Adverse Event|2|||
44220980|NCT01411215|79023504|FG000|Overall Study|Lack of Efficacy|2|||
44270783|NCT02293902|79197328|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
44270784|NCT02293902|79197324|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
44461618|NCT00524030|79470676|FG001|Overall Study|Withdrawal by Subject|8|||
44461619|NCT00524030|79470675|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
44461620|NCT00524030|79470676|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
44461621|NCT00524030|79470675|FG000|Overall Study|Protocol Violation|0|||
44461622|NCT00524030|79470676|FG001|Overall Study|Protocol Violation|1|||
44461623|NCT00524030|79470675|FG000|Overall Study|Pregnancy|1|||
44544204|NCT03188718|79557482|FG000|Overall Study|Withdrawal by Subject|1|||
44544205|NCT03188718|79557482|FG000|Overall Study|Device failure|3|||
44270785|NCT02293902|79197325|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
44461624|NCT00524030|79470676|FG001|Overall Study|Pregnancy|0|||
44220981|NCT01411215|79023505|FG001|Overall Study|Lack of Efficacy|4|||
44220982|NCT01411215|79023504|FG000|Overall Study|Lost to Follow-up|12|||
44220983|NCT01411215|79023505|FG001|Overall Study|Lost to Follow-up|18|||
44461625|NCT00524030|79470675|FG000|Overall Study|Adverse Event|3|||
44461626|NCT00524030|79470676|FG001|Overall Study|Adverse Event|21|||
44220984|NCT01411215|79023504|FG000|Overall Study|Did not meet entrance criteria|0|||
44220985|NCT01411215|79023505|FG001|Overall Study|Did not meet entrance criteria|1|||
44220986|NCT01411215|79023504|FG000|Overall Study|Study terminated by sponsor|2|||
44220987|NCT01411215|79023505|FG001|Overall Study|Study terminated by sponsor|15|||
44220988|NCT01411215|79023504|FG000|Overall Study|Protocol Violation|3|||
44220989|NCT01411215|79023505|FG001|Overall Study|Protocol Violation|5|||
44220990|NCT01411215|79023504|FG000|Overall Study|Withdrawal by Subject|34|||
44220991|NCT01411215|79023505|FG001|Overall Study|Withdrawal by Subject|21|||
44220992|NCT01411215|79023504|FG000|Overall Study|Other|12|||
44220993|NCT01411215|79023505|FG001|Overall Study|Other|17|||
44220994|NCT01411215|79023504|FG000|Overall Study|Screen failure|0|||
44220995|NCT01411215|79023505|FG001|Overall Study|Screen failure|1|||
44220996|NCT01449279|79023511|FG000|Overall Study|Lack of Efficacy|5|||
44220997|NCT01449279|79023511|FG000|Overall Study|Toxicity|2|||
44220998|NCT01447719|79023515|FG000|Overall Study|Image acquisition failure|2|||
44220999|NCT01447719|79023515|FG000|Overall Study|Invalid image or not imaged|3|||
44221000|NCT01447719|79023515|FG000|Overall Study|Subject still living at end of study|79|||
44221001|NCT01447719|79023515|FG000|Overall Study|Withdrawal by Subject|2|||
44221002|NCT01447719|79023515|FG000|Overall Study|Family withdrew autopsy consent|7|||
44221003|NCT01431963|79023524|FG000|Overall Study|Adverse Event|18|||
44221004|NCT01431963|79023524|FG000|Overall Study|Lack of Efficacy|7|||
44221005|NCT01431963|79023524|FG000|Overall Study|Protocol Violation|1|||
44221006|NCT01431963|79023524|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
44221007|NCT01431963|79023524|FG000|Overall Study|Physician Decision|4|||
44221008|NCT01431963|79023524|FG000|Overall Study|Withdrawal by Subject|3|||
44221009|NCT01447407|79023532|FG000|Overall Study|Withdrawal by Subject|2|||
44221010|NCT01447407|79023533|FG001|Overall Study|Withdrawal by Subject|0|||
44221011|NCT01447407|79023534|FG002|Overall Study|Withdrawal by Subject|0|||
44221012|NCT01447407|79023535|FG003|Overall Study|Withdrawal by Subject|1|||
44221013|NCT01447407|79023532|FG000|Overall Study|Physician Decision|0|||
44221014|NCT01447407|79023533|FG001|Overall Study|Physician Decision|0|||
44221015|NCT01447407|79023534|FG002|Overall Study|Physician Decision|1|||
44221016|NCT01447407|79023535|FG003|Overall Study|Physician Decision|1|||
44221017|NCT01446237|79023545|FG000|Overall Study|Adverse Event|1|||
44221018|NCT01446237|79023545|FG000|Overall Study|Lost to Follow-up|2|||
44221019|NCT01446237|79023545|FG000|Overall Study|Withdrawal by Subject|7|||
44221020|NCT01446159|79023689|FG000|Overall Study|Withdrawal by Subject|1|||
44221021|NCT01446159|79023690|FG001|Overall Study|Withdrawal by Subject|0|||
44221022|NCT01446159|79023691|FG002|Overall Study|Withdrawal by Subject|14|||
44221023|NCT01446159|79023692|FG003|Overall Study|Withdrawal by Subject|11|||
44221024|NCT01446159|79023689|FG000|Overall Study|Lost to Follow-up|0|||
44221025|NCT01446159|79023690|FG001|Overall Study|Lost to Follow-up|0|||
44221026|NCT01446159|79023691|FG002|Overall Study|Lost to Follow-up|1|||
44221027|NCT01446159|79023692|FG003|Overall Study|Lost to Follow-up|2|||
44221028|NCT01446159|79023689|FG000|Overall Study|Death|2|||
44221029|NCT01446159|79023690|FG001|Overall Study|Death|3|||
44221030|NCT01446159|79023691|FG002|Overall Study|Death|43|||
44221031|NCT01446159|79023692|FG003|Overall Study|Death|36|||
44221032|NCT01446159|79023689|FG000|Overall Study|Other|0|||
44270786|NCT02293902|79197326|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
44270787|NCT02293902|79197327|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
44221033|NCT01446159|79023690|FG001|Overall Study|Other|0|||
44221034|NCT01446159|79023691|FG002|Overall Study|Other|13|||
44221035|NCT01446159|79023692|FG003|Overall Study|Other|13|||
44221036|NCT01446003|79023728|FG000|Period 1|Protocol Violation|2|||
44221037|NCT01446003|79023729|FG001|Period 1|Protocol Violation|0|||
44221038|NCT01446003|79023728|FG000|Period 2|Adverse Event|1|||
44221039|NCT01446003|79023729|FG001|Period 2|Adverse Event|0|||
44221040|NCT01430559|79023746|FG000|Overall Study|Adverse Event|7|||
44221041|NCT01430559|79023747|FG001|Overall Study|Adverse Event|3|||
44221042|NCT01430559|79023746|FG000|Overall Study|Entry criteria not met|1|||
44270788|NCT02293902|79197328|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
44221043|NCT01430559|79023747|FG001|Overall Study|Entry criteria not met|1|||
44221044|NCT01430559|79023746|FG000|Overall Study|Lost to Follow-up|1|||
44221045|NCT01430559|79023747|FG001|Overall Study|Lost to Follow-up|0|||
44221046|NCT01430559|79023746|FG000|Overall Study|Medication error|1|||
44221047|NCT01430559|79023747|FG001|Overall Study|Medication error|0|||
44221048|NCT01430559|79023746|FG000|Overall Study|Withdrawal by Subject|3|||
44221049|NCT01430559|79023747|FG001|Overall Study|Withdrawal by Subject|2|||
44221050|NCT01430559|79023746|FG000|Overall Study|Protocol Violation|1|||
44221051|NCT01430559|79023747|FG001|Overall Study|Protocol Violation|0|||
44221052|NCT01430559|79023746|FG000|Overall Study|Other|3|||
44221053|NCT01430559|79023747|FG001|Overall Study|Other|3|||
44221054|NCT01430559|79023746|FG000|Overall Study|Randomized, Not Treated|3|||
44221055|NCT01430559|79023747|FG001|Overall Study|Randomized, Not Treated|3|||
44221056|NCT01410357|79023760|FG000|Overall Study|Death|2|||
44221057|NCT01410357|79023761|FG001|Overall Study|Death|1|||
44221058|NCT01410357|79023760|FG000|Overall Study|Withdrawal by Subject|1|||
44221059|NCT01410357|79023761|FG001|Overall Study|Withdrawal by Subject|2|||
44221060|NCT01410357|79023760|FG000|Overall Study|Lost to Follow-up|23|||
44221061|NCT01410357|79023761|FG001|Overall Study|Lost to Follow-up|21|||
44221062|NCT01409811|79023786|FG000|Overall Study|Insurance denial|1|||
44221063|NCT01445847|79023792|FG000|Overall Study|Protocol Violation|13|||
44221064|NCT01445847|79023793|FG001|Overall Study|Protocol Violation|14|||
44221065|NCT01445847|79023792|FG000|Overall Study|Missed Data|1|||
44221066|NCT01445847|79023793|FG001|Overall Study|Missed Data|0|||
44221067|NCT01445769|79023812|FG000|Overall Study|Consent Withdrawn|2|||
44221068|NCT01445769|79023812|FG000|Overall Study|Disease Progression|1|||
44221069|NCT01445769|79023812|FG000|Overall Study|Lost to Follow-up|5|||
44221070|NCT01445613|79023894|FG000|30-day Follow-up|Withdrawal by Subject|6|||
44221071|NCT01445613|79023894|FG000|30-day Follow-up|Physician Decision|3|||
44221072|NCT01445613|79023894|FG000|30-day Follow-up|Missed visit|23|||
44221073|NCT01445613|79023894|FG000|30-day Follow-up|Death|3|||
44221074|NCT01445613|79023894|FG000|1-year Follow-up|Withdrawal by Subject|12|||
44221075|NCT01445613|79023894|FG000|1-year Follow-up|Missed visit|29|||
44221076|NCT01445613|79023894|FG000|1-year Follow-up|Lost to Follow-up|2|||
44221077|NCT01445613|79023894|FG000|1-year Follow-up|Death|30|||
44270789|NCT02293902|79197324|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
44270790|NCT02293902|79197325|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
44270791|NCT02293902|79197326|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
44270792|NCT02293902|79197327|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
44373981|NCT00808483|79379154|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
44461627|NCT00524030|79470675|FG000|Overall Study|Death|0|||
44461628|NCT00524030|79470676|FG001|Overall Study|Death|1|||
44461629|NCT00523718|79470685|FG000|Overall Study|Withdrawal by Subject|1|||
44461630|NCT00523718|79470686|FG001|Overall Study|Withdrawal by Subject|0|||
44461631|NCT00523718|79470685|FG000|Overall Study|Protocol Violation|2|||
44461632|NCT00523718|79470686|FG001|Overall Study|Protocol Violation|0|||
44461633|NCT00523640|79470692|FG000|Overall Study|Death|1|||
44461634|NCT00345358|79470700|FG000|Primary Vaccination Phase|Other|0|||
44461635|NCT00345358|79470701|FG001|Primary Vaccination Phase|Other|1|||
44461636|NCT00345358|79470702|FG002|Primary Vaccination Phase|Other|1|||
44461637|NCT00345358|79470703|FG003|Primary Vaccination Phase|Other|0|||
44461638|NCT00345358|79470700|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
44221078|NCT01445613|79023894|FG000|1-year Follow-up|Physician Decision|2|||
44221079|NCT01445613|79023894|FG000|1-year Follow-up|Received a non-study stent|2|||
44221080|NCT01445535|79023998|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
44221081|NCT01445535|79023999|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
44221082|NCT01445535|79024000|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
44221083|NCT01445535|79024001|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
44221084|NCT01445535|79023998|FG000|Overall Study|Disease progression|1|||
44221085|NCT01445535|79023999|FG001|Overall Study|Disease progression|0|||
44221086|NCT01445535|79024000|FG002|Overall Study|Disease progression|1|||
44221087|NCT01445535|79024001|FG003|Overall Study|Disease progression|0|||
44221088|NCT01445535|79023998|FG000|Overall Study|PI discretion|0|||
44373982|NCT00808483|79379153|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
44373983|NCT00808483|79379154|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
44373984|NCT00808483|79379153|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
44373985|NCT00808483|79379154|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
44373986|NCT00810511|79379169|FG000|Overall Study|Protocol Violation|0|||
44373987|NCT00810511|79379170|FG001|Overall Study|Protocol Violation|1|||
44373988|NCT00810511|79379169|FG000|Overall Study|Lack of Efficacy|9|||
44373989|NCT00810511|79379170|FG001|Overall Study|Lack of Efficacy|1|||
44373990|NCT00810511|79379169|FG000|Overall Study|death in the family|0|||
44373991|NCT00810511|79379170|FG001|Overall Study|death in the family|1|||
44373992|NCT00810511|79379169|FG000|Overall Study|Lost to Follow-up|1|||
44373993|NCT00810511|79379170|FG001|Overall Study|Lost to Follow-up|0|||
44373994|NCT00810511|79379169|FG000|Overall Study|deposits on contact lens|0|||
44373995|NCT00810511|79379170|FG001|Overall Study|deposits on contact lens|1|||
44373996|NCT00596362|79379176|FG000|Overall Study|Progressive Disease|1|||
44373997|NCT00907803|79379183|FG000|Overall Study|Withdrawal of consent - long commute|1|||
44373998|NCT00907803|79379184|FG001|Overall Study|Withdrawal of consent - long commute|0|||
44270793|NCT02293902|79197328|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
44270794|NCT02278614|79197348|FG000|Overall Study|Withdrawal by Subject|3|||
44270795|NCT02278614|79197349|FG001|Overall Study|Withdrawal by Subject|5|||
44270796|NCT02278614|79197348|FG000|Overall Study|Adverse Event|1|||
44270797|NCT02278614|79197349|FG001|Overall Study|Adverse Event|0|||
44270798|NCT02278614|79197348|FG000|Overall Study|left eye was not eligible|1|||
44270799|NCT02278614|79197349|FG001|Overall Study|left eye was not eligible|0|||
44270800|NCT02318706|79197359|FG000|Double-blind Phase|Adverse Event|7|||
44270801|NCT02318706|79197360|FG001|Double-blind Phase|Adverse Event|4|||
44270802|NCT02318706|79197361|FG002|Double-blind Phase|Adverse Event|3|||
44270803|NCT02318706|79197362|FG003|Double-blind Phase|Adverse Event|10|||
44270804|NCT02318706|79197363|FG004|Double-blind Phase|Adverse Event|0|||
44270805|NCT02318706|79197359|FG000|Double-blind Phase|Lost to Follow-up|1|||
44461639|NCT00345358|79470701|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
44461640|NCT00345358|79470702|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
44221089|NCT01445535|79023999|FG001|Overall Study|PI discretion|0|||
44221090|NCT01445535|79024000|FG002|Overall Study|PI discretion|0|||
44221091|NCT01445535|79024001|FG003|Overall Study|PI discretion|1|||
44221092|NCT01445301|79024015|FG000|Overall Study|Adverse Event|15|||
44221093|NCT01445301|79024016|FG001|Overall Study|Adverse Event|25|||
44221094|NCT01445301|79024017|FG002|Overall Study|Adverse Event|4|||
44221095|NCT01445301|79024015|FG000|Overall Study|Lack of Efficacy|0|||
44270806|NCT02318706|79197360|FG001|Double-blind Phase|Lost to Follow-up|0|||
44270807|NCT02318706|79197361|FG002|Double-blind Phase|Lost to Follow-up|0|||
44270808|NCT02318706|79197362|FG003|Double-blind Phase|Lost to Follow-up|0|||
44270809|NCT02318706|79197363|FG004|Double-blind Phase|Lost to Follow-up|0|||
44270810|NCT02318706|79197359|FG000|Double-blind Phase|Protocol Violation|4|||
44270811|NCT02318706|79197360|FG001|Double-blind Phase|Protocol Violation|2|||
44270812|NCT02318706|79197361|FG002|Double-blind Phase|Protocol Violation|4|||
44270813|NCT02318706|79197362|FG003|Double-blind Phase|Protocol Violation|3|||
44270814|NCT02318706|79197363|FG004|Double-blind Phase|Protocol Violation|0|||
44270815|NCT02318706|79197359|FG000|Double-blind Phase|Withdrawal by Subject|9|||
44270816|NCT02318706|79197360|FG001|Double-blind Phase|Withdrawal by Subject|5|||
44270817|NCT02318706|79197361|FG002|Double-blind Phase|Withdrawal by Subject|7|||
44270818|NCT02318706|79197362|FG003|Double-blind Phase|Withdrawal by Subject|10|||
44270819|NCT02318706|79197363|FG004|Double-blind Phase|Withdrawal by Subject|0|||
44270820|NCT02318706|79197359|FG000|Double-blind Phase|Other|4|||
44270821|NCT02318706|79197360|FG001|Double-blind Phase|Other|1|||
44270822|NCT02318706|79197361|FG002|Double-blind Phase|Other|2|||
44270823|NCT02318706|79197362|FG003|Double-blind Phase|Other|1|||
44270824|NCT02318706|79197363|FG004|Double-blind Phase|Other|0|||
44270825|NCT02318706|79197359|FG000|Double-blind Phase|Death|0|||
44270826|NCT02318706|79197360|FG001|Double-blind Phase|Death|0|||
44270827|NCT02318706|79197361|FG002|Double-blind Phase|Death|2|||
44270828|NCT02318706|79197362|FG003|Double-blind Phase|Death|0|||
44270829|NCT02318706|79197363|FG004|Double-blind Phase|Death|0|||
44373999|NCT00907803|79379185|FG002|Overall Study|Withdrawal of consent - long commute|0|||
44374000|NCT00907803|79379183|FG000|Overall Study|Adverse Event|2|||
44374001|NCT00907803|79379184|FG001|Overall Study|Adverse Event|0|||
44374002|NCT00907803|79379185|FG002|Overall Study|Adverse Event|0|||
44374003|NCT00907803|79379183|FG000|Overall Study|Withdrawal by Subject|0|||
44374004|NCT00907803|79379184|FG001|Overall Study|Withdrawal by Subject|1|||
44221096|NCT01445301|79024016|FG001|Overall Study|Lack of Efficacy|1|||
44270830|NCT02318706|79197359|FG000|Open-label Extension Phase|Adverse Event|0|||
44270831|NCT02318706|79197360|FG001|Open-label Extension Phase|Adverse Event|0|||
44270832|NCT02318706|79197361|FG002|Open-label Extension Phase|Adverse Event|0|||
44374005|NCT00907803|79379185|FG002|Overall Study|Withdrawal by Subject|0|||
44374006|NCT00907803|79379183|FG000|Overall Study|Lost to Follow-up|0|||
44374007|NCT00907803|79379184|FG001|Overall Study|Lost to Follow-up|1|||
44374008|NCT00907803|79379185|FG002|Overall Study|Lost to Follow-up|0|||
44374009|NCT00907803|79379183|FG000|Overall Study|Protocol Violation|0|||
44374010|NCT00907803|79379184|FG001|Overall Study|Protocol Violation|1|||
44221097|NCT01445301|79024017|FG002|Overall Study|Lack of Efficacy|0|||
44221098|NCT01445301|79024015|FG000|Overall Study|Protocol Violation|1|||
44270833|NCT02318706|79197362|FG003|Open-label Extension Phase|Adverse Event|0|||
44270834|NCT02318706|79197363|FG004|Open-label Extension Phase|Adverse Event|21|||
44270835|NCT02318706|79197359|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
44270836|NCT02318706|79197360|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
44270837|NCT02318706|79197361|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
44270838|NCT02318706|79197362|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
44270839|NCT02318706|79197363|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
44270840|NCT02318706|79197359|FG000|Open-label Extension Phase|Death|0|||
44270841|NCT02318706|79197360|FG001|Open-label Extension Phase|Death|0|||
44461641|NCT00345358|79470703|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
44461642|NCT00345358|79470700|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
44461643|NCT00345358|79470701|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
44461644|NCT00345358|79470702|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
44461645|NCT00345358|79470703|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
44461646|NCT00345358|79470700|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
44461647|NCT00345358|79470701|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
44461648|NCT00345358|79470702|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
44461649|NCT00345358|79470703|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
44461650|NCT00345358|79470700|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
44461651|NCT00345358|79470701|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
44461652|NCT00345358|79470702|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
44461653|NCT00345358|79470703|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
44461654|NCT00345358|79470700|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
44461655|NCT00345358|79470701|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
44461656|NCT00345358|79470702|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
44461657|NCT00345358|79470703|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
44221099|NCT01445301|79024016|FG001|Overall Study|Protocol Violation|0|||
44221100|NCT01445301|79024017|FG002|Overall Study|Protocol Violation|0|||
44221101|NCT01445301|79024015|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
44461658|NCT03869684|79470716|FG000|Overall Study|Adverse Event|0|||
44461659|NCT03869684|79470717|FG001|Overall Study|Adverse Event|3|||
44461660|NCT03869684|79470718|FG002|Overall Study|Adverse Event|1|||
44461661|NCT03869684|79470716|FG000|Overall Study|Withdrawal by Subject|1|||
44461662|NCT03869684|79470717|FG001|Overall Study|Withdrawal by Subject|0|||
44461663|NCT03869684|79470718|FG002|Overall Study|Withdrawal by Subject|0|||
44461664|NCT03869684|79470716|FG000|Overall Study|Lost to Follow-up|1|||
44461665|NCT03869684|79470717|FG001|Overall Study|Lost to Follow-up|0|||
44461666|NCT03869684|79470718|FG002|Overall Study|Lost to Follow-up|0|||
44461667|NCT03869684|79470716|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
44461668|NCT03869684|79470717|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
44461669|NCT03869684|79470718|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
44461670|NCT00516074|79470728|FG000|Overall Study|Adverse Event|0|||
44461671|NCT00516074|79470729|FG001|Overall Study|Adverse Event|1|||
44461672|NCT00516074|79470728|FG000|Overall Study|Subject Decision|4|||
44461673|NCT00516074|79470729|FG001|Overall Study|Subject Decision|2|||
44544206|NCT03574753|79557486|FG000|Overall Study|Adverse Event|3|||
44544207|NCT03574753|79557486|FG000|Overall Study|Progression/relapse|19|||
44544208|NCT03574753|79557486|FG000|Overall Study|Death|1|||
44221102|NCT01445301|79024016|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
44221103|NCT01445301|79024017|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
44221104|NCT01445301|79024015|FG000|Overall Study|Physician Decision|0|||
44221105|NCT01445301|79024016|FG001|Overall Study|Physician Decision|2|||
44221106|NCT01445301|79024017|FG002|Overall Study|Physician Decision|0|||
44221107|NCT01445301|79024015|FG000|Overall Study|Withdrawal by Subject|5|||
44221108|NCT01445301|79024016|FG001|Overall Study|Withdrawal by Subject|6|||
44221109|NCT01445301|79024017|FG002|Overall Study|Withdrawal by Subject|4|||
44221110|NCT01409031|79024027|FG000|Overall Study|transferred to other hosp|1|||
44221111|NCT01409031|79024028|FG001|Overall Study|transferred to other hosp|0|||
44221112|NCT01430403|79024037|FG000|Overall Study|Lost to Follow-up|5|||
44221113|NCT01430403|79024038|FG001|Overall Study|Lost to Follow-up|5|||
44221114|NCT01430403|79024039|FG002|Overall Study|Lost to Follow-up|3|||
44270842|NCT02318706|79197361|FG002|Open-label Extension Phase|Death|0|||
44270843|NCT02318706|79197362|FG003|Open-label Extension Phase|Death|0|||
44270844|NCT02318706|79197363|FG004|Open-label Extension Phase|Death|1|||
44270845|NCT02318706|79197359|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
44270846|NCT02318706|79197360|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
44374011|NCT00907803|79379185|FG002|Overall Study|Protocol Violation|0|||
44374012|NCT00808249|79379197|FG000|Overall Study|Adverse Event|4|||
44374013|NCT00808249|79379198|FG001|Overall Study|Adverse Event|7|||
44374014|NCT00808249|79379199|FG002|Overall Study|Adverse Event|10|||
44374015|NCT00808249|79379200|FG003|Overall Study|Adverse Event|6|||
44374016|NCT00808249|79379197|FG000|Overall Study|Lost to Follow-up|2|||
44374017|NCT00808249|79379198|FG001|Overall Study|Lost to Follow-up|3|||
44374018|NCT00808249|79379199|FG002|Overall Study|Lost to Follow-up|3|||
44374019|NCT00808249|79379200|FG003|Overall Study|Lost to Follow-up|5|||
44374020|NCT00808249|79379197|FG000|Overall Study|Withdrawal by Subject|4|||
44374021|NCT00808249|79379198|FG001|Overall Study|Withdrawal by Subject|0|||
44374022|NCT00808249|79379199|FG002|Overall Study|Withdrawal by Subject|2|||
44461674|NCT00516074|79470728|FG000|Overall Study|Loss of Glucose Control|2|||
44461675|NCT00516074|79470729|FG001|Overall Study|Loss of Glucose Control|0|||
44461676|NCT00515294|79470739|FG000|Overall Study|Lost to Follow-up|3|||
44461677|NCT00515294|79470740|FG001|Overall Study|Lost to Follow-up|2|||
44461678|NCT00515294|79470741|FG002|Overall Study|Lost to Follow-up|3|||
44461679|NCT00515294|79470742|FG003|Overall Study|Lost to Follow-up|1|||
44461680|NCT00515294|79470739|FG000|Overall Study|Driver simulator problems|1|||
44270847|NCT02318706|79197361|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
44270848|NCT02318706|79197362|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
44270849|NCT02318706|79197363|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
44270850|NCT04583280|79197414|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
44270851|NCT04583280|79197415|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
44270852|NCT04489940|79197434|FG000|Overall Study|Other|2|||
44270853|NCT04489940|79197434|FG000|Overall Study|Withdrawal by Subject|2|||
44270854|NCT04489940|79197434|FG000|Overall Study|Death|5|||
44221115|NCT01430403|79024037|FG000|Overall Study|Physician Decision|1|||
44221116|NCT01430403|79024038|FG001|Overall Study|Physician Decision|0|||
44221117|NCT01430403|79024039|FG002|Overall Study|Physician Decision|0|||
44221118|NCT01430403|79024037|FG000|Overall Study|Protocol Violation|2|||
44270855|NCT04489940|79197434|FG000|Overall Study|Lost to Follow-up|1|||
44270856|NCT04365257|79197440|FG000|Overall Study|Physician Decision|1|||
44270857|NCT04365257|79197441|FG001|Overall Study|Physician Decision|0|||
44270858|NCT04365257|79197440|FG000|Overall Study|Patient Noncompliance|1|||
44270859|NCT04365257|79197441|FG001|Overall Study|Patient Noncompliance|0|||
44270860|NCT04365257|79197440|FG000|Overall Study|Withdrawal by Subject|0|||
44270861|NCT04365257|79197441|FG001|Overall Study|Withdrawal by Subject|1|||
44270862|NCT03395223|79197473|FG000|Overall Study|Lost to Follow-up|3|||
44270863|NCT03395223|79197473|FG000|Overall Study|Other|1|||
44270864|NCT02864940|79197503|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
44270865|NCT02864940|79197504|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
44270866|NCT02756611|79197523|FG000|Overall Study|Death|70|||
44270867|NCT02756611|79197523|FG000|Overall Study|Withdrawal by Subject|2|||
44270868|NCT02756611|79197523|FG000|Overall Study|Lost to Follow-up|3|||
44270869|NCT02756611|79197523|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
44270870|NCT02756611|79197523|FG000|Overall Study|Other|10|||
44270871|NCT02624518|79197527|FG000|Overall Study|Physician Decision|1|||
44270872|NCT02287623|79197533|FG000|Overall Study|Protocol Violation|0|||
44270873|NCT02287623|79197534|FG001|Overall Study|Protocol Violation|1|||
44270874|NCT01794520|79197556|FG000|Overall Study|Adverse events- related to progression|0|||
44270875|NCT01794520|79197557|FG001|Overall Study|Adverse events- related to progression|0|||
44270876|NCT01794520|79197558|FG002|Overall Study|Adverse events- related to progression|1|||
44270877|NCT01794520|79197559|FG003|Overall Study|Adverse events- related to progression|2|||
44270878|NCT01794520|79197560|FG004|Overall Study|Adverse events- related to progression|0|||
44270879|NCT01794520|79197561|FG005|Overall Study|Adverse events- related to progression|1|||
44270880|NCT01794520|79197562|FG006|Overall Study|Adverse events- related to progression|0|||
44270881|NCT01794520|79197556|FG000|Overall Study|Adverse event- not related to progression|1|||
44270882|NCT01794520|79197557|FG001|Overall Study|Adverse event- not related to progression|1|||
44270883|NCT01794520|79197558|FG002|Overall Study|Adverse event- not related to progression|0|||
44270884|NCT01794520|79197559|FG003|Overall Study|Adverse event- not related to progression|0|||
44270885|NCT01794520|79197560|FG004|Overall Study|Adverse event- not related to progression|2|||
44270886|NCT01794520|79197561|FG005|Overall Study|Adverse event- not related to progression|0|||
44270887|NCT01794520|79197562|FG006|Overall Study|Adverse event- not related to progression|0|||
44270888|NCT01794520|79197556|FG000|Overall Study|Progressive disease|5|||
44270889|NCT01794520|79197557|FG001|Overall Study|Progressive disease|6|||
44270890|NCT01794520|79197558|FG002|Overall Study|Progressive disease|2|||
44270891|NCT01794520|79197559|FG003|Overall Study|Progressive disease|5|||
44270892|NCT01794520|79197560|FG004|Overall Study|Progressive disease|27|||
44270893|NCT01794520|79197561|FG005|Overall Study|Progressive disease|18|||
44270894|NCT01794520|79197562|FG006|Overall Study|Progressive disease|0|||
44270895|NCT01794520|79197556|FG000|Overall Study|Withdrew consent|0|||
44270896|NCT01794520|79197557|FG001|Overall Study|Withdrew consent|0|||
44270897|NCT01794520|79197558|FG002|Overall Study|Withdrew consent|1|||
44270898|NCT01794520|79197559|FG003|Overall Study|Withdrew consent|1|||
44221119|NCT01430403|79024038|FG001|Overall Study|Protocol Violation|3|||
44221120|NCT01430403|79024039|FG002|Overall Study|Protocol Violation|2|||
44221121|NCT01430403|79024037|FG000|Overall Study|Withdrawal by Subject|9|||
44270899|NCT01794520|79197560|FG004|Overall Study|Withdrew consent|0|||
44270900|NCT01794520|79197561|FG005|Overall Study|Withdrew consent|0|||
44270901|NCT01794520|79197562|FG006|Overall Study|Withdrew consent|0|||
44270902|NCT01794520|79197556|FG000|Overall Study|Lost to Follow-up|0|||
44270903|NCT01794520|79197557|FG001|Overall Study|Lost to Follow-up|0|||
44270904|NCT01794520|79197558|FG002|Overall Study|Lost to Follow-up|0|||
44461681|NCT00515294|79470740|FG001|Overall Study|Driver simulator problems|1|||
44544209|NCT03573505|79557493|FG000|Overall Study|Adverse Event|1|||
44221122|NCT01430403|79024038|FG001|Overall Study|Withdrawal by Subject|1|||
44270905|NCT01794520|79197559|FG003|Overall Study|Lost to Follow-up|0|||
44270906|NCT01794520|79197560|FG004|Overall Study|Lost to Follow-up|1|||
44270907|NCT01794520|79197561|FG005|Overall Study|Lost to Follow-up|0|||
44270908|NCT01794520|79197562|FG006|Overall Study|Lost to Follow-up|0|||
44270909|NCT01794520|79197556|FG000|Overall Study|Toxicity|0|||
44270910|NCT01794520|79197557|FG001|Overall Study|Toxicity|2|||
44270911|NCT01794520|79197558|FG002|Overall Study|Toxicity|0|||
44270912|NCT01794520|79197559|FG003|Overall Study|Toxicity|0|||
44270913|NCT01794520|79197560|FG004|Overall Study|Toxicity|0|||
44270914|NCT01794520|79197561|FG005|Overall Study|Toxicity|0|||
44270915|NCT01794520|79197562|FG006|Overall Study|Toxicity|0|||
44270916|NCT01794520|79197556|FG000|Overall Study|Study terminated by sponsor|0|||
44270917|NCT01794520|79197557|FG001|Overall Study|Study terminated by sponsor|0|||
44270918|NCT01794520|79197558|FG002|Overall Study|Study terminated by sponsor|1|||
44270919|NCT01794520|79197559|FG003|Overall Study|Study terminated by sponsor|0|||
44270920|NCT01794520|79197560|FG004|Overall Study|Study terminated by sponsor|1|||
44270921|NCT01794520|79197561|FG005|Overall Study|Study terminated by sponsor|0|||
44270922|NCT01794520|79197562|FG006|Overall Study|Study terminated by sponsor|7|||
44270923|NCT01794520|79197556|FG000|Overall Study|Death|0|||
44270924|NCT01794520|79197557|FG001|Overall Study|Death|0|||
44270925|NCT01794520|79197558|FG002|Overall Study|Death|0|||
44270926|NCT01794520|79197559|FG003|Overall Study|Death|0|||
44270927|NCT01794520|79197560|FG004|Overall Study|Death|1|||
44270928|NCT01794520|79197561|FG005|Overall Study|Death|0|||
44270929|NCT01794520|79197562|FG006|Overall Study|Death|22|||
44270930|NCT01794520|79197556|FG000|Overall Study|Other, not specified|0|||
44221123|NCT01430403|79024039|FG002|Overall Study|Withdrawal by Subject|3|||
44221124|NCT01429623|79024054|FG000|Overall Study|Death|1|||
44270931|NCT01794520|79197557|FG001|Overall Study|Other, not specified|0|||
44270932|NCT01794520|79197558|FG002|Overall Study|Other, not specified|1|||
44270933|NCT01794520|79197559|FG003|Overall Study|Other, not specified|1|||
44270934|NCT01794520|79197560|FG004|Overall Study|Other, not specified|4|||
44270935|NCT01794520|79197561|FG005|Overall Study|Other, not specified|1|||
44270936|NCT01794520|79197562|FG006|Overall Study|Other, not specified|2|||
44270937|NCT01774019|79197585|FG000|Overall Study|No longer meets protocol criteria|2|||
44270938|NCT01774019|79197586|FG001|Overall Study|No longer meets protocol criteria|0|||
44270939|NCT01774019|79197585|FG000|Overall Study|Withdrawal by Subject|1|||
44270940|NCT01774019|79197586|FG001|Overall Study|Withdrawal by Subject|0|||
44270941|NCT01774019|79197585|FG000|Overall Study|Surgery delayed > 120 days|1|||
44270942|NCT01774019|79197586|FG001|Overall Study|Surgery delayed > 120 days|0|||
44270943|NCT01774019|79197585|FG000|Overall Study|Patient refused surgery|1|||
44270944|NCT01774019|79197586|FG001|Overall Study|Patient refused surgery|1|||
44270945|NCT01774019|79197585|FG000|Overall Study|Unable to implant study device|1|||
44270946|NCT01774019|79197586|FG001|Overall Study|Unable to implant study device|0|||
44270947|NCT01774019|79197585|FG000|Overall Study|Lost to Follow-up|0|||
44374023|NCT00808249|79379200|FG003|Overall Study|Withdrawal by Subject|4|||
44374024|NCT00808249|79379197|FG000|Overall Study|Protocol Violation|3|||
44374025|NCT00808249|79379198|FG001|Overall Study|Protocol Violation|3|||
44221125|NCT01429623|79024055|FG001|Overall Study|Death|0|||
44221126|NCT01429623|79024054|FG000|Overall Study|Adverse Event|7|||
44221127|NCT01429623|79024055|FG001|Overall Study|Adverse Event|14|||
44221128|NCT01429623|79024054|FG000|Overall Study|Withdrawal by Subject|19|||
44221129|NCT01429623|79024055|FG001|Overall Study|Withdrawal by Subject|13|||
44221130|NCT01429623|79024054|FG000|Overall Study|Physician Decision|2|||
44221131|NCT01429623|79024055|FG001|Overall Study|Physician Decision|3|||
44221132|NCT01429623|79024054|FG000|Overall Study|Protocol Violation|3|||
44374026|NCT00808249|79379199|FG002|Overall Study|Protocol Violation|3|||
44374027|NCT00808249|79379200|FG003|Overall Study|Protocol Violation|0|||
44374028|NCT00808249|79379197|FG000|Overall Study|Lack of Efficacy|1|||
44374029|NCT00808249|79379198|FG001|Overall Study|Lack of Efficacy|1|||
44374030|NCT00808249|79379199|FG002|Overall Study|Lack of Efficacy|0|||
44374031|NCT00808249|79379200|FG003|Overall Study|Lack of Efficacy|0|||
44374032|NCT00808249|79379197|FG000|Overall Study|study specific discontinuation criteria|1|||
44374033|NCT00808249|79379198|FG001|Overall Study|study specific discontinuation criteria|0|||
44374034|NCT00808249|79379199|FG002|Overall Study|study specific discontinuation criteria|1|||
44374035|NCT00808249|79379200|FG003|Overall Study|study specific discontinuation criteria|0|||
44374036|NCT00808249|79379197|FG000|Overall Study|All other reasons|2|||
44374037|NCT00808249|79379198|FG001|Overall Study|All other reasons|1|||
44374038|NCT00808249|79379199|FG002|Overall Study|All other reasons|3|||
44461682|NCT00515294|79470741|FG002|Overall Study|Driver simulator problems|1|||
44221133|NCT01429623|79024055|FG001|Overall Study|Protocol Violation|2|||
44221134|NCT01429623|79024054|FG000|Overall Study|Assorted|1|||
44221135|NCT01429623|79024055|FG001|Overall Study|Assorted|2|||
44270948|NCT01774019|79197586|FG001|Overall Study|Lost to Follow-up|3|||
44270949|NCT03251924|79197948|FG000|Overall Study|Disease Progression|6|||
44270950|NCT03251924|79197949|FG001|Overall Study|Disease Progression|6|||
44270951|NCT03251924|79197950|FG002|Overall Study|Disease Progression|7|||
44270952|NCT03251924|79197951|FG003|Overall Study|Disease Progression|8|||
44374039|NCT00808249|79379200|FG003|Overall Study|All other reasons|1|||
44374040|NCT00908895|79379212|FG000|Overall Study|Lost to Follow-up|1|||
44461683|NCT00515294|79470742|FG003|Overall Study|Driver simulator problems|3|||
44461684|NCT00515294|79470739|FG000|Overall Study|Caffeine amount inaccurate|5|||
44544210|NCT03573505|79557494|FG001|Overall Study|Adverse Event|1|||
44374041|NCT00908895|79379213|FG001|Overall Study|Lost to Follow-up|3|||
44270953|NCT03251924|79197952|FG004|Overall Study|Disease Progression|8|||
44270954|NCT03251924|79197953|FG005|Overall Study|Disease Progression|7|||
44270955|NCT03251924|79197954|FG006|Overall Study|Disease Progression|6|||
44270956|NCT03251924|79197955|FG007|Overall Study|Disease Progression|10|||
44270957|NCT03251924|79197956|FG008|Overall Study|Disease Progression|6|||
44270958|NCT03251924|79197948|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
44544211|NCT03573505|79557493|FG000|Overall Study|Consent withdrawn|0|||
44544212|NCT03573505|79557494|FG001|Overall Study|Consent withdrawn|1|||
44544213|NCT03573505|79557493|FG000|Overall Study|Disease progression|0|||
44544214|NCT03573505|79557494|FG001|Overall Study|Disease progression|1|||
44544215|NCT03573505|79557493|FG000|Overall Study|Site Terminated by Sponsor|1|||
44544216|NCT03573505|79557494|FG001|Overall Study|Site Terminated by Sponsor|1|||
44544217|NCT03573505|79557493|FG000|Overall Study|Study terminated by sponsor|50|||
44544218|NCT03573505|79557494|FG001|Overall Study|Study terminated by sponsor|45|||
44544219|NCT03573505|79557493|FG000|Overall Study|Reason not specified|0|||
44544220|NCT03573505|79557494|FG001|Overall Study|Reason not specified|1|||
44270959|NCT03251924|79197949|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
44270960|NCT03251924|79197950|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
44270961|NCT03251924|79197951|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
44270962|NCT03251924|79197952|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
44270963|NCT03251924|79197953|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
44270964|NCT03251924|79197954|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
44270965|NCT03251924|79197955|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
44270966|NCT03251924|79197956|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
44270967|NCT03251924|79197948|FG000|Overall Study|Death|0|||
44270968|NCT03251924|79197949|FG001|Overall Study|Death|1|||
44270969|NCT03251924|79197950|FG002|Overall Study|Death|0|||
44270970|NCT03251924|79197951|FG003|Overall Study|Death|1|||
44270971|NCT03251924|79197952|FG004|Overall Study|Death|1|||
44270972|NCT03251924|79197953|FG005|Overall Study|Death|1|||
44270973|NCT03251924|79197954|FG006|Overall Study|Death|0|||
44270974|NCT03251924|79197955|FG007|Overall Study|Death|0|||
44374042|NCT00908895|79379212|FG000|Overall Study|algodystrophy|2|||
44544221|NCT03573505|79557493|FG000|Overall Study|Death|0|||
44374043|NCT00908895|79379213|FG001|Overall Study|algodystrophy|2|||
44374044|NCT00908895|79379212|FG000|Overall Study|Adverse Event|1|||
44374045|NCT00908895|79379213|FG001|Overall Study|Adverse Event|1|||
44221136|NCT01429623|79024054|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
44374046|NCT00591253|79379222|FG000|Overall Study|Adverse Event|3|||
44221137|NCT01429623|79024055|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
44221138|NCT01429623|79024054|FG000|Overall Study|No post baseline data|4|||
44221139|NCT01429623|79024055|FG001|Overall Study|No post baseline data|4|||
44221140|NCT01408641|79024063|FG000|Overall Study|Physician Decision|1|||
44221141|NCT01408641|79024064|FG001|Overall Study|Physician Decision|0|||
44221142|NCT01429077|79024072|FG000|Overall Study|Lost to Follow-up|0|||
44221143|NCT01429077|79024073|FG001|Overall Study|Lost to Follow-up|3|||
44221144|NCT01428453|79024081|FG000|Overall Study|Adverse Event|2|||
44374047|NCT00591253|79379223|FG001|Overall Study|Adverse Event|3|||
44544222|NCT03573505|79557494|FG001|Overall Study|Death|4|||
44221145|NCT01428453|79024082|FG001|Overall Study|Adverse Event|7|||
44270975|NCT03251924|79197956|FG008|Overall Study|Death|0|||
44374048|NCT00591253|79379224|FG002|Overall Study|Adverse Event|1|||
44374049|NCT00591253|79379222|FG000|Overall Study|Protocol Violation|2|||
44374050|NCT00591253|79379223|FG001|Overall Study|Protocol Violation|2|||
44374051|NCT00591253|79379224|FG002|Overall Study|Protocol Violation|2|||
44374052|NCT00591253|79379222|FG000|Overall Study|Lost to Follow-up|2|||
44374053|NCT00591253|79379223|FG001|Overall Study|Lost to Follow-up|4|||
44374054|NCT00591253|79379224|FG002|Overall Study|Lost to Follow-up|0|||
44461685|NCT00515294|79470740|FG001|Overall Study|Caffeine amount inaccurate|0|||
44461686|NCT00515294|79470741|FG002|Overall Study|Caffeine amount inaccurate|7|||
44461687|NCT00515294|79470742|FG003|Overall Study|Caffeine amount inaccurate|0|||
44461688|NCT00345046|79470755|FG000|Overall Study|Protocol Violation|1|||
44461689|NCT00345046|79470756|FG001|Overall Study|Protocol Violation|1|||
44461690|NCT00345046|79470757|FG002|Overall Study|Protocol Violation|2|||
44461691|NCT00515216|79470765|FG000|Overall Study|Withdrawal by Subject|1|||
44461692|NCT00522626|79470770|FG000|Overall Study|Lost to Follow-up|7|||
44544223|NCT01376908|79557503|FG000|Overall Study|Protocol Violation|1|||
44221146|NCT01428453|79024081|FG000|Overall Study|Protocol Violation|1|||
44221147|NCT01428453|79024082|FG001|Overall Study|Protocol Violation|0|||
44544224|NCT01376908|79557504|FG001|Overall Study|Protocol Violation|1|||
44544225|NCT01376908|79557503|FG000|Overall Study|Withdrawal by Subject|1|||
44270976|NCT03251924|79197948|FG000|Overall Study|Study Drug Toxicity|0|||
44374055|NCT00591253|79379222|FG000|Overall Study|Withdrawal by Subject|1|||
44374056|NCT00591253|79379223|FG001|Overall Study|Withdrawal by Subject|7|||
44461693|NCT00440193|79470776|FG000|Treatment Period|Adverse Event|74|||
44461694|NCT00440193|79470777|FG001|Treatment Period|Adverse Event|67|||
44461695|NCT00440193|79470776|FG000|Treatment Period|Death|19|||
44461696|NCT00440193|79470777|FG001|Treatment Period|Death|22|||
44221148|NCT01428453|79024081|FG000|Overall Study|Lost to Follow-up|0|||
44221149|NCT01428453|79024082|FG001|Overall Study|Lost to Follow-up|1|||
44221150|NCT01428453|79024081|FG000|Overall Study|Withdrawal by Subject|3|||
44221151|NCT01428453|79024082|FG001|Overall Study|Withdrawal by Subject|1|||
44221152|NCT01408563|79024090|FG000|Overall Study|Ineligible after consent/ registration|2|||
44221153|NCT01442493|79024096|FG000|Overall Study|withdrawn from study|3|||
44221154|NCT01442493|79024097|FG001|Overall Study|withdrawn from study|2|||
44221155|NCT01442181|79024105|FG000|Overall Study|patient refused surgery|1|||
44221156|NCT01442181|79024106|FG001|Overall Study|patient refused surgery|0|||
44221157|NCT01442181|79024105|FG000|Overall Study|no insurance for surgery|1|||
44221158|NCT01442181|79024106|FG001|Overall Study|no insurance for surgery|0|||
44221159|NCT01442181|79024105|FG000|Overall Study|low ejection factor|0|||
44221160|NCT01442181|79024106|FG001|Overall Study|low ejection factor|1|||
44221161|NCT01442181|79024105|FG000|Overall Study|Lost to Follow-up|1|||
44221162|NCT01442181|79024106|FG001|Overall Study|Lost to Follow-up|1|||
44221163|NCT01442181|79024105|FG000|Overall Study|patient in an additional study|1|||
44221164|NCT01442181|79024106|FG001|Overall Study|patient in an additional study|0|||
44221165|NCT01442181|79024105|FG000|Overall Study|atrial fibrillation not noted|0|||
44221166|NCT01442181|79024106|FG001|Overall Study|atrial fibrillation not noted|1|||
44221167|NCT01442103|79024113|FG000|Overall Study|Lost to Follow-up|2|||
44221168|NCT01428219|79024117|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
44221169|NCT01428063|79024124|FG000|Overall Study|Lack of Efficacy|8|||
44221170|NCT01428063|79024125|FG001|Overall Study|Lack of Efficacy|4|||
44221171|NCT01428063|79024126|FG002|Overall Study|Lack of Efficacy|1|||
44221172|NCT01428063|79024124|FG000|Overall Study|Adverse Event|2|||
44221173|NCT01428063|79024125|FG001|Overall Study|Adverse Event|3|||
44221174|NCT01428063|79024126|FG002|Overall Study|Adverse Event|0|||
44221175|NCT01428063|79024124|FG000|Overall Study|Lost to Follow-up|0|||
44221176|NCT01428063|79024125|FG001|Overall Study|Lost to Follow-up|2|||
44221177|NCT01428063|79024126|FG002|Overall Study|Lost to Follow-up|0|||
44221178|NCT01428063|79024124|FG000|Overall Study|No longer meets study criteria|0|||
44221179|NCT01428063|79024125|FG001|Overall Study|No longer meets study criteria|1|||
44221180|NCT01428063|79024126|FG002|Overall Study|No longer meets study criteria|0|||
44221181|NCT01441635|79024284|FG000|Overall Study|Adverse Event|4|||
44221182|NCT01441635|79024285|FG001|Overall Study|Adverse Event|3|||
44221183|NCT01441635|79024286|FG002|Overall Study|Adverse Event|1|||
44221184|NCT01441635|79024287|FG003|Overall Study|Adverse Event|5|||
44221185|NCT01441635|79024288|FG004|Overall Study|Adverse Event|1|||
44221186|NCT01441635|79024289|FG005|Overall Study|Adverse Event|2|||
44221187|NCT01441635|79024290|FG006|Overall Study|Adverse Event|2|||
44221188|NCT01441635|79024291|FG007|Overall Study|Adverse Event|2|||
44221189|NCT01441635|79024292|FG008|Overall Study|Adverse Event|1|||
44221190|NCT01441635|79024293|FG009|Overall Study|Adverse Event|0|||
44221191|NCT01441635|79024284|FG000|Overall Study|Withdrawal by Subject|1|||
44221192|NCT01441635|79024285|FG001|Overall Study|Withdrawal by Subject|1|||
44221193|NCT01441635|79024286|FG002|Overall Study|Withdrawal by Subject|0|||
44221194|NCT01441635|79024287|FG003|Overall Study|Withdrawal by Subject|1|||
44221195|NCT01441635|79024288|FG004|Overall Study|Withdrawal by Subject|0|||
44221196|NCT01441635|79024289|FG005|Overall Study|Withdrawal by Subject|0|||
44221197|NCT01441635|79024290|FG006|Overall Study|Withdrawal by Subject|2|||
44221198|NCT01441635|79024291|FG007|Overall Study|Withdrawal by Subject|0|||
44221199|NCT01441635|79024292|FG008|Overall Study|Withdrawal by Subject|1|||
44221200|NCT01441635|79024293|FG009|Overall Study|Withdrawal by Subject|1|||
44221201|NCT01441635|79024284|FG000|Overall Study|Lost to Follow-up|0|||
44221202|NCT01441635|79024285|FG001|Overall Study|Lost to Follow-up|1|||
44221203|NCT01441635|79024286|FG002|Overall Study|Lost to Follow-up|1|||
44374057|NCT00591253|79379224|FG002|Overall Study|Withdrawal by Subject|6|||
44374058|NCT00591253|79379222|FG000|Overall Study|Lack of Efficacy|1|||
44374059|NCT00591253|79379223|FG001|Overall Study|Lack of Efficacy|0|||
44374060|NCT00591253|79379224|FG002|Overall Study|Lack of Efficacy|3|||
44461697|NCT00440193|79470776|FG000|Treatment Period|Lack of Efficacy|0|||
44221204|NCT01441635|79024287|FG003|Overall Study|Lost to Follow-up|1|||
44221205|NCT01441635|79024288|FG004|Overall Study|Lost to Follow-up|1|||
44221206|NCT01441635|79024289|FG005|Overall Study|Lost to Follow-up|3|||
44221207|NCT01441635|79024290|FG006|Overall Study|Lost to Follow-up|1|||
44221208|NCT01441635|79024291|FG007|Overall Study|Lost to Follow-up|1|||
44374061|NCT00591253|79379222|FG000|Overall Study|Other|5|||
44221209|NCT01441635|79024292|FG008|Overall Study|Lost to Follow-up|0|||
44221210|NCT01441635|79024293|FG009|Overall Study|Lost to Follow-up|1|||
44221211|NCT01441635|79024284|FG000|Overall Study|Noncompliance|0|||
44221212|NCT01441635|79024285|FG001|Overall Study|Noncompliance|1|||
44221213|NCT01441635|79024286|FG002|Overall Study|Noncompliance|0|||
44221214|NCT01441635|79024287|FG003|Overall Study|Noncompliance|0|||
44221215|NCT01441635|79024288|FG004|Overall Study|Noncompliance|0|||
44221216|NCT01441635|79024289|FG005|Overall Study|Noncompliance|0|||
44221217|NCT01441635|79024290|FG006|Overall Study|Noncompliance|1|||
44221218|NCT01441635|79024291|FG007|Overall Study|Noncompliance|0|||
44221219|NCT01441635|79024292|FG008|Overall Study|Noncompliance|0|||
44221220|NCT01441635|79024293|FG009|Overall Study|Noncompliance|0|||
44221221|NCT01441635|79024284|FG000|Overall Study|Surgery or Invasive Intervention|0|||
44221222|NCT01441635|79024285|FG001|Overall Study|Surgery or Invasive Intervention|0|||
44221223|NCT01441635|79024286|FG002|Overall Study|Surgery or Invasive Intervention|1|||
44221224|NCT01441635|79024287|FG003|Overall Study|Surgery or Invasive Intervention|0|||
44461698|NCT00440193|79470777|FG001|Treatment Period|Lack of Efficacy|1|||
44461699|NCT00440193|79470776|FG000|Treatment Period|Lost to Follow-up|12|||
44461700|NCT00440193|79470777|FG001|Treatment Period|Lost to Follow-up|18|||
44461701|NCT00440193|79470776|FG000|Treatment Period|Physician Decision|3|||
44461702|NCT00440193|79470777|FG001|Treatment Period|Physician Decision|6|||
44221225|NCT01441635|79024288|FG004|Overall Study|Surgery or Invasive Intervention|0|||
44461703|NCT00440193|79470776|FG000|Treatment Period|Protocol Violation|16|||
44461704|NCT00440193|79470777|FG001|Treatment Period|Protocol Violation|19|||
44461705|NCT00440193|79470776|FG000|Treatment Period|Withdrawal by Subject|36|||
44461706|NCT00440193|79470777|FG001|Treatment Period|Withdrawal by Subject|77|||
44461707|NCT00440193|79470776|FG000|Treatment Period|Clinical endpoint reached|28|||
44461708|NCT00440193|79470777|FG001|Treatment Period|Clinical endpoint reached|25|||
44461709|NCT00440193|79470776|FG000|Treatment Period|Study terminated by sponsor|102|||
44461710|NCT00440193|79470777|FG001|Treatment Period|Study terminated by sponsor|94|||
44461711|NCT00440193|79470776|FG000|Treatment Period|Protocol driven decision point|2|||
44461712|NCT00440193|79470777|FG001|Treatment Period|Protocol driven decision point|2|||
44461713|NCT00440193|79470776|FG000|Treatment Period|Switch to commercial drug|0|||
44461714|NCT00440193|79470777|FG001|Treatment Period|Switch to commercial drug|2|||
44461715|NCT00440193|79470776|FG000|Treatment Period|Technical problems|1|||
44461716|NCT00440193|79470777|FG001|Treatment Period|Technical problems|1|||
44461717|NCT00440193|79470776|FG000|Treatment Period|Participant convenience|5|||
44461718|NCT00440193|79470777|FG001|Treatment Period|Participant convenience|2|||
44461719|NCT00440193|79470776|FG000|Treatment Period|Participant did not receive treatment|7|||
44461720|NCT00440193|79470777|FG001|Treatment Period|Participant did not receive treatment|13|||
44461721|NCT00440193|79470776|FG000|Treatment Period|Site closed by investigator|0|||
44461722|NCT00440193|79470777|FG001|Treatment Period|Site closed by investigator|2|||
44461723|NCT00440193|79470776|FG000|Observational Period|Adverse Event|2|||
44461724|NCT00440193|79470777|FG001|Observational Period|Adverse Event|2|||
44461725|NCT00440193|79470776|FG000|Observational Period|Death|15|||
44461726|NCT00440193|79470777|FG001|Observational Period|Death|20|||
44461727|NCT00440193|79470776|FG000|Observational Period|Lost to Follow-up|12|||
44461728|NCT00440193|79470777|FG001|Observational Period|Lost to Follow-up|8|||
44221226|NCT01441635|79024289|FG005|Overall Study|Surgery or Invasive Intervention|0|||
44270977|NCT03251924|79197949|FG001|Overall Study|Study Drug Toxicity|0|||
44461729|NCT00440193|79470776|FG000|Observational Period|Protocol Violation|1|||
44221227|NCT01441635|79024290|FG006|Overall Study|Surgery or Invasive Intervention|0|||
44221228|NCT01441635|79024291|FG007|Overall Study|Surgery or Invasive Intervention|0|||
44221229|NCT01441635|79024292|FG008|Overall Study|Surgery or Invasive Intervention|0|||
44270978|NCT03251924|79197950|FG002|Overall Study|Study Drug Toxicity|0|||
44374062|NCT00591253|79379223|FG001|Overall Study|Other|5|||
44374063|NCT00591253|79379224|FG002|Overall Study|Other|3|||
44374064|NCT00908583|79379232|FG000|Phase 1|Withdrawal by Subject|1|||
44374065|NCT00908583|79379232|FG000|Phase 1|Adverse Event|4|||
44374066|NCT00908583|79379232|FG000|Phase 2|Physician Decision|1|||
44374067|NCT00908583|79379232|FG000|Phase 2|Adverse Event|1|||
44374068|NCT00908583|79379232|FG000|Phase 3|Adverse Event|2|||
44374069|NCT00908583|79379232|FG000|Phase 4|Adverse Event|1|||
44374070|NCT00908583|79379232|FG000|Phase 4|Physician Decision|1|||
44374071|NCT00908583|79379232|FG000|Phase 5|Adverse Event|3|||
44374072|NCT00909363|79379253|FG000|Overall Study|Withdrawal by Subject|1|||
44374073|NCT00909363|79379254|FG001|Overall Study|Withdrawal by Subject|0|||
44374074|NCT00909363|79379255|FG002|Overall Study|Withdrawal by Subject|0|||
44374075|NCT00909363|79379253|FG000|Overall Study|Lack of Efficacy|1|||
44374076|NCT00909363|79379254|FG001|Overall Study|Lack of Efficacy|0|||
44374077|NCT00909363|79379255|FG002|Overall Study|Lack of Efficacy|0|||
44374078|NCT00810355|79379269|FG000|Overall Study|Lost to Follow-up|13|||
44374079|NCT00810355|79379270|FG001|Overall Study|Lost to Follow-up|17|||
44374080|NCT00810355|79379271|FG002|Overall Study|Lost to Follow-up|11|||
44374081|NCT00810355|79379269|FG000|Overall Study|Withdrawal by Subject|1|||
44374082|NCT00810355|79379270|FG001|Overall Study|Withdrawal by Subject|0|||
44374083|NCT00810355|79379271|FG002|Overall Study|Withdrawal by Subject|0|||
44374084|NCT00908349|79379279|FG000|Overall Study|Adverse Event|10|||
44374085|NCT00908349|79379279|FG000|Overall Study|Withdrawal by Subject|9|||
44461730|NCT00440193|79470777|FG001|Observational Period|Protocol Violation|0|||
44461731|NCT00440193|79470776|FG000|Observational Period|Withdrawal by Subject|11|||
44374086|NCT00908349|79379279|FG000|Overall Study|Physician Decision|5|||
44374087|NCT00908349|79379279|FG000|Overall Study|Lost to Follow-up|5|||
44374088|NCT00908349|79379279|FG000|Overall Study|Various|6|||
44544226|NCT01376908|79557504|FG001|Overall Study|Withdrawal by Subject|2|||
44221230|NCT01441635|79024293|FG009|Overall Study|Surgery or Invasive Intervention|0|||
44221231|NCT01441635|79024284|FG000|Overall Study|Received Exclusionary Medication|1|||
44221232|NCT01441635|79024285|FG001|Overall Study|Received Exclusionary Medication|0|||
44221233|NCT01441635|79024286|FG002|Overall Study|Received Exclusionary Medication|0|||
44221234|NCT01441635|79024287|FG003|Overall Study|Received Exclusionary Medication|0|||
44221235|NCT01441635|79024288|FG004|Overall Study|Received Exclusionary Medication|0|||
44221236|NCT01441635|79024289|FG005|Overall Study|Received Exclusionary Medication|0|||
44221237|NCT01441635|79024290|FG006|Overall Study|Received Exclusionary Medication|0|||
44221238|NCT01441635|79024291|FG007|Overall Study|Received Exclusionary Medication|0|||
44221239|NCT01441635|79024292|FG008|Overall Study|Received Exclusionary Medication|0|||
44221240|NCT01441635|79024293|FG009|Overall Study|Received Exclusionary Medication|0|||
44221241|NCT01441635|79024284|FG000|Overall Study|Other|0|||
44221242|NCT01441635|79024285|FG001|Overall Study|Other|0|||
44221243|NCT01441635|79024286|FG002|Overall Study|Other|0|||
44221244|NCT01441635|79024287|FG003|Overall Study|Other|0|||
44221245|NCT01441635|79024288|FG004|Overall Study|Other|0|||
44221246|NCT01441635|79024289|FG005|Overall Study|Other|0|||
44221247|NCT01441635|79024290|FG006|Overall Study|Other|0|||
44221248|NCT01441635|79024291|FG007|Overall Study|Other|1|||
44221249|NCT01441635|79024292|FG008|Overall Study|Other|0|||
44221250|NCT01441635|79024293|FG009|Overall Study|Other|0|||
44221251|NCT01408485|79024315|FG000|Overall Study|Withdrawal by Subject|21|||
44221252|NCT01427907|79024321|FG000|Overall Study|Withdrawal by Subject|3|||
44221253|NCT01427907|79024322|FG001|Overall Study|Withdrawal by Subject|4|||
44221254|NCT01427751|79024330|FG000|Overall Study|Adverse Event|18|||
44221255|NCT01427751|79024331|FG001|Overall Study|Adverse Event|2|||
44221256|NCT01427751|79024330|FG000|Overall Study|No further treatment benefit expected|5|||
44221257|NCT01427751|79024331|FG001|Overall Study|No further treatment benefit expected|1|||
44221258|NCT01427751|79024330|FG000|Overall Study|Lost to Follow-up|3|||
44221259|NCT01427751|79024331|FG001|Overall Study|Lost to Follow-up|1|||
44221260|NCT01427751|79024330|FG000|Overall Study|Withdrawal of consent|2|||
44221261|NCT01427751|79024331|FG001|Overall Study|Withdrawal of consent|2|||
44221262|NCT01427751|79024330|FG000|Overall Study|Protocol Violation|6|||
44221263|NCT01427751|79024331|FG001|Overall Study|Protocol Violation|4|||
44221264|NCT01427751|79024330|FG000|Overall Study|Death|2|||
44221265|NCT01427751|79024331|FG001|Overall Study|Death|0|||
44221266|NCT01427751|79024330|FG000|Overall Study|Other miscellaneous reasons|6|||
44221267|NCT01427751|79024331|FG001|Overall Study|Other miscellaneous reasons|4|||
44221268|NCT01920061|79024357|FG000|Overall Study|Death|1|||
44221269|NCT01920061|79024358|FG001|Overall Study|Death|1|||
44221270|NCT01920061|79024359|FG002|Overall Study|Death|0|||
44221271|NCT01920061|79024360|FG003|Overall Study|Death|1|||
44221272|NCT01920061|79024361|FG004|Overall Study|Death|1|||
44221273|NCT01920061|79024362|FG005|Overall Study|Death|0|||
44221274|NCT01920061|79024363|FG006|Overall Study|Death|0|||
44221275|NCT01920061|79024364|FG007|Overall Study|Death|1|||
44221276|NCT01920061|79024365|FG008|Overall Study|Death|0|||
44221277|NCT01920061|79024366|FG009|Overall Study|Death|1|||
44221278|NCT01920061|79024367|FG010|Overall Study|Death|0|||
44221279|NCT01920061|79024368|FG011|Overall Study|Death|1|||
44221280|NCT01920061|79024369|FG012|Overall Study|Death|0|||
44221281|NCT01920061|79024370|FG013|Overall Study|Death|2|||
44221282|NCT01920061|79024371|FG014|Overall Study|Death|0|||
44221283|NCT01920061|79024372|FG015|Overall Study|Death|0|||
44221284|NCT01920061|79024373|FG016|Overall Study|Death|0|||
44221285|NCT01920061|79024374|FG017|Overall Study|Death|0|||
44221286|NCT01920061|79024375|FG018|Overall Study|Death|1|||
44221287|NCT01920061|79024376|FG019|Overall Study|Death|0|||
44221288|NCT01920061|79024357|FG000|Overall Study|Lost to Follow-up|0|||
44221289|NCT01920061|79024358|FG001|Overall Study|Lost to Follow-up|2|||
44221290|NCT01920061|79024359|FG002|Overall Study|Lost to Follow-up|0|||
44221291|NCT01920061|79024360|FG003|Overall Study|Lost to Follow-up|0|||
44221292|NCT01920061|79024361|FG004|Overall Study|Lost to Follow-up|0|||
44221293|NCT01920061|79024362|FG005|Overall Study|Lost to Follow-up|0|||
44221294|NCT01920061|79024363|FG006|Overall Study|Lost to Follow-up|1|||
44221295|NCT01920061|79024364|FG007|Overall Study|Lost to Follow-up|0|||
44221296|NCT01920061|79024365|FG008|Overall Study|Lost to Follow-up|0|||
44221297|NCT01920061|79024366|FG009|Overall Study|Lost to Follow-up|0|||
44221298|NCT01920061|79024367|FG010|Overall Study|Lost to Follow-up|3|||
44221299|NCT01920061|79024368|FG011|Overall Study|Lost to Follow-up|0|||
44221300|NCT01920061|79024369|FG012|Overall Study|Lost to Follow-up|0|||
44221301|NCT01920061|79024370|FG013|Overall Study|Lost to Follow-up|0|||
44381539|NCT00734851|79387623|FG000|Overall Study|Withdrawal by Subject|2|||
44221302|NCT01920061|79024371|FG014|Overall Study|Lost to Follow-up|0|||
44221303|NCT01920061|79024372|FG015|Overall Study|Lost to Follow-up|0|||
44221304|NCT01920061|79024373|FG016|Overall Study|Lost to Follow-up|0|||
44221305|NCT01920061|79024374|FG017|Overall Study|Lost to Follow-up|1|||
44221306|NCT01920061|79024375|FG018|Overall Study|Lost to Follow-up|4|||
44221307|NCT01920061|79024376|FG019|Overall Study|Lost to Follow-up|3|||
44221308|NCT01920061|79024357|FG000|Overall Study|Other|1|||
44221309|NCT01920061|79024358|FG001|Overall Study|Other|1|||
44270979|NCT03251924|79197951|FG003|Overall Study|Study Drug Toxicity|1|||
44270980|NCT03251924|79197952|FG004|Overall Study|Study Drug Toxicity|0|||
44270981|NCT03251924|79197953|FG005|Overall Study|Study Drug Toxicity|0|||
44270982|NCT03251924|79197954|FG006|Overall Study|Study Drug Toxicity|0|||
44270983|NCT03251924|79197955|FG007|Overall Study|Study Drug Toxicity|0|||
44270984|NCT03251924|79197956|FG008|Overall Study|Study Drug Toxicity|1|||
44270985|NCT03251924|79197948|FG000|Overall Study|Other Reasons|0|||
44270986|NCT03251924|79197949|FG001|Overall Study|Other Reasons|0|||
44270987|NCT03251924|79197950|FG002|Overall Study|Other Reasons|0|||
44270988|NCT03251924|79197951|FG003|Overall Study|Other Reasons|0|||
44270989|NCT03251924|79197952|FG004|Overall Study|Other Reasons|0|||
44270990|NCT03251924|79197953|FG005|Overall Study|Other Reasons|0|||
44270991|NCT03251924|79197954|FG006|Overall Study|Other Reasons|0|||
44270992|NCT03251924|79197955|FG007|Overall Study|Other Reasons|0|||
44270993|NCT03251924|79197956|FG008|Overall Study|Other Reasons|1|||
44270994|NCT03251924|79197948|FG000|Overall Study|Participant request to discontinue study treatment|0|||
44374089|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
44374090|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
44374091|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
44461732|NCT00440193|79470777|FG001|Observational Period|Withdrawal by Subject|8|||
44461733|NCT00440193|79470776|FG000|Observational Period|Physician Decision|1|||
44461734|NCT00440193|79470777|FG001|Observational Period|Physician Decision|0|||
44461735|NCT00440193|79470776|FG000|Observational Period|Clinical endpoint reached|1|||
44461736|NCT00440193|79470777|FG001|Observational Period|Clinical endpoint reached|0|||
44461737|NCT00440193|79470776|FG000|Observational Period|Participant convenience|2|||
44461738|NCT00440193|79470777|FG001|Observational Period|Participant convenience|0|||
44461739|NCT00511472|79470785|FG000|Overall Study|Clinical Adverse Event|1|||
44461740|NCT00511472|79470786|FG001|Overall Study|Clinical Adverse Event|2|||
44461741|NCT00511472|79470785|FG000|Overall Study|Laboratory Adverse Event|0|||
44461742|NCT00511472|79470786|FG001|Overall Study|Laboratory Adverse Event|2|||
44461743|NCT00511472|79470785|FG000|Overall Study|Not reported|2|||
44461744|NCT00511472|79470786|FG001|Overall Study|Not reported|2|||
44461745|NCT00514904|79470803|FG000|Overall Study|Withdrawal by Subject|3|||
44461746|NCT00514904|79470804|FG001|Overall Study|Withdrawal by Subject|2|||
44461747|NCT00514904|79470803|FG000|Overall Study|Lost to Follow-up|21|||
44461748|NCT00514904|79470804|FG001|Overall Study|Lost to Follow-up|3|||
44461749|NCT00440115|79470813|FG000|Overall Study|Death|7|||
44461750|NCT00440115|79470814|FG001|Overall Study|Death|9|||
44461751|NCT00440115|79470815|FG002|Overall Study|Death|5|||
44461752|NCT00440115|79470813|FG000|Overall Study|Incarceration|0|||
44461753|NCT00440115|79470814|FG001|Overall Study|Incarceration|2|||
44461754|NCT00440115|79470815|FG002|Overall Study|Incarceration|1|||
44461755|NCT00440037|79470823|FG000|Overall Study|Withdrawal by Subject|6|||
44461756|NCT00440037|79470823|FG000|Overall Study|Administrative decision|3|||
44461757|NCT00417027|79470830|FG000|Overall Study|Protocol Violation|0|||
44461758|NCT00417027|79470831|FG001|Overall Study|Protocol Violation|5|||
44461759|NCT00417027|79470832|FG002|Overall Study|Protocol Violation|5|||
44461760|NCT00416949|79470840|FG000|Overall Study|Patients refused to participate|5|||
44461761|NCT00416715|79470844|FG000|Overall Study|Not evaluable for joint aches|7|||
44461762|NCT00416715|79470844|FG000|Overall Study|Vitamin D levels not evaluable|8|||
44461763|NCT00406029|79470856|FG000|Overall Study|Adverse Event|12|||
44461764|NCT00406029|79470857|FG001|Overall Study|Adverse Event|2|||
44461765|NCT00406029|79470858|FG002|Overall Study|Adverse Event|5|||
44461766|NCT00406029|79470859|FG003|Overall Study|Adverse Event|10|||
44461767|NCT00406029|79470860|FG004|Overall Study|Adverse Event|7|||
44461768|NCT00406029|79470856|FG000|Overall Study|Withdrawal by Subject|3|||
44270995|NCT03251924|79197949|FG001|Overall Study|Participant request to discontinue study treatment|0|||
44374092|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
44374093|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
44374094|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
44374095|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
44374096|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
44374097|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
44374098|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
44270996|NCT03251924|79197950|FG002|Overall Study|Participant request to discontinue study treatment|0|||
44270997|NCT03251924|79197951|FG003|Overall Study|Participant request to discontinue study treatment|0|||
44270998|NCT03251924|79197952|FG004|Overall Study|Participant request to discontinue study treatment|0|||
44461769|NCT00406029|79470857|FG001|Overall Study|Withdrawal by Subject|4|||
44461770|NCT00406029|79470858|FG002|Overall Study|Withdrawal by Subject|2|||
44461771|NCT00406029|79470859|FG003|Overall Study|Withdrawal by Subject|2|||
44461772|NCT00406029|79470860|FG004|Overall Study|Withdrawal by Subject|0|||
44461773|NCT00406029|79470856|FG000|Overall Study|Protocol Violation|1|||
44270999|NCT03251924|79197953|FG005|Overall Study|Participant request to discontinue study treatment|0|||
44271000|NCT03251924|79197954|FG006|Overall Study|Participant request to discontinue study treatment|0|||
44271001|NCT03251924|79197955|FG007|Overall Study|Participant request to discontinue study treatment|1|||
44271002|NCT03251924|79197956|FG008|Overall Study|Participant request to discontinue study treatment|0|||
44271003|NCT03723707|79198044|FG000|Overall Study|Death|32|||
44271004|NCT03723707|79198045|FG001|Overall Study|Death|32|||
44271005|NCT03723707|79198044|FG000|Overall Study|Admitted to long term care|12|||
44271006|NCT03723707|79198045|FG001|Overall Study|Admitted to long term care|12|||
44271007|NCT03723707|79198044|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
44271008|NCT03723707|79198045|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
44271009|NCT03723707|79198044|FG000|Overall Study|Lost to Follow-up|40|||
44271010|NCT03723707|79198045|FG001|Overall Study|Lost to Follow-up|22|||
44271011|NCT03723707|79198044|FG000|Overall Study|Discontinued after study closure|24|||
44271012|NCT03723707|79198045|FG001|Overall Study|Discontinued after study closure|12|||
44271013|NCT01350141|79198155|FG000|Overall Study|Lost to Follow-up|1|||
44271014|NCT01350141|79198156|FG001|Overall Study|Lost to Follow-up|0|||
44271015|NCT01350141|79198157|FG002|Overall Study|Lost to Follow-up|1|||
44271016|NCT01350141|79198155|FG000|Overall Study|Withdrawal by Subject|1|||
44271017|NCT01350141|79198156|FG001|Overall Study|Withdrawal by Subject|0|||
44221310|NCT01920061|79024359|FG002|Overall Study|Other|2|||
44271018|NCT01350141|79198157|FG002|Overall Study|Withdrawal by Subject|0|||
44271019|NCT01350141|79198155|FG000|Overall Study|Randomized but not treated|1|||
44271020|NCT01350141|79198156|FG001|Overall Study|Randomized but not treated|0|||
44271021|NCT01350141|79198157|FG002|Overall Study|Randomized but not treated|0|||
44271022|NCT05045625|79198696|FG000|Overall Study|Lost to Follow-up|3|||
44271023|NCT04830969|79199078|FG000|Overall Study|Withdrawal by Subject|6|||
44271024|NCT04830969|79199079|FG001|Overall Study|Withdrawal by Subject|2|||
44271025|NCT04830969|79199078|FG000|Overall Study|Protocol Violation|3|||
44271026|NCT04830969|79199079|FG001|Overall Study|Protocol Violation|9|||
44271027|NCT04830969|79199078|FG000|Overall Study|Lost to Follow-up|4|||
44271028|NCT04830969|79199079|FG001|Overall Study|Lost to Follow-up|4|||
44271029|NCT02384993|79199390|FG000|Overall Study|Adverse Event|0|||
44271030|NCT02384993|79199391|FG001|Overall Study|Adverse Event|1|||
44221311|NCT01920061|79024360|FG003|Overall Study|Other|1|||
44221312|NCT01920061|79024361|FG004|Overall Study|Other|0|||
44221313|NCT01920061|79024362|FG005|Overall Study|Other|1|||
44221314|NCT01920061|79024363|FG006|Overall Study|Other|0|||
44271031|NCT01352117|79199435|FG000|Overall Study|Death|15|||
44271032|NCT01352117|79199436|FG001|Overall Study|Death|16|||
44271033|NCT01352117|79199435|FG000|Overall Study|Withdrawal by Subject|1|||
44271034|NCT01352117|79199436|FG001|Overall Study|Withdrawal by Subject|0|||
44271035|NCT01352117|79199435|FG000|Overall Study|Lost to Follow-up|2|||
44271036|NCT01352117|79199436|FG001|Overall Study|Lost to Follow-up|7|||
44271037|NCT01352117|79199435|FG000|Overall Study|Non-adherent to study requirements|1|||
44271038|NCT01352117|79199436|FG001|Overall Study|Non-adherent to study requirements|1|||
44271039|NCT01352117|79199435|FG000|Overall Study|Did not initiate study treatment|1|||
44271040|NCT01352117|79199436|FG001|Overall Study|Did not initiate study treatment|0|||
44271041|NCT01352117|79199435|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
44461774|NCT00406029|79470857|FG001|Overall Study|Protocol Violation|2|||
44221315|NCT01920061|79024364|FG007|Overall Study|Other|0|||
44221316|NCT01920061|79024365|FG008|Overall Study|Other|0|||
44221317|NCT01920061|79024366|FG009|Overall Study|Other|1|||
44221318|NCT01920061|79024367|FG010|Overall Study|Other|1|||
44221319|NCT01920061|79024368|FG011|Overall Study|Other|2|||
44221320|NCT01920061|79024369|FG012|Overall Study|Other|1|||
44221321|NCT01920061|79024370|FG013|Overall Study|Other|4|||
44221322|NCT01920061|79024371|FG014|Overall Study|Other|0|||
44221323|NCT01920061|79024372|FG015|Overall Study|Other|1|||
44221324|NCT01920061|79024373|FG016|Overall Study|Other|1|||
44221325|NCT01920061|79024374|FG017|Overall Study|Other|0|||
44221326|NCT01920061|79024375|FG018|Overall Study|Other|1|||
44271042|NCT01352117|79199436|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
44374099|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
44374100|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
44221327|NCT01920061|79024376|FG019|Overall Study|Other|1|||
44374101|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
44374102|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
44461775|NCT00406029|79470858|FG002|Overall Study|Protocol Violation|0|||
44221328|NCT01920061|79024357|FG000|Overall Study|Participant refused further follow-up|0|||
44221329|NCT01920061|79024358|FG001|Overall Study|Participant refused further follow-up|0|||
44221330|NCT01920061|79024359|FG002|Overall Study|Participant refused further follow-up|0|||
44271043|NCT03578237|79199507|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
44271044|NCT03578237|79199508|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
44271045|NCT02220725|79199591|FG000|Overall Study|Lost to Follow-up|0|||
44221331|NCT01920061|79024360|FG003|Overall Study|Participant refused further follow-up|0|||
44271046|NCT02220725|79199592|FG001|Overall Study|Lost to Follow-up|0|||
44271047|NCT02220725|79199593|FG002|Overall Study|Lost to Follow-up|0|||
44271048|NCT02220725|79199594|FG003|Overall Study|Lost to Follow-up|1|||
44271049|NCT02220725|79199591|FG000|Overall Study|Withdrawal by Subject|0|||
44271050|NCT02220725|79199592|FG001|Overall Study|Withdrawal by Subject|0|||
44271051|NCT02220725|79199593|FG002|Overall Study|Withdrawal by Subject|0|||
44271052|NCT02220725|79199594|FG003|Overall Study|Withdrawal by Subject|1|||
44271053|NCT02259517|79199636|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
44271054|NCT02259517|79199637|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
44271055|NCT02259517|79199638|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
44271056|NCT02259517|79199636|FG000|Overall Study|Withdrawal by Subject|0|||
44271057|NCT02259517|79199637|FG001|Overall Study|Withdrawal by Subject|0|||
44271058|NCT02259517|79199638|FG002|Overall Study|Withdrawal by Subject|3|||
44271059|NCT02277990|79199681|FG000|Overall Study|Death|170|||
44271060|NCT02277990|79199682|FG001|Overall Study|Death|188|||
44271061|NCT02277990|79199681|FG000|Overall Study|Withdrawal by Subject|64|||
44271062|NCT02277990|79199682|FG001|Overall Study|Withdrawal by Subject|53|||
44271063|NCT02277990|79199681|FG000|Overall Study|Physician Decision|40|||
44271064|NCT02277990|79199682|FG001|Overall Study|Physician Decision|34|||
44271065|NCT02277990|79199681|FG000|Overall Study|Lost to Follow-up|66|||
44271066|NCT02277990|79199682|FG001|Overall Study|Lost to Follow-up|69|||
44271067|NCT02277990|79199681|FG000|Overall Study|Had other reason|26|||
44271068|NCT02277990|79199682|FG001|Overall Study|Had other reason|32|||
44271069|NCT02317614|79199704|FG000|Overall Study|Lost to Follow-up|1|||
44271070|NCT02317614|79199705|FG001|Overall Study|Lost to Follow-up|1|||
44271071|NCT02317614|79199704|FG000|Overall Study|Withdrawal by Subject|1|||
44271072|NCT02317614|79199705|FG001|Overall Study|Withdrawal by Subject|0|||
44271073|NCT02317614|79199704|FG000|Overall Study|Death|1|||
44271074|NCT02317614|79199705|FG001|Overall Study|Death|1|||
44271075|NCT02276040|79199718|FG000|Overall Study|Physician Decision|15|||
44271076|NCT02315664|79199724|FG000|Overall Study|Lost to Follow-up|1|||
44271077|NCT02315664|79199725|FG001|Overall Study|Lost to Follow-up|1|||
44271078|NCT02315664|79199724|FG000|Overall Study|Withdrawal by Subject|0|||
44271079|NCT02315664|79199725|FG001|Overall Study|Withdrawal by Subject|3|||
44271080|NCT02314728|79199753|FG000|Overall Study|Protocol Violation|1|||
44271081|NCT02314728|79199754|FG001|Overall Study|Protocol Violation|0|||
44271082|NCT02314728|79199753|FG000|Overall Study|Lost to Follow-up|0|||
44271083|NCT02314728|79199754|FG001|Overall Study|Lost to Follow-up|1|||
44271084|NCT02275338|79199773|FG000|Overall Study|Adverse Event|15|||
44271085|NCT02275338|79199773|FG000|Overall Study|Lack of Efficacy|3|||
44271086|NCT02275338|79199773|FG000|Overall Study|Withdrawal by Subject|4|||
44271087|NCT02275338|79199773|FG000|Overall Study|Disease progression (death)|1|||
44271088|NCT02275338|79199773|FG000|Overall Study|Ineligible to start Phase 2|4|||
44271089|NCT02275338|79199773|FG000|Overall Study|Reason not specified|5|||
44271090|NCT02275338|79199773|FG000|Overall Study|Does not meet entry criteria|1|||
44271091|NCT02313558|79199780|FG000|Overall Study|Withdrawal by Subject|2|||
44271092|NCT02313558|79199781|FG001|Overall Study|Withdrawal by Subject|0|||
44271093|NCT02313558|79199780|FG000|Overall Study|Lost to Follow-up|4|||
44271094|NCT02313558|79199781|FG001|Overall Study|Lost to Follow-up|4|||
44271095|NCT01646268|79199809|FG000|Overall Study|Adverse Event|6|||
44271096|NCT01646268|79199810|FG001|Overall Study|Adverse Event|7|||
44271097|NCT01646268|79199809|FG000|Overall Study|Lack of Efficacy|1|||
44271098|NCT01646268|79199810|FG001|Overall Study|Lack of Efficacy|3|||
44271099|NCT01646268|79199809|FG000|Overall Study|Protocol Violation|0|||
44271100|NCT01646268|79199810|FG001|Overall Study|Protocol Violation|1|||
44271101|NCT01646268|79199809|FG000|Overall Study|Withdrawal by Subject|2|||
44271102|NCT01646268|79199810|FG001|Overall Study|Withdrawal by Subject|5|||
44271103|NCT01646268|79199809|FG000|Overall Study|Other|2|||
44271104|NCT01646268|79199810|FG001|Overall Study|Other|0|||
44271105|NCT02275026|79199816|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
44271106|NCT02275026|79199816|FG000|Overall Study|Withdrawal by Subject|4|||
44271107|NCT02275026|79199816|FG000|Overall Study|Ineligible due to medical history|13|||
44271108|NCT02275026|79199816|FG000|Overall Study|MRI malfunction precluded testing|1|||
44271109|NCT02275026|79199816|FG000|Overall Study|Ineligible after MRI findings|1|||
44271110|NCT02275026|79199816|FG000|Overall Study|Lost to Follow-up|2|||
44271111|NCT02275026|79199816|FG000|Overall Study|Scanner failure|1|||
44544227|NCT03736031|79557519|FG000|Overall Study|Death|2|||
44271112|NCT04579250|79199919|FG000|Overall Study|Withdrawal by Subject|1|||
44271113|NCT04579250|79199920|FG001|Overall Study|Withdrawal by Subject|1|||
44271114|NCT04579250|79199921|FG002|Overall Study|Withdrawal by Subject|0|||
44271115|NCT04579250|79199919|FG000|Overall Study|Lost to Follow-up|1|||
44271116|NCT04579250|79199920|FG001|Overall Study|Lost to Follow-up|1|||
44544228|NCT03736031|79557520|FG001|Overall Study|Death|4|||
44271117|NCT04579250|79199921|FG002|Overall Study|Lost to Follow-up|0|||
44271118|NCT04579250|79199919|FG000|Overall Study|Moved from area|0|||
44271119|NCT04579250|79199920|FG001|Overall Study|Moved from area|1|||
44271120|NCT04579250|79199921|FG002|Overall Study|Moved from area|2|||
44271121|NCT03175367|79199948|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
44271122|NCT03175367|79199949|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
44271123|NCT03175367|79199950|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
44271124|NCT03175367|79199951|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
44271125|NCT03175367|79199952|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
44271126|NCT03175367|79199953|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
44271127|NCT03175367|79199954|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
44271128|NCT03175367|79199948|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
44271129|NCT03175367|79199949|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
44271130|NCT03175367|79199950|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
44271131|NCT03175367|79199951|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
44271132|NCT03175367|79199952|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
44271133|NCT03175367|79199953|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
44271134|NCT03175367|79199954|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
44271135|NCT03175367|79199948|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
44271136|NCT03175367|79199949|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
44271137|NCT03175367|79199950|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
44271138|NCT03175367|79199951|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
44271139|NCT03175367|79199952|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
44271140|NCT03175367|79199953|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
44271141|NCT03175367|79199954|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
44271142|NCT03175367|79199948|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
44271143|NCT03175367|79199949|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
44271144|NCT03175367|79199950|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
44271145|NCT03175367|79199951|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
44271146|NCT03175367|79199952|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
44271147|NCT03175367|79199953|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
44271148|NCT03175367|79199954|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
44271149|NCT03175367|79199948|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44271150|NCT03175367|79199949|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44271151|NCT03175367|79199950|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
44271152|NCT03175367|79199951|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44221332|NCT01920061|79024361|FG004|Overall Study|Participant refused further follow-up|1|||
44221333|NCT01920061|79024362|FG005|Overall Study|Participant refused further follow-up|1|||
44221334|NCT01920061|79024363|FG006|Overall Study|Participant refused further follow-up|0|||
44221335|NCT01920061|79024364|FG007|Overall Study|Participant refused further follow-up|0|||
44221336|NCT01920061|79024365|FG008|Overall Study|Participant refused further follow-up|1|||
44221337|NCT01920061|79024366|FG009|Overall Study|Participant refused further follow-up|0|||
44221338|NCT01920061|79024367|FG010|Overall Study|Participant refused further follow-up|1|||
44221339|NCT01920061|79024368|FG011|Overall Study|Participant refused further follow-up|0|||
44271153|NCT03175367|79199952|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
44271154|NCT03175367|79199953|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44271155|NCT03175367|79199954|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44271156|NCT03175367|79199948|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
44271157|NCT03175367|79199949|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
44271158|NCT03175367|79199950|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
44271159|NCT03175367|79199951|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
44271160|NCT03175367|79199952|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
44271161|NCT03175367|79199953|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
44271162|NCT03175367|79199954|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
44271163|NCT03175367|79199948|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44271164|NCT03175367|79199949|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44271165|NCT03175367|79199950|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44271166|NCT03175367|79199951|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44271167|NCT03175367|79199952|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44271168|NCT03175367|79199953|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
44271169|NCT03175367|79199954|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
44461776|NCT00406029|79470859|FG003|Overall Study|Protocol Violation|2|||
44461777|NCT00406029|79470860|FG004|Overall Study|Protocol Violation|0|||
44461778|NCT00406029|79470856|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
44461779|NCT00406029|79470857|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
44461780|NCT00406029|79470858|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
44461781|NCT00406029|79470859|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
44221340|NCT01920061|79024369|FG012|Overall Study|Participant refused further follow-up|1|||
44544229|NCT03736031|79557519|FG000|Overall Study|Lost to Follow-up|21|||
44271170|NCT03990363|79200083|FG000|Overall Study|Withdrawal by Subject|10|||
44271171|NCT03990363|79200084|FG001|Overall Study|Withdrawal by Subject|9|||
44271172|NCT03990363|79200085|FG002|Overall Study|Withdrawal by Subject|18|||
44271173|NCT03990363|79200086|FG003|Overall Study|Withdrawal by Subject|11|||
44271174|NCT03990363|79200087|FG004|Overall Study|Withdrawal by Subject|9|||
44271175|NCT03990363|79200083|FG000|Overall Study|Physician Decision|1|||
44271176|NCT03990363|79200084|FG001|Overall Study|Physician Decision|0|||
44271177|NCT03990363|79200085|FG002|Overall Study|Physician Decision|0|||
44271178|NCT03990363|79200086|FG003|Overall Study|Physician Decision|0|||
44271179|NCT03990363|79200087|FG004|Overall Study|Physician Decision|0|||
44221341|NCT01920061|79024370|FG013|Overall Study|Participant refused further follow-up|0|||
44221342|NCT01920061|79024371|FG014|Overall Study|Participant refused further follow-up|1|||
44221343|NCT01920061|79024372|FG015|Overall Study|Participant refused further follow-up|2|||
44271180|NCT03990363|79200083|FG000|Overall Study|Adverse Event|1|||
44271181|NCT03990363|79200084|FG001|Overall Study|Adverse Event|3|||
44271182|NCT03990363|79200085|FG002|Overall Study|Adverse Event|2|||
44271183|NCT03990363|79200086|FG003|Overall Study|Adverse Event|2|||
44374103|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
44374104|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
44374105|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
44374106|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
44461782|NCT00406029|79470860|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
44461783|NCT00406029|79470856|FG000|Overall Study|Randomized in Error|0|||
44461784|NCT00406029|79470857|FG001|Overall Study|Randomized in Error|0|||
44461785|NCT00406029|79470858|FG002|Overall Study|Randomized in Error|2|||
44461786|NCT00406029|79470859|FG003|Overall Study|Randomized in Error|3|||
44461787|NCT00406029|79470860|FG004|Overall Study|Randomized in Error|1|||
44461788|NCT00514514|79470875|FG000|Pre-phase|Death|10|||
44461789|NCT00514514|79470876|FG001|Pre-phase|Death|0|||
44461790|NCT00514514|79470877|FG002|Pre-phase|Death|0|||
44461791|NCT00514514|79470875|FG000|Pre-phase|administrative problems|2|||
44461792|NCT00514514|79470876|FG001|Pre-phase|administrative problems|0|||
44461793|NCT00514514|79470877|FG002|Pre-phase|administrative problems|0|||
44461794|NCT00514514|79470875|FG000|Pre-phase|Protocol Violation|6|||
44461795|NCT00514514|79470876|FG001|Pre-phase|Protocol Violation|0|||
44461796|NCT00514514|79470877|FG002|Pre-phase|Protocol Violation|0|||
44461797|NCT00514514|79470875|FG000|Pre-phase|condition no longer requires study drug|7|||
44461798|NCT00514514|79470876|FG001|Pre-phase|condition no longer requires study drug|0|||
44461799|NCT00514514|79470877|FG002|Pre-phase|condition no longer requires study drug|0|||
44461800|NCT00514514|79470875|FG000|Pre-phase|abnormal test procedure results|15|||
44461801|NCT00514514|79470876|FG001|Pre-phase|abnormal test procedure results|0|||
44461802|NCT00514514|79470877|FG002|Pre-phase|abnormal test procedure results|0|||
44461803|NCT00514514|79470875|FG000|Pre-phase|Lost to Follow-up|2|||
44461804|NCT00514514|79470876|FG001|Pre-phase|Lost to Follow-up|0|||
44461805|NCT00514514|79470877|FG002|Pre-phase|Lost to Follow-up|0|||
44461806|NCT00514514|79470875|FG000|Pre-phase|abnormal lab values|23|||
44461807|NCT00514514|79470876|FG001|Pre-phase|abnormal lab values|0|||
44461808|NCT00514514|79470877|FG002|Pre-phase|abnormal lab values|0|||
44461809|NCT00514514|79470875|FG000|Pre-phase|Lack of Efficacy|35|||
44221344|NCT01920061|79024373|FG016|Overall Study|Participant refused further follow-up|1|||
44221345|NCT01920061|79024374|FG017|Overall Study|Participant refused further follow-up|1|||
44221346|NCT01920061|79024375|FG018|Overall Study|Participant refused further follow-up|0|||
44374107|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
44374108|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
44374109|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
44374110|NCT01125566|79379285|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
44461810|NCT00514514|79470876|FG001|Pre-phase|Lack of Efficacy|0|||
44461811|NCT00514514|79470877|FG002|Pre-phase|Lack of Efficacy|0|||
44461812|NCT00514514|79470875|FG000|Pre-phase|Adverse Event|137|||
44461813|NCT00514514|79470876|FG001|Pre-phase|Adverse Event|0|||
44461814|NCT00514514|79470877|FG002|Pre-phase|Adverse Event|0|||
44221347|NCT01920061|79024376|FG019|Overall Study|Participant refused further follow-up|0|||
44271184|NCT03990363|79200087|FG004|Overall Study|Adverse Event|0|||
44461815|NCT00514514|79470875|FG000|Pre-phase|Withdrawal by Subject|66|||
44461816|NCT00514514|79470876|FG001|Pre-phase|Withdrawal by Subject|0|||
44461817|NCT00514514|79470877|FG002|Pre-phase|Withdrawal by Subject|0|||
44461818|NCT00514514|79470875|FG000|Randomized - 9 Month|Death|3|||
44461819|NCT00514514|79470876|FG001|Randomized - 9 Month|Death|2|||
44271185|NCT03990363|79200083|FG000|Overall Study|Death|14|||
44271186|NCT03990363|79200084|FG001|Overall Study|Death|8|||
44271187|NCT03990363|79200085|FG002|Overall Study|Death|14|||
44271188|NCT03990363|79200086|FG003|Overall Study|Death|10|||
44461820|NCT00514514|79470877|FG002|Randomized - 9 Month|Death|2|||
44461821|NCT00514514|79470875|FG000|Randomized - 9 Month|Administrative problems|1|||
44461822|NCT00514514|79470876|FG001|Randomized - 9 Month|Administrative problems|1|||
44271189|NCT03990363|79200087|FG004|Overall Study|Death|11|||
44544230|NCT03736031|79557520|FG001|Overall Study|Lost to Follow-up|2|||
44374111|NCT01125566|79379286|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
44374112|NCT01125566|79379287|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
44374113|NCT01125566|79379285|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
44374114|NCT01125566|79379286|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
44374115|NCT01125566|79379287|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
44374116|NCT01125566|79379285|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
44374117|NCT01125566|79379286|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
44374118|NCT01125566|79379287|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
44374119|NCT01125566|79379285|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
44374120|NCT01125566|79379286|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
44374121|NCT01125566|79379287|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
44374122|NCT01125566|79379285|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
44374123|NCT01125566|79379286|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
44374124|NCT01125566|79379287|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
44374125|NCT00810277|79379294|FG000|Overall Study|Adverse Event|1|||
44374126|NCT00595582|79379298|FG000|Overall Study|Pilot study that PI terminated|2|||
44374127|NCT00595582|79379298|FG000|Overall Study|Lost to Follow-up|1|||
44461823|NCT00514514|79470877|FG002|Randomized - 9 Month|Administrative problems|2|||
44461824|NCT00514514|79470875|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
44461825|NCT00514514|79470876|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
44461826|NCT00514514|79470877|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
44461827|NCT00514514|79470875|FG000|Randomized - 9 Month|Protocol Violation|1|||
44461828|NCT00514514|79470876|FG001|Randomized - 9 Month|Protocol Violation|1|||
44461829|NCT00514514|79470877|FG002|Randomized - 9 Month|Protocol Violation|0|||
44461830|NCT00514514|79470875|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
44461831|NCT00514514|79470876|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
44461832|NCT00514514|79470877|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
44461833|NCT00514514|79470875|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
44461834|NCT00514514|79470876|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
44461835|NCT00514514|79470877|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
44461836|NCT00514514|79470875|FG000|Randomized - 9 Month|Adverse Event|25|||
44461837|NCT00514514|79470876|FG001|Randomized - 9 Month|Adverse Event|44|||
44461838|NCT00514514|79470877|FG002|Randomized - 9 Month|Adverse Event|27|||
44461839|NCT00514514|79470875|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
44461840|NCT00514514|79470876|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
44461841|NCT00514514|79470877|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
44461842|NCT00514514|79470875|FG000|Extension - 4 Years|Lost to Follow-up|12|||
44221348|NCT01426425|79024439|FG000|Overall Study|Exited prior to EP study|22|||
44221349|NCT01426425|79024439|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
44221350|NCT01426425|79024439|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
44221351|NCT01426347|79024452|FG000|Overall Study|Lost to Follow-up|0|||
44221352|NCT01426347|79024453|FG001|Overall Study|Lost to Follow-up|3|||
44221353|NCT01426347|79024452|FG000|Overall Study|Protocol Violation|2|||
44221354|NCT01426347|79024453|FG001|Overall Study|Protocol Violation|0|||
44221355|NCT01426347|79024452|FG000|Overall Study|Withdrawal by Subject|5|||
44221356|NCT01426347|79024453|FG001|Overall Study|Withdrawal by Subject|0|||
44221357|NCT01882465|79024459|FG000|Period 1|Lens Discomfort|0|||
44221358|NCT01882465|79024460|FG001|Period 1|Lens Discomfort|0|||
44221359|NCT01882465|79024461|FG002|Period 1|Lens Discomfort|0|||
44221360|NCT01882465|79024462|FG003|Period 1|Lens Discomfort|1|||
44221361|NCT01882465|79024463|FG004|Period 1|Lens Discomfort|0|||
44221362|NCT01882465|79024464|FG005|Period 1|Lens Discomfort|0|||
44221363|NCT01882465|79024465|FG006|Period 1|Lens Discomfort|0|||
44221364|NCT01882465|79024459|FG000|Period 1|Withdrawal by Subject|0|||
44221365|NCT01882465|79024460|FG001|Period 1|Withdrawal by Subject|0|||
44221366|NCT01882465|79024461|FG002|Period 1|Withdrawal by Subject|0|||
44221367|NCT01882465|79024462|FG003|Period 1|Withdrawal by Subject|0|||
44221368|NCT01882465|79024463|FG004|Period 1|Withdrawal by Subject|0|||
44221369|NCT01882465|79024464|FG005|Period 1|Withdrawal by Subject|0|||
44221370|NCT01882465|79024465|FG006|Period 1|Withdrawal by Subject|1|||
44221371|NCT01882465|79024459|FG000|Period 2|Protocol Violation|0|||
44221372|NCT01882465|79024460|FG001|Period 2|Protocol Violation|0|||
44221373|NCT01882465|79024461|FG002|Period 2|Protocol Violation|0|||
44221374|NCT01882465|79024462|FG003|Period 2|Protocol Violation|0|||
44461843|NCT00514514|79470876|FG001|Extension - 4 Years|Lost to Follow-up|10|||
44461844|NCT00514514|79470877|FG002|Extension - 4 Years|Lost to Follow-up|9|||
44221375|NCT01882465|79024463|FG004|Period 2|Protocol Violation|1|||
44461845|NCT00514514|79470875|FG000|Extension - 4 Years|Administrative problems|3|||
44221376|NCT01882465|79024464|FG005|Period 2|Protocol Violation|0|||
44221377|NCT01882465|79024465|FG006|Period 2|Protocol Violation|0|||
44221378|NCT01426269|79024473|FG000|Period 1: 12 Weeks|Adverse Event|5|||
44221379|NCT01426269|79024474|FG001|Period 1: 12 Weeks|Adverse Event|0|||
44271190|NCT03990363|79200083|FG000|Overall Study|Failure to meet randomization criteria|0|||
44374128|NCT00595582|79379298|FG000|Overall Study|Adverse Event|2|||
44374129|NCT00595582|79379298|FG000|Overall Study|Physician Decision|5|||
44374130|NCT00808015|79379302|FG000|Overall Study|Death|1|||
44374131|NCT00808015|79379302|FG000|Overall Study|Lack of Efficacy|58|||
44374132|NCT00808015|79379302|FG000|Overall Study|Lost to Follow-up|76|||
44374133|NCT00808015|79379302|FG000|Overall Study|Participants not willing to participate|158|||
44374134|NCT00808015|79379302|FG000|Overall Study|Adverse Event|22|||
44374135|NCT00808015|79379302|FG000|Overall Study|Other|25|||
44374136|NCT00808015|79379302|FG000|Overall Study|Enrolled but not treated|4|||
44374137|NCT00810199|79379308|FG000|Overall Study|Adverse Event|24|||
44374138|NCT00810199|79379309|FG001|Overall Study|Adverse Event|26|||
44374139|NCT00810199|79379308|FG000|Overall Study|Death|4|||
44374140|NCT00810199|79379309|FG001|Overall Study|Death|6|||
44374141|NCT00810199|79379308|FG000|Overall Study|Withdrew consent|9|||
44374142|NCT00810199|79379309|FG001|Overall Study|Withdrew consent|12|||
44374143|NCT00810199|79379308|FG000|Overall Study|Insufficient therapeutic response|5|||
44381540|NCT00734851|79387623|FG000|Overall Study|Lost to Follow-up|1|||
44381541|NCT00734851|79387623|FG000|Overall Study|Physician Decision|18|||
44381542|NCT00734617|79387629|FG000|Overall Study|Adverse Event|4|||
44381543|NCT00734617|79387630|FG001|Overall Study|Adverse Event|7|||
44381544|NCT00734617|79387629|FG000|Overall Study|Withdrawal by Subject|103|||
44381545|NCT00734617|79387630|FG001|Overall Study|Withdrawal by Subject|95|||
44381546|NCT00743431|79387636|FG000|Overall Study|Toxicity|6|||
44381547|NCT00743431|79387636|FG000|Overall Study|Tumor progression|56|||
44381548|NCT00743431|79387636|FG000|Overall Study|Withdrawal by Subject|13|||
44381549|NCT00743431|79387636|FG000|Overall Study|Death|9|||
44381550|NCT00743431|79387636|FG000|Overall Study|Reason for discontinuation not specified|29|||
44381551|NCT00743431|79387636|FG000|Overall Study|No documentation available|13|||
44381552|NCT00734539|79387642|FG000|Main Study|Death|33|||
44381553|NCT00734539|79387643|FG001|Main Study|Death|32|||
44381554|NCT00734539|79387642|FG000|Main Study|Physician Decision|2|||
44381555|NCT00734539|79387643|FG001|Main Study|Physician Decision|0|||
44381556|NCT00734539|79387642|FG000|Main Study|Withdrawal by Subject|1|||
44381557|NCT00734539|79387643|FG001|Main Study|Withdrawal by Subject|3|||
44381558|NCT00734539|79387642|FG000|Main Study|Enrolled in error; ineligible|1|||
44381559|NCT00734539|79387643|FG001|Main Study|Enrolled in error; ineligible|0|||
44381560|NCT00743275|79387654|FG000|Overall Study|Protocol Violation|0|||
44381561|NCT00743275|79387655|FG001|Overall Study|Protocol Violation|1|||
44381562|NCT00743197|79387663|FG000|Overall Study|Study terminated due to departure of PI.|1|||
44381563|NCT00743197|79387664|FG001|Overall Study|Study terminated due to departure of PI.|2|||
44381564|NCT00734071|79387672|FG000|Overall Study|Adverse Event|4|||
44381565|NCT00734071|79387673|FG001|Overall Study|Adverse Event|3|||
44381566|NCT00734071|79387672|FG000|Overall Study|Lack of Efficacy|3|||
44381567|NCT00734071|79387673|FG001|Overall Study|Lack of Efficacy|1|||
44381568|NCT00734071|79387672|FG000|Overall Study|Noncompliance|2|||
44381569|NCT00734071|79387673|FG001|Overall Study|Noncompliance|2|||
44381570|NCT00734071|79387672|FG000|Overall Study|Protocol Deviations|3|||
44381571|NCT00734071|79387673|FG001|Overall Study|Protocol Deviations|4|||
44381572|NCT00734071|79387672|FG000|Overall Study|Voluntary Withdrawal|9|||
44381573|NCT00734071|79387673|FG001|Overall Study|Voluntary Withdrawal|7|||
44381574|NCT00734071|79387672|FG000|Overall Study|Lost to Follow-up|16|||
44381575|NCT00734071|79387673|FG001|Overall Study|Lost to Follow-up|8|||
44381576|NCT00734071|79387672|FG000|Overall Study|Other|1|||
44381577|NCT00734071|79387673|FG001|Overall Study|Other|2|||
44381578|NCT00739297|79387679|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
44381579|NCT00739297|79387680|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
44381580|NCT00739297|79387681|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
44381581|NCT00739297|79387682|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
44381582|NCT00739297|79387683|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
44381583|NCT00739297|79387684|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
44381584|NCT00739297|79387685|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
44381585|NCT00739297|79387679|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
44381586|NCT00739297|79387680|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
44381587|NCT00739297|79387681|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
44381588|NCT00739297|79387682|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
44381589|NCT00739297|79387683|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
44381590|NCT00739297|79387684|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
44381591|NCT00739297|79387685|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
44374144|NCT00810199|79379309|FG001|Overall Study|Insufficient therapeutic response|14|||
44544231|NCT03736031|79557519|FG000|Overall Study|Withdrawal by Subject|9|||
44544232|NCT03736031|79557520|FG001|Overall Study|Withdrawal by Subject|0|||
44374145|NCT00810199|79379308|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
44374146|NCT00810199|79379309|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
44374147|NCT00810199|79379308|FG000|Overall Study|Administrative/Other|5|||
44374148|NCT00810199|79379309|FG001|Overall Study|Administrative/Other|6|||
44374149|NCT00810199|79379308|FG000|Overall Study|Protocol Violation|2|||
44374150|NCT00810199|79379309|FG001|Overall Study|Protocol Violation|6|||
44374151|NCT00810199|79379308|FG000|Overall Study|Failure to return|1|||
44374152|NCT00810199|79379309|FG001|Overall Study|Failure to return|4|||
44374153|NCT00810199|79379308|FG000|Overall Study|Did not receive study drug|2|||
44221380|NCT01426269|79024475|FG002|Period 1: 12 Weeks|Adverse Event|0|||
44221381|NCT01426269|79024473|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
44221382|NCT01426269|79024474|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
44221383|NCT01426269|79024475|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
44221384|NCT01426269|79024473|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
44374154|NCT00810199|79379309|FG001|Overall Study|Did not receive study drug|1|||
44221385|NCT01426269|79024474|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
44221386|NCT01426269|79024475|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
44221387|NCT01426269|79024473|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
44221388|NCT01426269|79024474|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
44221389|NCT01426269|79024475|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
44221390|NCT01426269|79024473|FG000|Period 1: 12 Weeks|Pregnancy|1|||
44221391|NCT01426269|79024474|FG001|Period 1: 12 Weeks|Pregnancy|0|||
44221392|NCT01426269|79024475|FG002|Period 1: 12 Weeks|Pregnancy|0|||
44221393|NCT01426269|79024473|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
44221394|NCT01426269|79024474|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
44221395|NCT01426269|79024475|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
44221396|NCT01426269|79024473|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
44221397|NCT01426269|79024474|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
44221398|NCT01426269|79024475|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
44221399|NCT01426269|79024473|FG000|Period 2: 40 Weeks|Adverse Event|0|||
44221400|NCT01426269|79024474|FG001|Period 2: 40 Weeks|Adverse Event|1|||
44221401|NCT01426269|79024475|FG002|Period 2: 40 Weeks|Adverse Event|2|||
44221402|NCT01426269|79024473|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
44221403|NCT01426269|79024474|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
44221404|NCT01426269|79024475|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
44221405|NCT01426269|79024473|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
44221406|NCT01426269|79024474|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
44221407|NCT01426269|79024475|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
44221408|NCT01426269|79024473|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
44221409|NCT01426269|79024474|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
44221410|NCT01426269|79024475|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
44221411|NCT01426269|79024473|FG000|Period 2: 40 Weeks|Site closed|0|||
44221412|NCT01426269|79024474|FG001|Period 2: 40 Weeks|Site closed|6|||
44221413|NCT01426269|79024475|FG002|Period 2: 40 Weeks|Site closed|5|||
44271191|NCT03990363|79200084|FG001|Overall Study|Failure to meet randomization criteria|1|||
44374155|NCT00877006|79379323|FG000|Treatment Period|Death|2|||
44374156|NCT00877006|79379324|FG001|Treatment Period|Death|1|||
44374157|NCT00877006|79379323|FG000|Treatment Period|Adverse Event|10|||
44374158|NCT00877006|79379324|FG001|Treatment Period|Adverse Event|3|||
44374159|NCT00877006|79379323|FG000|Treatment Period|Withdrawal by Subject|2|||
44374160|NCT00877006|79379324|FG001|Treatment Period|Withdrawal by Subject|3|||
44374161|NCT00877006|79379323|FG000|Treatment Period|Protocol Violation|1|||
44271192|NCT03990363|79200085|FG002|Overall Study|Failure to meet randomization criteria|1|||
44374162|NCT00877006|79379324|FG001|Treatment Period|Protocol Violation|0|||
44374163|NCT00877006|79379323|FG000|Treatment Period|Lost to Follow-up|0|||
44374164|NCT00877006|79379324|FG001|Treatment Period|Lost to Follow-up|1|||
44374165|NCT00877006|79379323|FG000|Treatment Period|Disease Progression|1|||
44374166|NCT00877006|79379324|FG001|Treatment Period|Disease Progression|2|||
44221414|NCT01426269|79024473|FG000|Period 2: 40 Weeks|Relapsed|0|||
44277795|NCT02138214|79238785|FG000|Overall Study|Screen Failure|0|||
44221415|NCT01426269|79024474|FG001|Period 2: 40 Weeks|Relapsed|9|||
44381592|NCT00739063|79387701|FG000|Overall Study|Screen failures|8|||
44381593|NCT01026194|79387707|FG000|Period 1：Double Blind Period|Adverse Event|2|||
44381594|NCT01026194|79387708|FG001|Period 1：Double Blind Period|Adverse Event|1|||
44381595|NCT01026194|79387707|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
44381596|NCT01026194|79387708|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
44381597|NCT01026194|79387707|FG000|Period 1：Double Blind Period|Physician Decision|0|||
44381598|NCT01026194|79387708|FG001|Period 1：Double Blind Period|Physician Decision|4|||
44381599|NCT01026194|79387707|FG000|Period 2：Open-label Period|Adverse Event|4|||
44461846|NCT00514514|79470876|FG001|Extension - 4 Years|Administrative problems|1|||
44461847|NCT00514514|79470877|FG002|Extension - 4 Years|Administrative problems|1|||
44461848|NCT00514514|79470875|FG000|Extension - 4 Years|Death|8|||
44461849|NCT00514514|79470876|FG001|Extension - 4 Years|Death|3|||
44461850|NCT00514514|79470877|FG002|Extension - 4 Years|Death|6|||
44461851|NCT00514514|79470875|FG000|Extension - 4 Years|Adverse Event|9|||
44461852|NCT00514514|79470876|FG001|Extension - 4 Years|Adverse Event|6|||
44461853|NCT00514514|79470877|FG002|Extension - 4 Years|Adverse Event|3|||
44461854|NCT00405639|79470887|FG000|Overall Study|Withdrawal by Subject|1|||
44461855|NCT00405639|79470888|FG001|Overall Study|Withdrawal by Subject|0|||
44461856|NCT00405639|79470887|FG000|Overall Study|Adverse Event|1|||
44461857|NCT00405639|79470888|FG001|Overall Study|Adverse Event|0|||
44461858|NCT00405639|79470887|FG000|Overall Study|Seizure prior to receiving BNP|1|||
44461859|NCT00405639|79470888|FG001|Overall Study|Seizure prior to receiving BNP|0|||
44461860|NCT00439725|79470896|FG000|Treatment Period|Withdrawal by Subject|22|||
44461861|NCT00439725|79470897|FG001|Treatment Period|Withdrawal by Subject|19|||
44461862|NCT00439725|79470896|FG000|Treatment Period|Study terminated by sponsor|156|||
44461863|NCT00439725|79470897|FG001|Treatment Period|Study terminated by sponsor|148|||
44461864|NCT00439725|79470896|FG000|Treatment Period|Site closed by investigator|1|||
44461865|NCT00439725|79470897|FG001|Treatment Period|Site closed by investigator|2|||
44461866|NCT00439725|79470896|FG000|Treatment Period|Adverse Event|39|||
44461867|NCT00439725|79470897|FG001|Treatment Period|Adverse Event|18|||
44461868|NCT00439725|79470896|FG000|Treatment Period|Physician Decision|1|||
44461869|NCT00439725|79470897|FG001|Treatment Period|Physician Decision|1|||
44461870|NCT00439725|79470896|FG000|Treatment Period|Protocol Violation|2|||
44461871|NCT00439725|79470897|FG001|Treatment Period|Protocol Violation|1|||
44461872|NCT00439725|79470896|FG000|Treatment Period|Clinical endpoint reached|6|||
44461873|NCT00439725|79470897|FG001|Treatment Period|Clinical endpoint reached|50|||
44461874|NCT00439725|79470896|FG000|Treatment Period|Technical problems|1|||
44461875|NCT00439725|79470897|FG001|Treatment Period|Technical problems|0|||
44461876|NCT00439725|79470896|FG000|Treatment Period|Lost to Follow-up|1|||
44461877|NCT00439725|79470897|FG001|Treatment Period|Lost to Follow-up|1|||
44461878|NCT00439725|79470896|FG000|Treatment Period|Participant convenience|1|||
44461879|NCT00439725|79470897|FG001|Treatment Period|Participant convenience|0|||
44221416|NCT01426269|79024475|FG002|Period 2: 40 Weeks|Relapsed|18|||
44461880|NCT00439725|79470896|FG000|Treatment Period|Protocol driven decision point|1|||
44461881|NCT00439725|79470897|FG001|Treatment Period|Protocol driven decision point|1|||
44221417|NCT01426113|79024488|FG000|Overall Study|Study Discontinued|1|||
44461882|NCT00439725|79470896|FG000|Treatment Period|Death|1|||
44461883|NCT00439725|79470897|FG001|Treatment Period|Death|1|||
44461884|NCT00439725|79470896|FG000|Treatment Period|Participant did not receive treatment|4|||
44461885|NCT00439725|79470897|FG001|Treatment Period|Participant did not receive treatment|4|||
44461886|NCT00439725|79470896|FG000|Observational Period|Withdrawal by Subject|2|||
44461887|NCT00439725|79470897|FG001|Observational Period|Withdrawal by Subject|2|||
44461888|NCT00439725|79470896|FG000|Observational Period|Lost to Follow-up|0|||
44461889|NCT00439725|79470897|FG001|Observational Period|Lost to Follow-up|1|||
44461890|NCT00439725|79470896|FG000|Observational Period|Death|0|||
44461891|NCT00439725|79470897|FG001|Observational Period|Death|2|||
44221418|NCT01426113|79024489|FG001|Overall Study|Study Discontinued|1|||
44221419|NCT01426113|79024488|FG000|Overall Study|Adverse Event|0|||
44221420|NCT01426113|79024489|FG001|Overall Study|Adverse Event|1|||
44374167|NCT00877006|79379323|FG000|Treatment Period|Started New Treatment Regimen|2|||
44374168|NCT00877006|79379324|FG001|Treatment Period|Started New Treatment Regimen|5|||
44374169|NCT00877006|79379323|FG000|Treatment Period|Other|4|||
44374170|NCT00877006|79379324|FG001|Treatment Period|Other|4|||
44374171|NCT00877006|79379323|FG000|Treatment Period|Randomized but Not Treated|3|||
44374172|NCT00877006|79379324|FG001|Treatment Period|Randomized but Not Treated|8|||
44374173|NCT00877006|79379323|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
44374174|NCT00877006|79379324|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
44374175|NCT00877006|79379323|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
44374176|NCT00877006|79379324|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
44374177|NCT00877006|79379323|FG000|Long-Term Follow-up Period|Death|26|||
44374178|NCT00877006|79379324|FG001|Long-Term Follow-up Period|Death|18|||
44461892|NCT00439725|79470896|FG000|Observational Period|Study termination by sponsor|1|||
44461893|NCT00439725|79470897|FG001|Observational Period|Study termination by sponsor|1|||
44221421|NCT01864603|79024497|FG000|Stage 2|DSMB design modification|86056|||
44461894|NCT00439725|79470896|FG000|Observational Period|Clinical endpoint reached|3|||
44461895|NCT00439725|79470897|FG001|Observational Period|Clinical endpoint reached|1|||
44461896|NCT00439725|79470896|FG000|Observational Period|Technical problems|1|||
44461897|NCT00439725|79470897|FG001|Observational Period|Technical problems|0|||
44461898|NCT00439725|79470896|FG000|Observational Period|Participant convenience|1|||
44461899|NCT00439725|79470897|FG001|Observational Period|Participant convenience|0|||
44461900|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Subject request|8|||
44221422|NCT01864603|79024498|FG001|Stage 2|DSMB design modification|92558|||
44221423|NCT01892293|79024509|FG000|Overall Study|Apheresed but not treated|4|||
44461901|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Subject request|11|||
44461902|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
44461903|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
44461904|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
44461905|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
44461906|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
44221424|NCT01393899|79024516|FG000|Overall Study|Study terminated by sponsor|1|||
44221425|NCT01393899|79024517|FG001|Overall Study|Study terminated by sponsor|0|||
44271193|NCT03990363|79200086|FG003|Overall Study|Failure to meet randomization criteria|0|||
44271194|NCT03990363|79200087|FG004|Overall Study|Failure to meet randomization criteria|0|||
44271195|NCT03990363|79200083|FG000|Overall Study|Lost to Follow-up|0|||
44271196|NCT03990363|79200084|FG001|Overall Study|Lost to Follow-up|0|||
44271197|NCT03990363|79200085|FG002|Overall Study|Lost to Follow-up|0|||
44271198|NCT03990363|79200086|FG003|Overall Study|Lost to Follow-up|1|||
44271199|NCT03990363|79200087|FG004|Overall Study|Lost to Follow-up|2|||
44271200|NCT03990363|79200083|FG000|Overall Study|Non-compliance with study drug|2|||
44271201|NCT03990363|79200084|FG001|Overall Study|Non-compliance with study drug|1|||
44271202|NCT03990363|79200085|FG002|Overall Study|Non-compliance with study drug|2|||
44271203|NCT03990363|79200086|FG003|Overall Study|Non-compliance with study drug|0|||
44271204|NCT03990363|79200087|FG004|Overall Study|Non-compliance with study drug|0|||
44221426|NCT01393899|79024518|FG002|Overall Study|Study terminated by sponsor|1|||
44221427|NCT01393899|79024516|FG000|Overall Study|Other|1|||
44221428|NCT01393899|79024517|FG001|Overall Study|Other|0|||
44221429|NCT01393899|79024518|FG002|Overall Study|Other|0|||
44221430|NCT01393899|79024516|FG000|Overall Study|Withdrawal by Subject|2|||
44221431|NCT01393899|79024517|FG001|Overall Study|Withdrawal by Subject|2|||
44221432|NCT01393899|79024518|FG002|Overall Study|Withdrawal by Subject|1|||
44221433|NCT01393899|79024516|FG000|Overall Study|Lost to Follow-up|0|||
44221434|NCT01393899|79024517|FG001|Overall Study|Lost to Follow-up|0|||
44221435|NCT01393899|79024518|FG002|Overall Study|Lost to Follow-up|1|||
44221436|NCT01393899|79024516|FG000|Overall Study|Does not meet entrance criteria|1|||
44221437|NCT01393899|79024517|FG001|Overall Study|Does not meet entrance criteria|0|||
44221438|NCT01393899|79024518|FG002|Overall Study|Does not meet entrance criteria|1|||
44221439|NCT01393899|79024516|FG000|Overall Study|Lack of Efficacy|26|||
44221440|NCT01393899|79024517|FG001|Overall Study|Lack of Efficacy|21|||
44221441|NCT01393899|79024518|FG002|Overall Study|Lack of Efficacy|16|||
44221442|NCT01393899|79024516|FG000|Overall Study|Adverse Event|1|||
44221443|NCT01393899|79024517|FG001|Overall Study|Adverse Event|5|||
44221444|NCT01393899|79024518|FG002|Overall Study|Adverse Event|3|||
44221445|NCT01393743|79024530|FG000|Core Study|Adverse Event|5|||
44221446|NCT01393743|79024531|FG001|Core Study|Adverse Event|9|||
44221447|NCT01393743|79024532|FG002|Core Study|Adverse Event|0|||
44221448|NCT01393743|79024530|FG000|Core Study|Lost to Follow-up|1|||
44221449|NCT01393743|79024531|FG001|Core Study|Lost to Follow-up|1|||
44221450|NCT01393743|79024532|FG002|Core Study|Lost to Follow-up|0|||
44221451|NCT01393743|79024530|FG000|Core Study|Participant's Choice|2|||
44221452|NCT01393743|79024531|FG001|Core Study|Participant's Choice|3|||
44221453|NCT01393743|79024532|FG002|Core Study|Participant's Choice|0|||
44221454|NCT01393743|79024530|FG000|Core Study|Inadequate therapeutic effect|2|||
44221455|NCT01393743|79024531|FG001|Core Study|Inadequate therapeutic effect|0|||
44221456|NCT01393743|79024532|FG002|Core Study|Inadequate therapeutic effect|0|||
44271205|NCT03990363|79200083|FG000|Overall Study|Study terminated by sponsor|0|||
44271206|NCT03990363|79200084|FG001|Overall Study|Study terminated by sponsor|1|||
44271207|NCT03990363|79200085|FG002|Overall Study|Study terminated by sponsor|0|||
44221457|NCT01393743|79024530|FG000|Extension Phase|Adverse Event|0|||
44221458|NCT01393743|79024531|FG001|Extension Phase|Adverse Event|0|||
44221459|NCT01393743|79024532|FG002|Extension Phase|Adverse Event|12|||
44221460|NCT01393743|79024530|FG000|Extension Phase|Lost to Follow-up|0|||
44221461|NCT01393743|79024531|FG001|Extension Phase|Lost to Follow-up|0|||
44271208|NCT03990363|79200086|FG003|Overall Study|Study terminated by sponsor|0|||
44374179|NCT00877006|79379323|FG000|Long-Term Follow-up Period|Other|7|||
44374180|NCT00877006|79379324|FG001|Long-Term Follow-up Period|Other|9|||
44374181|NCT00876928|79379334|FG000|Overall Study|Lost to Follow-up|2|||
44374182|NCT00876928|79379335|FG001|Overall Study|Lost to Follow-up|5|||
44374183|NCT00876928|79379334|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
44374184|NCT00876928|79379335|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
44374185|NCT00807937|79379345|FG000|Overall Study|Adverse Event|12|||
44374186|NCT00807937|79379346|FG001|Overall Study|Adverse Event|12|||
44374187|NCT00807937|79379347|FG002|Overall Study|Adverse Event|5|||
44374188|NCT00807937|79379348|FG003|Overall Study|Adverse Event|4|||
44374189|NCT00807937|79379345|FG000|Overall Study|Protocol Violation|4|||
44271209|NCT03990363|79200087|FG004|Overall Study|Study terminated by sponsor|0|||
44277796|NCT02138214|79238786|FG001|Overall Study|Screen Failure|1|||
44374190|NCT00807937|79379346|FG001|Overall Study|Protocol Violation|5|||
44221462|NCT01393743|79024532|FG002|Extension Phase|Lost to Follow-up|2|||
44221463|NCT01393743|79024530|FG000|Extension Phase|Participant choice|0|||
44221464|NCT01393743|79024531|FG001|Extension Phase|Participant choice|0|||
44461907|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
44221465|NCT01393743|79024532|FG002|Extension Phase|Participant choice|16|||
44221466|NCT01393743|79024530|FG000|Extension Phase|Inadequate therapeutic effect|0|||
44221467|NCT01393743|79024531|FG001|Extension Phase|Inadequate therapeutic effect|0|||
44221468|NCT01393743|79024532|FG002|Extension Phase|Inadequate therapeutic effect|7|||
44221469|NCT01393743|79024530|FG000|Extension Phase|Withdrawal by Subject|0|||
44221470|NCT01393743|79024531|FG001|Extension Phase|Withdrawal by Subject|0|||
44221471|NCT01393743|79024532|FG002|Extension Phase|Withdrawal by Subject|8|||
44461908|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
44461909|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
44461910|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
44461911|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
44461912|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Death|1|||
44461913|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Death|0|||
44461914|NCT00521586|79470905|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
44461915|NCT00521586|79470906|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
44461916|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
44461917|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
44461918|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
44461919|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
44461920|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
44461921|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
44461922|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
44461923|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
44461924|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
44461925|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
44461926|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
44461927|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
44461928|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
44461929|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
44461930|NCT00521586|79470905|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
44461931|NCT00521586|79470906|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
44461932|NCT00521586|79470905|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
44461933|NCT00521586|79470906|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
44461934|NCT00521586|79470905|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
44461935|NCT00521586|79470906|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
44461936|NCT00521586|79470905|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
44221472|NCT01393743|79024530|FG000|Extension Phase|Pregnancy|0|||
44221473|NCT01393743|79024531|FG001|Extension Phase|Pregnancy|0|||
44221474|NCT01393743|79024532|FG002|Extension Phase|Pregnancy|1|||
44221475|NCT01393743|79024530|FG000|Extension Phase|Other|0|||
44221476|NCT01393743|79024531|FG001|Extension Phase|Other|0|||
44221477|NCT01393743|79024532|FG002|Extension Phase|Other|14|||
44221478|NCT01405911|79024551|FG000|Overall Study|Pre-treatment lab AE|0|||
44221479|NCT01405911|79024552|FG001|Overall Study|Pre-treatment lab AE|1|||
44221480|NCT01405911|79024553|FG002|Overall Study|Pre-treatment lab AE|0|||
44221481|NCT01405911|79024551|FG000|Overall Study|Lost to Follow-up|0|||
44221482|NCT01405911|79024552|FG001|Overall Study|Lost to Follow-up|1|||
44221483|NCT01405911|79024553|FG002|Overall Study|Lost to Follow-up|0|||
44221484|NCT01405911|79024551|FG000|Overall Study|Protocol Violation|1|||
44221485|NCT01405911|79024552|FG001|Overall Study|Protocol Violation|0|||
44221486|NCT01405911|79024553|FG002|Overall Study|Protocol Violation|0|||
44221487|NCT01405911|79024551|FG000|Overall Study|Withdrawal by Subject|3|||
44221488|NCT01405911|79024552|FG001|Overall Study|Withdrawal by Subject|1|||
44221489|NCT01405911|79024553|FG002|Overall Study|Withdrawal by Subject|1|||
44221490|NCT01425801|79024561|FG000|Period 1|Withdrawal by Subject|0|||
44221491|NCT01425801|79024562|FG001|Period 1|Withdrawal by Subject|0|||
44221492|NCT01425801|79024563|FG002|Period 1|Withdrawal by Subject|0|||
44221493|NCT01425801|79024564|FG003|Period 1|Withdrawal by Subject|0|||
44461937|NCT00521586|79470906|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
44461938|NCT00515502|79470924|FG000|Treatment Period 1|Adverse Event|0|||
44461939|NCT00515502|79470925|FG001|Treatment Period 1|Adverse Event|0|||
44461940|NCT00515502|79470926|FG002|Treatment Period 1|Adverse Event|0|||
44221494|NCT01425801|79024565|FG004|Period 1|Withdrawal by Subject|1|||
44221495|NCT01425801|79024566|FG005|Period 1|Withdrawal by Subject|0|||
44221496|NCT01425801|79024561|FG000|Period 2|Withdrawal by Subject|0|||
44271210|NCT03990363|79200083|FG000|Overall Study|Site terminated by sponsor|2|||
44221497|NCT01425801|79024562|FG001|Period 2|Withdrawal by Subject|0|||
44221498|NCT01425801|79024563|FG002|Period 2|Withdrawal by Subject|0|||
44221499|NCT01425801|79024564|FG003|Period 2|Withdrawal by Subject|0|||
44461941|NCT00515502|79470927|FG003|Treatment Period 1|Adverse Event|0|||
44221500|NCT01425801|79024565|FG004|Period 2|Withdrawal by Subject|1|||
44221501|NCT01425801|79024566|FG005|Period 2|Withdrawal by Subject|0|||
44461942|NCT00515502|79470928|FG004|Treatment Period 1|Adverse Event|0|||
44461943|NCT00515502|79470929|FG005|Treatment Period 1|Adverse Event|0|||
44461944|NCT00515502|79470930|FG006|Treatment Period 1|Adverse Event|1|||
44461945|NCT00515502|79470931|FG007|Treatment Period 1|Adverse Event|0|||
44461946|NCT00515502|79470932|FG008|Treatment Period 1|Adverse Event|1|||
44461947|NCT00515502|79470933|FG009|Treatment Period 1|Adverse Event|0|||
44461948|NCT00515502|79470934|FG010|Treatment Period 1|Adverse Event|0|||
44461949|NCT00515502|79470935|FG011|Treatment Period 1|Adverse Event|1|||
44461950|NCT00515502|79470924|FG000|Treatment Period 2|Adverse Event|0|||
44461951|NCT00515502|79470925|FG001|Treatment Period 2|Adverse Event|1|||
44461952|NCT00515502|79470926|FG002|Treatment Period 2|Adverse Event|0|||
44461953|NCT00515502|79470927|FG003|Treatment Period 2|Adverse Event|0|||
44461954|NCT00515502|79470928|FG004|Treatment Period 2|Adverse Event|0|||
44461955|NCT00515502|79470929|FG005|Treatment Period 2|Adverse Event|0|||
44461956|NCT00515502|79470930|FG006|Treatment Period 2|Adverse Event|0|||
44461957|NCT00515502|79470931|FG007|Treatment Period 2|Adverse Event|0|||
44461958|NCT00515502|79470932|FG008|Treatment Period 2|Adverse Event|0|||
44461959|NCT00515502|79470933|FG009|Treatment Period 2|Adverse Event|0|||
44461960|NCT00515502|79470934|FG010|Treatment Period 2|Adverse Event|0|||
44461961|NCT00515502|79470935|FG011|Treatment Period 2|Adverse Event|0|||
44461962|NCT00439647|79470954|FG000|Overall Study|Withdrawal by Subject|25|||
44461963|NCT00439647|79470955|FG001|Overall Study|Withdrawal by Subject|22|||
44461964|NCT00439647|79470954|FG000|Overall Study|Death|15|||
44461965|NCT00439647|79470955|FG001|Overall Study|Death|18|||
44461966|NCT00439647|79470954|FG000|Overall Study|Adverse Event|11|||
44461967|NCT00439647|79470955|FG001|Overall Study|Adverse Event|11|||
44271211|NCT03990363|79200084|FG001|Overall Study|Site terminated by sponsor|1|||
44271212|NCT03990363|79200085|FG002|Overall Study|Site terminated by sponsor|2|||
44271213|NCT03990363|79200086|FG003|Overall Study|Site terminated by sponsor|0|||
44271214|NCT03990363|79200087|FG004|Overall Study|Site terminated by sponsor|2|||
44271215|NCT03990363|79200083|FG000|Overall Study|Not categorized|5|||
44271216|NCT03990363|79200084|FG001|Overall Study|Not categorized|5|||
44271217|NCT03990363|79200085|FG002|Overall Study|Not categorized|3|||
44271218|NCT03990363|79200086|FG003|Overall Study|Not categorized|2|||
44271219|NCT03990363|79200087|FG004|Overall Study|Not categorized|2|||
44374191|NCT00807937|79379347|FG002|Overall Study|Protocol Violation|3|||
44374192|NCT00807937|79379348|FG003|Overall Study|Protocol Violation|3|||
44374193|NCT00807937|79379345|FG000|Overall Study|Withdrawal by Subject|5|||
44374194|NCT00807937|79379346|FG001|Overall Study|Withdrawal by Subject|4|||
44374195|NCT00807937|79379347|FG002|Overall Study|Withdrawal by Subject|1|||
44374196|NCT00807937|79379348|FG003|Overall Study|Withdrawal by Subject|4|||
44374197|NCT00807937|79379345|FG000|Overall Study|Lost to Follow-up|4|||
44374198|NCT00807937|79379346|FG001|Overall Study|Lost to Follow-up|0|||
44374199|NCT00807937|79379347|FG002|Overall Study|Lost to Follow-up|2|||
44374200|NCT00807937|79379348|FG003|Overall Study|Lost to Follow-up|1|||
44374201|NCT00807937|79379345|FG000|Overall Study|Lack of Efficacy|0|||
44374202|NCT00807937|79379346|FG001|Overall Study|Lack of Efficacy|0|||
44374203|NCT00807937|79379347|FG002|Overall Study|Lack of Efficacy|1|||
44374204|NCT00807937|79379348|FG003|Overall Study|Lack of Efficacy|2|||
44374205|NCT00807937|79379345|FG000|Overall Study|Intake of prohibited medicine|0|||
44374206|NCT00807937|79379346|FG001|Overall Study|Intake of prohibited medicine|0|||
44374207|NCT00807937|79379347|FG002|Overall Study|Intake of prohibited medicine|2|||
44374208|NCT00807937|79379348|FG003|Overall Study|Intake of prohibited medicine|0|||
44374209|NCT00807937|79379345|FG000|Overall Study|All other reasons (not provided)|2|||
44374210|NCT00807937|79379346|FG001|Overall Study|All other reasons (not provided)|4|||
44374211|NCT00807937|79379347|FG002|Overall Study|All other reasons (not provided)|0|||
44374212|NCT00807937|79379348|FG003|Overall Study|All other reasons (not provided)|1|||
44374213|NCT00906945|79379363|FG000|Overall Study|Found to be not eligible|0|||
44374214|NCT00906945|79379364|FG001|Overall Study|Found to be not eligible|0|||
44374215|NCT00906945|79379365|FG002|Overall Study|Found to be not eligible|0|||
44374216|NCT00906945|79379366|FG003|Overall Study|Found to be not eligible|1|||
44374217|NCT00906945|79379367|FG004|Overall Study|Found to be not eligible|1|||
44374218|NCT00906945|79379368|FG005|Overall Study|Found to be not eligible|1|||
44374219|NCT00906945|79379363|FG000|Overall Study|Physician Decision|0|||
44374220|NCT00906945|79379364|FG001|Overall Study|Physician Decision|0|||
44374221|NCT00906945|79379365|FG002|Overall Study|Physician Decision|0|||
44374222|NCT00906945|79379366|FG003|Overall Study|Physician Decision|0|||
44374223|NCT00906945|79379367|FG004|Overall Study|Physician Decision|0|||
44374224|NCT00906945|79379368|FG005|Overall Study|Physician Decision|1|||
44271220|NCT04661839|79200157|FG000|Overall Study|Not Treated|0|||
44271221|NCT04661839|79200158|FG001|Overall Study|Not Treated|0|||
44271222|NCT04661839|79200159|FG002|Overall Study|Not Treated|1|||
44271223|NCT04661839|79200160|FG003|Overall Study|Not Treated|0|||
44374225|NCT00807235|79379386|FG000|Overall Study|Adverse Event|1|||
44374226|NCT00807235|79379387|FG001|Overall Study|Adverse Event|0|||
44374227|NCT00876694|79379395|FG000|Overall Study|Adverse Event|10|||
44461968|NCT00439647|79470954|FG000|Overall Study|Lost to Follow-up|4|||
44461969|NCT00439647|79470955|FG001|Overall Study|Lost to Follow-up|12|||
44461970|NCT00439647|79470954|FG000|Overall Study|Protocol Violation|3|||
44461971|NCT00439647|79470955|FG001|Overall Study|Protocol Violation|4|||
44271224|NCT04661839|79200157|FG000|Overall Study|Lost to Follow-up|1|||
44271225|NCT04661839|79200158|FG001|Overall Study|Lost to Follow-up|0|||
44461972|NCT00439647|79470954|FG000|Overall Study|Lack of Efficacy|0|||
44461973|NCT00439647|79470955|FG001|Overall Study|Lack of Efficacy|4|||
44461974|NCT00515112|79470963|FG000|Overall Study|Death|0|||
44461975|NCT00515112|79470964|FG001|Overall Study|Death|1|||
44461976|NCT00515112|79470963|FG000|Overall Study|The study was terminated|3|||
44461977|NCT00515112|79470964|FG001|Overall Study|The study was terminated|2|||
44461978|NCT00404547|79470972|FG000|Overall Study|Adverse Event|39|||
44461979|NCT00404547|79470973|FG001|Overall Study|Adverse Event|6|||
44461980|NCT00404547|79470972|FG000|Overall Study|Withdrawal by Subject|19|||
44461981|NCT00404547|79470973|FG001|Overall Study|Withdrawal by Subject|2|||
44461982|NCT00404547|79470972|FG000|Overall Study|Protocol Violation|0|||
44461983|NCT00404547|79470973|FG001|Overall Study|Protocol Violation|1|||
44271226|NCT04661839|79200159|FG002|Overall Study|Lost to Follow-up|0|||
44271227|NCT04661839|79200160|FG003|Overall Study|Lost to Follow-up|1|||
44271228|NCT02240485|79200261|FG000|3 Months Post-admission|Lost to Follow-up|1|||
44461984|NCT00404547|79470972|FG000|Overall Study|Lost to Follow-up|20|||
44461985|NCT00404547|79470973|FG001|Overall Study|Lost to Follow-up|9|||
44461986|NCT00404547|79470972|FG000|Overall Study|Lack of compliance|5|||
44461987|NCT00404547|79470973|FG001|Overall Study|Lack of compliance|1|||
44461988|NCT00404547|79470972|FG000|Overall Study|Other|4|||
44461989|NCT00404547|79470973|FG001|Overall Study|Other|0|||
44461990|NCT00404547|79470972|FG000|Overall Study|Reason not stated|3|||
44461991|NCT00404547|79470973|FG001|Overall Study|Reason not stated|6|||
44461992|NCT00515034|79470983|FG000|Overall Study|Adverse Event|2|||
44461993|NCT00515034|79470984|FG001|Overall Study|Adverse Event|0|||
44461994|NCT00515034|79470985|FG002|Overall Study|Adverse Event|1|||
44461995|NCT00515034|79470986|FG003|Overall Study|Adverse Event|0|||
44461996|NCT00515034|79470983|FG000|Overall Study|Death|4|||
44461997|NCT00515034|79470984|FG001|Overall Study|Death|2|||
44461998|NCT00515034|79470985|FG002|Overall Study|Death|1|||
44461999|NCT00515034|79470986|FG003|Overall Study|Death|3|||
44544233|NCT03602053|79557529|FG000|Overall Study|Withdrawal by Subject|7|||
44544234|NCT03602053|79557530|FG001|Overall Study|Withdrawal by Subject|9|||
44374228|NCT00876694|79379396|FG001|Overall Study|Adverse Event|7|||
44374229|NCT00876694|79379395|FG000|Overall Study|Subject withdrew consent|6|||
44374230|NCT00876694|79379396|FG001|Overall Study|Subject withdrew consent|4|||
44374231|NCT00876694|79379395|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44374232|NCT00876694|79379396|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44374233|NCT00876694|79379395|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44374234|NCT00876694|79379396|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44374235|NCT00876694|79379395|FG000|Overall Study|Administrative problems|1|||
44374236|NCT00876694|79379396|FG001|Overall Study|Administrative problems|1|||
44374237|NCT00876694|79379395|FG000|Overall Study|Death|1|||
44374238|NCT00876694|79379396|FG001|Overall Study|Death|0|||
44374239|NCT00805441|79379404|FG000|Overall Study|Adverse Event|5|||
44374240|NCT00805441|79379405|FG001|Overall Study|Adverse Event|2|||
44374241|NCT00805441|79379404|FG000|Overall Study|Lack of Efficacy|0|||
44374242|NCT00805441|79379405|FG001|Overall Study|Lack of Efficacy|2|||
44374243|NCT00805441|79379404|FG000|Overall Study|Protocol Violation|4|||
44374244|NCT00805441|79379405|FG001|Overall Study|Protocol Violation|8|||
44374245|NCT00805441|79379404|FG000|Overall Study|Lost to Follow-up|10|||
44374246|NCT00805441|79379405|FG001|Overall Study|Lost to Follow-up|13|||
44374247|NCT00805441|79379404|FG000|Overall Study|Withdrawal by Subject|15|||
44374248|NCT00805441|79379405|FG001|Overall Study|Withdrawal by Subject|9|||
44374249|NCT00805441|79379404|FG000|Overall Study|Physician Decision|0|||
44374250|NCT00805441|79379405|FG001|Overall Study|Physician Decision|1|||
44374251|NCT00805441|79379404|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
44374252|NCT00805441|79379405|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
44374253|NCT00590317|79379413|FG000|Overall Study|Lack of Efficacy|1|||
44462000|NCT00515034|79470983|FG000|Overall Study|Withdrawal by Subject|1|||
44462001|NCT00515034|79470984|FG001|Overall Study|Withdrawal by Subject|0|||
44544235|NCT03602053|79557531|FG002|Overall Study|Withdrawal by Subject|7|||
44271229|NCT02240485|79200262|FG001|3 Months Post-admission|Lost to Follow-up|5|||
44374254|NCT00590317|79379414|FG001|Overall Study|Lack of Efficacy|5|||
44374255|NCT01139762|79379423|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
44462002|NCT00515034|79470985|FG002|Overall Study|Withdrawal by Subject|3|||
44462003|NCT00515034|79470986|FG003|Overall Study|Withdrawal by Subject|0|||
44462004|NCT00515034|79470983|FG000|Overall Study|Physician Decision|0|||
44462005|NCT00515034|79470984|FG001|Overall Study|Physician Decision|0|||
44462006|NCT00515034|79470985|FG002|Overall Study|Physician Decision|1|||
44462007|NCT00515034|79470986|FG003|Overall Study|Physician Decision|1|||
44271230|NCT02240485|79200261|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
44374256|NCT01139762|79379424|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
44374257|NCT01139762|79379425|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
44374258|NCT01139762|79379423|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
44462008|NCT00515034|79470983|FG000|Overall Study|Other|1|||
44544236|NCT03602053|79557529|FG000|Overall Study|Lost to Follow-up|5|||
44462009|NCT00515034|79470984|FG001|Overall Study|Other|0|||
44462010|NCT00515034|79470985|FG002|Overall Study|Other|2|||
44462011|NCT00515034|79470986|FG003|Overall Study|Other|1|||
44462012|NCT00404235|79470998|FG000|Overall Study|Withdrawal by Subject|1|||
44462013|NCT00404235|79470999|FG001|Overall Study|Withdrawal by Subject|2|||
44462014|NCT00404079|79471007|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
44462015|NCT00404079|79471008|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
44462016|NCT00403845|79471014|FG000|Treatment Period 1|Subject withdrew consent|1|||
44462017|NCT00403845|79471015|FG001|Treatment Period 1|Subject withdrew consent|0|||
44462018|NCT00403845|79471016|FG002|Treatment Period 1|Subject withdrew consent|0|||
44462019|NCT00403845|79471017|FG003|Treatment Period 1|Subject withdrew consent|0|||
44462020|NCT00403845|79471014|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
44462021|NCT00403845|79471015|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
44462022|NCT00403845|79471016|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
44462023|NCT00403845|79471017|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
44462024|NCT00403845|79471014|FG000|Treatment Period 2|Subject withdrew consent|1|||
44462025|NCT00403845|79471015|FG001|Treatment Period 2|Subject withdrew consent|0|||
44462026|NCT00403845|79471016|FG002|Treatment Period 2|Subject withdrew consent|0|||
44462027|NCT00403845|79471017|FG003|Treatment Period 2|Subject withdrew consent|0|||
44462028|NCT00403845|79471014|FG000|Treatment Period 3|Subject withdrew consent|0|||
44462029|NCT00403845|79471015|FG001|Treatment Period 3|Subject withdrew consent|0|||
44462030|NCT00403845|79471016|FG002|Treatment Period 3|Subject withdrew consent|0|||
44462031|NCT00403845|79471017|FG003|Treatment Period 3|Subject withdrew consent|1|||
44462032|NCT00403845|79471014|FG000|Treatment Period 3|Adverse Event|0|||
44462033|NCT00403845|79471015|FG001|Treatment Period 3|Adverse Event|0|||
44462034|NCT00403845|79471016|FG002|Treatment Period 3|Adverse Event|0|||
44462035|NCT00403845|79471017|FG003|Treatment Period 3|Adverse Event|1|||
44462036|NCT00509262|79471029|FG000|Overall Study|Adverse Event|16|||
44462037|NCT00509262|79471030|FG001|Overall Study|Adverse Event|18|||
44462038|NCT00509262|79471029|FG000|Overall Study|Other|2|||
44462039|NCT00509262|79471030|FG001|Overall Study|Other|2|||
44462040|NCT00509262|79471029|FG000|Overall Study|Lack of Efficacy|1|||
44462041|NCT00509262|79471030|FG001|Overall Study|Lack of Efficacy|0|||
44462042|NCT00509262|79471029|FG000|Overall Study|Lost to Follow-up|1|||
44462043|NCT00509262|79471030|FG001|Overall Study|Lost to Follow-up|6|||
44462044|NCT00509262|79471029|FG000|Overall Study|Physician Decision|1|||
44462045|NCT00509262|79471030|FG001|Overall Study|Physician Decision|3|||
44462046|NCT00509262|79471029|FG000|Overall Study|Protocol Violation|2|||
44462047|NCT00509262|79471030|FG001|Overall Study|Protocol Violation|2|||
44462048|NCT00509262|79471029|FG000|Overall Study|Withdrawal by Subject|24|||
44462049|NCT00509262|79471030|FG001|Overall Study|Withdrawal by Subject|11|||
44462050|NCT00607997|79471040|FG000|Overall Study|Lack of Efficacy|6|||
44462051|NCT00607997|79471041|FG001|Overall Study|Lack of Efficacy|20|||
44462052|NCT00607997|79471042|FG002|Overall Study|Lack of Efficacy|14|||
44462053|NCT00607997|79471043|FG003|Overall Study|Lack of Efficacy|10|||
44462054|NCT00607997|79471040|FG000|Overall Study|Death|8|||
44462055|NCT00607997|79471041|FG001|Overall Study|Death|5|||
44462056|NCT00607997|79471042|FG002|Overall Study|Death|2|||
44462057|NCT00607997|79471043|FG003|Overall Study|Death|5|||
44462058|NCT00607997|79471040|FG000|Overall Study|Adverse Event|3|||
44462059|NCT00607997|79471041|FG001|Overall Study|Adverse Event|1|||
44462060|NCT00607997|79471042|FG002|Overall Study|Adverse Event|2|||
44462061|NCT00607997|79471043|FG003|Overall Study|Adverse Event|0|||
44462062|NCT00607997|79471040|FG000|Overall Study|Physician Decision|4|||
44462063|NCT00607997|79471041|FG001|Overall Study|Physician Decision|1|||
44462064|NCT00607997|79471042|FG002|Overall Study|Physician Decision|0|||
44462065|NCT00607997|79471043|FG003|Overall Study|Physician Decision|0|||
44462066|NCT00607997|79471040|FG000|Overall Study|Relapse, recurrent illness|4|||
44462067|NCT00607997|79471041|FG001|Overall Study|Relapse, recurrent illness|0|||
44462068|NCT00607997|79471042|FG002|Overall Study|Relapse, recurrent illness|2|||
44462069|NCT00607997|79471043|FG003|Overall Study|Relapse, recurrent illness|0|||
44462070|NCT00607997|79471040|FG000|Overall Study|Other without explanation|2|||
44462071|NCT00607997|79471041|FG001|Overall Study|Other without explanation|0|||
44462072|NCT00607997|79471042|FG002|Overall Study|Other without explanation|4|||
44462073|NCT00607997|79471043|FG003|Overall Study|Other without explanation|1|||
44462074|NCT00509106|79471060|FG000|Overall Study|Adverse Event|3|||
44271231|NCT02240485|79200262|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
44462075|NCT00509106|79471061|FG001|Overall Study|Adverse Event|2|||
44462076|NCT00509106|79471060|FG000|Overall Study|Noncompliance|0|||
44462077|NCT00509106|79471061|FG001|Overall Study|Noncompliance|1|||
44271232|NCT02240485|79200261|FG000|9 Months Post-admission|Lost to Follow-up|3|||
44462078|NCT00509106|79471060|FG000|Overall Study|At the request of sponsor/investigator|1|||
44462079|NCT00509106|79471061|FG001|Overall Study|At the request of sponsor/investigator|2|||
44544237|NCT03602053|79557530|FG001|Overall Study|Lost to Follow-up|6|||
44544238|NCT03602053|79557531|FG002|Overall Study|Lost to Follow-up|0|||
44462080|NCT00509106|79471060|FG000|Overall Study|Withdrew consent|4|||
44462081|NCT00509106|79471061|FG001|Overall Study|Withdrew consent|8|||
44462082|NCT00509106|79471060|FG000|Overall Study|Lost to Follow-up|16|||
44462083|NCT00509106|79471061|FG001|Overall Study|Lost to Follow-up|10|||
44462084|NCT00509106|79471060|FG000|Overall Study|Other|1|||
44462085|NCT00509106|79471061|FG001|Overall Study|Other|0|||
44462086|NCT00509106|79471060|FG000|Overall Study|Death|6|||
44462087|NCT00509106|79471061|FG001|Overall Study|Death|6|||
44462088|NCT00607919|79471069|FG000|Acute Phase|Adverse Event|9|||
44462089|NCT00607919|79471070|FG001|Acute Phase|Adverse Event|2|||
44462090|NCT00607919|79471069|FG000|Acute Phase|Entry Criteria Not Met|1|||
44462091|NCT00607919|79471070|FG001|Acute Phase|Entry Criteria Not Met|1|||
44462092|NCT00607919|79471069|FG000|Acute Phase|Lack of Efficacy|1|||
44462093|NCT00607919|79471070|FG001|Acute Phase|Lack of Efficacy|2|||
44462094|NCT00607919|79471069|FG000|Acute Phase|Lost to Follow-up|9|||
44462095|NCT00607919|79471070|FG001|Acute Phase|Lost to Follow-up|3|||
44462096|NCT00607919|79471069|FG000|Acute Phase|Parent/Caregiver Decision|6|||
44462097|NCT00607919|79471070|FG001|Acute Phase|Parent/Caregiver Decision|4|||
44462098|NCT00607919|79471069|FG000|Acute Phase|Protocol Violation|5|||
44462099|NCT00607919|79471070|FG001|Acute Phase|Protocol Violation|1|||
44462100|NCT00607919|79471069|FG000|Acute Phase|Withdrawal by Subject|3|||
44462101|NCT00607919|79471070|FG001|Acute Phase|Withdrawal by Subject|3|||
44462102|NCT00607919|79471069|FG000|Open-Label Phase|Adverse Event|1|||
44462103|NCT00607919|79471070|FG001|Open-Label Phase|Adverse Event|5|||
44462104|NCT00607919|79471069|FG000|Open-Label Phase|Lost to Follow-up|4|||
44462105|NCT00607919|79471070|FG001|Open-Label Phase|Lost to Follow-up|1|||
44462106|NCT00607919|79471069|FG000|Open-Label Phase|Protocol Violation|2|||
44462107|NCT00607919|79471070|FG001|Open-Label Phase|Protocol Violation|2|||
44462108|NCT00607919|79471069|FG000|Open-Label Phase|Withdrawal by Subject|2|||
44462109|NCT00607919|79471070|FG001|Open-Label Phase|Withdrawal by Subject|2|||
44462110|NCT00607919|79471069|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
44462111|NCT00607919|79471070|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
44462112|NCT00344968|79471081|FG000|Overall Study|Adverse Event|5|||
44462113|NCT00344968|79471082|FG001|Overall Study|Adverse Event|4|||
44462114|NCT00344968|79471083|FG002|Overall Study|Adverse Event|15|||
44462115|NCT00344968|79471081|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44462116|NCT00344968|79471082|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44462117|NCT00344968|79471083|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
44462118|NCT00344968|79471081|FG000|Overall Study|Protocol Violation|2|||
44462119|NCT00344968|79471082|FG001|Overall Study|Protocol Violation|2|||
44462120|NCT00344968|79471083|FG002|Overall Study|Protocol Violation|5|||
44462121|NCT00344968|79471081|FG000|Overall Study|Withdrawal by Subject|14|||
44462122|NCT00344968|79471082|FG001|Overall Study|Withdrawal by Subject|31|||
44462123|NCT00344968|79471083|FG002|Overall Study|Withdrawal by Subject|27|||
44462124|NCT00344968|79471081|FG000|Overall Study|Lost to Follow-up|24|||
44221502|NCT01425801|79024561|FG000|Period 3|Stability criteria not fullfilled|0|||
44221503|NCT01425801|79024562|FG001|Period 3|Stability criteria not fullfilled|0|||
44221504|NCT01425801|79024563|FG002|Period 3|Stability criteria not fullfilled|1|||
44221505|NCT01425801|79024564|FG003|Period 3|Stability criteria not fullfilled|0|||
44221506|NCT01425801|79024565|FG004|Period 3|Stability criteria not fullfilled|0|||
44221507|NCT01425801|79024566|FG005|Period 3|Stability criteria not fullfilled|0|||
44221508|NCT01425801|79024561|FG000|Period 4|Not able to maintain visit schedule|0|||
44221509|NCT01425801|79024562|FG001|Period 4|Not able to maintain visit schedule|0|||
44221510|NCT01425801|79024563|FG002|Period 4|Not able to maintain visit schedule|1|||
44221511|NCT01425801|79024564|FG003|Period 4|Not able to maintain visit schedule|0|||
44221512|NCT01425801|79024565|FG004|Period 4|Not able to maintain visit schedule|0|||
44221513|NCT01425801|79024566|FG005|Period 4|Not able to maintain visit schedule|0|||
44221514|NCT01425723|79024591|FG000|Overall Study|Lack of Efficacy|0|||
44221515|NCT01425723|79024592|FG001|Overall Study|Lack of Efficacy|1|||
44221516|NCT01425723|79024591|FG000|Overall Study|Withdrawal by Subject|1|||
44221517|NCT01425723|79024592|FG001|Overall Study|Withdrawal by Subject|4|||
44221518|NCT01425723|79024591|FG000|Overall Study|Lost to Follow-up|0|||
44462125|NCT00344968|79471082|FG001|Overall Study|Lost to Follow-up|37|||
44462126|NCT00344968|79471083|FG002|Overall Study|Lost to Follow-up|37|||
44462127|NCT00344968|79471081|FG000|Overall Study|Death|11|||
44462128|NCT00344968|79471082|FG001|Overall Study|Death|27|||
44221519|NCT01425723|79024592|FG001|Overall Study|Lost to Follow-up|3|||
44221520|NCT01425723|79024591|FG000|Overall Study|Physician Decision|2|||
44221521|NCT01425723|79024592|FG001|Overall Study|Physician Decision|0|||
44277797|NCT02138214|79238787|FG002|Overall Study|Screen Failure|0|||
44462129|NCT00344968|79471083|FG002|Overall Study|Death|31|||
44462130|NCT00344968|79471081|FG000|Overall Study|Other|0|||
44462131|NCT00344968|79471082|FG001|Overall Study|Other|1|||
44462132|NCT00344968|79471083|FG002|Overall Study|Other|0|||
44462133|NCT00509028|79471094|FG000|Overall Study|Adverse Event|2|||
44462134|NCT00509028|79471095|FG001|Overall Study|Adverse Event|0|||
44462135|NCT00509028|79471094|FG000|Overall Study|Withdrawal by Subject|4|||
44462136|NCT00509028|79471095|FG001|Overall Study|Withdrawal by Subject|3|||
44462137|NCT00509028|79471094|FG000|Overall Study|Lost to Follow-up|0|||
44462138|NCT00509028|79471095|FG001|Overall Study|Lost to Follow-up|1|||
44462139|NCT00509028|79471094|FG000|Overall Study|Protocol Violation|4|||
44462140|NCT00509028|79471095|FG001|Overall Study|Protocol Violation|2|||
44462141|NCT00509028|79471094|FG000|Overall Study|Non-compliance|2|||
44462142|NCT00509028|79471095|FG001|Overall Study|Non-compliance|1|||
44462143|NCT00352846|79471103|FG000|Overall Study|Disease progression|0|||
44462144|NCT00352846|79471104|FG001|Overall Study|Disease progression|2|||
44462145|NCT00352846|79471103|FG000|Overall Study|Withdrawal by Subject|3|||
44462146|NCT00352846|79471104|FG001|Overall Study|Withdrawal by Subject|8|||
44462147|NCT00352846|79471103|FG000|Overall Study|Ineligible|3|||
44462148|NCT00352846|79471104|FG001|Overall Study|Ineligible|2|||
44462149|NCT00352846|79471103|FG000|Overall Study|Non-compliance|2|||
44462150|NCT00352846|79471104|FG001|Overall Study|Non-compliance|0|||
44462151|NCT00352846|79471103|FG000|Overall Study|Death|0|||
44462152|NCT00352846|79471104|FG001|Overall Study|Death|1|||
44462153|NCT00508872|79471110|FG000|Overall Study|Lost to Follow-up|1|||
44462154|NCT00508872|79471110|FG000|Overall Study|Physician Decision|1|||
44462155|NCT00508482|79471117|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
44462156|NCT00508482|79471118|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
44462157|NCT00508482|79471119|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
44462158|NCT00508482|79471117|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
44462159|NCT00508482|79471118|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
44462160|NCT00508482|79471119|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
44462161|NCT00508482|79471117|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
44462162|NCT00508482|79471118|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
44462163|NCT00508482|79471119|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
44462164|NCT00344500|79471130|FG000|Overall Study|Adverse Event|6|||
44462165|NCT00344500|79471131|FG001|Overall Study|Adverse Event|2|||
44462166|NCT00344500|79471132|FG002|Overall Study|Adverse Event|0|||
44462167|NCT00344500|79471130|FG000|Overall Study|Lost to Follow-up|5|||
44462168|NCT00344500|79471131|FG001|Overall Study|Lost to Follow-up|13|||
44462169|NCT00344500|79471132|FG002|Overall Study|Lost to Follow-up|1|||
44462170|NCT00344500|79471130|FG000|Overall Study|Withdrawal by Subject|7|||
44462171|NCT00344500|79471131|FG001|Overall Study|Withdrawal by Subject|10|||
44462172|NCT00344500|79471132|FG002|Overall Study|Withdrawal by Subject|0|||
44462173|NCT00344500|79471130|FG000|Overall Study|Protocol Violation|4|||
44462174|NCT00344500|79471131|FG001|Overall Study|Protocol Violation|7|||
44462175|NCT00344500|79471132|FG002|Overall Study|Protocol Violation|1|||
44462176|NCT00344500|79471130|FG000|Overall Study|Not Noted|1|||
44462177|NCT00344500|79471131|FG001|Overall Study|Not Noted|3|||
44462178|NCT00344500|79471132|FG002|Overall Study|Not Noted|0|||
44544239|NCT03602053|79557529|FG000|Overall Study|Protocol Violation|3|||
44544240|NCT03602053|79557530|FG001|Overall Study|Protocol Violation|0|||
44221522|NCT01425723|79024591|FG000|Overall Study|Other|1|||
44221523|NCT01425723|79024592|FG001|Overall Study|Other|10|||
44221524|NCT01424397|79024623|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221525|NCT01424397|79024624|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221526|NCT01424397|79024625|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
44221527|NCT01424397|79024626|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221528|NCT01424397|79024627|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221529|NCT01424397|79024628|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221530|NCT01424397|79024629|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221531|NCT01424397|79024630|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221532|NCT01424397|79024631|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221533|NCT01424397|79024632|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221534|NCT01424397|79024633|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221535|NCT01424397|79024634|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
44221536|NCT01392963|79024650|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
44221537|NCT01392963|79024651|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
44221538|NCT01392963|79024650|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
44221539|NCT01392963|79024651|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
44221540|NCT01392963|79024650|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
44221541|NCT01392963|79024651|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
44221542|NCT01392573|79024661|FG000|Overall Study|Adverse Event|1|||
44221543|NCT01392573|79024662|FG001|Overall Study|Adverse Event|3|||
44221544|NCT01392573|79024661|FG000|Overall Study|Lack of Efficacy|1|||
44271233|NCT02240485|79200262|FG001|9 Months Post-admission|Lost to Follow-up|1|||
44462179|NCT00344032|79471141|FG000|Overall Study|Adverse Event|0|||
44221545|NCT01392573|79024662|FG001|Overall Study|Lack of Efficacy|2|||
44271234|NCT02240485|79200261|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
44271235|NCT02240485|79200262|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
44462180|NCT00344032|79471142|FG001|Overall Study|Adverse Event|1|||
44462181|NCT00344032|79471141|FG000|Overall Study|Withdrawal by Subject|6|||
44221546|NCT01392573|79024661|FG000|Overall Study|Protocol Violation|0|||
44462182|NCT00344032|79471142|FG001|Overall Study|Withdrawal by Subject|2|||
44462183|NCT00344032|79471141|FG000|Overall Study|Lost to Follow-up|4|||
44462184|NCT00344032|79471142|FG001|Overall Study|Lost to Follow-up|6|||
44462185|NCT00344032|79471141|FG000|Overall Study|Physician Decision|4|||
44462186|NCT00344032|79471142|FG001|Overall Study|Physician Decision|1|||
44462187|NCT00607373|79471150|FG000|Treatment Period|Adverse Event|0|||
44462188|NCT00607373|79471151|FG001|Treatment Period|Adverse Event|4|||
44462189|NCT00607373|79471150|FG000|Treatment Period|Physician Decision|0|||
44462190|NCT00607373|79471151|FG001|Treatment Period|Physician Decision|1|||
44462191|NCT00607373|79471150|FG000|Treatment Period|Withdrawal by Subject|0|||
44462192|NCT00607373|79471151|FG001|Treatment Period|Withdrawal by Subject|1|||
44462193|NCT00607373|79471150|FG000|Follow-up Period|Other|0|||
44462194|NCT00607373|79471151|FG001|Follow-up Period|Other|1|||
44462195|NCT00607373|79471150|FG000|Follow-up Period|Protocol Violation|0|||
44462196|NCT00607373|79471151|FG001|Follow-up Period|Protocol Violation|1|||
44462197|NCT00607373|79471150|FG000|Follow-up Period|Withdrawal by Subject|1|||
44462198|NCT00607373|79471151|FG001|Follow-up Period|Withdrawal by Subject|3|||
44462199|NCT00508404|79471157|FG000|Overall Study|Ongoing at Data Cut-off|12|||
44462200|NCT00508404|79471157|FG000|Overall Study|Adverse Event|2|||
44462201|NCT00508404|79471157|FG000|Overall Study|Death|16|||
44462202|NCT00508404|79471157|FG000|Overall Study|Physician Decision|2|||
44462203|NCT00508404|79471157|FG000|Overall Study|Withdrawal by Subject|3|||
44462204|NCT00508404|79471157|FG000|Overall Study|Protocol-specified Criteria|2|||
44462205|NCT00508404|79471157|FG000|Overall Study|Lost to Follow-up|2|||
44462206|NCT00508404|79471157|FG000|Overall Study|Other - Not Specified|3|||
44462207|NCT00352690|79471164|FG000|Overall Study|Determined to be ineligible|2|||
44462208|NCT00352690|79471165|FG001|Overall Study|Determined to be ineligible|0|||
44462209|NCT00609245|79471171|FG000|Overall Study|Adverse Event|1|||
44462210|NCT00343642|79471180|FG000|Overall Study|Lost to Follow-up|0|||
44462211|NCT00343642|79471181|FG001|Overall Study|Lost to Follow-up|1|||
44462212|NCT00343642|79471182|FG002|Overall Study|Lost to Follow-up|0|||
44221547|NCT01392573|79024662|FG001|Overall Study|Protocol Violation|2|||
44221548|NCT01392573|79024661|FG000|Overall Study|Withdrawal Criteria|13|||
44462213|NCT00343642|79471180|FG000|Overall Study|Pregnancy|1|||
44462214|NCT00343642|79471181|FG001|Overall Study|Pregnancy|0|||
44462215|NCT00343642|79471182|FG002|Overall Study|Pregnancy|2|||
44462216|NCT00343642|79471180|FG000|Overall Study|Withdrawal by Subject|2|||
44221549|NCT01392573|79024662|FG001|Overall Study|Withdrawal Criteria|15|||
44221550|NCT01392573|79024661|FG000|Overall Study|Site closure|8|||
44221551|NCT01392573|79024662|FG001|Overall Study|Site closure|7|||
44221552|NCT01392573|79024661|FG000|Overall Study|Unclassified|9|||
44221553|NCT01392573|79024662|FG001|Overall Study|Unclassified|6|||
44221554|NCT01392495|79024668|FG000|Overall Study|Death|3|||
44221555|NCT01392495|79024668|FG000|Overall Study|Administrative problems|8|||
44221556|NCT01392495|79024668|FG000|Overall Study|Withdrawal by Subject|2|||
44221557|NCT01392495|79024668|FG000|Overall Study|Adverse Event|3|||
44221558|NCT01405053|79024676|FG000|Overall Study|Adverse Event|3|||
44221559|NCT01405053|79024677|FG001|Overall Study|Adverse Event|0|||
44221560|NCT01405053|79024676|FG000|Overall Study|Lost to Follow-up|0|||
44221561|NCT01405053|79024677|FG001|Overall Study|Lost to Follow-up|1|||
44221562|NCT01405053|79024676|FG000|Overall Study|Participant choice|2|||
44221563|NCT01405053|79024677|FG001|Overall Study|Participant choice|1|||
44221564|NCT01405053|79024676|FG000|Overall Study|Inadequate therapeutic effect|2|||
44221565|NCT01405053|79024677|FG001|Overall Study|Inadequate therapeutic effect|1|||
44221566|NCT01405053|79024676|FG000|Overall Study|Withdrawal by Subject|3|||
44221567|NCT01405053|79024677|FG001|Overall Study|Withdrawal by Subject|4|||
44221568|NCT01405053|79024676|FG000|Overall Study|Other|0|||
44374259|NCT01139762|79379424|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
44374260|NCT01139762|79379425|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
44374261|NCT01139762|79379423|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
44374262|NCT01139762|79379424|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
44374263|NCT01139762|79379425|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
44374264|NCT01139762|79379423|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
44374265|NCT01139762|79379424|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
44374266|NCT01139762|79379425|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
44374267|NCT01139762|79379423|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
44374268|NCT01139762|79379424|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
44374269|NCT01139762|79379425|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
44374270|NCT01139762|79379423|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
44462217|NCT00343642|79471181|FG001|Overall Study|Withdrawal by Subject|3|||
44462218|NCT00343642|79471182|FG002|Overall Study|Withdrawal by Subject|4|||
44462219|NCT00343642|79471180|FG000|Overall Study|Adverse Event|0|||
44462220|NCT00343642|79471181|FG001|Overall Study|Adverse Event|0|||
44462221|NCT00343642|79471182|FG002|Overall Study|Adverse Event|1|||
44462222|NCT00343642|79471180|FG000|Overall Study|Flare up|6|||
44221569|NCT01405053|79024677|FG001|Overall Study|Other|1|||
44221570|NCT01403805|79024685|FG000|Overall Study|Withdrawal by Subject|0|||
44277798|NCT02092662|79238796|FG000|Overall Study|Lost to Follow-up|13|||
44462223|NCT00343642|79471181|FG001|Overall Study|Flare up|4|||
44462224|NCT00343642|79471182|FG002|Overall Study|Flare up|0|||
44462225|NCT00609167|79471195|FG000|Overall Study|Withdrawal by Subject|1|||
44462226|NCT00609167|79471196|FG001|Overall Study|Withdrawal by Subject|0|||
44462227|NCT00609167|79471195|FG000|Overall Study|Lack of Efficacy|1|||
44462228|NCT00609167|79471196|FG001|Overall Study|Lack of Efficacy|0|||
44462229|NCT00609167|79471195|FG000|Overall Study|Adverse Event|5|||
44462230|NCT00609167|79471196|FG001|Overall Study|Adverse Event|1|||
44462231|NCT00609167|79471195|FG000|Overall Study|Disease Progression|1|||
44462232|NCT00609167|79471196|FG001|Overall Study|Disease Progression|0|||
44462233|NCT00609167|79471195|FG000|Overall Study|Stem Cell Transplant|0|||
44462234|NCT00609167|79471196|FG001|Overall Study|Stem Cell Transplant|6|||
44462235|NCT00606281|79471204|FG000|Overall Study|Adverse Event|11|||
44462236|NCT00606281|79471205|FG001|Overall Study|Adverse Event|12|||
44462237|NCT00606281|79471204|FG000|Overall Study|Death|1|||
44462238|NCT00606281|79471205|FG001|Overall Study|Death|0|||
44462239|NCT00606281|79471204|FG000|Overall Study|Lack of Efficacy|28|||
44462240|NCT00606281|79471205|FG001|Overall Study|Lack of Efficacy|35|||
44462241|NCT00606281|79471204|FG000|Overall Study|Physician Decision|0|||
44462242|NCT00606281|79471205|FG001|Overall Study|Physician Decision|1|||
44462243|NCT00606281|79471204|FG000|Overall Study|Protocol Violation|3|||
44462244|NCT00606281|79471205|FG001|Overall Study|Protocol Violation|3|||
44462245|NCT00606281|79471204|FG000|Overall Study|Withdrawal by Subject|11|||
44462246|NCT00606281|79471205|FG001|Overall Study|Withdrawal by Subject|13|||
44462247|NCT00606281|79471204|FG000|Overall Study|Progression to depressive phase|1|||
44462248|NCT00606281|79471205|FG001|Overall Study|Progression to depressive phase|1|||
44462249|NCT00606281|79471204|FG000|Overall Study|Change of residence or other commitments|1|||
44462250|NCT00606281|79471205|FG001|Overall Study|Change of residence or other commitments|1|||
44462251|NCT00506142|79471213|FG000|Overall Study|Adverse Event|8|||
44462252|NCT00506142|79471214|FG001|Overall Study|Adverse Event|7|||
44462253|NCT00506142|79471213|FG000|Overall Study|Lack of Efficacy|21|||
44462254|NCT00506142|79471214|FG001|Overall Study|Lack of Efficacy|7|||
44462255|NCT00506142|79471213|FG000|Overall Study|Withdrawal by Subject|4|||
44462256|NCT00506142|79471214|FG001|Overall Study|Withdrawal by Subject|5|||
44462257|NCT00506142|79471213|FG000|Overall Study|Physician Decision|1|||
44462258|NCT00506142|79471214|FG001|Overall Study|Physician Decision|0|||
44462259|NCT00506142|79471213|FG000|Overall Study|New health condition|1|||
44462260|NCT00506142|79471214|FG001|Overall Study|New health condition|0|||
44462261|NCT00514020|79471220|FG000|Overall Study|Adverse Event|6|||
44462262|NCT00514020|79471220|FG000|Overall Study|Withdrawal by Subject|3|||
44462263|NCT00514020|79471220|FG000|Overall Study|Physician Decision|1|||
44462264|NCT00514020|79471220|FG000|Overall Study|disease progression|9|||
44462265|NCT00514020|79471220|FG000|Overall Study|other complicating disease|2|||
44462266|NCT00514020|79471220|FG000|Overall Study|patient went to radiation treatment|1|||
44462267|NCT00514020|79471220|FG000|Overall Study|"patients moved to the no tx group"|6|||
44462268|NCT00513708|79471227|FG000|Overall Study|Lost to Follow-up|4|||
44462269|NCT00513708|79471228|FG001|Overall Study|Lost to Follow-up|4|||
44462270|NCT00513708|79471229|FG002|Overall Study|Lost to Follow-up|4|||
44462271|NCT00513474|79471239|FG000|Overall Study|Death|6|||
44462272|NCT00513474|79471240|FG001|Overall Study|Death|9|||
44462273|NCT00513474|79471239|FG000|Overall Study|Participant Withdrew Consent|1|||
44462274|NCT00513474|79471240|FG001|Overall Study|Participant Withdrew Consent|0|||
44462275|NCT00505752|79471250|FG000|Overall Study|Adverse Event|1|||
44462276|NCT00505752|79471251|FG001|Overall Study|Adverse Event|0|||
44462277|NCT00505752|79471252|FG002|Overall Study|Adverse Event|1|||
44221571|NCT01403805|79024686|FG001|Overall Study|Withdrawal by Subject|4|||
44221572|NCT01403805|79024685|FG000|Overall Study|Lost to Follow-up|0|||
44462278|NCT00505752|79471253|FG003|Overall Study|Adverse Event|0|||
44221573|NCT01403805|79024686|FG001|Overall Study|Lost to Follow-up|2|||
44221574|NCT01403805|79024685|FG000|Overall Study|Death|0|||
44221575|NCT01403805|79024686|FG001|Overall Study|Death|1|||
44221576|NCT01423617|79024698|FG000|Overall Study|Lost to Follow-up|0|||
44221577|NCT01423617|79024699|FG001|Overall Study|Lost to Follow-up|1|||
44221578|NCT01392183|79024707|FG000|First Drug Administration|Adverse Event|3|||
44221579|NCT01392183|79024708|FG001|First Drug Administration|Adverse Event|2|||
44462279|NCT00505752|79471250|FG000|Overall Study|Lost to Follow-up|1|||
44462280|NCT00505752|79471251|FG001|Overall Study|Lost to Follow-up|0|||
44221580|NCT01392183|79024707|FG000|First Drug Administration|Death|1|||
44221581|NCT01392183|79024708|FG001|First Drug Administration|Death|0|||
44277799|NCT02092662|79238797|FG001|Overall Study|Lost to Follow-up|0|||
44462281|NCT00505752|79471252|FG002|Overall Study|Lost to Follow-up|0|||
44462282|NCT00505752|79471253|FG003|Overall Study|Lost to Follow-up|0|||
44462283|NCT00505752|79471250|FG000|Overall Study|Lack of ovarian response|1|||
44462284|NCT00505752|79471251|FG001|Overall Study|Lack of ovarian response|3|||
44462285|NCT00505752|79471252|FG002|Overall Study|Lack of ovarian response|0|||
44462286|NCT00505752|79471253|FG003|Overall Study|Lack of ovarian response|0|||
44462287|NCT00505752|79471250|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
44544241|NCT03602053|79557531|FG002|Overall Study|Protocol Violation|4|||
44462288|NCT00505752|79471251|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
44462289|NCT00505752|79471252|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
44462290|NCT00505752|79471253|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
44462291|NCT00505752|79471250|FG000|Overall Study|No oocytes retrieved|0|||
44462292|NCT00505752|79471251|FG001|Overall Study|No oocytes retrieved|2|||
44462293|NCT00505752|79471252|FG002|Overall Study|No oocytes retrieved|0|||
44462294|NCT00505752|79471253|FG003|Overall Study|No oocytes retrieved|1|||
44462295|NCT00505752|79471250|FG000|Overall Study|No Fertilization|1|||
44462296|NCT00505752|79471251|FG001|Overall Study|No Fertilization|1|||
44462297|NCT00505752|79471252|FG002|Overall Study|No Fertilization|2|||
44462298|NCT00505752|79471253|FG003|Overall Study|No Fertilization|1|||
44462299|NCT00505752|79471250|FG000|Overall Study|All embryos/blastocysts discarded|0|||
44462300|NCT00505752|79471251|FG001|Overall Study|All embryos/blastocysts discarded|0|||
44462301|NCT00505752|79471252|FG002|Overall Study|All embryos/blastocysts discarded|1|||
44462302|NCT00505752|79471253|FG003|Overall Study|All embryos/blastocysts discarded|1|||
44462303|NCT00505752|79471250|FG000|Overall Study|Other|1|||
44462304|NCT00505752|79471251|FG001|Overall Study|Other|2|||
44462305|NCT00505752|79471252|FG002|Overall Study|Other|1|||
44462306|NCT00505752|79471253|FG003|Overall Study|Other|2|||
44462307|NCT03601637|79471265|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
44462308|NCT03601637|79471266|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
44462309|NCT03601637|79471265|FG000|Overall Study|Adverse Event|1|||
44462310|NCT03601637|79471266|FG001|Overall Study|Adverse Event|1|||
44462311|NCT03601637|79471265|FG000|Overall Study|Other|0|||
44462312|NCT03601637|79471266|FG001|Overall Study|Other|1|||
44462313|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
44462314|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
44462315|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Death|0|||
44462316|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Death|2|||
44462317|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
44462318|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
44462319|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
44462320|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
44462321|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
44462322|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
44462323|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
44462324|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
44462325|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
44462326|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
44462327|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
44462328|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
44462329|NCT00343252|79471281|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
44462330|NCT00343252|79471282|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
44462331|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
44462332|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
44462333|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Death|3|||
44462334|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Death|3|||
44462335|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
44462336|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
44462337|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
44462338|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
44462339|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
44462340|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
44462341|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
44462342|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
44462343|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
44462344|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
44462345|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
44462346|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
44462347|NCT00343252|79471281|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
44462348|NCT00343252|79471282|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
44462349|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
44462350|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
44462351|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Death|4|||
44462352|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Death|5|||
44462353|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
44462354|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
44462355|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
44221582|NCT01392183|79024707|FG000|First Drug Administration|Withdrawal by Subject|10|||
44462356|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
44462357|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
44271236|NCT02240485|79200261|FG000|18 Months Post-admission|Lost to Follow-up|1|||
44271237|NCT02240485|79200262|FG001|18 Months Post-admission|Lost to Follow-up|1|||
44462358|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
44462359|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
44462360|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
44462361|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
44462362|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
44462363|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
44462364|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
44462365|NCT00343252|79471281|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
44462366|NCT00343252|79471282|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
44462367|NCT00342628|79471291|FG000|Overall Study|Withdrawal by Subject|19|||
44462368|NCT00342628|79471292|FG001|Overall Study|Withdrawal by Subject|19|||
44462369|NCT00342628|79471293|FG002|Overall Study|Withdrawal by Subject|18|||
44462370|NCT00342628|79471291|FG000|Overall Study|Death|1|||
44462371|NCT00342628|79471292|FG001|Overall Study|Death|1|||
44462372|NCT00342628|79471293|FG002|Overall Study|Death|0|||
44462373|NCT00342628|79471291|FG000|Overall Study|moved residence|0|||
44462374|NCT00342628|79471292|FG001|Overall Study|moved residence|1|||
44462375|NCT00342628|79471293|FG002|Overall Study|moved residence|1|||
44462376|NCT00505284|79471306|FG000|Overall Study|Adverse Event|3|||
44462377|NCT00505284|79471307|FG001|Overall Study|Adverse Event|7|||
44462378|NCT00505284|79471308|FG002|Overall Study|Adverse Event|9|||
44462379|NCT00505284|79471309|FG003|Overall Study|Adverse Event|14|||
44462380|NCT00505284|79471310|FG004|Overall Study|Adverse Event|22|||
44462381|NCT00505284|79471306|FG000|Overall Study|Protocol Violation|0|||
44462382|NCT00505284|79471307|FG001|Overall Study|Protocol Violation|1|||
44462383|NCT00505284|79471308|FG002|Overall Study|Protocol Violation|1|||
44462384|NCT00505284|79471309|FG003|Overall Study|Protocol Violation|0|||
44462385|NCT00505284|79471310|FG004|Overall Study|Protocol Violation|0|||
44462386|NCT00505284|79471306|FG000|Overall Study|Withdrawal by Subject|2|||
44462387|NCT00505284|79471307|FG001|Overall Study|Withdrawal by Subject|6|||
44462388|NCT00505284|79471308|FG002|Overall Study|Withdrawal by Subject|1|||
44462389|NCT00505284|79471309|FG003|Overall Study|Withdrawal by Subject|0|||
44462390|NCT00505284|79471310|FG004|Overall Study|Withdrawal by Subject|6|||
44462391|NCT00505284|79471306|FG000|Overall Study|Lack of Efficacy|0|||
44462392|NCT00505284|79471307|FG001|Overall Study|Lack of Efficacy|1|||
44462393|NCT00505284|79471308|FG002|Overall Study|Lack of Efficacy|1|||
44462394|NCT00505284|79471309|FG003|Overall Study|Lack of Efficacy|1|||
44462395|NCT00505284|79471310|FG004|Overall Study|Lack of Efficacy|1|||
44462396|NCT00505284|79471306|FG000|Overall Study|Physician Decision|0|||
44462397|NCT00505284|79471307|FG001|Overall Study|Physician Decision|1|||
44462398|NCT00505284|79471308|FG002|Overall Study|Physician Decision|0|||
44462399|NCT00505284|79471309|FG003|Overall Study|Physician Decision|0|||
44462400|NCT00505284|79471310|FG004|Overall Study|Physician Decision|0|||
44462401|NCT00505284|79471306|FG000|Overall Study|Other|5|||
44462402|NCT00505284|79471307|FG001|Overall Study|Other|0|||
44462403|NCT00505284|79471308|FG002|Overall Study|Other|0|||
44462404|NCT00505284|79471309|FG003|Overall Study|Other|4|||
44462405|NCT00505284|79471310|FG004|Overall Study|Other|4|||
44462406|NCT00337168|79471322|FG000|Overall Study|Death|5|||
44462407|NCT00337168|79471322|FG000|Overall Study|Not protocol specified|2|||
44462408|NCT00337168|79471322|FG000|Overall Study|Did not start therapy|1|||
44462409|NCT00606905|79471329|FG000|Overall Study|No Pregnancy|9|||
44462410|NCT00606905|79471330|FG001|Overall Study|No Pregnancy|6|||
44462411|NCT00606905|79471329|FG000|Overall Study|Non-Index Pregnancy|1|||
44271238|NCT02240485|79200261|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
44271239|NCT02240485|79200262|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
44271240|NCT04149535|79200285|FG000|Overall Study|Death|11|||
44271241|NCT04149535|79200286|FG001|Overall Study|Death|7|||
44462412|NCT00606905|79471330|FG001|Overall Study|Non-Index Pregnancy|4|||
44462413|NCT00606905|79471329|FG000|Overall Study|Withdrew|5|||
44462414|NCT00606905|79471330|FG001|Overall Study|Withdrew|5|||
44462415|NCT00606593|79471336|FG000|Overall Study|Adverse Event|0|||
44462416|NCT00606593|79471337|FG001|Overall Study|Adverse Event|0|||
44462417|NCT00606593|79471338|FG002|Overall Study|Adverse Event|0|||
44462418|NCT00606593|79471339|FG003|Overall Study|Adverse Event|1|||
44462419|NCT00606593|79471340|FG004|Overall Study|Adverse Event|1|||
44462420|NCT00606593|79471341|FG005|Overall Study|Adverse Event|0|||
44462421|NCT00606593|79471342|FG006|Overall Study|Adverse Event|1|||
44271242|NCT04149535|79200285|FG000|Overall Study|Physician Decision|10|||
44271243|NCT04149535|79200286|FG001|Overall Study|Physician Decision|4|||
44462422|NCT00606593|79471343|FG007|Overall Study|Adverse Event|2|||
44462423|NCT00606593|79471344|FG008|Overall Study|Adverse Event|1|||
44462424|NCT00606593|79471345|FG009|Overall Study|Adverse Event|0|||
44462425|NCT00606593|79471336|FG000|Overall Study|Withdrawal of consent|1|||
44462426|NCT00606593|79471337|FG001|Overall Study|Withdrawal of consent|0|||
44462427|NCT00606593|79471338|FG002|Overall Study|Withdrawal of consent|1|||
44462428|NCT00606593|79471339|FG003|Overall Study|Withdrawal of consent|0|||
44462429|NCT00606593|79471340|FG004|Overall Study|Withdrawal of consent|0|||
44462430|NCT00606593|79471341|FG005|Overall Study|Withdrawal of consent|0|||
44462431|NCT00606593|79471342|FG006|Overall Study|Withdrawal of consent|0|||
44462432|NCT00606593|79471343|FG007|Overall Study|Withdrawal of consent|0|||
44462433|NCT00606593|79471344|FG008|Overall Study|Withdrawal of consent|0|||
44271244|NCT04149535|79200285|FG000|Overall Study|Withdrawal by Subject|6|||
44271245|NCT04149535|79200286|FG001|Overall Study|Withdrawal by Subject|7|||
44271246|NCT04149535|79200285|FG000|Overall Study|Not described|2|||
44271247|NCT04149535|79200286|FG001|Overall Study|Not described|0|||
44271248|NCT02210559|79200304|FG000|Overall Study|Progressive Disease|3|||
44271249|NCT02210559|79200305|FG001|Overall Study|Progressive Disease|2|||
44462434|NCT00606593|79471345|FG009|Overall Study|Withdrawal of consent|0|||
44462435|NCT00606593|79471336|FG000|Overall Study|Administrative/Other|0|||
44271250|NCT02210559|79200304|FG000|Overall Study|Adverse Event|2|||
44271251|NCT02210559|79200305|FG001|Overall Study|Adverse Event|2|||
44462436|NCT00606593|79471337|FG001|Overall Study|Administrative/Other|0|||
44462437|NCT00606593|79471338|FG002|Overall Study|Administrative/Other|1|||
44462438|NCT00606593|79471339|FG003|Overall Study|Administrative/Other|0|||
44462439|NCT00606593|79471340|FG004|Overall Study|Administrative/Other|0|||
44462440|NCT00606593|79471341|FG005|Overall Study|Administrative/Other|0|||
44462441|NCT00606593|79471342|FG006|Overall Study|Administrative/Other|0|||
44462442|NCT00606593|79471343|FG007|Overall Study|Administrative/Other|0|||
44462443|NCT00606593|79471344|FG008|Overall Study|Administrative/Other|0|||
44462444|NCT00606593|79471345|FG009|Overall Study|Administrative/Other|0|||
44462445|NCT00605267|79471360|FG000|Overall Study|Adverse Event|0|||
44462446|NCT00605267|79471361|FG001|Overall Study|Adverse Event|1|||
44462447|NCT00605267|79471360|FG000|Overall Study|Lack of Efficacy|1|||
44462448|NCT00605267|79471361|FG001|Overall Study|Lack of Efficacy|5|||
44462449|NCT00605267|79471360|FG000|Overall Study|Withdrawal by Subject|2|||
44462450|NCT00605267|79471361|FG001|Overall Study|Withdrawal by Subject|3|||
44462451|NCT00605813|79471367|FG000|Overall Study|Protocol Violation|25|||
44462452|NCT00604721|79471380|FG000|Overall Study|Physician Decision|1|||
44462453|NCT00604721|79471380|FG000|Overall Study|Withdrawal by Subject|1|||
44462454|NCT00605657|79471385|FG000|Overall Study|Adverse Event|1|||
44462455|NCT00605657|79471385|FG000|Overall Study|Protocol Violation|1|||
44462456|NCT00604565|79471391|FG000|Overall Study|Study terminated|0|||
44462457|NCT00604565|79471392|FG001|Overall Study|Study terminated|3|||
44462458|NCT00605345|79471400|FG000|Overall Study|Withdrawal by Subject|1|||
44462459|NCT00605345|79471401|FG001|Overall Study|Withdrawal by Subject|0|||
44462460|NCT00605345|79471400|FG000|Overall Study|Adverse Event|0|||
44462461|NCT00605345|79471401|FG001|Overall Study|Adverse Event|1|||
44462462|NCT00605345|79471400|FG000|Overall Study|Protocol Violation|0|||
44462463|NCT00605345|79471401|FG001|Overall Study|Protocol Violation|2|||
44462464|NCT00604175|79471410|FG000|Entry Through Week 28|Death|2|||
44462465|NCT00604175|79471411|FG001|Entry Through Week 28|Death|0|||
44462466|NCT00604175|79471412|FG002|Entry Through Week 28|Death|0|||
44462467|NCT00604175|79471410|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
44462468|NCT00604175|79471411|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
44462469|NCT00604175|79471412|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
44462470|NCT00604175|79471410|FG000|Entry Through Week 28|Lost to Follow-up|4|||
44221583|NCT01392183|79024708|FG001|First Drug Administration|Withdrawal by Subject|17|||
44221584|NCT01402947|79024718|FG000|First Intervention|Adverse Event|0|||
44221585|NCT01402947|79024719|FG001|First Intervention|Adverse Event|1|||
44221586|NCT01402869|79024728|FG000|Overall Study|Required Tooth Extraction|0|||
44221587|NCT01402869|79024729|FG001|Overall Study|Required Tooth Extraction|0|||
44221588|NCT01402869|79024730|FG002|Overall Study|Required Tooth Extraction|1|||
44221589|NCT01391793|79024740|FG000|Overall Study|Ineligible|3|||
44221590|NCT01391793|79024741|FG001|Overall Study|Ineligible|0|||
44221591|NCT01391793|79024740|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
44221592|NCT01391793|79024741|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
44221593|NCT01391793|79024740|FG000|Overall Study|No DMSA|73|||
44221594|NCT01391793|79024741|FG001|Overall Study|No DMSA|57|||
44221595|NCT01422915|79024747|FG000|Overall Study|Adverse Event|1|||
44271252|NCT02210559|79200304|FG000|Overall Study|Physician Decision|1|||
44462471|NCT00604175|79471411|FG001|Entry Through Week 28|Lost to Follow-up|3|||
44462472|NCT00604175|79471412|FG002|Entry Through Week 28|Lost to Follow-up|0|||
44462473|NCT00604175|79471410|FG000|Entry Through Week 28|Ineligible|1|||
44462474|NCT00604175|79471411|FG001|Entry Through Week 28|Ineligible|0|||
44462475|NCT00604175|79471412|FG002|Entry Through Week 28|Ineligible|0|||
44271253|NCT02210559|79200305|FG001|Overall Study|Physician Decision|0|||
44271254|NCT02210559|79200304|FG000|Overall Study|Withdrawal by Subject|0|||
44271255|NCT02210559|79200305|FG001|Overall Study|Withdrawal by Subject|1|||
44277800|NCT02092350|79238806|FG000|Overall Study|Adverse Event|0|||
44462476|NCT00604175|79471410|FG000|Entry Through Week 28|Did not start intervention|2|||
44544242|NCT03602053|79557529|FG000|Overall Study|Physician Decision|1|||
44462477|NCT00604175|79471411|FG001|Entry Through Week 28|Did not start intervention|0|||
44462478|NCT00604175|79471412|FG002|Entry Through Week 28|Did not start intervention|1|||
44462479|NCT00604175|79471410|FG000|Week 29 Through Week 72|Death|0|||
44462480|NCT00604175|79471411|FG001|Week 29 Through Week 72|Death|0|||
44462481|NCT00604175|79471412|FG002|Week 29 Through Week 72|Death|1|||
44462482|NCT00604175|79471410|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
44462483|NCT00604175|79471411|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
44462484|NCT00604175|79471412|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
44462485|NCT00604175|79471410|FG000|Week 29 Through Week 72|Site closure|0|||
44462486|NCT00604175|79471411|FG001|Week 29 Through Week 72|Site closure|1|||
44462487|NCT00604175|79471412|FG002|Week 29 Through Week 72|Site closure|0|||
44462488|NCT00604175|79471410|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
44462489|NCT00604175|79471411|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
44544243|NCT03602053|79557530|FG001|Overall Study|Physician Decision|0|||
44221596|NCT01727024|79024752|FG000|Period 1|Lost to Follow-up|1|||
44221597|NCT01727024|79024753|FG001|Period 1|Lost to Follow-up|1|||
44221598|NCT01727024|79024752|FG000|Period 1|Withdrawal by Subject|2|||
44221599|NCT01727024|79024753|FG001|Period 1|Withdrawal by Subject|3|||
44374271|NCT01139762|79379424|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
44374272|NCT01139762|79379425|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
44374273|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
44374274|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
44374275|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
44374276|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Death|0|||
44221600|NCT01422213|79024762|FG000|Overall Study|Adverse Event|8|||
44221601|NCT01422213|79024763|FG001|Overall Study|Adverse Event|7|||
44221602|NCT01422213|79024764|FG002|Overall Study|Adverse Event|11|||
44374277|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Death|1|||
44374278|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Death|1|||
44374279|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
44374280|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
44374281|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
44374282|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
44374283|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
44374284|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
44374285|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
44374286|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
44462490|NCT00604175|79471412|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
44271256|NCT02210559|79200304|FG000|Overall Study|Other than specified|0|||
44271257|NCT02210559|79200305|FG001|Overall Study|Other than specified|1|||
44462491|NCT00605189|79471447|FG000|Overall Study|Adverse Event|1|||
44544244|NCT03602053|79557531|FG002|Overall Study|Physician Decision|0|||
44221603|NCT01422213|79024762|FG000|Overall Study|Lack of Efficacy|10|||
44221604|NCT01422213|79024763|FG001|Overall Study|Lack of Efficacy|2|||
44221605|NCT01422213|79024764|FG002|Overall Study|Lack of Efficacy|2|||
44271258|NCT02073279|79200462|FG000|Double-blind Period|Adverse Event|1|||
44462492|NCT00605189|79471448|FG001|Overall Study|Adverse Event|0|||
44462493|NCT00605189|79471449|FG002|Overall Study|Adverse Event|0|||
44462494|NCT00605189|79471447|FG000|Overall Study|Other|2|||
44462495|NCT00605189|79471448|FG001|Overall Study|Other|2|||
44462496|NCT00605189|79471449|FG002|Overall Study|Other|0|||
44462497|NCT00340834|79471462|FG000|Core Phase of Study|Adverse Event|26|||
44462498|NCT00340834|79471463|FG001|Core Phase of Study|Adverse Event|9|||
44462499|NCT00340834|79471464|FG002|Core Phase of Study|Adverse Event|9|||
44462500|NCT00340834|79471465|FG003|Core Phase of Study|Adverse Event|0|||
44462501|NCT00340834|79471466|FG004|Core Phase of Study|Adverse Event|0|||
44462502|NCT00340834|79471462|FG000|Core Phase of Study|Withdrawal by Subject|11|||
44271259|NCT02073279|79200463|FG001|Double-blind Period|Adverse Event|1|||
44271260|NCT02073279|79200462|FG000|Double-blind Period|Switched to another treatment|1|||
44271261|NCT02073279|79200463|FG001|Double-blind Period|Switched to another treatment|2|||
44271262|NCT02073279|79200462|FG000|Double-blind Period|Protocol Violation|0|||
44271263|NCT02073279|79200463|FG001|Double-blind Period|Protocol Violation|1|||
44462503|NCT00340834|79471463|FG001|Core Phase of Study|Withdrawal by Subject|9|||
44462504|NCT00340834|79471464|FG002|Core Phase of Study|Withdrawal by Subject|16|||
44462505|NCT00340834|79471465|FG003|Core Phase of Study|Withdrawal by Subject|0|||
44462506|NCT00340834|79471466|FG004|Core Phase of Study|Withdrawal by Subject|0|||
44462507|NCT00340834|79471462|FG000|Core Phase of Study|Administrative Problems|6|||
44271264|NCT02073279|79200462|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
44462508|NCT00340834|79471463|FG001|Core Phase of Study|Administrative Problems|2|||
44462509|NCT00340834|79471464|FG002|Core Phase of Study|Administrative Problems|7|||
44462510|NCT00340834|79471465|FG003|Core Phase of Study|Administrative Problems|0|||
44462511|NCT00340834|79471466|FG004|Core Phase of Study|Administrative Problems|0|||
44462512|NCT00340834|79471462|FG000|Core Phase of Study|Lack of Efficacy|3|||
44462513|NCT00340834|79471463|FG001|Core Phase of Study|Lack of Efficacy|3|||
44462514|NCT00340834|79471464|FG002|Core Phase of Study|Lack of Efficacy|7|||
44462515|NCT00340834|79471465|FG003|Core Phase of Study|Lack of Efficacy|0|||
44462516|NCT00340834|79471466|FG004|Core Phase of Study|Lack of Efficacy|0|||
44462517|NCT00340834|79471462|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
44462518|NCT00340834|79471463|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
44462519|NCT00340834|79471464|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
44462520|NCT00340834|79471465|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
44462521|NCT00340834|79471466|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
44462522|NCT00340834|79471462|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
44271265|NCT02073279|79200463|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
44271266|NCT02073279|79200462|FG000|Double-blind Period|Withdrawal by Subject|2|||
44271267|NCT02073279|79200463|FG001|Double-blind Period|Withdrawal by Subject|2|||
44271268|NCT02073279|79200462|FG000|Open-label Extension Period|Adverse Event|1|||
44374287|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
44374288|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
44374289|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
44374290|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
44374291|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
44374292|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
44374293|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
44374294|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
44374295|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
44374296|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
44374297|NCT01139762|79379423|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
44374298|NCT01139762|79379424|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
44374299|NCT01139762|79379425|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
44374300|NCT00805285|79379432|FG000|Overall Study|Lack of Efficacy|1|||
44374301|NCT01139450|79379439|FG000|Overall Study|Withdrawal by Subject|7|||
44374302|NCT01139450|79379440|FG001|Overall Study|Withdrawal by Subject|10|||
44374303|NCT01139450|79379441|FG002|Overall Study|Withdrawal by Subject|13|||
44374304|NCT01139450|79379439|FG000|Overall Study|Lack of Efficacy|3|||
44374305|NCT01139450|79379440|FG001|Overall Study|Lack of Efficacy|1|||
44374306|NCT01139450|79379441|FG002|Overall Study|Lack of Efficacy|8|||
44374307|NCT01139450|79379439|FG000|Overall Study|Protocol Violation|6|||
44374308|NCT01139450|79379440|FG001|Overall Study|Protocol Violation|5|||
44374309|NCT01139450|79379441|FG002|Overall Study|Protocol Violation|2|||
44374310|NCT01139450|79379439|FG000|Overall Study|Lost to Follow-up|9|||
44462523|NCT00340834|79471463|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
44462524|NCT00340834|79471464|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
44374311|NCT01139450|79379440|FG001|Overall Study|Lost to Follow-up|7|||
44462525|NCT00340834|79471465|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
44544245|NCT03602053|79557529|FG000|Overall Study|migration|2|||
44544246|NCT03602053|79557530|FG001|Overall Study|migration|3|||
44271269|NCT02073279|79200463|FG001|Open-label Extension Period|Adverse Event|0|||
44462526|NCT00340834|79471466|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
44462527|NCT00340834|79471462|FG000|Core Phase of Study|Lost to Follow-up|1|||
44462528|NCT00340834|79471463|FG001|Core Phase of Study|Lost to Follow-up|1|||
44462529|NCT00340834|79471464|FG002|Core Phase of Study|Lost to Follow-up|4|||
44462530|NCT00340834|79471465|FG003|Core Phase of Study|Lost to Follow-up|0|||
44462531|NCT00340834|79471466|FG004|Core Phase of Study|Lost to Follow-up|0|||
44462532|NCT00340834|79471462|FG000|Core Phase of Study|Death|2|||
44462533|NCT00340834|79471463|FG001|Core Phase of Study|Death|0|||
44462534|NCT00340834|79471464|FG002|Core Phase of Study|Death|0|||
44462535|NCT00340834|79471465|FG003|Core Phase of Study|Death|0|||
44462536|NCT00340834|79471466|FG004|Core Phase of Study|Death|0|||
44462537|NCT00340834|79471462|FG000|Core Phase of Study|Protocol Violation|0|||
44462538|NCT00340834|79471463|FG001|Core Phase of Study|Protocol Violation|0|||
44462539|NCT00340834|79471464|FG002|Core Phase of Study|Protocol Violation|2|||
44462540|NCT00340834|79471465|FG003|Core Phase of Study|Protocol Violation|0|||
44462541|NCT00340834|79471466|FG004|Core Phase of Study|Protocol Violation|0|||
44462542|NCT00340834|79471462|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
44462543|NCT00340834|79471463|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
44462544|NCT00340834|79471464|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
44462545|NCT00340834|79471465|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
44462546|NCT00340834|79471466|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
44462547|NCT00340834|79471462|FG000|Extension Phase of Study|Subject withdrew consent|26|||
44462548|NCT00340834|79471463|FG001|Extension Phase of Study|Subject withdrew consent|31|||
44462549|NCT00340834|79471464|FG002|Extension Phase of Study|Subject withdrew consent|0|||
44462550|NCT00340834|79471465|FG003|Extension Phase of Study|Subject withdrew consent|12|||
44462551|NCT00340834|79471466|FG004|Extension Phase of Study|Subject withdrew consent|15|||
44462552|NCT00340834|79471462|FG000|Extension Phase of Study|Adverse Event|21|||
44462553|NCT00340834|79471463|FG001|Extension Phase of Study|Adverse Event|22|||
44462554|NCT00340834|79471464|FG002|Extension Phase of Study|Adverse Event|0|||
44462555|NCT00340834|79471465|FG003|Extension Phase of Study|Adverse Event|19|||
44462556|NCT00340834|79471466|FG004|Extension Phase of Study|Adverse Event|7|||
44462557|NCT00340834|79471462|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
44462558|NCT00340834|79471463|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
44462559|NCT00340834|79471464|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
44462560|NCT00340834|79471465|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
44462561|NCT00340834|79471466|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
44462562|NCT00340834|79471462|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
44462563|NCT00340834|79471463|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
44462564|NCT00340834|79471464|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
44462565|NCT00340834|79471465|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
44462566|NCT00340834|79471466|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
44462567|NCT00340834|79471462|FG000|Extension Phase of Study|Lost to Follow-up|1|||
44462568|NCT00340834|79471463|FG001|Extension Phase of Study|Lost to Follow-up|1|||
44462569|NCT00340834|79471464|FG002|Extension Phase of Study|Lost to Follow-up|0|||
44462570|NCT00340834|79471465|FG003|Extension Phase of Study|Lost to Follow-up|2|||
44462571|NCT00340834|79471466|FG004|Extension Phase of Study|Lost to Follow-up|3|||
44462572|NCT00340834|79471462|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
44462573|NCT00340834|79471463|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
44462574|NCT00340834|79471464|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
44462575|NCT00340834|79471465|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
44462576|NCT00340834|79471466|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
44544247|NCT03602053|79557531|FG002|Overall Study|migration|0|||
44221606|NCT01422213|79024762|FG000|Overall Study|Non-compliance with study drug|0|||
44374312|NCT01139450|79379441|FG002|Overall Study|Lost to Follow-up|11|||
44374313|NCT01139450|79379439|FG000|Overall Study|Administrative|0|||
44374314|NCT01139450|79379440|FG001|Overall Study|Administrative|0|||
44374315|NCT01139450|79379441|FG002|Overall Study|Administrative|1|||
44374316|NCT01139450|79379439|FG000|Overall Study|Adverse Event|2|||
44374317|NCT01139450|79379440|FG001|Overall Study|Adverse Event|2|||
44374318|NCT01139450|79379441|FG002|Overall Study|Adverse Event|3|||
44374319|NCT00805207|79379458|FG000|Overall Study|Protocol Violation|0|||
44374320|NCT00805207|79379459|FG001|Overall Study|Protocol Violation|0|||
44221607|NCT01422213|79024763|FG001|Overall Study|Non-compliance with study drug|1|||
44221608|NCT01422213|79024764|FG002|Overall Study|Non-compliance with study drug|0|||
44221609|NCT01422213|79024762|FG000|Overall Study|Protocol Violation|0|||
44221610|NCT01422213|79024763|FG001|Overall Study|Protocol Violation|2|||
44221611|NCT01422213|79024764|FG002|Overall Study|Protocol Violation|4|||
44374321|NCT00805207|79379460|FG002|Overall Study|Protocol Violation|1|||
44374322|NCT00805207|79379461|FG003|Overall Study|Protocol Violation|0|||
44221612|NCT01422213|79024762|FG000|Overall Study|Withdrawal of Consent|7|||
44271270|NCT02073279|79200462|FG000|Open-label Extension Period|Lack of Efficacy|1|||
44462577|NCT00340834|79471462|FG000|Extension Phase of Study|Administrative problems|3|||
44462578|NCT00340834|79471463|FG001|Extension Phase of Study|Administrative problems|0|||
44462579|NCT00340834|79471464|FG002|Extension Phase of Study|Administrative problems|0|||
44462580|NCT00340834|79471465|FG003|Extension Phase of Study|Administrative problems|1|||
44462581|NCT00340834|79471466|FG004|Extension Phase of Study|Administrative problems|1|||
44462582|NCT00340834|79471462|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
44462583|NCT00340834|79471463|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
44462584|NCT00340834|79471464|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
44462585|NCT00340834|79471465|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
44462586|NCT00340834|79471466|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
44462587|NCT00340834|79471462|FG000|Extension Phase of Study|Protocol Violation|3|||
44462588|NCT00340834|79471463|FG001|Extension Phase of Study|Protocol Violation|0|||
44462589|NCT00340834|79471464|FG002|Extension Phase of Study|Protocol Violation|0|||
44462590|NCT00340834|79471465|FG003|Extension Phase of Study|Protocol Violation|0|||
44462591|NCT00340834|79471466|FG004|Extension Phase of Study|Protocol Violation|0|||
44462592|NCT00340834|79471462|FG000|Extension Phase of Study|Death|0|||
44462593|NCT00340834|79471463|FG001|Extension Phase of Study|Death|0|||
44462594|NCT00340834|79471464|FG002|Extension Phase of Study|Death|0|||
44462595|NCT00340834|79471465|FG003|Extension Phase of Study|Death|0|||
44462596|NCT00340834|79471466|FG004|Extension Phase of Study|Death|1|||
44462597|NCT00603941|79471479|FG000|Overall Study|Disease progression|6|||
44462598|NCT00603941|79471480|FG001|Overall Study|Disease progression|7|||
44462599|NCT00603941|79471481|FG002|Overall Study|Disease progression|1|||
44462600|NCT00603941|79471479|FG000|Overall Study|Adverse Event|1|||
44462601|NCT00603941|79471480|FG001|Overall Study|Adverse Event|0|||
44462602|NCT00603941|79471481|FG002|Overall Study|Adverse Event|1|||
44462603|NCT00603941|79471479|FG000|Overall Study|Physician Decision|0|||
44462604|NCT00603941|79471480|FG001|Overall Study|Physician Decision|1|||
44462605|NCT00603941|79471481|FG002|Overall Study|Physician Decision|0|||
44462606|NCT00603941|79471479|FG000|Overall Study|Withdrawal by Subject|0|||
44462607|NCT00603941|79471480|FG001|Overall Study|Withdrawal by Subject|2|||
44462608|NCT00603941|79471481|FG002|Overall Study|Withdrawal by Subject|0|||
44462609|NCT00340678|79471494|FG000|Overall Study|Lost to Follow-up|1|||
44462610|NCT00340678|79471495|FG001|Overall Study|Lost to Follow-up|0|||
44462611|NCT00340678|79471496|FG002|Overall Study|Lost to Follow-up|0|||
44462612|NCT00340678|79471497|FG003|Overall Study|Lost to Follow-up|0|||
44462613|NCT00336544|79471507|FG000|Overall Study|Lack of Efficacy|8|||
44462614|NCT00336544|79471508|FG001|Overall Study|Lack of Efficacy|5|||
44462615|NCT00336544|79471507|FG000|Overall Study|Adverse Event|4|||
44462616|NCT00336544|79471508|FG001|Overall Study|Adverse Event|9|||
44462617|NCT00336544|79471507|FG000|Overall Study|Withdrawal by Subject|4|||
44462618|NCT00336544|79471508|FG001|Overall Study|Withdrawal by Subject|3|||
44462619|NCT00336544|79471507|FG000|Overall Study|Other|3|||
44462620|NCT00336544|79471508|FG001|Overall Study|Other|5|||
44462621|NCT00605033|79471516|FG000|Overall Study|Adverse Event|2|||
44462622|NCT00605033|79471517|FG001|Overall Study|Adverse Event|2|||
44462623|NCT00605033|79471516|FG000|Overall Study|Lost to Follow-up|1|||
44462624|NCT00605033|79471517|FG001|Overall Study|Lost to Follow-up|1|||
44462625|NCT00605033|79471516|FG000|Overall Study|Withdrawal by Subject|3|||
44462626|NCT00605033|79471517|FG001|Overall Study|Withdrawal by Subject|4|||
44462627|NCT00605033|79471516|FG000|Overall Study|Protocol Violation|1|||
44462628|NCT00605033|79471517|FG001|Overall Study|Protocol Violation|1|||
44462629|NCT00339040|79471525|FG000|Stage I|Not able to attend clinic|1|||
44462630|NCT00339040|79471526|FG001|Stage I|Not able to attend clinic|0|||
44271271|NCT02073279|79200463|FG001|Open-label Extension Period|Lack of Efficacy|0|||
44374323|NCT00805207|79379462|FG004|Overall Study|Protocol Violation|0|||
44374324|NCT00805207|79379463|FG005|Overall Study|Protocol Violation|0|||
44374325|NCT00805207|79379464|FG006|Overall Study|Protocol Violation|0|||
44374326|NCT00805207|79379465|FG007|Overall Study|Protocol Violation|0|||
44374327|NCT00805207|79379466|FG008|Overall Study|Protocol Violation|0|||
44374328|NCT00805207|79379458|FG000|Overall Study|Physician Decision|0|||
44462631|NCT00339040|79471525|FG000|Stage I|Protocol Violation|1|||
44462632|NCT00339040|79471526|FG001|Stage I|Protocol Violation|1|||
44462633|NCT00339040|79471525|FG000|Stage II|Lost to Follow-up|3|||
44462634|NCT00339040|79471526|FG001|Stage II|Lost to Follow-up|0|||
44271272|NCT02073279|79200462|FG000|Open-label Extension Period|Lost to Follow-up|0|||
44374329|NCT00805207|79379459|FG001|Overall Study|Physician Decision|1|||
44374330|NCT00805207|79379460|FG002|Overall Study|Physician Decision|0|||
44374331|NCT00805207|79379461|FG003|Overall Study|Physician Decision|0|||
44462635|NCT00339040|79471525|FG000|Stage II|Withdrawal by Subject|1|||
44271273|NCT02073279|79200463|FG001|Open-label Extension Period|Lost to Follow-up|4|||
44462636|NCT00339040|79471526|FG001|Stage II|Withdrawal by Subject|2|||
44462637|NCT00339040|79471525|FG000|Stage II|Protocol Violation|3|||
44462638|NCT00339040|79471526|FG001|Stage II|Protocol Violation|0|||
44462639|NCT00339040|79471525|FG000|Stage II|Not able to attend clinic|1|||
44462640|NCT00339040|79471526|FG001|Stage II|Not able to attend clinic|0|||
44462641|NCT00339040|79471525|FG000|Stage II|Site closing|2|||
44462642|NCT00339040|79471526|FG001|Stage II|Site closing|0|||
44462643|NCT00338962|79471536|FG000|Overall Study|Lost to Follow-up|3|||
44462644|NCT00338962|79471537|FG001|Overall Study|Lost to Follow-up|3|||
44462645|NCT00338962|79471538|FG002|Overall Study|Lost to Follow-up|2|||
44462646|NCT00338962|79471539|FG003|Overall Study|Lost to Follow-up|3|||
44462647|NCT00338962|79471536|FG000|Overall Study|Withdrawal by Subject|1|||
44462648|NCT00338962|79471537|FG001|Overall Study|Withdrawal by Subject|0|||
44462649|NCT00338962|79471538|FG002|Overall Study|Withdrawal by Subject|0|||
44462650|NCT00338962|79471539|FG003|Overall Study|Withdrawal by Subject|0|||
44462651|NCT00338962|79471536|FG000|Overall Study|No Transportation|2|||
44462652|NCT00338962|79471537|FG001|Overall Study|No Transportation|0|||
44462653|NCT00338962|79471538|FG002|Overall Study|No Transportation|0|||
44462654|NCT00338962|79471539|FG003|Overall Study|No Transportation|0|||
44462655|NCT00338962|79471536|FG000|Overall Study|Time Constraint|2|||
44462656|NCT00338962|79471537|FG001|Overall Study|Time Constraint|0|||
44462657|NCT00338962|79471538|FG002|Overall Study|Time Constraint|0|||
44462658|NCT00338962|79471539|FG003|Overall Study|Time Constraint|0|||
44462659|NCT00338962|79471536|FG000|Overall Study|Moved|0|||
44462660|NCT00338962|79471537|FG001|Overall Study|Moved|1|||
44462661|NCT00338962|79471538|FG002|Overall Study|Moved|0|||
44462662|NCT00338962|79471539|FG003|Overall Study|Moved|0|||
44462663|NCT00338962|79471536|FG000|Overall Study|Adverse Event|0|||
44462664|NCT00338962|79471537|FG001|Overall Study|Adverse Event|0|||
44462665|NCT00338962|79471538|FG002|Overall Study|Adverse Event|2|||
44462666|NCT00338962|79471539|FG003|Overall Study|Adverse Event|0|||
44462667|NCT00338962|79471536|FG000|Overall Study|Poor Compliance|0|||
44462668|NCT00338962|79471537|FG001|Overall Study|Poor Compliance|0|||
44462669|NCT00338962|79471538|FG002|Overall Study|Poor Compliance|2|||
44462670|NCT00338962|79471539|FG003|Overall Study|Poor Compliance|0|||
44462671|NCT00568061|79471551|FG000|Overall Study|Inclusion / exclusion criteria|5|||
44462672|NCT00568061|79471552|FG001|Overall Study|Inclusion / exclusion criteria|1|||
44462673|NCT00568061|79471551|FG000|Overall Study|Adverse Event|0|||
44462674|NCT00568061|79471552|FG001|Overall Study|Adverse Event|1|||
44462675|NCT00338884|79471559|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
44462676|NCT00338884|79471559|FG000|Overall Study|Adverse Event|14|||
44462677|NCT00338884|79471559|FG000|Overall Study|Death|8|||
44462678|NCT00338884|79471559|FG000|Overall Study|Other|4|||
44462679|NCT00338884|79471559|FG000|Overall Study|Global Deterioration of Health Status|3|||
44462680|NCT00338884|79471559|FG000|Overall Study|Withdrawal by Subject|3|||
44462681|NCT00338884|79471559|FG000|Overall Study|Lost to Follow-up|1|||
44462682|NCT00338884|79471559|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
44462683|NCT00338806|79471565|FG000|Acute Phase|Withdrawal by Subject|0|||
44271274|NCT02073279|79200462|FG000|Open-label Extension Period|Switched to another treatment|1|||
44271275|NCT02073279|79200463|FG001|Open-label Extension Period|Switched to another treatment|4|||
44462684|NCT00338806|79471566|FG001|Acute Phase|Withdrawal by Subject|1|||
44462685|NCT00338806|79471565|FG000|Follow-up|Lost to Follow-up|1|||
44462686|NCT00338806|79471566|FG001|Follow-up|Lost to Follow-up|3|||
44462687|NCT03038100|79471576|FG000|Overall Study|Death|289|||
44462688|NCT03038100|79471577|FG001|Overall Study|Death|272|||
44462689|NCT03038100|79471576|FG000|Overall Study|Lost to Follow-up|9|||
44462690|NCT03038100|79471577|FG001|Overall Study|Lost to Follow-up|10|||
44462691|NCT03038100|79471576|FG000|Overall Study|Protocol Deviation|1|||
44462692|NCT03038100|79471577|FG001|Overall Study|Protocol Deviation|4|||
44462693|NCT03038100|79471576|FG000|Overall Study|Withdrawal by Subject|45|||
44462694|NCT03038100|79471577|FG001|Overall Study|Withdrawal by Subject|51|||
44462695|NCT03038100|79471576|FG000|Overall Study|Study Terminated By Sponsor|305|||
44462696|NCT03038100|79471577|FG001|Overall Study|Study Terminated By Sponsor|311|||
44462697|NCT03038100|79471576|FG000|Overall Study|Physician Decision|1|||
44462698|NCT03038100|79471577|FG001|Overall Study|Physician Decision|3|||
44462699|NCT00338728|79471584|FG000|Overall Study|Screen Failure|14|||
44271276|NCT02073279|79200462|FG000|Open-label Extension Period|Protocol Violation|0|||
44271277|NCT02073279|79200463|FG001|Open-label Extension Period|Protocol Violation|1|||
44271278|NCT02073279|79200462|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
44271279|NCT02073279|79200463|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
44271280|NCT02073279|79200462|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
44271281|NCT02073279|79200463|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
44462700|NCT00336856|79471588|FG000|Overall Study|Withdrawal by Subject|3|||
44462701|NCT00336856|79471588|FG000|Overall Study|Found ineligible at time of analysis|1|||
44462702|NCT00566501|79471594|FG000|Overall Study|Adverse Event|68|||
44462703|NCT00566501|79471595|FG001|Overall Study|Adverse Event|59|||
44462704|NCT00566501|79471594|FG000|Overall Study|Medication Non-compliance|5|||
44462705|NCT00566501|79471595|FG001|Overall Study|Medication Non-compliance|0|||
44462706|NCT00566501|79471594|FG000|Overall Study|Protocol Violation|2|||
44462707|NCT00566501|79471595|FG001|Overall Study|Protocol Violation|2|||
44462708|NCT00566501|79471594|FG000|Overall Study|Request of Investigator or Sponsor|6|||
44462709|NCT00566501|79471595|FG001|Overall Study|Request of Investigator or Sponsor|7|||
44462710|NCT00566501|79471594|FG000|Overall Study|Withdrawal by Subject|33|||
44462711|NCT00566501|79471595|FG001|Overall Study|Withdrawal by Subject|30|||
44462712|NCT00566501|79471594|FG000|Overall Study|Lack of Efficacy|8|||
44462713|NCT00566501|79471595|FG001|Overall Study|Lack of Efficacy|3|||
44462714|NCT00566501|79471594|FG000|Overall Study|Other|25|||
44462715|NCT00566501|79471595|FG001|Overall Study|Other|21|||
44462716|NCT00504894|79471604|FG000|Overall Study|fMRI technical problems|1|||
44462717|NCT00504894|79471605|FG001|Overall Study|fMRI technical problems|1|||
44462718|NCT00504894|79471606|FG002|Overall Study|fMRI technical problems|0|||
44462719|NCT00504894|79471604|FG000|Overall Study|Withdrawal by Subject|0|||
44462720|NCT00504894|79471605|FG001|Overall Study|Withdrawal by Subject|1|||
44462721|NCT00504894|79471606|FG002|Overall Study|Withdrawal by Subject|0|||
44462722|NCT00504894|79471604|FG000|Overall Study|Infusion technical problems|0|||
44462723|NCT00504894|79471605|FG001|Overall Study|Infusion technical problems|1|||
44462724|NCT00504894|79471606|FG002|Overall Study|Infusion technical problems|0|||
44462725|NCT00504894|79471604|FG000|Overall Study|poor subject data|2|||
44462726|NCT00504894|79471605|FG001|Overall Study|poor subject data|0|||
44462727|NCT00504894|79471606|FG002|Overall Study|poor subject data|0|||
44462728|NCT00513240|79471616|FG000|Overall Study|Did not have intended surgery|3|||
44462729|NCT00513240|79471617|FG001|Overall Study|Did not have intended surgery|0|||
44462730|NCT00513240|79471616|FG000|Overall Study|Death|3|||
44462731|NCT00513240|79471617|FG001|Overall Study|Death|3|||
44462732|NCT00513240|79471616|FG000|Overall Study|Withdrawal by Subject|7|||
44462733|NCT00513240|79471617|FG001|Overall Study|Withdrawal by Subject|4|||
44462734|NCT00504426|79471630|FG000|Overall Study|Adverse Event|0|||
44462735|NCT00504426|79471631|FG001|Overall Study|Adverse Event|0|||
44462736|NCT00504426|79471632|FG002|Overall Study|Adverse Event|2|||
44462737|NCT00504426|79471633|FG003|Overall Study|Adverse Event|0|||
44462738|NCT00504426|79471630|FG000|Overall Study|Protocol Violation|1|||
44462739|NCT00504426|79471631|FG001|Overall Study|Protocol Violation|1|||
44462740|NCT00504426|79471632|FG002|Overall Study|Protocol Violation|2|||
44462741|NCT00504426|79471633|FG003|Overall Study|Protocol Violation|0|||
44462742|NCT00504426|79471630|FG000|Overall Study|Withdrawal by Subject|2|||
44462743|NCT00504426|79471631|FG001|Overall Study|Withdrawal by Subject|0|||
44462744|NCT00504426|79471632|FG002|Overall Study|Withdrawal by Subject|0|||
44462745|NCT00504426|79471633|FG003|Overall Study|Withdrawal by Subject|0|||
44462746|NCT00504348|79471646|FG000|Overall Study|Adverse Event|3|||
44462747|NCT00504348|79471646|FG000|Overall Study|Lack of Efficacy|4|||
44462748|NCT00504348|79471646|FG000|Overall Study|Physician Decision|1|||
44462749|NCT00507546|79471652|FG000|Overall Study|Withdrawal by Subject|1|||
44462750|NCT00507546|79471653|FG001|Overall Study|Withdrawal by Subject|0|||
44462751|NCT00507546|79471652|FG000|Overall Study|Protocol Violation|1|||
44462752|NCT00507546|79471653|FG001|Overall Study|Protocol Violation|0|||
44462753|NCT00507546|79471652|FG000|Overall Study|Physician Decision|0|||
44462754|NCT00507546|79471653|FG001|Overall Study|Physician Decision|1|||
44462755|NCT00567593|79471661|FG000|Overall Study|Adverse Event|1|||
44462756|NCT00567593|79471661|FG000|Overall Study|Physician Decision|1|||
44462757|NCT00335764|79471670|FG000|Overall Study|wrong histology|1|||
44221613|NCT01422213|79024763|FG001|Overall Study|Withdrawal of Consent|3|||
44221614|NCT01422213|79024764|FG002|Overall Study|Withdrawal of Consent|5|||
44221615|NCT01422213|79024762|FG000|Overall Study|Lost to Follow-up|3|||
44221616|NCT01422213|79024763|FG001|Overall Study|Lost to Follow-up|3|||
44221617|NCT01422213|79024764|FG002|Overall Study|Lost to Follow-up|5|||
44221618|NCT01422213|79024762|FG000|Overall Study|Administrative or Other Reason(s)|5|||
44221619|NCT01422213|79024763|FG001|Overall Study|Administrative or Other Reason(s)|4|||
44221620|NCT01422213|79024764|FG002|Overall Study|Administrative or Other Reason(s)|2|||
44221621|NCT01390857|79024772|FG000|Overall Study|Protocol Violation|2|||
44221622|NCT01390857|79024772|FG000|Overall Study|Lost to Follow-up|1|||
44221623|NCT01390857|79024772|FG000|Overall Study|No Visit after the First Visit|7|||
44271282|NCT01673867|79200719|FG000|Randomization|Adverse event unrelated to study drug|1|||
44462758|NCT00335764|79471671|FG001|Overall Study|wrong histology|0|||
44462759|NCT00335764|79471672|FG002|Overall Study|wrong histology|0|||
44462760|NCT00335764|79471673|FG003|Overall Study|wrong histology|0|||
44462761|NCT00335764|79471674|FG004|Overall Study|wrong histology|1|||
44462762|NCT00567359|79471710|FG000|Overall Study|Withdrawal by Subject|1|||
44462763|NCT00492726|79471716|FG000|Overall Study|Adverse Event|10|||
44462764|NCT00492726|79471717|FG001|Overall Study|Adverse Event|6|||
44462765|NCT00492726|79471716|FG000|Overall Study|Death|7|||
44462766|NCT00492726|79471717|FG001|Overall Study|Death|2|||
44462767|NCT00492726|79471716|FG000|Overall Study|Lack of Efficacy|0|||
44221624|NCT01725386|79024778|FG000|Overall Study|Death|84|||
44221625|NCT01725386|79024779|FG001|Overall Study|Death|40|||
44462768|NCT00492726|79471717|FG001|Overall Study|Lack of Efficacy|2|||
44462769|NCT00492726|79471716|FG000|Overall Study|Lost to Follow-up|27|||
44462770|NCT00492726|79471717|FG001|Overall Study|Lost to Follow-up|19|||
44462771|NCT00492726|79471716|FG000|Overall Study|Physician Decision|0|||
44462772|NCT00492726|79471717|FG001|Overall Study|Physician Decision|1|||
44462773|NCT00492726|79471716|FG000|Overall Study|Withdrawal by Subject|6|||
44462774|NCT00492726|79471717|FG001|Overall Study|Withdrawal by Subject|3|||
44462775|NCT00492726|79471716|FG000|Overall Study|Non compliant with study medication|0|||
44462776|NCT00492726|79471717|FG001|Overall Study|Non compliant with study medication|3|||
44462777|NCT00309946|79471723|FG000|Overall Study|Withdrawal by Subject|1|||
44462778|NCT00492648|79471729|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
44462779|NCT00492648|79471730|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
44462780|NCT00506922|79471741|FG000|Overall Study|Physician Decision|0|||
44462781|NCT00506922|79471742|FG001|Overall Study|Physician Decision|0|||
44462782|NCT00506922|79471743|FG002|Overall Study|Physician Decision|0|||
44462783|NCT00506922|79471744|FG003|Overall Study|Physician Decision|2|||
44462784|NCT00506922|79471745|FG004|Overall Study|Physician Decision|0|||
44462785|NCT00506922|79471741|FG000|Overall Study|Withdrawal by Subject|0|||
44462786|NCT00506922|79471742|FG001|Overall Study|Withdrawal by Subject|0|||
44462787|NCT00506922|79471743|FG002|Overall Study|Withdrawal by Subject|0|||
44462788|NCT00506922|79471744|FG003|Overall Study|Withdrawal by Subject|0|||
44462789|NCT00506922|79471745|FG004|Overall Study|Withdrawal by Subject|1|||
44462790|NCT00492024|79471755|FG000|Treatment|Adverse Event|3|||
44462791|NCT00492024|79471756|FG001|Treatment|Adverse Event|1|||
44462792|NCT00492024|79471755|FG000|Treatment|Lack of Efficacy|21|||
44462793|NCT00492024|79471756|FG001|Treatment|Lack of Efficacy|20|||
44462794|NCT00492024|79471755|FG000|Treatment|Lost to Follow-up|3|||
44462795|NCT00492024|79471756|FG001|Treatment|Lost to Follow-up|1|||
44462796|NCT00492024|79471755|FG000|Treatment|Withdrawal by Subject|2|||
44462797|NCT00492024|79471756|FG001|Treatment|Withdrawal by Subject|0|||
44462798|NCT00492024|79471755|FG000|Follow up|Lack of Efficacy|0|||
44462799|NCT00492024|79471756|FG001|Follow up|Lack of Efficacy|1|||
44462800|NCT00492024|79471755|FG000|Follow up|Lost to Follow-up|1|||
44462801|NCT00492024|79471756|FG001|Follow up|Lost to Follow-up|1|||
44462802|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
44462803|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
44462804|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
44462805|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
44462806|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
44462807|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
44462808|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
44462809|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
44462810|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
44462811|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
44462812|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
44462813|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
44462814|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
44462815|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
44462816|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
44462817|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
44462818|NCT00491556|79471764|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
44462819|NCT00491556|79471765|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
44221626|NCT01725386|79024778|FG000|Overall Study|Lost to Follow-up|81|||
44221627|NCT01725386|79024779|FG001|Overall Study|Lost to Follow-up|6|||
44221628|NCT01725386|79024778|FG000|Overall Study|Withdrawal by Subject|10|||
44462820|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
44462821|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
44462822|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
44462823|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
44462824|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
44221629|NCT01725386|79024779|FG001|Overall Study|Withdrawal by Subject|0|||
44374332|NCT00805207|79379462|FG004|Overall Study|Physician Decision|0|||
44374333|NCT00805207|79379463|FG005|Overall Study|Physician Decision|1|||
44374334|NCT00805207|79379464|FG006|Overall Study|Physician Decision|0|||
44374335|NCT00805207|79379465|FG007|Overall Study|Physician Decision|0|||
44374336|NCT00805207|79379466|FG008|Overall Study|Physician Decision|0|||
44374337|NCT00805207|79379458|FG000|Overall Study|Withdrawal by Subject|0|||
44374338|NCT00805207|79379459|FG001|Overall Study|Withdrawal by Subject|1|||
44462825|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
44374339|NCT00805207|79379460|FG002|Overall Study|Withdrawal by Subject|0|||
44462826|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
44462827|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
44462828|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
44462829|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
44462830|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
44221630|NCT01402011|79024788|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
44221631|NCT01402011|79024789|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
44462831|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
44462832|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
44462833|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
44462834|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
44462835|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
44462836|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
44462837|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
44462838|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
44462839|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
44462840|NCT00491556|79471764|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
44462841|NCT00491556|79471765|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
44462842|NCT00506454|79471773|FG000|Overall Study|Withdrawal by Subject|1|||
44462843|NCT00506454|79471774|FG001|Overall Study|Withdrawal by Subject|1|||
44462844|NCT00485472|79471782|FG000|Overall Study|Adverse Event|8|||
44462845|NCT00485472|79471783|FG001|Overall Study|Adverse Event|5|||
44462846|NCT00485472|79471782|FG000|Overall Study|Lack of Efficacy|5|||
44462847|NCT00485472|79471783|FG001|Overall Study|Lack of Efficacy|4|||
44462848|NCT00485472|79471782|FG000|Overall Study|Withdrawal by Subject|1|||
44462849|NCT00485472|79471783|FG001|Overall Study|Withdrawal by Subject|0|||
44462850|NCT00485472|79471782|FG000|Overall Study|Protocol Violation|0|||
44462851|NCT00485472|79471783|FG001|Overall Study|Protocol Violation|1|||
44462852|NCT00485472|79471782|FG000|Overall Study|Other|2|||
44462853|NCT00485472|79471783|FG001|Overall Study|Other|1|||
44462854|NCT00485472|79471782|FG000|Overall Study|Lost to Follow-up|0|||
44462855|NCT00485472|79471783|FG001|Overall Study|Lost to Follow-up|1|||
44462856|NCT00491400|79471791|FG000|Overall Study|Withdrawal by Subject|5|||
44462857|NCT00491400|79471792|FG001|Overall Study|Withdrawal by Subject|4|||
44462858|NCT00491322|79471802|FG000|Overall Study|Protocol Violation|1|||
44462859|NCT00491322|79471803|FG001|Overall Study|Protocol Violation|0|||
44462860|NCT00491322|79471802|FG000|Overall Study|Pregnancy|0|||
44462861|NCT00491322|79471803|FG001|Overall Study|Pregnancy|1|||
44462862|NCT00502320|79471811|FG000|Overall Study|Lost to Follow-up|1|||
44374340|NCT00805207|79379461|FG003|Overall Study|Withdrawal by Subject|0|||
44374341|NCT00805207|79379462|FG004|Overall Study|Withdrawal by Subject|1|||
44374342|NCT00805207|79379463|FG005|Overall Study|Withdrawal by Subject|2|||
44374343|NCT00805207|79379464|FG006|Overall Study|Withdrawal by Subject|0|||
44462863|NCT00502320|79471812|FG001|Overall Study|Lost to Follow-up|1|||
44462864|NCT00502320|79471811|FG000|Overall Study|Withdrew Consent|1|||
44374344|NCT00805207|79379465|FG007|Overall Study|Withdrawal by Subject|0|||
44374345|NCT00805207|79379466|FG008|Overall Study|Withdrawal by Subject|0|||
44374346|NCT00805675|79379493|FG000|Overall Study|Adverse Event|0|||
44462865|NCT00502320|79471812|FG001|Overall Study|Withdrew Consent|0|||
44462866|NCT00502320|79471811|FG000|Overall Study|No longer met criteria|1|||
44462867|NCT00502320|79471812|FG001|Overall Study|No longer met criteria|0|||
44462868|NCT00502320|79471811|FG000|Overall Study|Screen Failure|0|||
44462869|NCT00502320|79471812|FG001|Overall Study|Screen Failure|1|||
44462870|NCT00502320|79471811|FG000|Overall Study|Adverse Event|3|||
44462871|NCT00502320|79471812|FG001|Overall Study|Adverse Event|5|||
44462872|NCT02567825|79471820|FG000|Overall Study|No follow-up post-randomization|5|||
44462873|NCT02567825|79471821|FG001|Overall Study|No follow-up post-randomization|1|||
44462874|NCT02567825|79471820|FG000|Overall Study|Follow-up less than 23 months|16|||
44462875|NCT02567825|79471821|FG001|Overall Study|Follow-up less than 23 months|20|||
44462876|NCT00490776|79471827|FG000|Overall Study|Withdrawal by Subject|1|||
44221632|NCT01402011|79024790|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
44221633|NCT01402011|79024788|FG000|Active Treatment Period|Withdrawal by Subject|1|||
44221634|NCT01402011|79024789|FG001|Active Treatment Period|Withdrawal by Subject|3|||
44221635|NCT01402011|79024790|FG002|Active Treatment Period|Withdrawal by Subject|0|||
44221636|NCT01402011|79024788|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
44221637|NCT01402011|79024789|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
44221638|NCT01402011|79024790|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
44221639|NCT01421667|79024805|FG000|Overall Study|Withdrawal by Subject|0|||
44221640|NCT01421667|79024806|FG001|Overall Study|Withdrawal by Subject|1|||
44221641|NCT01421667|79024807|FG002|Overall Study|Withdrawal by Subject|2|||
44271283|NCT01673867|79200720|FG001|Randomization|Adverse event unrelated to study drug|0|||
44462877|NCT00490776|79471827|FG000|Overall Study|Administrative Problems|1|||
44462878|NCT00490776|79471827|FG000|Overall Study|Death|1|||
44462879|NCT00490776|79471827|FG000|Overall Study|New Cancer Therapy|1|||
44462880|NCT00490776|79471827|FG000|Overall Study|Disease Progression|5|||
44462881|NCT00566735|79471833|FG000|Overall Study|Withdrawal by Subject|0|||
44374347|NCT00805675|79379494|FG001|Overall Study|Adverse Event|0|||
44374348|NCT00805675|79379495|FG002|Overall Study|Adverse Event|1|||
44374349|NCT00589303|79379509|FG000|Overall Study|Withdrawal by Subject|2|||
44462882|NCT00566735|79471834|FG001|Overall Study|Withdrawal by Subject|1|||
44462883|NCT00566735|79471833|FG000|Overall Study|Refused neuropsychological testing|2|||
44462884|NCT00566735|79471834|FG001|Overall Study|Refused neuropsychological testing|5|||
44462885|NCT00566735|79471833|FG000|Overall Study|Switched into a manic episode|0|||
44462886|NCT00566735|79471834|FG001|Overall Study|Switched into a manic episode|1|||
44462887|NCT00566111|79471842|FG000|Overall Study|Adverse Event|0|||
44462888|NCT00566111|79471843|FG001|Overall Study|Adverse Event|2|||
44462889|NCT00514046|79471858|FG000|Overall Study|transferred to another protocol|2|||
44462890|NCT00514046|79471859|FG001|Overall Study|transferred to another protocol|1|||
44462891|NCT00514046|79471860|FG002|Overall Study|transferred to another protocol|3|||
44462892|NCT00514046|79471861|FG003|Overall Study|transferred to another protocol|0|||
44462893|NCT00514046|79471862|FG004|Overall Study|transferred to another protocol|1|||
44462894|NCT00514046|79471863|FG005|Overall Study|transferred to another protocol|0|||
44462895|NCT00514046|79471864|FG006|Overall Study|transferred to another protocol|0|||
44462896|NCT00514046|79471865|FG007|Overall Study|transferred to another protocol|0|||
44462897|NCT00514046|79471866|FG008|Overall Study|transferred to another protocol|0|||
44462898|NCT00514046|79471858|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
44462899|NCT00514046|79471859|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
44462900|NCT00514046|79471860|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
44462901|NCT00514046|79471861|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
44462902|NCT00514046|79471862|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
44462903|NCT00514046|79471863|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
44462904|NCT00514046|79471864|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
44462905|NCT00514046|79471865|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
44462906|NCT00514046|79471866|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
44462907|NCT00514046|79471858|FG000|Overall Study|Disease progression on study|0|||
44462908|NCT00514046|79471859|FG001|Overall Study|Disease progression on study|0|||
44462909|NCT00514046|79471860|FG002|Overall Study|Disease progression on study|2|||
44462910|NCT00514046|79471861|FG003|Overall Study|Disease progression on study|0|||
44462911|NCT00514046|79471862|FG004|Overall Study|Disease progression on study|0|||
44462912|NCT00514046|79471863|FG005|Overall Study|Disease progression on study|1|||
44462913|NCT00514046|79471864|FG006|Overall Study|Disease progression on study|0|||
44462914|NCT00514046|79471865|FG007|Overall Study|Disease progression on study|0|||
44462915|NCT00514046|79471866|FG008|Overall Study|Disease progression on study|0|||
44462916|NCT00564629|79471890|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
44462917|NCT00564629|79471891|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
44462918|NCT00564395|79471897|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
44462919|NCT00564395|79471898|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
44462920|NCT00564395|79471897|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
44462921|NCT00564395|79471898|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
44462922|NCT00502242|79471906|FG000|Overall Study|Lack of Efficacy|1|||
44462923|NCT00502242|79471907|FG001|Overall Study|Lack of Efficacy|11|||
44462924|NCT00502242|79471906|FG000|Overall Study|Adverse Event|31|||
44462925|NCT00502242|79471907|FG001|Overall Study|Adverse Event|20|||
44221642|NCT01421667|79024808|FG003|Overall Study|Withdrawal by Subject|1|||
44221643|NCT01421667|79024805|FG000|Overall Study|Lost to Follow-up|0|||
44221644|NCT01421667|79024806|FG001|Overall Study|Lost to Follow-up|1|||
44221645|NCT01421667|79024807|FG002|Overall Study|Lost to Follow-up|0|||
44221646|NCT01421667|79024808|FG003|Overall Study|Lost to Follow-up|0|||
44374350|NCT00589303|79379510|FG001|Overall Study|Withdrawal by Subject|1|||
44374351|NCT00952380|79379521|FG000|Overall Study|Other|0|||
44374352|NCT00952380|79379522|FG001|Overall Study|Other|0|||
44221647|NCT01390779|79024826|FG000|Overall Study|Physician Decision|1|||
44221648|NCT01891669|79024840|FG000|Overall Study|Death|0|||
44221649|NCT01891669|79024841|FG001|Overall Study|Death|0|||
44374353|NCT00952380|79379523|FG002|Overall Study|Other|0|||
44221650|NCT01891669|79024842|FG002|Overall Study|Death|0|||
44374354|NCT00952380|79379524|FG003|Overall Study|Other|0|||
44374355|NCT00952380|79379525|FG004|Overall Study|Other|1|||
44374356|NCT00952380|79379521|FG000|Overall Study|Withdrawal by Subject|0|||
44374357|NCT00952380|79379522|FG001|Overall Study|Withdrawal by Subject|0|||
44374358|NCT00952380|79379523|FG002|Overall Study|Withdrawal by Subject|1|||
44374359|NCT00952380|79379524|FG003|Overall Study|Withdrawal by Subject|0|||
44374360|NCT00952380|79379525|FG004|Overall Study|Withdrawal by Subject|2|||
44462926|NCT00502242|79471906|FG000|Overall Study|Physician Decision|2|||
44462927|NCT00502242|79471907|FG001|Overall Study|Physician Decision|3|||
44462928|NCT00502242|79471906|FG000|Overall Study|Other - Unspecified|8|||
44462929|NCT00502242|79471907|FG001|Overall Study|Other - Unspecified|14|||
44462930|NCT00502242|79471906|FG000|Overall Study|Protocol Violation|3|||
44462931|NCT00502242|79471907|FG001|Overall Study|Protocol Violation|1|||
44221651|NCT01891669|79024843|FG003|Overall Study|Death|0|||
44221652|NCT01891669|79024844|FG004|Overall Study|Death|0|||
44374361|NCT00952380|79379521|FG000|Overall Study|Adverse Event|0|||
44374362|NCT00952380|79379522|FG001|Overall Study|Adverse Event|1|||
44462932|NCT00502242|79471906|FG000|Overall Study|Withdrawal by Subject|6|||
44462933|NCT00502242|79471907|FG001|Overall Study|Withdrawal by Subject|7|||
44462934|NCT03972137|79471917|FG000|Overall Study|Lost to Follow-up|2|||
44462935|NCT03972137|79471917|FG000|Overall Study|Withdrawal by Subject|4|||
44462936|NCT00490698|79471933|FG000|Overall Study|Withdrawal by Subject|1|||
44462937|NCT00490698|79471933|FG000|Overall Study|Disease Progression|7|||
44462938|NCT00490698|79471933|FG000|Overall Study|Physician Decision|2|||
44462939|NCT03855228|79471941|FG000|Overall Study|Adverse Event|2|||
44462940|NCT03855228|79471942|FG001|Overall Study|Adverse Event|4|||
44462941|NCT03855228|79471943|FG002|Overall Study|Adverse Event|4|||
44462942|NCT03855228|79471944|FG003|Overall Study|Adverse Event|8|||
44462943|NCT03855228|79471941|FG000|Overall Study|Treatment Failure|1|||
44462944|NCT03855228|79471942|FG001|Overall Study|Treatment Failure|2|||
44462945|NCT03855228|79471943|FG002|Overall Study|Treatment Failure|1|||
44462946|NCT03855228|79471944|FG003|Overall Study|Treatment Failure|8|||
44462947|NCT03855228|79471941|FG000|Overall Study|Lost to Follow-up|0|||
44462948|NCT03855228|79471942|FG001|Overall Study|Lost to Follow-up|0|||
44462949|NCT03855228|79471943|FG002|Overall Study|Lost to Follow-up|0|||
44462950|NCT03855228|79471944|FG003|Overall Study|Lost to Follow-up|1|||
44462951|NCT03855228|79471941|FG000|Overall Study|Protocol Violation|0|||
44462952|NCT03855228|79471942|FG001|Overall Study|Protocol Violation|1|||
44462953|NCT03855228|79471943|FG002|Overall Study|Protocol Violation|2|||
44462954|NCT03855228|79471944|FG003|Overall Study|Protocol Violation|1|||
44462955|NCT03855228|79471941|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
44462956|NCT03855228|79471942|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
44462957|NCT03855228|79471943|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
44462958|NCT03855228|79471944|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
44462959|NCT00511238|79471956|FG000|Overall Study|Adverse Event|13|||
44462960|NCT00511238|79471957|FG001|Overall Study|Adverse Event|33|||
44462961|NCT00511238|79471956|FG000|Overall Study|Withdrawal by Subject|2|||
44462962|NCT00511238|79471957|FG001|Overall Study|Withdrawal by Subject|22|||
44462963|NCT00511238|79471956|FG000|Overall Study|Progressive Disease|23|||
44462964|NCT00511238|79471957|FG001|Overall Study|Progressive Disease|157|||
44462965|NCT00511238|79471956|FG000|Overall Study|various reasons|4|||
44462966|NCT00511238|79471957|FG001|Overall Study|various reasons|14|||
44462967|NCT00513500|79471975|FG000|Overall Study|Lost to Follow-up|35|||
44462968|NCT00513500|79471976|FG001|Overall Study|Lost to Follow-up|39|||
44462969|NCT00513500|79471975|FG000|Overall Study|Death|2|||
44462970|NCT00513500|79471976|FG001|Overall Study|Death|1|||
44462971|NCT00513500|79471975|FG000|Overall Study|Hospitalized|4|||
44462972|NCT00513500|79471976|FG001|Overall Study|Hospitalized|14|||
44462973|NCT03969719|79471985|FG000|Overall Study|Other reasons not specified|1|||
44462974|NCT03969719|79471986|FG001|Overall Study|Other reasons not specified|1|||
44462975|NCT03969719|79471987|FG002|Overall Study|Other reasons not specified|3|||
44462976|NCT03969719|79471985|FG000|Overall Study|Withdrawal by Subject|2|||
44462977|NCT03969719|79471986|FG001|Overall Study|Withdrawal by Subject|3|||
44462978|NCT03969719|79471987|FG002|Overall Study|Withdrawal by Subject|2|||
44462979|NCT03969719|79471985|FG000|Overall Study|Protocol Violation|1|||
44462980|NCT03969719|79471986|FG001|Overall Study|Protocol Violation|2|||
44462981|NCT03969719|79471987|FG002|Overall Study|Protocol Violation|0|||
44462982|NCT03969719|79471985|FG000|Overall Study|Adverse Event|0|||
44462983|NCT03969719|79471986|FG001|Overall Study|Adverse Event|2|||
44462984|NCT03969719|79471987|FG002|Overall Study|Adverse Event|0|||
44462985|NCT03969719|79471985|FG000|Overall Study|Lost to Follow-up|0|||
44462986|NCT03969719|79471986|FG001|Overall Study|Lost to Follow-up|1|||
44462987|NCT03969719|79471987|FG002|Overall Study|Lost to Follow-up|0|||
44462988|NCT00511004|79471998|FG000|Overall Study|Lost to Follow-up|0|||
44462989|NCT00511004|79471999|FG001|Overall Study|Lost to Follow-up|0|||
44462990|NCT00511004|79472000|FG002|Overall Study|Lost to Follow-up|4|||
44462991|NCT02877134|79472027|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
44271284|NCT01673867|79200719|FG000|Randomization|Participant request to discontinue study treatment|0|||
44462992|NCT02877134|79472028|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
44462993|NCT02877134|79472029|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
44462994|NCT02877134|79472030|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
44462995|NCT02877134|79472031|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
44462996|NCT02877134|79472032|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
44462997|NCT02877134|79472033|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
44462998|NCT02877134|79472034|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
44462999|NCT02877134|79472035|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
44463000|NCT02877134|79472036|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
44463001|NCT02877134|79472037|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
44463002|NCT02877134|79472038|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
44463003|NCT02877134|79472027|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463004|NCT02877134|79472028|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
44463005|NCT02877134|79472029|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463006|NCT02877134|79472030|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
44271285|NCT01673867|79200720|FG001|Randomization|Participant request to discontinue study treatment|4|||
44374363|NCT00952380|79379523|FG002|Overall Study|Adverse Event|0|||
44463007|NCT02877134|79472031|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463008|NCT02877134|79472032|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463009|NCT02877134|79472033|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
44463010|NCT02877134|79472034|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463011|NCT02877134|79472035|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463012|NCT02877134|79472036|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463013|NCT02877134|79472037|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463014|NCT02877134|79472038|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
44463015|NCT02877134|79472027|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
44463016|NCT02877134|79472028|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
44463017|NCT02877134|79472029|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
44463018|NCT02877134|79472030|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
44463019|NCT02877134|79472031|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
44463020|NCT02877134|79472032|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
44463021|NCT02877134|79472033|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
44463022|NCT02877134|79472034|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
44463023|NCT02877134|79472035|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
44463024|NCT02877134|79472036|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
44463025|NCT02877134|79472037|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
44463026|NCT02877134|79472038|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
44463027|NCT02877134|79472027|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
44463028|NCT02877134|79472028|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
44463029|NCT02877134|79472029|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
44463030|NCT02877134|79472030|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
44463031|NCT02877134|79472031|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
44463032|NCT02877134|79472032|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
44463033|NCT02877134|79472033|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
44463034|NCT02877134|79472034|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
44463035|NCT02877134|79472035|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
44463036|NCT02877134|79472036|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
44463037|NCT02877134|79472037|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
44463038|NCT02877134|79472038|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
44463039|NCT02877134|79472027|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463040|NCT02877134|79472028|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463041|NCT02877134|79472029|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463042|NCT02877134|79472030|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463043|NCT02877134|79472031|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463044|NCT02877134|79472032|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463045|NCT02877134|79472033|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463046|NCT02877134|79472034|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463047|NCT02877134|79472035|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
44463048|NCT02877134|79472036|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463049|NCT02877134|79472037|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463050|NCT02877134|79472038|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
44463051|NCT02877134|79472027|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44463052|NCT02877134|79472028|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44463053|NCT02877134|79472029|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44463054|NCT02877134|79472030|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44463055|NCT02877134|79472031|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44544248|NCT03602053|79557529|FG000|Overall Study|Other|1|||
44374364|NCT00952380|79379524|FG003|Overall Study|Adverse Event|0|||
44374365|NCT00952380|79379525|FG004|Overall Study|Adverse Event|3|||
44374366|NCT00952380|79379521|FG000|Overall Study|Physician Decision|0|||
44374367|NCT00952380|79379522|FG001|Overall Study|Physician Decision|0|||
44374368|NCT00952380|79379523|FG002|Overall Study|Physician Decision|1|||
44374369|NCT00952380|79379524|FG003|Overall Study|Physician Decision|2|||
44374370|NCT00952380|79379525|FG004|Overall Study|Physician Decision|0|||
44374371|NCT00952380|79379521|FG000|Overall Study|Non-compliant to protocol|0|||
44374372|NCT00952380|79379522|FG001|Overall Study|Non-compliant to protocol|0|||
44374373|NCT00952380|79379523|FG002|Overall Study|Non-compliant to protocol|0|||
44374374|NCT00952380|79379524|FG003|Overall Study|Non-compliant to protocol|1|||
44463056|NCT02877134|79472032|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44374375|NCT00952380|79379525|FG004|Overall Study|Non-compliant to protocol|0|||
44374376|NCT00803179|79379542|FG000|Overall Study|Lost to Follow-up|3|||
44374377|NCT00804193|79379549|FG000|Overall Study|Lack of baseline fungus|32|||
44374378|NCT00804193|79379550|FG001|Overall Study|Lack of baseline fungus|31|||
44463057|NCT02877134|79472033|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
44463058|NCT02877134|79472034|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
44463059|NCT02877134|79472035|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
44463060|NCT02877134|79472036|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
44463061|NCT02877134|79472037|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
44463062|NCT02877134|79472038|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
44463063|NCT02877134|79472027|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463064|NCT02877134|79472028|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463065|NCT02877134|79472029|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463066|NCT02877134|79472030|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463067|NCT02877134|79472031|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463068|NCT02877134|79472032|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463069|NCT02877134|79472033|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463070|NCT02877134|79472034|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
44463071|NCT02877134|79472035|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
44463072|NCT02877134|79472036|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
44463073|NCT02877134|79472037|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463074|NCT02877134|79472038|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
44463075|NCT02877134|79472027|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
44463076|NCT02877134|79472028|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
44463077|NCT02877134|79472029|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
44463078|NCT02877134|79472030|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
44463079|NCT02877134|79472031|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
44463080|NCT02877134|79472032|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
44463081|NCT02877134|79472033|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
44463082|NCT02877134|79472034|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
44463083|NCT02877134|79472035|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
44463084|NCT02877134|79472036|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
44463085|NCT02877134|79472037|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
44463086|NCT02877134|79472038|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
44463087|NCT00563381|79472064|FG000|Overall Study|Adverse Event|264|||
44463088|NCT00563381|79472065|FG001|Overall Study|Adverse Event|292|||
44463089|NCT00563381|79472064|FG000|Overall Study|Protocol Violation|66|||
44221653|NCT01891669|79024845|FG005|Overall Study|Death|0|||
44221654|NCT01891669|79024846|FG006|Overall Study|Death|0|||
44221655|NCT01891669|79024847|FG007|Overall Study|Death|1|||
44221656|NCT01891669|79024848|FG008|Overall Study|Death|0|||
44221657|NCT01891669|79024849|FG009|Overall Study|Death|1|||
44221658|NCT01891669|79024840|FG000|Overall Study|Withdrawal by Subject|1|||
44221659|NCT01891669|79024841|FG001|Overall Study|Withdrawal by Subject|1|||
44221660|NCT01891669|79024842|FG002|Overall Study|Withdrawal by Subject|0|||
44221661|NCT01891669|79024843|FG003|Overall Study|Withdrawal by Subject|0|||
44221662|NCT01891669|79024844|FG004|Overall Study|Withdrawal by Subject|0|||
44221663|NCT01891669|79024845|FG005|Overall Study|Withdrawal by Subject|0|||
44221664|NCT01891669|79024846|FG006|Overall Study|Withdrawal by Subject|1|||
44221665|NCT01891669|79024847|FG007|Overall Study|Withdrawal by Subject|2|||
44221666|NCT01891669|79024848|FG008|Overall Study|Withdrawal by Subject|1|||
44221667|NCT01891669|79024849|FG009|Overall Study|Withdrawal by Subject|1|||
44221668|NCT01891669|79024840|FG000|Overall Study|Other|1|||
44221669|NCT01891669|79024841|FG001|Overall Study|Other|0|||
44221670|NCT01891669|79024842|FG002|Overall Study|Other|0|||
44221671|NCT01891669|79024843|FG003|Overall Study|Other|0|||
44221672|NCT01891669|79024844|FG004|Overall Study|Other|0|||
44221673|NCT01891669|79024845|FG005|Overall Study|Other|0|||
44221674|NCT01891669|79024846|FG006|Overall Study|Other|0|||
44221675|NCT01891669|79024847|FG007|Overall Study|Other|1|||
44463090|NCT00563381|79472065|FG001|Overall Study|Protocol Violation|74|||
44463091|NCT00563381|79472064|FG000|Overall Study|Lost to Follow-up|7|||
44221676|NCT01891669|79024848|FG008|Overall Study|Other|0|||
44221677|NCT01891669|79024849|FG009|Overall Study|Other|0|||
44221678|NCT01421511|79024882|FG000|Overall Study|Lost to Follow-up|11|||
44221679|NCT01421511|79024883|FG001|Overall Study|Lost to Follow-up|14|||
44277801|NCT02092350|79238807|FG001|Overall Study|Adverse Event|3|||
44271286|NCT01673867|79200719|FG000|Randomization|Withdrawal by participant|0|||
44271287|NCT01673867|79200720|FG001|Randomization|Withdrawal by participant|12|||
44271288|NCT01673867|79200719|FG000|Randomization|Lost to Follow-up|0|||
44271289|NCT01673867|79200720|FG001|Randomization|Lost to Follow-up|1|||
44271290|NCT01673867|79200719|FG000|Randomization|Participant no longer meets study criteria|4|||
44271291|NCT01673867|79200720|FG001|Randomization|Participant no longer meets study criteria|5|||
44271292|NCT01673867|79200719|FG000|Treatment|Disease Progression|208|||
44271293|NCT01673867|79200720|FG001|Treatment|Disease Progression|178|||
44463092|NCT00563381|79472065|FG001|Overall Study|Lost to Follow-up|15|||
44463093|NCT00563381|79472064|FG000|Overall Study|Withdrawal by Subject|192|||
44463094|NCT00563381|79472065|FG001|Overall Study|Withdrawal by Subject|209|||
44463095|NCT00563381|79472064|FG000|Overall Study|Lack of Efficacy|32|||
44463096|NCT00563381|79472065|FG001|Overall Study|Lack of Efficacy|24|||
44463097|NCT00563381|79472064|FG000|Overall Study|Individual different reasons|24|||
44463098|NCT00563381|79472065|FG001|Overall Study|Individual different reasons|34|||
44463099|NCT00512798|79472073|FG000|Overall Study|Death|0|||
44463100|NCT00512798|79472074|FG001|Overall Study|Death|3|||
44463101|NCT00512798|79472073|FG000|Overall Study|Adverse Event|2|||
44463102|NCT00512798|79472074|FG001|Overall Study|Adverse Event|4|||
44463103|NCT00512798|79472073|FG000|Overall Study|Progression of disease|14|||
44463104|NCT00512798|79472074|FG001|Overall Study|Progression of disease|20|||
44463105|NCT00512798|79472073|FG000|Overall Study|Withdrawal by Subject|3|||
44463106|NCT00512798|79472074|FG001|Overall Study|Withdrawal by Subject|0|||
44463107|NCT00565721|79472081|FG000|Overall Study|Screen Failure|2|||
44463108|NCT00565721|79472081|FG000|Overall Study|Lost to Follow-up|6|||
44463109|NCT00565721|79472081|FG000|Overall Study|Technical Problems|1|||
44463110|NCT00565721|79472081|FG000|Overall Study|Physician Decision|2|||
44463111|NCT00565721|79472081|FG000|Overall Study|Other reasons|6|||
44221680|NCT01421511|79024882|FG000|Overall Study|Randomized but didn't receive study drug|1|||
44221681|NCT01421511|79024883|FG001|Overall Study|Randomized but didn't receive study drug|7|||
44463112|NCT00561977|79472111|FG000|Overall Study|Withdrawal by Subject|0|||
44221682|NCT01421511|79024882|FG000|Overall Study|Physician Decision|0|||
44221683|NCT01421511|79024883|FG001|Overall Study|Physician Decision|1|||
44221684|NCT01421511|79024882|FG000|Overall Study|Withdrawal by Subject|6|||
44221685|NCT01421511|79024883|FG001|Overall Study|Withdrawal by Subject|5|||
44221686|NCT01421511|79024882|FG000|Overall Study|Death|1|||
44221687|NCT01421511|79024883|FG001|Overall Study|Death|1|||
44221688|NCT01864525|79024892|FG000|Overall Study|Adverse Event|1|||
44221689|NCT01864525|79024893|FG001|Overall Study|Adverse Event|0|||
44221690|NCT01421277|79024901|FG000|Overall Study|Lack of qualifying event|0|||
44221691|NCT01421277|79024902|FG001|Overall Study|Lack of qualifying event|61|||
44221692|NCT01421277|79024901|FG000|Overall Study|Incomplete baseline data|0|||
44271294|NCT01673867|79200719|FG000|Treatment|Study Drug Toxicity|23|||
44271295|NCT01673867|79200720|FG001|Treatment|Study Drug Toxicity|43|||
44374379|NCT00804193|79379551|FG002|Overall Study|Lack of baseline fungus|19|||
44374380|NCT00804193|79379549|FG000|Overall Study|Adverse Event|0|||
44374381|NCT00804193|79379550|FG001|Overall Study|Adverse Event|0|||
44374382|NCT00804193|79379551|FG002|Overall Study|Adverse Event|2|||
44374383|NCT00804193|79379549|FG000|Overall Study|Lack of Efficacy|1|||
44374384|NCT00804193|79379550|FG001|Overall Study|Lack of Efficacy|1|||
44374385|NCT00804193|79379551|FG002|Overall Study|Lack of Efficacy|3|||
44374386|NCT00804193|79379549|FG000|Overall Study|Protocol Violation|0|||
44374387|NCT00804193|79379550|FG001|Overall Study|Protocol Violation|8|||
44374388|NCT00804193|79379551|FG002|Overall Study|Protocol Violation|2|||
44374389|NCT00804193|79379549|FG000|Overall Study|Lost to Follow-up|3|||
44374390|NCT00804193|79379550|FG001|Overall Study|Lost to Follow-up|3|||
44374391|NCT00804193|79379551|FG002|Overall Study|Lost to Follow-up|4|||
44374392|NCT00804193|79379549|FG000|Overall Study|Withdrawal by Subject|3|||
44374393|NCT00804193|79379550|FG001|Overall Study|Withdrawal by Subject|1|||
44374394|NCT00804193|79379551|FG002|Overall Study|Withdrawal by Subject|2|||
44374395|NCT00957996|79379561|FG000|Overall Study|Death|4|||
44374396|NCT00957996|79379562|FG001|Overall Study|Death|10|||
44374397|NCT00957996|79379561|FG000|Overall Study|Lost to Follow-up|4|||
44463113|NCT00561977|79472112|FG001|Overall Study|Withdrawal by Subject|2|||
44463114|NCT00561977|79472113|FG002|Overall Study|Withdrawal by Subject|1|||
44463115|NCT00561977|79472111|FG000|Overall Study|Pregnancy|0|||
44463116|NCT00561977|79472112|FG001|Overall Study|Pregnancy|1|||
44463117|NCT00561977|79472113|FG002|Overall Study|Pregnancy|1|||
44463118|NCT00561821|79472125|FG000|Overall Study|Not treated|0|||
44221693|NCT01421277|79024902|FG001|Overall Study|Incomplete baseline data|31|||
44374398|NCT00957996|79379562|FG001|Overall Study|Lost to Follow-up|7|||
44374399|NCT00957996|79379561|FG000|Overall Study|Withdrawal by Subject|9|||
44463119|NCT00561821|79472126|FG001|Overall Study|Not treated|0|||
44463120|NCT00561821|79472127|FG002|Overall Study|Not treated|1|||
44271296|NCT01673867|79200719|FG000|Treatment|Death|2|||
44374400|NCT00957996|79379562|FG001|Overall Study|Withdrawal by Subject|2|||
44463121|NCT00561821|79472128|FG003|Overall Study|Not treated|0|||
44463122|NCT00561821|79472125|FG000|Overall Study|Withdrawal by Subject|0|||
44463123|NCT00561821|79472126|FG001|Overall Study|Withdrawal by Subject|1|||
44221694|NCT01891357|79024908|FG000|Overall Study|Protocol Violation|3|||
44221695|NCT01420965|79024915|FG000|Overall Study|Withdrawal by Subject|1|||
44463124|NCT00561821|79472127|FG002|Overall Study|Withdrawal by Subject|0|||
44463125|NCT00561821|79472128|FG003|Overall Study|Withdrawal by Subject|2|||
44463126|NCT00561821|79472125|FG000|Overall Study|Reasons not related to trial|2|||
44463127|NCT00561821|79472126|FG001|Overall Study|Reasons not related to trial|1|||
44221696|NCT01420965|79024916|FG001|Overall Study|Withdrawal by Subject|0|||
44221697|NCT01420965|79024917|FG002|Overall Study|Withdrawal by Subject|0|||
44463128|NCT00561821|79472127|FG002|Overall Study|Reasons not related to trial|0|||
44463129|NCT00561821|79472128|FG003|Overall Study|Reasons not related to trial|0|||
44463130|NCT00561821|79472125|FG000|Overall Study|Other (reason not specified)|1|||
44463131|NCT00561821|79472126|FG001|Overall Study|Other (reason not specified)|1|||
44463132|NCT00561821|79472127|FG002|Overall Study|Other (reason not specified)|0|||
44463133|NCT00561821|79472128|FG003|Overall Study|Other (reason not specified)|0|||
44463134|NCT00561821|79472125|FG000|Overall Study|Adverse Event|2|||
44463135|NCT00561821|79472126|FG001|Overall Study|Adverse Event|3|||
44463136|NCT00561821|79472127|FG002|Overall Study|Adverse Event|1|||
44463137|NCT00561821|79472128|FG003|Overall Study|Adverse Event|1|||
44463138|NCT00558701|79472140|FG000|Overall Study|Protocol Deviations|1|||
44463139|NCT00558701|79472141|FG001|Overall Study|Protocol Deviations|4|||
44463140|NCT03684044|79472149|FG000|Overall Study|Adverse Event|3|||
44463141|NCT03684044|79472150|FG001|Overall Study|Adverse Event|0|||
44463142|NCT03684044|79472149|FG000|Overall Study|Death|4|||
44463143|NCT03684044|79472150|FG001|Overall Study|Death|7|||
44463144|NCT03684044|79472149|FG000|Overall Study|Lost to Follow-up|3|||
44463145|NCT03684044|79472150|FG001|Overall Study|Lost to Follow-up|2|||
44463146|NCT03684044|79472149|FG000|Overall Study|Patient Not Available|0|||
44463147|NCT03684044|79472150|FG001|Overall Study|Patient Not Available|2|||
44463148|NCT03684044|79472149|FG000|Overall Study|Physician Decision|1|||
44463149|NCT03684044|79472150|FG001|Overall Study|Physician Decision|0|||
44463150|NCT03684044|79472149|FG000|Overall Study|Withdrawal by Subject|11|||
44463151|NCT03684044|79472150|FG001|Overall Study|Withdrawal by Subject|9|||
44463152|NCT00510692|79472158|FG000|Overall Study|Adverse Event|1|||
44463153|NCT00510692|79472159|FG001|Overall Study|Adverse Event|3|||
44463154|NCT00510692|79472158|FG000|Overall Study|Withdrawal by Subject|1|||
44463155|NCT00510692|79472159|FG001|Overall Study|Withdrawal by Subject|0|||
44463156|NCT00335452|79472171|FG000|Overall Study|Death|156|||
44463157|NCT00335452|79472172|FG001|Overall Study|Death|144|||
44463158|NCT00335452|79472173|FG002|Overall Study|Death|158|||
44463159|NCT00335452|79472174|FG003|Overall Study|Death|129|||
44463160|NCT00335452|79472171|FG000|Overall Study|Lost to Follow-up|2|||
44463161|NCT00335452|79472172|FG001|Overall Study|Lost to Follow-up|3|||
44463162|NCT00335452|79472173|FG002|Overall Study|Lost to Follow-up|1|||
44463163|NCT00335452|79472174|FG003|Overall Study|Lost to Follow-up|2|||
44463164|NCT00522548|79472191|FG000|Overall Study|Adverse Event|2|||
44463165|NCT00522548|79472192|FG001|Overall Study|Adverse Event|2|||
44463166|NCT00522548|79472191|FG000|Overall Study|Withdrawal by Subject|0|||
44463167|NCT00522548|79472192|FG001|Overall Study|Withdrawal by Subject|2|||
44463168|NCT00522392|79472200|FG000|Overall Study|Disease progression|0|||
44463169|NCT00522392|79472201|FG001|Overall Study|Disease progression|3|||
44221698|NCT01420965|79024915|FG000|Overall Study|Adverse Event|0|||
44221699|NCT01420965|79024916|FG001|Overall Study|Adverse Event|1|||
44221700|NCT01420965|79024917|FG002|Overall Study|Adverse Event|0|||
44221701|NCT01390389|79024927|FG000|Overall Study|Withdrawal by Subject|2|||
44463170|NCT00522392|79472200|FG000|Overall Study|Adverse Event|7|||
44463171|NCT00522392|79472201|FG001|Overall Study|Adverse Event|7|||
44463172|NCT00522392|79472200|FG000|Overall Study|Withdrawal by Subject|1|||
44463173|NCT00522392|79472201|FG001|Overall Study|Withdrawal by Subject|1|||
44463174|NCT00522392|79472200|FG000|Overall Study|Physician Decision|0|||
44463175|NCT00522392|79472201|FG001|Overall Study|Physician Decision|1|||
44463176|NCT00522392|79472200|FG000|Overall Study|Non-compliance|0|||
44463177|NCT00522392|79472201|FG001|Overall Study|Non-compliance|1|||
44463178|NCT00309244|79472209|FG000|Overall Study|Adverse Event|29|||
44463179|NCT00309244|79472210|FG001|Overall Study|Adverse Event|12|||
44221702|NCT01390389|79024928|FG001|Overall Study|Withdrawal by Subject|0|||
44221703|NCT01390389|79024927|FG000|Overall Study|Screen Fail|2|||
44221704|NCT01390389|79024928|FG001|Overall Study|Screen Fail|1|||
44463180|NCT00309244|79472209|FG000|Overall Study|Lost to Follow-up|6|||
44463181|NCT00309244|79472210|FG001|Overall Study|Lost to Follow-up|22|||
44463182|NCT00309244|79472209|FG000|Overall Study|Physician Decision|5|||
44463183|NCT00309244|79472210|FG001|Overall Study|Physician Decision|8|||
44463184|NCT00309244|79472209|FG000|Overall Study|Protocol Violation|6|||
44463185|NCT00309244|79472210|FG001|Overall Study|Protocol Violation|3|||
44463186|NCT00309244|79472209|FG000|Overall Study|Withdrawal by Subject|50|||
44463187|NCT00309244|79472210|FG001|Overall Study|Withdrawal by Subject|32|||
44463188|NCT00309244|79472209|FG000|Overall Study|Various|7|||
44463189|NCT00309244|79472210|FG001|Overall Study|Various|7|||
44463190|NCT00309244|79472209|FG000|Overall Study|Randomized but not dosed|11|||
44463191|NCT00309244|79472210|FG001|Overall Study|Randomized but not dosed|12|||
44463192|NCT00309244|79472209|FG000|Overall Study|Death|4|||
44463193|NCT00309244|79472210|FG001|Overall Study|Death|1|||
44463194|NCT00483756|79472219|FG000|Overall Study|Death|2|||
44463195|NCT00483756|79472220|FG001|Overall Study|Death|0|||
44463196|NCT00483756|79472221|FG002|Overall Study|Death|1|||
44463197|NCT00483756|79472219|FG000|Overall Study|Adverse Event|19|||
44463198|NCT00483756|79472220|FG001|Overall Study|Adverse Event|38|||
44463199|NCT00483756|79472221|FG002|Overall Study|Adverse Event|40|||
44463200|NCT00483756|79472219|FG000|Overall Study|Lack of Efficacy|1|||
44463201|NCT00483756|79472220|FG001|Overall Study|Lack of Efficacy|0|||
44463202|NCT00483756|79472221|FG002|Overall Study|Lack of Efficacy|0|||
44463203|NCT00483756|79472219|FG000|Overall Study|Lost to Follow-up|3|||
44463204|NCT00483756|79472220|FG001|Overall Study|Lost to Follow-up|1|||
44463205|NCT00483756|79472221|FG002|Overall Study|Lost to Follow-up|0|||
44463206|NCT00483756|79472219|FG000|Overall Study|Withdrawal by Subject|5|||
44463207|NCT00483756|79472220|FG001|Overall Study|Withdrawal by Subject|3|||
44463208|NCT00483756|79472221|FG002|Overall Study|Withdrawal by Subject|4|||
44463209|NCT00483756|79472219|FG000|Overall Study|Other|2|||
44463210|NCT00483756|79472220|FG001|Overall Study|Other|4|||
44463211|NCT00483756|79472221|FG002|Overall Study|Other|3|||
44463212|NCT00483756|79472219|FG000|Overall Study|Randomized, Not Treated|1|||
44463213|NCT00483756|79472220|FG001|Overall Study|Randomized, Not Treated|4|||
44463214|NCT00483756|79472221|FG002|Overall Study|Randomized, Not Treated|4|||
44463215|NCT00309166|79472231|FG000|Overall Study|Adverse event, non-fatal|1|||
44463216|NCT00309166|79472232|FG001|Overall Study|Adverse event, non-fatal|0|||
44463217|NCT00309166|79472231|FG000|Overall Study|Withdrawal by Subject|4|||
44463218|NCT00309166|79472232|FG001|Overall Study|Withdrawal by Subject|3|||
44463219|NCT00501852|79472238|FG000|Overall Study|Adverse Event|3|||
44221705|NCT01401465|79024940|FG000|Treatment Period 1|Adverse Event|4|||
44221706|NCT01401465|79024941|FG001|Treatment Period 1|Adverse Event|1|||
44221707|NCT01401465|79024940|FG000|Treatment Period 1|Pregnancy|0|||
44463220|NCT00501852|79472238|FG000|Overall Study|Withdrawal by Subject|2|||
44463221|NCT00482274|79472252|FG000|Overall Study|Adverse Event|1|||
44463222|NCT00490542|79472258|FG000|Overall Study|Lost to Follow-up|3|||
44463223|NCT00490542|79472259|FG001|Overall Study|Lost to Follow-up|0|||
44463224|NCT00490542|79472258|FG000|Overall Study|Adverse Event|3|||
44463225|NCT00490542|79472259|FG001|Overall Study|Adverse Event|3|||
44463226|NCT00490542|79472258|FG000|Overall Study|Lack of Efficacy|1|||
44463227|NCT00490542|79472259|FG001|Overall Study|Lack of Efficacy|1|||
44463228|NCT00501540|79472265|FG000|Overall Study|Death|5|||
44221708|NCT01401465|79024941|FG001|Treatment Period 1|Pregnancy|1|||
44221709|NCT01401465|79024940|FG000|Treatment Period 1|Protocol Violation|5|||
44221710|NCT01401465|79024941|FG001|Treatment Period 1|Protocol Violation|0|||
44221711|NCT01401465|79024940|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44221712|NCT01401465|79024941|FG001|Treatment Period 1|Withdrawal by Subject|4|||
44221713|NCT01401465|79024940|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
44221714|NCT01401465|79024941|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
44221715|NCT01401465|79024940|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
44221716|NCT01401465|79024941|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
44221717|NCT01401465|79024940|FG000|Treatment Period 1|Scheduling Difficulties|1|||
44271297|NCT01673867|79200720|FG001|Treatment|Death|3|||
44271298|NCT01673867|79200719|FG000|Treatment|Adverse event unrelated to study drug|23|||
44463229|NCT00322348|79472271|FG000|Overall Study|Adverse Event|0|||
44463230|NCT00322348|79472272|FG001|Overall Study|Adverse Event|1|||
44463231|NCT00322348|79472271|FG000|Overall Study|Withdrawal by Subject|1|||
44463232|NCT00322348|79472272|FG001|Overall Study|Withdrawal by Subject|4|||
44463233|NCT00322348|79472271|FG000|Overall Study|Lost to Follow-up|1|||
44463234|NCT00322348|79472272|FG001|Overall Study|Lost to Follow-up|0|||
44463235|NCT00322348|79472271|FG000|Overall Study|Death|0|||
44463236|NCT00322348|79472272|FG001|Overall Study|Death|2|||
44463237|NCT00322348|79472271|FG000|Overall Study|Disease Progression|30|||
44463238|NCT00322348|79472272|FG001|Overall Study|Disease Progression|25|||
44463239|NCT00322348|79472271|FG000|Overall Study|Reasons not specified|5|||
44463240|NCT00322348|79472272|FG001|Overall Study|Reasons not specified|1|||
44463241|NCT00501228|79472278|FG000|Overall Study|Withdrawal by Subject|1|||
44463242|NCT00308620|79472285|FG000|Overall Study|Death|1|||
44463243|NCT00308620|79472286|FG001|Overall Study|Death|1|||
44221718|NCT01401465|79024941|FG001|Treatment Period 1|Scheduling Difficulties|1|||
44221719|NCT01401465|79024940|FG000|Treatment Period 2|Lost to Follow-up|0|||
44221720|NCT01401465|79024941|FG001|Treatment Period 2|Lost to Follow-up|1|||
44221721|NCT01401465|79024940|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44221722|NCT01401465|79024941|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44221723|NCT01401153|79024952|FG000|First Test Day|Learning disabilities; illness|1|||
44221724|NCT01401153|79024953|FG001|First Test Day|Learning disabilities; illness|10|||
44221725|NCT01401153|79024952|FG000|Second Test Day|illness|0|||
44221726|NCT01401153|79024953|FG001|Second Test Day|illness|5|||
44221727|NCT01890967|79024966|FG000|Overall Study|Adverse Event|3|||
44221728|NCT01890967|79024967|FG001|Overall Study|Adverse Event|3|||
44221729|NCT01890967|79024968|FG002|Overall Study|Adverse Event|3|||
44221730|NCT01890967|79024969|FG003|Overall Study|Adverse Event|2|||
44221731|NCT01890967|79024970|FG004|Overall Study|Adverse Event|1|||
44221732|NCT01890967|79024971|FG005|Overall Study|Adverse Event|7|||
44221733|NCT01890967|79024966|FG000|Overall Study|Death|1|||
44221734|NCT01890967|79024967|FG001|Overall Study|Death|0|||
44221735|NCT01890967|79024968|FG002|Overall Study|Death|0|||
44374401|NCT00957996|79379561|FG000|Overall Study|Adverse Event|2|||
44374402|NCT00957996|79379562|FG001|Overall Study|Adverse Event|1|||
44374403|NCT00957996|79379561|FG000|Overall Study|Physician Decision|1|||
44374404|NCT00957996|79379562|FG001|Overall Study|Physician Decision|1|||
44221736|NCT01890967|79024969|FG003|Overall Study|Death|0|||
44374405|NCT00957996|79379561|FG000|Overall Study|Influenza-related complication|0|||
44374406|NCT00957996|79379562|FG001|Overall Study|Influenza-related complication|1|||
44374407|NCT00957996|79379561|FG000|Overall Study|Missing|1|||
44374408|NCT00957996|79379562|FG001|Overall Study|Missing|0|||
44374409|NCT00957996|79379561|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
44374410|NCT00957996|79379562|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
44374411|NCT00589693|79379572|FG000|Overall Study|randomized in error|12|||
44374412|NCT00589693|79379573|FG001|Overall Study|randomized in error|6|||
44374413|NCT00589693|79379572|FG000|Overall Study|Adverse Event|4|||
44374414|NCT00589693|79379573|FG001|Overall Study|Adverse Event|4|||
44374415|NCT00589693|79379572|FG000|Overall Study|Death|26|||
44374416|NCT00589693|79379573|FG001|Overall Study|Death|16|||
44374417|NCT00589693|79379572|FG000|Overall Study|Lack of Efficacy|0|||
44374418|NCT00589693|79379573|FG001|Overall Study|Lack of Efficacy|1|||
44374419|NCT00589693|79379572|FG000|Overall Study|Lost to Follow-up|1|||
44374420|NCT00589693|79379573|FG001|Overall Study|Lost to Follow-up|0|||
44374421|NCT00589693|79379572|FG000|Overall Study|Physician Decision|0|||
44374422|NCT00589693|79379573|FG001|Overall Study|Physician Decision|1|||
44374423|NCT00589693|79379572|FG000|Overall Study|Protocol Violation|1|||
44374424|NCT00589693|79379573|FG001|Overall Study|Protocol Violation|1|||
44374425|NCT00803101|79379581|FG000|Overall Study|Death / Serious Adverse Event|4|||
44374426|NCT00803101|79379582|FG001|Overall Study|Death / Serious Adverse Event|6|||
44374427|NCT00803101|79379581|FG000|Overall Study|Withdrawal by Subject|6|||
44374428|NCT00803101|79379582|FG001|Overall Study|Withdrawal by Subject|4|||
44374429|NCT00803101|79379581|FG000|Overall Study|Lost to Follow-up|2|||
44374430|NCT00803101|79379582|FG001|Overall Study|Lost to Follow-up|2|||
44374431|NCT00803101|79379581|FG000|Overall Study|Protocol Violation|1|||
44374432|NCT00803101|79379582|FG001|Overall Study|Protocol Violation|7|||
44374433|NCT00803101|79379581|FG000|Overall Study|Surgery finished outside protocol window|1|||
44374434|NCT00803101|79379582|FG001|Overall Study|Surgery finished outside protocol window|1|||
44374435|NCT00803101|79379581|FG000|Overall Study|Patient died outside SAE report period|1|||
44374436|NCT00803101|79379582|FG001|Overall Study|Patient died outside SAE report period|0|||
44374437|NCT00803101|79379581|FG000|Overall Study|Patient did not attend scheduled visit|2|||
44374438|NCT00803101|79379582|FG001|Overall Study|Patient did not attend scheduled visit|1|||
44374439|NCT00803101|79379581|FG000|Overall Study|Patient did not have surgery|1|||
44374440|NCT00803101|79379582|FG001|Overall Study|Patient did not have surgery|1|||
44221737|NCT01890967|79024970|FG004|Overall Study|Death|0|||
44221738|NCT01890967|79024971|FG005|Overall Study|Death|0|||
44221739|NCT01890967|79024966|FG000|Overall Study|Lost to Follow-up|1|||
44221740|NCT01890967|79024967|FG001|Overall Study|Lost to Follow-up|1|||
44221741|NCT01890967|79024968|FG002|Overall Study|Lost to Follow-up|1|||
44374441|NCT00801229|79379590|FG000|Signed Consent|Withdrawal by Subject|2|||
44374442|NCT00801229|79379591|FG001|Signed Consent|Withdrawal by Subject|2|||
44374443|NCT00801229|79379590|FG000|Signed Consent|Found Ineligible|1|||
44374444|NCT00801229|79379591|FG001|Signed Consent|Found Ineligible|1|||
44374445|NCT00801229|79379590|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
44463244|NCT00308620|79472287|FG002|Overall Study|Death|0|||
44463245|NCT00308620|79472285|FG000|Overall Study|Lost to Follow-up|0|||
44463246|NCT00308620|79472286|FG001|Overall Study|Lost to Follow-up|0|||
44463247|NCT00308620|79472287|FG002|Overall Study|Lost to Follow-up|1|||
44463248|NCT00492752|79472297|FG000|Double Blind Treatment|Death|13|||
44463249|NCT00492752|79472298|FG001|Double Blind Treatment|Death|0|||
44463250|NCT00492752|79472299|FG002|Double Blind Treatment|Death|2|||
44463251|NCT00492752|79472300|FG003|Double Blind Treatment|Death|0|||
44463252|NCT00492752|79472297|FG000|Double Blind Treatment|Adverse Event|1|||
44463253|NCT00492752|79472298|FG001|Double Blind Treatment|Adverse Event|0|||
44463254|NCT00492752|79472299|FG002|Double Blind Treatment|Adverse Event|0|||
44463255|NCT00492752|79472300|FG003|Double Blind Treatment|Adverse Event|0|||
44463256|NCT00492752|79472297|FG000|Double Blind Treatment|Protocol Violation|0|||
44463257|NCT00492752|79472298|FG001|Double Blind Treatment|Protocol Violation|0|||
44463258|NCT00492752|79472299|FG002|Double Blind Treatment|Protocol Violation|1|||
44463259|NCT00492752|79472300|FG003|Double Blind Treatment|Protocol Violation|0|||
44463260|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
44463261|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
44463262|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
44463263|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
44463264|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
44463265|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
44463266|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
44463267|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
44463268|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
44463269|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
44463270|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
44463271|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
44463272|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
44463273|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
44463274|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
44463275|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
44463276|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
44463277|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
44463278|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
44271299|NCT01673867|79200720|FG001|Treatment|Adverse event unrelated to study drug|10|||
44271300|NCT01673867|79200719|FG000|Treatment|Participant request to discontinue study treatment|7|||
44271301|NCT01673867|79200720|FG001|Treatment|Participant request to discontinue study treatment|17|||
44271302|NCT01673867|79200719|FG000|Treatment|Withdrawal by participant|5|||
44271303|NCT01673867|79200720|FG001|Treatment|Withdrawal by participant|5|||
44271304|NCT01673867|79200719|FG000|Treatment|Maximum clinical benefit|1|||
44271305|NCT01673867|79200720|FG001|Treatment|Maximum clinical benefit|10|||
44271306|NCT01673867|79200719|FG000|Treatment|Participant no longer meets study criteria|2|||
44271307|NCT01673867|79200720|FG001|Treatment|Participant no longer meets study criteria|0|||
44271308|NCT01673867|79200719|FG000|Treatment|Administrative reason by sponsor|3|||
44271309|NCT01673867|79200720|FG001|Treatment|Administrative reason by sponsor|0|||
44271310|NCT01673867|79200719|FG000|Treatment|Other reason|11|||
44271311|NCT01673867|79200720|FG001|Treatment|Other reason|2|||
44271312|NCT02041533|79200816|FG000|Pre-Treatment Period|Disease Progression|1|||
44271313|NCT02041533|79200817|FG001|Pre-Treatment Period|Disease Progression|1|||
44221742|NCT01890967|79024969|FG003|Overall Study|Lost to Follow-up|1|||
44221743|NCT01890967|79024970|FG004|Overall Study|Lost to Follow-up|0|||
44221744|NCT01890967|79024971|FG005|Overall Study|Lost to Follow-up|1|||
44221745|NCT01890967|79024966|FG000|Overall Study|Protocol Violation|0|||
44221746|NCT01890967|79024967|FG001|Overall Study|Protocol Violation|3|||
44221747|NCT01890967|79024968|FG002|Overall Study|Protocol Violation|3|||
44221748|NCT01890967|79024969|FG003|Overall Study|Protocol Violation|2|||
44221749|NCT01890967|79024970|FG004|Overall Study|Protocol Violation|4|||
44221750|NCT01890967|79024971|FG005|Overall Study|Protocol Violation|1|||
44221751|NCT01890967|79024966|FG000|Overall Study|Sponsor Decision|2|||
44221752|NCT01890967|79024967|FG001|Overall Study|Sponsor Decision|0|||
44221753|NCT01890967|79024968|FG002|Overall Study|Sponsor Decision|1|||
44463279|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
44544249|NCT03602053|79557530|FG001|Overall Study|Other|0|||
44271314|NCT02041533|79200816|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
44271315|NCT02041533|79200817|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
44271316|NCT02041533|79200816|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
44271317|NCT02041533|79200817|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
44271318|NCT02041533|79200816|FG000|Treatment Period|Disease progression|189|||
44271319|NCT02041533|79200817|FG001|Treatment Period|Disease progression|146|||
44271320|NCT02041533|79200816|FG000|Treatment Period|Study drug toxicity|30|||
44271321|NCT02041533|79200817|FG001|Treatment Period|Study drug toxicity|34|||
44271322|NCT02041533|79200816|FG000|Treatment Period|Death|1|||
44271323|NCT02041533|79200817|FG001|Treatment Period|Death|0|||
44271324|NCT02041533|79200816|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
44463280|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
44463281|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
44463282|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
44463283|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
44463284|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
44463285|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
44463286|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
44463287|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
44463288|NCT00492752|79472297|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
44463289|NCT00492752|79472298|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
44463290|NCT00492752|79472299|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
44463291|NCT00492752|79472300|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
44463292|NCT00308308|79472309|FG000|Overall Study|Adverse Event|17|||
44463293|NCT00308308|79472310|FG001|Overall Study|Adverse Event|2|||
44463294|NCT00308308|79472309|FG000|Overall Study|Lost to Follow-up|5|||
44463295|NCT00308308|79472310|FG001|Overall Study|Lost to Follow-up|5|||
44463296|NCT00308308|79472309|FG000|Overall Study|Physician Decision|15|||
44463297|NCT00308308|79472310|FG001|Overall Study|Physician Decision|7|||
44463298|NCT00308308|79472309|FG000|Overall Study|Protocol Violation|3|||
44463299|NCT00308308|79472310|FG001|Overall Study|Protocol Violation|14|||
44463300|NCT00308308|79472309|FG000|Overall Study|Withdrawal by Subject|47|||
44463301|NCT00308308|79472310|FG001|Overall Study|Withdrawal by Subject|19|||
44463302|NCT00308308|79472309|FG000|Overall Study|Various|7|||
44463303|NCT00308308|79472310|FG001|Overall Study|Various|5|||
44463304|NCT00308308|79472309|FG000|Overall Study|Randomized but not dosed|8|||
44463305|NCT00308308|79472310|FG001|Overall Study|Randomized but not dosed|16|||
44463306|NCT00308308|79472309|FG000|Overall Study|Other|1|||
44463307|NCT00308308|79472310|FG001|Overall Study|Other|0|||
44463308|NCT00505934|79472316|FG000|Overall Study|Adverse Event|1|||
44463309|NCT00505934|79472316|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
44463310|NCT00505934|79472316|FG000|Overall Study|Other: IV dose needed to be changed|1|||
44463311|NCT00505778|79472322|FG000|Overall Study|Adverse Event|2|||
44463312|NCT00505778|79472323|FG001|Overall Study|Adverse Event|7|||
44463313|NCT00505778|79472322|FG000|Overall Study|Physician Decision|8|||
44463314|NCT00505778|79472323|FG001|Overall Study|Physician Decision|14|||
44463315|NCT00505778|79472322|FG000|Overall Study|Lost to Follow-up|17|||
44463316|NCT00505778|79472323|FG001|Overall Study|Lost to Follow-up|23|||
44463317|NCT00505778|79472322|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
44463318|NCT00505778|79472323|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
44463319|NCT00505778|79472322|FG000|Overall Study|Protocol Violation|7|||
44374446|NCT00801229|79379591|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
44374447|NCT00801229|79379590|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
44374448|NCT00801229|79379591|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
44374449|NCT00801229|79379590|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
44374450|NCT00801229|79379591|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
44374451|NCT00801229|79379590|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
44374452|NCT00801229|79379591|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
44374453|NCT00801229|79379590|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
44374454|NCT00801229|79379591|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
44374455|NCT00801229|79379590|FG000|Received Study Drug/Placebo|Adverse Event|1|||
44374456|NCT00801229|79379591|FG001|Received Study Drug/Placebo|Adverse Event|1|||
44374457|NCT00948246|79379597|FG000|Overall Study|Lost to Follow-up|11|||
44374458|NCT00948246|79379597|FG000|Overall Study|Adverse Event|11|||
44374459|NCT00948246|79379597|FG000|Overall Study|Death|1|||
44374460|NCT00948246|79379597|FG000|Overall Study|Withdrawal by Subject|1|||
44374461|NCT00800683|79379603|FG000|Overall Study|Adverse Event|11|||
44374462|NCT00800683|79379604|FG001|Overall Study|Adverse Event|8|||
44463320|NCT00505778|79472323|FG001|Overall Study|Protocol Violation|9|||
44463321|NCT00505778|79472322|FG000|Overall Study|Withdrawal by Subject|29|||
44463322|NCT00505778|79472323|FG001|Overall Study|Withdrawal by Subject|14|||
44463323|NCT00505778|79472322|FG000|Overall Study|Relapse|65|||
44463324|NCT00505778|79472323|FG001|Overall Study|Relapse|65|||
44463325|NCT00505778|79472322|FG000|Overall Study|Took No Study Drug|2|||
44463326|NCT00505778|79472323|FG001|Overall Study|Took No Study Drug|2|||
44463327|NCT00308074|79472329|FG000|Overall Study|Withdrawal by Subject|1|||
44463328|NCT00500760|79472335|FG000|Overall Study|Death|32|||
44463329|NCT00500760|79472336|FG001|Overall Study|Death|15|||
44463330|NCT00500760|79472335|FG000|Overall Study|Withdrawal by Subject|5|||
44463331|NCT00500760|79472336|FG001|Overall Study|Withdrawal by Subject|7|||
44463332|NCT00500760|79472335|FG000|Overall Study|Administrative decision|2|||
44463333|NCT00500760|79472336|FG001|Overall Study|Administrative decision|0|||
44463334|NCT00500760|79472335|FG000|Overall Study|Lost to Follow-up|3|||
44463335|NCT00500760|79472336|FG001|Overall Study|Lost to Follow-up|0|||
44463336|NCT00500760|79472335|FG000|Overall Study|Other|1|||
44463337|NCT00500760|79472336|FG001|Overall Study|Other|2|||
44463338|NCT00505622|79472345|FG000|Overall Study|Adverse Event|5|||
44463339|NCT00505622|79472346|FG001|Overall Study|Adverse Event|6|||
44463340|NCT00505622|79472347|FG002|Overall Study|Adverse Event|4|||
44463341|NCT00505622|79472345|FG000|Overall Study|Protocol Violation|1|||
44463342|NCT00505622|79472346|FG001|Overall Study|Protocol Violation|1|||
44463343|NCT00505622|79472347|FG002|Overall Study|Protocol Violation|0|||
44463344|NCT00505622|79472345|FG000|Overall Study|Withdrawal by Subject|0|||
44463345|NCT00505622|79472346|FG001|Overall Study|Withdrawal by Subject|3|||
44463346|NCT00505622|79472347|FG002|Overall Study|Withdrawal by Subject|2|||
44463347|NCT00505622|79472345|FG000|Overall Study|Study termination by sponsor|115|||
44463348|NCT00505622|79472346|FG001|Overall Study|Study termination by sponsor|98|||
44463349|NCT00505622|79472347|FG002|Overall Study|Study termination by sponsor|90|||
44221754|NCT01890967|79024969|FG003|Overall Study|Sponsor Decision|3|||
44463350|NCT03851094|79472357|FG000|Overall Study|Withdrawal by Subject|0|||
44463351|NCT03851094|79472358|FG001|Overall Study|Withdrawal by Subject|1|||
44463352|NCT03851094|79472357|FG000|Overall Study|Participant lost device|0|||
44463353|NCT03851094|79472358|FG001|Overall Study|Participant lost device|1|||
44463354|NCT03851094|79472357|FG000|Overall Study|Participant returned device|0|||
44463355|NCT03851094|79472358|FG001|Overall Study|Participant returned device|2|||
44463356|NCT00505076|79472369|FG000|Overall Study|Adverse Event|1|||
44463357|NCT00505076|79472370|FG001|Overall Study|Adverse Event|0|||
44463358|NCT00505076|79472371|FG002|Overall Study|Adverse Event|1|||
44463359|NCT00505076|79472369|FG000|Overall Study|Protocol Violation|2|||
44221755|NCT01890967|79024970|FG004|Overall Study|Sponsor Decision|2|||
44221756|NCT01890967|79024971|FG005|Overall Study|Sponsor Decision|3|||
44221757|NCT01890967|79024966|FG000|Overall Study|Withdrawal by Subject|3|||
44221758|NCT01890967|79024967|FG001|Overall Study|Withdrawal by Subject|4|||
44221759|NCT01890967|79024968|FG002|Overall Study|Withdrawal by Subject|2|||
44221760|NCT01890967|79024969|FG003|Overall Study|Withdrawal by Subject|3|||
44221761|NCT01890967|79024970|FG004|Overall Study|Withdrawal by Subject|3|||
44221762|NCT01890967|79024971|FG005|Overall Study|Withdrawal by Subject|1|||
44221763|NCT01400919|79024990|FG000|Overall Study|Withdrawal by Subject|4|||
44221764|NCT01400919|79024990|FG000|Overall Study|Lost to Follow-up|2|||
44221765|NCT01400919|79024990|FG000|Overall Study|Missed visit|2|||
44271325|NCT02041533|79200817|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
44463360|NCT00505076|79472370|FG001|Overall Study|Protocol Violation|1|||
44463361|NCT00505076|79472371|FG002|Overall Study|Protocol Violation|2|||
44463362|NCT00505076|79472369|FG000|Overall Study|Withdrawal by Subject|0|||
44544250|NCT03602053|79557531|FG002|Overall Study|Other|0|||
44544251|NCT04831515|79557543|FG000|First Intervention|Adverse Event|0|||
44221766|NCT01864291|79024994|FG000|Overall Study|need for revision surgery|2|||
44271326|NCT02041533|79200816|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
44463363|NCT00505076|79472370|FG001|Overall Study|Withdrawal by Subject|1|||
44463364|NCT00505076|79472371|FG002|Overall Study|Withdrawal by Subject|2|||
44463365|NCT00307684|79472379|FG000|Open Label Phase|Lack of Efficacy|0|||
44463366|NCT00307684|79472380|FG001|Open Label Phase|Lack of Efficacy|0|||
44463367|NCT00307684|79472381|FG002|Open Label Phase|Lack of Efficacy|3|||
44463368|NCT00307684|79472379|FG000|Open Label Phase|Adverse Event|0|||
44463369|NCT00307684|79472380|FG001|Open Label Phase|Adverse Event|0|||
44463370|NCT00307684|79472381|FG002|Open Label Phase|Adverse Event|16|||
44463371|NCT00307684|79472379|FG000|Open Label Phase|Withdrawal by Subject|0|||
44463372|NCT00307684|79472380|FG001|Open Label Phase|Withdrawal by Subject|0|||
44463373|NCT00307684|79472381|FG002|Open Label Phase|Withdrawal by Subject|15|||
44463374|NCT00307684|79472379|FG000|Open Label Phase|Lost to Follow-up|0|||
44463375|NCT00307684|79472380|FG001|Open Label Phase|Lost to Follow-up|0|||
44463376|NCT00307684|79472381|FG002|Open Label Phase|Lost to Follow-up|11|||
44221767|NCT01400841|79024998|FG000|Initial Study Phase (6 Months)|Death|1|||
44221768|NCT01400841|79024998|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
44221769|NCT01863667|79025004|FG000|Overall Study|Adverse Event|1|||
44221770|NCT01863667|79025005|FG001|Overall Study|Adverse Event|0|||
44463377|NCT00307684|79472379|FG000|Open Label Phase|non compliance|0|||
44463378|NCT00307684|79472380|FG001|Open Label Phase|non compliance|0|||
44463379|NCT00307684|79472381|FG002|Open Label Phase|non compliance|5|||
44463380|NCT00307684|79472379|FG000|Open Label Phase|other|0|||
44463381|NCT00307684|79472380|FG001|Open Label Phase|other|0|||
44463382|NCT00307684|79472381|FG002|Open Label Phase|other|6|||
44463383|NCT00307684|79472379|FG000|Double Blind Phase|Lack of Efficacy|2|||
44463384|NCT00307684|79472380|FG001|Double Blind Phase|Lack of Efficacy|5|||
44463385|NCT00307684|79472381|FG002|Double Blind Phase|Lack of Efficacy|0|||
44463386|NCT00489918|79472394|FG000|Overall Study|Withdrawal by Subject|2|||
44463387|NCT00489918|79472395|FG001|Overall Study|Withdrawal by Subject|1|||
44463388|NCT00489918|79472396|FG002|Overall Study|Withdrawal by Subject|1|||
44463389|NCT00489918|79472397|FG003|Overall Study|Withdrawal by Subject|0|||
44463390|NCT00489918|79472398|FG004|Overall Study|Withdrawal by Subject|1|||
44463391|NCT00489918|79472394|FG000|Overall Study|Adverse Event|0|||
44221771|NCT01863667|79025004|FG000|Overall Study|Study terminated by Sponsor|30|||
44463392|NCT00489918|79472395|FG001|Overall Study|Adverse Event|1|||
44221772|NCT01863667|79025005|FG001|Overall Study|Study terminated by Sponsor|30|||
44221773|NCT01863667|79025004|FG000|Overall Study|Withdrawal by Subject|2|||
44221774|NCT01863667|79025005|FG001|Overall Study|Withdrawal by Subject|2|||
44221775|NCT01614769|79025011|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
44221776|NCT01614769|79025012|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
44374463|NCT00800683|79379603|FG000|Overall Study|Lost to Follow-up|3|||
44374464|NCT00800683|79379604|FG001|Overall Study|Lost to Follow-up|1|||
44374465|NCT00800683|79379603|FG000|Overall Study|Withdrawal by Subject|1|||
44374466|NCT00800683|79379604|FG001|Overall Study|Withdrawal by Subject|7|||
44374467|NCT00800683|79379603|FG000|Overall Study|Lack of Efficacy|1|||
44374468|NCT00800683|79379604|FG001|Overall Study|Lack of Efficacy|1|||
44374469|NCT00800683|79379603|FG000|Overall Study|Other|1|||
44374470|NCT00800683|79379604|FG001|Overall Study|Other|2|||
44374471|NCT01124864|79379616|FG000|Overall Study|Follow up phase competed as per protocol|18|||
44374472|NCT01124864|79379617|FG001|Overall Study|Follow up phase competed as per protocol|22|||
44463393|NCT00489918|79472396|FG002|Overall Study|Adverse Event|1|||
44463394|NCT00489918|79472397|FG003|Overall Study|Adverse Event|0|||
44463395|NCT00489918|79472398|FG004|Overall Study|Adverse Event|0|||
44463396|NCT00489918|79472394|FG000|Overall Study|Lost to Follow-up|0|||
44463397|NCT00489918|79472395|FG001|Overall Study|Lost to Follow-up|0|||
44463398|NCT00489918|79472396|FG002|Overall Study|Lost to Follow-up|1|||
44463399|NCT00489918|79472397|FG003|Overall Study|Lost to Follow-up|1|||
44221777|NCT01614769|79025013|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
44221778|NCT01614769|79025014|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
44374473|NCT01124864|79379618|FG002|Overall Study|Follow up phase competed as per protocol|24|||
44463400|NCT00489918|79472398|FG004|Overall Study|Lost to Follow-up|0|||
44463401|NCT00489918|79472394|FG000|Overall Study|Physician Decision|0|||
44463402|NCT00489918|79472395|FG001|Overall Study|Physician Decision|0|||
44463403|NCT00489918|79472396|FG002|Overall Study|Physician Decision|1|||
44463404|NCT00489918|79472397|FG003|Overall Study|Physician Decision|0|||
44463405|NCT00489918|79472398|FG004|Overall Study|Physician Decision|0|||
44463406|NCT00307294|79472410|FG000|Overall Study|Withdrawal by Subject|1|||
44463407|NCT03963401|79472421|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
44463408|NCT03963401|79472422|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
44463409|NCT03963401|79472423|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
44463410|NCT03963401|79472424|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
44463411|NCT03963401|79472425|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
44463412|NCT03963401|79472426|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
44463413|NCT03963401|79472421|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
44463414|NCT03963401|79472422|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
44463415|NCT03963401|79472423|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
44463416|NCT03963401|79472424|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
44463417|NCT03963401|79472425|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
44463418|NCT03963401|79472426|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
44463419|NCT03963401|79472421|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
44463420|NCT03963401|79472422|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
44463421|NCT03963401|79472423|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
44463422|NCT03963401|79472424|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
44463423|NCT03963401|79472425|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
44463424|NCT03963401|79472426|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
44463425|NCT03963401|79472421|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
44463426|NCT03963401|79472422|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
44463427|NCT03963401|79472423|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
44463428|NCT03963401|79472424|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
44463429|NCT03963401|79472425|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
44463430|NCT03963401|79472426|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
44463431|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
44463432|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
44463433|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
44463434|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
44463435|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
44463436|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
44463437|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
44463438|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
44463439|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
44463440|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
44463441|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
44463442|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
44463443|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
44463444|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
44463445|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
44463446|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
44463447|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
44221779|NCT01614769|79025015|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
44221780|NCT01614769|79025016|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
44221781|NCT01614769|79025011|FG000|Period 1|Protocol Violation|0|||
44221782|NCT01614769|79025012|FG001|Period 1|Protocol Violation|0|||
44221783|NCT01614769|79025013|FG002|Period 1|Protocol Violation|0|||
44221784|NCT01614769|79025014|FG003|Period 1|Protocol Violation|1|||
44221785|NCT01614769|79025015|FG004|Period 1|Protocol Violation|0|||
44221786|NCT01614769|79025016|FG005|Period 1|Protocol Violation|0|||
44221787|NCT01614769|79025011|FG000|Period 1|Withdrawal by Subject|1|||
44221788|NCT01614769|79025012|FG001|Period 1|Withdrawal by Subject|0|||
44221789|NCT01614769|79025013|FG002|Period 1|Withdrawal by Subject|0|||
44221790|NCT01614769|79025014|FG003|Period 1|Withdrawal by Subject|0|||
44221791|NCT01614769|79025015|FG004|Period 1|Withdrawal by Subject|0|||
44221792|NCT01614769|79025016|FG005|Period 1|Withdrawal by Subject|0|||
44221793|NCT01614769|79025011|FG000|Period 3|Withdrawal by Subject|0|||
44221794|NCT01614769|79025012|FG001|Period 3|Withdrawal by Subject|0|||
44221795|NCT01614769|79025013|FG002|Period 3|Withdrawal by Subject|1|||
44221796|NCT01614769|79025014|FG003|Period 3|Withdrawal by Subject|0|||
44221797|NCT01614769|79025015|FG004|Period 3|Withdrawal by Subject|0|||
44221798|NCT01614769|79025016|FG005|Period 3|Withdrawal by Subject|0|||
44221799|NCT01614457|79025026|FG000|Overall Study|Non-Compliance|1|||
44221800|NCT01614457|79025027|FG001|Overall Study|Non-Compliance|0|||
44221801|NCT01614457|79025026|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
44221802|NCT01614457|79025027|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
44221803|NCT01863433|79025033|FG000|Overall Study|Protocol Violation|1|||
44221804|NCT01862029|79025037|FG000|Overall Study|Physician Decision|1|||
44463448|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
44463449|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
44544252|NCT04831515|79557544|FG001|First Intervention|Adverse Event|1|||
44221805|NCT01835431|79025044|FG000|Overall Study|Adverse Event|1|||
44463450|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
44463451|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
44463452|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
44463453|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
44463454|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
44463455|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
44463456|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
44463457|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
44463458|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
44463459|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
44463460|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
44463461|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
44463462|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
44463463|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
44463464|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
44463465|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
44463466|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
44463467|NCT03963401|79472421|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
44463468|NCT03963401|79472422|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
44463469|NCT03963401|79472423|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
44463470|NCT03963401|79472424|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
44463471|NCT03963401|79472425|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
44463472|NCT03963401|79472426|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
44463473|NCT00334282|79472446|FG000|Overall Study|Lost to Follow-up|11|||
44463474|NCT00334282|79472447|FG001|Overall Study|Lost to Follow-up|5|||
44463475|NCT00334282|79472446|FG000|Overall Study|Withdrawal by Subject|17|||
44463476|NCT00334282|79472447|FG001|Overall Study|Withdrawal by Subject|3|||
44463477|NCT00334282|79472446|FG000|Overall Study|Death|194|||
44463478|NCT00334282|79472447|FG001|Overall Study|Death|100|||
44463479|NCT00306670|79472459|FG000|Overall Study|patients recruited; Genentech, the st|0|||
44463480|NCT00306670|79472460|FG001|Overall Study|patients recruited; Genentech, the st|2|||
44463481|NCT00306592|79472466|FG000|Overall Study|Adverse Event|8|||
44463482|NCT00306592|79472467|FG001|Overall Study|Adverse Event|15|||
44463483|NCT00306592|79472466|FG000|Overall Study|Lost to Follow-up|1|||
44463484|NCT00306592|79472467|FG001|Overall Study|Lost to Follow-up|0|||
44463485|NCT00306592|79472466|FG000|Overall Study|Noncompliance|0|||
44463486|NCT00306592|79472467|FG001|Overall Study|Noncompliance|2|||
44463487|NCT00306592|79472466|FG000|Overall Study|Persistent Antibodies|6|||
44463488|NCT00306592|79472467|FG001|Overall Study|Persistent Antibodies|3|||
44463489|NCT00306592|79472466|FG000|Overall Study|Voluntary|10|||
44463490|NCT00306592|79472467|FG001|Overall Study|Voluntary|6|||
44463491|NCT00306592|79472466|FG000|Overall Study|Other|5|||
44463492|NCT00306592|79472467|FG001|Overall Study|Other|10|||
44463493|NCT00306592|79472466|FG000|Overall Study|Other|1|||
44463494|NCT00306592|79472467|FG001|Overall Study|Other|2|||
44463495|NCT00306592|79472466|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
44463496|NCT00306592|79472467|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
44463497|NCT00321646|79472471|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
44463498|NCT00321646|79472471|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
44463499|NCT00321646|79472471|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
44463500|NCT00403767|79472477|FG000|Overall Study|Adverse Event|993|||
44463501|NCT00403767|79472478|FG001|Overall Study|Adverse Event|919|||
44463502|NCT00403767|79472477|FG000|Overall Study|Non-compliant with study medication|134|||
44463503|NCT00403767|79472478|FG001|Overall Study|Non-compliant with study medication|164|||
44463504|NCT00403767|79472477|FG000|Overall Study|Consent withdrawn|671|||
44221806|NCT01835431|79025045|FG001|Overall Study|Adverse Event|0|||
44221807|NCT01835431|79025044|FG000|Overall Study|other|0|||
44221808|NCT01835431|79025045|FG001|Overall Study|other|2|||
44221809|NCT01835431|79025044|FG000|Overall Study|Withdrawal by Subject|6|||
44221810|NCT01835431|79025045|FG001|Overall Study|Withdrawal by Subject|10|||
44463505|NCT00403767|79472478|FG001|Overall Study|Consent withdrawn|673|||
44463506|NCT00403767|79472477|FG000|Overall Study|Investigator dec./not protocol-related|191|||
44463507|NCT00403767|79472478|FG001|Overall Study|Investigator dec./not protocol-related|178|||
44463508|NCT00403767|79472477|FG000|Overall Study|Lost to Follow-up|6|||
44463509|NCT00403767|79472478|FG001|Overall Study|Lost to Follow-up|8|||
44463510|NCT00403767|79472477|FG000|Overall Study|Protocol Violation|142|||
44221811|NCT01835431|79025044|FG000|Overall Study|Protocol Violation|1|||
44463511|NCT00403767|79472478|FG001|Overall Study|Protocol Violation|124|||
44271327|NCT02041533|79200817|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
44374474|NCT01124864|79379619|FG003|Overall Study|Follow up phase competed as per protocol|18|||
44374475|NCT01124864|79379620|FG004|Overall Study|Follow up phase competed as per protocol|26|||
44374476|NCT01124864|79379621|FG005|Overall Study|Follow up phase competed as per protocol|2|||
44463512|NCT00403767|79472477|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
44463513|NCT00403767|79472478|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
44463514|NCT00403767|79472477|FG000|Overall Study|Study terminated by sponsor|82|||
44463515|NCT00403767|79472478|FG001|Overall Study|Study terminated by sponsor|69|||
44463516|NCT00403767|79472477|FG000|Overall Study|Missing/incomplete data|1|||
44463517|NCT00403767|79472478|FG001|Overall Study|Missing/incomplete data|1|||
44463518|NCT00492284|79472488|FG000|Overall Study|Adverse Event|0|||
44463519|NCT00492284|79472489|FG001|Overall Study|Adverse Event|1|||
44463520|NCT00492284|79472490|FG002|Overall Study|Adverse Event|1|||
44463521|NCT00492284|79472491|FG003|Overall Study|Adverse Event|2|||
44463522|NCT00492284|79472488|FG000|Overall Study|Lost to Follow-up|0|||
44463523|NCT00492284|79472489|FG001|Overall Study|Lost to Follow-up|0|||
44463524|NCT00492284|79472490|FG002|Overall Study|Lost to Follow-up|3|||
44463525|NCT00492284|79472491|FG003|Overall Study|Lost to Follow-up|1|||
44463526|NCT00492284|79472488|FG000|Overall Study|Death|0|||
44463527|NCT00492284|79472489|FG001|Overall Study|Death|3|||
44463528|NCT00492284|79472490|FG002|Overall Study|Death|2|||
44463529|NCT00492284|79472491|FG003|Overall Study|Death|5|||
44463530|NCT00492284|79472488|FG000|Overall Study|Withdrawal by Subject|1|||
44463531|NCT00492284|79472489|FG001|Overall Study|Withdrawal by Subject|0|||
44463532|NCT00492284|79472490|FG002|Overall Study|Withdrawal by Subject|0|||
44463533|NCT00492284|79472491|FG003|Overall Study|Withdrawal by Subject|2|||
44463534|NCT00510458|79472501|FG000|Overall Study|5 year not evaluable/missed|21|||
44463535|NCT00510458|79472501|FG000|Overall Study|Death|1|||
44221812|NCT01835431|79025045|FG001|Overall Study|Protocol Violation|0|||
44374477|NCT01124864|79379616|FG000|Overall Study|Death|6|||
44374478|NCT01124864|79379617|FG001|Overall Study|Death|9|||
44374479|NCT01124864|79379618|FG002|Overall Study|Death|6|||
44374480|NCT01124864|79379619|FG003|Overall Study|Death|2|||
44374481|NCT01124864|79379620|FG004|Overall Study|Death|1|||
44374482|NCT01124864|79379621|FG005|Overall Study|Death|0|||
44374483|NCT01124864|79379616|FG000|Overall Study|Withdrawal by Subject|2|||
44374484|NCT01124864|79379617|FG001|Overall Study|Withdrawal by Subject|3|||
44374485|NCT01124864|79379618|FG002|Overall Study|Withdrawal by Subject|4|||
44374486|NCT01124864|79379619|FG003|Overall Study|Withdrawal by Subject|0|||
44374487|NCT01124864|79379620|FG004|Overall Study|Withdrawal by Subject|2|||
44374488|NCT01124864|79379621|FG005|Overall Study|Withdrawal by Subject|1|||
44374489|NCT01124864|79379616|FG000|Overall Study|Lost to Follow-up|1|||
44374490|NCT01124864|79379617|FG001|Overall Study|Lost to Follow-up|1|||
44374491|NCT01124864|79379618|FG002|Overall Study|Lost to Follow-up|0|||
44221813|NCT01880593|79025053|FG000|Overall Study|Adverse Event|1|||
44221814|NCT01880593|79025054|FG001|Overall Study|Adverse Event|0|||
44221815|NCT01880593|79025053|FG000|Overall Study|Lack of Efficacy|1|||
44221816|NCT01880593|79025054|FG001|Overall Study|Lack of Efficacy|5|||
44221817|NCT01880593|79025053|FG000|Overall Study|Withdrawal by Subject|6|||
44221818|NCT01880593|79025054|FG001|Overall Study|Withdrawal by Subject|1|||
44221819|NCT01400451|79025063|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
44221820|NCT01400451|79025064|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
44221821|NCT01400451|79025065|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
44221822|NCT01400451|79025063|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
44271328|NCT02041533|79200816|FG000|Treatment Period|Participant withdrew consent|2|||
44271329|NCT02041533|79200817|FG001|Treatment Period|Participant withdrew consent|2|||
44374492|NCT01124864|79379619|FG003|Overall Study|Lost to Follow-up|1|||
44374493|NCT01124864|79379620|FG004|Overall Study|Lost to Follow-up|0|||
44374494|NCT01124864|79379621|FG005|Overall Study|Lost to Follow-up|0|||
44374495|NCT01124864|79379616|FG000|Overall Study|Protocol Violation|1|||
44374496|NCT01124864|79379617|FG001|Overall Study|Protocol Violation|0|||
44374497|NCT01124864|79379618|FG002|Overall Study|Protocol Violation|0|||
44463536|NCT00510458|79472501|FG000|Overall Study|Terminated|14|||
44463537|NCT00510458|79472501|FG000|Overall Study|Lost to Follow-up|6|||
44221823|NCT01400451|79025064|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
44374498|NCT01124864|79379619|FG003|Overall Study|Protocol Violation|0|||
44463538|NCT00510458|79472501|FG000|Overall Study|Withdrawal by Subject|3|||
44221824|NCT01400451|79025065|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
44463539|NCT00510458|79472501|FG000|Overall Study|Revision|2|||
44374499|NCT01124864|79379620|FG004|Overall Study|Protocol Violation|1|||
44463540|NCT00414765|79472508|FG000|Overall Study|Adverse Event|5|||
44463541|NCT00414765|79472509|FG001|Overall Study|Adverse Event|9|||
44463542|NCT00414765|79472508|FG000|Overall Study|Withdrawal by Subject|1|||
44463543|NCT00414765|79472509|FG001|Overall Study|Withdrawal by Subject|1|||
44463544|NCT00414765|79472508|FG000|Overall Study|Disease Progression|0|||
44463545|NCT00414765|79472509|FG001|Overall Study|Disease Progression|1|||
44463546|NCT00500682|79472517|FG000|Overall Study|Adverse Event|37|||
44463547|NCT00500682|79472518|FG001|Overall Study|Adverse Event|29|||
44463548|NCT00500682|79472517|FG000|Overall Study|Death|25|||
44463549|NCT00500682|79472518|FG001|Overall Study|Death|16|||
44463550|NCT00500682|79472517|FG000|Overall Study|Lost to Follow-up|11|||
44463551|NCT00500682|79472518|FG001|Overall Study|Lost to Follow-up|11|||
44463552|NCT00500682|79472517|FG000|Overall Study|Physician Decision|6|||
44463553|NCT00500682|79472518|FG001|Overall Study|Physician Decision|10|||
44463554|NCT00500682|79472517|FG000|Overall Study|Pregnancy|2|||
44463555|NCT00500682|79472518|FG001|Overall Study|Pregnancy|0|||
44463556|NCT00500682|79472517|FG000|Overall Study|Protocol Violation|1|||
44463557|NCT00500682|79472518|FG001|Overall Study|Protocol Violation|3|||
44463558|NCT00500682|79472517|FG000|Overall Study|Withdrawal by Subject|80|||
44463559|NCT00500682|79472518|FG001|Overall Study|Withdrawal by Subject|74|||
44463560|NCT00500682|79472517|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
44463561|NCT00500682|79472518|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
44463562|NCT00500370|79472526|FG000|Overall Study|Adverse Event|9|||
44463563|NCT00500370|79472527|FG001|Overall Study|Adverse Event|3|||
44463564|NCT00500370|79472526|FG000|Overall Study|Lost to Follow-up|10|||
44463565|NCT00500370|79472527|FG001|Overall Study|Lost to Follow-up|10|||
44463566|NCT00500370|79472526|FG000|Overall Study|Protocol Violation|2|||
44463567|NCT00500370|79472527|FG001|Overall Study|Protocol Violation|4|||
44463568|NCT00500370|79472526|FG000|Overall Study|Sponsor Decision|2|||
44463569|NCT00500370|79472527|FG001|Overall Study|Sponsor Decision|0|||
44463570|NCT00500370|79472526|FG000|Overall Study|Subject Decision|10|||
44463571|NCT00500370|79472527|FG001|Overall Study|Subject Decision|17|||
44463572|NCT00320788|79472538|FG000|Overall Study|Adverse Event|0|||
44463573|NCT00320788|79472539|FG001|Overall Study|Adverse Event|0|||
44463574|NCT00320788|79472540|FG002|Overall Study|Adverse Event|0|||
44463575|NCT00320788|79472541|FG003|Overall Study|Adverse Event|1|||
44463576|NCT00320788|79472542|FG004|Overall Study|Adverse Event|0|||
44463577|NCT00320788|79472538|FG000|Overall Study|Death|0|||
44463578|NCT00320788|79472539|FG001|Overall Study|Death|0|||
44463579|NCT00320788|79472540|FG002|Overall Study|Death|1|||
44463580|NCT00320788|79472541|FG003|Overall Study|Death|0|||
44463581|NCT00320788|79472542|FG004|Overall Study|Death|1|||
44374500|NCT01124864|79379621|FG005|Overall Study|Protocol Violation|0|||
44374501|NCT01113710|79379637|FG000|Overall Study|Adverse Event|64|||
44374502|NCT01113710|79379637|FG000|Overall Study|Lack of Efficacy|41|||
44374503|NCT01113710|79379637|FG000|Overall Study|No Information Available|40|||
44374504|NCT01113710|79379637|FG000|Overall Study|Withdrawal by Subject|28|||
44374505|NCT01113710|79379637|FG000|Overall Study|Lost to Follow-up|20|||
44374506|NCT01113710|79379637|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
44374507|NCT01113710|79379637|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
44374508|NCT01113710|79379637|FG000|Overall Study|Lack of Patient's Compliance|8|||
44374509|NCT01113710|79379637|FG000|Overall Study|Other|7|||
44374510|NCT01113710|79379637|FG000|Overall Study|Adverse Event/Other|5|||
44374511|NCT01113710|79379637|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
44374512|NCT01113710|79379637|FG000|Overall Study|Lack of Efficacy/Other|4|||
44374513|NCT01113710|79379637|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
44374514|NCT01113710|79379637|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
44374515|NCT01113710|79379637|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
44374516|NCT01113710|79379637|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
44374517|NCT01113710|79379637|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
44374518|NCT01113710|79379637|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
44374519|NCT01113710|79379637|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
44374520|NCT01113710|79379637|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
44374521|NCT01113710|79379637|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
44374522|NCT01113710|79379637|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
44374523|NCT01113710|79379637|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
44374524|NCT01113710|79379637|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
44374525|NCT01113710|79379637|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
44374526|NCT01124162|79379643|FG000|First Intervention|Adverse Event|2|||
44463582|NCT00320788|79472538|FG000|Overall Study|Lost to Follow-up|0|||
44463583|NCT00320788|79472539|FG001|Overall Study|Lost to Follow-up|2|||
44463584|NCT00320788|79472540|FG002|Overall Study|Lost to Follow-up|1|||
44463585|NCT00320788|79472541|FG003|Overall Study|Lost to Follow-up|0|||
44463586|NCT00320788|79472542|FG004|Overall Study|Lost to Follow-up|0|||
44463587|NCT00320788|79472538|FG000|Overall Study|Decision by the Sponsor|1|||
44463588|NCT00320788|79472539|FG001|Overall Study|Decision by the Sponsor|1|||
44463589|NCT00320788|79472540|FG002|Overall Study|Decision by the Sponsor|0|||
44463590|NCT00320788|79472541|FG003|Overall Study|Decision by the Sponsor|0|||
44463591|NCT00320788|79472542|FG004|Overall Study|Decision by the Sponsor|1|||
44463592|NCT00320788|79472538|FG000|Overall Study|Other|1|||
44463593|NCT00320788|79472539|FG001|Overall Study|Other|2|||
44463594|NCT00320788|79472540|FG002|Overall Study|Other|1|||
44463595|NCT00320788|79472541|FG003|Overall Study|Other|1|||
44463596|NCT00320788|79472542|FG004|Overall Study|Other|1|||
44463597|NCT00320788|79472538|FG000|Overall Study|Physician Decision|1|||
44463598|NCT00320788|79472539|FG001|Overall Study|Physician Decision|1|||
44463599|NCT00320788|79472540|FG002|Overall Study|Physician Decision|0|||
44463600|NCT00320788|79472541|FG003|Overall Study|Physician Decision|0|||
44463601|NCT00320788|79472542|FG004|Overall Study|Physician Decision|0|||
44463602|NCT00320788|79472538|FG000|Overall Study|Protocol Violation|0|||
44463603|NCT00320788|79472539|FG001|Overall Study|Protocol Violation|0|||
44463604|NCT00320788|79472540|FG002|Overall Study|Protocol Violation|0|||
44463605|NCT00320788|79472541|FG003|Overall Study|Protocol Violation|0|||
44463606|NCT00320788|79472542|FG004|Overall Study|Protocol Violation|1|||
44463607|NCT00320788|79472538|FG000|Overall Study|Withdrawal by Subject|3|||
44463608|NCT00320788|79472539|FG001|Overall Study|Withdrawal by Subject|0|||
44463609|NCT00320788|79472540|FG002|Overall Study|Withdrawal by Subject|0|||
44463610|NCT00320788|79472541|FG003|Overall Study|Withdrawal by Subject|3|||
44463611|NCT00320788|79472542|FG004|Overall Study|Withdrawal by Subject|1|||
44463612|NCT00503984|79472562|FG000|Overall Study|Protocol Violation|0|||
44463613|NCT00503984|79472563|FG001|Overall Study|Protocol Violation|1|||
44463614|NCT00503984|79472564|FG002|Overall Study|Protocol Violation|0|||
44463615|NCT00503984|79472565|FG003|Overall Study|Protocol Violation|0|||
44463616|NCT00503984|79472566|FG004|Overall Study|Protocol Violation|0|||
44463617|NCT00503984|79472567|FG005|Overall Study|Protocol Violation|0|||
44463618|NCT00503984|79472562|FG000|Overall Study|Adverse Event|0|||
44463619|NCT00503984|79472563|FG001|Overall Study|Adverse Event|1|||
44463620|NCT00503984|79472564|FG002|Overall Study|Adverse Event|0|||
44463621|NCT00503984|79472565|FG003|Overall Study|Adverse Event|0|||
44463622|NCT00503984|79472566|FG004|Overall Study|Adverse Event|0|||
44463623|NCT00503984|79472567|FG005|Overall Study|Adverse Event|0|||
44463624|NCT00503984|79472562|FG000|Overall Study|Death|0|||
44463625|NCT00503984|79472563|FG001|Overall Study|Death|0|||
44463626|NCT00503984|79472564|FG002|Overall Study|Death|0|||
44463627|NCT00503984|79472565|FG003|Overall Study|Death|0|||
44463628|NCT00503984|79472566|FG004|Overall Study|Death|1|||
44463629|NCT00503984|79472567|FG005|Overall Study|Death|0|||
44374527|NCT01124162|79379644|FG001|First Intervention|Adverse Event|0|||
44374528|NCT01124162|79379643|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44374529|NCT01124162|79379644|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44463630|NCT00565409|79472591|FG000|Period 1 Open Label|Adverse Event|17|||
44463631|NCT00565409|79472592|FG001|Period 1 Open Label|Adverse Event|0|||
44463632|NCT00565409|79472593|FG002|Period 1 Open Label|Adverse Event|0|||
44463633|NCT00565409|79472594|FG003|Period 1 Open Label|Adverse Event|0|||
44463634|NCT00565409|79472591|FG000|Period 1 Open Label|Death|2|||
44463635|NCT00565409|79472592|FG001|Period 1 Open Label|Death|0|||
44463636|NCT00565409|79472593|FG002|Period 1 Open Label|Death|0|||
44463637|NCT00565409|79472594|FG003|Period 1 Open Label|Death|0|||
44463638|NCT00565409|79472591|FG000|Period 1 Open Label|Lost to Follow-up|1|||
44463639|NCT00565409|79472592|FG001|Period 1 Open Label|Lost to Follow-up|0|||
44463640|NCT00565409|79472593|FG002|Period 1 Open Label|Lost to Follow-up|0|||
44463641|NCT00565409|79472594|FG003|Period 1 Open Label|Lost to Follow-up|0|||
44463642|NCT00565409|79472591|FG000|Period 1 Open Label|Other|21|||
44463643|NCT00565409|79472592|FG001|Period 1 Open Label|Other|0|||
44463644|NCT00565409|79472593|FG002|Period 1 Open Label|Other|0|||
44463645|NCT00565409|79472594|FG003|Period 1 Open Label|Other|0|||
44221825|NCT01400451|79025063|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
44221826|NCT01400451|79025064|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
44221827|NCT01400451|79025065|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
44374530|NCT00906399|79379653|FG000|Year 1|Randomized But Not Treated|0|||
44374531|NCT00906399|79379654|FG001|Year 1|Randomized But Not Treated|1|||
44374532|NCT00906399|79379655|FG002|Year 1|Randomized But Not Treated|3|||
44374533|NCT00906399|79379656|FG003|Year 1|Randomized But Not Treated|0|||
44374534|NCT00906399|79379657|FG004|Year 1|Randomized But Not Treated|0|||
44374535|NCT00906399|79379658|FG005|Year 1|Randomized But Not Treated|0|||
44463646|NCT00565409|79472591|FG000|Period 1 Open Label|Protocol Violation|14|||
44463647|NCT00565409|79472592|FG001|Period 1 Open Label|Protocol Violation|0|||
44463648|NCT00565409|79472593|FG002|Period 1 Open Label|Protocol Violation|0|||
44374536|NCT00906399|79379659|FG006|Year 1|Randomized But Not Treated|0|||
44463649|NCT00565409|79472594|FG003|Period 1 Open Label|Protocol Violation|0|||
44463650|NCT00565409|79472591|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
44463651|NCT00565409|79472592|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
44463652|NCT00565409|79472593|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
44463653|NCT00565409|79472594|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
44463654|NCT00565409|79472591|FG000|Period 1 Open Label|no conclusion of participation record|1|||
44463655|NCT00565409|79472592|FG001|Period 1 Open Label|no conclusion of participation record|0|||
44463656|NCT00565409|79472593|FG002|Period 1 Open Label|no conclusion of participation record|0|||
44463657|NCT00565409|79472594|FG003|Period 1 Open Label|no conclusion of participation record|0|||
44463658|NCT00565409|79472591|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
44463659|NCT00565409|79472592|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
44463660|NCT00565409|79472593|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
44463661|NCT00565409|79472594|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
44463662|NCT00565409|79472591|FG000|Period 2 Double-Blind|Adverse Event|0|||
44221828|NCT01400451|79025063|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
44221829|NCT01400451|79025064|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
44221830|NCT01400451|79025065|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
44221831|NCT01400451|79025063|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
44221832|NCT01400451|79025064|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
44221833|NCT01400451|79025065|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
44221834|NCT01400139|79025078|FG000|HYD Core Study|Adverse Event|210|||
44221835|NCT01400139|79025078|FG000|HYD Core Study|Lack of Efficacy|59|||
44221836|NCT01400139|79025078|FG000|HYD Core Study|Withdrawal by Subject|114|||
44221837|NCT01400139|79025078|FG000|HYD Core Study|Lost to Follow-up|39|||
44221838|NCT01400139|79025078|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
44374537|NCT00906399|79379653|FG000|Year 1|Adverse Event|4|||
44374538|NCT00906399|79379654|FG001|Year 1|Adverse Event|22|||
44374539|NCT00906399|79379655|FG002|Year 1|Adverse Event|24|||
44374540|NCT00906399|79379656|FG003|Year 1|Adverse Event|0|||
44374541|NCT00906399|79379657|FG004|Year 1|Adverse Event|0|||
44374542|NCT00906399|79379658|FG005|Year 1|Adverse Event|0|||
44374543|NCT00906399|79379659|FG006|Year 1|Adverse Event|0|||
44374544|NCT00906399|79379653|FG000|Year 1|Lost to Follow-up|4|||
44374545|NCT00906399|79379654|FG001|Year 1|Lost to Follow-up|4|||
44374546|NCT00906399|79379655|FG002|Year 1|Lost to Follow-up|2|||
44374547|NCT00906399|79379656|FG003|Year 1|Lost to Follow-up|0|||
44374548|NCT00906399|79379657|FG004|Year 1|Lost to Follow-up|0|||
44374549|NCT00906399|79379658|FG005|Year 1|Lost to Follow-up|0|||
44374550|NCT00906399|79379659|FG006|Year 1|Lost to Follow-up|0|||
44374551|NCT00906399|79379653|FG000|Year 1|Withdrawal by Subject|30|||
44374552|NCT00906399|79379654|FG001|Year 1|Withdrawal by Subject|32|||
44374553|NCT00906399|79379655|FG002|Year 1|Withdrawal by Subject|36|||
44374554|NCT00906399|79379656|FG003|Year 1|Withdrawal by Subject|0|||
44374555|NCT00906399|79379657|FG004|Year 1|Withdrawal by Subject|0|||
44374556|NCT00906399|79379658|FG005|Year 1|Withdrawal by Subject|0|||
44374557|NCT00906399|79379659|FG006|Year 1|Withdrawal by Subject|0|||
44374558|NCT00906399|79379653|FG000|Year 1|Physician Decision|0|||
44374559|NCT00906399|79379654|FG001|Year 1|Physician Decision|1|||
44374560|NCT00906399|79379655|FG002|Year 1|Physician Decision|3|||
44374561|NCT00906399|79379656|FG003|Year 1|Physician Decision|0|||
44374562|NCT00906399|79379657|FG004|Year 1|Physician Decision|0|||
44374563|NCT00906399|79379658|FG005|Year 1|Physician Decision|0|||
44374564|NCT00906399|79379659|FG006|Year 1|Physician Decision|0|||
44374565|NCT00906399|79379653|FG000|Year 1|Death|2|||
44374566|NCT00906399|79379654|FG001|Year 1|Death|1|||
44374567|NCT00906399|79379655|FG002|Year 1|Death|1|||
44374568|NCT00906399|79379656|FG003|Year 1|Death|0|||
44374569|NCT00906399|79379657|FG004|Year 1|Death|0|||
44374570|NCT00906399|79379658|FG005|Year 1|Death|0|||
44374571|NCT00906399|79379659|FG006|Year 1|Death|0|||
44374572|NCT00906399|79379653|FG000|Year 1|Other|4|||
44374573|NCT00906399|79379654|FG001|Year 1|Other|2|||
44374574|NCT00906399|79379655|FG002|Year 1|Other|7|||
44374575|NCT00906399|79379656|FG003|Year 1|Other|0|||
44374576|NCT00906399|79379657|FG004|Year 1|Other|0|||
44374577|NCT00906399|79379658|FG005|Year 1|Other|0|||
44374578|NCT00906399|79379659|FG006|Year 1|Other|0|||
44374579|NCT00906399|79379653|FG000|Year 2|Adverse Event|0|||
44374580|NCT00906399|79379654|FG001|Year 2|Adverse Event|0|||
44374581|NCT00906399|79379655|FG002|Year 2|Adverse Event|0|||
44374582|NCT00906399|79379656|FG003|Year 2|Adverse Event|9|||
44374583|NCT00906399|79379657|FG004|Year 2|Adverse Event|8|||
44374584|NCT00906399|79379658|FG005|Year 2|Adverse Event|11|||
44374585|NCT00906399|79379659|FG006|Year 2|Adverse Event|6|||
44374586|NCT00906399|79379653|FG000|Year 2|Lost to Follow-up|0|||
44374587|NCT00906399|79379654|FG001|Year 2|Lost to Follow-up|0|||
44374588|NCT00906399|79379655|FG002|Year 2|Lost to Follow-up|0|||
44374589|NCT00906399|79379656|FG003|Year 2|Lost to Follow-up|1|||
44374590|NCT00906399|79379657|FG004|Year 2|Lost to Follow-up|4|||
44221839|NCT01400139|79025078|FG000|HYD Core Study|Administrative|56|||
44374591|NCT00906399|79379658|FG005|Year 2|Lost to Follow-up|2|||
44374592|NCT00906399|79379659|FG006|Year 2|Lost to Follow-up|4|||
44374593|NCT00906399|79379653|FG000|Year 2|Withdrawal by Subject|0|||
44374594|NCT00906399|79379654|FG001|Year 2|Withdrawal by Subject|0|||
44374595|NCT00906399|79379655|FG002|Year 2|Withdrawal by Subject|0|||
44374596|NCT00906399|79379656|FG003|Year 2|Withdrawal by Subject|17|||
44374597|NCT00906399|79379657|FG004|Year 2|Withdrawal by Subject|18|||
44374598|NCT00906399|79379658|FG005|Year 2|Withdrawal by Subject|27|||
44374599|NCT00906399|79379659|FG006|Year 2|Withdrawal by Subject|13|||
44463663|NCT00565409|79472592|FG001|Period 2 Double-Blind|Adverse Event|7|||
44463664|NCT00565409|79472593|FG002|Period 2 Double-Blind|Adverse Event|4|||
44463665|NCT00565409|79472594|FG003|Period 2 Double-Blind|Adverse Event|5|||
44463666|NCT00565409|79472591|FG000|Period 2 Double-Blind|Death|0|||
44463667|NCT00565409|79472592|FG001|Period 2 Double-Blind|Death|2|||
44463668|NCT00565409|79472593|FG002|Period 2 Double-Blind|Death|0|||
44463669|NCT00565409|79472594|FG003|Period 2 Double-Blind|Death|0|||
44463670|NCT00565409|79472591|FG000|Period 2 Double-Blind|Protocol Violation|0|||
44463671|NCT00565409|79472592|FG001|Period 2 Double-Blind|Protocol Violation|4|||
44463672|NCT00565409|79472593|FG002|Period 2 Double-Blind|Protocol Violation|6|||
44463673|NCT00565409|79472594|FG003|Period 2 Double-Blind|Protocol Violation|2|||
44463674|NCT00565409|79472591|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
44271330|NCT02041533|79200816|FG000|Treatment Period|Maximum clinical benefit|0|||
44374600|NCT00906399|79379653|FG000|Year 2|Physician Decision|0|||
44374601|NCT00906399|79379654|FG001|Year 2|Physician Decision|0|||
44374602|NCT00906399|79379655|FG002|Year 2|Physician Decision|0|||
44374603|NCT00906399|79379656|FG003|Year 2|Physician Decision|0|||
44374604|NCT00906399|79379657|FG004|Year 2|Physician Decision|2|||
44374605|NCT00906399|79379658|FG005|Year 2|Physician Decision|6|||
44374606|NCT00906399|79379659|FG006|Year 2|Physician Decision|3|||
44374607|NCT00906399|79379653|FG000|Year 2|Death|0|||
44374608|NCT00906399|79379654|FG001|Year 2|Death|0|||
44374609|NCT00906399|79379655|FG002|Year 2|Death|0|||
44374610|NCT00906399|79379656|FG003|Year 2|Death|1|||
44374611|NCT00906399|79379657|FG004|Year 2|Death|0|||
44374612|NCT00906399|79379658|FG005|Year 2|Death|0|||
44374613|NCT00906399|79379659|FG006|Year 2|Death|3|||
44374614|NCT00906399|79379653|FG000|Year 2|Other|0|||
44374615|NCT00906399|79379654|FG001|Year 2|Other|0|||
44374616|NCT00906399|79379655|FG002|Year 2|Other|0|||
44374617|NCT00906399|79379656|FG003|Year 2|Other|2|||
44374618|NCT00906399|79379657|FG004|Year 2|Other|3|||
44374619|NCT00906399|79379658|FG005|Year 2|Other|1|||
44374620|NCT00906399|79379659|FG006|Year 2|Other|0|||
44374621|NCT01111838|79379671|FG000|Overall Study|Patient Ineligible|2|||
44374622|NCT01111838|79379671|FG000|Overall Study|Not Treated|3|||
44374623|NCT01111838|79379671|FG000|Overall Study|Clinical deterioration|1|||
44374624|NCT01111838|79379671|FG000|Overall Study|Other Complicating Disease|1|||
44374625|NCT00947856|79379677|FG000|Treatment Period|Progressive Disease|33|||
44374626|NCT00947856|79379678|FG001|Treatment Period|Progressive Disease|12|||
44374627|NCT00947856|79379677|FG000|Treatment Period|Adverse Event|15|||
44374628|NCT00947856|79379678|FG001|Treatment Period|Adverse Event|9|||
44374629|NCT00947856|79379677|FG000|Treatment Period|Physician Decision|14|||
44374630|NCT00947856|79379678|FG001|Treatment Period|Physician Decision|6|||
44374631|NCT00947856|79379677|FG000|Treatment Period|Study Stopped by Sponsor|4|||
44374632|NCT00947856|79379678|FG001|Treatment Period|Study Stopped by Sponsor|4|||
44374633|NCT00947856|79379677|FG000|Treatment Period|Withdrawal by Subject|12|||
44374634|NCT00947856|79379678|FG001|Treatment Period|Withdrawal by Subject|1|||
44374635|NCT00947856|79379677|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
44374636|NCT00947856|79379678|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
44374637|NCT00947856|79379677|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
44374638|NCT00947856|79379678|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
44374639|NCT00947856|79379677|FG000|Follow-up Period|Lost to Follow-up|7|||
44374640|NCT00947856|79379678|FG001|Follow-up Period|Lost to Follow-up|0|||
44374641|NCT00947856|79379677|FG000|Follow-up Period|Patient unavailable for site visits|1|||
44374642|NCT00947856|79379678|FG001|Follow-up Period|Patient unavailable for site visits|0|||
44374643|NCT00947856|79379677|FG000|Follow-up Period|Withdrawal by Subject|1|||
44463675|NCT00565409|79472592|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
44463676|NCT00565409|79472593|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
44271331|NCT02041533|79200817|FG001|Treatment Period|Maximum clinical benefit|18|||
44271332|NCT02041533|79200816|FG000|Treatment Period|Poor/Non-compliance|1|||
44374644|NCT00947856|79379678|FG001|Follow-up Period|Withdrawal by Subject|0|||
44374645|NCT00947544|79379693|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
44374646|NCT00947544|79379694|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
44374647|NCT00907335|79379706|FG000|Overall Study|Withdrawal by Subject|2|||
44374648|NCT00907335|79379707|FG001|Overall Study|Withdrawal by Subject|0|||
44374649|NCT00907335|79379706|FG000|Overall Study|Adverse Event|4|||
44374650|NCT00907335|79379707|FG001|Overall Study|Adverse Event|1|||
44374651|NCT00907335|79379706|FG000|Overall Study|Lost to Follow-up|2|||
44374652|NCT00907335|79379707|FG001|Overall Study|Lost to Follow-up|0|||
44463677|NCT00565409|79472594|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
44463678|NCT00565409|79472591|FG000|Period 2 Double-Blind|Other|0|||
44374653|NCT00947154|79379713|FG000|Overall Study|Lost to Follow-up|1|||
44463679|NCT00565409|79472592|FG001|Period 2 Double-Blind|Other|4|||
44463680|NCT00565409|79472593|FG002|Period 2 Double-Blind|Other|5|||
44463681|NCT00565409|79472594|FG003|Period 2 Double-Blind|Other|9|||
44463682|NCT00565409|79472591|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
44463683|NCT00565409|79472592|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
44463684|NCT00565409|79472593|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
44463685|NCT00565409|79472594|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
44463686|NCT00394251|79472606|FG000|Overall Study|Adverse Event|7|||
44463687|NCT00394251|79472607|FG001|Overall Study|Adverse Event|5|||
44463688|NCT00394251|79472606|FG000|Overall Study|Unacceptable Toxicity|20|||
44463689|NCT00394251|79472607|FG001|Overall Study|Unacceptable Toxicity|18|||
44463690|NCT00394251|79472606|FG000|Overall Study|Physician Decision|1|||
44463691|NCT00394251|79472607|FG001|Overall Study|Physician Decision|1|||
44463692|NCT00394251|79472606|FG000|Overall Study|Protocol Violation|0|||
44463693|NCT00394251|79472607|FG001|Overall Study|Protocol Violation|1|||
44463694|NCT00394251|79472606|FG000|Overall Study|Withdrawal by Subject|7|||
44463695|NCT00394251|79472607|FG001|Overall Study|Withdrawal by Subject|11|||
44463696|NCT00394251|79472606|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
44463697|NCT00394251|79472607|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
44463698|NCT00394095|79472619|FG000|Overall Study|Adverse Event|1|||
44463699|NCT00394095|79472620|FG001|Overall Study|Adverse Event|0|||
44271333|NCT02041533|79200817|FG001|Treatment Period|Poor/Non-compliance|0|||
44271334|NCT02041533|79200816|FG000|Treatment Period|Administrative reason by sponsor|1|||
44271335|NCT02041533|79200817|FG001|Treatment Period|Administrative reason by sponsor|0|||
44271336|NCT02041533|79200816|FG000|Treatment Period|Other reasons|9|||
44271337|NCT02041533|79200817|FG001|Treatment Period|Other reasons|2|||
44271338|NCT02041533|79200816|FG000|Treatment Period|Not Reported|0|||
44271339|NCT02041533|79200817|FG001|Treatment Period|Not Reported|1|||
44271340|NCT02907203|79200824|FG000|Overall Study|Death|1|||
44271341|NCT02907203|79200824|FG000|Overall Study|Lost to Follow-up|3|||
44271342|NCT02907203|79200824|FG000|Overall Study|Withdrawal by Subject|3|||
44271343|NCT02907203|79200824|FG000|Overall Study|Surgical bypass|1|||
44271344|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
44271345|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
44271346|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
44271347|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
44271348|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
44271349|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
44271350|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
44271351|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
44271352|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Death|1|||
44271353|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Death|1|||
44271354|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
44271355|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
44271356|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
44463700|NCT00503906|79472627|FG000|Overall Study|Withdrawal by Subject|1|||
44463701|NCT00305110|79472632|FG000|Overall Study|Missing data|29|||
44463702|NCT00491894|79472636|FG000|Overall Study|Adverse Event|14|||
44463703|NCT00491894|79472636|FG000|Overall Study|Withdrawal by Subject|5|||
44463704|NCT00491894|79472636|FG000|Overall Study|Death|3|||
44463705|NCT00491894|79472636|FG000|Overall Study|Lost to Follow-up|3|||
44463706|NCT00491894|79472636|FG000|Overall Study|Lack of Efficacy|2|||
44463707|NCT00491894|79472636|FG000|Overall Study|Other-Failed to meet any criteria|2|||
44463708|NCT00491894|79472636|FG000|Overall Study|Physician Decision|2|||
44463709|NCT00491894|79472636|FG000|Overall Study|Protocol Violation|2|||
44463710|NCT00491894|79472636|FG000|Overall Study|Other-Intake of prohibited medication|1|||
44463711|NCT00491504|79472644|FG000|Overall Study|Adverse Event|0|||
44463712|NCT00491504|79472645|FG001|Overall Study|Adverse Event|1|||
44463713|NCT00491504|79472646|FG002|Overall Study|Adverse Event|0|||
44463714|NCT00491504|79472647|FG003|Overall Study|Adverse Event|0|||
44463715|NCT00491504|79472644|FG000|Overall Study|Withdrawal by Subject|0|||
44463716|NCT00491504|79472645|FG001|Overall Study|Withdrawal by Subject|0|||
44463717|NCT00491504|79472646|FG002|Overall Study|Withdrawal by Subject|1|||
44463718|NCT00491504|79472647|FG003|Overall Study|Withdrawal by Subject|2|||
44463719|NCT00491504|79472644|FG000|Overall Study|Protocol Violation|0|||
44277802|NCT02092350|79238806|FG000|Overall Study|Death|2|||
44463720|NCT00491504|79472645|FG001|Overall Study|Protocol Violation|0|||
44463721|NCT00491504|79472646|FG002|Overall Study|Protocol Violation|3|||
44463722|NCT00491504|79472647|FG003|Overall Study|Protocol Violation|2|||
44463723|NCT00500292|79472658|FG000|Overall Study|Adverse Event|3|||
44463724|NCT00500292|79472659|FG001|Overall Study|Adverse Event|6|||
44463725|NCT00500292|79472660|FG002|Overall Study|Adverse Event|4|||
44463726|NCT00500292|79472658|FG000|Overall Study|Condition under investigation worsened|21|||
44463727|NCT00500292|79472659|FG001|Overall Study|Condition under investigation worsened|23|||
44463728|NCT00500292|79472660|FG002|Overall Study|Condition under investigation worsened|19|||
44463729|NCT00500292|79472658|FG000|Overall Study|Withdrawal by Subject|0|||
44463730|NCT00500292|79472659|FG001|Overall Study|Withdrawal by Subject|1|||
44463731|NCT00500292|79472660|FG002|Overall Study|Withdrawal by Subject|0|||
44463732|NCT00500292|79472658|FG000|Overall Study|Other|1|||
44463733|NCT00500292|79472659|FG001|Overall Study|Other|1|||
44463734|NCT00500292|79472660|FG002|Overall Study|Other|4|||
44463735|NCT00499746|79472668|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
44463736|NCT00499746|79472668|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
44463737|NCT00499746|79472668|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
44463738|NCT00499746|79472668|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
44463739|NCT00489216|79472682|FG000|Overall Study|Adverse Event|1|||
44463740|NCT00499590|79472689|FG000|Overall Study|Study Terminated|112|||
44463741|NCT00499590|79472690|FG001|Overall Study|Study Terminated|112|||
44463742|NCT00499590|79472691|FG002|Overall Study|Study Terminated|112|||
44463743|NCT00499590|79472689|FG000|Overall Study|Not treated|1|||
44463744|NCT00499590|79472690|FG001|Overall Study|Not treated|0|||
44463745|NCT00499590|79472691|FG002|Overall Study|Not treated|1|||
44463746|NCT00510146|79472702|FG000|Double-Blind Treatment|Adverse Event|30|||
44463747|NCT00510146|79472703|FG001|Double-Blind Treatment|Adverse Event|13|||
44463748|NCT00510146|79472702|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
44463749|NCT00510146|79472703|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
44463750|NCT00510146|79472702|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
44463751|NCT00510146|79472703|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
44463752|NCT00510146|79472702|FG000|Double-Blind Treatment|Physician Decision|6|||
44463753|NCT00510146|79472703|FG001|Double-Blind Treatment|Physician Decision|0|||
44463754|NCT00510146|79472702|FG000|Double-Blind Treatment|Protocol Violation|1|||
44463755|NCT00510146|79472703|FG001|Double-Blind Treatment|Protocol Violation|2|||
44463756|NCT00510146|79472702|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
44463757|NCT00510146|79472703|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
44463758|NCT00510146|79472702|FG000|Double-Blind Treatment|Clinical Relapse|0|||
44463759|NCT00510146|79472703|FG001|Double-Blind Treatment|Clinical Relapse|1|||
44463760|NCT00510146|79472702|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
44463761|NCT00510146|79472703|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
44463762|NCT00510146|79472702|FG000|Open-Label Treatment|Adverse Event|22|||
44463763|NCT00510146|79472703|FG001|Open-Label Treatment|Adverse Event|8|||
44463764|NCT00510146|79472702|FG000|Open-Label Treatment|Death|1|||
44463765|NCT00510146|79472703|FG001|Open-Label Treatment|Death|1|||
44463766|NCT00510146|79472702|FG000|Open-Label Treatment|Lack of Efficacy|4|||
44463767|NCT00510146|79472703|FG001|Open-Label Treatment|Lack of Efficacy|0|||
44463768|NCT00510146|79472702|FG000|Open-Label Treatment|Lost to Follow-up|10|||
44463769|NCT00510146|79472703|FG001|Open-Label Treatment|Lost to Follow-up|1|||
44463770|NCT00510146|79472702|FG000|Open-Label Treatment|Physician Decision|3|||
44463771|NCT00510146|79472703|FG001|Open-Label Treatment|Physician Decision|1|||
44463772|NCT00510146|79472702|FG000|Open-Label Treatment|Protocol Violation|4|||
44463773|NCT00510146|79472703|FG001|Open-Label Treatment|Protocol Violation|2|||
44463774|NCT00510146|79472702|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
44463775|NCT00510146|79472703|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
44463776|NCT00510146|79472702|FG000|Open-Label Treatment|Clinical Relapse|1|||
44463777|NCT00510146|79472703|FG001|Open-Label Treatment|Clinical Relapse|1|||
44463778|NCT00510146|79472702|FG000|Open-Label Treatment|Sponsor Decision|2|||
44463779|NCT00510146|79472703|FG001|Open-Label Treatment|Sponsor Decision|0|||
44463780|NCT00480636|79472711|FG000|Overall Study|Death|12|||
44463781|NCT00480636|79472711|FG000|Overall Study|Lost to Follow-up|4|||
44463782|NCT00480636|79472711|FG000|Overall Study|Other|2|||
44463783|NCT00480636|79472711|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
44463784|NCT00499122|79472715|FG000|Overall Study|Withdrawal by Subject|2|||
44463785|NCT00393939|79472722|FG000|Overall Study|Protocol Violation|1|||
44463786|NCT00393939|79472723|FG001|Overall Study|Protocol Violation|1|||
44463787|NCT00393939|79472722|FG000|Overall Study|Lost to Follow-up|2|||
44463788|NCT00393939|79472723|FG001|Overall Study|Lost to Follow-up|4|||
44463789|NCT00393939|79472722|FG000|Overall Study|Death|10|||
44463790|NCT00393939|79472723|FG001|Overall Study|Death|4|||
44463791|NCT00393939|79472722|FG000|Overall Study|Sponsor|5|||
44463792|NCT00393939|79472723|FG001|Overall Study|Sponsor|13|||
44463793|NCT00393939|79472722|FG000|Overall Study|Objective progression or relapse|239|||
44463794|NCT00393939|79472723|FG001|Overall Study|Objective progression or relapse|223|||
44463795|NCT00393939|79472722|FG000|Overall Study|Withdrawal by Subject|2|||
44544253|NCT03554629|79557550|FG000|Overall Study|Inadequate data|6|||
44463796|NCT00393939|79472723|FG001|Overall Study|Withdrawal by Subject|7|||
44463797|NCT00393939|79472722|FG000|Overall Study|Other|37|||
44463798|NCT00393939|79472723|FG001|Overall Study|Other|45|||
44463799|NCT00488982|79472729|FG000|Course 1|Physician Decision|0|||
44463800|NCT00488982|79472730|FG001|Course 1|Physician Decision|2|||
44463801|NCT00488982|79472731|FG002|Course 1|Physician Decision|4|||
44463802|NCT00488982|79472729|FG000|Course 1|Withdrawal by Subject|0|||
44463803|NCT00488982|79472730|FG001|Course 1|Withdrawal by Subject|8|||
44463804|NCT00488982|79472731|FG002|Course 1|Withdrawal by Subject|2|||
44463805|NCT00488982|79472729|FG000|Course 1|nonprotocol therapy|0|||
44463806|NCT00488982|79472730|FG001|Course 1|nonprotocol therapy|2|||
44463807|NCT00488982|79472731|FG002|Course 1|nonprotocol therapy|2|||
44463808|NCT00488982|79472729|FG000|Course 1|Adverse Event|0|||
44463809|NCT00488982|79472730|FG001|Course 1|Adverse Event|0|||
44463810|NCT00488982|79472731|FG002|Course 1|Adverse Event|6|||
44463811|NCT00488826|79472748|FG000|Overall Study|Withdrawal by Subject|40|||
44463812|NCT00488826|79472749|FG001|Overall Study|Withdrawal by Subject|35|||
44463813|NCT00488826|79472750|FG002|Overall Study|Withdrawal by Subject|19|||
44463814|NCT00488826|79472748|FG000|Overall Study|Protocol Violation|0|||
44463815|NCT00488826|79472749|FG001|Overall Study|Protocol Violation|0|||
44463816|NCT00488826|79472750|FG002|Overall Study|Protocol Violation|2|||
44463817|NCT00488826|79472748|FG000|Overall Study|Adverse Event|9|||
44463818|NCT00488826|79472749|FG001|Overall Study|Adverse Event|15|||
44463819|NCT00488826|79472750|FG002|Overall Study|Adverse Event|4|||
44463820|NCT00488826|79472748|FG000|Overall Study|Lost to Follow-up|5|||
44463821|NCT00488826|79472749|FG001|Overall Study|Lost to Follow-up|1|||
44463822|NCT00488826|79472750|FG002|Overall Study|Lost to Follow-up|0|||
44463823|NCT00488826|79472748|FG000|Overall Study|Protocol Deviations|2|||
44463824|NCT00488826|79472749|FG001|Overall Study|Protocol Deviations|1|||
44463825|NCT00488826|79472750|FG002|Overall Study|Protocol Deviations|1|||
44463826|NCT00393861|79472758|FG000|Overall Study|Adverse Event|2|||
44463827|NCT00393861|79472758|FG000|Overall Study|Disease Progression|24|||
44463828|NCT00480324|79472764|FG000|Overall Study|Adverse Event|1|||
44463829|NCT00480324|79472765|FG001|Overall Study|Adverse Event|1|||
44463830|NCT00480324|79472764|FG000|Overall Study|Protocol Violation|0|||
44463831|NCT00480324|79472765|FG001|Overall Study|Protocol Violation|1|||
44463832|NCT00480324|79472764|FG000|Overall Study|Withdrawal by Subject|14|||
44463833|NCT00480324|79472765|FG001|Overall Study|Withdrawal by Subject|5|||
44463834|NCT00480324|79472764|FG000|Overall Study|Lost to Follow-up|17|||
44463835|NCT00480324|79472765|FG001|Overall Study|Lost to Follow-up|8|||
44463836|NCT00480324|79472764|FG000|Overall Study|Subject's mother pregnant|0|||
44463837|NCT00480324|79472765|FG001|Overall Study|Subject's mother pregnant|1|||
44463838|NCT00488592|79472771|FG000|Overall Study|Withdrawal by Subject|1|||
44463839|NCT00488592|79472771|FG000|Overall Study|Disease progression|1|||
44463840|NCT00488592|79472771|FG000|Overall Study|Enrolled but not treated|1|||
44463841|NCT00488514|79472775|FG000|Overall Study|Adverse Event|41|||
44463842|NCT00488514|79472775|FG000|Overall Study|Lost to Follow-up|44|||
44463843|NCT00488514|79472775|FG000|Overall Study|Protocol Violation|32|||
44463844|NCT00488514|79472775|FG000|Overall Study|Withdrawal by Subject|106|||
44463845|NCT00488514|79472775|FG000|Overall Study|Lack of Efficacy|28|||
44463846|NCT00488514|79472775|FG000|Overall Study|Did not meet criteria for treatment|30|||
44463847|NCT00488514|79472775|FG000|Overall Study|Postive drug screen|1|||
44463848|NCT00488514|79472775|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
44463849|NCT00488514|79472775|FG000|Overall Study|Investigator decision|1|||
44463850|NCT00488514|79472775|FG000|Overall Study|Participant had too few migraines|5|||
44463851|NCT00488514|79472775|FG000|Overall Study|Increase in number of migraines|2|||
44463852|NCT00488514|79472775|FG000|Overall Study|Increased use of concomitant medication|1|||
44463853|NCT00320710|79472799|FG000|Overall Study|Disease progression|24|||
44463854|NCT00320710|79472800|FG001|Overall Study|Disease progression|19|||
44463855|NCT00320710|79472801|FG002|Overall Study|Disease progression|2|||
44463856|NCT00320710|79472799|FG000|Overall Study|Death|10|||
44463857|NCT00320710|79472800|FG001|Overall Study|Death|7|||
44463858|NCT00320710|79472801|FG002|Overall Study|Death|1|||
44221840|NCT01400139|79025078|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
44463859|NCT00320710|79472799|FG000|Overall Study|Administrative problems|1|||
44463860|NCT00320710|79472800|FG001|Overall Study|Administrative problems|2|||
44463861|NCT00320710|79472801|FG002|Overall Study|Administrative problems|0|||
44463862|NCT00320710|79472799|FG000|Overall Study|Withdrawal by Subject|20|||
44463863|NCT00320710|79472800|FG001|Overall Study|Withdrawal by Subject|26|||
44463864|NCT00320710|79472801|FG002|Overall Study|Withdrawal by Subject|1|||
44463865|NCT00320710|79472799|FG000|Overall Study|Protocol Violation|6|||
44463866|NCT00320710|79472800|FG001|Overall Study|Protocol Violation|5|||
44463867|NCT00320710|79472801|FG002|Overall Study|Protocol Violation|0|||
44463868|NCT00320710|79472799|FG000|Overall Study|Abnormal test procedure result(s)|2|||
44463869|NCT00320710|79472800|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44463870|NCT00320710|79472801|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44463871|NCT00320710|79472799|FG000|Overall Study|Abnormal laboratory value(s)|12|||
44463872|NCT00320710|79472800|FG001|Overall Study|Abnormal laboratory value(s)|3|||
44271357|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
44463873|NCT00320710|79472801|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44463874|NCT00320710|79472799|FG000|Overall Study|Adverse Event|18|||
44463875|NCT00320710|79472800|FG001|Overall Study|Adverse Event|14|||
44463876|NCT00320710|79472801|FG002|Overall Study|Adverse Event|1|||
44463877|NCT00320710|79472799|FG000|Overall Study|Lost to Follow-up|1|||
44463878|NCT00320710|79472800|FG001|Overall Study|Lost to Follow-up|0|||
44463879|NCT00320710|79472801|FG002|Overall Study|Lost to Follow-up|0|||
44463880|NCT00320398|79472810|FG000|Overall Study|Adverse Event|1|||
44463881|NCT00320398|79472811|FG001|Overall Study|Adverse Event|4|||
44463882|NCT00320398|79472810|FG000|Overall Study|Other|1|||
44463883|NCT00320398|79472811|FG001|Overall Study|Other|0|||
44463884|NCT00498186|79472818|FG000|Overall Study|Protocol Violation|10|||
44463885|NCT00498186|79472818|FG000|Overall Study|Lack of Efficacy|31|||
44463886|NCT00498186|79472818|FG000|Overall Study|Adverse Event|89|||
44463887|NCT00498186|79472818|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
44463888|NCT00498186|79472818|FG000|Overall Study|Withdrawal by Subject|18|||
44463889|NCT00498186|79472818|FG000|Overall Study|Lost to Follow-up|3|||
44463890|NCT00498186|79472818|FG000|Overall Study|Other|10|||
44463891|NCT00333970|79472824|FG000|Overall Study|Withdrawal by Subject|13|||
44463892|NCT00333970|79472825|FG001|Overall Study|Withdrawal by Subject|7|||
44463893|NCT00477594|79472833|FG000|Year 1 and Year 2|Adverse Event|4|||
44463894|NCT00477594|79472834|FG001|Year 1 and Year 2|Adverse Event|2|||
44463895|NCT00477594|79472833|FG000|Year 1 and Year 2|Physician Decision|2|||
44463896|NCT00477594|79472834|FG001|Year 1 and Year 2|Physician Decision|1|||
44463897|NCT00477594|79472833|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
44463898|NCT00477594|79472834|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
44463899|NCT00477594|79472833|FG000|Year 1 and Year 2|Other|1|||
44463900|NCT00477594|79472834|FG001|Year 1 and Year 2|Other|0|||
44463901|NCT00477594|79472833|FG000|Year 3|Adverse Event|1|||
44463902|NCT00477594|79472834|FG001|Year 3|Adverse Event|0|||
44463903|NCT00477594|79472833|FG000|Year 3|Withdrawal by Subject|1|||
44463904|NCT00477594|79472834|FG001|Year 3|Withdrawal by Subject|0|||
44463905|NCT00477594|79472833|FG000|Follow-up Period|Withdrawal by Subject|2|||
44463906|NCT00477594|79472834|FG001|Follow-up Period|Withdrawal by Subject|1|||
44463907|NCT00477594|79472833|FG000|Follow-up Period|Other|1|||
44463908|NCT00477594|79472834|FG001|Follow-up Period|Other|0|||
44463909|NCT00475722|79472842|FG000|Overall Study|Withdrawal by Subject|12|||
44463910|NCT00475722|79472843|FG001|Overall Study|Withdrawal by Subject|12|||
44544254|NCT03196791|79557580|FG000|Overall Study|Protocol Violation|7|||
44271358|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
44271359|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
44271360|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
44271361|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
44271362|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
44271363|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
44271364|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
44271365|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
44271366|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
44463911|NCT00475722|79472842|FG000|Overall Study|Protocol Violation|3|||
44463912|NCT00475722|79472843|FG001|Overall Study|Protocol Violation|0|||
44463913|NCT00304954|79472853|FG000|Overall Study|Withdrawal by Subject|0|||
44463914|NCT00304954|79472854|FG001|Overall Study|Withdrawal by Subject|0|||
44463915|NCT00304954|79472855|FG002|Overall Study|Withdrawal by Subject|1|||
44463916|NCT00304954|79472856|FG003|Overall Study|Withdrawal by Subject|0|||
44463917|NCT00304954|79472853|FG000|Overall Study|Adverse Event|1|||
44463918|NCT00304954|79472854|FG001|Overall Study|Adverse Event|0|||
44463919|NCT00304954|79472855|FG002|Overall Study|Adverse Event|0|||
44463920|NCT00304954|79472856|FG003|Overall Study|Adverse Event|0|||
44463921|NCT00475176|79472874|FG000|Overall Study|Adverse Event|2|||
44463922|NCT00475176|79472874|FG000|Overall Study|Withdrawal by Subject|1|||
44221841|NCT01400139|79025078|FG000|HYD Extension Period|Adverse Event|8|||
44221842|NCT01400139|79025078|FG000|HYD Extension Period|Withdrawal by Subject|5|||
44221843|NCT01400139|79025078|FG000|HYD Extension Period|Administrative|10|||
44221844|NCT01399905|79025086|FG000|Overall Study|Withdrawal by Subject|1|||
44221845|NCT01399905|79025087|FG001|Overall Study|Withdrawal by Subject|1|||
44221846|NCT01725308|79025101|FG000|Treatment Period I|Did Not Receive Drug|1|||
44221847|NCT01725308|79025102|FG001|Treatment Period I|Did Not Receive Drug|0|||
44221848|NCT01725308|79025103|FG002|Treatment Period I|Did Not Receive Drug|0|||
44221849|NCT01725308|79025101|FG000|Treatment Period I|Adverse Event|5|||
44463923|NCT00475176|79472874|FG000|Overall Study|Protocol Violation|1|||
44463924|NCT00414609|79472880|FG000|Core Study|Adverse Event|9|||
44463925|NCT00414609|79472881|FG001|Core Study|Adverse Event|11|||
44221850|NCT01725308|79025102|FG001|Treatment Period I|Adverse Event|4|||
44463926|NCT00414609|79472882|FG002|Core Study|Adverse Event|0|||
44463927|NCT00414609|79472880|FG000|Core Study|Abnormal laboratory values|0|||
44463928|NCT00414609|79472881|FG001|Core Study|Abnormal laboratory values|1|||
44463929|NCT00414609|79472882|FG002|Core Study|Abnormal laboratory values|0|||
44463930|NCT00414609|79472880|FG000|Core Study|Abnormal test procedure results|1|||
44463931|NCT00414609|79472881|FG001|Core Study|Abnormal test procedure results|1|||
44463932|NCT00414609|79472882|FG002|Core Study|Abnormal test procedure results|0|||
44463933|NCT00414609|79472880|FG000|Core Study|Protocol deviation|0|||
44463934|NCT00414609|79472881|FG001|Core Study|Protocol deviation|1|||
44271367|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
44271368|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
44271369|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
44271370|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
44271371|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
44271372|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
44463935|NCT00414609|79472882|FG002|Core Study|Protocol deviation|0|||
44463936|NCT00414609|79472880|FG000|Core Study|Patient withdrew consent|10|||
44463937|NCT00414609|79472881|FG001|Core Study|Patient withdrew consent|11|||
44463938|NCT00414609|79472882|FG002|Core Study|Patient withdrew consent|0|||
44463939|NCT00414609|79472880|FG000|Core Study|Lost to Follow-up|7|||
44463940|NCT00414609|79472881|FG001|Core Study|Lost to Follow-up|4|||
44271373|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
44271374|NCT00559585|79201920|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
44271375|NCT00559585|79201921|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
44374654|NCT01124006|79379721|FG000|Overall Study|Withdrawal by Subject|2|||
44463941|NCT00414609|79472882|FG002|Core Study|Lost to Follow-up|0|||
44463942|NCT00414609|79472880|FG000|Core Study|Administrative problems|0|||
44463943|NCT00414609|79472881|FG001|Core Study|Administrative problems|2|||
44463944|NCT00414609|79472882|FG002|Core Study|Administrative problems|0|||
44221851|NCT01725308|79025103|FG002|Treatment Period I|Adverse Event|21|||
44221852|NCT01725308|79025101|FG000|Treatment Period I|Insufficient Response|7|||
44374655|NCT01124006|79379722|FG001|Overall Study|Withdrawal by Subject|2|||
44374656|NCT01124006|79379723|FG002|Overall Study|Withdrawal by Subject|0|||
44374657|NCT01124006|79379721|FG000|Overall Study|Lost to Follow-up|1|||
44374658|NCT01124006|79379722|FG001|Overall Study|Lost to Follow-up|0|||
44374659|NCT01124006|79379723|FG002|Overall Study|Lost to Follow-up|1|||
44374660|NCT01124006|79379721|FG000|Overall Study|Other|0|||
44374661|NCT01124006|79379722|FG001|Overall Study|Other|0|||
44374662|NCT01124006|79379723|FG002|Overall Study|Other|1|||
44374663|NCT00952068|79379731|FG000|Overall Study|Adverse Event|3|||
44374664|NCT00952068|79379731|FG000|Overall Study|Withdrawal by Subject|4|||
44374665|NCT01123850|79379735|FG000|Overall Study|Slow enrollment|45|||
44463945|NCT00414609|79472880|FG000|Core Study|Death|7|||
44463946|NCT00414609|79472881|FG001|Core Study|Death|14|||
44463947|NCT00414609|79472882|FG002|Core Study|Death|0|||
44463948|NCT00414609|79472880|FG000|Extension Study|Adverse Event|0|||
44463949|NCT00414609|79472881|FG001|Extension Study|Adverse Event|0|||
44221853|NCT01725308|79025102|FG001|Treatment Period I|Insufficient Response|0|||
44221854|NCT01725308|79025103|FG002|Treatment Period I|Insufficient Response|5|||
44221855|NCT01725308|79025101|FG000|Treatment Period I|Worsening of the Target Disease|8|||
44221856|NCT01725308|79025102|FG001|Treatment Period I|Worsening of the Target Disease|0|||
44221857|NCT01725308|79025103|FG002|Treatment Period I|Worsening of the Target Disease|2|||
44463950|NCT00414609|79472882|FG002|Extension Study|Adverse Event|14|||
44463951|NCT00414609|79472880|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
44271376|NCT00559585|79201920|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
44271377|NCT00559585|79201921|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
44271378|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
44271379|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
44271380|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
44271381|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
44271382|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
44271383|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
44271384|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
44463952|NCT00414609|79472881|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
44463953|NCT00414609|79472882|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
44463954|NCT00414609|79472880|FG000|Extension Study|Withdrawal by Subject|0|||
44463955|NCT00414609|79472881|FG001|Extension Study|Withdrawal by Subject|0|||
44463956|NCT00414609|79472882|FG002|Extension Study|Withdrawal by Subject|13|||
44463957|NCT00414609|79472880|FG000|Extension Study|Lost to Follow-up|0|||
44463958|NCT00414609|79472881|FG001|Extension Study|Lost to Follow-up|0|||
44463959|NCT00414609|79472882|FG002|Extension Study|Lost to Follow-up|10|||
44463960|NCT00414609|79472880|FG000|Extension Study|Administrative problems|0|||
44463961|NCT00414609|79472881|FG001|Extension Study|Administrative problems|0|||
44463962|NCT00414609|79472882|FG002|Extension Study|Administrative problems|1|||
44463963|NCT00414609|79472880|FG000|Extension Study|Death|0|||
44463964|NCT00414609|79472881|FG001|Extension Study|Death|0|||
44463965|NCT00414609|79472882|FG002|Extension Study|Death|17|||
44463966|NCT00393705|79472893|FG000|Overall Study|Adverse Event|0|||
44463967|NCT00393705|79472894|FG001|Overall Study|Adverse Event|2|||
44463968|NCT00393705|79472893|FG000|Overall Study|Death|0|||
44463969|NCT00393705|79472894|FG001|Overall Study|Death|1|||
44463970|NCT00393705|79472893|FG000|Overall Study|Lost to Follow-up|2|||
44463971|NCT00393705|79472894|FG001|Overall Study|Lost to Follow-up|2|||
44463972|NCT00393705|79472893|FG000|Overall Study|Entry Criteria Not Met|10|||
44463973|NCT00393705|79472894|FG001|Overall Study|Entry Criteria Not Met|10|||
44463974|NCT00393705|79472893|FG000|Overall Study|Protocol Violation|4|||
44221858|NCT01725308|79025101|FG000|Treatment Period I|Changes in the Episodes|3|||
44463975|NCT00393705|79472894|FG001|Overall Study|Protocol Violation|3|||
44463976|NCT00393705|79472893|FG000|Overall Study|Withdrawal by Subject|5|||
44221859|NCT01725308|79025102|FG001|Treatment Period I|Changes in the Episodes|0|||
44463977|NCT00393705|79472894|FG001|Overall Study|Withdrawal by Subject|3|||
44463978|NCT00393705|79472893|FG000|Overall Study|Physician Decision|2|||
44463979|NCT00393705|79472894|FG001|Overall Study|Physician Decision|2|||
44463980|NCT00303628|79472902|FG000|Overall Study|Disease progression|0|||
44463981|NCT00303628|79472903|FG001|Overall Study|Disease progression|1|||
44463982|NCT00303628|79472902|FG000|Overall Study|Adverse Event|26|||
44463983|NCT00303628|79472903|FG001|Overall Study|Adverse Event|36|||
44463984|NCT00303628|79472902|FG000|Overall Study|Death|0|||
44463985|NCT00303628|79472903|FG001|Overall Study|Death|1|||
44463986|NCT00303628|79472902|FG000|Overall Study|Withdrawal by Subject|11|||
44463987|NCT00303628|79472903|FG001|Overall Study|Withdrawal by Subject|20|||
44463988|NCT00303628|79472902|FG000|Overall Study|Alternative therapy|2|||
44463989|NCT00303628|79472903|FG001|Overall Study|Alternative therapy|0|||
44463990|NCT00303628|79472902|FG000|Overall Study|Other complicating disease|0|||
44463991|NCT00303628|79472903|FG001|Overall Study|Other complicating disease|1|||
44463992|NCT00303628|79472902|FG000|Overall Study|Not start protocol therapy|3|||
44463993|NCT00303628|79472903|FG001|Overall Study|Not start protocol therapy|5|||
44463994|NCT00303628|79472902|FG000|Overall Study|Other|8|||
44463995|NCT00303628|79472903|FG001|Overall Study|Other|9|||
44544255|NCT03196791|79557581|FG001|Overall Study|Protocol Violation|3|||
44221860|NCT01725308|79025103|FG002|Treatment Period I|Changes in the Episodes|2|||
44221861|NCT01725308|79025101|FG000|Treatment Period I|Withdrawal of Consent|12|||
44221862|NCT01725308|79025102|FG001|Treatment Period I|Withdrawal of Consent|7|||
44221863|NCT01725308|79025103|FG002|Treatment Period I|Withdrawal of Consent|5|||
44271385|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
44271386|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
44463996|NCT00414453|79472909|FG000|Overall Study|Abnormal lab work|16|||
44463997|NCT00332488|79472922|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
44463998|NCT00332488|79472923|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
44463999|NCT00332488|79472924|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
44221864|NCT01725308|79025101|FG000|Treatment Period I|Lost to Follow-up|3|||
44464000|NCT00332488|79472922|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
44464001|NCT00332488|79472923|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
44464002|NCT00332488|79472924|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
44221865|NCT01725308|79025102|FG001|Treatment Period I|Lost to Follow-up|2|||
44221866|NCT01725308|79025103|FG002|Treatment Period I|Lost to Follow-up|2|||
44221867|NCT01725308|79025101|FG000|Treatment Period I|Protocol Deviations|3|||
44221868|NCT01725308|79025102|FG001|Treatment Period I|Protocol Deviations|1|||
44221869|NCT01725308|79025103|FG002|Treatment Period I|Protocol Deviations|1|||
44464003|NCT00332488|79472922|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
44464004|NCT00332488|79472923|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
44464005|NCT00332488|79472924|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
44464006|NCT00332488|79472922|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
44464007|NCT00332488|79472923|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
44464008|NCT00332488|79472924|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
44464009|NCT00332488|79472922|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
44464010|NCT00332488|79472923|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
44464011|NCT00332488|79472924|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
44464012|NCT00332488|79472922|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
44464013|NCT00332488|79472923|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
44464014|NCT00332488|79472924|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
44464015|NCT00332488|79472922|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
44221870|NCT01725308|79025101|FG000|Treatment Period I|Miscellaneous|2|||
44221871|NCT01725308|79025102|FG001|Treatment Period I|Miscellaneous|0|||
44221872|NCT01725308|79025103|FG002|Treatment Period I|Miscellaneous|3|||
44221873|NCT01725308|79025101|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
44374666|NCT01123382|79379741|FG000|Overall Study|Withdrawal by Subject|1|||
44374667|NCT01123382|79379742|FG001|Overall Study|Withdrawal by Subject|4|||
44374668|NCT01123382|79379741|FG000|Overall Study|Lost to Follow-up|1|||
44374669|NCT01123382|79379742|FG001|Overall Study|Lost to Follow-up|2|||
44374670|NCT00951912|79379751|FG000|Overall Study|Lack of Efficacy|1|||
44374671|NCT00951912|79379752|FG001|Overall Study|Lack of Efficacy|0|||
44374672|NCT00951912|79379753|FG002|Overall Study|Lack of Efficacy|0|||
44374673|NCT00951912|79379751|FG000|Overall Study|Adverse Event|0|||
44374674|NCT00951912|79379752|FG001|Overall Study|Adverse Event|1|||
44374675|NCT00951912|79379753|FG002|Overall Study|Adverse Event|1|||
44374676|NCT00951912|79379751|FG000|Overall Study|Lost to Follow-up|2|||
44374677|NCT00951912|79379752|FG001|Overall Study|Lost to Follow-up|2|||
44374678|NCT00951912|79379753|FG002|Overall Study|Lost to Follow-up|0|||
44374679|NCT00951912|79379751|FG000|Overall Study|Physician Decision|1|||
44374680|NCT00951912|79379752|FG001|Overall Study|Physician Decision|0|||
44374681|NCT00951912|79379753|FG002|Overall Study|Physician Decision|1|||
44374682|NCT00951912|79379751|FG000|Overall Study|Withdrawal by Subject|1|||
44374683|NCT00951912|79379752|FG001|Overall Study|Withdrawal by Subject|1|||
44374684|NCT00951912|79379753|FG002|Overall Study|Withdrawal by Subject|0|||
44374685|NCT00951912|79379751|FG000|Overall Study|Other:Depression|1|||
44374686|NCT00951912|79379752|FG001|Overall Study|Other:Depression|0|||
44374687|NCT00951912|79379753|FG002|Overall Study|Other:Depression|0|||
44374688|NCT00951912|79379751|FG000|Overall Study|Other: Colon cancer|1|||
44374689|NCT00951912|79379752|FG001|Overall Study|Other: Colon cancer|0|||
44374690|NCT00951912|79379753|FG002|Overall Study|Other: Colon cancer|0|||
44374691|NCT00951912|79379751|FG000|Overall Study|Other: Stroke|0|||
44374692|NCT00951912|79379752|FG001|Overall Study|Other: Stroke|1|||
44374693|NCT00951912|79379753|FG002|Overall Study|Other: Stroke|0|||
44374694|NCT01123148|79379761|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
44374695|NCT01123148|79379761|FG000|Overall Study|Didn't meet milestone criteria|1|||
44374696|NCT01123070|79379769|FG000|Part B Double Blind Period|Protocol Violation|0|||
44374697|NCT01123070|79379770|FG001|Part B Double Blind Period|Protocol Violation|0|||
44374698|NCT01123070|79379771|FG002|Part B Double Blind Period|Protocol Violation|0|||
44374699|NCT01123070|79379772|FG003|Part B Double Blind Period|Protocol Violation|1|||
44374700|NCT01123070|79379769|FG000|Part B Double Blind Period|Adverse Event|0|||
44374701|NCT01123070|79379770|FG001|Part B Double Blind Period|Adverse Event|0|||
44374702|NCT01123070|79379771|FG002|Part B Double Blind Period|Adverse Event|2|||
44374703|NCT01123070|79379772|FG003|Part B Double Blind Period|Adverse Event|0|||
44374704|NCT01123070|79379769|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
44374705|NCT01123070|79379770|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
44374706|NCT01123070|79379771|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
44374707|NCT01123070|79379772|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
44374708|NCT01122680|79379783|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
44374709|NCT01122680|79379784|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
44374710|NCT01122680|79379785|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
44374711|NCT01122680|79379786|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
44374712|NCT01122680|79379783|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
44374713|NCT01122680|79379784|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
44374714|NCT01122680|79379785|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
44374715|NCT01122680|79379786|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
44464016|NCT00332488|79472923|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
44464017|NCT00332488|79472924|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
44374716|NCT01122680|79379783|FG000|Period 1 (4 Weeks)|Other|1|||
44374717|NCT01122680|79379784|FG001|Period 1 (4 Weeks)|Other|1|||
44374718|NCT01122680|79379785|FG002|Period 1 (4 Weeks)|Other|0|||
44374719|NCT01122680|79379786|FG003|Period 1 (4 Weeks)|Other|0|||
44374720|NCT01122680|79379783|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
44374721|NCT01122680|79379784|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
44464018|NCT00332488|79472922|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
44464019|NCT00332488|79472923|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
44464020|NCT00332488|79472924|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
44464021|NCT00332488|79472922|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
44464022|NCT00332488|79472923|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
44464023|NCT00332488|79472924|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
44464024|NCT00332488|79472922|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
44464025|NCT00332488|79472923|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
44464026|NCT00332488|79472924|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
44271387|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
44271388|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
44374722|NCT01122680|79379785|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
44374723|NCT01122680|79379786|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
44374724|NCT01122680|79379783|FG000|Period 2 (4 Weeks)|Other|1|||
44374725|NCT01122680|79379784|FG001|Period 2 (4 Weeks)|Other|0|||
44374726|NCT01122680|79379785|FG002|Period 2 (4 Weeks)|Other|0|||
44374727|NCT01122680|79379786|FG003|Period 2 (4 Weeks)|Other|0|||
44374728|NCT01122680|79379783|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
44374729|NCT01122680|79379784|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
44374730|NCT01122680|79379785|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
44374731|NCT01122680|79379786|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
44374732|NCT01122680|79379783|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44374733|NCT01122680|79379784|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
44374734|NCT01122680|79379785|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44374735|NCT01122680|79379786|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44374736|NCT00946998|79379798|FG000|Overall Study|Exited prior to first outcome assessment|5|||
44374737|NCT00946998|79379799|FG001|Overall Study|Exited prior to first outcome assessment|3|||
44374738|NCT01138826|79379805|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
44374739|NCT01138826|79379806|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
44374740|NCT01138826|79379807|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
44374741|NCT01138826|79379808|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
44374742|NCT01138826|79379809|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
44374743|NCT01138826|79379810|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
44374744|NCT00906087|79379818|FG000|Initial Washout|Withdrawal by Subject|1|||
44374745|NCT00906087|79379818|FG000|Initial Washout|Physician Decision|1|||
44374746|NCT00907257|79379827|FG000|Overall Study|Adverse Event|0|||
44374747|NCT00907257|79379828|FG001|Overall Study|Adverse Event|4|||
44374748|NCT00907257|79379827|FG000|Overall Study|Protocol Violation|1|||
44374749|NCT00907257|79379828|FG001|Overall Study|Protocol Violation|2|||
44374750|NCT00907257|79379827|FG000|Overall Study|Lost to Follow-up|3|||
44374751|NCT00907257|79379828|FG001|Overall Study|Lost to Follow-up|3|||
44374752|NCT00907257|79379827|FG000|Overall Study|Withdrawal by Subject|1|||
44374753|NCT00907257|79379828|FG001|Overall Study|Withdrawal by Subject|2|||
44374754|NCT00907257|79379827|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
44374755|NCT00907257|79379828|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
44374756|NCT00907257|79379827|FG000|Overall Study|Moved|1|||
44374757|NCT00907257|79379828|FG001|Overall Study|Moved|0|||
44374758|NCT00907257|79379827|FG000|Overall Study|Personal Reasons|6|||
44374759|NCT00907257|79379828|FG001|Overall Study|Personal Reasons|1|||
44374760|NCT01138046|79379834|FG000|Overall Study|Withdrawal due to death|6|||
44374761|NCT00876460|79379846|FG000|Combination Therapy Phase|Progressive disease|2|||
44374762|NCT00876460|79379847|FG001|Combination Therapy Phase|Progressive disease|3|||
44374763|NCT00876460|79379848|FG002|Combination Therapy Phase|Progressive disease|3|||
44374764|NCT00876460|79379849|FG003|Combination Therapy Phase|Progressive disease|3|||
44374765|NCT00876460|79379850|FG004|Combination Therapy Phase|Progressive disease|3|||
44374766|NCT00876460|79379851|FG005|Combination Therapy Phase|Progressive disease|1|||
44374767|NCT00876460|79379852|FG006|Combination Therapy Phase|Progressive disease|1|||
44374768|NCT00876460|79379853|FG007|Combination Therapy Phase|Progressive disease|1|||
44374769|NCT00876460|79379846|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
44374770|NCT00876460|79379847|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
44374771|NCT00876460|79379848|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
44374772|NCT00876460|79379849|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
44464027|NCT00332488|79472922|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
44464028|NCT00332488|79472923|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
44374773|NCT00876460|79379850|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
44374774|NCT00876460|79379851|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
44464029|NCT00332488|79472924|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
44464030|NCT00332488|79472922|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
44374775|NCT00876460|79379852|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
44374776|NCT00876460|79379853|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
44374777|NCT00876460|79379846|FG000|Combination Therapy Phase|Adverse Event|0|||
44374778|NCT00876460|79379847|FG001|Combination Therapy Phase|Adverse Event|2|||
44464031|NCT00332488|79472923|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
44464032|NCT00332488|79472924|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
44464033|NCT00332332|79472934|FG000|Overall Study|Adverse Event|13|||
44464034|NCT00332332|79472934|FG000|Overall Study|Death|1|||
44464035|NCT00332332|79472934|FG000|Overall Study|Withdrawal by Subject|8|||
44464036|NCT00332332|79472934|FG000|Overall Study|Physician Decision|1|||
44464037|NCT00332332|79472934|FG000|Overall Study|Lost to Follow-up|3|||
44464038|NCT00332332|79472934|FG000|Overall Study|Protocol deviation|4|||
44464039|NCT00332332|79472934|FG000|Overall Study|Noncompliance|2|||
44464040|NCT00332332|79472934|FG000|Overall Study|Disease progression|2|||
44464041|NCT00332332|79472934|FG000|Overall Study|Other|18|||
44464042|NCT00332332|79472934|FG000|Overall Study|Did not receive study treatment|16|||
44464043|NCT00392925|79472942|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
44464044|NCT00392925|79472943|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
44464045|NCT00392925|79472944|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
44464046|NCT00392925|79472945|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
44464047|NCT00392925|79472942|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
44464048|NCT00392925|79472943|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
44464049|NCT00392925|79472944|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
44464050|NCT00392925|79472945|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
44464051|NCT00392925|79472942|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
44464052|NCT00392925|79472943|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
44464053|NCT00392925|79472944|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
44464054|NCT00392925|79472945|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
44464055|NCT00392925|79472942|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
44464056|NCT00392925|79472943|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
44464057|NCT00392925|79472944|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
44464058|NCT00392925|79472945|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
44464059|NCT00392925|79472942|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
44464060|NCT00392925|79472943|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
44464061|NCT00392925|79472944|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
44464062|NCT00392925|79472945|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
44464063|NCT00392925|79472942|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
44464064|NCT00392925|79472943|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
44464065|NCT00392925|79472944|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
44464066|NCT00392925|79472945|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
44464067|NCT00392925|79472942|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
44464068|NCT00392925|79472943|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
44464069|NCT00392925|79472944|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
44464070|NCT00392925|79472945|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
44464071|NCT00392925|79472942|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
44464072|NCT00392925|79472943|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
44464073|NCT00392925|79472944|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
44464074|NCT00392925|79472945|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
44464075|NCT00392925|79472942|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
44464076|NCT00392925|79472943|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
44464077|NCT00392925|79472944|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
44464078|NCT00392925|79472945|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
44464079|NCT00474786|79472963|FG000|Overall Study|Not Meeting Study Criteria|0|||
44464080|NCT00474786|79472964|FG001|Overall Study|Not Meeting Study Criteria|1|||
44464081|NCT00474786|79472963|FG000|Overall Study|Investigator Request|2|||
44464082|NCT00474786|79472964|FG001|Overall Study|Investigator Request|1|||
44464083|NCT00474786|79472963|FG000|Overall Study|Death|189|||
44271389|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
44374779|NCT00876460|79379848|FG002|Combination Therapy Phase|Adverse Event|0|||
44374780|NCT00876460|79379849|FG003|Combination Therapy Phase|Adverse Event|2|||
44374781|NCT00876460|79379850|FG004|Combination Therapy Phase|Adverse Event|2|||
44374782|NCT00876460|79379851|FG005|Combination Therapy Phase|Adverse Event|0|||
44374783|NCT00876460|79379852|FG006|Combination Therapy Phase|Adverse Event|3|||
44374784|NCT00876460|79379853|FG007|Combination Therapy Phase|Adverse Event|2|||
44374785|NCT00876460|79379846|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
44374786|NCT00876460|79379847|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
44374787|NCT00876460|79379848|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
44374788|NCT00876460|79379849|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
44374789|NCT00876460|79379850|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
44374790|NCT00876460|79379851|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
44374791|NCT00876460|79379852|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
44464084|NCT00474786|79472964|FG001|Overall Study|Death|170|||
44464085|NCT00474786|79472963|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
44374792|NCT00876460|79379853|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
44374793|NCT00876460|79379846|FG000|Combination Therapy Phase|Other reason not defined above|0|||
44464086|NCT00474786|79472964|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
44464087|NCT00474786|79472963|FG000|Overall Study|Lost to Follow-up|4|||
44464088|NCT00474786|79472964|FG001|Overall Study|Lost to Follow-up|7|||
44464089|NCT00474786|79472963|FG000|Overall Study|Protocol Violation|2|||
44464090|NCT00474786|79472964|FG001|Overall Study|Protocol Violation|0|||
44464091|NCT00474786|79472963|FG000|Overall Study|Withdrawal by Subject|15|||
44464092|NCT00474786|79472964|FG001|Overall Study|Withdrawal by Subject|15|||
44464093|NCT00474786|79472963|FG000|Overall Study|Other|5|||
44464094|NCT00474786|79472964|FG001|Overall Study|Other|0|||
44464095|NCT00392769|79472970|FG000|Overall Study|Clinical Deterioration|9|||
44464096|NCT00392769|79472970|FG000|Overall Study|Adverse Event|1|||
44464097|NCT00319696|79472974|FG000|Overall Study|Adverse Event|36|||
44464098|NCT00319696|79472974|FG000|Overall Study|withdrawal of consent|14|||
44464099|NCT00319696|79472974|FG000|Overall Study|administrative|7|||
44464100|NCT00319696|79472974|FG000|Overall Study|Lost to Follow-up|3|||
44464101|NCT00474630|79472986|FG000|Overall Study|Adverse Event|98|||
44464102|NCT00474630|79472987|FG001|Overall Study|Adverse Event|26|||
44464103|NCT00474630|79472986|FG000|Overall Study|Lost to Follow-up|22|||
44464104|NCT00474630|79472987|FG001|Overall Study|Lost to Follow-up|15|||
44464105|NCT00474630|79472986|FG000|Overall Study|Withdrawal by Subject|21|||
44464106|NCT00474630|79472987|FG001|Overall Study|Withdrawal by Subject|15|||
44464107|NCT00474630|79472986|FG000|Overall Study|Protocol Violation|3|||
44464108|NCT00474630|79472987|FG001|Overall Study|Protocol Violation|4|||
44464109|NCT00474630|79472986|FG000|Overall Study|Lack of Efficacy|5|||
44464110|NCT00474630|79472987|FG001|Overall Study|Lack of Efficacy|6|||
44464111|NCT00474630|79472986|FG000|Overall Study|Drug noncompliance, other|11|||
44464112|NCT00474630|79472987|FG001|Overall Study|Drug noncompliance, other|4|||
44464113|NCT00392379|79472996|FG000|Overall Study|Withdrawal by Subject|17|||
44464114|NCT00392379|79472997|FG001|Overall Study|Withdrawal by Subject|28|||
44464115|NCT00392379|79472996|FG000|Overall Study|Lost to Follow-up|4|||
44464116|NCT00392379|79472997|FG001|Overall Study|Lost to Follow-up|9|||
44464117|NCT00392379|79472996|FG000|Overall Study|Adverse Event|1|||
44464118|NCT00392379|79472997|FG001|Overall Study|Adverse Event|1|||
44464119|NCT00497874|79473005|FG000|Overall Study|Withdrawal by Subject|48|||
44464120|NCT00497874|79473006|FG001|Overall Study|Withdrawal by Subject|17|||
44464121|NCT00497874|79473005|FG000|Overall Study|Illness|8|||
44464122|NCT00497874|79473006|FG001|Overall Study|Illness|4|||
44464123|NCT00497874|79473005|FG000|Overall Study|Death|2|||
44464124|NCT00497874|79473006|FG001|Overall Study|Death|4|||
44464125|NCT00497874|79473005|FG000|Overall Study|Unable to contact|52|||
44464126|NCT00497874|79473006|FG001|Overall Study|Unable to contact|67|||
44464127|NCT00497874|79473005|FG000|Overall Study|Unable to schedule|37|||
44464128|NCT00497874|79473006|FG001|Overall Study|Unable to schedule|24|||
44221874|NCT01725308|79025102|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
44221875|NCT01725308|79025103|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
44221876|NCT01725308|79025101|FG000|Treatment Period II|Did Not Receive Drug|4|||
44221877|NCT01725308|79025102|FG001|Treatment Period II|Did Not Receive Drug|0|||
44221878|NCT01725308|79025103|FG002|Treatment Period II|Did Not Receive Drug|0|||
44221879|NCT01725308|79025101|FG000|Treatment Period II|Adverse Event|13|||
44221880|NCT01725308|79025102|FG001|Treatment Period II|Adverse Event|8|||
44221881|NCT01725308|79025103|FG002|Treatment Period II|Adverse Event|20|||
44374794|NCT00876460|79379847|FG001|Combination Therapy Phase|Other reason not defined above|0|||
44374795|NCT00876460|79379848|FG002|Combination Therapy Phase|Other reason not defined above|0|||
44374796|NCT00876460|79379849|FG003|Combination Therapy Phase|Other reason not defined above|0|||
44374797|NCT00876460|79379850|FG004|Combination Therapy Phase|Other reason not defined above|0|||
44374798|NCT00876460|79379851|FG005|Combination Therapy Phase|Other reason not defined above|0|||
44374799|NCT00876460|79379852|FG006|Combination Therapy Phase|Other reason not defined above|1|||
44374800|NCT00876460|79379853|FG007|Combination Therapy Phase|Other reason not defined above|2|||
44374801|NCT00876460|79379846|FG000|Combination Therapy Phase|Not treated|0|||
44374802|NCT00876460|79379847|FG001|Combination Therapy Phase|Not treated|0|||
44374803|NCT00876460|79379848|FG002|Combination Therapy Phase|Not treated|0|||
44464129|NCT00403455|79473014|FG000|Overall Study|Withdrawal by Subject|1|||
44464130|NCT00318370|79473018|FG000|Period 1|Lack of Efficacy|5|||
44464131|NCT00318370|79473019|FG001|Period 1|Lack of Efficacy|0|||
44464132|NCT00318370|79473020|FG002|Period 1|Lack of Efficacy|0|||
44464133|NCT00318370|79473018|FG000|Period 1|Physician Decision|1|||
44544256|NCT03196791|79557580|FG000|Overall Study|Withdrawal by Subject|3|||
44221882|NCT01725308|79025101|FG000|Treatment Period II|Insufficient Response|2|||
44374804|NCT00876460|79379849|FG003|Combination Therapy Phase|Not treated|0|||
44464134|NCT00318370|79473019|FG001|Period 1|Physician Decision|0|||
44464135|NCT00318370|79473020|FG002|Period 1|Physician Decision|0|||
44464136|NCT00318370|79473018|FG000|Period 1|Withdrawal by Subject|1|||
44464137|NCT00318370|79473019|FG001|Period 1|Withdrawal by Subject|0|||
44464138|NCT00318370|79473020|FG002|Period 1|Withdrawal by Subject|0|||
44464139|NCT00318370|79473018|FG000|Period 2|Adverse Event|0|||
44464140|NCT00318370|79473019|FG001|Period 2|Adverse Event|3|||
44464141|NCT00318370|79473020|FG002|Period 2|Adverse Event|0|||
44464142|NCT00318370|79473018|FG000|Period 2|Lack of Efficacy|0|||
44464143|NCT00318370|79473019|FG001|Period 2|Lack of Efficacy|5|||
44464144|NCT00318370|79473020|FG002|Period 2|Lack of Efficacy|0|||
44464145|NCT00318370|79473018|FG000|Period 2|Physician Decision|0|||
44464146|NCT00318370|79473019|FG001|Period 2|Physician Decision|1|||
44464147|NCT00318370|79473020|FG002|Period 2|Physician Decision|0|||
44464148|NCT00318370|79473018|FG000|Period 2|Withdrawal by Subject|0|||
44464149|NCT00318370|79473019|FG001|Period 2|Withdrawal by Subject|1|||
44464150|NCT00318370|79473020|FG002|Period 2|Withdrawal by Subject|0|||
44464151|NCT00318370|79473018|FG000|Period 2|Other|0|||
44464152|NCT00318370|79473019|FG001|Period 2|Other|1|||
44464153|NCT00318370|79473020|FG002|Period 2|Other|0|||
44464154|NCT00318370|79473018|FG000|Period 3|Adverse Event|0|||
44464155|NCT00318370|79473019|FG001|Period 3|Adverse Event|0|||
44464156|NCT00318370|79473020|FG002|Period 3|Adverse Event|1|||
44464157|NCT00318370|79473018|FG000|Period 3|Lack of Efficacy|0|||
44464158|NCT00318370|79473019|FG001|Period 3|Lack of Efficacy|0|||
44464159|NCT00318370|79473020|FG002|Period 3|Lack of Efficacy|24|||
44464160|NCT00318370|79473018|FG000|Period 3|Death|0|||
44221883|NCT01725308|79025102|FG001|Treatment Period II|Insufficient Response|4|||
44464161|NCT00318370|79473019|FG001|Period 3|Death|0|||
44221884|NCT01725308|79025103|FG002|Treatment Period II|Insufficient Response|6|||
44221885|NCT01725308|79025101|FG000|Treatment Period II|Worsening of the Target Disease|1|||
44221886|NCT01725308|79025102|FG001|Treatment Period II|Worsening of the Target Disease|4|||
44221887|NCT01725308|79025103|FG002|Treatment Period II|Worsening of the Target Disease|2|||
44221888|NCT01725308|79025101|FG000|Treatment Period II|Changes in the Episodes|1|||
44221889|NCT01725308|79025102|FG001|Treatment Period II|Changes in the Episodes|0|||
44221890|NCT01725308|79025103|FG002|Treatment Period II|Changes in the Episodes|5|||
44221891|NCT01725308|79025101|FG000|Treatment Period II|Withdrawal of Consent|28|||
44221892|NCT01725308|79025102|FG001|Treatment Period II|Withdrawal of Consent|2|||
44271390|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
44271391|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
44271392|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
44271393|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
44271394|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
44271395|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
44271396|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
44271397|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
44271398|NCT00559585|79201920|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
44271399|NCT00559585|79201921|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
44271400|NCT00559507|79201961|FG000|Overall Study|Not treated, patient ineligible|3|||
44271401|NCT00559273|79202217|FG000|Correction Period (20 Weeks)|Death|3|||
44271402|NCT00559273|79202218|FG001|Correction Period (20 Weeks)|Death|4|||
44271403|NCT00559273|79202217|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
44221893|NCT01725308|79025103|FG002|Treatment Period II|Withdrawal of Consent|16|||
44221894|NCT01725308|79025101|FG000|Treatment Period II|Lost to Follow-up|1|||
44221895|NCT01725308|79025102|FG001|Treatment Period II|Lost to Follow-up|5|||
44221896|NCT01725308|79025103|FG002|Treatment Period II|Lost to Follow-up|3|||
44221897|NCT01725308|79025101|FG000|Treatment Period II|Protocol Deviations|0|||
44221898|NCT01725308|79025102|FG001|Treatment Period II|Protocol Deviations|0|||
44271404|NCT00559273|79202218|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
44271405|NCT00559273|79202217|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
44374805|NCT00876460|79379850|FG004|Combination Therapy Phase|Not treated|0|||
44374806|NCT00876460|79379851|FG005|Combination Therapy Phase|Not treated|0|||
44374807|NCT00876460|79379852|FG006|Combination Therapy Phase|Not treated|1|||
44374808|NCT00876460|79379853|FG007|Combination Therapy Phase|Not treated|0|||
44374809|NCT00876460|79379846|FG000|Mono Therapy Phase|Progressive disease|0|||
44374810|NCT00876460|79379847|FG001|Mono Therapy Phase|Progressive disease|0|||
44374811|NCT00876460|79379848|FG002|Mono Therapy Phase|Progressive disease|0|||
44374812|NCT00876460|79379849|FG003|Mono Therapy Phase|Progressive disease|0|||
44374813|NCT00876460|79379850|FG004|Mono Therapy Phase|Progressive disease|2|||
44374814|NCT00876460|79379851|FG005|Mono Therapy Phase|Progressive disease|0|||
44374815|NCT00876460|79379852|FG006|Mono Therapy Phase|Progressive disease|1|||
44464162|NCT00318370|79473020|FG002|Period 3|Death|1|||
44464163|NCT00318370|79473018|FG000|Period 3|Physician Decision|0|||
44221899|NCT01725308|79025103|FG002|Treatment Period II|Protocol Deviations|1|||
44464164|NCT00318370|79473019|FG001|Period 3|Physician Decision|0|||
44464165|NCT00318370|79473020|FG002|Period 3|Physician Decision|1|||
44464166|NCT00318370|79473018|FG000|Period 3|Withdrawal by Subject|0|||
44464167|NCT00318370|79473019|FG001|Period 3|Withdrawal by Subject|0|||
44464168|NCT00318370|79473020|FG002|Period 3|Withdrawal by Subject|3|||
44464169|NCT00318370|79473018|FG000|Period 3|Other|0|||
44464170|NCT00318370|79473019|FG001|Period 3|Other|0|||
44464171|NCT00318370|79473020|FG002|Period 3|Other|3|||
44464172|NCT00510068|79473028|FG000|Double-blind Period|Disease progression|98|||
44464173|NCT00510068|79473029|FG001|Double-blind Period|Disease progression|169|||
44464174|NCT00510068|79473028|FG000|Double-blind Period|Final primary analysis|52|||
44464175|NCT00510068|79473029|FG001|Double-blind Period|Final primary analysis|18|||
44221900|NCT01725308|79025101|FG000|Treatment Period II|Miscellaneous|5|||
44221901|NCT01725308|79025102|FG001|Treatment Period II|Miscellaneous|3|||
44221902|NCT01725308|79025103|FG002|Treatment Period II|Miscellaneous|7|||
44221903|NCT01724528|79025120|FG000|Overall Study|Death|3|||
44374816|NCT00876460|79379853|FG007|Mono Therapy Phase|Progressive disease|3|||
44374817|NCT00876460|79379846|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
44374818|NCT00876460|79379847|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
44374819|NCT00876460|79379848|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
44374820|NCT00876460|79379849|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
44374821|NCT00876460|79379850|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
44374822|NCT00876460|79379851|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
44374823|NCT00876460|79379852|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
44374824|NCT00876460|79379853|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
44374825|NCT00876460|79379846|FG000|Mono Therapy Phase|Adverse Event|0|||
44374826|NCT00876460|79379847|FG001|Mono Therapy Phase|Adverse Event|0|||
44374827|NCT00876460|79379848|FG002|Mono Therapy Phase|Adverse Event|0|||
44374828|NCT00876460|79379849|FG003|Mono Therapy Phase|Adverse Event|1|||
44374829|NCT00876460|79379850|FG004|Mono Therapy Phase|Adverse Event|0|||
44374830|NCT00876460|79379851|FG005|Mono Therapy Phase|Adverse Event|0|||
44374831|NCT00876460|79379852|FG006|Mono Therapy Phase|Adverse Event|0|||
44374832|NCT00876460|79379853|FG007|Mono Therapy Phase|Adverse Event|0|||
44374833|NCT00908115|79379883|FG000|Overall Study|Other|14|||
44374834|NCT01137812|79379889|FG000|Overall Study|Adverse Event|21|||
44374835|NCT01137812|79379890|FG001|Overall Study|Adverse Event|14|||
44374836|NCT01137812|79379889|FG000|Overall Study|Lost to Follow-up|6|||
44374837|NCT01137812|79379890|FG001|Overall Study|Lost to Follow-up|8|||
44374838|NCT01137812|79379889|FG000|Overall Study|Physician Decision|25|||
44374839|NCT01137812|79379890|FG001|Overall Study|Physician Decision|17|||
44374840|NCT01137812|79379889|FG000|Overall Study|Protocol Violation|5|||
44374841|NCT01137812|79379890|FG001|Overall Study|Protocol Violation|4|||
44374842|NCT01137812|79379889|FG000|Overall Study|Withdrawal by Subject|5|||
44374843|NCT01137812|79379890|FG001|Overall Study|Withdrawal by Subject|13|||
44374844|NCT01137812|79379889|FG000|Overall Study|Death|2|||
44374845|NCT01137812|79379890|FG001|Overall Study|Death|0|||
44374846|NCT01137812|79379889|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
44374847|NCT01137812|79379890|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
44374848|NCT01137812|79379889|FG000|Overall Study|Other|19|||
44374849|NCT01137812|79379890|FG001|Overall Study|Other|27|||
44374850|NCT01137578|79379896|FG000|Overall Study|Participant requested to Discontinue|3|||
44374851|NCT01137578|79379897|FG001|Overall Study|Participant requested to Discontinue|0|||
44374852|NCT01137578|79379898|FG002|Overall Study|Participant requested to Discontinue|0|||
44374853|NCT01137578|79379896|FG000|Overall Study|Withdrawal by Subject|1|||
44374854|NCT01137578|79379897|FG001|Overall Study|Withdrawal by Subject|0|||
44374855|NCT01137578|79379898|FG002|Overall Study|Withdrawal by Subject|0|||
44374856|NCT01137578|79379896|FG000|Overall Study|Other|12|||
44374857|NCT01137578|79379897|FG001|Overall Study|Other|2|||
44374858|NCT01137578|79379898|FG002|Overall Study|Other|6|||
44374859|NCT00946920|79379928|FG000|Overall Study|Withdrawal by Subject|28|||
44374860|NCT00946920|79379929|FG001|Overall Study|Withdrawal by Subject|15|||
44374861|NCT00946920|79379928|FG000|Overall Study|Lost to Follow-up|2|||
44374862|NCT00946920|79379929|FG001|Overall Study|Lost to Follow-up|2|||
44374863|NCT00946920|79379928|FG000|Overall Study|Physician Decision|5|||
44374864|NCT00946920|79379929|FG001|Overall Study|Physician Decision|2|||
44374865|NCT00946920|79379928|FG000|Overall Study|Adverse Event|41|||
44374866|NCT00946920|79379929|FG001|Overall Study|Adverse Event|14|||
44374867|NCT00946920|79379928|FG000|Overall Study|Protocol Violation|16|||
44374868|NCT00946920|79379929|FG001|Overall Study|Protocol Violation|8|||
44374869|NCT00946920|79379928|FG000|Overall Study|Miscellaneous reasons|18|||
44464176|NCT00510068|79473028|FG000|Double-blind Period|Adverse Event|37|||
44374870|NCT00946920|79379929|FG001|Overall Study|Miscellaneous reasons|3|||
44374871|NCT00946530|79379939|FG000|Overall Study|Withdrawal by Subject|0|||
44374872|NCT00946530|79379940|FG001|Overall Study|Withdrawal by Subject|3|||
44374873|NCT00946530|79379941|FG002|Overall Study|Withdrawal by Subject|0|||
44374874|NCT00946530|79379942|FG003|Overall Study|Withdrawal by Subject|3|||
44464177|NCT00510068|79473029|FG001|Double-blind Period|Adverse Event|7|||
44464178|NCT00510068|79473028|FG000|Double-blind Period|Withdrawal by Subject|8|||
44374875|NCT00946530|79379939|FG000|Overall Study|Physician Decision|1|||
44374876|NCT00946530|79379940|FG001|Overall Study|Physician Decision|1|||
44221904|NCT01724528|79025121|FG001|Overall Study|Death|0|||
44374877|NCT00946530|79379941|FG002|Overall Study|Physician Decision|1|||
44374878|NCT00946530|79379942|FG003|Overall Study|Physician Decision|1|||
44374879|NCT00946296|79379958|FG000|Overall Study|Physician Decision|3|||
44464179|NCT00510068|79473029|FG001|Double-blind Period|Withdrawal by Subject|6|||
44464180|NCT00510068|79473028|FG000|Double-blind Period|Death|4|||
44464181|NCT00510068|79473029|FG001|Double-blind Period|Death|3|||
44464182|NCT00510068|79473028|FG000|Double-blind Period|Abnormal test result (s)|1|||
44464183|NCT00510068|79473029|FG001|Double-blind Period|Abnormal test result (s)|0|||
44464184|NCT00510068|79473028|FG000|Double-blind Period|Lost to Follow-up|1|||
44464185|NCT00510068|79473029|FG001|Double-blind Period|Lost to Follow-up|0|||
44464186|NCT00510068|79473028|FG000|Double-blind Period|Protocol Violation|6|||
44464187|NCT00510068|79473029|FG001|Double-blind Period|Protocol Violation|0|||
44464188|NCT00510068|79473028|FG000|Open-label Period|Disease Progression|124|||
44464189|NCT00510068|79473029|FG001|Open-label Period|Disease Progression|0|||
44464190|NCT00510068|79473028|FG000|Open-label Period|Adverse Event|46|||
44464191|NCT00510068|79473029|FG001|Open-label Period|Adverse Event|0|||
44464192|NCT00510068|79473028|FG000|Open-label Period|Withdrawal by Subject|21|||
44464193|NCT00510068|79473029|FG001|Open-label Period|Withdrawal by Subject|0|||
44464194|NCT00510068|79473028|FG000|Open-label Period|Administrative problems|17|||
44464195|NCT00510068|79473029|FG001|Open-label Period|Administrative problems|0|||
44464196|NCT00510068|79473028|FG000|Open-label Period|Death|7|||
44464197|NCT00510068|79473029|FG001|Open-label Period|Death|0|||
44464198|NCT00510068|79473028|FG000|Open-label Period|New cancer therapy|7|||
44464199|NCT00510068|79473029|FG001|Open-label Period|New cancer therapy|0|||
44464200|NCT00510068|79473028|FG000|Open-label Period|Protocol Violation|2|||
44464201|NCT00510068|79473029|FG001|Open-label Period|Protocol Violation|0|||
44464202|NCT00510068|79473028|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
44464203|NCT00510068|79473029|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
44464204|NCT00509600|79473037|FG000|Overall Study|Adverse Event|1|||
44464205|NCT00402987|79473045|FG000|Overall Study|Lack of Efficacy|0|||
44464206|NCT00402987|79473046|FG001|Overall Study|Lack of Efficacy|0|||
44464207|NCT00402987|79473047|FG002|Overall Study|Lack of Efficacy|1|||
44464208|NCT00402987|79473048|FG003|Overall Study|Lack of Efficacy|0|||
44464209|NCT00501644|79473072|FG000|Overall Study|Adverse Event|4|||
44464210|NCT00501644|79473072|FG000|Overall Study|Withdrawal by Subject|1|||
44464211|NCT00497796|79473078|FG000|Overall Study|Adverse event (not related)|9|||
44464212|NCT00497796|79473079|FG001|Overall Study|Adverse event (not related)|9|||
44464213|NCT00497796|79473078|FG000|Overall Study|Adverse event (related)|5|||
44464214|NCT00497796|79473079|FG001|Overall Study|Adverse event (related)|4|||
44464215|NCT00497796|79473078|FG000|Overall Study|CMV infection or disease treatment|30|||
44464216|NCT00497796|79473079|FG001|Overall Study|CMV infection or disease treatment|4|||
44464217|NCT00497796|79473078|FG000|Overall Study|Consent withdrawn|10|||
44464218|NCT00497796|79473079|FG001|Overall Study|Consent withdrawn|3|||
44464219|NCT00497796|79473078|FG000|Overall Study|Investigator/sponsor discretion|31|||
44464220|NCT00497796|79473079|FG001|Overall Study|Investigator/sponsor discretion|34|||
44464221|NCT00497796|79473078|FG000|Overall Study|Lost to Follow-up|0|||
44464222|NCT00497796|79473079|FG001|Overall Study|Lost to Follow-up|1|||
44464223|NCT00497796|79473078|FG000|Overall Study|Not applicable (randomized not treated)|0|||
44464224|NCT00497796|79473079|FG001|Overall Study|Not applicable (randomized not treated)|4|||
44464225|NCT00496782|79473087|FG000|Overall Study|Protocol Violation|1|||
44464226|NCT00496782|79473088|FG001|Overall Study|Protocol Violation|2|||
44464227|NCT00402831|79473096|FG000|Overall Study|Lost to Follow-up|1|||
44464228|NCT00402831|79473097|FG001|Overall Study|Lost to Follow-up|2|||
44464229|NCT00402831|79473096|FG000|Overall Study|Non-compliance with protocol|0|||
44374880|NCT00946296|79379959|FG001|Overall Study|Physician Decision|0|||
44374881|NCT00945906|79379965|FG000|Overall Study|Withdrawal by Subject|1|||
44374882|NCT00945906|79379965|FG000|Overall Study|Did not want to return for last visit|2|||
44374883|NCT00945906|79379965|FG000|Overall Study|Unable to return for last visit|2|||
44374884|NCT00945906|79379965|FG000|Overall Study|Moved to another country|2|||
44374885|NCT00594646|79379969|FG000|Overall Study|Withdrawal by Subject|1|||
44374886|NCT00594646|79379969|FG000|Overall Study|Lost to Follow-up|15|||
44374887|NCT01111604|79379977|FG000|Overall Study|Lost to Follow-up|0|||
44374888|NCT01111604|79379978|FG001|Overall Study|Lost to Follow-up|0|||
44374889|NCT01111604|79379979|FG002|Overall Study|Lost to Follow-up|1|||
44464230|NCT00402831|79473097|FG001|Overall Study|Non-compliance with protocol|1|||
44464231|NCT00496626|79473107|FG000|Overall Study|Lost to Follow-up|0|||
44464232|NCT00496626|79473108|FG001|Overall Study|Lost to Follow-up|1|||
44464233|NCT00496626|79473107|FG000|Overall Study|Protocol Violation|1|||
44464234|NCT00496626|79473108|FG001|Overall Study|Protocol Violation|0|||
44464235|NCT00496626|79473107|FG000|Overall Study|Withdrawal by Subject|5|||
44464236|NCT00496626|79473108|FG001|Overall Study|Withdrawal by Subject|4|||
44464237|NCT00496626|79473107|FG000|Overall Study|Relocated|0|||
44464238|NCT00496626|79473108|FG001|Overall Study|Relocated|1|||
44464239|NCT00471822|79473118|FG000|Overall Study|Protocol Violation|2|||
44271406|NCT00559273|79202218|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
44374890|NCT01111604|79379977|FG000|Overall Study|Withdrew Consent|3|||
44464240|NCT00471276|79473122|FG000|Overall Study|Death|2|||
44464241|NCT00471276|79473122|FG000|Overall Study|Adverse Event|16|||
44464242|NCT00471276|79473122|FG000|Overall Study|Protocol Violation|1|||
44464243|NCT00471276|79473122|FG000|Overall Study|Objective progression or relapse|54|||
44464244|NCT00471276|79473122|FG000|Overall Study|Global deterioration of health status|1|||
44464245|NCT00471276|79473122|FG000|Overall Study|Other|3|||
44464246|NCT00471276|79473122|FG000|Overall Study|Refused treatment|6|||
44221905|NCT01724528|79025120|FG000|Overall Study|Withdrawal by Subject|0|||
44221906|NCT01724528|79025121|FG001|Overall Study|Withdrawal by Subject|2|||
44221907|NCT01724528|79025120|FG000|Overall Study|Protocol Violation|0|||
44221908|NCT01724528|79025121|FG001|Overall Study|Protocol Violation|1|||
44221909|NCT01724528|79025120|FG000|Overall Study|Patient refused to attend last visit|1|||
44221910|NCT01724528|79025121|FG001|Overall Study|Patient refused to attend last visit|0|||
44221911|NCT01779440|79025129|FG000|Overall Study|Withdrawal by Subject|3|||
44221912|NCT01779440|79025130|FG001|Overall Study|Withdrawal by Subject|5|||
44221913|NCT01750346|79025139|FG000|Overall Study|Adverse Event|1|||
44221914|NCT01750346|79025140|FG001|Overall Study|Adverse Event|0|||
44221915|NCT01750346|79025141|FG002|Overall Study|Adverse Event|0|||
44221916|NCT01750268|79025151|FG000|Overall Study|Lost to Follow-up|0|||
44221917|NCT01750268|79025152|FG001|Overall Study|Lost to Follow-up|2|||
44221918|NCT01750268|79025151|FG000|Overall Study|Physician Decision|0|||
44221919|NCT01750268|79025152|FG001|Overall Study|Physician Decision|3|||
44221920|NCT01750268|79025151|FG000|Overall Study|Withdrawal by Subject|2|||
44221921|NCT01750268|79025152|FG001|Overall Study|Withdrawal by Subject|0|||
44221922|NCT01880437|79025161|FG000|Overall Study|Death|12|||
44271407|NCT00559273|79202217|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
44271408|NCT00559273|79202218|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
44271409|NCT00559273|79202217|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
44271410|NCT00559273|79202218|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
44374891|NCT01111604|79379978|FG001|Overall Study|Withdrew Consent|0|||
44374892|NCT01111604|79379979|FG002|Overall Study|Withdrew Consent|2|||
44374893|NCT01111604|79379977|FG000|Overall Study|Withdrawal by Subject|2|||
44374894|NCT01111604|79379978|FG001|Overall Study|Withdrawal by Subject|0|||
44374895|NCT01111604|79379979|FG002|Overall Study|Withdrawal by Subject|0|||
44221923|NCT01880437|79025162|FG001|Overall Study|Death|4|||
44374896|NCT01111604|79379977|FG000|Overall Study|Death|1|||
44374897|NCT01111604|79379978|FG001|Overall Study|Death|0|||
44374898|NCT01111604|79379979|FG002|Overall Study|Death|0|||
44374899|NCT01111604|79379977|FG000|Overall Study|Met Exclusion Criteria|2|||
44374900|NCT01111604|79379978|FG001|Overall Study|Met Exclusion Criteria|0|||
44374901|NCT01111604|79379979|FG002|Overall Study|Met Exclusion Criteria|0|||
44464247|NCT00470262|79473128|FG000|Overall Study|Withdrawal by Subject|2|||
44464248|NCT00470262|79473129|FG001|Overall Study|Withdrawal by Subject|0|||
44464249|NCT00496470|79473138|FG000|Overall Study|Adverse Event|8|||
44221924|NCT01880437|79025163|FG002|Overall Study|Death|17|||
44221925|NCT01880437|79025161|FG000|Overall Study|Study terminated by Sponsor|3|||
44221926|NCT01880437|79025162|FG001|Overall Study|Study terminated by Sponsor|0|||
44221927|NCT01880437|79025163|FG002|Overall Study|Study terminated by Sponsor|2|||
44374902|NCT00950742|79380007|FG000|Overall Study|Other Adverse Event|1|||
44374903|NCT00950742|79380008|FG001|Overall Study|Other Adverse Event|0|||
44464250|NCT00496470|79473139|FG001|Overall Study|Adverse Event|10|||
44464251|NCT00496470|79473138|FG000|Overall Study|Withdrawal by Subject|5|||
44464252|NCT00496470|79473139|FG001|Overall Study|Withdrawal by Subject|12|||
44464253|NCT00496470|79473138|FG000|Overall Study|Incorrectly enrolled|13|||
44464254|NCT00496470|79473139|FG001|Overall Study|Incorrectly enrolled|5|||
44464255|NCT00496470|79473138|FG000|Overall Study|Other reason|0|||
44464256|NCT00496470|79473139|FG001|Overall Study|Other reason|2|||
44464257|NCT00496080|79473145|FG000|Overall Study|Lost to Follow-up|9|||
44464258|NCT00496080|79473145|FG000|Overall Study|Surgical re-intervention|7|||
44464259|NCT00496080|79473145|FG000|Overall Study|Withdrawal by Subject|5|||
44464260|NCT00496080|79473145|FG000|Overall Study|Physician Decision|6|||
44464261|NCT00487578|79473152|FG000|Overall Study|Adverse Event|1|||
44464262|NCT00487578|79473153|FG001|Overall Study|Adverse Event|2|||
44464263|NCT00487578|79473152|FG000|Overall Study|Lack of Efficacy|0|||
44464264|NCT00487578|79473153|FG001|Overall Study|Lack of Efficacy|1|||
44464265|NCT00487578|79473152|FG000|Overall Study|Lost to Follow-up|0|||
44464266|NCT00487578|79473153|FG001|Overall Study|Lost to Follow-up|1|||
44464267|NCT00495612|79473161|FG000|Overall Study|Lost to Follow-up|1|||
44464268|NCT00495612|79473162|FG001|Overall Study|Lost to Follow-up|0|||
44464269|NCT00495612|79473161|FG000|Overall Study|Subject's Decision to Withdraw|3|||
44464270|NCT00495612|79473162|FG001|Overall Study|Subject's Decision to Withdraw|0|||
44464271|NCT00487188|79473170|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
44464272|NCT00487188|79473171|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
44464273|NCT00487188|79473172|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
44464274|NCT00487188|79473170|FG000|Induction Phase|Adverse Event|5|||
44464275|NCT00487188|79473171|FG001|Induction Phase|Adverse Event|0|||
44464276|NCT00487188|79473172|FG002|Induction Phase|Adverse Event|0|||
44464277|NCT00487188|79473170|FG000|Induction Phase|Lack of Efficacy|0|||
44464278|NCT00487188|79473171|FG001|Induction Phase|Lack of Efficacy|1|||
44464279|NCT00487188|79473172|FG002|Induction Phase|Lack of Efficacy|0|||
44464280|NCT00487188|79473170|FG000|Induction Phase|Protocol Violation|1|||
44464281|NCT00487188|79473171|FG001|Induction Phase|Protocol Violation|0|||
44464282|NCT00487188|79473172|FG002|Induction Phase|Protocol Violation|0|||
44464283|NCT00487188|79473170|FG000|Induction Phase|Refused Treatment|1|||
44464284|NCT00487188|79473171|FG001|Induction Phase|Refused Treatment|2|||
44464285|NCT00487188|79473172|FG002|Induction Phase|Refused Treatment|0|||
44464286|NCT00487188|79473170|FG000|Induction Phase|Lost to Follow-up|2|||
44464287|NCT00487188|79473171|FG001|Induction Phase|Lost to Follow-up|2|||
44464288|NCT00487188|79473172|FG002|Induction Phase|Lost to Follow-up|0|||
44464289|NCT00487188|79473170|FG000|Induction Phase|Administrative|0|||
44464290|NCT00487188|79473171|FG001|Induction Phase|Administrative|1|||
44464291|NCT00487188|79473172|FG002|Induction Phase|Administrative|0|||
44464292|NCT00487188|79473170|FG000|Maintenance Phase|Adverse Event|1|||
44464293|NCT00487188|79473171|FG001|Maintenance Phase|Adverse Event|0|||
44464294|NCT00487188|79473172|FG002|Maintenance Phase|Adverse Event|0|||
44464295|NCT00487188|79473170|FG000|Maintenance Phase|Death|1|||
44464296|NCT00487188|79473171|FG001|Maintenance Phase|Death|0|||
44464297|NCT00487188|79473172|FG002|Maintenance Phase|Death|0|||
44464298|NCT00487188|79473170|FG000|Maintenance Phase|Lost to Follow-up|1|||
44464299|NCT00487188|79473171|FG001|Maintenance Phase|Lost to Follow-up|0|||
44221928|NCT01861717|79025173|FG000|Overall Study|Lost to Follow-up|1|||
44221929|NCT01861717|79025173|FG000|Overall Study|Withdrawal by Subject|1|||
44221930|NCT01834729|79025182|FG000|Overall Study|Did not return bowel diaries|0|||
44221931|NCT01834729|79025183|FG001|Overall Study|Did not return bowel diaries|0|||
44221932|NCT01834729|79025184|FG002|Overall Study|Did not return bowel diaries|3|||
44221933|NCT01834729|79025185|FG003|Overall Study|Did not return bowel diaries|0|||
44221934|NCT01834729|79025182|FG000|Overall Study|Withdrawal by Subject|1|||
44221935|NCT01834729|79025183|FG001|Overall Study|Withdrawal by Subject|1|||
44221936|NCT01834729|79025184|FG002|Overall Study|Withdrawal by Subject|0|||
44221937|NCT01834729|79025185|FG003|Overall Study|Withdrawal by Subject|0|||
44221938|NCT01834729|79025182|FG000|Overall Study|Adverse Event|0|||
44221939|NCT01834729|79025183|FG001|Overall Study|Adverse Event|0|||
44464300|NCT00487188|79473172|FG002|Maintenance Phase|Lost to Follow-up|0|||
44464301|NCT00487188|79473170|FG000|Maintenance Phase|Administrative|0|||
44464302|NCT00487188|79473171|FG001|Maintenance Phase|Administrative|0|||
44464303|NCT00487188|79473172|FG002|Maintenance Phase|Administrative|1|||
44221940|NCT01834729|79025184|FG002|Overall Study|Adverse Event|0|||
44221941|NCT01834729|79025185|FG003|Overall Study|Adverse Event|2|||
44221942|NCT01860703|79025196|FG000|Overall Study|Adverse Event|1|||
44221943|NCT01860703|79025197|FG001|Overall Study|Adverse Event|4|||
44464304|NCT00509366|79473193|FG000|Overall Study|Not Treated (Screen Failure)|1|||
44464305|NCT00509366|79473194|FG001|Overall Study|Not Treated (Screen Failure)|1|||
44464306|NCT00509366|79473195|FG002|Overall Study|Not Treated (Screen Failure)|1|||
44464307|NCT00509366|79473196|FG003|Overall Study|Not Treated (Screen Failure)|0|||
44464308|NCT00509366|79473197|FG004|Overall Study|Not Treated (Screen Failure)|0|||
44221944|NCT01860703|79025198|FG002|Overall Study|Adverse Event|0|||
44464309|NCT00500318|79473209|FG000|Overall Study|Adverse Event|3|||
44464310|NCT00500318|79473210|FG001|Overall Study|Adverse Event|8|||
44464311|NCT00500318|79473209|FG000|Overall Study|Protocol Violation|1|||
44464312|NCT00500318|79473210|FG001|Overall Study|Protocol Violation|3|||
44464313|NCT00500318|79473209|FG000|Overall Study|Withdrawal by Subject|1|||
44464314|NCT00500318|79473210|FG001|Overall Study|Withdrawal by Subject|2|||
44464315|NCT00500318|79473209|FG000|Overall Study|Lack of Efficacy|0|||
44464316|NCT00500318|79473210|FG001|Overall Study|Lack of Efficacy|3|||
44464317|NCT00500318|79473209|FG000|Overall Study|Other Reason|0|||
44464318|NCT00500318|79473210|FG001|Overall Study|Other Reason|1|||
44464319|NCT00508820|79473218|FG000|Overall Study|Adverse Event|6|||
44464320|NCT00508820|79473219|FG001|Overall Study|Adverse Event|10|||
44464321|NCT00508820|79473218|FG000|Overall Study|Death|6|||
44464322|NCT00508820|79473219|FG001|Overall Study|Death|8|||
44464323|NCT00508820|79473218|FG000|Overall Study|Lost to Follow-up|1|||
44464324|NCT00508820|79473219|FG001|Overall Study|Lost to Follow-up|1|||
44464325|NCT00508820|79473218|FG000|Overall Study|Physician Decision|8|||
44464326|NCT00508820|79473219|FG001|Overall Study|Physician Decision|2|||
44464327|NCT00508820|79473218|FG000|Overall Study|Pregnancy|0|||
44464328|NCT00508820|79473219|FG001|Overall Study|Pregnancy|2|||
44464329|NCT00508820|79473218|FG000|Overall Study|Protocol Violation|2|||
44464330|NCT00508820|79473219|FG001|Overall Study|Protocol Violation|0|||
44464331|NCT00508820|79473218|FG000|Overall Study|Withdrawal by Subject|10|||
44464332|NCT00508820|79473219|FG001|Overall Study|Withdrawal by Subject|12|||
44464333|NCT00508820|79473218|FG000|Overall Study|Other|11|||
44464334|NCT00508820|79473219|FG001|Overall Study|Other|2|||
44464335|NCT00508820|79473218|FG000|Overall Study|Noncompliance|1|||
44464336|NCT00508820|79473219|FG001|Overall Study|Noncompliance|0|||
44464337|NCT00508820|79473218|FG000|Overall Study|Requirement for alternative therapy|7|||
44464338|NCT00508820|79473219|FG001|Overall Study|Requirement for alternative therapy|15|||
44464339|NCT00508820|79473218|FG000|Overall Study|Protocol-specified Criteria|3|||
44464340|NCT00508820|79473219|FG001|Overall Study|Protocol-specified Criteria|12|||
44464341|NCT00499694|79473225|FG000|Overall Study|Patient never received treatment.|1|||
44464342|NCT00486954|79473234|FG000|Pilot Part|Adverse Event|4|||
44464343|NCT00486954|79473235|FG001|Pilot Part|Adverse Event|0|||
44464344|NCT00486954|79473236|FG002|Pilot Part|Adverse Event|5|||
44464345|NCT00486954|79473237|FG003|Pilot Part|Adverse Event|0|||
44464346|NCT00486954|79473238|FG004|Pilot Part|Adverse Event|0|||
44464347|NCT00486954|79473234|FG000|Pilot Part|Disease Progression|2|||
44464348|NCT00486954|79473235|FG001|Pilot Part|Disease Progression|0|||
44464349|NCT00486954|79473236|FG002|Pilot Part|Disease Progression|1|||
44464350|NCT00486954|79473237|FG003|Pilot Part|Disease Progression|0|||
44464351|NCT00486954|79473238|FG004|Pilot Part|Disease Progression|0|||
44464352|NCT00486954|79473234|FG000|Randomized Part|Lost to Follow-up|0|||
44464353|NCT00486954|79473235|FG001|Randomized Part|Lost to Follow-up|0|||
44464354|NCT00486954|79473236|FG002|Randomized Part|Lost to Follow-up|0|||
44464355|NCT00486954|79473237|FG003|Randomized Part|Lost to Follow-up|0|||
44464356|NCT00486954|79473238|FG004|Randomized Part|Lost to Follow-up|1|||
44464357|NCT00486954|79473234|FG000|Randomized Part|Withdrawal by Subject|0|||
44464358|NCT00486954|79473235|FG001|Randomized Part|Withdrawal by Subject|0|||
44464359|NCT00486954|79473236|FG002|Randomized Part|Withdrawal by Subject|0|||
44464360|NCT00486954|79473237|FG003|Randomized Part|Withdrawal by Subject|1|||
44464361|NCT00486954|79473238|FG004|Randomized Part|Withdrawal by Subject|0|||
44464362|NCT00486954|79473234|FG000|Randomized Part|Sponsor Terminated Study|0|||
44464363|NCT00486954|79473235|FG001|Randomized Part|Sponsor Terminated Study|0|||
44464364|NCT00486954|79473236|FG002|Randomized Part|Sponsor Terminated Study|0|||
44464365|NCT00486954|79473237|FG003|Randomized Part|Sponsor Terminated Study|19|||
44464366|NCT00486954|79473238|FG004|Randomized Part|Sponsor Terminated Study|13|||
44464367|NCT00494676|79473248|FG000|Allocation|Withdrawal by Subject|2|||
44464368|NCT00494676|79473249|FG001|Allocation|Withdrawal by Subject|4|||
44464369|NCT00494676|79473248|FG000|First Intervention|Withdrawal by Subject|1|||
44221945|NCT01860703|79025199|FG003|Overall Study|Adverse Event|2|||
44221946|NCT01860703|79025196|FG000|Overall Study|Withdrawal by Subject|0|||
44464370|NCT00494676|79473249|FG001|First Intervention|Withdrawal by Subject|3|||
44464371|NCT00494676|79473248|FG000|Second Intervention|Withdrawal by Subject|1|||
44464372|NCT00494676|79473249|FG001|Second Intervention|Withdrawal by Subject|1|||
44464373|NCT00486720|79473257|FG000|Overall Study|Adverse Event|1|||
44464374|NCT00486720|79473258|FG001|Overall Study|Adverse Event|2|||
44464375|NCT00486720|79473257|FG000|Overall Study|Lack of Efficacy|4|||
44464376|NCT00486720|79473258|FG001|Overall Study|Lack of Efficacy|6|||
44464377|NCT00486720|79473257|FG000|Overall Study|Physician Decision|1|||
44464378|NCT00486720|79473258|FG001|Overall Study|Physician Decision|2|||
44544257|NCT03196791|79557581|FG001|Overall Study|Withdrawal by Subject|2|||
44464379|NCT00486720|79473257|FG000|Overall Study|Protocol Violation|1|||
44464380|NCT00486720|79473258|FG001|Overall Study|Protocol Violation|0|||
44464381|NCT00486720|79473257|FG000|Overall Study|Withdrawal by Subject|3|||
44544258|NCT03196635|79557587|FG000|Overall Study|Withdrawal by Subject|1|||
44464382|NCT00486720|79473258|FG001|Overall Study|Withdrawal by Subject|1|||
44464383|NCT00486720|79473257|FG000|Overall Study|Progressive Disease|0|||
44464384|NCT00486720|79473258|FG001|Overall Study|Progressive Disease|1|||
44464385|NCT00486330|79473264|FG000|Overall Study|Adverse Event|2|||
44464386|NCT00486252|79473268|FG000|Overall Study|Adverse Event|7|||
44464387|NCT00486252|79473268|FG000|Overall Study|Lack of Efficacy|9|||
44464388|NCT00486252|79473268|FG000|Overall Study|Lost to Follow-up|24|||
44464389|NCT00486252|79473268|FG000|Overall Study|Other|18|||
44464390|NCT00494442|79473276|FG000|Overall Study|Death|1|||
44464391|NCT00494442|79473277|FG001|Overall Study|Death|1|||
44464392|NCT00494442|79473276|FG000|Overall Study|Lack of Efficacy|16|||
44464393|NCT00494442|79473277|FG001|Overall Study|Lack of Efficacy|10|||
44464394|NCT00494442|79473276|FG000|Overall Study|Adverse Event|0|||
44464395|NCT00494442|79473277|FG001|Overall Study|Adverse Event|2|||
44464396|NCT00494442|79473276|FG000|Overall Study|Physician Decision|0|||
44464397|NCT00494442|79473277|FG001|Overall Study|Physician Decision|1|||
44464398|NCT00494442|79473276|FG000|Overall Study|Non-compliance|0|||
44464399|NCT00494442|79473277|FG001|Overall Study|Non-compliance|1|||
44464400|NCT00494442|79473276|FG000|Overall Study|Intercurrent illness|0|||
44464401|NCT00494442|79473277|FG001|Overall Study|Intercurrent illness|1|||
44464402|NCT03851016|79473285|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44464403|NCT03851016|79473286|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
44464404|NCT00493974|79473294|FG000|Overall Study|Death|1|||
44464405|NCT00493974|79473295|FG001|Overall Study|Death|2|||
44464406|NCT00493974|79473294|FG000|Overall Study|Withdrawal by Subject|8|||
44464407|NCT00493974|79473295|FG001|Overall Study|Withdrawal by Subject|6|||
44464408|NCT00493974|79473294|FG000|Overall Study|Lost to Follow-up|4|||
44464409|NCT00493974|79473295|FG001|Overall Study|Lost to Follow-up|6|||
44464410|NCT00469092|79473303|FG000|Overall Study|Adverse Event|5|||
44464411|NCT00469092|79473304|FG001|Overall Study|Adverse Event|4|||
44464412|NCT00469092|79473303|FG000|Overall Study|Lack of Efficacy|1|||
44464413|NCT00469092|79473304|FG001|Overall Study|Lack of Efficacy|0|||
44464414|NCT00469092|79473303|FG000|Overall Study|Lost to Follow-up|1|||
44464415|NCT00469092|79473304|FG001|Overall Study|Lost to Follow-up|2|||
44464416|NCT00469092|79473303|FG000|Overall Study|Protocol Violation|3|||
44464417|NCT00469092|79473304|FG001|Overall Study|Protocol Violation|3|||
44464418|NCT00469092|79473303|FG000|Overall Study|Withdrawal by Subject|4|||
44464419|NCT00469092|79473304|FG001|Overall Study|Withdrawal by Subject|4|||
44464420|NCT00469092|79473303|FG000|Overall Study|Withdrawal Criteria|3|||
44464421|NCT00469092|79473304|FG001|Overall Study|Withdrawal Criteria|4|||
44221947|NCT01860703|79025197|FG001|Overall Study|Withdrawal by Subject|1|||
44221948|NCT01860703|79025198|FG002|Overall Study|Withdrawal by Subject|0|||
44221949|NCT01860703|79025199|FG003|Overall Study|Withdrawal by Subject|0|||
44221950|NCT01860703|79025196|FG000|Overall Study|Personal reason|1|||
44221951|NCT01860703|79025197|FG001|Overall Study|Personal reason|0|||
44221952|NCT01860703|79025198|FG002|Overall Study|Personal reason|1|||
44464422|NCT00469092|79473303|FG000|Overall Study|Incorrectly Randomised|4|||
44464423|NCT00469092|79473304|FG001|Overall Study|Incorrectly Randomised|3|||
44464424|NCT00469092|79473303|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
44464425|NCT00469092|79473304|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
44464426|NCT00469092|79473303|FG000|Overall Study|Use of lipid lowering drug|1|||
44464427|NCT00469092|79473304|FG001|Overall Study|Use of lipid lowering drug|0|||
44464428|NCT00469092|79473303|FG000|Overall Study|Hypoglycaemic Episodes|1|||
44464429|NCT00469092|79473304|FG001|Overall Study|Hypoglycaemic Episodes|1|||
44464430|NCT00469092|79473303|FG000|Overall Study|Abnormal lab value|1|||
44464431|NCT00469092|79473304|FG001|Overall Study|Abnormal lab value|0|||
44464432|NCT00469092|79473303|FG000|Overall Study|Use of Corticosteroid|1|||
44464433|NCT00469092|79473304|FG001|Overall Study|Use of Corticosteroid|0|||
44221953|NCT01860703|79025199|FG003|Overall Study|Personal reason|0|||
44221954|NCT01399593|79025217|FG000|Overall Study|Physician Decision|1|||
44221955|NCT01399593|79025218|FG001|Overall Study|Physician Decision|0|||
44221956|NCT01399593|79025217|FG000|Overall Study|Adverse Event|1|||
44221957|NCT01399593|79025218|FG001|Overall Study|Adverse Event|0|||
44221958|NCT01399593|79025217|FG000|Overall Study|Death|1|||
44464434|NCT00499616|79473314|FG000|Overall Study|Death|1|||
44464435|NCT00499616|79473315|FG001|Overall Study|Death|5|||
44464436|NCT00499616|79473316|FG002|Overall Study|Death|3|||
44464437|NCT00499616|79473317|FG003|Overall Study|Death|1|||
44464438|NCT00499616|79473314|FG000|Overall Study|Lack of Efficacy|5|||
44464439|NCT00499616|79473315|FG001|Overall Study|Lack of Efficacy|0|||
44221959|NCT01399593|79025218|FG001|Overall Study|Death|1|||
44221960|NCT01399593|79025217|FG000|Overall Study|Transplantectomy|0|||
44221961|NCT01399593|79025218|FG001|Overall Study|Transplantectomy|1|||
44221962|NCT01833169|79025224|FG000|Overall Study|Disease Progression|99|||
44221963|NCT01833169|79025224|FG000|Overall Study|Adverse Event|33|||
44271411|NCT00559273|79202217|FG000|Evaluation Period (8 Weeks)|Death|1|||
44464440|NCT00499616|79473316|FG002|Overall Study|Lack of Efficacy|19|||
44464441|NCT00499616|79473317|FG003|Overall Study|Lack of Efficacy|0|||
44464442|NCT00499616|79473314|FG000|Overall Study|Lost to Follow-up|0|||
44464443|NCT00499616|79473315|FG001|Overall Study|Lost to Follow-up|0|||
44464444|NCT00499616|79473316|FG002|Overall Study|Lost to Follow-up|1|||
44464445|NCT00499616|79473317|FG003|Overall Study|Lost to Follow-up|0|||
44221964|NCT01833169|79025224|FG000|Overall Study|Withdrawal by Subject|9|||
44221965|NCT01833169|79025224|FG000|Overall Study|Death|3|||
44464446|NCT00499616|79473314|FG000|Overall Study|Physician Decision|6|||
44464447|NCT00499616|79473315|FG001|Overall Study|Physician Decision|16|||
44464448|NCT00499616|79473316|FG002|Overall Study|Physician Decision|9|||
44271412|NCT00559273|79202218|FG001|Evaluation Period (8 Weeks)|Death|3|||
44271413|NCT00559273|79202217|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
44271414|NCT00559273|79202218|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
44271415|NCT00559273|79202217|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
44271416|NCT00559273|79202218|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
44271417|NCT00559273|79202217|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
44271418|NCT00559273|79202218|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
44271419|NCT00558259|79202273|FG000|Overall Study|Adverse Event|50|||
44271420|NCT00558259|79202274|FG001|Overall Study|Adverse Event|81|||
44271421|NCT00558259|79202273|FG000|Overall Study|Protocol Violation|9|||
44271422|NCT00558259|79202274|FG001|Overall Study|Protocol Violation|5|||
44271423|NCT00558259|79202273|FG000|Overall Study|Withdrawal by Subject|12|||
44271424|NCT00558259|79202274|FG001|Overall Study|Withdrawal by Subject|13|||
44271425|NCT00558103|79202421|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
44271426|NCT00558103|79202422|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
44271427|NCT00558103|79202423|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
44271428|NCT00558103|79202424|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
44271429|NCT00558103|79202425|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
44271430|NCT00558103|79202426|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
44271431|NCT00558103|79202421|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
44271432|NCT00558103|79202422|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
44271433|NCT00558103|79202423|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
44271434|NCT00558103|79202424|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
44464449|NCT00499616|79473317|FG003|Overall Study|Physician Decision|0|||
44464450|NCT00499616|79473314|FG000|Overall Study|Withdrawal by Subject|1|||
44464451|NCT00499616|79473315|FG001|Overall Study|Withdrawal by Subject|0|||
44464452|NCT00499616|79473316|FG002|Overall Study|Withdrawal by Subject|1|||
44271435|NCT00558103|79202425|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
44271436|NCT00558103|79202426|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
44271437|NCT00558103|79202421|FG000|Randomized Treatment Phase|Disease Progression|1|||
44271438|NCT00558103|79202422|FG001|Randomized Treatment Phase|Disease Progression|0|||
44271439|NCT00558103|79202423|FG002|Randomized Treatment Phase|Disease Progression|1|||
44271440|NCT00558103|79202424|FG003|Randomized Treatment Phase|Disease Progression|0|||
44271441|NCT00558103|79202425|FG004|Randomized Treatment Phase|Disease Progression|0|||
44271442|NCT00558103|79202426|FG005|Randomized Treatment Phase|Disease Progression|0|||
44271443|NCT00558103|79202421|FG000|Randomized Treatment Phase|Adverse Event|0|||
44271444|NCT00558103|79202422|FG001|Randomized Treatment Phase|Adverse Event|0|||
44271445|NCT00558103|79202423|FG002|Randomized Treatment Phase|Adverse Event|0|||
44271446|NCT00558103|79202424|FG003|Randomized Treatment Phase|Adverse Event|1|||
44271447|NCT00558103|79202425|FG004|Randomized Treatment Phase|Adverse Event|1|||
44464453|NCT00499616|79473317|FG003|Overall Study|Withdrawal by Subject|0|||
44464454|NCT00499616|79473314|FG000|Overall Study|Ineligible|1|||
44464455|NCT00499616|79473315|FG001|Overall Study|Ineligible|2|||
44464456|NCT00499616|79473316|FG002|Overall Study|Ineligible|0|||
44464457|NCT00499616|79473317|FG003|Overall Study|Ineligible|15|||
44221966|NCT01833169|79025224|FG000|Overall Study|Physician Decision|2|||
44221967|NCT01860079|79025230|FG000|Overall Study|Physician Decision|14|||
44221968|NCT01860079|79025231|FG001|Overall Study|Physician Decision|22|||
44221969|NCT01388985|79025239|FG000|Overall Study|Death|0|||
44221970|NCT01388985|79025240|FG001|Overall Study|Death|1|||
44221971|NCT01388985|79025239|FG000|Overall Study|Lost to Follow-up|30|||
44221972|NCT01388985|79025240|FG001|Overall Study|Lost to Follow-up|30|||
44221973|NCT01388985|79025239|FG000|Overall Study|Withdrawal by Subject|13|||
44221974|NCT01388985|79025240|FG001|Overall Study|Withdrawal by Subject|4|||
44221975|NCT01388985|79025239|FG000|Overall Study|Subject unavailable|1|||
44221976|NCT01388985|79025240|FG001|Overall Study|Subject unavailable|1|||
44221977|NCT01388985|79025239|FG000|Overall Study|Other (no reason)|0|||
44221978|NCT01388985|79025240|FG001|Overall Study|Other (no reason)|1|||
44221979|NCT01388985|79025239|FG000|Overall Study|Error of nurse|5|||
44221980|NCT01388985|79025240|FG001|Overall Study|Error of nurse|1|||
44271448|NCT00558103|79202426|FG005|Randomized Treatment Phase|Adverse Event|0|||
44271449|NCT00558103|79202421|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
44464458|NCT00499616|79473314|FG000|Overall Study|Not evaluable|0|||
44221981|NCT01388907|79025248|FG000|Overall Study|Adverse Event|2|||
44271450|NCT00558103|79202422|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
44221982|NCT01388907|79025249|FG001|Overall Study|Adverse Event|0|||
44221983|NCT01388361|79025260|FG000|Overall Study|Adverse Event|0|||
44221984|NCT01388361|79025261|FG001|Overall Study|Adverse Event|5|||
44221985|NCT01388361|79025262|FG002|Overall Study|Adverse Event|1|||
44464459|NCT00499616|79473315|FG001|Overall Study|Not evaluable|0|||
44464460|NCT00499616|79473316|FG002|Overall Study|Not evaluable|0|||
44464461|NCT00499616|79473317|FG003|Overall Study|Not evaluable|41|||
44271451|NCT00558103|79202423|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
44271452|NCT00558103|79202424|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
44271453|NCT00558103|79202425|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
44271454|NCT00558103|79202426|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
44271455|NCT00558103|79202421|FG000|Monotherapy Extension Phase|Disease Progression|0|||
44464462|NCT00499616|79473314|FG000|Overall Study|Patient/Parent Refusal|1|||
44464463|NCT00499616|79473315|FG001|Overall Study|Patient/Parent Refusal|5|||
44464464|NCT00499616|79473316|FG002|Overall Study|Patient/Parent Refusal|3|||
44464465|NCT00499616|79473317|FG003|Overall Study|Patient/Parent Refusal|0|||
44464466|NCT00402597|79473335|FG000|Overall Study|Death|15|||
44464467|NCT00402597|79473336|FG001|Overall Study|Death|7|||
44464468|NCT00402597|79473337|FG002|Overall Study|Death|6|||
44464469|NCT00402597|79473338|FG003|Overall Study|Death|4|||
44464470|NCT00402597|79473339|FG004|Overall Study|Death|6|||
44464471|NCT00402597|79473335|FG000|Overall Study|Adverse Event|81|||
44464472|NCT00402597|79473336|FG001|Overall Study|Adverse Event|18|||
44464473|NCT00402597|79473337|FG002|Overall Study|Adverse Event|106|||
44464474|NCT00402597|79473338|FG003|Overall Study|Adverse Event|39|||
44464475|NCT00402597|79473339|FG004|Overall Study|Adverse Event|71|||
44464476|NCT00402597|79473335|FG000|Overall Study|Lost to Follow-up|8|||
44464477|NCT00402597|79473336|FG001|Overall Study|Lost to Follow-up|1|||
44464478|NCT00402597|79473337|FG002|Overall Study|Lost to Follow-up|8|||
44464479|NCT00402597|79473338|FG003|Overall Study|Lost to Follow-up|2|||
44464480|NCT00402597|79473339|FG004|Overall Study|Lost to Follow-up|3|||
44464481|NCT00402597|79473335|FG000|Overall Study|Withdrawal by Subject|57|||
44464482|NCT00402597|79473336|FG001|Overall Study|Withdrawal by Subject|16|||
44464483|NCT00402597|79473337|FG002|Overall Study|Withdrawal by Subject|65|||
44464484|NCT00402597|79473338|FG003|Overall Study|Withdrawal by Subject|15|||
44464485|NCT00402597|79473339|FG004|Overall Study|Withdrawal by Subject|24|||
44464486|NCT00402597|79473335|FG000|Overall Study|reason not specified|30|||
44464487|NCT00402597|79473336|FG001|Overall Study|reason not specified|4|||
44464488|NCT00402597|79473337|FG002|Overall Study|reason not specified|27|||
44464489|NCT00402597|79473338|FG003|Overall Study|reason not specified|14|||
44464490|NCT00402597|79473339|FG004|Overall Study|reason not specified|20|||
44464491|NCT00402363|79473355|FG000|Overall Study|Adverse Event|9|||
44464492|NCT00402363|79473356|FG001|Overall Study|Adverse Event|14|||
44464493|NCT00402363|79473357|FG002|Overall Study|Adverse Event|2|||
44464494|NCT00402363|79473358|FG003|Overall Study|Adverse Event|2|||
44464495|NCT00402363|79473355|FG000|Overall Study|Withdrew Consent|10|||
44464496|NCT00402363|79473356|FG001|Overall Study|Withdrew Consent|5|||
44464497|NCT00402363|79473357|FG002|Overall Study|Withdrew Consent|2|||
44464498|NCT00402363|79473358|FG003|Overall Study|Withdrew Consent|1|||
44464499|NCT00402363|79473355|FG000|Overall Study|Protocol Violation|3|||
44464500|NCT00402363|79473356|FG001|Overall Study|Protocol Violation|5|||
44464501|NCT00402363|79473357|FG002|Overall Study|Protocol Violation|0|||
44464502|NCT00402363|79473358|FG003|Overall Study|Protocol Violation|3|||
44464503|NCT00402363|79473355|FG000|Overall Study|Lost to Follow-up|5|||
44464504|NCT00402363|79473356|FG001|Overall Study|Lost to Follow-up|4|||
44221986|NCT01388361|79025260|FG000|Overall Study|Protocol Violation|0|||
44221987|NCT01388361|79025261|FG001|Overall Study|Protocol Violation|0|||
44221988|NCT01388361|79025262|FG002|Overall Study|Protocol Violation|2|||
44221989|NCT01388361|79025260|FG000|Overall Study|Withdrawal criteria|12|||
44221990|NCT01388361|79025261|FG001|Overall Study|Withdrawal criteria|7|||
44221991|NCT01388361|79025262|FG002|Overall Study|Withdrawal criteria|10|||
44221992|NCT01388361|79025260|FG000|Overall Study|Unclassified|0|||
44271456|NCT00558103|79202422|FG001|Monotherapy Extension Phase|Disease Progression|0|||
44271457|NCT00558103|79202423|FG002|Monotherapy Extension Phase|Disease Progression|0|||
44271458|NCT00558103|79202424|FG003|Monotherapy Extension Phase|Disease Progression|0|||
44374904|NCT00950742|79380007|FG000|Overall Study|Withdrawal by Subject|3|||
44374905|NCT00950742|79380008|FG001|Overall Study|Withdrawal by Subject|0|||
44374906|NCT00950742|79380007|FG000|Overall Study|Progressive Disease|6|||
44374907|NCT00950742|79380008|FG001|Overall Study|Progressive Disease|2|||
44374908|NCT00950742|79380007|FG000|Overall Study|Dose limiting toxicity|6|||
44374909|NCT00950742|79380008|FG001|Overall Study|Dose limiting toxicity|0|||
44374910|NCT00955110|79380018|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
44374911|NCT00955110|79380018|FG000|Treatment Phase|Adverse Event|2|||
44464505|NCT00402363|79473357|FG002|Overall Study|Lost to Follow-up|0|||
44464506|NCT00402363|79473358|FG003|Overall Study|Lost to Follow-up|2|||
44464507|NCT00402363|79473355|FG000|Overall Study|"Captured as Other"|6|||
44464508|NCT00402363|79473356|FG001|Overall Study|"Captured as Other"|2|||
44221993|NCT01388361|79025261|FG001|Overall Study|Unclassified|0|||
44277803|NCT02092350|79238807|FG001|Overall Study|Death|5|||
44221994|NCT01388361|79025262|FG002|Overall Study|Unclassified|1|||
44221995|NCT01399125|79025272|FG000|Overall Study|Adverse Event|32|||
44221996|NCT01399125|79025273|FG001|Overall Study|Adverse Event|30|||
44221997|NCT01399125|79025272|FG000|Overall Study|Abnormal Lab values|0|||
44221998|NCT01399125|79025273|FG001|Overall Study|Abnormal Lab values|1|||
44221999|NCT01399125|79025272|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44222000|NCT01399125|79025273|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
44222001|NCT01399125|79025272|FG000|Overall Study|Withdrawal by Subject|5|||
44222002|NCT01399125|79025273|FG001|Overall Study|Withdrawal by Subject|8|||
44464509|NCT00402363|79473357|FG002|Overall Study|"Captured as Other"|2|||
44464510|NCT00402363|79473358|FG003|Overall Study|"Captured as Other"|2|||
44464511|NCT00469014|79473378|FG000|Initial Phase Randomization|Disease Progression|0|||
44464512|NCT00469014|79473379|FG001|Initial Phase Randomization|Disease Progression|1|||
44464513|NCT00469014|79473380|FG002|Initial Phase Randomization|Disease Progression|1|||
44464514|NCT00469014|79473381|FG003|Initial Phase Randomization|Disease Progression|0|||
44222003|NCT01399125|79025272|FG000|Overall Study|Lost to Follow-up|2|||
44222004|NCT01399125|79025273|FG001|Overall Study|Lost to Follow-up|3|||
44271459|NCT00558103|79202425|FG004|Monotherapy Extension Phase|Disease Progression|0|||
44271460|NCT00558103|79202426|FG005|Monotherapy Extension Phase|Disease Progression|8|||
44271461|NCT00558025|79202463|FG000|Overall Study|Adverse Event|1|||
44271462|NCT00558025|79202464|FG001|Overall Study|Adverse Event|1|||
44271463|NCT00558025|79202463|FG000|Overall Study|Withdrawal by Subject|2|||
44271464|NCT00558025|79202464|FG001|Overall Study|Withdrawal by Subject|2|||
44464515|NCT00469014|79473378|FG000|Initial Phase Randomization|No Response|1|||
44464516|NCT00469014|79473379|FG001|Initial Phase Randomization|No Response|0|||
44464517|NCT00469014|79473380|FG002|Initial Phase Randomization|No Response|0|||
44464518|NCT00469014|79473381|FG003|Initial Phase Randomization|No Response|1|||
44464519|NCT00469014|79473378|FG000|Adaptive Randomization|Not Evaluable|1|||
44464520|NCT00469014|79473379|FG001|Adaptive Randomization|Not Evaluable|0|||
44464521|NCT00469014|79473380|FG002|Adaptive Randomization|Not Evaluable|0|||
44464522|NCT00469014|79473381|FG003|Adaptive Randomization|Not Evaluable|1|||
44464523|NCT00469014|79473378|FG000|Adaptive Randomization|No Response|0|||
44464524|NCT00469014|79473379|FG001|Adaptive Randomization|No Response|1|||
44464525|NCT00469014|79473380|FG002|Adaptive Randomization|No Response|0|||
44464526|NCT00469014|79473381|FG003|Adaptive Randomization|No Response|0|||
44464527|NCT00469014|79473378|FG000|Adaptive Randomization|Death|0|||
44464528|NCT00469014|79473379|FG001|Adaptive Randomization|Death|0|||
44464529|NCT00469014|79473380|FG002|Adaptive Randomization|Death|1|||
44464530|NCT00469014|79473381|FG003|Adaptive Randomization|Death|0|||
44464531|NCT00493038|79473393|FG000|Treatment|Adverse Event|8|||
44464532|NCT00493038|79473394|FG001|Treatment|Adverse Event|4|||
44464533|NCT00493038|79473393|FG000|Treatment|Lost to Follow-up|5|||
44464534|NCT00493038|79473394|FG001|Treatment|Lost to Follow-up|3|||
44464535|NCT00493038|79473393|FG000|Treatment|Withdrawal by Subject|11|||
44464536|NCT00493038|79473394|FG001|Treatment|Withdrawal by Subject|12|||
44464537|NCT00493038|79473393|FG000|Treatment|Other|0|||
44222005|NCT01399125|79025272|FG000|Overall Study|Administrative Problems|7|||
44271465|NCT00558025|79202463|FG000|Overall Study|Protocol Violation|1|||
44271466|NCT00558025|79202464|FG001|Overall Study|Protocol Violation|0|||
44374912|NCT00955110|79380018|FG000|Treatment Phase|Administrative reasons|2|||
44374913|NCT00955110|79380018|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
44374914|NCT00955110|79380018|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
44374915|NCT00950664|79380032|FG000|First Intervention|Lost to Follow-up|1|||
44374916|NCT00950664|79380033|FG001|First Intervention|Lost to Follow-up|3|||
44374917|NCT00950664|79380032|FG000|First Intervention|Withdrawal by Subject|2|||
44374918|NCT00950664|79380033|FG001|First Intervention|Withdrawal by Subject|2|||
44374919|NCT01111526|79380039|FG000|Overall Study|GVHD Disease Progression|0|||
44374920|NCT01111526|79380040|FG001|Overall Study|GVHD Disease Progression|1|||
44374921|NCT01111526|79380041|FG002|Overall Study|GVHD Disease Progression|2|||
44374922|NCT01111292|79380047|FG000|Treatment|Physician Decision|1|||
44374923|NCT01111292|79380048|FG001|Treatment|Physician Decision|1|||
44374924|NCT00944658|79380056|FG000|Treatment 12 Weeks|Adverse Event|0|||
44374925|NCT00944658|79380057|FG001|Treatment 12 Weeks|Adverse Event|2|||
44374926|NCT01110200|79380065|FG000|Overall Study|Adverse Event|28|||
44374927|NCT01110200|79380066|FG001|Overall Study|Adverse Event|28|||
44271467|NCT00557323|79202517|FG000|Overall Study|Death|3|||
44374928|NCT01110200|79380065|FG000|Overall Study|Withdrawal by Subject|25|||
44464538|NCT00493038|79473394|FG001|Treatment|Other|1|||
44464539|NCT00493038|79473393|FG000|Follow-up|Lost to Follow-up|1|||
44464540|NCT00493038|79473394|FG001|Follow-up|Lost to Follow-up|0|||
44464541|NCT00392223|79473402|FG000|Overall Study|Adverse Event|5|||
44374929|NCT01110200|79380066|FG001|Overall Study|Withdrawal by Subject|32|||
44222006|NCT01399125|79025273|FG001|Overall Study|Administrative Problems|11|||
44222007|NCT01399125|79025272|FG000|Overall Study|Death|0|||
44464542|NCT00392223|79473403|FG001|Overall Study|Adverse Event|4|||
44464543|NCT00392223|79473402|FG000|Overall Study|Lost to Follow-up|1|||
44464544|NCT00392223|79473403|FG001|Overall Study|Lost to Follow-up|4|||
44464545|NCT00392223|79473402|FG000|Overall Study|Protocol Violation|0|||
44464546|NCT00392223|79473403|FG001|Overall Study|Protocol Violation|3|||
44464547|NCT00392223|79473402|FG000|Overall Study|Withdrawal by Subject|3|||
44464548|NCT00392223|79473403|FG001|Overall Study|Withdrawal by Subject|2|||
44464549|NCT00402285|79473412|FG000|Overall Study|insufficient RNA quality|7|||
44464550|NCT00402285|79473413|FG001|Overall Study|insufficient RNA quality|6|||
44464551|NCT00402285|79473414|FG002|Overall Study|insufficient RNA quality|2|||
44464552|NCT00413283|79473424|FG000|Overall Study|Withdrawal by Subject|1|||
44464553|NCT00413283|79473425|FG001|Overall Study|Withdrawal by Subject|0|||
44464554|NCT00413283|79473426|FG002|Overall Study|Withdrawal by Subject|0|||
44464555|NCT00413283|79473427|FG003|Overall Study|Withdrawal by Subject|1|||
44464556|NCT00413283|79473424|FG000|Overall Study|Death|0|||
44464557|NCT00413283|79473425|FG001|Overall Study|Death|0|||
44464558|NCT00413283|79473426|FG002|Overall Study|Death|1|||
44464559|NCT00413283|79473427|FG003|Overall Study|Death|1|||
44464560|NCT00413283|79473424|FG000|Overall Study|Adverse Event|0|||
44464561|NCT00413283|79473425|FG001|Overall Study|Adverse Event|0|||
44464562|NCT00413283|79473426|FG002|Overall Study|Adverse Event|0|||
44464563|NCT00413283|79473427|FG003|Overall Study|Adverse Event|1|||
44464564|NCT00413283|79473424|FG000|Overall Study|Ineligibility determined|0|||
44464565|NCT00413283|79473425|FG001|Overall Study|Ineligibility determined|0|||
44464566|NCT00413283|79473426|FG002|Overall Study|Ineligibility determined|0|||
44464567|NCT00413283|79473427|FG003|Overall Study|Ineligibility determined|1|||
44464568|NCT00413283|79473424|FG000|Overall Study|Protocol deviation|0|||
44464569|NCT00413283|79473425|FG001|Overall Study|Protocol deviation|1|||
44464570|NCT00413283|79473426|FG002|Overall Study|Protocol deviation|0|||
44464571|NCT00413283|79473427|FG003|Overall Study|Protocol deviation|0|||
44464572|NCT00413283|79473424|FG000|Overall Study|Requirement for alternative therapy|0|||
44464573|NCT00413283|79473425|FG001|Overall Study|Requirement for alternative therapy|2|||
44464574|NCT00413283|79473426|FG002|Overall Study|Requirement for alternative therapy|0|||
44464575|NCT00413283|79473427|FG003|Overall Study|Requirement for alternative therapy|0|||
44464576|NCT00413283|79473424|FG000|Overall Study|Other|0|||
44464577|NCT00413283|79473425|FG001|Overall Study|Other|0|||
44464578|NCT00413283|79473426|FG002|Overall Study|Other|1|||
44464579|NCT00413283|79473427|FG003|Overall Study|Other|0|||
44464580|NCT00402051|79473439|FG000|Overall Study|Progressive Disease|13|||
44464581|NCT00402051|79473440|FG001|Overall Study|Progressive Disease|20|||
44464582|NCT00402051|79473439|FG000|Overall Study|Adverse Event|11|||
44464583|NCT00402051|79473440|FG001|Overall Study|Adverse Event|4|||
44464584|NCT00402051|79473439|FG000|Overall Study|Physician Decision|7|||
44464585|NCT00402051|79473440|FG001|Overall Study|Physician Decision|3|||
44222008|NCT01399125|79025273|FG001|Overall Study|Death|1|||
44222009|NCT01399125|79025272|FG000|Overall Study|Protocol Deviation|5|||
44222010|NCT01399125|79025273|FG001|Overall Study|Protocol Deviation|2|||
44222011|NCT01399047|79025281|FG000|Overall Study|Withdrawal by Subject|0|||
44222012|NCT01399047|79025282|FG001|Overall Study|Withdrawal by Subject|1|||
44222013|NCT01387737|79025292|FG000|Overall Study|Adverse Event|20|||
44222014|NCT01387737|79025293|FG001|Overall Study|Adverse Event|30|||
44222015|NCT01387737|79025292|FG000|Overall Study|Lack of Efficacy|1|||
44374930|NCT01110200|79380065|FG000|Overall Study|Lack of Efficacy|16|||
44374931|NCT01110200|79380066|FG001|Overall Study|Lack of Efficacy|25|||
44374932|NCT01110200|79380065|FG000|Overall Study|Protocol Violation|14|||
44374933|NCT01110200|79380066|FG001|Overall Study|Protocol Violation|12|||
44374934|NCT01110200|79380065|FG000|Overall Study|Physician Decision|13|||
44374935|NCT01110200|79380066|FG001|Overall Study|Physician Decision|17|||
44374936|NCT01110200|79380065|FG000|Overall Study|Lost to Follow-up|10|||
44374937|NCT01110200|79380066|FG001|Overall Study|Lost to Follow-up|7|||
44374938|NCT01108796|79380076|FG000|Overall Study|Adverse Event|0|||
44374939|NCT01108796|79380077|FG001|Overall Study|Adverse Event|1|||
44374940|NCT01108796|79380076|FG000|Overall Study|Lost to Follow-up|7|||
44464586|NCT00402051|79473439|FG000|Overall Study|Withdrawal by Subject|3|||
44464587|NCT00402051|79473440|FG001|Overall Study|Withdrawal by Subject|3|||
44464588|NCT00402051|79473439|FG000|Overall Study|Death - Related to Study Drug|1|||
44464589|NCT00402051|79473440|FG001|Overall Study|Death - Related to Study Drug|2|||
44464590|NCT00402051|79473439|FG000|Overall Study|Death Due to Study Disease|2|||
44464591|NCT00402051|79473440|FG001|Overall Study|Death Due to Study Disease|1|||
44464592|NCT00402051|79473439|FG000|Overall Study|Death Due to Adverse Event|0|||
44222016|NCT01387737|79025293|FG001|Overall Study|Lack of Efficacy|0|||
44374941|NCT01108796|79380077|FG001|Overall Study|Lost to Follow-up|6|||
44464593|NCT00402051|79473440|FG001|Overall Study|Death Due to Adverse Event|2|||
44464594|NCT00402051|79473439|FG000|Overall Study|Lost to Follow-up|1|||
44464595|NCT00402051|79473440|FG001|Overall Study|Lost to Follow-up|0|||
44464596|NCT00468858|79473449|FG000|Overall Study|Adverse Event|0|||
44464597|NCT00468858|79473450|FG001|Overall Study|Adverse Event|1|||
44464598|NCT00468858|79473451|FG002|Overall Study|Adverse Event|0|||
44464599|NCT00468858|79473449|FG000|Overall Study|Withdrawal by Subject|7|||
44464600|NCT00468858|79473450|FG001|Overall Study|Withdrawal by Subject|4|||
44464601|NCT00468858|79473451|FG002|Overall Study|Withdrawal by Subject|5|||
44464602|NCT00468858|79473449|FG000|Overall Study|Relocation|1|||
44464603|NCT00468858|79473450|FG001|Overall Study|Relocation|3|||
44464604|NCT00468858|79473451|FG002|Overall Study|Relocation|3|||
44464605|NCT00468858|79473449|FG000|Overall Study|Lost to Follow-up|1|||
44464606|NCT00468858|79473450|FG001|Overall Study|Lost to Follow-up|2|||
44271468|NCT00557323|79202517|FG000|Overall Study|Withdrawal by Subject|2|||
44271469|NCT00557323|79202517|FG000|Overall Study|Administrative change|2|||
44271470|NCT00557245|79202551|FG000|Overall Study|Lost to Follow-up|7|||
44271471|NCT00557245|79202552|FG001|Overall Study|Lost to Follow-up|8|||
44271472|NCT00557245|79202553|FG002|Overall Study|Lost to Follow-up|10|||
44271473|NCT00557245|79202551|FG000|Overall Study|Ineligible|5|||
44271474|NCT00557245|79202552|FG001|Overall Study|Ineligible|4|||
44271475|NCT00557245|79202553|FG002|Overall Study|Ineligible|2|||
44271476|NCT00556075|79202614|FG000|Overall Study|Lost to Follow-up|3|||
44271477|NCT00556075|79202615|FG001|Overall Study|Lost to Follow-up|0|||
44271478|NCT00556075|79202616|FG002|Overall Study|Lost to Follow-up|3|||
44271479|NCT00556075|79202614|FG000|Overall Study|Withdrawal by Subject|3|||
44271480|NCT00556075|79202615|FG001|Overall Study|Withdrawal by Subject|3|||
44271481|NCT00556075|79202616|FG002|Overall Study|Withdrawal by Subject|0|||
44271482|NCT00556075|79202614|FG000|Overall Study|Protocol Violation|1|||
44271483|NCT00556075|79202615|FG001|Overall Study|Protocol Violation|1|||
44271484|NCT00556075|79202616|FG002|Overall Study|Protocol Violation|3|||
44271485|NCT00556075|79202614|FG000|Overall Study|Not eligible|1|||
44271486|NCT00556075|79202615|FG001|Overall Study|Not eligible|1|||
44271487|NCT00556075|79202616|FG002|Overall Study|Not eligible|2|||
44271488|NCT00556075|79202614|FG000|Overall Study|Adverse Event|1|||
44271489|NCT00556075|79202615|FG001|Overall Study|Adverse Event|2|||
44271490|NCT00556075|79202616|FG002|Overall Study|Adverse Event|0|||
44271491|NCT00556075|79202614|FG000|Overall Study|Personal issues|4|||
44271492|NCT00556075|79202615|FG001|Overall Study|Personal issues|1|||
44271493|NCT00556075|79202616|FG002|Overall Study|Personal issues|0|||
44271494|NCT00556075|79202614|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
44271495|NCT00556075|79202615|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
44271496|NCT00556075|79202616|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
44464607|NCT00468858|79473451|FG002|Overall Study|Lost to Follow-up|5|||
44464608|NCT00468858|79473449|FG000|Overall Study|Other|0|||
44464609|NCT00468858|79473450|FG001|Overall Study|Other|0|||
44464610|NCT00468858|79473451|FG002|Overall Study|Other|1|||
44464611|NCT00401973|79473516|FG000|Overall Study|Adverse Event|2|||
44464612|NCT00401973|79473517|FG001|Overall Study|Adverse Event|8|||
44464613|NCT00401973|79473518|FG002|Overall Study|Adverse Event|4|||
44464614|NCT00401973|79473516|FG000|Overall Study|Clinical Relapse|0|||
44464615|NCT00401973|79473517|FG001|Overall Study|Clinical Relapse|1|||
44464616|NCT00401973|79473518|FG002|Overall Study|Clinical Relapse|1|||
44464617|NCT00401973|79473516|FG000|Overall Study|Lack of Efficacy|0|||
44222017|NCT01387737|79025292|FG000|Overall Study|Physician Decision|3|||
44222018|NCT01387737|79025293|FG001|Overall Study|Physician Decision|10|||
44222019|NCT01387737|79025292|FG000|Overall Study|Withdrawal by Subject|27|||
44222020|NCT01387737|79025293|FG001|Overall Study|Withdrawal by Subject|31|||
44222021|NCT01387737|79025292|FG000|Overall Study|Clearly not eligible for the study|1|||
44222022|NCT01387737|79025293|FG001|Overall Study|Clearly not eligible for the study|3|||
44222023|NCT01387347|79025301|FG000|Overall Study|Lost to Follow-up|2|||
44222024|NCT01387347|79025302|FG001|Overall Study|Lost to Follow-up|1|||
44222025|NCT01859923|79025316|FG000|Overall Study|Adverse Event|0|||
44222026|NCT01859923|79025317|FG001|Overall Study|Adverse Event|0|||
44464618|NCT00401973|79473517|FG001|Overall Study|Lack of Efficacy|0|||
44464619|NCT00401973|79473518|FG002|Overall Study|Lack of Efficacy|3|||
44222027|NCT01859923|79025318|FG002|Overall Study|Adverse Event|1|||
44464620|NCT00401973|79473516|FG000|Overall Study|Lost to Follow-up|2|||
44464621|NCT00401973|79473517|FG001|Overall Study|Lost to Follow-up|2|||
44222028|NCT01859923|79025319|FG003|Overall Study|Adverse Event|1|||
44222029|NCT01832155|79025334|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
44271497|NCT02289690|79202647|FG000|Overall Study|Adverse Event Related to Progression|0|||
44271498|NCT02289690|79202648|FG001|Overall Study|Adverse Event Related to Progression|1|||
44271499|NCT02289690|79202649|FG002|Overall Study|Adverse Event Related to Progression|1|||
44271500|NCT02289690|79202650|FG003|Overall Study|Adverse Event Related to Progression|0|||
44464622|NCT00401973|79473518|FG002|Overall Study|Lost to Follow-up|2|||
44464623|NCT00401973|79473516|FG000|Overall Study|Physician Decision|2|||
44222030|NCT01832155|79025335|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
44464624|NCT00401973|79473517|FG001|Overall Study|Physician Decision|0|||
44464625|NCT00401973|79473518|FG002|Overall Study|Physician Decision|1|||
44464626|NCT00401973|79473516|FG000|Overall Study|Protocol Violation|1|||
44464627|NCT00401973|79473517|FG001|Overall Study|Protocol Violation|2|||
44464628|NCT00401973|79473518|FG002|Overall Study|Protocol Violation|3|||
44464629|NCT00401973|79473516|FG000|Overall Study|Sponsor Decision|0|||
44464630|NCT00401973|79473517|FG001|Overall Study|Sponsor Decision|1|||
44464631|NCT00401973|79473518|FG002|Overall Study|Sponsor Decision|0|||
44464632|NCT00401973|79473516|FG000|Overall Study|Withdrawal by Subject|4|||
44464633|NCT00401973|79473517|FG001|Overall Study|Withdrawal by Subject|12|||
44464634|NCT00401973|79473518|FG002|Overall Study|Withdrawal by Subject|9|||
44464635|NCT00401193|79473531|FG000|Overall Study|Adverse Event|1|||
44464636|NCT00401193|79473532|FG001|Overall Study|Adverse Event|3|||
44464637|NCT00401193|79473533|FG002|Overall Study|Adverse Event|1|||
44464638|NCT00401193|79473531|FG000|Overall Study|Protocol Violation|3|||
44464639|NCT00401193|79473532|FG001|Overall Study|Protocol Violation|1|||
44464640|NCT00401193|79473533|FG002|Overall Study|Protocol Violation|1|||
44464641|NCT00401193|79473531|FG000|Overall Study|Lost to Follow-up|6|||
44464642|NCT00401193|79473532|FG001|Overall Study|Lost to Follow-up|5|||
44464643|NCT00401193|79473533|FG002|Overall Study|Lost to Follow-up|1|||
44464644|NCT00401193|79473531|FG000|Overall Study|Withdrawal by Subject|2|||
44464645|NCT00401193|79473532|FG001|Overall Study|Withdrawal by Subject|0|||
44464646|NCT00401193|79473533|FG002|Overall Study|Withdrawal by Subject|1|||
44464647|NCT00401193|79473531|FG000|Overall Study|Other Event|3|||
44464648|NCT00401193|79473532|FG001|Overall Study|Other Event|2|||
44464649|NCT00401193|79473533|FG002|Overall Study|Other Event|2|||
44464650|NCT00400569|79473542|FG000|Overall Study|Death|1|||
44464651|NCT00413049|79473551|FG000|Overall Study|Adverse Event|10|||
44464652|NCT00413049|79473552|FG001|Overall Study|Adverse Event|8|||
44464653|NCT00413049|79473551|FG000|Overall Study|Withdrawal by Subject|7|||
44464654|NCT00413049|79473552|FG001|Overall Study|Withdrawal by Subject|5|||
44464655|NCT00413049|79473551|FG000|Overall Study|Lost to Follow-up|2|||
44464656|NCT00413049|79473552|FG001|Overall Study|Lost to Follow-up|3|||
44464657|NCT00413049|79473551|FG000|Overall Study|Protocol Violation|3|||
44464658|NCT00413049|79473552|FG001|Overall Study|Protocol Violation|1|||
44464659|NCT00413049|79473551|FG000|Overall Study|Subject no longer requires study drug|0|||
44464660|NCT00413049|79473552|FG001|Overall Study|Subject no longer requires study drug|1|||
44464661|NCT00413049|79473551|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44464662|NCT00413049|79473552|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44464663|NCT00413049|79473551|FG000|Overall Study|Lack of Efficacy|1|||
44464664|NCT00413049|79473552|FG001|Overall Study|Lack of Efficacy|0|||
44464665|NCT00454194|79473560|FG000|Overall Study|Adverse Event|7|||
44464666|NCT00454194|79473561|FG001|Overall Study|Adverse Event|2|||
44464667|NCT00454194|79473560|FG000|Overall Study|Withdrawal by Subject|12|||
44464668|NCT00454194|79473561|FG001|Overall Study|Withdrawal by Subject|8|||
44464669|NCT00454194|79473560|FG000|Overall Study|Other Medical Problems|1|||
44464670|NCT00454194|79473561|FG001|Overall Study|Other Medical Problems|2|||
44464671|NCT00454194|79473560|FG000|Overall Study|Other Unspecified Reason|2|||
44464672|NCT00454194|79473561|FG001|Overall Study|Other Unspecified Reason|2|||
44464673|NCT00412971|79473569|FG000|Overall Study|Lost to Follow-up|17|||
44464674|NCT00412971|79473570|FG001|Overall Study|Lost to Follow-up|9|||
44464675|NCT00412971|79473569|FG000|Overall Study|Protocol Violation|13|||
44464676|NCT00412971|79473570|FG001|Overall Study|Protocol Violation|1|||
44464677|NCT00303472|79473583|FG000|Treatment Period|Adverse Event|0|||
44464678|NCT00303472|79473584|FG001|Treatment Period|Adverse Event|0|||
44464679|NCT00303472|79473585|FG002|Treatment Period|Adverse Event|0|||
44464680|NCT00303472|79473586|FG003|Treatment Period|Adverse Event|0|||
44464681|NCT00303472|79473587|FG004|Treatment Period|Adverse Event|1|||
44464682|NCT00303472|79473588|FG005|Treatment Period|Adverse Event|0|||
44464683|NCT00303472|79473589|FG006|Treatment Period|Adverse Event|0|||
44464684|NCT00303472|79473583|FG000|Treatment Period|Death|0|||
44544259|NCT03194217|79557609|FG000|Overall Study|Adverse Event|0|||
44544260|NCT03194217|79557610|FG001|Overall Study|Adverse Event|2|||
44271501|NCT02289690|79202651|FG004|Overall Study|Adverse Event Related to Progression|1|||
44464685|NCT00303472|79473584|FG001|Treatment Period|Death|0|||
44464686|NCT00303472|79473585|FG002|Treatment Period|Death|0|||
44464687|NCT00303472|79473586|FG003|Treatment Period|Death|1|||
44464688|NCT00303472|79473587|FG004|Treatment Period|Death|0|||
44464689|NCT00303472|79473588|FG005|Treatment Period|Death|0|||
44464690|NCT00303472|79473589|FG006|Treatment Period|Death|1|||
44464691|NCT00303472|79473583|FG000|Treatment Period|Withdrawal by Subject|0|||
44464692|NCT00303472|79473584|FG001|Treatment Period|Withdrawal by Subject|0|||
44464693|NCT00303472|79473585|FG002|Treatment Period|Withdrawal by Subject|0|||
44464694|NCT00303472|79473586|FG003|Treatment Period|Withdrawal by Subject|1|||
44271502|NCT02289690|79202652|FG005|Overall Study|Adverse Event Related to Progression|0|||
44271503|NCT02289690|79202653|FG006|Overall Study|Adverse Event Related to Progression|1|||
44271504|NCT02289690|79202654|FG007|Overall Study|Adverse Event Related to Progression|0|||
44271505|NCT02289690|79202655|FG008|Overall Study|Adverse Event Related to Progression|0|||
44271506|NCT02289690|79202656|FG009|Overall Study|Adverse Event Related to Progression|0|||
44271507|NCT02289690|79202647|FG000|Overall Study|Withdrawal by Subject|1|||
44271508|NCT02289690|79202648|FG001|Overall Study|Withdrawal by Subject|0|||
44271509|NCT02289690|79202649|FG002|Overall Study|Withdrawal by Subject|0|||
44271510|NCT02289690|79202650|FG003|Overall Study|Withdrawal by Subject|0|||
44271511|NCT02289690|79202651|FG004|Overall Study|Withdrawal by Subject|1|||
44271512|NCT02289690|79202652|FG005|Overall Study|Withdrawal by Subject|1|||
44271513|NCT02289690|79202653|FG006|Overall Study|Withdrawal by Subject|0|||
44271514|NCT02289690|79202654|FG007|Overall Study|Withdrawal by Subject|0|||
44271515|NCT02289690|79202655|FG008|Overall Study|Withdrawal by Subject|4|||
44271516|NCT02289690|79202656|FG009|Overall Study|Withdrawal by Subject|2|||
44464695|NCT00303472|79473587|FG004|Treatment Period|Withdrawal by Subject|0|||
44464696|NCT00303472|79473588|FG005|Treatment Period|Withdrawal by Subject|1|||
44464697|NCT00303472|79473589|FG006|Treatment Period|Withdrawal by Subject|0|||
44464698|NCT00303472|79473583|FG000|Treatment Period|Other|0|||
44464699|NCT00303472|79473584|FG001|Treatment Period|Other|0|||
44464700|NCT00303472|79473585|FG002|Treatment Period|Other|0|||
44464701|NCT00303472|79473586|FG003|Treatment Period|Other|0|||
44464702|NCT00303472|79473587|FG004|Treatment Period|Other|1|||
44464703|NCT00303472|79473588|FG005|Treatment Period|Other|0|||
44464704|NCT00303472|79473589|FG006|Treatment Period|Other|1|||
44464705|NCT00303472|79473583|FG000|Treatment Period|Disease Progression (to AML)|0|||
44464706|NCT00303472|79473584|FG001|Treatment Period|Disease Progression (to AML)|0|||
44464707|NCT00303472|79473585|FG002|Treatment Period|Disease Progression (to AML)|0|||
44464708|NCT00303472|79473586|FG003|Treatment Period|Disease Progression (to AML)|0|||
44464709|NCT00303472|79473587|FG004|Treatment Period|Disease Progression (to AML)|1|||
44464710|NCT00303472|79473588|FG005|Treatment Period|Disease Progression (to AML)|0|||
44464711|NCT00303472|79473589|FG006|Treatment Period|Disease Progression (to AML)|0|||
44464712|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Adverse Event|1|||
44464713|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Adverse Event|0|||
44464714|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Adverse Event|1|||
44464715|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Adverse Event|0|||
44464716|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Adverse Event|0|||
44464717|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Adverse Event|0|||
44464718|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Adverse Event|0|||
44464719|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Death|2|||
44464720|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Death|0|||
44464721|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Death|1|||
44464722|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Death|0|||
44464723|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Death|0|||
44464724|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Death|0|||
44464725|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Death|0|||
44464726|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
44464727|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
44464728|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
44464729|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
44464730|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
44464731|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
44464732|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
44464733|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Physician Decision|0|||
44464734|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Physician Decision|4|||
44464735|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Physician Decision|2|||
44464736|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Physician Decision|3|||
44271517|NCT02289690|79202647|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
44271518|NCT02289690|79202648|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
44271519|NCT02289690|79202649|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
44271520|NCT02289690|79202650|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
44464737|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Physician Decision|2|||
44464738|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Physician Decision|0|||
44464739|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Physician Decision|0|||
44464740|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
44271521|NCT02289690|79202651|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
44271522|NCT02289690|79202652|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
44464741|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
44464742|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
44464743|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
44464744|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
44464745|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
44464746|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
44464747|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Other|0|||
44464748|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Other|2|||
44464749|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Other|4|||
44464750|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Other|2|||
44464751|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Other|1|||
44464752|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Other|0|||
44464753|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Other|0|||
44464754|NCT00303472|79473583|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
44464755|NCT00303472|79473584|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
44464756|NCT00303472|79473585|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
44544261|NCT03194217|79557611|FG002|Overall Study|Adverse Event|3|||
44544262|NCT03194217|79557612|FG003|Overall Study|Adverse Event|3|||
44222031|NCT01832155|79025334|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
44222032|NCT01832155|79025335|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
44222033|NCT01879579|79025349|FG000|Overall Study|Phone incompatible with texting platform|3|||
44222034|NCT01879579|79025350|FG001|Overall Study|Phone incompatible with texting platform|0|||
44222035|NCT01879579|79025349|FG000|Overall Study|Did not enroll in texting platform|1|||
44222036|NCT01879579|79025350|FG001|Overall Study|Did not enroll in texting platform|0|||
44222037|NCT01879579|79025349|FG000|Overall Study|Did not initiate insulin treatment|1|||
44222038|NCT01879579|79025350|FG001|Overall Study|Did not initiate insulin treatment|0|||
44222039|NCT01879579|79025349|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
44374942|NCT01108718|79380087|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
44374943|NCT01108718|79380088|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
44374944|NCT01137110|79380095|FG000|Overall Study|Protocol Violation|1|||
44374945|NCT01137110|79380096|FG001|Overall Study|Protocol Violation|0|||
44374946|NCT01136954|79380104|FG000|Overall Study|Adverse Event|3|||
44374947|NCT01136954|79380105|FG001|Overall Study|Adverse Event|2|||
44374948|NCT01136954|79380104|FG000|Overall Study|Withdrawal by Subject|6|||
44374949|NCT01136954|79380105|FG001|Overall Study|Withdrawal by Subject|2|||
44374950|NCT01136954|79380104|FG000|Overall Study|Lack of Efficacy|14|||
44374951|NCT01136954|79380105|FG001|Overall Study|Lack of Efficacy|13|||
44374952|NCT01136954|79380104|FG000|Overall Study|Physician Decision|0|||
44544263|NCT03194217|79557609|FG000|Overall Study|Failure to meet randomisation criteria|0|||
44464757|NCT00303472|79473586|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
44464758|NCT00303472|79473587|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
44464759|NCT00303472|79473588|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
44464760|NCT00303472|79473589|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
44464761|NCT00468546|79473607|FG000|Week 24 Analysis|Lack of Efficacy|83|||
44464762|NCT00468546|79473608|FG001|Week 24 Analysis|Lack of Efficacy|37|||
44222040|NCT01879579|79025350|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
44464763|NCT00468546|79473607|FG000|Week 24 Analysis|Refused treatment|5|||
44464764|NCT00468546|79473608|FG001|Week 24 Analysis|Refused treatment|5|||
44464765|NCT00468546|79473607|FG000|Week 24 Analysis|Adverse Event|1|||
44464766|NCT00468546|79473608|FG001|Week 24 Analysis|Adverse Event|8|||
44464767|NCT00468546|79473607|FG000|Week 24 Analysis|Failure to return|3|||
44464768|NCT00468546|79473608|FG001|Week 24 Analysis|Failure to return|4|||
44464769|NCT00468546|79473607|FG000|Week 24 Analysis|Rescue therapy|2|||
44464770|NCT00468546|79473608|FG001|Week 24 Analysis|Rescue therapy|0|||
44464771|NCT00468546|79473607|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
44464772|NCT00468546|79473608|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
44464773|NCT00468546|79473607|FG000|Week 24 Analysis|Due to clinical hold|1|||
44464774|NCT00468546|79473608|FG001|Week 24 Analysis|Due to clinical hold|0|||
44464775|NCT00468546|79473607|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
44464776|NCT00468546|79473608|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
44464777|NCT00468546|79473607|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
44464778|NCT00468546|79473608|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
44464779|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
44464780|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
44464781|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Death|1|||
44464782|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Death|0|||
44464783|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
44464784|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
44464785|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
44464786|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
44464787|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
44464788|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
44464789|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
44464790|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
44464791|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
44464792|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
44464793|NCT00468546|79473607|FG000|Week 24 to Week 104 Analysis|Other|17|||
44464794|NCT00468546|79473608|FG001|Week 24 to Week 104 Analysis|Other|14|||
44464795|NCT00303316|79473616|FG000|Overall Study|Protocol Violation|1|||
44464796|NCT00303316|79473617|FG001|Overall Study|Protocol Violation|0|||
44464797|NCT00303316|79473616|FG000|Overall Study|Lost to Follow-up|0|||
44464798|NCT00303316|79473617|FG001|Overall Study|Lost to Follow-up|1|||
44464799|NCT00303316|79473616|FG000|Overall Study|Withdrawal by Subject|1|||
44464800|NCT00303316|79473617|FG001|Overall Study|Withdrawal by Subject|2|||
44464801|NCT00468312|79473625|FG000|Overall Study|Adverse Event|2|||
44464802|NCT00468312|79473626|FG001|Overall Study|Adverse Event|1|||
44464803|NCT00468312|79473625|FG000|Overall Study|Lack of Efficacy|0|||
44464804|NCT00468312|79473626|FG001|Overall Study|Lack of Efficacy|1|||
44464805|NCT00468312|79473625|FG000|Overall Study|Withdrawal by Subject|0|||
44464806|NCT00468312|79473626|FG001|Overall Study|Withdrawal by Subject|1|||
44464807|NCT00468312|79473625|FG000|Overall Study|Protocol Violation|2|||
44464808|NCT00468312|79473626|FG001|Overall Study|Protocol Violation|1|||
44464809|NCT00468312|79473625|FG000|Overall Study|Did not meet protocol eligibility|0|||
44464810|NCT00468312|79473626|FG001|Overall Study|Did not meet protocol eligibility|1|||
44464811|NCT00331864|79473634|FG000|Overall Study|Adverse Event|30|||
44464812|NCT00331864|79473635|FG001|Overall Study|Adverse Event|1|||
44464813|NCT00331864|79473634|FG000|Overall Study|Lack of Efficacy|4|||
44544264|NCT03194217|79557610|FG001|Overall Study|Failure to meet randomisation criteria|0|||
44544265|NCT03194217|79557611|FG002|Overall Study|Failure to meet randomisation criteria|0|||
44544266|NCT03194217|79557612|FG003|Overall Study|Failure to meet randomisation criteria|1|||
44222041|NCT01879579|79025349|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
44222042|NCT01879579|79025350|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
44222043|NCT01386645|79025362|FG000|Overall Study|Physician Decision|0|||
44222044|NCT01386645|79025363|FG001|Overall Study|Physician Decision|0|||
44222045|NCT01386645|79025364|FG002|Overall Study|Physician Decision|1|||
44222046|NCT01386645|79025362|FG000|Overall Study|Withdrawal by Subject|0|||
44222047|NCT01386645|79025363|FG001|Overall Study|Withdrawal by Subject|1|||
44222048|NCT01386645|79025364|FG002|Overall Study|Withdrawal by Subject|1|||
44464814|NCT00331864|79473635|FG001|Overall Study|Lack of Efficacy|0|||
44464815|NCT00331864|79473634|FG000|Overall Study|Protocol Violation|3|||
44464816|NCT00331864|79473635|FG001|Overall Study|Protocol Violation|0|||
44464817|NCT00331864|79473634|FG000|Overall Study|Withdrawal by Subject|10|||
44222049|NCT01387269|79025374|FG000|Overall Study|Death|38|||
44464818|NCT00331864|79473635|FG001|Overall Study|Withdrawal by Subject|0|||
44464819|NCT00331864|79473634|FG000|Overall Study|Lost to Follow-up|4|||
44464820|NCT00331864|79473635|FG001|Overall Study|Lost to Follow-up|3|||
44464821|NCT00331864|79473634|FG000|Overall Study|Administrative Problems|1|||
44464822|NCT00331864|79473635|FG001|Overall Study|Administrative Problems|0|||
44464823|NCT00331864|79473634|FG000|Overall Study|Death|6|||
44464824|NCT00331864|79473635|FG001|Overall Study|Death|0|||
44464825|NCT00331630|79473641|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
44464826|NCT00331630|79473641|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
44464827|NCT00331630|79473641|FG000|Follow up for 5 Years|Death|5|||
44222050|NCT01387269|79025375|FG001|Overall Study|Death|20|||
44222051|NCT01387269|79025374|FG000|Overall Study|Other|8|||
44464828|NCT00331630|79473641|FG000|Follow up for 5 Years|Data collection was stopped|24|||
44222052|NCT01387269|79025375|FG001|Overall Study|Other|7|||
44222053|NCT01387269|79025374|FG000|Overall Study|Unrelated AE|12|||
44222054|NCT01387269|79025375|FG001|Overall Study|Unrelated AE|3|||
44222055|NCT01387269|79025374|FG000|Overall Study|Withdrawal by patient|32|||
44464829|NCT00331552|79473647|FG000|Period 3: Phase II|Neurological Symptoms|1|||
44464830|NCT00331552|79473648|FG001|Period 3: Phase II|Neurological Symptoms|0|||
44464831|NCT00331552|79473647|FG000|Period 3: Phase II|Severe Nausea|1|||
44464832|NCT00331552|79473648|FG001|Period 3: Phase II|Severe Nausea|0|||
44464833|NCT00317356|79473663|FG000|Overall Study|Adverse Event|0|||
44464834|NCT00317356|79473664|FG001|Overall Study|Adverse Event|0|||
44464835|NCT00317356|79473665|FG002|Overall Study|Adverse Event|1|||
44464836|NCT00317356|79473666|FG003|Overall Study|Adverse Event|0|||
44464837|NCT00317356|79473663|FG000|Overall Study|Lack of Efficacy|1|||
44464838|NCT00317356|79473664|FG001|Overall Study|Lack of Efficacy|1|||
44464839|NCT00317356|79473665|FG002|Overall Study|Lack of Efficacy|0|||
44464840|NCT00317356|79473666|FG003|Overall Study|Lack of Efficacy|3|||
44464841|NCT00317356|79473663|FG000|Overall Study|Physician Decision|0|||
44464842|NCT00317356|79473664|FG001|Overall Study|Physician Decision|1|||
44464843|NCT00317356|79473665|FG002|Overall Study|Physician Decision|0|||
44464844|NCT00317356|79473666|FG003|Overall Study|Physician Decision|0|||
44544267|NCT03194217|79557609|FG000|Overall Study|Other|0|||
44544268|NCT03194217|79557610|FG001|Overall Study|Other|1|||
44544269|NCT03194217|79557611|FG002|Overall Study|Other|1|||
44544270|NCT03194217|79557612|FG003|Overall Study|Other|0|||
44544271|NCT00709618|79557622|FG000|Overall Study|Withdrawal by Subject|4|||
44544272|NCT00709618|79557622|FG000|Overall Study|Lost to Follow-up|1|||
44544273|NCT00709618|79557622|FG000|Overall Study|Study Closed/Terminated|25|||
44222056|NCT01387269|79025375|FG001|Overall Study|Withdrawal by patient|10|||
44222057|NCT01387269|79025374|FG000|Overall Study|Study drug-related AE|1|||
44222058|NCT01387269|79025375|FG001|Overall Study|Study drug-related AE|0|||
44222059|NCT01387269|79025374|FG000|Overall Study|Lost to Follow-up|1|||
44222060|NCT01387269|79025375|FG001|Overall Study|Lost to Follow-up|0|||
44222061|NCT01859143|79025383|FG000|Overall Study|Lost to Follow-up|2|||
44544274|NCT03193047|79557628|FG000|Overall Study|Physician Decision|1|||
44544275|NCT03193047|79557629|FG001|Overall Study|Physician Decision|0|||
44544276|NCT03193047|79557628|FG000|Overall Study|Participant Left State|1|||
44544277|NCT03193047|79557629|FG001|Overall Study|Participant Left State|0|||
44544278|NCT02918019|79557641|FG000|Overall Study|Death|0|||
44544279|NCT02918019|79557642|FG001|Overall Study|Death|0|||
44222062|NCT01859143|79025384|FG001|Overall Study|Lost to Follow-up|0|||
44374953|NCT01136954|79380105|FG001|Overall Study|Physician Decision|1|||
44374954|NCT01136954|79380104|FG000|Overall Study|Other|1|||
44374955|NCT01136954|79380105|FG001|Overall Study|Other|3|||
44374956|NCT01136876|79380114|FG000|Overall Study|Lost to Follow-up|0|||
44374957|NCT01136876|79380115|FG001|Overall Study|Lost to Follow-up|1|||
44374958|NCT01136876|79380114|FG000|Overall Study|Physician Decision|3|||
44374959|NCT01136876|79380115|FG001|Overall Study|Physician Decision|5|||
44374960|NCT01136876|79380114|FG000|Overall Study|Missing NGAL measurement|2|||
44374961|NCT01136876|79380115|FG001|Overall Study|Missing NGAL measurement|5|||
44374962|NCT01105130|79380126|FG000|Overall Study|Withdrawal by Subject|4|||
44374963|NCT01105130|79380127|FG001|Overall Study|Withdrawal by Subject|6|||
44464845|NCT00331006|79473676|FG000|Screening Phase|Withdrawal by Subject|1|||
44464846|NCT00331006|79473676|FG000|Screening Phase|enrollment halted|1|||
44464847|NCT00331006|79473676|FG000|Screening Phase|Lost to Follow-up|1|||
44464848|NCT00331006|79473676|FG000|Screening Phase|Ineligible for treatment phase|4|||
44464849|NCT00331006|79473676|FG000|Treatment Phase|Withdrawal by Subject|1|||
44544280|NCT02918019|79557643|FG002|Overall Study|Death|1|||
44544281|NCT02918019|79557644|FG003|Overall Study|Death|0|||
44222063|NCT01878253|79025391|FG000|Overall Study|Death|1|||
44374964|NCT01105130|79380128|FG002|Overall Study|Withdrawal by Subject|2|||
44374965|NCT01105130|79380126|FG000|Overall Study|Never Started|2|||
44374966|NCT01105130|79380127|FG001|Overall Study|Never Started|2|||
44544282|NCT02918019|79557641|FG000|Overall Study|Lost to Follow-up|1|||
44464850|NCT00331006|79473676|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
44464851|NCT00331006|79473676|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
44464852|NCT00302458|79473680|FG000|Overall Study|Lost to Follow-up|1|||
44464853|NCT00302458|79473680|FG000|Overall Study|Ineligible after screening|1|||
44464854|NCT00302458|79473680|FG000|Overall Study|Withdrawal by Subject|1|||
44464855|NCT00391053|79473692|FG000|Overall Study|Serious Adverse Events|1|||
44464856|NCT00391053|79473693|FG001|Overall Study|Serious Adverse Events|0|||
44464857|NCT00391053|79473694|FG002|Overall Study|Serious Adverse Events|1|||
44464858|NCT00391053|79473695|FG003|Overall Study|Serious Adverse Events|4|||
44464859|NCT00391053|79473692|FG000|Overall Study|Protocol Violation|2|||
44464860|NCT00391053|79473693|FG001|Overall Study|Protocol Violation|0|||
44464861|NCT00391053|79473694|FG002|Overall Study|Protocol Violation|0|||
44464862|NCT00391053|79473695|FG003|Overall Study|Protocol Violation|0|||
44464863|NCT00391053|79473692|FG000|Overall Study|Lost to Follow-up|1|||
44464864|NCT00391053|79473693|FG001|Overall Study|Lost to Follow-up|0|||
44464865|NCT00391053|79473694|FG002|Overall Study|Lost to Follow-up|0|||
44464866|NCT00391053|79473695|FG003|Overall Study|Lost to Follow-up|5|||
44464867|NCT00391053|79473692|FG000|Overall Study|Withdrawal by Subject|5|||
44464868|NCT00391053|79473693|FG001|Overall Study|Withdrawal by Subject|1|||
44464869|NCT00391053|79473694|FG002|Overall Study|Withdrawal by Subject|1|||
44464870|NCT00391053|79473695|FG003|Overall Study|Withdrawal by Subject|1|||
44464871|NCT00317044|79473708|FG000|Overall Study|Protocol Violation|28|||
44464872|NCT00317044|79473709|FG001|Overall Study|Protocol Violation|22|||
44464873|NCT00317044|79473710|FG002|Overall Study|Protocol Violation|20|||
44464874|NCT00317044|79473708|FG000|Overall Study|Adverse Event|4|||
44464875|NCT00317044|79473709|FG001|Overall Study|Adverse Event|7|||
44464876|NCT00317044|79473710|FG002|Overall Study|Adverse Event|4|||
44464877|NCT00317044|79473708|FG000|Overall Study|Withdrawal by Subject|10|||
44464878|NCT00317044|79473709|FG001|Overall Study|Withdrawal by Subject|7|||
44464879|NCT00317044|79473710|FG002|Overall Study|Withdrawal by Subject|12|||
44464880|NCT00317044|79473708|FG000|Overall Study|Lost to Follow-up|0|||
44464881|NCT00317044|79473709|FG001|Overall Study|Lost to Follow-up|2|||
44464882|NCT00317044|79473710|FG002|Overall Study|Lost to Follow-up|3|||
44464883|NCT00317044|79473708|FG000|Overall Study|Multiple Reasons|6|||
44464884|NCT00317044|79473709|FG001|Overall Study|Multiple Reasons|2|||
44464885|NCT00317044|79473710|FG002|Overall Study|Multiple Reasons|6|||
44464886|NCT00301834|79473718|FG000|Overall Study|Death|1|||
44464887|NCT00301366|79473725|FG000|Overall Study|Adverse Event|1|||
44464888|NCT00330928|79473729|FG000|Overall Study|Lost to Follow-up|6|||
44464889|NCT00330928|79473729|FG000|Overall Study|Physician Decision|9|||
44464890|NCT00330928|79473729|FG000|Overall Study|Death|1|||
44464891|NCT00330928|79473729|FG000|Overall Study|IVUS could not be performed.|1|||
44464892|NCT00330616|79473733|FG000|Overall Study|Adverse Event|13|||
44464893|NCT00330616|79473733|FG000|Overall Study|Lack of Efficacy|1|||
44464894|NCT00330616|79473733|FG000|Overall Study|Lost to Follow-up|2|||
44464895|NCT00330616|79473733|FG000|Overall Study|Withdrawal by Subject|4|||
44464896|NCT00330616|79473733|FG000|Overall Study|Other|1|||
44464897|NCT00466440|79473740|FG000|Overall Study|Adverse Event|0|||
44464898|NCT00466440|79473741|FG001|Overall Study|Adverse Event|3|||
44464899|NCT00466440|79473742|FG002|Overall Study|Adverse Event|1|||
44464900|NCT00466440|79473740|FG000|Overall Study|Death|1|||
44464901|NCT00466440|79473741|FG001|Overall Study|Death|1|||
44464902|NCT00466440|79473742|FG002|Overall Study|Death|0|||
44544283|NCT02918019|79557642|FG001|Overall Study|Lost to Follow-up|1|||
44277804|NCT02092350|79238806|FG000|Overall Study|Lost to Follow-up|3|||
44464903|NCT00466440|79473740|FG000|Overall Study|Progressive disease|13|||
44464904|NCT00466440|79473741|FG001|Overall Study|Progressive disease|5|||
44464905|NCT00466440|79473742|FG002|Overall Study|Progressive disease|4|||
44464906|NCT00466440|79473740|FG000|Overall Study|Lost to Follow-up|0|||
44464907|NCT00466440|79473741|FG001|Overall Study|Lost to Follow-up|1|||
44464908|NCT00466440|79473742|FG002|Overall Study|Lost to Follow-up|0|||
44464909|NCT00466440|79473740|FG000|Overall Study|Physician Decision|0|||
44464910|NCT00466440|79473741|FG001|Overall Study|Physician Decision|1|||
44464911|NCT00466440|79473742|FG002|Overall Study|Physician Decision|2|||
44464912|NCT00466440|79473740|FG000|Overall Study|Protocol entry criteria not met|0|||
44464913|NCT00466440|79473741|FG001|Overall Study|Protocol entry criteria not met|0|||
44464914|NCT00466440|79473742|FG002|Overall Study|Protocol entry criteria not met|4|||
44464915|NCT00466440|79473740|FG000|Overall Study|Withdrawal by Subject|0|||
44464916|NCT00466440|79473741|FG001|Overall Study|Withdrawal by Subject|1|||
44464917|NCT00466440|79473742|FG002|Overall Study|Withdrawal by Subject|0|||
44464918|NCT00466440|79473740|FG000|Overall Study|Sponsor decision|0|||
44464919|NCT00466440|79473741|FG001|Overall Study|Sponsor decision|0|||
44464920|NCT00466440|79473742|FG002|Overall Study|Sponsor decision|1|||
44464921|NCT00465972|79473761|FG000|Overall Study|Withdrawal by Subject|2|||
44464922|NCT00465972|79473762|FG001|Overall Study|Withdrawal by Subject|1|||
44464923|NCT00465894|79473772|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
44464924|NCT00465894|79473773|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
44464925|NCT00465894|79473772|FG000|Treatment For 12 Weeks|Family Issues|1|||
44464926|NCT00465894|79473773|FG001|Treatment For 12 Weeks|Family Issues|1|||
44464927|NCT00465894|79473772|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
44464928|NCT00465894|79473773|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
44464929|NCT00330460|79473797|FG000|Overall Study|Physician Decision|1|||
44464930|NCT00330460|79473798|FG001|Overall Study|Physician Decision|0|||
44464931|NCT00330460|79473797|FG000|Overall Study|Adverse Event|10|||
44464932|NCT00330460|79473798|FG001|Overall Study|Adverse Event|8|||
44464933|NCT00330460|79473797|FG000|Overall Study|Withdrawal by Subject|18|||
44464934|NCT00330460|79473798|FG001|Overall Study|Withdrawal by Subject|17|||
44464935|NCT00330460|79473797|FG000|Overall Study|Death|1|||
44464936|NCT00330460|79473798|FG001|Overall Study|Death|1|||
44464937|NCT00330460|79473797|FG000|Overall Study|Ineligibility determined|1|||
44464938|NCT00330460|79473798|FG001|Overall Study|Ineligibility determined|3|||
44464939|NCT00330460|79473797|FG000|Overall Study|Lost to Follow-up|8|||
44464940|NCT00330460|79473798|FG001|Overall Study|Lost to Follow-up|3|||
44464941|NCT00330460|79473797|FG000|Overall Study|Noncompliance|2|||
44464942|NCT00330460|79473798|FG001|Overall Study|Noncompliance|1|||
44464943|NCT00330460|79473797|FG000|Overall Study|Other|1|||
44464944|NCT00330460|79473798|FG001|Overall Study|Other|0|||
44464945|NCT00454116|79473807|FG000|Overall Study|Adverse Event|5|||
44464946|NCT00454116|79473808|FG001|Overall Study|Adverse Event|11|||
44464947|NCT00454116|79473809|FG002|Overall Study|Adverse Event|9|||
44464948|NCT00454116|79473807|FG000|Overall Study|Condition under investigation worsened|17|||
44464949|NCT00454116|79473808|FG001|Overall Study|Condition under investigation worsened|13|||
44464950|NCT00454116|79473809|FG002|Overall Study|Condition under investigation worsened|18|||
44464951|NCT00454116|79473807|FG000|Overall Study|Withdrawal by Subject|3|||
44464952|NCT00454116|79473808|FG001|Overall Study|Withdrawal by Subject|3|||
44464953|NCT00454116|79473809|FG002|Overall Study|Withdrawal by Subject|1|||
44464954|NCT00454116|79473807|FG000|Overall Study|Other|2|||
44464955|NCT00454116|79473808|FG001|Overall Study|Other|2|||
44464956|NCT00454116|79473809|FG002|Overall Study|Other|0|||
44464957|NCT00465816|79473820|FG000|Overall Study|Lost to Follow-up|0|||
44464958|NCT00465816|79473821|FG001|Overall Study|Lost to Follow-up|0|||
44464959|NCT00465816|79473822|FG002|Overall Study|Lost to Follow-up|2|||
44464960|NCT00465738|79473833|FG000|Overall Study|Lost to Follow-up|2|||
44464961|NCT00465738|79473834|FG001|Overall Study|Lost to Follow-up|0|||
44464962|NCT00465738|79473833|FG000|Overall Study|Adverse Event|0|||
44464963|NCT00465738|79473834|FG001|Overall Study|Adverse Event|1|||
44464964|NCT00465738|79473833|FG000|Overall Study|Withdrawal by Subject|2|||
44222064|NCT01878253|79025391|FG000|Overall Study|SIdus System Removal|3|||
44222065|NCT01878253|79025391|FG000|Overall Study|Withdrawal by Subject|1|||
44222066|NCT01878253|79025391|FG000|Overall Study|Lost to Follow-up|2|||
44222067|NCT01878253|79025391|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
44222068|NCT01878175|79025400|FG000|Overall Study|Developed contraindicated health problem|2|||
44222069|NCT01878097|79025407|FG000|Baseline|Surveys not fully completed|2497|||
44222070|NCT01878097|79025408|FG001|Baseline|Surveys not fully completed|1800|||
44222071|NCT01878097|79025407|FG000|Implementation Year 1|Surveys not fully completed|3202|||
44222072|NCT01878097|79025408|FG001|Implementation Year 1|Surveys not fully completed|2549|||
44222073|NCT01878097|79025407|FG000|Implementation Year 2|Surveys not fully completed|3281|||
44222074|NCT01878097|79025408|FG001|Implementation Year 2|Surveys not fully completed|2841|||
44222075|NCT01878097|79025407|FG000|Implementation Year 3|Surveys not fully completed|3494|||
44271523|NCT02289690|79202653|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
44464965|NCT00465738|79473834|FG001|Overall Study|Withdrawal by Subject|0|||
44464966|NCT00465738|79473833|FG000|Overall Study|Other|2|||
44464967|NCT00465738|79473834|FG001|Overall Study|Other|5|||
44464968|NCT00400179|79473842|FG000|Overall Study|Adverse Event|2|||
44464969|NCT00400179|79473843|FG001|Overall Study|Adverse Event|2|||
44464970|NCT00400179|79473842|FG000|Overall Study|Death|1|||
44464971|NCT00400179|79473843|FG001|Overall Study|Death|2|||
44464972|NCT00400179|79473842|FG000|Overall Study|Withdrew Consent|1|||
44464973|NCT00400179|79473843|FG001|Overall Study|Withdrew Consent|5|||
44464974|NCT00400179|79473842|FG000|Overall Study|Disease progression|1|||
44464975|NCT00400179|79473843|FG001|Overall Study|Disease progression|1|||
44464976|NCT00400179|79473842|FG000|Overall Study|Intercurrent illness|0|||
44464977|NCT00400179|79473843|FG001|Overall Study|Intercurrent illness|1|||
44464978|NCT00400179|79473842|FG000|Overall Study|Investigator judgment|0|||
44464979|NCT00400179|79473843|FG001|Overall Study|Investigator judgment|1|||
44464980|NCT00400179|79473842|FG000|Overall Study|Randomization error/patient ineligible|1|||
44464981|NCT00400179|79473843|FG001|Overall Study|Randomization error/patient ineligible|6|||
44464982|NCT00465270|79473851|FG000|Overall Study|Death|7|||
44464983|NCT00465270|79473852|FG001|Overall Study|Death|11|||
44464984|NCT00465270|79473851|FG000|Overall Study|Withdrawal by Subject|34|||
44464985|NCT00465270|79473852|FG001|Overall Study|Withdrawal by Subject|78|||
44464986|NCT00465270|79473851|FG000|Overall Study|Lost to Follow-up|60|||
44464987|NCT00465270|79473852|FG001|Overall Study|Lost to Follow-up|67|||
44464988|NCT00465270|79473851|FG000|Overall Study|Investigator request|3|||
44464989|NCT00465270|79473852|FG001|Overall Study|Investigator request|4|||
44464990|NCT00464568|79473858|FG000|Overall Study|Adverse Event|2|||
44464991|NCT00464490|79473877|FG000|Overall Study|Physician Decision|11|||
44464992|NCT00464490|79473878|FG001|Overall Study|Physician Decision|11|||
44464993|NCT03849300|79473888|FG000|Overall Study|move out to different area|1|||
44464994|NCT03849300|79473889|FG001|Overall Study|move out to different area|3|||
44464995|NCT03849300|79473890|FG002|Overall Study|move out to different area|1|||
44464996|NCT03849300|79473891|FG003|Overall Study|move out to different area|4|||
44464997|NCT03849300|79473888|FG000|Overall Study|scheduling/transportation conflict|4|||
44464998|NCT03849300|79473889|FG001|Overall Study|scheduling/transportation conflict|4|||
44464999|NCT03849300|79473890|FG002|Overall Study|scheduling/transportation conflict|3|||
44465000|NCT03849300|79473891|FG003|Overall Study|scheduling/transportation conflict|2|||
44465001|NCT00412893|79473905|FG000|Overall Study|Adverse Event|31|||
44374967|NCT01105130|79380128|FG002|Overall Study|Never Started|4|||
44374968|NCT01105130|79380126|FG000|Overall Study|Toxicity|1|||
44374969|NCT01105130|79380127|FG001|Overall Study|Toxicity|3|||
44374970|NCT01105130|79380128|FG002|Overall Study|Toxicity|2|||
44374971|NCT01105130|79380126|FG000|Overall Study|Multiple Reasons|3|||
44374972|NCT01105130|79380127|FG001|Overall Study|Multiple Reasons|0|||
44374973|NCT01105130|79380128|FG002|Overall Study|Multiple Reasons|2|||
44374974|NCT01108094|79380140|FG000|Overall Study|Adverse Event|2|||
44374975|NCT01108094|79380141|FG001|Overall Study|Adverse Event|0|||
44374976|NCT01108094|79380142|FG002|Overall Study|Adverse Event|0|||
44374977|NCT01108094|79380143|FG003|Overall Study|Adverse Event|0|||
44374978|NCT01108094|79380140|FG000|Overall Study|Withdrawal by Subject|1|||
44374979|NCT01108094|79380141|FG001|Overall Study|Withdrawal by Subject|0|||
44465002|NCT00412893|79473906|FG001|Overall Study|Adverse Event|53|||
44465003|NCT00412893|79473905|FG000|Overall Study|Death|17|||
44465004|NCT00412893|79473906|FG001|Overall Study|Death|21|||
44465005|NCT00412893|79473905|FG000|Overall Study|Insufficient Therapeutic Response|39|||
44465006|NCT00412893|79473906|FG001|Overall Study|Insufficient Therapeutic Response|23|||
44465007|NCT00412893|79473905|FG000|Overall Study|Lost to Follow-up|2|||
44465008|NCT00412893|79473906|FG001|Overall Study|Lost to Follow-up|1|||
44465009|NCT00412893|79473905|FG000|Overall Study|Violation of Selection at Entry|17|||
44465010|NCT00412893|79473906|FG001|Overall Study|Violation of Selection at Entry|10|||
44465011|NCT00412893|79473905|FG000|Overall Study|Other Protocol Violation|10|||
44465012|NCT00412893|79473906|FG001|Overall Study|Other Protocol Violation|6|||
44465013|NCT00412893|79473905|FG000|Overall Study|Did Not Cooperate|12|||
44465014|NCT00412893|79473906|FG001|Overall Study|Did Not Cooperate|9|||
44465015|NCT00412893|79473905|FG000|Overall Study|Administrative Reason|12|||
44465016|NCT00412893|79473906|FG001|Overall Study|Administrative Reason|15|||
44465017|NCT00412893|79473905|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
44465018|NCT00412893|79473906|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
44465019|NCT00412737|79473914|FG000|Overall Study|Death|1|||
44271524|NCT02289690|79202654|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
44374980|NCT01108094|79380142|FG002|Overall Study|Withdrawal by Subject|0|||
44465020|NCT00412737|79473915|FG001|Overall Study|Death|0|||
44374981|NCT01108094|79380143|FG003|Overall Study|Withdrawal by Subject|0|||
44374982|NCT00954174|79380160|FG000|Overall Study|Adverse Event|28|||
44465021|NCT00412737|79473914|FG000|Overall Study|Adverse Event|3|||
44465022|NCT00412737|79473915|FG001|Overall Study|Adverse Event|2|||
44465023|NCT00412737|79473914|FG000|Overall Study|Refused Treatment|6|||
44465024|NCT00412737|79473915|FG001|Overall Study|Refused Treatment|2|||
44465025|NCT00412737|79473914|FG000|Overall Study|Failure to Return|6|||
44465026|NCT00412737|79473915|FG001|Overall Study|Failure to Return|2|||
44465027|NCT00508742|79473923|FG000|Period 1: Infant Series|Adverse Event|5|||
44465028|NCT00508742|79473924|FG001|Period 1: Infant Series|Adverse Event|4|||
44465029|NCT00508742|79473923|FG000|Period 1: Infant Series|Protocol Violation|1|||
44465030|NCT00508742|79473924|FG001|Period 1: Infant Series|Protocol Violation|0|||
44465031|NCT00508742|79473923|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
44465032|NCT00508742|79473924|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
44465033|NCT00508742|79473923|FG000|Period 1: Infant Series|Physician Decision|1|||
44465034|NCT00508742|79473924|FG001|Period 1: Infant Series|Physician Decision|0|||
44465035|NCT00508742|79473923|FG000|Period 1: Infant Series|Other|4|||
44465036|NCT00508742|79473924|FG001|Period 1: Infant Series|Other|1|||
44222076|NCT01878097|79025408|FG001|Implementation Year 3|Surveys not fully completed|2980|||
44222077|NCT01878097|79025407|FG000|Implementation Year 4|Surveys not fully completed|3604|||
44222078|NCT01878097|79025408|FG001|Implementation Year 4|Surveys not fully completed|3007|||
44222079|NCT01750190|79025416|FG000|Overall Study|Adverse Event|47|||
44222080|NCT01750190|79025417|FG001|Overall Study|Adverse Event|19|||
44465037|NCT00508742|79473923|FG000|Period 2: After Infant Series|Adverse Event|2|||
44465038|NCT00508742|79473924|FG001|Period 2: After Infant Series|Adverse Event|6|||
44465039|NCT00508742|79473923|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
44465040|NCT00508742|79473924|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
44465041|NCT00508742|79473923|FG000|Period 2: After Infant Series|Protocol Violation|1|||
44465042|NCT00508742|79473924|FG001|Period 2: After Infant Series|Protocol Violation|0|||
44465043|NCT00508742|79473923|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
44465044|NCT00508742|79473924|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
44465045|NCT00508742|79473923|FG000|Period 2: After Infant Series|Failed to Return|1|||
44465046|NCT00508742|79473924|FG001|Period 2: After Infant Series|Failed to Return|0|||
44465047|NCT00508742|79473923|FG000|Period 2: After Infant Series|Other|2|||
44465048|NCT00508742|79473924|FG001|Period 2: After Infant Series|Other|1|||
44465049|NCT00508742|79473923|FG000|Period 3: Toddler Dose|Adverse Event|1|||
44465050|NCT00508742|79473924|FG001|Period 3: Toddler Dose|Adverse Event|0|||
44465051|NCT00508742|79473923|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
44465052|NCT00508742|79473924|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
44465053|NCT00508742|79473923|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
44465054|NCT00508742|79473924|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
44465055|NCT00508742|79473923|FG000|Period 3: Toddler Dose|Other|5|||
44465056|NCT00508742|79473924|FG001|Period 3: Toddler Dose|Other|4|||
44465057|NCT00508274|79473945|FG000|Overall Study|Adverse Event|5|||
44465058|NCT00508274|79473945|FG000|Overall Study|Death|7|||
44465059|NCT00508274|79473945|FG000|Overall Study|Disease progression|32|||
44465060|NCT00508274|79473945|FG000|Overall Study|Withdrawal by Subject|1|||
44465061|NCT00508274|79473945|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
44465062|NCT00508274|79473945|FG000|Overall Study|Missing|3|||
44222081|NCT01750190|79025416|FG000|Overall Study|Death|38|||
44222082|NCT01750190|79025417|FG001|Overall Study|Death|11|||
44465063|NCT00499460|79473951|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
44465064|NCT00499460|79473952|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
44222083|NCT01750190|79025416|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
44465065|NCT00499460|79473951|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
44465066|NCT00499460|79473952|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
44544284|NCT02918019|79557643|FG002|Overall Study|Lost to Follow-up|0|||
44277805|NCT02092350|79238807|FG001|Overall Study|Lost to Follow-up|1|||
44465067|NCT00499460|79473951|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
44465068|NCT00499460|79473952|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
44465069|NCT00412113|79473970|FG000|Overall Study|Adverse Event|11|||
44465070|NCT00412113|79473971|FG001|Overall Study|Adverse Event|15|||
44465071|NCT00412113|79473970|FG000|Overall Study|did not receive treatment|1|||
44465072|NCT00412113|79473971|FG001|Overall Study|did not receive treatment|0|||
44514767|NCT03107026|79520595|FG001|Overall Study|Withdrawal by Subject|5|||
44514768|NCT03107026|79520596|FG002|Overall Study|Withdrawal by Subject|17|||
44514769|NCT03107026|79520594|FG000|Overall Study|non compliance with study visits|1|||
44514770|NCT03107026|79520595|FG001|Overall Study|non compliance with study visits|2|||
44514771|NCT03107026|79520596|FG002|Overall Study|non compliance with study visits|0|||
44514772|NCT03107026|79520594|FG000|Overall Study|non-compliance with study drug|2|||
44514773|NCT03107026|79520595|FG001|Overall Study|non-compliance with study drug|2|||
44514774|NCT03107026|79520596|FG002|Overall Study|non-compliance with study drug|3|||
44514775|NCT03107026|79520594|FG000|Overall Study|Physician Decision|0|||
44514776|NCT03107026|79520595|FG001|Overall Study|Physician Decision|1|||
44514777|NCT03107026|79520596|FG002|Overall Study|Physician Decision|0|||
44514778|NCT03717480|79520604|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
44514779|NCT00005044|79520610|FG000|Overall Study|Protocol Violation|37|||
44514780|NCT00005044|79520611|FG001|Overall Study|Protocol Violation|46|||
44514781|NCT00005044|79520610|FG000|Overall Study|Withdrawal by Subject|1|||
44514782|NCT00005044|79520611|FG001|Overall Study|Withdrawal by Subject|5|||
44514783|NCT00005044|79520610|FG000|Overall Study|No protocol treatment|0|||
44514784|NCT00005044|79520611|FG001|Overall Study|No protocol treatment|1|||
44514785|NCT03084796|79520623|FG000|Overall Study|Adverse Event|4|||
44514786|NCT03084796|79520624|FG001|Overall Study|Adverse Event|5|||
44514787|NCT03084796|79520625|FG002|Overall Study|Adverse Event|6|||
44514788|NCT03084796|79520626|FG003|Overall Study|Adverse Event|2|||
44514789|NCT03084796|79520627|FG004|Overall Study|Adverse Event|3|||
44514790|NCT03084796|79520628|FG005|Overall Study|Adverse Event|5|||
44514791|NCT03084796|79520623|FG000|Overall Study|Withdrawal by Subject|3|||
44514792|NCT03084796|79520624|FG001|Overall Study|Withdrawal by Subject|5|||
44514793|NCT03084796|79520625|FG002|Overall Study|Withdrawal by Subject|2|||
44514794|NCT03084796|79520626|FG003|Overall Study|Withdrawal by Subject|1|||
44514795|NCT03084796|79520627|FG004|Overall Study|Withdrawal by Subject|3|||
44514796|NCT03084796|79520628|FG005|Overall Study|Withdrawal by Subject|0|||
44514797|NCT03084796|79520623|FG000|Overall Study|Protocol Violation|0|||
44514798|NCT03084796|79520624|FG001|Overall Study|Protocol Violation|0|||
44514799|NCT03084796|79520625|FG002|Overall Study|Protocol Violation|1|||
44514800|NCT03084796|79520626|FG003|Overall Study|Protocol Violation|0|||
44514801|NCT03084796|79520627|FG004|Overall Study|Protocol Violation|1|||
44514802|NCT03084796|79520628|FG005|Overall Study|Protocol Violation|1|||
44514803|NCT03084796|79520623|FG000|Overall Study|Lack of Efficacy|0|||
44514804|NCT03084796|79520624|FG001|Overall Study|Lack of Efficacy|0|||
44222084|NCT01750190|79025417|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
44222085|NCT01750190|79025416|FG000|Overall Study|Lost to Follow-up|28|||
44222086|NCT01750190|79025417|FG001|Overall Study|Lost to Follow-up|7|||
44222087|NCT01750190|79025416|FG000|Overall Study|Physician Decision|16|||
44222088|NCT01750190|79025417|FG001|Overall Study|Physician Decision|17|||
44222089|NCT01750190|79025416|FG000|Overall Study|Protocol Violation|6|||
44222090|NCT01750190|79025417|FG001|Overall Study|Protocol Violation|5|||
44222091|NCT01750190|79025416|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
44222092|NCT01750190|79025417|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
44222093|NCT01750190|79025416|FG000|Overall Study|Withdrawal by Subject|83|||
44222094|NCT01750190|79025417|FG001|Overall Study|Withdrawal by Subject|89|||
44222095|NCT01750190|79025416|FG000|Overall Study|Kidney Transplant|8|||
44222096|NCT01750190|79025417|FG001|Overall Study|Kidney Transplant|4|||
44222097|NCT01750190|79025416|FG000|Overall Study|Dialysis|22|||
44222098|NCT01750190|79025417|FG001|Overall Study|Dialysis|8|||
44222099|NCT01750190|79025416|FG000|Overall Study|Other than Specified|13|||
44222100|NCT01750190|79025417|FG001|Overall Study|Other than Specified|4|||
44222101|NCT01831765|79025426|FG000|Overall Study|Lack of Efficacy|1|||
44222102|NCT01831765|79025427|FG001|Overall Study|Lack of Efficacy|0|||
44222103|NCT01831765|79025428|FG002|Overall Study|Lack of Efficacy|0|||
44374983|NCT00954174|79380161|FG001|Overall Study|Adverse Event|23|||
44374984|NCT00954174|79380162|FG002|Overall Study|Adverse Event|4|||
44374985|NCT00954174|79380163|FG003|Overall Study|Adverse Event|9|||
44374986|NCT00954174|79380160|FG000|Overall Study|Death|4|||
44374987|NCT00954174|79380161|FG001|Overall Study|Death|2|||
44374988|NCT00954174|79380162|FG002|Overall Study|Death|0|||
44374989|NCT00954174|79380163|FG003|Overall Study|Death|0|||
44374990|NCT00954174|79380160|FG000|Overall Study|Lack of Efficacy|32|||
44374991|NCT00954174|79380161|FG001|Overall Study|Lack of Efficacy|22|||
44374992|NCT00954174|79380162|FG002|Overall Study|Lack of Efficacy|8|||
44374993|NCT00954174|79380163|FG003|Overall Study|Lack of Efficacy|6|||
44514805|NCT03084796|79520625|FG002|Overall Study|Lack of Efficacy|1|||
44514806|NCT03084796|79520626|FG003|Overall Study|Lack of Efficacy|0|||
44514807|NCT03084796|79520627|FG004|Overall Study|Lack of Efficacy|1|||
44514808|NCT03084796|79520628|FG005|Overall Study|Lack of Efficacy|0|||
44374994|NCT00954174|79380160|FG000|Overall Study|Withdrawal by Subject|14|||
44374995|NCT00954174|79380161|FG001|Overall Study|Withdrawal by Subject|10|||
44465073|NCT00411645|79473979|FG000|Overall Study|Consent Withdrawn|13|||
44465074|NCT00411645|79473980|FG001|Overall Study|Consent Withdrawn|22|||
44465075|NCT00411645|79473979|FG000|Overall Study|Death|56|||
44222104|NCT01831765|79025426|FG000|Overall Study|Other, sponsor withdrew subject|0|||
44222105|NCT01831765|79025427|FG001|Overall Study|Other, sponsor withdrew subject|1|||
44222106|NCT01831765|79025428|FG002|Overall Study|Other, sponsor withdrew subject|0|||
44222107|NCT01831765|79025426|FG000|Overall Study|Pregnancy|1|||
44222108|NCT01831765|79025427|FG001|Overall Study|Pregnancy|1|||
44222109|NCT01831765|79025428|FG002|Overall Study|Pregnancy|2|||
44222110|NCT01831765|79025426|FG000|Overall Study|Death|0|||
44465076|NCT00411645|79473980|FG001|Overall Study|Death|135|||
44465077|NCT00411645|79473979|FG000|Overall Study|Investigator/Sponsor Decision|10|||
44465078|NCT00411645|79473980|FG001|Overall Study|Investigator/Sponsor Decision|7|||
44271525|NCT02289690|79202655|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
44465079|NCT00411645|79473979|FG000|Overall Study|Lost to Follow-up|2|||
44465080|NCT00411645|79473980|FG001|Overall Study|Lost to Follow-up|0|||
44465081|NCT00490724|79473990|FG000|Period I|Physician Decision|0|||
44271526|NCT02289690|79202656|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
44465082|NCT00490724|79473991|FG001|Period I|Physician Decision|0|||
44465083|NCT00490724|79473992|FG002|Period I|Physician Decision|1|||
44465084|NCT00490724|79473990|FG000|Period II|Treatment Discontinuation|3|||
44465085|NCT00490724|79473991|FG001|Period II|Treatment Discontinuation|1|||
44465086|NCT00490724|79473992|FG002|Period II|Treatment Discontinuation|3|||
44465087|NCT03835221|79474000|FG000|Methafilcon A|Withdrawal by Subject|1|||
44465088|NCT00398073|79474008|FG000|Overall Study|Withdrawal by Subject|1|||
44465089|NCT00398073|79474009|FG001|Overall Study|Withdrawal by Subject|0|||
44271527|NCT02289690|79202647|FG000|Overall Study|Lost to Follow-up|0|||
44271528|NCT02289690|79202648|FG001|Overall Study|Lost to Follow-up|0|||
44271529|NCT02289690|79202649|FG002|Overall Study|Lost to Follow-up|0|||
44271530|NCT02289690|79202650|FG003|Overall Study|Lost to Follow-up|0|||
44271531|NCT02289690|79202651|FG004|Overall Study|Lost to Follow-up|0|||
44271532|NCT02289690|79202652|FG005|Overall Study|Lost to Follow-up|0|||
44271533|NCT02289690|79202653|FG006|Overall Study|Lost to Follow-up|0|||
44271534|NCT02289690|79202654|FG007|Overall Study|Lost to Follow-up|1|||
44465090|NCT00490646|79474017|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
44465091|NCT00490646|79474018|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
44271535|NCT02289690|79202655|FG008|Overall Study|Lost to Follow-up|0|||
44465092|NCT00490646|79474017|FG000|Overall Study|Never Treated (had an adverse event)|1|||
44465093|NCT00490646|79474018|FG001|Overall Study|Never Treated (had an adverse event)|0|||
44465094|NCT00490646|79474017|FG000|Overall Study|Never Treated (withdrew consent)|0|||
44465095|NCT00490646|79474018|FG001|Overall Study|Never Treated (withdrew consent)|1|||
44465096|NCT00388947|79474024|FG000|Overall Study|Protocol Violation|47|||
44465097|NCT00490568|79474028|FG000|Overall Study|Adverse Event|116|||
44271536|NCT02289690|79202656|FG009|Overall Study|Lost to Follow-up|2|||
44271537|NCT02289690|79202647|FG000|Overall Study|Death|0|||
44271538|NCT02289690|79202648|FG001|Overall Study|Death|0|||
44271539|NCT02289690|79202649|FG002|Overall Study|Death|0|||
44465098|NCT00490568|79474028|FG000|Overall Study|Lost to Follow-up|13|||
44222111|NCT01831765|79025427|FG001|Overall Study|Death|1|||
44222112|NCT01831765|79025428|FG002|Overall Study|Death|1|||
44222113|NCT01831765|79025426|FG000|Overall Study|Other, site closed|1|||
44222114|NCT01831765|79025427|FG001|Overall Study|Other, site closed|1|||
44222115|NCT01831765|79025428|FG002|Overall Study|Other, site closed|0|||
44222116|NCT01831765|79025426|FG000|Overall Study|Adverse Event|5|||
44222117|NCT01831765|79025427|FG001|Overall Study|Adverse Event|3|||
44222118|NCT01831765|79025428|FG002|Overall Study|Adverse Event|3|||
44222119|NCT01831765|79025426|FG000|Overall Study|Withdrawal by Subject|22|||
44222120|NCT01831765|79025427|FG001|Overall Study|Withdrawal by Subject|7|||
44465099|NCT00490568|79474028|FG000|Overall Study|Protocol Violation|45|||
44465100|NCT00490568|79474028|FG000|Overall Study|Withdrawal by Subject|135|||
44465101|NCT00490568|79474028|FG000|Overall Study|Still in the study at termination|974|||
44465102|NCT00490568|79474028|FG000|Overall Study|Other|1|||
44222121|NCT01831765|79025428|FG002|Overall Study|Withdrawal by Subject|17|||
44222122|NCT01831765|79025426|FG000|Overall Study|Withdrawal criteria|12|||
44271540|NCT02289690|79202650|FG003|Overall Study|Death|0|||
44271541|NCT02289690|79202651|FG004|Overall Study|Death|0|||
44271542|NCT02289690|79202652|FG005|Overall Study|Death|0|||
44465103|NCT00490568|79474028|FG000|Overall Study|Exclusion criteria met|1|||
44465104|NCT00490568|79474028|FG000|Overall Study|Caregiver related|20|||
44465105|NCT00490568|79474028|FG000|Overall Study|Abnormal ECG|25|||
44465106|NCT00490568|79474028|FG000|Overall Study|Participant refused follow-up|9|||
44465107|NCT00490568|79474028|FG000|Overall Study|Legal representative withdrew consent|1|||
44465108|NCT00490568|79474028|FG000|Overall Study|Disease progression|4|||
44222123|NCT01831765|79025427|FG001|Overall Study|Withdrawal criteria|10|||
44271543|NCT02289690|79202653|FG006|Overall Study|Death|0|||
44465109|NCT00490568|79474028|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
44465110|NCT00490568|79474028|FG000|Overall Study|Investigator decision|3|||
44465111|NCT00490568|79474028|FG000|Overall Study|Non-Compliance|7|||
44465112|NCT00490568|79474028|FG000|Overall Study|Efficacy related|3|||
44465113|NCT00490568|79474028|FG000|Overall Study|Participant died|1|||
44465114|NCT00490568|79474028|FG000|Overall Study|Participant withdrawal due to surgery|1|||
44465115|NCT00561353|79474043|FG000|Overall Study|Subject reached a virologic endpoint|2|||
44465116|NCT00561353|79474044|FG001|Overall Study|Subject reached a virologic endpoint|1|||
44465117|NCT00561353|79474045|FG002|Overall Study|Subject reached a virologic endpoint|1|||
44465118|NCT00561353|79474046|FG003|Overall Study|Subject reached a virologic endpoint|4|||
44465119|NCT00561353|79474047|FG004|Overall Study|Subject reached a virologic endpoint|1|||
44465120|NCT00561353|79474048|FG005|Overall Study|Subject reached a virologic endpoint|3|||
44465121|NCT00561353|79474049|FG006|Overall Study|Subject reached a virologic endpoint|4|||
44465122|NCT00561353|79474050|FG007|Overall Study|Subject reached a virologic endpoint|4|||
44465123|NCT00561353|79474051|FG008|Overall Study|Subject reached a virologic endpoint|5|||
44465124|NCT00561353|79474052|FG009|Overall Study|Subject reached a virologic endpoint|0|||
44465125|NCT00561353|79474043|FG000|Overall Study|Subject ineligible to continue the trial|0|||
44465126|NCT00561353|79474044|FG001|Overall Study|Subject ineligible to continue the trial|0|||
44465127|NCT00561353|79474045|FG002|Overall Study|Subject ineligible to continue the trial|0|||
44465128|NCT00561353|79474046|FG003|Overall Study|Subject ineligible to continue the trial|0|||
44465129|NCT00561353|79474047|FG004|Overall Study|Subject ineligible to continue the trial|0|||
44465130|NCT00561353|79474048|FG005|Overall Study|Subject ineligible to continue the trial|1|||
44465131|NCT00561353|79474049|FG006|Overall Study|Subject ineligible to continue the trial|1|||
44465132|NCT00561353|79474050|FG007|Overall Study|Subject ineligible to continue the trial|0|||
44465133|NCT00561353|79474051|FG008|Overall Study|Subject ineligible to continue the trial|2|||
44465134|NCT00561353|79474052|FG009|Overall Study|Subject ineligible to continue the trial|1|||
44465135|NCT00561353|79474043|FG000|Overall Study|Other|1|||
44465136|NCT00561353|79474044|FG001|Overall Study|Other|0|||
44465137|NCT00561353|79474045|FG002|Overall Study|Other|1|||
44465138|NCT00561353|79474046|FG003|Overall Study|Other|0|||
44465139|NCT00561353|79474047|FG004|Overall Study|Other|0|||
44465140|NCT00561353|79474048|FG005|Overall Study|Other|2|||
44465141|NCT00561353|79474049|FG006|Overall Study|Other|0|||
44465142|NCT00561353|79474050|FG007|Overall Study|Other|0|||
44465143|NCT00561353|79474051|FG008|Overall Study|Other|0|||
44465144|NCT00561353|79474052|FG009|Overall Study|Other|0|||
44465145|NCT00561353|79474043|FG000|Overall Study|Adverse Event|0|||
44465146|NCT00561353|79474044|FG001|Overall Study|Adverse Event|0|||
44465147|NCT00561353|79474045|FG002|Overall Study|Adverse Event|0|||
44465148|NCT00561353|79474046|FG003|Overall Study|Adverse Event|2|||
44465149|NCT00561353|79474047|FG004|Overall Study|Adverse Event|0|||
44465150|NCT00561353|79474048|FG005|Overall Study|Adverse Event|0|||
44465151|NCT00561353|79474049|FG006|Overall Study|Adverse Event|1|||
44465152|NCT00561353|79474050|FG007|Overall Study|Adverse Event|0|||
44465153|NCT00561353|79474051|FG008|Overall Study|Adverse Event|0|||
44465154|NCT00561353|79474052|FG009|Overall Study|Adverse Event|1|||
44465155|NCT00561353|79474043|FG000|Overall Study|Lost to Follow-up|2|||
44465156|NCT00561353|79474044|FG001|Overall Study|Lost to Follow-up|0|||
44465157|NCT00561353|79474045|FG002|Overall Study|Lost to Follow-up|1|||
44465158|NCT00561353|79474046|FG003|Overall Study|Lost to Follow-up|0|||
44374996|NCT00954174|79380162|FG002|Overall Study|Withdrawal by Subject|4|||
44374997|NCT00954174|79380163|FG003|Overall Study|Withdrawal by Subject|3|||
44374998|NCT00954174|79380160|FG000|Overall Study|Medical Reason|4|||
44374999|NCT00954174|79380161|FG001|Overall Study|Medical Reason|2|||
44375000|NCT00954174|79380162|FG002|Overall Study|Medical Reason|1|||
44375001|NCT00954174|79380163|FG003|Overall Study|Medical Reason|0|||
44375002|NCT00954174|79380160|FG000|Overall Study|Ineligible|40|||
44375003|NCT00954174|79380161|FG001|Overall Study|Ineligible|47|||
44375004|NCT00954174|79380162|FG002|Overall Study|Ineligible|7|||
44375005|NCT00954174|79380163|FG003|Overall Study|Ineligible|4|||
44375006|NCT00954174|79380160|FG000|Overall Study|Never Treated|4|||
44465159|NCT00561353|79474047|FG004|Overall Study|Lost to Follow-up|0|||
44465160|NCT00561353|79474048|FG005|Overall Study|Lost to Follow-up|0|||
44465161|NCT00561353|79474049|FG006|Overall Study|Lost to Follow-up|0|||
44271544|NCT02289690|79202654|FG007|Overall Study|Death|49|||
44375007|NCT00954174|79380161|FG001|Overall Study|Never Treated|17|||
44465162|NCT00561353|79474050|FG007|Overall Study|Lost to Follow-up|0|||
44465163|NCT00561353|79474051|FG008|Overall Study|Lost to Follow-up|0|||
44465164|NCT00561353|79474052|FG009|Overall Study|Lost to Follow-up|0|||
44465165|NCT00561353|79474043|FG000|Overall Study|Withdrawal by Subject|0|||
44465166|NCT00561353|79474044|FG001|Overall Study|Withdrawal by Subject|2|||
44465167|NCT00561353|79474045|FG002|Overall Study|Withdrawal by Subject|0|||
44465168|NCT00561353|79474046|FG003|Overall Study|Withdrawal by Subject|0|||
44465169|NCT00561353|79474047|FG004|Overall Study|Withdrawal by Subject|0|||
44465170|NCT00561353|79474048|FG005|Overall Study|Withdrawal by Subject|0|||
44465171|NCT00561353|79474049|FG006|Overall Study|Withdrawal by Subject|0|||
44514809|NCT03084796|79520623|FG000|Overall Study|Lost to Follow-up|0|||
44375008|NCT00954174|79380162|FG002|Overall Study|Never Treated|0|||
44375009|NCT00954174|79380163|FG003|Overall Study|Never Treated|3|||
44375010|NCT01136408|79380179|FG000|Overall Study|Adverse Event|4|||
44375011|NCT01136408|79380180|FG001|Overall Study|Adverse Event|8|||
44465172|NCT00561353|79474050|FG007|Overall Study|Withdrawal by Subject|0|||
44465173|NCT00561353|79474051|FG008|Overall Study|Withdrawal by Subject|0|||
44465174|NCT00561353|79474052|FG009|Overall Study|Withdrawal by Subject|0|||
44465175|NCT00560885|79474119|FG000|Overall Study|Death|7|||
44465176|NCT00560885|79474119|FG000|Overall Study|Withdrawal by Subject|1|||
44465177|NCT00397215|79474127|FG000|Month 0 (Day 0)|Adverse Event|0|||
44465178|NCT00397215|79474128|FG001|Month 0 (Day 0)|Adverse Event|1|||
44465179|NCT00397215|79474129|FG002|Month 0 (Day 0)|Adverse Event|0|||
44465180|NCT00397215|79474130|FG003|Month 0 (Day 0)|Adverse Event|0|||
44465181|NCT00397215|79474127|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
44465182|NCT00397215|79474128|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
44465183|NCT00397215|79474129|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
44465184|NCT00397215|79474130|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
44465185|NCT00397215|79474127|FG000|Month 0 (Day 0)|Other|4|||
44465186|NCT00397215|79474128|FG001|Month 0 (Day 0)|Other|1|||
44465187|NCT00397215|79474129|FG002|Month 0 (Day 0)|Other|3|||
44465188|NCT00397215|79474130|FG003|Month 0 (Day 0)|Other|3|||
44465189|NCT00397215|79474127|FG000|Month 6 (Day 180)|Adverse Event|0|||
44465190|NCT00397215|79474128|FG001|Month 6 (Day 180)|Adverse Event|3|||
44465191|NCT00397215|79474129|FG002|Month 6 (Day 180)|Adverse Event|2|||
44465192|NCT00397215|79474130|FG003|Month 6 (Day 180)|Adverse Event|0|||
44465193|NCT00397215|79474127|FG000|Month 6 (Day 180)|Other|2|||
44465194|NCT00397215|79474128|FG001|Month 6 (Day 180)|Other|0|||
44465195|NCT00397215|79474129|FG002|Month 6 (Day 180)|Other|3|||
44465196|NCT00397215|79474130|FG003|Month 6 (Day 180)|Other|0|||
44465197|NCT00556439|79474147|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
44465198|NCT00556439|79474148|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
44465199|NCT00556439|79474149|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
44465200|NCT00556439|79474150|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
44465201|NCT00556439|79474147|FG000|Study Entry to Week 12|Physician Decision|1|||
44465202|NCT00556439|79474148|FG001|Study Entry to Week 12|Physician Decision|0|||
44465203|NCT00556439|79474149|FG002|Study Entry to Week 12|Physician Decision|0|||
44465204|NCT00556439|79474150|FG003|Study Entry to Week 12|Physician Decision|0|||
44465205|NCT00556439|79474147|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
44465206|NCT00556439|79474148|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
44465207|NCT00556439|79474149|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
44465208|NCT00556439|79474150|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
44465209|NCT00556439|79474147|FG000|Study Entry to Week 12|Recurrent infection|1|||
44465210|NCT00556439|79474148|FG001|Study Entry to Week 12|Recurrent infection|0|||
44222124|NCT01831765|79025428|FG002|Overall Study|Withdrawal criteria|16|||
44375012|NCT01136408|79380181|FG002|Overall Study|Adverse Event|4|||
44222125|NCT01831765|79025426|FG000|Overall Study|Lost to Follow-up|2|||
44465211|NCT00556439|79474149|FG002|Study Entry to Week 12|Recurrent infection|0|||
44544285|NCT02918019|79557644|FG003|Overall Study|Lost to Follow-up|1|||
44222126|NCT01831765|79025427|FG001|Overall Study|Lost to Follow-up|3|||
44375013|NCT01136408|79380179|FG000|Overall Study|Protocol Violation|1|||
44375014|NCT01136408|79380180|FG001|Overall Study|Protocol Violation|1|||
44375015|NCT01136408|79380181|FG002|Overall Study|Protocol Violation|1|||
44375016|NCT01136174|79380197|FG000|Overall Study|Adverse Event|0|||
44375017|NCT01136174|79380198|FG001|Overall Study|Adverse Event|0|||
44465212|NCT00556439|79474150|FG003|Study Entry to Week 12|Recurrent infection|0|||
44465213|NCT00556439|79474147|FG000|Study Entry to Week 12|Malignancy|0|||
44465214|NCT00556439|79474148|FG001|Study Entry to Week 12|Malignancy|0|||
44465215|NCT00556439|79474149|FG002|Study Entry to Week 12|Malignancy|1|||
44465216|NCT00556439|79474150|FG003|Study Entry to Week 12|Malignancy|0|||
44465217|NCT00556439|79474147|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
44465218|NCT00556439|79474148|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
44465219|NCT00556439|79474149|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
44465220|NCT00556439|79474150|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
44465221|NCT00556439|79474147|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
44465222|NCT00556439|79474148|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
44465223|NCT00556439|79474149|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
44465224|NCT00556439|79474150|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
44465225|NCT00556439|79474147|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
44465226|NCT00556439|79474148|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
44465227|NCT00556439|79474149|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
44465228|NCT00556439|79474150|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
44465229|NCT00556439|79474147|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
44465230|NCT00556439|79474148|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
44465231|NCT00556439|79474149|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
44465232|NCT00556439|79474150|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
44465233|NCT00387465|79474163|FG000|Overall Study|Withdrawal by Subject|0|||
44465234|NCT00387465|79474164|FG001|Overall Study|Withdrawal by Subject|1|||
44465235|NCT00387465|79474165|FG002|Overall Study|Withdrawal by Subject|0|||
44465236|NCT00387153|79474182|FG000|Overall Study|Adverse Event|1|||
44465237|NCT00387153|79474182|FG000|Overall Study|Disease Progression|3|||
44465238|NCT00387153|79474182|FG000|Overall Study|Lack of Response|4|||
44465239|NCT00386607|79474186|FG000|Core|Adverse Event|40|||
44465240|NCT00386607|79474187|FG001|Core|Adverse Event|0|||
44465241|NCT00386607|79474186|FG000|Core|Abnormal laboratory value(s)|3|||
44465242|NCT00386607|79474187|FG001|Core|Abnormal laboratory value(s)|0|||
44465243|NCT00386607|79474186|FG000|Core|Unsatisfactory therapeutic effect|23|||
44465244|NCT00386607|79474187|FG001|Core|Unsatisfactory therapeutic effect|0|||
44465245|NCT00386607|79474186|FG000|Core|Condition no longer requires study drug|4|||
44465246|NCT00386607|79474187|FG001|Core|Condition no longer requires study drug|0|||
44465247|NCT00386607|79474186|FG000|Core|Patient withdrew consent|15|||
44465248|NCT00386607|79474187|FG001|Core|Patient withdrew consent|0|||
44465249|NCT00386607|79474186|FG000|Core|Lost to Follow-up|23|||
44465250|NCT00386607|79474187|FG001|Core|Lost to Follow-up|0|||
44465251|NCT00386607|79474186|FG000|Core|Administrative problems|1|||
44465252|NCT00386607|79474187|FG001|Core|Administrative problems|0|||
44465253|NCT00386607|79474186|FG000|Core|Protocol Deviation|6|||
44465254|NCT00386607|79474187|FG001|Core|Protocol Deviation|0|||
44465255|NCT00386607|79474186|FG000|Extension|Adverse Event|0|||
44465256|NCT00386607|79474187|FG001|Extension|Adverse Event|6|||
44465257|NCT00386607|79474186|FG000|Extension|Abnormal laboratory value(s)|0|||
44465258|NCT00386607|79474187|FG001|Extension|Abnormal laboratory value(s)|1|||
44465259|NCT00386607|79474186|FG000|Extension|Administrative problems|0|||
44465260|NCT00386607|79474187|FG001|Extension|Administrative problems|1|||
44465261|NCT00386607|79474186|FG000|Extension|Lost to Follow-up|0|||
44465262|NCT00386607|79474187|FG001|Extension|Lost to Follow-up|3|||
44465263|NCT00386607|79474186|FG000|Extension|Patient withdrew consent|0|||
44465264|NCT00386607|79474187|FG001|Extension|Patient withdrew consent|5|||
44465265|NCT00386607|79474186|FG000|Extension|Unsatisfactory therapeutic effect|0|||
44465266|NCT00386607|79474187|FG001|Extension|Unsatisfactory therapeutic effect|1|||
44465267|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
44465268|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
44465269|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
44465270|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
44465271|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
44465272|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
44465273|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
44465274|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
44465275|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
44465276|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
44222127|NCT01831765|79025428|FG002|Overall Study|Lost to Follow-up|3|||
44222128|NCT01749800|79025441|FG000|Overall Study|not meeting inclusion criteria|3|||
44465277|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
44465278|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
44465279|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
44465280|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
44465281|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
44465282|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
44465283|NCT00410163|79474201|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
44465284|NCT00410163|79474202|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
44465285|NCT00410163|79474201|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
44465286|NCT00410163|79474202|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
44465287|NCT00410163|79474201|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
44465288|NCT00410163|79474202|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
44465289|NCT00410163|79474201|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
44465290|NCT00410163|79474202|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
44465291|NCT00410163|79474201|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
44465292|NCT00410163|79474202|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
44465293|NCT00410163|79474201|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
44465294|NCT00410163|79474202|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
44465295|NCT00409617|79474238|FG000|Overall Study|Adverse Event|57|||
44465296|NCT00409617|79474238|FG000|Overall Study|Lack of Efficacy|54|||
44465297|NCT00409617|79474238|FG000|Overall Study|Lost to Follow-up|2|||
44465298|NCT00409617|79474238|FG000|Overall Study|Protocol Violation|24|||
44465299|NCT00409617|79474238|FG000|Overall Study|Withdrawal by Subject|8|||
44465300|NCT00409617|79474238|FG000|Overall Study|Administrative reasons|1|||
44465301|NCT00409617|79474238|FG000|Overall Study|Not described|14|||
44465302|NCT00300274|79474245|FG000|Overall Study|Withdrawal by Subject|12|||
44465303|NCT00300274|79474246|FG001|Overall Study|Withdrawal by Subject|3|||
44465304|NCT00300274|79474247|FG002|Overall Study|Withdrawal by Subject|14|||
44465305|NCT00300274|79474245|FG000|Overall Study|Lost to Follow-up|3|||
44465306|NCT00300274|79474246|FG001|Overall Study|Lost to Follow-up|4|||
44465307|NCT00300274|79474247|FG002|Overall Study|Lost to Follow-up|5|||
44465308|NCT00300274|79474245|FG000|Overall Study|Death|31|||
44465309|NCT00300274|79474246|FG001|Overall Study|Death|20|||
44465310|NCT00300274|79474247|FG002|Overall Study|Death|25|||
44465311|NCT00300274|79474245|FG000|Overall Study|Re-transplant|0|||
44465312|NCT00300274|79474246|FG001|Overall Study|Re-transplant|0|||
44465313|NCT00300274|79474247|FG002|Overall Study|Re-transplant|1|||
44465314|NCT00299728|79474257|FG000|Overall Study|Lost to Follow-up|0|||
44465315|NCT00299728|79474258|FG001|Overall Study|Lost to Follow-up|1|||
44465316|NCT00299728|79474257|FG000|Overall Study|Withdrawal by Subject|0|||
44465317|NCT00299728|79474258|FG001|Overall Study|Withdrawal by Subject|1|||
44465318|NCT00299728|79474257|FG000|Overall Study|Progressive disease|0|||
44465319|NCT00299728|79474258|FG001|Overall Study|Progressive disease|1|||
44465320|NCT00396591|79474264|FG000|Overall Study|Disease Progression|13|||
44465321|NCT00396591|79474264|FG000|Overall Study|Adverse Event|2|||
44465322|NCT00396591|79474264|FG000|Overall Study|Participant request|1|||
44465323|NCT00316264|79474271|FG000|Overall Study|Lost to Follow-up|0|||
44465324|NCT00316264|79474272|FG001|Overall Study|Lost to Follow-up|1|||
44465325|NCT00316264|79474273|FG002|Overall Study|Lost to Follow-up|0|||
44465326|NCT00316264|79474271|FG000|Overall Study|Withdrawal of Consent|3|||
44465327|NCT00316264|79474272|FG001|Overall Study|Withdrawal of Consent|5|||
44465328|NCT00316264|79474273|FG002|Overall Study|Withdrawal of Consent|6|||
44465329|NCT00316264|79474271|FG000|Overall Study|Death|2|||
44465330|NCT00316264|79474272|FG001|Overall Study|Death|0|||
44465331|NCT00316264|79474273|FG002|Overall Study|Death|0|||
44465332|NCT00316264|79474271|FG000|Overall Study|Other|1|||
44465333|NCT00316264|79474272|FG001|Overall Study|Other|1|||
44222129|NCT01749800|79025442|FG001|Overall Study|not meeting inclusion criteria|0|||
44222130|NCT01749800|79025443|FG002|Overall Study|not meeting inclusion criteria|0|||
44222131|NCT01749800|79025441|FG000|Overall Study|Withdrawal by Subject|0|||
44222132|NCT01749800|79025442|FG001|Overall Study|Withdrawal by Subject|1|||
44222133|NCT01749800|79025443|FG002|Overall Study|Withdrawal by Subject|0|||
44222134|NCT01830595|79025451|FG000|First Period|Withdrawal by Subject|1|||
44222135|NCT01830595|79025452|FG001|First Period|Withdrawal by Subject|3|||
44222136|NCT01830595|79025451|FG000|Washout|Withdrawal by Subject|2|||
44222137|NCT01830595|79025452|FG001|Washout|Withdrawal by Subject|2|||
44222138|NCT01748552|79025470|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
44465334|NCT00316264|79474273|FG002|Overall Study|Other|0|||
44465335|NCT00385827|79474284|FG000|Part 1|Adverse Event|1|||
44465336|NCT00385827|79474285|FG001|Part 1|Adverse Event|0|||
44465337|NCT00385827|79474286|FG002|Part 1|Adverse Event|0|||
44465338|NCT00385827|79474284|FG000|Part 1|Death|2|||
44465339|NCT00385827|79474285|FG001|Part 1|Death|0|||
44465340|NCT00385827|79474286|FG002|Part 1|Death|0|||
44222139|NCT01748552|79025471|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
44465341|NCT00385827|79474284|FG000|Part 1|Lack of Efficacy|5|||
44465342|NCT00385827|79474285|FG001|Part 1|Lack of Efficacy|0|||
44465343|NCT00385827|79474286|FG002|Part 1|Lack of Efficacy|0|||
44465344|NCT00385827|79474284|FG000|Part 1|Other|1|||
44465345|NCT00385827|79474285|FG001|Part 1|Other|0|||
44465346|NCT00385827|79474286|FG002|Part 1|Other|0|||
44465347|NCT00385827|79474284|FG000|Part 2|Adverse Event|0|||
44465348|NCT00385827|79474285|FG001|Part 2|Adverse Event|6|||
44465349|NCT00385827|79474286|FG002|Part 2|Adverse Event|10|||
44465350|NCT00385827|79474284|FG000|Part 2|Death|0|||
44465351|NCT00385827|79474285|FG001|Part 2|Death|0|||
44465352|NCT00385827|79474286|FG002|Part 2|Death|2|||
44465353|NCT00385827|79474284|FG000|Part 2|Lack of Efficacy|0|||
44465354|NCT00385827|79474285|FG001|Part 2|Lack of Efficacy|14|||
44465355|NCT00385827|79474286|FG002|Part 2|Lack of Efficacy|13|||
44465356|NCT00385827|79474284|FG000|Part 2|Randomized but not treated|0|||
44465357|NCT00385827|79474285|FG001|Part 2|Randomized but not treated|2|||
44465358|NCT00385827|79474286|FG002|Part 2|Randomized but not treated|2|||
44465359|NCT00385827|79474284|FG000|Part 2|Other|0|||
44465360|NCT00385827|79474285|FG001|Part 2|Other|11|||
44465361|NCT00385827|79474286|FG002|Part 2|Other|21|||
44465362|NCT00498602|79474303|FG000|Overall Study|Death|0|||
44465363|NCT00498602|79474304|FG001|Overall Study|Death|0|||
44465364|NCT00498602|79474305|FG002|Overall Study|Death|0|||
44465365|NCT00498602|79474306|FG003|Overall Study|Death|0|||
44465366|NCT00498602|79474307|FG004|Overall Study|Death|0|||
44465367|NCT00498602|79474308|FG005|Overall Study|Death|1|||
44465368|NCT00498602|79474309|FG006|Overall Study|Death|0|||
44465369|NCT00498602|79474303|FG000|Overall Study|Lack of Efficacy|1|||
44465370|NCT00498602|79474304|FG001|Overall Study|Lack of Efficacy|0|||
44465371|NCT00498602|79474305|FG002|Overall Study|Lack of Efficacy|0|||
44465372|NCT00498602|79474306|FG003|Overall Study|Lack of Efficacy|0|||
44465373|NCT00498602|79474307|FG004|Overall Study|Lack of Efficacy|0|||
44465374|NCT00498602|79474308|FG005|Overall Study|Lack of Efficacy|0|||
44465375|NCT00498602|79474309|FG006|Overall Study|Lack of Efficacy|0|||
44465376|NCT00498602|79474303|FG000|Overall Study|Lost to Follow-up|0|||
44465377|NCT00498602|79474304|FG001|Overall Study|Lost to Follow-up|2|||
44465378|NCT00498602|79474305|FG002|Overall Study|Lost to Follow-up|0|||
44465379|NCT00498602|79474306|FG003|Overall Study|Lost to Follow-up|2|||
44465380|NCT00498602|79474307|FG004|Overall Study|Lost to Follow-up|0|||
44465381|NCT00498602|79474308|FG005|Overall Study|Lost to Follow-up|0|||
44465382|NCT00498602|79474309|FG006|Overall Study|Lost to Follow-up|0|||
44465383|NCT00498602|79474303|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
44465384|NCT00498602|79474304|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
44465385|NCT00498602|79474305|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
44465386|NCT00498602|79474306|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
44465387|NCT00498602|79474307|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
44465388|NCT00498602|79474308|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
44465389|NCT00498602|79474309|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
44465390|NCT00498602|79474303|FG000|Overall Study|AE not related to Study Drug|1|||
44465391|NCT00498602|79474304|FG001|Overall Study|AE not related to Study Drug|3|||
44465392|NCT00498602|79474305|FG002|Overall Study|AE not related to Study Drug|0|||
44465393|NCT00498602|79474306|FG003|Overall Study|AE not related to Study Drug|0|||
44465394|NCT00498602|79474307|FG004|Overall Study|AE not related to Study Drug|2|||
44465395|NCT00498602|79474308|FG005|Overall Study|AE not related to Study Drug|2|||
44465396|NCT00498602|79474309|FG006|Overall Study|AE not related to Study Drug|1|||
44465397|NCT00498602|79474303|FG000|Overall Study|Caregiver Request|2|||
44465398|NCT00498602|79474304|FG001|Overall Study|Caregiver Request|2|||
44465399|NCT00498602|79474305|FG002|Overall Study|Caregiver Request|2|||
44465400|NCT00498602|79474306|FG003|Overall Study|Caregiver Request|0|||
44465401|NCT00498602|79474307|FG004|Overall Study|Caregiver Request|1|||
44465402|NCT00498602|79474308|FG005|Overall Study|Caregiver Request|2|||
44544286|NCT02918019|79557641|FG000|Overall Study|Principal investigator request|0|||
44544287|NCT02918019|79557642|FG001|Overall Study|Principal investigator request|0|||
44544288|NCT02918019|79557643|FG002|Overall Study|Principal investigator request|0|||
44544289|NCT02918019|79557644|FG003|Overall Study|Principal investigator request|1|||
44544290|NCT02918019|79557641|FG000|Overall Study|Physician Decision|1|||
44544291|NCT02918019|79557642|FG001|Overall Study|Physician Decision|3|||
44465403|NCT00498602|79474309|FG006|Overall Study|Caregiver Request|0|||
44465404|NCT00498602|79474303|FG000|Overall Study|Investigator Request|0|||
44465405|NCT00498602|79474304|FG001|Overall Study|Investigator Request|0|||
44465406|NCT00498602|79474305|FG002|Overall Study|Investigator Request|1|||
44465407|NCT00498602|79474306|FG003|Overall Study|Investigator Request|0|||
44465408|NCT00498602|79474307|FG004|Overall Study|Investigator Request|0|||
44465409|NCT00498602|79474308|FG005|Overall Study|Investigator Request|0|||
44465410|NCT00498602|79474309|FG006|Overall Study|Investigator Request|0|||
44465411|NCT00498602|79474303|FG000|Overall Study|Subject Request|3|||
44465412|NCT00498602|79474304|FG001|Overall Study|Subject Request|0|||
44465413|NCT00498602|79474305|FG002|Overall Study|Subject Request|1|||
44465414|NCT00498602|79474306|FG003|Overall Study|Subject Request|1|||
44465415|NCT00498602|79474307|FG004|Overall Study|Subject Request|1|||
44465416|NCT00498602|79474308|FG005|Overall Study|Subject Request|4|||
44465417|NCT00498602|79474309|FG006|Overall Study|Subject Request|1|||
44465418|NCT00498602|79474303|FG000|Overall Study|Other|2|||
44465419|NCT00498602|79474304|FG001|Overall Study|Other|3|||
44465420|NCT00498602|79474305|FG002|Overall Study|Other|1|||
44465421|NCT00498602|79474306|FG003|Overall Study|Other|0|||
44465422|NCT00498602|79474307|FG004|Overall Study|Other|0|||
44465423|NCT00498602|79474308|FG005|Overall Study|Other|3|||
44465424|NCT00498602|79474309|FG006|Overall Study|Other|0|||
44465425|NCT00507728|79474328|FG000|Randomization to Month 3|Lost to Follow-up|15|||
44465426|NCT00507728|79474329|FG001|Randomization to Month 3|Lost to Follow-up|14|||
44465427|NCT00507728|79474330|FG002|Randomization to Month 3|Lost to Follow-up|20|||
44465428|NCT00507728|79474328|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
44465429|NCT00507728|79474329|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
44465430|NCT00507728|79474330|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
44465431|NCT00498368|79474346|FG000|Overall Study|Withdrawal by Subject|3|||
44465432|NCT00498368|79474347|FG001|Overall Study|Withdrawal by Subject|2|||
44465433|NCT00385671|79474356|FG000|Overall Study|Adverse Event|14|||
44465434|NCT00385671|79474357|FG001|Overall Study|Adverse Event|27|||
44465435|NCT00385671|79474358|FG002|Overall Study|Adverse Event|18|||
44465436|NCT00385671|79474356|FG000|Overall Study|Lack of Efficacy|5|||
44465437|NCT00385671|79474357|FG001|Overall Study|Lack of Efficacy|9|||
44465438|NCT00385671|79474358|FG002|Overall Study|Lack of Efficacy|5|||
44465439|NCT00385671|79474356|FG000|Overall Study|Lost to Follow-up|6|||
44465440|NCT00385671|79474357|FG001|Overall Study|Lost to Follow-up|6|||
44465441|NCT00385671|79474358|FG002|Overall Study|Lost to Follow-up|5|||
44465442|NCT00385671|79474356|FG000|Overall Study|Physician Decision|2|||
44465443|NCT00385671|79474357|FG001|Overall Study|Physician Decision|1|||
44465444|NCT00385671|79474358|FG002|Overall Study|Physician Decision|2|||
44465445|NCT00385671|79474356|FG000|Overall Study|Protocol Violation|5|||
44465446|NCT00385671|79474357|FG001|Overall Study|Protocol Violation|2|||
44465447|NCT00385671|79474358|FG002|Overall Study|Protocol Violation|1|||
44465448|NCT00385671|79474356|FG000|Overall Study|Sponsor Decision|2|||
44465449|NCT00385671|79474357|FG001|Overall Study|Sponsor Decision|2|||
44465450|NCT00385671|79474358|FG002|Overall Study|Sponsor Decision|1|||
44465451|NCT00385671|79474356|FG000|Overall Study|Withdrawal by Subject|4|||
44465452|NCT00385671|79474357|FG001|Overall Study|Withdrawal by Subject|4|||
44465453|NCT00385671|79474358|FG002|Overall Study|Withdrawal by Subject|4|||
44465454|NCT00497198|79474370|FG000|Overall Study|Adverse Event|4|||
44465455|NCT00497198|79474371|FG001|Overall Study|Adverse Event|2|||
44465456|NCT00497198|79474370|FG000|Overall Study|Physician Decision|1|||
44465457|NCT00497198|79474371|FG001|Overall Study|Physician Decision|2|||
44465458|NCT00497198|79474370|FG000|Overall Study|Withdrawal by Subject|0|||
44465459|NCT00497198|79474371|FG001|Overall Study|Withdrawal by Subject|1|||
44465460|NCT00496964|79474379|FG000|Overall Study|Withdrawal by Subject|0|||
44465461|NCT00496964|79474380|FG001|Overall Study|Withdrawal by Subject|1|||
44465462|NCT00490490|79474388|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
44465463|NCT00490490|79474388|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
44465464|NCT00385593|79474394|FG000|Overall Study|Adverse Event|3|||
44465465|NCT00385593|79474395|FG001|Overall Study|Adverse Event|2|||
44465466|NCT00385593|79474394|FG000|Overall Study|Withdrawal by Subject|17|||
44465467|NCT00385593|79474395|FG001|Overall Study|Withdrawal by Subject|7|||
44465468|NCT00385593|79474394|FG000|Overall Study|Lost to Follow-up|12|||
44465469|NCT00385593|79474395|FG001|Overall Study|Lost to Follow-up|8|||
44465470|NCT00385593|79474394|FG000|Overall Study|Protocol Violation|7|||
44465471|NCT00385593|79474395|FG001|Overall Study|Protocol Violation|4|||
44465472|NCT00385593|79474394|FG000|Overall Study|Several reasons|17|||
44465473|NCT00385593|79474395|FG001|Overall Study|Several reasons|15|||
44465474|NCT00385593|79474394|FG000|Overall Study|Incorrect inclusion|2|||
44465475|NCT00385593|79474395|FG001|Overall Study|Incorrect inclusion|0|||
44222140|NCT01748552|79025472|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
44222141|NCT01748552|79025473|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
44222142|NCT01748552|79025474|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
44222143|NCT01748552|79025475|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
44222144|NCT01748552|79025476|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
44222145|NCT01748552|79025477|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
44222146|NCT01748552|79025478|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
44465476|NCT00385593|79474394|FG000|Overall Study|Incorrect randomization|0|||
44222147|NCT01748552|79025479|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
44222148|NCT01748552|79025480|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
44465477|NCT00385593|79474395|FG001|Overall Study|Incorrect randomization|1|||
44465478|NCT00495794|79474403|FG000|Overall Study|Pharmacist did not activate patient|522|||
44465479|NCT00495794|79474404|FG001|Overall Study|Pharmacist did not activate patient|0|||
44465480|NCT00495170|79474410|FG000|Overall Study|Lost to Follow-up|9|||
44465481|NCT00495170|79474410|FG000|Overall Study|Withdrawal by Subject|3|||
44465482|NCT00495170|79474410|FG000|Overall Study|Inappropriate staging|8|||
44465483|NCT03853148|79474418|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
44514810|NCT03084796|79520624|FG001|Overall Study|Lost to Follow-up|0|||
44465484|NCT03853148|79474419|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
44465485|NCT03853148|79474420|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
44465486|NCT03853148|79474421|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
44465487|NCT00385203|79474433|FG000|Overall Study|Adverse Event|5|||
44465488|NCT00385203|79474434|FG001|Overall Study|Adverse Event|4|||
44465489|NCT00385203|79474433|FG000|Overall Study|Death|1|||
44465490|NCT00385203|79474434|FG001|Overall Study|Death|0|||
44465491|NCT00385203|79474433|FG000|Overall Study|Condition under investigation worsened|18|||
44465492|NCT00385203|79474434|FG001|Overall Study|Condition under investigation worsened|3|||
44465493|NCT00385203|79474433|FG000|Overall Study|Incorrect enrollment|2|||
44465494|NCT00385203|79474434|FG001|Overall Study|Incorrect enrollment|0|||
44465495|NCT00408993|79474443|FG000|Overall Study|Adverse Event|15|||
44465496|NCT00408993|79474444|FG001|Overall Study|Adverse Event|4|||
44465497|NCT00408993|79474443|FG000|Overall Study|Protocol Violation|1|||
44465498|NCT00408993|79474444|FG001|Overall Study|Protocol Violation|6|||
44465499|NCT00408993|79474443|FG000|Overall Study|Lack of Efficacy|1|||
44465500|NCT00408993|79474444|FG001|Overall Study|Lack of Efficacy|4|||
44465501|NCT00408993|79474443|FG000|Overall Study|Withdrawal by Subject|2|||
44465502|NCT00408993|79474444|FG001|Overall Study|Withdrawal by Subject|3|||
44465503|NCT00395967|79474454|FG000|Treatment Period|Failed Mobilization|1|||
44465504|NCT00395967|79474454|FG000|Follow-up Period|Death|1|||
44465505|NCT00395967|79474454|FG000|Follow-up Period|Lost to Follow-up|1|||
44465506|NCT00395733|79474460|FG000|Period 2|Withdrawal by Subject|1|||
44222149|NCT01748552|79025481|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
44222150|NCT01748552|79025470|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222151|NCT01748552|79025471|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222152|NCT01748552|79025472|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222153|NCT01748552|79025473|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222154|NCT01748552|79025474|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222155|NCT01748552|79025475|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222156|NCT01748552|79025476|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
44465507|NCT00395733|79474461|FG001|Period 2|Withdrawal by Subject|2|||
44465508|NCT00395733|79474460|FG000|Period 2|Protocol Violation|0|||
44465509|NCT00395733|79474461|FG001|Period 2|Protocol Violation|1|||
44465510|NCT00395733|79474460|FG000|Period 2|Adverse Event|0|||
44465511|NCT00395733|79474461|FG001|Period 2|Adverse Event|2|||
44465512|NCT00395733|79474460|FG000|Period 2|Technical problems|1|||
44465513|NCT00395733|79474461|FG001|Period 2|Technical problems|0|||
44465514|NCT00395343|79474469|FG000|Overall Study|Adverse Event|13|||
44465515|NCT00395343|79474470|FG001|Overall Study|Adverse Event|5|||
44465516|NCT00395343|79474469|FG000|Overall Study|Lack of Efficacy|0|||
44465517|NCT00395343|79474470|FG001|Overall Study|Lack of Efficacy|1|||
44465518|NCT00395343|79474469|FG000|Overall Study|Lost to Follow-up|4|||
44465519|NCT00395343|79474470|FG001|Overall Study|Lost to Follow-up|4|||
44465520|NCT00395343|79474469|FG000|Overall Study|Physician Decision|2|||
44465521|NCT00395343|79474470|FG001|Overall Study|Physician Decision|4|||
44465522|NCT00395343|79474469|FG000|Overall Study|Protocol Violation|6|||
44465523|NCT00395343|79474470|FG001|Overall Study|Protocol Violation|8|||
44465524|NCT00395343|79474469|FG000|Overall Study|Withdrawal by Subject|11|||
44465525|NCT00395343|79474470|FG001|Overall Study|Withdrawal by Subject|12|||
44465526|NCT00395343|79474469|FG000|Overall Study|Other|5|||
44465527|NCT00395343|79474470|FG001|Overall Study|Other|2|||
44465528|NCT00560573|79474476|FG000|Overall Study|Death|4|||
44465529|NCT00560573|79474477|FG001|Overall Study|Death|1|||
44465530|NCT00560573|79474478|FG002|Overall Study|Death|4|||
44465531|NCT00560573|79474479|FG003|Overall Study|Death|5|||
44544292|NCT02918019|79557643|FG002|Overall Study|Physician Decision|2|||
44544293|NCT02918019|79557644|FG003|Overall Study|Physician Decision|0|||
44375018|NCT01136174|79380199|FG002|Overall Study|Adverse Event|0|||
44375019|NCT01136174|79380200|FG003|Overall Study|Adverse Event|4|||
44375020|NCT01135394|79380219|FG000|Screening|Lost to Follow-up|2|||
44375021|NCT01135394|79380219|FG000|Screening|Withdrawal by Subject|10|||
44375022|NCT01135394|79380219|FG000|Screening|Screening failure|16|||
44375023|NCT01135394|79380219|FG000|Screening|Physician Decision|5|||
44375024|NCT01135394|79380219|FG000|Baseline Assessment|Withdrawal by Subject|9|||
44375025|NCT01135394|79380219|FG000|Baseline Assessment|Physician Decision|3|||
44375026|NCT01135394|79380219|FG000|Baseline Assessment|Lost to Follow-up|2|||
44375027|NCT01135394|79380219|FG000|Baseline Assessment|Adverse Event|1|||
44375028|NCT01135394|79380219|FG000|Study Treatment|Withdrawal by Subject|1|||
44375029|NCT01135394|79380219|FG000|Study Treatment|Physician Decision|1|||
44465532|NCT00560573|79474480|FG004|Overall Study|Death|1|||
44375030|NCT01135394|79380219|FG000|Study Treatment|Adverse Event|2|||
44375031|NCT00949884|79380226|FG000|Overall Study|Adverse Event|14|||
44375032|NCT00949884|79380227|FG001|Overall Study|Adverse Event|3|||
44375033|NCT00949884|79380228|FG002|Overall Study|Adverse Event|12|||
44465533|NCT00560573|79474481|FG005|Overall Study|Death|10|||
44465534|NCT00560573|79474476|FG000|Overall Study|Lost to Follow-up|0|||
44465535|NCT00560573|79474477|FG001|Overall Study|Lost to Follow-up|0|||
44465536|NCT00560573|79474478|FG002|Overall Study|Lost to Follow-up|0|||
44465537|NCT00560573|79474479|FG003|Overall Study|Lost to Follow-up|1|||
44465538|NCT00560573|79474480|FG004|Overall Study|Lost to Follow-up|1|||
44465539|NCT00560573|79474481|FG005|Overall Study|Lost to Follow-up|0|||
44465540|NCT00560573|79474476|FG000|Overall Study|Withdrawal by Subject|0|||
44465541|NCT00560573|79474477|FG001|Overall Study|Withdrawal by Subject|0|||
44465542|NCT00560573|79474478|FG002|Overall Study|Withdrawal by Subject|0|||
44465543|NCT00560573|79474479|FG003|Overall Study|Withdrawal by Subject|1|||
44465544|NCT00560573|79474480|FG004|Overall Study|Withdrawal by Subject|1|||
44465545|NCT00560573|79474481|FG005|Overall Study|Withdrawal by Subject|0|||
44465546|NCT00560573|79474476|FG000|Overall Study|Other|2|||
44222157|NCT01748552|79025477|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
44465547|NCT00560573|79474477|FG001|Overall Study|Other|2|||
44465548|NCT00560573|79474478|FG002|Overall Study|Other|2|||
44465549|NCT00560573|79474479|FG003|Overall Study|Other|3|||
44465550|NCT00560573|79474480|FG004|Overall Study|Other|3|||
44465551|NCT00560573|79474481|FG005|Overall Study|Other|3|||
44465552|NCT00560573|79474476|FG000|Overall Study|Enrolled, not treated|0|||
44465553|NCT00560573|79474477|FG001|Overall Study|Enrolled, not treated|0|||
44465554|NCT00560573|79474478|FG002|Overall Study|Enrolled, not treated|0|||
44465555|NCT00560573|79474479|FG003|Overall Study|Enrolled, not treated|0|||
44465556|NCT00560573|79474480|FG004|Overall Study|Enrolled, not treated|1|||
44465557|NCT00560573|79474481|FG005|Overall Study|Enrolled, not treated|0|||
44465558|NCT03961529|79474514|FG000|Overall Study|Adverse Event|13|||
44465559|NCT03961529|79474515|FG001|Overall Study|Adverse Event|5|||
44465560|NCT03961529|79474516|FG002|Overall Study|Adverse Event|2|||
44465561|NCT03961529|79474514|FG000|Overall Study|Withdrawal by Subject|17|||
44465562|NCT03961529|79474515|FG001|Overall Study|Withdrawal by Subject|2|||
44465563|NCT03961529|79474516|FG002|Overall Study|Withdrawal by Subject|1|||
44465564|NCT03961529|79474514|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44465565|NCT03961529|79474515|FG001|Overall Study|Withdrawal by parent/guardian|7|||
44465566|NCT03961529|79474516|FG002|Overall Study|Withdrawal by parent/guardian|0|||
44465567|NCT03961529|79474514|FG000|Overall Study|Physician Decision|2|||
44465568|NCT03961529|79474515|FG001|Overall Study|Physician Decision|1|||
44465569|NCT03961529|79474516|FG002|Overall Study|Physician Decision|1|||
44465570|NCT03961529|79474514|FG000|Overall Study|Lost to Follow-up|2|||
44465571|NCT03961529|79474515|FG001|Overall Study|Lost to Follow-up|1|||
44544294|NCT02918019|79557641|FG000|Overall Study|Protocol deviation|1|||
44544295|NCT02918019|79557642|FG001|Overall Study|Protocol deviation|1|||
44222158|NCT01748552|79025478|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
44222159|NCT01748552|79025479|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222160|NCT01748552|79025480|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222161|NCT01748552|79025481|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
44222162|NCT01748162|79025523|FG000|Overall Study|no additional croup episodes to evaluate|2|||
44222163|NCT01748162|79025524|FG001|Overall Study|no additional croup episodes to evaluate|2|||
44222164|NCT01748162|79025523|FG000|Overall Study|participant consented but did not begin|0|||
44222165|NCT01748162|79025524|FG001|Overall Study|participant consented but did not begin|1|||
44222166|NCT01748162|79025523|FG000|Overall Study|reasons not available|3|||
44222167|NCT01748162|79025524|FG001|Overall Study|reasons not available|2|||
44222168|NCT01724216|79025530|FG000|Overall Study|Scan was not completed|1|||
44222169|NCT01723904|79025534|FG000|Overall Study|Noncompliant|3|||
44222170|NCT01723904|79025534|FG000|Overall Study|Adverse Event|5|||
44222171|NCT01723904|79025534|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
44222172|NCT01747772|79025538|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
44222173|NCT01830127|79025548|FG000|Overall Study|Adverse Event|1|||
44375034|NCT00949884|79380226|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
44375035|NCT00949884|79380227|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
44375036|NCT00949884|79380228|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
44375037|NCT00949884|79380226|FG000|Overall Study|Lost to Follow-up|7|||
44375038|NCT00949884|79380227|FG001|Overall Study|Lost to Follow-up|5|||
44375039|NCT00949884|79380228|FG002|Overall Study|Lost to Follow-up|5|||
44375040|NCT00949884|79380226|FG000|Overall Study|Physician Decision|5|||
44375041|NCT00949884|79380227|FG001|Overall Study|Physician Decision|0|||
44375042|NCT00949884|79380228|FG002|Overall Study|Physician Decision|6|||
44465572|NCT03961529|79474516|FG002|Overall Study|Lost to Follow-up|0|||
44465573|NCT03961529|79474514|FG000|Overall Study|Lack of Efficacy|2|||
44465574|NCT03961529|79474515|FG001|Overall Study|Lack of Efficacy|0|||
44465575|NCT03961529|79474516|FG002|Overall Study|Lack of Efficacy|1|||
44465576|NCT03961529|79474514|FG000|Overall Study|Other|6|||
44465577|NCT03961529|79474515|FG001|Overall Study|Other|1|||
44465578|NCT03961529|79474516|FG002|Overall Study|Other|0|||
44465579|NCT00494780|79474526|FG000|Overall Study|Adverse Event|1|||
44465580|NCT00494780|79474527|FG001|Overall Study|Adverse Event|0|||
44465581|NCT00494780|79474526|FG000|Overall Study|Withdrew before Dosed|0|||
44465582|NCT00494780|79474527|FG001|Overall Study|Withdrew before Dosed|1|||
44465583|NCT00494780|79474526|FG000|Overall Study|Progression of Study Disease|7|||
44465584|NCT00494780|79474527|FG001|Overall Study|Progression of Study Disease|8|||
44465585|NCT00494780|79474526|FG000|Overall Study|New Treatment|2|||
44465586|NCT00494780|79474527|FG001|Overall Study|New Treatment|2|||
44465587|NCT00494780|79474526|FG000|Overall Study|Non-compliance|1|||
44465588|NCT00494780|79474527|FG001|Overall Study|Non-compliance|0|||
44465589|NCT00494780|79474526|FG000|Overall Study|Residual Tumour Mass|0|||
44465590|NCT00494780|79474527|FG001|Overall Study|Residual Tumour Mass|1|||
44465591|NCT00494780|79474526|FG000|Overall Study|Insurance Issues|0|||
44465592|NCT00494780|79474527|FG001|Overall Study|Insurance Issues|1|||
44465593|NCT00490022|79474537|FG000|Overall Study|Adverse Event|0|||
44465594|NCT00490022|79474538|FG001|Overall Study|Adverse Event|2|||
44465595|NCT00490022|79474537|FG000|Overall Study|Withdrawal by Subject|1|||
44465596|NCT00490022|79474538|FG001|Overall Study|Withdrawal by Subject|0|||
44465597|NCT00490022|79474537|FG000|Overall Study|Subject failed to disclose concommitant|0|||
44465598|NCT00490022|79474538|FG001|Overall Study|Subject failed to disclose concommitant|1|||
44465599|NCT00493454|79474544|FG000|Overall Study|Withdrawal by Subject|1|||
44465600|NCT00493220|79474554|FG000|Third Intervention|Withdrawal by Subject|1|||
44465601|NCT00493220|79474555|FG001|Third Intervention|Withdrawal by Subject|0|||
44465602|NCT00493220|79474556|FG002|Third Intervention|Withdrawal by Subject|0|||
44465603|NCT00493220|79474557|FG003|Third Intervention|Withdrawal by Subject|0|||
44465604|NCT00493220|79474558|FG004|Third Intervention|Withdrawal by Subject|0|||
44465605|NCT00493220|79474559|FG005|Third Intervention|Withdrawal by Subject|0|||
44465606|NCT00394953|79474571|FG000|First Treatment Period|Adverse Event|1|||
44465607|NCT00394953|79474572|FG001|First Treatment Period|Adverse Event|2|||
44465608|NCT00394953|79474571|FG000|First Treatment Period|Death|6|||
44465609|NCT00394953|79474572|FG001|First Treatment Period|Death|7|||
44465610|NCT00394953|79474571|FG000|First Treatment Period|Lack of Efficacy|1|||
44465611|NCT00394953|79474572|FG001|First Treatment Period|Lack of Efficacy|1|||
44465612|NCT00394953|79474571|FG000|First Treatment Period|Withdrawal by Subject|6|||
44465613|NCT00394953|79474572|FG001|First Treatment Period|Withdrawal by Subject|3|||
44465614|NCT00394953|79474571|FG000|First Treatment Period|Lost to Follow-up|0|||
44465615|NCT00394953|79474572|FG001|First Treatment Period|Lost to Follow-up|1|||
44465616|NCT00394953|79474571|FG000|First Treatment Period|Renal transplant|11|||
44465617|NCT00394953|79474572|FG001|First Treatment Period|Renal transplant|7|||
44465618|NCT00394953|79474571|FG000|First Treatment Period|Not defined|4|||
44465619|NCT00394953|79474572|FG001|First Treatment Period|Not defined|1|||
44465620|NCT00394953|79474571|FG000|Second Treatment Period|Adverse Event|2|||
44465621|NCT00394953|79474572|FG001|Second Treatment Period|Adverse Event|5|||
44465622|NCT00394953|79474571|FG000|Second Treatment Period|Death|8|||
44465623|NCT00394953|79474572|FG001|Second Treatment Period|Death|4|||
44465624|NCT00394953|79474571|FG000|Second Treatment Period|Lack of Efficacy|9|||
44465625|NCT00394953|79474572|FG001|Second Treatment Period|Lack of Efficacy|47|||
44465626|NCT00394953|79474571|FG000|Second Treatment Period|Withdrawal by Subject|3|||
44465627|NCT00394953|79474572|FG001|Second Treatment Period|Withdrawal by Subject|3|||
44465628|NCT00394953|79474571|FG000|Second Treatment Period|Lost to Follow-up|0|||
44465629|NCT00394953|79474572|FG001|Second Treatment Period|Lost to Follow-up|1|||
44465630|NCT00394953|79474571|FG000|Second Treatment Period|Renal transplant|4|||
44465631|NCT00394953|79474572|FG001|Second Treatment Period|Renal transplant|6|||
44465632|NCT00394953|79474571|FG000|Second Treatment Period|Not defined|3|||
44465633|NCT00394953|79474572|FG001|Second Treatment Period|Not defined|8|||
44465634|NCT00485732|79474580|FG000|Overall Study|Protocol Violation|1|||
44465635|NCT00485732|79474581|FG001|Overall Study|Protocol Violation|3|||
44465636|NCT00485732|79474580|FG000|Overall Study|Withdrawal by Subject|5|||
44465637|NCT00485732|79474581|FG001|Overall Study|Withdrawal by Subject|4|||
44465638|NCT00485732|79474580|FG000|Overall Study|Lost to Follow-up|2|||
44465639|NCT00485732|79474581|FG001|Overall Study|Lost to Follow-up|2|||
44465640|NCT00489554|79474587|FG000|Overall Study|Adverse Event|2|||
44465641|NCT00489554|79474587|FG000|Overall Study|Withdrawal by Subject|1|||
44465642|NCT00489554|79474587|FG000|Overall Study|Lost to Follow-up|1|||
44465643|NCT00408681|79474591|FG000|Overall Study|Lack of Efficacy|2|||
44465644|NCT00408681|79474591|FG000|Overall Study|Adverse Event|7|||
44465645|NCT00560417|79474598|FG000|Overall Study|Adverse Event|3|||
44465646|NCT00560417|79474599|FG001|Overall Study|Adverse Event|2|||
44465647|NCT00560417|79474598|FG000|Overall Study|Entry Criteria Not Met|1|||
44465648|NCT00560417|79474599|FG001|Overall Study|Entry Criteria Not Met|0|||
44465649|NCT00560417|79474598|FG000|Overall Study|Lost to Follow-up|0|||
44465650|NCT00560417|79474599|FG001|Overall Study|Lost to Follow-up|1|||
44465651|NCT00560417|79474598|FG000|Overall Study|Physician Decision|2|||
44465652|NCT00560417|79474599|FG001|Overall Study|Physician Decision|6|||
44465653|NCT00560417|79474598|FG000|Overall Study|Protocol Violation|6|||
44465654|NCT00560417|79474599|FG001|Overall Study|Protocol Violation|5|||
44465655|NCT00560417|79474598|FG000|Overall Study|Sponsor Decision|2|||
44465656|NCT00560417|79474599|FG001|Overall Study|Sponsor Decision|0|||
44465657|NCT00560417|79474598|FG000|Overall Study|Withdrawal by Subject|3|||
44465658|NCT00560417|79474599|FG001|Overall Study|Withdrawal by Subject|3|||
44465659|NCT03968159|79474612|FG000|Overall Study|Adverse Event|4|||
44465660|NCT03968159|79474613|FG001|Overall Study|Adverse Event|4|||
44465661|NCT03968159|79474612|FG000|Overall Study|Lost to Follow-up|1|||
44465662|NCT03968159|79474613|FG001|Overall Study|Lost to Follow-up|1|||
44465663|NCT03968159|79474612|FG000|Overall Study|Use of prohibited medication|0|||
44465664|NCT03968159|79474613|FG001|Overall Study|Use of prohibited medication|1|||
44465665|NCT03968159|79474612|FG000|Overall Study|Protocol Violation|2|||
44271545|NCT02289690|79202655|FG008|Overall Study|Death|45|||
44271546|NCT02289690|79202656|FG009|Overall Study|Death|41|||
44271547|NCT02289690|79202647|FG000|Overall Study|Sponsor Discontinued Study|0|||
44271548|NCT02289690|79202648|FG001|Overall Study|Sponsor Discontinued Study|0|||
44465666|NCT03968159|79474613|FG001|Overall Study|Protocol Violation|2|||
44465667|NCT03968159|79474612|FG000|Overall Study|Withdrawal by Subject|4|||
44465668|NCT03968159|79474613|FG001|Overall Study|Withdrawal by Subject|6|||
44465669|NCT03968159|79474612|FG000|Overall Study|Lack of Efficacy|0|||
44465670|NCT03968159|79474613|FG001|Overall Study|Lack of Efficacy|1|||
44465671|NCT03968159|79474612|FG000|Overall Study|Not further specified|2|||
44465672|NCT03968159|79474613|FG001|Overall Study|Not further specified|0|||
44465673|NCT03966911|79474621|FG000|Overall Study|Adverse Event|1|||
44465674|NCT03966911|79474622|FG001|Overall Study|Adverse Event|1|||
44465675|NCT03966911|79474621|FG000|Overall Study|Withdrawal by Subject|8|||
44465676|NCT03966911|79474622|FG001|Overall Study|Withdrawal by Subject|2|||
44465677|NCT03966911|79474621|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
44465678|NCT03966911|79474622|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
44465679|NCT03966365|79474632|FG000|Overall Study|Protocol Violation|1|||
44465680|NCT03966365|79474633|FG001|Overall Study|Protocol Violation|0|||
44465681|NCT00375219|79474642|FG000|Overall Study|Failure to achieve a response|16|||
44465682|NCT00375219|79474643|FG001|Overall Study|Failure to achieve a response|2|||
44465683|NCT00375219|79474644|FG002|Overall Study|Failure to achieve a response|0|||
44465684|NCT00375219|79474642|FG000|Overall Study|Adverse Event|8|||
44465685|NCT00375219|79474643|FG001|Overall Study|Adverse Event|2|||
44465686|NCT00375219|79474644|FG002|Overall Study|Adverse Event|1|||
44465687|NCT00375219|79474642|FG000|Overall Study|Protocol Violation|1|||
44465688|NCT00375219|79474643|FG001|Overall Study|Protocol Violation|0|||
44465689|NCT00375219|79474644|FG002|Overall Study|Protocol Violation|1|||
44465690|NCT00375219|79474642|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
44465691|NCT00375219|79474643|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
44465692|NCT00375219|79474644|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
44465693|NCT00375219|79474642|FG000|Overall Study|Lost to Follow-up|1|||
44465694|NCT00375219|79474643|FG001|Overall Study|Lost to Follow-up|1|||
44465695|NCT00375219|79474644|FG002|Overall Study|Lost to Follow-up|0|||
44465696|NCT00375219|79474642|FG000|Overall Study|Disease progression|18|||
44465697|NCT00375219|79474643|FG001|Overall Study|Disease progression|9|||
44465698|NCT00375219|79474644|FG002|Overall Study|Disease progression|12|||
44375043|NCT00949884|79380226|FG000|Overall Study|Treatment non-compliance|5|||
44465699|NCT00375219|79474642|FG000|Overall Study|Death|4|||
44465700|NCT00375219|79474643|FG001|Overall Study|Death|3|||
44271549|NCT02289690|79202649|FG002|Overall Study|Sponsor Discontinued Study|0|||
44375044|NCT00949884|79380227|FG001|Overall Study|Treatment non-compliance|0|||
44375045|NCT00949884|79380228|FG002|Overall Study|Treatment non-compliance|8|||
44375046|NCT00949884|79380226|FG000|Overall Study|Withdrawal by Subject|13|||
44375047|NCT00949884|79380227|FG001|Overall Study|Withdrawal by Subject|4|||
44375048|NCT00949884|79380228|FG002|Overall Study|Withdrawal by Subject|16|||
44375049|NCT00949884|79380226|FG000|Overall Study|Lack of Efficacy|4|||
44375050|NCT00949884|79380227|FG001|Overall Study|Lack of Efficacy|2|||
44375051|NCT00949884|79380228|FG002|Overall Study|Lack of Efficacy|7|||
44375052|NCT00949884|79380226|FG000|Overall Study|Study terminated by sponsor|0|||
44465701|NCT00375219|79474644|FG002|Overall Study|Death|7|||
44465702|NCT00375219|79474642|FG000|Overall Study|Hematologic resistance|1|||
44465703|NCT00375219|79474643|FG001|Overall Study|Hematologic resistance|0|||
44465704|NCT00375219|79474644|FG002|Overall Study|Hematologic resistance|0|||
44465705|NCT00375219|79474642|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
44465706|NCT00375219|79474643|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
44465707|NCT00375219|79474644|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
44465708|NCT00375219|79474642|FG000|Overall Study|Allograft|2|||
44465709|NCT00375219|79474643|FG001|Overall Study|Allograft|0|||
44465710|NCT00375219|79474644|FG002|Overall Study|Allograft|0|||
44465711|NCT00375219|79474642|FG000|Overall Study|Cord blood transplantation|1|||
44465712|NCT00375219|79474643|FG001|Overall Study|Cord blood transplantation|0|||
44465713|NCT00375219|79474644|FG002|Overall Study|Cord blood transplantation|0|||
44271550|NCT02289690|79202650|FG003|Overall Study|Sponsor Discontinued Study|0|||
44271551|NCT02289690|79202651|FG004|Overall Study|Sponsor Discontinued Study|0|||
44271552|NCT02289690|79202652|FG005|Overall Study|Sponsor Discontinued Study|0|||
44271553|NCT02289690|79202653|FG006|Overall Study|Sponsor Discontinued Study|0|||
44271554|NCT02289690|79202654|FG007|Overall Study|Sponsor Discontinued Study|9|||
44271555|NCT02289690|79202655|FG008|Overall Study|Sponsor Discontinued Study|7|||
44271556|NCT02289690|79202656|FG009|Overall Study|Sponsor Discontinued Study|15|||
44271557|NCT02289690|79202647|FG000|Overall Study|Other|0|||
44271558|NCT02289690|79202648|FG001|Overall Study|Other|0|||
44271559|NCT02289690|79202649|FG002|Overall Study|Other|0|||
44271560|NCT02289690|79202650|FG003|Overall Study|Other|1|||
44271561|NCT02289690|79202651|FG004|Overall Study|Other|1|||
44465714|NCT00375219|79474642|FG000|Overall Study|Withdrawal by Subject|1|||
44465715|NCT00375219|79474643|FG001|Overall Study|Withdrawal by Subject|0|||
44465716|NCT00375219|79474644|FG002|Overall Study|Withdrawal by Subject|0|||
44465717|NCT03965351|79474653|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
44465718|NCT03965351|79474654|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
44465719|NCT03965351|79474653|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
44465720|NCT03965351|79474654|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
44465721|NCT00554801|79474662|FG000|Overall Study|left area before completion|5|||
44465722|NCT00554801|79474663|FG001|Overall Study|left area before completion|0|||
44465723|NCT00554801|79474662|FG000|Overall Study|Withdrawal by Subject|14|||
44465724|NCT00554801|79474663|FG001|Overall Study|Withdrawal by Subject|0|||
44465725|NCT00374907|79474673|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
44465726|NCT00374907|79474674|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
44465727|NCT00374907|79474673|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
44465728|NCT00374907|79474674|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
44465729|NCT00374907|79474673|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
44465730|NCT00374907|79474674|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
44465731|NCT00374907|79474673|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
44222174|NCT01830127|79025549|FG001|Overall Study|Adverse Event|6|||
44222175|NCT01830127|79025548|FG000|Overall Study|Lack of Efficacy|3|||
44222176|NCT01830127|79025549|FG001|Overall Study|Lack of Efficacy|0|||
44222177|NCT01830127|79025548|FG000|Overall Study|Withdrawal by Subject|1|||
44222178|NCT01830127|79025549|FG001|Overall Study|Withdrawal by Subject|1|||
44222179|NCT01830127|79025548|FG000|Overall Study|Other reason not defined above|0|||
44222180|NCT01830127|79025549|FG001|Overall Study|Other reason not defined above|2|||
44222181|NCT01614067|79025557|FG000|Overall Study|Pregnancy|1|||
44222182|NCT01614067|79025558|FG001|Overall Study|Pregnancy|0|||
44271562|NCT02289690|79202652|FG005|Overall Study|Other|0|||
44271563|NCT02289690|79202653|FG006|Overall Study|Other|1|||
44271564|NCT02289690|79202654|FG007|Overall Study|Other|2|||
44271565|NCT02289690|79202655|FG008|Overall Study|Other|3|||
44465732|NCT00374907|79474674|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
44222183|NCT01614067|79025557|FG000|Overall Study|Physician Decision|6|||
44222184|NCT01614067|79025558|FG001|Overall Study|Physician Decision|5|||
44222185|NCT01614067|79025557|FG000|Overall Study|Withdrawal by Subject|0|||
44222186|NCT01614067|79025558|FG001|Overall Study|Withdrawal by Subject|1|||
44222187|NCT01614067|79025557|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
44222188|NCT01614067|79025558|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
44222189|NCT01777490|79025568|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
44222190|NCT01777490|79025569|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
44222191|NCT01777490|79025570|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
44222192|NCT01777490|79025571|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
44514811|NCT03084796|79520625|FG002|Overall Study|Lost to Follow-up|1|||
44222193|NCT01397409|79025593|FG000|Stage 2|Adverse Event|0|||
44222194|NCT01397409|79025594|FG001|Stage 2|Adverse Event|0|||
44222195|NCT01397409|79025595|FG002|Stage 2|Adverse Event|0|||
44222196|NCT01397409|79025596|FG003|Stage 2|Adverse Event|0|||
44222197|NCT01397409|79025597|FG004|Stage 2|Adverse Event|6|||
44271566|NCT02289690|79202656|FG009|Overall Study|Other|1|||
44271567|NCT02289456|79202759|FG000|Induction Period|Death|2|||
44271568|NCT02289456|79202759|FG000|Induction Period|Adverse Event|11|||
44222198|NCT01397409|79025598|FG005|Stage 2|Adverse Event|3|||
44222199|NCT01397409|79025599|FG006|Stage 2|Adverse Event|0|||
44271569|NCT02289456|79202759|FG000|Induction Period|Progressive Disease (PD)|4|||
44222200|NCT01397409|79025600|FG007|Stage 2|Adverse Event|0|||
44271570|NCT02289456|79202759|FG000|Induction Period|Symptomatic Deterioration|4|||
44222201|NCT01397409|79025601|FG008|Stage 2|Adverse Event|0|||
44222202|NCT01397409|79025602|FG009|Stage 2|Adverse Event|0|||
44222203|NCT01397409|79025593|FG000|Stage 2|Personal Reasons|0|||
44222204|NCT01397409|79025594|FG001|Stage 2|Personal Reasons|0|||
44222205|NCT01397409|79025595|FG002|Stage 2|Personal Reasons|0|||
44222206|NCT01397409|79025596|FG003|Stage 2|Personal Reasons|0|||
44222207|NCT01397409|79025597|FG004|Stage 2|Personal Reasons|1|||
44222208|NCT01397409|79025598|FG005|Stage 2|Personal Reasons|0|||
44222209|NCT01397409|79025599|FG006|Stage 2|Personal Reasons|0|||
44222210|NCT01397409|79025600|FG007|Stage 2|Personal Reasons|0|||
44222211|NCT01397409|79025601|FG008|Stage 2|Personal Reasons|0|||
44222212|NCT01397409|79025602|FG009|Stage 2|Personal Reasons|0|||
44222213|NCT01397409|79025593|FG000|Stage 2|Other Miscellaneous Reasons|0|||
44222214|NCT01397409|79025594|FG001|Stage 2|Other Miscellaneous Reasons|0|||
44222215|NCT01397409|79025595|FG002|Stage 2|Other Miscellaneous Reasons|0|||
44271571|NCT02289456|79202759|FG000|Induction Period|Withdrawal by Subject|2|||
44271572|NCT02289456|79202759|FG000|Induction Period|Miscellaneous|1|||
44271573|NCT02289456|79202759|FG000|Monotherapy Period|Death|1|||
44271574|NCT02289456|79202759|FG000|Monotherapy Period|Adverse Event|1|||
44271575|NCT02289456|79202759|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
44271576|NCT02289456|79202759|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
44271577|NCT02289456|79202759|FG000|Monotherapy Period|Withdrawal by Subject|2|||
44271578|NCT02289456|79202759|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
44271579|NCT02289456|79202759|FG000|Monotherapy Period|Miscellaneous|1|||
44271580|NCT02274948|79202808|FG000|Overall Study|Lost to Follow-up|28|||
44271581|NCT02274948|79202809|FG001|Overall Study|Lost to Follow-up|25|||
44271582|NCT02274948|79202808|FG000|Overall Study|Withdrawal by Subject|64|||
44271583|NCT02274948|79202809|FG001|Overall Study|Withdrawal by Subject|58|||
44271584|NCT02274948|79202808|FG000|Overall Study|Stopped on family Practitioner advice|2|||
44271585|NCT02274948|79202809|FG001|Overall Study|Stopped on family Practitioner advice|5|||
44271586|NCT02274948|79202808|FG000|Overall Study|Left the area|4|||
44271587|NCT02274948|79202809|FG001|Overall Study|Left the area|3|||
44271588|NCT02274792|79202825|FG000|Overall Study|Withdrawal by Subject|13|||
44271589|NCT02274792|79202825|FG000|Overall Study|Lost to Follow-up|8|||
44271590|NCT02274792|79202825|FG000|Overall Study|Protocol Specified Criteria|2|||
44271591|NCT02274792|79202825|FG000|Overall Study|Sponsor Decision|2|||
44271592|NCT02274558|79202855|FG000|Overall Study|Adverse Event|2|||
44271593|NCT02274558|79202856|FG001|Overall Study|Adverse Event|4|||
44271594|NCT02274558|79202857|FG002|Overall Study|Adverse Event|2|||
44271595|NCT02274558|79202855|FG000|Overall Study|Non-compliance|2|||
44271596|NCT02274558|79202856|FG001|Overall Study|Non-compliance|1|||
44271597|NCT02274558|79202857|FG002|Overall Study|Non-compliance|0|||
44271598|NCT02274558|79202855|FG000|Overall Study|Withdrawal by Subject|1|||
44271599|NCT02274558|79202856|FG001|Overall Study|Withdrawal by Subject|5|||
44271600|NCT02274558|79202857|FG002|Overall Study|Withdrawal by Subject|4|||
44222216|NCT01397409|79025596|FG003|Stage 2|Other Miscellaneous Reasons|0|||
44222217|NCT01397409|79025597|FG004|Stage 2|Other Miscellaneous Reasons|1|||
44222218|NCT01397409|79025598|FG005|Stage 2|Other Miscellaneous Reasons|1|||
44222219|NCT01397409|79025599|FG006|Stage 2|Other Miscellaneous Reasons|0|||
44222220|NCT01397409|79025600|FG007|Stage 2|Other Miscellaneous Reasons|0|||
44222221|NCT01397409|79025601|FG008|Stage 2|Other Miscellaneous Reasons|0|||
44222222|NCT01397409|79025602|FG009|Stage 2|Other Miscellaneous Reasons|0|||
44222223|NCT01397409|79025593|FG000|Stage 3|Adverse Event|0|||
44222224|NCT01397409|79025594|FG001|Stage 3|Adverse Event|0|||
44222225|NCT01397409|79025595|FG002|Stage 3|Adverse Event|0|||
44222226|NCT01397409|79025596|FG003|Stage 3|Adverse Event|0|||
44222227|NCT01397409|79025597|FG004|Stage 3|Adverse Event|0|||
44222228|NCT01397409|79025598|FG005|Stage 3|Adverse Event|0|||
44271601|NCT02274558|79202855|FG000|Overall Study|Death|0|||
44271602|NCT02274558|79202856|FG001|Overall Study|Death|0|||
44271603|NCT02274558|79202857|FG002|Overall Study|Death|1|||
44271604|NCT02274558|79202855|FG000|Overall Study|Lost to Follow-up|2|||
44271605|NCT02274558|79202856|FG001|Overall Study|Lost to Follow-up|1|||
44271606|NCT02274558|79202857|FG002|Overall Study|Lost to Follow-up|1|||
44544296|NCT02918019|79557643|FG002|Overall Study|Protocol deviation|0|||
44271607|NCT02274558|79202855|FG000|Overall Study|Physician Decision|0|||
44271608|NCT02274558|79202856|FG001|Overall Study|Physician Decision|2|||
44544297|NCT02918019|79557644|FG003|Overall Study|Protocol deviation|2|||
44222229|NCT01397409|79025599|FG006|Stage 3|Adverse Event|0|||
44222230|NCT01397409|79025600|FG007|Stage 3|Adverse Event|1|||
44271609|NCT02274558|79202857|FG002|Overall Study|Physician Decision|1|||
44271610|NCT02287896|79202874|FG000|Second Injection Visit|Withdrawal by Subject|0|||
44544298|NCT02918019|79557641|FG000|Overall Study|Withdrawal by Subject|3|||
44222231|NCT01397409|79025601|FG008|Stage 3|Adverse Event|0|||
44222232|NCT01397409|79025602|FG009|Stage 3|Adverse Event|0|||
44222233|NCT01397409|79025593|FG000|Stage 3|Other Miscellaneous Reasons|0|||
44271611|NCT02287896|79202875|FG001|Second Injection Visit|Withdrawal by Subject|1|||
44222234|NCT01397409|79025594|FG001|Stage 3|Other Miscellaneous Reasons|0|||
44222235|NCT01397409|79025595|FG002|Stage 3|Other Miscellaneous Reasons|0|||
44222236|NCT01397409|79025596|FG003|Stage 3|Other Miscellaneous Reasons|0|||
44222237|NCT01397409|79025597|FG004|Stage 3|Other Miscellaneous Reasons|0|||
44222238|NCT01397409|79025598|FG005|Stage 3|Other Miscellaneous Reasons|0|||
44222239|NCT01397409|79025599|FG006|Stage 3|Other Miscellaneous Reasons|0|||
44222240|NCT01397409|79025600|FG007|Stage 3|Other Miscellaneous Reasons|1|||
44222241|NCT01397409|79025601|FG008|Stage 3|Other Miscellaneous Reasons|0|||
44222242|NCT01397409|79025602|FG009|Stage 3|Other Miscellaneous Reasons|0|||
44222243|NCT01397253|79025627|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
44222244|NCT01397253|79025628|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
44222245|NCT01777334|79025636|FG000|Overall Study|Adverse Event|18|||
44222246|NCT01777334|79025637|FG001|Overall Study|Adverse Event|14|||
44222247|NCT01777334|79025636|FG000|Overall Study|Lack of Efficacy|15|||
44222248|NCT01777334|79025637|FG001|Overall Study|Lack of Efficacy|29|||
44222249|NCT01777334|79025636|FG000|Overall Study|Protocol Violation|3|||
44222250|NCT01777334|79025637|FG001|Overall Study|Protocol Violation|7|||
44222251|NCT01777334|79025636|FG000|Overall Study|Lost to Follow-up|3|||
44222252|NCT01777334|79025637|FG001|Overall Study|Lost to Follow-up|2|||
44222253|NCT01777334|79025636|FG000|Overall Study|Withdrawal by Subject|14|||
44222254|NCT01777334|79025637|FG001|Overall Study|Withdrawal by Subject|11|||
44222255|NCT01383993|79025646|FG000|Overall Study|Adverse Event|1|||
44222256|NCT01383993|79025647|FG001|Overall Study|Adverse Event|1|||
44222257|NCT01383993|79025648|FG002|Overall Study|Adverse Event|0|||
44222258|NCT01383993|79025646|FG000|Overall Study|Withdrawal by Subject|0|||
44222259|NCT01383993|79025647|FG001|Overall Study|Withdrawal by Subject|0|||
44222260|NCT01383993|79025648|FG002|Overall Study|Withdrawal by Subject|1|||
44222261|NCT01383993|79025646|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
44222262|NCT01383993|79025647|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
44222263|NCT01383993|79025648|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
44222264|NCT01396395|79025659|FG000|Overall Study|Withdrawal by Subject|10|||
44222265|NCT01396395|79025660|FG001|Overall Study|Withdrawal by Subject|12|||
44222266|NCT01396395|79025659|FG000|Overall Study|Protocol Violation|3|||
44222267|NCT01396395|79025660|FG001|Overall Study|Protocol Violation|1|||
44222268|NCT01396395|79025659|FG000|Overall Study|Adverse Event|10|||
44222269|NCT01396395|79025660|FG001|Overall Study|Adverse Event|2|||
44222270|NCT01396395|79025659|FG000|Overall Study|Lost to Follow-up|17|||
44222271|NCT01396395|79025660|FG001|Overall Study|Lost to Follow-up|11|||
44465733|NCT00374907|79474673|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
44465734|NCT00374907|79474674|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
44465735|NCT00374127|79474682|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
44465736|NCT00374127|79474682|FG000|Overall Study|Blood could not be drawn.|2|||
44465737|NCT00374127|79474682|FG000|Overall Study|Protocol Violation|5|||
44465738|NCT00374127|79474682|FG000|Overall Study|Pregnancy|1|||
44465739|NCT00553787|79474695|FG000|Overall Study|Adverse Event|34|||
44465740|NCT00553787|79474696|FG001|Overall Study|Adverse Event|21|||
44465741|NCT00553787|79474697|FG002|Overall Study|Adverse Event|67|||
44465742|NCT00553787|79474695|FG000|Overall Study|Lost to Follow-up|132|||
44465743|NCT00553787|79474696|FG001|Overall Study|Lost to Follow-up|44|||
44465744|NCT00553787|79474697|FG002|Overall Study|Lost to Follow-up|78|||
44465745|NCT00553787|79474695|FG000|Overall Study|Withdrawal by Subject|151|||
44465746|NCT00553787|79474696|FG001|Overall Study|Withdrawal by Subject|40|||
44465747|NCT00553787|79474697|FG002|Overall Study|Withdrawal by Subject|83|||
44465748|NCT00553787|79474695|FG000|Overall Study|Lack of Efficacy|31|||
44465749|NCT00553787|79474696|FG001|Overall Study|Lack of Efficacy|1|||
44465750|NCT00553787|79474697|FG002|Overall Study|Lack of Efficacy|3|||
44465751|NCT00553787|79474695|FG000|Overall Study|Pregnancy|0|||
44465752|NCT00553787|79474696|FG001|Overall Study|Pregnancy|1|||
44465753|NCT00553787|79474697|FG002|Overall Study|Pregnancy|2|||
44465754|NCT00553787|79474695|FG000|Overall Study|non compliance|4|||
44465755|NCT00553787|79474696|FG001|Overall Study|non compliance|0|||
44465756|NCT00553787|79474697|FG002|Overall Study|non compliance|11|||
44222272|NCT01396395|79025659|FG000|Overall Study|Other|0|||
44222273|NCT01396395|79025660|FG001|Overall Study|Other|1|||
44222274|NCT01396317|79025670|FG000|Overall Study|Adverse Event|1|||
44465757|NCT00553787|79474695|FG000|Overall Study|Requirement for restricted medication|8|||
44465758|NCT00553787|79474696|FG001|Overall Study|Requirement for restricted medication|7|||
44465759|NCT00553787|79474697|FG002|Overall Study|Requirement for restricted medication|5|||
44544299|NCT02918019|79557642|FG001|Overall Study|Withdrawal by Subject|4|||
44544300|NCT02918019|79557643|FG002|Overall Study|Withdrawal by Subject|6|||
44222275|NCT01396317|79025671|FG001|Overall Study|Adverse Event|0|||
44222276|NCT01396161|79025686|FG000|Overall Study|Withdrawal by Subject|0|||
44222277|NCT01396161|79025687|FG001|Overall Study|Withdrawal by Subject|0|||
44222278|NCT01396161|79025688|FG002|Overall Study|Withdrawal by Subject|0|||
44222279|NCT01396161|79025689|FG003|Overall Study|Withdrawal by Subject|0|||
44222280|NCT01396161|79025690|FG004|Overall Study|Withdrawal by Subject|1|||
44222281|NCT01396161|79025691|FG005|Overall Study|Withdrawal by Subject|0|||
44222282|NCT01396161|79025692|FG006|Overall Study|Withdrawal by Subject|0|||
44465760|NCT00553787|79474695|FG000|Overall Study|Other|18|||
44544301|NCT02918019|79557644|FG003|Overall Study|Withdrawal by Subject|4|||
44271612|NCT00553501|79202933|FG000|Overall Study|Adverse Event|2|||
44271613|NCT00553501|79202933|FG000|Overall Study|Death|1|||
44271614|NCT00553501|79202933|FG000|Overall Study|Progression|1|||
44271615|NCT02287584|79202961|FG000|the Double-blind Phase|Adverse Event|17|||
44271616|NCT02287584|79202962|FG001|the Double-blind Phase|Adverse Event|17|||
44271617|NCT02287584|79202963|FG002|the Double-blind Phase|Adverse Event|12|||
44271618|NCT02287584|79202964|FG003|the Double-blind Phase|Adverse Event|0|||
44271619|NCT02287584|79202965|FG004|the Double-blind Phase|Adverse Event|0|||
44271620|NCT02287584|79202966|FG005|the Double-blind Phase|Adverse Event|0|||
44271621|NCT02287584|79202961|FG000|the Double-blind Phase|Lack of Efficacy|18|||
44271622|NCT02287584|79202962|FG001|the Double-blind Phase|Lack of Efficacy|8|||
44271623|NCT02287584|79202963|FG002|the Double-blind Phase|Lack of Efficacy|8|||
44271624|NCT02287584|79202964|FG003|the Double-blind Phase|Lack of Efficacy|0|||
44271625|NCT02287584|79202965|FG004|the Double-blind Phase|Lack of Efficacy|0|||
44271626|NCT02287584|79202966|FG005|the Double-blind Phase|Lack of Efficacy|0|||
44271627|NCT02287584|79202961|FG000|the Double-blind Phase|Lost to Follow-up|0|||
44271628|NCT02287584|79202962|FG001|the Double-blind Phase|Lost to Follow-up|1|||
44271629|NCT02287584|79202963|FG002|the Double-blind Phase|Lost to Follow-up|1|||
44271630|NCT02287584|79202964|FG003|the Double-blind Phase|Lost to Follow-up|0|||
44271631|NCT02287584|79202965|FG004|the Double-blind Phase|Lost to Follow-up|0|||
44271632|NCT02287584|79202966|FG005|the Double-blind Phase|Lost to Follow-up|0|||
44271633|NCT02287584|79202961|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
44271634|NCT02287584|79202962|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
44271635|NCT02287584|79202963|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
44271636|NCT02287584|79202964|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
44271637|NCT02287584|79202965|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
44271638|NCT02287584|79202966|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
44271639|NCT02287584|79202961|FG000|the Double-blind Phase|Pregnancy|0|||
44271640|NCT02287584|79202962|FG001|the Double-blind Phase|Pregnancy|1|||
44271641|NCT02287584|79202963|FG002|the Double-blind Phase|Pregnancy|0|||
44465761|NCT00553787|79474696|FG001|Overall Study|Other|10|||
44465762|NCT00553787|79474697|FG002|Overall Study|Other|13|||
44465763|NCT00407745|79474707|FG000|Overall Study|Lack of Efficacy|1|||
44465764|NCT00407745|79474708|FG001|Overall Study|Lack of Efficacy|2|||
44465765|NCT00407745|79474707|FG000|Overall Study|Withdrawal by Subject|3|||
44465766|NCT00407745|79474708|FG001|Overall Study|Withdrawal by Subject|3|||
44465767|NCT00407745|79474707|FG000|Overall Study|Protocol Violation|5|||
44465768|NCT00407745|79474708|FG001|Overall Study|Protocol Violation|3|||
44465769|NCT00407745|79474707|FG000|Overall Study|Adverse Event|8|||
44465770|NCT00407745|79474708|FG001|Overall Study|Adverse Event|8|||
44465771|NCT00407745|79474707|FG000|Overall Study|Other|2|||
44465772|NCT00407745|79474708|FG001|Overall Study|Other|0|||
44222283|NCT01396161|79025686|FG000|Overall Study|Other|0|||
44222284|NCT01396161|79025687|FG001|Overall Study|Other|0|||
44222285|NCT01396161|79025688|FG002|Overall Study|Other|0|||
44222286|NCT01396161|79025689|FG003|Overall Study|Other|0|||
44222287|NCT01396161|79025690|FG004|Overall Study|Other|0|||
44222288|NCT01396161|79025691|FG005|Overall Study|Other|0|||
44222289|NCT01396161|79025692|FG006|Overall Study|Other|1|||
44222290|NCT01396083|79025715|FG000|Overall Study|Adverse Event|2|||
44222291|NCT01396083|79025716|FG001|Overall Study|Adverse Event|28|||
44222292|NCT01396083|79025715|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44222293|NCT01396083|79025716|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
44271642|NCT02287584|79202964|FG003|the Double-blind Phase|Pregnancy|0|||
44271643|NCT02287584|79202965|FG004|the Double-blind Phase|Pregnancy|0|||
44375053|NCT00949884|79380227|FG001|Overall Study|Study terminated by sponsor|0|||
44375054|NCT00949884|79380228|FG002|Overall Study|Study terminated by sponsor|1|||
44375055|NCT00949650|79380239|FG000|Overall Study|Progressive disease|188|||
44375056|NCT00949650|79380240|FG001|Overall Study|Progressive disease|19|||
44375057|NCT00949650|79380239|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
44375058|NCT00949650|79380240|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
44375059|NCT00949650|79380239|FG000|Overall Study|Other Adverse Event (AE)|28|||
44375060|NCT00949650|79380240|FG001|Overall Study|Other Adverse Event (AE)|17|||
44375061|NCT00949650|79380239|FG000|Overall Study|Protocol Violation|1|||
44375062|NCT00949650|79380240|FG001|Overall Study|Protocol Violation|4|||
44375063|NCT00949650|79380239|FG000|Overall Study|Refusal to continue medication|7|||
44375064|NCT00949650|79380240|FG001|Overall Study|Refusal to continue medication|11|||
44375065|NCT00949650|79380239|FG000|Overall Study|Not treated|1|||
44465773|NCT00407745|79474707|FG000|Overall Study|Randomized, unknown if treated|0|||
44465774|NCT00407745|79474708|FG001|Overall Study|Randomized, unknown if treated|1|||
44222294|NCT01396083|79025715|FG000|Overall Study|Consent withdrawn|4|||
44271644|NCT02287584|79202966|FG005|the Double-blind Phase|Pregnancy|0|||
44271645|NCT02287584|79202961|FG000|the Double-blind Phase|Protocol Violation|0|||
44271646|NCT02287584|79202962|FG001|the Double-blind Phase|Protocol Violation|3|||
44271647|NCT02287584|79202963|FG002|the Double-blind Phase|Protocol Violation|0|||
44465775|NCT03958955|79474714|FG000|Overall Study|Adverse Event|1|||
44465776|NCT00464334|79474731|FG000|Overall Study|Adverse Event|0|||
44222295|NCT01396083|79025716|FG001|Overall Study|Consent withdrawn|5|||
44222296|NCT01396083|79025715|FG000|Overall Study|Protocol deviation(s)|0|||
44222297|NCT01396083|79025716|FG001|Overall Study|Protocol deviation(s)|1|||
44222298|NCT01396083|79025715|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44222299|NCT01396083|79025716|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44222300|NCT01396083|79025715|FG000|Overall Study|Administrative problems|1|||
44222301|NCT01396083|79025716|FG001|Overall Study|Administrative problems|0|||
44222302|NCT01396083|79025715|FG000|Overall Study|Lost to Follow-up|1|||
44222303|NCT01396083|79025716|FG001|Overall Study|Lost to Follow-up|0|||
44222304|NCT01723826|79025726|FG000|Overall Study|Adverse Event|4|||
44271648|NCT02287584|79202964|FG003|the Double-blind Phase|Protocol Violation|0|||
44271649|NCT02287584|79202965|FG004|the Double-blind Phase|Protocol Violation|0|||
44271650|NCT02287584|79202966|FG005|the Double-blind Phase|Protocol Violation|0|||
44271651|NCT02287584|79202961|FG000|the Double-blind Phase|other reasons|0|||
44271652|NCT02287584|79202962|FG001|the Double-blind Phase|other reasons|0|||
44271653|NCT02287584|79202963|FG002|the Double-blind Phase|other reasons|1|||
44271654|NCT02287584|79202964|FG003|the Double-blind Phase|other reasons|0|||
44271655|NCT02287584|79202965|FG004|the Double-blind Phase|other reasons|0|||
44271656|NCT02287584|79202966|FG005|the Double-blind Phase|other reasons|0|||
44271657|NCT02287584|79202961|FG000|the Open-label Phase|Did not receive drug|0|||
44271658|NCT02287584|79202962|FG001|the Open-label Phase|Did not receive drug|0|||
44271659|NCT02287584|79202963|FG002|the Open-label Phase|Did not receive drug|0|||
44271660|NCT02287584|79202964|FG003|the Open-label Phase|Did not receive drug|7|||
44271661|NCT02287584|79202965|FG004|the Open-label Phase|Did not receive drug|6|||
44271662|NCT02287584|79202966|FG005|the Open-label Phase|Did not receive drug|4|||
44271663|NCT02287584|79202961|FG000|the Open-label Phase|Adverse Event|0|||
44271664|NCT02287584|79202962|FG001|the Open-label Phase|Adverse Event|0|||
44271665|NCT02287584|79202963|FG002|the Open-label Phase|Adverse Event|0|||
44271666|NCT02287584|79202964|FG003|the Open-label Phase|Adverse Event|15|||
44271667|NCT02287584|79202965|FG004|the Open-label Phase|Adverse Event|12|||
44271668|NCT02287584|79202966|FG005|the Open-label Phase|Adverse Event|16|||
44271669|NCT02287584|79202961|FG000|the Open-label Phase|Lack of Efficacy|0|||
44271670|NCT02287584|79202962|FG001|the Open-label Phase|Lack of Efficacy|0|||
44271671|NCT02287584|79202963|FG002|the Open-label Phase|Lack of Efficacy|0|||
44271672|NCT02287584|79202964|FG003|the Open-label Phase|Lack of Efficacy|8|||
44271673|NCT02287584|79202965|FG004|the Open-label Phase|Lack of Efficacy|3|||
44271674|NCT02287584|79202966|FG005|the Open-label Phase|Lack of Efficacy|7|||
44271675|NCT02287584|79202961|FG000|the Open-label Phase|Lost to Follow-up|0|||
44271676|NCT02287584|79202962|FG001|the Open-label Phase|Lost to Follow-up|0|||
44271677|NCT02287584|79202963|FG002|the Open-label Phase|Lost to Follow-up|0|||
44271678|NCT02287584|79202964|FG003|the Open-label Phase|Lost to Follow-up|4|||
44271679|NCT02287584|79202965|FG004|the Open-label Phase|Lost to Follow-up|1|||
44271680|NCT02287584|79202966|FG005|the Open-label Phase|Lost to Follow-up|2|||
44271681|NCT02287584|79202961|FG000|the Open-label Phase|Withdrawal by Subject|0|||
44271682|NCT02287584|79202962|FG001|the Open-label Phase|Withdrawal by Subject|0|||
44271683|NCT02287584|79202963|FG002|the Open-label Phase|Withdrawal by Subject|0|||
44271684|NCT02287584|79202964|FG003|the Open-label Phase|Withdrawal by Subject|18|||
44271685|NCT02287584|79202965|FG004|the Open-label Phase|Withdrawal by Subject|29|||
44222305|NCT01723826|79025727|FG001|Overall Study|Adverse Event|1|||
44271686|NCT02287584|79202966|FG005|the Open-label Phase|Withdrawal by Subject|21|||
44375066|NCT00949650|79380240|FG001|Overall Study|Not treated|4|||
44271687|NCT02287584|79202961|FG000|the Open-label Phase|non-compliance|0|||
44271688|NCT02287584|79202962|FG001|the Open-label Phase|non-compliance|0|||
44271689|NCT02287584|79202963|FG002|the Open-label Phase|non-compliance|0|||
44222306|NCT01723826|79025728|FG002|Overall Study|Adverse Event|4|||
44222307|NCT01723826|79025729|FG003|Overall Study|Adverse Event|5|||
44222308|NCT01723826|79025726|FG000|Overall Study|Death according to AE eCRF|2|||
44222309|NCT01723826|79025727|FG001|Overall Study|Death according to AE eCRF|3|||
44222310|NCT01723826|79025728|FG002|Overall Study|Death according to AE eCRF|3|||
44271690|NCT02287584|79202964|FG003|the Open-label Phase|non-compliance|2|||
44271691|NCT02287584|79202965|FG004|the Open-label Phase|non-compliance|5|||
44271692|NCT02287584|79202966|FG005|the Open-label Phase|non-compliance|1|||
44271693|NCT02287584|79202961|FG000|the Open-label Phase|other reasons|0|||
44271694|NCT02287584|79202962|FG001|the Open-label Phase|other reasons|0|||
44271695|NCT02287584|79202963|FG002|the Open-label Phase|other reasons|0|||
44271696|NCT02287584|79202964|FG003|the Open-label Phase|other reasons|3|||
44271697|NCT02287584|79202965|FG004|the Open-label Phase|other reasons|6|||
44271698|NCT02287584|79202966|FG005|the Open-label Phase|other reasons|6|||
44271699|NCT00553267|79202999|FG000|Overall Study|Adverse Event|8|||
44271700|NCT00553267|79203000|FG001|Overall Study|Adverse Event|10|||
44271701|NCT00553267|79203001|FG002|Overall Study|Adverse Event|5|||
44271702|NCT00553267|79202999|FG000|Overall Study|Non compliant with protocol|3|||
44271703|NCT00553267|79203000|FG001|Overall Study|Non compliant with protocol|3|||
44271704|NCT00553267|79203001|FG002|Overall Study|Non compliant with protocol|2|||
44271705|NCT00553267|79202999|FG000|Overall Study|Lost to Follow-up|0|||
44271706|NCT00553267|79203000|FG001|Overall Study|Lost to Follow-up|0|||
44271707|NCT00553267|79203001|FG002|Overall Study|Lost to Follow-up|1|||
44271708|NCT00553267|79202999|FG000|Overall Study|Consent withdrawn|2|||
44271709|NCT00553267|79203000|FG001|Overall Study|Consent withdrawn|3|||
44271710|NCT00553267|79203001|FG002|Overall Study|Consent withdrawn|1|||
44271711|NCT00553267|79202999|FG000|Overall Study|Specified category|1|||
44271712|NCT00553267|79203000|FG001|Overall Study|Specified category|2|||
44271713|NCT00553267|79203001|FG002|Overall Study|Specified category|1|||
44271714|NCT02271984|79203015|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271715|NCT02271984|79203016|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271716|NCT02271984|79203017|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271717|NCT02271984|79203018|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271718|NCT02271984|79203019|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271719|NCT02271984|79203020|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
44271720|NCT02271984|79203021|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44222311|NCT01723826|79025729|FG003|Overall Study|Death according to AE eCRF|7|||
44222312|NCT01723826|79025726|FG000|Overall Study|Lost to Follow-up|1|||
44222313|NCT01723826|79025727|FG001|Overall Study|Lost to Follow-up|3|||
44222314|NCT01723826|79025728|FG002|Overall Study|Lost to Follow-up|1|||
44222315|NCT01723826|79025729|FG003|Overall Study|Lost to Follow-up|1|||
44222316|NCT01723826|79025726|FG000|Overall Study|Non-compliance|0|||
44222317|NCT01723826|79025727|FG001|Overall Study|Non-compliance|1|||
44222318|NCT01723826|79025728|FG002|Overall Study|Non-compliance|3|||
44271721|NCT02271984|79203022|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
44271722|NCT02271984|79203023|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271723|NCT02271984|79203024|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271724|NCT02271984|79203025|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271725|NCT02271984|79203026|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44271726|NCT02287038|79203077|FG000|Overall Study|Stopped attending appointments|3|||
44271727|NCT02287038|79203078|FG001|Overall Study|Stopped attending appointments|2|||
44271728|NCT02287038|79203077|FG000|Overall Study|Anxiety after starting medication|0|||
44271729|NCT02287038|79203078|FG001|Overall Study|Anxiety after starting medication|1|||
44271730|NCT02287038|79203077|FG000|Overall Study|Nausea after starting medication|1|||
44465777|NCT00464334|79474732|FG001|Overall Study|Adverse Event|0|||
44222319|NCT01723826|79025729|FG003|Overall Study|Non-compliance|3|||
44222320|NCT01723826|79025726|FG000|Overall Study|Non-compliance With Study Drug|0|||
44222321|NCT01723826|79025727|FG001|Overall Study|Non-compliance With Study Drug|1|||
44271731|NCT02287038|79203078|FG001|Overall Study|Nausea after starting medication|0|||
44271732|NCT02287038|79203077|FG000|Overall Study|Abnormal ECG after starting medication|1|||
44271733|NCT02287038|79203078|FG001|Overall Study|Abnormal ECG after starting medication|0|||
44271734|NCT02286960|79203088|FG000|Overall Study|Lost to Follow-up|3|||
44222322|NCT01723826|79025728|FG002|Overall Study|Non-compliance With Study Drug|0|||
44222323|NCT01723826|79025729|FG003|Overall Study|Non-compliance With Study Drug|0|||
44222324|NCT01723826|79025726|FG000|Overall Study|Other Reason|8|||
44271735|NCT02286960|79203089|FG001|Overall Study|Lost to Follow-up|3|||
44271736|NCT02286102|79203106|FG000|Overall Study|Screen Failure|1|||
44271737|NCT02286102|79203107|FG001|Overall Study|Screen Failure|1|||
44271738|NCT02285166|79203113|FG000|Overall Study|Case Report Forms Uncollected|564|||
44271739|NCT02285166|79203113|FG000|Overall Study|Protocol Deviation|402|||
44271740|NCT00555061|79203176|FG000|Overall Study|Adverse Event|3|||
44271741|NCT00555061|79203176|FG000|Overall Study|Protocol Violation|1|||
44271742|NCT00555061|79203176|FG000|Overall Study|Lost to Follow-up|2|||
44271743|NCT00555061|79203176|FG000|Overall Study|Withdrawal by Subject|2|||
44271744|NCT00555061|79203176|FG000|Overall Study|Participant enrolled, but never treated|1|||
44271745|NCT01642212|79203194|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
44271746|NCT01642212|79203195|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
44271747|NCT01642212|79203196|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
44271748|NCT01642212|79203197|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
44271749|NCT01642212|79203198|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
44271750|NCT01642212|79203194|FG000|Double-blind Treatment|Other|0|||
44271751|NCT01642212|79203195|FG001|Double-blind Treatment|Other|2|||
44271752|NCT01642212|79203196|FG002|Double-blind Treatment|Other|1|||
44271753|NCT01642212|79203197|FG003|Double-blind Treatment|Other|0|||
44271754|NCT01642212|79203198|FG004|Double-blind Treatment|Other|0|||
44271755|NCT01642212|79203194|FG000|Double-blind Treatment|Non-compliance|0|||
44271756|NCT01642212|79203195|FG001|Double-blind Treatment|Non-compliance|1|||
44271757|NCT01642212|79203196|FG002|Double-blind Treatment|Non-compliance|0|||
44271758|NCT01642212|79203197|FG003|Double-blind Treatment|Non-compliance|0|||
44271759|NCT01642212|79203198|FG004|Double-blind Treatment|Non-compliance|0|||
44271760|NCT01642212|79203194|FG000|Double-blind Treatment|Adverse Event|0|||
44271761|NCT01642212|79203195|FG001|Double-blind Treatment|Adverse Event|0|||
44271762|NCT01642212|79203196|FG002|Double-blind Treatment|Adverse Event|1|||
44271763|NCT01642212|79203197|FG003|Double-blind Treatment|Adverse Event|0|||
44271764|NCT01642212|79203198|FG004|Double-blind Treatment|Adverse Event|0|||
44222325|NCT01723826|79025727|FG001|Overall Study|Other Reason|6|||
44222326|NCT01723826|79025728|FG002|Overall Study|Other Reason|12|||
44222327|NCT01723826|79025729|FG003|Overall Study|Other Reason|14|||
44222328|NCT01723826|79025726|FG000|Overall Study|Physician Decision|1|||
44222329|NCT01723826|79025727|FG001|Overall Study|Physician Decision|3|||
44222330|NCT01723826|79025728|FG002|Overall Study|Physician Decision|4|||
44222331|NCT01723826|79025729|FG003|Overall Study|Physician Decision|11|||
44222332|NCT01723826|79025726|FG000|Overall Study|Protocol Violation|1|||
44465778|NCT00464334|79474733|FG002|Overall Study|Adverse Event|0|||
44465779|NCT00464334|79474734|FG003|Overall Study|Adverse Event|1|||
44465780|NCT00464334|79474735|FG004|Overall Study|Adverse Event|1|||
44465781|NCT00464334|79474736|FG005|Overall Study|Adverse Event|1|||
44465782|NCT00464334|79474737|FG006|Overall Study|Adverse Event|0|||
44222333|NCT01723826|79025727|FG001|Overall Study|Protocol Violation|1|||
44222334|NCT01723826|79025728|FG002|Overall Study|Protocol Violation|3|||
44222335|NCT01723826|79025729|FG003|Overall Study|Protocol Violation|1|||
44271765|NCT01642212|79203194|FG000|Open-label Extension|Adverse Event|0|||
44271766|NCT01642212|79203195|FG001|Open-label Extension|Adverse Event|0|||
44271767|NCT01642212|79203196|FG002|Open-label Extension|Adverse Event|0|||
44271768|NCT01642212|79203197|FG003|Open-label Extension|Adverse Event|3|||
44271769|NCT01642212|79203198|FG004|Open-label Extension|Adverse Event|0|||
44271770|NCT01642212|79203194|FG000|Open-label Extension|Sponsor Decision|0|||
44271771|NCT01642212|79203195|FG001|Open-label Extension|Sponsor Decision|0|||
44271772|NCT01642212|79203196|FG002|Open-label Extension|Sponsor Decision|0|||
44271773|NCT01642212|79203197|FG003|Open-label Extension|Sponsor Decision|7|||
44271774|NCT01642212|79203198|FG004|Open-label Extension|Sponsor Decision|4|||
44222336|NCT01723826|79025726|FG000|Overall Study|Withdrawal by Subject|10|||
44222337|NCT01723826|79025727|FG001|Overall Study|Withdrawal by Subject|17|||
44222338|NCT01723826|79025728|FG002|Overall Study|Withdrawal by Subject|27|||
44271775|NCT01642212|79203194|FG000|Open-label Extension|Consent Withdrawn|0|||
44271776|NCT01642212|79203195|FG001|Open-label Extension|Consent Withdrawn|0|||
44271777|NCT01642212|79203196|FG002|Open-label Extension|Consent Withdrawn|0|||
44271778|NCT01642212|79203197|FG003|Open-label Extension|Consent Withdrawn|0|||
44465783|NCT00464334|79474738|FG007|Overall Study|Adverse Event|0|||
44465784|NCT00464334|79474739|FG008|Overall Study|Adverse Event|2|||
44222339|NCT01723826|79025729|FG003|Overall Study|Withdrawal by Subject|48|||
44222340|NCT01721954|79025741|FG000|Overall Study|Death|58|||
44222341|NCT01721954|79025742|FG001|Overall Study|Death|64|||
44222342|NCT01721954|79025741|FG000|Overall Study|Withdrawal by Subject|8|||
44271779|NCT01642212|79203198|FG004|Open-label Extension|Consent Withdrawn|2|||
44222343|NCT01721954|79025742|FG001|Overall Study|Withdrawal by Subject|4|||
44222344|NCT01721954|79025741|FG000|Overall Study|Adverse Event|2|||
44222345|NCT01721954|79025742|FG001|Overall Study|Adverse Event|0|||
44222346|NCT01721954|79025741|FG000|Overall Study|Lost to Follow-up|2|||
44222347|NCT01721954|79025742|FG001|Overall Study|Lost to Follow-up|1|||
44222348|NCT01776554|79025750|FG000|Overall Study|Adverse Event|1|||
44222349|NCT01776554|79025751|FG001|Overall Study|Adverse Event|0|||
44222350|NCT01776554|79025750|FG000|Overall Study|Withdrawal by Subject|3|||
44222351|NCT01776554|79025751|FG001|Overall Study|Withdrawal by Subject|8|||
44222352|NCT01776554|79025750|FG000|Overall Study|Lost to Follow-up|6|||
44222353|NCT01776554|79025751|FG001|Overall Study|Lost to Follow-up|9|||
44222354|NCT01776554|79025750|FG000|Overall Study|Administrative Reason|2|||
44222355|NCT01776554|79025751|FG001|Overall Study|Administrative Reason|5|||
44222356|NCT01776554|79025750|FG000|Overall Study|Protocol Violation|1|||
44222357|NCT01776554|79025751|FG001|Overall Study|Protocol Violation|0|||
44222358|NCT01776554|79025750|FG000|Overall Study|Unclassified|4|||
44222359|NCT01776554|79025751|FG001|Overall Study|Unclassified|1|||
44222360|NCT01776008|79025758|FG000|Overall Study|ineligible|2|||
44222361|NCT01746368|79025764|FG000|Overall Study|Lost to Follow-up|2|||
44222362|NCT01746368|79025765|FG001|Overall Study|Lost to Follow-up|0|||
44222363|NCT01746368|79025764|FG000|Overall Study|Withdrawal by Subject|0|||
44222364|NCT01746368|79025765|FG001|Overall Study|Withdrawal by Subject|1|||
44222365|NCT01381575|79025774|FG000|Overall Study|Serious Adverse Event|1|||
44222366|NCT01381575|79025775|FG001|Overall Study|Serious Adverse Event|0|||
44222367|NCT01381575|79025776|FG002|Overall Study|Serious Adverse Event|0|||
44222368|NCT01381575|79025774|FG000|Overall Study|Non-Serious Adverse Event|0|||
44222369|NCT01381575|79025775|FG001|Overall Study|Non-Serious Adverse Event|0|||
44222370|NCT01381575|79025776|FG002|Overall Study|Non-Serious Adverse Event|1|||
44222371|NCT01381575|79025774|FG000|Overall Study|Protocol Violation|0|||
44222372|NCT01381575|79025775|FG001|Overall Study|Protocol Violation|1|||
44222373|NCT01381575|79025776|FG002|Overall Study|Protocol Violation|1|||
44222374|NCT01381575|79025774|FG000|Overall Study|Withdrawal by Subject|15|||
44222375|NCT01381575|79025775|FG001|Overall Study|Withdrawal by Subject|9|||
44222376|NCT01381575|79025776|FG002|Overall Study|Withdrawal by Subject|7|||
44222377|NCT01381575|79025774|FG000|Overall Study|Migrated/moved from study area|2|||
44222378|NCT01381575|79025775|FG001|Overall Study|Migrated/moved from study area|12|||
44222379|NCT01381575|79025776|FG002|Overall Study|Migrated/moved from study area|2|||
44222380|NCT01381575|79025774|FG000|Overall Study|Lost to Follow-up|8|||
44222381|NCT01381575|79025775|FG001|Overall Study|Lost to Follow-up|17|||
44222382|NCT01381575|79025776|FG002|Overall Study|Lost to Follow-up|9|||
44222383|NCT01858363|79025787|FG000|Overall Study|Death|35|||
44222384|NCT01858363|79025788|FG001|Overall Study|Death|9|||
44222385|NCT01858363|79025787|FG000|Overall Study|Withdrawal by Subject|28|||
44222386|NCT01858363|79025788|FG001|Overall Study|Withdrawal by Subject|14|||
44222387|NCT01858363|79025787|FG000|Overall Study|Lost to Follow-up|13|||
44222388|NCT01858363|79025788|FG001|Overall Study|Lost to Follow-up|3|||
44222389|NCT01877551|79025796|FG000|Overall Study|Physician Decision|0|||
44222390|NCT01877551|79025797|FG001|Overall Study|Physician Decision|1|||
44222391|NCT01396005|79025805|FG000|Overall Study|Withdrawal by Subject|0|||
44222392|NCT01396005|79025806|FG001|Overall Study|Withdrawal by Subject|1|||
44222393|NCT01396005|79025805|FG000|Overall Study|Non-compliance with protocol|0|||
44222394|NCT01396005|79025806|FG001|Overall Study|Non-compliance with protocol|1|||
44222395|NCT01877239|79025814|FG000|Overall Study|Adverse Event|4|||
44222396|NCT01877239|79025814|FG000|Overall Study|Disease Remission|1|||
44222397|NCT01877239|79025814|FG000|Overall Study|Withdrawal by Subject|4|||
44222398|NCT01877239|79025814|FG000|Overall Study|Other|2|||
44222399|NCT01877239|79025814|FG000|Overall Study|Lack of Efficacy|4|||
44222400|NCT01877239|79025814|FG000|Overall Study|Data not available|35|||
44222401|NCT01877083|79025818|FG000|Treatment Phase|Disease Progression|10|||
44222402|NCT01877083|79025818|FG000|Treatment Phase|Clinical Progression|1|||
44222403|NCT01877083|79025818|FG000|Treatment Phase|Adverse Event|6|||
44222404|NCT01877083|79025818|FG000|Treatment Phase|Withdrawal by Subject|2|||
44222405|NCT01877083|79025818|FG000|Treatment Phase|Lost to Follow-up|1|||
44222406|NCT01877083|79025818|FG000|Extension Phase|Disease Progression|3|||
44222407|NCT01877083|79025818|FG000|Extension Phase|Adverse Event|2|||
44222408|NCT01380327|79025825|FG000|Overall Study|Lost to Follow-up|0|||
44222409|NCT01380327|79025826|FG001|Overall Study|Lost to Follow-up|1|||
44222410|NCT01380327|79025827|FG002|Overall Study|Lost to Follow-up|1|||
44222411|NCT01380327|79025825|FG000|Overall Study|Protocol Violation|3|||
44222412|NCT01380327|79025826|FG001|Overall Study|Protocol Violation|2|||
44222413|NCT01380327|79025827|FG002|Overall Study|Protocol Violation|3|||
44222414|NCT01380327|79025825|FG000|Overall Study|Withdrawal by Subject|0|||
44222415|NCT01380327|79025826|FG001|Overall Study|Withdrawal by Subject|0|||
44222416|NCT01380327|79025827|FG002|Overall Study|Withdrawal by Subject|1|||
44222417|NCT01380327|79025825|FG000|Overall Study|Housing situation precluded ability to k|0|||
44222418|NCT01380327|79025826|FG001|Overall Study|Housing situation precluded ability to k|0|||
44271780|NCT01642212|79203194|FG000|Open-label Extension|Lost to Follow-up|0|||
44271781|NCT01642212|79203195|FG001|Open-label Extension|Lost to Follow-up|0|||
44271782|NCT01642212|79203196|FG002|Open-label Extension|Lost to Follow-up|0|||
44271783|NCT01642212|79203197|FG003|Open-label Extension|Lost to Follow-up|0|||
44271784|NCT01642212|79203198|FG004|Open-label Extension|Lost to Follow-up|1|||
44271785|NCT01642212|79203194|FG000|Open-label Extension|Other|0|||
44271786|NCT01642212|79203195|FG001|Open-label Extension|Other|0|||
44271787|NCT01642212|79203196|FG002|Open-label Extension|Other|0|||
44271788|NCT01642212|79203197|FG003|Open-label Extension|Other|0|||
44271789|NCT01642212|79203198|FG004|Open-label Extension|Other|1|||
44271790|NCT00552175|79203223|FG000|Overall Study|Lack of Efficacy|2|||
44271791|NCT00552175|79203224|FG001|Overall Study|Lack of Efficacy|0|||
44271792|NCT00552175|79203225|FG002|Overall Study|Lack of Efficacy|1|||
44271793|NCT00552175|79203223|FG000|Overall Study|Adverse Event|9|||
44271794|NCT00552175|79203224|FG001|Overall Study|Adverse Event|9|||
44271795|NCT00552175|79203225|FG002|Overall Study|Adverse Event|10|||
44271796|NCT00552175|79203223|FG000|Overall Study|Withdrawal by Subject|2|||
44271797|NCT00552175|79203224|FG001|Overall Study|Withdrawal by Subject|2|||
44271798|NCT00552175|79203225|FG002|Overall Study|Withdrawal by Subject|1|||
44271799|NCT00552175|79203223|FG000|Overall Study|Lost to Follow-up|0|||
44271800|NCT00552175|79203224|FG001|Overall Study|Lost to Follow-up|0|||
44271801|NCT00552175|79203225|FG002|Overall Study|Lost to Follow-up|1|||
44271802|NCT00552175|79203223|FG000|Overall Study|Entry Criteria Not Met|1|||
44271803|NCT00552175|79203224|FG001|Overall Study|Entry Criteria Not Met|1|||
44271804|NCT00552175|79203225|FG002|Overall Study|Entry Criteria Not Met|0|||
44271805|NCT00552175|79203223|FG000|Overall Study|Reason Not Specified|3|||
44271806|NCT00552175|79203224|FG001|Overall Study|Reason Not Specified|1|||
44271807|NCT00552175|79203225|FG002|Overall Study|Reason Not Specified|1|||
44271808|NCT01644474|79203236|FG000|Overall Study|Poor compliance to protocol|1|||
44271809|NCT01644474|79203237|FG001|Overall Study|Poor compliance to protocol|0|||
44271810|NCT01644474|79203236|FG000|Overall Study|Consent withdrawn by participant|0|||
44271811|NCT01644474|79203237|FG001|Overall Study|Consent withdrawn by participant|1|||
44271812|NCT01644474|79203236|FG000|Overall Study|Participant moved|0|||
44271813|NCT01644474|79203237|FG001|Overall Study|Participant moved|1|||
44271814|NCT01644474|79203236|FG000|Overall Study|Adverse Event|4|||
44271815|NCT01644474|79203237|FG001|Overall Study|Adverse Event|5|||
44271816|NCT01644474|79203236|FG000|Overall Study|Site scheduling error|1|||
44271817|NCT01644474|79203237|FG001|Overall Study|Site scheduling error|1|||
44271818|NCT01644474|79203236|FG000|Overall Study|Protocol Violation|1|||
44271819|NCT01644474|79203237|FG001|Overall Study|Protocol Violation|0|||
44271820|NCT02285010|79203272|FG000|Overall Study|not abdominal hysterectomy|2|||
44271821|NCT02285010|79203273|FG001|Overall Study|not abdominal hysterectomy|0|||
44465785|NCT00464334|79474740|FG009|Overall Study|Adverse Event|1|||
44465786|NCT00464334|79474741|FG010|Overall Study|Adverse Event|2|||
44465787|NCT00464334|79474731|FG000|Overall Study|Lack of Efficacy|0|||
44465788|NCT00464334|79474732|FG001|Overall Study|Lack of Efficacy|1|||
44465789|NCT00464334|79474733|FG002|Overall Study|Lack of Efficacy|0|||
44465790|NCT00464334|79474734|FG003|Overall Study|Lack of Efficacy|0|||
44465791|NCT00464334|79474735|FG004|Overall Study|Lack of Efficacy|0|||
44465792|NCT00464334|79474736|FG005|Overall Study|Lack of Efficacy|0|||
44465793|NCT00464334|79474737|FG006|Overall Study|Lack of Efficacy|0|||
44465794|NCT00464334|79474738|FG007|Overall Study|Lack of Efficacy|0|||
44222419|NCT01380327|79025827|FG002|Overall Study|Housing situation precluded ability to k|1|||
44222420|NCT01380327|79025825|FG000|Overall Study|Questionable onset of epilepsy|0|||
44222421|NCT01380327|79025826|FG001|Overall Study|Questionable onset of epilepsy|0|||
44222422|NCT01380327|79025827|FG002|Overall Study|Questionable onset of epilepsy|1|||
44222423|NCT01829425|79025837|FG000|Overall Study|Withdrawal by Subject|4|||
44222424|NCT01829425|79025838|FG001|Overall Study|Withdrawal by Subject|3|||
44222425|NCT01829425|79025837|FG000|Overall Study|Lost to Follow-up|2|||
44222426|NCT01829425|79025838|FG001|Overall Study|Lost to Follow-up|1|||
44222427|NCT01394991|79025855|FG000|Overall Study|Adverse Event|0|||
44222428|NCT01394991|79025856|FG001|Overall Study|Adverse Event|4|||
44465795|NCT00464334|79474739|FG008|Overall Study|Lack of Efficacy|0|||
44222429|NCT01394991|79025855|FG000|Overall Study|Lack of Efficacy|5|||
44271822|NCT02285010|79203272|FG000|Overall Study|Not spinal anesthesia|3|||
44271823|NCT02285010|79203273|FG001|Overall Study|Not spinal anesthesia|1|||
44465796|NCT00464334|79474740|FG009|Overall Study|Lack of Efficacy|0|||
44271824|NCT00551161|79203317|FG000|Overall Study|Withdrawal by Subject|1|||
44271825|NCT00550771|79203353|FG000|Overall Study|Adverse Event|11|||
44271826|NCT00550771|79203354|FG001|Overall Study|Adverse Event|3|||
44465797|NCT00464334|79474741|FG010|Overall Study|Lack of Efficacy|0|||
44465798|NCT00464334|79474731|FG000|Overall Study|Lost to Follow-up|0|||
44222430|NCT01394991|79025856|FG001|Overall Study|Lack of Efficacy|7|||
44271827|NCT00550771|79203353|FG000|Overall Study|Discontinued for study-related reasons|0|||
44271828|NCT00550771|79203354|FG001|Overall Study|Discontinued for study-related reasons|1|||
44465799|NCT00464334|79474732|FG001|Overall Study|Lost to Follow-up|0|||
44465800|NCT00464334|79474733|FG002|Overall Study|Lost to Follow-up|1|||
44222431|NCT01394991|79025855|FG000|Overall Study|Lost to Follow-up|6|||
44271829|NCT00550771|79203353|FG000|Overall Study|Physician Decision|2|||
44271830|NCT00550771|79203354|FG001|Overall Study|Physician Decision|0|||
44271831|NCT00550771|79203353|FG000|Overall Study|Withdrawal by Subject|0|||
44271832|NCT00550771|79203354|FG001|Overall Study|Withdrawal by Subject|1|||
44271833|NCT00550771|79203353|FG000|Overall Study|Protocol Violation|4|||
44271834|NCT00550771|79203354|FG001|Overall Study|Protocol Violation|5|||
44271835|NCT00550537|79203387|FG000|Overall Study|Death|18|||
44271836|NCT00550537|79203387|FG000|Overall Study|Adverse Event|20|||
44271837|NCT00550537|79203387|FG000|Overall Study|Disease progression before|46|||
44271838|NCT00550537|79203387|FG000|Overall Study|Withdrawal by Subject|7|||
44271839|NCT00550537|79203387|FG000|Overall Study|Change in treatment plan|4|||
44271840|NCT00550537|79203387|FG000|Overall Study|Other complicating ilness|3|||
44271841|NCT00550537|79203387|FG000|Overall Study|Declining performance status|2|||
44271842|NCT00550537|79203387|FG000|Overall Study|Treated closer to home|4|||
44271843|NCT00550147|79203405|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
44271844|NCT00550147|79203405|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
44271845|NCT00550147|79203405|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
44271846|NCT00550147|79203405|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
44271847|NCT00550147|79203405|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
44271848|NCT00550459|79203616|FG000|Overall Study|Adverse Event|0|||
44271849|NCT00550459|79203617|FG001|Overall Study|Adverse Event|2|||
44271850|NCT00550459|79203616|FG000|Overall Study|Withdrawal by Subject|1|||
44271851|NCT00550459|79203617|FG001|Overall Study|Withdrawal by Subject|1|||
44271852|NCT02823145|79203652|FG000|Enrollment|Other|1|||
44271853|NCT02823145|79203653|FG001|Enrollment|Other|0|||
44271854|NCT02823145|79203652|FG000|Treatment|Adverse Event|0|||
44271855|NCT02823145|79203653|FG001|Treatment|Adverse Event|11|||
44271856|NCT02823145|79203652|FG000|Treatment|Death|0|||
44271857|NCT02823145|79203653|FG001|Treatment|Death|3|||
44271858|NCT02823145|79203652|FG000|Treatment|Family Decision|0|||
44271859|NCT02823145|79203653|FG001|Treatment|Family Decision|1|||
44271860|NCT02823145|79203652|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
44271861|NCT02823145|79203653|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
44271862|NCT02823145|79203652|FG000|Treatment|Lack of Efficacy|0|||
44271863|NCT02823145|79203653|FG001|Treatment|Lack of Efficacy|48|||
44271864|NCT02823145|79203652|FG000|Treatment|Non-Compliance With E-Diary|0|||
44271865|NCT02823145|79203653|FG001|Treatment|Non-Compliance With E-Diary|1|||
44271866|NCT02823145|79203652|FG000|Treatment|Physician Decision|0|||
44271867|NCT02823145|79203653|FG001|Treatment|Physician Decision|2|||
44271868|NCT02823145|79203652|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
44271869|NCT02823145|79203653|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
44465801|NCT00464334|79474734|FG003|Overall Study|Lost to Follow-up|0|||
44465802|NCT00464334|79474735|FG004|Overall Study|Lost to Follow-up|1|||
44375067|NCT00949650|79380239|FG000|Overall Study|Other not specified above|5|||
44375068|NCT00949650|79380240|FG001|Overall Study|Other not specified above|0|||
44375069|NCT00908037|79380257|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44465803|NCT00464334|79474736|FG005|Overall Study|Lost to Follow-up|0|||
44222432|NCT01394991|79025856|FG001|Overall Study|Lost to Follow-up|8|||
44222433|NCT01394991|79025855|FG000|Overall Study|Physician Decision|1|||
44222434|NCT01394991|79025856|FG001|Overall Study|Physician Decision|3|||
44222435|NCT01394991|79025855|FG000|Overall Study|Protocol Violation|1|||
44222436|NCT01394991|79025856|FG001|Overall Study|Protocol Violation|1|||
44222437|NCT01394991|79025855|FG000|Overall Study|Withdrawal by Subject|20|||
44222438|NCT01394991|79025856|FG001|Overall Study|Withdrawal by Subject|17|||
44222439|NCT01394991|79025855|FG000|Overall Study|Chemotherapy Termination|10|||
44222440|NCT01394991|79025856|FG001|Overall Study|Chemotherapy Termination|15|||
44222441|NCT01394991|79025855|FG000|Overall Study|Disease Progression|7|||
44222442|NCT01394991|79025856|FG001|Overall Study|Disease Progression|7|||
44222443|NCT01394991|79025855|FG000|Overall Study|Prematurely Termination of Trial|9|||
44222444|NCT01394991|79025856|FG001|Overall Study|Prematurely Termination of Trial|10|||
44222445|NCT01829347|79025864|FG000|VTI-210|Death|5|||
44222446|NCT01829347|79025865|FG001|VTI-210|Death|3|||
44222447|NCT01829347|79025864|FG000|VTI-210|Withdrawal by Subject|1|||
44271870|NCT02823145|79203652|FG000|Treatment|Subject needed to take prohibited medication|0|||
44271871|NCT02823145|79203653|FG001|Treatment|Subject needed to take prohibited medication|1|||
44271872|NCT02823145|79203652|FG000|Treatment|Subject transferred to direct access programme|0|||
44271873|NCT02823145|79203653|FG001|Treatment|Subject transferred to direct access programme|1|||
44271874|NCT02823145|79203652|FG000|Treatment|Switching to commercially available drug|0|||
44271875|NCT02823145|79203653|FG001|Treatment|Switching to commercially available drug|11|||
44375070|NCT00908037|79380258|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44465804|NCT00464334|79474737|FG006|Overall Study|Lost to Follow-up|1|||
44271876|NCT02823145|79203652|FG000|Treatment|Transitioned to commercial supply of medication|0|||
44222448|NCT01829347|79025865|FG001|VTI-210|Withdrawal by Subject|0|||
44222449|NCT01829347|79025864|FG000|VTI-210E|Death|2|||
44222450|NCT01829347|79025865|FG001|VTI-210E|Death|1|||
44222451|NCT01829347|79025864|FG000|VTI-210E|Study terminated prematurely|1|||
44271877|NCT02823145|79203653|FG001|Treatment|Transitioned to commercial supply of medication|1|||
44271878|NCT02823145|79203652|FG000|Treatment|Withdrawal By Caregiver|0|||
44271879|NCT02823145|79203653|FG001|Treatment|Withdrawal By Caregiver|1|||
44271880|NCT02823145|79203652|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
44271881|NCT02823145|79203653|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
44271882|NCT02823145|79203652|FG000|Treatment|Withdrawal by Subject|0|||
44271883|NCT02823145|79203653|FG001|Treatment|Withdrawal by Subject|16|||
44271884|NCT02823145|79203652|FG000|Treatment|Reason unknown|0|||
44271885|NCT02823145|79203653|FG001|Treatment|Reason unknown|1|||
44271886|NCT01643928|79203917|FG000|Overall Study|Lost to Follow-up|1|||
44271887|NCT01643928|79203918|FG001|Overall Study|Lost to Follow-up|0|||
44271888|NCT01643928|79203919|FG002|Overall Study|Lost to Follow-up|2|||
44271889|NCT01643928|79203920|FG003|Overall Study|Lost to Follow-up|0|||
44271890|NCT01643928|79203921|FG004|Overall Study|Lost to Follow-up|0|||
44271891|NCT01643928|79203917|FG000|Overall Study|Withdrawal by Subject|2|||
44271892|NCT01643928|79203918|FG001|Overall Study|Withdrawal by Subject|0|||
44271893|NCT01643928|79203919|FG002|Overall Study|Withdrawal by Subject|0|||
44271894|NCT01643928|79203920|FG003|Overall Study|Withdrawal by Subject|1|||
44271895|NCT01643928|79203921|FG004|Overall Study|Withdrawal by Subject|0|||
44271896|NCT01643928|79203917|FG000|Overall Study|Pregnancy|0|||
44271897|NCT01643928|79203918|FG001|Overall Study|Pregnancy|0|||
44222452|NCT01829347|79025865|FG001|VTI-210E|Study terminated prematurely|5|||
44222453|NCT01394523|79025874|FG000|Overall Study|Unable to place block|1|||
44222454|NCT01394523|79025875|FG001|Overall Study|Unable to place block|0|||
44222455|NCT01394523|79025876|FG002|Overall Study|Unable to place block|0|||
44222456|NCT01857973|79025884|FG000|Overall Study|Subject did not meet required BG range|3|||
44222457|NCT01857973|79025884|FG000|Overall Study|drop out after 3 failed attempts|1|||
44222458|NCT01857973|79025884|FG000|Overall Study|Physician Decision|1|||
44222459|NCT01857583|79025892|FG000|Overall Study|Adverse Event|0|||
44222460|NCT01857583|79025893|FG001|Overall Study|Adverse Event|0|||
44222461|NCT01857583|79025894|FG002|Overall Study|Adverse Event|1|||
44222462|NCT01857583|79025895|FG003|Overall Study|Adverse Event|1|||
44222463|NCT01857583|79025892|FG000|Overall Study|Death|0|||
44222464|NCT01857583|79025893|FG001|Overall Study|Death|1|||
44222465|NCT01857583|79025894|FG002|Overall Study|Death|1|||
44222466|NCT01857583|79025895|FG003|Overall Study|Death|0|||
44222467|NCT01857583|79025892|FG000|Overall Study|Physician Decision|0|||
44271898|NCT01643928|79203919|FG002|Overall Study|Pregnancy|0|||
44271899|NCT01643928|79203920|FG003|Overall Study|Pregnancy|1|||
44271900|NCT01643928|79203921|FG004|Overall Study|Pregnancy|0|||
44271901|NCT01643928|79203917|FG000|Overall Study|Other|5|||
44465805|NCT00464334|79474738|FG007|Overall Study|Lost to Follow-up|0|||
44465806|NCT00464334|79474739|FG008|Overall Study|Lost to Follow-up|0|||
44465807|NCT00464334|79474740|FG009|Overall Study|Lost to Follow-up|0|||
44465808|NCT00464334|79474741|FG010|Overall Study|Lost to Follow-up|2|||
44465809|NCT00464334|79474731|FG000|Overall Study|Progressive Disease|0|||
44465810|NCT00464334|79474732|FG001|Overall Study|Progressive Disease|0|||
44465811|NCT00464334|79474733|FG002|Overall Study|Progressive Disease|0|||
44465812|NCT00464334|79474734|FG003|Overall Study|Progressive Disease|0|||
44465813|NCT00464334|79474735|FG004|Overall Study|Progressive Disease|0|||
44465814|NCT00464334|79474736|FG005|Overall Study|Progressive Disease|1|||
44465815|NCT00464334|79474737|FG006|Overall Study|Progressive Disease|0|||
44465816|NCT00464334|79474738|FG007|Overall Study|Progressive Disease|0|||
44465817|NCT00464334|79474739|FG008|Overall Study|Progressive Disease|1|||
44465818|NCT00464334|79474740|FG009|Overall Study|Progressive Disease|0|||
44465819|NCT00464334|79474741|FG010|Overall Study|Progressive Disease|0|||
44465820|NCT00464334|79474731|FG000|Overall Study|Study Terminated by Sponsor|0|||
44271902|NCT01643928|79203918|FG001|Overall Study|Other|1|||
44465821|NCT00464334|79474732|FG001|Overall Study|Study Terminated by Sponsor|0|||
44465822|NCT00464334|79474733|FG002|Overall Study|Study Terminated by Sponsor|0|||
44465823|NCT00464334|79474734|FG003|Overall Study|Study Terminated by Sponsor|1|||
44465824|NCT00464334|79474735|FG004|Overall Study|Study Terminated by Sponsor|0|||
44271903|NCT01643928|79203919|FG002|Overall Study|Other|1|||
44271904|NCT01643928|79203920|FG003|Overall Study|Other|0|||
44465825|NCT00464334|79474736|FG005|Overall Study|Study Terminated by Sponsor|0|||
44465826|NCT00464334|79474737|FG006|Overall Study|Study Terminated by Sponsor|0|||
44465827|NCT00464334|79474738|FG007|Overall Study|Study Terminated by Sponsor|0|||
44222468|NCT01857583|79025893|FG001|Overall Study|Physician Decision|0|||
44222469|NCT01857583|79025894|FG002|Overall Study|Physician Decision|0|||
44465828|NCT00464334|79474739|FG008|Overall Study|Study Terminated by Sponsor|0|||
44271905|NCT01643928|79203921|FG004|Overall Study|Other|0|||
44271906|NCT01643928|79203917|FG000|Overall Study|Adverse Event|2|||
44465829|NCT00464334|79474740|FG009|Overall Study|Study Terminated by Sponsor|0|||
44271907|NCT01643928|79203918|FG001|Overall Study|Adverse Event|1|||
44271908|NCT01643928|79203919|FG002|Overall Study|Adverse Event|0|||
44271909|NCT01643928|79203920|FG003|Overall Study|Adverse Event|1|||
44465830|NCT00464334|79474741|FG010|Overall Study|Study Terminated by Sponsor|0|||
44222470|NCT01857583|79025895|FG003|Overall Study|Physician Decision|1|||
44222471|NCT01857583|79025892|FG000|Overall Study|Withdrawal by Subject|1|||
44465831|NCT00464334|79474731|FG000|Overall Study|Withdrawal by Subject|1|||
44271910|NCT01643928|79203921|FG004|Overall Study|Adverse Event|2|||
44271911|NCT03237845|79204132|FG000|Overall Study|Adverse Event|0|||
44271912|NCT03237845|79204133|FG001|Overall Study|Adverse Event|1|||
44271913|NCT03237845|79204132|FG000|Overall Study|Lost to Follow-up|13|||
44271914|NCT03237845|79204133|FG001|Overall Study|Lost to Follow-up|10|||
44271915|NCT03237845|79204132|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
44271916|NCT03237845|79204133|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
44271917|NCT03237845|79204132|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
44222472|NCT01857583|79025893|FG001|Overall Study|Withdrawal by Subject|0|||
44222473|NCT01857583|79025894|FG002|Overall Study|Withdrawal by Subject|1|||
44222474|NCT01857583|79025895|FG003|Overall Study|Withdrawal by Subject|2|||
44222475|NCT01829191|79025907|FG000|Overall Study|Relocation|0|||
44222476|NCT01829191|79025908|FG001|Overall Study|Relocation|1|||
44222477|NCT01829191|79025907|FG000|Overall Study|Lens discomfort|0|||
44271918|NCT03237845|79204133|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
44271919|NCT03237845|79204132|FG000|Overall Study|Physician Decision|1|||
44271920|NCT03237845|79204133|FG001|Overall Study|Physician Decision|2|||
44271921|NCT03237845|79204132|FG000|Overall Study|Pregnancy|1|||
44271922|NCT03237845|79204133|FG001|Overall Study|Pregnancy|0|||
44271923|NCT03237845|79204132|FG000|Overall Study|Protocol Deviation|0|||
44271924|NCT03237845|79204133|FG001|Overall Study|Protocol Deviation|1|||
44271925|NCT03237845|79204132|FG000|Overall Study|Technical Problems|8|||
44271926|NCT03237845|79204133|FG001|Overall Study|Technical Problems|1|||
44271927|NCT03237845|79204132|FG000|Overall Study|Withdrawal by Subject|3|||
44375071|NCT00908037|79380259|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44375072|NCT00908037|79380260|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44222478|NCT01829191|79025908|FG001|Overall Study|Lens discomfort|3|||
44222479|NCT01829191|79025907|FG000|Overall Study|Lens handling difficulty|1|||
44222480|NCT01829191|79025908|FG001|Overall Study|Lens handling difficulty|4|||
44222481|NCT01829191|79025907|FG000|Overall Study|Protocol Violation|4|||
44222482|NCT01829191|79025908|FG001|Overall Study|Protocol Violation|1|||
44222483|NCT01829191|79025907|FG000|Overall Study|Withdrawal by Subject|2|||
44222484|NCT01829191|79025908|FG001|Overall Study|Withdrawal by Subject|3|||
44222485|NCT01829191|79025907|FG000|Overall Study|Lost to Follow-up|0|||
44222486|NCT01829191|79025908|FG001|Overall Study|Lost to Follow-up|1|||
44222487|NCT01829191|79025907|FG000|Overall Study|Subject was fit for ortho - k|0|||
44222488|NCT01829191|79025908|FG001|Overall Study|Subject was fit for ortho - k|1|||
44222489|NCT00211185|79025913|FG000|Overall Study|Death|2|||
44222490|NCT00211185|79025913|FG000|Overall Study|Disease progression|7|||
44222491|NCT00211185|79025913|FG000|Overall Study|Withdrawal by Subject|6|||
44222492|NCT00211185|79025913|FG000|Overall Study|Physician Decision|5|||
44222493|NCT00210639|79025919|FG000|Overall Study|Lost to Follow-up|37|||
44222494|NCT00210639|79025920|FG001|Overall Study|Lost to Follow-up|29|||
44222495|NCT00210639|79025919|FG000|Overall Study|Withdrawal by Subject|8|||
44222496|NCT00210639|79025920|FG001|Overall Study|Withdrawal by Subject|1|||
44271928|NCT03237845|79204133|FG001|Overall Study|Withdrawal by Subject|3|||
44271929|NCT03237845|79204132|FG000|Overall Study|Other Reasons|4|||
44271930|NCT03237845|79204133|FG001|Overall Study|Other Reasons|0|||
44271931|NCT01643850|79204220|FG000|Overall Study|Withdrawal by Subject|0|||
44375073|NCT00908037|79380261|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
44375074|NCT00908037|79380262|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44375075|NCT00908037|79380263|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
44375076|NCT00908037|79380264|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44375077|NCT00908037|79380265|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
44375078|NCT00908037|79380266|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44375079|NCT00908037|79380267|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44375080|NCT00908037|79380268|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
44375081|NCT00908037|79380257|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375082|NCT00908037|79380258|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375083|NCT00908037|79380259|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375084|NCT00908037|79380260|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375085|NCT00908037|79380261|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
44375086|NCT00908037|79380262|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375087|NCT00908037|79380263|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44465832|NCT00464334|79474732|FG001|Overall Study|Withdrawal by Subject|7|||
44271932|NCT01643850|79204221|FG001|Overall Study|Withdrawal by Subject|0|||
44271933|NCT01643850|79204222|FG002|Overall Study|Withdrawal by Subject|0|||
44277806|NCT02092350|79238806|FG000|Overall Study|Protocol Violation|1|||
44222497|NCT00210639|79025919|FG000|Overall Study|Other|18|||
44222498|NCT00210639|79025920|FG001|Overall Study|Other|12|||
44271934|NCT01643850|79204223|FG003|Overall Study|Withdrawal by Subject|0|||
44271935|NCT01643850|79204224|FG004|Overall Study|Withdrawal by Subject|1|||
44271936|NCT01643850|79204225|FG005|Overall Study|Withdrawal by Subject|0|||
44465833|NCT00464334|79474733|FG002|Overall Study|Withdrawal by Subject|4|||
44465834|NCT00464334|79474734|FG003|Overall Study|Withdrawal by Subject|2|||
44465835|NCT00464334|79474735|FG004|Overall Study|Withdrawal by Subject|2|||
44222499|NCT01829113|79025928|FG000|Overall Study|Disease Progression|37|||
44465836|NCT00464334|79474736|FG005|Overall Study|Withdrawal by Subject|2|||
44465837|NCT00464334|79474737|FG006|Overall Study|Withdrawal by Subject|2|||
44465838|NCT00464334|79474738|FG007|Overall Study|Withdrawal by Subject|1|||
44465839|NCT00464334|79474739|FG008|Overall Study|Withdrawal by Subject|3|||
44465840|NCT00464334|79474740|FG009|Overall Study|Withdrawal by Subject|0|||
44465841|NCT00464334|79474741|FG010|Overall Study|Withdrawal by Subject|0|||
44465842|NCT00299494|79474782|FG000|Overall Study|Withdrawal by Subject|0|||
44465843|NCT00299494|79474783|FG001|Overall Study|Withdrawal by Subject|0|||
44465844|NCT00299494|79474784|FG002|Overall Study|Withdrawal by Subject|0|||
44465845|NCT00299494|79474785|FG003|Overall Study|Withdrawal by Subject|3|||
44465846|NCT00299494|79474786|FG004|Overall Study|Withdrawal by Subject|1|||
44465847|NCT00299494|79474787|FG005|Overall Study|Withdrawal by Subject|4|||
44465848|NCT00299494|79474782|FG000|Overall Study|Physician Decision|0|||
44465849|NCT00299494|79474783|FG001|Overall Study|Physician Decision|0|||
44465850|NCT00299494|79474784|FG002|Overall Study|Physician Decision|0|||
44465851|NCT00299494|79474785|FG003|Overall Study|Physician Decision|0|||
44465852|NCT00299494|79474786|FG004|Overall Study|Physician Decision|1|||
44465853|NCT00299494|79474787|FG005|Overall Study|Physician Decision|0|||
44465854|NCT00299494|79474782|FG000|Overall Study|Death|3|||
44465855|NCT00299494|79474783|FG001|Overall Study|Death|1|||
44465856|NCT00299494|79474784|FG002|Overall Study|Death|4|||
44465857|NCT00299494|79474785|FG003|Overall Study|Death|6|||
44465858|NCT00299494|79474786|FG004|Overall Study|Death|18|||
44465859|NCT00299494|79474787|FG005|Overall Study|Death|19|||
44465860|NCT00299494|79474782|FG000|Overall Study|Lost to Follow-up|0|||
44222500|NCT01829113|79025929|FG001|Overall Study|Disease Progression|48|||
44222501|NCT01829113|79025928|FG000|Overall Study|Adverse Event|14|||
44465861|NCT00299494|79474783|FG001|Overall Study|Lost to Follow-up|0|||
44465862|NCT00299494|79474784|FG002|Overall Study|Lost to Follow-up|0|||
44222502|NCT01829113|79025929|FG001|Overall Study|Adverse Event|10|||
44222503|NCT01829113|79025928|FG000|Overall Study|Withdrawal by Subject|17|||
44222504|NCT01829113|79025929|FG001|Overall Study|Withdrawal by Subject|10|||
44222505|NCT01829113|79025928|FG000|Overall Study|Death|4|||
44222506|NCT01829113|79025929|FG001|Overall Study|Death|6|||
44222507|NCT01829113|79025928|FG000|Overall Study|Sponsor Decision|1|||
44222508|NCT01829113|79025929|FG001|Overall Study|Sponsor Decision|1|||
44222509|NCT01829113|79025928|FG000|Overall Study|No Study Treatment Received|3|||
44222510|NCT01829113|79025929|FG001|Overall Study|No Study Treatment Received|2|||
44222511|NCT01829113|79025928|FG000|Overall Study|Physician Decision|1|||
44222512|NCT01829113|79025929|FG001|Overall Study|Physician Decision|1|||
44222513|NCT01857271|79025937|FG000|Overall Study|Lost to Follow-up|1|||
44222514|NCT01745120|79025943|FG000|Overall Study|Investigator decision|1|||
44222515|NCT01745120|79025944|FG001|Overall Study|Investigator decision|0|||
44222516|NCT01828567|79025955|FG000|Overall Study|Lost to Follow-up|27|||
44222517|NCT01828567|79025956|FG001|Overall Study|Lost to Follow-up|9|||
44222518|NCT01828567|79025955|FG000|Overall Study|Excluded - did not meet criteria|4|||
44222519|NCT01828567|79025956|FG001|Overall Study|Excluded - did not meet criteria|1|||
44222520|NCT01721486|79025964|FG000|Overall Study|Protocol Violation|1|||
44222521|NCT01721486|79025965|FG001|Overall Study|Protocol Violation|0|||
44222522|NCT01721486|79025964|FG000|Overall Study|Physician Decision|0|||
44271937|NCT01643850|79204226|FG006|Overall Study|Withdrawal by Subject|0|||
44271938|NCT01643850|79204227|FG007|Overall Study|Withdrawal by Subject|0|||
44271939|NCT01643850|79204228|FG008|Overall Study|Withdrawal by Subject|0|||
44222523|NCT01721486|79025965|FG001|Overall Study|Physician Decision|1|||
44222524|NCT01775930|79025971|FG000|Overall Study|Futility stopping boundary met|1|||
44465863|NCT00299494|79474785|FG003|Overall Study|Lost to Follow-up|0|||
44271940|NCT01643850|79204220|FG000|Overall Study|Lost to Follow-up|0|||
44271941|NCT01643850|79204221|FG001|Overall Study|Lost to Follow-up|0|||
44271942|NCT01643850|79204222|FG002|Overall Study|Lost to Follow-up|0|||
44222525|NCT01856569|79025975|FG000|Overall Study|Other|1|||
44271943|NCT01643850|79204223|FG003|Overall Study|Lost to Follow-up|0|||
44271944|NCT01643850|79204224|FG004|Overall Study|Lost to Follow-up|0|||
44271945|NCT01643850|79204225|FG005|Overall Study|Lost to Follow-up|0|||
44271946|NCT01643850|79204226|FG006|Overall Study|Lost to Follow-up|1|||
44271947|NCT01643850|79204227|FG007|Overall Study|Lost to Follow-up|0|||
44271948|NCT01643850|79204228|FG008|Overall Study|Lost to Follow-up|1|||
44271949|NCT01643850|79204220|FG000|Overall Study|Adverse Event|0|||
44271950|NCT01643850|79204221|FG001|Overall Study|Adverse Event|0|||
44271951|NCT01643850|79204222|FG002|Overall Study|Adverse Event|0|||
44271952|NCT01643850|79204223|FG003|Overall Study|Adverse Event|0|||
44222526|NCT01856569|79025975|FG000|Overall Study|Changed Site/Structure|1|||
44222527|NCT01856569|79025975|FG000|Overall Study|Lost to Follow-up|3|||
44222528|NCT01856569|79025975|FG000|Overall Study|Did not met inclusion criteria|8|||
44222529|NCT01721408|79025981|FG000|Overall Study|Adverse Event|6|||
44222530|NCT01721408|79025982|FG001|Overall Study|Adverse Event|1|||
44222531|NCT01721408|79025981|FG000|Overall Study|Death|1|||
44222532|NCT01721408|79025982|FG001|Overall Study|Death|0|||
44222533|NCT01721408|79025981|FG000|Overall Study|Insufficient clinical response|15|||
44222534|NCT01721408|79025982|FG001|Overall Study|Insufficient clinical response|6|||
44222535|NCT01721408|79025981|FG000|Overall Study|No longer willing to participate study|9|||
44222536|NCT01721408|79025982|FG001|Overall Study|No longer willing to participate study|10|||
44222537|NCT01721408|79025981|FG000|Overall Study|Protocol Violation|0|||
44222538|NCT01721408|79025982|FG001|Overall Study|Protocol Violation|2|||
44222539|NCT01721408|79025981|FG000|Overall Study|Other|3|||
44222540|NCT01721408|79025982|FG001|Overall Study|Other|3|||
44222541|NCT01721408|79025981|FG000|Overall Study|Lost to Follow-up|1|||
44222542|NCT01721408|79025982|FG001|Overall Study|Lost to Follow-up|2|||
44222543|NCT01721408|79025981|FG000|Overall Study|Does not meet entrance criteria|1|||
44222544|NCT01721408|79025982|FG001|Overall Study|Does not meet entrance criteria|0|||
44222545|NCT01744496|79025990|FG000|Titration Period|Adverse Event|2|||
44222546|NCT01744496|79025991|FG001|Titration Period|Adverse Event|1|||
44222547|NCT01744496|79025990|FG000|Titration Period|Personal reasons|0|||
44222548|NCT01744496|79025991|FG001|Titration Period|Personal reasons|1|||
44222549|NCT01744496|79025990|FG000|Maintenance Period|Adverse Event|1|||
44222550|NCT01744496|79025991|FG001|Maintenance Period|Adverse Event|3|||
44222551|NCT01744496|79025990|FG000|Maintenance Period|Protocol Violation|1|||
44271953|NCT01643850|79204224|FG004|Overall Study|Adverse Event|1|||
44271954|NCT01643850|79204225|FG005|Overall Study|Adverse Event|0|||
44271955|NCT01643850|79204226|FG006|Overall Study|Adverse Event|0|||
44271956|NCT01643850|79204227|FG007|Overall Study|Adverse Event|0|||
44271957|NCT01643850|79204228|FG008|Overall Study|Adverse Event|0|||
44271958|NCT01643850|79204220|FG000|Overall Study|Administrative Problems|0|||
44271959|NCT01643850|79204221|FG001|Overall Study|Administrative Problems|0|||
44271960|NCT01643850|79204222|FG002|Overall Study|Administrative Problems|1|||
44271961|NCT01643850|79204223|FG003|Overall Study|Administrative Problems|0|||
44271962|NCT01643850|79204224|FG004|Overall Study|Administrative Problems|1|||
44271963|NCT01643850|79204225|FG005|Overall Study|Administrative Problems|0|||
44271964|NCT01643850|79204226|FG006|Overall Study|Administrative Problems|0|||
44271965|NCT01643850|79204227|FG007|Overall Study|Administrative Problems|0|||
44271966|NCT01643850|79204228|FG008|Overall Study|Administrative Problems|0|||
44271967|NCT02271594|79204296|FG000|Overall Study|Study closed; recruiting failure|19|||
44271968|NCT02271594|79204297|FG001|Overall Study|Study closed; recruiting failure|12|||
44271969|NCT02535923|79204316|FG000|Overall Study|Lost to Follow-up|5|||
44222552|NCT01744496|79025991|FG001|Maintenance Period|Protocol Violation|0|||
44222553|NCT01744496|79025990|FG000|Maintenance Period|Withdrawal by Subject|1|||
44222554|NCT01744496|79025991|FG001|Maintenance Period|Withdrawal by Subject|1|||
44544302|NCT02918019|79557641|FG000|Overall Study|Adverse Event|0|||
44544303|NCT02918019|79557642|FG001|Overall Study|Adverse Event|1|||
44222555|NCT01744496|79025990|FG000|Maintenance Period|Subject left town|1|||
44544304|NCT02918019|79557643|FG002|Overall Study|Adverse Event|0|||
44544305|NCT02918019|79557644|FG003|Overall Study|Adverse Event|1|||
44544306|NCT03055988|79557662|FG000|Period 1|Adverse Event|0|||
44271970|NCT02535923|79204317|FG001|Overall Study|Lost to Follow-up|5|||
44271971|NCT02535923|79204316|FG000|Overall Study|Withdrawal by Subject|4|||
44222556|NCT01744496|79025991|FG001|Maintenance Period|Subject left town|0|||
44222557|NCT01721330|79025999|FG000|Overall Study|Withdrawal by Subject|0|||
44222558|NCT01721330|79026000|FG001|Overall Study|Withdrawal by Subject|1|||
44271972|NCT02535923|79204317|FG001|Overall Study|Withdrawal by Subject|3|||
44271973|NCT02270736|79204326|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
44271974|NCT02270736|79204327|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
44271975|NCT02270736|79204328|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
44271976|NCT02270736|79204329|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
44271977|NCT02270736|79204330|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
44222559|NCT01828021|79026016|FG000|Overall Study|Adverse Event|5|||
44222560|NCT01828021|79026016|FG000|Overall Study|Lack of Efficacy|17|||
44222561|NCT01828021|79026016|FG000|Overall Study|Withdrawal by Subject|2|||
44222562|NCT01828021|79026016|FG000|Overall Study|Ileal obstruction, unrelated|1|||
44222563|NCT01827943|79026020|FG000|Overall Study|Protocol Violation|8|||
44222564|NCT01827943|79026020|FG000|Overall Study|Never treated because of an rapid progression|1|||
44222565|NCT00217971|79026026|FG000|Overall Study|Adverse Event|1|||
44222566|NCT00217971|79026027|FG001|Overall Study|Adverse Event|1|||
44222567|NCT00217971|79026026|FG000|Overall Study|Lost to Follow-up|15|||
44222568|NCT00217971|79026027|FG001|Overall Study|Lost to Follow-up|19|||
44222569|NCT00217971|79026026|FG000|Overall Study|Physician Decision|0|||
44222570|NCT00217971|79026027|FG001|Overall Study|Physician Decision|1|||
44222571|NCT00217971|79026026|FG000|Overall Study|Withdrawal by Subject|7|||
44222572|NCT00217971|79026027|FG001|Overall Study|Withdrawal by Subject|12|||
44222573|NCT00217971|79026026|FG000|Overall Study|non compliant|1|||
44222574|NCT00217971|79026027|FG001|Overall Study|non compliant|0|||
44222575|NCT00217581|79026033|FG000|Overall Study|Withdrawal by Subject|1|||
44222576|NCT01856257|79026041|FG000|Overall Study|Death|2|||
44222577|NCT01856257|79026042|FG001|Overall Study|Death|0|||
44222578|NCT01856257|79026043|FG002|Overall Study|Death|0|||
44222579|NCT01856257|79026044|FG003|Overall Study|Death|0|||
44222580|NCT01856257|79026041|FG000|Overall Study|Physician Decision|0|||
44222581|NCT01856257|79026042|FG001|Overall Study|Physician Decision|0|||
44222582|NCT01856257|79026043|FG002|Overall Study|Physician Decision|0|||
44271978|NCT02270736|79204326|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
44271979|NCT02270736|79204327|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
44271980|NCT02270736|79204328|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
44271981|NCT02270736|79204329|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
44271982|NCT02270736|79204330|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
44271983|NCT02270736|79204326|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
44222583|NCT01856257|79026044|FG003|Overall Study|Physician Decision|1|||
44271984|NCT02270736|79204327|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
44271985|NCT02270736|79204328|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
44271986|NCT02270736|79204329|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
44222584|NCT01856257|79026041|FG000|Overall Study|Withdrawal by Subject|1|||
44222585|NCT01856257|79026042|FG001|Overall Study|Withdrawal by Subject|1|||
44222586|NCT01856257|79026043|FG002|Overall Study|Withdrawal by Subject|0|||
44222587|NCT01856257|79026044|FG003|Overall Study|Withdrawal by Subject|0|||
44222588|NCT01856257|79026041|FG000|Overall Study|Donor complication|0|||
44222589|NCT01856257|79026042|FG001|Overall Study|Donor complication|0|||
44222590|NCT01856257|79026043|FG002|Overall Study|Donor complication|0|||
44222591|NCT01856257|79026044|FG003|Overall Study|Donor complication|1|||
44222592|NCT00215943|79026055|FG000|Overall Study|Disease Progression|3|||
44222593|NCT00215943|79026056|FG001|Overall Study|Disease Progression|5|||
44222594|NCT00215943|79026055|FG000|Overall Study|Alternate therapy|0|||
44271987|NCT02270736|79204330|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
44271988|NCT02270736|79204326|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
44271989|NCT02270736|79204327|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
44271990|NCT02270736|79204328|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
44271991|NCT02270736|79204329|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
44271992|NCT02270736|79204330|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
44271993|NCT02270736|79204326|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
44271994|NCT02270736|79204327|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
44271995|NCT02270736|79204328|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
44271996|NCT02270736|79204329|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
44271997|NCT02270736|79204330|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
44271998|NCT02270736|79204326|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
44271999|NCT02270736|79204327|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
44222595|NCT00215943|79026056|FG001|Overall Study|Alternate therapy|1|||
44222596|NCT00215943|79026055|FG000|Overall Study|Adverse Event|3|||
44222597|NCT00215943|79026056|FG001|Overall Study|Adverse Event|6|||
44272000|NCT02270736|79204328|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
44272001|NCT02270736|79204329|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
44272002|NCT02270736|79204330|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
44272003|NCT02270736|79204326|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
44272004|NCT02270736|79204327|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
44272005|NCT02270736|79204328|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
44272006|NCT02270736|79204329|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
44272007|NCT02270736|79204330|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
44222598|NCT00215943|79026055|FG000|Overall Study|Other disease|0|||
44222599|NCT00215943|79026056|FG001|Overall Study|Other disease|1|||
44222600|NCT00215943|79026055|FG000|Overall Study|Other complications|3|||
44222601|NCT00215943|79026056|FG001|Overall Study|Other complications|1|||
44222602|NCT01827319|79026062|FG000|Overall Study|Lost to Follow-up|3|||
44272008|NCT02270736|79204326|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
44272009|NCT02270736|79204327|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
44272010|NCT02270736|79204328|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
44272011|NCT02270736|79204329|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
44272012|NCT02270736|79204330|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
44272013|NCT02270736|79204326|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
44272014|NCT02270736|79204327|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
44272015|NCT02270736|79204328|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
44272016|NCT02270736|79204329|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
44272017|NCT02270736|79204330|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
44272018|NCT02269098|79204345|FG000|Overall Study|Lost to Follow-up|14|||
44272019|NCT02269098|79204346|FG001|Overall Study|Lost to Follow-up|9|||
44272020|NCT02283762|79204479|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
44272021|NCT02283762|79204480|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
44272022|NCT02283762|79204479|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
44272023|NCT02283762|79204480|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
44272024|NCT02283762|79204479|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
44272025|NCT02283762|79204480|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
44272026|NCT02283762|79204479|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
44272027|NCT02283762|79204480|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
44272028|NCT02283762|79204479|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
44272029|NCT02283762|79204480|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
44272030|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
44272031|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
44272032|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
44272033|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
44272034|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
44272035|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
44272036|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
44272037|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
44272038|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
44272039|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
44272040|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
44272041|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
44272042|NCT02283762|79204479|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
44272043|NCT02283762|79204480|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
44272044|NCT02283294|79204580|FG000|Overall Study|Lost to Follow-up|1|||
44272045|NCT02283294|79204581|FG001|Overall Study|Lost to Follow-up|1|||
44272046|NCT02283294|79204580|FG000|Overall Study|Withdrawal by Subject|1|||
44272047|NCT02283294|79204581|FG001|Overall Study|Withdrawal by Subject|6|||
44272048|NCT02283294|79204580|FG000|Overall Study|Protocol Violation|1|||
44272049|NCT02283294|79204581|FG001|Overall Study|Protocol Violation|0|||
44272050|NCT02283294|79204580|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
44272051|NCT02283294|79204581|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
44272052|NCT02282982|79204597|FG000|Overall Study|Lost to Follow-up|15|||
44272053|NCT02282982|79204597|FG000|Overall Study|Withdrew consent|2|||
44272054|NCT02282982|79204597|FG000|Overall Study|Death|4|||
44272055|NCT02282982|79204597|FG000|Overall Study|Lack of product|156|||
44375088|NCT00908037|79380264|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375089|NCT00908037|79380265|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
44375090|NCT00908037|79380266|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44222603|NCT01827163|79026066|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
44222604|NCT01827163|79026066|FG000|Overall Study|Adverse Event|9|||
44222605|NCT00215553|79026077|FG000|Overall Study|Adverse Event|0|||
44222606|NCT00215553|79026078|FG001|Overall Study|Adverse Event|1|||
44222607|NCT00215553|79026079|FG002|Overall Study|Adverse Event|2|||
44222608|NCT00215553|79026080|FG003|Overall Study|Adverse Event|1|||
44222609|NCT00215553|79026081|FG004|Overall Study|Adverse Event|2|||
44222610|NCT00215553|79026082|FG005|Overall Study|Adverse Event|6|||
44222611|NCT00215553|79026083|FG006|Overall Study|Adverse Event|0|||
44222612|NCT00214461|79026103|FG000|Overall Study|Adverse Event|0|||
44222613|NCT00214461|79026104|FG001|Overall Study|Adverse Event|0|||
44222614|NCT00214461|79026105|FG002|Overall Study|Adverse Event|1|||
44272056|NCT02282982|79204597|FG000|Overall Study|Palivizumab is ended|11|||
44272057|NCT02282982|79204597|FG000|Overall Study|Other, not specified|18|||
44272058|NCT02268864|79204639|FG000|Overall Study|Withdrawal by Subject|2|||
44272059|NCT02268864|79204640|FG001|Overall Study|Withdrawal by Subject|0|||
44272060|NCT02268864|79204641|FG002|Overall Study|Withdrawal by Subject|0|||
44272061|NCT02268864|79204639|FG000|Overall Study|Death|0|||
44272062|NCT02268864|79204640|FG001|Overall Study|Death|1|||
44272063|NCT02268864|79204641|FG002|Overall Study|Death|0|||
44375091|NCT00908037|79380267|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44222615|NCT00214461|79026106|FG003|Overall Study|Adverse Event|1|||
44222616|NCT00214461|79026103|FG000|Overall Study|Withdrawal by Subject|0|||
44222617|NCT00214461|79026104|FG001|Overall Study|Withdrawal by Subject|0|||
44222618|NCT00214461|79026105|FG002|Overall Study|Withdrawal by Subject|1|||
44222619|NCT00214461|79026106|FG003|Overall Study|Withdrawal by Subject|0|||
44272064|NCT02268786|79204670|FG000|Overall Study|No Euploid Embryos available|42|||
44272065|NCT02268786|79204671|FG001|Overall Study|No Euploid Embryos available|0|||
44272066|NCT02268786|79204670|FG000|Overall Study|Withdrawal by Subject|7|||
44272067|NCT02268786|79204671|FG001|Overall Study|Withdrawal by Subject|14|||
44272068|NCT02268786|79204670|FG000|Overall Study|Thaw Failure|6|||
44272069|NCT02268786|79204671|FG001|Overall Study|Thaw Failure|4|||
44272070|NCT02268786|79204670|FG000|Overall Study|Protocol Violation|1|||
44272071|NCT02268786|79204671|FG001|Overall Study|Protocol Violation|0|||
44222620|NCT00214383|79026118|FG000|Overall Study|Lost to Follow-up|16|||
44222621|NCT00214383|79026119|FG001|Overall Study|Lost to Follow-up|26|||
44222622|NCT00212355|79026125|FG000|Overall Study|Adverse Event|1|||
44222623|NCT00212355|79026125|FG000|Overall Study|Withdrawal by Subject|1|||
44222624|NCT00212355|79026125|FG000|Overall Study|A change of address|1|||
44222625|NCT00211887|79026132|FG000|Overall Study|Adverse Event|8|||
44222626|NCT00211887|79026133|FG001|Overall Study|Adverse Event|4|||
44222627|NCT00211887|79026134|FG002|Overall Study|Adverse Event|6|||
44222628|NCT00211887|79026132|FG000|Overall Study|Death|1|||
44272072|NCT02268396|79204686|FG000|Overall Study|Adverse Event|3|||
44272073|NCT02268396|79204686|FG000|Overall Study|Administrative|2|||
44272074|NCT02268396|79204686|FG000|Overall Study|Withdrawal by Subject|1|||
44272075|NCT02268396|79204686|FG000|Overall Study|Lost to Follow-up|2|||
44272076|NCT02268396|79204686|FG000|Overall Study|Protocol-Specified Criteria|2|||
44272077|NCT02268396|79204686|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
44272078|NCT02268084|79204692|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
44272079|NCT02268084|79204693|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
44272080|NCT02268084|79204692|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
44222629|NCT00211887|79026133|FG001|Overall Study|Death|1|||
44222630|NCT00211887|79026134|FG002|Overall Study|Death|1|||
44222631|NCT00211887|79026132|FG000|Overall Study|Lost to Follow-up|28|||
44222632|NCT00211887|79026133|FG001|Overall Study|Lost to Follow-up|13|||
44222633|NCT00211887|79026134|FG002|Overall Study|Lost to Follow-up|9|||
44222634|NCT00211887|79026132|FG000|Overall Study|Non-medical reason|31|||
44222635|NCT00211887|79026133|FG001|Overall Study|Non-medical reason|14|||
44222636|NCT00211887|79026134|FG002|Overall Study|Non-medical reason|8|||
44222637|NCT00211887|79026132|FG000|Overall Study|Other medical reason|15|||
44222638|NCT00211887|79026133|FG001|Overall Study|Other medical reason|11|||
44222639|NCT00211887|79026134|FG002|Overall Study|Other medical reason|7|||
44222640|NCT00211887|79026132|FG000|Overall Study|Side effects|19|||
44222641|NCT00211887|79026133|FG001|Overall Study|Side effects|13|||
44222642|NCT00211887|79026134|FG002|Overall Study|Side effects|5|||
44222643|NCT01855945|79026154|FG000|Overall Study|Adverse Event|0|||
44222644|NCT01855945|79026155|FG001|Overall Study|Adverse Event|0|||
44222645|NCT01855945|79026156|FG002|Overall Study|Adverse Event|0|||
44222646|NCT01855945|79026157|FG003|Overall Study|Adverse Event|0|||
44222647|NCT01855945|79026158|FG004|Overall Study|Adverse Event|0|||
44222648|NCT01855945|79026159|FG005|Overall Study|Adverse Event|0|||
44222649|NCT01855945|79026160|FG006|Overall Study|Adverse Event|1|||
44222650|NCT01855945|79026161|FG007|Overall Study|Adverse Event|0|||
44222651|NCT01855945|79026162|FG008|Overall Study|Adverse Event|0|||
44222652|NCT01855945|79026163|FG009|Overall Study|Adverse Event|0|||
44222653|NCT01855945|79026164|FG010|Overall Study|Adverse Event|0|||
44222654|NCT01855945|79026165|FG011|Overall Study|Adverse Event|0|||
44222655|NCT01855945|79026154|FG000|Overall Study|Death|0|||
44222656|NCT01855945|79026155|FG001|Overall Study|Death|0|||
44222657|NCT01855945|79026156|FG002|Overall Study|Death|0|||
44222658|NCT01855945|79026157|FG003|Overall Study|Death|0|||
44222659|NCT01855945|79026158|FG004|Overall Study|Death|0|||
44222660|NCT01855945|79026159|FG005|Overall Study|Death|0|||
44222661|NCT01855945|79026160|FG006|Overall Study|Death|2|||
44222662|NCT01855945|79026161|FG007|Overall Study|Death|0|||
44222663|NCT01855945|79026162|FG008|Overall Study|Death|0|||
44222664|NCT01855945|79026163|FG009|Overall Study|Death|0|||
44222665|NCT01855945|79026164|FG010|Overall Study|Death|0|||
44222666|NCT01855945|79026165|FG011|Overall Study|Death|0|||
44222667|NCT01855945|79026154|FG000|Overall Study|Lost to Follow-up|11|||
44222668|NCT01855945|79026155|FG001|Overall Study|Lost to Follow-up|10|||
44222669|NCT01855945|79026156|FG002|Overall Study|Lost to Follow-up|7|||
44222670|NCT01855945|79026157|FG003|Overall Study|Lost to Follow-up|3|||
44222671|NCT01855945|79026158|FG004|Overall Study|Lost to Follow-up|0|||
44222672|NCT01855945|79026159|FG005|Overall Study|Lost to Follow-up|3|||
44222673|NCT01855945|79026160|FG006|Overall Study|Lost to Follow-up|4|||
44222674|NCT01855945|79026161|FG007|Overall Study|Lost to Follow-up|7|||
44222675|NCT01855945|79026162|FG008|Overall Study|Lost to Follow-up|2|||
44222676|NCT01855945|79026163|FG009|Overall Study|Lost to Follow-up|0|||
44222677|NCT01855945|79026164|FG010|Overall Study|Lost to Follow-up|0|||
44222678|NCT01855945|79026165|FG011|Overall Study|Lost to Follow-up|2|||
44222679|NCT01855945|79026154|FG000|Overall Study|Other - Unclassified|1|||
44222680|NCT01855945|79026155|FG001|Overall Study|Other - Unclassified|1|||
44222681|NCT01855945|79026156|FG002|Overall Study|Other - Unclassified|1|||
44222682|NCT01855945|79026157|FG003|Overall Study|Other - Unclassified|0|||
44222683|NCT01855945|79026158|FG004|Overall Study|Other - Unclassified|0|||
44222684|NCT01855945|79026159|FG005|Overall Study|Other - Unclassified|0|||
44222685|NCT01855945|79026160|FG006|Overall Study|Other - Unclassified|2|||
44222686|NCT01855945|79026161|FG007|Overall Study|Other - Unclassified|1|||
44222687|NCT01855945|79026162|FG008|Overall Study|Other - Unclassified|0|||
44222688|NCT01855945|79026163|FG009|Overall Study|Other - Unclassified|0|||
44222689|NCT01855945|79026164|FG010|Overall Study|Other - Unclassified|1|||
44222690|NCT01855945|79026165|FG011|Overall Study|Other - Unclassified|0|||
44222691|NCT01855945|79026154|FG000|Overall Study|Withdrawal by Subject|4|||
44222692|NCT01855945|79026155|FG001|Overall Study|Withdrawal by Subject|0|||
44277807|NCT02092350|79238807|FG001|Overall Study|Protocol Violation|0|||
44222693|NCT01855945|79026156|FG002|Overall Study|Withdrawal by Subject|4|||
44222694|NCT01855945|79026157|FG003|Overall Study|Withdrawal by Subject|1|||
44222695|NCT01855945|79026158|FG004|Overall Study|Withdrawal by Subject|1|||
44222696|NCT01855945|79026159|FG005|Overall Study|Withdrawal by Subject|0|||
44222697|NCT01855945|79026160|FG006|Overall Study|Withdrawal by Subject|1|||
44222698|NCT01855945|79026161|FG007|Overall Study|Withdrawal by Subject|0|||
44222699|NCT01855945|79026162|FG008|Overall Study|Withdrawal by Subject|0|||
44222700|NCT01855945|79026163|FG009|Overall Study|Withdrawal by Subject|2|||
44222701|NCT01855945|79026164|FG010|Overall Study|Withdrawal by Subject|4|||
44222702|NCT01855945|79026165|FG011|Overall Study|Withdrawal by Subject|1|||
44222703|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Adverse Event|37|||
44222704|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Adverse Event|0|||
44222705|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Adverse Event|0|||
44222706|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Adverse Event|0|||
44375092|NCT00908037|79380268|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
44375093|NCT00908037|79380257|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44222707|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Death|2|||
44222708|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Death|0|||
44222709|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Death|0|||
44222710|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Death|0|||
44222711|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
44222712|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
44222713|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
44222714|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
44222715|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
44222716|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
44222717|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
44222718|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
44222719|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
44222720|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
44222721|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
44222722|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
44222723|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
44222724|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
44222725|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
44222726|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
44222727|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Physician Decision|4|||
44222728|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Physician Decision|0|||
44222729|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Physician Decision|0|||
44222730|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Physician Decision|0|||
44222731|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Pregnancy|1|||
44222732|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Pregnancy|0|||
44222733|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Pregnancy|0|||
44222734|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Pregnancy|0|||
44222735|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
44222736|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
44222737|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
44222738|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
44222739|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
44222740|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
44222741|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
44222742|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
44222743|NCT01855789|79026228|FG000|1) Baseline up to Week 24|Other|4|||
44222744|NCT01855789|79026229|FG001|1) Baseline up to Week 24|Other|0|||
44222745|NCT01855789|79026230|FG002|1) Baseline up to Week 24|Other|0|||
44222746|NCT01855789|79026231|FG003|1) Baseline up to Week 24|Other|0|||
44222747|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
44222748|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
44222749|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
44222750|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
44222751|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
44222752|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
44222753|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
44222754|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
44222755|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
44222756|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
44222757|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
44222758|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
44222759|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
44222760|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
44375094|NCT00908037|79380258|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44375095|NCT00908037|79380259|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44222761|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
44222762|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
44222763|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
44222764|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
44222765|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
44222766|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
44465864|NCT00299494|79474786|FG004|Overall Study|Lost to Follow-up|3|||
44272081|NCT02268084|79204693|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
44272082|NCT01643772|79204722|FG000|Overall Study|Protocol Violation|0|||
44272083|NCT01643772|79204723|FG001|Overall Study|Protocol Violation|0|||
44272084|NCT01643772|79204724|FG002|Overall Study|Protocol Violation|0|||
44272085|NCT01643772|79204725|FG003|Overall Study|Protocol Violation|1|||
44272086|NCT01643772|79204722|FG000|Overall Study|Adverse Event|0|||
44272087|NCT01643772|79204723|FG001|Overall Study|Adverse Event|0|||
44272088|NCT01643772|79204724|FG002|Overall Study|Adverse Event|0|||
44272089|NCT01643772|79204725|FG003|Overall Study|Adverse Event|1|||
44272090|NCT02265744|79204828|FG000|Overall Study|Poor/Non-compliance|1|||
44272091|NCT02265744|79204829|FG001|Overall Study|Poor/Non-compliance|1|||
44272092|NCT02265744|79204830|FG002|Overall Study|Poor/Non-compliance|0|||
44272093|NCT02265744|79204831|FG003|Overall Study|Poor/Non-compliance|0|||
44272094|NCT02265744|79204832|FG004|Overall Study|Poor/Non-compliance|2|||
44272095|NCT02265744|79204828|FG000|Overall Study|Lost to Follow-up|0|||
44272096|NCT02265744|79204829|FG001|Overall Study|Lost to Follow-up|0|||
44272097|NCT02265744|79204830|FG002|Overall Study|Lost to Follow-up|0|||
44272098|NCT02265744|79204831|FG003|Overall Study|Lost to Follow-up|1|||
44272099|NCT02265744|79204832|FG004|Overall Study|Lost to Follow-up|0|||
44272100|NCT02265744|79204828|FG000|Overall Study|Death|0|||
44272101|NCT02265744|79204829|FG001|Overall Study|Death|0|||
44272102|NCT02265744|79204830|FG002|Overall Study|Death|0|||
44272103|NCT02265744|79204831|FG003|Overall Study|Death|2|||
44272104|NCT02265744|79204832|FG004|Overall Study|Death|0|||
44272105|NCT02265744|79204828|FG000|Overall Study|Withdrawal by Subject|2|||
44272106|NCT02265744|79204829|FG001|Overall Study|Withdrawal by Subject|0|||
44272107|NCT02265744|79204830|FG002|Overall Study|Withdrawal by Subject|0|||
44272108|NCT02265744|79204831|FG003|Overall Study|Withdrawal by Subject|2|||
44272109|NCT02265744|79204832|FG004|Overall Study|Withdrawal by Subject|0|||
44272110|NCT02265744|79204828|FG000|Overall Study|Participant request to discontinue|2|||
44272111|NCT02265744|79204829|FG001|Overall Study|Participant request to discontinue|2|||
44272112|NCT02265744|79204830|FG002|Overall Study|Participant request to discontinue|2|||
44272113|NCT02265744|79204831|FG003|Overall Study|Participant request to discontinue|0|||
44222767|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
44222768|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
44222769|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
44222770|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
44222771|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
44222772|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
44222773|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
44222774|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
44222775|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
44222776|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
44222777|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
44222778|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
44222779|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
44222780|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
44222781|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
44222782|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
44222783|NCT01855789|79026228|FG000|2) Week 24 up to End of Study|Other|0|||
44222784|NCT01855789|79026229|FG001|2) Week 24 up to End of Study|Other|0|||
44222785|NCT01855789|79026230|FG002|2) Week 24 up to End of Study|Other|0|||
44222786|NCT01855789|79026231|FG003|2) Week 24 up to End of Study|Other|1|||
44222787|NCT01610791|79026237|FG000|Overall Study|Lost to Follow-up|7|||
44222788|NCT01610791|79026237|FG000|Overall Study|Adverse Event|6|||
44222789|NCT01610791|79026237|FG000|Overall Study|Physician Decision|1|||
44222790|NCT01610791|79026237|FG000|Overall Study|Adverse event and Investigator decision|1|||
44222791|NCT01610791|79026237|FG000|Overall Study|Death|1|||
44272114|NCT02265744|79204832|FG004|Overall Study|Participant request to discontinue|0|||
44272115|NCT02265744|79204828|FG000|Overall Study|Adverse Event|8|||
44272116|NCT02265744|79204829|FG001|Overall Study|Adverse Event|4|||
44272117|NCT02265744|79204830|FG002|Overall Study|Adverse Event|9|||
44272118|NCT02265744|79204831|FG003|Overall Study|Adverse Event|8|||
44272119|NCT02265744|79204832|FG004|Overall Study|Adverse Event|2|||
44272120|NCT02265744|79204828|FG000|Overall Study|Lack of Efficacy|2|||
44272121|NCT02265744|79204829|FG001|Overall Study|Lack of Efficacy|4|||
44272122|NCT02265744|79204830|FG002|Overall Study|Lack of Efficacy|3|||
44375096|NCT00908037|79380260|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
44222792|NCT01610791|79026237|FG000|Overall Study|Not determined|5|||
44222793|NCT01876381|79026241|FG000|Overall Study|Lack of Efficacy|5|||
44272123|NCT02265744|79204831|FG003|Overall Study|Lack of Efficacy|4|||
44272124|NCT02265744|79204832|FG004|Overall Study|Lack of Efficacy|5|||
44272125|NCT02265744|79204828|FG000|Overall Study|Reason not provided by Investigator|1|||
44272126|NCT02265744|79204829|FG001|Overall Study|Reason not provided by Investigator|0|||
44272127|NCT02265744|79204830|FG002|Overall Study|Reason not provided by Investigator|0|||
44272128|NCT02265744|79204831|FG003|Overall Study|Reason not provided by Investigator|2|||
44272129|NCT02265744|79204832|FG004|Overall Study|Reason not provided by Investigator|0|||
44272130|NCT02265744|79204828|FG000|Overall Study|Administrative reason by sponsor|3|||
44272131|NCT02265744|79204829|FG001|Overall Study|Administrative reason by sponsor|2|||
44272132|NCT02265744|79204830|FG002|Overall Study|Administrative reason by sponsor|2|||
44272133|NCT02265744|79204831|FG003|Overall Study|Administrative reason by sponsor|3|||
44272134|NCT02265744|79204832|FG004|Overall Study|Administrative reason by sponsor|3|||
44272135|NCT02265744|79204828|FG000|Overall Study|Subject no longer meets study criteria|0|||
44272136|NCT02265744|79204829|FG001|Overall Study|Subject no longer meets study criteria|0|||
44272137|NCT02265744|79204830|FG002|Overall Study|Subject no longer meets study criteria|0|||
44272138|NCT02265744|79204831|FG003|Overall Study|Subject no longer meets study criteria|0|||
44272139|NCT02265744|79204832|FG004|Overall Study|Subject no longer meets study criteria|1|||
44272140|NCT02265744|79204828|FG000|Overall Study|Pregnancy|1|||
44272141|NCT02265744|79204829|FG001|Overall Study|Pregnancy|2|||
44272142|NCT02265744|79204830|FG002|Overall Study|Pregnancy|1|||
44272143|NCT02265744|79204831|FG003|Overall Study|Pregnancy|1|||
44272144|NCT02265744|79204832|FG004|Overall Study|Pregnancy|0|||
44272145|NCT00085735|79204861|FG000|Overall Study|Adverse Event|1|||
44272146|NCT00085735|79204862|FG001|Overall Study|Adverse Event|0|||
44272147|NCT00085735|79204863|FG002|Overall Study|Adverse Event|0|||
44272148|NCT00085735|79204864|FG003|Overall Study|Adverse Event|0|||
44272149|NCT00085735|79204865|FG004|Overall Study|Adverse Event|0|||
44272150|NCT00085735|79204866|FG005|Overall Study|Adverse Event|0|||
44272151|NCT00085735|79204861|FG000|Overall Study|Lack of Efficacy|2|||
44272152|NCT00085735|79204862|FG001|Overall Study|Lack of Efficacy|4|||
44272153|NCT00085735|79204863|FG002|Overall Study|Lack of Efficacy|6|||
44272154|NCT00085735|79204864|FG003|Overall Study|Lack of Efficacy|3|||
44272155|NCT00085735|79204865|FG004|Overall Study|Lack of Efficacy|4|||
44272156|NCT00085735|79204866|FG005|Overall Study|Lack of Efficacy|3|||
44272157|NCT00085735|79204861|FG000|Overall Study|Lost to Follow-up|0|||
44272158|NCT00085735|79204862|FG001|Overall Study|Lost to Follow-up|1|||
44272159|NCT00085735|79204863|FG002|Overall Study|Lost to Follow-up|0|||
44272160|NCT00085735|79204864|FG003|Overall Study|Lost to Follow-up|0|||
44272161|NCT00085735|79204865|FG004|Overall Study|Lost to Follow-up|1|||
44272162|NCT00085735|79204866|FG005|Overall Study|Lost to Follow-up|0|||
44272163|NCT00085735|79204861|FG000|Overall Study|Physician Decision|2|||
44272164|NCT00085735|79204862|FG001|Overall Study|Physician Decision|3|||
44375097|NCT00908037|79380261|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44544307|NCT03055988|79557663|FG001|Period 1|Adverse Event|1|||
44544308|NCT03055988|79557662|FG000|Period 1|Lost to Follow-up|1|||
44544309|NCT03055988|79557663|FG001|Period 1|Lost to Follow-up|0|||
44544310|NCT03055988|79557662|FG000|Period 1|Withdrawal by Subject|0|||
44544311|NCT03055988|79557663|FG001|Period 1|Withdrawal by Subject|4|||
44222794|NCT01876381|79026241|FG000|Overall Study|Physician Decision|1|||
44222795|NCT01876381|79026241|FG000|Overall Study|Withdrawal by Subject|1|||
44222796|NCT01855399|79026256|FG000|6 Month|Lost to Follow-up|12|||
44222797|NCT01855399|79026257|FG001|6 Month|Lost to Follow-up|9|||
44222798|NCT01855399|79026256|FG000|6 Month|Withdrawal by Subject|8|||
44222799|NCT01855399|79026257|FG001|6 Month|Withdrawal by Subject|6|||
44222800|NCT01855399|79026256|FG000|12 Month|Lost to Follow-up|7|||
44272165|NCT00085735|79204863|FG002|Overall Study|Physician Decision|2|||
44272166|NCT00085735|79204864|FG003|Overall Study|Physician Decision|3|||
44272167|NCT00085735|79204865|FG004|Overall Study|Physician Decision|11|||
44272168|NCT00085735|79204866|FG005|Overall Study|Physician Decision|8|||
44375098|NCT00908037|79380262|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44544312|NCT03055988|79557662|FG000|Period 2|Adverse Event|0|||
44222801|NCT01855399|79026257|FG001|12 Month|Lost to Follow-up|11|||
44222802|NCT01875991|79026265|FG000|Overall Study|Withdrawal by Subject|6|||
44272169|NCT00085735|79204861|FG000|Overall Study|Protocol Violation|1|||
44272170|NCT00085735|79204862|FG001|Overall Study|Protocol Violation|0|||
44272171|NCT00085735|79204863|FG002|Overall Study|Protocol Violation|0|||
44272172|NCT00085735|79204864|FG003|Overall Study|Protocol Violation|0|||
44272173|NCT00085735|79204865|FG004|Overall Study|Protocol Violation|0|||
44272174|NCT00085735|79204866|FG005|Overall Study|Protocol Violation|0|||
44222803|NCT01875991|79026266|FG001|Overall Study|Withdrawal by Subject|6|||
44222804|NCT01875991|79026265|FG000|Overall Study|Sponsor Decision|1|||
44222805|NCT01875991|79026266|FG001|Overall Study|Sponsor Decision|0|||
44222806|NCT01855243|79026278|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
44222807|NCT01855243|79026279|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
44222808|NCT01855243|79026280|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
44222809|NCT01825837|79026292|FG000|PART I|Withdrawal by Subject|0|||
44222810|NCT01825837|79026293|FG001|PART I|Withdrawal by Subject|0|||
44222811|NCT01825837|79026294|FG002|PART I|Withdrawal by Subject|0|||
44222812|NCT01825837|79026295|FG003|PART I|Withdrawal by Subject|6|||
44222813|NCT01825837|79026292|FG000|PART I|Patient non-compliance|0|||
44222814|NCT01825837|79026293|FG001|PART I|Patient non-compliance|0|||
44222815|NCT01825837|79026294|FG002|PART I|Patient non-compliance|0|||
44222816|NCT01825837|79026295|FG003|PART I|Patient non-compliance|1|||
44222817|NCT01825837|79026292|FG000|PART I|Treatment failure|0|||
44222818|NCT01825837|79026293|FG001|PART I|Treatment failure|0|||
44222819|NCT01825837|79026294|FG002|PART I|Treatment failure|0|||
44222820|NCT01825837|79026295|FG003|PART I|Treatment failure|7|||
44222821|NCT01825837|79026292|FG000|PART I|reason unspecified|0|||
44222822|NCT01825837|79026293|FG001|PART I|reason unspecified|0|||
44222823|NCT01825837|79026294|FG002|PART I|reason unspecified|0|||
44222824|NCT01825837|79026295|FG003|PART I|reason unspecified|3|||
44222825|NCT01825837|79026292|FG000|PART II|Withdrawal by Subject|3|||
44222826|NCT01825837|79026293|FG001|PART II|Withdrawal by Subject|3|||
44222827|NCT01825837|79026294|FG002|PART II|Withdrawal by Subject|7|||
44222828|NCT01825837|79026295|FG003|PART II|Withdrawal by Subject|0|||
44222829|NCT01825837|79026292|FG000|PART II|Patient non-compliance|5|||
44272175|NCT00085735|79204861|FG000|Overall Study|Withdrawal by Subject|1|||
44272176|NCT00085735|79204862|FG001|Overall Study|Withdrawal by Subject|0|||
44272177|NCT00085735|79204863|FG002|Overall Study|Withdrawal by Subject|4|||
44272178|NCT00085735|79204864|FG003|Overall Study|Withdrawal by Subject|5|||
44272179|NCT00085735|79204865|FG004|Overall Study|Withdrawal by Subject|7|||
44272180|NCT00085735|79204866|FG005|Overall Study|Withdrawal by Subject|8|||
44222830|NCT01825837|79026293|FG001|PART II|Patient non-compliance|2|||
44222831|NCT01825837|79026294|FG002|PART II|Patient non-compliance|4|||
44222832|NCT01825837|79026295|FG003|PART II|Patient non-compliance|0|||
44222833|NCT01825837|79026292|FG000|PART II|Adverse Event|3|||
44222834|NCT01825837|79026293|FG001|PART II|Adverse Event|3|||
44222835|NCT01825837|79026294|FG002|PART II|Adverse Event|1|||
44222836|NCT01825837|79026295|FG003|PART II|Adverse Event|0|||
44222837|NCT01825837|79026292|FG000|PART II|Treatment failure|6|||
44222838|NCT01825837|79026293|FG001|PART II|Treatment failure|4|||
44222839|NCT01825837|79026294|FG002|PART II|Treatment failure|5|||
44222840|NCT01825837|79026295|FG003|PART II|Treatment failure|0|||
44222841|NCT01825837|79026292|FG000|PART II|reason unspecified|2|||
44222842|NCT01825837|79026293|FG001|PART II|reason unspecified|2|||
44222843|NCT01825837|79026294|FG002|PART II|reason unspecified|2|||
44222844|NCT01825837|79026295|FG003|PART II|reason unspecified|0|||
44222845|NCT01854697|79026308|FG000|Overall Study|Adverse Event|1|||
44222846|NCT01854697|79026309|FG001|Overall Study|Adverse Event|0|||
44222847|NCT01854697|79026310|FG002|Overall Study|Adverse Event|0|||
44222848|NCT01854697|79026311|FG003|Overall Study|Adverse Event|0|||
44222849|NCT01854697|79026312|FG004|Overall Study|Adverse Event|1|||
44222850|NCT01854697|79026308|FG000|Overall Study|Lost to Follow-up|4|||
44222851|NCT01854697|79026309|FG001|Overall Study|Lost to Follow-up|1|||
44222852|NCT01854697|79026310|FG002|Overall Study|Lost to Follow-up|1|||
44222853|NCT01854697|79026311|FG003|Overall Study|Lost to Follow-up|2|||
44222854|NCT01854697|79026312|FG004|Overall Study|Lost to Follow-up|0|||
44222855|NCT01854697|79026308|FG000|Overall Study|To enter another AbbVie study|1|||
44222856|NCT01854697|79026309|FG001|Overall Study|To enter another AbbVie study|0|||
44222857|NCT01854697|79026310|FG002|Overall Study|To enter another AbbVie study|0|||
44222858|NCT01854697|79026311|FG003|Overall Study|To enter another AbbVie study|0|||
44272181|NCT00085735|79204861|FG000|Overall Study|Patient ineligible|1|||
44272182|NCT00085735|79204862|FG001|Overall Study|Patient ineligible|0|||
44375099|NCT00908037|79380263|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
44222859|NCT01854697|79026312|FG004|Overall Study|To enter another AbbVie study|1|||
44222860|NCT01854697|79026308|FG000|Overall Study|Withdrew Consent|0|||
44222861|NCT01854697|79026309|FG001|Overall Study|Withdrew Consent|1|||
44222862|NCT01854697|79026310|FG002|Overall Study|Withdrew Consent|0|||
44222863|NCT01854697|79026311|FG003|Overall Study|Withdrew Consent|1|||
44465865|NCT00299494|79474787|FG005|Overall Study|Lost to Follow-up|1|||
44272183|NCT00085735|79204863|FG002|Overall Study|Patient ineligible|3|||
44222864|NCT01854697|79026312|FG004|Overall Study|Withdrew Consent|0|||
44222865|NCT01854697|79026308|FG000|Overall Study|Other|0|||
44222866|NCT01854697|79026309|FG001|Overall Study|Other|1|||
44222867|NCT01854697|79026310|FG002|Overall Study|Other|1|||
44222868|NCT01854697|79026311|FG003|Overall Study|Other|0|||
44222869|NCT01854697|79026312|FG004|Overall Study|Other|0|||
44222870|NCT01824979|79026324|FG000|Overall Study|Withdrawal by Subject|5|||
44222871|NCT01824979|79026325|FG001|Overall Study|Withdrawal by Subject|0|||
44222872|NCT01824979|79026324|FG000|Overall Study|Physician Decision|2|||
44222873|NCT01824979|79026325|FG001|Overall Study|Physician Decision|0|||
44222874|NCT01824979|79026324|FG000|Overall Study|Protocol Violation|6|||
44222875|NCT01824979|79026325|FG001|Overall Study|Protocol Violation|13|||
44222876|NCT01824823|79026333|FG000|Overall Study|Lack of Efficacy|1|||
44222877|NCT01824823|79026334|FG001|Overall Study|Lack of Efficacy|1|||
44222878|NCT01824823|79026333|FG000|Overall Study|Off-treatment reason not submitted|1|||
44222879|NCT01824823|79026334|FG001|Overall Study|Off-treatment reason not submitted|0|||
44222880|NCT01875367|79026342|FG000|Overall Study|Not complete at least 2 questionaries|4|||
44222881|NCT01875367|79026343|FG001|Overall Study|Not complete at least 2 questionaries|2|||
44222882|NCT01875367|79026342|FG000|Overall Study|Not receive study treatment|1|||
44222883|NCT01875367|79026343|FG001|Overall Study|Not receive study treatment|0|||
44222884|NCT01853839|79026353|FG000|Overall Study|Violated inclusion criteria|2|||
44222885|NCT01853839|79026353|FG000|Overall Study|Not meet ITT population definition|58|||
44222886|NCT01853839|79026353|FG000|Overall Study|End of treatment visit too early|33|||
44272184|NCT00085735|79204864|FG003|Overall Study|Patient ineligible|7|||
44272185|NCT00085735|79204865|FG004|Overall Study|Patient ineligible|17|||
44272186|NCT00085735|79204866|FG005|Overall Study|Patient ineligible|8|||
44272187|NCT00085735|79204861|FG000|Overall Study|Excess residual disease|2|||
44272188|NCT00085735|79204862|FG001|Overall Study|Excess residual disease|2|||
44272189|NCT00085735|79204863|FG002|Overall Study|Excess residual disease|1|||
44272190|NCT00085735|79204864|FG003|Overall Study|Excess residual disease|1|||
44272191|NCT00085735|79204865|FG004|Overall Study|Excess residual disease|1|||
44272192|NCT00085735|79204866|FG005|Overall Study|Excess residual disease|4|||
44272193|NCT00085735|79204861|FG000|Overall Study|Reason not documented|1|||
44272194|NCT00085735|79204862|FG001|Overall Study|Reason not documented|0|||
44272195|NCT00085735|79204863|FG002|Overall Study|Reason not documented|1|||
44272196|NCT00085735|79204864|FG003|Overall Study|Reason not documented|0|||
44272197|NCT00085735|79204865|FG004|Overall Study|Reason not documented|1|||
44272198|NCT00085735|79204866|FG005|Overall Study|Reason not documented|0|||
44272199|NCT00085735|79204861|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
44272200|NCT00085735|79204862|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
44272201|NCT00085735|79204863|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
44272202|NCT00085735|79204864|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
44272203|NCT00085735|79204865|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
44272204|NCT00085735|79204866|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
44272205|NCT04537793|79205168|FG000|Part B (24 Weeks)|Adverse Event|0|||
44272206|NCT04537793|79205169|FG001|Part B (24 Weeks)|Adverse Event|1|||
44272207|NCT01938001|79206418|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
44272208|NCT01938001|79206419|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
44272209|NCT01938001|79206418|FG000|Pre-Treatment|Death|1|||
44272210|NCT01938001|79206419|FG001|Pre-Treatment|Death|0|||
44272211|NCT01938001|79206418|FG000|Treatment|Death|2|||
44272212|NCT01938001|79206419|FG001|Treatment|Death|0|||
44272213|NCT01938001|79206418|FG000|Treatment|Adverse Event|14|||
44272214|NCT01938001|79206419|FG001|Treatment|Adverse Event|8|||
44272215|NCT01938001|79206418|FG000|Treatment|Progressive Disease|21|||
44272216|NCT01938001|79206419|FG001|Treatment|Progressive Disease|54|||
44272217|NCT01938001|79206418|FG000|Treatment|Withdrawal by Subject|13|||
44272218|NCT01938001|79206419|FG001|Treatment|Withdrawal by Subject|7|||
44272219|NCT01938001|79206418|FG000|Treatment|Other reasons|2|||
44272220|NCT01938001|79206419|FG001|Treatment|Other reasons|1|||
44272221|NCT01066663|79206580|FG000|Overall Study|Adverse Event|0|||
44272222|NCT01066663|79206581|FG001|Overall Study|Adverse Event|0|||
44272223|NCT01066663|79206582|FG002|Overall Study|Adverse Event|1|||
44272224|NCT03930745|79208784|FG000|Overall Study|Lost to Follow-up|10|||
44272225|NCT03930745|79208785|FG001|Overall Study|Lost to Follow-up|5|||
44272226|NCT03930745|79208784|FG000|Overall Study|Withdrawal by Subject|1|||
44272227|NCT03930745|79208785|FG001|Overall Study|Withdrawal by Subject|2|||
44272228|NCT03930745|79208784|FG000|Overall Study|Protocol Violation|2|||
44272229|NCT03930745|79208785|FG001|Overall Study|Protocol Violation|2|||
44465866|NCT00299494|79474782|FG000|Overall Study|Other - Unspecified|0|||
44465867|NCT00299494|79474783|FG001|Overall Study|Other - Unspecified|0|||
44465868|NCT00299494|79474784|FG002|Overall Study|Other - Unspecified|0|||
44465869|NCT00299494|79474785|FG003|Overall Study|Other - Unspecified|0|||
44465870|NCT00299494|79474786|FG004|Overall Study|Other - Unspecified|3|||
44465871|NCT00299494|79474787|FG005|Overall Study|Other - Unspecified|1|||
44222887|NCT01853839|79026353|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
44222888|NCT01874665|79026363|FG000|Overall Study|Adverse Event|6|||
44222889|NCT01874665|79026364|FG001|Overall Study|Adverse Event|2|||
44222890|NCT01874665|79026363|FG000|Overall Study|Withdrawal by Subject|4|||
44222891|NCT01874665|79026364|FG001|Overall Study|Withdrawal by Subject|1|||
44222892|NCT01874665|79026363|FG000|Overall Study|Physician Decision|3|||
44272230|NCT03930745|79208784|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
44272231|NCT03930745|79208785|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
44272232|NCT03930745|79208784|FG000|Overall Study|Adverse Event|0|||
44272233|NCT03930745|79208785|FG001|Overall Study|Adverse Event|1|||
44272234|NCT03930745|79208784|FG000|Overall Study|Pregnancy|0|||
44272235|NCT03930745|79208785|FG001|Overall Study|Pregnancy|1|||
44272236|NCT04473326|79211530|FG000|Overall Study|Death|0|||
44272237|NCT04473326|79211531|FG001|Overall Study|Death|1|||
44272238|NCT04473326|79211530|FG000|Overall Study|Withdrawal by Subject|1|||
44272239|NCT04473326|79211531|FG001|Overall Study|Withdrawal by Subject|2|||
44272240|NCT05993299|79211882|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
44272241|NCT05993299|79211882|FG000|Overall Study|Ongoing|4|||
44272242|NCT05239598|79211939|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
44272243|NCT05239598|79211940|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
44272244|NCT05239598|79211939|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
44272245|NCT05239598|79211940|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
44272246|NCT05010070|79211983|FG000|Overall Study|Lost to Follow-up|1|||
44272247|NCT05010070|79211983|FG000|Overall Study|Withdrawal by Subject|1|||
44272248|NCT04523480|79212008|FG000|Overall Study|Lost to Follow-up|30|||
44272249|NCT04523480|79212009|FG001|Overall Study|Lost to Follow-up|35|||
44272250|NCT04523480|79212010|FG002|Overall Study|Lost to Follow-up|0|||
44272251|NCT04454125|79212020|FG000|Overall Study|Lost to Follow-up|0|||
44272252|NCT04454125|79212021|FG001|Overall Study|Lost to Follow-up|1|||
44272253|NCT04307446|79212033|FG000|Overall Study|Lost to Follow-up|2|||
44272254|NCT04307446|79212034|FG001|Overall Study|Lost to Follow-up|0|||
44272255|NCT04143009|79212056|FG000|Pilot Trial|Lost to Follow-up|0|||
44272256|NCT04143009|79212057|FG001|Pilot Trial|Lost to Follow-up|1|||
44272257|NCT04143009|79212058|FG002|Pilot Trial|Lost to Follow-up|1|||
44272258|NCT04126317|79212068|FG000|Overall Study|Adverse Event|0|||
44272259|NCT04126317|79212069|FG001|Overall Study|Adverse Event|1|||
44272260|NCT04126317|79212068|FG000|Overall Study|Withdrawal by Subject|4|||
44272261|NCT04126317|79212069|FG001|Overall Study|Withdrawal by Subject|1|||
44272262|NCT04066894|79212075|FG000|Overall Study|Lack of Efficacy|1|||
44272263|NCT04066894|79212075|FG000|Overall Study|Screen Failure|1|||
44272264|NCT03929913|79212101|FG000|Overall Study|Death|4|||
44272265|NCT03929913|79212101|FG000|Overall Study|Lost to Follow-up|1|||
44272266|NCT03929913|79212101|FG000|Overall Study|Failed Procedure|2|||
44272267|NCT03832192|79212116|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
44272268|NCT03832192|79212117|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
44272269|NCT03738800|79212133|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
44272270|NCT03738800|79212134|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
44272271|NCT03738800|79212135|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44272272|NCT03738800|79212133|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
44272273|NCT03738800|79212134|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
44272274|NCT03738800|79212135|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
44272275|NCT03738800|79212133|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
44272276|NCT03738800|79212134|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
44272277|NCT03738800|79212135|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
44272278|NCT03682055|79212154|FG000|Overall Study|Lack of Efficacy|1|||
44272279|NCT03682055|79212155|FG001|Overall Study|Lack of Efficacy|2|||
44272280|NCT03682055|79212156|FG002|Overall Study|Lack of Efficacy|1|||
44272281|NCT03682055|79212157|FG003|Overall Study|Lack of Efficacy|2|||
44272282|NCT03682055|79212158|FG004|Overall Study|Lack of Efficacy|1|||
44272283|NCT03682055|79212159|FG005|Overall Study|Lack of Efficacy|3|||
44272284|NCT03682055|79212154|FG000|Overall Study|Withdrawal by Subject|0|||
44272285|NCT03682055|79212155|FG001|Overall Study|Withdrawal by Subject|0|||
44272286|NCT03682055|79212156|FG002|Overall Study|Withdrawal by Subject|0|||
44272287|NCT03682055|79212157|FG003|Overall Study|Withdrawal by Subject|0|||
44272288|NCT03682055|79212158|FG004|Overall Study|Withdrawal by Subject|0|||
44272289|NCT03682055|79212159|FG005|Overall Study|Withdrawal by Subject|1|||
44272290|NCT03682055|79212154|FG000|Overall Study|Termination of Study by Sponsor|0|||
44272291|NCT03682055|79212155|FG001|Overall Study|Termination of Study by Sponsor|0|||
44272292|NCT03682055|79212156|FG002|Overall Study|Termination of Study by Sponsor|0|||
44272293|NCT03682055|79212157|FG003|Overall Study|Termination of Study by Sponsor|0|||
44272294|NCT03682055|79212158|FG004|Overall Study|Termination of Study by Sponsor|0|||
44272295|NCT03682055|79212159|FG005|Overall Study|Termination of Study by Sponsor|3|||
44272296|NCT03547518|79212175|FG000|Overall Study|Lost to Follow-up|2|||
44272297|NCT03547518|79212176|FG001|Overall Study|Lost to Follow-up|0|||
44272298|NCT03519347|79212187|FG000|Interventional Crossover Period 1|Death|0|||
44272299|NCT03519347|79212188|FG001|Interventional Crossover Period 1|Death|0|||
44272300|NCT03519347|79212189|FG002|Interventional Crossover Period 1|Death|0|||
44272301|NCT03519347|79212190|FG003|Interventional Crossover Period 1|Death|1|||
44272302|NCT03199638|79212228|FG000|Overall Study|inability to drink glutamine during regularly|0|||
44272303|NCT03199638|79212229|FG001|Overall Study|inability to drink glutamine during regularly|2|||
44272304|NCT03015194|79212248|FG000|Overall Study|Death|10|||
44272305|NCT03015194|79212248|FG000|Overall Study|Withdrawal by Subject|2|||
44272306|NCT02873715|79212259|FG000|Overall Study|Lost to Follow-up|84|||
44272307|NCT02873715|79212260|FG001|Overall Study|Lost to Follow-up|94|||
44375100|NCT00908037|79380264|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44272308|NCT02873715|79212259|FG000|Overall Study|Withdrawal by Subject|7|||
44272309|NCT02873715|79212260|FG001|Overall Study|Withdrawal by Subject|26|||
44272310|NCT02536300|79212278|FG000|Overall Study|Investigator's Discretion|17|||
44272311|NCT02536300|79212279|FG001|Overall Study|Investigator's Discretion|11|||
44272312|NCT02536300|79212280|FG002|Overall Study|Investigator's Discretion|2|||
44272313|NCT02536300|79212278|FG000|Overall Study|Progressive Disease|11|||
44272314|NCT02536300|79212279|FG001|Overall Study|Progressive Disease|7|||
44272315|NCT02536300|79212280|FG002|Overall Study|Progressive Disease|6|||
44272316|NCT02536300|79212278|FG000|Overall Study|Study Terminated by Sponsor|6|||
44272317|NCT02536300|79212279|FG001|Overall Study|Study Terminated by Sponsor|4|||
44272318|NCT02536300|79212280|FG002|Overall Study|Study Terminated by Sponsor|7|||
44272319|NCT02536300|79212278|FG000|Overall Study|Death|7|||
44272320|NCT02536300|79212279|FG001|Overall Study|Death|0|||
44272321|NCT02536300|79212280|FG002|Overall Study|Death|5|||
44272322|NCT02536300|79212278|FG000|Overall Study|Withdrew Consent|4|||
44272323|NCT02536300|79212279|FG001|Overall Study|Withdrew Consent|2|||
44272324|NCT02536300|79212280|FG002|Overall Study|Withdrew Consent|0|||
44272325|NCT02536300|79212278|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
44272326|NCT02536300|79212279|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
44272327|NCT02536300|79212280|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
44272328|NCT02536300|79212278|FG000|Overall Study|Enrolled but Never Treated|0|||
44272329|NCT02536300|79212279|FG001|Overall Study|Enrolled but Never Treated|0|||
44272330|NCT02536300|79212280|FG002|Overall Study|Enrolled but Never Treated|1|||
44272331|NCT02536300|79212278|FG000|Overall Study|Non-compliance With Study Drug|1|||
44272332|NCT02536300|79212279|FG001|Overall Study|Non-compliance With Study Drug|0|||
44272333|NCT02536300|79212280|FG002|Overall Study|Non-compliance With Study Drug|0|||
44272334|NCT02536300|79212278|FG000|Overall Study|Protocol Violation|0|||
44222893|NCT01874665|79026364|FG001|Overall Study|Physician Decision|0|||
44222894|NCT01874665|79026363|FG000|Overall Study|Clinical Progressive Disease|4|||
44222895|NCT01874665|79026364|FG001|Overall Study|Clinical Progressive Disease|3|||
44222896|NCT01874665|79026363|FG000|Overall Study|Study Terminated by Sponsor|0|||
44222897|NCT01874665|79026364|FG001|Overall Study|Study Terminated by Sponsor|2|||
44222898|NCT01874665|79026363|FG000|Overall Study|Documented Progressive Disease|11|||
44222899|NCT01874665|79026364|FG001|Overall Study|Documented Progressive Disease|7|||
44222900|NCT01874665|79026363|FG000|Overall Study|Other|2|||
44272335|NCT02536300|79212279|FG001|Overall Study|Protocol Violation|1|||
44272336|NCT02536300|79212280|FG002|Overall Study|Protocol Violation|0|||
44272337|NCT01856686|79212290|FG000|Overall Study|Lost to Follow-up|5|||
44272338|NCT01856686|79212291|FG001|Overall Study|Lost to Follow-up|11|||
44272339|NCT01770145|79212297|FG000|Baseline|Adverse Event|20|||
44272340|NCT01770145|79212297|FG000|Baseline|Withdrawal by Subject|1|||
44272341|NCT01770145|79212297|FG000|Baseline|Lost to Follow-up|1|||
44272342|NCT01770145|79212297|FG000|Baseline|Unable to define optimal dose|4|||
44272343|NCT01770145|79212297|FG000|Treatment|Adverse Event|3|||
44222901|NCT01874665|79026364|FG001|Overall Study|Other|0|||
44222902|NCT01874431|79026379|FG000|Overall Study|Physician Decision|0|||
44222903|NCT01874431|79026380|FG001|Overall Study|Physician Decision|0|||
44222904|NCT01874431|79026381|FG002|Overall Study|Physician Decision|1|||
44222905|NCT01874431|79026382|FG003|Overall Study|Physician Decision|0|||
44222906|NCT01874431|79026383|FG004|Overall Study|Physician Decision|0|||
44222907|NCT01874431|79026384|FG005|Overall Study|Physician Decision|0|||
44222908|NCT01874431|79026385|FG006|Overall Study|Physician Decision|0|||
44222909|NCT01874431|79026386|FG007|Overall Study|Physician Decision|0|||
44222910|NCT01874431|79026379|FG000|Overall Study|Adverse Event|5|||
44272344|NCT01770145|79212297|FG000|Treatment|Withdrawal by Subject|1|||
44272345|NCT01749137|79212303|FG000|Overall Study|Adverse Event|4|||
44272346|NCT01749137|79212304|FG001|Overall Study|Adverse Event|4|||
44272347|NCT01749137|79212303|FG000|Overall Study|Lost to Follow-up|2|||
44272348|NCT01749137|79212304|FG001|Overall Study|Lost to Follow-up|3|||
44272349|NCT01749137|79212303|FG000|Overall Study|Physician Decision|1|||
44272350|NCT01749137|79212304|FG001|Overall Study|Physician Decision|0|||
44272351|NCT01749137|79212303|FG000|Overall Study|Withdrawal by Subject|8|||
44375101|NCT00908037|79380265|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44222911|NCT01874431|79026380|FG001|Overall Study|Adverse Event|4|||
44222912|NCT01874431|79026381|FG002|Overall Study|Adverse Event|6|||
44222913|NCT01874431|79026382|FG003|Overall Study|Adverse Event|5|||
44222914|NCT01874431|79026383|FG004|Overall Study|Adverse Event|2|||
44222915|NCT01874431|79026384|FG005|Overall Study|Adverse Event|8|||
44222916|NCT01874431|79026385|FG006|Overall Study|Adverse Event|2|||
44272352|NCT01749137|79212304|FG001|Overall Study|Withdrawal by Subject|4|||
44272353|NCT01726582|79212310|FG000|Overall Study|Physician Decision|99|||
44272354|NCT01726582|79212310|FG000|Overall Study|Death|85|||
44272355|NCT00794339|79212325|FG000|Overall Study|Withdrawal by Subject|3|||
44272356|NCT00794339|79212325|FG000|Overall Study|Ineligible|4|||
44272357|NCT00794339|79212325|FG000|Overall Study|Tx prior to ATSM|3|||
44272358|NCT00794339|79212325|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
44222917|NCT01874431|79026386|FG007|Overall Study|Adverse Event|3|||
44222918|NCT01874431|79026379|FG000|Overall Study|Protocol Violation|1|||
44272359|NCT00794339|79212325|FG000|Overall Study|Tx not per protocol|1|||
44272360|NCT00506662|79212352|FG000|Overall Study|Adverse Event|0|||
44272361|NCT00506662|79212353|FG001|Overall Study|Adverse Event|2|||
44272362|NCT00506662|79212352|FG000|Overall Study|Lack of Efficacy|1|||
44272363|NCT00506662|79212353|FG001|Overall Study|Lack of Efficacy|0|||
44272364|NCT00506662|79212352|FG000|Overall Study|Protocol Violation|2|||
44272365|NCT00506662|79212353|FG001|Overall Study|Protocol Violation|4|||
44272366|NCT00506662|79212352|FG000|Overall Study|Trial terminated|10|||
44272367|NCT00506662|79212353|FG001|Overall Study|Trial terminated|16|||
44272368|NCT00506662|79212352|FG000|Overall Study|Not recorded|4|||
44272369|NCT00506662|79212353|FG001|Overall Study|Not recorded|6|||
44272370|NCT00161213|79212359|FG000|Overall Study|Withdrawal by Subject|1|||
44272371|NCT00161213|79212359|FG000|Overall Study|Evaluable for toxicity but not response|1|||
44272372|NCT00006436|79212367|FG000|Overall Study|Refused further treatment|2|||
44272373|NCT00006436|79212367|FG000|Overall Study|Declined to participate (before treatment started)|1|||
44272374|NCT03838484|79212590|FG000|Overall Study|Lost to Follow-up|0|||
44272375|NCT03838484|79212591|FG001|Overall Study|Lost to Follow-up|1|||
44272376|NCT03838484|79212592|FG002|Overall Study|Lost to Follow-up|0|||
44272377|NCT03838484|79212593|FG003|Overall Study|Lost to Follow-up|0|||
44272378|NCT01349192|79212825|FG000|Overall Study|Protocol Violation|0|||
44272379|NCT01349192|79212826|FG001|Overall Study|Protocol Violation|1|||
44272380|NCT01349192|79212825|FG000|Overall Study|Withdrawal by Subject|0|||
44272381|NCT01349192|79212826|FG001|Overall Study|Withdrawal by Subject|2|||
44272382|NCT01349192|79212825|FG000|Overall Study|Lost to Follow-up|1|||
44272383|NCT01349192|79212826|FG001|Overall Study|Lost to Follow-up|3|||
44272384|NCT01349192|79212825|FG000|Overall Study|Failure to adhere to Protocol|2|||
44272385|NCT01349192|79212826|FG001|Overall Study|Failure to adhere to Protocol|0|||
44272386|NCT01721876|79213177|FG000|Overall Study|Not treated|1|||
44272387|NCT01721876|79213178|FG001|Overall Study|Not treated|4|||
44272388|NCT01721876|79213177|FG000|Overall Study|Disease progression / relapse|123|||
44272389|NCT01721876|79213178|FG001|Overall Study|Disease progression / relapse|156|||
44272390|NCT01721876|79213177|FG000|Overall Study|Death|6|||
44272391|NCT01721876|79213178|FG001|Overall Study|Death|13|||
44272392|NCT01721876|79213177|FG000|Overall Study|Adverse Event|41|||
44272393|NCT01721876|79213178|FG001|Overall Study|Adverse Event|165|||
44272394|NCT01721876|79213177|FG000|Overall Study|Protocol Violation|2|||
44272395|NCT01721876|79213178|FG001|Overall Study|Protocol Violation|1|||
44272396|NCT01721876|79213177|FG000|Overall Study|Withdrawal by Subject|15|||
44272397|NCT01721876|79213178|FG001|Overall Study|Withdrawal by Subject|38|||
44272398|NCT01721876|79213177|FG000|Overall Study|Reason not listed|34|||
44222919|NCT01874431|79026380|FG001|Overall Study|Protocol Violation|1|||
44222920|NCT01874431|79026381|FG002|Overall Study|Protocol Violation|1|||
44222921|NCT01874431|79026382|FG003|Overall Study|Protocol Violation|0|||
44222922|NCT01874431|79026383|FG004|Overall Study|Protocol Violation|3|||
44222923|NCT01874431|79026384|FG005|Overall Study|Protocol Violation|2|||
44222924|NCT01874431|79026385|FG006|Overall Study|Protocol Violation|1|||
44222925|NCT01874431|79026386|FG007|Overall Study|Protocol Violation|1|||
44222926|NCT01874431|79026379|FG000|Overall Study|Non-compliance|0|||
44222927|NCT01874431|79026380|FG001|Overall Study|Non-compliance|0|||
44272399|NCT01721876|79213178|FG001|Overall Study|Reason not listed|63|||
44272400|NCT01721876|79213177|FG000|Overall Study|Sponsor terminated trial|0|||
44272401|NCT01721876|79213178|FG001|Overall Study|Sponsor terminated trial|4|||
44272402|NCT02265510|79213409|FG000|Overall Study|Withdrawal by Subject|1|||
44272403|NCT02265510|79213410|FG001|Overall Study|Withdrawal by Subject|1|||
44272404|NCT02265510|79213411|FG002|Overall Study|Withdrawal by Subject|2|||
44272405|NCT02265510|79213412|FG003|Overall Study|Withdrawal by Subject|1|||
44272406|NCT02265510|79213413|FG004|Overall Study|Withdrawal by Subject|0|||
44272407|NCT02265510|79213414|FG005|Overall Study|Withdrawal by Subject|2|||
44222928|NCT01874431|79026381|FG002|Overall Study|Non-compliance|0|||
44222929|NCT01874431|79026382|FG003|Overall Study|Non-compliance|0|||
44222930|NCT01874431|79026383|FG004|Overall Study|Non-compliance|1|||
44514812|NCT03084796|79520626|FG003|Overall Study|Lost to Follow-up|1|||
44222931|NCT01874431|79026384|FG005|Overall Study|Non-compliance|0|||
44272408|NCT02265510|79213415|FG006|Overall Study|Withdrawal by Subject|0|||
44272409|NCT02265510|79213416|FG007|Overall Study|Withdrawal by Subject|2|||
44272410|NCT02265510|79213417|FG008|Overall Study|Withdrawal by Subject|0|||
44272411|NCT02265510|79213418|FG009|Overall Study|Withdrawal by Subject|0|||
44222932|NCT01874431|79026385|FG006|Overall Study|Non-compliance|1|||
44272412|NCT02265510|79213419|FG010|Overall Study|Withdrawal by Subject|0|||
44277808|NCT02092350|79238806|FG000|Overall Study|Physician Decision|1|||
44272413|NCT02265510|79213420|FG011|Overall Study|Withdrawal by Subject|0|||
44272414|NCT02265510|79213421|FG012|Overall Study|Withdrawal by Subject|1|||
44272415|NCT02265510|79213422|FG013|Overall Study|Withdrawal by Subject|0|||
44272416|NCT02265510|79213409|FG000|Overall Study|Disease Progression|0|||
44272417|NCT02265510|79213410|FG001|Overall Study|Disease Progression|1|||
44272418|NCT02265510|79213411|FG002|Overall Study|Disease Progression|2|||
44272419|NCT02265510|79213412|FG003|Overall Study|Disease Progression|1|||
44272420|NCT02265510|79213413|FG004|Overall Study|Disease Progression|1|||
44272421|NCT02265510|79213414|FG005|Overall Study|Disease Progression|0|||
44272422|NCT02265510|79213415|FG006|Overall Study|Disease Progression|0|||
44272423|NCT02265510|79213416|FG007|Overall Study|Disease Progression|0|||
44272424|NCT02265510|79213417|FG008|Overall Study|Disease Progression|0|||
44272425|NCT02265510|79213418|FG009|Overall Study|Disease Progression|0|||
44272426|NCT02265510|79213419|FG010|Overall Study|Disease Progression|0|||
44272427|NCT02265510|79213420|FG011|Overall Study|Disease Progression|0|||
44272428|NCT02265510|79213421|FG012|Overall Study|Disease Progression|0|||
44272429|NCT02265510|79213422|FG013|Overall Study|Disease Progression|0|||
44272430|NCT02265510|79213409|FG000|Overall Study|Death|2|||
44272431|NCT02265510|79213410|FG001|Overall Study|Death|0|||
44272432|NCT02265510|79213411|FG002|Overall Study|Death|2|||
44272433|NCT02265510|79213412|FG003|Overall Study|Death|2|||
44272434|NCT02265510|79213413|FG004|Overall Study|Death|1|||
44272435|NCT02265510|79213414|FG005|Overall Study|Death|3|||
44272436|NCT02265510|79213415|FG006|Overall Study|Death|2|||
44272437|NCT02265510|79213416|FG007|Overall Study|Death|1|||
44272438|NCT02265510|79213417|FG008|Overall Study|Death|3|||
44272439|NCT02265510|79213418|FG009|Overall Study|Death|3|||
44272440|NCT02265510|79213419|FG010|Overall Study|Death|4|||
44272441|NCT02265510|79213420|FG011|Overall Study|Death|12|||
44272442|NCT02265510|79213421|FG012|Overall Study|Death|7|||
44272443|NCT02265510|79213422|FG013|Overall Study|Death|6|||
44272444|NCT02265510|79213409|FG000|Overall Study|Lost to Follow-up|0|||
44272445|NCT02265510|79213410|FG001|Overall Study|Lost to Follow-up|0|||
44272446|NCT02265510|79213411|FG002|Overall Study|Lost to Follow-up|0|||
44272447|NCT02265510|79213412|FG003|Overall Study|Lost to Follow-up|0|||
44272448|NCT02265510|79213413|FG004|Overall Study|Lost to Follow-up|1|||
44272449|NCT02265510|79213414|FG005|Overall Study|Lost to Follow-up|0|||
44272450|NCT02265510|79213415|FG006|Overall Study|Lost to Follow-up|0|||
44272451|NCT02265510|79213416|FG007|Overall Study|Lost to Follow-up|0|||
44272452|NCT02265510|79213417|FG008|Overall Study|Lost to Follow-up|0|||
44272453|NCT02265510|79213418|FG009|Overall Study|Lost to Follow-up|2|||
44272454|NCT02265510|79213419|FG010|Overall Study|Lost to Follow-up|0|||
44272455|NCT02265510|79213420|FG011|Overall Study|Lost to Follow-up|0|||
44272456|NCT02265510|79213421|FG012|Overall Study|Lost to Follow-up|0|||
44272457|NCT02265510|79213422|FG013|Overall Study|Lost to Follow-up|2|||
44272458|NCT02265510|79213409|FG000|Overall Study|Other|0|||
44272459|NCT02265510|79213410|FG001|Overall Study|Other|1|||
44272460|NCT02265510|79213411|FG002|Overall Study|Other|0|||
44272461|NCT02265510|79213412|FG003|Overall Study|Other|0|||
44272462|NCT02265510|79213413|FG004|Overall Study|Other|0|||
44272463|NCT02265510|79213414|FG005|Overall Study|Other|0|||
44272464|NCT02265510|79213415|FG006|Overall Study|Other|0|||
44544313|NCT03055988|79557663|FG001|Period 2|Adverse Event|1|||
44222933|NCT01874431|79026386|FG007|Overall Study|Non-compliance|0|||
44222934|NCT01874431|79026379|FG000|Overall Study|Logistical difficulties|0|||
44222935|NCT01874431|79026380|FG001|Overall Study|Logistical difficulties|0|||
44222936|NCT01874431|79026381|FG002|Overall Study|Logistical difficulties|0|||
44222937|NCT01874431|79026382|FG003|Overall Study|Logistical difficulties|0|||
44222938|NCT01874431|79026383|FG004|Overall Study|Logistical difficulties|0|||
44222939|NCT01874431|79026384|FG005|Overall Study|Logistical difficulties|0|||
44222940|NCT01874431|79026385|FG006|Overall Study|Logistical difficulties|1|||
44272465|NCT02265510|79213416|FG007|Overall Study|Other|0|||
44272466|NCT02265510|79213417|FG008|Overall Study|Other|0|||
44272467|NCT02265510|79213418|FG009|Overall Study|Other|0|||
44272468|NCT02265510|79213419|FG010|Overall Study|Other|0|||
44375102|NCT00908037|79380266|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44375103|NCT00908037|79380267|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44375104|NCT00908037|79380268|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
44465872|NCT00299494|79474782|FG000|Overall Study|Other - site closure|0|||
44544314|NCT03055988|79557662|FG000|Period 2|Other than listed|1|||
44222941|NCT01874431|79026386|FG007|Overall Study|Logistical difficulties|0|||
44272469|NCT02265510|79213420|FG011|Overall Study|Other|0|||
44272470|NCT02265510|79213421|FG012|Overall Study|Other|0|||
44465873|NCT00299494|79474783|FG001|Overall Study|Other - site closure|0|||
44222942|NCT01874431|79026379|FG000|Overall Study|Withdrawal by Subject|0|||
44222943|NCT01874431|79026380|FG001|Overall Study|Withdrawal by Subject|0|||
44272471|NCT02265510|79213422|FG013|Overall Study|Other|0|||
44272472|NCT02265510|79213409|FG000|Overall Study|Study Terminated by Sponsor|0|||
44272473|NCT02265510|79213410|FG001|Overall Study|Study Terminated by Sponsor|0|||
44272474|NCT02265510|79213411|FG002|Overall Study|Study Terminated by Sponsor|0|||
44272475|NCT02265510|79213412|FG003|Overall Study|Study Terminated by Sponsor|0|||
44272476|NCT02265510|79213413|FG004|Overall Study|Study Terminated by Sponsor|0|||
44272477|NCT02265510|79213414|FG005|Overall Study|Study Terminated by Sponsor|1|||
44272478|NCT02265510|79213415|FG006|Overall Study|Study Terminated by Sponsor|1|||
44272479|NCT02265510|79213416|FG007|Overall Study|Study Terminated by Sponsor|1|||
44272480|NCT02265510|79213417|FG008|Overall Study|Study Terminated by Sponsor|1|||
44272481|NCT02265510|79213418|FG009|Overall Study|Study Terminated by Sponsor|2|||
44272482|NCT02265510|79213419|FG010|Overall Study|Study Terminated by Sponsor|1|||
44272483|NCT02265510|79213420|FG011|Overall Study|Study Terminated by Sponsor|4|||
44272484|NCT02265510|79213421|FG012|Overall Study|Study Terminated by Sponsor|1|||
44272485|NCT02265510|79213422|FG013|Overall Study|Study Terminated by Sponsor|2|||
44272486|NCT01238211|79213523|FG000|Overall Study|Continues active treatment|31|||
44272487|NCT01238211|79213523|FG000|Overall Study|Adverse Event|7|||
44272488|NCT01238211|79213523|FG000|Overall Study|Death|4|||
44272489|NCT01238211|79213523|FG000|Overall Study|Relapse/Progression|2|||
44272490|NCT01238211|79213523|FG000|Overall Study|Withdrawal by Subject|7|||
44272491|NCT01238211|79213523|FG000|Overall Study|Non-protocol treatment|4|||
44272492|NCT01238211|79213523|FG000|Overall Study|Investigator/Patient Decision|3|||
44272493|NCT02264574|79213699|FG000|Overall Study|Death|21|||
44272494|NCT02264574|79213700|FG001|Overall Study|Death|21|||
44272495|NCT02264574|79213699|FG000|Overall Study|Withdrawal by Subject|8|||
44272496|NCT02264574|79213700|FG001|Overall Study|Withdrawal by Subject|6|||
44272497|NCT02264574|79213699|FG000|Overall Study|Other, Not Specified|0|||
44272498|NCT02264574|79213700|FG001|Overall Study|Other, Not Specified|3|||
44272499|NCT01641900|79213740|FG000|Overall Study|Withdrawal by Subject|2|||
44272500|NCT01641900|79213741|FG001|Overall Study|Withdrawal by Subject|2|||
44272501|NCT01640808|79213806|FG000|Overall Study|Unable to continue dynamic CT|14|||
44272502|NCT01640808|79213807|FG001|Overall Study|Unable to continue dynamic CT|4|||
44272503|NCT01640808|79213806|FG000|Overall Study|Withdrawal by Subject|12|||
44272504|NCT01640808|79213807|FG001|Overall Study|Withdrawal by Subject|4|||
44272505|NCT01640808|79213806|FG000|Overall Study|Lost to Follow-up|4|||
44272506|NCT01640808|79213807|FG001|Overall Study|Lost to Follow-up|0|||
44272507|NCT01640808|79213806|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
44272508|NCT01640808|79213807|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
44272509|NCT01640808|79213806|FG000|Overall Study|Administration of anticancer drugs|2|||
44272510|NCT01640808|79213807|FG001|Overall Study|Administration of anticancer drugs|1|||
44272511|NCT01640808|79213806|FG000|Overall Study|Physician Decision|19|||
44272512|NCT01640808|79213807|FG001|Overall Study|Physician Decision|5|||
44272513|NCT01640808|79213806|FG000|Overall Study|Randomized but not treated|4|||
44272514|NCT01640808|79213807|FG001|Overall Study|Randomized but not treated|2|||
44272515|NCT02263326|79213828|FG000|Overall Study|Lost to Follow-up|1|||
44272516|NCT02263326|79213829|FG001|Overall Study|Lost to Follow-up|1|||
44272517|NCT02260986|79213935|FG000|Overall Study|Adverse Event|24|||
44272518|NCT02260986|79213936|FG001|Overall Study|Adverse Event|0|||
44272519|NCT02260986|79213937|FG002|Overall Study|Adverse Event|11|||
44272520|NCT02260986|79213935|FG000|Overall Study|Lack of Efficacy|27|||
44272521|NCT02260986|79213936|FG001|Overall Study|Lack of Efficacy|3|||
44272522|NCT02260986|79213937|FG002|Overall Study|Lack of Efficacy|0|||
44272523|NCT02260986|79213935|FG000|Overall Study|Protocol Violation|14|||
44272524|NCT02260986|79213936|FG001|Overall Study|Protocol Violation|5|||
44272525|NCT02260986|79213937|FG002|Overall Study|Protocol Violation|16|||
44272526|NCT02260986|79213935|FG000|Overall Study|Car accident|0|||
44272527|NCT02260986|79213936|FG001|Overall Study|Car accident|0|||
44272528|NCT02260986|79213937|FG002|Overall Study|Car accident|1|||
44272529|NCT02260986|79213935|FG000|Overall Study|Withdrawal by Subject|17|||
44272530|NCT02260986|79213936|FG001|Overall Study|Withdrawal by Subject|4|||
44272531|NCT02260986|79213937|FG002|Overall Study|Withdrawal by Subject|9|||
44272532|NCT02260986|79213935|FG000|Overall Study|Incorrect randomization|0|||
44272533|NCT02260986|79213936|FG001|Overall Study|Incorrect randomization|1|||
44272534|NCT02260986|79213937|FG002|Overall Study|Incorrect randomization|0|||
44272535|NCT02260986|79213935|FG000|Overall Study|Lack of investigation product supply|2|||
44272536|NCT02260986|79213936|FG001|Overall Study|Lack of investigation product supply|0|||
44272537|NCT02260986|79213937|FG002|Overall Study|Lack of investigation product supply|1|||
44272538|NCT02260986|79213935|FG000|Overall Study|Lost to Follow-up|4|||
44272539|NCT02260986|79213936|FG001|Overall Study|Lost to Follow-up|0|||
44272540|NCT02260986|79213937|FG002|Overall Study|Lost to Follow-up|3|||
44272541|NCT02260986|79213935|FG000|Overall Study|Pregnancy|2|||
44272542|NCT02260986|79213936|FG001|Overall Study|Pregnancy|0|||
44272543|NCT02260986|79213937|FG002|Overall Study|Pregnancy|0|||
44272544|NCT02259582|79213953|FG000|Overall Study|Physician Decision|0|||
44272545|NCT02259582|79213954|FG001|Overall Study|Physician Decision|1|||
44272546|NCT02259582|79213955|FG002|Overall Study|Physician Decision|0|||
44272547|NCT02259582|79213953|FG000|Overall Study|Death|0|||
44272548|NCT02259582|79213954|FG001|Overall Study|Death|0|||
44272549|NCT02259582|79213955|FG002|Overall Study|Death|1|||
44272550|NCT02259582|79213953|FG000|Overall Study|Adverse Event|1|||
44272551|NCT02259582|79213954|FG001|Overall Study|Adverse Event|0|||
44272552|NCT02259582|79213955|FG002|Overall Study|Adverse Event|1|||
44272553|NCT02259582|79213953|FG000|Overall Study|Withdrawal by Subject|0|||
44272554|NCT02259582|79213954|FG001|Overall Study|Withdrawal by Subject|0|||
44272555|NCT02259582|79213955|FG002|Overall Study|Withdrawal by Subject|1|||
44272556|NCT02259582|79213953|FG000|Overall Study|Disease progression|14|||
44272557|NCT02259582|79213954|FG001|Overall Study|Disease progression|15|||
44272558|NCT02259582|79213955|FG002|Overall Study|Disease progression|17|||
44272559|NCT02259582|79213953|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
44272560|NCT02259582|79213954|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
44272561|NCT02259582|79213955|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
44272562|NCT03238651|79213968|FG000|Overall Study|Other|0|||
44272563|NCT03238651|79213969|FG001|Overall Study|Other|0|||
44272564|NCT03238651|79213970|FG002|Overall Study|Other|0|||
44272565|NCT03238651|79213971|FG003|Overall Study|Other|0|||
44272566|NCT03238651|79213972|FG004|Overall Study|Other|1|||
44272567|NCT03238651|79213968|FG000|Overall Study|Progressive Disease|2|||
44272568|NCT03238651|79213969|FG001|Overall Study|Progressive Disease|2|||
44272569|NCT03238651|79213970|FG002|Overall Study|Progressive Disease|2|||
44272570|NCT03238651|79213971|FG003|Overall Study|Progressive Disease|2|||
44272571|NCT03238651|79213972|FG004|Overall Study|Progressive Disease|0|||
44272572|NCT03238651|79213968|FG000|Overall Study|Withdrawal by Subject|0|||
44272573|NCT03238651|79213969|FG001|Overall Study|Withdrawal by Subject|1|||
44272574|NCT03238651|79213970|FG002|Overall Study|Withdrawal by Subject|0|||
44272575|NCT03238651|79213971|FG003|Overall Study|Withdrawal by Subject|1|||
44272576|NCT03238651|79213972|FG004|Overall Study|Withdrawal by Subject|0|||
44272577|NCT03238651|79213968|FG000|Overall Study|Adverse Event|1|||
44272578|NCT03238651|79213969|FG001|Overall Study|Adverse Event|3|||
44272579|NCT03238651|79213970|FG002|Overall Study|Adverse Event|2|||
44272580|NCT03238651|79213971|FG003|Overall Study|Adverse Event|0|||
44272581|NCT03238651|79213972|FG004|Overall Study|Adverse Event|0|||
44272582|NCT05346055|79213996|FG000|Overall Study|Withdrawal by Subject|1|||
44272583|NCT05346055|79213996|FG000|Overall Study|Protocol Violation|1|||
44272584|NCT05346055|79213996|FG000|Overall Study|Therapist decision|1|||
44272585|NCT05211739|79214006|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
44272586|NCT05211739|79214007|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
44272587|NCT05211739|79214006|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
44272588|NCT05211739|79214007|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
44272589|NCT05211739|79214006|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
44272590|NCT05211739|79214007|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
44272591|NCT05211739|79214006|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
44272592|NCT05211739|79214007|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
44272593|NCT05085405|79214035|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
44272594|NCT05085405|79214036|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
44272595|NCT05085405|79214037|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
44272596|NCT05085405|79214038|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
44272597|NCT05085405|79214039|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
44272598|NCT05085405|79214040|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
44272599|NCT05085405|79214035|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
44272600|NCT05085405|79214036|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
44272601|NCT05085405|79214037|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
44272602|NCT05085405|79214038|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
44272603|NCT05085405|79214039|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
44222944|NCT01874431|79026381|FG002|Overall Study|Withdrawal by Subject|1|||
44222945|NCT01874431|79026382|FG003|Overall Study|Withdrawal by Subject|2|||
44222946|NCT01874431|79026383|FG004|Overall Study|Withdrawal by Subject|1|||
44222947|NCT01874431|79026384|FG005|Overall Study|Withdrawal by Subject|1|||
44222948|NCT01874431|79026385|FG006|Overall Study|Withdrawal by Subject|3|||
44222949|NCT01874431|79026386|FG007|Overall Study|Withdrawal by Subject|0|||
44222950|NCT01874431|79026379|FG000|Overall Study|Sponsor decision|0|||
44222951|NCT01874431|79026380|FG001|Overall Study|Sponsor decision|0|||
44222952|NCT01874431|79026381|FG002|Overall Study|Sponsor decision|0|||
44222953|NCT01874431|79026382|FG003|Overall Study|Sponsor decision|0|||
44272604|NCT05085405|79214040|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
44272605|NCT04932941|79214052|FG000|Overall Study|Lost to Follow-up|3|||
44465874|NCT00299494|79474784|FG002|Overall Study|Other - site closure|0|||
44465875|NCT00299494|79474785|FG003|Overall Study|Other - site closure|1|||
44465876|NCT00299494|79474786|FG004|Overall Study|Other - site closure|1|||
44222954|NCT01874431|79026383|FG004|Overall Study|Sponsor decision|1|||
44222955|NCT01874431|79026384|FG005|Overall Study|Sponsor decision|0|||
44222956|NCT01874431|79026385|FG006|Overall Study|Sponsor decision|0|||
44465877|NCT00299494|79474787|FG005|Overall Study|Other - site closure|1|||
44222957|NCT01874431|79026386|FG007|Overall Study|Sponsor decision|0|||
44222958|NCT01874431|79026379|FG000|Overall Study|Lost to Follow-up|0|||
44222959|NCT01874431|79026380|FG001|Overall Study|Lost to Follow-up|0|||
44465878|NCT00453180|79474814|FG000|Overall Study|Lost to Follow-up|2|||
44465879|NCT00453180|79474815|FG001|Overall Study|Lost to Follow-up|1|||
44465880|NCT00453180|79474814|FG000|Overall Study|Adverse Event|1|||
44465881|NCT00453180|79474815|FG001|Overall Study|Adverse Event|2|||
44465882|NCT00464178|79474821|FG000|Overall Study|Protocol Violation|1|||
44222960|NCT01874431|79026381|FG002|Overall Study|Lost to Follow-up|1|||
44222961|NCT01874431|79026382|FG003|Overall Study|Lost to Follow-up|0|||
44222962|NCT01874431|79026383|FG004|Overall Study|Lost to Follow-up|0|||
44222963|NCT01874431|79026384|FG005|Overall Study|Lost to Follow-up|0|||
44222964|NCT01874431|79026385|FG006|Overall Study|Lost to Follow-up|0|||
44222965|NCT01874431|79026386|FG007|Overall Study|Lost to Follow-up|0|||
44222966|NCT01824355|79026404|FG000|Overall Study|Adverse Event|2|||
44222967|NCT01824355|79026404|FG000|Overall Study|unevaluable reference method results per|1|||
44222968|NCT01823341|79026412|FG000|Overall Study|Failed run-in|7|||
44222969|NCT01823341|79026412|FG000|Overall Study|Withdrawal by Subject|7|||
44222970|NCT01823341|79026412|FG000|Overall Study|Adverse Event|1|||
44222971|NCT01853137|79026421|FG000|Overall Study|Lost to Follow-up|4|||
44222972|NCT01853137|79026422|FG001|Overall Study|Lost to Follow-up|1|||
44222973|NCT01823107|79026429|FG000|Overall Study|Withdrawal by Subject|1|||
44222974|NCT01874275|79026435|FG000|Overall Study|Lost to Follow-up|1|||
44222975|NCT01874275|79026436|FG001|Overall Study|Lost to Follow-up|0|||
44222976|NCT01873729|79026448|FG000|Overall Study|Withdrawal by Subject|1|||
44222977|NCT01873495|79026452|FG000|Overall Study|Withdrawal by Subject|1|||
44222978|NCT01873495|79026452|FG000|Overall Study|Physician Decision|3|||
44222979|NCT01873495|79026452|FG000|Overall Study|Adverse Event|1|||
44222980|NCT01873495|79026452|FG000|Overall Study|Removed for Transplantation|1|||
44222981|NCT01873495|79026452|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
44222982|NCT01852825|79026459|FG000|Overall Study|Withdrawal by Subject|2|||
44222983|NCT01852825|79026460|FG001|Overall Study|Withdrawal by Subject|0|||
44222984|NCT01852825|79026461|FG002|Overall Study|Withdrawal by Subject|0|||
44222985|NCT01822561|79026469|FG000|Overall Study|Withdrawal by Subject|2|||
44222986|NCT01852591|79026494|FG000|Overall Study|Withdrawal by Subject|2|||
44222987|NCT01852591|79026494|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
44222988|NCT01852045|79026501|FG000|Overall Study|Adverse Event|1|||
44222989|NCT01852045|79026502|FG001|Overall Study|Adverse Event|0|||
44222990|NCT01852045|79026503|FG002|Overall Study|Adverse Event|0|||
44222991|NCT01852045|79026501|FG000|Overall Study|Lack of Efficacy|3|||
44222992|NCT01852045|79026502|FG001|Overall Study|Lack of Efficacy|0|||
44222993|NCT01852045|79026503|FG002|Overall Study|Lack of Efficacy|0|||
44222994|NCT01852045|79026501|FG000|Overall Study|Lost to Follow-up|0|||
44222995|NCT01852045|79026502|FG001|Overall Study|Lost to Follow-up|1|||
44222996|NCT01852045|79026503|FG002|Overall Study|Lost to Follow-up|1|||
44222997|NCT01852045|79026501|FG000|Overall Study|Withdrawal by Subject|1|||
44222998|NCT01852045|79026502|FG001|Overall Study|Withdrawal by Subject|0|||
44222999|NCT01852045|79026503|FG002|Overall Study|Withdrawal by Subject|1|||
44223000|NCT01852045|79026501|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44223001|NCT01852045|79026502|FG001|Overall Study|Other Miscellaneous Reasons|3|||
44223002|NCT01852045|79026503|FG002|Overall Study|Other Miscellaneous Reasons|2|||
44223003|NCT01821937|79026522|FG000|Overall Study|Adverse Event|0|||
44223004|NCT01821937|79026523|FG001|Overall Study|Adverse Event|3|||
44223005|NCT01821625|79026531|FG000|Overall Study|Withdrawal by Subject|2|||
44223006|NCT01821625|79026531|FG000|Overall Study|Lack of Efficacy|2|||
44223007|NCT01821625|79026531|FG000|Overall Study|Adverse Event|1|||
44223008|NCT01821625|79026531|FG000|Overall Study|Medical contraindication|1|||
44223009|NCT01821391|79026537|FG000|Overall Study|Adverse Event|1|||
44223010|NCT01821391|79026538|FG001|Overall Study|Adverse Event|0|||
44223011|NCT01873417|79026546|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
44223012|NCT01873417|79026546|FG000|Overall Study|Adverse Event|24|||
44223013|NCT01873417|79026546|FG000|Overall Study|Lost to Follow-up|2|||
44223014|NCT01873417|79026546|FG000|Overall Study|Withdrawal by Subject|2|||
44223015|NCT01873417|79026546|FG000|Overall Study|Physician Decision|3|||
44272606|NCT04932941|79214053|FG001|Overall Study|Lost to Follow-up|1|||
44272607|NCT04932941|79214052|FG000|Overall Study|Withdrawal by Subject|7|||
44272608|NCT04932941|79214053|FG001|Overall Study|Withdrawal by Subject|4|||
44223016|NCT01872715|79026550|FG000|Overall Study|Adverse Event|1|||
44465883|NCT00464178|79474821|FG000|Overall Study|Withdrawal by Subject|1|||
44223017|NCT01872715|79026550|FG000|Overall Study|Protocol Violation|1|||
44223018|NCT01872715|79026550|FG000|Overall Study|Withdrawal by Subject|2|||
44223019|NCT01871545|79026566|FG000|Overall Study|Death|2|||
44223020|NCT01871545|79026567|FG001|Overall Study|Death|0|||
44223021|NCT01871545|79026566|FG000|Overall Study|Lack of Efficacy|11|||
44223022|NCT01871545|79026567|FG001|Overall Study|Lack of Efficacy|2|||
44223023|NCT01871545|79026566|FG000|Overall Study|Physician Decision|4|||
44223024|NCT01871545|79026567|FG001|Overall Study|Physician Decision|0|||
44223025|NCT01871545|79026566|FG000|Overall Study|Withdrawal by Subject|0|||
44223026|NCT01871545|79026567|FG001|Overall Study|Withdrawal by Subject|1|||
44223027|NCT01613599|79026576|FG000|Overall Study|Death|9|||
44223028|NCT01613599|79026576|FG000|Overall Study|Lost to Follow-up|5|||
44272609|NCT04932941|79214052|FG000|Overall Study|Other|4|||
44272610|NCT04932941|79214053|FG001|Overall Study|Other|2|||
44272611|NCT04662073|79214113|FG000|Overall Study|Withdrawal by Subject|1|||
44272612|NCT04662073|79214114|FG001|Overall Study|Withdrawal by Subject|0|||
44272613|NCT04656418|79214122|FG000|Overall Study|Withdrawal by Subject|1|||
44272614|NCT04656418|79214123|FG001|Overall Study|Withdrawal by Subject|3|||
44272615|NCT04622306|79214130|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
44272616|NCT04622306|79214131|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
44272617|NCT04622306|79214132|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
44272618|NCT04622306|79214133|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
44272619|NCT04622306|79214134|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
44272620|NCT04622306|79214135|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
44272621|NCT04622306|79214130|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
44272622|NCT04622306|79214131|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
44272623|NCT04622306|79214132|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
44272624|NCT04622306|79214133|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
44272625|NCT04622306|79214134|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
44272626|NCT04622306|79214135|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
44272627|NCT04601103|79214147|FG000|Overall Study|Needed crown & cleaning|0|||
44272628|NCT04601103|79214148|FG001|Overall Study|Needed crown & cleaning|0|||
44272629|NCT04601103|79214149|FG002|Overall Study|Needed crown & cleaning|1|||
44272630|NCT04601103|79214147|FG000|Overall Study|study was terminated|18|||
44272631|NCT04601103|79214148|FG001|Overall Study|study was terminated|18|||
44272632|NCT04601103|79214149|FG002|Overall Study|study was terminated|16|||
44272633|NCT04575597|79214163|FG000|Overall Study|Death|0|||
44272634|NCT04575597|79214164|FG001|Overall Study|Death|0|||
44272635|NCT04575597|79214165|FG002|Overall Study|Death|0|||
44272636|NCT04575597|79214166|FG003|Overall Study|Death|1|||
44272637|NCT04575597|79214167|FG004|Overall Study|Death|3|||
44272638|NCT04575597|79214168|FG005|Overall Study|Death|14|||
44272639|NCT04575597|79214163|FG000|Overall Study|Lost to Follow-up|2|||
44272640|NCT04575597|79214164|FG001|Overall Study|Lost to Follow-up|1|||
44272641|NCT04575597|79214165|FG002|Overall Study|Lost to Follow-up|1|||
44272642|NCT04575597|79214166|FG003|Overall Study|Lost to Follow-up|2|||
44272643|NCT04575597|79214167|FG004|Overall Study|Lost to Follow-up|10|||
44272644|NCT04575597|79214168|FG005|Overall Study|Lost to Follow-up|8|||
44272645|NCT04575597|79214163|FG000|Overall Study|Withdrawal by Subject|2|||
44272646|NCT04575597|79214164|FG001|Overall Study|Withdrawal by Subject|2|||
44272647|NCT04575597|79214165|FG002|Overall Study|Withdrawal by Subject|4|||
44272648|NCT04575597|79214166|FG003|Overall Study|Withdrawal by Subject|2|||
44272649|NCT04575597|79214167|FG004|Overall Study|Withdrawal by Subject|25|||
44272650|NCT04575597|79214168|FG005|Overall Study|Withdrawal by Subject|28|||
44375105|NCT00908037|79380257|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375106|NCT00908037|79380258|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375107|NCT00908037|79380259|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375108|NCT00908037|79380260|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375109|NCT00908037|79380261|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44223029|NCT01613599|79026576|FG000|Overall Study|Withdrawal by Subject|8|||
44223030|NCT01613599|79026576|FG000|Overall Study|Reason not specified|3|||
44223031|NCT01850641|79026580|FG000|Overall Study|Physician Decision|1|||
44223032|NCT01850641|79026580|FG000|Overall Study|Decrease in serum phosphorus|1|||
44223033|NCT01850641|79026580|FG000|Overall Study|Decrease in serum calcium|2|||
44223034|NCT01850641|79026580|FG000|Overall Study|Increase in serum ferritin|1|||
44223035|NCT01850563|79026586|FG000|Overall Study|Not eligible|3|||
44223036|NCT01850563|79026587|FG001|Overall Study|Not eligible|0|||
44223037|NCT04999839|79026630|FG000|Overall Study|Adverse Event|1|||
44223038|NCT04999839|79026631|FG001|Overall Study|Adverse Event|1|||
44223039|NCT04999839|79026632|FG002|Overall Study|Adverse Event|1|||
44223040|NCT04999839|79026633|FG003|Overall Study|Adverse Event|1|||
44223041|NCT04999839|79026634|FG004|Overall Study|Adverse Event|1|||
44223042|NCT04999839|79026630|FG000|Overall Study|Lost to Follow-up|2|||
44223043|NCT04999839|79026631|FG001|Overall Study|Lost to Follow-up|0|||
44223044|NCT04999839|79026632|FG002|Overall Study|Lost to Follow-up|2|||
44223045|NCT04999839|79026633|FG003|Overall Study|Lost to Follow-up|4|||
44223046|NCT04999839|79026634|FG004|Overall Study|Lost to Follow-up|1|||
44223047|NCT04999839|79026630|FG000|Overall Study|Withdrawal by Subject|6|||
44272651|NCT04575597|79214163|FG000|Overall Study|Not Recorded|0|||
44272652|NCT04575597|79214164|FG001|Overall Study|Not Recorded|0|||
44272653|NCT04575597|79214165|FG002|Overall Study|Not Recorded|0|||
44272654|NCT04575597|79214166|FG003|Overall Study|Not Recorded|0|||
44272655|NCT04575597|79214167|FG004|Overall Study|Not Recorded|0|||
44272656|NCT04575597|79214168|FG005|Overall Study|Not Recorded|2|||
44272657|NCT04575597|79214163|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44272658|NCT04575597|79214164|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44272659|NCT04575597|79214165|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44223048|NCT04999839|79026631|FG001|Overall Study|Withdrawal by Subject|5|||
44223049|NCT04999839|79026632|FG002|Overall Study|Withdrawal by Subject|3|||
44223050|NCT04999839|79026633|FG003|Overall Study|Withdrawal by Subject|2|||
44223051|NCT04999839|79026634|FG004|Overall Study|Withdrawal by Subject|2|||
44223052|NCT04999839|79026630|FG000|Overall Study|Lack of Efficacy|0|||
44223053|NCT04999839|79026631|FG001|Overall Study|Lack of Efficacy|1|||
44223054|NCT04999839|79026632|FG002|Overall Study|Lack of Efficacy|0|||
44223055|NCT04999839|79026633|FG003|Overall Study|Lack of Efficacy|0|||
44223056|NCT04999839|79026634|FG004|Overall Study|Lack of Efficacy|0|||
44223057|NCT04999839|79026630|FG000|Overall Study|Physician Decision|0|||
44223058|NCT04999839|79026631|FG001|Overall Study|Physician Decision|0|||
44223059|NCT04999839|79026632|FG002|Overall Study|Physician Decision|0|||
44223060|NCT04999839|79026633|FG003|Overall Study|Physician Decision|0|||
44223061|NCT04999839|79026634|FG004|Overall Study|Physician Decision|1|||
44223062|NCT04999839|79026630|FG000|Overall Study|Sponsor request|0|||
44223063|NCT04999839|79026631|FG001|Overall Study|Sponsor request|1|||
44223064|NCT04999839|79026632|FG002|Overall Study|Sponsor request|0|||
44223065|NCT04999839|79026633|FG003|Overall Study|Sponsor request|0|||
44223066|NCT04999839|79026634|FG004|Overall Study|Sponsor request|0|||
44223067|NCT04999839|79026630|FG000|Overall Study|Other|0|||
44223068|NCT04999839|79026631|FG001|Overall Study|Other|0|||
44223069|NCT04999839|79026632|FG002|Overall Study|Other|1|||
44223070|NCT04999839|79026633|FG003|Overall Study|Other|0|||
44223071|NCT04999839|79026634|FG004|Overall Study|Other|0|||
44223072|NCT04696146|79026678|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
44223073|NCT04696146|79026679|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
44223074|NCT04696146|79026678|FG000|Overall Study|Off hours issue with product|1|||
44223075|NCT04696146|79026679|FG001|Overall Study|Off hours issue with product|0|||
44223076|NCT04658940|79026685|FG000|Overall Study|Withdrawal by Subject|1|||
44223077|NCT04629066|79026691|FG000|Overall Study|Lost to Follow-up|3|||
44223078|NCT04629066|79026692|FG001|Overall Study|Lost to Follow-up|2|||
44223079|NCT04598269|79026700|FG000|Overall Study|Adverse Event|0|||
44223080|NCT04598269|79026701|FG001|Overall Study|Adverse Event|3|||
44223081|NCT04598269|79026700|FG000|Overall Study|Withdrawal by Subject|1|||
44223082|NCT04598269|79026701|FG001|Overall Study|Withdrawal by Subject|4|||
44223083|NCT04598269|79026700|FG000|Overall Study|Lost to Follow-up|1|||
44223084|NCT04598269|79026701|FG001|Overall Study|Lost to Follow-up|0|||
44223085|NCT04598269|79026700|FG000|Overall Study|Not Treated|2|||
44223086|NCT04598269|79026701|FG001|Overall Study|Not Treated|0|||
44223087|NCT04591015|79026709|FG000|Overall Study|Death|6|||
44223088|NCT04591015|79026710|FG001|Overall Study|Death|4|||
44223089|NCT04591015|79026709|FG000|Overall Study|Withdrawal by Subject|6|||
44223090|NCT04591015|79026710|FG001|Overall Study|Withdrawal by Subject|3|||
44223091|NCT04591015|79026709|FG000|Overall Study|Lost to Follow-up|16|||
44223092|NCT04591015|79026710|FG001|Overall Study|Lost to Follow-up|11|||
44223093|NCT04566692|79026718|FG000|Overall Study|Adverse Event|2|||
44223094|NCT04566692|79026719|FG001|Overall Study|Adverse Event|0|||
44223095|NCT04566692|79026718|FG000|Overall Study|Withdrawal by Subject|1|||
44223096|NCT04566692|79026719|FG001|Overall Study|Withdrawal by Subject|1|||
44223097|NCT04533412|79026734|FG000|Overall Study|Withdrawal by Subject|1|||
44223098|NCT04533412|79026735|FG001|Overall Study|Withdrawal by Subject|1|||
44223099|NCT04533412|79026734|FG000|Overall Study|Lost to Follow-up|1|||
44223100|NCT04533412|79026735|FG001|Overall Study|Lost to Follow-up|4|||
44223101|NCT04515147|79026747|FG000|Overall Study|Withdrawal by Subject|1|||
44223102|NCT04515147|79026748|FG001|Overall Study|Withdrawal by Subject|0|||
44223103|NCT04515147|79026749|FG002|Overall Study|Withdrawal by Subject|10|||
44223104|NCT04515147|79026750|FG003|Overall Study|Withdrawal by Subject|18|||
44223105|NCT04515147|79026751|FG004|Overall Study|Withdrawal by Subject|1|||
44223106|NCT04515147|79026752|FG005|Overall Study|Withdrawal by Subject|8|||
44223107|NCT04515147|79026747|FG000|Overall Study|Lost to Follow-up|0|||
44223108|NCT04515147|79026748|FG001|Overall Study|Lost to Follow-up|1|||
44223109|NCT04515147|79026749|FG002|Overall Study|Lost to Follow-up|5|||
44223110|NCT04515147|79026750|FG003|Overall Study|Lost to Follow-up|6|||
44223111|NCT04515147|79026751|FG004|Overall Study|Lost to Follow-up|2|||
44223112|NCT04515147|79026752|FG005|Overall Study|Lost to Follow-up|1|||
44223113|NCT04515147|79026747|FG000|Overall Study|Adverse Event|0|||
44223114|NCT04515147|79026748|FG001|Overall Study|Adverse Event|0|||
44223115|NCT04515147|79026749|FG002|Overall Study|Adverse Event|0|||
44223116|NCT04515147|79026750|FG003|Overall Study|Adverse Event|2|||
44223117|NCT04515147|79026751|FG004|Overall Study|Adverse Event|0|||
44223118|NCT04515147|79026752|FG005|Overall Study|Adverse Event|0|||
44223119|NCT04515147|79026747|FG000|Overall Study|Miscellaneous|0|||
44223120|NCT04515147|79026748|FG001|Overall Study|Miscellaneous|0|||
44223121|NCT04515147|79026749|FG002|Overall Study|Miscellaneous|0|||
44223122|NCT04515147|79026750|FG003|Overall Study|Miscellaneous|1|||
44223123|NCT04515147|79026751|FG004|Overall Study|Miscellaneous|0|||
44223124|NCT04515147|79026752|FG005|Overall Study|Miscellaneous|1|||
44223125|NCT04479618|79026774|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
44465884|NCT00560105|79474828|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
44223126|NCT04479618|79026775|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
44223127|NCT04479618|79026776|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
44223128|NCT04479618|79026774|FG000|Overall Study|Lack of Efficacy|1|||
44223129|NCT04479618|79026775|FG001|Overall Study|Lack of Efficacy|0|||
44223130|NCT04479618|79026776|FG002|Overall Study|Lack of Efficacy|0|||
44223131|NCT04479618|79026774|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
44465885|NCT00560105|79474829|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
44465886|NCT00467610|79474835|FG000|Overall Study|Withdrawal by Subject|1|||
44465887|NCT00316186|79474839|FG000|Overall Study|Adverse Event|6|||
44465888|NCT00316186|79474839|FG000|Overall Study|Disease Progression|4|||
44465889|NCT00316186|79474839|FG000|Overall Study|Lost to Follow-up|1|||
44465890|NCT00316186|79474839|FG000|Overall Study|Other|1|||
44465891|NCT00453102|79474843|FG000|Overall Study|Withdrawal by Subject|2|||
44465892|NCT00299182|79474854|FG000|Overall Study|Withdrawal by Subject|0|||
44465893|NCT00299182|79474855|FG001|Overall Study|Withdrawal by Subject|0|||
44465894|NCT00299182|79474856|FG002|Overall Study|Withdrawal by Subject|1|||
44465895|NCT00299182|79474857|FG003|Overall Study|Withdrawal by Subject|0|||
44465896|NCT00299182|79474858|FG004|Overall Study|Withdrawal by Subject|1|||
44465897|NCT00299182|79474859|FG005|Overall Study|Withdrawal by Subject|2|||
44465898|NCT00299182|79474860|FG006|Overall Study|Withdrawal by Subject|0|||
44465899|NCT00299182|79474854|FG000|Overall Study|Chemotherapy Changed|0|||
44465900|NCT00299182|79474855|FG001|Overall Study|Chemotherapy Changed|0|||
44465901|NCT00299182|79474856|FG002|Overall Study|Chemotherapy Changed|1|||
44465902|NCT00299182|79474857|FG003|Overall Study|Chemotherapy Changed|0|||
44465903|NCT00299182|79474858|FG004|Overall Study|Chemotherapy Changed|1|||
44465904|NCT00299182|79474859|FG005|Overall Study|Chemotherapy Changed|0|||
44465905|NCT00299182|79474860|FG006|Overall Study|Chemotherapy Changed|1|||
44465906|NCT00299182|79474854|FG000|Overall Study|Adverse Event|0|||
44465907|NCT00299182|79474855|FG001|Overall Study|Adverse Event|0|||
44465908|NCT00299182|79474856|FG002|Overall Study|Adverse Event|0|||
44465909|NCT00299182|79474857|FG003|Overall Study|Adverse Event|0|||
44465910|NCT00299182|79474858|FG004|Overall Study|Adverse Event|0|||
44465911|NCT00299182|79474859|FG005|Overall Study|Adverse Event|1|||
44465912|NCT00299182|79474860|FG006|Overall Study|Adverse Event|0|||
44465913|NCT00299182|79474854|FG000|Overall Study|Not Eligible|0|||
44465914|NCT00299182|79474855|FG001|Overall Study|Not Eligible|0|||
44465915|NCT00299182|79474856|FG002|Overall Study|Not Eligible|0|||
44465916|NCT00299182|79474857|FG003|Overall Study|Not Eligible|0|||
44465917|NCT00299182|79474858|FG004|Overall Study|Not Eligible|1|||
44465918|NCT00299182|79474859|FG005|Overall Study|Not Eligible|0|||
44465919|NCT00299182|79474860|FG006|Overall Study|Not Eligible|0|||
44465920|NCT00467142|79474878|FG000|Overall Study|Withdrawal by Subject|1|||
44465921|NCT00467142|79474878|FG000|Overall Study|Adverse Event|1|||
44465922|NCT00467142|79474878|FG000|Overall Study|Protocol Violation|1|||
44465923|NCT00553475|79474885|FG000|Overall Study|Adverse Event|7|||
44465924|NCT00553475|79474886|FG001|Overall Study|Adverse Event|17|||
44465925|NCT00553475|79474887|FG002|Overall Study|Adverse Event|13|||
44465926|NCT00553475|79474885|FG000|Overall Study|Lack of Efficacy|7|||
44465927|NCT00553475|79474886|FG001|Overall Study|Lack of Efficacy|1|||
44465928|NCT00553475|79474887|FG002|Overall Study|Lack of Efficacy|0|||
44465929|NCT00553475|79474885|FG000|Overall Study|Withdrawal by Subject|1|||
44465930|NCT00553475|79474886|FG001|Overall Study|Withdrawal by Subject|1|||
44465931|NCT00553475|79474887|FG002|Overall Study|Withdrawal by Subject|0|||
44465932|NCT00553475|79474885|FG000|Overall Study|Physician Decision|1|||
44465933|NCT00553475|79474886|FG001|Overall Study|Physician Decision|0|||
44465934|NCT00553475|79474887|FG002|Overall Study|Physician Decision|0|||
44465935|NCT00553475|79474885|FG000|Overall Study|Due to moving|0|||
44465936|NCT00553475|79474886|FG001|Overall Study|Due to moving|1|||
44465937|NCT00553475|79474887|FG002|Overall Study|Due to moving|0|||
44465938|NCT00329602|79474899|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
44465939|NCT00329602|79474900|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
44465940|NCT00329602|79474901|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
44465941|NCT00329602|79474899|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
44465942|NCT00329602|79474900|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
44544315|NCT03055988|79557663|FG001|Period 2|Other than listed|1|||
44223132|NCT04479618|79026775|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
44544316|NCT01250912|79557669|FG000|Overall Study|Lost to Follow-up|1|||
44223133|NCT04479618|79026776|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
44223134|NCT04479618|79026774|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
44223135|NCT04479618|79026775|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
44223136|NCT04479618|79026776|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
44277809|NCT02092350|79238807|FG001|Overall Study|Physician Decision|1|||
44272660|NCT04575597|79214166|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44272661|NCT04575597|79214167|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
44272662|NCT04575597|79214168|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
44272663|NCT04546724|79214190|FG000|Overall Study|Withdrawal by Subject|145|||
44272664|NCT04546724|79214191|FG001|Overall Study|Withdrawal by Subject|41|||
44272665|NCT04546724|79214190|FG000|Overall Study|Adverse Event|1|||
44272666|NCT04546724|79214191|FG001|Overall Study|Adverse Event|1|||
44272667|NCT04546724|79214190|FG000|Overall Study|Lost to Follow-up|186|||
44272668|NCT04546724|79214191|FG001|Overall Study|Lost to Follow-up|63|||
44272669|NCT04546724|79214190|FG000|Overall Study|Physician Decision|8|||
44272670|NCT04546724|79214191|FG001|Overall Study|Physician Decision|2|||
44272671|NCT04546724|79214190|FG000|Overall Study|Death|2|||
44272672|NCT04546724|79214191|FG001|Overall Study|Death|1|||
44272673|NCT04546724|79214190|FG000|Overall Study|subject has been out of town|1|||
44272674|NCT04546724|79214191|FG001|Overall Study|subject has been out of town|0|||
44272675|NCT04546724|79214190|FG000|Overall Study|subject is incarcerated|2|||
44272676|NCT04546724|79214191|FG001|Overall Study|subject is incarcerated|0|||
44272677|NCT04546724|79214190|FG000|Overall Study|subject is relocating|12|||
44272678|NCT04546724|79214191|FG001|Overall Study|subject is relocating|4|||
44272679|NCT04546724|79214190|FG000|Overall Study|Subject in another study|1|||
44272680|NCT04546724|79214191|FG001|Overall Study|Subject in another study|1|||
44272681|NCT04391842|79214207|FG000|Overall Study|Withdrawal by Subject|2|||
44272682|NCT04327024|79214230|FG000|Overall Study|Death|1|||
44272683|NCT04327024|79214231|FG001|Overall Study|Death|2|||
44272684|NCT04327024|79214232|FG002|Overall Study|Death|1|||
44272685|NCT04327024|79214230|FG000|Overall Study|Non-compliance with study drug|0|||
44272686|NCT04327024|79214231|FG001|Overall Study|Non-compliance with study drug|1|||
44272687|NCT04327024|79214232|FG002|Overall Study|Non-compliance with study drug|0|||
44272688|NCT04327024|79214230|FG000|Overall Study|Withdrawal by Subject|1|||
44272689|NCT04327024|79214231|FG001|Overall Study|Withdrawal by Subject|1|||
44272690|NCT04327024|79214232|FG002|Overall Study|Withdrawal by Subject|2|||
44272691|NCT04322149|79214245|FG000|Overall Study|Adverse Event|1|||
44272692|NCT04322149|79214246|FG001|Overall Study|Adverse Event|1|||
44272693|NCT04322149|79214247|FG002|Overall Study|Adverse Event|0|||
44272694|NCT04322149|79214248|FG003|Overall Study|Adverse Event|0|||
44272695|NCT04322149|79214245|FG000|Overall Study|Withdrawal by Subject|0|||
44272696|NCT04322149|79214246|FG001|Overall Study|Withdrawal by Subject|0|||
44272697|NCT04322149|79214247|FG002|Overall Study|Withdrawal by Subject|0|||
44272698|NCT04322149|79214248|FG003|Overall Study|Withdrawal by Subject|2|||
44272699|NCT04322149|79214245|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
44272700|NCT04322149|79214246|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
44272701|NCT04322149|79214247|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
44272702|NCT04322149|79214248|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
44272703|NCT04294459|79214269|FG000|Overall Study|Adverse Event|0|||
44272704|NCT04294459|79214270|FG001|Overall Study|Adverse Event|1|||
44272705|NCT04226742|79214279|FG000|Overall Study|Lost to Follow-up|16|||
44272706|NCT04226742|79214280|FG001|Overall Study|Lost to Follow-up|13|||
44272707|NCT04226742|79214279|FG000|Overall Study|Withdrawal by Subject|5|||
44272708|NCT04226742|79214280|FG001|Overall Study|Withdrawal by Subject|3|||
44272709|NCT04194528|79214286|FG000|Overall Study|Adverse Event|1|||
44272710|NCT04146012|79214318|FG000|Overall Study|Study Terminated|30|||
44272711|NCT04146012|79214319|FG001|Overall Study|Study Terminated|15|||
44272712|NCT04085458|79214325|FG000|Overall Study|Other|1|||
44272713|NCT04085458|79214325|FG000|Overall Study|Withdrawal by Subject|2|||
44272714|NCT04085458|79214325|FG000|Overall Study|Adverse Event|2|||
44544317|NCT03733301|79557679|FG000|Overall Study|Screen Fail|1|||
44223137|NCT04479618|79026774|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
44223138|NCT04479618|79026775|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
44223139|NCT04479618|79026776|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
44223140|NCT04479618|79026774|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
44223141|NCT04479618|79026775|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
44223142|NCT04479618|79026776|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
44223143|NCT04476043|79026791|FG000|Overall Study|Withdrawal by Subject|1|||
44223144|NCT04476043|79026792|FG001|Overall Study|Withdrawal by Subject|3|||
44223145|NCT04476043|79026793|FG002|Overall Study|Withdrawal by Subject|4|||
44223146|NCT04476043|79026794|FG003|Overall Study|Withdrawal by Subject|1|||
44223147|NCT04476043|79026791|FG000|Overall Study|Lost to Follow-up|1|||
44272715|NCT04033159|79214331|FG000|Washout Period|Physician Decision|0|||
44272716|NCT04033159|79214332|FG001|Washout Period|Physician Decision|1|||
44272717|NCT04033159|79214333|FG002|Washout Period|Physician Decision|0|||
44272718|NCT04033159|79214331|FG000|Washout Period|Study terminated by Sponsor|0|||
44272719|NCT04033159|79214332|FG001|Washout Period|Study terminated by Sponsor|7|||
44272720|NCT04033159|79214333|FG002|Washout Period|Study terminated by Sponsor|0|||
44272721|NCT04033159|79214331|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
44272722|NCT04033159|79214332|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
44272723|NCT04033159|79214333|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
44272724|NCT03969888|79214349|FG000|Overall Study|Never Received Study Drug|0|||
44272725|NCT03969888|79214350|FG001|Overall Study|Never Received Study Drug|0|||
44272726|NCT03969888|79214351|FG002|Overall Study|Never Received Study Drug|1|||
44272727|NCT03969888|79214352|FG003|Overall Study|Never Received Study Drug|0|||
44272728|NCT03969888|79214353|FG004|Overall Study|Never Received Study Drug|0|||
44272729|NCT03969888|79214354|FG005|Overall Study|Never Received Study Drug|0|||
44272730|NCT03969888|79214355|FG006|Overall Study|Never Received Study Drug|1|||
44272731|NCT03969888|79214356|FG007|Overall Study|Never Received Study Drug|0|||
44272732|NCT03969888|79214349|FG000|Overall Study|Reason Not Specified|0|||
44272733|NCT03969888|79214350|FG001|Overall Study|Reason Not Specified|0|||
44272734|NCT03969888|79214351|FG002|Overall Study|Reason Not Specified|0|||
44272735|NCT03969888|79214352|FG003|Overall Study|Reason Not Specified|0|||
44272736|NCT03969888|79214353|FG004|Overall Study|Reason Not Specified|0|||
44272737|NCT03969888|79214354|FG005|Overall Study|Reason Not Specified|0|||
44272738|NCT03969888|79214355|FG006|Overall Study|Reason Not Specified|0|||
44272739|NCT03969888|79214356|FG007|Overall Study|Reason Not Specified|1|||
44272740|NCT03952559|79214380|FG000|Double Blind Treatment Period|Adverse Event|0|||
44272741|NCT03952559|79214381|FG001|Double Blind Treatment Period|Adverse Event|2|||
44223148|NCT04476043|79026792|FG001|Overall Study|Lost to Follow-up|1|||
44223149|NCT04476043|79026793|FG002|Overall Study|Lost to Follow-up|2|||
44223150|NCT04476043|79026794|FG003|Overall Study|Lost to Follow-up|1|||
44223151|NCT04476043|79026791|FG000|Overall Study|Adverse Event|2|||
44223152|NCT04476043|79026792|FG001|Overall Study|Adverse Event|0|||
44223153|NCT04476043|79026793|FG002|Overall Study|Adverse Event|1|||
44223154|NCT04476043|79026794|FG003|Overall Study|Adverse Event|0|||
44223155|NCT04476043|79026791|FG000|Overall Study|Protocol Violation|0|||
44223156|NCT04476043|79026792|FG001|Overall Study|Protocol Violation|1|||
44223157|NCT04476043|79026793|FG002|Overall Study|Protocol Violation|0|||
44223158|NCT04476043|79026794|FG003|Overall Study|Protocol Violation|0|||
44223159|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
44223160|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
44223161|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
44223162|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
44223163|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
44223164|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
44223165|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
44223166|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
44272742|NCT03952559|79214382|FG002|Double Blind Treatment Period|Adverse Event|1|||
44272743|NCT03952559|79214383|FG003|Double Blind Treatment Period|Adverse Event|0|||
44272744|NCT03952559|79214384|FG004|Double Blind Treatment Period|Adverse Event|1|||
44272745|NCT03952559|79214380|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
44272746|NCT03952559|79214381|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
44223167|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
44223168|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
44272747|NCT03952559|79214382|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
44272748|NCT03952559|79214383|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
44272749|NCT03952559|79214384|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
44272750|NCT03952559|79214380|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
44272751|NCT03952559|79214381|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
44272752|NCT03952559|79214382|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
44272753|NCT03952559|79214383|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
44272754|NCT03952559|79214384|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
44272755|NCT03952559|79214380|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
44272756|NCT03952559|79214381|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
44272757|NCT03952559|79214382|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
44272758|NCT03952559|79214383|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
44272759|NCT03952559|79214384|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
44272760|NCT03945175|79214420|FG000|Overall Study|Did not meet inclusion criteria|31|||
44272761|NCT03945175|79214420|FG000|Overall Study|Withdrew consent|2|||
44272762|NCT03945175|79214420|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
44272763|NCT03945175|79214420|FG000|Overall Study|Early termination during Mydayis treatment|1|||
44272764|NCT03942406|79214431|FG000|Overall Study|Lost to Follow-up|4|||
44272765|NCT03942406|79214432|FG001|Overall Study|Lost to Follow-up|5|||
44272766|NCT03942406|79214433|FG002|Overall Study|Lost to Follow-up|3|||
44272767|NCT03942406|79214434|FG003|Overall Study|Lost to Follow-up|7|||
44272768|NCT03942406|79214435|FG004|Overall Study|Lost to Follow-up|1|||
44272769|NCT03942406|79214436|FG005|Overall Study|Lost to Follow-up|0|||
44272770|NCT03942406|79214437|FG006|Overall Study|Lost to Follow-up|0|||
44272771|NCT03942406|79214431|FG000|Overall Study|Withdrawal by Subject|3|||
44272772|NCT03942406|79214432|FG001|Overall Study|Withdrawal by Subject|1|||
44272773|NCT03942406|79214433|FG002|Overall Study|Withdrawal by Subject|1|||
44272774|NCT03942406|79214434|FG003|Overall Study|Withdrawal by Subject|3|||
44272775|NCT03942406|79214435|FG004|Overall Study|Withdrawal by Subject|0|||
44272776|NCT03942406|79214436|FG005|Overall Study|Withdrawal by Subject|0|||
44272777|NCT03942406|79214437|FG006|Overall Study|Withdrawal by Subject|0|||
44272778|NCT03942406|79214431|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
44272779|NCT03942406|79214432|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
44272780|NCT03942406|79214433|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
44272781|NCT03942406|79214434|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
44272782|NCT03942406|79214435|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
44272783|NCT03942406|79214436|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
44272784|NCT03942406|79214437|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
44272785|NCT03909100|79214471|FG000|Overall Study|Protocol Deviation|2|||
44272786|NCT03909100|79214471|FG000|Overall Study|Technical Problems|4|||
44272787|NCT03909100|79214471|FG000|Overall Study|Withdrawal by Subject|4|||
44272788|NCT03909100|79214471|FG000|Overall Study|Lost to Follow-up|1|||
44272789|NCT03909100|79214471|FG000|Overall Study|Reason not Specified|4|||
44272790|NCT03896295|79214493|FG000|Overall Study|Adverse Event|0|||
44272791|NCT03896295|79214494|FG001|Overall Study|Adverse Event|1|||
44272792|NCT03896295|79214493|FG000|Overall Study|COVID-19|7|||
44272793|NCT03896295|79214494|FG001|Overall Study|COVID-19|29|||
44272794|NCT03734666|79214535|FG000|Overall Study|Other|7|||
44272795|NCT03734666|79214536|FG001|Overall Study|Other|4|||
44272796|NCT03734666|79214535|FG000|Overall Study|Lost to Follow-up|12|||
44272797|NCT03734666|79214536|FG001|Overall Study|Lost to Follow-up|12|||
44514813|NCT03084796|79520627|FG004|Overall Study|Lost to Follow-up|3|||
44375110|NCT00908037|79380262|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375111|NCT00908037|79380263|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375112|NCT00908037|79380264|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375113|NCT00908037|79380265|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375114|NCT00908037|79380266|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44272798|NCT03635489|79214549|FG000|Overall Study|Death|6|||
44272799|NCT03635489|79214550|FG001|Overall Study|Death|3|||
44272800|NCT03635489|79214549|FG000|Overall Study|Lost to Follow-up|0|||
44272801|NCT03635489|79214550|FG001|Overall Study|Lost to Follow-up|1|||
44272802|NCT03635489|79214549|FG000|Overall Study|Withdrawal by Subject|1|||
44375115|NCT00908037|79380267|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
44375116|NCT00908037|79380268|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
44272803|NCT03635489|79214550|FG001|Overall Study|Withdrawal by Subject|2|||
44272804|NCT03633617|79214561|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
44272805|NCT03633617|79214562|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
44272806|NCT03633617|79214563|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272807|NCT03633617|79214564|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272808|NCT03633617|79214565|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272809|NCT03633617|79214566|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272810|NCT03633617|79214567|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272811|NCT03633617|79214568|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272812|NCT03633617|79214569|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272813|NCT03633617|79214570|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272814|NCT03633617|79214571|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
44272815|NCT03633617|79214561|FG000|Part A|Unconfirmed early termination visit|1|||
44272816|NCT03633617|79214562|FG001|Part A|Unconfirmed early termination visit|0|||
44272817|NCT03633617|79214563|FG002|Part A|Unconfirmed early termination visit|0|||
44272818|NCT03633617|79214564|FG003|Part A|Unconfirmed early termination visit|0|||
44272819|NCT03633617|79214565|FG004|Part A|Unconfirmed early termination visit|0|||
44272820|NCT03633617|79214566|FG005|Part A|Unconfirmed early termination visit|0|||
44272821|NCT03633617|79214567|FG006|Part A|Unconfirmed early termination visit|0|||
44272822|NCT03633617|79214568|FG007|Part A|Unconfirmed early termination visit|0|||
44272823|NCT03633617|79214569|FG008|Part A|Unconfirmed early termination visit|0|||
44272824|NCT03633617|79214570|FG009|Part A|Unconfirmed early termination visit|0|||
44272825|NCT03633617|79214571|FG010|Part A|Unconfirmed early termination visit|0|||
44272826|NCT03633617|79214561|FG000|Part A|Adverse Event|0|||
44272827|NCT03633617|79214562|FG001|Part A|Adverse Event|1|||
44272828|NCT03633617|79214563|FG002|Part A|Adverse Event|0|||
44272829|NCT03633617|79214564|FG003|Part A|Adverse Event|0|||
44223169|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
44223170|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
44223171|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
44223172|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
44223173|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
44223174|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
44223175|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
44223176|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
44223177|NCT04418765|79026807|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
44223178|NCT04418765|79026808|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
44272830|NCT03633617|79214565|FG004|Part A|Adverse Event|0|||
44272831|NCT03633617|79214566|FG005|Part A|Adverse Event|0|||
44272832|NCT03633617|79214567|FG006|Part A|Adverse Event|0|||
44272833|NCT03633617|79214568|FG007|Part A|Adverse Event|0|||
44272834|NCT03633617|79214569|FG008|Part A|Adverse Event|0|||
44272835|NCT03633617|79214570|FG009|Part A|Adverse Event|0|||
44223179|NCT04418765|79026809|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
44272836|NCT03633617|79214571|FG010|Part A|Adverse Event|0|||
44272837|NCT03633617|79214561|FG000|Part A|Pregnancy|1|||
44272838|NCT03633617|79214562|FG001|Part A|Pregnancy|0|||
44223180|NCT04418765|79026807|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
44223181|NCT04418765|79026808|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
44223182|NCT04418765|79026809|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
44223183|NCT04418765|79026807|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
44223184|NCT04418765|79026808|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
44272839|NCT03633617|79214563|FG002|Part A|Pregnancy|0|||
44272840|NCT03633617|79214564|FG003|Part A|Pregnancy|0|||
44272841|NCT03633617|79214565|FG004|Part A|Pregnancy|0|||
44272842|NCT03633617|79214566|FG005|Part A|Pregnancy|0|||
44272843|NCT03633617|79214567|FG006|Part A|Pregnancy|0|||
44272844|NCT03633617|79214568|FG007|Part A|Pregnancy|0|||
44272845|NCT03633617|79214569|FG008|Part A|Pregnancy|0|||
44223185|NCT04418765|79026809|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
44223186|NCT04418765|79026807|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
44223187|NCT04418765|79026808|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
44223188|NCT04418765|79026809|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
44223189|NCT04418765|79026807|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
44223190|NCT04418765|79026808|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
44223191|NCT04418765|79026809|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
44223192|NCT04418765|79026807|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
44272846|NCT03633617|79214570|FG009|Part A|Pregnancy|0|||
44272847|NCT03633617|79214571|FG010|Part A|Pregnancy|0|||
44272848|NCT03633617|79214561|FG000|Part A|Withdrawal by Subject|0|||
44272849|NCT03633617|79214562|FG001|Part A|Withdrawal by Subject|1|||
44272850|NCT03633617|79214563|FG002|Part A|Withdrawal by Subject|0|||
44272851|NCT03633617|79214564|FG003|Part A|Withdrawal by Subject|0|||
44272852|NCT03633617|79214565|FG004|Part A|Withdrawal by Subject|0|||
44272853|NCT03633617|79214566|FG005|Part A|Withdrawal by Subject|0|||
44272854|NCT03633617|79214567|FG006|Part A|Withdrawal by Subject|0|||
44272855|NCT03633617|79214568|FG007|Part A|Withdrawal by Subject|0|||
44272856|NCT03633617|79214569|FG008|Part A|Withdrawal by Subject|0|||
44272857|NCT03633617|79214570|FG009|Part A|Withdrawal by Subject|0|||
44272858|NCT03633617|79214571|FG010|Part A|Withdrawal by Subject|0|||
44272859|NCT03633617|79214561|FG000|Part B|Adverse Event|0|||
44223193|NCT04418765|79026808|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
44223194|NCT04418765|79026809|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
44272860|NCT03633617|79214562|FG001|Part B|Adverse Event|0|||
44272861|NCT03633617|79214563|FG002|Part B|Adverse Event|2|||
44272862|NCT03633617|79214564|FG003|Part B|Adverse Event|2|||
44272863|NCT03633617|79214565|FG004|Part B|Adverse Event|1|||
44272864|NCT03633617|79214566|FG005|Part B|Adverse Event|0|||
44272865|NCT03633617|79214567|FG006|Part B|Adverse Event|0|||
44272866|NCT03633617|79214568|FG007|Part B|Adverse Event|0|||
44272867|NCT03633617|79214569|FG008|Part B|Adverse Event|0|||
44272868|NCT03633617|79214570|FG009|Part B|Adverse Event|0|||
44272869|NCT03633617|79214571|FG010|Part B|Adverse Event|0|||
44272870|NCT03633617|79214561|FG000|Part B|Withdrawal by Subject|0|||
44272871|NCT03633617|79214562|FG001|Part B|Withdrawal by Subject|0|||
44272872|NCT03633617|79214563|FG002|Part B|Withdrawal by Subject|1|||
44272873|NCT03633617|79214564|FG003|Part B|Withdrawal by Subject|0|||
44272874|NCT03633617|79214565|FG004|Part B|Withdrawal by Subject|2|||
44272875|NCT03633617|79214566|FG005|Part B|Withdrawal by Subject|0|||
44272876|NCT03633617|79214567|FG006|Part B|Withdrawal by Subject|0|||
44272877|NCT03633617|79214568|FG007|Part B|Withdrawal by Subject|0|||
44272878|NCT03633617|79214569|FG008|Part B|Withdrawal by Subject|0|||
44272879|NCT03633617|79214570|FG009|Part B|Withdrawal by Subject|0|||
44272880|NCT03633617|79214571|FG010|Part B|Withdrawal by Subject|0|||
44465943|NCT00329602|79474901|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
44465944|NCT00329602|79474899|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
44465945|NCT00329602|79474900|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
44514814|NCT03084796|79520628|FG005|Overall Study|Lost to Follow-up|1|||
44223195|NCT04418765|79026807|FG000|Extension Period (48 Weeks)|Other than specified|0|||
44272881|NCT03633617|79214561|FG000|Part B|Lost to Follow-up|0|||
44272882|NCT03633617|79214562|FG001|Part B|Lost to Follow-up|0|||
44272883|NCT03633617|79214563|FG002|Part B|Lost to Follow-up|0|||
44272884|NCT03633617|79214564|FG003|Part B|Lost to Follow-up|0|||
44272885|NCT03633617|79214565|FG004|Part B|Lost to Follow-up|1|||
44272886|NCT03633617|79214566|FG005|Part B|Lost to Follow-up|0|||
44272887|NCT03633617|79214567|FG006|Part B|Lost to Follow-up|0|||
44272888|NCT03633617|79214568|FG007|Part B|Lost to Follow-up|0|||
44223196|NCT04418765|79026808|FG001|Extension Period (48 Weeks)|Other than specified|5|||
44272889|NCT03633617|79214569|FG008|Part B|Lost to Follow-up|0|||
44272890|NCT03633617|79214570|FG009|Part B|Lost to Follow-up|0|||
44272891|NCT03633617|79214571|FG010|Part B|Lost to Follow-up|0|||
44272892|NCT03633617|79214561|FG000|Part B|Physician Decision|0|||
44272893|NCT03633617|79214562|FG001|Part B|Physician Decision|0|||
44272894|NCT03633617|79214563|FG002|Part B|Physician Decision|0|||
44272895|NCT03633617|79214564|FG003|Part B|Physician Decision|0|||
44272896|NCT03633617|79214565|FG004|Part B|Physician Decision|1|||
44272897|NCT03633617|79214566|FG005|Part B|Physician Decision|0|||
44272898|NCT03633617|79214567|FG006|Part B|Physician Decision|0|||
44272899|NCT03633617|79214568|FG007|Part B|Physician Decision|0|||
44272900|NCT03633617|79214569|FG008|Part B|Physician Decision|0|||
44272901|NCT03633617|79214570|FG009|Part B|Physician Decision|0|||
44223197|NCT04418765|79026809|FG002|Extension Period (48 Weeks)|Other than specified|2|||
44223198|NCT04266795|79026827|FG000|Overall Study|Adverse Event|10|||
44223199|NCT04266795|79026828|FG001|Overall Study|Adverse Event|19|||
44223200|NCT04266795|79026827|FG000|Overall Study|Death|7|||
44223201|NCT04266795|79026828|FG001|Overall Study|Death|8|||
44272902|NCT03633617|79214571|FG010|Part B|Physician Decision|0|||
44272903|NCT03633617|79214561|FG000|Part B|COVID-19 Restrictions|0|||
44272904|NCT03633617|79214562|FG001|Part B|COVID-19 Restrictions|0|||
44272905|NCT03633617|79214563|FG002|Part B|COVID-19 Restrictions|1|||
44272906|NCT03633617|79214564|FG003|Part B|COVID-19 Restrictions|0|||
44272907|NCT03633617|79214565|FG004|Part B|COVID-19 Restrictions|0|||
44272908|NCT03633617|79214566|FG005|Part B|COVID-19 Restrictions|0|||
44272909|NCT03633617|79214567|FG006|Part B|COVID-19 Restrictions|0|||
44272910|NCT03633617|79214568|FG007|Part B|COVID-19 Restrictions|0|||
44272911|NCT03633617|79214569|FG008|Part B|COVID-19 Restrictions|0|||
44272912|NCT03633617|79214570|FG009|Part B|COVID-19 Restrictions|0|||
44272913|NCT03633617|79214571|FG010|Part B|COVID-19 Restrictions|0|||
44272914|NCT03633617|79214561|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272915|NCT03633617|79214562|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272916|NCT03633617|79214563|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
44272917|NCT03633617|79214564|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272918|NCT03633617|79214565|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272919|NCT03633617|79214566|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272920|NCT03633617|79214567|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272921|NCT03633617|79214568|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272922|NCT03633617|79214569|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272923|NCT03633617|79214570|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272924|NCT03633617|79214571|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
44272925|NCT03633617|79214561|FG000|Part C (& Follow-up)|Adverse Event|0|||
44272926|NCT03633617|79214562|FG001|Part C (& Follow-up)|Adverse Event|0|||
44272927|NCT03633617|79214563|FG002|Part C (& Follow-up)|Adverse Event|0|||
44272928|NCT03633617|79214564|FG003|Part C (& Follow-up)|Adverse Event|0|||
44272929|NCT03633617|79214565|FG004|Part C (& Follow-up)|Adverse Event|0|||
44272930|NCT03633617|79214566|FG005|Part C (& Follow-up)|Adverse Event|1|||
44272931|NCT03633617|79214567|FG006|Part C (& Follow-up)|Adverse Event|0|||
44272932|NCT03633617|79214568|FG007|Part C (& Follow-up)|Adverse Event|1|||
44272933|NCT03633617|79214569|FG008|Part C (& Follow-up)|Adverse Event|0|||
44272934|NCT03633617|79214570|FG009|Part C (& Follow-up)|Adverse Event|0|||
44272935|NCT03633617|79214571|FG010|Part C (& Follow-up)|Adverse Event|0|||
44272936|NCT03633617|79214561|FG000|Part C (& Follow-up)|Pregnancy|0|||
44272937|NCT03633617|79214562|FG001|Part C (& Follow-up)|Pregnancy|0|||
44272938|NCT03633617|79214563|FG002|Part C (& Follow-up)|Pregnancy|0|||
44272939|NCT03633617|79214564|FG003|Part C (& Follow-up)|Pregnancy|0|||
44272940|NCT03633617|79214565|FG004|Part C (& Follow-up)|Pregnancy|0|||
44272941|NCT03633617|79214566|FG005|Part C (& Follow-up)|Pregnancy|0|||
44465946|NCT00329602|79474901|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
44465947|NCT00329602|79474899|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
44465948|NCT00329602|79474900|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
44465949|NCT00329602|79474901|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
44223202|NCT04266795|79026827|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
44223203|NCT04266795|79026828|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
44223204|NCT04266795|79026827|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
44223205|NCT04266795|79026828|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44223206|NCT04266795|79026827|FG000|Overall Study|Progressive Disease|12|||
44272942|NCT03633617|79214567|FG006|Part C (& Follow-up)|Pregnancy|0|||
44272943|NCT03633617|79214568|FG007|Part C (& Follow-up)|Pregnancy|0|||
44272944|NCT03633617|79214569|FG008|Part C (& Follow-up)|Pregnancy|0|||
44272945|NCT03633617|79214570|FG009|Part C (& Follow-up)|Pregnancy|1|||
44272946|NCT03633617|79214571|FG010|Part C (& Follow-up)|Pregnancy|0|||
44223207|NCT04266795|79026828|FG001|Overall Study|Progressive Disease|9|||
44272947|NCT03633617|79214561|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
44272948|NCT03633617|79214562|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
44272949|NCT03633617|79214563|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
44272950|NCT03633617|79214564|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
44272951|NCT03633617|79214565|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
44272952|NCT03633617|79214566|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
44272953|NCT03633617|79214567|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
44272954|NCT03633617|79214568|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
44272955|NCT03633617|79214569|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
44272956|NCT03633617|79214570|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
44223208|NCT04266795|79026827|FG000|Overall Study|Withdrawal by Patient|5|||
44272957|NCT03633617|79214571|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
44272958|NCT03633617|79214561|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
44272959|NCT03633617|79214562|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
44272960|NCT03633617|79214563|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
44272961|NCT03633617|79214564|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
44272962|NCT03633617|79214565|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
44272963|NCT03633617|79214566|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
44272964|NCT03633617|79214567|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
44223209|NCT04266795|79026828|FG001|Overall Study|Withdrawal by Patient|6|||
44223210|NCT04266795|79026827|FG000|Overall Study|Disease Relapse|3|||
44223211|NCT04266795|79026828|FG001|Overall Study|Disease Relapse|6|||
44272965|NCT03633617|79214568|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
44272966|NCT03633617|79214569|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
44272967|NCT03633617|79214570|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
44272968|NCT03633617|79214571|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
44272969|NCT03633617|79214561|FG000|Part C (& Follow-up)|Physician Decision|0|||
44272970|NCT03633617|79214562|FG001|Part C (& Follow-up)|Physician Decision|0|||
44272971|NCT03633617|79214563|FG002|Part C (& Follow-up)|Physician Decision|0|||
44272972|NCT03633617|79214564|FG003|Part C (& Follow-up)|Physician Decision|0|||
44272973|NCT03633617|79214565|FG004|Part C (& Follow-up)|Physician Decision|0|||
44272974|NCT03633617|79214566|FG005|Part C (& Follow-up)|Physician Decision|0|||
44272975|NCT03633617|79214567|FG006|Part C (& Follow-up)|Physician Decision|0|||
44272976|NCT03633617|79214568|FG007|Part C (& Follow-up)|Physician Decision|1|||
44272977|NCT03633617|79214569|FG008|Part C (& Follow-up)|Physician Decision|0|||
44272978|NCT03633617|79214570|FG009|Part C (& Follow-up)|Physician Decision|0|||
44272979|NCT03633617|79214571|FG010|Part C (& Follow-up)|Physician Decision|1|||
44272980|NCT03633617|79214561|FG000|Part C (& Follow-up)|COVID-19 related|0|||
44272981|NCT03633617|79214562|FG001|Part C (& Follow-up)|COVID-19 related|0|||
44272982|NCT03633617|79214563|FG002|Part C (& Follow-up)|COVID-19 related|0|||
44465950|NCT00329602|79474899|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
44223212|NCT04266795|79026827|FG000|Overall Study|Reason not Specified|12|||
44223213|NCT04266795|79026828|FG001|Overall Study|Reason not Specified|10|||
44223214|NCT04266795|79026827|FG000|Overall Study|Participants Ongoing on Treatment|25|||
44223215|NCT04266795|79026828|FG001|Overall Study|Participants Ongoing on Treatment|23|||
44223216|NCT04212169|79026838|FG000|Overall Study|Adverse Event|0|||
44223217|NCT04212169|79026839|FG001|Overall Study|Adverse Event|0|||
44223218|NCT04212169|79026840|FG002|Overall Study|Adverse Event|0|||
44223219|NCT04212169|79026841|FG003|Overall Study|Adverse Event|2|||
44223220|NCT04212169|79026838|FG000|Overall Study|Lost to Follow-up|1|||
44223221|NCT04212169|79026839|FG001|Overall Study|Lost to Follow-up|0|||
44223222|NCT04212169|79026840|FG002|Overall Study|Lost to Follow-up|0|||
44223223|NCT04212169|79026841|FG003|Overall Study|Lost to Follow-up|2|||
44223224|NCT04212169|79026838|FG000|Overall Study|Withdrawal by Subject|10|||
44223225|NCT04212169|79026839|FG001|Overall Study|Withdrawal by Subject|2|||
44223226|NCT04212169|79026840|FG002|Overall Study|Withdrawal by Subject|5|||
44223227|NCT04212169|79026841|FG003|Overall Study|Withdrawal by Subject|7|||
44223228|NCT04212169|79026838|FG000|Overall Study|Other reason, unspecified|3|||
44272983|NCT03633617|79214564|FG003|Part C (& Follow-up)|COVID-19 related|0|||
44272984|NCT03633617|79214565|FG004|Part C (& Follow-up)|COVID-19 related|0|||
44272985|NCT03633617|79214566|FG005|Part C (& Follow-up)|COVID-19 related|1|||
44272986|NCT03633617|79214567|FG006|Part C (& Follow-up)|COVID-19 related|0|||
44223229|NCT04212169|79026839|FG001|Overall Study|Other reason, unspecified|1|||
44223230|NCT04212169|79026840|FG002|Overall Study|Other reason, unspecified|0|||
44223231|NCT04212169|79026841|FG003|Overall Study|Other reason, unspecified|2|||
44223232|NCT04109313|79026870|FG000|Overall Study|Pregnancy|1|||
44223233|NCT04109313|79026870|FG000|Overall Study|Adverse Event|11|||
44223234|NCT04109313|79026870|FG000|Overall Study|Lack of Efficacy|11|||
44223235|NCT04109313|79026870|FG000|Overall Study|Lost to Follow-up|1|||
44272987|NCT03633617|79214568|FG007|Part C (& Follow-up)|COVID-19 related|0|||
44272988|NCT03633617|79214569|FG008|Part C (& Follow-up)|COVID-19 related|0|||
44272989|NCT03633617|79214570|FG009|Part C (& Follow-up)|COVID-19 related|0|||
44272990|NCT03633617|79214571|FG010|Part C (& Follow-up)|COVID-19 related|0|||
44272991|NCT03633617|79214561|FG000|Part C (& Follow-up)|Protocol Violation|0|||
44223236|NCT04109313|79026870|FG000|Overall Study|Physician Decision|2|||
44223237|NCT04109313|79026870|FG000|Overall Study|Subject Decision|13|||
44223238|NCT04109313|79026870|FG000|Overall Study|Covid-19 situation|2|||
44223239|NCT04089865|79026879|FG000|Overall Study|Withdrawal by Subject|2|||
44272992|NCT03633617|79214562|FG001|Part C (& Follow-up)|Protocol Violation|0|||
44272993|NCT03633617|79214563|FG002|Part C (& Follow-up)|Protocol Violation|0|||
44272994|NCT03633617|79214564|FG003|Part C (& Follow-up)|Protocol Violation|0|||
44272995|NCT03633617|79214565|FG004|Part C (& Follow-up)|Protocol Violation|0|||
44223240|NCT04089865|79026880|FG001|Overall Study|Withdrawal by Subject|2|||
44223241|NCT04089865|79026881|FG002|Overall Study|Withdrawal by Subject|7|||
44272996|NCT03633617|79214566|FG005|Part C (& Follow-up)|Protocol Violation|0|||
44272997|NCT03633617|79214567|FG006|Part C (& Follow-up)|Protocol Violation|0|||
44272998|NCT03633617|79214568|FG007|Part C (& Follow-up)|Protocol Violation|0|||
44272999|NCT03633617|79214569|FG008|Part C (& Follow-up)|Protocol Violation|0|||
44273000|NCT03633617|79214570|FG009|Part C (& Follow-up)|Protocol Violation|3|||
44273001|NCT03633617|79214571|FG010|Part C (& Follow-up)|Protocol Violation|1|||
44273002|NCT03633617|79214561|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
44273003|NCT03633617|79214562|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
44273004|NCT03633617|79214563|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
44273005|NCT03633617|79214564|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
44273006|NCT03633617|79214565|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
44273007|NCT03633617|79214566|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
44273008|NCT03633617|79214567|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
44273009|NCT03633617|79214568|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
44273010|NCT03633617|79214569|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
44273011|NCT03633617|79214570|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
44273012|NCT03633617|79214571|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
44273013|NCT03631784|79214601|FG000|Overall Study|Death|48|||
44273014|NCT03631784|79214602|FG001|Overall Study|Death|28|||
44273015|NCT03631784|79214601|FG000|Overall Study|Lost to Follow-up|1|||
44273016|NCT03631784|79214602|FG001|Overall Study|Lost to Follow-up|0|||
44273017|NCT03631784|79214601|FG000|Overall Study|Withdrawal by Subject|0|||
44273018|NCT03631784|79214602|FG001|Overall Study|Withdrawal by Subject|3|||
44273019|NCT03631784|79214601|FG000|Overall Study|Participants Ongoing|63|||
44273020|NCT03631784|79214602|FG001|Overall Study|Participants Ongoing|71|||
44273021|NCT03617705|79214608|FG000|Overall Study|Withdrawal by Subject|2|||
44273022|NCT03617705|79214608|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
44273023|NCT03617705|79214608|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
44273024|NCT03607422|79214618|FG000|Overall Study|Adverse Event|7|||
44273025|NCT03607422|79214619|FG001|Overall Study|Adverse Event|3|||
44273026|NCT03607422|79214620|FG002|Overall Study|Adverse Event|2|||
44273027|NCT03607422|79214621|FG003|Overall Study|Adverse Event|0|||
44273028|NCT03607422|79214622|FG004|Overall Study|Adverse Event|2|||
44273029|NCT03607422|79214623|FG005|Overall Study|Adverse Event|0|||
44273030|NCT03607422|79214618|FG000|Overall Study|Withdrawal by Subject|11|||
44273031|NCT03607422|79214619|FG001|Overall Study|Withdrawal by Subject|3|||
44273032|NCT03607422|79214620|FG002|Overall Study|Withdrawal by Subject|6|||
44273033|NCT03607422|79214621|FG003|Overall Study|Withdrawal by Subject|2|||
44273034|NCT03607422|79214622|FG004|Overall Study|Withdrawal by Subject|0|||
44273035|NCT03607422|79214623|FG005|Overall Study|Withdrawal by Subject|0|||
44273036|NCT03607422|79214618|FG000|Overall Study|Lost to Follow-up|0|||
44273037|NCT03607422|79214619|FG001|Overall Study|Lost to Follow-up|0|||
44223242|NCT04089865|79026882|FG003|Overall Study|Withdrawal by Subject|2|||
44223243|NCT04017832|79026910|FG000|Overall Study|Withdrawal by Subject|13|||
44223244|NCT04017832|79026911|FG001|Overall Study|Withdrawal by Subject|12|||
44223245|NCT04017832|79026912|FG002|Overall Study|Withdrawal by Subject|21|||
44223246|NCT04017832|79026913|FG003|Overall Study|Withdrawal by Subject|7|||
44223247|NCT04017832|79026910|FG000|Overall Study|Lost to Follow-up|0|||
44273038|NCT03607422|79214620|FG002|Overall Study|Lost to Follow-up|1|||
44273039|NCT03607422|79214621|FG003|Overall Study|Lost to Follow-up|0|||
44273040|NCT03607422|79214622|FG004|Overall Study|Lost to Follow-up|0|||
44273041|NCT03607422|79214623|FG005|Overall Study|Lost to Follow-up|0|||
44273042|NCT03607422|79214618|FG000|Overall Study|Other|12|||
44273043|NCT03607422|79214619|FG001|Overall Study|Other|4|||
44273044|NCT03607422|79214620|FG002|Overall Study|Other|1|||
44273045|NCT03607422|79214621|FG003|Overall Study|Other|2|||
44273046|NCT03607422|79214622|FG004|Overall Study|Other|0|||
44273047|NCT03607422|79214623|FG005|Overall Study|Other|2|||
44273048|NCT03607422|79214618|FG000|Overall Study|Ongoing at Time of Analysis|8|||
44273049|NCT03607422|79214619|FG001|Overall Study|Ongoing at Time of Analysis|0|||
44273050|NCT03607422|79214620|FG002|Overall Study|Ongoing at Time of Analysis|2|||
44273051|NCT03607422|79214621|FG003|Overall Study|Ongoing at Time of Analysis|1|||
44273052|NCT03607422|79214622|FG004|Overall Study|Ongoing at Time of Analysis|1|||
44273053|NCT03607422|79214623|FG005|Overall Study|Ongoing at Time of Analysis|1|||
44273054|NCT03568318|79214661|FG000|Overall Study|Adverse Event|3|||
44273055|NCT03568318|79214662|FG001|Overall Study|Adverse Event|1|||
44273056|NCT03568318|79214663|FG002|Overall Study|Adverse Event|1|||
44273057|NCT03568318|79214664|FG003|Overall Study|Adverse Event|0|||
44273058|NCT03568318|79214665|FG004|Overall Study|Adverse Event|1|||
44273059|NCT03568318|79214666|FG005|Overall Study|Adverse Event|0|||
44273060|NCT03568318|79214661|FG000|Overall Study|Withdrawal by Subject|6|||
44273061|NCT03568318|79214662|FG001|Overall Study|Withdrawal by Subject|5|||
44273062|NCT03568318|79214663|FG002|Overall Study|Withdrawal by Subject|2|||
44273063|NCT03568318|79214664|FG003|Overall Study|Withdrawal by Subject|1|||
44273064|NCT03568318|79214665|FG004|Overall Study|Withdrawal by Subject|0|||
44273065|NCT03568318|79214666|FG005|Overall Study|Withdrawal by Subject|0|||
44273066|NCT03568318|79214661|FG000|Overall Study|Lost to Follow-up|3|||
44273067|NCT03568318|79214662|FG001|Overall Study|Lost to Follow-up|2|||
44273068|NCT03568318|79214663|FG002|Overall Study|Lost to Follow-up|2|||
44273069|NCT03568318|79214664|FG003|Overall Study|Lost to Follow-up|2|||
44273070|NCT03568318|79214665|FG004|Overall Study|Lost to Follow-up|1|||
44273071|NCT03568318|79214666|FG005|Overall Study|Lost to Follow-up|0|||
44273072|NCT03568318|79214661|FG000|Overall Study|Other|3|||
44273073|NCT03568318|79214662|FG001|Overall Study|Other|1|||
44273074|NCT03568318|79214663|FG002|Overall Study|Other|3|||
44273075|NCT03568318|79214664|FG003|Overall Study|Other|0|||
44273076|NCT03568318|79214665|FG004|Overall Study|Other|0|||
44273077|NCT03568318|79214666|FG005|Overall Study|Other|0|||
44273078|NCT03568318|79214661|FG000|Overall Study|Ongoing at Time of Analysis|5|||
44273079|NCT03568318|79214662|FG001|Overall Study|Ongoing at Time of Analysis|3|||
44273080|NCT03568318|79214663|FG002|Overall Study|Ongoing at Time of Analysis|2|||
44273081|NCT03568318|79214664|FG003|Overall Study|Ongoing at Time of Analysis|1|||
44273082|NCT03568318|79214665|FG004|Overall Study|Ongoing at Time of Analysis|0|||
44273083|NCT03568318|79214666|FG005|Overall Study|Ongoing at Time of Analysis|0|||
44273084|NCT03550794|79214682|FG000|Overall Study|No longer met inclusion criteria|1|||
44273085|NCT03550794|79214683|FG001|Overall Study|No longer met inclusion criteria|2|||
44273086|NCT03550794|79214682|FG000|Overall Study|Goals of care changed|1|||
44273087|NCT03550794|79214683|FG001|Overall Study|Goals of care changed|0|||
44273088|NCT03550794|79214682|FG000|Overall Study|Withdrawal by Subject|2|||
44273089|NCT03550794|79214683|FG001|Overall Study|Withdrawal by Subject|0|||
44273090|NCT03550794|79214682|FG000|Overall Study|Death|0|||
44273091|NCT03550794|79214683|FG001|Overall Study|Death|1|||
44223248|NCT04017832|79026911|FG001|Overall Study|Lost to Follow-up|3|||
44223249|NCT04017832|79026912|FG002|Overall Study|Lost to Follow-up|3|||
44223250|NCT04017832|79026913|FG003|Overall Study|Lost to Follow-up|1|||
44223251|NCT04017832|79026910|FG000|Overall Study|Physician Decision|1|||
44223252|NCT04017832|79026911|FG001|Overall Study|Physician Decision|1|||
44223253|NCT04017832|79026912|FG002|Overall Study|Physician Decision|1|||
44223254|NCT04017832|79026913|FG003|Overall Study|Physician Decision|1|||
44223255|NCT04017832|79026910|FG000|Overall Study|Death|2|||
44223256|NCT04017832|79026911|FG001|Overall Study|Death|2|||
44223257|NCT04017832|79026912|FG002|Overall Study|Death|1|||
44223258|NCT04017832|79026913|FG003|Overall Study|Death|0|||
44223259|NCT03952806|79026929|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
44223260|NCT03952806|79026930|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
44223261|NCT03952806|79026929|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
44223262|NCT03952806|79026930|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
44223263|NCT03952806|79026929|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
44223264|NCT03952806|79026930|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
44273092|NCT03427125|79214722|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
44273093|NCT03427125|79214723|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
44273094|NCT03427125|79214724|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
44273095|NCT03341273|79214739|FG000|Overall Study|Lost to Follow-up|7|||
44273096|NCT03341273|79214740|FG001|Overall Study|Lost to Follow-up|7|||
44273097|NCT03341273|79214739|FG000|Overall Study|Withdrawal by Subject|4|||
44273098|NCT03341273|79214740|FG001|Overall Study|Withdrawal by Subject|2|||
44273099|NCT03341273|79214739|FG000|Overall Study|Physician Decision|1|||
44273100|NCT03341273|79214740|FG001|Overall Study|Physician Decision|0|||
44273101|NCT03341273|79214739|FG000|Overall Study|Protocol Violation|0|||
44273102|NCT03341273|79214740|FG001|Overall Study|Protocol Violation|1|||
44273103|NCT03341273|79214739|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
44223265|NCT03952806|79026929|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
44273104|NCT03341273|79214740|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
44273105|NCT03341273|79214739|FG000|Overall Study|Became ineligible after enrollment|1|||
44273106|NCT03341273|79214740|FG001|Overall Study|Became ineligible after enrollment|0|||
44273107|NCT03341273|79214739|FG000|Overall Study|Not Eligible at Enrollment|0|||
44273108|NCT03341273|79214740|FG001|Overall Study|Not Eligible at Enrollment|1|||
44273109|NCT03341273|79214739|FG000|Overall Study|Participant incarcerated|1|||
44273110|NCT03341273|79214740|FG001|Overall Study|Participant incarcerated|0|||
44273111|NCT03284710|79214750|FG000|Overall Study|Withdrawal by Subject|1|||
44273112|NCT03284710|79214751|FG001|Overall Study|Withdrawal by Subject|0|||
44273113|NCT03284710|79214752|FG002|Overall Study|Withdrawal by Subject|1|||
44273114|NCT03284710|79214753|FG003|Overall Study|Withdrawal by Subject|6|||
44273115|NCT03284710|79214750|FG000|Overall Study|Lost to Follow-up|3|||
44273116|NCT03284710|79214751|FG001|Overall Study|Lost to Follow-up|3|||
44273117|NCT03284710|79214752|FG002|Overall Study|Lost to Follow-up|1|||
44273118|NCT03284710|79214753|FG003|Overall Study|Lost to Follow-up|0|||
44273119|NCT03284710|79214750|FG000|Overall Study|Physician Decision|1|||
44273120|NCT03284710|79214751|FG001|Overall Study|Physician Decision|0|||
44273121|NCT03284710|79214752|FG002|Overall Study|Physician Decision|0|||
44273122|NCT03284710|79214753|FG003|Overall Study|Physician Decision|0|||
44273123|NCT03284710|79214750|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
44273124|NCT03284710|79214751|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
44273125|NCT03284710|79214752|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
44273126|NCT03284710|79214753|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
44273127|NCT03284710|79214750|FG000|Overall Study|HIV Infection|0|||
44273128|NCT03284710|79214751|FG001|Overall Study|HIV Infection|2|||
44273129|NCT03284710|79214752|FG002|Overall Study|HIV Infection|2|||
44273130|NCT03284710|79214753|FG003|Overall Study|HIV Infection|1|||
44273131|NCT03248167|79214772|FG000|Overall Study|Withdrawal by Subject|2|||
44273132|NCT03248167|79214773|FG001|Overall Study|Withdrawal by Subject|2|||
44273133|NCT03248167|79214772|FG000|Overall Study|Physician Decision|0|||
44273134|NCT03248167|79214773|FG001|Overall Study|Physician Decision|1|||
44273135|NCT03248167|79214772|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
44273136|NCT03248167|79214773|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
44273137|NCT03248167|79214772|FG000|Overall Study|Lost to Follow-up|1|||
44273138|NCT03248167|79214773|FG001|Overall Study|Lost to Follow-up|0|||
44273139|NCT03220737|79214787|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
44273140|NCT03220737|79214788|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
44273141|NCT03220737|79214789|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
44273142|NCT03220737|79214790|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
44273143|NCT03220737|79214791|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
44273144|NCT03220737|79214792|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
44273145|NCT03220737|79214793|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
44273146|NCT03220737|79214787|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
44375117|NCT00908037|79380257|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44465951|NCT00329602|79474900|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
44223266|NCT03952806|79026930|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
44223267|NCT03952806|79026929|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
44223268|NCT03952806|79026930|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
44223269|NCT03952806|79026929|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
44223270|NCT03952806|79026930|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
44223271|NCT03952806|79026929|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
44223272|NCT03952806|79026930|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
44223273|NCT03952806|79026929|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
44223274|NCT03952806|79026930|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
44223275|NCT03952806|79026929|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
44223276|NCT03952806|79026930|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
44223277|NCT03952806|79026929|FG000|OLE Phase (48 Weeks)|Other|16|||
44223278|NCT03952806|79026930|FG001|OLE Phase (48 Weeks)|Other|13|||
44223279|NCT03924947|79026955|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
44223280|NCT03924947|79026956|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
44223281|NCT03924947|79026957|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
44223282|NCT03924947|79026958|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
44273147|NCT03220737|79214788|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
44273148|NCT03220737|79214789|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
44273149|NCT03220737|79214790|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
44273150|NCT03220737|79214791|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
44273151|NCT03220737|79214792|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
44273152|NCT03220737|79214793|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
44273153|NCT03220737|79214787|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
44273154|NCT03220737|79214788|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
44273155|NCT03220737|79214789|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
44273156|NCT03220737|79214790|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
44273157|NCT03220737|79214791|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
44375118|NCT00908037|79380258|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44375119|NCT00908037|79380259|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44273158|NCT03220737|79214792|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
44273159|NCT03220737|79214793|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
44273160|NCT03220737|79214787|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
44273161|NCT03220737|79214788|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
44273162|NCT03220737|79214789|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
44273163|NCT03220737|79214790|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
44273164|NCT03220737|79214791|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
44273165|NCT03220737|79214792|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
44273166|NCT03220737|79214793|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
44273167|NCT03220737|79214787|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
44273168|NCT03220737|79214788|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
44273169|NCT03220737|79214789|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
44273170|NCT03220737|79214790|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
44273171|NCT03220737|79214791|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
44273172|NCT03220737|79214792|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
44273173|NCT03220737|79214793|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
44273174|NCT03220737|79214787|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
44273175|NCT03220737|79214788|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
44223283|NCT03924947|79026959|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
44223284|NCT03924947|79026960|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
44223285|NCT03845985|79026985|FG000|Overall Study|Lost to Follow-up|2|||
44223286|NCT03845985|79026986|FG001|Overall Study|Lost to Follow-up|1|||
44223287|NCT03845985|79026985|FG000|Overall Study|Physician Decision|1|||
44223288|NCT03845985|79026986|FG001|Overall Study|Physician Decision|0|||
44223289|NCT03845985|79026985|FG000|Overall Study|Withdrawal by Subject|4|||
44223290|NCT03845985|79026986|FG001|Overall Study|Withdrawal by Subject|1|||
44223291|NCT03745651|79026995|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
44223292|NCT03745651|79026996|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
44223293|NCT03745651|79026997|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223294|NCT03745651|79026998|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223295|NCT03745651|79026999|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223296|NCT03745651|79027000|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223297|NCT03745651|79027001|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223298|NCT03745651|79026995|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
44223299|NCT03745651|79026996|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
44223300|NCT03745651|79026997|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
44223301|NCT03745651|79026998|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223302|NCT03745651|79026999|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223303|NCT03745651|79027000|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223304|NCT03745651|79027001|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223305|NCT03745651|79026995|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
44223306|NCT03745651|79026996|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223307|NCT03745651|79026997|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
44223308|NCT03745651|79026998|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223309|NCT03745651|79026999|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223310|NCT03745651|79027000|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223311|NCT03745651|79027001|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223312|NCT03745651|79026995|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223313|NCT03745651|79026996|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
44223314|NCT03745651|79026997|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223315|NCT03745651|79026998|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223316|NCT03745651|79026999|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223317|NCT03745651|79027000|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223318|NCT03745651|79027001|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223319|NCT03745651|79026995|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
44223320|NCT03745651|79026996|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
44223321|NCT03745651|79026997|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
44223322|NCT03745651|79026998|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223323|NCT03745651|79026999|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223324|NCT03745651|79027000|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223325|NCT03745651|79027001|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223326|NCT03745651|79026995|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
44273176|NCT03220737|79214789|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
44273177|NCT03220737|79214790|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
44273178|NCT03220737|79214791|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
44465952|NCT00329602|79474901|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
44465953|NCT00329602|79474899|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
44465954|NCT00329602|79474900|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
44465955|NCT00329602|79474901|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
44465956|NCT00463866|79474919|FG000|Overall Study|Adverse Event|70|||
44465957|NCT00463866|79474920|FG001|Overall Study|Adverse Event|93|||
44465958|NCT00463866|79474919|FG000|Overall Study|Withdrawal by Subject|81|||
44465959|NCT00463866|79474920|FG001|Overall Study|Withdrawal by Subject|79|||
44465960|NCT00463866|79474919|FG000|Overall Study|Lost to Follow-up|46|||
44465961|NCT00463866|79474920|FG001|Overall Study|Lost to Follow-up|55|||
44465962|NCT00463866|79474919|FG000|Overall Study|Incorrect Enrolment|64|||
44465963|NCT00463866|79474920|FG001|Overall Study|Incorrect Enrolment|66|||
44465964|NCT00463866|79474919|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
44465965|NCT00463866|79474920|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
44465966|NCT00463866|79474919|FG000|Overall Study|Safety Reason|1|||
44465967|NCT00463866|79474920|FG001|Overall Study|Safety Reason|3|||
44465968|NCT00463866|79474919|FG000|Overall Study|Mis-Randomization of subject|0|||
44465969|NCT00463866|79474920|FG001|Overall Study|Mis-Randomization of subject|1|||
44465970|NCT00463866|79474919|FG000|Overall Study|Other|22|||
44465971|NCT00463866|79474920|FG001|Overall Study|Other|22|||
44465972|NCT00313846|79474928|FG000|Overall Study|Withdrawal by Subject|2|||
44465973|NCT00313846|79474929|FG001|Overall Study|Withdrawal by Subject|0|||
44465974|NCT00313846|79474928|FG000|Overall Study|Adverse Event|1|||
44465975|NCT00313846|79474929|FG001|Overall Study|Adverse Event|8|||
44465976|NCT00313846|79474928|FG000|Overall Study|Administrative|2|||
44465977|NCT00313846|79474929|FG001|Overall Study|Administrative|3|||
44465978|NCT00551135|79474940|FG000|Overall Study|Adverse Event|1|||
44465979|NCT00551135|79474941|FG001|Overall Study|Adverse Event|0|||
44465980|NCT00551135|79474942|FG002|Overall Study|Adverse Event|1|||
44465981|NCT00551135|79474943|FG003|Overall Study|Adverse Event|1|||
44465982|NCT00551135|79474940|FG000|Overall Study|Lost to Follow-up|0|||
44465983|NCT00551135|79474941|FG001|Overall Study|Lost to Follow-up|0|||
44465984|NCT00551135|79474942|FG002|Overall Study|Lost to Follow-up|0|||
44465985|NCT00551135|79474943|FG003|Overall Study|Lost to Follow-up|1|||
44465986|NCT00551135|79474940|FG000|Overall Study|Other|3|||
44465987|NCT00551135|79474941|FG001|Overall Study|Other|2|||
44465988|NCT00551135|79474942|FG002|Overall Study|Other|1|||
44465989|NCT00551135|79474943|FG003|Overall Study|Other|2|||
44465990|NCT00551135|79474940|FG000|Overall Study|Withdrawal by Subject|1|||
44465991|NCT00551135|79474941|FG001|Overall Study|Withdrawal by Subject|0|||
44465992|NCT00551135|79474942|FG002|Overall Study|Withdrawal by Subject|3|||
44465993|NCT00551135|79474943|FG003|Overall Study|Withdrawal by Subject|1|||
44465994|NCT00299104|79474956|FG000|Treatment Period|Adverse Event|14|||
44465995|NCT00299104|79474957|FG001|Treatment Period|Adverse Event|9|||
44465996|NCT00299104|79474958|FG002|Treatment Period|Adverse Event|7|||
44465997|NCT00299104|79474956|FG000|Treatment Period|Death|1|||
44465998|NCT00299104|79474957|FG001|Treatment Period|Death|1|||
44465999|NCT00299104|79474958|FG002|Treatment Period|Death|1|||
44466000|NCT00299104|79474956|FG000|Treatment Period|Insufficient therapeutic response|34|||
44466001|NCT00299104|79474957|FG001|Treatment Period|Insufficient therapeutic response|13|||
44466002|NCT00299104|79474958|FG002|Treatment Period|Insufficient therapeutic response|8|||
44466003|NCT00299104|79474956|FG000|Treatment Period|Failure to return|9|||
44466004|NCT00299104|79474957|FG001|Treatment Period|Failure to return|8|||
44466005|NCT00299104|79474958|FG002|Treatment Period|Failure to return|8|||
44223327|NCT03745651|79026996|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
44223328|NCT03745651|79026997|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
44223329|NCT03745651|79026998|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
44223330|NCT03745651|79026999|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
44223331|NCT03745651|79027000|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
44223332|NCT03745651|79027001|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
44223333|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223334|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223335|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44277810|NCT02092350|79238806|FG000|Overall Study|Screen Failure|1|||
44466006|NCT00299104|79474956|FG000|Treatment Period|Violation of selection criteria|1|||
44466007|NCT00299104|79474957|FG001|Treatment Period|Violation of selection criteria|2|||
44466008|NCT00299104|79474958|FG002|Treatment Period|Violation of selection criteria|0|||
44466009|NCT00299104|79474956|FG000|Treatment Period|Protocol Violation|1|||
44466010|NCT00299104|79474957|FG001|Treatment Period|Protocol Violation|1|||
44466011|NCT00299104|79474958|FG002|Treatment Period|Protocol Violation|0|||
44466012|NCT00299104|79474956|FG000|Treatment Period|Refused treatment|9|||
44466013|NCT00299104|79474957|FG001|Treatment Period|Refused treatment|2|||
44466014|NCT00299104|79474958|FG002|Treatment Period|Refused treatment|2|||
44466015|NCT00299104|79474956|FG000|Treatment Period|Withdrew consent|14|||
44466016|NCT00299104|79474957|FG001|Treatment Period|Withdrew consent|19|||
44273179|NCT03220737|79214792|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
44273180|NCT03220737|79214793|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
44273181|NCT03220737|79214787|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
44273182|NCT03220737|79214788|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
44273183|NCT03220737|79214789|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
44273184|NCT03220737|79214790|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
44273185|NCT03220737|79214791|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
44273186|NCT03220737|79214792|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
44273187|NCT03220737|79214793|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
44273188|NCT03220737|79214787|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
44273189|NCT03220737|79214788|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
44273190|NCT03220737|79214789|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
44273191|NCT03220737|79214790|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
44273192|NCT03220737|79214791|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
44223336|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223337|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223338|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
44223339|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223340|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223341|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223342|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223343|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
44223344|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223345|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
44223346|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
44223347|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
44223348|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
44223349|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
44223350|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
44223351|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
44223352|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
44223353|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
44223354|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223355|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223356|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223357|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
44223358|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223359|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
44223360|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
44223361|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
44223362|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
44223363|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
44223364|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
44223365|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
44223366|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
44223367|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
44223368|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223369|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223370|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223371|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223372|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223373|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
44223374|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223375|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
44223376|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
44223377|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
44223378|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
44223379|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
44273193|NCT03220737|79214792|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
44273194|NCT03220737|79214793|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
44273195|NCT03198728|79214817|FG000|Overall Study|Adverse Event|10|||
44375120|NCT00908037|79380260|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44273196|NCT03198728|79214818|FG001|Overall Study|Adverse Event|5|||
44273197|NCT03198728|79214817|FG000|Overall Study|Lost to Follow-up|21|||
44375121|NCT00908037|79380261|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44223380|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
44223381|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
44223382|NCT03745651|79026995|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
44273198|NCT03198728|79214818|FG001|Overall Study|Lost to Follow-up|7|||
44273199|NCT03198728|79214817|FG000|Overall Study|Physician Decision|7|||
44273200|NCT03198728|79214818|FG001|Overall Study|Physician Decision|2|||
44273201|NCT03198728|79214817|FG000|Overall Study|Withdrawal by Subject|14|||
44273202|NCT03198728|79214818|FG001|Overall Study|Withdrawal by Subject|10|||
44273203|NCT03144804|79214841|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
44273204|NCT03142334|79214847|FG000|Overall Study|Death|18|||
44273205|NCT03142334|79214848|FG001|Overall Study|Death|33|||
44273206|NCT03142334|79214847|FG000|Overall Study|Withdrawal by Subject|15|||
44466017|NCT00299104|79474958|FG002|Treatment Period|Withdrew consent|9|||
44466018|NCT00299104|79474956|FG000|Treatment Period|Administrative reasons|106|||
44466019|NCT00299104|79474957|FG001|Treatment Period|Administrative reasons|120|||
44466020|NCT00299104|79474958|FG002|Treatment Period|Administrative reasons|137|||
44466021|NCT00299104|79474956|FG000|Safety Follow-Up (SFU) Period|Death|3|||
44466022|NCT00299104|79474957|FG001|Safety Follow-Up (SFU) Period|Death|2|||
44466023|NCT00299104|79474958|FG002|Safety Follow-Up (SFU) Period|Death|1|||
44466024|NCT00299104|79474956|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
44544318|NCT03733301|79557680|FG001|Overall Study|Screen Fail|0|||
44544319|NCT03733301|79557681|FG002|Overall Study|Screen Fail|0|||
44544320|NCT03733301|79557679|FG000|Overall Study|Non-compliance|1|||
44544321|NCT03733301|79557680|FG001|Overall Study|Non-compliance|0|||
44544322|NCT03733301|79557681|FG002|Overall Study|Non-compliance|0|||
44544323|NCT03733301|79557679|FG000|Overall Study|Lack of Efficacy|2|||
44544324|NCT03733301|79557680|FG001|Overall Study|Lack of Efficacy|3|||
44544325|NCT03733301|79557681|FG002|Overall Study|Lack of Efficacy|0|||
44544326|NCT03733301|79557679|FG000|Overall Study|Adverse Event|0|||
44544327|NCT03733301|79557680|FG001|Overall Study|Adverse Event|1|||
44544328|NCT03733301|79557681|FG002|Overall Study|Adverse Event|3|||
44223383|NCT03745651|79026996|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
44223384|NCT03745651|79026997|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
44223385|NCT03745651|79026998|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
44223386|NCT03745651|79026999|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
44223387|NCT03745651|79027000|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
44223388|NCT03745651|79027001|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
44223389|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
44223390|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
44223391|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
44223392|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223393|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223394|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44223395|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
44273207|NCT03142334|79214848|FG001|Overall Study|Withdrawal by Subject|11|||
44273208|NCT03142334|79214847|FG000|Overall Study|Ongoing on trial follow up|463|||
44273209|NCT03142334|79214848|FG001|Overall Study|Ongoing on trial follow up|454|||
44273210|NCT03126539|79214856|FG000|Overall Study|Lost to Follow-up|1|||
44375122|NCT00908037|79380262|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44375123|NCT00908037|79380263|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44375124|NCT00908037|79380264|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44375125|NCT00908037|79380265|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44375126|NCT00908037|79380266|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
44375127|NCT00908037|79380267|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
44375128|NCT00908037|79380268|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
44375129|NCT00908037|79380257|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375130|NCT00908037|79380258|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375131|NCT00908037|79380259|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375132|NCT00908037|79380260|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375133|NCT00908037|79380261|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375134|NCT00908037|79380262|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375135|NCT00908037|79380263|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375136|NCT00908037|79380264|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375137|NCT00908037|79380265|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375138|NCT00908037|79380266|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
44466025|NCT00299104|79474957|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
44544329|NCT03733301|79557679|FG000|Overall Study|Withdrawal by Subject|3|||
44544330|NCT03733301|79557680|FG001|Overall Study|Withdrawal by Subject|5|||
44544331|NCT03733301|79557681|FG002|Overall Study|Withdrawal by Subject|1|||
44466026|NCT00299104|79474958|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
44466027|NCT00299104|79474956|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
44466028|NCT00299104|79474957|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
44466029|NCT00299104|79474958|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
44466030|NCT00299104|79474956|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
44466031|NCT00299104|79474957|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
44466032|NCT00299104|79474958|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
44466033|NCT00299104|79474956|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
44466034|NCT00299104|79474957|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
44466035|NCT00299104|79474958|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
44466036|NCT00299104|79474956|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
44466037|NCT00299104|79474957|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
44466038|NCT00299104|79474958|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
44466039|NCT00299104|79474956|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
44466040|NCT00299104|79474957|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
44466041|NCT00299104|79474958|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
44466042|NCT00299104|79474956|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
44466043|NCT00299104|79474957|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
44466044|NCT00299104|79474958|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
44466045|NCT00313612|79474968|FG000|Overall Study|Patient never received treatment|0|||
44466046|NCT00313612|79474969|FG001|Overall Study|Patient never received treatment|1|||
44466047|NCT00507416|79474978|FG000|Overall Study|Adverse Event|58|||
44466048|NCT00507416|79474979|FG001|Overall Study|Adverse Event|67|||
44466049|NCT00507416|79474980|FG002|Overall Study|Adverse Event|65|||
44466050|NCT00507416|79474978|FG000|Overall Study|Protocol Violation|1|||
44466051|NCT00507416|79474979|FG001|Overall Study|Protocol Violation|2|||
44466052|NCT00507416|79474980|FG002|Overall Study|Protocol Violation|0|||
44466053|NCT00507416|79474978|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
44466054|NCT00507416|79474979|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
44466055|NCT00507416|79474980|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
44466056|NCT00507416|79474978|FG000|Overall Study|Progressive Disease|20|||
44466057|NCT00507416|79474979|FG001|Overall Study|Progressive Disease|10|||
44466058|NCT00507416|79474980|FG002|Overall Study|Progressive Disease|13|||
44466059|NCT00507416|79474978|FG000|Overall Study|Patient declined further treatment|18|||
44466060|NCT00507416|79474979|FG001|Overall Study|Patient declined further treatment|14|||
44466061|NCT00507416|79474980|FG002|Overall Study|Patient declined further treatment|11|||
44466062|NCT00507416|79474978|FG000|Overall Study|Other|11|||
44466063|NCT00507416|79474979|FG001|Overall Study|Other|16|||
44466064|NCT00507416|79474980|FG002|Overall Study|Other|13|||
44466065|NCT00507416|79474978|FG000|Overall Study|Did not Receive Study Treatment|3|||
44466066|NCT00507416|79474979|FG001|Overall Study|Did not Receive Study Treatment|9|||
44466067|NCT00507416|79474980|FG002|Overall Study|Did not Receive Study Treatment|4|||
44466068|NCT00489476|79474992|FG000|Overall Study|Lost to Follow-up|0|||
44466069|NCT00489476|79474993|FG001|Overall Study|Lost to Follow-up|1|||
44466070|NCT00489476|79474994|FG002|Overall Study|Lost to Follow-up|0|||
44466071|NCT00489476|79474995|FG003|Overall Study|Lost to Follow-up|0|||
44466072|NCT00550745|79475007|FG000|Overall Study|Death|20|||
44466073|NCT00550745|79475008|FG001|Overall Study|Death|16|||
44466074|NCT00550745|79475007|FG000|Overall Study|Lost to Follow-up|45|||
44466075|NCT00550745|79475008|FG001|Overall Study|Lost to Follow-up|30|||
44466076|NCT00550745|79475007|FG000|Overall Study|Physician Decision|0|||
44466077|NCT00550745|79475008|FG001|Overall Study|Physician Decision|2|||
44466078|NCT00550745|79475007|FG000|Overall Study|Protocol Violation|4|||
44466079|NCT00550745|79475008|FG001|Overall Study|Protocol Violation|2|||
44466080|NCT00550745|79475007|FG000|Overall Study|Withdrawal by Subject|17|||
44466081|NCT00550745|79475008|FG001|Overall Study|Withdrawal by Subject|10|||
44466082|NCT00550745|79475007|FG000|Overall Study|Screen failure|1|||
44544332|NCT02871297|79557690|FG000|Overall Study|Adverse Event|34|||
44544333|NCT02871297|79557690|FG000|Overall Study|Lack of Efficacy|10|||
44544334|NCT02871297|79557690|FG000|Overall Study|Non-compliance with study drug|15|||
44466083|NCT00550745|79475008|FG001|Overall Study|Screen failure|0|||
44544335|NCT02871297|79557690|FG000|Overall Study|Protocol Violation|3|||
44466084|NCT00452790|79475016|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
44375139|NCT00908037|79380267|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375140|NCT00908037|79380268|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
44375141|NCT00908037|79380257|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375142|NCT00908037|79380258|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375143|NCT00908037|79380259|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375144|NCT00908037|79380260|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44544336|NCT02871297|79557690|FG000|Overall Study|Withdrawal by Subject|20|||
44544337|NCT02871297|79557690|FG000|Overall Study|Lost to Follow-up|13|||
44544338|NCT02871297|79557690|FG000|Overall Study|Rolled over to 13546A|2|||
44544339|NCT02871297|79557690|FG000|Overall Study|Other than specified|39|||
44544340|NCT03554005|79557700|FG000|Overall Study|Not in participant's best interest|0|||
44544341|NCT03554005|79557701|FG001|Overall Study|Not in participant's best interest|0|||
44544342|NCT03554005|79557702|FG002|Overall Study|Not in participant's best interest|0|||
44544343|NCT03554005|79557703|FG003|Overall Study|Not in participant's best interest|0|||
44544344|NCT03554005|79557704|FG004|Overall Study|Not in participant's best interest|0|||
44544345|NCT03554005|79557705|FG005|Overall Study|Not in participant's best interest|1|||
44544346|NCT03554005|79557700|FG000|Overall Study|Disease Progression|1|||
44544347|NCT03554005|79557701|FG001|Overall Study|Disease Progression|1|||
44544348|NCT03554005|79557702|FG002|Overall Study|Disease Progression|1|||
44544349|NCT03554005|79557703|FG003|Overall Study|Disease Progression|1|||
44544350|NCT03554005|79557704|FG004|Overall Study|Disease Progression|5|||
44544351|NCT03554005|79557705|FG005|Overall Study|Disease Progression|6|||
44544352|NCT03554005|79557700|FG000|Overall Study|Adverse Event|0|||
44544353|NCT03554005|79557701|FG001|Overall Study|Adverse Event|0|||
44544354|NCT03554005|79557702|FG002|Overall Study|Adverse Event|0|||
44544355|NCT03554005|79557703|FG003|Overall Study|Adverse Event|0|||
44544356|NCT03554005|79557704|FG004|Overall Study|Adverse Event|0|||
44544357|NCT03554005|79557705|FG005|Overall Study|Adverse Event|3|||
44544358|NCT03554005|79557700|FG000|Overall Study|Physician Decision|0|||
44544359|NCT03554005|79557701|FG001|Overall Study|Physician Decision|0|||
44544360|NCT03554005|79557702|FG002|Overall Study|Physician Decision|0|||
44544361|NCT03554005|79557703|FG003|Overall Study|Physician Decision|0|||
44544362|NCT03554005|79557704|FG004|Overall Study|Physician Decision|1|||
44544363|NCT03554005|79557705|FG005|Overall Study|Physician Decision|0|||
44544364|NCT03554005|79557700|FG000|Overall Study|Other|0|||
44544365|NCT03554005|79557701|FG001|Overall Study|Other|0|||
44544366|NCT03554005|79557702|FG002|Overall Study|Other|0|||
44544367|NCT03554005|79557703|FG003|Overall Study|Other|0|||
44544368|NCT03554005|79557704|FG004|Overall Study|Other|0|||
44544369|NCT03554005|79557705|FG005|Overall Study|Other|1|||
44544370|NCT00709228|79557719|FG000|Overall Study|Not treated|14|||
44544371|NCT00709228|79557719|FG000|Overall Study|Eligibility criteria not met|281|||
44544372|NCT00709228|79557719|FG000|Overall Study|Adverse events|2|||
44544373|NCT00709228|79557719|FG000|Overall Study|Discontinued treatment|14|||
44544374|NCT00709228|79557719|FG000|Overall Study|Did not enter follow-up|4|||
44544375|NCT00709228|79557719|FG000|Overall Study|Discontinued follow-up|5|||
44544376|NCT00709228|79557719|FG000|Overall Study|Disease progression|1|||
44544377|NCT00709228|79557719|FG000|Overall Study|Lost to Follow-up|6|||
44544378|NCT00709228|79557719|FG000|Overall Study|Non-compliance|5|||
44544379|NCT03219372|79557725|FG000|Overall Study|Withdrawal by Subject|1|||
44544380|NCT03219372|79557726|FG001|Overall Study|Withdrawal by Subject|0|||
44544381|NCT03056690|79557741|FG000|Overall Study|Adverse Event|3|||
44544382|NCT03056690|79557742|FG001|Overall Study|Adverse Event|2|||
44544383|NCT03056690|79557741|FG000|Overall Study|Lack of Efficacy|1|||
44544384|NCT03056690|79557742|FG001|Overall Study|Lack of Efficacy|2|||
44544385|NCT03056690|79557741|FG000|Overall Study|Lost to Follow-up|3|||
44544386|NCT03056690|79557742|FG001|Overall Study|Lost to Follow-up|2|||
44544387|NCT03056690|79557741|FG000|Overall Study|Protocol Violation|2|||
44544388|NCT03056690|79557742|FG001|Overall Study|Protocol Violation|2|||
44544389|NCT03056690|79557741|FG000|Overall Study|Withdrawal by Subject|3|||
44544390|NCT03056690|79557742|FG001|Overall Study|Withdrawal by Subject|6|||
44544391|NCT03056690|79557741|FG000|Overall Study|Non-compliance with Study Drug|1|||
44544392|NCT03056690|79557742|FG001|Overall Study|Non-compliance with Study Drug|0|||
44544393|NCT03056690|79557741|FG000|Overall Study|Miscellaneous|1|||
44544394|NCT03056690|79557742|FG001|Overall Study|Miscellaneous|2|||
44544395|NCT03191799|79557748|FG000|Overall Study|Withdrawal by Subject|4|||
44544396|NCT03191799|79557748|FG000|Overall Study|Physician Decision|2|||
44544397|NCT03191799|79557748|FG000|Overall Study|Lost to Follow-up|1|||
44544398|NCT03191799|79557748|FG000|Overall Study|Death|2|||
44544399|NCT00708916|79557752|FG000|Overall Study|Subject Noncompliance|2|||
44544400|NCT00708916|79557752|FG000|Overall Study|Adverse Event|2|||
44223396|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
44223397|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44223398|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44223399|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44223400|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44544401|NCT02352753|79557757|FG000|6-Month Dosing Period|Decision by sponsor|2|||
44544402|NCT02352753|79557757|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
44544403|NCT02352753|79557757|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
44544404|NCT02352753|79557757|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
44544405|NCT02352753|79557757|FG000|3-Month Dosing Period|Decision by sponsor|14|||
44544406|NCT02352753|79557757|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
44273211|NCT03126539|79214857|FG001|Overall Study|Lost to Follow-up|1|||
44544407|NCT04532294|79557768|FG000|Overall Study|Withdrawal by Subject|0|||
44544408|NCT04532294|79557769|FG001|Overall Study|Withdrawal by Subject|0|||
44544409|NCT04532294|79557770|FG002|Overall Study|Withdrawal by Subject|1|||
44544410|NCT04532294|79557768|FG000|Overall Study|Participants Not Dosed|0|||
44544411|NCT04532294|79557769|FG001|Overall Study|Participants Not Dosed|0|||
44544412|NCT04532294|79557770|FG002|Overall Study|Participants Not Dosed|2|||
44544413|NCT03197766|79557782|FG000|Overall Study|Withdrawal by Subject|2|||
44544414|NCT03197766|79557783|FG001|Overall Study|Withdrawal by Subject|0|||
44544415|NCT03738332|79557789|FG000|Overall Study|Withdrawal by Subject|1|||
44544416|NCT03173456|79557799|FG000|Baseline|Medication dispensing system malfunction'|0|||
44544417|NCT03173456|79557800|FG001|Baseline|Medication dispensing system malfunction'|1|||
44544418|NCT03173456|79557801|FG002|Baseline|Medication dispensing system malfunction'|0|||
44544419|NCT03173456|79557802|FG003|Baseline|Medication dispensing system malfunction'|0|||
44544420|NCT03173456|79557803|FG004|Baseline|Medication dispensing system malfunction'|2|||
44544421|NCT03173456|79557799|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
44544422|NCT03173456|79557800|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
44544423|NCT03173456|79557801|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
44544424|NCT03173456|79557802|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
44544425|NCT03173456|79557803|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
44544426|NCT03197376|79557826|FG000|Primary and Booster Phase|Adverse Event|0|||
44544427|NCT03197376|79557827|FG001|Primary and Booster Phase|Adverse Event|0|||
44544428|NCT03197376|79557828|FG002|Primary and Booster Phase|Adverse Event|0|||
44223401|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44223402|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44223403|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
44223404|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
44223405|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
44223406|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223407|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223408|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223409|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44223410|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
44223411|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
44223412|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223413|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223414|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223415|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223416|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
44223417|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
44223418|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
44223419|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
44223420|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
44223421|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
44223422|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
44223423|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
44223424|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223425|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
44223426|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223427|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223428|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44466085|NCT00452790|79475017|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
44466086|NCT00452790|79475016|FG000|Infant Series|Parent/legal guardian request|8|||
44466087|NCT00452790|79475017|FG001|Infant Series|Parent/legal guardian request|6|||
44466088|NCT00452790|79475016|FG000|Infant Series|Failed to return|4|||
44466089|NCT00452790|79475017|FG001|Infant Series|Failed to return|1|||
44466090|NCT00452790|79475016|FG000|Infant Series|Protocol Violation|1|||
44466091|NCT00452790|79475017|FG001|Infant Series|Protocol Violation|3|||
44466092|NCT00452790|79475016|FG000|Infant Series|Lost to Follow-up|2|||
44466093|NCT00452790|79475017|FG001|Infant Series|Lost to Follow-up|2|||
44223429|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44223430|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
44466094|NCT00452790|79475016|FG000|Infant Series|Adverse Event|1|||
44466095|NCT00452790|79475017|FG001|Infant Series|Adverse Event|2|||
44544429|NCT03197376|79557829|FG003|Primary and Booster Phase|Adverse Event|1|||
44544430|NCT03197376|79557826|FG000|Primary and Booster Phase|Death|1|||
44544431|NCT03197376|79557827|FG001|Primary and Booster Phase|Death|0|||
44544432|NCT03197376|79557828|FG002|Primary and Booster Phase|Death|0|||
44466096|NCT00452790|79475016|FG000|Infant Series|Other reasons|1|||
44466097|NCT00452790|79475017|FG001|Infant Series|Other reasons|2|||
44466098|NCT00452790|79475016|FG000|Infant Series|Investigator request|0|||
44466099|NCT00452790|79475017|FG001|Infant Series|Investigator request|1|||
44466100|NCT00452790|79475016|FG000|Infant Series|Death|0|||
44466101|NCT00452790|79475017|FG001|Infant Series|Death|1|||
44466102|NCT00452790|79475016|FG000|After Infant Series|Investigator request|10|||
44466103|NCT00452790|79475017|FG001|After Infant Series|Investigator request|10|||
44466104|NCT00452790|79475016|FG000|After Infant Series|Adverse Event|4|||
44466105|NCT00452790|79475017|FG001|After Infant Series|Adverse Event|1|||
44466106|NCT00452790|79475016|FG000|After Infant Series|Parent/legal guardian request|1|||
44466107|NCT00452790|79475017|FG001|After Infant Series|Parent/legal guardian request|3|||
44466108|NCT00452790|79475016|FG000|After Infant Series|Lost to Follow-up|4|||
44466109|NCT00452790|79475017|FG001|After Infant Series|Lost to Follow-up|0|||
44466110|NCT00452790|79475016|FG000|After Infant Series|Failed to return|1|||
44466111|NCT00452790|79475017|FG001|After Infant Series|Failed to return|0|||
44466112|NCT00452790|79475016|FG000|After Infant Series|Other reasons|1|||
44466113|NCT00452790|79475017|FG001|After Infant Series|Other reasons|0|||
44466114|NCT00452790|79475016|FG000|Toddler Dose|Failed to return|0|||
44466115|NCT00452790|79475017|FG001|Toddler Dose|Failed to return|1|||
44466116|NCT00452790|79475016|FG000|Toddler Dose|Parent/legal guardian request|0|||
44466117|NCT00452790|79475017|FG001|Toddler Dose|Parent/legal guardian request|1|||
44466118|NCT00463788|79475029|FG000|Overall Study|Progressive Disease|86|||
44466119|NCT00463788|79475030|FG001|Overall Study|Progressive Disease|42|||
44466120|NCT00463788|79475029|FG000|Overall Study|Adverse Event|6|||
44466121|NCT00463788|79475030|FG001|Overall Study|Adverse Event|2|||
44466122|NCT00463788|79475029|FG000|Overall Study|Withdrawal by Subject|6|||
44466123|NCT00463788|79475030|FG001|Overall Study|Withdrawal by Subject|2|||
44466124|NCT00463788|79475029|FG000|Overall Study|Death|4|||
44466125|NCT00463788|79475030|FG001|Overall Study|Death|3|||
44466126|NCT00463788|79475029|FG000|Overall Study|Symptomatic Deterioration|2|||
44466127|NCT00463788|79475030|FG001|Overall Study|Symptomatic Deterioration|3|||
44466128|NCT00463788|79475029|FG000|Overall Study|Lost to Follow-up|1|||
44466129|NCT00463788|79475030|FG001|Overall Study|Lost to Follow-up|0|||
44223431|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
44223432|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
44273212|NCT03126539|79214858|FG002|Overall Study|Lost to Follow-up|1|||
44273213|NCT03126539|79214859|FG003|Overall Study|Lost to Follow-up|0|||
44273214|NCT03126539|79214860|FG004|Overall Study|Lost to Follow-up|0|||
44273215|NCT03123250|79214873|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
44223433|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
44223434|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223435|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223436|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44223437|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44273216|NCT03099096|79214877|FG000|Overall Study|Adverse Event|1|||
44273217|NCT03099096|79214877|FG000|Overall Study|Physician Decision|1|||
44273218|NCT03043664|79214881|FG000|Overall Study|Lost to Follow-up|1|||
44273219|NCT03041467|79214887|FG000|Overall Study|Death|40|||
44273220|NCT03041467|79214888|FG001|Overall Study|Death|36|||
44273221|NCT03041467|79214887|FG000|Overall Study|Withdrawal by Subject|36|||
44273222|NCT03041467|79214888|FG001|Overall Study|Withdrawal by Subject|37|||
44273223|NCT03041467|79214887|FG000|Overall Study|Lost to Follow-up|6|||
44273224|NCT03041467|79214888|FG001|Overall Study|Lost to Follow-up|7|||
44273225|NCT03041467|79214887|FG000|Overall Study|Declined consent for study extension|21|||
44273226|NCT03041467|79214888|FG001|Overall Study|Declined consent for study extension|33|||
44273227|NCT03041467|79214887|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
44466130|NCT00463788|79475029|FG000|Overall Study|Protocol Violation|0|||
44466131|NCT00463788|79475030|FG001|Overall Study|Protocol Violation|1|||
44466132|NCT00463788|79475029|FG000|Overall Study|Other|3|||
44466133|NCT00463788|79475030|FG001|Overall Study|Other|0|||
44223438|NCT03745638|79027020|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
44223439|NCT03745638|79027021|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
44223440|NCT03745638|79027022|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
44223441|NCT03745638|79027023|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
44273228|NCT03041467|79214888|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
44273229|NCT03041467|79214887|FG000|Overall Study|48 Month visit not completed|9|||
44273230|NCT03041467|79214888|FG001|Overall Study|48 Month visit not completed|4|||
44273231|NCT03019406|79214900|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
44273232|NCT03019406|79214901|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
44466134|NCT00463788|79475029|FG000|Overall Study|Randomized but not treated|1|||
44466135|NCT00463788|79475030|FG001|Overall Study|Randomized but not treated|1|||
44466136|NCT00548249|79475042|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
44466137|NCT00548249|79475043|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
44273233|NCT03019406|79214902|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
44273234|NCT03019406|79214903|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
44223442|NCT03745638|79027024|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
44223443|NCT03745638|79027025|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
44223444|NCT03745638|79027026|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
44223445|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223446|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223447|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223448|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223449|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
44223450|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
44223451|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
44223452|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223453|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223454|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223455|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
44223456|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
44223457|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
44223458|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
44223459|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
44223460|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
44223461|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
44223462|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
44223463|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
44223464|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
44223465|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
44223466|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223467|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223468|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223469|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223470|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
44223471|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
44223472|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
44223473|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223474|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223475|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223476|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223477|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223478|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
44223479|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
44223480|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
44223481|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
44223482|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
44223483|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
44223484|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
44223485|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
44223486|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
44223487|NCT03745638|79027020|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
44273235|NCT02972593|79214918|FG000|Overall Study|Lost to Follow-up|19|||
44273236|NCT02972593|79214919|FG001|Overall Study|Lost to Follow-up|15|||
44466138|NCT00548249|79475044|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
44466139|NCT00548249|79475045|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
44273237|NCT02972593|79214918|FG000|Overall Study|Protocol Violation|1|||
44273238|NCT02972593|79214919|FG001|Overall Study|Protocol Violation|0|||
44273239|NCT02949700|79214931|FG000|Phase I|Withdrawal by Subject|1|||
44273240|NCT02949700|79214932|FG001|Phase I|Withdrawal by Subject|1|||
44273241|NCT02949700|79214933|FG002|Phase I|Withdrawal by Subject|0|||
44273242|NCT02949700|79214934|FG003|Phase I|Withdrawal by Subject|0|||
44273243|NCT02949700|79214931|FG000|Phase I|Protocol Violation|1|||
44273244|NCT02949700|79214932|FG001|Phase I|Protocol Violation|0|||
44273245|NCT02949700|79214933|FG002|Phase I|Protocol Violation|0|||
44466140|NCT00548249|79475046|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
44466141|NCT00548249|79475042|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
44466142|NCT00548249|79475043|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
44466143|NCT00548249|79475044|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
44466144|NCT00548249|79475045|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
44466145|NCT00548249|79475046|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
44466146|NCT00548249|79475042|FG000|Overall Study|Protocol Violation|1|||
44466147|NCT00548249|79475043|FG001|Overall Study|Protocol Violation|1|||
44466148|NCT00548249|79475044|FG002|Overall Study|Protocol Violation|4|||
44466149|NCT00548249|79475045|FG003|Overall Study|Protocol Violation|0|||
44466150|NCT00548249|79475046|FG004|Overall Study|Protocol Violation|3|||
44466151|NCT00548249|79475042|FG000|Overall Study|Miscellaneous|2|||
44466152|NCT00548249|79475043|FG001|Overall Study|Miscellaneous|3|||
44466153|NCT00548249|79475044|FG002|Overall Study|Miscellaneous|2|||
44466154|NCT00548249|79475045|FG003|Overall Study|Miscellaneous|0|||
44466155|NCT00548249|79475046|FG004|Overall Study|Miscellaneous|2|||
44466156|NCT00548249|79475042|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
44466157|NCT00548249|79475043|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
44466158|NCT00548249|79475044|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
44466159|NCT00548249|79475045|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
44466160|NCT00548249|79475046|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
44466161|NCT00548249|79475042|FG000|Overall Study|Adverse Event|2|||
44466162|NCT00548249|79475043|FG001|Overall Study|Adverse Event|2|||
44466163|NCT00548249|79475044|FG002|Overall Study|Adverse Event|0|||
44466164|NCT00548249|79475045|FG003|Overall Study|Adverse Event|1|||
44466165|NCT00548249|79475046|FG004|Overall Study|Adverse Event|1|||
44466166|NCT00548249|79475042|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
44466167|NCT00548249|79475043|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
44466168|NCT00548249|79475044|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
44466169|NCT00548249|79475045|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
44466170|NCT00548249|79475046|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
44466171|NCT00548249|79475042|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
44466172|NCT00548249|79475043|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
44466173|NCT00548249|79475044|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
44466174|NCT00548249|79475045|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
44466175|NCT00548249|79475046|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
44466176|NCT00548249|79475042|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
44466177|NCT00548249|79475043|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
44466178|NCT00548249|79475044|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
44223488|NCT03745638|79027021|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
44223489|NCT03745638|79027022|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
44223490|NCT03745638|79027023|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
44223491|NCT03745638|79027024|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
44223492|NCT03745638|79027025|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
44223493|NCT03745638|79027026|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
44223494|NCT03699475|79027056|FG000|Overall Study|Death|1|||
44223495|NCT03668613|79027062|FG000|Overall Study|Adverse Event|0|||
44223496|NCT03668613|79027063|FG001|Overall Study|Adverse Event|2|||
44223497|NCT03668613|79027062|FG000|Overall Study|Lack of Efficacy|0|||
44223498|NCT03668613|79027063|FG001|Overall Study|Lack of Efficacy|1|||
44223499|NCT03650413|79027070|FG000|Overall Study|Adverse Event|1|||
44223500|NCT03650413|79027070|FG000|Overall Study|Lack of Efficacy|17|||
44223501|NCT03650413|79027070|FG000|Overall Study|Other|9|||
44223502|NCT03650413|79027070|FG000|Overall Study|Physician Decision|2|||
44223503|NCT03650413|79027070|FG000|Overall Study|Study Terminated By Sponsor|16|||
44223504|NCT03650413|79027070|FG000|Overall Study|Withdrawal by Subject|16|||
44223505|NCT03596242|79027080|FG000|Overall Study|Lost to Follow-up|2|||
44223506|NCT03596242|79027081|FG001|Overall Study|Lost to Follow-up|2|||
44223507|NCT03471078|79027089|FG000|Overall Study|Withdrawal by Subject|9|||
44223508|NCT03471078|79027090|FG001|Overall Study|Withdrawal by Subject|1|||
44223509|NCT03471078|79027089|FG000|Overall Study|Adverse Event|4|||
44223510|NCT03471078|79027090|FG001|Overall Study|Adverse Event|1|||
44223511|NCT03471078|79027089|FG000|Overall Study|Physician Decision|3|||
44223512|NCT03471078|79027090|FG001|Overall Study|Physician Decision|2|||
44223513|NCT03471078|79027089|FG000|Overall Study|Death|2|||
44273246|NCT02949700|79214934|FG003|Phase I|Protocol Violation|0|||
44273247|NCT02949700|79214931|FG000|Phase II|Withdrawal by Subject|0|||
44273248|NCT02949700|79214932|FG001|Phase II|Withdrawal by Subject|0|||
44273249|NCT02949700|79214933|FG002|Phase II|Withdrawal by Subject|0|||
44273250|NCT02949700|79214934|FG003|Phase II|Withdrawal by Subject|2|||
44273251|NCT02949700|79214931|FG000|Phase II|Protocol Violation|0|||
44273252|NCT02949700|79214932|FG001|Phase II|Protocol Violation|0|||
44273253|NCT02949700|79214933|FG002|Phase II|Protocol Violation|1|||
44273254|NCT02949700|79214934|FG003|Phase II|Protocol Violation|3|||
44273255|NCT02947087|79214945|FG000|Overall Study|Withdrawal by Subject|3|||
44273256|NCT02947087|79214946|FG001|Overall Study|Withdrawal by Subject|2|||
44273257|NCT02868216|79214954|FG000|Overall Study|Death|0|||
44273258|NCT02868216|79214955|FG001|Overall Study|Death|1|||
44273259|NCT02868216|79214954|FG000|Overall Study|coronary artery bypass|1|||
44273260|NCT02868216|79214955|FG001|Overall Study|coronary artery bypass|0|||
44273261|NCT02868216|79214954|FG000|Overall Study|Withdrawal by Subject|7|||
44466179|NCT00548249|79475045|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
44466180|NCT00548249|79475046|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
44466181|NCT00548249|79475042|FG000|Overall Study|Prolonged hospitalization|0|||
44466182|NCT00548249|79475043|FG001|Overall Study|Prolonged hospitalization|0|||
44466183|NCT00548249|79475044|FG002|Overall Study|Prolonged hospitalization|2|||
44466184|NCT00548249|79475045|FG003|Overall Study|Prolonged hospitalization|1|||
44466185|NCT00548249|79475046|FG004|Overall Study|Prolonged hospitalization|0|||
44466186|NCT00548249|79475042|FG000|Overall Study|Withdrawal by Subject|2|||
44466187|NCT00548249|79475043|FG001|Overall Study|Withdrawal by Subject|0|||
44466188|NCT00548249|79475044|FG002|Overall Study|Withdrawal by Subject|0|||
44466189|NCT00548249|79475045|FG003|Overall Study|Withdrawal by Subject|0|||
44466190|NCT00548249|79475046|FG004|Overall Study|Withdrawal by Subject|0|||
44466191|NCT00548249|79475042|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
44273262|NCT02868216|79214955|FG001|Overall Study|Withdrawal by Subject|5|||
44273263|NCT02841995|79214964|FG000|Overall Study|Disease progression|5|||
44273264|NCT02841995|79214965|FG001|Overall Study|Disease progression|11|||
44273265|NCT02841995|79214966|FG002|Overall Study|Disease progression|8|||
44273266|NCT02841995|79214964|FG000|Overall Study|Withdrawal by Subject|2|||
44273267|NCT02841995|79214965|FG001|Overall Study|Withdrawal by Subject|4|||
44273268|NCT02841995|79214966|FG002|Overall Study|Withdrawal by Subject|4|||
44273269|NCT02841995|79214964|FG000|Overall Study|Adverse Event|2|||
44273270|NCT02841995|79214965|FG001|Overall Study|Adverse Event|0|||
44273271|NCT02841995|79214966|FG002|Overall Study|Adverse Event|1|||
44273272|NCT02841995|79214964|FG000|Overall Study|Investigator decision|2|||
44273273|NCT02841995|79214965|FG001|Overall Study|Investigator decision|0|||
44273274|NCT02841995|79214966|FG002|Overall Study|Investigator decision|1|||
44273275|NCT02841995|79214964|FG000|Overall Study|Death|0|||
44273276|NCT02841995|79214965|FG001|Overall Study|Death|0|||
44273277|NCT02841995|79214966|FG002|Overall Study|Death|2|||
44273278|NCT02841995|79214964|FG000|Overall Study|Noncompliance to protocol|1|||
44273279|NCT02841995|79214965|FG001|Overall Study|Noncompliance to protocol|0|||
44466192|NCT00548249|79475043|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
44466193|NCT00548249|79475044|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
44466194|NCT00548249|79475045|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
44466195|NCT00548249|79475046|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
44466196|NCT00548249|79475042|FG000|Overall Study|Sponsor's request|0|||
44466197|NCT00548249|79475043|FG001|Overall Study|Sponsor's request|0|||
44223514|NCT03471078|79027090|FG001|Overall Study|Death|0|||
44223515|NCT03471078|79027089|FG000|Overall Study|Other|3|||
44223516|NCT03471078|79027090|FG001|Overall Study|Other|2|||
44223517|NCT03308188|79027128|FG000|Overall Study|Withdrawal by Subject|0|||
44223518|NCT03308188|79027129|FG001|Overall Study|Withdrawal by Subject|3|||
44223519|NCT03308188|79027128|FG000|Overall Study|Death|0|||
44223520|NCT03308188|79027129|FG001|Overall Study|Death|1|||
44223521|NCT03113968|79027150|FG000|Overall Study|Withdrawal by Subject|31|||
44273280|NCT02841995|79214966|FG002|Overall Study|Noncompliance to protocol|0|||
44273281|NCT02841995|79214964|FG000|Overall Study|Sponsor decision|1|||
44273282|NCT02841995|79214965|FG001|Overall Study|Sponsor decision|0|||
44273283|NCT02841995|79214966|FG002|Overall Study|Sponsor decision|0|||
44466198|NCT00548249|79475044|FG002|Overall Study|Sponsor's request|0|||
44544433|NCT03197376|79557829|FG003|Primary and Booster Phase|Death|2|||
44273284|NCT02841995|79214964|FG000|Overall Study|Other|4|||
44273285|NCT02841995|79214965|FG001|Overall Study|Other|1|||
44273286|NCT02841995|79214966|FG002|Overall Study|Other|5|||
44273287|NCT02643966|79214974|FG000|First Screening Round|ineligible|1|||
44223522|NCT03113968|79027151|FG001|Overall Study|Withdrawal by Subject|4|||
44223523|NCT02864251|79027160|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
44223524|NCT02864251|79027161|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
44223525|NCT02864251|79027162|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
44273288|NCT02643966|79214974|FG000|First Screening Round|excluded from analysis|2|||
44273289|NCT02643966|79214974|FG000|First Screening Round|Lost to Follow-up|56|||
44273290|NCT02643966|79214974|FG000|First Screening Round|Withdrawal by Subject|28|||
44273291|NCT02643966|79214974|FG000|First Screening Round|Death|1|||
44273292|NCT02643966|79214974|FG000|Between First and Second Screening|Lost to Follow-up|65|||
44273293|NCT02643966|79214974|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
44273294|NCT02643966|79214974|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
44273295|NCT02643966|79214974|FG000|Second Screening Round|Withdrawal by Subject|20|||
44223526|NCT02864251|79027160|FG000|Pre-Treatment|Withdrawal by Participant|0|||
44223527|NCT02864251|79027161|FG001|Pre-Treatment|Withdrawal by Participant|0|||
44223528|NCT02864251|79027162|FG002|Pre-Treatment|Withdrawal by Participant|4|||
44223529|NCT02864251|79027160|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
44223530|NCT02864251|79027161|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
44223531|NCT02864251|79027162|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
44223532|NCT02864251|79027160|FG000|Pre-Treatment|Other Reasons|0|||
44223533|NCT02864251|79027161|FG001|Pre-Treatment|Other Reasons|1|||
44223534|NCT02864251|79027162|FG002|Pre-Treatment|Other Reasons|1|||
44223535|NCT02864251|79027160|FG000|Treatment|Disease Progression|109|||
44223536|NCT02864251|79027161|FG001|Treatment|Disease Progression|52|||
44273296|NCT02643966|79214974|FG000|Second Screening Round|Lost to Follow-up|57|||
44273297|NCT02643966|79214974|FG000|Second Screening Round|Physician Decision|2|||
44273298|NCT02643966|79214974|FG000|Second Screening Round|Death|4|||
44466199|NCT00548249|79475045|FG003|Overall Study|Sponsor's request|1|||
44466200|NCT00548249|79475046|FG004|Overall Study|Sponsor's request|0|||
44466201|NCT00463476|79475060|FG000|Overall Study|Withdrawal by Subject|1|||
44466202|NCT00463476|79475061|FG001|Overall Study|Withdrawal by Subject|2|||
44466203|NCT00463476|79475060|FG000|Overall Study|Lost to Follow-up|1|||
44466204|NCT00463476|79475061|FG001|Overall Study|Lost to Follow-up|1|||
44466205|NCT03839940|79475069|FG000|Overall Study|Withdrawal by Subject|3|||
44466206|NCT03839940|79475070|FG001|Overall Study|Withdrawal by Subject|0|||
44466207|NCT03839940|79475069|FG000|Overall Study|Protocol Violation|0|||
44466208|NCT03839940|79475070|FG001|Overall Study|Protocol Violation|1|||
44466209|NCT03839940|79475069|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
44466210|NCT03839940|79475070|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
44273299|NCT02643966|79214974|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
44273300|NCT02643966|79214974|FG000|Between Second and Third Screening|Death|1|||
44273301|NCT02643966|79214974|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
44273302|NCT02643966|79214974|FG000|Third Screening Round|PI excluded|2|||
44273303|NCT02643966|79214974|FG000|Third Screening Round|Lost to Follow-up|241|||
44466211|NCT03839628|79475078|FG000|Overall Study|Withdrawal by Subject|1|||
44466212|NCT00462462|79475084|FG000|Overall Study|Physician Decision|0|||
44466213|NCT00462462|79475085|FG001|Overall Study|Physician Decision|1|||
44466214|NCT00462384|79475093|FG000|Overall Study|Adverse Event|2|||
44466215|NCT00462384|79475093|FG000|Overall Study|Death|2|||
44466216|NCT00462384|79475093|FG000|Overall Study|Withdrawal by Subject|1|||
44466217|NCT00462384|79475093|FG000|Overall Study|Other|4|||
44466218|NCT00452400|79475102|FG000|Overall Study|Adverse Event|1|||
44466219|NCT00452400|79475103|FG001|Overall Study|Adverse Event|1|||
44466220|NCT00452400|79475104|FG002|Overall Study|Adverse Event|5|||
44466221|NCT00452400|79475105|FG003|Overall Study|Adverse Event|0|||
44466222|NCT00452400|79475106|FG004|Overall Study|Adverse Event|2|||
44466223|NCT00452400|79475102|FG000|Overall Study|Protocol Violation|0|||
44466224|NCT00452400|79475103|FG001|Overall Study|Protocol Violation|0|||
44466225|NCT00452400|79475104|FG002|Overall Study|Protocol Violation|1|||
44466226|NCT00452400|79475105|FG003|Overall Study|Protocol Violation|0|||
44466227|NCT00452400|79475106|FG004|Overall Study|Protocol Violation|0|||
44466228|NCT00452400|79475102|FG000|Overall Study|Lost to Follow-up|1|||
44273304|NCT02554383|79215003|FG000|Overall Study|Ineligible|3|||
44273305|NCT02554383|79215004|FG001|Overall Study|Ineligible|2|||
44466229|NCT00452400|79475103|FG001|Overall Study|Lost to Follow-up|0|||
44466230|NCT00452400|79475104|FG002|Overall Study|Lost to Follow-up|0|||
44466231|NCT00452400|79475105|FG003|Overall Study|Lost to Follow-up|0|||
44466232|NCT00452400|79475106|FG004|Overall Study|Lost to Follow-up|0|||
44273306|NCT02554383|79215003|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
44273307|NCT02554383|79215004|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
44273308|NCT02554383|79215003|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
44273309|NCT02554383|79215004|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
44223537|NCT02864251|79027162|FG002|Treatment|Disease Progression|101|||
44223538|NCT02864251|79027160|FG000|Treatment|Study Drug Toxicity|9|||
44223539|NCT02864251|79027161|FG001|Treatment|Study Drug Toxicity|4|||
44223540|NCT02864251|79027162|FG002|Treatment|Study Drug Toxicity|10|||
44223541|NCT02864251|79027160|FG000|Treatment|Death|0|||
44466233|NCT00452400|79475102|FG000|Overall Study|Withdrawal by Subject|1|||
44466234|NCT00452400|79475103|FG001|Overall Study|Withdrawal by Subject|0|||
44466235|NCT00452400|79475104|FG002|Overall Study|Withdrawal by Subject|1|||
44466236|NCT00452400|79475105|FG003|Overall Study|Withdrawal by Subject|0|||
44466237|NCT00452400|79475106|FG004|Overall Study|Withdrawal by Subject|0|||
44223542|NCT02864251|79027161|FG001|Treatment|Death|2|||
44466238|NCT00452400|79475102|FG000|Overall Study|Lack of Efficacy|2|||
44466239|NCT00452400|79475103|FG001|Overall Study|Lack of Efficacy|0|||
44466240|NCT00452400|79475104|FG002|Overall Study|Lack of Efficacy|0|||
44466241|NCT00452400|79475105|FG003|Overall Study|Lack of Efficacy|0|||
44466242|NCT00452400|79475106|FG004|Overall Study|Lack of Efficacy|0|||
44466243|NCT00452400|79475102|FG000|Overall Study|Other reasons not listed above|0|||
44466244|NCT00452400|79475103|FG001|Overall Study|Other reasons not listed above|0|||
44466245|NCT00452400|79475104|FG002|Overall Study|Other reasons not listed above|0|||
44466246|NCT00452400|79475105|FG003|Overall Study|Other reasons not listed above|1|||
44466247|NCT00452400|79475106|FG004|Overall Study|Other reasons not listed above|1|||
44466248|NCT00462306|79475120|FG000|Overall Study|insufficient data|0|||
44466249|NCT00462306|79475121|FG001|Overall Study|insufficient data|13|||
44466250|NCT00461682|79475129|FG000|Overall Study|Protocol Violation|1|||
44466251|NCT00443430|79475137|FG000|Overall Study|Lack of Efficacy|3|||
44466252|NCT00443430|79475138|FG001|Overall Study|Lack of Efficacy|3|||
44466253|NCT00443430|79475137|FG000|Overall Study|Adverse Event|1|||
44466254|NCT00443430|79475138|FG001|Overall Study|Adverse Event|1|||
44466255|NCT00460746|79475144|FG000|Overall Study|Adverse Event|1|||
44466256|NCT00460746|79475144|FG000|Overall Study|Lost to Follow-up|1|||
44466257|NCT00443118|79475151|FG000|Overall Study|unknown primary outcome|3|||
44466258|NCT00443118|79475152|FG001|Overall Study|unknown primary outcome|1|||
44466259|NCT00443118|79475153|FG002|Overall Study|unknown primary outcome|0|||
44466260|NCT00443118|79475151|FG000|Overall Study|Withdrawal by Subject|1|||
44466261|NCT00443118|79475152|FG001|Overall Study|Withdrawal by Subject|0|||
44466262|NCT00443118|79475153|FG002|Overall Study|Withdrawal by Subject|0|||
44466263|NCT00460434|79475181|FG000|Overall Study|Lost to Follow-up|3|||
44466264|NCT00460434|79475182|FG001|Overall Study|Lost to Follow-up|7|||
44466265|NCT00373425|79475193|FG000|Overall Study|Relapse of NSCLC|116|||
44466266|NCT00373425|79475194|FG001|Overall Study|Relapse of NSCLC|104|||
44466267|NCT00373425|79475195|FG002|Overall Study|Relapse of NSCLC|19|||
44466268|NCT00373425|79475196|FG003|Overall Study|Relapse of NSCLC|2|||
44466269|NCT00373425|79475197|FG004|Overall Study|Relapse of NSCLC|26|||
44466270|NCT00373425|79475193|FG000|Overall Study|Adverse Event|191|||
44466271|NCT00373425|79475194|FG001|Overall Study|Adverse Event|22|||
44466272|NCT00373425|79475195|FG002|Overall Study|Adverse Event|59|||
44466273|NCT00373425|79475196|FG003|Overall Study|Adverse Event|0|||
44466274|NCT00373425|79475197|FG004|Overall Study|Adverse Event|34|||
44466275|NCT00373425|79475193|FG000|Overall Study|Patient request|35|||
44466276|NCT00373425|79475194|FG001|Overall Study|Patient request|18|||
44466277|NCT00373425|79475195|FG002|Overall Study|Patient request|43|||
44466278|NCT00373425|79475196|FG003|Overall Study|Patient request|6|||
44466279|NCT00373425|79475197|FG004|Overall Study|Patient request|7|||
44466280|NCT00373425|79475193|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
44466281|NCT00373425|79475194|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
44466282|NCT00373425|79475195|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
44466283|NCT00373425|79475196|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
44466284|NCT00373425|79475197|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
44466285|NCT00373425|79475193|FG000|Overall Study|Death|7|||
44466286|NCT00373425|79475194|FG001|Overall Study|Death|0|||
44466287|NCT00373425|79475195|FG002|Overall Study|Death|3|||
44466288|NCT00373425|79475196|FG003|Overall Study|Death|1|||
44466289|NCT00373425|79475197|FG004|Overall Study|Death|0|||
44466290|NCT00459342|79475206|FG000|Overall Study|Not eligible|1|||
44466291|NCT00443040|79475213|FG000|Overall Study|Withdrawal by Subject|1|||
44466292|NCT00443040|79475214|FG001|Overall Study|Withdrawal by Subject|0|||
44466293|NCT00443040|79475215|FG002|Overall Study|Withdrawal by Subject|0|||
44466294|NCT00443040|79475213|FG000|Overall Study|Converted to an open laparotomy|3|||
44466295|NCT00443040|79475214|FG001|Overall Study|Converted to an open laparotomy|0|||
44466296|NCT00443040|79475215|FG002|Overall Study|Converted to an open laparotomy|1|||
44466297|NCT00442962|79475223|FG000|Overall Study|Pregnancy|1|||
44466298|NCT00442962|79475223|FG000|Overall Study|Lost to Follow-up|7|||
44466299|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
44466300|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
44466301|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
44466302|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
44466303|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
44466304|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
44466305|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
44466306|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
44466307|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
44466308|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
44466309|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
44466310|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
44466311|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
44466312|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
44466313|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
44466314|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
44466315|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
44466316|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
44466317|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
44273310|NCT02554383|79215003|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
44273311|NCT02554383|79215004|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
44273312|NCT02522871|79215012|FG000|Overall Study|Protocol Violation|1|||
44273313|NCT02522871|79215013|FG001|Overall Study|Protocol Violation|4|||
44273314|NCT02522871|79215012|FG000|Overall Study|Treated without randomization|1|||
44273315|NCT02522871|79215013|FG001|Overall Study|Treated without randomization|0|||
44273316|NCT02522871|79215012|FG000|Overall Study|Death|9|||
44273317|NCT02522871|79215013|FG001|Overall Study|Death|9|||
44273318|NCT02522871|79215012|FG000|Overall Study|Died in operating room prior to transplant|0|||
44273319|NCT02522871|79215013|FG001|Overall Study|Died in operating room prior to transplant|1|||
44273320|NCT02519439|79215028|FG000|Overall Study|Study Termination|19|||
44466318|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
44466319|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
44466320|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
44466321|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
44466322|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
44466323|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
44273321|NCT02519439|79215028|FG000|Overall Study|Withdrawal by Subject|1|||
44273322|NCT02519439|79215028|FG000|Overall Study|Adverse Event|1|||
44273323|NCT02147184|79215038|FG000|Overall Study|Lost to Follow-up|28|||
44466324|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
44466325|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
44466326|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
44466327|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
44466328|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
44466329|NCT00313300|79475232|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
44466330|NCT00313300|79475233|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
44466331|NCT00313300|79475234|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
44466332|NCT00313300|79475235|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
44466333|NCT00313300|79475236|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
44466334|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
44466335|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
44466336|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
44466337|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
44466338|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
44466339|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
44466340|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
44466341|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
44466342|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
44466343|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
44466344|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
44466345|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
44466346|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
44466347|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
44466348|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
44466349|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
44466350|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
44466351|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
44466352|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
44466353|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
44466354|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
44466355|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
44273324|NCT02147184|79215039|FG001|Overall Study|Lost to Follow-up|15|||
44273325|NCT02147184|79215038|FG000|Overall Study|Study Burden|11|||
44273326|NCT02147184|79215039|FG001|Overall Study|Study Burden|7|||
44375145|NCT00908037|79380261|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375146|NCT00908037|79380262|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375147|NCT00908037|79380263|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375148|NCT00908037|79380264|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375149|NCT00908037|79380265|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375150|NCT00908037|79380266|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375151|NCT00908037|79380267|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
44273327|NCT02147184|79215038|FG000|Overall Study|Pregnancy|6|||
44273328|NCT02147184|79215039|FG001|Overall Study|Pregnancy|0|||
44273329|NCT02147184|79215038|FG000|Overall Study|Moved out of state|3|||
44466356|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
44466357|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
44466358|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
44466359|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
44466360|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
44466361|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
44466362|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
44466363|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
44466364|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
44466365|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
44466366|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
44466367|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
44466368|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
44466369|NCT00313300|79475232|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
44466370|NCT00313300|79475233|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
44466371|NCT00313300|79475234|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
44466372|NCT00313300|79475235|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
44466373|NCT00313300|79475236|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
44466374|NCT00313300|79475232|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
44466375|NCT00313300|79475233|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
44223543|NCT02864251|79027162|FG002|Treatment|Death|3|||
44223544|NCT02864251|79027160|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
44223545|NCT02864251|79027161|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
44223546|NCT02864251|79027162|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
44223547|NCT02864251|79027160|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
44466376|NCT00313300|79475234|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
44466377|NCT00313300|79475235|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
44466378|NCT00313300|79475236|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
44466379|NCT00313300|79475232|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
44466380|NCT00313300|79475233|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
44466381|NCT00313300|79475234|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
44466382|NCT00313300|79475235|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
44466383|NCT00313300|79475236|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
44466384|NCT00313300|79475232|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
44466385|NCT00313300|79475233|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
44466386|NCT00313300|79475234|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
44466387|NCT00313300|79475235|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
44273330|NCT02147184|79215039|FG001|Overall Study|Moved out of state|3|||
44273331|NCT02147184|79215038|FG000|Overall Study|Physician Decision|0|||
44466388|NCT00313300|79475236|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
44466389|NCT00313300|79475232|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
44466390|NCT00313300|79475233|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
44466391|NCT00313300|79475234|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
44466392|NCT00313300|79475235|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
44466393|NCT00313300|79475236|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
44466394|NCT00313300|79475232|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
44466395|NCT00313300|79475233|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
44466396|NCT00313300|79475234|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
44466397|NCT00313300|79475235|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
44223548|NCT02864251|79027161|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
44223549|NCT02864251|79027162|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
44223550|NCT02864251|79027160|FG000|Treatment|Withdrawal by Participant|8|||
44223551|NCT02864251|79027161|FG001|Treatment|Withdrawal by Participant|5|||
44223552|NCT02864251|79027162|FG002|Treatment|Withdrawal by Participant|13|||
44223553|NCT02864251|79027160|FG000|Treatment|Maximum Clinical Benefit|1|||
44223554|NCT02864251|79027161|FG001|Treatment|Maximum Clinical Benefit|0|||
44273332|NCT02147184|79215039|FG001|Overall Study|Physician Decision|2|||
44273333|NCT02147184|79215038|FG000|Overall Study|Other|1|||
44273334|NCT02147184|79215039|FG001|Overall Study|Other|0|||
44273335|NCT02101021|79215050|FG000|Overall Study|Death|4|||
44273336|NCT02101021|79215051|FG001|Overall Study|Death|3|||
44273337|NCT02101021|79215052|FG002|Overall Study|Death|6|||
44273338|NCT02101021|79215053|FG003|Overall Study|Death|0|||
44223555|NCT02864251|79027162|FG002|Treatment|Maximum Clinical Benefit|1|||
44223556|NCT02864251|79027160|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
44273339|NCT02101021|79215054|FG004|Overall Study|Death|3|||
44273340|NCT02101021|79215050|FG000|Overall Study|Withdrew Consent from study|1|||
44273341|NCT02101021|79215051|FG001|Overall Study|Withdrew Consent from study|1|||
44273342|NCT02101021|79215052|FG002|Overall Study|Withdrew Consent from study|0|||
44273343|NCT02101021|79215053|FG003|Overall Study|Withdrew Consent from study|2|||
44273344|NCT02101021|79215054|FG004|Overall Study|Withdrew Consent from study|0|||
44273345|NCT02101021|79215050|FG000|Overall Study|Lost to Follow-up|1|||
44273346|NCT02101021|79215051|FG001|Overall Study|Lost to Follow-up|0|||
44223557|NCT02864251|79027161|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
44223558|NCT02864251|79027162|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
44223559|NCT02864251|79027160|FG000|Treatment|Other Reasons|1|||
44223560|NCT02864251|79027161|FG001|Treatment|Other Reasons|1|||
44223561|NCT02864251|79027162|FG002|Treatment|Other Reasons|4|||
44223562|NCT02864251|79027160|FG000|Treatment|Administrative Reason by Sponsor|1|||
44273347|NCT02101021|79215052|FG002|Overall Study|Lost to Follow-up|0|||
44273348|NCT02101021|79215053|FG003|Overall Study|Lost to Follow-up|0|||
44273349|NCT02101021|79215054|FG004|Overall Study|Lost to Follow-up|0|||
44273350|NCT02101021|79215050|FG000|Overall Study|Study Terminated by Sponsor|1|||
44273351|NCT02101021|79215051|FG001|Overall Study|Study Terminated by Sponsor|0|||
44273352|NCT02101021|79215052|FG002|Overall Study|Study Terminated by Sponsor|1|||
44273353|NCT02101021|79215053|FG003|Overall Study|Study Terminated by Sponsor|1|||
44273354|NCT02101021|79215054|FG004|Overall Study|Study Terminated by Sponsor|1|||
44273355|NCT02031536|79215079|FG000|Overall Study|ineligible|1|||
44273356|NCT02031536|79215080|FG001|Overall Study|ineligible|0|||
44273357|NCT02028455|79215094|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
44273358|NCT02028455|79215095|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
44273359|NCT02028455|79215096|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
44273360|NCT02028455|79215097|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
44273361|NCT02028455|79215098|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
44273362|NCT02028455|79215099|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
44273363|NCT02028455|79215100|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
44273364|NCT02028455|79215101|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
44273365|NCT02028455|79215094|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
44273366|NCT02028455|79215095|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
44273367|NCT02028455|79215096|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
44273368|NCT02028455|79215097|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
44273369|NCT02028455|79215098|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
44273370|NCT02028455|79215099|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
44273371|NCT02028455|79215100|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
44273372|NCT02028455|79215101|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
44466398|NCT00313300|79475236|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
44466399|NCT00313300|79475232|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
44466400|NCT00313300|79475233|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
44466401|NCT00313300|79475234|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
44466402|NCT00313300|79475235|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
44466403|NCT00313300|79475236|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
44466404|NCT00459186|79475254|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
44466405|NCT00459186|79475254|FG000|PET Imaging and Assessment|Adverse Event|3|||
44466406|NCT00328510|79475260|FG000|Overall Study|Gag disorder, could not use frame|4|||
44466407|NCT00328510|79475261|FG001|Overall Study|Gag disorder, could not use frame|0|||
44466408|NCT00328510|79475260|FG000|Overall Study|Dentition problems, could not use frame|1|||
44466409|NCT00328510|79475261|FG001|Overall Study|Dentition problems, could not use frame|0|||
44466410|NCT00328510|79475260|FG000|Overall Study|Withdrawal by Subject|4|||
44466411|NCT00328510|79475261|FG001|Overall Study|Withdrawal by Subject|2|||
44466412|NCT00328510|79475260|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
44466413|NCT00328510|79475261|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
44466414|NCT00328510|79475260|FG000|Overall Study|Treatment changed to a single fraction|1|||
44466415|NCT00328510|79475261|FG001|Overall Study|Treatment changed to a single fraction|1|||
44466416|NCT00313144|79475267|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
44466417|NCT00313144|79475267|FG000|Overall Study|Death|7|||
44466418|NCT00313144|79475267|FG000|Overall Study|Lost to Follow-up|5|||
44466419|NCT00313144|79475267|FG000|Overall Study|Withdrawal by Subject|4|||
44223563|NCT02864251|79027161|FG001|Treatment|Administrative Reason by Sponsor|0|||
44223564|NCT02864251|79027162|FG002|Treatment|Administrative Reason by Sponsor|0|||
44223565|NCT02570113|79027196|FG000|Overall Study|Withdrawal by Subject|3|||
44223566|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
44223567|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
44223568|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
44223569|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
44223570|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
44223571|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
44466420|NCT00313144|79475267|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
44466421|NCT00313144|79475267|FG000|Overall Study|Physician Decision|4|||
44466422|NCT00313144|79475267|FG000|Overall Study|Adverse event - transient|5|||
44466423|NCT00313144|79475267|FG000|Overall Study|Liver transplant|1|||
44466424|NCT00313144|79475267|FG000|Overall Study|Insurance (homecare provider) change|1|||
44466425|NCT00313144|79475267|FG000|Overall Study|Change to different product|1|||
44466426|NCT00313144|79475267|FG000|Overall Study|Due to termination of the study|66|||
44466427|NCT00459108|79475280|FG000|Overall Study|Withdrawal by Subject|5|||
44466428|NCT00459108|79475280|FG000|Overall Study|Adverse Event|3|||
44466429|NCT00459108|79475280|FG000|Overall Study|Death|2|||
44466430|NCT00459108|79475280|FG000|Overall Study|Progression|1|||
44223572|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
44223573|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
44223574|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Other|18|||
44223575|NCT02565914|79027200|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
44466431|NCT00458484|79475292|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
44466432|NCT00458484|79475293|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
44466433|NCT00458484|79475294|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
44466434|NCT00458484|79475295|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
44466435|NCT00458484|79475296|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
44466436|NCT00458484|79475297|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
44223576|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
44223577|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Other|1|||
44223578|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
44223579|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
44223580|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
44223581|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
44223582|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
44223583|NCT02565914|79027200|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
44223584|NCT02565914|79027200|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
44223585|NCT02565914|79027200|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
44223586|NCT02565914|79027200|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
44223587|NCT02565914|79027200|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
44466437|NCT00458484|79475298|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
44466438|NCT00328198|79475323|FG000|Treatment|Adverse Event|21|||
44466439|NCT00328198|79475323|FG000|Treatment|Death|1|||
44466440|NCT00328198|79475323|FG000|Treatment|Physician Decision|5|||
44466441|NCT00328198|79475323|FG000|Treatment|Withdrawal by Subject|5|||
44466442|NCT00328198|79475323|FG000|Treatment|Evidence of disease progression|2|||
44466443|NCT00328198|79475323|FG000|Treatment|Non-compliance|1|||
44466444|NCT00328198|79475323|FG000|Treatment|Confirmed complete response, MRD -|3|||
44466445|NCT00328198|79475323|FG000|Follow-up|Lost to Follow-up|4|||
44466446|NCT00328198|79475323|FG000|Follow-up|Death|31|||
44466447|NCT00450450|79475329|FG000|Overall Study|Death|1|||
44466448|NCT00450450|79475330|FG001|Overall Study|Death|3|||
44466449|NCT00450450|79475329|FG000|Overall Study|Relapse|2|||
44466450|NCT00450450|79475330|FG001|Overall Study|Relapse|0|||
44466451|NCT00450450|79475329|FG000|Overall Study|Missing Data|2|||
44544434|NCT03197376|79557826|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
44223588|NCT02565914|79027200|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
44223589|NCT02565914|79027200|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
44223590|NCT02248701|79027210|FG000|Overall Study|Withdrawal by Subject|2|||
44273373|NCT02028455|79215094|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
44273374|NCT02028455|79215095|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
44466452|NCT00450450|79475330|FG001|Overall Study|Missing Data|0|||
44466453|NCT00442572|79475338|FG000|Overall Study|Relapse|8|||
44466454|NCT00442572|79475339|FG001|Overall Study|Relapse|1|||
44466455|NCT00442572|79475338|FG000|Overall Study|Lost to Follow-up|0|||
44466456|NCT00442572|79475339|FG001|Overall Study|Lost to Follow-up|1|||
44466457|NCT00442572|79475338|FG000|Overall Study|Withdrawal by Subject|0|||
44466458|NCT00442572|79475339|FG001|Overall Study|Withdrawal by Subject|1|||
44466459|NCT00442416|79475348|FG000|Overall Study|Adverse Event|4|||
44466460|NCT00442416|79475349|FG001|Overall Study|Adverse Event|1|||
44466461|NCT00442416|79475348|FG000|Overall Study|Death|1|||
44466462|NCT00442416|79475349|FG001|Overall Study|Death|0|||
44466463|NCT00442416|79475348|FG000|Overall Study|Lack of Efficacy|2|||
44466464|NCT00442416|79475349|FG001|Overall Study|Lack of Efficacy|0|||
44466465|NCT00442416|79475348|FG000|Overall Study|Protocol Violation|2|||
44466466|NCT00442416|79475349|FG001|Overall Study|Protocol Violation|3|||
44466467|NCT00442416|79475348|FG000|Overall Study|Withdrew consent|1|||
44466468|NCT00442416|79475349|FG001|Overall Study|Withdrew consent|2|||
44466469|NCT00442416|79475348|FG000|Overall Study|Administrative/Other|27|||
44466470|NCT00442416|79475349|FG001|Overall Study|Administrative/Other|33|||
44466471|NCT00441792|79475357|FG000|Overall Study|Lost to Follow-up|0|||
44466472|NCT00441792|79475358|FG001|Overall Study|Lost to Follow-up|2|||
44466473|NCT00312208|79475366|FG000|Overall Study|Adverse Event|97|||
44466474|NCT00312208|79475367|FG001|Overall Study|Adverse Event|61|||
44466475|NCT00312208|79475366|FG000|Overall Study|Protocol Violation|5|||
44466476|NCT00312208|79475367|FG001|Overall Study|Protocol Violation|3|||
44466477|NCT00312208|79475366|FG000|Overall Study|Death|2|||
44466478|NCT00312208|79475367|FG001|Overall Study|Death|1|||
44466479|NCT00312208|79475366|FG000|Overall Study|Lack of Efficacy|7|||
44466480|NCT00312208|79475367|FG001|Overall Study|Lack of Efficacy|4|||
44466481|NCT00312208|79475366|FG000|Overall Study|Lost to Follow-up|3|||
44466482|NCT00312208|79475367|FG001|Overall Study|Lost to Follow-up|5|||
44466483|NCT00312208|79475366|FG000|Overall Study|Withdrawal by Subject|53|||
44466484|NCT00312208|79475367|FG001|Overall Study|Withdrawal by Subject|42|||
44466485|NCT00312208|79475366|FG000|Overall Study|Other|5|||
44466486|NCT00312208|79475367|FG001|Overall Study|Other|7|||
44466487|NCT00297778|79475375|FG000|Overall Study|Adverse Event|16|||
44466488|NCT00297778|79475376|FG001|Overall Study|Adverse Event|10|||
44466489|NCT00297778|79475375|FG000|Overall Study|Withdrawal by Subject|1|||
44466490|NCT00297778|79475376|FG001|Overall Study|Withdrawal by Subject|5|||
44466491|NCT00297778|79475375|FG000|Overall Study|Lack of Efficacy|2|||
44466492|NCT00297778|79475376|FG001|Overall Study|Lack of Efficacy|1|||
44466493|NCT00297778|79475375|FG000|Overall Study|Non-compliant with trial protocol|0|||
44466494|NCT00297778|79475376|FG001|Overall Study|Non-compliant with trial protocol|3|||
44466495|NCT00297778|79475375|FG000|Overall Study|Other|0|||
44466496|NCT00297778|79475376|FG001|Overall Study|Other|1|||
44466497|NCT03848832|79475385|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
44466498|NCT03848832|79475386|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
44466499|NCT03848832|79475387|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
44466500|NCT03848832|79475385|FG000|Overall Study|Withdrawal by Subject|0|||
44466501|NCT03848832|79475386|FG001|Overall Study|Withdrawal by Subject|0|||
44466502|NCT03848832|79475387|FG002|Overall Study|Withdrawal by Subject|1|||
44466503|NCT03848832|79475385|FG000|Overall Study|Withdrawal (Covid-19)|0|||
44466504|NCT03848832|79475386|FG001|Overall Study|Withdrawal (Covid-19)|2|||
44466505|NCT03848832|79475387|FG002|Overall Study|Withdrawal (Covid-19)|0|||
44466506|NCT03848832|79475385|FG000|Overall Study|Physician Decision|2|||
44466507|NCT03848832|79475386|FG001|Overall Study|Physician Decision|1|||
44466508|NCT03848832|79475387|FG002|Overall Study|Physician Decision|3|||
44466509|NCT03848832|79475385|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
44466510|NCT03848832|79475386|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
44466511|NCT03848832|79475387|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
44466512|NCT03848832|79475385|FG000|Overall Study|Adverse Event|1|||
44466513|NCT03848832|79475386|FG001|Overall Study|Adverse Event|0|||
44466514|NCT03848832|79475387|FG002|Overall Study|Adverse Event|0|||
44466515|NCT00450372|79475397|FG000|Overall Study|Physician Decision|1|||
44466516|NCT00327340|79475406|FG000|Overall Study|Withdrawal by Subject|1|||
44466517|NCT00327340|79475407|FG001|Overall Study|Withdrawal by Subject|5|||
44466518|NCT00327340|79475406|FG000|Overall Study|Physician Decision|1|||
44466519|NCT00327340|79475407|FG001|Overall Study|Physician Decision|1|||
44466520|NCT00327340|79475406|FG000|Overall Study|Disease Progression|10|||
44466521|NCT00327340|79475407|FG001|Overall Study|Disease Progression|19|||
44466522|NCT00327340|79475406|FG000|Overall Study|Symptomatic Disease|0|||
44466523|NCT00327340|79475407|FG001|Overall Study|Symptomatic Disease|2|||
44466524|NCT00327340|79475406|FG000|Overall Study|Adverse Event|3|||
44466525|NCT00327340|79475407|FG001|Overall Study|Adverse Event|3|||
44466526|NCT00548093|79475417|FG000|Overall Study|Death|33|||
44466527|NCT00548093|79475418|FG001|Overall Study|Death|13|||
44466528|NCT00548093|79475417|FG000|Overall Study|Lost to Follow-up|3|||
44466529|NCT00548093|79475418|FG001|Overall Study|Lost to Follow-up|1|||
44466530|NCT00548093|79475417|FG000|Overall Study|Objective progression or relapse|1|||
44466531|NCT00548093|79475418|FG001|Overall Study|Objective progression or relapse|1|||
44466532|NCT00548093|79475417|FG000|Overall Study|Other|11|||
44466533|NCT00548093|79475418|FG001|Overall Study|Other|1|||
44466534|NCT00548093|79475417|FG000|Overall Study|Withdrawal by Subject|1|||
44466535|NCT00548093|79475418|FG001|Overall Study|Withdrawal by Subject|0|||
44466536|NCT00548093|79475417|FG000|Overall Study|Completed post-treatment follow-up|1|||
44466537|NCT00548093|79475418|FG001|Overall Study|Completed post-treatment follow-up|0|||
44466538|NCT00450216|79475429|FG000|Overall Study|Adverse Event|38|||
44466539|NCT00450216|79475430|FG001|Overall Study|Adverse Event|23|||
44466540|NCT00450216|79475429|FG000|Overall Study|Withdrawal by Subject|48|||
44466541|NCT00450216|79475430|FG001|Overall Study|Withdrawal by Subject|26|||
44466542|NCT00450216|79475429|FG000|Overall Study|Lost to Follow-up|16|||
44466543|NCT00450216|79475430|FG001|Overall Study|Lost to Follow-up|9|||
44466544|NCT00450216|79475429|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
44466545|NCT00450216|79475430|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
44466546|NCT00450216|79475429|FG000|Overall Study|misc|21|||
44466547|NCT00450216|79475430|FG001|Overall Study|misc|20|||
44466548|NCT00441480|79475438|FG000|Overall Study|Protocol Violation|1|||
44466549|NCT00441480|79475439|FG001|Overall Study|Protocol Violation|1|||
44466550|NCT00441480|79475438|FG000|Overall Study|Withdrawal by Subject|2|||
44466551|NCT00441480|79475439|FG001|Overall Study|Withdrawal by Subject|3|||
44466552|NCT00547703|79475447|FG000|Overall Study|Lost to Follow-up|1|||
44466553|NCT00547703|79475448|FG001|Overall Study|Lost to Follow-up|0|||
44466554|NCT00297232|79475454|FG000|Overall Study|Lack of Efficacy|7|||
44466555|NCT00297232|79475454|FG000|Overall Study|Lost to Follow-up|10|||
44273375|NCT02028455|79215096|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
44273376|NCT02028455|79215097|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
44466556|NCT00297232|79475454|FG000|Overall Study|Adverse Event|63|||
44466557|NCT00297232|79475454|FG000|Overall Study|Voluntary Withdrawal|120|||
44223591|NCT02248701|79027211|FG001|Overall Study|Withdrawal by Subject|1|||
44223592|NCT02248701|79027210|FG000|Overall Study|Physician Decision|0|||
44223593|NCT02248701|79027211|FG001|Overall Study|Physician Decision|1|||
44223594|NCT02248701|79027210|FG000|Overall Study|Adverse Event|1|||
44223595|NCT02248701|79027211|FG001|Overall Study|Adverse Event|0|||
44223596|NCT02248701|79027210|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
44223597|NCT02248701|79027211|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
44223598|NCT02204982|79027219|FG000|Overall Study|Patient ineligible-medical monitor|1|||
44223599|NCT02204982|79027220|FG001|Overall Study|Patient ineligible-medical monitor|0|||
44223600|NCT02204982|79027219|FG000|Overall Study|Withdrawal by Subject|1|||
44223601|NCT02204982|79027220|FG001|Overall Study|Withdrawal by Subject|0|||
44223602|NCT02204982|79027219|FG000|Overall Study|Adverse Event|1|||
44223603|NCT02204982|79027220|FG001|Overall Study|Adverse Event|0|||
44223604|NCT02204982|79027219|FG000|Overall Study|Adverse Event and Investigator decision|1|||
44223605|NCT02204982|79027220|FG001|Overall Study|Adverse Event and Investigator decision|0|||
44223606|NCT02204982|79027219|FG000|Overall Study|Physician Decision|0|||
44223607|NCT02204982|79027220|FG001|Overall Study|Physician Decision|2|||
44223608|NCT02204982|79027219|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
44223609|NCT02204982|79027220|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
44223610|NCT02204982|79027219|FG000|Overall Study|Termination of Study bySponsor|0|||
44223611|NCT02204982|79027220|FG001|Overall Study|Termination of Study bySponsor|1|||
44223612|NCT02101385|79027228|FG000|Study Treatment|Disease Progression|9|||
44223613|NCT02101385|79027229|FG001|Study Treatment|Disease Progression|3|||
44223614|NCT02101385|79027228|FG000|Study Treatment|Alternative therapy|0|||
44223615|NCT02101385|79027229|FG001|Study Treatment|Alternative therapy|1|||
44277811|NCT02092350|79238807|FG001|Overall Study|Screen Failure|0|||
44466558|NCT00297232|79475454|FG000|Overall Study|Subject was Noncompliant|9|||
44466559|NCT00297232|79475454|FG000|Overall Study|Death|9|||
44466560|NCT00297232|79475454|FG000|Overall Study|Anti-natalizumab Positive|8|||
44466561|NCT00297232|79475454|FG000|Overall Study|Switched to Commercial Tysabri|22|||
44466562|NCT00297232|79475454|FG000|Overall Study|Disease Progression|8|||
44466563|NCT00297232|79475454|FG000|Overall Study|Fear of PML|10|||
44223616|NCT02101385|79027228|FG000|Study Treatment|No treatment, per protocol criteria|0|||
44223617|NCT02101385|79027229|FG001|Study Treatment|No treatment, per protocol criteria|4|||
44223618|NCT02101385|79027228|FG000|Study Treatment|Patient Non compliance|0|||
44466564|NCT00297232|79475454|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
44466565|NCT00297232|79475454|FG000|Overall Study|Miscellaneous|5|||
44466566|NCT00297232|79475454|FG000|Overall Study|Sponsor Decision|34|||
44466567|NCT00297232|79475454|FG000|Overall Study|Subject Relocated|7|||
44466568|NCT00297232|79475454|FG000|Overall Study|Subject Withdrew Consent|37|||
44466569|NCT00297232|79475454|FG000|Overall Study|Persistently Positive Antibodies|11|||
44466570|NCT00297232|79475454|FG000|Overall Study|Investigator Withdrew From Program|19|||
44466571|NCT00297232|79475454|FG000|Overall Study|Did Not Enroll to Week 264|34|||
44466572|NCT00297232|79475454|FG000|Overall Study|Did Not Enroll to Week 480|17|||
44466573|NCT00297232|79475454|FG000|Overall Study|No data available after Week 264|161|||
44466574|NCT00297232|79475454|FG000|Overall Study|Other|1|||
44466575|NCT00449670|79475470|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
44466576|NCT00449670|79475471|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
44466577|NCT00449670|79475470|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
44466578|NCT00449670|79475471|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
44466579|NCT00449670|79475470|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
44466580|NCT00449670|79475471|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
44466581|NCT00449670|79475470|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
44466582|NCT00449670|79475471|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
44466583|NCT00449670|79475470|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
44466584|NCT00449670|79475471|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
44466585|NCT00449670|79475470|FG000|Booster Phase (Study no.109873)|Other|0|||
44466586|NCT00449670|79475471|FG001|Booster Phase (Study no.109873)|Other|2|||
44466587|NCT00296374|79475487|FG000|Overall Study|Adverse Event|14|||
44466588|NCT00296374|79475488|FG001|Overall Study|Adverse Event|10|||
44466589|NCT00296374|79475489|FG002|Overall Study|Adverse Event|7|||
44466590|NCT00296374|79475487|FG000|Overall Study|Withdrawal by Subject|3|||
44466591|NCT00296374|79475488|FG001|Overall Study|Withdrawal by Subject|5|||
44466592|NCT00296374|79475489|FG002|Overall Study|Withdrawal by Subject|11|||
44466593|NCT00296374|79475487|FG000|Overall Study|Incorrect enrollment|3|||
44466594|NCT00296374|79475488|FG001|Overall Study|Incorrect enrollment|3|||
44466595|NCT00296374|79475489|FG002|Overall Study|Incorrect enrollment|4|||
44466596|NCT00296374|79475487|FG000|Overall Study|Protocol Violation|1|||
44466597|NCT00296374|79475488|FG001|Overall Study|Protocol Violation|2|||
44466598|NCT00296374|79475489|FG002|Overall Study|Protocol Violation|3|||
44466599|NCT00296374|79475487|FG000|Overall Study|Lost to Follow-up|3|||
44466600|NCT00296374|79475488|FG001|Overall Study|Lost to Follow-up|1|||
44466601|NCT00296374|79475489|FG002|Overall Study|Lost to Follow-up|1|||
44466602|NCT00296374|79475487|FG000|Overall Study|Relocated to another state|1|||
44466603|NCT00296374|79475488|FG001|Overall Study|Relocated to another state|0|||
44466604|NCT00296374|79475489|FG002|Overall Study|Relocated to another state|0|||
44466605|NCT00296374|79475487|FG000|Overall Study|Stopped drug before end of study visit|0|||
44466606|NCT00296374|79475488|FG001|Overall Study|Stopped drug before end of study visit|1|||
44466607|NCT00296374|79475489|FG002|Overall Study|Stopped drug before end of study visit|0|||
44466608|NCT00296374|79475487|FG000|Overall Study|Nephrologist introduced ACE|0|||
44466609|NCT00296374|79475488|FG001|Overall Study|Nephrologist introduced ACE|1|||
44466610|NCT00296374|79475489|FG002|Overall Study|Nephrologist introduced ACE|0|||
44466611|NCT00296374|79475487|FG000|Overall Study|Pregnancy|0|||
44466612|NCT00296374|79475488|FG001|Overall Study|Pregnancy|0|||
44466613|NCT00296374|79475489|FG002|Overall Study|Pregnancy|2|||
44466614|NCT00296374|79475487|FG000|Overall Study|Other|0|||
44466615|NCT00296374|79475488|FG001|Overall Study|Other|0|||
44466616|NCT00296374|79475489|FG002|Overall Study|Other|1|||
44466617|NCT00326950|79475512|FG000|Overall Study|Progressive Disease|1|||
44466618|NCT00548717|79475518|FG000|Overall Study|Death|5|||
44466619|NCT00548717|79475519|FG001|Overall Study|Death|2|||
44466620|NCT00548717|79475518|FG000|Overall Study|Relapse|3|||
44466621|NCT00548717|79475519|FG001|Overall Study|Relapse|0|||
44466622|NCT00548717|79475518|FG000|Overall Study|Alternative treatment for GVHD|1|||
44466623|NCT00548717|79475519|FG001|Overall Study|Alternative treatment for GVHD|0|||
44466624|NCT00441168|79475530|FG000|Treatment Period|Death|3|||
44223619|NCT02101385|79027229|FG001|Study Treatment|Patient Non compliance|2|||
44466625|NCT00441168|79475531|FG001|Treatment Period|Death|0|||
44466626|NCT00441168|79475530|FG000|Treatment Period|Adverse Event|1|||
44466627|NCT00441168|79475531|FG001|Treatment Period|Adverse Event|2|||
44223620|NCT02101385|79027228|FG000|Study Treatment|Withdrawal by Subject|5|||
44466628|NCT00441168|79475530|FG000|Treatment Period|Progressive Disease|0|||
44466629|NCT00441168|79475531|FG001|Treatment Period|Progressive Disease|2|||
44466630|NCT00441168|79475530|FG000|Treatment Period|Protocol Violation|0|||
44466631|NCT00441168|79475531|FG001|Treatment Period|Protocol Violation|1|||
44466632|NCT00441168|79475530|FG000|Treatment Period|Lost to Follow-up|0|||
44466633|NCT00441168|79475531|FG001|Treatment Period|Lost to Follow-up|1|||
44466634|NCT00441168|79475530|FG000|Treatment Period|Withdrawal by Subject|3|||
44466635|NCT00441168|79475531|FG001|Treatment Period|Withdrawal by Subject|0|||
44466636|NCT00441168|79475530|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
44466637|NCT00441168|79475531|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
44466638|NCT00441168|79475530|FG000|Treatment Period|refractory disease|1|||
44466639|NCT00441168|79475531|FG001|Treatment Period|refractory disease|0|||
44466640|NCT00441168|79475530|FG000|Follow-up Period|Death|3|||
44466641|NCT00441168|79475531|FG001|Follow-up Period|Death|0|||
44466642|NCT00441168|79475530|FG000|Follow-up Period|Lost to Follow-up|5|||
44466643|NCT00441168|79475531|FG001|Follow-up Period|Lost to Follow-up|6|||
44466644|NCT00441168|79475530|FG000|Follow-up Period|Withdrawal by Subject|3|||
44466645|NCT00441168|79475531|FG001|Follow-up Period|Withdrawal by Subject|0|||
44466646|NCT00441168|79475530|FG000|Follow-up Period|Other|1|||
44466647|NCT00441168|79475531|FG001|Follow-up Period|Other|3|||
44466648|NCT00296140|79475539|FG000|Overall Study|Lost to Follow-up|1|||
44466649|NCT00296140|79475540|FG001|Overall Study|Lost to Follow-up|0|||
44466650|NCT00296140|79475539|FG000|Overall Study|Withdrawal by Subject|1|||
44466651|NCT00296140|79475540|FG001|Overall Study|Withdrawal by Subject|0|||
44466652|NCT00296140|79475539|FG000|Overall Study|Discharge to Nursing Home|1|||
44223621|NCT02101385|79027229|FG001|Study Treatment|Withdrawal by Subject|2|||
44223622|NCT02101385|79027228|FG000|Study Treatment|screen failure|1|||
44223623|NCT02101385|79027229|FG001|Study Treatment|screen failure|0|||
44223624|NCT02101385|79027228|FG000|Study Treatment|AE/Side Effects/Complications|8|||
44223625|NCT02101385|79027229|FG001|Study Treatment|AE/Side Effects/Complications|0|||
44223626|NCT02101385|79027228|FG000|Study Treatment|Lost to Follow-up|1|||
44223627|NCT02101385|79027229|FG001|Study Treatment|Lost to Follow-up|0|||
44223628|NCT02101385|79027228|FG000|Study Treatment|Disease Progression before treatment|1|||
44273377|NCT02028455|79215098|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
44273378|NCT02028455|79215099|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
44273379|NCT02028455|79215100|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
44273380|NCT02028455|79215101|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
44273381|NCT02028455|79215094|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
44273382|NCT02028455|79215095|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
44273383|NCT02028455|79215096|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
44273384|NCT02028455|79215097|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
44273385|NCT02028455|79215098|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
44273386|NCT02028455|79215099|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
44273387|NCT02028455|79215100|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
44273388|NCT02028455|79215101|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
44273389|NCT02019641|79215125|FG000|10-Week Follow up|Withdrawal by investigator|2|||
44273390|NCT02019641|79215126|FG001|10-Week Follow up|Withdrawal by investigator|0|||
44273391|NCT02019641|79215127|FG002|10-Week Follow up|Withdrawal by investigator|0|||
44273392|NCT02019641|79215125|FG000|10-Week Follow up|Withdrawal by Subject|1|||
44273393|NCT02019641|79215126|FG001|10-Week Follow up|Withdrawal by Subject|1|||
44273394|NCT02019641|79215127|FG002|10-Week Follow up|Withdrawal by Subject|0|||
44273395|NCT02019641|79215125|FG000|20-Week Follow up|Withdrawal by investigator|0|||
44273396|NCT02019641|79215126|FG001|20-Week Follow up|Withdrawal by investigator|0|||
44273397|NCT02019641|79215127|FG002|20-Week Follow up|Withdrawal by investigator|1|||
44273398|NCT01964430|79215136|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
44466653|NCT00296140|79475540|FG001|Overall Study|Discharge to Nursing Home|0|||
44466654|NCT03958331|79475549|FG000|Overall Study|Withdrawal by Subject|3|||
44466655|NCT03958331|79475550|FG001|Overall Study|Withdrawal by Subject|1|||
44466656|NCT03958331|79475551|FG002|Overall Study|Withdrawal by Subject|5|||
44223629|NCT02101385|79027229|FG001|Study Treatment|Disease Progression before treatment|0|||
44273399|NCT01964430|79215137|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
44273400|NCT01964430|79215136|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
44466657|NCT03958331|79475549|FG000|Overall Study|Weaned from medicine|2|||
44466658|NCT03958331|79475550|FG001|Overall Study|Weaned from medicine|0|||
44223630|NCT02101385|79027228|FG000|Study Treatment|Death|1|||
44223631|NCT02101385|79027229|FG001|Study Treatment|Death|0|||
44273401|NCT01964430|79215137|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
44273402|NCT01964430|79215136|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
44273403|NCT01964430|79215137|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
44466659|NCT03958331|79475551|FG002|Overall Study|Weaned from medicine|0|||
44466660|NCT03958331|79475549|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
44514815|NCT03084796|79520623|FG000|Overall Study|Randomization error|0|||
44273404|NCT01964430|79215136|FG000|Treatment Period|Adverse Event|71|||
44273405|NCT01964430|79215137|FG001|Treatment Period|Adverse Event|37|||
44273406|NCT01964430|79215136|FG000|Treatment Period|Withdrawal by Subject|36|||
44273407|NCT01964430|79215137|FG001|Treatment Period|Withdrawal by Subject|27|||
44273408|NCT01964430|79215136|FG000|Treatment Period|Death|1|||
44273409|NCT01964430|79215137|FG001|Treatment Period|Death|3|||
44273410|NCT01964430|79215136|FG000|Treatment Period|Protocol Deviation|0|||
44466661|NCT03958331|79475550|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
44466662|NCT03958331|79475551|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
44466663|NCT03956615|79475557|FG000|Overall Study|No multiple myeloma confirmed|2|||
44466664|NCT03956615|79475557|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
44466665|NCT03956615|79475557|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
44466666|NCT03956615|79475557|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
44466667|NCT03956225|79475563|FG000|Overall Study|Lack of Efficacy|1|||
44466668|NCT03956225|79475564|FG001|Overall Study|Lack of Efficacy|1|||
44466669|NCT03956225|79475563|FG000|Overall Study|Lost to Follow-up|0|||
44466670|NCT03956225|79475564|FG001|Overall Study|Lost to Follow-up|1|||
44466671|NCT03956225|79475563|FG000|Overall Study|Withdrawal by Subject|2|||
44466672|NCT03956225|79475564|FG001|Overall Study|Withdrawal by Subject|1|||
44466673|NCT03956225|79475563|FG000|Overall Study|Other Reasons|2|||
44466674|NCT03956225|79475564|FG001|Overall Study|Other Reasons|1|||
44466675|NCT00457626|79475573|FG000|Overall Study|Adverse Event|3|||
44466676|NCT00457626|79475573|FG000|Overall Study|Administrative Problems|2|||
44466677|NCT00457626|79475573|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
44466678|NCT00373113|79475579|FG000|Overall Study|Death|1|||
44466679|NCT00373113|79475580|FG001|Overall Study|Death|7|||
44223632|NCT02101385|79027228|FG000|Follow up|Lost to Follow-up|4|||
44223633|NCT02101385|79027229|FG001|Follow up|Lost to Follow-up|9|||
44466680|NCT00373113|79475579|FG000|Overall Study|Adverse Event|38|||
44466681|NCT00373113|79475580|FG001|Overall Study|Adverse Event|24|||
44466682|NCT00373113|79475579|FG000|Overall Study|Study terminated by sponsor|9|||
44466683|NCT00373113|79475580|FG001|Overall Study|Study terminated by sponsor|1|||
44466684|NCT00373113|79475579|FG000|Overall Study|Global deterioration of health status|10|||
44466685|NCT00373113|79475580|FG001|Overall Study|Global deterioration of health status|7|||
44466686|NCT00373113|79475579|FG000|Overall Study|Lost to Follow-up|1|||
44466687|NCT00373113|79475580|FG001|Overall Study|Lost to Follow-up|3|||
44466688|NCT00373113|79475579|FG000|Overall Study|Objective progression or relapse|150|||
44466689|NCT00373113|79475580|FG001|Overall Study|Objective progression or relapse|169|||
44223634|NCT02101385|79027228|FG000|Follow up|Refused to follow up|5|||
44223635|NCT02101385|79027229|FG001|Follow up|Refused to follow up|4|||
44223636|NCT02101385|79027228|FG000|Follow up|Death|21|||
44223637|NCT02101385|79027229|FG001|Follow up|Death|39|||
44223638|NCT02101385|79027228|FG000|Follow up|study completed|33|||
44223639|NCT02101385|79027229|FG001|Follow up|study completed|52|||
44223640|NCT02101385|79027228|FG000|Follow up|screen failure|2|||
44223641|NCT02101385|79027229|FG001|Follow up|screen failure|0|||
44223642|NCT02101385|79027228|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
44223643|NCT02101385|79027229|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
44223644|NCT02101385|79027228|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
44466690|NCT00373113|79475579|FG000|Overall Study|Other|14|||
44466691|NCT00373113|79475580|FG001|Overall Study|Other|17|||
44466692|NCT00373113|79475579|FG000|Overall Study|Protocol Violation|5|||
44466693|NCT00373113|79475580|FG001|Overall Study|Protocol Violation|1|||
44466694|NCT00373113|79475579|FG000|Overall Study|Withdrawal by Subject|10|||
44273411|NCT01964430|79215137|FG001|Treatment Period|Protocol Deviation|1|||
44273412|NCT01964430|79215136|FG000|Treatment Period|Physician Decision|5|||
44273413|NCT01964430|79215137|FG001|Treatment Period|Physician Decision|4|||
44466695|NCT00373113|79475580|FG001|Overall Study|Withdrawal by Subject|15|||
44466696|NCT00407511|79475586|FG000|Overall Study|Adverse Event|9|||
44466697|NCT00407511|79475586|FG000|Overall Study|Lost to Follow-up|4|||
44223645|NCT02101385|79027229|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
44466698|NCT00407511|79475586|FG000|Overall Study|Other|5|||
44466699|NCT00407511|79475586|FG000|Overall Study|Withdrawal by Subject|4|||
44466700|NCT00384189|79475594|FG000|Overall Study|Reason Not Specified|50|||
44466701|NCT00384189|79475595|FG001|Overall Study|Reason Not Specified|57|||
44466702|NCT00384189|79475596|FG002|Overall Study|Reason Not Specified|58|||
44466703|NCT00384189|79475597|FG003|Overall Study|Reason Not Specified|40|||
44466704|NCT00326716|79475609|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
44466705|NCT00326716|79475610|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
44466706|NCT00326716|79475611|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
44466707|NCT00326716|79475612|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
44466708|NCT00548405|79475645|FG000|Overall Study|Adverse Event|6|||
44466709|NCT00548405|79475646|FG001|Overall Study|Adverse Event|2|||
44466710|NCT00548405|79475647|FG002|Overall Study|Adverse Event|0|||
44466711|NCT00548405|79475645|FG000|Overall Study|Lack of Efficacy|6|||
44466712|NCT00548405|79475646|FG001|Overall Study|Lack of Efficacy|0|||
44466713|NCT00548405|79475647|FG002|Overall Study|Lack of Efficacy|0|||
44466714|NCT00548405|79475645|FG000|Overall Study|Physician Decision|3|||
44466715|NCT00548405|79475646|FG001|Overall Study|Physician Decision|4|||
44466716|NCT00548405|79475647|FG002|Overall Study|Physician Decision|1|||
44466717|NCT00548405|79475645|FG000|Overall Study|Pregnancy|1|||
44466718|NCT00548405|79475646|FG001|Overall Study|Pregnancy|0|||
44466719|NCT00548405|79475647|FG002|Overall Study|Pregnancy|0|||
44466720|NCT00548405|79475645|FG000|Overall Study|Protocol Violation|1|||
44466721|NCT00548405|79475646|FG001|Overall Study|Protocol Violation|0|||
44466722|NCT00548405|79475647|FG002|Overall Study|Protocol Violation|0|||
44466723|NCT00548405|79475645|FG000|Overall Study|Withdrawal by Subject|36|||
44466724|NCT00548405|79475646|FG001|Overall Study|Withdrawal by Subject|12|||
44466725|NCT00548405|79475647|FG002|Overall Study|Withdrawal by Subject|5|||
44466726|NCT00548405|79475645|FG000|Overall Study|Lost to Follow-up|1|||
44466727|NCT00548405|79475646|FG001|Overall Study|Lost to Follow-up|1|||
44466728|NCT00548405|79475647|FG002|Overall Study|Lost to Follow-up|2|||
44466729|NCT00548405|79475645|FG000|Overall Study|Death|0|||
44466730|NCT00548405|79475646|FG001|Overall Study|Death|1|||
44466731|NCT00548405|79475647|FG002|Overall Study|Death|1|||
44466732|NCT00548405|79475645|FG000|Overall Study|Sponsor decision|1|||
44466733|NCT00548405|79475646|FG001|Overall Study|Sponsor decision|0|||
44466734|NCT00548405|79475647|FG002|Overall Study|Sponsor decision|0|||
44466735|NCT00548405|79475645|FG000|Overall Study|Randomized but not treated|1|||
44466736|NCT00548405|79475646|FG001|Overall Study|Randomized but not treated|0|||
44466737|NCT00548405|79475647|FG002|Overall Study|Randomized but not treated|0|||
44466738|NCT00295750|79475659|FG000|Overall Study|Adverse Event|19|||
44466739|NCT00295750|79475660|FG001|Overall Study|Adverse Event|15|||
44466740|NCT00295750|79475661|FG002|Overall Study|Adverse Event|12|||
44466741|NCT00295750|79475659|FG000|Overall Study|Lack of Efficacy|1|||
44466742|NCT00295750|79475660|FG001|Overall Study|Lack of Efficacy|1|||
44466743|NCT00295750|79475661|FG002|Overall Study|Lack of Efficacy|0|||
44466744|NCT00295750|79475659|FG000|Overall Study|Lost to Follow-up|1|||
44466745|NCT00295750|79475660|FG001|Overall Study|Lost to Follow-up|4|||
44466746|NCT00295750|79475661|FG002|Overall Study|Lost to Follow-up|1|||
44466747|NCT00295750|79475659|FG000|Overall Study|Taking prohibited therapy|2|||
44466748|NCT00295750|79475660|FG001|Overall Study|Taking prohibited therapy|3|||
44466749|NCT00295750|79475661|FG002|Overall Study|Taking prohibited therapy|2|||
44466750|NCT00295750|79475659|FG000|Overall Study|Administrative errors|2|||
44466751|NCT00295750|79475660|FG001|Overall Study|Administrative errors|4|||
44466752|NCT00295750|79475661|FG002|Overall Study|Administrative errors|5|||
44466753|NCT00295750|79475659|FG000|Overall Study|Trial drug errors|1|||
44466754|NCT00295750|79475660|FG001|Overall Study|Trial drug errors|1|||
44466755|NCT00295750|79475661|FG002|Overall Study|Trial drug errors|0|||
44466756|NCT00295750|79475659|FG000|Overall Study|Disease progression|2|||
44466757|NCT00295750|79475660|FG001|Overall Study|Disease progression|1|||
44544435|NCT03197376|79557827|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
44223646|NCT02101385|79027228|FG000|Follow up|Withdrawal by Subject|2|||
44223647|NCT02101385|79027229|FG001|Follow up|Withdrawal by Subject|2|||
44223648|NCT02101385|79027228|FG000|Follow up|PI requested closure of site|0|||
44223649|NCT02101385|79027229|FG001|Follow up|PI requested closure of site|5|||
44223650|NCT02068443|79027244|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44223651|NCT02068443|79027245|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
44223652|NCT02068443|79027246|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
44223653|NCT02068443|79027244|FG000|Overall Study|Voluntary Withdrawal|4|||
44223654|NCT02068443|79027245|FG001|Overall Study|Voluntary Withdrawal|0|||
44223655|NCT02068443|79027246|FG002|Overall Study|Voluntary Withdrawal|1|||
44223656|NCT02068443|79027244|FG000|Overall Study|Lack of Efficacy|2|||
44466758|NCT00295750|79475661|FG002|Overall Study|Disease progression|0|||
44466759|NCT00295750|79475659|FG000|Overall Study|Personal reasons|0|||
44466760|NCT00295750|79475660|FG001|Overall Study|Personal reasons|1|||
44466761|NCT00295750|79475661|FG002|Overall Study|Personal reasons|0|||
44466762|NCT00295750|79475659|FG000|Overall Study|Randomized but never received trial drug|4|||
44466763|NCT00295750|79475660|FG001|Overall Study|Randomized but never received trial drug|3|||
44466764|NCT00295750|79475661|FG002|Overall Study|Randomized but never received trial drug|3|||
44466765|NCT00295750|79475659|FG000|Overall Study|Withdrawal by Subject|9|||
44466766|NCT00295750|79475660|FG001|Overall Study|Withdrawal by Subject|4|||
44466767|NCT00295750|79475661|FG002|Overall Study|Withdrawal by Subject|7|||
44466768|NCT00295750|79475659|FG000|Overall Study|Protocol Violation|2|||
44466769|NCT00295750|79475660|FG001|Overall Study|Protocol Violation|4|||
44466770|NCT00295750|79475661|FG002|Overall Study|Protocol Violation|2|||
44466771|NCT03948581|79475671|FG000|Overall Study|Lost to Follow-up|0|||
44466772|NCT03948581|79475672|FG001|Overall Study|Lost to Follow-up|1|||
44466773|NCT00548327|79475680|FG000|Overall Study|Adverse Event|0|||
44466774|NCT00548327|79475681|FG001|Overall Study|Adverse Event|1|||
44466775|NCT03953183|79475703|FG000|Overall Study|Physician Decision|0|||
44466776|NCT03953183|79475704|FG001|Overall Study|Physician Decision|1|||
44466777|NCT03953183|79475703|FG000|Overall Study|Withdrawal by Subject|0|||
44466778|NCT03953183|79475704|FG001|Overall Study|Withdrawal by Subject|1|||
44466779|NCT00406653|79475714|FG000|Induction Period|Adverse Event|1|||
44466780|NCT00406653|79475715|FG001|Induction Period|Adverse Event|10|||
44466781|NCT00406653|79475716|FG002|Induction Period|Adverse Event|4|||
44466782|NCT00406653|79475717|FG003|Induction Period|Adverse Event|11|||
44466783|NCT00406653|79475718|FG004|Induction Period|Adverse Event|0|||
44466784|NCT00406653|79475719|FG005|Induction Period|Adverse Event|0|||
44466785|NCT00406653|79475720|FG006|Induction Period|Adverse Event|0|||
44466786|NCT00406653|79475714|FG000|Induction Period|Lack of Efficacy|11|||
44466787|NCT00406653|79475715|FG001|Induction Period|Lack of Efficacy|14|||
44466788|NCT00406653|79475716|FG002|Induction Period|Lack of Efficacy|8|||
44466789|NCT00406653|79475717|FG003|Induction Period|Lack of Efficacy|10|||
44466790|NCT00406653|79475718|FG004|Induction Period|Lack of Efficacy|0|||
44466791|NCT00406653|79475719|FG005|Induction Period|Lack of Efficacy|0|||
44466792|NCT00406653|79475720|FG006|Induction Period|Lack of Efficacy|0|||
44466793|NCT00406653|79475714|FG000|Induction Period|Lost to Follow-up|0|||
44466794|NCT00406653|79475715|FG001|Induction Period|Lost to Follow-up|2|||
44466795|NCT00406653|79475716|FG002|Induction Period|Lost to Follow-up|0|||
44466796|NCT00406653|79475717|FG003|Induction Period|Lost to Follow-up|0|||
44466797|NCT00406653|79475718|FG004|Induction Period|Lost to Follow-up|0|||
44466798|NCT00406653|79475719|FG005|Induction Period|Lost to Follow-up|0|||
44466799|NCT00406653|79475720|FG006|Induction Period|Lost to Follow-up|0|||
44466800|NCT00406653|79475714|FG000|Induction Period|Withdrawal of Consent|2|||
44466801|NCT00406653|79475715|FG001|Induction Period|Withdrawal of Consent|5|||
44466802|NCT00406653|79475716|FG002|Induction Period|Withdrawal of Consent|1|||
44466803|NCT00406653|79475717|FG003|Induction Period|Withdrawal of Consent|2|||
44223657|NCT02068443|79027245|FG001|Overall Study|Lack of Efficacy|1|||
44223658|NCT02068443|79027246|FG002|Overall Study|Lack of Efficacy|0|||
44223659|NCT02068443|79027244|FG000|Overall Study|Other Reason Not Specified|1|||
44223660|NCT02068443|79027245|FG001|Overall Study|Other Reason Not Specified|0|||
44223661|NCT02068443|79027246|FG002|Overall Study|Other Reason Not Specified|0|||
44223662|NCT02065869|79027254|FG000|Overall Study|Death|7|||
44223663|NCT02065869|79027254|FG000|Overall Study|Disease relapse|16|||
44223664|NCT02065869|79027254|FG000|Overall Study|Lost to Follow-up|4|||
44223665|NCT02065869|79027254|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
44223666|NCT02065869|79027254|FG000|Overall Study|Withdrawal by Subject|1|||
44223667|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
44223668|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
44223669|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
44223670|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
44223671|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
44223672|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
44466804|NCT00406653|79475718|FG004|Induction Period|Withdrawal of Consent|0|||
44466805|NCT00406653|79475719|FG005|Induction Period|Withdrawal of Consent|0|||
44466806|NCT00406653|79475720|FG006|Induction Period|Withdrawal of Consent|0|||
44466807|NCT00406653|79475714|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
44466808|NCT00406653|79475715|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
44466809|NCT00406653|79475716|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
44466810|NCT00406653|79475717|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
44466811|NCT00406653|79475718|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
44466812|NCT00406653|79475719|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
44466813|NCT00406653|79475720|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
44466814|NCT00406653|79475714|FG000|Induction Period|Pregnancy|1|||
44223673|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
44223674|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
44223675|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
44223676|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
44223677|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44223678|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44223679|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44466815|NCT00406653|79475715|FG001|Induction Period|Pregnancy|0|||
44466816|NCT00406653|79475716|FG002|Induction Period|Pregnancy|0|||
44466817|NCT00406653|79475717|FG003|Induction Period|Pregnancy|0|||
44466818|NCT00406653|79475718|FG004|Induction Period|Pregnancy|0|||
44466819|NCT00406653|79475719|FG005|Induction Period|Pregnancy|0|||
44466820|NCT00406653|79475720|FG006|Induction Period|Pregnancy|0|||
44466821|NCT00406653|79475714|FG000|Induction Period|Declined participation but followup done|0|||
44466822|NCT00406653|79475715|FG001|Induction Period|Declined participation but followup done|2|||
44466823|NCT00406653|79475716|FG002|Induction Period|Declined participation but followup done|1|||
44466824|NCT00406653|79475717|FG003|Induction Period|Declined participation but followup done|1|||
44466825|NCT00406653|79475718|FG004|Induction Period|Declined participation but followup done|0|||
44466826|NCT00406653|79475719|FG005|Induction Period|Declined participation but followup done|0|||
44466827|NCT00406653|79475720|FG006|Induction Period|Declined participation but followup done|0|||
44466828|NCT00406653|79475714|FG000|Induction Period|Given prohibited drug|0|||
44466829|NCT00406653|79475715|FG001|Induction Period|Given prohibited drug|1|||
44466830|NCT00406653|79475716|FG002|Induction Period|Given prohibited drug|2|||
44466831|NCT00406653|79475717|FG003|Induction Period|Given prohibited drug|0|||
44466832|NCT00406653|79475718|FG004|Induction Period|Given prohibited drug|0|||
44466833|NCT00406653|79475719|FG005|Induction Period|Given prohibited drug|0|||
44466834|NCT00406653|79475720|FG006|Induction Period|Given prohibited drug|0|||
44466835|NCT00406653|79475714|FG000|Induction Period|Incarcerated|0|||
44466836|NCT00406653|79475715|FG001|Induction Period|Incarcerated|0|||
44466837|NCT00406653|79475716|FG002|Induction Period|Incarcerated|1|||
44466838|NCT00406653|79475717|FG003|Induction Period|Incarcerated|0|||
44466839|NCT00406653|79475718|FG004|Induction Period|Incarcerated|0|||
44466840|NCT00406653|79475719|FG005|Induction Period|Incarcerated|0|||
44466841|NCT00406653|79475720|FG006|Induction Period|Incarcerated|0|||
44466842|NCT00406653|79475714|FG000|Induction Period|Patient relocated|0|||
44466843|NCT00406653|79475715|FG001|Induction Period|Patient relocated|0|||
44466844|NCT00406653|79475716|FG002|Induction Period|Patient relocated|1|||
44466845|NCT00406653|79475717|FG003|Induction Period|Patient relocated|0|||
44466846|NCT00406653|79475718|FG004|Induction Period|Patient relocated|0|||
44466847|NCT00406653|79475719|FG005|Induction Period|Patient relocated|0|||
44466848|NCT00406653|79475720|FG006|Induction Period|Patient relocated|0|||
44466849|NCT00406653|79475714|FG000|Maintenance Period|Adverse Event|0|||
44466850|NCT00406653|79475715|FG001|Maintenance Period|Adverse Event|0|||
44466851|NCT00406653|79475716|FG002|Maintenance Period|Adverse Event|0|||
44466852|NCT00406653|79475717|FG003|Maintenance Period|Adverse Event|0|||
44466853|NCT00406653|79475718|FG004|Maintenance Period|Adverse Event|1|||
44466854|NCT00406653|79475719|FG005|Maintenance Period|Adverse Event|1|||
44466855|NCT00406653|79475720|FG006|Maintenance Period|Adverse Event|0|||
44466856|NCT00406653|79475714|FG000|Maintenance Period|Lack of Efficacy|0|||
44466857|NCT00406653|79475715|FG001|Maintenance Period|Lack of Efficacy|0|||
44466858|NCT00406653|79475716|FG002|Maintenance Period|Lack of Efficacy|0|||
44466859|NCT00406653|79475717|FG003|Maintenance Period|Lack of Efficacy|0|||
44466860|NCT00406653|79475718|FG004|Maintenance Period|Lack of Efficacy|20|||
44466861|NCT00406653|79475719|FG005|Maintenance Period|Lack of Efficacy|26|||
44466862|NCT00406653|79475720|FG006|Maintenance Period|Lack of Efficacy|0|||
44466863|NCT00406653|79475714|FG000|Maintenance Period|Lost to Follow-up|0|||
44466864|NCT00406653|79475715|FG001|Maintenance Period|Lost to Follow-up|0|||
44466865|NCT00406653|79475716|FG002|Maintenance Period|Lost to Follow-up|0|||
44223680|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
44223681|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
44223682|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44223683|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44223684|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44223685|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44223686|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
44466866|NCT00406653|79475717|FG003|Maintenance Period|Lost to Follow-up|0|||
44466867|NCT00406653|79475718|FG004|Maintenance Period|Lost to Follow-up|2|||
44466868|NCT00406653|79475719|FG005|Maintenance Period|Lost to Follow-up|1|||
44466869|NCT00406653|79475720|FG006|Maintenance Period|Lost to Follow-up|0|||
44466870|NCT00406653|79475714|FG000|Maintenance Period|Withdrawal of Consent|0|||
44466871|NCT00406653|79475715|FG001|Maintenance Period|Withdrawal of Consent|0|||
44466872|NCT00406653|79475716|FG002|Maintenance Period|Withdrawal of Consent|0|||
44466873|NCT00406653|79475717|FG003|Maintenance Period|Withdrawal of Consent|0|||
44544436|NCT03197376|79557828|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
44466874|NCT00406653|79475718|FG004|Maintenance Period|Withdrawal of Consent|2|||
44466875|NCT00406653|79475719|FG005|Maintenance Period|Withdrawal of Consent|0|||
44466876|NCT00406653|79475720|FG006|Maintenance Period|Withdrawal of Consent|0|||
44466877|NCT00406653|79475714|FG000|Maintenance Period|Pregnancy|0|||
44466878|NCT00406653|79475715|FG001|Maintenance Period|Pregnancy|0|||
44466879|NCT00406653|79475716|FG002|Maintenance Period|Pregnancy|0|||
44544437|NCT03197376|79557829|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
44466880|NCT00406653|79475717|FG003|Maintenance Period|Pregnancy|0|||
44466881|NCT00406653|79475718|FG004|Maintenance Period|Pregnancy|0|||
44466882|NCT00406653|79475719|FG005|Maintenance Period|Pregnancy|1|||
44466883|NCT00406653|79475720|FG006|Maintenance Period|Pregnancy|0|||
44466884|NCT00406653|79475714|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
44466885|NCT00406653|79475715|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
44466886|NCT00406653|79475716|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
44466887|NCT00406653|79475717|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
44466888|NCT00406653|79475718|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
44223687|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
44223688|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
44223689|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
44223690|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
44223691|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
44223692|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
44223693|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
44223694|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
44223695|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
44223696|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
44223697|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
44223698|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223699|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223700|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
44223701|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
44223702|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223703|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223704|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223705|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223706|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
44223707|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223708|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223709|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
44223710|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
44223711|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223712|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223713|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223714|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223715|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223716|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
44223717|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223718|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223719|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223720|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223721|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
44223722|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223723|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223724|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223725|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223726|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
44223727|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223728|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223729|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223730|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
44223731|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
44466889|NCT00406653|79475719|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
44466890|NCT00406653|79475720|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
44466891|NCT00406653|79475714|FG000|Maintenance Period|Error in disease score evaluation|0|||
44466892|NCT00406653|79475715|FG001|Maintenance Period|Error in disease score evaluation|0|||
44466893|NCT00406653|79475716|FG002|Maintenance Period|Error in disease score evaluation|0|||
44466894|NCT00406653|79475717|FG003|Maintenance Period|Error in disease score evaluation|0|||
44466895|NCT00406653|79475718|FG004|Maintenance Period|Error in disease score evaluation|1|||
44466896|NCT00406653|79475719|FG005|Maintenance Period|Error in disease score evaluation|0|||
44466897|NCT00406653|79475720|FG006|Maintenance Period|Error in disease score evaluation|0|||
44466898|NCT00406653|79475714|FG000|Open-Label Period|Death|0|||
44466899|NCT00406653|79475715|FG001|Open-Label Period|Death|0|||
44466900|NCT00406653|79475716|FG002|Open-Label Period|Death|0|||
44466901|NCT00406653|79475717|FG003|Open-Label Period|Death|0|||
44466902|NCT00406653|79475718|FG004|Open-Label Period|Death|0|||
44466903|NCT00406653|79475719|FG005|Open-Label Period|Death|0|||
44466904|NCT00406653|79475720|FG006|Open-Label Period|Death|1|||
44466905|NCT00406653|79475714|FG000|Open-Label Period|Adverse Event|0|||
44466906|NCT00406653|79475715|FG001|Open-Label Period|Adverse Event|0|||
44466907|NCT00406653|79475716|FG002|Open-Label Period|Adverse Event|0|||
44466908|NCT00406653|79475717|FG003|Open-Label Period|Adverse Event|0|||
44466909|NCT00406653|79475718|FG004|Open-Label Period|Adverse Event|0|||
44466910|NCT00406653|79475719|FG005|Open-Label Period|Adverse Event|0|||
44466911|NCT00406653|79475720|FG006|Open-Label Period|Adverse Event|18|||
44466912|NCT00406653|79475714|FG000|Open-Label Period|Lack of Efficacy|0|||
44466913|NCT00406653|79475715|FG001|Open-Label Period|Lack of Efficacy|0|||
44466914|NCT00406653|79475716|FG002|Open-Label Period|Lack of Efficacy|0|||
44466915|NCT00406653|79475717|FG003|Open-Label Period|Lack of Efficacy|0|||
44466916|NCT00406653|79475718|FG004|Open-Label Period|Lack of Efficacy|0|||
44466917|NCT00406653|79475719|FG005|Open-Label Period|Lack of Efficacy|0|||
44223732|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
44466918|NCT00406653|79475720|FG006|Open-Label Period|Lack of Efficacy|160|||
44466919|NCT00406653|79475714|FG000|Open-Label Period|Lost to Follow-up|0|||
44466920|NCT00406653|79475715|FG001|Open-Label Period|Lost to Follow-up|0|||
44466921|NCT00406653|79475716|FG002|Open-Label Period|Lost to Follow-up|0|||
44466922|NCT00406653|79475717|FG003|Open-Label Period|Lost to Follow-up|0|||
44466923|NCT00406653|79475718|FG004|Open-Label Period|Lost to Follow-up|0|||
44466924|NCT00406653|79475719|FG005|Open-Label Period|Lost to Follow-up|0|||
44466925|NCT00406653|79475720|FG006|Open-Label Period|Lost to Follow-up|6|||
44466926|NCT00406653|79475714|FG000|Open-Label Period|Withdrawal of Consent|0|||
44466927|NCT00406653|79475715|FG001|Open-Label Period|Withdrawal of Consent|0|||
44466928|NCT00406653|79475716|FG002|Open-Label Period|Withdrawal of Consent|0|||
44466929|NCT00406653|79475717|FG003|Open-Label Period|Withdrawal of Consent|0|||
44466930|NCT00406653|79475718|FG004|Open-Label Period|Withdrawal of Consent|0|||
44466931|NCT00406653|79475719|FG005|Open-Label Period|Withdrawal of Consent|0|||
44466932|NCT00406653|79475720|FG006|Open-Label Period|Withdrawal of Consent|11|||
44466933|NCT00406653|79475714|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
44466934|NCT00406653|79475715|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
44466935|NCT00406653|79475716|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
44223733|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223734|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223735|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223736|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
44223737|NCT02018861|79027269|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223738|NCT02018861|79027270|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223739|NCT02018861|79027271|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44273414|NCT01964430|79215136|FG000|Treatment Period|Disease Relapse|28|||
44466936|NCT00406653|79475717|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
44466937|NCT00406653|79475718|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
44466938|NCT00406653|79475719|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
44466939|NCT00406653|79475720|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
44466940|NCT00406653|79475714|FG000|Open-Label Period|Pregnancy|0|||
44466941|NCT00406653|79475715|FG001|Open-Label Period|Pregnancy|0|||
44466942|NCT00406653|79475716|FG002|Open-Label Period|Pregnancy|0|||
44223740|NCT02018861|79027272|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
44466943|NCT00406653|79475717|FG003|Open-Label Period|Pregnancy|0|||
44466944|NCT00406653|79475718|FG004|Open-Label Period|Pregnancy|0|||
44466945|NCT00406653|79475719|FG005|Open-Label Period|Pregnancy|0|||
44466946|NCT00406653|79475720|FG006|Open-Label Period|Pregnancy|2|||
44466947|NCT00406653|79475714|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
44466948|NCT00406653|79475715|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
44466949|NCT00406653|79475716|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
44466950|NCT00406653|79475717|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
44223741|NCT02018861|79027273|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
44223742|NCT02018861|79027274|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223743|NCT02018861|79027275|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223744|NCT02018861|79027276|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223745|NCT02018861|79027277|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223746|NCT02018861|79027278|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
44223747|NCT02018861|79027269|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223748|NCT02018861|79027270|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223749|NCT02018861|79027271|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223750|NCT02018861|79027272|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223751|NCT02018861|79027273|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223752|NCT02018861|79027274|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223753|NCT02018861|79027275|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
44466951|NCT00406653|79475718|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
44466952|NCT00406653|79475719|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
44466953|NCT00406653|79475720|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
44466954|NCT00406653|79475714|FG000|Open-Label Period|Declined participation but followup done|0|||
44466955|NCT00406653|79475715|FG001|Open-Label Period|Declined participation but followup done|0|||
44466956|NCT00406653|79475716|FG002|Open-Label Period|Declined participation but followup done|0|||
44466957|NCT00406653|79475717|FG003|Open-Label Period|Declined participation but followup done|0|||
44466958|NCT00406653|79475718|FG004|Open-Label Period|Declined participation but followup done|0|||
44466959|NCT00406653|79475719|FG005|Open-Label Period|Declined participation but followup done|0|||
44466960|NCT00406653|79475720|FG006|Open-Label Period|Declined participation but followup done|8|||
44466961|NCT00406653|79475714|FG000|Open-Label Period|Discontinued by Sponsor|0|||
44466962|NCT00406653|79475715|FG001|Open-Label Period|Discontinued by Sponsor|0|||
44466963|NCT00406653|79475716|FG002|Open-Label Period|Discontinued by Sponsor|0|||
44466964|NCT00406653|79475717|FG003|Open-Label Period|Discontinued by Sponsor|0|||
44466965|NCT00406653|79475718|FG004|Open-Label Period|Discontinued by Sponsor|0|||
44466966|NCT00406653|79475719|FG005|Open-Label Period|Discontinued by Sponsor|0|||
44466967|NCT00406653|79475720|FG006|Open-Label Period|Discontinued by Sponsor|1|||
44466968|NCT00406653|79475714|FG000|Open-Label Period|Refused followup|0|||
44466969|NCT00406653|79475715|FG001|Open-Label Period|Refused followup|0|||
44466970|NCT00406653|79475716|FG002|Open-Label Period|Refused followup|0|||
44466971|NCT00406653|79475717|FG003|Open-Label Period|Refused followup|0|||
44466972|NCT00406653|79475718|FG004|Open-Label Period|Refused followup|0|||
44466973|NCT00406653|79475719|FG005|Open-Label Period|Refused followup|0|||
44466974|NCT00406653|79475720|FG006|Open-Label Period|Refused followup|1|||
44466975|NCT00547157|79475742|FG000|Overall Study|Other|1|||
44466976|NCT00547157|79475743|FG001|Overall Study|Other|0|||
44466977|NCT00547157|79475742|FG000|Overall Study|Death|38|||
44466978|NCT00547157|79475743|FG001|Overall Study|Death|18|||
44466979|NCT00547157|79475742|FG000|Overall Study|Withdrawal by Subject|3|||
44466980|NCT00547157|79475743|FG001|Overall Study|Withdrawal by Subject|1|||
44466981|NCT00547157|79475742|FG000|Overall Study|Administrative decision|3|||
44466982|NCT00547157|79475743|FG001|Overall Study|Administrative decision|2|||
44466983|NCT00547157|79475742|FG000|Overall Study|Lost to Follow-up|4|||
44466984|NCT00547157|79475743|FG001|Overall Study|Lost to Follow-up|2|||
44466985|NCT00384033|79475753|FG000|Overall Study|Adverse Event|10|||
44466986|NCT00384033|79475754|FG001|Overall Study|Adverse Event|8|||
44466987|NCT00384033|79475755|FG002|Overall Study|Adverse Event|11|||
44466988|NCT00384033|79475756|FG003|Overall Study|Adverse Event|20|||
44466989|NCT00384033|79475753|FG000|Overall Study|Failed to return|1|||
44466990|NCT00384033|79475754|FG001|Overall Study|Failed to return|3|||
44466991|NCT00384033|79475755|FG002|Overall Study|Failed to return|2|||
44466992|NCT00384033|79475756|FG003|Overall Study|Failed to return|2|||
44466993|NCT00384033|79475753|FG000|Overall Study|Physician Decision|1|||
44466994|NCT00384033|79475754|FG001|Overall Study|Physician Decision|0|||
44466995|NCT00384033|79475755|FG002|Overall Study|Physician Decision|0|||
44466996|NCT00384033|79475756|FG003|Overall Study|Physician Decision|0|||
44466997|NCT00384033|79475753|FG000|Overall Study|Lost to Follow-up|6|||
44223754|NCT02018861|79027276|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
44223755|NCT02018861|79027277|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44223756|NCT02018861|79027278|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
44466998|NCT00384033|79475754|FG001|Overall Study|Lost to Follow-up|12|||
44466999|NCT00384033|79475755|FG002|Overall Study|Lost to Follow-up|7|||
44467000|NCT00384033|79475756|FG003|Overall Study|Lost to Follow-up|7|||
44467001|NCT00384033|79475753|FG000|Overall Study|Other|2|||
44467002|NCT00384033|79475754|FG001|Overall Study|Other|0|||
44467003|NCT00384033|79475755|FG002|Overall Study|Other|0|||
44467004|NCT00384033|79475756|FG003|Overall Study|Other|0|||
44467005|NCT00384033|79475753|FG000|Overall Study|Protocol Violation|5|||
44467006|NCT00384033|79475754|FG001|Overall Study|Protocol Violation|0|||
44467007|NCT00384033|79475755|FG002|Overall Study|Protocol Violation|5|||
44467008|NCT00384033|79475756|FG003|Overall Study|Protocol Violation|6|||
44467009|NCT00384033|79475753|FG000|Overall Study|Withdrawal by Subject|6|||
44467010|NCT00384033|79475754|FG001|Overall Study|Withdrawal by Subject|2|||
44467011|NCT00384033|79475755|FG002|Overall Study|Withdrawal by Subject|5|||
44467012|NCT00384033|79475756|FG003|Overall Study|Withdrawal by Subject|2|||
44467013|NCT00384033|79475753|FG000|Overall Study|Lack of Efficacy|7|||
44467014|NCT00384033|79475754|FG001|Overall Study|Lack of Efficacy|3|||
44467015|NCT00384033|79475755|FG002|Overall Study|Lack of Efficacy|3|||
44467016|NCT00384033|79475756|FG003|Overall Study|Lack of Efficacy|1|||
44467017|NCT00384033|79475753|FG000|Overall Study|Randomized but not treated|3|||
44467018|NCT00384033|79475754|FG001|Overall Study|Randomized but not treated|7|||
44467019|NCT00384033|79475755|FG002|Overall Study|Randomized but not treated|10|||
44467020|NCT00384033|79475756|FG003|Overall Study|Randomized but not treated|2|||
44467021|NCT00546377|79475766|FG000|Overall Study|Deemed ineligible|1|||
44467022|NCT00546377|79475766|FG000|Overall Study|Adverse Event|6|||
44467023|NCT00545753|79475773|FG000|Overall Study|Withdrawal by Subject|0|||
44467024|NCT00545753|79475774|FG001|Overall Study|Withdrawal by Subject|1|||
44273415|NCT01964430|79215137|FG001|Treatment Period|Disease Relapse|38|||
44467025|NCT00545753|79475775|FG002|Overall Study|Withdrawal by Subject|10|||
44467026|NCT00545753|79475773|FG000|Overall Study|Lost to Follow-up|13|||
44467027|NCT00545753|79475774|FG001|Overall Study|Lost to Follow-up|3|||
44467028|NCT00545753|79475775|FG002|Overall Study|Lost to Follow-up|12|||
44467029|NCT00545753|79475773|FG000|Overall Study|Protocol Violation|3|||
44467030|NCT00545753|79475774|FG001|Overall Study|Protocol Violation|1|||
44467031|NCT00545753|79475775|FG002|Overall Study|Protocol Violation|4|||
44467032|NCT00406419|79475787|FG000|Overall Study|Death|3|||
44467033|NCT00406419|79475788|FG001|Overall Study|Death|1|||
44467034|NCT00406419|79475789|FG002|Overall Study|Death|4|||
44467035|NCT00406419|79475787|FG000|Overall Study|Protocol Violation|6|||
44467036|NCT00406419|79475788|FG001|Overall Study|Protocol Violation|2|||
44467037|NCT00406419|79475789|FG002|Overall Study|Protocol Violation|5|||
44467038|NCT00406419|79475787|FG000|Overall Study|Study Terminated by Sponsor|260|||
44467039|NCT00406419|79475788|FG001|Overall Study|Study Terminated by Sponsor|288|||
44467040|NCT00406419|79475789|FG002|Overall Study|Study Terminated by Sponsor|282|||
44467041|NCT00406419|79475787|FG000|Overall Study|Withdrawal by Subject|17|||
44467042|NCT00406419|79475788|FG001|Overall Study|Withdrawal by Subject|24|||
44467043|NCT00406419|79475789|FG002|Overall Study|Withdrawal by Subject|26|||
44467044|NCT00406419|79475787|FG000|Overall Study|Lack of Efficacy|12|||
44467045|NCT00406419|79475788|FG001|Overall Study|Lack of Efficacy|1|||
44467046|NCT00406419|79475789|FG002|Overall Study|Lack of Efficacy|6|||
44467047|NCT00406419|79475787|FG000|Overall Study|Non-Compliance with Study Drug|5|||
44467048|NCT00406419|79475788|FG001|Overall Study|Non-Compliance with Study Drug|6|||
44467049|NCT00406419|79475789|FG002|Overall Study|Non-Compliance with Study Drug|3|||
44467050|NCT00406419|79475787|FG000|Overall Study|Adverse Event|10|||
44467051|NCT00406419|79475788|FG001|Overall Study|Adverse Event|12|||
44467052|NCT00406419|79475789|FG002|Overall Study|Adverse Event|16|||
44467053|NCT00406419|79475787|FG000|Overall Study|Lost to Follow-up|11|||
44467054|NCT00406419|79475788|FG001|Overall Study|Lost to Follow-up|10|||
44467055|NCT00406419|79475789|FG002|Overall Study|Lost to Follow-up|5|||
44467056|NCT00325468|79475802|FG000|Overall Study|Adverse Event|1|||
44273416|NCT01964430|79215136|FG000|Treatment Period|Other reasons|1|||
44273417|NCT01964430|79215137|FG001|Treatment Period|Other reasons|3|||
44273418|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
44273419|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
44273420|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
44273421|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
44273422|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
44273423|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
44273424|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
44273425|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
44273426|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
44467057|NCT00325468|79475803|FG001|Overall Study|Adverse Event|1|||
44467058|NCT00325468|79475804|FG002|Overall Study|Adverse Event|0|||
44273427|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
44273428|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
44467059|NCT00325468|79475805|FG003|Overall Study|Adverse Event|5|||
44467060|NCT00325468|79475806|FG004|Overall Study|Adverse Event|1|||
44467061|NCT00325468|79475802|FG000|Overall Study|Death|2|||
44467062|NCT00325468|79475803|FG001|Overall Study|Death|0|||
44467063|NCT00325468|79475804|FG002|Overall Study|Death|2|||
44467064|NCT00325468|79475805|FG003|Overall Study|Death|4|||
44467065|NCT00325468|79475806|FG004|Overall Study|Death|0|||
44467066|NCT00325468|79475802|FG000|Overall Study|Lost to Follow-up|0|||
44467067|NCT00325468|79475803|FG001|Overall Study|Lost to Follow-up|0|||
44467068|NCT00325468|79475804|FG002|Overall Study|Lost to Follow-up|1|||
44467069|NCT00325468|79475805|FG003|Overall Study|Lost to Follow-up|2|||
44467070|NCT00325468|79475806|FG004|Overall Study|Lost to Follow-up|2|||
44467071|NCT00325468|79475802|FG000|Overall Study|Physician Decision|1|||
44467072|NCT00325468|79475803|FG001|Overall Study|Physician Decision|1|||
44467073|NCT00325468|79475804|FG002|Overall Study|Physician Decision|0|||
44467074|NCT00325468|79475805|FG003|Overall Study|Physician Decision|1|||
44467075|NCT00325468|79475806|FG004|Overall Study|Physician Decision|0|||
44467076|NCT00325468|79475802|FG000|Overall Study|Withdrawal by Subject|3|||
44467077|NCT00325468|79475803|FG001|Overall Study|Withdrawal by Subject|1|||
44467078|NCT00325468|79475804|FG002|Overall Study|Withdrawal by Subject|0|||
44467079|NCT00325468|79475805|FG003|Overall Study|Withdrawal by Subject|14|||
44467080|NCT00325468|79475806|FG004|Overall Study|Withdrawal by Subject|4|||
44467081|NCT00325468|79475802|FG000|Overall Study|site closure etc|4|||
44467082|NCT00325468|79475803|FG001|Overall Study|site closure etc|2|||
44467083|NCT00325468|79475804|FG002|Overall Study|site closure etc|1|||
44467084|NCT00325468|79475805|FG003|Overall Study|site closure etc|8|||
44467085|NCT00325468|79475806|FG004|Overall Study|site closure etc|1|||
44467086|NCT00311584|79475821|FG000|Overall Study|Death|1|||
44467087|NCT00311584|79475822|FG001|Overall Study|Death|0|||
44467088|NCT00311584|79475821|FG000|Overall Study|Lack of Efficacy|12|||
44467089|NCT00311584|79475822|FG001|Overall Study|Lack of Efficacy|15|||
44467090|NCT00311584|79475821|FG000|Overall Study|Physician Decision|4|||
44467091|NCT00311584|79475822|FG001|Overall Study|Physician Decision|5|||
44467092|NCT00311584|79475821|FG000|Overall Study|Withdrawal by Subject|1|||
44467093|NCT00311584|79475822|FG001|Overall Study|Withdrawal by Subject|1|||
44467094|NCT00311584|79475821|FG000|Overall Study|ineligible|2|||
44467095|NCT00311584|79475822|FG001|Overall Study|ineligible|2|||
44467096|NCT00383331|79475830|FG000|Overall Study|Protocol Violation|0|||
44467097|NCT00383331|79475831|FG001|Overall Study|Protocol Violation|1|||
44467098|NCT03934541|79475841|FG000|Overall Study|Study Terminated by Sponsor|0|||
44467099|NCT03934541|79475842|FG001|Overall Study|Study Terminated by Sponsor|1|||
44467100|NCT03934541|79475843|FG002|Overall Study|Study Terminated by Sponsor|0|||
44467101|NCT03934541|79475844|FG003|Overall Study|Study Terminated by Sponsor|0|||
44467102|NCT00325234|79475856|FG000|Overall Study|Adverse Event|10|||
44467103|NCT00325234|79475857|FG001|Overall Study|Adverse Event|7|||
44467104|NCT00325234|79475856|FG000|Overall Study|Death due to Study Disease|1|||
44467105|NCT00325234|79475857|FG001|Overall Study|Death due to Study Disease|0|||
44467106|NCT00325234|79475856|FG000|Overall Study|Entry Criteria Not Met|1|||
44467107|NCT00325234|79475857|FG001|Overall Study|Entry Criteria Not Met|2|||
44467108|NCT00325234|79475856|FG000|Overall Study|Subject Decision|6|||
44467109|NCT00325234|79475857|FG001|Overall Study|Subject Decision|8|||
44467110|NCT00325234|79475856|FG000|Overall Study|Physician Decision|17|||
44467111|NCT00325234|79475857|FG001|Overall Study|Physician Decision|12|||
44467112|NCT00325234|79475856|FG000|Overall Study|Progressive Disease|34|||
44467113|NCT00325234|79475857|FG001|Overall Study|Progressive Disease|37|||
44467114|NCT00366249|79475867|FG000|Overall Study|Adverse Event|53|||
44467115|NCT00366249|79475868|FG001|Overall Study|Adverse Event|28|||
44467116|NCT00366249|79475867|FG000|Overall Study|Death|0|||
44223757|NCT02018861|79027269|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223758|NCT02018861|79027270|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223759|NCT02018861|79027271|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223760|NCT02018861|79027272|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223761|NCT02018861|79027273|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223762|NCT02018861|79027274|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223763|NCT02018861|79027275|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
44273429|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
44273430|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
44273431|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
44273432|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
44273433|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
44273434|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
44273435|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
44273436|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
44467117|NCT00366249|79475868|FG001|Overall Study|Death|1|||
44467118|NCT00366249|79475867|FG000|Overall Study|Physician Decision|5|||
44467119|NCT00366249|79475868|FG001|Overall Study|Physician Decision|2|||
44467120|NCT00366249|79475867|FG000|Overall Study|Lost to Follow-up|2|||
44467121|NCT00366249|79475868|FG001|Overall Study|Lost to Follow-up|0|||
44467122|NCT00366249|79475867|FG000|Overall Study|Protocol Violation|1|||
44467123|NCT00366249|79475868|FG001|Overall Study|Protocol Violation|2|||
44467124|NCT00366249|79475867|FG000|Overall Study|Withdrawal by Subject|18|||
44467125|NCT00366249|79475868|FG001|Overall Study|Withdrawal by Subject|4|||
44467126|NCT00366249|79475867|FG000|Overall Study|Lack of Efficacy|21|||
44467127|NCT00366249|79475868|FG001|Overall Study|Lack of Efficacy|21|||
44467128|NCT00366249|79475867|FG000|Overall Study|Most due to osteomylitis status|31|||
44467129|NCT00366249|79475868|FG001|Overall Study|Most due to osteomylitis status|20|||
44467130|NCT00325156|79475874|FG000|Overall Study|Protocol Violation|8|||
44223764|NCT02018861|79027276|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
44223765|NCT02018861|79027277|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223766|NCT02018861|79027278|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
44223767|NCT02018861|79027269|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223768|NCT02018861|79027270|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223769|NCT02018861|79027271|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223770|NCT02018861|79027272|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44467131|NCT00325156|79475874|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
44467132|NCT00325156|79475874|FG000|Overall Study|Migrated/moved from study area|12|||
44467133|NCT00325156|79475874|FG000|Overall Study|Adverse event, non-fatal|3|||
44467134|NCT00325156|79475874|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
44467135|NCT00325156|79475874|FG000|Overall Study|Other|1|||
44467136|NCT00325156|79475874|FG000|Overall Study|Withdrawal by Subject|31|||
44467137|NCT03927911|79475884|FG000|Overall Study|problems with eDiary|0|||
44467138|NCT03927911|79475885|FG001|Overall Study|problems with eDiary|1|||
44467139|NCT03927911|79475886|FG002|Overall Study|problems with eDiary|0|||
44467140|NCT03927911|79475887|FG003|Overall Study|problems with eDiary|1|||
44467141|NCT03927911|79475888|FG004|Overall Study|problems with eDiary|0|||
44467142|NCT03927911|79475889|FG005|Overall Study|problems with eDiary|4|||
44467143|NCT03927911|79475884|FG000|Overall Study|Adverse Event|0|||
44467144|NCT03927911|79475885|FG001|Overall Study|Adverse Event|0|||
44467145|NCT03927911|79475886|FG002|Overall Study|Adverse Event|0|||
44467146|NCT03927911|79475887|FG003|Overall Study|Adverse Event|0|||
44467147|NCT03927911|79475888|FG004|Overall Study|Adverse Event|0|||
44467148|NCT03927911|79475889|FG005|Overall Study|Adverse Event|1|||
44467149|NCT03927911|79475884|FG000|Overall Study|not treated -study terminated by sponsor|0|||
44467150|NCT03927911|79475885|FG001|Overall Study|not treated -study terminated by sponsor|1|||
44467151|NCT03927911|79475886|FG002|Overall Study|not treated -study terminated by sponsor|0|||
44467152|NCT03927911|79475887|FG003|Overall Study|not treated -study terminated by sponsor|0|||
44467153|NCT03927911|79475888|FG004|Overall Study|not treated -study terminated by sponsor|0|||
44467154|NCT03927911|79475889|FG005|Overall Study|not treated -study terminated by sponsor|0|||
44467155|NCT03927911|79475884|FG000|Overall Study|Surgery cancelled|0|||
44467156|NCT03927911|79475885|FG001|Overall Study|Surgery cancelled|0|||
44467157|NCT03927911|79475886|FG002|Overall Study|Surgery cancelled|0|||
44467158|NCT03927911|79475887|FG003|Overall Study|Surgery cancelled|1|||
44467159|NCT03927911|79475888|FG004|Overall Study|Surgery cancelled|0|||
44467160|NCT03927911|79475889|FG005|Overall Study|Surgery cancelled|1|||
44467161|NCT03927911|79475884|FG000|Overall Study|Protocol Violation|0|||
44467162|NCT03927911|79475885|FG001|Overall Study|Protocol Violation|0|||
44467163|NCT03927911|79475886|FG002|Overall Study|Protocol Violation|0|||
44467164|NCT03927911|79475887|FG003|Overall Study|Protocol Violation|0|||
44467165|NCT03927911|79475888|FG004|Overall Study|Protocol Violation|0|||
44467166|NCT03927911|79475889|FG005|Overall Study|Protocol Violation|1|||
44467167|NCT00383019|79475905|FG000|Overall Study|Adverse Event|5|||
44467168|NCT00383019|79475906|FG001|Overall Study|Adverse Event|1|||
44467169|NCT00383019|79475905|FG000|Overall Study|Withdrawal by Subject|0|||
44223771|NCT02018861|79027273|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223772|NCT02018861|79027274|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223773|NCT02018861|79027275|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223774|NCT02018861|79027276|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44223775|NCT02018861|79027277|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
44467170|NCT00383019|79475906|FG001|Overall Study|Withdrawal by Subject|1|||
44467171|NCT00310804|79475914|FG000|Overall Study|Lost to Follow-up|2|||
44467172|NCT00310804|79475915|FG001|Overall Study|Lost to Follow-up|0|||
44467173|NCT00310804|79475914|FG000|Overall Study|Withdrawal by Subject|3|||
44467174|NCT00310804|79475915|FG001|Overall Study|Withdrawal by Subject|0|||
44467175|NCT03826186|79475937|FG000|Overall Study|Protocol Violation|2|||
44467176|NCT03826186|79475938|FG001|Overall Study|Protocol Violation|0|||
44467177|NCT03826186|79475937|FG000|Overall Study|Withdrawal by Subject|1|||
44467178|NCT03826186|79475938|FG001|Overall Study|Withdrawal by Subject|0|||
44467179|NCT00382863|79475946|FG000|Overall Study|Death|9|||
44467180|NCT00382863|79475947|FG001|Overall Study|Death|9|||
44223776|NCT02018861|79027278|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
44467181|NCT00382863|79475946|FG000|Overall Study|Lost to Follow-up|1|||
44467182|NCT00382863|79475947|FG001|Overall Study|Lost to Follow-up|2|||
44467183|NCT00382863|79475946|FG000|Overall Study|Withdrawal by Subject|5|||
44467184|NCT00382863|79475947|FG001|Overall Study|Withdrawal by Subject|25|||
44467185|NCT03933449|79475955|FG000|Overall Study|Adverse Event|6|||
44467186|NCT03933449|79475956|FG001|Overall Study|Adverse Event|4|||
44467187|NCT03933449|79475955|FG000|Overall Study|Death|55|||
44467188|NCT03933449|79475956|FG001|Overall Study|Death|57|||
44467189|NCT03933449|79475955|FG000|Overall Study|Sponsor Decision|1|||
44467190|NCT03933449|79475956|FG001|Overall Study|Sponsor Decision|0|||
44467191|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
44514816|NCT03084796|79520624|FG001|Overall Study|Randomization error|0|||
44467192|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
44467193|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
44467194|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
44467195|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
44467196|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
44467197|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
44467198|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
44467199|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
44467200|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
44467201|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
44467202|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
44467203|NCT00290758|79475979|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
44467204|NCT00290758|79475980|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
44467205|NCT00290758|79475979|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
44467206|NCT00290758|79475980|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
44223777|NCT02018861|79027269|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223778|NCT02018861|79027270|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223779|NCT02018861|79027271|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223780|NCT02018861|79027272|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223781|NCT02018861|79027273|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223782|NCT02018861|79027274|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223783|NCT02018861|79027275|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223784|NCT02018861|79027276|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44223785|NCT02018861|79027277|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
44223786|NCT02018861|79027278|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
44375152|NCT00908037|79380268|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
44375153|NCT00908037|79380257|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375154|NCT00908037|79380258|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375155|NCT00908037|79380259|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44223787|NCT02018861|79027269|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223788|NCT02018861|79027270|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223789|NCT02018861|79027271|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223790|NCT02018861|79027272|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223791|NCT02018861|79027273|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223792|NCT02018861|79027274|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223793|NCT02018861|79027275|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223794|NCT02018861|79027276|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223795|NCT02018861|79027277|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
44223796|NCT02018861|79027278|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
44223797|NCT01827384|79027330|FG000|Overall Study|Switched to alternative treatment|0|||
44223798|NCT01827384|79027331|FG001|Overall Study|Switched to alternative treatment|0|||
44223799|NCT01827384|79027332|FG002|Overall Study|Switched to alternative treatment|0|||
44223800|NCT01827384|79027333|FG003|Overall Study|Switched to alternative treatment|0|||
44375156|NCT00908037|79380260|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375157|NCT00908037|79380261|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375158|NCT00908037|79380262|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375159|NCT00908037|79380263|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375160|NCT00908037|79380264|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375161|NCT00908037|79380265|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375162|NCT00908037|79380266|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
44375163|NCT00908037|79380267|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375164|NCT00908037|79380268|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
44375165|NCT00908037|79380257|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375166|NCT00908037|79380258|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375167|NCT00908037|79380259|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375168|NCT00908037|79380260|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375169|NCT00908037|79380261|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375170|NCT00908037|79380262|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375171|NCT00908037|79380263|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375172|NCT00908037|79380264|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375173|NCT00908037|79380265|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375174|NCT00908037|79380266|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44375175|NCT00908037|79380267|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
44467207|NCT00372567|79475993|FG000|Phase 3 Study|Adverse Event|5|||
44467208|NCT00372567|79475994|FG001|Phase 3 Study|Adverse Event|1|||
44467209|NCT00372567|79475995|FG002|Phase 3 Study|Adverse Event|1|||
44467210|NCT00372567|79475993|FG000|Phase 3 Study|Death|1|||
44467211|NCT00372567|79475994|FG001|Phase 3 Study|Death|1|||
44467212|NCT00372567|79475995|FG002|Phase 3 Study|Death|0|||
44467213|NCT00372567|79475993|FG000|Phase 3 Study|Protocol Violation|0|||
44467214|NCT00372567|79475994|FG001|Phase 3 Study|Protocol Violation|0|||
44467215|NCT00372567|79475995|FG002|Phase 3 Study|Protocol Violation|1|||
44467216|NCT00372567|79475993|FG000|Phase 3 Study|Objective progression or relapse|10|||
44467217|NCT00372567|79475994|FG001|Phase 3 Study|Objective progression or relapse|13|||
44467218|NCT00372567|79475995|FG002|Phase 3 Study|Objective progression or relapse|4|||
44467219|NCT00372567|79475993|FG000|Phase 3 Study|Global deterioration of health status|0|||
44467220|NCT00372567|79475994|FG001|Phase 3 Study|Global deterioration of health status|1|||
44467221|NCT00372567|79475995|FG002|Phase 3 Study|Global deterioration of health status|0|||
44467222|NCT00372567|79475993|FG000|Phase 3 Study|Other|2|||
44467223|NCT00372567|79475994|FG001|Phase 3 Study|Other|2|||
44467224|NCT00372567|79475995|FG002|Phase 3 Study|Other|1|||
44467225|NCT00372567|79475993|FG000|Phase 3 Study|study terminated by sponsor|13|||
44467226|NCT00372567|79475994|FG001|Phase 3 Study|study terminated by sponsor|8|||
44467227|NCT00372567|79475995|FG002|Phase 3 Study|study terminated by sponsor|5|||
44467228|NCT00365547|79476003|FG000|Overall Study|Insurance did not cover Avastin|1|||
44467229|NCT00365547|79476003|FG000|Overall Study|Screen failure|1|||
44467230|NCT00365547|79476003|FG000|Overall Study|Withdrawal by Subject|1|||
44467231|NCT00545441|79476012|FG000|Overall Study|Fistula draining at 6 months|2|||
44467232|NCT00545441|79476013|FG001|Overall Study|Fistula draining at 6 months|4|||
44467233|NCT00545441|79476012|FG000|Overall Study|Lost to Follow-up|9|||
44467234|NCT00545441|79476013|FG001|Overall Study|Lost to Follow-up|5|||
44467235|NCT00545441|79476012|FG000|Overall Study|Technical failure|0|||
44467236|NCT00545441|79476013|FG001|Overall Study|Technical failure|1|||
44467237|NCT00545441|79476012|FG000|Overall Study|Withdrawal by Subject|1|||
44467238|NCT00545441|79476013|FG001|Overall Study|Withdrawal by Subject|1|||
44467239|NCT00545441|79476012|FG000|Overall Study|Persistence or recurrence of fistula|5|||
44467240|NCT00545441|79476013|FG001|Overall Study|Persistence or recurrence of fistula|2|||
44467241|NCT00545441|79476012|FG000|Overall Study|Patients were not treated|1|||
44467242|NCT00545441|79476013|FG001|Overall Study|Patients were not treated|3|||
44467243|NCT00294658|79476021|FG000|Overall Study|Death|0|||
44467244|NCT00294658|79476022|FG001|Overall Study|Death|1|||
44467245|NCT00294658|79476021|FG000|Overall Study|Lost to Follow-up|4|||
44467246|NCT00294658|79476022|FG001|Overall Study|Lost to Follow-up|0|||
44273437|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
44273438|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
44273439|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
44273440|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
44273441|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
44273442|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
44467247|NCT00294658|79476021|FG000|Overall Study|Physician Decision|1|||
44467248|NCT00294658|79476022|FG001|Overall Study|Physician Decision|2|||
44467249|NCT00294658|79476021|FG000|Overall Study|Pregnancy|0|||
44467250|NCT00294658|79476022|FG001|Overall Study|Pregnancy|1|||
44467251|NCT00294658|79476021|FG000|Overall Study|Withdrawal by Subject|0|||
44467252|NCT00294658|79476022|FG001|Overall Study|Withdrawal by Subject|4|||
44467253|NCT00294658|79476021|FG000|Overall Study|Found to have invasive thymoma|1|||
44467254|NCT00294658|79476022|FG001|Overall Study|Found to have invasive thymoma|0|||
44467255|NCT00294658|79476021|FG000|Overall Study|Patient and family were not satisfied|0|||
44467256|NCT00294658|79476022|FG001|Overall Study|Patient and family were not satisfied|1|||
44467257|NCT03923933|79476030|FG000|Overall Study|Lost to Follow-up|1|||
44467258|NCT03923933|79476031|FG001|Overall Study|Lost to Follow-up|0|||
44273443|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
44467259|NCT03923933|79476030|FG000|Overall Study|Withdrawal by Subject|0|||
44467260|NCT03923933|79476031|FG001|Overall Study|Withdrawal by Subject|1|||
44467261|NCT00372489|79476037|FG000|Overall Study|Adverse Event|18|||
44467262|NCT00372489|79476037|FG000|Overall Study|Lack of Efficacy|1|||
44467263|NCT00372489|79476037|FG000|Overall Study|Lost to Follow-up|3|||
44467264|NCT00372489|79476037|FG000|Overall Study|Physician Decision|3|||
44273444|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
44467265|NCT00372489|79476037|FG000|Overall Study|Withdrawal by Subject|5|||
44467266|NCT00372489|79476037|FG000|Overall Study|Patient Relocation|2|||
44467267|NCT00372489|79476037|FG000|Overall Study|Renal transplant|6|||
44467268|NCT00372489|79476037|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
44467269|NCT00372411|79476044|FG000|Overall Study|Withdrawal by Subject|3|||
44467270|NCT00372411|79476045|FG001|Overall Study|Withdrawal by Subject|4|||
44467271|NCT00372411|79476046|FG002|Overall Study|Withdrawal by Subject|1|||
44467272|NCT00372411|79476044|FG000|Overall Study|Death|0|||
44467273|NCT00372411|79476045|FG001|Overall Study|Death|2|||
44544438|NCT03197376|79557826|FG000|Primary and Booster Phase|Physician Decision|1|||
44467274|NCT00372411|79476046|FG002|Overall Study|Death|1|||
44467275|NCT00372411|79476044|FG000|Overall Study|Lost to Follow-up|1|||
44467276|NCT00372411|79476045|FG001|Overall Study|Lost to Follow-up|1|||
44467277|NCT00372411|79476046|FG002|Overall Study|Lost to Follow-up|1|||
44467278|NCT00372411|79476044|FG000|Overall Study|Adverse Event|1|||
44467279|NCT00372411|79476045|FG001|Overall Study|Adverse Event|1|||
44467280|NCT00372411|79476046|FG002|Overall Study|Adverse Event|0|||
44467281|NCT00372255|79476056|FG000|Overall Study|Withdrawn for other reasons|2|||
44467282|NCT00372255|79476057|FG001|Overall Study|Withdrawn for other reasons|1|||
44467283|NCT00274456|79476068|FG000|Overall Study|Still on treatment|2|||
44467284|NCT00274456|79476069|FG001|Overall Study|Still on treatment|3|||
44467285|NCT00274456|79476070|FG002|Overall Study|Still on treatment|5|||
44467286|NCT00274456|79476071|FG003|Overall Study|Still on treatment|1|||
44467287|NCT00274456|79476068|FG000|Overall Study|Unacceptable toxicity|10|||
44467288|NCT00274456|79476069|FG001|Overall Study|Unacceptable toxicity|5|||
44467289|NCT00274456|79476070|FG002|Overall Study|Unacceptable toxicity|12|||
44467290|NCT00274456|79476071|FG003|Overall Study|Unacceptable toxicity|16|||
44467291|NCT00274456|79476068|FG000|Overall Study|Adverse Event|0|||
44467292|NCT00274456|79476069|FG001|Overall Study|Adverse Event|1|||
44467293|NCT00274456|79476070|FG002|Overall Study|Adverse Event|2|||
44467294|NCT00274456|79476071|FG003|Overall Study|Adverse Event|2|||
44467295|NCT00274456|79476068|FG000|Overall Study|Physician Decision|7|||
44467296|NCT00274456|79476069|FG001|Overall Study|Physician Decision|5|||
44467297|NCT00274456|79476070|FG002|Overall Study|Physician Decision|6|||
44467298|NCT00274456|79476071|FG003|Overall Study|Physician Decision|13|||
44467299|NCT00274456|79476068|FG000|Overall Study|Lost to Follow-up|0|||
44467300|NCT00274456|79476069|FG001|Overall Study|Lost to Follow-up|0|||
44467301|NCT00274456|79476070|FG002|Overall Study|Lost to Follow-up|1|||
44467302|NCT00274456|79476071|FG003|Overall Study|Lost to Follow-up|0|||
44467303|NCT00274456|79476068|FG000|Overall Study|Withdrawal by Subject|18|||
44467304|NCT00274456|79476069|FG001|Overall Study|Withdrawal by Subject|13|||
44467305|NCT00274456|79476070|FG002|Overall Study|Withdrawal by Subject|9|||
44467306|NCT00274456|79476071|FG003|Overall Study|Withdrawal by Subject|13|||
44467307|NCT00364923|79476081|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
44467308|NCT00364923|79476081|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
44467309|NCT00381849|79476087|FG000|Wash Out|Withdrawal by Subject|0|||
44467310|NCT00381849|79476088|FG001|Wash Out|Withdrawal by Subject|1|||
44467311|NCT00273052|79476096|FG000|Overall Study|Withdrawal by Subject|16|||
44467312|NCT00273052|79476097|FG001|Overall Study|Withdrawal by Subject|19|||
44467313|NCT00273052|79476096|FG000|Overall Study|Adverse Event|21|||
44467314|NCT00273052|79476097|FG001|Overall Study|Adverse Event|19|||
44467315|NCT00273052|79476096|FG000|Overall Study|Protocol Violation|14|||
44467316|NCT00273052|79476097|FG001|Overall Study|Protocol Violation|18|||
44467317|NCT00273052|79476096|FG000|Overall Study|Lost to Follow-up|7|||
44467318|NCT00273052|79476097|FG001|Overall Study|Lost to Follow-up|25|||
44467319|NCT00273052|79476096|FG000|Overall Study|Lack of Efficacy|6|||
44467320|NCT00273052|79476097|FG001|Overall Study|Lack of Efficacy|4|||
44467321|NCT00273052|79476096|FG000|Overall Study|Non-Compliance|3|||
44467322|NCT00273052|79476097|FG001|Overall Study|Non-Compliance|1|||
44467323|NCT00273052|79476096|FG000|Overall Study|Other|2|||
44467324|NCT00273052|79476097|FG001|Overall Study|Other|0|||
44467325|NCT00273052|79476096|FG000|Overall Study|Worsening serum lipid levels|0|||
44467326|NCT00273052|79476097|FG001|Overall Study|Worsening serum lipid levels|2|||
44467327|NCT00290290|79476105|FG000|Overall Study|Death|3|||
44467328|NCT00290290|79476106|FG001|Overall Study|Death|4|||
44467329|NCT00290290|79476105|FG000|Overall Study|Withdrawal by Subject|2|||
44467330|NCT00290290|79476106|FG001|Overall Study|Withdrawal by Subject|2|||
44467331|NCT00290290|79476105|FG000|Overall Study|Underwent clean surgical procedure|13|||
44467332|NCT00290290|79476106|FG001|Overall Study|Underwent clean surgical procedure|12|||
44467333|NCT00272038|79476112|FG000|Overall Study|withdrew before they received 2 cycles|7|||
44467334|NCT00271024|79476121|FG000|Overall Study|Lost Interest|3|||
44467335|NCT00271024|79476122|FG001|Overall Study|Lost Interest|4|||
44375176|NCT00908037|79380268|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
44467336|NCT00271024|79476123|FG002|Overall Study|Lost Interest|2|||
44375177|NCT00904215|79380320|FG000|Overall Study|Adverse Event|25|||
44467337|NCT00271024|79476124|FG003|Overall Study|Lost Interest|3|||
44467338|NCT00271024|79476121|FG000|Overall Study|Unknown/Unspecified|11|||
44467339|NCT00271024|79476122|FG001|Overall Study|Unknown/Unspecified|11|||
44375178|NCT00904215|79380320|FG000|Overall Study|Protocol Violation|10|||
44375179|NCT00904215|79380320|FG000|Overall Study|Lost to Follow-up|63|||
44375180|NCT00904215|79380320|FG000|Overall Study|Withdrawal by Subject|9|||
44375181|NCT00904215|79380320|FG000|Overall Study|Other|28|||
44375182|NCT00905307|79380330|FG000|Overall Study|Switched to Open Label Rescue|7|||
44375183|NCT00905307|79380331|FG001|Overall Study|Switched to Open Label Rescue|17|||
44375184|NCT00905307|79380332|FG002|Overall Study|Switched to Open Label Rescue|11|||
44375185|NCT00905307|79380333|FG003|Overall Study|Switched to Open Label Rescue|11|||
44375186|NCT00905307|79380334|FG004|Overall Study|Switched to Open Label Rescue|4|||
44467340|NCT00271024|79476123|FG002|Overall Study|Unknown/Unspecified|8|||
44467341|NCT00271024|79476124|FG003|Overall Study|Unknown/Unspecified|4|||
44467342|NCT00271024|79476121|FG000|Overall Study|Protocol Violation|1|||
44467343|NCT00271024|79476122|FG001|Overall Study|Protocol Violation|6|||
44467344|NCT00271024|79476123|FG002|Overall Study|Protocol Violation|5|||
44467345|NCT00271024|79476124|FG003|Overall Study|Protocol Violation|11|||
44467346|NCT00271024|79476121|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
44467347|NCT00271024|79476122|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
44467348|NCT00271024|79476123|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
44467349|NCT00271024|79476124|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
44467350|NCT00271024|79476121|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
44467351|NCT00271024|79476122|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
44467352|NCT00271024|79476123|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
44467353|NCT00271024|79476124|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
44467354|NCT00381693|79476134|FG000|Overall Study|Death|1|||
44467355|NCT00381693|79476134|FG000|Overall Study|Adverse Event|4|||
44467356|NCT00381693|79476134|FG000|Overall Study|Patient Choice|1|||
44467357|NCT00381693|79476134|FG000|Overall Study|Progression|2|||
44467358|NCT00545363|79476140|FG000|Overall Study|Adverse Event|6|||
44467359|NCT00545363|79476141|FG001|Overall Study|Adverse Event|7|||
44467360|NCT00545363|79476140|FG000|Overall Study|Withdrawal by Subject|6|||
44467361|NCT00545363|79476141|FG001|Overall Study|Withdrawal by Subject|5|||
44467362|NCT00545363|79476140|FG000|Overall Study|Non-compliance|3|||
44467363|NCT00545363|79476141|FG001|Overall Study|Non-compliance|1|||
44467364|NCT00545363|79476140|FG000|Overall Study|Did not meet entry criteria|1|||
44467365|NCT00545363|79476141|FG001|Overall Study|Did not meet entry criteria|1|||
44467366|NCT00545363|79476140|FG000|Overall Study|Lost to Follow-up|2|||
44467367|NCT00545363|79476141|FG001|Overall Study|Lost to Follow-up|0|||
44467368|NCT00545363|79476140|FG000|Overall Study|Other|1|||
44467369|NCT00545363|79476141|FG001|Overall Study|Other|1|||
44467370|NCT00457392|79476149|FG000|Overall Study|Objective Progression or Relapse|229|||
44467371|NCT00457392|79476150|FG001|Overall Study|Objective Progression or Relapse|296|||
44467372|NCT00457392|79476149|FG000|Overall Study|Death|106|||
44467373|NCT00457392|79476150|FG001|Overall Study|Death|106|||
44467374|NCT00457392|79476149|FG000|Overall Study|Adverse Event|84|||
44467375|NCT00457392|79476150|FG001|Overall Study|Adverse Event|41|||
44467376|NCT00457392|79476149|FG000|Overall Study|Global Deterioration of Health Status|22|||
44467377|NCT00457392|79476150|FG001|Overall Study|Global Deterioration of Health Status|8|||
44467378|NCT00457392|79476149|FG000|Overall Study|Withdrawal by Subject|14|||
44467379|NCT00457392|79476150|FG001|Overall Study|Withdrawal by Subject|8|||
44467380|NCT00457392|79476149|FG000|Overall Study|Lost to Follow-up|6|||
44467381|NCT00457392|79476150|FG001|Overall Study|Lost to Follow-up|7|||
44467382|NCT00457392|79476149|FG000|Overall Study|Protocol Violation|4|||
44467383|NCT00457392|79476150|FG001|Overall Study|Protocol Violation|3|||
44467384|NCT00457392|79476149|FG000|Overall Study|Other|7|||
44467385|NCT00457392|79476150|FG001|Overall Study|Other|4|||
44467386|NCT00457392|79476149|FG000|Overall Study|Study Terminated by Sponsor|1|||
44467387|NCT00457392|79476150|FG001|Overall Study|Study Terminated by Sponsor|4|||
44467388|NCT00457392|79476149|FG000|Overall Study|Randomized, Not Treated|7|||
44467389|NCT00457392|79476150|FG001|Overall Study|Randomized, Not Treated|3|||
44467390|NCT00545051|79476158|FG000|Overall Study|Adverse Event|7|||
44467391|NCT00545051|79476159|FG001|Overall Study|Adverse Event|3|||
44467392|NCT00545051|79476158|FG000|Overall Study|Death|1|||
44467393|NCT00545051|79476159|FG001|Overall Study|Death|0|||
44467394|NCT00545051|79476158|FG000|Overall Study|Violation of inclusion/exclusion|0|||
44467395|NCT00545051|79476159|FG001|Overall Study|Violation of inclusion/exclusion|2|||
44467396|NCT00545051|79476158|FG000|Overall Study|Protocol Violation|1|||
44467397|NCT00545051|79476159|FG001|Overall Study|Protocol Violation|0|||
44223801|NCT01827384|79027334|FG004|Overall Study|Switched to alternative treatment|0|||
44223802|NCT01827384|79027335|FG005|Overall Study|Switched to alternative treatment|0|||
44223803|NCT01827384|79027336|FG006|Overall Study|Switched to alternative treatment|0|||
44223804|NCT01827384|79027337|FG007|Overall Study|Switched to alternative treatment|0|||
44223805|NCT01827384|79027338|FG008|Overall Study|Switched to alternative treatment|0|||
44223806|NCT01827384|79027339|FG009|Overall Study|Switched to alternative treatment|0|||
44467398|NCT00545051|79476158|FG000|Overall Study|Withdrawal by Subject|0|||
44467399|NCT00545051|79476159|FG001|Overall Study|Withdrawal by Subject|1|||
44467400|NCT00545051|79476158|FG000|Overall Study|Administrative reasons|0|||
44467401|NCT00545051|79476159|FG001|Overall Study|Administrative reasons|1|||
44467402|NCT00381615|79476169|FG000|Overall Study|Withdrawal by Subject|1|||
44467403|NCT00381615|79476170|FG001|Overall Study|Withdrawal by Subject|3|||
44467404|NCT00381615|79476171|FG002|Overall Study|Withdrawal by Subject|0|||
44514817|NCT03084796|79520625|FG002|Overall Study|Randomization error|1|||
44467405|NCT00381615|79476172|FG003|Overall Study|Withdrawal by Subject|1|||
44273445|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
44273446|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
44273447|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
44273448|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
44273449|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
44273450|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
44273451|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
44467406|NCT00381615|79476169|FG000|Overall Study|Lost to Follow-up|3|||
44467407|NCT00381615|79476170|FG001|Overall Study|Lost to Follow-up|2|||
44467408|NCT00381615|79476171|FG002|Overall Study|Lost to Follow-up|0|||
44467409|NCT00381615|79476172|FG003|Overall Study|Lost to Follow-up|1|||
44467410|NCT00381615|79476169|FG000|Overall Study|Protocol Violation|0|||
44467411|NCT00381615|79476170|FG001|Overall Study|Protocol Violation|0|||
44467412|NCT00381615|79476171|FG002|Overall Study|Protocol Violation|1|||
44467413|NCT00381615|79476172|FG003|Overall Study|Protocol Violation|0|||
44467414|NCT00371865|79476186|FG000|Overall Study|Lack of Efficacy|0|||
44467415|NCT00371865|79476187|FG001|Overall Study|Lack of Efficacy|2|||
44467416|NCT00371865|79476186|FG000|Overall Study|Protocol Violation|3|||
44467417|NCT00371865|79476187|FG001|Overall Study|Protocol Violation|2|||
44467418|NCT00371865|79476186|FG000|Overall Study|Withdrawal by Subject|12|||
44467419|NCT00371865|79476187|FG001|Overall Study|Withdrawal by Subject|10|||
44467420|NCT00364845|79476195|FG000|Overall Study|Adverse Event|1|||
44467421|NCT00364845|79476196|FG001|Overall Study|Adverse Event|0|||
44467422|NCT00364845|79476195|FG000|Overall Study|Withdrawal by Subject|2|||
44467423|NCT00364845|79476196|FG001|Overall Study|Withdrawal by Subject|1|||
44467424|NCT00364845|79476195|FG000|Overall Study|Physician Decision|8|||
44467425|NCT00364845|79476196|FG001|Overall Study|Physician Decision|8|||
44467426|NCT00364845|79476195|FG000|Overall Study|Lost to Follow-up|0|||
44467427|NCT00364845|79476196|FG001|Overall Study|Lost to Follow-up|1|||
44467428|NCT00364845|79476195|FG000|Overall Study|Death|0|||
44467429|NCT00364845|79476196|FG001|Overall Study|Death|1|||
44467430|NCT00293722|79476202|FG000|Overall Study|Other|427|||
44467431|NCT00381303|79476208|FG000|Overall Study|Lost to Follow-up|25|||
44467432|NCT00381303|79476209|FG001|Overall Study|Lost to Follow-up|9|||
44467433|NCT00381303|79476208|FG000|Overall Study|AE/HIV-related event|22|||
44467434|NCT00381303|79476209|FG001|Overall Study|AE/HIV-related event|6|||
44467435|NCT00381303|79476208|FG000|Overall Study|Non-Adherence|13|||
44467436|NCT00381303|79476209|FG001|Overall Study|Non-Adherence|6|||
44467437|NCT00381303|79476208|FG000|Overall Study|Withdrawal by Subject|13|||
44467438|NCT00381303|79476209|FG001|Overall Study|Withdrawal by Subject|6|||
44467439|NCT00381303|79476208|FG000|Overall Study|Virologic failure|6|||
44467440|NCT00381303|79476209|FG001|Overall Study|Virologic failure|4|||
44467441|NCT00381303|79476208|FG000|Overall Study|Ineligible to continue the trial|2|||
44467442|NCT00381303|79476209|FG001|Overall Study|Ineligible to continue the trial|1|||
44467443|NCT00381303|79476208|FG000|Overall Study|Pregnancy|2|||
44467444|NCT00381303|79476209|FG001|Overall Study|Pregnancy|0|||
44467445|NCT00381303|79476208|FG000|Overall Study|Physician Decision|1|||
44467446|NCT00381303|79476209|FG001|Overall Study|Physician Decision|0|||
44467447|NCT00381303|79476208|FG000|Overall Study|Physician's decision to close the site|3|||
44467448|NCT00381303|79476209|FG001|Overall Study|Physician's decision to close the site|1|||
44467449|NCT00381303|79476208|FG000|Overall Study|Subject moved out of state|2|||
44544439|NCT03197376|79557827|FG001|Primary and Booster Phase|Physician Decision|0|||
44544440|NCT03197376|79557828|FG002|Primary and Booster Phase|Physician Decision|1|||
44544441|NCT03197376|79557829|FG003|Primary and Booster Phase|Physician Decision|3|||
44544442|NCT03197376|79557826|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
44544443|NCT03197376|79557827|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
44544444|NCT03197376|79557828|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
44544445|NCT03197376|79557829|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
44223807|NCT01827384|79027340|FG010|Overall Study|Switched to alternative treatment|0|||
44223808|NCT01827384|79027341|FG011|Overall Study|Switched to alternative treatment|0|||
44223809|NCT01827384|79027342|FG012|Overall Study|Switched to alternative treatment|0|||
44223810|NCT01827384|79027343|FG013|Overall Study|Switched to alternative treatment|2|||
44223811|NCT01827384|79027330|FG000|Overall Study|Disease progression before treatment|0|||
44223812|NCT01827384|79027331|FG001|Overall Study|Disease progression before treatment|0|||
44223813|NCT01827384|79027332|FG002|Overall Study|Disease progression before treatment|0|||
44223814|NCT01827384|79027333|FG003|Overall Study|Disease progression before treatment|0|||
44223815|NCT01827384|79027334|FG004|Overall Study|Disease progression before treatment|0|||
44273452|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
44273453|NCT01898494|79215147|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
44467450|NCT00381303|79476209|FG001|Overall Study|Subject moved out of state|0|||
44467451|NCT00381303|79476208|FG000|Overall Study|Subject taking too many different meds|1|||
44467452|NCT00381303|79476209|FG001|Overall Study|Subject taking too many different meds|0|||
44467453|NCT00381303|79476208|FG000|Overall Study|No virologic response by week 12|1|||
44467454|NCT00381303|79476209|FG001|Overall Study|No virologic response by week 12|0|||
44467455|NCT00381303|79476208|FG000|Overall Study|Subject was too busy for appointments|1|||
44467456|NCT00381303|79476209|FG001|Overall Study|Subject was too busy for appointments|0|||
44467457|NCT00381303|79476208|FG000|Overall Study|Subject did not continue visits|1|||
44467458|NCT00381303|79476209|FG001|Overall Study|Subject did not continue visits|0|||
44467459|NCT00381303|79476208|FG000|Overall Study|Subject primary physician's decision|1|||
44467460|NCT00381303|79476209|FG001|Overall Study|Subject primary physician's decision|0|||
44467461|NCT00448812|79476229|FG000|Year 2|Missed visit but remained in study|4|||
44467462|NCT00448812|79476230|FG001|Year 2|Missed visit but remained in study|1|||
44467463|NCT00448812|79476229|FG000|Year 3|Withdrawal by Subject|1|||
44467464|NCT00448812|79476230|FG001|Year 3|Withdrawal by Subject|3|||
44467465|NCT00448812|79476229|FG000|Year 3|Lost to Follow-up|1|||
44467466|NCT00448812|79476230|FG001|Year 3|Lost to Follow-up|0|||
44467467|NCT00448812|79476229|FG000|Year 3|Missed visit but remained in study|2|||
44273454|NCT01898494|79215148|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
44273455|NCT01898494|79215149|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
44273456|NCT01898494|79215150|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
44223816|NCT01827384|79027335|FG005|Overall Study|Disease progression before treatment|0|||
44223817|NCT01827384|79027336|FG006|Overall Study|Disease progression before treatment|0|||
44223818|NCT01827384|79027337|FG007|Overall Study|Disease progression before treatment|0|||
44223819|NCT01827384|79027338|FG008|Overall Study|Disease progression before treatment|0|||
44223820|NCT01827384|79027339|FG009|Overall Study|Disease progression before treatment|0|||
44223821|NCT01827384|79027340|FG010|Overall Study|Disease progression before treatment|0|||
44273457|NCT01898494|79215151|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
44273458|NCT01898494|79215147|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
44273459|NCT01898494|79215148|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
44273460|NCT01898494|79215149|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
44467468|NCT00448812|79476230|FG001|Year 3|Missed visit but remained in study|0|||
44467469|NCT00448812|79476229|FG000|Year 5|Missed visit but remained in study|1|||
44467470|NCT00448812|79476230|FG001|Year 5|Missed visit but remained in study|0|||
44467471|NCT00364689|79476251|FG000|Overall Study|Lost to Follow-up|1|||
44467472|NCT00545129|79476259|FG000|Overall Study|Lack of Efficacy|2|||
44467473|NCT00545129|79476260|FG001|Overall Study|Lack of Efficacy|5|||
44467474|NCT00545129|79476259|FG000|Overall Study|Death|2|||
44467475|NCT00545129|79476260|FG001|Overall Study|Death|1|||
44467476|NCT00545129|79476259|FG000|Overall Study|Adverse Event|1|||
44467477|NCT00545129|79476260|FG001|Overall Study|Adverse Event|1|||
44467478|NCT00545129|79476259|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
44467479|NCT00545129|79476260|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
44467480|NCT00545129|79476259|FG000|Overall Study|Other|3|||
44467481|NCT00545129|79476260|FG001|Overall Study|Other|3|||
44467482|NCT00364611|79476268|FG000|Overall Study|Did not receive study medication|0|||
44467483|NCT00364611|79476269|FG001|Overall Study|Did not receive study medication|1|||
44467484|NCT00364611|79476268|FG000|Overall Study|Adverse Event|7|||
44467485|NCT00364611|79476269|FG001|Overall Study|Adverse Event|4|||
44467486|NCT00364611|79476268|FG000|Overall Study|Participant's Request|3|||
44467487|NCT00364611|79476269|FG001|Overall Study|Participant's Request|4|||
44467488|NCT00364611|79476268|FG000|Overall Study|Disease Progression|38|||
44467489|NCT00364611|79476269|FG001|Overall Study|Disease Progression|8|||
44467490|NCT00364611|79476268|FG000|Overall Study|Investigator decision|2|||
44467491|NCT00364611|79476269|FG001|Overall Study|Investigator decision|2|||
44467492|NCT00364611|79476268|FG000|Overall Study|Found Ineligible|1|||
44467493|NCT00364611|79476269|FG001|Overall Study|Found Ineligible|0|||
44467494|NCT00364611|79476268|FG000|Overall Study|Presumed CR on Study|0|||
44467495|NCT00364611|79476269|FG001|Overall Study|Presumed CR on Study|1|||
44467496|NCT00364611|79476268|FG000|Overall Study|Receiving Liver Ablation|0|||
44467497|NCT00364611|79476269|FG001|Overall Study|Receiving Liver Ablation|1|||
44467498|NCT00364533|79476280|FG000|Overall Study|Adverse Event|8|||
44467499|NCT00364533|79476281|FG001|Overall Study|Adverse Event|7|||
44467500|NCT00364533|79476282|FG002|Overall Study|Adverse Event|15|||
44223822|NCT01827384|79027341|FG011|Overall Study|Disease progression before treatment|0|||
44223823|NCT01827384|79027342|FG012|Overall Study|Disease progression before treatment|0|||
44223824|NCT01827384|79027343|FG013|Overall Study|Disease progression before treatment|4|||
44223825|NCT01827384|79027330|FG000|Overall Study|Ineligible|0|||
44223826|NCT01827384|79027331|FG001|Overall Study|Ineligible|0|||
44273461|NCT01898494|79215150|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
44467501|NCT00364533|79476283|FG003|Overall Study|Adverse Event|5|||
44467502|NCT00364533|79476284|FG004|Overall Study|Adverse Event|2|||
44467503|NCT00364533|79476280|FG000|Overall Study|Withdrawal by Subject|4|||
44467504|NCT00364533|79476281|FG001|Overall Study|Withdrawal by Subject|8|||
44467505|NCT00364533|79476282|FG002|Overall Study|Withdrawal by Subject|6|||
44467506|NCT00364533|79476283|FG003|Overall Study|Withdrawal by Subject|6|||
44467507|NCT00364533|79476284|FG004|Overall Study|Withdrawal by Subject|6|||
44467508|NCT00364533|79476280|FG000|Overall Study|Lack of Efficacy|22|||
44467509|NCT00364533|79476281|FG001|Overall Study|Lack of Efficacy|22|||
44467510|NCT00364533|79476282|FG002|Overall Study|Lack of Efficacy|21|||
44467511|NCT00364533|79476283|FG003|Overall Study|Lack of Efficacy|17|||
44467512|NCT00364533|79476284|FG004|Overall Study|Lack of Efficacy|42|||
44467513|NCT00364533|79476280|FG000|Overall Study|Subject discharged from hospital|4|||
44467514|NCT00364533|79476281|FG001|Overall Study|Subject discharged from hospital|1|||
44467515|NCT00364533|79476282|FG002|Overall Study|Subject discharged from hospital|2|||
44467516|NCT00364533|79476283|FG003|Overall Study|Subject discharged from hospital|3|||
44467517|NCT00364533|79476284|FG004|Overall Study|Subject discharged from hospital|1|||
44467518|NCT00364533|79476280|FG000|Overall Study|Variations in drug compliance|2|||
44467519|NCT00364533|79476281|FG001|Overall Study|Variations in drug compliance|1|||
44467520|NCT00364533|79476282|FG002|Overall Study|Variations in drug compliance|1|||
44467521|NCT00364533|79476283|FG003|Overall Study|Variations in drug compliance|0|||
44467522|NCT00364533|79476284|FG004|Overall Study|Variations in drug compliance|0|||
44467523|NCT00364533|79476280|FG000|Overall Study|Non-compliance|1|||
44467524|NCT00364533|79476281|FG001|Overall Study|Non-compliance|0|||
44467525|NCT00364533|79476282|FG002|Overall Study|Non-compliance|0|||
44467526|NCT00364533|79476283|FG003|Overall Study|Non-compliance|0|||
44467527|NCT00364533|79476284|FG004|Overall Study|Non-compliance|0|||
44467528|NCT00364533|79476280|FG000|Overall Study|Protocol Violation|1|||
44467529|NCT00364533|79476281|FG001|Overall Study|Protocol Violation|1|||
44467530|NCT00364533|79476282|FG002|Overall Study|Protocol Violation|0|||
44467531|NCT00364533|79476283|FG003|Overall Study|Protocol Violation|0|||
44223827|NCT01827384|79027332|FG002|Overall Study|Ineligible|0|||
44223828|NCT01827384|79027333|FG003|Overall Study|Ineligible|0|||
44223829|NCT01827384|79027334|FG004|Overall Study|Ineligible|0|||
44223830|NCT01827384|79027335|FG005|Overall Study|Ineligible|0|||
44223831|NCT01827384|79027336|FG006|Overall Study|Ineligible|0|||
44223832|NCT01827384|79027337|FG007|Overall Study|Ineligible|0|||
44273462|NCT01898494|79215151|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
44273463|NCT01898494|79215147|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
44273464|NCT01898494|79215148|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
44273465|NCT01898494|79215149|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
44467532|NCT00364533|79476284|FG004|Overall Study|Protocol Violation|0|||
44467533|NCT04006847|79476296|FG000|Overall Study|Product issue|1|||
44467534|NCT00544817|79476300|FG000|Combined Modality|Lack of Efficacy|2|||
44467535|NCT00544817|79476300|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
44467536|NCT00544817|79476300|FG000|Combined Modality|Adverse Event|2|||
44467537|NCT00544817|79476300|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
44467538|NCT00544817|79476300|FG000|No Treatment Interval|Lack of Efficacy|8|||
44467539|NCT00544817|79476300|FG000|No Treatment Interval|Physician Decision|3|||
44467540|NCT00544817|79476300|FG000|No Treatment Interval|Adverse Event|1|||
44467541|NCT00544817|79476300|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
44467542|NCT00544817|79476300|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
44467543|NCT00544817|79476300|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
44467544|NCT00289978|79476307|FG000|Overall Study|Withdrawal by Subject|31|||
44467545|NCT00289978|79476308|FG001|Overall Study|Withdrawal by Subject|17|||
44467546|NCT00289978|79476309|FG002|Overall Study|Withdrawal by Subject|28|||
44467547|NCT00289978|79476307|FG000|Overall Study|Adverse Event|22|||
44467548|NCT00289978|79476308|FG001|Overall Study|Adverse Event|13|||
44467549|NCT00289978|79476309|FG002|Overall Study|Adverse Event|18|||
44467550|NCT00289978|79476307|FG000|Overall Study|Lack of Efficacy|13|||
44467551|NCT00289978|79476308|FG001|Overall Study|Lack of Efficacy|6|||
44467552|NCT00289978|79476309|FG002|Overall Study|Lack of Efficacy|25|||
44467553|NCT00289978|79476307|FG000|Overall Study|Abnormal laboratory value(s)|20|||
44467554|NCT00289978|79476308|FG001|Overall Study|Abnormal laboratory value(s)|9|||
44467555|NCT00289978|79476309|FG002|Overall Study|Abnormal laboratory value(s)|1|||
44467556|NCT00289978|79476307|FG000|Overall Study|Lost to Follow-up|3|||
44467557|NCT00289978|79476308|FG001|Overall Study|Lost to Follow-up|5|||
44467558|NCT00289978|79476309|FG002|Overall Study|Lost to Follow-up|7|||
44273466|NCT01898494|79215150|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
44273467|NCT01898494|79215151|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
44273468|NCT01898494|79215147|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
44467559|NCT00289978|79476307|FG000|Overall Study|Protocol Violation|5|||
44467560|NCT00289978|79476308|FG001|Overall Study|Protocol Violation|5|||
44223833|NCT01827384|79027338|FG008|Overall Study|Ineligible|0|||
44223834|NCT01827384|79027339|FG009|Overall Study|Ineligible|0|||
44467561|NCT00289978|79476309|FG002|Overall Study|Protocol Violation|4|||
44467562|NCT00289978|79476307|FG000|Overall Study|Abnormal test procedure result(s)|2|||
44223835|NCT01827384|79027340|FG010|Overall Study|Ineligible|0|||
44223836|NCT01827384|79027341|FG011|Overall Study|Ineligible|0|||
44273469|NCT01898494|79215148|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
44467563|NCT00289978|79476308|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44467564|NCT00289978|79476309|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44467565|NCT00289978|79476307|FG000|Overall Study|Death|1|||
44467566|NCT00289978|79476308|FG001|Overall Study|Death|0|||
44467567|NCT00289978|79476309|FG002|Overall Study|Death|2|||
44467568|NCT00543803|79476317|FG000|Overall Study|Adverse Event|14|||
44467569|NCT00543803|79476317|FG000|Overall Study|Lack of Efficacy|22|||
44467570|NCT00543803|79476317|FG000|Overall Study|Lost to Follow-up|20|||
44467571|NCT00543803|79476317|FG000|Overall Study|Other|86|||
44467572|NCT00542321|79476325|FG000|Overall Study|Death|0|||
44467573|NCT00542321|79476326|FG001|Overall Study|Death|1|||
44467574|NCT00289900|79476338|FG000|Overall Study|Adverse Event|28|||
44467575|NCT00289900|79476339|FG001|Overall Study|Adverse Event|40|||
44544446|NCT03197376|79557826|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
44544447|NCT03197376|79557827|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
44223837|NCT01827384|79027342|FG012|Overall Study|Ineligible|0|||
44223838|NCT01827384|79027343|FG013|Overall Study|Ineligible|19|||
44223839|NCT01827384|79027330|FG000|Overall Study|Participant died before treatment|0|||
44223840|NCT01827384|79027331|FG001|Overall Study|Participant died before treatment|0|||
44223841|NCT01827384|79027332|FG002|Overall Study|Participant died before treatment|0|||
44223842|NCT01827384|79027333|FG003|Overall Study|Participant died before treatment|0|||
44223843|NCT01827384|79027334|FG004|Overall Study|Participant died before treatment|0|||
44223844|NCT01827384|79027335|FG005|Overall Study|Participant died before treatment|0|||
44223845|NCT01827384|79027336|FG006|Overall Study|Participant died before treatment|0|||
44223846|NCT01827384|79027337|FG007|Overall Study|Participant died before treatment|0|||
44223847|NCT01827384|79027338|FG008|Overall Study|Participant died before treatment|0|||
44223848|NCT01827384|79027339|FG009|Overall Study|Participant died before treatment|0|||
44223849|NCT01827384|79027340|FG010|Overall Study|Participant died before treatment|0|||
44223850|NCT01827384|79027341|FG011|Overall Study|Participant died before treatment|0|||
44223851|NCT01827384|79027342|FG012|Overall Study|Participant died before treatment|0|||
44223852|NCT01827384|79027343|FG013|Overall Study|Participant died before treatment|5|||
44223853|NCT01827384|79027330|FG000|Overall Study|Insufficient tumor cells|0|||
44223854|NCT01827384|79027331|FG001|Overall Study|Insufficient tumor cells|0|||
44223855|NCT01827384|79027332|FG002|Overall Study|Insufficient tumor cells|0|||
44223856|NCT01827384|79027333|FG003|Overall Study|Insufficient tumor cells|0|||
44223857|NCT01827384|79027334|FG004|Overall Study|Insufficient tumor cells|0|||
44223858|NCT01827384|79027335|FG005|Overall Study|Insufficient tumor cells|0|||
44223859|NCT01827384|79027336|FG006|Overall Study|Insufficient tumor cells|0|||
44223860|NCT01827384|79027337|FG007|Overall Study|Insufficient tumor cells|0|||
44223861|NCT01827384|79027338|FG008|Overall Study|Insufficient tumor cells|0|||
44223862|NCT01827384|79027339|FG009|Overall Study|Insufficient tumor cells|0|||
44223863|NCT01827384|79027340|FG010|Overall Study|Insufficient tumor cells|0|||
44223864|NCT01827384|79027341|FG011|Overall Study|Insufficient tumor cells|0|||
44223865|NCT01827384|79027342|FG012|Overall Study|Insufficient tumor cells|0|||
44223866|NCT01827384|79027343|FG013|Overall Study|Insufficient tumor cells|13|||
44223867|NCT01827384|79027330|FG000|Overall Study|No actionable mutation|0|||
44223868|NCT01827384|79027331|FG001|Overall Study|No actionable mutation|0|||
44223869|NCT01827384|79027332|FG002|Overall Study|No actionable mutation|0|||
44223870|NCT01827384|79027333|FG003|Overall Study|No actionable mutation|0|||
44223871|NCT01827384|79027334|FG004|Overall Study|No actionable mutation|0|||
44223872|NCT01827384|79027335|FG005|Overall Study|No actionable mutation|0|||
44223873|NCT01827384|79027336|FG006|Overall Study|No actionable mutation|0|||
44223874|NCT01827384|79027337|FG007|Overall Study|No actionable mutation|0|||
44223875|NCT01827384|79027338|FG008|Overall Study|No actionable mutation|0|||
44223876|NCT01827384|79027339|FG009|Overall Study|No actionable mutation|0|||
44223877|NCT01827384|79027340|FG010|Overall Study|No actionable mutation|0|||
44223878|NCT01827384|79027341|FG011|Overall Study|No actionable mutation|0|||
44223879|NCT01827384|79027342|FG012|Overall Study|No actionable mutation|0|||
44223880|NCT01827384|79027343|FG013|Overall Study|No actionable mutation|73|||
44223881|NCT01827384|79027330|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
44223882|NCT01827384|79027331|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
44223883|NCT01827384|79027332|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
44223884|NCT01827384|79027333|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
44223885|NCT01827384|79027334|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
44223886|NCT01827384|79027335|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
44223887|NCT01827384|79027336|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
44223888|NCT01827384|79027337|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
44375187|NCT00905307|79380335|FG005|Overall Study|Switched to Open Label Rescue|15|||
44375188|NCT00905307|79380330|FG000|Overall Study|Lost to Follow-up|0|||
44375189|NCT00905307|79380331|FG001|Overall Study|Lost to Follow-up|0|||
44375190|NCT00905307|79380332|FG002|Overall Study|Lost to Follow-up|0|||
44375191|NCT00905307|79380333|FG003|Overall Study|Lost to Follow-up|0|||
44375192|NCT00905307|79380334|FG004|Overall Study|Lost to Follow-up|1|||
44375193|NCT00905307|79380335|FG005|Overall Study|Lost to Follow-up|1|||
44375194|NCT00905307|79380330|FG000|Overall Study|Adverse Event|3|||
44375195|NCT00905307|79380331|FG001|Overall Study|Adverse Event|4|||
44467576|NCT00289900|79476340|FG002|Overall Study|Adverse Event|13|||
44467577|NCT00289900|79476341|FG003|Overall Study|Adverse Event|19|||
44223889|NCT01827384|79027338|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
44223890|NCT01827384|79027339|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
44223891|NCT01827384|79027340|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
44223892|NCT01827384|79027341|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
44223893|NCT01827384|79027342|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
44223894|NCT01827384|79027343|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
44223895|NCT01585194|79027378|FG000|Overall Study|Withdrawal by Subject|1|||
44223896|NCT01585194|79027378|FG000|Overall Study|Physician Decision|2|||
44223897|NCT01585194|79027378|FG000|Overall Study|Lack of insurance|1|||
44273470|NCT01898494|79215149|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
44273471|NCT01898494|79215150|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
44273472|NCT01898494|79215151|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
44273473|NCT01898494|79215147|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
44273474|NCT01898494|79215148|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
44273475|NCT01898494|79215149|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
44273476|NCT01898494|79215150|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
44273477|NCT01898494|79215151|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
44273478|NCT01898494|79215147|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
44273479|NCT01898494|79215148|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
44273480|NCT01898494|79215149|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
44273481|NCT01898494|79215150|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
44273482|NCT01898494|79215151|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
44273483|NCT01898494|79215147|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
44273484|NCT01898494|79215148|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
44273485|NCT01898494|79215149|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
44273486|NCT01898494|79215150|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
44273487|NCT01898494|79215151|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
44273488|NCT01863043|79215165|FG000|Overall Study|Death|6|||
44273489|NCT01863043|79215166|FG001|Overall Study|Death|1|||
44273490|NCT01863043|79215165|FG000|Overall Study|Withdrawal by Subject|0|||
44273491|NCT01863043|79215166|FG001|Overall Study|Withdrawal by Subject|2|||
44273492|NCT01863043|79215165|FG000|Overall Study|Adverse Event|7|||
44223898|NCT01377389|79027382|FG000|Overall Study|Withdrawal by Subject|1|||
44223899|NCT01377389|79027382|FG000|Overall Study|Screen failure|2|||
44273493|NCT01863043|79215166|FG001|Overall Study|Adverse Event|8|||
44273494|NCT01863043|79215165|FG000|Overall Study|exclusion criteria found after enrollment|0|||
44273495|NCT01863043|79215166|FG001|Overall Study|exclusion criteria found after enrollment|1|||
44273496|NCT01841359|79215172|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
44273497|NCT01841359|79215172|FG000|Overall Study|Concommitant medical issues|2|||
44273498|NCT01841359|79215172|FG000|Overall Study|Adverse Event|3|||
44273499|NCT01841359|79215172|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
44223900|NCT01287611|79027388|FG000|Overall Study|Lost to Follow-up|29|||
44223901|NCT01287611|79027389|FG001|Overall Study|Lost to Follow-up|16|||
44223902|NCT01287611|79027388|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
44223903|NCT01287611|79027389|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
44223904|NCT01194271|79027397|FG000|Overall Study|Withdrawal by Subject|1|||
44223905|NCT01194271|79027397|FG000|Overall Study|Ineligible, Screen Failure|1|||
44467578|NCT00289900|79476342|FG004|Overall Study|Adverse Event|20|||
44467579|NCT00289900|79476343|FG005|Overall Study|Adverse Event|33|||
44467580|NCT00289900|79476338|FG000|Overall Study|Lost to Follow-up|7|||
44467581|NCT00289900|79476339|FG001|Overall Study|Lost to Follow-up|7|||
44467582|NCT00289900|79476340|FG002|Overall Study|Lost to Follow-up|8|||
44467583|NCT00289900|79476341|FG003|Overall Study|Lost to Follow-up|8|||
44467584|NCT00289900|79476342|FG004|Overall Study|Lost to Follow-up|4|||
44273500|NCT01660451|79215182|FG000|Overall Study|Protocol Violation|0|||
44273501|NCT01660451|79215183|FG001|Overall Study|Protocol Violation|1|||
44467585|NCT00289900|79476343|FG005|Overall Study|Lost to Follow-up|8|||
44467586|NCT00289900|79476338|FG000|Overall Study|Participant had flushing|18|||
44223906|NCT01194271|79027397|FG000|Overall Study|Death|1|||
44223907|NCT01119508|79027412|FG000|Overall Study|Adverse Event|56|||
44223908|NCT01119508|79027412|FG000|Overall Study|Withdrawal by Subject|2|||
44467587|NCT00289900|79476339|FG001|Overall Study|Participant had flushing|42|||
44467588|NCT00289900|79476340|FG002|Overall Study|Participant had flushing|1|||
44273502|NCT01660451|79215184|FG002|Overall Study|Protocol Violation|1|||
44273503|NCT01660451|79215182|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
44273504|NCT01660451|79215183|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
44467589|NCT00289900|79476341|FG003|Overall Study|Participant had flushing|2|||
44467590|NCT00289900|79476342|FG004|Overall Study|Participant had flushing|0|||
44467591|NCT00289900|79476343|FG005|Overall Study|Participant had flushing|4|||
44467592|NCT00289900|79476338|FG000|Overall Study|Other|0|||
44223909|NCT01119508|79027412|FG000|Overall Study|Died before tumor response evaluation|1|||
44223910|NCT00754338|79027424|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
44467593|NCT00289900|79476339|FG001|Overall Study|Other|0|||
44467594|NCT00289900|79476340|FG002|Overall Study|Other|0|||
44467595|NCT00289900|79476341|FG003|Overall Study|Other|5|||
44467596|NCT00289900|79476342|FG004|Overall Study|Other|1|||
44467597|NCT00289900|79476343|FG005|Overall Study|Other|0|||
44467598|NCT00289900|79476338|FG000|Overall Study|Participant moved|1|||
44467599|NCT00289900|79476339|FG001|Overall Study|Participant moved|0|||
44467600|NCT00289900|79476340|FG002|Overall Study|Participant moved|0|||
44467601|NCT00289900|79476341|FG003|Overall Study|Participant moved|1|||
44467602|NCT00289900|79476342|FG004|Overall Study|Participant moved|1|||
44467603|NCT00289900|79476343|FG005|Overall Study|Participant moved|1|||
44467604|NCT00289900|79476338|FG000|Overall Study|Withdrawal by Subject|10|||
44467605|NCT00289900|79476339|FG001|Overall Study|Withdrawal by Subject|21|||
44467606|NCT00289900|79476340|FG002|Overall Study|Withdrawal by Subject|8|||
44467607|NCT00289900|79476341|FG003|Overall Study|Withdrawal by Subject|18|||
44467608|NCT00289900|79476342|FG004|Overall Study|Withdrawal by Subject|12|||
44467609|NCT00289900|79476343|FG005|Overall Study|Withdrawal by Subject|11|||
44467610|NCT00289900|79476338|FG000|Overall Study|Protocol Violation|3|||
44467611|NCT00289900|79476339|FG001|Overall Study|Protocol Violation|9|||
44467612|NCT00289900|79476340|FG002|Overall Study|Protocol Violation|2|||
44467613|NCT00289900|79476341|FG003|Overall Study|Protocol Violation|6|||
44467614|NCT00289900|79476342|FG004|Overall Study|Protocol Violation|7|||
44467615|NCT00289900|79476343|FG005|Overall Study|Protocol Violation|4|||
44467616|NCT00289900|79476338|FG000|Overall Study|site terminated|1|||
44467617|NCT00289900|79476339|FG001|Overall Study|site terminated|0|||
44467618|NCT00289900|79476340|FG002|Overall Study|site terminated|1|||
44467619|NCT00289900|79476341|FG003|Overall Study|site terminated|0|||
44467620|NCT00289900|79476342|FG004|Overall Study|site terminated|0|||
44467621|NCT00289900|79476343|FG005|Overall Study|site terminated|0|||
44467622|NCT00289900|79476338|FG000|Overall Study|Not treated|0|||
44467623|NCT00289900|79476339|FG001|Overall Study|Not treated|1|||
44467624|NCT00289900|79476340|FG002|Overall Study|Not treated|0|||
44467625|NCT00289900|79476341|FG003|Overall Study|Not treated|0|||
44467626|NCT00289900|79476342|FG004|Overall Study|Not treated|0|||
44467627|NCT00289900|79476343|FG005|Overall Study|Not treated|0|||
44467628|NCT00543725|79476362|FG000|Overall Study|Adverse Event|18|||
44467629|NCT00543725|79476363|FG001|Overall Study|Adverse Event|27|||
44467630|NCT00543725|79476362|FG000|Overall Study|Sponsor's Decision|0|||
44467631|NCT00543725|79476363|FG001|Overall Study|Sponsor's Decision|1|||
44467632|NCT00543725|79476362|FG000|Overall Study|Subject Non-Compliant|4|||
44273505|NCT01660451|79215184|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
44273506|NCT01660451|79215182|FG000|Overall Study|AE with Clinical PD|1|||
44273507|NCT01660451|79215183|FG001|Overall Study|AE with Clinical PD|3|||
44273508|NCT01660451|79215184|FG002|Overall Study|AE with Clinical PD|9|||
44467633|NCT00543725|79476363|FG001|Overall Study|Subject Non-Compliant|4|||
44223911|NCT00754338|79027425|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
44223912|NCT00754338|79027426|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
44223913|NCT00754338|79027427|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
44223914|NCT00754338|79027424|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
44223915|NCT00754338|79027425|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
44223916|NCT00754338|79027426|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
44223917|NCT00754338|79027427|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
44273509|NCT01660451|79215182|FG000|Overall Study|Sponsor Decision|0|||
44273510|NCT01660451|79215183|FG001|Overall Study|Sponsor Decision|0|||
44273511|NCT01660451|79215184|FG002|Overall Study|Sponsor Decision|1|||
44273512|NCT01660451|79215182|FG000|Overall Study|Protocol Deviation|0|||
44375196|NCT00905307|79380332|FG002|Overall Study|Adverse Event|5|||
44375197|NCT00905307|79380333|FG003|Overall Study|Adverse Event|11|||
44375198|NCT00905307|79380334|FG004|Overall Study|Adverse Event|3|||
44375199|NCT00905307|79380335|FG005|Overall Study|Adverse Event|5|||
44375200|NCT00905307|79380330|FG000|Overall Study|Withdrawal by Subject|5|||
44375201|NCT00905307|79380331|FG001|Overall Study|Withdrawal by Subject|13|||
44375202|NCT00905307|79380332|FG002|Overall Study|Withdrawal by Subject|15|||
44375203|NCT00905307|79380333|FG003|Overall Study|Withdrawal by Subject|11|||
44375204|NCT00905307|79380334|FG004|Overall Study|Withdrawal by Subject|4|||
44375205|NCT00905307|79380335|FG005|Overall Study|Withdrawal by Subject|13|||
44375206|NCT00905307|79380330|FG000|Overall Study|Protocol Violation|1|||
44375207|NCT00905307|79380331|FG001|Overall Study|Protocol Violation|0|||
44375208|NCT00905307|79380332|FG002|Overall Study|Protocol Violation|1|||
44375209|NCT00905307|79380333|FG003|Overall Study|Protocol Violation|0|||
44375210|NCT00905307|79380334|FG004|Overall Study|Protocol Violation|0|||
44375211|NCT00905307|79380335|FG005|Overall Study|Protocol Violation|0|||
44375212|NCT00905307|79380330|FG000|Overall Study|Lack of Efficacy|6|||
44375213|NCT00905307|79380331|FG001|Overall Study|Lack of Efficacy|3|||
44375214|NCT00905307|79380332|FG002|Overall Study|Lack of Efficacy|5|||
44467634|NCT00543725|79476362|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
44467635|NCT00543725|79476363|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
44467636|NCT00543725|79476362|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
44467637|NCT00543725|79476363|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
44467638|NCT00543725|79476362|FG000|Overall Study|Protocol Violation|0|||
44467639|NCT00543725|79476363|FG001|Overall Study|Protocol Violation|1|||
44467640|NCT00543725|79476362|FG000|Overall Study|Withdrawal by Subject|4|||
44467641|NCT00543725|79476363|FG001|Overall Study|Withdrawal by Subject|13|||
44467642|NCT00543725|79476362|FG000|Overall Study|Lost to Follow-up|15|||
44467643|NCT00543725|79476363|FG001|Overall Study|Lost to Follow-up|11|||
44467644|NCT00543725|79476362|FG000|Overall Study|Other|3|||
44467645|NCT00543725|79476363|FG001|Overall Study|Other|3|||
44467646|NCT00269152|79476371|FG000|Overall Study|Adverse Event|9|||
44467647|NCT00269152|79476372|FG001|Overall Study|Adverse Event|3|||
44467648|NCT00269152|79476371|FG000|Overall Study|Withdrawal by Subject|7|||
44467649|NCT00269152|79476372|FG001|Overall Study|Withdrawal by Subject|3|||
44467650|NCT00269152|79476371|FG000|Overall Study|Physician Decision|2|||
44467651|NCT00269152|79476372|FG001|Overall Study|Physician Decision|3|||
44467652|NCT00269152|79476371|FG000|Overall Study|Protocol Violation|0|||
44467653|NCT00269152|79476372|FG001|Overall Study|Protocol Violation|1|||
44467654|NCT00379899|79476380|FG000|Overall Study|Adverse Event|7|||
44467655|NCT00379899|79476381|FG001|Overall Study|Adverse Event|3|||
44467656|NCT00379899|79476380|FG000|Overall Study|Death|10|||
44467657|NCT00379899|79476381|FG001|Overall Study|Death|10|||
44467658|NCT00379899|79476380|FG000|Overall Study|Lost to Follow-up|2|||
44467659|NCT00379899|79476381|FG001|Overall Study|Lost to Follow-up|4|||
44467660|NCT00379899|79476380|FG000|Overall Study|Physician Decision|3|||
44467661|NCT00379899|79476381|FG001|Overall Study|Physician Decision|4|||
44467662|NCT00379899|79476380|FG000|Overall Study|Withdrawal by Subject|5|||
44467663|NCT00379899|79476381|FG001|Overall Study|Withdrawal by Subject|5|||
44467664|NCT00379899|79476380|FG000|Overall Study|Ineligibility determined|0|||
44467665|NCT00379899|79476381|FG001|Overall Study|Ineligibility determined|1|||
44467666|NCT00379899|79476380|FG000|Overall Study|Noncompliance|1|||
44467667|NCT00379899|79476381|FG001|Overall Study|Noncompliance|1|||
44467668|NCT00379899|79476380|FG000|Overall Study|Parathyroidectomy|0|||
44467669|NCT00379899|79476381|FG001|Overall Study|Parathyroidectomy|2|||
44467670|NCT00379899|79476380|FG000|Overall Study|Renal transplantation|5|||
44467671|NCT00379899|79476381|FG001|Overall Study|Renal transplantation|4|||
44467672|NCT00379899|79476380|FG000|Overall Study|Coronary artery bypass graft|1|||
44467673|NCT00379899|79476381|FG001|Overall Study|Coronary artery bypass graft|1|||
44467674|NCT00379899|79476380|FG000|Overall Study|Other protocol-specified criteria|3|||
44467675|NCT00379899|79476381|FG001|Overall Study|Other protocol-specified criteria|4|||
44467676|NCT00379899|79476380|FG000|Overall Study|Other|3|||
44467677|NCT00379899|79476381|FG001|Overall Study|Other|1|||
44467678|NCT00371787|79476389|FG000|Overall Study|Withdrawal by Subject|3|||
44467679|NCT00371787|79476390|FG001|Overall Study|Withdrawal by Subject|1|||
44467680|NCT00363129|79476398|FG000|Overall Study|Withdrawal by Subject|11|||
44467681|NCT00363129|79476399|FG001|Overall Study|Withdrawal by Subject|18|||
44467682|NCT00363129|79476398|FG000|Overall Study|Adverse Event|8|||
44467683|NCT00363129|79476399|FG001|Overall Study|Adverse Event|3|||
44467684|NCT00363129|79476398|FG000|Overall Study|Alternate Treatment|2|||
44467685|NCT00363129|79476399|FG001|Overall Study|Alternate Treatment|4|||
44467686|NCT00363129|79476398|FG000|Overall Study|Other Medical Problems|2|||
44467687|NCT00363129|79476399|FG001|Overall Study|Other Medical Problems|4|||
44467688|NCT00363129|79476398|FG000|Overall Study|Death|0|||
44467689|NCT00363129|79476399|FG001|Overall Study|Death|1|||
44467690|NCT00363129|79476398|FG000|Overall Study|Other Reasons|6|||
44467691|NCT00363129|79476399|FG001|Overall Study|Other Reasons|3|||
44467692|NCT00268996|79476407|FG000|Overall Study|Adverse Event|11|||
44467693|NCT00268996|79476408|FG001|Overall Study|Adverse Event|7|||
44467694|NCT00268996|79476407|FG000|Overall Study|Lost to Follow-up|3|||
44467695|NCT00268996|79476408|FG001|Overall Study|Lost to Follow-up|1|||
44467696|NCT00268996|79476407|FG000|Overall Study|Withdrawal by Subject|5|||
44467697|NCT00268996|79476408|FG001|Overall Study|Withdrawal by Subject|11|||
44467698|NCT00268996|79476407|FG000|Overall Study|Non-compliance|1|||
44467699|NCT00268996|79476408|FG001|Overall Study|Non-compliance|0|||
44467700|NCT00268996|79476407|FG000|Overall Study|Other|1|||
44223918|NCT00574496|79027453|FG000|Overall Study|Withdrawal by Subject|1|||
44223919|NCT00499083|79027457|FG000|Overall Study|Not evaluable|3|||
44467701|NCT00268996|79476408|FG001|Overall Study|Other|1|||
44467702|NCT00371397|79476416|FG000|Session 1|Withdrawal by Subject|1|||
44467703|NCT00371397|79476417|FG001|Session 1|Withdrawal by Subject|0|||
44467704|NCT00371397|79476418|FG002|Session 1|Withdrawal by Subject|0|||
44467705|NCT00371397|79476419|FG003|Session 1|Withdrawal by Subject|0|||
44467706|NCT00371397|79476420|FG004|Session 1|Withdrawal by Subject|0|||
44467707|NCT00371397|79476421|FG005|Session 1|Withdrawal by Subject|0|||
44467708|NCT00371397|79476422|FG006|Session 1|Withdrawal by Subject|0|||
44467709|NCT00371397|79476423|FG007|Session 1|Withdrawal by Subject|1|||
44467710|NCT00371397|79476424|FG008|Session 1|Withdrawal by Subject|0|||
44467711|NCT00371397|79476425|FG009|Session 1|Withdrawal by Subject|0|||
44467712|NCT00371397|79476426|FG010|Session 1|Withdrawal by Subject|0|||
44467713|NCT00371397|79476427|FG011|Session 1|Withdrawal by Subject|0|||
44467714|NCT00379587|79476433|FG000|Overall Study|Lost to Follow-up|2|||
44467715|NCT00289276|79476439|FG000|Second Part of FAST Study (Expansion)|Death|0|||
44467716|NCT00289276|79476440|FG001|Second Part of FAST Study (Expansion)|Death|2|||
44467717|NCT00289276|79476439|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
44375215|NCT00905307|79380333|FG003|Overall Study|Lack of Efficacy|4|||
44467718|NCT00289276|79476440|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
44467719|NCT00289198|79476448|FG000|Overall Study|Adverse Event|0|||
44467720|NCT00289198|79476449|FG001|Overall Study|Adverse Event|2|||
44467721|NCT00289198|79476448|FG000|Overall Study|Protocol Violation|2|||
44223920|NCT00418886|79027463|FG000|Overall Study|discontinue treatment survival follow up|90|||
44223921|NCT00418886|79027464|FG001|Overall Study|discontinue treatment survival follow up|91|||
44223922|NCT00418886|79027463|FG000|Overall Study|Death|122|||
44223923|NCT00418886|79027464|FG001|Overall Study|Death|147|||
44223924|NCT00418886|79027463|FG000|Overall Study|Withdrawal by Subject|9|||
44223925|NCT00418886|79027464|FG001|Overall Study|Withdrawal by Subject|10|||
44223926|NCT00418886|79027463|FG000|Overall Study|Lost to Follow-up|4|||
44544448|NCT03197376|79557828|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
44544449|NCT03197376|79557829|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
44467722|NCT00289198|79476449|FG001|Overall Study|Protocol Violation|1|||
44467723|NCT00289198|79476448|FG000|Overall Study|Withdrawal by Subject|4|||
44467724|NCT00289198|79476449|FG001|Overall Study|Withdrawal by Subject|1|||
44467725|NCT00289198|79476448|FG000|Overall Study|Lack of Efficacy|2|||
44467726|NCT00289198|79476449|FG001|Overall Study|Lack of Efficacy|0|||
44467727|NCT00289198|79476448|FG000|Overall Study|Other: Low compliance|0|||
44467728|NCT00289198|79476449|FG001|Overall Study|Other: Low compliance|1|||
44467729|NCT00289198|79476448|FG000|Overall Study|Other: Physician's decision|0|||
44467730|NCT00289198|79476449|FG001|Overall Study|Other: Physician's decision|1|||
44467731|NCT00289198|79476448|FG000|Overall Study|Other: Unable to attend on schedule|2|||
44467732|NCT00289198|79476449|FG001|Overall Study|Other: Unable to attend on schedule|1|||
44467733|NCT00289198|79476448|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
44467734|NCT00289198|79476449|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
44467735|NCT00289198|79476448|FG000|Overall Study|Other: Impossible to come on visit|0|||
44467736|NCT00289198|79476449|FG001|Overall Study|Other: Impossible to come on visit|1|||
44467737|NCT00363051|79476458|FG000|Overall Study|Adminstrative problems|1|||
44467738|NCT00363051|79476459|FG001|Overall Study|Adminstrative problems|1|||
44467739|NCT00363051|79476458|FG000|Overall Study|Adverse Event|21|||
44467740|NCT00363051|79476459|FG001|Overall Study|Adverse Event|12|||
44467741|NCT00363051|79476458|FG000|Overall Study|New Cancer Therapy|2|||
44544450|NCT03197376|79557826|FG000|Primary and Booster Phase|Not vaccine related|1|||
44544451|NCT03197376|79557827|FG001|Primary and Booster Phase|Not vaccine related|2|||
44544452|NCT03197376|79557828|FG002|Primary and Booster Phase|Not vaccine related|0|||
44544453|NCT03197376|79557829|FG003|Primary and Booster Phase|Not vaccine related|6|||
44375216|NCT00905307|79380334|FG004|Overall Study|Lack of Efficacy|4|||
44375217|NCT00905307|79380335|FG005|Overall Study|Lack of Efficacy|8|||
44223927|NCT00418886|79027464|FG001|Overall Study|Lost to Follow-up|6|||
44223928|NCT00418886|79027463|FG000|Overall Study|withdrawn due to other reason|1|||
44223929|NCT00418886|79027464|FG001|Overall Study|withdrawn due to other reason|0|||
44223930|NCT00418886|79027463|FG000|Overall Study|randomised but no treatment received|0|||
44223931|NCT00418886|79027464|FG001|Overall Study|randomised but no treatment received|1|||
44223932|NCT01819129|79027476|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
44223933|NCT01819129|79027477|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
44223934|NCT01819129|79027476|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
44223935|NCT01819129|79027477|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
44223936|NCT01819129|79027476|FG000|Overall Study|Other, Subject moved out of the country|0|||
44223937|NCT01819129|79027477|FG001|Overall Study|Other, Subject moved out of the country|1|||
44223938|NCT01819129|79027476|FG000|Overall Study|Withdrawal by Subject|15|||
44223939|NCT01819129|79027477|FG001|Overall Study|Withdrawal by Subject|15|||
44223940|NCT01819129|79027476|FG000|Overall Study|Lost to Follow-up|5|||
44223941|NCT01819129|79027477|FG001|Overall Study|Lost to Follow-up|2|||
44375218|NCT00907881|79380362|FG000|Overall Study|Lost to Follow-up|59|||
44375219|NCT00907881|79380362|FG000|Overall Study|Noncompliance|5|||
44375220|NCT00907881|79380362|FG000|Overall Study|Withdrawal by Subject|5|||
44375221|NCT00907881|79380362|FG000|Overall Study|Protocol Violation|1|||
44375222|NCT00907881|79380362|FG000|Overall Study|Missing discontinuation information|15|||
44375223|NCT00904917|79380370|FG000|Overall Study|Lost to Follow-up|2|||
44375224|NCT00904917|79380371|FG001|Overall Study|Lost to Follow-up|2|||
44375225|NCT00904917|79380372|FG002|Overall Study|Lost to Follow-up|2|||
44375226|NCT00904917|79380373|FG003|Overall Study|Lost to Follow-up|2|||
44375227|NCT00904839|79380388|FG000|Overall Study|Adverse Event|0|||
44375228|NCT00904839|79380389|FG001|Overall Study|Adverse Event|5|||
44375229|NCT00904839|79380390|FG002|Overall Study|Adverse Event|4|||
44375230|NCT00904839|79380388|FG000|Overall Study|Protocol Violation|0|||
44375231|NCT00904839|79380389|FG001|Overall Study|Protocol Violation|1|||
44273513|NCT01660451|79215183|FG001|Overall Study|Protocol Deviation|0|||
44273514|NCT01660451|79215184|FG002|Overall Study|Protocol Deviation|1|||
44273515|NCT01660451|79215182|FG000|Overall Study|Physician Decision|1|||
44273516|NCT01660451|79215183|FG001|Overall Study|Physician Decision|2|||
44273517|NCT01660451|79215184|FG002|Overall Study|Physician Decision|5|||
44273518|NCT01660451|79215182|FG000|Overall Study|Withdrawal by Subject|1|||
44273519|NCT01660451|79215183|FG001|Overall Study|Withdrawal by Subject|0|||
44467742|NCT00363051|79476459|FG001|Overall Study|New Cancer Therapy|1|||
44467743|NCT00363051|79476458|FG000|Overall Study|Withdrawal by Subject|11|||
44467744|NCT00363051|79476459|FG001|Overall Study|Withdrawal by Subject|3|||
44467745|NCT00363051|79476458|FG000|Overall Study|Lost to Follow-up|0|||
44467746|NCT00363051|79476459|FG001|Overall Study|Lost to Follow-up|1|||
44467747|NCT00363051|79476458|FG000|Overall Study|Protocol Violation|0|||
44467748|NCT00363051|79476459|FG001|Overall Study|Protocol Violation|2|||
44467749|NCT00363051|79476458|FG000|Overall Study|Death|3|||
44467750|NCT00363051|79476459|FG001|Overall Study|Death|2|||
44467751|NCT00379353|79476469|FG000|Overall Study|Hospitalization|3|||
44467752|NCT00379353|79476470|FG001|Overall Study|Hospitalization|3|||
44467753|NCT00379353|79476469|FG000|Overall Study|Withdrawal by Subject|5|||
44467754|NCT00379353|79476470|FG001|Overall Study|Withdrawal by Subject|2|||
44467755|NCT00379353|79476469|FG000|Overall Study|Death|1|||
44467756|NCT00379353|79476470|FG001|Overall Study|Death|0|||
44467757|NCT00379353|79476469|FG000|Overall Study|Cardiac Tamponade|1|||
44467758|NCT00379353|79476470|FG001|Overall Study|Cardiac Tamponade|0|||
44467759|NCT00379353|79476469|FG000|Overall Study|Non-compliance|1|||
44467760|NCT00379353|79476470|FG001|Overall Study|Non-compliance|0|||
44467761|NCT00379353|79476469|FG000|Overall Study|Conflicting drug treatment|0|||
44467762|NCT00379353|79476470|FG001|Overall Study|Conflicting drug treatment|1|||
44467763|NCT00378573|79476486|FG000|Treatment Period|Adverse Event|9|||
44467764|NCT00378573|79476486|FG000|Treatment Period|Physician Decision|1|||
44467765|NCT00378573|79476486|FG000|Treatment Period|Withdrawal by Subject|2|||
44467766|NCT00378573|79476486|FG000|Treatment Period|Disease Progression|4|||
44467767|NCT00378573|79476486|FG000|Treatment Period|Sponsor decision to close study|1|||
44467768|NCT00378573|79476486|FG000|Follow-up|Death|12|||
44467769|NCT00378573|79476486|FG000|Follow-up|Lost to Follow-up|1|||
44467770|NCT00378573|79476486|FG000|Follow-up|Withdrawal by Subject|1|||
44467771|NCT03831945|79476492|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
44467772|NCT03831945|79476493|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
44467773|NCT03831945|79476492|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
44467774|NCT03831945|79476493|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
44467775|NCT03831945|79476492|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
44273520|NCT01660451|79215184|FG002|Overall Study|Withdrawal by Subject|16|||
44273521|NCT01660451|79215182|FG000|Overall Study|Ongoing with treatment|3|||
44273522|NCT01660451|79215183|FG001|Overall Study|Ongoing with treatment|3|||
44273523|NCT01660451|79215184|FG002|Overall Study|Ongoing with treatment|46|||
44273524|NCT01390584|79215203|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
44273525|NCT01390584|79215204|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
44467776|NCT03831945|79476493|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
44467777|NCT00457002|79476501|FG000|Overall Study|Death|40|||
44467778|NCT00457002|79476502|FG001|Overall Study|Death|47|||
44467779|NCT00457002|79476501|FG000|Overall Study|Adverse Event|284|||
44273526|NCT01390584|79215205|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
44273527|NCT01242800|79215216|FG000|Overall Study|Patient refusal|0|||
44273528|NCT01242800|79215217|FG001|Overall Study|Patient refusal|10|||
44273529|NCT01242800|79215216|FG000|Overall Study|Physician Decision|0|||
44273530|NCT01242800|79215217|FG001|Overall Study|Physician Decision|1|||
44273531|NCT01242800|79215216|FG000|Overall Study|Disease progression|0|||
44273532|NCT01242800|79215217|FG001|Overall Study|Disease progression|3|||
44273533|NCT01242800|79215216|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
44273534|NCT01242800|79215217|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
44273535|NCT01242800|79215216|FG000|Overall Study|Reasons not reported|0|||
44273536|NCT01242800|79215217|FG001|Overall Study|Reasons not reported|4|||
44273537|NCT01216683|79215226|FG000|Induction|Never started treatment|0|||
44273538|NCT01216683|79215227|FG001|Induction|Never started treatment|6|||
44273539|NCT01216683|79215228|FG002|Induction|Never started treatment|3|||
44273540|NCT01216683|79215226|FG000|Induction|Lack of Efficacy|4|||
44273541|NCT01216683|79215227|FG001|Induction|Lack of Efficacy|3|||
44467780|NCT00457002|79476502|FG001|Overall Study|Adverse Event|260|||
44467781|NCT00457002|79476501|FG000|Overall Study|Withdrawal by Subject|299|||
44467782|NCT00457002|79476502|FG001|Overall Study|Withdrawal by Subject|271|||
44467783|NCT00457002|79476501|FG000|Overall Study|Lost to Follow-up|72|||
44467784|NCT00457002|79476502|FG001|Overall Study|Lost to Follow-up|71|||
44467785|NCT00457002|79476501|FG000|Overall Study|Poor/Non-compliance|46|||
44467786|NCT00457002|79476502|FG001|Overall Study|Poor/Non-compliance|33|||
44273542|NCT01216683|79215228|FG002|Induction|Lack of Efficacy|7|||
44273543|NCT01216683|79215226|FG000|Induction|Adverse Event|0|||
44273544|NCT01216683|79215227|FG001|Induction|Adverse Event|5|||
44273545|NCT01216683|79215228|FG002|Induction|Adverse Event|5|||
44273546|NCT01216683|79215226|FG000|Induction|Death|0|||
44467787|NCT00457002|79476501|FG000|Overall Study|No longer met criteria|41|||
44467788|NCT00457002|79476502|FG001|Overall Study|No longer met criteria|37|||
44467789|NCT00457002|79476501|FG000|Overall Study|Administrative reason by Sponsor|1|||
44467790|NCT00457002|79476502|FG001|Overall Study|Administrative reason by Sponsor|0|||
44467791|NCT00457002|79476501|FG000|Overall Study|non-specified|29|||
44273547|NCT01216683|79215227|FG001|Induction|Death|0|||
44273548|NCT01216683|79215228|FG002|Induction|Death|2|||
44273549|NCT01216683|79215226|FG000|Induction|Withdrawal by Subject|0|||
44467792|NCT00457002|79476502|FG001|Overall Study|non-specified|38|||
44467793|NCT00457002|79476501|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
44467794|NCT00457002|79476502|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
44467795|NCT00362115|79476515|FG000|Overall Study|Adverse Event|0|||
44467796|NCT00362115|79476516|FG001|Overall Study|Adverse Event|1|||
44467797|NCT00362115|79476517|FG002|Overall Study|Adverse Event|1|||
44467798|NCT00362115|79476518|FG003|Overall Study|Adverse Event|1|||
44467799|NCT00362115|79476519|FG004|Overall Study|Adverse Event|2|||
44467800|NCT00362115|79476520|FG005|Overall Study|Adverse Event|2|||
44467801|NCT00362115|79476521|FG006|Overall Study|Adverse Event|1|||
44467802|NCT00362115|79476515|FG000|Overall Study|Protocol Violation|0|||
44467803|NCT00362115|79476516|FG001|Overall Study|Protocol Violation|0|||
44544454|NCT03197376|79557826|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
44223942|NCT01819129|79027476|FG000|Overall Study|Lack of Efficacy|0|||
44223943|NCT01819129|79027477|FG001|Overall Study|Lack of Efficacy|1|||
44467804|NCT00362115|79476517|FG002|Overall Study|Protocol Violation|0|||
44467805|NCT00362115|79476518|FG003|Overall Study|Protocol Violation|0|||
44467806|NCT00362115|79476519|FG004|Overall Study|Protocol Violation|0|||
44467807|NCT00362115|79476520|FG005|Overall Study|Protocol Violation|1|||
44467808|NCT00362115|79476521|FG006|Overall Study|Protocol Violation|0|||
44467809|NCT00362115|79476515|FG000|Overall Study|Lost to Follow-up|0|||
44467810|NCT00362115|79476516|FG001|Overall Study|Lost to Follow-up|1|||
44467811|NCT00362115|79476517|FG002|Overall Study|Lost to Follow-up|0|||
44467812|NCT00362115|79476518|FG003|Overall Study|Lost to Follow-up|0|||
44467813|NCT00362115|79476519|FG004|Overall Study|Lost to Follow-up|2|||
44467814|NCT00362115|79476520|FG005|Overall Study|Lost to Follow-up|0|||
44467815|NCT00362115|79476521|FG006|Overall Study|Lost to Follow-up|1|||
44467816|NCT00362115|79476515|FG000|Overall Study|Withdrawal by Subject|1|||
44467817|NCT00362115|79476516|FG001|Overall Study|Withdrawal by Subject|3|||
44467818|NCT00362115|79476517|FG002|Overall Study|Withdrawal by Subject|1|||
44223944|NCT01819129|79027476|FG000|Overall Study|Adverse Event|1|||
44223945|NCT01819129|79027477|FG001|Overall Study|Adverse Event|4|||
44223946|NCT01819129|79027476|FG000|Overall Study|Death|1|||
44223947|NCT01819129|79027477|FG001|Overall Study|Death|1|||
44223948|NCT01819129|79027476|FG000|Overall Study|Withdrawal Criteria|20|||
44223949|NCT01819129|79027477|FG001|Overall Study|Withdrawal Criteria|15|||
44223950|NCT04022889|79027485|FG000|Stage 1: Period 1|Adverse Event|1|||
44223951|NCT04022889|79027486|FG001|Stage 1: Period 1|Adverse Event|0|||
44223952|NCT04022889|79027487|FG002|Stage 1: Period 1|Adverse Event|0|||
44223953|NCT04022889|79027485|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
44223954|NCT04022889|79027486|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
44273550|NCT01216683|79215227|FG001|Induction|Withdrawal by Subject|4|||
44273551|NCT01216683|79215228|FG002|Induction|Withdrawal by Subject|2|||
44273552|NCT01216683|79215226|FG000|Induction|Other disease|0|||
44467819|NCT00362115|79476518|FG003|Overall Study|Withdrawal by Subject|0|||
44467820|NCT00362115|79476519|FG004|Overall Study|Withdrawal by Subject|1|||
44467821|NCT00362115|79476520|FG005|Overall Study|Withdrawal by Subject|3|||
44467822|NCT00362115|79476521|FG006|Overall Study|Withdrawal by Subject|4|||
44467823|NCT00362115|79476515|FG000|Overall Study|Lack of Efficacy|1|||
44467824|NCT00362115|79476516|FG001|Overall Study|Lack of Efficacy|0|||
44467825|NCT00362115|79476517|FG002|Overall Study|Lack of Efficacy|5|||
44544455|NCT03197376|79557827|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
44223955|NCT04022889|79027487|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
44223956|NCT04022889|79027485|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
44223957|NCT04022889|79027486|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
44223958|NCT04022889|79027487|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
44223959|NCT04022889|79027485|FG000|Stage 2|Screen Failure|0|||
44223960|NCT04022889|79027486|FG001|Stage 2|Screen Failure|0|||
44273553|NCT01216683|79215227|FG001|Induction|Other disease|1|||
44273554|NCT01216683|79215228|FG002|Induction|Other disease|2|||
44273555|NCT01216683|79215226|FG000|Continuation|Lack of Efficacy|3|||
44467826|NCT00362115|79476518|FG003|Overall Study|Lack of Efficacy|2|||
44467827|NCT00362115|79476519|FG004|Overall Study|Lack of Efficacy|2|||
44467828|NCT00362115|79476520|FG005|Overall Study|Lack of Efficacy|0|||
44223961|NCT04022889|79027487|FG002|Stage 2|Screen Failure|3|||
44273556|NCT01216683|79215227|FG001|Continuation|Lack of Efficacy|2|||
44467829|NCT00362115|79476521|FG006|Overall Study|Lack of Efficacy|3|||
44467830|NCT00362115|79476515|FG000|Overall Study|Physician Decision|0|||
44467831|NCT00362115|79476516|FG001|Overall Study|Physician Decision|0|||
44467832|NCT00362115|79476517|FG002|Overall Study|Physician Decision|0|||
44467833|NCT00362115|79476518|FG003|Overall Study|Physician Decision|0|||
44467834|NCT00362115|79476519|FG004|Overall Study|Physician Decision|0|||
44467835|NCT00362115|79476520|FG005|Overall Study|Physician Decision|0|||
44467836|NCT00362115|79476521|FG006|Overall Study|Physician Decision|3|||
44467837|NCT00362115|79476515|FG000|Overall Study|Other|0|||
44467838|NCT00362115|79476516|FG001|Overall Study|Other|1|||
44467839|NCT00362115|79476517|FG002|Overall Study|Other|0|||
44467840|NCT00362115|79476518|FG003|Overall Study|Other|1|||
44467841|NCT00362115|79476519|FG004|Overall Study|Other|0|||
44467842|NCT00362115|79476520|FG005|Overall Study|Other|1|||
44467843|NCT00362115|79476521|FG006|Overall Study|Other|0|||
44467844|NCT00485264|79476543|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
44467845|NCT00485264|79476544|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
44467846|NCT00485264|79476545|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
44467847|NCT00485264|79476546|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
44467848|NCT00485264|79476547|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
44467849|NCT00485264|79476548|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
44467850|NCT00485264|79476543|FG000|Overall Study|Death|1|||
44467851|NCT00485264|79476544|FG001|Overall Study|Death|0|||
44467852|NCT00485264|79476545|FG002|Overall Study|Death|0|||
44467853|NCT00485264|79476546|FG003|Overall Study|Death|0|||
44467854|NCT00485264|79476547|FG004|Overall Study|Death|1|||
44467855|NCT00485264|79476548|FG005|Overall Study|Death|0|||
44467856|NCT00485264|79476543|FG000|Overall Study|Adverse Event|1|||
44467857|NCT00485264|79476544|FG001|Overall Study|Adverse Event|0|||
44467858|NCT00485264|79476545|FG002|Overall Study|Adverse Event|2|||
44467859|NCT00485264|79476546|FG003|Overall Study|Adverse Event|3|||
44467860|NCT00485264|79476547|FG004|Overall Study|Adverse Event|1|||
44467861|NCT00485264|79476548|FG005|Overall Study|Adverse Event|3|||
44467862|NCT00485264|79476543|FG000|Overall Study|Pregnancy|4|||
44467863|NCT00485264|79476544|FG001|Overall Study|Pregnancy|0|||
44467864|NCT00485264|79476545|FG002|Overall Study|Pregnancy|0|||
44467865|NCT00485264|79476546|FG003|Overall Study|Pregnancy|0|||
44467866|NCT00485264|79476547|FG004|Overall Study|Pregnancy|0|||
44467867|NCT00485264|79476548|FG005|Overall Study|Pregnancy|0|||
44467868|NCT00485264|79476543|FG000|Overall Study|Disallowed Medication|0|||
44467869|NCT00485264|79476544|FG001|Overall Study|Disallowed Medication|0|||
44467870|NCT00485264|79476545|FG002|Overall Study|Disallowed Medication|0|||
44467871|NCT00485264|79476546|FG003|Overall Study|Disallowed Medication|0|||
44467872|NCT00485264|79476547|FG004|Overall Study|Disallowed Medication|0|||
44467873|NCT00485264|79476548|FG005|Overall Study|Disallowed Medication|1|||
44467874|NCT00485264|79476543|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
44467875|NCT00485264|79476544|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
44467876|NCT00485264|79476545|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
44544456|NCT03197376|79557828|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
44544457|NCT03197376|79557829|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
44544458|NCT03197376|79557826|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
44544459|NCT03197376|79557827|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
44273557|NCT01216683|79215228|FG002|Continuation|Lack of Efficacy|7|||
44375232|NCT00904839|79380390|FG002|Overall Study|Protocol Violation|1|||
44375233|NCT00904839|79380388|FG000|Overall Study|Lost to Follow-up|0|||
44375234|NCT00904839|79380389|FG001|Overall Study|Lost to Follow-up|1|||
44375235|NCT00904839|79380390|FG002|Overall Study|Lost to Follow-up|2|||
44375236|NCT00904839|79380388|FG000|Overall Study|Withdrawal by Subject|0|||
44375237|NCT00904839|79380389|FG001|Overall Study|Withdrawal by Subject|2|||
44375238|NCT00904839|79380390|FG002|Overall Study|Withdrawal by Subject|0|||
44375239|NCT00904839|79380388|FG000|Overall Study|Not treated|1|||
44375240|NCT00904839|79380389|FG001|Overall Study|Not treated|0|||
44375241|NCT00904839|79380390|FG002|Overall Study|Not treated|1|||
44375242|NCT00904839|79380388|FG000|Overall Study|Other than above|0|||
44375243|NCT00904839|79380389|FG001|Overall Study|Other than above|9|||
44375244|NCT00904839|79380390|FG002|Overall Study|Other than above|7|||
44375245|NCT00903357|79380401|FG000|First Intervention|Withdrawal by Subject|5|||
44467877|NCT00485264|79476546|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
44467878|NCT00485264|79476547|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
44467879|NCT00485264|79476548|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
44467880|NCT00485264|79476543|FG000|Overall Study|Lack of Efficacy|0|||
44467881|NCT00485264|79476544|FG001|Overall Study|Lack of Efficacy|1|||
44467882|NCT00485264|79476545|FG002|Overall Study|Lack of Efficacy|0|||
44467883|NCT00485264|79476546|FG003|Overall Study|Lack of Efficacy|0|||
44467884|NCT00485264|79476547|FG004|Overall Study|Lack of Efficacy|0|||
44467885|NCT00485264|79476548|FG005|Overall Study|Lack of Efficacy|0|||
44467886|NCT00485264|79476543|FG000|Overall Study|Guardian Consent Withdrawn|1|||
44467887|NCT00485264|79476544|FG001|Overall Study|Guardian Consent Withdrawn|0|||
44467888|NCT00485264|79476545|FG002|Overall Study|Guardian Consent Withdrawn|0|||
44273558|NCT01216683|79215226|FG000|Continuation|Adverse Event|5|||
44273559|NCT01216683|79215227|FG001|Continuation|Adverse Event|3|||
44273560|NCT01216683|79215228|FG002|Continuation|Adverse Event|16|||
44273561|NCT01216683|79215226|FG000|Continuation|Death|1|||
44273562|NCT01216683|79215227|FG001|Continuation|Death|0|||
44467889|NCT00485264|79476546|FG003|Overall Study|Guardian Consent Withdrawn|0|||
44467890|NCT00485264|79476547|FG004|Overall Study|Guardian Consent Withdrawn|1|||
44467891|NCT00485264|79476548|FG005|Overall Study|Guardian Consent Withdrawn|0|||
44467892|NCT00485264|79476543|FG000|Overall Study|Physician Decision|0|||
44467893|NCT00485264|79476544|FG001|Overall Study|Physician Decision|2|||
44467894|NCT00485264|79476545|FG002|Overall Study|Physician Decision|0|||
44467895|NCT00485264|79476546|FG003|Overall Study|Physician Decision|0|||
44467896|NCT00485264|79476547|FG004|Overall Study|Physician Decision|0|||
44467897|NCT00485264|79476548|FG005|Overall Study|Physician Decision|0|||
44467898|NCT00485264|79476543|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
44467899|NCT00485264|79476544|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
44467900|NCT00485264|79476545|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
44467901|NCT00485264|79476546|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
44467902|NCT00485264|79476547|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
44467903|NCT00485264|79476548|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
44467904|NCT00485264|79476543|FG000|Overall Study|Not Able to Attend Clinic|5|||
44467905|NCT00485264|79476544|FG001|Overall Study|Not Able to Attend Clinic|0|||
44467906|NCT00485264|79476545|FG002|Overall Study|Not Able to Attend Clinic|0|||
44467907|NCT00485264|79476546|FG003|Overall Study|Not Able to Attend Clinic|1|||
44467908|NCT00485264|79476547|FG004|Overall Study|Not Able to Attend Clinic|1|||
44467909|NCT00485264|79476548|FG005|Overall Study|Not Able to Attend Clinic|2|||
44467910|NCT00485264|79476543|FG000|Overall Study|Non-Compliant|17|||
44467911|NCT00485264|79476544|FG001|Overall Study|Non-Compliant|2|||
44467912|NCT00485264|79476545|FG002|Overall Study|Non-Compliant|1|||
44467913|NCT00485264|79476546|FG003|Overall Study|Non-Compliant|0|||
44223962|NCT04022889|79027485|FG000|Stage 2|Ineligible for apheresis donation|0|||
44223963|NCT04022889|79027486|FG001|Stage 2|Ineligible for apheresis donation|0|||
44467914|NCT00485264|79476547|FG004|Overall Study|Non-Compliant|1|||
44467915|NCT00485264|79476548|FG005|Overall Study|Non-Compliant|0|||
44467916|NCT00485264|79476543|FG000|Overall Study|Lost to Follow-up|2|||
44467917|NCT00485264|79476544|FG001|Overall Study|Lost to Follow-up|1|||
44467918|NCT00485264|79476545|FG002|Overall Study|Lost to Follow-up|1|||
44467919|NCT00485264|79476546|FG003|Overall Study|Lost to Follow-up|0|||
44467920|NCT00485264|79476547|FG004|Overall Study|Lost to Follow-up|0|||
44223964|NCT04022889|79027487|FG002|Stage 2|Ineligible for apheresis donation|2|||
44223965|NCT04022889|79027485|FG000|Stage 2|Adverse Event|0|||
44223966|NCT04022889|79027486|FG001|Stage 2|Adverse Event|0|||
44223967|NCT04022889|79027487|FG002|Stage 2|Adverse Event|2|||
44223968|NCT04022889|79027485|FG000|Stage 2|Protocol Violation|0|||
44223969|NCT04022889|79027486|FG001|Stage 2|Protocol Violation|0|||
44223970|NCT04022889|79027487|FG002|Stage 2|Protocol Violation|1|||
44223971|NCT04022889|79027485|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
44273563|NCT01216683|79215228|FG002|Continuation|Death|2|||
44375246|NCT00903357|79380402|FG001|First Intervention|Withdrawal by Subject|3|||
44375247|NCT00903357|79380401|FG000|First Intervention|Flu|0|||
44375248|NCT00903357|79380402|FG001|First Intervention|Flu|1|||
44375249|NCT00903357|79380401|FG000|Wash Out Period of 2 Weeks|Flu|0|||
44375250|NCT00903357|79380402|FG001|Wash Out Period of 2 Weeks|Flu|1|||
44375251|NCT00903357|79380401|FG000|Second Intervention|Lost to Follow-up|1|||
44375252|NCT00903357|79380402|FG001|Second Intervention|Lost to Follow-up|0|||
44375253|NCT00904371|79380412|FG000|Overall Study|Adverse Event|2|||
44375254|NCT00904371|79380412|FG000|Overall Study|Lost to Follow-up|4|||
44375255|NCT00904371|79380412|FG000|Overall Study|Discontinued at target blood pressure|2|||
44375256|NCT00904371|79380412|FG000|Overall Study|Continued with Tritace|1|||
44375257|NCT01104662|79380424|FG000|Overall Study|Adverse Event|2|||
44375258|NCT01104662|79380425|FG001|Overall Study|Adverse Event|2|||
44375259|NCT01104662|79380426|FG002|Overall Study|Adverse Event|0|||
44467921|NCT00485264|79476548|FG005|Overall Study|Lost to Follow-up|1|||
44467922|NCT00485264|79476543|FG000|Overall Study|Other Reason|3|||
44467923|NCT00485264|79476544|FG001|Overall Study|Other Reason|0|||
44467924|NCT00485264|79476545|FG002|Overall Study|Other Reason|0|||
44467925|NCT00485264|79476546|FG003|Overall Study|Other Reason|0|||
44467926|NCT00485264|79476547|FG004|Overall Study|Other Reason|0|||
44467927|NCT00485264|79476548|FG005|Overall Study|Other Reason|0|||
44223972|NCT04022889|79027486|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
44223973|NCT04022889|79027487|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
44223974|NCT01849783|79027505|FG000|Overall Study|Adverse Event|5|||
44223975|NCT01849783|79027505|FG000|Overall Study|Death|2|||
44273564|NCT01216683|79215226|FG000|Continuation|Withdrawal by Subject|4|||
44467928|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
44273565|NCT01216683|79215227|FG001|Continuation|Withdrawal by Subject|5|||
44375260|NCT01104662|79380427|FG003|Overall Study|Adverse Event|1|||
44375261|NCT01104662|79380428|FG004|Overall Study|Adverse Event|1|||
44514818|NCT03084796|79520626|FG003|Overall Study|Randomization error|0|||
44467929|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
44467930|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
44467931|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
44467932|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
44467933|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
44467934|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
44467935|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
44467936|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
44467937|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
44467938|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
44467939|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
44467940|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
44467941|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
44467942|NCT00293254|79476569|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
44467943|NCT00293254|79476570|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
44467944|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
44467945|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
44467946|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Death|4|||
44467947|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Death|1|||
44467948|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
44467949|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
44467950|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
44467951|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
44467952|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
44467953|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
44467954|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
44467955|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
44467956|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
44467957|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
44467958|NCT00293254|79476569|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
44467959|NCT00293254|79476570|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
44467960|NCT00293254|79476569|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
44467961|NCT00293254|79476570|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
44467962|NCT00293254|79476569|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
44467963|NCT00293254|79476570|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
44467964|NCT00293254|79476569|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
44467965|NCT00293254|79476570|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
44467966|NCT00293254|79476569|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
44467967|NCT00293254|79476570|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
44467968|NCT00293254|79476569|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
44467969|NCT00293254|79476570|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
44467970|NCT00293254|79476569|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
44467971|NCT00293254|79476570|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
44467972|NCT00293254|79476569|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
44467973|NCT00293254|79476570|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
44467974|NCT00293254|79476569|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
44467975|NCT00293254|79476570|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
44467976|NCT00293254|79476569|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
44467977|NCT00293254|79476570|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
44467978|NCT00293254|79476569|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
44467979|NCT00293254|79476570|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
44467980|NCT00293254|79476569|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
44467981|NCT00293254|79476570|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
44467982|NCT00456846|79476584|FG000|Overall Study|Adverse Event|2|||
44467983|NCT00456846|79476585|FG001|Overall Study|Adverse Event|15|||
44467984|NCT00456846|79476584|FG000|Overall Study|Physician Decision|11|||
44467985|NCT00456846|79476585|FG001|Overall Study|Physician Decision|6|||
44223976|NCT01849783|79027505|FG000|Overall Study|Physician Decision|1|||
44223977|NCT01849783|79027505|FG000|Overall Study|Withdrawal by Subject|1|||
44223978|NCT01849783|79027505|FG000|Overall Study|Unable to comply|2|||
44223979|NCT01849783|79027505|FG000|Overall Study|Disease progression|11|||
44467986|NCT00456846|79476584|FG000|Overall Study|Protocol Deviation|2|||
44467987|NCT00456846|79476585|FG001|Overall Study|Protocol Deviation|0|||
44467988|NCT00456846|79476584|FG000|Overall Study|Participant Discretion|1|||
44223980|NCT01611883|79027517|FG000|Overall Study|Adverse Event|1|||
44375262|NCT01104662|79380429|FG005|Overall Study|Adverse Event|1|||
44375263|NCT01104662|79380430|FG006|Overall Study|Adverse Event|0|||
44375264|NCT01104662|79380431|FG007|Overall Study|Adverse Event|0|||
44375265|NCT01104662|79380424|FG000|Overall Study|Clinical Failure|1|||
44375266|NCT01104662|79380425|FG001|Overall Study|Clinical Failure|0|||
44375267|NCT01104662|79380426|FG002|Overall Study|Clinical Failure|0|||
44375268|NCT01104662|79380427|FG003|Overall Study|Clinical Failure|0|||
44375269|NCT01104662|79380428|FG004|Overall Study|Clinical Failure|0|||
44375270|NCT01104662|79380429|FG005|Overall Study|Clinical Failure|1|||
44375271|NCT01104662|79380430|FG006|Overall Study|Clinical Failure|0|||
44375272|NCT01104662|79380431|FG007|Overall Study|Clinical Failure|0|||
44375273|NCT01104662|79380424|FG000|Overall Study|Participant left investigator's care|1|||
44375274|NCT01104662|79380425|FG001|Overall Study|Participant left investigator's care|1|||
44375275|NCT01104662|79380426|FG002|Overall Study|Participant left investigator's care|0|||
44375276|NCT01104662|79380427|FG003|Overall Study|Participant left investigator's care|0|||
44375277|NCT01104662|79380428|FG004|Overall Study|Participant left investigator's care|0|||
44467989|NCT00456846|79476585|FG001|Overall Study|Participant Discretion|5|||
44467990|NCT00456846|79476584|FG000|Overall Study|Other|0|||
44467991|NCT00456846|79476585|FG001|Overall Study|Other|2|||
44467992|NCT00448344|79476593|FG000|Overall Study|Lost to Follow-up|20|||
44467993|NCT00448344|79476594|FG001|Overall Study|Lost to Follow-up|22|||
44467994|NCT00448344|79476593|FG000|Overall Study|Withdrawal by Subject|6|||
44467995|NCT00448344|79476594|FG001|Overall Study|Withdrawal by Subject|8|||
44467996|NCT00448344|79476593|FG000|Overall Study|Death|3|||
44467997|NCT00448344|79476594|FG001|Overall Study|Death|4|||
44467998|NCT00448344|79476593|FG000|Overall Study|Physician Decision|1|||
44467999|NCT00448344|79476594|FG001|Overall Study|Physician Decision|2|||
44468000|NCT00484094|79476600|FG000|Overall Study|Discontinued|39|||
44468001|NCT00484094|79476600|FG000|Overall Study|Other|3|||
44468002|NCT00447876|79476606|FG000|Overall Study|Withdrawal by Subject|1|||
44468003|NCT00447876|79476607|FG001|Overall Study|Withdrawal by Subject|4|||
44468004|NCT00447876|79476606|FG000|Overall Study|Lost to Follow-up|1|||
44468005|NCT00447876|79476607|FG001|Overall Study|Lost to Follow-up|0|||
44468006|NCT00447876|79476606|FG000|Overall Study|Deterioration of symptomology|1|||
44468007|NCT00447876|79476607|FG001|Overall Study|Deterioration of symptomology|0|||
44468008|NCT00456612|79476613|FG000|Overall Study|Withdrawal by Subject|3|||
44468009|NCT00456300|79476618|FG000|Overall Study|Adverse Event|1|||
44468010|NCT00456300|79476619|FG001|Overall Study|Adverse Event|0|||
44468011|NCT00267748|79476630|FG000|Non-randomized Period|Progressive disease|10|||
44468012|NCT00267748|79476631|FG001|Non-randomized Period|Progressive disease|0|||
44468013|NCT00267748|79476632|FG002|Non-randomized Period|Progressive disease|0|||
44468014|NCT00267748|79476630|FG000|Non-randomized Period|Adverse Event|8|||
44468015|NCT00267748|79476631|FG001|Non-randomized Period|Adverse Event|0|||
44223981|NCT01611883|79027518|FG001|Overall Study|Adverse Event|1|||
44223982|NCT01848457|79027528|FG000|Overall Study|Death|1|||
44223983|NCT01848457|79027529|FG001|Overall Study|Death|0|||
44223984|NCT01848457|79027530|FG002|Overall Study|Death|0|||
44223985|NCT01848457|79027531|FG003|Overall Study|Death|0|||
44223986|NCT01817725|79027549|FG000|Overall Study|Withdrawal by Subject|1|||
44223987|NCT01870999|79027556|FG000|Overall Study|Adverse Event|0|||
44223988|NCT01870999|79027557|FG001|Overall Study|Adverse Event|4|||
44223989|NCT01870999|79027558|FG002|Overall Study|Adverse Event|1|||
44223990|NCT01870999|79027556|FG000|Overall Study|Subject met withdrawal criteria|3|||
44223991|NCT01870999|79027557|FG001|Overall Study|Subject met withdrawal criteria|2|||
44223992|NCT01870999|79027558|FG002|Overall Study|Subject met withdrawal criteria|0|||
44223993|NCT01870999|79027556|FG000|Overall Study|Subject withdrawn by Investigator|1|||
44223994|NCT01870999|79027557|FG001|Overall Study|Subject withdrawn by Investigator|0|||
44223995|NCT01870999|79027558|FG002|Overall Study|Subject withdrawn by Investigator|0|||
44223996|NCT01870999|79027556|FG000|Overall Study|Withdrawal by Subject|0|||
44223997|NCT01870999|79027557|FG001|Overall Study|Withdrawal by Subject|2|||
44223998|NCT01870999|79027558|FG002|Overall Study|Withdrawal by Subject|5|||
44223999|NCT01870999|79027556|FG000|Overall Study|Protocol Violation|0|||
44224000|NCT01870999|79027557|FG001|Overall Study|Protocol Violation|0|||
44224001|NCT01870999|79027558|FG002|Overall Study|Protocol Violation|1|||
44224002|NCT01870921|79027566|FG000|Overall Study|Subject decision|80|||
44224003|NCT01870921|79027566|FG000|Overall Study|Severe non-compliance to protocol|7|||
44224004|NCT01870921|79027566|FG000|Overall Study|Subject Lost to Follow up|2|||
44224005|NCT01870921|79027566|FG000|Overall Study|Other|1|||
44224006|NCT01848145|79027579|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
44224007|NCT01848145|79027579|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
44224008|NCT01848145|79027579|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
44224009|NCT01848145|79027579|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
44224010|NCT01848145|79027579|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
44468016|NCT00267748|79476632|FG002|Non-randomized Period|Adverse Event|0|||
44468017|NCT00267748|79476630|FG000|Non-randomized Period|Death|1|||
44468018|NCT00267748|79476631|FG001|Non-randomized Period|Death|0|||
44468019|NCT00267748|79476632|FG002|Non-randomized Period|Death|0|||
44224011|NCT01848145|79027579|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
44224012|NCT01848145|79027579|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
44224013|NCT01847755|79027583|FG000|Overall Study|Adverse Event|2|||
44224014|NCT01847755|79027583|FG000|Overall Study|Withdrawal by Subject|2|||
44224015|NCT01847755|79027583|FG000|Overall Study|Physician Decision|1|||
44224016|NCT01847443|79027614|FG000|Study Period 1|Withdrawal by Subject|0|||
44468020|NCT00267748|79476630|FG000|Non-randomized Period|Participant not willing to participate|1|||
44468021|NCT00267748|79476631|FG001|Non-randomized Period|Participant not willing to participate|0|||
44468022|NCT00267748|79476632|FG002|Non-randomized Period|Participant not willing to participate|0|||
44468023|NCT00267748|79476630|FG000|Non-randomized Period|Other|3|||
44468024|NCT00267748|79476631|FG001|Non-randomized Period|Other|0|||
44468025|NCT00267748|79476632|FG002|Non-randomized Period|Other|0|||
44468026|NCT00267748|79476630|FG000|Randomized Period|Death|0|||
44468027|NCT00267748|79476631|FG001|Randomized Period|Death|2|||
44468028|NCT00267748|79476632|FG002|Randomized Period|Death|3|||
44468029|NCT00267748|79476630|FG000|Randomized Period|Adverse Event|0|||
44224017|NCT01847443|79027615|FG001|Study Period 1|Withdrawal by Subject|1|||
44224018|NCT01847443|79027616|FG002|Study Period 1|Withdrawal by Subject|0|||
44273566|NCT01216683|79215228|FG002|Continuation|Withdrawal by Subject|9|||
44273567|NCT01216683|79215226|FG000|Continuation|Other diseases|0|||
44273568|NCT01216683|79215227|FG001|Continuation|Other diseases|2|||
44273569|NCT01216683|79215228|FG002|Continuation|Other diseases|1|||
44273570|NCT01216683|79215226|FG000|Continuation|Physician Decision|1|||
44273571|NCT01216683|79215227|FG001|Continuation|Physician Decision|0|||
44273572|NCT01216683|79215228|FG002|Continuation|Physician Decision|1|||
44273573|NCT01216683|79215226|FG000|Continuation|Non-compliance|1|||
44468030|NCT00267748|79476631|FG001|Randomized Period|Adverse Event|23|||
44468031|NCT00267748|79476632|FG002|Randomized Period|Adverse Event|25|||
44468032|NCT00267748|79476630|FG000|Randomized Period|Global deterioration of health status|0|||
44224019|NCT01847443|79027617|FG003|Study Period 1|Withdrawal by Subject|0|||
44224020|NCT01847443|79027614|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
44224021|NCT01847443|79027615|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
44224022|NCT01847443|79027616|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
44224023|NCT01847443|79027617|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
44224024|NCT01847443|79027614|FG000|Washout Period Before Study Period 2|Other reason|1|||
44224025|NCT01847443|79027615|FG001|Washout Period Before Study Period 2|Other reason|0|||
44224026|NCT01847443|79027616|FG002|Washout Period Before Study Period 2|Other reason|0|||
44224027|NCT01847443|79027617|FG003|Washout Period Before Study Period 2|Other reason|0|||
44224028|NCT01847443|79027614|FG000|Washout Period Before Study Period 3|Other reason|1|||
44224029|NCT01847443|79027615|FG001|Washout Period Before Study Period 3|Other reason|0|||
44224030|NCT01847443|79027616|FG002|Washout Period Before Study Period 3|Other reason|0|||
44224031|NCT01847443|79027617|FG003|Washout Period Before Study Period 3|Other reason|0|||
44224032|NCT01847443|79027614|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
44224033|NCT01847443|79027615|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
44224034|NCT01847443|79027616|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
44224035|NCT01847443|79027617|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
44224036|NCT01847443|79027614|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
44224037|NCT01847443|79027615|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
44224038|NCT01847443|79027616|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
44224039|NCT01847443|79027617|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
44224040|NCT01847209|79027636|FG000|Overall Study|Withdrawal by Subject|1|||
44224041|NCT01847209|79027636|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
44224042|NCT01846741|79027640|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
44224043|NCT01870843|79027679|FG000|Overall Study|Adverse Event|10|||
44224044|NCT01870843|79027679|FG000|Overall Study|Lost to Follow-up|24|||
44224045|NCT01870843|79027679|FG000|Overall Study|Death|1|||
44224046|NCT01870843|79027679|FG000|Overall Study|Withdrawal by Subject|18|||
44224047|NCT01816477|79027685|FG000|Overall Study|Withdrawal by Subject|13|||
44224048|NCT01816477|79027686|FG001|Overall Study|Withdrawal by Subject|1|||
44224049|NCT01816477|79027685|FG000|Overall Study|Unable to tolerate catheter placement|3|||
44273574|NCT01216683|79215227|FG001|Continuation|Non-compliance|0|||
44468033|NCT00267748|79476631|FG001|Randomized Period|Global deterioration of health status|6|||
44468034|NCT00267748|79476632|FG002|Randomized Period|Global deterioration of health status|7|||
44468035|NCT00267748|79476630|FG000|Randomized Period|Lost to Follow-up|0|||
44273575|NCT01216683|79215228|FG002|Continuation|Non-compliance|1|||
44273576|NCT01216683|79215226|FG000|Continuation|Insurance change|0|||
44224050|NCT01816477|79027686|FG001|Overall Study|Unable to tolerate catheter placement|0|||
44224051|NCT01846507|79027692|FG000|Overall Study|Lost to Follow-up|4|||
44224052|NCT01846507|79027692|FG000|Overall Study|Protocol Violation|1|||
44224053|NCT01846507|79027692|FG000|Overall Study|Missing data|2|||
44468036|NCT00267748|79476631|FG001|Randomized Period|Lost to Follow-up|1|||
44468037|NCT00267748|79476632|FG002|Randomized Period|Lost to Follow-up|0|||
44514819|NCT03084796|79520627|FG004|Overall Study|Randomization error|0|||
44468038|NCT00267748|79476630|FG000|Randomized Period|Objective progression or relapse|0|||
44468039|NCT00267748|79476631|FG001|Randomized Period|Objective progression or relapse|77|||
44468040|NCT00267748|79476632|FG002|Randomized Period|Objective progression or relapse|86|||
44468041|NCT00267748|79476630|FG000|Randomized Period|Withdrawal by Subject|0|||
44468042|NCT00267748|79476631|FG001|Randomized Period|Withdrawal by Subject|9|||
44468043|NCT00267748|79476632|FG002|Randomized Period|Withdrawal by Subject|2|||
44468044|NCT00267748|79476630|FG000|Randomized Period|Other|0|||
44468045|NCT00267748|79476631|FG001|Randomized Period|Other|9|||
44468046|NCT00267748|79476632|FG002|Randomized Period|Other|6|||
44468047|NCT00267748|79476630|FG000|Randomized Period|randomized but not treated|0|||
44468048|NCT00267748|79476631|FG001|Randomized Period|randomized but not treated|0|||
44468049|NCT00267748|79476632|FG002|Randomized Period|randomized but not treated|3|||
44468050|NCT00267202|79476641|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
44468051|NCT00267202|79476642|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
44468052|NCT00267202|79476641|FG000|Overall Study|Withdrawal by Subject|12|||
44468053|NCT00267202|79476642|FG001|Overall Study|Withdrawal by Subject|15|||
44468054|NCT00267202|79476641|FG000|Overall Study|Adverse Event|13|||
44468055|NCT00267202|79476642|FG001|Overall Study|Adverse Event|7|||
44468056|NCT00267202|79476641|FG000|Overall Study|Protocol Violation|2|||
44468057|NCT00267202|79476642|FG001|Overall Study|Protocol Violation|3|||
44468058|NCT00267202|79476641|FG000|Overall Study|Administrative problems|2|||
44468059|NCT00267202|79476642|FG001|Overall Study|Administrative problems|1|||
44468060|NCT00267202|79476641|FG000|Overall Study|Lost to Follow-up|3|||
44468061|NCT00267202|79476642|FG001|Overall Study|Lost to Follow-up|0|||
44468062|NCT00267046|79476651|FG000|Overall Study|Disease progression|4|||
44468063|NCT00267046|79476652|FG001|Overall Study|Disease progression|2|||
44468064|NCT00267046|79476651|FG000|Overall Study|Chemotoxicity|2|||
44468065|NCT00267046|79476652|FG001|Overall Study|Chemotoxicity|0|||
44468066|NCT00267046|79476651|FG000|Overall Study|Open-label palifermin|2|||
44468067|NCT00267046|79476652|FG001|Overall Study|Open-label palifermin|7|||
44468068|NCT00267046|79476651|FG000|Overall Study|Surgery|3|||
44468069|NCT00267046|79476652|FG001|Overall Study|Surgery|1|||
44468070|NCT00267046|79476651|FG000|Overall Study|Withdrawal by Subject|1|||
44468071|NCT00267046|79476652|FG001|Overall Study|Withdrawal by Subject|0|||
44468072|NCT00267046|79476651|FG000|Overall Study|Radiation|0|||
44468073|NCT00267046|79476652|FG001|Overall Study|Radiation|1|||
44468074|NCT00441090|79476663|FG000|Overall Study|Adverse Event|0|||
44468075|NCT00441090|79476664|FG001|Overall Study|Adverse Event|1|||
44468076|NCT00441090|79476665|FG002|Overall Study|Adverse Event|1|||
44468077|NCT00441090|79476666|FG003|Overall Study|Adverse Event|0|||
44468078|NCT00441090|79476667|FG004|Overall Study|Adverse Event|0|||
44468079|NCT00441090|79476663|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
44468080|NCT00441090|79476664|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
44468081|NCT00441090|79476665|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
44468082|NCT00441090|79476666|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
44468083|NCT00441090|79476667|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
44468084|NCT00441090|79476663|FG000|Overall Study|Withdrawal by Subject|1|||
44468085|NCT00441090|79476664|FG001|Overall Study|Withdrawal by Subject|0|||
44468086|NCT00441090|79476665|FG002|Overall Study|Withdrawal by Subject|1|||
44468087|NCT00441090|79476666|FG003|Overall Study|Withdrawal by Subject|0|||
44468088|NCT00441090|79476667|FG004|Overall Study|Withdrawal by Subject|0|||
44468089|NCT00441090|79476663|FG000|Overall Study|Lack of Efficacy|1|||
44468090|NCT00441090|79476664|FG001|Overall Study|Lack of Efficacy|0|||
44468091|NCT00441090|79476665|FG002|Overall Study|Lack of Efficacy|0|||
44224054|NCT01846039|79027698|FG000|Overall Study|Protocol Violation|1|||
44224055|NCT01846039|79027698|FG000|Overall Study|Subject Withdrew Consent|1|||
44224056|NCT01610167|79027705|FG000|Overall Study|Scheduling conflict.|0|||
44224057|NCT01610167|79027706|FG001|Overall Study|Scheduling conflict.|0|||
44224058|NCT01610167|79027707|FG002|Overall Study|Scheduling conflict.|2|||
44224059|NCT01816243|79027715|FG000|Overall Study|Adverse Event|6|||
44224060|NCT01816243|79027715|FG000|Overall Study|Lost to Follow-up|1|||
44224061|NCT01816243|79027715|FG000|Overall Study|Lack of Efficacy|1|||
44224062|NCT01816243|79027715|FG000|Overall Study|Not eligible for the study|1|||
44468092|NCT00441090|79476666|FG003|Overall Study|Lack of Efficacy|0|||
44468093|NCT00441090|79476667|FG004|Overall Study|Lack of Efficacy|0|||
44468094|NCT00441012|79476681|FG000|Overall Study|Adverse Event|0|||
44468095|NCT00441012|79476682|FG001|Overall Study|Adverse Event|1|||
44468096|NCT00441012|79476681|FG000|Overall Study|Lost to Follow-up|3|||
44468097|NCT00441012|79476682|FG001|Overall Study|Lost to Follow-up|3|||
44468098|NCT00441012|79476681|FG000|Overall Study|Protocol Violation|10|||
44468099|NCT00441012|79476682|FG001|Overall Study|Protocol Violation|9|||
44468100|NCT00441012|79476681|FG000|Overall Study|Withdrawal by Subject|4|||
44468101|NCT00441012|79476682|FG001|Overall Study|Withdrawal by Subject|0|||
44468102|NCT00441012|79476681|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
44468103|NCT00441012|79476682|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
44224063|NCT01816243|79027715|FG000|Overall Study|Amputation|3|||
44224064|NCT01845805|79027721|FG000|Overall Study|Withdrawal by Subject|1|||
44468104|NCT00286468|79476691|FG000|Overall Study|Hyperglycemic Rescue|28|||
44468105|NCT00286468|79476692|FG001|Overall Study|Hyperglycemic Rescue|30|||
44468106|NCT00286468|79476693|FG002|Overall Study|Hyperglycemic Rescue|31|||
44468107|NCT00286468|79476691|FG000|Overall Study|Adverse Event|2|||
44468108|NCT00286468|79476692|FG001|Overall Study|Adverse Event|6|||
44468109|NCT00286468|79476693|FG002|Overall Study|Adverse Event|4|||
44468110|NCT00286468|79476691|FG000|Overall Study|Protocol Violation|0|||
44468111|NCT00286468|79476692|FG001|Overall Study|Protocol Violation|3|||
44468112|NCT00286468|79476693|FG002|Overall Study|Protocol Violation|1|||
44468113|NCT00286468|79476691|FG000|Overall Study|Lost to Follow-up|1|||
44468114|NCT00286468|79476692|FG001|Overall Study|Lost to Follow-up|1|||
44468115|NCT00286468|79476693|FG002|Overall Study|Lost to Follow-up|2|||
44468116|NCT00286468|79476691|FG000|Overall Study|Withdrawal by Subject|3|||
44468117|NCT00286468|79476692|FG001|Overall Study|Withdrawal by Subject|8|||
44468118|NCT00286468|79476693|FG002|Overall Study|Withdrawal by Subject|11|||
44468119|NCT00286468|79476691|FG000|Overall Study|Physician Decision|3|||
44468120|NCT00286468|79476692|FG001|Overall Study|Physician Decision|2|||
44468121|NCT00286468|79476693|FG002|Overall Study|Physician Decision|1|||
44468122|NCT00507026|79476704|FG000|Overall Study|Lack of Efficacy|6|||
44468123|NCT00507026|79476705|FG001|Overall Study|Lack of Efficacy|4|||
44468124|NCT00507026|79476706|FG002|Overall Study|Lack of Efficacy|21|||
44468125|NCT00507026|79476704|FG000|Overall Study|Withdrawal by Subject|2|||
44468126|NCT00507026|79476705|FG001|Overall Study|Withdrawal by Subject|0|||
44468127|NCT00507026|79476706|FG002|Overall Study|Withdrawal by Subject|0|||
44468128|NCT00507026|79476704|FG000|Overall Study|Investigator Decision|1|||
44468129|NCT00507026|79476705|FG001|Overall Study|Investigator Decision|0|||
44468130|NCT00507026|79476706|FG002|Overall Study|Investigator Decision|0|||
44468131|NCT00507026|79476704|FG000|Overall Study|Adverse Event|2|||
44468132|NCT00507026|79476705|FG001|Overall Study|Adverse Event|0|||
44468133|NCT00507026|79476706|FG002|Overall Study|Adverse Event|0|||
44468134|NCT00507026|79476704|FG000|Overall Study|Protocol Violation|1|||
44468135|NCT00507026|79476705|FG001|Overall Study|Protocol Violation|0|||
44468136|NCT00507026|79476706|FG002|Overall Study|Protocol Violation|0|||
44468137|NCT00507026|79476704|FG000|Overall Study|Other|1|||
44468138|NCT00507026|79476705|FG001|Overall Study|Other|0|||
44468139|NCT00507026|79476706|FG002|Overall Study|Other|0|||
44468140|NCT00446550|79476716|FG000|Overall Study|Adverse Event|1|||
44468141|NCT00446550|79476717|FG001|Overall Study|Adverse Event|0|||
44468142|NCT03847974|79476724|FG000|Overall Study|relocated out of region|3|||
44468143|NCT03847974|79476724|FG000|Overall Study|Withdrawal by Subject|2|||
44468144|NCT03847974|79476724|FG000|Overall Study|Adverse Event|1|||
44468145|NCT03976102|79476730|FG000|Overall Study|Withdrawal by Subject|4|||
44468146|NCT03976102|79476731|FG001|Overall Study|Withdrawal by Subject|4|||
44468147|NCT03976102|79476730|FG000|Overall Study|Adverse Event|2|||
44468148|NCT03976102|79476731|FG001|Overall Study|Adverse Event|4|||
44468149|NCT03976102|79476730|FG000|Overall Study|Not related to Covid-19|9|||
44468150|NCT03976102|79476731|FG001|Overall Study|Not related to Covid-19|13|||
44468151|NCT03976102|79476730|FG000|Overall Study|Lost to Follow-up|0|||
44468152|NCT03976102|79476731|FG001|Overall Study|Lost to Follow-up|2|||
44468153|NCT03976102|79476730|FG000|Overall Study|Death|3|||
44468154|NCT03976102|79476731|FG001|Overall Study|Death|2|||
44468155|NCT03976102|79476730|FG000|Overall Study|Physician Decision|1|||
44468156|NCT03976102|79476731|FG001|Overall Study|Physician Decision|1|||
44468157|NCT00506948|79476740|FG000|Overall Study|Death|4|||
44468158|NCT00506948|79476740|FG000|Overall Study|Adverse Event|5|||
44468159|NCT00506948|79476740|FG000|Overall Study|Physician Decision|1|||
44468160|NCT00286234|79476748|FG000|Overall Study|Protocol Violation|1|||
44468161|NCT00286234|79476749|FG001|Overall Study|Protocol Violation|2|||
44468162|NCT00286234|79476750|FG002|Overall Study|Protocol Violation|0|||
44468163|NCT00286234|79476751|FG003|Overall Study|Protocol Violation|1|||
44468164|NCT00286234|79476748|FG000|Overall Study|Physician Decision|1|||
44468165|NCT00286234|79476749|FG001|Overall Study|Physician Decision|0|||
44468166|NCT00286234|79476750|FG002|Overall Study|Physician Decision|0|||
44375278|NCT01104662|79380429|FG005|Overall Study|Participant left investigator's care|0|||
44468167|NCT00286234|79476751|FG003|Overall Study|Physician Decision|1|||
44468168|NCT00286234|79476748|FG000|Overall Study|Adverse Event|0|||
44468169|NCT00286234|79476749|FG001|Overall Study|Adverse Event|0|||
44375279|NCT01104662|79380430|FG006|Overall Study|Participant left investigator's care|0|||
44375280|NCT01104662|79380431|FG007|Overall Study|Participant left investigator's care|0|||
44375281|NCT01104662|79380424|FG000|Overall Study|Reason not specified|3|||
44375282|NCT01104662|79380425|FG001|Overall Study|Reason not specified|3|||
44375283|NCT01104662|79380426|FG002|Overall Study|Reason not specified|0|||
44375284|NCT01104662|79380427|FG003|Overall Study|Reason not specified|0|||
44375285|NCT01104662|79380428|FG004|Overall Study|Reason not specified|0|||
44375286|NCT01104662|79380429|FG005|Overall Study|Reason not specified|1|||
44468170|NCT00286234|79476750|FG002|Overall Study|Adverse Event|0|||
44468171|NCT00286234|79476751|FG003|Overall Study|Adverse Event|1|||
44468172|NCT00286234|79476748|FG000|Overall Study|Adverse Event|0|||
44468173|NCT00286234|79476749|FG001|Overall Study|Adverse Event|0|||
44468174|NCT00286234|79476750|FG002|Overall Study|Adverse Event|0|||
44468175|NCT00286234|79476751|FG003|Overall Study|Adverse Event|1|||
44468176|NCT00445848|79476761|FG000|Overall Study|Adverse Event|14|||
44468177|NCT00445848|79476761|FG000|Overall Study|Withdrawal by Subject|4|||
44468178|NCT00445848|79476761|FG000|Overall Study|Progression|62|||
44468179|NCT00445848|79476761|FG000|Overall Study|Other-Not protocol specified|5|||
44468180|NCT00286156|79476768|FG000|Overall Study|Missed 12 month visit|0|||
44468181|NCT00286156|79476769|FG001|Overall Study|Missed 12 month visit|0|||
44468182|NCT00286156|79476770|FG002|Overall Study|Missed 12 month visit|1|||
44468183|NCT00286156|79476768|FG000|Overall Study|AE: pulmonary embolus|0|||
44468184|NCT00286156|79476769|FG001|Overall Study|AE: pulmonary embolus|1|||
44468185|NCT00286156|79476770|FG002|Overall Study|AE: pulmonary embolus|0|||
44468186|NCT00286156|79476768|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
44468187|NCT00286156|79476769|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
44468188|NCT00286156|79476770|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
44468189|NCT00286156|79476768|FG000|Overall Study|AE: pneumonia|1|||
44468190|NCT00286156|79476769|FG001|Overall Study|AE: pneumonia|0|||
44468191|NCT00286156|79476770|FG002|Overall Study|AE: pneumonia|0|||
44468192|NCT00455520|79476780|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
44468193|NCT00455520|79476781|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
44468194|NCT00455520|79476780|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
44468195|NCT00455520|79476781|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
44468196|NCT00455520|79476780|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
44468197|NCT00455520|79476781|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
44224065|NCT01845805|79027722|FG001|Overall Study|Withdrawal by Subject|2|||
44224066|NCT01845805|79027721|FG000|Overall Study|Disease Progression|13|||
44224067|NCT01845805|79027722|FG001|Overall Study|Disease Progression|14|||
44224068|NCT01845805|79027721|FG000|Overall Study|Drug-related Toxicity|4|||
44224069|NCT01845805|79027722|FG001|Overall Study|Drug-related Toxicity|0|||
44224070|NCT01845025|79027730|FG000|Overall Study|Adverse Event|6|||
44224071|NCT01845025|79027731|FG001|Overall Study|Adverse Event|3|||
44224072|NCT01845025|79027730|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44224073|NCT01845025|79027731|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44224074|NCT01845025|79027730|FG000|Overall Study|Withdrawal by Subject|48|||
44224075|NCT01845025|79027731|FG001|Overall Study|Withdrawal by Subject|44|||
44224076|NCT01845025|79027730|FG000|Overall Study|Lost to Follow-up|13|||
44224077|NCT01845025|79027731|FG001|Overall Study|Lost to Follow-up|13|||
44224078|NCT01845025|79027730|FG000|Overall Study|Administrative problems|8|||
44224079|NCT01845025|79027731|FG001|Overall Study|Administrative problems|8|||
44224080|NCT01845025|79027730|FG000|Overall Study|Death|2|||
44224081|NCT01845025|79027731|FG001|Overall Study|Death|0|||
44224082|NCT01845025|79027730|FG000|Overall Study|Protocol deviation|3|||
44224083|NCT01845025|79027731|FG001|Overall Study|Protocol deviation|6|||
44224084|NCT01845025|79027730|FG000|Overall Study|Missing|1|||
44224085|NCT01845025|79027731|FG001|Overall Study|Missing|1|||
44224086|NCT01870297|79027772|FG000|Overall Study|Adverse Event|0|||
44224087|NCT01870297|79027773|FG001|Overall Study|Adverse Event|0|||
44224088|NCT01870297|79027774|FG002|Overall Study|Adverse Event|0|||
44224089|NCT01870297|79027775|FG003|Overall Study|Adverse Event|0|||
44224090|NCT01870297|79027776|FG004|Overall Study|Adverse Event|2|||
44224091|NCT01870297|79027777|FG005|Overall Study|Adverse Event|0|||
44224092|NCT01870297|79027778|FG006|Overall Study|Adverse Event|0|||
44224093|NCT01870297|79027772|FG000|Overall Study|Lost to Follow-up|0|||
44224094|NCT01870297|79027773|FG001|Overall Study|Lost to Follow-up|1|||
44224095|NCT01870297|79027774|FG002|Overall Study|Lost to Follow-up|1|||
44224096|NCT01870297|79027775|FG003|Overall Study|Lost to Follow-up|0|||
44224097|NCT01870297|79027776|FG004|Overall Study|Lost to Follow-up|0|||
44224098|NCT01870297|79027777|FG005|Overall Study|Lost to Follow-up|0|||
44224099|NCT01870297|79027778|FG006|Overall Study|Lost to Follow-up|0|||
44224100|NCT01870297|79027772|FG000|Overall Study|Withdrawal by Subject|0|||
44224101|NCT01870297|79027773|FG001|Overall Study|Withdrawal by Subject|0|||
44224102|NCT01870297|79027774|FG002|Overall Study|Withdrawal by Subject|0|||
44224103|NCT01870297|79027775|FG003|Overall Study|Withdrawal by Subject|0|||
44375287|NCT01104662|79380430|FG006|Overall Study|Reason not specified|0|||
44375288|NCT01104662|79380431|FG007|Overall Study|Reason not specified|0|||
44375289|NCT01104662|79380424|FG000|Overall Study|Randomized but not treated|3|||
44375290|NCT01104662|79380425|FG001|Overall Study|Randomized but not treated|4|||
44375291|NCT01104662|79380426|FG002|Overall Study|Randomized but not treated|1|||
44375292|NCT01104662|79380427|FG003|Overall Study|Randomized but not treated|0|||
44375293|NCT01104662|79380428|FG004|Overall Study|Randomized but not treated|0|||
44375294|NCT01104662|79380429|FG005|Overall Study|Randomized but not treated|1|||
44375295|NCT01104662|79380430|FG006|Overall Study|Randomized but not treated|0|||
44375296|NCT01104662|79380431|FG007|Overall Study|Randomized but not treated|0|||
44375297|NCT01104584|79380450|FG000|Overall Study|Study drug never administered|21|||
44375298|NCT01104584|79380450|FG000|Overall Study|Study prematurely discontinued|2|||
44375299|NCT01103960|79380474|FG000|Overall Study|Adverse Event|2|||
44224104|NCT01870297|79027776|FG004|Overall Study|Withdrawal by Subject|1|||
44224105|NCT01870297|79027777|FG005|Overall Study|Withdrawal by Subject|1|||
44224106|NCT01870297|79027778|FG006|Overall Study|Withdrawal by Subject|1|||
44224107|NCT01870297|79027772|FG000|Overall Study|Sponsor Decision|0|||
44224108|NCT01870297|79027773|FG001|Overall Study|Sponsor Decision|6|||
44224109|NCT01870297|79027774|FG002|Overall Study|Sponsor Decision|0|||
44224110|NCT01870297|79027775|FG003|Overall Study|Sponsor Decision|0|||
44224111|NCT01870297|79027776|FG004|Overall Study|Sponsor Decision|0|||
44224112|NCT01870297|79027777|FG005|Overall Study|Sponsor Decision|0|||
44224113|NCT01870297|79027778|FG006|Overall Study|Sponsor Decision|1|||
44224114|NCT01814761|79027805|FG000|Overall Study|Other Reasons|1|||
44224115|NCT01814761|79027806|FG001|Overall Study|Other Reasons|10|||
44224116|NCT01814761|79027805|FG000|Overall Study|Ocular Adverse Event|6|||
44224117|NCT01814761|79027806|FG001|Overall Study|Ocular Adverse Event|15|||
44224118|NCT01814761|79027805|FG000|Overall Study|Lost to Follow-up|1|||
44224119|NCT01814761|79027806|FG001|Overall Study|Lost to Follow-up|5|||
44273577|NCT01216683|79215227|FG001|Continuation|Insurance change|1|||
44273578|NCT01216683|79215228|FG002|Continuation|Insurance change|0|||
44273579|NCT01216683|79215226|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
44273580|NCT01216683|79215227|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
44273581|NCT01216683|79215228|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
44273582|NCT01216683|79215226|FG000|Continuation|Not reported|0|||
44273583|NCT01216683|79215227|FG001|Continuation|Not reported|0|||
44273584|NCT01216683|79215228|FG002|Continuation|Not reported|1|||
44273585|NCT01216683|79215226|FG000|Continuation|Never started treatment|0|||
44273586|NCT01216683|79215227|FG001|Continuation|Never started treatment|1|||
44224120|NCT01843933|79027814|FG000|Overall Study|Data lost|6|||
44224121|NCT01843933|79027815|FG001|Overall Study|Data lost|4|||
44224122|NCT01814371|79027823|FG000|Overall Study|Lost to Follow-up|30|||
44224123|NCT01814371|79027824|FG001|Overall Study|Lost to Follow-up|27|||
44224124|NCT01814137|79027898|FG000|Overall Study|Adverse Event|0|||
44224125|NCT01814137|79027899|FG001|Overall Study|Adverse Event|1|||
44224126|NCT01814137|79027898|FG000|Overall Study|Withdrawal by Subject|2|||
44224127|NCT01814137|79027899|FG001|Overall Study|Withdrawal by Subject|2|||
44224128|NCT01814137|79027898|FG000|Overall Study|Physician Decision|1|||
44224129|NCT01814137|79027899|FG001|Overall Study|Physician Decision|1|||
44224130|NCT01814137|79027898|FG000|Overall Study|Unclassified|2|||
44224131|NCT01814137|79027899|FG001|Overall Study|Unclassified|1|||
44224132|NCT01813435|79027916|FG000|Overall Study|did not finish experimental regimen|1902|||
44224133|NCT01813435|79027917|FG001|Overall Study|did not finish experimental regimen|770|||
44273587|NCT01216683|79215228|FG002|Continuation|Never started treatment|5|||
44468198|NCT00455520|79476780|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
44224134|NCT01813435|79027916|FG000|Overall Study|Lost to Follow-up|268|||
44224135|NCT01813435|79027917|FG001|Overall Study|Lost to Follow-up|237|||
44224136|NCT01813357|79027925|FG000|Overall Study|Lost to Follow-up|5|||
44224137|NCT01813357|79027926|FG001|Overall Study|Lost to Follow-up|6|||
44224138|NCT01812655|79027935|FG000|Overall Study|Protocol Violation|1|||
44224139|NCT01812655|79027936|FG001|Overall Study|Protocol Violation|1|||
44224140|NCT01812655|79027937|FG002|Overall Study|Protocol Violation|0|||
44224141|NCT01812109|79027958|FG000|Overall Study|research personnel delay|16|||
44224142|NCT01812109|79027958|FG000|Overall Study|NIRS Unattainable|17|||
44224143|NCT01811953|79027968|FG000|Overall Study|Adverse Event|0|||
44224144|NCT01811953|79027969|FG001|Overall Study|Adverse Event|0|||
44224145|NCT01811953|79027970|FG002|Overall Study|Adverse Event|0|||
44224146|NCT01811953|79027971|FG003|Overall Study|Adverse Event|1|||
44224147|NCT01811953|79027972|FG004|Overall Study|Adverse Event|0|||
44224148|NCT01811953|79027973|FG005|Overall Study|Adverse Event|1|||
44224149|NCT01811953|79027968|FG000|Overall Study|Protocol Violation|0|||
44224150|NCT01811953|79027969|FG001|Overall Study|Protocol Violation|0|||
44224151|NCT01811953|79027970|FG002|Overall Study|Protocol Violation|0|||
44224152|NCT01811953|79027971|FG003|Overall Study|Protocol Violation|0|||
44224153|NCT01811953|79027972|FG004|Overall Study|Protocol Violation|1|||
44224154|NCT01811953|79027973|FG005|Overall Study|Protocol Violation|0|||
44224155|NCT01811563|79027989|FG000|Overall Study|Lost to Follow-up|5|||
44224156|NCT01811563|79027990|FG001|Overall Study|Lost to Follow-up|2|||
44224157|NCT01811563|79027989|FG000|Overall Study|Incorrect Randomization procedure|0|||
44273588|NCT01145495|79215249|FG000|Overall Study|Adverse Event|6|||
44468199|NCT00455520|79476781|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
44224158|NCT01811563|79027990|FG001|Overall Study|Incorrect Randomization procedure|1|||
44224159|NCT01811485|79027999|FG000|Overall Study|Adverse Event|1|||
44273589|NCT01145495|79215249|FG000|Overall Study|Withdrawal by Subject|6|||
44273590|NCT01145495|79215249|FG000|Overall Study|Disease progression after respone|2|||
44224160|NCT01811485|79028000|FG001|Overall Study|Adverse Event|3|||
44224161|NCT01811485|79028001|FG002|Overall Study|Adverse Event|2|||
44224162|NCT01811485|79027999|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44273591|NCT01124695|79215255|FG000|Overall Study|Disease progression|77|||
44273592|NCT01124695|79215255|FG000|Overall Study|Adverse Event|11|||
44224163|NCT01811485|79028000|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44273593|NCT01124695|79215255|FG000|Overall Study|Death|1|||
44273594|NCT01124695|79215255|FG000|Overall Study|Withdrawal by Subject|7|||
44273595|NCT01124695|79215255|FG000|Overall Study|Physician Decision|3|||
44273596|NCT01124695|79215255|FG000|Overall Study|Alternative therapy|9|||
44273597|NCT01124695|79215255|FG000|Overall Study|No documentation that patient went off treatment|4|||
44273598|NCT01124695|79215255|FG000|Overall Study|Ineligible|9|||
44273599|NCT01124695|79215255|FG000|Overall Study|Ineligible and never start treatment|2|||
44273600|NCT01084083|79215266|FG000|Overall Study|Adverse Event|5|||
44273601|NCT01084083|79215266|FG000|Overall Study|Death|1|||
44273602|NCT01084083|79215266|FG000|Overall Study|Withdrawal by Subject|2|||
44273603|NCT01084083|79215266|FG000|Overall Study|Complicating disease|1|||
44273604|NCT01084083|79215266|FG000|Overall Study|Other|2|||
44273605|NCT01084083|79215266|FG000|Overall Study|Never started assigned therapy|1|||
44273606|NCT01079780|79215274|FG000|Overall Study|Disease progression|43|||
44273607|NCT01079780|79215275|FG001|Overall Study|Disease progression|7|||
44273608|NCT01079780|79215276|FG002|Overall Study|Disease progression|31|||
44273609|NCT01079780|79215274|FG000|Overall Study|Adverse Event|13|||
44273610|NCT01079780|79215275|FG001|Overall Study|Adverse Event|5|||
44273611|NCT01079780|79215276|FG002|Overall Study|Adverse Event|7|||
44273612|NCT01079780|79215274|FG000|Overall Study|Death|2|||
44273613|NCT01079780|79215275|FG001|Overall Study|Death|0|||
44273614|NCT01079780|79215276|FG002|Overall Study|Death|2|||
44273615|NCT01079780|79215274|FG000|Overall Study|Withdrawal by Subject|6|||
44273616|NCT01079780|79215275|FG001|Overall Study|Withdrawal by Subject|4|||
44273617|NCT01079780|79215276|FG002|Overall Study|Withdrawal by Subject|4|||
44273618|NCT01079780|79215274|FG000|Overall Study|Alternative therapy|2|||
44273619|NCT01079780|79215275|FG001|Overall Study|Alternative therapy|0|||
44273620|NCT01079780|79215276|FG002|Overall Study|Alternative therapy|2|||
44273621|NCT01079780|79215274|FG000|Overall Study|Physician Decision|1|||
44273622|NCT01079780|79215275|FG001|Overall Study|Physician Decision|0|||
44273623|NCT01079780|79215276|FG002|Overall Study|Physician Decision|1|||
44273624|NCT01079780|79215274|FG000|Overall Study|Error made in lesion measurement|1|||
44273625|NCT01079780|79215275|FG001|Overall Study|Error made in lesion measurement|0|||
44273626|NCT01079780|79215276|FG002|Overall Study|Error made in lesion measurement|0|||
44273627|NCT01079780|79215274|FG000|Overall Study|Patient had surgery|1|||
44273628|NCT01079780|79215275|FG001|Overall Study|Patient had surgery|0|||
44273629|NCT01079780|79215276|FG002|Overall Study|Patient had surgery|0|||
44273630|NCT01079780|79215274|FG000|Overall Study|Treatment cycle delay|0|||
44273631|NCT01079780|79215275|FG001|Overall Study|Treatment cycle delay|0|||
44273632|NCT01079780|79215276|FG002|Overall Study|Treatment cycle delay|1|||
44273633|NCT01079780|79215274|FG000|Overall Study|Never started treatment|1|||
44273634|NCT01079780|79215275|FG001|Overall Study|Never started treatment|0|||
44273635|NCT01079780|79215276|FG002|Overall Study|Never started treatment|2|||
44273636|NCT01013961|79215286|FG000|Overall Study|Adverse Event|2|||
44273637|NCT01013961|79215287|FG001|Overall Study|Adverse Event|2|||
44273638|NCT01013961|79215286|FG000|Overall Study|Withdrawal by Subject|1|||
44273639|NCT01013961|79215287|FG001|Overall Study|Withdrawal by Subject|0|||
44273640|NCT01013961|79215286|FG000|Overall Study|Physician Decision|0|||
44273641|NCT01013961|79215287|FG001|Overall Study|Physician Decision|1|||
44273642|NCT00834093|79215302|FG000|Overall Study|Progressive Disease|3|||
44273643|NCT00834093|79215302|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
44273644|NCT00606294|79215308|FG000|Overall Study|Withdrawal by Subject|36|||
44273645|NCT00606294|79215309|FG001|Overall Study|Withdrawal by Subject|0|||
44273646|NCT00583596|79215315|FG000|Overall Study|Lost to Follow-up|110|||
44273647|NCT00583596|79215315|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
44273648|NCT00583596|79215315|FG000|Overall Study|Death|2|||
44273649|NCT00583596|79215315|FG000|Overall Study|Withdrawal by Subject|6|||
44273650|NCT00583596|79215315|FG000|Overall Study|Lost to Follow-up|94|||
44273651|NCT00583596|79215315|FG000|Overall Study|Data not complete|1|||
44273652|NCT00583596|79215315|FG000|Overall Study|Not consented|15|||
44273653|NCT00583596|79215315|FG000|Overall Study|Outside f-up window|26|||
44273654|NCT00316888|79215326|FG000|Overall Study|Adverse Event|4|||
44273655|NCT00316888|79215327|FG001|Overall Study|Adverse Event|5|||
44273656|NCT00316888|79215326|FG000|Overall Study|Withdrawal by Subject|2|||
44273657|NCT00316888|79215327|FG001|Overall Study|Withdrawal by Subject|2|||
44273658|NCT00316888|79215326|FG000|Overall Study|Not start protocol therapy|0|||
44273659|NCT00316888|79215327|FG001|Overall Study|Not start protocol therapy|1|||
44273660|NCT00274924|79215336|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
44273661|NCT00274924|79215337|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
44273662|NCT00274924|79215338|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
44273663|NCT00274924|79215336|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
44273664|NCT00274924|79215337|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
44273665|NCT00274924|79215338|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
44273666|NCT00274924|79215336|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
44273667|NCT00274924|79215337|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
44273668|NCT00274924|79215338|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
44273669|NCT00274924|79215336|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
44224164|NCT01811485|79028001|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
44224165|NCT01811485|79027999|FG000|Overall Study|Administrative problems|1|||
44224166|NCT01811485|79028000|FG001|Overall Study|Administrative problems|0|||
44224167|NCT01811485|79028001|FG002|Overall Study|Administrative problems|0|||
44224168|NCT01811485|79027999|FG000|Overall Study|Protocol Deviation|0|||
44224169|NCT01811485|79028000|FG001|Overall Study|Protocol Deviation|1|||
44224170|NCT01811485|79028001|FG002|Overall Study|Protocol Deviation|0|||
44224171|NCT01810939|79028012|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
44273670|NCT00274924|79215337|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
44273671|NCT00274924|79215338|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
44273672|NCT00274924|79215336|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
44273673|NCT00274924|79215337|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
44273674|NCT00274924|79215338|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
44273675|NCT00274924|79215336|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
44273676|NCT00274924|79215337|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
44273677|NCT00274924|79215338|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
44273678|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
44273679|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
44273680|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
44273681|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
44224172|NCT01810939|79028013|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
44224173|NCT01810939|79028014|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
44224174|NCT01810939|79028012|FG000|Part A Treatment Period|Protocol Violation|2|||
44224175|NCT01810939|79028013|FG001|Part A Treatment Period|Protocol Violation|0|||
44224176|NCT01810939|79028014|FG002|Part A Treatment Period|Protocol Violation|0|||
44273682|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
44273683|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
44273684|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
44273685|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
44273686|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
44273687|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
44273688|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
44273689|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
44273690|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
44273691|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
44273692|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
44273693|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
44273694|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
44273695|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
44273696|NCT00274924|79215336|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
44273697|NCT00274924|79215337|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
44273698|NCT00274924|79215338|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
44273699|NCT00104884|79215345|FG000|Overall Study|Disease progression|4|||
44273700|NCT00096174|79215349|FG000|Overall Study|Lack of Efficacy|9|||
44224177|NCT01810939|79028012|FG000|Part A Treatment Period|Adverse Event|10|||
44224178|NCT01810939|79028013|FG001|Part A Treatment Period|Adverse Event|0|||
44224179|NCT01810939|79028014|FG002|Part A Treatment Period|Adverse Event|0|||
44224180|NCT01810939|79028012|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
44224181|NCT01810939|79028013|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
44224182|NCT01810939|79028014|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
44224183|NCT01810939|79028012|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
44224184|NCT01810939|79028013|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
44224185|NCT01810939|79028014|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
44273701|NCT00096174|79215349|FG000|Overall Study|Adverse Event|15|||
44273702|NCT00096174|79215349|FG000|Overall Study|Death|6|||
44273703|NCT00096174|79215349|FG000|Overall Study|Withdrawal by Subject|15|||
44273704|NCT00096174|79215349|FG000|Overall Study|Not started protocol therapy|3|||
44273705|NCT00096174|79215349|FG000|Overall Study|Ineligible|6|||
44273706|NCT00096174|79215349|FG000|Overall Study|other reason|8|||
44273707|NCT00080938|79215353|FG000|Overall Study|Adverse Event|3|||
44468200|NCT00455520|79476780|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
44273708|NCT00080938|79215353|FG000|Overall Study|Withdrawal by Subject|6|||
44273709|NCT00080938|79215353|FG000|Overall Study|Death|2|||
44375300|NCT01103960|79380475|FG001|Overall Study|Adverse Event|1|||
44375301|NCT01103960|79380474|FG000|Overall Study|Withdrawal by Subject|2|||
44375302|NCT01103960|79380475|FG001|Overall Study|Withdrawal by Subject|1|||
44224186|NCT01810939|79028012|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
44224187|NCT01810939|79028013|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
44224188|NCT01810939|79028014|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
44375303|NCT01103960|79380474|FG000|Overall Study|Other|1|||
44224189|NCT01810939|79028012|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
44224190|NCT01810939|79028013|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
44224191|NCT01810939|79028014|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
44224192|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
44224193|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
44224194|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
44224195|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
44224196|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
44224197|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
44224198|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
44224199|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
44224200|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
44224201|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
44224202|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
44224203|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
44224204|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
44224205|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
44224206|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
44224207|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
44224208|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
44224209|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
44224210|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
44224211|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
44224212|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
44224213|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
44224214|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
44224215|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
44224216|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
44224217|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
44224218|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
44224219|NCT01810939|79028012|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
44224220|NCT01810939|79028013|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
44224221|NCT01810939|79028014|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
44224222|NCT01810783|79028033|FG000|Overall Study|Adverse Event|32|||
44224223|NCT01810783|79028033|FG000|Overall Study|Withdrawal by Subject|22|||
44224224|NCT01810783|79028033|FG000|Overall Study|Lack of Efficacy|12|||
44224225|NCT01810783|79028033|FG000|Overall Study|Lost to Follow-up|10|||
44224226|NCT01810783|79028033|FG000|Overall Study|Protocol Violation|5|||
44224227|NCT01810783|79028033|FG000|Overall Study|Non-compliance with IMP|4|||
44224228|NCT01810783|79028033|FG000|Overall Study|Adminstrative or other reason(s)|23|||
44224229|NCT01810783|79028033|FG000|Overall Study|Enrolled, not treated|1|||
44224230|NCT01808209|79028054|FG000|Overall Study|Lost to Follow-up|0|||
44224231|NCT01808209|79028055|FG001|Overall Study|Lost to Follow-up|1|||
44224232|NCT01807117|79028065|FG000|Overall Study|Physician Decision|2|||
44224233|NCT01807117|79028065|FG000|Overall Study|Disease diagnosis not a study disease|1|||
44224234|NCT01806961|79028071|FG000|Overall Study|sponsor decision|16|||
44224235|NCT01613131|79028077|FG000|Overall Study|Withdrawal by Subject|3|||
44224236|NCT01613131|79028078|FG001|Overall Study|Withdrawal by Subject|5|||
44224237|NCT01868893|79028084|FG000|Overall Study|Adverse Event|2|||
44224238|NCT01868893|79028084|FG000|Overall Study|Commercial availability of study drug|17|||
44224239|NCT01868893|79028084|FG000|Overall Study|Neutropenia|1|||
44224240|NCT01868503|79028090|FG000|Overall Study|Withdrawal by Subject|1|||
44224241|NCT01868503|79028090|FG000|Overall Study|Protocol Violation|1|||
44224242|NCT01868035|79028100|FG000|Overall Study|Lost to Follow-up|3|||
44224243|NCT01868035|79028100|FG000|Overall Study|Withdrawal by Subject|1|||
44224244|NCT01868035|79028100|FG000|Overall Study|Progressive Disease|2|||
44224245|NCT01868035|79028100|FG000|Overall Study|Non-compliance|1|||
44224246|NCT01609933|79028104|FG000|Overall Study|Adverse Event|1|||
44224247|NCT01609933|79028104|FG000|Overall Study|Withdrawal by Subject|3|||
44224248|NCT01843777|79028112|FG000|Overall Study|Withdrawal by Subject|1|||
44224249|NCT01843777|79028113|FG001|Overall Study|Withdrawal by Subject|0|||
44224250|NCT01842607|79028119|FG000|Overall Study|Adverse Event|11|||
44224251|NCT01842607|79028119|FG000|Overall Study|Lack of Efficacy|19|||
44224252|NCT01842607|79028119|FG000|Overall Study|Protocol Violation|8|||
44224253|NCT01842607|79028119|FG000|Overall Study|Protocol defined stopping criteria|2|||
44224254|NCT01842607|79028119|FG000|Overall Study|Lost to Follow-up|3|||
44224255|NCT01842607|79028119|FG000|Overall Study|Physician Decision|9|||
44224256|NCT01842607|79028119|FG000|Overall Study|Withdrawal by Subject|14|||
44224257|NCT01803607|79028125|FG000|Overall Study|Adverse Event|5|||
44224258|NCT01803607|79028126|FG001|Overall Study|Adverse Event|3|||
44224259|NCT01803607|79028125|FG000|Overall Study|Lack of Efficacy|0|||
44224260|NCT01803607|79028126|FG001|Overall Study|Lack of Efficacy|1|||
44224261|NCT01803607|79028125|FG000|Overall Study|Protocol Violation|3|||
44224262|NCT01803607|79028126|FG001|Overall Study|Protocol Violation|2|||
44224263|NCT01803607|79028125|FG000|Overall Study|Study terminated by sponsor|54|||
44224264|NCT01803607|79028126|FG001|Overall Study|Study terminated by sponsor|56|||
44224265|NCT01803607|79028125|FG000|Overall Study|Withdrawal by Subject|6|||
44224266|NCT01803607|79028126|FG001|Overall Study|Withdrawal by Subject|5|||
44224267|NCT01867021|79028134|FG000|Overall Study|Adverse Event|0|||
44224268|NCT01867021|79028135|FG001|Overall Study|Adverse Event|1|||
44224269|NCT01867021|79028134|FG000|Overall Study|Not Eligible|0|||
44224270|NCT01867021|79028135|FG001|Overall Study|Not Eligible|1|||
44224271|NCT01867021|79028134|FG000|Overall Study|Death|1|||
44224272|NCT01867021|79028135|FG001|Overall Study|Death|0|||
44224273|NCT01867021|79028134|FG000|Overall Study|Lost to Follow-up|0|||
44224274|NCT01867021|79028135|FG001|Overall Study|Lost to Follow-up|2|||
44224275|NCT01867021|79028134|FG000|Overall Study|Withdrawal by Subject|1|||
44224276|NCT01867021|79028135|FG001|Overall Study|Withdrawal by Subject|6|||
44224277|NCT01866709|79028148|FG000|Overall Study|Adverse Event|1|||
44224278|NCT01866709|79028149|FG001|Overall Study|Adverse Event|0|||
44224279|NCT01841593|79028157|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
44224280|NCT01841593|79028158|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
44224281|NCT01841593|79028157|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
44224282|NCT01841593|79028158|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
44224283|NCT01866319|79028411|FG000|Overall Study|Adverse Event|12|||
44224284|NCT01866319|79028412|FG001|Overall Study|Adverse Event|5|||
44468201|NCT00455520|79476781|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
44468202|NCT00455520|79476780|FG000|Open Label Tapentadol Extended Release|All other|33|||
44468203|NCT00455520|79476781|FG001|Open Label Tapentadol Extended Release|All other|0|||
44468204|NCT00455520|79476780|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
44468205|NCT00455520|79476781|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
44468206|NCT00455520|79476780|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
44468207|NCT00455520|79476781|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
44468208|NCT00455520|79476780|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
44468209|NCT00455520|79476781|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
44468210|NCT00455520|79476780|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
44224285|NCT01866319|79028413|FG002|Overall Study|Adverse Event|9|||
44468211|NCT00455520|79476781|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
44468212|NCT00455520|79476780|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
44468213|NCT00455520|79476781|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
44468214|NCT00455520|79476780|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
44468215|NCT00455520|79476781|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
44468216|NCT00440700|79476790|FG000|Overall Study|Withdrawal by Subject|8|||
44468217|NCT00440700|79476791|FG001|Overall Study|Withdrawal by Subject|8|||
44224286|NCT01866319|79028411|FG000|Overall Study|Clinical progression|3|||
44224287|NCT01866319|79028412|FG001|Overall Study|Clinical progression|2|||
44224288|NCT01866319|79028413|FG002|Overall Study|Clinical progression|2|||
44224289|NCT01866319|79028411|FG000|Overall Study|Death|153|||
44468218|NCT00440700|79476792|FG002|Overall Study|Withdrawal by Subject|4|||
44468219|NCT00284050|79476803|FG000|Overall Study|Adverse Event|1|||
44468220|NCT00284050|79476804|FG001|Overall Study|Adverse Event|1|||
44468221|NCT00284050|79476805|FG002|Overall Study|Adverse Event|1|||
44468222|NCT00284050|79476803|FG000|Overall Study|Lack of Efficacy|0|||
44468223|NCT00284050|79476804|FG001|Overall Study|Lack of Efficacy|1|||
44468224|NCT00284050|79476805|FG002|Overall Study|Lack of Efficacy|3|||
44468225|NCT00284050|79476803|FG000|Overall Study|Protocol Violation|0|||
44468226|NCT00284050|79476804|FG001|Overall Study|Protocol Violation|1|||
44468227|NCT00284050|79476805|FG002|Overall Study|Protocol Violation|2|||
44468228|NCT00284050|79476803|FG000|Overall Study|Withdrawal by Subject|2|||
44468229|NCT00284050|79476804|FG001|Overall Study|Withdrawal by Subject|2|||
44468230|NCT00284050|79476805|FG002|Overall Study|Withdrawal by Subject|2|||
44468231|NCT00284050|79476803|FG000|Overall Study|Lost to Follow-up|1|||
44468232|NCT00284050|79476804|FG001|Overall Study|Lost to Follow-up|0|||
44468233|NCT00284050|79476805|FG002|Overall Study|Lost to Follow-up|1|||
44468234|NCT00284050|79476803|FG000|Overall Study|Death|1|||
44468235|NCT00284050|79476804|FG001|Overall Study|Death|0|||
44468236|NCT00284050|79476805|FG002|Overall Study|Death|0|||
44468237|NCT00293020|79476813|FG000|Overall Study|Withdrawal by Subject|34|||
44468238|NCT00293020|79476813|FG000|Overall Study|Adverse Event|30|||
44468239|NCT00293020|79476813|FG000|Overall Study|Death|32|||
44468240|NCT00293020|79476813|FG000|Overall Study|Lack of Efficacy|12|||
44468241|NCT00293020|79476813|FG000|Overall Study|Lost to Follow-up|4|||
44468242|NCT00293020|79476813|FG000|Overall Study|Protocol Violation|6|||
44224290|NCT01866319|79028412|FG001|Overall Study|Death|154|||
44224291|NCT01866319|79028413|FG002|Overall Study|Death|147|||
44224292|NCT01866319|79028411|FG000|Overall Study|Lost to Follow-up|6|||
44224293|NCT01866319|79028412|FG001|Overall Study|Lost to Follow-up|3|||
44224294|NCT01866319|79028413|FG002|Overall Study|Lost to Follow-up|8|||
44468243|NCT00293020|79476813|FG000|Overall Study|Physician Decision|21|||
44468244|NCT00293020|79476813|FG000|Overall Study|Other Reason|22|||
44468245|NCT00293020|79476813|FG000|Overall Study|No dose taken|1|||
44468246|NCT00377637|79476821|FG000|Induction Phase|Adverse Event|12|||
44468247|NCT00377637|79476822|FG001|Induction Phase|Adverse Event|21|||
44468248|NCT00377637|79476823|FG002|Induction Phase|Adverse Event|0|||
44468249|NCT00377637|79476824|FG003|Induction Phase|Adverse Event|0|||
44468250|NCT00377637|79476821|FG000|Induction Phase|Deterioration/serum creatinine|2|||
44468251|NCT00377637|79476822|FG001|Induction Phase|Deterioration/serum creatinine|0|||
44468252|NCT00377637|79476823|FG002|Induction Phase|Deterioration/serum creatinine|0|||
44468253|NCT00377637|79476824|FG003|Induction Phase|Deterioration/serum creatinine|0|||
44468254|NCT00377637|79476821|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
44468255|NCT00377637|79476822|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
44468256|NCT00377637|79476823|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
44468257|NCT00377637|79476824|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
44468258|NCT00377637|79476821|FG000|Induction Phase|Lost to Follow-up|2|||
44468259|NCT00377637|79476822|FG001|Induction Phase|Lost to Follow-up|1|||
44468260|NCT00377637|79476823|FG002|Induction Phase|Lost to Follow-up|0|||
44468261|NCT00377637|79476824|FG003|Induction Phase|Lost to Follow-up|0|||
44468262|NCT00377637|79476821|FG000|Induction Phase|Death|1|||
44468263|NCT00377637|79476822|FG001|Induction Phase|Death|3|||
44468264|NCT00377637|79476823|FG002|Induction Phase|Death|0|||
44468265|NCT00377637|79476824|FG003|Induction Phase|Death|0|||
44468266|NCT00377637|79476821|FG000|Induction Phase|Withdrawal by Subject|5|||
44468267|NCT00377637|79476822|FG001|Induction Phase|Withdrawal by Subject|6|||
44468268|NCT00377637|79476823|FG002|Induction Phase|Withdrawal by Subject|0|||
44468269|NCT00377637|79476824|FG003|Induction Phase|Withdrawal by Subject|0|||
44468270|NCT00377637|79476821|FG000|Induction Phase|Physician Decision|3|||
44468271|NCT00377637|79476822|FG001|Induction Phase|Physician Decision|1|||
44468272|NCT00377637|79476823|FG002|Induction Phase|Physician Decision|0|||
44468273|NCT00377637|79476824|FG003|Induction Phase|Physician Decision|0|||
44468274|NCT00377637|79476821|FG000|Induction Phase|Sponsor decision|1|||
44468275|NCT00377637|79476822|FG001|Induction Phase|Sponsor decision|2|||
44468276|NCT00377637|79476823|FG002|Induction Phase|Sponsor decision|0|||
44224295|NCT01866319|79028411|FG000|Overall Study|Physician Decision|1|||
44224296|NCT01866319|79028412|FG001|Overall Study|Physician Decision|0|||
44224297|NCT01866319|79028413|FG002|Overall Study|Physician Decision|1|||
44224298|NCT01866319|79028411|FG000|Overall Study|Protocol Violation|0|||
44468277|NCT00377637|79476824|FG003|Induction Phase|Sponsor decision|0|||
44468278|NCT00377637|79476821|FG000|Induction Phase|Non-Compliance|1|||
44273710|NCT00080938|79215353|FG000|Overall Study|Lack of Efficacy|7|||
44468279|NCT00377637|79476822|FG001|Induction Phase|Non-Compliance|0|||
44468280|NCT00377637|79476823|FG002|Induction Phase|Non-Compliance|0|||
44468281|NCT00377637|79476824|FG003|Induction Phase|Non-Compliance|0|||
44468282|NCT00377637|79476821|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
44468283|NCT00377637|79476822|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
44468284|NCT00377637|79476823|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
44224299|NCT01866319|79028412|FG001|Overall Study|Protocol Violation|0|||
44514820|NCT03084796|79520628|FG005|Overall Study|Randomization error|0|||
44468285|NCT00377637|79476824|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
44468286|NCT00377637|79476821|FG000|Maintenance Phase|Adverse Event|0|||
44468287|NCT00377637|79476822|FG001|Maintenance Phase|Adverse Event|0|||
44468288|NCT00377637|79476823|FG002|Maintenance Phase|Adverse Event|29|||
44468289|NCT00377637|79476824|FG003|Maintenance Phase|Adverse Event|43|||
44224300|NCT01866319|79028413|FG002|Overall Study|Protocol Violation|1|||
44224301|NCT01866319|79028411|FG000|Overall Study|Withdrawal by Subject|32|||
44224302|NCT01866319|79028412|FG001|Overall Study|Withdrawal by Subject|14|||
44224303|NCT01866319|79028413|FG002|Overall Study|Withdrawal by Subject|12|||
44224304|NCT01802515|79028440|FG000|Overall Study|Withdrawal by Subject|3|||
44224305|NCT01802515|79028441|FG001|Overall Study|Withdrawal by Subject|0|||
44224306|NCT01802515|79028442|FG002|Overall Study|Withdrawal by Subject|0|||
44224307|NCT01802437|79028452|FG000|Overall Study|Lost to Follow-up|1|||
44224308|NCT01802437|79028453|FG001|Overall Study|Lost to Follow-up|0|||
44224309|NCT01802437|79028452|FG000|Overall Study|Withdrawal by Subject|3|||
44224310|NCT01802437|79028453|FG001|Overall Study|Withdrawal by Subject|4|||
44224311|NCT01801735|79028560|FG000|Overall Study|Adverse Event|79|||
44224312|NCT01801735|79028560|FG000|Overall Study|Lack of Efficacy|28|||
44224313|NCT01801735|79028560|FG000|Overall Study|Withdrawal by Subject|27|||
44224314|NCT01801735|79028560|FG000|Overall Study|Protocol Violation|25|||
44224315|NCT01801735|79028560|FG000|Overall Study|Lost to Follow-up|15|||
44224316|NCT01801735|79028560|FG000|Overall Study|Non-compliance with Trial Drug|13|||
44224317|NCT01801735|79028560|FG000|Overall Study|Physician Decision|3|||
44224318|NCT01801735|79028560|FG000|Overall Study|Death|1|||
44224319|NCT01801735|79028560|FG000|Overall Study|Other, including site closure|19|||
44224320|NCT01840579|79029318|FG000|Overall Study|Status not recorded|0|||
44224321|NCT01840579|79029319|FG001|Overall Study|Status not recorded|0|||
44224322|NCT01840579|79029320|FG002|Overall Study|Status not recorded|2|||
44224323|NCT01840579|79029321|FG003|Overall Study|Status not recorded|3|||
44468290|NCT00377637|79476821|FG000|Maintenance Phase|Physician Decision|0|||
44468291|NCT00377637|79476822|FG001|Maintenance Phase|Physician Decision|0|||
44468292|NCT00377637|79476823|FG002|Maintenance Phase|Physician Decision|5|||
44468293|NCT00377637|79476824|FG003|Maintenance Phase|Physician Decision|4|||
44468294|NCT00377637|79476821|FG000|Maintenance Phase|Lost to Follow-up|0|||
44468295|NCT00377637|79476822|FG001|Maintenance Phase|Lost to Follow-up|0|||
44468296|NCT00377637|79476823|FG002|Maintenance Phase|Lost to Follow-up|3|||
44468297|NCT00377637|79476824|FG003|Maintenance Phase|Lost to Follow-up|1|||
44468298|NCT00377637|79476821|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44468299|NCT00377637|79476822|FG001|Maintenance Phase|Withdrawal by Subject|0|||
44468300|NCT00377637|79476823|FG002|Maintenance Phase|Withdrawal by Subject|3|||
44468301|NCT00377637|79476824|FG003|Maintenance Phase|Withdrawal by Subject|3|||
44468302|NCT00377637|79476821|FG000|Maintenance Phase|Sponsor decision|0|||
44468303|NCT00377637|79476822|FG001|Maintenance Phase|Sponsor decision|0|||
44468304|NCT00377637|79476823|FG002|Maintenance Phase|Sponsor decision|2|||
44468305|NCT00377637|79476824|FG003|Maintenance Phase|Sponsor decision|3|||
44468306|NCT00377637|79476821|FG000|Maintenance Phase|Non-compliance|0|||
44468307|NCT00377637|79476822|FG001|Maintenance Phase|Non-compliance|0|||
44468308|NCT00377637|79476823|FG002|Maintenance Phase|Non-compliance|1|||
44468309|NCT00377637|79476824|FG003|Maintenance Phase|Non-compliance|1|||
44468310|NCT00377637|79476821|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
44468311|NCT00377637|79476822|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
44468312|NCT00377637|79476823|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
44468313|NCT00377637|79476824|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
44468314|NCT00377637|79476821|FG000|Maintenance Phase|Death|0|||
44468315|NCT00377637|79476822|FG001|Maintenance Phase|Death|0|||
44468316|NCT00377637|79476823|FG002|Maintenance Phase|Death|0|||
44468317|NCT00377637|79476824|FG003|Maintenance Phase|Death|1|||
44468318|NCT00377403|79476840|FG000|Overall Study|Unable to contact for telephone intervie|4|||
44468319|NCT00377403|79476841|FG001|Overall Study|Unable to contact for telephone intervie|7|||
44468320|NCT00370149|79476849|FG000|Overall Study|Physician Decision|16|||
44224324|NCT01840579|79029322|FG004|Overall Study|Status not recorded|4|||
44224325|NCT01840579|79029323|FG005|Overall Study|Status not recorded|3|||
44224326|NCT01840579|79029324|FG006|Overall Study|Status not recorded|0|||
44468321|NCT00370149|79476850|FG001|Overall Study|Physician Decision|16|||
44468322|NCT00370149|79476849|FG000|Overall Study|Protocol Violation|1|||
44468323|NCT00370149|79476850|FG001|Overall Study|Protocol Violation|0|||
44224327|NCT01840579|79029325|FG007|Overall Study|Status not recorded|3|||
44468324|NCT00370149|79476849|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
44468325|NCT00370149|79476850|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
44468326|NCT00370149|79476849|FG000|Overall Study|Pre-existing infection|0|||
44468327|NCT00370149|79476850|FG001|Overall Study|Pre-existing infection|1|||
44468328|NCT00370149|79476849|FG000|Overall Study|Antibiotic coated dressing placed|0|||
44468329|NCT00370149|79476850|FG001|Overall Study|Antibiotic coated dressing placed|1|||
44224328|NCT01840579|79029326|FG008|Overall Study|Status not recorded|3|||
44224329|NCT01840579|79029327|FG009|Overall Study|Status not recorded|3|||
44224330|NCT01840579|79029318|FG000|Overall Study|Progressive disease|3|||
44224331|NCT01840579|79029319|FG001|Overall Study|Progressive disease|5|||
44468330|NCT00292942|79476863|FG000|Overall Study|Withdrawal by Subject|0|||
44468331|NCT00292942|79476864|FG001|Overall Study|Withdrawal by Subject|0|||
44468332|NCT00292942|79476865|FG002|Overall Study|Withdrawal by Subject|1|||
44468333|NCT00292942|79476866|FG003|Overall Study|Withdrawal by Subject|0|||
44468334|NCT00292942|79476863|FG000|Overall Study|Adverse Event|0|||
44468335|NCT00292942|79476864|FG001|Overall Study|Adverse Event|0|||
44468336|NCT00292942|79476865|FG002|Overall Study|Adverse Event|0|||
44468337|NCT00292942|79476866|FG003|Overall Study|Adverse Event|1|||
44468338|NCT00483938|79476886|FG000|Overall Study|Protocol Violation|0|||
44468339|NCT00483938|79476887|FG001|Overall Study|Protocol Violation|0|||
44468340|NCT00483938|79476888|FG002|Overall Study|Protocol Violation|0|||
44468341|NCT00483938|79476889|FG003|Overall Study|Protocol Violation|0|||
44468342|NCT00483938|79476890|FG004|Overall Study|Protocol Violation|0|||
44468343|NCT00483938|79476891|FG005|Overall Study|Protocol Violation|0|||
44468344|NCT00483938|79476892|FG006|Overall Study|Protocol Violation|3|||
44468345|NCT00483938|79476886|FG000|Overall Study|Withdrawal by Subject|1|||
44468346|NCT00483938|79476887|FG001|Overall Study|Withdrawal by Subject|6|||
44224332|NCT01840579|79029320|FG002|Overall Study|Progressive disease|0|||
44224333|NCT01840579|79029321|FG003|Overall Study|Progressive disease|0|||
44224334|NCT01840579|79029322|FG004|Overall Study|Progressive disease|0|||
44224335|NCT01840579|79029323|FG005|Overall Study|Progressive disease|0|||
44224336|NCT01840579|79029324|FG006|Overall Study|Progressive disease|0|||
44224337|NCT01840579|79029325|FG007|Overall Study|Progressive disease|0|||
44224338|NCT01840579|79029326|FG008|Overall Study|Progressive disease|0|||
44224339|NCT01840579|79029327|FG009|Overall Study|Progressive disease|0|||
44224340|NCT01840579|79029318|FG000|Overall Study|Ongoing in study|0|||
44224341|NCT01840579|79029319|FG001|Overall Study|Ongoing in study|1|||
44468347|NCT00483938|79476888|FG002|Overall Study|Withdrawal by Subject|0|||
44468348|NCT00483938|79476889|FG003|Overall Study|Withdrawal by Subject|0|||
44468349|NCT00483938|79476890|FG004|Overall Study|Withdrawal by Subject|1|||
44468350|NCT00483938|79476891|FG005|Overall Study|Withdrawal by Subject|3|||
44468351|NCT00483938|79476892|FG006|Overall Study|Withdrawal by Subject|2|||
44468352|NCT00483938|79476886|FG000|Overall Study|Lost to Follow-up|1|||
44468353|NCT00483938|79476887|FG001|Overall Study|Lost to Follow-up|2|||
44468354|NCT00483938|79476888|FG002|Overall Study|Lost to Follow-up|0|||
44468355|NCT00483938|79476889|FG003|Overall Study|Lost to Follow-up|2|||
44468356|NCT00483938|79476890|FG004|Overall Study|Lost to Follow-up|1|||
44468357|NCT00483938|79476891|FG005|Overall Study|Lost to Follow-up|1|||
44224342|NCT01840579|79029320|FG002|Overall Study|Ongoing in study|0|||
44224343|NCT01840579|79029321|FG003|Overall Study|Ongoing in study|0|||
44224344|NCT01840579|79029322|FG004|Overall Study|Ongoing in study|0|||
44224345|NCT01840579|79029323|FG005|Overall Study|Ongoing in study|0|||
44224346|NCT01840579|79029324|FG006|Overall Study|Ongoing in study|0|||
44224347|NCT01840579|79029325|FG007|Overall Study|Ongoing in study|0|||
44224348|NCT01840579|79029326|FG008|Overall Study|Ongoing in study|0|||
44224349|NCT01840579|79029327|FG009|Overall Study|Ongoing in study|0|||
44224350|NCT01840579|79029318|FG000|Overall Study|Death|0|||
44375304|NCT01103960|79380475|FG001|Overall Study|Other|0|||
44375305|NCT01107392|79380483|FG000|Overall Study|Adverse Event|2|||
44375306|NCT01107392|79380484|FG001|Overall Study|Adverse Event|0|||
44224351|NCT01840579|79029319|FG001|Overall Study|Death|0|||
44224352|NCT01840579|79029320|FG002|Overall Study|Death|0|||
44224353|NCT01840579|79029321|FG003|Overall Study|Death|0|||
44224354|NCT01840579|79029322|FG004|Overall Study|Death|0|||
44224355|NCT01840579|79029323|FG005|Overall Study|Death|1|||
44224356|NCT01840579|79029324|FG006|Overall Study|Death|0|||
44375307|NCT01107392|79380483|FG000|Overall Study|Personal Reasons|2|||
44375308|NCT01107392|79380484|FG001|Overall Study|Personal Reasons|3|||
44375309|NCT01107392|79380483|FG000|Overall Study|Administrative decision|1|||
44375310|NCT01107392|79380484|FG001|Overall Study|Administrative decision|0|||
44375311|NCT01106846|79380492|FG000|Overall Study|Change in surgical procedure|0|||
44375312|NCT01106846|79380493|FG001|Overall Study|Change in surgical procedure|1|||
44375313|NCT00902577|79380499|FG000|Overall Study|Withdrawal by Subject|6|||
44375314|NCT00902577|79380499|FG000|Overall Study|FMISO production failure|2|||
44375315|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
44375316|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
44375317|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
44468358|NCT00483938|79476892|FG006|Overall Study|Lost to Follow-up|3|||
44468359|NCT00483938|79476886|FG000|Overall Study|Death|0|||
44468360|NCT00483938|79476887|FG001|Overall Study|Death|2|||
44224357|NCT01840579|79029325|FG007|Overall Study|Death|0|||
44224358|NCT01840579|79029326|FG008|Overall Study|Death|0|||
44224359|NCT01840579|79029327|FG009|Overall Study|Death|0|||
44224360|NCT01840579|79029318|FG000|Overall Study|Adverse Event|0|||
44224361|NCT01840579|79029319|FG001|Overall Study|Adverse Event|1|||
44224362|NCT01840579|79029320|FG002|Overall Study|Adverse Event|0|||
44224363|NCT01840579|79029321|FG003|Overall Study|Adverse Event|0|||
44224364|NCT01840579|79029322|FG004|Overall Study|Adverse Event|0|||
44224365|NCT01840579|79029323|FG005|Overall Study|Adverse Event|0|||
44468361|NCT00483938|79476888|FG002|Overall Study|Death|0|||
44468362|NCT00483938|79476889|FG003|Overall Study|Death|0|||
44468363|NCT00483938|79476890|FG004|Overall Study|Death|0|||
44468364|NCT00483938|79476891|FG005|Overall Study|Death|0|||
44468365|NCT00483938|79476892|FG006|Overall Study|Death|0|||
44468366|NCT00483938|79476886|FG000|Overall Study|Other|3|||
44224366|NCT01840579|79029324|FG006|Overall Study|Adverse Event|0|||
44224367|NCT01840579|79029325|FG007|Overall Study|Adverse Event|0|||
44224368|NCT01840579|79029326|FG008|Overall Study|Adverse Event|0|||
44273711|NCT00080938|79215353|FG000|Overall Study|other disease|1|||
44273712|NCT00080938|79215353|FG000|Overall Study|Not started protocol therapy|1|||
44273713|NCT00080938|79215353|FG000|Overall Study|Ineligible|4|||
44468367|NCT00483938|79476887|FG001|Overall Study|Other|9|||
44468368|NCT00483938|79476888|FG002|Overall Study|Other|0|||
44468369|NCT00483938|79476889|FG003|Overall Study|Other|4|||
44468370|NCT00483938|79476890|FG004|Overall Study|Other|0|||
44468371|NCT00483938|79476891|FG005|Overall Study|Other|4|||
44468372|NCT00483938|79476892|FG006|Overall Study|Other|32|||
44468373|NCT00370071|79476911|FG000|Overall Study|Withdrawal by Subject|2|||
44273714|NCT00074282|79215357|FG000|Step 1|Adverse Event|32|||
44273715|NCT00074282|79215358|FG001|Step 1|Adverse Event|0|||
44273716|NCT00074282|79215359|FG002|Step 1|Adverse Event|0|||
44273717|NCT00074282|79215357|FG000|Step 1|Death|6|||
44273718|NCT00074282|79215358|FG001|Step 1|Death|0|||
44273719|NCT00074282|79215359|FG002|Step 1|Death|0|||
44273720|NCT00074282|79215357|FG000|Step 1|Withdrawal by Subject|7|||
44273721|NCT00074282|79215358|FG001|Step 1|Withdrawal by Subject|0|||
44273722|NCT00074282|79215359|FG002|Step 1|Withdrawal by Subject|0|||
44273723|NCT00074282|79215357|FG000|Step 1|Disease progression|2|||
44273724|NCT00074282|79215358|FG001|Step 1|Disease progression|0|||
44273725|NCT00074282|79215359|FG002|Step 1|Disease progression|0|||
44273726|NCT00074282|79215357|FG000|Step 1|Alternative therapy|2|||
44273727|NCT00074282|79215358|FG001|Step 1|Alternative therapy|0|||
44273728|NCT00074282|79215359|FG002|Step 1|Alternative therapy|0|||
44273729|NCT00074282|79215357|FG000|Step 1|Other complicating disease|2|||
44273730|NCT00074282|79215358|FG001|Step 1|Other complicating disease|0|||
44273731|NCT00074282|79215359|FG002|Step 1|Other complicating disease|0|||
44273732|NCT00074282|79215357|FG000|Step 1|Physician Decision|1|||
44273733|NCT00074282|79215358|FG001|Step 1|Physician Decision|0|||
44273734|NCT00074282|79215359|FG002|Step 1|Physician Decision|0|||
44273735|NCT00074282|79215357|FG000|Step 1|Ineligible|4|||
44273736|NCT00074282|79215358|FG001|Step 1|Ineligible|0|||
44273737|NCT00074282|79215359|FG002|Step 1|Ineligible|0|||
44273738|NCT00074282|79215357|FG000|Step 1|Never started treatment|2|||
44273739|NCT00074282|79215358|FG001|Step 1|Never started treatment|0|||
44273740|NCT00074282|79215359|FG002|Step 1|Never started treatment|0|||
44273741|NCT00074282|79215357|FG000|Step 2|Adverse Event|0|||
44273742|NCT00074282|79215358|FG001|Step 2|Adverse Event|2|||
44273743|NCT00074282|79215359|FG002|Step 2|Adverse Event|12|||
44468374|NCT00369915|79476917|FG000|Overall Study|expected side effects|2|||
44224369|NCT01840579|79029327|FG009|Overall Study|Adverse Event|0|||
44224370|NCT01840579|79029318|FG000|Overall Study|Follow-up ended by Sponsor|0|||
44224371|NCT01840579|79029319|FG001|Overall Study|Follow-up ended by Sponsor|0|||
44224372|NCT01840579|79029320|FG002|Overall Study|Follow-up ended by Sponsor|0|||
44273744|NCT00074282|79215357|FG000|Step 2|Disease progression|0|||
44468375|NCT00369915|79476918|FG001|Overall Study|expected side effects|1|||
44224373|NCT01840579|79029321|FG003|Overall Study|Follow-up ended by Sponsor|0|||
44224374|NCT01840579|79029322|FG004|Overall Study|Follow-up ended by Sponsor|0|||
44224375|NCT01840579|79029323|FG005|Overall Study|Follow-up ended by Sponsor|0|||
44273745|NCT00074282|79215358|FG001|Step 2|Disease progression|0|||
44273746|NCT00074282|79215359|FG002|Step 2|Disease progression|5|||
44273747|NCT00074282|79215357|FG000|Step 2|Death|0|||
44273748|NCT00074282|79215358|FG001|Step 2|Death|0|||
44468376|NCT00369915|79476917|FG000|Overall Study|Withdrawal by Subject|4|||
44468377|NCT00369915|79476918|FG001|Overall Study|Withdrawal by Subject|1|||
44273749|NCT00074282|79215359|FG002|Step 2|Death|3|||
44273750|NCT00074282|79215357|FG000|Step 2|Withdrawal by Subject|0|||
44273751|NCT00074282|79215358|FG001|Step 2|Withdrawal by Subject|0|||
44273752|NCT00074282|79215359|FG002|Step 2|Withdrawal by Subject|2|||
44273753|NCT00074282|79215357|FG000|Step 2|Physician Decision|0|||
44273754|NCT00074282|79215358|FG001|Step 2|Physician Decision|0|||
44273755|NCT00074282|79215359|FG002|Step 2|Physician Decision|1|||
44468378|NCT00369915|79476917|FG000|Overall Study|W/drawl by investigators|0|||
44468379|NCT00369915|79476918|FG001|Overall Study|W/drawl by investigators|1|||
44468380|NCT00369681|79476924|FG000|Overall Study|Death|1|||
44224376|NCT01840579|79029324|FG006|Overall Study|Follow-up ended by Sponsor|2|||
44224377|NCT01840579|79029325|FG007|Overall Study|Follow-up ended by Sponsor|0|||
44224378|NCT01840579|79029326|FG008|Overall Study|Follow-up ended by Sponsor|0|||
44224379|NCT01840579|79029327|FG009|Overall Study|Follow-up ended by Sponsor|0|||
44224380|NCT01801111|79029406|FG000|Overall Study|Adverse Event|12|||
44224381|NCT01801111|79029406|FG000|Overall Study|Death|8|||
44224382|NCT01801111|79029406|FG000|Overall Study|Physician Decision|5|||
44224383|NCT01801111|79029406|FG000|Overall Study|Other|1|||
44224384|NCT01801111|79029406|FG000|Overall Study|Withdrawal by Subject|4|||
44224385|NCT01801111|79029406|FG000|Overall Study|Study Terminated by Sponsor|27|||
44224386|NCT01801111|79029406|FG000|Overall Study|Progressive Disease|81|||
44224387|NCT01773967|79029438|FG000|Overall Study|Lost to Follow-up|15|||
44224388|NCT01773967|79029439|FG001|Overall Study|Lost to Follow-up|13|||
44224389|NCT01773889|79029449|FG000|Overall Study|lack of funding|2|||
44224390|NCT01839487|79029627|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
44224391|NCT01839487|79029628|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
44224392|NCT01839487|79029629|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
44224393|NCT01839487|79029630|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
44224394|NCT01839487|79029631|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
44224395|NCT01839487|79029632|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
44224396|NCT01839487|79029627|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
44224397|NCT01839487|79029628|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
44224398|NCT01839487|79029629|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
44224399|NCT01839487|79029630|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
44224400|NCT01839487|79029631|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
44224401|NCT01839487|79029632|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
44224402|NCT01839487|79029627|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
44224403|NCT01839487|79029628|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
44224404|NCT01839487|79029629|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
44224405|NCT01839487|79029630|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
44224406|NCT01839487|79029631|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
44224407|NCT01839487|79029632|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
44224408|NCT01839487|79029627|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
44224409|NCT01839487|79029628|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
44224410|NCT01839487|79029629|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
44224411|NCT01839487|79029630|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
44224412|NCT01839487|79029631|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
44224413|NCT01839487|79029632|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
44224414|NCT01839487|79029627|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
44224415|NCT01839487|79029628|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
44224416|NCT01839487|79029629|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
44224417|NCT01839487|79029630|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
44224418|NCT01839487|79029631|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
44224419|NCT01839487|79029632|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
44224420|NCT01839487|79029627|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
44224421|NCT01839487|79029628|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
44224422|NCT01839487|79029629|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
44224423|NCT01839487|79029630|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
44224424|NCT01839487|79029631|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
44224425|NCT01839487|79029632|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
44224426|NCT01839487|79029627|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
44224427|NCT01839487|79029628|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
44224428|NCT01839487|79029629|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
44224429|NCT01839487|79029630|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
44224430|NCT01839487|79029631|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
44224431|NCT01839487|79029632|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
44224432|NCT01839487|79029627|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
44224433|NCT01839487|79029628|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
44224434|NCT01839487|79029629|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
44224435|NCT01839487|79029630|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
44224436|NCT01839487|79029631|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
44224437|NCT01839487|79029632|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
44224438|NCT01839487|79029627|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
44224439|NCT01839487|79029628|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
44224440|NCT01839487|79029629|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
44224441|NCT01839487|79029630|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
44224442|NCT01839487|79029631|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
44273756|NCT00074282|79215357|FG000|Step 2|Ineligible|0|||
44273757|NCT00074282|79215358|FG001|Step 2|Ineligible|0|||
44273758|NCT00074282|79215359|FG002|Step 2|Ineligible|1|||
44273759|NCT00071981|79215371|FG000|Overall Study|Lack of Efficacy|37|||
44273760|NCT00071981|79215372|FG001|Overall Study|Lack of Efficacy|29|||
44273761|NCT00071981|79215373|FG002|Overall Study|Lack of Efficacy|30|||
44273762|NCT00071981|79215374|FG003|Overall Study|Lack of Efficacy|43|||
44273763|NCT00071981|79215371|FG000|Overall Study|Adverse Event|4|||
44273764|NCT00071981|79215372|FG001|Overall Study|Adverse Event|4|||
44273765|NCT00071981|79215373|FG002|Overall Study|Adverse Event|3|||
44273766|NCT00071981|79215374|FG003|Overall Study|Adverse Event|1|||
44273767|NCT00071981|79215371|FG000|Overall Study|Death|0|||
44273768|NCT00071981|79215372|FG001|Overall Study|Death|0|||
44273769|NCT00071981|79215373|FG002|Overall Study|Death|1|||
44273770|NCT00071981|79215374|FG003|Overall Study|Death|1|||
44273771|NCT00071981|79215371|FG000|Overall Study|Withdrawal by Subject|3|||
44224443|NCT01839487|79029632|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
44224444|NCT01799941|79029659|FG000|Overall Study|Adverse Event|34|||
44224445|NCT01799941|79029659|FG000|Overall Study|Withdrawal by Subject|21|||
44224446|NCT01799941|79029659|FG000|Overall Study|Death|2|||
44224447|NCT01799941|79029659|FG000|Overall Study|Investigator Decision|4|||
44224448|NCT01799941|79029659|FG000|Overall Study|Lack of Efficacy|3|||
44224449|NCT01799941|79029659|FG000|Overall Study|Lost to Follow-up|17|||
44224450|NCT01799941|79029659|FG000|Overall Study|Other|15|||
44224451|NCT01799239|79029687|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
44224452|NCT01799239|79029688|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
44224453|NCT01799239|79029687|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
44224454|NCT01799239|79029688|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
44224455|NCT01799239|79029687|FG000|Period 1 (7 Days)|Protocol Violation|0|||
44224456|NCT01799239|79029688|FG001|Period 1 (7 Days)|Protocol Violation|1|||
44224457|NCT01799239|79029687|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
44224458|NCT01799239|79029688|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
44224459|NCT01799239|79029687|FG000|Period 2 (7 Days)|Protocol Violation|1|||
44224460|NCT01799239|79029688|FG001|Period 2 (7 Days)|Protocol Violation|0|||
44224461|NCT02999854|79029704|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
44273772|NCT00071981|79215372|FG001|Overall Study|Withdrawal by Subject|1|||
44273773|NCT00071981|79215373|FG002|Overall Study|Withdrawal by Subject|0|||
44273774|NCT00071981|79215374|FG003|Overall Study|Withdrawal by Subject|0|||
44273775|NCT00071981|79215371|FG000|Overall Study|No protocol therapy|2|||
44273776|NCT00071981|79215372|FG001|Overall Study|No protocol therapy|5|||
44273777|NCT00071981|79215373|FG002|Overall Study|No protocol therapy|1|||
44273778|NCT00071981|79215374|FG003|Overall Study|No protocol therapy|0|||
44273779|NCT00071981|79215371|FG000|Overall Study|others (not specified in the study)|0|||
44273780|NCT00071981|79215372|FG001|Overall Study|others (not specified in the study)|2|||
44273781|NCT00071981|79215373|FG002|Overall Study|others (not specified in the study)|2|||
44273782|NCT00071981|79215374|FG003|Overall Study|others (not specified in the study)|0|||
44273783|NCT00070291|79215384|FG000|Step 1|Withdrawal by Subject|1|||
44273784|NCT00070291|79215384|FG000|Step 1|Adverse Event|1|||
44273785|NCT00070291|79215384|FG000|Step 2|Adverse Event|1|||
44273786|NCT00064350|79215391|FG000|Induction Treatment|Disease Progression|5|||
44273787|NCT00064350|79215392|FG001|Induction Treatment|Disease Progression|1|||
44273788|NCT00064350|79215393|FG002|Induction Treatment|Disease Progression|110|||
44273789|NCT00064350|79215391|FG000|Induction Treatment|Adverse Event|0|||
44273790|NCT00064350|79215392|FG001|Induction Treatment|Adverse Event|2|||
44273791|NCT00064350|79215393|FG002|Induction Treatment|Adverse Event|49|||
44273792|NCT00064350|79215391|FG000|Induction Treatment|Death|0|||
44273793|NCT00064350|79215392|FG001|Induction Treatment|Death|0|||
44273794|NCT00064350|79215393|FG002|Induction Treatment|Death|9|||
44273795|NCT00064350|79215391|FG000|Induction Treatment|Withdrawal by Subject|0|||
44273796|NCT00064350|79215392|FG001|Induction Treatment|Withdrawal by Subject|0|||
44273797|NCT00064350|79215393|FG002|Induction Treatment|Withdrawal by Subject|21|||
44273798|NCT00064350|79215391|FG000|Induction Treatment|Ineligible or never started treatment|3|||
44273799|NCT00064350|79215392|FG001|Induction Treatment|Ineligible or never started treatment|6|||
44273800|NCT00064350|79215393|FG002|Induction Treatment|Ineligible or never started treatment|34|||
44273801|NCT00064350|79215391|FG000|Induction Treatment|Other|0|||
44273802|NCT00064350|79215392|FG001|Induction Treatment|Other|0|||
44273803|NCT00064350|79215393|FG002|Induction Treatment|Other|13|||
44224462|NCT02999854|79029705|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
44224463|NCT02999854|79029704|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
44224464|NCT02999854|79029705|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
44273804|NCT00064350|79215391|FG000|Randomization|Adverse Event|8|||
44273805|NCT00064350|79215392|FG001|Randomization|Adverse Event|3|||
44273806|NCT00064350|79215393|FG002|Randomization|Adverse Event|0|||
44273807|NCT00064350|79215391|FG000|Randomization|Death|3|||
44273808|NCT00064350|79215392|FG001|Randomization|Death|0|||
44273809|NCT00064350|79215393|FG002|Randomization|Death|0|||
44273810|NCT00064350|79215391|FG000|Randomization|Withdrawal by Subject|1|||
44273811|NCT00064350|79215392|FG001|Randomization|Withdrawal by Subject|0|||
44273812|NCT00064350|79215393|FG002|Randomization|Withdrawal by Subject|0|||
44273813|NCT00064350|79215391|FG000|Randomization|Ineligible or never started treatment|9|||
44273814|NCT00064350|79215392|FG001|Randomization|Ineligible or never started treatment|15|||
44273815|NCT00064350|79215393|FG002|Randomization|Ineligible or never started treatment|0|||
44273816|NCT00064350|79215391|FG000|Randomization|Other|5|||
44273817|NCT00064350|79215392|FG001|Randomization|Other|0|||
44273818|NCT00064350|79215393|FG002|Randomization|Other|0|||
44273819|NCT00064350|79215391|FG000|Cross-Over|Adverse Event|0|||
44273820|NCT00064350|79215392|FG001|Cross-Over|Adverse Event|1|||
44273821|NCT00064350|79215393|FG002|Cross-Over|Adverse Event|0|||
44273822|NCT00064350|79215391|FG000|Cross-Over|Death|1|||
44273823|NCT00064350|79215392|FG001|Cross-Over|Death|3|||
44273824|NCT00064350|79215393|FG002|Cross-Over|Death|0|||
44273825|NCT00064350|79215391|FG000|Cross-Over|Withdrawal by Subject|2|||
44273826|NCT00064350|79215392|FG001|Cross-Over|Withdrawal by Subject|2|||
44273827|NCT00064350|79215393|FG002|Cross-Over|Withdrawal by Subject|0|||
44273828|NCT00064350|79215391|FG000|Cross-Over|Ineligible or never started treatment|3|||
44273829|NCT00064350|79215392|FG001|Cross-Over|Ineligible or never started treatment|6|||
44273830|NCT00064350|79215393|FG002|Cross-Over|Ineligible or never started treatment|0|||
44273831|NCT00064350|79215391|FG000|Cross-Over|Other|0|||
44273832|NCT00064350|79215392|FG001|Cross-Over|Other|2|||
44468381|NCT00266812|79476930|FG000|Overall Study|Disease Progression|9|||
44468382|NCT00266812|79476931|FG001|Overall Study|Disease Progression|3|||
44468383|NCT00266812|79476930|FG000|Overall Study|Death|5|||
44468384|NCT00266812|79476931|FG001|Overall Study|Death|4|||
44468385|NCT00266812|79476930|FG000|Overall Study|Adverse Event|3|||
44468386|NCT00266812|79476931|FG001|Overall Study|Adverse Event|1|||
44224465|NCT02999854|79029704|FG000|Active Study Phase (up to 18 Months)|Death|7|||
44224466|NCT02999854|79029705|FG001|Active Study Phase (up to 18 Months)|Death|5|||
44224467|NCT02999854|79029704|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
44224468|NCT02999854|79029705|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
44224469|NCT02999854|79029704|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
44224470|NCT02999854|79029705|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
44224471|NCT02999854|79029704|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
44224472|NCT02999854|79029705|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
44224473|NCT02999854|79029704|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
44224474|NCT02999854|79029705|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
44224475|NCT02999854|79029704|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
44224476|NCT02999854|79029705|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
44224477|NCT04146363|79029833|FG000|Induction Period|Adverse Event|1|||
44224478|NCT04146363|79029834|FG001|Induction Period|Adverse Event|2|||
44224479|NCT04146363|79029835|FG002|Induction Period|Adverse Event|0|||
44224480|NCT04146363|79029836|FG003|Induction Period|Adverse Event|0|||
44224481|NCT04146363|79029837|FG004|Induction Period|Adverse Event|0|||
44224482|NCT04146363|79029838|FG005|Induction Period|Adverse Event|0|||
44224483|NCT04146363|79029839|FG006|Induction Period|Adverse Event|0|||
44224484|NCT04146363|79029840|FG007|Induction Period|Adverse Event|0|||
44224485|NCT04146363|79029841|FG008|Induction Period|Adverse Event|0|||
44224486|NCT04146363|79029842|FG009|Induction Period|Adverse Event|0|||
44224487|NCT04146363|79029843|FG010|Induction Period|Adverse Event|0|||
44224488|NCT04146363|79029833|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
44224489|NCT04146363|79029834|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
44224490|NCT04146363|79029835|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
44224491|NCT04146363|79029836|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
44224492|NCT04146363|79029837|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
44224493|NCT04146363|79029838|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
44224494|NCT04146363|79029839|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
44224495|NCT04146363|79029840|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
44224496|NCT04146363|79029841|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
44224497|NCT04146363|79029842|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
44224498|NCT04146363|79029843|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
44273833|NCT00064350|79215393|FG002|Cross-Over|Other|0|||
44273834|NCT00063986|79215402|FG000|Overall Study|Withdrawal by Subject|1|||
44224499|NCT04146363|79029833|FG000|Induction Period|Lack of Efficacy|7|||
44224500|NCT04146363|79029834|FG001|Induction Period|Lack of Efficacy|2|||
44224501|NCT04146363|79029835|FG002|Induction Period|Lack of Efficacy|0|||
44224502|NCT04146363|79029836|FG003|Induction Period|Lack of Efficacy|0|||
44273835|NCT00063986|79215402|FG000|Overall Study|Ineligible|1|||
44273836|NCT00063986|79215402|FG000|Overall Study|Intra-operatively ineligible|4|||
44273837|NCT00057954|79215410|FG000|Overall Study|Death|1|||
44273838|NCT00057954|79215410|FG000|Overall Study|Disease progression|1|||
44273839|NCT00049530|79215414|FG000|Overall Study|Lack of Efficacy|25|||
44273840|NCT00049530|79215414|FG000|Overall Study|Adverse Event|2|||
44468387|NCT00266812|79476930|FG000|Overall Study|Protocol Violation|0|||
44468388|NCT00266812|79476931|FG001|Overall Study|Protocol Violation|1|||
44468389|NCT00266812|79476930|FG000|Overall Study|Withdrawal by Subject|0|||
44273841|NCT00049530|79215414|FG000|Overall Study|Death|1|||
44468390|NCT00266812|79476931|FG001|Overall Study|Withdrawal by Subject|2|||
44468391|NCT00266812|79476930|FG000|Overall Study|Discontinued before starting study drug|4|||
44468392|NCT00266812|79476931|FG001|Overall Study|Discontinued before starting study drug|0|||
44468393|NCT00488774|79476941|FG000|Overall Study|Withdrawal of consent|2|||
44468394|NCT00488774|79476942|FG001|Overall Study|Withdrawal of consent|2|||
44468395|NCT00488774|79476943|FG002|Overall Study|Withdrawal of consent|2|||
44468396|NCT00488774|79476944|FG003|Overall Study|Withdrawal of consent|0|||
44468397|NCT00488774|79476941|FG000|Overall Study|Other|6|||
44468398|NCT00488774|79476942|FG001|Overall Study|Other|3|||
44468399|NCT00488774|79476943|FG002|Overall Study|Other|2|||
44468400|NCT00488774|79476944|FG003|Overall Study|Other|2|||
44468401|NCT00488774|79476941|FG000|Overall Study|Lost to Follow-up|0|||
44468402|NCT00488774|79476942|FG001|Overall Study|Lost to Follow-up|0|||
44468403|NCT00488774|79476943|FG002|Overall Study|Lost to Follow-up|1|||
44468404|NCT00488774|79476944|FG003|Overall Study|Lost to Follow-up|1|||
44468405|NCT00361569|79476959|FG000|Overall Study|Protocol Violation|3|||
44468406|NCT00361569|79476960|FG001|Overall Study|Protocol Violation|2|||
44468407|NCT00361569|79476961|FG002|Overall Study|Protocol Violation|4|||
44468408|NCT00361569|79476962|FG003|Overall Study|Protocol Violation|2|||
44468409|NCT00361569|79476959|FG000|Overall Study|Withdrawal by Subject|2|||
44468410|NCT00361569|79476960|FG001|Overall Study|Withdrawal by Subject|1|||
44468411|NCT00361569|79476961|FG002|Overall Study|Withdrawal by Subject|9|||
44468412|NCT00361569|79476962|FG003|Overall Study|Withdrawal by Subject|14|||
44468413|NCT00361569|79476959|FG000|Overall Study|Adverse Event|3|||
44468414|NCT00361569|79476960|FG001|Overall Study|Adverse Event|5|||
44468415|NCT00361569|79476961|FG002|Overall Study|Adverse Event|2|||
44468416|NCT00361569|79476962|FG003|Overall Study|Adverse Event|2|||
44468417|NCT00361569|79476959|FG000|Overall Study|Lost to Follow-up|2|||
44468418|NCT00361569|79476960|FG001|Overall Study|Lost to Follow-up|3|||
44468419|NCT00361569|79476961|FG002|Overall Study|Lost to Follow-up|3|||
44468420|NCT00361569|79476962|FG003|Overall Study|Lost to Follow-up|2|||
44468421|NCT00361569|79476959|FG000|Overall Study|Not specified by investigator|2|||
44468422|NCT00361569|79476960|FG001|Overall Study|Not specified by investigator|0|||
44468423|NCT00361569|79476961|FG002|Overall Study|Not specified by investigator|0|||
44468424|NCT00361569|79476962|FG003|Overall Study|Not specified by investigator|1|||
44468425|NCT00488618|79476974|FG000|Overall Study|Adverse Event|13|||
44468426|NCT00488618|79476975|FG001|Overall Study|Adverse Event|17|||
44468427|NCT00488618|79476974|FG000|Overall Study|Insufficient Therapeutic Response|18|||
44468428|NCT00488618|79476975|FG001|Overall Study|Insufficient Therapeutic Response|11|||
44468429|NCT00488618|79476974|FG000|Overall Study|Protocol Violation|0|||
44468430|NCT00488618|79476975|FG001|Overall Study|Protocol Violation|2|||
44468431|NCT00488618|79476974|FG000|Overall Study|Withdrawal of Consent|15|||
44468432|NCT00488618|79476975|FG001|Overall Study|Withdrawal of Consent|13|||
44468433|NCT00488618|79476974|FG000|Overall Study|Lost to Follow-up|1|||
44468434|NCT00488618|79476975|FG001|Overall Study|Lost to Follow-up|0|||
44468435|NCT00266656|79476983|FG000|Overall Study|Death|1|||
44468436|NCT00266656|79476984|FG001|Overall Study|Death|0|||
44468437|NCT00266656|79476983|FG000|Overall Study|Lost to Follow-up|4|||
44468438|NCT00266656|79476984|FG001|Overall Study|Lost to Follow-up|1|||
44468439|NCT00266656|79476983|FG000|Overall Study|Withdrawal by Subject|4|||
44468440|NCT00266656|79476984|FG001|Overall Study|Withdrawal by Subject|2|||
44468441|NCT00266656|79476983|FG000|Overall Study|Did Not Reach Final Height|4|||
44468442|NCT00266656|79476984|FG001|Overall Study|Did Not Reach Final Height|8|||
44468443|NCT00266656|79476983|FG000|Overall Study|Parent/Caregiver Decision|1|||
44468444|NCT00266656|79476984|FG001|Overall Study|Parent/Caregiver Decision|2|||
44273842|NCT00049530|79215414|FG000|Overall Study|symptomatic deterioration|1|||
44273843|NCT00049530|79215414|FG000|Overall Study|ineligible|3|||
44273844|NCT00045305|79215418|FG000|Overall Study|Lack of Efficacy|6|||
44273845|NCT00045305|79215418|FG000|Overall Study|Adverse Event|3|||
44273846|NCT00045305|79215418|FG000|Overall Study|Death|3|||
44468445|NCT00483704|79476993|FG000|Randomization|Withdrawal by Subject|19|||
44468446|NCT00483704|79476994|FG001|Randomization|Withdrawal by Subject|28|||
44468447|NCT00483704|79476995|FG002|Randomization|Withdrawal by Subject|18|||
44468448|NCT00483704|79476993|FG000|Randomization|Protocol Violation|14|||
44468449|NCT00483704|79476994|FG001|Randomization|Protocol Violation|25|||
44468450|NCT00483704|79476995|FG002|Randomization|Protocol Violation|22|||
44468451|NCT00483704|79476993|FG000|Randomization|Lost to Follow-up|14|||
44468452|NCT00483704|79476994|FG001|Randomization|Lost to Follow-up|14|||
44468453|NCT00483704|79476995|FG002|Randomization|Lost to Follow-up|19|||
44468454|NCT00483704|79476993|FG000|Randomization|Pregnancy|1|||
44468455|NCT00483704|79476994|FG001|Randomization|Pregnancy|0|||
44273847|NCT00045305|79215418|FG000|Overall Study|site error|2|||
44468456|NCT00483704|79476995|FG002|Randomization|Pregnancy|0|||
44468457|NCT00483704|79476993|FG000|Randomization|Physician Decision|2|||
44468458|NCT00483704|79476994|FG001|Randomization|Physician Decision|4|||
44468459|NCT00483704|79476995|FG002|Randomization|Physician Decision|0|||
44273848|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
44468460|NCT00483704|79476993|FG000|Randomization|Progressive disease|0|||
44468461|NCT00483704|79476994|FG001|Randomization|Progressive disease|0|||
44468462|NCT00483704|79476995|FG002|Randomization|Progressive disease|1|||
44468463|NCT00483704|79476993|FG000|Randomization|Lack of qualifying migraines|21|||
44468464|NCT00483704|79476994|FG001|Randomization|Lack of qualifying migraines|25|||
44468465|NCT00483704|79476995|FG002|Randomization|Lack of qualifying migraines|31|||
44468466|NCT00483704|79476993|FG000|Treatment|Lack of qualifying migraines|101|||
44468467|NCT00483704|79476994|FG001|Treatment|Lack of qualifying migraines|99|||
44468468|NCT00483704|79476995|FG002|Treatment|Lack of qualifying migraines|116|||
44468469|NCT00483704|79476993|FG000|Treatment|Adverse Event|3|||
44468470|NCT00483704|79476994|FG001|Treatment|Adverse Event|5|||
44468471|NCT00483704|79476995|FG002|Treatment|Adverse Event|4|||
44468472|NCT00483704|79476993|FG000|Treatment|Withdrawal by Subject|16|||
44468473|NCT00483704|79476994|FG001|Treatment|Withdrawal by Subject|12|||
44468474|NCT00483704|79476995|FG002|Treatment|Withdrawal by Subject|21|||
44468475|NCT00483704|79476993|FG000|Treatment|Protocol Violation|6|||
44468476|NCT00483704|79476994|FG001|Treatment|Protocol Violation|3|||
44468477|NCT00483704|79476995|FG002|Treatment|Protocol Violation|5|||
44468478|NCT00483704|79476993|FG000|Treatment|Lost to Follow-up|2|||
44468479|NCT00483704|79476994|FG001|Treatment|Lost to Follow-up|7|||
44468480|NCT00483704|79476995|FG002|Treatment|Lost to Follow-up|5|||
44468481|NCT00483704|79476993|FG000|Treatment|Lack of Efficacy|1|||
44468482|NCT00483704|79476994|FG001|Treatment|Lack of Efficacy|1|||
44468483|NCT00483704|79476995|FG002|Treatment|Lack of Efficacy|1|||
44468484|NCT00483704|79476993|FG000|Treatment|Pregnancy|0|||
44468485|NCT00483704|79476994|FG001|Treatment|Pregnancy|1|||
44468486|NCT00483704|79476995|FG002|Treatment|Pregnancy|0|||
44468487|NCT00483704|79476993|FG000|Treatment|Physician Decision|0|||
44468488|NCT00483704|79476994|FG001|Treatment|Physician Decision|1|||
44468489|NCT00483704|79476995|FG002|Treatment|Physician Decision|4|||
44468490|NCT00483548|79477008|FG000|Overall Study|Randomized; not treated with study drug|1|||
44468491|NCT00483548|79477009|FG001|Overall Study|Randomized; not treated with study drug|3|||
44468492|NCT00483548|79477008|FG000|Overall Study|Adverse Event|25|||
44468493|NCT00483548|79477009|FG001|Overall Study|Adverse Event|14|||
44468494|NCT00483548|79477008|FG000|Overall Study|Laboratory abnormality|1|||
44468495|NCT00483548|79477009|FG001|Overall Study|Laboratory abnormality|2|||
44468496|NCT00483548|79477008|FG000|Overall Study|Lack of Efficacy|4|||
44468497|NCT00483548|79477009|FG001|Overall Study|Lack of Efficacy|8|||
44468498|NCT00483548|79477008|FG000|Overall Study|Protocol Violation|11|||
44468499|NCT00483548|79477009|FG001|Overall Study|Protocol Violation|7|||
44468500|NCT00483548|79477008|FG000|Overall Study|Pregnancy|1|||
44468501|NCT00483548|79477009|FG001|Overall Study|Pregnancy|0|||
44468502|NCT00483548|79477008|FG000|Overall Study|Protocol required discontinuation|6|||
44468503|NCT00483548|79477009|FG001|Overall Study|Protocol required discontinuation|6|||
44468504|NCT00483548|79477008|FG000|Overall Study|Unable to comply with protocol schedule|1|||
44468505|NCT00483548|79477009|FG001|Overall Study|Unable to comply with protocol schedule|0|||
44468506|NCT00483548|79477008|FG000|Overall Study|Non-compliance with medication|2|||
44468507|NCT00483548|79477009|FG001|Overall Study|Non-compliance with medication|0|||
44468508|NCT00483548|79477008|FG000|Overall Study|Lost to Follow-up|3|||
44468509|NCT00483548|79477009|FG001|Overall Study|Lost to Follow-up|4|||
44468510|NCT00483548|79477008|FG000|Overall Study|Withdrawal by Subject|5|||
44468511|NCT00483548|79477009|FG001|Overall Study|Withdrawal by Subject|2|||
44468512|NCT00445770|79477018|FG000|Overall Study|Adverse Event|9|||
44468513|NCT00445770|79477019|FG001|Overall Study|Adverse Event|15|||
44468514|NCT00445770|79477020|FG002|Overall Study|Adverse Event|19|||
44468515|NCT00445770|79477018|FG000|Overall Study|Lack of Efficacy|38|||
44468516|NCT00445770|79477019|FG001|Overall Study|Lack of Efficacy|13|||
44468517|NCT00445770|79477020|FG002|Overall Study|Lack of Efficacy|6|||
44468518|NCT00445770|79477018|FG000|Overall Study|Lost to Follow-up|0|||
44468519|NCT00445770|79477019|FG001|Overall Study|Lost to Follow-up|2|||
44468520|NCT00445770|79477020|FG002|Overall Study|Lost to Follow-up|0|||
44468521|NCT00445770|79477018|FG000|Overall Study|Other|6|||
44468522|NCT00445770|79477019|FG001|Overall Study|Other|5|||
44468523|NCT00445770|79477020|FG002|Overall Study|Other|6|||
44468524|NCT00266032|79477033|FG000|Treatment|Adverse Event|42|||
44468525|NCT00266032|79477034|FG001|Treatment|Adverse Event|26|||
44468526|NCT00266032|79477035|FG002|Treatment|Adverse Event|10|||
44468527|NCT00266032|79477033|FG000|Treatment|Lost to Follow-up|19|||
44468528|NCT00266032|79477034|FG001|Treatment|Lost to Follow-up|4|||
44468529|NCT00266032|79477035|FG002|Treatment|Lost to Follow-up|2|||
44468530|NCT00266032|79477033|FG000|Treatment|Pregnancy|3|||
44468531|NCT00266032|79477034|FG001|Treatment|Pregnancy|2|||
44224503|NCT04146363|79029837|FG004|Induction Period|Lack of Efficacy|0|||
44468532|NCT00266032|79477035|FG002|Treatment|Pregnancy|2|||
44468533|NCT00266032|79477033|FG000|Treatment|Protocol Violation|6|||
44468534|NCT00266032|79477034|FG001|Treatment|Protocol Violation|14|||
44468535|NCT00266032|79477035|FG002|Treatment|Protocol Violation|13|||
44468536|NCT00266032|79477033|FG000|Treatment|Withdrawal by Subject|28|||
44468537|NCT00266032|79477034|FG001|Treatment|Withdrawal by Subject|13|||
44468538|NCT00266032|79477035|FG002|Treatment|Withdrawal by Subject|12|||
44468539|NCT00266032|79477033|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
44468540|NCT00266032|79477034|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
44468541|NCT00266032|79477035|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
44468542|NCT00266032|79477033|FG000|Open-label Safety Extension|Adverse Event|5|||
44468543|NCT00266032|79477034|FG001|Open-label Safety Extension|Adverse Event|0|||
44468544|NCT00266032|79477035|FG002|Open-label Safety Extension|Adverse Event|4|||
44468545|NCT00266032|79477033|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
44468546|NCT00266032|79477034|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
44468547|NCT00266032|79477035|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
44468548|NCT00266032|79477033|FG000|Open-label Safety Extension|Pregnancy|4|||
44468549|NCT00266032|79477034|FG001|Open-label Safety Extension|Pregnancy|1|||
44468550|NCT00266032|79477035|FG002|Open-label Safety Extension|Pregnancy|2|||
44468551|NCT00266032|79477033|FG000|Open-label Safety Extension|Protocol Violation|1|||
44468552|NCT00266032|79477034|FG001|Open-label Safety Extension|Protocol Violation|3|||
44468553|NCT00266032|79477035|FG002|Open-label Safety Extension|Protocol Violation|2|||
44468554|NCT00266032|79477033|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
44468555|NCT00266032|79477034|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
44468556|NCT00266032|79477035|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
44468557|NCT00266032|79477033|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
44468558|NCT00266032|79477034|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
44468559|NCT00266032|79477035|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
44468560|NCT00483002|79477043|FG000|Overall Study|Adverse Event|68|||
44468561|NCT00483002|79477043|FG000|Overall Study|Lack of Efficacy|555|||
44468562|NCT00483002|79477043|FG000|Overall Study|Lost to Follow-up|962|||
44468563|NCT00483002|79477043|FG000|Overall Study|Other|2|||
44468564|NCT00483002|79477043|FG000|Overall Study|Other|967|||
44468565|NCT00482612|79477051|FG000|In-treatment Period|No study medication administered|0|||
44468566|NCT00482612|79477052|FG001|In-treatment Period|No study medication administered|0|||
44468567|NCT00482612|79477053|FG002|In-treatment Period|No study medication administered|1|||
44468568|NCT00482612|79477054|FG003|In-treatment Period|No study medication administered|0|||
44468569|NCT00482612|79477051|FG000|Follow-up Period|Other|4|||
44468570|NCT00482612|79477052|FG001|Follow-up Period|Other|2|||
44468571|NCT00482612|79477053|FG002|Follow-up Period|Other|1|||
44468572|NCT00482612|79477054|FG003|Follow-up Period|Other|2|||
44468573|NCT00482612|79477051|FG000|Follow-up Period|Lack of compliance|0|||
44224504|NCT04146363|79029838|FG005|Induction Period|Lack of Efficacy|0|||
44224505|NCT04146363|79029839|FG006|Induction Period|Lack of Efficacy|0|||
44224506|NCT04146363|79029840|FG007|Induction Period|Lack of Efficacy|0|||
44224507|NCT04146363|79029841|FG008|Induction Period|Lack of Efficacy|0|||
44224508|NCT04146363|79029842|FG009|Induction Period|Lack of Efficacy|0|||
44468574|NCT00482612|79477052|FG001|Follow-up Period|Lack of compliance|0|||
44468575|NCT00482612|79477053|FG002|Follow-up Period|Lack of compliance|1|||
44468576|NCT00482612|79477054|FG003|Follow-up Period|Lack of compliance|0|||
44468577|NCT00482612|79477051|FG000|Follow-up Period|Lost to Follow-up|0|||
44468578|NCT00482612|79477052|FG001|Follow-up Period|Lost to Follow-up|4|||
44468579|NCT00482612|79477053|FG002|Follow-up Period|Lost to Follow-up|2|||
44468580|NCT00482612|79477054|FG003|Follow-up Period|Lost to Follow-up|1|||
44468581|NCT00482612|79477051|FG000|Follow-up Period|Adverse Event|4|||
44468582|NCT00482612|79477052|FG001|Follow-up Period|Adverse Event|7|||
44468583|NCT00482612|79477053|FG002|Follow-up Period|Adverse Event|9|||
44468584|NCT00482612|79477054|FG003|Follow-up Period|Adverse Event|0|||
44468585|NCT00482612|79477051|FG000|Follow-up Period|Lack of Efficacy|2|||
44468586|NCT00482612|79477052|FG001|Follow-up Period|Lack of Efficacy|0|||
44468587|NCT00482612|79477053|FG002|Follow-up Period|Lack of Efficacy|1|||
44468588|NCT00482612|79477054|FG003|Follow-up Period|Lack of Efficacy|0|||
44468589|NCT00482612|79477051|FG000|Follow-up Period|Withdrawal by Subject|3|||
44468590|NCT00482612|79477052|FG001|Follow-up Period|Withdrawal by Subject|5|||
44468591|NCT00482612|79477053|FG002|Follow-up Period|Withdrawal by Subject|7|||
44224509|NCT04146363|79029843|FG010|Induction Period|Lack of Efficacy|0|||
44224510|NCT04146363|79029833|FG000|Induction Period|Lost to Follow-up|1|||
44224511|NCT04146363|79029834|FG001|Induction Period|Lost to Follow-up|4|||
44224512|NCT04146363|79029835|FG002|Induction Period|Lost to Follow-up|0|||
44468592|NCT00482612|79477054|FG003|Follow-up Period|Withdrawal by Subject|2|||
44468593|NCT00482612|79477051|FG000|Follow-up Period|Reasons not related to trial|1|||
44468594|NCT00482612|79477052|FG001|Follow-up Period|Reasons not related to trial|0|||
44468595|NCT00482612|79477053|FG002|Follow-up Period|Reasons not related to trial|1|||
44468596|NCT00482612|79477054|FG003|Follow-up Period|Reasons not related to trial|3|||
44468597|NCT00282568|79477068|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
44224513|NCT04146363|79029836|FG003|Induction Period|Lost to Follow-up|0|||
44224514|NCT04146363|79029837|FG004|Induction Period|Lost to Follow-up|0|||
44468598|NCT00282568|79477068|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
44468599|NCT00282568|79477068|FG000|Extended Treatment Period|Adverse Event|17|||
44224515|NCT04146363|79029838|FG005|Induction Period|Lost to Follow-up|0|||
44224516|NCT04146363|79029839|FG006|Induction Period|Lost to Follow-up|0|||
44468600|NCT00282568|79477068|FG000|Extended Treatment Period|Non-compliance|4|||
44468601|NCT00282568|79477068|FG000|Extended Treatment Period|Physician Decision|1|||
44468602|NCT00282568|79477068|FG000|Extended Treatment Period|Lost to Follow-up|2|||
44468603|NCT00265564|79477074|FG000|Overall Study|Lost to Follow-up|5|||
44468604|NCT00265564|79477075|FG001|Overall Study|Lost to Follow-up|7|||
44468605|NCT00265564|79477074|FG000|Overall Study|met exclusion criteria|5|||
44468606|NCT00265564|79477075|FG001|Overall Study|met exclusion criteria|2|||
44468607|NCT00376623|79477084|FG000|Overall Study|Progressive disease|35|||
44468608|NCT00376623|79477085|FG001|Overall Study|Progressive disease|22|||
44468609|NCT00376623|79477086|FG002|Overall Study|Progressive disease|17|||
44468610|NCT00376623|79477084|FG000|Overall Study|Lost to Follow-up|0|||
44468611|NCT00376623|79477085|FG001|Overall Study|Lost to Follow-up|1|||
44468612|NCT00376623|79477086|FG002|Overall Study|Lost to Follow-up|0|||
44468613|NCT00376623|79477084|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
44468614|NCT00376623|79477085|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
44468615|NCT00376623|79477086|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
44468616|NCT00376623|79477084|FG000|Overall Study|Not treated with BI 2536|1|||
44468617|NCT00376623|79477085|FG001|Overall Study|Not treated with BI 2536|0|||
44468618|NCT00376623|79477086|FG002|Overall Study|Not treated with BI 2536|0|||
44468619|NCT00376623|79477084|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
44468620|NCT00376623|79477085|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
44468621|NCT00376623|79477086|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
44468622|NCT00376623|79477084|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
44468623|NCT00376623|79477085|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
44468624|NCT00376623|79477086|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
44468625|NCT00376623|79477084|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
44468626|NCT00376623|79477085|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
44468627|NCT00376623|79477086|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
44468628|NCT00376623|79477084|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
44468629|NCT00376623|79477085|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
44468630|NCT00376623|79477086|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
44468631|NCT00376623|79477084|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
44468632|NCT00376623|79477085|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
44468633|NCT00376623|79477086|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
44468634|NCT00376623|79477084|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
44468635|NCT00376623|79477085|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
44468636|NCT00376623|79477086|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
44468637|NCT00376623|79477084|FG000|Overall Study|Increase of tumour markers|0|||
44468638|NCT00376623|79477085|FG001|Overall Study|Increase of tumour markers|1|||
44468639|NCT00376623|79477086|FG002|Overall Study|Increase of tumour markers|0|||
44468640|NCT00376623|79477084|FG000|Overall Study|Bone metastasis|1|||
44468641|NCT00376623|79477085|FG001|Overall Study|Bone metastasis|0|||
44468642|NCT00376623|79477086|FG002|Overall Study|Bone metastasis|0|||
44468643|NCT00445692|79477100|FG000|Overall Study|Adverse Event|11|||
44468644|NCT00445692|79477100|FG000|Overall Study|Lack of Efficacy|5|||
44468645|NCT03824236|79477109|FG000|Overall Study|Lost to Follow-up|0|||
44468646|NCT03824236|79477110|FG001|Overall Study|Lost to Follow-up|0|||
44468647|NCT03824236|79477111|FG002|Overall Study|Lost to Follow-up|1|||
44468648|NCT00282412|79477119|FG000|Overall Study|Death|2|||
44468649|NCT00282334|79477125|FG000|Overall Study|Withdrawal by Subject|8|||
44468650|NCT00282334|79477126|FG001|Overall Study|Withdrawal by Subject|5|||
44468651|NCT00282256|79477132|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
44468652|NCT00282256|79477132|FG000|Extension Treatment Period|Adverse Event|2|||
44468653|NCT00265330|79477136|FG000|Overall Study|Adverse Event|41|||
44468654|NCT00265330|79477136|FG000|Overall Study|Lost to Follow-up|8|||
44468655|NCT00265330|79477136|FG000|Overall Study|Withdrawal by Subject|34|||
44468656|NCT00265330|79477136|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
44468657|NCT00265330|79477136|FG000|Overall Study|Lack of Efficacy|4|||
44468658|NCT00265330|79477136|FG000|Overall Study|Family Scheduling Conflicts|1|||
44468659|NCT00265330|79477136|FG000|Overall Study|Began Taking Formulary Geodon|1|||
44468660|NCT00265330|79477136|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
44468661|NCT00265330|79477136|FG000|Overall Study|Site Closed by Sponsor|1|||
44468662|NCT00265330|79477136|FG000|Overall Study|Principal Investigators Request|1|||
44468663|NCT00265330|79477136|FG000|Overall Study|Withdrew Consent|1|||
44468664|NCT00265330|79477136|FG000|Overall Study|Protocol Violation|1|||
44468665|NCT00292318|79477142|FG000|Overall Study|Study terminated by officials|2|||
44468666|NCT00292318|79477143|FG001|Overall Study|Study terminated by officials|1|||
44468667|NCT00281632|79477149|FG000|Overall Study|Adverse Event|7|||
44468668|NCT00281632|79477149|FG000|Overall Study|Withdrawal by Subject|2|||
44468669|NCT00281632|79477149|FG000|Overall Study|Disease Progression|22|||
44468670|NCT00281632|79477149|FG000|Overall Study|Death|1|||
44468671|NCT00281632|79477149|FG000|Overall Study|Physician Decision|1|||
44468672|NCT00281632|79477149|FG000|Overall Study|Ongoing|3|||
44468673|NCT00543569|79477165|FG000|Overall Study|Death|2|||
44468674|NCT00543569|79477166|FG001|Overall Study|Death|2|||
44468675|NCT00543569|79477167|FG002|Overall Study|Death|3|||
44468676|NCT00543569|79477168|FG003|Overall Study|Death|1|||
44468677|NCT00543569|79477165|FG000|Overall Study|Lost to Follow-up|0|||
44468678|NCT00543569|79477166|FG001|Overall Study|Lost to Follow-up|0|||
44468679|NCT00543569|79477167|FG002|Overall Study|Lost to Follow-up|1|||
44468680|NCT00543569|79477168|FG003|Overall Study|Lost to Follow-up|1|||
44468681|NCT00543569|79477165|FG000|Overall Study|Miscellaneous Reasons|7|||
44468682|NCT00543569|79477166|FG001|Overall Study|Miscellaneous Reasons|3|||
44468683|NCT00543569|79477167|FG002|Overall Study|Miscellaneous Reasons|11|||
44468684|NCT00543569|79477168|FG003|Overall Study|Miscellaneous Reasons|4|||
44468685|NCT00543569|79477165|FG000|Overall Study|Randomized but never received study drug|3|||
44468686|NCT00543569|79477166|FG001|Overall Study|Randomized but never received study drug|3|||
44468687|NCT00543569|79477167|FG002|Overall Study|Randomized but never received study drug|5|||
44468688|NCT00543569|79477168|FG003|Overall Study|Randomized but never received study drug|3|||
44468689|NCT00445458|79477182|FG000|Overall Study|Disease Progression|3|||
44468690|NCT00445458|79477183|FG001|Overall Study|Disease Progression|4|||
44468691|NCT00445458|79477184|FG002|Overall Study|Disease Progression|54|||
44468692|NCT00445458|79477185|FG003|Overall Study|Disease Progression|27|||
44468693|NCT00445458|79477182|FG000|Overall Study|Withdrawal by Subject|0|||
44468694|NCT00445458|79477183|FG001|Overall Study|Withdrawal by Subject|0|||
44224517|NCT04146363|79029840|FG007|Induction Period|Lost to Follow-up|0|||
44224518|NCT04146363|79029841|FG008|Induction Period|Lost to Follow-up|0|||
44224519|NCT04146363|79029842|FG009|Induction Period|Lost to Follow-up|0|||
44468695|NCT00445458|79477184|FG002|Overall Study|Withdrawal by Subject|7|||
44468696|NCT00445458|79477185|FG003|Overall Study|Withdrawal by Subject|0|||
44468697|NCT00445458|79477182|FG000|Overall Study|Adverse Event|0|||
44468698|NCT00445458|79477183|FG001|Overall Study|Adverse Event|0|||
44468699|NCT00445458|79477184|FG002|Overall Study|Adverse Event|3|||
44468700|NCT00445458|79477185|FG003|Overall Study|Adverse Event|0|||
44468701|NCT00445458|79477182|FG000|Overall Study|Death|0|||
44468702|NCT00445458|79477183|FG001|Overall Study|Death|1|||
44468703|NCT00445458|79477184|FG002|Overall Study|Death|2|||
44468704|NCT00445458|79477185|FG003|Overall Study|Death|0|||
44468705|NCT00445458|79477182|FG000|Overall Study|Physician Decision|0|||
44468706|NCT00445458|79477183|FG001|Overall Study|Physician Decision|0|||
44468707|NCT00445458|79477184|FG002|Overall Study|Physician Decision|1|||
44468708|NCT00445458|79477185|FG003|Overall Study|Physician Decision|1|||
44468709|NCT00445458|79477182|FG000|Overall Study|Surgery|0|||
44468710|NCT00445458|79477183|FG001|Overall Study|Surgery|0|||
44468711|NCT00445458|79477184|FG002|Overall Study|Surgery|1|||
44468712|NCT00445458|79477185|FG003|Overall Study|Surgery|0|||
44468713|NCT03914417|79477198|FG000|Overall Study|Withdrawal by Subject|2|||
44468714|NCT00541385|79477204|FG000|Overall Study|Adverse Event|6|||
44468715|NCT00541385|79477205|FG001|Overall Study|Adverse Event|3|||
44468716|NCT00541385|79477204|FG000|Overall Study|Withdrawal by Subject|2|||
44468717|NCT00541385|79477205|FG001|Overall Study|Withdrawal by Subject|2|||
44468718|NCT00541385|79477204|FG000|Overall Study|Lost to Follow-up|6|||
44468719|NCT00541385|79477205|FG001|Overall Study|Lost to Follow-up|1|||
44468720|NCT00541385|79477204|FG000|Overall Study|Parasite reappearance/malaria|67|||
44468721|NCT00541385|79477205|FG001|Overall Study|Parasite reappearance/malaria|32|||
44468722|NCT00265096|79477214|FG000|Overall Study|Adverse Event|14|||
44468723|NCT00265096|79477215|FG001|Overall Study|Adverse Event|18|||
44468724|NCT00265096|79477216|FG002|Overall Study|Adverse Event|18|||
44468725|NCT00265096|79477214|FG000|Overall Study|Lost to Follow-up|2|||
44468726|NCT00265096|79477215|FG001|Overall Study|Lost to Follow-up|5|||
44468727|NCT00265096|79477216|FG002|Overall Study|Lost to Follow-up|3|||
44468728|NCT00265096|79477214|FG000|Overall Study|Death|0|||
44468729|NCT00265096|79477215|FG001|Overall Study|Death|1|||
44468730|NCT00265096|79477216|FG002|Overall Study|Death|2|||
44468731|NCT00265096|79477214|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
44468732|NCT00265096|79477215|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
44468733|NCT00265096|79477216|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
44468734|NCT00265096|79477214|FG000|Overall Study|Other|11|||
44468735|NCT00265096|79477215|FG001|Overall Study|Other|19|||
44468736|NCT00265096|79477216|FG002|Overall Study|Other|10|||
44468737|NCT00281320|79477228|FG000|Overall Study|Adverse Event|12|||
44468738|NCT00281320|79477229|FG001|Overall Study|Adverse Event|9|||
44468739|NCT00281320|79477228|FG000|Overall Study|Lack of Efficacy|4|||
44468740|NCT00281320|79477229|FG001|Overall Study|Lack of Efficacy|3|||
44468741|NCT00281320|79477228|FG000|Overall Study|Withdrawal by Subject|5|||
44468742|NCT00281320|79477229|FG001|Overall Study|Withdrawal by Subject|6|||
44468743|NCT00281320|79477228|FG000|Overall Study|Lost to Follow-up|1|||
44468744|NCT00281320|79477229|FG001|Overall Study|Lost to Follow-up|2|||
44468745|NCT00281320|79477228|FG000|Overall Study|Other|3|||
44468746|NCT00281320|79477229|FG001|Overall Study|Other|1|||
44468747|NCT00541307|79477241|FG000|Overall Study|Death|5|||
44468748|NCT00541307|79477241|FG000|Overall Study|Physician Decision|3|||
44468749|NCT00541307|79477241|FG000|Overall Study|Withdrawal by Subject|6|||
44468750|NCT00541307|79477241|FG000|Overall Study|Lost to Follow-up|4|||
44468751|NCT00541307|79477241|FG000|Overall Study|Subject returned early (outside window)|1|||
44468752|NCT00541307|79477241|FG000|Overall Study|Surgical Bypass|5|||
44468753|NCT00541229|79477251|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
44468754|NCT00541229|79477252|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
44468755|NCT00541229|79477253|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
44468756|NCT00541229|79477254|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
44468757|NCT00541229|79477255|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
44468758|NCT00541229|79477256|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
44468759|NCT00541229|79477251|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
44468760|NCT00541229|79477252|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
44468761|NCT00541229|79477253|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
44468762|NCT00541229|79477254|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
44468763|NCT00541229|79477255|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
44468764|NCT00541229|79477256|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
44468765|NCT00541229|79477251|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
44468766|NCT00541229|79477252|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
44468767|NCT00541229|79477253|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
44468768|NCT00541229|79477254|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
44468769|NCT00541229|79477255|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
44468770|NCT00541229|79477256|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
44468771|NCT00541229|79477251|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
44468772|NCT00541229|79477252|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
44468773|NCT00541229|79477253|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
44468774|NCT00541229|79477254|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
44468775|NCT00541229|79477255|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
44468776|NCT00541229|79477256|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
44468777|NCT00541229|79477251|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
44468778|NCT00541229|79477252|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
44468779|NCT00541229|79477253|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
44468780|NCT00541229|79477254|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
44468781|NCT00541229|79477255|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
44468782|NCT00541229|79477256|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
44468783|NCT00541229|79477251|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
44468784|NCT00541229|79477252|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
44468785|NCT00541229|79477253|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
44468786|NCT00541229|79477254|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
44468787|NCT00541229|79477255|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
44468788|NCT00541229|79477256|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
44468789|NCT00541229|79477251|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
44468790|NCT00541229|79477252|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
44468791|NCT00541229|79477253|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
44468792|NCT00541229|79477254|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
44468793|NCT00541229|79477255|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
44468794|NCT00541229|79477256|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
44468795|NCT00541229|79477251|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
44468796|NCT00541229|79477252|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
44468797|NCT00541229|79477253|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
44468798|NCT00541229|79477254|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
44468799|NCT00541229|79477255|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
44468800|NCT00541229|79477256|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
44468801|NCT00541229|79477251|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
44468802|NCT00541229|79477252|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
44468803|NCT00541229|79477253|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
44224520|NCT04146363|79029843|FG010|Induction Period|Lost to Follow-up|0|||
44468804|NCT00541229|79477254|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
44468805|NCT00541229|79477255|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
44468806|NCT00541229|79477256|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
44468807|NCT00541229|79477251|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
44468808|NCT00541229|79477252|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
44468809|NCT00541229|79477253|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
44468810|NCT00541229|79477254|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
44468811|NCT00541229|79477255|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
44468812|NCT00541229|79477256|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
44468813|NCT00541229|79477251|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
44468814|NCT00541229|79477252|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
44468815|NCT00541229|79477253|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
44468816|NCT00541229|79477254|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
44468817|NCT00541229|79477255|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
44468818|NCT00541229|79477256|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
44468819|NCT00541229|79477251|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
44468820|NCT00541229|79477252|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
44468821|NCT00541229|79477253|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
44468822|NCT00541229|79477254|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
44468823|NCT00541229|79477255|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
44468824|NCT00541229|79477256|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
44468825|NCT00541229|79477251|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
44468826|NCT00541229|79477252|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
44468827|NCT00541229|79477253|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
44468828|NCT00541229|79477254|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
44468829|NCT00541229|79477255|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
44468830|NCT00541229|79477256|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
44468831|NCT00541229|79477251|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
44468832|NCT00541229|79477252|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
44468833|NCT00541229|79477253|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
44468834|NCT00541229|79477254|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
44468835|NCT00541229|79477255|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
44468836|NCT00541229|79477256|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
44468837|NCT00541229|79477251|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
44468838|NCT00541229|79477252|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
44468839|NCT00541229|79477253|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
44468840|NCT00541229|79477254|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
44468841|NCT00541229|79477255|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
44468842|NCT00541229|79477256|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
44468843|NCT00541229|79477251|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
44468844|NCT00541229|79477252|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
44468845|NCT00541229|79477253|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
44468846|NCT00541229|79477254|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
44468847|NCT00541229|79477255|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
44468848|NCT00541229|79477256|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
44468849|NCT00481988|79477266|FG000|Overall Study|Withdrawal by Subject|1|||
44468850|NCT00481988|79477267|FG001|Overall Study|Withdrawal by Subject|1|||
44468851|NCT00481832|79477284|FG000|Enrollment|Physician Decision|8|||
44468852|NCT00481832|79477284|FG000|Enrollment|Unable to collect enough stem cells|2|||
44468853|NCT00481832|79477284|FG000|Inter-transplant Period|Adverse Event|4|||
44224521|NCT04146363|79029833|FG000|Induction Period|Positive quantiferon test|0|||
44224522|NCT04146363|79029834|FG001|Induction Period|Positive quantiferon test|1|||
44224523|NCT04146363|79029835|FG002|Induction Period|Positive quantiferon test|0|||
44224524|NCT04146363|79029836|FG003|Induction Period|Positive quantiferon test|0|||
44224525|NCT04146363|79029837|FG004|Induction Period|Positive quantiferon test|0|||
44224526|NCT04146363|79029838|FG005|Induction Period|Positive quantiferon test|0|||
44224527|NCT04146363|79029839|FG006|Induction Period|Positive quantiferon test|0|||
44224528|NCT04146363|79029840|FG007|Induction Period|Positive quantiferon test|0|||
44224529|NCT04146363|79029841|FG008|Induction Period|Positive quantiferon test|0|||
44224530|NCT04146363|79029842|FG009|Induction Period|Positive quantiferon test|0|||
44224531|NCT04146363|79029843|FG010|Induction Period|Positive quantiferon test|0|||
44224532|NCT04146363|79029833|FG000|Induction Period|Protocol Deviation|5|||
44224533|NCT04146363|79029834|FG001|Induction Period|Protocol Deviation|6|||
44224534|NCT04146363|79029835|FG002|Induction Period|Protocol Deviation|0|||
44224535|NCT04146363|79029836|FG003|Induction Period|Protocol Deviation|0|||
44224536|NCT04146363|79029837|FG004|Induction Period|Protocol Deviation|0|||
44224537|NCT04146363|79029838|FG005|Induction Period|Protocol Deviation|0|||
44468854|NCT00481832|79477284|FG000|Inter-transplant Period|Death|3|||
44468855|NCT00481832|79477284|FG000|Inter-transplant Period|Physician Decision|4|||
44468856|NCT00481832|79477284|FG000|Inter-transplant Period|Disease relapse|11|||
44468857|NCT00481832|79477284|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
44468858|NCT00481676|79477290|FG000|Overall Study|Adverse Event|0|||
44468859|NCT00481676|79477291|FG001|Overall Study|Adverse Event|1|||
44468860|NCT00481676|79477290|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44468861|NCT00481676|79477291|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
44468862|NCT00481676|79477290|FG000|Overall Study|Administrative problem|1|||
44468863|NCT00481676|79477291|FG001|Overall Study|Administrative problem|0|||
44468864|NCT00542789|79477299|FG000|Overall Study|Adverse Event|18|||
44468865|NCT00542789|79477300|FG001|Overall Study|Adverse Event|17|||
44468866|NCT00542789|79477299|FG000|Overall Study|Withdrawal by Subject|7|||
44468867|NCT00542789|79477300|FG001|Overall Study|Withdrawal by Subject|3|||
44468868|NCT00542789|79477299|FG000|Overall Study|Protocol Violation|8|||
44468869|NCT00542789|79477300|FG001|Overall Study|Protocol Violation|1|||
44468870|NCT00542789|79477299|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
44468871|NCT00542789|79477300|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
44468872|NCT00464672|79477308|FG000|Overall Study|withdrawal of consent|0|||
44468873|NCT00464672|79477309|FG001|Overall Study|withdrawal of consent|0|||
44468874|NCT00464672|79477310|FG002|Overall Study|withdrawal of consent|0|||
44468875|NCT00464672|79477311|FG003|Overall Study|withdrawal of consent|1|||
44468876|NCT00464672|79477312|FG004|Overall Study|withdrawal of consent|9|||
44468877|NCT00464672|79477313|FG005|Overall Study|withdrawal of consent|4|||
44224538|NCT04146363|79029839|FG006|Induction Period|Protocol Deviation|0|||
44224539|NCT04146363|79029840|FG007|Induction Period|Protocol Deviation|0|||
44224540|NCT04146363|79029841|FG008|Induction Period|Protocol Deviation|0|||
44224541|NCT04146363|79029842|FG009|Induction Period|Protocol Deviation|0|||
44224542|NCT04146363|79029843|FG010|Induction Period|Protocol Deviation|0|||
44224543|NCT04146363|79029833|FG000|Induction Period|Withdrawal by Subject|6|||
44224544|NCT04146363|79029834|FG001|Induction Period|Withdrawal by Subject|3|||
44224545|NCT04146363|79029835|FG002|Induction Period|Withdrawal by Subject|0|||
44224546|NCT04146363|79029836|FG003|Induction Period|Withdrawal by Subject|0|||
44468878|NCT00464672|79477308|FG000|Overall Study|Lost to Follow-up|25|||
44468879|NCT00464672|79477309|FG001|Overall Study|Lost to Follow-up|10|||
44224547|NCT04146363|79029837|FG004|Induction Period|Withdrawal by Subject|0|||
44224548|NCT04146363|79029838|FG005|Induction Period|Withdrawal by Subject|0|||
44273849|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
44468880|NCT00464672|79477310|FG002|Overall Study|Lost to Follow-up|0|||
44468881|NCT00464672|79477311|FG003|Overall Study|Lost to Follow-up|0|||
44468882|NCT00464672|79477312|FG004|Overall Study|Lost to Follow-up|1|||
44468883|NCT00464672|79477313|FG005|Overall Study|Lost to Follow-up|0|||
44468884|NCT00473876|79477343|FG000|Overall Study|Lost to Follow-up|3|||
44468885|NCT00473876|79477344|FG001|Overall Study|Lost to Follow-up|1|||
44468886|NCT00463580|79477354|FG000|Overall Study|Lost to Follow-up|1|||
44468887|NCT00463580|79477355|FG001|Overall Study|Lost to Follow-up|0|||
44224549|NCT04146363|79029839|FG006|Induction Period|Withdrawal by Subject|0|||
44224550|NCT04146363|79029840|FG007|Induction Period|Withdrawal by Subject|0|||
44468888|NCT00463580|79477354|FG000|Overall Study|Schedule conflict|2|||
44468889|NCT00463580|79477355|FG001|Overall Study|Schedule conflict|0|||
44468890|NCT00463580|79477354|FG000|Overall Study|Medical/psychiatric complications|0|||
44468891|NCT00463580|79477355|FG001|Overall Study|Medical/psychiatric complications|2|||
44468892|NCT00540449|79477369|FG000|Overall Study|Adverse Event|12|||
44468893|NCT00540449|79477370|FG001|Overall Study|Adverse Event|32|||
44468894|NCT00540449|79477369|FG000|Overall Study|Sponsor's Decision|1|||
44468895|NCT00540449|79477370|FG001|Overall Study|Sponsor's Decision|1|||
44468896|NCT00540449|79477369|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
44468897|NCT00540449|79477370|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
44468898|NCT00540449|79477369|FG000|Overall Study|Lost to Follow-up|19|||
44468899|NCT00540449|79477370|FG001|Overall Study|Lost to Follow-up|17|||
44468900|NCT00540449|79477369|FG000|Overall Study|Subject Non-Compliant|7|||
44468901|NCT00540449|79477370|FG001|Overall Study|Subject Non-Compliant|5|||
44468902|NCT00540449|79477369|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
44468903|NCT00540449|79477370|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
44224551|NCT04146363|79029841|FG008|Induction Period|Withdrawal by Subject|0|||
44224552|NCT04146363|79029842|FG009|Induction Period|Withdrawal by Subject|0|||
44468904|NCT00540449|79477369|FG000|Overall Study|Withdrawal by Subject|10|||
44468905|NCT00540449|79477370|FG001|Overall Study|Withdrawal by Subject|10|||
44468906|NCT00540449|79477369|FG000|Overall Study|Other|1|||
44468907|NCT00540449|79477370|FG001|Overall Study|Other|4|||
44468908|NCT03911843|79477378|FG000|Overall Study|Adverse Event|2|||
44468909|NCT03911843|79477379|FG001|Overall Study|Adverse Event|0|||
44468910|NCT03911843|79477378|FG000|Overall Study|Protocol Violation|2|||
44468911|NCT03911843|79477379|FG001|Overall Study|Protocol Violation|0|||
44468912|NCT03911843|79477378|FG000|Overall Study|Lost to Follow-up|0|||
44468913|NCT03911843|79477379|FG001|Overall Study|Lost to Follow-up|1|||
44468914|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Adverse Event|9|||
44468915|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Adverse Event|4|||
44468916|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Adverse Event|5|||
44468917|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Adverse Event|9|||
44468918|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Adverse Event|8|||
44468919|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Adverse Event|0|||
44468920|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Adverse Event|0|||
44468921|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
44468922|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
44468923|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
44468924|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
44468925|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
44468926|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
44468927|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
44468928|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Death|1|||
44468929|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Death|1|||
44468930|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Death|1|||
44224553|NCT04146363|79029843|FG010|Induction Period|Withdrawal by Subject|0|||
44468931|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Death|1|||
44468932|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Death|0|||
44468933|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Death|0|||
44468934|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Death|0|||
44468935|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
44468936|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
44468937|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
44468938|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
44468939|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
44468940|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
44468941|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
44468942|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
44468943|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
44468944|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
44468945|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
44468946|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
44468947|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
44468948|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
44468949|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
44468950|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
44468951|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
44468952|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
44468953|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
44224554|NCT04146363|79029833|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224555|NCT04146363|79029834|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224556|NCT04146363|79029835|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224557|NCT04146363|79029836|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224558|NCT04146363|79029837|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224559|NCT04146363|79029838|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
44468954|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
44468955|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
44468956|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Other|2|||
44468957|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Other|9|||
44468958|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Other|9|||
44468959|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Other|3|||
44468960|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Other|2|||
44468961|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Other|0|||
44468962|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Other|0|||
44468963|NCT00361335|79477390|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
44468964|NCT00361335|79477391|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
44468965|NCT00361335|79477392|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
44468966|NCT00361335|79477393|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
44468967|NCT00361335|79477394|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
44468968|NCT00361335|79477395|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
44468969|NCT00361335|79477396|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
44468970|NCT00361335|79477390|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
44468971|NCT00361335|79477391|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
44468972|NCT00361335|79477392|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
44468973|NCT00361335|79477393|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
44468974|NCT00361335|79477394|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
44468975|NCT00361335|79477395|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
44468976|NCT00361335|79477396|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
44468977|NCT00361335|79477390|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
44468978|NCT00361335|79477391|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
44468979|NCT00361335|79477392|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
44468980|NCT00361335|79477393|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
44468981|NCT00361335|79477394|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
44468982|NCT00361335|79477395|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
44468983|NCT00361335|79477396|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
44468984|NCT00361335|79477390|FG000|SC Period: Week E0 to Week E24|Death|0|||
44468985|NCT00361335|79477391|FG001|SC Period: Week E0 to Week E24|Death|0|||
44468986|NCT00361335|79477392|FG002|SC Period: Week E0 to Week E24|Death|0|||
44468987|NCT00361335|79477393|FG003|SC Period: Week E0 to Week E24|Death|0|||
44468988|NCT00361335|79477394|FG004|SC Period: Week E0 to Week E24|Death|0|||
44468989|NCT00361335|79477395|FG005|SC Period: Week E0 to Week E24|Death|0|||
44468990|NCT00361335|79477396|FG006|SC Period: Week E0 to Week E24|Death|1|||
44468991|NCT00361335|79477390|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
44468992|NCT00361335|79477391|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
44468993|NCT00361335|79477392|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
44468994|NCT00361335|79477393|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
44468995|NCT00361335|79477394|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
44468996|NCT00361335|79477395|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
44468997|NCT00361335|79477396|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
44468998|NCT00361335|79477390|FG000|SC Period: Week E0 to Week E24|Other|1|||
44468999|NCT00361335|79477391|FG001|SC Period: Week E0 to Week E24|Other|0|||
44469000|NCT00361335|79477392|FG002|SC Period: Week E0 to Week E24|Other|0|||
44469001|NCT00361335|79477393|FG003|SC Period: Week E0 to Week E24|Other|1|||
44469002|NCT00361335|79477394|FG004|SC Period: Week E0 to Week E24|Other|0|||
44469003|NCT00361335|79477395|FG005|SC Period: Week E0 to Week E24|Other|1|||
44469004|NCT00361335|79477396|FG006|SC Period: Week E0 to Week E24|Other|2|||
44469005|NCT00361335|79477390|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
44469006|NCT00361335|79477391|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
44469007|NCT00361335|79477392|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
44469008|NCT00361335|79477393|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
44469009|NCT00361335|79477394|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
44469010|NCT00361335|79477395|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
44469011|NCT00361335|79477396|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
44469012|NCT00264550|79477416|FG000|Overall Study|Death|0|||
44469013|NCT00264550|79477417|FG001|Overall Study|Death|3|||
44469014|NCT00264550|79477418|FG002|Overall Study|Death|0|||
44469015|NCT00264550|79477419|FG003|Overall Study|Death|0|||
44469016|NCT00264550|79477416|FG000|Overall Study|Lost to Follow-up|3|||
44469017|NCT00264550|79477417|FG001|Overall Study|Lost to Follow-up|1|||
44469018|NCT00264550|79477418|FG002|Overall Study|Lost to Follow-up|1|||
44469019|NCT00264550|79477419|FG003|Overall Study|Lost to Follow-up|1|||
44469020|NCT00264550|79477416|FG000|Overall Study|Adverse Event|23|||
44469021|NCT00264550|79477417|FG001|Overall Study|Adverse Event|18|||
44469022|NCT00264550|79477418|FG002|Overall Study|Adverse Event|9|||
44469023|NCT00264550|79477419|FG003|Overall Study|Adverse Event|14|||
44469024|NCT00264550|79477416|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44469025|NCT00264550|79477417|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
44469026|NCT00264550|79477418|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
44469027|NCT00264550|79477419|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
44469028|NCT00264550|79477416|FG000|Overall Study|Discontinued oral study agent|0|||
44469029|NCT00264550|79477417|FG001|Overall Study|Discontinued oral study agent|1|||
44469030|NCT00264550|79477418|FG002|Overall Study|Discontinued oral study agent|0|||
44469031|NCT00264550|79477419|FG003|Overall Study|Discontinued oral study agent|0|||
44469032|NCT00264550|79477416|FG000|Overall Study|Other|13|||
44469033|NCT00264550|79477417|FG001|Overall Study|Other|7|||
44469034|NCT00264550|79477418|FG002|Overall Study|Other|3|||
44469035|NCT00264550|79477419|FG003|Overall Study|Other|9|||
44469036|NCT00541931|79477431|FG000|Overall Study|Adverse Event|1|||
44469037|NCT00541931|79477432|FG001|Overall Study|Adverse Event|0|||
44469038|NCT00541931|79477431|FG000|Overall Study|Lost to Follow-up|3|||
44469039|NCT00541931|79477432|FG001|Overall Study|Lost to Follow-up|3|||
44469040|NCT00541931|79477431|FG000|Overall Study|Withdrawal by Subject|1|||
44469041|NCT00541931|79477432|FG001|Overall Study|Withdrawal by Subject|0|||
44469042|NCT00541931|79477431|FG000|Overall Study|Transportation Issue|0|||
44469043|NCT00541931|79477432|FG001|Overall Study|Transportation Issue|1|||
44469044|NCT00368979|79477442|FG000|Overall Study|Adverse Event|9|||
44224560|NCT04146363|79029839|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
44224561|NCT04146363|79029840|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
44469045|NCT00368979|79477443|FG001|Overall Study|Adverse Event|16|||
44469046|NCT00368979|79477442|FG000|Overall Study|Lack of Efficacy|5|||
44375318|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
44375319|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
44375320|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
44375321|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
44375322|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
44375323|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
44375324|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
44375325|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
44375326|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
44375327|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
44375328|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
44375329|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
44375330|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44375331|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
44375332|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44375333|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
44375334|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44375335|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44375336|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
44375337|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
44375338|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
44375339|NCT01106690|79380534|FG000|Core Period: Baseline to Week 26|Other|10|||
44375340|NCT01106690|79380535|FG001|Core Period: Baseline to Week 26|Other|2|||
44375341|NCT01106690|79380536|FG002|Core Period: Baseline to Week 26|Other|6|||
44469047|NCT00368979|79477443|FG001|Overall Study|Lack of Efficacy|3|||
44469048|NCT00368979|79477442|FG000|Overall Study|Other|3|||
44469049|NCT00368979|79477443|FG001|Overall Study|Other|1|||
44224562|NCT04146363|79029841|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224563|NCT04146363|79029842|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224564|NCT04146363|79029843|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
44224565|NCT04146363|79029833|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224566|NCT04146363|79029834|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224567|NCT04146363|79029835|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224568|NCT04146363|79029836|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224569|NCT04146363|79029837|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224570|NCT04146363|79029838|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224571|NCT04146363|79029839|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224572|NCT04146363|79029840|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
44224573|NCT04146363|79029841|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224574|NCT04146363|79029842|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224575|NCT04146363|79029843|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44224576|NCT04146363|79029833|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224577|NCT04146363|79029834|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224578|NCT04146363|79029835|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224579|NCT04146363|79029836|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224580|NCT04146363|79029837|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224581|NCT04146363|79029838|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224582|NCT04146363|79029839|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
44224583|NCT04146363|79029840|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
44224584|NCT04146363|79029841|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224585|NCT04146363|79029842|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224586|NCT04146363|79029843|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44224587|NCT04146363|79029833|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224588|NCT04146363|79029834|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224589|NCT04146363|79029835|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
44224590|NCT04146363|79029836|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224591|NCT04146363|79029837|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224592|NCT04146363|79029838|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
44224593|NCT04146363|79029839|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224594|NCT04146363|79029840|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224595|NCT04146363|79029841|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224596|NCT04146363|79029842|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224597|NCT04146363|79029843|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
44224598|NCT04146363|79029833|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44224599|NCT04146363|79029834|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44224600|NCT04146363|79029835|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44224601|NCT04146363|79029836|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44224602|NCT04146363|79029837|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
44224603|NCT04146363|79029838|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
44224604|NCT04146363|79029839|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
44224605|NCT04146363|79029840|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
44224606|NCT04146363|79029841|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44224607|NCT04146363|79029842|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44273850|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
44273851|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
44273852|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|Death|1|||
44273853|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|Death|1|||
44273854|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
44273855|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
44273856|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
44273857|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
44375342|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
44375343|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
44375344|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
44375345|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44469050|NCT00368979|79477442|FG000|Overall Study|Lost to Follow-up|1|||
44224608|NCT04146363|79029843|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44224609|NCT04146363|79029833|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44273858|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
44273859|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
44469051|NCT00368979|79477443|FG001|Overall Study|Lost to Follow-up|0|||
44224610|NCT04146363|79029834|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44469052|NCT00368979|79477442|FG000|Overall Study|Protocol Violation|2|||
44469053|NCT00368979|79477443|FG001|Overall Study|Protocol Violation|1|||
44469054|NCT00368979|79477442|FG000|Overall Study|Withdrawal by Subject|5|||
44469055|NCT00368979|79477443|FG001|Overall Study|Withdrawal by Subject|9|||
44469056|NCT00264238|79477449|FG000|Overall Study|Protocol Violation|1|||
44469057|NCT00540293|79477455|FG000|Overall Study|Adverse event related to study drug|10|||
44469058|NCT00540293|79477455|FG000|Overall Study|Adverse event not related to study drug|7|||
44469059|NCT00540293|79477455|FG000|Overall Study|Withdrawal by Subject|6|||
44469060|NCT00540293|79477455|FG000|Overall Study|Protocol violation, & subject schedule|12|||
44469061|NCT00359073|79477496|FG000|Overall Study|Withdrawal by Subject|1|||
44469062|NCT00359073|79477497|FG001|Overall Study|Withdrawal by Subject|1|||
44224611|NCT04146363|79029835|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
44224612|NCT04146363|79029836|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44224613|NCT04146363|79029837|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44224614|NCT04146363|79029838|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
44544460|NCT03197376|79557828|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
44544461|NCT03197376|79557829|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
44544462|NCT03197376|79557826|FG000|Immune Persistence Phase|Not vaccine related|1|||
44544463|NCT03197376|79557827|FG001|Immune Persistence Phase|Not vaccine related|0|||
44544464|NCT03197376|79557828|FG002|Immune Persistence Phase|Not vaccine related|1|||
44544465|NCT03197376|79557829|FG003|Immune Persistence Phase|Not vaccine related|1|||
44544466|NCT03600805|79557866|FG000|Overall Study|Adverse Event|2|||
44544467|NCT03600805|79557867|FG001|Overall Study|Adverse Event|1|||
44544468|NCT03600805|79557868|FG002|Overall Study|Adverse Event|1|||
44544469|NCT03600805|79557869|FG003|Overall Study|Adverse Event|7|||
44224615|NCT04146363|79029839|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
44224616|NCT04146363|79029840|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
44224617|NCT04146363|79029841|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44469063|NCT00359073|79477496|FG000|Overall Study|Eligibility criteria no longer met|3|||
44469064|NCT00359073|79477497|FG001|Overall Study|Eligibility criteria no longer met|0|||
44469065|NCT00359073|79477496|FG000|Overall Study|developed RV16 antibody|0|||
44469066|NCT00359073|79477497|FG001|Overall Study|developed RV16 antibody|1|||
44469067|NCT03918239|79477507|FG000|Overall Study|Lost to Follow-up|3|||
44469068|NCT03918239|79477508|FG001|Overall Study|Lost to Follow-up|1|||
44469069|NCT03918239|79477507|FG000|Overall Study|Pregnancy|0|||
44469070|NCT03918239|79477508|FG001|Overall Study|Pregnancy|2|||
44469071|NCT03918239|79477507|FG000|Overall Study|Withdrawal by Subject|3|||
44469072|NCT03918239|79477508|FG001|Overall Study|Withdrawal by Subject|3|||
44469073|NCT03918239|79477507|FG000|Overall Study|positive urine drug screening results|4|||
44469074|NCT03918239|79477508|FG001|Overall Study|positive urine drug screening results|1|||
44469075|NCT00368745|79477516|FG000|Double-blind Treatment Period|Adverse Event|6|||
44469076|NCT00368745|79477517|FG001|Double-blind Treatment Period|Adverse Event|6|||
44469077|NCT00368745|79477516|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
44469078|NCT00368745|79477517|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
44469079|NCT00368745|79477516|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
44469080|NCT00368745|79477517|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
44469081|NCT00368745|79477516|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
44469082|NCT00368745|79477517|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
44469083|NCT00368745|79477516|FG000|Double-blind Treatment Period|Other|7|||
44469084|NCT00368745|79477517|FG001|Double-blind Treatment Period|Other|6|||
44469085|NCT00454818|79477531|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
44469086|NCT00454818|79477532|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
44469087|NCT00454818|79477533|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
44469088|NCT00454818|79477534|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
44469089|NCT00454818|79477535|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
44224618|NCT04146363|79029842|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44224619|NCT04146363|79029843|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44224620|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224621|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224622|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
44469090|NCT00454818|79477531|FG000|Phase I: Open-label Dose-escalation|Death|0|||
44469091|NCT00454818|79477532|FG001|Phase I: Open-label Dose-escalation|Death|1|||
44469092|NCT00454818|79477533|FG002|Phase I: Open-label Dose-escalation|Death|0|||
44469093|NCT00454818|79477534|FG003|Phase I: Open-label Dose-escalation|Death|0|||
44224623|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224624|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224625|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
44469094|NCT00454818|79477535|FG004|Phase I: Open-label Dose-escalation|Death|0|||
44544470|NCT03600805|79557866|FG000|Overall Study|Lack of Efficacy|2|||
44469095|NCT00454818|79477531|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
44469096|NCT00454818|79477532|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
44469097|NCT00454818|79477533|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
44469098|NCT00454818|79477534|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
44469099|NCT00454818|79477535|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
44469100|NCT00454818|79477531|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
44469101|NCT00454818|79477532|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
44469102|NCT00454818|79477533|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
44469103|NCT00454818|79477534|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
44469104|NCT00454818|79477535|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
44469105|NCT00454818|79477531|FG000|Phase 2: Randomized Double-blind|Death|0|||
44469106|NCT00454818|79477532|FG001|Phase 2: Randomized Double-blind|Death|1|||
44469107|NCT00454818|79477533|FG002|Phase 2: Randomized Double-blind|Death|0|||
44224626|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224627|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224628|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
44224629|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
44224630|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
44224631|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224632|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224633|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224634|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224635|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224636|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224637|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224638|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44224639|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
44224640|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
44224641|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
44469108|NCT00454818|79477534|FG003|Phase 2: Randomized Double-blind|Death|0|||
44224642|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224643|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224644|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224645|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224646|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224647|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224648|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224649|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224650|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
44224651|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
44224652|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44224653|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224654|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224655|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224656|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224657|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224658|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224659|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224660|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
44375346|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
44469109|NCT00454818|79477535|FG004|Phase 2: Randomized Double-blind|Death|1|||
44469110|NCT00454818|79477531|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
44469111|NCT00454818|79477532|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
44469112|NCT00454818|79477533|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
44469113|NCT00454818|79477534|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
44469114|NCT00454818|79477535|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
44469115|NCT00454818|79477531|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
44469116|NCT00454818|79477532|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
44469117|NCT00454818|79477533|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
44469118|NCT00454818|79477534|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
44469119|NCT00454818|79477535|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
44469120|NCT00445224|79477554|FG000|Specific Exercises|Withdrawal by Subject|3|||
44469121|NCT00445224|79477555|FG001|Specific Exercises|Withdrawal by Subject|3|||
44469122|NCT00445224|79477554|FG000|Specific Exercises|Withdrawal by Subject|1|||
44469123|NCT00445224|79477555|FG001|Specific Exercises|Withdrawal by Subject|0|||
44469124|NCT00358917|79477572|FG000|Overall Study|Adverse Event|14|||
44469125|NCT00358917|79477573|FG001|Overall Study|Adverse Event|21|||
44469126|NCT00358917|79477572|FG000|Overall Study|Withdrawal by Subject|5|||
44469127|NCT00358917|79477573|FG001|Overall Study|Withdrawal by Subject|7|||
44469128|NCT00358917|79477572|FG000|Overall Study|Lost to Follow-up|20|||
44469129|NCT00358917|79477573|FG001|Overall Study|Lost to Follow-up|17|||
44469130|NCT00358917|79477572|FG000|Overall Study|Noncompliance|12|||
44469131|NCT00358917|79477573|FG001|Overall Study|Noncompliance|11|||
44469132|NCT00358917|79477572|FG000|Overall Study|Death|2|||
44469133|NCT00358917|79477573|FG001|Overall Study|Death|3|||
44469134|NCT00358917|79477572|FG000|Overall Study|Virologic failure|11|||
44469135|NCT00358917|79477573|FG001|Overall Study|Virologic failure|8|||
44469136|NCT00358917|79477572|FG000|Overall Study|Unable to Continue Participation|2|||
44469137|NCT00358917|79477573|FG001|Overall Study|Unable to Continue Participation|2|||
44224661|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
44224662|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
44224663|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
44224664|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224665|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224666|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44469138|NCT00264004|79477585|FG000|Overall Study|Adverse Event|2|||
44469139|NCT00264004|79477586|FG001|Overall Study|Adverse Event|3|||
44469140|NCT00264004|79477587|FG002|Overall Study|Adverse Event|6|||
44469141|NCT00264004|79477588|FG003|Overall Study|Adverse Event|4|||
44469142|NCT00264004|79477585|FG000|Overall Study|Withdrawal by Subject|0|||
44469143|NCT00264004|79477586|FG001|Overall Study|Withdrawal by Subject|1|||
44469144|NCT00264004|79477587|FG002|Overall Study|Withdrawal by Subject|2|||
44469145|NCT00264004|79477588|FG003|Overall Study|Withdrawal by Subject|2|||
44469146|NCT00264004|79477585|FG000|Overall Study|Other|2|||
44469147|NCT00264004|79477586|FG001|Overall Study|Other|2|||
44469148|NCT00264004|79477587|FG002|Overall Study|Other|0|||
44469149|NCT00264004|79477588|FG003|Overall Study|Other|3|||
44469150|NCT00264004|79477585|FG000|Overall Study|Development study specific disc. crit.|1|||
44469151|NCT00264004|79477586|FG001|Overall Study|Development study specific disc. crit.|0|||
44469152|NCT00264004|79477587|FG002|Overall Study|Development study specific disc. crit.|1|||
44469153|NCT00264004|79477588|FG003|Overall Study|Development study specific disc. crit.|0|||
44469154|NCT00264004|79477585|FG000|Overall Study|Cond. under inv. worsened|9|||
44469155|NCT00264004|79477586|FG001|Overall Study|Cond. under inv. worsened|5|||
44469156|NCT00264004|79477587|FG002|Overall Study|Cond. under inv. worsened|3|||
44469157|NCT00264004|79477588|FG003|Overall Study|Cond. under inv. worsened|4|||
44469158|NCT00264004|79477585|FG000|Overall Study|Not treated|3|||
44469159|NCT00264004|79477586|FG001|Overall Study|Not treated|0|||
44469160|NCT00264004|79477587|FG002|Overall Study|Not treated|2|||
44469161|NCT00264004|79477588|FG003|Overall Study|Not treated|2|||
44469162|NCT00368355|79477600|FG000|Overall Study|Adverse Event|1|||
44469163|NCT00368355|79477601|FG001|Overall Study|Adverse Event|0|||
44469164|NCT00368355|79477600|FG000|Overall Study|Death|2|||
44469165|NCT00368355|79477601|FG001|Overall Study|Death|4|||
44469166|NCT00368355|79477600|FG000|Overall Study|Relapse|6|||
44469167|NCT00368355|79477601|FG001|Overall Study|Relapse|10|||
44469168|NCT00368355|79477600|FG000|Overall Study|Subsequent transplant|0|||
44469169|NCT00368355|79477601|FG001|Overall Study|Subsequent transplant|3|||
44469170|NCT00368355|79477600|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
44469171|NCT00368355|79477601|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
44469172|NCT00445146|79477607|FG000|Overall Study|Withdrew Consent|29|||
44469173|NCT00445146|79477607|FG000|Overall Study|Lack of Efficacy|28|||
44469174|NCT00445146|79477607|FG000|Overall Study|Investigator's Discretion|22|||
44469175|NCT00445146|79477607|FG000|Overall Study|Adverse Event|13|||
44469176|NCT00445146|79477607|FG000|Overall Study|Lost to Follow-up|13|||
44469177|NCT00445146|79477607|FG000|Overall Study|Death|9|||
44224667|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224668|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224669|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224670|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224671|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44224672|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
44469178|NCT00445146|79477607|FG000|Overall Study|Protocol Violation|4|||
44469179|NCT00445146|79477607|FG000|Overall Study|Pregnancy|1|||
44469180|NCT00368277|79477613|FG000|Overall Study|Adverse Event|33|||
44469181|NCT00368277|79477614|FG001|Overall Study|Adverse Event|49|||
44469182|NCT00368277|79477613|FG000|Overall Study|Death|2|||
44469183|NCT00368277|79477614|FG001|Overall Study|Death|1|||
44469184|NCT00368277|79477613|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
44469185|NCT00368277|79477614|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
44469186|NCT00368277|79477613|FG000|Overall Study|Protocol deviation|7|||
44469187|NCT00368277|79477614|FG001|Overall Study|Protocol deviation|0|||
44469188|NCT00368277|79477613|FG000|Overall Study|Patient withdrew consent|32|||
44469189|NCT00368277|79477614|FG001|Overall Study|Patient withdrew consent|28|||
44469190|NCT00368277|79477613|FG000|Overall Study|Lost to Follow-up|8|||
44469191|NCT00368277|79477614|FG001|Overall Study|Lost to Follow-up|6|||
44469192|NCT00280150|79477624|FG000|Overall Study|Adverse Event|0|||
44469193|NCT00280150|79477625|FG001|Overall Study|Adverse Event|1|||
44469194|NCT00280150|79477626|FG002|Overall Study|Adverse Event|2|||
44224673|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
44224674|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
44469195|NCT00280150|79477627|FG003|Overall Study|Adverse Event|3|||
44469196|NCT00280150|79477624|FG000|Overall Study|Lack of Efficacy|0|||
44469197|NCT00280150|79477625|FG001|Overall Study|Lack of Efficacy|0|||
44469198|NCT00280150|79477626|FG002|Overall Study|Lack of Efficacy|0|||
44469199|NCT00280150|79477627|FG003|Overall Study|Lack of Efficacy|3|||
44469200|NCT00280150|79477624|FG000|Overall Study|Physician Decision|0|||
44469201|NCT00280150|79477625|FG001|Overall Study|Physician Decision|0|||
44469202|NCT00280150|79477626|FG002|Overall Study|Physician Decision|0|||
44469203|NCT00280150|79477627|FG003|Overall Study|Physician Decision|1|||
44469204|NCT00280150|79477624|FG000|Overall Study|Protocol Violation|0|||
44469205|NCT00280150|79477625|FG001|Overall Study|Protocol Violation|0|||
44469206|NCT00280150|79477626|FG002|Overall Study|Protocol Violation|0|||
44469207|NCT00280150|79477627|FG003|Overall Study|Protocol Violation|1|||
44469208|NCT00280150|79477624|FG000|Overall Study|Withdrawal by Subject|0|||
44469209|NCT00280150|79477625|FG001|Overall Study|Withdrawal by Subject|0|||
44469210|NCT00280150|79477626|FG002|Overall Study|Withdrawal by Subject|0|||
44544471|NCT03600805|79557867|FG001|Overall Study|Lack of Efficacy|1|||
44469211|NCT00280150|79477627|FG003|Overall Study|Withdrawal by Subject|1|||
44469212|NCT00280150|79477624|FG000|Overall Study|Did not get consolidation therapy|3|||
44469213|NCT00280150|79477625|FG001|Overall Study|Did not get consolidation therapy|0|||
44469214|NCT00280150|79477626|FG002|Overall Study|Did not get consolidation therapy|3|||
44469215|NCT00280150|79477627|FG003|Overall Study|Did not get consolidation therapy|0|||
44224675|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224676|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224677|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
44469216|NCT00280150|79477624|FG000|Overall Study|Declining Performance Status|0|||
44469217|NCT00280150|79477625|FG001|Overall Study|Declining Performance Status|0|||
44469218|NCT00280150|79477626|FG002|Overall Study|Declining Performance Status|0|||
44469219|NCT00280150|79477627|FG003|Overall Study|Declining Performance Status|1|||
44469220|NCT00279916|79477640|FG000|Overall Study|Withdrawal by Subject|4|||
44469221|NCT00279916|79477641|FG001|Overall Study|Withdrawal by Subject|3|||
44469222|NCT00279916|79477640|FG000|Overall Study|Lost to Follow-up|3|||
44469223|NCT00279916|79477641|FG001|Overall Study|Lost to Follow-up|2|||
44469224|NCT00358527|79477649|FG000|Overall Study|Adverse Event|4|||
44469225|NCT00358527|79477650|FG001|Overall Study|Adverse Event|0|||
44469226|NCT00358527|79477649|FG000|Overall Study|Withdrawal by Subject|1|||
44469227|NCT00358527|79477650|FG001|Overall Study|Withdrawal by Subject|1|||
44469228|NCT00358527|79477649|FG000|Overall Study|Non-compliance with protocol|6|||
44469229|NCT00358527|79477650|FG001|Overall Study|Non-compliance with protocol|1|||
44469230|NCT00358527|79477649|FG000|Overall Study|Administrative|2|||
44469231|NCT00358527|79477650|FG001|Overall Study|Administrative|1|||
44469232|NCT00251758|79477659|FG000|Overall Study|Adverse Event|7|||
44469233|NCT00251758|79477660|FG001|Overall Study|Adverse Event|9|||
44469234|NCT00251758|79477661|FG002|Overall Study|Adverse Event|11|||
44469235|NCT00251758|79477659|FG000|Overall Study|Lost to Follow-up|4|||
44469236|NCT00251758|79477660|FG001|Overall Study|Lost to Follow-up|2|||
44469237|NCT00251758|79477661|FG002|Overall Study|Lost to Follow-up|5|||
44469238|NCT00251758|79477659|FG000|Overall Study|Withdrawal by Subject|13|||
44469239|NCT00251758|79477660|FG001|Overall Study|Withdrawal by Subject|7|||
44469240|NCT00251758|79477661|FG002|Overall Study|Withdrawal by Subject|3|||
44469241|NCT00251758|79477659|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
44469242|NCT00251758|79477660|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
44469243|NCT00251758|79477661|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
44224678|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224679|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224680|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224681|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
44469244|NCT00251758|79477659|FG000|Overall Study|Lack of Efficacy|3|||
44469245|NCT00251758|79477660|FG001|Overall Study|Lack of Efficacy|0|||
44469246|NCT00251758|79477661|FG002|Overall Study|Lack of Efficacy|0|||
44469247|NCT00251758|79477659|FG000|Overall Study|Noncompliant|0|||
44469248|NCT00251758|79477660|FG001|Overall Study|Noncompliant|2|||
44469249|NCT00251758|79477661|FG002|Overall Study|Noncompliant|2|||
44469250|NCT00251758|79477659|FG000|Overall Study|Pregnancy|0|||
44469251|NCT00251758|79477660|FG001|Overall Study|Pregnancy|1|||
44469252|NCT00251758|79477661|FG002|Overall Study|Pregnancy|0|||
44469253|NCT00251758|79477659|FG000|Overall Study|Per Subject Request|0|||
44224682|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224683|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224684|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
44224685|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
44224686|NCT04146363|79029833|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224687|NCT04146363|79029834|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224688|NCT04146363|79029835|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224689|NCT04146363|79029836|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224690|NCT04146363|79029837|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224691|NCT04146363|79029838|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224692|NCT04146363|79029839|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224693|NCT04146363|79029840|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224694|NCT04146363|79029841|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224695|NCT04146363|79029842|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
44224696|NCT04146363|79029843|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
44224697|NCT01838941|79029868|FG000|Overall Study|Adverse Event|1|||
44469254|NCT00251758|79477660|FG001|Overall Study|Per Subject Request|0|||
44469255|NCT00251758|79477661|FG002|Overall Study|Per Subject Request|1|||
44469256|NCT00251758|79477659|FG000|Overall Study|Per Investigator Request|1|||
44469257|NCT00251758|79477660|FG001|Overall Study|Per Investigator Request|0|||
44469258|NCT00251758|79477661|FG002|Overall Study|Per Investigator Request|0|||
44469259|NCT00279214|79477671|FG000|Overall Study|Physician Decision|3|||
44469260|NCT00279214|79477672|FG001|Overall Study|Physician Decision|2|||
44469261|NCT00262834|79477680|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
44224698|NCT01838941|79029868|FG000|Overall Study|Withdrawal by Subject|1|||
44224699|NCT01773109|79029873|FG000|Overall Study|Symptomatic Progression|2|||
44224700|NCT01773109|79029873|FG000|Overall Study|Death|1|||
44224701|NCT01772719|79029877|FG000|Overall Study|Withdrawal by Subject|3|||
44224702|NCT01772719|79029877|FG000|Overall Study|Adverse Event|2|||
44224703|NCT01772719|79029877|FG000|Overall Study|Protocol Violation|1|||
44224704|NCT01772719|79029877|FG000|Overall Study|Lost to Follow-up|1|||
44224705|NCT01798927|79029884|FG000|Overall Study|Withdrawal by Subject|1|||
44224706|NCT01276288|79029953|FG000|Overall Study|Adverse Event|1|||
44224707|NCT01276288|79029954|FG001|Overall Study|Adverse Event|1|||
44224708|NCT01276288|79029955|FG002|Overall Study|Adverse Event|0|||
44224709|NCT01276288|79029956|FG003|Overall Study|Adverse Event|0|||
44224710|NCT01276288|79029953|FG000|Overall Study|not treated|1|||
44224711|NCT01276288|79029954|FG001|Overall Study|not treated|0|||
44224712|NCT01276288|79029955|FG002|Overall Study|not treated|0|||
44224713|NCT01276288|79029956|FG003|Overall Study|not treated|0|||
44469262|NCT00262834|79477681|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
44469263|NCT00541775|79477690|FG000|Overall Study|Adverse Event|3|||
44469264|NCT00541775|79477691|FG001|Overall Study|Adverse Event|2|||
44469265|NCT00541775|79477692|FG002|Overall Study|Adverse Event|1|||
44469266|NCT00541775|79477690|FG000|Overall Study|Lack of Efficacy|0|||
44469267|NCT00541775|79477691|FG001|Overall Study|Lack of Efficacy|0|||
44469268|NCT00541775|79477692|FG002|Overall Study|Lack of Efficacy|3|||
44469269|NCT00541775|79477690|FG000|Overall Study|Lost to Follow-up|0|||
44469270|NCT00541775|79477691|FG001|Overall Study|Lost to Follow-up|0|||
44469271|NCT00541775|79477692|FG002|Overall Study|Lost to Follow-up|2|||
44469272|NCT00541775|79477690|FG000|Overall Study|Protocol Violation|1|||
44469273|NCT00541775|79477691|FG001|Overall Study|Protocol Violation|0|||
44469274|NCT00541775|79477692|FG002|Overall Study|Protocol Violation|0|||
44469275|NCT00541775|79477690|FG000|Overall Study|Withdrawal by Subject and Other|5|||
44469276|NCT00541775|79477691|FG001|Overall Study|Withdrawal by Subject and Other|0|||
44469277|NCT00541775|79477692|FG002|Overall Study|Withdrawal by Subject and Other|2|||
44469278|NCT00539513|79477702|FG000|Overall Study|Withdrawal by Subject|2|||
44469279|NCT00539513|79477703|FG001|Overall Study|Withdrawal by Subject|1|||
44469280|NCT00539513|79477702|FG000|Overall Study|Lost to Follow-up|0|||
44469281|NCT00539513|79477703|FG001|Overall Study|Lost to Follow-up|1|||
44469282|NCT00454584|79477712|FG000|Controlled Period|Adverse Event|5|||
44469283|NCT00454584|79477713|FG001|Controlled Period|Adverse Event|2|||
44469284|NCT00454584|79477714|FG002|Controlled Period|Adverse Event|1|||
44469285|NCT00454584|79477715|FG003|Controlled Period|Adverse Event|0|||
44469286|NCT00454584|79477716|FG004|Controlled Period|Adverse Event|0|||
44224714|NCT02702271|79029980|FG000|Overall Study|Death|36|||
44224715|NCT02702271|79029981|FG001|Overall Study|Death|7|||
44224716|NCT02702271|79029980|FG000|Overall Study|Lost to Follow-up|12|||
44224717|NCT02702271|79029981|FG001|Overall Study|Lost to Follow-up|0|||
44224718|NCT02702271|79029980|FG000|Overall Study|Withdrawal by Subject|8|||
44224719|NCT02702271|79029981|FG001|Overall Study|Withdrawal by Subject|1|||
44224720|NCT02702271|79029980|FG000|Overall Study|Physician Decision|2|||
44224721|NCT02702271|79029981|FG001|Overall Study|Physician Decision|0|||
44224722|NCT02702271|79029980|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
44224723|NCT02702271|79029981|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
44224724|NCT01276054|79030066|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
44224725|NCT01276054|79030067|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
44224726|NCT01798849|79030076|FG000|Overall Study|Physician Decision|0|||
44224727|NCT01798849|79030077|FG001|Overall Study|Physician Decision|0|||
44224728|NCT01798849|79030078|FG002|Overall Study|Physician Decision|1|||
44224729|NCT01797835|79030158|FG000|Overall Study|Lost to Follow-up|31|||
44224730|NCT01797835|79030159|FG001|Overall Study|Lost to Follow-up|27|||
44224731|NCT01275430|79030165|FG000|Overall Study|Adverse Event|1|||
44224732|NCT01275430|79030165|FG000|Overall Study|No Contrast Injection|6|||
44224733|NCT01275430|79030165|FG000|Overall Study|Device Malfunction|1|||
44224734|NCT01275430|79030165|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
44469287|NCT00454584|79477717|FG005|Controlled Period|Adverse Event|0|||
44469288|NCT00454584|79477712|FG000|Controlled Period|Lost to Follow-up|1|||
44469289|NCT00454584|79477713|FG001|Controlled Period|Lost to Follow-up|2|||
44469290|NCT00454584|79477714|FG002|Controlled Period|Lost to Follow-up|2|||
44544472|NCT03600805|79557868|FG002|Overall Study|Lack of Efficacy|0|||
44544473|NCT03600805|79557869|FG003|Overall Study|Lack of Efficacy|0|||
44544474|NCT03600805|79557866|FG000|Overall Study|Withdrawal by Subject|1|||
44224735|NCT01838551|79030170|FG000|Overall Study|Adverse Event|16|||
44224736|NCT01838551|79030170|FG000|Overall Study|Death|1|||
44224737|NCT01838551|79030170|FG000|Overall Study|Lack of Efficacy|10|||
44273860|NCT00033657|79215424|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
44224738|NCT01838551|79030170|FG000|Overall Study|Physician Decision|4|||
44224739|NCT01838551|79030170|FG000|Overall Study|Withdrawal by Subject|10|||
44469291|NCT00454584|79477715|FG003|Controlled Period|Lost to Follow-up|0|||
44469292|NCT00454584|79477716|FG004|Controlled Period|Lost to Follow-up|0|||
44469293|NCT00454584|79477717|FG005|Controlled Period|Lost to Follow-up|0|||
44469294|NCT00454584|79477712|FG000|Controlled Period|Other|5|||
44469295|NCT00454584|79477713|FG001|Controlled Period|Other|4|||
44469296|NCT00454584|79477714|FG002|Controlled Period|Other|2|||
44469297|NCT00454584|79477715|FG003|Controlled Period|Other|0|||
44469298|NCT00454584|79477716|FG004|Controlled Period|Other|0|||
44469299|NCT00454584|79477717|FG005|Controlled Period|Other|0|||
44469300|NCT00454584|79477712|FG000|After Controlled Period|Adverse Event|0|||
44469301|NCT00454584|79477713|FG001|After Controlled Period|Adverse Event|0|||
44469302|NCT00454584|79477714|FG002|After Controlled Period|Adverse Event|0|||
44469303|NCT00454584|79477715|FG003|After Controlled Period|Adverse Event|9|||
44469304|NCT00454584|79477716|FG004|After Controlled Period|Adverse Event|3|||
44469305|NCT00454584|79477717|FG005|After Controlled Period|Adverse Event|9|||
44469306|NCT00454584|79477712|FG000|After Controlled Period|Lack of Efficacy|0|||
44469307|NCT00454584|79477713|FG001|After Controlled Period|Lack of Efficacy|0|||
44469308|NCT00454584|79477714|FG002|After Controlled Period|Lack of Efficacy|0|||
44469309|NCT00454584|79477715|FG003|After Controlled Period|Lack of Efficacy|1|||
44469310|NCT00454584|79477716|FG004|After Controlled Period|Lack of Efficacy|0|||
44469311|NCT00454584|79477717|FG005|After Controlled Period|Lack of Efficacy|0|||
44469312|NCT00454584|79477712|FG000|After Controlled Period|Lost to Follow-up|0|||
44469313|NCT00454584|79477713|FG001|After Controlled Period|Lost to Follow-up|0|||
44469314|NCT00454584|79477714|FG002|After Controlled Period|Lost to Follow-up|0|||
44469315|NCT00454584|79477715|FG003|After Controlled Period|Lost to Follow-up|2|||
44469316|NCT00454584|79477716|FG004|After Controlled Period|Lost to Follow-up|4|||
44469317|NCT00454584|79477717|FG005|After Controlled Period|Lost to Follow-up|6|||
44469318|NCT00454584|79477712|FG000|After Controlled Period|Other|0|||
44469319|NCT00454584|79477713|FG001|After Controlled Period|Other|0|||
44469320|NCT00454584|79477714|FG002|After Controlled Period|Other|0|||
44469321|NCT00454584|79477715|FG003|After Controlled Period|Other|1|||
44469322|NCT00454584|79477716|FG004|After Controlled Period|Other|0|||
44469323|NCT00454584|79477717|FG005|After Controlled Period|Other|0|||
44469324|NCT00454584|79477712|FG000|After Controlled Period|Other|0|||
44469325|NCT00454584|79477713|FG001|After Controlled Period|Other|0|||
44469326|NCT00454584|79477714|FG002|After Controlled Period|Other|0|||
44469327|NCT00454584|79477715|FG003|After Controlled Period|Other|13|||
44469328|NCT00454584|79477716|FG004|After Controlled Period|Other|5|||
44469329|NCT00454584|79477717|FG005|After Controlled Period|Other|17|||
44469330|NCT00445068|79477731|FG000|Overall Study|Disease progression|26|||
44469331|NCT00445068|79477731|FG000|Overall Study|Adverse Event|5|||
44469332|NCT00445068|79477731|FG000|Overall Study|Abnormal laboratory value|2|||
44224740|NCT01838551|79030170|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
44224741|NCT01797445|79030176|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
44224742|NCT01797445|79030177|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
44224743|NCT01797445|79030176|FG000|Double-Blind Phase|Adverse Event|3|||
44224744|NCT01797445|79030177|FG001|Double-Blind Phase|Adverse Event|0|||
44469333|NCT00445068|79477731|FG000|Overall Study|Withdrawal by Subject|2|||
44469334|NCT00445068|79477731|FG000|Overall Study|Death|1|||
44469335|NCT00539279|79477737|FG000|Treatment|Withdrawal by Subject|10|||
44469336|NCT00539279|79477738|FG001|Treatment|Withdrawal by Subject|8|||
44469337|NCT00539279|79477737|FG000|Treatment|Death|1|||
44469338|NCT00539279|79477738|FG001|Treatment|Death|0|||
44469339|NCT00539279|79477737|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
44469340|NCT00539279|79477738|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
44469341|NCT00539279|79477737|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
44469342|NCT00539279|79477738|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
44469343|NCT00444912|79477746|FG000|Overall Study|Death|1|||
44224745|NCT01797445|79030176|FG000|Double-Blind Phase|Death|5|||
44224746|NCT01797445|79030177|FG001|Double-Blind Phase|Death|4|||
44224747|NCT01797445|79030176|FG000|Double-Blind Phase|Pregnancy|0|||
44224748|NCT01797445|79030177|FG001|Double-Blind Phase|Pregnancy|1|||
44469344|NCT00444912|79477747|FG001|Overall Study|Death|2|||
44469345|NCT00444912|79477746|FG000|Overall Study|Lost to Follow-up|1|||
44469346|NCT00444912|79477747|FG001|Overall Study|Lost to Follow-up|0|||
44469347|NCT00444912|79477746|FG000|Overall Study|Participant Failed Mobilization|1|||
44469348|NCT00444912|79477747|FG001|Overall Study|Participant Failed Mobilization|0|||
44224749|NCT01797445|79030176|FG000|Double-Blind Phase|Lack of Efficacy|1|||
44469349|NCT00538733|79477753|FG000|Overall Study|Adverse Event|8|||
44469350|NCT00538733|79477753|FG000|Overall Study|Death|1|||
44469351|NCT00538733|79477753|FG000|Overall Study|declined to participate|2|||
44469352|NCT00538733|79477753|FG000|Overall Study|still on therapy|1|||
44469353|NCT00444678|79477760|FG000|Overall Study|Toxicity|11|||
44469354|NCT00444678|79477760|FG000|Overall Study|Disease Progression|12|||
44469355|NCT00444678|79477760|FG000|Overall Study|Death|3|||
44469356|NCT00444678|79477760|FG000|Overall Study|Physician Decision|3|||
44469357|NCT00444678|79477760|FG000|Overall Study|Withdrawal by Subject|2|||
44469358|NCT00358449|79477767|FG000|Overall Study|Adverse Event|1|||
44469359|NCT00358449|79477768|FG001|Overall Study|Adverse Event|0|||
44469360|NCT00358449|79477769|FG002|Overall Study|Adverse Event|1|||
44469361|NCT00358449|79477767|FG000|Overall Study|Lost to Follow-up|1|||
44469362|NCT00358449|79477768|FG001|Overall Study|Lost to Follow-up|0|||
44469363|NCT00358449|79477769|FG002|Overall Study|Lost to Follow-up|0|||
44469364|NCT00358449|79477767|FG000|Overall Study|Withdrawal by Subject|2|||
44469365|NCT00358449|79477768|FG001|Overall Study|Withdrawal by Subject|0|||
44469366|NCT00358449|79477769|FG002|Overall Study|Withdrawal by Subject|0|||
44224750|NCT01797445|79030177|FG001|Double-Blind Phase|Lack of Efficacy|2|||
44224751|NCT01797445|79030176|FG000|Double-Blind Phase|Investigator's Discretion|15|||
44224752|NCT01797445|79030177|FG001|Double-Blind Phase|Investigator's Discretion|17|||
44224753|NCT01797445|79030176|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
44224754|NCT01797445|79030177|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
44224755|NCT01797445|79030176|FG000|Double-Blind Phase|Protocol Violation|0|||
44224756|NCT01797445|79030177|FG001|Double-Blind Phase|Protocol Violation|1|||
44224757|NCT01797445|79030176|FG000|Double-Blind Phase|Withdrew Consent|20|||
44224758|NCT01797445|79030177|FG001|Double-Blind Phase|Withdrew Consent|35|||
44224759|NCT01797445|79030176|FG000|Double-Blind Phase|Lost to Follow-up|34|||
44224760|NCT01797445|79030177|FG001|Double-Blind Phase|Lost to Follow-up|26|||
44224761|NCT01797445|79030176|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
44224762|NCT01797445|79030177|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
44224763|NCT01611259|79030185|FG000|Overall Study|Physician Decision|1|||
44224764|NCT01611259|79030185|FG000|Overall Study|Lack of Efficacy|2|||
44224765|NCT01611259|79030185|FG000|Overall Study|Adverse Event|4|||
44224766|NCT01611259|79030185|FG000|Overall Study|Withdrawal by Subject|7|||
44224767|NCT01795495|79030192|FG000|Overall Study|Protocol Violation|1|||
44224768|NCT01795495|79030193|FG001|Overall Study|Protocol Violation|0|||
44224769|NCT01795495|79030194|FG002|Overall Study|Protocol Violation|1|||
44224770|NCT01795495|79030192|FG000|Overall Study|Physician Decision|0|||
44224771|NCT01795495|79030193|FG001|Overall Study|Physician Decision|0|||
44224772|NCT01795495|79030194|FG002|Overall Study|Physician Decision|1|||
44224773|NCT01794949|79030204|FG000|Overall Study|Lost to Follow-up|1|||
44224774|NCT01794949|79030205|FG001|Overall Study|Lost to Follow-up|0|||
44224775|NCT01770379|79030214|FG000|Overall Study|Technical issues|1|||
44224776|NCT01770379|79030215|FG001|Overall Study|Technical issues|0|||
44224777|NCT01770379|79030216|FG002|Overall Study|Technical issues|0|||
44224778|NCT01770379|79030214|FG000|Overall Study|Withdrawal by Subject|7|||
44224779|NCT01770379|79030215|FG001|Overall Study|Withdrawal by Subject|10|||
44224780|NCT01770379|79030216|FG002|Overall Study|Withdrawal by Subject|7|||
44224781|NCT01770379|79030214|FG000|Overall Study|study terminated by sponsor|22|||
44224782|NCT01770379|79030215|FG001|Overall Study|study terminated by sponsor|23|||
44224783|NCT01770379|79030216|FG002|Overall Study|study terminated by sponsor|22|||
44224784|NCT01770379|79030214|FG000|Overall Study|Protocol Violation|0|||
44224785|NCT01770379|79030215|FG001|Overall Study|Protocol Violation|1|||
44224786|NCT01770379|79030216|FG002|Overall Study|Protocol Violation|1|||
44224787|NCT01770379|79030214|FG000|Overall Study|Physician Decision|0|||
44224788|NCT01770379|79030215|FG001|Overall Study|Physician Decision|1|||
44224789|NCT01770379|79030216|FG002|Overall Study|Physician Decision|2|||
44224790|NCT01770379|79030214|FG000|Overall Study|Lost to Follow-up|0|||
44224791|NCT01770379|79030215|FG001|Overall Study|Lost to Follow-up|0|||
44224792|NCT01770379|79030216|FG002|Overall Study|Lost to Follow-up|2|||
44224793|NCT01770379|79030214|FG000|Overall Study|Lack of Efficacy|8|||
44224794|NCT01770379|79030215|FG001|Overall Study|Lack of Efficacy|6|||
44224795|NCT01770379|79030216|FG002|Overall Study|Lack of Efficacy|6|||
44224796|NCT01770379|79030214|FG000|Overall Study|Adverse Event|1|||
44224797|NCT01770379|79030215|FG001|Overall Study|Adverse Event|3|||
44224798|NCT01770379|79030216|FG002|Overall Study|Adverse Event|2|||
44469367|NCT00358449|79477767|FG000|Overall Study|Lack of Efficacy|0|||
44469368|NCT00358449|79477768|FG001|Overall Study|Lack of Efficacy|1|||
44469369|NCT00358449|79477769|FG002|Overall Study|Lack of Efficacy|0|||
44469370|NCT00358449|79477767|FG000|Overall Study|Steriod Inhaler was Increased|0|||
44224799|NCT01986881|79030229|FG000|Overall Study|Death|228|||
44224800|NCT01986881|79030230|FG001|Overall Study|Death|233|||
44224801|NCT01986881|79030231|FG002|Overall Study|Death|247|||
44224802|NCT01986881|79030229|FG000|Overall Study|Lost to Follow-up|51|||
44224803|NCT01986881|79030230|FG001|Overall Study|Lost to Follow-up|44|||
44224804|NCT01986881|79030231|FG002|Overall Study|Lost to Follow-up|55|||
44224805|NCT01986881|79030229|FG000|Overall Study|Physician Decision|7|||
44469371|NCT00358449|79477768|FG001|Overall Study|Steriod Inhaler was Increased|0|||
44469372|NCT00358449|79477769|FG002|Overall Study|Steriod Inhaler was Increased|1|||
44224806|NCT01986881|79030230|FG001|Overall Study|Physician Decision|4|||
44224807|NCT01986881|79030231|FG002|Overall Study|Physician Decision|6|||
44469373|NCT00539981|79477781|FG000|Overall Study|Adverse events (AE)|3|||
44224808|NCT01986881|79030229|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
44224809|NCT01986881|79030230|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
44224810|NCT01986881|79030231|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
44224811|NCT01986881|79030229|FG000|Overall Study|Withdrawal by Subject|41|||
44224812|NCT01986881|79030230|FG001|Overall Study|Withdrawal by Subject|60|||
44224813|NCT01986881|79030231|FG002|Overall Study|Withdrawal by Subject|45|||
44224814|NCT01986881|79030229|FG000|Overall Study|Subject Moved|0|||
44469374|NCT00539981|79477782|FG001|Overall Study|Adverse events (AE)|3|||
44469375|NCT00539981|79477781|FG000|Overall Study|Lost to Follow-up|260|||
44469376|NCT00539981|79477782|FG001|Overall Study|Lost to Follow-up|251|||
44469377|NCT00539981|79477781|FG000|Overall Study|Withdrew consent|22|||
44469378|NCT00539981|79477782|FG001|Overall Study|Withdrew consent|14|||
44469379|NCT00539981|79477781|FG000|Overall Study|Death|1|||
44469380|NCT00539981|79477782|FG001|Overall Study|Death|1|||
44469381|NCT00539981|79477781|FG000|Overall Study|Other reason-unspecified|9|||
44469382|NCT00539981|79477782|FG001|Overall Study|Other reason-unspecified|13|||
44469383|NCT00367341|79477793|FG000|Overall Study|Physician Decision|1|||
44469384|NCT00367341|79477794|FG001|Overall Study|Physician Decision|0|||
44469385|NCT00367341|79477793|FG000|Overall Study|Protocol Violation|1|||
44469386|NCT00367341|79477794|FG001|Overall Study|Protocol Violation|0|||
44469387|NCT00440466|79477803|FG000|Overall Study|Death|3|||
44469388|NCT00440466|79477804|FG001|Overall Study|Death|2|||
44469389|NCT00440466|79477805|FG002|Overall Study|Death|9|||
44469390|NCT00440466|79477803|FG000|Overall Study|Adverse Event|3|||
44469391|NCT00440466|79477804|FG001|Overall Study|Adverse Event|4|||
44469392|NCT00440466|79477805|FG002|Overall Study|Adverse Event|11|||
44469393|NCT00440466|79477803|FG000|Overall Study|Lost to Follow-up|1|||
44224815|NCT01986881|79030230|FG001|Overall Study|Subject Moved|1|||
44224816|NCT01986881|79030231|FG002|Overall Study|Subject Moved|0|||
44224817|NCT01986881|79030229|FG000|Overall Study|Other|1|||
44224818|NCT01986881|79030230|FG001|Overall Study|Other|2|||
44224819|NCT01986881|79030231|FG002|Overall Study|Other|2|||
44224820|NCT01609543|79030262|FG000|Overall Study|Disease Progression|28|||
44224821|NCT01609543|79030262|FG000|Overall Study|Adverse Event|5|||
44224822|NCT01609543|79030262|FG000|Overall Study|Withdrawal by Subject|1|||
44224823|NCT01609543|79030262|FG000|Overall Study|Protocol Violation|1|||
44224824|NCT01609543|79030262|FG000|Overall Study|Death|7|||
44224825|NCT02003183|79030269|FG000|Overall Study|Lost to Follow-up|0|||
44224826|NCT02003183|79030270|FG001|Overall Study|Lost to Follow-up|2|||
44224827|NCT01986647|79030280|FG000|Overall Study|Lost to Follow-up|4|||
44224828|NCT01986647|79030281|FG001|Overall Study|Lost to Follow-up|1|||
44224829|NCT01986647|79030282|FG002|Overall Study|Lost to Follow-up|4|||
44224830|NCT01986647|79030283|FG003|Overall Study|Lost to Follow-up|4|||
44224831|NCT01986647|79030280|FG000|Overall Study|Withdrawal by Subject|1|||
44224832|NCT01986647|79030281|FG001|Overall Study|Withdrawal by Subject|3|||
44224833|NCT01986647|79030282|FG002|Overall Study|Withdrawal by Subject|2|||
44224834|NCT01986647|79030283|FG003|Overall Study|Withdrawal by Subject|3|||
44224835|NCT01986647|79030280|FG000|Overall Study|Health|5|||
44224836|NCT01986647|79030281|FG001|Overall Study|Health|3|||
44224837|NCT01986647|79030282|FG002|Overall Study|Health|6|||
44224838|NCT01986647|79030283|FG003|Overall Study|Health|4|||
44224839|NCT02002091|79030299|FG000|Screening|Lost to Follow-up|10|||
44224840|NCT02002091|79030300|FG001|Screening|Lost to Follow-up|12|||
44469394|NCT00440466|79477804|FG001|Overall Study|Lost to Follow-up|0|||
44469395|NCT00440466|79477805|FG002|Overall Study|Lost to Follow-up|2|||
44469396|NCT00440466|79477803|FG000|Overall Study|Physician Decision|2|||
44469397|NCT00440466|79477804|FG001|Overall Study|Physician Decision|0|||
44469398|NCT00440466|79477805|FG002|Overall Study|Physician Decision|1|||
44469399|NCT00440466|79477803|FG000|Overall Study|Protocol Violation|2|||
44469400|NCT00440466|79477804|FG001|Overall Study|Protocol Violation|0|||
44469401|NCT00440466|79477805|FG002|Overall Study|Protocol Violation|4|||
44469402|NCT00440466|79477803|FG000|Overall Study|Withdrawal by Subject|2|||
44469403|NCT00440466|79477804|FG001|Overall Study|Withdrawal by Subject|5|||
44469404|NCT00440466|79477805|FG002|Overall Study|Withdrawal by Subject|9|||
44469405|NCT00440466|79477803|FG000|Overall Study|Began Dialysis|0|||
44469406|NCT00440466|79477804|FG001|Overall Study|Began Dialysis|0|||
44469407|NCT00440466|79477805|FG002|Overall Study|Began Dialysis|1|||
44469408|NCT00440466|79477803|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
44224841|NCT02002091|79030299|FG000|Screening|Death|3|||
44224842|NCT02002091|79030300|FG001|Screening|Death|2|||
44224843|NCT01985321|79030337|FG000|Overall Study|Protocol Violation|4|||
44375347|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
44224844|NCT01985321|79030338|FG001|Overall Study|Protocol Violation|3|||
44224845|NCT01985321|79030337|FG000|Overall Study|Withdrawal by Subject|1|||
44224846|NCT01985321|79030338|FG001|Overall Study|Withdrawal by Subject|0|||
44469409|NCT00440466|79477804|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
44469410|NCT00440466|79477805|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
44469411|NCT00537485|79477815|FG000|Overall Study|Adverse Event|10|||
44469412|NCT00537485|79477816|FG001|Overall Study|Adverse Event|5|||
44469413|NCT00537485|79477815|FG000|Overall Study|Withdrawal by Subject|3|||
44469414|NCT00537485|79477816|FG001|Overall Study|Withdrawal by Subject|2|||
44469415|NCT00537485|79477815|FG000|Overall Study|Withdrawal by Subject|1|||
44469416|NCT00537485|79477816|FG001|Overall Study|Withdrawal by Subject|3|||
44224847|NCT01985321|79030337|FG000|Overall Study|Lost to Follow-up|5|||
44224848|NCT01985321|79030338|FG001|Overall Study|Lost to Follow-up|2|||
44224849|NCT01985321|79030337|FG000|Overall Study|Subject treated wrong type of sore|1|||
44224850|NCT01985321|79030338|FG001|Overall Study|Subject treated wrong type of sore|0|||
44469417|NCT00537485|79477815|FG000|Overall Study|Physician Decision|1|||
44469418|NCT00537485|79477816|FG001|Overall Study|Physician Decision|0|||
44469419|NCT00537329|79477822|FG000|Overall Study|Death|10|||
44469420|NCT00537329|79477822|FG000|Overall Study|Adverse Event|3|||
44469421|NCT00537329|79477822|FG000|Overall Study|Lack of Efficacy|2|||
44469422|NCT00537329|79477822|FG000|Overall Study|Lost to Follow-up|6|||
44469423|NCT00537329|79477822|FG000|Overall Study|Withdrawal by Subject|4|||
44469424|NCT00537329|79477822|FG000|Overall Study|Other|1|||
44469425|NCT03897179|79477826|FG000|Overall Study|Withdrawal by Subject|1|||
44469426|NCT03905135|79477832|FG000|Dose Escalation|Adverse Event|1|||
44469427|NCT03905135|79477833|FG001|Dose Escalation|Adverse Event|1|||
44469428|NCT03905135|79477832|FG000|Dose Escalation|Progressive disease|3|||
44469429|NCT03905135|79477833|FG001|Dose Escalation|Progressive disease|1|||
44469430|NCT03905135|79477832|FG000|Dose Escalation|Intercurrent illness|1|||
44469431|NCT03905135|79477833|FG001|Dose Escalation|Intercurrent illness|0|||
44469432|NCT00357903|79477843|FG000|Overall Study|Adverse Event|87|||
44469433|NCT00357903|79477844|FG001|Overall Study|Adverse Event|4|||
44469434|NCT00357903|79477843|FG000|Overall Study|Death|33|||
44469435|NCT00357903|79477844|FG001|Overall Study|Death|0|||
44469436|NCT00357903|79477843|FG000|Overall Study|Lost to Follow-up|23|||
44469437|NCT00357903|79477844|FG001|Overall Study|Lost to Follow-up|4|||
44469438|NCT00357903|79477843|FG000|Overall Study|Physician Decision|39|||
44469439|NCT00357903|79477844|FG001|Overall Study|Physician Decision|5|||
44469440|NCT00357903|79477843|FG000|Overall Study|Withdrawal by Subject|57|||
44469441|NCT00357903|79477844|FG001|Overall Study|Withdrawal by Subject|7|||
44469442|NCT00357903|79477843|FG000|Overall Study|Completed month 12 only|0|||
44469443|NCT00357903|79477844|FG001|Overall Study|Completed month 12 only|1|||
44469444|NCT00357903|79477843|FG000|Overall Study|Protocol issues|14|||
44469445|NCT00357903|79477844|FG001|Overall Study|Protocol issues|3|||
44469446|NCT00357903|79477843|FG000|Overall Study|Response status|61|||
44469447|NCT00357903|79477844|FG001|Overall Study|Response status|9|||
44469448|NCT00357903|79477843|FG000|Overall Study|Other|49|||
44469449|NCT00357903|79477844|FG001|Overall Study|Other|10|||
44469450|NCT00348933|79477851|FG000|Overall Study|Withdrawal by Subject|10|||
44469451|NCT00348933|79477851|FG000|Overall Study|Lost to Follow-up|6|||
44469452|NCT00348933|79477851|FG000|Overall Study|Protocol Violation|2|||
44469453|NCT00348933|79477851|FG000|Overall Study|Adverse Event|7|||
44469454|NCT03896477|79477859|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
44469455|NCT03896477|79477860|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
44469456|NCT03896477|79477861|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
44469457|NCT03896477|79477859|FG000|Overall Study|Parent Requested Withdrawal|8|||
44469458|NCT03896477|79477860|FG001|Overall Study|Parent Requested Withdrawal|12|||
44469459|NCT03896477|79477861|FG002|Overall Study|Parent Requested Withdrawal|9|||
44469460|NCT03896477|79477859|FG000|Overall Study|Adverse Event|0|||
44469461|NCT03896477|79477860|FG001|Overall Study|Adverse Event|0|||
44469462|NCT03896477|79477861|FG002|Overall Study|Adverse Event|1|||
44469463|NCT03896477|79477859|FG000|Overall Study|Death|1|||
44469464|NCT03896477|79477860|FG001|Overall Study|Death|0|||
44469465|NCT03896477|79477861|FG002|Overall Study|Death|0|||
44469466|NCT03896477|79477859|FG000|Overall Study|Other|5|||
44469467|NCT03896477|79477860|FG001|Overall Study|Other|6|||
44469468|NCT03896477|79477861|FG002|Overall Study|Other|7|||
44469469|NCT03896477|79477859|FG000|Overall Study|Lost to Follow-up|2|||
44469470|NCT03896477|79477860|FG001|Overall Study|Lost to Follow-up|1|||
44469471|NCT03896477|79477861|FG002|Overall Study|Lost to Follow-up|1|||
44469472|NCT00444600|79477876|FG000|Overall Study|Death|7|||
44469473|NCT00444600|79477877|FG001|Overall Study|Death|5|||
44469474|NCT00444600|79477878|FG002|Overall Study|Death|3|||
44469475|NCT00444600|79477879|FG003|Overall Study|Death|2|||
44469476|NCT00444600|79477876|FG000|Overall Study|Dropped|11|||
44469477|NCT00444600|79477877|FG001|Overall Study|Dropped|11|||
44469478|NCT00444600|79477878|FG002|Overall Study|Dropped|7|||
44469479|NCT00444600|79477879|FG003|Overall Study|Dropped|7|||
44469480|NCT00444600|79477876|FG000|Overall Study|Missed visit|1|||
44469481|NCT00444600|79477877|FG001|Overall Study|Missed visit|0|||
44469482|NCT00444600|79477878|FG002|Overall Study|Missed visit|0|||
44469483|NCT00444600|79477879|FG003|Overall Study|Missed visit|1|||
44469484|NCT00537095|79477897|FG000|Overall Study|surgery|1|||
44469485|NCT00537095|79477898|FG001|Overall Study|surgery|0|||
44469486|NCT00537095|79477897|FG000|Overall Study|Adverse Event|24|||
44469487|NCT00537095|79477898|FG001|Overall Study|Adverse Event|4|||
44469488|NCT00537095|79477897|FG000|Overall Study|disease progression|21|||
44469489|NCT00537095|79477898|FG001|Overall Study|disease progression|48|||
44469490|NCT00537095|79477897|FG000|Overall Study|Death|3|||
44469491|NCT00537095|79477898|FG001|Overall Study|Death|1|||
44469492|NCT00537095|79477897|FG000|Overall Study|Withdrawal by Subject|2|||
44469493|NCT00537095|79477898|FG001|Overall Study|Withdrawal by Subject|2|||
44469494|NCT00537095|79477897|FG000|Overall Study|subjective disease progression|0|||
44469495|NCT00537095|79477898|FG001|Overall Study|subjective disease progression|1|||
44469496|NCT00537095|79477897|FG000|Overall Study|Incorrect enrolment|0|||
44469497|NCT00537095|79477898|FG001|Overall Study|Incorrect enrolment|1|||
44469498|NCT00443898|79477908|FG000|Overall Study|Adverse Event|0|||
44469499|NCT00443898|79477909|FG001|Overall Study|Adverse Event|0|||
44469500|NCT00443898|79477910|FG002|Overall Study|Adverse Event|1|||
44469501|NCT00443898|79477911|FG003|Overall Study|Adverse Event|1|||
44469502|NCT00443898|79477908|FG000|Overall Study|Lack of Efficacy|2|||
44469503|NCT00443898|79477909|FG001|Overall Study|Lack of Efficacy|3|||
44469504|NCT00443898|79477910|FG002|Overall Study|Lack of Efficacy|3|||
44469505|NCT00443898|79477911|FG003|Overall Study|Lack of Efficacy|1|||
44469506|NCT00443898|79477908|FG000|Overall Study|Protocol Violation|1|||
44469507|NCT00443898|79477909|FG001|Overall Study|Protocol Violation|1|||
44469508|NCT00443898|79477910|FG002|Overall Study|Protocol Violation|1|||
44469509|NCT00443898|79477911|FG003|Overall Study|Protocol Violation|0|||
44469510|NCT00443898|79477908|FG000|Overall Study|Withdrawal by Subject|11|||
44469511|NCT00443898|79477909|FG001|Overall Study|Withdrawal by Subject|10|||
44469512|NCT00443898|79477910|FG002|Overall Study|Withdrawal by Subject|10|||
44469513|NCT00443898|79477911|FG003|Overall Study|Withdrawal by Subject|6|||
44469514|NCT00443898|79477908|FG000|Overall Study|Lost to Follow-up|10|||
44469515|NCT00443898|79477909|FG001|Overall Study|Lost to Follow-up|10|||
44224851|NCT02000921|79030347|FG000|Overall Study|Withdrawal by Subject|3|||
44224852|NCT02000921|79030348|FG001|Overall Study|Withdrawal by Subject|10|||
44224853|NCT02000921|79030349|FG002|Overall Study|Withdrawal by Subject|5|||
44224854|NCT02000921|79030347|FG000|Overall Study|Lost to Follow-up|2|||
44224855|NCT02000921|79030348|FG001|Overall Study|Lost to Follow-up|4|||
44224856|NCT02000921|79030349|FG002|Overall Study|Lost to Follow-up|5|||
44224857|NCT02000921|79030347|FG000|Overall Study|Physician Decision|0|||
44224858|NCT02000921|79030348|FG001|Overall Study|Physician Decision|2|||
44224859|NCT02000921|79030349|FG002|Overall Study|Physician Decision|0|||
44224860|NCT01836523|79030395|FG000|Overall Study|Adverse Event|15|||
44224861|NCT01836523|79030396|FG001|Overall Study|Adverse Event|41|||
44224862|NCT01836523|79030397|FG002|Overall Study|Adverse Event|49|||
44224863|NCT01836523|79030398|FG003|Overall Study|Adverse Event|14|||
44224864|NCT01836523|79030395|FG000|Overall Study|Protocol Violation|6|||
44224865|NCT01836523|79030396|FG001|Overall Study|Protocol Violation|3|||
44224866|NCT01836523|79030397|FG002|Overall Study|Protocol Violation|2|||
44224867|NCT01836523|79030398|FG003|Overall Study|Protocol Violation|4|||
44224868|NCT01836523|79030395|FG000|Overall Study|Met Withdrawal Criteria|13|||
44224869|NCT01836523|79030396|FG001|Overall Study|Met Withdrawal Criteria|13|||
44224870|NCT01836523|79030397|FG002|Overall Study|Met Withdrawal Criteria|21|||
44224871|NCT01836523|79030398|FG003|Overall Study|Met Withdrawal Criteria|27|||
44469516|NCT00443898|79477910|FG002|Overall Study|Lost to Follow-up|14|||
44469517|NCT00443898|79477911|FG003|Overall Study|Lost to Follow-up|10|||
44469518|NCT00443898|79477908|FG000|Overall Study|Death|0|||
44469519|NCT00443898|79477909|FG001|Overall Study|Death|1|||
44469520|NCT00443898|79477910|FG002|Overall Study|Death|0|||
44469521|NCT00443898|79477911|FG003|Overall Study|Death|0|||
44469522|NCT00537017|79477921|FG000|Treatment Phase|Adverse Event|19|||
44469523|NCT00537017|79477921|FG000|Treatment Phase|Withdrawal by Subject|13|||
44469524|NCT00537017|79477921|FG000|Treatment Phase|Protocol Violation|2|||
44469525|NCT00537017|79477921|FG000|Follow-up Phase|Withdrawal by Subject|9|||
44469526|NCT00348309|79477928|FG000|Overall Study|Adverse Event|56|||
44469527|NCT00348309|79477929|FG001|Overall Study|Adverse Event|28|||
44469528|NCT00348309|79477930|FG002|Overall Study|Adverse Event|63|||
44469529|NCT00348309|79477928|FG000|Overall Study|Lost to Follow-up|6|||
44469530|NCT00348309|79477929|FG001|Overall Study|Lost to Follow-up|7|||
44469531|NCT00348309|79477930|FG002|Overall Study|Lost to Follow-up|4|||
44469532|NCT00348309|79477928|FG000|Overall Study|Protocol Violation|7|||
44469533|NCT00348309|79477929|FG001|Overall Study|Protocol Violation|12|||
44469534|NCT00348309|79477930|FG002|Overall Study|Protocol Violation|7|||
44469535|NCT00348309|79477928|FG000|Overall Study|Withdrawal by Subject|33|||
44469536|NCT00348309|79477929|FG001|Overall Study|Withdrawal by Subject|37|||
44224872|NCT01836523|79030395|FG000|Overall Study|Unclassified|17|||
44224873|NCT01836523|79030396|FG001|Overall Study|Unclassified|28|||
44224874|NCT01836523|79030397|FG002|Overall Study|Unclassified|19|||
44224875|NCT01836523|79030398|FG003|Overall Study|Unclassified|29|||
44224876|NCT01275196|79030410|FG000|Overall Study|Adverse Event|3|||
44224877|NCT01275196|79030411|FG001|Overall Study|Adverse Event|5|||
44469537|NCT00348309|79477930|FG002|Overall Study|Withdrawal by Subject|40|||
44469538|NCT00348309|79477928|FG000|Overall Study|Non-compliance|8|||
44469539|NCT00348309|79477929|FG001|Overall Study|Non-compliance|6|||
44469540|NCT00348309|79477930|FG002|Overall Study|Non-compliance|8|||
44469541|NCT00348309|79477928|FG000|Overall Study|Death of caregiver|1|||
44469542|NCT00348309|79477929|FG001|Overall Study|Death of caregiver|0|||
44224878|NCT01275196|79030410|FG000|Overall Study|Withdrawal by Subject|4|||
44224879|NCT01275196|79030411|FG001|Overall Study|Withdrawal by Subject|5|||
44224880|NCT01275196|79030410|FG000|Overall Study|Lost to Follow-up|1|||
44224881|NCT01275196|79030411|FG001|Overall Study|Lost to Follow-up|0|||
44224882|NCT01275196|79030410|FG000|Overall Study|Disease Progression|6|||
44224883|NCT01275196|79030411|FG001|Overall Study|Disease Progression|5|||
44469543|NCT00348309|79477930|FG002|Overall Study|Death of caregiver|1|||
44469544|NCT00348309|79477928|FG000|Overall Study|Lack of insight, dementia|1|||
44224884|NCT01275196|79030410|FG000|Overall Study|Protocol Violation|1|||
44224885|NCT01275196|79030411|FG001|Overall Study|Protocol Violation|0|||
44224886|NCT01275196|79030410|FG000|Overall Study|Suboptimal response/treatment failure|5|||
44224887|NCT01275196|79030411|FG001|Overall Study|Suboptimal response/treatment failure|6|||
44273861|NCT00033657|79215425|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
44273862|NCT00033657|79215424|FG000|Surgical Resection|not complete resection|0|||
44273863|NCT00033657|79215425|FG001|Surgical Resection|not complete resection|3|||
44273864|NCT00033657|79215424|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
44273865|NCT00033657|79215425|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
44273866|NCT00033657|79215424|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
44273867|NCT00033657|79215425|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
44273868|NCT00033657|79215424|FG000|Adjuvant Chemotherapy|Death|2|||
44273869|NCT00033657|79215425|FG001|Adjuvant Chemotherapy|Death|1|||
44273870|NCT00033657|79215424|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
44273871|NCT00033657|79215425|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
44273872|NCT00033657|79215424|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
44273873|NCT00033657|79215425|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
44273874|NCT00033657|79215424|FG000|Adjuvant Chemotherapy|Other|0|||
44273875|NCT00033657|79215425|FG001|Adjuvant Chemotherapy|Other|2|||
44273876|NCT00003389|79215435|FG000|Overall Study|Disease progression|6|||
44273877|NCT00003389|79215436|FG001|Overall Study|Disease progression|1|||
44273878|NCT00003389|79215435|FG000|Overall Study|Adverse Event|13|||
44273879|NCT00003389|79215436|FG001|Overall Study|Adverse Event|2|||
44273880|NCT00003389|79215435|FG000|Overall Study|Death|0|||
44375348|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44375349|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
44469545|NCT00348309|79477929|FG001|Overall Study|Lack of insight, dementia|0|||
44469546|NCT00348309|79477930|FG002|Overall Study|Lack of insight, dementia|0|||
44469547|NCT00348309|79477928|FG000|Overall Study|Wrong bottle allocated|1|||
44469548|NCT00348309|79477929|FG001|Overall Study|Wrong bottle allocated|0|||
44469549|NCT00348309|79477930|FG002|Overall Study|Wrong bottle allocated|0|||
44469550|NCT00348309|79477928|FG000|Overall Study|Caregiver sick|1|||
44469551|NCT00348309|79477929|FG001|Overall Study|Caregiver sick|0|||
44469552|NCT00348309|79477930|FG002|Overall Study|Caregiver sick|0|||
44469553|NCT00348309|79477928|FG000|Overall Study|Use of prohibited medication|5|||
44469554|NCT00348309|79477929|FG001|Overall Study|Use of prohibited medication|2|||
44469555|NCT00348309|79477930|FG002|Overall Study|Use of prohibited medication|2|||
44469556|NCT00348309|79477928|FG000|Overall Study|Caregiver withdrawal|3|||
44469557|NCT00348309|79477929|FG001|Overall Study|Caregiver withdrawal|0|||
44469558|NCT00348309|79477930|FG002|Overall Study|Caregiver withdrawal|7|||
44469559|NCT00348309|79477928|FG000|Overall Study|Unable to complete ET visit|1|||
44224888|NCT01984697|79030424|FG000|Overall Study|Adverse Event|0|||
44224889|NCT01984697|79030425|FG001|Overall Study|Adverse Event|0|||
44224890|NCT01984697|79030426|FG002|Overall Study|Adverse Event|2|||
44224891|NCT01984697|79030427|FG003|Overall Study|Adverse Event|0|||
44224892|NCT01984697|79030428|FG004|Overall Study|Adverse Event|0|||
44224893|NCT01984697|79030424|FG000|Overall Study|Lost to Follow-up|14|||
44224894|NCT01984697|79030425|FG001|Overall Study|Lost to Follow-up|5|||
44224895|NCT01984697|79030426|FG002|Overall Study|Lost to Follow-up|10|||
44224896|NCT01984697|79030427|FG003|Overall Study|Lost to Follow-up|6|||
44224897|NCT01984697|79030428|FG004|Overall Study|Lost to Follow-up|21|||
44224898|NCT01984697|79030424|FG000|Overall Study|Physician Decision|3|||
44224899|NCT01984697|79030425|FG001|Overall Study|Physician Decision|0|||
44224900|NCT01984697|79030426|FG002|Overall Study|Physician Decision|0|||
44469560|NCT00348309|79477929|FG001|Overall Study|Unable to complete ET visit|0|||
44469561|NCT00348309|79477930|FG002|Overall Study|Unable to complete ET visit|0|||
44469562|NCT00348309|79477928|FG000|Overall Study|PI closing medical practice|1|||
44469563|NCT00348309|79477929|FG001|Overall Study|PI closing medical practice|0|||
44469564|NCT00348309|79477930|FG002|Overall Study|PI closing medical practice|0|||
44469565|NCT00348309|79477928|FG000|Overall Study|Principal investigator's decision|1|||
44469566|NCT00348309|79477929|FG001|Overall Study|Principal investigator's decision|0|||
44224901|NCT01984697|79030427|FG003|Overall Study|Physician Decision|1|||
44224902|NCT01984697|79030428|FG004|Overall Study|Physician Decision|0|||
44273881|NCT00003389|79215436|FG001|Overall Study|Death|3|||
44469567|NCT00348309|79477930|FG002|Overall Study|Principal investigator's decision|0|||
44469568|NCT00348309|79477928|FG000|Overall Study|No disponibility of medication|1|||
44273882|NCT00003389|79215435|FG000|Overall Study|Withdrawal by Subject|12|||
44469569|NCT00348309|79477929|FG001|Overall Study|No disponibility of medication|0|||
44469570|NCT00348309|79477930|FG002|Overall Study|No disponibility of medication|0|||
44224903|NCT01984697|79030424|FG000|Overall Study|Protocol Violation|8|||
44224904|NCT01984697|79030425|FG001|Overall Study|Protocol Violation|5|||
44224905|NCT01984697|79030426|FG002|Overall Study|Protocol Violation|3|||
44375350|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
44224906|NCT01984697|79030427|FG003|Overall Study|Protocol Violation|2|||
44469571|NCT00348309|79477928|FG000|Overall Study|Worsened neurodegenerative disease|1|||
44469572|NCT00348309|79477929|FG001|Overall Study|Worsened neurodegenerative disease|0|||
44469573|NCT00348309|79477930|FG002|Overall Study|Worsened neurodegenerative disease|0|||
44224907|NCT01984697|79030428|FG004|Overall Study|Protocol Violation|0|||
44224908|NCT01984697|79030424|FG000|Overall Study|Withdrawal by Subject|15|||
44224909|NCT01984697|79030425|FG001|Overall Study|Withdrawal by Subject|21|||
44224910|NCT01984697|79030426|FG002|Overall Study|Withdrawal by Subject|13|||
44224911|NCT01984697|79030427|FG003|Overall Study|Withdrawal by Subject|11|||
44224912|NCT01984697|79030428|FG004|Overall Study|Withdrawal by Subject|13|||
44224913|NCT01984697|79030424|FG000|Overall Study|Missed last follow-up visit|1|||
44224914|NCT01984697|79030425|FG001|Overall Study|Missed last follow-up visit|0|||
44224915|NCT01984697|79030426|FG002|Overall Study|Missed last follow-up visit|0|||
44224916|NCT01984697|79030427|FG003|Overall Study|Missed last follow-up visit|0|||
44224917|NCT01984697|79030428|FG004|Overall Study|Missed last follow-up visit|0|||
44224918|NCT01984697|79030424|FG000|Overall Study|Death|0|||
44224919|NCT01984697|79030425|FG001|Overall Study|Death|0|||
44224920|NCT01984697|79030426|FG002|Overall Study|Death|0|||
44224921|NCT01984697|79030427|FG003|Overall Study|Death|1|||
44224922|NCT01984697|79030428|FG004|Overall Study|Death|0|||
44469574|NCT00348309|79477928|FG000|Overall Study|Cognitive and behaviour worsening|2|||
44469575|NCT00348309|79477929|FG001|Overall Study|Cognitive and behaviour worsening|0|||
44469576|NCT00348309|79477930|FG002|Overall Study|Cognitive and behaviour worsening|0|||
44469577|NCT00348309|79477928|FG000|Overall Study|Worsening of alzheimer|1|||
44469578|NCT00348309|79477929|FG001|Overall Study|Worsening of alzheimer|0|||
44469579|NCT00348309|79477930|FG002|Overall Study|Worsening of alzheimer|1|||
44469580|NCT00348309|79477928|FG000|Overall Study|Did not appear in time for Visit 3|1|||
44469581|NCT00348309|79477929|FG001|Overall Study|Did not appear in time for Visit 3|0|||
44469582|NCT00348309|79477930|FG002|Overall Study|Did not appear in time for Visit 3|0|||
44469583|NCT00348309|79477928|FG000|Overall Study|Participant died|2|||
44469584|NCT00348309|79477929|FG001|Overall Study|Participant died|1|||
44469585|NCT00348309|79477930|FG002|Overall Study|Participant died|1|||
44469586|NCT00348309|79477928|FG000|Overall Study|Decision of sponsor|1|||
44469587|NCT00348309|79477929|FG001|Overall Study|Decision of sponsor|0|||
44469588|NCT00348309|79477930|FG002|Overall Study|Decision of sponsor|0|||
44469589|NCT00348309|79477928|FG000|Overall Study|Ineffectiveness of treatment|0|||
44469590|NCT00348309|79477929|FG001|Overall Study|Ineffectiveness of treatment|1|||
44469591|NCT00348309|79477930|FG002|Overall Study|Ineffectiveness of treatment|0|||
44469592|NCT00348309|79477928|FG000|Overall Study|A foul of exclusion criteria|0|||
44469593|NCT00348309|79477929|FG001|Overall Study|A foul of exclusion criteria|1|||
44469594|NCT00348309|79477930|FG002|Overall Study|A foul of exclusion criteria|0|||
44469595|NCT00348309|79477928|FG000|Overall Study|Participant was hospitalized|0|||
44469596|NCT00348309|79477929|FG001|Overall Study|Participant was hospitalized|1|||
44469597|NCT00348309|79477930|FG002|Overall Study|Participant was hospitalized|0|||
44469598|NCT00348309|79477928|FG000|Overall Study|Sponsor refuseal|0|||
44469599|NCT00348309|79477929|FG001|Overall Study|Sponsor refuseal|1|||
44469600|NCT00348309|79477930|FG002|Overall Study|Sponsor refuseal|1|||
44469601|NCT00348309|79477928|FG000|Overall Study|Forgot often medication|0|||
44469602|NCT00348309|79477929|FG001|Overall Study|Forgot often medication|1|||
44469603|NCT00348309|79477930|FG002|Overall Study|Forgot often medication|0|||
44469604|NCT00348309|79477928|FG000|Overall Study|Medical Monitor decision|0|||
44469605|NCT00348309|79477929|FG001|Overall Study|Medical Monitor decision|0|||
44469606|NCT00348309|79477930|FG002|Overall Study|Medical Monitor decision|1|||
44469607|NCT00348309|79477928|FG000|Overall Study|Increased dose of Aricept|0|||
44469608|NCT00348309|79477929|FG001|Overall Study|Increased dose of Aricept|0|||
44469609|NCT00348309|79477930|FG002|Overall Study|Increased dose of Aricept|1|||
44469610|NCT00348309|79477928|FG000|Overall Study|Site closure|0|||
44469611|NCT00348309|79477929|FG001|Overall Study|Site closure|0|||
44224923|NCT01984697|79030424|FG000|Overall Study|Pregnancy|2|||
44469612|NCT00348309|79477930|FG002|Overall Study|Site closure|1|||
44469613|NCT00348309|79477928|FG000|Overall Study|Adverse event not attended|0|||
44469614|NCT00348309|79477929|FG001|Overall Study|Adverse event not attended|0|||
44469615|NCT00348309|79477930|FG002|Overall Study|Adverse event not attended|1|||
44469616|NCT00348309|79477928|FG000|Overall Study|ECG abnormal|0|||
44469617|NCT00348309|79477929|FG001|Overall Study|ECG abnormal|0|||
44224924|NCT01984697|79030425|FG001|Overall Study|Pregnancy|0|||
44224925|NCT01984697|79030426|FG002|Overall Study|Pregnancy|1|||
44469618|NCT00348309|79477930|FG002|Overall Study|ECG abnormal|2|||
44469619|NCT00348309|79477928|FG000|Overall Study|Cardiologist recommendations|0|||
44469620|NCT00348309|79477929|FG001|Overall Study|Cardiologist recommendations|0|||
44224926|NCT01984697|79030427|FG003|Overall Study|Pregnancy|0|||
44224927|NCT01984697|79030428|FG004|Overall Study|Pregnancy|1|||
44224928|NCT02000531|79030442|FG000|Overall Study|Lost to Follow-up|1|||
44224929|NCT02000531|79030443|FG001|Overall Study|Lost to Follow-up|0|||
44469621|NCT00348309|79477930|FG002|Overall Study|Cardiologist recommendations|1|||
44469622|NCT00348309|79477928|FG000|Overall Study|HCV career|0|||
44469623|NCT00348309|79477929|FG001|Overall Study|HCV career|0|||
44224930|NCT02000531|79030442|FG000|Overall Study|Discontinued due to data cut-off|3|||
44469624|NCT00348309|79477930|FG002|Overall Study|HCV career|1|||
44469625|NCT00440310|79477941|FG000|Overall Study|Lost to Follow-up|4|||
44469626|NCT00440310|79477942|FG001|Overall Study|Lost to Follow-up|5|||
44469627|NCT00440310|79477941|FG000|Overall Study|Protocol Violation|0|||
44469628|NCT00440310|79477942|FG001|Overall Study|Protocol Violation|1|||
44469629|NCT00440310|79477941|FG000|Overall Study|Withdrawal by Subject|15|||
44469630|NCT00440310|79477942|FG001|Overall Study|Withdrawal by Subject|14|||
44469631|NCT00440310|79477941|FG000|Overall Study|No Reply at EOS|7|||
44224931|NCT02000531|79030443|FG001|Overall Study|Discontinued due to data cut-off|8|||
44224932|NCT01609231|79030451|FG000|Overall Study|Adverse Event|1|||
44224933|NCT01609231|79030452|FG001|Overall Study|Adverse Event|3|||
44224934|NCT01609231|79030451|FG000|Overall Study|Physician Decision|1|||
44224935|NCT01609231|79030452|FG001|Overall Study|Physician Decision|0|||
44224936|NCT01609231|79030451|FG000|Overall Study|Withdrawal by Subject|1|||
44224937|NCT01609231|79030452|FG001|Overall Study|Withdrawal by Subject|0|||
44224938|NCT01793935|79030460|FG000|Overall Study|Pregnancy|1|||
44224939|NCT01793935|79030461|FG001|Overall Study|Pregnancy|0|||
44224940|NCT01793935|79030460|FG000|Overall Study|Protocol Violation|2|||
44224941|NCT01793935|79030461|FG001|Overall Study|Protocol Violation|1|||
44273883|NCT00003389|79215436|FG001|Overall Study|Withdrawal by Subject|5|||
44273884|NCT00003389|79215435|FG000|Overall Study|Alternative therapy|2|||
44273885|NCT00003389|79215436|FG001|Overall Study|Alternative therapy|1|||
44273886|NCT00003389|79215435|FG000|Overall Study|Complicating disease|1|||
44273887|NCT00003389|79215436|FG001|Overall Study|Complicating disease|0|||
44273888|NCT00003389|79215435|FG000|Overall Study|Off-treatment reason missing|31|||
44469632|NCT00440310|79477942|FG001|Overall Study|No Reply at EOS|7|||
44469633|NCT00440310|79477941|FG000|Overall Study|Other|1|||
44469634|NCT00440310|79477942|FG001|Overall Study|Other|0|||
44469635|NCT00440310|79477941|FG000|Overall Study|Status Unknown|1|||
44469636|NCT00440310|79477942|FG001|Overall Study|Status Unknown|3|||
44469637|NCT00440232|79477950|FG000|Overall Study|Lost to Follow-up|1|||
44469638|NCT00440232|79477951|FG001|Overall Study|Lost to Follow-up|1|||
44469639|NCT00440232|79477950|FG000|Overall Study|Unable to treat within allowed time|0|||
44469640|NCT00440232|79477951|FG001|Overall Study|Unable to treat within allowed time|1|||
44469641|NCT00440232|79477950|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
44469642|NCT00440232|79477951|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
44469643|NCT00356889|79477957|FG000|Overall Study|Protocol Violation|2|||
44469644|NCT00356889|79477957|FG000|Overall Study|Adverse Event|1|||
44469645|NCT00356811|79477962|FG000|Overall Study|Death|35|||
44469646|NCT00356811|79477962|FG000|Overall Study|Lost to Follow-up|2|||
44469647|NCT00356811|79477962|FG000|Overall Study|Withdrawal by Subject|6|||
44469648|NCT00356811|79477962|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
44469649|NCT00356811|79477962|FG000|Overall Study|Study Is Terminating|3|||
44469650|NCT00356811|79477962|FG000|Overall Study|Site Closed during Follow-up|2|||
44469651|NCT00439218|79477967|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
44469652|NCT00535223|79477986|FG000|Overall Study|Withdrawal by Subject|4|||
44469653|NCT00535223|79477987|FG001|Overall Study|Withdrawal by Subject|1|||
44469654|NCT00536939|79477993|FG000|Overall Study|Withdrawal by Subject|1|||
44469655|NCT00536939|79477994|FG001|Overall Study|Withdrawal by Subject|0|||
44469656|NCT00536939|79477993|FG000|Overall Study|Other Complicating Disease|1|||
44469657|NCT00536939|79477994|FG001|Overall Study|Other Complicating Disease|0|||
44469658|NCT00347919|79478002|FG000|Overall Study|Lost to Follow-up|11|||
44469659|NCT00347919|79478003|FG001|Overall Study|Lost to Follow-up|13|||
44469660|NCT00347919|79478004|FG002|Overall Study|Lost to Follow-up|0|||
44469661|NCT00347919|79478002|FG000|Overall Study|Withdrawal by Subject|6|||
44469662|NCT00347919|79478003|FG001|Overall Study|Withdrawal by Subject|8|||
44469663|NCT00347919|79478004|FG002|Overall Study|Withdrawal by Subject|0|||
44469664|NCT00347919|79478002|FG000|Overall Study|Physician Decision|1|||
44469665|NCT00347919|79478003|FG001|Overall Study|Physician Decision|1|||
44469666|NCT00347919|79478004|FG002|Overall Study|Physician Decision|0|||
44469667|NCT00347919|79478002|FG000|Overall Study|Sponsor terminated study|15|||
44273889|NCT00003389|79215436|FG001|Overall Study|Off-treatment reason missing|21|||
44381600|NCT01026194|79387708|FG001|Period 2：Open-label Period|Adverse Event|5|||
44224942|NCT01793935|79030460|FG000|Overall Study|Adverse Event|2|||
44224943|NCT01793935|79030461|FG001|Overall Study|Adverse Event|0|||
44224944|NCT01793935|79030460|FG000|Overall Study|Patient did not take study medication|1|||
44381601|NCT01026194|79387707|FG000|Period 2：Open-label Period|Physician Decision|3|||
44381602|NCT01026194|79387708|FG001|Period 2：Open-label Period|Physician Decision|1|||
44381603|NCT01026194|79387707|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
44381604|NCT01026194|79387708|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
44381605|NCT01033136|79387718|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
44381606|NCT01033136|79387719|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
44381607|NCT00738673|79387729|FG000|Overall Study|Adverse Event|1|||
44381608|NCT00738673|79387730|FG001|Overall Study|Adverse Event|0|||
44381609|NCT00738673|79387729|FG000|Overall Study|Lack of Efficacy|19|||
44381610|NCT00738673|79387730|FG001|Overall Study|Lack of Efficacy|8|||
44469668|NCT00347919|79478003|FG001|Overall Study|Sponsor terminated study|10|||
44469669|NCT00347919|79478004|FG002|Overall Study|Sponsor terminated study|16|||
44469670|NCT00347919|79478002|FG000|Overall Study|Death|35|||
44469671|NCT00347919|79478003|FG001|Overall Study|Death|42|||
44469672|NCT00347919|79478004|FG002|Overall Study|Death|19|||
44469673|NCT00347919|79478002|FG000|Overall Study|Par. Started Other Treatment|1|||
44469674|NCT00347919|79478003|FG001|Overall Study|Par. Started Other Treatment|1|||
44469675|NCT00347919|79478004|FG002|Overall Study|Par. Started Other Treatment|1|||
44469676|NCT00347919|79478002|FG000|Overall Study|Missing|2|||
44469677|NCT00347919|79478003|FG001|Overall Study|Missing|1|||
44469678|NCT00347919|79478004|FG002|Overall Study|Missing|2|||
44469679|NCT00439140|79478017|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
44469680|NCT00439140|79478018|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
44469681|NCT00439140|79478019|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
44469682|NCT00439140|79478017|FG000|Treatment Cycle 1|Personal reasons|0|||
44469683|NCT00439140|79478018|FG001|Treatment Cycle 1|Personal reasons|2|||
44469684|NCT00439140|79478019|FG002|Treatment Cycle 1|Personal reasons|0|||
44469685|NCT00439140|79478017|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
44469686|NCT00439140|79478018|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
44469687|NCT00439140|79478019|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
44469688|NCT00439140|79478017|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
44224945|NCT01793935|79030461|FG001|Overall Study|Patient did not take study medication|1|||
44224946|NCT01793935|79030460|FG000|Overall Study|Lost to Follow-up|0|||
44224947|NCT01793935|79030461|FG001|Overall Study|Lost to Follow-up|1|||
44224948|NCT02092025|79030467|FG000|Overall Study|Case Report Forms Uncollected|44|||
44224949|NCT02092025|79030467|FG000|Overall Study|Protocol Deviation|24|||
44224950|NCT01769443|79030473|FG000|Overall Study|Study closure|1|||
44224951|NCT01769443|79030474|FG001|Overall Study|Study closure|0|||
44224952|NCT01768117|79030481|FG000|Overall Study|Lost to Follow-up|1|||
44224953|NCT01768117|79030481|FG000|Overall Study|Withdrawal by Subject|2|||
44224954|NCT01768117|79030481|FG000|Overall Study|Protocol Violation|3|||
44224955|NCT01767493|79030485|FG000|Overall Study|screen failures|3|||
44224956|NCT01274182|79030492|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
44224957|NCT01274182|79030493|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44224958|NCT01274182|79030494|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
44224959|NCT01274182|79030492|FG000|Overall Study|Adverse Event|4|||
44224960|NCT01274182|79030493|FG001|Overall Study|Adverse Event|5|||
44224961|NCT01274182|79030494|FG002|Overall Study|Adverse Event|3|||
44224962|NCT01274182|79030492|FG000|Overall Study|Withdrawal by Subject|5|||
44469689|NCT00439140|79478018|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
44469690|NCT00439140|79478019|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
44469691|NCT00439140|79478017|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
44469692|NCT00439140|79478018|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
44469693|NCT00439140|79478019|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
44224963|NCT01274182|79030493|FG001|Overall Study|Withdrawal by Subject|5|||
44469694|NCT00356421|79478029|FG000|Overall Study|Lack of Efficacy|3|||
44469695|NCT00356421|79478030|FG001|Overall Study|Lack of Efficacy|0|||
44469696|NCT00356421|79478029|FG000|Overall Study|Withdrawal by Subject|9|||
44469697|NCT00356421|79478030|FG001|Overall Study|Withdrawal by Subject|2|||
44469698|NCT00356421|79478029|FG000|Overall Study|Related to study drug|15|||
44469699|NCT00356421|79478030|FG001|Overall Study|Related to study drug|12|||
44469700|NCT00356421|79478029|FG000|Overall Study|Not related to study drug|5|||
44469701|NCT00356421|79478030|FG001|Overall Study|Not related to study drug|3|||
44469702|NCT00443820|79478040|FG000|Overall Study|Adverse Event|1|||
44469703|NCT00443820|79478041|FG001|Overall Study|Adverse Event|1|||
44469704|NCT00443820|79478042|FG002|Overall Study|Adverse Event|0|||
44469705|NCT00443820|79478043|FG003|Overall Study|Adverse Event|0|||
44469706|NCT00443820|79478040|FG000|Overall Study|Lack of Efficacy|3|||
44469707|NCT00443820|79478041|FG001|Overall Study|Lack of Efficacy|2|||
44469708|NCT00443820|79478042|FG002|Overall Study|Lack of Efficacy|1|||
44469709|NCT00443820|79478043|FG003|Overall Study|Lack of Efficacy|1|||
44469710|NCT00443820|79478040|FG000|Overall Study|Protocol Violation|2|||
44469711|NCT00443820|79478041|FG001|Overall Study|Protocol Violation|1|||
44224964|NCT01274182|79030494|FG002|Overall Study|Withdrawal by Subject|3|||
44224965|NCT01274182|79030492|FG000|Overall Study|Lost to Follow-up|2|||
44469712|NCT00443820|79478042|FG002|Overall Study|Protocol Violation|2|||
44469713|NCT00443820|79478043|FG003|Overall Study|Protocol Violation|1|||
44544475|NCT03600805|79557867|FG001|Overall Study|Withdrawal by Subject|0|||
44224966|NCT01274182|79030493|FG001|Overall Study|Lost to Follow-up|3|||
44469714|NCT00443820|79478040|FG000|Overall Study|Withdrawal by Subject|6|||
44469715|NCT00443820|79478041|FG001|Overall Study|Withdrawal by Subject|7|||
44544476|NCT03600805|79557868|FG002|Overall Study|Withdrawal by Subject|0|||
44544477|NCT03600805|79557869|FG003|Overall Study|Withdrawal by Subject|1|||
44544478|NCT03600805|79557866|FG000|Overall Study|Other unspecified|14|||
44224967|NCT01274182|79030494|FG002|Overall Study|Lost to Follow-up|1|||
44224968|NCT01274182|79030492|FG000|Overall Study|Protocol Violation|3|||
44224969|NCT01274182|79030493|FG001|Overall Study|Protocol Violation|2|||
44469716|NCT00443820|79478042|FG002|Overall Study|Withdrawal by Subject|8|||
44469717|NCT00443820|79478043|FG003|Overall Study|Withdrawal by Subject|9|||
44469718|NCT00443820|79478040|FG000|Overall Study|Lost to Follow-up|9|||
44469719|NCT00443820|79478041|FG001|Overall Study|Lost to Follow-up|8|||
44469720|NCT00443820|79478042|FG002|Overall Study|Lost to Follow-up|6|||
44469721|NCT00443820|79478043|FG003|Overall Study|Lost to Follow-up|5|||
44469722|NCT00443820|79478040|FG000|Overall Study|Administrative problems|0|||
44469723|NCT00443820|79478041|FG001|Overall Study|Administrative problems|0|||
44469724|NCT00443820|79478042|FG002|Overall Study|Administrative problems|0|||
44469725|NCT00443820|79478043|FG003|Overall Study|Administrative problems|1|||
44469726|NCT00443820|79478040|FG000|Overall Study|Death|0|||
44469727|NCT00443820|79478041|FG001|Overall Study|Death|0|||
44469728|NCT00443820|79478042|FG002|Overall Study|Death|1|||
44375351|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
44375352|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
44469729|NCT00443820|79478043|FG003|Overall Study|Death|0|||
44469730|NCT00438672|79478055|FG000|Overall Study|Lost to Follow-up|7|||
44469731|NCT00438672|79478056|FG001|Overall Study|Lost to Follow-up|9|||
44469732|NCT00438360|79478064|FG000|Overall Study|Adverse Event|6|||
44469733|NCT00438360|79478065|FG001|Overall Study|Adverse Event|1|||
44469734|NCT00438360|79478064|FG000|Overall Study|Lack of Efficacy|42|||
44469735|NCT00438360|79478065|FG001|Overall Study|Lack of Efficacy|27|||
44469736|NCT00438360|79478064|FG000|Overall Study|Other|24|||
44469737|NCT00438360|79478065|FG001|Overall Study|Other|15|||
44469738|NCT00536471|79478075|FG000|Overall Study|Lost to Follow-up|48|||
44469739|NCT00536471|79478076|FG001|Overall Study|Lost to Follow-up|23|||
44469740|NCT00536471|79478077|FG002|Overall Study|Lost to Follow-up|48|||
44469741|NCT00536471|79478078|FG003|Overall Study|Lost to Follow-up|22|||
44469742|NCT00536471|79478075|FG000|Overall Study|Adverse Event|32|||
44469743|NCT00536471|79478076|FG001|Overall Study|Adverse Event|16|||
44469744|NCT00536471|79478077|FG002|Overall Study|Adverse Event|28|||
44469745|NCT00536471|79478078|FG003|Overall Study|Adverse Event|13|||
44469746|NCT00536471|79478075|FG000|Overall Study|Withdrawal by Subject|40|||
44469747|NCT00536471|79478076|FG001|Overall Study|Withdrawal by Subject|24|||
44469748|NCT00536471|79478077|FG002|Overall Study|Withdrawal by Subject|43|||
44469749|NCT00536471|79478078|FG003|Overall Study|Withdrawal by Subject|21|||
44469750|NCT00536471|79478075|FG000|Overall Study|Lack of Efficacy|17|||
44469751|NCT00536471|79478076|FG001|Overall Study|Lack of Efficacy|18|||
44469752|NCT00536471|79478077|FG002|Overall Study|Lack of Efficacy|11|||
44469753|NCT00536471|79478078|FG003|Overall Study|Lack of Efficacy|9|||
44469754|NCT00536471|79478075|FG000|Overall Study|Protocol Violation|8|||
44469755|NCT00536471|79478076|FG001|Overall Study|Protocol Violation|1|||
44469756|NCT00536471|79478077|FG002|Overall Study|Protocol Violation|2|||
44469757|NCT00536471|79478078|FG003|Overall Study|Protocol Violation|3|||
44469758|NCT00536471|79478075|FG000|Overall Study|Physician Decision|11|||
44469759|NCT00536471|79478076|FG001|Overall Study|Physician Decision|1|||
44469760|NCT00536471|79478077|FG002|Overall Study|Physician Decision|3|||
44469761|NCT00536471|79478078|FG003|Overall Study|Physician Decision|2|||
44469762|NCT00536471|79478075|FG000|Overall Study|Death|0|||
44469763|NCT00536471|79478076|FG001|Overall Study|Death|0|||
44469764|NCT00536471|79478077|FG002|Overall Study|Death|1|||
44469765|NCT00536471|79478078|FG003|Overall Study|Death|2|||
44469766|NCT00536471|79478075|FG000|Overall Study|Sponsor Decision|0|||
44469767|NCT00536471|79478076|FG001|Overall Study|Sponsor Decision|1|||
44469768|NCT00536471|79478077|FG002|Overall Study|Sponsor Decision|3|||
44469769|NCT00536471|79478078|FG003|Overall Study|Sponsor Decision|2|||
44469770|NCT00359619|79478102|FG000|Overall Study|Adverse Event|0|||
44469771|NCT00359619|79478103|FG001|Overall Study|Adverse Event|0|||
44469772|NCT00359619|79478104|FG002|Overall Study|Adverse Event|1|||
44469773|NCT00359619|79478105|FG003|Overall Study|Adverse Event|0|||
44469774|NCT00359619|79478106|FG004|Overall Study|Adverse Event|0|||
44469775|NCT00359619|79478107|FG005|Overall Study|Adverse Event|0|||
44469776|NCT00359619|79478108|FG006|Overall Study|Adverse Event|1|||
44469777|NCT00359619|79478102|FG000|Overall Study|Withdrawal by Subject|3|||
44469778|NCT00359619|79478103|FG001|Overall Study|Withdrawal by Subject|1|||
44375353|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
44469779|NCT00359619|79478104|FG002|Overall Study|Withdrawal by Subject|4|||
44469780|NCT00359619|79478105|FG003|Overall Study|Withdrawal by Subject|2|||
44375354|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
44469781|NCT00359619|79478106|FG004|Overall Study|Withdrawal by Subject|2|||
44469782|NCT00359619|79478107|FG005|Overall Study|Withdrawal by Subject|0|||
44469783|NCT00359619|79478108|FG006|Overall Study|Withdrawal by Subject|3|||
44469784|NCT00359619|79478102|FG000|Overall Study|Other|1|||
44469785|NCT00359619|79478103|FG001|Overall Study|Other|0|||
44469786|NCT00359619|79478104|FG002|Overall Study|Other|0|||
44469787|NCT00359619|79478105|FG003|Overall Study|Other|0|||
44469788|NCT00359619|79478106|FG004|Overall Study|Other|0|||
44469789|NCT00359619|79478107|FG005|Overall Study|Other|0|||
44469790|NCT00359619|79478108|FG006|Overall Study|Other|0|||
44469791|NCT00359619|79478102|FG000|Overall Study|Lost to Follow-up|4|||
44469792|NCT00359619|79478103|FG001|Overall Study|Lost to Follow-up|4|||
44469793|NCT00359619|79478104|FG002|Overall Study|Lost to Follow-up|2|||
44469794|NCT00359619|79478105|FG003|Overall Study|Lost to Follow-up|1|||
44469795|NCT00359619|79478106|FG004|Overall Study|Lost to Follow-up|1|||
44469796|NCT00359619|79478107|FG005|Overall Study|Lost to Follow-up|5|||
44469797|NCT00359619|79478108|FG006|Overall Study|Lost to Follow-up|0|||
44469798|NCT00437658|79478127|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
44469799|NCT00437658|79478128|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
44469800|NCT00437658|79478129|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
44469801|NCT00437658|79478127|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
44469802|NCT00437658|79478128|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
44469803|NCT00437658|79478129|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
44469804|NCT00437658|79478127|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
44469805|NCT00437658|79478128|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
44469806|NCT00437658|79478129|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
44469807|NCT00437658|79478127|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
44469808|NCT00437658|79478128|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
44469809|NCT00437658|79478129|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
44469810|NCT00437658|79478127|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
44469811|NCT00437658|79478128|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
44469812|NCT00437658|79478129|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
44469813|NCT00437658|79478127|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
44469814|NCT00437658|79478128|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
44469815|NCT00437658|79478129|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
44469816|NCT00437658|79478127|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
44469817|NCT00437658|79478128|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
44469818|NCT00437658|79478129|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
44469819|NCT00437658|79478127|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
44469820|NCT00437658|79478128|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
44469821|NCT00437658|79478129|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
44469822|NCT00437658|79478127|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
44469823|NCT00437658|79478128|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
44469824|NCT00437658|79478129|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
44469825|NCT00437658|79478127|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
44469826|NCT00437658|79478128|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
44469827|NCT00437658|79478129|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
44469828|NCT00437658|79478127|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
44469829|NCT00437658|79478128|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
44469830|NCT00437658|79478129|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
44469831|NCT00437658|79478127|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
44469832|NCT00437658|79478128|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
44469833|NCT00437658|79478129|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
44469834|NCT00356265|79478140|FG000|Overall Study|Withdrawal by Subject|0|||
44469835|NCT00356265|79478141|FG001|Overall Study|Withdrawal by Subject|0|||
44469836|NCT00356265|79478142|FG002|Overall Study|Withdrawal by Subject|1|||
44469837|NCT00535145|79478151|FG000|Phase I|Adverse Event|3|||
44469838|NCT00535145|79478151|FG000|Phase I|Lost to Follow-up|7|||
44469839|NCT00535145|79478151|FG000|Phase I|Withdrawal by Subject|6|||
44469840|NCT00535145|79478151|FG000|Phase I|(eligibility)|8|||
44469841|NCT00535145|79478151|FG000|Phase I|(protocol violation)|1|||
44469842|NCT00535145|79478151|FG000|Phase I|(PI decision)|1|||
44469843|NCT00535145|79478151|FG000|Phase I|(diagnosis)|3|||
44469844|NCT00535145|79478151|FG000|Phase II|Adverse Event|2|||
44469845|NCT00535145|79478151|FG000|Phase II|Lack of Efficacy|1|||
44469846|NCT00535145|79478151|FG000|Phase II|Lost to Follow-up|5|||
44469847|NCT00535145|79478151|FG000|Phase II|Withdrawal by Subject|5|||
44469848|NCT00535145|79478151|FG000|Phase II|Subject non-compliance|2|||
44469849|NCT00437268|79478161|FG000|Overall Study|Adverse Event|1|||
44469850|NCT00437268|79478162|FG001|Overall Study|Adverse Event|1|||
44469851|NCT00437268|79478161|FG000|Overall Study|Withdrawal by Subject|2|||
44469852|NCT00437268|79478162|FG001|Overall Study|Withdrawal by Subject|2|||
44469853|NCT00437268|79478161|FG000|Overall Study|Progressive disease|9|||
44469854|NCT00437268|79478162|FG001|Overall Study|Progressive disease|9|||
44469855|NCT00437268|79478161|FG000|Overall Study|Physician Decision|1|||
44469856|NCT00437268|79478162|FG001|Overall Study|Physician Decision|0|||
44469857|NCT00437268|79478161|FG000|Overall Study|Death|0|||
44469858|NCT00437268|79478162|FG001|Overall Study|Death|1|||
44469859|NCT00437034|79478170|FG000|Overall Study|Adverse Event|1|||
44469860|NCT00437034|79478170|FG000|Overall Study|Disease progression during treatment|5|||
44469861|NCT00337467|79478174|FG000|Overall Study|Adverse Event|3|||
44469862|NCT00337467|79478174|FG000|Overall Study|Subject Withdrew Consent|2|||
44224970|NCT01274182|79030494|FG002|Overall Study|Protocol Violation|0|||
44224971|NCT01274182|79030492|FG000|Overall Study|Death|1|||
44469863|NCT00337467|79478174|FG000|Overall Study|Pregnancy|1|||
44469864|NCT00337467|79478174|FG000|Overall Study|Lost to Follow-up|2|||
44469865|NCT00337467|79478174|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
44469866|NCT00337077|79478184|FG000|Overall Study|Progressive disease|25|||
44469867|NCT00337077|79478185|FG001|Overall Study|Progressive disease|37|||
44469868|NCT00337077|79478186|FG002|Overall Study|Progressive disease|19|||
44469869|NCT00337077|79478184|FG000|Overall Study|Adverse Event|7|||
44469870|NCT00337077|79478185|FG001|Overall Study|Adverse Event|7|||
44224972|NCT01274182|79030493|FG001|Overall Study|Death|0|||
44224973|NCT01274182|79030494|FG002|Overall Study|Death|1|||
44224974|NCT01984229|79030508|FG000|Safety Follow-up Period|Adverse Event|1|||
44224975|NCT01984229|79030509|FG001|Safety Follow-up Period|Adverse Event|1|||
44224976|NCT01984229|79030508|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
44224977|NCT01984229|79030509|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
44224978|NCT01835899|79030524|FG000|Overall Study|Adverse Event|0|||
44224979|NCT01835899|79030525|FG001|Overall Study|Adverse Event|0|||
44469871|NCT00337077|79478186|FG002|Overall Study|Adverse Event|1|||
44469872|NCT00337077|79478184|FG000|Overall Study|Death|0|||
44469873|NCT00337077|79478185|FG001|Overall Study|Death|1|||
44469874|NCT00337077|79478186|FG002|Overall Study|Death|0|||
44469875|NCT00337077|79478184|FG000|Overall Study|Withdrawal by Subject|7|||
44469876|NCT00337077|79478185|FG001|Overall Study|Withdrawal by Subject|2|||
44469877|NCT00337077|79478186|FG002|Overall Study|Withdrawal by Subject|2|||
44469878|NCT00337077|79478184|FG000|Overall Study|Alternative therapy|1|||
44469879|NCT00337077|79478185|FG001|Overall Study|Alternative therapy|0|||
44469880|NCT00337077|79478186|FG002|Overall Study|Alternative therapy|0|||
44469881|NCT00337077|79478184|FG000|Overall Study|Physician Decision|1|||
44469882|NCT00337077|79478185|FG001|Overall Study|Physician Decision|4|||
44469883|NCT00337077|79478186|FG002|Overall Study|Physician Decision|2|||
44469884|NCT00337077|79478184|FG000|Overall Study|Never started treatment|1|||
44469885|NCT00337077|79478185|FG001|Overall Study|Never started treatment|1|||
44469886|NCT00337077|79478186|FG002|Overall Study|Never started treatment|0|||
44469887|NCT00337077|79478184|FG000|Overall Study|Ineligible|1|||
44469888|NCT00337077|79478185|FG001|Overall Study|Ineligible|1|||
44469889|NCT00337077|79478186|FG002|Overall Study|Ineligible|1|||
44469890|NCT00428220|79478192|FG000|Overall Study|Participant died|8|||
44469891|NCT00428220|79478192|FG000|Overall Study|Global deterioration of health status|7|||
44469892|NCT00428220|79478192|FG000|Overall Study|Lost to Follow-up|4|||
44469893|NCT00428220|79478192|FG000|Overall Study|Objective progression or relapse|123|||
44469894|NCT00428220|79478192|FG000|Overall Study|Participant refused continued treatment|7|||
44469895|NCT00428220|79478192|FG000|Overall Study|Adverse Event|51|||
44469896|NCT00428220|79478192|FG000|Overall Study|Other|23|||
44469897|NCT00345579|79478222|FG000|Overall Study|Adverse Event|9|||
44469898|NCT00345579|79478223|FG001|Overall Study|Adverse Event|6|||
44469899|NCT00345579|79478222|FG000|Overall Study|Protocol Violation|14|||
44469900|NCT00345579|79478223|FG001|Overall Study|Protocol Violation|5|||
44469901|NCT00345579|79478222|FG000|Overall Study|Withdrawal by Subject|50|||
44469902|NCT00345579|79478223|FG001|Overall Study|Withdrawal by Subject|17|||
44469903|NCT00345579|79478222|FG000|Overall Study|Lost to Follow-up|82|||
44469904|NCT00345579|79478223|FG001|Overall Study|Lost to Follow-up|36|||
44469905|NCT00345579|79478222|FG000|Overall Study|Other|9|||
44469906|NCT00345579|79478223|FG001|Overall Study|Other|1|||
44469907|NCT00335829|79478230|FG000|Overall Study|Withdrawal by Subject|1|||
44469908|NCT00335829|79478230|FG000|Overall Study|Lost to Follow-up|1|||
44469909|NCT00335829|79478230|FG000|Overall Study|Adverse Event|1|||
44469910|NCT00344019|79478237|FG000|Overall Study|did not meet final inclusion criteria|0|||
44469911|NCT00344019|79478238|FG001|Overall Study|did not meet final inclusion criteria|0|||
44469912|NCT00344019|79478239|FG002|Overall Study|did not meet final inclusion criteria|74|||
44469913|NCT00535847|79478253|FG000|Overall Study|Adverse Event|5|||
44469914|NCT00535847|79478254|FG001|Overall Study|Adverse Event|3|||
44469915|NCT00535847|79478255|FG002|Overall Study|Adverse Event|2|||
44469916|NCT00535847|79478253|FG000|Overall Study|Non compliance|1|||
44469917|NCT00535847|79478254|FG001|Overall Study|Non compliance|1|||
44469918|NCT00535847|79478255|FG002|Overall Study|Non compliance|0|||
44224980|NCT01835899|79030526|FG002|Overall Study|Adverse Event|1|||
44469919|NCT00535847|79478253|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
44469920|NCT00535847|79478254|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
44469921|NCT00535847|79478255|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
44469922|NCT00334893|79478269|FG000|Overall Study|Not Treated|1|||
44469923|NCT00334893|79478270|FG001|Overall Study|Not Treated|0|||
44469924|NCT00334737|79478281|FG000|Hospital Phase|Death|1|||
44469925|NCT00334737|79478282|FG001|Hospital Phase|Death|2|||
44469926|NCT00334737|79478283|FG002|Hospital Phase|Death|3|||
44469927|NCT00334737|79478281|FG000|Hospital Phase|Withdrawal by Subject|0|||
44469928|NCT00334737|79478282|FG001|Hospital Phase|Withdrawal by Subject|0|||
44469929|NCT00334737|79478283|FG002|Hospital Phase|Withdrawal by Subject|1|||
44469930|NCT00334737|79478281|FG000|Hospital Phase|Did not receive study drug|1|||
44224981|NCT01835899|79030524|FG000|Overall Study|Other than stated above|0|||
44224982|NCT01835899|79030525|FG001|Overall Study|Other than stated above|1|||
44469931|NCT00334737|79478282|FG001|Hospital Phase|Did not receive study drug|0|||
44544479|NCT03600805|79557867|FG001|Overall Study|Other unspecified|6|||
44224983|NCT01835899|79030526|FG002|Overall Study|Other than stated above|0|||
44224984|NCT01766401|79030538|FG000|Overall Study|Adverse Event|7|||
44224985|NCT01766401|79030539|FG001|Overall Study|Adverse Event|22|||
44469932|NCT00334737|79478283|FG002|Hospital Phase|Did not receive study drug|0|||
44469933|NCT00334737|79478281|FG000|Follow up Phase|Lost to Follow-up|5|||
44469934|NCT00334737|79478282|FG001|Follow up Phase|Lost to Follow-up|3|||
44469935|NCT00334737|79478283|FG002|Follow up Phase|Lost to Follow-up|6|||
44469936|NCT00427908|79478295|FG000|Primary Phase|Lost to Follow-up|4|||
44469937|NCT00427908|79478296|FG001|Primary Phase|Lost to Follow-up|0|||
44469938|NCT00427908|79478297|FG002|Primary Phase|Lost to Follow-up|2|||
44469939|NCT00427908|79478298|FG003|Primary Phase|Lost to Follow-up|0|||
44469940|NCT00427908|79478295|FG000|Primary Phase|Withdrawal by Subject|1|||
44224986|NCT01766401|79030538|FG000|Overall Study|Lack of Efficacy|1|||
44469941|NCT00427908|79478296|FG001|Primary Phase|Withdrawal by Subject|2|||
44469942|NCT00427908|79478297|FG002|Primary Phase|Withdrawal by Subject|1|||
44469943|NCT00427908|79478298|FG003|Primary Phase|Withdrawal by Subject|0|||
44469944|NCT00427908|79478295|FG000|Primary Phase|Adverse Event|0|||
44469945|NCT00427908|79478296|FG001|Primary Phase|Adverse Event|1|||
44469946|NCT00427908|79478297|FG002|Primary Phase|Adverse Event|0|||
44469947|NCT00427908|79478298|FG003|Primary Phase|Adverse Event|0|||
44469948|NCT00334113|79478335|FG000|Overall Study|Lost to Follow-up|2|||
44469949|NCT00334113|79478336|FG001|Overall Study|Lost to Follow-up|2|||
44469950|NCT00334113|79478335|FG000|Overall Study|Withdrawal by Subject|0|||
44469951|NCT00334113|79478336|FG001|Overall Study|Withdrawal by Subject|1|||
44469952|NCT00416598|79478342|FG000|Induction & Intensification|Adverse Event|38|||
44469953|NCT00416598|79478342|FG000|Induction & Intensification|Death|32|||
44469954|NCT00416598|79478342|FG000|Induction & Intensification|Withdrawal by Subject|46|||
44469955|NCT00416598|79478342|FG000|Induction & Intensification|Alternative Treatment|135|||
44469956|NCT00416598|79478342|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
44469957|NCT00416598|79478342|FG000|Induction & Intensification|Relapse/progression|29|||
44469958|NCT00416598|79478342|FG000|Induction & Intensification|Failed induction|87|||
44469959|NCT00416598|79478342|FG000|Decitabine Maintenance|Adverse Event|5|||
44469960|NCT00416598|79478342|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
44469961|NCT00416598|79478342|FG000|Decitabine Maintenance|Progression/relapse|38|||
44469962|NCT00416598|79478342|FG000|Decitabine Maintenance|Alternative treatment|2|||
44469963|NCT00416598|79478342|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
44469964|NCT00534599|79478348|FG000|Overall Study|Adverse Event|25|||
44469965|NCT00534599|79478349|FG001|Overall Study|Adverse Event|4|||
44469966|NCT00534599|79478348|FG000|Overall Study|Incorrect enrollment|2|||
44469967|NCT00534599|79478349|FG001|Overall Study|Incorrect enrollment|1|||
44469968|NCT00534599|79478348|FG000|Overall Study|Mis-randomization|2|||
44469969|NCT00534599|79478349|FG001|Overall Study|Mis-randomization|2|||
44469970|NCT00534599|79478348|FG000|Overall Study|Developed study-specific d/c criteria|5|||
44469971|NCT00534599|79478349|FG001|Overall Study|Developed study-specific d/c criteria|0|||
44469972|NCT00534599|79478348|FG000|Overall Study|Lack of Efficacy|0|||
44469973|NCT00534599|79478349|FG001|Overall Study|Lack of Efficacy|1|||
44469974|NCT00534599|79478348|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
44469975|NCT00534599|79478349|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
44469976|NCT00534599|79478348|FG000|Overall Study|Protocol Violation|1|||
44469977|NCT00534599|79478349|FG001|Overall Study|Protocol Violation|3|||
44469978|NCT00534599|79478348|FG000|Overall Study|Lost to Follow-up|11|||
44469979|NCT00534599|79478349|FG001|Overall Study|Lost to Follow-up|14|||
44469980|NCT00534599|79478348|FG000|Overall Study|Withdrawal by Subject|4|||
44469981|NCT00534599|79478349|FG001|Overall Study|Withdrawal by Subject|6|||
44469982|NCT00534599|79478348|FG000|Overall Study|Other|7|||
44469983|NCT00534599|79478349|FG001|Overall Study|Other|0|||
44469984|NCT03892889|79478372|FG000|Overall Study|Adverse Event|17|||
44469985|NCT03892889|79478372|FG000|Overall Study|Lack of Efficacy|1|||
44469986|NCT03892889|79478372|FG000|Overall Study|Lost to Follow-up|46|||
44469987|NCT03892889|79478372|FG000|Overall Study|Non-compliance with study drug|22|||
44469988|NCT03892889|79478372|FG000|Overall Study|Pregnancy|1|||
44469989|NCT03892889|79478372|FG000|Overall Study|Protocol Deviation|3|||
44469990|NCT03892889|79478372|FG000|Overall Study|Withdrawal by Subject|50|||
44469991|NCT03892889|79478372|FG000|Overall Study|Withdrawal by Caregiver|1|||
44224987|NCT01766401|79030539|FG001|Overall Study|Lack of Efficacy|2|||
44469992|NCT03892889|79478372|FG000|Overall Study|Study Terminated by Sponsor|50|||
44469993|NCT03892889|79478372|FG000|Overall Study|Physician Decision|8|||
44469994|NCT03892889|79478372|FG000|Overall Study|Reason not Specified|5|||
44469995|NCT00473330|79478379|FG000|Core Study|Adverse Event|4|||
44469996|NCT00473330|79478380|FG001|Core Study|Adverse Event|4|||
44544480|NCT03600805|79557868|FG002|Overall Study|Other unspecified|7|||
44224988|NCT01766401|79030538|FG000|Overall Study|Protocol Violation|3|||
44469997|NCT00473330|79478381|FG002|Core Study|Adverse Event|1|||
44469998|NCT00473330|79478379|FG000|Core Study|Death|6|||
44469999|NCT00473330|79478380|FG001|Core Study|Death|4|||
44470000|NCT00473330|79478381|FG002|Core Study|Death|4|||
44470001|NCT00473330|79478379|FG000|Core Study|Lost to Follow-up|5|||
44470002|NCT00473330|79478380|FG001|Core Study|Lost to Follow-up|5|||
44470003|NCT00473330|79478381|FG002|Core Study|Lost to Follow-up|10|||
44470004|NCT00473330|79478379|FG000|Core Study|Physician Decision|2|||
44470005|NCT00473330|79478380|FG001|Core Study|Physician Decision|1|||
44470006|NCT00473330|79478381|FG002|Core Study|Physician Decision|3|||
44470007|NCT00473330|79478379|FG000|Core Study|Subject Non-compliance|1|||
44470008|NCT00473330|79478380|FG001|Core Study|Subject Non-compliance|2|||
44470009|NCT00473330|79478381|FG002|Core Study|Subject Non-compliance|1|||
44470010|NCT00473330|79478379|FG000|Core Study|Subject Required Other Therapy|0|||
44470011|NCT00473330|79478380|FG001|Core Study|Subject Required Other Therapy|1|||
44470012|NCT00473330|79478381|FG002|Core Study|Subject Required Other Therapy|3|||
44470013|NCT00473330|79478379|FG000|Core Study|Subject's Decision|9|||
44470014|NCT00473330|79478380|FG001|Core Study|Subject's Decision|8|||
44470015|NCT00473330|79478381|FG002|Core Study|Subject's Decision|19|||
44470016|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
44470017|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
44470018|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
44470019|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Death|2|||
44470020|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Death|0|||
44470021|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Death|0|||
44470022|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
44470023|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
44470024|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
44470025|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
44470026|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
44470027|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
44470028|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
44470029|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
44470030|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
44470031|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
44470032|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
44470033|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
44470034|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
44470035|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
44470036|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
44470037|NCT00473330|79478379|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
44470038|NCT00473330|79478380|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
44470039|NCT00473330|79478381|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
44470040|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
44470041|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
44470042|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
44470043|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Death|2|||
44470044|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Death|2|||
44470045|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Death|1|||
44470046|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
44470047|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
44470048|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
44470049|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
44470050|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
44470051|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
44470052|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
44470053|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
44470054|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
44470055|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
44470056|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
44470057|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
44470058|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
44470059|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
44470060|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
44470061|NCT00473330|79478379|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
44470062|NCT00473330|79478380|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
44470063|NCT00473330|79478381|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
44470064|NCT00416520|79478411|FG000|Open-label Period|Adverse Event|28|||
44470065|NCT00416520|79478412|FG001|Open-label Period|Adverse Event|10|||
44470066|NCT00416520|79478413|FG002|Open-label Period|Adverse Event|0|||
44470067|NCT00416520|79478414|FG003|Open-label Period|Adverse Event|0|||
44470068|NCT00416520|79478411|FG000|Open-label Period|Death|2|||
44470069|NCT00416520|79478412|FG001|Open-label Period|Death|1|||
44470070|NCT00416520|79478413|FG002|Open-label Period|Death|0|||
44470071|NCT00416520|79478414|FG003|Open-label Period|Death|0|||
44470072|NCT00416520|79478411|FG000|Open-label Period|Lack of Efficacy|8|||
44470073|NCT00416520|79478412|FG001|Open-label Period|Lack of Efficacy|1|||
44470074|NCT00416520|79478413|FG002|Open-label Period|Lack of Efficacy|0|||
44470075|NCT00416520|79478414|FG003|Open-label Period|Lack of Efficacy|0|||
44470076|NCT00416520|79478411|FG000|Open-label Period|Protocol Violation|3|||
44470077|NCT00416520|79478412|FG001|Open-label Period|Protocol Violation|3|||
44470078|NCT00416520|79478413|FG002|Open-label Period|Protocol Violation|0|||
44470079|NCT00416520|79478414|FG003|Open-label Period|Protocol Violation|0|||
44470080|NCT00416520|79478411|FG000|Open-label Period|Withdrawal by Subject|16|||
44470081|NCT00416520|79478412|FG001|Open-label Period|Withdrawal by Subject|5|||
44470082|NCT00416520|79478413|FG002|Open-label Period|Withdrawal by Subject|0|||
44470083|NCT00416520|79478414|FG003|Open-label Period|Withdrawal by Subject|0|||
44470084|NCT00416520|79478411|FG000|Open-label Period|Other Reasons|3|||
44470085|NCT00416520|79478412|FG001|Open-label Period|Other Reasons|12|||
44470086|NCT00416520|79478413|FG002|Open-label Period|Other Reasons|0|||
44470087|NCT00416520|79478414|FG003|Open-label Period|Other Reasons|0|||
44470088|NCT00416520|79478411|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
44470089|NCT00416520|79478412|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
44470090|NCT00416520|79478413|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
44470091|NCT00416520|79478414|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
44470092|NCT00416520|79478411|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
44470093|NCT00416520|79478412|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
44470094|NCT00416520|79478413|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
44470095|NCT00416520|79478414|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
44470096|NCT00416520|79478411|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
44470097|NCT00416520|79478412|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
44470098|NCT00416520|79478413|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
44470099|NCT00416520|79478414|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
44470100|NCT00533429|79478426|FG000|Overall Study|Adverse Event|3|||
44470101|NCT00533429|79478427|FG001|Overall Study|Adverse Event|1|||
44470102|NCT00533429|79478426|FG000|Overall Study|Death|1|||
44470103|NCT00533429|79478427|FG001|Overall Study|Death|0|||
44470104|NCT00533429|79478426|FG000|Overall Study|Withdrawal by Subject|2|||
44470105|NCT00533429|79478427|FG001|Overall Study|Withdrawal by Subject|0|||
44470106|NCT00533429|79478426|FG000|Overall Study|Progressive Disease|12|||
44470107|NCT00533429|79478427|FG001|Overall Study|Progressive Disease|13|||
44470108|NCT00533429|79478426|FG000|Overall Study|Symptomatic deterioration|1|||
44470109|NCT00533429|79478427|FG001|Overall Study|Symptomatic deterioration|2|||
44470110|NCT00533273|79478437|FG000|Double-blind|Withdrew consent|0|||
44470111|NCT00533273|79478438|FG001|Double-blind|Withdrew consent|2|||
44470112|NCT00533273|79478437|FG000|Open-label|Withdrawal by Subject|6|||
44470113|NCT00533273|79478438|FG001|Open-label|Withdrawal by Subject|0|||
44470114|NCT03891641|79478446|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
44470115|NCT03891641|79478447|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
44470116|NCT00339183|79478455|FG000|Overall Study|Adverse Event|5|||
44470117|NCT00339183|79478456|FG001|Overall Study|Adverse Event|3|||
44470118|NCT00339183|79478455|FG000|Overall Study|Withdrawal by Subject|16|||
44470119|NCT00339183|79478456|FG001|Overall Study|Withdrawal by Subject|19|||
44470120|NCT00339183|79478455|FG000|Overall Study|Physician Decision|2|||
44470121|NCT00339183|79478456|FG001|Overall Study|Physician Decision|4|||
44470122|NCT00339183|79478455|FG000|Overall Study|Lost to Follow-up|17|||
44470123|NCT00339183|79478456|FG001|Overall Study|Lost to Follow-up|17|||
44470124|NCT00339183|79478455|FG000|Overall Study|Protocol-specified criteria|12|||
44470125|NCT00339183|79478456|FG001|Overall Study|Protocol-specified criteria|8|||
44470126|NCT00339183|79478455|FG000|Overall Study|Missing reason|3|||
44470127|NCT00339183|79478456|FG001|Overall Study|Missing reason|1|||
44470128|NCT00339183|79478455|FG000|Overall Study|Other|46|||
44470129|NCT00339183|79478456|FG001|Overall Study|Other|40|||
44470130|NCT00339183|79478455|FG000|Overall Study|Ongoing|20|||
44470131|NCT00339183|79478456|FG001|Overall Study|Ongoing|13|||
44470132|NCT00532883|79478470|FG000|Overall Study|Adverse Event|1|||
44224989|NCT01766401|79030539|FG001|Overall Study|Protocol Violation|8|||
44224990|NCT01766401|79030538|FG000|Overall Study|Withdrawal by Subject|15|||
44470133|NCT00532883|79478471|FG001|Overall Study|Adverse Event|0|||
44470134|NCT00532883|79478472|FG002|Overall Study|Adverse Event|0|||
44470135|NCT00532883|79478473|FG003|Overall Study|Adverse Event|1|||
44470136|NCT00532883|79478470|FG000|Overall Study|Lost to Follow-up|1|||
44470137|NCT00532883|79478471|FG001|Overall Study|Lost to Follow-up|1|||
44470138|NCT00532883|79478472|FG002|Overall Study|Lost to Follow-up|1|||
44470139|NCT00532883|79478473|FG003|Overall Study|Lost to Follow-up|0|||
44470140|NCT00532883|79478470|FG000|Overall Study|Withdrawal by Subject|0|||
44273890|NCT00003389|79215435|FG000|Overall Study|Ineligible|33|||
44470141|NCT00532883|79478471|FG001|Overall Study|Withdrawal by Subject|1|||
44470142|NCT00532883|79478472|FG002|Overall Study|Withdrawal by Subject|1|||
44470143|NCT00532883|79478473|FG003|Overall Study|Withdrawal by Subject|0|||
44470144|NCT00532883|79478470|FG000|Overall Study|Subject was Nonadherent|0|||
44470145|NCT00532883|79478471|FG001|Overall Study|Subject was Nonadherent|1|||
44470146|NCT00532883|79478472|FG002|Overall Study|Subject was Nonadherent|1|||
44470147|NCT00532883|79478473|FG003|Overall Study|Subject was Nonadherent|0|||
44470148|NCT00532883|79478470|FG000|Overall Study|Early Study Termination|4|||
44470149|NCT00532883|79478471|FG001|Overall Study|Early Study Termination|4|||
44470150|NCT00532883|79478472|FG002|Overall Study|Early Study Termination|1|||
44470151|NCT00532883|79478473|FG003|Overall Study|Early Study Termination|4|||
44470152|NCT00354159|79478485|FG000|Randomized Study Period|Withdrawal by Subject|5|||
44470153|NCT00354159|79478486|FG001|Randomized Study Period|Withdrawal by Subject|3|||
44470154|NCT00354159|79478485|FG000|Randomized Study Period|Physician Decision|6|||
44470155|NCT00354159|79478486|FG001|Randomized Study Period|Physician Decision|10|||
44470156|NCT00354159|79478485|FG000|Randomized Study Period|Lost to Follow-up|4|||
44470157|NCT00354159|79478486|FG001|Randomized Study Period|Lost to Follow-up|0|||
44470158|NCT00354159|79478485|FG000|Randomized Study Period|Death|7|||
44470159|NCT00354159|79478486|FG001|Randomized Study Period|Death|9|||
44470160|NCT00354159|79478485|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
44470161|NCT00354159|79478486|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
44470162|NCT00354159|79478485|FG000|Long-term Follow-up|Physician Decision|127|||
44224991|NCT01766401|79030539|FG001|Overall Study|Withdrawal by Subject|12|||
44470163|NCT00354159|79478486|FG001|Long-term Follow-up|Physician Decision|122|||
44470164|NCT00354159|79478485|FG000|Long-term Follow-up|Lost to Follow-up|1|||
44470165|NCT00354159|79478486|FG001|Long-term Follow-up|Lost to Follow-up|0|||
44470166|NCT00354159|79478485|FG000|Long-term Follow-up|Death|14|||
44470167|NCT00354159|79478486|FG001|Long-term Follow-up|Death|11|||
44470168|NCT00354159|79478485|FG000|Long-term Follow-up|Study Closed|29|||
44470169|NCT00354159|79478486|FG001|Long-term Follow-up|Study Closed|34|||
44470170|NCT00338949|79478501|FG000|Subject Screening|Screen failures|11|||
44470171|NCT00338949|79478502|FG001|Subject Screening|Screen failures|11|||
44470172|NCT00338949|79478501|FG000|Randomization|Withdrawal by Subject|1|||
44470173|NCT00338949|79478502|FG001|Randomization|Withdrawal by Subject|0|||
44470174|NCT00338949|79478501|FG000|Randomization|Adverse Event|0|||
44470175|NCT00338949|79478502|FG001|Randomization|Adverse Event|5|||
44470176|NCT00332709|79478510|FG000|Overall Study|Adverse Event|11|||
44470177|NCT00332709|79478511|FG001|Overall Study|Adverse Event|14|||
44470178|NCT00332709|79478510|FG000|Overall Study|Withdrawal by Subject|2|||
44470179|NCT00332709|79478511|FG001|Overall Study|Withdrawal by Subject|3|||
44470180|NCT00332709|79478510|FG000|Overall Study|Lost to Follow-up|2|||
44470181|NCT00332709|79478511|FG001|Overall Study|Lost to Follow-up|0|||
44470182|NCT00332709|79478510|FG000|Overall Study|Administrative Problems|0|||
44470183|NCT00332709|79478511|FG001|Overall Study|Administrative Problems|3|||
44470184|NCT00332709|79478510|FG000|Overall Study|Abnormal test procedure result|1|||
44470185|NCT00332709|79478511|FG001|Overall Study|Abnormal test procedure result|0|||
44470186|NCT00332241|79478519|FG000|Overall Study|Lack of Efficacy|6|||
44470187|NCT00332241|79478520|FG001|Overall Study|Lack of Efficacy|1|||
44470188|NCT00332241|79478519|FG000|Overall Study|Adverse Event|3|||
44470189|NCT00332241|79478520|FG001|Overall Study|Adverse Event|5|||
44470190|NCT00332241|79478519|FG000|Overall Study|Withdrawal by Subject|2|||
44470191|NCT00332241|79478520|FG001|Overall Study|Withdrawal by Subject|1|||
44224992|NCT01766401|79030538|FG000|Overall Study|Lost to Follow-up|10|||
44470192|NCT00332241|79478519|FG000|Overall Study|Lost to Follow-up|4|||
44224993|NCT01766401|79030539|FG001|Overall Study|Lost to Follow-up|11|||
44224994|NCT01766401|79030538|FG000|Overall Study|Pregnancy|1|||
44224995|NCT01766401|79030539|FG001|Overall Study|Pregnancy|1|||
44224996|NCT01272934|79030547|FG000|Overall Study|Adverse Event|0|||
44224997|NCT01272934|79030548|FG001|Overall Study|Adverse Event|1|||
44470193|NCT00332241|79478520|FG001|Overall Study|Lost to Follow-up|1|||
44470194|NCT00337935|79478528|FG000|Overall Study|Adverse Event|2|||
44224998|NCT01272934|79030547|FG000|Overall Study|Abnormal Laboratory Value|0|||
44224999|NCT01272934|79030548|FG001|Overall Study|Abnormal Laboratory Value|1|||
44225000|NCT01983683|79030566|FG000|Overall Study|Withdrawal by Subject|14|||
44225001|NCT01983683|79030567|FG001|Overall Study|Withdrawal by Subject|18|||
44225002|NCT01983683|79030566|FG000|Overall Study|Death|11|||
44225003|NCT01983683|79030567|FG001|Overall Study|Death|15|||
44225004|NCT01983683|79030566|FG000|Overall Study|Physician Decision|8|||
44470195|NCT00337935|79478529|FG001|Overall Study|Adverse Event|5|||
44470196|NCT00337935|79478528|FG000|Overall Study|Death|2|||
44470197|NCT00337935|79478529|FG001|Overall Study|Death|8|||
44470198|NCT00337935|79478528|FG000|Overall Study|Physician Decision|1|||
44470199|NCT00337935|79478529|FG001|Overall Study|Physician Decision|1|||
44470200|NCT00337935|79478528|FG000|Overall Study|Lost to Follow-up|0|||
44470201|NCT00337935|79478529|FG001|Overall Study|Lost to Follow-up|1|||
44470202|NCT00337935|79478528|FG000|Overall Study|Protocol Violation|4|||
44225005|NCT01983683|79030567|FG001|Overall Study|Physician Decision|9|||
44225006|NCT01983683|79030566|FG000|Overall Study|Lost to Follow-up|4|||
44225007|NCT01983683|79030567|FG001|Overall Study|Lost to Follow-up|8|||
44225008|NCT01983683|79030566|FG000|Overall Study|Sponsor Decision|1|||
44225009|NCT01983683|79030567|FG001|Overall Study|Sponsor Decision|1|||
44225010|NCT01998893|79030573|FG000|Overall Study|Adverse Event|2|||
44225011|NCT01998893|79030573|FG000|Overall Study|Death|1|||
44225012|NCT01998893|79030573|FG000|Overall Study|Lost to Follow-up|8|||
44470203|NCT00337935|79478529|FG001|Overall Study|Protocol Violation|3|||
44470204|NCT00337935|79478528|FG000|Overall Study|Withdrawal by Subject|1|||
44470205|NCT00337935|79478529|FG001|Overall Study|Withdrawal by Subject|7|||
44470206|NCT00337935|79478528|FG000|Overall Study|Other|0|||
44470207|NCT00337935|79478529|FG001|Overall Study|Other|1|||
44470208|NCT00337935|79478528|FG000|Overall Study|Lack of Efficacy|0|||
44470209|NCT00337935|79478529|FG001|Overall Study|Lack of Efficacy|1|||
44470210|NCT00337779|79478538|FG000|Overall Study|Withdrawal by Subject|10|||
44470211|NCT00337779|79478539|FG001|Overall Study|Withdrawal by Subject|12|||
44470212|NCT00337779|79478538|FG000|Overall Study|Sponsor decision|1|||
44470213|NCT00337779|79478539|FG001|Overall Study|Sponsor decision|1|||
44470214|NCT00337779|79478538|FG000|Overall Study|Physician Decision|3|||
44470215|NCT00337779|79478539|FG001|Overall Study|Physician Decision|6|||
44470216|NCT00337779|79478538|FG000|Overall Study|Protocol Violation|1|||
44470217|NCT00337779|79478539|FG001|Overall Study|Protocol Violation|1|||
44470218|NCT00337779|79478538|FG000|Overall Study|Lost to Follow-up|6|||
44470219|NCT00337779|79478539|FG001|Overall Study|Lost to Follow-up|5|||
44470220|NCT00337779|79478538|FG000|Overall Study|Adverse Event|28|||
44470221|NCT00337779|79478539|FG001|Overall Study|Adverse Event|51|||
44470222|NCT00337779|79478538|FG000|Overall Study|Pregnancy|3|||
44470223|NCT00337779|79478539|FG001|Overall Study|Pregnancy|2|||
44470224|NCT00337779|79478538|FG000|Overall Study|Death|0|||
44470225|NCT00337779|79478539|FG001|Overall Study|Death|1|||
44470226|NCT00352755|79478545|FG000|Overall Study|Physician Decision|1|||
44225013|NCT01998893|79030573|FG000|Overall Study|Physician Decision|2|||
44225014|NCT01998893|79030573|FG000|Overall Study|Protocol Violation|2|||
44225015|NCT01998893|79030573|FG000|Overall Study|Withdrawal by Subject|1|||
44225016|NCT01998893|79030573|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
44225017|NCT01791985|79030577|FG000|Overall Study|Adverse Event|7|||
44225018|NCT01791985|79030577|FG000|Overall Study|Withdrawal by Subject|1|||
44225019|NCT01998737|79030584|FG000|Overall Study|Corrupted database|23|||
44225020|NCT01998737|79030585|FG001|Overall Study|Corrupted database|0|||
44225021|NCT01791517|79030594|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
44225022|NCT01791517|79030595|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
44225023|NCT01791517|79030596|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
44225024|NCT01791517|79030597|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
44225025|NCT01791517|79030598|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
44225026|NCT01791517|79030599|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
44225027|NCT01791517|79030600|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
44225028|NCT01791517|79030601|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
44225029|NCT01791517|79030602|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
44225030|NCT01791517|79030603|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
44225031|NCT01791517|79030604|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
44225032|NCT01791517|79030605|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
44225033|NCT01791517|79030594|FG000|Phase I: Period 1|Adverse Event|0|||
44225034|NCT01791517|79030595|FG001|Phase I: Period 1|Adverse Event|0|||
44225035|NCT01791517|79030596|FG002|Phase I: Period 1|Adverse Event|1|||
44470227|NCT00352755|79478545|FG000|Overall Study|Adverse Event|1|||
44470228|NCT00533897|79478552|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
44470229|NCT00533897|79478553|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
44470230|NCT00533897|79478554|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
44470231|NCT00533897|79478555|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
44470232|NCT00533897|79478556|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
44470233|NCT00533897|79478557|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
44470234|NCT00533897|79478558|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
44470235|NCT00533897|79478559|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
44470236|NCT00533897|79478552|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
44225036|NCT01791517|79030597|FG003|Phase I: Period 1|Adverse Event|1|||
44225037|NCT01791517|79030598|FG004|Phase I: Period 1|Adverse Event|0|||
44225038|NCT01791517|79030599|FG005|Phase I: Period 1|Adverse Event|0|||
44470237|NCT00533897|79478553|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44470238|NCT00533897|79478554|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44470239|NCT00533897|79478555|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44470240|NCT00533897|79478556|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44470241|NCT00533897|79478557|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44225039|NCT01791517|79030600|FG006|Phase I: Period 1|Adverse Event|0|||
44225040|NCT01791517|79030601|FG007|Phase I: Period 1|Adverse Event|0|||
44470242|NCT00533897|79478558|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44470243|NCT00533897|79478559|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
44225041|NCT01791517|79030602|FG008|Phase I: Period 1|Adverse Event|0|||
44225042|NCT01791517|79030603|FG009|Phase I: Period 1|Adverse Event|0|||
44225043|NCT01791517|79030604|FG010|Phase I: Period 1|Adverse Event|0|||
44225044|NCT01791517|79030605|FG011|Phase I: Period 1|Adverse Event|0|||
44225045|NCT01791517|79030594|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
44225046|NCT01791517|79030595|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225047|NCT01791517|79030596|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225048|NCT01791517|79030597|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225049|NCT01791517|79030598|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225050|NCT01791517|79030599|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225051|NCT01791517|79030600|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225052|NCT01791517|79030601|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225053|NCT01791517|79030602|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225054|NCT01791517|79030603|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225055|NCT01791517|79030604|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225056|NCT01791517|79030605|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
44225057|NCT01791517|79030594|FG000|Phase I: Period 1|Protocol Violation|0|||
44225058|NCT01791517|79030595|FG001|Phase I: Period 1|Protocol Violation|1|||
44225059|NCT01791517|79030596|FG002|Phase I: Period 1|Protocol Violation|0|||
44225060|NCT01791517|79030597|FG003|Phase I: Period 1|Protocol Violation|0|||
44225061|NCT01791517|79030598|FG004|Phase I: Period 1|Protocol Violation|0|||
44225062|NCT01791517|79030599|FG005|Phase I: Period 1|Protocol Violation|0|||
44225063|NCT01791517|79030600|FG006|Phase I: Period 1|Protocol Violation|0|||
44225064|NCT01791517|79030601|FG007|Phase I: Period 1|Protocol Violation|0|||
44225065|NCT01791517|79030602|FG008|Phase I: Period 1|Protocol Violation|0|||
44225066|NCT01791517|79030603|FG009|Phase I: Period 1|Protocol Violation|0|||
44225067|NCT01791517|79030604|FG010|Phase I: Period 1|Protocol Violation|0|||
44225068|NCT01791517|79030605|FG011|Phase I: Period 1|Protocol Violation|0|||
44225069|NCT01791517|79030594|FG000|Phase I: Period 1|Lost to Follow-up|0|||
44225070|NCT01791517|79030595|FG001|Phase I: Period 1|Lost to Follow-up|0|||
44470244|NCT00533897|79478552|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
44470245|NCT00533897|79478553|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44470246|NCT00533897|79478554|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44470247|NCT00533897|79478555|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44225071|NCT01791517|79030596|FG002|Phase I: Period 1|Lost to Follow-up|0|||
44470248|NCT00533897|79478556|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44470249|NCT00533897|79478557|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44470250|NCT00533897|79478558|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44470251|NCT00533897|79478559|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
44470252|NCT00533897|79478552|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
44225072|NCT01791517|79030597|FG003|Phase I: Period 1|Lost to Follow-up|1|||
44225073|NCT01791517|79030598|FG004|Phase I: Period 1|Lost to Follow-up|0|||
44225074|NCT01791517|79030599|FG005|Phase I: Period 1|Lost to Follow-up|0|||
44225075|NCT01791517|79030600|FG006|Phase I: Period 1|Lost to Follow-up|1|||
44225076|NCT01791517|79030601|FG007|Phase I: Period 1|Lost to Follow-up|0|||
44225077|NCT01791517|79030602|FG008|Phase I: Period 1|Lost to Follow-up|1|||
44225078|NCT01791517|79030603|FG009|Phase I: Period 1|Lost to Follow-up|1|||
44225079|NCT01791517|79030604|FG010|Phase I: Period 1|Lost to Follow-up|0|||
44225080|NCT01791517|79030605|FG011|Phase I: Period 1|Lost to Follow-up|0|||
44225081|NCT01791517|79030594|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225082|NCT01791517|79030595|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225083|NCT01791517|79030596|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225084|NCT01791517|79030597|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225085|NCT01791517|79030598|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225086|NCT01791517|79030599|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225087|NCT01791517|79030600|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225088|NCT01791517|79030601|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225089|NCT01791517|79030602|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225090|NCT01791517|79030603|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
44470253|NCT00533897|79478553|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44225091|NCT01791517|79030604|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
44225092|NCT01791517|79030605|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
44225093|NCT01791517|79030594|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
44225094|NCT01791517|79030595|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225095|NCT01791517|79030596|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225096|NCT01791517|79030597|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225097|NCT01791517|79030598|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225098|NCT01791517|79030599|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225099|NCT01791517|79030600|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225100|NCT01791517|79030601|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225101|NCT01791517|79030602|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225102|NCT01791517|79030603|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225103|NCT01791517|79030604|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225104|NCT01791517|79030605|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
44225105|NCT01791517|79030594|FG000|Phase I: Period 2|Protocol Violation|0|||
44225106|NCT01791517|79030595|FG001|Phase I: Period 2|Protocol Violation|0|||
44225107|NCT01791517|79030596|FG002|Phase I: Period 2|Protocol Violation|0|||
44225108|NCT01791517|79030597|FG003|Phase I: Period 2|Protocol Violation|1|||
44225109|NCT01791517|79030598|FG004|Phase I: Period 2|Protocol Violation|0|||
44225110|NCT01791517|79030599|FG005|Phase I: Period 2|Protocol Violation|0|||
44470254|NCT00533897|79478554|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44470255|NCT00533897|79478555|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44470256|NCT00533897|79478556|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44470257|NCT00533897|79478557|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44470258|NCT00533897|79478558|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44470259|NCT00533897|79478559|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
44470260|NCT00533897|79478552|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
44470261|NCT00533897|79478553|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470262|NCT00533897|79478554|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470263|NCT00533897|79478555|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470264|NCT00533897|79478556|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470265|NCT00533897|79478557|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470266|NCT00533897|79478558|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470267|NCT00533897|79478559|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
44470268|NCT00533897|79478552|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
44470269|NCT00533897|79478553|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470270|NCT00533897|79478554|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470271|NCT00533897|79478555|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470272|NCT00533897|79478556|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470273|NCT00533897|79478557|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470274|NCT00533897|79478558|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470275|NCT00533897|79478559|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
44470276|NCT00533897|79478552|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
44470277|NCT00533897|79478553|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
44470278|NCT00533897|79478554|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
44470279|NCT00533897|79478555|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
44470280|NCT00533897|79478556|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
44470281|NCT00533897|79478557|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
44470282|NCT00533897|79478558|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
44470283|NCT00533897|79478559|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
44225111|NCT01791517|79030600|FG006|Phase I: Period 2|Protocol Violation|0|||
44225112|NCT01791517|79030601|FG007|Phase I: Period 2|Protocol Violation|0|||
44225113|NCT01791517|79030602|FG008|Phase I: Period 2|Protocol Violation|0|||
44225114|NCT01791517|79030603|FG009|Phase I: Period 2|Protocol Violation|0|||
44225115|NCT01791517|79030604|FG010|Phase I: Period 2|Protocol Violation|0|||
44225116|NCT01791517|79030605|FG011|Phase I: Period 2|Protocol Violation|0|||
44225117|NCT01791517|79030594|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
44225118|NCT01791517|79030595|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
44225119|NCT01791517|79030596|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
44225120|NCT01791517|79030597|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
44470284|NCT00533897|79478552|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44470285|NCT00533897|79478553|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44225121|NCT01791517|79030598|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
44225122|NCT01791517|79030599|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
44225123|NCT01791517|79030600|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
44225124|NCT01791517|79030601|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
44470286|NCT00533897|79478554|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
44544481|NCT03600805|79557869|FG003|Overall Study|Other unspecified|11|||
44225125|NCT01791517|79030602|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
44225126|NCT01791517|79030603|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
44225127|NCT01791517|79030604|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
44225128|NCT01791517|79030605|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
44225129|NCT01791517|79030594|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225130|NCT01791517|79030595|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225131|NCT01791517|79030596|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44470287|NCT00533897|79478555|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44544482|NCT02729740|79557881|FG000|Overall Study|Early Termination|130|||
44225132|NCT01791517|79030597|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44273891|NCT00003389|79215436|FG001|Overall Study|Ineligible|27|||
44225133|NCT01791517|79030598|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225134|NCT01791517|79030599|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225135|NCT01791517|79030600|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225136|NCT01791517|79030601|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225137|NCT01791517|79030602|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225138|NCT01791517|79030603|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225139|NCT01791517|79030604|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
44470288|NCT00533897|79478556|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44470289|NCT00533897|79478557|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44470290|NCT00533897|79478558|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44470291|NCT00533897|79478559|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
44470292|NCT00533897|79478552|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44470293|NCT00533897|79478553|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44273892|NCT00003138|79215444|FG000|Step 1|Reasons off treatment not documented|60|||
44273893|NCT00003138|79215445|FG001|Step 1|Reasons off treatment not documented|57|||
44273894|NCT00003138|79215444|FG000|Step 1|Never started treatment|1|||
44273895|NCT00003138|79215445|FG001|Step 1|Never started treatment|0|||
44273896|NCT00003138|79215444|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
44273897|NCT00003138|79215445|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
44470294|NCT00533897|79478554|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44470295|NCT00533897|79478555|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44470296|NCT00533897|79478556|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44470297|NCT00533897|79478557|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
44470298|NCT00533897|79478558|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44470299|NCT00533897|79478559|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
44470300|NCT00533897|79478552|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44225140|NCT01791517|79030605|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
44225141|NCT01791517|79030594|FG000|Phase I: Period 2|Lens Discomfort|0|||
44225142|NCT01791517|79030595|FG001|Phase I: Period 2|Lens Discomfort|0|||
44225143|NCT01791517|79030596|FG002|Phase I: Period 2|Lens Discomfort|0|||
44225144|NCT01791517|79030597|FG003|Phase I: Period 2|Lens Discomfort|0|||
44225145|NCT01791517|79030598|FG004|Phase I: Period 2|Lens Discomfort|0|||
44225146|NCT01791517|79030599|FG005|Phase I: Period 2|Lens Discomfort|1|||
44225147|NCT01791517|79030600|FG006|Phase I: Period 2|Lens Discomfort|0|||
44225148|NCT01791517|79030601|FG007|Phase I: Period 2|Lens Discomfort|0|||
44225149|NCT01791517|79030602|FG008|Phase I: Period 2|Lens Discomfort|0|||
44225150|NCT01791517|79030603|FG009|Phase I: Period 2|Lens Discomfort|0|||
44273898|NCT00003138|79215444|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
44225151|NCT01791517|79030604|FG010|Phase I: Period 2|Lens Discomfort|0|||
44225152|NCT01791517|79030605|FG011|Phase I: Period 2|Lens Discomfort|0|||
44225153|NCT01791517|79030594|FG000|Phase I: Period 2|Lost to Follow-up|0|||
44225154|NCT01791517|79030595|FG001|Phase I: Period 2|Lost to Follow-up|3|||
44225155|NCT01791517|79030596|FG002|Phase I: Period 2|Lost to Follow-up|2|||
44225156|NCT01791517|79030597|FG003|Phase I: Period 2|Lost to Follow-up|0|||
44225157|NCT01791517|79030598|FG004|Phase I: Period 2|Lost to Follow-up|0|||
44225158|NCT01791517|79030599|FG005|Phase I: Period 2|Lost to Follow-up|0|||
44225159|NCT01791517|79030600|FG006|Phase I: Period 2|Lost to Follow-up|0|||
44225160|NCT01791517|79030601|FG007|Phase I: Period 2|Lost to Follow-up|0|||
44225161|NCT01791517|79030602|FG008|Phase I: Period 2|Lost to Follow-up|0|||
44225162|NCT01791517|79030603|FG009|Phase I: Period 2|Lost to Follow-up|0|||
44225163|NCT01791517|79030604|FG010|Phase I: Period 2|Lost to Follow-up|0|||
44225164|NCT01791517|79030605|FG011|Phase I: Period 2|Lost to Follow-up|0|||
44225165|NCT01791517|79030594|FG000|Phase I: Period 3|Lens Discomfort|0|||
44225166|NCT01791517|79030595|FG001|Phase I: Period 3|Lens Discomfort|0|||
44225167|NCT01791517|79030596|FG002|Phase I: Period 3|Lens Discomfort|0|||
44273899|NCT00003138|79215445|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
44273900|NCT00003138|79215444|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
44273901|NCT00003138|79215445|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
44273902|NCT00003138|79215444|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
44273903|NCT00003138|79215445|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
44273904|NCT00002525|79215456|FG000|Overall Study|Adverse Event|36|||
44273905|NCT00002525|79215457|FG001|Overall Study|Adverse Event|0|||
44470301|NCT00533897|79478553|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44470302|NCT00533897|79478554|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44470303|NCT00533897|79478555|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44544483|NCT02729740|79557881|FG000|Overall Study|Other|1|||
44225168|NCT01791517|79030597|FG003|Phase I: Period 3|Lens Discomfort|0|||
44225169|NCT01791517|79030598|FG004|Phase I: Period 3|Lens Discomfort|0|||
44225170|NCT01791517|79030599|FG005|Phase I: Period 3|Lens Discomfort|0|||
44225171|NCT01791517|79030600|FG006|Phase I: Period 3|Lens Discomfort|0|||
44225172|NCT01791517|79030601|FG007|Phase I: Period 3|Lens Discomfort|0|||
44470304|NCT00533897|79478556|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44470305|NCT00533897|79478557|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
44470306|NCT00533897|79478558|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44470307|NCT00533897|79478559|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
44470308|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
44470309|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
44470310|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
44470311|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
44470312|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
44470313|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
44470314|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
44544484|NCT03196284|79557891|FG000|Main Part|Withdrawal by Subject|0|||
44544485|NCT03196284|79557892|FG001|Main Part|Withdrawal by Subject|1|||
44544486|NCT03196284|79557893|FG002|Main Part|Withdrawal by Subject|0|||
44544487|NCT03196284|79557891|FG000|Extension Part|Lack of Efficacy|0|||
44544488|NCT03196284|79557892|FG001|Extension Part|Lack of Efficacy|0|||
44544489|NCT03196284|79557893|FG002|Extension Part|Lack of Efficacy|1|||
44544490|NCT03196284|79557891|FG000|Extension Part|Withdrawal by Subject|0|||
44544491|NCT03196284|79557892|FG001|Extension Part|Withdrawal by Subject|0|||
44544492|NCT03196284|79557893|FG002|Extension Part|Withdrawal by Subject|1|||
44544493|NCT03196284|79557891|FG000|Extension Part|Physician Decision|0|||
44544494|NCT03196284|79557892|FG001|Extension Part|Physician Decision|0|||
44544495|NCT03196284|79557893|FG002|Extension Part|Physician Decision|1|||
44225173|NCT01791517|79030602|FG008|Phase I: Period 3|Lens Discomfort|0|||
44225174|NCT01791517|79030603|FG009|Phase I: Period 3|Lens Discomfort|0|||
44225175|NCT01791517|79030604|FG010|Phase I: Period 3|Lens Discomfort|0|||
44470315|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
44470316|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Death|0|||
44470317|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Death|0|||
44470318|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Death|0|||
44470319|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Death|0|||
44470320|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Death|0|||
44470321|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Death|0|||
44470322|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Death|1|||
44470323|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Death|3|||
44470324|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
44470325|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
44470326|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
44470327|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
44470328|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
44470329|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
44470330|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
44470331|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
44470332|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470333|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470334|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470335|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470336|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470337|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470338|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
44470339|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
44470340|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Adverse Event|0|||
44470341|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Adverse Event|0|||
44470342|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Adverse Event|0|||
44470343|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Adverse Event|0|||
44470344|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Adverse Event|0|||
44470345|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Adverse Event|0|||
44470346|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Adverse Event|2|||
44470347|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Adverse Event|5|||
44470348|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Pregnancy|0|||
44470349|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Pregnancy|0|||
44470350|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Pregnancy|0|||
44470351|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Pregnancy|0|||
44470352|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Pregnancy|0|||
44273906|NCT00002525|79215456|FG000|Overall Study|Death|5|||
44470353|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Pregnancy|0|||
44470354|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Pregnancy|0|||
44544496|NCT03730961|79557915|FG000|Overall Study|Adverse Event|0|||
44544497|NCT03730961|79557916|FG001|Overall Study|Adverse Event|1|||
44544498|NCT01078454|79557924|FG000|Overall Study|Adverse Event|1|||
44470355|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Pregnancy|2|||
44544499|NCT01078454|79557925|FG001|Overall Study|Adverse Event|1|||
44544500|NCT01078454|79557924|FG000|Overall Study|Death|0|||
44544501|NCT01078454|79557925|FG001|Overall Study|Death|1|||
44470356|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
44470357|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
44470358|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
44470359|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
44470360|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
44470361|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
44470362|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
44470363|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
44470364|NCT00533897|79478552|FG000|Long Term Extension (LTE)|Other|0|||
44470365|NCT00533897|79478553|FG001|Long Term Extension (LTE)|Other|0|||
44470366|NCT00533897|79478554|FG002|Long Term Extension (LTE)|Other|0|||
44470367|NCT00533897|79478555|FG003|Long Term Extension (LTE)|Other|0|||
44470368|NCT00533897|79478556|FG004|Long Term Extension (LTE)|Other|0|||
44470369|NCT00533897|79478557|FG005|Long Term Extension (LTE)|Other|0|||
44470370|NCT00533897|79478558|FG006|Long Term Extension (LTE)|Other|1|||
44470371|NCT00533897|79478559|FG007|Long Term Extension (LTE)|Other|6|||
44470372|NCT00426660|79478590|FG000|Overall Study|Death|14|||
44470373|NCT00426660|79478590|FG000|Overall Study|Adverse Event|23|||
44470374|NCT00426660|79478590|FG000|Overall Study|Insufficient Clinical Response|22|||
44470375|NCT00426660|79478590|FG000|Overall Study|Lost to Follow-up|15|||
44225176|NCT01791517|79030605|FG011|Phase I: Period 3|Lens Discomfort|1|||
44225177|NCT01791517|79030594|FG000|Phase I: Period 3|Lost to Follow-up|0|||
44225178|NCT01791517|79030595|FG001|Phase I: Period 3|Lost to Follow-up|1|||
44225179|NCT01791517|79030596|FG002|Phase I: Period 3|Lost to Follow-up|0|||
44225180|NCT01791517|79030597|FG003|Phase I: Period 3|Lost to Follow-up|0|||
44225181|NCT01791517|79030598|FG004|Phase I: Period 3|Lost to Follow-up|1|||
44225182|NCT01791517|79030599|FG005|Phase I: Period 3|Lost to Follow-up|0|||
44225183|NCT01791517|79030600|FG006|Phase I: Period 3|Lost to Follow-up|0|||
44225184|NCT01791517|79030601|FG007|Phase I: Period 3|Lost to Follow-up|0|||
44225185|NCT01791517|79030602|FG008|Phase I: Period 3|Lost to Follow-up|0|||
44225186|NCT01791517|79030603|FG009|Phase I: Period 3|Lost to Follow-up|0|||
44225187|NCT01791517|79030604|FG010|Phase I: Period 3|Lost to Follow-up|0|||
44225188|NCT01791517|79030605|FG011|Phase I: Period 3|Lost to Follow-up|0|||
44225189|NCT01791517|79030594|FG000|Phase I: Period 3|Adverse Event|0|||
44225190|NCT01791517|79030595|FG001|Phase I: Period 3|Adverse Event|0|||
44225191|NCT01791517|79030596|FG002|Phase I: Period 3|Adverse Event|0|||
44225192|NCT01791517|79030597|FG003|Phase I: Period 3|Adverse Event|1|||
44225193|NCT01791517|79030598|FG004|Phase I: Period 3|Adverse Event|0|||
44225194|NCT01791517|79030599|FG005|Phase I: Period 3|Adverse Event|0|||
44225195|NCT01791517|79030600|FG006|Phase I: Period 3|Adverse Event|0|||
44225196|NCT01791517|79030601|FG007|Phase I: Period 3|Adverse Event|0|||
44225197|NCT01791517|79030602|FG008|Phase I: Period 3|Adverse Event|0|||
44225198|NCT01791517|79030603|FG009|Phase I: Period 3|Adverse Event|0|||
44225199|NCT01791517|79030604|FG010|Phase I: Period 3|Adverse Event|0|||
44225200|NCT01791517|79030605|FG011|Phase I: Period 3|Adverse Event|0|||
44225201|NCT01791517|79030594|FG000|Phase II|Lost to Follow-up|1|||
44225202|NCT01791517|79030595|FG001|Phase II|Lost to Follow-up|0|||
44225203|NCT01791517|79030596|FG002|Phase II|Lost to Follow-up|1|||
44225204|NCT01791517|79030597|FG003|Phase II|Lost to Follow-up|0|||
44225205|NCT01791517|79030598|FG004|Phase II|Lost to Follow-up|1|||
44225206|NCT01791517|79030599|FG005|Phase II|Lost to Follow-up|2|||
44225207|NCT01791517|79030600|FG006|Phase II|Lost to Follow-up|0|||
44225208|NCT01791517|79030601|FG007|Phase II|Lost to Follow-up|1|||
44225209|NCT01791517|79030602|FG008|Phase II|Lost to Follow-up|1|||
44225210|NCT01791517|79030603|FG009|Phase II|Lost to Follow-up|1|||
44225211|NCT01791517|79030604|FG010|Phase II|Lost to Follow-up|0|||
44225212|NCT01791517|79030605|FG011|Phase II|Lost to Follow-up|0|||
44225213|NCT01791517|79030594|FG000|Phase II|Withdrawal by Subject|1|||
44225214|NCT01791517|79030595|FG001|Phase II|Withdrawal by Subject|0|||
44225215|NCT01791517|79030596|FG002|Phase II|Withdrawal by Subject|0|||
44225216|NCT01791517|79030597|FG003|Phase II|Withdrawal by Subject|0|||
44225217|NCT01791517|79030598|FG004|Phase II|Withdrawal by Subject|0|||
44225218|NCT01791517|79030599|FG005|Phase II|Withdrawal by Subject|2|||
44225219|NCT01791517|79030600|FG006|Phase II|Withdrawal by Subject|0|||
44225220|NCT01791517|79030601|FG007|Phase II|Withdrawal by Subject|1|||
44225221|NCT01791517|79030602|FG008|Phase II|Withdrawal by Subject|0|||
44225222|NCT01791517|79030603|FG009|Phase II|Withdrawal by Subject|0|||
44225223|NCT01791517|79030604|FG010|Phase II|Withdrawal by Subject|1|||
44225224|NCT01791517|79030605|FG011|Phase II|Withdrawal by Subject|0|||
44225225|NCT01791517|79030594|FG000|Phase II|Lack of Efficacy|0|||
44225226|NCT01791517|79030595|FG001|Phase II|Lack of Efficacy|0|||
44225227|NCT01791517|79030596|FG002|Phase II|Lack of Efficacy|0|||
44470376|NCT00426660|79478590|FG000|Overall Study|Other|23|||
44470377|NCT00426660|79478590|FG000|Overall Study|Withdrawal by Subject|18|||
44470378|NCT00426660|79478590|FG000|Overall Study|Protocol Violation|1|||
44225228|NCT01791517|79030597|FG003|Phase II|Lack of Efficacy|0|||
44225229|NCT01791517|79030598|FG004|Phase II|Lack of Efficacy|1|||
44225230|NCT01791517|79030599|FG005|Phase II|Lack of Efficacy|0|||
44225231|NCT01791517|79030600|FG006|Phase II|Lack of Efficacy|0|||
44225232|NCT01791517|79030601|FG007|Phase II|Lack of Efficacy|0|||
44225233|NCT01791517|79030602|FG008|Phase II|Lack of Efficacy|0|||
44225234|NCT01791517|79030603|FG009|Phase II|Lack of Efficacy|0|||
44225235|NCT01791517|79030604|FG010|Phase II|Lack of Efficacy|0|||
44225236|NCT01791517|79030605|FG011|Phase II|Lack of Efficacy|0|||
44225237|NCT01791517|79030594|FG000|Phase II|Adverse Event|0|||
44225238|NCT01791517|79030595|FG001|Phase II|Adverse Event|0|||
44225239|NCT01791517|79030596|FG002|Phase II|Adverse Event|0|||
44225240|NCT01791517|79030597|FG003|Phase II|Adverse Event|0|||
44470379|NCT00426660|79478590|FG000|Overall Study|Enrolled Not Treated|15|||
44470380|NCT00426270|79478594|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
44470381|NCT00426270|79478594|FG000|Overall Study|Adverse Event|5|||
44470382|NCT00330681|79478600|FG000|Overall Study|Adverse Event|3|||
44470383|NCT00330681|79478601|FG001|Overall Study|Adverse Event|6|||
44470384|NCT00330681|79478600|FG000|Overall Study|Protocol Violation|0|||
44470385|NCT00330681|79478601|FG001|Overall Study|Protocol Violation|1|||
44470386|NCT00330681|79478600|FG000|Overall Study|Withdrawal by Subject|5|||
44470387|NCT00330681|79478601|FG001|Overall Study|Withdrawal by Subject|5|||
44470388|NCT00330681|79478600|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
44470389|NCT00330681|79478601|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
44470390|NCT00329901|79478610|FG000|Overall Study|Withdrawal by Subject|4|||
44470391|NCT00329901|79478611|FG001|Overall Study|Withdrawal by Subject|3|||
44470392|NCT00329901|79478612|FG002|Overall Study|Withdrawal by Subject|2|||
44470393|NCT00329901|79478610|FG000|Overall Study|Lost to Follow-up|2|||
44470394|NCT00329901|79478611|FG001|Overall Study|Lost to Follow-up|0|||
44470395|NCT00329901|79478612|FG002|Overall Study|Lost to Follow-up|1|||
44470396|NCT00329901|79478610|FG000|Overall Study|Protocol Violation|1|||
44470397|NCT00329901|79478611|FG001|Overall Study|Protocol Violation|0|||
44273907|NCT00002525|79215457|FG001|Overall Study|Death|0|||
44273908|NCT00002525|79215456|FG000|Overall Study|Withdrawal by Subject|11|||
44273909|NCT00002525|79215457|FG001|Overall Study|Withdrawal by Subject|0|||
44273910|NCT00002525|79215456|FG000|Overall Study|Start non-protocol therapy|1|||
44273911|NCT00002525|79215457|FG001|Overall Study|Start non-protocol therapy|0|||
44273912|NCT00002525|79215456|FG000|Overall Study|Other complicating disease|1|||
44273913|NCT00002525|79215457|FG001|Overall Study|Other complicating disease|0|||
44381611|NCT00738673|79387729|FG000|Overall Study|Protocol Violation|1|||
44470398|NCT00329901|79478612|FG002|Overall Study|Protocol Violation|1|||
44470399|NCT00329901|79478610|FG000|Overall Study|Unable to classify|2|||
44470400|NCT00329901|79478611|FG001|Overall Study|Unable to classify|2|||
44225241|NCT01791517|79030598|FG004|Phase II|Adverse Event|0|||
44470401|NCT00329901|79478612|FG002|Overall Study|Unable to classify|0|||
44470402|NCT00436956|79478624|FG000|Overall Study|Not evaluable|1|||
44470403|NCT00436956|79478625|FG001|Overall Study|Not evaluable|0|||
44225242|NCT01791517|79030599|FG005|Phase II|Adverse Event|0|||
44225243|NCT01791517|79030600|FG006|Phase II|Adverse Event|2|||
44225244|NCT01791517|79030601|FG007|Phase II|Adverse Event|1|||
44225245|NCT01791517|79030602|FG008|Phase II|Adverse Event|0|||
44225246|NCT01791517|79030603|FG009|Phase II|Adverse Event|1|||
44225247|NCT01791517|79030604|FG010|Phase II|Adverse Event|0|||
44225248|NCT01791517|79030605|FG011|Phase II|Adverse Event|0|||
44225249|NCT01791517|79030594|FG000|Phase II|Lens Handling Difficulties|0|||
44225250|NCT01791517|79030595|FG001|Phase II|Lens Handling Difficulties|0|||
44225251|NCT01791517|79030596|FG002|Phase II|Lens Handling Difficulties|0|||
44225252|NCT01791517|79030597|FG003|Phase II|Lens Handling Difficulties|0|||
44225253|NCT01791517|79030598|FG004|Phase II|Lens Handling Difficulties|0|||
44470404|NCT00329745|79478634|FG000|Overall Study|Protocol Violation|1|||
44470405|NCT00329745|79478635|FG001|Overall Study|Protocol Violation|0|||
44470406|NCT00329745|79478634|FG000|Overall Study|Withdrawal by Subject|0|||
44470407|NCT00329745|79478635|FG001|Overall Study|Withdrawal by Subject|1|||
44225254|NCT01791517|79030599|FG005|Phase II|Lens Handling Difficulties|0|||
44225255|NCT01791517|79030600|FG006|Phase II|Lens Handling Difficulties|0|||
44273914|NCT00002525|79215456|FG000|Overall Study|Duke's A, B1, D disease|92|||
44273915|NCT00002525|79215457|FG001|Overall Study|Duke's A, B1, D disease|0|||
44470408|NCT00329745|79478634|FG000|Overall Study|Lost to Follow-up|86|||
44470409|NCT00329745|79478635|FG001|Overall Study|Lost to Follow-up|101|||
44470410|NCT00436644|79478641|FG000|Overall Study|Adverse Event|2|||
44470411|NCT00436644|79478641|FG000|Overall Study|Death|1|||
44225256|NCT01791517|79030601|FG007|Phase II|Lens Handling Difficulties|0|||
44225257|NCT01791517|79030602|FG008|Phase II|Lens Handling Difficulties|1|||
44273916|NCT00002525|79215456|FG000|Overall Study|Error|6|||
44225258|NCT01791517|79030603|FG009|Phase II|Lens Handling Difficulties|0|||
44273917|NCT00002525|79215457|FG001|Overall Study|Error|0|||
44381612|NCT00738673|79387730|FG001|Overall Study|Protocol Violation|2|||
44381613|NCT00738673|79387729|FG000|Overall Study|Withdrawal by Subject|3|||
44381614|NCT00738673|79387730|FG001|Overall Study|Withdrawal by Subject|1|||
44381615|NCT00811954|79387739|FG000|Overall Study|Death|10|||
44381616|NCT00811954|79387740|FG001|Overall Study|Death|6|||
44381617|NCT00811954|79387741|FG002|Overall Study|Death|13|||
44381618|NCT00811954|79387739|FG000|Overall Study|Lost to Follow-up|29|||
44381619|NCT00811954|79387740|FG001|Overall Study|Lost to Follow-up|23|||
44225259|NCT01791517|79030604|FG010|Phase II|Lens Handling Difficulties|0|||
44225260|NCT01791517|79030605|FG011|Phase II|Lens Handling Difficulties|0|||
44225261|NCT01791517|79030594|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
44225262|NCT01791517|79030595|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
44225263|NCT01791517|79030596|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
44375355|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
44375356|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44375357|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Other|8|||
44225264|NCT01791517|79030597|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
44225265|NCT01791517|79030598|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
44225266|NCT01791517|79030599|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
44225267|NCT01791517|79030600|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
44225268|NCT01791517|79030601|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
44225269|NCT01791517|79030602|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
44225270|NCT01791517|79030603|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
44225271|NCT01791517|79030604|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
44225272|NCT01791517|79030605|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
44225273|NCT01791517|79030594|FG000|Phase II|Pre-Existing Ocular Issue|0|||
44225274|NCT01791517|79030595|FG001|Phase II|Pre-Existing Ocular Issue|0|||
44225275|NCT01791517|79030596|FG002|Phase II|Pre-Existing Ocular Issue|0|||
44381620|NCT00811954|79387741|FG002|Overall Study|Lost to Follow-up|34|||
44225276|NCT01791517|79030597|FG003|Phase II|Pre-Existing Ocular Issue|0|||
44225277|NCT01791517|79030598|FG004|Phase II|Pre-Existing Ocular Issue|0|||
44225278|NCT01791517|79030599|FG005|Phase II|Pre-Existing Ocular Issue|0|||
44381621|NCT00811954|79387739|FG000|Overall Study|Not able to get to clinic|28|||
44381622|NCT00811954|79387740|FG001|Overall Study|Not able to get to clinic|35|||
44381623|NCT00811954|79387741|FG002|Overall Study|Not able to get to clinic|30|||
44381624|NCT00811954|79387739|FG000|Overall Study|Not willing to adhere to requirements|12|||
44381625|NCT00811954|79387740|FG001|Overall Study|Not willing to adhere to requirements|2|||
44381626|NCT00811954|79387741|FG002|Overall Study|Not willing to adhere to requirements|16|||
44381627|NCT00811954|79387739|FG000|Overall Study|Withdraw consent prior study completion|4|||
44381628|NCT00811954|79387740|FG001|Overall Study|Withdraw consent prior study completion|6|||
44381629|NCT00811954|79387741|FG002|Overall Study|Withdraw consent prior study completion|5|||
44381630|NCT00811954|79387739|FG000|Overall Study|Site Closure|4|||
44381631|NCT00811954|79387740|FG001|Overall Study|Site Closure|0|||
44381632|NCT00811954|79387741|FG002|Overall Study|Site Closure|1|||
44381633|NCT00811954|79387739|FG000|Overall Study|Severe Debilitation|2|||
44381634|NCT00811954|79387740|FG001|Overall Study|Severe Debilitation|0|||
44381635|NCT00811954|79387741|FG002|Overall Study|Severe Debilitation|1|||
44381636|NCT00811954|79387739|FG000|Overall Study|Complete Protocol: No follow-up|0|||
44381637|NCT00811954|79387740|FG001|Overall Study|Complete Protocol: No follow-up|0|||
44381638|NCT00811954|79387741|FG002|Overall Study|Complete Protocol: No follow-up|1|||
44381639|NCT01032200|79387751|FG000|Overall Study|Death|1|||
44381640|NCT01032200|79387752|FG001|Overall Study|Death|1|||
44381641|NCT01032200|79387751|FG000|Overall Study|Withdrawal by Subject|1|||
44381642|NCT01032200|79387752|FG001|Overall Study|Withdrawal by Subject|3|||
44381643|NCT01032200|79387751|FG000|Overall Study|Toxicity|0|||
44381644|NCT01032200|79387752|FG001|Overall Study|Toxicity|2|||
44381645|NCT01032200|79387751|FG000|Overall Study|Progression|1|||
44381646|NCT01032200|79387752|FG001|Overall Study|Progression|0|||
44381647|NCT01032200|79387751|FG000|Overall Study|Multiple|1|||
44381648|NCT01032200|79387752|FG001|Overall Study|Multiple|1|||
44381649|NCT00738283|79387758|FG000|Overall Study|Death|1|||
44381650|NCT00738283|79387758|FG000|Overall Study|Transfer to another facility|2|||
44381651|NCT00738283|79387758|FG000|Overall Study|Discharge home prior to end of study|1|||
44381652|NCT00586105|79387771|FG000|Overall Study|Adverse Event|4|||
44381653|NCT00586105|79387771|FG000|Overall Study|Death|2|||
44381654|NCT00586105|79387771|FG000|Overall Study|Protocol Violation|1|||
44381655|NCT00586105|79387771|FG000|Overall Study|Withdrawal by Subject|3|||
44381656|NCT00586105|79387771|FG000|Overall Study|Disease progression|19|||
44381657|NCT00586105|79387771|FG000|Overall Study|Switched to commercial drug|9|||
44381658|NCT00586105|79387771|FG000|Overall Study|Reason not reported|1|||
44381659|NCT00743119|79387775|FG000|Overall Study|unreliable|3|||
44381660|NCT00743119|79387775|FG000|Overall Study|Withdrawal by Subject|1|||
44381661|NCT00733369|79387789|FG000|Overall Study|Lost to Follow-up|2|||
44381662|NCT00733369|79387790|FG001|Overall Study|Lost to Follow-up|1|||
44381663|NCT00733369|79387789|FG000|Overall Study|Adverse Event|4|||
44381664|NCT00733369|79387790|FG001|Overall Study|Adverse Event|4|||
44381665|NCT00733369|79387789|FG000|Overall Study|Protocol Violation|4|||
44381666|NCT00733369|79387790|FG001|Overall Study|Protocol Violation|4|||
44381667|NCT00813124|79387796|FG000|Overall Study|Death|2|||
44381668|NCT00813124|79387796|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
44381669|NCT00813124|79387796|FG000|Overall Study|Withdrawal by Subject|1|||
44470412|NCT00324987|79478647|FG000|Overall Study|Adverse Event|2|||
44470413|NCT00324987|79478648|FG001|Overall Study|Adverse Event|1|||
44470414|NCT00324987|79478647|FG000|Overall Study|Withdrawal by Subject|1|||
44470415|NCT00324987|79478648|FG001|Overall Study|Withdrawal by Subject|1|||
44470416|NCT00324987|79478647|FG000|Overall Study|Progression|1|||
44470417|NCT00324987|79478648|FG001|Overall Study|Progression|1|||
44470418|NCT00324987|79478647|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
44470419|NCT00324987|79478648|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
44470420|NCT00324675|79478656|FG000|Overall Study|Adverse Event|1|||
44470421|NCT00324675|79478657|FG001|Overall Study|Adverse Event|0|||
44470422|NCT00436566|79478663|FG000|Overall Study|Withdrawal by Subject|2|||
44470423|NCT00436566|79478663|FG000|Overall Study|Protocol Violation|1|||
44470424|NCT00352365|79478667|FG000|Induction Therapy|Adverse Event|7|||
44470425|NCT00352365|79478667|FG000|Induction Therapy|Progression/Relapse|8|||
44470426|NCT00352365|79478667|FG000|Induction Therapy|Death|7|||
44470427|NCT00352365|79478667|FG000|Induction Therapy|Not protocol specified|1|||
44470428|NCT00352365|79478667|FG000|Induction Therapy|Not eligible|3|||
44470429|NCT00352365|79478667|FG000|Induction Therapy|Death before starting protocol therapy|1|||
44470430|NCT00352365|79478667|FG000|Maintenance Therapy|Progression/Relapse|3|||
44470431|NCT00352365|79478667|FG000|Maintenance Therapy|Death|2|||
44470432|NCT00352365|79478667|FG000|Maintenance Therapy|Not protocol specified|3|||
44470433|NCT00352365|79478667|FG000|Maintenance Therapy|Not eligible|4|||
44470434|NCT00532493|79478677|FG000|Overall Study|Death|1|||
44470435|NCT00532493|79478678|FG001|Overall Study|Death|1|||
44470436|NCT00532493|79478677|FG000|Overall Study|Lost to Follow-up|10|||
44470437|NCT00532493|79478678|FG001|Overall Study|Lost to Follow-up|7|||
44470438|NCT00532493|79478677|FG000|Overall Study|Withdrawal by Subject|7|||
44470439|NCT00532493|79478678|FG001|Overall Study|Withdrawal by Subject|9|||
44470440|NCT00532493|79478677|FG000|Overall Study|Physician Decision|1|||
44470441|NCT00532493|79478678|FG001|Overall Study|Physician Decision|6|||
44470442|NCT00532493|79478677|FG000|Overall Study|Adverse Event|6|||
44470443|NCT00532493|79478678|FG001|Overall Study|Adverse Event|5|||
44470444|NCT00532493|79478677|FG000|Overall Study|Protocol Deviation|1|||
44470445|NCT00532493|79478678|FG001|Overall Study|Protocol Deviation|0|||
44470446|NCT00532493|79478677|FG000|Overall Study|Subject Moved Away|3|||
44470447|NCT00532493|79478678|FG001|Overall Study|Subject Moved Away|1|||
44470448|NCT00532493|79478677|FG000|Overall Study|Contraindicative Medication|1|||
44470449|NCT00532493|79478678|FG001|Overall Study|Contraindicative Medication|0|||
44470450|NCT00533507|79478686|FG000|Overall Study|Withdrawal by Subject|1|||
44470451|NCT03886493|79478690|FG000|Overall Study|Adverse Event|1|||
44470452|NCT00352053|79478696|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
44470453|NCT00352053|79478697|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
44470454|NCT00352053|79478696|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
44470455|NCT00352053|79478697|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
44470456|NCT00352053|79478696|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
44470457|NCT00352053|79478697|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
44470458|NCT00352053|79478696|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
44470459|NCT00352053|79478697|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
44470460|NCT00352053|79478696|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
44470461|NCT00352053|79478697|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
44470462|NCT00352053|79478696|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
44470463|NCT00352053|79478697|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
44470464|NCT00352053|79478696|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
44470465|NCT00352053|79478697|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
44470466|NCT00352053|79478696|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
44470467|NCT00352053|79478697|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
44470468|NCT00352053|79478696|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
44470469|NCT00352053|79478697|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
44470470|NCT00352053|79478696|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
44470471|NCT00352053|79478697|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
44470472|NCT00352053|79478696|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
44470473|NCT00352053|79478697|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
44470474|NCT00352053|79478696|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
44470475|NCT00352053|79478697|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
44470476|NCT00352053|79478696|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
44470477|NCT00352053|79478697|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
44470478|NCT00351819|79478713|FG000|Overall Study|Lost to Follow-up|4|||
44470479|NCT00351819|79478714|FG001|Overall Study|Lost to Follow-up|4|||
44470480|NCT00351819|79478713|FG000|Overall Study|Withdrawal by Subject|0|||
44470481|NCT00351819|79478714|FG001|Overall Study|Withdrawal by Subject|4|||
44470482|NCT00351819|79478713|FG000|Overall Study|Elevated PSA|1|||
44470483|NCT00351819|79478714|FG001|Overall Study|Elevated PSA|1|||
44470484|NCT00351819|79478713|FG000|Overall Study|Traumatic ankle fracture|1|||
44470485|NCT00351819|79478714|FG001|Overall Study|Traumatic ankle fracture|0|||
44470486|NCT00351819|79478713|FG000|Overall Study|Unprofessional behavior|1|||
44470487|NCT00351819|79478714|FG001|Overall Study|Unprofessional behavior|0|||
44470488|NCT00351819|79478713|FG000|Overall Study|Non-compliance|0|||
44470489|NCT00351819|79478714|FG001|Overall Study|Non-compliance|1|||
44470490|NCT00351819|79478713|FG000|Overall Study|Incarcerated|0|||
44470491|NCT00351819|79478714|FG001|Overall Study|Incarcerated|1|||
44470492|NCT00351819|79478713|FG000|Overall Study|Enrolled in another trial|0|||
44470493|NCT00351819|79478714|FG001|Overall Study|Enrolled in another trial|1|||
44470494|NCT00351351|79478722|FG000|Overall Study|surgical access pbs; device issues|9|||
44470495|NCT00351351|79478723|FG001|Overall Study|surgical access pbs; device issues|4|||
44470496|NCT00323115|79478729|FG000|Vaccine Administration|Adverse Event|1|||
44470497|NCT00323115|79478729|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
44470498|NCT00322881|79478738|FG000|Overall Study|Death|2|||
44470499|NCT00322881|79478738|FG000|Overall Study|Adverse Event|1|||
44470500|NCT00322881|79478738|FG000|Overall Study|Disease Progression|2|||
44470501|NCT00415194|79478744|FG000|Overall Study|Adverse Event|37|||
44470502|NCT00415194|79478745|FG001|Overall Study|Adverse Event|32|||
44225279|NCT01791517|79030600|FG006|Phase II|Pre-Existing Ocular Issue|0|||
44225280|NCT01791517|79030601|FG007|Phase II|Pre-Existing Ocular Issue|0|||
44225281|NCT01791517|79030602|FG008|Phase II|Pre-Existing Ocular Issue|0|||
44225282|NCT01791517|79030603|FG009|Phase II|Pre-Existing Ocular Issue|0|||
44225283|NCT01791517|79030604|FG010|Phase II|Pre-Existing Ocular Issue|0|||
44225284|NCT01791517|79030605|FG011|Phase II|Pre-Existing Ocular Issue|1|||
44225285|NCT01998581|79030625|FG000|Overall Study|Refused repeat treatment|20|||
44225286|NCT01998581|79030626|FG001|Overall Study|Refused repeat treatment|4|||
44225287|NCT01998581|79030625|FG000|Overall Study|Protocol Violation|1|||
44225288|NCT01998581|79030626|FG001|Overall Study|Protocol Violation|0|||
44225289|NCT01998581|79030625|FG000|Overall Study|Withdrawal by Subject|8|||
44225290|NCT01998581|79030626|FG001|Overall Study|Withdrawal by Subject|1|||
44470503|NCT00415194|79478744|FG000|Overall Study|Entry Criteria Not Met|4|||
44470504|NCT00415194|79478745|FG001|Overall Study|Entry Criteria Not Met|8|||
44470505|NCT00415194|79478744|FG000|Overall Study|Lost to Follow-up|1|||
44470506|NCT00415194|79478745|FG001|Overall Study|Lost to Follow-up|0|||
44470507|NCT00415194|79478744|FG000|Overall Study|Physician Decision|10|||
44470508|NCT00415194|79478745|FG001|Overall Study|Physician Decision|16|||
44470509|NCT00415194|79478744|FG000|Overall Study|Progressive Disease|180|||
44470510|NCT00415194|79478745|FG001|Overall Study|Progressive Disease|217|||
44470511|NCT00415194|79478744|FG000|Overall Study|Protocol Violation|4|||
44470512|NCT00415194|79478745|FG001|Overall Study|Protocol Violation|2|||
44470513|NCT00415194|79478744|FG000|Overall Study|Withdrawal by Subject|28|||
44470514|NCT00415194|79478745|FG001|Overall Study|Withdrawal by Subject|21|||
44470515|NCT00415194|79478744|FG000|Overall Study|Death Due to Study Disease|26|||
44470516|NCT00415194|79478745|FG001|Overall Study|Death Due to Study Disease|29|||
44470517|NCT00415194|79478744|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
44470518|NCT00415194|79478745|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
44470519|NCT00415194|79478744|FG000|Overall Study|Death Due to Procedural Related AE|0|||
44470520|NCT00415194|79478745|FG001|Overall Study|Death Due to Procedural Related AE|1|||
44470521|NCT00415194|79478744|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
44470522|NCT00415194|79478745|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
44470523|NCT00436332|79478751|FG000|Overall Study|Adverse Event|9|||
44470524|NCT00436332|79478751|FG000|Overall Study|Withdrawal by Subject|2|||
44470525|NCT00436332|79478751|FG000|Overall Study|Progression|59|||
44470526|NCT00436332|79478751|FG000|Overall Study|Death|2|||
44470527|NCT00436332|79478751|FG000|Overall Study|Not Protocol Specified|6|||
44470528|NCT00436332|79478751|FG000|Overall Study|Ineligible|2|||
44470529|NCT00436332|79478751|FG000|Overall Study|Never Received Treatment|3|||
44470530|NCT00532259|79478755|FG000|Overall Study|Withdrawal by Subject|2|||
44470531|NCT00532259|79478755|FG000|Overall Study|Adverse Event|1|||
44225291|NCT01998581|79030625|FG000|Overall Study|Lost to Follow-up|12|||
44225292|NCT01998581|79030626|FG001|Overall Study|Lost to Follow-up|4|||
44225293|NCT01998581|79030625|FG000|Overall Study|Adverse Event|1|||
44470532|NCT00532259|79478755|FG000|Overall Study|Death|1|||
44470533|NCT00532259|79478755|FG000|Overall Study|Lack of Efficacy|21|||
44470534|NCT00532259|79478755|FG000|Overall Study|Lost to Follow-up|3|||
44470535|NCT00532259|79478755|FG000|Overall Study|Physician Decision|3|||
44225294|NCT01998581|79030626|FG001|Overall Study|Adverse Event|1|||
44225295|NCT01998581|79030625|FG000|Overall Study|Other reasons|3|||
44470536|NCT00532259|79478755|FG000|Overall Study|Protocol Violation|1|||
44470537|NCT00322491|79478762|FG000|Overall Study|Adverse Event|1|||
44470538|NCT00322491|79478763|FG001|Overall Study|Adverse Event|0|||
44470539|NCT00322491|79478762|FG000|Overall Study|Death|1|||
44375358|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Other|3|||
44470540|NCT00322491|79478763|FG001|Overall Study|Death|2|||
44470541|NCT00322023|79478773|FG000|Overall Study|various|0|||
44225296|NCT01998581|79030626|FG001|Overall Study|Other reasons|2|||
44225297|NCT01998581|79030625|FG000|Overall Study|Randomized but withdrew before treatment|1|||
44470542|NCT00322023|79478774|FG001|Overall Study|various|2|||
44470543|NCT00322023|79478775|FG002|Overall Study|various|6|||
44470544|NCT00414960|79478785|FG000|Overall Study|Adverse Event|4|||
44470545|NCT00414960|79478786|FG001|Overall Study|Adverse Event|0|||
44470546|NCT00414960|79478785|FG000|Overall Study|Withdrawal by Subject|3|||
44470547|NCT00414960|79478786|FG001|Overall Study|Withdrawal by Subject|0|||
44470548|NCT00414960|79478785|FG000|Overall Study|Physician Decision|0|||
44470549|NCT00414960|79478786|FG001|Overall Study|Physician Decision|1|||
44470550|NCT00321789|79478794|FG000|Overall Study|Lost to Follow-up|4|||
44470551|NCT00321789|79478795|FG001|Overall Study|Lost to Follow-up|7|||
44470552|NCT00321789|79478794|FG000|Overall Study|Withdrawal by Subject|6|||
44470553|NCT00321789|79478795|FG001|Overall Study|Withdrawal by Subject|6|||
44470554|NCT00321789|79478794|FG000|Overall Study|Protocol Violation|5|||
44470555|NCT00321789|79478795|FG001|Overall Study|Protocol Violation|3|||
44225298|NCT01998581|79030626|FG001|Overall Study|Randomized but withdrew before treatment|0|||
44470556|NCT00414726|79478803|FG000|Overall Study|Withdrawal by Subject|0|||
44470557|NCT00414726|79478804|FG001|Overall Study|Withdrawal by Subject|1|||
44225299|NCT01983293|79030635|FG000|Overall Study|Withdrawal by Subject|29|||
44225300|NCT01983293|79030636|FG001|Overall Study|Withdrawal by Subject|15|||
44225301|NCT01983293|79030635|FG000|Overall Study|Missing 12-month visit|3|||
44225302|NCT01983293|79030636|FG001|Overall Study|Missing 12-month visit|3|||
44225303|NCT01983293|79030635|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
44375359|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Other|4|||
44375360|NCT01106690|79380534|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
44375361|NCT01106690|79380535|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44375362|NCT01106690|79380536|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44375363|NCT01103180|79380566|FG000|Overall Study|Withdrawal by Subject|8|||
44375364|NCT01103180|79380567|FG001|Overall Study|Withdrawal by Subject|13|||
44375365|NCT01103180|79380566|FG000|Overall Study|Lost to Follow-up|13|||
44375366|NCT01103180|79380567|FG001|Overall Study|Lost to Follow-up|7|||
44375367|NCT01103180|79380566|FG000|Overall Study|Physician Decision|1|||
44375368|NCT01103180|79380567|FG001|Overall Study|Physician Decision|0|||
44375369|NCT01103180|79380566|FG000|Overall Study|Protocol Violation|0|||
44375370|NCT01103180|79380567|FG001|Overall Study|Protocol Violation|1|||
44375371|NCT00944034|79380585|FG000|Overall Study|Inappropriate enrollment|0|||
44470558|NCT00531947|79478812|FG000|Overall Study|Adverse Event|5|||
44225304|NCT01983293|79030636|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
44225305|NCT01791205|79030644|FG000|Phase II|Lack of Efficacy|6|||
44225306|NCT01791205|79030645|FG001|Phase II|Lack of Efficacy|0|||
44225307|NCT01791205|79030644|FG000|Phase II|Adverse Event|2|||
44225308|NCT01791205|79030645|FG001|Phase II|Adverse Event|0|||
44225309|NCT01791205|79030644|FG000|Phase II|Safety|1|||
44225310|NCT01791205|79030645|FG001|Phase II|Safety|0|||
44225311|NCT01791205|79030644|FG000|Phase II|Lost to Follow-up|1|||
44225312|NCT01791205|79030645|FG001|Phase II|Lost to Follow-up|0|||
44225313|NCT01791205|79030644|FG000|Phase II|Remission of disease|1|||
44225314|NCT01791205|79030645|FG001|Phase II|Remission of disease|0|||
44225315|NCT01791205|79030644|FG000|Phase II|Physician's decision|1|||
44225316|NCT01791205|79030645|FG001|Phase II|Physician's decision|0|||
44225317|NCT01272232|79030654|FG000|Weeks 0-56|Adverse Event|39|||
44225318|NCT01272232|79030655|FG001|Weeks 0-56|Adverse Event|18|||
44225319|NCT01272232|79030656|FG002|Weeks 0-56|Adverse Event|7|||
44225320|NCT01272232|79030654|FG000|Weeks 0-56|Lack of Efficacy|0|||
44225321|NCT01272232|79030655|FG001|Weeks 0-56|Lack of Efficacy|0|||
44225322|NCT01272232|79030656|FG002|Weeks 0-56|Lack of Efficacy|3|||
44225323|NCT01272232|79030654|FG000|Weeks 0-56|Protocol Violation|12|||
44225324|NCT01272232|79030655|FG001|Weeks 0-56|Protocol Violation|8|||
44225325|NCT01272232|79030656|FG002|Weeks 0-56|Protocol Violation|13|||
44225326|NCT01272232|79030654|FG000|Weeks 0-56|Withdrawal criteria|32|||
44225327|NCT01272232|79030655|FG001|Weeks 0-56|Withdrawal criteria|14|||
44225328|NCT01272232|79030656|FG002|Weeks 0-56|Withdrawal criteria|37|||
44225329|NCT01272232|79030654|FG000|Weeks 0-56|Unclassified|16|||
44225330|NCT01272232|79030655|FG001|Weeks 0-56|Unclassified|7|||
44225331|NCT01272232|79030656|FG002|Weeks 0-56|Unclassified|12|||
44225332|NCT01272232|79030654|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
44225333|NCT01272232|79030655|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
44470559|NCT00531947|79478813|FG001|Overall Study|Adverse Event|10|||
44225334|NCT01272232|79030656|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
44225335|NCT01272232|79030654|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
44225336|NCT01272232|79030655|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
44225337|NCT01272232|79030656|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
44225338|NCT01272232|79030654|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
44225339|NCT01272232|79030655|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
44273918|NCT00002525|79215456|FG000|Overall Study|Other|26|||
44375372|NCT00944034|79380586|FG001|Overall Study|Inappropriate enrollment|1|||
44375373|NCT00944034|79380587|FG002|Overall Study|Inappropriate enrollment|0|||
44470560|NCT00531947|79478812|FG000|Overall Study|Lost to Follow-up|12|||
44470561|NCT00531947|79478813|FG001|Overall Study|Lost to Follow-up|9|||
44470562|NCT00531947|79478812|FG000|Overall Study|Withdrawal by Subject|14|||
44470563|NCT00531947|79478813|FG001|Overall Study|Withdrawal by Subject|19|||
44470564|NCT00531947|79478812|FG000|Overall Study|Protocol Violation|2|||
44470565|NCT00531947|79478813|FG001|Overall Study|Protocol Violation|1|||
44470566|NCT00531947|79478812|FG000|Overall Study|Non-Compliance|4|||
44470567|NCT00531947|79478813|FG001|Overall Study|Non-Compliance|7|||
44470568|NCT00531947|79478812|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
44470569|NCT00531947|79478813|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
44470570|NCT00530855|79478819|FG000|Overall Study|Lack of Efficacy|20|||
44470571|NCT00530855|79478819|FG000|Overall Study|Withdrawal by Subject|30|||
44470572|NCT00530855|79478819|FG000|Overall Study|Fatal Serious AE|3|||
44470573|NCT00530855|79478819|FG000|Overall Study|Non Fatal Serious AE|7|||
44470574|NCT00530855|79478819|FG000|Overall Study|Non Fatal Non Serious AE|12|||
44470575|NCT00530855|79478819|FG000|Overall Study|Protocol Violation|3|||
44470576|NCT00530855|79478819|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
44470577|NCT00530855|79478819|FG000|Overall Study|Lost to Follow-up|9|||
44470578|NCT00530855|79478819|FG000|Overall Study|Other reason for premature termination|17|||
44225340|NCT01272232|79030656|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
44470579|NCT00530777|79478825|FG000|Overall Study|Lost to Follow-up|0|||
44470580|NCT00530777|79478826|FG001|Overall Study|Lost to Follow-up|1|||
44470581|NCT00530777|79478825|FG000|Overall Study|Death|1|||
44470582|NCT00530777|79478826|FG001|Overall Study|Death|2|||
44470583|NCT00530777|79478825|FG000|Overall Study|Physician Decision|1|||
44470584|NCT00530777|79478826|FG001|Overall Study|Physician Decision|0|||
44470585|NCT00530777|79478825|FG000|Overall Study|Withdrawal by Subject|0|||
44470586|NCT00530777|79478826|FG001|Overall Study|Withdrawal by Subject|1|||
44470587|NCT00530777|79478825|FG000|Overall Study|Unable to adhere to visit schedule|5|||
44470588|NCT00530777|79478826|FG001|Overall Study|Unable to adhere to visit schedule|1|||
44470589|NCT03882047|79478835|FG000|Overall Study|Adverse Event|0|||
44470590|NCT03882047|79478836|FG001|Overall Study|Adverse Event|2|||
44470591|NCT03882047|79478837|FG002|Overall Study|Adverse Event|2|||
44470592|NCT03882047|79478835|FG000|Overall Study|Treatment Failure|3|||
44470593|NCT03882047|79478836|FG001|Overall Study|Treatment Failure|3|||
44470594|NCT03882047|79478837|FG002|Overall Study|Treatment Failure|12|||
44470595|NCT03882047|79478835|FG000|Overall Study|Lost to Follow-up|0|||
44470596|NCT03882047|79478836|FG001|Overall Study|Lost to Follow-up|1|||
44470597|NCT03882047|79478837|FG002|Overall Study|Lost to Follow-up|0|||
44470598|NCT03882047|79478835|FG000|Overall Study|Did Not Wish to Continue|1|||
44470599|NCT03882047|79478836|FG001|Overall Study|Did Not Wish to Continue|4|||
44470600|NCT03882047|79478837|FG002|Overall Study|Did Not Wish to Continue|1|||
44470601|NCT03882047|79478835|FG000|Overall Study|Noncompliance With Protocol|2|||
44470602|NCT03882047|79478836|FG001|Overall Study|Noncompliance With Protocol|0|||
44470603|NCT03882047|79478837|FG002|Overall Study|Noncompliance With Protocol|0|||
44470604|NCT03882047|79478835|FG000|Overall Study|Did Not Meet Eligibility|0|||
44225341|NCT01272232|79030654|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
44225342|NCT01272232|79030655|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
44225343|NCT01272232|79030656|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
44225344|NCT01272232|79030654|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
44225345|NCT01272232|79030655|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
44225346|NCT01272232|79030656|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
44225347|NCT01791127|79030664|FG000|Overall Study|Death|356|||
44225348|NCT01791127|79030664|FG000|Overall Study|Patient has withdrawn from study|293|||
44225349|NCT01791127|79030664|FG000|Overall Study|Lost to Follow-up|42|||
44225350|NCT01791127|79030664|FG000|Overall Study|All Siello leads are explanted|31|||
44225351|NCT01791127|79030664|FG000|Overall Study|Completion of 30 day safety registry|1|||
44225352|NCT01791127|79030664|FG000|Overall Study|Study terminated for EP Passion|749|||
44225353|NCT01997333|79030695|FG000|Randomization and Treatment|Disease Progression|70|||
44225354|NCT01997333|79030696|FG001|Randomization and Treatment|Disease Progression|159|||
44273919|NCT00002525|79215457|FG001|Overall Study|Other|0|||
44273920|NCT00002525|79215456|FG000|Overall Study|Never start protocol therapy|8|||
44470605|NCT03882047|79478836|FG001|Overall Study|Did Not Meet Eligibility|0|||
44470606|NCT03882047|79478837|FG002|Overall Study|Did Not Meet Eligibility|1|||
44470607|NCT00530621|79478847|FG000|Overall Study|Adverse Event|11|||
44470608|NCT00530621|79478848|FG001|Overall Study|Adverse Event|8|||
44470609|NCT00530621|79478847|FG000|Overall Study|Physician Decision|2|||
44470610|NCT00530621|79478848|FG001|Overall Study|Physician Decision|4|||
44470611|NCT00530621|79478847|FG000|Overall Study|Progressive Disease (PD)|47|||
44470612|NCT00530621|79478848|FG001|Overall Study|Progressive Disease (PD)|40|||
44225355|NCT01997333|79030695|FG000|Randomization and Treatment|Adverse Event|10|||
44470613|NCT00530621|79478847|FG000|Overall Study|Sponsor Decision|12|||
44470614|NCT00530621|79478848|FG001|Overall Study|Sponsor Decision|15|||
44470615|NCT00530621|79478847|FG000|Overall Study|Subject Decision|4|||
44470616|NCT00530621|79478848|FG001|Overall Study|Subject Decision|7|||
44470617|NCT00530621|79478847|FG000|Overall Study|Death|3|||
44470618|NCT00530621|79478848|FG001|Overall Study|Death|6|||
44470619|NCT00530621|79478847|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
44225356|NCT01997333|79030696|FG001|Randomization and Treatment|Adverse Event|32|||
44225357|NCT01997333|79030695|FG000|Randomization and Treatment|Physician Decision|0|||
44225358|NCT01997333|79030696|FG001|Randomization and Treatment|Physician Decision|4|||
44470620|NCT00530621|79478848|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
44470621|NCT00531479|79478860|FG000|Overall Study|Death|68|||
44470622|NCT00531479|79478861|FG001|Overall Study|Death|71|||
44470623|NCT00531479|79478860|FG000|Overall Study|Lost to Follow-up|0|||
44470624|NCT00531479|79478861|FG001|Overall Study|Lost to Follow-up|2|||
44470625|NCT00531479|79478860|FG000|Overall Study|Other|0|||
44470626|NCT00531479|79478861|FG001|Overall Study|Other|1|||
44470627|NCT00531479|79478860|FG000|Overall Study|Withdrawal by Subject|6|||
44470628|NCT00531479|79478861|FG001|Overall Study|Withdrawal by Subject|6|||
44225359|NCT01997333|79030695|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
44225360|NCT01997333|79030696|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
44470629|NCT00531479|79478860|FG000|Overall Study|Did not receive treatment|2|||
44470630|NCT00531479|79478861|FG001|Overall Study|Did not receive treatment|3|||
44470631|NCT00530075|79478867|FG000|Overall Study|Adverse Event|1|||
44470632|NCT00530075|79478867|FG000|Overall Study|Death|1|||
44470633|NCT00530075|79478867|FG000|Overall Study|Lack of Efficacy|3|||
44470634|NCT00530075|79478867|FG000|Overall Study|Protocol Violation|1|||
44470635|NCT00530075|79478867|FG000|Overall Study|Withdrawal by Subject|1|||
44470636|NCT00531011|79478873|FG000|Overall Study|Withdrawal by Subject|2|||
44470637|NCT00531011|79478874|FG001|Overall Study|Withdrawal by Subject|4|||
44470638|NCT00531011|79478873|FG000|Overall Study|Death|1|||
44470639|NCT00531011|79478874|FG001|Overall Study|Death|0|||
44470640|NCT00531011|79478873|FG000|Overall Study|Lost to Follow-up|1|||
44470641|NCT00531011|79478874|FG001|Overall Study|Lost to Follow-up|0|||
44470642|NCT00531011|79478873|FG000|Overall Study|Physician Decision|0|||
44470643|NCT00531011|79478874|FG001|Overall Study|Physician Decision|3|||
44470644|NCT00529217|79478880|FG000|Overall Study|Lack of Efficacy|2|||
44470645|NCT00529217|79478880|FG000|Overall Study|Unable to adhere to study schedule|2|||
44470646|NCT00471146|79478887|FG000|Overall Study|Adverse Event|32|||
44470647|NCT00471146|79478888|FG001|Overall Study|Adverse Event|33|||
44470648|NCT00471146|79478887|FG000|Overall Study|Withdrawal by Subject|14|||
44470649|NCT00471146|79478888|FG001|Overall Study|Withdrawal by Subject|11|||
44470650|NCT00471146|79478887|FG000|Overall Study|Death|11|||
44470651|NCT00471146|79478888|FG001|Overall Study|Death|12|||
44470652|NCT00471146|79478887|FG000|Overall Study|Lost to Follow-up|4|||
44470653|NCT00471146|79478888|FG001|Overall Study|Lost to Follow-up|2|||
44470654|NCT00471146|79478887|FG000|Overall Study|Protocol Violation|2|||
44470655|NCT00471146|79478888|FG001|Overall Study|Protocol Violation|2|||
44470656|NCT00471146|79478887|FG000|Overall Study|Objective progression or relapse|84|||
44470657|NCT00471146|79478888|FG001|Overall Study|Objective progression or relapse|87|||
44470658|NCT00471146|79478887|FG000|Overall Study|Global deterioration of health status|12|||
44470659|NCT00471146|79478888|FG001|Overall Study|Global deterioration of health status|14|||
44470660|NCT00471146|79478887|FG000|Overall Study|Randomized but not treated|9|||
44470661|NCT00471146|79478888|FG001|Overall Study|Randomized but not treated|8|||
44470662|NCT00471146|79478887|FG000|Overall Study|Other|4|||
44470663|NCT00471146|79478888|FG001|Overall Study|Other|5|||
44470664|NCT00469898|79478894|FG000|Overall Study|Adverse Event|7|||
44470665|NCT00469898|79478894|FG000|Overall Study|Withdrawal by Subject|4|||
44470666|NCT00469898|79478894|FG000|Overall Study|Death|4|||
44225361|NCT01997333|79030695|FG000|Randomization and Treatment|Did not receive treatment|17|||
44225362|NCT01997333|79030696|FG001|Randomization and Treatment|Did not receive treatment|5|||
44225363|NCT01997333|79030695|FG000|Survival Follow up|Withdrawal by Subject|15|||
44225364|NCT01997333|79030696|FG001|Survival Follow up|Withdrawal by Subject|6|||
44225365|NCT01997333|79030695|FG000|Survival Follow up|Lost to Follow-up|0|||
44225366|NCT01997333|79030696|FG001|Survival Follow up|Lost to Follow-up|6|||
44225367|NCT01997333|79030695|FG000|Survival Follow up|Various|1|||
44225368|NCT01997333|79030696|FG001|Survival Follow up|Various|2|||
44225369|NCT01982435|79030760|FG000|Overall Study|Adverse Event|1|||
44225370|NCT01982435|79030761|FG001|Overall Study|Adverse Event|0|||
44375374|NCT00944034|79380588|FG003|Overall Study|Inappropriate enrollment|1|||
44470667|NCT00469898|79478894|FG000|Overall Study|Disease progression|9|||
44470668|NCT00469898|79478894|FG000|Overall Study|Decreased performance status|1|||
44470669|NCT00529763|79478901|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
44470670|NCT00529763|79478902|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
44470671|NCT00529763|79478903|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
44470672|NCT00529763|79478901|FG000|Overall Study|Death|1|||
44470673|NCT00529763|79478902|FG001|Overall Study|Death|1|||
44375375|NCT00944034|79380589|FG004|Overall Study|Inappropriate enrollment|2|||
44470674|NCT00529763|79478903|FG002|Overall Study|Death|1|||
44470675|NCT00529763|79478901|FG000|Overall Study|Disease Progression|10|||
44470676|NCT00529763|79478902|FG001|Overall Study|Disease Progression|16|||
44470677|NCT00529763|79478903|FG002|Overall Study|Disease Progression|11|||
44470678|NCT00529763|79478901|FG000|Overall Study|Lost to Follow-up|1|||
44470679|NCT00529763|79478902|FG001|Overall Study|Lost to Follow-up|2|||
44470680|NCT00529763|79478903|FG002|Overall Study|Lost to Follow-up|3|||
44225371|NCT01620983|79030801|FG000|Overall Study|Lost to Follow-up|8|||
44225372|NCT01620983|79030802|FG001|Overall Study|Lost to Follow-up|4|||
44225373|NCT01620983|79030803|FG002|Overall Study|Lost to Follow-up|9|||
44225374|NCT01620983|79030801|FG000|Overall Study|Withdrawal by Subject|6|||
44225375|NCT01620983|79030802|FG001|Overall Study|Withdrawal by Subject|8|||
44225376|NCT01620983|79030803|FG002|Overall Study|Withdrawal by Subject|1|||
44470681|NCT00529763|79478901|FG000|Overall Study|Stem Cell Transplant|0|||
44470682|NCT00529763|79478902|FG001|Overall Study|Stem Cell Transplant|3|||
44470683|NCT00529763|79478903|FG002|Overall Study|Stem Cell Transplant|1|||
44470684|NCT00529763|79478901|FG000|Overall Study|Study Drug Toxicity|3|||
44470685|NCT00529763|79478902|FG001|Overall Study|Study Drug Toxicity|6|||
44470686|NCT00529763|79478903|FG002|Overall Study|Study Drug Toxicity|4|||
44470687|NCT00529763|79478901|FG000|Overall Study|Participant Withdrew Consent|2|||
44470688|NCT00529763|79478902|FG001|Overall Study|Participant Withdrew Consent|3|||
44470689|NCT00529763|79478903|FG002|Overall Study|Participant Withdrew Consent|4|||
44470690|NCT00529763|79478901|FG000|Overall Study|Other reasons|2|||
44470691|NCT00529763|79478902|FG001|Overall Study|Other reasons|0|||
44470692|NCT00529763|79478903|FG002|Overall Study|Other reasons|2|||
44470693|NCT00529763|79478901|FG000|Overall Study|Participant request to discontinue treatment|1|||
44470694|NCT00529763|79478902|FG001|Overall Study|Participant request to discontinue treatment|1|||
44470695|NCT00529763|79478903|FG002|Overall Study|Participant request to discontinue treatment|3|||
44470696|NCT00486902|79478918|FG000|Overall Study|Withdrawal by Subject|1|||
44225377|NCT01620983|79030801|FG000|Overall Study|Death|2|||
44225378|NCT01620983|79030802|FG001|Overall Study|Death|0|||
44225379|NCT01620983|79030803|FG002|Overall Study|Death|0|||
44225380|NCT01620983|79030801|FG000|Overall Study|Physician Decision|3|||
44225381|NCT01620983|79030802|FG001|Overall Study|Physician Decision|10|||
44225382|NCT01620983|79030803|FG002|Overall Study|Physician Decision|5|||
44225383|NCT01996709|79030813|FG000|Overall Study|Withdrawal by Subject|1|||
44225384|NCT01996709|79030814|FG001|Overall Study|Withdrawal by Subject|0|||
44225385|NCT01996709|79030813|FG000|Overall Study|Lost to Follow-up|3|||
44225386|NCT01996709|79030814|FG001|Overall Study|Lost to Follow-up|0|||
44225387|NCT01996709|79030813|FG000|Overall Study|Subject Non-Compliant|1|||
44225388|NCT01996709|79030814|FG001|Overall Study|Subject Non-Compliant|0|||
44225389|NCT01996709|79030813|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
44225390|NCT01996709|79030814|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
44225391|NCT01996319|79030839|FG000|Overall Study|Protocol Violation|1|||
44225392|NCT01996319|79030840|FG001|Overall Study|Protocol Violation|0|||
44225393|NCT01996319|79030839|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
44225394|NCT01996319|79030840|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
44225395|NCT01996319|79030839|FG000|Overall Study|Adverse Event|2|||
44225396|NCT01996319|79030840|FG001|Overall Study|Adverse Event|2|||
44225397|NCT01279486|79030846|FG000|Overall Study|Lost to Follow-up|1|||
44225398|NCT01279954|79030852|FG000|Overall Study|Lack of Efficacy|3|||
44225399|NCT01279954|79030853|FG001|Overall Study|Lack of Efficacy|4|||
44225400|NCT01278862|79030864|FG000|Overall Study|Lost to Follow-up|1|||
44225401|NCT01278862|79030865|FG001|Overall Study|Lost to Follow-up|1|||
44225402|NCT01278394|79030880|FG000|Overall Study|Lost to Follow-up|1|||
44225403|NCT01981187|79030884|FG000|Overall Study|Participant/guardian decision|2|||
44225404|NCT01981187|79030884|FG000|Overall Study|Physician Decision|1|||
44225405|NCT01981187|79030884|FG000|Overall Study|Disease progression|2|||
44225406|NCT01981187|79030884|FG000|Overall Study|Adverse Event|7|||
44225407|NCT01278160|79030890|FG000|Overall Study|Adverse Event|1|||
44225408|NCT01278160|79030891|FG001|Overall Study|Adverse Event|1|||
44225409|NCT01278160|79030890|FG000|Overall Study|Lost to Follow-up|0|||
44225410|NCT01278160|79030891|FG001|Overall Study|Lost to Follow-up|1|||
44225411|NCT01278160|79030890|FG000|Overall Study|Withdrawal by Subject|3|||
44225412|NCT01278160|79030891|FG001|Overall Study|Withdrawal by Subject|2|||
44225413|NCT01278160|79030890|FG000|Overall Study|Unclassified|1|||
44225414|NCT01278160|79030891|FG001|Overall Study|Unclassified|2|||
44225415|NCT01996241|79030899|FG000|Overall Study|Lost to Follow-up|252|||
44225416|NCT01996241|79030900|FG001|Overall Study|Lost to Follow-up|235|||
44470697|NCT00486902|79478919|FG001|Overall Study|Withdrawal by Subject|2|||
44225417|NCT02091869|79030910|FG000|Overall Study|Withdrawal by Subject|0|||
44225418|NCT02091869|79030911|FG001|Overall Study|Withdrawal by Subject|3|||
44225419|NCT01981109|79030926|FG000|Overall Study|Death|36|||
44225420|NCT01981109|79030926|FG000|Overall Study|Withdrawal by Subject|40|||
44470698|NCT00486902|79478918|FG000|Overall Study|decision for postpartum tubal ligation|3|||
44470699|NCT00486902|79478919|FG001|Overall Study|decision for postpartum tubal ligation|1|||
44470700|NCT00486902|79478918|FG000|Overall Study|spinal anesthetic protocal violation|1|||
44225421|NCT01981109|79030926|FG000|Overall Study|Lost to Follow-up|9|||
44225422|NCT01981109|79030926|FG000|Overall Study|No Discontinuation Documentation|37|||
44225423|NCT01981109|79030926|FG000|Overall Study|Study Termination|100|||
44225424|NCT01981109|79030926|FG000|Overall Study|No data available|2|||
44225425|NCT00248794|79030934|FG000|Overall Study|Lost to Follow-up|6|||
44225426|NCT00248794|79030935|FG001|Overall Study|Lost to Follow-up|8|||
44225427|NCT00248794|79030936|FG002|Overall Study|Lost to Follow-up|3|||
44470701|NCT00486902|79478919|FG001|Overall Study|spinal anesthetic protocal violation|1|||
44470702|NCT00486902|79478918|FG000|Overall Study|Did not meet inclusion criteria|1|||
44470703|NCT00486902|79478919|FG001|Overall Study|Did not meet inclusion criteria|0|||
44225428|NCT01995539|79030950|FG000|Overall Study|Screening Failure|1|||
44225429|NCT01995539|79030950|FG000|Overall Study|Withdrawal by Investigator|15|||
44225430|NCT01995539|79030950|FG000|Overall Study|Withdrawal by Subject|11|||
44225431|NCT01995539|79030950|FG000|Overall Study|Lost to Follow-up|5|||
44470704|NCT00486902|79478918|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
44470705|NCT00486902|79478919|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
44470706|NCT03687827|79478925|FG000|Treatment Period 1|Death|0|||
44470707|NCT03687827|79478926|FG001|Treatment Period 1|Death|1|||
44470708|NCT03687827|79478925|FG000|Treatment Period 1|Lost to Follow-up|2|||
44470709|NCT03687827|79478926|FG001|Treatment Period 1|Lost to Follow-up|2|||
44470710|NCT03687827|79478925|FG000|Treatment Period 1|Physician Decision|5|||
44470711|NCT03687827|79478926|FG001|Treatment Period 1|Physician Decision|2|||
44470712|NCT03687827|79478925|FG000|Treatment Period 1|Withdrawal by Subject|7|||
44470713|NCT03687827|79478926|FG001|Treatment Period 1|Withdrawal by Subject|3|||
44470714|NCT03687827|79478925|FG000|Treatment Period 2|Physician Decision|4|||
44470715|NCT03687827|79478926|FG001|Treatment Period 2|Physician Decision|1|||
44470716|NCT03687827|79478925|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44470717|NCT03687827|79478926|FG001|Treatment Period 2|Withdrawal by Subject|2|||
44470718|NCT00529529|79478935|FG000|Overall Study|Adverse Event|12|||
44470719|NCT00529529|79478936|FG001|Overall Study|Adverse Event|17|||
44470720|NCT00529529|79478937|FG002|Overall Study|Adverse Event|8|||
44470721|NCT00529529|79478935|FG000|Overall Study|Subject withdrew consent|12|||
44470722|NCT00529529|79478936|FG001|Overall Study|Subject withdrew consent|9|||
44225432|NCT01995539|79030950|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
44225433|NCT01835587|79030958|FG000|Overall Study|Disease Recurrence or Relapse|0|||
44225434|NCT01835587|79030959|FG001|Overall Study|Disease Recurrence or Relapse|3|||
44225435|NCT01835587|79030960|FG002|Overall Study|Disease Recurrence or Relapse|0|||
44225436|NCT01835587|79030961|FG003|Overall Study|Disease Recurrence or Relapse|3|||
44225437|NCT01835587|79030958|FG000|Overall Study|Withdrawal by Subject|2|||
44225438|NCT01835587|79030959|FG001|Overall Study|Withdrawal by Subject|0|||
44225439|NCT01835587|79030960|FG002|Overall Study|Withdrawal by Subject|0|||
44225440|NCT01835587|79030961|FG003|Overall Study|Withdrawal by Subject|3|||
44225441|NCT01835587|79030958|FG000|Overall Study|Adverse Event|0|||
44225442|NCT01835587|79030959|FG001|Overall Study|Adverse Event|0|||
44225443|NCT01835587|79030960|FG002|Overall Study|Adverse Event|2|||
44225444|NCT01835587|79030961|FG003|Overall Study|Adverse Event|2|||
44225445|NCT01835587|79030958|FG000|Overall Study|Death|0|||
44225446|NCT01835587|79030959|FG001|Overall Study|Death|0|||
44225447|NCT01835587|79030960|FG002|Overall Study|Death|0|||
44225448|NCT01835587|79030961|FG003|Overall Study|Death|1|||
44225449|NCT01835587|79030958|FG000|Overall Study|Miscellaneous|0|||
44225450|NCT01835587|79030959|FG001|Overall Study|Miscellaneous|1|||
44225451|NCT01835587|79030960|FG002|Overall Study|Miscellaneous|0|||
44225452|NCT01835587|79030961|FG003|Overall Study|Miscellaneous|0|||
44225453|NCT01736917|79030978|FG000|Overall Study|Adverse Event|1|||
44225454|NCT01736917|79030978|FG000|Overall Study|Protocol Violation|10|||
44225455|NCT01277302|79030987|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
44225456|NCT01277302|79030988|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
44225457|NCT01277302|79030989|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
44225458|NCT01277302|79030987|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
44225459|NCT01277302|79030988|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
44225460|NCT01277302|79030989|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
44225461|NCT01277302|79030987|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
44225462|NCT01277302|79030988|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
44225463|NCT01277302|79030989|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
44225464|NCT01277302|79030987|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
44225465|NCT01277302|79030988|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
44225466|NCT01277302|79030989|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
44225467|NCT01277302|79030987|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
44470723|NCT00529529|79478937|FG002|Overall Study|Subject withdrew consent|12|||
44470724|NCT00529529|79478935|FG000|Overall Study|Protocol deviation|8|||
44225468|NCT01277302|79030988|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
44470725|NCT00529529|79478936|FG001|Overall Study|Protocol deviation|12|||
44470726|NCT00529529|79478937|FG002|Overall Study|Protocol deviation|5|||
44225469|NCT01277302|79030989|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
44225470|NCT01277302|79030987|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
44225471|NCT01277302|79030988|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
44225472|NCT01277302|79030989|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
44375376|NCT00944034|79380590|FG005|Overall Study|Inappropriate enrollment|1|||
44470727|NCT00529529|79478935|FG000|Overall Study|Lost to Follow-up|5|||
44470728|NCT00529529|79478936|FG001|Overall Study|Lost to Follow-up|3|||
44470729|NCT00529529|79478937|FG002|Overall Study|Lost to Follow-up|1|||
44470730|NCT00529529|79478935|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44470731|NCT00529529|79478936|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44470732|NCT00529529|79478937|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44470733|NCT00529529|79478935|FG000|Overall Study|Death|2|||
44470734|NCT00529529|79478936|FG001|Overall Study|Death|0|||
44470735|NCT00529529|79478937|FG002|Overall Study|Death|0|||
44470736|NCT00529529|79478935|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44470737|NCT00529529|79478936|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44470738|NCT00529529|79478937|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44470739|NCT00529529|79478935|FG000|Overall Study|Administrative problems|1|||
44470740|NCT00529529|79478936|FG001|Overall Study|Administrative problems|0|||
44470741|NCT00529529|79478937|FG002|Overall Study|Administrative problems|3|||
44470742|NCT05655377|79478945|FG000|Overall Study|Withdrawal by Subject|2|||
44470743|NCT00486434|79478951|FG000|Overall Study|Withdrawal by Subject|34|||
44470744|NCT00486434|79478952|FG001|Overall Study|Withdrawal by Subject|39|||
44470745|NCT00486434|79478951|FG000|Overall Study|Adverse Event|118|||
44470746|NCT00486434|79478952|FG001|Overall Study|Adverse Event|44|||
44470747|NCT00486434|79478951|FG000|Overall Study|Protocol Violation|22|||
44470748|NCT00486434|79478952|FG001|Overall Study|Protocol Violation|21|||
44470749|NCT00486434|79478951|FG000|Overall Study|Lack of Efficacy|12|||
44470750|NCT00486434|79478952|FG001|Overall Study|Lack of Efficacy|19|||
44470751|NCT00486434|79478951|FG000|Overall Study|Lost to Follow-up|2|||
44470752|NCT00486434|79478952|FG001|Overall Study|Lost to Follow-up|3|||
44470753|NCT00486434|79478951|FG000|Overall Study|Death|1|||
44470754|NCT00486434|79478952|FG001|Overall Study|Death|2|||
44470755|NCT00486434|79478951|FG000|Overall Study|Personal reasons|5|||
44470756|NCT00486434|79478952|FG001|Overall Study|Personal reasons|6|||
44470757|NCT00424632|79478961|FG000|Overall Study|Death|0|||
44470758|NCT00424632|79478962|FG001|Overall Study|Death|0|||
44470759|NCT00424632|79478963|FG002|Overall Study|Death|0|||
44470760|NCT00424632|79478964|FG003|Overall Study|Death|0|||
44470761|NCT00424632|79478965|FG004|Overall Study|Death|0|||
44470762|NCT00424632|79478966|FG005|Overall Study|Death|2|||
44470763|NCT00424632|79478967|FG006|Overall Study|Death|0|||
44470764|NCT00424632|79478968|FG007|Overall Study|Death|0|||
44470765|NCT00424632|79478969|FG008|Overall Study|Death|0|||
44470766|NCT00424632|79478970|FG009|Overall Study|Death|0|||
44470767|NCT00424632|79478961|FG000|Overall Study|Adverse Event|0|||
44470768|NCT00424632|79478962|FG001|Overall Study|Adverse Event|0|||
44470769|NCT00424632|79478963|FG002|Overall Study|Adverse Event|0|||
44470770|NCT00424632|79478964|FG003|Overall Study|Adverse Event|0|||
44470771|NCT00424632|79478965|FG004|Overall Study|Adverse Event|0|||
44470772|NCT00424632|79478966|FG005|Overall Study|Adverse Event|0|||
44470773|NCT00424632|79478967|FG006|Overall Study|Adverse Event|0|||
44470774|NCT00424632|79478968|FG007|Overall Study|Adverse Event|0|||
44470775|NCT00424632|79478969|FG008|Overall Study|Adverse Event|3|||
44470776|NCT00424632|79478970|FG009|Overall Study|Adverse Event|2|||
44470777|NCT00424632|79478961|FG000|Overall Study|Global deterioration of health status|0|||
44470778|NCT00424632|79478962|FG001|Overall Study|Global deterioration of health status|0|||
44470779|NCT00424632|79478963|FG002|Overall Study|Global deterioration of health status|0|||
44470780|NCT00424632|79478964|FG003|Overall Study|Global deterioration of health status|1|||
44470781|NCT00424632|79478965|FG004|Overall Study|Global deterioration of health status|1|||
44470782|NCT00424632|79478966|FG005|Overall Study|Global deterioration of health status|0|||
44470783|NCT00424632|79478967|FG006|Overall Study|Global deterioration of health status|0|||
44470784|NCT00424632|79478968|FG007|Overall Study|Global deterioration of health status|0|||
44470785|NCT00424632|79478969|FG008|Overall Study|Global deterioration of health status|0|||
44470786|NCT00424632|79478970|FG009|Overall Study|Global deterioration of health status|0|||
44470787|NCT00424632|79478961|FG000|Overall Study|Objective progression or relapse|1|||
44273921|NCT00002525|79215457|FG001|Overall Study|Never start protocol therapy|0|||
44470788|NCT00424632|79478962|FG001|Overall Study|Objective progression or relapse|1|||
44470789|NCT00424632|79478963|FG002|Overall Study|Objective progression or relapse|1|||
44470790|NCT00424632|79478964|FG003|Overall Study|Objective progression or relapse|2|||
44470791|NCT00424632|79478965|FG004|Overall Study|Objective progression or relapse|2|||
44470792|NCT00424632|79478966|FG005|Overall Study|Objective progression or relapse|13|||
44470793|NCT00424632|79478967|FG006|Overall Study|Objective progression or relapse|7|||
44470794|NCT00424632|79478968|FG007|Overall Study|Objective progression or relapse|3|||
44470795|NCT00424632|79478969|FG008|Overall Study|Objective progression or relapse|12|||
44470796|NCT00424632|79478970|FG009|Overall Study|Objective progression or relapse|4|||
44470797|NCT00424632|79478961|FG000|Overall Study|Other|0|||
44470798|NCT00424632|79478962|FG001|Overall Study|Other|0|||
44470799|NCT00424632|79478963|FG002|Overall Study|Other|0|||
44470800|NCT00424632|79478964|FG003|Overall Study|Other|1|||
44470801|NCT00424632|79478965|FG004|Overall Study|Other|0|||
44470802|NCT00424632|79478966|FG005|Overall Study|Other|0|||
44470803|NCT00424632|79478967|FG006|Overall Study|Other|0|||
44470804|NCT00424632|79478968|FG007|Overall Study|Other|0|||
44470805|NCT00424632|79478969|FG008|Overall Study|Other|1|||
44470806|NCT00424632|79478970|FG009|Overall Study|Other|0|||
44470807|NCT00529451|79479005|FG000|Overall Study|Subject withdrew consent|16|||
44470808|NCT00529451|79479006|FG001|Overall Study|Subject withdrew consent|21|||
44470809|NCT00529451|79479007|FG002|Overall Study|Subject withdrew consent|13|||
44470810|NCT00529451|79479008|FG003|Overall Study|Subject withdrew consent|12|||
44470811|NCT00529451|79479005|FG000|Overall Study|Adverse Event|9|||
44470812|NCT00529451|79479006|FG001|Overall Study|Adverse Event|16|||
44470813|NCT00529451|79479007|FG002|Overall Study|Adverse Event|14|||
44470814|NCT00529451|79479008|FG003|Overall Study|Adverse Event|8|||
44470815|NCT00529451|79479005|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
44470816|NCT00529451|79479006|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
44470817|NCT00529451|79479007|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
44470818|NCT00529451|79479008|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
44470819|NCT00529451|79479005|FG000|Overall Study|Lost to Follow-up|4|||
44470820|NCT00529451|79479006|FG001|Overall Study|Lost to Follow-up|7|||
44470821|NCT00529451|79479007|FG002|Overall Study|Lost to Follow-up|4|||
44470822|NCT00529451|79479008|FG003|Overall Study|Lost to Follow-up|4|||
44470823|NCT00529451|79479005|FG000|Overall Study|Protocol deviation|1|||
44470824|NCT00529451|79479006|FG001|Overall Study|Protocol deviation|1|||
44470825|NCT00529451|79479007|FG002|Overall Study|Protocol deviation|4|||
44470826|NCT00529451|79479008|FG003|Overall Study|Protocol deviation|1|||
44470827|NCT00529451|79479005|FG000|Overall Study|Administrative problems|1|||
44470828|NCT00529451|79479006|FG001|Overall Study|Administrative problems|1|||
44470829|NCT00529451|79479007|FG002|Overall Study|Administrative problems|0|||
44470830|NCT00529451|79479008|FG003|Overall Study|Administrative problems|2|||
44470831|NCT03876743|79479025|FG000|Overall Study|Lost to Follow-up|6|||
44470832|NCT03876743|79479026|FG001|Overall Study|Lost to Follow-up|4|||
44470833|NCT03876743|79479027|FG002|Overall Study|Lost to Follow-up|4|||
44470834|NCT03876743|79479028|FG003|Overall Study|Lost to Follow-up|7|||
44470835|NCT00486278|79479042|FG000|Overall Study|Adverse Event|5|||
44470836|NCT00486278|79479042|FG000|Overall Study|Withdrawal by Subject|2|||
44470837|NCT00486278|79479042|FG000|Overall Study|Physician Decision|2|||
44470838|NCT00321711|79479061|FG000|Part A|Adverse Event|3|||
44470839|NCT00321711|79479062|FG001|Part A|Adverse Event|3|||
44470840|NCT00321711|79479063|FG002|Part A|Adverse Event|2|||
44470841|NCT00321711|79479064|FG003|Part A|Adverse Event|0|||
44470842|NCT00321711|79479065|FG004|Part A|Adverse Event|0|||
44470843|NCT00321711|79479061|FG000|Part A|Withdrawal by Subject|1|||
44470844|NCT00321711|79479062|FG001|Part A|Withdrawal by Subject|1|||
44470845|NCT00321711|79479063|FG002|Part A|Withdrawal by Subject|1|||
44470846|NCT00321711|79479064|FG003|Part A|Withdrawal by Subject|0|||
44470847|NCT00321711|79479065|FG004|Part A|Withdrawal by Subject|0|||
44470848|NCT00321711|79479061|FG000|Part A|Disease progression|0|||
44470849|NCT00321711|79479062|FG001|Part A|Disease progression|1|||
44470850|NCT00321711|79479063|FG002|Part A|Disease progression|0|||
44470851|NCT00321711|79479064|FG003|Part A|Disease progression|0|||
44470852|NCT00321711|79479065|FG004|Part A|Disease progression|0|||
44470853|NCT00321711|79479061|FG000|Part A|Requirement for alternative therapy|0|||
44470854|NCT00321711|79479062|FG001|Part A|Requirement for alternative therapy|2|||
44470855|NCT00321711|79479063|FG002|Part A|Requirement for alternative therapy|1|||
44470856|NCT00321711|79479064|FG003|Part A|Requirement for alternative therapy|0|||
44470857|NCT00321711|79479065|FG004|Part A|Requirement for alternative therapy|0|||
44470858|NCT00321711|79479061|FG000|Part A|Physician Decision|0|||
44470859|NCT00321711|79479062|FG001|Part A|Physician Decision|1|||
44470860|NCT00321711|79479063|FG002|Part A|Physician Decision|3|||
44470861|NCT00321711|79479064|FG003|Part A|Physician Decision|0|||
44470862|NCT00321711|79479065|FG004|Part A|Physician Decision|0|||
44470863|NCT00321711|79479061|FG000|Part A|Other|1|||
44470864|NCT00321711|79479062|FG001|Part A|Other|2|||
44470865|NCT00321711|79479063|FG002|Part A|Other|3|||
44470866|NCT00321711|79479064|FG003|Part A|Other|0|||
44470867|NCT00321711|79479065|FG004|Part A|Other|0|||
44470868|NCT00321711|79479061|FG000|Part A|Protocol deviation|0|||
44470869|NCT00321711|79479062|FG001|Part A|Protocol deviation|0|||
44470870|NCT00321711|79479063|FG002|Part A|Protocol deviation|1|||
44470871|NCT00321711|79479064|FG003|Part A|Protocol deviation|0|||
44225473|NCT01277302|79030987|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
44470872|NCT00321711|79479065|FG004|Part A|Protocol deviation|0|||
44470873|NCT00321711|79479061|FG000|Part B|Noncompliance|0|||
44470874|NCT00321711|79479062|FG001|Part B|Noncompliance|0|||
44470875|NCT00321711|79479063|FG002|Part B|Noncompliance|0|||
44470876|NCT00321711|79479064|FG003|Part B|Noncompliance|0|||
44470877|NCT00321711|79479065|FG004|Part B|Noncompliance|1|||
44470878|NCT00321711|79479061|FG000|Part B|Adverse Event|0|||
44470879|NCT00321711|79479062|FG001|Part B|Adverse Event|0|||
44470880|NCT00321711|79479063|FG002|Part B|Adverse Event|0|||
44470881|NCT00321711|79479064|FG003|Part B|Adverse Event|2|||
44470882|NCT00321711|79479065|FG004|Part B|Adverse Event|1|||
44470883|NCT00321711|79479061|FG000|Part B|Disease progression|0|||
44470884|NCT00321711|79479062|FG001|Part B|Disease progression|0|||
44470885|NCT00321711|79479063|FG002|Part B|Disease progression|0|||
44470886|NCT00321711|79479064|FG003|Part B|Disease progression|1|||
44470887|NCT00321711|79479065|FG004|Part B|Disease progression|0|||
44470888|NCT00321711|79479061|FG000|Part B|Physician Decision|0|||
44470889|NCT00321711|79479062|FG001|Part B|Physician Decision|0|||
44470890|NCT00321711|79479063|FG002|Part B|Physician Decision|0|||
44470891|NCT00321711|79479064|FG003|Part B|Physician Decision|1|||
44470892|NCT00321711|79479065|FG004|Part B|Physician Decision|2|||
44470893|NCT00321711|79479061|FG000|Part B|Death|0|||
44470894|NCT00321711|79479062|FG001|Part B|Death|0|||
44470895|NCT00321711|79479063|FG002|Part B|Death|0|||
44470896|NCT00321711|79479064|FG003|Part B|Death|2|||
44470897|NCT00321711|79479065|FG004|Part B|Death|1|||
44470898|NCT00486044|79479079|FG000|Overall Study|Withdrawal by Subject|2|||
44470899|NCT00486044|79479080|FG001|Overall Study|Withdrawal by Subject|1|||
44470900|NCT00486044|79479079|FG000|Overall Study|Adverse Event|0|||
44470901|NCT00486044|79479080|FG001|Overall Study|Adverse Event|1|||
44470902|NCT00486044|79479079|FG000|Overall Study|Lost to Follow-up|0|||
44470903|NCT00486044|79479080|FG001|Overall Study|Lost to Follow-up|1|||
44470904|NCT00351273|79479089|FG000|Overall Study|Lost to Follow-up|1|||
44470905|NCT00351273|79479090|FG001|Overall Study|Lost to Follow-up|2|||
44470906|NCT00351273|79479091|FG002|Overall Study|Lost to Follow-up|5|||
44470907|NCT00327717|79479106|FG000|Overall Study|Adverse Event|6|||
44470908|NCT00327717|79479107|FG001|Overall Study|Adverse Event|6|||
44470909|NCT00327717|79479106|FG000|Overall Study|Lack of Efficacy|0|||
44470910|NCT00327717|79479107|FG001|Overall Study|Lack of Efficacy|1|||
44470911|NCT00327717|79479106|FG000|Overall Study|Withdrawal by Subject|3|||
44470912|NCT00327717|79479107|FG001|Overall Study|Withdrawal by Subject|7|||
44470913|NCT00463346|79479115|FG000|Overall Study|Withdrawal by Subject|3|||
44470914|NCT00463346|79479116|FG001|Overall Study|Withdrawal by Subject|3|||
44470915|NCT00462488|79479126|FG000|Overall Study|Protocol Violation|1|||
44470916|NCT00462488|79479127|FG001|Overall Study|Protocol Violation|0|||
44470917|NCT00462488|79479126|FG000|Overall Study|Lack of Efficacy|19|||
44470918|NCT00462488|79479127|FG001|Overall Study|Lack of Efficacy|17|||
44470919|NCT00454142|79479133|FG000|Overall Study|Withdrawal by Subject|1|||
44470920|NCT00424476|79479142|FG000|Overall Study|Withdrawal by Subject|7|||
44470921|NCT00424476|79479143|FG001|Overall Study|Withdrawal by Subject|6|||
44470922|NCT00424476|79479144|FG002|Overall Study|Withdrawal by Subject|3|||
44470923|NCT00424476|79479142|FG000|Overall Study|Adverse Event|19|||
44470924|NCT00424476|79479143|FG001|Overall Study|Adverse Event|16|||
44470925|NCT00424476|79479144|FG002|Overall Study|Adverse Event|15|||
44470926|NCT00424476|79479142|FG000|Overall Study|Lack of Efficacy|16|||
44470927|NCT00424476|79479143|FG001|Overall Study|Lack of Efficacy|12|||
44470928|NCT00424476|79479144|FG002|Overall Study|Lack of Efficacy|12|||
44470929|NCT00424476|79479142|FG000|Overall Study|Lack of Compliance|1|||
44470930|NCT00424476|79479143|FG001|Overall Study|Lack of Compliance|1|||
44470931|NCT00424476|79479144|FG002|Overall Study|Lack of Compliance|1|||
44470932|NCT00424476|79479142|FG000|Overall Study|Lost to Follow-up|4|||
44470933|NCT00424476|79479143|FG001|Overall Study|Lost to Follow-up|6|||
44470934|NCT00424476|79479144|FG002|Overall Study|Lost to Follow-up|3|||
44470935|NCT00424476|79479142|FG000|Overall Study|Protocol Violation|7|||
44470936|NCT00424476|79479143|FG001|Overall Study|Protocol Violation|2|||
44470937|NCT00424476|79479144|FG002|Overall Study|Protocol Violation|3|||
44470938|NCT00424476|79479142|FG000|Overall Study|Physician Decision|3|||
44470939|NCT00424476|79479143|FG001|Overall Study|Physician Decision|2|||
44470940|NCT00424476|79479144|FG002|Overall Study|Physician Decision|3|||
44470941|NCT00424476|79479142|FG000|Overall Study|Other|4|||
44470942|NCT00424476|79479143|FG001|Overall Study|Other|3|||
44470943|NCT00424476|79479144|FG002|Overall Study|Other|9|||
44470944|NCT00453986|79479157|FG000|Overall Study|Lost to Follow-up|6|||
44470945|NCT00453986|79479158|FG001|Overall Study|Lost to Follow-up|5|||
44470946|NCT00453986|79479159|FG002|Overall Study|Lost to Follow-up|6|||
44470947|NCT00453986|79479160|FG003|Overall Study|Lost to Follow-up|2|||
44470948|NCT00453986|79479161|FG004|Overall Study|Lost to Follow-up|0|||
44470949|NCT00435942|79479179|FG000|Overall Study|Death|17|||
44470950|NCT00435942|79479180|FG001|Overall Study|Death|10|||
44470951|NCT00435942|79479179|FG000|Overall Study|Withdrawal by Subject|2|||
44470952|NCT00435942|79479180|FG001|Overall Study|Withdrawal by Subject|0|||
44470953|NCT00435942|79479179|FG000|Overall Study|Lost to Follow-up|0|||
44470954|NCT00435942|79479180|FG001|Overall Study|Lost to Follow-up|16|||
44470955|NCT00435942|79479179|FG000|Overall Study|Conversion to Open Repair|1|||
44470956|NCT00435942|79479180|FG001|Overall Study|Conversion to Open Repair|0|||
44470957|NCT00435942|79479179|FG000|Overall Study|Technical Failure|3|||
44470958|NCT00435942|79479180|FG001|Overall Study|Technical Failure|0|||
44225474|NCT01277302|79030988|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
44225475|NCT01277302|79030989|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
44225476|NCT01277302|79030987|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
44225477|NCT01277302|79030988|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
44225478|NCT01277302|79030989|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
44225479|NCT01277302|79030987|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
44225480|NCT01277302|79030988|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
44225481|NCT01277302|79030989|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
44470959|NCT00435942|79479179|FG000|Overall Study|Other|0|||
44225482|NCT01980875|79031000|FG000|Overall Study|Withdrew Consent|1|||
44225483|NCT01980875|79031001|FG001|Overall Study|Withdrew Consent|1|||
44225484|NCT01980875|79031002|FG002|Overall Study|Withdrew Consent|1|||
44225485|NCT01980875|79031000|FG000|Overall Study|Study Terminated by Sponsor|7|||
44225486|NCT01980875|79031001|FG001|Overall Study|Study Terminated by Sponsor|24|||
44225487|NCT01980875|79031002|FG002|Overall Study|Study Terminated by Sponsor|22|||
44225488|NCT01980875|79031000|FG000|Overall Study|Lost to Follow-up|0|||
44225489|NCT01980875|79031001|FG001|Overall Study|Lost to Follow-up|0|||
44225490|NCT01980875|79031002|FG002|Overall Study|Lost to Follow-up|1|||
44225491|NCT01995461|79031010|FG000|Overall Study|Death|1|||
44225492|NCT01995461|79031010|FG000|Overall Study|Lost to Follow-up|2|||
44225493|NCT01995461|79031010|FG000|Overall Study|Withdrawal by Subject|2|||
44225494|NCT01980095|79031016|FG000|Overall Study|Lost to Follow-up|6|||
44470960|NCT00435942|79479180|FG001|Overall Study|Other|1|||
44470961|NCT00453362|79479186|FG000|Overall Study|Adverse Event|5|||
44470962|NCT00453362|79479186|FG000|Overall Study|Death|7|||
44470963|NCT00453362|79479186|FG000|Overall Study|Physician Decision|2|||
44470964|NCT00453362|79479186|FG000|Overall Study|Withdrawal by Subject|3|||
44470965|NCT00453362|79479186|FG000|Overall Study|Progression of disease|56|||
44470966|NCT00453362|79479186|FG000|Overall Study|Screening Failure|14|||
44470967|NCT00424398|79479205|FG000|Overall Study|Withdrawal by Subject|2|||
44470968|NCT00424398|79479206|FG001|Overall Study|Withdrawal by Subject|1|||
44470969|NCT00424398|79479207|FG002|Overall Study|Withdrawal by Subject|0|||
44470970|NCT00424398|79479205|FG000|Overall Study|Subject met exclusion criteria|1|||
44470971|NCT00424398|79479206|FG001|Overall Study|Subject met exclusion criteria|0|||
44470972|NCT00424398|79479207|FG002|Overall Study|Subject met exclusion criteria|0|||
44470973|NCT00461786|79479215|FG000|Overall Study|Entry Criteria Not Met|2|||
44470974|NCT00461786|79479215|FG000|Overall Study|Inevaluable (Never Treated)|1|||
44273922|NCT02259348|79215465|FG000|Overall Study|Donors|6|||
44273923|NCT02259348|79215465|FG000|Overall Study|Death|4|||
44273924|NCT02259114|79215722|FG000|Overall Study|Progressive Disease|14|||
44273925|NCT02259114|79215723|FG001|Overall Study|Progressive Disease|2|||
44470975|NCT00435162|79479222|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
44470976|NCT00435162|79479223|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
44470977|NCT00435162|79479224|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
44470978|NCT00435162|79479225|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
44470979|NCT00435162|79479226|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
44470980|NCT00435162|79479227|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
44470981|NCT03836664|79479242|FG000|Overall Study|Didn't complete forms and lost drug|3|||
44470982|NCT03836664|79479243|FG001|Overall Study|Didn't complete forms and lost drug|3|||
44470983|NCT00350727|79479256|FG000|Phase I: Dose Escalation|Adverse Event|4|||
44470984|NCT00350727|79479257|FG001|Phase I: Dose Escalation|Adverse Event|0|||
44470985|NCT00350727|79479258|FG002|Phase I: Dose Escalation|Adverse Event|0|||
44470986|NCT00350727|79479256|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
44470987|NCT00350727|79479257|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
44470988|NCT00350727|79479258|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
44470989|NCT00350727|79479256|FG000|Phase I: Dose Escalation|Death|1|||
44470990|NCT00350727|79479257|FG001|Phase I: Dose Escalation|Death|0|||
44470991|NCT00350727|79479258|FG002|Phase I: Dose Escalation|Death|0|||
44470992|NCT00350727|79479256|FG000|Phase I: Dose Escalation|Physician Decision|1|||
44470993|NCT00350727|79479257|FG001|Phase I: Dose Escalation|Physician Decision|0|||
44470994|NCT00350727|79479258|FG002|Phase I: Dose Escalation|Physician Decision|0|||
44470995|NCT00350727|79479256|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
44225495|NCT01980095|79031017|FG001|Overall Study|Lost to Follow-up|7|||
44470996|NCT00350727|79479257|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
44470997|NCT00350727|79479258|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
44470998|NCT00350727|79479256|FG000|Phase II|Disease Progression|0|||
44470999|NCT00350727|79479257|FG001|Phase II|Disease Progression|15|||
44471000|NCT00350727|79479258|FG002|Phase II|Disease Progression|16|||
44471001|NCT00350727|79479256|FG000|Phase II|Clinical Deterioration|0|||
44471002|NCT00350727|79479257|FG001|Phase II|Clinical Deterioration|1|||
44225496|NCT01980095|79031016|FG000|Overall Study|Withdrawal by Subject|2|||
44225497|NCT01980095|79031017|FG001|Overall Study|Withdrawal by Subject|3|||
44225498|NCT01980095|79031016|FG000|Overall Study|Poor compliance|5|||
44225499|NCT01980095|79031017|FG001|Overall Study|Poor compliance|0|||
44471003|NCT00350727|79479258|FG002|Phase II|Clinical Deterioration|0|||
44273926|NCT02259114|79215724|FG002|Overall Study|Progressive Disease|10|||
44471004|NCT00350727|79479256|FG000|Phase II|Withdrawal by Subject|0|||
44471005|NCT00350727|79479257|FG001|Phase II|Withdrawal by Subject|2|||
44471006|NCT00350727|79479258|FG002|Phase II|Withdrawal by Subject|1|||
44471007|NCT00350727|79479256|FG000|Phase II|Adverse Event|0|||
44471008|NCT00350727|79479257|FG001|Phase II|Adverse Event|1|||
44471009|NCT00350727|79479258|FG002|Phase II|Adverse Event|1|||
44471010|NCT00350727|79479256|FG000|Phase II|Death|0|||
44471011|NCT00350727|79479257|FG001|Phase II|Death|0|||
44471012|NCT00350727|79479258|FG002|Phase II|Death|2|||
44471013|NCT00350727|79479256|FG000|Phase II|Sponsor Terminated Study|0|||
44471014|NCT00350727|79479257|FG001|Phase II|Sponsor Terminated Study|0|||
44471015|NCT00350727|79479258|FG002|Phase II|Sponsor Terminated Study|1|||
44471016|NCT00350727|79479256|FG000|Phase II|Enrolled in Rollover Study|0|||
44471017|NCT00350727|79479257|FG001|Phase II|Enrolled in Rollover Study|0|||
44471018|NCT00350727|79479258|FG002|Phase II|Enrolled in Rollover Study|1|||
44471019|NCT00434304|79479277|FG000|Overall Study|Adverse Event|14|||
44471020|NCT00434304|79479277|FG000|Overall Study|Lack of Efficacy|2|||
44471021|NCT00434304|79479277|FG000|Overall Study|Withdrawal by Subject|4|||
44471022|NCT00424008|79479284|FG000|Overall Study|Adverse Event|8|||
44471023|NCT00424008|79479285|FG001|Overall Study|Adverse Event|6|||
44471024|NCT00424008|79479284|FG000|Overall Study|Lack of Efficacy|40|||
44471025|NCT00424008|79479285|FG001|Overall Study|Lack of Efficacy|34|||
44471026|NCT00424008|79479284|FG000|Overall Study|Lost to Follow-up|1|||
44471027|NCT00424008|79479285|FG001|Overall Study|Lost to Follow-up|2|||
44471028|NCT00424008|79479284|FG000|Overall Study|Withdrawal by Subject|5|||
44471029|NCT00424008|79479285|FG001|Overall Study|Withdrawal by Subject|8|||
44471030|NCT00424008|79479284|FG000|Overall Study|Noncompliance with protocol|13|||
44471031|NCT00424008|79479285|FG001|Overall Study|Noncompliance with protocol|7|||
44471032|NCT00424008|79479284|FG000|Overall Study|Did not meet protocol eligibility|16|||
44471033|NCT00424008|79479285|FG001|Overall Study|Did not meet protocol eligibility|21|||
44471034|NCT00424008|79479284|FG000|Overall Study|Administrative|266|||
44471035|NCT00424008|79479285|FG001|Overall Study|Administrative|257|||
44471036|NCT00423930|79479292|FG000|Overall Study|Withdrawal by Subject|2|||
44471037|NCT00423852|79479296|FG000|Overall Study|Removed pior to the high-dose portion|3|||
44471038|NCT00461708|79479302|FG000|Overall Study|Adverse Event|17|||
44471039|NCT00461708|79479303|FG001|Overall Study|Adverse Event|7|||
44471040|NCT00461708|79479302|FG000|Overall Study|Lack of Efficacy|68|||
44471041|NCT00461708|79479303|FG001|Overall Study|Lack of Efficacy|20|||
44471042|NCT00461708|79479302|FG000|Overall Study|Physician Decision|10|||
44471043|NCT00461708|79479303|FG001|Overall Study|Physician Decision|4|||
44471044|NCT00461708|79479302|FG000|Overall Study|Withdrawal by Subject|8|||
44471045|NCT00461708|79479303|FG001|Overall Study|Withdrawal by Subject|2|||
44471046|NCT00461708|79479302|FG000|Overall Study|Other|4|||
44471047|NCT00461708|79479303|FG001|Overall Study|Other|4|||
44471048|NCT00461708|79479302|FG000|Overall Study|Death|8|||
44471049|NCT00461708|79479303|FG001|Overall Study|Death|1|||
44471050|NCT00327171|79479314|FG000|Overall Study|Did not receive study medication|3|||
44471051|NCT00327171|79479315|FG001|Overall Study|Did not receive study medication|0|||
44471052|NCT00327171|79479314|FG000|Overall Study|Adverse Event|23|||
44471053|NCT00327171|79479315|FG001|Overall Study|Adverse Event|23|||
44471054|NCT00327171|79479314|FG000|Overall Study|Disease progression/lack of efficacy|68|||
44471055|NCT00327171|79479315|FG001|Overall Study|Disease progression/lack of efficacy|69|||
44471056|NCT00327171|79479314|FG000|Overall Study|Investigator/participant request|1|||
44471057|NCT00327171|79479315|FG001|Overall Study|Investigator/participant request|8|||
44471058|NCT00327171|79479314|FG000|Overall Study|Clinical progression|12|||
44471059|NCT00327171|79479315|FG001|Overall Study|Clinical progression|8|||
44471060|NCT00327171|79479314|FG000|Overall Study|Undisclosed history of ischemia|0|||
44471061|NCT00327171|79479315|FG001|Overall Study|Undisclosed history of ischemia|1|||
44471062|NCT00327171|79479314|FG000|Overall Study|Other|1|||
44471063|NCT00327171|79479315|FG001|Overall Study|Other|0|||
44471064|NCT00461630|79479323|FG000|Overall Study|Death|798|||
44471065|NCT00461630|79479324|FG001|Overall Study|Death|732|||
44471066|NCT00461630|79479323|FG000|Overall Study|Lost to Follow-up|108|||
44471067|NCT00461630|79479324|FG001|Overall Study|Lost to Follow-up|95|||
44471068|NCT00461552|79479332|FG000|Overall Study|Drug Dispensing error|0|||
44471069|NCT00461552|79479333|FG001|Overall Study|Drug Dispensing error|2|||
44471070|NCT00453206|79479339|FG000|Overall Study|Death|1|||
44225500|NCT01980095|79031016|FG000|Overall Study|Safety issue|0|||
44225501|NCT01980095|79031017|FG001|Overall Study|Safety issue|1|||
44471071|NCT03850496|79479346|FG000|Overall Study|Withdrawal by Subject|1|||
44471072|NCT03850496|79479347|FG001|Overall Study|Withdrawal by Subject|0|||
44471073|NCT03850496|79479348|FG002|Overall Study|Withdrawal by Subject|0|||
44471074|NCT03850496|79479346|FG000|Overall Study|Lost to Follow-up|0|||
44471075|NCT03850496|79479347|FG001|Overall Study|Lost to Follow-up|1|||
44471076|NCT03850496|79479348|FG002|Overall Study|Lost to Follow-up|4|||
44471077|NCT00327015|79479360|FG000|Overall Study|Lack of Efficacy|18|||
44471078|NCT00327015|79479361|FG001|Overall Study|Lack of Efficacy|18|||
44471079|NCT00327015|79479362|FG002|Overall Study|Lack of Efficacy|35|||
44471080|NCT00327015|79479363|FG003|Overall Study|Lack of Efficacy|29|||
44471081|NCT00327015|79479360|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
44471082|NCT00327015|79479361|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
44471083|NCT00327015|79479362|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
44471084|NCT00327015|79479363|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
44471085|NCT00327015|79479360|FG000|Overall Study|Lost to Follow-up|22|||
44471086|NCT00327015|79479361|FG001|Overall Study|Lost to Follow-up|23|||
44471087|NCT00327015|79479362|FG002|Overall Study|Lost to Follow-up|29|||
44471088|NCT00327015|79479363|FG003|Overall Study|Lost to Follow-up|22|||
44471089|NCT00327015|79479360|FG000|Overall Study|Adverse Event|14|||
44471090|NCT00327015|79479361|FG001|Overall Study|Adverse Event|10|||
44471091|NCT00327015|79479362|FG002|Overall Study|Adverse Event|14|||
44471092|NCT00327015|79479363|FG003|Overall Study|Adverse Event|14|||
44471093|NCT00327015|79479360|FG000|Overall Study|Subject no longer meets study criteria|4|||
44471094|NCT00327015|79479361|FG001|Overall Study|Subject no longer meets study criteria|2|||
44471095|NCT00327015|79479362|FG002|Overall Study|Subject no longer meets study criteria|8|||
44471096|NCT00327015|79479363|FG003|Overall Study|Subject no longer meets study criteria|7|||
44471097|NCT00327015|79479360|FG000|Overall Study|Poor/Noncompliance|11|||
44471098|NCT00327015|79479361|FG001|Overall Study|Poor/Noncompliance|8|||
44471099|NCT00327015|79479362|FG002|Overall Study|Poor/Noncompliance|4|||
44471100|NCT00327015|79479363|FG003|Overall Study|Poor/Noncompliance|5|||
44471101|NCT00327015|79479360|FG000|Overall Study|Physician Decision|0|||
44471102|NCT00327015|79479361|FG001|Overall Study|Physician Decision|1|||
44471103|NCT00327015|79479362|FG002|Overall Study|Physician Decision|3|||
44471104|NCT00327015|79479363|FG003|Overall Study|Physician Decision|2|||
44471105|NCT00327015|79479360|FG000|Overall Study|Death|1|||
44471106|NCT00327015|79479361|FG001|Overall Study|Death|2|||
44471107|NCT00327015|79479362|FG002|Overall Study|Death|2|||
44471108|NCT00327015|79479363|FG003|Overall Study|Death|3|||
44471109|NCT00327015|79479360|FG000|Overall Study|Pregnancy|0|||
44471110|NCT00327015|79479361|FG001|Overall Study|Pregnancy|2|||
44471111|NCT00327015|79479362|FG002|Overall Study|Pregnancy|1|||
44471112|NCT00327015|79479363|FG003|Overall Study|Pregnancy|1|||
44471113|NCT00327015|79479360|FG000|Overall Study|Administrative Reason by Sponsor|1|||
44471114|NCT00327015|79479361|FG001|Overall Study|Administrative Reason by Sponsor|2|||
44471115|NCT00327015|79479362|FG002|Overall Study|Administrative Reason by Sponsor|2|||
44471116|NCT00327015|79479363|FG003|Overall Study|Administrative Reason by Sponsor|1|||
44471117|NCT00434148|79479375|FG000|Overall Study|Adverse Event|18|||
44471118|NCT00434148|79479376|FG001|Overall Study|Adverse Event|18|||
44471119|NCT00434148|79479375|FG000|Overall Study|Lack of Efficacy|25|||
44471120|NCT00434148|79479376|FG001|Overall Study|Lack of Efficacy|28|||
44471121|NCT00434148|79479375|FG000|Overall Study|Withdrawal by Subject|15|||
44471122|NCT00434148|79479376|FG001|Overall Study|Withdrawal by Subject|15|||
44471123|NCT00434148|79479375|FG000|Overall Study|Protocol Violation|4|||
44471124|NCT00434148|79479376|FG001|Overall Study|Protocol Violation|0|||
44471125|NCT00434148|79479375|FG000|Overall Study|Administrative problems|6|||
44471126|NCT00434148|79479376|FG001|Overall Study|Administrative problems|10|||
44471127|NCT00434148|79479375|FG000|Overall Study|Lost to Follow-up|0|||
44471128|NCT00434148|79479376|FG001|Overall Study|Lost to Follow-up|1|||
44471129|NCT00434148|79479375|FG000|Overall Study|Condition no longer requires study drug|1|||
44471130|NCT00434148|79479376|FG001|Overall Study|Condition no longer requires study drug|0|||
44471131|NCT00434148|79479375|FG000|Overall Study|Abnormal test procedure result|0|||
44471132|NCT00434148|79479376|FG001|Overall Study|Abnormal test procedure result|1|||
44471133|NCT00468728|79479384|FG000|Treatment|criteria for mITT population|4|||
44471134|NCT00468728|79479385|FG001|Treatment|criteria for mITT population|11|||
44471135|NCT00468728|79479384|FG000|Follow-up|mITT failure|34|||
44471136|NCT00468728|79479385|FG001|Follow-up|mITT failure|31|||
44471137|NCT00433914|79479395|FG000|Overall Study|Withdrawal by Subject|0|||
44471138|NCT00433914|79479396|FG001|Overall Study|Withdrawal by Subject|2|||
44471139|NCT00433914|79479395|FG000|Overall Study|Lost to Follow-up|0|||
44471140|NCT00433914|79479396|FG001|Overall Study|Lost to Follow-up|1|||
44471141|NCT00468650|79479402|FG000|Overall Study|Lost to Follow-up|4|||
44471142|NCT00468650|79479402|FG000|Overall Study|Withdrawal by Subject|2|||
44471143|NCT00468650|79479402|FG000|Overall Study|Protocol Violation|1|||
44471144|NCT00423150|79479407|FG000|Overall Study|Adverse Event|11|||
44471145|NCT00423150|79479407|FG000|Overall Study|Progression of disease being studied|69|||
44471146|NCT00423150|79479407|FG000|Overall Study|Withdrawal by Subject|1|||
44471147|NCT00423150|79479407|FG000|Overall Study|Non-compliance with protocol|1|||
44471148|NCT00423150|79479407|FG000|Overall Study|Administrative|4|||
44471149|NCT00433836|79479413|FG000|Overall Study|Adverse Event|7|||
44471150|NCT00433836|79479414|FG001|Overall Study|Adverse Event|0|||
44471151|NCT00433836|79479413|FG000|Overall Study|Lost to Follow-up|3|||
44471152|NCT00433836|79479414|FG001|Overall Study|Lost to Follow-up|0|||
44471153|NCT00433836|79479413|FG000|Overall Study|Withdrawal by Subject|2|||
44471154|NCT00433836|79479414|FG001|Overall Study|Withdrawal by Subject|1|||
44471155|NCT00433836|79479413|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44471156|NCT00433836|79479414|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44471157|NCT00433836|79479413|FG000|Overall Study|Protocol Violation|0|||
44471158|NCT00433836|79479414|FG001|Overall Study|Protocol Violation|2|||
44471159|NCT00433836|79479413|FG000|Overall Study|Condition no longer requires study drug|0|||
44471160|NCT00433836|79479414|FG001|Overall Study|Condition no longer requires study drug|1|||
44471161|NCT00433836|79479413|FG000|Overall Study|Abnormal laboratory values|0|||
44471162|NCT00433836|79479414|FG001|Overall Study|Abnormal laboratory values|1|||
44471163|NCT00433446|79479420|FG000|Overall Study|Adverse Event|4|||
44471164|NCT00433446|79479420|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
44471165|NCT00433446|79479420|FG000|Overall Study|Progression|44|||
44471166|NCT00433446|79479420|FG000|Overall Study|Other - Not Protocol specified|3|||
44471167|NCT00433446|79479420|FG000|Overall Study|Ineligible|9|||
44471168|NCT00468104|79479424|FG000|First Intervention|Protocol Violation|2|||
44471169|NCT00468104|79479425|FG001|First Intervention|Protocol Violation|1|||
44471170|NCT00468104|79479424|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
44471171|NCT00468104|79479425|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
44471172|NCT00468104|79479424|FG000|First Intervention|died within 3 weeks|1|||
44471173|NCT00468104|79479425|FG001|First Intervention|died within 3 weeks|0|||
44471174|NCT00468104|79479424|FG000|First Intervention|malposition/blocked chest tube tube|2|||
44471175|NCT00468104|79479425|FG001|First Intervention|malposition/blocked chest tube tube|0|||
44471176|NCT00468104|79479424|FG000|First Intervention|large lung mass with minimal effusion|1|||
44471177|NCT00468104|79479425|FG001|First Intervention|large lung mass with minimal effusion|0|||
44471178|NCT00468104|79479424|FG000|First Intervention|associated prolonged pneumothorax|1|||
44471179|NCT00468104|79479425|FG001|First Intervention|associated prolonged pneumothorax|0|||
44471180|NCT00468104|79479424|FG000|First Intervention|trapped lung|1|||
44471181|NCT00468104|79479425|FG001|First Intervention|trapped lung|0|||
44471182|NCT00468104|79479424|FG000|Second Intervention|Withdrawal by Subject|5|||
44471183|NCT00468104|79479425|FG001|Second Intervention|Withdrawal by Subject|2|||
44471184|NCT00468104|79479424|FG000|Second Intervention|discarded for malposition of chest tube|0|||
44471185|NCT00468104|79479425|FG001|Second Intervention|discarded for malposition of chest tube|2|||
44471186|NCT00326625|79479436|FG000|Overall Study|Adverse Event|20|||
44471187|NCT00326625|79479437|FG001|Overall Study|Adverse Event|9|||
44471188|NCT00326625|79479436|FG000|Overall Study|Withdrawal by Subject|15|||
44471189|NCT00326625|79479437|FG001|Overall Study|Withdrawal by Subject|12|||
44471190|NCT00326625|79479436|FG000|Overall Study|Death|18|||
44471191|NCT00326625|79479437|FG001|Overall Study|Death|16|||
44471192|NCT00326625|79479436|FG000|Overall Study|Lost to Follow-up|1|||
44471193|NCT00326625|79479437|FG001|Overall Study|Lost to Follow-up|0|||
44471194|NCT00326625|79479436|FG000|Overall Study|prescheduled medical intervention|0|||
44471195|NCT00326625|79479437|FG001|Overall Study|prescheduled medical intervention|1|||
44471196|NCT00433290|79479445|FG000|Overall Study|Adverse Event|24|||
44471197|NCT00433290|79479446|FG001|Overall Study|Adverse Event|7|||
44471198|NCT00433290|79479445|FG000|Overall Study|Lack of Efficacy|1|||
44471199|NCT00433290|79479446|FG001|Overall Study|Lack of Efficacy|5|||
44471200|NCT00433290|79479445|FG000|Overall Study|Withdrawal by Subject|4|||
44225502|NCT01980095|79031016|FG000|Overall Study|Study drug discontinued|1|||
44225503|NCT01980095|79031017|FG001|Overall Study|Study drug discontinued|0|||
44225504|NCT01980095|79031016|FG000|Overall Study|Randomized by mistake|1|||
44471201|NCT00433290|79479446|FG001|Overall Study|Withdrawal by Subject|2|||
44471202|NCT00433290|79479445|FG000|Overall Study|Protocol Violation|3|||
44471203|NCT00433290|79479446|FG001|Overall Study|Protocol Violation|2|||
44471204|NCT00433290|79479445|FG000|Overall Study|Physician Decision|2|||
44471205|NCT00433290|79479446|FG001|Overall Study|Physician Decision|0|||
44471206|NCT00433290|79479445|FG000|Overall Study|Entry Criteria Not Met|0|||
44471207|NCT00433290|79479446|FG001|Overall Study|Entry Criteria Not Met|1|||
44471208|NCT00433290|79479445|FG000|Overall Study|Lost to Follow-up|1|||
44471209|NCT00433290|79479446|FG001|Overall Study|Lost to Follow-up|0|||
44471210|NCT00467870|79479458|FG000|Overall Study|Adverse Event|13|||
44471211|NCT00467870|79479459|FG001|Overall Study|Adverse Event|9|||
44471212|NCT00467870|79479460|FG002|Overall Study|Adverse Event|1|||
44471213|NCT00467870|79479461|FG003|Overall Study|Adverse Event|15|||
44471214|NCT00467870|79479462|FG004|Overall Study|Adverse Event|15|||
44471215|NCT00467870|79479463|FG005|Overall Study|Adverse Event|1|||
44471216|NCT00467870|79479458|FG000|Overall Study|Protocol Violation|2|||
44471217|NCT00467870|79479459|FG001|Overall Study|Protocol Violation|1|||
44471218|NCT00467870|79479460|FG002|Overall Study|Protocol Violation|1|||
44471219|NCT00467870|79479461|FG003|Overall Study|Protocol Violation|2|||
44471220|NCT00467870|79479462|FG004|Overall Study|Protocol Violation|0|||
44471221|NCT00467870|79479463|FG005|Overall Study|Protocol Violation|0|||
44471222|NCT00467870|79479458|FG000|Overall Study|Withdrawal by Subject|14|||
44471223|NCT00467870|79479459|FG001|Overall Study|Withdrawal by Subject|21|||
44471224|NCT00467870|79479460|FG002|Overall Study|Withdrawal by Subject|0|||
44471225|NCT00467870|79479461|FG003|Overall Study|Withdrawal by Subject|9|||
44471226|NCT00467870|79479462|FG004|Overall Study|Withdrawal by Subject|10|||
44471227|NCT00467870|79479463|FG005|Overall Study|Withdrawal by Subject|1|||
44471228|NCT00467870|79479458|FG000|Overall Study|Lost to Follow-up|5|||
44471229|NCT00467870|79479459|FG001|Overall Study|Lost to Follow-up|3|||
44471230|NCT00467870|79479460|FG002|Overall Study|Lost to Follow-up|1|||
44471231|NCT00467870|79479461|FG003|Overall Study|Lost to Follow-up|1|||
44471232|NCT00467870|79479462|FG004|Overall Study|Lost to Follow-up|3|||
44471233|NCT00467870|79479463|FG005|Overall Study|Lost to Follow-up|0|||
44471234|NCT00467870|79479458|FG000|Overall Study|Subject Non-compliance|3|||
44471235|NCT00467870|79479459|FG001|Overall Study|Subject Non-compliance|4|||
44471236|NCT00467870|79479460|FG002|Overall Study|Subject Non-compliance|0|||
44471237|NCT00467870|79479461|FG003|Overall Study|Subject Non-compliance|1|||
44471238|NCT00467870|79479462|FG004|Overall Study|Subject Non-compliance|5|||
44471239|NCT00467870|79479463|FG005|Overall Study|Subject Non-compliance|0|||
44471240|NCT00467870|79479458|FG000|Overall Study|Other/Unknown|8|||
44471241|NCT00467870|79479459|FG001|Overall Study|Other/Unknown|5|||
44471242|NCT00467870|79479460|FG002|Overall Study|Other/Unknown|1|||
44471243|NCT00467870|79479461|FG003|Overall Study|Other/Unknown|5|||
44471244|NCT00467870|79479462|FG004|Overall Study|Other/Unknown|4|||
44471245|NCT00467870|79479463|FG005|Overall Study|Other/Unknown|0|||
44471246|NCT00467558|79479475|FG000|Overall Study|Lost to Follow-up|2|||
44471247|NCT00467558|79479476|FG001|Overall Study|Lost to Follow-up|0|||
44471248|NCT00422292|79479486|FG000|Overall Study|Serious adverse events|1|||
44471249|NCT00422292|79479487|FG001|Overall Study|Serious adverse events|4|||
44471250|NCT00422292|79479488|FG002|Overall Study|Serious adverse events|0|||
44471251|NCT00422292|79479489|FG003|Overall Study|Serious adverse events|0|||
44471252|NCT00422292|79479486|FG000|Overall Study|Adverse Event|1|||
44471253|NCT00422292|79479487|FG001|Overall Study|Adverse Event|0|||
44471254|NCT00422292|79479488|FG002|Overall Study|Adverse Event|1|||
44471255|NCT00422292|79479489|FG003|Overall Study|Adverse Event|0|||
44471256|NCT00422292|79479486|FG000|Overall Study|Protocol Violation|4|||
44471257|NCT00422292|79479487|FG001|Overall Study|Protocol Violation|25|||
44471258|NCT00422292|79479488|FG002|Overall Study|Protocol Violation|8|||
44471259|NCT00422292|79479489|FG003|Overall Study|Protocol Violation|5|||
44471260|NCT00422292|79479486|FG000|Overall Study|Lost to Follow-up|6|||
44471261|NCT00422292|79479487|FG001|Overall Study|Lost to Follow-up|12|||
44471262|NCT00422292|79479488|FG002|Overall Study|Lost to Follow-up|6|||
44471263|NCT00422292|79479489|FG003|Overall Study|Lost to Follow-up|6|||
44471264|NCT00422292|79479486|FG000|Overall Study|Withdrawal by Subject|6|||
44471265|NCT00422292|79479487|FG001|Overall Study|Withdrawal by Subject|25|||
44471266|NCT00422292|79479488|FG002|Overall Study|Withdrawal by Subject|7|||
44225505|NCT01980095|79031017|FG001|Overall Study|Randomized by mistake|0|||
44225506|NCT01980017|79031027|FG000|Overall Study|Lost to Follow-up|30|||
44225507|NCT01980017|79031028|FG001|Overall Study|Lost to Follow-up|21|||
44471267|NCT00422292|79479489|FG003|Overall Study|Withdrawal by Subject|13|||
44471268|NCT00452348|79479501|FG000|Overall Study|Adverse Event|6|||
44471269|NCT00452348|79479502|FG001|Overall Study|Adverse Event|9|||
44471270|NCT00452348|79479501|FG000|Overall Study|Lack of Efficacy|10|||
44471271|NCT00452348|79479502|FG001|Overall Study|Lack of Efficacy|9|||
44225508|NCT01980017|79031027|FG000|Overall Study|Death|0|||
44471272|NCT00452348|79479501|FG000|Overall Study|Lost to Follow-up|14|||
44471273|NCT00452348|79479502|FG001|Overall Study|Lost to Follow-up|8|||
44471274|NCT00452348|79479501|FG000|Overall Study|Protocol Violation|22|||
44471275|NCT00452348|79479502|FG001|Overall Study|Protocol Violation|28|||
44471276|NCT00452348|79479501|FG000|Overall Study|Withdrawal by Subject|18|||
44471277|NCT00452348|79479502|FG001|Overall Study|Withdrawal by Subject|21|||
44471278|NCT00452348|79479501|FG000|Overall Study|Other|9|||
44471279|NCT00452348|79479502|FG001|Overall Study|Other|9|||
44471280|NCT00452114|79479510|FG000|Overall Study|Physician Decision|3|||
44471281|NCT00452114|79479511|FG001|Overall Study|Physician Decision|3|||
44471282|NCT00320541|79479519|FG000|Overall Study|Adverse Event|21|||
44471283|NCT00320541|79479520|FG001|Overall Study|Adverse Event|19|||
44471284|NCT00320541|79479519|FG000|Overall Study|Protocol Violation|0|||
44471285|NCT00320541|79479520|FG001|Overall Study|Protocol Violation|1|||
44471286|NCT00320541|79479519|FG000|Overall Study|Withdrawal by Subject|12|||
44471287|NCT00320541|79479520|FG001|Overall Study|Withdrawal by Subject|16|||
44471288|NCT00320541|79479519|FG000|Overall Study|Physician Decision|9|||
44471289|NCT00320541|79479520|FG001|Overall Study|Physician Decision|13|||
44225509|NCT01980017|79031028|FG001|Overall Study|Death|1|||
44225510|NCT01978145|79031037|FG000|Treatment Period 1|Adverse Event|1|||
44225511|NCT01978145|79031038|FG001|Treatment Period 1|Adverse Event|9|||
44471290|NCT00320541|79479519|FG000|Overall Study|Other|3|||
44471291|NCT00320541|79479520|FG001|Overall Study|Other|4|||
44471292|NCT00320541|79479519|FG000|Overall Study|Sponsor Decision|2|||
44471293|NCT00320541|79479520|FG001|Overall Study|Sponsor Decision|1|||
44225512|NCT01978145|79031037|FG000|Treatment Period 1|Physician Decision|1|||
44225513|NCT01978145|79031038|FG001|Treatment Period 1|Physician Decision|0|||
44225514|NCT01978145|79031037|FG000|Treatment Period 1|Withdrawal by Subject|5|||
44225515|NCT01978145|79031038|FG001|Treatment Period 1|Withdrawal by Subject|4|||
44225516|NCT01978145|79031037|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
44375377|NCT00944034|79380591|FG006|Overall Study|Inappropriate enrollment|0|||
44375378|NCT00944034|79380592|FG007|Overall Study|Inappropriate enrollment|0|||
44471294|NCT00320541|79479519|FG000|Overall Study|Death due to Study Disease|1|||
44471295|NCT00320541|79479520|FG001|Overall Study|Death due to Study Disease|3|||
44471296|NCT00320541|79479519|FG000|Overall Study|Death due to Adverse Event(s)|1|||
44471297|NCT00320541|79479520|FG001|Overall Study|Death due to Adverse Event(s)|0|||
44471298|NCT00320541|79479519|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
44471299|NCT00320541|79479520|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
44471300|NCT00320385|79479528|FG000|Overall Study|Lost to Follow-up|7|||
44471301|NCT00320385|79479529|FG001|Overall Study|Lost to Follow-up|10|||
44471302|NCT00320385|79479528|FG000|Overall Study|Withdrawal by Subject|6|||
44471303|NCT00320385|79479529|FG001|Overall Study|Withdrawal by Subject|7|||
44471304|NCT00320385|79479528|FG000|Overall Study|Sponsor Terminated Study|2|||
44471305|NCT00320385|79479529|FG001|Overall Study|Sponsor Terminated Study|1|||
44471306|NCT00320385|79479528|FG000|Overall Study|Investigator Decision|0|||
44471307|NCT00320385|79479529|FG001|Overall Study|Investigator Decision|1|||
44471308|NCT00320385|79479528|FG000|Overall Study|Death|1|||
44471309|NCT00320385|79479529|FG001|Overall Study|Death|2|||
44471310|NCT00320385|79479528|FG000|Overall Study|Serious Adverse Event|1|||
44471311|NCT00320385|79479529|FG001|Overall Study|Serious Adverse Event|0|||
44471312|NCT00320385|79479528|FG000|Overall Study|Withdrew Consent|1|||
44471313|NCT00320385|79479529|FG001|Overall Study|Withdrew Consent|0|||
44471314|NCT00320385|79479528|FG000|Overall Study|Adverse Event|0|||
44471315|NCT00320385|79479529|FG001|Overall Study|Adverse Event|1|||
44471316|NCT00326001|79479537|FG000|Overall Study|Adverse Event|4|||
44471317|NCT00326001|79479538|FG001|Overall Study|Adverse Event|5|||
44471318|NCT00326001|79479537|FG000|Overall Study|Physician Decision|3|||
44471319|NCT00326001|79479538|FG001|Overall Study|Physician Decision|3|||
44471320|NCT00309777|79479548|FG000|Overall Study|Adverse Event|13|||
44471321|NCT00309777|79479549|FG001|Overall Study|Adverse Event|2|||
44471322|NCT00309777|79479550|FG002|Overall Study|Adverse Event|8|||
44471323|NCT00309777|79479551|FG003|Overall Study|Adverse Event|1|||
44471324|NCT00309777|79479548|FG000|Overall Study|Protocol Violation|4|||
44544502|NCT03345004|79557942|FG000|Overall Study|Physician Decision|1|||
44544503|NCT03345004|79557943|FG001|Overall Study|Physician Decision|0|||
44544504|NCT03345004|79557942|FG000|Overall Study|Withdrawal by Subject|0|||
44544505|NCT03345004|79557943|FG001|Overall Study|Withdrawal by Subject|1|||
44544506|NCT03552757|79557954|FG000|Overall Study|Withdrawal by Subject|10|||
44544507|NCT03552757|79557955|FG001|Overall Study|Withdrawal by Subject|5|||
44544508|NCT03552757|79557956|FG002|Overall Study|Withdrawal by Subject|12|||
44375379|NCT00944034|79380593|FG008|Overall Study|Inappropriate enrollment|1|||
44471325|NCT00309777|79479549|FG001|Overall Study|Protocol Violation|1|||
44471326|NCT00309777|79479550|FG002|Overall Study|Protocol Violation|3|||
44471327|NCT00309777|79479551|FG003|Overall Study|Protocol Violation|1|||
44471328|NCT00309777|79479548|FG000|Overall Study|Withdrawal by Subject|6|||
44471329|NCT00309777|79479549|FG001|Overall Study|Withdrawal by Subject|5|||
44471330|NCT00309777|79479550|FG002|Overall Study|Withdrawal by Subject|7|||
44471331|NCT00309777|79479551|FG003|Overall Study|Withdrawal by Subject|2|||
44544509|NCT03552757|79557954|FG000|Overall Study|Lost to Follow-up|2|||
44225517|NCT01978145|79031038|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
44225518|NCT01978145|79031037|FG000|Washout Period 1|Adverse Event|0|||
44375380|NCT00944034|79380594|FG009|Overall Study|Inappropriate enrollment|1|||
44375381|NCT00944034|79380595|FG010|Overall Study|Inappropriate enrollment|0|||
44471332|NCT00309777|79479548|FG000|Overall Study|Lost to Follow-up|0|||
44471333|NCT00309777|79479549|FG001|Overall Study|Lost to Follow-up|0|||
44544510|NCT03552757|79557955|FG001|Overall Study|Lost to Follow-up|7|||
44225519|NCT01978145|79031038|FG001|Washout Period 1|Adverse Event|1|||
44471334|NCT00309777|79479550|FG002|Overall Study|Lost to Follow-up|1|||
44471335|NCT00309777|79479551|FG003|Overall Study|Lost to Follow-up|0|||
44471336|NCT00309777|79479548|FG000|Overall Study|Death|0|||
44471337|NCT00309777|79479549|FG001|Overall Study|Death|1|||
44471338|NCT00309777|79479550|FG002|Overall Study|Death|0|||
44471339|NCT00309777|79479551|FG003|Overall Study|Death|0|||
44471340|NCT00309387|79479563|FG000|Overall Study|Death|72|||
44471341|NCT00309387|79479564|FG001|Overall Study|Death|73|||
44471342|NCT00309387|79479563|FG000|Overall Study|Lost to Follow-up|70|||
44471343|NCT00309387|79479564|FG001|Overall Study|Lost to Follow-up|86|||
44471344|NCT00325143|79479571|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
44471345|NCT00325143|79479571|FG000|Overall Study|Migrated/moved from study area|1|||
44471346|NCT00325143|79479571|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
44471347|NCT00325143|79479571|FG000|Overall Study|Withdrawal by Subject|8|||
44471348|NCT00319839|79479575|FG000|Overall Study|Adverse Event|5|||
44471349|NCT00319839|79479575|FG000|Overall Study|Withdrawal by Subject|1|||
44471350|NCT00319449|79479581|FG000|Overall Study|Subject did not wish to continue|1|||
44471351|NCT00319449|79479582|FG001|Overall Study|Subject did not wish to continue|0|||
44471352|NCT00319449|79479581|FG000|Overall Study|Noncompliance with the protocol|1|||
44471353|NCT00319449|79479582|FG001|Overall Study|Noncompliance with the protocol|0|||
44471354|NCT00308997|79479590|FG000|Overall Study|Subject feigned clinical data|0|||
44471355|NCT00308997|79479591|FG001|Overall Study|Subject feigned clinical data|1|||
44471356|NCT00308997|79479590|FG000|Overall Study|Unable to tolerate intervention|1|||
44471357|NCT00308997|79479591|FG001|Overall Study|Unable to tolerate intervention|0|||
44471358|NCT00308685|79479599|FG000|Overall Study|Lost to Follow-up|1|||
44471359|NCT00308685|79479600|FG001|Overall Study|Lost to Follow-up|0|||
44471360|NCT00308685|79479599|FG000|Overall Study|Need to administer prohibited medication|1|||
44471361|NCT00308685|79479600|FG001|Overall Study|Need to administer prohibited medication|2|||
44471362|NCT00308685|79479599|FG000|Overall Study|Other than specified|1|||
44471363|NCT00308685|79479600|FG001|Overall Study|Other than specified|3|||
44471364|NCT00317109|79479608|FG000|Overall Study|Withdrawal by Subject|2|||
44471365|NCT00317109|79479609|FG001|Overall Study|Withdrawal by Subject|0|||
44471366|NCT00317109|79479608|FG000|Overall Study|Migated/moved from study area|1|||
44471367|NCT00317109|79479609|FG001|Overall Study|Migated/moved from study area|0|||
44471368|NCT00316719|79479617|FG000|Overall Study|Adverse Event|0|||
44471369|NCT00316719|79479618|FG001|Overall Study|Adverse Event|6|||
44471370|NCT00316719|79479617|FG000|Overall Study|Consent withdrawn|2|||
44471371|NCT00316719|79479618|FG001|Overall Study|Consent withdrawn|0|||
44471372|NCT00422058|79479630|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
44471373|NCT00422058|79479631|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
44471374|NCT00422058|79479632|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
44471375|NCT00422058|79479633|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
44471376|NCT00422058|79479634|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
44471377|NCT00422058|79479635|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
44471378|NCT00422058|79479630|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
44225520|NCT01978145|79031037|FG000|Washout Period 1|Withdrawal by Subject|1|||
44225521|NCT01978145|79031038|FG001|Washout Period 1|Withdrawal by Subject|1|||
44225522|NCT01978145|79031037|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
44225523|NCT01978145|79031038|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
44225524|NCT01978145|79031037|FG000|Treatment Period 2|Adverse Event|3|||
44375382|NCT00944034|79380596|FG011|Overall Study|Inappropriate enrollment|0|||
44375383|NCT00944034|79380585|FG000|Overall Study|Withdrawal by Subject|3|||
44471379|NCT00422058|79479631|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
44471380|NCT00422058|79479632|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
44471381|NCT00422058|79479633|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
44471382|NCT00422058|79479634|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
44471383|NCT00422058|79479635|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
44471384|NCT00422058|79479630|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
44471385|NCT00422058|79479631|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
44375384|NCT00944034|79380586|FG001|Overall Study|Withdrawal by Subject|2|||
44375385|NCT00944034|79380587|FG002|Overall Study|Withdrawal by Subject|6|||
44375386|NCT00944034|79380588|FG003|Overall Study|Withdrawal by Subject|2|||
44471386|NCT00422058|79479632|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
44471387|NCT00422058|79479633|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
44471388|NCT00422058|79479634|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
44471389|NCT00422058|79479635|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
44471390|NCT00422058|79479630|FG000|Double-Blind, Week 0-20|Other|11|||
44471391|NCT00422058|79479631|FG001|Double-Blind, Week 0-20|Other|3|||
44471392|NCT00422058|79479632|FG002|Double-Blind, Week 0-20|Other|8|||
44471393|NCT00422058|79479633|FG003|Double-Blind, Week 0-20|Other|8|||
44471394|NCT00422058|79479634|FG004|Double-Blind, Week 0-20|Other|4|||
44471395|NCT00422058|79479635|FG005|Double-Blind, Week 0-20|Other|10|||
44471396|NCT00422058|79479630|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
44225525|NCT01978145|79031038|FG001|Treatment Period 2|Adverse Event|3|||
44471397|NCT00422058|79479631|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
44471398|NCT00422058|79479632|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
44471399|NCT00422058|79479633|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
44471400|NCT00422058|79479634|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
44471401|NCT00422058|79479635|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
44471402|NCT00422058|79479630|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
44471403|NCT00422058|79479631|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
44225526|NCT01978145|79031037|FG000|Treatment Period 2|Protocol Violation|0|||
44225527|NCT01978145|79031038|FG001|Treatment Period 2|Protocol Violation|1|||
44225528|NCT01978145|79031037|FG000|Treatment Period 2|Lost to Follow-up|1|||
44225529|NCT01978145|79031038|FG001|Treatment Period 2|Lost to Follow-up|1|||
44225530|NCT01978145|79031037|FG000|Treatment Period 2|Withdrawal by Subject|7|||
44225531|NCT01978145|79031038|FG001|Treatment Period 2|Withdrawal by Subject|4|||
44471404|NCT00422058|79479632|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
44471405|NCT00422058|79479633|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
44471406|NCT00422058|79479634|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
44471407|NCT00422058|79479635|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
44471408|NCT00422058|79479630|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
44471409|NCT00422058|79479631|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
44471410|NCT00422058|79479632|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
44225532|NCT01978145|79031037|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
44225533|NCT01978145|79031038|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
44225534|NCT01967537|79031044|FG000|Overall Study|Withdrawal by Subject|52|||
44471411|NCT00422058|79479633|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
44471412|NCT00422058|79479634|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
44471413|NCT00422058|79479635|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
44471414|NCT00422058|79479630|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
44471415|NCT00422058|79479631|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
44471416|NCT00422058|79479632|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
44225535|NCT01967537|79031044|FG000|Overall Study|Refuse treatment|2|||
44225536|NCT01967537|79031044|FG000|Overall Study|Lost to Follow-up|6|||
44225537|NCT01967225|79031052|FG000|Overall Study|Adverse Event|3|||
44225538|NCT01967225|79031053|FG001|Overall Study|Adverse Event|1|||
44225539|NCT01967225|79031052|FG000|Overall Study|Withdrawal by Subject|2|||
44225540|NCT01967225|79031053|FG001|Overall Study|Withdrawal by Subject|1|||
44225541|NCT01967225|79031052|FG000|Overall Study|Lack of Efficacy|1|||
44225542|NCT01967225|79031053|FG001|Overall Study|Lack of Efficacy|1|||
44225543|NCT01967225|79031052|FG000|Overall Study|Switching to other therapy|2|||
44225544|NCT01967225|79031053|FG001|Overall Study|Switching to other therapy|0|||
44225545|NCT01967225|79031052|FG000|Overall Study|Protocol driven decision point|1|||
44225546|NCT01967225|79031053|FG001|Overall Study|Protocol driven decision point|0|||
44225547|NCT01967225|79031052|FG000|Overall Study|Logistical difficulties|1|||
44225548|NCT01967225|79031053|FG001|Overall Study|Logistical difficulties|0|||
44225549|NCT01967225|79031052|FG000|Overall Study|Protocol Violation|2|||
44225550|NCT01967225|79031053|FG001|Overall Study|Protocol Violation|0|||
44225551|NCT01967147|79031063|FG000|Overall Study|Adverse Event|5|||
44225552|NCT01967147|79031064|FG001|Overall Study|Adverse Event|2|||
44471417|NCT00422058|79479633|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
44471418|NCT00422058|79479634|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
44471419|NCT00422058|79479635|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
44471420|NCT00422058|79479630|FG000|Open-Label Extension, Week 20-104|Other|13|||
44471421|NCT00422058|79479631|FG001|Open-Label Extension, Week 20-104|Other|14|||
44471422|NCT00422058|79479632|FG002|Open-Label Extension, Week 20-104|Other|6|||
44471423|NCT00422058|79479633|FG003|Open-Label Extension, Week 20-104|Other|13|||
44471424|NCT00422058|79479634|FG004|Open-Label Extension, Week 20-104|Other|16|||
44471425|NCT00422058|79479635|FG005|Open-Label Extension, Week 20-104|Other|18|||
44471426|NCT00413244|79479659|FG000|Overall Study|Withdrawal by Subject|10|||
44471427|NCT00413244|79479660|FG001|Overall Study|Withdrawal by Subject|1|||
44471428|NCT00420420|79479688|FG000|Overall Study|Adverse Event|5|||
44471429|NCT00420420|79479689|FG001|Overall Study|Adverse Event|3|||
44471430|NCT00420420|79479688|FG000|Overall Study|Protocol Violation|1|||
44225553|NCT01967147|79031063|FG000|Overall Study|Lack of Efficacy|1|||
44225554|NCT01967147|79031064|FG001|Overall Study|Lack of Efficacy|4|||
44225555|NCT01967147|79031063|FG000|Overall Study|Lost to Follow-up|1|||
44225556|NCT01967147|79031064|FG001|Overall Study|Lost to Follow-up|2|||
44225557|NCT01967147|79031063|FG000|Overall Study|Withdrawal by Subject|2|||
44471431|NCT00420420|79479689|FG001|Overall Study|Protocol Violation|1|||
44544511|NCT03552757|79557956|FG002|Overall Study|Lost to Follow-up|7|||
44225558|NCT01967147|79031064|FG001|Overall Study|Withdrawal by Subject|4|||
44225559|NCT01967147|79031063|FG000|Overall Study|Non-compliance with Study Drug|0|||
44225560|NCT01967147|79031064|FG001|Overall Study|Non-compliance with Study Drug|3|||
44471432|NCT00420420|79479688|FG000|Overall Study|Withdrawal by Subject|1|||
44471433|NCT00420420|79479689|FG001|Overall Study|Withdrawal by Subject|0|||
44471434|NCT00420420|79479688|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
44471435|NCT00420420|79479689|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
44471436|NCT00420342|79479698|FG000|Overall Study|Lost to Follow-up|1|||
44471437|NCT00420342|79479699|FG001|Overall Study|Lost to Follow-up|0|||
44471438|NCT00420342|79479700|FG002|Overall Study|Lost to Follow-up|1|||
44471439|NCT00420342|79479698|FG000|Overall Study|Withdrawal by Subject|0|||
44471440|NCT00420342|79479699|FG001|Overall Study|Withdrawal by Subject|2|||
44471441|NCT00420342|79479700|FG002|Overall Study|Withdrawal by Subject|0|||
44471442|NCT00432744|79479710|FG000|Months 0-6|Withdrawal by Subject|4|||
44471443|NCT00432744|79479711|FG001|Months 0-6|Withdrawal by Subject|4|||
44471444|NCT00432744|79479710|FG000|Months 0-6|Too disabled to score|1|||
44471445|NCT00432744|79479711|FG001|Months 0-6|Too disabled to score|0|||
44471446|NCT00432744|79479710|FG000|Months 7 - 12|Withdrawal by Subject|1|||
44471447|NCT00432744|79479711|FG001|Months 7 - 12|Withdrawal by Subject|0|||
44471448|NCT00432744|79479710|FG000|Months 7 - 12|Too disabled to score|0|||
44471449|NCT00432744|79479711|FG001|Months 7 - 12|Too disabled to score|1|||
44471450|NCT00432666|79479719|FG000|Main Period|Adverse Event|1|||
44471451|NCT00432666|79479720|FG001|Main Period|Adverse Event|1|||
44471452|NCT00432666|79479719|FG000|Main Period|Consent Withdrawn|1|||
44471453|NCT00432666|79479720|FG001|Main Period|Consent Withdrawn|0|||
44471454|NCT00432666|79479719|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
44471455|NCT00432666|79479720|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
44471456|NCT00432666|79479719|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
44471457|NCT00432666|79479720|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
44471458|NCT00432666|79479719|FG000|Open-Label Extension Period|Adverse Event|5|||
44471459|NCT00432666|79479720|FG001|Open-Label Extension Period|Adverse Event|0|||
44471460|NCT00432666|79479719|FG000|Open-Label Extension Period|Consent withdrawn|10|||
44471461|NCT00432666|79479720|FG001|Open-Label Extension Period|Consent withdrawn|0|||
44471462|NCT00432666|79479719|FG000|Open-Label Extension Period|Physician Decision|3|||
44471463|NCT00432666|79479720|FG001|Open-Label Extension Period|Physician Decision|0|||
44471464|NCT00451958|79479730|FG000|CS21A (NCT00451958)|Adverse Event|21|||
44471465|NCT00451958|79479731|FG001|CS21A (NCT00451958)|Adverse Event|34|||
44471466|NCT00451958|79479732|FG002|CS21A (NCT00451958)|Adverse Event|14|||
44471467|NCT00451958|79479733|FG003|CS21A (NCT00451958)|Adverse Event|17|||
44471468|NCT00451958|79479734|FG004|CS21A (NCT00451958)|Adverse Event|0|||
44471469|NCT00451958|79479730|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
44471470|NCT00451958|79479731|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
44471471|NCT00451958|79479732|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
44471472|NCT00451958|79479733|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
44471473|NCT00451958|79479734|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
44471474|NCT00451958|79479730|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
44471475|NCT00451958|79479731|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
44471476|NCT00451958|79479732|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
44471477|NCT00451958|79479733|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
44225561|NCT01967147|79031063|FG000|Overall Study|Other|4|||
44225562|NCT01967147|79031064|FG001|Overall Study|Other|5|||
44225563|NCT01967069|79031073|FG000|Overall Study|Adverse Event|2|||
44471478|NCT00451958|79479734|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
44471479|NCT00451958|79479730|FG000|CS21A (NCT00451958)|Physician Decision|2|||
44471480|NCT00451958|79479731|FG001|CS21A (NCT00451958)|Physician Decision|4|||
44471481|NCT00451958|79479732|FG002|CS21A (NCT00451958)|Physician Decision|4|||
44471482|NCT00451958|79479733|FG003|CS21A (NCT00451958)|Physician Decision|4|||
44471483|NCT00451958|79479734|FG004|CS21A (NCT00451958)|Physician Decision|0|||
44225564|NCT01967069|79031074|FG001|Overall Study|Adverse Event|2|||
44225565|NCT01967069|79031073|FG000|Overall Study|Lost to Follow-up|5|||
44225566|NCT01967069|79031074|FG001|Overall Study|Lost to Follow-up|2|||
44225567|NCT01967069|79031073|FG000|Overall Study|Withdrawal by Subject|1|||
44273927|NCT02259114|79215725|FG003|Overall Study|Progressive Disease|2|||
44273928|NCT02259114|79215726|FG004|Overall Study|Progressive Disease|5|||
44273929|NCT02259114|79215722|FG000|Overall Study|Adverse Event|2|||
44471484|NCT00451958|79479730|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
44471485|NCT00451958|79479731|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
44471486|NCT00451958|79479732|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
44471487|NCT00451958|79479733|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
44471488|NCT00451958|79479734|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
44471489|NCT00451958|79479730|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
44471490|NCT00451958|79479731|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
44471491|NCT00451958|79479732|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
44471492|NCT00451958|79479733|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
44471493|NCT00451958|79479734|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
44225568|NCT01967069|79031074|FG001|Overall Study|Withdrawal by Subject|3|||
44225569|NCT01967069|79031073|FG000|Overall Study|Lack of Efficacy|0|||
44225570|NCT01967069|79031074|FG001|Overall Study|Lack of Efficacy|1|||
44273930|NCT02259114|79215723|FG001|Overall Study|Adverse Event|1|||
44544512|NCT03552757|79557954|FG000|Overall Study|Death|1|||
44225571|NCT01790503|79031091|FG000|Overall Study|Adverse Event|1|||
44471494|NCT00432276|79479750|FG000|Overall Study|Hyperglycemic Rescue|44|||
44471495|NCT00432276|79479751|FG001|Overall Study|Hyperglycemic Rescue|87|||
44471496|NCT00432276|79479750|FG000|Overall Study|Adverse Event|13|||
44471497|NCT00432276|79479751|FG001|Overall Study|Adverse Event|16|||
44471498|NCT00432276|79479750|FG000|Overall Study|Protocol Violation|25|||
44471499|NCT00432276|79479751|FG001|Overall Study|Protocol Violation|20|||
44471500|NCT00432276|79479750|FG000|Overall Study|Lost to Follow-up|6|||
44471501|NCT00432276|79479751|FG001|Overall Study|Lost to Follow-up|2|||
44471502|NCT00432276|79479750|FG000|Overall Study|Withdrawal by Subject|25|||
44471503|NCT00432276|79479751|FG001|Overall Study|Withdrawal by Subject|20|||
44471504|NCT00432276|79479750|FG000|Overall Study|Physician Decision|6|||
44471505|NCT00432276|79479751|FG001|Overall Study|Physician Decision|8|||
44471506|NCT00432276|79479750|FG000|Overall Study|Other|2|||
44471507|NCT00432276|79479751|FG001|Overall Study|Other|3|||
44471508|NCT00413010|79479759|FG000|Overall Study|Adverse Event|8|||
44471509|NCT00413010|79479760|FG001|Overall Study|Adverse Event|4|||
44471510|NCT00413010|79479759|FG000|Overall Study|Laboratory abnormality|0|||
44471511|NCT00413010|79479760|FG001|Overall Study|Laboratory abnormality|2|||
44471512|NCT00413010|79479759|FG000|Overall Study|Lack of Efficacy|0|||
44471513|NCT00413010|79479760|FG001|Overall Study|Lack of Efficacy|3|||
44471514|NCT00413010|79479759|FG000|Overall Study|Lost to Follow-up|3|||
44471515|NCT00413010|79479760|FG001|Overall Study|Lost to Follow-up|0|||
44471516|NCT00413010|79479759|FG000|Overall Study|Withdrawal by Subject|7|||
44471517|NCT00413010|79479760|FG001|Overall Study|Withdrawal by Subject|2|||
44471518|NCT00413010|79479759|FG000|Overall Study|Due to termination of the study|54|||
44471519|NCT00413010|79479760|FG001|Overall Study|Due to termination of the study|52|||
44471520|NCT00459290|79479766|FG000|Overall Study|Adverse Event|3|||
44471521|NCT00459290|79479766|FG000|Overall Study|Ineligible|2|||
44471522|NCT00443534|79479777|FG000|Overall Study|Lack of Efficacy|67|||
44471523|NCT00443534|79479777|FG000|Overall Study|Adverse Event|16|||
44471524|NCT00443534|79479777|FG000|Overall Study|Death|9|||
44471525|NCT00443534|79479777|FG000|Overall Study|Withdrawal by Subject|8|||
44471526|NCT00443534|79479777|FG000|Overall Study|Study Terminated by Sponsor|12|||
44471527|NCT00443534|79479777|FG000|Overall Study|Other|10|||
44471528|NCT00443534|79479777|FG000|Overall Study|Enrolled, Not Treated|1|||
44471529|NCT00419952|79479783|FG000|Overall Study|Adverse Event|8|||
44471530|NCT00419952|79479784|FG001|Overall Study|Adverse Event|10|||
44471531|NCT00419952|79479783|FG000|Overall Study|Withdrawal by Subject|44|||
44471532|NCT00419952|79479784|FG001|Overall Study|Withdrawal by Subject|43|||
44471533|NCT00419952|79479783|FG000|Overall Study|Lost to Follow-up|43|||
44471534|NCT00419952|79479784|FG001|Overall Study|Lost to Follow-up|34|||
44471535|NCT00419952|79479783|FG000|Overall Study|Protocol Violation|32|||
44471536|NCT00419952|79479784|FG001|Overall Study|Protocol Violation|24|||
44471537|NCT00419952|79479783|FG000|Overall Study|Pregnancy|4|||
44471538|NCT00419952|79479784|FG001|Overall Study|Pregnancy|2|||
44471539|NCT00419952|79479783|FG000|Overall Study|Physician Decision|1|||
44471540|NCT00419952|79479784|FG001|Overall Study|Physician Decision|3|||
44471541|NCT00419952|79479783|FG000|Overall Study|Incorrectly enrolled|10|||
44471542|NCT00419952|79479784|FG001|Overall Study|Incorrectly enrolled|3|||
44471543|NCT00419952|79479783|FG000|Overall Study|Intake of prohibited medication|2|||
44471544|NCT00419952|79479784|FG001|Overall Study|Intake of prohibited medication|2|||
44471545|NCT00419952|79479783|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
44471546|NCT00419952|79479784|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
44471547|NCT00419952|79479783|FG000|Overall Study|Diary or medication non-compliance|2|||
44225572|NCT01790503|79031092|FG001|Overall Study|Adverse Event|0|||
44225573|NCT01790503|79031093|FG002|Overall Study|Adverse Event|0|||
44225574|NCT01790503|79031094|FG003|Overall Study|Adverse Event|0|||
44225575|NCT01790503|79031095|FG004|Overall Study|Adverse Event|0|||
44225576|NCT01790503|79031096|FG005|Overall Study|Adverse Event|2|||
44225577|NCT01790503|79031097|FG006|Overall Study|Adverse Event|0|||
44225578|NCT01790503|79031098|FG007|Overall Study|Adverse Event|0|||
44471548|NCT00419952|79479784|FG001|Overall Study|Diary or medication non-compliance|4|||
44225579|NCT01790503|79031099|FG008|Overall Study|Adverse Event|2|||
44375387|NCT00944034|79380589|FG004|Overall Study|Withdrawal by Subject|5|||
44471549|NCT00419952|79479783|FG000|Overall Study|Abnormal ECG|1|||
44471550|NCT00419952|79479784|FG001|Overall Study|Abnormal ECG|0|||
44471551|NCT00443456|79479790|FG000|Overall Study|Adverse Event|16|||
44471552|NCT00443456|79479790|FG000|Overall Study|Move|1|||
44471553|NCT00443456|79479790|FG000|Overall Study|Withdrawal by Subject|1|||
44471554|NCT00419562|79479800|FG000|Overall Study|Lost to Follow-up|12|||
44471555|NCT00419562|79479801|FG001|Overall Study|Lost to Follow-up|13|||
44471556|NCT00419562|79479800|FG000|Overall Study|Withdrawal by Subject|20|||
44471557|NCT00419562|79479801|FG001|Overall Study|Withdrawal by Subject|18|||
44471558|NCT00419562|79479800|FG000|Overall Study|Participant Institutionalized|1|||
44225580|NCT01790503|79031100|FG009|Overall Study|Adverse Event|4|||
44225581|NCT01790503|79031101|FG010|Overall Study|Adverse Event|7|||
44471559|NCT00419562|79479801|FG001|Overall Study|Participant Institutionalized|0|||
44471560|NCT00432042|79479810|FG000|Overall Study|Protocol Violation|2|||
44225582|NCT01790503|79031091|FG000|Overall Study|Withdrawal by Subject|0|||
44225583|NCT01790503|79031092|FG001|Overall Study|Withdrawal by Subject|0|||
44225584|NCT01790503|79031093|FG002|Overall Study|Withdrawal by Subject|1|||
44471561|NCT00432042|79479811|FG001|Overall Study|Protocol Violation|0|||
44225585|NCT01790503|79031094|FG003|Overall Study|Withdrawal by Subject|1|||
44225586|NCT01790503|79031095|FG004|Overall Study|Withdrawal by Subject|1|||
44225587|NCT01790503|79031096|FG005|Overall Study|Withdrawal by Subject|2|||
44225588|NCT01790503|79031097|FG006|Overall Study|Withdrawal by Subject|1|||
44225589|NCT01790503|79031098|FG007|Overall Study|Withdrawal by Subject|0|||
44225590|NCT01790503|79031099|FG008|Overall Study|Withdrawal by Subject|0|||
44225591|NCT01790503|79031100|FG009|Overall Study|Withdrawal by Subject|0|||
44225592|NCT01790503|79031101|FG010|Overall Study|Withdrawal by Subject|1|||
44225593|NCT01790503|79031091|FG000|Overall Study|Disease progression|2|||
44471562|NCT00432042|79479812|FG002|Overall Study|Protocol Violation|0|||
44471563|NCT00432042|79479810|FG000|Overall Study|Withdrawal by Subject|0|||
44471564|NCT00432042|79479811|FG001|Overall Study|Withdrawal by Subject|0|||
44471565|NCT00432042|79479812|FG002|Overall Study|Withdrawal by Subject|2|||
44471566|NCT00432042|79479810|FG000|Overall Study|Lost to Follow-up|5|||
44471567|NCT00432042|79479811|FG001|Overall Study|Lost to Follow-up|1|||
44471568|NCT00432042|79479812|FG002|Overall Study|Lost to Follow-up|0|||
44471569|NCT00308139|79479822|FG000|Overall Study|Adverse Event|20|||
44471570|NCT00308139|79479823|FG001|Overall Study|Adverse Event|14|||
44471571|NCT00308139|79479822|FG000|Overall Study|Lost to Follow-up|13|||
44471572|NCT00308139|79479823|FG001|Overall Study|Lost to Follow-up|8|||
44471573|NCT00308139|79479822|FG000|Overall Study|Protocol Violation|3|||
44471574|NCT00308139|79479823|FG001|Overall Study|Protocol Violation|2|||
44471575|NCT00308139|79479822|FG000|Overall Study|Withdrawal of Consent|40|||
44471576|NCT00308139|79479823|FG001|Overall Study|Withdrawal of Consent|42|||
44471577|NCT00308139|79479822|FG000|Overall Study|Investigator Decision|11|||
44471578|NCT00308139|79479823|FG001|Overall Study|Investigator Decision|10|||
44471579|NCT00308139|79479822|FG000|Overall Study|Loss of Glucose Control|5|||
44471580|NCT00308139|79479823|FG001|Overall Study|Loss of Glucose Control|7|||
44471581|NCT00308139|79479822|FG000|Overall Study|Administrative|1|||
44471582|NCT00308139|79479823|FG001|Overall Study|Administrative|4|||
44471583|NCT00308139|79479822|FG000|Overall Study|Other|1|||
44471584|NCT00308139|79479823|FG001|Overall Study|Other|0|||
44471585|NCT00459134|79479851|FG000|Overall Study|Physician Decision|1|||
44471586|NCT00459134|79479852|FG001|Overall Study|Physician Decision|1|||
44471587|NCT00459134|79479851|FG000|Overall Study|Withdrawal by Subject|8|||
44471588|NCT00459134|79479852|FG001|Overall Study|Withdrawal by Subject|7|||
44471589|NCT00459134|79479851|FG000|Overall Study|Lost to Follow-up|6|||
44471590|NCT00459134|79479852|FG001|Overall Study|Lost to Follow-up|7|||
44471591|NCT00459134|79479851|FG000|Overall Study|Surgery|1|||
44471592|NCT00459134|79479852|FG001|Overall Study|Surgery|2|||
44471593|NCT00459134|79479851|FG000|Overall Study|Toxicity|4|||
44471594|NCT00459134|79479852|FG001|Overall Study|Toxicity|5|||
44471595|NCT00459134|79479851|FG000|Overall Study|Progression|1|||
44471596|NCT00459134|79479852|FG001|Overall Study|Progression|0|||
44471597|NCT00459134|79479851|FG000|Overall Study|Multiple Reasons|2|||
44471598|NCT00459134|79479852|FG001|Overall Study|Multiple Reasons|3|||
44471599|NCT00459056|79479860|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
44471600|NCT00459056|79479861|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
44471601|NCT00431964|79479869|FG000|Overall Study|Adverse Event|1|||
44471602|NCT00431964|79479870|FG001|Overall Study|Adverse Event|0|||
44471603|NCT00431964|79479869|FG000|Overall Study|Lost to Follow-up|1|||
44471604|NCT00431964|79479870|FG001|Overall Study|Lost to Follow-up|2|||
44471605|NCT00431964|79479869|FG000|Overall Study|Physician Decision|2|||
44471606|NCT00431964|79479870|FG001|Overall Study|Physician Decision|2|||
44471607|NCT00431964|79479869|FG000|Overall Study|Withdrawal by Subject|2|||
44471608|NCT00431964|79479870|FG001|Overall Study|Withdrawal by Subject|1|||
44471609|NCT00431964|79479869|FG000|Overall Study|Parental Consent Withdrawn|0|||
44471610|NCT00431964|79479870|FG001|Overall Study|Parental Consent Withdrawn|2|||
44471611|NCT00431964|79479869|FG000|Overall Study|Due to Unstable Health|0|||
44471612|NCT00431964|79479870|FG001|Overall Study|Due to Unstable Health|1|||
44471613|NCT00412854|79479878|FG000|Overall Study|Withdrawn due to adverse events|1|||
44471614|NCT00412854|79479879|FG001|Overall Study|Withdrawn due to adverse events|5|||
44471615|NCT00412854|79479878|FG000|Overall Study|Withdrawn for other reasons|13|||
44471616|NCT00412854|79479879|FG001|Overall Study|Withdrawn for other reasons|11|||
44225594|NCT01790503|79031092|FG001|Overall Study|Disease progression|1|||
44471617|NCT00431496|79479885|FG000|Overall Study|Adverse Event|3|||
44471618|NCT00431496|79479885|FG000|Overall Study|Lost to Follow-up|1|||
44225595|NCT01790503|79031093|FG002|Overall Study|Disease progression|0|||
44225596|NCT01790503|79031094|FG003|Overall Study|Disease progression|1|||
44225597|NCT01790503|79031095|FG004|Overall Study|Disease progression|2|||
44471619|NCT00431496|79479885|FG000|Overall Study|Withdrawal by Subject|2|||
44471620|NCT00431496|79479885|FG000|Overall Study|Protocol-specified criteria|5|||
44471621|NCT00316173|79479891|FG000|Run-in Phase|Adverse Event|1|||
44471622|NCT00316173|79479892|FG001|Run-in Phase|Adverse Event|0|||
44225598|NCT01790503|79031096|FG005|Overall Study|Disease progression|1|||
44225599|NCT01790503|79031097|FG006|Overall Study|Disease progression|0|||
44225600|NCT01790503|79031098|FG007|Overall Study|Disease progression|1|||
44225601|NCT01790503|79031099|FG008|Overall Study|Disease progression|0|||
44225602|NCT01790503|79031100|FG009|Overall Study|Disease progression|17|||
44225603|NCT01790503|79031101|FG010|Overall Study|Disease progression|7|||
44225604|NCT01790503|79031091|FG000|Overall Study|Protocol Violation|0|||
44225605|NCT01790503|79031092|FG001|Overall Study|Protocol Violation|0|||
44225606|NCT01790503|79031093|FG002|Overall Study|Protocol Violation|0|||
44225607|NCT01790503|79031094|FG003|Overall Study|Protocol Violation|0|||
44225608|NCT01790503|79031095|FG004|Overall Study|Protocol Violation|0|||
44225609|NCT01790503|79031096|FG005|Overall Study|Protocol Violation|0|||
44225610|NCT01790503|79031097|FG006|Overall Study|Protocol Violation|0|||
44225611|NCT01790503|79031098|FG007|Overall Study|Protocol Violation|0|||
44225612|NCT01790503|79031099|FG008|Overall Study|Protocol Violation|0|||
44225613|NCT01790503|79031100|FG009|Overall Study|Protocol Violation|1|||
44225614|NCT01790503|79031101|FG010|Overall Study|Protocol Violation|0|||
44225615|NCT01790503|79031091|FG000|Overall Study|Physician Decision|0|||
44225616|NCT01790503|79031092|FG001|Overall Study|Physician Decision|0|||
44225617|NCT01790503|79031093|FG002|Overall Study|Physician Decision|0|||
44225618|NCT01790503|79031094|FG003|Overall Study|Physician Decision|0|||
44225619|NCT01790503|79031095|FG004|Overall Study|Physician Decision|0|||
44225620|NCT01790503|79031096|FG005|Overall Study|Physician Decision|0|||
44225621|NCT01790503|79031097|FG006|Overall Study|Physician Decision|0|||
44225622|NCT01790503|79031098|FG007|Overall Study|Physician Decision|0|||
44225623|NCT01790503|79031099|FG008|Overall Study|Physician Decision|0|||
44225624|NCT01790503|79031100|FG009|Overall Study|Physician Decision|1|||
44225625|NCT01790503|79031101|FG010|Overall Study|Physician Decision|1|||
44225626|NCT01790503|79031091|FG000|Overall Study|Death|0|||
44225627|NCT01790503|79031092|FG001|Overall Study|Death|0|||
44225628|NCT01790503|79031093|FG002|Overall Study|Death|0|||
44225629|NCT01790503|79031094|FG003|Overall Study|Death|0|||
44225630|NCT01790503|79031095|FG004|Overall Study|Death|0|||
44225631|NCT01790503|79031096|FG005|Overall Study|Death|0|||
44225632|NCT01790503|79031097|FG006|Overall Study|Death|0|||
44225633|NCT01790503|79031098|FG007|Overall Study|Death|0|||
44225634|NCT01790503|79031099|FG008|Overall Study|Death|0|||
44225635|NCT01790503|79031100|FG009|Overall Study|Death|1|||
44225636|NCT01790503|79031101|FG010|Overall Study|Death|0|||
44225637|NCT01790503|79031091|FG000|Overall Study|Non Compliance|0|||
44225638|NCT01790503|79031092|FG001|Overall Study|Non Compliance|0|||
44225639|NCT01790503|79031093|FG002|Overall Study|Non Compliance|0|||
44225640|NCT01790503|79031094|FG003|Overall Study|Non Compliance|0|||
44225641|NCT01790503|79031095|FG004|Overall Study|Non Compliance|1|||
44225642|NCT01790503|79031096|FG005|Overall Study|Non Compliance|0|||
44225643|NCT01790503|79031097|FG006|Overall Study|Non Compliance|0|||
44225644|NCT01790503|79031098|FG007|Overall Study|Non Compliance|0|||
44225645|NCT01790503|79031099|FG008|Overall Study|Non Compliance|0|||
44225646|NCT01790503|79031100|FG009|Overall Study|Non Compliance|0|||
44225647|NCT01790503|79031101|FG010|Overall Study|Non Compliance|0|||
44225648|NCT01790503|79031091|FG000|Overall Study|Other|0|||
44225649|NCT01790503|79031092|FG001|Overall Study|Other|0|||
44225650|NCT01790503|79031093|FG002|Overall Study|Other|0|||
44225651|NCT01790503|79031094|FG003|Overall Study|Other|0|||
44225652|NCT01790503|79031095|FG004|Overall Study|Other|1|||
44225653|NCT01790503|79031096|FG005|Overall Study|Other|0|||
44225654|NCT01790503|79031097|FG006|Overall Study|Other|0|||
44225655|NCT01790503|79031098|FG007|Overall Study|Other|0|||
44225656|NCT01790503|79031099|FG008|Overall Study|Other|1|||
44225657|NCT01790503|79031100|FG009|Overall Study|Other|2|||
44225658|NCT01790503|79031101|FG010|Overall Study|Other|0|||
44225659|NCT01790113|79031140|FG000|Overall Study|Adverse Event|2|||
44225660|NCT01790113|79031141|FG001|Overall Study|Adverse Event|7|||
44225661|NCT01790113|79031140|FG000|Overall Study|Study ended due to FDA clearance|1|||
44225662|NCT01790113|79031141|FG001|Overall Study|Study ended due to FDA clearance|68|||
44225663|NCT01789567|79031147|FG000|Overall Study|Death|6|||
44225664|NCT01765543|79031151|FG000|Overall Study|Death|1|||
44225665|NCT01765543|79031151|FG000|Overall Study|Withdrawal by Subject|2|||
44225666|NCT01765153|79031161|FG000|Training Phase 1|Format of intervention differed|1|||
44225667|NCT01765153|79031162|FG001|Training Phase 1|Format of intervention differed|0|||
44225668|NCT01765153|79031161|FG000|Training Phase 1|Poor participation in intervention|0|||
44225669|NCT01765153|79031162|FG001|Training Phase 1|Poor participation in intervention|1|||
44225670|NCT01765153|79031161|FG000|Rest Phase 1|Withdrawal by Subject|0|||
44225671|NCT01765153|79031162|FG001|Rest Phase 1|Withdrawal by Subject|1|||
44225672|NCT01765153|79031161|FG000|Training Phase 2|Withdrawal by Subject|0|||
44225673|NCT01765153|79031162|FG001|Training Phase 2|Withdrawal by Subject|1|||
44225674|NCT01765153|79031161|FG000|Rest Phase 2|Lost to Follow-up|2|||
44225675|NCT01765153|79031162|FG001|Rest Phase 2|Lost to Follow-up|1|||
44225676|NCT00248170|79031174|FG000|Overall Study|Withdrawal by Subject|71|||
44225677|NCT00248170|79031175|FG001|Overall Study|Withdrawal by Subject|79|||
44225678|NCT00248170|79031174|FG000|Overall Study|Protocol Violation|35|||
44471623|NCT00316173|79479891|FG000|Run-in Phase|Protocol Violation|1|||
44471624|NCT00316173|79479892|FG001|Run-in Phase|Protocol Violation|0|||
44471625|NCT00316173|79479891|FG000|Run-in Phase|Study Follow-up Stopped|5|||
44225679|NCT00248170|79031175|FG001|Overall Study|Protocol Violation|30|||
44225680|NCT00248170|79031174|FG000|Overall Study|Lost to Follow-up|28|||
44471626|NCT00316173|79479892|FG001|Run-in Phase|Study Follow-up Stopped|0|||
44471627|NCT00316173|79479891|FG000|Treatment Phase|Adverse Event|0|||
44471628|NCT00316173|79479892|FG001|Treatment Phase|Adverse Event|1|||
44471629|NCT00316173|79479891|FG000|Treatment Phase|Lack of Efficacy|0|||
44471630|NCT00316173|79479892|FG001|Treatment Phase|Lack of Efficacy|3|||
44471631|NCT00316173|79479891|FG000|Treatment Phase|Lost to Follow-up|0|||
44471632|NCT00316173|79479892|FG001|Treatment Phase|Lost to Follow-up|3|||
44471633|NCT00316173|79479891|FG000|Treatment Phase|Withdrawal by Subject|0|||
44471634|NCT00316173|79479892|FG001|Treatment Phase|Withdrawal by Subject|1|||
44471635|NCT00316173|79479891|FG000|Treatment Phase|Study Follow-up Stopped|0|||
44471636|NCT00316173|79479892|FG001|Treatment Phase|Study Follow-up Stopped|34|||
44471637|NCT00412542|79479899|FG000|Overall Study|Withdrawal by Subject|0|||
44225681|NCT00248170|79031175|FG001|Overall Study|Lost to Follow-up|35|||
44225682|NCT00248170|79031174|FG000|Overall Study|Disease progression|196|||
44471638|NCT00412542|79479900|FG001|Overall Study|Withdrawal by Subject|2|||
44471639|NCT00412542|79479899|FG000|Overall Study|Not Eligible|0|||
44471640|NCT00412542|79479900|FG001|Overall Study|Not Eligible|1|||
44471641|NCT00316017|79479907|FG000|Overall Study|Protocol Violation|11|||
44471642|NCT00316017|79479908|FG001|Overall Study|Protocol Violation|13|||
44471643|NCT00316017|79479909|FG002|Overall Study|Protocol Violation|19|||
44471644|NCT00451178|79479919|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
44471645|NCT00451178|79479920|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
44471646|NCT00451178|79479919|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
44471647|NCT00451178|79479920|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
44471648|NCT00451178|79479919|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
44471649|NCT00451178|79479920|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
44471650|NCT00451178|79479919|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
44471651|NCT00451178|79479920|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
44471652|NCT00451178|79479919|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
44471653|NCT00451178|79479920|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
44471654|NCT00451178|79479919|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
44471655|NCT00451178|79479920|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
44471656|NCT00451178|79479919|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
44471657|NCT00451178|79479920|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
44471658|NCT00451178|79479919|FG000|Prior to Maintenance Therapy|PD|2|||
44471659|NCT00451178|79479920|FG001|Prior to Maintenance Therapy|PD|0|||
44471660|NCT00451178|79479919|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
44471661|NCT00451178|79479920|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
44471662|NCT00451178|79479919|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
44471663|NCT00451178|79479920|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
44471664|NCT00451178|79479919|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
44471665|NCT00451178|79479920|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
44471666|NCT00451178|79479919|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
44471667|NCT00451178|79479920|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
44471668|NCT00451178|79479919|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
44471669|NCT00451178|79479920|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
44471670|NCT00451178|79479919|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
44471671|NCT00451178|79479920|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
44471672|NCT00451178|79479919|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
44471673|NCT00451178|79479920|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
44471674|NCT00450866|79479930|FG000|Overall Study|Adverse Event|0|||
44471675|NCT00450866|79479931|FG001|Overall Study|Adverse Event|1|||
44471676|NCT00450866|79479930|FG000|Overall Study|Withdrawal by Subject|5|||
44544513|NCT03552757|79557955|FG001|Overall Study|Death|1|||
44225683|NCT00248170|79031175|FG001|Overall Study|Disease progression|216|||
44225684|NCT00248170|79031174|FG000|Overall Study|Death|28|||
44225685|NCT00248170|79031175|FG001|Overall Study|Death|47|||
44225686|NCT00248170|79031174|FG000|Overall Study|Adverse Event|311|||
44471677|NCT00450866|79479931|FG001|Overall Study|Withdrawal by Subject|2|||
44471678|NCT00450866|79479930|FG000|Overall Study|Death|1|||
44471679|NCT00450866|79479931|FG001|Overall Study|Death|0|||
44544514|NCT03552757|79557956|FG002|Overall Study|Death|1|||
44544515|NCT03730103|79557969|FG000|Overall Study|Did not meet inclusion criteria|0|||
44544516|NCT03730103|79557970|FG001|Overall Study|Did not meet inclusion criteria|5|||
44471680|NCT00450866|79479930|FG000|Overall Study|Physician Decision|1|||
44471681|NCT00450866|79479931|FG001|Overall Study|Physician Decision|0|||
44544517|NCT03727841|79557978|FG000|Overall Study|Physician Decision|3|||
44544518|NCT03727841|79557979|FG001|Overall Study|Physician Decision|1|||
44225687|NCT00248170|79031175|FG001|Overall Study|Adverse Event|296|||
44471682|NCT00442598|79479940|FG000|Overall Study|Adverse Event|1|||
44471683|NCT00442598|79479941|FG001|Overall Study|Adverse Event|0|||
44471684|NCT00442598|79479942|FG002|Overall Study|Adverse Event|0|||
44471685|NCT00442598|79479940|FG000|Overall Study|Tumor progression|3|||
44471686|NCT00442598|79479941|FG001|Overall Study|Tumor progression|4|||
44471687|NCT00442598|79479942|FG002|Overall Study|Tumor progression|0|||
44471688|NCT00442598|79479940|FG000|Overall Study|Clinical deterioration|1|||
44471689|NCT00442598|79479941|FG001|Overall Study|Clinical deterioration|2|||
44471690|NCT00442598|79479942|FG002|Overall Study|Clinical deterioration|0|||
44471691|NCT00442598|79479940|FG000|Overall Study|CA125 progression|0|||
44471692|NCT00442598|79479941|FG001|Overall Study|CA125 progression|1|||
44225688|NCT00248170|79031174|FG000|Overall Study|Administrative problems|22|||
44225689|NCT00248170|79031175|FG001|Overall Study|Administrative problems|25|||
44225690|NCT00248170|79031174|FG000|Overall Study|Abnormal test procedure(s) result|49|||
44225691|NCT00248170|79031175|FG001|Overall Study|Abnormal test procedure(s) result|61|||
44471693|NCT00442598|79479942|FG002|Overall Study|CA125 progression|0|||
44471694|NCT00442598|79479940|FG000|Overall Study|Reduced creatinine clearance|1|||
44471695|NCT00442598|79479941|FG001|Overall Study|Reduced creatinine clearance|0|||
44471696|NCT00442598|79479942|FG002|Overall Study|Reduced creatinine clearance|0|||
44471697|NCT00442598|79479940|FG000|Overall Study|Death|0|||
44471698|NCT00442598|79479941|FG001|Overall Study|Death|1|||
44471699|NCT00442598|79479942|FG002|Overall Study|Death|0|||
44471700|NCT00442286|79479952|FG000|Overall Study|Death|2|||
44471701|NCT00442286|79479953|FG001|Overall Study|Death|2|||
44471702|NCT00442286|79479952|FG000|Overall Study|Lost to Follow-up|1|||
44471703|NCT00442286|79479953|FG001|Overall Study|Lost to Follow-up|0|||
44471704|NCT00442286|79479952|FG000|Overall Study|Withdrawal by Subject|2|||
44471705|NCT00442286|79479953|FG001|Overall Study|Withdrawal by Subject|0|||
44471706|NCT00442286|79479952|FG000|Overall Study|System explanted|1|||
44471707|NCT00442286|79479953|FG001|Overall Study|System explanted|0|||
44471708|NCT00442286|79479952|FG000|Overall Study|Patient Injury|1|||
44471709|NCT00442286|79479953|FG001|Overall Study|Patient Injury|0|||
44471710|NCT00441974|79479961|FG000|Overall Study|Adverse Event|6|||
44471711|NCT00441974|79479961|FG000|Overall Study|Consent Withdrawn|35|||
44471712|NCT00441974|79479961|FG000|Overall Study|Lost to Follow-up|80|||
44471713|NCT00441974|79479961|FG000|Overall Study|Protocol Violation|7|||
44471714|NCT00441584|79479968|FG000|Overall Study|Lack of Efficacy|79|||
44471715|NCT00441584|79479968|FG000|Overall Study|Withdrawal by Subject|8|||
44471716|NCT00441584|79479968|FG000|Overall Study|Adverse Event|6|||
44471717|NCT00441584|79479968|FG000|Overall Study|Protocol Violation|5|||
44471718|NCT00441584|79479968|FG000|Overall Study|Lost to Follow-up|4|||
44471719|NCT00441584|79479968|FG000|Overall Study|Failure to meet eligibility criteria|3|||
44471720|NCT00430716|79479975|FG000|Double Blind Phase|Death|1|||
44471721|NCT00430716|79479976|FG001|Double Blind Phase|Death|0|||
44471722|NCT00430716|79479977|FG002|Double Blind Phase|Death|0|||
44471723|NCT00430716|79479975|FG000|Double Blind Phase|No longer willing to participate|2|||
44143749|NCT02732119|78933070|FG004|Phase II|Study terminated by sponsor|2|||
44225692|NCT00248170|79031174|FG000|Overall Study|Abnormal laboratory values|4|||
44225693|NCT00248170|79031175|FG001|Overall Study|Abnormal laboratory values|0|||
44225694|NCT00248170|79031174|FG000|Overall Study|Protocol deviation|17|||
44225695|NCT00248170|79031175|FG001|Overall Study|Protocol deviation|19|||
44471724|NCT00430716|79479976|FG001|Double Blind Phase|No longer willing to participate|1|||
44471725|NCT00430716|79479977|FG002|Double Blind Phase|No longer willing to participate|1|||
44471726|NCT00430716|79479975|FG000|Double Blind Phase|Other|0|||
44471727|NCT00430716|79479976|FG001|Double Blind Phase|Other|2|||
44471728|NCT00430716|79479977|FG002|Double Blind Phase|Other|0|||
44471729|NCT00430716|79479975|FG000|Double Blind Phase|Study terminated by sponsor|1|||
44471730|NCT00430716|79479976|FG001|Double Blind Phase|Study terminated by sponsor|1|||
44471731|NCT00430716|79479977|FG002|Double Blind Phase|Study terminated by sponsor|2|||
44471732|NCT00430716|79479975|FG000|Double Blind Phase|Adverse Event|1|||
44471733|NCT00430716|79479976|FG001|Double Blind Phase|Adverse Event|1|||
44471734|NCT00430716|79479977|FG002|Double Blind Phase|Adverse Event|3|||
44471735|NCT00430716|79479975|FG000|Double Blind Phase|Not treated|1|||
44471736|NCT00430716|79479976|FG001|Double Blind Phase|Not treated|0|||
44471737|NCT00430716|79479977|FG002|Double Blind Phase|Not treated|0|||
44471738|NCT00430716|79479975|FG000|Open Label Phase|Lost to Follow-up|1|||
44471739|NCT00430716|79479976|FG001|Open Label Phase|Lost to Follow-up|0|||
44143750|NCT02732119|78933066|FG000|Phase II|Other|0|||
44143751|NCT02732119|78933067|FG001|Phase II|Other|0|||
44143752|NCT02732119|78933068|FG002|Phase II|Other|0|||
44143753|NCT02732119|78933069|FG003|Phase II|Other|2|||
44143754|NCT02732119|78933070|FG004|Phase II|Other|0|||
44143755|NCT02732119|78933066|FG000|Phase II|Physician Decision|0|||
44143756|NCT02732119|78933067|FG001|Phase II|Physician Decision|0|||
44143757|NCT02732119|78933068|FG002|Phase II|Physician Decision|0|||
44143758|NCT02732119|78933069|FG003|Phase II|Physician Decision|8|||
44143759|NCT02732119|78933070|FG004|Phase II|Physician Decision|5|||
44143760|NCT03252925|78933093|FG000|Overall Study|Withdrawal by Subject|1|||
44143761|NCT03252925|78933094|FG001|Overall Study|Withdrawal by Subject|0|||
44471740|NCT00430716|79479977|FG002|Open Label Phase|Lost to Follow-up|1|||
44471741|NCT00430716|79479975|FG000|Open Label Phase|No longer willing to participate|0|||
44471742|NCT00430716|79479976|FG001|Open Label Phase|No longer willing to participate|1|||
44471743|NCT00430716|79479977|FG002|Open Label Phase|No longer willing to participate|1|||
44471744|NCT00430716|79479975|FG000|Open Label Phase|Other|3|||
44471745|NCT00430716|79479976|FG001|Open Label Phase|Other|1|||
44471746|NCT00430716|79479977|FG002|Open Label Phase|Other|1|||
44471747|NCT00430716|79479975|FG000|Open Label Phase|Protocol Violation|1|||
44471748|NCT00430716|79479976|FG001|Open Label Phase|Protocol Violation|0|||
44471749|NCT00430716|79479977|FG002|Open Label Phase|Protocol Violation|0|||
44471750|NCT00430716|79479975|FG000|Open Label Phase|Study terminated by sponsor|4|||
44471751|NCT00430716|79479976|FG001|Open Label Phase|Study terminated by sponsor|5|||
44471752|NCT00430716|79479977|FG002|Open Label Phase|Study terminated by sponsor|4|||
44471753|NCT00441272|79479987|FG000|Overall Study|Study terminated prior to enrollment|25|||
44471754|NCT00441272|79479988|FG001|Overall Study|Study terminated prior to enrollment|25|||
44471755|NCT00430638|79479996|FG000|Overall Study|Adverse Event|15|||
44471756|NCT00430638|79479997|FG001|Overall Study|Adverse Event|15|||
44471757|NCT00430638|79479996|FG000|Overall Study|Uncontrolled blood pressure|48|||
44471758|NCT00430638|79479997|FG001|Overall Study|Uncontrolled blood pressure|13|||
44471759|NCT00430638|79479996|FG000|Overall Study|Lost to Follow-up|1|||
44471760|NCT00430638|79479997|FG001|Overall Study|Lost to Follow-up|7|||
44471761|NCT00430638|79479996|FG000|Overall Study|Protocol Violation|6|||
44471762|NCT00430638|79479997|FG001|Overall Study|Protocol Violation|4|||
44471763|NCT00430638|79479996|FG000|Overall Study|Withdrawal by Subject|4|||
44471764|NCT00430638|79479997|FG001|Overall Study|Withdrawal by Subject|6|||
44471765|NCT00430638|79479996|FG000|Overall Study|Non-compliant|2|||
44471766|NCT00430638|79479997|FG001|Overall Study|Non-compliant|1|||
44471767|NCT00430638|79479996|FG000|Overall Study|Other|2|||
44471768|NCT00430638|79479997|FG001|Overall Study|Other|2|||
44471769|NCT00430482|79480009|FG000|Completed Treatment|Insufficient Treatment|7|||
44471770|NCT00430482|79480010|FG001|Completed Treatment|Insufficient Treatment|11|||
44471771|NCT00449930|79480018|FG000|Overall Study|Adverse Event|9|||
44471772|NCT00449930|79480019|FG001|Overall Study|Adverse Event|19|||
44471773|NCT00449930|79480018|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
44471774|NCT00449930|79480019|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
44471775|NCT00449930|79480018|FG000|Overall Study|Lack of Efficacy|10|||
44471776|NCT00449930|79480019|FG001|Overall Study|Lack of Efficacy|1|||
44471777|NCT00449930|79480018|FG000|Overall Study|Lost to Follow-up|9|||
44471778|NCT00449930|79480019|FG001|Overall Study|Lost to Follow-up|14|||
44471779|NCT00449930|79480018|FG000|Overall Study|Physician Decision|1|||
44471780|NCT00449930|79480019|FG001|Overall Study|Physician Decision|2|||
44471781|NCT00449930|79480018|FG000|Overall Study|Protocol Violation|14|||
44471782|NCT00449930|79480019|FG001|Overall Study|Protocol Violation|15|||
44471783|NCT00449930|79480018|FG000|Overall Study|Withdrawal by Subject|16|||
44471784|NCT00449930|79480019|FG001|Overall Study|Withdrawal by Subject|23|||
44471785|NCT00449930|79480018|FG000|Overall Study|Glycemic discontinuation criteria|1|||
44471786|NCT00449930|79480019|FG001|Overall Study|Glycemic discontinuation criteria|1|||
44471787|NCT00449696|79480027|FG000|Overall Study|Other Treatment Required|6|||
44471788|NCT00449696|79480028|FG001|Overall Study|Other Treatment Required|1|||
44471789|NCT00449696|79480027|FG000|Overall Study|Withdrawal by Subject|5|||
44471790|NCT00449696|79480028|FG001|Overall Study|Withdrawal by Subject|5|||
44471791|NCT00449696|79480027|FG000|Overall Study|Lost to Follow-up|2|||
44471792|NCT00449696|79480028|FG001|Overall Study|Lost to Follow-up|3|||
44471793|NCT00449696|79480027|FG000|Overall Study|Others|7|||
44471794|NCT00449696|79480028|FG001|Overall Study|Others|0|||
44471795|NCT00441116|79480036|FG000|Overall Study|Adverse Event|1|||
44471796|NCT00441116|79480037|FG001|Overall Study|Adverse Event|1|||
44471797|NCT00441116|79480036|FG000|Overall Study|Withdrawal by Subject|1|||
44471798|NCT00441116|79480037|FG001|Overall Study|Withdrawal by Subject|0|||
44471799|NCT00441116|79480036|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
44471800|NCT00441116|79480037|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
44471801|NCT00430248|79480046|FG000|Overall Study|Adverse Event|49|||
44471802|NCT00430248|79480047|FG001|Overall Study|Adverse Event|61|||
44471803|NCT00430248|79480048|FG002|Overall Study|Adverse Event|64|||
44471804|NCT00430248|79480046|FG000|Overall Study|Protocol Violation|10|||
44471805|NCT00430248|79480047|FG001|Overall Study|Protocol Violation|2|||
44471806|NCT00430248|79480048|FG002|Overall Study|Protocol Violation|4|||
44471807|NCT00430248|79480046|FG000|Overall Study|Personal Reasons|12|||
44471808|NCT00430248|79480047|FG001|Overall Study|Personal Reasons|24|||
44471809|NCT00430248|79480048|FG002|Overall Study|Personal Reasons|9|||
44471810|NCT00430248|79480046|FG000|Overall Study|Lost to Follow-up|28|||
44471811|NCT00430248|79480047|FG001|Overall Study|Lost to Follow-up|33|||
44471812|NCT00430248|79480048|FG002|Overall Study|Lost to Follow-up|28|||
44471813|NCT00430248|79480046|FG000|Overall Study|Therapeutic Failure|1|||
44471814|NCT00430248|79480047|FG001|Overall Study|Therapeutic Failure|1|||
44471815|NCT00430248|79480048|FG002|Overall Study|Therapeutic Failure|1|||
44471816|NCT00430248|79480046|FG000|Overall Study|Withdrawal by Subject|14|||
44471817|NCT00430248|79480047|FG001|Overall Study|Withdrawal by Subject|20|||
44471818|NCT00430248|79480048|FG002|Overall Study|Withdrawal by Subject|16|||
44471819|NCT00430248|79480046|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44471820|NCT00430248|79480047|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
44471821|NCT00430248|79480048|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44471822|NCT00430248|79480046|FG000|Overall Study|Gout Flare|3|||
44471823|NCT00430248|79480047|FG001|Overall Study|Gout Flare|7|||
44471824|NCT00430248|79480048|FG002|Overall Study|Gout Flare|2|||
44471825|NCT00430248|79480046|FG000|Overall Study|Reason Not Specified|8|||
44471826|NCT00430248|79480047|FG001|Overall Study|Reason Not Specified|8|||
44471827|NCT00430248|79480048|FG002|Overall Study|Reason Not Specified|11|||
44471828|NCT00449540|79480058|FG000|Pretreatment Phase|No migraine experienced|66|||
44471829|NCT00449540|79480059|FG001|Pretreatment Phase|No migraine experienced|0|||
44471830|NCT00449540|79480060|FG002|Pretreatment Phase|No migraine experienced|0|||
44471831|NCT00449540|79480058|FG000|Treatment Phase|did not experience or treat migraine|0|||
44471832|NCT00449540|79480059|FG001|Treatment Phase|did not experience or treat migraine|20|||
44471833|NCT00449540|79480060|FG002|Treatment Phase|did not experience or treat migraine|17|||
44471834|NCT00411762|79480068|FG000|Overall Study|Withdrawal by Subject|5|||
44471835|NCT00429858|79480072|FG000|Overall Study|Withdrawal by Subject|1|||
44471836|NCT00429858|79480072|FG000|Overall Study|Study Termination|1|||
44471837|NCT00449150|79480080|FG000|Overall Study|Adverse Event|11|||
44471838|NCT00449150|79480081|FG001|Overall Study|Adverse Event|18|||
44471839|NCT00449150|79480082|FG002|Overall Study|Adverse Event|9|||
44471840|NCT00449150|79480080|FG000|Overall Study|Lack of Efficacy|1|||
44471841|NCT00449150|79480081|FG001|Overall Study|Lack of Efficacy|2|||
44471842|NCT00449150|79480082|FG002|Overall Study|Lack of Efficacy|2|||
44471843|NCT00449150|79480080|FG000|Overall Study|Other|16|||
44471844|NCT00449150|79480081|FG001|Overall Study|Other|13|||
44471845|NCT00449150|79480082|FG002|Overall Study|Other|14|||
44471846|NCT00449150|79480080|FG000|Overall Study|Withdrawal by Subject|17|||
44471847|NCT00449150|79480081|FG001|Overall Study|Withdrawal by Subject|18|||
44471848|NCT00449150|79480082|FG002|Overall Study|Withdrawal by Subject|21|||
44471849|NCT00449150|79480080|FG000|Overall Study|Protocol Violation|1|||
44471850|NCT00449150|79480081|FG001|Overall Study|Protocol Violation|2|||
44471851|NCT00449150|79480082|FG002|Overall Study|Protocol Violation|1|||
44471852|NCT00428844|79480096|FG000|Completed Study Drug Treatment|Adverse Event|2|||
44471853|NCT00428844|79480097|FG001|Completed Study Drug Treatment|Adverse Event|4|||
44471854|NCT00428844|79480098|FG002|Completed Study Drug Treatment|Adverse Event|4|||
44471855|NCT00428844|79480096|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
44471856|NCT00428844|79480097|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
44471857|NCT00428844|79480098|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
44471858|NCT00428844|79480096|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
44471859|NCT00428844|79480097|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
44273931|NCT02259114|79215724|FG002|Overall Study|Adverse Event|0|||
44273932|NCT02259114|79215725|FG003|Overall Study|Adverse Event|0|||
44273933|NCT02259114|79215726|FG004|Overall Study|Adverse Event|1|||
44273934|NCT02259114|79215722|FG000|Overall Study|Death|3|||
44471860|NCT00428844|79480098|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
44471861|NCT00428844|79480096|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
44471862|NCT00428844|79480097|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
44471863|NCT00428844|79480098|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
44471864|NCT00428844|79480096|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
44471865|NCT00428844|79480097|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
44471866|NCT00428844|79480098|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
44471867|NCT00428844|79480096|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
44471868|NCT00428844|79480097|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
44471869|NCT00428844|79480098|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
44471870|NCT00428844|79480096|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
44471871|NCT00428844|79480097|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
44471872|NCT00428844|79480098|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
44471873|NCT00428844|79480096|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
44471874|NCT00428844|79480097|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
44225696|NCT01764997|79031186|FG000|Run-in Period|Adverse Event|15|||
44225697|NCT01764997|79031187|FG001|Run-in Period|Adverse Event|0|||
44225698|NCT01764997|79031188|FG002|Run-in Period|Adverse Event|0|||
44225699|NCT01764997|79031189|FG003|Run-in Period|Adverse Event|0|||
44544519|NCT03552523|79557985|FG000|Overall Study|Withdrawal by Subject|1|||
44544520|NCT03552523|79557986|FG001|Overall Study|Withdrawal by Subject|1|||
44225700|NCT01764997|79031190|FG004|Run-in Period|Adverse Event|0|||
44225701|NCT01764997|79031186|FG000|Run-in Period|Lack of Efficacy|5|||
44471875|NCT00428844|79480098|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
44225702|NCT01764997|79031187|FG001|Run-in Period|Lack of Efficacy|0|||
44225703|NCT01764997|79031188|FG002|Run-in Period|Lack of Efficacy|0|||
44225704|NCT01764997|79031189|FG003|Run-in Period|Lack of Efficacy|0|||
44225705|NCT01764997|79031190|FG004|Run-in Period|Lack of Efficacy|0|||
44471876|NCT00428844|79480096|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
44471877|NCT00428844|79480097|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
44471878|NCT00428844|79480098|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
44471879|NCT00457418|79480106|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
44471880|NCT00457418|79480106|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
44471881|NCT00457418|79480106|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
44471882|NCT00457418|79480106|FG000|Post PK Maintenance|Adverse Event|10|||
44471883|NCT00457418|79480106|FG000|Post PK Maintenance|Progression of Disease|6|||
44471884|NCT00457418|79480106|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
44471885|NCT00457418|79480106|FG000|Post PK Maintenance|Lost to Follow-up|1|||
44471886|NCT00449072|79480112|FG000|Overall Study|Adverse Event|3|||
44471887|NCT00449072|79480113|FG001|Overall Study|Adverse Event|1|||
44471888|NCT00449072|79480112|FG000|Overall Study|Protocol Violation|14|||
44471889|NCT00449072|79480113|FG001|Overall Study|Protocol Violation|12|||
44471890|NCT00449072|79480112|FG000|Overall Study|Lost to Follow-up|5|||
44471891|NCT00449072|79480113|FG001|Overall Study|Lost to Follow-up|7|||
44471892|NCT00449072|79480112|FG000|Overall Study|Withdrawal by Subject|11|||
44471893|NCT00449072|79480113|FG001|Overall Study|Withdrawal by Subject|8|||
44471894|NCT00449072|79480112|FG000|Overall Study|Lack of Efficacy|1|||
44471895|NCT00449072|79480113|FG001|Overall Study|Lack of Efficacy|1|||
44471896|NCT00449072|79480112|FG000|Overall Study|Physician Decision|1|||
44471897|NCT00449072|79480113|FG001|Overall Study|Physician Decision|0|||
44471898|NCT00449072|79480112|FG000|Overall Study|Not treated|0|||
44471899|NCT00449072|79480113|FG001|Overall Study|Not treated|1|||
44471900|NCT00449072|79480112|FG000|Overall Study|Excluded medication|0|||
44471901|NCT00449072|79480113|FG001|Overall Study|Excluded medication|2|||
44471902|NCT00449072|79480112|FG000|Overall Study|Non-compliance|2|||
44471903|NCT00449072|79480113|FG001|Overall Study|Non-compliance|5|||
44471904|NCT00449072|79480112|FG000|Overall Study|Sponsor decision|1|||
44471905|NCT00449072|79480113|FG001|Overall Study|Sponsor decision|3|||
44471906|NCT00449072|79480112|FG000|Overall Study|Relocation|3|||
44471907|NCT00449072|79480113|FG001|Overall Study|Relocation|2|||
44471908|NCT00428610|79480122|FG000|Overall Study|Death Due to Adverse Event|3|||
44471909|NCT00428610|79480123|FG001|Overall Study|Death Due to Adverse Event|0|||
44471910|NCT00428610|79480124|FG002|Overall Study|Death Due to Adverse Event|5|||
44471911|NCT00428610|79480122|FG000|Overall Study|Death Due to Progressive Disease|0|||
44471912|NCT00428610|79480123|FG001|Overall Study|Death Due to Progressive Disease|0|||
44471913|NCT00428610|79480124|FG002|Overall Study|Death Due to Progressive Disease|2|||
44471914|NCT00428610|79480122|FG000|Overall Study|Adverse Event|2|||
44471915|NCT00428610|79480123|FG001|Overall Study|Adverse Event|3|||
44471916|NCT00428610|79480124|FG002|Overall Study|Adverse Event|2|||
44471917|NCT00428610|79480122|FG000|Overall Study|Investigator Decision|2|||
44471918|NCT00428610|79480123|FG001|Overall Study|Investigator Decision|1|||
44471919|NCT00428610|79480124|FG002|Overall Study|Investigator Decision|1|||
44471920|NCT00428610|79480122|FG000|Overall Study|Progressive Disease|42|||
44471921|NCT00428610|79480123|FG001|Overall Study|Progressive Disease|14|||
44471922|NCT00428610|79480124|FG002|Overall Study|Progressive Disease|22|||
44471923|NCT00428610|79480122|FG000|Overall Study|Withdrawal by Subject|4|||
44471924|NCT00428610|79480123|FG001|Overall Study|Withdrawal by Subject|0|||
44471925|NCT00428610|79480124|FG002|Overall Study|Withdrawal by Subject|0|||
44471926|NCT00419094|79480134|FG000|Overall Study|Adverse Event|3|||
44471927|NCT00419094|79480135|FG001|Overall Study|Adverse Event|7|||
44225706|NCT01764997|79031186|FG000|Run-in Period|Poor compliance to protocol|1|||
44225707|NCT01764997|79031187|FG001|Run-in Period|Poor compliance to protocol|0|||
44225708|NCT01764997|79031188|FG002|Run-in Period|Poor compliance to protocol|0|||
44471928|NCT00419094|79480134|FG000|Overall Study|Lack of Efficacy|1|||
44225709|NCT01764997|79031189|FG003|Run-in Period|Poor compliance to protocol|0|||
44225710|NCT01764997|79031190|FG004|Run-in Period|Poor compliance to protocol|0|||
44225711|NCT01764997|79031186|FG000|Run-in Period|Other than specified above|17|||
44225712|NCT01764997|79031187|FG001|Run-in Period|Other than specified above|0|||
44225713|NCT01764997|79031188|FG002|Run-in Period|Other than specified above|0|||
44225714|NCT01764997|79031189|FG003|Run-in Period|Other than specified above|0|||
44225715|NCT01764997|79031190|FG004|Run-in Period|Other than specified above|0|||
44273935|NCT02259114|79215723|FG001|Overall Study|Death|0|||
44471929|NCT00419094|79480135|FG001|Overall Study|Lack of Efficacy|0|||
44225716|NCT01764997|79031186|FG000|Study Drug Treatment Period|Adverse Event|0|||
44471930|NCT00419094|79480134|FG000|Overall Study|Lost to Follow-up|0|||
44471931|NCT00419094|79480135|FG001|Overall Study|Lost to Follow-up|2|||
44471932|NCT00419094|79480134|FG000|Overall Study|Protocol Violation|1|||
44471933|NCT00419094|79480135|FG001|Overall Study|Protocol Violation|14|||
44471934|NCT00419094|79480134|FG000|Overall Study|Withdrawal of consent|1|||
44471935|NCT00419094|79480135|FG001|Overall Study|Withdrawal of consent|5|||
44471936|NCT00419094|79480134|FG000|Overall Study|Other: Error determining exit criteria|1|||
44471937|NCT00419094|79480135|FG001|Overall Study|Other: Error determining exit criteria|0|||
44471938|NCT00419094|79480134|FG000|Overall Study|Other: Patient non-compliant|0|||
44225717|NCT01764997|79031187|FG001|Study Drug Treatment Period|Adverse Event|1|||
44471939|NCT00419094|79480135|FG001|Overall Study|Other: Patient non-compliant|1|||
44471940|NCT00419094|79480134|FG000|Overall Study|Other: No contact for extended period|0|||
44471941|NCT00419094|79480135|FG001|Overall Study|Other: No contact for extended period|1|||
44471942|NCT00448916|79480145|FG000|Overall Study|Adverse Event|2|||
44471943|NCT00448916|79480146|FG001|Overall Study|Adverse Event|2|||
44471944|NCT00448916|79480147|FG002|Overall Study|Adverse Event|3|||
44471945|NCT00448916|79480148|FG003|Overall Study|Adverse Event|2|||
44471946|NCT00448916|79480145|FG000|Overall Study|Lack of Efficacy|1|||
44471947|NCT00448916|79480146|FG001|Overall Study|Lack of Efficacy|0|||
44471948|NCT00448916|79480147|FG002|Overall Study|Lack of Efficacy|2|||
44471949|NCT00448916|79480148|FG003|Overall Study|Lack of Efficacy|1|||
44471950|NCT00448916|79480145|FG000|Overall Study|Withdrawal by Subject|3|||
44471951|NCT00448916|79480146|FG001|Overall Study|Withdrawal by Subject|3|||
44471952|NCT00448916|79480147|FG002|Overall Study|Withdrawal by Subject|1|||
44471953|NCT00448916|79480148|FG003|Overall Study|Withdrawal by Subject|1|||
44471954|NCT00448916|79480145|FG000|Overall Study|Other|1|||
44471955|NCT00448916|79480146|FG001|Overall Study|Other|0|||
44471956|NCT00448916|79480147|FG002|Overall Study|Other|0|||
44471957|NCT00448916|79480148|FG003|Overall Study|Other|0|||
44471958|NCT00448916|79480145|FG000|Overall Study|Lost to Follow-up|0|||
44471959|NCT00448916|79480146|FG001|Overall Study|Lost to Follow-up|1|||
44471960|NCT00448916|79480147|FG002|Overall Study|Lost to Follow-up|0|||
44471961|NCT00448916|79480148|FG003|Overall Study|Lost to Follow-up|1|||
44471962|NCT00448916|79480145|FG000|Overall Study|Protocol Violation|0|||
44471963|NCT00448916|79480146|FG001|Overall Study|Protocol Violation|0|||
44471964|NCT00448916|79480147|FG002|Overall Study|Protocol Violation|0|||
44471965|NCT00448916|79480148|FG003|Overall Study|Protocol Violation|1|||
44471966|NCT00418938|79480162|FG000|Overall Study|Reimbursement|1|||
44471967|NCT00418938|79480163|FG001|Overall Study|Reimbursement|0|||
44471968|NCT00418938|79480162|FG000|Overall Study|Administrative decision|3|||
44471969|NCT00418938|79480163|FG001|Overall Study|Administrative decision|3|||
44471970|NCT00418938|79480162|FG000|Overall Study|Withdrawal by Subject|16|||
44471971|NCT00418938|79480163|FG001|Overall Study|Withdrawal by Subject|15|||
44471972|NCT00418938|79480162|FG000|Overall Study|Lost to Follow-up|1|||
44471973|NCT00418938|79480163|FG001|Overall Study|Lost to Follow-up|3|||
44471974|NCT00418938|79480162|FG000|Overall Study|Adverse Event|1|||
44471975|NCT00418938|79480163|FG001|Overall Study|Adverse Event|1|||
44471976|NCT00418938|79480162|FG000|Overall Study|On-going|1|||
44471977|NCT00418938|79480163|FG001|Overall Study|On-going|1|||
44471978|NCT00418938|79480162|FG000|Overall Study|Ineligibility Determined|1|||
44471979|NCT00418938|79480163|FG001|Overall Study|Ineligibility Determined|0|||
44471980|NCT00448760|79480169|FG000|Overall Study|Death|3|||
44471981|NCT00418314|79480175|FG000|Overall Study|Withdrawal by Subject|1|||
44471982|NCT00418314|79480176|FG001|Overall Study|Withdrawal by Subject|2|||
44471983|NCT00448448|79480184|FG000|Overall Study|Withdrawal by Subject|13|||
44471984|NCT00448448|79480185|FG001|Overall Study|Withdrawal by Subject|2|||
44471985|NCT00448448|79480184|FG000|Overall Study|On protocol when study ended|83|||
44471986|NCT00448448|79480185|FG001|Overall Study|On protocol when study ended|36|||
44471987|NCT00448448|79480184|FG000|Overall Study|Lost to Follow-up|2|||
44471988|NCT00448448|79480185|FG001|Overall Study|Lost to Follow-up|1|||
44471989|NCT00448448|79480184|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
44471990|NCT00448448|79480185|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
44471991|NCT00448448|79480184|FG000|Overall Study|Signed consent lost|0|||
44471992|NCT00448448|79480185|FG001|Overall Study|Signed consent lost|1|||
44471993|NCT00405912|79480194|FG000|Overall Study|Withdrawal by Subject|12|||
44471994|NCT00405912|79480195|FG001|Overall Study|Withdrawal by Subject|11|||
44471995|NCT00405912|79480196|FG002|Overall Study|Withdrawal by Subject|12|||
44471996|NCT00405912|79480194|FG000|Overall Study|Lost to Follow-up|4|||
44471997|NCT00405912|79480195|FG001|Overall Study|Lost to Follow-up|8|||
44471998|NCT00405912|79480196|FG002|Overall Study|Lost to Follow-up|4|||
44273936|NCT02259114|79215724|FG002|Overall Study|Death|1|||
44273937|NCT02259114|79215725|FG003|Overall Study|Death|0|||
44471999|NCT00448136|79480206|FG000|Overall Study|Death|3|||
44472000|NCT00448136|79480207|FG001|Overall Study|Death|8|||
44472001|NCT00448136|79480206|FG000|Overall Study|Investigator's decision (progression)|1|||
44472002|NCT00448136|79480207|FG001|Overall Study|Investigator's decision (progression)|0|||
44472003|NCT00447902|79480215|FG000|Overall Study|Adverse Event|0|||
44472004|NCT00447902|79480216|FG001|Overall Study|Adverse Event|3|||
44472005|NCT00447902|79480215|FG000|Overall Study|Protocol Violation|1|||
44472006|NCT00447902|79480216|FG001|Overall Study|Protocol Violation|0|||
44472007|NCT00447902|79480215|FG000|Overall Study|Withdrawal by Subject|0|||
44472008|NCT00447902|79480216|FG001|Overall Study|Withdrawal by Subject|1|||
44472009|NCT00447902|79480215|FG000|Overall Study|included patients who discontinued|1|||
44472010|NCT00447902|79480216|FG001|Overall Study|included patients who discontinued|1|||
44472011|NCT00447902|79480215|FG000|Overall Study|Lack of Efficacy|2|||
44273938|NCT02259114|79215726|FG004|Overall Study|Death|0|||
44472012|NCT00447902|79480216|FG001|Overall Study|Lack of Efficacy|1|||
44472013|NCT00307437|79480225|FG000|Controlled Period|Adverse Event|7|||
44472014|NCT00307437|79480226|FG001|Controlled Period|Adverse Event|2|||
44472015|NCT00307437|79480227|FG002|Controlled Period|Adverse Event|5|||
44472016|NCT00307437|79480228|FG003|Controlled Period|Adverse Event|0|||
44472017|NCT00307437|79480229|FG004|Controlled Period|Adverse Event|0|||
44472018|NCT00307437|79480230|FG005|Controlled Period|Adverse Event|0|||
44472019|NCT00307437|79480231|FG006|Controlled Period|Adverse Event|0|||
44472020|NCT00307437|79480225|FG000|Controlled Period|Death|0|||
44472021|NCT00307437|79480226|FG001|Controlled Period|Death|0|||
44472022|NCT00307437|79480227|FG002|Controlled Period|Death|1|||
44472023|NCT00307437|79480228|FG003|Controlled Period|Death|0|||
44472024|NCT00307437|79480229|FG004|Controlled Period|Death|0|||
44472025|NCT00307437|79480230|FG005|Controlled Period|Death|0|||
44225718|NCT01764997|79031188|FG002|Study Drug Treatment Period|Adverse Event|0|||
44472026|NCT00307437|79480231|FG006|Controlled Period|Death|0|||
44472027|NCT00307437|79480225|FG000|Controlled Period|Lack of Efficacy|2|||
44472028|NCT00307437|79480226|FG001|Controlled Period|Lack of Efficacy|0|||
44472029|NCT00307437|79480227|FG002|Controlled Period|Lack of Efficacy|0|||
44472030|NCT00307437|79480228|FG003|Controlled Period|Lack of Efficacy|0|||
44472031|NCT00307437|79480229|FG004|Controlled Period|Lack of Efficacy|0|||
44472032|NCT00307437|79480230|FG005|Controlled Period|Lack of Efficacy|0|||
44472033|NCT00307437|79480231|FG006|Controlled Period|Lack of Efficacy|0|||
44472034|NCT00307437|79480225|FG000|Controlled Period|Lost to Follow-up|2|||
44472035|NCT00307437|79480226|FG001|Controlled Period|Lost to Follow-up|3|||
44472036|NCT00307437|79480227|FG002|Controlled Period|Lost to Follow-up|0|||
44472037|NCT00307437|79480228|FG003|Controlled Period|Lost to Follow-up|0|||
44472038|NCT00307437|79480229|FG004|Controlled Period|Lost to Follow-up|0|||
44472039|NCT00307437|79480230|FG005|Controlled Period|Lost to Follow-up|0|||
44472040|NCT00307437|79480231|FG006|Controlled Period|Lost to Follow-up|0|||
44472041|NCT00307437|79480225|FG000|Controlled Period|Other|5|||
44472042|NCT00307437|79480226|FG001|Controlled Period|Other|1|||
44472043|NCT00307437|79480227|FG002|Controlled Period|Other|3|||
44472044|NCT00307437|79480228|FG003|Controlled Period|Other|0|||
44472045|NCT00307437|79480229|FG004|Controlled Period|Other|0|||
44472046|NCT00307437|79480230|FG005|Controlled Period|Other|0|||
44472047|NCT00307437|79480231|FG006|Controlled Period|Other|0|||
44472048|NCT00307437|79480225|FG000|After Controlled Period|Adverse Event|0|||
44225719|NCT01764997|79031189|FG003|Study Drug Treatment Period|Adverse Event|0|||
44225720|NCT01764997|79031190|FG004|Study Drug Treatment Period|Adverse Event|24|||
44225721|NCT01764997|79031186|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
44225722|NCT01764997|79031187|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
44273939|NCT02259114|79215722|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
44273940|NCT02259114|79215723|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
44225723|NCT01764997|79031188|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
44225724|NCT01764997|79031189|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
44225725|NCT01764997|79031190|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
44225726|NCT01764997|79031186|FG000|Study Drug Treatment Period|Other than specified above|0|||
44225727|NCT01764997|79031187|FG001|Study Drug Treatment Period|Other than specified above|0|||
44225728|NCT01764997|79031188|FG002|Study Drug Treatment Period|Other than specified above|0|||
44225729|NCT01764997|79031189|FG003|Study Drug Treatment Period|Other than specified above|0|||
44225730|NCT01764997|79031190|FG004|Study Drug Treatment Period|Other than specified above|10|||
44225731|NCT01276756|79031202|FG000|Overall Study|Lost to Follow-up|2|||
44225732|NCT01276756|79031203|FG001|Overall Study|Lost to Follow-up|0|||
44225733|NCT01276756|79031202|FG000|Overall Study|Adverse Event|3|||
44273941|NCT02259114|79215724|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
44273942|NCT02259114|79215725|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
44273943|NCT02259114|79215726|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
44273944|NCT02259114|79215722|FG000|Overall Study|Withdrawal by Subject|0|||
44273945|NCT02259114|79215723|FG001|Overall Study|Withdrawal by Subject|0|||
44273946|NCT02259114|79215724|FG002|Overall Study|Withdrawal by Subject|1|||
44273947|NCT02259114|79215725|FG003|Overall Study|Withdrawal by Subject|1|||
44273948|NCT02259114|79215726|FG004|Overall Study|Withdrawal by Subject|0|||
44273949|NCT02259114|79215722|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
44273950|NCT02259114|79215723|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
44273951|NCT02259114|79215724|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
44375388|NCT00944034|79380590|FG005|Overall Study|Withdrawal by Subject|8|||
44472049|NCT00307437|79480226|FG001|After Controlled Period|Adverse Event|0|||
44472050|NCT00307437|79480227|FG002|After Controlled Period|Adverse Event|0|||
44472051|NCT00307437|79480228|FG003|After Controlled Period|Adverse Event|18|||
44472052|NCT00307437|79480229|FG004|After Controlled Period|Adverse Event|16|||
44225734|NCT01276756|79031203|FG001|Overall Study|Adverse Event|2|||
44273952|NCT02259114|79215725|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
44273953|NCT02259114|79215726|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
44375389|NCT00944034|79380591|FG006|Overall Study|Withdrawal by Subject|2|||
44472053|NCT00307437|79480230|FG005|After Controlled Period|Adverse Event|31|||
44472054|NCT00307437|79480231|FG006|After Controlled Period|Adverse Event|40|||
44472055|NCT00307437|79480225|FG000|After Controlled Period|Death|0|||
44472056|NCT00307437|79480226|FG001|After Controlled Period|Death|0|||
44472057|NCT00307437|79480227|FG002|After Controlled Period|Death|0|||
44472058|NCT00307437|79480228|FG003|After Controlled Period|Death|3|||
44472059|NCT00307437|79480229|FG004|After Controlled Period|Death|1|||
44472060|NCT00307437|79480230|FG005|After Controlled Period|Death|1|||
44472061|NCT00307437|79480231|FG006|After Controlled Period|Death|3|||
44472062|NCT00307437|79480225|FG000|After Controlled Period|Lack of Efficacy|0|||
44472063|NCT00307437|79480226|FG001|After Controlled Period|Lack of Efficacy|0|||
44472064|NCT00307437|79480227|FG002|After Controlled Period|Lack of Efficacy|0|||
44472065|NCT00307437|79480228|FG003|After Controlled Period|Lack of Efficacy|15|||
44472066|NCT00307437|79480229|FG004|After Controlled Period|Lack of Efficacy|17|||
44472067|NCT00307437|79480230|FG005|After Controlled Period|Lack of Efficacy|37|||
44472068|NCT00307437|79480231|FG006|After Controlled Period|Lack of Efficacy|24|||
44472069|NCT00307437|79480225|FG000|After Controlled Period|Lost to Follow-up|0|||
44472070|NCT00307437|79480226|FG001|After Controlled Period|Lost to Follow-up|0|||
44472071|NCT00307437|79480227|FG002|After Controlled Period|Lost to Follow-up|0|||
44472072|NCT00307437|79480228|FG003|After Controlled Period|Lost to Follow-up|7|||
44472073|NCT00307437|79480229|FG004|After Controlled Period|Lost to Follow-up|12|||
44472074|NCT00307437|79480230|FG005|After Controlled Period|Lost to Follow-up|13|||
44472075|NCT00307437|79480231|FG006|After Controlled Period|Lost to Follow-up|18|||
44472076|NCT00307437|79480225|FG000|After Controlled Period|Other|0|||
44472077|NCT00307437|79480226|FG001|After Controlled Period|Other|0|||
44472078|NCT00307437|79480227|FG002|After Controlled Period|Other|0|||
44472079|NCT00307437|79480228|FG003|After Controlled Period|Other|15|||
44472080|NCT00307437|79480229|FG004|After Controlled Period|Other|9|||
44472081|NCT00307437|79480230|FG005|After Controlled Period|Other|40|||
44472082|NCT00307437|79480231|FG006|After Controlled Period|Other|28|||
44472083|NCT00440726|79480256|FG000|Phase 1|Dose-Limiting Toxicity|0|||
44472084|NCT00440726|79480257|FG001|Phase 1|Dose-Limiting Toxicity|1|||
44472085|NCT00440726|79480258|FG002|Phase 1|Dose-Limiting Toxicity|0|||
44472086|NCT00440726|79480256|FG000|Phase 1|Physician Decision|1|||
44472087|NCT00440726|79480257|FG001|Phase 1|Physician Decision|0|||
44472088|NCT00440726|79480258|FG002|Phase 1|Physician Decision|0|||
44472089|NCT00440726|79480256|FG000|Phase 2|Death|0|||
44472090|NCT00440726|79480257|FG001|Phase 2|Death|0|||
44472091|NCT00440726|79480258|FG002|Phase 2|Death|1|||
44472092|NCT00440726|79480256|FG000|Phase 2|Adverse Event|0|||
44472093|NCT00440726|79480257|FG001|Phase 2|Adverse Event|0|||
44472094|NCT00440726|79480258|FG002|Phase 2|Adverse Event|1|||
44472095|NCT00447590|79480269|FG000|Overall Study|Withdrawal by Subject|26|||
44472096|NCT00447590|79480269|FG000|Overall Study|Lost to Follow-up|24|||
44472097|NCT00447590|79480269|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
44472098|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
44472099|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
44472100|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
44472101|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
44472102|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
44472103|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
44472104|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
44472105|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
44472106|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
44472107|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
44472108|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
44472109|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
44472110|NCT00447278|79480275|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
44472111|NCT00447278|79480276|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
44472112|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
44225735|NCT00246376|79031214|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
44225736|NCT00246376|79031215|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
44225737|NCT00246376|79031216|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
44225738|NCT00246376|79031217|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
44225739|NCT00246376|79031218|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
44225740|NCT00246376|79031214|FG000|Overall Study|Adverse Event|2|||
44225741|NCT00246376|79031215|FG001|Overall Study|Adverse Event|3|||
44472113|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
44472114|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
44472115|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
44472116|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
44472117|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
44225742|NCT00246376|79031216|FG002|Overall Study|Adverse Event|1|||
44225743|NCT00246376|79031217|FG003|Overall Study|Adverse Event|3|||
44472118|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
44472119|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
44472120|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
44472121|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
44472122|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
44472123|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
44472124|NCT00447278|79480275|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
44472125|NCT00447278|79480276|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
44472126|NCT00446966|79480285|FG000|Overall Study|Lost to Follow-up|10|||
44472127|NCT00446966|79480286|FG001|Overall Study|Lost to Follow-up|7|||
44472128|NCT00446654|79480294|FG000|Overall Study|Withdrawal by Subject|1|||
44472129|NCT00446654|79480295|FG001|Overall Study|Withdrawal by Subject|0|||
44472130|NCT00446654|79480294|FG000|Overall Study|Adverse Event|1|||
44472131|NCT00446654|79480295|FG001|Overall Study|Adverse Event|0|||
44472132|NCT00405756|79480304|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
44472133|NCT00405756|79480305|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
44472134|NCT00405756|79480306|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
44472135|NCT00405756|79480304|FG000|Double-blind Treatment|Adverse Event|31|||
44472136|NCT00405756|79480305|FG001|Double-blind Treatment|Adverse Event|27|||
44472137|NCT00405756|79480306|FG002|Double-blind Treatment|Adverse Event|12|||
44472138|NCT00405756|79480304|FG000|Double-blind Treatment|Disease Progression|47|||
44472139|NCT00405756|79480305|FG001|Double-blind Treatment|Disease Progression|81|||
44472140|NCT00405756|79480306|FG002|Double-blind Treatment|Disease Progression|102|||
44472141|NCT00405756|79480304|FG000|Double-blind Treatment|Lack of Efficacy|1|||
44472142|NCT00405756|79480305|FG001|Double-blind Treatment|Lack of Efficacy|4|||
44472143|NCT00405756|79480306|FG002|Double-blind Treatment|Lack of Efficacy|2|||
44472144|NCT00405756|79480304|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
44472145|NCT00405756|79480305|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
44472146|NCT00405756|79480306|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
44472147|NCT00405756|79480304|FG000|Double-blind Treatment|Lost to Follow-up|1|||
44472148|NCT00405756|79480305|FG001|Double-blind Treatment|Lost to Follow-up|0|||
44472149|NCT00405756|79480306|FG002|Double-blind Treatment|Lost to Follow-up|0|||
44472150|NCT00405756|79480304|FG000|Double-blind Treatment|Death|4|||
44472151|NCT00405756|79480305|FG001|Double-blind Treatment|Death|4|||
44472152|NCT00405756|79480306|FG002|Double-blind Treatment|Death|4|||
44472153|NCT00405756|79480304|FG000|Double-blind Treatment|Protocol Violation|1|||
44472154|NCT00405756|79480305|FG001|Double-blind Treatment|Protocol Violation|0|||
44472155|NCT00405756|79480306|FG002|Double-blind Treatment|Protocol Violation|2|||
44472156|NCT00405756|79480304|FG000|Double-blind Treatment|Other|7|||
44472157|NCT00405756|79480305|FG001|Double-blind Treatment|Other|4|||
44472158|NCT00405756|79480306|FG002|Double-blind Treatment|Other|4|||
44472159|NCT00405756|79480304|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
44472160|NCT00405756|79480305|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
44472161|NCT00405756|79480306|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
44472162|NCT00405756|79480304|FG000|Open-label Extension|Adverse Event|1|||
44472163|NCT00405756|79480305|FG001|Open-label Extension|Adverse Event|3|||
44472164|NCT00405756|79480306|FG002|Open-label Extension|Adverse Event|7|||
44472165|NCT00405756|79480304|FG000|Open-label Extension|Disease Progression|8|||
44472166|NCT00405756|79480305|FG001|Open-label Extension|Disease Progression|23|||
44472167|NCT00405756|79480306|FG002|Open-label Extension|Disease Progression|26|||
44472168|NCT00405756|79480304|FG000|Open-label Extension|Withdrawal by Subject|2|||
44472169|NCT00405756|79480305|FG001|Open-label Extension|Withdrawal by Subject|3|||
44472170|NCT00405756|79480306|FG002|Open-label Extension|Withdrawal by Subject|3|||
44472171|NCT00405756|79480304|FG000|Open-label Extension|Death|1|||
44472172|NCT00405756|79480305|FG001|Open-label Extension|Death|2|||
44472173|NCT00405756|79480306|FG002|Open-label Extension|Death|4|||
44472174|NCT00405756|79480304|FG000|Open-label Extension|Other|0|||
44472175|NCT00405756|79480305|FG001|Open-label Extension|Other|1|||
44472176|NCT00405756|79480306|FG002|Open-label Extension|Other|7|||
44472177|NCT00405756|79480304|FG000|Follow-up|Ongoing in Follow-up Period|52|||
44472178|NCT00405756|79480305|FG001|Follow-up|Ongoing in Follow-up Period|51|||
44472179|NCT00405756|79480306|FG002|Follow-up|Ongoing in Follow-up Period|60|||
44472180|NCT00405756|79480304|FG000|Follow-up|Death|21|||
44472181|NCT00405756|79480305|FG001|Follow-up|Death|31|||
44472182|NCT00405756|79480306|FG002|Follow-up|Death|24|||
44472183|NCT00405756|79480304|FG000|Follow-up|Lost to Follow-up|2|||
44472184|NCT00405756|79480305|FG001|Follow-up|Lost to Follow-up|8|||
44375390|NCT00944034|79380592|FG007|Overall Study|Withdrawal by Subject|2|||
44472185|NCT00405756|79480306|FG002|Follow-up|Lost to Follow-up|4|||
44472186|NCT00456092|79480317|FG000|Extension Phase|Grade 2 or Greater AE|2|||
44472187|NCT00456092|79480318|FG001|Extension Phase|Grade 2 or Greater AE|2|||
44472188|NCT00456092|79480319|FG002|Extension Phase|Grade 2 or Greater AE|0|||
44472189|NCT00456092|79480320|FG003|Extension Phase|Grade 2 or Greater AE|0|||
44472190|NCT00456092|79480321|FG004|Extension Phase|Grade 2 or Greater AE|2|||
44472191|NCT00456092|79480317|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
44472192|NCT00456092|79480318|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
44472193|NCT00456092|79480319|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
44472194|NCT00456092|79480320|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
44472195|NCT00456092|79480321|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
44472196|NCT00456092|79480317|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
44472197|NCT00456092|79480318|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
44472198|NCT00456092|79480319|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
44472199|NCT00456092|79480320|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
44472200|NCT00456092|79480321|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
44472201|NCT00456092|79480317|FG000|Extension Phase|Withdrew Consent|2|||
44472202|NCT00456092|79480318|FG001|Extension Phase|Withdrew Consent|0|||
44472203|NCT00456092|79480319|FG002|Extension Phase|Withdrew Consent|0|||
44472204|NCT00456092|79480320|FG003|Extension Phase|Withdrew Consent|0|||
44472205|NCT00456092|79480321|FG004|Extension Phase|Withdrew Consent|0|||
44472206|NCT00456092|79480317|FG000|Extension Phase|Lost to Follow-up|1|||
44472207|NCT00456092|79480318|FG001|Extension Phase|Lost to Follow-up|1|||
44472208|NCT00456092|79480319|FG002|Extension Phase|Lost to Follow-up|0|||
44472209|NCT00456092|79480320|FG003|Extension Phase|Lost to Follow-up|0|||
44472210|NCT00456092|79480321|FG004|Extension Phase|Lost to Follow-up|1|||
44472211|NCT00456092|79480317|FG000|Extension Phase|Other|2|||
44472212|NCT00456092|79480318|FG001|Extension Phase|Other|0|||
44472213|NCT00456092|79480319|FG002|Extension Phase|Other|0|||
44472214|NCT00456092|79480320|FG003|Extension Phase|Other|1|||
44472215|NCT00456092|79480321|FG004|Extension Phase|Other|1|||
44472216|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
44472217|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
44472218|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
44472219|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
44472220|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
44472221|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
44472222|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
44472223|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
44472224|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
44472225|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
44472226|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
44472227|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
44472228|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
44472229|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
44472230|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
44472231|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
44472232|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
44472233|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
44472234|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
44472235|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
44472236|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
44472237|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
44472238|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
44472239|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
44472240|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
44472241|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
44472242|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
44472243|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
44472244|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
44472245|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
44472246|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
44472247|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
44472248|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
44472249|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
44472250|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
44472251|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
44472252|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
44472253|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
44472254|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
44472255|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
44472256|NCT00456092|79480317|FG000|Treatment Phase (12 Weeks)|Other|1|||
44225744|NCT00246376|79031218|FG004|Overall Study|Adverse Event|1|||
44225745|NCT00246376|79031214|FG000|Overall Study|Lost to Follow-up|2|||
44472257|NCT00456092|79480318|FG001|Treatment Phase (12 Weeks)|Other|0|||
44472258|NCT00456092|79480319|FG002|Treatment Phase (12 Weeks)|Other|1|||
44472259|NCT00456092|79480320|FG003|Treatment Phase (12 Weeks)|Other|0|||
44472260|NCT00456092|79480321|FG004|Treatment Phase (12 Weeks)|Other|0|||
44472261|NCT00411450|79480335|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
44472262|NCT00404820|79480343|FG000|Overall Study|Adverse Event|4|||
44472263|NCT00404820|79480344|FG001|Overall Study|Adverse Event|16|||
44472264|NCT00404820|79480343|FG000|Overall Study|Withdrawal by Subject|5|||
44472265|NCT00404820|79480344|FG001|Overall Study|Withdrawal by Subject|3|||
44472266|NCT00404820|79480343|FG000|Overall Study|Lost to Follow-up|7|||
44472267|NCT00404820|79480344|FG001|Overall Study|Lost to Follow-up|3|||
44472268|NCT00404820|79480343|FG000|Overall Study|Administrative problems|2|||
44472269|NCT00404820|79480344|FG001|Overall Study|Administrative problems|0|||
44472270|NCT00404820|79480343|FG000|Overall Study|Death|1|||
44472271|NCT00404820|79480344|FG001|Overall Study|Death|0|||
44472272|NCT00404820|79480343|FG000|Overall Study|Other|0|||
44472273|NCT00404820|79480344|FG001|Overall Study|Other|2|||
44472274|NCT00417612|79480352|FG000|Overall Study|Errant diagnosis|0|||
44472275|NCT00417612|79480353|FG001|Overall Study|Errant diagnosis|1|||
44472276|NCT00417612|79480352|FG000|Overall Study|Adverse Event|2|||
44472277|NCT00417612|79480353|FG001|Overall Study|Adverse Event|0|||
44472278|NCT00417612|79480352|FG000|Overall Study|Protocol Violation|0|||
44472279|NCT00417612|79480353|FG001|Overall Study|Protocol Violation|2|||
44472280|NCT00417612|79480352|FG000|Overall Study|Lost to Follow-up|1|||
44472281|NCT00417612|79480353|FG001|Overall Study|Lost to Follow-up|0|||
44472282|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
44472283|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
44472284|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
44472285|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
44472286|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
44472287|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
44472288|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
44472289|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
44472290|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
44472291|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
44472292|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
44472293|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
44472294|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
44472295|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
44472296|NCT00446030|79480363|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
44472297|NCT00446030|79480364|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
44472298|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
44472299|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
44472300|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
44472301|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
44472302|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
44472303|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
44225746|NCT00246376|79031215|FG001|Overall Study|Lost to Follow-up|11|||
44225747|NCT00246376|79031216|FG002|Overall Study|Lost to Follow-up|11|||
44225748|NCT00246376|79031217|FG003|Overall Study|Lost to Follow-up|16|||
44225749|NCT00246376|79031218|FG004|Overall Study|Lost to Follow-up|13|||
44225750|NCT01764841|79031276|FG000|Overall Study|Logistical Difficulties|0|||
44225751|NCT01764841|79031277|FG001|Overall Study|Logistical Difficulties|1|||
44225752|NCT01764841|79031278|FG002|Overall Study|Logistical Difficulties|0|||
44225753|NCT01764841|79031279|FG003|Overall Study|Logistical Difficulties|0|||
44225754|NCT01764841|79031276|FG000|Overall Study|Death|3|||
44225755|NCT01764841|79031277|FG001|Overall Study|Death|0|||
44225756|NCT01764841|79031278|FG002|Overall Study|Death|1|||
44225757|NCT01764841|79031279|FG003|Overall Study|Death|4|||
44472304|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
44544521|NCT03345550|79557994|FG000|Overall Study|Withdrawal by Subject|1|||
44544522|NCT03345550|79557995|FG001|Overall Study|Withdrawal by Subject|0|||
44544523|NCT03345550|79557994|FG000|Overall Study|Lost to Follow-up|4|||
44544524|NCT03345550|79557995|FG001|Overall Study|Lost to Follow-up|5|||
44544525|NCT03186378|79558003|FG000|Overall Study|Lost to Follow-up|1|||
44544526|NCT03186378|79558004|FG001|Overall Study|Lost to Follow-up|0|||
44544527|NCT00687596|79558012|FG000|Overall Study|Adverse Event (AE)|10|||
44544528|NCT00687596|79558013|FG001|Overall Study|Adverse Event (AE)|3|||
44375391|NCT00944034|79380593|FG008|Overall Study|Withdrawal by Subject|3|||
44472305|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
44544529|NCT00687596|79558012|FG000|Overall Study|Radiological Disease Progression|6|||
44544530|NCT00687596|79558013|FG001|Overall Study|Radiological Disease Progression|2|||
44225758|NCT01764841|79031276|FG000|Overall Study|No Follow Up|1|||
44472306|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
44472307|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
44472308|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
44472309|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
44472310|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
44472311|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
44544531|NCT00687596|79558012|FG000|Overall Study|Clinical Disease Progression|1|||
44544532|NCT00687596|79558013|FG001|Overall Study|Clinical Disease Progression|3|||
44472312|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
44472313|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
44472314|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
44472315|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
44472316|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
44472317|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
44472318|NCT00446030|79480363|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
44472319|NCT00446030|79480364|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
44472320|NCT00411216|79480372|FG000|Overall Study|Ten participants were entered into the c|0|||
44472321|NCT00411216|79480373|FG001|Overall Study|Ten participants were entered into the c|2|||
44472322|NCT00410514|79480382|FG000|Overall Study|Adverse Event|2|||
44472323|NCT00410514|79480383|FG001|Overall Study|Adverse Event|2|||
44472324|NCT00410514|79480384|FG002|Overall Study|Adverse Event|2|||
44472325|NCT00410514|79480382|FG000|Overall Study|Protocol Violation|0|||
44472326|NCT00410514|79480383|FG001|Overall Study|Protocol Violation|1|||
44472327|NCT00410514|79480384|FG002|Overall Study|Protocol Violation|1|||
44472328|NCT00410514|79480382|FG000|Overall Study|Lost to Follow-up|0|||
44472329|NCT00410514|79480383|FG001|Overall Study|Lost to Follow-up|0|||
44472330|NCT00410514|79480384|FG002|Overall Study|Lost to Follow-up|2|||
44472331|NCT00410514|79480382|FG000|Overall Study|Non-compliant with study procedures|0|||
44472332|NCT00410514|79480383|FG001|Overall Study|Non-compliant with study procedures|0|||
44472333|NCT00410514|79480384|FG002|Overall Study|Non-compliant with study procedures|2|||
44472334|NCT03847610|79480392|FG000|Overall Study|Withdrawal by Subject|1|||
44472335|NCT03843632|79480400|FG000|Overall Study|Withdrawal by Subject|1|||
44472336|NCT03843632|79480401|FG001|Overall Study|Withdrawal by Subject|0|||
44472337|NCT03843632|79480402|FG002|Overall Study|Withdrawal by Subject|0|||
44472338|NCT03843632|79480403|FG003|Overall Study|Withdrawal by Subject|0|||
44472339|NCT00439556|79480416|FG000|Overall Study|Patient was taken off study for non-comp|0|||
44472340|NCT00439556|79480417|FG001|Overall Study|Patient was taken off study for non-comp|1|||
44472341|NCT00439556|79480418|FG002|Overall Study|Patient was taken off study for non-comp|0|||
44472342|NCT00410202|79480430|FG000|On-Treatment|Continuing treatment|69|||
44472343|NCT00410202|79480431|FG001|On-Treatment|Continuing treatment|71|||
44472344|NCT00410202|79480432|FG002|On-Treatment|Continuing treatment|66|||
44472345|NCT00410202|79480430|FG000|On-Treatment|Adverse Event|1|||
44472346|NCT00410202|79480431|FG001|On-Treatment|Adverse Event|3|||
44472347|NCT00410202|79480432|FG002|On-Treatment|Adverse Event|2|||
44472348|NCT00410202|79480430|FG000|On-Treatment|Death|1|||
44472349|NCT00410202|79480431|FG001|On-Treatment|Death|0|||
44472350|NCT00410202|79480432|FG002|On-Treatment|Death|0|||
44472351|NCT00410202|79480430|FG000|On-Treatment|Lost to Follow-up|1|||
44472352|NCT00410202|79480431|FG001|On-Treatment|Lost to Follow-up|0|||
44472353|NCT00410202|79480432|FG002|On-Treatment|Lost to Follow-up|1|||
44472354|NCT00410202|79480430|FG000|On-Treatment|Lack of Efficacy|1|||
44472355|NCT00410202|79480431|FG001|On-Treatment|Lack of Efficacy|4|||
44472356|NCT00410202|79480432|FG002|On-Treatment|Lack of Efficacy|0|||
44472357|NCT00410202|79480430|FG000|On-Treatment|Withdrawal by Subject|2|||
44472358|NCT00410202|79480431|FG001|On-Treatment|Withdrawal by Subject|1|||
44472359|NCT00410202|79480432|FG002|On-Treatment|Withdrawal by Subject|1|||
44544533|NCT00687596|79558012|FG000|Overall Study|Investigator Discretion|3|||
44544534|NCT00687596|79558013|FG001|Overall Study|Investigator Discretion|1|||
44472360|NCT00410202|79480430|FG000|On-Treatment|Other Reason|0|||
44472361|NCT00410202|79480431|FG001|On-Treatment|Other Reason|0|||
44472362|NCT00410202|79480432|FG002|On-Treatment|Other Reason|1|||
44472363|NCT00410202|79480430|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
44472364|NCT00410202|79480431|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
44472365|NCT00410202|79480432|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
44472366|NCT00410202|79480430|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
44472367|NCT00410202|79480431|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
44472368|NCT00410202|79480432|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
44472369|NCT00410202|79480430|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
44472370|NCT00410202|79480431|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
44472371|NCT00410202|79480432|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
44472372|NCT00445328|79480443|FG000|Overall Study|Death|0|||
44472373|NCT00445328|79480444|FG001|Overall Study|Death|1|||
44472374|NCT00445328|79480443|FG000|Overall Study|Adverse Event|0|||
44472375|NCT00445328|79480444|FG001|Overall Study|Adverse Event|3|||
44472376|NCT00445328|79480443|FG000|Overall Study|Other|0|||
44472377|NCT00445328|79480444|FG001|Overall Study|Other|2|||
44472378|NCT00445328|79480443|FG000|Overall Study|Withdrawal by Subject|2|||
44472379|NCT00445328|79480444|FG001|Overall Study|Withdrawal by Subject|0|||
44472380|NCT00445328|79480443|FG000|Overall Study|Protocol Violation|1|||
44472381|NCT00445328|79480444|FG001|Overall Study|Protocol Violation|0|||
44472382|NCT00455312|79480452|FG000|Overall Study|Death|0|||
44472383|NCT00455312|79480453|FG001|Overall Study|Death|1|||
44472384|NCT00444626|79480459|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
44472385|NCT00444626|79480459|FG000|Initial Treatment Period|Adverse Event|1|||
44472386|NCT00444626|79480459|FG000|Initial Treatment Period|Lost to Follow-up|9|||
44472387|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
44472388|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
44472389|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
44472390|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
44472391|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
44472392|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
44472393|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
44472394|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
44472395|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
44472396|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
44472397|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
44472398|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
44472399|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
44472400|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
44472401|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
44472402|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
44472403|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
44472404|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
44472405|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Death|0|||
44472406|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Death|0|||
44472407|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Death|1|||
44472408|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Death|0|||
44472409|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Death|0|||
44472410|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Death|0|||
44472411|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Death|0|||
44472412|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Death|0|||
44472413|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Death|0|||
44472414|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
44472415|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
44472416|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
44472417|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
44472418|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
44472419|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
44472420|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
44472421|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
44472422|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
44472423|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
44472424|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
44472425|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
44472426|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
44472427|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
44472428|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
44472429|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
44472430|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
44472431|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
44472432|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
44472433|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
44472434|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
44472435|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
44472436|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
44472437|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
44472438|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
44472439|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
44472440|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
44472441|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
44472442|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
44472443|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
44472444|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
44472445|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
44472446|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
44472447|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
44225759|NCT01764841|79031277|FG001|Overall Study|No Follow Up|0|||
44472448|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
44472449|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
44472450|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
44472451|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
44472452|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
44472453|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
44472454|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
44472455|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
44472456|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
44472457|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
44472458|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
44472459|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472460|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
44472461|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472462|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472463|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472464|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472465|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472466|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472467|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
44472468|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
44472469|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
44472470|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
44472471|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
44472472|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
44472473|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
44472474|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
44472475|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
44472476|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
44472477|NCT00404352|79480486|FG000|Double Blind (up to 24 Month)|Other|0|||
44472478|NCT00404352|79480487|FG001|Double Blind (up to 24 Month)|Other|1|||
44472479|NCT00404352|79480488|FG002|Double Blind (up to 24 Month)|Other|0|||
44472480|NCT00404352|79480489|FG003|Double Blind (up to 24 Month)|Other|0|||
44472481|NCT00404352|79480490|FG004|Double Blind (up to 24 Month)|Other|0|||
44472482|NCT00404352|79480491|FG005|Double Blind (up to 24 Month)|Other|0|||
44472483|NCT00404352|79480492|FG006|Double Blind (up to 24 Month)|Other|0|||
44472484|NCT00404352|79480493|FG007|Double Blind (up to 24 Month)|Other|0|||
44472485|NCT00404352|79480494|FG008|Double Blind (up to 24 Month)|Other|0|||
44472486|NCT00404352|79480486|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
44472487|NCT00404352|79480487|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
44472488|NCT00404352|79480488|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
44472489|NCT00404352|79480489|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
44472490|NCT00404352|79480490|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
44472491|NCT00404352|79480491|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
44472492|NCT00404352|79480492|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
44472493|NCT00404352|79480493|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
44472494|NCT00404352|79480494|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
44472495|NCT00404352|79480486|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
44472496|NCT00404352|79480487|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
44472497|NCT00404352|79480488|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
44472498|NCT00404352|79480489|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
44472499|NCT00404352|79480490|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
44472500|NCT00404352|79480491|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
44472501|NCT00404352|79480492|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
44472502|NCT00404352|79480493|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
44472503|NCT00404352|79480494|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
44472504|NCT00404352|79480486|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472505|NCT00404352|79480487|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472506|NCT00404352|79480488|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472507|NCT00404352|79480489|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472508|NCT00404352|79480490|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
44472509|NCT00404352|79480491|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472510|NCT00404352|79480492|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472511|NCT00404352|79480493|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472512|NCT00404352|79480494|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
44472513|NCT00404352|79480486|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44225760|NCT01764841|79031278|FG002|Overall Study|No Follow Up|1|||
44225761|NCT01764841|79031279|FG003|Overall Study|No Follow Up|0|||
44472514|NCT00404352|79480487|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472515|NCT00404352|79480488|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472516|NCT00404352|79480489|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472517|NCT00404352|79480490|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472518|NCT00404352|79480491|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
44472519|NCT00404352|79480492|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472520|NCT00404352|79480493|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472521|NCT00404352|79480494|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
44472522|NCT00404352|79480486|FG000|Open Label (up to 24 Month)|Disease progression|0|||
44472523|NCT00404352|79480487|FG001|Open Label (up to 24 Month)|Disease progression|0|||
44472524|NCT00404352|79480488|FG002|Open Label (up to 24 Month)|Disease progression|0|||
44472525|NCT00404352|79480489|FG003|Open Label (up to 24 Month)|Disease progression|1|||
44472526|NCT00404352|79480490|FG004|Open Label (up to 24 Month)|Disease progression|0|||
44472527|NCT00404352|79480491|FG005|Open Label (up to 24 Month)|Disease progression|0|||
44472528|NCT00404352|79480492|FG006|Open Label (up to 24 Month)|Disease progression|0|||
44472529|NCT00404352|79480493|FG007|Open Label (up to 24 Month)|Disease progression|0|||
44472530|NCT00404352|79480494|FG008|Open Label (up to 24 Month)|Disease progression|0|||
44472531|NCT00404352|79480486|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472532|NCT00404352|79480487|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472533|NCT00404352|79480488|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472534|NCT00404352|79480489|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472535|NCT00404352|79480490|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472536|NCT00404352|79480491|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472537|NCT00404352|79480492|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
44472538|NCT00404352|79480493|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
44472539|NCT00404352|79480494|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
44472540|NCT00404352|79480486|FG000|Open Label Extension (up to 36 Months)|Other|0|||
44472541|NCT00404352|79480487|FG001|Open Label Extension (up to 36 Months)|Other|0|||
44472542|NCT00404352|79480488|FG002|Open Label Extension (up to 36 Months)|Other|0|||
44472543|NCT00404352|79480489|FG003|Open Label Extension (up to 36 Months)|Other|0|||
44472544|NCT00404352|79480490|FG004|Open Label Extension (up to 36 Months)|Other|0|||
44472545|NCT00404352|79480491|FG005|Open Label Extension (up to 36 Months)|Other|0|||
44472546|NCT00404352|79480492|FG006|Open Label Extension (up to 36 Months)|Other|0|||
44472547|NCT00404352|79480493|FG007|Open Label Extension (up to 36 Months)|Other|0|||
44472548|NCT00404352|79480494|FG008|Open Label Extension (up to 36 Months)|Other|2|||
44472549|NCT00439244|79480514|FG000|Overall Study|Adverse Event|5|||
44472550|NCT00439244|79480515|FG001|Overall Study|Adverse Event|2|||
44472551|NCT00439244|79480516|FG002|Overall Study|Adverse Event|3|||
44472552|NCT00439244|79480514|FG000|Overall Study|Withdrawal by Subject|3|||
44472553|NCT00439244|79480515|FG001|Overall Study|Withdrawal by Subject|1|||
44472554|NCT00439244|79480516|FG002|Overall Study|Withdrawal by Subject|2|||
44472555|NCT00439244|79480514|FG000|Overall Study|Lost to Follow-up|2|||
44472556|NCT00439244|79480515|FG001|Overall Study|Lost to Follow-up|1|||
44472557|NCT00439244|79480516|FG002|Overall Study|Lost to Follow-up|2|||
44472558|NCT00439244|79480514|FG000|Overall Study|Death|0|||
44472559|NCT00439244|79480515|FG001|Overall Study|Death|1|||
44472560|NCT00439244|79480516|FG002|Overall Study|Death|0|||
44472561|NCT00439244|79480514|FG000|Overall Study|Protocol Violation|0|||
44472562|NCT00439244|79480515|FG001|Overall Study|Protocol Violation|1|||
44472563|NCT00439244|79480516|FG002|Overall Study|Protocol Violation|0|||
44472564|NCT00439244|79480514|FG000|Overall Study|Administrative problems|1|||
44472565|NCT00439244|79480515|FG001|Overall Study|Administrative problems|0|||
44472566|NCT00439244|79480516|FG002|Overall Study|Administrative problems|0|||
44225762|NCT01764841|79031276|FG000|Overall Study|Protocol Violation|0|||
44225763|NCT01764841|79031277|FG001|Overall Study|Protocol Violation|1|||
44225764|NCT01764841|79031278|FG002|Overall Study|Protocol Violation|0|||
44225765|NCT01764841|79031279|FG003|Overall Study|Protocol Violation|0|||
44225766|NCT01764841|79031276|FG000|Overall Study|Withdrawal by Subject|16|||
44225767|NCT01764841|79031277|FG001|Overall Study|Withdrawal by Subject|24|||
44225768|NCT01764841|79031278|FG002|Overall Study|Withdrawal by Subject|11|||
44225769|NCT01764841|79031279|FG003|Overall Study|Withdrawal by Subject|15|||
44225770|NCT01764841|79031276|FG000|Overall Study|Lost to Follow-up|3|||
44225771|NCT01764841|79031277|FG001|Overall Study|Lost to Follow-up|0|||
44225772|NCT01764841|79031278|FG002|Overall Study|Lost to Follow-up|1|||
44225773|NCT01764841|79031279|FG003|Overall Study|Lost to Follow-up|0|||
44225774|NCT00245050|79031291|FG000|Overall Study|Adverse Event|3|||
44225775|NCT00245050|79031292|FG001|Overall Study|Adverse Event|2|||
44472567|NCT04844762|79480524|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472568|NCT04844762|79480525|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472569|NCT04844762|79480526|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
44472570|NCT04844762|79480527|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44225776|NCT00243412|79031330|FG000|Overall Study|Death|0|||
44225777|NCT00243412|79031331|FG001|Overall Study|Death|1|||
44225778|NCT00243412|79031330|FG000|Overall Study|Adverse Event|4|||
44225779|NCT00243412|79031331|FG001|Overall Study|Adverse Event|2|||
44472571|NCT04844762|79480528|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472572|NCT04844762|79480529|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472573|NCT04844762|79480524|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
44472574|NCT04844762|79480525|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
44472575|NCT04844762|79480526|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
44472576|NCT04844762|79480527|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
44472577|NCT04844762|79480528|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
44472578|NCT04844762|79480529|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
44472579|NCT04844762|79480524|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472580|NCT04844762|79480525|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472581|NCT04844762|79480526|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
44472582|NCT04844762|79480527|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
44472583|NCT04844762|79480528|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472584|NCT04844762|79480529|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
44472585|NCT04844762|79480524|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472586|NCT04844762|79480525|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472587|NCT04844762|79480526|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
44472588|NCT04844762|79480527|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
44472589|NCT04844762|79480528|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
44472590|NCT04844762|79480529|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472591|NCT04844762|79480524|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
44472592|NCT04844762|79480525|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
44472593|NCT04844762|79480526|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472594|NCT04844762|79480527|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472595|NCT04844762|79480528|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472596|NCT04844762|79480529|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472597|NCT04844762|79480524|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
44472598|NCT04844762|79480525|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472599|NCT04844762|79480526|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472600|NCT04844762|79480527|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472601|NCT04844762|79480528|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472602|NCT04844762|79480529|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472603|NCT04844762|79480524|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472604|NCT04844762|79480525|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472605|NCT04844762|79480526|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472606|NCT04844762|79480527|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472607|NCT04844762|79480528|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
44472608|NCT04844762|79480529|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
44472609|NCT04844762|79480524|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
44472610|NCT04844762|79480525|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472611|NCT04844762|79480526|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472612|NCT04844762|79480527|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472613|NCT04844762|79480528|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472614|NCT04844762|79480529|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
44472615|NCT04844762|79480524|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
44472616|NCT04844762|79480525|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472617|NCT04844762|79480526|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472618|NCT04844762|79480527|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472619|NCT04844762|79480528|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
44472620|NCT04844762|79480529|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
44472621|NCT04844762|79480524|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
44472622|NCT04844762|79480525|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
44472623|NCT04844762|79480526|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
44472624|NCT04844762|79480527|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
44544535|NCT00687596|79558012|FG000|Overall Study|Sponsor Terminated Study|6|||
44544536|NCT00687596|79558013|FG001|Overall Study|Sponsor Terminated Study|17|||
44225780|NCT00243412|79031330|FG000|Overall Study|Lost to Follow-up|0|||
44225781|NCT00243412|79031331|FG001|Overall Study|Lost to Follow-up|1|||
44225782|NCT00243412|79031330|FG000|Overall Study|Physician Decision|1|||
44225783|NCT00243412|79031331|FG001|Overall Study|Physician Decision|1|||
44472625|NCT04844762|79480528|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
44472626|NCT04844762|79480529|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
44472627|NCT04844762|79480524|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
44472628|NCT04844762|79480525|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
44472629|NCT04844762|79480526|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
44472630|NCT04844762|79480527|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
44472631|NCT04844762|79480528|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
44472632|NCT04844762|79480529|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
44472633|NCT00438464|79480553|FG000|Overall Study|Terminated Early|14|||
44472634|NCT00438464|79480554|FG001|Overall Study|Terminated Early|5|||
44472635|NCT00438464|79480553|FG000|Overall Study|Incomplete data submission|0|||
44472636|NCT00438464|79480554|FG001|Overall Study|Incomplete data submission|2|||
44472637|NCT00437294|79480574|FG000|Overall Study|Adverse Event|5|||
44472638|NCT00437294|79480575|FG001|Overall Study|Adverse Event|4|||
44472639|NCT00437294|79480574|FG000|Overall Study|Death|5|||
44225784|NCT00243412|79031330|FG000|Overall Study|Withdrawal by Subject|4|||
44225785|NCT00243412|79031331|FG001|Overall Study|Withdrawal by Subject|5|||
44225786|NCT00243412|79031330|FG000|Overall Study|Other|1|||
44225787|NCT00243412|79031331|FG001|Overall Study|Other|1|||
44225788|NCT03805750|79031346|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
44472640|NCT00437294|79480575|FG001|Overall Study|Death|2|||
44472641|NCT00437294|79480574|FG000|Overall Study|Physician Decision|0|||
44472642|NCT00437294|79480575|FG001|Overall Study|Physician Decision|3|||
44472643|NCT00437294|79480574|FG000|Overall Study|Withdrawal by Subject|5|||
44472644|NCT00437294|79480575|FG001|Overall Study|Withdrawal by Subject|0|||
44472645|NCT00437294|79480574|FG000|Overall Study|Progressive Disease|19|||
44472646|NCT00437294|79480575|FG001|Overall Study|Progressive Disease|23|||
44472647|NCT00437294|79480574|FG000|Overall Study|Sponsor Decision|8|||
44472648|NCT00437294|79480575|FG001|Overall Study|Sponsor Decision|9|||
44472649|NCT00437294|79480574|FG000|Overall Study|Protocol Violation|0|||
44472650|NCT00437294|79480575|FG001|Overall Study|Protocol Violation|1|||
44472651|NCT00437294|79480574|FG000|Overall Study|Entry criteria not met|1|||
44472652|NCT00437294|79480575|FG001|Overall Study|Entry criteria not met|1|||
44472653|NCT00443846|79480589|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
44472654|NCT00443846|79480590|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
44472655|NCT00443846|79480589|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
44472656|NCT00443846|79480590|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
44472657|NCT00443846|79480589|FG000|Overall Study|Adverse Event|0|||
44472658|NCT00443846|79480590|FG001|Overall Study|Adverse Event|1|||
44472659|NCT00443846|79480589|FG000|Overall Study|Personal reason|8|||
44472660|NCT00443846|79480590|FG001|Overall Study|Personal reason|3|||
44472661|NCT00443846|79480589|FG000|Overall Study|Lost to Follow-up|1|||
44472662|NCT00443846|79480590|FG001|Overall Study|Lost to Follow-up|2|||
44472663|NCT00436826|79480598|FG000|Double Blind Period (DBP)|Adverse Event|2|||
44472664|NCT00436826|79480599|FG001|Double Blind Period (DBP)|Adverse Event|0|||
44472665|NCT00436826|79480600|FG002|Double Blind Period (DBP)|Adverse Event|0|||
44472666|NCT00436826|79480601|FG003|Double Blind Period (DBP)|Adverse Event|0|||
44472667|NCT00436826|79480602|FG004|Double Blind Period (DBP)|Adverse Event|0|||
44472668|NCT00436826|79480603|FG005|Double Blind Period (DBP)|Adverse Event|0|||
44472669|NCT00436826|79480598|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
44472670|NCT00436826|79480599|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
44472671|NCT00436826|79480600|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
44472672|NCT00436826|79480601|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
44472673|NCT00436826|79480602|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
44472674|NCT00436826|79480603|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
44472675|NCT00436826|79480598|FG000|Double Blind Period (DBP)|Other|10|||
44225789|NCT03805750|79031347|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
44225790|NCT03804268|79031355|FG000|Overall Study|Adverse Event|2|||
44225791|NCT03804268|79031356|FG001|Overall Study|Adverse Event|2|||
44225792|NCT03804268|79031355|FG000|Overall Study|Withdrawal by Subject|2|||
44225793|NCT03804268|79031356|FG001|Overall Study|Withdrawal by Subject|0|||
44225794|NCT03804268|79031355|FG000|Overall Study|Lost to Follow-up|1|||
44225795|NCT03804268|79031356|FG001|Overall Study|Lost to Follow-up|0|||
44225796|NCT03804268|79031355|FG000|Overall Study|Physician Decision|2|||
44225797|NCT03804268|79031356|FG001|Overall Study|Physician Decision|0|||
44472676|NCT00436826|79480599|FG001|Double Blind Period (DBP)|Other|11|||
44472677|NCT00436826|79480600|FG002|Double Blind Period (DBP)|Other|0|||
44472678|NCT00436826|79480601|FG003|Double Blind Period (DBP)|Other|0|||
44225798|NCT00243022|79031381|FG000|Overall Study|Withdrawal by Subject|1|||
44225799|NCT00243022|79031382|FG001|Overall Study|Withdrawal by Subject|0|||
44225800|NCT00243022|79031381|FG000|Overall Study|Death|1|||
44375392|NCT00944034|79380594|FG009|Overall Study|Withdrawal by Subject|4|||
44472679|NCT00436826|79480602|FG004|Double Blind Period (DBP)|Other|0|||
44472680|NCT00436826|79480603|FG005|Double Blind Period (DBP)|Other|0|||
44472681|NCT00436826|79480598|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
44225801|NCT00243022|79031382|FG001|Overall Study|Death|0|||
44472682|NCT00436826|79480599|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
44472683|NCT00436826|79480600|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
44472684|NCT00436826|79480601|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
44472685|NCT00436826|79480602|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
44472686|NCT00436826|79480603|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
44225802|NCT00243022|79031381|FG000|Overall Study|Difficult Travel Distance|0|||
44225803|NCT00243022|79031382|FG001|Overall Study|Difficult Travel Distance|1|||
44472687|NCT00436826|79480598|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
44472688|NCT00436826|79480599|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
44472689|NCT00436826|79480600|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
44472690|NCT00436826|79480601|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
44472691|NCT00436826|79480602|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
44225804|NCT01736683|79031467|FG000|Overall Study|Disease Relapse|0|||
44225805|NCT01736683|79031468|FG001|Overall Study|Disease Relapse|0|||
44225806|NCT01736683|79031469|FG002|Overall Study|Disease Relapse|2|||
44225807|NCT01736683|79031470|FG003|Overall Study|Disease Relapse|1|||
44225808|NCT01736683|79031471|FG004|Overall Study|Disease Relapse|0|||
44225809|NCT01736683|79031467|FG000|Overall Study|Adverse Event|0|||
44225810|NCT01736683|79031468|FG001|Overall Study|Adverse Event|2|||
44225811|NCT01736683|79031469|FG002|Overall Study|Adverse Event|2|||
44225812|NCT01736683|79031470|FG003|Overall Study|Adverse Event|3|||
44225813|NCT01736683|79031471|FG004|Overall Study|Adverse Event|2|||
44225814|NCT01736683|79031467|FG000|Overall Study|Withdrawal by Subject|0|||
44225815|NCT01736683|79031468|FG001|Overall Study|Withdrawal by Subject|0|||
44225816|NCT01736683|79031469|FG002|Overall Study|Withdrawal by Subject|3|||
44225817|NCT01736683|79031470|FG003|Overall Study|Withdrawal by Subject|1|||
44225818|NCT01736683|79031471|FG004|Overall Study|Withdrawal by Subject|1|||
44225819|NCT01736683|79031467|FG000|Overall Study|Lack of Therapeutic Effect|7|||
44225820|NCT01736683|79031468|FG001|Overall Study|Lack of Therapeutic Effect|4|||
44225821|NCT01736683|79031469|FG002|Overall Study|Lack of Therapeutic Effect|13|||
44225822|NCT01736683|79031470|FG003|Overall Study|Lack of Therapeutic Effect|20|||
44225823|NCT01736683|79031471|FG004|Overall Study|Lack of Therapeutic Effect|1|||
44225824|NCT01736683|79031467|FG000|Overall Study|Progressive Disease|0|||
44225825|NCT01736683|79031468|FG001|Overall Study|Progressive Disease|0|||
44225826|NCT01736683|79031469|FG002|Overall Study|Progressive Disease|0|||
44225827|NCT01736683|79031470|FG003|Overall Study|Progressive Disease|1|||
44225828|NCT01736683|79031471|FG004|Overall Study|Progressive Disease|0|||
44225829|NCT01736683|79031467|FG000|Overall Study|Other|0|||
44225830|NCT01736683|79031468|FG001|Overall Study|Other|0|||
44225831|NCT01736683|79031469|FG002|Overall Study|Other|1|||
44225832|NCT01736683|79031470|FG003|Overall Study|Other|9|||
44225833|NCT01736683|79031471|FG004|Overall Study|Other|1|||
44225834|NCT01788943|79031487|FG000|Overall Study|Withdrawal by Subject|1|||
44225835|NCT01788943|79031488|FG001|Overall Study|Withdrawal by Subject|0|||
44225836|NCT01788163|79031515|FG000|Overall Study|Other|53|||
44225837|NCT01788163|79031516|FG001|Overall Study|Other|0|||
44225838|NCT01788163|79031517|FG002|Overall Study|Other|0|||
44273954|NCT02259114|79215722|FG000|Overall Study|Not Treated|1|||
44273955|NCT02259114|79215723|FG001|Overall Study|Not Treated|0|||
44472692|NCT00436826|79480603|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
44472693|NCT00436826|79480598|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
44472694|NCT00436826|79480599|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
44472695|NCT00436826|79480600|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
44472696|NCT00436826|79480601|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
44472697|NCT00436826|79480602|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
44472698|NCT00436826|79480603|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
44472699|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
44472700|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
44472701|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
44472702|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
44472703|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
44472704|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
44472705|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
44472706|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
44225839|NCT01788163|79031518|FG003|Overall Study|Other|0|||
44225840|NCT01788163|79031519|FG004|Overall Study|Other|0|||
44225841|NCT01788163|79031520|FG005|Overall Study|Other|7|||
44225842|NCT01788163|79031521|FG006|Overall Study|Other|1|||
44225843|NCT01788163|79031522|FG007|Overall Study|Other|48|||
44225844|NCT01788163|79031523|FG008|Overall Study|Other|15|||
44225845|NCT01788163|79031515|FG000|Overall Study|Withdrawal by Subject|2|||
44225846|NCT01788163|79031516|FG001|Overall Study|Withdrawal by Subject|0|||
44225847|NCT01788163|79031517|FG002|Overall Study|Withdrawal by Subject|0|||
44472707|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
44472708|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
44472709|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
44225848|NCT01788163|79031518|FG003|Overall Study|Withdrawal by Subject|0|||
44472710|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
44472711|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Death|7|||
44472712|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Death|4|||
44273956|NCT02259114|79215724|FG002|Overall Study|Not Treated|0|||
44472713|NCT00410124|79480621|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
44472714|NCT00410124|79480622|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
44472715|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
44472716|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
44472717|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
44472718|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
44472719|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
44472720|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
44472721|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
44472722|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
44472723|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
44472724|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
44472725|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
44472726|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
44472727|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
44472728|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
44472729|NCT00410124|79480621|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
44472730|NCT00410124|79480622|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
44472731|NCT00410046|79480632|FG000|Overall Study|Adverse Event|3|||
44472732|NCT00410046|79480632|FG000|Overall Study|Withdrawal by Subject|1|||
44472733|NCT00410046|79480632|FG000|Overall Study|Lost to Follow-up|1|||
44472734|NCT00416624|79480641|FG000|Overall Study|Withdrawal by Subject|1|||
44472735|NCT00416624|79480642|FG001|Overall Study|Withdrawal by Subject|6|||
44472736|NCT00416624|79480643|FG002|Overall Study|Withdrawal by Subject|4|||
44472737|NCT00416624|79480644|FG003|Overall Study|Withdrawal by Subject|9|||
44472738|NCT00416624|79480641|FG000|Overall Study|Death|4|||
44472739|NCT00416624|79480642|FG001|Overall Study|Death|7|||
44472740|NCT00416624|79480643|FG002|Overall Study|Death|7|||
44472741|NCT00416624|79480644|FG003|Overall Study|Death|1|||
44472742|NCT00416624|79480641|FG000|Overall Study|Adverse Event|8|||
44472743|NCT00416624|79480642|FG001|Overall Study|Adverse Event|3|||
44472744|NCT00416624|79480643|FG002|Overall Study|Adverse Event|2|||
44472745|NCT00416624|79480644|FG003|Overall Study|Adverse Event|2|||
44472746|NCT00416624|79480641|FG000|Overall Study|Other|8|||
44472747|NCT00416624|79480642|FG001|Overall Study|Other|11|||
44472748|NCT00416624|79480643|FG002|Overall Study|Other|5|||
44472749|NCT00416624|79480644|FG003|Overall Study|Other|5|||
44472750|NCT00416624|79480641|FG000|Overall Study|Cancel|1|||
44225849|NCT01788163|79031519|FG004|Overall Study|Withdrawal by Subject|0|||
44225850|NCT01788163|79031520|FG005|Overall Study|Withdrawal by Subject|0|||
44225851|NCT01788163|79031521|FG006|Overall Study|Withdrawal by Subject|0|||
44225852|NCT01788163|79031522|FG007|Overall Study|Withdrawal by Subject|0|||
44225853|NCT01788163|79031523|FG008|Overall Study|Withdrawal by Subject|1|||
44225854|NCT01787461|79031659|FG000|Overall Study|Adverse Event|4|||
44225855|NCT01787461|79031660|FG001|Overall Study|Adverse Event|3|||
44225856|NCT01787461|79031659|FG000|Overall Study|Lost to Follow-up|3|||
44225857|NCT01787461|79031660|FG001|Overall Study|Lost to Follow-up|2|||
44225858|NCT01787461|79031659|FG000|Overall Study|No longer met eligibility criteria|1|||
44225859|NCT01787461|79031660|FG001|Overall Study|No longer met eligibility criteria|0|||
44225860|NCT01787461|79031659|FG000|Overall Study|Withdrawal by Subject|3|||
44472751|NCT00416624|79480642|FG001|Overall Study|Cancel|0|||
44472752|NCT00416624|79480643|FG002|Overall Study|Cancel|0|||
44472753|NCT00416624|79480644|FG003|Overall Study|Cancel|0|||
44225861|NCT01787461|79031660|FG001|Overall Study|Withdrawal by Subject|4|||
44273957|NCT02259114|79215725|FG003|Overall Study|Not Treated|0|||
44273958|NCT02259114|79215726|FG004|Overall Study|Not Treated|0|||
44273959|NCT02258334|79215781|FG000|Overall Study|Adverse Event|1|||
44472754|NCT00262600|79480657|FG000|Overall Study|Lost to Follow-up|17|||
44472755|NCT00262600|79480658|FG001|Overall Study|Lost to Follow-up|31|||
44472756|NCT00262600|79480659|FG002|Overall Study|Lost to Follow-up|41|||
44472757|NCT00262600|79480657|FG000|Overall Study|Withdrawal by Subject|128|||
44472758|NCT00262600|79480658|FG001|Overall Study|Withdrawal by Subject|145|||
44472759|NCT00262600|79480659|FG002|Overall Study|Withdrawal by Subject|139|||
44472760|NCT00262600|79480657|FG000|Overall Study|Not Treated|32|||
44472761|NCT00262600|79480658|FG001|Overall Study|Not Treated|17|||
44225862|NCT01787461|79031659|FG000|Overall Study|Protocol Violation|3|||
44225863|NCT01787461|79031660|FG001|Overall Study|Protocol Violation|0|||
44225864|NCT01786993|79031685|FG000|Overall Study|Death|6|||
44225865|NCT01786993|79031686|FG001|Overall Study|Death|7|||
44225866|NCT01786993|79031685|FG000|Overall Study|Withdrawal by Subject|3|||
44225867|NCT01786993|79031686|FG001|Overall Study|Withdrawal by Subject|2|||
44225868|NCT01786993|79031685|FG000|Overall Study|Lost to Follow-up|0|||
44225869|NCT01786993|79031686|FG001|Overall Study|Lost to Follow-up|1|||
44225870|NCT01786993|79031685|FG000|Overall Study|Subject Non-Compliance|1|||
44225871|NCT01786993|79031686|FG001|Overall Study|Subject Non-Compliance|0|||
44225872|NCT01786993|79031685|FG000|Overall Study|System Explant|1|||
44225873|NCT01786993|79031686|FG001|Overall Study|System Explant|0|||
44225874|NCT01786993|79031685|FG000|Overall Study|Hospice Admission|1|||
44225875|NCT01786993|79031686|FG001|Overall Study|Hospice Admission|0|||
44225876|NCT01966445|79031711|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
44225877|NCT01966445|79031712|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
44225878|NCT01966445|79031713|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
44225879|NCT01966445|79031714|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
44225880|NCT01966445|79031715|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
44225881|NCT01966445|79031716|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
44225882|NCT01966445|79031717|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
44472762|NCT00262600|79480659|FG002|Overall Study|Not Treated|24|||
44472763|NCT00262600|79480657|FG000|Overall Study|Other|58|||
44472764|NCT00262600|79480658|FG001|Overall Study|Other|59|||
44472765|NCT00262600|79480659|FG002|Overall Study|Other|62|||
44472766|NCT00409578|79480671|FG000|Overall Study|Adverse Event|27|||
44472767|NCT00409578|79480672|FG001|Overall Study|Adverse Event|37|||
44472768|NCT00409578|79480673|FG002|Overall Study|Adverse Event|25|||
44472769|NCT00409578|79480674|FG003|Overall Study|Adverse Event|33|||
44472770|NCT00409578|79480671|FG000|Overall Study|Abnormal laboratory value(s)|2|||
44472771|NCT00409578|79480672|FG001|Overall Study|Abnormal laboratory value(s)|2|||
44472772|NCT00409578|79480673|FG002|Overall Study|Abnormal laboratory value(s)|2|||
44472773|NCT00409578|79480674|FG003|Overall Study|Abnormal laboratory value(s)|4|||
44472774|NCT00409578|79480671|FG000|Overall Study|Lack of Efficacy|0|||
44472775|NCT00409578|79480672|FG001|Overall Study|Lack of Efficacy|0|||
44472776|NCT00409578|79480673|FG002|Overall Study|Lack of Efficacy|0|||
44472777|NCT00409578|79480674|FG003|Overall Study|Lack of Efficacy|2|||
44472778|NCT00409578|79480671|FG000|Overall Study|Subject no longer requires study drug|0|||
44472779|NCT00409578|79480672|FG001|Overall Study|Subject no longer requires study drug|0|||
44472780|NCT00409578|79480673|FG002|Overall Study|Subject no longer requires study drug|0|||
44472781|NCT00409578|79480674|FG003|Overall Study|Subject no longer requires study drug|1|||
44472782|NCT00409578|79480671|FG000|Overall Study|Withdrawal by Subject|8|||
44472783|NCT00409578|79480672|FG001|Overall Study|Withdrawal by Subject|15|||
44472784|NCT00409578|79480673|FG002|Overall Study|Withdrawal by Subject|16|||
44472785|NCT00409578|79480674|FG003|Overall Study|Withdrawal by Subject|17|||
44472786|NCT00409578|79480671|FG000|Overall Study|Lost to Follow-up|2|||
44472787|NCT00409578|79480672|FG001|Overall Study|Lost to Follow-up|0|||
44472788|NCT00409578|79480673|FG002|Overall Study|Lost to Follow-up|2|||
44472789|NCT00409578|79480674|FG003|Overall Study|Lost to Follow-up|2|||
44472790|NCT00409578|79480671|FG000|Overall Study|Administrative problems|8|||
44472791|NCT00409578|79480672|FG001|Overall Study|Administrative problems|9|||
44472792|NCT00409578|79480673|FG002|Overall Study|Administrative problems|2|||
44472793|NCT00409578|79480674|FG003|Overall Study|Administrative problems|4|||
44472794|NCT00409578|79480671|FG000|Overall Study|Death|2|||
44472795|NCT00409578|79480672|FG001|Overall Study|Death|4|||
44472796|NCT00409578|79480673|FG002|Overall Study|Death|4|||
44472797|NCT00409578|79480674|FG003|Overall Study|Death|2|||
44472798|NCT00409578|79480671|FG000|Overall Study|Protocol Violation|3|||
44472799|NCT00409578|79480672|FG001|Overall Study|Protocol Violation|2|||
44472800|NCT00409578|79480673|FG002|Overall Study|Protocol Violation|3|||
44472801|NCT00409578|79480674|FG003|Overall Study|Protocol Violation|1|||
44225883|NCT01966445|79031711|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
44273960|NCT02258334|79215782|FG001|Overall Study|Adverse Event|0|||
44273961|NCT02258334|79215783|FG002|Overall Study|Adverse Event|0|||
44273962|NCT02258334|79215784|FG003|Overall Study|Adverse Event|0|||
44273963|NCT04960202|79215821|FG000|Overall Study|Other|12|||
44273964|NCT04960202|79215822|FG001|Overall Study|Other|10|||
44273965|NCT04960202|79215821|FG000|Overall Study|Withdrawal by Subject|43|||
44472802|NCT00409578|79480671|FG000|Overall Study|Missing|0|||
44472803|NCT00409578|79480672|FG001|Overall Study|Missing|1|||
44472804|NCT00409578|79480673|FG002|Overall Study|Missing|0|||
44472805|NCT00409578|79480674|FG003|Overall Study|Missing|1|||
44472806|NCT00428090|79480688|FG000|Overall Study|Adverse Event|10|||
44472807|NCT00428090|79480689|FG001|Overall Study|Adverse Event|8|||
44472808|NCT00428090|79480690|FG002|Overall Study|Adverse Event|10|||
44225884|NCT01966445|79031712|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
44225885|NCT01966445|79031713|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
44472809|NCT00428090|79480691|FG003|Overall Study|Adverse Event|11|||
44472810|NCT00428090|79480688|FG000|Overall Study|Lost to Follow-up|3|||
44472811|NCT00428090|79480689|FG001|Overall Study|Lost to Follow-up|6|||
44472812|NCT00428090|79480690|FG002|Overall Study|Lost to Follow-up|1|||
44472813|NCT00428090|79480691|FG003|Overall Study|Lost to Follow-up|4|||
44472814|NCT00428090|79480688|FG000|Overall Study|Protocol Violation|3|||
44472815|NCT00428090|79480689|FG001|Overall Study|Protocol Violation|1|||
44472816|NCT00428090|79480690|FG002|Overall Study|Protocol Violation|3|||
44472817|NCT00428090|79480691|FG003|Overall Study|Protocol Violation|3|||
44472818|NCT00428090|79480688|FG000|Overall Study|Withdrawal by Subject|10|||
44472819|NCT00428090|79480689|FG001|Overall Study|Withdrawal by Subject|12|||
44472820|NCT00428090|79480690|FG002|Overall Study|Withdrawal by Subject|15|||
44472821|NCT00428090|79480691|FG003|Overall Study|Withdrawal by Subject|5|||
44472822|NCT00428090|79480688|FG000|Overall Study|Sponsor terminated study|0|||
44472823|NCT00428090|79480689|FG001|Overall Study|Sponsor terminated study|1|||
44472824|NCT00428090|79480690|FG002|Overall Study|Sponsor terminated study|0|||
44472825|NCT00428090|79480691|FG003|Overall Study|Sponsor terminated study|0|||
44472826|NCT00428090|79480688|FG000|Overall Study|Non-compliance|4|||
44472827|NCT00428090|79480689|FG001|Overall Study|Non-compliance|0|||
44472828|NCT00428090|79480690|FG002|Overall Study|Non-compliance|1|||
44472829|NCT00428090|79480691|FG003|Overall Study|Non-compliance|3|||
44472830|NCT00428090|79480688|FG000|Overall Study|Par. did not returned to visit|1|||
44472831|NCT00428090|79480689|FG001|Overall Study|Par. did not returned to visit|0|||
44472832|NCT00428090|79480690|FG002|Overall Study|Par. did not returned to visit|0|||
44472833|NCT00428090|79480691|FG003|Overall Study|Par. did not returned to visit|1|||
44472834|NCT00428090|79480688|FG000|Overall Study|Follow-Up visit not possible|1|||
44472835|NCT00428090|79480689|FG001|Overall Study|Follow-Up visit not possible|0|||
44472836|NCT00428090|79480690|FG002|Overall Study|Follow-Up visit not possible|0|||
44472837|NCT00428090|79480691|FG003|Overall Study|Follow-Up visit not possible|0|||
44472838|NCT00428090|79480688|FG000|Overall Study|Prohibited medication used for SAE|1|||
44472839|NCT00428090|79480689|FG001|Overall Study|Prohibited medication used for SAE|0|||
44472840|NCT00428090|79480690|FG002|Overall Study|Prohibited medication used for SAE|0|||
44472841|NCT00428090|79480691|FG003|Overall Study|Prohibited medication used for SAE|0|||
44472842|NCT00428090|79480688|FG000|Overall Study|Death of par.|1|||
44472843|NCT00428090|79480689|FG001|Overall Study|Death of par.|0|||
44472844|NCT00428090|79480690|FG002|Overall Study|Death of par.|1|||
44472845|NCT00428090|79480691|FG003|Overall Study|Death of par.|0|||
44472846|NCT00428090|79480688|FG000|Overall Study|Visit 7 exceed the visit window|0|||
44472847|NCT00428090|79480689|FG001|Overall Study|Visit 7 exceed the visit window|1|||
44472848|NCT00428090|79480690|FG002|Overall Study|Visit 7 exceed the visit window|0|||
44472849|NCT00428090|79480691|FG003|Overall Study|Visit 7 exceed the visit window|0|||
44472850|NCT00428090|79480688|FG000|Overall Study|Medical monitor terminated par.|0|||
44472851|NCT00428090|79480689|FG001|Overall Study|Medical monitor terminated par.|1|||
44472852|NCT00428090|79480690|FG002|Overall Study|Medical monitor terminated par.|0|||
44273966|NCT04960202|79215822|FG001|Overall Study|Withdrawal by Subject|45|||
44273967|NCT04960202|79215821|FG000|Overall Study|Lost to Follow-up|20|||
44225886|NCT01966445|79031714|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
44225887|NCT01966445|79031715|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
44225888|NCT01966445|79031716|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
44225889|NCT01966445|79031717|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
44225890|NCT01966445|79031711|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
44225891|NCT01966445|79031712|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
44225892|NCT01966445|79031713|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
44273968|NCT04960202|79215822|FG001|Overall Study|Lost to Follow-up|17|||
44273969|NCT04960202|79215821|FG000|Overall Study|Death|0|||
44273970|NCT04960202|79215822|FG001|Overall Study|Death|15|||
44273971|NCT02257632|79215892|FG000|Overall Study|Withdrawal by Subject|0|||
44472853|NCT00428090|79480691|FG003|Overall Study|Medical monitor terminated par.|0|||
44472854|NCT00428090|79480688|FG000|Overall Study|Mental status of par. was|0|||
44472855|NCT00428090|79480689|FG001|Overall Study|Mental status of par. was|1|||
44472856|NCT00428090|79480690|FG002|Overall Study|Mental status of par. was|0|||
44472857|NCT00428090|79480691|FG003|Overall Study|Mental status of par. was|0|||
44472858|NCT00428090|79480688|FG000|Overall Study|Worsening of AD|0|||
44472859|NCT00428090|79480689|FG001|Overall Study|Worsening of AD|0|||
44225893|NCT01966445|79031714|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
44472860|NCT00428090|79480690|FG002|Overall Study|Worsening of AD|1|||
44472861|NCT00428090|79480691|FG003|Overall Study|Worsening of AD|0|||
44225894|NCT01966445|79031715|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
44472862|NCT00428090|79480688|FG000|Overall Study|Excluded for concerning QTc value|0|||
44225895|NCT01966445|79031716|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
44273972|NCT02257632|79215893|FG001|Overall Study|Withdrawal by Subject|1|||
44273973|NCT02257632|79215892|FG000|Overall Study|Adverse Event|1|||
44472863|NCT00428090|79480689|FG001|Overall Study|Excluded for concerning QTc value|0|||
44472864|NCT00428090|79480690|FG002|Overall Study|Excluded for concerning QTc value|1|||
44544537|NCT02892409|79558021|FG000|Overall Study|Adverse Event|1|||
44472865|NCT00428090|79480691|FG003|Overall Study|Excluded for concerning QTc value|0|||
44472866|NCT00428090|79480688|FG000|Overall Study|Insufficient AD documentation|0|||
44472867|NCT00428090|79480689|FG001|Overall Study|Insufficient AD documentation|0|||
44472868|NCT00428090|79480690|FG002|Overall Study|Insufficient AD documentation|1|||
44472869|NCT00428090|79480691|FG003|Overall Study|Insufficient AD documentation|0|||
44472870|NCT00428090|79480688|FG000|Overall Study|High MMSE scores|0|||
44472871|NCT00428090|79480689|FG001|Overall Study|High MMSE scores|0|||
44472872|NCT00428090|79480690|FG002|Overall Study|High MMSE scores|1|||
44472873|NCT00428090|79480691|FG003|Overall Study|High MMSE scores|0|||
44472874|NCT00428090|79480688|FG000|Overall Study|Deterioration of cognitive status|0|||
44472875|NCT00428090|79480689|FG001|Overall Study|Deterioration of cognitive status|0|||
44472876|NCT00428090|79480690|FG002|Overall Study|Deterioration of cognitive status|1|||
44472877|NCT00428090|79480691|FG003|Overall Study|Deterioration of cognitive status|0|||
44472878|NCT00428090|79480688|FG000|Overall Study|Serious adverse event|0|||
44472879|NCT00428090|79480689|FG001|Overall Study|Serious adverse event|0|||
44472880|NCT00428090|79480690|FG002|Overall Study|Serious adverse event|1|||
44472881|NCT00428090|79480691|FG003|Overall Study|Serious adverse event|0|||
44472882|NCT00428090|79480688|FG000|Overall Study|Excluded for heart insufficiency|0|||
44472883|NCT00428090|79480689|FG001|Overall Study|Excluded for heart insufficiency|0|||
44472884|NCT00428090|79480690|FG002|Overall Study|Excluded for heart insufficiency|1|||
44472885|NCT00428090|79480691|FG003|Overall Study|Excluded for heart insufficiency|0|||
44472886|NCT00428090|79480688|FG000|Overall Study|Raised Creatinine Value|0|||
44472887|NCT00428090|79480689|FG001|Overall Study|Raised Creatinine Value|0|||
44472888|NCT00428090|79480690|FG002|Overall Study|Raised Creatinine Value|0|||
44472889|NCT00428090|79480691|FG003|Overall Study|Raised Creatinine Value|1|||
44472890|NCT00416312|79480709|FG000|Overall Study|tumors not visible on imaging|2|||
44472891|NCT00436436|79480713|FG000|Overall Study|Progression|4|||
44472892|NCT00436436|79480713|FG000|Overall Study|Adverse Event|2|||
44472893|NCT00436436|79480713|FG000|Overall Study|Death|6|||
44472894|NCT00262522|79480721|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
44472895|NCT00262522|79480722|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
44472896|NCT00262522|79480723|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
44472897|NCT00262522|79480724|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
44472898|NCT00262522|79480721|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
44472899|NCT00262522|79480722|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
44472900|NCT00262522|79480723|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
44472901|NCT00262522|79480724|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
44472902|NCT00262522|79480721|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
44472903|NCT00262522|79480722|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
44472904|NCT00262522|79480723|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
44225896|NCT01966445|79031717|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
44225897|NCT01966445|79031711|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
44225898|NCT01966445|79031712|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
44225899|NCT01966445|79031713|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
44225900|NCT01966445|79031714|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
44225901|NCT01966445|79031715|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
44225902|NCT01966445|79031716|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
44225903|NCT01966445|79031717|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
44273974|NCT02257632|79215893|FG001|Overall Study|Adverse Event|2|||
44273975|NCT01642914|79215927|FG000|Overall Study|Adverse Event|11|||
44273976|NCT01642914|79215928|FG001|Overall Study|Adverse Event|7|||
44273977|NCT01642914|79215929|FG002|Overall Study|Adverse Event|15|||
44273978|NCT01642914|79215927|FG000|Overall Study|Lack of Efficacy|9|||
44472905|NCT00262522|79480724|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
44472906|NCT00262522|79480721|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
44472907|NCT00262522|79480722|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
44472908|NCT00262522|79480723|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
44472909|NCT00262522|79480724|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
44472910|NCT00262522|79480721|FG000|Study Start Through 8 Weeks|Death|1|||
44472911|NCT00262522|79480722|FG001|Study Start Through 8 Weeks|Death|0|||
44472912|NCT00262522|79480723|FG002|Study Start Through 8 Weeks|Death|0|||
44472913|NCT00262522|79480724|FG003|Study Start Through 8 Weeks|Death|0|||
44472914|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
44472915|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
44273979|NCT01642914|79215928|FG001|Overall Study|Lack of Efficacy|4|||
44472916|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
44472917|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
44472918|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
44273980|NCT01642914|79215929|FG002|Overall Study|Lack of Efficacy|2|||
44375393|NCT00944034|79380595|FG010|Overall Study|Withdrawal by Subject|0|||
44472919|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
44472920|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
44472921|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
44472922|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
44472923|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
44472924|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
44472925|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
44472926|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
44472927|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
44472928|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
44472929|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
44472930|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Death|2|||
44472931|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Death|0|||
44472932|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Death|1|||
44472933|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Death|0|||
44472934|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
44472935|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
44472936|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
44472937|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
44472938|NCT00262522|79480721|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
44472939|NCT00262522|79480722|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
44472940|NCT00262522|79480723|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
44472941|NCT00262522|79480724|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
44472942|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
44472943|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
44472944|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
44472945|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
44472946|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
44472947|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
44472948|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
44472949|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
44472950|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
44472951|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
44472952|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
44472953|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
44472954|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
44472955|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
44472956|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
44472957|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
44472958|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Death|2|||
44472959|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Death|0|||
44472960|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Death|2|||
44472961|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Death|0|||
44472962|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
44472963|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
44472964|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
44472965|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
44472966|NCT00262522|79480721|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
44472967|NCT00262522|79480722|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
44472968|NCT00262522|79480723|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
44544538|NCT02892409|79558022|FG001|Overall Study|Adverse Event|0|||
44225904|NCT01966445|79031711|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
44225905|NCT01966445|79031712|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
44225906|NCT01966445|79031713|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
44225907|NCT01966445|79031714|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
44225908|NCT01966445|79031715|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
44225909|NCT01966445|79031716|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
44225910|NCT01966445|79031717|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
44225911|NCT01763905|79031737|FG000|Overall Study|Withdrawal by Subject|1|||
44225912|NCT01763905|79031738|FG001|Overall Study|Withdrawal by Subject|1|||
44225913|NCT01763905|79031739|FG002|Overall Study|Withdrawal by Subject|0|||
44225914|NCT01763905|79031740|FG003|Overall Study|Withdrawal by Subject|1|||
44225915|NCT01763905|79031737|FG000|Overall Study|Decision by sponsor|5|||
44472969|NCT00262522|79480724|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
44472970|NCT00436280|79480732|FG000|Period 1: Induction|Adverse Event|8|||
44472971|NCT00436280|79480732|FG000|Period 1: Induction|Progressive Disease|12|||
44544539|NCT02892409|79558021|FG000|Overall Study|Withdrawal by Subject|2|||
44544540|NCT02892409|79558022|FG001|Overall Study|Withdrawal by Subject|1|||
44544541|NCT03219216|79558030|FG000|Overall Study|Lost to Follow-up|0|||
44544542|NCT03219216|79558031|FG001|Overall Study|Lost to Follow-up|1|||
44225916|NCT01763905|79031738|FG001|Overall Study|Decision by sponsor|0|||
44225917|NCT01763905|79031739|FG002|Overall Study|Decision by sponsor|8|||
44472972|NCT00436280|79480732|FG000|Period 1: Induction|Stable Disease|6|||
44472973|NCT00436280|79480732|FG000|Period 1: Induction|Withdrawal by Subject|1|||
44472974|NCT00436280|79480732|FG000|Period 1: Induction|Death|1|||
44472975|NCT00436280|79480732|FG000|Period 2: Consolidation|Adverse Event|1|||
44472976|NCT00436280|79480732|FG000|Period 2: Consolidation|Progressive Disease|10|||
44472977|NCT00436280|79480732|FG000|Period 2: Consolidation|Stable Disease|1|||
44472978|NCT00436280|79480732|FG000|Period 2: Consolidation|Physician Decision|2|||
44472979|NCT00436280|79480732|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
44472980|NCT00436280|79480732|FG000|Period 2: Consolidation|Death|1|||
44472981|NCT00436280|79480732|FG000|Period 3: Maintenance|Adverse Event|6|||
44472982|NCT00436280|79480732|FG000|Period 3: Maintenance|Progressive Disease|12|||
44472983|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
44472984|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
44472985|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
44472986|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
44472987|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
44472988|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
44472989|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
44472990|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
44472991|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Death|0|||
44472992|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Death|1|||
44472993|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
44472994|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
44472995|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
44472996|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
44472997|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
44472998|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
44472999|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
44473000|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
44473001|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
44473002|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
44473003|NCT00394836|79480738|FG000|Teatment or Follow-up Phase|Non compliance|0|||
44473004|NCT00394836|79480739|FG001|Teatment or Follow-up Phase|Non compliance|1|||
44473005|NCT00394836|79480738|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
44473006|NCT00394836|79480739|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
44473007|NCT00394836|79480738|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
44473008|NCT00394836|79480739|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
44473009|NCT00394836|79480738|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
44473010|NCT00394836|79480739|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
44473011|NCT00394836|79480738|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
44473012|NCT00394836|79480739|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
44473013|NCT00250588|79480750|FG000|Overall Study|Withdrawal by Subject|3|||
44473014|NCT00250588|79480751|FG001|Overall Study|Withdrawal by Subject|6|||
44473015|NCT00250588|79480752|FG002|Overall Study|Withdrawal by Subject|0|||
44473016|NCT00250588|79480750|FG000|Overall Study|Lost to Follow-up|6|||
44473017|NCT00250588|79480751|FG001|Overall Study|Lost to Follow-up|13|||
44473018|NCT00250588|79480752|FG002|Overall Study|Lost to Follow-up|13|||
44473019|NCT00416078|79480762|FG000|Overall Study|Death|3|||
44473020|NCT00416078|79480763|FG001|Overall Study|Death|4|||
44473021|NCT00416078|79480762|FG000|Overall Study|Withdrawal by Subject|3|||
44473022|NCT00416078|79480763|FG001|Overall Study|Withdrawal by Subject|2|||
44473023|NCT00416078|79480762|FG000|Overall Study|Physician Decision|1|||
44473024|NCT00416078|79480763|FG001|Overall Study|Physician Decision|0|||
44473025|NCT00416078|79480762|FG000|Overall Study|Lost to Follow-up|4|||
44473026|NCT00416078|79480763|FG001|Overall Study|Lost to Follow-up|2|||
44473027|NCT00394524|79480771|FG000|Overall Study|Protocol Violation|2|||
44473028|NCT00394524|79480772|FG001|Overall Study|Protocol Violation|3|||
44473029|NCT00394524|79480771|FG000|Overall Study|Death|1|||
44473030|NCT00394524|79480772|FG001|Overall Study|Death|0|||
44473031|NCT00394524|79480771|FG000|Overall Study|Withdrawal by Subject|0|||
44473032|NCT00394524|79480772|FG001|Overall Study|Withdrawal by Subject|1|||
44473033|NCT00409344|79480782|FG000|Overall Study|no enrollment|0|||
44473034|NCT00409344|79480783|FG001|Overall Study|no enrollment|0|||
44473035|NCT00415610|79480792|FG000|Overall Study|Death|3|||
44473036|NCT00415610|79480793|FG001|Overall Study|Death|2|||
44473037|NCT00415610|79480794|FG002|Overall Study|Death|5|||
44473038|NCT00394212|79480804|FG000|Overall Study|Lost to Follow-up|3|||
44473039|NCT00394212|79480805|FG001|Overall Study|Lost to Follow-up|0|||
44473040|NCT00394212|79480804|FG000|Overall Study|Withdrawal by Subject|4|||
44473041|NCT00394212|79480805|FG001|Overall Study|Withdrawal by Subject|1|||
44473042|NCT00250432|79480813|FG000|Overall Study|Adverse Event|25|||
44473043|NCT00250432|79480814|FG001|Overall Study|Adverse Event|29|||
44544543|NCT03195660|79558045|FG000|Overall Study|The study was terminated|2|||
44544544|NCT03194490|79558051|FG000|Overall Study|Lost to Follow-up|1|||
44473044|NCT00250432|79480813|FG000|Overall Study|Lack of Efficacy|2|||
44473045|NCT00250432|79480814|FG001|Overall Study|Lack of Efficacy|1|||
44473046|NCT00250432|79480813|FG000|Overall Study|Lost to Follow-up|6|||
44473047|NCT00250432|79480814|FG001|Overall Study|Lost to Follow-up|5|||
44473048|NCT00250432|79480813|FG000|Overall Study|Patient Moved|0|||
44473049|NCT00250432|79480814|FG001|Overall Study|Patient Moved|1|||
44473050|NCT00250432|79480813|FG000|Overall Study|Protocol Violation|0|||
44473051|NCT00250432|79480814|FG001|Overall Study|Protocol Violation|3|||
44473052|NCT00250432|79480813|FG000|Overall Study|Withdrawal by Subject|6|||
44473053|NCT00250432|79480814|FG001|Overall Study|Withdrawal by Subject|2|||
44473054|NCT00250432|79480813|FG000|Overall Study|Pt died out of posttherapy report period|6|||
44473055|NCT00250432|79480814|FG001|Overall Study|Pt died out of posttherapy report period|5|||
44473056|NCT00250432|79480813|FG000|Overall Study|Pt was considered untreatable|0|||
44473057|NCT00250432|79480814|FG001|Overall Study|Pt was considered untreatable|1|||
44473058|NCT00250276|79480824|FG000|Overall Study|Serious Adverse Event|0|||
44473059|NCT00250276|79480825|FG001|Overall Study|Serious Adverse Event|0|||
44473060|NCT00250276|79480826|FG002|Overall Study|Serious Adverse Event|1|||
44473061|NCT00250276|79480827|FG003|Overall Study|Serious Adverse Event|0|||
44473062|NCT00250276|79480824|FG000|Overall Study|Non-serious Adverse Event|2|||
44473063|NCT00250276|79480825|FG001|Overall Study|Non-serious Adverse Event|0|||
44473064|NCT00250276|79480826|FG002|Overall Study|Non-serious Adverse Event|0|||
44473065|NCT00250276|79480827|FG003|Overall Study|Non-serious Adverse Event|2|||
44473066|NCT00250276|79480824|FG000|Overall Study|Protocol Violation|0|||
44473067|NCT00250276|79480825|FG001|Overall Study|Protocol Violation|1|||
44473068|NCT00250276|79480826|FG002|Overall Study|Protocol Violation|0|||
44473069|NCT00250276|79480827|FG003|Overall Study|Protocol Violation|0|||
44473070|NCT00250276|79480824|FG000|Overall Study|Withdrawal by Subject|1|||
44473071|NCT00250276|79480825|FG001|Overall Study|Withdrawal by Subject|2|||
44473072|NCT00250276|79480826|FG002|Overall Study|Withdrawal by Subject|3|||
44473073|NCT00250276|79480827|FG003|Overall Study|Withdrawal by Subject|2|||
44473074|NCT00250276|79480824|FG000|Overall Study|Migrated/moved from study area|3|||
44473075|NCT00250276|79480825|FG001|Overall Study|Migrated/moved from study area|0|||
44473076|NCT00250276|79480826|FG002|Overall Study|Migrated/moved from study area|2|||
44473077|NCT00250276|79480827|FG003|Overall Study|Migrated/moved from study area|7|||
44473078|NCT00250276|79480824|FG000|Overall Study|Lost to Follow-up|11|||
44473079|NCT00250276|79480825|FG001|Overall Study|Lost to Follow-up|18|||
44473080|NCT00250276|79480826|FG002|Overall Study|Lost to Follow-up|13|||
44473081|NCT00250276|79480827|FG003|Overall Study|Lost to Follow-up|8|||
44473082|NCT00249808|79480842|FG000|Overall Study|Other|27|||
44473083|NCT00249808|79480842|FG000|Overall Study|Protocol Violation|3|||
44473084|NCT00249808|79480842|FG000|Overall Study|Lost to Follow-up|8|||
44473085|NCT00249808|79480842|FG000|Overall Study|Adverse Event|81|||
44473086|NCT00249808|79480842|FG000|Overall Study|Lack of Efficacy|52|||
44473087|NCT00249808|79480842|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
44473088|NCT00278512|79480848|FG000|Overall Study|Death|1|||
44473089|NCT00278512|79480849|FG001|Overall Study|Death|0|||
44473090|NCT00427934|79480859|FG000|Overall Study|Adverse Event|1|||
44473091|NCT00427934|79480860|FG001|Overall Study|Adverse Event|0|||
44473092|NCT00427934|79480861|FG002|Overall Study|Adverse Event|5|||
44473093|NCT00427934|79480862|FG003|Overall Study|Adverse Event|4|||
44473094|NCT00427934|79480859|FG000|Overall Study|Lack of Efficacy|0|||
44473095|NCT00427934|79480860|FG001|Overall Study|Lack of Efficacy|0|||
44473096|NCT00427934|79480861|FG002|Overall Study|Lack of Efficacy|5|||
44473097|NCT00427934|79480862|FG003|Overall Study|Lack of Efficacy|2|||
44473098|NCT00427934|79480859|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
44225918|NCT01763905|79031740|FG003|Overall Study|Decision by sponsor|0|||
44473099|NCT00427934|79480860|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
44225919|NCT01763905|79031737|FG000|Overall Study|Lost to Follow-up|0|||
44473100|NCT00427934|79480861|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
44473101|NCT00427934|79480862|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
44473102|NCT00427934|79480859|FG000|Overall Study|Other|0|||
44473103|NCT00427934|79480860|FG001|Overall Study|Other|0|||
44473104|NCT00427934|79480861|FG002|Overall Study|Other|11|||
44473105|NCT00427934|79480862|FG003|Overall Study|Other|5|||
44473106|NCT00427934|79480859|FG000|Overall Study|Withdrawal by Subject|0|||
44473107|NCT00427934|79480860|FG001|Overall Study|Withdrawal by Subject|0|||
44473108|NCT00427934|79480861|FG002|Overall Study|Withdrawal by Subject|1|||
44473109|NCT00427934|79480862|FG003|Overall Study|Withdrawal by Subject|3|||
44225920|NCT01763905|79031738|FG001|Overall Study|Lost to Follow-up|0|||
44473110|NCT00435188|79480876|FG000|Overall Study|Death|1|||
44473111|NCT00435188|79480877|FG001|Overall Study|Death|6|||
44473112|NCT00435188|79480876|FG000|Overall Study|Withdrawal by Subject|16|||
44473113|NCT00435188|79480877|FG001|Overall Study|Withdrawal by Subject|11|||
44473114|NCT00435188|79480876|FG000|Overall Study|Lost to Follow-up|5|||
44473115|NCT00435188|79480877|FG001|Overall Study|Lost to Follow-up|6|||
44473116|NCT00427778|79480885|FG000|First Intervention (4 Weeks)|no longer interested|1|||
44473117|NCT00427778|79480886|FG001|First Intervention (4 Weeks)|no longer interested|0|||
44473118|NCT00427778|79480885|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
44473119|NCT00427778|79480886|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
44473120|NCT00427778|79480885|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
44473121|NCT00427778|79480886|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
44473122|NCT00427778|79480885|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
44473123|NCT00427778|79480886|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
44473124|NCT00427700|79480907|FG000|Overall Study|Lost to Follow-up|2|||
44473125|NCT00427700|79480908|FG001|Overall Study|Lost to Follow-up|5|||
44473126|NCT00427700|79480907|FG000|Overall Study|no induction of menses|1|||
44473127|NCT00427700|79480908|FG001|Overall Study|no induction of menses|4|||
44473128|NCT00427700|79480907|FG000|Overall Study|Pregnancy|0|||
44473129|NCT00427700|79480908|FG001|Overall Study|Pregnancy|2|||
44473130|NCT00409188|79480917|FG000|Overall Study|Ongoing at data cut-off|383|||
44473131|NCT00409188|79480918|FG001|Overall Study|Ongoing at data cut-off|175|||
44225921|NCT01763905|79031739|FG002|Overall Study|Lost to Follow-up|1|||
44225922|NCT01763905|79031740|FG003|Overall Study|Lost to Follow-up|0|||
44225923|NCT02091167|79031752|FG000|Overall Study|Lost to Follow-up|0|||
44225924|NCT02091167|79031753|FG001|Overall Study|Lost to Follow-up|2|||
44473132|NCT00434954|79480926|FG000|Overall Study|Adverse Event|17|||
44473133|NCT00434954|79480927|FG001|Overall Study|Adverse Event|2|||
44473134|NCT00434954|79480926|FG000|Overall Study|Entry criteria not met|14|||
44473135|NCT00434954|79480927|FG001|Overall Study|Entry criteria not met|16|||
44473136|NCT00434954|79480926|FG000|Overall Study|Lost to Follow-up|0|||
44473137|NCT00434954|79480927|FG001|Overall Study|Lost to Follow-up|1|||
44473138|NCT00434954|79480926|FG000|Overall Study|Physician Decision|6|||
44473139|NCT00434954|79480927|FG001|Overall Study|Physician Decision|3|||
44473140|NCT00434954|79480926|FG000|Overall Study|Protocol Violation|36|||
44473141|NCT00434954|79480927|FG001|Overall Study|Protocol Violation|27|||
44473142|NCT00434954|79480926|FG000|Overall Study|Sponsor decision|1|||
44473143|NCT00434954|79480927|FG001|Overall Study|Sponsor decision|0|||
44473144|NCT00434954|79480926|FG000|Overall Study|Subject decision|8|||
44473145|NCT00434954|79480927|FG001|Overall Study|Subject decision|22|||
44473146|NCT00276484|79480935|FG000|Overall Study|Adverse Event|4|||
44473147|NCT00276484|79480936|FG001|Overall Study|Adverse Event|7|||
44473148|NCT00276484|79480935|FG000|Overall Study|Lost to Follow-up|1|||
44473149|NCT00276484|79480936|FG001|Overall Study|Lost to Follow-up|1|||
44473150|NCT00276484|79480935|FG000|Overall Study|Protocol Violation|0|||
44473151|NCT00276484|79480936|FG001|Overall Study|Protocol Violation|1|||
44473152|NCT00276484|79480935|FG000|Overall Study|Withdrawal by Subject|4|||
44473153|NCT00276484|79480936|FG001|Overall Study|Withdrawal by Subject|3|||
44473154|NCT00276484|79480935|FG000|Overall Study|Could not take time off work|0|||
44473155|NCT00276484|79480936|FG001|Overall Study|Could not take time off work|1|||
44473156|NCT00426842|79480942|FG000|Overall Study|Lost to Follow-up|1|||
44473157|NCT00434876|79480950|FG000|Overall Study|Lost to Follow-up|1|||
44473158|NCT00434876|79480951|FG001|Overall Study|Lost to Follow-up|1|||
44473159|NCT00276094|79480960|FG000|Overall Study|Adverse Event|15|||
44473160|NCT00276094|79480961|FG001|Overall Study|Adverse Event|13|||
44473161|NCT00276094|79480962|FG002|Overall Study|Adverse Event|11|||
44473162|NCT00276094|79480960|FG000|Overall Study|Withdrawal by Subject|14|||
44473163|NCT00276094|79480961|FG001|Overall Study|Withdrawal by Subject|14|||
44473164|NCT00276094|79480962|FG002|Overall Study|Withdrawal by Subject|12|||
44473165|NCT00276094|79480960|FG000|Overall Study|Protocol Violation|16|||
44473166|NCT00276094|79480961|FG001|Overall Study|Protocol Violation|7|||
44473167|NCT00276094|79480962|FG002|Overall Study|Protocol Violation|10|||
44473168|NCT00276094|79480960|FG000|Overall Study|Lost to Follow-up|8|||
44473169|NCT00276094|79480961|FG001|Overall Study|Lost to Follow-up|6|||
44473170|NCT00276094|79480962|FG002|Overall Study|Lost to Follow-up|4|||
44473171|NCT00276094|79480960|FG000|Overall Study|Other-Subject moved out of country|1|||
44473172|NCT00276094|79480961|FG001|Overall Study|Other-Subject moved out of country|0|||
44225925|NCT02091089|79031759|FG000|Overall Study|Lost to Follow-up|2|||
44225926|NCT01763203|79031774|FG000|Overall Study|Death|4|||
44473173|NCT00276094|79480962|FG002|Overall Study|Other-Subject moved out of country|0|||
44473174|NCT00276094|79480960|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
44473175|NCT00276094|79480961|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
44473176|NCT00276094|79480962|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
44473177|NCT00276094|79480960|FG000|Overall Study|Other-Lack of efficacy|1|||
44473178|NCT00276094|79480961|FG001|Overall Study|Other-Lack of efficacy|0|||
44473179|NCT00276094|79480962|FG002|Overall Study|Other-Lack of efficacy|0|||
44225927|NCT01763203|79031775|FG001|Overall Study|Death|7|||
44225928|NCT01763203|79031774|FG000|Overall Study|Lost to Follow-up|12|||
44473180|NCT00276094|79480960|FG000|Overall Study|Other-Refused follow-up visit|1|||
44473181|NCT00276094|79480961|FG001|Overall Study|Other-Refused follow-up visit|0|||
44473182|NCT00276094|79480962|FG002|Overall Study|Other-Refused follow-up visit|0|||
44473183|NCT00276094|79480960|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
44473184|NCT00276094|79480961|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
44473185|NCT00276094|79480962|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
44473186|NCT00276094|79480960|FG000|Overall Study|Other-Relocation|0|||
44473187|NCT00276094|79480961|FG001|Overall Study|Other-Relocation|1|||
44473188|NCT00276094|79480962|FG002|Overall Study|Other-Relocation|0|||
44473189|NCT00276094|79480960|FG000|Overall Study|Other-Study medication lost|0|||
44473190|NCT00276094|79480961|FG001|Overall Study|Other-Study medication lost|0|||
44473191|NCT00276094|79480962|FG002|Overall Study|Other-Study medication lost|1|||
44473192|NCT00276016|79480976|FG000|Intervention 1|Withdrawal by Subject|0|||
44473193|NCT00276016|79480977|FG001|Intervention 1|Withdrawal by Subject|1|||
44473194|NCT00276016|79480978|FG002|Intervention 1|Withdrawal by Subject|0|||
44473195|NCT00276016|79480979|FG003|Intervention 1|Withdrawal by Subject|0|||
44473196|NCT00276016|79480980|FG004|Intervention 1|Withdrawal by Subject|0|||
44473197|NCT00276016|79480981|FG005|Intervention 1|Withdrawal by Subject|0|||
44473198|NCT00434642|79480992|FG000|Blinded Treatment Phase|Adverse Event|12|||
44473199|NCT00434642|79480993|FG001|Blinded Treatment Phase|Adverse Event|58|||
44473200|NCT00434642|79480992|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
44473201|NCT00434642|79480993|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
44473202|NCT00434642|79480992|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
44473203|NCT00434642|79480993|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
44473204|NCT00434642|79480992|FG000|Blinded Treatment Phase|Physician Decision|19|||
44473205|NCT00434642|79480993|FG001|Blinded Treatment Phase|Physician Decision|27|||
44473206|NCT00434642|79480992|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
44473207|NCT00434642|79480993|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
44473208|NCT00434642|79480992|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
44473209|NCT00434642|79480993|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
44473210|NCT00434642|79480992|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
44473211|NCT00434642|79480993|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
44473212|NCT00434642|79480992|FG000|Open-label Treatment Phase|Adverse Event|0|||
44473213|NCT00434642|79480993|FG001|Open-label Treatment Phase|Adverse Event|5|||
44473214|NCT00434642|79480992|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
44473215|NCT00434642|79480993|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
44473216|NCT00434330|79481005|FG000|Overall Study|Adverse Event|0|||
44473217|NCT00434330|79481006|FG001|Overall Study|Adverse Event|0|||
44473218|NCT00434330|79481007|FG002|Overall Study|Adverse Event|1|||
44473219|NCT00434330|79481008|FG003|Overall Study|Adverse Event|0|||
44473220|NCT00434330|79481009|FG004|Overall Study|Adverse Event|0|||
44473221|NCT00434330|79481010|FG005|Overall Study|Adverse Event|0|||
44473222|NCT00434330|79481005|FG000|Overall Study|Death|1|||
44473223|NCT00434330|79481006|FG001|Overall Study|Death|0|||
44473224|NCT00434330|79481007|FG002|Overall Study|Death|0|||
44473225|NCT00434330|79481008|FG003|Overall Study|Death|0|||
44544545|NCT03194490|79558052|FG001|Overall Study|Lost to Follow-up|3|||
44544546|NCT03194490|79558051|FG000|Overall Study|participant developed specific neck pain|1|||
44225929|NCT01763203|79031775|FG001|Overall Study|Lost to Follow-up|12|||
44225930|NCT01763203|79031774|FG000|Overall Study|Withdrawal by Subject|8|||
44225931|NCT01763203|79031775|FG001|Overall Study|Withdrawal by Subject|12|||
44225932|NCT01763203|79031774|FG000|Overall Study|Moved out of study region|7|||
44225933|NCT01763203|79031775|FG001|Overall Study|Moved out of study region|10|||
44225934|NCT01763203|79031774|FG000|Overall Study|Physician Decision|2|||
44225935|NCT01763203|79031775|FG001|Overall Study|Physician Decision|1|||
44225936|NCT01763047|79031792|FG000|Period 1|Test Article Not Available|4|||
44225937|NCT01763047|79031793|FG001|Period 1|Test Article Not Available|1|||
44225938|NCT01763047|79031792|FG000|Period 1|Protocol Violation|4|||
44225939|NCT01763047|79031793|FG001|Period 1|Protocol Violation|4|||
44225940|NCT01763047|79031792|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
44225941|NCT01763047|79031793|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
44225942|NCT01763047|79031792|FG000|Period 1|Adverse Event|0|||
44225943|NCT01763047|79031793|FG001|Period 1|Adverse Event|1|||
44225944|NCT01763047|79031792|FG000|Period 1|Unsatisfactory Visual Response|0|||
44225945|NCT01763047|79031793|FG001|Period 1|Unsatisfactory Visual Response|3|||
44225946|NCT01763047|79031792|FG000|Period 1|Lens Power Not Available|0|||
44473226|NCT00434330|79481009|FG004|Overall Study|Death|1|||
44473227|NCT00434330|79481010|FG005|Overall Study|Death|1|||
44473228|NCT00434330|79481005|FG000|Overall Study|Withdrawal by Subject|0|||
44473229|NCT00434330|79481006|FG001|Overall Study|Withdrawal by Subject|0|||
44473230|NCT00434330|79481007|FG002|Overall Study|Withdrawal by Subject|1|||
44473231|NCT00434330|79481008|FG003|Overall Study|Withdrawal by Subject|1|||
44225947|NCT01763047|79031793|FG001|Period 1|Lens Power Not Available|1|||
44473232|NCT00434330|79481009|FG004|Overall Study|Withdrawal by Subject|0|||
44225948|NCT01763047|79031792|FG000|Period 1|Study Site office Closed|0|||
44225949|NCT01763047|79031793|FG001|Period 1|Study Site office Closed|1|||
44375394|NCT00944034|79380596|FG011|Overall Study|Withdrawal by Subject|4|||
44225950|NCT01763047|79031792|FG000|Period 2|Lens Discomfort|1|||
44225951|NCT01763047|79031793|FG001|Period 2|Lens Discomfort|0|||
44225952|NCT01763047|79031792|FG000|Period 2|No longer meets Eligibility Criteria|1|||
44225953|NCT01763047|79031793|FG001|Period 2|No longer meets Eligibility Criteria|0|||
44225954|NCT01763047|79031792|FG000|Period 2|Study Site office Closed|1|||
44225955|NCT01763047|79031793|FG001|Period 2|Study Site office Closed|1|||
44225956|NCT01763047|79031792|FG000|Period 2|Unsatisfactory Visual Response|1|||
44225957|NCT01763047|79031793|FG001|Period 2|Unsatisfactory Visual Response|1|||
44225958|NCT01763047|79031792|FG000|Period 2|Protocol Violation|0|||
44225959|NCT01763047|79031793|FG001|Period 2|Protocol Violation|2|||
44225960|NCT01763047|79031792|FG000|Period 2|Unsatisfactory lens Fitting|0|||
44225961|NCT01763047|79031793|FG001|Period 2|Unsatisfactory lens Fitting|1|||
44225962|NCT01977677|79031805|FG000|Overall Study|Unrelated Adverse Event|0|||
44225963|NCT01977677|79031806|FG001|Overall Study|Unrelated Adverse Event|0|||
44225964|NCT01977677|79031807|FG002|Overall Study|Unrelated Adverse Event|1|||
44225965|NCT01762345|79031815|FG000|Overall Study|Adverse Event|5|||
44225966|NCT01762345|79031815|FG000|Overall Study|Protocol Violation|2|||
44225967|NCT02090855|79031820|FG000|Overall Study|no evaluable Standard of Truth results|2|||
44225968|NCT01761565|79031827|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
44225969|NCT01619579|79031837|FG000|Overall Study|Withdrawal by Subject|0|||
44225970|NCT01619579|79031838|FG001|Overall Study|Withdrawal by Subject|3|||
44225971|NCT01736215|79031844|FG000|Overall Study|Early termination of erythropoietin use|1|||
44225972|NCT01736215|79031844|FG000|Overall Study|Adverse Event|4|||
44225973|NCT01736215|79031844|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
44225974|NCT01736215|79031844|FG000|Overall Study|Insufficient data to perform analysis|8|||
44225975|NCT01786603|79031850|FG000|Overall Study|Death|5|||
44225976|NCT01786603|79031851|FG001|Overall Study|Death|1|||
44225977|NCT01786603|79031850|FG000|Overall Study|Adverse Event|6|||
44225978|NCT01786603|79031851|FG001|Overall Study|Adverse Event|2|||
44225979|NCT01786603|79031850|FG000|Overall Study|Physician decision to withdraw|6|||
44225980|NCT01786603|79031851|FG001|Overall Study|Physician decision to withdraw|7|||
44225981|NCT01786603|79031850|FG000|Overall Study|Lost to Follow-up|1|||
44225982|NCT01786603|79031851|FG001|Overall Study|Lost to Follow-up|2|||
44225983|NCT01619423|79031874|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
44225984|NCT01619423|79031875|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
44225985|NCT01619423|79031876|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
44225986|NCT01619423|79031877|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
44225987|NCT01735279|79031890|FG000|Overall Study|Lost to Follow-up|11|||
44225988|NCT01735279|79031891|FG001|Overall Study|Lost to Follow-up|8|||
44225989|NCT01759381|79031899|FG000|Overall Study|Death|1|||
44225990|NCT01759381|79031900|FG001|Overall Study|Death|0|||
44225991|NCT01758523|79031919|FG000|Overall Study|Adverse Event|2|||
44225992|NCT01758523|79031920|FG001|Overall Study|Adverse Event|1|||
44225993|NCT01758523|79031919|FG000|Overall Study|Lack of Efficacy|4|||
44225994|NCT01758523|79031920|FG001|Overall Study|Lack of Efficacy|2|||
44225995|NCT01758523|79031919|FG000|Overall Study|Lost to Follow-up|3|||
44225996|NCT01758523|79031920|FG001|Overall Study|Lost to Follow-up|4|||
44225997|NCT01758523|79031919|FG000|Overall Study|Withdrawal by Subject|12|||
44225998|NCT01758523|79031920|FG001|Overall Study|Withdrawal by Subject|7|||
44225999|NCT01758289|79031943|FG000|Overall Study|Premature Study Termination|44|||
44226000|NCT01758289|79031943|FG000|Overall Study|Adverse Event|9|||
44226001|NCT01757821|79031967|FG000|Overall Study|Adverse Event|1|||
44226002|NCT01735201|79031996|FG000|Overall Study|Adverse Event|1|||
44226003|NCT01735201|79031997|FG001|Overall Study|Adverse Event|1|||
44226004|NCT01735201|79031998|FG002|Overall Study|Adverse Event|0|||
44226005|NCT01735201|79031999|FG003|Overall Study|Adverse Event|1|||
44226006|NCT01735201|79032000|FG004|Overall Study|Adverse Event|1|||
44226007|NCT01735201|79032001|FG005|Overall Study|Adverse Event|3|||
44473233|NCT00434330|79481010|FG005|Overall Study|Withdrawal by Subject|0|||
44473234|NCT00434330|79481005|FG000|Overall Study|Renal transplant|0|||
44473235|NCT00434330|79481006|FG001|Overall Study|Renal transplant|0|||
44473236|NCT00434330|79481007|FG002|Overall Study|Renal transplant|0|||
44473237|NCT00434330|79481008|FG003|Overall Study|Renal transplant|1|||
44473238|NCT00434330|79481009|FG004|Overall Study|Renal transplant|0|||
44473239|NCT00434330|79481010|FG005|Overall Study|Renal transplant|0|||
44473240|NCT00434330|79481005|FG000|Overall Study|Subject Not Compliant With Study|0|||
44473241|NCT00434330|79481006|FG001|Overall Study|Subject Not Compliant With Study|0|||
44473242|NCT00434330|79481007|FG002|Overall Study|Subject Not Compliant With Study|1|||
44143762|NCT03252925|78933093|FG000|Overall Study|Protocol Violation|6|||
44226008|NCT01735201|79032002|FG006|Overall Study|Adverse Event|2|||
44226009|NCT01735201|79032003|FG007|Overall Study|Adverse Event|1|||
44226010|NCT01735201|79031996|FG000|Overall Study|Personal Reasons|1|||
44226011|NCT01735201|79031997|FG001|Overall Study|Personal Reasons|0|||
44226012|NCT01735201|79031998|FG002|Overall Study|Personal Reasons|0|||
44226013|NCT01735201|79031999|FG003|Overall Study|Personal Reasons|0|||
44226014|NCT01735201|79032000|FG004|Overall Study|Personal Reasons|0|||
44226015|NCT01735201|79032001|FG005|Overall Study|Personal Reasons|0|||
44473243|NCT00434330|79481008|FG003|Overall Study|Subject Not Compliant With Study|0|||
44473244|NCT00434330|79481009|FG004|Overall Study|Subject Not Compliant With Study|0|||
44473245|NCT00434330|79481010|FG005|Overall Study|Subject Not Compliant With Study|0|||
44473246|NCT00426764|79481024|FG000|Overall Study|Protocol Violation|1|||
44473247|NCT00426764|79481024|FG000|Overall Study|Withdrawal by Subject|4|||
44473248|NCT00426764|79481024|FG000|Overall Study|Physician Decision|6|||
44473249|NCT00426764|79481024|FG000|Overall Study|Compassionate Use|1|||
44473250|NCT00426764|79481024|FG000|Overall Study|Progressive Disease|83|||
44473251|NCT00426764|79481024|FG000|Overall Study|Adverse Event|24|||
44473252|NCT00426764|79481024|FG000|Overall Study|Other|1|||
44473253|NCT00426764|79481024|FG000|Overall Study|Death|1|||
44473254|NCT00426764|79481024|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
44473255|NCT00434252|79481036|FG000|Overall Study|Lack of Efficacy|50|||
44473256|NCT00434252|79481037|FG001|Overall Study|Lack of Efficacy|100|||
44473257|NCT00434252|79481036|FG000|Overall Study|Adverse Event|6|||
44473258|NCT00434252|79481037|FG001|Overall Study|Adverse Event|13|||
44473259|NCT00434252|79481036|FG000|Overall Study|Death|1|||
44226016|NCT01735201|79032002|FG006|Overall Study|Personal Reasons|0|||
44226017|NCT01735201|79032003|FG007|Overall Study|Personal Reasons|0|||
44226018|NCT01735201|79031996|FG000|Overall Study|Protocol Violation|1|||
44226019|NCT01735201|79031997|FG001|Overall Study|Protocol Violation|0|||
44226020|NCT01735201|79031998|FG002|Overall Study|Protocol Violation|0|||
44226021|NCT01735201|79031999|FG003|Overall Study|Protocol Violation|0|||
44226022|NCT01735201|79032000|FG004|Overall Study|Protocol Violation|0|||
44226023|NCT01735201|79032001|FG005|Overall Study|Protocol Violation|0|||
44226024|NCT01735201|79032002|FG006|Overall Study|Protocol Violation|0|||
44226025|NCT01735201|79032003|FG007|Overall Study|Protocol Violation|0|||
44226026|NCT01735201|79031996|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44226027|NCT01735201|79031997|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44226028|NCT01735201|79031998|FG002|Overall Study|Other Miscellaneous Reasons|0|||
44226029|NCT01735201|79031999|FG003|Overall Study|Other Miscellaneous Reasons|1|||
44226030|NCT01735201|79032000|FG004|Overall Study|Other Miscellaneous Reasons|0|||
44226031|NCT01735201|79032001|FG005|Overall Study|Other Miscellaneous Reasons|2|||
44226032|NCT01735201|79032002|FG006|Overall Study|Other Miscellaneous Reasons|1|||
44226033|NCT01735201|79032003|FG007|Overall Study|Other Miscellaneous Reasons|1|||
44226034|NCT01734811|79032023|FG000|Overall Study|Lost to Follow-up|2|||
44226035|NCT01734811|79032024|FG001|Overall Study|Lost to Follow-up|3|||
44226036|NCT01734811|79032023|FG000|Overall Study|Withdrawal by Subject|2|||
44226037|NCT01734811|79032024|FG001|Overall Study|Withdrawal by Subject|0|||
44226038|NCT01757275|79032032|FG000|Overall Study|Lost to Follow-up|1|||
44226039|NCT01757275|79032033|FG001|Overall Study|Lost to Follow-up|2|||
44226040|NCT01757275|79032032|FG000|Overall Study|Adverse Event|3|||
44226041|NCT01757275|79032033|FG001|Overall Study|Adverse Event|3|||
44226042|NCT01757275|79032032|FG000|Overall Study|Withdrawal by Subject|2|||
44226043|NCT01757275|79032033|FG001|Overall Study|Withdrawal by Subject|4|||
44226044|NCT01757275|79032032|FG000|Overall Study|Not treated|3|||
44226045|NCT01757275|79032033|FG001|Overall Study|Not treated|4|||
44226046|NCT01757197|79032048|FG000|Overall Study|Death|2|||
44226047|NCT01784965|79032072|FG000|Overall Study|Withdrawal by Subject|6|||
44226048|NCT01784965|79032073|FG001|Overall Study|Withdrawal by Subject|3|||
44226049|NCT01784965|79032072|FG000|Overall Study|Adverse Event|0|||
44226050|NCT01784965|79032073|FG001|Overall Study|Adverse Event|8|||
44226051|NCT01784419|79032081|FG000|Overall Study|Adverse Event|3|||
44226052|NCT01784029|79032088|FG000|Overall Study|Lost to Follow-up|19|||
44226053|NCT01784029|79032089|FG001|Overall Study|Lost to Follow-up|20|||
44226054|NCT01784029|79032090|FG002|Overall Study|Lost to Follow-up|22|||
44226055|NCT01733329|79032112|FG000|Overall Study|Protocol Violation|1|||
44226056|NCT01733329|79032113|FG001|Overall Study|Protocol Violation|1|||
44226057|NCT01733329|79032112|FG000|Overall Study|Uterine artery injury|1|||
44226058|NCT01733329|79032113|FG001|Overall Study|Uterine artery injury|0|||
44226059|NCT01783483|79032121|FG000|Overall Study|Death|3|||
44226060|NCT01783483|79032122|FG001|Overall Study|Death|3|||
44473260|NCT00434252|79481037|FG001|Overall Study|Death|2|||
44473261|NCT00434252|79481036|FG000|Overall Study|Lost to Follow-up|0|||
44473262|NCT00434252|79481037|FG001|Overall Study|Lost to Follow-up|1|||
44473263|NCT00434252|79481036|FG000|Overall Study|Physician Decision|4|||
44473264|NCT00434252|79481037|FG001|Overall Study|Physician Decision|8|||
44226061|NCT01783483|79032121|FG000|Overall Study|Lost to Follow-up|14|||
44226062|NCT01783483|79032122|FG001|Overall Study|Lost to Follow-up|10|||
44226063|NCT01783483|79032121|FG000|Overall Study|Withdrawal by Subject|2|||
44226064|NCT01783483|79032122|FG001|Overall Study|Withdrawal by Subject|1|||
44226065|NCT01783483|79032121|FG000|Overall Study|Physician Decision|1|||
44226066|NCT01783483|79032122|FG001|Overall Study|Physician Decision|1|||
44473265|NCT00434252|79481036|FG000|Overall Study|Withdrawal by Subject|3|||
44473266|NCT00434252|79481037|FG001|Overall Study|Withdrawal by Subject|7|||
44473267|NCT00425750|79481043|FG000|Overall Study|Death|1|||
44226067|NCT01607593|79032141|FG000|Overall Study|Adverse Event|15|||
44226068|NCT01607593|79032141|FG000|Overall Study|Lack of Efficacy|16|||
44473268|NCT00425750|79481043|FG000|Overall Study|Withdrawal by Subject|3|||
44473269|NCT00425750|79481043|FG000|Overall Study|Adverse Event|3|||
44473270|NCT00425750|79481043|FG000|Overall Study|Progression of disease|18|||
44473271|NCT00414908|79481049|FG000|Overall Study|Protocol Violation|1|||
44473272|NCT00414908|79481050|FG001|Overall Study|Protocol Violation|1|||
44473273|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Adverse Event|30|||
44473274|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Adverse Event|25|||
44473275|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Adverse Event|23|||
44473276|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Adverse Event|14|||
44473277|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Death|0|||
44473278|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Death|0|||
44473279|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Death|1|||
44473280|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Death|0|||
44473281|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Physician Decision|0|||
44473282|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Physician Decision|1|||
44473283|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Physician Decision|0|||
44473284|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Physician Decision|1|||
44473285|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
44473286|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
44473287|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
44473288|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
44473289|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Other|6|||
44473290|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Other|1|||
44473291|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Other|0|||
44473292|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Other|2|||
44473293|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
44473294|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
44473295|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
44473296|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
44473297|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
44473298|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
44473299|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
44473300|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
44473301|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
44473302|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
44473303|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
44473304|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
44473305|NCT00242710|79481062|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
44473306|NCT00242710|79481063|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
44473307|NCT00242710|79481064|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
44473308|NCT00242710|79481065|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
44473309|NCT00242710|79481062|FG000|Period Between Core Study and Extension|Adverse Event|2|||
44473310|NCT00242710|79481063|FG001|Period Between Core Study and Extension|Adverse Event|3|||
44473311|NCT00242710|79481064|FG002|Period Between Core Study and Extension|Adverse Event|5|||
44473312|NCT00242710|79481065|FG003|Period Between Core Study and Extension|Adverse Event|2|||
44473313|NCT00242710|79481062|FG000|Period Between Core Study and Extension|Physician Decision|1|||
44473314|NCT00242710|79481063|FG001|Period Between Core Study and Extension|Physician Decision|1|||
44473315|NCT00242710|79481064|FG002|Period Between Core Study and Extension|Physician Decision|0|||
44473316|NCT00242710|79481065|FG003|Period Between Core Study and Extension|Physician Decision|0|||
44473317|NCT00242710|79481062|FG000|Period Between Core Study and Extension|Other|24|||
44473318|NCT00242710|79481063|FG001|Period Between Core Study and Extension|Other|24|||
44473319|NCT00242710|79481064|FG002|Period Between Core Study and Extension|Other|9|||
44473320|NCT00242710|79481065|FG003|Period Between Core Study and Extension|Other|11|||
44473321|NCT00242710|79481062|FG000|Period Between Core Study and Extension|Extension not Available|17|||
44473322|NCT00242710|79481063|FG001|Period Between Core Study and Extension|Extension not Available|21|||
44473323|NCT00242710|79481064|FG002|Period Between Core Study and Extension|Extension not Available|8|||
44473324|NCT00242710|79481065|FG003|Period Between Core Study and Extension|Extension not Available|7|||
44473325|NCT00242710|79481062|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
44473326|NCT00242710|79481063|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
44473327|NCT00242710|79481064|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
44473328|NCT00242710|79481065|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
44473329|NCT00242710|79481062|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
44473330|NCT00242710|79481063|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
44473331|NCT00242710|79481064|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
44473332|NCT00242710|79481065|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
44473333|NCT00242710|79481062|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
44226069|NCT01607593|79032141|FG000|Overall Study|Lost to Follow-up|25|||
44473334|NCT00242710|79481063|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
44473335|NCT00242710|79481064|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
44473336|NCT00242710|79481065|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
44226070|NCT01607593|79032141|FG000|Overall Study|Continuation|33|||
44473337|NCT00242710|79481062|FG000|Study Extension (up to Year 2)|Death|0|||
44473338|NCT00242710|79481063|FG001|Study Extension (up to Year 2)|Death|0|||
44473339|NCT00242710|79481064|FG002|Study Extension (up to Year 2)|Death|0|||
44473340|NCT00242710|79481065|FG003|Study Extension (up to Year 2)|Death|1|||
44473341|NCT00242710|79481062|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
44473342|NCT00242710|79481063|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
44473343|NCT00242710|79481064|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
44473344|NCT00242710|79481065|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
44473345|NCT00242710|79481062|FG000|Study Extension (up to Year 2)|Other|3|||
44473346|NCT00242710|79481063|FG001|Study Extension (up to Year 2)|Other|5|||
44473347|NCT00242710|79481064|FG002|Study Extension (up to Year 2)|Other|4|||
44473348|NCT00242710|79481065|FG003|Study Extension (up to Year 2)|Other|3|||
44473349|NCT00242710|79481062|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
44473350|NCT00242710|79481063|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
44473351|NCT00242710|79481064|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
44473352|NCT00242710|79481065|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
44473353|NCT00242710|79481062|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
44473354|NCT00242710|79481063|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
44473355|NCT00242710|79481064|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
44473356|NCT00242710|79481065|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
44473357|NCT00408876|79481079|FG000|Overall Study|Adverse Event|9|||
44473358|NCT00408876|79481080|FG001|Overall Study|Adverse Event|17|||
44473359|NCT00408876|79481081|FG002|Overall Study|Adverse Event|27|||
44473360|NCT00408876|79481082|FG003|Overall Study|Adverse Event|10|||
44473361|NCT00408876|79481079|FG000|Overall Study|Withdrawal by Subject|3|||
44473362|NCT00408876|79481080|FG001|Overall Study|Withdrawal by Subject|6|||
44473363|NCT00408876|79481081|FG002|Overall Study|Withdrawal by Subject|6|||
44473364|NCT00408876|79481082|FG003|Overall Study|Withdrawal by Subject|14|||
44473365|NCT00408876|79481079|FG000|Overall Study|Lack of Efficacy|2|||
44473366|NCT00408876|79481080|FG001|Overall Study|Lack of Efficacy|4|||
44473367|NCT00408876|79481081|FG002|Overall Study|Lack of Efficacy|5|||
44473368|NCT00408876|79481082|FG003|Overall Study|Lack of Efficacy|6|||
44473369|NCT00408876|79481079|FG000|Overall Study|Lost to Follow-up|1|||
44473370|NCT00408876|79481080|FG001|Overall Study|Lost to Follow-up|6|||
44473371|NCT00408876|79481081|FG002|Overall Study|Lost to Follow-up|5|||
44473372|NCT00408876|79481082|FG003|Overall Study|Lost to Follow-up|2|||
44473373|NCT00408876|79481079|FG000|Overall Study|Protocol Violation|0|||
44473374|NCT00408876|79481080|FG001|Overall Study|Protocol Violation|3|||
44226071|NCT01607593|79032141|FG000|Overall Study|Other|4|||
44226072|NCT01755637|79032154|FG000|Period 1|Adverse Event|0|||
44226073|NCT01755637|79032155|FG001|Period 1|Adverse Event|1|||
44473375|NCT00408876|79481081|FG002|Overall Study|Protocol Violation|4|||
44473376|NCT00408876|79481082|FG003|Overall Study|Protocol Violation|3|||
44473377|NCT00408876|79481079|FG000|Overall Study|Physician Decision|1|||
44473378|NCT00408876|79481080|FG001|Overall Study|Physician Decision|0|||
44473379|NCT00408876|79481081|FG002|Overall Study|Physician Decision|3|||
44473380|NCT00408876|79481082|FG003|Overall Study|Physician Decision|0|||
44473381|NCT00240994|79481092|FG000|Overall Study|Lost to Follow-up|1|||
44473382|NCT00240994|79481092|FG000|Overall Study|Protocol Violation|1|||
44473383|NCT00240994|79481092|FG000|Overall Study|Graft failure|1|||
44473384|NCT00239590|79481096|FG000|Randomized|Lost to Follow-up|0|||
44473385|NCT00239590|79481097|FG001|Randomized|Lost to Follow-up|1|||
44473386|NCT00239590|79481096|FG000|Randomized|Withdrawal by Subject|0|||
44473387|NCT00239590|79481097|FG001|Randomized|Withdrawal by Subject|1|||
44473388|NCT00239590|79481096|FG000|Completed Study Protocol|Adverse Event|1|||
44473389|NCT00239590|79481097|FG001|Completed Study Protocol|Adverse Event|1|||
44473390|NCT00239590|79481096|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
44473391|NCT00239590|79481097|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
44473392|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
44473393|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
44473394|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Death|0|||
44473395|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Death|0|||
44473396|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
44473397|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
44226074|NCT01732549|79032173|FG000|Overall Study|Adverse Event|13|||
44473398|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
44473399|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
44473400|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
44473401|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
44473402|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
44473403|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
44473404|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
44473405|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
44473406|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
44473407|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
44473408|NCT00433160|79481107|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
44473409|NCT00433160|79481108|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
44473410|NCT00433160|79481107|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
44473411|NCT00433160|79481108|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
44473412|NCT00433160|79481107|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
44473413|NCT00433160|79481108|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
44473414|NCT00433160|79481107|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
44473415|NCT00433160|79481108|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
44473416|NCT00433160|79481107|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
44473417|NCT00433160|79481108|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
44473418|NCT00433160|79481107|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
44473419|NCT00433160|79481108|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
44473420|NCT00433160|79481107|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
44473421|NCT00433160|79481108|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
44473422|NCT00433160|79481107|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
44473423|NCT00433160|79481108|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
44473424|NCT00239356|79481120|FG000|Overall Study|Lack of Efficacy|1|||
44473425|NCT00239356|79481121|FG001|Overall Study|Lack of Efficacy|0|||
44473426|NCT00239356|79481120|FG000|Overall Study|Adverse Event|6|||
44473427|NCT00239356|79481121|FG001|Overall Study|Adverse Event|0|||
44473428|NCT00239356|79481120|FG000|Overall Study|Withdrawal by Subject|15|||
44473429|NCT00239356|79481121|FG001|Overall Study|Withdrawal by Subject|6|||
44473430|NCT00239356|79481120|FG000|Overall Study|Lost to Follow-up|3|||
44473431|NCT00239356|79481121|FG001|Overall Study|Lost to Follow-up|0|||
44473432|NCT00239356|79481120|FG000|Overall Study|poor/non-compliance|2|||
44473433|NCT00239356|79481121|FG001|Overall Study|poor/non-compliance|0|||
44473434|NCT00239356|79481120|FG000|Overall Study|Pregnancy|1|||
44473435|NCT00239356|79481121|FG001|Overall Study|Pregnancy|0|||
44473436|NCT00239356|79481120|FG000|Overall Study|Administrative reason|0|||
44473437|NCT00239356|79481121|FG001|Overall Study|Administrative reason|1|||
44473438|NCT00239356|79481120|FG000|Overall Study|Drug available on market|11|||
44473439|NCT00239356|79481121|FG001|Overall Study|Drug available on market|2|||
44473440|NCT00393510|79481129|FG000|Overall Study|Physician Decision|3|||
44473441|NCT00393510|79481130|FG001|Overall Study|Physician Decision|9|||
44473442|NCT00425438|79481138|FG000|Overall Study|Termination by Sponsor|25|||
44473443|NCT00425438|79481139|FG001|Overall Study|Termination by Sponsor|27|||
44473444|NCT00275002|79481147|FG000|Overall Study|Death|1|||
44473445|NCT00275002|79481148|FG001|Overall Study|Death|0|||
44473446|NCT00275002|79481147|FG000|Overall Study|Disease progression|21|||
44473447|NCT00275002|79481148|FG001|Overall Study|Disease progression|15|||
44473448|NCT00275002|79481147|FG000|Overall Study|Adverse Event|0|||
44473449|NCT00275002|79481148|FG001|Overall Study|Adverse Event|1|||
44473450|NCT00433004|79481156|FG000|Overall Study|Lost to Follow-up|5|||
44473451|NCT00433004|79481157|FG001|Overall Study|Lost to Follow-up|7|||
44473452|NCT00238264|79481163|FG000|Overall Study|Death|7|||
44473453|NCT00238264|79481163|FG000|Overall Study|Lost to Follow-up|18|||
44473454|NCT00238264|79481163|FG000|Overall Study|Withdrawal by Subject|4|||
44473455|NCT00238264|79481163|FG000|Overall Study|Ineligible|7|||
44473456|NCT00414596|79481167|FG000|Overall Study|Protocol Violation|2|||
44473457|NCT00393042|79481171|FG000|First Intervention|Withdrawal by Subject|1|||
44473458|NCT00393042|79481172|FG001|First Intervention|Withdrawal by Subject|2|||
44473459|NCT00393042|79481171|FG000|First Intervention|Lost to Follow-up|3|||
44473460|NCT00393042|79481172|FG001|First Intervention|Lost to Follow-up|3|||
44473461|NCT00393042|79481171|FG000|First Intervention|Protocol Violation|1|||
44473462|NCT00393042|79481172|FG001|First Intervention|Protocol Violation|0|||
44473463|NCT00393042|79481171|FG000|First Intervention|Adverse Event|0|||
44544547|NCT03194490|79558052|FG001|Overall Study|participant developed specific neck pain|0|||
44544548|NCT03217968|79558059|FG000|Overall Study|Withdrawal by Subject|4|||
44473464|NCT00393042|79481172|FG001|First Intervention|Adverse Event|1|||
44473465|NCT00393042|79481171|FG000|Second Intervetion|Adverse Event|0|||
44473466|NCT00393042|79481172|FG001|Second Intervetion|Adverse Event|3|||
44473467|NCT00393042|79481171|FG000|Second Intervetion|Withdrawal by Subject|0|||
44473468|NCT00393042|79481172|FG001|Second Intervetion|Withdrawal by Subject|2|||
44143763|NCT03252925|78933094|FG001|Overall Study|Protocol Violation|0|||
44473469|NCT00393042|79481171|FG000|Second Intervetion|Lack of Efficacy|1|||
44473470|NCT00393042|79481172|FG001|Second Intervetion|Lack of Efficacy|0|||
44473471|NCT00393042|79481171|FG000|Second Intervetion|Lost to Follow-up|0|||
44473472|NCT00393042|79481172|FG001|Second Intervetion|Lost to Follow-up|2|||
44473473|NCT00393042|79481171|FG000|Second Intervetion|Protocol Violation|1|||
44473474|NCT00393042|79481172|FG001|Second Intervetion|Protocol Violation|1|||
44473475|NCT00392808|79481230|FG000|Overall Study|Lost to Follow-up|3|||
44473476|NCT00392808|79481231|FG001|Overall Study|Lost to Follow-up|2|||
44473477|NCT00392808|79481232|FG002|Overall Study|Lost to Follow-up|1|||
44473478|NCT00392808|79481233|FG003|Overall Study|Lost to Follow-up|2|||
44473479|NCT00392808|79481230|FG000|Overall Study|Unable to withdraw blood|3|||
44473480|NCT00392808|79481231|FG001|Overall Study|Unable to withdraw blood|1|||
44473481|NCT00392808|79481232|FG002|Overall Study|Unable to withdraw blood|1|||
44473482|NCT00392808|79481233|FG003|Overall Study|Unable to withdraw blood|2|||
44473483|NCT00274846|79481252|FG000|Overall Study|Did not receive adequate NK cells|1|||
44473484|NCT00237796|79481259|FG000|Overall Study|Baseline and one other ILSS required|10|||
44473485|NCT00237796|79481260|FG001|Overall Study|Baseline and one other ILSS required|5|||
44473486|NCT00414440|79481269|FG000|Core Period|Withdrawal by Subject|70|||
44473487|NCT00414440|79481270|FG001|Core Period|Withdrawal by Subject|32|||
44473488|NCT00414440|79481269|FG000|Extension Period|Lost to Follow-up|44|||
44473489|NCT00414440|79481270|FG001|Extension Period|Lost to Follow-up|52|||
44473490|NCT00414440|79481269|FG000|Extension Period|Did not consent to continue follow up|61|||
44473491|NCT00414440|79481270|FG001|Extension Period|Did not consent to continue follow up|54|||
44473492|NCT00414440|79481269|FG000|Extension Period|Other|1|||
44473493|NCT00414440|79481270|FG001|Extension Period|Other|1|||
44473494|NCT00414440|79481269|FG000|Extension Period|Administrative|16|||
44473495|NCT00414440|79481270|FG001|Extension Period|Administrative|16|||
44473496|NCT00414440|79481269|FG000|Extension Period|Death|1|||
44473497|NCT00414440|79481270|FG001|Extension Period|Death|2|||
44473498|NCT00414440|79481269|FG000|Extension Period|Withdrawal by Subject|9|||
44473499|NCT00414440|79481270|FG001|Extension Period|Withdrawal by Subject|7|||
44473500|NCT00414440|79481269|FG000|Extension Period|Not included in follow up period|18|||
44473501|NCT00414440|79481270|FG001|Extension Period|Not included in follow up period|8|||
44473502|NCT00209560|79481278|FG000|Overall Study|Lack of Efficacy|1|||
44473503|NCT00209560|79481279|FG001|Overall Study|Lack of Efficacy|0|||
44473504|NCT00236080|79481290|FG000|Overall Study|Adverse Event|0|||
44473505|NCT00236080|79481291|FG001|Overall Study|Adverse Event|0|||
44473506|NCT00236080|79481292|FG002|Overall Study|Adverse Event|3|||
44473507|NCT00236080|79481293|FG003|Overall Study|Adverse Event|1|||
44226075|NCT01732549|79032174|FG001|Overall Study|Adverse Event|3|||
44226076|NCT01732549|79032173|FG000|Overall Study|Consent withdrawn|13|||
44226077|NCT01732549|79032174|FG001|Overall Study|Consent withdrawn|6|||
44226078|NCT01732549|79032173|FG000|Overall Study|Disease progression|37|||
44226079|NCT01732549|79032174|FG001|Overall Study|Disease progression|50|||
44473508|NCT00236080|79481294|FG004|Overall Study|Adverse Event|0|||
44473509|NCT00236080|79481290|FG000|Overall Study|Lost to Follow-up|0|||
44473510|NCT00236080|79481291|FG001|Overall Study|Lost to Follow-up|1|||
44473511|NCT00236080|79481292|FG002|Overall Study|Lost to Follow-up|0|||
44226080|NCT01732549|79032173|FG000|Overall Study|Other|8|||
44226081|NCT01732549|79032174|FG001|Overall Study|Other|14|||
44226082|NCT01755091|79032193|FG000|Overall Study|Withdrawal by Subject|6|||
44473512|NCT00236080|79481293|FG003|Overall Study|Lost to Follow-up|0|||
44473513|NCT00236080|79481294|FG004|Overall Study|Lost to Follow-up|0|||
44473514|NCT00236080|79481290|FG000|Overall Study|Physician Decision|1|||
44473515|NCT00236080|79481291|FG001|Overall Study|Physician Decision|0|||
44473516|NCT00236080|79481292|FG002|Overall Study|Physician Decision|1|||
44473517|NCT00236080|79481293|FG003|Overall Study|Physician Decision|1|||
44473518|NCT00236080|79481294|FG004|Overall Study|Physician Decision|1|||
44473519|NCT00236080|79481290|FG000|Overall Study|Withdrawal by Subject|1|||
44473520|NCT00236080|79481291|FG001|Overall Study|Withdrawal by Subject|0|||
44473521|NCT00236080|79481292|FG002|Overall Study|Withdrawal by Subject|0|||
44473522|NCT00236080|79481293|FG003|Overall Study|Withdrawal by Subject|0|||
44473523|NCT00236080|79481294|FG004|Overall Study|Withdrawal by Subject|0|||
44473524|NCT00236080|79481290|FG000|Overall Study|Miscellaneous|0|||
44226083|NCT01755091|79032194|FG001|Overall Study|Withdrawal by Subject|1|||
44226084|NCT01755091|79032195|FG002|Overall Study|Withdrawal by Subject|3|||
44473525|NCT00236080|79481291|FG001|Overall Study|Miscellaneous|0|||
44473526|NCT00236080|79481292|FG002|Overall Study|Miscellaneous|1|||
44473527|NCT00236080|79481293|FG003|Overall Study|Miscellaneous|0|||
44473528|NCT00236080|79481294|FG004|Overall Study|Miscellaneous|0|||
44473529|NCT00432380|79481309|FG000|Overall Study|Migrated/moved from study area|3|||
44473530|NCT00432380|79481310|FG001|Overall Study|Migrated/moved from study area|4|||
44473531|NCT00432380|79481311|FG002|Overall Study|Migrated/moved from study area|1|||
44473532|NCT00432380|79481309|FG000|Overall Study|Adverse Event|1|||
44473533|NCT00432380|79481310|FG001|Overall Study|Adverse Event|0|||
44473534|NCT00432380|79481311|FG002|Overall Study|Adverse Event|0|||
44473535|NCT00234052|79481320|FG000|Treatment|Withdrawal by Subject|3|||
44226085|NCT01755091|79032193|FG000|Overall Study|Adverse Event|1|||
44226086|NCT01755091|79032194|FG001|Overall Study|Adverse Event|1|||
44473536|NCT00234052|79481320|FG000|Treatment|Adverse Event|5|||
44473537|NCT00234052|79481320|FG000|Treatment|Death|2|||
44473538|NCT00234052|79481320|FG000|Treatment|Progressive Disease|11|||
44473539|NCT00234052|79481320|FG000|Follow-up for 5 Years|Death|41|||
44473540|NCT00234052|79481320|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
44473541|NCT00234052|79481320|FG000|Follow-up for 5 Years|Other|7|||
44473542|NCT00408408|79481330|FG000|Overall Study|No follow up data|2|||
44473543|NCT00408408|79481331|FG001|Overall Study|No follow up data|3|||
44473544|NCT00408408|79481332|FG002|Overall Study|No follow up data|0|||
44473545|NCT00408408|79481333|FG003|Overall Study|No follow up data|7|||
44473546|NCT00408408|79481334|FG004|Overall Study|No follow up data|5|||
44473547|NCT00408408|79481335|FG005|Overall Study|No follow up data|3|||
44473548|NCT00414050|79481353|FG000|Overall Study|Adverse Event|1|||
44473549|NCT00414050|79481354|FG001|Overall Study|Adverse Event|1|||
44473550|NCT00414050|79481355|FG002|Overall Study|Adverse Event|1|||
44473551|NCT00414050|79481356|FG003|Overall Study|Adverse Event|1|||
44473552|NCT00414050|79481353|FG000|Overall Study|Lost to Follow-up|2|||
44473553|NCT00414050|79481354|FG001|Overall Study|Lost to Follow-up|2|||
44473554|NCT00414050|79481355|FG002|Overall Study|Lost to Follow-up|1|||
44473555|NCT00414050|79481356|FG003|Overall Study|Lost to Follow-up|1|||
44473556|NCT00414050|79481353|FG000|Overall Study|Withdrawal by Subject|5|||
44473557|NCT00414050|79481354|FG001|Overall Study|Withdrawal by Subject|3|||
44473558|NCT00414050|79481355|FG002|Overall Study|Withdrawal by Subject|2|||
44473559|NCT00414050|79481356|FG003|Overall Study|Withdrawal by Subject|4|||
44473560|NCT00414050|79481353|FG000|Overall Study|Subject discontinued for other reason|1|||
44473561|NCT00414050|79481354|FG001|Overall Study|Subject discontinued for other reason|2|||
44473562|NCT00414050|79481355|FG002|Overall Study|Subject discontinued for other reason|2|||
44473563|NCT00414050|79481356|FG003|Overall Study|Subject discontinued for other reason|1|||
44473564|NCT00414050|79481353|FG000|Overall Study|Subject Moved|0|||
44473565|NCT00414050|79481354|FG001|Overall Study|Subject Moved|0|||
44473566|NCT00414050|79481355|FG002|Overall Study|Subject Moved|0|||
44473567|NCT00414050|79481356|FG003|Overall Study|Subject Moved|1|||
44473568|NCT00413972|79481370|FG000|Overall Study|Adverse Event|2|||
44473569|NCT00413972|79481371|FG001|Overall Study|Adverse Event|1|||
44473570|NCT00413972|79481372|FG002|Overall Study|Adverse Event|0|||
44473571|NCT00413972|79481373|FG003|Overall Study|Adverse Event|0|||
44473572|NCT00413972|79481370|FG000|Overall Study|Lost to Follow-up|1|||
44473573|NCT00413972|79481371|FG001|Overall Study|Lost to Follow-up|2|||
44473574|NCT00413972|79481372|FG002|Overall Study|Lost to Follow-up|1|||
44473575|NCT00413972|79481373|FG003|Overall Study|Lost to Follow-up|0|||
44473576|NCT00413972|79481370|FG000|Overall Study|Withdrawal by Subject|4|||
44473577|NCT00413972|79481371|FG001|Overall Study|Withdrawal by Subject|5|||
44473578|NCT00413972|79481372|FG002|Overall Study|Withdrawal by Subject|7|||
44473579|NCT00413972|79481373|FG003|Overall Study|Withdrawal by Subject|2|||
44375395|NCT00944034|79380585|FG000|Overall Study|Lost to Follow-up|0|||
44375396|NCT00944034|79380586|FG001|Overall Study|Lost to Follow-up|4|||
44375397|NCT00944034|79380587|FG002|Overall Study|Lost to Follow-up|2|||
44375398|NCT00944034|79380588|FG003|Overall Study|Lost to Follow-up|0|||
44375399|NCT00944034|79380589|FG004|Overall Study|Lost to Follow-up|5|||
44375400|NCT00944034|79380590|FG005|Overall Study|Lost to Follow-up|7|||
44375401|NCT00944034|79380591|FG006|Overall Study|Lost to Follow-up|0|||
44375402|NCT00944034|79380592|FG007|Overall Study|Lost to Follow-up|1|||
44375403|NCT00944034|79380593|FG008|Overall Study|Lost to Follow-up|5|||
44375404|NCT00944034|79380594|FG009|Overall Study|Lost to Follow-up|1|||
44375405|NCT00944034|79380595|FG010|Overall Study|Lost to Follow-up|1|||
44375406|NCT00944034|79380596|FG011|Overall Study|Lost to Follow-up|0|||
44375407|NCT00944034|79380585|FG000|Overall Study|Death|0|||
44375408|NCT00944034|79380586|FG001|Overall Study|Death|0|||
44375409|NCT00944034|79380587|FG002|Overall Study|Death|1|||
44375410|NCT00944034|79380588|FG003|Overall Study|Death|0|||
44375411|NCT00944034|79380589|FG004|Overall Study|Death|0|||
44375412|NCT00944034|79380590|FG005|Overall Study|Death|0|||
44375413|NCT00944034|79380591|FG006|Overall Study|Death|0|||
44375414|NCT00944034|79380592|FG007|Overall Study|Death|0|||
44375415|NCT00944034|79380593|FG008|Overall Study|Death|0|||
44375416|NCT00944034|79380594|FG009|Overall Study|Death|0|||
44375417|NCT00944034|79380595|FG010|Overall Study|Death|0|||
44473580|NCT00413972|79481370|FG000|Overall Study|Protocol Violation|0|||
44473581|NCT00413972|79481371|FG001|Overall Study|Protocol Violation|0|||
44473582|NCT00413972|79481372|FG002|Overall Study|Protocol Violation|2|||
44473583|NCT00413972|79481373|FG003|Overall Study|Protocol Violation|0|||
44473584|NCT00413972|79481370|FG000|Overall Study|Other|0|||
44473585|NCT00413972|79481371|FG001|Overall Study|Other|0|||
44375418|NCT00944034|79380596|FG011|Overall Study|Death|0|||
44473586|NCT00413972|79481372|FG002|Overall Study|Other|0|||
44473587|NCT00413972|79481373|FG003|Overall Study|Other|1|||
44473588|NCT00259012|79481385|FG000|Overall Study|Adverse Event|0|||
44473589|NCT00259012|79481386|FG001|Overall Study|Adverse Event|1|||
44473590|NCT00259012|79481385|FG000|Overall Study|Withdrawal by Subject|1|||
44473591|NCT00259012|79481386|FG001|Overall Study|Withdrawal by Subject|0|||
44375419|NCT00944034|79380585|FG000|Overall Study|Protocol Violation|2|||
44375420|NCT00944034|79380586|FG001|Overall Study|Protocol Violation|0|||
44473592|NCT00259012|79481385|FG000|Overall Study|Physician Decision|0|||
44473593|NCT00259012|79481386|FG001|Overall Study|Physician Decision|1|||
44473594|NCT00259012|79481385|FG000|Overall Study|Lost to Follow-up|0|||
44473595|NCT00259012|79481386|FG001|Overall Study|Lost to Follow-up|1|||
44473596|NCT00259012|79481385|FG000|Overall Study|Protocol Violation|1|||
44473597|NCT00259012|79481386|FG001|Overall Study|Protocol Violation|1|||
44473598|NCT00209170|79481394|FG000|Overall Study|Adverse Event|0|||
44473599|NCT00209170|79481395|FG001|Overall Study|Adverse Event|1|||
44473600|NCT00209170|79481394|FG000|Overall Study|Withdrawal by Subject|2|||
44473601|NCT00209170|79481395|FG001|Overall Study|Withdrawal by Subject|1|||
44473602|NCT00209170|79481394|FG000|Overall Study|Lack of Efficacy|0|||
44473603|NCT00209170|79481395|FG001|Overall Study|Lack of Efficacy|1|||
44473604|NCT00413894|79481401|FG000|Overall Study|Withdrawal by Subject|10|||
44473605|NCT00413894|79481401|FG000|Overall Study|Administrative Reasons|1|||
44473606|NCT00413894|79481401|FG000|Overall Study|Hb <10 grams/deciliter|12|||
44473607|NCT00413894|79481401|FG000|Overall Study|Adverse Event|28|||
44473608|NCT00413894|79481401|FG000|Overall Study|Protocol Violation|11|||
44473609|NCT00413894|79481401|FG000|Overall Study|Other|18|||
44473610|NCT00407550|79481410|FG000|Overall Study|Adverse Event|0|||
44473611|NCT00407550|79481411|FG001|Overall Study|Adverse Event|1|||
44473612|NCT00407550|79481410|FG000|Overall Study|Withdrawal by Subject|0|||
44473613|NCT00407550|79481411|FG001|Overall Study|Withdrawal by Subject|2|||
44473614|NCT00407550|79481410|FG000|Overall Study|Death|1|||
44473615|NCT00407550|79481411|FG001|Overall Study|Death|0|||
44473616|NCT00407550|79481410|FG000|Overall Study|Insurance or Other medical condition|2|||
44473617|NCT00407550|79481411|FG001|Overall Study|Insurance or Other medical condition|1|||
44473618|NCT00209092|79481419|FG000|Overall Study|Progression of disease|7|||
44473619|NCT00209092|79481420|FG001|Overall Study|Progression of disease|1|||
44473620|NCT00209092|79481419|FG000|Overall Study|Adverse Event|0|||
44473621|NCT00209092|79481420|FG001|Overall Study|Adverse Event|1|||
44473622|NCT00209092|79481419|FG000|Overall Study|Withdrawal by Subject|1|||
44473623|NCT00209092|79481420|FG001|Overall Study|Withdrawal by Subject|0|||
44473624|NCT00403494|79481428|FG000|Overall Study|Adverse Event|10|||
44473625|NCT00403494|79481429|FG001|Overall Study|Adverse Event|8|||
44473626|NCT00403494|79481428|FG000|Overall Study|Withdrew Consent|3|||
44473627|NCT00403494|79481429|FG001|Overall Study|Withdrew Consent|2|||
44473628|NCT00403494|79481428|FG000|Overall Study|Inappropriately enrolled|0|||
44473629|NCT00403494|79481429|FG001|Overall Study|Inappropriately enrolled|1|||
44473630|NCT00403494|79481428|FG000|Overall Study|Lost to Follow-up|0|||
44473631|NCT00403494|79481429|FG001|Overall Study|Lost to Follow-up|2|||
44473632|NCT00403494|79481428|FG000|Overall Study|Protocol noncompliance|0|||
44473633|NCT00403494|79481429|FG001|Overall Study|Protocol noncompliance|1|||
44473634|NCT00403494|79481428|FG000|Overall Study|Death|1|||
44473635|NCT00403494|79481429|FG001|Overall Study|Death|0|||
44473636|NCT00403494|79481428|FG000|Overall Study|Sponsor Request|1|||
44473637|NCT00403494|79481429|FG001|Overall Study|Sponsor Request|0|||
44473638|NCT00403260|79481439|FG000|Overall Study|Adverse Event|5|||
44473639|NCT00403260|79481440|FG001|Overall Study|Adverse Event|4|||
44473640|NCT00403260|79481439|FG000|Overall Study|Withdrawal by Subject|5|||
44473641|NCT00403260|79481440|FG001|Overall Study|Withdrawal by Subject|6|||
44473642|NCT00403260|79481439|FG000|Overall Study|Lost to Follow-up|49|||
44473643|NCT00403260|79481440|FG001|Overall Study|Lost to Follow-up|25|||
44473644|NCT00403260|79481439|FG000|Overall Study|Re-appearance of P. falciparum|34|||
44473645|NCT00403260|79481440|FG001|Overall Study|Re-appearance of P. falciparum|25|||
44473646|NCT00403260|79481439|FG000|Overall Study|P. vivax infection|26|||
44473647|NCT00403260|79481440|FG001|Overall Study|P. vivax infection|4|||
44473648|NCT00403260|79481439|FG000|Overall Study|Mixed infection with P. vivax|2|||
44473649|NCT00403260|79481440|FG001|Overall Study|Mixed infection with P. vivax|0|||
44473650|NCT00403260|79481439|FG000|Overall Study|Mixed infection with P. falciparum|1|||
44473651|NCT00403260|79481440|FG001|Overall Study|Mixed infection with P. falciparum|0|||
44473652|NCT00403260|79481439|FG000|Overall Study|P. vivax infection at screening|1|||
44473653|NCT00403260|79481440|FG001|Overall Study|P. vivax infection at screening|0|||
44473654|NCT00403260|79481439|FG000|Overall Study|P. ovale infection|1|||
44473655|NCT00403260|79481440|FG001|Overall Study|P. ovale infection|0|||
44473656|NCT00403260|79481439|FG000|Overall Study|Gametocyte re-appearance|1|||
44473657|NCT00403260|79481440|FG001|Overall Study|Gametocyte re-appearance|1|||
44473658|NCT00403260|79481439|FG000|Overall Study|Withdrawn from study accidentally|0|||
44473659|NCT00403260|79481440|FG001|Overall Study|Withdrawn from study accidentally|1|||
44473660|NCT00406848|79481448|FG000|Overall Study|Withdrawal by Subject|27|||
44473661|NCT00406848|79481449|FG001|Overall Study|Withdrawal by Subject|22|||
44473662|NCT00406848|79481448|FG000|Overall Study|Adverse Event|38|||
44473663|NCT00406848|79481449|FG001|Overall Study|Adverse Event|7|||
44473664|NCT00406848|79481448|FG000|Overall Study|Lack of Efficacy|9|||
44473665|NCT00406848|79481449|FG001|Overall Study|Lack of Efficacy|14|||
44473666|NCT00406848|79481448|FG000|Overall Study|Protocol Violation|10|||
44473667|NCT00406848|79481449|FG001|Overall Study|Protocol Violation|6|||
44473668|NCT00406848|79481448|FG000|Overall Study|Lost to Follow-up|6|||
44473669|NCT00406848|79481449|FG001|Overall Study|Lost to Follow-up|2|||
44473670|NCT00406848|79481448|FG000|Overall Study|Physician Decision|2|||
44473671|NCT00406848|79481449|FG001|Overall Study|Physician Decision|2|||
44473672|NCT00406848|79481448|FG000|Overall Study|Sponsor Decision|1|||
44473673|NCT00406848|79481449|FG001|Overall Study|Sponsor Decision|1|||
44473674|NCT00406692|79481458|FG000|Overall Study|Withdrawal by Subject|4|||
44473675|NCT00406692|79481458|FG000|Overall Study|Physician Decision|1|||
44473676|NCT00406692|79481458|FG000|Overall Study|Adverse Event|1|||
44473677|NCT00406692|79481458|FG000|Overall Study|Lack of Efficacy|1|||
44473678|NCT00315705|79481464|FG000|Phase 1|Refused further treatment|1|||
44473679|NCT00315705|79481464|FG000|Phase 1|Failure to achieve response|8|||
44473680|NCT00315705|79481464|FG000|Phase 1|Disease relapse|4|||
44473681|NCT00315705|79481464|FG000|Phase 1|Scheduled for transplant|9|||
44473682|NCT00315705|79481464|FG000|Phase 1|Death|3|||
44473683|NCT00315705|79481464|FG000|Phase 2|Physician Decision|4|||
44473684|NCT00315705|79481464|FG000|Phase 2|Adverse Event|1|||
44473685|NCT00315705|79481464|FG000|Phase 2|Failure to achieve response|3|||
44473686|NCT00315705|79481464|FG000|Phase 2|Disease relapse|1|||
44473687|NCT00315705|79481464|FG000|Phase 2|Scheduled for transplant|8|||
44473688|NCT00315705|79481464|FG000|Phase 2|Other|1|||
44473689|NCT00315705|79481464|FG000|Phase 2|Death|7|||
44473690|NCT00307125|79481483|FG000|Screening Phase|Adverse Event|1|||
44473691|NCT00307125|79481484|FG001|Screening Phase|Adverse Event|0|||
44473692|NCT00307125|79481485|FG002|Screening Phase|Adverse Event|0|||
44473693|NCT00307125|79481483|FG000|Screening Phase|Protocol Violation|27|||
44473694|NCT00307125|79481484|FG001|Screening Phase|Protocol Violation|0|||
44473695|NCT00307125|79481485|FG002|Screening Phase|Protocol Violation|0|||
44473696|NCT00307125|79481483|FG000|Screening Phase|Lost to Follow-up|87|||
44473697|NCT00307125|79481484|FG001|Screening Phase|Lost to Follow-up|0|||
44473698|NCT00307125|79481485|FG002|Screening Phase|Lost to Follow-up|0|||
44473699|NCT00307125|79481483|FG000|Screening Phase|Death|10|||
44473700|NCT00307125|79481484|FG001|Screening Phase|Death|0|||
44473701|NCT00307125|79481485|FG002|Screening Phase|Death|0|||
44473702|NCT00307125|79481483|FG000|Screening Phase|Withdrawal by Subject|77|||
44473703|NCT00307125|79481484|FG001|Screening Phase|Withdrawal by Subject|0|||
44473704|NCT00307125|79481485|FG002|Screening Phase|Withdrawal by Subject|0|||
44473705|NCT00307125|79481483|FG000|Screening Phase|Physician Decision|26|||
44473706|NCT00307125|79481484|FG001|Screening Phase|Physician Decision|0|||
44473707|NCT00307125|79481485|FG002|Screening Phase|Physician Decision|0|||
44473708|NCT00307125|79481483|FG000|Screening Phase|Sponsor Decision|4|||
44473709|NCT00307125|79481484|FG001|Screening Phase|Sponsor Decision|0|||
44473710|NCT00307125|79481485|FG002|Screening Phase|Sponsor Decision|0|||
44473711|NCT00307125|79481483|FG000|Screening Phase|Study Terminated|17|||
44473712|NCT00307125|79481484|FG001|Screening Phase|Study Terminated|0|||
44473713|NCT00307125|79481485|FG002|Screening Phase|Study Terminated|0|||
44473714|NCT00307125|79481483|FG000|Screening Phase|Graft Loss|3|||
44473715|NCT00307125|79481484|FG001|Screening Phase|Graft Loss|0|||
44473716|NCT00307125|79481485|FG002|Screening Phase|Graft Loss|0|||
44473717|NCT00307125|79481483|FG000|Screening Phase|Graft Failure|8|||
44473718|NCT00307125|79481484|FG001|Screening Phase|Graft Failure|0|||
44473719|NCT00307125|79481485|FG002|Screening Phase|Graft Failure|0|||
44473720|NCT00307125|79481483|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
44473721|NCT00307125|79481484|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
44473722|NCT00307125|79481485|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
44226087|NCT01755091|79032195|FG002|Overall Study|Adverse Event|1|||
44473723|NCT00307125|79481483|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
44473724|NCT00307125|79481484|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
44473725|NCT00307125|79481485|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
44473726|NCT00307125|79481483|FG000|Screening Phase|Moved or transferred facilities|34|||
44473727|NCT00307125|79481484|FG001|Screening Phase|Moved or transferred facilities|0|||
44473728|NCT00307125|79481485|FG002|Screening Phase|Moved or transferred facilities|0|||
44226088|NCT01755091|79032193|FG000|Overall Study|Lost to Follow-up|1|||
44375421|NCT00944034|79380587|FG002|Overall Study|Protocol Violation|0|||
44473729|NCT00307125|79481483|FG000|Screening Phase|Received Pancreas Transplant|8|||
44473730|NCT00307125|79481484|FG001|Screening Phase|Received Pancreas Transplant|0|||
44473731|NCT00307125|79481485|FG002|Screening Phase|Received Pancreas Transplant|0|||
44473732|NCT00307125|79481483|FG000|Screening Phase|Ineligible for pilot|4|||
44473733|NCT00307125|79481484|FG001|Screening Phase|Ineligible for pilot|0|||
44473734|NCT00307125|79481485|FG002|Screening Phase|Ineligible for pilot|0|||
44473735|NCT00307125|79481483|FG000|Screening Phase|Try to get pregnant|1|||
44473736|NCT00307125|79481484|FG001|Screening Phase|Try to get pregnant|0|||
44226089|NCT01755091|79032194|FG001|Overall Study|Lost to Follow-up|0|||
44473737|NCT00307125|79481485|FG002|Screening Phase|Try to get pregnant|0|||
44473738|NCT00307125|79481483|FG000|Screening Phase|Developed acute leukemia|1|||
44473739|NCT00307125|79481484|FG001|Screening Phase|Developed acute leukemia|0|||
44473740|NCT00307125|79481485|FG002|Screening Phase|Developed acute leukemia|0|||
44473741|NCT00307125|79481483|FG000|Screening Phase|Metastatic colon cancer|1|||
44473742|NCT00307125|79481484|FG001|Screening Phase|Metastatic colon cancer|0|||
44473743|NCT00307125|79481485|FG002|Screening Phase|Metastatic colon cancer|0|||
44473744|NCT00307125|79481483|FG000|Screening Phase|Malignancy|1|||
44473745|NCT00307125|79481484|FG001|Screening Phase|Malignancy|0|||
44473746|NCT00307125|79481485|FG002|Screening Phase|Malignancy|0|||
44473747|NCT00307125|79481483|FG000|Screening Phase|PAK|1|||
44473748|NCT00307125|79481484|FG001|Screening Phase|PAK|0|||
44473749|NCT00307125|79481485|FG002|Screening Phase|PAK|0|||
44473750|NCT00307125|79481483|FG000|Screening Phase|Ineligible|1|||
44473751|NCT00307125|79481484|FG001|Screening Phase|Ineligible|0|||
44473752|NCT00307125|79481485|FG002|Screening Phase|Ineligible|0|||
44473753|NCT00307125|79481483|FG000|Screening Phase|Screen Error|1|||
44473754|NCT00307125|79481484|FG001|Screening Phase|Screen Error|0|||
44473755|NCT00307125|79481485|FG002|Screening Phase|Screen Error|0|||
44473756|NCT00307125|79481483|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
44473757|NCT00307125|79481484|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
44473758|NCT00307125|79481485|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
44473759|NCT00307125|79481483|FG000|Screening Phase|AMR and treated with rituximab|1|||
44473760|NCT00307125|79481484|FG001|Screening Phase|AMR and treated with rituximab|0|||
44473761|NCT00307125|79481485|FG002|Screening Phase|AMR and treated with rituximab|0|||
44473762|NCT00307125|79481483|FG000|Screening Phase|Coronary artery bypass|1|||
44473763|NCT00307125|79481484|FG001|Screening Phase|Coronary artery bypass|0|||
44473764|NCT00307125|79481485|FG002|Screening Phase|Coronary artery bypass|0|||
44473765|NCT00307125|79481483|FG000|Pilot Phase|Lost to Follow-up|0|||
44473766|NCT00307125|79481484|FG001|Pilot Phase|Lost to Follow-up|1|||
44473767|NCT00307125|79481485|FG002|Pilot Phase|Lost to Follow-up|0|||
44473768|NCT00307125|79481483|FG000|Pilot Phase|Withdrawal by Subject|0|||
44473769|NCT00307125|79481484|FG001|Pilot Phase|Withdrawal by Subject|1|||
44473770|NCT00307125|79481485|FG002|Pilot Phase|Withdrawal by Subject|1|||
44473771|NCT00307047|79481497|FG000|Overall Study|Lost to Follow-up|35|||
44473772|NCT00307047|79481498|FG001|Overall Study|Lost to Follow-up|24|||
44473773|NCT00307047|79481497|FG000|Overall Study|Withdrawal by Subject|6|||
44473774|NCT00307047|79481498|FG001|Overall Study|Withdrawal by Subject|6|||
44473775|NCT00307047|79481497|FG000|Overall Study|Physician Decision|1|||
44473776|NCT00307047|79481498|FG001|Overall Study|Physician Decision|2|||
44473777|NCT00307047|79481497|FG000|Overall Study|Lost to follow-up for other reasons|0|||
44473778|NCT00307047|79481498|FG001|Overall Study|Lost to follow-up for other reasons|1|||
44473779|NCT00307047|79481497|FG000|Overall Study|All death, all MI, all Revascularization|27|||
44473780|NCT00307047|79481498|FG001|Overall Study|All death, all MI, all Revascularization|16|||
44473781|NCT00306891|79481508|FG000|Part A|Withdrawal by Subject|1|||
44473782|NCT00306891|79481509|FG001|Part A|Withdrawal by Subject|1|||
44473783|NCT00306891|79481510|FG002|Part A|Withdrawal by Subject|0|||
44473784|NCT00306891|79481511|FG003|Part A|Withdrawal by Subject|0|||
44473785|NCT00306891|79481508|FG000|Part A|Condition under investigation worsened|2|||
44473786|NCT00306891|79481509|FG001|Part A|Condition under investigation worsened|2|||
44473787|NCT00306891|79481510|FG002|Part A|Condition under investigation worsened|0|||
44473788|NCT00306891|79481511|FG003|Part A|Condition under investigation worsened|0|||
44473789|NCT00306891|79481508|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
44473790|NCT00306891|79481509|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
44473791|NCT00306891|79481510|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
44473792|NCT00306891|79481511|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
44473793|NCT00306891|79481508|FG000|Part A|Partial bowel obstruction|1|||
44473794|NCT00306891|79481509|FG001|Part A|Partial bowel obstruction|0|||
44473795|NCT00306891|79481510|FG002|Part A|Partial bowel obstruction|0|||
44544549|NCT03217968|79558059|FG000|Overall Study|Lost to Follow-up|1|||
44473796|NCT00306891|79481511|FG003|Part A|Partial bowel obstruction|0|||
44473797|NCT00306891|79481508|FG000|Part A|Reaccumul. of ascites following drainage|0|||
44375422|NCT00944034|79380588|FG003|Overall Study|Protocol Violation|1|||
44375423|NCT00944034|79380589|FG004|Overall Study|Protocol Violation|2|||
44473798|NCT00306891|79481509|FG001|Part A|Reaccumul. of ascites following drainage|1|||
44473799|NCT00306891|79481510|FG002|Part A|Reaccumul. of ascites following drainage|0|||
44473800|NCT00306891|79481511|FG003|Part A|Reaccumul. of ascites following drainage|0|||
44473801|NCT00306891|79481508|FG000|Part A|Suspicion of second malignancy|0|||
44473802|NCT00306891|79481509|FG001|Part A|Suspicion of second malignancy|1|||
44473803|NCT00306891|79481510|FG002|Part A|Suspicion of second malignancy|0|||
44473804|NCT00306891|79481511|FG003|Part A|Suspicion of second malignancy|0|||
44473805|NCT00306891|79481508|FG000|Part A|QTC interval outwith elig. criteria|1|||
44473806|NCT00306891|79481509|FG001|Part A|QTC interval outwith elig. criteria|0|||
44473807|NCT00306891|79481510|FG002|Part A|QTC interval outwith elig. criteria|0|||
44544550|NCT03217968|79558059|FG000|Overall Study|Protocol Violation|6|||
44473808|NCT00306891|79481511|FG003|Part A|QTC interval outwith elig. criteria|0|||
44473809|NCT00306891|79481508|FG000|Part B|Death|0|||
44473810|NCT00306891|79481509|FG001|Part B|Death|0|||
44473811|NCT00306891|79481510|FG002|Part B|Death|1|||
44473812|NCT00306891|79481511|FG003|Part B|Death|2|||
44473813|NCT00306891|79481508|FG000|Part B|Adverse Event|0|||
44473814|NCT00306891|79481509|FG001|Part B|Adverse Event|0|||
44473815|NCT00306891|79481510|FG002|Part B|Adverse Event|5|||
44473816|NCT00306891|79481511|FG003|Part B|Adverse Event|5|||
44473817|NCT00306891|79481508|FG000|Part B|Withdrawal by Subject|0|||
44473818|NCT00306891|79481509|FG001|Part B|Withdrawal by Subject|0|||
44473819|NCT00306891|79481510|FG002|Part B|Withdrawal by Subject|3|||
44473820|NCT00306891|79481511|FG003|Part B|Withdrawal by Subject|1|||
44473821|NCT00306891|79481508|FG000|Part B|Condition under investigation worsened|0|||
44473822|NCT00306891|79481509|FG001|Part B|Condition under investigation worsened|0|||
44473823|NCT00306891|79481510|FG002|Part B|Condition under investigation worsened|2|||
44473824|NCT00306891|79481511|FG003|Part B|Condition under investigation worsened|8|||
44473825|NCT00306891|79481508|FG000|Part B|Development of study specific disc crit.|0|||
44473826|NCT00306891|79481509|FG001|Part B|Development of study specific disc crit.|0|||
44473827|NCT00306891|79481510|FG002|Part B|Development of study specific disc crit.|0|||
44473828|NCT00306891|79481511|FG003|Part B|Development of study specific disc crit.|1|||
44473829|NCT00314145|79481524|FG000|Overall Study|Withdrawal by Subject|8|||
44473830|NCT00314145|79481525|FG001|Overall Study|Withdrawal by Subject|10|||
44473831|NCT00314145|79481524|FG000|Overall Study|Lost to Follow-up|5|||
44473832|NCT00314145|79481525|FG001|Overall Study|Lost to Follow-up|12|||
44473833|NCT00314145|79481524|FG000|Overall Study|Physician Decision|3|||
44473834|NCT00314145|79481525|FG001|Overall Study|Physician Decision|4|||
44473835|NCT00314145|79481524|FG000|Overall Study|Adverse Event|0|||
44473836|NCT00314145|79481525|FG001|Overall Study|Adverse Event|3|||
44473837|NCT00314145|79481524|FG000|Overall Study|Protocol Violation|3|||
44473838|NCT00314145|79481525|FG001|Overall Study|Protocol Violation|0|||
44473839|NCT00314145|79481524|FG000|Overall Study|Sponsor Decision|2|||
44473840|NCT00314145|79481525|FG001|Overall Study|Sponsor Decision|0|||
44473841|NCT00313911|79481534|FG000|Overall Study|Serious adverse event|6|||
44473842|NCT00313911|79481535|FG001|Overall Study|Serious adverse event|1|||
44473843|NCT00313911|79481534|FG000|Overall Study|Adverse Event|2|||
44473844|NCT00313911|79481535|FG001|Overall Study|Adverse Event|3|||
44473845|NCT00313911|79481534|FG000|Overall Study|Protocol Violation|19|||
44473846|NCT00313911|79481535|FG001|Overall Study|Protocol Violation|10|||
44473847|NCT00313911|79481534|FG000|Overall Study|Lost to Follow-up|27|||
44473848|NCT00313911|79481535|FG001|Overall Study|Lost to Follow-up|14|||
44226090|NCT01755091|79032195|FG002|Overall Study|Lost to Follow-up|1|||
44226091|NCT01755091|79032193|FG000|Overall Study|Physician Decision|1|||
44226092|NCT01755091|79032194|FG001|Overall Study|Physician Decision|1|||
44226093|NCT01755091|79032195|FG002|Overall Study|Physician Decision|2|||
44226094|NCT01754467|79032228|FG000|Overall Study|Lost to Follow-up|1|||
44226095|NCT01753999|79032232|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
44473849|NCT00313911|79481534|FG000|Overall Study|Withdrawal by Subject|39|||
44473850|NCT00313911|79481535|FG001|Overall Study|Withdrawal by Subject|12|||
44473851|NCT00313911|79481534|FG000|Overall Study|Did not meet age criteria|1|||
44473852|NCT00313911|79481535|FG001|Overall Study|Did not meet age criteria|1|||
44226096|NCT01753999|79032233|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
44473853|NCT00391872|79481543|FG000|Overall Study|Protocol Violation|7|||
44473854|NCT00391872|79481544|FG001|Overall Study|Protocol Violation|2|||
44473855|NCT00391872|79481543|FG000|Overall Study|Withdrawal by Subject|296|||
44473856|NCT00391872|79481544|FG001|Overall Study|Withdrawal by Subject|249|||
44473857|NCT00391872|79481543|FG000|Overall Study|Reason unknown|2|||
44473858|NCT00391872|79481544|FG001|Overall Study|Reason unknown|4|||
44473859|NCT00391872|79481543|FG000|Overall Study|Lost to Follow-up|2|||
44473860|NCT00391872|79481544|FG001|Overall Study|Lost to Follow-up|0|||
44473861|NCT00391170|79481552|FG000|Overall Study|Withdrawal by Subject|1|||
44473862|NCT00391170|79481553|FG001|Overall Study|Withdrawal by Subject|0|||
44473863|NCT00391170|79481552|FG000|Overall Study|Adverse Event|3|||
44473864|NCT00391170|79481553|FG001|Overall Study|Adverse Event|2|||
44473865|NCT00391170|79481552|FG000|Overall Study|Physician Decision|2|||
44473866|NCT00391170|79481553|FG001|Overall Study|Physician Decision|2|||
44473867|NCT00402324|79481561|FG000|Overall Study|Lost to Follow-up|11|||
44473868|NCT00402324|79481562|FG001|Overall Study|Lost to Follow-up|11|||
44473869|NCT00402324|79481561|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
44473870|NCT00402324|79481562|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
44473871|NCT00402324|79481561|FG000|Overall Study|Protocol Violation|8|||
44473872|NCT00402324|79481562|FG001|Overall Study|Protocol Violation|7|||
44473873|NCT00402324|79481561|FG000|Overall Study|Withdrawal by Subject|5|||
44473874|NCT00402324|79481562|FG001|Overall Study|Withdrawal by Subject|2|||
44473875|NCT00402324|79481561|FG000|Overall Study|Physician Decision|2|||
44473876|NCT00402324|79481562|FG001|Overall Study|Physician Decision|4|||
44473877|NCT00402324|79481561|FG000|Overall Study|Sponsor Decision|4|||
44473878|NCT00402324|79481562|FG001|Overall Study|Sponsor Decision|5|||
44473879|NCT00402324|79481561|FG000|Overall Study|Lack of Efficacy|1|||
44473880|NCT00402324|79481562|FG001|Overall Study|Lack of Efficacy|4|||
44473881|NCT00402324|79481561|FG000|Overall Study|Adverse Event|6|||
44473882|NCT00402324|79481562|FG001|Overall Study|Adverse Event|4|||
44473883|NCT00402324|79481561|FG000|Overall Study|Death|1|||
44473884|NCT00402324|79481562|FG001|Overall Study|Death|0|||
44473885|NCT00294723|79481571|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
44473886|NCT00294723|79481572|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
44473887|NCT00294723|79481573|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
44473888|NCT00294723|79481571|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
44473889|NCT00294723|79481572|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
44473890|NCT00294723|79481573|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
44473891|NCT00294723|79481571|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
44473892|NCT00294723|79481572|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
44473893|NCT00294723|79481573|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
44473894|NCT00294723|79481571|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
44473895|NCT00294723|79481572|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
44473896|NCT00294723|79481573|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
44473897|NCT00294723|79481571|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
44473898|NCT00294723|79481572|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
44473899|NCT00294723|79481573|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
44473900|NCT00294723|79481571|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
44473901|NCT00294723|79481572|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
44473902|NCT00294723|79481573|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
44473903|NCT00294723|79481571|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
44473904|NCT00294723|79481572|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
44473905|NCT00294723|79481573|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
44473906|NCT00294723|79481571|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
44473907|NCT00294723|79481572|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
44473908|NCT00294723|79481573|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
44473909|NCT00294723|79481571|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
44473910|NCT00294723|79481572|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
44473911|NCT00294723|79481573|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
44473912|NCT00294723|79481571|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
44473913|NCT00294723|79481572|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
44473914|NCT00294723|79481573|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
44473915|NCT00294723|79481571|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
44473916|NCT00294723|79481572|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
44473917|NCT00294723|79481573|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
44473918|NCT00294723|79481571|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
44226097|NCT01753999|79032232|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
44473919|NCT00294723|79481572|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
44473920|NCT00294723|79481573|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
44226098|NCT01753999|79032233|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
44473921|NCT00402246|79481586|FG000|Overall Study|Death|62|||
44473922|NCT00402246|79481587|FG001|Overall Study|Death|58|||
44473923|NCT00402246|79481586|FG000|Overall Study|Lost to Follow-up|20|||
44473924|NCT00402246|79481587|FG001|Overall Study|Lost to Follow-up|28|||
44473925|NCT00402246|79481586|FG000|Overall Study|Withdrawal by Subject|72|||
44473926|NCT00402246|79481587|FG001|Overall Study|Withdrawal by Subject|87|||
44473927|NCT00402246|79481586|FG000|Overall Study|Physician Decision|24|||
44473928|NCT00402246|79481587|FG001|Overall Study|Physician Decision|26|||
44544551|NCT03192306|79558065|FG000|Overall Study|Did not treat cold sore during study|149|||
44143764|NCT03252925|78933093|FG000|Overall Study|Adverse Event|1|||
44473929|NCT00402246|79481586|FG000|Overall Study|Protocol Violation|25|||
44473930|NCT00402246|79481587|FG001|Overall Study|Protocol Violation|24|||
44473931|NCT00402246|79481586|FG000|Overall Study|Missed Final Visit|1|||
44473932|NCT00402246|79481587|FG001|Overall Study|Missed Final Visit|2|||
44473933|NCT00402246|79481586|FG000|Overall Study|Insurance Issues|2|||
44473934|NCT00402246|79481587|FG001|Overall Study|Insurance Issues|1|||
44473935|NCT00402246|79481586|FG000|Overall Study|Heart Transplant|0|||
44473936|NCT00402246|79481587|FG001|Overall Study|Heart Transplant|1|||
44473937|NCT00402246|79481586|FG000|Overall Study|Patient's device explanted|6|||
44473938|NCT00402246|79481587|FG001|Overall Study|Patient's device explanted|2|||
44473939|NCT00402246|79481586|FG000|Overall Study|Center Closure|5|||
44473940|NCT00402246|79481587|FG001|Overall Study|Center Closure|3|||
44473941|NCT00402246|79481586|FG000|Overall Study|Deterioriating Condition|3|||
44473942|NCT00402246|79481587|FG001|Overall Study|Deterioriating Condition|2|||
44473943|NCT00375492|79481597|FG000|Overall Study|Adverse Event|4|||
44473944|NCT00375492|79481598|FG001|Overall Study|Adverse Event|5|||
44473945|NCT00375492|79481597|FG000|Overall Study|Entry Criteria Not Met|0|||
44473946|NCT00375492|79481598|FG001|Overall Study|Entry Criteria Not Met|1|||
44473947|NCT00375492|79481597|FG000|Overall Study|Loss of Glucose Control|0|||
44473948|NCT00375492|79481598|FG001|Overall Study|Loss of Glucose Control|1|||
44473949|NCT00375492|79481597|FG000|Overall Study|Lost to Follow-up|10|||
44473950|NCT00375492|79481598|FG001|Overall Study|Lost to Follow-up|5|||
44473951|NCT00375492|79481597|FG000|Overall Study|Physician Decision|0|||
44473952|NCT00375492|79481598|FG001|Overall Study|Physician Decision|4|||
44473953|NCT00375492|79481597|FG000|Overall Study|Protocol Violation|6|||
44473954|NCT00375492|79481598|FG001|Overall Study|Protocol Violation|3|||
44473955|NCT00375492|79481597|FG000|Overall Study|Sponsor Decision|0|||
44473956|NCT00375492|79481598|FG001|Overall Study|Sponsor Decision|1|||
44473957|NCT00375492|79481597|FG000|Overall Study|Withdrawal by Subject|6|||
44473958|NCT00375492|79481598|FG001|Overall Study|Withdrawal by Subject|6|||
44473959|NCT00306189|79481608|FG000|Overall Study|Physician Decision|0|||
44473960|NCT00306189|79481609|FG001|Overall Study|Physician Decision|0|||
44473961|NCT00306189|79481610|FG002|Overall Study|Physician Decision|0|||
44473962|NCT00306189|79481611|FG003|Overall Study|Physician Decision|1|||
44473963|NCT00306189|79481608|FG000|Overall Study|Adverse Event|3|||
44473964|NCT00306189|79481609|FG001|Overall Study|Adverse Event|3|||
44473965|NCT00306189|79481610|FG002|Overall Study|Adverse Event|2|||
44473966|NCT00306189|79481611|FG003|Overall Study|Adverse Event|2|||
44473967|NCT00306189|79481608|FG000|Overall Study|Withdrawal by Subject|4|||
44473968|NCT00306189|79481609|FG001|Overall Study|Withdrawal by Subject|2|||
44473969|NCT00306189|79481610|FG002|Overall Study|Withdrawal by Subject|8|||
44473970|NCT00306189|79481611|FG003|Overall Study|Withdrawal by Subject|1|||
44473971|NCT00306189|79481608|FG000|Overall Study|Ineligibility determined|1|||
44473972|NCT00306189|79481609|FG001|Overall Study|Ineligibility determined|1|||
44473973|NCT00306189|79481610|FG002|Overall Study|Ineligibility determined|1|||
44473974|NCT00306189|79481611|FG003|Overall Study|Ineligibility determined|1|||
44473975|NCT00306189|79481608|FG000|Overall Study|Other|1|||
44473976|NCT00306189|79481609|FG001|Overall Study|Other|0|||
44473977|NCT00306189|79481610|FG002|Overall Study|Other|0|||
44473978|NCT00306189|79481611|FG003|Overall Study|Other|0|||
44473979|NCT00312897|79481623|FG000|Overall Study|Adverse Event|1|||
44473980|NCT00312897|79481624|FG001|Overall Study|Adverse Event|0|||
44473981|NCT00312897|79481623|FG000|Overall Study|Lost to Follow-up|2|||
44473982|NCT00312897|79481624|FG001|Overall Study|Lost to Follow-up|0|||
44473983|NCT00312897|79481623|FG000|Overall Study|Physician Decision|1|||
44473984|NCT00312897|79481624|FG001|Overall Study|Physician Decision|0|||
44473985|NCT00312897|79481623|FG000|Overall Study|Withdrawal by Subject|1|||
44473986|NCT00312897|79481624|FG001|Overall Study|Withdrawal by Subject|3|||
44473987|NCT00312897|79481623|FG000|Overall Study|Pregnancy|1|||
44226099|NCT01753999|79032232|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
44473988|NCT00312897|79481624|FG001|Overall Study|Pregnancy|0|||
44473989|NCT00312897|79481623|FG000|Overall Study|discontinued prior to getting treatment|0|||
44473990|NCT00312897|79481624|FG001|Overall Study|discontinued prior to getting treatment|3|||
44473991|NCT00312663|79481633|FG000|Immunization Phase|Adverse Event|0|||
44473992|NCT00312663|79481634|FG001|Immunization Phase|Adverse Event|1|||
44473993|NCT00312663|79481635|FG002|Immunization Phase|Adverse Event|0|||
44473994|NCT00294645|79481646|FG000|Overall Study|Death|10|||
44473995|NCT00294645|79481647|FG001|Overall Study|Death|18|||
44226100|NCT01753999|79032233|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
44473996|NCT00294645|79481646|FG000|Overall Study|Lost to Follow-up|1|||
44473997|NCT00294645|79481647|FG001|Overall Study|Lost to Follow-up|10|||
44473998|NCT00294645|79481646|FG000|Overall Study|Withdrawal by Subject|18|||
44473999|NCT00294645|79481647|FG001|Overall Study|Withdrawal by Subject|34|||
44474000|NCT00294645|79481646|FG000|Overall Study|Physician Decision|15|||
44474001|NCT00294645|79481647|FG001|Overall Study|Physician Decision|20|||
44474002|NCT00294645|79481646|FG000|Overall Study|Other|4|||
44474003|NCT00294645|79481647|FG001|Overall Study|Other|10|||
44474004|NCT00305877|79481655|FG000|Overall Study|Lack of Efficacy|6|||
44474005|NCT00305877|79481656|FG001|Overall Study|Lack of Efficacy|9|||
44474006|NCT00305877|79481655|FG000|Overall Study|Adverse Event|9|||
44474007|NCT00305877|79481656|FG001|Overall Study|Adverse Event|14|||
44474008|NCT00305877|79481655|FG000|Overall Study|Death|0|||
44474009|NCT00305877|79481656|FG001|Overall Study|Death|1|||
44474010|NCT00305877|79481655|FG000|Overall Study|Withdrawal by Subject|4|||
44474011|NCT00305877|79481656|FG001|Overall Study|Withdrawal by Subject|2|||
44474012|NCT00305877|79481655|FG000|Overall Study|Physician Decision|1|||
44474013|NCT00305877|79481656|FG001|Overall Study|Physician Decision|1|||
44474014|NCT00305877|79481655|FG000|Overall Study|Never start treatment|2|||
44474015|NCT00305877|79481656|FG001|Overall Study|Never start treatment|5|||
44474016|NCT00305877|79481655|FG000|Overall Study|Ineligible|2|||
44474017|NCT00305877|79481656|FG001|Overall Study|Ineligible|1|||
44474018|NCT00305877|79481655|FG000|Overall Study|Transportation issue with daily RT|0|||
44474019|NCT00305877|79481656|FG001|Overall Study|Transportation issue with daily RT|1|||
44474020|NCT00312195|79481664|FG000|Overall Study|Adverse Event|4|||
44474021|NCT00312195|79481665|FG001|Overall Study|Adverse Event|6|||
44474022|NCT00312195|79481664|FG000|Overall Study|Lost to Follow-up|1|||
44474023|NCT00312195|79481665|FG001|Overall Study|Lost to Follow-up|0|||
44474024|NCT00312195|79481664|FG000|Overall Study|Protocol Violation|1|||
44474025|NCT00312195|79481665|FG001|Overall Study|Protocol Violation|0|||
44226101|NCT01753999|79032232|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
44226102|NCT01753999|79032233|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
44226103|NCT01753999|79032232|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
44226104|NCT01753999|79032233|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
44226105|NCT01753999|79032232|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
44226106|NCT01753999|79032233|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
44474026|NCT00305253|79481675|FG000|Overall Study|Withdrawal by Subject|0|||
44474027|NCT00305253|79481676|FG001|Overall Study|Withdrawal by Subject|1|||
44474028|NCT00293709|79481682|FG000|Overall Study|Other|47|||
44226107|NCT01783015|79032253|FG000|Blinded Treatment|Adverse Event|0|||
44474029|NCT00311181|79481686|FG000|Overall Study|Final DFTs were not obtained|96|||
44474030|NCT00293397|79481690|FG000|Overall Study|Death|2|||
44474031|NCT00290745|79481695|FG000|Overall Study|Withdrawal by Subject|4|||
44474032|NCT00290745|79481695|FG000|Overall Study|Physician Decision|2|||
44474033|NCT00290745|79481695|FG000|Overall Study|Surgery after 3 months for progression|3|||
44474034|NCT00290745|79481695|FG000|Overall Study|Baseline MRI not available|3|||
44474035|NCT00402168|79481701|FG000|Randomized|Lost to Follow-up|1|||
44474036|NCT00402168|79481702|FG001|Randomized|Lost to Follow-up|0|||
44474037|NCT00402168|79481701|FG000|Randomized|Withdrawal by Subject|0|||
44474038|NCT00402168|79481702|FG001|Randomized|Withdrawal by Subject|1|||
44474039|NCT00402168|79481701|FG000|Treatment (up to 12 Months)|Death|0|||
44474040|NCT00402168|79481702|FG001|Treatment (up to 12 Months)|Death|1|||
44474041|NCT00402168|79481701|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
44474042|NCT00402168|79481702|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
44474043|NCT00402168|79481701|FG000|Treatment (up to 12 Months)|non-specified|0|||
44474044|NCT00402168|79481702|FG001|Treatment (up to 12 Months)|non-specified|1|||
44474045|NCT00402168|79481701|FG000|Long Term (LT)|Adverse Event|1|||
44226108|NCT01783015|79032254|FG001|Blinded Treatment|Adverse Event|1|||
44226109|NCT01783015|79032255|FG002|Blinded Treatment|Adverse Event|0|||
44474046|NCT00402168|79481702|FG001|Long Term (LT)|Adverse Event|5|||
44474047|NCT00402168|79481701|FG000|Long Term (LT)|Withdrawal by Subject|4|||
44474048|NCT00402168|79481702|FG001|Long Term (LT)|Withdrawal by Subject|7|||
44226110|NCT01783015|79032253|FG000|Blinded Treatment|Protocol Violation|0|||
44226111|NCT01783015|79032254|FG001|Blinded Treatment|Protocol Violation|1|||
44226112|NCT01783015|79032255|FG002|Blinded Treatment|Protocol Violation|0|||
44226113|NCT01783015|79032253|FG000|Blinded Treatment|Withdrawal by Subject|0|||
44226114|NCT01783015|79032254|FG001|Blinded Treatment|Withdrawal by Subject|1|||
44226115|NCT01783015|79032255|FG002|Blinded Treatment|Withdrawal by Subject|0|||
44226116|NCT01783015|79032253|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
44226117|NCT01783015|79032254|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
44226118|NCT01783015|79032255|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
44226119|NCT01783015|79032253|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
44226120|NCT01783015|79032254|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
44226121|NCT01783015|79032255|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
44226122|NCT01782859|79032265|FG000|Overall Study|Protocol Violation|6|||
44226123|NCT01782859|79032266|FG001|Overall Study|Protocol Violation|6|||
44226124|NCT01782859|79032265|FG000|Overall Study|Withdrawal by Subject|0|||
44226125|NCT01782859|79032266|FG001|Overall Study|Withdrawal by Subject|1|||
44474049|NCT00402168|79481701|FG000|Long Term (LT)|Pregnancy|0|||
44474050|NCT00402168|79481702|FG001|Long Term (LT)|Pregnancy|1|||
44474051|NCT00402168|79481701|FG000|Long Term (LT)|Lost to Follow-up|1|||
44474052|NCT00402168|79481702|FG001|Long Term (LT)|Lost to Follow-up|0|||
44474053|NCT00402168|79481701|FG000|Long Term (LT)|Death|4|||
44474054|NCT00402168|79481702|FG001|Long Term (LT)|Death|0|||
44474055|NCT00402168|79481701|FG000|Long Term (LT)|Lack of Efficacy|0|||
44474056|NCT00402168|79481702|FG001|Long Term (LT)|Lack of Efficacy|2|||
44474057|NCT00402168|79481701|FG000|Long Term (LT)|non-specified|1|||
44474058|NCT00402168|79481702|FG001|Long Term (LT)|non-specified|2|||
44474059|NCT00402168|79481701|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
44474060|NCT00402168|79481702|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
44474061|NCT00402168|79481701|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
44474062|NCT00402168|79481702|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
44474063|NCT00290589|79481718|FG000|Overall Study|Lost to Follow-up|2|||
44474064|NCT00290589|79481719|FG001|Overall Study|Lost to Follow-up|2|||
44474065|NCT00290511|79481725|FG000|Overall Study|Adverse Event|1|||
44474066|NCT00290511|79481725|FG000|Overall Study|Death|1|||
44474067|NCT00290511|79481725|FG000|Overall Study|Physician Decision|1|||
44474068|NCT00290511|79481725|FG000|Overall Study|Withdrawal by Subject|1|||
44474069|NCT00290433|79481729|FG000|Overall Study|Disease Progression|13|||
44226126|NCT01782469|79032273|FG000|Overall Study|Lost to Follow-up|1|||
44226127|NCT01782313|79032277|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
44226128|NCT01782313|79032277|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
44226129|NCT01782313|79032277|FG000|Treated Cycle 3|Progressive Disease|21|||
44226130|NCT01782313|79032277|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
44226131|NCT01782313|79032277|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
44226132|NCT01782313|79032277|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
44226133|NCT01782313|79032277|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
44226134|NCT01782313|79032277|FG000|Survival Follow up|Lost to Follow-up|1|||
44226135|NCT01781611|79032300|FG000|Overall Study|Adverse Event|4|||
44226136|NCT01781611|79032301|FG001|Overall Study|Adverse Event|0|||
44226137|NCT01781299|79032318|FG000|Overall Study|Withdrawal by Subject|0|||
44226138|NCT01781299|79032319|FG001|Overall Study|Withdrawal by Subject|1|||
44226139|NCT01732471|79032325|FG000|Overall Study|Withdrawal by Subject|1|||
44226140|NCT01780987|79032344|FG000|Overall Study|Adverse Event|0|||
44226141|NCT01780987|79032345|FG001|Overall Study|Adverse Event|4|||
44226142|NCT01780987|79032344|FG000|Overall Study|Withdrawal by Subject|2|||
44226143|NCT01780987|79032345|FG001|Overall Study|Withdrawal by Subject|0|||
44226144|NCT01780987|79032344|FG000|Overall Study|Request of Changing Hospital|0|||
44226145|NCT01780987|79032345|FG001|Overall Study|Request of Changing Hospital|1|||
44226146|NCT01780987|79032344|FG000|Overall Study|Changing Residence|1|||
44226147|NCT01780987|79032345|FG001|Overall Study|Changing Residence|0|||
44226148|NCT01780987|79032344|FG000|Overall Study|Not Receiving any Study Medication|0|||
44226149|NCT01780987|79032345|FG001|Overall Study|Not Receiving any Study Medication|1|||
44474070|NCT00290433|79481729|FG000|Overall Study|Adverse Event|14|||
44474071|NCT00290433|79481729|FG000|Overall Study|Withdrawal by Subject|1|||
44474072|NCT00290433|79481729|FG000|Overall Study|Non-Compliance|1|||
44474073|NCT00290433|79481729|FG000|Overall Study|Congestive Heart Failure|1|||
44474074|NCT00290433|79481729|FG000|Overall Study|Transplant in CR|5|||
44474075|NCT00290433|79481729|FG000|Overall Study|Unrelated Infection/Death|1|||
44474076|NCT00304083|79481735|FG000|Overall Study|Withdrawal by Subject|4|||
44226150|NCT01730053|79032434|FG000|Overall Study|Participant moved|0|||
44226151|NCT01730053|79032435|FG001|Overall Study|Participant moved|0|||
44226152|NCT01730053|79032436|FG002|Overall Study|Participant moved|1|||
44226153|NCT01730053|79032437|FG003|Overall Study|Participant moved|0|||
44226154|NCT01730053|79032438|FG004|Overall Study|Participant moved|0|||
44226155|NCT01730053|79032439|FG005|Overall Study|Participant moved|0|||
44226156|NCT01730053|79032434|FG000|Overall Study|Physician Decision|0|||
44474077|NCT00304083|79481736|FG001|Overall Study|Withdrawal by Subject|2|||
44474078|NCT00304083|79481735|FG000|Overall Study|Physician Decision|8|||
44474079|NCT00304083|79481736|FG001|Overall Study|Physician Decision|3|||
44474080|NCT00304083|79481735|FG000|Overall Study|Disease Progression|5|||
44474081|NCT00304083|79481736|FG001|Overall Study|Disease Progression|1|||
44474082|NCT00304083|79481735|FG000|Overall Study|Other|5|||
44474083|NCT00304083|79481736|FG001|Overall Study|Other|2|||
44474084|NCT00293241|79481744|FG000|Overall Study|Lost to Follow-up|9|||
44474085|NCT00293241|79481745|FG001|Overall Study|Lost to Follow-up|16|||
44474086|NCT00293241|79481744|FG000|Overall Study|Physician Decision|23|||
44474087|NCT00293241|79481745|FG001|Overall Study|Physician Decision|17|||
44474088|NCT00293241|79481744|FG000|Overall Study|Withdrawal by Subject|4|||
44474089|NCT00293241|79481745|FG001|Overall Study|Withdrawal by Subject|8|||
44474090|NCT00391092|79481756|FG000|Overall Study|Death|78|||
44474091|NCT00391092|79481757|FG001|Overall Study|Death|81|||
44474092|NCT00391092|79481756|FG000|Overall Study|Lost to Follow-up|13|||
44474093|NCT00391092|79481757|FG001|Overall Study|Lost to Follow-up|18|||
44474094|NCT00391092|79481756|FG000|Overall Study|Alive on treatment|29|||
44474095|NCT00391092|79481757|FG001|Overall Study|Alive on treatment|33|||
44474096|NCT00391092|79481756|FG000|Overall Study|Alive in follow-up|88|||
44474097|NCT00391092|79481757|FG001|Overall Study|Alive in follow-up|84|||
44474098|NCT00374868|79481763|FG000|Overall Study|Adverse Event|12|||
44474099|NCT00374868|79481763|FG000|Overall Study|Progressive Disease|7|||
44474100|NCT00374868|79481763|FG000|Overall Study|Physician Decision|13|||
44474101|NCT00374868|79481763|FG000|Overall Study|Lost to Follow-up|1|||
44474102|NCT00374868|79481763|FG000|Overall Study|Death|2|||
44474103|NCT00374868|79481763|FG000|Overall Study|Other - Not Specified|1|||
44474104|NCT00374556|79481769|FG000|Overall Study|Lost to Follow-up|1|||
44474105|NCT00374556|79481770|FG001|Overall Study|Lost to Follow-up|0|||
44474106|NCT00374556|79481769|FG000|Overall Study|Removed at baseline due to medical cond|0|||
44474107|NCT00374556|79481770|FG001|Overall Study|Removed at baseline due to medical cond|1|||
44474108|NCT00290355|79481778|FG000|Overall Study|Serious adverse event|7|||
44474109|NCT00290355|79481779|FG001|Overall Study|Serious adverse event|4|||
44474110|NCT00290355|79481778|FG000|Overall Study|Study product reactogenicity|1|||
44474111|NCT00290355|79481779|FG001|Overall Study|Study product reactogenicity|0|||
44226157|NCT01730053|79032435|FG001|Overall Study|Physician Decision|0|||
44226158|NCT01730053|79032436|FG002|Overall Study|Physician Decision|0|||
44226159|NCT01730053|79032437|FG003|Overall Study|Physician Decision|1|||
44226160|NCT01730053|79032438|FG004|Overall Study|Physician Decision|0|||
44226161|NCT01730053|79032439|FG005|Overall Study|Physician Decision|0|||
44226162|NCT01730053|79032434|FG000|Overall Study|Adverse Event|2|||
44474112|NCT00290355|79481778|FG000|Overall Study|Protocol Violation|1|||
44474113|NCT00290355|79481779|FG001|Overall Study|Protocol Violation|0|||
44474114|NCT00290355|79481778|FG000|Overall Study|Withdrawal by Subject|2|||
44474115|NCT00290355|79481779|FG001|Overall Study|Withdrawal by Subject|0|||
44474116|NCT00290355|79481778|FG000|Overall Study|Migrated / moved from the study area|1|||
44474117|NCT00290355|79481779|FG001|Overall Study|Migrated / moved from the study area|0|||
44474118|NCT00290355|79481778|FG000|Overall Study|Lost to Follow-up|3|||
44474119|NCT00290355|79481779|FG001|Overall Study|Lost to Follow-up|1|||
44474120|NCT00290355|79481778|FG000|Overall Study|Other|2|||
44474121|NCT00290355|79481779|FG001|Overall Study|Other|0|||
44474122|NCT00374322|79481787|FG000|Overall Study|Lost to Follow-up|92|||
44474123|NCT00374322|79481788|FG001|Overall Study|Lost to Follow-up|90|||
44474124|NCT00374322|79481787|FG000|Overall Study|Protocol Violation|8|||
44474125|NCT00374322|79481788|FG001|Overall Study|Protocol Violation|3|||
44474126|NCT00374322|79481787|FG000|Overall Study|Withdrawal by Subject|235|||
44474127|NCT00374322|79481788|FG001|Overall Study|Withdrawal by Subject|167|||
44474128|NCT00374322|79481787|FG000|Overall Study|Sponsor Terminated Study|866|||
44474129|NCT00374322|79481788|FG001|Overall Study|Sponsor Terminated Study|990|||
44474130|NCT00374322|79481787|FG000|Overall Study|Physician Decision|36|||
44474131|NCT00374322|79481788|FG001|Overall Study|Physician Decision|32|||
44226163|NCT01730053|79032435|FG001|Overall Study|Adverse Event|6|||
44226164|NCT01730053|79032436|FG002|Overall Study|Adverse Event|3|||
44474132|NCT00374322|79481787|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
44474133|NCT00374322|79481788|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
44474134|NCT00374322|79481787|FG000|Overall Study|Sponsor Decision|2|||
44474135|NCT00374322|79481788|FG001|Overall Study|Sponsor Decision|3|||
44474136|NCT00374322|79481787|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
44474137|NCT00374322|79481788|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
44474138|NCT00374322|79481787|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
44474139|NCT00374322|79481788|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
44474140|NCT00374322|79481787|FG000|Overall Study|Severe Toxicity|1|||
44474141|NCT00374322|79481788|FG001|Overall Study|Severe Toxicity|0|||
44474142|NCT00374322|79481787|FG000|Overall Study|Site Closed|2|||
44226165|NCT01730053|79032437|FG003|Overall Study|Adverse Event|3|||
44226166|NCT01730053|79032438|FG004|Overall Study|Adverse Event|2|||
44474143|NCT00374322|79481788|FG001|Overall Study|Site Closed|2|||
44474144|NCT00374322|79481787|FG000|Overall Study|Participant Changed Physician|1|||
44474145|NCT00374322|79481788|FG001|Overall Study|Participant Changed Physician|0|||
44474146|NCT00374322|79481787|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
44474147|NCT00374322|79481788|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
44474148|NCT00374322|79481787|FG000|Overall Study|Noncompliance with Study Requirements|0|||
44474149|NCT00374322|79481788|FG001|Overall Study|Noncompliance with Study Requirements|1|||
44474150|NCT00374322|79481787|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
44474151|NCT00374322|79481788|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
44474152|NCT00374322|79481787|FG000|Overall Study|Did Not Receive Study Medication|8|||
44474153|NCT00374322|79481788|FG001|Overall Study|Did Not Receive Study Medication|6|||
44474154|NCT00303459|79481797|FG000|Overall Study|Death|33|||
44474155|NCT00303459|79481798|FG001|Overall Study|Death|44|||
44474156|NCT00303459|79481797|FG000|Overall Study|Withdrawal of consent|32|||
44474157|NCT00303459|79481798|FG001|Overall Study|Withdrawal of consent|26|||
44474158|NCT00303459|79481797|FG000|Overall Study|Lost to Follow-up|5|||
44474159|NCT00303459|79481798|FG001|Overall Study|Lost to Follow-up|4|||
44474160|NCT00303459|79481797|FG000|Overall Study|Administrative reason|7|||
44474161|NCT00303459|79481798|FG001|Overall Study|Administrative reason|7|||
44474162|NCT00303459|79481797|FG000|Overall Study|Decision by the investigator|5|||
44474163|NCT00303459|79481798|FG001|Overall Study|Decision by the investigator|7|||
44474164|NCT00303459|79481797|FG000|Overall Study|Lung transplantation|1|||
44474165|NCT00303459|79481798|FG001|Overall Study|Lung transplantation|1|||
44474166|NCT00289887|79481807|FG000|Overall Study|Adverse Event|3|||
44474167|NCT00289887|79481808|FG001|Overall Study|Adverse Event|3|||
44474168|NCT00289887|79481807|FG000|Overall Study|Lack of Efficacy|3|||
44474169|NCT00289887|79481808|FG001|Overall Study|Lack of Efficacy|11|||
44474170|NCT00289887|79481807|FG000|Overall Study|Lost to Follow-up|3|||
44474171|NCT00289887|79481808|FG001|Overall Study|Lost to Follow-up|3|||
44474172|NCT00289887|79481807|FG000|Overall Study|Protocol Violation|3|||
44474173|NCT00289887|79481808|FG001|Overall Study|Protocol Violation|1|||
44474174|NCT00289887|79481807|FG000|Overall Study|Withdrawal by Subject|3|||
44474175|NCT00289887|79481808|FG001|Overall Study|Withdrawal by Subject|8|||
44474176|NCT00289887|79481807|FG000|Overall Study|Other|7|||
44474177|NCT00289887|79481808|FG001|Overall Study|Other|3|||
44474178|NCT00303069|79481818|FG000|Overall Study|Lost to Follow-up|1|||
44474179|NCT00303069|79481819|FG001|Overall Study|Lost to Follow-up|0|||
44474180|NCT00303069|79481820|FG002|Overall Study|Lost to Follow-up|0|||
44474181|NCT00303069|79481821|FG003|Overall Study|Lost to Follow-up|2|||
44474182|NCT00303069|79481818|FG000|Overall Study|subject moved|1|||
44474183|NCT00303069|79481819|FG001|Overall Study|subject moved|0|||
44474184|NCT00303069|79481820|FG002|Overall Study|subject moved|0|||
44474185|NCT00303069|79481821|FG003|Overall Study|subject moved|0|||
44474186|NCT00303069|79481818|FG000|Overall Study|Recruitment into Army Reserves|0|||
44474187|NCT00303069|79481819|FG001|Overall Study|Recruitment into Army Reserves|0|||
44474188|NCT00303069|79481820|FG002|Overall Study|Recruitment into Army Reserves|1|||
44474189|NCT00303069|79481821|FG003|Overall Study|Recruitment into Army Reserves|0|||
44474190|NCT00401544|79481835|FG000|Overall Study|Adverse Event|5|||
44474191|NCT00401544|79481836|FG001|Overall Study|Adverse Event|1|||
44474192|NCT00401544|79481837|FG002|Overall Study|Adverse Event|1|||
44474193|NCT00401544|79481838|FG003|Overall Study|Adverse Event|1|||
44474194|NCT00401544|79481835|FG000|Overall Study|Death|3|||
44474195|NCT00401544|79481836|FG001|Overall Study|Death|6|||
44474196|NCT00401544|79481837|FG002|Overall Study|Death|2|||
44474197|NCT00401544|79481838|FG003|Overall Study|Death|5|||
44474198|NCT00401544|79481835|FG000|Overall Study|Lost to Follow-up|2|||
44474199|NCT00401544|79481836|FG001|Overall Study|Lost to Follow-up|0|||
44474200|NCT00401544|79481837|FG002|Overall Study|Lost to Follow-up|1|||
44226167|NCT01730053|79032439|FG005|Overall Study|Adverse Event|2|||
44226168|NCT01730053|79032434|FG000|Overall Study|Poor compliance to protocol|1|||
44474201|NCT00401544|79481838|FG003|Overall Study|Lost to Follow-up|1|||
44474202|NCT00401544|79481835|FG000|Overall Study|Withdrawal by Subject|7|||
44474203|NCT00401544|79481836|FG001|Overall Study|Withdrawal by Subject|6|||
44474204|NCT00401544|79481837|FG002|Overall Study|Withdrawal by Subject|6|||
44474205|NCT00401544|79481838|FG003|Overall Study|Withdrawal by Subject|5|||
44474206|NCT00401544|79481835|FG000|Overall Study|Physician Decision|1|||
44474207|NCT00401544|79481836|FG001|Overall Study|Physician Decision|3|||
44474208|NCT00401544|79481837|FG002|Overall Study|Physician Decision|0|||
44474209|NCT00401544|79481838|FG003|Overall Study|Physician Decision|0|||
44474210|NCT00401544|79481835|FG000|Overall Study|Ineligibility determined|0|||
44474211|NCT00401544|79481836|FG001|Overall Study|Ineligibility determined|1|||
44474212|NCT00401544|79481837|FG002|Overall Study|Ineligibility determined|0|||
44474213|NCT00401544|79481838|FG003|Overall Study|Ineligibility determined|2|||
44474214|NCT00401544|79481835|FG000|Overall Study|Disease progression|0|||
44474215|NCT00401544|79481836|FG001|Overall Study|Disease progression|1|||
44474216|NCT00401544|79481837|FG002|Overall Study|Disease progression|0|||
44474217|NCT00401544|79481838|FG003|Overall Study|Disease progression|0|||
44474218|NCT00401544|79481835|FG000|Overall Study|Other|0|||
44474219|NCT00401544|79481836|FG001|Overall Study|Other|0|||
44474220|NCT00401544|79481837|FG002|Overall Study|Other|2|||
44474221|NCT00401544|79481838|FG003|Overall Study|Other|2|||
44474222|NCT00289731|79481856|FG000|Overall Study|Adverse Event|1|||
44474223|NCT00289731|79481857|FG001|Overall Study|Adverse Event|2|||
44474224|NCT00289731|79481858|FG002|Overall Study|Adverse Event|2|||
44474225|NCT00289731|79481856|FG000|Overall Study|Other|1|||
44474226|NCT00289731|79481857|FG001|Overall Study|Other|0|||
44474227|NCT00289731|79481858|FG002|Overall Study|Other|0|||
44474228|NCT00289185|79481870|FG000|Overall Study|Withdrawal by Subject|4|||
44474229|NCT00289185|79481871|FG001|Overall Study|Withdrawal by Subject|8|||
44474230|NCT00289185|79481870|FG000|Overall Study|Lost to Follow-up|23|||
44474231|NCT00289185|79481871|FG001|Overall Study|Lost to Follow-up|17|||
44474232|NCT00289185|79481870|FG000|Overall Study|Death|1|||
44474233|NCT00289185|79481871|FG001|Overall Study|Death|1|||
44474234|NCT00292461|79481880|FG000|Overall Study|Adverse Event|4|||
44474235|NCT00292461|79481881|FG001|Overall Study|Adverse Event|2|||
44474236|NCT00292461|79481880|FG000|Overall Study|Lack of Efficacy|1|||
44474237|NCT00292461|79481881|FG001|Overall Study|Lack of Efficacy|0|||
44474238|NCT00292461|79481880|FG000|Overall Study|Withdrawal by Subject|0|||
44226169|NCT01730053|79032435|FG001|Overall Study|Poor compliance to protocol|2|||
44226170|NCT01730053|79032436|FG002|Overall Study|Poor compliance to protocol|2|||
44226171|NCT01730053|79032437|FG003|Overall Study|Poor compliance to protocol|0|||
44226172|NCT01730053|79032438|FG004|Overall Study|Poor compliance to protocol|0|||
44226173|NCT01730053|79032439|FG005|Overall Study|Poor compliance to protocol|2|||
44226174|NCT01730053|79032434|FG000|Overall Study|Other than specified|2|||
44226175|NCT01730053|79032435|FG001|Overall Study|Other than specified|6|||
44226176|NCT01730053|79032436|FG002|Overall Study|Other than specified|5|||
44226177|NCT01730053|79032437|FG003|Overall Study|Other than specified|4|||
44226178|NCT01730053|79032438|FG004|Overall Study|Other than specified|7|||
44226179|NCT01730053|79032439|FG005|Overall Study|Other than specified|9|||
44375424|NCT00944034|79380590|FG005|Overall Study|Protocol Violation|3|||
44474239|NCT00292461|79481881|FG001|Overall Study|Withdrawal by Subject|1|||
44474240|NCT00292461|79481880|FG000|Overall Study|Protocol Violation|4|||
44474241|NCT00292461|79481881|FG001|Overall Study|Protocol Violation|3|||
44474242|NCT00292461|79481880|FG000|Overall Study|Lost to Follow-up|1|||
44474243|NCT00292461|79481881|FG001|Overall Study|Lost to Follow-up|0|||
44474244|NCT00288639|79481887|FG000|Overall Study|Adverse Event|5|||
44474245|NCT00288639|79481887|FG000|Overall Study|Lack of Efficacy|4|||
44474246|NCT00288639|79481887|FG000|Overall Study|Withdrawal by Subject|2|||
44474247|NCT00288639|79481887|FG000|Overall Study|Other|1|||
44474248|NCT00390858|79481893|FG000|Overall Study|Adverse Event|6|||
44474249|NCT00390858|79481894|FG001|Overall Study|Adverse Event|2|||
44474250|NCT00390858|79481893|FG000|Overall Study|Lack of Efficacy|0|||
44474251|NCT00390858|79481894|FG001|Overall Study|Lack of Efficacy|1|||
44474252|NCT00390858|79481893|FG000|Overall Study|Withdrawal by Subject|3|||
44474253|NCT00390858|79481894|FG001|Overall Study|Withdrawal by Subject|4|||
44474254|NCT00390780|79481902|FG000|Overall Study|Not completed|10|||
44474255|NCT00390780|79481903|FG001|Overall Study|Not completed|4|||
44474256|NCT00390780|79481902|FG000|Overall Study|Protocol Violation|6|||
44474257|NCT00390780|79481903|FG001|Overall Study|Protocol Violation|4|||
44474258|NCT00390780|79481902|FG000|Overall Study|Lost to Follow-up|3|||
44474259|NCT00390780|79481903|FG001|Overall Study|Lost to Follow-up|6|||
44474260|NCT00390780|79481902|FG000|Overall Study|Adverse Event|2|||
44474261|NCT00390780|79481903|FG001|Overall Study|Adverse Event|3|||
44375425|NCT00944034|79380591|FG006|Overall Study|Protocol Violation|0|||
44375426|NCT00944034|79380592|FG007|Overall Study|Protocol Violation|1|||
44226180|NCT01752985|79032474|FG000|Treatment Period|Subject request to discontinue treatment|1|||
44375427|NCT00944034|79380593|FG008|Overall Study|Protocol Violation|1|||
44375428|NCT00944034|79380594|FG009|Overall Study|Protocol Violation|4|||
44474262|NCT00390780|79481902|FG000|Overall Study|Death|1|||
44474263|NCT00390780|79481903|FG001|Overall Study|Death|3|||
44474264|NCT00390780|79481902|FG000|Overall Study|Withdrawal by Subject|1|||
44474265|NCT00390780|79481903|FG001|Overall Study|Withdrawal by Subject|2|||
44474266|NCT00390780|79481902|FG000|Overall Study|Inclusion criteria not satisfied|0|||
44474267|NCT00390780|79481903|FG001|Overall Study|Inclusion criteria not satisfied|2|||
44474268|NCT00390780|79481902|FG000|Overall Study|Lost to follow up and other reasons|0|||
44474269|NCT00390780|79481903|FG001|Overall Study|Lost to follow up and other reasons|1|||
44474270|NCT00390780|79481902|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
44474271|NCT00390780|79481903|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
44474272|NCT00390780|79481902|FG000|Overall Study|SAE, death|0|||
44474273|NCT00390780|79481903|FG001|Overall Study|SAE, death|1|||
44474274|NCT00390546|79481911|FG000|Overall Study|Renal impairment|1|||
44474275|NCT00390546|79481912|FG001|Overall Study|Renal impairment|0|||
44474276|NCT00390546|79481911|FG000|Overall Study|Physician Decision|5|||
44474277|NCT00390546|79481912|FG001|Overall Study|Physician Decision|5|||
44474278|NCT00390468|79481919|FG000|Overall Study|Protocol Violation|2|||
44474279|NCT00390468|79481919|FG000|Overall Study|Lack of Efficacy|1|||
44474280|NCT00400764|79481928|FG000|Phase Ib|Adverse Event|1|||
44474281|NCT00400764|79481929|FG001|Phase Ib|Adverse Event|0|||
44474282|NCT00400764|79481930|FG002|Phase Ib|Adverse Event|0|||
44474283|NCT00400764|79481931|FG003|Phase Ib|Adverse Event|0|||
44474284|NCT00400764|79481932|FG004|Phase Ib|Adverse Event|0|||
44474285|NCT00400764|79481928|FG000|Phase Ib|Death|1|||
44474286|NCT00400764|79481929|FG001|Phase Ib|Death|0|||
44474287|NCT00400764|79481930|FG002|Phase Ib|Death|0|||
44474288|NCT00400764|79481931|FG003|Phase Ib|Death|0|||
44474289|NCT00400764|79481932|FG004|Phase Ib|Death|0|||
44474290|NCT00400764|79481928|FG000|Phase Ib|Disease Progression|4|||
44474291|NCT00400764|79481929|FG001|Phase Ib|Disease Progression|4|||
44474292|NCT00400764|79481930|FG002|Phase Ib|Disease Progression|0|||
44474293|NCT00400764|79481931|FG003|Phase Ib|Disease Progression|0|||
44474294|NCT00400764|79481932|FG004|Phase Ib|Disease Progression|0|||
44474295|NCT00400764|79481928|FG000|Phase II|Death|0|||
44474296|NCT00400764|79481929|FG001|Phase II|Death|0|||
44474297|NCT00400764|79481930|FG002|Phase II|Death|1|||
44474298|NCT00400764|79481931|FG003|Phase II|Death|2|||
44474299|NCT00400764|79481932|FG004|Phase II|Death|0|||
44474300|NCT00400764|79481928|FG000|Phase II|Lost to Follow-up|0|||
44474301|NCT00400764|79481929|FG001|Phase II|Lost to Follow-up|0|||
44474302|NCT00400764|79481930|FG002|Phase II|Lost to Follow-up|1|||
44474303|NCT00400764|79481931|FG003|Phase II|Lost to Follow-up|0|||
44474304|NCT00400764|79481932|FG004|Phase II|Lost to Follow-up|0|||
44474305|NCT00400764|79481928|FG000|Phase II|Physician Decision|0|||
44474306|NCT00400764|79481929|FG001|Phase II|Physician Decision|0|||
44474307|NCT00400764|79481930|FG002|Phase II|Physician Decision|1|||
44474308|NCT00400764|79481931|FG003|Phase II|Physician Decision|1|||
44474309|NCT00400764|79481932|FG004|Phase II|Physician Decision|0|||
44474310|NCT00400764|79481928|FG000|Phase II|Sponsor's decision to terminate|0|||
44474311|NCT00400764|79481929|FG001|Phase II|Sponsor's decision to terminate|0|||
44474312|NCT00400764|79481930|FG002|Phase II|Sponsor's decision to terminate|18|||
44474313|NCT00400764|79481931|FG003|Phase II|Sponsor's decision to terminate|22|||
44474314|NCT00400764|79481932|FG004|Phase II|Sponsor's decision to terminate|11|||
44474315|NCT00400764|79481928|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
44474316|NCT00400764|79481929|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
44474317|NCT00400764|79481930|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
44474318|NCT00400764|79481931|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
44474319|NCT00400764|79481932|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
44474320|NCT00400764|79481928|FG000|Phase II|Withdrawal by Subject|0|||
44474321|NCT00400764|79481929|FG001|Phase II|Withdrawal by Subject|0|||
44474322|NCT00400764|79481930|FG002|Phase II|Withdrawal by Subject|1|||
44474323|NCT00400764|79481931|FG003|Phase II|Withdrawal by Subject|1|||
44474324|NCT00400764|79481932|FG004|Phase II|Withdrawal by Subject|0|||
44474325|NCT00302211|79481952|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
44474326|NCT00302211|79481953|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
44474327|NCT00302211|79481954|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
44474328|NCT00302211|79481955|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
44474329|NCT00302211|79481956|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
44474330|NCT00302211|79481952|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
44474331|NCT00302211|79481953|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
44474332|NCT00302211|79481954|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
44474333|NCT00302211|79481955|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
44474334|NCT00302211|79481956|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
44474335|NCT00302211|79481952|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
44474336|NCT00302211|79481953|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
44474337|NCT00302211|79481954|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
44474338|NCT00302211|79481955|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
44474339|NCT00302211|79481956|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
44474340|NCT00302211|79481952|FG000|Double Blind Period (New Patients)|Disease progression|0|||
44474341|NCT00302211|79481953|FG001|Double Blind Period (New Patients)|Disease progression|1|||
44474342|NCT00302211|79481954|FG002|Double Blind Period (New Patients)|Disease progression|1|||
44474343|NCT00302211|79481955|FG003|Double Blind Period (New Patients)|Disease progression|0|||
44474344|NCT00302211|79481956|FG004|Double Blind Period (New Patients)|Disease progression|0|||
44474345|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
44474346|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
44474347|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
44474348|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
44474349|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
44474350|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
44474351|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
44474352|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
44474353|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
44474354|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
44474355|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
44474356|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
44474357|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
44474358|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
44474359|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
44474360|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
44474361|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
44474362|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
44474363|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
44474364|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
44474365|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Death|0|||
44474366|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Death|0|||
44474367|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Death|0|||
44474368|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Death|1|||
44474369|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Death|1|||
44474370|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
44474371|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
44474372|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
44474373|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
44474374|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
44474375|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
44474376|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
44474377|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
44474378|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
44474379|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
44474380|NCT00302211|79481952|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
44474381|NCT00302211|79481953|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
44474382|NCT00302211|79481954|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
44474383|NCT00302211|79481955|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
44474384|NCT00302211|79481956|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
44474385|NCT00288015|79481968|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
44474386|NCT00288015|79481968|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
44474387|NCT00288015|79481968|FG000|First Response Assessment|Withdrawal by Subject|1|||
44474388|NCT00288015|79481968|FG000|First Response Assessment|Death|1|||
44474389|NCT00288015|79481968|FG000|First Response Assessment|Physician Decision|2|||
44474390|NCT00288015|79481968|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
44474391|NCT00288015|79481968|FG000|Follow up for Survival x 2 Years|Death|13|||
44474392|NCT00288015|79481968|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
44474393|NCT00288015|79481968|FG000|Follow up for Survival x 2 Years|Other|9|||
44474394|NCT00389064|79481974|FG000|Overall Study|Adverse Event|11|||
44474395|NCT00389064|79481975|FG001|Overall Study|Adverse Event|3|||
44474396|NCT00389064|79481974|FG000|Overall Study|Lack of Efficacy|3|||
44474397|NCT00389064|79481975|FG001|Overall Study|Lack of Efficacy|14|||
44474398|NCT00389064|79481974|FG000|Overall Study|Withdrawal by Subject|17|||
44474399|NCT00389064|79481975|FG001|Overall Study|Withdrawal by Subject|27|||
44474400|NCT00389064|79481974|FG000|Overall Study|Physician Decision|2|||
44474401|NCT00389064|79481975|FG001|Overall Study|Physician Decision|2|||
44474402|NCT00389064|79481974|FG000|Overall Study|Lost to Follow-up|1|||
44474403|NCT00389064|79481975|FG001|Overall Study|Lost to Follow-up|2|||
44474404|NCT00389064|79481974|FG000|Overall Study|Protocol Violation|2|||
44474405|NCT00389064|79481975|FG001|Overall Study|Protocol Violation|0|||
44474406|NCT00389064|79481974|FG000|Overall Study|Multiple Reasons|9|||
44474407|NCT00389064|79481975|FG001|Overall Study|Multiple Reasons|11|||
44474408|NCT00388674|79481983|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
44474409|NCT00388674|79481984|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
44474410|NCT00388674|79481983|FG000|Initial Treatment|Adverse Event|22|||
44474411|NCT00388674|79481984|FG001|Initial Treatment|Adverse Event|87|||
44474412|NCT00388674|79481983|FG000|Initial Treatment|Death|215|||
44474413|NCT00388674|79481984|FG001|Initial Treatment|Death|216|||
44474414|NCT00388674|79481983|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
44474415|NCT00388674|79481984|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
44474416|NCT00388674|79481983|FG000|Initial Treatment|HCC|12|||
44474417|NCT00388674|79481984|FG001|Initial Treatment|HCC|20|||
44474418|NCT00388674|79481983|FG000|Initial Treatment|Lost to Follow-up|526|||
44474419|NCT00388674|79481984|FG001|Initial Treatment|Lost to Follow-up|624|||
44474420|NCT00388674|79481983|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
44474421|NCT00388674|79481984|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
44474422|NCT00388674|79481983|FG000|Initial Treatment|Never Treated with Study Medication|1|||
44474423|NCT00388674|79481984|FG001|Initial Treatment|Never Treated with Study Medication|7|||
44474424|NCT00388674|79481983|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
44474425|NCT00388674|79481984|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
44474426|NCT00388674|79481983|FG000|Initial Treatment|Not Defined|125|||
44474427|NCT00388674|79481984|FG001|Initial Treatment|Not Defined|172|||
44474428|NCT00388674|79481983|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
44474429|NCT00388674|79481984|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
44474430|NCT00388674|79481983|FG000|Initial Treatment|Pregnancy|26|||
44474431|NCT00388674|79481984|FG001|Initial Treatment|Pregnancy|16|||
44474432|NCT00388674|79481983|FG000|Initial Treatment|Study Drug Toxicity|5|||
44474433|NCT00388674|79481984|FG001|Initial Treatment|Study Drug Toxicity|92|||
44474434|NCT00388674|79481983|FG000|Initial Treatment|Participant Request|501|||
44474435|NCT00388674|79481984|FG001|Initial Treatment|Participant Request|673|||
44474436|NCT00388674|79481983|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
44474437|NCT00388674|79481984|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
44474438|NCT00388674|79481983|FG000|Initial Treatment|Not Reported|10|||
44474439|NCT00388674|79481984|FG001|Initial Treatment|Not Reported|12|||
44474440|NCT00388674|79481983|FG000|End of Study|Administrative Reason By Sponsor|299|||
44474441|NCT00388674|79481984|FG001|End of Study|Administrative Reason By Sponsor|253|||
44474442|NCT00388674|79481983|FG000|End of Study|Death|239|||
44474443|NCT00388674|79481984|FG001|End of Study|Death|262|||
44474444|NCT00388674|79481983|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
44474445|NCT00388674|79481984|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
44474446|NCT00388674|79481983|FG000|End of Study|HCC|8|||
44474447|NCT00388674|79481984|FG001|End of Study|HCC|7|||
44474448|NCT00388674|79481983|FG000|End of Study|Lost to Follow-up|587|||
44474449|NCT00388674|79481984|FG001|End of Study|Lost to Follow-up|715|||
44474450|NCT00388674|79481983|FG000|End of Study|Malignancy (Non-HCC)|1|||
44474451|NCT00388674|79481984|FG001|End of Study|Malignancy (Non-HCC)|1|||
44474452|NCT00388674|79481983|FG000|End of Study|Non-Study Related Comorbidities|3|||
44474453|NCT00388674|79481984|FG001|End of Study|Non-Study Related Comorbidities|4|||
44474454|NCT00388674|79481983|FG000|End of Study|Not Defined|135|||
44474455|NCT00388674|79481984|FG001|End of Study|Not Defined|214|||
44474456|NCT00388674|79481983|FG000|End of Study|Participant Withdrew Consent|437|||
44474457|NCT00388674|79481984|FG001|End of Study|Participant Withdrew Consent|673|||
44474458|NCT00388674|79481983|FG000|End of Study|No Off-Treatment Status Data|22|||
44474459|NCT00388674|79481984|FG001|End of Study|No Off-Treatment Status Data|30|||
44474460|NCT00388674|79481983|FG000|End of Study|Not Reported|0|||
44474461|NCT00388674|79481984|FG001|End of Study|Not Reported|1|||
44474462|NCT00388362|79481990|FG000|Enrolled|Ineligible|1|||
44474463|NCT00388362|79481990|FG000|Enrolled|Adverse Event|9|||
44474464|NCT00388362|79481990|FG000|Enrolled|Death|1|||
44474465|NCT00388362|79481990|FG000|Enrolled|Loss insurance|1|||
44474466|NCT00388362|79481990|FG000|Enrolled|Withdrawal by Subject|1|||
44474467|NCT00388362|79481990|FG000|Remained on Study Median of 514 Days|Death|2|||
44474468|NCT00387894|79481994|FG000|Overall Study|Withdrawal by Subject|1|||
44474469|NCT00387426|79481998|FG000|Overall Study|Lack of Response|7|||
44474470|NCT00387426|79481998|FG000|Overall Study|Toxicities|4|||
44474471|NCT00387426|79481998|FG000|Overall Study|Disease Progression|3|||
44474472|NCT00387348|79482005|FG000|Overall Study|Death|1|||
44474473|NCT00387348|79482006|FG001|Overall Study|Death|1|||
44474474|NCT00387348|79482007|FG002|Overall Study|Death|0|||
44474475|NCT00387348|79482005|FG000|Overall Study|Physician Decision|1|||
44474476|NCT00387348|79482006|FG001|Overall Study|Physician Decision|0|||
44474477|NCT00387348|79482007|FG002|Overall Study|Physician Decision|1|||
44474478|NCT00387348|79482005|FG000|Overall Study|Withdrawal by Subject|0|||
44474479|NCT00387348|79482006|FG001|Overall Study|Withdrawal by Subject|2|||
44474480|NCT00387348|79482007|FG002|Overall Study|Withdrawal by Subject|2|||
44474481|NCT00387348|79482005|FG000|Overall Study|Adverse Event|1|||
44474482|NCT00387348|79482006|FG001|Overall Study|Adverse Event|0|||
44474483|NCT00387348|79482007|FG002|Overall Study|Adverse Event|1|||
44474484|NCT00413660|79482027|FG000|Up To Week 12|Adverse Event|1|||
44474485|NCT00413660|79482028|FG001|Up To Week 12|Adverse Event|3|||
44474486|NCT00413660|79482029|FG002|Up To Week 12|Adverse Event|1|||
44474487|NCT00413660|79482030|FG003|Up To Week 12|Adverse Event|4|||
44474488|NCT00413660|79482031|FG004|Up To Week 12|Adverse Event|6|||
44474489|NCT00413660|79482032|FG005|Up To Week 12|Adverse Event|4|||
44474490|NCT00413660|79482033|FG006|Up To Week 12|Adverse Event|1|||
44474491|NCT00413660|79482034|FG007|Up To Week 12|Adverse Event|0|||
44474492|NCT00413660|79482035|FG008|Up To Week 12|Adverse Event|0|||
44474493|NCT00413660|79482036|FG009|Up To Week 12|Adverse Event|0|||
44474494|NCT00413660|79482037|FG010|Up To Week 12|Adverse Event|0|||
44474495|NCT00413660|79482027|FG000|Up To Week 12|Lack of Efficacy|2|||
44474496|NCT00413660|79482028|FG001|Up To Week 12|Lack of Efficacy|0|||
44474497|NCT00413660|79482029|FG002|Up To Week 12|Lack of Efficacy|0|||
44474498|NCT00413660|79482030|FG003|Up To Week 12|Lack of Efficacy|0|||
44474499|NCT00413660|79482031|FG004|Up To Week 12|Lack of Efficacy|0|||
44474500|NCT00413660|79482032|FG005|Up To Week 12|Lack of Efficacy|0|||
44474501|NCT00413660|79482033|FG006|Up To Week 12|Lack of Efficacy|5|||
44474502|NCT00413660|79482034|FG007|Up To Week 12|Lack of Efficacy|0|||
44474503|NCT00413660|79482035|FG008|Up To Week 12|Lack of Efficacy|0|||
44474504|NCT00413660|79482036|FG009|Up To Week 12|Lack of Efficacy|0|||
44474505|NCT00413660|79482037|FG010|Up To Week 12|Lack of Efficacy|0|||
44474506|NCT00413660|79482027|FG000|Up To Week 12|Lost to Follow-up|0|||
44474507|NCT00413660|79482028|FG001|Up To Week 12|Lost to Follow-up|1|||
44474508|NCT00413660|79482029|FG002|Up To Week 12|Lost to Follow-up|0|||
44474509|NCT00413660|79482030|FG003|Up To Week 12|Lost to Follow-up|0|||
44474510|NCT00413660|79482031|FG004|Up To Week 12|Lost to Follow-up|1|||
44474511|NCT00413660|79482032|FG005|Up To Week 12|Lost to Follow-up|0|||
44474512|NCT00413660|79482033|FG006|Up To Week 12|Lost to Follow-up|0|||
44474513|NCT00413660|79482034|FG007|Up To Week 12|Lost to Follow-up|0|||
44474514|NCT00413660|79482035|FG008|Up To Week 12|Lost to Follow-up|0|||
44474515|NCT00413660|79482036|FG009|Up To Week 12|Lost to Follow-up|0|||
44474516|NCT00413660|79482037|FG010|Up To Week 12|Lost to Follow-up|0|||
44474517|NCT00413660|79482027|FG000|Up To Week 12|Withdrawal by Subject|0|||
44474518|NCT00413660|79482028|FG001|Up To Week 12|Withdrawal by Subject|2|||
44474519|NCT00413660|79482029|FG002|Up To Week 12|Withdrawal by Subject|0|||
44474520|NCT00413660|79482030|FG003|Up To Week 12|Withdrawal by Subject|2|||
44474521|NCT00413660|79482031|FG004|Up To Week 12|Withdrawal by Subject|0|||
44474522|NCT00413660|79482032|FG005|Up To Week 12|Withdrawal by Subject|2|||
44474523|NCT00413660|79482033|FG006|Up To Week 12|Withdrawal by Subject|2|||
44474524|NCT00413660|79482034|FG007|Up To Week 12|Withdrawal by Subject|0|||
44474525|NCT00413660|79482035|FG008|Up To Week 12|Withdrawal by Subject|0|||
44474526|NCT00413660|79482036|FG009|Up To Week 12|Withdrawal by Subject|0|||
44474527|NCT00413660|79482037|FG010|Up To Week 12|Withdrawal by Subject|0|||
44474528|NCT00413660|79482027|FG000|Up To Week 12|Randomized, Not Treated|1|||
44474529|NCT00413660|79482028|FG001|Up To Week 12|Randomized, Not Treated|0|||
44474530|NCT00413660|79482029|FG002|Up To Week 12|Randomized, Not Treated|0|||
44474531|NCT00413660|79482030|FG003|Up To Week 12|Randomized, Not Treated|1|||
44474532|NCT00413660|79482031|FG004|Up To Week 12|Randomized, Not Treated|0|||
44474533|NCT00413660|79482032|FG005|Up To Week 12|Randomized, Not Treated|0|||
44474534|NCT00413660|79482033|FG006|Up To Week 12|Randomized, Not Treated|0|||
44474535|NCT00413660|79482034|FG007|Up To Week 12|Randomized, Not Treated|0|||
44474536|NCT00413660|79482035|FG008|Up To Week 12|Randomized, Not Treated|0|||
44474537|NCT00413660|79482036|FG009|Up To Week 12|Randomized, Not Treated|0|||
44474538|NCT00413660|79482037|FG010|Up To Week 12|Randomized, Not Treated|0|||
44474539|NCT00413660|79482027|FG000|Up To Week 12|Other|3|||
44474540|NCT00413660|79482028|FG001|Up To Week 12|Other|1|||
44474541|NCT00413660|79482029|FG002|Up To Week 12|Other|6|||
44474542|NCT00413660|79482030|FG003|Up To Week 12|Other|1|||
44474543|NCT00413660|79482031|FG004|Up To Week 12|Other|2|||
44474544|NCT00413660|79482032|FG005|Up To Week 12|Other|4|||
44474545|NCT00413660|79482033|FG006|Up To Week 12|Other|3|||
44474546|NCT00413660|79482034|FG007|Up To Week 12|Other|0|||
44544552|NCT03192306|79558066|FG001|Overall Study|Did not treat cold sore during study|143|||
44226181|NCT01752985|79032475|FG001|Treatment Period|Subject request to discontinue treatment|0|||
44226182|NCT01752985|79032476|FG002|Treatment Period|Subject request to discontinue treatment|1|||
44226183|NCT01752985|79032474|FG000|Treatment Period|Subject no longer meets study criteria|0|||
44273981|NCT01642914|79215927|FG000|Overall Study|Protocol Violation|15|||
44273982|NCT01642914|79215928|FG001|Overall Study|Protocol Violation|13|||
44273983|NCT01642914|79215929|FG002|Overall Study|Protocol Violation|6|||
44273984|NCT01642914|79215927|FG000|Overall Study|Withdrawal by Subject|5|||
44273985|NCT01642914|79215928|FG001|Overall Study|Withdrawal by Subject|5|||
44273986|NCT01642914|79215929|FG002|Overall Study|Withdrawal by Subject|10|||
44273987|NCT01642914|79215927|FG000|Overall Study|Lost to Follow-up|5|||
44226184|NCT01752985|79032475|FG001|Treatment Period|Subject no longer meets study criteria|1|||
44226185|NCT01752985|79032476|FG002|Treatment Period|Subject no longer meets study criteria|1|||
44226186|NCT01752985|79032474|FG000|Treatment Period|Adverse Event|2|||
44226187|NCT01752985|79032475|FG001|Treatment Period|Adverse Event|1|||
44226188|NCT01752985|79032476|FG002|Treatment Period|Adverse Event|2|||
44273988|NCT01642914|79215928|FG001|Overall Study|Lost to Follow-up|3|||
44226189|NCT01752985|79032474|FG000|Treatment Period|Withdrawal by Subject|1|||
44273989|NCT01642914|79215929|FG002|Overall Study|Lost to Follow-up|7|||
44273990|NCT01642914|79215927|FG000|Overall Study|Other Reason|1|||
44474547|NCT00413660|79482035|FG008|Up To Week 12|Other|0|||
44474548|NCT00413660|79482036|FG009|Up To Week 12|Other|0|||
44474549|NCT00413660|79482037|FG010|Up To Week 12|Other|0|||
44474550|NCT00413660|79482027|FG000|Post Week 12|Adverse Event|2|||
44474551|NCT00413660|79482028|FG001|Post Week 12|Adverse Event|0|||
44474552|NCT00413660|79482029|FG002|Post Week 12|Adverse Event|2|||
44474553|NCT00413660|79482030|FG003|Post Week 12|Adverse Event|1|||
44474554|NCT00413660|79482031|FG004|Post Week 12|Adverse Event|4|||
44474555|NCT00413660|79482032|FG005|Post Week 12|Adverse Event|2|||
44474556|NCT00413660|79482033|FG006|Post Week 12|Adverse Event|2|||
44474557|NCT00413660|79482034|FG007|Post Week 12|Adverse Event|0|||
44474558|NCT00413660|79482035|FG008|Post Week 12|Adverse Event|0|||
44474559|NCT00413660|79482036|FG009|Post Week 12|Adverse Event|0|||
44474560|NCT00413660|79482037|FG010|Post Week 12|Adverse Event|0|||
44474561|NCT00413660|79482027|FG000|Post Week 12|Lack of Efficacy|0|||
44474562|NCT00413660|79482028|FG001|Post Week 12|Lack of Efficacy|0|||
44474563|NCT00413660|79482029|FG002|Post Week 12|Lack of Efficacy|1|||
44474564|NCT00413660|79482030|FG003|Post Week 12|Lack of Efficacy|0|||
44474565|NCT00413660|79482031|FG004|Post Week 12|Lack of Efficacy|0|||
44474566|NCT00413660|79482032|FG005|Post Week 12|Lack of Efficacy|0|||
44474567|NCT00413660|79482033|FG006|Post Week 12|Lack of Efficacy|0|||
44474568|NCT00413660|79482034|FG007|Post Week 12|Lack of Efficacy|0|||
44474569|NCT00413660|79482035|FG008|Post Week 12|Lack of Efficacy|0|||
44474570|NCT00413660|79482036|FG009|Post Week 12|Lack of Efficacy|1|||
44474571|NCT00413660|79482037|FG010|Post Week 12|Lack of Efficacy|0|||
44474572|NCT00413660|79482027|FG000|Post Week 12|Lost to Follow-up|0|||
44474573|NCT00413660|79482028|FG001|Post Week 12|Lost to Follow-up|1|||
44474574|NCT00413660|79482029|FG002|Post Week 12|Lost to Follow-up|1|||
44474575|NCT00413660|79482030|FG003|Post Week 12|Lost to Follow-up|0|||
44474576|NCT00413660|79482031|FG004|Post Week 12|Lost to Follow-up|0|||
44474577|NCT00413660|79482032|FG005|Post Week 12|Lost to Follow-up|0|||
44474578|NCT00413660|79482033|FG006|Post Week 12|Lost to Follow-up|0|||
44474579|NCT00413660|79482034|FG007|Post Week 12|Lost to Follow-up|0|||
44474580|NCT00413660|79482035|FG008|Post Week 12|Lost to Follow-up|0|||
44474581|NCT00413660|79482036|FG009|Post Week 12|Lost to Follow-up|0|||
44474582|NCT00413660|79482037|FG010|Post Week 12|Lost to Follow-up|0|||
44474583|NCT00413660|79482027|FG000|Post Week 12|Withdrawal by Subject|0|||
44474584|NCT00413660|79482028|FG001|Post Week 12|Withdrawal by Subject|1|||
44474585|NCT00413660|79482029|FG002|Post Week 12|Withdrawal by Subject|1|||
44474586|NCT00413660|79482030|FG003|Post Week 12|Withdrawal by Subject|0|||
44474587|NCT00413660|79482031|FG004|Post Week 12|Withdrawal by Subject|1|||
44474588|NCT00413660|79482032|FG005|Post Week 12|Withdrawal by Subject|0|||
44474589|NCT00413660|79482033|FG006|Post Week 12|Withdrawal by Subject|0|||
44474590|NCT00413660|79482034|FG007|Post Week 12|Withdrawal by Subject|0|||
44474591|NCT00413660|79482035|FG008|Post Week 12|Withdrawal by Subject|0|||
44474592|NCT00413660|79482036|FG009|Post Week 12|Withdrawal by Subject|0|||
44226190|NCT01752985|79032475|FG001|Treatment Period|Withdrawal by Subject|1|||
44474593|NCT00413660|79482037|FG010|Post Week 12|Withdrawal by Subject|1|||
44474594|NCT00413660|79482027|FG000|Post Week 12|Other|1|||
44474595|NCT00413660|79482028|FG001|Post Week 12|Other|2|||
44474596|NCT00413660|79482029|FG002|Post Week 12|Other|3|||
44474597|NCT00413660|79482030|FG003|Post Week 12|Other|0|||
44474598|NCT00413660|79482031|FG004|Post Week 12|Other|1|||
44474599|NCT00413660|79482032|FG005|Post Week 12|Other|1|||
44544553|NCT03192306|79558065|FG000|Overall Study|Withdrawal by Subject|1|||
44143765|NCT03252925|78933094|FG001|Overall Study|Adverse Event|0|||
44143766|NCT03252925|78933093|FG000|Overall Study|Lost to Follow-up|6|||
44143767|NCT03252925|78933094|FG001|Overall Study|Lost to Follow-up|6|||
44474600|NCT00413660|79482033|FG006|Post Week 12|Other|1|||
44474601|NCT00413660|79482034|FG007|Post Week 12|Other|0|||
44474602|NCT00413660|79482035|FG008|Post Week 12|Other|0|||
44474603|NCT00413660|79482036|FG009|Post Week 12|Other|0|||
44474604|NCT00413660|79482037|FG010|Post Week 12|Other|0|||
44474605|NCT00431834|79482071|FG000|Overall Study|Withdrawal by Subject|7|||
44226191|NCT01752985|79032476|FG002|Treatment Period|Withdrawal by Subject|0|||
44226192|NCT01752985|79032474|FG000|Treatment Period|Lost to Follow-up|0|||
44226193|NCT01752985|79032475|FG001|Treatment Period|Lost to Follow-up|0|||
44226194|NCT01752985|79032476|FG002|Treatment Period|Lost to Follow-up|1|||
44226195|NCT01751113|79032484|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
44226196|NCT01751113|79032485|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
44226197|NCT01751113|79032486|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
44226198|NCT01751113|79032487|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
44226199|NCT01751113|79032488|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
44226200|NCT01751113|79032489|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
44474606|NCT00431834|79482071|FG000|Overall Study|Death|3|||
44474607|NCT00431834|79482071|FG000|Overall Study|Missed Endpoint Visit|2|||
44474608|NCT00431834|79482071|FG000|Overall Study|Lost to Follow-up|1|||
44474609|NCT00431444|79482080|FG000|Overall Study|Protocol Violation|1|||
44474610|NCT00431444|79482081|FG001|Overall Study|Protocol Violation|4|||
44474611|NCT00431444|79482080|FG000|Overall Study|Adverse Event|2|||
44474612|NCT00431444|79482081|FG001|Overall Study|Adverse Event|1|||
44474613|NCT00431444|79482080|FG000|Overall Study|Withdrawal by Subject|1|||
44474614|NCT00431444|79482081|FG001|Overall Study|Withdrawal by Subject|1|||
44474615|NCT00431444|79482080|FG000|Overall Study|Lost to Follow-up|1|||
44474616|NCT00431444|79482081|FG001|Overall Study|Lost to Follow-up|0|||
44474617|NCT00431444|79482080|FG000|Overall Study|Administrative Problems|0|||
44474618|NCT00431444|79482081|FG001|Overall Study|Administrative Problems|1|||
44474619|NCT00430352|79482087|FG000|Overall Study|Disease progression|58|||
44474620|NCT00430352|79482087|FG000|Overall Study|Withdrawal by Subject|11|||
44474621|NCT00430352|79482087|FG000|Overall Study|Adverse Event|16|||
44474622|NCT00430352|79482087|FG000|Overall Study|Death|5|||
44474623|NCT00430352|79482087|FG000|Overall Study|Other|48|||
44474624|NCT00287469|79482093|FG000|Overall Study|serious adverse event|1|||
44474625|NCT00287469|79482094|FG001|Overall Study|serious adverse event|6|||
44474626|NCT00287469|79482093|FG000|Overall Study|Adverse Event|1|||
44474627|NCT00287469|79482094|FG001|Overall Study|Adverse Event|1|||
44474628|NCT00287469|79482093|FG000|Overall Study|moved from area|144|||
44474629|NCT00287469|79482094|FG001|Overall Study|moved from area|138|||
44474630|NCT00287469|79482093|FG000|Overall Study|Lost to Follow-up|74|||
44474631|NCT00287469|79482094|FG001|Overall Study|Lost to Follow-up|69|||
44474632|NCT00429572|79482102|FG000|Overall Study|Disease progression|1|||
44474633|NCT00287079|79482108|FG000|Overall Study|Qualifying relapse|12|||
44474634|NCT00287079|79482109|FG001|Overall Study|Qualifying relapse|1|||
44474635|NCT00287079|79482108|FG000|Overall Study|Non-qualifying relapse|1|||
44474636|NCT00287079|79482109|FG001|Overall Study|Non-qualifying relapse|0|||
44474637|NCT00287079|79482108|FG000|Overall Study|Adverse Event|5|||
44474638|NCT00287079|79482109|FG001|Overall Study|Adverse Event|0|||
44474639|NCT00287079|79482108|FG000|Overall Study|Protocol Violation|1|||
44474640|NCT00287079|79482109|FG001|Overall Study|Protocol Violation|0|||
44474641|NCT00287079|79482108|FG000|Overall Study|Other|3|||
44474642|NCT00287079|79482109|FG001|Overall Study|Other|0|||
44474643|NCT00429494|79482115|FG000|Overall Study|Withdrawal by Subject|9|||
44474644|NCT00429494|79482115|FG000|Overall Study|Death|6|||
44474645|NCT00429416|79482119|FG000|Overall Study|Death|1|||
44474646|NCT00429182|79482123|FG000|Overall Study|Not evaluable, Disease Progression|2|||
44474647|NCT00429182|79482123|FG000|Overall Study|Not eligible|5|||
44474648|NCT00429104|79482127|FG000|Overall Study|Protocol Violation|1|||
44474649|NCT00429026|79482131|FG000|Overall Study|Inevaluable for response.|40|||
44474650|NCT00301821|79482135|FG000|Overall Study|Ineligible|25|||
44474651|NCT00301821|79482135|FG000|Overall Study|Cancel|1|||
44273991|NCT01642914|79215928|FG001|Overall Study|Other Reason|0|||
44474652|NCT00372996|79482141|FG000|Overall Study|Death|11|||
44474653|NCT00372996|79482142|FG001|Overall Study|Death|4|||
44474654|NCT00372996|79482143|FG002|Overall Study|Death|8|||
44474655|NCT00372996|79482144|FG003|Overall Study|Death|7|||
44474656|NCT00372996|79482141|FG000|Overall Study|Lost to Follow-up|0|||
44474657|NCT00372996|79482142|FG001|Overall Study|Lost to Follow-up|2|||
44474658|NCT00372996|79482143|FG002|Overall Study|Lost to Follow-up|0|||
44474659|NCT00372996|79482144|FG003|Overall Study|Lost to Follow-up|1|||
44474660|NCT00372996|79482141|FG000|Overall Study|Withdrawal by Subject|12|||
44474661|NCT00372996|79482142|FG001|Overall Study|Withdrawal by Subject|6|||
44474662|NCT00372996|79482143|FG002|Overall Study|Withdrawal by Subject|9|||
44226201|NCT01751113|79032484|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
44226202|NCT01751113|79032485|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
44226203|NCT01751113|79032486|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
44226204|NCT01751113|79032487|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
44226205|NCT01751113|79032488|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
44226206|NCT01751113|79032489|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
44226207|NCT01750879|79032500|FG000|Overall Study|Adverse Event|8|||
44226208|NCT01750879|79032501|FG001|Overall Study|Adverse Event|0|||
44226209|NCT01750879|79032500|FG000|Overall Study|Lack of Efficacy|1|||
44226210|NCT01750879|79032501|FG001|Overall Study|Lack of Efficacy|0|||
44226211|NCT01750879|79032500|FG000|Overall Study|Withdrawal by Subject|1|||
44474663|NCT00372996|79482144|FG003|Overall Study|Withdrawal by Subject|5|||
44474664|NCT00372996|79482141|FG000|Overall Study|Study Terminated by Sponsor|4|||
44474665|NCT00372996|79482142|FG001|Overall Study|Study Terminated by Sponsor|0|||
44226212|NCT01750879|79032501|FG001|Overall Study|Withdrawal by Subject|0|||
44226213|NCT01750879|79032500|FG000|Overall Study|Did not complete per protocol|0|||
44226214|NCT01750879|79032501|FG001|Overall Study|Did not complete per protocol|3|||
44226215|NCT01719380|79032527|FG000|Overall Study|Adverse Event|0|||
44226216|NCT01719380|79032528|FG001|Overall Study|Adverse Event|0|||
44226217|NCT01719380|79032529|FG002|Overall Study|Adverse Event|1|||
44226218|NCT01719380|79032530|FG003|Overall Study|Adverse Event|2|||
44226219|NCT01719380|79032531|FG004|Overall Study|Adverse Event|0|||
44226220|NCT01719380|79032532|FG005|Overall Study|Adverse Event|1|||
44226221|NCT01719380|79032533|FG006|Overall Study|Adverse Event|0|||
44226222|NCT01719380|79032534|FG007|Overall Study|Adverse Event|1|||
44226223|NCT01719380|79032535|FG008|Overall Study|Adverse Event|4|||
44226224|NCT01719380|79032536|FG009|Overall Study|Adverse Event|3|||
44226225|NCT01719380|79032527|FG000|Overall Study|Death|0|||
44474666|NCT00372996|79482143|FG002|Overall Study|Study Terminated by Sponsor|4|||
44474667|NCT00372996|79482144|FG003|Overall Study|Study Terminated by Sponsor|0|||
44474668|NCT00372996|79482141|FG000|Overall Study|Other|10|||
44474669|NCT00372996|79482142|FG001|Overall Study|Other|2|||
44474670|NCT00372996|79482143|FG002|Overall Study|Other|7|||
44273992|NCT01642914|79215929|FG002|Overall Study|Other Reason|0|||
44273993|NCT01642602|79215988|FG000|Overall Study|Adverse Event|2|||
44273994|NCT02256540|79216054|FG000|Overall Study|Withdrawal by Subject|0|||
44474671|NCT00372996|79482144|FG003|Overall Study|Other|7|||
44226226|NCT01719380|79032528|FG001|Overall Study|Death|1|||
44474672|NCT00399516|79482154|FG000|Overall Study|Lost to Follow-up|2|||
44474673|NCT00399360|79482162|FG000|Overall Study|Lost to Follow-up|2|||
44474674|NCT00399360|79482163|FG001|Overall Study|Lost to Follow-up|1|||
44474675|NCT00399360|79482164|FG002|Overall Study|Lost to Follow-up|2|||
44474676|NCT00399360|79482165|FG003|Overall Study|Lost to Follow-up|4|||
44474677|NCT00399360|79482162|FG000|Overall Study|Adverse Event|0|||
44474678|NCT00399360|79482163|FG001|Overall Study|Adverse Event|0|||
44474679|NCT00399360|79482164|FG002|Overall Study|Adverse Event|1|||
44474680|NCT00399360|79482165|FG003|Overall Study|Adverse Event|0|||
44474681|NCT00399360|79482162|FG000|Overall Study|Withdrawal by Subject|0|||
44474682|NCT00399360|79482163|FG001|Overall Study|Withdrawal by Subject|2|||
44474683|NCT00399360|79482164|FG002|Overall Study|Withdrawal by Subject|0|||
44474684|NCT00399360|79482165|FG003|Overall Study|Withdrawal by Subject|2|||
44474685|NCT00428948|79482182|FG000|Overall Study|Lost to Follow-up|15|||
44474686|NCT00428948|79482183|FG001|Overall Study|Lost to Follow-up|8|||
44474687|NCT00428948|79482182|FG000|Overall Study|Adverse Event|148|||
44474688|NCT00428948|79482183|FG001|Overall Study|Adverse Event|24|||
44474689|NCT00428948|79482182|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
44474690|NCT00428948|79482183|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
44474691|NCT00428948|79482182|FG000|Overall Study|Investigator Withdrew Subject|3|||
44226227|NCT01719380|79032529|FG002|Overall Study|Death|0|||
44273995|NCT02256540|79216055|FG001|Overall Study|Withdrawal by Subject|1|||
44273996|NCT02256540|79216056|FG002|Overall Study|Withdrawal by Subject|1|||
44375429|NCT00944034|79380595|FG010|Overall Study|Protocol Violation|0|||
44375430|NCT00944034|79380596|FG011|Overall Study|Protocol Violation|0|||
44375431|NCT00944034|79380585|FG000|Overall Study|Unable to classify|0|||
44474692|NCT00428948|79482183|FG001|Overall Study|Investigator Withdrew Subject|4|||
44474693|NCT00428948|79482182|FG000|Overall Study|Subject Withdrew Consent|50|||
44226228|NCT01719380|79032530|FG003|Overall Study|Death|0|||
44474694|NCT00428948|79482183|FG001|Overall Study|Subject Withdrew Consent|30|||
44474695|NCT00428948|79482182|FG000|Overall Study|Protocol Deviation|1|||
44226229|NCT01719380|79032531|FG004|Overall Study|Death|0|||
44375432|NCT00944034|79380586|FG001|Overall Study|Unable to classify|0|||
44375433|NCT00944034|79380587|FG002|Overall Study|Unable to classify|0|||
44474696|NCT00428948|79482183|FG001|Overall Study|Protocol Deviation|1|||
44474697|NCT00428792|79482191|FG000|Overall Study|Lack of Efficacy|1|||
44474698|NCT00428792|79482192|FG001|Overall Study|Lack of Efficacy|3|||
44474699|NCT00428792|79482191|FG000|Overall Study|Lost to Follow-up|0|||
44474700|NCT00428792|79482192|FG001|Overall Study|Lost to Follow-up|1|||
44474701|NCT00300885|79482200|FG000|Treatment|Adverse Event|134|||
44474702|NCT00300885|79482201|FG001|Treatment|Adverse Event|82|||
44474703|NCT00300885|79482200|FG000|Treatment|Death|20|||
44474704|NCT00300885|79482201|FG001|Treatment|Death|7|||
44474705|NCT00300885|79482200|FG000|Treatment|Lack of Efficacy|1|||
44474706|NCT00300885|79482201|FG001|Treatment|Lack of Efficacy|1|||
44474707|NCT00300885|79482200|FG000|Treatment|Lost to Follow-up|3|||
44474708|NCT00300885|79482201|FG001|Treatment|Lost to Follow-up|2|||
44474709|NCT00300885|79482200|FG000|Treatment|Physician Decision|4|||
44474710|NCT00300885|79482201|FG001|Treatment|Physician Decision|5|||
44474711|NCT00300885|79482200|FG000|Treatment|Protocol Violation|11|||
44474712|NCT00300885|79482201|FG001|Treatment|Protocol Violation|11|||
44474713|NCT00300885|79482200|FG000|Treatment|Withdrawal by Subject|26|||
44474714|NCT00300885|79482201|FG001|Treatment|Withdrawal by Subject|23|||
44474715|NCT00300885|79482200|FG000|Treatment|Disease progression|171|||
44474716|NCT00300885|79482201|FG001|Treatment|Disease progression|238|||
44474717|NCT00300885|79482200|FG000|Treatment|Random code broken (subject died)|0|||
44474718|NCT00300885|79482201|FG001|Treatment|Random code broken (subject died)|1|||
44474719|NCT00300885|79482200|FG000|Treatment|Non-compliant with study medication|3|||
44474720|NCT00300885|79482201|FG001|Treatment|Non-compliant with study medication|4|||
44474721|NCT00300885|79482200|FG000|Follow-up|Death|141|||
44474722|NCT00300885|79482201|FG001|Follow-up|Death|163|||
44474723|NCT00300885|79482200|FG000|Follow-up|Lost to Follow-up|11|||
44474724|NCT00300885|79482201|FG001|Follow-up|Lost to Follow-up|7|||
44474725|NCT00300885|79482200|FG000|Follow-up|Withdrawal by Subject|26|||
44474726|NCT00300885|79482201|FG001|Follow-up|Withdrawal by Subject|25|||
44474727|NCT00386334|79482209|FG000|Double Blind Period|Adverse Event|9|||
44474728|NCT00386334|79482210|FG001|Double Blind Period|Adverse Event|14|||
44474729|NCT00386334|79482209|FG000|Double Blind Period|Protocol Violation|1|||
44474730|NCT00386334|79482210|FG001|Double Blind Period|Protocol Violation|1|||
44474731|NCT00386334|79482209|FG000|Double Blind Period|Withdrawal by Subject|9|||
44474732|NCT00386334|79482210|FG001|Double Blind Period|Withdrawal by Subject|13|||
44474733|NCT00386334|79482209|FG000|Double Blind Period|Lack of Efficacy|20|||
44474734|NCT00386334|79482210|FG001|Double Blind Period|Lack of Efficacy|11|||
44474735|NCT00386334|79482209|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
44474736|NCT00386334|79482210|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
44474737|NCT00386334|79482209|FG000|Double Blind Period|Other|3|||
44474738|NCT00386334|79482210|FG001|Double Blind Period|Other|3|||
44474739|NCT00386334|79482209|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
44474740|NCT00386334|79482210|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
44474741|NCT00428714|79482227|FG000|Overall Study|Progressive Disease|28|||
44474742|NCT00428714|79482228|FG001|Overall Study|Progressive Disease|36|||
44474743|NCT00428714|79482227|FG000|Overall Study|Withdrawal by Subject|0|||
44474744|NCT00428714|79482228|FG001|Overall Study|Withdrawal by Subject|3|||
44474745|NCT00428714|79482227|FG000|Overall Study|Adverse Event|0|||
44474746|NCT00428714|79482228|FG001|Overall Study|Adverse Event|2|||
44474747|NCT00428714|79482227|FG000|Overall Study|Physician Decision|1|||
44474748|NCT00428714|79482228|FG001|Overall Study|Physician Decision|1|||
44474749|NCT00428714|79482227|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
44474750|NCT00428714|79482228|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
44474751|NCT00428714|79482227|FG000|Overall Study|Death due to other then PD|1|||
44474752|NCT00428714|79482228|FG001|Overall Study|Death due to other then PD|0|||
44474753|NCT00292227|79482237|FG000|Patch Period|Adverse Event|1|||
44474754|NCT00292227|79482238|FG001|Patch Period|Adverse Event|0|||
44474755|NCT00292227|79482239|FG002|Patch Period|Adverse Event|2|||
44474756|NCT00292227|79482237|FG000|Patch Period|Withdrawal by Subject|0|||
44474757|NCT00292227|79482238|FG001|Patch Period|Withdrawal by Subject|0|||
44474758|NCT00292227|79482239|FG002|Patch Period|Withdrawal by Subject|1|||
44474759|NCT00386100|79482249|FG000|Overall Study|Did not receive study medication|6|||
44474760|NCT00386100|79482250|FG001|Overall Study|Did not receive study medication|4|||
44474761|NCT00386100|79482249|FG000|Overall Study|Adverse Event|15|||
44474762|NCT00386100|79482250|FG001|Overall Study|Adverse Event|25|||
44474763|NCT00386100|79482249|FG000|Overall Study|Death|0|||
44474764|NCT00386100|79482250|FG001|Overall Study|Death|1|||
44474765|NCT00386100|79482249|FG000|Overall Study|Insufficient therapeutic effect|30|||
44474766|NCT00386100|79482250|FG001|Overall Study|Insufficient therapeutic effect|6|||
44474767|NCT00386100|79482249|FG000|Overall Study|Lost to Follow-up|29|||
44474768|NCT00386100|79482250|FG001|Overall Study|Lost to Follow-up|29|||
44474769|NCT00386100|79482249|FG000|Overall Study|Non-compliance|18|||
44474770|NCT00386100|79482250|FG001|Overall Study|Non-compliance|19|||
44474771|NCT00386100|79482249|FG000|Overall Study|Protocol Violation|5|||
44474772|NCT00386100|79482250|FG001|Overall Study|Protocol Violation|3|||
44474773|NCT00386100|79482249|FG000|Overall Study|Withdrawal by Subject|32|||
44474774|NCT00386100|79482250|FG001|Overall Study|Withdrawal by Subject|31|||
44474775|NCT00386100|79482249|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
44474776|NCT00386100|79482250|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
44474777|NCT00386100|79482249|FG000|Overall Study|BMD <2.5|1|||
44474778|NCT00386100|79482250|FG001|Overall Study|BMD <2.5|0|||
44474779|NCT00386100|79482249|FG000|Overall Study|Consecutive elevated Hba1C|1|||
44474780|NCT00386100|79482250|FG001|Overall Study|Consecutive elevated Hba1C|0|||
44474781|NCT00386100|79482249|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
44474782|NCT00386100|79482250|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
44474783|NCT00386100|79482249|FG000|Overall Study|Laboratory findings|1|||
44474784|NCT00386100|79482250|FG001|Overall Study|Laboratory findings|0|||
44474785|NCT00386100|79482249|FG000|Overall Study|Participant's concern due to CPK levels|1|||
44474786|NCT00386100|79482250|FG001|Overall Study|Participant's concern due to CPK levels|0|||
44474787|NCT00386100|79482249|FG000|Overall Study|Participant moving out of state|2|||
44474788|NCT00386100|79482250|FG001|Overall Study|Participant moving out of state|0|||
44474789|NCT00386100|79482249|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
44474790|NCT00386100|79482250|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
44474791|NCT00386100|79482249|FG000|Overall Study|Didn't meet entry criteria|1|||
44474792|NCT00386100|79482250|FG001|Overall Study|Didn't meet entry criteria|1|||
44474793|NCT00386100|79482249|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
44474794|NCT00386100|79482250|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
44474795|NCT00386100|79482249|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
44474796|NCT00386100|79482250|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
44474797|NCT00386100|79482249|FG000|Overall Study|Bad metabolic control & patient security|1|||
44474798|NCT00386100|79482250|FG001|Overall Study|Bad metabolic control & patient security|0|||
44474799|NCT00386100|79482249|FG000|Overall Study|Bone loss by DXA bone scan|1|||
44474800|NCT00386100|79482250|FG001|Overall Study|Bone loss by DXA bone scan|0|||
44474801|NCT00386100|79482249|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
44474802|NCT00386100|79482250|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
44474803|NCT00386100|79482249|FG000|Overall Study|7.6% bone loss|1|||
44474804|NCT00386100|79482250|FG001|Overall Study|7.6% bone loss|0|||
44474805|NCT00386100|79482249|FG000|Overall Study|Osteoporosis|0|||
44474806|NCT00386100|79482250|FG001|Overall Study|Osteoporosis|1|||
44474807|NCT00386100|79482249|FG000|Overall Study|Positive pregnancy test|1|||
44474808|NCT00386100|79482250|FG001|Overall Study|Positive pregnancy test|3|||
44474809|NCT00386100|79482249|FG000|Overall Study|Out of country for 5 months|1|||
44474810|NCT00386100|79482250|FG001|Overall Study|Out of country for 5 months|0|||
44474811|NCT00386100|79482249|FG000|Overall Study|Hb1Ac >8%|0|||
44474812|NCT00386100|79482250|FG001|Overall Study|Hb1Ac >8%|1|||
44474813|NCT00386100|79482249|FG000|Overall Study|Participant randomized in error|1|||
44474814|NCT00386100|79482250|FG001|Overall Study|Participant randomized in error|0|||
44474815|NCT00300495|79482258|FG000|Overall Study|Protocol Violation|4|||
44474816|NCT00300495|79482259|FG001|Overall Study|Protocol Violation|1|||
44474817|NCT00386022|79482267|FG000|Plus Estrogen|Lost to Follow-up|2|||
44474818|NCT00386022|79482268|FG001|Plus Estrogen|Lost to Follow-up|0|||
44474819|NCT00386022|79482267|FG000|Plus Estrogen|Adverse Event|0|||
44474820|NCT00386022|79482268|FG001|Plus Estrogen|Adverse Event|1|||
44474821|NCT00286455|79482279|FG000|Overall Study|Hyperglycemia rescue|19|||
44474822|NCT00286455|79482280|FG001|Overall Study|Hyperglycemia rescue|13|||
44474823|NCT00286455|79482281|FG002|Overall Study|Hyperglycemia rescue|10|||
44474824|NCT00286455|79482279|FG000|Overall Study|Adverse Event|1|||
44474825|NCT00286455|79482280|FG001|Overall Study|Adverse Event|3|||
44474826|NCT00286455|79482281|FG002|Overall Study|Adverse Event|2|||
44474827|NCT00286455|79482279|FG000|Overall Study|Lost to Follow-up|0|||
44474828|NCT00286455|79482280|FG001|Overall Study|Lost to Follow-up|3|||
44474829|NCT00286455|79482281|FG002|Overall Study|Lost to Follow-up|3|||
44474830|NCT00286455|79482279|FG000|Overall Study|Physician Decision|3|||
44474831|NCT00286455|79482280|FG001|Overall Study|Physician Decision|0|||
44474832|NCT00286455|79482281|FG002|Overall Study|Physician Decision|2|||
44474833|NCT00286455|79482279|FG000|Overall Study|Protocol Violation|1|||
44474834|NCT00286455|79482280|FG001|Overall Study|Protocol Violation|1|||
44474835|NCT00286455|79482281|FG002|Overall Study|Protocol Violation|0|||
44474836|NCT00286455|79482279|FG000|Overall Study|Participant Non-compliance|1|||
44474837|NCT00286455|79482280|FG001|Overall Study|Participant Non-compliance|0|||
44474838|NCT00286455|79482281|FG002|Overall Study|Participant Non-compliance|0|||
44474839|NCT00286455|79482279|FG000|Overall Study|Withdrawal by Subject|0|||
44226230|NCT01719380|79032532|FG005|Overall Study|Death|0|||
44226231|NCT01719380|79032533|FG006|Overall Study|Death|0|||
44474840|NCT00286455|79482280|FG001|Overall Study|Withdrawal by Subject|8|||
44474841|NCT00286455|79482281|FG002|Overall Study|Withdrawal by Subject|7|||
44474842|NCT00385944|79482291|FG000|1st Maintenance Dose Period|Physician Decision|1|||
44474843|NCT00385944|79482292|FG001|1st Maintenance Dose Period|Physician Decision|0|||
44474844|NCT00385944|79482293|FG002|1st Maintenance Dose Period|Physician Decision|0|||
44474845|NCT00385944|79482291|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
44474846|NCT00385944|79482292|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
44474847|NCT00385944|79482293|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
44474848|NCT00385944|79482291|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
44474849|NCT00385944|79482292|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
44474850|NCT00385944|79482293|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
44474851|NCT00385944|79482291|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
44474852|NCT00385944|79482292|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
44474853|NCT00385944|79482293|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
44474854|NCT00286221|79482312|FG000|Overall Study|Protocol Violation|2|||
44474855|NCT00286221|79482313|FG001|Overall Study|Protocol Violation|1|||
44474856|NCT00286221|79482314|FG002|Overall Study|Protocol Violation|6|||
44474857|NCT00286221|79482315|FG003|Overall Study|Protocol Violation|4|||
44474858|NCT00286221|79482312|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
44474859|NCT00286221|79482313|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
44474860|NCT00286221|79482314|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
44474861|NCT00286221|79482315|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
44474862|NCT00286221|79482312|FG000|Overall Study|Inability to trigger PCA|2|||
44474863|NCT00286221|79482313|FG001|Overall Study|Inability to trigger PCA|0|||
44474864|NCT00286221|79482314|FG002|Overall Study|Inability to trigger PCA|0|||
44474865|NCT00286221|79482315|FG003|Overall Study|Inability to trigger PCA|0|||
44474866|NCT00286221|79482312|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
44474867|NCT00286221|79482313|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
44474868|NCT00286221|79482314|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
44474869|NCT00286221|79482315|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
44474870|NCT00285207|79482327|FG000|Overall Study|Lost to Follow-up|3|||
44474871|NCT00285207|79482328|FG001|Overall Study|Lost to Follow-up|2|||
44474872|NCT00285207|79482327|FG000|Overall Study|Withdrawal by Subject|5|||
44474873|NCT00285207|79482328|FG001|Overall Study|Withdrawal by Subject|2|||
44474874|NCT00285207|79482327|FG000|Overall Study|Pregnancy|1|||
44474875|NCT00285207|79482328|FG001|Overall Study|Pregnancy|1|||
44474876|NCT00285207|79482327|FG000|Overall Study|non-compliance|0|||
44474877|NCT00285207|79482328|FG001|Overall Study|non-compliance|1|||
44474878|NCT00398112|79482334|FG000|Overall Study|Adverse Event|4|||
44474879|NCT00398112|79482334|FG000|Overall Study|Disease progression|9|||
44474880|NCT00398112|79482334|FG000|Overall Study|Alternative treatment|1|||
44474881|NCT00398112|79482334|FG000|Overall Study|Withdrawal by Subject|3|||
44474882|NCT00398112|79482334|FG000|Overall Study|Death|1|||
44474883|NCT00424346|79482342|FG000|Core Study|Adverse Event|5|||
44474884|NCT00424346|79482343|FG001|Core Study|Adverse Event|3|||
44474885|NCT00424346|79482344|FG002|Core Study|Adverse Event|1|||
44474886|NCT00424346|79482345|FG003|Core Study|Adverse Event|1|||
44474887|NCT00424346|79482342|FG000|Core Study|Abnormal Laboratory Values|0|||
44474888|NCT00424346|79482343|FG001|Core Study|Abnormal Laboratory Values|1|||
44375434|NCT00944034|79380588|FG003|Overall Study|Unable to classify|0|||
44375435|NCT00944034|79380589|FG004|Overall Study|Unable to classify|0|||
44375436|NCT00944034|79380590|FG005|Overall Study|Unable to classify|1|||
44375437|NCT00944034|79380591|FG006|Overall Study|Unable to classify|1|||
44375438|NCT00944034|79380592|FG007|Overall Study|Unable to classify|1|||
44375439|NCT00944034|79380593|FG008|Overall Study|Unable to classify|0|||
44375440|NCT00944034|79380594|FG009|Overall Study|Unable to classify|0|||
44375441|NCT00944034|79380595|FG010|Overall Study|Unable to classify|0|||
44375442|NCT00944034|79380596|FG011|Overall Study|Unable to classify|0|||
44375443|NCT00944034|79380585|FG000|Overall Study|Administrative reason|0|||
44375444|NCT00944034|79380586|FG001|Overall Study|Administrative reason|0|||
44375445|NCT00944034|79380587|FG002|Overall Study|Administrative reason|0|||
44375446|NCT00944034|79380588|FG003|Overall Study|Administrative reason|0|||
44375447|NCT00944034|79380589|FG004|Overall Study|Administrative reason|0|||
44375448|NCT00944034|79380590|FG005|Overall Study|Administrative reason|0|||
44375449|NCT00944034|79380591|FG006|Overall Study|Administrative reason|1|||
44375450|NCT00944034|79380592|FG007|Overall Study|Administrative reason|0|||
44375451|NCT00944034|79380593|FG008|Overall Study|Administrative reason|0|||
44375452|NCT00944034|79380594|FG009|Overall Study|Administrative reason|0|||
44375453|NCT00944034|79380595|FG010|Overall Study|Administrative reason|0|||
44375454|NCT00944034|79380596|FG011|Overall Study|Administrative reason|0|||
44375455|NCT00941304|79380644|FG000|Overall Study|Lost to Follow-up|1|||
44375456|NCT00941304|79380645|FG001|Overall Study|Lost to Follow-up|0|||
44375457|NCT00941304|79380646|FG002|Overall Study|Lost to Follow-up|0|||
44375458|NCT00941304|79380647|FG003|Overall Study|Lost to Follow-up|0|||
44375459|NCT00941304|79380648|FG004|Overall Study|Lost to Follow-up|0|||
44544554|NCT03192306|79558066|FG001|Overall Study|Withdrawal by Subject|1|||
44375460|NCT00941070|79380660|FG000|Overall Study|Patient non-compliant|1|||
44375461|NCT01098812|79380669|FG000|Overall Study|Death|2|||
44474889|NCT00424346|79482344|FG002|Core Study|Abnormal Laboratory Values|0|||
44474890|NCT00424346|79482345|FG003|Core Study|Abnormal Laboratory Values|0|||
44474891|NCT00424346|79482342|FG000|Core Study|Lack of Efficacy|1|||
44474892|NCT00424346|79482343|FG001|Core Study|Lack of Efficacy|3|||
44474893|NCT00424346|79482344|FG002|Core Study|Lack of Efficacy|0|||
44474894|NCT00424346|79482345|FG003|Core Study|Lack of Efficacy|4|||
44474895|NCT00424346|79482342|FG000|Core Study|Withdrawal by Subject|1|||
44474896|NCT00424346|79482343|FG001|Core Study|Withdrawal by Subject|0|||
44474897|NCT00424346|79482344|FG002|Core Study|Withdrawal by Subject|0|||
44474898|NCT00424346|79482345|FG003|Core Study|Withdrawal by Subject|2|||
44474899|NCT00424346|79482342|FG000|Core Study|Lost to Follow-up|1|||
44474900|NCT00424346|79482343|FG001|Core Study|Lost to Follow-up|1|||
44474901|NCT00424346|79482344|FG002|Core Study|Lost to Follow-up|0|||
44474902|NCT00424346|79482345|FG003|Core Study|Lost to Follow-up|0|||
44474903|NCT00424346|79482342|FG000|Core Study|Administrative Problems|1|||
44474904|NCT00424346|79482343|FG001|Core Study|Administrative Problems|0|||
44474905|NCT00424346|79482344|FG002|Core Study|Administrative Problems|1|||
44474906|NCT00424346|79482345|FG003|Core Study|Administrative Problems|0|||
44474907|NCT00424346|79482342|FG000|Core Study|Protocol Violation|0|||
44474908|NCT00424346|79482343|FG001|Core Study|Protocol Violation|0|||
44474909|NCT00424346|79482344|FG002|Core Study|Protocol Violation|2|||
44474910|NCT00424346|79482345|FG003|Core Study|Protocol Violation|0|||
44474911|NCT00424346|79482342|FG000|Extension Phase|Adverse Event|0|||
44474912|NCT00424346|79482343|FG001|Extension Phase|Adverse Event|9|||
44474913|NCT00424346|79482344|FG002|Extension Phase|Adverse Event|5|||
44474914|NCT00424346|79482345|FG003|Extension Phase|Adverse Event|4|||
44474915|NCT00424346|79482342|FG000|Extension Phase|Lack of Efficacy|0|||
44474916|NCT00424346|79482343|FG001|Extension Phase|Lack of Efficacy|16|||
44474917|NCT00424346|79482344|FG002|Extension Phase|Lack of Efficacy|14|||
44474918|NCT00424346|79482345|FG003|Extension Phase|Lack of Efficacy|11|||
44474919|NCT00424346|79482342|FG000|Extension Phase|Withdrawal by Subject|0|||
44474920|NCT00424346|79482343|FG001|Extension Phase|Withdrawal by Subject|5|||
44474921|NCT00424346|79482344|FG002|Extension Phase|Withdrawal by Subject|3|||
44474922|NCT00424346|79482345|FG003|Extension Phase|Withdrawal by Subject|4|||
44474923|NCT00424346|79482342|FG000|Extension Phase|Lost to Follow-up|0|||
44474924|NCT00424346|79482343|FG001|Extension Phase|Lost to Follow-up|2|||
44474925|NCT00424346|79482344|FG002|Extension Phase|Lost to Follow-up|0|||
44474926|NCT00424346|79482345|FG003|Extension Phase|Lost to Follow-up|0|||
44474927|NCT00424346|79482342|FG000|Extension Phase|Administrative Problems|0|||
44474928|NCT00424346|79482343|FG001|Extension Phase|Administrative Problems|69|||
44474929|NCT00424346|79482344|FG002|Extension Phase|Administrative Problems|32|||
44474930|NCT00424346|79482345|FG003|Extension Phase|Administrative Problems|35|||
44474931|NCT00424346|79482342|FG000|Extension Phase|Death|0|||
44474932|NCT00424346|79482343|FG001|Extension Phase|Death|0|||
44474933|NCT00424346|79482344|FG002|Extension Phase|Death|0|||
44474934|NCT00424346|79482345|FG003|Extension Phase|Death|1|||
44474935|NCT00424346|79482342|FG000|Extension Phase|Protocol Violation|0|||
44474936|NCT00424346|79482343|FG001|Extension Phase|Protocol Violation|1|||
44474937|NCT00424346|79482344|FG002|Extension Phase|Protocol Violation|1|||
44474938|NCT00424346|79482345|FG003|Extension Phase|Protocol Violation|0|||
44474939|NCT00283959|79482358|FG000|Extension Period|Low Compliance|1|||
44474940|NCT00372528|79482362|FG000|Overall Study|Lack of Efficacy|1|||
44474941|NCT00372528|79482362|FG000|Overall Study|Adverse Event|1|||
44474942|NCT00372528|79482362|FG000|Overall Study|Study Terminated by Sponsor|18|||
44474943|NCT00372528|79482362|FG000|Overall Study|Other|1|||
44474944|NCT00283803|79482366|FG000|Overall Study|Physician Decision|9|||
44474945|NCT00283803|79482366|FG000|Overall Study|Withdrawal by Subject|4|||
44474946|NCT00397488|79482370|FG000|Overall Study|Withdrawal by Subject|3|||
44474947|NCT00397488|79482370|FG000|Overall Study|Adverse Event|3|||
44474948|NCT00397488|79482370|FG000|Overall Study|Death|1|||
44474949|NCT00424190|79482376|FG000|Overall Study|Withdrew consent|3|||
44474950|NCT00424190|79482377|FG001|Overall Study|Withdrew consent|4|||
44474951|NCT00424190|79482376|FG000|Overall Study|Death|3|||
44474952|NCT00424190|79482377|FG001|Overall Study|Death|0|||
44474953|NCT00424190|79482376|FG000|Overall Study|Noncompliance|1|||
44474954|NCT00424190|79482377|FG001|Overall Study|Noncompliance|2|||
44474955|NCT00424190|79482376|FG000|Overall Study|Request of sponsor or investigator|0|||
44474956|NCT00424190|79482377|FG001|Overall Study|Request of sponsor or investigator|2|||
44474957|NCT00424190|79482376|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
44474958|NCT00424190|79482377|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
44474959|NCT00424190|79482376|FG000|Overall Study|Other|15|||
44474960|NCT00424190|79482377|FG001|Overall Study|Other|21|||
44474961|NCT00428246|79482386|FG000|Overall Study|Withdrawal by Subject|0|||
44474962|NCT00428246|79482387|FG001|Overall Study|Withdrawal by Subject|0|||
44474963|NCT00428246|79482388|FG002|Overall Study|Withdrawal by Subject|1|||
44474964|NCT00428246|79482386|FG000|Overall Study|Adverse Event|1|||
44474965|NCT00428246|79482387|FG001|Overall Study|Adverse Event|0|||
44474966|NCT00428246|79482388|FG002|Overall Study|Adverse Event|0|||
44474967|NCT00274287|79482396|FG000|Overall Study|Withdrawal by Subject|1|||
44474968|NCT00274287|79482396|FG000|Overall Study|subject non-compliance|1|||
44474969|NCT00423800|79482403|FG000|Overall Study|Protocol Violation|0|||
44474970|NCT00423800|79482404|FG001|Overall Study|Protocol Violation|1|||
44544555|NCT03192306|79558065|FG000|Overall Study|Lost to Follow-up|1|||
44474971|NCT00405548|79482413|FG000|Overall Study|Cognitive Memory problems on study day|1|||
44474972|NCT00405548|79482414|FG001|Overall Study|Cognitive Memory problems on study day|0|||
44474973|NCT00405548|79482413|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
44474974|NCT00405548|79482414|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
44544556|NCT03192306|79558066|FG001|Overall Study|Lost to Follow-up|0|||
44474975|NCT00405548|79482413|FG000|Overall Study|Unable to self-administer shots|1|||
44474976|NCT00405548|79482414|FG001|Overall Study|Unable to self-administer shots|0|||
44474977|NCT00405548|79482413|FG000|Overall Study|Venous access failed during study day|1|||
44474978|NCT00405548|79482414|FG001|Overall Study|Venous access failed during study day|0|||
44474979|NCT00405548|79482413|FG000|Overall Study|Withdrawal by Subject|1|||
44474980|NCT00405548|79482414|FG001|Overall Study|Withdrawal by Subject|0|||
44474981|NCT00405392|79482422|FG000|Overall Study|Adverse Event|15|||
44474982|NCT00405392|79482423|FG001|Overall Study|Adverse Event|14|||
44474983|NCT00405392|79482422|FG000|Overall Study|Did not meet Eligibility criteria|7|||
44474984|NCT00405392|79482423|FG001|Overall Study|Did not meet Eligibility criteria|2|||
44474985|NCT00405392|79482422|FG000|Overall Study|Withdrawal by Subject|4|||
44474986|NCT00405392|79482423|FG001|Overall Study|Withdrawal by Subject|3|||
44474987|NCT00405392|79482422|FG000|Overall Study|Lost to Follow-up|1|||
44474988|NCT00405392|79482423|FG001|Overall Study|Lost to Follow-up|2|||
44474989|NCT00405392|79482422|FG000|Overall Study|Data missing|2|||
44474990|NCT00405392|79482423|FG001|Overall Study|Data missing|0|||
44474991|NCT00405392|79482422|FG000|Overall Study|Non-compliance|0|||
44474992|NCT00405392|79482423|FG001|Overall Study|Non-compliance|1|||
44474993|NCT00405392|79482422|FG000|Overall Study|Other|1|||
44474994|NCT00405392|79482423|FG001|Overall Study|Other|5|||
44474995|NCT00282243|79482429|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
44474996|NCT00282243|79482429|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
44474997|NCT00282243|79482429|FG000|Extension Treatment Period|Adverse Event|15|||
44474998|NCT00282243|79482429|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
44474999|NCT00282243|79482429|FG000|Extension Treatment Period|Non-compliance|2|||
44475000|NCT00282243|79482429|FG000|Extension Treatment Period|Physician Decision|1|||
44475001|NCT00272961|79482438|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
44475002|NCT00272961|79482439|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
44475003|NCT00272961|79482440|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
44475004|NCT00272961|79482441|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
44475005|NCT00272961|79482442|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
44475006|NCT00272961|79482438|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
44475007|NCT00272961|79482439|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
44475008|NCT00272961|79482440|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
44475009|NCT00272961|79482441|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
44475010|NCT00272961|79482442|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
44475011|NCT00272961|79482438|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
44475012|NCT00272961|79482439|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
44475013|NCT00272961|79482440|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
44475014|NCT00272961|79482441|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
44475015|NCT00272961|79482442|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
44475016|NCT00272961|79482438|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
44475017|NCT00272961|79482439|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
44475018|NCT00272961|79482440|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
44475019|NCT00272961|79482441|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
44475020|NCT00272961|79482442|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
44475021|NCT00272961|79482438|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
44475022|NCT00272961|79482439|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
44475023|NCT00272961|79482440|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
44475024|NCT00272961|79482441|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
44475025|NCT00272961|79482442|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
44475026|NCT00272961|79482438|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
44375462|NCT01098812|79380670|FG001|Overall Study|Death|0|||
44375463|NCT01098812|79380671|FG002|Overall Study|Death|1|||
44375464|NCT01098812|79380669|FG000|Overall Study|Lost to Follow-up|0|||
44375465|NCT01098812|79380670|FG001|Overall Study|Lost to Follow-up|1|||
44375466|NCT01098812|79380671|FG002|Overall Study|Lost to Follow-up|0|||
44375467|NCT00903201|79380681|FG000|Overall Study|Adverse Event|1|||
44375468|NCT00903201|79380682|FG001|Overall Study|Adverse Event|4|||
44375469|NCT00903201|79380683|FG002|Overall Study|Adverse Event|0|||
44375470|NCT00903201|79380681|FG000|Overall Study|Protocol Violation|2|||
44375471|NCT00903201|79380682|FG001|Overall Study|Protocol Violation|1|||
44475027|NCT00272961|79482439|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
44475028|NCT00272961|79482440|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
44544557|NCT03192306|79558065|FG000|Overall Study|Protocol Violation|1|||
44544558|NCT03192306|79558066|FG001|Overall Study|Protocol Violation|1|||
44544559|NCT03216954|79558089|FG000|Overall Study|Adverse Event|0|||
44375472|NCT00903201|79380683|FG002|Overall Study|Protocol Violation|0|||
44375473|NCT00903201|79380681|FG000|Overall Study|Lost to Follow-up|0|||
44375474|NCT00903201|79380682|FG001|Overall Study|Lost to Follow-up|1|||
44375475|NCT00903201|79380683|FG002|Overall Study|Lost to Follow-up|0|||
44375476|NCT00903201|79380681|FG000|Overall Study|Physician Decision|1|||
44475029|NCT00272961|79482441|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
44475030|NCT00272961|79482442|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
44475031|NCT00272961|79482438|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
44475032|NCT00272961|79482439|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
44475033|NCT00272961|79482440|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
44475034|NCT00272961|79482441|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
44475035|NCT00272961|79482442|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
44475036|NCT00272961|79482438|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
44475037|NCT00272961|79482439|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
44475038|NCT00272961|79482440|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
44475039|NCT00272961|79482441|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
44475040|NCT00272961|79482442|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
44475041|NCT00282087|79482454|FG000|Overall Study|Death|1|||
44475042|NCT00404924|79482461|FG000|Overall Study|Adverse Event|75|||
44475043|NCT00404924|79482462|FG001|Overall Study|Adverse Event|16|||
44475044|NCT00404924|79482461|FG000|Overall Study|Condition under investigation worsened|475|||
44475045|NCT00404924|79482462|FG001|Overall Study|Condition under investigation worsened|264|||
44475046|NCT00404924|79482461|FG000|Overall Study|Lost to Follow-up|1|||
44475047|NCT00404924|79482462|FG001|Overall Study|Lost to Follow-up|1|||
44475048|NCT00404924|79482461|FG000|Overall Study|Withdrawal by Subject|26|||
44475049|NCT00404924|79482462|FG001|Overall Study|Withdrawal by Subject|13|||
44475050|NCT00404924|79482461|FG000|Overall Study|Other|25|||
44475051|NCT00404924|79482462|FG001|Overall Study|Other|11|||
44475052|NCT00404924|79482461|FG000|Overall Study|Randomised but not received treatment|1|||
44475053|NCT00404924|79482462|FG001|Overall Study|Randomised but not received treatment|1|||
44475054|NCT00281697|79482470|FG000|Overall Study|> 60 days since last dose of study drug|4|||
44475055|NCT00281697|79482471|FG001|Overall Study|> 60 days since last dose of study drug|4|||
44475056|NCT00281697|79482470|FG000|Overall Study|Adverse Event|54|||
44475057|NCT00281697|79482471|FG001|Overall Study|Adverse Event|15|||
44475058|NCT00281697|79482470|FG000|Overall Study|Death|8|||
44475059|NCT00281697|79482471|FG001|Overall Study|Death|3|||
44475060|NCT00281697|79482470|FG000|Overall Study|Disease progression|279|||
44475061|NCT00281697|79482471|FG001|Overall Study|Disease progression|149|||
44475062|NCT00281697|79482470|FG000|Overall Study|Other|5|||
44475063|NCT00281697|79482471|FG001|Overall Study|Other|6|||
44375477|NCT00903201|79380682|FG001|Overall Study|Physician Decision|0|||
44375478|NCT00903201|79380683|FG002|Overall Study|Physician Decision|1|||
44475064|NCT00281697|79482470|FG000|Overall Study|Physician's decision to withdraw|15|||
44475065|NCT00281697|79482471|FG001|Overall Study|Physician's decision to withdraw|12|||
44475066|NCT00281697|79482470|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
44475067|NCT00281697|79482471|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
44475068|NCT00281697|79482470|FG000|Overall Study|Did not receive study drug|3|||
44475069|NCT00281697|79482471|FG001|Overall Study|Did not receive study drug|2|||
44475070|NCT00271947|79482477|FG000|Overall Study|Lost to Follow-up|1|||
44475071|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Death|186|||
44475072|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Death|222|||
44475073|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Death|0|||
44475074|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
44475075|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
44475076|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
44475077|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
44475078|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
44475079|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
44475080|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
44475081|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
44475082|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
44475083|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Adverse Event|83|||
44475084|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Adverse Event|100|||
44475085|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Adverse Event|0|||
44475086|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Other|70|||
44475087|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Other|75|||
44475088|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Other|0|||
44475089|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
44475090|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
44475091|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
44475092|NCT00232180|79482483|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
44544560|NCT03216954|79558090|FG001|Overall Study|Adverse Event|0|||
44475093|NCT00232180|79482484|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
44544561|NCT03216954|79558091|FG002|Overall Study|Adverse Event|1|||
44544562|NCT03216954|79558092|FG003|Overall Study|Adverse Event|0|||
44375479|NCT00903201|79380681|FG000|Overall Study|Withdrawal by Subject|1|||
44475094|NCT00232180|79482485|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
44475095|NCT00232180|79482483|FG000|Open Label Phase|Death|0|||
44475096|NCT00232180|79482484|FG001|Open Label Phase|Death|0|||
44475097|NCT00232180|79482485|FG002|Open Label Phase|Death|48|||
44475098|NCT00232180|79482483|FG000|Open Label Phase|Lost to Follow-up|0|||
44475099|NCT00232180|79482484|FG001|Open Label Phase|Lost to Follow-up|0|||
44475100|NCT00232180|79482485|FG002|Open Label Phase|Lost to Follow-up|5|||
44475101|NCT00232180|79482483|FG000|Open Label Phase|Protocol Violation|0|||
44475102|NCT00232180|79482484|FG001|Open Label Phase|Protocol Violation|0|||
44475103|NCT00232180|79482485|FG002|Open Label Phase|Protocol Violation|3|||
44475104|NCT00232180|79482483|FG000|Open Label Phase|Study terminated by sponsor|0|||
44475105|NCT00232180|79482484|FG001|Open Label Phase|Study terminated by sponsor|0|||
44475106|NCT00232180|79482485|FG002|Open Label Phase|Study terminated by sponsor|3|||
44475107|NCT00232180|79482483|FG000|Open Label Phase|Withdrawal by Subject|0|||
44475108|NCT00232180|79482484|FG001|Open Label Phase|Withdrawal by Subject|0|||
44475109|NCT00232180|79482485|FG002|Open Label Phase|Withdrawal by Subject|37|||
44475110|NCT00232180|79482483|FG000|Open Label Phase|Other|0|||
44475111|NCT00232180|79482484|FG001|Open Label Phase|Other|0|||
44475112|NCT00232180|79482485|FG002|Open Label Phase|Other|16|||
44475113|NCT00232180|79482483|FG000|Open Label Phase|Adverse Event|0|||
44475114|NCT00232180|79482484|FG001|Open Label Phase|Adverse Event|0|||
44475115|NCT00232180|79482485|FG002|Open Label Phase|Adverse Event|25|||
44475116|NCT00232180|79482483|FG000|Open Label Phase|Laboratory abnormality|0|||
44475117|NCT00232180|79482484|FG001|Open Label Phase|Laboratory abnormality|0|||
44475118|NCT00232180|79482485|FG002|Open Label Phase|Laboratory abnormality|10|||
44475119|NCT00232180|79482483|FG000|Open Label Phase|Randomized but not treated|0|||
44475120|NCT00232180|79482484|FG001|Open Label Phase|Randomized but not treated|0|||
44475121|NCT00232180|79482485|FG002|Open Label Phase|Randomized but not treated|1|||
44475122|NCT00280683|79482496|FG000|Overall Study|Withdrawal by Subject|1|||
44475123|NCT00280683|79482497|FG001|Overall Study|Withdrawal by Subject|2|||
44475124|NCT00280683|79482496|FG000|Overall Study|Adverse Event|1|||
44475125|NCT00280683|79482497|FG001|Overall Study|Adverse Event|1|||
44475126|NCT00270855|79482507|FG000|Overall Study|Withdrawal by Subject|8|||
44475127|NCT00270855|79482508|FG001|Overall Study|Withdrawal by Subject|8|||
44475128|NCT00404768|79482520|FG000|Part A and B|Withdrawn due to labor progression|1|||
44475129|NCT00404768|79482521|FG001|Part A and B|Withdrawn due to labor progression|0|||
44475130|NCT00404768|79482522|FG002|Part A and B|Withdrawn due to labor progression|0|||
44475131|NCT00404768|79482523|FG003|Part A and B|Withdrawn due to labor progression|0|||
44475132|NCT00404768|79482520|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
44475133|NCT00404768|79482521|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
44475134|NCT00404768|79482522|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
44475135|NCT00404768|79482523|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
44475136|NCT00404768|79482520|FG000|Part C|Adverse Event|0|||
44475137|NCT00404768|79482521|FG001|Part C|Adverse Event|0|||
44475138|NCT00404768|79482522|FG002|Part C|Adverse Event|0|||
44475139|NCT00404768|79482523|FG003|Part C|Adverse Event|3|||
44475140|NCT00404768|79482520|FG000|Part C|Lost to Follow-up|0|||
44475141|NCT00404768|79482521|FG001|Part C|Lost to Follow-up|0|||
44475142|NCT00404768|79482522|FG002|Part C|Lost to Follow-up|3|||
44475143|NCT00404768|79482523|FG003|Part C|Lost to Follow-up|1|||
44475144|NCT00404768|79482520|FG000|Part C|Withdrawal by Subject|0|||
44475145|NCT00404768|79482521|FG001|Part C|Withdrawal by Subject|0|||
44475146|NCT00404768|79482522|FG002|Part C|Withdrawal by Subject|2|||
44475147|NCT00404768|79482523|FG003|Part C|Withdrawal by Subject|1|||
44475148|NCT00404768|79482520|FG000|Part C|Early withdrawal from study medication|0|||
44475149|NCT00404768|79482521|FG001|Part C|Early withdrawal from study medication|0|||
44475150|NCT00404768|79482522|FG002|Part C|Early withdrawal from study medication|1|||
44475151|NCT00404768|79482523|FG003|Part C|Early withdrawal from study medication|0|||
44475152|NCT00404768|79482520|FG000|Part C|Participant did not respond to therapy|0|||
44475153|NCT00404768|79482521|FG001|Part C|Participant did not respond to therapy|0|||
44475154|NCT00404768|79482522|FG002|Part C|Participant did not respond to therapy|1|||
44475155|NCT00404768|79482523|FG003|Part C|Participant did not respond to therapy|1|||
44475156|NCT00404768|79482520|FG000|Part C|Physician withdrew the study medication|0|||
44475157|NCT00404768|79482521|FG001|Part C|Physician withdrew the study medication|0|||
44475158|NCT00404768|79482522|FG002|Part C|Physician withdrew the study medication|1|||
44475159|NCT00404768|79482523|FG003|Part C|Physician withdrew the study medication|0|||
44475160|NCT00404768|79482520|FG000|Part C|Participant delivered baby|0|||
44475161|NCT00404768|79482521|FG001|Part C|Participant delivered baby|0|||
44475162|NCT00404768|79482522|FG002|Part C|Participant delivered baby|0|||
44475163|NCT00404768|79482523|FG003|Part C|Participant delivered baby|1|||
44475164|NCT00404768|79482520|FG000|Part C|Unsatisfactory uterine response to IP|0|||
44475165|NCT00404768|79482521|FG001|Part C|Unsatisfactory uterine response to IP|0|||
44475166|NCT00404768|79482522|FG002|Part C|Unsatisfactory uterine response to IP|0|||
44475167|NCT00404768|79482523|FG003|Part C|Unsatisfactory uterine response to IP|1|||
44475168|NCT00404768|79482520|FG000|Part C|Active labor|0|||
44475169|NCT00404768|79482521|FG001|Part C|Active labor|0|||
44475170|NCT00404768|79482522|FG002|Part C|Active labor|0|||
44475171|NCT00404768|79482523|FG003|Part C|Active labor|1|||
44475172|NCT00404768|79482520|FG000|Part C|Lack of Efficacy|0|||
44475173|NCT00404768|79482521|FG001|Part C|Lack of Efficacy|0|||
44475174|NCT00404768|79482522|FG002|Part C|Lack of Efficacy|0|||
44475175|NCT00404768|79482523|FG003|Part C|Lack of Efficacy|2|||
44475176|NCT00404768|79482520|FG000|Part C|Treatment failure|0|||
44475177|NCT00404768|79482521|FG001|Part C|Treatment failure|0|||
44475178|NCT00404768|79482522|FG002|Part C|Treatment failure|0|||
44475179|NCT00404768|79482523|FG003|Part C|Treatment failure|1|||
44475180|NCT00404768|79482520|FG000|Part C|Investigator discretion|0|||
44475181|NCT00404768|79482521|FG001|Part C|Investigator discretion|0|||
44475182|NCT00404768|79482522|FG002|Part C|Investigator discretion|0|||
44475183|NCT00404768|79482523|FG003|Part C|Investigator discretion|1|||
44475184|NCT00404768|79482520|FG000|Part C|Researcher suspended study medication|0|||
44475185|NCT00404768|79482521|FG001|Part C|Researcher suspended study medication|0|||
44475186|NCT00404768|79482522|FG002|Part C|Researcher suspended study medication|0|||
44475187|NCT00404768|79482523|FG003|Part C|Researcher suspended study medication|1|||
44475188|NCT00270231|79482538|FG000|First Intervention|Lost to Follow-up|1|||
44475189|NCT00270231|79482539|FG001|First Intervention|Lost to Follow-up|1|||
44475190|NCT00270231|79482538|FG000|Washout Period|Lost to Follow-up|1|||
44475191|NCT00270231|79482539|FG001|Washout Period|Lost to Follow-up|0|||
44475192|NCT00270231|79482538|FG000|Second Intervention|Lost to Follow-up|0|||
44475193|NCT00270231|79482539|FG001|Second Intervention|Lost to Follow-up|1|||
44475194|NCT00258856|79482549|FG000|Overall Study|Lost to Follow-up|1|||
44475195|NCT00258856|79482550|FG001|Overall Study|Lost to Follow-up|0|||
44475196|NCT00258856|79482551|FG002|Overall Study|Lost to Follow-up|2|||
44475197|NCT00258856|79482552|FG003|Overall Study|Lost to Follow-up|0|||
44475198|NCT00258856|79482549|FG000|Overall Study|Non-compliance|2|||
44226232|NCT01719380|79032534|FG007|Overall Study|Death|0|||
44226233|NCT01719380|79032535|FG008|Overall Study|Death|3|||
44226234|NCT01719380|79032536|FG009|Overall Study|Death|3|||
44226235|NCT01719380|79032527|FG000|Overall Study|Participant/Guardian Decision|0|||
44226236|NCT01719380|79032528|FG001|Overall Study|Participant/Guardian Decision|0|||
44475199|NCT00258856|79482550|FG001|Overall Study|Non-compliance|0|||
44475200|NCT00258856|79482551|FG002|Overall Study|Non-compliance|0|||
44475201|NCT00258856|79482552|FG003|Overall Study|Non-compliance|1|||
44475202|NCT00269919|79482562|FG000|Overall Study|Other|26|||
44475203|NCT00269919|79482562|FG000|Overall Study|Started but not treated|1|||
44475204|NCT00258154|79482569|FG000|Overall Study|Adverse Event|1|||
44475205|NCT00258154|79482570|FG001|Overall Study|Adverse Event|0|||
44475206|NCT00258154|79482569|FG000|Overall Study|Lost to Follow-up|0|||
44475207|NCT00258154|79482570|FG001|Overall Study|Lost to Follow-up|1|||
44475208|NCT00258154|79482569|FG000|Overall Study|Protocol Violation|2|||
44475209|NCT00258154|79482570|FG001|Overall Study|Protocol Violation|1|||
44475210|NCT00258154|79482569|FG000|Overall Study|Withdrawal by Subject|3|||
44475211|NCT00258154|79482570|FG001|Overall Study|Withdrawal by Subject|4|||
44475212|NCT00258154|79482569|FG000|Overall Study|Patient Moved|3|||
44475213|NCT00258154|79482570|FG001|Overall Study|Patient Moved|1|||
44475214|NCT00257920|79482578|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
44475215|NCT00257920|79482579|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
44475216|NCT00257920|79482578|FG000|Period: Second Intervention|Other|2|||
44475217|NCT00257920|79482579|FG001|Period: Second Intervention|Other|1|||
44475218|NCT00268983|79482588|FG000|Overall Study|Death|3|||
44475219|NCT00268983|79482589|FG001|Overall Study|Death|0|||
44475220|NCT00257608|79482597|FG000|Chemotherapy Phase|Adverse Event|138|||
44475221|NCT00257608|79482598|FG001|Chemotherapy Phase|Adverse Event|0|||
44226237|NCT01719380|79032529|FG002|Overall Study|Participant/Guardian Decision|1|||
44226238|NCT01719380|79032530|FG003|Overall Study|Participant/Guardian Decision|0|||
44226239|NCT01719380|79032531|FG004|Overall Study|Participant/Guardian Decision|0|||
44226240|NCT01719380|79032532|FG005|Overall Study|Participant/Guardian Decision|0|||
44226241|NCT01719380|79032533|FG006|Overall Study|Participant/Guardian Decision|0|||
44226242|NCT01719380|79032534|FG007|Overall Study|Participant/Guardian Decision|0|||
44226243|NCT01719380|79032535|FG008|Overall Study|Participant/Guardian Decision|2|||
44226244|NCT01719380|79032536|FG009|Overall Study|Participant/Guardian Decision|2|||
44226245|NCT01719380|79032527|FG000|Overall Study|Physician Decision|0|||
44475222|NCT00257608|79482599|FG002|Chemotherapy Phase|Adverse Event|0|||
44475223|NCT00257608|79482597|FG000|Chemotherapy Phase|Disease progression|139|||
44475224|NCT00257608|79482598|FG001|Chemotherapy Phase|Disease progression|0|||
44475225|NCT00257608|79482599|FG002|Chemotherapy Phase|Disease progression|0|||
44475226|NCT00257608|79482597|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
44475227|NCT00257608|79482598|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
44544563|NCT03216954|79558093|FG004|Overall Study|Adverse Event|1|||
44544564|NCT03216954|79558089|FG000|Overall Study|Withdrawal by Subject|2|||
44475228|NCT00257608|79482599|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
44475229|NCT00257608|79482597|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
44475230|NCT00257608|79482598|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
44544565|NCT03216954|79558090|FG001|Overall Study|Withdrawal by Subject|0|||
44475231|NCT00257608|79482599|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
44475232|NCT00257608|79482597|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
44475233|NCT00257608|79482598|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
44475234|NCT00257608|79482599|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
44475235|NCT00257608|79482597|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
44475236|NCT00257608|79482598|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
44475237|NCT00257608|79482599|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
44475238|NCT00257608|79482597|FG000|Chemotherapy Phase|Physician Decision|28|||
44475239|NCT00257608|79482598|FG001|Chemotherapy Phase|Physician Decision|0|||
44475240|NCT00257608|79482599|FG002|Chemotherapy Phase|Physician Decision|0|||
44475241|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Adverse Event|0|||
44475242|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Adverse Event|34|||
44475243|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Adverse Event|38|||
44475244|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Disease progression|0|||
44475245|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Disease progression|204|||
44475246|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Disease progression|168|||
44475247|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
44475248|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
44475249|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
44475250|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
44475251|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
44475252|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
44475253|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
44475254|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
44475255|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
44475256|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
44475257|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
44475258|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
44475259|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
44475260|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
44475261|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
44475262|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Physician Decision|0|||
44475263|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Physician Decision|8|||
44475264|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Physician Decision|11|||
44475265|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
44475266|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
44475267|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
44475268|NCT00257608|79482597|FG000|Post Chemotherapy Phase|Not treated|0|||
44475269|NCT00257608|79482598|FG001|Post Chemotherapy Phase|Not treated|4|||
44475270|NCT00257608|79482599|FG002|Post Chemotherapy Phase|Not treated|7|||
44475271|NCT00231478|79482614|FG000|Overall Study|Protocol Violation|3|||
44475272|NCT00231478|79482615|FG001|Overall Study|Protocol Violation|2|||
44475273|NCT00231478|79482614|FG000|Overall Study|Refused Treatment|1|||
44475274|NCT00231478|79482615|FG001|Overall Study|Refused Treatment|1|||
44475275|NCT00231478|79482614|FG000|Overall Study|Withdrawal by Subject|1|||
44475276|NCT00231478|79482615|FG001|Overall Study|Withdrawal by Subject|0|||
44475277|NCT00231478|79482614|FG000|Overall Study|Adverse Event|0|||
44475278|NCT00231478|79482615|FG001|Overall Study|Adverse Event|1|||
44475279|NCT00231478|79482614|FG000|Overall Study|Administrative|3|||
44475280|NCT00231478|79482615|FG001|Overall Study|Administrative|2|||
44475281|NCT00413192|79482625|FG000|Overall Study|Disease progression|26|||
44475282|NCT00413192|79482626|FG001|Overall Study|Disease progression|31|||
44475283|NCT00413192|79482627|FG002|Overall Study|Disease progression|16|||
44226246|NCT01719380|79032528|FG001|Overall Study|Physician Decision|0|||
44226247|NCT01719380|79032529|FG002|Overall Study|Physician Decision|2|||
44226248|NCT01719380|79032530|FG003|Overall Study|Physician Decision|0|||
44226249|NCT01719380|79032531|FG004|Overall Study|Physician Decision|0|||
44226250|NCT01719380|79032532|FG005|Overall Study|Physician Decision|0|||
44475284|NCT00413192|79482628|FG003|Overall Study|Disease progression|25|||
44475285|NCT00413192|79482625|FG000|Overall Study|Toxicity|3|||
44475286|NCT00413192|79482626|FG001|Overall Study|Toxicity|2|||
44475287|NCT00413192|79482627|FG002|Overall Study|Toxicity|2|||
44475288|NCT00413192|79482628|FG003|Overall Study|Toxicity|2|||
44475289|NCT00413192|79482625|FG000|Overall Study|Withdrawal by Subject|3|||
44475290|NCT00413192|79482626|FG001|Overall Study|Withdrawal by Subject|5|||
44475291|NCT00413192|79482627|FG002|Overall Study|Withdrawal by Subject|0|||
44475292|NCT00413192|79482628|FG003|Overall Study|Withdrawal by Subject|1|||
44475293|NCT00413192|79482625|FG000|Overall Study|Intercurrent illness|0|||
44475294|NCT00413192|79482626|FG001|Overall Study|Intercurrent illness|0|||
44475295|NCT00413192|79482627|FG002|Overall Study|Intercurrent illness|0|||
44475296|NCT00413192|79482628|FG003|Overall Study|Intercurrent illness|1|||
44475297|NCT00413192|79482625|FG000|Overall Study|Intercurrent death|0|||
44475298|NCT00413192|79482626|FG001|Overall Study|Intercurrent death|1|||
44475299|NCT00413192|79482627|FG002|Overall Study|Intercurrent death|0|||
44475300|NCT00413192|79482628|FG003|Overall Study|Intercurrent death|0|||
44475301|NCT00413192|79482625|FG000|Overall Study|Other|5|||
44475302|NCT00413192|79482626|FG001|Overall Study|Other|1|||
44475303|NCT00413192|79482627|FG002|Overall Study|Other|1|||
44475304|NCT00413192|79482628|FG003|Overall Study|Other|2|||
44475305|NCT00413192|79482625|FG000|Overall Study|Not treated|0|||
44475306|NCT00413192|79482626|FG001|Overall Study|Not treated|0|||
44475307|NCT00413192|79482627|FG002|Overall Study|Not treated|0|||
44475308|NCT00413192|79482628|FG003|Overall Study|Not treated|1|||
44475309|NCT00207142|79482641|FG000|Induction Phase|Adverse Event|9|||
44475310|NCT00207142|79482642|FG001|Induction Phase|Adverse Event|0|||
44226251|NCT01719380|79032533|FG006|Overall Study|Physician Decision|0|||
44226252|NCT01719380|79032534|FG007|Overall Study|Physician Decision|0|||
44226253|NCT01719380|79032535|FG008|Overall Study|Physician Decision|1|||
44226254|NCT01719380|79032536|FG009|Overall Study|Physician Decision|1|||
44226255|NCT01719380|79032527|FG000|Overall Study|Lack of Efficacy|2|||
44226256|NCT01719380|79032528|FG001|Overall Study|Lack of Efficacy|6|||
44226257|NCT01719380|79032529|FG002|Overall Study|Lack of Efficacy|5|||
44226258|NCT01719380|79032530|FG003|Overall Study|Lack of Efficacy|6|||
44226259|NCT01719380|79032531|FG004|Overall Study|Lack of Efficacy|3|||
44226260|NCT01719380|79032532|FG005|Overall Study|Lack of Efficacy|7|||
44226261|NCT01719380|79032533|FG006|Overall Study|Lack of Efficacy|10|||
44226262|NCT01719380|79032534|FG007|Overall Study|Lack of Efficacy|6|||
44475311|NCT00207142|79482643|FG002|Induction Phase|Adverse Event|0|||
44475312|NCT00207142|79482644|FG003|Induction Phase|Adverse Event|0|||
44475313|NCT00207142|79482641|FG000|Induction Phase|Death|1|||
44475314|NCT00207142|79482642|FG001|Induction Phase|Death|0|||
44475315|NCT00207142|79482643|FG002|Induction Phase|Death|0|||
44475316|NCT00207142|79482644|FG003|Induction Phase|Death|0|||
44475317|NCT00207142|79482641|FG000|Induction Phase|Lack of Efficacy|1|||
44475318|NCT00207142|79482642|FG001|Induction Phase|Lack of Efficacy|0|||
44475319|NCT00207142|79482643|FG002|Induction Phase|Lack of Efficacy|0|||
44475320|NCT00207142|79482644|FG003|Induction Phase|Lack of Efficacy|0|||
44475321|NCT00207142|79482641|FG000|Induction Phase|Lost to Follow-up|5|||
44475322|NCT00207142|79482642|FG001|Induction Phase|Lost to Follow-up|0|||
44475323|NCT00207142|79482643|FG002|Induction Phase|Lost to Follow-up|0|||
44475324|NCT00207142|79482644|FG003|Induction Phase|Lost to Follow-up|0|||
44475325|NCT00207142|79482641|FG000|Induction Phase|Physician Decision|2|||
44475326|NCT00207142|79482642|FG001|Induction Phase|Physician Decision|0|||
44475327|NCT00207142|79482643|FG002|Induction Phase|Physician Decision|0|||
44475328|NCT00207142|79482644|FG003|Induction Phase|Physician Decision|0|||
44226263|NCT01719380|79032535|FG008|Overall Study|Lack of Efficacy|39|||
44475329|NCT00207142|79482641|FG000|Induction Phase|Poor/noncompliance|2|||
44475330|NCT00207142|79482642|FG001|Induction Phase|Poor/noncompliance|0|||
44475331|NCT00207142|79482643|FG002|Induction Phase|Poor/noncompliance|0|||
44475332|NCT00207142|79482644|FG003|Induction Phase|Poor/noncompliance|0|||
44475333|NCT00207142|79482641|FG000|Induction Phase|Pregnancy|1|||
44475334|NCT00207142|79482642|FG001|Induction Phase|Pregnancy|0|||
44475335|NCT00207142|79482643|FG002|Induction Phase|Pregnancy|0|||
44475336|NCT00207142|79482644|FG003|Induction Phase|Pregnancy|0|||
44475337|NCT00207142|79482641|FG000|Induction Phase|Subject no longer meets study criteria|3|||
44475338|NCT00207142|79482642|FG001|Induction Phase|Subject no longer meets study criteria|0|||
44475339|NCT00207142|79482643|FG002|Induction Phase|Subject no longer meets study criteria|0|||
44475340|NCT00207142|79482644|FG003|Induction Phase|Subject no longer meets study criteria|0|||
44475341|NCT00207142|79482641|FG000|Induction Phase|Withdrawal by Subject|4|||
44475342|NCT00207142|79482642|FG001|Induction Phase|Withdrawal by Subject|0|||
44475343|NCT00207142|79482643|FG002|Induction Phase|Withdrawal by Subject|0|||
44475344|NCT00207142|79482644|FG003|Induction Phase|Withdrawal by Subject|0|||
44475345|NCT00207142|79482641|FG000|Induction Phase|Incarceration|1|||
44475346|NCT00207142|79482642|FG001|Induction Phase|Incarceration|0|||
44226264|NCT01719380|79032536|FG009|Overall Study|Lack of Efficacy|42|||
44226265|NCT01719380|79032527|FG000|Overall Study|Progressive Disease|0|||
44226266|NCT01719380|79032528|FG001|Overall Study|Progressive Disease|0|||
44226267|NCT01719380|79032529|FG002|Overall Study|Progressive Disease|0|||
44226268|NCT01719380|79032530|FG003|Overall Study|Progressive Disease|0|||
44226269|NCT01719380|79032531|FG004|Overall Study|Progressive Disease|0|||
44226270|NCT01719380|79032532|FG005|Overall Study|Progressive Disease|0|||
44226271|NCT01719380|79032533|FG006|Overall Study|Progressive Disease|0|||
44226272|NCT01719380|79032534|FG007|Overall Study|Progressive Disease|0|||
44475347|NCT00207142|79482643|FG002|Induction Phase|Incarceration|0|||
44475348|NCT00207142|79482644|FG003|Induction Phase|Incarceration|0|||
44475349|NCT00207142|79482641|FG000|Induction Phase|Missing lab data|1|||
44475350|NCT00207142|79482642|FG001|Induction Phase|Missing lab data|0|||
44475351|NCT00207142|79482643|FG002|Induction Phase|Missing lab data|0|||
44475352|NCT00207142|79482644|FG003|Induction Phase|Missing lab data|0|||
44475353|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
44475354|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
44475355|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
44475356|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
44475357|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
44475358|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
44475359|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
44475360|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
44475361|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
44475362|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
44475363|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
44475364|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
44475365|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
44475366|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
44475367|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
44475368|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
44475369|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
44475370|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
44475371|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
44475372|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
44475373|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
44475374|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
44475375|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
44475376|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
44475377|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
44475378|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
44475379|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
44475380|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
44475381|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Death|0|||
44475382|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Death|0|||
44475383|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Death|0|||
44475384|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Death|1|||
44475385|NCT00207142|79482641|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
44475386|NCT00207142|79482642|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
44475387|NCT00207142|79482643|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
44475388|NCT00207142|79482644|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
44475389|NCT00268905|79482662|FG000|Overall Study|Adverse Event|3|||
44475390|NCT00268905|79482663|FG001|Overall Study|Adverse Event|0|||
44475391|NCT00268905|79482664|FG002|Overall Study|Adverse Event|4|||
44475392|NCT00268905|79482662|FG000|Overall Study|Lost to Follow-up|0|||
44475393|NCT00268905|79482663|FG001|Overall Study|Lost to Follow-up|1|||
44475394|NCT00268905|79482664|FG002|Overall Study|Lost to Follow-up|0|||
44475395|NCT00268905|79482662|FG000|Overall Study|Withdrawal by Subject|0|||
44475396|NCT00268905|79482663|FG001|Overall Study|Withdrawal by Subject|0|||
44475397|NCT00268905|79482664|FG002|Overall Study|Withdrawal by Subject|3|||
44475398|NCT00268905|79482662|FG000|Overall Study|Progressive Disease|28|||
44475399|NCT00268905|79482663|FG001|Overall Study|Progressive Disease|4|||
44475400|NCT00268905|79482664|FG002|Overall Study|Progressive Disease|3|||
44475401|NCT00268905|79482662|FG000|Overall Study|Physician Decision|3|||
44475402|NCT00268905|79482663|FG001|Overall Study|Physician Decision|0|||
44475403|NCT00268905|79482664|FG002|Overall Study|Physician Decision|1|||
44475404|NCT00268905|79482662|FG000|Overall Study|Clinical Progression|9|||
44475405|NCT00268905|79482663|FG001|Overall Study|Clinical Progression|4|||
44475406|NCT00268905|79482664|FG002|Overall Study|Clinical Progression|1|||
44475407|NCT00206518|79482674|FG000|Overall Study|Lack of Efficacy|6|||
44475408|NCT00206518|79482675|FG001|Overall Study|Lack of Efficacy|4|||
44475409|NCT00206518|79482674|FG000|Overall Study|Adverse Event|2|||
44475410|NCT00206518|79482675|FG001|Overall Study|Adverse Event|1|||
44475411|NCT00206518|79482674|FG000|Overall Study|Physician Decision|1|||
44475412|NCT00206518|79482675|FG001|Overall Study|Physician Decision|0|||
44475413|NCT00206518|79482674|FG000|Overall Study|Protocol Violation|1|||
44475414|NCT00206518|79482675|FG001|Overall Study|Protocol Violation|1|||
44475415|NCT00423722|79482683|FG000|Overall Study|Death|4|||
44475416|NCT00423722|79482684|FG001|Overall Study|Death|4|||
44475417|NCT00423722|79482683|FG000|Overall Study|Declined to participate|2|||
44226273|NCT01719380|79032535|FG008|Overall Study|Progressive Disease|1|||
44226274|NCT01719380|79032536|FG009|Overall Study|Progressive Disease|0|||
44226275|NCT01743560|79032586|FG000|Overall Study|Disease progression|26|||
44475418|NCT00423722|79482684|FG001|Overall Study|Declined to participate|3|||
44475419|NCT00423722|79482683|FG000|Overall Study|Unable to complete questionnaires|4|||
44475420|NCT00423722|79482684|FG001|Overall Study|Unable to complete questionnaires|4|||
44475421|NCT00423722|79482683|FG000|Overall Study|Withdrawal by Subject|4|||
44475422|NCT00423722|79482684|FG001|Overall Study|Withdrawal by Subject|2|||
44475423|NCT00206440|79482698|FG000|Overall Study|Protocol Violation|1|||
44475424|NCT00206440|79482699|FG001|Overall Study|Protocol Violation|2|||
44475425|NCT00206440|79482698|FG000|Overall Study|Adverse Event|4|||
44475426|NCT00206440|79482699|FG001|Overall Study|Adverse Event|2|||
44475427|NCT00268437|79482705|FG000|Overall Study|Ineligible|1|||
44475428|NCT00423488|79482712|FG000|Overall Study|No evidence of study drug intake|2|||
44475429|NCT00423488|79482713|FG001|Overall Study|No evidence of study drug intake|1|||
44475430|NCT00423488|79482712|FG000|Overall Study|No post baseline data|3|||
44475431|NCT00423488|79482713|FG001|Overall Study|No post baseline data|0|||
44475432|NCT00404066|79482719|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
44475433|NCT00404066|79482719|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
44475434|NCT00423332|79482725|FG000|Overall Study|Adverse Event|6|||
44475435|NCT00423332|79482726|FG001|Overall Study|Adverse Event|2|||
44475436|NCT00423332|79482725|FG000|Overall Study|Withdrawal by Subject|1|||
44475437|NCT00423332|79482726|FG001|Overall Study|Withdrawal by Subject|0|||
44475438|NCT00423332|79482725|FG000|Overall Study|Condition under investigation worsened|1|||
44475439|NCT00423332|79482726|FG001|Overall Study|Condition under investigation worsened|1|||
44475440|NCT00423332|79482725|FG000|Overall Study|Progressive at Week 6|0|||
44475441|NCT00423332|79482726|FG001|Overall Study|Progressive at Week 6|1|||
44475442|NCT00423332|79482725|FG000|Overall Study|Unblinded before 12 weeks|1|||
44475443|NCT00423332|79482726|FG001|Overall Study|Unblinded before 12 weeks|3|||
44475444|NCT00413036|79482733|FG000|Overall Study|Adverse Event|44|||
44475445|NCT00413036|79482733|FG000|Overall Study|Lack of Efficacy|129|||
44475446|NCT00413036|79482733|FG000|Overall Study|Withdrawal by Subject|7|||
44475447|NCT00413036|79482733|FG000|Overall Study|Death|9|||
44475448|NCT00413036|79482733|FG000|Overall Study|Other|26|||
44475449|NCT00413036|79482733|FG000|Overall Study|Missing|2|||
44475450|NCT00412958|79482741|FG000|Overall Study|Withdrawal by Subject|3|||
44475451|NCT00412958|79482742|FG001|Overall Study|Withdrawal by Subject|0|||
44475452|NCT00412958|79482743|FG002|Overall Study|Withdrawal by Subject|0|||
44475453|NCT00412958|79482744|FG003|Overall Study|Withdrawal by Subject|1|||
44475454|NCT00412958|79482741|FG000|Overall Study|Adverse Event|0|||
44475455|NCT00412958|79482742|FG001|Overall Study|Adverse Event|1|||
44475456|NCT00412958|79482743|FG002|Overall Study|Adverse Event|0|||
44475457|NCT00412958|79482744|FG003|Overall Study|Adverse Event|0|||
44475458|NCT00412958|79482741|FG000|Overall Study|Lost to Follow-up|0|||
44475459|NCT00412958|79482742|FG001|Overall Study|Lost to Follow-up|1|||
44475460|NCT00412958|79482743|FG002|Overall Study|Lost to Follow-up|0|||
44475461|NCT00412958|79482744|FG003|Overall Study|Lost to Follow-up|0|||
44475462|NCT00412958|79482741|FG000|Overall Study|Death|0|||
44475463|NCT00412958|79482742|FG001|Overall Study|Death|1|||
44475464|NCT00412958|79482743|FG002|Overall Study|Death|0|||
44475465|NCT00412958|79482744|FG003|Overall Study|Death|0|||
44475466|NCT00412958|79482741|FG000|Overall Study|Transport issue|0|||
44475467|NCT00412958|79482742|FG001|Overall Study|Transport issue|1|||
44475468|NCT00412958|79482743|FG002|Overall Study|Transport issue|0|||
44475469|NCT00412958|79482744|FG003|Overall Study|Transport issue|0|||
44475470|NCT00423176|79482756|FG000|Overall Study|Adverse Event|4|||
44475471|NCT00423176|79482757|FG001|Overall Study|Adverse Event|6|||
44475472|NCT00423176|79482756|FG000|Overall Study|Treatment Failure|1|||
44475473|NCT00423176|79482757|FG001|Overall Study|Treatment Failure|6|||
44475474|NCT00423176|79482756|FG000|Overall Study|Lost to Follow-up|4|||
44475475|NCT00423176|79482757|FG001|Overall Study|Lost to Follow-up|7|||
44475476|NCT00423176|79482756|FG000|Overall Study|Withdrawal by Subject|4|||
44475477|NCT00423176|79482757|FG001|Overall Study|Withdrawal by Subject|3|||
44475478|NCT00423176|79482756|FG000|Overall Study|Protocol Violation|1|||
44475479|NCT00423176|79482757|FG001|Overall Study|Protocol Violation|3|||
44475480|NCT00423176|79482756|FG000|Overall Study|Did not meet protocol eligibility|2|||
44475481|NCT00423176|79482757|FG001|Overall Study|Did not meet protocol eligibility|4|||
44475482|NCT00412880|79482763|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
44475483|NCT00412880|79482763|FG000|Overall Study|Consent withdrawn|1|||
44475484|NCT00412880|79482763|FG000|Overall Study|Adverse Event|1|||
44475485|NCT00412880|79482763|FG000|Overall Study|Progressive disease|20|||
44475486|NCT00268203|79482767|FG000|Overall Study|Lost to Follow-up|92|||
44475487|NCT00268203|79482767|FG000|Overall Study|Withdrawal by Subject|9|||
44475488|NCT00268203|79482767|FG000|Overall Study|Received Other NHL Therapy|7|||
44475489|NCT00268203|79482767|FG000|Overall Study|Progressive Disease|359|||
44475490|NCT00268203|79482767|FG000|Overall Study|Death|84|||
44475491|NCT00268203|79482767|FG000|Overall Study|Reason Not Specified|34|||
44475492|NCT00268203|79482767|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
44475493|NCT00384930|79482776|FG000|Overall Study|Adverse Event|5|||
44475494|NCT00384930|79482777|FG001|Overall Study|Adverse Event|4|||
44475495|NCT00384930|79482778|FG002|Overall Study|Adverse Event|12|||
44475496|NCT00384930|79482779|FG003|Overall Study|Adverse Event|11|||
44226276|NCT01743560|79032586|FG000|Overall Study|Adverse Event|8|||
44475497|NCT00384930|79482780|FG004|Overall Study|Adverse Event|14|||
44475498|NCT00384930|79482776|FG000|Overall Study|Entry Criteria Not Met|2|||
44475499|NCT00384930|79482777|FG001|Overall Study|Entry Criteria Not Met|6|||
44475500|NCT00384930|79482778|FG002|Overall Study|Entry Criteria Not Met|7|||
44475501|NCT00384930|79482779|FG003|Overall Study|Entry Criteria Not Met|8|||
44475502|NCT00384930|79482780|FG004|Overall Study|Entry Criteria Not Met|4|||
44475503|NCT00384930|79482776|FG000|Overall Study|Lack of Efficacy|1|||
44475504|NCT00384930|79482777|FG001|Overall Study|Lack of Efficacy|1|||
44475505|NCT00384930|79482778|FG002|Overall Study|Lack of Efficacy|2|||
44475506|NCT00384930|79482779|FG003|Overall Study|Lack of Efficacy|1|||
44475507|NCT00384930|79482780|FG004|Overall Study|Lack of Efficacy|2|||
44475508|NCT00384930|79482776|FG000|Overall Study|Lost to Follow-up|5|||
44475509|NCT00384930|79482777|FG001|Overall Study|Lost to Follow-up|3|||
44475510|NCT00384930|79482778|FG002|Overall Study|Lost to Follow-up|0|||
44475511|NCT00384930|79482779|FG003|Overall Study|Lost to Follow-up|4|||
44475512|NCT00384930|79482780|FG004|Overall Study|Lost to Follow-up|6|||
44475513|NCT00384930|79482776|FG000|Overall Study|Physician Decision|0|||
44475514|NCT00384930|79482777|FG001|Overall Study|Physician Decision|1|||
44475515|NCT00384930|79482778|FG002|Overall Study|Physician Decision|1|||
44475516|NCT00384930|79482779|FG003|Overall Study|Physician Decision|0|||
44475517|NCT00384930|79482780|FG004|Overall Study|Physician Decision|1|||
44475518|NCT00384930|79482776|FG000|Overall Study|Protocol Violation|1|||
44475519|NCT00384930|79482777|FG001|Overall Study|Protocol Violation|0|||
44475520|NCT00384930|79482778|FG002|Overall Study|Protocol Violation|1|||
44475521|NCT00384930|79482779|FG003|Overall Study|Protocol Violation|6|||
44475522|NCT00384930|79482780|FG004|Overall Study|Protocol Violation|4|||
44475523|NCT00384930|79482776|FG000|Overall Study|Sponsor Decision|3|||
44475524|NCT00384930|79482777|FG001|Overall Study|Sponsor Decision|4|||
44475525|NCT00384930|79482778|FG002|Overall Study|Sponsor Decision|0|||
44475526|NCT00384930|79482779|FG003|Overall Study|Sponsor Decision|5|||
44475527|NCT00384930|79482780|FG004|Overall Study|Sponsor Decision|0|||
44475528|NCT00384930|79482776|FG000|Overall Study|Withdrawal by Subject|9|||
44475529|NCT00384930|79482777|FG001|Overall Study|Withdrawal by Subject|7|||
44475530|NCT00384930|79482778|FG002|Overall Study|Withdrawal by Subject|7|||
44475531|NCT00384930|79482779|FG003|Overall Study|Withdrawal by Subject|6|||
44475532|NCT00384930|79482780|FG004|Overall Study|Withdrawal by Subject|16|||
44475533|NCT00384930|79482776|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
44475534|NCT00384930|79482777|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
44226277|NCT01743560|79032586|FG000|Overall Study|Death|3|||
44475535|NCT00384930|79482778|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
44475536|NCT00384930|79482779|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
44475537|NCT00384930|79482780|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
44475538|NCT00423098|79482797|FG000|Overall Study|Adverse Event|1|||
44475539|NCT00423098|79482798|FG001|Overall Study|Adverse Event|2|||
44475540|NCT00423098|79482797|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44475541|NCT00423098|79482798|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44475542|NCT00423098|79482797|FG000|Overall Study|Administrative problems|0|||
44475543|NCT00423098|79482798|FG001|Overall Study|Administrative problems|1|||
44475544|NCT00423098|79482797|FG000|Overall Study|Death|2|||
44475545|NCT00423098|79482798|FG001|Overall Study|Death|0|||
44475546|NCT00750698|79482806|FG000|Overall Study|Withdrawal by Subject|1|||
44475547|NCT00750698|79482807|FG001|Overall Study|Withdrawal by Subject|0|||
44475548|NCT00750698|79482806|FG000|Overall Study|Progressive disease|5|||
44475549|NCT00750698|79482807|FG001|Overall Study|Progressive disease|2|||
44475550|NCT00411788|79482813|FG000|Overall Study|Protocol Violation|1|||
44475551|NCT00411788|79482813|FG000|Overall Study|Adverse Event|1|||
44475552|NCT00422942|79482817|FG000|Overall Study|Study terminated by Sponsor|3|||
44475553|NCT00422162|79482823|FG000|Overall Study|Adverse Event|11|||
44475554|NCT00422162|79482824|FG001|Overall Study|Adverse Event|9|||
44475555|NCT00422162|79482823|FG000|Overall Study|Lack of Efficacy|4|||
44475556|NCT00422162|79482824|FG001|Overall Study|Lack of Efficacy|10|||
44475557|NCT00422162|79482823|FG000|Overall Study|Withdrawal by Subject|7|||
44475558|NCT00422162|79482824|FG001|Overall Study|Withdrawal by Subject|6|||
44475559|NCT00422162|79482823|FG000|Overall Study|Lost to Follow-up|1|||
44475560|NCT00422162|79482824|FG001|Overall Study|Lost to Follow-up|2|||
44475561|NCT00422162|79482823|FG000|Overall Study|Non-Compliant with Protocol|1|||
44475562|NCT00422162|79482824|FG001|Overall Study|Non-Compliant with Protocol|1|||
44475563|NCT00422162|79482823|FG000|Overall Study|Other|0|||
44475564|NCT00422162|79482824|FG001|Overall Study|Other|1|||
44475565|NCT00422162|79482823|FG000|Overall Study|Didn't Receive Treatment|0|||
44475566|NCT00422162|79482824|FG001|Overall Study|Didn't Receive Treatment|1|||
44475567|NCT00411632|79482840|FG000|Overall Study|Death|1|||
44475568|NCT00422084|79482846|FG000|Overall Study|Adverse Event|21|||
44475569|NCT00422084|79482847|FG001|Overall Study|Adverse Event|7|||
44475570|NCT00422084|79482846|FG000|Overall Study|Withdrawal by Subject|12|||
44475571|NCT00422084|79482847|FG001|Overall Study|Withdrawal by Subject|9|||
44475572|NCT00422084|79482846|FG000|Overall Study|Lost to Follow-up|14|||
44475573|NCT00422084|79482847|FG001|Overall Study|Lost to Follow-up|9|||
44475574|NCT00422084|79482846|FG000|Overall Study|Protocol Violation|4|||
44475575|NCT00422084|79482847|FG001|Overall Study|Protocol Violation|1|||
44143768|NCT01327885|78933102|FG000|Overall Study|Disease progression-according to RECIST|173|||
44475576|NCT00422084|79482846|FG000|Overall Study|Lack of Efficacy|40|||
44143769|NCT01327885|78933103|FG001|Overall Study|Disease progression-according to RECIST|165|||
44143770|NCT01327885|78933102|FG000|Overall Study|Clinical progression|24|||
44143771|NCT01327885|78933103|FG001|Overall Study|Clinical progression|27|||
44143772|NCT01327885|78933102|FG000|Overall Study|Adverse Event|14|||
44475577|NCT00422084|79482847|FG001|Overall Study|Lack of Efficacy|42|||
44475578|NCT00422084|79482846|FG000|Overall Study|P. vivax infection|3|||
44475579|NCT00422084|79482847|FG001|Overall Study|P. vivax infection|6|||
44475580|NCT00422084|79482846|FG000|Overall Study|Cyesis|1|||
44475581|NCT00422084|79482847|FG001|Overall Study|Cyesis|0|||
44475582|NCT00422084|79482846|FG000|Overall Study|Withdrawn from study accidentally|1|||
44475583|NCT00422084|79482847|FG001|Overall Study|Withdrawn from study accidentally|0|||
44475584|NCT00422084|79482846|FG000|Overall Study|Non-compliance|1|||
44475585|NCT00422084|79482847|FG001|Overall Study|Non-compliance|0|||
44475586|NCT00422084|79482846|FG000|Overall Study|Re-location|0|||
44475587|NCT00422084|79482847|FG001|Overall Study|Re-location|1|||
44475588|NCT00422084|79482846|FG000|Overall Study|Not defined|1|||
44475589|NCT00422084|79482847|FG001|Overall Study|Not defined|1|||
44475590|NCT00421928|79482856|FG000|Overall Study|Adverse Event|61|||
44475591|NCT00421928|79482857|FG001|Overall Study|Adverse Event|140|||
44475592|NCT00421928|79482858|FG002|Overall Study|Adverse Event|22|||
44475593|NCT00421928|79482856|FG000|Overall Study|Lost to Follow-up|5|||
44475594|NCT00421928|79482857|FG001|Overall Study|Lost to Follow-up|0|||
44475595|NCT00421928|79482858|FG002|Overall Study|Lost to Follow-up|3|||
44475596|NCT00421928|79482856|FG000|Overall Study|Withdrawal by Subject|50|||
44475597|NCT00421928|79482857|FG001|Overall Study|Withdrawal by Subject|48|||
44475598|NCT00421928|79482858|FG002|Overall Study|Withdrawal by Subject|43|||
44475599|NCT00421928|79482856|FG000|Overall Study|Lack of Efficacy|15|||
44475600|NCT00421928|79482857|FG001|Overall Study|Lack of Efficacy|7|||
44475601|NCT00421928|79482858|FG002|Overall Study|Lack of Efficacy|35|||
44475602|NCT00421928|79482856|FG000|Overall Study|Study drug non-compliant|6|||
44475603|NCT00421928|79482857|FG001|Overall Study|Study drug non-compliant|7|||
44475604|NCT00421928|79482858|FG002|Overall Study|Study drug non-compliant|4|||
44475605|NCT00421928|79482856|FG000|Overall Study|All other|26|||
44475606|NCT00421928|79482857|FG001|Overall Study|All other|21|||
44475607|NCT00421928|79482858|FG002|Overall Study|All other|27|||
44475608|NCT00421928|79482856|FG000|Overall Study|Death|0|||
44475609|NCT00421928|79482857|FG001|Overall Study|Death|1|||
44475610|NCT00421928|79482858|FG002|Overall Study|Death|0|||
44475611|NCT00383292|79482869|FG000|Overall Study|Adverse Event|4|||
44475612|NCT00383292|79482870|FG001|Overall Study|Adverse Event|1|||
44475613|NCT00383292|79482871|FG002|Overall Study|Adverse Event|2|||
44475614|NCT00383292|79482869|FG000|Overall Study|Death|3|||
44475615|NCT00383292|79482870|FG001|Overall Study|Death|3|||
44475616|NCT00383292|79482871|FG002|Overall Study|Death|3|||
44475617|NCT00383292|79482869|FG000|Overall Study|Physician Decision|4|||
44475618|NCT00383292|79482870|FG001|Overall Study|Physician Decision|0|||
44475619|NCT00383292|79482871|FG002|Overall Study|Physician Decision|1|||
44475620|NCT00383292|79482869|FG000|Overall Study|Withdrawal by Subject|3|||
44475621|NCT00383292|79482870|FG001|Overall Study|Withdrawal by Subject|2|||
44475622|NCT00383292|79482871|FG002|Overall Study|Withdrawal by Subject|2|||
44475623|NCT00383292|79482869|FG000|Overall Study|Other|1|||
44475624|NCT00383292|79482870|FG001|Overall Study|Other|0|||
44475625|NCT00383292|79482871|FG002|Overall Study|Other|0|||
44475626|NCT00372060|79482882|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
44475627|NCT00372060|79482883|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
44475628|NCT00372060|79482882|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
44475629|NCT00372060|79482883|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
44475630|NCT00372060|79482882|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
44475631|NCT00372060|79482883|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
44475632|NCT00372060|79482882|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
44475633|NCT00372060|79482883|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
44475634|NCT00372060|79482882|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
44475635|NCT00372060|79482883|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
44475636|NCT00372060|79482882|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
44475637|NCT00372060|79482883|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
44475638|NCT00421304|79482895|FG000|Overall Study|Lost to Follow-up|5|||
44375480|NCT00903201|79380682|FG001|Overall Study|Withdrawal by Subject|0|||
44475639|NCT00421304|79482896|FG001|Overall Study|Lost to Follow-up|2|||
44375481|NCT00903201|79380683|FG002|Overall Study|Withdrawal by Subject|1|||
44475640|NCT00421304|79482897|FG002|Overall Study|Lost to Follow-up|5|||
44475641|NCT00421304|79482895|FG000|Overall Study|Withdrawal by Subject|2|||
44375482|NCT00902265|79380693|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
44375483|NCT00902265|79380693|FG000|Overall Study|Adverse Event|2|||
44375484|NCT00902265|79380693|FG000|Overall Study|Lack of Efficacy|2|||
44475642|NCT00421304|79482896|FG001|Overall Study|Withdrawal by Subject|2|||
44475643|NCT00421304|79482897|FG002|Overall Study|Withdrawal by Subject|2|||
44475644|NCT00421304|79482895|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
44475645|NCT00421304|79482896|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
44475646|NCT00421304|79482897|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
44475647|NCT00421304|79482895|FG000|Overall Study|Did not attend Day 360 visit|0|||
44475648|NCT00421304|79482896|FG001|Overall Study|Did not attend Day 360 visit|0|||
44475649|NCT00421304|79482897|FG002|Overall Study|Did not attend Day 360 visit|1|||
44475650|NCT00396630|79482909|FG000|Overall Study|Lost to Follow-up|1|||
44475651|NCT00396630|79482910|FG001|Overall Study|Lost to Follow-up|1|||
44475652|NCT00396630|79482909|FG000|Overall Study|Withdrawal by Subject|1|||
44475653|NCT00396630|79482910|FG001|Overall Study|Withdrawal by Subject|1|||
44475654|NCT00396630|79482909|FG000|Overall Study|Not vaccinated at Visit 3|3|||
44475655|NCT00396630|79482910|FG001|Overall Study|Not vaccinated at Visit 3|3|||
44475656|NCT00396318|79482917|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
44475657|NCT00396162|79482923|FG000|Overall Study|Withdrawal by Subject|2|||
44475658|NCT00396162|79482924|FG001|Overall Study|Withdrawal by Subject|3|||
44475659|NCT00381888|79482934|FG000|Overall Study|Death|1|||
44475660|NCT00381888|79482934|FG000|Overall Study|Withdrawal by Subject|1|||
44475661|NCT00381888|79482934|FG000|Overall Study|Physician Decision|1|||
44475662|NCT00381888|79482934|FG000|Overall Study|Protocol Violation|9|||
44475663|NCT00381888|79482934|FG000|Overall Study|Had laparoscopic surgery|2|||
44475664|NCT00381888|79482934|FG000|Overall Study|Surgery was cancelled|2|||
44475665|NCT00381888|79482934|FG000|Overall Study|Adverse Event|1|||
44475666|NCT00267969|79482941|FG000|Controlled Period|Adverse Event|6|||
44475667|NCT00267969|79482942|FG001|Controlled Period|Adverse Event|0|||
44475668|NCT00267969|79482943|FG002|Controlled Period|Adverse Event|2|||
44475669|NCT00267969|79482944|FG003|Controlled Period|Adverse Event|0|||
44475670|NCT00267969|79482945|FG004|Controlled Period|Adverse Event|0|||
44475671|NCT00267969|79482946|FG005|Controlled Period|Adverse Event|0|||
44475672|NCT00267969|79482947|FG006|Controlled Period|Adverse Event|0|||
44475673|NCT00267969|79482941|FG000|Controlled Period|Lack of Efficacy|3|||
44475674|NCT00267969|79482942|FG001|Controlled Period|Lack of Efficacy|0|||
44475675|NCT00267969|79482943|FG002|Controlled Period|Lack of Efficacy|1|||
44475676|NCT00267969|79482944|FG003|Controlled Period|Lack of Efficacy|0|||
44475677|NCT00267969|79482945|FG004|Controlled Period|Lack of Efficacy|0|||
44475678|NCT00267969|79482946|FG005|Controlled Period|Lack of Efficacy|0|||
44475679|NCT00267969|79482947|FG006|Controlled Period|Lack of Efficacy|0|||
44475680|NCT00267969|79482941|FG000|Controlled Period|Lost to Follow-up|1|||
44475681|NCT00267969|79482942|FG001|Controlled Period|Lost to Follow-up|0|||
44475682|NCT00267969|79482943|FG002|Controlled Period|Lost to Follow-up|1|||
44475683|NCT00267969|79482944|FG003|Controlled Period|Lost to Follow-up|0|||
44475684|NCT00267969|79482945|FG004|Controlled Period|Lost to Follow-up|0|||
44475685|NCT00267969|79482946|FG005|Controlled Period|Lost to Follow-up|0|||
44475686|NCT00267969|79482947|FG006|Controlled Period|Lost to Follow-up|0|||
44475687|NCT00267969|79482941|FG000|Controlled Period|Randomized but not treated|0|||
44475688|NCT00267969|79482942|FG001|Controlled Period|Randomized but not treated|0|||
44475689|NCT00267969|79482943|FG002|Controlled Period|Randomized but not treated|1|||
44475690|NCT00267969|79482944|FG003|Controlled Period|Randomized but not treated|0|||
44475691|NCT00267969|79482945|FG004|Controlled Period|Randomized but not treated|0|||
44475692|NCT00267969|79482946|FG005|Controlled Period|Randomized but not treated|0|||
44475693|NCT00267969|79482947|FG006|Controlled Period|Randomized but not treated|0|||
44475694|NCT00267969|79482941|FG000|Controlled Period|Other|2|||
44475695|NCT00267969|79482942|FG001|Controlled Period|Other|1|||
44475696|NCT00267969|79482943|FG002|Controlled Period|Other|6|||
44475697|NCT00267969|79482944|FG003|Controlled Period|Other|0|||
44475698|NCT00267969|79482945|FG004|Controlled Period|Other|0|||
44475699|NCT00267969|79482946|FG005|Controlled Period|Other|0|||
44475700|NCT00267969|79482947|FG006|Controlled Period|Other|0|||
44475701|NCT00267969|79482941|FG000|After Controlled Period|Adverse Event|0|||
44475702|NCT00267969|79482942|FG001|After Controlled Period|Adverse Event|0|||
44475703|NCT00267969|79482943|FG002|After Controlled Period|Adverse Event|0|||
44475704|NCT00267969|79482944|FG003|After Controlled Period|Adverse Event|7|||
44475705|NCT00267969|79482945|FG004|After Controlled Period|Adverse Event|8|||
44475706|NCT00267969|79482946|FG005|After Controlled Period|Adverse Event|23|||
44226278|NCT01743560|79032586|FG000|Overall Study|Withdrawal by Subject|2|||
44226279|NCT01743560|79032586|FG000|Overall Study|Protocol Violation|1|||
44475707|NCT00267969|79482947|FG006|After Controlled Period|Adverse Event|21|||
44475708|NCT00267969|79482941|FG000|After Controlled Period|Death|0|||
44475709|NCT00267969|79482942|FG001|After Controlled Period|Death|0|||
44475710|NCT00267969|79482943|FG002|After Controlled Period|Death|0|||
44475711|NCT00267969|79482944|FG003|After Controlled Period|Death|1|||
44475712|NCT00267969|79482945|FG004|After Controlled Period|Death|2|||
44475713|NCT00267969|79482946|FG005|After Controlled Period|Death|0|||
44475714|NCT00267969|79482947|FG006|After Controlled Period|Death|1|||
44475715|NCT00267969|79482941|FG000|After Controlled Period|Lack of Efficacy|0|||
44475716|NCT00267969|79482942|FG001|After Controlled Period|Lack of Efficacy|0|||
44475717|NCT00267969|79482943|FG002|After Controlled Period|Lack of Efficacy|0|||
44475718|NCT00267969|79482944|FG003|After Controlled Period|Lack of Efficacy|10|||
44475719|NCT00267969|79482945|FG004|After Controlled Period|Lack of Efficacy|6|||
44475720|NCT00267969|79482946|FG005|After Controlled Period|Lack of Efficacy|28|||
44475721|NCT00267969|79482947|FG006|After Controlled Period|Lack of Efficacy|15|||
44475722|NCT00267969|79482941|FG000|After Controlled Period|Lost to Follow-up|0|||
44475723|NCT00267969|79482942|FG001|After Controlled Period|Lost to Follow-up|0|||
44475724|NCT00267969|79482943|FG002|After Controlled Period|Lost to Follow-up|0|||
44475725|NCT00267969|79482944|FG003|After Controlled Period|Lost to Follow-up|5|||
44475726|NCT00267969|79482945|FG004|After Controlled Period|Lost to Follow-up|8|||
44475727|NCT00267969|79482946|FG005|After Controlled Period|Lost to Follow-up|9|||
44475728|NCT00267969|79482947|FG006|After Controlled Period|Lost to Follow-up|10|||
44475729|NCT00267969|79482941|FG000|After Controlled Period|Other|0|||
44475730|NCT00267969|79482942|FG001|After Controlled Period|Other|0|||
44475731|NCT00267969|79482943|FG002|After Controlled Period|Other|0|||
44475732|NCT00267969|79482944|FG003|After Controlled Period|Other|13|||
44475733|NCT00267969|79482945|FG004|After Controlled Period|Other|11|||
44475734|NCT00267969|79482946|FG005|After Controlled Period|Other|22|||
44475735|NCT00267969|79482947|FG006|After Controlled Period|Other|25|||
44475736|NCT00280293|79482967|FG000|Overall Study|Protocol Violation|3|||
44475737|NCT00280293|79482968|FG001|Overall Study|Protocol Violation|0|||
44475738|NCT00280293|79482967|FG000|Overall Study|Physician Decision|5|||
44475739|NCT00280293|79482968|FG001|Overall Study|Physician Decision|4|||
44475740|NCT00280293|79482967|FG000|Overall Study|Lost to Follow-up|14|||
44475741|NCT00280293|79482968|FG001|Overall Study|Lost to Follow-up|12|||
44475742|NCT00280293|79482967|FG000|Overall Study|Withdrawal by Subject|3|||
44475743|NCT00280293|79482968|FG001|Overall Study|Withdrawal by Subject|5|||
44475744|NCT00280293|79482967|FG000|Overall Study|Incarceration/Legal Reasons|1|||
44475745|NCT00280293|79482968|FG001|Overall Study|Incarceration/Legal Reasons|1|||
44475746|NCT00280293|79482967|FG000|Overall Study|Adverse Event|0|||
44475747|NCT00280293|79482968|FG001|Overall Study|Adverse Event|1|||
44475748|NCT00421148|79482994|FG000|Overall Study|Lost to Follow-up|0|||
44475749|NCT00421148|79482995|FG001|Overall Study|Lost to Follow-up|0|||
44475750|NCT00421148|79482996|FG002|Overall Study|Lost to Follow-up|0|||
44475751|NCT00421148|79482997|FG003|Overall Study|Lost to Follow-up|0|||
44475752|NCT00421148|79482998|FG004|Overall Study|Lost to Follow-up|0|||
44475753|NCT00421148|79482999|FG005|Overall Study|Lost to Follow-up|0|||
44475754|NCT00421148|79483000|FG006|Overall Study|Lost to Follow-up|0|||
44475755|NCT00421148|79483001|FG007|Overall Study|Lost to Follow-up|0|||
44475756|NCT00421148|79483002|FG008|Overall Study|Lost to Follow-up|0|||
44475757|NCT00421148|79483003|FG009|Overall Study|Lost to Follow-up|0|||
44475758|NCT00421148|79483004|FG010|Overall Study|Lost to Follow-up|0|||
44475759|NCT00421148|79483005|FG011|Overall Study|Lost to Follow-up|0|||
44475760|NCT00421148|79483006|FG012|Overall Study|Lost to Follow-up|0|||
44475761|NCT00421148|79483007|FG013|Overall Study|Lost to Follow-up|0|||
44475762|NCT00421148|79483008|FG014|Overall Study|Lost to Follow-up|0|||
44475763|NCT00421148|79483009|FG015|Overall Study|Lost to Follow-up|0|||
44475764|NCT00421148|79483010|FG016|Overall Study|Lost to Follow-up|0|||
44475765|NCT00421148|79483011|FG017|Overall Study|Lost to Follow-up|1|||
44475766|NCT00421148|79483012|FG018|Overall Study|Lost to Follow-up|0|||
44475767|NCT00421148|79483013|FG019|Overall Study|Lost to Follow-up|0|||
44475768|NCT00421148|79482994|FG000|Overall Study|Withdrawal by Subject|0|||
44475769|NCT00421148|79482995|FG001|Overall Study|Withdrawal by Subject|0|||
44475770|NCT00421148|79482996|FG002|Overall Study|Withdrawal by Subject|0|||
44475771|NCT00421148|79482997|FG003|Overall Study|Withdrawal by Subject|0|||
44475772|NCT00421148|79482998|FG004|Overall Study|Withdrawal by Subject|0|||
44475773|NCT00421148|79482999|FG005|Overall Study|Withdrawal by Subject|0|||
44475774|NCT00421148|79483000|FG006|Overall Study|Withdrawal by Subject|0|||
44475775|NCT00421148|79483001|FG007|Overall Study|Withdrawal by Subject|0|||
44475776|NCT00421148|79483002|FG008|Overall Study|Withdrawal by Subject|0|||
44475777|NCT00421148|79483003|FG009|Overall Study|Withdrawal by Subject|0|||
44475778|NCT00421148|79483004|FG010|Overall Study|Withdrawal by Subject|0|||
44475779|NCT00421148|79483005|FG011|Overall Study|Withdrawal by Subject|0|||
44475780|NCT00421148|79483006|FG012|Overall Study|Withdrawal by Subject|0|||
44475781|NCT00421148|79483007|FG013|Overall Study|Withdrawal by Subject|0|||
44475782|NCT00421148|79483008|FG014|Overall Study|Withdrawal by Subject|0|||
44475783|NCT00421148|79483009|FG015|Overall Study|Withdrawal by Subject|0|||
44475784|NCT00421148|79483010|FG016|Overall Study|Withdrawal by Subject|0|||
44475785|NCT00421148|79483011|FG017|Overall Study|Withdrawal by Subject|1|||
44475786|NCT00421148|79483012|FG018|Overall Study|Withdrawal by Subject|0|||
44475787|NCT00421148|79483013|FG019|Overall Study|Withdrawal by Subject|0|||
44475788|NCT00421148|79482994|FG000|Overall Study|Protocol Violation|0|||
44475789|NCT00421148|79482995|FG001|Overall Study|Protocol Violation|0|||
44475790|NCT00421148|79482996|FG002|Overall Study|Protocol Violation|0|||
44475791|NCT00421148|79482997|FG003|Overall Study|Protocol Violation|0|||
44475792|NCT00421148|79482998|FG004|Overall Study|Protocol Violation|0|||
44475793|NCT00421148|79482999|FG005|Overall Study|Protocol Violation|1|||
44475794|NCT00421148|79483000|FG006|Overall Study|Protocol Violation|0|||
44475795|NCT00421148|79483001|FG007|Overall Study|Protocol Violation|0|||
44475796|NCT00421148|79483002|FG008|Overall Study|Protocol Violation|0|||
44475797|NCT00421148|79483003|FG009|Overall Study|Protocol Violation|0|||
44475798|NCT00421148|79483004|FG010|Overall Study|Protocol Violation|0|||
44475799|NCT00421148|79483005|FG011|Overall Study|Protocol Violation|0|||
44143773|NCT01327885|78933103|FG001|Overall Study|Adverse Event|10|||
44475800|NCT00421148|79483006|FG012|Overall Study|Protocol Violation|0|||
44143774|NCT01327885|78933102|FG000|Overall Study|Subject choice|5|||
44475801|NCT00421148|79483007|FG013|Overall Study|Protocol Violation|0|||
44475802|NCT00421148|79483008|FG014|Overall Study|Protocol Violation|0|||
44475803|NCT00421148|79483009|FG015|Overall Study|Protocol Violation|0|||
44475804|NCT00421148|79483010|FG016|Overall Study|Protocol Violation|0|||
44475805|NCT00421148|79483011|FG017|Overall Study|Protocol Violation|0|||
44475806|NCT00421148|79483012|FG018|Overall Study|Protocol Violation|1|||
44475807|NCT00421148|79483013|FG019|Overall Study|Protocol Violation|0|||
44475808|NCT00403754|79483055|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
44475809|NCT00403754|79483056|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
44475810|NCT00403754|79483057|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
44475811|NCT00403754|79483058|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
44475812|NCT00403754|79483055|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
44475813|NCT00403754|79483056|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
44475814|NCT00403754|79483057|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
44475815|NCT00403754|79483058|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
44475816|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Death|2|||
44475817|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Death|0|||
44475818|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Adverse Event|33|||
44475819|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Adverse Event|31|||
44475820|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
44475821|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
44475822|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
44475823|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
44475824|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
44475825|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
44475826|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Other|7|||
44475827|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Other|8|||
44475828|NCT00280059|79483072|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
44475829|NCT00280059|79483073|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
44475830|NCT00403130|79483087|FG000|2 Years From Start of Treatment|Not Eligible|3|||
44475831|NCT00403130|79483087|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
44475832|NCT00403130|79483087|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
44475833|NCT00403130|79483087|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
44475834|NCT00402740|79483091|FG000|Overall Study|Withdrawal by Subject|18|||
44475835|NCT00402740|79483091|FG000|Overall Study|Death|50|||
44475836|NCT00402740|79483091|FG000|Overall Study|Lost to Follow-up|6|||
44475837|NCT00402740|79483091|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
44475838|NCT00402740|79483091|FG000|Overall Study|Subject disposition unknown.|1|||
44475839|NCT00420290|79483101|FG000|Overall Study|Adverse Event|3|||
44475840|NCT00420290|79483102|FG001|Overall Study|Adverse Event|1|||
44475841|NCT00420290|79483101|FG000|Overall Study|Withdrawal by Subject|0|||
44475842|NCT00420290|79483102|FG001|Overall Study|Withdrawal by Subject|2|||
44475843|NCT00420290|79483101|FG000|Overall Study|did not meet inclusion/exclusion|1|||
44475844|NCT00420290|79483102|FG001|Overall Study|did not meet inclusion/exclusion|1|||
44475845|NCT00267189|79483110|FG000|Overall Study|Patient withdrew consent|1|||
44475846|NCT00267189|79483111|FG001|Overall Study|Patient withdrew consent|1|||
44475847|NCT00267189|79483110|FG000|Overall Study|Death|1|||
44475848|NCT00267189|79483111|FG001|Overall Study|Death|0|||
44475849|NCT00267189|79483110|FG000|Overall Study|Missing|3|||
44475850|NCT00267189|79483111|FG001|Overall Study|Missing|0|||
44475851|NCT03834350|79483117|FG000|Overall Study|Withdrawal by Subject|1|||
44475852|NCT00402116|79483125|FG000|Overall Study|Jaw infection after surgery-other|1|||
44475853|NCT00402116|79483126|FG001|Overall Study|Jaw infection after surgery-other|0|||
44475854|NCT00402116|79483127|FG002|Overall Study|Jaw infection after surgery-other|0|||
44475855|NCT00402116|79483125|FG000|Overall Study|Withdrawal by Subject|1|||
44475856|NCT00402116|79483126|FG001|Overall Study|Withdrawal by Subject|0|||
44475857|NCT00402116|79483127|FG002|Overall Study|Withdrawal by Subject|5|||
44475858|NCT00402116|79483125|FG000|Overall Study|Treatment completed per protocol|1|||
44475859|NCT00402116|79483126|FG001|Overall Study|Treatment completed per protocol|1|||
44475860|NCT00402116|79483127|FG002|Overall Study|Treatment completed per protocol|2|||
44475861|NCT00402116|79483125|FG000|Overall Study|other complicating disease|0|||
44475862|NCT00402116|79483126|FG001|Overall Study|other complicating disease|0|||
44475863|NCT00402116|79483127|FG002|Overall Study|other complicating disease|2|||
44475864|NCT00402116|79483125|FG000|Overall Study|Disease Progression|0|||
44475865|NCT00402116|79483126|FG001|Overall Study|Disease Progression|4|||
44475866|NCT00402116|79483127|FG002|Overall Study|Disease Progression|38|||
44475867|NCT00402116|79483125|FG000|Overall Study|mistaken thrombocytopenia|0|||
44475868|NCT00402116|79483126|FG001|Overall Study|mistaken thrombocytopenia|0|||
44475869|NCT00402116|79483127|FG002|Overall Study|mistaken thrombocytopenia|1|||
44475870|NCT00402116|79483125|FG000|Overall Study|decline related hyponatremia/tumor|0|||
44475871|NCT00402116|79483126|FG001|Overall Study|decline related hyponatremia/tumor|0|||
44475872|NCT00402116|79483127|FG002|Overall Study|decline related hyponatremia/tumor|1|||
44475873|NCT00402116|79483125|FG000|Overall Study|Adverse Event|0|||
44475874|NCT00402116|79483126|FG001|Overall Study|Adverse Event|1|||
44475875|NCT00402116|79483127|FG002|Overall Study|Adverse Event|6|||
44475876|NCT00401960|79483157|FG000|Overall Study|Lost to Follow-up|3|||
44475877|NCT00401960|79483158|FG001|Overall Study|Lost to Follow-up|0|||
44475878|NCT00401960|79483157|FG000|Overall Study|Death|2|||
44475879|NCT00401960|79483158|FG001|Overall Study|Death|0|||
44475880|NCT00401726|79483168|FG000|Overall Study|Adverse Event|34|||
44475881|NCT00401726|79483169|FG001|Overall Study|Adverse Event|45|||
44475882|NCT00401726|79483168|FG000|Overall Study|Death|0|||
44226280|NCT01743560|79032586|FG000|Overall Study|>1 dose of study drug|3|||
44226281|NCT01743092|79032616|FG000|Overall Study|Lost to Follow-up|14|||
44226282|NCT01743092|79032617|FG001|Overall Study|Lost to Follow-up|15|||
44475883|NCT00401726|79483169|FG001|Overall Study|Death|3|||
44475884|NCT00401726|79483168|FG000|Overall Study|Sponsor Request|0|||
44475885|NCT00401726|79483169|FG001|Overall Study|Sponsor Request|1|||
44475886|NCT00401726|79483168|FG000|Overall Study|Physician Decision|3|||
44475887|NCT00401726|79483169|FG001|Overall Study|Physician Decision|6|||
44475888|NCT00401726|79483168|FG000|Overall Study|Lost to Follow-up|23|||
44475889|NCT00401726|79483169|FG001|Overall Study|Lost to Follow-up|20|||
44475890|NCT00401726|79483168|FG000|Overall Study|Protocol Violation|6|||
44475891|NCT00401726|79483169|FG001|Overall Study|Protocol Violation|3|||
44475892|NCT00401726|79483168|FG000|Overall Study|Withdrawal by Subject|18|||
44475893|NCT00401726|79483169|FG001|Overall Study|Withdrawal by Subject|24|||
44475894|NCT00401726|79483168|FG000|Overall Study|Lack of Efficacy|4|||
44475895|NCT00401726|79483169|FG001|Overall Study|Lack of Efficacy|6|||
44475896|NCT00401726|79483168|FG000|Overall Study|Protocol Deviation|9|||
44475897|NCT00401726|79483169|FG001|Overall Study|Protocol Deviation|4|||
44475898|NCT00371826|79483178|FG000|Core Phase (12 Months)|Adverse Event|15|||
44475899|NCT00371826|79483179|FG001|Core Phase (12 Months)|Adverse Event|4|||
44475900|NCT00371826|79483180|FG002|Core Phase (12 Months)|Adverse Event|9|||
44475901|NCT00371826|79483178|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
44475902|NCT00371826|79483179|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
44475903|NCT00371826|79483180|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
44475904|NCT00371826|79483178|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
44475905|NCT00371826|79483179|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
44475906|NCT00371826|79483180|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
44475907|NCT00371826|79483178|FG000|Core Phase (12 Months)|Protocol Violation|1|||
44475908|NCT00371826|79483179|FG001|Core Phase (12 Months)|Protocol Violation|0|||
44475909|NCT00371826|79483180|FG002|Core Phase (12 Months)|Protocol Violation|1|||
44475910|NCT00371826|79483178|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
44475911|NCT00371826|79483179|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
44475912|NCT00371826|79483180|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
44475913|NCT00371826|79483178|FG000|Core Phase (12 Months)|Administrative problems|1|||
44475914|NCT00371826|79483179|FG001|Core Phase (12 Months)|Administrative problems|0|||
44475915|NCT00371826|79483180|FG002|Core Phase (12 Months)|Administrative problems|8|||
44475916|NCT00371826|79483178|FG000|Core Phase (12 Months)|Graft Loss|0|||
44475917|NCT00371826|79483179|FG001|Core Phase (12 Months)|Graft Loss|1|||
44475918|NCT00371826|79483180|FG002|Core Phase (12 Months)|Graft Loss|0|||
44475919|NCT00371826|79483178|FG000|Extension Phase (24 Months)|Adverse Event|4|||
44475920|NCT00371826|79483179|FG001|Extension Phase (24 Months)|Adverse Event|5|||
44226283|NCT01780831|79032650|FG000|Overall Study|Withdrawal by Subject|0|||
44226284|NCT01780831|79032651|FG001|Overall Study|Withdrawal by Subject|0|||
44475921|NCT00371826|79483180|FG002|Extension Phase (24 Months)|Adverse Event|0|||
44475922|NCT00371826|79483178|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
44475923|NCT00371826|79483179|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
44475924|NCT00371826|79483180|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
44475925|NCT00371826|79483178|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
44475926|NCT00371826|79483179|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
44475927|NCT00371826|79483180|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
44475928|NCT00371826|79483178|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
44475929|NCT00371826|79483179|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
44475930|NCT00371826|79483180|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
44475931|NCT00371826|79483178|FG000|Extension Phase (24 Months)|Administrative problems|0|||
44475932|NCT00371826|79483179|FG001|Extension Phase (24 Months)|Administrative problems|0|||
44475933|NCT00371826|79483180|FG002|Extension Phase (24 Months)|Administrative problems|2|||
44475934|NCT00396084|79483194|FG000|Overall Study|Adverse Event|0|||
44475935|NCT00396084|79483195|FG001|Overall Study|Adverse Event|0|||
44475936|NCT00396084|79483196|FG002|Overall Study|Adverse Event|0|||
44475937|NCT00396084|79483197|FG003|Overall Study|Adverse Event|0|||
44475938|NCT00396084|79483198|FG004|Overall Study|Adverse Event|1|||
44475939|NCT00396084|79483199|FG005|Overall Study|Adverse Event|2|||
44475940|NCT00396084|79483194|FG000|Overall Study|Withdrawal by Subject|0|||
44475941|NCT00396084|79483195|FG001|Overall Study|Withdrawal by Subject|0|||
44475942|NCT00396084|79483196|FG002|Overall Study|Withdrawal by Subject|0|||
44475943|NCT00396084|79483197|FG003|Overall Study|Withdrawal by Subject|1|||
44475944|NCT00396084|79483198|FG004|Overall Study|Withdrawal by Subject|0|||
44475945|NCT00396084|79483199|FG005|Overall Study|Withdrawal by Subject|0|||
44475946|NCT00395850|79483221|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
44475947|NCT00395850|79483222|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
44475948|NCT00395850|79483223|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
44475949|NCT00395850|79483224|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
44475950|NCT00395850|79483221|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
44475951|NCT00395850|79483222|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
44475952|NCT00395850|79483223|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
44475953|NCT00395850|79483224|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
44475954|NCT00395850|79483221|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
44475955|NCT00395850|79483222|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
44475956|NCT00395850|79483223|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
44475957|NCT00395850|79483224|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
44475958|NCT00395850|79483221|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
44475959|NCT00395850|79483222|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
44475960|NCT00395850|79483223|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
44475961|NCT00395850|79483224|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
44475962|NCT00395850|79483221|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
44475963|NCT00395850|79483222|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
44475964|NCT00395850|79483223|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
44475965|NCT00395850|79483224|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
44475966|NCT00395850|79483221|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
44475967|NCT00395850|79483222|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
44475968|NCT00395850|79483223|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
44475969|NCT00395850|79483224|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
44475970|NCT00395850|79483221|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
44475971|NCT00395850|79483222|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
44475972|NCT00395850|79483223|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
44475973|NCT00395850|79483224|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
44475974|NCT00420212|79483237|FG000|Overall Study|Adverse Event|22|||
44475975|NCT00420212|79483238|FG001|Overall Study|Adverse Event|40|||
44475976|NCT00420212|79483239|FG002|Overall Study|Adverse Event|36|||
44475977|NCT00420212|79483237|FG000|Overall Study|Lost to Follow-up|9|||
44475978|NCT00420212|79483238|FG001|Overall Study|Lost to Follow-up|11|||
44475979|NCT00420212|79483239|FG002|Overall Study|Lost to Follow-up|11|||
44475980|NCT00420212|79483237|FG000|Overall Study|Withdrawal by Subject|31|||
44475981|NCT00420212|79483238|FG001|Overall Study|Withdrawal by Subject|22|||
44475982|NCT00420212|79483239|FG002|Overall Study|Withdrawal by Subject|19|||
44475983|NCT00420212|79483237|FG000|Overall Study|Physician Decision|4|||
44475984|NCT00420212|79483238|FG001|Overall Study|Physician Decision|4|||
44475985|NCT00420212|79483239|FG002|Overall Study|Physician Decision|3|||
44475986|NCT00420212|79483237|FG000|Overall Study|Protocol Violation|4|||
44475987|NCT00420212|79483238|FG001|Overall Study|Protocol Violation|4|||
44475988|NCT00420212|79483239|FG002|Overall Study|Protocol Violation|8|||
44475989|NCT00420212|79483237|FG000|Overall Study|Death|0|||
44475990|NCT00420212|79483238|FG001|Overall Study|Death|0|||
44475991|NCT00420212|79483239|FG002|Overall Study|Death|1|||
44375485|NCT00902265|79380693|FG000|Overall Study|Protocol Violation|1|||
44475992|NCT00420212|79483237|FG000|Overall Study|Other-Unspecified|21|||
44475993|NCT00420212|79483238|FG001|Overall Study|Other-Unspecified|14|||
44475994|NCT00420212|79483239|FG002|Overall Study|Other-Unspecified|18|||
44475995|NCT00401258|79483250|FG000|Overall Study|Adverse Event|7|||
44475996|NCT00380874|79483256|FG000|Overall Study|Adverse Event|7|||
44475997|NCT00380874|79483257|FG001|Overall Study|Adverse Event|7|||
44475998|NCT00380874|79483256|FG000|Overall Study|Death|1|||
44475999|NCT00380874|79483257|FG001|Overall Study|Death|0|||
44476000|NCT00380874|79483256|FG000|Overall Study|Withdrawal by Subject|2|||
44476001|NCT00380874|79483257|FG001|Overall Study|Withdrawal by Subject|1|||
44476002|NCT00380874|79483256|FG000|Overall Study|Not related to study drug|3|||
44476003|NCT00380874|79483257|FG001|Overall Study|Not related to study drug|2|||
44476004|NCT00420056|79483263|FG000|Overall Study|Objective progression or relapse|17|||
44476005|NCT00411554|79483269|FG000|Overall Study|Adverse Event|2|||
44476006|NCT00411554|79483270|FG001|Overall Study|Adverse Event|4|||
44476007|NCT00411554|79483269|FG000|Overall Study|Lack of Efficacy|2|||
44476008|NCT00411554|79483270|FG001|Overall Study|Lack of Efficacy|5|||
44476009|NCT00411554|79483269|FG000|Overall Study|Withdrawal by Subject|3|||
44476010|NCT00411554|79483270|FG001|Overall Study|Withdrawal by Subject|0|||
44476011|NCT00411554|79483269|FG000|Overall Study|Patient Moved|1|||
44476012|NCT00411554|79483270|FG001|Overall Study|Patient Moved|0|||
44476013|NCT00400712|79483278|FG000|Overall Study|Death|1|||
44476014|NCT00400712|79483279|FG001|Overall Study|Death|0|||
44476015|NCT00400712|79483278|FG000|Overall Study|Withdrawal by Subject|11|||
44476016|NCT00400712|79483279|FG001|Overall Study|Withdrawal by Subject|12|||
44476017|NCT00400712|79483278|FG000|Overall Study|Physician Decision|5|||
44476018|NCT00400712|79483279|FG001|Overall Study|Physician Decision|4|||
44476019|NCT00380718|79483287|FG000|Overall Study|Adverse Event|1|||
44476020|NCT00380718|79483287|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
44476021|NCT00380250|79483293|FG000|Overall Study|Withdrawal by Subject|39|||
44476022|NCT00380250|79483294|FG001|Overall Study|Withdrawal by Subject|28|||
44476023|NCT00380250|79483293|FG000|Overall Study|Adverse Event|20|||
44476024|NCT00380250|79483294|FG001|Overall Study|Adverse Event|9|||
44476025|NCT00380250|79483293|FG000|Overall Study|Lack of Efficacy|10|||
44476026|NCT00380250|79483294|FG001|Overall Study|Lack of Efficacy|8|||
44476027|NCT00380250|79483293|FG000|Overall Study|Protocol Violation|15|||
44476028|NCT00380250|79483294|FG001|Overall Study|Protocol Violation|5|||
44476029|NCT00380250|79483293|FG000|Overall Study|Lost to Follow-up|14|||
44476030|NCT00380250|79483294|FG001|Overall Study|Lost to Follow-up|5|||
44476031|NCT00380250|79483293|FG000|Overall Study|Physician Decision|1|||
44476032|NCT00380250|79483294|FG001|Overall Study|Physician Decision|0|||
44476033|NCT00400400|79483302|FG000|Overall Study|Adverse Event|9|||
44476034|NCT00400400|79483303|FG001|Overall Study|Adverse Event|8|||
44476035|NCT00400400|79483302|FG000|Overall Study|Protocol Violation|2|||
44476036|NCT00400400|79483303|FG001|Overall Study|Protocol Violation|0|||
44476037|NCT00400400|79483302|FG000|Overall Study|Withdrawal by Subject|1|||
44476038|NCT00400400|79483303|FG001|Overall Study|Withdrawal by Subject|3|||
44476039|NCT00400400|79483302|FG000|Overall Study|Administrative Problem|1|||
44476040|NCT00400400|79483303|FG001|Overall Study|Administrative Problem|0|||
44476041|NCT00400400|79483302|FG000|Overall Study|Lost to Follow-up|0|||
44476042|NCT00400400|79483303|FG001|Overall Study|Lost to Follow-up|1|||
44476043|NCT00400400|79483302|FG000|Overall Study|Did not receive study drug|1|||
44476044|NCT00400400|79483303|FG001|Overall Study|Did not receive study drug|3|||
44476045|NCT00395694|79483311|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
44476046|NCT00395694|79483312|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
44476047|NCT00395694|79483311|FG000|Continuation Phase|Adverse Event|1|||
44476048|NCT00395694|79483312|FG001|Continuation Phase|Adverse Event|0|||
44476049|NCT00395694|79483311|FG000|Continuation Phase|Lack of Efficacy|12|||
44476050|NCT00395694|79483312|FG001|Continuation Phase|Lack of Efficacy|11|||
44476051|NCT00395694|79483311|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
44476052|NCT00395694|79483312|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
44476053|NCT00395694|79483311|FG000|Continuation Phase|Poor Compliance|1|||
44476054|NCT00395694|79483312|FG001|Continuation Phase|Poor Compliance|0|||
44476055|NCT00395694|79483311|FG000|Continuation Phase|Withdrawal by Subject|0|||
44476056|NCT00395694|79483312|FG001|Continuation Phase|Withdrawal by Subject|2|||
44476057|NCT00419744|79483324|FG000|Overall Study|Adverse Event|39|||
44476058|NCT00419744|79483325|FG001|Overall Study|Adverse Event|40|||
44476059|NCT00419744|79483326|FG002|Overall Study|Adverse Event|50|||
44476060|NCT00419744|79483324|FG000|Overall Study|Withdrawal by Subject|45|||
44476061|NCT00419744|79483325|FG001|Overall Study|Withdrawal by Subject|49|||
44476062|NCT00419744|79483326|FG002|Overall Study|Withdrawal by Subject|52|||
44476063|NCT00419744|79483324|FG000|Overall Study|Lost to Follow-up|8|||
44476064|NCT00419744|79483325|FG001|Overall Study|Lost to Follow-up|10|||
44476065|NCT00419744|79483326|FG002|Overall Study|Lost to Follow-up|6|||
44476066|NCT00419744|79483324|FG000|Overall Study|Protocol Violation|4|||
44476067|NCT00419744|79483325|FG001|Overall Study|Protocol Violation|7|||
44476068|NCT00419744|79483326|FG002|Overall Study|Protocol Violation|8|||
44476069|NCT00419744|79483324|FG000|Overall Study|Randomized in error|9|||
44476070|NCT00419744|79483325|FG001|Overall Study|Randomized in error|6|||
44476071|NCT00419744|79483326|FG002|Overall Study|Randomized in error|7|||
44476072|NCT00419744|79483324|FG000|Overall Study|Moving out of state|2|||
44476073|NCT00419744|79483325|FG001|Overall Study|Moving out of state|0|||
44476074|NCT00419744|79483326|FG002|Overall Study|Moving out of state|1|||
44476075|NCT00419744|79483324|FG000|Overall Study|Physician Decision|10|||
44476076|NCT00419744|79483325|FG001|Overall Study|Physician Decision|5|||
44476077|NCT00419744|79483326|FG002|Overall Study|Physician Decision|6|||
44476078|NCT00419744|79483324|FG000|Overall Study|Spirometry mouthpiece issues|0|||
44476079|NCT00419744|79483325|FG001|Overall Study|Spirometry mouthpiece issues|1|||
44476080|NCT00419744|79483326|FG002|Overall Study|Spirometry mouthpiece issues|2|||
44476081|NCT00419744|79483324|FG000|Overall Study|Incorrect medication kit dispensed|0|||
44476082|NCT00419744|79483325|FG001|Overall Study|Incorrect medication kit dispensed|0|||
44476083|NCT00419744|79483326|FG002|Overall Study|Incorrect medication kit dispensed|1|||
44476084|NCT00395538|79483337|FG000|Overall Study|Did not re-consent to revised protocol|1|||
44476085|NCT00395538|79483338|FG001|Overall Study|Did not re-consent to revised protocol|10|||
44476086|NCT00395538|79483339|FG002|Overall Study|Did not re-consent to revised protocol|0|||
44476087|NCT00395538|79483337|FG000|Overall Study|FDA partial hold on PTH|0|||
44476088|NCT00395538|79483338|FG001|Overall Study|FDA partial hold on PTH|0|||
44476089|NCT00395538|79483339|FG002|Overall Study|FDA partial hold on PTH|11|||
44476090|NCT00395538|79483337|FG000|Overall Study|Failed screening|0|||
44476091|NCT00395538|79483338|FG001|Overall Study|Failed screening|0|||
44476092|NCT00395538|79483339|FG002|Overall Study|Failed screening|4|||
44476093|NCT00395538|79483337|FG000|Overall Study|Switch to Natpara|0|||
44476094|NCT00395538|79483338|FG001|Overall Study|Switch to Natpara|0|||
44476095|NCT00395538|79483339|FG002|Overall Study|Switch to Natpara|3|||
44476096|NCT00395538|79483337|FG000|Overall Study|Adverse Event|1|||
44476097|NCT00395538|79483338|FG001|Overall Study|Adverse Event|0|||
44476098|NCT00395538|79483339|FG002|Overall Study|Adverse Event|2|||
44476099|NCT00395538|79483337|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
44476100|NCT00395538|79483338|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
44476101|NCT00395538|79483339|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
44476102|NCT00395538|79483337|FG000|Overall Study|Non-compliance with study protocol|0|||
44476103|NCT00395538|79483338|FG001|Overall Study|Non-compliance with study protocol|1|||
44476104|NCT00395538|79483339|FG002|Overall Study|Non-compliance with study protocol|0|||
44476105|NCT00395538|79483337|FG000|Overall Study|PTH resistance|0|||
44476106|NCT00395538|79483338|FG001|Overall Study|PTH resistance|0|||
44476107|NCT00395538|79483339|FG002|Overall Study|PTH resistance|1|||
44476108|NCT00395538|79483337|FG000|Overall Study|Pregnancy|1|||
44476109|NCT00395538|79483338|FG001|Overall Study|Pregnancy|0|||
44476110|NCT00395538|79483339|FG002|Overall Study|Pregnancy|0|||
44476111|NCT00395538|79483337|FG000|Overall Study|Partial recovery of parathyroid function|0|||
44476112|NCT00395538|79483338|FG001|Overall Study|Partial recovery of parathyroid function|0|||
44476113|NCT00395538|79483339|FG002|Overall Study|Partial recovery of parathyroid function|1|||
44476114|NCT00395538|79483337|FG000|Overall Study|Participant elected to discontinue|0|||
44476115|NCT00395538|79483338|FG001|Overall Study|Participant elected to discontinue|0|||
44476116|NCT00395538|79483339|FG002|Overall Study|Participant elected to discontinue|1|||
44476117|NCT00395460|79483349|FG000|Overall Study|Withdrawal by Subject|1|||
44476118|NCT00395460|79483350|FG001|Overall Study|Withdrawal by Subject|0|||
44476119|NCT00395304|79483356|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44476120|NCT00395304|79483357|FG001|Treatment Period 1|Withdrawal by Subject|3|||
44476121|NCT00395304|79483358|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44476122|NCT00395304|79483359|FG003|Treatment Period 1|Withdrawal by Subject|2|||
44476123|NCT00395304|79483360|FG004|Treatment Period 1|Withdrawal by Subject|1|||
44476124|NCT00395304|79483361|FG005|Treatment Period 1|Withdrawal by Subject|1|||
44476125|NCT00395304|79483356|FG000|Treatment Period 1|Lost to Follow-up|1|||
44476126|NCT00395304|79483357|FG001|Treatment Period 1|Lost to Follow-up|0|||
44476127|NCT00395304|79483358|FG002|Treatment Period 1|Lost to Follow-up|0|||
44476128|NCT00395304|79483359|FG003|Treatment Period 1|Lost to Follow-up|1|||
44476129|NCT00395304|79483360|FG004|Treatment Period 1|Lost to Follow-up|0|||
44476130|NCT00395304|79483361|FG005|Treatment Period 1|Lost to Follow-up|1|||
44476131|NCT00395304|79483356|FG000|Treatment Period 1|Physician Decision|0|||
44476132|NCT00395304|79483357|FG001|Treatment Period 1|Physician Decision|1|||
44476133|NCT00395304|79483358|FG002|Treatment Period 1|Physician Decision|0|||
44476134|NCT00395304|79483359|FG003|Treatment Period 1|Physician Decision|0|||
44476135|NCT00395304|79483360|FG004|Treatment Period 1|Physician Decision|0|||
44476136|NCT00395304|79483361|FG005|Treatment Period 1|Physician Decision|0|||
44476137|NCT00395304|79483356|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44476138|NCT00395304|79483357|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44476139|NCT00395304|79483358|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44476140|NCT00395304|79483359|FG003|Treatment Period 2|Withdrawal by Subject|1|||
44476141|NCT00395304|79483360|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44476142|NCT00395304|79483361|FG005|Treatment Period 2|Withdrawal by Subject|2|||
44476143|NCT00395304|79483356|FG000|Treatment Period 2|Lost to Follow-up|0|||
44476144|NCT00395304|79483357|FG001|Treatment Period 2|Lost to Follow-up|3|||
44476145|NCT00395304|79483358|FG002|Treatment Period 2|Lost to Follow-up|0|||
44476146|NCT00395304|79483359|FG003|Treatment Period 2|Lost to Follow-up|0|||
44476147|NCT00395304|79483360|FG004|Treatment Period 2|Lost to Follow-up|0|||
44544566|NCT03216954|79558091|FG002|Overall Study|Withdrawal by Subject|0|||
44544567|NCT03216954|79558092|FG003|Overall Study|Withdrawal by Subject|0|||
44544568|NCT03216954|79558093|FG004|Overall Study|Withdrawal by Subject|0|||
44476148|NCT00395304|79483361|FG005|Treatment Period 2|Lost to Follow-up|0|||
44476149|NCT00395304|79483356|FG000|Treatment Period 2|Physician Decision|0|||
44476150|NCT00395304|79483357|FG001|Treatment Period 2|Physician Decision|0|||
44476151|NCT00395304|79483358|FG002|Treatment Period 2|Physician Decision|1|||
44476152|NCT00395304|79483359|FG003|Treatment Period 2|Physician Decision|0|||
44476153|NCT00395304|79483360|FG004|Treatment Period 2|Physician Decision|0|||
44476154|NCT00395304|79483361|FG005|Treatment Period 2|Physician Decision|0|||
44476155|NCT00395304|79483356|FG000|Treatment Period 2|Other|0|||
44476156|NCT00395304|79483357|FG001|Treatment Period 2|Other|1|||
44476157|NCT00395304|79483358|FG002|Treatment Period 2|Other|0|||
44476158|NCT00395304|79483359|FG003|Treatment Period 2|Other|0|||
44476159|NCT00395304|79483360|FG004|Treatment Period 2|Other|0|||
44476160|NCT00395304|79483361|FG005|Treatment Period 2|Other|0|||
44476161|NCT00395304|79483356|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44476162|NCT00395304|79483357|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44476163|NCT00395304|79483358|FG002|Treatment Period 3|Withdrawal by Subject|0|||
44476164|NCT00395304|79483359|FG003|Treatment Period 3|Withdrawal by Subject|1|||
44476165|NCT00395304|79483360|FG004|Treatment Period 3|Withdrawal by Subject|0|||
44476166|NCT00395304|79483361|FG005|Treatment Period 3|Withdrawal by Subject|1|||
44476167|NCT00395304|79483356|FG000|Treatment Period 3|Lost to Follow-up|1|||
44476168|NCT00395304|79483357|FG001|Treatment Period 3|Lost to Follow-up|1|||
44476169|NCT00395304|79483358|FG002|Treatment Period 3|Lost to Follow-up|0|||
44476170|NCT00395304|79483359|FG003|Treatment Period 3|Lost to Follow-up|0|||
44476171|NCT00395304|79483360|FG004|Treatment Period 3|Lost to Follow-up|0|||
44476172|NCT00395304|79483361|FG005|Treatment Period 3|Lost to Follow-up|0|||
44476173|NCT00395304|79483356|FG000|Treatment Period 3|Physician Decision|0|||
44476174|NCT00395304|79483357|FG001|Treatment Period 3|Physician Decision|1|||
44476175|NCT00395304|79483358|FG002|Treatment Period 3|Physician Decision|0|||
44476176|NCT00395304|79483359|FG003|Treatment Period 3|Physician Decision|0|||
44476177|NCT00395304|79483360|FG004|Treatment Period 3|Physician Decision|0|||
44476178|NCT00395304|79483361|FG005|Treatment Period 3|Physician Decision|0|||
44476179|NCT00395304|79483356|FG000|Treatment Period 3|Other|0|||
44476180|NCT00395304|79483357|FG001|Treatment Period 3|Other|0|||
44476181|NCT00395304|79483358|FG002|Treatment Period 3|Other|0|||
44476182|NCT00395304|79483359|FG003|Treatment Period 3|Other|1|||
44476183|NCT00395304|79483360|FG004|Treatment Period 3|Other|0|||
44476184|NCT00395304|79483361|FG005|Treatment Period 3|Other|0|||
44476185|NCT00395226|79483370|FG000|Overall Study|Adverse Event|4|||
44476186|NCT00395226|79483371|FG001|Overall Study|Adverse Event|3|||
44476187|NCT00395226|79483370|FG000|Overall Study|Withdrawal by Subject|0|||
44476188|NCT00395226|79483371|FG001|Overall Study|Withdrawal by Subject|1|||
44476189|NCT00395226|79483370|FG000|Overall Study|Lost to Follow-up|0|||
44476190|NCT00395226|79483371|FG001|Overall Study|Lost to Follow-up|1|||
44476191|NCT00394914|79483379|FG000|Treatment Period|Adverse Event|0|||
44476192|NCT00394914|79483380|FG001|Treatment Period|Adverse Event|3|||
44476193|NCT00394914|79483381|FG002|Treatment Period|Adverse Event|1|||
44476194|NCT00394914|79483379|FG000|Treatment Period|Lost to Follow-up|0|||
44476195|NCT00394914|79483380|FG001|Treatment Period|Lost to Follow-up|1|||
44476196|NCT00394914|79483381|FG002|Treatment Period|Lost to Follow-up|0|||
44476197|NCT00394914|79483379|FG000|Treatment Period|Withdrawal by Subject|0|||
44476198|NCT00394914|79483380|FG001|Treatment Period|Withdrawal by Subject|2|||
44476199|NCT00394914|79483381|FG002|Treatment Period|Withdrawal by Subject|2|||
44476200|NCT00394914|79483379|FG000|Treatment Period|Noncompliance with protocol|0|||
44476201|NCT00394914|79483380|FG001|Treatment Period|Noncompliance with protocol|3|||
44476202|NCT00394914|79483381|FG002|Treatment Period|Noncompliance with protocol|2|||
44476203|NCT00394914|79483379|FG000|Treatment Period|Did not meet protocol eligibility|0|||
44476204|NCT00394914|79483380|FG001|Treatment Period|Did not meet protocol eligibility|1|||
44476205|NCT00394914|79483381|FG002|Treatment Period|Did not meet protocol eligibility|1|||
44476206|NCT00366444|79483389|FG000|Overall Study|Withdrawal by Subject|1|||
44476207|NCT00366444|79483390|FG001|Overall Study|Withdrawal by Subject|1|||
44476208|NCT00366444|79483389|FG000|Overall Study|Lack of Efficacy|0|||
44476209|NCT00366444|79483390|FG001|Overall Study|Lack of Efficacy|1|||
44476210|NCT00365976|79483398|FG000|Overall Study|Withdrawal by Subject|1|||
44476211|NCT00365976|79483399|FG001|Overall Study|Withdrawal by Subject|5|||
44476212|NCT00379236|79483407|FG000|Double-blind|Adverse Event|11|||
44476213|NCT00379236|79483408|FG001|Double-blind|Adverse Event|6|||
44476214|NCT00379236|79483409|FG002|Double-blind|Adverse Event|0|||
44476215|NCT00379236|79483407|FG000|Double-blind|Protocol Violation|3|||
44476216|NCT00379236|79483408|FG001|Double-blind|Protocol Violation|3|||
44476217|NCT00379236|79483409|FG002|Double-blind|Protocol Violation|0|||
44476218|NCT00379236|79483407|FG000|Double-blind|Withdrawal by Subject|12|||
44476219|NCT00379236|79483408|FG001|Double-blind|Withdrawal by Subject|13|||
44476220|NCT00379236|79483409|FG002|Double-blind|Withdrawal by Subject|0|||
44476221|NCT00379236|79483407|FG000|Double-blind|Lost to Follow-up|4|||
44476222|NCT00379236|79483408|FG001|Double-blind|Lost to Follow-up|3|||
44476223|NCT00379236|79483409|FG002|Double-blind|Lost to Follow-up|0|||
44476224|NCT00379236|79483407|FG000|Double-blind|Use of exclusionary medication|1|||
44476225|NCT00379236|79483408|FG001|Double-blind|Use of exclusionary medication|2|||
44476226|NCT00379236|79483409|FG002|Double-blind|Use of exclusionary medication|0|||
44476227|NCT00379236|79483407|FG000|Double-blind|Other|3|||
44476228|NCT00379236|79483408|FG001|Double-blind|Other|7|||
44476229|NCT00379236|79483409|FG002|Double-blind|Other|0|||
44476230|NCT00379236|79483407|FG000|Double-blind|Data could not be retrieved|2|||
44476231|NCT00379236|79483408|FG001|Double-blind|Data could not be retrieved|2|||
44476232|NCT00379236|79483409|FG002|Double-blind|Data could not be retrieved|0|||
44476233|NCT00379236|79483407|FG000|Open-label Extension|Adverse Event|0|||
44476234|NCT00379236|79483408|FG001|Open-label Extension|Adverse Event|0|||
44476235|NCT00379236|79483409|FG002|Open-label Extension|Adverse Event|13|||
44226285|NCT01780831|79032652|FG002|Overall Study|Withdrawal by Subject|4|||
44226286|NCT01780831|79032653|FG003|Overall Study|Withdrawal by Subject|0|||
44476236|NCT00379236|79483407|FG000|Open-label Extension|Protocol Violation|0|||
44476237|NCT00379236|79483408|FG001|Open-label Extension|Protocol Violation|0|||
44476238|NCT00379236|79483409|FG002|Open-label Extension|Protocol Violation|7|||
44476239|NCT00379236|79483407|FG000|Open-label Extension|Withdrawal by Subject|0|||
44476240|NCT00379236|79483408|FG001|Open-label Extension|Withdrawal by Subject|0|||
44476241|NCT00379236|79483409|FG002|Open-label Extension|Withdrawal by Subject|13|||
44476242|NCT00379236|79483407|FG000|Open-label Extension|Lost to Follow-up|0|||
44476243|NCT00379236|79483408|FG001|Open-label Extension|Lost to Follow-up|0|||
44476244|NCT00379236|79483409|FG002|Open-label Extension|Lost to Follow-up|12|||
44476245|NCT00379236|79483407|FG000|Open-label Extension|Use of exclusionary medication|0|||
44476246|NCT00379236|79483408|FG001|Open-label Extension|Use of exclusionary medication|0|||
44476247|NCT00379236|79483409|FG002|Open-label Extension|Use of exclusionary medication|3|||
44476248|NCT00379236|79483407|FG000|Open-label Extension|Other|0|||
44476249|NCT00379236|79483408|FG001|Open-label Extension|Other|0|||
44476250|NCT00379236|79483409|FG002|Open-label Extension|Other|7|||
44476251|NCT00379080|79483424|FG000|Overall Study|Withdrawal by Subject|0|||
44476252|NCT00379080|79483425|FG001|Overall Study|Withdrawal by Subject|4|||
44476253|NCT00379080|79483426|FG002|Overall Study|Withdrawal by Subject|0|||
44476254|NCT00378534|79483451|FG000|Overall Study|Participants did not receive transplant|3|||
44476255|NCT00378534|79483452|FG001|Overall Study|Participants did not receive transplant|0|||
44476256|NCT00377676|79483459|FG000|Overall Study|Adverse Event|498|||
44476257|NCT00377676|79483460|FG001|Overall Study|Adverse Event|107|||
44476258|NCT00377676|79483459|FG000|Overall Study|Protocol Violation|33|||
44476259|NCT00377676|79483460|FG001|Overall Study|Protocol Violation|27|||
44476260|NCT00377676|79483459|FG000|Overall Study|Death|5|||
44476261|NCT00377676|79483460|FG001|Overall Study|Death|2|||
44476262|NCT00377676|79483459|FG000|Overall Study|Withdrawal by Subject|187|||
44476263|NCT00377676|79483460|FG001|Overall Study|Withdrawal by Subject|72|||
44476264|NCT00377676|79483459|FG000|Overall Study|Lost to Follow-up|120|||
44476265|NCT00377676|79483460|FG001|Overall Study|Lost to Follow-up|56|||
44476266|NCT00377676|79483459|FG000|Overall Study|Other|118|||
44476267|NCT00377676|79483460|FG001|Overall Study|Other|58|||
44476268|NCT00377520|79483466|FG000|Overall Study|Ineligible (Prior radiation)|1|||
44226287|NCT01780831|79032650|FG000|Overall Study|Lost to Follow-up|0|||
44226288|NCT01780831|79032651|FG001|Overall Study|Lost to Follow-up|0|||
44226289|NCT01780831|79032652|FG002|Overall Study|Lost to Follow-up|0|||
44226290|NCT01780831|79032653|FG003|Overall Study|Lost to Follow-up|1|||
44226291|NCT01778023|79032712|FG000|Overall Study|Withdrawal by Subject|0|||
44226292|NCT01778023|79032713|FG001|Overall Study|Withdrawal by Subject|3|||
44226293|NCT01753297|79032721|FG000|Overall Study|Lost to Follow-up|7|||
44226294|NCT01753297|79032722|FG001|Overall Study|Lost to Follow-up|2|||
44476269|NCT00377364|79483472|FG000|Overall Study|Lost to Follow-up|1|||
44476270|NCT00377364|79483473|FG001|Overall Study|Lost to Follow-up|0|||
44476271|NCT00377364|79483472|FG000|Overall Study|Withdrawal by Subject|1|||
44476272|NCT00377364|79483473|FG001|Overall Study|Withdrawal by Subject|0|||
44476273|NCT03831282|79483481|FG000|Overall Study|Could not place sensor|1|||
44476274|NCT00365508|79483487|FG000|Overall Study|Lost to Follow-up|139|||
44226295|NCT01753297|79032721|FG000|Overall Study|Withdrawal by Subject|26|||
44226296|NCT01753297|79032722|FG001|Overall Study|Withdrawal by Subject|23|||
44476275|NCT00365508|79483488|FG001|Overall Study|Lost to Follow-up|154|||
44476276|NCT00365352|79483497|FG000|Overall Study|Adverse Event|6|||
44476277|NCT00365352|79483498|FG001|Overall Study|Adverse Event|7|||
44476278|NCT00365352|79483499|FG002|Overall Study|Adverse Event|8|||
44476279|NCT00365352|79483497|FG000|Overall Study|Participant Withdrew Consent|8|||
44544569|NCT03216954|79558089|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
44375486|NCT00943722|79380711|FG000|Base Study|Adverse Event|0|||
44226297|NCT01753297|79032721|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
44226298|NCT01753297|79032722|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
44476280|NCT00365352|79483498|FG001|Overall Study|Participant Withdrew Consent|3|||
44476281|NCT00365352|79483499|FG002|Overall Study|Participant Withdrew Consent|4|||
44476282|NCT00365352|79483497|FG000|Overall Study|Lack of Efficacy|3|||
44476283|NCT00365352|79483498|FG001|Overall Study|Lack of Efficacy|0|||
44476284|NCT00365352|79483499|FG002|Overall Study|Lack of Efficacy|0|||
44476285|NCT00365352|79483497|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
44476286|NCT00365352|79483498|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
44476287|NCT00365352|79483499|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
44476288|NCT00365352|79483497|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
44476289|NCT00365352|79483498|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
44476290|NCT00365352|79483499|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
44476291|NCT00365352|79483497|FG000|Overall Study|Lost to Follow-up|1|||
44476292|NCT00365352|79483498|FG001|Overall Study|Lost to Follow-up|1|||
44476293|NCT00365352|79483499|FG002|Overall Study|Lost to Follow-up|0|||
44476294|NCT00365352|79483497|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
44476295|NCT00365352|79483498|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
44476296|NCT00365352|79483499|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
44476297|NCT00376506|79483512|FG000|Overall Study|Death|0|||
44476298|NCT00376506|79483513|FG001|Overall Study|Death|2|||
44476299|NCT00410384|79483525|FG000|Overall Study|Withdrawal by Subject|28|||
44476300|NCT00410384|79483526|FG001|Overall Study|Withdrawal by Subject|17|||
44226299|NCT01753297|79032721|FG000|Overall Study|Death|0|||
44226300|NCT01753297|79032722|FG001|Overall Study|Death|2|||
44226301|NCT01753297|79032721|FG000|Overall Study|Did not attend end of study visit|7|||
44476301|NCT00410384|79483527|FG002|Overall Study|Withdrawal by Subject|20|||
44476302|NCT00410384|79483525|FG000|Overall Study|Adverse Event|23|||
44476303|NCT00410384|79483526|FG001|Overall Study|Adverse Event|18|||
44476304|NCT00410384|79483527|FG002|Overall Study|Adverse Event|23|||
44476305|NCT00410384|79483525|FG000|Overall Study|Lack of Efficacy|20|||
44476306|NCT00410384|79483526|FG001|Overall Study|Lack of Efficacy|12|||
44476307|NCT00410384|79483527|FG002|Overall Study|Lack of Efficacy|17|||
44476308|NCT00410384|79483525|FG000|Overall Study|Lack of Compliance|2|||
44476309|NCT00410384|79483526|FG001|Overall Study|Lack of Compliance|2|||
44476310|NCT00410384|79483527|FG002|Overall Study|Lack of Compliance|2|||
44476311|NCT00410384|79483525|FG000|Overall Study|Lost to Follow-up|4|||
44476312|NCT00410384|79483526|FG001|Overall Study|Lost to Follow-up|6|||
44476313|NCT00410384|79483527|FG002|Overall Study|Lost to Follow-up|6|||
44476314|NCT00410384|79483525|FG000|Overall Study|Protocol Violation|6|||
44476315|NCT00410384|79483526|FG001|Overall Study|Protocol Violation|6|||
44476316|NCT00410384|79483527|FG002|Overall Study|Protocol Violation|6|||
44476317|NCT00410384|79483525|FG000|Overall Study|Physician Decision|3|||
44476318|NCT00410384|79483526|FG001|Overall Study|Physician Decision|3|||
44476319|NCT00410384|79483527|FG002|Overall Study|Physician Decision|4|||
44476320|NCT00410384|79483525|FG000|Overall Study|Other|3|||
44476321|NCT00410384|79483526|FG001|Overall Study|Other|8|||
44226302|NCT01753297|79032722|FG001|Overall Study|Did not attend end of study visit|8|||
44226303|NCT01777321|79032732|FG000|Overall Study|Withdrawal by Subject|0|||
44226304|NCT01777321|79032733|FG001|Overall Study|Withdrawal by Subject|1|||
44226305|NCT01729819|79032741|FG000|Overall Study|Adverse Event|2|||
44226306|NCT01729819|79032742|FG001|Overall Study|Adverse Event|4|||
44226307|NCT01729819|79032741|FG000|Overall Study|Lack of Efficacy|1|||
44226308|NCT01729819|79032742|FG001|Overall Study|Lack of Efficacy|0|||
44226309|NCT01729819|79032741|FG000|Overall Study|Lost to Follow-up|2|||
44375487|NCT00943722|79380712|FG001|Base Study|Adverse Event|0|||
44476322|NCT00410384|79483527|FG002|Overall Study|Other|4|||
44476323|NCT00370032|79483537|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
44476324|NCT00370032|79483538|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
44476325|NCT00370032|79483537|FG000|Washout Period|Withdrawal by Subject|0|||
44476326|NCT00370032|79483538|FG001|Washout Period|Withdrawal by Subject|1|||
44544570|NCT03216954|79558090|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
44544571|NCT03216954|79558091|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
44476327|NCT00370032|79483537|FG000|Washout Period|Lost to Follow-up|0|||
44476328|NCT00370032|79483538|FG001|Washout Period|Lost to Follow-up|1|||
44476329|NCT00370032|79483537|FG000|Washout Period|Adverse Event|1|||
44476330|NCT00370032|79483538|FG001|Washout Period|Adverse Event|0|||
44476331|NCT00370032|79483537|FG000|Follow-up Period|Withdrawal by Subject|1|||
44226310|NCT01729819|79032742|FG001|Overall Study|Lost to Follow-up|0|||
44226311|NCT01729819|79032741|FG000|Overall Study|Other reason|1|||
44226312|NCT01729819|79032742|FG001|Overall Study|Other reason|0|||
44226313|NCT01729819|79032741|FG000|Overall Study|Protocol Violation|0|||
44226314|NCT01729819|79032742|FG001|Overall Study|Protocol Violation|1|||
44226315|NCT01729819|79032741|FG000|Overall Study|Withdrawal by Subject|0|||
44226316|NCT01729819|79032742|FG001|Overall Study|Withdrawal by Subject|2|||
44476332|NCT00370032|79483538|FG001|Follow-up Period|Withdrawal by Subject|0|||
44476333|NCT00410072|79483555|FG000|Day 1 to Week 48|Adverse Event|1|||
44476334|NCT00410072|79483556|FG001|Day 1 to Week 48|Adverse Event|2|||
44476335|NCT00410072|79483555|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
44476336|NCT00410072|79483556|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
44476337|NCT00410072|79483555|FG000|Day 1 to Week 48|Other|0|||
44476338|NCT00410072|79483556|FG001|Day 1 to Week 48|Other|1|||
44476339|NCT00410072|79483555|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
44476340|NCT00410072|79483556|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
44476341|NCT00410072|79483555|FG000|Day 1 to Week 48|Pregnancy|0|||
44476342|NCT00410072|79483556|FG001|Day 1 to Week 48|Pregnancy|2|||
44476343|NCT00410072|79483555|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
44476344|NCT00410072|79483556|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
44476345|NCT00410072|79483555|FG000|After Week 48 to Week 96|Adverse Event|1|||
44476346|NCT00410072|79483556|FG001|After Week 48 to Week 96|Adverse Event|2|||
44476347|NCT00410072|79483555|FG000|After Week 48 to Week 96|Death|0|||
44476348|NCT00410072|79483556|FG001|After Week 48 to Week 96|Death|1|||
44476349|NCT00410072|79483555|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
44476350|NCT00410072|79483556|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
44476351|NCT00410072|79483555|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
44476352|NCT00410072|79483556|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
44476353|NCT00410072|79483555|FG000|After Week 48 to Week 96|Other|2|||
44476354|NCT00410072|79483556|FG001|After Week 48 to Week 96|Other|0|||
44476355|NCT00410072|79483555|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
44476356|NCT00410072|79483556|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
44476357|NCT00410072|79483555|FG000|After Week 48 to Week 96|Pregnancy|0|||
44476358|NCT00410072|79483556|FG001|After Week 48 to Week 96|Pregnancy|2|||
44476359|NCT00410072|79483555|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
44476360|NCT00410072|79483556|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
44476361|NCT00409838|79483564|FG000|Short-term Period|Adverse Event|0|||
44476362|NCT00409838|79483565|FG001|Short-term Period|Adverse Event|1|||
44476363|NCT00409838|79483564|FG000|Short-term Period|Lost to Follow-up|0|||
44476364|NCT00409838|79483565|FG001|Short-term Period|Lost to Follow-up|1|||
44476365|NCT00409838|79483564|FG000|Short-term Period|Withdrawal by Subject|2|||
44476366|NCT00409838|79483565|FG001|Short-term Period|Withdrawal by Subject|3|||
44476367|NCT00409838|79483564|FG000|Short-term Period|Never Treated|1|||
44476368|NCT00409838|79483565|FG001|Short-term Period|Never Treated|0|||
44476369|NCT00409838|79483564|FG000|Long-term Extension Period|Adverse Event|10|||
44476370|NCT00409838|79483565|FG001|Long-term Extension Period|Adverse Event|0|||
44476371|NCT00409838|79483564|FG000|Long-term Extension Period|Death|1|||
44476372|NCT00409838|79483565|FG001|Long-term Extension Period|Death|0|||
44476373|NCT00409838|79483564|FG000|Long-term Extension Period|Lack of Efficacy|2|||
44476374|NCT00409838|79483565|FG001|Long-term Extension Period|Lack of Efficacy|0|||
44476375|NCT00409838|79483564|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
44476376|NCT00409838|79483565|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
44476377|NCT00409838|79483564|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
44476378|NCT00409838|79483565|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
44476379|NCT00409838|79483564|FG000|Long-term Extension Period|Pregnancy|1|||
44476380|NCT00409838|79483565|FG001|Long-term Extension Period|Pregnancy|0|||
44476381|NCT00399542|79483590|FG000|Overall Study|Adverse Event|18|||
44476382|NCT00399542|79483591|FG001|Overall Study|Adverse Event|15|||
44476383|NCT00399542|79483590|FG000|Overall Study|Protocol Violation|13|||
44476384|NCT00399542|79483591|FG001|Overall Study|Protocol Violation|3|||
44476385|NCT00399542|79483590|FG000|Overall Study|Withdrawal by Subject|28|||
44476386|NCT00399542|79483591|FG001|Overall Study|Withdrawal by Subject|10|||
44476387|NCT00399542|79483590|FG000|Overall Study|Lack of Efficacy|18|||
44476388|NCT00399542|79483591|FG001|Overall Study|Lack of Efficacy|8|||
44476389|NCT00399542|79483590|FG000|Overall Study|Lost to Follow-up|6|||
44476390|NCT00399542|79483591|FG001|Overall Study|Lost to Follow-up|6|||
44476391|NCT00399542|79483590|FG000|Overall Study|Other|1|||
44476392|NCT00399542|79483591|FG001|Overall Study|Other|0|||
44544572|NCT03216954|79558092|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
44476393|NCT00399542|79483590|FG000|Overall Study|Physician Decision|0|||
44476394|NCT00399542|79483591|FG001|Overall Study|Physician Decision|1|||
44476395|NCT00409682|79483600|FG000|Open-label Induction Period|Adverse Event|1|||
44476396|NCT00409682|79483601|FG001|Open-label Induction Period|Adverse Event|0|||
44476397|NCT00409682|79483602|FG002|Open-label Induction Period|Adverse Event|0|||
44476398|NCT00409682|79483600|FG000|Open-label Induction Period|Lack of Efficacy|1|||
44476399|NCT00409682|79483601|FG001|Open-label Induction Period|Lack of Efficacy|0|||
44476400|NCT00409682|79483602|FG002|Open-label Induction Period|Lack of Efficacy|0|||
44476401|NCT00409682|79483600|FG000|Open-label Induction Period|Protocol Violation|1|||
44476402|NCT00409682|79483601|FG001|Open-label Induction Period|Protocol Violation|0|||
44476403|NCT00409682|79483602|FG002|Open-label Induction Period|Protocol Violation|0|||
44476404|NCT00409682|79483600|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
44476405|NCT00409682|79483601|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
44476406|NCT00409682|79483602|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
44476407|NCT00409682|79483600|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
44476408|NCT00409682|79483601|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
44476409|NCT00409682|79483602|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
44476410|NCT00409682|79483600|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
44476411|NCT00409682|79483601|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
44476412|NCT00409682|79483602|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
44476413|NCT00409682|79483600|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
44476414|NCT00409682|79483601|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
44476415|NCT00409682|79483602|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
44476416|NCT00409682|79483600|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
44476417|NCT00409682|79483601|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
44476418|NCT00409682|79483602|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
44476419|NCT00409682|79483600|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
44476420|NCT00409682|79483601|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
44476421|NCT00409682|79483602|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
44476422|NCT00409682|79483600|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
44476423|NCT00409682|79483601|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
44476424|NCT00409682|79483602|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
44476425|NCT00398216|79483614|FG000|Overall Study|Adverse Event|4|||
44476426|NCT00398216|79483615|FG001|Overall Study|Adverse Event|2|||
44476427|NCT00398216|79483616|FG002|Overall Study|Adverse Event|5|||
44476428|NCT00398216|79483617|FG003|Overall Study|Adverse Event|7|||
44476429|NCT00398216|79483618|FG004|Overall Study|Adverse Event|2|||
44476430|NCT00398216|79483614|FG000|Overall Study|Protocol Violation|2|||
44476431|NCT00398216|79483615|FG001|Overall Study|Protocol Violation|4|||
44476432|NCT00398216|79483616|FG002|Overall Study|Protocol Violation|5|||
44476433|NCT00398216|79483617|FG003|Overall Study|Protocol Violation|7|||
44476434|NCT00398216|79483618|FG004|Overall Study|Protocol Violation|5|||
44476435|NCT00398216|79483614|FG000|Overall Study|Lost to Follow-up|1|||
44476436|NCT00398216|79483615|FG001|Overall Study|Lost to Follow-up|6|||
44476437|NCT00398216|79483616|FG002|Overall Study|Lost to Follow-up|4|||
44476438|NCT00398216|79483617|FG003|Overall Study|Lost to Follow-up|4|||
44476439|NCT00398216|79483618|FG004|Overall Study|Lost to Follow-up|1|||
44476440|NCT00398216|79483614|FG000|Overall Study|Death|0|||
44476441|NCT00398216|79483615|FG001|Overall Study|Death|3|||
44476442|NCT00398216|79483616|FG002|Overall Study|Death|0|||
44476443|NCT00398216|79483617|FG003|Overall Study|Death|0|||
44476444|NCT00398216|79483618|FG004|Overall Study|Death|0|||
44476445|NCT00398216|79483614|FG000|Overall Study|Withdrawal by Subject|1|||
44476446|NCT00398216|79483615|FG001|Overall Study|Withdrawal by Subject|0|||
44476447|NCT00398216|79483616|FG002|Overall Study|Withdrawal by Subject|3|||
44476448|NCT00398216|79483617|FG003|Overall Study|Withdrawal by Subject|1|||
44476449|NCT00398216|79483618|FG004|Overall Study|Withdrawal by Subject|2|||
44476450|NCT00398216|79483614|FG000|Overall Study|administrative reasons|3|||
44476451|NCT00398216|79483615|FG001|Overall Study|administrative reasons|4|||
44476452|NCT00398216|79483616|FG002|Overall Study|administrative reasons|4|||
44476453|NCT00398216|79483617|FG003|Overall Study|administrative reasons|3|||
44476454|NCT00398216|79483618|FG004|Overall Study|administrative reasons|3|||
44476455|NCT00398216|79483614|FG000|Overall Study|entrance criteria|0|||
44476456|NCT00398216|79483615|FG001|Overall Study|entrance criteria|0|||
44476457|NCT00398216|79483616|FG002|Overall Study|entrance criteria|0|||
44476458|NCT00398216|79483617|FG003|Overall Study|entrance criteria|0|||
44476459|NCT00398216|79483618|FG004|Overall Study|entrance criteria|2|||
44476460|NCT00398138|79483630|FG000|Overall Study|Adverse Event|2|||
44476461|NCT00397982|79483634|FG000|Overall Study|Withdrawal by Subject|1|||
44476462|NCT00397982|79483634|FG000|Overall Study|Adverse Event|1|||
44143775|NCT01327885|78933103|FG001|Overall Study|Subject choice|10|||
44375488|NCT00943722|79380713|FG002|Base Study|Adverse Event|0|||
44476463|NCT00397982|79483634|FG000|Overall Study|noncompliance|1|||
44476464|NCT00397982|79483634|FG000|Overall Study|Unrelated health issues|1|||
44476465|NCT00408902|79483639|FG000|Overall Study|Lack of Efficacy|7|||
44476466|NCT00408902|79483639|FG000|Overall Study|Adverse Event|3|||
44476467|NCT00397514|79483644|FG000|Overall Study|Withdrawal by Subject|1|||
44476468|NCT00397514|79483644|FG000|Overall Study|Pacing wire malfunction|1|||
44476469|NCT00397514|79483644|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
44476470|NCT00397514|79483644|FG000|Overall Study|early extubation|2|||
44476471|NCT00397514|79483644|FG000|Overall Study|poor echocardiographic windows|1|||
44476472|NCT00397046|79483658|FG000|Overall Study|Disease Progression|3|||
44476473|NCT00397046|79483659|FG001|Overall Study|Disease Progression|3|||
44476474|NCT00397046|79483660|FG002|Overall Study|Disease Progression|10|||
44476475|NCT00397046|79483661|FG003|Overall Study|Disease Progression|5|||
44476476|NCT00396812|79483672|FG000|Overall Study|Physician Decision|1|||
44476477|NCT00396656|79483676|FG000|First Treatment Period|Withdrawal by Subject|0|||
44476478|NCT00396656|79483677|FG001|First Treatment Period|Withdrawal by Subject|2|||
44476479|NCT00396656|79483676|FG000|Second Treatment Period|Adverse Event|0|||
44476480|NCT00396656|79483677|FG001|Second Treatment Period|Adverse Event|1|||
44476481|NCT00408434|79483690|FG000|Overall Study|Adverse Event|0|||
44476482|NCT00408434|79483691|FG001|Overall Study|Adverse Event|0|||
44476483|NCT00408434|79483692|FG002|Overall Study|Adverse Event|1|||
44476484|NCT00408434|79483693|FG003|Overall Study|Adverse Event|0|||
44476485|NCT00408434|79483694|FG004|Overall Study|Adverse Event|0|||
44476486|NCT00408434|79483695|FG005|Overall Study|Adverse Event|0|||
44476487|NCT00408434|79483696|FG006|Overall Study|Adverse Event|0|||
44476488|NCT00408434|79483690|FG000|Overall Study|Progressive disease|6|||
44476489|NCT00408434|79483691|FG001|Overall Study|Progressive disease|3|||
44476490|NCT00408434|79483692|FG002|Overall Study|Progressive disease|4|||
44476491|NCT00408434|79483693|FG003|Overall Study|Progressive disease|3|||
44476492|NCT00408434|79483694|FG004|Overall Study|Progressive disease|3|||
44476493|NCT00408434|79483695|FG005|Overall Study|Progressive disease|1|||
44476494|NCT00408434|79483696|FG006|Overall Study|Progressive disease|4|||
44476495|NCT00408434|79483690|FG000|Overall Study|Other|0|||
44476496|NCT00408434|79483691|FG001|Overall Study|Other|0|||
44476497|NCT00408434|79483692|FG002|Overall Study|Other|1|||
44476498|NCT00408434|79483693|FG003|Overall Study|Other|0|||
44476499|NCT00408434|79483694|FG004|Overall Study|Other|2|||
44476500|NCT00408434|79483695|FG005|Overall Study|Other|1|||
44476501|NCT00408434|79483696|FG006|Overall Study|Other|0|||
44476502|NCT00408434|79483690|FG000|Overall Study|Terminated by Investigator|0|||
44476503|NCT00408434|79483691|FG001|Overall Study|Terminated by Investigator|0|||
44476504|NCT00408434|79483692|FG002|Overall Study|Terminated by Investigator|0|||
44476505|NCT00408434|79483693|FG003|Overall Study|Terminated by Investigator|0|||
44476506|NCT00408434|79483694|FG004|Overall Study|Terminated by Investigator|1|||
44476507|NCT00408434|79483695|FG005|Overall Study|Terminated by Investigator|1|||
44476508|NCT00408434|79483696|FG006|Overall Study|Terminated by Investigator|0|||
44476509|NCT00418184|79483715|FG000|Double-blind Phase|Withdrawal by Subject|22|||
44476510|NCT00418184|79483716|FG001|Double-blind Phase|Withdrawal by Subject|9|||
44476511|NCT00418184|79483715|FG000|Double-blind Phase|Adverse Event|2|||
44476512|NCT00418184|79483716|FG001|Double-blind Phase|Adverse Event|1|||
44476513|NCT00418184|79483715|FG000|Double-blind Phase|Poor compliance|3|||
44476514|NCT00418184|79483716|FG001|Double-blind Phase|Poor compliance|1|||
44476515|NCT00407030|79483725|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
44476516|NCT00407030|79483726|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
44476517|NCT00407030|79483727|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
44476518|NCT00407030|79483725|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
44476519|NCT00407030|79483726|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
44476520|NCT00407030|79483727|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
44476521|NCT00407030|79483725|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
44476522|NCT00407030|79483726|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
44476523|NCT00407030|79483727|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
44476524|NCT00407030|79483725|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
44476525|NCT00407030|79483726|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
44476526|NCT00407030|79483727|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
44476527|NCT00407030|79483725|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
44476528|NCT00407030|79483726|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
44476529|NCT00407030|79483727|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
44476530|NCT00407030|79483725|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
44476531|NCT00407030|79483726|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
44476532|NCT00407030|79483727|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
44476533|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
44476534|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
44476535|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
44476536|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
44476537|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
44476538|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
44476539|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
44476540|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
44476541|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
44476542|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
44476543|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
44476544|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
44476545|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
44476546|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
44476547|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
44476548|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
44476549|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
44476550|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
44476551|NCT00407030|79483725|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
44476552|NCT00407030|79483726|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
44476553|NCT00407030|79483727|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
44476554|NCT00406718|79483740|FG000|Overall Study|Withdrawal by Subject|2|||
44476555|NCT00406718|79483741|FG001|Overall Study|Withdrawal by Subject|9|||
44476556|NCT00406718|79483742|FG002|Overall Study|Withdrawal by Subject|4|||
44476557|NCT00406718|79483740|FG000|Overall Study|Lost to Follow-up|2|||
44476558|NCT00406718|79483741|FG001|Overall Study|Lost to Follow-up|5|||
44476559|NCT00406718|79483742|FG002|Overall Study|Lost to Follow-up|4|||
44476560|NCT00394706|79483760|FG000|Overall Study|Withdrawal by Subject|2|||
44476561|NCT00394706|79483761|FG001|Overall Study|Withdrawal by Subject|0|||
44476562|NCT00394706|79483762|FG002|Overall Study|Withdrawal by Subject|1|||
44476563|NCT00394706|79483763|FG003|Overall Study|Withdrawal by Subject|0|||
44476564|NCT00394706|79483764|FG004|Overall Study|Withdrawal by Subject|0|||
44476565|NCT00394706|79483765|FG005|Overall Study|Withdrawal by Subject|2|||
44476566|NCT00394706|79483766|FG006|Overall Study|Withdrawal by Subject|1|||
44476567|NCT00394706|79483767|FG007|Overall Study|Withdrawal by Subject|0|||
44476568|NCT00394706|79483760|FG000|Overall Study|Lost to Follow-up|2|||
44476569|NCT00394706|79483761|FG001|Overall Study|Lost to Follow-up|2|||
44476570|NCT00394706|79483762|FG002|Overall Study|Lost to Follow-up|8|||
44476571|NCT00394706|79483763|FG003|Overall Study|Lost to Follow-up|1|||
44476572|NCT00394706|79483764|FG004|Overall Study|Lost to Follow-up|2|||
44476573|NCT00394706|79483765|FG005|Overall Study|Lost to Follow-up|5|||
44476574|NCT00394706|79483766|FG006|Overall Study|Lost to Follow-up|2|||
44476575|NCT00394706|79483767|FG007|Overall Study|Lost to Follow-up|0|||
44476576|NCT00394472|79483783|FG000|Overall Study|Protocol Violation|1|||
44476577|NCT00394472|79483784|FG001|Overall Study|Protocol Violation|3|||
44476578|NCT00394472|79483783|FG000|Overall Study|incorrect enrolment|4|||
44476579|NCT00394472|79483784|FG001|Overall Study|incorrect enrolment|2|||
44476580|NCT00394472|79483783|FG000|Overall Study|Adverse Event|4|||
44476581|NCT00394472|79483784|FG001|Overall Study|Adverse Event|2|||
44476582|NCT00394472|79483783|FG000|Overall Study|Withdrawal by Subject|0|||
44476583|NCT00394472|79483784|FG001|Overall Study|Withdrawal by Subject|2|||
44476584|NCT00394472|79483783|FG000|Overall Study|Physician Decision|0|||
44476585|NCT00394472|79483784|FG001|Overall Study|Physician Decision|1|||
44476586|NCT00394472|79483783|FG000|Overall Study|Lost to Follow-up|0|||
44476587|NCT00394472|79483784|FG001|Overall Study|Lost to Follow-up|1|||
44476588|NCT00419120|79483790|FG000|Long Term Follow up Period|study ongoing|10|||
44476589|NCT00395642|79483794|FG000|Overall Study|Death|4|||
44476590|NCT00395642|79483794|FG000|Overall Study|Lost to Follow-up|1|||
44273997|NCT02256540|79216054|FG000|Overall Study|Back pain preventing exercise|0|||
44273998|NCT02256540|79216055|FG001|Overall Study|Back pain preventing exercise|0|||
44273999|NCT02256540|79216056|FG002|Overall Study|Back pain preventing exercise|1|||
44274000|NCT01640184|79216080|FG000|Overall Study|Death|1|||
44274001|NCT01640184|79216081|FG001|Overall Study|Death|0|||
44274002|NCT01640184|79216082|FG002|Overall Study|Death|0|||
44274003|NCT01640184|79216080|FG000|Overall Study|Lost to Follow-up|4|||
44274004|NCT01640184|79216081|FG001|Overall Study|Lost to Follow-up|1|||
44274005|NCT01640184|79216082|FG002|Overall Study|Lost to Follow-up|0|||
44274006|NCT01640184|79216080|FG000|Overall Study|Physician Decision|3|||
44274007|NCT01640184|79216081|FG001|Overall Study|Physician Decision|0|||
44274008|NCT01640184|79216082|FG002|Overall Study|Physician Decision|0|||
44274009|NCT01640184|79216080|FG000|Overall Study|Withdrawal by Subject|0|||
44274010|NCT01640184|79216081|FG001|Overall Study|Withdrawal by Subject|1|||
44274011|NCT01640184|79216082|FG002|Overall Study|Withdrawal by Subject|1|||
44274012|NCT01640184|79216080|FG000|Overall Study|Protocol Violation|0|||
44274013|NCT01640184|79216081|FG001|Overall Study|Protocol Violation|0|||
44274014|NCT01640184|79216082|FG002|Overall Study|Protocol Violation|1|||
44476591|NCT00395642|79483794|FG000|Overall Study|Physician Decision|7|||
44476592|NCT00395642|79483794|FG000|Overall Study|Withdrawal by Subject|1|||
44476593|NCT00395486|79483800|FG000|Overall Study|Adverse Event|1|||
44476594|NCT00395486|79483801|FG001|Overall Study|Adverse Event|2|||
44476595|NCT00395486|79483800|FG000|Overall Study|Withdrawal by Subject|5|||
44476596|NCT00395486|79483801|FG001|Overall Study|Withdrawal by Subject|2|||
44274015|NCT02256384|79216102|FG000|Overall Study|Withdrawal by Subject|12|||
44274016|NCT02256384|79216102|FG000|Overall Study|Equipment not capturing data|2|||
44274017|NCT02255760|79216145|FG000|Overall Study|Lost to Follow-up|0|||
44476597|NCT00395486|79483800|FG000|Overall Study|Lost to Follow-up|0|||
44476598|NCT00395486|79483801|FG001|Overall Study|Lost to Follow-up|1|||
44476599|NCT00395018|79483807|FG000|On-Treatment|Death|4|||
44476600|NCT00395018|79483807|FG000|On-Treatment|Other Reason|2|||
44274018|NCT02255760|79216146|FG001|Overall Study|Lost to Follow-up|1|||
44476601|NCT00395018|79483807|FG000|On-Treatment|Poor/non-compliance|2|||
44274019|NCT02255760|79216147|FG002|Overall Study|Lost to Follow-up|0|||
44274020|NCT02255760|79216148|FG003|Overall Study|Lost to Follow-up|0|||
44274021|NCT02255760|79216149|FG004|Overall Study|Lost to Follow-up|0|||
44274022|NCT01641822|79216245|FG000|Run-in Phase|Noncompliance with study drug|1|||
44274023|NCT01641822|79216246|FG001|Run-in Phase|Noncompliance with study drug|0|||
44274024|NCT01641822|79216247|FG002|Run-in Phase|Noncompliance with study drug|0|||
44274025|NCT01641822|79216245|FG000|Run-in Phase|Adverse Event|3|||
44274026|NCT01641822|79216246|FG001|Run-in Phase|Adverse Event|0|||
44274027|NCT01641822|79216247|FG002|Run-in Phase|Adverse Event|0|||
44274028|NCT01641822|79216245|FG000|Run-in Phase|Withdrew consent|1|||
44274029|NCT01641822|79216246|FG001|Run-in Phase|Withdrew consent|0|||
44274030|NCT01641822|79216247|FG002|Run-in Phase|Withdrew consent|0|||
44274031|NCT01641822|79216245|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
44274032|NCT01641822|79216246|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
44274033|NCT01641822|79216247|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
44274034|NCT01641822|79216245|FG000|Comparative Phase|Noncompliance with study drug|0|||
44274035|NCT01641822|79216246|FG001|Comparative Phase|Noncompliance with study drug|1|||
44274036|NCT01641822|79216247|FG002|Comparative Phase|Noncompliance with study drug|0|||
44274037|NCT01641822|79216245|FG000|Comparative Phase|Investigator's discretion|0|||
44274038|NCT01641822|79216246|FG001|Comparative Phase|Investigator's discretion|0|||
44274039|NCT01641822|79216247|FG002|Comparative Phase|Investigator's discretion|1|||
44274040|NCT01641822|79216245|FG000|Comparative Phase|Pregnancy|0|||
44274041|NCT01641822|79216246|FG001|Comparative Phase|Pregnancy|0|||
44274042|NCT01641822|79216247|FG002|Comparative Phase|Pregnancy|1|||
44274043|NCT01641822|79216245|FG000|Comparative Phase|Adverse event, serious fatal|0|||
44274044|NCT01641822|79216246|FG001|Comparative Phase|Adverse event, serious fatal|1|||
44274045|NCT01641822|79216247|FG002|Comparative Phase|Adverse event, serious fatal|0|||
44274046|NCT01641822|79216245|FG000|Comparative Phase|Withdrew consent|0|||
44274047|NCT01641822|79216246|FG001|Comparative Phase|Withdrew consent|3|||
44274048|NCT01641822|79216247|FG002|Comparative Phase|Withdrew consent|7|||
44274049|NCT01641822|79216245|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
44274050|NCT01641822|79216246|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
44274051|NCT01641822|79216247|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
44274052|NCT01641198|79216327|FG000|After 12 Months of Function|Lost to Follow-up|3|||
44274053|NCT01641198|79216328|FG001|After 12 Months of Function|Lost to Follow-up|2|||
44274054|NCT01641198|79216329|FG002|After 12 Months of Function|Lost to Follow-up|2|||
44274055|NCT01641198|79216327|FG000|After 12 Months of Function|Protocol Violation|1|||
44274056|NCT01641198|79216328|FG001|After 12 Months of Function|Protocol Violation|0|||
44274057|NCT01641198|79216329|FG002|After 12 Months of Function|Protocol Violation|0|||
44274058|NCT01641198|79216327|FG000|After 12 Months of Function|Adverse Event|0|||
44274059|NCT01641198|79216328|FG001|After 12 Months of Function|Adverse Event|1|||
44274060|NCT01641198|79216329|FG002|After 12 Months of Function|Adverse Event|0|||
44274061|NCT01641198|79216327|FG000|After 24 Months of Function|Lost to Follow-up|4|||
44274062|NCT01641198|79216328|FG001|After 24 Months of Function|Lost to Follow-up|9|||
44274063|NCT01641198|79216329|FG002|After 24 Months of Function|Lost to Follow-up|6|||
44274064|NCT01641198|79216327|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
44274065|NCT01641198|79216328|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
44274066|NCT01641198|79216329|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
44274067|NCT01641198|79216327|FG000|At 15-20 Years of Function|Death|1|||
44274068|NCT01641198|79216328|FG001|At 15-20 Years of Function|Death|0|||
44274069|NCT01641198|79216329|FG002|At 15-20 Years of Function|Death|1|||
44274070|NCT01639560|79216414|FG000|Overall Study|Withdrawal by Subject|9|||
44274071|NCT01639560|79216415|FG001|Overall Study|Withdrawal by Subject|14|||
44476602|NCT00395018|79483807|FG000|On-Treatment|Subject no longer meets study criteria|2|||
44476603|NCT00395018|79483807|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
44476604|NCT00395018|79483807|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
44476605|NCT00395018|79483807|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
44476606|NCT00375518|79483813|FG000|Overall Study|Withdrawal by Subject|2|||
44476607|NCT00375518|79483814|FG001|Overall Study|Withdrawal by Subject|10|||
44476608|NCT00375518|79483813|FG000|Overall Study|Patient Not Treated|6|||
44476609|NCT00375518|79483814|FG001|Overall Study|Patient Not Treated|6|||
44476610|NCT00375518|79483813|FG000|Overall Study|Death|0|||
44274072|NCT01639560|79216414|FG000|Overall Study|Lack of Efficacy|1|||
44476611|NCT00375518|79483814|FG001|Overall Study|Death|1|||
44274073|NCT01639560|79216415|FG001|Overall Study|Lack of Efficacy|2|||
44274074|NCT01639560|79216414|FG000|Overall Study|Lost to Follow-up|9|||
44476612|NCT00256750|79483823|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
44476613|NCT00256750|79483824|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
44476614|NCT00256750|79483825|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
44274075|NCT01639560|79216415|FG001|Overall Study|Lost to Follow-up|11|||
44274076|NCT01639560|79216414|FG000|Overall Study|Adverse Event|0|||
44375489|NCT00943722|79380714|FG003|Base Study|Adverse Event|1|||
44476615|NCT00256750|79483823|FG000|Transplanted Pre-Treatment|Other|2|||
44375490|NCT00943722|79380715|FG004|Base Study|Adverse Event|0|||
44375491|NCT00943722|79380716|FG005|Base Study|Adverse Event|0|||
44476616|NCT00256750|79483824|FG001|Transplanted Pre-Treatment|Other|0|||
44476617|NCT00256750|79483825|FG002|Transplanted Pre-Treatment|Other|0|||
44476618|NCT00256750|79483823|FG000|Transplanted Pre-Treatment|Death|1|||
44476619|NCT00256750|79483824|FG001|Transplanted Pre-Treatment|Death|0|||
44476620|NCT00256750|79483825|FG002|Transplanted Pre-Treatment|Death|0|||
44226317|NCT01776541|79032753|FG000|Overall Study|Administrative Reason|6|||
44226318|NCT01776541|79032754|FG001|Overall Study|Administrative Reason|2|||
44226319|NCT01776541|79032753|FG000|Overall Study|Death|4|||
44226320|NCT01776541|79032754|FG001|Overall Study|Death|0|||
44226321|NCT01776541|79032753|FG000|Overall Study|Lost to Follow-up|27|||
44226322|NCT01776541|79032754|FG001|Overall Study|Lost to Follow-up|48|||
44226323|NCT01776541|79032753|FG000|Overall Study|Unclassified|5|||
44226324|NCT01776541|79032754|FG001|Overall Study|Unclassified|4|||
44226325|NCT01776541|79032753|FG000|Overall Study|Protocol Violation|2|||
44226326|NCT01776541|79032754|FG001|Overall Study|Protocol Violation|1|||
44226327|NCT01776541|79032753|FG000|Overall Study|Withdrawal by Subject|12|||
44226328|NCT01776541|79032754|FG001|Overall Study|Withdrawal by Subject|20|||
44226329|NCT01742078|79032783|FG000|Overall Study|Withdrawal by Subject|0|||
44226330|NCT01742078|79032784|FG001|Overall Study|Withdrawal by Subject|0|||
44226331|NCT01742078|79032785|FG002|Overall Study|Withdrawal by Subject|0|||
44226332|NCT01742078|79032786|FG003|Overall Study|Withdrawal by Subject|1|||
44226333|NCT01742078|79032787|FG004|Overall Study|Withdrawal by Subject|0|||
44226334|NCT01742078|79032788|FG005|Overall Study|Withdrawal by Subject|0|||
44226335|NCT01742078|79032789|FG006|Overall Study|Withdrawal by Subject|0|||
44226336|NCT01742078|79032790|FG007|Overall Study|Withdrawal by Subject|0|||
44226337|NCT01742078|79032791|FG008|Overall Study|Withdrawal by Subject|0|||
44226338|NCT01741688|79032813|FG000|Overall Study|Lack of insurance coverage|2|||
44226339|NCT01741688|79032813|FG000|Overall Study|Withdrawal by Subject|1|||
44226340|NCT01709084|79032820|FG000|Overall Study|Lost to Follow-up|4|||
44226341|NCT01709084|79032821|FG001|Overall Study|Lost to Follow-up|7|||
44226342|NCT01709084|79032820|FG000|Overall Study|Withdrawal by Subject|2|||
44375492|NCT00943722|79380717|FG006|Base Study|Adverse Event|0|||
44375493|NCT00943722|79380711|FG000|Base Study|Lost to Follow-up|12|||
44476621|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
44476622|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
44476623|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
44476624|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Death|3|||
44476625|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Death|2|||
44476626|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Death|4|||
44476627|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
44476628|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
44476629|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
44476630|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
44476631|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
44476632|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
44476633|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Other|5|||
44476634|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Other|4|||
44476635|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Other|2|||
44476636|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
44476637|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
44476638|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
44476639|NCT00256750|79483823|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
44226343|NCT01709084|79032821|FG001|Overall Study|Withdrawal by Subject|2|||
44226344|NCT01709084|79032820|FG000|Overall Study|Adverse Event|5|||
44226345|NCT01709084|79032821|FG001|Overall Study|Adverse Event|0|||
44226346|NCT01709084|79032820|FG000|Overall Study|Other|5|||
44226347|NCT01709084|79032821|FG001|Overall Study|Other|3|||
44375494|NCT00943722|79380712|FG001|Base Study|Lost to Follow-up|8|||
44375495|NCT00943722|79380713|FG002|Base Study|Lost to Follow-up|10|||
44476640|NCT00256750|79483824|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
44274077|NCT01639560|79216415|FG001|Overall Study|Adverse Event|2|||
44476641|NCT00256750|79483825|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
44476642|NCT00256750|79483823|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
44476643|NCT00256750|79483824|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
44476644|NCT00256750|79483825|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
44476645|NCT00256750|79483823|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
44476646|NCT00256750|79483824|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
44476647|NCT00256750|79483825|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
44476648|NCT00256750|79483823|FG000|Post-Transplant Treated (24 Months)|Death|3|||
44476649|NCT00256750|79483824|FG001|Post-Transplant Treated (24 Months)|Death|0|||
44476650|NCT00256750|79483825|FG002|Post-Transplant Treated (24 Months)|Death|0|||
44476651|NCT00256750|79483823|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
44476652|NCT00256750|79483824|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
44476653|NCT00256750|79483825|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
44476654|NCT00256750|79483823|FG000|Post-Transplant Treated (24 Months)|Other|2|||
44476655|NCT00256750|79483824|FG001|Post-Transplant Treated (24 Months)|Other|0|||
44476656|NCT00256750|79483825|FG002|Post-Transplant Treated (24 Months)|Other|1|||
44476657|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
44476658|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
44476659|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
44476660|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
44476661|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
44476662|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
44476663|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Death|0|||
44476664|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Death|2|||
44476665|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Death|1|||
44476666|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
44476667|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
44476668|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
44476669|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
44476670|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
44476671|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
44476672|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
44226348|NCT01709084|79032820|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
44476673|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
44476674|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
44476675|NCT00256750|79483823|FG000|Post-Transplant Treated (36 Months)|Other|0|||
44476676|NCT00256750|79483824|FG001|Post-Transplant Treated (36 Months)|Other|1|||
44476677|NCT00256750|79483825|FG002|Post-Transplant Treated (36 Months)|Other|1|||
44476678|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
44476679|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
44476680|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
44476681|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
44476682|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
44476683|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
44476684|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
44476685|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
44476686|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
44476687|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
44476688|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
44476689|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
44476690|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
44476691|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
44476692|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
44476693|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
44476694|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
44476695|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
44476696|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
44476697|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
44476698|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
44476699|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
44476700|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
44226349|NCT01709084|79032821|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
44226350|NCT01709084|79032820|FG000|Overall Study|Not Treated|0|||
44226351|NCT01709084|79032821|FG001|Overall Study|Not Treated|2|||
44226352|NCT01729039|79032829|FG000|Overall Study|disqualified|2|||
44514821|NCT03717012|79520644|FG000|Overall Study|Due to trial termination|1|||
44226353|NCT01729039|79032830|FG001|Overall Study|disqualified|5|||
44226354|NCT01729039|79032829|FG000|Overall Study|Withdrawal by Subject|8|||
44476701|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
44476702|NCT00256750|79483823|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
44476703|NCT00256750|79483824|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
44476704|NCT00256750|79483825|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
44476705|NCT00279201|79483836|FG000|Initiation|Death|1|||
44476706|NCT00279201|79483837|FG001|Initiation|Death|5|||
44476707|NCT00279201|79483838|FG002|Initiation|Death|0|||
44476708|NCT00279201|79483839|FG003|Initiation|Death|0|||
44476709|NCT00279201|79483840|FG004|Initiation|Death|0|||
44476710|NCT00279201|79483841|FG005|Initiation|Death|0|||
44476711|NCT00279201|79483836|FG000|Initiation|Adverse Event|6|||
44476712|NCT00279201|79483837|FG001|Initiation|Adverse Event|15|||
44476713|NCT00279201|79483838|FG002|Initiation|Adverse Event|0|||
44476714|NCT00279201|79483839|FG003|Initiation|Adverse Event|0|||
44476715|NCT00279201|79483840|FG004|Initiation|Adverse Event|0|||
44476716|NCT00279201|79483841|FG005|Initiation|Adverse Event|0|||
44476717|NCT00279201|79483836|FG000|Initiation|Lost to Follow-up|42|||
44476718|NCT00279201|79483837|FG001|Initiation|Lost to Follow-up|41|||
44476719|NCT00279201|79483838|FG002|Initiation|Lost to Follow-up|0|||
44476720|NCT00279201|79483839|FG003|Initiation|Lost to Follow-up|0|||
44476721|NCT00279201|79483840|FG004|Initiation|Lost to Follow-up|0|||
44476722|NCT00279201|79483841|FG005|Initiation|Lost to Follow-up|0|||
44476723|NCT00279201|79483836|FG000|Initiation|Entry Criteria Exclusion|7|||
44476724|NCT00279201|79483837|FG001|Initiation|Entry Criteria Exclusion|9|||
44476725|NCT00279201|79483838|FG002|Initiation|Entry Criteria Exclusion|0|||
44476726|NCT00279201|79483839|FG003|Initiation|Entry Criteria Exclusion|0|||
44476727|NCT00279201|79483840|FG004|Initiation|Entry Criteria Exclusion|0|||
44476728|NCT00279201|79483841|FG005|Initiation|Entry Criteria Exclusion|0|||
44476729|NCT00279201|79483836|FG000|Initiation|Protocol Violation|9|||
44476730|NCT00279201|79483837|FG001|Initiation|Protocol Violation|10|||
44476731|NCT00279201|79483838|FG002|Initiation|Protocol Violation|0|||
44476732|NCT00279201|79483839|FG003|Initiation|Protocol Violation|0|||
44476733|NCT00279201|79483840|FG004|Initiation|Protocol Violation|0|||
44476734|NCT00279201|79483841|FG005|Initiation|Protocol Violation|0|||
44476735|NCT00279201|79483836|FG000|Initiation|Withdrawal by Subject|35|||
44476736|NCT00279201|79483837|FG001|Initiation|Withdrawal by Subject|41|||
44476737|NCT00279201|79483838|FG002|Initiation|Withdrawal by Subject|0|||
44476738|NCT00279201|79483839|FG003|Initiation|Withdrawal by Subject|0|||
44476739|NCT00279201|79483840|FG004|Initiation|Withdrawal by Subject|0|||
44476740|NCT00279201|79483841|FG005|Initiation|Withdrawal by Subject|0|||
44476741|NCT00279201|79483836|FG000|Initiation|Physician Decision|15|||
44476742|NCT00279201|79483837|FG001|Initiation|Physician Decision|18|||
44476743|NCT00279201|79483838|FG002|Initiation|Physician Decision|0|||
44476744|NCT00279201|79483839|FG003|Initiation|Physician Decision|0|||
44476745|NCT00279201|79483840|FG004|Initiation|Physician Decision|0|||
44476746|NCT00279201|79483841|FG005|Initiation|Physician Decision|0|||
44476747|NCT00279201|79483836|FG000|Initiation|Sponsor Decision|13|||
44476748|NCT00279201|79483837|FG001|Initiation|Sponsor Decision|5|||
44476749|NCT00279201|79483838|FG002|Initiation|Sponsor Decision|0|||
44476750|NCT00279201|79483839|FG003|Initiation|Sponsor Decision|0|||
44476751|NCT00279201|79483840|FG004|Initiation|Sponsor Decision|0|||
44476752|NCT00279201|79483841|FG005|Initiation|Sponsor Decision|0|||
44476753|NCT00279201|79483836|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
44476754|NCT00279201|79483837|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
44476755|NCT00279201|79483838|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
44476756|NCT00279201|79483839|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
44476757|NCT00279201|79483840|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
44476758|NCT00279201|79483841|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
44226355|NCT01729039|79032830|FG001|Overall Study|Withdrawal by Subject|7|||
44226356|NCT01775995|79032841|FG000|Overall Study|Lost to Follow-up|1|||
44226357|NCT01775995|79032842|FG001|Overall Study|Lost to Follow-up|1|||
44226358|NCT01741532|79032850|FG000|Overall Study|Adverse Event|4|||
44226359|NCT01741532|79032851|FG001|Overall Study|Adverse Event|0|||
44226360|NCT01741532|79032850|FG000|Overall Study|Withdrawal by Subject|1|||
44226361|NCT01741532|79032851|FG001|Overall Study|Withdrawal by Subject|1|||
44274078|NCT01601652|79216437|FG000|Overall Study|Death|1|||
44476759|NCT00279201|79483836|FG000|Maintenance|Lack of Efficacy|32|||
44476760|NCT00279201|79483837|FG001|Maintenance|Lack of Efficacy|30|||
44476761|NCT00279201|79483838|FG002|Maintenance|Lack of Efficacy|0|||
44476762|NCT00279201|79483839|FG003|Maintenance|Lack of Efficacy|0|||
44476763|NCT00279201|79483840|FG004|Maintenance|Lack of Efficacy|0|||
44226362|NCT01741532|79032850|FG000|Overall Study|Protocol Violation|0|||
44476764|NCT00279201|79483841|FG005|Maintenance|Lack of Efficacy|0|||
44476765|NCT00279201|79483836|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
44226363|NCT01741532|79032851|FG001|Overall Study|Protocol Violation|1|||
44476766|NCT00279201|79483837|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
44476767|NCT00279201|79483838|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
44476768|NCT00279201|79483839|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
44476769|NCT00279201|79483840|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
44476770|NCT00279201|79483841|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
44476771|NCT00279201|79483836|FG000|Maintenance|Adverse Event|4|||
44476772|NCT00279201|79483837|FG001|Maintenance|Adverse Event|4|||
44476773|NCT00279201|79483838|FG002|Maintenance|Adverse Event|0|||
44476774|NCT00279201|79483839|FG003|Maintenance|Adverse Event|0|||
44476775|NCT00279201|79483840|FG004|Maintenance|Adverse Event|0|||
44476776|NCT00279201|79483841|FG005|Maintenance|Adverse Event|0|||
44476777|NCT00279201|79483836|FG000|Maintenance|Death|4|||
44476778|NCT00279201|79483837|FG001|Maintenance|Death|4|||
44476779|NCT00279201|79483838|FG002|Maintenance|Death|0|||
44476780|NCT00279201|79483839|FG003|Maintenance|Death|0|||
44476781|NCT00279201|79483840|FG004|Maintenance|Death|0|||
44476782|NCT00279201|79483841|FG005|Maintenance|Death|0|||
44476783|NCT00279201|79483836|FG000|Maintenance|Lost to Follow-up|17|||
44476784|NCT00279201|79483837|FG001|Maintenance|Lost to Follow-up|13|||
44476785|NCT00279201|79483838|FG002|Maintenance|Lost to Follow-up|0|||
44476786|NCT00279201|79483839|FG003|Maintenance|Lost to Follow-up|0|||
44476787|NCT00279201|79483840|FG004|Maintenance|Lost to Follow-up|0|||
44476788|NCT00279201|79483841|FG005|Maintenance|Lost to Follow-up|0|||
44476789|NCT00279201|79483836|FG000|Maintenance|Entry Criteria Exclusion|1|||
44476790|NCT00279201|79483837|FG001|Maintenance|Entry Criteria Exclusion|4|||
44476791|NCT00279201|79483838|FG002|Maintenance|Entry Criteria Exclusion|0|||
44476792|NCT00279201|79483839|FG003|Maintenance|Entry Criteria Exclusion|0|||
44476793|NCT00279201|79483840|FG004|Maintenance|Entry Criteria Exclusion|0|||
44476794|NCT00279201|79483841|FG005|Maintenance|Entry Criteria Exclusion|0|||
44476795|NCT00279201|79483836|FG000|Maintenance|Protocol Violation|16|||
44476796|NCT00279201|79483837|FG001|Maintenance|Protocol Violation|24|||
44476797|NCT00279201|79483838|FG002|Maintenance|Protocol Violation|0|||
44476798|NCT00279201|79483839|FG003|Maintenance|Protocol Violation|0|||
44476799|NCT00279201|79483840|FG004|Maintenance|Protocol Violation|0|||
44476800|NCT00279201|79483841|FG005|Maintenance|Protocol Violation|0|||
44476801|NCT00279201|79483836|FG000|Maintenance|Withdrawal by Subject|18|||
44476802|NCT00279201|79483837|FG001|Maintenance|Withdrawal by Subject|18|||
44476803|NCT00279201|79483838|FG002|Maintenance|Withdrawal by Subject|0|||
44476804|NCT00279201|79483839|FG003|Maintenance|Withdrawal by Subject|0|||
44476805|NCT00279201|79483840|FG004|Maintenance|Withdrawal by Subject|0|||
44476806|NCT00279201|79483841|FG005|Maintenance|Withdrawal by Subject|0|||
44476807|NCT00279201|79483836|FG000|Maintenance|Physician Decision|9|||
44476808|NCT00279201|79483837|FG001|Maintenance|Physician Decision|9|||
44476809|NCT00279201|79483838|FG002|Maintenance|Physician Decision|0|||
44476810|NCT00279201|79483839|FG003|Maintenance|Physician Decision|0|||
44476811|NCT00279201|79483840|FG004|Maintenance|Physician Decision|0|||
44476812|NCT00279201|79483841|FG005|Maintenance|Physician Decision|0|||
44476813|NCT00279201|79483836|FG000|Maintenance|Sponsor Decision|4|||
44476814|NCT00279201|79483837|FG001|Maintenance|Sponsor Decision|0|||
44476815|NCT00279201|79483838|FG002|Maintenance|Sponsor Decision|0|||
44476816|NCT00279201|79483839|FG003|Maintenance|Sponsor Decision|0|||
44476817|NCT00279201|79483840|FG004|Maintenance|Sponsor Decision|0|||
44476818|NCT00279201|79483841|FG005|Maintenance|Sponsor Decision|0|||
44476819|NCT00279201|79483836|FG000|Maintenance|HbA1c>7.5%|123|||
44476820|NCT00279201|79483837|FG001|Maintenance|HbA1c>7.5%|126|||
44476821|NCT00279201|79483838|FG002|Maintenance|HbA1c>7.5%|0|||
44476822|NCT00279201|79483839|FG003|Maintenance|HbA1c>7.5%|0|||
44476823|NCT00279201|79483840|FG004|Maintenance|HbA1c>7.5%|0|||
44476824|NCT00279201|79483841|FG005|Maintenance|HbA1c>7.5%|0|||
44476825|NCT00279201|79483836|FG000|Intensification Addendum|Withdrawal by Subject|0|||
44476826|NCT00279201|79483837|FG001|Intensification Addendum|Withdrawal by Subject|0|||
44476827|NCT00279201|79483838|FG002|Intensification Addendum|Withdrawal by Subject|12|||
44476828|NCT00279201|79483839|FG003|Intensification Addendum|Withdrawal by Subject|14|||
44476829|NCT00279201|79483840|FG004|Intensification Addendum|Withdrawal by Subject|9|||
44476830|NCT00279201|79483841|FG005|Intensification Addendum|Withdrawal by Subject|18|||
44476831|NCT00279201|79483836|FG000|Intensification Addendum|Lost to Follow-up|0|||
44476832|NCT00279201|79483837|FG001|Intensification Addendum|Lost to Follow-up|0|||
44476833|NCT00279201|79483838|FG002|Intensification Addendum|Lost to Follow-up|4|||
44476834|NCT00279201|79483839|FG003|Intensification Addendum|Lost to Follow-up|6|||
44476835|NCT00279201|79483840|FG004|Intensification Addendum|Lost to Follow-up|7|||
44476836|NCT00279201|79483841|FG005|Intensification Addendum|Lost to Follow-up|7|||
44476837|NCT00279201|79483836|FG000|Intensification Addendum|Protocol Violation|0|||
44476838|NCT00279201|79483837|FG001|Intensification Addendum|Protocol Violation|0|||
44476839|NCT00279201|79483838|FG002|Intensification Addendum|Protocol Violation|2|||
44476840|NCT00279201|79483839|FG003|Intensification Addendum|Protocol Violation|2|||
44476841|NCT00279201|79483840|FG004|Intensification Addendum|Protocol Violation|6|||
44476842|NCT00279201|79483841|FG005|Intensification Addendum|Protocol Violation|6|||
44476843|NCT00279201|79483836|FG000|Intensification Addendum|Adverse Event|0|||
44476844|NCT00279201|79483837|FG001|Intensification Addendum|Adverse Event|0|||
44476845|NCT00279201|79483838|FG002|Intensification Addendum|Adverse Event|0|||
44476846|NCT00279201|79483839|FG003|Intensification Addendum|Adverse Event|4|||
44476847|NCT00279201|79483840|FG004|Intensification Addendum|Adverse Event|1|||
44476848|NCT00279201|79483841|FG005|Intensification Addendum|Adverse Event|3|||
44476849|NCT00279201|79483836|FG000|Intensification Addendum|Physician Decision|0|||
44476850|NCT00279201|79483837|FG001|Intensification Addendum|Physician Decision|0|||
44476851|NCT00279201|79483838|FG002|Intensification Addendum|Physician Decision|4|||
44476852|NCT00279201|79483839|FG003|Intensification Addendum|Physician Decision|1|||
44476853|NCT00279201|79483840|FG004|Intensification Addendum|Physician Decision|3|||
44476854|NCT00279201|79483841|FG005|Intensification Addendum|Physician Decision|2|||
44226364|NCT01741532|79032850|FG000|Overall Study|Worsening of the disease|3|||
44476855|NCT00279201|79483836|FG000|Intensification Addendum|Sponsor Decision|0|||
44476856|NCT00279201|79483837|FG001|Intensification Addendum|Sponsor Decision|0|||
44476857|NCT00279201|79483838|FG002|Intensification Addendum|Sponsor Decision|0|||
44476858|NCT00279201|79483839|FG003|Intensification Addendum|Sponsor Decision|0|||
44476859|NCT00279201|79483840|FG004|Intensification Addendum|Sponsor Decision|1|||
44476860|NCT00279201|79483841|FG005|Intensification Addendum|Sponsor Decision|1|||
44226365|NCT01741532|79032851|FG001|Overall Study|Worsening of the disease|1|||
44226366|NCT01741532|79032850|FG000|Overall Study|Sponsor decision|1|||
44226367|NCT01741532|79032851|FG001|Overall Study|Sponsor decision|0|||
44226368|NCT01741532|79032850|FG000|Overall Study|Medical event|1|||
44476861|NCT00279201|79483836|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
44476862|NCT00279201|79483837|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
44476863|NCT00279201|79483838|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
44476864|NCT00279201|79483839|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
44476865|NCT00279201|79483840|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
44476866|NCT00279201|79483841|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
44476867|NCT00279201|79483836|FG000|Intensification Addendum|Lack of Efficacy|0|||
44476868|NCT00279201|79483837|FG001|Intensification Addendum|Lack of Efficacy|0|||
44476869|NCT00279201|79483838|FG002|Intensification Addendum|Lack of Efficacy|0|||
44476870|NCT00279201|79483839|FG003|Intensification Addendum|Lack of Efficacy|1|||
44476871|NCT00279201|79483840|FG004|Intensification Addendum|Lack of Efficacy|1|||
44476872|NCT00279201|79483841|FG005|Intensification Addendum|Lack of Efficacy|0|||
44476873|NCT00279201|79483836|FG000|Intensification Addendum|Death|0|||
44476874|NCT00279201|79483837|FG001|Intensification Addendum|Death|0|||
44476875|NCT00279201|79483838|FG002|Intensification Addendum|Death|0|||
44476876|NCT00279201|79483839|FG003|Intensification Addendum|Death|0|||
44476877|NCT00279201|79483840|FG004|Intensification Addendum|Death|1|||
44476878|NCT00279201|79483841|FG005|Intensification Addendum|Death|0|||
44476879|NCT00203476|79483877|FG000|Overall Study|Lost to Follow-up|1|||
44476880|NCT00203476|79483878|FG001|Overall Study|Lost to Follow-up|0|||
44476881|NCT00203476|79483879|FG002|Overall Study|Lost to Follow-up|0|||
44476882|NCT00203476|79483877|FG000|Overall Study|Withdrawal by Subject|0|||
44476883|NCT00203476|79483878|FG001|Overall Study|Withdrawal by Subject|1|||
44476884|NCT00203476|79483879|FG002|Overall Study|Withdrawal by Subject|0|||
44476885|NCT00203242|79483887|FG000|Overall Study|Lost to Follow-up|1|||
44476886|NCT00200356|79483893|FG000|Overall Study|Lack of Efficacy|3|||
44476887|NCT00200356|79483894|FG001|Overall Study|Lack of Efficacy|3|||
44476888|NCT00200356|79483893|FG000|Overall Study|Protocol Violation|4|||
44476889|NCT00200356|79483894|FG001|Overall Study|Protocol Violation|4|||
44476890|NCT00200356|79483893|FG000|Overall Study|Nontreatment|1|||
44476891|NCT00200356|79483894|FG001|Overall Study|Nontreatment|0|||
44476892|NCT00227344|79483902|FG000|Overall Study|study terminated early|12|||
44476893|NCT00227344|79483903|FG001|Overall Study|study terminated early|5|||
44476894|NCT00227266|79483912|FG000|Overall Study|Withdrawal by Subject|0|||
44476895|NCT00227266|79483913|FG001|Overall Study|Withdrawal by Subject|0|||
44476896|NCT00227266|79483914|FG002|Overall Study|Withdrawal by Subject|1|||
44476897|NCT00227266|79483912|FG000|Overall Study|Protocol Violation|1|||
44476898|NCT00227266|79483913|FG001|Overall Study|Protocol Violation|0|||
44476899|NCT00227266|79483914|FG002|Overall Study|Protocol Violation|1|||
44544573|NCT03216954|79558093|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
44544574|NCT03599089|79558105|FG000|Overall Study|Lost to Follow-up|1|||
44544575|NCT03599089|79558106|FG001|Overall Study|Lost to Follow-up|0|||
44544576|NCT03599089|79558107|FG002|Overall Study|Lost to Follow-up|0|||
44226369|NCT01741532|79032851|FG001|Overall Study|Medical event|0|||
44226370|NCT01719224|79032861|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
44476900|NCT00227266|79483912|FG000|Overall Study|Excessive weight gain|0|||
44476901|NCT00227266|79483913|FG001|Overall Study|Excessive weight gain|0|||
44476902|NCT00227266|79483914|FG002|Overall Study|Excessive weight gain|2|||
44544577|NCT03599089|79558108|FG003|Overall Study|Lost to Follow-up|0|||
44476903|NCT00256282|79483925|FG000|Overall Study|Disease progression, relapse during acti|12|||
44274079|NCT03952130|79216475|FG000|Overall Study|Adverse Event|0|||
44274080|NCT03952130|79216476|FG001|Overall Study|Adverse Event|1|||
44274081|NCT03952130|79216475|FG000|Overall Study|Lost to Follow-up|1|||
44274082|NCT03952130|79216476|FG001|Overall Study|Lost to Follow-up|0|||
44476904|NCT00256282|79483925|FG000|Overall Study|Adverse Event|3|||
44476905|NCT00256282|79483925|FG000|Overall Study|Physician Decision|1|||
44476906|NCT00266877|79483932|FG000|Overall Study|Death|1|||
44476907|NCT00266877|79483933|FG001|Overall Study|Death|1|||
44476908|NCT00266877|79483934|FG002|Overall Study|Death|1|||
44476909|NCT00266877|79483932|FG000|Overall Study|Adverse Event|6|||
44476910|NCT00266877|79483933|FG001|Overall Study|Adverse Event|4|||
44476911|NCT00266877|79483934|FG002|Overall Study|Adverse Event|1|||
44476912|NCT00266877|79483932|FG000|Overall Study|Physician Decision|2|||
44476913|NCT00266877|79483933|FG001|Overall Study|Physician Decision|1|||
44476914|NCT00266877|79483934|FG002|Overall Study|Physician Decision|1|||
44476915|NCT00266877|79483932|FG000|Overall Study|Withdrawal by Subject|3|||
44476916|NCT00266877|79483933|FG001|Overall Study|Withdrawal by Subject|1|||
44476917|NCT00266877|79483934|FG002|Overall Study|Withdrawal by Subject|1|||
44476918|NCT00266877|79483932|FG000|Overall Study|Disease Progression|72|||
44476919|NCT00266877|79483933|FG001|Overall Study|Disease Progression|37|||
44476920|NCT00266877|79483934|FG002|Overall Study|Disease Progression|23|||
44476921|NCT00266877|79483932|FG000|Overall Study|Symptomatic Deterioration|6|||
44476922|NCT00266877|79483933|FG001|Overall Study|Symptomatic Deterioration|3|||
44476923|NCT00266877|79483934|FG002|Overall Study|Symptomatic Deterioration|1|||
44476924|NCT00266877|79483932|FG000|Overall Study|Hospitalization|1|||
44476925|NCT00266877|79483933|FG001|Overall Study|Hospitalization|0|||
44476926|NCT00266877|79483934|FG002|Overall Study|Hospitalization|0|||
44476927|NCT00266877|79483932|FG000|Overall Study|Concomitant Radiotherapy|0|||
44476928|NCT00266877|79483933|FG001|Overall Study|Concomitant Radiotherapy|1|||
44476929|NCT00266877|79483934|FG002|Overall Study|Concomitant Radiotherapy|0|||
44476930|NCT00256204|79483946|FG000|Overall Study|Adverse Event|10|||
44476931|NCT00256204|79483947|FG001|Overall Study|Adverse Event|14|||
44476932|NCT00256204|79483948|FG002|Overall Study|Adverse Event|16|||
44476933|NCT00256204|79483949|FG003|Overall Study|Adverse Event|14|||
44476934|NCT00256204|79483946|FG000|Overall Study|Death|0|||
44476935|NCT00256204|79483947|FG001|Overall Study|Death|1|||
44476936|NCT00256204|79483948|FG002|Overall Study|Death|0|||
44476937|NCT00256204|79483949|FG003|Overall Study|Death|0|||
44476938|NCT00256204|79483946|FG000|Overall Study|Lost to Follow-up|1|||
44476939|NCT00256204|79483947|FG001|Overall Study|Lost to Follow-up|1|||
44476940|NCT00256204|79483948|FG002|Overall Study|Lost to Follow-up|1|||
44476941|NCT00256204|79483949|FG003|Overall Study|Lost to Follow-up|2|||
44476942|NCT00256204|79483946|FG000|Overall Study|Protocol Violation|1|||
44476943|NCT00256204|79483947|FG001|Overall Study|Protocol Violation|0|||
44544578|NCT03599089|79558105|FG000|Overall Study|Withdrawal by Subject|2|||
44544579|NCT03599089|79558106|FG001|Overall Study|Withdrawal by Subject|1|||
44544580|NCT03599089|79558107|FG002|Overall Study|Withdrawal by Subject|0|||
44544581|NCT03599089|79558108|FG003|Overall Study|Withdrawal by Subject|0|||
44544582|NCT03599089|79558105|FG000|Overall Study|Lack of Efficacy|0|||
44544583|NCT03599089|79558106|FG001|Overall Study|Lack of Efficacy|0|||
44544584|NCT03599089|79558107|FG002|Overall Study|Lack of Efficacy|1|||
44544585|NCT03599089|79558108|FG003|Overall Study|Lack of Efficacy|2|||
44544586|NCT03192150|79558120|FG000|Overall Study|Adverse Event|14|||
44544587|NCT03192150|79558121|FG001|Overall Study|Adverse Event|12|||
44226371|NCT01719224|79032862|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
44226372|NCT01717976|79032873|FG000|Overall Study|Protocol Violation|0|||
44226373|NCT01717976|79032874|FG001|Overall Study|Protocol Violation|1|||
44226374|NCT01740440|79032880|FG000|Overall Study|Lost to Follow-up|3|||
44226375|NCT01740128|79032887|FG000|Overall Study|Pregnancy|0|||
44226376|NCT01740128|79032888|FG001|Overall Study|Pregnancy|1|||
44226377|NCT01740128|79032887|FG000|Overall Study|Protocol Violation|1|||
44226378|NCT01740128|79032888|FG001|Overall Study|Protocol Violation|2|||
44226379|NCT01740128|79032887|FG000|Overall Study|Lost to Follow-up|2|||
44476944|NCT00256204|79483948|FG002|Overall Study|Protocol Violation|2|||
44476945|NCT00256204|79483949|FG003|Overall Study|Protocol Violation|1|||
44476946|NCT00256204|79483946|FG000|Overall Study|Physician Decision|0|||
44544588|NCT03192150|79558120|FG000|Overall Study|Lack of Efficacy|23|||
44544589|NCT03192150|79558121|FG001|Overall Study|Lack of Efficacy|30|||
44544590|NCT03192150|79558120|FG000|Overall Study|Lost to Follow-up|1|||
44226380|NCT01740128|79032888|FG001|Overall Study|Lost to Follow-up|2|||
44226381|NCT01740128|79032887|FG000|Overall Study|Withdrawal by Subject|1|||
44274083|NCT03952130|79216475|FG000|Overall Study|Withdrawal by Subject|1|||
44476947|NCT00256204|79483947|FG001|Overall Study|Physician Decision|0|||
44476948|NCT00256204|79483948|FG002|Overall Study|Physician Decision|1|||
44226382|NCT01740128|79032888|FG001|Overall Study|Withdrawal by Subject|0|||
44476949|NCT00256204|79483949|FG003|Overall Study|Physician Decision|2|||
44476950|NCT00256204|79483946|FG000|Overall Study|Withdrawal by Subject|17|||
44544591|NCT03192150|79558121|FG001|Overall Study|Lost to Follow-up|1|||
44476951|NCT00256204|79483947|FG001|Overall Study|Withdrawal by Subject|6|||
44476952|NCT00256204|79483948|FG002|Overall Study|Withdrawal by Subject|7|||
44476953|NCT00256204|79483949|FG003|Overall Study|Withdrawal by Subject|5|||
44476954|NCT00256204|79483946|FG000|Overall Study|Need for additional prohibited treatment|38|||
44476955|NCT00256204|79483947|FG001|Overall Study|Need for additional prohibited treatment|28|||
44476956|NCT00256204|79483948|FG002|Overall Study|Need for additional prohibited treatment|27|||
44226383|NCT01740128|79032887|FG000|Overall Study|Insufficient protocol compliance|2|||
44226384|NCT01740128|79032888|FG001|Overall Study|Insufficient protocol compliance|2|||
44226385|NCT01976741|79032904|FG000|Overall Study|Withdrawal by Subject|1|||
44226386|NCT01976741|79032905|FG001|Overall Study|Withdrawal by Subject|0|||
44226387|NCT01976741|79032906|FG002|Overall Study|Withdrawal by Subject|1|||
44226388|NCT01976741|79032907|FG003|Overall Study|Withdrawal by Subject|1|||
44226389|NCT01976741|79032908|FG004|Overall Study|Withdrawal by Subject|0|||
44226390|NCT01976741|79032909|FG005|Overall Study|Withdrawal by Subject|0|||
44226391|NCT01976741|79032910|FG006|Overall Study|Withdrawal by Subject|1|||
44226392|NCT01976741|79032911|FG007|Overall Study|Withdrawal by Subject|4|||
44226393|NCT01976741|79032912|FG008|Overall Study|Withdrawal by Subject|0|||
44226394|NCT01976741|79032913|FG009|Overall Study|Withdrawal by Subject|0|||
44226395|NCT01976741|79032904|FG000|Overall Study|Adverse Event|0|||
44226396|NCT01976741|79032905|FG001|Overall Study|Adverse Event|0|||
44226397|NCT01976741|79032906|FG002|Overall Study|Adverse Event|2|||
44226398|NCT01976741|79032907|FG003|Overall Study|Adverse Event|0|||
44226399|NCT01976741|79032908|FG004|Overall Study|Adverse Event|0|||
44226400|NCT01976741|79032909|FG005|Overall Study|Adverse Event|0|||
44226401|NCT01976741|79032910|FG006|Overall Study|Adverse Event|3|||
44226402|NCT01976741|79032911|FG007|Overall Study|Adverse Event|8|||
44226403|NCT01976741|79032912|FG008|Overall Study|Adverse Event|1|||
44226404|NCT01976741|79032913|FG009|Overall Study|Adverse Event|4|||
44226405|NCT01727713|79032947|FG000|Overall Study|Lost to Follow-up|5|||
44226406|NCT01727713|79032947|FG000|Overall Study|Adverse Event|10|||
44226407|NCT01727713|79032947|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
44226408|NCT01727713|79032947|FG000|Overall Study|Withdrawal by Subject|13|||
44226409|NCT01727713|79032947|FG000|Overall Study|Protocol Deviation|2|||
44226410|NCT01965431|79032951|FG000|Overall Study|Adverse Event|0|||
44226411|NCT01965431|79032952|FG001|Overall Study|Adverse Event|1|||
44226412|NCT01965431|79032953|FG002|Overall Study|Adverse Event|0|||
44375496|NCT00943722|79380714|FG003|Base Study|Lost to Follow-up|8|||
44375497|NCT00943722|79380715|FG004|Base Study|Lost to Follow-up|11|||
44226413|NCT01965431|79032954|FG003|Overall Study|Adverse Event|0|||
44226414|NCT01965431|79032955|FG004|Overall Study|Adverse Event|0|||
44226415|NCT01965431|79032956|FG005|Overall Study|Adverse Event|0|||
44375498|NCT00943722|79380716|FG005|Base Study|Lost to Follow-up|0|||
44375499|NCT00943722|79380717|FG006|Base Study|Lost to Follow-up|0|||
44375500|NCT00943722|79380711|FG000|Base Study|Physician Decision|1|||
44375501|NCT00943722|79380712|FG001|Base Study|Physician Decision|0|||
44476957|NCT00256204|79483949|FG003|Overall Study|Need for additional prohibited treatment|25|||
44476958|NCT00256126|79483964|FG000|Overall Study|Adverse Event|1|||
44476959|NCT00256126|79483965|FG001|Overall Study|Adverse Event|0|||
44476960|NCT00256126|79483964|FG000|Overall Study|Other|1|||
44476961|NCT00256126|79483965|FG001|Overall Study|Other|2|||
44476962|NCT00278889|79483974|FG000|Overall Study|Withdrawal by Subject|0|||
44476963|NCT00278889|79483975|FG001|Overall Study|Withdrawal by Subject|5|||
44476964|NCT00278889|79483976|FG002|Overall Study|Withdrawal by Subject|3|||
44476965|NCT00278889|79483974|FG000|Overall Study|Lost to Follow-up|1|||
44476966|NCT00278889|79483975|FG001|Overall Study|Lost to Follow-up|1|||
44476967|NCT00278889|79483976|FG002|Overall Study|Lost to Follow-up|0|||
44476968|NCT00278889|79483974|FG000|Overall Study|Death|24|||
44476969|NCT00278889|79483975|FG001|Overall Study|Death|21|||
44476970|NCT00278889|79483976|FG002|Overall Study|Death|17|||
44476971|NCT00278109|79483984|FG000|Overall Study|Adverse Event|3|||
44476972|NCT00278109|79483984|FG000|Overall Study|social circumstances|1|||
44476973|NCT00296517|79483990|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
44476974|NCT00296517|79483991|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
44476975|NCT00296517|79483990|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
44476976|NCT00296517|79483991|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
44476977|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
44476978|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
44226416|NCT01965431|79032951|FG000|Overall Study|Other than stated above|6|||
44226417|NCT01965431|79032952|FG001|Overall Study|Other than stated above|5|||
44226418|NCT01965431|79032953|FG002|Overall Study|Other than stated above|6|||
44226419|NCT01965431|79032954|FG003|Overall Study|Other than stated above|6|||
44226420|NCT01965431|79032955|FG004|Overall Study|Other than stated above|6|||
44375502|NCT00943722|79380713|FG002|Base Study|Physician Decision|0|||
44226421|NCT01965431|79032956|FG005|Overall Study|Other than stated above|6|||
44476979|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
44375503|NCT00943722|79380714|FG003|Base Study|Physician Decision|0|||
44375504|NCT00943722|79380715|FG004|Base Study|Physician Decision|1|||
44476980|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
44476981|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
44476982|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
44476983|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
44476984|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
44476985|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
44476986|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
44476987|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
44476988|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
44476989|NCT00296517|79483990|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
44476990|NCT00296517|79483991|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
44476991|NCT00224770|79484000|FG000|Overall Study|Lost to Follow-up|4|||
44476992|NCT00224770|79484001|FG001|Overall Study|Lost to Follow-up|2|||
44476993|NCT00224770|79484002|FG002|Overall Study|Lost to Follow-up|0|||
44476994|NCT00266409|79484015|FG000|Overall Study|Lack of Efficacy|2|||
44476995|NCT00266409|79484016|FG001|Overall Study|Lack of Efficacy|6|||
44476996|NCT00266409|79484017|FG002|Overall Study|Lack of Efficacy|1|||
44476997|NCT00266409|79484018|FG003|Overall Study|Lack of Efficacy|2|||
44476998|NCT00266409|79484015|FG000|Overall Study|Adverse Event|7|||
44476999|NCT00266409|79484016|FG001|Overall Study|Adverse Event|2|||
44477000|NCT00266409|79484017|FG002|Overall Study|Adverse Event|1|||
44477001|NCT00266409|79484018|FG003|Overall Study|Adverse Event|1|||
44477002|NCT00266409|79484015|FG000|Overall Study|Lost to Follow-up|18|||
44477003|NCT00266409|79484016|FG001|Overall Study|Lost to Follow-up|21|||
44477004|NCT00266409|79484017|FG002|Overall Study|Lost to Follow-up|6|||
44477005|NCT00266409|79484018|FG003|Overall Study|Lost to Follow-up|8|||
44477006|NCT00266409|79484015|FG000|Overall Study|Withdrawal by Subject|6|||
44477007|NCT00266409|79484016|FG001|Overall Study|Withdrawal by Subject|10|||
44477008|NCT00266409|79484017|FG002|Overall Study|Withdrawal by Subject|3|||
44477009|NCT00266409|79484018|FG003|Overall Study|Withdrawal by Subject|9|||
44477010|NCT00266409|79484015|FG000|Overall Study|Protocol Violation|5|||
44477011|NCT00266409|79484016|FG001|Overall Study|Protocol Violation|3|||
44477012|NCT00266409|79484017|FG002|Overall Study|Protocol Violation|4|||
44477013|NCT00266409|79484018|FG003|Overall Study|Protocol Violation|2|||
44477014|NCT00266409|79484015|FG000|Overall Study|Other|7|||
44477015|NCT00266409|79484016|FG001|Overall Study|Other|4|||
44477016|NCT00266409|79484017|FG002|Overall Study|Other|2|||
44477017|NCT00266409|79484018|FG003|Overall Study|Other|0|||
44477018|NCT00277095|79484028|FG000|Overall Study|Death|2|||
44477019|NCT00277095|79484028|FG000|Overall Study|Explanted|7|||
44477020|NCT00277095|79484028|FG000|Overall Study|Lost to Follow-up|2|||
44477021|NCT00277095|79484028|FG000|Overall Study|Missed Follow-up|9|||
44477022|NCT00277095|79484028|FG000|Overall Study|Physician Decision|1|||
44477023|NCT00265785|79484032|FG000|Overall Study|Adverse Event|4|||
44477024|NCT00265785|79484032|FG000|Overall Study|Withdrawal by Subject|3|||
44477025|NCT00265785|79484032|FG000|Overall Study|Progression/Relapse|15|||
44477026|NCT00265785|79484032|FG000|Overall Study|Not protocol specified|2|||
44477027|NCT00265785|79484032|FG000|Overall Study|Ineligible|1|||
44477028|NCT00265785|79484032|FG000|Overall Study|Did not receive protocol treatment|2|||
44477029|NCT00276159|79484036|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
44477030|NCT00265395|79484042|FG000|Overall Study|Adverse Event|3|||
44477031|NCT00265395|79484043|FG001|Overall Study|Adverse Event|6|||
44477032|NCT00265395|79484042|FG000|Overall Study|Lost to Follow-up|2|||
44477033|NCT00265395|79484043|FG001|Overall Study|Lost to Follow-up|1|||
44477034|NCT00265395|79484042|FG000|Overall Study|Withdrawal by Subject|1|||
44477035|NCT00265395|79484043|FG001|Overall Study|Withdrawal by Subject|6|||
44477036|NCT00265395|79484042|FG000|Overall Study|Protocol Violation|2|||
44477037|NCT00265395|79484043|FG001|Overall Study|Protocol Violation|2|||
44477038|NCT00265395|79484042|FG000|Overall Study|Lack of Efficacy|0|||
44477039|NCT00265395|79484043|FG001|Overall Study|Lack of Efficacy|1|||
44477040|NCT00265395|79484042|FG000|Overall Study|Administrative|0|||
44477041|NCT00265395|79484043|FG001|Overall Study|Administrative|1|||
44477042|NCT00195442|79484048|FG000|Overall Study|Less than expected therapeutic effect|38|||
44477043|NCT00195442|79484048|FG000|Overall Study|Lost to Follow-up|27|||
44226422|NCT01976663|79032966|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
44477044|NCT00195442|79484048|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
44477045|NCT00195442|79484048|FG000|Overall Study|Intermittent product shortage|21|||
44477046|NCT00195442|79484048|FG000|Overall Study|Death|7|||
44477047|NCT00195442|79484048|FG000|Overall Study|No reason specified|4|||
44477048|NCT00195442|79484048|FG000|Overall Study|Poor cooperation|2|||
44477049|NCT00195442|79484048|FG000|Overall Study|Other|14|||
44477050|NCT00275301|79484052|FG000|Overall Study|Adverse Event|5|||
44477051|NCT00251745|79484059|FG000|Overall Study|Adverse Event|7|||
44477052|NCT00251745|79484060|FG001|Overall Study|Adverse Event|9|||
44477053|NCT00251745|79484061|FG002|Overall Study|Adverse Event|11|||
44477054|NCT00251745|79484059|FG000|Overall Study|Lost to Follow-up|4|||
44477055|NCT00251745|79484060|FG001|Overall Study|Lost to Follow-up|2|||
44477056|NCT00251745|79484061|FG002|Overall Study|Lost to Follow-up|5|||
44477057|NCT00251745|79484059|FG000|Overall Study|Withdrawal by Subject|13|||
44477058|NCT00251745|79484060|FG001|Overall Study|Withdrawal by Subject|7|||
44477059|NCT00251745|79484061|FG002|Overall Study|Withdrawal by Subject|3|||
44477060|NCT00251745|79484059|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
44477061|NCT00251745|79484060|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
44477062|NCT00251745|79484061|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
44477063|NCT00251745|79484059|FG000|Overall Study|Lack of Efficacy|3|||
44477064|NCT00251745|79484060|FG001|Overall Study|Lack of Efficacy|0|||
44477065|NCT00251745|79484061|FG002|Overall Study|Lack of Efficacy|0|||
44477066|NCT00251745|79484059|FG000|Overall Study|Noncompliant|0|||
44477067|NCT00251745|79484060|FG001|Overall Study|Noncompliant|2|||
44477068|NCT00251745|79484061|FG002|Overall Study|Noncompliant|2|||
44477069|NCT00251745|79484059|FG000|Overall Study|Pregnancy|0|||
44477070|NCT00251745|79484060|FG001|Overall Study|Pregnancy|1|||
44477071|NCT00251745|79484061|FG002|Overall Study|Pregnancy|0|||
44477072|NCT00251745|79484059|FG000|Overall Study|Per Subject Request|0|||
44477073|NCT00251745|79484060|FG001|Overall Study|Per Subject Request|0|||
44477074|NCT00251745|79484061|FG002|Overall Study|Per Subject Request|1|||
44477075|NCT00251745|79484059|FG000|Overall Study|Per Investigator Request|1|||
44477076|NCT00251745|79484060|FG001|Overall Study|Per Investigator Request|0|||
44477077|NCT00251745|79484061|FG002|Overall Study|Per Investigator Request|0|||
44477078|NCT00255190|79484071|FG000|Overall Study|Adverse Event|17|||
44477079|NCT00255190|79484072|FG001|Overall Study|Adverse Event|36|||
44477080|NCT00255190|79484071|FG000|Overall Study|Protocol Violation|2|||
44477081|NCT00255190|79484072|FG001|Overall Study|Protocol Violation|2|||
44477082|NCT00255190|79484071|FG000|Overall Study|Lost to Follow-up|10|||
44477083|NCT00255190|79484072|FG001|Overall Study|Lost to Follow-up|27|||
44477084|NCT00255190|79484071|FG000|Overall Study|Withdrew Consent|17|||
44477085|NCT00255190|79484072|FG001|Overall Study|Withdrew Consent|48|||
44477086|NCT00255190|79484071|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
44477087|NCT00255190|79484072|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
44274084|NCT03952130|79216476|FG001|Overall Study|Withdrawal by Subject|5|||
44274085|NCT01640964|79216520|FG000|Overall Study|Lost to Follow-up|0|||
44274086|NCT01640964|79216521|FG001|Overall Study|Lost to Follow-up|0|||
44274087|NCT01640964|79216522|FG002|Overall Study|Lost to Follow-up|1|||
44274088|NCT01640964|79216520|FG000|Overall Study|Protocol Deviation|1|||
44274089|NCT01640964|79216521|FG001|Overall Study|Protocol Deviation|1|||
44274090|NCT01640964|79216522|FG002|Overall Study|Protocol Deviation|2|||
44274091|NCT01638390|79216633|FG000|Overall Study|screening failures|21|||
44274092|NCT01600716|79216664|FG000|Overall Study|Other Reasons|3|||
44274093|NCT01600716|79216665|FG001|Overall Study|Other Reasons|1|||
44274094|NCT01600716|79216664|FG000|Overall Study|Personal Reasons|0|||
44274095|NCT01600716|79216665|FG001|Overall Study|Personal Reasons|2|||
44274096|NCT01600716|79216664|FG000|Overall Study|Lost to Follow-up|0|||
44274097|NCT01600716|79216665|FG001|Overall Study|Lost to Follow-up|2|||
44274098|NCT01600716|79216664|FG000|Overall Study|Pregnancy|1|||
44274099|NCT01600716|79216665|FG001|Overall Study|Pregnancy|0|||
44274100|NCT01600716|79216664|FG000|Overall Study|Lack of Efficacy|2|||
44274101|NCT01600716|79216665|FG001|Overall Study|Lack of Efficacy|1|||
44274102|NCT01600716|79216664|FG000|Overall Study|Adverse Event|1|||
44274103|NCT01600716|79216665|FG001|Overall Study|Adverse Event|1|||
44477088|NCT00255190|79484071|FG000|Overall Study|Erosive esophagitis not healed|0|||
44544592|NCT03192150|79558120|FG000|Overall Study|Withdrawal by Subject|4|||
44274104|NCT01600326|79216777|FG000|Overall Study|Lost to Follow-up|1|||
44477089|NCT00255190|79484072|FG001|Overall Study|Erosive esophagitis not healed|20|||
44477090|NCT00255190|79484071|FG000|Overall Study|Various|4|||
44477091|NCT00255190|79484072|FG001|Overall Study|Various|23|||
44477092|NCT00359424|79484080|FG000|Overall Study|Death|99|||
44477093|NCT00359424|79484081|FG001|Overall Study|Death|58|||
44477094|NCT00359424|79484080|FG000|Overall Study|Lost to Follow-up|19|||
44477095|NCT00359424|79484081|FG001|Overall Study|Lost to Follow-up|7|||
44477096|NCT00359424|79484080|FG000|Overall Study|Withdrawal by Subject|10|||
44477097|NCT00359424|79484081|FG001|Overall Study|Withdrawal by Subject|2|||
44477098|NCT00359424|79484080|FG000|Overall Study|follow up not conducted|2|||
44477099|NCT00359424|79484081|FG001|Overall Study|follow up not conducted|0|||
44477100|NCT00255034|79484089|FG000|Overall Study|Withdrawal by Subject|15|||
44477101|NCT00255034|79484090|FG001|Overall Study|Withdrawal by Subject|38|||
44477102|NCT00254566|79484098|FG000|Overall Study|Death|1|||
44477103|NCT00254566|79484099|FG001|Overall Study|Death|0|||
44477104|NCT00254566|79484098|FG000|Overall Study|Adverse Event|5|||
44477105|NCT00254566|79484099|FG001|Overall Study|Adverse Event|4|||
44477106|NCT00254566|79484098|FG000|Overall Study|Lack of Efficacy|12|||
44477107|NCT00254566|79484099|FG001|Overall Study|Lack of Efficacy|9|||
44477108|NCT00254566|79484098|FG000|Overall Study|Other|1|||
44477109|NCT00254566|79484099|FG001|Overall Study|Other|5|||
44477110|NCT00254566|79484098|FG000|Overall Study|Withdrawal by Subject|5|||
44477111|NCT00254566|79484099|FG001|Overall Study|Withdrawal by Subject|6|||
44477112|NCT00254566|79484098|FG000|Overall Study|Lost to Follow-up|7|||
44477113|NCT00254566|79484099|FG001|Overall Study|Lost to Follow-up|2|||
44477114|NCT00358956|79484105|FG000|Overall Study|Adverse Event|3|||
44477115|NCT00358956|79484105|FG000|Overall Study|condition under investigation worsened|4|||
44477116|NCT00358956|79484105|FG000|Overall Study|Withdrawal by Subject|1|||
44477117|NCT03830892|79484111|FG000|Overall Study|Physician Decision|2|||
44226423|NCT01976663|79032966|FG000|Overall Study|Personal Reasons|6|||
44477118|NCT03830892|79484112|FG001|Overall Study|Physician Decision|3|||
44477119|NCT03830892|79484111|FG000|Overall Study|Study terminated due to COVID|4|||
44477120|NCT03830892|79484112|FG001|Overall Study|Study terminated due to COVID|0|||
44477121|NCT03830892|79484111|FG000|Overall Study|Protocol Violation|0|||
44477122|NCT03830892|79484112|FG001|Overall Study|Protocol Violation|1|||
44477123|NCT03830892|79484111|FG000|Overall Study|Withdrawal by Subject|0|||
44477124|NCT03830892|79484112|FG001|Overall Study|Withdrawal by Subject|2|||
44477125|NCT00253630|79484118|FG000|Overall Study|ineligible|2|||
44477126|NCT00358644|79484122|FG000|Overall Study|Progressive Disease|21|||
44477127|NCT00358644|79484122|FG000|Overall Study|Adverse Event|7|||
44477128|NCT00358644|79484122|FG000|Overall Study|Death|11|||
44477129|NCT00358644|79484122|FG000|Overall Study|Withdrawal by Subject|4|||
44477130|NCT00358644|79484122|FG000|Overall Study|Physician Decision|6|||
44477131|NCT00358644|79484122|FG000|Overall Study|Patient not eligible for study|1|||
44477132|NCT00364182|79484129|FG000|First Intervention|Secondary prophylaxis|1|||
44477133|NCT00364182|79484130|FG001|First Intervention|Secondary prophylaxis|0|||
44226424|NCT01976663|79032966|FG000|Overall Study|Withdrawal by Subject|4|||
44226425|NCT01976663|79032966|FG000|Overall Study|Screen Failure|3|||
44226426|NCT01976663|79032966|FG000|Overall Study|Adverse Event|2|||
44226427|NCT01976663|79032966|FG000|Overall Study|Lost to Follow-up|3|||
44226428|NCT01775137|79032974|FG000|Overall Study|Death|1|||
44226429|NCT01775137|79032974|FG000|Overall Study|Protocol deviation|2|||
44226430|NCT01775137|79032974|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44226431|NCT01775137|79032974|FG000|Overall Study|Adverse Event|1|||
44226432|NCT01775137|79032974|FG000|Overall Study|Withdrawal by participants|5|||
44226433|NCT01976507|79032981|FG000|Overall Study|Adverse Event|6|||
44226434|NCT01976507|79032981|FG000|Overall Study|ablation not done, drug not given|1|||
44226435|NCT01964963|79032985|FG000|Overall Study|Case Report Forms Uncollected|888|||
44226436|NCT01964963|79032985|FG000|Overall Study|Protocol Deviation|50|||
44226437|NCT01964963|79032985|FG000|Overall Study|Data Reliability was not Assured|5|||
44477134|NCT00364182|79484131|FG002|First Intervention|Secondary prophylaxis|0|||
44477135|NCT00364182|79484129|FG000|First Intervention|Withdrawal by Subject|2|||
44477136|NCT00364182|79484130|FG001|First Intervention|Withdrawal by Subject|0|||
44477137|NCT00364182|79484131|FG002|First Intervention|Withdrawal by Subject|0|||
44143776|NCT01327885|78933102|FG000|Overall Study|Other|8|||
44477138|NCT00364182|79484129|FG000|Second Intervention|non-compliance|0|||
44477139|NCT00364182|79484130|FG001|Second Intervention|non-compliance|1|||
44477140|NCT00364182|79484131|FG002|Second Intervention|non-compliance|1|||
44477141|NCT00364182|79484129|FG000|Second Intervention|Protocol Violation|0|||
44477142|NCT00364182|79484130|FG001|Second Intervention|Protocol Violation|1|||
44143777|NCT01327885|78933103|FG001|Overall Study|Other|6|||
44143778|NCT01327885|78933102|FG000|Overall Study|Withdrawal of consent from study|3|||
44143779|NCT01327885|78933103|FG001|Overall Study|Withdrawal of consent from study|4|||
44143780|NCT01327885|78933102|FG000|Overall Study|Not treated|1|||
44143781|NCT01327885|78933103|FG001|Overall Study|Not treated|1|||
44143782|NCT01327885|78933102|FG000|Overall Study|Administrative decision|0|||
44143783|NCT01327885|78933103|FG001|Overall Study|Administrative decision|1|||
44477143|NCT00364182|79484131|FG002|Second Intervention|Protocol Violation|0|||
44477144|NCT00364182|79484129|FG000|Second Intervention|Adverse Event|0|||
44477145|NCT00364182|79484130|FG001|Second Intervention|Adverse Event|0|||
44477146|NCT00364182|79484131|FG002|Second Intervention|Adverse Event|1|||
44477147|NCT00364182|79484129|FG000|Third Intervention|non-compliance|0|||
44477148|NCT00364182|79484130|FG001|Third Intervention|non-compliance|1|||
44477149|NCT00364182|79484131|FG002|Third Intervention|non-compliance|0|||
44477150|NCT00364182|79484129|FG000|Third Intervention|Lost to Follow-up|0|||
44477151|NCT00364182|79484130|FG001|Third Intervention|Lost to Follow-up|0|||
44477152|NCT00364182|79484131|FG002|Third Intervention|Lost to Follow-up|1|||
44477153|NCT00369486|79484146|FG000|4-Week Visit|Missed visit|2|||
44477154|NCT00369486|79484147|FG001|4-Week Visit|Missed visit|2|||
44477155|NCT00369486|79484148|FG002|4-Week Visit|Missed visit|0|||
44477156|NCT00369486|79484149|FG003|4-Week Visit|Missed visit|2|||
44477157|NCT00369486|79484150|FG004|4-Week Visit|Missed visit|1|||
44477158|NCT00369486|79484146|FG000|4-Week Visit|Dropped|0|||
44477159|NCT00369486|79484147|FG001|4-Week Visit|Dropped|0|||
44477160|NCT00369486|79484148|FG002|4-Week Visit|Dropped|1|||
44477161|NCT00369486|79484149|FG003|4-Week Visit|Dropped|0|||
44477162|NCT00369486|79484150|FG004|4-Week Visit|Dropped|0|||
44477163|NCT00369486|79484146|FG000|8-Week Visit|Missed visit|0|||
44477164|NCT00369486|79484147|FG001|8-Week Visit|Missed visit|1|||
44477165|NCT00369486|79484148|FG002|8-Week Visit|Missed visit|0|||
44477166|NCT00369486|79484149|FG003|8-Week Visit|Missed visit|0|||
44477167|NCT00369486|79484150|FG004|8-Week Visit|Missed visit|1|||
44477168|NCT00369486|79484146|FG000|8-Week Visit|Dropped|0|||
44477169|NCT00369486|79484147|FG001|8-Week Visit|Dropped|0|||
44477170|NCT00369486|79484148|FG002|8-Week Visit|Dropped|0|||
44477171|NCT00369486|79484149|FG003|8-Week Visit|Dropped|1|||
44477172|NCT00369486|79484150|FG004|8-Week Visit|Dropped|0|||
44477173|NCT00369486|79484146|FG000|17-Week Visit|Missed visit|0|||
44477174|NCT00369486|79484147|FG001|17-Week Visit|Missed visit|0|||
44226438|NCT01964105|79032992|FG000|Overall Study|Lost to Follow-up|2|||
44477175|NCT00369486|79484148|FG002|17-Week Visit|Missed visit|1|||
44477176|NCT00369486|79484149|FG003|17-Week Visit|Missed visit|1|||
44477177|NCT00369486|79484150|FG004|17-Week Visit|Missed visit|1|||
44477178|NCT00369486|79484146|FG000|34-Week Visit|Dropped|0|||
44477179|NCT00369486|79484147|FG001|34-Week Visit|Dropped|1|||
44477180|NCT00369486|79484148|FG002|34-Week Visit|Dropped|1|||
44477181|NCT00369486|79484149|FG003|34-Week Visit|Dropped|3|||
44477182|NCT00369486|79484150|FG004|34-Week Visit|Dropped|3|||
44477183|NCT00363480|79484162|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
44477184|NCT00363480|79484162|FG000|Overall Study|Adverse Event|4|||
44477185|NCT00363480|79484162|FG000|Overall Study|Lost to Follow-up|5|||
44477186|NCT00363480|79484162|FG000|Overall Study|Withdrawal by Subject|5|||
44477187|NCT00363480|79484162|FG000|Overall Study|Non-compliance of subject|1|||
44477188|NCT00363480|79484162|FG000|Overall Study|Participant discontinued on its own|1|||
44477189|NCT00363246|79484166|FG000|Overall Study|Death|40|||
44477190|NCT00363246|79484166|FG000|Overall Study|Withdrawal by Subject|19|||
44477191|NCT00363246|79484166|FG000|Overall Study|Lost to Follow-up|14|||
44477192|NCT00363246|79484166|FG000|Overall Study|Bad health|6|||
44226439|NCT01964105|79032993|FG001|Overall Study|Lost to Follow-up|13|||
44226440|NCT01964105|79032994|FG002|Overall Study|Lost to Follow-up|0|||
44226441|NCT01974323|79033004|FG000|Overall Study|Other Reasons|25|||
44226442|NCT01974323|79033005|FG001|Overall Study|Other Reasons|28|||
44226443|NCT01974323|79033004|FG000|Overall Study|Protocol Violation|2|||
44226444|NCT01974323|79033005|FG001|Overall Study|Protocol Violation|2|||
44477193|NCT00363246|79484166|FG000|Overall Study|Stopped using wheelchair|11|||
44477194|NCT00363246|79484166|FG000|Overall Study|Subject expressed security concerns|2|||
44477195|NCT00363246|79484166|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
44477196|NCT00223990|79484173|FG000|Overall Study|Moved from area|2|||
44477197|NCT00223990|79484174|FG001|Overall Study|Moved from area|1|||
44477198|NCT00223990|79484173|FG000|Overall Study|Withdrawal by Subject|4|||
44477199|NCT00223990|79484174|FG001|Overall Study|Withdrawal by Subject|8|||
44477200|NCT00223990|79484173|FG000|Overall Study|Lost to Follow-up|1|||
44477201|NCT00223990|79484174|FG001|Overall Study|Lost to Follow-up|0|||
44477202|NCT00221104|79484182|FG000|Overall Study|Adverse Event|1|||
44477203|NCT00221104|79484183|FG001|Overall Study|Adverse Event|0|||
44477204|NCT00221104|79484182|FG000|Overall Study|Physician Decision|1|||
44477205|NCT00221104|79484183|FG001|Overall Study|Physician Decision|0|||
44477206|NCT00221104|79484182|FG000|Overall Study|Protocol Violation|2|||
44477207|NCT00221104|79484183|FG001|Overall Study|Protocol Violation|0|||
44477208|NCT00221104|79484182|FG000|Overall Study|Withdrawal by Subject|42|||
44477209|NCT00221104|79484183|FG001|Overall Study|Withdrawal by Subject|29|||
44477210|NCT00221104|79484182|FG000|Overall Study|Others|37|||
44226445|NCT01974323|79033004|FG000|Overall Study|Personal Reasons|15|||
44226446|NCT01974323|79033005|FG001|Overall Study|Personal Reasons|19|||
44477211|NCT00221104|79484183|FG001|Overall Study|Others|47|||
44477212|NCT00189202|79484191|FG000|Overall Study|Physician Decision|5|||
44226447|NCT01974323|79033004|FG000|Overall Study|Lost to Follow-up|45|||
44477213|NCT00187486|79484195|FG000|Overall Study|Protocol Violation|1|||
44477214|NCT00220636|79484199|FG000|Overall Study|Withdrawal by Subject|4|||
44226448|NCT01974323|79033005|FG001|Overall Study|Lost to Follow-up|40|||
44226449|NCT01974323|79033004|FG000|Overall Study|Pregnancy|2|||
44226450|NCT01974323|79033005|FG001|Overall Study|Pregnancy|1|||
44226451|NCT01974323|79033004|FG000|Overall Study|Lack of Efficacy|1|||
44226452|NCT01974323|79033005|FG001|Overall Study|Lack of Efficacy|1|||
44226453|NCT01974323|79033004|FG000|Overall Study|Adverse Event|2|||
44477215|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
44477216|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
44477217|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Death|1|||
44477218|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Death|3|||
44477219|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
44477220|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
44477221|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
44477222|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
44226454|NCT01974323|79033005|FG001|Overall Study|Adverse Event|2|||
44226455|NCT01963403|79033013|FG000|Overall Study|Lost to Follow-up|2|||
44226456|NCT01963403|79033014|FG001|Overall Study|Lost to Follow-up|3|||
44226457|NCT01963403|79033013|FG000|Overall Study|Implant removal|0|||
44226458|NCT01963403|79033014|FG001|Overall Study|Implant removal|1|||
44226459|NCT01973387|79033024|FG000|Overall Study|Adverse Event|14|||
44477223|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
44477224|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
44477225|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
44477226|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
44477227|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
44477228|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
44477229|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
44477230|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
44477231|NCT00362232|79484206|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
44477232|NCT00362232|79484207|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
44477233|NCT00362232|79484206|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
44477234|NCT00362232|79484207|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
44477235|NCT00362232|79484206|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
44477236|NCT00362232|79484207|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
44477237|NCT00362232|79484206|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
44477238|NCT00362232|79484207|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
44477239|NCT00362232|79484206|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
44477240|NCT00362232|79484207|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
44477241|NCT00219544|79484213|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
44226460|NCT01973387|79033025|FG001|Overall Study|Adverse Event|4|||
44226461|NCT01973387|79033024|FG000|Overall Study|Withdrawal by Subject|7|||
44226462|NCT01973387|79033025|FG001|Overall Study|Withdrawal by Subject|4|||
44226463|NCT01973387|79033024|FG000|Overall Study|Study terminated by sponsor|63|||
44226464|NCT01973387|79033025|FG001|Overall Study|Study terminated by sponsor|0|||
44226465|NCT01973387|79033024|FG000|Overall Study|Progressive disease or relapse|16|||
44226466|NCT01973387|79033025|FG001|Overall Study|Progressive disease or relapse|5|||
44274105|NCT01600326|79216778|FG001|Overall Study|Lost to Follow-up|1|||
44274106|NCT01637142|79216914|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
44274107|NCT01636986|79216932|FG000|Overall Study|Withdrawal by Subject|0|||
44477242|NCT00219544|79484214|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
44477243|NCT00219544|79484213|FG000|Single Blind Treatment Period|Adverse Event|9|||
44544593|NCT03192150|79558121|FG001|Overall Study|Withdrawal by Subject|2|||
44544594|NCT03192150|79558120|FG000|Overall Study|Protocol Violation|5|||
44544595|NCT03192150|79558121|FG001|Overall Study|Protocol Violation|2|||
44544596|NCT03192150|79558120|FG000|Overall Study|Surgery Canceled|6|||
44544597|NCT03192150|79558121|FG001|Overall Study|Surgery Canceled|2|||
44544598|NCT03192150|79558120|FG000|Overall Study|Other-Various Administrative Reasons|2|||
44544599|NCT03192150|79558121|FG001|Overall Study|Other-Various Administrative Reasons|5|||
44544600|NCT03597529|79558129|FG000|Overall Study|Lost to Follow-up|10|||
44477244|NCT00219544|79484214|FG001|Single Blind Treatment Period|Adverse Event|0|||
44477245|NCT00219544|79484213|FG000|Single Blind Treatment Period|Protocol Violation|4|||
44477246|NCT00219544|79484214|FG001|Single Blind Treatment Period|Protocol Violation|0|||
44477247|NCT00219544|79484213|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
44544601|NCT03597529|79558130|FG001|Overall Study|Lost to Follow-up|12|||
44544602|NCT03597529|79558129|FG000|Overall Study|Physician Decision|3|||
44226467|NCT01973387|79033024|FG000|Overall Study|Death|4|||
44226468|NCT01973387|79033025|FG001|Overall Study|Death|3|||
44477248|NCT00219544|79484214|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
44477249|NCT00219544|79484213|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
44544603|NCT03597529|79558130|FG001|Overall Study|Physician Decision|1|||
44544604|NCT03597529|79558129|FG000|Overall Study|Withdrawal by Subject|6|||
44226469|NCT01973387|79033024|FG000|Overall Study|Randomized, not treated|2|||
44226470|NCT01973387|79033025|FG001|Overall Study|Randomized, not treated|2|||
44226471|NCT01973231|79033033|FG000|Overall Study|Protocol Violation|1|||
44226472|NCT01973231|79033034|FG001|Overall Study|Protocol Violation|1|||
44226473|NCT01973231|79033033|FG000|Overall Study|Lost to Follow-up|1|||
44226474|NCT01973231|79033034|FG001|Overall Study|Lost to Follow-up|1|||
44226475|NCT01973231|79033033|FG000|Overall Study|unclassified|2|||
44226476|NCT01973231|79033034|FG001|Overall Study|unclassified|1|||
44226477|NCT01973231|79033033|FG000|Overall Study|Withdrawal by Subject|7|||
44477250|NCT00219544|79484214|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
44477251|NCT00219544|79484213|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
44477252|NCT00219544|79484214|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
44477253|NCT00357552|79484222|FG000|Screening|Did not meet eligibility criteria|84|||
44477254|NCT00357552|79484222|FG000|Weeks 0 to 24|Death|1|||
44477255|NCT00357552|79484222|FG000|Weeks 24 to 104|Death|3|||
44477256|NCT00357552|79484222|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
44477257|NCT00187096|79484233|FG000|Overall Study|unacceptable toxicity|0|||
44477258|NCT00187096|79484234|FG001|Overall Study|unacceptable toxicity|0|||
44477259|NCT00187096|79484235|FG002|Overall Study|unacceptable toxicity|1|||
44477260|NCT00357396|79484245|FG000|Overall Study|Adverse Event|1|||
44477261|NCT00357396|79484246|FG001|Overall Study|Adverse Event|0|||
44477262|NCT00186628|79484251|FG000|Overall Study|Death|2|||
44477263|NCT00186628|79484251|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
44226478|NCT01973231|79033034|FG001|Overall Study|Withdrawal by Subject|9|||
44477264|NCT00368550|79484259|FG000|Overall Study|Adverse Event|7|||
44477265|NCT00368550|79484260|FG001|Overall Study|Adverse Event|4|||
44477266|NCT00368550|79484259|FG000|Overall Study|Lack of Efficacy|4|||
44544605|NCT03597529|79558130|FG001|Overall Study|Withdrawal by Subject|3|||
44544606|NCT03597529|79558129|FG000|Overall Study|Non-compliant with study activities|1|||
44544607|NCT03597529|79558130|FG001|Overall Study|Non-compliant with study activities|2|||
44544608|NCT03180528|79558136|FG000|Overall Study|Adverse Event|1|||
44544609|NCT03180528|79558136|FG000|Overall Study|Withdrawal by Subject|1|||
44544610|NCT03180528|79558136|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
44544611|NCT03597295|79558140|FG000|Overall Study|Death|70|||
44544612|NCT03597295|79558140|FG000|Overall Study|Lost to Follow-up|7|||
44544613|NCT03180138|79558147|FG000|Overall Study|Mobile-phone could not be verified|2|||
44544614|NCT03180138|79558148|FG001|Overall Study|Mobile-phone could not be verified|13|||
44544615|NCT03180138|79558149|FG002|Overall Study|Mobile-phone could not be verified|15|||
44544616|NCT03180138|79558147|FG000|Overall Study|No prior immunization records|17|||
44544617|NCT03180138|79558148|FG001|Overall Study|No prior immunization records|0|||
44544618|NCT03180138|79558149|FG002|Overall Study|No prior immunization records|6|||
44477267|NCT00368550|79484260|FG001|Overall Study|Lack of Efficacy|9|||
44477268|NCT00368550|79484259|FG000|Overall Study|Withdrawal by Subject|17|||
44477269|NCT00368550|79484260|FG001|Overall Study|Withdrawal by Subject|10|||
44477270|NCT00368472|79484266|FG000|Overall Study|Adverse Event|22|||
44477271|NCT00368472|79484266|FG000|Overall Study|Medication non-compliance|4|||
44477272|NCT00368472|79484266|FG000|Overall Study|Protocol Violation|2|||
44477273|NCT00368472|79484266|FG000|Overall Study|Request of Investigator or Sponsor|3|||
44477274|NCT00368472|79484266|FG000|Overall Study|Withdrawal by Subject|40|||
44477275|NCT00368472|79484266|FG000|Overall Study|Diary non-compliance|1|||
44477276|NCT00368472|79484266|FG000|Overall Study|Other|32|||
44477277|NCT00368472|79484266|FG000|Overall Study|Missing Final Disposition Date|1|||
44477278|NCT00357006|79484273|FG000|Overall Study|Lost to Follow-up|1|||
44226479|NCT01961687|79033040|FG000|Overall Study|Lost to Follow-up|19|||
44226480|NCT01961687|79033040|FG000|Overall Study|Re-operation|17|||
44226481|NCT01961687|79033040|FG000|Overall Study|Death|7|||
44226482|NCT01961687|79033040|FG000|Overall Study|Withdrawal by Subject|6|||
44226483|NCT01961687|79033040|FG000|Overall Study|Adverse Event|6|||
44226484|NCT01961687|79033040|FG000|Overall Study|Moved to area without study site|2|||
44226485|NCT01961687|79033040|FG000|Overall Study|Sponsor decision|2|||
44544619|NCT03180138|79558147|FG000|Overall Study|Found to be >24 mon after randomization|3|||
44477279|NCT00357006|79484274|FG001|Overall Study|Lost to Follow-up|2|||
44477280|NCT00357006|79484275|FG002|Overall Study|Lost to Follow-up|1|||
44544620|NCT03180138|79558148|FG001|Overall Study|Found to be >24 mon after randomization|0|||
44544621|NCT03180138|79558149|FG002|Overall Study|Found to be >24 mon after randomization|3|||
44226486|NCT01961687|79033040|FG000|Overall Study|Physician Decision|1|||
44226487|NCT01961687|79033040|FG000|Overall Study|Unable to meet follow-up requirements|1|||
44226488|NCT01961609|79033102|FG000|Initiation|Missing|3|||
44226489|NCT01961609|79033103|FG001|Initiation|Missing|2|||
44226490|NCT01961609|79033104|FG002|Initiation|Missing|0|||
44226491|NCT01961609|79033105|FG003|Initiation|Missing|0|||
44226492|NCT01961609|79033102|FG000|Initiation|Protocol deviation|1|||
44477281|NCT00357006|79484273|FG000|Overall Study|Withdrawal by Subject|1|||
44477282|NCT00357006|79484274|FG001|Overall Study|Withdrawal by Subject|3|||
44477283|NCT00357006|79484275|FG002|Overall Study|Withdrawal by Subject|2|||
44477284|NCT00165646|79484286|FG000|Overall Study|Adverse Event|1|||
44477285|NCT00165646|79484287|FG001|Overall Study|Adverse Event|1|||
44226493|NCT01961609|79033103|FG001|Initiation|Protocol deviation|0|||
44226494|NCT01961609|79033104|FG002|Initiation|Protocol deviation|0|||
44477286|NCT00165646|79484288|FG002|Overall Study|Adverse Event|1|||
44477287|NCT00165646|79484286|FG000|Overall Study|Lack of Efficacy|1|||
44477288|NCT00165646|79484287|FG001|Overall Study|Lack of Efficacy|2|||
44477289|NCT00165646|79484288|FG002|Overall Study|Lack of Efficacy|0|||
44477290|NCT00165646|79484286|FG000|Overall Study|Withdrawal by Subject|0|||
44477291|NCT00165646|79484287|FG001|Overall Study|Withdrawal by Subject|2|||
44477292|NCT00165646|79484288|FG002|Overall Study|Withdrawal by Subject|1|||
44477293|NCT00165646|79484286|FG000|Overall Study|Physician Decision|2|||
44477294|NCT00165646|79484287|FG001|Overall Study|Physician Decision|0|||
44477295|NCT00165646|79484288|FG002|Overall Study|Physician Decision|2|||
44477296|NCT00165646|79484286|FG000|Overall Study|Protocol Violation|1|||
44477297|NCT00165646|79484287|FG001|Overall Study|Protocol Violation|0|||
44477298|NCT00165646|79484288|FG002|Overall Study|Protocol Violation|0|||
44477299|NCT00367770|79484296|FG000|Overall Study|Adverse Event|1|||
44477300|NCT00367770|79484296|FG000|Overall Study|Withdrawal by Subject|1|||
44477301|NCT00185614|79484300|FG000|Inter-treatment Period|Physician Decision|1|||
44477302|NCT00185614|79484300|FG000|Inter-treatment Period|Relapse|2|||
44477303|NCT00185614|79484300|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
44477304|NCT00162370|79484304|FG000|Efficacy Population|Lost to Follow-up|51|||
44477305|NCT00361842|79484313|FG000|Overall Study|Withdrawal by Subject|2|||
44477306|NCT00361842|79484314|FG001|Overall Study|Withdrawal by Subject|3|||
44477307|NCT00361842|79484313|FG000|Overall Study|Death|2|||
44477308|NCT00361842|79484314|FG001|Overall Study|Death|1|||
44477309|NCT00361842|79484313|FG000|Overall Study|Disease progression|19|||
44477310|NCT00361842|79484314|FG001|Overall Study|Disease progression|20|||
44477311|NCT00361842|79484313|FG000|Overall Study|Adverse Event|2|||
44477312|NCT00361842|79484314|FG001|Overall Study|Adverse Event|3|||
44477313|NCT00361842|79484313|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
44477314|NCT00361842|79484314|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
44477315|NCT00361842|79484313|FG000|Overall Study|Other|1|||
44477316|NCT00361842|79484314|FG001|Overall Study|Other|0|||
44477317|NCT00361842|79484313|FG000|Overall Study|Other|0|||
44477318|NCT00361842|79484314|FG001|Overall Study|Other|2|||
44477319|NCT00361296|79484322|FG000|Overall Study|Physician Decision|1|||
44477320|NCT00361296|79484322|FG000|Overall Study|Lack of Efficacy|2|||
44477321|NCT00356148|79484328|FG000|Overall Study|Reoperation within 30 days|2|||
44477322|NCT00356148|79484329|FG001|Overall Study|Reoperation within 30 days|1|||
44477323|NCT00361218|79484336|FG000|Overall Study|Lost to Follow-up|11|||
44477324|NCT00361218|79484336|FG000|Overall Study|Personal Reasons|7|||
44477325|NCT00361218|79484336|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
44477326|NCT00367458|79484342|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
44477327|NCT00367458|79484343|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
44477328|NCT00162136|79484355|FG000|Overall Study|Adverse Event|1|||
44477329|NCT00162136|79484355|FG000|Overall Study|Death|1|||
44477330|NCT00162136|79484355|FG000|Overall Study|Disease Progression/Relapse|23|||
44477331|NCT00162136|79484355|FG000|Overall Study|Investigator Request|5|||
44477332|NCT00162136|79484355|FG000|Overall Study|Study Drug Toxicity|4|||
44477333|NCT00162136|79484355|FG000|Overall Study|Withdrawal by Subject|1|||
44477334|NCT00252694|79484381|FG000|Overall Study|Withdrawal by Subject|83|||
44477335|NCT00252694|79484382|FG001|Overall Study|Withdrawal by Subject|91|||
44477336|NCT00252694|79484381|FG000|Overall Study|Death|36|||
44477337|NCT00252694|79484382|FG001|Overall Study|Death|34|||
44477338|NCT00252694|79484381|FG000|Overall Study|Mostly Lost to Follow Up|8|||
44477339|NCT00252694|79484382|FG001|Overall Study|Mostly Lost to Follow Up|13|||
44477340|NCT00252694|79484381|FG000|Overall Study|Patient Moving|17|||
44477341|NCT00252694|79484382|FG001|Overall Study|Patient Moving|16|||
44477342|NCT00185458|79484388|FG000|Contraception Phase|Adverse Event|37|||
44477343|NCT00185458|79484388|FG000|Contraception Phase|Lost to Follow-up|10|||
44477344|NCT00185458|79484388|FG000|Contraception Phase|Protocol Violation|2|||
44226495|NCT01961609|79033105|FG003|Initiation|Protocol deviation|0|||
44226496|NCT01961609|79033102|FG000|Initiation|Death|0|||
44226497|NCT01961609|79033103|FG001|Initiation|Death|1|||
44226498|NCT01961609|79033104|FG002|Initiation|Death|0|||
44226499|NCT01961609|79033105|FG003|Initiation|Death|0|||
44226500|NCT01961609|79033102|FG000|Initiation|Administrative problems|1|||
44226501|NCT01961609|79033103|FG001|Initiation|Administrative problems|0|||
44226502|NCT01961609|79033104|FG002|Initiation|Administrative problems|0|||
44477345|NCT00185458|79484388|FG000|Contraception Phase|Physician Decision|2|||
44477346|NCT00185458|79484388|FG000|Contraception Phase|Withdrawal by Subject|7|||
44477347|NCT00185458|79484388|FG000|HRT Phase|Adverse Event|18|||
44477348|NCT00185458|79484388|FG000|HRT Phase|Lost to Follow-up|4|||
44477349|NCT00185458|79484388|FG000|HRT Phase|Protocol Violation|2|||
44477350|NCT00185458|79484388|FG000|HRT Phase|Withdrawal by Subject|3|||
44477351|NCT00185380|79484403|FG000|Overall Study|Adverse Event|41|||
44477352|NCT00185380|79484404|FG001|Overall Study|Adverse Event|43|||
44477353|NCT00185380|79484405|FG002|Overall Study|Adverse Event|48|||
44226503|NCT01961609|79033105|FG003|Initiation|Administrative problems|0|||
44477354|NCT00185380|79484403|FG000|Overall Study|Lost to Follow-up|0|||
44477355|NCT00185380|79484404|FG001|Overall Study|Lost to Follow-up|4|||
44477356|NCT00185380|79484405|FG002|Overall Study|Lost to Follow-up|3|||
44477357|NCT00185380|79484403|FG000|Overall Study|Pregnancy|1|||
44477358|NCT00185380|79484404|FG001|Overall Study|Pregnancy|4|||
44477359|NCT00185380|79484405|FG002|Overall Study|Pregnancy|0|||
44477360|NCT00185380|79484403|FG000|Overall Study|Protocol Violation|2|||
44477361|NCT00185380|79484404|FG001|Overall Study|Protocol Violation|2|||
44477362|NCT00185380|79484405|FG002|Overall Study|Protocol Violation|1|||
44477363|NCT00185380|79484403|FG000|Overall Study|Withdrawal by Subject|1|||
44477364|NCT00185380|79484404|FG001|Overall Study|Withdrawal by Subject|2|||
44477365|NCT00185380|79484405|FG002|Overall Study|Withdrawal by Subject|0|||
44477366|NCT00185380|79484403|FG000|Overall Study|Failed insertion|1|||
44477367|NCT00185380|79484404|FG001|Overall Study|Failed insertion|1|||
44477368|NCT00185380|79484405|FG002|Overall Study|Failed insertion|2|||
44477369|NCT00185380|79484403|FG000|Overall Study|Planned pregnancy|9|||
44477370|NCT00185380|79484404|FG001|Overall Study|Planned pregnancy|12|||
44477371|NCT00185380|79484405|FG002|Overall Study|Planned pregnancy|12|||
44477372|NCT00185380|79484403|FG000|Overall Study|No need for contraception|3|||
44477373|NCT00185380|79484404|FG001|Overall Study|No need for contraception|3|||
44477374|NCT00185380|79484405|FG002|Overall Study|No need for contraception|3|||
44477375|NCT00185380|79484403|FG000|Overall Study|Could not attend visits|2|||
44477376|NCT00185380|79484404|FG001|Overall Study|Could not attend visits|0|||
44477377|NCT00185380|79484405|FG002|Overall Study|Could not attend visits|4|||
44477378|NCT00185380|79484403|FG000|Overall Study|personal reason|6|||
44477379|NCT00185380|79484404|FG001|Overall Study|personal reason|1|||
44477380|NCT00185380|79484405|FG002|Overall Study|personal reason|1|||
44477381|NCT00160654|79484413|FG000|Overall Study|Adverse Event|14|||
44477382|NCT00160654|79484413|FG000|Overall Study|Lack of Efficacy|4|||
44477383|NCT00160654|79484413|FG000|Overall Study|Lost to Follow-up|2|||
44477384|NCT00160654|79484413|FG000|Overall Study|Intake of expired drug|7|||
44477385|NCT00160654|79484413|FG000|Overall Study|Psychological trauma|1|||
44477386|NCT00160654|79484413|FG000|Overall Study|Sponsor decision|1|||
44477387|NCT00160654|79484413|FG000|Overall Study|Patient met exclusion criteria|1|||
44477388|NCT00160654|79484413|FG000|Overall Study|Patient decision|1|||
44477389|NCT00160654|79484413|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
44477390|NCT00160654|79484413|FG000|Overall Study|Met exclusion criteria|1|||
44477391|NCT00366678|79484419|FG000|Infant Series|Withdrawal by Subject|8|||
44477392|NCT00366678|79484420|FG001|Infant Series|Withdrawal by Subject|6|||
44477393|NCT00366678|79484421|FG002|Infant Series|Withdrawal by Subject|0|||
44477394|NCT00366678|79484419|FG000|Infant Series|Protocol Violation|4|||
44477395|NCT00366678|79484420|FG001|Infant Series|Protocol Violation|3|||
44477396|NCT00366678|79484421|FG002|Infant Series|Protocol Violation|0|||
44477397|NCT00366678|79484419|FG000|Infant Series|Failed to return|1|||
44477398|NCT00366678|79484420|FG001|Infant Series|Failed to return|1|||
44477399|NCT00366678|79484421|FG002|Infant Series|Failed to return|0|||
44477400|NCT00366678|79484419|FG000|Infant Series|Adverse Event|1|||
44477401|NCT00366678|79484420|FG001|Infant Series|Adverse Event|0|||
44477402|NCT00366678|79484421|FG002|Infant Series|Adverse Event|0|||
44477403|NCT00366678|79484419|FG000|After Infant|Withdrawal by Subject|8|||
44477404|NCT00366678|79484420|FG001|After Infant|Withdrawal by Subject|4|||
44477405|NCT00366678|79484421|FG002|After Infant|Withdrawal by Subject|0|||
44477406|NCT00366678|79484419|FG000|After Infant|Lost to Follow-up|2|||
44477407|NCT00366678|79484420|FG001|After Infant|Lost to Follow-up|1|||
44477408|NCT00366678|79484421|FG002|After Infant|Lost to Follow-up|0|||
44477409|NCT00366678|79484419|FG000|After Infant|Failed to return|5|||
44477410|NCT00366678|79484420|FG001|After Infant|Failed to return|5|||
44477411|NCT00366678|79484421|FG002|After Infant|Failed to return|0|||
44477412|NCT00366678|79484419|FG000|After Infant|Adverse Event|1|||
44477413|NCT00366678|79484420|FG001|After Infant|Adverse Event|0|||
44477414|NCT00366678|79484421|FG002|After Infant|Adverse Event|0|||
44477415|NCT00366678|79484419|FG000|After Infant|Protocol Violation|1|||
44477416|NCT00366678|79484420|FG001|After Infant|Protocol Violation|0|||
44477417|NCT00366678|79484421|FG002|After Infant|Protocol Violation|0|||
44477418|NCT00366678|79484419|FG000|Toddler Dose|Protocol Violation|2|||
44477419|NCT00366678|79484420|FG001|Toddler Dose|Protocol Violation|1|||
44544622|NCT03597139|79558159|FG000|Overall Study|Adverse Event|3|||
44477420|NCT00366678|79484421|FG002|Toddler Dose|Protocol Violation|0|||
44477421|NCT00366678|79484419|FG000|Toddler Dose|Failed to return|1|||
44477422|NCT00366678|79484420|FG001|Toddler Dose|Failed to return|0|||
44477423|NCT00366678|79484421|FG002|Toddler Dose|Failed to return|0|||
44477424|NCT00366678|79484419|FG000|Toddler Dose|Withdrawal by Subject|1|||
44477425|NCT00366678|79484420|FG001|Toddler Dose|Withdrawal by Subject|0|||
44477426|NCT00366678|79484421|FG002|Toddler Dose|Withdrawal by Subject|0|||
44477427|NCT00366678|79484419|FG000|Toddler Dose|protocol deviation|1|||
44477428|NCT00366678|79484420|FG001|Toddler Dose|protocol deviation|0|||
44477429|NCT00366678|79484421|FG002|Toddler Dose|protocol deviation|0|||
44477430|NCT00355368|79484468|FG000|Overall Study|Protocol Violation|8|||
44477431|NCT00355368|79484469|FG001|Overall Study|Protocol Violation|7|||
44477432|NCT00355368|79484468|FG000|Overall Study|cardiac arrest prior to intubation|2|||
44477433|NCT00355368|79484469|FG001|Overall Study|cardiac arrest prior to intubation|2|||
44477434|NCT00360282|79484475|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
44477435|NCT00360282|79484476|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
44477436|NCT00360282|79484477|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
44477437|NCT00360282|79484478|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
44477438|NCT00360282|79484475|FG000|Second Intervention|Adverse Event|0|||
44477439|NCT00360282|79484476|FG001|Second Intervention|Adverse Event|1|||
44477440|NCT00360282|79484477|FG002|Second Intervention|Adverse Event|0|||
44477441|NCT00360282|79484478|FG003|Second Intervention|Adverse Event|0|||
44477442|NCT00373958|79484488|FG000|Infant Series|Withdrawal by Subject|13|||
44477443|NCT00373958|79484489|FG001|Infant Series|Withdrawal by Subject|15|||
44477444|NCT00373958|79484488|FG000|Infant Series|Failed to return|8|||
44477445|NCT00373958|79484489|FG001|Infant Series|Failed to return|13|||
44477446|NCT00373958|79484488|FG000|Infant Series|Lost to Follow-up|6|||
44477447|NCT00373958|79484489|FG001|Infant Series|Lost to Follow-up|5|||
44477448|NCT00373958|79484488|FG000|Infant Series|Protocol Violation|3|||
44477449|NCT00373958|79484489|FG001|Infant Series|Protocol Violation|7|||
44477450|NCT00373958|79484488|FG000|Infant Series|Lost Kaiser coverage|4|||
44477451|NCT00373958|79484489|FG001|Infant Series|Lost Kaiser coverage|0|||
44477452|NCT00373958|79484488|FG000|Infant Series|Child relocated|1|||
44477453|NCT00373958|79484489|FG001|Infant Series|Child relocated|0|||
44477454|NCT00373958|79484488|FG000|Infant Series|Consent was not received|1|||
44477455|NCT00373958|79484489|FG001|Infant Series|Consent was not received|0|||
44477456|NCT00373958|79484488|FG000|Infant Series|Adverse Event|3|||
44477457|NCT00373958|79484489|FG001|Infant Series|Adverse Event|1|||
44477458|NCT00373958|79484488|FG000|Infant Series|Physician Decision|1|||
44477459|NCT00373958|79484489|FG001|Infant Series|Physician Decision|1|||
44477460|NCT00373958|79484488|FG000|Toddler Dose|Lost to Follow-up|5|||
44477461|NCT00373958|79484489|FG001|Toddler Dose|Lost to Follow-up|8|||
44477462|NCT00373958|79484488|FG000|Toddler Dose|Withdrawal by Subject|2|||
44477463|NCT00373958|79484489|FG001|Toddler Dose|Withdrawal by Subject|2|||
44477464|NCT00373958|79484488|FG000|Toddler Dose|Failed to return|1|||
44477465|NCT00373958|79484489|FG001|Toddler Dose|Failed to return|2|||
44477466|NCT00373958|79484488|FG000|Toddler Dose|Protocol Violation|0|||
44477467|NCT00373958|79484489|FG001|Toddler Dose|Protocol Violation|1|||
44477468|NCT00373958|79484488|FG000|Toddler Dose|Withdrawn after infant series|22|||
44477469|NCT00373958|79484489|FG001|Toddler Dose|Withdrawn after infant series|25|||
44477470|NCT00373880|79484518|FG000|Overall Study|Physician Decision|3|||
44477471|NCT00373880|79484518|FG000|Overall Study|Arrested|1|||
44477472|NCT00373880|79484518|FG000|Overall Study|Protocol Violation|14|||
44477473|NCT00184600|79484533|FG000|Overall Study|Adverse Event|9|||
44477474|NCT00184600|79484534|FG001|Overall Study|Adverse Event|0|||
44477475|NCT00184600|79484535|FG002|Overall Study|Adverse Event|5|||
44477476|NCT00184600|79484533|FG000|Overall Study|Death|3|||
44477477|NCT00184600|79484534|FG001|Overall Study|Death|9|||
44477478|NCT00184600|79484535|FG002|Overall Study|Death|7|||
44477479|NCT00184600|79484533|FG000|Overall Study|Lack of Efficacy|3|||
44477480|NCT00184600|79484534|FG001|Overall Study|Lack of Efficacy|1|||
44477481|NCT00184600|79484535|FG002|Overall Study|Lack of Efficacy|3|||
44477482|NCT00184600|79484533|FG000|Overall Study|Lost to Follow-up|4|||
44477483|NCT00184600|79484534|FG001|Overall Study|Lost to Follow-up|6|||
44477484|NCT00184600|79484535|FG002|Overall Study|Lost to Follow-up|1|||
44477485|NCT00184600|79484533|FG000|Overall Study|Protocol Violation|2|||
44477486|NCT00184600|79484534|FG001|Overall Study|Protocol Violation|2|||
44477487|NCT00184600|79484535|FG002|Overall Study|Protocol Violation|3|||
44477488|NCT00184600|79484533|FG000|Overall Study|Withdrawal by Subject|20|||
44477489|NCT00184600|79484534|FG001|Overall Study|Withdrawal by Subject|28|||
44477490|NCT00184600|79484535|FG002|Overall Study|Withdrawal by Subject|12|||
44477491|NCT00184600|79484533|FG000|Overall Study|Unclassified|4|||
44477492|NCT00184600|79484534|FG001|Overall Study|Unclassified|5|||
44477493|NCT00184600|79484535|FG002|Overall Study|Unclassified|3|||
44477494|NCT00265317|79484547|FG000|Lead-In|Objective progression or relapse|6|||
44477495|NCT00265317|79484548|FG001|Lead-In|Objective progression or relapse|11|||
44544623|NCT03597139|79558160|FG001|Overall Study|Adverse Event|0|||
44477496|NCT00265317|79484549|FG002|Lead-In|Objective progression or relapse|0|||
44477497|NCT00265317|79484550|FG003|Lead-In|Objective progression or relapse|0|||
44477498|NCT00265317|79484547|FG000|Lead-In|Adverse Event|2|||
44477499|NCT00265317|79484548|FG001|Lead-In|Adverse Event|1|||
44477500|NCT00265317|79484549|FG002|Lead-In|Adverse Event|0|||
44477501|NCT00265317|79484550|FG003|Lead-In|Adverse Event|0|||
44477502|NCT00265317|79484547|FG000|Lead-In|Death|3|||
44477503|NCT00265317|79484548|FG001|Lead-In|Death|5|||
44477504|NCT00265317|79484549|FG002|Lead-In|Death|0|||
44477505|NCT00265317|79484550|FG003|Lead-In|Death|0|||
44477506|NCT00265317|79484547|FG000|Lead-In|Withdrawal/other than adverse event|1|||
44477507|NCT00265317|79484548|FG001|Lead-In|Withdrawal/other than adverse event|0|||
44477508|NCT00265317|79484549|FG002|Lead-In|Withdrawal/other than adverse event|0|||
44477509|NCT00265317|79484550|FG003|Lead-In|Withdrawal/other than adverse event|0|||
44477510|NCT00265317|79484547|FG000|Phase 2|Objective progression or relapse|0|||
44477511|NCT00265317|79484548|FG001|Phase 2|Objective progression or relapse|0|||
44477512|NCT00265317|79484549|FG002|Phase 2|Objective progression or relapse|37|||
44477513|NCT00265317|79484550|FG003|Phase 2|Objective progression or relapse|38|||
44477514|NCT00265317|79484547|FG000|Phase 2|Global deterioration of health status|0|||
44477515|NCT00265317|79484548|FG001|Phase 2|Global deterioration of health status|0|||
44477516|NCT00265317|79484549|FG002|Phase 2|Global deterioration of health status|3|||
44477517|NCT00265317|79484550|FG003|Phase 2|Global deterioration of health status|0|||
44477518|NCT00265317|79484547|FG000|Phase 2|Adverse Event|0|||
44477519|NCT00265317|79484548|FG001|Phase 2|Adverse Event|0|||
44477520|NCT00265317|79484549|FG002|Phase 2|Adverse Event|7|||
44477521|NCT00265317|79484550|FG003|Phase 2|Adverse Event|5|||
44477522|NCT00265317|79484547|FG000|Phase 2|Death|0|||
44477523|NCT00265317|79484548|FG001|Phase 2|Death|0|||
44477524|NCT00265317|79484549|FG002|Phase 2|Death|12|||
44477525|NCT00265317|79484550|FG003|Phase 2|Death|15|||
44477526|NCT00265317|79484547|FG000|Phase 2|Protocol Violation|0|||
44226504|NCT01961609|79033102|FG000|Initiation|Withdrawal by Subject|1|||
44226505|NCT01961609|79033103|FG001|Initiation|Withdrawal by Subject|2|||
44477527|NCT00265317|79484548|FG001|Phase 2|Protocol Violation|0|||
44477528|NCT00265317|79484549|FG002|Phase 2|Protocol Violation|1|||
44477529|NCT00265317|79484550|FG003|Phase 2|Protocol Violation|4|||
44477530|NCT00265317|79484547|FG000|Phase 2|Lost to Follow-up|0|||
44477531|NCT00265317|79484548|FG001|Phase 2|Lost to Follow-up|0|||
44477532|NCT00265317|79484549|FG002|Phase 2|Lost to Follow-up|0|||
44477533|NCT00265317|79484550|FG003|Phase 2|Lost to Follow-up|1|||
44477534|NCT00265317|79484547|FG000|Phase 2|Withdrawal/other than adverse event|0|||
44477535|NCT00265317|79484548|FG001|Phase 2|Withdrawal/other than adverse event|0|||
44477536|NCT00265317|79484549|FG002|Phase 2|Withdrawal/other than adverse event|2|||
44477537|NCT00265317|79484550|FG003|Phase 2|Withdrawal/other than adverse event|1|||
44477538|NCT00265317|79484547|FG000|Phase 2|Study terminated by sponsor|0|||
44477539|NCT00265317|79484548|FG001|Phase 2|Study terminated by sponsor|0|||
44477540|NCT00265317|79484549|FG002|Phase 2|Study terminated by sponsor|1|||
44477541|NCT00265317|79484550|FG003|Phase 2|Study terminated by sponsor|0|||
44477542|NCT00265317|79484547|FG000|Phase 2|Other|0|||
44477543|NCT00265317|79484548|FG001|Phase 2|Other|0|||
44477544|NCT00265317|79484549|FG002|Phase 2|Other|1|||
44477545|NCT00265317|79484550|FG003|Phase 2|Other|1|||
44477546|NCT00373490|79484571|FG000|Overall Study|Adverse Event|0|||
44477547|NCT00373490|79484572|FG001|Overall Study|Adverse Event|1|||
44477548|NCT00373490|79484571|FG000|Overall Study|Lack of Efficacy|9|||
44477549|NCT00373490|79484572|FG001|Overall Study|Lack of Efficacy|4|||
44477550|NCT00373490|79484571|FG000|Overall Study|Withdrawal by Subject|0|||
44477551|NCT00373490|79484572|FG001|Overall Study|Withdrawal by Subject|1|||
44477552|NCT00251589|79484582|FG000|Overall Study|Adverse Event|5|||
44477553|NCT00251589|79484583|FG001|Overall Study|Adverse Event|1|||
44477554|NCT00251589|79484584|FG002|Overall Study|Adverse Event|2|||
44477555|NCT00251589|79484585|FG003|Overall Study|Adverse Event|1|||
44477556|NCT00251589|79484582|FG000|Overall Study|Withdrawal by Subject|1|||
44477557|NCT00251589|79484583|FG001|Overall Study|Withdrawal by Subject|1|||
44477558|NCT00251589|79484584|FG002|Overall Study|Withdrawal by Subject|0|||
44477559|NCT00251589|79484585|FG003|Overall Study|Withdrawal by Subject|0|||
44477560|NCT00251589|79484582|FG000|Overall Study|Discontinued due to progressive disease|9|||
44477561|NCT00251589|79484583|FG001|Overall Study|Discontinued due to progressive disease|1|||
44477562|NCT00251589|79484584|FG002|Overall Study|Discontinued due to progressive disease|0|||
44226506|NCT01961609|79033104|FG002|Initiation|Withdrawal by Subject|0|||
44226507|NCT01961609|79033105|FG003|Initiation|Withdrawal by Subject|0|||
44226508|NCT01961609|79033102|FG000|Initiation|Lack of Efficacy|2|||
44226509|NCT01961609|79033103|FG001|Initiation|Lack of Efficacy|1|||
44226510|NCT01961609|79033104|FG002|Initiation|Lack of Efficacy|0|||
44226511|NCT01961609|79033105|FG003|Initiation|Lack of Efficacy|0|||
44226512|NCT01961609|79033102|FG000|Initiation|Abnormal lab values|0|||
44477563|NCT00251589|79484585|FG003|Overall Study|Discontinued due to progressive disease|1|||
44477564|NCT00265239|79484597|FG000|Overall Study|Adverse Event|2|||
44226513|NCT01961609|79033103|FG001|Initiation|Abnormal lab values|1|||
44226514|NCT01961609|79033104|FG002|Initiation|Abnormal lab values|0|||
44226515|NCT01961609|79033105|FG003|Initiation|Abnormal lab values|0|||
44477565|NCT00265239|79484598|FG001|Overall Study|Adverse Event|1|||
44477566|NCT00350298|79484606|FG000|Overall Study|Death|7|||
44477567|NCT00350298|79484607|FG001|Overall Study|Death|8|||
44477568|NCT00350298|79484606|FG000|Overall Study|Lost to Follow-up|1|||
44477569|NCT00350298|79484607|FG001|Overall Study|Lost to Follow-up|2|||
44477570|NCT00350298|79484606|FG000|Overall Study|Withdrawal by Subject|1|||
44477571|NCT00350298|79484607|FG001|Overall Study|Withdrawal by Subject|3|||
44477572|NCT00159874|79484620|FG000|Overall Study|Adverse Event|2|||
44477573|NCT00159874|79484621|FG001|Overall Study|Adverse Event|2|||
44477574|NCT00159874|79484622|FG002|Overall Study|Adverse Event|5|||
44477575|NCT00159874|79484623|FG003|Overall Study|Adverse Event|1|||
44477576|NCT00159874|79484624|FG004|Overall Study|Adverse Event|1|||
44477577|NCT00159874|79484625|FG005|Overall Study|Adverse Event|2|||
44477578|NCT00159874|79484626|FG006|Overall Study|Adverse Event|0|||
44477579|NCT00159874|79484620|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
44477580|NCT00159874|79484621|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
44477581|NCT00159874|79484622|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
44477582|NCT00159874|79484623|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
44477583|NCT00159874|79484624|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
44477584|NCT00159874|79484625|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
44477585|NCT00159874|79484626|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
44477586|NCT00159874|79484620|FG000|Overall Study|Lack of Efficacy|2|||
44477587|NCT00159874|79484621|FG001|Overall Study|Lack of Efficacy|0|||
44477588|NCT00159874|79484622|FG002|Overall Study|Lack of Efficacy|1|||
44477589|NCT00159874|79484623|FG003|Overall Study|Lack of Efficacy|1|||
44477590|NCT00159874|79484624|FG004|Overall Study|Lack of Efficacy|0|||
44477591|NCT00159874|79484625|FG005|Overall Study|Lack of Efficacy|3|||
44477592|NCT00159874|79484626|FG006|Overall Study|Lack of Efficacy|0|||
44477593|NCT00159874|79484620|FG000|Overall Study|Lost to Follow-up|1|||
44477594|NCT00159874|79484621|FG001|Overall Study|Lost to Follow-up|0|||
44477595|NCT00159874|79484622|FG002|Overall Study|Lost to Follow-up|3|||
44477596|NCT00159874|79484623|FG003|Overall Study|Lost to Follow-up|0|||
44477597|NCT00159874|79484624|FG004|Overall Study|Lost to Follow-up|1|||
44477598|NCT00159874|79484625|FG005|Overall Study|Lost to Follow-up|2|||
44477599|NCT00159874|79484626|FG006|Overall Study|Lost to Follow-up|1|||
44477600|NCT00159874|79484620|FG000|Overall Study|Other|8|||
44477601|NCT00159874|79484621|FG001|Overall Study|Other|8|||
44477602|NCT00159874|79484622|FG002|Overall Study|Other|8|||
44477603|NCT00159874|79484623|FG003|Overall Study|Other|0|||
44477604|NCT00159874|79484624|FG004|Overall Study|Other|2|||
44477605|NCT00159874|79484625|FG005|Overall Study|Other|1|||
44477606|NCT00159874|79484626|FG006|Overall Study|Other|3|||
44477607|NCT00159874|79484620|FG000|Overall Study|Protocol Violation|0|||
44477608|NCT00159874|79484621|FG001|Overall Study|Protocol Violation|5|||
44477609|NCT00159874|79484622|FG002|Overall Study|Protocol Violation|2|||
44477610|NCT00159874|79484623|FG003|Overall Study|Protocol Violation|0|||
44477611|NCT00159874|79484624|FG004|Overall Study|Protocol Violation|0|||
44477612|NCT00159874|79484625|FG005|Overall Study|Protocol Violation|0|||
44477613|NCT00159874|79484626|FG006|Overall Study|Protocol Violation|0|||
44477614|NCT00159874|79484620|FG000|Overall Study|Death|3|||
44477615|NCT00159874|79484621|FG001|Overall Study|Death|8|||
44477616|NCT00159874|79484622|FG002|Overall Study|Death|15|||
44477617|NCT00159874|79484623|FG003|Overall Study|Death|0|||
44477618|NCT00159874|79484624|FG004|Overall Study|Death|1|||
44477619|NCT00159874|79484625|FG005|Overall Study|Death|2|||
44477620|NCT00159874|79484626|FG006|Overall Study|Death|0|||
44477621|NCT00159874|79484620|FG000|Overall Study|Withdrawal by Subject|2|||
44477622|NCT00159874|79484621|FG001|Overall Study|Withdrawal by Subject|6|||
44477623|NCT00159874|79484622|FG002|Overall Study|Withdrawal by Subject|8|||
44477624|NCT00159874|79484623|FG003|Overall Study|Withdrawal by Subject|4|||
44477625|NCT00159874|79484624|FG004|Overall Study|Withdrawal by Subject|3|||
44477626|NCT00159874|79484625|FG005|Overall Study|Withdrawal by Subject|2|||
44477627|NCT00159874|79484626|FG006|Overall Study|Withdrawal by Subject|1|||
44477628|NCT00159874|79484620|FG000|Overall Study|Pregnancy|1|||
44477629|NCT00159874|79484621|FG001|Overall Study|Pregnancy|1|||
44477630|NCT00159874|79484622|FG002|Overall Study|Pregnancy|0|||
44477631|NCT00159874|79484623|FG003|Overall Study|Pregnancy|0|||
44477632|NCT00159874|79484624|FG004|Overall Study|Pregnancy|0|||
44226516|NCT01961609|79033102|FG000|Initiation|Adverse Event|3|||
44226517|NCT01961609|79033103|FG001|Initiation|Adverse Event|5|||
44226518|NCT01961609|79033104|FG002|Initiation|Adverse Event|0|||
44226519|NCT01961609|79033105|FG003|Initiation|Adverse Event|0|||
44226520|NCT01961609|79033102|FG000|Initiation|Randomized but not treated|1|||
44226521|NCT01961609|79033103|FG001|Initiation|Randomized but not treated|1|||
44477633|NCT00159874|79484625|FG005|Overall Study|Pregnancy|0|||
44226522|NCT01961609|79033104|FG002|Initiation|Randomized but not treated|0|||
44226523|NCT01961609|79033105|FG003|Initiation|Randomized but not treated|0|||
44226524|NCT01961609|79033102|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
44226525|NCT01961609|79033103|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
44226526|NCT01961609|79033104|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
44226527|NCT01961609|79033105|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
44226528|NCT01961609|79033102|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
44477634|NCT00159874|79484626|FG006|Overall Study|Pregnancy|0|||
44477635|NCT00349908|79484644|FG000|Overall Study|Withdrawal by Subject|0|||
44477636|NCT00349908|79484645|FG001|Overall Study|Withdrawal by Subject|4|||
44477637|NCT00184054|79484652|FG000|Overall Study|Adverse Event|1|||
44477638|NCT00183430|79484658|FG000|Overall Study|Adverse Event|1|||
44477639|NCT00183430|79484659|FG001|Overall Study|Adverse Event|0|||
44477640|NCT00183430|79484658|FG000|Overall Study|Lost to Follow-up|3|||
44477641|NCT00183430|79484659|FG001|Overall Study|Lost to Follow-up|0|||
44477642|NCT00183430|79484658|FG000|Overall Study|did not meet inclusion criteria|1|||
44477643|NCT00183430|79484659|FG001|Overall Study|did not meet inclusion criteria|0|||
44477644|NCT00183430|79484658|FG000|Overall Study|Withdrawal by Subject|1|||
44477645|NCT00183430|79484659|FG001|Overall Study|Withdrawal by Subject|0|||
44477646|NCT00183274|79484665|FG000|Phase 1: Open-Label|Adverse Event|31|||
44477647|NCT00183274|79484666|FG001|Phase 1: Open-Label|Adverse Event|0|||
44477648|NCT00183274|79484667|FG002|Phase 1: Open-Label|Adverse Event|0|||
44477649|NCT00183274|79484668|FG003|Phase 1: Open-Label|Adverse Event|0|||
44477650|NCT00183274|79484669|FG004|Phase 1: Open-Label|Adverse Event|0|||
44477651|NCT00183274|79484670|FG005|Phase 1: Open-Label|Adverse Event|0|||
44477652|NCT00183274|79484665|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
44477653|NCT00183274|79484666|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
44477654|NCT00183274|79484667|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
44477655|NCT00183274|79484668|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
44477656|NCT00183274|79484669|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
44477657|NCT00183274|79484670|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
44477658|NCT00183274|79484665|FG000|Phase 1: Open-Label|Protocol Violation|11|||
44477659|NCT00183274|79484666|FG001|Phase 1: Open-Label|Protocol Violation|0|||
44477660|NCT00183274|79484667|FG002|Phase 1: Open-Label|Protocol Violation|0|||
44477661|NCT00183274|79484668|FG003|Phase 1: Open-Label|Protocol Violation|0|||
44477662|NCT00183274|79484669|FG004|Phase 1: Open-Label|Protocol Violation|0|||
44477663|NCT00183274|79484670|FG005|Phase 1: Open-Label|Protocol Violation|0|||
44477664|NCT00183274|79484665|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
44477665|NCT00183274|79484666|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
44477666|NCT00183274|79484667|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
44477667|NCT00183274|79484668|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
44477668|NCT00183274|79484669|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
44477669|NCT00183274|79484670|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
44477670|NCT00183274|79484665|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
44477671|NCT00183274|79484666|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
44477672|NCT00183274|79484667|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
44477673|NCT00183274|79484668|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
44477674|NCT00183274|79484669|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
44477675|NCT00183274|79484670|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
44477676|NCT00183274|79484665|FG000|Phase 1: Open-Label|Other|9|||
44477677|NCT00183274|79484666|FG001|Phase 1: Open-Label|Other|0|||
44477678|NCT00183274|79484667|FG002|Phase 1: Open-Label|Other|0|||
44477679|NCT00183274|79484668|FG003|Phase 1: Open-Label|Other|0|||
44477680|NCT00183274|79484669|FG004|Phase 1: Open-Label|Other|0|||
44477681|NCT00183274|79484670|FG005|Phase 1: Open-Label|Other|0|||
44477682|NCT00183274|79484665|FG000|Phase 2: Double-Blind|Relapsed|0|||
44477683|NCT00183274|79484666|FG001|Phase 2: Double-Blind|Relapsed|8|||
44477684|NCT00183274|79484667|FG002|Phase 2: Double-Blind|Relapsed|29|||
44477685|NCT00183274|79484668|FG003|Phase 2: Double-Blind|Relapsed|0|||
44477686|NCT00183274|79484669|FG004|Phase 2: Double-Blind|Relapsed|0|||
44477687|NCT00183274|79484670|FG005|Phase 2: Double-Blind|Relapsed|0|||
44477688|NCT00183274|79484665|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
44477689|NCT00183274|79484666|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
44477690|NCT00183274|79484667|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
44477691|NCT00183274|79484668|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
44477692|NCT00183274|79484669|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
44477693|NCT00183274|79484670|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
44477694|NCT00183274|79484665|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
44477695|NCT00183274|79484666|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
44477696|NCT00183274|79484667|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
44477697|NCT00183274|79484668|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
44477698|NCT00183274|79484669|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
44477699|NCT00183274|79484670|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
44477700|NCT00183274|79484665|FG000|Phase 3: Double-Blind|Relapsed|0|||
44477701|NCT00183274|79484666|FG001|Phase 3: Double-Blind|Relapsed|0|||
44477702|NCT00183274|79484667|FG002|Phase 3: Double-Blind|Relapsed|0|||
44477703|NCT00183274|79484668|FG003|Phase 3: Double-Blind|Relapsed|1|||
44477704|NCT00183274|79484669|FG004|Phase 3: Double-Blind|Relapsed|11|||
44477705|NCT00183274|79484670|FG005|Phase 3: Double-Blind|Relapsed|2|||
44477706|NCT00183196|79484688|FG000|Overall Study|Withdrawal by Subject|18|||
44477707|NCT00183196|79484689|FG001|Overall Study|Withdrawal by Subject|11|||
44477708|NCT00183196|79484690|FG002|Overall Study|Withdrawal by Subject|13|||
44375505|NCT00943722|79380716|FG005|Base Study|Physician Decision|0|||
44375506|NCT00943722|79380717|FG006|Base Study|Physician Decision|0|||
44477709|NCT00183196|79484688|FG000|Overall Study|Adverse Event|1|||
44477710|NCT00183196|79484689|FG001|Overall Study|Adverse Event|2|||
44477711|NCT00183196|79484690|FG002|Overall Study|Adverse Event|2|||
44477712|NCT00183196|79484688|FG000|Overall Study|Legal event|1|||
44477713|NCT00183196|79484689|FG001|Overall Study|Legal event|1|||
44477714|NCT00183196|79484690|FG002|Overall Study|Legal event|1|||
44477715|NCT00183196|79484688|FG000|Overall Study|Required more intensive care|0|||
44477716|NCT00183196|79484689|FG001|Overall Study|Required more intensive care|1|||
44477717|NCT00183196|79484690|FG002|Overall Study|Required more intensive care|2|||
44477718|NCT00349752|79484700|FG000|Overall Study|Adverse Event|8|||
44477719|NCT00349752|79484701|FG001|Overall Study|Adverse Event|12|||
44477720|NCT00349752|79484700|FG000|Overall Study|Lack of Efficacy|37|||
44477721|NCT00349752|79484701|FG001|Overall Study|Lack of Efficacy|42|||
44477722|NCT00349752|79484700|FG000|Overall Study|Lost to Follow-up|4|||
44477723|NCT00349752|79484701|FG001|Overall Study|Lost to Follow-up|2|||
44477724|NCT00349752|79484700|FG000|Overall Study|Personal reasons|6|||
44477725|NCT00349752|79484701|FG001|Overall Study|Personal reasons|5|||
44477726|NCT00349752|79484700|FG000|Overall Study|Other: Required exclusionary medication|0|||
44477727|NCT00349752|79484701|FG001|Overall Study|Other: Required exclusionary medication|1|||
44477728|NCT00349752|79484700|FG000|Overall Study|Other: Non compliance|0|||
44477729|NCT00349752|79484701|FG001|Overall Study|Other: Non compliance|1|||
44477730|NCT00349752|79484700|FG000|Overall Study|Other: Patient stopped steroids|0|||
44477731|NCT00349752|79484701|FG001|Overall Study|Other: Patient stopped steroids|1|||
44477732|NCT00349752|79484700|FG000|Overall Study|Other: Patient's steroid use|1|||
44477733|NCT00349752|79484701|FG001|Overall Study|Other: Patient's steroid use|0|||
44477734|NCT00349752|79484700|FG000|Overall Study|Other: Ineligible|1|||
44477735|NCT00349752|79484701|FG001|Overall Study|Other: Ineligible|0|||
44477736|NCT00349752|79484700|FG000|Overall Study|Other: Inadvertently unblinded|1|||
44477737|NCT00349752|79484701|FG001|Overall Study|Other: Inadvertently unblinded|0|||
44477738|NCT00349752|79484700|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
44477739|NCT00349752|79484701|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
44477740|NCT00174460|79484709|FG000|Overall Study|Withdrawal by Subject|0|||
44477741|NCT00174460|79484710|FG001|Overall Study|Withdrawal by Subject|1|||
44375507|NCT00943722|79380711|FG000|Base Study|Pregnancy|0|||
44375508|NCT00943722|79380712|FG001|Base Study|Pregnancy|0|||
44375509|NCT00943722|79380713|FG002|Base Study|Pregnancy|1|||
44375510|NCT00943722|79380714|FG003|Base Study|Pregnancy|0|||
44477742|NCT00348816|79484717|FG000|Overall Study|Noncompliance with radiation treatment|1|||
44477743|NCT00265083|79484726|FG000|Overall Study|Adverse Event|5|||
44477744|NCT00265083|79484727|FG001|Overall Study|Adverse Event|13|||
44477745|NCT00265083|79484728|FG002|Overall Study|Adverse Event|15|||
44477746|NCT00265083|79484726|FG000|Overall Study|Lost to Follow-up|3|||
44477747|NCT00265083|79484727|FG001|Overall Study|Lost to Follow-up|4|||
44477748|NCT00265083|79484728|FG002|Overall Study|Lost to Follow-up|4|||
44477749|NCT00265083|79484726|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
44477750|NCT00265083|79484727|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
44477751|NCT00265083|79484728|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
44477752|NCT00265083|79484726|FG000|Overall Study|Other|1|||
44477753|NCT00265083|79484727|FG001|Overall Study|Other|12|||
44477754|NCT00265083|79484728|FG002|Overall Study|Other|9|||
44477755|NCT00264849|79484739|FG000|Overall Study|Adverse Event|7|||
44477756|NCT00264849|79484740|FG001|Overall Study|Adverse Event|2|||
44477757|NCT00264849|79484739|FG000|Overall Study|Withdrawal by Subject|7|||
44477758|NCT00264849|79484740|FG001|Overall Study|Withdrawal by Subject|11|||
44477759|NCT00264849|79484739|FG000|Overall Study|Protocol Violation|5|||
44477760|NCT00264849|79484740|FG001|Overall Study|Protocol Violation|3|||
44477761|NCT00264849|79484739|FG000|Overall Study|Lack of Efficacy|1|||
44477762|NCT00264849|79484740|FG001|Overall Study|Lack of Efficacy|6|||
44477763|NCT00264849|79484739|FG000|Overall Study|Lost to Follow-up|0|||
44477764|NCT00264849|79484740|FG001|Overall Study|Lost to Follow-up|2|||
44477765|NCT00264849|79484739|FG000|Overall Study|Death|0|||
44477766|NCT00264849|79484740|FG001|Overall Study|Death|1|||
44477767|NCT00264849|79484739|FG000|Overall Study|Administrative Problems|2|||
44477768|NCT00264849|79484740|FG001|Overall Study|Administrative Problems|0|||
44477769|NCT00211809|79484746|FG000|Overall Study|Lack of Efficacy|1|||
44477770|NCT00211809|79484746|FG000|Overall Study|Lost to Follow-up|2|||
44477771|NCT00211809|79484746|FG000|Overall Study|Pregnancy|1|||
44477772|NCT00211809|79484746|FG000|Overall Study|side effects|2|||
44477773|NCT00129766|79484754|FG000|Overall Study|Death|3|||
44477774|NCT00129766|79484755|FG001|Overall Study|Death|8|||
44477775|NCT00129766|79484754|FG000|Overall Study|Withdrawal of consent|31|||
44477776|NCT00129766|79484755|FG001|Overall Study|Withdrawal of consent|30|||
44477777|NCT00129766|79484754|FG000|Overall Study|Lost to Follow-up|26|||
44477778|NCT00129766|79484755|FG001|Overall Study|Lost to Follow-up|21|||
44477779|NCT00150592|79484764|FG000|Overall Study|Adverse Event|4|||
44477780|NCT00150592|79484765|FG001|Overall Study|Adverse Event|1|||
44477781|NCT00150592|79484764|FG000|Overall Study|Protocol Violation|1|||
44477782|NCT00150592|79484765|FG001|Overall Study|Protocol Violation|0|||
44477783|NCT00150592|79484764|FG000|Overall Study|Withdrawal by Subject|1|||
44477784|NCT00150592|79484765|FG001|Overall Study|Withdrawal by Subject|2|||
44375511|NCT00943722|79380715|FG004|Base Study|Pregnancy|2|||
44375512|NCT00943722|79380716|FG005|Base Study|Pregnancy|0|||
44477785|NCT00150592|79484764|FG000|Overall Study|Non-compliance|1|||
44477786|NCT00150592|79484765|FG001|Overall Study|Non-compliance|0|||
44477787|NCT00149890|79484773|FG000|Overall Study|Adverse Event|1|||
44477788|NCT00149890|79484774|FG001|Overall Study|Adverse Event|8|||
44477789|NCT00149890|79484773|FG000|Overall Study|Lack of Efficacy|8|||
44477790|NCT00149890|79484774|FG001|Overall Study|Lack of Efficacy|9|||
44477791|NCT00149890|79484773|FG000|Overall Study|Protocol Violation|1|||
44477792|NCT00149890|79484774|FG001|Overall Study|Protocol Violation|0|||
44477793|NCT00149890|79484773|FG000|Overall Study|Lost to Follow-up|1|||
44477794|NCT00149890|79484774|FG001|Overall Study|Lost to Follow-up|0|||
44477795|NCT00149890|79484773|FG000|Overall Study|Graft Loss|2|||
44477796|NCT00149890|79484774|FG001|Overall Study|Graft Loss|1|||
44477797|NCT00174382|79484780|FG000|Overall Study|Death|2|||
44477798|NCT00174382|79484780|FG000|Overall Study|Adverse Event|19|||
44477799|NCT00174382|79484780|FG000|Overall Study|Withdrawal by Subject|6|||
44477800|NCT00174382|79484780|FG000|Overall Study|Protocol Violation|3|||
44477801|NCT00174382|79484780|FG000|Overall Study|Arrived early for last visit in error|1|||
44477802|NCT00174382|79484780|FG000|Overall Study|Subject felt pill not effective enough|1|||
44477803|NCT00174382|79484780|FG000|Overall Study|Lost to Follow-up|1|||
44477804|NCT00355134|79484789|FG000|Core Phase|Withdrawal by Subject|35|||
44477805|NCT00355134|79484790|FG001|Core Phase|Withdrawal by Subject|24|||
44477806|NCT00355134|79484791|FG002|Core Phase|Withdrawal by Subject|35|||
44477807|NCT00355134|79484792|FG003|Core Phase|Withdrawal by Subject|0|||
44477808|NCT00355134|79484793|FG004|Core Phase|Withdrawal by Subject|0|||
44477809|NCT00355134|79484789|FG000|Core Phase|Adverse Event|28|||
44477810|NCT00355134|79484790|FG001|Core Phase|Adverse Event|22|||
44477811|NCT00355134|79484791|FG002|Core Phase|Adverse Event|16|||
44477812|NCT00355134|79484792|FG003|Core Phase|Adverse Event|0|||
44477813|NCT00355134|79484793|FG004|Core Phase|Adverse Event|0|||
44477814|NCT00355134|79484789|FG000|Core Phase|Lost to Follow-up|17|||
44477815|NCT00355134|79484790|FG001|Core Phase|Lost to Follow-up|13|||
44477816|NCT00355134|79484791|FG002|Core Phase|Lost to Follow-up|21|||
44477817|NCT00355134|79484792|FG003|Core Phase|Lost to Follow-up|0|||
44477818|NCT00355134|79484793|FG004|Core Phase|Lost to Follow-up|0|||
44477819|NCT00355134|79484789|FG000|Core Phase|Abnormal laboratory value(s)|19|||
44477820|NCT00355134|79484790|FG001|Core Phase|Abnormal laboratory value(s)|14|||
44477821|NCT00355134|79484791|FG002|Core Phase|Abnormal laboratory value(s)|2|||
44477822|NCT00355134|79484792|FG003|Core Phase|Abnormal laboratory value(s)|0|||
44477823|NCT00355134|79484793|FG004|Core Phase|Abnormal laboratory value(s)|0|||
44477824|NCT00355134|79484789|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
44477825|NCT00355134|79484790|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
44477826|NCT00355134|79484791|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
44477827|NCT00355134|79484792|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
44477828|NCT00355134|79484793|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
44477829|NCT00355134|79484789|FG000|Core Phase|Administrative problems|5|||
44477830|NCT00355134|79484790|FG001|Core Phase|Administrative problems|3|||
44477831|NCT00355134|79484791|FG002|Core Phase|Administrative problems|5|||
44477832|NCT00355134|79484792|FG003|Core Phase|Administrative problems|0|||
44477833|NCT00355134|79484793|FG004|Core Phase|Administrative problems|0|||
44477834|NCT00355134|79484789|FG000|Core Phase|Protocol Violation|3|||
44477835|NCT00355134|79484790|FG001|Core Phase|Protocol Violation|2|||
44477836|NCT00355134|79484791|FG002|Core Phase|Protocol Violation|2|||
44477837|NCT00355134|79484792|FG003|Core Phase|Protocol Violation|0|||
44477838|NCT00355134|79484793|FG004|Core Phase|Protocol Violation|0|||
44477839|NCT00355134|79484789|FG000|Core Phase|Abnormal test procedure result(s)|1|||
44477840|NCT00355134|79484790|FG001|Core Phase|Abnormal test procedure result(s)|2|||
44477841|NCT00355134|79484791|FG002|Core Phase|Abnormal test procedure result(s)|1|||
44477842|NCT00355134|79484792|FG003|Core Phase|Abnormal test procedure result(s)|0|||
44477843|NCT00355134|79484793|FG004|Core Phase|Abnormal test procedure result(s)|0|||
44477844|NCT00355134|79484789|FG000|Core Phase|Condition no longer requires study drug|1|||
44477845|NCT00355134|79484790|FG001|Core Phase|Condition no longer requires study drug|0|||
44477846|NCT00355134|79484791|FG002|Core Phase|Condition no longer requires study drug|1|||
44477847|NCT00355134|79484792|FG003|Core Phase|Condition no longer requires study drug|0|||
44477848|NCT00355134|79484793|FG004|Core Phase|Condition no longer requires study drug|0|||
44477849|NCT00355134|79484789|FG000|Extension Phase|Withdrawal by Subject|7|||
44477850|NCT00355134|79484790|FG001|Extension Phase|Withdrawal by Subject|11|||
44477851|NCT00355134|79484791|FG002|Extension Phase|Withdrawal by Subject|0|||
44477852|NCT00355134|79484792|FG003|Extension Phase|Withdrawal by Subject|7|||
44477853|NCT00355134|79484793|FG004|Extension Phase|Withdrawal by Subject|5|||
44477854|NCT00355134|79484789|FG000|Extension Phase|Adverse Event|13|||
44477855|NCT00355134|79484790|FG001|Extension Phase|Adverse Event|9|||
44477856|NCT00355134|79484791|FG002|Extension Phase|Adverse Event|0|||
44477857|NCT00355134|79484792|FG003|Extension Phase|Adverse Event|3|||
44477858|NCT00355134|79484793|FG004|Extension Phase|Adverse Event|5|||
44477859|NCT00355134|79484789|FG000|Extension Phase|Lost to Follow-up|2|||
44477860|NCT00355134|79484790|FG001|Extension Phase|Lost to Follow-up|6|||
44544624|NCT03597139|79558159|FG000|Overall Study|Protocol Non-compliance|1|||
44477861|NCT00355134|79484791|FG002|Extension Phase|Lost to Follow-up|0|||
44477862|NCT00355134|79484792|FG003|Extension Phase|Lost to Follow-up|2|||
44477863|NCT00355134|79484793|FG004|Extension Phase|Lost to Follow-up|4|||
44477864|NCT00355134|79484789|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
44477865|NCT00355134|79484790|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
44477866|NCT00355134|79484791|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
44477867|NCT00355134|79484792|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
44477868|NCT00355134|79484793|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
44477869|NCT00355134|79484789|FG000|Extension Phase|Administrative problems|2|||
44477870|NCT00355134|79484790|FG001|Extension Phase|Administrative problems|4|||
44477871|NCT00355134|79484791|FG002|Extension Phase|Administrative problems|0|||
44477872|NCT00355134|79484792|FG003|Extension Phase|Administrative problems|1|||
44226529|NCT01961609|79033103|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
44477873|NCT00355134|79484793|FG004|Extension Phase|Administrative problems|1|||
44477874|NCT00355134|79484789|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
44477875|NCT00355134|79484790|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
44477876|NCT00355134|79484791|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
44477877|NCT00355134|79484792|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
44477878|NCT00355134|79484793|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
44477879|NCT00355134|79484789|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
44544625|NCT03597139|79558160|FG001|Overall Study|Protocol Non-compliance|0|||
44544626|NCT03179202|79558166|FG000|Overall Study|Screen Failure|67|||
44544627|NCT03179202|79558166|FG000|Overall Study|Subject Lost to Follow Up|12|||
44544628|NCT03179202|79558166|FG000|Overall Study|Withdrawal by Subject|7|||
44544629|NCT03179202|79558166|FG000|Overall Study|Adverse Event|3|||
44544630|NCT03179202|79558166|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
44544631|NCT03179202|79558166|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
44544632|NCT00708214|79558175|FG000|Overall Study|Other Adverse Event|3|||
44544633|NCT00708214|79558176|FG001|Overall Study|Other Adverse Event|6|||
44544634|NCT00708214|79558177|FG002|Overall Study|Other Adverse Event|2|||
44544635|NCT00708214|79558175|FG000|Overall Study|Other|0|||
44544636|NCT00708214|79558176|FG001|Overall Study|Other|1|||
44544637|NCT00708214|79558177|FG002|Overall Study|Other|1|||
44544638|NCT00708214|79558175|FG000|Overall Study|Progressive Disease|4|||
44544639|NCT00708214|79558176|FG001|Overall Study|Progressive Disease|6|||
44544640|NCT00708214|79558177|FG002|Overall Study|Progressive Disease|5|||
44544641|NCT03570697|79558192|FG000|Overall Study|Lost to Follow-up|0|||
44544642|NCT03570697|79558193|FG001|Overall Study|Lost to Follow-up|1|||
44544643|NCT03570697|79558192|FG000|Overall Study|Death|2|||
44226530|NCT01961609|79033104|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
44226531|NCT01961609|79033105|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
44226532|NCT01961609|79033102|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
44226533|NCT01961609|79033103|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
44226534|NCT01961609|79033104|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
44226535|NCT01961609|79033105|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
44226536|NCT01961609|79033102|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
44226537|NCT01961609|79033103|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
44226538|NCT01961609|79033104|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
44477880|NCT00355134|79484790|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
44477881|NCT00355134|79484791|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
44477882|NCT00355134|79484792|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
44477883|NCT00355134|79484793|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
44477884|NCT00355134|79484789|FG000|Extension Phase|Protocol Violation|0|||
44477885|NCT00355134|79484790|FG001|Extension Phase|Protocol Violation|0|||
44477886|NCT00355134|79484791|FG002|Extension Phase|Protocol Violation|0|||
44477887|NCT00355134|79484792|FG003|Extension Phase|Protocol Violation|1|||
44544644|NCT03570697|79558193|FG001|Overall Study|Death|0|||
44544645|NCT03570697|79558192|FG000|Overall Study|Withdrawal by Subject|4|||
44226539|NCT01961609|79033105|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
44226540|NCT01961609|79033102|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
44226541|NCT01961609|79033103|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
44226542|NCT01961609|79033104|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
44226543|NCT01961609|79033105|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
44226544|NCT01961609|79033102|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
44544646|NCT03570697|79558193|FG001|Overall Study|Withdrawal by Subject|2|||
44544647|NCT03569371|79558210|FG000|Overall Study|Lack of Efficacy|1|||
44544648|NCT03569371|79558210|FG000|Overall Study|Lost to Follow-up|1|||
44544649|NCT03569371|79558210|FG000|Overall Study|Adverse Event|1|||
44477888|NCT00355134|79484793|FG004|Extension Phase|Protocol Violation|0|||
44477889|NCT00171730|79484803|FG000|Overall Study|Adverse Event|3|||
44477890|NCT00171730|79484803|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
44477891|NCT00171730|79484803|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
44544650|NCT01318070|79558217|FG000|Overall Study|Adverse Event|1|||
44477892|NCT00171730|79484803|FG000|Overall Study|Withdrawal by Subject|3|||
44477893|NCT00355056|79484815|FG000|Randomization Period|Early Termination|4|||
44477894|NCT00355056|79484816|FG001|Randomization Period|Early Termination|6|||
44544651|NCT01318070|79558218|FG001|Overall Study|Adverse Event|1|||
44477895|NCT00348348|79484832|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
44477896|NCT00348348|79484833|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
44477897|NCT00348348|79484832|FG000|Overall Study|Lack of Efficacy|1|||
44477898|NCT00348348|79484833|FG001|Overall Study|Lack of Efficacy|1|||
44544652|NCT01318070|79558219|FG002|Overall Study|Adverse Event|5|||
44544653|NCT01318070|79558217|FG000|Overall Study|Withdrawal by Subject|0|||
44544654|NCT01318070|79558218|FG001|Overall Study|Withdrawal by Subject|1|||
44544655|NCT01318070|79558219|FG002|Overall Study|Withdrawal by Subject|1|||
44544656|NCT01318070|79558217|FG000|Overall Study|Lack of Efficacy|0|||
44544657|NCT01318070|79558218|FG001|Overall Study|Lack of Efficacy|0|||
44544658|NCT01318070|79558219|FG002|Overall Study|Lack of Efficacy|1|||
44544659|NCT01318070|79558217|FG000|Overall Study|Principal Investigator Discretion|1|||
44544660|NCT01318070|79558218|FG001|Overall Study|Principal Investigator Discretion|0|||
44544661|NCT01318070|79558219|FG002|Overall Study|Principal Investigator Discretion|0|||
44544662|NCT02895295|79558230|FG000|Overall Study|Survey Non-response|71|||
44544663|NCT02895295|79558231|FG001|Overall Study|Survey Non-response|94|||
44544664|NCT02895295|79558232|FG002|Overall Study|Survey Non-response|92|||
44226545|NCT01961609|79033103|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
44226546|NCT01961609|79033104|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
44226547|NCT01961609|79033105|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
44226548|NCT01961609|79033102|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
44226549|NCT01961609|79033103|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
44226550|NCT01961609|79033104|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
44226551|NCT01961609|79033105|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
44226552|NCT01961609|79033102|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
44226553|NCT01961609|79033103|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
44226554|NCT01961609|79033104|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
44226555|NCT01961609|79033105|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
44226556|NCT01961609|79033102|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
44226557|NCT01961609|79033103|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
44226558|NCT01961609|79033104|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
44226559|NCT01961609|79033105|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
44226560|NCT01961609|79033102|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
44226561|NCT01961609|79033103|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
44226562|NCT01961609|79033104|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
44226563|NCT01961609|79033105|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
44226564|NCT01961609|79033102|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
44226565|NCT01961609|79033103|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
44226566|NCT01961609|79033104|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
44226567|NCT01961609|79033105|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
44226568|NCT01961609|79033102|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
44226569|NCT01961609|79033103|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
44226570|NCT01961609|79033104|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
44226571|NCT01961609|79033105|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
44226572|NCT01774981|79033214|FG000|Overall Study|Adverse Event|0|||
44226573|NCT01774981|79033215|FG001|Overall Study|Adverse Event|0|||
44226574|NCT01774981|79033216|FG002|Overall Study|Adverse Event|0|||
44226575|NCT01774981|79033217|FG003|Overall Study|Adverse Event|0|||
44226576|NCT01774981|79033218|FG004|Overall Study|Adverse Event|0|||
44226577|NCT01774981|79033219|FG005|Overall Study|Adverse Event|1|||
44226578|NCT01774981|79033220|FG006|Overall Study|Adverse Event|0|||
44226579|NCT01774981|79033221|FG007|Overall Study|Adverse Event|0|||
44226580|NCT01774981|79033214|FG000|Overall Study|Withdrawal by Subject|0|||
44226581|NCT01774981|79033215|FG001|Overall Study|Withdrawal by Subject|0|||
44226582|NCT01774981|79033216|FG002|Overall Study|Withdrawal by Subject|0|||
44226583|NCT01774981|79033217|FG003|Overall Study|Withdrawal by Subject|0|||
44375513|NCT00943722|79380717|FG006|Base Study|Pregnancy|0|||
44375514|NCT00943722|79380711|FG000|Base Study|Protocol Violation|0|||
44477899|NCT00348348|79484832|FG000|Overall Study|Lost to Follow-up|8|||
44226584|NCT01774981|79033218|FG004|Overall Study|Withdrawal by Subject|0|||
44226585|NCT01774981|79033219|FG005|Overall Study|Withdrawal by Subject|0|||
44544665|NCT00245960|79558242|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
44544666|NCT00245960|79558243|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
44226586|NCT01774981|79033220|FG006|Overall Study|Withdrawal by Subject|0|||
44226587|NCT01774981|79033221|FG007|Overall Study|Withdrawal by Subject|1|||
44375515|NCT00943722|79380712|FG001|Base Study|Protocol Violation|1|||
44375516|NCT00943722|79380713|FG002|Base Study|Protocol Violation|0|||
44477900|NCT00348348|79484833|FG001|Overall Study|Lost to Follow-up|10|||
44477901|NCT00348348|79484832|FG000|Overall Study|Withdrawal by Subject|4|||
44477902|NCT00348348|79484833|FG001|Overall Study|Withdrawal by Subject|1|||
44477903|NCT00348348|79484832|FG000|Overall Study|Other|7|||
44477904|NCT00348348|79484833|FG001|Overall Study|Other|4|||
44477905|NCT00348348|79484832|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
44477906|NCT00348348|79484833|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
44477907|NCT00348348|79484832|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
44477908|NCT00348348|79484833|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
44477909|NCT00348348|79484832|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
44477910|NCT00348348|79484833|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
44226588|NCT01774981|79033214|FG000|Overall Study|Death|0|||
44375517|NCT00943722|79380714|FG003|Base Study|Protocol Violation|0|||
44375518|NCT00943722|79380715|FG004|Base Study|Protocol Violation|2|||
44375519|NCT00943722|79380716|FG005|Base Study|Protocol Violation|0|||
44477911|NCT00348348|79484832|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
44477912|NCT00348348|79484833|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
44477913|NCT00348348|79484832|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
44477914|NCT00348348|79484833|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
44477915|NCT00348348|79484832|FG000|Overall Study|Adverse event probably related to study|1|||
44477916|NCT00348348|79484833|FG001|Overall Study|Adverse event probably related to study|0|||
44477917|NCT00347958|79484839|FG000|Overall Study|Adverse Event|1|||
44477918|NCT00347958|79484839|FG000|Overall Study|Protocol Violation|2|||
44477919|NCT00347958|79484839|FG000|Overall Study|Withdrawal by Subject|1|||
44477920|NCT00354744|79484843|FG000|Overall Study|Adverse Event|2|||
44477921|NCT00354744|79484843|FG000|Overall Study|Death|2|||
44477922|NCT00354744|79484843|FG000|Overall Study|Lack of Efficacy|11|||
44477923|NCT00354744|79484843|FG000|Overall Study|Lost to Follow-up|2|||
44477924|NCT00354744|79484843|FG000|Overall Study|Physician Decision|11|||
44477925|NCT00354744|79484843|FG000|Overall Study|Withdrawal by Subject|14|||
44477926|NCT00373256|79484851|FG000|Overall Study|Adverse Event (AE)|1|||
44477927|NCT00373256|79484852|FG001|Overall Study|Adverse Event (AE)|5|||
44477928|NCT00373256|79484851|FG000|Overall Study|Lost to Follow-up|2|||
44477929|NCT00373256|79484852|FG001|Overall Study|Lost to Follow-up|1|||
44477930|NCT00373256|79484851|FG000|Overall Study|Death|9|||
44477931|NCT00373256|79484852|FG001|Overall Study|Death|8|||
44477932|NCT00373256|79484851|FG000|Overall Study|Objective Progression or Relapse|111|||
44477933|NCT00373256|79484852|FG001|Overall Study|Objective Progression or Relapse|104|||
44477934|NCT00373256|79484851|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
44477935|NCT00373256|79484852|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
44477936|NCT00373256|79484851|FG000|Overall Study|Other|73|||
44477937|NCT00373256|79484852|FG001|Overall Study|Other|107|||
44477938|NCT00373256|79484851|FG000|Overall Study|Protocol Violation|0|||
44477939|NCT00373256|79484852|FG001|Overall Study|Protocol Violation|2|||
44477940|NCT00373256|79484851|FG000|Overall Study|Study Terminated by Sponsor|41|||
44477941|NCT00373256|79484852|FG001|Overall Study|Study Terminated by Sponsor|13|||
44477942|NCT00394082|79484858|FG000|Overall Study|Unacceptable toxicity|15|||
44477943|NCT00394082|79484858|FG000|Overall Study|Adverse Event|4|||
44477944|NCT00394082|79484858|FG000|Overall Study|Physician Decision|4|||
44477945|NCT00394082|79484858|FG000|Overall Study|Withdrawal by Subject|2|||
44477946|NCT00394082|79484858|FG000|Overall Study|Other|1|||
44375520|NCT00943722|79380717|FG006|Base Study|Protocol Violation|0|||
44375521|NCT00943722|79380711|FG000|Base Study|Withdrawal by Subject|12|||
44375522|NCT00943722|79380712|FG001|Base Study|Withdrawal by Subject|13|||
44375523|NCT00943722|79380713|FG002|Base Study|Withdrawal by Subject|2|||
44375524|NCT00943722|79380714|FG003|Base Study|Withdrawal by Subject|13|||
44375525|NCT00943722|79380715|FG004|Base Study|Withdrawal by Subject|8|||
44375526|NCT00943722|79380716|FG005|Base Study|Withdrawal by Subject|0|||
44375527|NCT00943722|79380717|FG006|Base Study|Withdrawal by Subject|0|||
44375528|NCT00943722|79380711|FG000|Base Study|Month 12 visit not completed|0|||
44375529|NCT00943722|79380712|FG001|Base Study|Month 12 visit not completed|0|||
44375530|NCT00943722|79380713|FG002|Base Study|Month 12 visit not completed|0|||
44375531|NCT00943722|79380714|FG003|Base Study|Month 12 visit not completed|0|||
44477947|NCT00393848|79484866|FG000|Overall Study|Surgical schedule|0|||
44477948|NCT00393848|79484867|FG001|Overall Study|Surgical schedule|0|||
44226589|NCT01774981|79033215|FG001|Overall Study|Death|0|||
44226590|NCT01774981|79033216|FG002|Overall Study|Death|0|||
44226591|NCT01774981|79033217|FG003|Overall Study|Death|0|||
44375532|NCT00943722|79380715|FG004|Base Study|Month 12 visit not completed|2|||
44375533|NCT00943722|79380716|FG005|Base Study|Month 12 visit not completed|0|||
44477949|NCT00393848|79484868|FG002|Overall Study|Surgical schedule|0|||
44477950|NCT00393848|79484869|FG003|Overall Study|Surgical schedule|1|||
44477951|NCT00393848|79484866|FG000|Overall Study|Personal reasons|0|||
44477952|NCT00393848|79484867|FG001|Overall Study|Personal reasons|0|||
44477953|NCT00393848|79484868|FG002|Overall Study|Personal reasons|2|||
44477954|NCT00393848|79484869|FG003|Overall Study|Personal reasons|0|||
44477955|NCT00393458|79484884|FG000|Overall Study|Adverse Event|35|||
44477956|NCT00393458|79484885|FG001|Overall Study|Adverse Event|24|||
44477957|NCT00393458|79484886|FG002|Overall Study|Adverse Event|40|||
44477958|NCT00393458|79484887|FG003|Overall Study|Adverse Event|35|||
44477959|NCT00393458|79484884|FG000|Overall Study|Subject withdrew consent|27|||
44477960|NCT00393458|79484885|FG001|Overall Study|Subject withdrew consent|40|||
44477961|NCT00393458|79484886|FG002|Overall Study|Subject withdrew consent|33|||
44477962|NCT00393458|79484887|FG003|Overall Study|Subject withdrew consent|50|||
44477963|NCT00393458|79484884|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
44477964|NCT00393458|79484885|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
44477965|NCT00393458|79484886|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
44477966|NCT00393458|79484887|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
44477967|NCT00393458|79484884|FG000|Overall Study|Protocol deviation|11|||
44477968|NCT00393458|79484885|FG001|Overall Study|Protocol deviation|11|||
44477969|NCT00393458|79484886|FG002|Overall Study|Protocol deviation|11|||
44477970|NCT00393458|79484887|FG003|Overall Study|Protocol deviation|10|||
44477971|NCT00393458|79484884|FG000|Overall Study|Administrative problems|7|||
44477972|NCT00393458|79484885|FG001|Overall Study|Administrative problems|8|||
44477973|NCT00393458|79484886|FG002|Overall Study|Administrative problems|5|||
44477974|NCT00393458|79484887|FG003|Overall Study|Administrative problems|2|||
44477975|NCT00393458|79484884|FG000|Overall Study|Lost to Follow-up|5|||
44477976|NCT00393458|79484885|FG001|Overall Study|Lost to Follow-up|6|||
44477977|NCT00393458|79484886|FG002|Overall Study|Lost to Follow-up|5|||
44477978|NCT00393458|79484887|FG003|Overall Study|Lost to Follow-up|3|||
44477979|NCT00393458|79484884|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44477980|NCT00393458|79484885|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44477981|NCT00393458|79484886|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44477982|NCT00393458|79484887|FG003|Overall Study|Abnormal laboratory value(s)|0|||
44477983|NCT00393458|79484884|FG000|Overall Study|Death|1|||
44477984|NCT00393458|79484885|FG001|Overall Study|Death|1|||
44477985|NCT00393458|79484886|FG002|Overall Study|Death|5|||
44477986|NCT00393458|79484887|FG003|Overall Study|Death|5|||
44477987|NCT00393458|79484884|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44477988|NCT00393458|79484885|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44477989|NCT00393458|79484886|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44477990|NCT00393458|79484887|FG003|Overall Study|Abnormal test procedure result(s)|2|||
44477991|NCT00393458|79484884|FG000|Overall Study|Subject no longer requires study drug|0|||
44477992|NCT00393458|79484885|FG001|Overall Study|Subject no longer requires study drug|1|||
44477993|NCT00393458|79484886|FG002|Overall Study|Subject no longer requires study drug|0|||
44477994|NCT00393458|79484887|FG003|Overall Study|Subject no longer requires study drug|0|||
44477995|NCT00417482|79484900|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
44477996|NCT00417482|79484901|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
44477997|NCT00417482|79484902|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
44477998|NCT00417482|79484900|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
44477999|NCT00417482|79484901|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
44478000|NCT00417482|79484902|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
44478001|NCT00417482|79484900|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
44478002|NCT00417482|79484901|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
44478003|NCT00417482|79484902|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
44478004|NCT00417482|79484900|FG000|Phase B 1st 16 Weeks|Death|1|||
44478005|NCT00417482|79484901|FG001|Phase B 1st 16 Weeks|Death|0|||
44478006|NCT00417482|79484902|FG002|Phase B 1st 16 Weeks|Death|0|||
44478007|NCT00417482|79484900|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
44478008|NCT00417482|79484901|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
44478009|NCT00417482|79484902|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
44478010|NCT00417482|79484900|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
44478011|NCT00417482|79484901|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
44478012|NCT00417482|79484902|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
44478013|NCT00417482|79484900|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
44478014|NCT00417482|79484901|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
44478015|NCT00417482|79484902|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
44478016|NCT00417482|79484900|FG000|Phase B 2nd 16 Weeks|Death|1|||
44478017|NCT00417482|79484901|FG001|Phase B 2nd 16 Weeks|Death|1|||
44478018|NCT00417482|79484902|FG002|Phase B 2nd 16 Weeks|Death|0|||
44478019|NCT00417248|79484916|FG000|Overall Study|Study Terminated|6|||
44478020|NCT00417248|79484916|FG000|Overall Study|Death|1|||
44478021|NCT00417248|79484916|FG000|Overall Study|Lack of Efficacy|1|||
44478022|NCT00392288|79484924|FG000|Overall Study|Adverse Event|17|||
44478023|NCT00392288|79484925|FG001|Overall Study|Adverse Event|7|||
44478024|NCT00392288|79484926|FG002|Overall Study|Adverse Event|8|||
44478025|NCT00392288|79484924|FG000|Overall Study|Lack of Efficacy|8|||
44478026|NCT00392288|79484925|FG001|Overall Study|Lack of Efficacy|5|||
44478027|NCT00392288|79484926|FG002|Overall Study|Lack of Efficacy|3|||
44478028|NCT00392288|79484924|FG000|Overall Study|Protocol Violation|1|||
44478029|NCT00392288|79484925|FG001|Overall Study|Protocol Violation|3|||
44478030|NCT00392288|79484926|FG002|Overall Study|Protocol Violation|1|||
44478031|NCT00392288|79484924|FG000|Overall Study|Lost to Follow-up|1|||
44478032|NCT00392288|79484925|FG001|Overall Study|Lost to Follow-up|1|||
44478033|NCT00392288|79484926|FG002|Overall Study|Lost to Follow-up|1|||
44478034|NCT00392288|79484924|FG000|Overall Study|Withdrawal by Subject|1|||
44478035|NCT00392288|79484925|FG001|Overall Study|Withdrawal by Subject|0|||
44478036|NCT00392288|79484926|FG002|Overall Study|Withdrawal by Subject|2|||
44478037|NCT00392288|79484924|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
44478038|NCT00392288|79484925|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
44478039|NCT00392288|79484926|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
44478040|NCT00392288|79484924|FG000|Overall Study|Other|3|||
44478041|NCT00392288|79484925|FG001|Overall Study|Other|4|||
44478042|NCT00392288|79484926|FG002|Overall Study|Other|1|||
44478043|NCT00417170|79484936|FG000|Overall Study|Adverse Event|1|||
44478044|NCT00417170|79484937|FG001|Overall Study|Adverse Event|1|||
44478045|NCT00417170|79484936|FG000|Overall Study|Withdrawal by Subject|1|||
44478046|NCT00417170|79484937|FG001|Overall Study|Withdrawal by Subject|1|||
44478047|NCT00417170|79484936|FG000|Overall Study|Lost to Follow-up|0|||
44478048|NCT00417170|79484937|FG001|Overall Study|Lost to Follow-up|1|||
44478049|NCT00392990|79484945|FG000|Treatment on Study|Adverse Event|3|||
44478050|NCT00392990|79484946|FG001|Treatment on Study|Adverse Event|1|||
44478051|NCT00392990|79484945|FG000|Follow up for 2 Years|Death|4|||
44478052|NCT00392990|79484946|FG001|Follow up for 2 Years|Death|0|||
44478053|NCT00249873|79484954|FG000|Overall Study|Not treated|7|||
44478054|NCT00249873|79484955|FG001|Overall Study|Not treated|8|||
44478055|NCT00249873|79484954|FG000|Overall Study|Significant thrombocytopenia|9|||
44478056|NCT00249873|79484955|FG001|Overall Study|Significant thrombocytopenia|8|||
44478057|NCT00249873|79484954|FG000|Overall Study|Severe allergic reaction|8|||
44478058|NCT00249873|79484955|FG001|Overall Study|Severe allergic reaction|1|||
44478059|NCT00249873|79484954|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
44478060|NCT00249873|79484955|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
44478061|NCT00249873|79484954|FG000|Overall Study|Other Serious Adverse Event|86|||
44478062|NCT00249873|79484955|FG001|Overall Study|Other Serious Adverse Event|97|||
44478063|NCT00249873|79484954|FG000|Overall Study|Qualifying condition not present|20|||
44478064|NCT00249873|79484955|FG001|Overall Study|Qualifying condition not present|23|||
44478065|NCT00249873|79484954|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
44478066|NCT00249873|79484955|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
44478067|NCT00249873|79484954|FG000|Overall Study|Withdrawal by Subject|504|||
44478068|NCT00249873|79484955|FG001|Overall Study|Withdrawal by Subject|466|||
44478069|NCT00249873|79484954|FG000|Overall Study|Lost to Follow-up|4|||
44478070|NCT00249873|79484955|FG001|Overall Study|Lost to Follow-up|7|||
44478071|NCT00249873|79484954|FG000|Overall Study|Minor bleeding|99|||
44478072|NCT00249873|79484955|FG001|Overall Study|Minor bleeding|37|||
44478073|NCT00249873|79484954|FG000|Overall Study|Non-compliance|41|||
44478074|NCT00249873|79484955|FG001|Overall Study|Non-compliance|46|||
44478075|NCT00249873|79484954|FG000|Overall Study|Other non serious Adverse Event|112|||
44478076|NCT00249873|79484955|FG001|Overall Study|Other non serious Adverse Event|108|||
44478077|NCT00249873|79484954|FG000|Overall Study|Other contraindicated medication|1|||
44478078|NCT00249873|79484955|FG001|Overall Study|Other contraindicated medication|0|||
44478079|NCT00249873|79484954|FG000|Overall Study|Patient not wish to continue after May08|3|||
44478080|NCT00249873|79484955|FG001|Overall Study|Patient not wish to continue after May08|4|||
44478081|NCT00249873|79484954|FG000|Overall Study|Physician withdrew consent|59|||
44478082|NCT00249873|79484955|FG001|Overall Study|Physician withdrew consent|60|||
44478083|NCT00249873|79484954|FG000|Overall Study|Open label clopidogrel required|31|||
44478084|NCT00249873|79484955|FG001|Overall Study|Open label clopidogrel required|42|||
44478085|NCT00249873|79484954|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
44478086|NCT00249873|79484955|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
44478087|NCT00249873|79484954|FG000|Overall Study|Oral anticoagulant required|159|||
44478088|NCT00249873|79484955|FG001|Overall Study|Oral anticoagulant required|157|||
44478089|NCT00249873|79484954|FG000|Overall Study|Study drug intolerance|5|||
44478090|NCT00249873|79484955|FG001|Overall Study|Study drug intolerance|0|||
44478091|NCT00249873|79484954|FG000|Overall Study|Surgery/ procedure|9|||
44478092|NCT00249873|79484955|FG001|Overall Study|Surgery/ procedure|9|||
44478093|NCT00249873|79484954|FG000|Overall Study|Event related to cardiac condition|12|||
44478094|NCT00249873|79484955|FG001|Overall Study|Event related to cardiac condition|21|||
44478095|NCT00249873|79484954|FG000|Overall Study|Thromboembolic/outcome event|82|||
44478096|NCT00249873|79484955|FG001|Overall Study|Thromboembolic/outcome event|122|||
44478097|NCT00392210|79484963|FG000|First Voiding Trial|Physician Decision|2|||
44478098|NCT00392210|79484964|FG001|First Voiding Trial|Physician Decision|2|||
44478099|NCT00391976|79484973|FG000|Overall Study|Adverse Event|0|||
44478100|NCT00391976|79484974|FG001|Overall Study|Adverse Event|0|||
44478101|NCT00391976|79484975|FG002|Overall Study|Adverse Event|1|||
44478102|NCT00391976|79484973|FG000|Overall Study|Withdrawal of consent|0|||
44478103|NCT00391976|79484974|FG001|Overall Study|Withdrawal of consent|1|||
44478104|NCT00391976|79484975|FG002|Overall Study|Withdrawal of consent|1|||
44478105|NCT00391976|79484973|FG000|Overall Study|Lost to Follow-up|1|||
44544667|NCT00245960|79558242|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
44478106|NCT00391976|79484974|FG001|Overall Study|Lost to Follow-up|2|||
44478107|NCT00391976|79484975|FG002|Overall Study|Lost to Follow-up|0|||
44478108|NCT00391976|79484973|FG000|Overall Study|Inappropriate enrollment|1|||
44478109|NCT00391976|79484974|FG001|Overall Study|Inappropriate enrollment|1|||
44478110|NCT00391976|79484975|FG002|Overall Study|Inappropriate enrollment|0|||
44478111|NCT00391976|79484973|FG000|Overall Study|Protocol deviation/violation|4|||
44478112|NCT00391976|79484974|FG001|Overall Study|Protocol deviation/violation|2|||
44478113|NCT00391976|79484975|FG002|Overall Study|Protocol deviation/violation|1|||
44478114|NCT00391976|79484973|FG000|Overall Study|Recurrence/no eradication of infection|21|||
44478115|NCT00391976|79484974|FG001|Overall Study|Recurrence/no eradication of infection|19|||
44478116|NCT00391976|79484975|FG002|Overall Study|Recurrence/no eradication of infection|0|||
44478117|NCT00391976|79484973|FG000|Overall Study|Unable to classify|0|||
44478118|NCT00391976|79484974|FG001|Overall Study|Unable to classify|0|||
44478119|NCT00391976|79484975|FG002|Overall Study|Unable to classify|1|||
44478120|NCT00391976|79484973|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
44478121|NCT00391976|79484974|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
44478122|NCT00391976|79484975|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
44478123|NCT00391898|79484987|FG000|Overall Study|Adverse Event|3|||
44478124|NCT00391898|79484988|FG001|Overall Study|Adverse Event|0|||
44478125|NCT00391898|79484987|FG000|Overall Study|Other|8|||
44478126|NCT00391898|79484988|FG001|Overall Study|Other|10|||
44478127|NCT00391586|79484994|FG000|Overall Study|Progressive disease|13|||
44478128|NCT00391586|79484994|FG000|Overall Study|Adverse Event|5|||
44478129|NCT00391586|79484994|FG000|Overall Study|Physician Decision|2|||
44478130|NCT00391586|79484994|FG000|Overall Study|Death|4|||
44478131|NCT00391430|79485001|FG000|Overall Study|Withdrawal by Subject|3|||
44478132|NCT00391430|79485002|FG001|Overall Study|Withdrawal by Subject|0|||
44478133|NCT00391430|79485003|FG002|Overall Study|Withdrawal by Subject|12|||
44478134|NCT00391274|79485013|FG000|Overall Study|Death Due to Study Disease|55|||
44478135|NCT00391274|79485014|FG001|Overall Study|Death Due to Study Disease|45|||
44478136|NCT00391274|79485013|FG000|Overall Study|Lost to Follow-up|0|||
44478137|NCT00391274|79485014|FG001|Overall Study|Lost to Follow-up|3|||
44478138|NCT00391274|79485013|FG000|Overall Study|Physician Decision|4|||
44478139|NCT00391274|79485014|FG001|Overall Study|Physician Decision|2|||
44478140|NCT00391274|79485013|FG000|Overall Study|Withdrawal by Subject|0|||
44478141|NCT00391274|79485014|FG001|Overall Study|Withdrawal by Subject|3|||
44478142|NCT00391274|79485013|FG000|Overall Study|Death Due to Adverse Event|1|||
44478143|NCT00391274|79485014|FG001|Overall Study|Death Due to Adverse Event|3|||
44478144|NCT00391274|79485013|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
44478145|NCT00391274|79485014|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
44478146|NCT00391274|79485013|FG000|Overall Study|Death Not Study Related|0|||
44478147|NCT00391274|79485014|FG001|Overall Study|Death Not Study Related|1|||
44478148|NCT00391118|79485023|FG000|Overall Study|Adverse Event|3|||
44478149|NCT00391118|79485024|FG001|Overall Study|Adverse Event|10|||
44478150|NCT00391118|79485025|FG002|Overall Study|Adverse Event|7|||
44478151|NCT00391118|79485023|FG000|Overall Study|Lost to Follow-up|0|||
44478152|NCT00391118|79485024|FG001|Overall Study|Lost to Follow-up|2|||
44478153|NCT00391118|79485025|FG002|Overall Study|Lost to Follow-up|3|||
44478154|NCT00391118|79485023|FG000|Overall Study|Withdrawal by Subject|0|||
44478155|NCT00391118|79485024|FG001|Overall Study|Withdrawal by Subject|9|||
44478156|NCT00391118|79485025|FG002|Overall Study|Withdrawal by Subject|1|||
44478157|NCT00391118|79485023|FG000|Overall Study|Death|0|||
44478158|NCT00391118|79485024|FG001|Overall Study|Death|1|||
44478159|NCT00391118|79485025|FG002|Overall Study|Death|0|||
44478160|NCT00391118|79485023|FG000|Overall Study|Physician Decision|0|||
44478161|NCT00391118|79485024|FG001|Overall Study|Physician Decision|3|||
44226592|NCT01774981|79033218|FG004|Overall Study|Death|1|||
44226593|NCT01774981|79033219|FG005|Overall Study|Death|0|||
44226594|NCT01774981|79033220|FG006|Overall Study|Death|0|||
44226595|NCT01774981|79033221|FG007|Overall Study|Death|0|||
44226596|NCT01972841|79033250|FG000|Overall Study|Randomized but Never Received Treatment|2|||
44478162|NCT00391118|79485025|FG002|Overall Study|Physician Decision|0|||
44478163|NCT00391118|79485023|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
44478164|NCT00391118|79485024|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
44478165|NCT00391118|79485025|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
44478166|NCT00391118|79485023|FG000|Overall Study|Progressive Disease|7|||
44478167|NCT00391118|79485024|FG001|Overall Study|Progressive Disease|26|||
44478168|NCT00391118|79485025|FG002|Overall Study|Progressive Disease|43|||
44478169|NCT00391118|79485023|FG000|Overall Study|Sponsor Decision|0|||
44226597|NCT01972841|79033251|FG001|Overall Study|Randomized but Never Received Treatment|5|||
44478170|NCT00391118|79485024|FG001|Overall Study|Sponsor Decision|1|||
44478171|NCT00391118|79485025|FG002|Overall Study|Sponsor Decision|3|||
44478172|NCT00391118|79485023|FG000|Overall Study|Protocol Violation|1|||
44478173|NCT00391118|79485024|FG001|Overall Study|Protocol Violation|0|||
44478174|NCT00391118|79485025|FG002|Overall Study|Protocol Violation|0|||
44478175|NCT00390884|79485038|FG000|Overall Study|Withdrawal by Subject|2|||
44478176|NCT00390884|79485039|FG001|Overall Study|Withdrawal by Subject|2|||
44478177|NCT00365846|79485045|FG000|Overall Study|Lost to Follow-up|1|||
44478178|NCT00264537|79485055|FG000|Overall Study|Death|0|||
44478179|NCT00264537|79485056|FG001|Overall Study|Death|3|||
44478180|NCT00264537|79485057|FG002|Overall Study|Death|3|||
44478181|NCT00264537|79485058|FG003|Overall Study|Death|2|||
44478182|NCT00264537|79485055|FG000|Overall Study|Lost to Follow-up|3|||
44478183|NCT00264537|79485056|FG001|Overall Study|Lost to Follow-up|4|||
44478184|NCT00264537|79485057|FG002|Overall Study|Lost to Follow-up|7|||
44478185|NCT00264537|79485058|FG003|Overall Study|Lost to Follow-up|6|||
44478186|NCT00264537|79485055|FG000|Overall Study|Adverse Event|21|||
44478187|NCT00264537|79485056|FG001|Overall Study|Adverse Event|32|||
44478188|NCT00264537|79485057|FG002|Overall Study|Adverse Event|24|||
44478189|NCT00264537|79485058|FG003|Overall Study|Adverse Event|34|||
44478190|NCT00264537|79485055|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
44478191|NCT00264537|79485056|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
44478192|NCT00264537|79485057|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
44478193|NCT00264537|79485058|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
44478194|NCT00264537|79485055|FG000|Overall Study|Other|21|||
44478195|NCT00264537|79485056|FG001|Overall Study|Other|11|||
44478196|NCT00264537|79485057|FG002|Overall Study|Other|10|||
44478197|NCT00264537|79485058|FG003|Overall Study|Other|11|||
44478198|NCT00264537|79485055|FG000|Overall Study|Not treated|0|||
44478199|NCT00264537|79485056|FG001|Overall Study|Not treated|2|||
44478200|NCT00264537|79485057|FG002|Overall Study|Not treated|1|||
44478201|NCT00264537|79485058|FG003|Overall Study|Not treated|0|||
44478202|NCT00371462|79485072|FG000|Overall Study|Withdrawal by Subject|1|||
44478203|NCT00371462|79485073|FG001|Overall Study|Withdrawal by Subject|0|||
44478204|NCT00371462|79485072|FG000|Overall Study|Other|7|||
44478205|NCT00371462|79485073|FG001|Overall Study|Other|8|||
44478206|NCT00371150|79485081|FG000|Overall Study|Lost to Follow-up|3|||
44478207|NCT00371150|79485082|FG001|Overall Study|Lost to Follow-up|2|||
44478208|NCT00264303|79485094|FG000|Overall Study|Adverse Event|4|||
44478209|NCT00264303|79485095|FG001|Overall Study|Adverse Event|3|||
44478210|NCT00264303|79485094|FG000|Overall Study|Lack of Efficacy|10|||
44478211|NCT00264303|79485095|FG001|Overall Study|Lack of Efficacy|13|||
44478212|NCT00264303|79485094|FG000|Overall Study|Lost to Follow-up|3|||
44478213|NCT00264303|79485095|FG001|Overall Study|Lost to Follow-up|3|||
44478214|NCT00264303|79485094|FG000|Overall Study|Withdrawal by Subject|2|||
44478215|NCT00264303|79485095|FG001|Overall Study|Withdrawal by Subject|3|||
44478216|NCT00264303|79485094|FG000|Overall Study|Various reasons listed in study report|6|||
44478217|NCT00264303|79485095|FG001|Overall Study|Various reasons listed in study report|7|||
44478218|NCT00370682|79485104|FG000|Overall Study|Moved from area|0|||
44478219|NCT00370682|79485105|FG001|Overall Study|Moved from area|2|||
44478220|NCT00370682|79485106|FG002|Overall Study|Moved from area|0|||
44478221|NCT00370682|79485104|FG000|Overall Study|Lost to Follow-up|0|||
44478222|NCT00370682|79485105|FG001|Overall Study|Lost to Follow-up|1|||
44478223|NCT00370682|79485106|FG002|Overall Study|Lost to Follow-up|1|||
44478224|NCT00264147|79485123|FG000|Treatment I Period|Adverse Event|3|||
44478225|NCT00264147|79485124|FG001|Treatment I Period|Adverse Event|6|||
44478226|NCT00264147|79485125|FG002|Treatment I Period|Adverse Event|3|||
44478227|NCT00264147|79485126|FG003|Treatment I Period|Adverse Event|5|||
44478228|NCT00264147|79485127|FG004|Treatment I Period|Adverse Event|7|||
44478229|NCT00264147|79485128|FG005|Treatment I Period|Adverse Event|0|||
44478230|NCT00264147|79485123|FG000|Treatment I Period|Laboratory Adverse Event|0|||
44478231|NCT00264147|79485124|FG001|Treatment I Period|Laboratory Adverse Event|0|||
44478232|NCT00264147|79485125|FG002|Treatment I Period|Laboratory Adverse Event|0|||
44478233|NCT00264147|79485126|FG003|Treatment I Period|Laboratory Adverse Event|1|||
44478234|NCT00264147|79485127|FG004|Treatment I Period|Laboratory Adverse Event|0|||
44478235|NCT00264147|79485128|FG005|Treatment I Period|Laboratory Adverse Event|0|||
44478236|NCT00264147|79485123|FG000|Treatment I Period|Lack of Efficacy|6|||
44478237|NCT00264147|79485124|FG001|Treatment I Period|Lack of Efficacy|2|||
44478238|NCT00264147|79485125|FG002|Treatment I Period|Lack of Efficacy|8|||
44478239|NCT00264147|79485126|FG003|Treatment I Period|Lack of Efficacy|0|||
44478240|NCT00264147|79485127|FG004|Treatment I Period|Lack of Efficacy|1|||
44478241|NCT00264147|79485128|FG005|Treatment I Period|Lack of Efficacy|0|||
44478242|NCT00264147|79485123|FG000|Treatment I Period|Lost to Follow-up|1|||
44478243|NCT00264147|79485124|FG001|Treatment I Period|Lost to Follow-up|0|||
44478244|NCT00264147|79485125|FG002|Treatment I Period|Lost to Follow-up|0|||
44478245|NCT00264147|79485126|FG003|Treatment I Period|Lost to Follow-up|1|||
44478246|NCT00264147|79485127|FG004|Treatment I Period|Lost to Follow-up|1|||
44478247|NCT00264147|79485128|FG005|Treatment I Period|Lost to Follow-up|0|||
44478248|NCT00264147|79485123|FG000|Treatment I Period|Protocol Violation|2|||
44478249|NCT00264147|79485124|FG001|Treatment I Period|Protocol Violation|2|||
44478250|NCT00264147|79485125|FG002|Treatment I Period|Protocol Violation|0|||
44478251|NCT00264147|79485126|FG003|Treatment I Period|Protocol Violation|0|||
44478252|NCT00264147|79485127|FG004|Treatment I Period|Protocol Violation|0|||
44478253|NCT00264147|79485128|FG005|Treatment I Period|Protocol Violation|0|||
44478254|NCT00264147|79485123|FG000|Treatment I Period|Withdrawal by Subject|2|||
44478255|NCT00264147|79485124|FG001|Treatment I Period|Withdrawal by Subject|0|||
44478256|NCT00264147|79485125|FG002|Treatment I Period|Withdrawal by Subject|0|||
44478257|NCT00264147|79485126|FG003|Treatment I Period|Withdrawal by Subject|2|||
44478258|NCT00264147|79485127|FG004|Treatment I Period|Withdrawal by Subject|2|||
44478259|NCT00264147|79485128|FG005|Treatment I Period|Withdrawal by Subject|0|||
44478260|NCT00264147|79485123|FG000|Treatment I Period|Patient out of town for an extended time|0|||
44478261|NCT00264147|79485124|FG001|Treatment I Period|Patient out of town for an extended time|1|||
44478262|NCT00264147|79485125|FG002|Treatment I Period|Patient out of town for an extended time|0|||
44478263|NCT00264147|79485126|FG003|Treatment I Period|Patient out of town for an extended time|0|||
44478264|NCT00264147|79485127|FG004|Treatment I Period|Patient out of town for an extended time|0|||
44478265|NCT00264147|79485128|FG005|Treatment I Period|Patient out of town for an extended time|0|||
44478266|NCT00264147|79485123|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
44478267|NCT00264147|79485124|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
44478268|NCT00264147|79485125|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
44478269|NCT00264147|79485126|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
44478270|NCT00264147|79485127|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
44478271|NCT00264147|79485128|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
44478272|NCT00264147|79485123|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
44478273|NCT00264147|79485124|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
44478274|NCT00264147|79485125|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
44478275|NCT00264147|79485126|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
44478276|NCT00264147|79485127|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
44478277|NCT00264147|79485128|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
44478278|NCT00264147|79485123|FG000|Treatment II Period|Adverse Event|0|||
44478279|NCT00264147|79485124|FG001|Treatment II Period|Adverse Event|0|||
44478280|NCT00264147|79485125|FG002|Treatment II Period|Adverse Event|0|||
44478281|NCT00264147|79485126|FG003|Treatment II Period|Adverse Event|0|||
44478282|NCT00264147|79485127|FG004|Treatment II Period|Adverse Event|9|||
44478283|NCT00264147|79485128|FG005|Treatment II Period|Adverse Event|9|||
44478284|NCT00264147|79485123|FG000|Treatment II Period|Laboratory Adverse Event|0|||
44478285|NCT00264147|79485124|FG001|Treatment II Period|Laboratory Adverse Event|0|||
44478286|NCT00264147|79485125|FG002|Treatment II Period|Laboratory Adverse Event|0|||
44478287|NCT00264147|79485126|FG003|Treatment II Period|Laboratory Adverse Event|0|||
44478288|NCT00264147|79485127|FG004|Treatment II Period|Laboratory Adverse Event|0|||
44478289|NCT00264147|79485128|FG005|Treatment II Period|Laboratory Adverse Event|1|||
44478290|NCT00264147|79485123|FG000|Treatment II Period|Lack of Efficacy|0|||
44478291|NCT00264147|79485124|FG001|Treatment II Period|Lack of Efficacy|0|||
44478292|NCT00264147|79485125|FG002|Treatment II Period|Lack of Efficacy|0|||
44478293|NCT00264147|79485126|FG003|Treatment II Period|Lack of Efficacy|0|||
44478294|NCT00264147|79485127|FG004|Treatment II Period|Lack of Efficacy|20|||
44478295|NCT00264147|79485128|FG005|Treatment II Period|Lack of Efficacy|19|||
44478296|NCT00264147|79485123|FG000|Treatment II Period|Lost to Follow-up|0|||
44478297|NCT00264147|79485124|FG001|Treatment II Period|Lost to Follow-up|0|||
44478298|NCT00264147|79485125|FG002|Treatment II Period|Lost to Follow-up|0|||
44478299|NCT00264147|79485126|FG003|Treatment II Period|Lost to Follow-up|0|||
44478300|NCT00264147|79485127|FG004|Treatment II Period|Lost to Follow-up|1|||
44478301|NCT00264147|79485128|FG005|Treatment II Period|Lost to Follow-up|1|||
44478302|NCT00264147|79485123|FG000|Treatment II Period|Withdrawal by Subject|0|||
44478303|NCT00264147|79485124|FG001|Treatment II Period|Withdrawal by Subject|0|||
44478304|NCT00264147|79485125|FG002|Treatment II Period|Withdrawal by Subject|0|||
44478305|NCT00264147|79485126|FG003|Treatment II Period|Withdrawal by Subject|0|||
44478306|NCT00264147|79485127|FG004|Treatment II Period|Withdrawal by Subject|3|||
44478307|NCT00264147|79485128|FG005|Treatment II Period|Withdrawal by Subject|2|||
44478308|NCT00264147|79485123|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
44478309|NCT00264147|79485124|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
44478310|NCT00264147|79485125|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
44478311|NCT00264147|79485126|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
44478312|NCT00264147|79485127|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
44478313|NCT00264147|79485128|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
44478314|NCT00263757|79485144|FG000|Overall Study|Withdrawal by Subject|5|||
44478315|NCT00263757|79485145|FG001|Overall Study|Withdrawal by Subject|4|||
44478316|NCT00263757|79485144|FG000|Overall Study|Screen failure|0|||
44478317|NCT00263757|79485145|FG001|Overall Study|Screen failure|1|||
44478318|NCT00263757|79485144|FG000|Overall Study|Adverse Event|3|||
44478319|NCT00263757|79485145|FG001|Overall Study|Adverse Event|3|||
44478320|NCT00263211|79485153|FG000|Overall Study|Death|1|||
44478321|NCT00263211|79485154|FG001|Overall Study|Death|0|||
44478322|NCT00263211|79485153|FG000|Overall Study|Withdrawal by Subject|3|||
44478323|NCT00263211|79485154|FG001|Overall Study|Withdrawal by Subject|0|||
44478324|NCT00263211|79485153|FG000|Overall Study|Protocol Violation|1|||
44478325|NCT00263211|79485154|FG001|Overall Study|Protocol Violation|0|||
44478326|NCT00263211|79485153|FG000|Overall Study|Disease Progression|0|||
44478327|NCT00263211|79485154|FG001|Overall Study|Disease Progression|1|||
44478328|NCT00248625|79485165|FG000|Overall Study|Withdrawal by Subject|0|||
44478329|NCT00248625|79485166|FG001|Overall Study|Withdrawal by Subject|2|||
44478330|NCT00262821|79485174|FG000|Overall Study|Ineligible - wrong stage|0|||
44478331|NCT00262821|79485175|FG001|Overall Study|Ineligible - wrong stage|3|||
44478332|NCT00262821|79485174|FG000|Overall Study|Ineligible - wrong cell type|2|||
44478333|NCT00262821|79485175|FG001|Overall Study|Ineligible - wrong cell type|2|||
44478334|NCT00262821|79485174|FG000|Overall Study|Ineligible - wrong primary|0|||
44478335|NCT00262821|79485175|FG001|Overall Study|Ineligible - wrong primary|1|||
44478336|NCT00262821|79485174|FG000|Overall Study|Ineligible - inadequate pathology|1|||
44478337|NCT00262821|79485175|FG001|Overall Study|Ineligible - inadequate pathology|3|||
44478338|NCT00262821|79485174|FG000|Overall Study|Ineligible - elevated creatinine|0|||
44478339|NCT00262821|79485175|FG001|Overall Study|Ineligible - elevated creatinine|2|||
44478340|NCT00262821|79485174|FG000|Overall Study|Ineligible - required test not done|1|||
44478341|NCT00262821|79485175|FG001|Overall Study|Ineligible - required test not done|4|||
44478342|NCT00262821|79485174|FG000|Overall Study|Inevaluable - inadequate data|0|||
44478343|NCT00262821|79485175|FG001|Overall Study|Inevaluable - inadequate data|4|||
44478344|NCT00262743|79485183|FG000|Overall Study|Adverse Event|0|||
44478345|NCT00262743|79485184|FG001|Overall Study|Adverse Event|9|||
44478346|NCT00262743|79485183|FG000|Overall Study|Disease progression|0|||
44478347|NCT00262743|79485184|FG001|Overall Study|Disease progression|3|||
44478348|NCT00262119|79485191|FG000|Overall Study|Lost to Follow-up|38|||
44478349|NCT00262119|79485192|FG001|Overall Study|Lost to Follow-up|51|||
44478350|NCT00262119|79485193|FG002|Overall Study|Lost to Follow-up|42|||
44478351|NCT00262119|79485191|FG000|Overall Study|Death|20|||
44478352|NCT00262119|79485192|FG001|Overall Study|Death|19|||
44478353|NCT00262119|79485193|FG002|Overall Study|Death|16|||
44478354|NCT00170950|79485203|FG000|Overall Study|Death|236|||
44478355|NCT00170950|79485204|FG001|Overall Study|Death|274|||
44478356|NCT00170950|79485203|FG000|Overall Study|Withdrawal by Subject|496|||
44478357|NCT00170950|79485204|FG001|Overall Study|Withdrawal by Subject|498|||
44478358|NCT00170950|79485203|FG000|Overall Study|Lost to Follow-up|134|||
44478359|NCT00170950|79485204|FG001|Overall Study|Lost to Follow-up|115|||
44478360|NCT00170950|79485203|FG000|Overall Study|Missing|2|||
44478361|NCT00170950|79485204|FG001|Overall Study|Missing|1|||
44478362|NCT00170950|79485203|FG000|Overall Study|Termination Data Not Recorded|17|||
44478363|NCT00170950|79485204|FG001|Overall Study|Termination Data Not Recorded|22|||
44478364|NCT00239577|79485214|FG000|Primary Phase|Adverse Event|0|||
44478365|NCT00239577|79485215|FG001|Primary Phase|Adverse Event|0|||
44478366|NCT00239577|79485216|FG002|Primary Phase|Adverse Event|1|||
44478367|NCT00239577|79485217|FG003|Primary Phase|Adverse Event|0|||
44478368|NCT00239577|79485214|FG000|Primary Phase|Other|5|||
44478369|NCT00239577|79485215|FG001|Primary Phase|Other|3|||
44478370|NCT00239577|79485216|FG002|Primary Phase|Other|2|||
44478371|NCT00239577|79485217|FG003|Primary Phase|Other|0|||
44478372|NCT00262041|79485233|FG000|Overall Study|Withdrawal by Subject|0|||
44478373|NCT00262041|79485234|FG001|Overall Study|Withdrawal by Subject|3|||
44478374|NCT00262041|79485235|FG002|Overall Study|Withdrawal by Subject|1|||
44478375|NCT00262041|79485233|FG000|Overall Study|Lost to Follow-up|1|||
44478376|NCT00262041|79485234|FG001|Overall Study|Lost to Follow-up|1|||
44478377|NCT00262041|79485235|FG002|Overall Study|Lost to Follow-up|5|||
44478378|NCT00262041|79485233|FG000|Overall Study|Unable to classify|1|||
44478379|NCT00262041|79485234|FG001|Overall Study|Unable to classify|0|||
44478380|NCT00262041|79485235|FG002|Overall Study|Unable to classify|0|||
44478381|NCT00208767|79485251|FG000|Overall Study|Adverse Event|9|||
44478382|NCT00208767|79485252|FG001|Overall Study|Adverse Event|1|||
44478383|NCT00208767|79485251|FG000|Overall Study|Withdrawal by Subject|14|||
44478384|NCT00208767|79485252|FG001|Overall Study|Withdrawal by Subject|3|||
44478385|NCT00208767|79485251|FG000|Overall Study|Death|1|||
44478386|NCT00208767|79485252|FG001|Overall Study|Death|0|||
44478387|NCT00208767|79485251|FG000|Overall Study|Lost to Follow-up|3|||
44478388|NCT00208767|79485252|FG001|Overall Study|Lost to Follow-up|3|||
44478389|NCT00390806|79485260|FG000|Overall Study|Lost to Follow-up|7|||
44478390|NCT00390806|79485261|FG001|Overall Study|Lost to Follow-up|6|||
44478391|NCT00390806|79485260|FG000|Overall Study|Protocol Violation|2|||
44478392|NCT00390806|79485261|FG001|Overall Study|Protocol Violation|2|||
44478393|NCT00390806|79485260|FG000|Overall Study|Withdrawal by Subject|12|||
44478394|NCT00390806|79485261|FG001|Overall Study|Withdrawal by Subject|15|||
44478395|NCT00390806|79485260|FG000|Overall Study|Investigator Decision|4|||
44544668|NCT00245960|79558243|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
44544669|NCT00245960|79558242|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
44478396|NCT00390806|79485261|FG001|Overall Study|Investigator Decision|6|||
44478397|NCT00390806|79485260|FG000|Overall Study|Death|1|||
44478398|NCT00390806|79485261|FG001|Overall Study|Death|0|||
44478399|NCT00390806|79485260|FG000|Overall Study|Physician Decision|0|||
44478400|NCT00390806|79485261|FG001|Overall Study|Physician Decision|1|||
44478401|NCT00390806|79485260|FG000|Overall Study|Ongoing|4|||
44478402|NCT00390806|79485261|FG001|Overall Study|Ongoing|2|||
44478403|NCT00390572|79485269|FG000|Overall Study|Lost to Follow-up|8|||
44478404|NCT00390572|79485270|FG001|Overall Study|Lost to Follow-up|4|||
44478405|NCT00390572|79485269|FG000|Overall Study|health condition|0|||
44478406|NCT00390572|79485270|FG001|Overall Study|health condition|1|||
44478407|NCT00390416|79485280|FG000|Overall Study|Withdrawal by Subject|1|||
44478408|NCT00390416|79485280|FG000|Overall Study|Not treated|3|||
44478409|NCT00261495|79485286|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
44478410|NCT00261495|79485287|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
44478411|NCT00261495|79485286|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
44478412|NCT00261495|79485287|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
44478413|NCT00261495|79485286|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
44478414|NCT00261495|79485287|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
44478415|NCT00261495|79485286|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
44478416|NCT00261495|79485287|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
44478417|NCT00261495|79485286|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
44478418|NCT00261495|79485287|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
44478419|NCT00261495|79485286|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
44478420|NCT00261495|79485287|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
44478421|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
44478422|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
44478423|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
44478424|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
44478425|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
44478426|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
44478427|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
44478428|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
44478429|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
44478430|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
44478431|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
44478432|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
44478433|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
44478434|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
44478435|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
44478436|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
44478437|NCT00261495|79485286|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
44478438|NCT00261495|79485287|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
44478439|NCT00261495|79485286|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
44478440|NCT00261495|79485287|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
44478441|NCT00261495|79485286|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
44478442|NCT00261495|79485287|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
44478443|NCT00261495|79485286|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
44478444|NCT00261495|79485287|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
44478445|NCT00261495|79485286|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
44478446|NCT00261495|79485287|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
44478447|NCT00261495|79485286|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
44478448|NCT00261495|79485287|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
44478449|NCT00261495|79485286|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
44478450|NCT00261495|79485287|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
44478451|NCT00168844|79485296|FG000|Overall Study|Adverse Event|31|||
44478452|NCT00168844|79485297|FG001|Overall Study|Adverse Event|32|||
44478453|NCT00168844|79485298|FG002|Overall Study|Adverse Event|48|||
44478454|NCT00168844|79485296|FG000|Overall Study|Lost to Follow-up|4|||
44478455|NCT00168844|79485297|FG001|Overall Study|Lost to Follow-up|5|||
44478456|NCT00168844|79485298|FG002|Overall Study|Lost to Follow-up|11|||
44478457|NCT00168844|79485296|FG000|Overall Study|Withdrawal by Subject|12|||
44478458|NCT00168844|79485297|FG001|Overall Study|Withdrawal by Subject|9|||
44478459|NCT00168844|79485298|FG002|Overall Study|Withdrawal by Subject|19|||
44478460|NCT00168844|79485296|FG000|Overall Study|Protocol Violation|2|||
44478461|NCT00168844|79485297|FG001|Overall Study|Protocol Violation|2|||
44478462|NCT00168844|79485298|FG002|Overall Study|Protocol Violation|4|||
44478463|NCT00168844|79485296|FG000|Overall Study|Other|6|||
44478464|NCT00168844|79485297|FG001|Overall Study|Other|7|||
44478465|NCT00168844|79485298|FG002|Overall Study|Other|9|||
44478466|NCT00365456|79485306|FG000|Trial Period I (12 Months)|Adverse Event|84|||
44226598|NCT01972841|79033252|FG002|Overall Study|Randomized but Never Received Treatment|4|||
44226599|NCT01972841|79033253|FG003|Overall Study|Randomized but Never Received Treatment|2|||
44226600|NCT01972841|79033254|FG004|Overall Study|Randomized but Never Received Treatment|6|||
44226601|NCT01972841|79033255|FG005|Overall Study|Randomized but Never Received Treatment|13|||
44226602|NCT01972841|79033250|FG000|Overall Study|Adverse Event|13|||
44226603|NCT01972841|79033251|FG001|Overall Study|Adverse Event|8|||
44226604|NCT01972841|79033252|FG002|Overall Study|Adverse Event|12|||
44226605|NCT01972841|79033253|FG003|Overall Study|Adverse Event|9|||
44226606|NCT01972841|79033254|FG004|Overall Study|Adverse Event|21|||
44478467|NCT00365456|79485307|FG001|Trial Period I (12 Months)|Adverse Event|0|||
44478468|NCT00365456|79485306|FG000|Trial Period I (12 Months)|Non-compliance|3|||
44478469|NCT00365456|79485307|FG001|Trial Period I (12 Months)|Non-compliance|0|||
44478470|NCT00365456|79485306|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
44478471|NCT00365456|79485307|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
44478472|NCT00365456|79485306|FG000|Trial Period I (12 Months)|Other|11|||
44478473|NCT00365456|79485307|FG001|Trial Period I (12 Months)|Other|0|||
44478474|NCT00365456|79485306|FG000|Trial Period II (12 Months)|Adverse Event|0|||
44478475|NCT00365456|79485307|FG001|Trial Period II (12 Months)|Adverse Event|6|||
44478476|NCT00365456|79485306|FG000|Trial Period II (12 Months)|Non-compliance|0|||
44478477|NCT00365456|79485307|FG001|Trial Period II (12 Months)|Non-compliance|2|||
44478478|NCT00365456|79485306|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
44478479|NCT00365456|79485307|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
44478480|NCT00365456|79485306|FG000|Trial Period II (12 Months)|Other|0|||
44478481|NCT00365456|79485307|FG001|Trial Period II (12 Months)|Other|1|||
44478482|NCT00365456|79485306|FG000|Trial Period III (12 Months)|Adverse Event|13|||
44478483|NCT00365456|79485307|FG001|Trial Period III (12 Months)|Adverse Event|3|||
44478484|NCT00365456|79485306|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
44478485|NCT00365456|79485307|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
44478486|NCT00365456|79485306|FG000|Trial Period III (12 Months)|Other|1|||
44478487|NCT00365456|79485307|FG001|Trial Period III (12 Months)|Other|1|||
44478488|NCT00147238|79485313|FG000|Overall Study|Inevaluable|8|||
44478489|NCT00206427|79485317|FG000|Overall Study|Adverse Event|2|||
44478490|NCT00146848|79485324|FG000|Pre-randomization|Death|19|||
44478491|NCT00146848|79485325|FG001|Pre-randomization|Death|0|||
44478492|NCT00146848|79485326|FG002|Pre-randomization|Death|0|||
44478493|NCT00146848|79485324|FG000|Pre-randomization|Lost to Follow-up|70|||
44478494|NCT00146848|79485325|FG001|Pre-randomization|Lost to Follow-up|0|||
44478495|NCT00146848|79485326|FG002|Pre-randomization|Lost to Follow-up|0|||
44478496|NCT00146848|79485324|FG000|Pre-randomization|Physician Decision|8|||
44478497|NCT00146848|79485325|FG001|Pre-randomization|Physician Decision|0|||
44478498|NCT00146848|79485326|FG002|Pre-randomization|Physician Decision|0|||
44478499|NCT00146848|79485324|FG000|Pre-randomization|Protocol Violation|172|||
44478500|NCT00146848|79485325|FG001|Pre-randomization|Protocol Violation|0|||
44478501|NCT00146848|79485326|FG002|Pre-randomization|Protocol Violation|0|||
44478502|NCT00146848|79485324|FG000|Pre-randomization|Withdrawal by Subject|40|||
44478503|NCT00146848|79485325|FG001|Pre-randomization|Withdrawal by Subject|0|||
44478504|NCT00146848|79485326|FG002|Pre-randomization|Withdrawal by Subject|0|||
44478505|NCT00146848|79485324|FG000|Post-randomization|Lost to Follow-up|12|||
44478506|NCT00146848|79485325|FG001|Post-randomization|Lost to Follow-up|15|||
44478507|NCT00146848|79485326|FG002|Post-randomization|Lost to Follow-up|12|||
44478508|NCT00146848|79485324|FG000|Post-randomization|Withdrawn|26|||
44478509|NCT00146848|79485325|FG001|Post-randomization|Withdrawn|32|||
44478510|NCT00146848|79485326|FG002|Post-randomization|Withdrawn|27|||
44478511|NCT00205881|79485334|FG000|Overall Study|Withdrawal by Subject|16|||
44478512|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
44478513|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
44478514|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
44478515|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
44478516|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
44478517|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
44478518|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
44478519|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
44478520|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
44478521|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
44478522|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
44478523|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
44478524|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
44478525|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
44478526|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
44478527|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
44478528|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
44478529|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
44478530|NCT00365378|79485341|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
44478531|NCT00365378|79485342|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
44478532|NCT00365378|79485343|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
44478533|NCT00365378|79485341|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
44478534|NCT00365378|79485342|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
44478535|NCT00365378|79485343|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
44478536|NCT00365378|79485341|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
44478537|NCT00365378|79485342|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
44478538|NCT00365378|79485343|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
44478539|NCT00365378|79485341|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
44478540|NCT00365378|79485342|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
44478541|NCT00365378|79485343|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
44478542|NCT00365378|79485341|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
44478543|NCT00365378|79485342|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
44226607|NCT01972841|79033255|FG005|Overall Study|Adverse Event|26|||
44226608|NCT01972841|79033250|FG000|Overall Study|Lack of Efficacy|1|||
44226609|NCT01972841|79033251|FG001|Overall Study|Lack of Efficacy|0|||
44226610|NCT01972841|79033252|FG002|Overall Study|Lack of Efficacy|0|||
44226611|NCT01972841|79033253|FG003|Overall Study|Lack of Efficacy|2|||
44226612|NCT01972841|79033254|FG004|Overall Study|Lack of Efficacy|4|||
44478544|NCT00365378|79485343|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
44478545|NCT00365378|79485341|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
44478546|NCT00365378|79485342|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
44478547|NCT00365378|79485343|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
44478548|NCT00365378|79485341|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
44478549|NCT00365378|79485342|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
44478550|NCT00365378|79485343|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
44478551|NCT00365378|79485341|FG000|Extension|Adverse Event|0|||
44478552|NCT00365378|79485342|FG001|Extension|Adverse Event|0|||
44478553|NCT00365378|79485343|FG002|Extension|Adverse Event|1|||
44478554|NCT00365378|79485341|FG000|Extension|Moved|0|||
44478555|NCT00365378|79485342|FG001|Extension|Moved|0|||
44478556|NCT00365378|79485343|FG002|Extension|Moved|8|||
44478557|NCT00365378|79485341|FG000|Extension|Lost to Follow-up|0|||
44478558|NCT00365378|79485342|FG001|Extension|Lost to Follow-up|0|||
44478559|NCT00365378|79485343|FG002|Extension|Lost to Follow-up|57|||
44478560|NCT00365378|79485341|FG000|Extension|Protocol Violation|0|||
44478561|NCT00365378|79485342|FG001|Extension|Protocol Violation|0|||
44478562|NCT00365378|79485343|FG002|Extension|Protocol Violation|2|||
44478563|NCT00365378|79485341|FG000|Extension|Withdrawal by Subject|0|||
44478564|NCT00365378|79485342|FG001|Extension|Withdrawal by Subject|0|||
44478565|NCT00365378|79485343|FG002|Extension|Withdrawal by Subject|98|||
44478566|NCT00365378|79485341|FG000|Extension|Other|0|||
44478567|NCT00365378|79485342|FG001|Extension|Other|0|||
44478568|NCT00365378|79485343|FG002|Extension|Other|31|||
44478569|NCT00389324|79485350|FG000|Run-In Phase|Adverse Event|1|||
44478570|NCT00389324|79485350|FG000|Run-In Phase|Lost to Follow-up|1|||
44478571|NCT00389324|79485350|FG000|Run-In Phase|Withdrawal by Subject|1|||
44478572|NCT00389324|79485350|FG000|Subcutaneous Phase|Adverse Event|2|||
44478573|NCT00389324|79485350|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
44478574|NCT00389324|79485350|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
44478575|NCT00389324|79485350|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
44478576|NCT00365300|79485359|FG000|Open-label Phase|Adverse Event|4|||
44478577|NCT00365300|79485360|FG001|Open-label Phase|Adverse Event|0|||
44478578|NCT00365300|79485359|FG000|Open-label Phase|Failed to Return|1|||
44478579|NCT00365300|79485360|FG001|Open-label Phase|Failed to Return|0|||
44478580|NCT00365300|79485359|FG000|Open-label Phase|Physician Decision|1|||
44478581|NCT00365300|79485360|FG001|Open-label Phase|Physician Decision|0|||
44478582|NCT00365300|79485359|FG000|Open-label Phase|Noncompliance|9|||
44478583|NCT00365300|79485360|FG001|Open-label Phase|Noncompliance|0|||
44478584|NCT00365300|79485359|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
44478585|NCT00365300|79485360|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
44478586|NCT00365300|79485359|FG000|Open-label Phase|Protocol Violation|1|||
44226613|NCT01972841|79033255|FG005|Overall Study|Lack of Efficacy|1|||
44226614|NCT01972841|79033250|FG000|Overall Study|Lost to Follow-up|4|||
44226615|NCT01972841|79033251|FG001|Overall Study|Lost to Follow-up|2|||
44226616|NCT01972841|79033252|FG002|Overall Study|Lost to Follow-up|4|||
44226617|NCT01972841|79033253|FG003|Overall Study|Lost to Follow-up|2|||
44226618|NCT01972841|79033254|FG004|Overall Study|Lost to Follow-up|9|||
44226619|NCT01972841|79033255|FG005|Overall Study|Lost to Follow-up|3|||
44226620|NCT01972841|79033250|FG000|Overall Study|Protocol Violation|2|||
44226621|NCT01972841|79033251|FG001|Overall Study|Protocol Violation|2|||
44226622|NCT01972841|79033252|FG002|Overall Study|Protocol Violation|3|||
44226623|NCT01972841|79033253|FG003|Overall Study|Protocol Violation|5|||
44226624|NCT01972841|79033254|FG004|Overall Study|Protocol Violation|9|||
44226625|NCT01972841|79033255|FG005|Overall Study|Protocol Violation|4|||
44226626|NCT01972841|79033250|FG000|Overall Study|Withdrawal by participants|21|||
44478587|NCT00365300|79485360|FG001|Open-label Phase|Protocol Violation|0|||
44478588|NCT00365300|79485359|FG000|Open-label Phase|Lack of Efficacy|1|||
44478589|NCT00365300|79485360|FG001|Open-label Phase|Lack of Efficacy|0|||
44478590|NCT00365300|79485359|FG000|Open-label Phase|Patient skipped open label phase|1|||
44478591|NCT00365300|79485360|FG001|Open-label Phase|Patient skipped open label phase|0|||
44478592|NCT00365300|79485359|FG000|Double-blind Phase|Failed to return|1|||
44478593|NCT00365300|79485360|FG001|Double-blind Phase|Failed to return|0|||
44478594|NCT00365300|79485359|FG000|Double-blind Phase|Noncompliance|1|||
44478595|NCT00365300|79485360|FG001|Double-blind Phase|Noncompliance|1|||
44478596|NCT00365300|79485359|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44478597|NCT00365300|79485360|FG001|Double-blind Phase|Withdrawal by Subject|1|||
44478598|NCT00365300|79485359|FG000|Double-blind Phase|Protocol Violation|3|||
44226627|NCT01972841|79033251|FG001|Overall Study|Withdrawal by participants|27|||
44226628|NCT01972841|79033252|FG002|Overall Study|Withdrawal by participants|23|||
44226629|NCT01972841|79033253|FG003|Overall Study|Withdrawal by participants|16|||
44226630|NCT01972841|79033254|FG004|Overall Study|Withdrawal by participants|33|||
44226631|NCT01972841|79033255|FG005|Overall Study|Withdrawal by participants|34|||
44226632|NCT01972841|79033250|FG000|Overall Study|Miscellaneous|0|||
44226633|NCT01972841|79033251|FG001|Overall Study|Miscellaneous|0|||
44226634|NCT01972841|79033252|FG002|Overall Study|Miscellaneous|4|||
44226635|NCT01972841|79033253|FG003|Overall Study|Miscellaneous|1|||
44226636|NCT01972841|79033254|FG004|Overall Study|Miscellaneous|0|||
44226637|NCT01972841|79033255|FG005|Overall Study|Miscellaneous|4|||
44226638|NCT01972841|79033250|FG000|Overall Study|Did not have end of treatment page|0|||
44226639|NCT01972841|79033251|FG001|Overall Study|Did not have end of treatment page|0|||
44478599|NCT00365300|79485360|FG001|Double-blind Phase|Protocol Violation|1|||
44478600|NCT00365300|79485359|FG000|Double-blind Phase|Lack of Efficacy|6|||
44478601|NCT00365300|79485360|FG001|Double-blind Phase|Lack of Efficacy|6|||
44478602|NCT00370292|79485371|FG000|Overall Study|Disease Progression|4|||
44478603|NCT00370292|79485371|FG000|Overall Study|Adverse Event|7|||
44478604|NCT00370292|79485371|FG000|Overall Study|Physician Decision|2|||
44478605|NCT00369824|79485388|FG000|Overall Study|Adverse Event|0|||
44478606|NCT00369824|79485389|FG001|Overall Study|Adverse Event|2|||
44478607|NCT00369824|79485390|FG002|Overall Study|Adverse Event|0|||
44478608|NCT00369824|79485391|FG003|Overall Study|Adverse Event|0|||
44478609|NCT00369824|79485392|FG004|Overall Study|Adverse Event|1|||
44478610|NCT00369824|79485393|FG005|Overall Study|Adverse Event|0|||
44478611|NCT00369824|79485388|FG000|Overall Study|Protocol Violation|0|||
44478612|NCT00369824|79485389|FG001|Overall Study|Protocol Violation|1|||
44478613|NCT00369824|79485390|FG002|Overall Study|Protocol Violation|0|||
44478614|NCT00369824|79485391|FG003|Overall Study|Protocol Violation|1|||
44478615|NCT00369824|79485392|FG004|Overall Study|Protocol Violation|1|||
44478616|NCT00369824|79485393|FG005|Overall Study|Protocol Violation|0|||
44478617|NCT00369824|79485388|FG000|Overall Study|Withdrawal by Subject|9|||
44478618|NCT00369824|79485389|FG001|Overall Study|Withdrawal by Subject|5|||
44478619|NCT00369824|79485390|FG002|Overall Study|Withdrawal by Subject|5|||
44478620|NCT00369824|79485391|FG003|Overall Study|Withdrawal by Subject|4|||
44478621|NCT00369824|79485392|FG004|Overall Study|Withdrawal by Subject|6|||
44478622|NCT00369824|79485393|FG005|Overall Study|Withdrawal by Subject|2|||
44478623|NCT00369824|79485388|FG000|Overall Study|Lost to Follow-up|6|||
44478624|NCT00369824|79485389|FG001|Overall Study|Lost to Follow-up|11|||
44478625|NCT00369824|79485390|FG002|Overall Study|Lost to Follow-up|7|||
44478626|NCT00369824|79485391|FG003|Overall Study|Lost to Follow-up|8|||
44478627|NCT00369824|79485392|FG004|Overall Study|Lost to Follow-up|9|||
44226640|NCT01972841|79033252|FG002|Overall Study|Did not have end of treatment page|0|||
44226641|NCT01972841|79033253|FG003|Overall Study|Did not have end of treatment page|0|||
44226642|NCT01972841|79033254|FG004|Overall Study|Did not have end of treatment page|1|||
44226643|NCT01972841|79033255|FG005|Overall Study|Did not have end of treatment page|0|||
44226644|NCT01774903|79033269|FG000|Overall Study|Adverse Event|7|||
44226645|NCT01774903|79033269|FG000|Overall Study|Withdrawal by Subject|2|||
44226646|NCT01774903|79033269|FG000|Overall Study|Lack of Efficacy|1|||
44226647|NCT01774903|79033269|FG000|Overall Study|Ineligible to continue the trial|1|||
44226648|NCT01774591|79033276|FG000|Overall Study|Physician Decision|1|||
44226649|NCT01774591|79033277|FG001|Overall Study|Physician Decision|1|||
44226650|NCT01774591|79033276|FG000|Overall Study|Withdrawal by Subject|0|||
44226651|NCT01774591|79033277|FG001|Overall Study|Withdrawal by Subject|1|||
44226652|NCT01774591|79033276|FG000|Overall Study|Adverse Event|0|||
44226653|NCT01774591|79033277|FG001|Overall Study|Adverse Event|2|||
44226654|NCT01708915|79033287|FG000|Overall Study|Adverse Event|1|||
44226655|NCT01708915|79033288|FG001|Overall Study|Adverse Event|0|||
44226656|NCT01708915|79033289|FG002|Overall Study|Adverse Event|9|||
44226657|NCT01708915|79033290|FG003|Overall Study|Adverse Event|13|||
44375534|NCT00943722|79380717|FG006|Base Study|Month 12 visit not completed|0|||
44478628|NCT00369824|79485393|FG005|Overall Study|Lost to Follow-up|6|||
44478629|NCT00369824|79485388|FG000|Overall Study|Other|0|||
44478630|NCT00369824|79485389|FG001|Overall Study|Other|0|||
44478631|NCT00369824|79485390|FG002|Overall Study|Other|0|||
44226658|NCT01708915|79033287|FG000|Overall Study|Lack of Efficacy|84|||
44226659|NCT01708915|79033288|FG001|Overall Study|Lack of Efficacy|60|||
44226660|NCT01708915|79033289|FG002|Overall Study|Lack of Efficacy|35|||
44226661|NCT01708915|79033290|FG003|Overall Study|Lack of Efficacy|15|||
44478632|NCT00369824|79485391|FG003|Overall Study|Other|2|||
44478633|NCT00369824|79485392|FG004|Overall Study|Other|1|||
44478634|NCT00369824|79485393|FG005|Overall Study|Other|3|||
44226662|NCT01708915|79033287|FG000|Overall Study|Protocol Violation|0|||
44226663|NCT01708915|79033288|FG001|Overall Study|Protocol Violation|0|||
44226664|NCT01708915|79033289|FG002|Overall Study|Protocol Violation|0|||
44478635|NCT00369668|79485410|FG000|Overall Study|Lack of Efficacy|4|||
44478636|NCT00369668|79485411|FG001|Overall Study|Lack of Efficacy|5|||
44226665|NCT01708915|79033290|FG003|Overall Study|Protocol Violation|1|||
44226666|NCT01708915|79033287|FG000|Overall Study|Withdrawal by Subject|0|||
44226667|NCT01708915|79033288|FG001|Overall Study|Withdrawal by Subject|1|||
44375535|NCT00943722|79380711|FG000|First Extension Study: EXT 1|Adverse Event|0|||
44375536|NCT00943722|79380712|FG001|First Extension Study: EXT 1|Adverse Event|0|||
44375537|NCT00943722|79380713|FG002|First Extension Study: EXT 1|Adverse Event|0|||
44375538|NCT00943722|79380714|FG003|First Extension Study: EXT 1|Adverse Event|0|||
44375539|NCT00943722|79380715|FG004|First Extension Study: EXT 1|Adverse Event|0|||
44375540|NCT00943722|79380716|FG005|First Extension Study: EXT 1|Adverse Event|1|||
44375541|NCT00943722|79380717|FG006|First Extension Study: EXT 1|Adverse Event|0|||
44375542|NCT00943722|79380711|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
44375543|NCT00943722|79380712|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
44375544|NCT00943722|79380713|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
44375545|NCT00943722|79380714|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
44375546|NCT00943722|79380715|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
44375547|NCT00943722|79380716|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
44375548|NCT00943722|79380717|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
44375549|NCT00943722|79380711|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
44375550|NCT00943722|79380712|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
44375551|NCT00943722|79380713|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
44375552|NCT00943722|79380714|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
44375553|NCT00943722|79380715|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
44375554|NCT00943722|79380716|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
44143784|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
44143785|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
44375555|NCT00943722|79380717|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
44375556|NCT00943722|79380711|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
44375557|NCT00943722|79380712|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
44375558|NCT00943722|79380713|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
44375559|NCT00943722|79380714|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
44375560|NCT00943722|79380715|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
44375561|NCT00943722|79380716|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
44375562|NCT00943722|79380717|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
44375563|NCT00943722|79380711|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
44375564|NCT00943722|79380712|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
44375565|NCT00943722|79380713|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
44375566|NCT00943722|79380714|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
44375567|NCT00943722|79380715|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
44375568|NCT00943722|79380716|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
44375569|NCT00943722|79380717|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
44478637|NCT00369668|79485412|FG002|Overall Study|Lack of Efficacy|7|||
44478638|NCT00388154|79485423|FG000|Overall Study|Withdrawal by Subject|1|||
44478639|NCT00387764|79485427|FG000|Overall Study|Adverse Event|12|||
44143786|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
44143787|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
44143788|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
44143789|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
44143790|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
44143791|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
44143792|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
44143793|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
44143794|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
44143795|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
44143796|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
44143797|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
44143798|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
44143799|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
44143800|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
44143801|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
44143802|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
44143803|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
44143804|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Death|2|||
44143805|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Death|2|||
44143806|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Death|0|||
44143807|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Death|0|||
44478640|NCT00387764|79485427|FG000|Overall Study|Withdrawal by Subject|8|||
44478641|NCT00387764|79485427|FG000|Overall Study|Sponsor Terminated Study|1|||
44478642|NCT00387764|79485427|FG000|Overall Study|Physician Decision|1|||
44226668|NCT01708915|79033289|FG002|Overall Study|Withdrawal by Subject|2|||
44226669|NCT01708915|79033290|FG003|Overall Study|Withdrawal by Subject|2|||
44226670|NCT01708915|79033287|FG000|Overall Study|Other reasons than stated above|1|||
44226671|NCT01708915|79033288|FG001|Overall Study|Other reasons than stated above|1|||
44226672|NCT01708915|79033289|FG002|Overall Study|Other reasons than stated above|0|||
44478643|NCT00387764|79485427|FG000|Overall Study|Other|2|||
44478644|NCT00387764|79485427|FG000|Overall Study|Death|7|||
44478645|NCT00386360|79485433|FG000|Overall Study|Adverse Event|4|||
44478646|NCT00386360|79485434|FG001|Overall Study|Adverse Event|2|||
44478647|NCT00386360|79485433|FG000|Overall Study|Physician Decision|2|||
44478648|NCT00386360|79485434|FG001|Overall Study|Physician Decision|2|||
44478649|NCT00386360|79485433|FG000|Overall Study|Lost to Follow-up|0|||
44478650|NCT00386360|79485434|FG001|Overall Study|Lost to Follow-up|2|||
44478651|NCT00386360|79485433|FG000|Overall Study|Protocol Violation|0|||
44478652|NCT00386360|79485434|FG001|Overall Study|Protocol Violation|3|||
44478653|NCT00386360|79485433|FG000|Overall Study|Withdrawal by Subject|3|||
44478654|NCT00386360|79485434|FG001|Overall Study|Withdrawal by Subject|6|||
44478655|NCT00386360|79485433|FG000|Overall Study|Did not take any study medication|0|||
44478656|NCT00386360|79485434|FG001|Overall Study|Did not take any study medication|2|||
44478657|NCT00369278|79485442|FG000|Overall Study|Adverse Event|14|||
44478658|NCT00369278|79485443|FG001|Overall Study|Adverse Event|11|||
44478659|NCT00369278|79485442|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44478660|NCT00369278|79485443|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
44478661|NCT00369278|79485442|FG000|Overall Study|Protocol Violation|2|||
44478662|NCT00369278|79485443|FG001|Overall Study|Protocol Violation|1|||
44226673|NCT01708915|79033290|FG003|Overall Study|Other reasons than stated above|2|||
44226674|NCT01708291|79033302|FG000|Overall Study|fighting|2|||
44226675|NCT01708291|79033303|FG001|Overall Study|fighting|1|||
44226676|NCT01708057|79033309|FG000|Overall Study|Withdrawal due to study termination.|1|||
44226677|NCT01708057|79033310|FG001|Overall Study|Withdrawal due to study termination.|1|||
44226678|NCT01708057|79033311|FG002|Overall Study|Withdrawal due to study termination.|1|||
44226679|NCT01748071|79033328|FG000|Overall Study|Adverse Event|2|||
44226680|NCT01748071|79033329|FG001|Overall Study|Adverse Event|2|||
44226681|NCT01748071|79033330|FG002|Overall Study|Adverse Event|0|||
44226682|NCT01972529|79033342|FG000|Overall Study|Adverse Event|0|||
44226683|NCT01972529|79033343|FG001|Overall Study|Adverse Event|1|||
44226684|NCT01972529|79033344|FG002|Overall Study|Adverse Event|0|||
44226685|NCT01972529|79033345|FG003|Overall Study|Adverse Event|0|||
44226686|NCT01972529|79033342|FG000|Overall Study|Lost to Follow-up|1|||
44226687|NCT01972529|79033343|FG001|Overall Study|Lost to Follow-up|0|||
44226688|NCT01972529|79033344|FG002|Overall Study|Lost to Follow-up|0|||
44226689|NCT01972529|79033345|FG003|Overall Study|Lost to Follow-up|0|||
44226690|NCT01972529|79033342|FG000|Overall Study|Participant Choice|0|||
44226691|NCT01972529|79033343|FG001|Overall Study|Participant Choice|1|||
44226692|NCT01972529|79033344|FG002|Overall Study|Participant Choice|0|||
44226693|NCT01972529|79033345|FG003|Overall Study|Participant Choice|0|||
44226694|NCT01972529|79033342|FG000|Overall Study|Withdrawl of Consent|1|||
44226695|NCT01972529|79033343|FG001|Overall Study|Withdrawl of Consent|2|||
44375570|NCT00943722|79380711|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
44375571|NCT00943722|79380712|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
44375572|NCT00943722|79380713|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
44375573|NCT00943722|79380714|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
44375574|NCT00943722|79380715|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
44375575|NCT00943722|79380716|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
44375576|NCT00943722|79380717|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
44375577|NCT00943722|79380711|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
44375578|NCT00943722|79380712|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
44375579|NCT00943722|79380713|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
44226696|NCT01972529|79033344|FG002|Overall Study|Withdrawl of Consent|0|||
44226697|NCT01972529|79033345|FG003|Overall Study|Withdrawl of Consent|1|||
44226698|NCT01972529|79033342|FG000|Overall Study|Other|0|||
44226699|NCT01972529|79033343|FG001|Overall Study|Other|0|||
44226700|NCT01972529|79033344|FG002|Overall Study|Other|0|||
44226701|NCT01972529|79033345|FG003|Overall Study|Other|2|||
44375580|NCT00943722|79380714|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
44375581|NCT00943722|79380715|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
44375582|NCT00943722|79380716|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
44478663|NCT00369278|79485442|FG000|Overall Study|Withdrawal by Subject|2|||
44478664|NCT00369278|79485443|FG001|Overall Study|Withdrawal by Subject|2|||
44478665|NCT00369278|79485442|FG000|Overall Study|Lost to Follow-up|1|||
44478666|NCT00369278|79485443|FG001|Overall Study|Lost to Follow-up|0|||
44478667|NCT00369278|79485442|FG000|Overall Study|Graft loss|1|||
44478668|NCT00369278|79485443|FG001|Overall Study|Graft loss|2|||
44478669|NCT00529373|79485451|FG000|Base Study|Adverse Event|525|||
44478670|NCT00529373|79485452|FG001|Base Study|Adverse Event|470|||
44478671|NCT00529373|79485451|FG000|Base Study|Lack of Efficacy|16|||
44478672|NCT00529373|79485452|FG001|Base Study|Lack of Efficacy|75|||
44478673|NCT00529373|79485451|FG000|Base Study|Lost to Follow-up|221|||
44478674|NCT00529373|79485452|FG001|Base Study|Lost to Follow-up|208|||
44478675|NCT00529373|79485451|FG000|Base Study|Other Protocol Specified Criteria|19|||
44478676|NCT00529373|79485452|FG001|Base Study|Other Protocol Specified Criteria|20|||
44478677|NCT00529373|79485451|FG000|Base Study|Physician Decision|60|||
44478678|NCT00529373|79485452|FG001|Base Study|Physician Decision|52|||
44478679|NCT00529373|79485451|FG000|Base Study|Protocol Violation|48|||
44478680|NCT00529373|79485452|FG001|Base Study|Protocol Violation|38|||
44478681|NCT00529373|79485451|FG000|Base Study|Withdrawal by Subject|1062|||
44478682|NCT00529373|79485452|FG001|Base Study|Withdrawal by Subject|967|||
44478683|NCT00529373|79485451|FG000|Base Study|Did not continue into Extension|1795|||
44478684|NCT00529373|79485452|FG001|Base Study|Did not continue into Extension|2238|||
44478685|NCT00529373|79485451|FG000|First Extension Study|Adverse Event|162|||
44478686|NCT00529373|79485452|FG001|First Extension Study|Adverse Event|142|||
44478687|NCT00529373|79485451|FG000|First Extension Study|Lack of Efficacy|65|||
44478688|NCT00529373|79485452|FG001|First Extension Study|Lack of Efficacy|427|||
44478689|NCT00529373|79485451|FG000|First Extension Study|Lost to Follow-up|41|||
44478690|NCT00529373|79485452|FG001|First Extension Study|Lost to Follow-up|37|||
44478691|NCT00529373|79485451|FG000|First Extension Study|Other|27|||
44478692|NCT00529373|79485452|FG001|First Extension Study|Other|47|||
44478693|NCT00529373|79485451|FG000|First Extension Study|Physician Decision|50|||
44478694|NCT00529373|79485452|FG001|First Extension Study|Physician Decision|45|||
44478695|NCT00529373|79485451|FG000|First Extension Study|Protocol Violation|16|||
44478696|NCT00529373|79485452|FG001|First Extension Study|Protocol Violation|13|||
44478697|NCT00529373|79485451|FG000|First Extension Study|Withdrawal by Subject|296|||
44478698|NCT00529373|79485452|FG001|First Extension Study|Withdrawal by Subject|287|||
44478699|NCT00529373|79485451|FG000|First Extension Study|Disposition record non-existing|0|||
44478700|NCT00529373|79485452|FG001|First Extension Study|Disposition record non-existing|1|||
44478701|NCT00529373|79485451|FG000|First Extension Study|Discontinued after 5 years completion|208|||
44478702|NCT00529373|79485452|FG001|First Extension Study|Discontinued after 5 years completion|346|||
44478703|NCT00529373|79485451|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
44478704|NCT00529373|79485452|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
44478705|NCT00529373|79485451|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
44478706|NCT00529373|79485452|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
44478707|NCT00529373|79485451|FG000|Second Extension Study|Adverse Event|101|||
44478708|NCT00529373|79485452|FG001|Second Extension Study|Adverse Event|51|||
44478709|NCT00529373|79485451|FG000|Second Extension Study|Lack of Efficacy|7|||
44478710|NCT00529373|79485452|FG001|Second Extension Study|Lack of Efficacy|15|||
44478711|NCT00529373|79485451|FG000|Second Extension Study|Lost to Follow-up|18|||
44478712|NCT00529373|79485452|FG001|Second Extension Study|Lost to Follow-up|12|||
44478713|NCT00529373|79485451|FG000|Second Extension Study|Other|7|||
44478714|NCT00529373|79485452|FG001|Second Extension Study|Other|12|||
44478715|NCT00529373|79485451|FG000|Second Extension Study|Physician Decision|63|||
44478716|NCT00529373|79485452|FG001|Second Extension Study|Physician Decision|26|||
44478717|NCT00529373|79485451|FG000|Second Extension Study|Protocol Violation|2|||
44478718|NCT00529373|79485452|FG001|Second Extension Study|Protocol Violation|1|||
44478719|NCT00529373|79485451|FG000|Second Extension Study|Withdrawal by Subject|97|||
44478720|NCT00529373|79485452|FG001|Second Extension Study|Withdrawal by Subject|75|||
44478721|NCT00529373|79485451|FG000|Second Extension Study|Status Missing|5|||
44478722|NCT00529373|79485452|FG001|Second Extension Study|Status Missing|5|||
44478723|NCT00369122|79485466|FG000|Overall Study|Ineligible|10|||
44478724|NCT00369122|79485466|FG000|Overall Study|No protocol treatment|1|||
44478725|NCT03687125|79485472|FG000|Overall Study|Progressive Disease|2|||
44478726|NCT03687125|79485473|FG001|Overall Study|Progressive Disease|1|||
44478727|NCT03687125|79485472|FG000|Overall Study|Protocol Violation|1|||
44478728|NCT03687125|79485473|FG001|Overall Study|Protocol Violation|0|||
44478729|NCT03872843|79485483|FG000|Overall Study|Lost to Follow-up|5|||
44478730|NCT03872843|79485484|FG001|Overall Study|Lost to Follow-up|7|||
44478731|NCT00146770|79485492|FG000|Overall Study|Adverse Event|2|||
44478732|NCT00146770|79485493|FG001|Overall Study|Adverse Event|0|||
44478733|NCT00146770|79485492|FG000|Overall Study|Pregnancy|1|||
44478734|NCT00146770|79485493|FG001|Overall Study|Pregnancy|0|||
44478735|NCT00146770|79485492|FG000|Overall Study|Withdrawal by Subject|2|||
44478736|NCT00146770|79485493|FG001|Overall Study|Withdrawal by Subject|0|||
44478737|NCT03874013|79485501|FG000|Overall Study|Adverse Event|0|||
44478738|NCT03874013|79485502|FG001|Overall Study|Adverse Event|1|||
44478739|NCT00168064|79485510|FG000|Overall Study|Adverse Event|26|||
44478740|NCT00168064|79485511|FG001|Overall Study|Adverse Event|22|||
44478741|NCT00168064|79485510|FG000|Overall Study|Withdrawal by Subject|3|||
44478742|NCT00168064|79485511|FG001|Overall Study|Withdrawal by Subject|4|||
44478743|NCT00168064|79485510|FG000|Overall Study|Lack of Efficacy|4|||
44478744|NCT00168064|79485511|FG001|Overall Study|Lack of Efficacy|4|||
44478745|NCT00168064|79485510|FG000|Overall Study|Lost to Follow-up|4|||
44478746|NCT00168064|79485511|FG001|Overall Study|Lost to Follow-up|3|||
44478747|NCT00168064|79485510|FG000|Overall Study|Non-compliance|2|||
44226702|NCT01972529|79033342|FG000|Overall Study|Not treated|0|||
44226703|NCT01972529|79033343|FG001|Overall Study|Not treated|1|||
44226704|NCT01972529|79033344|FG002|Overall Study|Not treated|2|||
44226705|NCT01972529|79033345|FG003|Overall Study|Not treated|1|||
44226706|NCT01747915|79033359|FG000|Overall Study|Other|1|||
44226707|NCT01747915|79033360|FG001|Overall Study|Other|1|||
44226708|NCT01747915|79033361|FG002|Overall Study|Other|1|||
44226709|NCT01747915|79033359|FG000|Overall Study|Adverse Event|8|||
44226710|NCT01747915|79033360|FG001|Overall Study|Adverse Event|5|||
44226711|NCT01747915|79033361|FG002|Overall Study|Adverse Event|2|||
44226712|NCT01747915|79033359|FG000|Overall Study|Death|0|||
44226713|NCT01747915|79033360|FG001|Overall Study|Death|0|||
44226714|NCT01747915|79033361|FG002|Overall Study|Death|1|||
44226715|NCT01747915|79033359|FG000|Overall Study|Lack of Efficacy|0|||
44226716|NCT01747915|79033360|FG001|Overall Study|Lack of Efficacy|1|||
44226717|NCT01747915|79033361|FG002|Overall Study|Lack of Efficacy|0|||
44226718|NCT01747915|79033359|FG000|Overall Study|Lost to Follow-up|1|||
44226719|NCT01747915|79033360|FG001|Overall Study|Lost to Follow-up|0|||
44226720|NCT01747915|79033361|FG002|Overall Study|Lost to Follow-up|0|||
44226721|NCT01747915|79033359|FG000|Overall Study|Withdrawal by Subject|4|||
44226722|NCT01747915|79033360|FG001|Overall Study|Withdrawal by Subject|4|||
44226723|NCT01747915|79033361|FG002|Overall Study|Withdrawal by Subject|1|||
44226724|NCT01747915|79033359|FG000|Overall Study|Protocol Violation|1|||
44226725|NCT01747915|79033360|FG001|Overall Study|Protocol Violation|0|||
44226726|NCT01747915|79033361|FG002|Overall Study|Protocol Violation|0|||
44226727|NCT01747915|79033359|FG000|Overall Study|Pregnancy|0|||
44226728|NCT01747915|79033360|FG001|Overall Study|Pregnancy|0|||
44226729|NCT01747915|79033361|FG002|Overall Study|Pregnancy|1|||
44226730|NCT01961297|79033371|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
44226731|NCT01961297|79033372|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
44226732|NCT01960907|79033380|FG000|Overall Study|Death|4|||
44226733|NCT01960907|79033381|FG001|Overall Study|Death|3|||
44226734|NCT01960907|79033380|FG000|Overall Study|Withdrawal by Subject|32|||
44226735|NCT01960907|79033381|FG001|Overall Study|Withdrawal by Subject|42|||
44226736|NCT01747837|79033392|FG000|Overall Study|Lost to Follow-up|5|||
44226737|NCT01747837|79033393|FG001|Overall Study|Lost to Follow-up|2|||
44226738|NCT01747837|79033392|FG000|Overall Study|Death|4|||
44226739|NCT01747837|79033393|FG001|Overall Study|Death|4|||
44226740|NCT01971203|79033401|FG000|Overall Study|Protocol Violation|3|||
44226741|NCT01971203|79033402|FG001|Overall Study|Protocol Violation|2|||
44226742|NCT01971203|79033401|FG000|Overall Study|Withdrawal by Subject|5|||
44226743|NCT01971203|79033402|FG001|Overall Study|Withdrawal by Subject|6|||
44226744|NCT01971203|79033401|FG000|Overall Study|Adverse Event|1|||
44226745|NCT01971203|79033402|FG001|Overall Study|Adverse Event|0|||
44226746|NCT01605877|79033408|FG000|Overall Study|Withdrawal by Subject|1|||
44226747|NCT01970501|79033432|FG000|Overall Study|Discontinuation of study by sponsor|16|||
44226748|NCT01970501|79033433|FG001|Overall Study|Discontinuation of study by sponsor|14|||
44226749|NCT01970501|79033432|FG000|Overall Study|Withdrawal by Subject|6|||
44226750|NCT01970501|79033433|FG001|Overall Study|Withdrawal by Subject|7|||
44226751|NCT01970501|79033432|FG000|Overall Study|Adverse Event|2|||
44226752|NCT01970501|79033433|FG001|Overall Study|Adverse Event|4|||
44226753|NCT01970501|79033432|FG000|Overall Study|Death|1|||
44226754|NCT01970501|79033433|FG001|Overall Study|Death|3|||
44226755|NCT01970501|79033432|FG000|Overall Study|Physician Decision|2|||
44226756|NCT01970501|79033433|FG001|Overall Study|Physician Decision|0|||
44478748|NCT00168064|79485511|FG001|Overall Study|Non-compliance|3|||
44478749|NCT00168064|79485510|FG000|Overall Study|Concurrent Illness|4|||
44478750|NCT00168064|79485511|FG001|Overall Study|Concurrent Illness|3|||
44226757|NCT01969799|79033441|FG000|Overall Study|Adverse Event|0|||
44226758|NCT01969799|79033442|FG001|Overall Study|Adverse Event|1|||
44226759|NCT01969799|79033441|FG000|Overall Study|Death|16|||
44226760|NCT01969799|79033442|FG001|Overall Study|Death|11|||
44226761|NCT01969799|79033441|FG000|Overall Study|Lost to Follow-up|0|||
44226762|NCT01969799|79033442|FG001|Overall Study|Lost to Follow-up|2|||
44226763|NCT01969799|79033441|FG000|Overall Study|Physician Decision|1|||
44226764|NCT01969799|79033442|FG001|Overall Study|Physician Decision|0|||
44226765|NCT01969721|79033448|FG000|Overall Study|Adverse Event|3|||
44226766|NCT01969721|79033449|FG001|Overall Study|Adverse Event|8|||
44226767|NCT01969721|79033450|FG002|Overall Study|Adverse Event|3|||
44226768|NCT01969721|79033451|FG003|Overall Study|Adverse Event|2|||
44226769|NCT01969721|79033448|FG000|Overall Study|Lack of Efficacy|0|||
44226770|NCT01969721|79033449|FG001|Overall Study|Lack of Efficacy|0|||
44226771|NCT01969721|79033450|FG002|Overall Study|Lack of Efficacy|1|||
44226772|NCT01969721|79033451|FG003|Overall Study|Lack of Efficacy|0|||
44226773|NCT01969721|79033448|FG000|Overall Study|Non compliant with protocol|1|||
44478751|NCT00168064|79485510|FG000|Overall Study|Subject's Best interest|2|||
44226774|NCT01969721|79033449|FG001|Overall Study|Non compliant with protocol|1|||
44226775|NCT01969721|79033450|FG002|Overall Study|Non compliant with protocol|0|||
44226776|NCT01969721|79033451|FG003|Overall Study|Non compliant with protocol|2|||
44226777|NCT01969721|79033448|FG000|Overall Study|Other not defined above|0|||
44226778|NCT01969721|79033449|FG001|Overall Study|Other not defined above|2|||
44226779|NCT01969721|79033450|FG002|Overall Study|Other not defined above|0|||
44226780|NCT01969721|79033451|FG003|Overall Study|Other not defined above|0|||
44478752|NCT00168064|79485511|FG001|Overall Study|Subject's Best interest|2|||
44478753|NCT00168064|79485510|FG000|Overall Study|Various|4|||
44478754|NCT00168064|79485511|FG001|Overall Study|Various|3|||
44478755|NCT00166114|79485521|FG000|Overall Study|Protocol Violation|2|||
44478756|NCT00166114|79485522|FG001|Overall Study|Protocol Violation|1|||
44478757|NCT00166114|79485521|FG000|Overall Study|Withdrawal by Subject|10|||
44226781|NCT01969721|79033448|FG000|Overall Study|Discontinued during washout periods.|0|||
44226782|NCT01969721|79033449|FG001|Overall Study|Discontinued during washout periods.|1|||
44226783|NCT01969721|79033450|FG002|Overall Study|Discontinued during washout periods.|1|||
44226784|NCT01969721|79033451|FG003|Overall Study|Discontinued during washout periods.|2|||
44226785|NCT01969565|79033461|FG000|Overall Study|Withdrawal by Subject|1|||
44226786|NCT01968707|79033474|FG000|Overall Study|Did not meet treatment day baseline|49|||
44226787|NCT01968707|79033475|FG001|Overall Study|Did not meet treatment day baseline|12|||
44226788|NCT01968707|79033476|FG002|Overall Study|Did not meet treatment day baseline|41|||
44226789|NCT01968707|79033477|FG003|Overall Study|Did not meet treatment day baseline|44|||
44226790|NCT01968707|79033478|FG004|Overall Study|Did not meet treatment day baseline|36|||
44226791|NCT01968707|79033479|FG005|Overall Study|Did not meet treatment day baseline|11|||
44226792|NCT01968707|79033480|FG006|Overall Study|Did not meet treatment day baseline|34|||
44226793|NCT01968707|79033481|FG007|Overall Study|Did not meet treatment day baseline|35|||
44226794|NCT01959581|79033514|FG000|Overall Study|Lost to Follow-up|5|||
44226795|NCT01746901|79033518|FG000|Naloxone Challenge Phase|Adverse Event|2|||
44226796|NCT01746901|79033519|FG001|Naloxone Challenge Phase|Adverse Event|0|||
44226797|NCT01746901|79033520|FG002|Naloxone Challenge Phase|Adverse Event|0|||
44226798|NCT01746901|79033521|FG003|Naloxone Challenge Phase|Adverse Event|0|||
44226799|NCT01746901|79033522|FG004|Naloxone Challenge Phase|Adverse Event|0|||
44226800|NCT01746901|79033523|FG005|Naloxone Challenge Phase|Adverse Event|0|||
44226801|NCT01746901|79033524|FG006|Naloxone Challenge Phase|Adverse Event|0|||
44226802|NCT01746901|79033525|FG007|Naloxone Challenge Phase|Adverse Event|0|||
44226803|NCT01746901|79033526|FG008|Naloxone Challenge Phase|Adverse Event|0|||
44226804|NCT01746901|79033518|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
44226805|NCT01746901|79033519|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226806|NCT01746901|79033520|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226807|NCT01746901|79033521|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226808|NCT01746901|79033522|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226809|NCT01746901|79033523|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226810|NCT01746901|79033524|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226811|NCT01746901|79033525|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226812|NCT01746901|79033526|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
44226813|NCT01746901|79033518|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226814|NCT01746901|79033519|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
44226815|NCT01746901|79033520|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226816|NCT01746901|79033521|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226817|NCT01746901|79033522|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226818|NCT01746901|79033523|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226819|NCT01746901|79033524|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226820|NCT01746901|79033525|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226821|NCT01746901|79033526|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44226822|NCT01746901|79033518|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44226823|NCT01746901|79033519|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
44226824|NCT01746901|79033520|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
44226825|NCT01746901|79033521|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44226826|NCT01746901|79033522|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44478758|NCT00166114|79485522|FG001|Overall Study|Withdrawal by Subject|4|||
44478759|NCT00166114|79485521|FG000|Overall Study|Adverse Event|2|||
44478760|NCT00166114|79485522|FG001|Overall Study|Adverse Event|1|||
44478761|NCT03686969|79485530|FG000|Overall Study|Study terminated|1|||
44478762|NCT03686969|79485531|FG001|Overall Study|Study terminated|0|||
44226827|NCT01746901|79033523|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44226828|NCT01746901|79033524|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44226829|NCT01746901|79033525|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44226830|NCT01746901|79033526|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
44226831|NCT01746901|79033518|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226832|NCT01746901|79033519|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
44478763|NCT00145600|79485541|FG000|Overall Study|Death|1|||
44478764|NCT00145600|79485542|FG001|Overall Study|Death|2|||
44478765|NCT00145600|79485543|FG002|Overall Study|Death|2|||
44478766|NCT00145600|79485544|FG003|Overall Study|Death|6|||
44478767|NCT00145600|79485541|FG000|Overall Study|Ineligible|3|||
44478768|NCT00145600|79485542|FG001|Overall Study|Ineligible|0|||
44478769|NCT00145600|79485543|FG002|Overall Study|Ineligible|1|||
44478770|NCT00145600|79485544|FG003|Overall Study|Ineligible|5|||
44478771|NCT00145600|79485541|FG000|Overall Study|Lost to Follow-up|2|||
44478772|NCT00145600|79485542|FG001|Overall Study|Lost to Follow-up|6|||
44478773|NCT00145600|79485543|FG002|Overall Study|Lost to Follow-up|2|||
44478774|NCT00145600|79485544|FG003|Overall Study|Lost to Follow-up|4|||
44478775|NCT00145600|79485541|FG000|Overall Study|Noncompliance|1|||
44478776|NCT00145600|79485542|FG001|Overall Study|Noncompliance|0|||
44478777|NCT00145600|79485543|FG002|Overall Study|Noncompliance|0|||
44478778|NCT00145600|79485544|FG003|Overall Study|Noncompliance|0|||
44478779|NCT00145600|79485541|FG000|Overall Study|Withdrawal by Subject|1|||
44478780|NCT00145600|79485542|FG001|Overall Study|Withdrawal by Subject|2|||
44478781|NCT00145600|79485543|FG002|Overall Study|Withdrawal by Subject|0|||
44478782|NCT00145600|79485544|FG003|Overall Study|Withdrawal by Subject|1|||
44478783|NCT00129376|79485568|FG000|Overall Study|Adverse Event|1|||
44478784|NCT00129376|79485568|FG000|Overall Study|Lack of Efficacy|1|||
44478785|NCT00129220|79485575|FG000|Study Period II|Adverse Event|9|||
44478786|NCT00129220|79485576|FG001|Study Period II|Adverse Event|5|||
44478787|NCT00129220|79485577|FG002|Study Period II|Adverse Event|7|||
44478788|NCT00129220|79485575|FG000|Study Period II|Lack of Efficacy|15|||
44478789|NCT00129220|79485576|FG001|Study Period II|Lack of Efficacy|1|||
44478790|NCT00129220|79485577|FG002|Study Period II|Lack of Efficacy|28|||
44478791|NCT00129220|79485575|FG000|Study Period II|Entry Criteria Not Met|2|||
44478792|NCT00129220|79485576|FG001|Study Period II|Entry Criteria Not Met|0|||
44478793|NCT00129220|79485577|FG002|Study Period II|Entry Criteria Not Met|2|||
44478794|NCT00129220|79485575|FG000|Study Period II|Protocol Violation|4|||
44478795|NCT00129220|79485576|FG001|Study Period II|Protocol Violation|2|||
44478796|NCT00129220|79485577|FG002|Study Period II|Protocol Violation|1|||
44478797|NCT00129220|79485575|FG000|Study Period II|Physician Decision|0|||
44478798|NCT00129220|79485576|FG001|Study Period II|Physician Decision|1|||
44478799|NCT00129220|79485577|FG002|Study Period II|Physician Decision|0|||
44478800|NCT00129220|79485575|FG000|Study Period II|Withdrawal by Subject|1|||
44478801|NCT00129220|79485576|FG001|Study Period II|Withdrawal by Subject|3|||
44478802|NCT00129220|79485577|FG002|Study Period II|Withdrawal by Subject|4|||
44478803|NCT00129220|79485575|FG000|Study Period II|Reason Not Specified|2|||
44478804|NCT00129220|79485576|FG001|Study Period II|Reason Not Specified|0|||
44478805|NCT00129220|79485577|FG002|Study Period II|Reason Not Specified|5|||
44478806|NCT00129220|79485575|FG000|Study Period III|Adverse Event|1|||
44478807|NCT00129220|79485576|FG001|Study Period III|Adverse Event|0|||
44478808|NCT00129220|79485577|FG002|Study Period III|Adverse Event|3|||
44478809|NCT00129220|79485575|FG000|Study Period III|Protocol Violation|1|||
44478810|NCT00129220|79485576|FG001|Study Period III|Protocol Violation|1|||
44478811|NCT00129220|79485577|FG002|Study Period III|Protocol Violation|2|||
44478812|NCT00129220|79485575|FG000|Study Period III|Withdrawal by Subject|1|||
44478813|NCT00129220|79485576|FG001|Study Period III|Withdrawal by Subject|0|||
44226833|NCT01746901|79033520|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
44226834|NCT01746901|79033521|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226835|NCT01746901|79033522|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226836|NCT01746901|79033523|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226837|NCT01746901|79033524|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226838|NCT01746901|79033525|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226839|NCT01746901|79033526|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
44226840|NCT01746901|79033518|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44226841|NCT01746901|79033519|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
44226842|NCT01746901|79033520|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
44226843|NCT01746901|79033521|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44226844|NCT01746901|79033522|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44478814|NCT00129220|79485577|FG002|Study Period III|Withdrawal by Subject|3|||
44478815|NCT00129220|79485575|FG000|Study Period III|Sponsor Decision|1|||
44478816|NCT00129220|79485576|FG001|Study Period III|Sponsor Decision|0|||
44478817|NCT00129220|79485577|FG002|Study Period III|Sponsor Decision|0|||
44478818|NCT00129220|79485575|FG000|Study Period III|Reason Not Specified|9|||
44478819|NCT00129220|79485576|FG001|Study Period III|Reason Not Specified|0|||
44478820|NCT00129220|79485577|FG002|Study Period III|Reason Not Specified|2|||
44478821|NCT00128830|79485597|FG000|Overall Study|Adverse Event|10|||
44478822|NCT00128830|79485597|FG000|Overall Study|Withdrawal by Subject|14|||
44478823|NCT00128830|79485597|FG000|Overall Study|Lost to Follow-up|4|||
44478824|NCT00128830|79485597|FG000|Overall Study|Reached a virologic endpoint|29|||
44478825|NCT00128830|79485597|FG000|Overall Study|Non-compliant|4|||
44478826|NCT00128830|79485597|FG000|Overall Study|Discontinued or ineligible for study|2|||
44478827|NCT00128830|79485597|FG000|Overall Study|Other|9|||
44478828|NCT03686033|79485603|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
44478829|NCT03686033|79485604|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
44478830|NCT03686033|79485605|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
44478831|NCT03686033|79485606|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
44478832|NCT03686033|79485607|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
44478833|NCT03686033|79485608|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
44478834|NCT00128206|79485624|FG000|Overall Study|Lost to Follow-up|137|||
44478835|NCT00128206|79485625|FG001|Overall Study|Lost to Follow-up|118|||
44478836|NCT00128206|79485624|FG000|Overall Study|Adverse Event|0|||
44478837|NCT00128206|79485625|FG001|Overall Study|Adverse Event|2|||
44478838|NCT03685643|79485633|FG000|Overall Study|Lost to Follow-up|14|||
44478839|NCT03685643|79485634|FG001|Overall Study|Lost to Follow-up|22|||
44478840|NCT03823378|79485646|FG000|Overall Study|Adverse Event|2|||
44478841|NCT03823378|79485647|FG001|Overall Study|Adverse Event|2|||
44478842|NCT03823378|79485648|FG002|Overall Study|Adverse Event|0|||
44478843|NCT03823378|79485649|FG003|Overall Study|Adverse Event|0|||
44478844|NCT03823378|79485650|FG004|Overall Study|Adverse Event|0|||
44478845|NCT03823378|79485651|FG005|Overall Study|Adverse Event|0|||
44478846|NCT03823378|79485646|FG000|Overall Study|Lost to Follow-up|0|||
44478847|NCT03823378|79485647|FG001|Overall Study|Lost to Follow-up|1|||
44478848|NCT03823378|79485648|FG002|Overall Study|Lost to Follow-up|0|||
44478849|NCT03823378|79485649|FG003|Overall Study|Lost to Follow-up|0|||
44478850|NCT03823378|79485650|FG004|Overall Study|Lost to Follow-up|1|||
44478851|NCT03823378|79485651|FG005|Overall Study|Lost to Follow-up|0|||
44478852|NCT03823378|79485646|FG000|Overall Study|Withdrawal by Subject|0|||
44478853|NCT03823378|79485647|FG001|Overall Study|Withdrawal by Subject|1|||
44478854|NCT03823378|79485648|FG002|Overall Study|Withdrawal by Subject|4|||
44478855|NCT03823378|79485649|FG003|Overall Study|Withdrawal by Subject|2|||
44478856|NCT03823378|79485650|FG004|Overall Study|Withdrawal by Subject|0|||
44478857|NCT03823378|79485651|FG005|Overall Study|Withdrawal by Subject|1|||
44478858|NCT03823378|79485646|FG000|Overall Study|Other, not specified|19|||
44478859|NCT03823378|79485647|FG001|Overall Study|Other, not specified|12|||
44478860|NCT03823378|79485648|FG002|Overall Study|Other, not specified|6|||
44478861|NCT03823378|79485649|FG003|Overall Study|Other, not specified|8|||
44478862|NCT03823378|79485650|FG004|Overall Study|Other, not specified|17|||
44478863|NCT03823378|79485651|FG005|Overall Study|Other, not specified|7|||
44478864|NCT00142792|79485668|FG000|Overall Study|Death|0|||
44478865|NCT00142792|79485669|FG001|Overall Study|Death|0|||
44478866|NCT00142792|79485670|FG002|Overall Study|Death|1|||
44478867|NCT00142792|79485668|FG000|Overall Study|Withdrawal by Subject|3|||
44478868|NCT00142792|79485669|FG001|Overall Study|Withdrawal by Subject|2|||
44478869|NCT00142792|79485670|FG002|Overall Study|Withdrawal by Subject|3|||
44478870|NCT00142792|79485668|FG000|Overall Study|Lost to Follow-up|8|||
44478871|NCT00142792|79485669|FG001|Overall Study|Lost to Follow-up|11|||
44478872|NCT00142792|79485670|FG002|Overall Study|Lost to Follow-up|7|||
44478873|NCT00142792|79485668|FG000|Overall Study|No category|1|||
44478874|NCT00142792|79485669|FG001|Overall Study|No category|2|||
44478875|NCT00142792|79485670|FG002|Overall Study|No category|1|||
44478876|NCT00141778|79485681|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
44478877|NCT00141778|79485682|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
44478878|NCT00141778|79485683|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
44478879|NCT00141778|79485681|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
44478880|NCT00141778|79485682|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
44375583|NCT00943722|79380717|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
44478881|NCT00141778|79485683|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
44478882|NCT00141778|79485681|FG000|Started Study Medication|Withdrawal by Subject|0|||
44478883|NCT00141778|79485682|FG001|Started Study Medication|Withdrawal by Subject|2|||
44375584|NCT00943722|79380711|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
44478884|NCT00141778|79485683|FG002|Started Study Medication|Withdrawal by Subject|0|||
44478885|NCT00141778|79485681|FG000|Started Study Medication|Difficulty Swallowing|0|||
44478886|NCT00141778|79485682|FG001|Started Study Medication|Difficulty Swallowing|1|||
44478887|NCT00141778|79485683|FG002|Started Study Medication|Difficulty Swallowing|0|||
44478888|NCT00141778|79485681|FG000|Started Study Medication|Chest Discomfort|0|||
44478889|NCT00141778|79485682|FG001|Started Study Medication|Chest Discomfort|0|||
44478890|NCT00141778|79485683|FG002|Started Study Medication|Chest Discomfort|1|||
44478891|NCT00127660|79485695|FG000|Overall Study|Protocol Violation|3|||
44478892|NCT00127660|79485696|FG001|Overall Study|Protocol Violation|3|||
44478893|NCT00127660|79485697|FG002|Overall Study|Protocol Violation|5|||
44478894|NCT00127660|79485698|FG003|Overall Study|Protocol Violation|0|||
44478895|NCT03817528|79485708|FG000|Overall Study|Withdrawal by Subject|1|||
44478896|NCT03817528|79485708|FG000|Overall Study|Adverse Event|2|||
44478897|NCT00115336|79485714|FG000|Overall Study|Hospital discharge before study drug|0|||
44478898|NCT00115336|79485715|FG001|Overall Study|Hospital discharge before study drug|1|||
44478899|NCT00205803|79485725|FG000|Infant Series|Lost to Follow-up|10|||
44478900|NCT00205803|79485726|FG001|Infant Series|Lost to Follow-up|4|||
44478901|NCT00205803|79485725|FG000|Infant Series|Withdrawal by Subject|2|||
44478902|NCT00205803|79485726|FG001|Infant Series|Withdrawal by Subject|5|||
44478903|NCT00205803|79485725|FG000|Infant Series|Physician Decision|3|||
44478904|NCT00205803|79485726|FG001|Infant Series|Physician Decision|1|||
44478905|NCT00205803|79485725|FG000|Infant Series|Protocol Violation|1|||
44478906|NCT00205803|79485726|FG001|Infant Series|Protocol Violation|0|||
44478907|NCT00205803|79485725|FG000|Infant Series|Lost Kaiser coverage|0|||
44478908|NCT00205803|79485726|FG001|Infant Series|Lost Kaiser coverage|1|||
44478909|NCT00205803|79485725|FG000|Infant Series|Non-compliant|1|||
44478910|NCT00205803|79485726|FG001|Infant Series|Non-compliant|0|||
44478911|NCT00205803|79485725|FG000|Infant Series|Sponsor request|1|||
44478912|NCT00205803|79485726|FG001|Infant Series|Sponsor request|0|||
44478913|NCT00205803|79485725|FG000|After Infant Series|Adverse Event|1|||
44478914|NCT00205803|79485726|FG001|After Infant Series|Adverse Event|1|||
44478915|NCT00205803|79485725|FG000|After Infant Series|Protocol Violation|1|||
44478916|NCT00205803|79485726|FG001|After Infant Series|Protocol Violation|1|||
44478917|NCT00205803|79485725|FG000|After Infant Series|Lost to Follow-up|2|||
44478918|NCT00205803|79485726|FG001|After Infant Series|Lost to Follow-up|1|||
44478919|NCT00205803|79485725|FG000|After Infant Series|Physician Decision|3|||
44478920|NCT00205803|79485726|FG001|After Infant Series|Physician Decision|2|||
44478921|NCT00205803|79485725|FG000|After Infant Series|Withdrawal by Subject|1|||
44478922|NCT00205803|79485726|FG001|After Infant Series|Withdrawal by Subject|4|||
44478923|NCT00205803|79485725|FG000|After Infant Series|Other|10|||
44478924|NCT00205803|79485726|FG001|After Infant Series|Other|4|||
44478925|NCT00205803|79485725|FG000|Toddler Dose|Lost to Follow-up|2|||
44478926|NCT00205803|79485726|FG001|Toddler Dose|Lost to Follow-up|3|||
44478927|NCT00127192|79485755|FG000|Overall Study|Adverse Event|0|||
44478928|NCT00127192|79485756|FG001|Overall Study|Adverse Event|1|||
44478929|NCT00127192|79485757|FG002|Overall Study|Adverse Event|1|||
44478930|NCT00127192|79485758|FG003|Overall Study|Adverse Event|1|||
44478931|NCT00127192|79485759|FG004|Overall Study|Adverse Event|0|||
44478932|NCT00127192|79485755|FG000|Overall Study|Lack of Efficacy|2|||
44478933|NCT00127192|79485756|FG001|Overall Study|Lack of Efficacy|0|||
44478934|NCT00127192|79485757|FG002|Overall Study|Lack of Efficacy|0|||
44478935|NCT00127192|79485758|FG003|Overall Study|Lack of Efficacy|0|||
44478936|NCT00127192|79485759|FG004|Overall Study|Lack of Efficacy|2|||
44478937|NCT00127192|79485755|FG000|Overall Study|Withdrawal by Subject|0|||
44478938|NCT00127192|79485756|FG001|Overall Study|Withdrawal by Subject|0|||
44478939|NCT00127192|79485757|FG002|Overall Study|Withdrawal by Subject|1|||
44478940|NCT00127192|79485758|FG003|Overall Study|Withdrawal by Subject|0|||
44478941|NCT00127192|79485759|FG004|Overall Study|Withdrawal by Subject|3|||
44478942|NCT00127192|79485755|FG000|Overall Study|Adverse event in pre-treatment period|1|||
44226845|NCT01746901|79033523|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44226846|NCT01746901|79033524|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44226847|NCT01746901|79033525|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44226848|NCT01746901|79033526|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44226849|NCT01746901|79033518|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
44226850|NCT01746901|79033519|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
44226851|NCT01746901|79033520|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
44226852|NCT01746901|79033521|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
44226853|NCT01746901|79033522|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
44226854|NCT01746901|79033523|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
44226855|NCT01746901|79033524|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
44226856|NCT01746901|79033525|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
44226857|NCT01746901|79033526|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
44226858|NCT01746901|79033518|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44478943|NCT00127192|79485756|FG001|Overall Study|Adverse event in pre-treatment period|0|||
44478944|NCT00127192|79485757|FG002|Overall Study|Adverse event in pre-treatment period|0|||
44478945|NCT00127192|79485758|FG003|Overall Study|Adverse event in pre-treatment period|0|||
44478946|NCT00127192|79485759|FG004|Overall Study|Adverse event in pre-treatment period|0|||
44478947|NCT00205179|79485773|FG000|Overall Study|Death|0|||
44478948|NCT00205179|79485774|FG001|Overall Study|Death|2|||
44478949|NCT00205179|79485773|FG000|Overall Study|Physician Decision|1|||
44478950|NCT00205179|79485774|FG001|Overall Study|Physician Decision|1|||
44478951|NCT00205179|79485773|FG000|Overall Study|Adverse Event|1|||
44478952|NCT00205179|79485774|FG001|Overall Study|Adverse Event|1|||
44478953|NCT00127036|79485783|FG000|Overall Study|Insufficient Data for Analysis|6|||
44478954|NCT00127036|79485784|FG001|Overall Study|Insufficient Data for Analysis|11|||
44478955|NCT00127036|79485783|FG000|Overall Study|Screen Failure|2|||
44478956|NCT00127036|79485784|FG001|Overall Study|Screen Failure|0|||
44478957|NCT00259857|79485792|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
44478958|NCT00259857|79485793|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
44478959|NCT00259857|79485792|FG000|24 Months Treatment|Lost to Follow-up|0|||
44478960|NCT00259857|79485793|FG001|24 Months Treatment|Lost to Follow-up|3|||
44478961|NCT00203307|79485801|FG000|First Intervention|Adverse Event|2|||
44478962|NCT00203307|79485802|FG001|First Intervention|Adverse Event|0|||
44478963|NCT00126568|79485808|FG000|Overall Study|Death|2|||
44478964|NCT00114634|79485813|FG000|Overall Study|failure to return forms|3|||
44478965|NCT00202839|79485821|FG000|Overall Study|Adverse Event|1|||
44478966|NCT00202839|79485822|FG001|Overall Study|Adverse Event|5|||
44478967|NCT00202839|79485821|FG000|Overall Study|Physician Decision|12|||
44478968|NCT00202839|79485822|FG001|Overall Study|Physician Decision|0|||
44478969|NCT00202839|79485821|FG000|Overall Study|Withdrawal by Subject|6|||
44478970|NCT00202839|79485822|FG001|Overall Study|Withdrawal by Subject|2|||
44478971|NCT00202839|79485821|FG000|Overall Study|Protocol Violation|2|||
44478972|NCT00202839|79485822|FG001|Overall Study|Protocol Violation|1|||
44478973|NCT00202839|79485821|FG000|Overall Study|Lost to Follow-up|3|||
44478974|NCT00202839|79485822|FG001|Overall Study|Lost to Follow-up|2|||
44478975|NCT00201201|79485830|FG000|Overall Study|Death|0|||
44478976|NCT00201201|79485831|FG001|Overall Study|Death|2|||
44478977|NCT00201201|79485830|FG000|Overall Study|Withdrawal by Subject|5|||
44478978|NCT00201201|79485831|FG001|Overall Study|Withdrawal by Subject|5|||
44478979|NCT00126490|79485837|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
44478980|NCT00346632|79485843|FG000|Overall Study|Progressive Disease|2|||
44478981|NCT00346632|79485844|FG001|Overall Study|Progressive Disease|2|||
44478982|NCT00346632|79485845|FG002|Overall Study|Progressive Disease|4|||
44478983|NCT00346632|79485846|FG003|Overall Study|Progressive Disease|3|||
44478984|NCT00346632|79485847|FG004|Overall Study|Progressive Disease|3|||
44478985|NCT00346632|79485848|FG005|Overall Study|Progressive Disease|1|||
44478986|NCT00346632|79485849|FG006|Overall Study|Progressive Disease|2|||
44478987|NCT00346632|79485850|FG007|Overall Study|Progressive Disease|2|||
44478988|NCT00346632|79485851|FG008|Overall Study|Progressive Disease|2|||
44478989|NCT00346632|79485852|FG009|Overall Study|Progressive Disease|2|||
44478990|NCT00346632|79485843|FG000|Overall Study|Adverse Event|0|||
44478991|NCT00346632|79485844|FG001|Overall Study|Adverse Event|0|||
44478992|NCT00346632|79485845|FG002|Overall Study|Adverse Event|0|||
44478993|NCT00346632|79485846|FG003|Overall Study|Adverse Event|0|||
44478994|NCT00346632|79485847|FG004|Overall Study|Adverse Event|1|||
44478995|NCT00346632|79485848|FG005|Overall Study|Adverse Event|1|||
44478996|NCT00346632|79485849|FG006|Overall Study|Adverse Event|1|||
44478997|NCT00346632|79485850|FG007|Overall Study|Adverse Event|0|||
44478998|NCT00346632|79485851|FG008|Overall Study|Adverse Event|0|||
44478999|NCT00346632|79485852|FG009|Overall Study|Adverse Event|0|||
44479000|NCT00346632|79485843|FG000|Overall Study|Death|0|||
44479001|NCT00346632|79485844|FG001|Overall Study|Death|0|||
44479002|NCT00346632|79485845|FG002|Overall Study|Death|1|||
44479003|NCT00346632|79485846|FG003|Overall Study|Death|0|||
44479004|NCT00346632|79485847|FG004|Overall Study|Death|0|||
44479005|NCT00346632|79485848|FG005|Overall Study|Death|0|||
44479006|NCT00346632|79485849|FG006|Overall Study|Death|0|||
44479007|NCT00346632|79485850|FG007|Overall Study|Death|0|||
44479008|NCT00346632|79485851|FG008|Overall Study|Death|0|||
44479009|NCT00346632|79485852|FG009|Overall Study|Death|0|||
44479010|NCT00346632|79485843|FG000|Overall Study|Protocol Violation|0|||
44479011|NCT00346632|79485844|FG001|Overall Study|Protocol Violation|0|||
44479012|NCT00346632|79485845|FG002|Overall Study|Protocol Violation|0|||
44479013|NCT00346632|79485846|FG003|Overall Study|Protocol Violation|0|||
44479014|NCT00346632|79485847|FG004|Overall Study|Protocol Violation|0|||
44479015|NCT00346632|79485848|FG005|Overall Study|Protocol Violation|0|||
44479016|NCT00346632|79485849|FG006|Overall Study|Protocol Violation|1|||
44479017|NCT00346632|79485850|FG007|Overall Study|Protocol Violation|0|||
44479018|NCT00346632|79485851|FG008|Overall Study|Protocol Violation|0|||
44479019|NCT00346632|79485852|FG009|Overall Study|Protocol Violation|0|||
44479020|NCT00346632|79485843|FG000|Overall Study|Withdrawal by Subject|0|||
44479021|NCT00346632|79485844|FG001|Overall Study|Withdrawal by Subject|0|||
44479022|NCT00346632|79485845|FG002|Overall Study|Withdrawal by Subject|0|||
44479023|NCT00346632|79485846|FG003|Overall Study|Withdrawal by Subject|0|||
44479024|NCT00346632|79485847|FG004|Overall Study|Withdrawal by Subject|0|||
44479025|NCT00346632|79485848|FG005|Overall Study|Withdrawal by Subject|0|||
44479026|NCT00346632|79485849|FG006|Overall Study|Withdrawal by Subject|1|||
44479027|NCT00346632|79485850|FG007|Overall Study|Withdrawal by Subject|0|||
44479028|NCT00346632|79485851|FG008|Overall Study|Withdrawal by Subject|0|||
44479029|NCT00346632|79485852|FG009|Overall Study|Withdrawal by Subject|0|||
44479030|NCT00346632|79485843|FG000|Overall Study|Switched to alternative treatment|0|||
44479031|NCT00346632|79485844|FG001|Overall Study|Switched to alternative treatment|0|||
44479032|NCT00346632|79485845|FG002|Overall Study|Switched to alternative treatment|1|||
44479033|NCT00346632|79485846|FG003|Overall Study|Switched to alternative treatment|0|||
44479034|NCT00346632|79485847|FG004|Overall Study|Switched to alternative treatment|0|||
44479035|NCT00346632|79485848|FG005|Overall Study|Switched to alternative treatment|0|||
44479036|NCT00346632|79485849|FG006|Overall Study|Switched to alternative treatment|0|||
44479037|NCT00346632|79485850|FG007|Overall Study|Switched to alternative treatment|0|||
44479038|NCT00346632|79485851|FG008|Overall Study|Switched to alternative treatment|0|||
44479039|NCT00346632|79485852|FG009|Overall Study|Switched to alternative treatment|0|||
44479040|NCT00346632|79485843|FG000|Overall Study|Not Stated|1|||
44479041|NCT00346632|79485844|FG001|Overall Study|Not Stated|1|||
44479042|NCT00346632|79485845|FG002|Overall Study|Not Stated|0|||
44479043|NCT00346632|79485846|FG003|Overall Study|Not Stated|0|||
44479044|NCT00346632|79485847|FG004|Overall Study|Not Stated|0|||
44479045|NCT00346632|79485848|FG005|Overall Study|Not Stated|0|||
44479046|NCT00346632|79485849|FG006|Overall Study|Not Stated|0|||
44479047|NCT00346632|79485850|FG007|Overall Study|Not Stated|2|||
44479048|NCT00346632|79485851|FG008|Overall Study|Not Stated|2|||
44479049|NCT00346632|79485852|FG009|Overall Study|Not Stated|1|||
44479050|NCT00200967|79485916|FG000|First Treatment Period|Withdrawal by Subject|5|||
44479051|NCT00200967|79485917|FG001|First Treatment Period|Withdrawal by Subject|1|||
44479052|NCT00200967|79485916|FG000|First Treatment Period|Pregnancy|1|||
44479053|NCT00200967|79485917|FG001|First Treatment Period|Pregnancy|0|||
44479054|NCT00200967|79485916|FG000|Wash-out Period|Lost to Follow-up|0|||
44479055|NCT00200967|79485917|FG001|Wash-out Period|Lost to Follow-up|1|||
44479056|NCT00200967|79485916|FG000|Second Treatment Period|Withdrawal by Subject|1|||
44479057|NCT00200967|79485917|FG001|Second Treatment Period|Withdrawal by Subject|2|||
44479058|NCT00200967|79485916|FG000|Run-out Period|Lost to Follow-up|1|||
44479059|NCT00200967|79485917|FG001|Run-out Period|Lost to Follow-up|0|||
44479060|NCT00354432|79485927|FG000|Overall Study|Adverse Event|3|||
44479061|NCT00354432|79485928|FG001|Overall Study|Adverse Event|1|||
44479062|NCT00354432|79485929|FG002|Overall Study|Adverse Event|5|||
44479063|NCT00354432|79485930|FG003|Overall Study|Adverse Event|5|||
44479064|NCT00354432|79485927|FG000|Overall Study|Off/Toxicity|3|||
44479065|NCT00354432|79485928|FG001|Overall Study|Off/Toxicity|7|||
44479066|NCT00354432|79485929|FG002|Overall Study|Off/Toxicity|5|||
44479067|NCT00354432|79485930|FG003|Overall Study|Off/Toxicity|5|||
44479068|NCT00140140|79485943|FG000|Overall Study|Unacceptable toxicity|1|||
44479069|NCT00140140|79485944|FG001|Overall Study|Unacceptable toxicity|1|||
44479070|NCT00140140|79485945|FG002|Overall Study|Unacceptable toxicity|2|||
44479071|NCT00140140|79485943|FG000|Overall Study|Physician Decision|1|||
44479072|NCT00140140|79485944|FG001|Overall Study|Physician Decision|1|||
44479073|NCT00140140|79485945|FG002|Overall Study|Physician Decision|0|||
44479074|NCT00346398|79485954|FG000|Overall Study|Lost to Follow-up|3|||
44479075|NCT00346398|79485955|FG001|Overall Study|Lost to Follow-up|0|||
44479076|NCT00346398|79485954|FG000|Overall Study|Withdrawal by Subject|0|||
44479077|NCT00346398|79485955|FG001|Overall Study|Withdrawal by Subject|2|||
44479078|NCT00346164|79485965|FG000|Overall Study|Adverse Event|0|||
44479079|NCT00346164|79485966|FG001|Overall Study|Adverse Event|0|||
44479080|NCT00346164|79485967|FG002|Overall Study|Adverse Event|0|||
44479081|NCT00346164|79485968|FG003|Overall Study|Adverse Event|1|||
44479082|NCT00346164|79485965|FG000|Overall Study|Lack of Efficacy|0|||
44479083|NCT00346164|79485966|FG001|Overall Study|Lack of Efficacy|1|||
44479084|NCT00346164|79485967|FG002|Overall Study|Lack of Efficacy|7|||
44479085|NCT00346164|79485968|FG003|Overall Study|Lack of Efficacy|25|||
44479086|NCT00346164|79485965|FG000|Overall Study|Physician Decision|0|||
44479087|NCT00346164|79485966|FG001|Overall Study|Physician Decision|1|||
44479088|NCT00346164|79485967|FG002|Overall Study|Physician Decision|2|||
44479089|NCT00346164|79485968|FG003|Overall Study|Physician Decision|27|||
44479090|NCT00346164|79485965|FG000|Overall Study|Protocol Violation|6|||
44479091|NCT00346164|79485966|FG001|Overall Study|Protocol Violation|2|||
44479092|NCT00346164|79485967|FG002|Overall Study|Protocol Violation|10|||
44479093|NCT00346164|79485968|FG003|Overall Study|Protocol Violation|4|||
44479094|NCT00346164|79485965|FG000|Overall Study|Withdrawal by Subject|0|||
44375585|NCT00943722|79380712|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
44479095|NCT00346164|79485966|FG001|Overall Study|Withdrawal by Subject|0|||
44479096|NCT00346164|79485967|FG002|Overall Study|Withdrawal by Subject|2|||
44479097|NCT00346164|79485968|FG003|Overall Study|Withdrawal by Subject|0|||
44479098|NCT00346164|79485965|FG000|Overall Study|Ineligible|11|||
44479099|NCT00346164|79485966|FG001|Overall Study|Ineligible|2|||
44479100|NCT00346164|79485967|FG002|Overall Study|Ineligible|2|||
44479101|NCT00346164|79485968|FG003|Overall Study|Ineligible|23|||
44479102|NCT00346164|79485965|FG000|Overall Study|Refusal of further protocol therapy|0|||
44479103|NCT00346164|79485966|FG001|Overall Study|Refusal of further protocol therapy|1|||
44479104|NCT00346164|79485967|FG002|Overall Study|Refusal of further protocol therapy|3|||
44479105|NCT00346164|79485968|FG003|Overall Study|Refusal of further protocol therapy|15|||
44479106|NCT00346164|79485965|FG000|Overall Study|Inability to start week 16 tx on time|0|||
44479107|NCT00346164|79485966|FG001|Overall Study|Inability to start week 16 tx on time|0|||
44479108|NCT00346164|79485967|FG002|Overall Study|Inability to start week 16 tx on time|0|||
44479109|NCT00346164|79485968|FG003|Overall Study|Inability to start week 16 tx on time|11|||
44479110|NCT00114244|79485996|FG000|Overall Study|Adverse Event|2|||
44479111|NCT00114244|79485997|FG001|Overall Study|Adverse Event|5|||
44479112|NCT00114244|79485996|FG000|Overall Study|Withdrawal by Subject|0|||
44479113|NCT00114244|79485997|FG001|Overall Study|Withdrawal by Subject|2|||
44479114|NCT00138658|79486003|FG000|Overall Study|Adverse Event|23|||
44479115|NCT00138658|79486003|FG000|Overall Study|Death|1|||
44479116|NCT00138658|79486003|FG000|Overall Study|Disease Progression|21|||
44479117|NCT00138658|79486003|FG000|Overall Study|Physician Decision|11|||
44479118|NCT00138658|79486003|FG000|Overall Study|Withdrawal by Subject|5|||
44479119|NCT00337662|79486012|FG000|Study Period II|Lost to Follow-up|0|||
44479120|NCT00337662|79486013|FG001|Study Period II|Lost to Follow-up|0|||
44479121|NCT00337662|79486014|FG002|Study Period II|Lost to Follow-up|0|||
44479122|NCT00337662|79486015|FG003|Study Period II|Lost to Follow-up|35|||
44479123|NCT00337662|79486012|FG000|Study Period II|Withdrawal by Subject|0|||
44479124|NCT00337662|79486013|FG001|Study Period II|Withdrawal by Subject|0|||
44479125|NCT00337662|79486014|FG002|Study Period II|Withdrawal by Subject|0|||
44479126|NCT00337662|79486015|FG003|Study Period II|Withdrawal by Subject|20|||
44479127|NCT00337662|79486012|FG000|Study Period II|Adverse Event|0|||
44479128|NCT00337662|79486013|FG001|Study Period II|Adverse Event|0|||
44479129|NCT00337662|79486014|FG002|Study Period II|Adverse Event|0|||
44479130|NCT00337662|79486015|FG003|Study Period II|Adverse Event|16|||
44479131|NCT00337662|79486012|FG000|Study Period II|Physician Decision|0|||
44479132|NCT00337662|79486013|FG001|Study Period II|Physician Decision|0|||
44479133|NCT00337662|79486014|FG002|Study Period II|Physician Decision|0|||
44479134|NCT00337662|79486015|FG003|Study Period II|Physician Decision|13|||
44479135|NCT00337662|79486012|FG000|Study Period II|Entry Criteria Not Met|0|||
44479136|NCT00337662|79486013|FG001|Study Period II|Entry Criteria Not Met|0|||
44479137|NCT00337662|79486014|FG002|Study Period II|Entry Criteria Not Met|0|||
44479138|NCT00337662|79486015|FG003|Study Period II|Entry Criteria Not Met|6|||
44479139|NCT00337662|79486012|FG000|Study Period II|Protocol Violation|0|||
44479140|NCT00337662|79486013|FG001|Study Period II|Protocol Violation|0|||
44479141|NCT00337662|79486014|FG002|Study Period II|Protocol Violation|0|||
44479142|NCT00337662|79486015|FG003|Study Period II|Protocol Violation|6|||
44479143|NCT00337662|79486012|FG000|Study Period II|Lack of Efficacy|0|||
44479144|NCT00337662|79486013|FG001|Study Period II|Lack of Efficacy|0|||
44479145|NCT00337662|79486014|FG002|Study Period II|Lack of Efficacy|0|||
44479146|NCT00337662|79486015|FG003|Study Period II|Lack of Efficacy|7|||
44479147|NCT00337662|79486012|FG000|Study Period II|Sponsor Decision|0|||
44479148|NCT00337662|79486013|FG001|Study Period II|Sponsor Decision|0|||
44479149|NCT00337662|79486014|FG002|Study Period II|Sponsor Decision|0|||
44479150|NCT00337662|79486015|FG003|Study Period II|Sponsor Decision|2|||
44479151|NCT00337662|79486012|FG000|Study Period II|Parent/Caregiver Decision|0|||
44479152|NCT00337662|79486013|FG001|Study Period II|Parent/Caregiver Decision|0|||
44479153|NCT00337662|79486014|FG002|Study Period II|Parent/Caregiver Decision|0|||
44479154|NCT00337662|79486015|FG003|Study Period II|Parent/Caregiver Decision|1|||
44479155|NCT00337662|79486012|FG000|Study Period III|Lost to Follow-up|14|||
44479156|NCT00337662|79486013|FG001|Study Period III|Lost to Follow-up|16|||
44479157|NCT00337662|79486014|FG002|Study Period III|Lost to Follow-up|14|||
44479158|NCT00337662|79486015|FG003|Study Period III|Lost to Follow-up|0|||
44479159|NCT00337662|79486012|FG000|Study Period III|Withdrawal by Subject|18|||
44479160|NCT00337662|79486013|FG001|Study Period III|Withdrawal by Subject|14|||
44479161|NCT00337662|79486014|FG002|Study Period III|Withdrawal by Subject|12|||
44479162|NCT00337662|79486015|FG003|Study Period III|Withdrawal by Subject|0|||
44479163|NCT00337662|79486012|FG000|Study Period III|Adverse Event|9|||
44479164|NCT00337662|79486013|FG001|Study Period III|Adverse Event|10|||
44544670|NCT00245960|79558243|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
44479165|NCT00337662|79486014|FG002|Study Period III|Adverse Event|8|||
44479166|NCT00337662|79486015|FG003|Study Period III|Adverse Event|0|||
44479167|NCT00337662|79486012|FG000|Study Period III|Protocol Violation|3|||
44479168|NCT00337662|79486013|FG001|Study Period III|Protocol Violation|8|||
44544671|NCT00245960|79558242|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
44226859|NCT01746901|79033519|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226860|NCT01746901|79033520|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226861|NCT01746901|79033521|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226862|NCT01746901|79033522|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226863|NCT01746901|79033523|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226864|NCT01746901|79033524|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226865|NCT01746901|79033525|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
44479169|NCT00337662|79486014|FG002|Study Period III|Protocol Violation|2|||
44479170|NCT00337662|79486015|FG003|Study Period III|Protocol Violation|0|||
44479171|NCT00337662|79486012|FG000|Study Period III|Physician Decision|6|||
44479172|NCT00337662|79486013|FG001|Study Period III|Physician Decision|5|||
44479173|NCT00337662|79486014|FG002|Study Period III|Physician Decision|0|||
44479174|NCT00337662|79486015|FG003|Study Period III|Physician Decision|0|||
44479175|NCT00337662|79486012|FG000|Study Period III|Entry Criteria Not Met|4|||
44479176|NCT00337662|79486013|FG001|Study Period III|Entry Criteria Not Met|1|||
44479177|NCT00337662|79486014|FG002|Study Period III|Entry Criteria Not Met|3|||
44479178|NCT00337662|79486015|FG003|Study Period III|Entry Criteria Not Met|0|||
44479179|NCT00337662|79486012|FG000|Study Period III|Lack of Efficacy|4|||
44479180|NCT00337662|79486013|FG001|Study Period III|Lack of Efficacy|4|||
44479181|NCT00337662|79486014|FG002|Study Period III|Lack of Efficacy|2|||
44479182|NCT00337662|79486015|FG003|Study Period III|Lack of Efficacy|0|||
44479183|NCT00337662|79486012|FG000|Study Period III|Parent/Caregiver Decision|0|||
44479184|NCT00337662|79486013|FG001|Study Period III|Parent/Caregiver Decision|0|||
44479185|NCT00337662|79486014|FG002|Study Period III|Parent/Caregiver Decision|2|||
44479186|NCT00337662|79486015|FG003|Study Period III|Parent/Caregiver Decision|0|||
44479187|NCT00337662|79486012|FG000|Study Period III|Sponsor Decision|1|||
44479188|NCT00337662|79486013|FG001|Study Period III|Sponsor Decision|0|||
44479189|NCT00337662|79486014|FG002|Study Period III|Sponsor Decision|1|||
44479190|NCT00337662|79486015|FG003|Study Period III|Sponsor Decision|0|||
44479191|NCT00337662|79486012|FG000|Study Period III|Clinical Relapse|1|||
44479192|NCT00337662|79486013|FG001|Study Period III|Clinical Relapse|0|||
44479193|NCT00337662|79486014|FG002|Study Period III|Clinical Relapse|0|||
44479194|NCT00337662|79486015|FG003|Study Period III|Clinical Relapse|0|||
44479195|NCT00138424|79486030|FG000|Overall Study|Physician Decision|0|||
44479196|NCT00138424|79486031|FG001|Overall Study|Physician Decision|1|||
44479197|NCT00138424|79486032|FG002|Overall Study|Physician Decision|0|||
44479198|NCT00138424|79486033|FG003|Overall Study|Physician Decision|0|||
44479199|NCT00368966|79486047|FG000|Infant Series|Withdrawal by Subject|11|||
44479200|NCT00368966|79486048|FG001|Infant Series|Withdrawal by Subject|6|||
44479201|NCT00368966|79486047|FG000|Infant Series|Protocol Violation|2|||
44479202|NCT00368966|79486048|FG001|Infant Series|Protocol Violation|1|||
44479203|NCT00368966|79486047|FG000|Infant Series|Lost to Follow-up|2|||
44479204|NCT00368966|79486048|FG001|Infant Series|Lost to Follow-up|0|||
44479205|NCT00368966|79486047|FG000|Infant Series|Randomization error|0|||
44479206|NCT00368966|79486048|FG001|Infant Series|Randomization error|1|||
44479207|NCT00368966|79486047|FG000|Infant Series|Failed to meet eligibility criteria|0|||
44479208|NCT00368966|79486048|FG001|Infant Series|Failed to meet eligibility criteria|1|||
44479209|NCT00368966|79486047|FG000|Infant Series|Adverse Event|0|||
44479210|NCT00368966|79486048|FG001|Infant Series|Adverse Event|1|||
44479211|NCT00368966|79486047|FG000|Infant Series|Failed to return|1|||
44479212|NCT00368966|79486048|FG001|Infant Series|Failed to return|0|||
44479213|NCT00368966|79486047|FG000|After Infant|Failed to return|3|||
44479214|NCT00368966|79486048|FG001|After Infant|Failed to return|1|||
44479215|NCT00368966|79486047|FG000|After Infant|Adverse Event|1|||
44479216|NCT00368966|79486048|FG001|After Infant|Adverse Event|2|||
44479217|NCT00368966|79486047|FG000|After Infant|Withdrawal by Subject|1|||
44479218|NCT00368966|79486048|FG001|After Infant|Withdrawal by Subject|1|||
44479219|NCT00368966|79486047|FG000|After Infant|Death|1|||
44479220|NCT00368966|79486048|FG001|After Infant|Death|0|||
44479221|NCT00368966|79486047|FG000|After Infant|Lost to Follow-up|0|||
44479222|NCT00368966|79486048|FG001|After Infant|Lost to Follow-up|1|||
44479223|NCT00368966|79486047|FG000|Toddler Dose|Withdrawal by Subject|1|||
44479224|NCT00368966|79486048|FG001|Toddler Dose|Withdrawal by Subject|1|||
44479225|NCT00368966|79486047|FG000|Toddler Dose|Lost to Follow-up|0|||
44479226|NCT00368966|79486048|FG001|Toddler Dose|Lost to Follow-up|2|||
44479227|NCT00114166|79486081|FG000|Overall Study|Wrong primary|0|||
44479228|NCT00114166|79486082|FG001|Overall Study|Wrong primary|1|||
44479229|NCT00125242|79486092|FG000|Overall Study|did not qualify|7|||
44479230|NCT00125242|79486093|FG001|Overall Study|did not qualify|2|||
44479231|NCT00337428|79486100|FG000|Overall Study|Withdrawal by Subject|1|||
44479232|NCT00337428|79486101|FG001|Overall Study|Withdrawal by Subject|2|||
44479233|NCT00337428|79486100|FG000|Overall Study|Lack of Time|1|||
44479234|NCT00337428|79486101|FG001|Overall Study|Lack of Time|1|||
44479235|NCT00337428|79486100|FG000|Overall Study|Unwilling to Continue|1|||
44479236|NCT00337428|79486101|FG001|Overall Study|Unwilling to Continue|0|||
44479237|NCT00337428|79486100|FG000|Overall Study|Anorexia|1|||
44479238|NCT00337428|79486101|FG001|Overall Study|Anorexia|0|||
44479239|NCT00235989|79486111|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
44479240|NCT00235989|79486112|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
44479241|NCT00235989|79486113|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
44479242|NCT00235989|79486114|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
44479243|NCT00235989|79486115|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
44544672|NCT00245960|79558243|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
44479244|NCT00235989|79486116|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
44479245|NCT00235989|79486111|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
44479246|NCT00235989|79486112|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
44479247|NCT00235989|79486113|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
44479248|NCT00235989|79486114|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
44479249|NCT00235989|79486115|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
44479250|NCT00235989|79486116|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
44479251|NCT00235989|79486111|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
44479252|NCT00235989|79486112|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
44479253|NCT00235989|79486113|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
44479254|NCT00235989|79486114|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
44479255|NCT00235989|79486115|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
44479256|NCT00235989|79486116|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
44479257|NCT00235989|79486111|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
44479258|NCT00235989|79486112|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
44479259|NCT00235989|79486113|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
44479260|NCT00235989|79486114|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
44479261|NCT00235989|79486115|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
44479262|NCT00235989|79486116|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
44479263|NCT00235989|79486111|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
44479264|NCT00235989|79486112|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
44479265|NCT00235989|79486113|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
44479266|NCT00235989|79486114|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
44479267|NCT00235989|79486115|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
44479268|NCT00235989|79486116|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
44479269|NCT00113386|79486128|FG000|Overall Study|Withdrawal by Subject|1|||
44479270|NCT00113386|79486129|FG001|Overall Study|Withdrawal by Subject|0|||
44479271|NCT00113386|79486128|FG000|Overall Study|Physician Decision|0|||
44479272|NCT00113386|79486129|FG001|Overall Study|Physician Decision|1|||
44479273|NCT00113386|79486128|FG000|Overall Study|Toxicity|3|||
44479274|NCT00113386|79486129|FG001|Overall Study|Toxicity|0|||
44479275|NCT00113386|79486128|FG000|Overall Study|Ineligible|1|||
44479276|NCT00113386|79486129|FG001|Overall Study|Ineligible|2|||
44479277|NCT00113386|79486128|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
44479278|NCT00113386|79486129|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
44479279|NCT00353262|79486135|FG000|Overall Study|Adverse Event|8|||
44479280|NCT00353262|79486135|FG000|Overall Study|Withdrawal by Subject|2|||
44479281|NCT00353262|79486135|FG000|Overall Study|Insufficient Therapeutic Response|13|||
44479282|NCT00353262|79486135|FG000|Overall Study|Progression|1|||
44479283|NCT00353262|79486135|FG000|Overall Study|Surgery|4|||
44479284|NCT00353262|79486135|FG000|Overall Study|Break from Chemotherapy|1|||
44479285|NCT00337272|79486141|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
44479286|NCT00337272|79486142|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
44479287|NCT00337272|79486141|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
44479288|NCT00337272|79486142|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
44479289|NCT00337272|79486141|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
44479290|NCT00337272|79486142|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
44479291|NCT00337272|79486141|FG000|Treatment Period|Non-compliance|1|||
44479292|NCT00337272|79486142|FG001|Treatment Period|Non-compliance|1|||
44479293|NCT00337272|79486141|FG000|Treatment Period|Withdrawal by Subject|0|||
44479294|NCT00337272|79486142|FG001|Treatment Period|Withdrawal by Subject|1|||
44479295|NCT00337272|79486141|FG000|Withdrawal Period|Non-compliance|0|||
44479296|NCT00337272|79486142|FG001|Withdrawal Period|Non-compliance|1|||
44479297|NCT00125164|79486152|FG000|Overall Study|Adverse Event|0|||
44479298|NCT00125164|79486153|FG001|Overall Study|Adverse Event|0|||
44479299|NCT00125164|79486154|FG002|Overall Study|Adverse Event|2|||
44479300|NCT00125164|79486155|FG003|Overall Study|Adverse Event|4|||
44479301|NCT00125164|79486152|FG000|Overall Study|Lost to Follow-up|0|||
44479302|NCT00125164|79486153|FG001|Overall Study|Lost to Follow-up|0|||
44479303|NCT00125164|79486154|FG002|Overall Study|Lost to Follow-up|1|||
44479304|NCT00125164|79486155|FG003|Overall Study|Lost to Follow-up|1|||
44479305|NCT00125164|79486152|FG000|Overall Study|Withdrawal by Subject|2|||
44479306|NCT00125164|79486153|FG001|Overall Study|Withdrawal by Subject|0|||
44479307|NCT00125164|79486154|FG002|Overall Study|Withdrawal by Subject|1|||
44479308|NCT00125164|79486155|FG003|Overall Study|Withdrawal by Subject|1|||
44479309|NCT00136318|79486167|FG000|Overall Study|Adverse Event|5|||
44479310|NCT00136318|79486168|FG001|Overall Study|Adverse Event|5|||
44479311|NCT00136318|79486167|FG000|Overall Study|Withdrawal by Subject|2|||
44479312|NCT00136318|79486168|FG001|Overall Study|Withdrawal by Subject|2|||
44479313|NCT00136084|79486177|FG000|Overall Study|Death|12|||
44479314|NCT00136084|79486178|FG001|Overall Study|Death|5|||
44479315|NCT00136084|79486177|FG000|Overall Study|Unacceptable toxicity|8|||
44479316|NCT00136084|79486178|FG001|Overall Study|Unacceptable toxicity|11|||
44479317|NCT00136084|79486177|FG000|Overall Study|Relapse|20|||
44479318|NCT00136084|79486178|FG001|Overall Study|Relapse|23|||
44479319|NCT00136084|79486177|FG000|Overall Study|Lost to Follow-up|2|||
44479320|NCT00136084|79486178|FG001|Overall Study|Lost to Follow-up|0|||
44479321|NCT00136084|79486177|FG000|Overall Study|No Response|1|||
44479322|NCT00136084|79486178|FG001|Overall Study|No Response|2|||
44479323|NCT00136084|79486177|FG000|Overall Study|Withdrawal by Subject|5|||
44479324|NCT00136084|79486178|FG001|Overall Study|Withdrawal by Subject|1|||
44479325|NCT00364832|79486199|FG000|Core Period|Early Withdrawals|2|||
44479326|NCT00364832|79486200|FG001|Core Period|Early Withdrawals|2|||
44479327|NCT00364832|79486201|FG002|Core Period|Early Withdrawals|1|||
44479328|NCT00364832|79486202|FG003|Core Period|Early Withdrawals|1|||
44479329|NCT00364832|79486203|FG004|Core Period|Early Withdrawals|0|||
44479330|NCT00364832|79486204|FG005|Core Period|Early Withdrawals|0|||
44479331|NCT00364832|79486205|FG006|Core Period|Early Withdrawals|4|||
44479332|NCT00364832|79486206|FG007|Core Period|Early Withdrawals|1|||
44479333|NCT00364832|79486207|FG008|Core Period|Early Withdrawals|0|||
44479334|NCT00364832|79486208|FG009|Core Period|Early Withdrawals|0|||
44479335|NCT00364832|79486209|FG010|Core Period|Early Withdrawals|0|||
44479336|NCT00364832|79486210|FG011|Core Period|Early Withdrawals|0|||
44479337|NCT00364832|79486199|FG000|Extension Year 1|Early Withdrawals|0|||
44479338|NCT00364832|79486200|FG001|Extension Year 1|Early Withdrawals|0|||
44479339|NCT00364832|79486201|FG002|Extension Year 1|Early Withdrawals|0|||
44479340|NCT00364832|79486202|FG003|Extension Year 1|Early Withdrawals|0|||
44479341|NCT00364832|79486203|FG004|Extension Year 1|Early Withdrawals|0|||
44479342|NCT00364832|79486204|FG005|Extension Year 1|Early Withdrawals|0|||
44479343|NCT00364832|79486205|FG006|Extension Year 1|Early Withdrawals|0|||
44479344|NCT00364832|79486206|FG007|Extension Year 1|Early Withdrawals|0|||
44479345|NCT00364832|79486207|FG008|Extension Year 1|Early Withdrawals|0|||
44479346|NCT00364832|79486208|FG009|Extension Year 1|Early Withdrawals|4|||
44479347|NCT00364832|79486209|FG010|Extension Year 1|Early Withdrawals|2|||
44479348|NCT00364832|79486210|FG011|Extension Year 1|Early Withdrawals|10|||
44479349|NCT00364832|79486199|FG000|Extension Year 2|Early Withdrawals|0|||
44479350|NCT00364832|79486200|FG001|Extension Year 2|Early Withdrawals|0|||
44479351|NCT00364832|79486201|FG002|Extension Year 2|Early Withdrawals|0|||
44479352|NCT00364832|79486202|FG003|Extension Year 2|Early Withdrawals|0|||
44479353|NCT00364832|79486203|FG004|Extension Year 2|Early Withdrawals|0|||
44479354|NCT00364832|79486204|FG005|Extension Year 2|Early Withdrawals|0|||
44479355|NCT00364832|79486205|FG006|Extension Year 2|Early Withdrawals|0|||
44479356|NCT00364832|79486206|FG007|Extension Year 2|Early Withdrawals|0|||
44479357|NCT00364832|79486207|FG008|Extension Year 2|Early Withdrawals|0|||
44479358|NCT00364832|79486208|FG009|Extension Year 2|Early Withdrawals|5|||
44479359|NCT00364832|79486209|FG010|Extension Year 2|Early Withdrawals|5|||
44479360|NCT00364832|79486210|FG011|Extension Year 2|Early Withdrawals|3|||
44479361|NCT00235755|79486230|FG000|4-Week Titration Phase|Adverse Event|6|||
44479362|NCT00235755|79486231|FG001|4-Week Titration Phase|Adverse Event|14|||
44479363|NCT00235755|79486232|FG002|4-Week Titration Phase|Adverse Event|20|||
44479364|NCT00235755|79486230|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
44479365|NCT00235755|79486231|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
44479366|NCT00235755|79486232|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
44479367|NCT00235755|79486230|FG000|4-Week Titration Phase|Protocol Violation|2|||
44479368|NCT00235755|79486231|FG001|4-Week Titration Phase|Protocol Violation|2|||
44479369|NCT00235755|79486232|FG002|4-Week Titration Phase|Protocol Violation|1|||
44479370|NCT00235755|79486230|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
44479371|NCT00235755|79486231|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
44479372|NCT00235755|79486232|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
44479373|NCT00235755|79486230|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
44479374|NCT00235755|79486231|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
44479375|NCT00235755|79486232|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
44479376|NCT00235755|79486230|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
44479377|NCT00235755|79486231|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
44479378|NCT00235755|79486232|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
44143808|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Death|0|||
44479379|NCT00235755|79486230|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
44479380|NCT00235755|79486231|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
44479381|NCT00235755|79486232|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
44479382|NCT00235755|79486230|FG000|12-Week Maintenance Phase|Adverse Event|8|||
44479383|NCT00235755|79486231|FG001|12-Week Maintenance Phase|Adverse Event|12|||
44479384|NCT00235755|79486232|FG002|12-Week Maintenance Phase|Adverse Event|26|||
44479385|NCT00235755|79486230|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
44479386|NCT00235755|79486231|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
44479387|NCT00235755|79486232|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
44479388|NCT00235755|79486230|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
44479389|NCT00235755|79486231|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
44479390|NCT00235755|79486232|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
44479391|NCT00235755|79486230|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
44479392|NCT00235755|79486231|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
44479393|NCT00235755|79486232|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
44479394|NCT00235755|79486230|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
44479395|NCT00235755|79486231|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
44479396|NCT00235755|79486232|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
44479397|NCT00235755|79486230|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
44479398|NCT00235755|79486231|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
44479399|NCT00235755|79486232|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
44479400|NCT00337194|79486257|FG000|Overall Study|Adverse Event|5|||
44479401|NCT00337194|79486258|FG001|Overall Study|Adverse Event|1|||
44479402|NCT00337194|79486257|FG000|Overall Study|Death|2|||
44479403|NCT00337194|79486258|FG001|Overall Study|Death|0|||
44479404|NCT00337194|79486257|FG000|Overall Study|Withdrawal by Subject|1|||
44479405|NCT00337194|79486258|FG001|Overall Study|Withdrawal by Subject|0|||
44479406|NCT00337194|79486257|FG000|Overall Study|Disease progression|1|||
44479407|NCT00337194|79486258|FG001|Overall Study|Disease progression|2|||
44479408|NCT00337194|79486257|FG000|Overall Study|Subsequent non-protocol therapy|3|||
44479409|NCT00337194|79486258|FG001|Overall Study|Subsequent non-protocol therapy|1|||
44479410|NCT03826914|79486268|FG000|Overall Study|Withdrawal by Subject|1|||
44479411|NCT03826914|79486269|FG001|Overall Study|Withdrawal by Subject|1|||
44479412|NCT00385736|79486280|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
44479413|NCT00385736|79486281|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
44479414|NCT00385736|79486282|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
44479415|NCT00385736|79486280|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
44479416|NCT00385736|79486281|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
44479417|NCT00385736|79486282|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
44479418|NCT00385736|79486280|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
44479419|NCT00385736|79486281|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
44479420|NCT00385736|79486282|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
44479421|NCT00385736|79486280|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
44479422|NCT00385736|79486281|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
44479423|NCT00385736|79486282|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
44479424|NCT00385736|79486280|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
44479425|NCT00385736|79486281|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
44479426|NCT00385736|79486282|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
44479427|NCT00385736|79486280|FG000|Efficacy Analysis Set - Induction|Other|0|||
44479428|NCT00385736|79486281|FG001|Efficacy Analysis Set - Induction|Other|0|||
44479429|NCT00385736|79486282|FG002|Efficacy Analysis Set - Induction|Other|1|||
44479430|NCT00385736|79486280|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
44479431|NCT00385736|79486281|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
44479432|NCT00385736|79486282|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
44479433|NCT00385736|79486280|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
44479434|NCT00385736|79486281|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
44479435|NCT00385736|79486282|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
44479436|NCT00385736|79486280|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
44479437|NCT00385736|79486281|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
44479438|NCT00385736|79486282|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
44479439|NCT00385736|79486280|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
44479440|NCT00385736|79486281|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
44479441|NCT00385736|79486282|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
44479442|NCT00385736|79486280|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
44479443|NCT00385736|79486281|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
44479444|NCT00385736|79486282|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
44479445|NCT00385736|79486280|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
44479446|NCT00385736|79486281|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
44479447|NCT00385736|79486282|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
44375586|NCT00943722|79380713|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
44479448|NCT00385736|79486280|FG000|Safety Analysis Set|Adverse Event|23|||
44479449|NCT00385736|79486281|FG001|Safety Analysis Set|Adverse Event|15|||
44479450|NCT00385736|79486282|FG002|Safety Analysis Set|Adverse Event|23|||
44479451|NCT00385736|79486280|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
44479452|NCT00385736|79486281|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
44479453|NCT00385736|79486282|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
44479454|NCT00385736|79486280|FG000|Safety Analysis Set|Lost to Follow-up|0|||
44479455|NCT00385736|79486281|FG001|Safety Analysis Set|Lost to Follow-up|2|||
44479456|NCT00385736|79486282|FG002|Safety Analysis Set|Lost to Follow-up|2|||
44479457|NCT00385736|79486280|FG000|Safety Analysis Set|Lack of Efficacy|38|||
44479458|NCT00385736|79486281|FG001|Safety Analysis Set|Lack of Efficacy|16|||
44479459|NCT00385736|79486282|FG002|Safety Analysis Set|Lack of Efficacy|31|||
44479460|NCT00385736|79486280|FG000|Safety Analysis Set|Protocol Violation|2|||
44479461|NCT00385736|79486281|FG001|Safety Analysis Set|Protocol Violation|1|||
44479462|NCT00385736|79486282|FG002|Safety Analysis Set|Protocol Violation|6|||
44479463|NCT00385736|79486280|FG000|Safety Analysis Set|Other|1|||
44479464|NCT00385736|79486281|FG001|Safety Analysis Set|Other|4|||
44479465|NCT00385736|79486282|FG002|Safety Analysis Set|Other|4|||
44479466|NCT00195819|79486293|FG000|Double-Blind|Withdrawal by Subject|1|||
44479467|NCT00195819|79486294|FG001|Double-Blind|Withdrawal by Subject|0|||
44479468|NCT00195819|79486293|FG000|Double-Blind|Moved|1|||
44479469|NCT00195819|79486294|FG001|Double-Blind|Moved|0|||
44479470|NCT00195819|79486293|FG000|Open-label|Adverse Event|0|||
44479471|NCT00195819|79486294|FG001|Open-label|Adverse Event|9|||
44479472|NCT00195819|79486293|FG000|Open-label|Lack of Efficacy|0|||
44479473|NCT00195819|79486294|FG001|Open-label|Lack of Efficacy|2|||
44479474|NCT00195819|79486293|FG000|Open-label|Pregnancy|0|||
44479475|NCT00195819|79486294|FG001|Open-label|Pregnancy|1|||
44479476|NCT00195819|79486293|FG000|Open-label|Protocol Violation|0|||
44479477|NCT00195819|79486294|FG001|Open-label|Protocol Violation|2|||
44479478|NCT00195819|79486293|FG000|Open-label|Moved|0|||
44479479|NCT00195819|79486294|FG001|Open-label|Moved|1|||
44479480|NCT00195819|79486293|FG000|Open-label|Withdrawal by Subject|0|||
44479481|NCT00195819|79486294|FG001|Open-label|Withdrawal by Subject|5|||
44479482|NCT00527735|79486309|FG000|Overall Study|Disease progression|47|||
44479483|NCT00527735|79486310|FG001|Overall Study|Disease progression|61|||
44479484|NCT00527735|79486311|FG002|Overall Study|Disease progression|53|||
44479485|NCT00527735|79486309|FG000|Overall Study|Death|23|||
44479486|NCT00527735|79486310|FG001|Overall Study|Death|13|||
44479487|NCT00527735|79486311|FG002|Overall Study|Death|15|||
44479488|NCT00527735|79486309|FG000|Overall Study|Completed treatment in treatment phase|14|||
44479489|NCT00527735|79486310|FG001|Overall Study|Completed treatment in treatment phase|13|||
44479490|NCT00527735|79486311|FG002|Overall Study|Completed treatment in treatment phase|18|||
44479491|NCT00527735|79486309|FG000|Overall Study|Adverse Event|10|||
44479492|NCT00527735|79486310|FG001|Overall Study|Adverse Event|6|||
44479493|NCT00527735|79486311|FG002|Overall Study|Adverse Event|7|||
44479494|NCT00527735|79486309|FG000|Overall Study|Not identified|5|||
44479495|NCT00527735|79486310|FG001|Overall Study|Not identified|5|||
44479496|NCT00527735|79486311|FG002|Overall Study|Not identified|5|||
44479497|NCT00527735|79486309|FG000|Overall Study|Withdrawal by Subject|5|||
44479498|NCT00527735|79486310|FG001|Overall Study|Withdrawal by Subject|4|||
44479499|NCT00527735|79486311|FG002|Overall Study|Withdrawal by Subject|3|||
44479500|NCT00527735|79486309|FG000|Overall Study|No longer met study criteria|2|||
44479501|NCT00527735|79486310|FG001|Overall Study|No longer met study criteria|2|||
44479502|NCT00527735|79486311|FG002|Overall Study|No longer met study criteria|1|||
44479503|NCT00527735|79486309|FG000|Overall Study|Lost to Follow-up|0|||
44479504|NCT00527735|79486310|FG001|Overall Study|Lost to Follow-up|0|||
44479505|NCT00527735|79486311|FG002|Overall Study|Lost to Follow-up|3|||
44479506|NCT00527735|79486309|FG000|Overall Study|Poor compliance or noncompliance|0|||
44479507|NCT00527735|79486310|FG001|Overall Study|Poor compliance or noncompliance|1|||
44479508|NCT00527735|79486311|FG002|Overall Study|Poor compliance or noncompliance|1|||
44479509|NCT00527735|79486309|FG000|Overall Study|Completed treatment during maintenance|2|||
44479510|NCT00527735|79486310|FG001|Overall Study|Completed treatment during maintenance|2|||
44479511|NCT00527735|79486311|FG002|Overall Study|Completed treatment during maintenance|1|||
44479512|NCT00336492|79486334|FG000|Overall Study|Adverse Event|4|||
44479513|NCT00336492|79486335|FG001|Overall Study|Adverse Event|3|||
44479514|NCT00336492|79486336|FG002|Overall Study|Adverse Event|6|||
44479515|NCT00336492|79486334|FG000|Overall Study|Lack of Efficacy|6|||
44479516|NCT00336492|79486335|FG001|Overall Study|Lack of Efficacy|1|||
44479517|NCT00336492|79486336|FG002|Overall Study|Lack of Efficacy|4|||
44479518|NCT00336492|79486334|FG000|Overall Study|Other|5|||
44479519|NCT00336492|79486335|FG001|Overall Study|Other|0|||
44479520|NCT00336492|79486336|FG002|Overall Study|Other|1|||
44479521|NCT00194025|79486344|FG000|Overall Study|Adverse Event|1|||
44479522|NCT00194025|79486344|FG000|Overall Study|non-adherence with study medication|4|||
44479523|NCT00368108|79486351|FG000|Overall Study|Adverse Event|38|||
44479524|NCT00368108|79486352|FG001|Overall Study|Adverse Event|26|||
44479525|NCT00368108|79486353|FG002|Overall Study|Adverse Event|44|||
44479526|NCT00368108|79486351|FG000|Overall Study|Abnormal Laboratory Value|0|||
44479527|NCT00368108|79486352|FG001|Overall Study|Abnormal Laboratory Value|0|||
44479528|NCT00368108|79486353|FG002|Overall Study|Abnormal Laboratory Value|3|||
44479529|NCT00368108|79486351|FG000|Overall Study|Protocol Violation|5|||
44479530|NCT00368108|79486352|FG001|Overall Study|Protocol Violation|9|||
44479531|NCT00368108|79486353|FG002|Overall Study|Protocol Violation|9|||
44479532|NCT00368108|79486351|FG000|Overall Study|Withdrawal by Subject|9|||
44479533|NCT00368108|79486352|FG001|Overall Study|Withdrawal by Subject|3|||
44479534|NCT00368108|79486353|FG002|Overall Study|Withdrawal by Subject|5|||
44479535|NCT00368108|79486351|FG000|Overall Study|Lack of Efficacy|7|||
44479536|NCT00368108|79486352|FG001|Overall Study|Lack of Efficacy|8|||
44479537|NCT00368108|79486353|FG002|Overall Study|Lack of Efficacy|5|||
44479538|NCT00368108|79486351|FG000|Overall Study|Physician Decision|2|||
44479539|NCT00368108|79486352|FG001|Overall Study|Physician Decision|0|||
44479540|NCT00368108|79486353|FG002|Overall Study|Physician Decision|1|||
44479541|NCT00368108|79486351|FG000|Overall Study|Other|3|||
44479542|NCT00368108|79486352|FG001|Overall Study|Other|7|||
44479543|NCT00368108|79486353|FG002|Overall Study|Other|1|||
44479544|NCT00364130|79486363|FG000|Intervention Period|Lost to Follow-up|4|||
44479545|NCT00364130|79486364|FG001|Intervention Period|Lost to Follow-up|3|||
44479546|NCT00364130|79486363|FG000|Intervention Period|Pregnancy|1|||
44479547|NCT00364130|79486364|FG001|Intervention Period|Pregnancy|0|||
44479548|NCT00364130|79486363|FG000|Intervention Period|Withdrawal by Subject|4|||
44479549|NCT00364130|79486364|FG001|Intervention Period|Withdrawal by Subject|5|||
44479550|NCT00364130|79486363|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
44479551|NCT00364130|79486364|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
44479552|NCT00521339|79486372|FG000|Treatment Phase|Adverse Event|2|||
44479553|NCT00521339|79486373|FG001|Treatment Phase|Adverse Event|0|||
44479554|NCT00521339|79486374|FG002|Treatment Phase|Adverse Event|0|||
44479555|NCT00521339|79486372|FG000|Treatment Phase|Intolerability to study drug|2|||
44479556|NCT00521339|79486373|FG001|Treatment Phase|Intolerability to study drug|0|||
44479557|NCT00521339|79486374|FG002|Treatment Phase|Intolerability to study drug|0|||
44479558|NCT00521339|79486372|FG000|Treatment Phase|Lack of Efficacy|3|||
44479559|NCT00521339|79486373|FG001|Treatment Phase|Lack of Efficacy|0|||
44479560|NCT00521339|79486374|FG002|Treatment Phase|Lack of Efficacy|0|||
44479561|NCT00521339|79486372|FG000|Treatment Phase|Withdrawal by Subject|3|||
44479562|NCT00521339|79486373|FG001|Treatment Phase|Withdrawal by Subject|0|||
44479563|NCT00521339|79486374|FG002|Treatment Phase|Withdrawal by Subject|0|||
44479564|NCT00521339|79486372|FG000|Treatment Phase|Lost to Follow-up|1|||
44479565|NCT00521339|79486373|FG001|Treatment Phase|Lost to Follow-up|0|||
44479566|NCT00521339|79486374|FG002|Treatment Phase|Lost to Follow-up|0|||
44479567|NCT00521339|79486372|FG000|Treatment Phase|Protocol Violation|1|||
44479568|NCT00521339|79486373|FG001|Treatment Phase|Protocol Violation|0|||
44479569|NCT00521339|79486374|FG002|Treatment Phase|Protocol Violation|0|||
44479570|NCT00521339|79486372|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
44479571|NCT00521339|79486373|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
44479572|NCT00521339|79486374|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
44479573|NCT00521339|79486372|FG000|Treatment Extension Phase|Death|0|||
44479574|NCT00521339|79486373|FG001|Treatment Extension Phase|Death|0|||
44479575|NCT00521339|79486374|FG002|Treatment Extension Phase|Death|1|||
44479576|NCT00363896|79486397|FG000|Overall Study|Withdrawal by Subject|29|||
44479577|NCT00363896|79486398|FG001|Overall Study|Withdrawal by Subject|16|||
44479578|NCT00363896|79486397|FG000|Overall Study|Adverse Event|24|||
44479579|NCT00363896|79486398|FG001|Overall Study|Adverse Event|13|||
44479580|NCT00363896|79486397|FG000|Overall Study|COPD exacerbation|13|||
44479581|NCT00363896|79486398|FG001|Overall Study|COPD exacerbation|7|||
44479582|NCT00363896|79486397|FG000|Overall Study|Lack of Efficacy|12|||
44479583|NCT00363896|79486398|FG001|Overall Study|Lack of Efficacy|8|||
44479584|NCT00363896|79486397|FG000|Overall Study|Protocol Violation|6|||
44479585|NCT00363896|79486398|FG001|Overall Study|Protocol Violation|1|||
44479586|NCT00363896|79486397|FG000|Overall Study|Lost to Follow-up|3|||
44479587|NCT00363896|79486398|FG001|Overall Study|Lost to Follow-up|0|||
44479588|NCT00363896|79486397|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
44479589|NCT00363896|79486398|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
44479590|NCT00363896|79486397|FG000|Overall Study|Other|1|||
44479591|NCT00363896|79486398|FG001|Overall Study|Other|2|||
44479592|NCT00527423|79486407|FG000|Overall Study|Protocol Violation|1|||
44226866|NCT01746901|79033526|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
44226867|NCT01746901|79033518|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
44226868|NCT01746901|79033519|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
44226869|NCT01746901|79033520|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
44226870|NCT01746901|79033521|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
44226871|NCT01746901|79033522|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
44226872|NCT01746901|79033523|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
44226873|NCT01746901|79033524|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
44375587|NCT00943722|79380714|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
44375588|NCT00943722|79380715|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
44479593|NCT00527423|79486407|FG000|Overall Study|Adverse Event|5|||
44375589|NCT00943722|79380716|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
44479594|NCT00527423|79486407|FG000|Overall Study|Physician Decision|4|||
44479595|NCT00527423|79486407|FG000|Overall Study|Withdrawal by Subject|10|||
44479596|NCT00527423|79486407|FG000|Overall Study|Lost to Follow-up|4|||
44479597|NCT00527423|79486407|FG000|Overall Study|OTHER|4|||
44479598|NCT00527423|79486407|FG000|Overall Study|Death|9|||
44226874|NCT01746901|79033525|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
44479599|NCT00527111|79486415|FG000|Overall Study|Adverse Event|14|||
44479600|NCT00527111|79486416|FG001|Overall Study|Adverse Event|13|||
44479601|NCT00527111|79486415|FG000|Overall Study|Death|0|||
44479602|NCT00527111|79486416|FG001|Overall Study|Death|1|||
44479603|NCT00527111|79486415|FG000|Overall Study|Investigator Request|2|||
44479604|NCT00527111|79486416|FG001|Overall Study|Investigator Request|1|||
44479605|NCT00527111|79486415|FG000|Overall Study|Patient Request|2|||
44479606|NCT00527111|79486416|FG001|Overall Study|Patient Request|5|||
44479607|NCT00527111|79486415|FG000|Overall Study|Other|2|||
44479608|NCT00527111|79486416|FG001|Overall Study|Other|2|||
44479609|NCT00384956|79486422|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
44479610|NCT00367640|79486430|FG000|Overall Study|Adverse Event|3|||
44479611|NCT00367640|79486431|FG001|Overall Study|Adverse Event|6|||
44479612|NCT00367640|79486432|FG002|Overall Study|Adverse Event|8|||
44479613|NCT00367640|79486433|FG003|Overall Study|Adverse Event|0|||
44479614|NCT00367640|79486430|FG000|Overall Study|Withdrawal by Subject|8|||
44479615|NCT00367640|79486431|FG001|Overall Study|Withdrawal by Subject|11|||
44479616|NCT00367640|79486432|FG002|Overall Study|Withdrawal by Subject|8|||
44479617|NCT00367640|79486433|FG003|Overall Study|Withdrawal by Subject|6|||
44479618|NCT00367640|79486430|FG000|Overall Study|Any other reason not above-mentioned|7|||
44479619|NCT00367640|79486431|FG001|Overall Study|Any other reason not above-mentioned|5|||
44479620|NCT00367640|79486432|FG002|Overall Study|Any other reason not above-mentioned|3|||
44479621|NCT00367640|79486433|FG003|Overall Study|Any other reason not above-mentioned|4|||
44479622|NCT00367484|79486443|FG000|Overall Study|Adverse Event|7|||
44479623|NCT00367484|79486443|FG000|Overall Study|Withdrew informed consent|5|||
44479624|NCT00367484|79486443|FG000|Overall Study|Travel to USA|1|||
44479625|NCT00367484|79486443|FG000|Overall Study|Lost to Follow-up|1|||
44479626|NCT00367484|79486443|FG000|Overall Study|Protocol Violation|1|||
44479627|NCT00367484|79486443|FG000|Overall Study|The choice of the patient|1|||
44479628|NCT00367484|79486443|FG000|Overall Study|Lack of Efficacy|1|||
44479629|NCT00526799|79486449|FG000|Overall Study|Withdrawal by Subject|1|||
44479630|NCT00526799|79486450|FG001|Overall Study|Withdrawal by Subject|0|||
44226875|NCT01746901|79033526|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
44226876|NCT01746901|79033518|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226877|NCT01746901|79033519|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226878|NCT01746901|79033520|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226879|NCT01746901|79033521|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
44226880|NCT01746901|79033522|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226881|NCT01746901|79033523|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226882|NCT01746901|79033524|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226883|NCT01746901|79033525|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226884|NCT01746901|79033526|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
44226885|NCT01746901|79033518|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226886|NCT01746901|79033519|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226887|NCT01746901|79033520|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226888|NCT01746901|79033521|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226889|NCT01746901|79033522|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226890|NCT01746901|79033523|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
44226891|NCT01746901|79033524|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226892|NCT01746901|79033525|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
44226893|NCT01746901|79033526|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
44226894|NCT01746901|79033518|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226895|NCT01746901|79033519|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226896|NCT01746901|79033520|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226897|NCT01746901|79033521|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226898|NCT01746901|79033522|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226899|NCT01746901|79033523|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226900|NCT01746901|79033524|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
44226901|NCT01746901|79033525|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
44226902|NCT01746901|79033526|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
44226903|NCT01968551|79033565|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
44226904|NCT01968551|79033566|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
44226905|NCT01968551|79033567|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
44226906|NCT01968551|79033565|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
44226907|NCT01968551|79033566|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
44226908|NCT01968551|79033567|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
44479631|NCT00526799|79486449|FG000|Overall Study|Intercurrent Complicating Disease|0|||
44479632|NCT00526799|79486450|FG001|Overall Study|Intercurrent Complicating Disease|1|||
44479633|NCT00526331|79486456|FG000|Overall Study|Sponsor Termination|55|||
44479634|NCT00520481|79486462|FG000|Overall Study|Adverse Event|4|||
44479635|NCT00520481|79486463|FG001|Overall Study|Adverse Event|1|||
44479636|NCT00520481|79486462|FG000|Overall Study|Withdrawal by Subject|3|||
44479637|NCT00520481|79486463|FG001|Overall Study|Withdrawal by Subject|0|||
44544673|NCT00245960|79558242|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
44226909|NCT01968551|79033565|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
44226910|NCT01968551|79033566|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
44226911|NCT01968551|79033567|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
44226912|NCT01968551|79033565|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
44226913|NCT01968551|79033566|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
44226914|NCT01968551|79033567|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
44226915|NCT01968551|79033565|FG000|Extension Phase|Adverse Event|0|||
44226916|NCT01968551|79033566|FG001|Extension Phase|Adverse Event|0|||
44479638|NCT00520403|79486471|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
44479639|NCT00520403|79486471|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
44479640|NCT00520403|79486471|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
44479641|NCT00520403|79486471|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
44479642|NCT00520403|79486471|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
44479643|NCT00520403|79486471|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
44479644|NCT00520403|79486471|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
44479645|NCT00520403|79486471|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
44479646|NCT00520013|79486478|FG000|Overall Study|Withdrawal by Subject|0|||
44479647|NCT00520013|79486479|FG001|Overall Study|Withdrawal by Subject|0|||
44479648|NCT00520013|79486480|FG002|Overall Study|Withdrawal by Subject|1|||
44479649|NCT00520013|79486478|FG000|Overall Study|Adverse Event|2|||
44479650|NCT00520013|79486479|FG001|Overall Study|Adverse Event|10|||
44479651|NCT00520013|79486480|FG002|Overall Study|Adverse Event|7|||
44479652|NCT00520013|79486478|FG000|Overall Study|Progressive Disease|7|||
44479653|NCT00520013|79486479|FG001|Overall Study|Progressive Disease|3|||
44479654|NCT00520013|79486480|FG002|Overall Study|Progressive Disease|0|||
44479655|NCT00520013|79486478|FG000|Overall Study|Clinical Progression|3|||
44479656|NCT00520013|79486479|FG001|Overall Study|Clinical Progression|1|||
44479657|NCT00520013|79486480|FG002|Overall Study|Clinical Progression|0|||
44479658|NCT00520013|79486478|FG000|Overall Study|Death|0|||
44479659|NCT00520013|79486479|FG001|Overall Study|Death|1|||
44479660|NCT00520013|79486480|FG002|Overall Study|Death|0|||
44479661|NCT00520013|79486478|FG000|Overall Study|Physician Decision|0|||
44479662|NCT00520013|79486479|FG001|Overall Study|Physician Decision|0|||
44479663|NCT00520013|79486480|FG002|Overall Study|Physician Decision|3|||
44479664|NCT00519779|79486488|FG000|Overall Study|Withdrawal by Subject|0|||
44479665|NCT00519779|79486489|FG001|Overall Study|Withdrawal by Subject|1|||
44479666|NCT00526097|79486497|FG000|Overall Study|Adverse Event|6|||
44479667|NCT00526097|79486498|FG001|Overall Study|Adverse Event|44|||
44479668|NCT00526097|79486497|FG000|Overall Study|Protocol Violation|4|||
44479669|NCT00526097|79486498|FG001|Overall Study|Protocol Violation|10|||
44479670|NCT00526097|79486497|FG000|Overall Study|Withdrawal by Subject|3|||
44479671|NCT00526097|79486498|FG001|Overall Study|Withdrawal by Subject|1|||
44479672|NCT00526097|79486497|FG000|Overall Study|Other|2|||
44479673|NCT00526097|79486498|FG001|Overall Study|Other|1|||
44479674|NCT00525785|79486504|FG000|Overall Study|Withdrawal by Subject|1|||
44479675|NCT00525785|79486504|FG000|Overall Study|Lack of Efficacy|1|||
44479676|NCT00525785|79486504|FG000|Overall Study|Physician Decision|1|||
44479677|NCT00525161|79486508|FG000|Overall Study|Adverse Event|1|||
44479678|NCT00524771|79486514|FG000|Overall Study|Protocol Violation|220|||
44479679|NCT00524771|79486515|FG001|Overall Study|Protocol Violation|585|||
44479680|NCT00135694|79486525|FG000|Overall Study|Adverse Event|17|||
44479681|NCT00135694|79486526|FG001|Overall Study|Adverse Event|4|||
44479682|NCT00135694|79486527|FG002|Overall Study|Adverse Event|0|||
44479683|NCT00135694|79486525|FG000|Overall Study|Death|14|||
44479684|NCT00135694|79486526|FG001|Overall Study|Death|1|||
44479685|NCT00135694|79486527|FG002|Overall Study|Death|2|||
44479686|NCT00135694|79486525|FG000|Overall Study|Lost to Follow-up|8|||
44479687|NCT00135694|79486526|FG001|Overall Study|Lost to Follow-up|7|||
44479688|NCT00135694|79486527|FG002|Overall Study|Lost to Follow-up|1|||
44479689|NCT00135694|79486525|FG000|Overall Study|Withdrawal by Subject|41|||
44479690|NCT00135694|79486526|FG001|Overall Study|Withdrawal by Subject|7|||
44479691|NCT00135694|79486527|FG002|Overall Study|Withdrawal by Subject|4|||
44375590|NCT00943722|79380717|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
44375591|NCT00943722|79380711|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
44479692|NCT00135694|79486525|FG000|Overall Study|Protocol Violation|19|||
44479693|NCT00135694|79486526|FG001|Overall Study|Protocol Violation|1|||
44479694|NCT00135694|79486527|FG002|Overall Study|Protocol Violation|0|||
44479695|NCT00135694|79486525|FG000|Overall Study|Hepatitis C related reasons|39|||
44479696|NCT00135694|79486526|FG001|Overall Study|Hepatitis C related reasons|1|||
44479697|NCT00135694|79486527|FG002|Overall Study|Hepatitis C related reasons|0|||
44479698|NCT00135694|79486525|FG000|Overall Study|Ineligible for Random assignment|42|||
44479699|NCT00135694|79486526|FG001|Overall Study|Ineligible for Random assignment|0|||
44479700|NCT00135694|79486527|FG002|Overall Study|Ineligible for Random assignment|0|||
44226917|NCT01968551|79033567|FG002|Extension Phase|Adverse Event|2|||
44226918|NCT01968551|79033565|FG000|Extension Phase|Death|0|||
44479701|NCT00524459|79486535|FG000|Overall Study|Withdrawal by Subject|1|||
44479702|NCT00524459|79486535|FG000|Overall Study|Other|1|||
44479703|NCT00519623|79486539|FG000|Overall Study|Adverse Event|1|||
44479704|NCT00519077|79486543|FG000|Overall Study|Death|6|||
44479705|NCT00519077|79486543|FG000|Overall Study|Other|2|||
44479706|NCT00124618|79486547|FG000|Overall Study|Ineligible|1|||
44479707|NCT00124462|79486553|FG000|Overall Study|Lost to Follow-up|3|||
44479708|NCT00124462|79486554|FG001|Overall Study|Lost to Follow-up|3|||
44479709|NCT00124462|79486553|FG000|Overall Study|Physician Decision|3|||
44479710|NCT00124462|79486554|FG001|Overall Study|Physician Decision|4|||
44479711|NCT00124462|79486553|FG000|Overall Study|Withdrawal by Subject|4|||
44479712|NCT00124462|79486554|FG001|Overall Study|Withdrawal by Subject|5|||
44479713|NCT00124462|79486553|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
44479714|NCT00124462|79486554|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
44479715|NCT00124072|79486564|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
44479716|NCT00124072|79486565|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
44479717|NCT00124072|79486566|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
44479718|NCT00124072|79486567|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
44479719|NCT00124072|79486564|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
44479720|NCT00124072|79486565|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
44479721|NCT00124072|79486566|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
44479722|NCT00124072|79486567|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
44479723|NCT00124072|79486564|FG000|Overall Study|Death|499|||
44479724|NCT00124072|79486565|FG001|Overall Study|Death|484|||
44479725|NCT00124072|79486566|FG002|Overall Study|Death|471|||
44479726|NCT00124072|79486567|FG003|Overall Study|Death|480|||
44479727|NCT00362648|79486581|FG000|Overall Study|Adverse Event|12|||
44479728|NCT00362648|79486582|FG001|Overall Study|Adverse Event|21|||
44479729|NCT00362648|79486583|FG002|Overall Study|Adverse Event|1|||
44479730|NCT00362648|79486584|FG003|Overall Study|Adverse Event|0|||
44479731|NCT00362648|79486581|FG000|Overall Study|Lost to Follow-up|62|||
44479732|NCT00362648|79486582|FG001|Overall Study|Lost to Follow-up|69|||
44479733|NCT00362648|79486583|FG002|Overall Study|Lost to Follow-up|4|||
44479734|NCT00362648|79486584|FG003|Overall Study|Lost to Follow-up|3|||
44479735|NCT00362648|79486581|FG000|Overall Study|Protocol Violation|4|||
44479736|NCT00362648|79486582|FG001|Overall Study|Protocol Violation|2|||
44479737|NCT00362648|79486583|FG002|Overall Study|Protocol Violation|2|||
44479738|NCT00362648|79486584|FG003|Overall Study|Protocol Violation|2|||
44479739|NCT00362648|79486581|FG000|Overall Study|Withdrawal by Subject|48|||
44479740|NCT00362648|79486582|FG001|Overall Study|Withdrawal by Subject|42|||
44479741|NCT00362648|79486583|FG002|Overall Study|Withdrawal by Subject|2|||
44479742|NCT00362648|79486584|FG003|Overall Study|Withdrawal by Subject|6|||
44479743|NCT00524303|79486601|FG000|Overall Study|Lost to Follow-up|6|||
44479744|NCT00524303|79486602|FG001|Overall Study|Lost to Follow-up|0|||
44479745|NCT00524303|79486603|FG002|Overall Study|Lost to Follow-up|3|||
44479746|NCT00524303|79486601|FG000|Overall Study|Protocol Violation|0|||
44479747|NCT00524303|79486602|FG001|Overall Study|Protocol Violation|1|||
44479748|NCT00524303|79486603|FG002|Overall Study|Protocol Violation|1|||
44479749|NCT00524303|79486601|FG000|Overall Study|Withdrawal by Subject|3|||
44226919|NCT01968551|79033566|FG001|Extension Phase|Death|1|||
44226920|NCT01968551|79033567|FG002|Extension Phase|Death|0|||
44226921|NCT01968551|79033565|FG000|Extension Phase|Withdrew Consent|0|||
44226922|NCT01968551|79033566|FG001|Extension Phase|Withdrew Consent|0|||
44226923|NCT01968551|79033567|FG002|Extension Phase|Withdrew Consent|1|||
44226924|NCT01968551|79033565|FG000|Extension Phase|Lost to Follow-up|1|||
44226925|NCT01968551|79033566|FG001|Extension Phase|Lost to Follow-up|0|||
44226926|NCT01968551|79033567|FG002|Extension Phase|Lost to Follow-up|1|||
44226927|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
44375592|NCT00943722|79380712|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
44375593|NCT00943722|79380713|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
44544674|NCT00245960|79558243|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
44544675|NCT00245960|79558242|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
44479750|NCT00524303|79486602|FG001|Overall Study|Withdrawal by Subject|0|||
44479751|NCT00524303|79486603|FG002|Overall Study|Withdrawal by Subject|4|||
44479752|NCT00524303|79486601|FG000|Overall Study|Death|0|||
44479753|NCT00524303|79486602|FG001|Overall Study|Death|2|||
44544676|NCT00245960|79558243|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
44544677|NCT00245960|79558242|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
44226928|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
44226929|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
44375594|NCT00943722|79380714|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
44479754|NCT00524303|79486603|FG002|Overall Study|Death|3|||
44479755|NCT00524303|79486601|FG000|Overall Study|Adverse Event|1|||
44479756|NCT00524303|79486602|FG001|Overall Study|Adverse Event|2|||
44479757|NCT00524303|79486603|FG002|Overall Study|Adverse Event|3|||
44479758|NCT00524303|79486601|FG000|Overall Study|Did not Complete Study Dosing|1|||
44479759|NCT00524303|79486602|FG001|Overall Study|Did not Complete Study Dosing|0|||
44226930|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
44226931|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
44226932|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
44226933|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
44226934|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
44226935|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
44226936|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
44226937|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
44226938|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
44479760|NCT00524303|79486603|FG002|Overall Study|Did not Complete Study Dosing|0|||
44479761|NCT00524303|79486601|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
44479762|NCT00524303|79486602|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
44479763|NCT00524303|79486603|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
44479764|NCT00524303|79486601|FG000|Overall Study|Disease Progression|0|||
44479765|NCT00524303|79486602|FG001|Overall Study|Disease Progression|4|||
44479766|NCT00524303|79486603|FG002|Overall Study|Disease Progression|1|||
44479767|NCT00524303|79486601|FG000|Overall Study|Disease Recurrence|0|||
44479768|NCT00524303|79486602|FG001|Overall Study|Disease Recurrence|1|||
44479769|NCT00524303|79486603|FG002|Overall Study|Disease Recurrence|0|||
44479770|NCT00524303|79486601|FG000|Overall Study|Sponsor Request|0|||
44479771|NCT00524303|79486602|FG001|Overall Study|Sponsor Request|0|||
44479772|NCT00524303|79486603|FG002|Overall Study|Sponsor Request|1|||
44479773|NCT00524303|79486601|FG000|Overall Study|Physician Decision|0|||
44479774|NCT00524303|79486602|FG001|Overall Study|Physician Decision|0|||
44479775|NCT00524303|79486603|FG002|Overall Study|Physician Decision|1|||
44479776|NCT00524303|79486601|FG000|Overall Study|Completed 5 years|0|||
44479777|NCT00524303|79486602|FG001|Overall Study|Completed 5 years|0|||
44479778|NCT00524303|79486603|FG002|Overall Study|Completed 5 years|1|||
44479779|NCT00335556|79486620|FG000|Overall Study|Death|0|||
44226939|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
44226940|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
44226941|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
44226942|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
44226943|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
44226944|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
44226945|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
44226946|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
44226947|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
44226948|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
44226949|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
44226950|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
44226951|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
44479780|NCT00335556|79486621|FG001|Overall Study|Death|5|||
44479781|NCT00335556|79486622|FG002|Overall Study|Death|0|||
44479782|NCT00335556|79486623|FG003|Overall Study|Death|0|||
44479783|NCT00335556|79486624|FG004|Overall Study|Death|1|||
44479784|NCT00335556|79486625|FG005|Overall Study|Death|0|||
44226952|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
44226953|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
44226954|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
44226955|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
44226956|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
44226957|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
44226958|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
44226959|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
44226960|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
44226961|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
44226962|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
44226963|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
44479785|NCT00335556|79486620|FG000|Overall Study|Lack of Efficacy|0|||
44226964|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
44226965|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
44375595|NCT00943722|79380715|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
44375596|NCT00943722|79380716|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
44226966|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
44375597|NCT00943722|79380717|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
44479786|NCT00335556|79486621|FG001|Overall Study|Lack of Efficacy|19|||
44479787|NCT00335556|79486622|FG002|Overall Study|Lack of Efficacy|3|||
44479788|NCT00335556|79486623|FG003|Overall Study|Lack of Efficacy|3|||
44479789|NCT00335556|79486624|FG004|Overall Study|Lack of Efficacy|0|||
44479790|NCT00335556|79486625|FG005|Overall Study|Lack of Efficacy|1|||
44479791|NCT00335556|79486620|FG000|Overall Study|Physician Decision|0|||
44375598|NCT00901485|79380740|FG000|Overall Study|Lack of Efficacy|0|||
44375599|NCT00901485|79380741|FG001|Overall Study|Lack of Efficacy|2|||
44375600|NCT00901485|79380740|FG000|Overall Study|Withdrawal by Subject|1|||
44375601|NCT00901485|79380741|FG001|Overall Study|Withdrawal by Subject|2|||
44375602|NCT00896337|79380747|FG000|Overall Study|Death|7|||
44375603|NCT00896337|79380747|FG000|Overall Study|Withdrawal by Subject|7|||
44375604|NCT00896337|79380747|FG000|Overall Study|Lost to Follow-up|11|||
44375605|NCT00953706|79380758|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
44375606|NCT00953706|79380759|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
44479792|NCT00335556|79486621|FG001|Overall Study|Physician Decision|6|||
44479793|NCT00335556|79486622|FG002|Overall Study|Physician Decision|2|||
44479794|NCT00335556|79486623|FG003|Overall Study|Physician Decision|1|||
44479795|NCT00335556|79486624|FG004|Overall Study|Physician Decision|0|||
44479796|NCT00335556|79486625|FG005|Overall Study|Physician Decision|0|||
44479797|NCT00335556|79486620|FG000|Overall Study|Ineligible|2|||
44479798|NCT00335556|79486621|FG001|Overall Study|Ineligible|0|||
44479799|NCT00335556|79486622|FG002|Overall Study|Ineligible|0|||
44479800|NCT00335556|79486623|FG003|Overall Study|Ineligible|0|||
44479801|NCT00335556|79486624|FG004|Overall Study|Ineligible|0|||
44479802|NCT00335556|79486625|FG005|Overall Study|Ineligible|0|||
44479803|NCT00335556|79486620|FG000|Overall Study|Refusal of further protocol therapy|0|||
44479804|NCT00335556|79486621|FG001|Overall Study|Refusal of further protocol therapy|4|||
44226967|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
44226968|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
44226969|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
44226970|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
44226971|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
44479805|NCT00335556|79486622|FG002|Overall Study|Refusal of further protocol therapy|0|||
44479806|NCT00335556|79486623|FG003|Overall Study|Refusal of further protocol therapy|1|||
44479807|NCT00335556|79486624|FG004|Overall Study|Refusal of further protocol therapy|0|||
44479808|NCT00335556|79486625|FG005|Overall Study|Refusal of further protocol therapy|0|||
44479809|NCT00518687|79486646|FG000|Overall Study|Adverse Event|201|||
44479810|NCT00518687|79486647|FG001|Overall Study|Adverse Event|177|||
44479811|NCT00518687|79486646|FG000|Overall Study|Lost to Follow-up|144|||
44479812|NCT00518687|79486647|FG001|Overall Study|Lost to Follow-up|155|||
44479813|NCT00518687|79486646|FG000|Overall Study|Physician Decision|42|||
44479814|NCT00518687|79486647|FG001|Overall Study|Physician Decision|48|||
44479815|NCT00518687|79486646|FG000|Overall Study|Progressive disease|2|||
44479816|NCT00518687|79486647|FG001|Overall Study|Progressive disease|2|||
44479817|NCT00518687|79486646|FG000|Overall Study|Protocol Violation|8|||
44479818|NCT00518687|79486647|FG001|Overall Study|Protocol Violation|10|||
44479819|NCT00518687|79486646|FG000|Overall Study|Study terminated by sponsor|930|||
44479820|NCT00518687|79486647|FG001|Overall Study|Study terminated by sponsor|918|||
44479821|NCT00518687|79486646|FG000|Overall Study|Withdrawal by Subject|110|||
44479822|NCT00518687|79486647|FG001|Overall Study|Withdrawal by Subject|110|||
44479823|NCT00134056|79486655|FG000|Randomization|Not eligible for assigned treatment|22|||
44479824|NCT00134056|79486656|FG001|Randomization|Not eligible for assigned treatment|20|||
44479825|NCT00134056|79486655|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
44479826|NCT00134056|79486656|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
44479827|NCT00134056|79486655|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
44479828|NCT00134056|79486656|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
44479829|NCT00134056|79486655|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
44479830|NCT00134056|79486656|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
44479831|NCT00134056|79486655|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
44479832|NCT00134056|79486656|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
44479833|NCT00518531|79486667|FG000|Treatment Period 1|Adverse Event|5|||
44479834|NCT00518531|79486668|FG001|Treatment Period 1|Adverse Event|0|||
44479835|NCT00518531|79486667|FG000|Treatment Period 1|Lost to Follow-up|5|||
44479836|NCT00518531|79486668|FG001|Treatment Period 1|Lost to Follow-up|3|||
44226972|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
44479837|NCT00518531|79486667|FG000|Treatment Period 1|Physician Decision|1|||
44479838|NCT00518531|79486668|FG001|Treatment Period 1|Physician Decision|0|||
44479839|NCT00518531|79486667|FG000|Treatment Period 1|Protocol Violation|2|||
44479840|NCT00518531|79486668|FG001|Treatment Period 1|Protocol Violation|0|||
44479841|NCT00518531|79486667|FG000|Treatment Period 1|Withdrawal by Subject|4|||
44479842|NCT00518531|79486668|FG001|Treatment Period 1|Withdrawal by Subject|6|||
44479843|NCT00518531|79486667|FG000|Treatment Period 1|Early crossover|1|||
44479844|NCT00518531|79486668|FG001|Treatment Period 1|Early crossover|3|||
44479845|NCT00518531|79486667|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44479846|NCT00518531|79486668|FG001|Treatment Period 2|Withdrawal by Subject|8|||
44479847|NCT00518531|79486667|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
44544678|NCT00245960|79558243|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
44479848|NCT00518531|79486668|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
44479849|NCT00518531|79486667|FG000|Treatment Period 2|Adverse Event|1|||
44479850|NCT00518531|79486668|FG001|Treatment Period 2|Adverse Event|7|||
44479851|NCT00518531|79486667|FG000|Treatment Period 2|Protocol-specified criteria|0|||
44479852|NCT00518531|79486668|FG001|Treatment Period 2|Protocol-specified criteria|1|||
44479853|NCT00518531|79486667|FG000|Treatment Period 2|Non-compliance|1|||
44479854|NCT00518531|79486668|FG001|Treatment Period 2|Non-compliance|2|||
44479855|NCT00351468|79486676|FG000|Overall Study|Adverse Event|42|||
44479856|NCT00351468|79486676|FG000|Overall Study|Withdrawal by Subject|39|||
44479857|NCT00351468|79486676|FG000|Overall Study|Various -follow up w clinical team|39|||
44479858|NCT00351468|79486676|FG000|Overall Study|Lack of Efficacy|32|||
44479859|NCT00351468|79486676|FG000|Overall Study|Non-compliance|8|||
44479860|NCT00351468|79486676|FG000|Overall Study|Lost to Follow-up|4|||
44479861|NCT00351468|79486676|FG000|Overall Study|Protocol Violation|3|||
44479862|NCT00523991|79486683|FG000|Overall Study|Adverse Event|6|||
44479863|NCT00523991|79486684|FG001|Overall Study|Adverse Event|5|||
44479864|NCT00523991|79486683|FG000|Overall Study|Protocol Violation|1|||
44479865|NCT00523991|79486684|FG001|Overall Study|Protocol Violation|4|||
44479866|NCT00523991|79486683|FG000|Overall Study|Lost to Follow-up|4|||
44479867|NCT00523991|79486684|FG001|Overall Study|Lost to Follow-up|1|||
44479868|NCT00523991|79486683|FG000|Overall Study|Withdrawal by Subject|7|||
44479869|NCT00523991|79486684|FG001|Overall Study|Withdrawal by Subject|17|||
44479870|NCT00523991|79486683|FG000|Overall Study|Other reason (not specified)|3|||
44479871|NCT00523991|79486684|FG001|Overall Study|Other reason (not specified)|0|||
44479872|NCT00350844|79486690|FG000|Overall Study|Lost to Follow-up|1|||
44479873|NCT00345540|79486694|FG000|Overall Study|Withdrawal by Subject|1|||
44479874|NCT00335322|79486701|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
44479875|NCT00335322|79486702|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
44479876|NCT00335322|79486703|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
44479877|NCT00523367|79486714|FG000|Overall Study|19 screen failures|19|||
44479878|NCT00523367|79486714|FG000|Overall Study|4 Withdrawn by PI|4|||
44479879|NCT03755765|79486721|FG000|Overall Study|Withdrawal by Subject|2|||
44479880|NCT03755765|79486722|FG001|Overall Study|Withdrawal by Subject|4|||
44479881|NCT03755765|79486723|FG002|Overall Study|Withdrawal by Subject|4|||
44479882|NCT00344448|79486731|FG000|Screening|Withdrawal by Subject|0|||
44479883|NCT00344448|79486732|FG001|Screening|Withdrawal by Subject|1|||
44479884|NCT00344448|79486731|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
44479885|NCT00344448|79486732|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
44479886|NCT00344448|79486731|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
44479887|NCT00344448|79486732|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
44479888|NCT00344448|79486731|FG000|Open Label|Withdrawal by Subject|1|||
44479889|NCT00344448|79486732|FG001|Open Label|Withdrawal by Subject|1|||
44479890|NCT00344448|79486731|FG000|Open Label|Study terminated|1|||
44479891|NCT00344448|79486732|FG001|Open Label|Study terminated|0|||
44479892|NCT00324168|79486740|FG000|Overall Study|Lost to Follow-up|19|||
44479893|NCT00324168|79486741|FG001|Overall Study|Lost to Follow-up|18|||
44479894|NCT00324168|79486740|FG000|Overall Study|Death|3|||
44479895|NCT00324168|79486741|FG001|Overall Study|Death|3|||
44479896|NCT00324168|79486740|FG000|Overall Study|Patient did not visit in f/u window|6|||
44479897|NCT00324168|79486741|FG001|Overall Study|Patient did not visit in f/u window|9|||
44479898|NCT00517829|79486749|FG000|Overall Study|Adverse Event|22|||
44479899|NCT00517829|79486750|FG001|Overall Study|Adverse Event|34|||
44479900|NCT00517829|79486749|FG000|Overall Study|Disease Progression|39|||
44479901|NCT00517829|79486750|FG001|Overall Study|Disease Progression|32|||
44479902|NCT00517829|79486749|FG000|Overall Study|Patient Request|6|||
44479903|NCT00517829|79486750|FG001|Overall Study|Patient Request|5|||
44479904|NCT00517829|79486749|FG000|Overall Study|Investigator Request|5|||
44479905|NCT00517829|79486750|FG001|Overall Study|Investigator Request|3|||
44479906|NCT00517829|79486749|FG000|Overall Study|Other|3|||
44479907|NCT00517829|79486750|FG001|Overall Study|Other|1|||
44479908|NCT00343512|79486756|FG000|Overall Study|Withdrawal by Subject|2|||
44479909|NCT00334542|79486761|FG000|Overall Study|Adverse Event|3|||
44479910|NCT00334542|79486761|FG000|Overall Study|Withdrawal by Subject|1|||
44479911|NCT00334542|79486761|FG000|Overall Study|New cancer diagnosis|1|||
44479912|NCT00112294|79486768|FG000|Overall Study|Still on study|5|||
44479913|NCT00112294|79486769|FG001|Overall Study|Still on study|0|||
44479914|NCT00235443|79486781|FG000|Overall Study|Adverse Event|4|||
44479915|NCT00235443|79486782|FG001|Overall Study|Adverse Event|12|||
44479916|NCT00235443|79486783|FG002|Overall Study|Adverse Event|17|||
44479917|NCT00235443|79486784|FG003|Overall Study|Adverse Event|44|||
44479918|NCT00235443|79486785|FG004|Overall Study|Adverse Event|10|||
44479919|NCT00235443|79486786|FG005|Overall Study|Adverse Event|15|||
44479920|NCT00235443|79486781|FG000|Overall Study|Lack of Efficacy|0|||
44479921|NCT00235443|79486782|FG001|Overall Study|Lack of Efficacy|1|||
44479922|NCT00235443|79486783|FG002|Overall Study|Lack of Efficacy|5|||
44479923|NCT00235443|79486784|FG003|Overall Study|Lack of Efficacy|12|||
44479924|NCT00235443|79486785|FG004|Overall Study|Lack of Efficacy|2|||
44479925|NCT00235443|79486786|FG005|Overall Study|Lack of Efficacy|9|||
44479926|NCT00235443|79486781|FG000|Overall Study|Withdrawal by Subject|3|||
44479927|NCT00235443|79486782|FG001|Overall Study|Withdrawal by Subject|9|||
44479928|NCT00235443|79486783|FG002|Overall Study|Withdrawal by Subject|25|||
44479929|NCT00235443|79486784|FG003|Overall Study|Withdrawal by Subject|24|||
44479930|NCT00235443|79486785|FG004|Overall Study|Withdrawal by Subject|10|||
44479931|NCT00235443|79486786|FG005|Overall Study|Withdrawal by Subject|12|||
44479932|NCT00235443|79486781|FG000|Overall Study|Lost to Follow-up|0|||
44479933|NCT00235443|79486782|FG001|Overall Study|Lost to Follow-up|8|||
44479934|NCT00235443|79486783|FG002|Overall Study|Lost to Follow-up|6|||
44479935|NCT00235443|79486784|FG003|Overall Study|Lost to Follow-up|6|||
44479936|NCT00235443|79486785|FG004|Overall Study|Lost to Follow-up|4|||
44479937|NCT00235443|79486786|FG005|Overall Study|Lost to Follow-up|3|||
44479938|NCT00235443|79486781|FG000|Overall Study|Unsatisfactory compliance|0|||
44479939|NCT00235443|79486782|FG001|Overall Study|Unsatisfactory compliance|2|||
44479940|NCT00235443|79486783|FG002|Overall Study|Unsatisfactory compliance|3|||
44479941|NCT00235443|79486784|FG003|Overall Study|Unsatisfactory compliance|4|||
44479942|NCT00235443|79486785|FG004|Overall Study|Unsatisfactory compliance|1|||
44479943|NCT00235443|79486786|FG005|Overall Study|Unsatisfactory compliance|0|||
44479944|NCT00235443|79486781|FG000|Overall Study|Other reasons for premature termination|1|||
44479945|NCT00235443|79486782|FG001|Overall Study|Other reasons for premature termination|6|||
44479946|NCT00235443|79486783|FG002|Overall Study|Other reasons for premature termination|6|||
44479947|NCT00235443|79486784|FG003|Overall Study|Other reasons for premature termination|7|||
44479948|NCT00235443|79486785|FG004|Overall Study|Other reasons for premature termination|3|||
44479949|NCT00235443|79486786|FG005|Overall Study|Other reasons for premature termination|6|||
44479950|NCT00234039|79486802|FG000|Overall Study|Adverse Event|2|||
44479951|NCT00234039|79486802|FG000|Overall Study|Progression/relapse|34|||
44479952|NCT00234039|79486802|FG000|Overall Study|Other - Not Protocol Specified|3|||
44479953|NCT00234039|79486802|FG000|Overall Study|Ineligible|9|||
44479954|NCT00234039|79486802|FG000|Overall Study|No Protocol Treatment Received|2|||
44479955|NCT00323622|79486814|FG000|Overall Study|Other|30|||
44479956|NCT00323622|79486815|FG001|Overall Study|Other|91|||
44479957|NCT00323622|79486816|FG002|Overall Study|Other|4|||
44479958|NCT00323622|79486817|FG003|Overall Study|Other|12|||
44479959|NCT00323622|79486818|FG004|Overall Study|Other|32|||
44479960|NCT00323622|79486819|FG005|Overall Study|Other|74|||
44479961|NCT00323622|79486820|FG006|Overall Study|Other|5|||
44479962|NCT00323622|79486821|FG007|Overall Study|Other|13|||
44479963|NCT00323622|79486814|FG000|Overall Study|Death|1|||
44479964|NCT00323622|79486815|FG001|Overall Study|Death|1|||
44479965|NCT00323622|79486816|FG002|Overall Study|Death|0|||
44479966|NCT00323622|79486817|FG003|Overall Study|Death|0|||
44479967|NCT00323622|79486818|FG004|Overall Study|Death|7|||
44479968|NCT00323622|79486819|FG005|Overall Study|Death|0|||
44479969|NCT00323622|79486820|FG006|Overall Study|Death|0|||
44479970|NCT00323622|79486821|FG007|Overall Study|Death|2|||
44479971|NCT00189423|79486849|FG000|Overall Study|Death|746|||
44479972|NCT00189423|79486850|FG001|Overall Study|Death|747|||
44226973|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
44479973|NCT00189423|79486849|FG000|Overall Study|Withdrawal by Subject|9|||
44479974|NCT00189423|79486850|FG001|Overall Study|Withdrawal by Subject|9|||
44479975|NCT00189423|79486849|FG000|Overall Study|Lost to Follow-up|10|||
44479976|NCT00189423|79486850|FG001|Overall Study|Lost to Follow-up|10|||
44479977|NCT00323310|79486856|FG000|Overall Study|Withdrawal by Subject|1|||
44226974|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
44226975|NCT01707992|79033582|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
44226976|NCT01707992|79033583|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
44226977|NCT01707992|79033584|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
44479978|NCT00323310|79486856|FG000|Overall Study|a parent refused blood draw|1|||
44544679|NCT00245960|79558242|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
44544680|NCT00245960|79558243|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
44479979|NCT00323310|79486856|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
44479980|NCT00186537|79486863|FG000|Overall Study|Withdrawal by Subject|4|||
44479981|NCT00186537|79486864|FG001|Overall Study|Withdrawal by Subject|0|||
44479982|NCT00186537|79486865|FG002|Overall Study|Withdrawal by Subject|3|||
44479983|NCT00186537|79486863|FG000|Overall Study|ALT > 1.5 x ULN|3|||
44479984|NCT00186537|79486864|FG001|Overall Study|ALT > 1.5 x ULN|0|||
44479985|NCT00186537|79486865|FG002|Overall Study|ALT > 1.5 x ULN|0|||
44479986|NCT00517751|79486873|FG000|Overall Study|Death|3|||
44479987|NCT00517751|79486873|FG000|Overall Study|Withdrawal by Subject|37|||
44479988|NCT00517751|79486873|FG000|Overall Study|Lost to Follow-up|4|||
44479989|NCT00517751|79486873|FG000|Overall Study|patient not over due|6|||
44479990|NCT00517751|79486873|FG000|Overall Study|Patient not due for visit|76|||
44479991|NCT00517751|79486873|FG000|Overall Study|Missing|3|||
44479992|NCT00322842|79486879|FG000|Overall Study|Withdrawal by Subject|0|||
44479993|NCT00322842|79486880|FG001|Overall Study|Withdrawal by Subject|1|||
44479994|NCT00322842|79486879|FG000|Overall Study|Lost to Follow-up|0|||
44479995|NCT00322842|79486880|FG001|Overall Study|Lost to Follow-up|1|||
44479996|NCT00322842|79486879|FG000|Overall Study|Refused transplant|1|||
44479997|NCT00322842|79486880|FG001|Overall Study|Refused transplant|0|||
44479998|NCT00322842|79486879|FG000|Overall Study|Death|1|||
44479999|NCT00322842|79486880|FG001|Overall Study|Death|0|||
44480000|NCT00255723|79486889|FG000|Overall Study|Adverse Event|1|||
44480001|NCT00255723|79486890|FG001|Overall Study|Adverse Event|1|||
44480002|NCT00255723|79486889|FG000|Overall Study|Death|0|||
44480003|NCT00255723|79486890|FG001|Overall Study|Death|1|||
44480004|NCT00255723|79486889|FG000|Overall Study|Response Data Not Available|1|||
44480005|NCT00255723|79486890|FG001|Overall Study|Response Data Not Available|0|||
44480006|NCT00132808|79486899|FG000|Stratum I|Adverse Event|2|||
44480007|NCT00132808|79486900|FG001|Stratum I|Adverse Event|1|||
44480008|NCT00132808|79486901|FG002|Stratum I|Adverse Event|0|||
44480009|NCT00132808|79486899|FG000|Stratum I|Lost to Follow-up|3|||
44480010|NCT00132808|79486900|FG001|Stratum I|Lost to Follow-up|4|||
44480011|NCT00132808|79486901|FG002|Stratum I|Lost to Follow-up|1|||
44480012|NCT00132808|79486899|FG000|Stratum I|Withdrawal by Subject|4|||
44480013|NCT00132808|79486900|FG001|Stratum I|Withdrawal by Subject|7|||
44480014|NCT00132808|79486901|FG002|Stratum I|Withdrawal by Subject|3|||
44480015|NCT00132808|79486899|FG000|Stratum I|Abnormal test procedure result (s)|0|||
44480016|NCT00132808|79486900|FG001|Stratum I|Abnormal test procedure result (s)|0|||
44480017|NCT00132808|79486901|FG002|Stratum I|Abnormal test procedure result (s)|1|||
44480018|NCT00132808|79486899|FG000|Stratum II|Adverse Event|1|||
44480019|NCT00132808|79486900|FG001|Stratum II|Adverse Event|2|||
44480020|NCT00132808|79486901|FG002|Stratum II|Adverse Event|1|||
44480021|NCT00132808|79486899|FG000|Stratum II|Death|1|||
44480022|NCT00132808|79486900|FG001|Stratum II|Death|0|||
44480023|NCT00132808|79486901|FG002|Stratum II|Death|0|||
44480024|NCT00132808|79486899|FG000|Stratum II|Lost to Follow-up|2|||
44480025|NCT00132808|79486900|FG001|Stratum II|Lost to Follow-up|2|||
44480026|NCT00132808|79486901|FG002|Stratum II|Lost to Follow-up|1|||
44480027|NCT00132808|79486899|FG000|Stratum II|Protocol Violation|0|||
44480028|NCT00132808|79486900|FG001|Stratum II|Protocol Violation|2|||
44226978|NCT01707992|79033585|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
44544681|NCT00245960|79558242|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
44544682|NCT00245960|79558243|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
44544683|NCT00245960|79558242|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
44544684|NCT00245960|79558243|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
44544685|NCT00245960|79558242|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
44544686|NCT00245960|79558243|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
44226979|NCT01707992|79033586|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
44226980|NCT01707992|79033587|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
44226981|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
44226982|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
44544687|NCT00245960|79558242|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
44544688|NCT00245960|79558243|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
44544689|NCT02729194|79558249|FG000|Overall Study|Withdrawal by Subject|3|||
44226983|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
44226984|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
44226985|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
44226986|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
44226987|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
44226988|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
44226989|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
44274108|NCT01636986|79216933|FG001|Overall Study|Withdrawal by Subject|1|||
44274109|NCT01636986|79216932|FG000|Overall Study|Corneal Staining|0|||
44274110|NCT01636986|79216933|FG001|Overall Study|Corneal Staining|1|||
44480029|NCT00132808|79486901|FG002|Stratum II|Protocol Violation|1|||
44480030|NCT00132808|79486899|FG000|Stratum II|Withdrawal by Subject|4|||
44480031|NCT00132808|79486900|FG001|Stratum II|Withdrawal by Subject|9|||
44480032|NCT00132808|79486901|FG002|Stratum II|Withdrawal by Subject|6|||
44480033|NCT00517361|79486909|FG000|Overall Study|Death|6|||
44480034|NCT00517361|79486909|FG000|Overall Study|The study was terminated|5|||
44480035|NCT00516893|79486913|FG000|Overall Study|Lost to Follow-up|4|||
44274111|NCT01601496|79217023|FG000|Overall Study|Physician Decision|1|||
44480036|NCT00516893|79486913|FG000|Overall Study|Adverse Event|3|||
44480037|NCT00516893|79486913|FG000|Overall Study|Withdrawal by Subject|2|||
44480038|NCT00516893|79486913|FG000|Overall Study|Noncompliance|2|||
44480039|NCT00516893|79486913|FG000|Overall Study|Death|1|||
44480040|NCT00516893|79486913|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
44480041|NCT00516893|79486913|FG000|Overall Study|Relocated|1|||
44480042|NCT00516893|79486913|FG000|Overall Study|Pregnancy|1|||
44480043|NCT00516893|79486913|FG000|Overall Study|Received Medication From Another Study|1|||
44480044|NCT00522431|79486917|FG000|Overall Study|Adverse Event|5|||
44480045|NCT00522431|79486917|FG000|Overall Study|Protocol Violation|2|||
44480046|NCT00522431|79486917|FG000|Overall Study|Withdrawal by Subject|2|||
44480047|NCT00522431|79486917|FG000|Overall Study|Subject non-compliance|1|||
44480048|NCT00522431|79486917|FG000|Overall Study|Other/unknown|1|||
44480049|NCT00185211|79486923|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
44480050|NCT00185211|79486924|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
44480051|NCT00185211|79486923|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
44480052|NCT00185211|79486924|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
44480053|NCT00185211|79486923|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
44480054|NCT00185211|79486924|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
44480055|NCT00185211|79486923|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
44480056|NCT00185211|79486924|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
44480057|NCT00185211|79486923|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
44480058|NCT00185211|79486924|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
44480059|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
44480060|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
44480061|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
44480062|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
44480063|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
44480064|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
44480065|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
44480066|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
44480067|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
44480068|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
44480069|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
44480070|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
44480071|NCT00185211|79486923|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
44480072|NCT00185211|79486924|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
44480073|NCT00516737|79486933|FG000|Overall Study|Lost to Follow-up|2|||
44226990|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
44480074|NCT00516737|79486934|FG001|Overall Study|Lost to Follow-up|0|||
44480075|NCT00516737|79486933|FG000|Overall Study|Physician Decision|0|||
44480076|NCT00516737|79486934|FG001|Overall Study|Physician Decision|1|||
44480077|NCT00516737|79486933|FG000|Overall Study|Withdrawal by Subject|0|||
44480078|NCT00516737|79486934|FG001|Overall Study|Withdrawal by Subject|1|||
44480079|NCT00516737|79486933|FG000|Overall Study|Lack of Qualifying Event|9|||
44480080|NCT00516737|79486934|FG001|Overall Study|Lack of Qualifying Event|6|||
44480081|NCT00132730|79486944|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
44480082|NCT00132730|79486945|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
44480083|NCT00132730|79486946|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
44480084|NCT00132730|79486947|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
44480085|NCT00132730|79486948|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
44480086|NCT00132730|79486949|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
44480087|NCT00132730|79486944|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
44480088|NCT00132730|79486945|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
44226991|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
44226992|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
44226993|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
44226994|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
44226995|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
44226996|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
44226997|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
44226998|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
44226999|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
44227000|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
44227001|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
44227002|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
44227003|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
44227004|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
44227005|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
44227006|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
44227007|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
44514822|NCT03717012|79520645|FG001|Overall Study|Due to trial termination|2|||
44227008|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
44480089|NCT00132730|79486946|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
44480090|NCT00132730|79486947|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
44480091|NCT00132730|79486948|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
44480092|NCT00132730|79486949|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
44480093|NCT00132730|79486944|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
44480094|NCT00132730|79486945|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
44480095|NCT00132730|79486946|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
44480096|NCT00132730|79486947|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
44480097|NCT00132730|79486948|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
44480098|NCT00132730|79486949|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
44480099|NCT00132730|79486944|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
44480100|NCT00132730|79486945|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
44480101|NCT00132730|79486946|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
44480102|NCT00132730|79486947|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
44480103|NCT00132730|79486948|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
44480104|NCT00132730|79486949|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
44480105|NCT00132730|79486944|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
44480106|NCT00132730|79486945|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
44480107|NCT00132730|79486946|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
44480108|NCT00132730|79486947|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
44480109|NCT00132730|79486948|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
44480110|NCT00132730|79486949|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
44480111|NCT00132730|79486944|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
44480112|NCT00132730|79486945|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
44480113|NCT00132730|79486946|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
44480114|NCT00132730|79486947|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
44480115|NCT00132730|79486948|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
44480116|NCT00132730|79486949|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
44480117|NCT00132730|79486944|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
44480118|NCT00132730|79486945|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
44480119|NCT00132730|79486946|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
44480120|NCT00132730|79486947|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
44480121|NCT00132730|79486948|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
44480122|NCT00132730|79486949|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
44480123|NCT00132730|79486944|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
44480124|NCT00132730|79486945|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
44480125|NCT00132730|79486946|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
44480126|NCT00132730|79486947|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
44480127|NCT00132730|79486948|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
44480128|NCT00132730|79486949|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
44480129|NCT00132730|79486944|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
44480130|NCT00132730|79486945|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
44480131|NCT00132730|79486946|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
44480132|NCT00132730|79486947|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
44480133|NCT00132730|79486948|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
44480134|NCT00132730|79486949|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
44480135|NCT00132730|79486944|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
44480136|NCT00132730|79486945|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
44480137|NCT00132730|79486946|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
44480138|NCT00132730|79486947|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
44480139|NCT00132730|79486948|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
44480140|NCT00132730|79486949|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
44480141|NCT00132730|79486944|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
44480142|NCT00132730|79486945|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
44480143|NCT00132730|79486946|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
44480144|NCT00132730|79486947|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
44480145|NCT00132730|79486948|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
44480146|NCT00132730|79486949|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
44480147|NCT00132730|79486944|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
44480148|NCT00132730|79486945|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
44480149|NCT00132730|79486946|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
44480150|NCT00132730|79486947|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
44480151|NCT00132730|79486948|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
44480152|NCT00132730|79486949|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
44480153|NCT00232557|79486965|FG000|Overall Study|Lost to Follow-up|3|||
44480154|NCT00232557|79486966|FG001|Overall Study|Lost to Follow-up|5|||
44480155|NCT00522275|79486972|FG000|Overall Study|Adverse Event|35|||
44274112|NCT01601496|79217023|FG000|Overall Study|Withdrawal by Subject|1|||
44274113|NCT01601496|79217023|FG000|Overall Study|Lost to Follow-up|6|||
44274114|NCT01601496|79217023|FG000|Overall Study|Death|4|||
44274115|NCT01601496|79217023|FG000|Overall Study|Other: patient refusal to continue|3|||
44274116|NCT03211832|79217029|FG000|Overall Study|No longer with agency|32|||
44274117|NCT03211832|79217030|FG001|Overall Study|No longer with agency|49|||
44274118|NCT03211832|79217031|FG002|Overall Study|No longer with agency|30|||
44274119|NCT03211832|79217029|FG000|Overall Study|Declined survey|3|||
44274120|NCT03211832|79217030|FG001|Overall Study|Declined survey|3|||
44274121|NCT03211832|79217031|FG002|Overall Study|Declined survey|2|||
44375607|NCT00953706|79380760|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
44480156|NCT00522275|79486972|FG000|Overall Study|Lack of Efficacy|80|||
44480157|NCT00522275|79486972|FG000|Overall Study|Subject withdrew consent|16|||
44480158|NCT00522275|79486972|FG000|Overall Study|Protocol deviation|1|||
44480159|NCT00522275|79486972|FG000|Overall Study|Unsatisfactory compliance|11|||
44480160|NCT00522275|79486972|FG000|Overall Study|Lost to Follow-up|8|||
44480161|NCT00522275|79486972|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
44480162|NCT00522275|79486972|FG000|Overall Study|Other: Subject is pregnant|2|||
44480163|NCT00522275|79486972|FG000|Overall Study|Other: Subject relocated|2|||
44480164|NCT00522275|79486972|FG000|Overall Study|Other: Subject arrested|1|||
44480165|NCT00522275|79486972|FG000|Overall Study|Other: Site / clinic closed|4|||
44480166|NCT00522275|79486972|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
44480167|NCT00522275|79486972|FG000|Overall Study|Other: Sponsor request|2|||
44480168|NCT00522275|79486972|FG000|Overall Study|Other: Subject ran out of medication|1|||
44480169|NCT00522275|79486972|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
44480170|NCT00522041|79486978|FG000|Overall Study|Adverse Event|9|||
44480171|NCT00522041|79486979|FG001|Overall Study|Adverse Event|3|||
44480172|NCT00522041|79486978|FG000|Overall Study|Protocol Violation|2|||
44480173|NCT00522041|79486979|FG001|Overall Study|Protocol Violation|0|||
44480174|NCT00522041|79486978|FG000|Overall Study|Lost to Follow-up|1|||
44480175|NCT00522041|79486979|FG001|Overall Study|Lost to Follow-up|4|||
44274122|NCT03211832|79217029|FG000|Overall Study|Not available during data collection|1|||
44480176|NCT00522041|79486978|FG000|Overall Study|Voluntary withdrawal|5|||
44480177|NCT00522041|79486979|FG001|Overall Study|Voluntary withdrawal|4|||
44480178|NCT00522041|79486978|FG000|Overall Study|Did not receive treatment|0|||
44544690|NCT03178266|79558255|FG000|Overall Study|Death|0|||
44544691|NCT03178266|79558256|FG001|Overall Study|Death|1|||
44544692|NCT03178266|79558255|FG000|Overall Study|Disont. Early|0|||
44227009|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
44227010|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
44227011|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Death|0|||
44227012|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Death|0|||
44227013|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Death|0|||
44480179|NCT00522041|79486979|FG001|Overall Study|Did not receive treatment|1|||
44480180|NCT00122980|79486988|FG000|Overall Study|Death|0|||
44480181|NCT00122980|79486989|FG001|Overall Study|Death|1|||
44480182|NCT00122980|79486988|FG000|Overall Study|Physician Decision|2|||
44480183|NCT00122980|79486989|FG001|Overall Study|Physician Decision|0|||
44480184|NCT00122980|79486988|FG000|Overall Study|Protocol Violation|5|||
44480185|NCT00122980|79486989|FG001|Overall Study|Protocol Violation|1|||
44480186|NCT00122980|79486988|FG000|Overall Study|Withdrawal by Subject|2|||
44480187|NCT00122980|79486989|FG001|Overall Study|Withdrawal by Subject|3|||
44480188|NCT00122980|79486988|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
44480189|NCT00122980|79486989|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
44480190|NCT00122980|79486988|FG000|Overall Study|Study termination|27|||
44480191|NCT00122980|79486989|FG001|Overall Study|Study termination|35|||
44480192|NCT03868631|79486997|FG000|Baseline to Week 6|Adverse Event|0|||
44480193|NCT03868631|79486998|FG001|Baseline to Week 6|Adverse Event|3|||
44480194|NCT03868631|79486997|FG000|Baseline to Week 6|Protocol Violation|1|||
44480195|NCT03868631|79486998|FG001|Baseline to Week 6|Protocol Violation|1|||
44480196|NCT03868631|79486997|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
44480197|NCT03868631|79486998|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
44480198|NCT03868631|79486997|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
44480199|NCT03868631|79486998|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
44480200|NCT03868631|79486997|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
44480201|NCT03868631|79486998|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
44480202|NCT03868631|79486997|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
44480203|NCT03868631|79486998|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
44480204|NCT05142332|79487006|FG000|Overall Study|Withdrawal by Subject|0|||
44480205|NCT05142332|79487007|FG001|Overall Study|Withdrawal by Subject|1|||
44480206|NCT05142332|79487008|FG002|Overall Study|Withdrawal by Subject|2|||
44480207|NCT05142332|79487009|FG003|Overall Study|Withdrawal by Subject|0|||
44480208|NCT05142332|79487010|FG004|Overall Study|Withdrawal by Subject|0|||
44480209|NCT05142332|79487011|FG005|Overall Study|Withdrawal by Subject|2|||
44480210|NCT05142332|79487012|FG006|Overall Study|Withdrawal by Subject|6|||
44480211|NCT05142332|79487006|FG000|Overall Study|Left ED|3|||
44480212|NCT05142332|79487007|FG001|Overall Study|Left ED|0|||
44480213|NCT05142332|79487008|FG002|Overall Study|Left ED|4|||
44480214|NCT05142332|79487009|FG003|Overall Study|Left ED|6|||
44480215|NCT05142332|79487010|FG004|Overall Study|Left ED|1|||
44480216|NCT05142332|79487011|FG005|Overall Study|Left ED|2|||
44480217|NCT05142332|79487012|FG006|Overall Study|Left ED|6|||
44480218|NCT05142332|79487006|FG000|Overall Study|Physician Decision|0|||
44480219|NCT05142332|79487007|FG001|Overall Study|Physician Decision|0|||
44480220|NCT05142332|79487008|FG002|Overall Study|Physician Decision|2|||
44480221|NCT05142332|79487009|FG003|Overall Study|Physician Decision|1|||
44480222|NCT05142332|79487010|FG004|Overall Study|Physician Decision|0|||
44480223|NCT05142332|79487011|FG005|Overall Study|Physician Decision|0|||
44480224|NCT05142332|79487012|FG006|Overall Study|Physician Decision|3|||
44480225|NCT05142332|79487006|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
44480226|NCT05142332|79487007|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
44480227|NCT05142332|79487008|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
44480228|NCT05142332|79487009|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
44480229|NCT05142332|79487010|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
44480230|NCT05142332|79487011|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
44480231|NCT05142332|79487012|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
44480232|NCT04556838|79487061|FG000|Overall Study|Withdrawal by Subject|3|||
44480233|NCT04556838|79487062|FG001|Overall Study|Withdrawal by Subject|1|||
44480234|NCT04556838|79487063|FG002|Overall Study|Withdrawal by Subject|2|||
44227014|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Death|2|||
44480235|NCT04556838|79487061|FG000|Overall Study|Adverse Event|0|||
44480236|NCT04556838|79487062|FG001|Overall Study|Adverse Event|1|||
44480237|NCT04556838|79487063|FG002|Overall Study|Adverse Event|1|||
44480238|NCT04556838|79487061|FG000|Overall Study|Lost to Follow-up|0|||
44480239|NCT04556838|79487062|FG001|Overall Study|Lost to Follow-up|0|||
44480240|NCT04556838|79487063|FG002|Overall Study|Lost to Follow-up|2|||
44480241|NCT04556838|79487061|FG000|Overall Study|Subject travel|0|||
44480242|NCT04556838|79487062|FG001|Overall Study|Subject travel|1|||
44480243|NCT04556838|79487063|FG002|Overall Study|Subject travel|0|||
44480244|NCT04556838|79487061|FG000|Overall Study|Physician Decision|1|||
44480245|NCT04556838|79487062|FG001|Overall Study|Physician Decision|0|||
44480246|NCT04556838|79487063|FG002|Overall Study|Physician Decision|0|||
44480247|NCT04523181|79487082|FG000|Overall Study|Withdrawal by Subject|4|||
44480248|NCT04523181|79487083|FG001|Overall Study|Withdrawal by Subject|5|||
44480249|NCT04523181|79487082|FG000|Overall Study|Lost to Follow-up|2|||
44480250|NCT04523181|79487083|FG001|Overall Study|Lost to Follow-up|3|||
44480251|NCT04523181|79487082|FG000|Overall Study|Physician Decision|1|||
44480252|NCT04523181|79487083|FG001|Overall Study|Physician Decision|0|||
44480253|NCT04523181|79487082|FG000|Overall Study|Transferred to external facility.|1|||
44480254|NCT04523181|79487083|FG001|Overall Study|Transferred to external facility.|1|||
44480255|NCT04439799|79487093|FG000|Overall Study|Lost to Follow-up|6|||
44480256|NCT04439799|79487094|FG001|Overall Study|Lost to Follow-up|6|||
44480257|NCT04439799|79487093|FG000|Overall Study|Withdrawal by Subject|2|||
44480258|NCT04439799|79487094|FG001|Overall Study|Withdrawal by Subject|6|||
44480259|NCT04439799|79487093|FG000|Overall Study|Adverse Event|2|||
44480260|NCT04439799|79487094|FG001|Overall Study|Adverse Event|5|||
44480261|NCT04071626|79487110|FG000|Overall Study|Withdrawal by Subject|1|||
44480262|NCT04071626|79487111|FG001|Overall Study|Withdrawal by Subject|1|||
44480263|NCT04071626|79487110|FG000|Overall Study|Protocol Violation|0|||
44480264|NCT04071626|79487111|FG001|Overall Study|Protocol Violation|1|||
44480265|NCT04051008|79487120|FG000|Overall Study|Withdrawal by Subject|2|||
44480266|NCT04051008|79487121|FG001|Overall Study|Withdrawal by Subject|0|||
44480267|NCT04051008|79487122|FG002|Overall Study|Withdrawal by Subject|1|||
44480268|NCT03812185|79487144|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
44480269|NCT03789110|79487150|FG000|Overall Study|Adverse Event|2|||
44480270|NCT03789110|79487150|FG000|Overall Study|Physician Decision|1|||
44480271|NCT03789110|79487150|FG000|Overall Study|Withdrawal by Subject|2|||
44480272|NCT03789110|79487150|FG000|Overall Study|Lack of Efficacy|22|||
44480273|NCT03789110|79487150|FG000|Overall Study|still on treatment|3|||
44480274|NCT03692910|79487167|FG000|Overall Study|Lost to Follow-up|4|||
44480275|NCT03692910|79487168|FG001|Overall Study|Lost to Follow-up|0|||
44480276|NCT03692910|79487169|FG002|Overall Study|Lost to Follow-up|0|||
44480277|NCT03692910|79487167|FG000|Overall Study|Withdrawal by Subject|2|||
44480278|NCT03692910|79487168|FG001|Overall Study|Withdrawal by Subject|0|||
44480279|NCT03692910|79487169|FG002|Overall Study|Withdrawal by Subject|0|||
44480280|NCT03645863|79487178|FG000|Overall Study|Withdrawal by Subject|1|||
44480281|NCT03645863|79487179|FG001|Overall Study|Withdrawal by Subject|0|||
44480282|NCT03645863|79487180|FG002|Overall Study|Withdrawal by Subject|0|||
44480283|NCT03220776|79487201|FG000|Overall Study|Claustrophobia|0|||
44480284|NCT03220776|79487202|FG001|Overall Study|Claustrophobia|1|||
44480285|NCT03220776|79487203|FG002|Overall Study|Claustrophobia|1|||
44480286|NCT03220776|79487204|FG003|Overall Study|Claustrophobia|0|||
44480287|NCT03220776|79487205|FG004|Overall Study|Claustrophobia|1|||
44480288|NCT03220776|79487206|FG005|Overall Study|Claustrophobia|0|||
44480289|NCT03220776|79487201|FG000|Overall Study|MRI Equipment Failure|1|||
44480290|NCT03220776|79487202|FG001|Overall Study|MRI Equipment Failure|0|||
44480291|NCT03220776|79487203|FG002|Overall Study|MRI Equipment Failure|0|||
44480292|NCT03220776|79487204|FG003|Overall Study|MRI Equipment Failure|0|||
44480293|NCT03220776|79487205|FG004|Overall Study|MRI Equipment Failure|0|||
44480294|NCT03220776|79487206|FG005|Overall Study|MRI Equipment Failure|0|||
44480295|NCT03220776|79487201|FG000|Overall Study|Inclimate Weather|0|||
44480296|NCT03220776|79487202|FG001|Overall Study|Inclimate Weather|0|||
44480297|NCT03220776|79487203|FG002|Overall Study|Inclimate Weather|0|||
44480298|NCT03220776|79487204|FG003|Overall Study|Inclimate Weather|0|||
44480299|NCT03220776|79487205|FG004|Overall Study|Inclimate Weather|0|||
44227015|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Death|0|||
44227016|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Death|0|||
44480300|NCT03220776|79487206|FG005|Overall Study|Inclimate Weather|1|||
44480301|NCT03220776|79487201|FG000|Overall Study|Physician Decision|0|||
44480302|NCT03220776|79487202|FG001|Overall Study|Physician Decision|0|||
44480303|NCT03220776|79487203|FG002|Overall Study|Physician Decision|0|||
44480304|NCT03220776|79487204|FG003|Overall Study|Physician Decision|1|||
44480305|NCT03220776|79487205|FG004|Overall Study|Physician Decision|0|||
44480306|NCT03220776|79487206|FG005|Overall Study|Physician Decision|0|||
44480307|NCT03220776|79487201|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
44480308|NCT03220776|79487202|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
44480309|NCT03220776|79487203|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
44480310|NCT03220776|79487204|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
44480311|NCT03220776|79487205|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
44514823|NCT03717012|79520644|FG000|Overall Study|Protocol Violation|0|||
44480312|NCT03220776|79487206|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
44480313|NCT03220776|79487201|FG000|Overall Study|Protocol Violation|0|||
44480314|NCT03220776|79487202|FG001|Overall Study|Protocol Violation|0|||
44480315|NCT03220776|79487203|FG002|Overall Study|Protocol Violation|0|||
44480316|NCT03220776|79487204|FG003|Overall Study|Protocol Violation|2|||
44480317|NCT03220776|79487205|FG004|Overall Study|Protocol Violation|0|||
44480318|NCT03220776|79487206|FG005|Overall Study|Protocol Violation|1|||
44480319|NCT03220776|79487201|FG000|Overall Study|Withdrawal by Subject|1|||
44480320|NCT03220776|79487202|FG001|Overall Study|Withdrawal by Subject|0|||
44480321|NCT03220776|79487203|FG002|Overall Study|Withdrawal by Subject|0|||
44480322|NCT03220776|79487204|FG003|Overall Study|Withdrawal by Subject|0|||
44480323|NCT03220776|79487205|FG004|Overall Study|Withdrawal by Subject|0|||
44480324|NCT03220776|79487206|FG005|Overall Study|Withdrawal by Subject|0|||
44480325|NCT03201874|79487216|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
44480326|NCT03201874|79487217|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
44480327|NCT03201874|79487216|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
44480328|NCT03201874|79487217|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
44480329|NCT03006926|79487244|FG000|Overall Study|Adverse Event|0|||
44480330|NCT03006926|79487245|FG001|Overall Study|Adverse Event|27|||
44480331|NCT03006926|79487244|FG000|Overall Study|Withdrawal by Subject|0|||
44480332|NCT03006926|79487245|FG001|Overall Study|Withdrawal by Subject|1|||
44480333|NCT03006926|79487244|FG000|Overall Study|Radiological Disease Progression|0|||
44480334|NCT03006926|79487245|FG001|Overall Study|Radiological Disease Progression|52|||
44480335|NCT03006926|79487244|FG000|Overall Study|Clinical Disease Progression|0|||
44480336|NCT03006926|79487245|FG001|Overall Study|Clinical Disease Progression|10|||
44480337|NCT03006926|79487244|FG000|Overall Study|Other|0|||
44480338|NCT03006926|79487245|FG001|Overall Study|Other|8|||
44480339|NCT02684058|79487271|FG000|Treatment Period|Progressive disease|4|||
44480340|NCT02684058|79487272|FG001|Treatment Period|Progressive disease|10|||
44480341|NCT02684058|79487273|FG002|Treatment Period|Progressive disease|19|||
44480342|NCT02684058|79487271|FG000|Treatment Period|Adverse Event|3|||
44480343|NCT02684058|79487272|FG001|Treatment Period|Adverse Event|8|||
44480344|NCT02684058|79487273|FG002|Treatment Period|Adverse Event|1|||
44480345|NCT02684058|79487271|FG000|Treatment Period|Physician Decision|5|||
44480346|NCT02684058|79487272|FG001|Treatment Period|Physician Decision|1|||
44480347|NCT02684058|79487273|FG002|Treatment Period|Physician Decision|2|||
44480348|NCT02684058|79487271|FG000|Treatment Period|New therapy for study indication|1|||
44480349|NCT02684058|79487272|FG001|Treatment Period|New therapy for study indication|0|||
44480350|NCT02684058|79487273|FG002|Treatment Period|New therapy for study indication|0|||
44480351|NCT02684058|79487271|FG000|Treatment Period|Protocol deviation|0|||
44480352|NCT02684058|79487272|FG001|Treatment Period|Protocol deviation|1|||
44480353|NCT02684058|79487273|FG002|Treatment Period|Protocol deviation|0|||
44480354|NCT02684058|79487271|FG000|Treatment Period|Subject/guardian decision|4|||
44480355|NCT02684058|79487272|FG001|Treatment Period|Subject/guardian decision|3|||
44480356|NCT02684058|79487273|FG002|Treatment Period|Subject/guardian decision|0|||
44480357|NCT02684058|79487271|FG000|Treatment Period|Death|0|||
44480358|NCT02684058|79487272|FG001|Treatment Period|Death|0|||
44480359|NCT02684058|79487273|FG002|Treatment Period|Death|2|||
44480360|NCT02684058|79487271|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
44480361|NCT02684058|79487272|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
44480362|NCT02684058|79487273|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
44480363|NCT02684058|79487271|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
44480364|NCT02684058|79487272|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
44480365|NCT02684058|79487273|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
44480366|NCT02684058|79487271|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
44480367|NCT02684058|79487272|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
44480368|NCT02684058|79487273|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
44480369|NCT02684058|79487271|FG000|Post-treatment Efficacy Follow-up|Death|0|||
44480370|NCT02684058|79487272|FG001|Post-treatment Efficacy Follow-up|Death|0|||
44227017|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
44480371|NCT02684058|79487273|FG002|Post-treatment Efficacy Follow-up|Death|3|||
44227018|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
44227019|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
44227020|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
44227021|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
44227022|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
44480372|NCT02684058|79487271|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
44480373|NCT02684058|79487272|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
44480374|NCT02684058|79487273|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
44480375|NCT02684058|79487271|FG000|Post-treatment Survival Follow-up|Death|0|||
44480376|NCT02684058|79487272|FG001|Post-treatment Survival Follow-up|Death|0|||
44227023|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
44480377|NCT02684058|79487273|FG002|Post-treatment Survival Follow-up|Death|7|||
44480378|NCT02684058|79487271|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
44480379|NCT02684058|79487272|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
44480380|NCT02684058|79487273|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
44480381|NCT02684058|79487271|FG000|Crossover Treatment Period|Progressive disease|0|||
44480382|NCT02684058|79487272|FG001|Crossover Treatment Period|Progressive disease|1|||
44480383|NCT02684058|79487273|FG002|Crossover Treatment Period|Progressive disease|0|||
44480384|NCT02561273|79487290|FG000|Overall Study|Protocol Violation|1|||
44274123|NCT03211832|79217030|FG001|Overall Study|Not available during data collection|0|||
44274124|NCT03211832|79217031|FG002|Overall Study|Not available during data collection|2|||
44227024|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
44227025|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
44227026|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
44227027|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
44227028|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
44227029|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
44227030|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
44227031|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
44227032|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
44274125|NCT04887948|79217040|FG000|Overall Study|Death|1|||
44274126|NCT04887948|79217041|FG001|Overall Study|Death|0|||
44227033|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
44227034|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
44480385|NCT02561273|79487291|FG001|Overall Study|Protocol Violation|0|||
44480386|NCT02025010|79487327|FG000|Overall Study|Symptomatic or radiographic progression|36|||
44480387|NCT02025010|79487327|FG000|Overall Study|Adverse Event|6|||
44480388|NCT02025010|79487327|FG000|Overall Study|Physician Decision|7|||
44480389|NCT02025010|79487327|FG000|Overall Study|Withdrawal by Subject|3|||
44480390|NCT02025010|79487327|FG000|Overall Study|Intercurrent illness|3|||
44480391|NCT02025010|79487327|FG000|Overall Study|Patients still on treatment|3|||
44480392|NCT02025010|79487327|FG000|Overall Study|Never initiate the treatment|2|||
44480393|NCT02006576|79487336|FG000|Overall Study|Withdrawal by Subject|4|||
44480394|NCT02006576|79487337|FG001|Overall Study|Withdrawal by Subject|6|||
44480395|NCT02006576|79487338|FG002|Overall Study|Withdrawal by Subject|2|||
44480396|NCT02006576|79487336|FG000|Overall Study|Death|0|||
44480397|NCT02006576|79487337|FG001|Overall Study|Death|0|||
44227035|NCT01707992|79033582|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
44227036|NCT01707992|79033583|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
44227037|NCT01707992|79033584|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
44227038|NCT01707992|79033585|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
44274127|NCT04887948|79217042|FG002|Overall Study|Death|0|||
44274128|NCT04887948|79217040|FG000|Overall Study|Lost to Follow-up|1|||
44274129|NCT04887948|79217041|FG001|Overall Study|Lost to Follow-up|0|||
44274130|NCT04887948|79217042|FG002|Overall Study|Lost to Follow-up|3|||
44480398|NCT02006576|79487338|FG002|Overall Study|Death|1|||
44480399|NCT02006576|79487336|FG000|Overall Study|Lost to Follow-up|1|||
44480400|NCT02006576|79487337|FG001|Overall Study|Lost to Follow-up|0|||
44480401|NCT02006576|79487338|FG002|Overall Study|Lost to Follow-up|1|||
44480402|NCT02006576|79487336|FG000|Overall Study|Screen Failure, too sick, other|13|||
44480403|NCT02006576|79487337|FG001|Overall Study|Screen Failure, too sick, other|1|||
44480404|NCT02006576|79487338|FG002|Overall Study|Screen Failure, too sick, other|13|||
44480405|NCT01651403|79487348|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
44480406|NCT01651403|79487349|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
44480407|NCT01651403|79487348|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
44480408|NCT01651403|79487349|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
44274131|NCT04887948|79217040|FG000|Overall Study|Physician Decision|0|||
44274132|NCT04887948|79217041|FG001|Overall Study|Physician Decision|4|||
44274133|NCT04887948|79217042|FG002|Overall Study|Physician Decision|1|||
44274134|NCT04887948|79217040|FG000|Overall Study|Protocol Violation|1|||
44375608|NCT00953706|79380761|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
44480409|NCT01651403|79487348|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
44274135|NCT04887948|79217041|FG001|Overall Study|Protocol Violation|1|||
44274136|NCT04887948|79217042|FG002|Overall Study|Protocol Violation|0|||
44480410|NCT01651403|79487349|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
44274137|NCT04887948|79217040|FG000|Overall Study|Withdrawal by Subject|0|||
44480411|NCT01651403|79487348|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
44375609|NCT00953706|79380758|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
44480412|NCT01651403|79487349|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
44480413|NCT01651403|79487348|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
44480414|NCT01651403|79487349|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
44480415|NCT01651403|79487348|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
44480416|NCT01651403|79487349|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
44480417|NCT01515748|79487362|FG000|Overall Study|Withdrawal by Subject|32|||
44480418|NCT01515748|79487363|FG001|Overall Study|Withdrawal by Subject|41|||
44480419|NCT01515748|79487362|FG000|Overall Study|Lost to Follow-up|2|||
44480420|NCT01515748|79487363|FG001|Overall Study|Lost to Follow-up|4|||
44480421|NCT01515748|79487362|FG000|Overall Study|Other than specified above|5|||
44480422|NCT01515748|79487363|FG001|Overall Study|Other than specified above|10|||
44480423|NCT01309672|79487370|FG000|Overall Study|Lack of Efficacy|20|||
44480424|NCT01309672|79487370|FG000|Overall Study|Other|9|||
44480425|NCT01309672|79487370|FG000|Overall Study|Adverse Event|5|||
44480426|NCT01309672|79487370|FG000|Overall Study|Withdrawal by Subject|3|||
44480427|NCT00340704|79487388|FG000|PK Study|Adverse Event|0|||
44480428|NCT00340704|79487389|FG001|PK Study|Adverse Event|1|||
44480429|NCT00340704|79487390|FG002|PK Study|Adverse Event|0|||
44480430|NCT00340704|79487391|FG003|PK Study|Adverse Event|0|||
44480431|NCT00340704|79487392|FG004|PK Study|Adverse Event|0|||
44480432|NCT00340704|79487393|FG005|PK Study|Adverse Event|0|||
44480433|NCT00340704|79487394|FG006|PK Study|Adverse Event|0|||
44480434|NCT00340704|79487395|FG007|PK Study|Adverse Event|0|||
44480435|NCT00340704|79487396|FG008|PK Study|Adverse Event|0|||
44480436|NCT00340704|79487388|FG000|PK Study|Not treated|0|||
44480437|NCT00340704|79487389|FG001|PK Study|Not treated|0|||
44480438|NCT00340704|79487390|FG002|PK Study|Not treated|1|||
44480439|NCT00340704|79487391|FG003|PK Study|Not treated|0|||
44480440|NCT00340704|79487392|FG004|PK Study|Not treated|0|||
44480441|NCT00340704|79487393|FG005|PK Study|Not treated|0|||
44480442|NCT00340704|79487394|FG006|PK Study|Not treated|0|||
44480443|NCT00340704|79487395|FG007|PK Study|Not treated|0|||
44480444|NCT00340704|79487396|FG008|PK Study|Not treated|0|||
44480445|NCT00340704|79487388|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
44480446|NCT00340704|79487389|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
44480447|NCT00340704|79487390|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
44480448|NCT00340704|79487391|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
44480449|NCT00340704|79487392|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
44480450|NCT00340704|79487393|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
44480451|NCT00340704|79487394|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
44480452|NCT00340704|79487395|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
44480453|NCT00340704|79487396|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
44480454|NCT00340704|79487388|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480455|NCT00340704|79487389|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480456|NCT00340704|79487390|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480457|NCT00340704|79487391|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480458|NCT00340704|79487392|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480459|NCT00340704|79487393|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
44480460|NCT00340704|79487394|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480461|NCT00340704|79487395|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480462|NCT00340704|79487396|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
44480463|NCT00340704|79487388|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480464|NCT00340704|79487389|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480465|NCT00340704|79487390|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480466|NCT00340704|79487391|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480467|NCT00340704|79487392|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
44480468|NCT00340704|79487393|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
44480469|NCT00340704|79487394|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480470|NCT00340704|79487395|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480471|NCT00340704|79487396|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
44480472|NCT00340704|79487388|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
44480473|NCT00340704|79487389|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
44480474|NCT00340704|79487390|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
44480475|NCT00340704|79487391|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
44480476|NCT00340704|79487392|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
44480477|NCT00340704|79487393|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
44480478|NCT00340704|79487394|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
44480479|NCT00340704|79487395|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
44480480|NCT00340704|79487396|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
44480481|NCT00132496|79487424|FG000|Overall Study|Withdrawal by Subject|1|||
44480482|NCT00132496|79487425|FG001|Overall Study|Withdrawal by Subject|2|||
44480483|NCT00132496|79487424|FG000|Overall Study|Physician Decision|1|||
44480484|NCT00132496|79487425|FG001|Overall Study|Physician Decision|0|||
44480485|NCT00231777|79487433|FG000|Overall Study|Lost to Follow-up|3|||
44480486|NCT00231777|79487434|FG001|Overall Study|Lost to Follow-up|0|||
44480487|NCT00231777|79487433|FG000|Overall Study|Other|3|||
44480488|NCT00231777|79487434|FG001|Overall Study|Other|2|||
44480489|NCT00231465|79487440|FG000|Overall Study|Completed only one cycle|1|||
44480490|NCT00231465|79487440|FG000|Overall Study|Did not have follow up CT scans|1|||
44480491|NCT00254397|79487448|FG000|Overall Study|Disease Progression|4|||
44480492|NCT00254397|79487449|FG001|Overall Study|Disease Progression|1|||
44480493|NCT00254397|79487450|FG002|Overall Study|Disease Progression|16|||
44480494|NCT00254397|79487451|FG003|Overall Study|Disease Progression|23|||
44480495|NCT00254397|79487448|FG000|Overall Study|Non-Compliant|0|||
44480496|NCT00254397|79487449|FG001|Overall Study|Non-Compliant|0|||
44480497|NCT00254397|79487450|FG002|Overall Study|Non-Compliant|0|||
44480498|NCT00254397|79487451|FG003|Overall Study|Non-Compliant|1|||
44480499|NCT00254397|79487448|FG000|Overall Study|Adverse Event|2|||
44480500|NCT00254397|79487449|FG001|Overall Study|Adverse Event|0|||
44480501|NCT00254397|79487450|FG002|Overall Study|Adverse Event|3|||
44480502|NCT00254397|79487451|FG003|Overall Study|Adverse Event|1|||
44480503|NCT00254163|79487462|FG000|Overall Study|Adverse Event|29|||
44480504|NCT00254163|79487463|FG001|Overall Study|Adverse Event|26|||
44480505|NCT00254163|79487462|FG000|Overall Study|Patient request/withdrew consent|6|||
44480506|NCT00254163|79487463|FG001|Overall Study|Patient request/withdrew consent|4|||
44480507|NCT00254163|79487462|FG000|Overall Study|Investigator request|1|||
44480508|NCT00254163|79487463|FG001|Overall Study|Investigator request|3|||
44480509|NCT00254163|79487462|FG000|Overall Study|Failed entry|1|||
44480510|NCT00254163|79487463|FG001|Overall Study|Failed entry|3|||
44480511|NCT00254163|79487462|FG000|Overall Study|Progressive disease|0|||
44480512|NCT00254163|79487463|FG001|Overall Study|Progressive disease|1|||
44480513|NCT00254163|79487462|FG000|Overall Study|Death|0|||
44480514|NCT00254163|79487463|FG001|Overall Study|Death|1|||
44480515|NCT00254163|79487462|FG000|Overall Study|Other|8|||
44480516|NCT00254163|79487463|FG001|Overall Study|Other|8|||
44480517|NCT03869333|79487473|FG000|Overall Study|Lost to Follow-up|1|||
44480518|NCT03869333|79487474|FG001|Overall Study|Lost to Follow-up|0|||
44480519|NCT03869333|79487475|FG002|Overall Study|Lost to Follow-up|0|||
44480520|NCT03869333|79487476|FG003|Overall Study|Lost to Follow-up|0|||
44480521|NCT03869333|79487473|FG000|Overall Study|Pregnancy|1|||
44480522|NCT03869333|79487474|FG001|Overall Study|Pregnancy|0|||
44480523|NCT03869333|79487475|FG002|Overall Study|Pregnancy|0|||
44227039|NCT01707992|79033586|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
44227040|NCT01707992|79033587|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
44227041|NCT01946165|79033604|FG000|Overall Study|Physician Decision|2|||
44227042|NCT01946165|79033605|FG001|Overall Study|Physician Decision|0|||
44227043|NCT01946165|79033604|FG000|Overall Study|Withdrawal by Subject|0|||
44227044|NCT01946165|79033605|FG001|Overall Study|Withdrawal by Subject|2|||
44227045|NCT01707667|79033614|FG000|Period 1|expulsion of colonic sensor catheter|1|||
44227046|NCT01707667|79033615|FG001|Period 1|expulsion of colonic sensor catheter|0|||
44227047|NCT01959503|79033623|FG000|Overall Study|Death|2|||
44227048|NCT01959503|79033624|FG001|Overall Study|Death|1|||
44227049|NCT01959503|79033623|FG000|Overall Study|Randomized but not treated|1|||
44227050|NCT01959503|79033624|FG001|Overall Study|Randomized but not treated|1|||
44227051|NCT01605799|79033632|FG000|Overall Study|Withdrawal by Subject|2|||
44227052|NCT01605799|79033633|FG001|Overall Study|Withdrawal by Subject|1|||
44227053|NCT01706575|79033639|FG000|Overall Study|Participant Withdrew Consent|4|||
44227054|NCT01706575|79033639|FG000|Overall Study|Lost to Follow-up|2|||
44375610|NCT00953706|79380759|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
44480524|NCT03869333|79487476|FG003|Overall Study|Pregnancy|0|||
44480525|NCT03869333|79487473|FG000|Overall Study|Physician Decision|0|||
44480526|NCT03869333|79487474|FG001|Overall Study|Physician Decision|1|||
44480527|NCT03869333|79487475|FG002|Overall Study|Physician Decision|0|||
44480528|NCT03869333|79487476|FG003|Overall Study|Physician Decision|0|||
44480529|NCT00110890|79487488|FG000|Overall Study|Adverse Event|30|||
44480530|NCT00110890|79487489|FG001|Overall Study|Adverse Event|7|||
44480531|NCT00110890|79487488|FG000|Overall Study|Death|16|||
44480532|NCT00110890|79487489|FG001|Overall Study|Death|9|||
44480533|NCT00110890|79487488|FG000|Overall Study|Lost to Follow-up|3|||
44227055|NCT01706575|79033639|FG000|Overall Study|Started but not Treated|6|||
44227056|NCT01959425|79033645|FG000|Overall Study|Withdrawal by Subject|5|||
44227057|NCT01959425|79033646|FG001|Overall Study|Withdrawal by Subject|4|||
44480534|NCT00110890|79487489|FG001|Overall Study|Lost to Follow-up|1|||
44480535|NCT00110890|79487488|FG000|Overall Study|Physician Decision|4|||
44227058|NCT01959425|79033645|FG000|Overall Study|Lost to Follow-up|1|||
44227059|NCT01959425|79033646|FG001|Overall Study|Lost to Follow-up|0|||
44227060|NCT01959425|79033645|FG000|Overall Study|Discontinued Subjects|6|||
44227061|NCT01959425|79033646|FG001|Overall Study|Discontinued Subjects|4|||
44227062|NCT01725529|79033655|FG000|Overall Study|Adverse Event|1|||
44227063|NCT01725529|79033656|FG001|Overall Study|Adverse Event|0|||
44227064|NCT01725529|79033657|FG002|Overall Study|Adverse Event|0|||
44227065|NCT01725529|79033655|FG000|Overall Study|Lost to Follow-up|2|||
44227066|NCT01725529|79033656|FG001|Overall Study|Lost to Follow-up|1|||
44227067|NCT01725529|79033657|FG002|Overall Study|Lost to Follow-up|1|||
44227068|NCT01725529|79033655|FG000|Overall Study|Protocol Violation|0|||
44227069|NCT01725529|79033656|FG001|Overall Study|Protocol Violation|1|||
44227070|NCT01725529|79033657|FG002|Overall Study|Protocol Violation|1|||
44480536|NCT00110890|79487489|FG001|Overall Study|Physician Decision|5|||
44480537|NCT00110890|79487488|FG000|Overall Study|Withdrawal by Subject|17|||
44480538|NCT00110890|79487489|FG001|Overall Study|Withdrawal by Subject|5|||
44480539|NCT00110890|79487488|FG000|Overall Study|Protocol Deviation|1|||
44480540|NCT00110890|79487489|FG001|Overall Study|Protocol Deviation|0|||
44480541|NCT00110890|79487488|FG000|Overall Study|Noncompliance|10|||
44480542|NCT00110890|79487489|FG001|Overall Study|Noncompliance|0|||
44480543|NCT00110890|79487488|FG000|Overall Study|Kidney Transplant|16|||
44480544|NCT00110890|79487489|FG001|Overall Study|Kidney Transplant|12|||
44480545|NCT00110890|79487488|FG000|Overall Study|Invest. Product Commercially Available|217|||
44480546|NCT00110890|79487489|FG001|Overall Study|Invest. Product Commercially Available|110|||
44480547|NCT00110890|79487488|FG000|Overall Study|Other|34|||
44480548|NCT00110890|79487489|FG001|Overall Study|Other|23|||
44480549|NCT00110890|79487488|FG000|Overall Study|Ineligibility determined|3|||
44480550|NCT00110890|79487489|FG001|Overall Study|Ineligibility determined|0|||
44480551|NCT00110890|79487488|FG000|Overall Study|Requirement for alternative therapy|0|||
44480552|NCT00110890|79487489|FG001|Overall Study|Requirement for alternative therapy|1|||
44480553|NCT00110890|79487488|FG000|Overall Study|Disease progression|0|||
44480554|NCT00110890|79487489|FG001|Overall Study|Disease progression|1|||
44480555|NCT00110890|79487488|FG000|Overall Study|Parathyroidectomy|0|||
44480556|NCT00110890|79487489|FG001|Overall Study|Parathyroidectomy|1|||
44480557|NCT00110890|79487488|FG000|Overall Study|Did not enter follow-up phase|10|||
44480558|NCT00110890|79487489|FG001|Overall Study|Did not enter follow-up phase|4|||
44480559|NCT00182637|79487495|FG000|Overall Study|Adverse Event|2|||
44227071|NCT01725529|79033655|FG000|Overall Study|Withdrawal by Subject|12|||
44227072|NCT01725529|79033656|FG001|Overall Study|Withdrawal by Subject|14|||
44227073|NCT01725529|79033657|FG002|Overall Study|Withdrawal by Subject|8|||
44480560|NCT00182637|79487495|FG000|Overall Study|Disease Progression|1|||
44480561|NCT00182325|79487502|FG000|Overall Study|Lost to Follow-up|7|||
44480562|NCT00182325|79487503|FG001|Overall Study|Lost to Follow-up|7|||
44480563|NCT00182325|79487502|FG000|Overall Study|Miscarriage|5|||
44227074|NCT01605097|79033665|FG000|Overall Study|Protocol Violation|1|||
44227075|NCT01605019|79033672|FG000|Overall Study|pt did not meet transplant endpoint|3|||
44227076|NCT01605019|79033673|FG001|Overall Study|pt did not meet transplant endpoint|0|||
44227077|NCT01705717|79033681|FG000|Overall Study|Adverse Event|2|||
44480564|NCT00182325|79487503|FG001|Overall Study|Miscarriage|3|||
44227078|NCT01705717|79033682|FG001|Overall Study|Adverse Event|2|||
44227079|NCT01705717|79033681|FG000|Overall Study|Lack of Efficacy|0|||
44227080|NCT01705717|79033682|FG001|Overall Study|Lack of Efficacy|1|||
44227081|NCT01705717|79033681|FG000|Overall Study|Other|0|||
44227082|NCT01705717|79033682|FG001|Overall Study|Other|2|||
44227083|NCT01744483|79033690|FG000|Overall Study|Death|9|||
44227084|NCT01744483|79033691|FG001|Overall Study|Death|4|||
44227085|NCT01744483|79033692|FG002|Overall Study|Death|11|||
44227086|NCT01744483|79033690|FG000|Overall Study|Lost to Follow-up|8|||
44227087|NCT01744483|79033691|FG001|Overall Study|Lost to Follow-up|9|||
44227088|NCT01744483|79033692|FG002|Overall Study|Lost to Follow-up|11|||
44227089|NCT01744483|79033690|FG000|Overall Study|Protocol Violation|1|||
44227090|NCT01744483|79033691|FG001|Overall Study|Protocol Violation|2|||
44227091|NCT01744483|79033692|FG002|Overall Study|Protocol Violation|1|||
44227092|NCT01744483|79033690|FG000|Overall Study|Withdrawal by Subject|4|||
44227093|NCT01744483|79033691|FG001|Overall Study|Withdrawal by Subject|6|||
44227094|NCT01744483|79033692|FG002|Overall Study|Withdrawal by Subject|2|||
44480565|NCT00182325|79487502|FG000|Overall Study|Did not complete survey|22|||
44375611|NCT00953706|79380760|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
44375612|NCT00953706|79380761|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
44375613|NCT00953706|79380758|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
44375614|NCT00953706|79380759|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
44375615|NCT00953706|79380760|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
44375616|NCT00953706|79380761|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
44375617|NCT00953706|79380758|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
44375618|NCT00953706|79380759|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
44375619|NCT00953706|79380760|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
44375620|NCT00953706|79380761|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
44375621|NCT00953706|79380758|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
44375622|NCT00953706|79380759|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
44375623|NCT00953706|79380760|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
44375624|NCT00953706|79380761|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
44544693|NCT03178266|79558256|FG001|Overall Study|Disont. Early|1|||
44544694|NCT03178266|79558255|FG000|Overall Study|Withdrawal by Subject|0|||
44227095|NCT01744483|79033690|FG000|Overall Study|No ICU Admit|5|||
44227096|NCT01744483|79033691|FG001|Overall Study|No ICU Admit|1|||
44227097|NCT01744483|79033692|FG002|Overall Study|No ICU Admit|2|||
44227098|NCT01744483|79033690|FG000|Overall Study|Routed to OSH|2|||
44227099|NCT01744483|79033691|FG001|Overall Study|Routed to OSH|0|||
44227100|NCT01744483|79033692|FG002|Overall Study|Routed to OSH|1|||
44227101|NCT01744093|79033702|FG000|Overall Study|Withdrawal by Subject|6|||
44227102|NCT01744093|79033703|FG001|Overall Study|Withdrawal by Subject|1|||
44227103|NCT01725451|79033717|FG000|Period 1|Withdrawal by Subject|1|||
44227104|NCT01725451|79033718|FG001|Period 1|Withdrawal by Subject|0|||
44227105|NCT01725451|79033719|FG002|Period 1|Withdrawal by Subject|0|||
44227106|NCT01725451|79033720|FG003|Period 1|Withdrawal by Subject|0|||
44227107|NCT01725451|79033717|FG000|Washout From Period 3|Protocol Violation|0|||
44227108|NCT01725451|79033718|FG001|Washout From Period 3|Protocol Violation|0|||
44227109|NCT01725451|79033719|FG002|Washout From Period 3|Protocol Violation|1|||
44227110|NCT01725451|79033720|FG003|Washout From Period 3|Protocol Violation|0|||
44227111|NCT01725451|79033717|FG000|Washout From Period 3|Adverse Event|0|||
44227112|NCT01725451|79033718|FG001|Washout From Period 3|Adverse Event|1|||
44227113|NCT01725451|79033719|FG002|Washout From Period 3|Adverse Event|0|||
44227114|NCT01725451|79033720|FG003|Washout From Period 3|Adverse Event|0|||
44227115|NCT01725451|79033717|FG000|Period 4|Adverse Event|0|||
44227116|NCT01725451|79033718|FG001|Period 4|Adverse Event|0|||
44227117|NCT01725451|79033719|FG002|Period 4|Adverse Event|1|||
44227118|NCT01725451|79033720|FG003|Period 4|Adverse Event|0|||
44227119|NCT01707290|79033737|FG000|Overall Study|Adverse event (AE)|1|||
44227120|NCT01707290|79033738|FG001|Overall Study|Adverse event (AE)|0|||
44227121|NCT01707290|79033737|FG000|Overall Study|Physician Decision|1|||
44227122|NCT01707290|79033738|FG001|Overall Study|Physician Decision|0|||
44227123|NCT01707290|79033737|FG000|Overall Study|Lost to Follow-up|3|||
44227124|NCT01707290|79033738|FG001|Overall Study|Lost to Follow-up|0|||
44227125|NCT01707290|79033737|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
44227126|NCT01707290|79033738|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
44227127|NCT01707290|79033737|FG000|Overall Study|Commercial drug available|60|||
44227128|NCT01707290|79033738|FG001|Overall Study|Commercial drug available|1|||
44227129|NCT01707290|79033737|FG000|Overall Study|Other unspecified|17|||
44227130|NCT01707290|79033738|FG001|Overall Study|Other unspecified|0|||
44227131|NCT01717040|79033749|FG000|Overall Study|Lost to Follow-up|2|||
44227132|NCT01717040|79033750|FG001|Overall Study|Lost to Follow-up|3|||
44227133|NCT01717040|79033749|FG000|Overall Study|Lack of Efficacy|1|||
44227134|NCT01717040|79033750|FG001|Overall Study|Lack of Efficacy|1|||
44227135|NCT01717040|79033749|FG000|Overall Study|Adverse Event|1|||
44227136|NCT01717040|79033750|FG001|Overall Study|Adverse Event|0|||
44480566|NCT00182325|79487503|FG001|Overall Study|Did not complete survey|43|||
44480567|NCT00122278|79487511|FG000|Overall Study|Lost to Follow-up|2|||
44480568|NCT00122278|79487512|FG001|Overall Study|Lost to Follow-up|0|||
44480569|NCT00182091|79487522|FG000|Overall Study|Withdrawal by Subject|1|||
44480570|NCT00182091|79487523|FG001|Overall Study|Withdrawal by Subject|0|||
44480571|NCT00182091|79487524|FG002|Overall Study|Withdrawal by Subject|0|||
44480572|NCT00182091|79487525|FG003|Overall Study|Withdrawal by Subject|0|||
44480573|NCT00181155|79487533|FG000|Overall Study|Physician Decision|1|||
44480574|NCT00181155|79487534|FG001|Overall Study|Physician Decision|0|||
44480575|NCT00181155|79487533|FG000|Overall Study|Withdrawal by Subject|1|||
44480576|NCT00181155|79487534|FG001|Overall Study|Withdrawal by Subject|0|||
44480577|NCT00322452|79487543|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44480578|NCT00322452|79487544|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44480579|NCT00322452|79487543|FG000|Overall Study|Lost to Follow-up|5|||
44480580|NCT00322452|79487544|FG001|Overall Study|Lost to Follow-up|2|||
44480581|NCT00322452|79487543|FG000|Overall Study|Withdrawal by Subject|19|||
44480582|NCT00322452|79487544|FG001|Overall Study|Withdrawal by Subject|46|||
44480583|NCT00322452|79487543|FG000|Overall Study|Death|223|||
44480584|NCT00322452|79487544|FG001|Overall Study|Death|227|||
44480585|NCT00110812|79487553|FG000|Main Study|Death|0|||
44480586|NCT00110812|79487554|FG001|Main Study|Death|0|||
44480587|NCT00110812|79487555|FG002|Main Study|Death|2|||
44480588|NCT00110812|79487553|FG000|Main Study|Withdrawal by Subject|0|||
44480589|NCT00110812|79487554|FG001|Main Study|Withdrawal by Subject|0|||
44480590|NCT00110812|79487555|FG002|Main Study|Withdrawal by Subject|1|||
44480591|NCT00110812|79487553|FG000|Main Study|Lost to Follow-up|8|||
44480592|NCT00110812|79487554|FG001|Main Study|Lost to Follow-up|11|||
44480593|NCT00110812|79487555|FG002|Main Study|Lost to Follow-up|10|||
44480594|NCT00110812|79487553|FG000|Extended Follow-up|Death|1|||
44480595|NCT00110812|79487554|FG001|Extended Follow-up|Death|0|||
44480596|NCT00110812|79487555|FG002|Extended Follow-up|Death|3|||
44480597|NCT00110812|79487553|FG000|Extended Follow-up|Withdrawal by Subject|0|||
44480598|NCT00110812|79487554|FG001|Extended Follow-up|Withdrawal by Subject|1|||
44480599|NCT00110812|79487555|FG002|Extended Follow-up|Withdrawal by Subject|0|||
44480600|NCT00110812|79487553|FG000|Extended Follow-up|Lost to Follow-up|1|||
44480601|NCT00110812|79487554|FG001|Extended Follow-up|Lost to Follow-up|3|||
44480602|NCT00110812|79487555|FG002|Extended Follow-up|Lost to Follow-up|1|||
44480603|NCT00516269|79487570|FG000|Overall Study|Adverse Event|2|||
44480604|NCT00516269|79487571|FG001|Overall Study|Adverse Event|1|||
44480605|NCT00516269|79487570|FG000|Overall Study|Lost to Follow-up|0|||
44480606|NCT00516269|79487571|FG001|Overall Study|Lost to Follow-up|1|||
44480607|NCT00516269|79487570|FG000|Overall Study|Protocol Violation|0|||
44480608|NCT00516269|79487571|FG001|Overall Study|Protocol Violation|1|||
44480609|NCT00229203|79487579|FG000|Overall Study|Progressive disease|18|||
44480610|NCT00229203|79487580|FG001|Overall Study|Progressive disease|9|||
44480611|NCT00229203|79487579|FG000|Overall Study|Toxicity|6|||
44480612|NCT00229203|79487580|FG001|Overall Study|Toxicity|1|||
44480613|NCT00229203|79487579|FG000|Overall Study|Death|4|||
44480614|NCT00229203|79487580|FG001|Overall Study|Death|2|||
44480615|NCT00229203|79487579|FG000|Overall Study|Other|3|||
44480616|NCT00229203|79487580|FG001|Overall Study|Other|3|||
44480617|NCT00229203|79487579|FG000|Overall Study|Withdrawal by Subject|1|||
44480618|NCT00229203|79487580|FG001|Overall Study|Withdrawal by Subject|4|||
44480619|NCT00228813|79487586|FG000|Overall Study|Death|4|||
44480620|NCT00322374|79487593|FG000|Starting Dose|Physician Decision|2|||
44480621|NCT00322374|79487594|FG001|Starting Dose|Physician Decision|0|||
44480622|NCT00322374|79487595|FG002|Starting Dose|Physician Decision|0|||
44480623|NCT00322374|79487596|FG003|Starting Dose|Physician Decision|0|||
44480624|NCT00322374|79487593|FG000|Starting Dose|Study Drug Toxicity|4|||
44480625|NCT00322374|79487594|FG001|Starting Dose|Study Drug Toxicity|0|||
44480626|NCT00322374|79487595|FG002|Starting Dose|Study Drug Toxicity|0|||
44375625|NCT00953706|79380758|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
44480627|NCT00322374|79487596|FG003|Starting Dose|Study Drug Toxicity|0|||
44480628|NCT00322374|79487593|FG000|First Escalation|Documented Disease Progression|0|||
44480629|NCT00322374|79487594|FG001|First Escalation|Documented Disease Progression|6|||
44480630|NCT00322374|79487595|FG002|First Escalation|Documented Disease Progression|0|||
44480631|NCT00322374|79487596|FG003|First Escalation|Documented Disease Progression|0|||
44480632|NCT00322374|79487593|FG000|First Escalation|Physician Decision|0|||
44480633|NCT00322374|79487594|FG001|First Escalation|Physician Decision|12|||
44480634|NCT00322374|79487595|FG002|First Escalation|Physician Decision|0|||
44480635|NCT00322374|79487596|FG003|First Escalation|Physician Decision|0|||
44480636|NCT00322374|79487593|FG000|First Escalation|Study Drug Toxicity|0|||
44480637|NCT00322374|79487594|FG001|First Escalation|Study Drug Toxicity|11|||
44480638|NCT00322374|79487595|FG002|First Escalation|Study Drug Toxicity|0|||
44480639|NCT00322374|79487596|FG003|First Escalation|Study Drug Toxicity|0|||
44480640|NCT00322374|79487593|FG000|First Escalation|Participant Request|0|||
44480641|NCT00322374|79487594|FG001|First Escalation|Participant Request|1|||
44480642|NCT00322374|79487595|FG002|First Escalation|Participant Request|0|||
44480643|NCT00322374|79487596|FG003|First Escalation|Participant Request|0|||
44480644|NCT00322374|79487593|FG000|Second Escalation|Physician Decision|0|||
44480645|NCT00322374|79487594|FG001|Second Escalation|Physician Decision|0|||
44480646|NCT00322374|79487595|FG002|Second Escalation|Physician Decision|5|||
44480647|NCT00322374|79487596|FG003|Second Escalation|Physician Decision|0|||
44480648|NCT00322374|79487593|FG000|Second Escalation|Study Drug Toxicity|0|||
44480649|NCT00322374|79487594|FG001|Second Escalation|Study Drug Toxicity|0|||
44480650|NCT00322374|79487595|FG002|Second Escalation|Study Drug Toxicity|1|||
44480651|NCT00322374|79487596|FG003|Second Escalation|Study Drug Toxicity|0|||
44480652|NCT00174447|79487609|FG000|Overall Study|Adverse Event|19|||
44480653|NCT00174447|79487609|FG000|Overall Study|Withdrawal by Subject|15|||
44480654|NCT00174447|79487609|FG000|Overall Study|Protocol Violation|1|||
44480655|NCT00174447|79487609|FG000|Overall Study|Lack of Efficacy|1|||
44480656|NCT00174447|79487609|FG000|Overall Study|Administrative reason/Other|2|||
44480657|NCT00321984|79487616|FG000|Overall Study|Adverse Event|9|||
44480658|NCT00321984|79487617|FG001|Overall Study|Adverse Event|6|||
44480659|NCT00321984|79487618|FG002|Overall Study|Adverse Event|8|||
44480660|NCT00321984|79487616|FG000|Overall Study|Protocol Violation|0|||
44480661|NCT00321984|79487617|FG001|Overall Study|Protocol Violation|1|||
44480662|NCT00321984|79487618|FG002|Overall Study|Protocol Violation|1|||
44480663|NCT00321984|79487616|FG000|Overall Study|Lost to Follow-up|2|||
44480664|NCT00321984|79487617|FG001|Overall Study|Lost to Follow-up|4|||
44480665|NCT00321984|79487618|FG002|Overall Study|Lost to Follow-up|2|||
44480666|NCT00321984|79487616|FG000|Overall Study|Withdrawal by Subject|8|||
44480667|NCT00321984|79487617|FG001|Overall Study|Withdrawal by Subject|6|||
44480668|NCT00321984|79487618|FG002|Overall Study|Withdrawal by Subject|5|||
44480669|NCT00321984|79487616|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
44480670|NCT00321984|79487617|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
44480671|NCT00321984|79487618|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
44480672|NCT00321984|79487616|FG000|Overall Study|Lack of Efficacy|3|||
44480673|NCT00321984|79487617|FG001|Overall Study|Lack of Efficacy|1|||
44480674|NCT00321984|79487618|FG002|Overall Study|Lack of Efficacy|3|||
44480675|NCT00321984|79487616|FG000|Overall Study|Noncompliant|0|||
44480676|NCT00321984|79487617|FG001|Overall Study|Noncompliant|0|||
44480677|NCT00321984|79487618|FG002|Overall Study|Noncompliant|2|||
44480678|NCT00321984|79487616|FG000|Overall Study|Pregnancy|0|||
44480679|NCT00321984|79487617|FG001|Overall Study|Pregnancy|1|||
44480680|NCT00321984|79487618|FG002|Overall Study|Pregnancy|0|||
44480681|NCT00321984|79487616|FG000|Overall Study|Per Subject Request|1|||
44480682|NCT00321984|79487617|FG001|Overall Study|Per Subject Request|0|||
44480683|NCT00321984|79487618|FG002|Overall Study|Per Subject Request|0|||
44480684|NCT00321984|79487616|FG000|Overall Study|Per Investigator Request|1|||
44480685|NCT00321984|79487617|FG001|Overall Study|Per Investigator Request|0|||
44480686|NCT00321984|79487618|FG002|Overall Study|Per Investigator Request|0|||
44480687|NCT00321984|79487616|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
44480688|NCT00321984|79487617|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
44480689|NCT00321984|79487618|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
44480690|NCT00515099|79487628|FG000|Overall Study|Lost to Follow-up|0|||
44480691|NCT00515099|79487629|FG001|Overall Study|Lost to Follow-up|4|||
44480692|NCT00515099|79487628|FG000|Overall Study|Withdrawal by Subject|2|||
44480693|NCT00515099|79487629|FG001|Overall Study|Withdrawal by Subject|0|||
44480694|NCT00515099|79487628|FG000|Overall Study|IRB Recommendation|1|||
44480695|NCT00515099|79487629|FG001|Overall Study|IRB Recommendation|0|||
44480696|NCT00110266|79487635|FG000|Overall Study|Adverse Event|27|||
44480697|NCT00110266|79487635|FG000|Overall Study|Abnormal laboratory value|15|||
44480698|NCT00110266|79487635|FG000|Overall Study|Withdrawal by Subject|16|||
44480699|NCT00110266|79487635|FG000|Overall Study|Death|17|||
44480700|NCT00110266|79487635|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44480701|NCT00110266|79487635|FG000|Overall Study|Participant condition no longer requires study drug|1|||
44480702|NCT00174291|79487642|FG000|Overall Study|Lost to Follow-up|1|||
44480703|NCT00174291|79487643|FG001|Overall Study|Lost to Follow-up|1|||
44480704|NCT00174291|79487642|FG000|Overall Study|Protocol Violation|0|||
44480705|NCT00174291|79487643|FG001|Overall Study|Protocol Violation|2|||
44480706|NCT00174291|79487642|FG000|Overall Study|Study terminated by sponsor|1|||
44480707|NCT00174291|79487643|FG001|Overall Study|Study terminated by sponsor|0|||
44274138|NCT04887948|79217041|FG001|Overall Study|Withdrawal by Subject|6|||
44480708|NCT00174291|79487642|FG000|Overall Study|Withdrawal by Subject|3|||
44480709|NCT00174291|79487643|FG001|Overall Study|Withdrawal by Subject|3|||
44480710|NCT00366548|79487651|FG000|Infant Series|Adverse Event|1|||
44480711|NCT00366548|79487652|FG001|Infant Series|Adverse Event|3|||
44480712|NCT00366548|79487651|FG000|Infant Series|Protocol Violation|0|||
44480713|NCT00366548|79487652|FG001|Infant Series|Protocol Violation|1|||
44480714|NCT00366548|79487651|FG000|Infant Series|Withdrawal by Subject|3|||
44274139|NCT04887948|79217042|FG002|Overall Study|Withdrawal by Subject|1|||
44480715|NCT00366548|79487652|FG001|Infant Series|Withdrawal by Subject|1|||
44480716|NCT00366548|79487651|FG000|After Infant Series|Withdrawal by Subject|3|||
44480717|NCT00366548|79487652|FG001|After Infant Series|Withdrawal by Subject|1|||
44480718|NCT00366548|79487651|FG000|After Infant Series|Adverse Event|2|||
44480719|NCT00366548|79487652|FG001|After Infant Series|Adverse Event|0|||
44480720|NCT00366548|79487651|FG000|After Infant Series|Lost to Follow-up|1|||
44480721|NCT00366548|79487652|FG001|After Infant Series|Lost to Follow-up|0|||
44480722|NCT00252057|79487678|FG000|Overall Study|Withdrawal by Subject|2|||
44480723|NCT00252057|79487679|FG001|Overall Study|Withdrawal by Subject|5|||
44480724|NCT00252057|79487678|FG000|Overall Study|Death|1|||
44480725|NCT00252057|79487679|FG001|Overall Study|Death|2|||
44480726|NCT00252057|79487678|FG000|Overall Study|Participant previously enrolled|0|||
44480727|NCT00252057|79487679|FG001|Overall Study|Participant previously enrolled|1|||
44480728|NCT00132028|79487685|FG000|Overall Study|Adverse Event|7|||
44480729|NCT00132028|79487685|FG000|Overall Study|Death|2|||
44480730|NCT00132028|79487685|FG000|Overall Study|Lack of Efficacy|11|||
44480731|NCT00132028|79487685|FG000|Overall Study|Withdrawal by Subject|2|||
44480732|NCT00132028|79487685|FG000|Overall Study|not eligible|2|||
44480733|NCT00132028|79487685|FG000|Overall Study|Physician Decision|3|||
44480734|NCT00131248|79487689|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
44480735|NCT00131248|79487690|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
44480736|NCT00362414|79487696|FG000|Overall Study|Death|2|||
44480737|NCT00362414|79487696|FG000|Overall Study|Adverse Event|1|||
44480738|NCT00096382|79487705|FG000|Overall Study|Not treated|1|||
44480739|NCT00096382|79487706|FG001|Overall Study|Not treated|0|||
44480740|NCT00096382|79487705|FG000|Overall Study|Death during treatment|1|||
44480741|NCT00096382|79487706|FG001|Overall Study|Death during treatment|0|||
44480742|NCT00359294|79487717|FG000|Overall Study|Progressive disease|1|||
44480743|NCT00359294|79487718|FG001|Overall Study|Progressive disease|1|||
44480744|NCT00359294|79487719|FG002|Overall Study|Progressive disease|2|||
44480745|NCT00359294|79487720|FG003|Overall Study|Progressive disease|3|||
44480746|NCT00359294|79487721|FG004|Overall Study|Progressive disease|2|||
44480747|NCT00359294|79487717|FG000|Overall Study|Withdrawal by Subject|0|||
44480748|NCT00359294|79487718|FG001|Overall Study|Withdrawal by Subject|0|||
44480749|NCT00359294|79487719|FG002|Overall Study|Withdrawal by Subject|0|||
44480750|NCT00359294|79487720|FG003|Overall Study|Withdrawal by Subject|0|||
44480751|NCT00359294|79487721|FG004|Overall Study|Withdrawal by Subject|1|||
44480752|NCT00359294|79487717|FG000|Overall Study|Not treated|0|||
44480753|NCT00359294|79487718|FG001|Overall Study|Not treated|0|||
44480754|NCT00359294|79487719|FG002|Overall Study|Not treated|0|||
44480755|NCT00359294|79487720|FG003|Overall Study|Not treated|1|||
44480756|NCT00359294|79487721|FG004|Overall Study|Not treated|0|||
44480757|NCT00359294|79487717|FG000|Overall Study|Physician Decision|0|||
44480758|NCT00359294|79487718|FG001|Overall Study|Physician Decision|0|||
44480759|NCT00359294|79487719|FG002|Overall Study|Physician Decision|1|||
44480760|NCT00359294|79487720|FG003|Overall Study|Physician Decision|0|||
44480761|NCT00359294|79487721|FG004|Overall Study|Physician Decision|0|||
44480762|NCT00384332|79487731|FG000|Overall Study|Lost to Follow-up|4|||
44480763|NCT00384332|79487732|FG001|Overall Study|Lost to Follow-up|0|||
44480764|NCT00096226|79487740|FG000|Overall Study|Ineligible|2|||
44480765|NCT00096226|79487740|FG000|Overall Study|Protocol treatment not started|1|||
44480766|NCT00105508|79487746|FG000|Overall Study|Prephase Dropout|1|||
44480767|NCT00105508|79487747|FG001|Overall Study|Prephase Dropout|0|||
44480768|NCT00105508|79487746|FG000|Overall Study|Adverse Event|16|||
44480769|NCT00105508|79487747|FG001|Overall Study|Adverse Event|19|||
44480770|NCT00105508|79487746|FG000|Overall Study|Insufficient Efficacy|1|||
44480771|NCT00105508|79487747|FG001|Overall Study|Insufficient Efficacy|0|||
44480772|NCT00105508|79487746|FG000|Overall Study|Withdrawal by Subject|10|||
44480773|NCT00105508|79487747|FG001|Overall Study|Withdrawal by Subject|6|||
44480774|NCT00105508|79487746|FG000|Overall Study|Lost to Follow-up|3|||
44480775|NCT00105508|79487747|FG001|Overall Study|Lost to Follow-up|0|||
44480776|NCT00105508|79487746|FG000|Overall Study|Protocol Violation|1|||
44480777|NCT00105508|79487747|FG001|Overall Study|Protocol Violation|2|||
44480778|NCT00105508|79487746|FG000|Overall Study|Other|8|||
44480779|NCT00105508|79487747|FG001|Overall Study|Other|9|||
44480780|NCT00105196|79487755|FG000|Overall Study|Lack of Efficacy|2|||
44480781|NCT00105196|79487756|FG001|Overall Study|Lack of Efficacy|3|||
44480782|NCT00105196|79487755|FG000|Overall Study|Adverse Event|11|||
44480783|NCT00105196|79487756|FG001|Overall Study|Adverse Event|3|||
44480784|NCT00105196|79487755|FG000|Overall Study|Withdrawal by Subject|6|||
44480785|NCT00105196|79487756|FG001|Overall Study|Withdrawal by Subject|6|||
44480786|NCT00105196|79487755|FG000|Overall Study|Lost to Follow-up|3|||
44544695|NCT03178266|79558256|FG001|Overall Study|Withdrawal by Subject|2|||
44480787|NCT00105196|79487756|FG001|Overall Study|Lost to Follow-up|2|||
44480788|NCT00105196|79487755|FG000|Overall Study|Poor/noncompliance|3|||
44480789|NCT00105196|79487756|FG001|Overall Study|Poor/noncompliance|4|||
44480790|NCT00105196|79487755|FG000|Overall Study|Protocol Violation|5|||
44480791|NCT00105196|79487756|FG001|Overall Study|Protocol Violation|2|||
44480792|NCT00105196|79487755|FG000|Overall Study|pending surgery|0|||
44480793|NCT00105196|79487756|FG001|Overall Study|pending surgery|1|||
44480794|NCT00105196|79487755|FG000|Overall Study|marijuana use|0|||
44480795|NCT00105196|79487756|FG001|Overall Study|marijuana use|1|||
44480796|NCT00105196|79487755|FG000|Overall Study|Subject became unblinded|0|||
44480797|NCT00105196|79487756|FG001|Overall Study|Subject became unblinded|1|||
44480798|NCT03820024|79487764|FG000|Overall Study|Physician Decision|1|||
44480799|NCT03820024|79487765|FG001|Overall Study|Physician Decision|2|||
44480800|NCT03819634|79487771|FG000|Overall Study|Physician Decision|2|||
44480801|NCT00104572|79487778|FG000|Overall Study|Withdrawal by Subject|3|||
44480802|NCT00104572|79487779|FG001|Overall Study|Withdrawal by Subject|3|||
44480803|NCT00104572|79487780|FG002|Overall Study|Withdrawal by Subject|0|||
44480804|NCT00514943|79487790|FG000|Stage 1|Progressive disease|4|||
44480805|NCT00514943|79487791|FG001|Stage 1|Progressive disease|8|||
44480806|NCT00514943|79487790|FG000|Stage 1|Other Adverse Event|16|||
44480807|NCT00514943|79487791|FG001|Stage 1|Other Adverse Event|6|||
44480808|NCT00514943|79487790|FG000|Stage 1|Not treated|1|||
44480809|NCT00514943|79487791|FG001|Stage 1|Not treated|2|||
44480810|NCT00514943|79487790|FG000|Stage 1|Patient refused to continue study meds|8|||
44480811|NCT00514943|79487791|FG001|Stage 1|Patient refused to continue study meds|3|||
44480812|NCT00514943|79487790|FG000|Stage 1|Other than stated above|1|||
44480813|NCT00514943|79487791|FG001|Stage 1|Other than stated above|7|||
44480814|NCT00514943|79487790|FG000|Stage 2|Progressive disease|27|||
44480815|NCT00514943|79487791|FG001|Stage 2|Progressive disease|24|||
44480816|NCT00514943|79487790|FG000|Stage 2|Other Adverse Event|3|||
44480817|NCT00514943|79487791|FG001|Stage 2|Other Adverse Event|10|||
44480818|NCT00514943|79487790|FG000|Stage 2|Patient refused to continue study meds|2|||
44480819|NCT00514943|79487791|FG001|Stage 2|Patient refused to continue study meds|0|||
44480820|NCT00514943|79487790|FG000|Stage 2|Other than stated above|0|||
44480821|NCT00514943|79487791|FG001|Stage 2|Other than stated above|2|||
44480822|NCT03864653|79487812|FG000|Overall Study|Withdrawal by Subject|1|||
44480823|NCT00103402|79487818|FG000|Overall Study|Adverse Event|3|||
44480824|NCT00103402|79487819|FG001|Overall Study|Adverse Event|4|||
44480825|NCT00103402|79487818|FG000|Overall Study|Lost to Follow-up|8|||
44480826|NCT00103402|79487819|FG001|Overall Study|Lost to Follow-up|7|||
44480827|NCT00103402|79487818|FG000|Overall Study|Dissatisfied/No longer interested|6|||
44480828|NCT00103402|79487819|FG001|Overall Study|Dissatisfied/No longer interested|6|||
44480829|NCT00103402|79487818|FG000|Overall Study|Personal constraints/Other|5|||
44480830|NCT00103402|79487819|FG001|Overall Study|Personal constraints/Other|0|||
44480831|NCT03864341|79487825|FG000|Overall Study|Withdrawal by Subject|1|||
44480832|NCT00095836|79487829|FG000|Overall Study|Lost to Follow-up|1|||
44480833|NCT00095836|79487829|FG000|Overall Study|Adverse Event|1|||
44480834|NCT00095836|79487829|FG000|Overall Study|Death|2|||
44480835|NCT00168831|79487836|FG000|Overall Study|Adverse Event|36|||
44227137|NCT01717040|79033749|FG000|Overall Study|Required Medication Change|0|||
44227138|NCT01717040|79033750|FG001|Overall Study|Required Medication Change|1|||
44227139|NCT01717040|79033749|FG000|Overall Study|New Substance Use Disorder|1|||
44227140|NCT01717040|79033750|FG001|Overall Study|New Substance Use Disorder|0|||
44227141|NCT01743469|79033777|FG000|Active Treatment Phase|Adverse Event|10|||
44227142|NCT01743469|79033778|FG001|Active Treatment Phase|Adverse Event|5|||
44227143|NCT01743469|79033779|FG002|Active Treatment Phase|Adverse Event|8|||
44227144|NCT01743469|79033780|FG003|Active Treatment Phase|Adverse Event|1|||
44227145|NCT01743469|79033777|FG000|Active Treatment Phase|Disease Progression|40|||
44227146|NCT01743469|79033778|FG001|Active Treatment Phase|Disease Progression|47|||
44227147|NCT01743469|79033779|FG002|Active Treatment Phase|Disease Progression|30|||
44227148|NCT01743469|79033780|FG003|Active Treatment Phase|Disease Progression|20|||
44480836|NCT00168831|79487837|FG001|Overall Study|Adverse Event|47|||
44480837|NCT00168831|79487838|FG002|Overall Study|Adverse Event|74|||
44480838|NCT00168831|79487836|FG000|Overall Study|Lost to Follow-up|5|||
44480839|NCT00168831|79487837|FG001|Overall Study|Lost to Follow-up|6|||
44480840|NCT00168831|79487838|FG002|Overall Study|Lost to Follow-up|4|||
44480841|NCT00168831|79487836|FG000|Overall Study|Withdrawal by Subject|7|||
44480842|NCT00168831|79487837|FG001|Overall Study|Withdrawal by Subject|14|||
44480843|NCT00168831|79487838|FG002|Overall Study|Withdrawal by Subject|19|||
44480844|NCT00168831|79487836|FG000|Overall Study|Protocol Violation|6|||
44227149|NCT01743469|79033777|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
44227150|NCT01743469|79033778|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
44480845|NCT00168831|79487837|FG001|Overall Study|Protocol Violation|11|||
44480846|NCT00168831|79487838|FG002|Overall Study|Protocol Violation|11|||
44480847|NCT00168831|79487836|FG000|Overall Study|Other|6|||
44480848|NCT00168831|79487837|FG001|Overall Study|Other|3|||
44480849|NCT00168831|79487838|FG002|Overall Study|Other|6|||
44480850|NCT00103012|79487849|FG000|Overall Study|Withdrawal by Subject|2|||
44480851|NCT00103012|79487850|FG001|Overall Study|Withdrawal by Subject|1|||
44480852|NCT00103012|79487851|FG002|Overall Study|Withdrawal by Subject|2|||
44480853|NCT00103012|79487849|FG000|Overall Study|Pregnancy|1|||
44480854|NCT00103012|79487850|FG001|Overall Study|Pregnancy|0|||
44480855|NCT00103012|79487851|FG002|Overall Study|Pregnancy|0|||
44480856|NCT00103012|79487849|FG000|Overall Study|Adverse Event|0|||
44480857|NCT00103012|79487850|FG001|Overall Study|Adverse Event|0|||
44480858|NCT00103012|79487851|FG002|Overall Study|Adverse Event|1|||
44480859|NCT00103012|79487849|FG000|Overall Study|Subject non-compliant with medications|0|||
44480860|NCT00103012|79487850|FG001|Overall Study|Subject non-compliant with medications|0|||
44480861|NCT00103012|79487851|FG002|Overall Study|Subject non-compliant with medications|1|||
44480862|NCT00512135|79487859|FG000|Overall Study|Not Treated|5|||
44480863|NCT00512135|79487859|FG000|Overall Study|Lack of Efficacy|2|||
44480864|NCT00512135|79487859|FG000|Overall Study|Adverse Event|6|||
44480865|NCT00512135|79487859|FG000|Overall Study|Withdrawal by Subject|22|||
44480866|NCT00512135|79487859|FG000|Overall Study|Lost to Follow-up|27|||
44480867|NCT00512135|79487859|FG000|Overall Study|Other|22|||
44480868|NCT00251979|79487866|FG000|Overall Study|Protocol Violation|3|||
44480869|NCT00251979|79487867|FG001|Overall Study|Protocol Violation|5|||
44480870|NCT00251979|79487866|FG000|Overall Study|Adverse Event|11|||
44480871|NCT00251979|79487867|FG001|Overall Study|Adverse Event|17|||
44480872|NCT00251979|79487866|FG000|Overall Study|Withdrawal by Subject|13|||
44480873|NCT00251979|79487867|FG001|Overall Study|Withdrawal by Subject|7|||
44480874|NCT00251979|79487866|FG000|Overall Study|Lost to Follow-up|8|||
44480875|NCT00251979|79487867|FG001|Overall Study|Lost to Follow-up|6|||
44480876|NCT00251979|79487866|FG000|Overall Study|Death|3|||
44480877|NCT00251979|79487867|FG001|Overall Study|Death|5|||
44480878|NCT00511901|79487875|FG000|Overall Study|Withdrawal by Subject|1|||
44480879|NCT00511901|79487876|FG001|Overall Study|Withdrawal by Subject|3|||
44480880|NCT03862625|79487884|FG000|Overall Study|Lost to Follow-up|0|||
44480881|NCT03862625|79487885|FG001|Overall Study|Lost to Follow-up|1|||
44480882|NCT00163215|79487891|FG000|Overall Study|Lack of Efficacy|3|||
44480883|NCT00163215|79487891|FG000|Overall Study|Withdrawal by Subject|5|||
44480884|NCT00163215|79487891|FG000|Overall Study|Other|7|||
44480885|NCT00228423|79487897|FG000|Overall Study|Adverse Event|2|||
44480886|NCT00228423|79487898|FG001|Overall Study|Adverse Event|5|||
44480887|NCT00228423|79487897|FG000|Overall Study|Withdrawal by Subject|7|||
44480888|NCT00228423|79487898|FG001|Overall Study|Withdrawal by Subject|3|||
44480889|NCT00228423|79487897|FG000|Overall Study|Protocol Violation|1|||
44480890|NCT00228423|79487898|FG001|Overall Study|Protocol Violation|3|||
44480891|NCT00228423|79487897|FG000|Overall Study|Physician Decision|0|||
44480892|NCT00228423|79487898|FG001|Overall Study|Physician Decision|1|||
44480893|NCT00511667|79487906|FG000|Overall Study|Adverse Event|1|||
44480894|NCT00511667|79487907|FG001|Overall Study|Adverse Event|0|||
44480895|NCT00511667|79487906|FG000|Overall Study|Protocol Violation|1|||
44480896|NCT00511667|79487907|FG001|Overall Study|Protocol Violation|1|||
44480897|NCT00511667|79487906|FG000|Overall Study|Withdrawal by Subject|2|||
44480898|NCT00511667|79487907|FG001|Overall Study|Withdrawal by Subject|0|||
44480899|NCT00511667|79487906|FG000|Overall Study|Site terminated|6|||
44480900|NCT00511667|79487907|FG001|Overall Study|Site terminated|1|||
44480901|NCT00511667|79487906|FG000|Overall Study|Other|2|||
44480902|NCT00511667|79487907|FG001|Overall Study|Other|1|||
44480903|NCT00227877|79487923|FG000|Pre-visit Assessment|Technical difficulties|7|||
44480904|NCT00227877|79487924|FG001|Pre-visit Assessment|Technical difficulties|3|||
44480905|NCT00227877|79487925|FG002|Pre-visit Assessment|Technical difficulties|0|||
44480906|NCT00227877|79487926|FG003|Pre-visit Assessment|Technical difficulties|0|||
44480907|NCT00227877|79487923|FG000|Post-visit Checklist|Lost to Follow-up|24|||
44480908|NCT00227877|79487924|FG001|Post-visit Checklist|Lost to Follow-up|13|||
44480909|NCT00227877|79487925|FG002|Post-visit Checklist|Lost to Follow-up|1|||
44480910|NCT00227877|79487926|FG003|Post-visit Checklist|Lost to Follow-up|0|||
44480911|NCT00227877|79487923|FG000|3-months Follow-up|Completed late|135|||
44480912|NCT00227877|79487924|FG001|3-months Follow-up|Completed late|128|||
44480913|NCT00227877|79487925|FG002|3-months Follow-up|Completed late|34|||
44480914|NCT00227877|79487926|FG003|3-months Follow-up|Completed late|8|||
44480915|NCT00227877|79487923|FG000|3-months Follow-up|Lost to Follow-up|178|||
44480916|NCT00227877|79487924|FG001|3-months Follow-up|Lost to Follow-up|139|||
44480917|NCT00227877|79487925|FG002|3-months Follow-up|Lost to Follow-up|18|||
44227151|NCT01743469|79033779|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
44227152|NCT01743469|79033780|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
44480918|NCT00227877|79487926|FG003|3-months Follow-up|Lost to Follow-up|13|||
44480919|NCT00227877|79487923|FG000|12-months Follow-up|Completed late|78|||
44480920|NCT00227877|79487924|FG001|12-months Follow-up|Completed late|74|||
44514824|NCT03717012|79520645|FG001|Overall Study|Protocol Violation|2|||
44514825|NCT03717012|79520644|FG000|Overall Study|Adverse Event|0|||
44514826|NCT03717012|79520645|FG001|Overall Study|Adverse Event|1|||
44480921|NCT00227877|79487925|FG002|12-months Follow-up|Completed late|1|||
44480922|NCT00227877|79487926|FG003|12-months Follow-up|Completed late|0|||
44480923|NCT00227877|79487923|FG000|12-months Follow-up|Lost to Follow-up|232|||
44480924|NCT00227877|79487924|FG001|12-months Follow-up|Lost to Follow-up|189|||
44480925|NCT00227877|79487925|FG002|12-months Follow-up|Lost to Follow-up|30|||
44480926|NCT00227877|79487926|FG003|12-months Follow-up|Lost to Follow-up|26|||
44480927|NCT00513695|79487938|FG000|Overall Study|Discontinued therapy|2|||
44480928|NCT00513695|79487938|FG000|Overall Study|Progression prior to surgery|3|||
44480929|NCT00162981|79487944|FG000|Overall Study|Adverse Event|2|||
44480930|NCT00162981|79487945|FG001|Overall Study|Adverse Event|5|||
44480931|NCT00162981|79487944|FG000|Overall Study|Withdrawal by Subject|1|||
44480932|NCT00162981|79487945|FG001|Overall Study|Withdrawal by Subject|1|||
44480933|NCT00162981|79487944|FG000|Overall Study|Physician Decision|1|||
44480934|NCT00162981|79487945|FG001|Overall Study|Physician Decision|0|||
44480935|NCT00511433|79487953|FG000|Overall Study|Adverse Event|5|||
44480936|NCT00511433|79487954|FG001|Overall Study|Adverse Event|0|||
44480937|NCT00511433|79487953|FG000|Overall Study|Other Reason|1|||
44480938|NCT00511433|79487954|FG001|Overall Study|Other Reason|1|||
44480939|NCT00099268|79487964|FG000|Overall Study|Withdrawal by Subject|46|||
44480940|NCT00099268|79487965|FG001|Overall Study|Withdrawal by Subject|28|||
44480941|NCT00099268|79487964|FG000|Overall Study|Adverse Event|19|||
44480942|NCT00099268|79487965|FG001|Overall Study|Adverse Event|19|||
44480943|NCT00099268|79487964|FG000|Overall Study|Protocol Violation|9|||
44480944|NCT00099268|79487965|FG001|Overall Study|Protocol Violation|8|||
44480945|NCT00099268|79487964|FG000|Overall Study|Lost to Follow-up|6|||
44480946|NCT00099268|79487965|FG001|Overall Study|Lost to Follow-up|4|||
44544696|NCT03548935|79558264|FG000|Overall Study|Withdrawal by Subject|26|||
44544697|NCT03548935|79558265|FG001|Overall Study|Withdrawal by Subject|17|||
44480947|NCT00099268|79487964|FG000|Overall Study|Lack of Efficacy|5|||
44480948|NCT00099268|79487965|FG001|Overall Study|Lack of Efficacy|18|||
44480949|NCT00099268|79487964|FG000|Overall Study|Administrative problems|4|||
44480950|NCT00099268|79487965|FG001|Overall Study|Administrative problems|4|||
44480951|NCT00099268|79487964|FG000|Overall Study|Death|3|||
44480952|NCT00099268|79487965|FG001|Overall Study|Death|1|||
44480953|NCT00511355|79487973|FG000|Overall Study|Adverse Event|4|||
44480954|NCT00511355|79487974|FG001|Overall Study|Adverse Event|4|||
44480955|NCT00511355|79487973|FG000|Overall Study|Pregnancy Wish|1|||
44480956|NCT00511355|79487974|FG001|Overall Study|Pregnancy Wish|0|||
44480957|NCT00511355|79487973|FG000|Overall Study|Lost to Follow-up|2|||
44480958|NCT00511355|79487974|FG001|Overall Study|Lost to Follow-up|1|||
44480959|NCT00511355|79487973|FG000|Overall Study|Other Reason|0|||
44480960|NCT00511355|79487974|FG001|Overall Study|Other Reason|1|||
44480961|NCT00511355|79487973|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
44480962|NCT00511355|79487974|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
44480963|NCT00511355|79487973|FG000|Overall Study|Withdrawal of informed consent|0|||
44480964|NCT00511355|79487974|FG001|Overall Study|Withdrawal of informed consent|1|||
44480965|NCT00511355|79487973|FG000|Overall Study|Other reason pre-treatment|0|||
44480966|NCT00511355|79487974|FG001|Overall Study|Other reason pre-treatment|1|||
44480967|NCT00095212|79487984|FG000|Overall Study|Withdrawal by Subject|1|||
44480968|NCT00095212|79487985|FG001|Overall Study|Withdrawal by Subject|3|||
44480969|NCT00120874|79487993|FG000|Overall Study|Death|0|||
44480970|NCT00120874|79487994|FG001|Overall Study|Death|1|||
44480971|NCT00120406|79488002|FG000|Overall Study|Death|9|||
44480972|NCT00120406|79488003|FG001|Overall Study|Death|4|||
44480973|NCT00120406|79488002|FG000|Overall Study|Withdrawal by Subject|5|||
44480974|NCT00120406|79488003|FG001|Overall Study|Withdrawal by Subject|7|||
44480975|NCT00120406|79488002|FG000|Overall Study|Lost to Follow-up|5|||
44480976|NCT00120406|79488003|FG001|Overall Study|Lost to Follow-up|2|||
44480977|NCT00120406|79488002|FG000|Overall Study|received non-study stent|0|||
44480978|NCT00120406|79488003|FG001|Overall Study|received non-study stent|2|||
44480979|NCT00120406|79488002|FG000|Overall Study|patient moved but has not withdrawn|0|||
44480980|NCT00120406|79488003|FG001|Overall Study|patient moved but has not withdrawn|1|||
44480981|NCT00120250|79488009|FG000|Overall Study|Lost to Follow-up|1|||
44480982|NCT00120250|79488010|FG001|Overall Study|Lost to Follow-up|1|||
44480983|NCT00120250|79488009|FG000|Overall Study|Protocol Violation|0|||
44480984|NCT00120250|79488010|FG001|Overall Study|Protocol Violation|1|||
44480985|NCT00511199|79488019|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
44480986|NCT00511199|79488020|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
44480987|NCT00511199|79488019|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
44480988|NCT00511199|79488020|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
44480989|NCT00511199|79488019|FG000|Overall Study|Withdrawal of Informed Consent|19|||
44480990|NCT00511199|79488020|FG001|Overall Study|Withdrawal of Informed Consent|4|||
44480991|NCT00511199|79488019|FG000|Overall Study|Pregnancy|6|||
44480992|NCT00511199|79488020|FG001|Overall Study|Pregnancy|3|||
44480993|NCT00511199|79488019|FG000|Overall Study|Pregnancy Wish|16|||
44480994|NCT00511199|79488020|FG001|Overall Study|Pregnancy Wish|8|||
44480995|NCT00511199|79488019|FG000|Overall Study|Lost to Follow-up|40|||
44480996|NCT00511199|79488020|FG001|Overall Study|Lost to Follow-up|17|||
44480997|NCT00511199|79488019|FG000|Overall Study|Other Reason|78|||
44480998|NCT00511199|79488020|FG001|Overall Study|Other Reason|37|||
44480999|NCT00384176|79488031|FG000|Overall Study|Death|239|||
44481000|NCT00384176|79488032|FG001|Overall Study|Death|247|||
44481001|NCT00384176|79488033|FG002|Overall Study|Death|105|||
44481002|NCT00384176|79488031|FG000|Overall Study|Withdrawal by Subject|52|||
44481003|NCT00384176|79488032|FG001|Overall Study|Withdrawal by Subject|48|||
44481004|NCT00384176|79488033|FG002|Overall Study|Withdrawal by Subject|22|||
44481005|NCT00384176|79488031|FG000|Overall Study|Lost to Follow-up|16|||
44481006|NCT00384176|79488032|FG001|Overall Study|Lost to Follow-up|18|||
44481007|NCT00384176|79488033|FG002|Overall Study|Lost to Follow-up|4|||
44481008|NCT00384176|79488031|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
44481009|NCT00384176|79488032|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
44481010|NCT00384176|79488033|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
44481011|NCT00384176|79488031|FG000|Overall Study|Longer QTC as Visit 1|1|||
44481012|NCT00384176|79488032|FG001|Overall Study|Longer QTC as Visit 1|0|||
44481013|NCT00384176|79488033|FG002|Overall Study|Longer QTC as Visit 1|0|||
44481014|NCT00384176|79488031|FG000|Overall Study|Toxicity of treatment|1|||
44481015|NCT00384176|79488032|FG001|Overall Study|Toxicity of treatment|0|||
44481016|NCT00384176|79488033|FG002|Overall Study|Toxicity of treatment|0|||
44481017|NCT00384176|79488031|FG000|Overall Study|Did not receive study treatment|0|||
44481018|NCT00384176|79488032|FG001|Overall Study|Did not receive study treatment|1|||
44481019|NCT00384176|79488033|FG002|Overall Study|Did not receive study treatment|1|||
44481020|NCT00384176|79488031|FG000|Overall Study|Physician Decision|0|||
44481021|NCT00384176|79488032|FG001|Overall Study|Physician Decision|2|||
44481022|NCT00384176|79488033|FG002|Overall Study|Physician Decision|0|||
44481023|NCT00384176|79488031|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
44481024|NCT00384176|79488032|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
44481025|NCT00384176|79488033|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
44481026|NCT00513305|79488043|FG000|Overall Study|Adverse Event|6|||
44481027|NCT00513305|79488044|FG001|Overall Study|Adverse Event|2|||
44481028|NCT00513305|79488043|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
44481029|NCT00513305|79488044|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
44481030|NCT00513305|79488043|FG000|Overall Study|Lack of Efficacy|8|||
44481031|NCT00513305|79488044|FG001|Overall Study|Lack of Efficacy|13|||
44481032|NCT00513305|79488043|FG000|Overall Study|Withdrawal by Subject|1|||
44481033|NCT00513305|79488044|FG001|Overall Study|Withdrawal by Subject|2|||
44481034|NCT00513305|79488043|FG000|Overall Study|Disease progression|8|||
44481035|NCT00513305|79488044|FG001|Overall Study|Disease progression|5|||
44481036|NCT00513305|79488043|FG000|Overall Study|Eligible for stem cell transplant|1|||
44481037|NCT00513305|79488044|FG001|Overall Study|Eligible for stem cell transplant|0|||
44481038|NCT00513305|79488043|FG000|Overall Study|Hematologic counts did not recover|1|||
44481039|NCT00513305|79488044|FG001|Overall Study|Hematologic counts did not recover|0|||
44481040|NCT00513305|79488043|FG000|Overall Study|Physician Decision|1|||
44481041|NCT00513305|79488044|FG001|Overall Study|Physician Decision|0|||
44481042|NCT00513305|79488043|FG000|Overall Study|Persistent hypocellularity|0|||
44481043|NCT00513305|79488044|FG001|Overall Study|Persistent hypocellularity|1|||
44481044|NCT00513305|79488043|FG000|Overall Study|Sponsor Decision|0|||
44481045|NCT00513305|79488044|FG001|Overall Study|Sponsor Decision|2|||
44481046|NCT00513071|79488050|FG000|Overall Study|Adverse Event|1|||
44481047|NCT00513071|79488050|FG000|Overall Study|Withdrawal by Subject|1|||
44227153|NCT01743469|79033777|FG000|Active Treatment Phase|Missing|1|||
44227154|NCT01743469|79033778|FG001|Active Treatment Phase|Missing|0|||
44227155|NCT01743469|79033779|FG002|Active Treatment Phase|Missing|0|||
44227156|NCT01743469|79033780|FG003|Active Treatment Phase|Missing|0|||
44227157|NCT01743469|79033777|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
44227158|NCT01743469|79033778|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
44227159|NCT01743469|79033779|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
44481048|NCT00513071|79488050|FG000|Overall Study|Physician Decision|3|||
44481049|NCT00510887|79488054|FG000|Overall Study|Lost to Follow-up|1|||
44481050|NCT00358826|79488062|FG000|Core Study|Adverse Event|1|||
44481051|NCT00358826|79488063|FG001|Core Study|Adverse Event|3|||
44481052|NCT00358826|79488064|FG002|Core Study|Adverse Event|1|||
44481053|NCT00358826|79488065|FG003|Core Study|Adverse Event|1|||
44481054|NCT00358826|79488066|FG004|Core Study|Adverse Event|0|||
44481055|NCT00358826|79488067|FG005|Core Study|Adverse Event|0|||
44227160|NCT01743469|79033780|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
44481056|NCT00358826|79488068|FG006|Core Study|Adverse Event|0|||
44481057|NCT00358826|79488069|FG007|Core Study|Adverse Event|0|||
44481058|NCT00358826|79488062|FG000|Core Study|Withdrawal by Subject|2|||
44481059|NCT00358826|79488063|FG001|Core Study|Withdrawal by Subject|2|||
44481060|NCT00358826|79488064|FG002|Core Study|Withdrawal by Subject|0|||
44481061|NCT00358826|79488065|FG003|Core Study|Withdrawal by Subject|0|||
44481062|NCT00358826|79488066|FG004|Core Study|Withdrawal by Subject|0|||
44481063|NCT00358826|79488067|FG005|Core Study|Withdrawal by Subject|0|||
44481064|NCT00358826|79488068|FG006|Core Study|Withdrawal by Subject|0|||
44481065|NCT00358826|79488069|FG007|Core Study|Withdrawal by Subject|0|||
44481066|NCT00358826|79488062|FG000|Core Study|Lost to Follow-up|0|||
44481067|NCT00358826|79488063|FG001|Core Study|Lost to Follow-up|0|||
44481068|NCT00358826|79488064|FG002|Core Study|Lost to Follow-up|0|||
44481069|NCT00358826|79488065|FG003|Core Study|Lost to Follow-up|1|||
44481070|NCT00358826|79488066|FG004|Core Study|Lost to Follow-up|0|||
44481071|NCT00358826|79488067|FG005|Core Study|Lost to Follow-up|0|||
44481072|NCT00358826|79488068|FG006|Core Study|Lost to Follow-up|0|||
44481073|NCT00358826|79488069|FG007|Core Study|Lost to Follow-up|0|||
44481074|NCT00358826|79488062|FG000|Core Study|Physician Decision|0|||
44481075|NCT00358826|79488063|FG001|Core Study|Physician Decision|0|||
44481076|NCT00358826|79488064|FG002|Core Study|Physician Decision|1|||
44481077|NCT00358826|79488065|FG003|Core Study|Physician Decision|0|||
44481078|NCT00358826|79488066|FG004|Core Study|Physician Decision|0|||
44481079|NCT00358826|79488067|FG005|Core Study|Physician Decision|0|||
44481080|NCT00358826|79488068|FG006|Core Study|Physician Decision|0|||
44481081|NCT00358826|79488069|FG007|Core Study|Physician Decision|0|||
44481082|NCT00358826|79488062|FG000|MDCT Substudy|Adverse Event|0|||
44481083|NCT00358826|79488063|FG001|MDCT Substudy|Adverse Event|0|||
44481084|NCT00358826|79488064|FG002|MDCT Substudy|Adverse Event|0|||
44481085|NCT00358826|79488065|FG003|MDCT Substudy|Adverse Event|0|||
44481086|NCT00358826|79488066|FG004|MDCT Substudy|Adverse Event|1|||
44481087|NCT00358826|79488067|FG005|MDCT Substudy|Adverse Event|0|||
44481088|NCT00358826|79488068|FG006|MDCT Substudy|Adverse Event|0|||
44481089|NCT00358826|79488069|FG007|MDCT Substudy|Adverse Event|0|||
44481090|NCT00358826|79488062|FG000|MDCT Substudy|Lost to Follow-up|0|||
44481091|NCT00358826|79488063|FG001|MDCT Substudy|Lost to Follow-up|0|||
44481092|NCT00358826|79488064|FG002|MDCT Substudy|Lost to Follow-up|0|||
44481093|NCT00358826|79488065|FG003|MDCT Substudy|Lost to Follow-up|0|||
44481094|NCT00358826|79488066|FG004|MDCT Substudy|Lost to Follow-up|0|||
44481095|NCT00358826|79488067|FG005|MDCT Substudy|Lost to Follow-up|1|||
44481096|NCT00358826|79488068|FG006|MDCT Substudy|Lost to Follow-up|0|||
44481097|NCT00358826|79488069|FG007|MDCT Substudy|Lost to Follow-up|0|||
44481098|NCT00358826|79488062|FG000|MDCT Substudy|Withdrawal by Subject|0|||
44481099|NCT00358826|79488063|FG001|MDCT Substudy|Withdrawal by Subject|0|||
44481100|NCT00358826|79488064|FG002|MDCT Substudy|Withdrawal by Subject|0|||
44481101|NCT00358826|79488065|FG003|MDCT Substudy|Withdrawal by Subject|0|||
44481102|NCT00358826|79488066|FG004|MDCT Substudy|Withdrawal by Subject|0|||
44481103|NCT00358826|79488067|FG005|MDCT Substudy|Withdrawal by Subject|1|||
44481104|NCT00358826|79488068|FG006|MDCT Substudy|Withdrawal by Subject|0|||
44481105|NCT00358826|79488069|FG007|MDCT Substudy|Withdrawal by Subject|0|||
44481106|NCT00510653|79488083|FG000|Overall Study|Withdrawal by Subject|8|||
44481107|NCT00510653|79488083|FG000|Overall Study|Monetary|3|||
44481108|NCT00362336|79488090|FG000|Overall Study|Serious Adverse Event|1|||
44481109|NCT00362336|79488091|FG001|Overall Study|Serious Adverse Event|0|||
44481110|NCT00362336|79488092|FG002|Overall Study|Serious Adverse Event|1|||
44481111|NCT00362336|79488090|FG000|Overall Study|Protocol Violation|0|||
44481112|NCT00362336|79488091|FG001|Overall Study|Protocol Violation|0|||
44481113|NCT00362336|79488092|FG002|Overall Study|Protocol Violation|1|||
44481114|NCT00362336|79488090|FG000|Overall Study|Lost to Follow-up|6|||
44481115|NCT00362336|79488091|FG001|Overall Study|Lost to Follow-up|4|||
44481116|NCT00362336|79488092|FG002|Overall Study|Lost to Follow-up|0|||
44481117|NCT00362336|79488090|FG000|Overall Study|Withdrawal by Subject|3|||
44481118|NCT00362336|79488091|FG001|Overall Study|Withdrawal by Subject|3|||
44481119|NCT00362336|79488092|FG002|Overall Study|Withdrawal by Subject|1|||
44481120|NCT00506285|79488109|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
44481121|NCT00506285|79488110|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
44481122|NCT00506285|79488109|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
44481123|NCT00506285|79488110|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
44544698|NCT03548935|79558264|FG000|Overall Study|Lost to Follow-up|39|||
44274140|NCT04887948|79217040|FG000|Overall Study|No longer met eligibility criteria|1|||
44274141|NCT04887948|79217041|FG001|Overall Study|No longer met eligibility criteria|2|||
44481124|NCT00506285|79488109|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
44481125|NCT00506285|79488110|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
44481126|NCT00506285|79488109|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
44481127|NCT00506285|79488110|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
44481128|NCT00506285|79488109|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
44481129|NCT00506285|79488110|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
44481130|NCT00506129|79488118|FG000|Overall Study|Disease Progression/Relapse|15|||
44481131|NCT00506129|79488118|FG000|Overall Study|Death|7|||
44481132|NCT00358670|79488124|FG000|Overall Study|Adverse Event|26|||
44481133|NCT00358670|79488125|FG001|Overall Study|Adverse Event|29|||
44481134|NCT00358670|79488124|FG000|Overall Study|Lack of Efficacy|20|||
44481135|NCT00358670|79488125|FG001|Overall Study|Lack of Efficacy|23|||
44481136|NCT00358670|79488124|FG000|Overall Study|Protocol Violation|6|||
44481137|NCT00358670|79488125|FG001|Overall Study|Protocol Violation|9|||
44481138|NCT00358670|79488124|FG000|Overall Study|Lost to Follow-up|4|||
44481139|NCT00358670|79488125|FG001|Overall Study|Lost to Follow-up|5|||
44481140|NCT00358670|79488124|FG000|Overall Study|Withdrawal by Subject|13|||
44481141|NCT00358670|79488125|FG001|Overall Study|Withdrawal by Subject|24|||
44481142|NCT00358670|79488124|FG000|Overall Study|Protocol Defined Clinical Event|0|||
44481143|NCT00358670|79488125|FG001|Overall Study|Protocol Defined Clinical Event|1|||
44481144|NCT00358670|79488124|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
44481145|NCT00358670|79488125|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
44481146|NCT00358670|79488124|FG000|Overall Study|Administrative|153|||
44481147|NCT00358670|79488125|FG001|Overall Study|Administrative|125|||
44481148|NCT00505661|79488131|FG000|Overall Study|Not Eligible|4|||
44481149|NCT00383786|79488137|FG000|Overall Study|Protocol Violation|2|||
44481150|NCT00383786|79488138|FG001|Overall Study|Protocol Violation|6|||
44481151|NCT00383786|79488137|FG000|Overall Study|Withdrawal by Subject|2|||
44481152|NCT00383786|79488138|FG001|Overall Study|Withdrawal by Subject|5|||
44481153|NCT00383786|79488137|FG000|Overall Study|Physician Decision|0|||
44481154|NCT00383786|79488138|FG001|Overall Study|Physician Decision|1|||
44481155|NCT00383708|79488144|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
44481156|NCT00383708|79488144|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
44481157|NCT00383708|79488144|FG000|Run-in Period|Protocol Violation|4|||
44481158|NCT00383708|79488144|FG000|Run-in Period|Adverse Event|2|||
44481159|NCT00383708|79488144|FG000|Run-in Period|Claustrophobia|1|||
44481160|NCT00383708|79488144|FG000|Co-administration Period|Adverse Event|5|||
44481161|NCT00504881|79488151|FG000|Overall Study|Lack of Efficacy|1|||
44375626|NCT00953706|79380759|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
44375627|NCT00953706|79380760|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
44375628|NCT00953706|79380761|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
44375629|NCT00953706|79380758|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
44481162|NCT00504881|79488152|FG001|Overall Study|Lack of Efficacy|5|||
44481163|NCT00504881|79488151|FG000|Overall Study|Lost to Follow-up|0|||
44481164|NCT00504881|79488152|FG001|Overall Study|Lost to Follow-up|2|||
44481165|NCT00504881|79488151|FG000|Overall Study|Withdrawal by Subject|1|||
44481166|NCT00504881|79488152|FG001|Overall Study|Withdrawal by Subject|4|||
44481167|NCT00504881|79488151|FG000|Overall Study|Non-Compliance|1|||
44481168|NCT00504881|79488152|FG001|Overall Study|Non-Compliance|0|||
44481169|NCT00504881|79488151|FG000|Overall Study|No Birth Control|0|||
44481170|NCT00504881|79488152|FG001|Overall Study|No Birth Control|1|||
44481171|NCT00504881|79488151|FG000|Overall Study|Safety Visit not performed|0|||
44481172|NCT00504881|79488152|FG001|Overall Study|Safety Visit not performed|1|||
44481173|NCT00504881|79488151|FG000|Overall Study|AE, serious fatal|0|||
44481174|NCT00504881|79488152|FG001|Overall Study|AE, serious fatal|1|||
44481175|NCT00504881|79488151|FG000|Overall Study|SAE, non-fatal|2|||
44481176|NCT00504881|79488152|FG001|Overall Study|SAE, non-fatal|6|||
44481177|NCT00504881|79488151|FG000|Overall Study|AE, non-serious non-fatal|4|||
44481178|NCT00504881|79488152|FG001|Overall Study|AE, non-serious non-fatal|14|||
44481179|NCT00504881|79488151|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
44481180|NCT00504881|79488152|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
44481181|NCT00504881|79488151|FG000|Overall Study|AE of unknown type|1|||
44481182|NCT00504881|79488152|FG001|Overall Study|AE of unknown type|0|||
44481183|NCT00504725|79488162|FG000|Overall Study|Protocol Violation|1|||
44481184|NCT00504725|79488163|FG001|Overall Study|Protocol Violation|0|||
44481185|NCT00383240|79488173|FG000|Overall Study|Adverse Event|4|||
44481186|NCT00383240|79488174|FG001|Overall Study|Adverse Event|6|||
44227161|NCT01743469|79033777|FG000|Follow-up Period - Post-Treatment|Death|43|||
44227162|NCT01743469|79033778|FG001|Follow-up Period - Post-Treatment|Death|47|||
44227163|NCT01743469|79033779|FG002|Follow-up Period - Post-Treatment|Death|22|||
44227164|NCT01743469|79033780|FG003|Follow-up Period - Post-Treatment|Death|16|||
44227165|NCT01743469|79033777|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
44227166|NCT01743469|79033778|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
44481187|NCT00383240|79488175|FG002|Overall Study|Adverse Event|9|||
44481188|NCT00383240|79488176|FG003|Overall Study|Adverse Event|7|||
44481189|NCT00383240|79488173|FG000|Overall Study|Treatment Failure|8|||
44481190|NCT00383240|79488174|FG001|Overall Study|Treatment Failure|13|||
44481191|NCT00383240|79488175|FG002|Overall Study|Treatment Failure|47|||
44481192|NCT00383240|79488176|FG003|Overall Study|Treatment Failure|46|||
44481193|NCT00383240|79488173|FG000|Overall Study|Lost to Follow-up|3|||
44481194|NCT00383240|79488174|FG001|Overall Study|Lost to Follow-up|0|||
44481195|NCT00383240|79488175|FG002|Overall Study|Lost to Follow-up|0|||
44481196|NCT00383240|79488176|FG003|Overall Study|Lost to Follow-up|2|||
44481197|NCT00383240|79488173|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
44481198|NCT00383240|79488174|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
44481199|NCT00383240|79488175|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
44481200|NCT00383240|79488176|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
44481201|NCT00383240|79488173|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
44481202|NCT00383240|79488174|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
44481203|NCT00383240|79488175|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
44481204|NCT00383240|79488176|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
44481205|NCT00383240|79488173|FG000|Overall Study|Protocol Violation|4|||
44481206|NCT00383240|79488174|FG001|Overall Study|Protocol Violation|5|||
44481207|NCT00383240|79488175|FG002|Overall Study|Protocol Violation|9|||
44481208|NCT00383240|79488176|FG003|Overall Study|Protocol Violation|6|||
44481209|NCT00383240|79488173|FG000|Overall Study|Did not meet protocol eligibility|9|||
44481210|NCT00383240|79488174|FG001|Overall Study|Did not meet protocol eligibility|4|||
44481211|NCT00383240|79488175|FG002|Overall Study|Did not meet protocol eligibility|9|||
44481212|NCT00383240|79488176|FG003|Overall Study|Did not meet protocol eligibility|3|||
44481213|NCT00383240|79488173|FG000|Overall Study|Administrative|1|||
44481214|NCT00383240|79488174|FG001|Overall Study|Administrative|1|||
44481215|NCT00383240|79488175|FG002|Overall Study|Administrative|0|||
44481216|NCT00383240|79488176|FG003|Overall Study|Administrative|0|||
44481217|NCT00362180|79488196|FG000|Treated Period|Withdrawal by Subject|1|||
44481218|NCT00362180|79488197|FG001|Treated Period|Withdrawal by Subject|0|||
44481219|NCT00362180|79488198|FG002|Treated Period|Withdrawal by Subject|0|||
44481220|NCT00362180|79488199|FG003|Treated Period|Withdrawal by Subject|0|||
44481221|NCT00362180|79488200|FG004|Treated Period|Withdrawal by Subject|0|||
44481222|NCT00362180|79488201|FG005|Treated Period|Withdrawal by Subject|0|||
44481223|NCT00362180|79488202|FG006|Treated Period|Withdrawal by Subject|0|||
44481224|NCT00362180|79488203|FG007|Treated Period|Withdrawal by Subject|0|||
44481225|NCT00362180|79488204|FG008|Treated Period|Withdrawal by Subject|0|||
44481226|NCT00362180|79488196|FG000|Treated Period|Adverse Event|0|||
44481227|NCT00362180|79488197|FG001|Treated Period|Adverse Event|0|||
44481228|NCT00362180|79488198|FG002|Treated Period|Adverse Event|0|||
44481229|NCT00362180|79488199|FG003|Treated Period|Adverse Event|0|||
44481230|NCT00362180|79488200|FG004|Treated Period|Adverse Event|0|||
44481231|NCT00362180|79488201|FG005|Treated Period|Adverse Event|1|||
44481232|NCT00362180|79488202|FG006|Treated Period|Adverse Event|0|||
44481233|NCT00362180|79488203|FG007|Treated Period|Adverse Event|1|||
44481234|NCT00362180|79488204|FG008|Treated Period|Adverse Event|0|||
44481235|NCT00383162|79488222|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
44481236|NCT00383162|79488223|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
44481237|NCT00383162|79488222|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
44481238|NCT00383162|79488223|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
44481239|NCT00383162|79488222|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
44481240|NCT00383162|79488223|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
44481241|NCT00383162|79488222|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
44481242|NCT00383162|79488223|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
44481243|NCT00383162|79488222|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
44481244|NCT00383162|79488223|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
44481245|NCT00383162|79488222|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
44481246|NCT00383162|79488223|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
44481247|NCT00383162|79488222|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
44481248|NCT00383162|79488223|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
44481249|NCT00383162|79488222|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
44481250|NCT00383162|79488223|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
44481251|NCT00383162|79488222|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
44481252|NCT00383162|79488223|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
44481253|NCT00358436|79488231|FG000|Overall Study|Adverse Event|29|||
44481254|NCT00358436|79488232|FG001|Overall Study|Adverse Event|13|||
44481255|NCT00358436|79488231|FG000|Overall Study|Lack of Efficacy|34|||
44481256|NCT00358436|79488232|FG001|Overall Study|Lack of Efficacy|36|||
44481257|NCT00358436|79488231|FG000|Overall Study|Lost to Follow-up|11|||
44481258|NCT00358436|79488232|FG001|Overall Study|Lost to Follow-up|6|||
44481259|NCT00358436|79488231|FG000|Overall Study|Protocol Violation|8|||
44481260|NCT00358436|79488232|FG001|Overall Study|Protocol Violation|3|||
44274142|NCT04887948|79217042|FG002|Overall Study|No longer met eligibility criteria|1|||
44481261|NCT00358436|79488231|FG000|Overall Study|Withdrawal by Subject|40|||
44481262|NCT00358436|79488232|FG001|Overall Study|Withdrawal by Subject|17|||
44481263|NCT00358436|79488231|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
44481264|NCT00358436|79488232|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
44481265|NCT00358436|79488231|FG000|Overall Study|COPD exacerbation|22|||
44481266|NCT00358436|79488232|FG001|Overall Study|COPD exacerbation|10|||
44481267|NCT00358436|79488231|FG000|Overall Study|Other|6|||
44481268|NCT00358436|79488232|FG001|Overall Study|Other|1|||
44481269|NCT00383084|79488242|FG000|Overall Study|Withdrawal by Subject|12|||
44481270|NCT00383084|79488243|FG001|Overall Study|Withdrawal by Subject|10|||
44481271|NCT00361634|79488249|FG000|Overall Study|Lost to Follow-up|1|||
44481272|NCT00361634|79488249|FG000|Overall Study|Withdrawal by Subject|1|||
44481273|NCT00357968|79488255|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
44481274|NCT00357968|79488256|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
44481275|NCT00357968|79488255|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
44481276|NCT00357968|79488256|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
44481277|NCT00357656|79488279|FG000|Overall Study|Other, No surgery performed|0|||
44481278|NCT00357656|79488280|FG001|Overall Study|Other, No surgery performed|3|||
44481279|NCT00357500|79488298|FG000|Overall Study|Adverse Event|3|||
44481280|NCT00357500|79488298|FG000|Overall Study|Withdrawal by Subject|5|||
44481281|NCT00357500|79488298|FG000|Overall Study|Progressive Disease|65|||
44481282|NCT00357500|79488298|FG000|Overall Study|Not Started Protocol Therapy|4|||
44481283|NCT00357110|79488304|FG000|Overall Study|Early study termination|5|||
44481284|NCT00357110|79488305|FG001|Overall Study|Early study termination|5|||
44481285|NCT00098722|79488314|FG000|Double Blind Phase|Adverse Event|7|||
44481286|NCT00098722|79488315|FG001|Double Blind Phase|Adverse Event|7|||
44481287|NCT00098722|79488316|FG002|Double Blind Phase|Adverse Event|3|||
44481288|NCT00098722|79488317|FG003|Double Blind Phase|Adverse Event|0|||
44481289|NCT00098722|79488318|FG004|Double Blind Phase|Adverse Event|0|||
44481290|NCT00098722|79488319|FG005|Double Blind Phase|Adverse Event|0|||
44481291|NCT00098722|79488320|FG006|Double Blind Phase|Adverse Event|0|||
44481292|NCT00098722|79488314|FG000|Double Blind Phase|Death|2|||
44481293|NCT00098722|79488315|FG001|Double Blind Phase|Death|5|||
44481294|NCT00098722|79488316|FG002|Double Blind Phase|Death|0|||
44481295|NCT00098722|79488317|FG003|Double Blind Phase|Death|0|||
44481296|NCT00098722|79488318|FG004|Double Blind Phase|Death|0|||
44481297|NCT00098722|79488319|FG005|Double Blind Phase|Death|0|||
44481298|NCT00098722|79488320|FG006|Double Blind Phase|Death|0|||
44481299|NCT00098722|79488314|FG000|Double Blind Phase|Lack of Efficacy|21|||
44481300|NCT00098722|79488315|FG001|Double Blind Phase|Lack of Efficacy|23|||
44481301|NCT00098722|79488316|FG002|Double Blind Phase|Lack of Efficacy|15|||
44481302|NCT00098722|79488317|FG003|Double Blind Phase|Lack of Efficacy|0|||
44481303|NCT00098722|79488318|FG004|Double Blind Phase|Lack of Efficacy|0|||
44481304|NCT00098722|79488319|FG005|Double Blind Phase|Lack of Efficacy|0|||
44481305|NCT00098722|79488320|FG006|Double Blind Phase|Lack of Efficacy|0|||
44481306|NCT00098722|79488314|FG000|Double Blind Phase|Participant defaulted|16|||
44481307|NCT00098722|79488315|FG001|Double Blind Phase|Participant defaulted|11|||
44481308|NCT00098722|79488316|FG002|Double Blind Phase|Participant defaulted|9|||
44481309|NCT00098722|79488317|FG003|Double Blind Phase|Participant defaulted|0|||
44481310|NCT00098722|79488318|FG004|Double Blind Phase|Participant defaulted|0|||
44481311|NCT00098722|79488319|FG005|Double Blind Phase|Participant defaulted|0|||
44481312|NCT00098722|79488320|FG006|Double Blind Phase|Participant defaulted|0|||
44481313|NCT00098722|79488314|FG000|Double Blind Phase|Pregnancy|1|||
44227167|NCT01743469|79033779|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
44227168|NCT01743469|79033780|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
44227169|NCT01743001|79033792|FG000|Overall Study|Physician Decision|1|||
44227170|NCT01743001|79033793|FG001|Overall Study|Physician Decision|0|||
44227171|NCT01743001|79033792|FG000|Overall Study|Pregnancy|1|||
44227172|NCT01743001|79033793|FG001|Overall Study|Pregnancy|0|||
44227173|NCT01743001|79033792|FG000|Overall Study|Death|1|||
44227174|NCT01743001|79033793|FG001|Overall Study|Death|0|||
44227175|NCT01704079|79033812|FG000|Overall Study|Withdrawal by Subject|5|||
44227176|NCT01704079|79033813|FG001|Overall Study|Withdrawal by Subject|7|||
44227177|NCT01704079|79033812|FG000|Overall Study|Lost to Follow-up|2|||
44227178|NCT01704079|79033813|FG001|Overall Study|Lost to Follow-up|5|||
44227179|NCT01704079|79033812|FG000|Overall Study|Adverse Event|4|||
44227180|NCT01704079|79033813|FG001|Overall Study|Adverse Event|7|||
44481314|NCT00098722|79488315|FG001|Double Blind Phase|Pregnancy|0|||
44481315|NCT00098722|79488316|FG002|Double Blind Phase|Pregnancy|0|||
44481316|NCT00098722|79488317|FG003|Double Blind Phase|Pregnancy|0|||
44481317|NCT00098722|79488318|FG004|Double Blind Phase|Pregnancy|0|||
44227181|NCT01704079|79033812|FG000|Overall Study|Protocol Violation|1|||
44227182|NCT01704079|79033813|FG001|Overall Study|Protocol Violation|0|||
44227183|NCT01704079|79033812|FG000|Overall Study|Subject noncompliance|2|||
44227184|NCT01704079|79033813|FG001|Overall Study|Subject noncompliance|3|||
44227185|NCT01704079|79033812|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
44481318|NCT00098722|79488319|FG005|Double Blind Phase|Pregnancy|0|||
44227186|NCT01704079|79033813|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
44227187|NCT01703845|79033821|FG000|Overall Study|Adverse Event|1|||
44227188|NCT01703845|79033822|FG001|Overall Study|Adverse Event|0|||
44227189|NCT01703845|79033821|FG000|Overall Study|Protocol Violation|1|||
44481319|NCT00098722|79488320|FG006|Double Blind Phase|Pregnancy|0|||
44481320|NCT00098722|79488314|FG000|Double Blind Phase|Randomized, not treated|4|||
44481321|NCT00098722|79488315|FG001|Double Blind Phase|Randomized, not treated|3|||
44514827|NCT03717012|79520644|FG000|Overall Study|Lung transplant|0|||
44227190|NCT01703845|79033822|FG001|Overall Study|Protocol Violation|0|||
44227191|NCT01703845|79033821|FG000|Overall Study|other than stated above|1|||
44227192|NCT01703845|79033822|FG001|Overall Study|other than stated above|0|||
44227193|NCT01724359|79033830|FG000|Overall Study|Adverse Event|10|||
44227194|NCT01724359|79033830|FG000|Overall Study|Death|1|||
44227195|NCT01724359|79033830|FG000|Overall Study|Other|20|||
44227196|NCT01703221|79033839|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
44481322|NCT00098722|79488316|FG002|Double Blind Phase|Randomized, not treated|3|||
44481323|NCT00098722|79488317|FG003|Double Blind Phase|Randomized, not treated|0|||
44481324|NCT00098722|79488318|FG004|Double Blind Phase|Randomized, not treated|0|||
44481325|NCT00098722|79488319|FG005|Double Blind Phase|Randomized, not treated|0|||
44481326|NCT00098722|79488320|FG006|Double Blind Phase|Randomized, not treated|0|||
44481327|NCT00098722|79488314|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
44481328|NCT00098722|79488315|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
44481329|NCT00098722|79488316|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
44481330|NCT00098722|79488317|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
44481331|NCT00098722|79488318|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
44481332|NCT00098722|79488319|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
44481333|NCT00098722|79488320|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
44481334|NCT00098722|79488314|FG000|Double Blind Phase|Other|7|||
44481335|NCT00098722|79488315|FG001|Double Blind Phase|Other|8|||
44481336|NCT00098722|79488316|FG002|Double Blind Phase|Other|7|||
44481337|NCT00098722|79488317|FG003|Double Blind Phase|Other|0|||
44481338|NCT00098722|79488318|FG004|Double Blind Phase|Other|0|||
44227197|NCT01703221|79033840|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
44481339|NCT00098722|79488319|FG005|Double Blind Phase|Other|0|||
44481340|NCT00098722|79488320|FG006|Double Blind Phase|Other|0|||
44481341|NCT00098722|79488314|FG000|Open Label Phase|Adverse Event|0|||
44481342|NCT00098722|79488315|FG001|Open Label Phase|Adverse Event|0|||
44481343|NCT00098722|79488316|FG002|Open Label Phase|Adverse Event|0|||
44481344|NCT00098722|79488317|FG003|Open Label Phase|Adverse Event|5|||
44481345|NCT00098722|79488318|FG004|Open Label Phase|Adverse Event|0|||
44481346|NCT00098722|79488319|FG005|Open Label Phase|Adverse Event|0|||
44481347|NCT00098722|79488320|FG006|Open Label Phase|Adverse Event|0|||
44481348|NCT00098722|79488314|FG000|Open Label Phase|Death|0|||
44481349|NCT00098722|79488315|FG001|Open Label Phase|Death|0|||
44481350|NCT00098722|79488316|FG002|Open Label Phase|Death|0|||
44481351|NCT00098722|79488317|FG003|Open Label Phase|Death|2|||
44481352|NCT00098722|79488318|FG004|Open Label Phase|Death|0|||
44481353|NCT00098722|79488319|FG005|Open Label Phase|Death|0|||
44481354|NCT00098722|79488320|FG006|Open Label Phase|Death|0|||
44481355|NCT00098722|79488314|FG000|Open Label Phase|Lack of Efficacy|0|||
44481356|NCT00098722|79488315|FG001|Open Label Phase|Lack of Efficacy|0|||
44481357|NCT00098722|79488316|FG002|Open Label Phase|Lack of Efficacy|0|||
44481358|NCT00098722|79488317|FG003|Open Label Phase|Lack of Efficacy|8|||
44481359|NCT00098722|79488318|FG004|Open Label Phase|Lack of Efficacy|0|||
44481360|NCT00098722|79488319|FG005|Open Label Phase|Lack of Efficacy|0|||
44481361|NCT00098722|79488320|FG006|Open Label Phase|Lack of Efficacy|0|||
44481362|NCT00098722|79488314|FG000|Open Label Phase|Pregnancy|0|||
44481363|NCT00098722|79488315|FG001|Open Label Phase|Pregnancy|0|||
44481364|NCT00098722|79488316|FG002|Open Label Phase|Pregnancy|0|||
44481365|NCT00098722|79488317|FG003|Open Label Phase|Pregnancy|1|||
44481366|NCT00098722|79488318|FG004|Open Label Phase|Pregnancy|0|||
44544699|NCT03548935|79558265|FG001|Overall Study|Lost to Follow-up|28|||
44481367|NCT00098722|79488319|FG005|Open Label Phase|Pregnancy|0|||
44544700|NCT03548935|79558264|FG000|Overall Study|Death|1|||
44481368|NCT00098722|79488320|FG006|Open Label Phase|Pregnancy|0|||
44481369|NCT00098722|79488314|FG000|Open Label Phase|Participant defaulted|0|||
44481370|NCT00098722|79488315|FG001|Open Label Phase|Participant defaulted|0|||
44481371|NCT00098722|79488316|FG002|Open Label Phase|Participant defaulted|0|||
44481372|NCT00098722|79488317|FG003|Open Label Phase|Participant defaulted|18|||
44481373|NCT00098722|79488318|FG004|Open Label Phase|Participant defaulted|0|||
44481374|NCT00098722|79488319|FG005|Open Label Phase|Participant defaulted|0|||
44481375|NCT00098722|79488320|FG006|Open Label Phase|Participant defaulted|0|||
44544701|NCT03548935|79558265|FG001|Overall Study|Death|1|||
44481376|NCT00098722|79488314|FG000|Open Label Phase|Ongoing at cut-off date|0|||
44481377|NCT00098722|79488315|FG001|Open Label Phase|Ongoing at cut-off date|0|||
44481378|NCT00098722|79488316|FG002|Open Label Phase|Ongoing at cut-off date|0|||
44481379|NCT00098722|79488317|FG003|Open Label Phase|Ongoing at cut-off date|220|||
44481380|NCT00098722|79488318|FG004|Open Label Phase|Ongoing at cut-off date|50|||
44481381|NCT00098722|79488319|FG005|Open Label Phase|Ongoing at cut-off date|0|||
44481382|NCT00098722|79488320|FG006|Open Label Phase|Ongoing at cut-off date|0|||
44481383|NCT00098722|79488314|FG000|Open Label Phase|Other|0|||
44481384|NCT00098722|79488315|FG001|Open Label Phase|Other|0|||
44481385|NCT00098722|79488316|FG002|Open Label Phase|Other|0|||
44481386|NCT00098722|79488317|FG003|Open Label Phase|Other|18|||
44481387|NCT00098722|79488318|FG004|Open Label Phase|Other|0|||
44481388|NCT00098722|79488319|FG005|Open Label Phase|Other|0|||
44481389|NCT00098722|79488320|FG006|Open Label Phase|Other|0|||
44481390|NCT00098722|79488314|FG000|Observation Phase|Death|0|||
44481391|NCT00098722|79488315|FG001|Observation Phase|Death|0|||
44481392|NCT00098722|79488316|FG002|Observation Phase|Death|0|||
44481393|NCT00098722|79488317|FG003|Observation Phase|Death|0|||
44481394|NCT00098722|79488318|FG004|Observation Phase|Death|0|||
44481395|NCT00098722|79488319|FG005|Observation Phase|Death|5|||
44481396|NCT00098722|79488320|FG006|Observation Phase|Death|3|||
44481397|NCT00098722|79488314|FG000|Observation Phase|Lack of Efficacy|0|||
44481398|NCT00098722|79488315|FG001|Observation Phase|Lack of Efficacy|0|||
44481399|NCT00098722|79488316|FG002|Observation Phase|Lack of Efficacy|0|||
44227198|NCT01703221|79033841|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
44227199|NCT01703221|79033839|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
44227200|NCT01703221|79033840|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
44227201|NCT01703221|79033841|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
44227202|NCT01703221|79033839|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
44227203|NCT01703221|79033840|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44227204|NCT01703221|79033841|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44227205|NCT01703221|79033839|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
44227206|NCT01703221|79033840|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44227207|NCT01703221|79033841|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
44227208|NCT01703221|79033839|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44227209|NCT01703221|79033840|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44227210|NCT01703221|79033841|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
44227211|NCT01703221|79033839|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
44227212|NCT01703221|79033840|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
44227213|NCT01703221|79033841|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
44227214|NCT01703221|79033839|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
44227215|NCT01703221|79033840|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
44227216|NCT01703221|79033841|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
44227217|NCT01703221|79033839|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
44227218|NCT01703221|79033840|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
44227219|NCT01703221|79033841|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
44227220|NCT01722877|79033855|FG000|Overall Study|Death|1|||
44227221|NCT01722877|79033855|FG000|Overall Study|Lost to Follow-up|1|||
44227222|NCT01703065|79033900|FG000|Overall Study|Lack of Efficacy|1|||
44227223|NCT01703065|79033901|FG001|Overall Study|Lack of Efficacy|0|||
44227224|NCT01702987|79033914|FG000|Overall Study|Withdrawal by Subject|1|||
44227225|NCT01702987|79033915|FG001|Overall Study|Withdrawal by Subject|0|||
44227226|NCT01702519|79033936|FG000|Washout Period|Lost to Follow-up|1|||
44227227|NCT01702519|79033937|FG001|Washout Period|Lost to Follow-up|0|||
44227228|NCT01702519|79033936|FG000|Washout Period|Withdrawal by Subject|0|||
44227229|NCT01702519|79033937|FG001|Washout Period|Withdrawal by Subject|2|||
44227230|NCT01739803|79033949|FG000|Overall Study|Lost to Follow-up|9|||
44227231|NCT01739803|79033950|FG001|Overall Study|Lost to Follow-up|6|||
44227232|NCT01739335|79033962|FG000|Overall Study|Lost to Follow-up|7|||
44274143|NCT04887948|79217040|FG000|Overall Study|Other|2|||
44481400|NCT00098722|79488317|FG003|Observation Phase|Lack of Efficacy|0|||
44481401|NCT00098722|79488318|FG004|Observation Phase|Lack of Efficacy|0|||
44481402|NCT00098722|79488319|FG005|Observation Phase|Lack of Efficacy|2|||
44481403|NCT00098722|79488320|FG006|Observation Phase|Lack of Efficacy|0|||
44481404|NCT00098722|79488314|FG000|Observation Phase|Participant defaulted|0|||
44481405|NCT00098722|79488315|FG001|Observation Phase|Participant defaulted|0|||
44481406|NCT00098722|79488316|FG002|Observation Phase|Participant defaulted|0|||
44481407|NCT00098722|79488317|FG003|Observation Phase|Participant defaulted|0|||
44481408|NCT00098722|79488318|FG004|Observation Phase|Participant defaulted|0|||
44481409|NCT00098722|79488319|FG005|Observation Phase|Participant defaulted|17|||
44481410|NCT00098722|79488320|FG006|Observation Phase|Participant defaulted|4|||
44481411|NCT00098722|79488314|FG000|Observation Phase|Other|0|||
44481412|NCT00098722|79488315|FG001|Observation Phase|Other|0|||
44481413|NCT00098722|79488316|FG002|Observation Phase|Other|0|||
44481414|NCT00098722|79488317|FG003|Observation Phase|Other|0|||
44481415|NCT00098722|79488318|FG004|Observation Phase|Other|0|||
44481416|NCT00098722|79488319|FG005|Observation Phase|Other|21|||
44481417|NCT00098722|79488320|FG006|Observation Phase|Other|10|||
44481418|NCT00098254|79488332|FG000|Overall Study|Adverse Event|2|||
44481419|NCT00098254|79488332|FG000|Overall Study|Death|1|||
44481420|NCT00095056|79488338|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
44481421|NCT00095056|79488339|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
44481422|NCT00095056|79488338|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
44481423|NCT00095056|79488339|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
44481424|NCT00095056|79488338|FG000|Phase A (Weeks 0-12)|Death|1|||
44481425|NCT00095056|79488339|FG001|Phase A (Weeks 0-12)|Death|0|||
44481426|NCT00095056|79488338|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
44481427|NCT00095056|79488339|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
44481428|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
44481429|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
44481430|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
44481431|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
44481432|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
44481433|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
44481434|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
44481435|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
44481436|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Death|3|||
44481437|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Death|1|||
44481438|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
44481439|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
44481440|NCT00095056|79488338|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
44481441|NCT00095056|79488339|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
44481442|NCT00098020|79488345|FG000|Overall Study|Adverse Event|2|||
44481443|NCT00098020|79488345|FG000|Overall Study|Lost to Follow-up|1|||
44481444|NCT00098020|79488345|FG000|Overall Study|elevated liver enzymes|1|||
44481445|NCT00098020|79488345|FG000|Overall Study|Low urine PCR|1|||
44481446|NCT00098020|79488345|FG000|Overall Study|Low epidermal growth factor receptor|1|||
44481447|NCT00381680|79488351|FG000|Overall Study|Adverse Event|9|||
44481448|NCT00381680|79488352|FG001|Overall Study|Adverse Event|3|||
44481449|NCT00381680|79488351|FG000|Overall Study|Death|10|||
44481450|NCT00381680|79488352|FG001|Overall Study|Death|7|||
44481451|NCT00381680|79488351|FG000|Overall Study|Lost to Follow-up|3|||
44481452|NCT00381680|79488352|FG001|Overall Study|Lost to Follow-up|2|||
44481453|NCT00381680|79488351|FG000|Overall Study|Physician Decision|25|||
44227233|NCT01739335|79033963|FG001|Overall Study|Lost to Follow-up|4|||
44227234|NCT01739335|79033962|FG000|Overall Study|Ineligible patient randomized|0|||
44227235|NCT01739335|79033963|FG001|Overall Study|Ineligible patient randomized|1|||
44227236|NCT01702363|79033988|FG000|Overall Study|Adverse Event|14|||
44227237|NCT01702363|79033988|FG000|Overall Study|Lack of Efficacy|4|||
44227238|NCT01702363|79033988|FG000|Overall Study|Withdrawal by Subject|2|||
44227239|NCT01722097|79033995|FG000|Overall Study|Patient sheets not returned|6|||
44227240|NCT01722097|79033996|FG001|Overall Study|Patient sheets not returned|5|||
44227241|NCT01701973|79034011|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44227242|NCT01701973|79034012|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
44227243|NCT01701973|79034013|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44481454|NCT00381680|79488352|FG001|Overall Study|Physician Decision|6|||
44481455|NCT00381680|79488351|FG000|Overall Study|Withdrawal by Subject|3|||
44481456|NCT00381680|79488352|FG001|Overall Study|Withdrawal by Subject|1|||
44481457|NCT00381680|79488351|FG000|Overall Study|Entry onto another COG Trial|1|||
44481458|NCT00381680|79488352|FG001|Overall Study|Entry onto another COG Trial|2|||
44481459|NCT00381680|79488351|FG000|Overall Study|Alternative Therapy|11|||
44481460|NCT00381680|79488352|FG001|Overall Study|Alternative Therapy|5|||
44481461|NCT00381680|79488351|FG000|Overall Study|Secondary Malignancy|3|||
44481462|NCT00381680|79488352|FG001|Overall Study|Secondary Malignancy|0|||
44481463|NCT00381680|79488351|FG000|Overall Study|Delay initiation|1|||
44481464|NCT00381680|79488352|FG001|Overall Study|Delay initiation|0|||
44481465|NCT00381680|79488351|FG000|Overall Study|Stem Cell Transplant|26|||
44481466|NCT00381680|79488352|FG001|Overall Study|Stem Cell Transplant|10|||
44481467|NCT00381680|79488351|FG000|Overall Study|Relapse|18|||
44227244|NCT01701973|79034014|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44227245|NCT01701973|79034015|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44227246|NCT01701973|79034016|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44481468|NCT00381680|79488352|FG001|Overall Study|Relapse|9|||
44481469|NCT00381680|79488351|FG000|Overall Study|Induction Failure|4|||
44481470|NCT00381680|79488352|FG001|Overall Study|Induction Failure|1|||
44227247|NCT01701973|79034017|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44481471|NCT00381680|79488351|FG000|Overall Study|Progression|1|||
44481472|NCT00381680|79488352|FG001|Overall Study|Progression|1|||
44481473|NCT00381680|79488351|FG000|Overall Study|Other not otherwise specified|7|||
44481474|NCT00381680|79488352|FG001|Overall Study|Other not otherwise specified|2|||
44481475|NCT00381680|79488351|FG000|Overall Study|Ineligible|3|||
44481476|NCT00381680|79488352|FG001|Overall Study|Ineligible|1|||
44481477|NCT00360698|79488364|FG000|Run-In|Physician Decision|0|||
44481478|NCT00360698|79488365|FG001|Run-In|Physician Decision|1|||
44481479|NCT00360698|79488364|FG000|Run-In|Withdrawal by Subject|0|||
44481480|NCT00360698|79488365|FG001|Run-In|Withdrawal by Subject|2|||
44481481|NCT00360698|79488364|FG000|Run-In|Non compliance with treatment procedure|0|||
44481482|NCT00360698|79488365|FG001|Run-In|Non compliance with treatment procedure|1|||
44481483|NCT00360698|79488364|FG000|Run-In|Sponsor request|0|||
44481484|NCT00360698|79488365|FG001|Run-In|Sponsor request|2|||
44481485|NCT00360698|79488364|FG000|Run-In|Patient did not meet inclusion criteria|0|||
44481486|NCT00360698|79488365|FG001|Run-In|Patient did not meet inclusion criteria|1|||
44481487|NCT00360698|79488364|FG000|Run-In|Patient personal reasons|0|||
44481488|NCT00360698|79488365|FG001|Run-In|Patient personal reasons|2|||
44481489|NCT00360698|79488364|FG000|Run-In|Need of insulin with meals|0|||
44481490|NCT00360698|79488365|FG001|Run-In|Need of insulin with meals|1|||
44481491|NCT00360698|79488364|FG000|Treatment Period|Non compliance with treatment procedure|1|||
44481492|NCT00360698|79488365|FG001|Treatment Period|Non compliance with treatment procedure|0|||
44481493|NCT00360698|79488364|FG000|Treatment Period|Early termination by error|0|||
44481494|NCT00360698|79488365|FG001|Treatment Period|Early termination by error|1|||
44481495|NCT00380978|79488373|FG000|Overall Study|Refused allocated intervention|0|||
44481496|NCT00380978|79488374|FG001|Overall Study|Refused allocated intervention|6|||
44481497|NCT00380978|79488373|FG000|Overall Study|Wrong study envelope|0|||
44481498|NCT00380978|79488374|FG001|Overall Study|Wrong study envelope|2|||
44481499|NCT00380978|79488373|FG000|Overall Study|Allocation prior to analgesia request|1|||
44481500|NCT00380978|79488374|FG001|Overall Study|Allocation prior to analgesia request|2|||
44481501|NCT00380978|79488373|FG000|Overall Study|Parous patient|1|||
44481502|NCT00380978|79488374|FG001|Overall Study|Parous patient|0|||
44481503|NCT00162123|79488388|FG000|Overall Study|Disease progression|27|||
44481504|NCT00162123|79488389|FG001|Overall Study|Disease progression|19|||
44481505|NCT00162123|79488390|FG002|Overall Study|Disease progression|10|||
44481506|NCT00162123|79488391|FG003|Overall Study|Disease progression|4|||
44481507|NCT00162123|79488392|FG004|Overall Study|Disease progression|8|||
44481508|NCT00162123|79488393|FG005|Overall Study|Disease progression|3|||
44481509|NCT00162123|79488394|FG006|Overall Study|Disease progression|1|||
44481510|NCT00162123|79488395|FG007|Overall Study|Disease progression|0|||
44481511|NCT00162123|79488388|FG000|Overall Study|Study drug toxicity|6|||
44481512|NCT00162123|79488389|FG001|Overall Study|Study drug toxicity|1|||
44481513|NCT00162123|79488390|FG002|Overall Study|Study drug toxicity|5|||
44481514|NCT00162123|79488391|FG003|Overall Study|Study drug toxicity|0|||
44481515|NCT00162123|79488392|FG004|Overall Study|Study drug toxicity|4|||
44481516|NCT00162123|79488393|FG005|Overall Study|Study drug toxicity|1|||
44481517|NCT00162123|79488394|FG006|Overall Study|Study drug toxicity|1|||
44481518|NCT00162123|79488395|FG007|Overall Study|Study drug toxicity|0|||
44481519|NCT00162123|79488388|FG000|Overall Study|Death|3|||
44481520|NCT00162123|79488389|FG001|Overall Study|Death|3|||
44481521|NCT00162123|79488390|FG002|Overall Study|Death|1|||
44481522|NCT00162123|79488391|FG003|Overall Study|Death|1|||
44481523|NCT00162123|79488392|FG004|Overall Study|Death|1|||
44481524|NCT00162123|79488393|FG005|Overall Study|Death|1|||
44481525|NCT00162123|79488394|FG006|Overall Study|Death|0|||
44481526|NCT00162123|79488395|FG007|Overall Study|Death|0|||
44481527|NCT00162123|79488388|FG000|Overall Study|Withdrawal by Subject|2|||
44481528|NCT00162123|79488389|FG001|Overall Study|Withdrawal by Subject|0|||
44481529|NCT00162123|79488390|FG002|Overall Study|Withdrawal by Subject|2|||
44481530|NCT00162123|79488391|FG003|Overall Study|Withdrawal by Subject|1|||
44481531|NCT00162123|79488392|FG004|Overall Study|Withdrawal by Subject|1|||
44481532|NCT00162123|79488393|FG005|Overall Study|Withdrawal by Subject|2|||
44481533|NCT00162123|79488394|FG006|Overall Study|Withdrawal by Subject|1|||
44481534|NCT00162123|79488395|FG007|Overall Study|Withdrawal by Subject|0|||
44481535|NCT00162123|79488388|FG000|Overall Study|Deterioration without progression|2|||
44481536|NCT00162123|79488389|FG001|Overall Study|Deterioration without progression|2|||
44481537|NCT00162123|79488390|FG002|Overall Study|Deterioration without progression|3|||
44481538|NCT00162123|79488391|FG003|Overall Study|Deterioration without progression|0|||
44481539|NCT00162123|79488392|FG004|Overall Study|Deterioration without progression|1|||
44481540|NCT00162123|79488393|FG005|Overall Study|Deterioration without progression|0|||
44375630|NCT00953706|79380759|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
44375631|NCT00953706|79380760|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
44375632|NCT00953706|79380761|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
44481541|NCT00162123|79488394|FG006|Overall Study|Deterioration without progression|0|||
44481542|NCT00162123|79488395|FG007|Overall Study|Deterioration without progression|0|||
44481543|NCT00162123|79488388|FG000|Overall Study|Adverse Event|1|||
44481544|NCT00162123|79488389|FG001|Overall Study|Adverse Event|2|||
44481545|NCT00162123|79488390|FG002|Overall Study|Adverse Event|0|||
44481546|NCT00162123|79488391|FG003|Overall Study|Adverse Event|2|||
44481547|NCT00162123|79488392|FG004|Overall Study|Adverse Event|1|||
44481548|NCT00162123|79488393|FG005|Overall Study|Adverse Event|0|||
44481549|NCT00162123|79488394|FG006|Overall Study|Adverse Event|0|||
44481550|NCT00162123|79488395|FG007|Overall Study|Adverse Event|0|||
44481551|NCT00162123|79488388|FG000|Overall Study|Not specified (before treatment)|2|||
44481552|NCT00162123|79488389|FG001|Overall Study|Not specified (before treatment)|0|||
44481553|NCT00162123|79488390|FG002|Overall Study|Not specified (before treatment)|0|||
44481554|NCT00162123|79488391|FG003|Overall Study|Not specified (before treatment)|0|||
44481555|NCT00162123|79488392|FG004|Overall Study|Not specified (before treatment)|12|||
44481556|NCT00162123|79488393|FG005|Overall Study|Not specified (before treatment)|1|||
44481557|NCT00162123|79488394|FG006|Overall Study|Not specified (before treatment)|0|||
44481558|NCT00162123|79488395|FG007|Overall Study|Not specified (before treatment)|0|||
44481559|NCT00162123|79488388|FG000|Overall Study|Not specified (after start of treatment)|0|||
44481560|NCT00162123|79488389|FG001|Overall Study|Not specified (after start of treatment)|0|||
44481561|NCT00162123|79488390|FG002|Overall Study|Not specified (after start of treatment)|0|||
44481562|NCT00162123|79488391|FG003|Overall Study|Not specified (after start of treatment)|0|||
44481563|NCT00162123|79488392|FG004|Overall Study|Not specified (after start of treatment)|3|||
44481564|NCT00162123|79488393|FG005|Overall Study|Not specified (after start of treatment)|0|||
44481565|NCT00162123|79488394|FG006|Overall Study|Not specified (after start of treatment)|0|||
44481566|NCT00162123|79488395|FG007|Overall Study|Not specified (after start of treatment)|0|||
44481567|NCT00162123|79488388|FG000|Overall Study|Physician Decision|1|||
44481568|NCT00162123|79488389|FG001|Overall Study|Physician Decision|2|||
44481569|NCT00162123|79488390|FG002|Overall Study|Physician Decision|0|||
44481570|NCT00162123|79488391|FG003|Overall Study|Physician Decision|0|||
44481571|NCT00162123|79488392|FG004|Overall Study|Physician Decision|0|||
44481572|NCT00162123|79488393|FG005|Overall Study|Physician Decision|1|||
44481573|NCT00162123|79488394|FG006|Overall Study|Physician Decision|1|||
44481574|NCT00162123|79488395|FG007|Overall Study|Physician Decision|0|||
44481575|NCT00162123|79488388|FG000|Overall Study|Tumor assessment only (not treated)|0|||
44481576|NCT00162123|79488389|FG001|Overall Study|Tumor assessment only (not treated)|0|||
44481577|NCT00162123|79488390|FG002|Overall Study|Tumor assessment only (not treated)|0|||
44481578|NCT00162123|79488391|FG003|Overall Study|Tumor assessment only (not treated)|0|||
44481579|NCT00162123|79488392|FG004|Overall Study|Tumor assessment only (not treated)|0|||
44481580|NCT00162123|79488393|FG005|Overall Study|Tumor assessment only (not treated)|0|||
44481581|NCT00162123|79488394|FG006|Overall Study|Tumor assessment only (not treated)|0|||
44481582|NCT00162123|79488395|FG007|Overall Study|Tumor assessment only (not treated)|1|||
44481583|NCT00162123|79488388|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
44481584|NCT00162123|79488389|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
44481585|NCT00162123|79488390|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
44481586|NCT00162123|79488391|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
44481587|NCT00162123|79488392|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
44481588|NCT00162123|79488393|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
44481589|NCT00162123|79488394|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
44481590|NCT00162123|79488395|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
44481591|NCT00227721|79488414|FG000|Overall Study|On study, but never treated.|1|||
44481592|NCT00226941|79488422|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
44481593|NCT00226941|79488423|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
44481594|NCT00226941|79488424|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
44481595|NCT00226941|79488425|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
44481596|NCT00226941|79488422|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
44481597|NCT00226941|79488423|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
44481598|NCT00226941|79488424|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
44481599|NCT00226941|79488425|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
44227248|NCT01701973|79034018|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
44481600|NCT00356408|79488445|FG000|Overall Study|Adverse Event|9|||
44481601|NCT00356408|79488445|FG000|Overall Study|Lack of Efficacy|36|||
44481602|NCT00356408|79488445|FG000|Overall Study|Lost to Follow-up|2|||
44481603|NCT00356408|79488445|FG000|Overall Study|Withdrawal by Subject|6|||
44481604|NCT00356408|79488445|FG000|Overall Study|Other: Principal investigator discretion|3|||
44481605|NCT00356408|79488445|FG000|Overall Study|Other: Sponsor request|1|||
44481606|NCT00356408|79488445|FG000|Overall Study|Other: Azathioprine stopped|1|||
44481607|NCT00356408|79488445|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
44227249|NCT01721317|79034069|FG000|Overall Study|Study Closed / Terminated|2|||
44227250|NCT01721317|79034070|FG001|Overall Study|Study Closed / Terminated|2|||
44481608|NCT00356408|79488445|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
44481609|NCT00509795|79488460|FG000|Overall Study|Adverse Event|4|||
44481610|NCT00509795|79488461|FG001|Overall Study|Adverse Event|3|||
44481611|NCT00509795|79488462|FG002|Overall Study|Adverse Event|5|||
44481612|NCT00509795|79488463|FG003|Overall Study|Adverse Event|4|||
44481613|NCT00509795|79488460|FG000|Overall Study|Death|3|||
44481614|NCT00509795|79488461|FG001|Overall Study|Death|1|||
44481615|NCT00509795|79488462|FG002|Overall Study|Death|2|||
44481616|NCT00509795|79488463|FG003|Overall Study|Death|7|||
44481617|NCT00509795|79488460|FG000|Overall Study|Lack of Efficacy|0|||
44481618|NCT00509795|79488461|FG001|Overall Study|Lack of Efficacy|0|||
44481619|NCT00509795|79488462|FG002|Overall Study|Lack of Efficacy|2|||
44481620|NCT00509795|79488463|FG003|Overall Study|Lack of Efficacy|2|||
44481621|NCT00509795|79488460|FG000|Overall Study|Lost to Follow-up|1|||
44481622|NCT00509795|79488461|FG001|Overall Study|Lost to Follow-up|2|||
44481623|NCT00509795|79488462|FG002|Overall Study|Lost to Follow-up|4|||
44481624|NCT00509795|79488463|FG003|Overall Study|Lost to Follow-up|4|||
44481625|NCT00509795|79488460|FG000|Overall Study|OTHER|1|||
44481626|NCT00509795|79488461|FG001|Overall Study|OTHER|0|||
44481627|NCT00509795|79488462|FG002|Overall Study|OTHER|4|||
44481628|NCT00509795|79488463|FG003|Overall Study|OTHER|1|||
44481629|NCT00509795|79488460|FG000|Overall Study|Protocol Violation|3|||
44481630|NCT00509795|79488461|FG001|Overall Study|Protocol Violation|0|||
44481631|NCT00509795|79488462|FG002|Overall Study|Protocol Violation|3|||
44481632|NCT00509795|79488463|FG003|Overall Study|Protocol Violation|1|||
44481633|NCT00509795|79488460|FG000|Overall Study|Withdrawal by Subject|10|||
44481634|NCT00509795|79488461|FG001|Overall Study|Withdrawal by Subject|5|||
44481635|NCT00509795|79488462|FG002|Overall Study|Withdrawal by Subject|7|||
44481636|NCT00509795|79488463|FG003|Overall Study|Withdrawal by Subject|8|||
44481637|NCT00165789|79488478|FG000|Overall Study|Adverse Event|0|||
44481638|NCT00165789|79488479|FG001|Overall Study|Adverse Event|3|||
44481639|NCT00165789|79488480|FG002|Overall Study|Adverse Event|0|||
44481640|NCT00165789|79488481|FG003|Overall Study|Adverse Event|12|||
44481641|NCT00165789|79488478|FG000|Overall Study|Withdrawal by Subject|0|||
44481642|NCT00165789|79488479|FG001|Overall Study|Withdrawal by Subject|1|||
44481643|NCT00165789|79488480|FG002|Overall Study|Withdrawal by Subject|1|||
44481644|NCT00165789|79488481|FG003|Overall Study|Withdrawal by Subject|2|||
44481645|NCT00504257|79488491|FG000|Overall Study|Withdrawal by Subject|2|||
44481646|NCT00504257|79488491|FG000|Overall Study|ineligible histology|2|||
44481647|NCT00509093|79488495|FG000|Overall Study|Adverse Event|10|||
44481648|NCT00509093|79488495|FG000|Overall Study|Disease Progression|9|||
44481649|NCT00509093|79488495|FG000|Overall Study|Transformed into MDS|1|||
44481650|NCT00509093|79488495|FG000|Overall Study|Withdrawal by Subject|3|||
44481651|NCT00509093|79488495|FG000|Overall Study|Physician Decision|1|||
44481652|NCT00160641|79488499|FG000|Overall Study|Adverse Event|102|||
44481653|NCT00160641|79488499|FG000|Overall Study|Withdrawal by Subject|87|||
44481654|NCT00160641|79488499|FG000|Overall Study|Lost to Follow-up|8|||
44481655|NCT00160641|79488499|FG000|Overall Study|Lack of Efficacy|12|||
44481656|NCT00160641|79488499|FG000|Overall Study|Protocol Violation|3|||
44481657|NCT00160641|79488499|FG000|Overall Study|Other|9|||
44481658|NCT00493025|79488503|FG000|Overall Study|Physician Decision|19|||
44481659|NCT00160563|79488511|FG000|Overall Study|Adverse Event|1|||
44481660|NCT00160563|79488512|FG001|Overall Study|Adverse Event|1|||
44481661|NCT00160563|79488513|FG002|Overall Study|Adverse Event|1|||
44481662|NCT00160563|79488511|FG000|Overall Study|Lost to Follow-up|1|||
44481663|NCT00160563|79488512|FG001|Overall Study|Lost to Follow-up|1|||
44481664|NCT00160563|79488513|FG002|Overall Study|Lost to Follow-up|2|||
44481665|NCT00160563|79488511|FG000|Overall Study|Protocol Violation|0|||
44481666|NCT00160563|79488512|FG001|Overall Study|Protocol Violation|0|||
44481667|NCT00160563|79488513|FG002|Overall Study|Protocol Violation|3|||
44481668|NCT00160563|79488511|FG000|Overall Study|Withdrawal by Subject|1|||
44481669|NCT00160563|79488512|FG001|Overall Study|Withdrawal by Subject|2|||
44481670|NCT00160563|79488513|FG002|Overall Study|Withdrawal by Subject|3|||
44481671|NCT00160563|79488511|FG000|Overall Study|Other (listed in the study report)|48|||
44481672|NCT00160563|79488512|FG001|Overall Study|Other (listed in the study report)|40|||
44481673|NCT00160563|79488513|FG002|Overall Study|Other (listed in the study report)|81|||
44481674|NCT00160563|79488511|FG000|Overall Study|Missing reason|0|||
44481675|NCT00160563|79488512|FG001|Overall Study|Missing reason|1|||
44481676|NCT00160563|79488513|FG002|Overall Study|Missing reason|0|||
44481677|NCT00380744|79488529|FG000|Overall Study|Death|0|||
44481678|NCT00380744|79488530|FG001|Overall Study|Death|0|||
44481679|NCT00380744|79488531|FG002|Overall Study|Death|0|||
44481680|NCT00380744|79488532|FG003|Overall Study|Death|0|||
44481681|NCT00380744|79488533|FG004|Overall Study|Death|0|||
44481682|NCT00380744|79488534|FG005|Overall Study|Death|0|||
44481683|NCT00380744|79488535|FG006|Overall Study|Death|1|||
44481684|NCT00380744|79488529|FG000|Overall Study|Withdrawal by Subject|1|||
44481685|NCT00380744|79488530|FG001|Overall Study|Withdrawal by Subject|0|||
44481686|NCT00380744|79488531|FG002|Overall Study|Withdrawal by Subject|0|||
44481687|NCT00380744|79488532|FG003|Overall Study|Withdrawal by Subject|0|||
44481688|NCT00380744|79488533|FG004|Overall Study|Withdrawal by Subject|0|||
44481689|NCT00380744|79488534|FG005|Overall Study|Withdrawal by Subject|0|||
44481690|NCT00380744|79488535|FG006|Overall Study|Withdrawal by Subject|0|||
44481691|NCT00380588|79488554|FG000|Overall Study|Unequivocal Disease Progression|25|||
44481692|NCT00380588|79488555|FG001|Overall Study|Unequivocal Disease Progression|34|||
44481693|NCT00380588|79488554|FG000|Overall Study|Next Cycle Not Started|4|||
44481694|NCT00380588|79488555|FG001|Overall Study|Next Cycle Not Started|0|||
44481695|NCT00380588|79488554|FG000|Overall Study|Adverse Event|7|||
44481696|NCT00380588|79488555|FG001|Overall Study|Adverse Event|3|||
44481697|NCT00380588|79488554|FG000|Overall Study|Withdrawal by Subject|1|||
44481698|NCT00380588|79488555|FG001|Overall Study|Withdrawal by Subject|3|||
44481699|NCT00380588|79488554|FG000|Overall Study|Physician Decision|2|||
44481700|NCT00380588|79488555|FG001|Overall Study|Physician Decision|0|||
44481701|NCT00379808|79488561|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
44481702|NCT00379808|79488562|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
44481703|NCT00355784|79488571|FG000|Overall Study|Withdrawal by Subject|0|||
44481704|NCT00355784|79488572|FG001|Overall Study|Withdrawal by Subject|0|||
44481705|NCT00355784|79488573|FG002|Overall Study|Withdrawal by Subject|2|||
44481706|NCT00355472|79488582|FG000|Overall Study|Physician Decision|1|||
44481707|NCT00492557|79488596|FG000|Overall Study|Subject request|12|||
44481708|NCT00492557|79488597|FG001|Overall Study|Subject request|11|||
44481709|NCT00492557|79488596|FG000|Overall Study|Protocol Violation|7|||
44481710|NCT00492557|79488597|FG001|Overall Study|Protocol Violation|8|||
44481711|NCT00492557|79488596|FG000|Overall Study|Other|2|||
44481712|NCT00492557|79488597|FG001|Overall Study|Other|2|||
44481713|NCT00492557|79488596|FG000|Overall Study|Death|1|||
44481714|NCT00492557|79488597|FG001|Overall Study|Death|1|||
44481715|NCT00492557|79488596|FG000|Overall Study|Adverse Event|1|||
44481716|NCT00492557|79488597|FG001|Overall Study|Adverse Event|0|||
44481717|NCT00492557|79488596|FG000|Overall Study|Failed to return|1|||
44481718|NCT00492557|79488597|FG001|Overall Study|Failed to return|0|||
44481719|NCT00492557|79488596|FG000|Overall Study|Lost to Follow-up|0|||
44481720|NCT00492557|79488597|FG001|Overall Study|Lost to Follow-up|1|||
44481721|NCT00508391|79488608|FG000|First Treatment|Withdrawal by Subject|6|||
44481722|NCT00508391|79488609|FG001|First Treatment|Withdrawal by Subject|3|||
44481723|NCT00508391|79488608|FG000|Second Treatment|Withdrawal by Subject|2|||
44481724|NCT00508391|79488609|FG001|Second Treatment|Withdrawal by Subject|0|||
44481725|NCT00508157|79488619|FG000|Overall Study|Adverse Event|0|||
44481726|NCT00508157|79488620|FG001|Overall Study|Adverse Event|1|||
44481727|NCT00508157|79488619|FG000|Overall Study|Subject Withdrew Consent|1|||
44481728|NCT00508157|79488620|FG001|Overall Study|Subject Withdrew Consent|0|||
44481729|NCT00508157|79488619|FG000|Overall Study|Lost to Follow-up|1|||
44481730|NCT00508157|79488620|FG001|Overall Study|Lost to Follow-up|0|||
44481731|NCT00508157|79488619|FG000|Overall Study|Subject no longer met study criteria|0|||
44481732|NCT00508157|79488620|FG001|Overall Study|Subject no longer met study criteria|1|||
44481733|NCT00508157|79488619|FG000|Overall Study|Other known cause|0|||
44481734|NCT00508157|79488620|FG001|Overall Study|Other known cause|1|||
44481735|NCT00378560|79488628|FG000|Overall Study|Adverse Event|1|||
44481736|NCT00378560|79488629|FG001|Overall Study|Adverse Event|0|||
44481737|NCT00378560|79488628|FG000|Overall Study|Lost to Follow-up|24|||
44481738|NCT00378560|79488629|FG001|Overall Study|Lost to Follow-up|29|||
44481739|NCT00378560|79488628|FG000|Overall Study|Protocol Violation|2|||
44481740|NCT00378560|79488629|FG001|Overall Study|Protocol Violation|0|||
44481741|NCT00378560|79488628|FG000|Overall Study|Withdrawal by Subject|17|||
44481742|NCT00378560|79488629|FG001|Overall Study|Withdrawal by Subject|21|||
44481743|NCT00378560|79488628|FG000|Overall Study|Moved|4|||
44481744|NCT00378560|79488629|FG001|Overall Study|Moved|3|||
44481745|NCT00378560|79488628|FG000|Overall Study|Pregnancy|7|||
44481746|NCT00378560|79488629|FG001|Overall Study|Pregnancy|5|||
44481747|NCT00378560|79488628|FG000|Overall Study|Laboratory test values abnormal|1|||
44481748|NCT00378560|79488629|FG001|Overall Study|Laboratory test values abnormal|0|||
44481749|NCT00508001|79488638|FG000|Overall Study|Adverse Event|2|||
44481750|NCT00508001|79488639|FG001|Overall Study|Adverse Event|0|||
44481751|NCT00508001|79488640|FG002|Overall Study|Adverse Event|4|||
44481752|NCT00508001|79488638|FG000|Overall Study|condition under investigation worsened|13|||
44481753|NCT00508001|79488639|FG001|Overall Study|condition under investigation worsened|7|||
44481754|NCT00508001|79488640|FG002|Overall Study|condition under investigation worsened|1|||
44481755|NCT00508001|79488638|FG000|Overall Study|Death|0|||
44481756|NCT00508001|79488639|FG001|Overall Study|Death|1|||
44481757|NCT00508001|79488640|FG002|Overall Study|Death|1|||
44481758|NCT00508001|79488638|FG000|Overall Study|Withdrawal by Subject|4|||
44481759|NCT00508001|79488639|FG001|Overall Study|Withdrawal by Subject|4|||
44481760|NCT00508001|79488640|FG002|Overall Study|Withdrawal by Subject|1|||
44481761|NCT00507689|79488651|FG000|Pre-Randomization Period|Adverse Event|1|||
44481762|NCT00507689|79488652|FG001|Pre-Randomization Period|Adverse Event|0|||
44481763|NCT00507689|79488651|FG000|Pre-Randomization Period|Physician Decision|1|||
44481764|NCT00507689|79488652|FG001|Pre-Randomization Period|Physician Decision|0|||
44481765|NCT00507689|79488651|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
44481766|NCT00507689|79488652|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
44481767|NCT00507689|79488651|FG000|Randomized Period|Adverse Event|1|||
44481768|NCT00507689|79488652|FG001|Randomized Period|Adverse Event|1|||
44481769|NCT00507689|79488651|FG000|Randomized Period|Withdrawal by Subject|0|||
44481770|NCT00507689|79488652|FG001|Randomized Period|Withdrawal by Subject|1|||
44481771|NCT00491387|79488659|FG000|Overall Study|study terminated|20|||
44481772|NCT00491075|79488663|FG000|Overall Study|Withdrawal by Subject|1|||
44481773|NCT00491075|79488663|FG000|Overall Study|Physician Decision|1|||
44481774|NCT00507455|79488670|FG000|Overall Study|Adverse Event|3|||
44481775|NCT00507455|79488671|FG001|Overall Study|Adverse Event|3|||
44481776|NCT00507455|79488672|FG002|Overall Study|Adverse Event|6|||
44481777|NCT00507455|79488670|FG000|Overall Study|Withdrawal by Subject|2|||
44481778|NCT00507455|79488671|FG001|Overall Study|Withdrawal by Subject|1|||
44481779|NCT00507455|79488672|FG002|Overall Study|Withdrawal by Subject|2|||
44481780|NCT00507455|79488670|FG000|Overall Study|Protocol Violation|4|||
44481781|NCT00507455|79488671|FG001|Overall Study|Protocol Violation|1|||
44481782|NCT00507455|79488672|FG002|Overall Study|Protocol Violation|1|||
44481783|NCT00507455|79488670|FG000|Overall Study|Lost to Follow-up|2|||
44481784|NCT00507455|79488671|FG001|Overall Study|Lost to Follow-up|0|||
44481785|NCT00507455|79488672|FG002|Overall Study|Lost to Follow-up|2|||
44481786|NCT00507455|79488670|FG000|Overall Study|Lack of Efficacy|0|||
44481787|NCT00507455|79488671|FG001|Overall Study|Lack of Efficacy|1|||
44481788|NCT00507455|79488672|FG002|Overall Study|Lack of Efficacy|0|||
44481789|NCT00507455|79488670|FG000|Overall Study|Other - miscellaneous reason|1|||
44481790|NCT00507455|79488671|FG001|Overall Study|Other - miscellaneous reason|0|||
44481791|NCT00507455|79488672|FG002|Overall Study|Other - miscellaneous reason|1|||
44481792|NCT00506831|79488680|FG000|Overall Study|Death|1|||
44481793|NCT00506831|79488680|FG000|Overall Study|Withdrawal by Subject|1|||
44481794|NCT00506753|79488686|FG000|Overall Study|Lost to Follow-up|21|||
44481795|NCT00506753|79488687|FG001|Overall Study|Lost to Follow-up|15|||
44481796|NCT00490919|79488695|FG000|Open-label Run-in Period|Adverse Event|239|||
44481797|NCT00490919|79488696|FG001|Open-label Run-in Period|Adverse Event|0|||
44481798|NCT00490919|79488697|FG002|Open-label Run-in Period|Adverse Event|0|||
44481799|NCT00490919|79488695|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
44481800|NCT00490919|79488696|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
44481801|NCT00490919|79488697|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
44481802|NCT00490919|79488695|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
44481803|NCT00490919|79488696|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
44481804|NCT00490919|79488697|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
44481805|NCT00490919|79488695|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
44481806|NCT00490919|79488696|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
44481807|NCT00490919|79488697|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
44481808|NCT00490919|79488695|FG000|Open-label Run-in Period|Administrative|40|||
44481809|NCT00490919|79488696|FG001|Open-label Run-in Period|Administrative|0|||
44481810|NCT00490919|79488697|FG002|Open-label Run-in Period|Administrative|0|||
44481811|NCT00490919|79488695|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
44481812|NCT00490919|79488696|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
44481813|NCT00490919|79488697|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
44481814|NCT00490919|79488695|FG000|Double-blind Phase|Adverse Event|0|||
44481815|NCT00490919|79488696|FG001|Double-blind Phase|Adverse Event|40|||
44481816|NCT00490919|79488697|FG002|Double-blind Phase|Adverse Event|20|||
44481817|NCT00490919|79488695|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44481818|NCT00490919|79488696|FG001|Double-blind Phase|Withdrawal by Subject|10|||
44481819|NCT00490919|79488697|FG002|Double-blind Phase|Withdrawal by Subject|11|||
44481820|NCT00490919|79488695|FG000|Double-blind Phase|Lost to Follow-up|0|||
44481821|NCT00490919|79488696|FG001|Double-blind Phase|Lost to Follow-up|8|||
44481822|NCT00490919|79488697|FG002|Double-blind Phase|Lost to Follow-up|11|||
44481823|NCT00490919|79488695|FG000|Double-blind Phase|Lack of Efficacy|0|||
44481824|NCT00490919|79488696|FG001|Double-blind Phase|Lack of Efficacy|22|||
44481825|NCT00490919|79488697|FG002|Double-blind Phase|Lack of Efficacy|36|||
44481826|NCT00490919|79488695|FG000|Double-blind Phase|Administrative|0|||
44481827|NCT00490919|79488696|FG001|Double-blind Phase|Administrative|6|||
44481828|NCT00490919|79488697|FG002|Double-blind Phase|Administrative|6|||
44481829|NCT00503867|79488704|FG000|Overall Study|Lost to Follow-up|1|||
44481830|NCT00503867|79488704|FG000|Overall Study|Adverse Event|1|||
44481831|NCT00503399|79488710|FG000|Overall Study|Death|2|||
44481832|NCT00503399|79488711|FG001|Overall Study|Death|1|||
44481833|NCT00503399|79488710|FG000|Overall Study|Protocol Violation|1|||
44481834|NCT00503399|79488711|FG001|Overall Study|Protocol Violation|0|||
44481835|NCT00503399|79488710|FG000|Overall Study|Withdrawal by Subject|4|||
44481836|NCT00503399|79488711|FG001|Overall Study|Withdrawal by Subject|2|||
44481837|NCT00503399|79488710|FG000|Overall Study|Adverse Event|0|||
44481838|NCT00503399|79488711|FG001|Overall Study|Adverse Event|3|||
44481839|NCT00503399|79488710|FG000|Overall Study|Lost to Follow-up|0|||
44481840|NCT00503399|79488711|FG001|Overall Study|Lost to Follow-up|2|||
44481841|NCT00506519|79488720|FG000|Overall Study|Death|4|||
44481842|NCT00506519|79488721|FG001|Overall Study|Death|6|||
44481843|NCT00506519|79488722|FG002|Overall Study|Death|0|||
44481844|NCT00506519|79488720|FG000|Overall Study|Adverse Event|1|||
44481845|NCT00506519|79488721|FG001|Overall Study|Adverse Event|0|||
44481846|NCT00506519|79488722|FG002|Overall Study|Adverse Event|0|||
44481847|NCT00503009|79488736|FG000|Overall Study|Protocol Violation|1|||
44481848|NCT00503009|79488737|FG001|Overall Study|Protocol Violation|0|||
44481849|NCT00503009|79488738|FG002|Overall Study|Protocol Violation|1|||
44481850|NCT00503009|79488736|FG000|Overall Study|Withdrawal by Subject|0|||
44481851|NCT00503009|79488737|FG001|Overall Study|Withdrawal by Subject|1|||
44481852|NCT00503009|79488738|FG002|Overall Study|Withdrawal by Subject|1|||
44481853|NCT00503009|79488736|FG000|Overall Study|Physician Decision|0|||
44481854|NCT00503009|79488737|FG001|Overall Study|Physician Decision|1|||
44481855|NCT00503009|79488738|FG002|Overall Study|Physician Decision|1|||
44481856|NCT00160251|79488752|FG000|Prior to Amendment 2|Adverse Event|2|||
44481857|NCT00160251|79488753|FG001|Prior to Amendment 2|Adverse Event|1|||
44481858|NCT00160251|79488754|FG002|Prior to Amendment 2|Adverse Event|3|||
44481859|NCT00160251|79488755|FG003|Prior to Amendment 2|Adverse Event|1|||
44481860|NCT00160251|79488756|FG004|Prior to Amendment 2|Adverse Event|1|||
44481861|NCT00160251|79488757|FG005|Prior to Amendment 2|Adverse Event|1|||
44481862|NCT00160251|79488758|FG006|Prior to Amendment 2|Adverse Event|1|||
44481863|NCT00160251|79488759|FG007|Prior to Amendment 2|Adverse Event|0|||
44481864|NCT00160251|79488752|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
44481865|NCT00160251|79488753|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
44481866|NCT00160251|79488754|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
44481867|NCT00160251|79488755|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
44481868|NCT00160251|79488756|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
44481869|NCT00160251|79488757|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
44481870|NCT00160251|79488758|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
44481871|NCT00160251|79488759|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
44481872|NCT00160251|79488752|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
44481873|NCT00160251|79488753|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
44481874|NCT00160251|79488754|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
44481875|NCT00160251|79488755|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
44481876|NCT00160251|79488756|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
44481877|NCT00160251|79488757|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
44481878|NCT00160251|79488758|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
44481879|NCT00160251|79488759|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
44481880|NCT00160251|79488752|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
44481881|NCT00160251|79488753|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
44481882|NCT00160251|79488754|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
44481883|NCT00160251|79488755|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
44481884|NCT00160251|79488756|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
44481885|NCT00160251|79488757|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
44481886|NCT00160251|79488758|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
44481887|NCT00160251|79488759|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
44481888|NCT00160251|79488752|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
44481889|NCT00160251|79488753|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
44481890|NCT00160251|79488754|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
44481891|NCT00160251|79488755|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
44481892|NCT00160251|79488756|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
44481893|NCT00160251|79488757|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
44481894|NCT00160251|79488758|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
44481895|NCT00160251|79488759|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
44481896|NCT00160251|79488752|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
44481897|NCT00160251|79488753|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
44481898|NCT00160251|79488754|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
44481899|NCT00160251|79488755|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
44481900|NCT00160251|79488756|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
44481901|NCT00160251|79488757|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
44481902|NCT00160251|79488758|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
44481903|NCT00160251|79488759|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
44481904|NCT00160251|79488752|FG000|Post-amendment 2|Adverse Event|0|||
44481905|NCT00160251|79488753|FG001|Post-amendment 2|Adverse Event|0|||
44481906|NCT00160251|79488754|FG002|Post-amendment 2|Adverse Event|0|||
44481907|NCT00160251|79488755|FG003|Post-amendment 2|Adverse Event|0|||
44481908|NCT00160251|79488756|FG004|Post-amendment 2|Adverse Event|0|||
44481909|NCT00160251|79488757|FG005|Post-amendment 2|Adverse Event|0|||
44481910|NCT00160251|79488758|FG006|Post-amendment 2|Adverse Event|0|||
44481911|NCT00160251|79488759|FG007|Post-amendment 2|Adverse Event|20|||
44481912|NCT00160251|79488752|FG000|Post-amendment 2|Lack of Efficacy|0|||
44481913|NCT00160251|79488753|FG001|Post-amendment 2|Lack of Efficacy|0|||
44481914|NCT00160251|79488754|FG002|Post-amendment 2|Lack of Efficacy|0|||
44481915|NCT00160251|79488755|FG003|Post-amendment 2|Lack of Efficacy|0|||
44481916|NCT00160251|79488756|FG004|Post-amendment 2|Lack of Efficacy|0|||
44481917|NCT00160251|79488757|FG005|Post-amendment 2|Lack of Efficacy|0|||
44481918|NCT00160251|79488758|FG006|Post-amendment 2|Lack of Efficacy|0|||
44481919|NCT00160251|79488759|FG007|Post-amendment 2|Lack of Efficacy|24|||
44481920|NCT00160251|79488752|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481921|NCT00160251|79488753|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481922|NCT00160251|79488754|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481923|NCT00160251|79488755|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481924|NCT00160251|79488756|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481925|NCT00160251|79488757|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481926|NCT00160251|79488758|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
44481927|NCT00160251|79488759|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
44481928|NCT00506441|79488816|FG000|Period 1; Open-label Period|Adverse Event|21|||
44481929|NCT00506441|79488817|FG001|Period 1; Open-label Period|Adverse Event|0|||
44481930|NCT00506441|79488816|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
44481931|NCT00506441|79488817|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
44481932|NCT00506441|79488816|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
44481933|NCT00506441|79488817|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
44481934|NCT00506441|79488816|FG000|Period 1; Open-label Period|Physician Decision|5|||
44481935|NCT00506441|79488817|FG001|Period 1; Open-label Period|Physician Decision|0|||
44481936|NCT00506441|79488816|FG000|Period 1; Open-label Period|Protocol Violation|9|||
44481937|NCT00506441|79488817|FG001|Period 1; Open-label Period|Protocol Violation|0|||
44481938|NCT00506441|79488816|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
44481939|NCT00506441|79488817|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
44481940|NCT00506441|79488816|FG000|Period 1; Open-label Period|Other Reasons|13|||
44481941|NCT00506441|79488817|FG001|Period 1; Open-label Period|Other Reasons|0|||
44481942|NCT00506441|79488816|FG000|Period 2; Double-blind Period|Adverse Event|0|||
44481943|NCT00506441|79488817|FG001|Period 2; Double-blind Period|Adverse Event|1|||
44481944|NCT00506441|79488816|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
44481945|NCT00506441|79488817|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
44481946|NCT00506441|79488816|FG000|Period 2; Double-blind Period|Physician Decision|1|||
44481947|NCT00506441|79488817|FG001|Period 2; Double-blind Period|Physician Decision|1|||
44481948|NCT00506441|79488816|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
44481949|NCT00506441|79488817|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
44481950|NCT00506441|79488816|FG000|Period 2; Double-blind Period|Other Reason|1|||
44481951|NCT00506441|79488817|FG001|Period 2; Double-blind Period|Other Reason|1|||
44481952|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
44481953|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
44481954|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Graft loss|1|||
44481955|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Graft loss|2|||
44481956|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Death|5|||
44481957|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Death|3|||
44481958|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
44481959|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
44481960|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
44481961|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
44481962|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
44481963|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
44481964|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
44481965|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
44481966|NCT00378014|79488844|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
44481967|NCT00378014|79488845|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
44481968|NCT00378014|79488844|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
44481969|NCT00378014|79488845|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
44481970|NCT00378014|79488844|FG000|Extension (Month 12 to Month 59)|Death|1|||
44481971|NCT00378014|79488845|FG001|Extension (Month 12 to Month 59)|Death|2|||
44481972|NCT00378014|79488844|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
44481973|NCT00378014|79488845|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
44481974|NCT00378014|79488844|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
44481975|NCT00378014|79488845|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
44481976|NCT00378014|79488844|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
44481977|NCT00378014|79488845|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
44481978|NCT00378014|79488844|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
44375633|NCT00953706|79380758|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
44375634|NCT00953706|79380759|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
44375635|NCT00953706|79380760|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
44481979|NCT00378014|79488845|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
44481980|NCT00485303|79488853|FG000|Overall Study|Adverse Event|5|||
44481981|NCT00485303|79488853|FG000|Overall Study|Progressive Disease|44|||
44481982|NCT00485303|79488853|FG000|Overall Study|Other|3|||
44481983|NCT00485303|79488853|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
44481984|NCT00485303|79488853|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
44481985|NCT00490841|79488857|FG000|Overall Study|Death|5|||
44481986|NCT00490841|79488857|FG000|Overall Study|Withdrawal by Subject|4|||
44481987|NCT00490841|79488857|FG000|Overall Study|Lost to Follow-up|1|||
44481988|NCT00490841|79488857|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
44481989|NCT00377858|79488864|FG000|Overall Study|Withdrawal by Subject|12|||
44481990|NCT00377858|79488865|FG001|Overall Study|Withdrawal by Subject|11|||
44481991|NCT00377858|79488864|FG000|Overall Study|Lost to Follow-up|6|||
44481992|NCT00377858|79488865|FG001|Overall Study|Lost to Follow-up|1|||
44481993|NCT00377858|79488864|FG000|Overall Study|Physician Decision|5|||
44481994|NCT00377858|79488865|FG001|Overall Study|Physician Decision|5|||
44481995|NCT00377858|79488864|FG000|Overall Study|Protocol Violation|3|||
44481996|NCT00377858|79488865|FG001|Overall Study|Protocol Violation|4|||
44481997|NCT00377858|79488864|FG000|Overall Study|Adverse Event|2|||
44481998|NCT00377858|79488865|FG001|Overall Study|Adverse Event|1|||
44481999|NCT00377858|79488864|FG000|Overall Study|Entry Criteria Not Met|2|||
44482000|NCT00377858|79488865|FG001|Overall Study|Entry Criteria Not Met|0|||
44482001|NCT00377858|79488864|FG000|Overall Study|Sponsor Decision|1|||
44482002|NCT00377858|79488865|FG001|Overall Study|Sponsor Decision|2|||
44482003|NCT00377858|79488864|FG000|Overall Study|Death|0|||
44482004|NCT00377858|79488865|FG001|Overall Study|Death|3|||
44482005|NCT00502775|79488874|FG000|Overall Study|Adverse Event|1|||
44482006|NCT00502775|79488875|FG001|Overall Study|Adverse Event|2|||
44482007|NCT00502775|79488876|FG002|Overall Study|Adverse Event|1|||
44482008|NCT00502775|79488874|FG000|Overall Study|Protocol Violation|1|||
44482009|NCT00502775|79488875|FG001|Overall Study|Protocol Violation|5|||
44482010|NCT00502775|79488876|FG002|Overall Study|Protocol Violation|2|||
44482011|NCT00502775|79488874|FG000|Overall Study|Withdrawal by Subject|1|||
44482012|NCT00502775|79488875|FG001|Overall Study|Withdrawal by Subject|1|||
44482013|NCT00502775|79488876|FG002|Overall Study|Withdrawal by Subject|2|||
44482014|NCT00502775|79488874|FG000|Overall Study|Sponsor Terminated Study|1|||
44482015|NCT00502775|79488875|FG001|Overall Study|Sponsor Terminated Study|0|||
44482016|NCT00502775|79488876|FG002|Overall Study|Sponsor Terminated Study|1|||
44482017|NCT00502775|79488874|FG000|Overall Study|Non-compliance with eDiary|4|||
44482018|NCT00502775|79488875|FG001|Overall Study|Non-compliance with eDiary|1|||
44482019|NCT00502775|79488876|FG002|Overall Study|Non-compliance with eDiary|1|||
44482020|NCT00502775|79488874|FG000|Overall Study|Subject unable to swallow capsule|1|||
44227251|NCT01721317|79034069|FG000|Overall Study|Physician Decision|0|||
44227252|NCT01721317|79034070|FG001|Overall Study|Physician Decision|1|||
44227253|NCT01721317|79034069|FG000|Overall Study|Withdrawal by Subject|0|||
44227254|NCT01721317|79034070|FG001|Overall Study|Withdrawal by Subject|1|||
44482021|NCT00502775|79488875|FG001|Overall Study|Subject unable to swallow capsule|0|||
44482022|NCT00502775|79488876|FG002|Overall Study|Subject unable to swallow capsule|1|||
44482023|NCT00502775|79488874|FG000|Overall Study|Logpad compliance <80%|1|||
44482024|NCT00502775|79488875|FG001|Overall Study|Logpad compliance <80%|0|||
44482025|NCT00502775|79488876|FG002|Overall Study|Logpad compliance <80%|0|||
44482026|NCT00502775|79488874|FG000|Overall Study|Randomized in error|0|||
44482027|NCT00502775|79488875|FG001|Overall Study|Randomized in error|1|||
44482028|NCT00502775|79488876|FG002|Overall Study|Randomized in error|1|||
44482029|NCT00502775|79488874|FG000|Overall Study|Non-compliance|0|||
44482030|NCT00502775|79488875|FG001|Overall Study|Non-compliance|2|||
44482031|NCT00502775|79488876|FG002|Overall Study|Non-compliance|2|||
44482032|NCT00502775|79488874|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
44482033|NCT00502775|79488875|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
44482034|NCT00502775|79488876|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
44482035|NCT00502775|79488874|FG000|Overall Study|Declining pollen counts|0|||
44482036|NCT00502775|79488875|FG001|Overall Study|Declining pollen counts|1|||
44482037|NCT00502775|79488876|FG002|Overall Study|Declining pollen counts|1|||
44482038|NCT00502775|79488874|FG000|Overall Study|Subject in jail|0|||
44482039|NCT00502775|79488875|FG001|Overall Study|Subject in jail|1|||
44482040|NCT00502775|79488876|FG002|Overall Study|Subject in jail|0|||
44482041|NCT00502775|79488874|FG000|Overall Study|Subject took disallowed drug|0|||
44482042|NCT00502775|79488875|FG001|Overall Study|Subject took disallowed drug|0|||
44482043|NCT00502775|79488876|FG002|Overall Study|Subject took disallowed drug|1|||
44482044|NCT00502697|79488886|FG000|Overall Study|Withdrawal by Subject|3|||
44482045|NCT00502697|79488887|FG001|Overall Study|Withdrawal by Subject|1|||
44482046|NCT00502697|79488886|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
44482047|NCT00502697|79488887|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
44482048|NCT00502697|79488886|FG000|Overall Study|found not to meet eligibility criteria|3|||
44482049|NCT00502697|79488887|FG001|Overall Study|found not to meet eligibility criteria|4|||
44482050|NCT00502697|79488886|FG000|Overall Study|did not meet assignment criteria|4|||
44482051|NCT00502697|79488887|FG001|Overall Study|did not meet assignment criteria|2|||
44482052|NCT00485069|79488895|FG000|Overall Study|Adverse Event|10|||
44482053|NCT00485069|79488896|FG001|Overall Study|Adverse Event|4|||
44482054|NCT00485069|79488895|FG000|Overall Study|Lack of Efficacy|2|||
44482055|NCT00485069|79488896|FG001|Overall Study|Lack of Efficacy|1|||
44482056|NCT00485069|79488895|FG000|Overall Study|Protocol Violation|0|||
44482057|NCT00485069|79488896|FG001|Overall Study|Protocol Violation|1|||
44482058|NCT00485069|79488895|FG000|Overall Study|Withdrawal by Subject|6|||
44482059|NCT00485069|79488896|FG001|Overall Study|Withdrawal by Subject|6|||
44482060|NCT00355082|79488911|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
44482061|NCT00355082|79488912|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
44482062|NCT00355082|79488913|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
44482063|NCT00355082|79488911|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
44482064|NCT00355082|79488912|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
44482065|NCT00355082|79488913|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
44482066|NCT00355082|79488911|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
44482067|NCT00355082|79488912|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
44482068|NCT00355082|79488913|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
44482069|NCT00355082|79488911|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
44274144|NCT04887948|79217041|FG001|Overall Study|Other|1|||
44274145|NCT04887948|79217042|FG002|Overall Study|Other|1|||
44274146|NCT01638000|79217180|FG000|Overall Study|Randomized but Never Received Drug|7|||
44274147|NCT01638000|79217181|FG001|Overall Study|Randomized but Never Received Drug|10|||
44274148|NCT01638000|79217180|FG000|Overall Study|Adverse Event|14|||
44482070|NCT00355082|79488912|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
44482071|NCT00355082|79488913|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
44482072|NCT00355082|79488911|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
44482073|NCT00355082|79488912|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
44482074|NCT00355082|79488913|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
44482075|NCT00355082|79488911|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
44227255|NCT01701193|79034080|FG000|Overall Study|Withdrawal by Subject|2|||
44227256|NCT01701193|79034081|FG001|Overall Study|Withdrawal by Subject|2|||
44227257|NCT01701193|79034082|FG002|Overall Study|Withdrawal by Subject|1|||
44227258|NCT01701193|79034083|FG003|Overall Study|Withdrawal by Subject|2|||
44227259|NCT01701193|79034080|FG000|Overall Study|Adverse Event|1|||
44227260|NCT01701193|79034081|FG001|Overall Study|Adverse Event|0|||
44227261|NCT01701193|79034082|FG002|Overall Study|Adverse Event|0|||
44482076|NCT00355082|79488912|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
44482077|NCT00355082|79488913|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
44482078|NCT00355082|79488911|FG000|Continuation Phase|Adverse Event|2|||
44227262|NCT01701193|79034083|FG003|Overall Study|Adverse Event|0|||
44482079|NCT00355082|79488912|FG001|Continuation Phase|Adverse Event|0|||
44227263|NCT01959347|79034131|FG000|Overall Study|Protocol Violation|9|||
44227264|NCT01959347|79034132|FG001|Overall Study|Protocol Violation|7|||
44227265|NCT01959035|79034158|FG000|Overall Study|Adverse Event|5|||
44274149|NCT01638000|79217181|FG001|Overall Study|Adverse Event|16|||
44482080|NCT00355082|79488913|FG002|Continuation Phase|Adverse Event|1|||
44482081|NCT00355082|79488911|FG000|Continuation Phase|Lost to Follow-up|2|||
44482082|NCT00355082|79488912|FG001|Continuation Phase|Lost to Follow-up|0|||
44482083|NCT00355082|79488913|FG002|Continuation Phase|Lost to Follow-up|1|||
44482084|NCT00355082|79488911|FG000|Continuation Phase|Protocol Violation|1|||
44482085|NCT00355082|79488912|FG001|Continuation Phase|Protocol Violation|0|||
44227266|NCT01959035|79034158|FG000|Overall Study|Withdrawal by Subject|4|||
44227267|NCT01959035|79034158|FG000|Overall Study|Lost to Follow-up|1|||
44227268|NCT01959035|79034158|FG000|Overall Study|Other (no primary reason given)|1|||
44227269|NCT01700959|79034168|FG000|Overall Study|Adverse Event|0|||
44227270|NCT01700959|79034169|FG001|Overall Study|Adverse Event|1|||
44227271|NCT01700959|79034170|FG002|Overall Study|Adverse Event|1|||
44227272|NCT01700959|79034171|FG003|Overall Study|Adverse Event|2|||
44227273|NCT01700959|79034172|FG004|Overall Study|Adverse Event|0|||
44227274|NCT01700959|79034173|FG005|Overall Study|Adverse Event|2|||
44227275|NCT01700959|79034168|FG000|Overall Study|Withdrawal by Subject|15|||
44227276|NCT01700959|79034169|FG001|Overall Study|Withdrawal by Subject|9|||
44227277|NCT01700959|79034170|FG002|Overall Study|Withdrawal by Subject|12|||
44227278|NCT01700959|79034171|FG003|Overall Study|Withdrawal by Subject|11|||
44227279|NCT01700959|79034172|FG004|Overall Study|Withdrawal by Subject|8|||
44274150|NCT01638000|79217180|FG000|Overall Study|Lack of Efficacy|5|||
44274151|NCT01638000|79217181|FG001|Overall Study|Lack of Efficacy|6|||
44274152|NCT01638000|79217180|FG000|Overall Study|Protocol Violation|11|||
44274153|NCT01638000|79217181|FG001|Overall Study|Protocol Violation|13|||
44274154|NCT01638000|79217180|FG000|Overall Study|Withdrawal by Subject|21|||
44274155|NCT01638000|79217181|FG001|Overall Study|Withdrawal by Subject|24|||
44482086|NCT00355082|79488913|FG002|Continuation Phase|Protocol Violation|1|||
44482087|NCT00355082|79488911|FG000|Continuation Phase|Withdrawal by Subject|4|||
44482088|NCT00355082|79488912|FG001|Continuation Phase|Withdrawal by Subject|0|||
44482089|NCT00355082|79488913|FG002|Continuation Phase|Withdrawal by Subject|0|||
44482090|NCT00355082|79488911|FG000|Continuation Phase|Lack of Efficacy|5|||
44482091|NCT00355082|79488912|FG001|Continuation Phase|Lack of Efficacy|0|||
44482092|NCT00355082|79488913|FG002|Continuation Phase|Lack of Efficacy|0|||
44482093|NCT00355082|79488911|FG000|Continuation Phase|Site Closed by Sponsor|8|||
44482094|NCT00355082|79488912|FG001|Continuation Phase|Site Closed by Sponsor|0|||
44482095|NCT00355082|79488913|FG002|Continuation Phase|Site Closed by Sponsor|0|||
44482096|NCT00355082|79488911|FG000|Continuation Phase|Scheduling Error|1|||
44482097|NCT00355082|79488912|FG001|Continuation Phase|Scheduling Error|0|||
44482098|NCT00355082|79488913|FG002|Continuation Phase|Scheduling Error|0|||
44482099|NCT00355082|79488911|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
44482100|NCT00355082|79488912|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
44482101|NCT00355082|79488913|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
44482102|NCT00502307|79488924|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
44482103|NCT00502307|79488925|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
44482104|NCT00502307|79488926|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
44482105|NCT00502307|79488924|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
44482106|NCT00502307|79488925|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
44482107|NCT00502307|79488926|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
44482108|NCT00502307|79488924|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
44482109|NCT00502307|79488925|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
44482110|NCT00502307|79488926|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
44482111|NCT00502307|79488924|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
44482112|NCT00502307|79488925|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
44482113|NCT00502307|79488926|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
44482114|NCT00502307|79488924|FG000|Maintenance Period|Progressive disease|80|||
44482115|NCT00502307|79488925|FG001|Maintenance Period|Progressive disease|0|||
44482116|NCT00502307|79488926|FG002|Maintenance Period|Progressive disease|0|||
44482117|NCT00502307|79488924|FG000|Maintenance Period|Discontinued due to other reasons|68|||
44482118|NCT00502307|79488925|FG001|Maintenance Period|Discontinued due to other reasons|0|||
44482119|NCT00502307|79488926|FG002|Maintenance Period|Discontinued due to other reasons|0|||
44482120|NCT00484679|79488943|FG000|Overall Study|Withdrawal by Subject|3|||
44482121|NCT00377312|79488949|FG000|Overall Study|Adverse Event|1|||
44482122|NCT00377312|79488950|FG001|Overall Study|Adverse Event|1|||
44482123|NCT00377234|79488958|FG000|Overall Study|Adverse Event|14|||
44482124|NCT00377234|79488959|FG001|Overall Study|Adverse Event|17|||
44482125|NCT00377234|79488958|FG000|Overall Study|Withdrawal by Subject|11|||
44482126|NCT00377234|79488959|FG001|Overall Study|Withdrawal by Subject|9|||
44482127|NCT00377234|79488958|FG000|Overall Study|Lost to Follow-up|4|||
44482128|NCT00377234|79488959|FG001|Overall Study|Lost to Follow-up|2|||
44482129|NCT00377234|79488958|FG000|Overall Study|Administrative|2|||
44482130|NCT00377234|79488959|FG001|Overall Study|Administrative|1|||
44482131|NCT00377234|79488958|FG000|Overall Study|Not assigned|3|||
44482132|NCT00377234|79488959|FG001|Overall Study|Not assigned|2|||
44482133|NCT00377156|79488973|FG000|Overall Study|Death|23|||
44482134|NCT00377156|79488974|FG001|Overall Study|Death|19|||
44482135|NCT00377156|79488973|FG000|Overall Study|Withdrawal by Subject|16|||
44482136|NCT00377156|79488974|FG001|Overall Study|Withdrawal by Subject|24|||
44227280|NCT01700959|79034173|FG005|Overall Study|Withdrawal by Subject|12|||
44274156|NCT01638000|79217180|FG000|Overall Study|Miscellaneous|2|||
44227281|NCT01700959|79034168|FG000|Overall Study|Ineligible|2|||
44227282|NCT01700959|79034169|FG001|Overall Study|Ineligible|1|||
44227283|NCT01700959|79034170|FG002|Overall Study|Ineligible|2|||
44227284|NCT01700959|79034171|FG003|Overall Study|Ineligible|0|||
44227285|NCT01700959|79034172|FG004|Overall Study|Ineligible|0|||
44227286|NCT01700959|79034173|FG005|Overall Study|Ineligible|1|||
44227287|NCT01700959|79034168|FG000|Overall Study|Noncompliant|9|||
44227288|NCT01700959|79034169|FG001|Overall Study|Noncompliant|9|||
44227289|NCT01700959|79034170|FG002|Overall Study|Noncompliant|17|||
44227290|NCT01700959|79034171|FG003|Overall Study|Noncompliant|18|||
44227291|NCT01700959|79034172|FG004|Overall Study|Noncompliant|15|||
44227292|NCT01700959|79034173|FG005|Overall Study|Noncompliant|9|||
44274157|NCT01638000|79217181|FG001|Overall Study|Miscellaneous|2|||
44482137|NCT00377156|79488973|FG000|Overall Study|Had follow-up <90 d|3|||
44482138|NCT00377156|79488974|FG001|Overall Study|Had follow-up <90 d|6|||
44482139|NCT00377156|79488973|FG000|Overall Study|Cancellation|1|||
44482140|NCT00377156|79488974|FG001|Overall Study|Cancellation|0|||
44482141|NCT00377156|79488973|FG000|Overall Study|Refused testing|0|||
44482142|NCT00377156|79488974|FG001|Overall Study|Refused testing|1|||
44482143|NCT00377156|79488973|FG000|Overall Study|Ineligible|0|||
44482144|NCT00377156|79488974|FG001|Overall Study|Ineligible|1|||
44482145|NCT00377156|79488973|FG000|Overall Study|Disability or language problem|0|||
44482146|NCT00377156|79488974|FG001|Overall Study|Disability or language problem|1|||
44482147|NCT00377156|79488973|FG000|Overall Study|Other|5|||
44482148|NCT00377156|79488974|FG001|Overall Study|Other|2|||
44482149|NCT00376688|79488982|FG000|Overall Study|Adverse Event|3|||
44482150|NCT00376688|79488982|FG000|Overall Study|Death|1|||
44482151|NCT00376532|79488988|FG000|Overall Study|Lack sufficient blood sample|6|||
44482152|NCT00376532|79488989|FG001|Overall Study|Lack sufficient blood sample|6|||
44482153|NCT00376220|79488997|FG000|Overall Study|Lost to Follow-up|7|||
44482154|NCT00376220|79488998|FG001|Overall Study|Lost to Follow-up|10|||
44482155|NCT00376220|79488997|FG000|Overall Study|Withdrawal by Subject|3|||
44482156|NCT00376220|79488998|FG001|Overall Study|Withdrawal by Subject|2|||
44482157|NCT00375752|79489006|FG000|Overall Study|Lack of Efficacy|4|||
44482158|NCT00375752|79489007|FG001|Overall Study|Lack of Efficacy|4|||
44482159|NCT00375752|79489006|FG000|Overall Study|Adverse Event|1|||
44482160|NCT00375752|79489007|FG001|Overall Study|Adverse Event|6|||
44482161|NCT00375752|79489006|FG000|Overall Study|Withdrawal by Subject|6|||
44482162|NCT00375752|79489007|FG001|Overall Study|Withdrawal by Subject|1|||
44482163|NCT00375752|79489006|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
44482164|NCT00375752|79489007|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
44482165|NCT00375752|79489006|FG000|Overall Study|Protocol Violation|0|||
44482166|NCT00375752|79489007|FG001|Overall Study|Protocol Violation|2|||
44482167|NCT00375752|79489006|FG000|Overall Study|Administrative Problems|0|||
44482168|NCT00375752|79489007|FG001|Overall Study|Administrative Problems|1|||
44482169|NCT00484289|79489016|FG000|Long Term Phase|Adverse Event|1|||
44482170|NCT00484289|79489017|FG001|Long Term Phase|Adverse Event|17|||
44482171|NCT00484289|79489018|FG002|Long Term Phase|Adverse Event|5|||
44482172|NCT00484289|79489016|FG000|Long Term Phase|Withdrawal by Subject|0|||
44482173|NCT00484289|79489017|FG001|Long Term Phase|Withdrawal by Subject|7|||
44482174|NCT00484289|79489018|FG002|Long Term Phase|Withdrawal by Subject|6|||
44482175|NCT00484289|79489016|FG000|Long Term Phase|Inadequate response|2|||
44482176|NCT00484289|79489017|FG001|Long Term Phase|Inadequate response|7|||
44482177|NCT00484289|79489018|FG002|Long Term Phase|Inadequate response|4|||
44482178|NCT00484289|79489016|FG000|Long Term Phase|Other Reason|0|||
44482179|NCT00484289|79489017|FG001|Long Term Phase|Other Reason|5|||
44482180|NCT00484289|79489018|FG002|Long Term Phase|Other Reason|1|||
44482181|NCT00484289|79489016|FG000|Post Marketing Phase|Adverse Event|0|||
44482182|NCT00484289|79489017|FG001|Post Marketing Phase|Adverse Event|1|||
44482183|NCT00484289|79489018|FG002|Post Marketing Phase|Adverse Event|0|||
44482184|NCT00490529|79489027|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
44482185|NCT00490529|79489027|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
44482186|NCT00490529|79489027|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
44482187|NCT00490529|79489027|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
44482188|NCT00490529|79489027|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
44482189|NCT00490529|79489027|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
44482190|NCT00333840|79489033|FG000|First-line Treatment Period|Adverse Event|38|||
44482191|NCT00333840|79489034|FG001|First-line Treatment Period|Adverse Event|37|||
44482192|NCT00333840|79489035|FG002|First-line Treatment Period|Adverse Event|0|||
44482193|NCT00333840|79489036|FG003|First-line Treatment Period|Adverse Event|0|||
44482194|NCT00333840|79489033|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
44482195|NCT00333840|79489034|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
44482196|NCT00333840|79489035|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
44482197|NCT00333840|79489036|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
44482198|NCT00333840|79489033|FG000|First-line Treatment Period|Abnormal procedure|2|||
44482199|NCT00333840|79489034|FG001|First-line Treatment Period|Abnormal procedure|0|||
44482200|NCT00333840|79489035|FG002|First-line Treatment Period|Abnormal procedure|0|||
44482201|NCT00333840|79489036|FG003|First-line Treatment Period|Abnormal procedure|0|||
44482202|NCT00333840|79489033|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
44482203|NCT00333840|79489034|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
44482204|NCT00333840|79489035|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
44482205|NCT00333840|79489036|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
44482206|NCT00333840|79489033|FG000|First-line Treatment Period|No longer required study drug|21|||
44482207|NCT00333840|79489034|FG001|First-line Treatment Period|No longer required study drug|8|||
44482208|NCT00333840|79489035|FG002|First-line Treatment Period|No longer required study drug|0|||
44482209|NCT00333840|79489036|FG003|First-line Treatment Period|No longer required study drug|0|||
44482210|NCT00333840|79489033|FG000|First-line Treatment Period|Protocol Violation|17|||
44482211|NCT00333840|79489034|FG001|First-line Treatment Period|Protocol Violation|17|||
44274158|NCT01637922|79217240|FG000|Overall Study|Adverse Event|0|||
44482212|NCT00333840|79489035|FG002|First-line Treatment Period|Protocol Violation|0|||
44482213|NCT00333840|79489036|FG003|First-line Treatment Period|Protocol Violation|0|||
44482214|NCT00333840|79489033|FG000|First-line Treatment Period|Subject withdrew consent|57|||
44482215|NCT00333840|79489034|FG001|First-line Treatment Period|Subject withdrew consent|77|||
44482216|NCT00333840|79489035|FG002|First-line Treatment Period|Subject withdrew consent|0|||
44482217|NCT00333840|79489036|FG003|First-line Treatment Period|Subject withdrew consent|0|||
44482218|NCT00333840|79489033|FG000|First-line Treatment Period|Lost to Follow-up|15|||
44482219|NCT00333840|79489034|FG001|First-line Treatment Period|Lost to Follow-up|6|||
44482220|NCT00333840|79489035|FG002|First-line Treatment Period|Lost to Follow-up|0|||
44482221|NCT00333840|79489036|FG003|First-line Treatment Period|Lost to Follow-up|0|||
44482222|NCT00333840|79489033|FG000|First-line Treatment Period|Administrative problems|12|||
44482223|NCT00333840|79489034|FG001|First-line Treatment Period|Administrative problems|6|||
44482224|NCT00333840|79489035|FG002|First-line Treatment Period|Administrative problems|0|||
44482225|NCT00333840|79489036|FG003|First-line Treatment Period|Administrative problems|0|||
44482226|NCT00333840|79489033|FG000|First-line Treatment Period|Death|19|||
44482227|NCT00333840|79489034|FG001|First-line Treatment Period|Death|2|||
44482228|NCT00333840|79489035|FG002|First-line Treatment Period|Death|0|||
44482229|NCT00333840|79489036|FG003|First-line Treatment Period|Death|0|||
44482230|NCT00333840|79489033|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
44482231|NCT00333840|79489034|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
44482232|NCT00333840|79489035|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
44482233|NCT00333840|79489036|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
44482234|NCT00333840|79489033|FG000|Second-line Treatment Period|Adverse Event|0|||
44482235|NCT00333840|79489034|FG001|Second-line Treatment Period|Adverse Event|0|||
44482236|NCT00333840|79489035|FG002|Second-line Treatment Period|Adverse Event|3|||
44482237|NCT00333840|79489036|FG003|Second-line Treatment Period|Adverse Event|34|||
44482238|NCT00333840|79489033|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
44482239|NCT00333840|79489034|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
44482240|NCT00333840|79489035|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
44482241|NCT00333840|79489036|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
44482242|NCT00333840|79489033|FG000|Second-line Treatment Period|Abnormal procedure|0|||
44482243|NCT00333840|79489034|FG001|Second-line Treatment Period|Abnormal procedure|0|||
44482244|NCT00333840|79489035|FG002|Second-line Treatment Period|Abnormal procedure|0|||
44482245|NCT00333840|79489036|FG003|Second-line Treatment Period|Abnormal procedure|1|||
44482246|NCT00333840|79489033|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
44482247|NCT00333840|79489034|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
44482248|NCT00333840|79489035|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
44482249|NCT00333840|79489036|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
44482250|NCT00333840|79489033|FG000|Second-line Treatment Period|No longer required study drug|0|||
44482251|NCT00333840|79489034|FG001|Second-line Treatment Period|No longer required study drug|0|||
44482252|NCT00333840|79489035|FG002|Second-line Treatment Period|No longer required study drug|1|||
44482253|NCT00333840|79489036|FG003|Second-line Treatment Period|No longer required study drug|14|||
44482254|NCT00333840|79489033|FG000|Second-line Treatment Period|Protocol Violation|0|||
44482255|NCT00333840|79489034|FG001|Second-line Treatment Period|Protocol Violation|0|||
44482256|NCT00333840|79489035|FG002|Second-line Treatment Period|Protocol Violation|1|||
44482257|NCT00333840|79489036|FG003|Second-line Treatment Period|Protocol Violation|10|||
44482258|NCT00333840|79489033|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
44482259|NCT00333840|79489034|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
44482260|NCT00333840|79489035|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
44482261|NCT00333840|79489036|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
44482262|NCT00333840|79489033|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
44482263|NCT00333840|79489034|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
44482264|NCT00333840|79489035|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
44482265|NCT00333840|79489036|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
44482266|NCT00333840|79489033|FG000|Second-line Treatment Period|Administrative problems|0|||
44482267|NCT00333840|79489034|FG001|Second-line Treatment Period|Administrative problems|0|||
44482268|NCT00333840|79489035|FG002|Second-line Treatment Period|Administrative problems|0|||
44482269|NCT00333840|79489036|FG003|Second-line Treatment Period|Administrative problems|7|||
44482270|NCT00333840|79489033|FG000|Second-line Treatment Period|Death|0|||
44482271|NCT00333840|79489034|FG001|Second-line Treatment Period|Death|0|||
44482272|NCT00333840|79489035|FG002|Second-line Treatment Period|Death|0|||
44482273|NCT00333840|79489036|FG003|Second-line Treatment Period|Death|9|||
44482274|NCT00490451|79489052|FG000|Overall Study|Adverse Event|3|||
44482275|NCT00490451|79489053|FG001|Overall Study|Adverse Event|3|||
44482276|NCT00490451|79489052|FG000|Overall Study|Death|3|||
44482277|NCT00490451|79489053|FG001|Overall Study|Death|1|||
44482278|NCT00490451|79489052|FG000|Overall Study|Withdrawal by Subject|2|||
44544702|NCT03547687|79558271|FG000|Overall Study|Withdrawal by Subject|1|||
44544703|NCT03547687|79558271|FG000|Overall Study|Death|1|||
44544704|NCT03547531|79558277|FG000|Overall Study|not coming in data collection : sick|2|||
44544705|NCT03547531|79558278|FG001|Overall Study|not coming in data collection : sick|2|||
44482279|NCT00490451|79489053|FG001|Overall Study|Withdrawal by Subject|0|||
44482280|NCT00490451|79489052|FG000|Overall Study|Investigator Decision|1|||
44482281|NCT00490451|79489053|FG001|Overall Study|Investigator Decision|0|||
44227293|NCT01700959|79034168|FG000|Overall Study|Side effects|1|||
44482282|NCT00490451|79489052|FG000|Overall Study|Protocol Violation|1|||
44482283|NCT00490451|79489053|FG001|Overall Study|Protocol Violation|0|||
44482284|NCT00490451|79489052|FG000|Overall Study|Progressive Disease|53|||
44482285|NCT00490451|79489053|FG001|Overall Study|Progressive Disease|34|||
44482286|NCT00321906|79489061|FG000|Overall Study|Adverse Event|36|||
44482287|NCT00321906|79489062|FG001|Overall Study|Adverse Event|44|||
44482288|NCT00321906|79489061|FG000|Overall Study|Death|9|||
44482289|NCT00321906|79489062|FG001|Overall Study|Death|6|||
44482290|NCT00321906|79489061|FG000|Overall Study|Lost to Follow-up|1|||
44482291|NCT00321906|79489062|FG001|Overall Study|Lost to Follow-up|2|||
44482292|NCT00321906|79489061|FG000|Overall Study|Withdrawal by Subject|0|||
44482293|NCT00321906|79489062|FG001|Overall Study|Withdrawal by Subject|4|||
44482294|NCT00339144|79489071|FG000|Overall Study|Disease progression|5|||
44482295|NCT00339144|79489072|FG001|Overall Study|Disease progression|2|||
44482296|NCT00339144|79489073|FG002|Overall Study|Disease progression|2|||
44482297|NCT00339144|79489071|FG000|Overall Study|Study drug toxicity|3|||
44482298|NCT00339144|79489072|FG001|Overall Study|Study drug toxicity|1|||
44482299|NCT00339144|79489073|FG002|Overall Study|Study drug toxicity|1|||
44482300|NCT00339144|79489071|FG000|Overall Study|Participant's request to discontinuation|1|||
44482301|NCT00339144|79489072|FG001|Overall Study|Participant's request to discontinuation|0|||
44482302|NCT00339144|79489073|FG002|Overall Study|Participant's request to discontinuation|1|||
44482303|NCT00321828|79489082|FG000|Overall Study|Ineligible|3|||
44482304|NCT00321828|79489082|FG000|Overall Study|No follow up data|1|||
44482305|NCT00333138|79489089|FG000|Core Study (6 Months)|Adverse Event|4|||
44482306|NCT00333138|79489090|FG001|Core Study (6 Months)|Adverse Event|5|||
44482307|NCT00333138|79489091|FG002|Core Study (6 Months)|Adverse Event|8|||
44482308|NCT00333138|79489089|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
44482309|NCT00333138|79489090|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
44482310|NCT00333138|79489091|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
44482311|NCT00333138|79489089|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
44482312|NCT00333138|79489090|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
44482313|NCT00333138|79489091|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
44482314|NCT00333138|79489089|FG000|Core Study (6 Months)|Protocol Violation|1|||
44482315|NCT00333138|79489090|FG001|Core Study (6 Months)|Protocol Violation|0|||
44482316|NCT00333138|79489091|FG002|Core Study (6 Months)|Protocol Violation|1|||
44482317|NCT00333138|79489089|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
44482318|NCT00333138|79489090|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
44482319|NCT00333138|79489091|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
44482320|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
44482321|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
44482322|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
44482323|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
44482324|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
44482325|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
44482326|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
44482327|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
44482328|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
44482329|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
44482330|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
44482331|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
44482332|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
44482333|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
44482334|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
44482335|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
44482336|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
44482337|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
44482338|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
44482339|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
44482340|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
44482341|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
44227294|NCT01700959|79034169|FG001|Overall Study|Side effects|4|||
44227295|NCT01700959|79034170|FG002|Overall Study|Side effects|8|||
44482342|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
44482343|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
44482344|NCT00333138|79489089|FG000|Extension Study (Month6 to End of Study)|Death|0|||
44482345|NCT00333138|79489090|FG001|Extension Study (Month6 to End of Study)|Death|1|||
44482346|NCT00333138|79489091|FG002|Extension Study (Month6 to End of Study)|Death|0|||
44482347|NCT00332202|79489103|FG000|Overall Study|Adverse Event|72|||
44227296|NCT01700959|79034171|FG003|Overall Study|Side effects|4|||
44227297|NCT01700959|79034172|FG004|Overall Study|Side effects|4|||
44482348|NCT00332202|79489104|FG001|Overall Study|Adverse Event|28|||
44482349|NCT00332202|79489103|FG000|Overall Study|Lost to Follow-up|2|||
44482350|NCT00332202|79489104|FG001|Overall Study|Lost to Follow-up|1|||
44482351|NCT00332202|79489103|FG000|Overall Study|Physician Decision|6|||
44482352|NCT00332202|79489104|FG001|Overall Study|Physician Decision|8|||
44482353|NCT00332202|79489103|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
44482354|NCT00332202|79489104|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
44482355|NCT00332202|79489103|FG000|Overall Study|Protocol Violation|7|||
44482356|NCT00332202|79489104|FG001|Overall Study|Protocol Violation|2|||
44482357|NCT00332202|79489103|FG000|Overall Study|Sponsor Decision|1|||
44482358|NCT00332202|79489104|FG001|Overall Study|Sponsor Decision|2|||
44482359|NCT00332202|79489103|FG000|Overall Study|Withdrawal by Subject|36|||
44482360|NCT00332202|79489104|FG001|Overall Study|Withdrawal by Subject|17|||
44482361|NCT00332202|79489103|FG000|Overall Study|Progressive Disease|106|||
44482362|NCT00332202|79489104|FG001|Overall Study|Progressive Disease|60|||
44482363|NCT00332202|79489103|FG000|Overall Study|Death|5|||
44482364|NCT00332202|79489104|FG001|Overall Study|Death|2|||
44482365|NCT00331422|79489119|FG000|Overall Study|Did not receive entire study regimen|5|||
44482366|NCT00331344|79489124|FG000|Phase I|Adverse Event|0|||
44482367|NCT00331344|79489125|FG001|Phase I|Adverse Event|0|||
44482368|NCT00331344|79489126|FG002|Phase I|Adverse Event|0|||
44482369|NCT00331344|79489127|FG003|Phase I|Adverse Event|1|||
44482370|NCT00331344|79489128|FG004|Phase I|Adverse Event|2|||
44482371|NCT00331344|79489129|FG005|Phase I|Adverse Event|2|||
44482372|NCT00331344|79489130|FG006|Phase I|Adverse Event|0|||
44482373|NCT00331344|79489131|FG007|Phase I|Adverse Event|1|||
44482374|NCT00331344|79489132|FG008|Phase I|Adverse Event|0|||
44482375|NCT00331344|79489124|FG000|Phase II|Death|0|||
44482376|NCT00331344|79489125|FG001|Phase II|Death|0|||
44482377|NCT00331344|79489126|FG002|Phase II|Death|0|||
44482378|NCT00331344|79489127|FG003|Phase II|Death|0|||
44482379|NCT00331344|79489128|FG004|Phase II|Death|0|||
44482380|NCT00331344|79489129|FG005|Phase II|Death|0|||
44482381|NCT00331344|79489130|FG006|Phase II|Death|0|||
44482382|NCT00331344|79489131|FG007|Phase II|Death|0|||
44482383|NCT00331344|79489132|FG008|Phase II|Death|4|||
44482384|NCT00321672|79489149|FG000|Overall Study|Withdrawal by Subject|5|||
44482385|NCT00321672|79489150|FG001|Overall Study|Withdrawal by Subject|1|||
44482386|NCT00321672|79489151|FG002|Overall Study|Withdrawal by Subject|2|||
44482387|NCT00321672|79489152|FG003|Overall Study|Withdrawal by Subject|0|||
44482388|NCT00321672|79489149|FG000|Overall Study|Noncompliance|1|||
44482389|NCT00321672|79489150|FG001|Overall Study|Noncompliance|2|||
44482390|NCT00321672|79489151|FG002|Overall Study|Noncompliance|1|||
44482391|NCT00321672|79489152|FG003|Overall Study|Noncompliance|0|||
44482392|NCT00321672|79489149|FG000|Overall Study|Adverse Event|1|||
44482393|NCT00321672|79489150|FG001|Overall Study|Adverse Event|1|||
44482394|NCT00321672|79489151|FG002|Overall Study|Adverse Event|0|||
44482395|NCT00321672|79489152|FG003|Overall Study|Adverse Event|0|||
44482396|NCT00321672|79489149|FG000|Overall Study|Lack of Efficacy|1|||
44482397|NCT00321672|79489150|FG001|Overall Study|Lack of Efficacy|1|||
44482398|NCT00321672|79489151|FG002|Overall Study|Lack of Efficacy|0|||
44482399|NCT00321672|79489152|FG003|Overall Study|Lack of Efficacy|0|||
44482400|NCT00321672|79489149|FG000|Overall Study|Lost to Follow-up|2|||
44482401|NCT00321672|79489150|FG001|Overall Study|Lost to Follow-up|0|||
44482402|NCT00321672|79489151|FG002|Overall Study|Lost to Follow-up|4|||
44482403|NCT00321672|79489152|FG003|Overall Study|Lost to Follow-up|2|||
44482404|NCT00321672|79489149|FG000|Overall Study|Death|1|||
44482405|NCT00321672|79489150|FG001|Overall Study|Death|0|||
44482406|NCT00321672|79489151|FG002|Overall Study|Death|0|||
44482407|NCT00321672|79489152|FG003|Overall Study|Death|0|||
44482408|NCT00321672|79489149|FG000|Overall Study|Too far to travel for visits|1|||
44482409|NCT00321672|79489150|FG001|Overall Study|Too far to travel for visits|0|||
44482410|NCT00321672|79489151|FG002|Overall Study|Too far to travel for visits|0|||
44482411|NCT00321672|79489152|FG003|Overall Study|Too far to travel for visits|0|||
44482412|NCT00321672|79489149|FG000|Overall Study|Incarcerated|0|||
44482413|NCT00321672|79489150|FG001|Overall Study|Incarcerated|0|||
44482414|NCT00321672|79489151|FG002|Overall Study|Incarcerated|2|||
44482415|NCT00321672|79489152|FG003|Overall Study|Incarcerated|0|||
44482416|NCT00321672|79489149|FG000|Overall Study|Moved out of state|0|||
44482417|NCT00321672|79489150|FG001|Overall Study|Moved out of state|1|||
44482418|NCT00321672|79489151|FG002|Overall Study|Moved out of state|1|||
44482419|NCT00321672|79489152|FG003|Overall Study|Moved out of state|0|||
44482420|NCT00321672|79489149|FG000|Overall Study|Protocol Violation|0|||
44482421|NCT00321672|79489150|FG001|Overall Study|Protocol Violation|0|||
44482422|NCT00321672|79489151|FG002|Overall Study|Protocol Violation|1|||
44482423|NCT00321672|79489152|FG003|Overall Study|Protocol Violation|0|||
44482424|NCT00321672|79489149|FG000|Overall Study|Diagnosis of testicular cancer|0|||
44482425|NCT00321672|79489150|FG001|Overall Study|Diagnosis of testicular cancer|1|||
44482426|NCT00321672|79489151|FG002|Overall Study|Diagnosis of testicular cancer|0|||
44482427|NCT00321672|79489152|FG003|Overall Study|Diagnosis of testicular cancer|0|||
44482428|NCT00321672|79489149|FG000|Overall Study|Extensive travel required for new job|0|||
44482429|NCT00321672|79489150|FG001|Overall Study|Extensive travel required for new job|1|||
44482430|NCT00321672|79489151|FG002|Overall Study|Extensive travel required for new job|0|||
44482431|NCT00321672|79489152|FG003|Overall Study|Extensive travel required for new job|0|||
44482432|NCT00321048|79489168|FG000|Overall Study|Withdrawal by Subject|6|||
44482433|NCT00321048|79489169|FG001|Overall Study|Withdrawal by Subject|8|||
44482434|NCT00330174|79489177|FG000|Overall Study|Withdrawal by Subject|7|||
44482435|NCT00330174|79489178|FG001|Overall Study|Withdrawal by Subject|7|||
44482436|NCT00330174|79489177|FG000|Overall Study|Lost to Follow-up|4|||
44482437|NCT00330174|79489178|FG001|Overall Study|Lost to Follow-up|1|||
44482438|NCT00330174|79489177|FG000|Overall Study|Clinical deterioration|1|||
44482439|NCT00330174|79489178|FG001|Overall Study|Clinical deterioration|2|||
44482440|NCT00330174|79489177|FG000|Overall Study|Excessive missed visits|3|||
44482441|NCT00330174|79489178|FG001|Overall Study|Excessive missed visits|8|||
44482442|NCT00330174|79489177|FG000|Overall Study|Miscellaneous reasons|7|||
44482443|NCT00330174|79489178|FG001|Overall Study|Miscellaneous reasons|1|||
44482444|NCT00320424|79489184|FG000|Overall Study|Adverse Event|3|||
44482445|NCT00320424|79489184|FG000|Overall Study|Other|3|||
44482446|NCT00338286|79489190|FG000|Overall Study|Withdrawal by Subject|50|||
44482447|NCT00338286|79489191|FG001|Overall Study|Withdrawal by Subject|54|||
44482448|NCT00338286|79489190|FG000|Overall Study|Lost to Follow-up|80|||
44482449|NCT00338286|79489191|FG001|Overall Study|Lost to Follow-up|66|||
44482450|NCT00338286|79489190|FG000|Overall Study|Other|103|||
44227298|NCT01700959|79034173|FG005|Overall Study|Side effects|1|||
44227299|NCT01738477|79034195|FG000|Overall Study|Lost to Follow-up|1|||
44227300|NCT01738477|79034196|FG001|Overall Study|Lost to Follow-up|4|||
44227301|NCT01737931|79034212|FG000|Overall Study|Withdrawal by Subject|0|||
44227302|NCT01737931|79034213|FG001|Overall Study|Withdrawal by Subject|1|||
44227303|NCT01737931|79034214|FG002|Overall Study|Withdrawal by Subject|1|||
44227304|NCT01737931|79034212|FG000|Overall Study|Physician Decision|0|||
44227305|NCT01737931|79034213|FG001|Overall Study|Physician Decision|1|||
44227306|NCT01737931|79034214|FG002|Overall Study|Physician Decision|0|||
44227307|NCT01958489|79034220|FG000|Period 2|Adverse Event|0|||
44227308|NCT01958489|79034221|FG001|Period 2|Adverse Event|1|||
44227309|NCT01721161|79034234|FG000|Overall Study|Adverse Event|2|||
44227310|NCT01721161|79034235|FG001|Overall Study|Adverse Event|3|||
44227311|NCT01721161|79034234|FG000|Overall Study|Lost to Follow-up|1|||
44482451|NCT00338286|79489191|FG001|Overall Study|Other|93|||
44482452|NCT00329784|79489201|FG000|Overall Study|Lost to Follow-up|0|||
44482453|NCT00329784|79489202|FG001|Overall Study|Lost to Follow-up|1|||
44482454|NCT00329784|79489203|FG002|Overall Study|Lost to Follow-up|0|||
44482455|NCT00329784|79489204|FG003|Overall Study|Lost to Follow-up|0|||
44482456|NCT00329784|79489201|FG000|Overall Study|Withdrawal by Subject|4|||
44482457|NCT00329784|79489202|FG001|Overall Study|Withdrawal by Subject|2|||
44482458|NCT00329784|79489203|FG002|Overall Study|Withdrawal by Subject|0|||
44482459|NCT00329784|79489204|FG003|Overall Study|Withdrawal by Subject|0|||
44482460|NCT00329784|79489201|FG000|Overall Study|Other|1|||
44482461|NCT00329784|79489202|FG001|Overall Study|Other|2|||
44482462|NCT00329784|79489203|FG002|Overall Study|Other|0|||
44482463|NCT00329784|79489204|FG003|Overall Study|Other|0|||
44482464|NCT00337818|79489219|FG000|Overall Study|Lost to Follow-up|289|||
44482465|NCT00337818|79489220|FG001|Overall Study|Lost to Follow-up|91|||
44482466|NCT00337818|79489221|FG002|Overall Study|Lost to Follow-up|107|||
44482467|NCT00329550|79489232|FG000|Overall Study|Adverse Event|3|||
44482468|NCT00329550|79489233|FG001|Overall Study|Adverse Event|4|||
44482469|NCT00329550|79489234|FG002|Overall Study|Adverse Event|2|||
44482470|NCT00329550|79489232|FG000|Overall Study|Withdrawal of Consent|1|||
44482471|NCT00329550|79489233|FG001|Overall Study|Withdrawal of Consent|0|||
44482472|NCT00329550|79489234|FG002|Overall Study|Withdrawal of Consent|1|||
44482473|NCT00329550|79489232|FG000|Overall Study|Due to Relocation|0|||
44482474|NCT00329550|79489233|FG001|Overall Study|Due to Relocation|0|||
44482475|NCT00329550|79489234|FG002|Overall Study|Due to Relocation|1|||
44482476|NCT00375674|79489246|FG000|Overall Study|Other|26|||
44544706|NCT03547531|79558277|FG000|Overall Study|having family occasion|0|||
44227312|NCT01721161|79034235|FG001|Overall Study|Lost to Follow-up|2|||
44227313|NCT01721161|79034234|FG000|Overall Study|Withdrawal by Subject|1|||
44227314|NCT01721161|79034235|FG001|Overall Study|Withdrawal by Subject|1|||
44227315|NCT01721161|79034234|FG000|Overall Study|Other|0|||
44227316|NCT01721161|79034235|FG001|Overall Study|Other|1|||
44227317|NCT01699867|79034242|FG000|Overall Study|Screening Failure|3|||
44482477|NCT00375674|79489247|FG001|Overall Study|Other|18|||
44482478|NCT00375674|79489246|FG000|Overall Study|Death|67|||
44482479|NCT00375674|79489247|FG001|Overall Study|Death|76|||
44482480|NCT00375674|79489246|FG000|Overall Study|Participants refused further follow-up|31|||
44482481|NCT00375674|79489247|FG001|Overall Study|Participants refused further follow-up|30|||
44482482|NCT00375674|79489246|FG000|Overall Study|Lost to Follow-up|17|||
44482483|NCT00375674|79489247|FG001|Overall Study|Lost to Follow-up|15|||
44482484|NCT00375674|79489246|FG000|Overall Study|Enrolled but not treated|3|||
44482485|NCT00375674|79489247|FG001|Overall Study|Enrolled but not treated|2|||
44482486|NCT00350402|79489255|FG000|Overall Study|Lost to Follow-up|1|||
44482487|NCT00350402|79489256|FG001|Overall Study|Lost to Follow-up|1|||
44482488|NCT00320190|79489270|FG000|First 12 Months|Completed but did not enter extension|5|||
44482489|NCT00320190|79489271|FG001|First 12 Months|Completed but did not enter extension|3|||
44482490|NCT00320190|79489270|FG000|First 12 Months|Sponsor terminated study|2|||
44482491|NCT00320190|79489271|FG001|First 12 Months|Sponsor terminated study|2|||
44482492|NCT00320190|79489270|FG000|First 12 Months|Lost to Follow-up|0|||
44482493|NCT00320190|79489271|FG001|First 12 Months|Lost to Follow-up|1|||
44274159|NCT01637922|79217241|FG001|Overall Study|Adverse Event|1|||
44274160|NCT01637922|79217240|FG000|Overall Study|Protocol Violation|0|||
44274161|NCT01637922|79217241|FG001|Overall Study|Protocol Violation|1|||
44274162|NCT01637922|79217240|FG000|Overall Study|Withdrawal by Subject|0|||
44274163|NCT01637922|79217241|FG001|Overall Study|Withdrawal by Subject|3|||
44274164|NCT01637922|79217240|FG000|Overall Study|Lost to Follow-up|2|||
44274165|NCT01637922|79217241|FG001|Overall Study|Lost to Follow-up|0|||
44274166|NCT01638546|79217445|FG000|Overall Study|Adverse Event|1|||
44274167|NCT01638546|79217446|FG001|Overall Study|Adverse Event|3|||
44274168|NCT03172494|79217466|FG000|Overall Study|Adverse Event|5|||
44274169|NCT03172494|79217467|FG001|Overall Study|Adverse Event|1|||
44274170|NCT03172494|79217468|FG002|Overall Study|Adverse Event|15|||
44274171|NCT03172494|79217466|FG000|Overall Study|Protocol Violation|3|||
44274172|NCT03172494|79217467|FG001|Overall Study|Protocol Violation|2|||
44274173|NCT03172494|79217468|FG002|Overall Study|Protocol Violation|1|||
44274174|NCT03172494|79217466|FG000|Overall Study|Lack of Efficacy|0|||
44274175|NCT03172494|79217467|FG001|Overall Study|Lack of Efficacy|0|||
44274176|NCT03172494|79217468|FG002|Overall Study|Lack of Efficacy|4|||
44274177|NCT03172494|79217466|FG000|Overall Study|Pregnancy|0|||
44274178|NCT03172494|79217467|FG001|Overall Study|Pregnancy|1|||
44274179|NCT03172494|79217468|FG002|Overall Study|Pregnancy|0|||
44274180|NCT03172494|79217466|FG000|Overall Study|Withdrawal by Subject|10|||
44274181|NCT03172494|79217467|FG001|Overall Study|Withdrawal by Subject|8|||
44274182|NCT03172494|79217468|FG002|Overall Study|Withdrawal by Subject|8|||
44274183|NCT03172494|79217466|FG000|Overall Study|Severe hypoglycaemic episode|0|||
44274184|NCT03172494|79217467|FG001|Overall Study|Severe hypoglycaemic episode|0|||
44274185|NCT03172494|79217468|FG002|Overall Study|Severe hypoglycaemic episode|1|||
44274186|NCT03172494|79217466|FG000|Overall Study|Non-compliance towards treatment|2|||
44274187|NCT03172494|79217467|FG001|Overall Study|Non-compliance towards treatment|0|||
44274188|NCT03172494|79217468|FG002|Overall Study|Non-compliance towards treatment|0|||
44482494|NCT00320190|79489270|FG000|First 12 Months|Enrollment failure|0|||
44482495|NCT00320190|79489271|FG001|First 12 Months|Enrollment failure|1|||
44482496|NCT00320190|79489270|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
44482497|NCT00320190|79489271|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
44482498|NCT00320190|79489270|FG000|First 12 Months|Investigator request|0|||
44482499|NCT00320190|79489271|FG001|First 12 Months|Investigator request|1|||
44482500|NCT00320190|79489270|FG000|First 12 Months|Study drug toxicity|0|||
44482501|NCT00320190|79489271|FG001|First 12 Months|Study drug toxicity|1|||
44482502|NCT00320190|79489270|FG000|First 12 Months|Withdrawal by Subject|0|||
44482503|NCT00320190|79489271|FG001|First 12 Months|Withdrawal by Subject|1|||
44482504|NCT00320190|79489270|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
44482505|NCT00320190|79489271|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
44482506|NCT00320190|79489270|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
44482507|NCT00320190|79489271|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
44482508|NCT00320190|79489270|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
44482509|NCT00320190|79489271|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
44482510|NCT00320112|79489279|FG000|Overall Study|Lost to Follow-up|3|||
44482511|NCT00320112|79489280|FG001|Overall Study|Lost to Follow-up|4|||
44482512|NCT00320112|79489279|FG000|Overall Study|Withdrawal by Subject|3|||
44482513|NCT00320112|79489280|FG001|Overall Study|Withdrawal by Subject|0|||
44482514|NCT00320112|79489279|FG000|Overall Study|Death|2|||
44274189|NCT01636362|79217569|FG000|Overall Study|Physician Decision|6|||
44375636|NCT00953706|79380761|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
44375637|NCT00953706|79380758|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
44375638|NCT00953706|79380759|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
44482515|NCT00320112|79489280|FG001|Overall Study|Death|1|||
44482516|NCT00319956|79489294|FG000|Overall Study|Death|20|||
44482517|NCT00319956|79489295|FG001|Overall Study|Death|24|||
44482518|NCT00349622|79489303|FG000|Overall Study|Death|168|||
44482519|NCT00349622|79489304|FG001|Overall Study|Death|86|||
44274190|NCT01636362|79217569|FG000|Overall Study|Subject healed, not returning|1|||
44274191|NCT01636362|79217569|FG000|Overall Study|Withdrawal by Subject|1|||
44274192|NCT03042468|79217634|FG000|Overall Study|Death|0|||
44274193|NCT03042468|79217635|FG001|Overall Study|Death|1|||
44274194|NCT03042468|79217636|FG002|Overall Study|Death|1|||
44274195|NCT03042468|79217637|FG003|Overall Study|Death|0|||
44274196|NCT03042468|79217638|FG004|Overall Study|Death|0|||
44482520|NCT00349622|79489303|FG000|Overall Study|Lost to Follow-up|5|||
44482521|NCT00349622|79489304|FG001|Overall Study|Lost to Follow-up|1|||
44482522|NCT00349622|79489303|FG000|Overall Study|Withdrawal by Subject|5|||
44482523|NCT00349622|79489304|FG001|Overall Study|Withdrawal by Subject|9|||
44482524|NCT00354614|79489310|FG000|Overall Study|Lack of Efficacy|28|||
44482525|NCT00360308|79489317|FG000|Overall Study|Adverse Event|15|||
44482526|NCT00360308|79489318|FG001|Overall Study|Adverse Event|14|||
44482527|NCT00360308|79489319|FG002|Overall Study|Adverse Event|25|||
44482528|NCT00360308|79489317|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
44482529|NCT00360308|79489318|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
44482530|NCT00360308|79489319|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
44482531|NCT00360308|79489317|FG000|Overall Study|Protocol Violation|2|||
44482532|NCT00360308|79489318|FG001|Overall Study|Protocol Violation|1|||
44482533|NCT00360308|79489319|FG002|Overall Study|Protocol Violation|2|||
44482534|NCT00360308|79489317|FG000|Overall Study|Withdrawal by Subject|11|||
44482535|NCT00360308|79489318|FG001|Overall Study|Withdrawal by Subject|7|||
44482536|NCT00360308|79489319|FG002|Overall Study|Withdrawal by Subject|14|||
44482537|NCT00360308|79489317|FG000|Overall Study|Lack of Efficacy|3|||
44482538|NCT00360308|79489318|FG001|Overall Study|Lack of Efficacy|0|||
44482539|NCT00360308|79489319|FG002|Overall Study|Lack of Efficacy|2|||
44482540|NCT00360308|79489317|FG000|Overall Study|Other|2|||
44482541|NCT00360308|79489318|FG001|Overall Study|Other|1|||
44482542|NCT00360308|79489319|FG002|Overall Study|Other|1|||
44482543|NCT00360308|79489317|FG000|Overall Study|Study termination by sponsor|43|||
44482544|NCT00360308|79489318|FG001|Overall Study|Study termination by sponsor|55|||
44482545|NCT00360308|79489319|FG002|Overall Study|Study termination by sponsor|44|||
44482546|NCT00348686|79489331|FG000|Overall Study|Withdrawal by Subject|45|||
44482547|NCT00348686|79489331|FG000|Overall Study|Adverse Event|5|||
44482548|NCT00348686|79489331|FG000|Overall Study|Protocol Violation|6|||
44482549|NCT00348686|79489331|FG000|Overall Study|Lost to Follow-up|2|||
44482550|NCT00348686|79489331|FG000|Overall Study|Multiple Reasons|8|||
44227318|NCT01699789|79034261|FG000|Overall Study|Withdrawal by Subject|18|||
44227319|NCT01699789|79034262|FG001|Overall Study|Withdrawal by Subject|23|||
44227320|NCT01699789|79034261|FG000|Overall Study|Death|1|||
44227321|NCT01699789|79034262|FG001|Overall Study|Death|2|||
44227322|NCT01699789|79034261|FG000|Overall Study|Lost to Follow-up|83|||
44227323|NCT01699789|79034262|FG001|Overall Study|Lost to Follow-up|101|||
44227324|NCT01944059|79034292|FG000|Overall Study|Lost to Follow-up|1|||
44482551|NCT00360230|79489342|FG000|Overall Study|Withdrawal by Subject|1|||
44482552|NCT00360230|79489343|FG001|Overall Study|Withdrawal by Subject|1|||
44482553|NCT00360230|79489344|FG002|Overall Study|Withdrawal by Subject|0|||
44227325|NCT01944059|79034292|FG000|Overall Study|Physician Decision|3|||
44227326|NCT01944059|79034292|FG000|Overall Study|Withdrawal by Subject|1|||
44227327|NCT01944059|79034292|FG000|Overall Study|Adverse Event|2|||
44482554|NCT00360230|79489345|FG003|Overall Study|Withdrawal by Subject|1|||
44482555|NCT00360230|79489346|FG004|Overall Study|Withdrawal by Subject|1|||
44482556|NCT00360230|79489347|FG005|Overall Study|Withdrawal by Subject|1|||
44482557|NCT00360230|79489348|FG006|Overall Study|Withdrawal by Subject|0|||
44482558|NCT00360230|79489342|FG000|Overall Study|Migrated|4|||
44482559|NCT00360230|79489343|FG001|Overall Study|Migrated|1|||
44482560|NCT00360230|79489344|FG002|Overall Study|Migrated|3|||
44482561|NCT00360230|79489345|FG003|Overall Study|Migrated|1|||
44482562|NCT00360230|79489346|FG004|Overall Study|Migrated|4|||
44482563|NCT00360230|79489347|FG005|Overall Study|Migrated|1|||
44482564|NCT00360230|79489348|FG006|Overall Study|Migrated|1|||
44482565|NCT00360230|79489342|FG000|Overall Study|Other|1|||
44482566|NCT00360230|79489343|FG001|Overall Study|Other|0|||
44482567|NCT00360230|79489344|FG002|Overall Study|Other|0|||
44482568|NCT00360230|79489345|FG003|Overall Study|Other|0|||
44482569|NCT00360230|79489346|FG004|Overall Study|Other|0|||
44482570|NCT00360230|79489347|FG005|Overall Study|Other|0|||
44482571|NCT00360230|79489348|FG006|Overall Study|Other|0|||
44482572|NCT00360230|79489342|FG000|Overall Study|Protocol Violation|0|||
44482573|NCT00360230|79489343|FG001|Overall Study|Protocol Violation|0|||
44482574|NCT00360230|79489344|FG002|Overall Study|Protocol Violation|0|||
44227328|NCT01720225|79034299|FG000|Overall Study|Withdrawal by Subject|0|||
44227329|NCT01720225|79034300|FG001|Overall Study|Withdrawal by Subject|1|||
44482575|NCT00360230|79489345|FG003|Overall Study|Protocol Violation|0|||
44482576|NCT00360230|79489346|FG004|Overall Study|Protocol Violation|0|||
44482577|NCT00360230|79489347|FG005|Overall Study|Protocol Violation|1|||
44482578|NCT00360230|79489348|FG006|Overall Study|Protocol Violation|0|||
44482579|NCT00360230|79489342|FG000|Overall Study|Death|0|||
44482580|NCT00360230|79489343|FG001|Overall Study|Death|1|||
44482581|NCT00360230|79489344|FG002|Overall Study|Death|0|||
44482582|NCT00360230|79489345|FG003|Overall Study|Death|0|||
44227330|NCT01720225|79034299|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
44227331|NCT01720225|79034300|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
44227332|NCT01943591|79034308|FG000|Overall Study|Lost to Follow-up|3|||
44482583|NCT00360230|79489346|FG004|Overall Study|Death|0|||
44482584|NCT00360230|79489347|FG005|Overall Study|Death|1|||
44482585|NCT00360230|79489348|FG006|Overall Study|Death|1|||
44482586|NCT00348374|79489368|FG000|Overall Study|Adverse Event|1|||
44482587|NCT00348374|79489369|FG001|Overall Study|Adverse Event|4|||
44482588|NCT00348374|79489368|FG000|Overall Study|Lost to Follow-up|1|||
44482589|NCT00348374|79489369|FG001|Overall Study|Lost to Follow-up|3|||
44482590|NCT00348374|79489368|FG000|Overall Study|Withdrawal by Subject|5|||
44482591|NCT00348374|79489369|FG001|Overall Study|Withdrawal by Subject|5|||
44482592|NCT00348374|79489368|FG000|Overall Study|Other|11|||
44482593|NCT00348374|79489369|FG001|Overall Study|Other|12|||
44482594|NCT00348374|79489368|FG000|Overall Study|ongoing at date of cutoff|1|||
44482595|NCT00348374|79489369|FG001|Overall Study|ongoing at date of cutoff|1|||
44482596|NCT00348374|79489368|FG000|Overall Study|randomized but did not receive treatment|0|||
44482597|NCT00348374|79489369|FG001|Overall Study|randomized but did not receive treatment|7|||
44482598|NCT00353366|79489376|FG000|Overall Study|Adverse Event|8|||
44482599|NCT00353366|79489376|FG000|Overall Study|Protocol Violation|12|||
44227333|NCT01943591|79034309|FG001|Overall Study|Lost to Follow-up|4|||
44227334|NCT01943591|79034308|FG000|Overall Study|Death|2|||
44227335|NCT01943591|79034309|FG001|Overall Study|Death|7|||
44227336|NCT01699087|79034315|FG000|Overall Study|Lost to Follow-up|7|||
44227337|NCT01699087|79034315|FG000|Overall Study|Screen failure (prior to treatment)|15|||
44227338|NCT01699087|79034315|FG000|Overall Study|Unable to make future visits|2|||
44227339|NCT01943435|79034323|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
44227340|NCT01943435|79034324|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
44227341|NCT01943435|79034325|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
44227342|NCT01943435|79034323|FG000|Intervention Period|Withdrawal by Subject|3|||
44227343|NCT01943435|79034324|FG001|Intervention Period|Withdrawal by Subject|3|||
44227344|NCT01943435|79034325|FG002|Intervention Period|Withdrawal by Subject|4|||
44227345|NCT01943435|79034323|FG000|2 Month Follow up|Lost to Follow-up|2|||
44227346|NCT01943435|79034324|FG001|2 Month Follow up|Lost to Follow-up|3|||
44227347|NCT01943435|79034325|FG002|2 Month Follow up|Lost to Follow-up|0|||
44227348|NCT01943435|79034323|FG000|6 Month Follow up|Lost to Follow-up|12|||
44227349|NCT01943435|79034324|FG001|6 Month Follow up|Lost to Follow-up|7|||
44482600|NCT00353366|79489376|FG000|Overall Study|Withdrawal by Subject|12|||
44482601|NCT00353366|79489376|FG000|Overall Study|Lost to Follow-up|92|||
44482602|NCT00353366|79489376|FG000|Overall Study|Other|19|||
44482603|NCT00352664|79489382|FG000|Overall Study|Withdrawal by Subject|7|||
44482604|NCT00352664|79489383|FG001|Overall Study|Withdrawal by Subject|0|||
44482605|NCT00490139|79489393|FG000|Overall Study|Death|106|||
44482606|NCT00490139|79489394|FG001|Overall Study|Death|119|||
44482607|NCT00490139|79489395|FG002|Overall Study|Death|168|||
44482608|NCT00490139|79489396|FG003|Overall Study|Death|135|||
44482609|NCT00490139|79489393|FG000|Overall Study|Lost to Follow-up|56|||
44482610|NCT00490139|79489394|FG001|Overall Study|Lost to Follow-up|46|||
44482611|NCT00490139|79489395|FG002|Overall Study|Lost to Follow-up|58|||
44482612|NCT00490139|79489396|FG003|Overall Study|Lost to Follow-up|56|||
44482613|NCT00490139|79489393|FG000|Overall Study|Participant Withdrew Consent|146|||
44482614|NCT00490139|79489394|FG001|Overall Study|Participant Withdrew Consent|110|||
44482615|NCT00490139|79489395|FG002|Overall Study|Participant Withdrew Consent|208|||
44482616|NCT00490139|79489396|FG003|Overall Study|Participant Withdrew Consent|116|||
44227350|NCT01943435|79034325|FG002|6 Month Follow up|Lost to Follow-up|15|||
44482617|NCT00348140|79489411|FG000|Overall Study|Adverse Event|46|||
44482618|NCT00348140|79489412|FG001|Overall Study|Adverse Event|49|||
44482619|NCT00348140|79489413|FG002|Overall Study|Adverse Event|78|||
44482620|NCT00348140|79489411|FG000|Overall Study|Lost to Follow-up|4|||
44482621|NCT00348140|79489412|FG001|Overall Study|Lost to Follow-up|4|||
44482622|NCT00348140|79489413|FG002|Overall Study|Lost to Follow-up|4|||
44482623|NCT00348140|79489411|FG000|Overall Study|Protocol Violation|12|||
44482624|NCT00348140|79489412|FG001|Overall Study|Protocol Violation|13|||
44482625|NCT00348140|79489413|FG002|Overall Study|Protocol Violation|14|||
44482626|NCT00348140|79489411|FG000|Overall Study|Withdrawal by Subject|32|||
44227351|NCT01942733|79034343|FG000|Overall Study|Lost to Follow-up|1|||
44227352|NCT01942733|79034343|FG000|Overall Study|Non-compliance with IMP|1|||
44227353|NCT01942733|79034343|FG000|Overall Study|Administrative|1|||
44227354|NCT01957865|79034359|FG000|Overall Study|Found HIV negative|0|||
44227355|NCT01957865|79034360|FG001|Overall Study|Found HIV negative|0|||
44227356|NCT01957865|79034361|FG002|Overall Study|Found HIV negative|1|||
44227357|NCT01957865|79034359|FG000|Overall Study|Lost to Follow-up|0|||
44274197|NCT03042468|79217639|FG005|Overall Study|Death|0|||
44482627|NCT00348140|79489412|FG001|Overall Study|Withdrawal by Subject|40|||
44482628|NCT00348140|79489413|FG002|Overall Study|Withdrawal by Subject|40|||
44482629|NCT00348140|79489411|FG000|Overall Study|Non-compliance|8|||
44482630|NCT00348140|79489412|FG001|Overall Study|Non-compliance|13|||
44227358|NCT01957865|79034360|FG001|Overall Study|Lost to Follow-up|2|||
44227359|NCT01957865|79034361|FG002|Overall Study|Lost to Follow-up|2|||
44227360|NCT01957787|79034370|FG000|Overall Study|Death|18|||
44227361|NCT01957787|79034370|FG000|Overall Study|Lost to Follow-up|3|||
44227362|NCT01957787|79034370|FG000|Overall Study|Withdrawal by Subject|3|||
44482631|NCT00348140|79489413|FG002|Overall Study|Non-compliance|5|||
44482632|NCT00348140|79489411|FG000|Overall Study|Participant at risk due to study drug|2|||
44482633|NCT00348140|79489412|FG001|Overall Study|Participant at risk due to study drug|0|||
44227363|NCT01957787|79034370|FG000|Overall Study|Entered Hospice or Similar Program|2|||
44227364|NCT01957787|79034370|FG000|Overall Study|Index Tumor(s) Resected|2|||
44227365|NCT01957787|79034370|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
44227366|NCT01957787|79034370|FG000|Overall Study|Local therapy, not cryoablation|6|||
44227367|NCT01698775|79034376|FG000|Phase A|Adverse Event|2|||
44227368|NCT01698775|79034377|FG001|Phase A|Adverse Event|1|||
44227369|NCT01698775|79034376|FG000|Phase A|Death|1|||
44227370|NCT01698775|79034377|FG001|Phase A|Death|1|||
44227371|NCT01698775|79034376|FG000|Phase A|Lack of Efficacy|1|||
44227372|NCT01698775|79034377|FG001|Phase A|Lack of Efficacy|0|||
44227373|NCT01698775|79034376|FG000|Phase A|Lost to Follow-up|1|||
44227374|NCT01698775|79034377|FG001|Phase A|Lost to Follow-up|2|||
44227375|NCT01698775|79034376|FG000|Phase A|Protocol Violation|1|||
44227376|NCT01698775|79034377|FG001|Phase A|Protocol Violation|0|||
44227377|NCT01698775|79034376|FG000|Phase A|Withdrawal by Subject|3|||
44227378|NCT01698775|79034377|FG001|Phase A|Withdrawal by Subject|4|||
44227379|NCT01698775|79034376|FG000|Phase A|Kidney [transplant]|0|||
44227380|NCT01698775|79034377|FG001|Phase A|Kidney [transplant]|1|||
44227381|NCT01698775|79034376|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
44227382|NCT01698775|79034377|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
44227383|NCT01698775|79034376|FG000|Phase B|Adverse Event|6|||
44227384|NCT01698775|79034377|FG001|Phase B|Adverse Event|3|||
44227385|NCT01698775|79034376|FG000|Phase B|Death|0|||
44227386|NCT01698775|79034377|FG001|Phase B|Death|1|||
44227387|NCT01698775|79034376|FG000|Phase B|Lack of Efficacy|0|||
44227388|NCT01698775|79034377|FG001|Phase B|Lack of Efficacy|1|||
44227389|NCT01698775|79034376|FG000|Phase B|Lost to Follow-up|0|||
44227390|NCT01698775|79034377|FG001|Phase B|Lost to Follow-up|1|||
44227391|NCT01698775|79034376|FG000|Phase B|Physician Decision|1|||
44227392|NCT01698775|79034377|FG001|Phase B|Physician Decision|1|||
44227393|NCT01698775|79034376|FG000|Phase B|Protocol Violation|1|||
44227394|NCT01698775|79034377|FG001|Phase B|Protocol Violation|1|||
44227395|NCT01698775|79034376|FG000|Phase B|Withdrawal by Subject|6|||
44227396|NCT01698775|79034377|FG001|Phase B|Withdrawal by Subject|2|||
44227397|NCT01941095|79034387|FG000|Overall Study|Insufficient therapeutic response|13|||
44227398|NCT01941095|79034387|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
44274198|NCT03042468|79217634|FG000|Overall Study|Withdrawal by Subject|0|||
44274199|NCT03042468|79217635|FG001|Overall Study|Withdrawal by Subject|0|||
44482634|NCT00348140|79489413|FG002|Overall Study|Participant at risk due to study drug|0|||
44482635|NCT00348140|79489411|FG000|Overall Study|Conditional medication increased dose|1|||
44482636|NCT00348140|79489412|FG001|Overall Study|Conditional medication increased dose|0|||
44482637|NCT00348140|79489413|FG002|Overall Study|Conditional medication increased dose|0|||
44482638|NCT00348140|79489411|FG000|Overall Study|Caregiver related|4|||
44482639|NCT00348140|79489412|FG001|Overall Study|Caregiver related|7|||
44482640|NCT00348140|79489413|FG002|Overall Study|Caregiver related|3|||
44482641|NCT00348140|79489411|FG000|Overall Study|Participant hospitalised|3|||
44482642|NCT00348140|79489412|FG001|Overall Study|Participant hospitalised|0|||
44482643|NCT00348140|79489413|FG002|Overall Study|Participant hospitalised|0|||
44482644|NCT00348140|79489411|FG000|Overall Study|Efficacy related|1|||
44482645|NCT00348140|79489412|FG001|Overall Study|Efficacy related|1|||
44482646|NCT00348140|79489413|FG002|Overall Study|Efficacy related|0|||
44482647|NCT00348140|79489411|FG000|Overall Study|Administration related|3|||
44482648|NCT00348140|79489412|FG001|Overall Study|Administration related|1|||
44482649|NCT00348140|79489413|FG002|Overall Study|Administration related|1|||
44482650|NCT00348140|79489411|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
44482651|NCT00348140|79489412|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
44482652|NCT00348140|79489413|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
44482653|NCT00348140|79489411|FG000|Overall Study|Participant unwell|1|||
44482654|NCT00348140|79489412|FG001|Overall Study|Participant unwell|0|||
44482655|NCT00348140|79489413|FG002|Overall Study|Participant unwell|0|||
44227399|NCT01941095|79034387|FG000|Overall Study|Adverse Event|11|||
44227400|NCT01941095|79034387|FG000|Overall Study|Physician Decision|3|||
44227401|NCT01941095|79034387|FG000|Overall Study|Withdrawal by Subject|17|||
44227402|NCT01941095|79034387|FG000|Overall Study|Lost to Follow-up|10|||
44227403|NCT01957709|79034402|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
44227404|NCT01957553|79034419|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
44482656|NCT00348140|79489411|FG000|Overall Study|Screen failure|1|||
44482657|NCT00348140|79489412|FG001|Overall Study|Screen failure|0|||
44227405|NCT01957553|79034420|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
44227406|NCT01957553|79034419|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
44227407|NCT01957553|79034420|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
44227408|NCT01957553|79034419|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
44227409|NCT01957553|79034420|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
44227410|NCT01957553|79034419|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
44274200|NCT03042468|79217636|FG002|Overall Study|Withdrawal by Subject|0|||
44227411|NCT01957553|79034420|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
44227412|NCT01957553|79034419|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
44482658|NCT00348140|79489413|FG002|Overall Study|Screen failure|0|||
44482659|NCT00348140|79489411|FG000|Overall Study|Investigator decided to discontinue|4|||
44482660|NCT00348140|79489412|FG001|Overall Study|Investigator decided to discontinue|1|||
44482661|NCT00348140|79489413|FG002|Overall Study|Investigator decided to discontinue|4|||
44482662|NCT00348140|79489411|FG000|Overall Study|Decided to discontinue on their own|1|||
44482663|NCT00348140|79489412|FG001|Overall Study|Decided to discontinue on their own|4|||
44482664|NCT00348140|79489413|FG002|Overall Study|Decided to discontinue on their own|1|||
44482665|NCT00348140|79489411|FG000|Overall Study|Use of prohibited drug|1|||
44482666|NCT00348140|79489412|FG001|Overall Study|Use of prohibited drug|0|||
44482667|NCT00348140|79489413|FG002|Overall Study|Use of prohibited drug|2|||
44482668|NCT00348140|79489411|FG000|Overall Study|Disease progression|1|||
44482669|NCT00348140|79489412|FG001|Overall Study|Disease progression|2|||
44482670|NCT00348140|79489413|FG002|Overall Study|Disease progression|5|||
44482671|NCT00348140|79489411|FG000|Overall Study|Increased risk of cardiac infarction|0|||
44482672|NCT00348140|79489412|FG001|Overall Study|Increased risk of cardiac infarction|1|||
44482673|NCT00348140|79489413|FG002|Overall Study|Increased risk of cardiac infarction|0|||
44482674|NCT00348140|79489411|FG000|Overall Study|Serious adverse event|0|||
44482675|NCT00348140|79489412|FG001|Overall Study|Serious adverse event|1|||
44482676|NCT00348140|79489413|FG002|Overall Study|Serious adverse event|0|||
44482677|NCT00348140|79489411|FG000|Overall Study|Abnormal ECG|0|||
44482678|NCT00348140|79489412|FG001|Overall Study|Abnormal ECG|1|||
44482679|NCT00348140|79489413|FG002|Overall Study|Abnormal ECG|3|||
44482680|NCT00348140|79489411|FG000|Overall Study|Participant died|0|||
44482681|NCT00348140|79489412|FG001|Overall Study|Participant died|1|||
44482682|NCT00348140|79489413|FG002|Overall Study|Participant died|0|||
44482683|NCT00348140|79489411|FG000|Overall Study|Exclusion criteria met|0|||
44482684|NCT00348140|79489412|FG001|Overall Study|Exclusion criteria met|0|||
44482685|NCT00348140|79489413|FG002|Overall Study|Exclusion criteria met|1|||
44482686|NCT00348140|79489411|FG000|Overall Study|Memory declined|0|||
44482687|NCT00348140|79489412|FG001|Overall Study|Memory declined|0|||
44482688|NCT00348140|79489413|FG002|Overall Study|Memory declined|1|||
44482689|NCT00490061|79489422|FG000|Overall Study|Physician Decision|1|||
44482690|NCT00483119|79489428|FG000|Overall Study|Adverse Event|0|||
44482691|NCT00483119|79489429|FG001|Overall Study|Adverse Event|1|||
44482692|NCT00483119|79489428|FG000|Overall Study|Physician Decision|1|||
44482693|NCT00483119|79489429|FG001|Overall Study|Physician Decision|0|||
44482694|NCT00483041|79489437|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
44482695|NCT00483041|79489438|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
44482696|NCT00501293|79489446|FG000|Optimization Period|Enrolled in error|1|||
44482697|NCT00501293|79489447|FG001|Optimization Period|Enrolled in error|0|||
44482698|NCT00501293|79489446|FG000|Maintenance Period|Withdrawal by Subject|14|||
44482699|NCT00501293|79489447|FG001|Maintenance Period|Withdrawal by Subject|13|||
44482700|NCT00501293|79489446|FG000|Maintenance Period|Lost to Follow-up|12|||
44482701|NCT00501293|79489447|FG001|Maintenance Period|Lost to Follow-up|7|||
44482702|NCT00501293|79489446|FG000|Maintenance Period|Adverse Event|6|||
44482703|NCT00501293|79489447|FG001|Maintenance Period|Adverse Event|6|||
44482704|NCT00501293|79489446|FG000|Maintenance Period|Protocol Violation|2|||
44482705|NCT00501293|79489447|FG001|Maintenance Period|Protocol Violation|1|||
44482706|NCT00501293|79489446|FG000|Maintenance Period|Lack of Efficacy|4|||
44482707|NCT00501293|79489447|FG001|Maintenance Period|Lack of Efficacy|1|||
44482708|NCT00501293|79489446|FG000|Maintenance Period|Noncompliant with study medication|5|||
44482709|NCT00501293|79489447|FG001|Maintenance Period|Noncompliant with study medication|0|||
44227413|NCT01957553|79034420|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
44227414|NCT01957553|79034419|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
44227415|NCT01957553|79034420|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
44227416|NCT01957553|79034419|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
44482710|NCT00501293|79489446|FG000|Maintenance Period|Went into rehabilitation|1|||
44482711|NCT00501293|79489447|FG001|Maintenance Period|Went into rehabilitation|0|||
44482712|NCT00501293|79489446|FG000|Maintenance Period|Would not wear patch|1|||
44482713|NCT00501293|79489447|FG001|Maintenance Period|Would not wear patch|0|||
44482714|NCT00501293|79489446|FG000|Maintenance Period|Application site reaction|1|||
44482715|NCT00501293|79489447|FG001|Maintenance Period|Application site reaction|0|||
44482716|NCT00482729|79489456|FG000|Overall Study|Adverse Event|29|||
44482717|NCT00482729|79489457|FG001|Overall Study|Adverse Event|33|||
44482718|NCT00482729|79489456|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
44482719|NCT00482729|79489457|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
44482720|NCT00482729|79489456|FG000|Overall Study|Hyperglycemia Criteria|7|||
44482721|NCT00482729|79489457|FG001|Overall Study|Hyperglycemia Criteria|5|||
44482722|NCT00482729|79489456|FG000|Overall Study|Lack of Efficacy|4|||
44482723|NCT00482729|79489457|FG001|Overall Study|Lack of Efficacy|16|||
44482724|NCT00482729|79489456|FG000|Overall Study|Lost to Follow-up|86|||
44227417|NCT01957553|79034420|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
44482725|NCT00482729|79489457|FG001|Overall Study|Lost to Follow-up|66|||
44482726|NCT00482729|79489456|FG000|Overall Study|Physician Decision|10|||
44482727|NCT00482729|79489457|FG001|Overall Study|Physician Decision|7|||
44482728|NCT00482729|79489456|FG000|Overall Study|Pregnancy|4|||
44482729|NCT00482729|79489457|FG001|Overall Study|Pregnancy|2|||
44482730|NCT00482729|79489456|FG000|Overall Study|Protocol Violation|10|||
44482731|NCT00482729|79489457|FG001|Overall Study|Protocol Violation|18|||
44482732|NCT00482729|79489456|FG000|Overall Study|Withdrawal by Subject|67|||
44482733|NCT00482729|79489457|FG001|Overall Study|Withdrawal by Subject|69|||
44482734|NCT00359762|79489465|FG000|Period II|Adverse Event|17|||
44482735|NCT00359762|79489466|FG001|Period II|Adverse Event|0|||
44482736|NCT00359762|79489467|FG002|Period II|Adverse Event|0|||
44482737|NCT00359762|79489468|FG003|Period II|Adverse Event|0|||
44482738|NCT00359762|79489469|FG004|Period II|Adverse Event|49|||
44482739|NCT00359762|79489465|FG000|Period II|Protocol Violation|18|||
44482740|NCT00359762|79489466|FG001|Period II|Protocol Violation|0|||
44482741|NCT00359762|79489467|FG002|Period II|Protocol Violation|0|||
44482742|NCT00359762|79489468|FG003|Period II|Protocol Violation|0|||
44482743|NCT00359762|79489469|FG004|Period II|Protocol Violation|11|||
44482744|NCT00359762|79489465|FG000|Period II|Physician Decision|17|||
44482745|NCT00359762|79489466|FG001|Period II|Physician Decision|0|||
44482746|NCT00359762|79489467|FG002|Period II|Physician Decision|0|||
44482747|NCT00359762|79489468|FG003|Period II|Physician Decision|0|||
44482748|NCT00359762|79489469|FG004|Period II|Physician Decision|23|||
44482749|NCT00359762|79489465|FG000|Period II|Death|2|||
44482750|NCT00359762|79489466|FG001|Period II|Death|0|||
44482751|NCT00359762|79489467|FG002|Period II|Death|0|||
44482752|NCT00359762|79489468|FG003|Period II|Death|0|||
44482753|NCT00359762|79489469|FG004|Period II|Death|4|||
44482754|NCT00359762|79489465|FG000|Period II|Lack of Efficacy|11|||
44482755|NCT00359762|79489466|FG001|Period II|Lack of Efficacy|0|||
44482756|NCT00359762|79489467|FG002|Period II|Lack of Efficacy|0|||
44482757|NCT00359762|79489468|FG003|Period II|Lack of Efficacy|0|||
44482758|NCT00359762|79489469|FG004|Period II|Lack of Efficacy|8|||
44482759|NCT00359762|79489465|FG000|Period II|Lost to follow up|5|||
44482760|NCT00359762|79489466|FG001|Period II|Lost to follow up|0|||
44482761|NCT00359762|79489467|FG002|Period II|Lost to follow up|0|||
44482762|NCT00359762|79489468|FG003|Period II|Lost to follow up|0|||
44482763|NCT00359762|79489469|FG004|Period II|Lost to follow up|5|||
44482764|NCT00359762|79489465|FG000|Period II|Entry Criteria Not Met|8|||
44482765|NCT00359762|79489466|FG001|Period II|Entry Criteria Not Met|0|||
44482766|NCT00359762|79489467|FG002|Period II|Entry Criteria Not Met|0|||
44482767|NCT00359762|79489468|FG003|Period II|Entry Criteria Not Met|0|||
44482768|NCT00359762|79489469|FG004|Period II|Entry Criteria Not Met|4|||
44482769|NCT00359762|79489465|FG000|Period II|Subject Decision|50|||
44482770|NCT00359762|79489466|FG001|Period II|Subject Decision|0|||
44482771|NCT00359762|79489467|FG002|Period II|Subject Decision|0|||
44482772|NCT00359762|79489468|FG003|Period II|Subject Decision|0|||
44482773|NCT00359762|79489469|FG004|Period II|Subject Decision|70|||
44482774|NCT00359762|79489465|FG000|Period III|Protocol Violation|0|||
44482775|NCT00359762|79489466|FG001|Period III|Protocol Violation|5|||
44482776|NCT00359762|79489467|FG002|Period III|Protocol Violation|3|||
44482777|NCT00359762|79489468|FG003|Period III|Protocol Violation|8|||
44482778|NCT00359762|79489469|FG004|Period III|Protocol Violation|0|||
44227418|NCT01957553|79034419|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
44227419|NCT01957553|79034420|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
44227420|NCT01957553|79034419|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
44227421|NCT01957553|79034420|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
44227422|NCT01957475|79034445|FG000|Test Period 1|Withdrawal by Subject|1|||
44227423|NCT01957475|79034446|FG001|Test Period 1|Withdrawal by Subject|0|||
44227424|NCT01957475|79034445|FG000|Test Period 1|Other|1|||
44227425|NCT01957475|79034446|FG001|Test Period 1|Other|0|||
44227426|NCT01957475|79034445|FG000|Test Period 1|Lack of Efficacy|0|||
44227427|NCT01957475|79034446|FG001|Test Period 1|Lack of Efficacy|1|||
44227428|NCT01957475|79034445|FG000|Test Period 2|Adverse Event|1|||
44227429|NCT01957475|79034446|FG001|Test Period 2|Adverse Event|0|||
44227430|NCT01940939|79034454|FG000|Overall Study|Withdrawal by Subject|2|||
44482779|NCT00359762|79489465|FG000|Period III|Adverse Event|0|||
44482780|NCT00359762|79489466|FG001|Period III|Adverse Event|3|||
44482781|NCT00359762|79489467|FG002|Period III|Adverse Event|4|||
44482782|NCT00359762|79489468|FG003|Period III|Adverse Event|10|||
44482783|NCT00359762|79489469|FG004|Period III|Adverse Event|0|||
44482784|NCT00359762|79489465|FG000|Period III|Physician Decision|0|||
44482785|NCT00359762|79489466|FG001|Period III|Physician Decision|5|||
44482786|NCT00359762|79489467|FG002|Period III|Physician Decision|9|||
44482787|NCT00359762|79489468|FG003|Period III|Physician Decision|15|||
44482788|NCT00359762|79489469|FG004|Period III|Physician Decision|0|||
44227431|NCT01940939|79034455|FG001|Overall Study|Withdrawal by Subject|8|||
44227432|NCT01957397|79034461|FG000|Test Period 1|sudden leakage/small bag|1|||
44482789|NCT00359762|79489465|FG000|Period III|Lack of Efficacy|0|||
44482790|NCT00359762|79489466|FG001|Period III|Lack of Efficacy|7|||
44482791|NCT00359762|79489467|FG002|Period III|Lack of Efficacy|5|||
44482792|NCT00359762|79489468|FG003|Period III|Lack of Efficacy|9|||
44482793|NCT00359762|79489469|FG004|Period III|Lack of Efficacy|0|||
44482794|NCT00359762|79489465|FG000|Period III|Lost to follow up|0|||
44482795|NCT00359762|79489466|FG001|Period III|Lost to follow up|1|||
44482796|NCT00359762|79489467|FG002|Period III|Lost to follow up|1|||
44482797|NCT00359762|79489468|FG003|Period III|Lost to follow up|2|||
44482798|NCT00359762|79489469|FG004|Period III|Lost to follow up|0|||
44482799|NCT00359762|79489465|FG000|Period III|Entry Criteria Not Met|0|||
44482800|NCT00359762|79489466|FG001|Period III|Entry Criteria Not Met|1|||
44482801|NCT00359762|79489467|FG002|Period III|Entry Criteria Not Met|0|||
44482802|NCT00359762|79489468|FG003|Period III|Entry Criteria Not Met|1|||
44482803|NCT00359762|79489469|FG004|Period III|Entry Criteria Not Met|0|||
44482804|NCT00359762|79489465|FG000|Period III|Subject Decision|0|||
44482805|NCT00359762|79489466|FG001|Period III|Subject Decision|7|||
44482806|NCT00359762|79489467|FG002|Period III|Subject Decision|8|||
44482807|NCT00359762|79489468|FG003|Period III|Subject Decision|20|||
44482808|NCT00359762|79489469|FG004|Period III|Subject Decision|0|||
44482809|NCT00347438|79489483|FG000|Overall Study|Withdrawal by Subject|1|||
44482810|NCT00347438|79489483|FG000|Overall Study|Physician Decision|1|||
44482811|NCT00329238|79489489|FG000|Overall Study|Adverse Event|147|||
44482812|NCT00329238|79489490|FG001|Overall Study|Adverse Event|129|||
44482813|NCT00329238|79489489|FG000|Overall Study|Protocol Violation|23|||
44482814|NCT00329238|79489490|FG001|Overall Study|Protocol Violation|34|||
44482815|NCT00329238|79489489|FG000|Overall Study|Lost to Follow-up|2|||
44482816|NCT00329238|79489490|FG001|Overall Study|Lost to Follow-up|6|||
44482817|NCT00329238|79489489|FG000|Overall Study|Withdrawal by Subject|64|||
44482818|NCT00329238|79489490|FG001|Overall Study|Withdrawal by Subject|58|||
44482819|NCT00329238|79489489|FG000|Overall Study|Other reason (not specified)|40|||
44482820|NCT00329238|79489490|FG001|Overall Study|Other reason (not specified)|54|||
44482821|NCT00329160|79489498|FG000|Overall Study|Adverse Event|27|||
44482822|NCT00329160|79489498|FG000|Overall Study|Withdrawal by Subject|13|||
44482823|NCT00329160|79489498|FG000|Overall Study|Protocol Violation|2|||
44482824|NCT00329160|79489498|FG000|Overall Study|Did not Receive Study Drug|1|||
44482825|NCT00329160|79489498|FG000|Overall Study|Incomplete IVUS|45|||
44482826|NCT00328926|79489505|FG000|Overall Study|Pregnancy|2|||
44482827|NCT00328926|79489506|FG001|Overall Study|Pregnancy|1|||
44482828|NCT00328926|79489507|FG002|Overall Study|Pregnancy|0|||
44482829|NCT00328926|79489505|FG000|Overall Study|Lost to Follow-up|0|||
44482830|NCT00328926|79489506|FG001|Overall Study|Lost to Follow-up|1|||
44482831|NCT00328926|79489507|FG002|Overall Study|Lost to Follow-up|0|||
44482832|NCT00328926|79489505|FG000|Overall Study|Death|0|||
44482833|NCT00328926|79489506|FG001|Overall Study|Death|0|||
44482834|NCT00328926|79489507|FG002|Overall Study|Death|1|||
44482835|NCT00328926|79489505|FG000|Overall Study|In vitro fertilization treatment|0|||
44482836|NCT00328926|79489506|FG001|Overall Study|In vitro fertilization treatment|0|||
44482837|NCT00328926|79489507|FG002|Overall Study|In vitro fertilization treatment|1|||
44482838|NCT00328926|79489505|FG000|Overall Study|Lack of ovarian response|0|||
44482839|NCT00328926|79489506|FG001|Overall Study|Lack of ovarian response|1|||
44482840|NCT00328926|79489507|FG002|Overall Study|Lack of ovarian response|0|||
44482841|NCT00319254|79489515|FG000|Overall Study|Withdrawal by Subject|4|||
44482842|NCT00319254|79489515|FG000|Overall Study|Death|46|||
44482843|NCT00319254|79489515|FG000|Overall Study|Lost to Follow-up|2|||
44482844|NCT00319254|79489515|FG000|Overall Study|Enrolled, Not Treated|2|||
44482845|NCT00319098|79489523|FG000|Overall Study|Serious adverse event|3|||
44482846|NCT00319098|79489524|FG001|Overall Study|Serious adverse event|0|||
44482847|NCT00319098|79489523|FG000|Overall Study|Adverse Event|20|||
44482848|NCT00319098|79489524|FG001|Overall Study|Adverse Event|1|||
44482849|NCT00319098|79489523|FG000|Overall Study|Withdrawal by Subject|37|||
44482850|NCT00319098|79489524|FG001|Overall Study|Withdrawal by Subject|8|||
44482851|NCT00319098|79489523|FG000|Overall Study|Migrated/moved from study area|2|||
44482852|NCT00319098|79489524|FG001|Overall Study|Migrated/moved from study area|1|||
44482853|NCT00319098|79489523|FG000|Overall Study|Lost to Follow-up|37|||
44482854|NCT00319098|79489524|FG001|Overall Study|Lost to Follow-up|13|||
44482855|NCT00319098|79489523|FG000|Overall Study|Others|33|||
44482856|NCT00319098|79489524|FG001|Overall Study|Others|8|||
44482857|NCT00319098|79489523|FG000|Overall Study|Protocol Violation|3|||
44482858|NCT00319098|79489524|FG001|Overall Study|Protocol Violation|1|||
44482859|NCT00347360|79489549|FG000|Overall Study|Adverse Event|1|||
44482860|NCT00347360|79489550|FG001|Overall Study|Adverse Event|2|||
44482861|NCT00347360|79489551|FG002|Overall Study|Adverse Event|0|||
44482862|NCT00347360|79489552|FG003|Overall Study|Adverse Event|4|||
44482863|NCT00347360|79489553|FG004|Overall Study|Adverse Event|1|||
44482864|NCT00347360|79489554|FG005|Overall Study|Adverse Event|2|||
44482865|NCT00347360|79489555|FG006|Overall Study|Adverse Event|2|||
44482866|NCT00347360|79489556|FG007|Overall Study|Adverse Event|0|||
44482867|NCT00347360|79489557|FG008|Overall Study|Adverse Event|2|||
44482868|NCT00347360|79489558|FG009|Overall Study|Adverse Event|3|||
44482869|NCT00347360|79489559|FG010|Overall Study|Adverse Event|3|||
44482870|NCT00347360|79489560|FG011|Overall Study|Adverse Event|1|||
44482871|NCT00347360|79489561|FG012|Overall Study|Adverse Event|3|||
44482872|NCT00347360|79489562|FG013|Overall Study|Adverse Event|2|||
44482873|NCT00347360|79489563|FG014|Overall Study|Adverse Event|2|||
44482874|NCT00347360|79489549|FG000|Overall Study|Lost to Follow-up|0|||
44482875|NCT00347360|79489550|FG001|Overall Study|Lost to Follow-up|0|||
44482876|NCT00347360|79489551|FG002|Overall Study|Lost to Follow-up|0|||
44482877|NCT00347360|79489552|FG003|Overall Study|Lost to Follow-up|2|||
44482878|NCT00347360|79489553|FG004|Overall Study|Lost to Follow-up|1|||
44482879|NCT00347360|79489554|FG005|Overall Study|Lost to Follow-up|1|||
44482880|NCT00347360|79489555|FG006|Overall Study|Lost to Follow-up|0|||
44482881|NCT00347360|79489556|FG007|Overall Study|Lost to Follow-up|1|||
44482882|NCT00347360|79489557|FG008|Overall Study|Lost to Follow-up|1|||
44482883|NCT00347360|79489558|FG009|Overall Study|Lost to Follow-up|2|||
44482884|NCT00347360|79489559|FG010|Overall Study|Lost to Follow-up|0|||
44482885|NCT00347360|79489560|FG011|Overall Study|Lost to Follow-up|0|||
44482886|NCT00347360|79489561|FG012|Overall Study|Lost to Follow-up|1|||
44482887|NCT00347360|79489562|FG013|Overall Study|Lost to Follow-up|0|||
44482888|NCT00347360|79489563|FG014|Overall Study|Lost to Follow-up|0|||
44482889|NCT00347360|79489549|FG000|Overall Study|Protocol Violation|2|||
44482890|NCT00347360|79489550|FG001|Overall Study|Protocol Violation|3|||
44482891|NCT00347360|79489551|FG002|Overall Study|Protocol Violation|1|||
44482892|NCT00347360|79489552|FG003|Overall Study|Protocol Violation|2|||
44482893|NCT00347360|79489553|FG004|Overall Study|Protocol Violation|1|||
44482894|NCT00347360|79489554|FG005|Overall Study|Protocol Violation|2|||
44482895|NCT00347360|79489555|FG006|Overall Study|Protocol Violation|0|||
44482896|NCT00347360|79489556|FG007|Overall Study|Protocol Violation|0|||
44482897|NCT00347360|79489557|FG008|Overall Study|Protocol Violation|1|||
44482898|NCT00347360|79489558|FG009|Overall Study|Protocol Violation|2|||
44482899|NCT00347360|79489559|FG010|Overall Study|Protocol Violation|0|||
44482900|NCT00347360|79489560|FG011|Overall Study|Protocol Violation|0|||
44482901|NCT00347360|79489561|FG012|Overall Study|Protocol Violation|0|||
44482902|NCT00347360|79489562|FG013|Overall Study|Protocol Violation|1|||
44482903|NCT00347360|79489563|FG014|Overall Study|Protocol Violation|0|||
44482904|NCT00347360|79489549|FG000|Overall Study|Withdrawal by Subject|0|||
44482905|NCT00347360|79489550|FG001|Overall Study|Withdrawal by Subject|1|||
44482906|NCT00347360|79489551|FG002|Overall Study|Withdrawal by Subject|2|||
44482907|NCT00347360|79489552|FG003|Overall Study|Withdrawal by Subject|4|||
44482908|NCT00347360|79489553|FG004|Overall Study|Withdrawal by Subject|1|||
44482909|NCT00347360|79489554|FG005|Overall Study|Withdrawal by Subject|2|||
44482910|NCT00347360|79489555|FG006|Overall Study|Withdrawal by Subject|1|||
44482911|NCT00347360|79489556|FG007|Overall Study|Withdrawal by Subject|1|||
44482912|NCT00347360|79489557|FG008|Overall Study|Withdrawal by Subject|1|||
44482913|NCT00347360|79489558|FG009|Overall Study|Withdrawal by Subject|1|||
44482914|NCT00347360|79489559|FG010|Overall Study|Withdrawal by Subject|0|||
44482915|NCT00347360|79489560|FG011|Overall Study|Withdrawal by Subject|3|||
44482916|NCT00347360|79489561|FG012|Overall Study|Withdrawal by Subject|4|||
44482917|NCT00347360|79489562|FG013|Overall Study|Withdrawal by Subject|2|||
44482918|NCT00347360|79489563|FG014|Overall Study|Withdrawal by Subject|1|||
44482919|NCT00347360|79489549|FG000|Overall Study|Lack of Efficacy|1|||
44482920|NCT00347360|79489550|FG001|Overall Study|Lack of Efficacy|1|||
44482921|NCT00347360|79489551|FG002|Overall Study|Lack of Efficacy|3|||
44482922|NCT00347360|79489552|FG003|Overall Study|Lack of Efficacy|1|||
44482923|NCT00347360|79489553|FG004|Overall Study|Lack of Efficacy|0|||
44482924|NCT00347360|79489554|FG005|Overall Study|Lack of Efficacy|1|||
44482925|NCT00347360|79489555|FG006|Overall Study|Lack of Efficacy|0|||
44482926|NCT00347360|79489556|FG007|Overall Study|Lack of Efficacy|1|||
44482927|NCT00347360|79489557|FG008|Overall Study|Lack of Efficacy|1|||
44482928|NCT00347360|79489558|FG009|Overall Study|Lack of Efficacy|0|||
44482929|NCT00347360|79489559|FG010|Overall Study|Lack of Efficacy|0|||
44482930|NCT00347360|79489560|FG011|Overall Study|Lack of Efficacy|0|||
44227433|NCT01957397|79034462|FG001|Test Period 1|sudden leakage/small bag|1|||
44482931|NCT00347360|79489561|FG012|Overall Study|Lack of Efficacy|0|||
44482932|NCT00347360|79489562|FG013|Overall Study|Lack of Efficacy|0|||
44482933|NCT00347360|79489563|FG014|Overall Study|Lack of Efficacy|0|||
44482934|NCT00347360|79489549|FG000|Overall Study|Reason not listed/blank|1|||
44482935|NCT00347360|79489550|FG001|Overall Study|Reason not listed/blank|0|||
44482936|NCT00347360|79489551|FG002|Overall Study|Reason not listed/blank|0|||
44482937|NCT00347360|79489552|FG003|Overall Study|Reason not listed/blank|0|||
44482938|NCT00347360|79489553|FG004|Overall Study|Reason not listed/blank|0|||
44482939|NCT00347360|79489554|FG005|Overall Study|Reason not listed/blank|0|||
44482940|NCT00347360|79489555|FG006|Overall Study|Reason not listed/blank|1|||
44482941|NCT00347360|79489556|FG007|Overall Study|Reason not listed/blank|0|||
44482942|NCT00347360|79489557|FG008|Overall Study|Reason not listed/blank|0|||
44482943|NCT00347360|79489558|FG009|Overall Study|Reason not listed/blank|0|||
44482944|NCT00347360|79489559|FG010|Overall Study|Reason not listed/blank|0|||
44482945|NCT00347360|79489560|FG011|Overall Study|Reason not listed/blank|0|||
44482946|NCT00347360|79489561|FG012|Overall Study|Reason not listed/blank|0|||
44482947|NCT00347360|79489562|FG013|Overall Study|Reason not listed/blank|1|||
44482948|NCT00347360|79489563|FG014|Overall Study|Reason not listed/blank|0|||
44482949|NCT00347360|79489549|FG000|Overall Study|Per sponsors instruction|0|||
44482950|NCT00347360|79489550|FG001|Overall Study|Per sponsors instruction|1|||
44482951|NCT00347360|79489551|FG002|Overall Study|Per sponsors instruction|0|||
44482952|NCT00347360|79489552|FG003|Overall Study|Per sponsors instruction|0|||
44482953|NCT00347360|79489553|FG004|Overall Study|Per sponsors instruction|0|||
44482954|NCT00347360|79489554|FG005|Overall Study|Per sponsors instruction|0|||
44482955|NCT00347360|79489555|FG006|Overall Study|Per sponsors instruction|0|||
44482956|NCT00347360|79489556|FG007|Overall Study|Per sponsors instruction|0|||
44482957|NCT00347360|79489557|FG008|Overall Study|Per sponsors instruction|0|||
44482958|NCT00347360|79489558|FG009|Overall Study|Per sponsors instruction|0|||
44482959|NCT00347360|79489559|FG010|Overall Study|Per sponsors instruction|0|||
44482960|NCT00347360|79489560|FG011|Overall Study|Per sponsors instruction|0|||
44482961|NCT00347360|79489561|FG012|Overall Study|Per sponsors instruction|0|||
44482962|NCT00347360|79489562|FG013|Overall Study|Per sponsors instruction|0|||
44482963|NCT00347360|79489563|FG014|Overall Study|Per sponsors instruction|0|||
44482964|NCT00347360|79489549|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
44482965|NCT00347360|79489550|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
44482966|NCT00347360|79489551|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
44482967|NCT00347360|79489552|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
44482968|NCT00347360|79489553|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
44482969|NCT00347360|79489554|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
44482970|NCT00347360|79489555|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
44227434|NCT01957397|79034461|FG000|Test Period 1|Withdrawal by Subject|1|||
44227435|NCT01957397|79034462|FG001|Test Period 1|Withdrawal by Subject|0|||
44227436|NCT01957397|79034461|FG000|Test Period 2|Adverse Event|0|||
44227437|NCT01957397|79034462|FG001|Test Period 2|Adverse Event|1|||
44227438|NCT01957397|79034461|FG000|Test Period 3|Adverse Event|1|||
44227439|NCT01957397|79034462|FG001|Test Period 3|Adverse Event|2|||
44227440|NCT01957397|79034461|FG000|Test Period 3|the adhesive did not work|1|||
44227441|NCT01957397|79034462|FG001|Test Period 3|the adhesive did not work|0|||
44227442|NCT01940705|79034476|FG000|Overall Study|Lost to Follow-up|1|||
44227443|NCT01940705|79034477|FG001|Overall Study|Lost to Follow-up|3|||
44227444|NCT01940705|79034478|FG002|Overall Study|Lost to Follow-up|2|||
44227445|NCT01940705|79034479|FG003|Overall Study|Lost to Follow-up|2|||
44227446|NCT01940705|79034476|FG000|Overall Study|Withdrawal by Subject|2|||
44227447|NCT01940705|79034477|FG001|Overall Study|Withdrawal by Subject|2|||
44482971|NCT00347360|79489556|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
44227448|NCT01940705|79034478|FG002|Overall Study|Withdrawal by Subject|3|||
44227449|NCT01940705|79034479|FG003|Overall Study|Withdrawal by Subject|2|||
44227450|NCT01940705|79034476|FG000|Overall Study|Intervention not given|0|||
44274201|NCT03042468|79217637|FG003|Overall Study|Withdrawal by Subject|0|||
44482972|NCT00347360|79489557|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
44482973|NCT00347360|79489558|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
44482974|NCT00347360|79489559|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
44482975|NCT00347360|79489560|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
44482976|NCT00347360|79489561|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
44482977|NCT00347360|79489562|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
44544707|NCT03547531|79558278|FG001|Overall Study|having family occasion|2|||
44544708|NCT03566485|79558286|FG000|Overall Study|Disease progression|5|||
44544709|NCT03566485|79558287|FG001|Overall Study|Disease progression|4|||
44227451|NCT01940705|79034477|FG001|Overall Study|Intervention not given|3|||
44227452|NCT01940705|79034478|FG002|Overall Study|Intervention not given|3|||
44227453|NCT01940705|79034479|FG003|Overall Study|Intervention not given|0|||
44227454|NCT01940705|79034476|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
44274202|NCT03042468|79217638|FG004|Overall Study|Withdrawal by Subject|0|||
44274203|NCT03042468|79217639|FG005|Overall Study|Withdrawal by Subject|1|||
44482978|NCT00347360|79489563|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
44482979|NCT00347360|79489549|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
44482980|NCT00347360|79489550|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
44482981|NCT00347360|79489551|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
44482982|NCT00347360|79489552|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
44482983|NCT00347360|79489553|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
44482984|NCT00347360|79489554|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
44482985|NCT00347360|79489555|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
44482986|NCT00347360|79489556|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
44482987|NCT00347360|79489557|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
44482988|NCT00347360|79489558|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
44482989|NCT00347360|79489559|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
44482990|NCT00347360|79489560|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
44482991|NCT00347360|79489561|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
44482992|NCT00347360|79489562|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
44482993|NCT00347360|79489563|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
44482994|NCT00347360|79489549|FG000|Overall Study|Abnormal lab values|0|||
44482995|NCT00347360|79489550|FG001|Overall Study|Abnormal lab values|0|||
44482996|NCT00347360|79489551|FG002|Overall Study|Abnormal lab values|0|||
44482997|NCT00347360|79489552|FG003|Overall Study|Abnormal lab values|0|||
44482998|NCT00347360|79489553|FG004|Overall Study|Abnormal lab values|0|||
44482999|NCT00347360|79489554|FG005|Overall Study|Abnormal lab values|0|||
44483000|NCT00347360|79489555|FG006|Overall Study|Abnormal lab values|1|||
44483001|NCT00347360|79489556|FG007|Overall Study|Abnormal lab values|0|||
44483002|NCT00347360|79489557|FG008|Overall Study|Abnormal lab values|0|||
44483003|NCT00347360|79489558|FG009|Overall Study|Abnormal lab values|0|||
44483004|NCT00347360|79489559|FG010|Overall Study|Abnormal lab values|0|||
44483005|NCT00347360|79489560|FG011|Overall Study|Abnormal lab values|0|||
44483006|NCT00347360|79489561|FG012|Overall Study|Abnormal lab values|0|||
44483007|NCT00347360|79489562|FG013|Overall Study|Abnormal lab values|0|||
44483008|NCT00347360|79489563|FG014|Overall Study|Abnormal lab values|0|||
44483009|NCT00347360|79489549|FG000|Overall Study|PI recommended early withdrawal|0|||
44483010|NCT00347360|79489550|FG001|Overall Study|PI recommended early withdrawal|0|||
44483011|NCT00347360|79489551|FG002|Overall Study|PI recommended early withdrawal|0|||
44483012|NCT00347360|79489552|FG003|Overall Study|PI recommended early withdrawal|0|||
44483013|NCT00347360|79489553|FG004|Overall Study|PI recommended early withdrawal|0|||
44483014|NCT00347360|79489554|FG005|Overall Study|PI recommended early withdrawal|0|||
44483015|NCT00347360|79489555|FG006|Overall Study|PI recommended early withdrawal|0|||
44483016|NCT00347360|79489556|FG007|Overall Study|PI recommended early withdrawal|0|||
44483017|NCT00347360|79489557|FG008|Overall Study|PI recommended early withdrawal|0|||
44483018|NCT00347360|79489558|FG009|Overall Study|PI recommended early withdrawal|1|||
44483019|NCT00347360|79489559|FG010|Overall Study|PI recommended early withdrawal|0|||
44483020|NCT00347360|79489560|FG011|Overall Study|PI recommended early withdrawal|0|||
44483021|NCT00347360|79489561|FG012|Overall Study|PI recommended early withdrawal|0|||
44483022|NCT00347360|79489562|FG013|Overall Study|PI recommended early withdrawal|0|||
44483023|NCT00347360|79489563|FG014|Overall Study|PI recommended early withdrawal|0|||
44483024|NCT00347360|79489549|FG000|Overall Study|Did not meet criteria before ABPM|0|||
44483025|NCT00347360|79489550|FG001|Overall Study|Did not meet criteria before ABPM|0|||
44483026|NCT00347360|79489551|FG002|Overall Study|Did not meet criteria before ABPM|0|||
44483027|NCT00347360|79489552|FG003|Overall Study|Did not meet criteria before ABPM|0|||
44483028|NCT00347360|79489553|FG004|Overall Study|Did not meet criteria before ABPM|0|||
44227455|NCT01940705|79034477|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
44227456|NCT01940705|79034478|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
44227457|NCT01940705|79034479|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
44483029|NCT00347360|79489554|FG005|Overall Study|Did not meet criteria before ABPM|0|||
44483030|NCT00347360|79489555|FG006|Overall Study|Did not meet criteria before ABPM|0|||
44483031|NCT00347360|79489556|FG007|Overall Study|Did not meet criteria before ABPM|0|||
44483032|NCT00347360|79489557|FG008|Overall Study|Did not meet criteria before ABPM|0|||
44483033|NCT00347360|79489558|FG009|Overall Study|Did not meet criteria before ABPM|0|||
44483034|NCT00347360|79489559|FG010|Overall Study|Did not meet criteria before ABPM|1|||
44483035|NCT00347360|79489560|FG011|Overall Study|Did not meet criteria before ABPM|0|||
44483036|NCT00347360|79489561|FG012|Overall Study|Did not meet criteria before ABPM|0|||
44227458|NCT01957163|79034504|FG000|Overall Study|Adverse Event|5|||
44227459|NCT01957163|79034505|FG001|Overall Study|Adverse Event|2|||
44227460|NCT01957163|79034506|FG002|Overall Study|Adverse Event|4|||
44227461|NCT01957163|79034504|FG000|Overall Study|Lack of Efficacy|5|||
44227462|NCT01957163|79034505|FG001|Overall Study|Lack of Efficacy|4|||
44227463|NCT01957163|79034506|FG002|Overall Study|Lack of Efficacy|9|||
44227464|NCT01957163|79034504|FG000|Overall Study|Protocol Violation|1|||
44375639|NCT00953706|79380760|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
44375640|NCT00953706|79380761|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
44483037|NCT00347360|79489562|FG013|Overall Study|Did not meet criteria before ABPM|0|||
44483038|NCT00347360|79489563|FG014|Overall Study|Did not meet criteria before ABPM|0|||
44483039|NCT00347360|79489549|FG000|Overall Study|Randomized in error|0|||
44483040|NCT00347360|79489550|FG001|Overall Study|Randomized in error|0|||
44483041|NCT00347360|79489551|FG002|Overall Study|Randomized in error|0|||
44483042|NCT00347360|79489552|FG003|Overall Study|Randomized in error|0|||
44483043|NCT00347360|79489553|FG004|Overall Study|Randomized in error|0|||
44483044|NCT00347360|79489554|FG005|Overall Study|Randomized in error|0|||
44227465|NCT01957163|79034505|FG001|Overall Study|Protocol Violation|2|||
44227466|NCT01957163|79034506|FG002|Overall Study|Protocol Violation|0|||
44483045|NCT00347360|79489555|FG006|Overall Study|Randomized in error|0|||
44483046|NCT00347360|79489556|FG007|Overall Study|Randomized in error|0|||
44227467|NCT01957163|79034504|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
44227468|NCT01957163|79034505|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
44227469|NCT01957163|79034506|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
44227470|NCT01957163|79034504|FG000|Overall Study|Lost to Follow-up|0|||
44227471|NCT01957163|79034505|FG001|Overall Study|Lost to Follow-up|1|||
44227472|NCT01957163|79034506|FG002|Overall Study|Lost to Follow-up|0|||
44227473|NCT01957163|79034504|FG000|Overall Study|Withdrawal by Subject|4|||
44227474|NCT01957163|79034505|FG001|Overall Study|Withdrawal by Subject|2|||
44227475|NCT01957163|79034506|FG002|Overall Study|Withdrawal by Subject|4|||
44227476|NCT01939223|79034560|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
44227477|NCT01939223|79034561|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
44227478|NCT01939223|79034560|FG000|Overall Study|Disease recurrence (radiological)|1|||
44227479|NCT01939223|79034561|FG001|Overall Study|Disease recurrence (radiological)|3|||
44227480|NCT01939223|79034560|FG000|Overall Study|Study stopped by Sponsor|5|||
44227481|NCT01939223|79034561|FG001|Overall Study|Study stopped by Sponsor|7|||
44227482|NCT01939223|79034560|FG000|Overall Study|Withdrawal by Subject|6|||
44227483|NCT01939223|79034561|FG001|Overall Study|Withdrawal by Subject|0|||
44227484|NCT01954745|79034606|FG000|Overall Study|Radiological Progression|11|||
44227485|NCT01954745|79034606|FG000|Overall Study|Clinical Progression|5|||
44227486|NCT01954745|79034606|FG000|Overall Study|Adverse Event|2|||
44227487|NCT01954745|79034606|FG000|Overall Study|Death|1|||
44227488|NCT01954121|79034621|FG000|Overall Study|Lack of Efficacy|94|||
44227489|NCT01954121|79034622|FG001|Overall Study|Lack of Efficacy|41|||
44227490|NCT01954121|79034621|FG000|Overall Study|Protocol Violation|0|||
44483047|NCT00347360|79489557|FG008|Overall Study|Randomized in error|0|||
44483048|NCT00347360|79489558|FG009|Overall Study|Randomized in error|0|||
44483049|NCT00347360|79489559|FG010|Overall Study|Randomized in error|0|||
44483050|NCT00347360|79489560|FG011|Overall Study|Randomized in error|1|||
44483051|NCT00347360|79489561|FG012|Overall Study|Randomized in error|0|||
44227491|NCT01954121|79034622|FG001|Overall Study|Protocol Violation|2|||
44227492|NCT01954121|79034621|FG000|Overall Study|Lost to Follow-up|5|||
44227493|NCT01954121|79034622|FG001|Overall Study|Lost to Follow-up|6|||
44227494|NCT01954121|79034621|FG000|Overall Study|Withdrawal by Subject|18|||
44227495|NCT01954121|79034622|FG001|Overall Study|Withdrawal by Subject|12|||
44227496|NCT01954121|79034621|FG000|Overall Study|Pregnancy|1|||
44375641|NCT00953706|79380758|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
44375642|NCT00953706|79380759|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
44483052|NCT00347360|79489562|FG013|Overall Study|Randomized in error|0|||
44483053|NCT00347360|79489563|FG014|Overall Study|Randomized in error|0|||
44483054|NCT00347360|79489549|FG000|Overall Study|Failed inclusion criteria #4|0|||
44483055|NCT00347360|79489550|FG001|Overall Study|Failed inclusion criteria #4|0|||
44483056|NCT00347360|79489551|FG002|Overall Study|Failed inclusion criteria #4|0|||
44483057|NCT00347360|79489552|FG003|Overall Study|Failed inclusion criteria #4|0|||
44483058|NCT00347360|79489553|FG004|Overall Study|Failed inclusion criteria #4|0|||
44483059|NCT00347360|79489554|FG005|Overall Study|Failed inclusion criteria #4|0|||
44483060|NCT00347360|79489555|FG006|Overall Study|Failed inclusion criteria #4|0|||
44483061|NCT00347360|79489556|FG007|Overall Study|Failed inclusion criteria #4|0|||
44483062|NCT00347360|79489557|FG008|Overall Study|Failed inclusion criteria #4|0|||
44483063|NCT00347360|79489558|FG009|Overall Study|Failed inclusion criteria #4|0|||
44483064|NCT00347360|79489559|FG010|Overall Study|Failed inclusion criteria #4|0|||
44483065|NCT00347360|79489560|FG011|Overall Study|Failed inclusion criteria #4|1|||
44483066|NCT00347360|79489561|FG012|Overall Study|Failed inclusion criteria #4|0|||
44483067|NCT00347360|79489562|FG013|Overall Study|Failed inclusion criteria #4|0|||
44483068|NCT00347360|79489563|FG014|Overall Study|Failed inclusion criteria #4|0|||
44483069|NCT00347360|79489549|FG000|Overall Study|Prolonged duration between visits|0|||
44483070|NCT00347360|79489550|FG001|Overall Study|Prolonged duration between visits|0|||
44483071|NCT00347360|79489551|FG002|Overall Study|Prolonged duration between visits|0|||
44483072|NCT00347360|79489552|FG003|Overall Study|Prolonged duration between visits|0|||
44483073|NCT00347360|79489553|FG004|Overall Study|Prolonged duration between visits|0|||
44483074|NCT00347360|79489554|FG005|Overall Study|Prolonged duration between visits|0|||
44483075|NCT00347360|79489555|FG006|Overall Study|Prolonged duration between visits|0|||
44483076|NCT00347360|79489556|FG007|Overall Study|Prolonged duration between visits|0|||
44227497|NCT01954121|79034622|FG001|Overall Study|Pregnancy|1|||
44227498|NCT01954121|79034621|FG000|Overall Study|AE, serious fatal|1|||
44227499|NCT01954121|79034622|FG001|Overall Study|AE, serious fatal|0|||
44227500|NCT01954121|79034621|FG000|Overall Study|AE, non-serious non-fatal|5|||
44375643|NCT00953706|79380760|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
44227501|NCT01954121|79034622|FG001|Overall Study|AE, non-serious non-fatal|22|||
44227502|NCT01954121|79034621|FG000|Overall Study|SAE, non-fatal|1|||
44375644|NCT00953706|79380761|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
44483077|NCT00347360|79489557|FG008|Overall Study|Prolonged duration between visits|0|||
44483078|NCT00347360|79489558|FG009|Overall Study|Prolonged duration between visits|0|||
44483079|NCT00347360|79489559|FG010|Overall Study|Prolonged duration between visits|0|||
44483080|NCT00347360|79489560|FG011|Overall Study|Prolonged duration between visits|0|||
44483081|NCT00347360|79489561|FG012|Overall Study|Prolonged duration between visits|1|||
44483082|NCT00347360|79489562|FG013|Overall Study|Prolonged duration between visits|0|||
44483083|NCT00347360|79489563|FG014|Overall Study|Prolonged duration between visits|0|||
44483084|NCT00347360|79489549|FG000|Overall Study|Subject left town, ran out of study drug|0|||
44483085|NCT00347360|79489550|FG001|Overall Study|Subject left town, ran out of study drug|0|||
44483086|NCT00347360|79489551|FG002|Overall Study|Subject left town, ran out of study drug|0|||
44483087|NCT00347360|79489552|FG003|Overall Study|Subject left town, ran out of study drug|0|||
44483088|NCT00347360|79489553|FG004|Overall Study|Subject left town, ran out of study drug|0|||
44483089|NCT00347360|79489554|FG005|Overall Study|Subject left town, ran out of study drug|0|||
44483090|NCT00347360|79489555|FG006|Overall Study|Subject left town, ran out of study drug|0|||
44483091|NCT00347360|79489556|FG007|Overall Study|Subject left town, ran out of study drug|0|||
44483092|NCT00347360|79489557|FG008|Overall Study|Subject left town, ran out of study drug|0|||
44483093|NCT00347360|79489558|FG009|Overall Study|Subject left town, ran out of study drug|0|||
44483094|NCT00347360|79489559|FG010|Overall Study|Subject left town, ran out of study drug|0|||
44483095|NCT00347360|79489560|FG011|Overall Study|Subject left town, ran out of study drug|0|||
44483096|NCT00347360|79489561|FG012|Overall Study|Subject left town, ran out of study drug|0|||
44483097|NCT00347360|79489562|FG013|Overall Study|Subject left town, ran out of study drug|1|||
44483098|NCT00347360|79489563|FG014|Overall Study|Subject left town, ran out of study drug|0|||
44483099|NCT00347360|79489549|FG000|Overall Study|Subject refuse to sign updated consent|0|||
44483100|NCT00347360|79489550|FG001|Overall Study|Subject refuse to sign updated consent|0|||
44483101|NCT00347360|79489551|FG002|Overall Study|Subject refuse to sign updated consent|0|||
44483102|NCT00347360|79489552|FG003|Overall Study|Subject refuse to sign updated consent|0|||
44483103|NCT00347360|79489553|FG004|Overall Study|Subject refuse to sign updated consent|0|||
44483104|NCT00347360|79489554|FG005|Overall Study|Subject refuse to sign updated consent|0|||
44483105|NCT00347360|79489555|FG006|Overall Study|Subject refuse to sign updated consent|0|||
44483106|NCT00347360|79489556|FG007|Overall Study|Subject refuse to sign updated consent|0|||
44483107|NCT00347360|79489557|FG008|Overall Study|Subject refuse to sign updated consent|0|||
44483108|NCT00347360|79489558|FG009|Overall Study|Subject refuse to sign updated consent|0|||
44483109|NCT00347360|79489559|FG010|Overall Study|Subject refuse to sign updated consent|0|||
44483110|NCT00347360|79489560|FG011|Overall Study|Subject refuse to sign updated consent|0|||
44483111|NCT00347360|79489561|FG012|Overall Study|Subject refuse to sign updated consent|0|||
44227503|NCT01954121|79034622|FG001|Overall Study|SAE, non-fatal|4|||
44227504|NCT01954121|79034621|FG000|Overall Study|Non-compliant with study procedures|1|||
44227505|NCT01954121|79034622|FG001|Overall Study|Non-compliant with study procedures|0|||
44227506|NCT01954121|79034621|FG000|Overall Study|Non-compliant patient|1|||
44227507|NCT01954121|79034622|FG001|Overall Study|Non-compliant patient|1|||
44227508|NCT01954121|79034621|FG000|Overall Study|Subject did not follow instructions|0|||
44227509|NCT01954121|79034622|FG001|Overall Study|Subject did not follow instructions|2|||
44227510|NCT01952015|79034657|FG000|Induction|Protocol Violation|1|||
44227511|NCT01952015|79034657|FG000|Maintenance|Adverse Event|2|||
44227512|NCT01952015|79034657|FG000|Treatment Period 3|Physician Decision|9|||
44227513|NCT01951703|79034690|FG000|First Intervention|Withdrawal by Subject|1|||
44227514|NCT01951703|79034691|FG001|First Intervention|Withdrawal by Subject|0|||
44227515|NCT01951703|79034690|FG000|First Intervention|Subject was not compliant|1|||
44227516|NCT01951703|79034691|FG001|First Intervention|Subject was not compliant|1|||
44227517|NCT01951703|79034690|FG000|First Intervention|Physician Decision|1|||
44227518|NCT01951703|79034691|FG001|First Intervention|Physician Decision|0|||
44227519|NCT01951703|79034690|FG000|Second Intervention|Protocol Violation|0|||
44227520|NCT01951703|79034691|FG001|Second Intervention|Protocol Violation|1|||
44227521|NCT01951703|79034690|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
44227522|NCT01951703|79034691|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
44227523|NCT01937351|79034717|FG000|Overall Study|Withdrawal by Subject|4|||
44227524|NCT01937351|79034718|FG001|Overall Study|Withdrawal by Subject|2|||
44227525|NCT01937351|79034717|FG000|Overall Study|Death|1|||
44227526|NCT01937351|79034718|FG001|Overall Study|Death|0|||
44227527|NCT01937351|79034717|FG000|Overall Study|Not treated w device, per protocol fail|4|||
44227528|NCT01937351|79034718|FG001|Overall Study|Not treated w device, per protocol fail|0|||
44227529|NCT01737697|79034751|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44375645|NCT00953706|79380758|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
44375646|NCT00953706|79380759|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
44227530|NCT01737697|79034752|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
44227531|NCT01737697|79034753|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227532|NCT01737697|79034754|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
44227533|NCT01737697|79034755|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
44227534|NCT01737697|79034756|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44274204|NCT03042468|79217634|FG000|Overall Study|Lost to Follow-up|0|||
44483112|NCT00347360|79489562|FG013|Overall Study|Subject refuse to sign updated consent|0|||
44483113|NCT00347360|79489563|FG014|Overall Study|Subject refuse to sign updated consent|1|||
44483114|NCT00347360|79489549|FG000|Overall Study|Visits conflicted with new job|0|||
44227535|NCT01737697|79034757|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227536|NCT01737697|79034758|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227537|NCT01737697|79034759|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227538|NCT01737697|79034760|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227539|NCT01737697|79034761|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227540|NCT01737697|79034762|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44483115|NCT00347360|79489550|FG001|Overall Study|Visits conflicted with new job|0|||
44483116|NCT00347360|79489551|FG002|Overall Study|Visits conflicted with new job|0|||
44483117|NCT00347360|79489552|FG003|Overall Study|Visits conflicted with new job|0|||
44483118|NCT00347360|79489553|FG004|Overall Study|Visits conflicted with new job|0|||
44483119|NCT00347360|79489554|FG005|Overall Study|Visits conflicted with new job|0|||
44483120|NCT00347360|79489555|FG006|Overall Study|Visits conflicted with new job|1|||
44483121|NCT00347360|79489556|FG007|Overall Study|Visits conflicted with new job|0|||
44483122|NCT00347360|79489557|FG008|Overall Study|Visits conflicted with new job|0|||
44483123|NCT00347360|79489558|FG009|Overall Study|Visits conflicted with new job|0|||
44483124|NCT00347360|79489559|FG010|Overall Study|Visits conflicted with new job|0|||
44483125|NCT00347360|79489560|FG011|Overall Study|Visits conflicted with new job|0|||
44483126|NCT00347360|79489561|FG012|Overall Study|Visits conflicted with new job|0|||
44483127|NCT00347360|79489562|FG013|Overall Study|Visits conflicted with new job|0|||
44483128|NCT00347360|79489563|FG014|Overall Study|Visits conflicted with new job|0|||
44483129|NCT00319020|79489597|FG000|Overall Study|Death|2|||
44483130|NCT00319020|79489598|FG001|Overall Study|Death|2|||
44483131|NCT00319020|79489597|FG000|Overall Study|Withdrawal by Subject|4|||
44483132|NCT00319020|79489598|FG001|Overall Study|Withdrawal by Subject|1|||
44483133|NCT00319020|79489597|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
44483134|NCT00319020|79489598|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
44483135|NCT00319020|79489597|FG000|Overall Study|Administrative reason|0|||
44483136|NCT00319020|79489598|FG001|Overall Study|Administrative reason|5|||
44483137|NCT00319020|79489597|FG000|Overall Study|Disease progression|0|||
44483138|NCT00319020|79489598|FG001|Overall Study|Disease progression|2|||
44483139|NCT00319020|79489597|FG000|Overall Study|Transplant|0|||
44483140|NCT00319020|79489598|FG001|Overall Study|Transplant|1|||
44483141|NCT00319020|79489597|FG000|Overall Study|Treatment failure|0|||
44483142|NCT00319020|79489598|FG001|Overall Study|Treatment failure|1|||
44483143|NCT00319020|79489597|FG000|Overall Study|Adverse Event|0|||
44483144|NCT00319020|79489598|FG001|Overall Study|Adverse Event|1|||
44483145|NCT00352118|79489606|FG000|Overall Study|Physician Decision|4|||
44483146|NCT00318474|79489612|FG000|Overall Study|Adverse Event|1|||
44483147|NCT00318474|79489613|FG001|Overall Study|Adverse Event|1|||
44483148|NCT00318474|79489612|FG000|Overall Study|Lost to Follow-up|0|||
44483149|NCT00318474|79489613|FG001|Overall Study|Lost to Follow-up|1|||
44483150|NCT00318474|79489612|FG000|Overall Study|Pregnancy|0|||
44483151|NCT00318474|79489613|FG001|Overall Study|Pregnancy|2|||
44483152|NCT00318474|79489612|FG000|Overall Study|Protocol Violation|1|||
44483153|NCT00318474|79489613|FG001|Overall Study|Protocol Violation|0|||
44483154|NCT00318474|79489612|FG000|Overall Study|Withdrawal by Subject|3|||
44483155|NCT00318474|79489613|FG001|Overall Study|Withdrawal by Subject|2|||
44483156|NCT00318474|79489612|FG000|Overall Study|Fall in GFR|3|||
44483157|NCT00318474|79489613|FG001|Overall Study|Fall in GFR|3|||
44483158|NCT00318474|79489612|FG000|Overall Study|Post-therapy hyperflycemia|0|||
44483159|NCT00318474|79489613|FG001|Overall Study|Post-therapy hyperflycemia|1|||
44483160|NCT00318474|79489612|FG000|Overall Study|Trial terminated|10|||
44483161|NCT00318474|79489613|FG001|Overall Study|Trial terminated|7|||
44483162|NCT00350870|79489623|FG000|Overall Study|Withdrawal by Subject|21|||
44483163|NCT00350870|79489624|FG001|Overall Study|Withdrawal by Subject|17|||
44483164|NCT00350870|79489625|FG002|Overall Study|Withdrawal by Subject|15|||
44483165|NCT00350870|79489626|FG003|Overall Study|Withdrawal by Subject|14|||
44483166|NCT00350870|79489623|FG000|Overall Study|Physician Decision|1|||
44483167|NCT00350870|79489624|FG001|Overall Study|Physician Decision|0|||
44483168|NCT00350870|79489625|FG002|Overall Study|Physician Decision|1|||
44483169|NCT00350870|79489626|FG003|Overall Study|Physician Decision|1|||
44483170|NCT00350792|79489636|FG000|Overall Study|Adverse Event|11|||
44483171|NCT00350792|79489636|FG000|Overall Study|Death from Study Disease|1|||
44483172|NCT00350792|79489636|FG000|Overall Study|Death from Study Drug Toxicity|1|||
44483173|NCT00350792|79489636|FG000|Overall Study|Death Not Study Drug Related|2|||
44483174|NCT00350792|79489636|FG000|Overall Study|Protocol Violation|1|||
44483175|NCT00350792|79489636|FG000|Overall Study|Withdrawal by Subject|4|||
44483176|NCT00350792|79489636|FG000|Overall Study|Physician Decision|2|||
44483177|NCT00350792|79489636|FG000|Overall Study|Lack of Efficacy|11|||
44483178|NCT00317772|79489644|FG000|Overall Study|Adverse Event|0|||
44483179|NCT00317772|79489645|FG001|Overall Study|Adverse Event|0|||
44483180|NCT00317772|79489646|FG002|Overall Study|Adverse Event|0|||
44483181|NCT00317772|79489647|FG003|Overall Study|Adverse Event|2|||
44483182|NCT00317772|79489644|FG000|Overall Study|Disease Progression|2|||
44483183|NCT00317772|79489645|FG001|Overall Study|Disease Progression|2|||
44483184|NCT00317772|79489646|FG002|Overall Study|Disease Progression|1|||
44483185|NCT00317772|79489647|FG003|Overall Study|Disease Progression|7|||
44483186|NCT00350636|79489660|FG000|Overall Study|Adverse Event|19|||
44483187|NCT00350636|79489661|FG001|Overall Study|Adverse Event|13|||
44483188|NCT00350636|79489660|FG000|Overall Study|Protocol Violation|1|||
44483189|NCT00350636|79489661|FG001|Overall Study|Protocol Violation|3|||
44483190|NCT00350636|79489660|FG000|Overall Study|Withdrawal by Subject|13|||
44483191|NCT00350636|79489661|FG001|Overall Study|Withdrawal by Subject|17|||
44483192|NCT00350636|79489660|FG000|Overall Study|Lost to Follow-up|9|||
44483193|NCT00350636|79489661|FG001|Overall Study|Lost to Follow-up|8|||
44483194|NCT00350636|79489660|FG000|Overall Study|Physician Decision|0|||
44483195|NCT00350636|79489661|FG001|Overall Study|Physician Decision|2|||
44483196|NCT00350636|79489660|FG000|Overall Study|Other|1|||
44483197|NCT00350636|79489661|FG001|Overall Study|Other|2|||
44483198|NCT00346268|79489669|FG000|Overall Study|Adverse Event|1|||
44483199|NCT00346268|79489670|FG001|Overall Study|Adverse Event|0|||
44483200|NCT00346268|79489669|FG000|Overall Study|Protocol Violation|1|||
44483201|NCT00346268|79489670|FG001|Overall Study|Protocol Violation|0|||
44483202|NCT00346268|79489669|FG000|Overall Study|Participant refused|0|||
44483203|NCT00346268|79489670|FG001|Overall Study|Participant refused|3|||
44483204|NCT00327444|79489678|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
44483205|NCT00327444|79489679|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
44483206|NCT00327444|79489678|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
44483207|NCT00327444|79489679|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
44483208|NCT00327444|79489678|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
44483209|NCT00327444|79489679|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
44483210|NCT00327444|79489678|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
44483211|NCT00327444|79489679|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
44227541|NCT01737697|79034763|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227542|NCT01737697|79034764|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227543|NCT01737697|79034765|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
44227544|NCT01737697|79034751|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
44227545|NCT01737697|79034752|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
44227546|NCT01737697|79034753|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
44375647|NCT00953706|79380760|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
44483212|NCT00327444|79489678|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
44483213|NCT00327444|79489679|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
44483214|NCT00327444|79489678|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
44483215|NCT00327444|79489679|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
44483216|NCT00327444|79489678|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
44483217|NCT00327444|79489679|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
44483218|NCT00327444|79489678|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
44483219|NCT00327444|79489679|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
44483220|NCT00337610|79489689|FG000|Overall Study|Adverse Event|2|||
44483221|NCT00337610|79489690|FG001|Overall Study|Adverse Event|2|||
44483222|NCT00337610|79489689|FG000|Overall Study|Death|0|||
44483223|NCT00337610|79489690|FG001|Overall Study|Death|1|||
44483224|NCT00337610|79489689|FG000|Overall Study|Lack of Efficacy|6|||
44483225|NCT00337610|79489690|FG001|Overall Study|Lack of Efficacy|3|||
44483226|NCT00337610|79489689|FG000|Overall Study|Lost to Follow-up|3|||
44483227|NCT00337610|79489690|FG001|Overall Study|Lost to Follow-up|3|||
44483228|NCT00337610|79489689|FG000|Overall Study|Withdrawal by Subject|6|||
44483229|NCT00337610|79489690|FG001|Overall Study|Withdrawal by Subject|5|||
44483230|NCT00316914|79489698|FG000|Overall Study|Withdrawal by Subject|5|||
44483231|NCT00316914|79489699|FG001|Overall Study|Withdrawal by Subject|3|||
44483232|NCT00316914|79489698|FG000|Overall Study|Adverse Event|8|||
44483233|NCT00316914|79489699|FG001|Overall Study|Adverse Event|7|||
44483234|NCT00316914|79489698|FG000|Overall Study|Other Problems|6|||
44483235|NCT00316914|79489699|FG001|Overall Study|Other Problems|11|||
44483236|NCT00316914|79489698|FG000|Overall Study|Missing end of treatment documentation|14|||
44375648|NCT00953706|79380761|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
44227547|NCT01737697|79034754|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227548|NCT01737697|79034755|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227549|NCT01737697|79034756|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44375649|NCT00940992|79380774|FG000|Overall Study|Adverse Event|2|||
44483237|NCT00316914|79489699|FG001|Overall Study|Missing end of treatment documentation|15|||
44483238|NCT00336284|79489707|FG000|Overall Study|Death|52|||
44483239|NCT00336284|79489708|FG001|Overall Study|Death|26|||
44483240|NCT00336284|79489707|FG000|Overall Study|Lost to Follow-up|82|||
44483241|NCT00336284|79489708|FG001|Overall Study|Lost to Follow-up|61|||
44483242|NCT00336284|79489707|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
44483243|NCT00336284|79489708|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
44483244|NCT00316602|79489716|FG000|Overall Study|Withdrawal by Subject|3|||
44483245|NCT00316602|79489717|FG001|Overall Study|Withdrawal by Subject|2|||
44483246|NCT00316602|79489716|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
44483247|NCT00316602|79489717|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
44483248|NCT00316602|79489716|FG000|Overall Study|Adverse Event|1|||
44483249|NCT00316602|79489717|FG001|Overall Study|Adverse Event|0|||
44483250|NCT00316602|79489716|FG000|Overall Study|Other|3|||
44483251|NCT00316602|79489717|FG001|Overall Study|Other|6|||
44483252|NCT00335972|79489725|FG000|Overall Study|not given treatments|0|||
44483253|NCT00335972|79489726|FG001|Overall Study|not given treatments|3|||
44483254|NCT00346034|79489732|FG000|Overall Study|Adverse Event|34|||
44483255|NCT00346034|79489732|FG000|Overall Study|Lack of Efficacy|8|||
44483256|NCT00346034|79489732|FG000|Overall Study|Withdrawal by Subject|13|||
44483257|NCT00346034|79489732|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
44483258|NCT00346034|79489732|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
44483259|NCT00345878|79489738|FG000|Overall Study|Adverse Event|1|||
44483260|NCT00345878|79489739|FG001|Overall Study|Adverse Event|0|||
44483261|NCT00345878|79489738|FG000|Overall Study|Lost to Follow-up|2|||
44483262|NCT00345878|79489739|FG001|Overall Study|Lost to Follow-up|1|||
44483263|NCT00345878|79489738|FG000|Overall Study|Other|1|||
44483264|NCT00345878|79489739|FG001|Overall Study|Other|0|||
44483265|NCT00335738|79489747|FG000|Overall Study|Physician Decision|6|||
44483266|NCT00335738|79489748|FG001|Overall Study|Physician Decision|0|||
44483267|NCT00335738|79489747|FG000|Overall Study|Withdrawal by Subject|2|||
44483268|NCT00335738|79489748|FG001|Overall Study|Withdrawal by Subject|0|||
44483269|NCT00335738|79489747|FG000|Overall Study|Ineligible|3|||
44483270|NCT00335738|79489748|FG001|Overall Study|Ineligible|4|||
44483271|NCT00334958|79489766|FG000|Overall Study|Medication Noncompliance|0|||
44483272|NCT00334958|79489767|FG001|Overall Study|Medication Noncompliance|3|||
44483273|NCT00334958|79489766|FG000|Overall Study|Protocol Violation|2|||
44483274|NCT00334958|79489767|FG001|Overall Study|Protocol Violation|2|||
44483275|NCT00334958|79489766|FG000|Overall Study|Request of the investigator or sponsor|0|||
44483276|NCT00334958|79489767|FG001|Overall Study|Request of the investigator or sponsor|1|||
44483277|NCT00334958|79489766|FG000|Overall Study|Withdrawal by Subject|7|||
44483278|NCT00334958|79489767|FG001|Overall Study|Withdrawal by Subject|4|||
44483279|NCT00334958|79489766|FG000|Overall Study|Adverse Event|27|||
44483280|NCT00334958|79489767|FG001|Overall Study|Adverse Event|12|||
44483281|NCT00334958|79489766|FG000|Overall Study|Other|1|||
44483282|NCT00334958|79489767|FG001|Overall Study|Other|2|||
44483283|NCT00326898|79489776|FG000|Overall Study|Disease progression|52|||
44483284|NCT00326898|79489777|FG001|Overall Study|Disease progression|54|||
44483285|NCT00326898|79489778|FG002|Overall Study|Disease progression|102|||
44483286|NCT00326898|79489776|FG000|Overall Study|Adverse Event|124|||
44483287|NCT00326898|79489777|FG001|Overall Study|Adverse Event|128|||
44483288|NCT00326898|79489778|FG002|Overall Study|Adverse Event|33|||
44483289|NCT00326898|79489776|FG000|Overall Study|Death|2|||
44483290|NCT00326898|79489777|FG001|Overall Study|Death|0|||
44483291|NCT00326898|79489778|FG002|Overall Study|Death|0|||
44483292|NCT00326898|79489776|FG000|Overall Study|Withdrawal by Subject|134|||
44483293|NCT00326898|79489777|FG001|Overall Study|Withdrawal by Subject|128|||
44483294|NCT00326898|79489778|FG002|Overall Study|Withdrawal by Subject|32|||
44483295|NCT00326898|79489776|FG000|Overall Study|Alternative therapy|1|||
44483296|NCT00326898|79489777|FG001|Overall Study|Alternative therapy|0|||
44483297|NCT00326898|79489778|FG002|Overall Study|Alternative therapy|0|||
44483298|NCT00326898|79489776|FG000|Overall Study|Other complicating disease|5|||
44483299|NCT00326898|79489777|FG001|Overall Study|Other complicating disease|5|||
44483300|NCT00326898|79489778|FG002|Overall Study|Other complicating disease|4|||
44483301|NCT00326898|79489776|FG000|Overall Study|Other/Missing/Unknown|33|||
44483302|NCT00326898|79489777|FG001|Overall Study|Other/Missing/Unknown|28|||
44483303|NCT00326898|79489778|FG002|Overall Study|Other/Missing/Unknown|32|||
44483304|NCT00326118|79489788|FG000|Active Phase|Withdrawal by Subject|4|||
44483305|NCT00326118|79489789|FG001|Active Phase|Withdrawal by Subject|1|||
44483306|NCT00334802|79489798|FG000|Overall Study|Progressive Disease|2|||
44483307|NCT00334802|79489799|FG001|Overall Study|Progressive Disease|24|||
44483308|NCT00334802|79489798|FG000|Overall Study|Toxicity|1|||
44483309|NCT00334802|79489799|FG001|Overall Study|Toxicity|5|||
44483310|NCT00334802|79489798|FG000|Overall Study|Lack of Efficacy|1|||
44483311|NCT00334802|79489799|FG001|Overall Study|Lack of Efficacy|3|||
44483312|NCT00334802|79489798|FG000|Overall Study|Patient Condition Aggrevated|1|||
44483313|NCT00334802|79489799|FG001|Overall Study|Patient Condition Aggrevated|0|||
44483314|NCT00334802|79489798|FG000|Overall Study|Physician Decision|1|||
44483315|NCT00334802|79489799|FG001|Overall Study|Physician Decision|0|||
44483316|NCT00334802|79489798|FG000|Overall Study|Withdrawal by Subject|0|||
44483317|NCT00334802|79489799|FG001|Overall Study|Withdrawal by Subject|4|||
44483318|NCT00334802|79489798|FG000|Overall Study|Adverse Event|0|||
44483319|NCT00334802|79489799|FG001|Overall Study|Adverse Event|3|||
44483320|NCT00334802|79489798|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
44483321|NCT00334802|79489799|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
44483322|NCT00307164|79489810|FG000|Overall Study|Death|1|||
44483323|NCT00307164|79489811|FG001|Overall Study|Death|0|||
44483324|NCT00307164|79489810|FG000|Overall Study|Severe debilitation, unable to continue|1|||
44483325|NCT00307164|79489811|FG001|Overall Study|Severe debilitation, unable to continue|0|||
44483326|NCT00307164|79489810|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
44483327|NCT00307164|79489811|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
44483328|NCT00307164|79489810|FG000|Overall Study|Withdrawal by Subject|1|||
44483329|NCT00307164|79489811|FG001|Overall Study|Withdrawal by Subject|8|||
44483330|NCT00307164|79489810|FG000|Overall Study|Not compliant with requirements|4|||
44483331|NCT00307164|79489811|FG001|Overall Study|Not compliant with requirements|4|||
44483332|NCT00307164|79489810|FG000|Overall Study|Lost to Follow-up|6|||
44483333|NCT00307164|79489811|FG001|Overall Study|Lost to Follow-up|1|||
44483334|NCT03827564|79489819|FG000|Overall Study|Discontinued due to Study Termination|1|||
44483335|NCT03827564|79489820|FG001|Overall Study|Discontinued due to Study Termination|0|||
44483336|NCT00307086|79489826|FG000|Overall Study|ineligible|5|||
44483337|NCT00325416|79489832|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
44483338|NCT00325416|79489833|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
44483339|NCT00325416|79489832|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
44483340|NCT00325416|79489833|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
44483341|NCT00325416|79489832|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
44483342|NCT00325416|79489833|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
44483343|NCT00325416|79489832|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
44483344|NCT00325416|79489833|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
44483345|NCT00325416|79489832|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
44483346|NCT00325416|79489833|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
44483347|NCT00325416|79489832|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
44483348|NCT00325416|79489833|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
44483349|NCT00314808|79489839|FG000|Overall Study|Disease Progression without AE|4|||
44483350|NCT00314808|79489839|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
44483351|NCT05845567|79489843|FG000|Overall Study|Withdrawal by Subject|1|||
44483352|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
44483353|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
44483354|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
44483355|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Death|1|||
44483356|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Death|0|||
44483357|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Death|0|||
44483358|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
44227550|NCT01737697|79034757|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227551|NCT01737697|79034758|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227552|NCT01737697|79034759|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227553|NCT01737697|79034760|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227554|NCT01737697|79034761|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227555|NCT01737697|79034762|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227556|NCT01737697|79034763|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227557|NCT01737697|79034764|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227558|NCT01737697|79034765|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
44227559|NCT01737697|79034751|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227560|NCT01737697|79034752|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227561|NCT01737697|79034753|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227562|NCT01737697|79034754|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
44227563|NCT01737697|79034755|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227564|NCT01737697|79034756|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227565|NCT01737697|79034757|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227566|NCT01737697|79034758|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227567|NCT01737697|79034759|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227568|NCT01737697|79034760|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227569|NCT01737697|79034761|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227570|NCT01737697|79034762|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227571|NCT01737697|79034763|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227572|NCT01737697|79034764|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
44483359|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
44483360|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
44483361|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
44483362|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
44483363|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
44483364|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
44483365|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
44483366|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
44483367|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
44483368|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
44483369|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
44483370|NCT05073315|79489864|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
44483371|NCT05073315|79489865|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
44483372|NCT05073315|79489866|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
44483373|NCT05073315|79489864|FG000|Period 2|Adverse Event|0|||
44483374|NCT05073315|79489865|FG001|Period 2|Adverse Event|3|||
44483375|NCT05073315|79489866|FG002|Period 2|Adverse Event|6|||
44483376|NCT05073315|79489864|FG000|Period 2|Lost to Follow-up|0|||
44483377|NCT05073315|79489865|FG001|Period 2|Lost to Follow-up|5|||
44483378|NCT05073315|79489866|FG002|Period 2|Lost to Follow-up|5|||
44483379|NCT05073315|79489864|FG000|Period 2|Withdrawal by Subject|0|||
44483380|NCT05073315|79489865|FG001|Period 2|Withdrawal by Subject|4|||
44483381|NCT05073315|79489866|FG002|Period 2|Withdrawal by Subject|9|||
44483382|NCT05073315|79489864|FG000|Period 2|Protocol Violation|0|||
44483383|NCT05073315|79489865|FG001|Period 2|Protocol Violation|0|||
44483384|NCT05073315|79489866|FG002|Period 2|Protocol Violation|1|||
44483385|NCT04752566|79489883|FG000|Overall Study|Protocol Violation|0|||
44483386|NCT04752566|79489884|FG001|Overall Study|Protocol Violation|1|||
44483387|NCT04752566|79489883|FG000|Overall Study|Death|1|||
44483388|NCT04752566|79489884|FG001|Overall Study|Death|0|||
44483389|NCT04752566|79489883|FG000|Overall Study|Adverse Event|1|||
44483390|NCT04752566|79489884|FG001|Overall Study|Adverse Event|0|||
44483391|NCT04752566|79489883|FG000|Overall Study|Withdrawal by Subject|2|||
44483392|NCT04752566|79489884|FG001|Overall Study|Withdrawal by Subject|0|||
44483393|NCT04752566|79489883|FG000|Overall Study|Physician Decision|1|||
44483394|NCT04752566|79489884|FG001|Overall Study|Physician Decision|1|||
44483395|NCT04741074|79489892|FG000|Overall Study|Withdrawal by Subject|1|||
44483396|NCT04741074|79489893|FG001|Overall Study|Withdrawal by Subject|1|||
44483397|NCT04741074|79489892|FG000|Overall Study|Study terminated prematurely|1|||
44483398|NCT04741074|79489893|FG001|Overall Study|Study terminated prematurely|0|||
44483399|NCT04127786|79489905|FG000|Primary Series|Adverse Event|1|||
44483400|NCT04127786|79489906|FG001|Primary Series|Adverse Event|0|||
44483401|NCT04127786|79489907|FG002|Primary Series|Adverse Event|0|||
44483402|NCT04127786|79489908|FG003|Primary Series|Adverse Event|1|||
44483403|NCT04127786|79489909|FG004|Primary Series|Adverse Event|0|||
44483404|NCT04127786|79489910|FG005|Primary Series|Adverse Event|1|||
44483405|NCT04127786|79489905|FG000|Primary Series|Protocol Violation|5|||
44483406|NCT04127786|79489906|FG001|Primary Series|Protocol Violation|3|||
44483407|NCT04127786|79489907|FG002|Primary Series|Protocol Violation|4|||
44483408|NCT04127786|79489908|FG003|Primary Series|Protocol Violation|3|||
44483409|NCT04127786|79489909|FG004|Primary Series|Protocol Violation|2|||
44483410|NCT04127786|79489910|FG005|Primary Series|Protocol Violation|0|||
44483411|NCT04127786|79489905|FG000|Primary Series|Withdrawal by Subject|0|||
44483412|NCT04127786|79489906|FG001|Primary Series|Withdrawal by Subject|0|||
44483413|NCT04127786|79489907|FG002|Primary Series|Withdrawal by Subject|0|||
44274205|NCT03042468|79217635|FG001|Overall Study|Lost to Follow-up|0|||
44274206|NCT03042468|79217636|FG002|Overall Study|Lost to Follow-up|0|||
44483414|NCT04127786|79489908|FG003|Primary Series|Withdrawal by Subject|1|||
44483415|NCT04127786|79489909|FG004|Primary Series|Withdrawal by Subject|0|||
44483416|NCT04127786|79489910|FG005|Primary Series|Withdrawal by Subject|0|||
44483417|NCT04127786|79489905|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
44483418|NCT04127786|79489906|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
44483419|NCT04127786|79489907|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
44483420|NCT04127786|79489908|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
44483421|NCT04127786|79489909|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
44483422|NCT04127786|79489910|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
44483423|NCT04127786|79489905|FG000|Booster Phase|Withdrawal by Subject|2|||
44483424|NCT04127786|79489906|FG001|Booster Phase|Withdrawal by Subject|0|||
44274207|NCT03042468|79217637|FG003|Overall Study|Lost to Follow-up|0|||
44483425|NCT04127786|79489907|FG002|Booster Phase|Withdrawal by Subject|0|||
44483426|NCT04127786|79489908|FG003|Booster Phase|Withdrawal by Subject|0|||
44483427|NCT04127786|79489909|FG004|Booster Phase|Withdrawal by Subject|0|||
44483428|NCT04127786|79489910|FG005|Booster Phase|Withdrawal by Subject|0|||
44483429|NCT03553836|79489953|FG000|Overall Study|Ongoing in Study|460|||
44483430|NCT03553836|79489954|FG001|Overall Study|Ongoing in Study|459|||
44227573|NCT01737697|79034765|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
44227574|NCT01737697|79034751|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227575|NCT01737697|79034752|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
44227576|NCT01737697|79034753|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227577|NCT01737697|79034754|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44483431|NCT03553836|79489953|FG000|Overall Study|Withdrawal by Subject|9|||
44483432|NCT03553836|79489954|FG001|Overall Study|Withdrawal by Subject|10|||
44483433|NCT03553836|79489953|FG000|Overall Study|Lost to Follow-up|1|||
44483434|NCT03553836|79489954|FG001|Overall Study|Lost to Follow-up|3|||
44483435|NCT03553836|79489953|FG000|Overall Study|Death|17|||
44483436|NCT03553836|79489954|FG001|Overall Study|Death|17|||
44483437|NCT03488719|79489968|FG000|Overall Study|Adverse Event|0|||
44483438|NCT03488719|79489969|FG001|Overall Study|Adverse Event|4|||
44483439|NCT03488719|79489970|FG002|Overall Study|Adverse Event|2|||
44483440|NCT03488719|79489968|FG000|Overall Study|Other|0|||
44483441|NCT03488719|79489969|FG001|Overall Study|Other|0|||
44483442|NCT03488719|79489970|FG002|Overall Study|Other|5|||
44483443|NCT03488225|79489978|FG000|Overall Study|Off Protocol Therapy|2|||
44483444|NCT03488225|79489978|FG000|Overall Study|Stem Cell Transplant|2|||
44483445|NCT03198559|79489982|FG000|Overall Study|Adverse Event|2|||
44483446|NCT03188042|79489989|FG000|Overall Study|Withdrawal by Subject|1|||
44483447|NCT03188042|79489990|FG001|Overall Study|Withdrawal by Subject|1|||
44483448|NCT03113136|79489999|FG000|Overall Study|Lost to Follow-up|22|||
44483449|NCT03113136|79490000|FG001|Overall Study|Lost to Follow-up|47|||
44483450|NCT03113136|79490001|FG002|Overall Study|Lost to Follow-up|54|||
44483451|NCT03113136|79489999|FG000|Overall Study|Withdrawal by Subject|4|||
44483452|NCT03113136|79490000|FG001|Overall Study|Withdrawal by Subject|13|||
44483453|NCT03113136|79490001|FG002|Overall Study|Withdrawal by Subject|14|||
44483454|NCT03113136|79489999|FG000|Overall Study|Ineligible|0|||
44483455|NCT03113136|79490000|FG001|Overall Study|Ineligible|2|||
44483456|NCT03113136|79490001|FG002|Overall Study|Ineligible|1|||
44483457|NCT03113136|79489999|FG000|Overall Study|Study Team Decision|1|||
44483458|NCT03113136|79490000|FG001|Overall Study|Study Team Decision|4|||
44483459|NCT03113136|79490001|FG002|Overall Study|Study Team Decision|0|||
44483460|NCT02968004|79490013|FG000|Overall Study|Adverse Event|1|||
44483461|NCT02968004|79490014|FG001|Overall Study|Adverse Event|0|||
44483462|NCT02968004|79490013|FG000|Overall Study|Withdrawal by Subject|0|||
44483463|NCT02968004|79490014|FG001|Overall Study|Withdrawal by Subject|1|||
44483464|NCT02797184|79490020|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
44483465|NCT02797184|79490021|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
44483466|NCT02577406|79490029|FG000|Randomized Period|Death|1|||
44483467|NCT02577406|79490030|FG001|Randomized Period|Death|0|||
44483468|NCT02577406|79490029|FG000|Randomized Period|Other reasons|0|||
44483469|NCT02577406|79490030|FG001|Randomized Period|Other reasons|20|||
44483470|NCT02577406|79490029|FG000|Treatment Period|Transition to commercially available treatment|1|||
44483471|NCT02577406|79490030|FG001|Treatment Period|Transition to commercially available treatment|0|||
44483472|NCT02577406|79490029|FG000|Treatment Period|Progressive disease|47|||
44227578|NCT01737697|79034755|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227579|NCT01737697|79034756|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227580|NCT01737697|79034757|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227581|NCT01737697|79034758|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227582|NCT01737697|79034759|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227583|NCT01737697|79034760|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227584|NCT01737697|79034761|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227585|NCT01737697|79034762|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44483473|NCT02577406|79490030|FG001|Treatment Period|Progressive disease|36|||
44483474|NCT02577406|79490029|FG000|Treatment Period|Death|36|||
44483475|NCT02577406|79490030|FG001|Treatment Period|Death|23|||
44483476|NCT02577406|79490029|FG000|Treatment Period|Other reasons|3|||
44483477|NCT02577406|79490030|FG001|Treatment Period|Other reasons|37|||
44483478|NCT02577406|79490029|FG000|Treatment Period|Withdrawal by Subject|10|||
44483479|NCT02577406|79490030|FG001|Treatment Period|Withdrawal by Subject|24|||
44483480|NCT02577406|79490029|FG000|Treatment Period|Adverse Event|17|||
44227586|NCT01737697|79034763|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44483481|NCT02577406|79490030|FG001|Treatment Period|Adverse Event|12|||
44483482|NCT02577406|79490029|FG000|Treatment Period|Disease relapse|27|||
44483483|NCT02577406|79490030|FG001|Treatment Period|Disease relapse|1|||
44483484|NCT02577406|79490029|FG000|Treatment Period|HSCT|6|||
44483485|NCT02577406|79490030|FG001|Treatment Period|HSCT|2|||
44483486|NCT02577406|79490029|FG000|Treatment Period|Lost to Follow-up|0|||
44483487|NCT02577406|79490030|FG001|Treatment Period|Lost to Follow-up|1|||
44227587|NCT01737697|79034764|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227588|NCT01737697|79034765|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
44227589|NCT01737697|79034751|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227590|NCT01737697|79034752|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227591|NCT01737697|79034753|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227592|NCT01737697|79034754|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227593|NCT01737697|79034755|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
44227594|NCT01737697|79034756|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227595|NCT01737697|79034757|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227596|NCT01737697|79034758|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227597|NCT01737697|79034759|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227598|NCT01737697|79034760|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227599|NCT01737697|79034761|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227600|NCT01737697|79034762|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227601|NCT01737697|79034763|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227602|NCT01737697|79034764|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44227603|NCT01737697|79034765|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
44483488|NCT02577406|79490029|FG000|Treatment Period|Protocol Violation|0|||
44483489|NCT02577406|79490030|FG001|Treatment Period|Protocol Violation|1|||
44483490|NCT02438722|79490042|FG000|Overall Study|Adverse Event|12|||
44483491|NCT02438722|79490043|FG001|Overall Study|Adverse Event|9|||
44483492|NCT02438722|79490042|FG000|Overall Study|Refusal unrelated to AE|2|||
44483493|NCT02438722|79490043|FG001|Overall Study|Refusal unrelated to AE|5|||
44483494|NCT02438722|79490042|FG000|Overall Study|Disease progression/relapse|46|||
44483495|NCT02438722|79490043|FG001|Overall Study|Disease progression/relapse|51|||
44483496|NCT02438722|79490042|FG000|Overall Study|Death|0|||
44483497|NCT02438722|79490043|FG001|Overall Study|Death|3|||
44483498|NCT02438722|79490042|FG000|Overall Study|Physician Decision|2|||
44483499|NCT02438722|79490043|FG001|Overall Study|Physician Decision|2|||
44483500|NCT02438722|79490042|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
44483501|NCT02438722|79490043|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
44483502|NCT02438722|79490042|FG000|Overall Study|Withdrawal by Subject|0|||
44483503|NCT02438722|79490043|FG001|Overall Study|Withdrawal by Subject|1|||
44483504|NCT02438722|79490042|FG000|Overall Study|On protocol treatment|15|||
44483505|NCT02438722|79490043|FG001|Overall Study|On protocol treatment|14|||
44483506|NCT02438722|79490042|FG000|Overall Study|Did not receive protocol treatment|5|||
44483507|NCT02438722|79490043|FG001|Overall Study|Did not receive protocol treatment|0|||
44483508|NCT02422498|79490049|FG000|Overall Study|Inevaluable|4|||
44483509|NCT02347891|79490055|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
44483510|NCT02347891|79490056|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
44483511|NCT02347891|79490055|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
44483512|NCT02347891|79490056|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
44483513|NCT02023164|79490074|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
44483514|NCT02023164|79490075|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
44483515|NCT01959139|79490094|FG000|Phase II|Disease progression|0|||
44483516|NCT01959139|79490095|FG001|Phase II|Disease progression|0|||
44483517|NCT01959139|79490096|FG002|Phase II|Disease progression|26|||
44483518|NCT01959139|79490097|FG003|Phase II|Disease progression|34|||
44483519|NCT01959139|79490094|FG000|Phase II|Adverse Event|0|||
44483520|NCT01959139|79490095|FG001|Phase II|Adverse Event|0|||
44483521|NCT01959139|79490096|FG002|Phase II|Adverse Event|10|||
44483522|NCT01959139|79490097|FG003|Phase II|Adverse Event|11|||
44483523|NCT01959139|79490094|FG000|Phase II|Patient Refusal|0|||
44483524|NCT01959139|79490095|FG001|Phase II|Patient Refusal|0|||
44483525|NCT01959139|79490096|FG002|Phase II|Patient Refusal|5|||
44483526|NCT01959139|79490097|FG003|Phase II|Patient Refusal|4|||
44483527|NCT01959139|79490094|FG000|Phase II|Death|0|||
44483528|NCT01959139|79490095|FG001|Phase II|Death|0|||
44483529|NCT01959139|79490096|FG002|Phase II|Death|3|||
44483530|NCT01959139|79490097|FG003|Phase II|Death|1|||
44483531|NCT01959139|79490094|FG000|Phase II|Other/Unknown|0|||
44483532|NCT01959139|79490095|FG001|Phase II|Other/Unknown|0|||
44483533|NCT01959139|79490096|FG002|Phase II|Other/Unknown|8|||
44483534|NCT01959139|79490097|FG003|Phase II|Other/Unknown|5|||
44483535|NCT01959139|79490094|FG000|Phase II|On treatment|0|||
44227604|NCT01737697|79034751|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227605|NCT01737697|79034752|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
44483536|NCT01959139|79490095|FG001|Phase II|On treatment|0|||
44483537|NCT01959139|79490096|FG002|Phase II|On treatment|4|||
44483538|NCT01959139|79490097|FG003|Phase II|On treatment|0|||
44483539|NCT01602380|79490114|FG000|Overall Study|Death|147|||
44274208|NCT03042468|79217638|FG004|Overall Study|Lost to Follow-up|1|||
44483540|NCT01602380|79490115|FG001|Overall Study|Death|145|||
44483541|NCT01602380|79490114|FG000|Overall Study|Withdrawal by Subject|39|||
44483542|NCT01602380|79490115|FG001|Overall Study|Withdrawal by Subject|41|||
44483543|NCT01602380|79490114|FG000|Overall Study|Lost to Follow-up|15|||
44483544|NCT01602380|79490115|FG001|Overall Study|Lost to Follow-up|12|||
44483545|NCT01602380|79490114|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44483546|NCT01602380|79490115|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
44483547|NCT01602380|79490114|FG000|Overall Study|Other|2|||
44483548|NCT01602380|79490115|FG001|Overall Study|Other|0|||
44483549|NCT01132326|79490143|FG000|Overall Study|Lack of Efficacy|25|||
44483550|NCT01132326|79490143|FG000|Overall Study|Adverse Event|37|||
44483551|NCT01132326|79490143|FG000|Overall Study|Protocol Violation|1|||
44483552|NCT01132326|79490143|FG000|Overall Study|Lost to Follow-up|16|||
44483553|NCT01132326|79490143|FG000|Overall Study|Withdrawal by Subject|40|||
44483554|NCT01132326|79490143|FG000|Overall Study|Physician Decision|10|||
44483555|NCT01132326|79490143|FG000|Overall Study|Study Termination|80|||
44483556|NCT01132326|79490143|FG000|Overall Study|Declining Health|1|||
44483557|NCT01132326|79490143|FG000|Overall Study|Pregnancy|1|||
44483558|NCT01132326|79490143|FG000|Overall Study|Caregiver Withdrew Consent|1|||
44483559|NCT01132326|79490143|FG000|Overall Study|Death|5|||
44483560|NCT01132326|79490143|FG000|Overall Study|Subject Unable to Come To Visits|1|||
44483561|NCT00150709|79490151|FG000|Overall Study|Protocol Violation|7|||
44483562|NCT00150709|79490152|FG001|Overall Study|Protocol Violation|8|||
44483563|NCT00150709|79490153|FG002|Overall Study|Protocol Violation|3|||
44483564|NCT00150709|79490154|FG003|Overall Study|Protocol Violation|1|||
44483565|NCT00150709|79490151|FG000|Overall Study|Adverse Event|8|||
44483566|NCT00150709|79490152|FG001|Overall Study|Adverse Event|2|||
44483567|NCT00150709|79490153|FG002|Overall Study|Adverse Event|2|||
44483568|NCT00150709|79490154|FG003|Overall Study|Adverse Event|3|||
44483569|NCT00150709|79490151|FG000|Overall Study|Lack of Efficacy|6|||
44483570|NCT00150709|79490152|FG001|Overall Study|Lack of Efficacy|11|||
44483571|NCT00150709|79490153|FG002|Overall Study|Lack of Efficacy|9|||
44483572|NCT00150709|79490154|FG003|Overall Study|Lack of Efficacy|0|||
44483573|NCT00150709|79490151|FG000|Overall Study|Withdrawal by Subject|7|||
44483574|NCT00150709|79490152|FG001|Overall Study|Withdrawal by Subject|10|||
44483575|NCT00150709|79490153|FG002|Overall Study|Withdrawal by Subject|5|||
44483576|NCT00150709|79490154|FG003|Overall Study|Withdrawal by Subject|0|||
44483577|NCT00150709|79490151|FG000|Overall Study|Lost to Follow-up|3|||
44483578|NCT00150709|79490152|FG001|Overall Study|Lost to Follow-up|2|||
44483579|NCT00150709|79490153|FG002|Overall Study|Lost to Follow-up|0|||
44483580|NCT00150709|79490154|FG003|Overall Study|Lost to Follow-up|0|||
44483581|NCT00150709|79490151|FG000|Overall Study|Sponsor decision|0|||
44483582|NCT00150709|79490152|FG001|Overall Study|Sponsor decision|0|||
44483583|NCT00150709|79490153|FG002|Overall Study|Sponsor decision|0|||
44483584|NCT00150709|79490154|FG003|Overall Study|Sponsor decision|1|||
44483585|NCT00150709|79490151|FG000|Overall Study|Site/Investigator discontinued the study|5|||
44483586|NCT00150709|79490152|FG001|Overall Study|Site/Investigator discontinued the study|5|||
44483587|NCT00150709|79490153|FG002|Overall Study|Site/Investigator discontinued the study|2|||
44483588|NCT00150709|79490154|FG003|Overall Study|Site/Investigator discontinued the study|0|||
44483589|NCT00150709|79490151|FG000|Overall Study|Decision of parent(s)|1|||
44483590|NCT00150709|79490152|FG001|Overall Study|Decision of parent(s)|2|||
44483591|NCT00150709|79490153|FG002|Overall Study|Decision of parent(s)|0|||
44483592|NCT00150709|79490154|FG003|Overall Study|Decision of parent(s)|0|||
44483593|NCT00150709|79490151|FG000|Overall Study|Decision of parent(s) and investigator|3|||
44483594|NCT00150709|79490152|FG001|Overall Study|Decision of parent(s) and investigator|0|||
44483595|NCT00150709|79490153|FG002|Overall Study|Decision of parent(s) and investigator|0|||
44483596|NCT00150709|79490154|FG003|Overall Study|Decision of parent(s) and investigator|0|||
44483597|NCT00150709|79490151|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
44483598|NCT00150709|79490152|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
44483599|NCT00150709|79490153|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
44483600|NCT00150709|79490154|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
44483601|NCT00150709|79490151|FG000|Overall Study|Investigator decision|1|||
44483602|NCT00150709|79490152|FG001|Overall Study|Investigator decision|0|||
44274209|NCT03042468|79217639|FG005|Overall Study|Lost to Follow-up|1|||
44274210|NCT01634178|79217657|FG000|Treatment Period 1|Adverse Event|0|||
44274211|NCT01634178|79217658|FG001|Treatment Period 1|Adverse Event|1|||
44483603|NCT00150709|79490153|FG002|Overall Study|Investigator decision|0|||
44483604|NCT00150709|79490154|FG003|Overall Study|Investigator decision|1|||
44483605|NCT00150709|79490151|FG000|Overall Study|Subject relocated|2|||
44483606|NCT00150709|79490152|FG001|Overall Study|Subject relocated|2|||
44483607|NCT00150709|79490153|FG002|Overall Study|Subject relocated|1|||
44274212|NCT01634178|79217657|FG000|Treatment Period 2|Adverse Event|1|||
44274213|NCT01634178|79217658|FG001|Treatment Period 2|Adverse Event|0|||
44483608|NCT00150709|79490154|FG003|Overall Study|Subject relocated|0|||
44483609|NCT00150709|79490151|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
44483610|NCT00150709|79490152|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
44483611|NCT00150709|79490153|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
44483612|NCT00150709|79490154|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
44483613|NCT00150709|79490151|FG000|Overall Study|Convenience|0|||
44483614|NCT00150709|79490152|FG001|Overall Study|Convenience|1|||
44483615|NCT00150709|79490153|FG002|Overall Study|Convenience|0|||
44483616|NCT00150709|79490154|FG003|Overall Study|Convenience|0|||
44483617|NCT00150709|79490151|FG000|Overall Study|Subject entered new drug study|0|||
44483618|NCT00150709|79490152|FG001|Overall Study|Subject entered new drug study|1|||
44483619|NCT00150709|79490153|FG002|Overall Study|Subject entered new drug study|0|||
44483620|NCT00150709|79490154|FG003|Overall Study|Subject entered new drug study|0|||
44483621|NCT00150709|79490151|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
44483622|NCT00150709|79490152|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
44483623|NCT00150709|79490153|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
44483624|NCT00150709|79490154|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
44483625|NCT00150709|79490151|FG000|Overall Study|Lack of ease of swallowing|0|||
44483626|NCT00150709|79490152|FG001|Overall Study|Lack of ease of swallowing|1|||
44483627|NCT00150709|79490153|FG002|Overall Study|Lack of ease of swallowing|0|||
44483628|NCT00150709|79490154|FG003|Overall Study|Lack of ease of swallowing|0|||
44483629|NCT00314574|79490166|FG000|Overall Study|Death|3|||
44483630|NCT00314574|79490167|FG001|Overall Study|Death|0|||
44483631|NCT00314574|79490166|FG000|Overall Study|Adverse Event|11|||
44483632|NCT00314574|79490167|FG001|Overall Study|Adverse Event|16|||
44227606|NCT01737697|79034753|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
44227607|NCT01737697|79034754|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
44227608|NCT01737697|79034755|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
44227609|NCT01737697|79034756|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227610|NCT01737697|79034757|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227611|NCT01737697|79034758|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227612|NCT01737697|79034759|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227613|NCT01737697|79034760|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227614|NCT01737697|79034761|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227615|NCT01737697|79034762|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227616|NCT01737697|79034763|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227617|NCT01737697|79034764|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227618|NCT01737697|79034765|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
44227619|NCT01737697|79034751|FG000|Subacute Phase|Adverse Event|0|||
44227620|NCT01737697|79034752|FG001|Subacute Phase|Adverse Event|0|||
44227621|NCT01737697|79034753|FG002|Subacute Phase|Adverse Event|0|||
44227622|NCT01737697|79034754|FG003|Subacute Phase|Adverse Event|0|||
44227623|NCT01737697|79034755|FG004|Subacute Phase|Adverse Event|0|||
44227624|NCT01737697|79034756|FG005|Subacute Phase|Adverse Event|1|||
44227625|NCT01737697|79034757|FG006|Subacute Phase|Adverse Event|1|||
44227626|NCT01737697|79034758|FG007|Subacute Phase|Adverse Event|1|||
44227627|NCT01737697|79034759|FG008|Subacute Phase|Adverse Event|1|||
44227628|NCT01737697|79034760|FG009|Subacute Phase|Adverse Event|1|||
44227629|NCT01737697|79034761|FG010|Subacute Phase|Adverse Event|4|||
44227630|NCT01737697|79034762|FG011|Subacute Phase|Adverse Event|1|||
44227631|NCT01737697|79034763|FG012|Subacute Phase|Adverse Event|1|||
44227632|NCT01737697|79034764|FG013|Subacute Phase|Adverse Event|0|||
44227633|NCT01737697|79034765|FG014|Subacute Phase|Adverse Event|0|||
44227634|NCT01737697|79034751|FG000|Subacute Phase|Withdrawal by Subject|0|||
44227635|NCT01737697|79034752|FG001|Subacute Phase|Withdrawal by Subject|0|||
44227636|NCT01737697|79034753|FG002|Subacute Phase|Withdrawal by Subject|0|||
44227637|NCT01737697|79034754|FG003|Subacute Phase|Withdrawal by Subject|0|||
44227638|NCT01737697|79034755|FG004|Subacute Phase|Withdrawal by Subject|0|||
44227639|NCT01737697|79034756|FG005|Subacute Phase|Withdrawal by Subject|1|||
44227640|NCT01737697|79034757|FG006|Subacute Phase|Withdrawal by Subject|0|||
44227641|NCT01737697|79034758|FG007|Subacute Phase|Withdrawal by Subject|2|||
44227642|NCT01737697|79034759|FG008|Subacute Phase|Withdrawal by Subject|0|||
44227643|NCT01737697|79034760|FG009|Subacute Phase|Withdrawal by Subject|1|||
44227644|NCT01737697|79034761|FG010|Subacute Phase|Withdrawal by Subject|0|||
44483633|NCT00314574|79490166|FG000|Overall Study|Lost to Follow-up|19|||
44483634|NCT00314574|79490167|FG001|Overall Study|Lost to Follow-up|25|||
44483635|NCT00314574|79490166|FG000|Overall Study|Withdrawal by Subject|33|||
44483636|NCT00314574|79490167|FG001|Overall Study|Withdrawal by Subject|22|||
44483637|NCT00314574|79490166|FG000|Overall Study|Physician Decision|22|||
44483638|NCT00314574|79490167|FG001|Overall Study|Physician Decision|15|||
44227645|NCT01737697|79034762|FG011|Subacute Phase|Withdrawal by Subject|1|||
44483639|NCT00314574|79490166|FG000|Overall Study|Pregnancy|6|||
44227646|NCT01737697|79034763|FG012|Subacute Phase|Withdrawal by Subject|1|||
44227647|NCT01737697|79034764|FG013|Subacute Phase|Withdrawal by Subject|1|||
44227648|NCT01737697|79034765|FG014|Subacute Phase|Withdrawal by Subject|0|||
44227649|NCT01737697|79034751|FG000|Subacute Phase|Lost to Follow-up|0|||
44227650|NCT01737697|79034752|FG001|Subacute Phase|Lost to Follow-up|0|||
44227651|NCT01737697|79034753|FG002|Subacute Phase|Lost to Follow-up|0|||
44227652|NCT01737697|79034754|FG003|Subacute Phase|Lost to Follow-up|0|||
44483640|NCT00314574|79490167|FG001|Overall Study|Pregnancy|4|||
44227653|NCT01737697|79034755|FG004|Subacute Phase|Lost to Follow-up|0|||
44227654|NCT01737697|79034756|FG005|Subacute Phase|Lost to Follow-up|0|||
44227655|NCT01737697|79034757|FG006|Subacute Phase|Lost to Follow-up|0|||
44227656|NCT01737697|79034758|FG007|Subacute Phase|Lost to Follow-up|0|||
44227657|NCT01737697|79034759|FG008|Subacute Phase|Lost to Follow-up|0|||
44227658|NCT01737697|79034760|FG009|Subacute Phase|Lost to Follow-up|0|||
44227659|NCT01737697|79034761|FG010|Subacute Phase|Lost to Follow-up|0|||
44227660|NCT01737697|79034762|FG011|Subacute Phase|Lost to Follow-up|0|||
44227661|NCT01737697|79034763|FG012|Subacute Phase|Lost to Follow-up|0|||
44227662|NCT01737697|79034764|FG013|Subacute Phase|Lost to Follow-up|0|||
44227663|NCT01737697|79034765|FG014|Subacute Phase|Lost to Follow-up|1|||
44227664|NCT01737697|79034751|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
44227665|NCT01737697|79034752|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
44227666|NCT01737697|79034753|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
44227667|NCT01737697|79034754|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
44227668|NCT01737697|79034755|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
44227669|NCT01737697|79034756|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
44227670|NCT01737697|79034757|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
44227671|NCT01737697|79034758|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
44227672|NCT01737697|79034759|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
44227673|NCT01737697|79034760|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
44227674|NCT01737697|79034761|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
44227675|NCT01737697|79034762|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
44227676|NCT01737697|79034763|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
44227677|NCT01737697|79034764|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
44227678|NCT01737697|79034765|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
44227679|NCT01737697|79034751|FG000|Subacute Phase|Protocol Violation|0|||
44227680|NCT01737697|79034752|FG001|Subacute Phase|Protocol Violation|0|||
44227681|NCT01737697|79034753|FG002|Subacute Phase|Protocol Violation|0|||
44227682|NCT01737697|79034754|FG003|Subacute Phase|Protocol Violation|0|||
44227683|NCT01737697|79034755|FG004|Subacute Phase|Protocol Violation|0|||
44227684|NCT01737697|79034756|FG005|Subacute Phase|Protocol Violation|1|||
44483641|NCT00314574|79490166|FG000|Overall Study|Data unknown at database lock|0|||
44483642|NCT00314574|79490167|FG001|Overall Study|Data unknown at database lock|1|||
44483643|NCT00314340|79490173|FG000|Overall Study|lost interest|1|||
44483644|NCT00306852|79490181|FG000|Overall Study|Death|14|||
44483645|NCT00306852|79490182|FG001|Overall Study|Death|14|||
44483646|NCT00306852|79490181|FG000|Overall Study|Lost to Follow-up|15|||
44483647|NCT00306852|79490182|FG001|Overall Study|Lost to Follow-up|24|||
44483648|NCT00314262|79490188|FG000|Overall Study|Adverse Event|2|||
44483649|NCT00314262|79490188|FG000|Overall Study|Withdrawal by Subject|2|||
44483650|NCT00314262|79490188|FG000|Overall Study|Physician Decision|1|||
44483651|NCT00333866|79490196|FG000|Overall Study|Adverse Event|23|||
44483652|NCT00333866|79490197|FG001|Overall Study|Adverse Event|37|||
44483653|NCT00333866|79490198|FG002|Overall Study|Adverse Event|38|||
44483654|NCT00333866|79490199|FG003|Overall Study|Adverse Event|47|||
44483655|NCT00333866|79490196|FG000|Overall Study|Other|3|||
44483656|NCT00333866|79490197|FG001|Overall Study|Other|2|||
44483657|NCT00333866|79490198|FG002|Overall Study|Other|2|||
44483658|NCT00333866|79490199|FG003|Overall Study|Other|2|||
44483659|NCT00333866|79490196|FG000|Overall Study|Lack of Efficacy|8|||
44483660|NCT00333866|79490197|FG001|Overall Study|Lack of Efficacy|6|||
44483661|NCT00333866|79490198|FG002|Overall Study|Lack of Efficacy|3|||
44483662|NCT00333866|79490199|FG003|Overall Study|Lack of Efficacy|5|||
44483663|NCT00333866|79490196|FG000|Overall Study|Lost to Follow-up|1|||
44483664|NCT00333866|79490197|FG001|Overall Study|Lost to Follow-up|2|||
44483665|NCT00333866|79490198|FG002|Overall Study|Lost to Follow-up|2|||
44483666|NCT00333866|79490199|FG003|Overall Study|Lost to Follow-up|2|||
44483667|NCT00333866|79490196|FG000|Overall Study|Withdrawal by Subject|8|||
44483668|NCT00333866|79490197|FG001|Overall Study|Withdrawal by Subject|14|||
44483669|NCT00333866|79490198|FG002|Overall Study|Withdrawal by Subject|4|||
44227685|NCT01737697|79034757|FG006|Subacute Phase|Protocol Violation|0|||
44227686|NCT01737697|79034758|FG007|Subacute Phase|Protocol Violation|0|||
44227687|NCT01737697|79034759|FG008|Subacute Phase|Protocol Violation|0|||
44274214|NCT02412306|79217700|FG000|Overall Study|Lost to Follow-up|0|||
44483670|NCT00333866|79490199|FG003|Overall Study|Withdrawal by Subject|9|||
44483671|NCT00333866|79490196|FG000|Overall Study|Randomized but not Treated|5|||
44483672|NCT00333866|79490197|FG001|Overall Study|Randomized but not Treated|3|||
44483673|NCT00333866|79490198|FG002|Overall Study|Randomized but not Treated|2|||
44483674|NCT00333866|79490199|FG003|Overall Study|Randomized but not Treated|1|||
44227688|NCT01737697|79034760|FG009|Subacute Phase|Protocol Violation|0|||
44227689|NCT01737697|79034761|FG010|Subacute Phase|Protocol Violation|1|||
44227690|NCT01737697|79034762|FG011|Subacute Phase|Protocol Violation|0|||
44274215|NCT02412306|79217701|FG001|Overall Study|Lost to Follow-up|1|||
44227691|NCT01737697|79034763|FG012|Subacute Phase|Protocol Violation|0|||
44227692|NCT01737697|79034764|FG013|Subacute Phase|Protocol Violation|0|||
44227693|NCT01737697|79034765|FG014|Subacute Phase|Protocol Violation|0|||
44483675|NCT00324740|79490209|FG000|Overall Study|Withdrawal by Subject|1|||
44483676|NCT00324740|79490210|FG001|Overall Study|Withdrawal by Subject|0|||
44483677|NCT00324740|79490211|FG002|Overall Study|Withdrawal by Subject|1|||
44483678|NCT00333788|79490218|FG000|Overall Study|Adverse Event|44|||
44483679|NCT00333788|79490218|FG000|Overall Study|Lack of Efficacy|80|||
44483680|NCT00333788|79490218|FG000|Overall Study|Lost to Follow-up|2|||
44483681|NCT00333788|79490218|FG000|Overall Study|Withdrawal by Subject|24|||
44483682|NCT00333788|79490218|FG000|Overall Study|Other: Non-compliance|2|||
44483683|NCT00333788|79490218|FG000|Overall Study|Other: Moved|2|||
44483684|NCT00333788|79490218|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
44483685|NCT00333788|79490218|FG000|Overall Study|Other: Investigator decision|1|||
44483686|NCT00333788|79490218|FG000|Overall Study|Other: Quality of life concern|1|||
44483687|NCT00333788|79490218|FG000|Overall Study|Other: Sponsor decision|1|||
44483688|NCT00333788|79490218|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
44227694|NCT01737697|79034751|FG000|Subacute Phase|Physician Decision|0|||
44227695|NCT01737697|79034752|FG001|Subacute Phase|Physician Decision|0|||
44227696|NCT01737697|79034753|FG002|Subacute Phase|Physician Decision|0|||
44227697|NCT01737697|79034754|FG003|Subacute Phase|Physician Decision|0|||
44227698|NCT01737697|79034755|FG004|Subacute Phase|Physician Decision|0|||
44227699|NCT01737697|79034756|FG005|Subacute Phase|Physician Decision|0|||
44227700|NCT01737697|79034757|FG006|Subacute Phase|Physician Decision|0|||
44227701|NCT01737697|79034758|FG007|Subacute Phase|Physician Decision|0|||
44227702|NCT01737697|79034759|FG008|Subacute Phase|Physician Decision|1|||
44227703|NCT01737697|79034760|FG009|Subacute Phase|Physician Decision|0|||
44227704|NCT01737697|79034761|FG010|Subacute Phase|Physician Decision|0|||
44227705|NCT01737697|79034762|FG011|Subacute Phase|Physician Decision|0|||
44483689|NCT00333788|79490218|FG000|Overall Study|Other: Medical monitor decision|1|||
44483690|NCT00333788|79490218|FG000|Overall Study|Other: Physician decision|1|||
44483691|NCT00333788|79490218|FG000|Overall Study|Other: Signed consent for another study|1|||
44483692|NCT00324116|79490222|FG000|Overall Study|Adverse Event|5|||
44483693|NCT00324116|79490222|FG000|Overall Study|Lack of Efficacy|17|||
44483694|NCT00324116|79490222|FG000|Overall Study|Withdrawal by Subject|5|||
44483695|NCT00324116|79490222|FG000|Overall Study|Other|5|||
44483696|NCT00332696|79490228|FG000|Overall Study|Death|24|||
44483697|NCT00332696|79490229|FG001|Overall Study|Death|14|||
44483698|NCT00332696|79490228|FG000|Overall Study|Insufficient therapeutic effect|4|||
44483699|NCT00332696|79490229|FG001|Overall Study|Insufficient therapeutic effect|11|||
44483700|NCT00332696|79490228|FG000|Overall Study|Adverse Event|1|||
44483701|NCT00332696|79490229|FG001|Overall Study|Adverse Event|2|||
44483702|NCT00332696|79490228|FG000|Overall Study|Condition does not justify treatment|0|||
44483703|NCT00332696|79490229|FG001|Overall Study|Condition does not justify treatment|2|||
44483704|NCT00332696|79490228|FG000|Overall Study|Lost to Follow-up|0|||
44483705|NCT00332696|79490229|FG001|Overall Study|Lost to Follow-up|1|||
44483706|NCT00332696|79490228|FG000|Overall Study|Withdrawal by Subject|1|||
44483707|NCT00332696|79490229|FG001|Overall Study|Withdrawal by Subject|0|||
44483708|NCT00313716|79490241|FG000|Overall Study|Death|3|||
44483709|NCT00313716|79490242|FG001|Overall Study|Death|2|||
44483710|NCT00313716|79490243|FG002|Overall Study|Death|9|||
44483711|NCT00313716|79490244|FG003|Overall Study|Death|3|||
44483712|NCT00313716|79490245|FG004|Overall Study|Death|5|||
44483713|NCT00313716|79490246|FG005|Overall Study|Death|9|||
44483714|NCT00313716|79490241|FG000|Overall Study|Lost to Follow-up|2|||
44483715|NCT00313716|79490242|FG001|Overall Study|Lost to Follow-up|5|||
44483716|NCT00313716|79490243|FG002|Overall Study|Lost to Follow-up|2|||
44483717|NCT00313716|79490244|FG003|Overall Study|Lost to Follow-up|1|||
44227706|NCT01737697|79034763|FG012|Subacute Phase|Physician Decision|0|||
44483718|NCT00313716|79490245|FG004|Overall Study|Lost to Follow-up|0|||
44483719|NCT00313716|79490246|FG005|Overall Study|Lost to Follow-up|4|||
44483720|NCT00313716|79490241|FG000|Overall Study|Withdrawal by Subject|0|||
44483721|NCT00313716|79490242|FG001|Overall Study|Withdrawal by Subject|1|||
44227707|NCT01737697|79034764|FG013|Subacute Phase|Physician Decision|0|||
44227708|NCT01737697|79034765|FG014|Subacute Phase|Physician Decision|0|||
44227709|NCT01737697|79034751|FG000|Subacute Phase|Death|0|||
44227710|NCT01737697|79034752|FG001|Subacute Phase|Death|0|||
44227711|NCT01737697|79034753|FG002|Subacute Phase|Death|0|||
44227712|NCT01737697|79034754|FG003|Subacute Phase|Death|0|||
44227713|NCT01737697|79034755|FG004|Subacute Phase|Death|0|||
44227714|NCT01737697|79034756|FG005|Subacute Phase|Death|0|||
44227715|NCT01737697|79034757|FG006|Subacute Phase|Death|0|||
44227716|NCT01737697|79034758|FG007|Subacute Phase|Death|0|||
44227717|NCT01737697|79034759|FG008|Subacute Phase|Death|0|||
44227718|NCT01737697|79034760|FG009|Subacute Phase|Death|0|||
44227719|NCT01737697|79034761|FG010|Subacute Phase|Death|1|||
44227720|NCT01737697|79034762|FG011|Subacute Phase|Death|0|||
44227721|NCT01737697|79034763|FG012|Subacute Phase|Death|0|||
44227722|NCT01737697|79034764|FG013|Subacute Phase|Death|0|||
44227723|NCT01737697|79034765|FG014|Subacute Phase|Death|0|||
44227724|NCT01682863|79034921|FG000|Overall Study|Subject/guardian decision|19|||
44227725|NCT01682863|79034922|FG001|Overall Study|Subject/guardian decision|12|||
44227726|NCT01682863|79034923|FG002|Overall Study|Subject/guardian decision|10|||
44227727|NCT01682863|79034921|FG000|Overall Study|Lost to Follow-up|5|||
44227728|NCT01682863|79034922|FG001|Overall Study|Lost to Follow-up|1|||
44227729|NCT01682863|79034923|FG002|Overall Study|Lost to Follow-up|6|||
44227730|NCT01682863|79034921|FG000|Overall Study|Death|1|||
44227731|NCT01682863|79034922|FG001|Overall Study|Death|3|||
44227732|NCT01682863|79034923|FG002|Overall Study|Death|4|||
44227733|NCT01682863|79034921|FG000|Overall Study|Protocol deviation|1|||
44227734|NCT01682863|79034922|FG001|Overall Study|Protocol deviation|0|||
44227735|NCT01682863|79034923|FG002|Overall Study|Protocol deviation|1|||
44227736|NCT01682863|79034921|FG000|Overall Study|Technical problems|1|||
44227737|NCT01682863|79034922|FG001|Overall Study|Technical problems|0|||
44227738|NCT01682863|79034923|FG002|Overall Study|Technical problems|0|||
44483722|NCT00313716|79490243|FG002|Overall Study|Withdrawal by Subject|1|||
44483723|NCT00313716|79490244|FG003|Overall Study|Withdrawal by Subject|0|||
44483724|NCT00313716|79490245|FG004|Overall Study|Withdrawal by Subject|1|||
44483725|NCT00313716|79490246|FG005|Overall Study|Withdrawal by Subject|0|||
44483726|NCT00313170|79490267|FG000|Overall Study|Death|2|||
44483727|NCT00313170|79490268|FG001|Overall Study|Death|4|||
44483728|NCT00313170|79490269|FG002|Overall Study|Death|2|||
44483729|NCT00313170|79490267|FG000|Overall Study|Adverse Event|1|||
44483730|NCT00313170|79490268|FG001|Overall Study|Adverse Event|2|||
44483731|NCT00313170|79490269|FG002|Overall Study|Adverse Event|0|||
44483732|NCT00313170|79490267|FG000|Overall Study|Disease progression|31|||
44483733|NCT00313170|79490268|FG001|Overall Study|Disease progression|26|||
44483734|NCT00313170|79490269|FG002|Overall Study|Disease progression|27|||
44483735|NCT00313170|79490267|FG000|Overall Study|Withdrawal by Subject|1|||
44483736|NCT00313170|79490268|FG001|Overall Study|Withdrawal by Subject|0|||
44483737|NCT00313170|79490269|FG002|Overall Study|Withdrawal by Subject|1|||
44483738|NCT00313170|79490267|FG000|Overall Study|Incorrect enrollment|0|||
44483739|NCT00313170|79490268|FG001|Overall Study|Incorrect enrollment|2|||
44483740|NCT00313170|79490269|FG002|Overall Study|Incorrect enrollment|1|||
44483741|NCT00313170|79490267|FG000|Overall Study|Lost to Follow-up|0|||
44483742|NCT00313170|79490268|FG001|Overall Study|Lost to Follow-up|0|||
44483743|NCT00313170|79490269|FG002|Overall Study|Lost to Follow-up|1|||
44483744|NCT00313170|79490267|FG000|Overall Study|Progression (investigators opinion)|1|||
44483745|NCT00313170|79490268|FG001|Overall Study|Progression (investigators opinion)|0|||
44483746|NCT00313170|79490269|FG002|Overall Study|Progression (investigators opinion)|0|||
44483747|NCT00332462|79490278|FG000|Overall Study|Adverse Event|5|||
44483748|NCT00332462|79490278|FG000|Overall Study|Abnormal Lab Value|1|||
44483749|NCT00332462|79490278|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44483750|NCT00332462|79490278|FG000|Overall Study|no longer requires study drug|1|||
44483751|NCT00332462|79490278|FG000|Overall Study|Death|3|||
44483752|NCT00332462|79490278|FG000|Overall Study|Graft Loss|2|||
44227739|NCT01682863|79034921|FG000|Overall Study|Adverse Event|0|||
44227740|NCT01682863|79034922|FG001|Overall Study|Adverse Event|1|||
44227741|NCT01682863|79034923|FG002|Overall Study|Adverse Event|2|||
44274216|NCT02412306|79217702|FG002|Overall Study|Lost to Follow-up|0|||
44274217|NCT02412306|79217703|FG003|Overall Study|Lost to Follow-up|0|||
44483753|NCT00324038|79490287|FG000|Overall Study|Adverse Event|38|||
44483754|NCT00324038|79490288|FG001|Overall Study|Adverse Event|23|||
44483755|NCT00324038|79490287|FG000|Overall Study|Lack of Efficacy|5|||
44544710|NCT03566485|79558286|FG000|Overall Study|Clinical progression|0|||
44483756|NCT00324038|79490288|FG001|Overall Study|Lack of Efficacy|13|||
44227742|NCT01682863|79034921|FG000|Overall Study|Physician Decision|0|||
44227743|NCT01682863|79034922|FG001|Overall Study|Physician Decision|0|||
44227744|NCT01682863|79034923|FG002|Overall Study|Physician Decision|1|||
44227745|NCT01951625|79034936|FG000|Treatment Period|Protocol Violation|2|||
44227746|NCT01951625|79034937|FG001|Treatment Period|Protocol Violation|0|||
44227747|NCT01951625|79034938|FG002|Treatment Period|Protocol Violation|1|||
44227748|NCT01951625|79034939|FG003|Treatment Period|Protocol Violation|3|||
44227749|NCT01951625|79034940|FG004|Treatment Period|Protocol Violation|2|||
44483757|NCT00324038|79490287|FG000|Overall Study|Lost to Follow-up|0|||
44544711|NCT03566485|79558287|FG001|Overall Study|Clinical progression|1|||
44483758|NCT00324038|79490288|FG001|Overall Study|Lost to Follow-up|2|||
44483759|NCT00324038|79490287|FG000|Overall Study|Other|6|||
44483760|NCT00324038|79490288|FG001|Overall Study|Other|13|||
44483761|NCT00159861|79490296|FG000|Core Study - 16 Weeks|Death|3|||
44483762|NCT00159861|79490297|FG001|Core Study - 16 Weeks|Death|0|||
44483763|NCT00159861|79490296|FG000|Core Study - 16 Weeks|Adverse Event|12|||
44483764|NCT00159861|79490297|FG001|Core Study - 16 Weeks|Adverse Event|6|||
44483765|NCT00159861|79490296|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
44483766|NCT00159861|79490297|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
44483767|NCT00159861|79490296|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
44483768|NCT00159861|79490297|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
44483769|NCT00159861|79490296|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
44483770|NCT00159861|79490297|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
44483771|NCT00159861|79490296|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
44483772|NCT00159861|79490297|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
44483773|NCT00159861|79490296|FG000|Extension Study - up to 3 Years|Death|24|||
44483774|NCT00159861|79490297|FG001|Extension Study - up to 3 Years|Death|28|||
44483775|NCT00159861|79490296|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
44483776|NCT00159861|79490297|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
44483777|NCT00159861|79490296|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
44483778|NCT00159861|79490297|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
44483779|NCT00159861|79490296|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
44483780|NCT00159861|79490297|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
44483781|NCT00159861|79490296|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
44483782|NCT00159861|79490297|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
44483783|NCT00331760|79490310|FG000|Overall Study|Ineligible / no protocol treatment|15|||
44483784|NCT00331760|79490311|FG001|Overall Study|Ineligible / no protocol treatment|8|||
44483785|NCT00225147|79490322|FG000|Open-label Phase|Lost to Follow-up|0|||
44483786|NCT00225147|79490323|FG001|Open-label Phase|Lost to Follow-up|0|||
44483787|NCT00225147|79490324|FG002|Open-label Phase|Lost to Follow-up|0|||
44483788|NCT00225147|79490325|FG003|Open-label Phase|Lost to Follow-up|4|||
44227750|NCT01951625|79034936|FG000|Treatment Period|Physician Decision|0|||
44227751|NCT01951625|79034937|FG001|Treatment Period|Physician Decision|0|||
44227752|NCT01951625|79034938|FG002|Treatment Period|Physician Decision|0|||
44227753|NCT01951625|79034939|FG003|Treatment Period|Physician Decision|0|||
44227754|NCT01951625|79034940|FG004|Treatment Period|Physician Decision|1|||
44227755|NCT01951625|79034936|FG000|Treatment Period|Protocol driven decision point|0|||
44227756|NCT01951625|79034937|FG001|Treatment Period|Protocol driven decision point|5|||
44227757|NCT01951625|79034938|FG002|Treatment Period|Protocol driven decision point|0|||
44227758|NCT01951625|79034939|FG003|Treatment Period|Protocol driven decision point|2|||
44227759|NCT01951625|79034940|FG004|Treatment Period|Protocol driven decision point|1|||
44227760|NCT01951625|79034936|FG000|Treatment Period|Non compliance with study drug|1|||
44227761|NCT01951625|79034937|FG001|Treatment Period|Non compliance with study drug|2|||
44227762|NCT01951625|79034938|FG002|Treatment Period|Non compliance with study drug|2|||
44227763|NCT01951625|79034939|FG003|Treatment Period|Non compliance with study drug|0|||
44227764|NCT01951625|79034940|FG004|Treatment Period|Non compliance with study drug|0|||
44227765|NCT01951625|79034936|FG000|Treatment Period|Death|3|||
44227766|NCT01951625|79034937|FG001|Treatment Period|Death|2|||
44227767|NCT01951625|79034938|FG002|Treatment Period|Death|2|||
44227768|NCT01951625|79034939|FG003|Treatment Period|Death|1|||
44227769|NCT01951625|79034940|FG004|Treatment Period|Death|2|||
44227770|NCT01951625|79034936|FG000|Treatment Period|Adverse Event|7|||
44227771|NCT01951625|79034937|FG001|Treatment Period|Adverse Event|10|||
44227772|NCT01951625|79034938|FG002|Treatment Period|Adverse Event|9|||
44227773|NCT01951625|79034939|FG003|Treatment Period|Adverse Event|8|||
44227774|NCT01951625|79034940|FG004|Treatment Period|Adverse Event|8|||
44227775|NCT01951625|79034936|FG000|Treatment Period|Withdrawal by Subject|5|||
44227776|NCT01951625|79034937|FG001|Treatment Period|Withdrawal by Subject|2|||
44227777|NCT01951625|79034938|FG002|Treatment Period|Withdrawal by Subject|1|||
44227778|NCT01951625|79034939|FG003|Treatment Period|Withdrawal by Subject|7|||
44227779|NCT01951625|79034940|FG004|Treatment Period|Withdrawal by Subject|3|||
44227780|NCT01951625|79034936|FG000|Treatment Period|Lost to Follow-up|1|||
44544712|NCT03566485|79558286|FG000|Overall Study|Toxicity|0|||
44227781|NCT01951625|79034937|FG001|Treatment Period|Lost to Follow-up|0|||
44227782|NCT01951625|79034938|FG002|Treatment Period|Lost to Follow-up|0|||
44227783|NCT01951625|79034939|FG003|Treatment Period|Lost to Follow-up|1|||
44227784|NCT01951625|79034940|FG004|Treatment Period|Lost to Follow-up|0|||
44483789|NCT00225147|79490322|FG000|Open-label Phase|Withdrawal by Subject|0|||
44483790|NCT00225147|79490323|FG001|Open-label Phase|Withdrawal by Subject|0|||
44483791|NCT00225147|79490324|FG002|Open-label Phase|Withdrawal by Subject|0|||
44227785|NCT01951625|79034936|FG000|Follow Up Period|Non-compliance with study drug|1|||
44227786|NCT01951625|79034937|FG001|Follow Up Period|Non-compliance with study drug|0|||
44227787|NCT01951625|79034938|FG002|Follow Up Period|Non-compliance with study drug|0|||
44227788|NCT01951625|79034939|FG003|Follow Up Period|Non-compliance with study drug|0|||
44544713|NCT03566485|79558287|FG001|Overall Study|Toxicity|2|||
44227789|NCT01951625|79034940|FG004|Follow Up Period|Non-compliance with study drug|0|||
44227790|NCT01951625|79034936|FG000|Follow Up Period|Death|1|||
44227791|NCT01951625|79034937|FG001|Follow Up Period|Death|3|||
44227792|NCT01951625|79034938|FG002|Follow Up Period|Death|2|||
44483792|NCT00225147|79490325|FG003|Open-label Phase|Withdrawal by Subject|6|||
44483793|NCT00313014|79490340|FG000|Overall Study|Withdrawal by Subject|11|||
44483794|NCT00313014|79490341|FG001|Overall Study|Withdrawal by Subject|7|||
44483795|NCT00313014|79490342|FG002|Overall Study|Withdrawal by Subject|5|||
44483796|NCT00313014|79490340|FG000|Overall Study|Adverse Event|14|||
44483797|NCT00313014|79490341|FG001|Overall Study|Adverse Event|29|||
44483798|NCT00313014|79490342|FG002|Overall Study|Adverse Event|16|||
44483799|NCT00313014|79490340|FG000|Overall Study|Lost to Follow-up|7|||
44483800|NCT00313014|79490341|FG001|Overall Study|Lost to Follow-up|6|||
44483801|NCT00313014|79490342|FG002|Overall Study|Lost to Follow-up|10|||
44483802|NCT00313014|79490340|FG000|Overall Study|Administrative|9|||
44483803|NCT00313014|79490341|FG001|Overall Study|Administrative|6|||
44483804|NCT00313014|79490342|FG002|Overall Study|Administrative|14|||
44483805|NCT00313014|79490340|FG000|Overall Study|Lack of Efficacy|52|||
44483806|NCT00313014|79490341|FG001|Overall Study|Lack of Efficacy|25|||
44483807|NCT00313014|79490342|FG002|Overall Study|Lack of Efficacy|16|||
44483808|NCT00157209|79490353|FG000|Overall Study|Ongoing at data cut-off|10|||
44483809|NCT00157209|79490354|FG001|Overall Study|Ongoing at data cut-off|0|||
44483810|NCT00312858|79490362|FG000|Overall Study|Adverse Event|0|||
44483811|NCT00312858|79490363|FG001|Overall Study|Adverse Event|1|||
44483812|NCT00312858|79490362|FG000|Overall Study|Lost to Follow-up|25|||
44483813|NCT00312858|79490363|FG001|Overall Study|Lost to Follow-up|42|||
44483814|NCT00312858|79490362|FG000|Overall Study|Protocol Violation|3|||
44483815|NCT00312858|79490363|FG001|Overall Study|Protocol Violation|8|||
44483816|NCT00312858|79490362|FG000|Overall Study|Withdraw by Participant|20|||
44483817|NCT00312858|79490363|FG001|Overall Study|Withdraw by Participant|20|||
44483818|NCT00312858|79490362|FG000|Overall Study|Participant Moved|11|||
44483819|NCT00312858|79490363|FG001|Overall Study|Participant Moved|10|||
44483820|NCT00312858|79490362|FG000|Overall Study|Other|9|||
44483821|NCT00312858|79490363|FG001|Overall Study|Other|12|||
44483822|NCT00312702|79490372|FG000|Immunization Phase|Lost to Follow-up|0|||
44483823|NCT00312702|79490373|FG001|Immunization Phase|Lost to Follow-up|1|||
44483824|NCT00312702|79490374|FG002|Immunization Phase|Lost to Follow-up|0|||
44483825|NCT00156819|79490385|FG000|Overall Study|Lost to Follow-up|1|||
44483826|NCT00156819|79490386|FG001|Overall Study|Lost to Follow-up|1|||
44483827|NCT00156819|79490387|FG002|Overall Study|Lost to Follow-up|3|||
44483828|NCT03825042|79490397|FG000|Overall Study|Adverse Event|1|||
44483829|NCT03825042|79490398|FG001|Overall Study|Adverse Event|0|||
44483830|NCT03825042|79490397|FG000|Overall Study|Withdrawal by Subject|1|||
44483831|NCT03825042|79490398|FG001|Overall Study|Withdrawal by Subject|0|||
44483832|NCT00129987|79490406|FG000|1st Educational Session|Withdrawal by Subject|141|||
44483833|NCT00129987|79490407|FG001|1st Educational Session|Withdrawal by Subject|109|||
44483834|NCT00129987|79490406|FG000|1 Year|Withdrawal by Subject|32|||
44483835|NCT00129987|79490407|FG001|1 Year|Withdrawal by Subject|21|||
44483836|NCT00224133|79490413|FG000|Overall Study|Adverse Event|93|||
44483837|NCT00224133|79490413|FG000|Overall Study|Protocol Violation|6|||
44483838|NCT00224133|79490413|FG000|Overall Study|Withdrawal by Subject|33|||
44483839|NCT00224133|79490413|FG000|Overall Study|Lack of Efficacy|58|||
44483840|NCT00224133|79490413|FG000|Overall Study|Lost to Follow-up|21|||
44483841|NCT00224133|79490413|FG000|Overall Study|Physician Decision|1|||
44483842|NCT00224133|79490413|FG000|Overall Study|Other|14|||
44483843|NCT00224055|79490419|FG000|Overall Study|Adverse Event|9|||
44483844|NCT00224055|79490420|FG001|Overall Study|Adverse Event|3|||
44483845|NCT00224055|79490419|FG000|Overall Study|Lost to Follow-up|1|||
44544714|NCT03176238|79558295|FG000|Overall Study|Unacceptable AEs|15|||
44544715|NCT03176238|79558296|FG001|Overall Study|Unacceptable AEs|8|||
44544716|NCT03176238|79558295|FG000|Overall Study|Abnormal lab value(s)|2|||
44227793|NCT01951625|79034939|FG003|Follow Up Period|Death|2|||
44483846|NCT00224055|79490420|FG001|Overall Study|Lost to Follow-up|2|||
44483847|NCT00224055|79490419|FG000|Overall Study|Protocol Violation|1|||
44483848|NCT00224055|79490420|FG001|Overall Study|Protocol Violation|1|||
44483849|NCT00224055|79490419|FG000|Overall Study|Inclusion Violation|3|||
44483850|NCT00224055|79490420|FG001|Overall Study|Inclusion Violation|6|||
44483851|NCT00224055|79490419|FG000|Overall Study|Withdrawal by Subject|0|||
44483852|NCT00224055|79490420|FG001|Overall Study|Withdrawal by Subject|2|||
44483853|NCT00224055|79490419|FG000|Overall Study|Other|1|||
44483854|NCT00224055|79490420|FG001|Overall Study|Other|0|||
44483855|NCT00150345|79490428|FG000|Overall Study|Death|5|||
44483856|NCT00150345|79490429|FG001|Overall Study|Death|2|||
44483857|NCT00150345|79490428|FG000|Overall Study|Adverse Event|8|||
44483858|NCT00150345|79490429|FG001|Overall Study|Adverse Event|6|||
44227794|NCT01951625|79034940|FG004|Follow Up Period|Death|1|||
44483859|NCT00150345|79490428|FG000|Overall Study|Lack of Efficacy|5|||
44483860|NCT00150345|79490429|FG001|Overall Study|Lack of Efficacy|4|||
44483861|NCT00150345|79490428|FG000|Overall Study|Withdrawal by Subject|3|||
44483862|NCT00150345|79490429|FG001|Overall Study|Withdrawal by Subject|4|||
44483863|NCT00150345|79490428|FG000|Overall Study|Laboratory abnormality|1|||
44483864|NCT00150345|79490429|FG001|Overall Study|Laboratory abnormality|2|||
44483865|NCT00150345|79490428|FG000|Overall Study|Other|12|||
44483866|NCT00150345|79490429|FG001|Overall Study|Other|14|||
44483867|NCT00223977|79490439|FG000|Overall Study|Adverse Event|7|||
44483868|NCT00223977|79490440|FG001|Overall Study|Adverse Event|10|||
44483869|NCT00223977|79490441|FG002|Overall Study|Adverse Event|0|||
44483870|NCT00223977|79490439|FG000|Overall Study|Protocol Violation|0|||
44483871|NCT00223977|79490440|FG001|Overall Study|Protocol Violation|0|||
44483872|NCT00223977|79490441|FG002|Overall Study|Protocol Violation|1|||
44483873|NCT00223977|79490439|FG000|Overall Study|Withdrawal by Subject|1|||
44483874|NCT00223977|79490440|FG001|Overall Study|Withdrawal by Subject|1|||
44483875|NCT00223977|79490441|FG002|Overall Study|Withdrawal by Subject|2|||
44483876|NCT00223977|79490439|FG000|Overall Study|Other|1|||
44483877|NCT00223977|79490440|FG001|Overall Study|Other|0|||
44483878|NCT00223977|79490441|FG002|Overall Study|Other|0|||
44483879|NCT00148941|79490453|FG000|Overall Study|Lost to Follow-up|17|||
44483880|NCT00148941|79490454|FG001|Overall Study|Lost to Follow-up|24|||
44483881|NCT00148941|79490455|FG002|Overall Study|Lost to Follow-up|18|||
44483882|NCT00148941|79490456|FG003|Overall Study|Lost to Follow-up|22|||
44483883|NCT00148941|79490453|FG000|Overall Study|Withdrawal by Subject|1|||
44483884|NCT00148941|79490454|FG001|Overall Study|Withdrawal by Subject|0|||
44483885|NCT00148941|79490455|FG002|Overall Study|Withdrawal by Subject|1|||
44483886|NCT00148941|79490456|FG003|Overall Study|Withdrawal by Subject|0|||
44483887|NCT00148941|79490453|FG000|Overall Study|Other|0|||
44483888|NCT00148941|79490454|FG001|Overall Study|Other|0|||
44483889|NCT00148941|79490455|FG002|Overall Study|Other|1|||
44483890|NCT00148941|79490456|FG003|Overall Study|Other|2|||
44483891|NCT00148317|79490466|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
44483892|NCT00148317|79490466|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
44483893|NCT00148317|79490466|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
44483894|NCT00323882|79490478|FG000|Overall Study|Adverse Event|2|||
44483895|NCT00323882|79490479|FG001|Overall Study|Adverse Event|1|||
44483896|NCT00323882|79490480|FG002|Overall Study|Adverse Event|1|||
44483897|NCT00323882|79490481|FG003|Overall Study|Adverse Event|1|||
44483898|NCT00323882|79490482|FG004|Overall Study|Adverse Event|3|||
44483899|NCT00323882|79490478|FG000|Overall Study|Disease Progression|6|||
44483900|NCT00323882|79490479|FG001|Overall Study|Disease Progression|4|||
44227795|NCT01951625|79034936|FG000|Follow Up Period|Logistical difficulties|1|||
44483901|NCT00323882|79490480|FG002|Overall Study|Disease Progression|10|||
44483902|NCT00323882|79490481|FG003|Overall Study|Disease Progression|5|||
44483903|NCT00323882|79490482|FG004|Overall Study|Disease Progression|22|||
44483904|NCT00323882|79490478|FG000|Overall Study|Death|0|||
44483905|NCT00323882|79490479|FG001|Overall Study|Death|1|||
44483906|NCT00323882|79490480|FG002|Overall Study|Death|1|||
44483907|NCT00323882|79490481|FG003|Overall Study|Death|0|||
44483908|NCT00323882|79490482|FG004|Overall Study|Death|5|||
44483909|NCT00323882|79490478|FG000|Overall Study|Lost to Follow-up|0|||
44483910|NCT00323882|79490479|FG001|Overall Study|Lost to Follow-up|0|||
44483911|NCT00323882|79490480|FG002|Overall Study|Lost to Follow-up|1|||
44483912|NCT00323882|79490481|FG003|Overall Study|Lost to Follow-up|0|||
44483913|NCT00323882|79490482|FG004|Overall Study|Lost to Follow-up|1|||
44483914|NCT00323882|79490478|FG000|Overall Study|Other|0|||
44483915|NCT00323882|79490479|FG001|Overall Study|Other|0|||
44483916|NCT00323882|79490480|FG002|Overall Study|Other|0|||
44483917|NCT00323882|79490481|FG003|Overall Study|Other|1|||
44483918|NCT00323882|79490482|FG004|Overall Study|Other|1|||
44483919|NCT00331682|79490503|FG000|Overall Study|Adverse Event|1|||
44483920|NCT00323492|79490509|FG000|Study Phase 1|Adverse Event|2|||
44483921|NCT00323492|79490510|FG001|Study Phase 1|Adverse Event|0|||
44483922|NCT00323492|79490511|FG002|Study Phase 1|Adverse Event|0|||
44483923|NCT00323492|79490509|FG000|Study Phase 2|Adverse Event|1|||
44227796|NCT01951625|79034937|FG001|Follow Up Period|Logistical difficulties|2|||
44227797|NCT01951625|79034938|FG002|Follow Up Period|Logistical difficulties|0|||
44227798|NCT01951625|79034939|FG003|Follow Up Period|Logistical difficulties|0|||
44227799|NCT01951625|79034940|FG004|Follow Up Period|Logistical difficulties|0|||
44227800|NCT01951625|79034936|FG000|Follow Up Period|Adverse Event|0|||
44483924|NCT00323492|79490510|FG001|Study Phase 2|Adverse Event|0|||
44483925|NCT00323492|79490511|FG002|Study Phase 2|Adverse Event|0|||
44483926|NCT00323492|79490509|FG000|Study Phase 2|Physician Decision|1|||
44483927|NCT00323492|79490510|FG001|Study Phase 2|Physician Decision|0|||
44483928|NCT00323492|79490511|FG002|Study Phase 2|Physician Decision|0|||
44483929|NCT00323492|79490509|FG000|Study Phase 2|Lost to Follow-up|1|||
44483930|NCT00323492|79490510|FG001|Study Phase 2|Lost to Follow-up|0|||
44483931|NCT00323492|79490511|FG002|Study Phase 2|Lost to Follow-up|0|||
44483932|NCT00323492|79490509|FG000|Study Phase 2|Withdrawal by Subject|0|||
44483933|NCT00323492|79490510|FG001|Study Phase 2|Withdrawal by Subject|1|||
44483934|NCT00323492|79490511|FG002|Study Phase 2|Withdrawal by Subject|0|||
44483935|NCT00323492|79490509|FG000|Study Phase 2|Noncompliance with study schedule|0|||
44483936|NCT00323492|79490510|FG001|Study Phase 2|Noncompliance with study schedule|0|||
44483937|NCT00323492|79490511|FG002|Study Phase 2|Noncompliance with study schedule|1|||
44483938|NCT00323492|79490509|FG000|Study Phase 2|Protocol Violation|1|||
44483939|NCT00323492|79490510|FG001|Study Phase 2|Protocol Violation|0|||
44483940|NCT00323492|79490511|FG002|Study Phase 2|Protocol Violation|0|||
44483941|NCT00331136|79490522|FG000|Overall Study|Adverse Event|3|||
44483942|NCT00331136|79490523|FG001|Overall Study|Adverse Event|5|||
44483943|NCT00331136|79490524|FG002|Overall Study|Adverse Event|0|||
44483944|NCT00331136|79490525|FG003|Overall Study|Adverse Event|1|||
44483945|NCT00331136|79490522|FG000|Overall Study|Withdrawal by Subject|0|||
44483946|NCT00331136|79490523|FG001|Overall Study|Withdrawal by Subject|1|||
44483947|NCT00331136|79490524|FG002|Overall Study|Withdrawal by Subject|0|||
44483948|NCT00331136|79490525|FG003|Overall Study|Withdrawal by Subject|0|||
44483949|NCT00331136|79490522|FG000|Overall Study|Lost to Follow-up|0|||
44483950|NCT00331136|79490523|FG001|Overall Study|Lost to Follow-up|1|||
44483951|NCT00331136|79490524|FG002|Overall Study|Lost to Follow-up|0|||
44483952|NCT00331136|79490525|FG003|Overall Study|Lost to Follow-up|0|||
44483953|NCT00331136|79490522|FG000|Overall Study|Protocol Violation|1|||
44483954|NCT00331136|79490523|FG001|Overall Study|Protocol Violation|0|||
44483955|NCT00331136|79490524|FG002|Overall Study|Protocol Violation|0|||
44483956|NCT00331136|79490525|FG003|Overall Study|Protocol Violation|0|||
44483957|NCT00331136|79490522|FG000|Overall Study|Not treated|1|||
44483958|NCT00331136|79490523|FG001|Overall Study|Not treated|0|||
44483959|NCT00331136|79490524|FG002|Overall Study|Not treated|0|||
44483960|NCT00331136|79490525|FG003|Overall Study|Not treated|0|||
44483961|NCT00323414|79490537|FG000|Overall Study|Withdrawal by Subject|0|||
44483962|NCT00323414|79490538|FG001|Overall Study|Withdrawal by Subject|1|||
44483963|NCT00330668|79490544|FG000|BID Dosing Period|Adverse Event|1|||
44483964|NCT00330668|79490544|FG000|BID Dosing Period|Lost to Follow-up|7|||
44483965|NCT00330668|79490544|FG000|BID Dosing Period|Non-Compliance|5|||
44483966|NCT00330668|79490544|FG000|BID Dosing Period|Withdrawal by Subject|19|||
44483967|NCT00330668|79490544|FG000|BID Dosing Period|Sponsor's decision|1|||
44483968|NCT00330668|79490544|FG000|BID Dosing Period|Other|3|||
44483969|NCT00330668|79490544|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
44483970|NCT00330668|79490544|FG000|QD Dosing Period|Other|1|||
44483971|NCT00330668|79490544|FG000|QD Dosing Period|Withdrawal by Subject|1|||
44483972|NCT00330668|79490544|FG000|QD Dosing Period|Lost to Follow-up|2|||
44483973|NCT00306384|79490551|FG000|Overall Study|Adverse Event|103|||
44483974|NCT00306384|79490552|FG001|Overall Study|Adverse Event|87|||
44483975|NCT00306384|79490553|FG002|Overall Study|Adverse Event|40|||
44483976|NCT00306384|79490551|FG000|Overall Study|Major protocol deviation|43|||
44483977|NCT00306384|79490552|FG001|Overall Study|Major protocol deviation|51|||
44483978|NCT00306384|79490553|FG002|Overall Study|Major protocol deviation|18|||
44483979|NCT00306384|79490551|FG000|Overall Study|Lost to Follow-up|57|||
44483980|NCT00306384|79490552|FG001|Overall Study|Lost to Follow-up|41|||
44483981|NCT00306384|79490553|FG002|Overall Study|Lost to Follow-up|35|||
44483982|NCT00306384|79490551|FG000|Overall Study|Voluntary withdrawal|199|||
44483983|NCT00306384|79490552|FG001|Overall Study|Voluntary withdrawal|187|||
44483984|NCT00306384|79490553|FG002|Overall Study|Voluntary withdrawal|91|||
44483985|NCT00306384|79490551|FG000|Overall Study|Study termination|1|||
44483986|NCT00306384|79490552|FG001|Overall Study|Study termination|0|||
44483987|NCT00306384|79490553|FG002|Overall Study|Study termination|1|||
44483988|NCT00306384|79490551|FG000|Overall Study|Pregnancy|3|||
44483989|NCT00306384|79490552|FG001|Overall Study|Pregnancy|1|||
44483990|NCT00306384|79490553|FG002|Overall Study|Pregnancy|1|||
44483991|NCT00306384|79490551|FG000|Overall Study|Lack of Efficacy|26|||
44483992|NCT00306384|79490552|FG001|Overall Study|Lack of Efficacy|40|||
44483993|NCT00306384|79490553|FG002|Overall Study|Lack of Efficacy|38|||
44483994|NCT00306384|79490551|FG000|Overall Study|Investigator discretion|28|||
44483995|NCT00306384|79490552|FG001|Overall Study|Investigator discretion|31|||
44483996|NCT00306384|79490553|FG002|Overall Study|Investigator discretion|21|||
44483997|NCT00306384|79490551|FG000|Overall Study|Other|80|||
44483998|NCT00306384|79490552|FG001|Overall Study|Other|70|||
44483999|NCT00306384|79490553|FG002|Overall Study|Other|32|||
44484000|NCT00306384|79490551|FG000|Overall Study|Site closure|2|||
44484001|NCT00306384|79490552|FG001|Overall Study|Site closure|0|||
44484002|NCT00306384|79490553|FG002|Overall Study|Site closure|0|||
44484003|NCT00305604|79490563|FG000|Overall Study|Adverse Event|6|||
44484004|NCT00305604|79490564|FG001|Overall Study|Adverse Event|3|||
44484005|NCT00305604|79490563|FG000|Overall Study|Lack of Efficacy|11|||
44484006|NCT00305604|79490564|FG001|Overall Study|Lack of Efficacy|18|||
44484007|NCT00305604|79490563|FG000|Overall Study|Lost to Follow-up|0|||
44484008|NCT00305604|79490564|FG001|Overall Study|Lost to Follow-up|4|||
44484009|NCT00305604|79490563|FG000|Overall Study|Protocol Violation|2|||
44484010|NCT00305604|79490564|FG001|Overall Study|Protocol Violation|1|||
44484011|NCT00305604|79490563|FG000|Overall Study|Withdrawal by Subject|12|||
44484012|NCT00305604|79490564|FG001|Overall Study|Withdrawal by Subject|21|||
44484013|NCT00305604|79490563|FG000|Overall Study|Patient moved|1|||
44484014|NCT00305604|79490564|FG001|Overall Study|Patient moved|0|||
44484015|NCT00501059|79490572|FG000|Overall Study|Protocol Violation|80|||
44484016|NCT00501059|79490573|FG001|Overall Study|Protocol Violation|69|||
44484017|NCT00501059|79490572|FG000|Overall Study|Death|140|||
44484018|NCT00501059|79490573|FG001|Overall Study|Death|137|||
44484019|NCT00501059|79490572|FG000|Overall Study|Other|236|||
44484020|NCT00501059|79490573|FG001|Overall Study|Other|239|||
44484021|NCT00501059|79490572|FG000|Overall Study|Missing end-of-study page|91|||
44484022|NCT00501059|79490573|FG001|Overall Study|Missing end-of-study page|92|||
44484023|NCT00501059|79490572|FG000|Overall Study|Clinical endpoint reached|110|||
44484024|NCT00501059|79490573|FG001|Overall Study|Clinical endpoint reached|123|||
44484025|NCT00501059|79490572|FG000|Overall Study|Insufficient therapeutic effect|4|||
44484026|NCT00501059|79490573|FG001|Overall Study|Insufficient therapeutic effect|5|||
44484027|NCT00501059|79490572|FG000|Overall Study|Consent withdrawn by subject|817|||
44484028|NCT00501059|79490573|FG001|Overall Study|Consent withdrawn by subject|873|||
44484029|NCT00501059|79490572|FG000|Overall Study|Non-compliant with study treatment|23|||
44484030|NCT00501059|79490573|FG001|Overall Study|Non-compliant with study treatment|16|||
44484031|NCT00501059|79490572|FG000|Overall Study|Reason not given|3|||
44484032|NCT00501059|79490573|FG001|Overall Study|Reason not given|1|||
44484033|NCT00501059|79490572|FG000|Overall Study|Adverse Event|129|||
44484034|NCT00501059|79490573|FG001|Overall Study|Adverse Event|122|||
44484035|NCT00501059|79490572|FG000|Overall Study|Lost to Follow-up|210|||
44484036|NCT00501059|79490573|FG001|Overall Study|Lost to Follow-up|198|||
44484037|NCT00501059|79490572|FG000|Overall Study|Not treated|25|||
44484038|NCT00501059|79490573|FG001|Overall Study|Not treated|17|||
44484039|NCT00344318|79490585|FG000|Overall Study|Adverse Event|0|||
44484040|NCT00344318|79490586|FG001|Overall Study|Adverse Event|3|||
44484041|NCT00344318|79490587|FG002|Overall Study|Adverse Event|0|||
44484042|NCT00344318|79490588|FG003|Overall Study|Adverse Event|1|||
44484043|NCT00344318|79490585|FG000|Overall Study|Withdrawal by Subject|2|||
44484044|NCT00344318|79490586|FG001|Overall Study|Withdrawal by Subject|2|||
44484045|NCT00344318|79490587|FG002|Overall Study|Withdrawal by Subject|0|||
44484046|NCT00344318|79490588|FG003|Overall Study|Withdrawal by Subject|2|||
44484047|NCT00344318|79490585|FG000|Overall Study|Lost to Follow-up|2|||
44484048|NCT00344318|79490586|FG001|Overall Study|Lost to Follow-up|0|||
44484049|NCT00344318|79490587|FG002|Overall Study|Lost to Follow-up|1|||
44484050|NCT00344318|79490588|FG003|Overall Study|Lost to Follow-up|0|||
44484051|NCT00323258|79490602|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
44484052|NCT00323258|79490603|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
44484053|NCT00323258|79490602|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
44484054|NCT00323258|79490603|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
44484055|NCT00323258|79490602|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
44484056|NCT00323258|79490603|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
44484057|NCT00323258|79490602|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
44484058|NCT00323258|79490603|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
44484059|NCT00323258|79490602|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
44484060|NCT00323258|79490603|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
44484061|NCT00323258|79490602|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
44484062|NCT00323258|79490603|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
44484063|NCT00323258|79490602|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
44484064|NCT00323258|79490603|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
44484065|NCT00322868|79490609|FG000|Overall Study|disease progression|1|||
44484066|NCT00343382|79490617|FG000|Overall Study|Adverse Event|2|||
44484067|NCT00343382|79490618|FG001|Overall Study|Adverse Event|10|||
44484068|NCT00343382|79490619|FG002|Overall Study|Adverse Event|7|||
44544717|NCT03176238|79558296|FG001|Overall Study|Abnormal lab value(s)|0|||
44544718|NCT03176238|79558295|FG000|Overall Study|Inter-current illness|0|||
44544719|NCT03176238|79558296|FG001|Overall Study|Inter-current illness|1|||
44227801|NCT01951625|79034937|FG001|Follow Up Period|Adverse Event|3|||
44484069|NCT00343382|79490617|FG000|Overall Study|Withdrawal by Subject|1|||
44484070|NCT00343382|79490618|FG001|Overall Study|Withdrawal by Subject|2|||
44484071|NCT00343382|79490619|FG002|Overall Study|Withdrawal by Subject|6|||
44484072|NCT00343382|79490617|FG000|Overall Study|Other Reason Not Specified|1|||
44484073|NCT00343382|79490618|FG001|Overall Study|Other Reason Not Specified|2|||
44484074|NCT00343382|79490619|FG002|Overall Study|Other Reason Not Specified|4|||
44484075|NCT00481871|79490632|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
44484076|NCT00481871|79490633|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
44484077|NCT00481871|79490634|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
44484078|NCT00481871|79490635|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
44484079|NCT00481871|79490636|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
44484080|NCT00329420|79490647|FG000|Re-induction Phase|Lack of Efficacy|0|||
44484081|NCT00329420|79490648|FG001|Re-induction Phase|Lack of Efficacy|1|||
44484082|NCT00329420|79490649|FG002|Re-induction Phase|Lack of Efficacy|0|||
44484083|NCT00329420|79490647|FG000|Re-induction Phase|Withdrawal of Consent|0|||
44484084|NCT00329420|79490648|FG001|Re-induction Phase|Withdrawal of Consent|0|||
44484085|NCT00329420|79490649|FG002|Re-induction Phase|Withdrawal of Consent|1|||
44484086|NCT00329420|79490647|FG000|Re-induction Phase|Did not respond to re-induction|6|||
44484087|NCT00329420|79490648|FG001|Re-induction Phase|Did not respond to re-induction|5|||
44484088|NCT00329420|79490649|FG002|Re-induction Phase|Did not respond to re-induction|7|||
44484089|NCT00329420|79490647|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
44484090|NCT00329420|79490648|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
44484091|NCT00329420|79490649|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
44484092|NCT00329420|79490647|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
44484093|NCT00329420|79490648|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
44484094|NCT00329420|79490649|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
44484095|NCT00329420|79490647|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
44484096|NCT00329420|79490648|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
44484097|NCT00329420|79490649|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
44484098|NCT00329108|79490661|FG000|Overall Study|Adverse Event|2|||
44484099|NCT00329108|79490662|FG001|Overall Study|Adverse Event|2|||
44484100|NCT00329108|79490661|FG000|Overall Study|Lack of Efficacy|3|||
44484101|NCT00329108|79490662|FG001|Overall Study|Lack of Efficacy|3|||
44484102|NCT00329108|79490661|FG000|Overall Study|Withdrawal by Subject|0|||
44484103|NCT00329108|79490662|FG001|Overall Study|Withdrawal by Subject|2|||
44484104|NCT00329108|79490661|FG000|Overall Study|symptomatic deterioration|1|||
44484105|NCT00329108|79490662|FG001|Overall Study|symptomatic deterioration|1|||
44484106|NCT00329108|79490661|FG000|Overall Study|Subject no longer willing to participate|2|||
44484107|NCT00329108|79490662|FG001|Overall Study|Subject no longer willing to participate|2|||
44484108|NCT00329108|79490661|FG000|Overall Study|study terminated by sponsor|1|||
44484109|NCT00329108|79490662|FG001|Overall Study|study terminated by sponsor|0|||
44484110|NCT00329108|79490661|FG000|Overall Study|withdrew patient after SAE resolved|1|||
44484111|NCT00329108|79490662|FG001|Overall Study|withdrew patient after SAE resolved|0|||
44484112|NCT00329108|79490661|FG000|Overall Study|Protocol Violation|0|||
44484113|NCT00329108|79490662|FG001|Overall Study|Protocol Violation|2|||
44484114|NCT00329030|79490670|FG000|Overall Study|Withdrawal by Subject|1|||
44484115|NCT00329030|79490671|FG001|Overall Study|Withdrawal by Subject|3|||
44484116|NCT00329030|79490670|FG000|Overall Study|Progressive Disease|6|||
44484117|NCT00329030|79490671|FG001|Overall Study|Progressive Disease|2|||
44484118|NCT00329030|79490670|FG000|Overall Study|Ineligible Pathology|1|||
44484119|NCT00329030|79490671|FG001|Overall Study|Ineligible Pathology|1|||
44484120|NCT00328562|79490677|FG000|Overall Study|Disease progression|1|||
44484121|NCT00328172|79490686|FG000|Overall Study|Adverse Event|3|||
44484122|NCT00328172|79490687|FG001|Overall Study|Adverse Event|2|||
44484123|NCT00328172|79490688|FG002|Overall Study|Adverse Event|1|||
44484124|NCT00328172|79490689|FG003|Overall Study|Adverse Event|2|||
44484125|NCT00328172|79490690|FG004|Overall Study|Adverse Event|1|||
44484126|NCT00328172|79490686|FG000|Overall Study|Protocol Violation|0|||
44484127|NCT00328172|79490687|FG001|Overall Study|Protocol Violation|1|||
44484128|NCT00328172|79490688|FG002|Overall Study|Protocol Violation|1|||
44484129|NCT00328172|79490689|FG003|Overall Study|Protocol Violation|0|||
44484130|NCT00328172|79490690|FG004|Overall Study|Protocol Violation|0|||
44484131|NCT00328172|79490686|FG000|Overall Study|Lost to Follow-up|1|||
44484132|NCT00328172|79490687|FG001|Overall Study|Lost to Follow-up|1|||
44484133|NCT00328172|79490688|FG002|Overall Study|Lost to Follow-up|2|||
44484134|NCT00328172|79490689|FG003|Overall Study|Lost to Follow-up|1|||
44484135|NCT00328172|79490690|FG004|Overall Study|Lost to Follow-up|1|||
44484136|NCT00328172|79490686|FG000|Overall Study|Withdrawal by Subject|1|||
44484137|NCT00328172|79490687|FG001|Overall Study|Withdrawal by Subject|1|||
44484138|NCT00328172|79490688|FG002|Overall Study|Withdrawal by Subject|1|||
44484139|NCT00328172|79490689|FG003|Overall Study|Withdrawal by Subject|6|||
44484140|NCT00328172|79490690|FG004|Overall Study|Withdrawal by Subject|0|||
44484141|NCT00328172|79490686|FG000|Overall Study|Lack of Efficacy|14|||
44484142|NCT00328172|79490687|FG001|Overall Study|Lack of Efficacy|9|||
44484143|NCT00328172|79490688|FG002|Overall Study|Lack of Efficacy|4|||
44484144|NCT00328172|79490689|FG003|Overall Study|Lack of Efficacy|4|||
44484145|NCT00328172|79490690|FG004|Overall Study|Lack of Efficacy|3|||
44484146|NCT00328172|79490686|FG000|Overall Study|Other reason (not specified)|3|||
44484147|NCT00328172|79490687|FG001|Overall Study|Other reason (not specified)|0|||
44484148|NCT00328172|79490688|FG002|Overall Study|Other reason (not specified)|1|||
44484149|NCT00328172|79490689|FG003|Overall Study|Other reason (not specified)|0|||
44484150|NCT00328172|79490690|FG004|Overall Study|Other reason (not specified)|0|||
44484151|NCT00328094|79490704|FG000|Overall Study|Physician Decision|3|||
44484152|NCT00328094|79490705|FG001|Overall Study|Physician Decision|3|||
44227802|NCT01951625|79034938|FG002|Follow Up Period|Adverse Event|2|||
44227803|NCT01951625|79034939|FG003|Follow Up Period|Adverse Event|3|||
44484153|NCT00500903|79490714|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
44484154|NCT00500903|79490715|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
44484155|NCT00500903|79490716|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
44484156|NCT00500903|79490714|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
44484157|NCT00500903|79490715|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
44484158|NCT00500903|79490716|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
44484159|NCT00500903|79490714|FG000|Overall Study|Progressive Disease|41|||
44484160|NCT00500903|79490715|FG001|Overall Study|Progressive Disease|2|||
44484161|NCT00500903|79490716|FG002|Overall Study|Progressive Disease|15|||
44484162|NCT00500903|79490714|FG000|Overall Study|Patient Declined Further Treatment|0|||
44484163|NCT00500903|79490715|FG001|Overall Study|Patient Declined Further Treatment|0|||
44484164|NCT00500903|79490716|FG002|Overall Study|Patient Declined Further Treatment|3|||
44484165|NCT00500903|79490714|FG000|Overall Study|Symptomatic Deterioration|2|||
44484166|NCT00500903|79490715|FG001|Overall Study|Symptomatic Deterioration|0|||
44484167|NCT00500903|79490716|FG002|Overall Study|Symptomatic Deterioration|0|||
44484168|NCT00500903|79490714|FG000|Overall Study|Reason Not Specified|10|||
44484169|NCT00500903|79490715|FG001|Overall Study|Reason Not Specified|0|||
44484170|NCT00500903|79490716|FG002|Overall Study|Reason Not Specified|2|||
44484171|NCT00295932|79490765|FG000|Overall Study|Not Treated|0|||
44484172|NCT00295932|79490766|FG001|Overall Study|Not Treated|0|||
44484173|NCT00295932|79490767|FG002|Overall Study|Not Treated|0|||
44484174|NCT00295932|79490768|FG003|Overall Study|Not Treated|0|||
44484175|NCT00295932|79490769|FG004|Overall Study|Not Treated|0|||
44484176|NCT00295932|79490770|FG005|Overall Study|Not Treated|0|||
44484177|NCT00295932|79490771|FG006|Overall Study|Not Treated|0|||
44484178|NCT00295932|79490772|FG007|Overall Study|Not Treated|0|||
44484179|NCT00295932|79490773|FG008|Overall Study|Not Treated|0|||
44484180|NCT00295932|79490774|FG009|Overall Study|Not Treated|0|||
44484181|NCT00295932|79490775|FG010|Overall Study|Not Treated|1|||
44484182|NCT00305448|79490804|FG000|Overall Study|Protocol Violation|0|||
44484183|NCT00305448|79490805|FG001|Overall Study|Protocol Violation|1|||
44484184|NCT00305448|79490806|FG002|Overall Study|Protocol Violation|0|||
44484185|NCT00305448|79490804|FG000|Overall Study|Withdrawal by Subject|2|||
44484186|NCT00305448|79490805|FG001|Overall Study|Withdrawal by Subject|0|||
44484187|NCT00305448|79490806|FG002|Overall Study|Withdrawal by Subject|1|||
44484188|NCT00305448|79490804|FG000|Overall Study|Adverse Event|1|||
44484189|NCT00305448|79490805|FG001|Overall Study|Adverse Event|0|||
44544720|NCT03176238|79558295|FG000|Overall Study|Consent withdrawal|14|||
44544721|NCT03176238|79558296|FG001|Overall Study|Consent withdrawal|2|||
44484190|NCT00305448|79490806|FG002|Overall Study|Adverse Event|1|||
44484191|NCT00305448|79490804|FG000|Overall Study|Disease Progression|27|||
44544722|NCT03176238|79558295|FG000|Overall Study|Lost to Follow-up|3|||
44544723|NCT03176238|79558296|FG001|Overall Study|Lost to Follow-up|0|||
44484192|NCT00305448|79490805|FG001|Overall Study|Disease Progression|31|||
44484193|NCT00305448|79490806|FG002|Overall Study|Disease Progression|28|||
44484194|NCT00305448|79490804|FG000|Overall Study|Subjective Disease Progression|1|||
44484195|NCT00305448|79490805|FG001|Overall Study|Subjective Disease Progression|2|||
44484196|NCT00305448|79490806|FG002|Overall Study|Subjective Disease Progression|2|||
44484197|NCT00305448|79490804|FG000|Overall Study|Tumor Marker Elevation|0|||
44484198|NCT00305448|79490805|FG001|Overall Study|Tumor Marker Elevation|0|||
44484199|NCT00305448|79490806|FG002|Overall Study|Tumor Marker Elevation|1|||
44484200|NCT00305058|79490817|FG000|Overall Study|Participant too young|1|||
44484201|NCT00305058|79490818|FG001|Overall Study|Participant too young|0|||
44484202|NCT00305058|79490817|FG000|Overall Study|Missing data collection instrument|3|||
44484203|NCT00305058|79490818|FG001|Overall Study|Missing data collection instrument|2|||
44484204|NCT00305058|79490817|FG000|Overall Study|Missing outcome data|3|||
44484205|NCT00305058|79490818|FG001|Overall Study|Missing outcome data|2|||
44484206|NCT00295854|79490827|FG000|Overall Study|Adverse Event|7|||
44484207|NCT00295854|79490828|FG001|Overall Study|Adverse Event|7|||
44484208|NCT00295854|79490829|FG002|Overall Study|Adverse Event|6|||
44484209|NCT00295854|79490827|FG000|Overall Study|Protocol Violation|1|||
44484210|NCT00295854|79490828|FG001|Overall Study|Protocol Violation|1|||
44484211|NCT00295854|79490829|FG002|Overall Study|Protocol Violation|1|||
44484212|NCT00295854|79490827|FG000|Overall Study|Lost to Follow-up|2|||
44484213|NCT00295854|79490828|FG001|Overall Study|Lost to Follow-up|0|||
44484214|NCT00295854|79490829|FG002|Overall Study|Lost to Follow-up|1|||
44484215|NCT00295854|79490827|FG000|Overall Study|Withdrawal by Subject|3|||
44484216|NCT00295854|79490828|FG001|Overall Study|Withdrawal by Subject|7|||
44484217|NCT00295854|79490829|FG002|Overall Study|Withdrawal by Subject|4|||
44484218|NCT00295854|79490827|FG000|Overall Study|did not continue to meet criteria|1|||
44484219|NCT00295854|79490828|FG001|Overall Study|did not continue to meet criteria|1|||
44484220|NCT00295854|79490829|FG002|Overall Study|did not continue to meet criteria|2|||
44484221|NCT00295854|79490827|FG000|Overall Study|required a prohibited medication|1|||
44484222|NCT00295854|79490828|FG001|Overall Study|required a prohibited medication|0|||
44484223|NCT00295854|79490829|FG002|Overall Study|required a prohibited medication|0|||
44484224|NCT00295854|79490827|FG000|Overall Study|Other|3|||
44484225|NCT00295854|79490828|FG001|Overall Study|Other|5|||
44484226|NCT00295854|79490829|FG002|Overall Study|Other|1|||
44484227|NCT00327470|79490839|FG000|Overall Study|Randomized, but not treated|0|||
44484228|NCT00327470|79490840|FG001|Overall Study|Randomized, but not treated|2|||
44484229|NCT00327470|79490839|FG000|Overall Study|Adverse Event|9|||
44484230|NCT00327470|79490840|FG001|Overall Study|Adverse Event|14|||
44484231|NCT00327470|79490839|FG000|Overall Study|Lack of Efficacy|7|||
44484232|NCT00327470|79490840|FG001|Overall Study|Lack of Efficacy|19|||
44484233|NCT00327470|79490839|FG000|Overall Study|Other|5|||
44484234|NCT00327470|79490840|FG001|Overall Study|Other|9|||
44484235|NCT00327470|79490839|FG000|Overall Study|Lost to Follow-up|1|||
44484236|NCT00327470|79490840|FG001|Overall Study|Lost to Follow-up|3|||
44484237|NCT00327470|79490839|FG000|Overall Study|Withdrawal by Subject|6|||
44484238|NCT00327470|79490840|FG001|Overall Study|Withdrawal by Subject|12|||
44484239|NCT00327470|79490839|FG000|Overall Study|Death|1|||
44484240|NCT00327470|79490840|FG001|Overall Study|Death|4|||
44484241|NCT00322556|79490846|FG000|Overall Study|Adverse Event|1|||
44484242|NCT00322556|79490846|FG000|Overall Study|Withdrawal by Subject|1|||
44484243|NCT00322556|79490846|FG000|Overall Study|Lost to Follow-up|3|||
44484244|NCT00322556|79490846|FG000|Overall Study|Other Reason|7|||
44484245|NCT00321932|79490855|FG000|Overall Study|Death|3|||
44227804|NCT01951625|79034940|FG004|Follow Up Period|Adverse Event|5|||
44227805|NCT01951625|79034936|FG000|Follow Up Period|Withdrawal by Subject|4|||
44227806|NCT01951625|79034937|FG001|Follow Up Period|Withdrawal by Subject|1|||
44227807|NCT01951625|79034938|FG002|Follow Up Period|Withdrawal by Subject|0|||
44227808|NCT01951625|79034939|FG003|Follow Up Period|Withdrawal by Subject|5|||
44227809|NCT01951625|79034940|FG004|Follow Up Period|Withdrawal by Subject|3|||
44227810|NCT01951625|79034936|FG000|Follow Up Period|Lost to Follow-up|1|||
44484246|NCT00321932|79490856|FG001|Overall Study|Death|6|||
44484247|NCT00321932|79490855|FG000|Overall Study|Withdrawal by Subject|3|||
44484248|NCT00321932|79490856|FG001|Overall Study|Withdrawal by Subject|6|||
44484249|NCT00321932|79490855|FG000|Overall Study|Early relapse|2|||
44484250|NCT00321932|79490856|FG001|Overall Study|Early relapse|8|||
44484251|NCT00321932|79490855|FG000|Overall Study|Missing data|2|||
44484252|NCT00321932|79490856|FG001|Overall Study|Missing data|1|||
44484253|NCT00326612|79490865|FG000|Overall Study|They did not have a seizure requiring tx|129|||
44484254|NCT00326612|79490866|FG001|Overall Study|They did not have a seizure requiring tx|137|||
44484255|NCT00325130|79490878|FG000|Overall Study|Lost to Follow-up|6|||
44484256|NCT00325130|79490879|FG001|Overall Study|Lost to Follow-up|14|||
44484257|NCT00325130|79490878|FG000|Overall Study|Withdrawal by Subject|12|||
44484258|NCT00325130|79490879|FG001|Overall Study|Withdrawal by Subject|14|||
44484259|NCT00325130|79490878|FG000|Overall Study|Protocol Deviation|0|||
44484260|NCT00325130|79490879|FG001|Overall Study|Protocol Deviation|1|||
44484261|NCT00325130|79490878|FG000|Overall Study|Moved|0|||
44484262|NCT00325130|79490879|FG001|Overall Study|Moved|1|||
44484263|NCT00325130|79490878|FG000|Overall Study|Patient Discontinued for Other|1|||
44484264|NCT00325130|79490879|FG001|Overall Study|Patient Discontinued for Other|0|||
44484265|NCT00321854|79490887|FG000|Overall Study|Adverse Event|41|||
44484266|NCT00321854|79490888|FG001|Overall Study|Adverse Event|43|||
44484267|NCT00321854|79490887|FG000|Overall Study|Lack of Efficacy|9|||
44484268|NCT00321854|79490888|FG001|Overall Study|Lack of Efficacy|14|||
44484269|NCT00321854|79490887|FG000|Overall Study|Protocol Violation|6|||
44484270|NCT00321854|79490888|FG001|Overall Study|Protocol Violation|5|||
44484271|NCT00321854|79490887|FG000|Overall Study|Lost to Follow-up|0|||
44484272|NCT00321854|79490888|FG001|Overall Study|Lost to Follow-up|2|||
44484273|NCT00321854|79490887|FG000|Overall Study|Withdrawal by Subject|6|||
44484274|NCT00321854|79490888|FG001|Overall Study|Withdrawal by Subject|17|||
44484275|NCT00321854|79490887|FG000|Overall Study|Other|1|||
44484276|NCT00321854|79490888|FG001|Overall Study|Other|1|||
44484277|NCT00310388|79490896|FG000|Primary Reporting Phase|Adverse Event|101|||
44484278|NCT00310388|79490897|FG001|Primary Reporting Phase|Adverse Event|0|||
44484279|NCT00310388|79490896|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
44484280|NCT00310388|79490897|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
44484281|NCT00310388|79490896|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
44484282|NCT00310388|79490897|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
44484283|NCT00310388|79490896|FG000|Primary Reporting Phase|Protocol Violation|10|||
44484284|NCT00310388|79490897|FG001|Primary Reporting Phase|Protocol Violation|0|||
44484285|NCT00310388|79490896|FG000|Primary Reporting Phase|Pregnancy|3|||
44484286|NCT00310388|79490897|FG001|Primary Reporting Phase|Pregnancy|0|||
44484287|NCT00310388|79490896|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
44484288|NCT00310388|79490897|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
44484289|NCT00310388|79490896|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
44484290|NCT00310388|79490897|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
44484291|NCT00310388|79490896|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
44484292|NCT00310388|79490897|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
44484293|NCT00310388|79490896|FG000|Primary Reporting Phase|Physician Decision|2|||
44484294|NCT00310388|79490897|FG001|Primary Reporting Phase|Physician Decision|0|||
44484295|NCT00310388|79490896|FG000|Primary Reporting Phase|Request of the sponsor|19|||
44484296|NCT00310388|79490897|FG001|Primary Reporting Phase|Request of the sponsor|0|||
44484297|NCT00310388|79490896|FG000|Primary Reporting Phase|Failed to return|8|||
44484298|NCT00310388|79490897|FG001|Primary Reporting Phase|Failed to return|0|||
44484299|NCT00310388|79490896|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
44484300|NCT00310388|79490897|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
44484301|NCT00310388|79490896|FG000|Primary Reporting Phase|Participant request|2|||
44484302|NCT00310388|79490897|FG001|Primary Reporting Phase|Participant request|0|||
44484303|NCT00310388|79490896|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
44484304|NCT00310388|79490897|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
44484305|NCT00310388|79490896|FG000|Primary Reporting Phase|Discontinuation of study|1|||
44484306|NCT00310388|79490897|FG001|Primary Reporting Phase|Discontinuation of study|0|||
44484307|NCT00310388|79490896|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
44484308|NCT00310388|79490897|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
44484309|NCT00310388|79490896|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
44484310|NCT00310388|79490897|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
44484311|NCT00310388|79490896|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
44227811|NCT01951625|79034937|FG001|Follow Up Period|Lost to Follow-up|0|||
44227812|NCT01951625|79034938|FG002|Follow Up Period|Lost to Follow-up|0|||
44227813|NCT01951625|79034939|FG003|Follow Up Period|Lost to Follow-up|1|||
44227814|NCT01951625|79034940|FG004|Follow Up Period|Lost to Follow-up|1|||
44227815|NCT04400890|79034955|FG000|Overall Study|Withdrawal by Subject|3|||
44227816|NCT04400890|79034956|FG001|Overall Study|Withdrawal by Subject|2|||
44227817|NCT01936649|79034962|FG000|Overall Study|Withdrawal by Subject|4|||
44227818|NCT01936649|79034962|FG000|Overall Study|Physician Decision|2|||
44227819|NCT01936649|79034962|FG000|Overall Study|Protocol Violation|2|||
44227820|NCT01936649|79034962|FG000|Overall Study|Other than specified above|5|||
44227821|NCT01720069|79034969|FG000|Overall Study|Could not use e-diary correctly|0|||
44227822|NCT01720069|79034970|FG001|Overall Study|Could not use e-diary correctly|1|||
44227823|NCT01720069|79034971|FG002|Overall Study|Could not use e-diary correctly|1|||
44227824|NCT01720069|79034969|FG000|Overall Study|Randomised without baseline values|0|||
44227825|NCT01720069|79034970|FG001|Overall Study|Randomised without baseline values|0|||
44227826|NCT01720069|79034971|FG002|Overall Study|Randomised without baseline values|1|||
44227827|NCT01720069|79034969|FG000|Overall Study|Adverse Event|0|||
44227828|NCT01720069|79034970|FG001|Overall Study|Adverse Event|0|||
44227829|NCT01720069|79034971|FG002|Overall Study|Adverse Event|1|||
44227830|NCT01720069|79034969|FG000|Overall Study|Lack of Efficacy|0|||
44227831|NCT01720069|79034970|FG001|Overall Study|Lack of Efficacy|4|||
44227832|NCT01720069|79034971|FG002|Overall Study|Lack of Efficacy|0|||
44227833|NCT01720069|79034969|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
44227834|NCT01720069|79034970|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
44227835|NCT01720069|79034971|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
44227836|NCT01720069|79034969|FG000|Overall Study|Withdrawal by Subject|0|||
44227837|NCT01720069|79034970|FG001|Overall Study|Withdrawal by Subject|2|||
44227838|NCT01720069|79034971|FG002|Overall Study|Withdrawal by Subject|1|||
44227839|NCT01720069|79034969|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
44227840|NCT01720069|79034970|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
44227841|NCT01720069|79034971|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
44227842|NCT01720069|79034969|FG000|Overall Study|Non-compliance on using e-diary|0|||
44227843|NCT01720069|79034970|FG001|Overall Study|Non-compliance on using e-diary|0|||
44227844|NCT01720069|79034971|FG002|Overall Study|Non-compliance on using e-diary|1|||
44227845|NCT01720069|79034969|FG000|Overall Study|Lost to Follow-up|0|||
44227846|NCT01720069|79034970|FG001|Overall Study|Lost to Follow-up|0|||
44227847|NCT01720069|79034971|FG002|Overall Study|Lost to Follow-up|1|||
44227848|NCT01719757|79035017|FG000|Overall Study|Adverse Event|38|||
44484312|NCT00310388|79490897|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
44484313|NCT00310388|79490896|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
44484314|NCT00310388|79490897|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
44484315|NCT00310388|79490896|FG000|Primary Reporting Phase|Participant passed away|1|||
44484316|NCT00310388|79490897|FG001|Primary Reporting Phase|Participant passed away|0|||
44484317|NCT00310388|79490896|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
44484318|NCT00310388|79490897|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
44484319|NCT00310388|79490896|FG000|Primary Reporting Phase|Missing|1|||
44484320|NCT00310388|79490897|FG001|Primary Reporting Phase|Missing|0|||
44484321|NCT00310388|79490896|FG000|Primary Reporting Phase|Other|1|||
44484322|NCT00310388|79490897|FG001|Primary Reporting Phase|Other|0|||
44484323|NCT00310388|79490896|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
44484324|NCT00310388|79490897|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
44484325|NCT00310388|79490896|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
44484326|NCT00310388|79490897|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
44484327|NCT00310388|79490896|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
44484328|NCT00310388|79490897|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
44484329|NCT00310388|79490896|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
44484330|NCT00310388|79490897|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
44484331|NCT00500357|79490902|FG000|Overall Study|Death|1|||
44484332|NCT00309842|79490917|FG000|Overall Study|Lost to Follow-up|1|||
44484333|NCT00325754|79490923|FG000|Overall Study|Adverse Event|4|||
44227849|NCT01719757|79035017|FG000|Overall Study|Withdrawal by Subject|15|||
44227850|NCT01719757|79035017|FG000|Overall Study|Lost to Follow-up|20|||
44227851|NCT01719757|79035017|FG000|Overall Study|Protocol Violation|1|||
44227852|NCT01719757|79035017|FG000|Overall Study|well controlled pain|27|||
44227853|NCT01718509|79035025|FG000|Overall Study|Lost to Follow-up|18|||
44227854|NCT01718509|79035026|FG001|Overall Study|Lost to Follow-up|15|||
44227855|NCT01718509|79035025|FG000|Overall Study|Withdrawal by Subject|7|||
44227856|NCT01718509|79035026|FG001|Overall Study|Withdrawal by Subject|13|||
44227857|NCT01718509|79035025|FG000|Overall Study|Adverse Event|5|||
44227858|NCT01718509|79035026|FG001|Overall Study|Adverse Event|7|||
44484334|NCT00325754|79490924|FG001|Overall Study|Adverse Event|1|||
44484335|NCT00499889|79490930|FG000|Overall Study|Infection prior to treatment|1|||
44484336|NCT00309608|79490939|FG000|Overall Study|Adverse Event|1|||
44484337|NCT00309608|79490940|FG001|Overall Study|Adverse Event|5|||
44484338|NCT00309608|79490941|FG002|Overall Study|Adverse Event|3|||
44484339|NCT00309608|79490942|FG003|Overall Study|Adverse Event|2|||
44484340|NCT00309608|79490943|FG004|Overall Study|Adverse Event|3|||
44484341|NCT00309608|79490939|FG000|Overall Study|Protocol Violation|2|||
44484342|NCT00309608|79490940|FG001|Overall Study|Protocol Violation|0|||
44484343|NCT00309608|79490941|FG002|Overall Study|Protocol Violation|0|||
44484344|NCT00309608|79490942|FG003|Overall Study|Protocol Violation|0|||
44484345|NCT00309608|79490943|FG004|Overall Study|Protocol Violation|0|||
44484346|NCT00309608|79490939|FG000|Overall Study|Lost to Follow-up|0|||
44484347|NCT00309608|79490940|FG001|Overall Study|Lost to Follow-up|0|||
44484348|NCT00309608|79490941|FG002|Overall Study|Lost to Follow-up|2|||
44484349|NCT00309608|79490942|FG003|Overall Study|Lost to Follow-up|0|||
44484350|NCT00309608|79490943|FG004|Overall Study|Lost to Follow-up|1|||
44484351|NCT00309608|79490939|FG000|Overall Study|Withdrawal by Subject|1|||
44484352|NCT00309608|79490940|FG001|Overall Study|Withdrawal by Subject|4|||
44227859|NCT01718509|79035025|FG000|Overall Study|Other|13|||
44227860|NCT01718509|79035026|FG001|Overall Study|Other|11|||
44227861|NCT01718509|79035025|FG000|Overall Study|Protocol Violation|4|||
44227862|NCT01718509|79035026|FG001|Overall Study|Protocol Violation|2|||
44227863|NCT01718509|79035025|FG000|Overall Study|Lack of Efficacy|1|||
44227864|NCT01718509|79035026|FG001|Overall Study|Lack of Efficacy|0|||
44227865|NCT01604941|79035065|FG000|Overall Study|Adverse Event|1|||
44227866|NCT01604941|79035066|FG001|Overall Study|Adverse Event|2|||
44227867|NCT01604941|79035067|FG002|Overall Study|Adverse Event|0|||
44484353|NCT00309608|79490941|FG002|Overall Study|Withdrawal by Subject|2|||
44484354|NCT00309608|79490942|FG003|Overall Study|Withdrawal by Subject|0|||
44484355|NCT00309608|79490943|FG004|Overall Study|Withdrawal by Subject|0|||
44227868|NCT01604941|79035068|FG003|Overall Study|Adverse Event|0|||
44227869|NCT01604941|79035069|FG004|Overall Study|Adverse Event|1|||
44227870|NCT01604941|79035070|FG005|Overall Study|Adverse Event|5|||
44227871|NCT01604941|79035065|FG000|Overall Study|Non-compliance|1|||
44484356|NCT00309608|79490939|FG000|Overall Study|Other incl. Lack of efficacy|10|||
44484357|NCT00309608|79490940|FG001|Overall Study|Other incl. Lack of efficacy|4|||
44484358|NCT00309608|79490941|FG002|Overall Study|Other incl. Lack of efficacy|3|||
44484359|NCT00309608|79490942|FG003|Overall Study|Other incl. Lack of efficacy|4|||
44484360|NCT00309608|79490943|FG004|Overall Study|Other incl. Lack of efficacy|0|||
44484361|NCT00309452|79490957|FG000|Overall Study|Withdrawal by Subject|3|||
44484362|NCT00309452|79490958|FG001|Overall Study|Withdrawal by Subject|0|||
44484363|NCT00308750|79490967|FG000|Overall Study|Adverse Event|9|||
44484364|NCT00308750|79490968|FG001|Overall Study|Adverse Event|9|||
44484365|NCT00308750|79490969|FG002|Overall Study|Adverse Event|13|||
44484366|NCT00308750|79490967|FG000|Overall Study|Withdrawal by Subject|6|||
44484367|NCT00308750|79490968|FG001|Overall Study|Withdrawal by Subject|2|||
44484368|NCT00308750|79490969|FG002|Overall Study|Withdrawal by Subject|3|||
44484369|NCT00308750|79490967|FG000|Overall Study|Physician Decision|3|||
44484370|NCT00308750|79490968|FG001|Overall Study|Physician Decision|4|||
44484371|NCT00308750|79490969|FG002|Overall Study|Physician Decision|3|||
44484372|NCT00308750|79490967|FG000|Overall Study|Sponsor Decision|1|||
44227872|NCT01604941|79035066|FG001|Overall Study|Non-compliance|0|||
44227873|NCT01604941|79035067|FG002|Overall Study|Non-compliance|0|||
44227874|NCT01604941|79035068|FG003|Overall Study|Non-compliance|0|||
44227875|NCT01604941|79035069|FG004|Overall Study|Non-compliance|0|||
44227876|NCT01604941|79035070|FG005|Overall Study|Non-compliance|0|||
44227877|NCT01604941|79035065|FG000|Overall Study|Participant Decision|0|||
44227878|NCT01604941|79035066|FG001|Overall Study|Participant Decision|0|||
44227879|NCT01604941|79035067|FG002|Overall Study|Participant Decision|0|||
44227880|NCT01604941|79035068|FG003|Overall Study|Participant Decision|0|||
44227881|NCT01604941|79035069|FG004|Overall Study|Participant Decision|0|||
44227882|NCT01604941|79035070|FG005|Overall Study|Participant Decision|2|||
44484373|NCT00308750|79490968|FG001|Overall Study|Sponsor Decision|0|||
44484374|NCT00308750|79490969|FG002|Overall Study|Sponsor Decision|0|||
44484375|NCT00308750|79490967|FG000|Overall Study|Disease Progression|47|||
44484376|NCT00308750|79490968|FG001|Overall Study|Disease Progression|24|||
44484377|NCT00308750|79490969|FG002|Overall Study|Disease Progression|28|||
44484378|NCT00308750|79490967|FG000|Overall Study|Unrelated Complication|3|||
44484379|NCT00308750|79490968|FG001|Overall Study|Unrelated Complication|0|||
44227883|NCT01604941|79035065|FG000|Overall Study|Early Study Termination|9|||
44227884|NCT01604941|79035066|FG001|Overall Study|Early Study Termination|2|||
44484380|NCT00308750|79490969|FG002|Overall Study|Unrelated Complication|1|||
44484381|NCT00308750|79490967|FG000|Overall Study|Death|1|||
44484382|NCT00308750|79490968|FG001|Overall Study|Death|0|||
44227885|NCT01604941|79035067|FG002|Overall Study|Early Study Termination|3|||
44227886|NCT01604941|79035068|FG003|Overall Study|Early Study Termination|3|||
44227887|NCT01604941|79035069|FG004|Overall Study|Early Study Termination|0|||
44227888|NCT01604941|79035070|FG005|Overall Study|Early Study Termination|0|||
44227889|NCT01604785|79035078|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
44227890|NCT01604785|79035079|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
44484383|NCT00308750|79490969|FG002|Overall Study|Death|1|||
44484384|NCT00308750|79490967|FG000|Overall Study|Protocol Violation|1|||
44484385|NCT00308750|79490968|FG001|Overall Study|Protocol Violation|0|||
44484386|NCT00308750|79490969|FG002|Overall Study|Protocol Violation|0|||
44484387|NCT00308750|79490967|FG000|Overall Study|New Primary Disease Identified|1|||
44484388|NCT00308750|79490968|FG001|Overall Study|New Primary Disease Identified|1|||
44484389|NCT00308750|79490969|FG002|Overall Study|New Primary Disease Identified|0|||
44484390|NCT00489359|79490980|FG000|Overall Study|Death|0|||
44484391|NCT00489359|79490981|FG001|Overall Study|Death|2|||
44484392|NCT00489359|79490980|FG000|Overall Study|Progressive Disease|5|||
44484393|NCT00489359|79490981|FG001|Overall Study|Progressive Disease|6|||
44484394|NCT00489359|79490980|FG000|Overall Study|Lost to Follow-up|1|||
44484395|NCT00489359|79490981|FG001|Overall Study|Lost to Follow-up|0|||
44484396|NCT00489359|79490980|FG000|Overall Study|Withdrawal by Subject|1|||
44484397|NCT00489359|79490981|FG001|Overall Study|Withdrawal by Subject|5|||
44484398|NCT00489359|79490980|FG000|Overall Study|Adverse Event|0|||
44484399|NCT00489359|79490981|FG001|Overall Study|Adverse Event|16|||
44484400|NCT00481247|79490994|FG000|Overall Study|Death|0|||
44484401|NCT00481247|79490995|FG001|Overall Study|Death|1|||
44484402|NCT00481247|79490994|FG000|Overall Study|Disease progression|18|||
44484403|NCT00481247|79490995|FG001|Overall Study|Disease progression|22|||
44484404|NCT00481247|79490994|FG000|Overall Study|Intolerance|42|||
44484405|NCT00481247|79490995|FG001|Overall Study|Intolerance|17|||
44484406|NCT00481247|79490994|FG000|Overall Study|Treatment failure|10|||
44484407|NCT00481247|79490995|FG001|Overall Study|Treatment failure|14|||
44484408|NCT00481247|79490994|FG000|Overall Study|AE unrelated to study drug|13|||
44484409|NCT00481247|79490995|FG001|Overall Study|AE unrelated to study drug|4|||
44484410|NCT00481247|79490994|FG000|Overall Study|Withdrawal by Subject|8|||
44484411|NCT00481247|79490995|FG001|Overall Study|Withdrawal by Subject|13|||
44227891|NCT01681849|79035088|FG000|Overall Study|Protocol Violation|2|||
44484412|NCT00481247|79490994|FG000|Overall Study|Pregnancy|2|||
44227892|NCT01681849|79035089|FG001|Overall Study|Protocol Violation|0|||
44227893|NCT01681849|79035090|FG002|Overall Study|Protocol Violation|0|||
44484413|NCT00481247|79490995|FG001|Overall Study|Pregnancy|1|||
44484414|NCT00481247|79490994|FG000|Overall Study|Lost to Follow-up|1|||
44227894|NCT01681849|79035088|FG000|Overall Study|Withdrawal by Subject|3|||
44227895|NCT01681849|79035089|FG001|Overall Study|Withdrawal by Subject|5|||
44227896|NCT01681849|79035090|FG002|Overall Study|Withdrawal by Subject|33|||
44227897|NCT01681849|79035088|FG000|Overall Study|Lost to Follow-up|3|||
44227898|NCT01681849|79035089|FG001|Overall Study|Lost to Follow-up|2|||
44227899|NCT01681849|79035090|FG002|Overall Study|Lost to Follow-up|6|||
44227900|NCT01681771|79035099|FG000|Overall Study|Lost to Follow-up|4|||
44227901|NCT01681771|79035100|FG001|Overall Study|Lost to Follow-up|2|||
44227902|NCT04250350|79035106|FG000|Overall Study|Withdrawal by Subject|13|||
44227903|NCT04250350|79035106|FG000|Overall Study|Lost to Follow-up|8|||
44227904|NCT04250350|79035106|FG000|Overall Study|Adverse Event|5|||
44227905|NCT04250350|79035106|FG000|Overall Study|Lack of Efficacy|4|||
44227906|NCT04250350|79035106|FG000|Overall Study|Physician Decision|1|||
44227907|NCT04250350|79035106|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
44227908|NCT01718353|79035137|FG000|Overall Study|Lost to Follow-up|0|||
44227909|NCT01718353|79035138|FG001|Overall Study|Lost to Follow-up|1|||
44227910|NCT01718353|79035137|FG000|Overall Study|Principal Investigator's Decision|10|||
44227911|NCT01718353|79035138|FG001|Overall Study|Principal Investigator's Decision|4|||
44227912|NCT01718353|79035137|FG000|Overall Study|Randomized but not treated|2|||
44227913|NCT01718353|79035138|FG001|Overall Study|Randomized but not treated|0|||
44375650|NCT00940992|79380775|FG001|Overall Study|Adverse Event|0|||
44375651|NCT00940992|79380776|FG002|Overall Study|Adverse Event|1|||
44484415|NCT00481247|79490995|FG001|Overall Study|Lost to Follow-up|2|||
44484416|NCT00481247|79490994|FG000|Overall Study|Poor compliance/noncompliance|1|||
44484417|NCT00481247|79490995|FG001|Overall Study|Poor compliance/noncompliance|7|||
44484418|NCT00481247|79490994|FG000|Overall Study|Administrative reason by sponsor|157|||
44484419|NCT00481247|79490995|FG001|Overall Study|Administrative reason by sponsor|162|||
44484420|NCT00481247|79490994|FG000|Overall Study|Varied|6|||
44484421|NCT00481247|79490995|FG001|Overall Study|Varied|15|||
44484422|NCT00481247|79490994|FG000|Overall Study|Did not receive treatment|1|||
44484423|NCT00481247|79490995|FG001|Overall Study|Did not receive treatment|2|||
44484424|NCT00480857|79491001|FG000|Overall Study|Lack of Efficacy|2|||
44484425|NCT00480779|79491007|FG000|Overall Study|Other|2|||
44484426|NCT00480779|79491008|FG001|Overall Study|Other|0|||
44484427|NCT00480779|79491007|FG000|Overall Study|Job and Health-related|0|||
44484428|NCT00480779|79491008|FG001|Overall Study|Job and Health-related|3|||
44484429|NCT00499031|79491014|FG000|Overall Study|Improper pre-protocol treatment|1|||
44484430|NCT00499031|79491014|FG000|Overall Study|Required test not done|1|||
44484431|NCT00499031|79491014|FG000|Overall Study|Never treated|1|||
44484432|NCT00498797|79491020|FG000|Overall Study|Withdrawal by Subject|4|||
44484433|NCT00498797|79491021|FG001|Overall Study|Withdrawal by Subject|2|||
44484434|NCT00498797|79491020|FG000|Overall Study|Adverse Event|12|||
44484435|NCT00498797|79491021|FG001|Overall Study|Adverse Event|5|||
44484436|NCT00498797|79491020|FG000|Overall Study|Condition under investigation worsened|19|||
44484437|NCT00498797|79491021|FG001|Overall Study|Condition under investigation worsened|21|||
44484438|NCT00498797|79491020|FG000|Overall Study|Other|3|||
44227914|NCT01716715|79035148|FG000|Overall Study|Never Treated|2|||
44227915|NCT01716715|79035149|FG001|Overall Study|Never Treated|4|||
44484439|NCT00498797|79491021|FG001|Overall Study|Other|1|||
44484440|NCT00498485|79491029|FG000|Overall Study|Adverse Event|1|||
44227916|NCT01697449|79035157|FG000|Overall Study|Disease progression|47|||
44227917|NCT01697449|79035157|FG000|Overall Study|Adverse Event|7|||
44484441|NCT00498485|79491030|FG001|Overall Study|Adverse Event|5|||
44484442|NCT00480077|79491040|FG000|Overall Study|Death|19|||
44484443|NCT00480077|79491041|FG001|Overall Study|Death|15|||
44484444|NCT00480077|79491040|FG000|Overall Study|early exit|12|||
44484445|NCT00480077|79491041|FG001|Overall Study|early exit|11|||
44484446|NCT00498173|79491049|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
44484447|NCT00498173|79491050|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
44484448|NCT00498173|79491051|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
44484449|NCT00295620|79491061|FG000|Overall Study|Lost to Follow-up|9|||
44484450|NCT00295620|79491062|FG001|Overall Study|Lost to Follow-up|5|||
44484451|NCT00295620|79491061|FG000|Overall Study|Withdrawal by Subject|37|||
44484452|NCT00295620|79491062|FG001|Overall Study|Withdrawal by Subject|50|||
44484453|NCT00295620|79491061|FG000|Overall Study|Death|206|||
44484454|NCT00295620|79491062|FG001|Overall Study|Death|207|||
44484455|NCT00295620|79491061|FG000|Overall Study|Other reasons|10|||
44484456|NCT00295620|79491062|FG001|Overall Study|Other reasons|9|||
44484457|NCT00295620|79491061|FG000|Overall Study|Discontinuation by sponsor|580|||
44484458|NCT00295620|79491062|FG001|Overall Study|Discontinuation by sponsor|593|||
44484459|NCT00295620|79491061|FG000|Overall Study|Protocol Violation|30|||
44484460|NCT00295620|79491062|FG001|Overall Study|Protocol Violation|32|||
44484461|NCT00310440|79491070|FG000|Overall Study|Lost to Follow-up|17|||
44484462|NCT00310440|79491071|FG001|Overall Study|Lost to Follow-up|8|||
44484463|NCT00310440|79491070|FG000|Overall Study|Withdrawal by Subject|2|||
44484464|NCT00310440|79491071|FG001|Overall Study|Withdrawal by Subject|1|||
44484465|NCT00310440|79491070|FG000|Overall Study|Missed 12 Month Visit|7|||
44484466|NCT00310440|79491071|FG001|Overall Study|Missed 12 Month Visit|4|||
44227918|NCT01697449|79035157|FG000|Overall Study|Lost to Follow-up|5|||
44227919|NCT01697449|79035157|FG000|Overall Study|Withdrawal by Subject|2|||
44227920|NCT01697449|79035157|FG000|Overall Study|Physician Decision|1|||
44227921|NCT01697449|79035157|FG000|Overall Study|Death|2|||
44227922|NCT01697449|79035157|FG000|Overall Study|Other|1|||
44227923|NCT01697449|79035157|FG000|Overall Study|Missing|25|||
44227924|NCT01696279|79035164|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
44484467|NCT00304356|79491077|FG000|Nitazoxanide|Physician Decision|5|||
44484468|NCT00304356|79491077|FG000|Nitazoxanide|Physician Decision|1|||
44484469|NCT00304356|79491077|FG000|Nitazoxanide|number is 0|1|||
44484470|NCT00304356|79491077|FG000|Nitazoxanide|Physician Decision|1|||
44484471|NCT00304356|79491077|FG000|Nitazoxanide|Physician Decision|1|||
44484472|NCT00304356|79491077|FG000|Nitazoxanide|Physician Decision|1|||
44484473|NCT00321620|79491083|FG000|Overall Study|Death|269|||
44484474|NCT00321620|79491084|FG001|Overall Study|Death|294|||
44484475|NCT00321620|79491083|FG000|Overall Study|Withdrawal by Subject|164|||
44484476|NCT00321620|79491084|FG001|Overall Study|Withdrawal by Subject|147|||
44484477|NCT00321620|79491083|FG000|Overall Study|Disease progression|113|||
44484478|NCT00321620|79491084|FG001|Overall Study|Disease progression|117|||
44484479|NCT00321620|79491083|FG000|Overall Study|Adverse Event|43|||
44484480|NCT00321620|79491084|FG001|Overall Study|Adverse Event|56|||
44484481|NCT00321620|79491083|FG000|Overall Study|Lost to Follow-up|13|||
44484482|NCT00321620|79491084|FG001|Overall Study|Lost to Follow-up|9|||
44484483|NCT00321620|79491083|FG000|Overall Study|Physician Decision|4|||
44484484|NCT00321620|79491084|FG001|Overall Study|Physician Decision|1|||
44484485|NCT00321620|79491083|FG000|Overall Study|Noncompliance|14|||
44484486|NCT00321620|79491084|FG001|Overall Study|Noncompliance|7|||
44484487|NCT00321620|79491083|FG000|Overall Study|Protocol deviation|4|||
44484488|NCT00321620|79491084|FG001|Overall Study|Protocol deviation|3|||
44484489|NCT00321620|79491083|FG000|Overall Study|Ineligibility determined|2|||
44484490|NCT00321620|79491084|FG001|Overall Study|Ineligibility determined|3|||
44484491|NCT00321620|79491083|FG000|Overall Study|Participant request|75|||
44227925|NCT01696279|79035165|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
44227926|NCT01696279|79035166|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
44227927|NCT01696279|79035167|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
44274218|NCT02412306|79217704|FG004|Overall Study|Lost to Follow-up|0|||
44227928|NCT01696279|79035164|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
44227929|NCT01696279|79035165|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
44274219|NCT02412306|79217700|FG000|Overall Study|Withdrawal by Subject|0|||
44274220|NCT02412306|79217701|FG001|Overall Study|Withdrawal by Subject|0|||
44274221|NCT02412306|79217702|FG002|Overall Study|Withdrawal by Subject|1|||
44274222|NCT02412306|79217703|FG003|Overall Study|Withdrawal by Subject|0|||
44484492|NCT00321620|79491084|FG001|Overall Study|Participant request|52|||
44484493|NCT00321620|79491083|FG000|Overall Study|Other|42|||
44484494|NCT00321620|79491084|FG001|Overall Study|Other|33|||
44484495|NCT00304278|79491090|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
44484496|NCT00304278|79491090|FG000|Overall Study|PT had medical condition preventing TX|1|||
44484497|NCT00291018|79491097|FG000|Overall Study|Not Consented or Declined PAS|12|||
44274223|NCT02412306|79217704|FG004|Overall Study|Withdrawal by Subject|0|||
44274224|NCT02412306|79217700|FG000|Overall Study|Death|5|||
44227930|NCT01696279|79035166|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
44227931|NCT01696279|79035167|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
44227932|NCT01696279|79035164|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
44227933|NCT01696279|79035165|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
44227934|NCT01696279|79035166|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
44227935|NCT01696279|79035167|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
44227936|NCT01696279|79035164|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
44227937|NCT01696279|79035165|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
44227938|NCT01696279|79035166|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
44227939|NCT01696279|79035167|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
44227940|NCT01696279|79035164|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
44227941|NCT01696279|79035165|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
44227942|NCT01696279|79035166|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
44227943|NCT01696279|79035167|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
44227944|NCT01696279|79035164|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
44227945|NCT01696279|79035165|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
44227946|NCT01696279|79035166|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
44227947|NCT01696279|79035167|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
44227948|NCT01696279|79035164|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
44227949|NCT01696279|79035165|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
44227950|NCT01696279|79035166|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
44227951|NCT01696279|79035167|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
44227952|NCT01696279|79035164|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
44227953|NCT01696279|79035165|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
44227954|NCT01696279|79035166|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
44227955|NCT01696279|79035167|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
44227956|NCT01696279|79035164|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
44227957|NCT01696279|79035165|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
44227958|NCT01696279|79035166|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
44227959|NCT01696279|79035167|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
44227960|NCT01696279|79035164|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
44227961|NCT01696279|79035165|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
44227962|NCT01696279|79035166|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
44227963|NCT01696279|79035167|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
44227964|NCT01696279|79035164|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
44227965|NCT01696279|79035165|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
44227966|NCT01696279|79035166|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
44227967|NCT01696279|79035167|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
44227968|NCT01681069|79035178|FG000|Overall Study|Withdrawal by Subject|4|||
44227969|NCT01681069|79035179|FG001|Overall Study|Withdrawal by Subject|5|||
44227970|NCT01681069|79035178|FG000|Overall Study|Protocol Violation|1|||
44227971|NCT01681069|79035179|FG001|Overall Study|Protocol Violation|1|||
44227972|NCT01681069|79035178|FG000|Overall Study|Adverse Event|0|||
44227973|NCT01681069|79035179|FG001|Overall Study|Adverse Event|1|||
44227974|NCT01716559|79035185|FG000|Overall Study|Adverse Event|11|||
44227975|NCT01716559|79035185|FG000|Overall Study|Death|21|||
44227976|NCT01716559|79035185|FG000|Overall Study|Withdrawal by Subject|4|||
44227977|NCT01716559|79035185|FG000|Overall Study|Other withdrawal reason|75|||
44227978|NCT01936181|79035191|FG000|Randomised, Double-blind|Adverse Event|27|||
44227979|NCT01936181|79035192|FG001|Randomised, Double-blind|Adverse Event|21|||
44227980|NCT01936181|79035193|FG002|Randomised, Double-blind|Adverse Event|0|||
44227981|NCT01936181|79035194|FG003|Randomised, Double-blind|Adverse Event|0|||
44227982|NCT01936181|79035191|FG000|Randomised, Double-blind|Protocol Violation|1|||
44227983|NCT01936181|79035192|FG001|Randomised, Double-blind|Protocol Violation|5|||
44227984|NCT01936181|79035193|FG002|Randomised, Double-blind|Protocol Violation|0|||
44227985|NCT01936181|79035194|FG003|Randomised, Double-blind|Protocol Violation|0|||
44227986|NCT01936181|79035191|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
44227987|NCT01936181|79035192|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
44227988|NCT01936181|79035193|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
44227989|NCT01936181|79035194|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
44227990|NCT01936181|79035191|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
44227991|NCT01936181|79035192|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
44227992|NCT01936181|79035193|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
44227993|NCT01936181|79035194|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
44227994|NCT01936181|79035191|FG000|Randomised, Double-blind|Pregnancy|0|||
44274225|NCT02412306|79217701|FG001|Overall Study|Death|7|||
44274226|NCT02412306|79217702|FG002|Overall Study|Death|15|||
44274227|NCT02412306|79217703|FG003|Overall Study|Death|0|||
44274228|NCT02412306|79217704|FG004|Overall Study|Death|2|||
44274229|NCT04285723|79217727|FG000|Overall Study|Subject decision|1|||
44274230|NCT04285723|79217728|FG001|Overall Study|Subject decision|2|||
44274231|NCT04285723|79217727|FG000|Overall Study|Physician Decision|1|||
44274232|NCT04285723|79217728|FG001|Overall Study|Physician Decision|0|||
44274233|NCT04285723|79217727|FG000|Overall Study|No efficiency|1|||
44274234|NCT04285723|79217728|FG001|Overall Study|No efficiency|0|||
44274235|NCT01352221|79217742|FG000|Double-blind Phase|Adverse Event|6|||
44274236|NCT01352221|79217743|FG001|Double-blind Phase|Adverse Event|4|||
44274237|NCT01352221|79217744|FG002|Double-blind Phase|Adverse Event|0|||
44274238|NCT01352221|79217745|FG003|Double-blind Phase|Adverse Event|0|||
44274239|NCT01352221|79217742|FG000|Double-blind Phase|Withdrawal by Subject|3|||
44274240|NCT01352221|79217743|FG001|Double-blind Phase|Withdrawal by Subject|5|||
44274241|NCT01352221|79217744|FG002|Double-blind Phase|Withdrawal by Subject|0|||
44274242|NCT01352221|79217745|FG003|Double-blind Phase|Withdrawal by Subject|0|||
44274243|NCT01352221|79217742|FG000|Double-blind Phase|Lost to Follow-up|0|||
44274244|NCT01352221|79217743|FG001|Double-blind Phase|Lost to Follow-up|1|||
44274245|NCT01352221|79217744|FG002|Double-blind Phase|Lost to Follow-up|0|||
44274246|NCT01352221|79217745|FG003|Double-blind Phase|Lost to Follow-up|0|||
44274247|NCT01352221|79217742|FG000|Double-blind Phase|Protocol Violation|0|||
44274248|NCT01352221|79217743|FG001|Double-blind Phase|Protocol Violation|1|||
44274249|NCT01352221|79217744|FG002|Double-blind Phase|Protocol Violation|0|||
44274250|NCT01352221|79217745|FG003|Double-blind Phase|Protocol Violation|0|||
44274251|NCT01352221|79217742|FG000|Open-label Phase|Physician Decision|0|||
44274252|NCT01352221|79217743|FG001|Open-label Phase|Physician Decision|0|||
44274253|NCT01352221|79217744|FG002|Open-label Phase|Physician Decision|2|||
44274254|NCT01352221|79217745|FG003|Open-label Phase|Physician Decision|1|||
44274255|NCT01352221|79217742|FG000|Open-label Phase|Pregnancy|0|||
44274256|NCT01352221|79217743|FG001|Open-label Phase|Pregnancy|0|||
44274257|NCT01352221|79217744|FG002|Open-label Phase|Pregnancy|1|||
44274258|NCT01352221|79217745|FG003|Open-label Phase|Pregnancy|0|||
44484498|NCT00291018|79491098|FG001|Overall Study|Not Consented or Declined PAS|15|||
44484499|NCT00291018|79491099|FG002|Overall Study|Not Consented or Declined PAS|15|||
44484500|NCT00291018|79491097|FG000|Overall Study|Death|3|||
44484501|NCT00291018|79491098|FG001|Overall Study|Death|3|||
44484502|NCT00291018|79491099|FG002|Overall Study|Death|4|||
44484503|NCT00291018|79491097|FG000|Overall Study|Withdrawal by Subject|2|||
44484504|NCT00291018|79491098|FG001|Overall Study|Withdrawal by Subject|8|||
44484505|NCT00291018|79491099|FG002|Overall Study|Withdrawal by Subject|1|||
44484506|NCT00291018|79491097|FG000|Overall Study|Failures|5|||
44484507|NCT00291018|79491098|FG001|Overall Study|Failures|12|||
44484508|NCT00291018|79491099|FG002|Overall Study|Failures|5|||
44484509|NCT00291018|79491097|FG000|Overall Study|Lost to Follow-up|3|||
44484510|NCT00291018|79491098|FG001|Overall Study|Lost to Follow-up|4|||
44484511|NCT00291018|79491099|FG002|Overall Study|Lost to Follow-up|18|||
44484512|NCT00320606|79491110|FG000|Overall Study|Adverse Event|1|||
44484513|NCT00320606|79491110|FG000|Overall Study|Protocol Violation|1|||
44484514|NCT00320606|79491110|FG000|Overall Study|Withdrawal by Subject|1|||
44484515|NCT00307736|79491115|FG000|Overall Study|Adverse Event|0|||
44484516|NCT00307736|79491116|FG001|Overall Study|Adverse Event|0|||
44484517|NCT00307736|79491117|FG002|Overall Study|Adverse Event|1|||
44484518|NCT00307736|79491118|FG003|Overall Study|Adverse Event|3|||
44484519|NCT00307736|79491115|FG000|Overall Study|Withdrawal by Subject|0|||
44484520|NCT00307736|79491116|FG001|Overall Study|Withdrawal by Subject|0|||
44484521|NCT00307736|79491117|FG002|Overall Study|Withdrawal by Subject|2|||
44484522|NCT00307736|79491118|FG003|Overall Study|Withdrawal by Subject|0|||
44484523|NCT00320528|79491132|FG000|Study Period II|Adverse Event|3|||
44484524|NCT00320528|79491133|FG001|Study Period II|Adverse Event|4|||
44484525|NCT00320528|79491134|FG002|Study Period II|Adverse Event|8|||
44484526|NCT00320528|79491132|FG000|Study Period II|Parent/Caregiver Decision|8|||
44484527|NCT00320528|79491133|FG001|Study Period II|Parent/Caregiver Decision|3|||
44484528|NCT00320528|79491134|FG002|Study Period II|Parent/Caregiver Decision|11|||
44274259|NCT01352221|79217742|FG000|Open-label Phase|Adverse Event|0|||
44274260|NCT01352221|79217743|FG001|Open-label Phase|Adverse Event|0|||
44274261|NCT01352221|79217744|FG002|Open-label Phase|Adverse Event|8|||
44274262|NCT01352221|79217745|FG003|Open-label Phase|Adverse Event|4|||
44484529|NCT00320528|79491132|FG000|Study Period II|Withdrawal by Subject|0|||
44484530|NCT00320528|79491133|FG001|Study Period II|Withdrawal by Subject|1|||
44484531|NCT00320528|79491134|FG002|Study Period II|Withdrawal by Subject|1|||
44484532|NCT00320528|79491132|FG000|Study Period II|Entry Criteria Exclusion|0|||
44484533|NCT00320528|79491133|FG001|Study Period II|Entry Criteria Exclusion|2|||
44484534|NCT00320528|79491134|FG002|Study Period II|Entry Criteria Exclusion|2|||
44274263|NCT01352221|79217742|FG000|Open-label Phase|Withdrawal by Subject|0|||
44274264|NCT01352221|79217743|FG001|Open-label Phase|Withdrawal by Subject|0|||
44274265|NCT01352221|79217744|FG002|Open-label Phase|Withdrawal by Subject|1|||
44484535|NCT00320528|79491132|FG000|Study Period III|Adverse Event|1|||
44484536|NCT00320528|79491133|FG001|Study Period III|Adverse Event|0|||
44484537|NCT00320528|79491134|FG002|Study Period III|Adverse Event|0|||
44484538|NCT00320528|79491132|FG000|Study Period III|Lost to Follow-up|1|||
44484539|NCT00320528|79491133|FG001|Study Period III|Lost to Follow-up|0|||
44484540|NCT00320528|79491134|FG002|Study Period III|Lost to Follow-up|0|||
44484541|NCT00320528|79491132|FG000|Study Period III|Withdrawal by Subject|1|||
44484542|NCT00320528|79491133|FG001|Study Period III|Withdrawal by Subject|1|||
44484543|NCT00320528|79491134|FG002|Study Period III|Withdrawal by Subject|2|||
44484544|NCT00320528|79491132|FG000|Study Period III|Lack of Efficacy|2|||
44484545|NCT00320528|79491133|FG001|Study Period III|Lack of Efficacy|0|||
44484546|NCT00320528|79491134|FG002|Study Period III|Lack of Efficacy|0|||
44484547|NCT00320528|79491132|FG000|Study Period III|Parent/Caregiver Decision|14|||
44484548|NCT00320528|79491133|FG001|Study Period III|Parent/Caregiver Decision|3|||
44484549|NCT00320528|79491134|FG002|Study Period III|Parent/Caregiver Decision|11|||
44484550|NCT00320528|79491132|FG000|Study Period III|Protocol Violation|0|||
44484551|NCT00320528|79491133|FG001|Study Period III|Protocol Violation|1|||
44484552|NCT00320528|79491134|FG002|Study Period III|Protocol Violation|0|||
44484553|NCT00320528|79491132|FG000|Study Period III|Physician Decision|0|||
44484554|NCT00320528|79491133|FG001|Study Period III|Physician Decision|1|||
44484555|NCT00320528|79491134|FG002|Study Period III|Physician Decision|2|||
44484556|NCT00320528|79491132|FG000|Study Period III|Sponsor Decision|0|||
44484557|NCT00320528|79491133|FG001|Study Period III|Sponsor Decision|0|||
44484558|NCT00320528|79491134|FG002|Study Period III|Sponsor Decision|1|||
44484559|NCT00320528|79491132|FG000|Study Period III|Atomoxetine Commercially Available|68|||
44484560|NCT00320528|79491133|FG001|Study Period III|Atomoxetine Commercially Available|25|||
44484561|NCT00320528|79491134|FG002|Study Period III|Atomoxetine Commercially Available|90|||
44484562|NCT00320372|79491145|FG000|Overall Study|Physician Decision|4|||
44484563|NCT00320372|79491146|FG001|Overall Study|Physician Decision|7|||
44484564|NCT00320372|79491145|FG000|Overall Study|Death|7|||
44484565|NCT00320372|79491146|FG001|Overall Study|Death|8|||
44484566|NCT00320372|79491145|FG000|Overall Study|Withdrawal by Subject|55|||
44484567|NCT00320372|79491146|FG001|Overall Study|Withdrawal by Subject|37|||
44484568|NCT00320372|79491145|FG000|Overall Study|Non-Compliance|40|||
44484569|NCT00320372|79491146|FG001|Overall Study|Non-Compliance|39|||
44484570|NCT00320372|79491145|FG000|Overall Study|Did not Meet (I/E)|3|||
44484571|NCT00320372|79491146|FG001|Overall Study|Did not Meet (I/E)|1|||
44484572|NCT00320372|79491145|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
44484573|NCT00320372|79491146|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
44484574|NCT00294762|79491162|FG000|Overall Study|Did not receive study treatment|3|||
44484575|NCT00294762|79491163|FG001|Overall Study|Did not receive study treatment|3|||
44484576|NCT00294684|79491171|FG000|Overall Study|Lost to Follow-up|5|||
44484577|NCT00294684|79491172|FG001|Overall Study|Lost to Follow-up|8|||
44484578|NCT00307034|79491180|FG000|Overall Study|Adverse Event|1|||
44484579|NCT00307034|79491181|FG001|Overall Study|Adverse Event|2|||
44484580|NCT00307034|79491180|FG000|Overall Study|Withdrawal by Subject|1|||
44484581|NCT00307034|79491181|FG001|Overall Study|Withdrawal by Subject|2|||
44484582|NCT00307034|79491180|FG000|Overall Study|Lost to Follow-up|0|||
44484583|NCT00307034|79491181|FG001|Overall Study|Lost to Follow-up|3|||
44484584|NCT00320216|79491192|FG000|Overall Study|Adverse Event|0|||
44484585|NCT00320216|79491193|FG001|Overall Study|Adverse Event|6|||
44484586|NCT00320216|79491194|FG002|Overall Study|Adverse Event|0|||
44274266|NCT01352221|79217745|FG003|Open-label Phase|Withdrawal by Subject|6|||
44274267|NCT01352221|79217742|FG000|Open-label Phase|Worsening of IBD|0|||
44484587|NCT00320216|79491195|FG003|Overall Study|Adverse Event|2|||
44484588|NCT00320216|79491196|FG004|Overall Study|Adverse Event|2|||
44484589|NCT00320216|79491192|FG000|Overall Study|Lack of Efficacy|6|||
44484590|NCT00320216|79491193|FG001|Overall Study|Lack of Efficacy|2|||
44484591|NCT00320216|79491194|FG002|Overall Study|Lack of Efficacy|1|||
44484592|NCT00320216|79491195|FG003|Overall Study|Lack of Efficacy|0|||
44484593|NCT00320216|79491196|FG004|Overall Study|Lack of Efficacy|1|||
44484594|NCT00320216|79491192|FG000|Overall Study|Lost to Follow-up|3|||
44484595|NCT00320216|79491193|FG001|Overall Study|Lost to Follow-up|0|||
44484596|NCT00320216|79491194|FG002|Overall Study|Lost to Follow-up|0|||
44484597|NCT00320216|79491195|FG003|Overall Study|Lost to Follow-up|0|||
44484598|NCT00320216|79491196|FG004|Overall Study|Lost to Follow-up|0|||
44484599|NCT00320216|79491192|FG000|Overall Study|Other|7|||
44484600|NCT00320216|79491193|FG001|Overall Study|Other|2|||
44484601|NCT00320216|79491194|FG002|Overall Study|Other|5|||
44484602|NCT00320216|79491195|FG003|Overall Study|Other|1|||
44484603|NCT00320216|79491196|FG004|Overall Study|Other|3|||
44484604|NCT00290706|79491217|FG000|Overall Study|Withdrawal by Subject|2|||
44484605|NCT00290706|79491218|FG001|Overall Study|Withdrawal by Subject|0|||
44484606|NCT00290706|79491219|FG002|Overall Study|Withdrawal by Subject|0|||
44484607|NCT00290706|79491220|FG003|Overall Study|Withdrawal by Subject|0|||
44484608|NCT00290706|79491217|FG000|Overall Study|Progressive Disease|3|||
44484609|NCT00290706|79491218|FG001|Overall Study|Progressive Disease|5|||
44484610|NCT00290706|79491219|FG002|Overall Study|Progressive Disease|4|||
44484611|NCT00290706|79491220|FG003|Overall Study|Progressive Disease|10|||
44484612|NCT00290706|79491217|FG000|Overall Study|Adverse Event|0|||
44484613|NCT00290706|79491218|FG001|Overall Study|Adverse Event|1|||
44484614|NCT00290706|79491219|FG002|Overall Study|Adverse Event|2|||
44484615|NCT00290706|79491220|FG003|Overall Study|Adverse Event|0|||
44484616|NCT00290706|79491217|FG000|Overall Study|Receive auto transplant or radiation|0|||
44484617|NCT00290706|79491218|FG001|Overall Study|Receive auto transplant or radiation|0|||
44484618|NCT00290706|79491219|FG002|Overall Study|Receive auto transplant or radiation|0|||
44484619|NCT00290706|79491220|FG003|Overall Study|Receive auto transplant or radiation|1|||
44484620|NCT00290706|79491217|FG000|Overall Study|Physician Decision|0|||
44484621|NCT00290706|79491218|FG001|Overall Study|Physician Decision|0|||
44484622|NCT00290706|79491219|FG002|Overall Study|Physician Decision|0|||
44484623|NCT00290706|79491220|FG003|Overall Study|Physician Decision|1|||
44484624|NCT00303186|79491231|FG000|Overall Study|Other|52|||
44484625|NCT00294060|79491235|FG000|Overall Study|Death|225|||
44484626|NCT00294060|79491235|FG000|Overall Study|Other|59|||
44484627|NCT00294060|79491235|FG000|Overall Study|Lost to Follow-up|55|||
44484628|NCT00294060|79491235|FG000|Overall Study|Withdrawal by Subject|11|||
44484629|NCT00294060|79491235|FG000|Overall Study|Physician Decision|797|||
44484630|NCT00294060|79491235|FG000|Overall Study|Medical condition|3|||
44484631|NCT00294060|79491235|FG000|Overall Study|Device explanted/not replaced|23|||
44484632|NCT00303108|79491242|FG000|Overall Study|Adverse Event|5|||
44484633|NCT00303108|79491243|FG001|Overall Study|Adverse Event|6|||
44484634|NCT00303108|79491244|FG002|Overall Study|Adverse Event|7|||
44484635|NCT00303108|79491242|FG000|Overall Study|Patient Request|4|||
44484636|NCT00303108|79491243|FG001|Overall Study|Patient Request|2|||
44484637|NCT00303108|79491244|FG002|Overall Study|Patient Request|8|||
44484638|NCT00303108|79491242|FG000|Overall Study|Failed Entry|1|||
44484639|NCT00303108|79491243|FG001|Overall Study|Failed Entry|0|||
44484640|NCT00303108|79491244|FG002|Overall Study|Failed Entry|1|||
44484641|NCT00303108|79491242|FG000|Overall Study|ineligible|2|||
44484642|NCT00303108|79491243|FG001|Overall Study|ineligible|1|||
44484643|NCT00303108|79491244|FG002|Overall Study|ineligible|0|||
44484644|NCT00302952|79491253|FG000|Overall Study|Physician Decision|1|||
44484645|NCT00302952|79491254|FG001|Overall Study|Physician Decision|1|||
44484646|NCT00302952|79491253|FG000|Overall Study|Withdrawal by Subject|2|||
44484647|NCT00302952|79491254|FG001|Overall Study|Withdrawal by Subject|3|||
44484648|NCT00302952|79491253|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
44484649|NCT00302952|79491254|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
44484650|NCT00302718|79491264|FG000|Overall Study|Participant left the hospital|1|||
44484651|NCT00302718|79491265|FG001|Overall Study|Participant left the hospital|0|||
44484652|NCT00302718|79491266|FG002|Overall Study|Participant left the hospital|0|||
44484653|NCT00302718|79491267|FG003|Overall Study|Participant left the hospital|1|||
44484654|NCT00302718|79491264|FG000|Overall Study|Withdrawal by Subject|0|||
44484655|NCT00302718|79491265|FG001|Overall Study|Withdrawal by Subject|1|||
44484656|NCT00302718|79491266|FG002|Overall Study|Withdrawal by Subject|0|||
44484657|NCT00302718|79491267|FG003|Overall Study|Withdrawal by Subject|0|||
44484658|NCT00302718|79491264|FG000|Overall Study|Participant left primary care setting|0|||
44484659|NCT00302718|79491265|FG001|Overall Study|Participant left primary care setting|0|||
44484660|NCT00302718|79491266|FG002|Overall Study|Participant left primary care setting|2|||
44484661|NCT00302718|79491267|FG003|Overall Study|Participant left primary care setting|1|||
44484662|NCT00302328|79491285|FG000|Overall Study|Physician Decision|0|||
44484663|NCT00302328|79491286|FG001|Overall Study|Physician Decision|1|||
44484664|NCT00302328|79491287|FG002|Overall Study|Physician Decision|0|||
44484665|NCT00301080|79491298|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
44484666|NCT00301080|79491299|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
44484667|NCT00301080|79491300|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
44544724|NCT03176238|79558295|FG000|Overall Study|Administrative problems|1|||
44484668|NCT00301080|79491301|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
44484669|NCT00301080|79491302|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
44484670|NCT00290238|79491313|FG000|Overall Study|Study terminated|27|||
44544725|NCT03176238|79558296|FG001|Overall Study|Administrative problems|0|||
44484671|NCT00290238|79491314|FG001|Overall Study|Study terminated|27|||
44484672|NCT00290238|79491313|FG000|Overall Study|Lost to Follow-up|0|||
44484673|NCT00290238|79491314|FG001|Overall Study|Lost to Follow-up|1|||
44484674|NCT00290238|79491313|FG000|Overall Study|Withdrawal by Subject|15|||
44484675|NCT00290238|79491314|FG001|Overall Study|Withdrawal by Subject|13|||
44484676|NCT00289848|79491322|FG000|Overall Study|Adverse Event|6|||
44484677|NCT00289848|79491323|FG001|Overall Study|Adverse Event|4|||
44484678|NCT00289848|79491322|FG000|Overall Study|Death|1|||
44484679|NCT00289848|79491323|FG001|Overall Study|Death|0|||
44484680|NCT00289848|79491322|FG000|Overall Study|Lack of Efficacy|20|||
44484681|NCT00289848|79491323|FG001|Overall Study|Lack of Efficacy|24|||
44484682|NCT00289848|79491322|FG000|Overall Study|Lost to Follow-up|3|||
44484683|NCT00289848|79491323|FG001|Overall Study|Lost to Follow-up|1|||
44484684|NCT00289848|79491322|FG000|Overall Study|Protocol Violation|5|||
44484685|NCT00289848|79491323|FG001|Overall Study|Protocol Violation|2|||
44484686|NCT00289848|79491322|FG000|Overall Study|Withdrawal by Subject|5|||
44484687|NCT00289848|79491323|FG001|Overall Study|Withdrawal by Subject|11|||
44484688|NCT00289848|79491322|FG000|Overall Study|Patient Moved|6|||
44484689|NCT00289848|79491323|FG001|Overall Study|Patient Moved|2|||
44484690|NCT00289848|79491322|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
44484691|NCT00289848|79491323|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
44484692|NCT00289770|79491329|FG000|Year 15|Withdrawal by Subject|1|||
44484693|NCT00289536|79491333|FG000|Period 3|Lost to Follow-up|0|||
44484694|NCT00289536|79491334|FG001|Period 3|Lost to Follow-up|0|||
44484695|NCT00289536|79491335|FG002|Period 3|Lost to Follow-up|1|||
44484696|NCT00289458|79491344|FG000|Overall Study|Death|1|||
44484697|NCT00289458|79491345|FG001|Overall Study|Death|0|||
44484698|NCT00289458|79491346|FG002|Overall Study|Death|0|||
44484699|NCT00289458|79491344|FG000|Overall Study|Physician Decision|3|||
44484700|NCT00289458|79491345|FG001|Overall Study|Physician Decision|4|||
44484701|NCT00289458|79491346|FG002|Overall Study|Physician Decision|2|||
44484702|NCT00289458|79491344|FG000|Overall Study|Withdrawal by Subject|2|||
44484703|NCT00289458|79491345|FG001|Overall Study|Withdrawal by Subject|2|||
44484704|NCT00289458|79491346|FG002|Overall Study|Withdrawal by Subject|4|||
44484705|NCT00288912|79491357|FG000|Overall Study|Developed exclusion criterion|4|||
44484706|NCT00288912|79491358|FG001|Overall Study|Developed exclusion criterion|6|||
44484707|NCT00288912|79491359|FG002|Overall Study|Developed exclusion criterion|7|||
44484708|NCT00288912|79491357|FG000|Overall Study|Lost to Follow-up|9|||
44484709|NCT00288912|79491358|FG001|Overall Study|Lost to Follow-up|6|||
44484710|NCT00288912|79491359|FG002|Overall Study|Lost to Follow-up|9|||
44484711|NCT00288912|79491357|FG000|Overall Study|Withdrawal by Subject|4|||
44484712|NCT00288912|79491358|FG001|Overall Study|Withdrawal by Subject|5|||
44484713|NCT00288912|79491359|FG002|Overall Study|Withdrawal by Subject|12|||
44484714|NCT00305864|79491371|FG000|Overall Study|Ineligible / No protocol treatment|0|||
44484715|NCT00305864|79491372|FG001|Overall Study|Ineligible / No protocol treatment|1|||
44484716|NCT00305864|79491373|FG002|Overall Study|Ineligible / No protocol treatment|1|||
44484717|NCT00305864|79491374|FG003|Overall Study|Ineligible / No protocol treatment|13|||
44484718|NCT00295880|79491384|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
44484719|NCT00295880|79491384|FG000|Overall Study|Unit randomization did not occur|1|||
44484720|NCT00319982|79491390|FG000|Overall Study|Withdrawal by Subject|1|||
44484721|NCT00319982|79491391|FG001|Overall Study|Withdrawal by Subject|0|||
44484722|NCT00319592|79491399|FG000|Overall Study|Protocol Violation|1|||
44484723|NCT00319592|79491400|FG001|Overall Study|Protocol Violation|0|||
44484724|NCT00319592|79491399|FG000|Overall Study|Physician Decision|0|||
44484725|NCT00319592|79491400|FG001|Overall Study|Physician Decision|1|||
44227995|NCT01936181|79035192|FG001|Randomised, Double-blind|Pregnancy|1|||
44484726|NCT00295490|79491410|FG000|Overall Study|Protocol Violation|0|||
44484727|NCT00295490|79491411|FG001|Overall Study|Protocol Violation|0|||
44484728|NCT00295490|79491412|FG002|Overall Study|Protocol Violation|3|||
44484729|NCT00295490|79491413|FG003|Overall Study|Protocol Violation|3|||
44484730|NCT00295490|79491410|FG000|Overall Study|Withdrawal by Subject|0|||
44484731|NCT00295490|79491411|FG001|Overall Study|Withdrawal by Subject|2|||
44484732|NCT00295490|79491412|FG002|Overall Study|Withdrawal by Subject|0|||
44484733|NCT00295490|79491413|FG003|Overall Study|Withdrawal by Subject|1|||
44484734|NCT00295490|79491410|FG000|Overall Study|Lost to Follow-up|0|||
44484735|NCT00295490|79491411|FG001|Overall Study|Lost to Follow-up|0|||
44227996|NCT01936181|79035193|FG002|Randomised, Double-blind|Pregnancy|0|||
44484736|NCT00295490|79491412|FG002|Overall Study|Lost to Follow-up|1|||
44227997|NCT01936181|79035194|FG003|Randomised, Double-blind|Pregnancy|0|||
44484737|NCT00295490|79491413|FG003|Overall Study|Lost to Follow-up|0|||
44484738|NCT00295490|79491410|FG000|Overall Study|Adverse Event|1|||
44484739|NCT00295490|79491411|FG001|Overall Study|Adverse Event|0|||
44484740|NCT00295490|79491412|FG002|Overall Study|Adverse Event|0|||
44484741|NCT00295490|79491413|FG003|Overall Study|Adverse Event|0|||
44484742|NCT00295490|79491410|FG000|Overall Study|Other|0|||
44484743|NCT00295490|79491411|FG001|Overall Study|Other|2|||
44484744|NCT00295490|79491412|FG002|Overall Study|Other|0|||
44484745|NCT00295490|79491413|FG003|Overall Study|Other|1|||
44484746|NCT00305006|79491425|FG000|Overall Study|Withdrawal by Subject|1|||
44484747|NCT00305006|79491426|FG001|Overall Study|Withdrawal by Subject|0|||
44484748|NCT00305006|79491425|FG000|Overall Study|Failure to complete pretest|0|||
44484749|NCT00305006|79491426|FG001|Overall Study|Failure to complete pretest|1|||
44484750|NCT00319436|79491434|FG000|Overall Study|Withdrawal by Subject|6|||
44484751|NCT00319436|79491435|FG001|Overall Study|Withdrawal by Subject|7|||
44484752|NCT00319046|79491441|FG000|Overall Study|withdrawal of subject's consent|7|||
44484753|NCT00319046|79491441|FG000|Overall Study|administrative reason|1|||
44484754|NCT00303602|79491447|FG000|Overall Study|Adverse Event|2|||
44484755|NCT00303602|79491448|FG001|Overall Study|Adverse Event|2|||
44484756|NCT00303602|79491447|FG000|Overall Study|Withdrawal by Subject|5|||
44484757|NCT00303602|79491448|FG001|Overall Study|Withdrawal by Subject|6|||
44484758|NCT00303602|79491447|FG000|Overall Study|Lost to Follow-up|5|||
44484759|NCT00303602|79491448|FG001|Overall Study|Lost to Follow-up|2|||
44484760|NCT00303602|79491447|FG000|Overall Study|Protocol entry criteria not met|2|||
44484761|NCT00303602|79491448|FG001|Overall Study|Protocol entry criteria not met|2|||
44484762|NCT00303602|79491447|FG000|Overall Study|Physician Decision|2|||
44484763|NCT00303602|79491448|FG001|Overall Study|Physician Decision|1|||
44484764|NCT00303602|79491447|FG000|Overall Study|Noncompliance|2|||
44484765|NCT00303602|79491448|FG001|Overall Study|Noncompliance|2|||
44484766|NCT00303602|79491447|FG000|Overall Study|Protocol Violation|1|||
44484767|NCT00303602|79491448|FG001|Overall Study|Protocol Violation|0|||
44484768|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
44227998|NCT01936181|79035191|FG000|Randomised, Double-blind|Physician Decision|4|||
44227999|NCT01936181|79035192|FG001|Randomised, Double-blind|Physician Decision|4|||
44228000|NCT01936181|79035193|FG002|Randomised, Double-blind|Physician Decision|0|||
44228001|NCT01936181|79035194|FG003|Randomised, Double-blind|Physician Decision|0|||
44228002|NCT01936181|79035191|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
44228003|NCT01936181|79035192|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
44228004|NCT01936181|79035193|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
44484769|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
44484770|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
44484771|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Death|1|||
44484772|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Death|3|||
44484773|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Death|1|||
44484774|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
44484775|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
44484776|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
44484777|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
44484778|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
44484779|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
44484780|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
44484781|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
44484782|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
44484783|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
44484784|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
44484785|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
44484786|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
44484787|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
44484788|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
44484789|NCT00299130|79491457|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
44484790|NCT00299130|79491458|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
44484791|NCT00299130|79491459|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
44484792|NCT00299130|79491457|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
44484793|NCT00299130|79491458|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
44484794|NCT00299130|79491459|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
44484795|NCT00299130|79491457|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
44484796|NCT00299130|79491458|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
44484797|NCT00299130|79491459|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
44484798|NCT00299130|79491457|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
44484799|NCT00299130|79491458|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
44484800|NCT00299130|79491459|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
44228005|NCT01936181|79035194|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
44484801|NCT00299130|79491457|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
44484802|NCT00299130|79491458|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
44484803|NCT00299130|79491459|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
44484804|NCT00299130|79491457|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
44484805|NCT00299130|79491458|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
44484806|NCT00299130|79491459|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
44484807|NCT00299130|79491457|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
44484808|NCT00299130|79491458|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
44484809|NCT00299130|79491459|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
44484810|NCT00299130|79491457|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
44484811|NCT00299130|79491458|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
44484812|NCT00299130|79491459|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
44484813|NCT00299130|79491457|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
44484814|NCT00299130|79491458|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
44484815|NCT00299130|79491459|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
44484816|NCT00299130|79491457|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
44484817|NCT00299130|79491458|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
44484818|NCT00299130|79491459|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
44484819|NCT00288054|79491474|FG000|Overall Study|Protocol Violation|2|||
44484820|NCT00288054|79491474|FG000|Overall Study|Lack of Efficacy|16|||
44484821|NCT00288054|79491474|FG000|Overall Study|Adverse Event|3|||
44484822|NCT00288054|79491474|FG000|Overall Study|Withdrawal by Subject|1|||
44484823|NCT00288054|79491474|FG000|Overall Study|Not protocol specified|2|||
44484824|NCT00287586|79491482|FG000|Overall Study|Withdrew Consent|19|||
44484825|NCT00287586|79491483|FG001|Overall Study|Withdrew Consent|30|||
44484826|NCT00287586|79491482|FG000|Overall Study|Lost to Follow-up|5|||
44484827|NCT00287586|79491483|FG001|Overall Study|Lost to Follow-up|4|||
44484828|NCT00287586|79491482|FG000|Overall Study|Death|2|||
44484829|NCT00287586|79491483|FG001|Overall Study|Death|3|||
44484830|NCT00287586|79491482|FG000|Overall Study|Elevated Hematocrit|3|||
44484831|NCT00287586|79491483|FG001|Overall Study|Elevated Hematocrit|0|||
44484832|NCT00287586|79491482|FG000|Overall Study|Rash|3|||
44484833|NCT00287586|79491483|FG001|Overall Study|Rash|0|||
44484834|NCT00287586|79491482|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
44484835|NCT00287586|79491483|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
44484836|NCT00287586|79491482|FG000|Overall Study|Stroke|2|||
44484837|NCT00287586|79491483|FG001|Overall Study|Stroke|0|||
44484838|NCT00287586|79491482|FG000|Overall Study|Myocardial Infarction|1|||
44484839|NCT00287586|79491483|FG001|Overall Study|Myocardial Infarction|0|||
44484840|NCT00287586|79491482|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
44484841|NCT00287586|79491483|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
44484842|NCT00287586|79491482|FG000|Overall Study|Cognitive Impairment|1|||
44484843|NCT00287586|79491483|FG001|Overall Study|Cognitive Impairment|0|||
44484844|NCT00287586|79491482|FG000|Overall Study|Pancreatic Cancer|1|||
44484845|NCT00287586|79491483|FG001|Overall Study|Pancreatic Cancer|3|||
44484846|NCT00287586|79491482|FG000|Overall Study|Sleep Apnea|1|||
44484847|NCT00287586|79491483|FG001|Overall Study|Sleep Apnea|0|||
44484848|NCT00287586|79491482|FG000|Overall Study|Shoulder Pain|1|||
44484849|NCT00287586|79491483|FG001|Overall Study|Shoulder Pain|0|||
44484850|NCT00287586|79491482|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
44484851|NCT00287586|79491483|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
44484852|NCT00287586|79491482|FG000|Overall Study|Nonadherence|1|||
44484853|NCT00287586|79491483|FG001|Overall Study|Nonadherence|1|||
44484854|NCT00287586|79491482|FG000|Overall Study|Enrolled in Another Study|1|||
44484855|NCT00287586|79491483|FG001|Overall Study|Enrolled in Another Study|0|||
44484856|NCT00287586|79491482|FG000|Overall Study|Major Depression|0|||
44484857|NCT00287586|79491483|FG001|Overall Study|Major Depression|2|||
44484858|NCT00287586|79491482|FG000|Overall Study|Lung Cancer|0|||
44484859|NCT00287586|79491483|FG001|Overall Study|Lung Cancer|2|||
44484860|NCT00287586|79491482|FG000|Overall Study|Elevated IPSS Score|0|||
44484861|NCT00287586|79491483|FG001|Overall Study|Elevated IPSS Score|1|||
44484862|NCT00287586|79491482|FG000|Overall Study|Retroperitoneal Cancer|0|||
44484863|NCT00287586|79491483|FG001|Overall Study|Retroperitoneal Cancer|1|||
44484864|NCT00287586|79491482|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
44484865|NCT00287586|79491483|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
44484866|NCT00287586|79491482|FG000|Overall Study|Mood Swings and Irritability|0|||
44484867|NCT00287586|79491483|FG001|Overall Study|Mood Swings and Irritability|1|||
44484868|NCT00287586|79491482|FG000|Overall Study|Bradycardia|0|||
44484869|NCT00287586|79491483|FG001|Overall Study|Bradycardia|1|||
44484870|NCT00287586|79491482|FG000|Overall Study|Itchy Swollen Eyes|0|||
44484871|NCT00287586|79491483|FG001|Overall Study|Itchy Swollen Eyes|1|||
44484872|NCT00287586|79491482|FG000|Overall Study|Recurrent Melanoma|0|||
44484873|NCT00287586|79491483|FG001|Overall Study|Recurrent Melanoma|1|||
44484874|NCT00287118|79491489|FG000|Overall Study|Adverse Event|30|||
44484875|NCT00287118|79491489|FG000|Overall Study|Death|1|||
44484876|NCT00287118|79491489|FG000|Overall Study|Lack of Efficacy|11|||
44484877|NCT00287118|79491489|FG000|Overall Study|Lost to Follow-up|1|||
44484878|NCT00287118|79491489|FG000|Overall Study|Protocol Violation|2|||
44484879|NCT00287118|79491489|FG000|Overall Study|Other|7|||
44484880|NCT00293202|79491495|FG000|Overall Study|Withdrawal by Subject|1|||
44484881|NCT00293202|79491496|FG001|Overall Study|Withdrawal by Subject|2|||
44484882|NCT00293202|79491495|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
44484883|NCT00293202|79491496|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
44484884|NCT00293202|79491495|FG000|Overall Study|on-hold due to fistula maturation time|1|||
44484885|NCT00293202|79491496|FG001|Overall Study|on-hold due to fistula maturation time|0|||
44484886|NCT00298896|79491506|FG000|Overall Study|Death|3|||
44484887|NCT00298896|79491506|FG000|Overall Study|Physician Decision|2|||
44484888|NCT00298896|79491506|FG000|Overall Study|Intercurrent Illness|1|||
44484889|NCT00298896|79491506|FG000|Overall Study|Disease Progression|41|||
44484890|NCT00298896|79491506|FG000|Overall Study|Withdrawal by Subject|2|||
44484891|NCT00298896|79491506|FG000|Overall Study|Assigned to treatment in error|1|||
44484892|NCT00286494|79491513|FG000|Overall Study|Hyperglycemic rescue|12|||
44484893|NCT00286494|79491514|FG001|Overall Study|Hyperglycemic rescue|19|||
44484894|NCT00286494|79491515|FG002|Overall Study|Hyperglycemic rescue|18|||
44484895|NCT00286494|79491513|FG000|Overall Study|Withdrawal by Subject|2|||
44484896|NCT00286494|79491514|FG001|Overall Study|Withdrawal by Subject|10|||
44484897|NCT00286494|79491515|FG002|Overall Study|Withdrawal by Subject|9|||
44484898|NCT00286494|79491513|FG000|Overall Study|Adverse Event|3|||
44484899|NCT00286494|79491514|FG001|Overall Study|Adverse Event|8|||
44484900|NCT00286494|79491515|FG002|Overall Study|Adverse Event|6|||
44484901|NCT00286494|79491513|FG000|Overall Study|Physician Decision|5|||
44484902|NCT00286494|79491514|FG001|Overall Study|Physician Decision|5|||
44484903|NCT00286494|79491515|FG002|Overall Study|Physician Decision|1|||
44484904|NCT00286494|79491513|FG000|Overall Study|Lost to Follow-up|3|||
44484905|NCT00286494|79491514|FG001|Overall Study|Lost to Follow-up|1|||
44484906|NCT00286494|79491515|FG002|Overall Study|Lost to Follow-up|3|||
44484907|NCT00286494|79491513|FG000|Overall Study|Protocol Violation|1|||
44484908|NCT00286494|79491514|FG001|Overall Study|Protocol Violation|1|||
44484909|NCT00286494|79491515|FG002|Overall Study|Protocol Violation|2|||
44484910|NCT00298740|79491523|FG000|Overall Study|Lack of Efficacy|6|||
44484911|NCT00298740|79491523|FG000|Overall Study|Withdrawal by Subject|3|||
44484912|NCT00285012|79491529|FG000|Assigned to Study Treatment (Tx)|Other|2|||
44484913|NCT00285012|79491530|FG001|Assigned to Study Treatment (Tx)|Other|3|||
44228006|NCT01936181|79035191|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
44228007|NCT01936181|79035192|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
44228008|NCT01936181|79035193|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
44228009|NCT01936181|79035194|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
44228010|NCT01936181|79035191|FG000|Transition-extension|Adverse Event|3|||
44228011|NCT01936181|79035192|FG001|Transition-extension|Adverse Event|0|||
44228012|NCT01936181|79035193|FG002|Transition-extension|Adverse Event|3|||
44228013|NCT01936181|79035194|FG003|Transition-extension|Adverse Event|1|||
44274268|NCT01352221|79217743|FG001|Open-label Phase|Worsening of IBD|0|||
44274269|NCT01352221|79217744|FG002|Open-label Phase|Worsening of IBD|1|||
44274270|NCT01352221|79217745|FG003|Open-label Phase|Worsening of IBD|0|||
44274271|NCT01634100|79217771|FG000|Overall Study|Withdrawal by Subject|1|||
44484914|NCT00285012|79491529|FG000|Received Study Tx|Death|2|||
44484915|NCT00285012|79491530|FG001|Received Study Tx|Death|1|||
44484916|NCT00285012|79491529|FG000|Received Study Tx|Adverse Event|5|||
44484917|NCT00285012|79491530|FG001|Received Study Tx|Adverse Event|11|||
44484918|NCT00285012|79491529|FG000|Received Study Tx|Lack of Efficacy|0|||
44484919|NCT00285012|79491530|FG001|Received Study Tx|Lack of Efficacy|3|||
44484920|NCT00285012|79491529|FG000|Received Study Tx|Lost to Follow-up|29|||
44484921|NCT00285012|79491530|FG001|Received Study Tx|Lost to Follow-up|31|||
44228014|NCT01936181|79035191|FG000|Transition-extension|Lost to Follow-up|3|||
44274272|NCT01634100|79217772|FG001|Overall Study|Withdrawal by Subject|0|||
44484922|NCT00285012|79491529|FG000|Received Study Tx|Withdrawal by Subject|31|||
44484923|NCT00285012|79491530|FG001|Received Study Tx|Withdrawal by Subject|43|||
44484924|NCT00285012|79491529|FG000|Received Study Tx|Other|5|||
44484925|NCT00285012|79491530|FG001|Received Study Tx|Other|5|||
44484926|NCT00284934|79491538|FG000|Overall Study|Adverse Event|1|||
44484927|NCT00284934|79491539|FG001|Overall Study|Adverse Event|2|||
44484928|NCT00284934|79491538|FG000|Overall Study|Other reasons|3|||
44484929|NCT00284934|79491539|FG001|Overall Study|Other reasons|1|||
44228015|NCT01936181|79035192|FG001|Transition-extension|Lost to Follow-up|0|||
44228016|NCT01936181|79035193|FG002|Transition-extension|Lost to Follow-up|1|||
44228017|NCT01936181|79035194|FG003|Transition-extension|Lost to Follow-up|2|||
44228018|NCT01936181|79035191|FG000|Transition-extension|Physician Decision|2|||
44484930|NCT00284856|79491548|FG000|Overall Study|Adverse Event|3|||
44484931|NCT00284856|79491549|FG001|Overall Study|Adverse Event|3|||
44484932|NCT00284856|79491550|FG002|Overall Study|Adverse Event|3|||
44484933|NCT00284856|79491548|FG000|Overall Study|Lack of Efficacy|2|||
44484934|NCT00284856|79491549|FG001|Overall Study|Lack of Efficacy|1|||
44484935|NCT00284856|79491550|FG002|Overall Study|Lack of Efficacy|8|||
44484936|NCT00284856|79491548|FG000|Overall Study|Lost to Follow-up|25|||
44484937|NCT00284856|79491549|FG001|Overall Study|Lost to Follow-up|21|||
44484938|NCT00284856|79491550|FG002|Overall Study|Lost to Follow-up|22|||
44484939|NCT00284856|79491548|FG000|Overall Study|Protocol Violation|5|||
44484940|NCT00284856|79491549|FG001|Overall Study|Protocol Violation|4|||
44484941|NCT00284856|79491550|FG002|Overall Study|Protocol Violation|5|||
44484942|NCT00284856|79491548|FG000|Overall Study|Withdrawal by Subject|12|||
44484943|NCT00284856|79491549|FG001|Overall Study|Withdrawal by Subject|16|||
44484944|NCT00284856|79491550|FG002|Overall Study|Withdrawal by Subject|18|||
44484945|NCT00284856|79491548|FG000|Overall Study|Other|4|||
44484946|NCT00284856|79491549|FG001|Overall Study|Other|5|||
44484947|NCT00284856|79491550|FG002|Overall Study|Other|4|||
44484948|NCT00298272|79491560|FG000|Double-blind Phase|Adverse Event|2|||
44484949|NCT00298272|79491561|FG001|Double-blind Phase|Adverse Event|0|||
44484950|NCT00298272|79491560|FG000|Double-blind Phase|Failure to Return|2|||
44484951|NCT00298272|79491561|FG001|Double-blind Phase|Failure to Return|0|||
44484952|NCT00298272|79491560|FG000|Double-blind Phase|Protocol Violation|2|||
44484953|NCT00298272|79491561|FG001|Double-blind Phase|Protocol Violation|0|||
44484954|NCT00298272|79491560|FG000|Double-blind Phase|Withdrawal by Subject|2|||
44484955|NCT00298272|79491561|FG001|Double-blind Phase|Withdrawal by Subject|0|||
44484956|NCT00298272|79491560|FG000|Open Label Retreatment Phase|Adverse Event|1|||
44484957|NCT00298272|79491561|FG001|Open Label Retreatment Phase|Adverse Event|2|||
44484958|NCT00298272|79491560|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
44484959|NCT00298272|79491561|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
44484960|NCT00298272|79491560|FG000|Open Label Retreatment Phase|Failure to Return|1|||
44228019|NCT01936181|79035192|FG001|Transition-extension|Physician Decision|0|||
44484961|NCT00298272|79491561|FG001|Open Label Retreatment Phase|Failure to Return|0|||
44484962|NCT00298272|79491560|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
44484963|NCT00298272|79491561|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
44228020|NCT01936181|79035193|FG002|Transition-extension|Physician Decision|0|||
44484964|NCT00298272|79491560|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
44484965|NCT00298272|79491561|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
44484966|NCT00298272|79491560|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
44484967|NCT00298272|79491561|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
44484968|NCT00298272|79491560|FG000|Safety Follow-up Phase|Failure to Return|1|||
44484969|NCT00298272|79491561|FG001|Safety Follow-up Phase|Failure to Return|1|||
44484970|NCT00298272|79491560|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
44484971|NCT00298272|79491561|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
44484972|NCT00298272|79491560|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
44484973|NCT00298272|79491561|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
44484974|NCT00283842|79491575|FG000|Overall Study|Adverse Event|8|||
44484975|NCT00283842|79491576|FG001|Overall Study|Adverse Event|7|||
44484976|NCT00283842|79491577|FG002|Overall Study|Adverse Event|21|||
44484977|NCT00283842|79491578|FG003|Overall Study|Adverse Event|21|||
44484978|NCT00283842|79491579|FG004|Overall Study|Adverse Event|5|||
44484979|NCT00283842|79491575|FG000|Overall Study|Protocol Violation|1|||
44484980|NCT00283842|79491576|FG001|Overall Study|Protocol Violation|5|||
44484981|NCT00283842|79491577|FG002|Overall Study|Protocol Violation|4|||
44484982|NCT00283842|79491578|FG003|Overall Study|Protocol Violation|0|||
44484983|NCT00283842|79491579|FG004|Overall Study|Protocol Violation|0|||
44484984|NCT00283842|79491575|FG000|Overall Study|Protocol deviation|0|||
44484985|NCT00283842|79491576|FG001|Overall Study|Protocol deviation|0|||
44484986|NCT00283842|79491577|FG002|Overall Study|Protocol deviation|0|||
44484987|NCT00283842|79491578|FG003|Overall Study|Protocol deviation|0|||
44484988|NCT00283842|79491579|FG004|Overall Study|Protocol deviation|2|||
44484989|NCT00283842|79491575|FG000|Overall Study|Withdrawal by Subject|2|||
44484990|NCT00283842|79491576|FG001|Overall Study|Withdrawal by Subject|1|||
44484991|NCT00283842|79491577|FG002|Overall Study|Withdrawal by Subject|1|||
44484992|NCT00283842|79491578|FG003|Overall Study|Withdrawal by Subject|5|||
44484993|NCT00283842|79491579|FG004|Overall Study|Withdrawal by Subject|4|||
44484994|NCT00283842|79491575|FG000|Overall Study|Lack of Efficacy|1|||
44484995|NCT00283842|79491576|FG001|Overall Study|Lack of Efficacy|3|||
44484996|NCT00283842|79491577|FG002|Overall Study|Lack of Efficacy|1|||
44484997|NCT00283842|79491578|FG003|Overall Study|Lack of Efficacy|0|||
44484998|NCT00283842|79491579|FG004|Overall Study|Lack of Efficacy|3|||
44484999|NCT00283842|79491575|FG000|Overall Study|Lost to Follow-up|0|||
44485000|NCT00283842|79491576|FG001|Overall Study|Lost to Follow-up|2|||
44485001|NCT00283842|79491577|FG002|Overall Study|Lost to Follow-up|4|||
44485002|NCT00283842|79491578|FG003|Overall Study|Lost to Follow-up|1|||
44485003|NCT00283842|79491579|FG004|Overall Study|Lost to Follow-up|1|||
44485004|NCT00298038|79491593|FG000|Overall Study|Lost to Follow-up|0|||
44485005|NCT00298038|79491594|FG001|Overall Study|Lost to Follow-up|1|||
44485006|NCT00298038|79491593|FG000|Overall Study|Liver Transplant|0|||
44485007|NCT00298038|79491594|FG001|Overall Study|Liver Transplant|1|||
44485008|NCT00298038|79491593|FG000|Overall Study|Protocol Violation|1|||
44485009|NCT00298038|79491594|FG001|Overall Study|Protocol Violation|3|||
44485010|NCT00298038|79491593|FG000|Overall Study|Death|6|||
44485011|NCT00298038|79491594|FG001|Overall Study|Death|3|||
44485012|NCT00298038|79491593|FG000|Overall Study|Withdrawal by Subject|6|||
44485013|NCT00298038|79491594|FG001|Overall Study|Withdrawal by Subject|9|||
44485014|NCT00298038|79491593|FG000|Overall Study|Adverse Event|8|||
44485015|NCT00298038|79491594|FG001|Overall Study|Adverse Event|7|||
44485016|NCT00298038|79491593|FG000|Overall Study|Breakthrough overt HE episode|28|||
44485017|NCT00298038|79491594|FG001|Overall Study|Breakthrough overt HE episode|69|||
44485018|NCT00298038|79491593|FG000|Overall Study|Noncompliance|1|||
44485019|NCT00298038|79491594|FG001|Overall Study|Noncompliance|0|||
44485020|NCT00298038|79491593|FG000|Overall Study|Cocaine Abuse|1|||
44485021|NCT00298038|79491594|FG001|Overall Study|Cocaine Abuse|0|||
44485022|NCT00298038|79491593|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
44485023|NCT00298038|79491594|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
44485024|NCT00283686|79491604|FG000|Overall Study|Death|1|||
44485025|NCT00283686|79491605|FG001|Overall Study|Death|1|||
44485026|NCT00283686|79491606|FG002|Overall Study|Death|1|||
44485027|NCT00283686|79491607|FG003|Overall Study|Death|0|||
44485028|NCT00283686|79491604|FG000|Overall Study|Lost to Follow-up|21|||
44485029|NCT00283686|79491605|FG001|Overall Study|Lost to Follow-up|31|||
44485030|NCT00283686|79491606|FG002|Overall Study|Lost to Follow-up|26|||
44485031|NCT00283686|79491607|FG003|Overall Study|Lost to Follow-up|20|||
44485032|NCT00283686|79491604|FG000|Overall Study|Less than full participation|7|||
44485033|NCT00283686|79491605|FG001|Overall Study|Less than full participation|9|||
44485034|NCT00283686|79491606|FG002|Overall Study|Less than full participation|6|||
44485035|NCT00283686|79491607|FG003|Overall Study|Less than full participation|12|||
44485036|NCT00297882|79491619|FG000|Day 14|Lack of Efficacy|12|||
44485037|NCT00297882|79491620|FG001|Day 14|Lack of Efficacy|49|||
44485038|NCT00297882|79491619|FG000|Day 28|Lost to Follow-up|13|||
44485039|NCT00297882|79491620|FG001|Day 28|Lost to Follow-up|23|||
44485040|NCT00297882|79491619|FG000|Day 28|Lack of Efficacy|3|||
44485041|NCT00297882|79491620|FG001|Day 28|Lack of Efficacy|0|||
44485042|NCT00297648|79491628|FG000|Overall Study|Adverse Event|13|||
44485043|NCT00297648|79491628|FG000|Overall Study|Lack of Efficacy|18|||
44485044|NCT00297648|79491628|FG000|Overall Study|Lost to Follow-up|1|||
44485045|NCT00297648|79491628|FG000|Overall Study|Withdrawal by Subject|3|||
44485046|NCT00297648|79491628|FG000|Overall Study|Other: Incompliance|1|||
44485047|NCT00283296|79491632|FG000|Overall Study|in-home trial not completed|5|||
44485048|NCT00297492|79491640|FG000|Set Quit Date|Lost to Follow-up|7|||
44485049|NCT00297492|79491641|FG001|Set Quit Date|Lost to Follow-up|13|||
44485050|NCT00297492|79491642|FG002|Set Quit Date|Lost to Follow-up|5|||
44485051|NCT00297492|79491640|FG000|6 Month Follow-up|Lost to Follow-up|63|||
44485052|NCT00297492|79491641|FG001|6 Month Follow-up|Lost to Follow-up|49|||
44485053|NCT00297492|79491642|FG002|6 Month Follow-up|Lost to Follow-up|27|||
44485054|NCT00297258|79491650|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
44485055|NCT00297258|79491650|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
44485056|NCT00297258|79491650|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
44485057|NCT00297258|79491650|FG000|Overall Study|Intercurrent Illness|3|||
44485058|NCT00297258|79491650|FG000|Overall Study|Intercurrent Death|2|||
44485059|NCT00297258|79491650|FG000|Overall Study|Deteriorization of General Condition|1|||
44485060|NCT00297258|79491650|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
44485061|NCT00297258|79491650|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
44485062|NCT00297258|79491650|FG000|Overall Study|Switch to Commercial Treatment|1|||
44485063|NCT00297258|79491650|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
44485064|NCT00496769|79491659|FG000|Double Blind|>=1 reason assigned per patient|558|||
44485065|NCT00496769|79491660|FG001|Double Blind|>=1 reason assigned per patient|649|||
44485066|NCT00496769|79491661|FG002|Double Blind|>=1 reason assigned per patient|0|||
44485067|NCT00496769|79491659|FG000|Open Label|>=1 reason assigned per patient|0|||
44485068|NCT00496769|79491660|FG001|Open Label|>=1 reason assigned per patient|0|||
44485069|NCT00496769|79491661|FG002|Open Label|>=1 reason assigned per patient|1011|||
44485070|NCT00478673|79491670|FG000|30-Days Post-Procedure|Death|2|||
44485071|NCT00478673|79491670|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
44485072|NCT00478673|79491670|FG000|30-Days Post-Procedure|Missed Visit|7|||
44485073|NCT00478673|79491670|FG000|12-Months Post-Procedure|Death|23|||
44485074|NCT00478673|79491670|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
44485075|NCT00478673|79491670|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
44485076|NCT00478673|79491670|FG000|12-Months Post-Procedure|Missed Visit|25|||
44485077|NCT00478673|79491670|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
44485078|NCT00488345|79491677|FG000|Overall Study|Adverse Event|0|||
44485079|NCT00488345|79491678|FG001|Overall Study|Adverse Event|1|||
44485080|NCT00488345|79491679|FG002|Overall Study|Adverse Event|1|||
44485081|NCT00488345|79491677|FG000|Overall Study|Unable to administer antibiotics at home|0|||
44485082|NCT00488345|79491678|FG001|Overall Study|Unable to administer antibiotics at home|1|||
44485083|NCT00488345|79491679|FG002|Overall Study|Unable to administer antibiotics at home|0|||
44485084|NCT00488345|79491677|FG000|Overall Study|Institutional Review Board review|0|||
44485085|NCT00488345|79491678|FG001|Overall Study|Institutional Review Board review|0|||
44485086|NCT00488345|79491679|FG002|Overall Study|Institutional Review Board review|1|||
44485087|NCT00488345|79491677|FG000|Overall Study|Surgical team recommendation|0|||
44485088|NCT00488345|79491678|FG001|Overall Study|Surgical team recommendation|1|||
44485089|NCT00488345|79491679|FG002|Overall Study|Surgical team recommendation|0|||
44485090|NCT00488345|79491677|FG000|Overall Study|Parent/legal guardian request|0|||
44485091|NCT00488345|79491678|FG001|Overall Study|Parent/legal guardian request|1|||
44485092|NCT00488345|79491679|FG002|Overall Study|Parent/legal guardian request|1|||
44485093|NCT00283062|79491692|FG000|Overall Study|Did not receive any study medication|5|||
44485094|NCT00283062|79491693|FG001|Overall Study|Did not receive any study medication|4|||
44375652|NCT00940992|79380774|FG000|Overall Study|subject request|2|||
44485095|NCT00283062|79491694|FG002|Overall Study|Did not receive any study medication|36|||
44485096|NCT00283062|79491695|FG003|Overall Study|Did not receive any study medication|45|||
44485097|NCT00283062|79491692|FG000|Overall Study|Adverse Event|2|||
44485098|NCT00283062|79491693|FG001|Overall Study|Adverse Event|0|||
44485099|NCT00283062|79491694|FG002|Overall Study|Adverse Event|1|||
44485100|NCT00283062|79491695|FG003|Overall Study|Adverse Event|0|||
44485101|NCT00283062|79491692|FG000|Overall Study|Lost to Follow-up|1|||
44485102|NCT00283062|79491693|FG001|Overall Study|Lost to Follow-up|0|||
44485103|NCT00283062|79491694|FG002|Overall Study|Lost to Follow-up|1|||
44485104|NCT00283062|79491695|FG003|Overall Study|Lost to Follow-up|0|||
44485105|NCT00283062|79491692|FG000|Overall Study|Progressive disease|0|||
44485106|NCT00283062|79491693|FG001|Overall Study|Progressive disease|0|||
44485107|NCT00283062|79491694|FG002|Overall Study|Progressive disease|1|||
44485108|NCT00283062|79491695|FG003|Overall Study|Progressive disease|0|||
44485109|NCT00283062|79491692|FG000|Overall Study|Participant did not wish to continue|3|||
44485110|NCT00283062|79491693|FG001|Overall Study|Participant did not wish to continue|2|||
44485111|NCT00283062|79491694|FG002|Overall Study|Participant did not wish to continue|1|||
44485112|NCT00283062|79491695|FG003|Overall Study|Participant did not wish to continue|0|||
44485113|NCT00283062|79491692|FG000|Overall Study|Undefined|0|||
44485114|NCT00283062|79491693|FG001|Overall Study|Undefined|1|||
44485115|NCT00283062|79491694|FG002|Overall Study|Undefined|1|||
44485116|NCT00283062|79491695|FG003|Overall Study|Undefined|4|||
44485117|NCT00283062|79491692|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
44485118|NCT00283062|79491693|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
44485119|NCT00283062|79491694|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
44485120|NCT00283062|79491695|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
44485121|NCT00282984|79491707|FG000|Overall Study|Death|2|||
44485122|NCT00282984|79491708|FG001|Overall Study|Death|5|||
44485123|NCT00282984|79491707|FG000|Overall Study|Adverse Event|8|||
44485124|NCT00282984|79491708|FG001|Overall Study|Adverse Event|5|||
44485125|NCT00282984|79491707|FG000|Overall Study|Lack of Efficacy|0|||
44485126|NCT00282984|79491708|FG001|Overall Study|Lack of Efficacy|2|||
44485127|NCT00282984|79491707|FG000|Overall Study|Lost to Follow-up|14|||
44485128|NCT00282984|79491708|FG001|Overall Study|Lost to Follow-up|10|||
44485129|NCT00282984|79491707|FG000|Overall Study|Withdrawal by Participant|22|||
44485130|NCT00282984|79491708|FG001|Overall Study|Withdrawal by Participant|34|||
44485131|NCT00282984|79491707|FG000|Overall Study|Participant stopped study medication|2|||
44485132|NCT00282984|79491708|FG001|Overall Study|Participant stopped study medication|2|||
44485133|NCT00282984|79491707|FG000|Overall Study|Participant only allowed phone follow-up|0|||
44485134|NCT00282984|79491708|FG001|Overall Study|Participant only allowed phone follow-up|1|||
44485135|NCT00282984|79491707|FG000|Overall Study|Participant used antipsychosis meds|0|||
44485136|NCT00282984|79491708|FG001|Overall Study|Participant used antipsychosis meds|1|||
44485137|NCT00282984|79491707|FG000|Overall Study|lack of motivation|1|||
44485138|NCT00282984|79491708|FG001|Overall Study|lack of motivation|0|||
44485139|NCT00282984|79491707|FG000|Overall Study|in prison|0|||
44485140|NCT00282984|79491708|FG001|Overall Study|in prison|1|||
44485141|NCT00282984|79491707|FG000|Overall Study|Protocol Violation|2|||
44485142|NCT00282984|79491708|FG001|Overall Study|Protocol Violation|0|||
44485143|NCT00282438|79491716|FG000|Overall Study|Lack of Efficacy|1|||
44485144|NCT00282438|79491717|FG001|Overall Study|Lack of Efficacy|0|||
44485145|NCT00282438|79491716|FG000|Overall Study|Death|0|||
44485146|NCT00282438|79491717|FG001|Overall Study|Death|1|||
44485147|NCT00296400|79491726|FG000|Overall Study|Adverse Event|7|||
44485148|NCT00296400|79491727|FG001|Overall Study|Adverse Event|7|||
44485149|NCT00296400|79491728|FG002|Overall Study|Adverse Event|7|||
44485150|NCT00296400|79491726|FG000|Overall Study|Withdrawal by Subject|5|||
44485151|NCT00296400|79491727|FG001|Overall Study|Withdrawal by Subject|6|||
44485152|NCT00296400|79491728|FG002|Overall Study|Withdrawal by Subject|2|||
44485153|NCT00296400|79491726|FG000|Overall Study|Incorrect enrollment|2|||
44485154|NCT00296400|79491727|FG001|Overall Study|Incorrect enrollment|0|||
44485155|NCT00296400|79491728|FG002|Overall Study|Incorrect enrollment|0|||
44485156|NCT00296400|79491726|FG000|Overall Study|Protocol Violation|1|||
44485157|NCT00296400|79491727|FG001|Overall Study|Protocol Violation|1|||
44485158|NCT00296400|79491728|FG002|Overall Study|Protocol Violation|1|||
44485159|NCT00296400|79491726|FG000|Overall Study|Lost to Follow-up|1|||
44485160|NCT00296400|79491727|FG001|Overall Study|Lost to Follow-up|1|||
44485161|NCT00296400|79491728|FG002|Overall Study|Lost to Follow-up|2|||
44485162|NCT00296400|79491726|FG000|Overall Study|Study specific discontinuation criteria|0|||
44485163|NCT00296400|79491727|FG001|Overall Study|Study specific discontinuation criteria|0|||
44485164|NCT00296400|79491728|FG002|Overall Study|Study specific discontinuation criteria|1|||
44485165|NCT00296400|79491726|FG000|Overall Study|Visit 10 was performed earlier|0|||
44485166|NCT00296400|79491727|FG001|Overall Study|Visit 10 was performed earlier|1|||
44485167|NCT00296400|79491728|FG002|Overall Study|Visit 10 was performed earlier|0|||
44485168|NCT00296400|79491726|FG000|Overall Study|Pregnancy|1|||
44485169|NCT00296400|79491727|FG001|Overall Study|Pregnancy|2|||
44485170|NCT00296400|79491728|FG002|Overall Study|Pregnancy|0|||
44485171|NCT00296244|79491741|FG000|Overall Study|Underwent retransplant|0|||
44485172|NCT00296244|79491742|FG001|Overall Study|Underwent retransplant|1|||
44485173|NCT00274716|79491759|FG000|Phase A|Other non-reported reason|4|||
44485174|NCT00274716|79491760|FG001|Phase A|Other non-reported reason|2|||
44485175|NCT00274716|79491761|FG002|Phase A|Other non-reported reason|1|||
44485176|NCT00274716|79491762|FG003|Phase A|Other non-reported reason|2|||
44485177|NCT00274716|79491763|FG004|Phase A|Other non-reported reason|0|||
44485178|NCT00274716|79491764|FG005|Phase A|Other non-reported reason|1|||
44485179|NCT00274716|79491759|FG000|Phase A|Participant moved|0|||
44485180|NCT00274716|79491760|FG001|Phase A|Participant moved|0|||
44485181|NCT00274716|79491761|FG002|Phase A|Participant moved|1|||
44485182|NCT00274716|79491762|FG003|Phase A|Participant moved|0|||
44485183|NCT00274716|79491763|FG004|Phase A|Participant moved|0|||
44485184|NCT00274716|79491764|FG005|Phase A|Participant moved|1|||
44485185|NCT00274716|79491759|FG000|Phase A|Site Terminated|0|||
44485186|NCT00274716|79491760|FG001|Phase A|Site Terminated|0|||
44485187|NCT00274716|79491761|FG002|Phase A|Site Terminated|0|||
44485188|NCT00274716|79491762|FG003|Phase A|Site Terminated|1|||
44485189|NCT00274716|79491763|FG004|Phase A|Site Terminated|0|||
44485190|NCT00274716|79491764|FG005|Phase A|Site Terminated|0|||
44485191|NCT00274716|79491759|FG000|Phase A|Protocol Violation|1|||
44485192|NCT00274716|79491760|FG001|Phase A|Protocol Violation|0|||
44485193|NCT00274716|79491761|FG002|Phase A|Protocol Violation|0|||
44485194|NCT00274716|79491762|FG003|Phase A|Protocol Violation|1|||
44485195|NCT00274716|79491763|FG004|Phase A|Protocol Violation|0|||
44485196|NCT00274716|79491764|FG005|Phase A|Protocol Violation|0|||
44485197|NCT00274716|79491759|FG000|Phase A|Met criteria for discontinuation|1|||
44485198|NCT00274716|79491760|FG001|Phase A|Met criteria for discontinuation|1|||
44485199|NCT00274716|79491761|FG002|Phase A|Met criteria for discontinuation|0|||
44485200|NCT00274716|79491762|FG003|Phase A|Met criteria for discontinuation|0|||
44485201|NCT00274716|79491763|FG004|Phase A|Met criteria for discontinuation|0|||
44485202|NCT00274716|79491764|FG005|Phase A|Met criteria for discontinuation|0|||
44228021|NCT01936181|79035194|FG003|Transition-extension|Physician Decision|1|||
44228022|NCT01936181|79035191|FG000|Transition-extension|Withdrawal by Subject|7|||
44228023|NCT01936181|79035192|FG001|Transition-extension|Withdrawal by Subject|0|||
44228024|NCT01936181|79035193|FG002|Transition-extension|Withdrawal by Subject|2|||
44228025|NCT01936181|79035194|FG003|Transition-extension|Withdrawal by Subject|1|||
44228026|NCT01696045|79035207|FG000|Overall Study|Study drug toxicity|1|||
44228027|NCT01696045|79035208|FG001|Overall Study|Study drug toxicity|5|||
44228028|NCT01696045|79035207|FG000|Overall Study|Disease progression|2|||
44228029|NCT01696045|79035208|FG001|Overall Study|Disease progression|2|||
44228030|NCT01716169|79035214|FG000|Overall Study|Adverse Event|1|||
44228031|NCT01716169|79035214|FG000|Overall Study|Lost to Follow-up|1|||
44228032|NCT01716169|79035214|FG000|Overall Study|Withdrawal by Subject|1|||
44228033|NCT01716169|79035214|FG000|Overall Study|inconsistent dressing application|1|||
44485203|NCT00274716|79491759|FG000|Phase A|Withdrawal by Subject|2|||
44485204|NCT00274716|79491760|FG001|Phase A|Withdrawal by Subject|2|||
44485205|NCT00274716|79491761|FG002|Phase A|Withdrawal by Subject|1|||
44228034|NCT01935947|79035223|FG000|Overall Study|Adverse Event|0|||
44485206|NCT00274716|79491762|FG003|Phase A|Withdrawal by Subject|3|||
44485207|NCT00274716|79491763|FG004|Phase A|Withdrawal by Subject|0|||
44485208|NCT00274716|79491764|FG005|Phase A|Withdrawal by Subject|1|||
44228035|NCT01935947|79035224|FG001|Overall Study|Adverse Event|2|||
44228036|NCT01935947|79035225|FG002|Overall Study|Adverse Event|0|||
44228037|NCT01935947|79035223|FG000|Overall Study|Diease Progression|2|||
44228038|NCT01935947|79035224|FG001|Overall Study|Diease Progression|2|||
44485209|NCT00274716|79491759|FG000|Phase A|Adverse Event|2|||
44485210|NCT00274716|79491760|FG001|Phase A|Adverse Event|3|||
44485211|NCT00274716|79491761|FG002|Phase A|Adverse Event|3|||
44485212|NCT00274716|79491762|FG003|Phase A|Adverse Event|0|||
44485213|NCT00274716|79491763|FG004|Phase A|Adverse Event|2|||
44228039|NCT01935947|79035225|FG002|Overall Study|Diease Progression|2|||
44228040|NCT01935947|79035223|FG000|Overall Study|Death|1|||
44228041|NCT01935947|79035224|FG001|Overall Study|Death|0|||
44485214|NCT00274716|79491764|FG005|Phase A|Adverse Event|0|||
44485215|NCT00274716|79491759|FG000|Phase A|Completed but did not enter Phase B|1|||
44485216|NCT00274716|79491760|FG001|Phase A|Completed but did not enter Phase B|2|||
44485217|NCT00274716|79491761|FG002|Phase A|Completed but did not enter Phase B|2|||
44485218|NCT00274716|79491762|FG003|Phase A|Completed but did not enter Phase B|2|||
44485219|NCT00274716|79491763|FG004|Phase A|Completed but did not enter Phase B|1|||
44485220|NCT00274716|79491764|FG005|Phase A|Completed but did not enter Phase B|1|||
44485221|NCT00274716|79491759|FG000|Phase B|Adverse Event|0|||
44485222|NCT00274716|79491760|FG001|Phase B|Adverse Event|0|||
44485223|NCT00274716|79491761|FG002|Phase B|Adverse Event|2|||
44485224|NCT00274716|79491762|FG003|Phase B|Adverse Event|0|||
44485225|NCT00274716|79491763|FG004|Phase B|Adverse Event|0|||
44485226|NCT00274716|79491764|FG005|Phase B|Adverse Event|1|||
44485227|NCT00274716|79491759|FG000|Phase B|Protocol Violation|0|||
44485228|NCT00274716|79491760|FG001|Phase B|Protocol Violation|2|||
44485229|NCT00274716|79491761|FG002|Phase B|Protocol Violation|0|||
44485230|NCT00274716|79491762|FG003|Phase B|Protocol Violation|0|||
44485231|NCT00274716|79491763|FG004|Phase B|Protocol Violation|0|||
44485232|NCT00274716|79491764|FG005|Phase B|Protocol Violation|0|||
44485233|NCT00274716|79491759|FG000|Phase B|Withdrawal by Subject|0|||
44485234|NCT00274716|79491760|FG001|Phase B|Withdrawal by Subject|1|||
44485235|NCT00274716|79491761|FG002|Phase B|Withdrawal by Subject|0|||
44485236|NCT00274716|79491762|FG003|Phase B|Withdrawal by Subject|0|||
44485237|NCT00274716|79491763|FG004|Phase B|Withdrawal by Subject|0|||
44485238|NCT00274716|79491764|FG005|Phase B|Withdrawal by Subject|0|||
44485239|NCT00274716|79491759|FG000|Phase B|Participant moved|1|||
44485240|NCT00274716|79491760|FG001|Phase B|Participant moved|0|||
44485241|NCT00274716|79491761|FG002|Phase B|Participant moved|0|||
44485242|NCT00274716|79491762|FG003|Phase B|Participant moved|0|||
44485243|NCT00274716|79491763|FG004|Phase B|Participant moved|0|||
44485244|NCT00274716|79491764|FG005|Phase B|Participant moved|0|||
44485245|NCT00274716|79491759|FG000|Phase B|Other non-reported reason|0|||
44485246|NCT00274716|79491760|FG001|Phase B|Other non-reported reason|0|||
44485247|NCT00274716|79491761|FG002|Phase B|Other non-reported reason|1|||
44485248|NCT00274716|79491762|FG003|Phase B|Other non-reported reason|1|||
44485249|NCT00274716|79491763|FG004|Phase B|Other non-reported reason|0|||
44485250|NCT00274716|79491764|FG005|Phase B|Other non-reported reason|0|||
44485251|NCT00274716|79491759|FG000|Phase B|Lost to Follow-up|0|||
44485252|NCT00274716|79491760|FG001|Phase B|Lost to Follow-up|1|||
44485253|NCT00274716|79491761|FG002|Phase B|Lost to Follow-up|0|||
44485254|NCT00274716|79491762|FG003|Phase B|Lost to Follow-up|0|||
44485255|NCT00274716|79491763|FG004|Phase B|Lost to Follow-up|0|||
44485256|NCT00274716|79491764|FG005|Phase B|Lost to Follow-up|0|||
44485257|NCT00282048|79491782|FG000|Overall Study|Lack of Efficacy|30|||
44485258|NCT00282048|79491782|FG000|Overall Study|Adverse Event|22|||
44485259|NCT00282048|79491782|FG000|Overall Study|Withdrawal by Subject|1|||
44485260|NCT00282048|79491782|FG000|Overall Study|Other|8|||
44485261|NCT00282048|79491782|FG000|Overall Study|Ongoing|1|||
44485262|NCT00474539|79491788|FG000|Infant Series|Withdrawal by Subject|3|||
44485263|NCT00474539|79491789|FG001|Infant Series|Withdrawal by Subject|4|||
44485264|NCT00474539|79491788|FG000|Infant Series|Randomization error|5|||
44485265|NCT00474539|79491789|FG001|Infant Series|Randomization error|0|||
44485266|NCT00474539|79491788|FG000|Infant Series|Lost to Follow-up|2|||
44485267|NCT00474539|79491789|FG001|Infant Series|Lost to Follow-up|1|||
44485268|NCT00474539|79491788|FG000|Infant Series|Protocol Violation|0|||
44485269|NCT00474539|79491789|FG001|Infant Series|Protocol Violation|1|||
44485270|NCT00474539|79491788|FG000|After Infant Series|Lost to Follow-up|3|||
44485271|NCT00474539|79491789|FG001|After Infant Series|Lost to Follow-up|0|||
44485272|NCT00474539|79491788|FG000|After Infant Series|Withdrawal by Subject|1|||
44485273|NCT00474539|79491789|FG001|After Infant Series|Withdrawal by Subject|0|||
44485274|NCT00474539|79491788|FG000|Toddler Dose|Protocol Violation|1|||
44485275|NCT00474539|79491789|FG001|Toddler Dose|Protocol Violation|0|||
44485276|NCT00281580|79491836|FG000|Overall Study|Adverse Event|2|||
44485277|NCT00281580|79491837|FG001|Overall Study|Adverse Event|0|||
44485278|NCT00281580|79491838|FG002|Overall Study|Adverse Event|2|||
44485279|NCT00281580|79491839|FG003|Overall Study|Adverse Event|4|||
44228042|NCT01935947|79035225|FG002|Overall Study|Death|0|||
44485280|NCT00281580|79491840|FG004|Overall Study|Adverse Event|1|||
44485281|NCT00281580|79491841|FG005|Overall Study|Adverse Event|0|||
44485282|NCT00281580|79491842|FG006|Overall Study|Adverse Event|1|||
44485283|NCT00281580|79491843|FG007|Overall Study|Adverse Event|0|||
44485284|NCT00281580|79491844|FG008|Overall Study|Adverse Event|1|||
44485285|NCT00281580|79491845|FG009|Overall Study|Adverse Event|6|||
44485286|NCT00281580|79491846|FG010|Overall Study|Adverse Event|0|||
44485287|NCT00281580|79491847|FG011|Overall Study|Adverse Event|5|||
44485288|NCT00281580|79491848|FG012|Overall Study|Adverse Event|8|||
44485289|NCT00281580|79491849|FG013|Overall Study|Adverse Event|2|||
44485290|NCT00281580|79491850|FG014|Overall Study|Adverse Event|3|||
44485291|NCT00281580|79491851|FG015|Overall Study|Adverse Event|3|||
44485292|NCT00281580|79491836|FG000|Overall Study|Protocol Violation|0|||
44375653|NCT00940992|79380775|FG001|Overall Study|subject request|1|||
44485293|NCT00281580|79491837|FG001|Overall Study|Protocol Violation|0|||
44485294|NCT00281580|79491838|FG002|Overall Study|Protocol Violation|1|||
44485295|NCT00281580|79491839|FG003|Overall Study|Protocol Violation|1|||
44375654|NCT00940992|79380776|FG002|Overall Study|subject request|0|||
44485296|NCT00281580|79491840|FG004|Overall Study|Protocol Violation|0|||
44485297|NCT00281580|79491841|FG005|Overall Study|Protocol Violation|0|||
44485298|NCT00281580|79491842|FG006|Overall Study|Protocol Violation|1|||
44485299|NCT00281580|79491843|FG007|Overall Study|Protocol Violation|0|||
44485300|NCT00281580|79491844|FG008|Overall Study|Protocol Violation|2|||
44485301|NCT00281580|79491845|FG009|Overall Study|Protocol Violation|0|||
44485302|NCT00281580|79491846|FG010|Overall Study|Protocol Violation|1|||
44485303|NCT00281580|79491847|FG011|Overall Study|Protocol Violation|2|||
44485304|NCT00281580|79491848|FG012|Overall Study|Protocol Violation|0|||
44485305|NCT00281580|79491849|FG013|Overall Study|Protocol Violation|1|||
44485306|NCT00281580|79491850|FG014|Overall Study|Protocol Violation|1|||
44485307|NCT00281580|79491851|FG015|Overall Study|Protocol Violation|3|||
44485308|NCT00281580|79491836|FG000|Overall Study|Withdrawal by Subject|3|||
44485309|NCT00281580|79491837|FG001|Overall Study|Withdrawal by Subject|0|||
44485310|NCT00281580|79491838|FG002|Overall Study|Withdrawal by Subject|1|||
44485311|NCT00281580|79491839|FG003|Overall Study|Withdrawal by Subject|1|||
44485312|NCT00281580|79491840|FG004|Overall Study|Withdrawal by Subject|1|||
44485313|NCT00281580|79491841|FG005|Overall Study|Withdrawal by Subject|2|||
44485314|NCT00281580|79491842|FG006|Overall Study|Withdrawal by Subject|2|||
44485315|NCT00281580|79491843|FG007|Overall Study|Withdrawal by Subject|0|||
44485316|NCT00281580|79491844|FG008|Overall Study|Withdrawal by Subject|1|||
44485317|NCT00281580|79491845|FG009|Overall Study|Withdrawal by Subject|4|||
44485318|NCT00281580|79491846|FG010|Overall Study|Withdrawal by Subject|1|||
44485319|NCT00281580|79491847|FG011|Overall Study|Withdrawal by Subject|1|||
44485320|NCT00281580|79491848|FG012|Overall Study|Withdrawal by Subject|2|||
44485321|NCT00281580|79491849|FG013|Overall Study|Withdrawal by Subject|2|||
44485322|NCT00281580|79491850|FG014|Overall Study|Withdrawal by Subject|1|||
44485323|NCT00281580|79491851|FG015|Overall Study|Withdrawal by Subject|5|||
44485324|NCT00281580|79491836|FG000|Overall Study|Lack of Efficacy|2|||
44485325|NCT00281580|79491837|FG001|Overall Study|Lack of Efficacy|1|||
44485326|NCT00281580|79491838|FG002|Overall Study|Lack of Efficacy|1|||
44485327|NCT00281580|79491839|FG003|Overall Study|Lack of Efficacy|6|||
44228043|NCT01618019|79035238|FG000|Overall Study|Withdrawal by Subject|14|||
44375655|NCT00940992|79380774|FG000|Overall Study|Lost to Follow-up|0|||
44375656|NCT00940992|79380775|FG001|Overall Study|Lost to Follow-up|1|||
44485328|NCT00281580|79491840|FG004|Overall Study|Lack of Efficacy|2|||
44485329|NCT00281580|79491841|FG005|Overall Study|Lack of Efficacy|0|||
44485330|NCT00281580|79491842|FG006|Overall Study|Lack of Efficacy|0|||
44485331|NCT00281580|79491843|FG007|Overall Study|Lack of Efficacy|0|||
44485332|NCT00281580|79491844|FG008|Overall Study|Lack of Efficacy|0|||
44485333|NCT00281580|79491845|FG009|Overall Study|Lack of Efficacy|0|||
44485334|NCT00281580|79491846|FG010|Overall Study|Lack of Efficacy|0|||
44485335|NCT00281580|79491847|FG011|Overall Study|Lack of Efficacy|1|||
44485336|NCT00281580|79491848|FG012|Overall Study|Lack of Efficacy|0|||
44485337|NCT00281580|79491849|FG013|Overall Study|Lack of Efficacy|2|||
44485338|NCT00281580|79491850|FG014|Overall Study|Lack of Efficacy|1|||
44485339|NCT00281580|79491851|FG015|Overall Study|Lack of Efficacy|0|||
44485340|NCT00281580|79491836|FG000|Overall Study|Lost to Follow-up|0|||
44485341|NCT00281580|79491837|FG001|Overall Study|Lost to Follow-up|0|||
44485342|NCT00281580|79491838|FG002|Overall Study|Lost to Follow-up|0|||
44485343|NCT00281580|79491839|FG003|Overall Study|Lost to Follow-up|3|||
44485344|NCT00281580|79491840|FG004|Overall Study|Lost to Follow-up|0|||
44485345|NCT00281580|79491841|FG005|Overall Study|Lost to Follow-up|1|||
44375657|NCT00940992|79380776|FG002|Overall Study|Lost to Follow-up|1|||
44485346|NCT00281580|79491842|FG006|Overall Study|Lost to Follow-up|0|||
44485347|NCT00281580|79491843|FG007|Overall Study|Lost to Follow-up|1|||
44485348|NCT00281580|79491844|FG008|Overall Study|Lost to Follow-up|2|||
44485349|NCT00281580|79491845|FG009|Overall Study|Lost to Follow-up|1|||
44485350|NCT00281580|79491846|FG010|Overall Study|Lost to Follow-up|1|||
44485351|NCT00281580|79491847|FG011|Overall Study|Lost to Follow-up|0|||
44485352|NCT00281580|79491848|FG012|Overall Study|Lost to Follow-up|1|||
44485353|NCT00281580|79491849|FG013|Overall Study|Lost to Follow-up|0|||
44485354|NCT00281580|79491850|FG014|Overall Study|Lost to Follow-up|0|||
44485355|NCT00281580|79491851|FG015|Overall Study|Lost to Follow-up|0|||
44485356|NCT00281580|79491836|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
44485357|NCT00281580|79491837|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
44485358|NCT00281580|79491838|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
44485359|NCT00281580|79491839|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
44485360|NCT00281580|79491840|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
44485361|NCT00281580|79491841|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
44485362|NCT00281580|79491842|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
44485363|NCT00281580|79491843|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
44485364|NCT00281580|79491844|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
44485365|NCT00281580|79491845|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
44485366|NCT00281580|79491846|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
44485367|NCT00281580|79491847|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
44375658|NCT00938964|79380786|FG000|Overall Study|Death|3|||
44485368|NCT00281580|79491848|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
44485369|NCT00281580|79491849|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
44485370|NCT00281580|79491850|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
44485371|NCT00281580|79491851|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
44375659|NCT00938964|79380787|FG001|Overall Study|Death|3|||
44485372|NCT00495755|79491920|FG000|Overall Study|Adverse Event|3|||
44485373|NCT00495677|79491932|FG000|Stage 1 (25 Days)|Adverse Event|0|||
44485374|NCT00495677|79491933|FG001|Stage 1 (25 Days)|Adverse Event|0|||
44485375|NCT00495677|79491934|FG002|Stage 1 (25 Days)|Adverse Event|1|||
44485376|NCT00495677|79491935|FG003|Stage 1 (25 Days)|Adverse Event|0|||
44485377|NCT00495677|79491936|FG004|Stage 1 (25 Days)|Adverse Event|0|||
44485378|NCT00495677|79491937|FG005|Stage 1 (25 Days)|Adverse Event|0|||
44485379|NCT00495677|79491938|FG006|Stage 1 (25 Days)|Adverse Event|0|||
44485380|NCT00495521|79491956|FG000|Overall Study|Physician Decision|0|||
44485381|NCT00495521|79491957|FG001|Overall Study|Physician Decision|1|||
44485382|NCT00273858|79491963|FG000|Overall Study|Not completed 24 month observation time|334|||
44228044|NCT01618019|79035239|FG001|Overall Study|Withdrawal by Subject|14|||
44228045|NCT01593787|79035248|FG000|Overall Study|Adverse Event|1|||
44228046|NCT01593787|79035249|FG001|Overall Study|Adverse Event|0|||
44228047|NCT01593787|79035250|FG002|Overall Study|Adverse Event|0|||
44228048|NCT01951157|79035263|FG000|Overall Study|Progressive Disease|12|||
44228049|NCT01951157|79035264|FG001|Overall Study|Progressive Disease|13|||
44228050|NCT01951157|79035265|FG002|Overall Study|Progressive Disease|10|||
44228051|NCT01951157|79035263|FG000|Overall Study|Treatment-unrelated AE|1|||
44485383|NCT00273858|79491963|FG000|Overall Study|Lost to Follow-up|101|||
44485384|NCT00273858|79491963|FG000|Overall Study|Withdrawal by Subject|21|||
44485385|NCT00273858|79491963|FG000|Overall Study|Adverse Event|81|||
44485386|NCT00494507|79491971|FG000|Double-Blind Phase|Adverse Event|2|||
44485387|NCT00494507|79491972|FG001|Double-Blind Phase|Adverse Event|0|||
44485388|NCT00494507|79491973|FG002|Double-Blind Phase|Adverse Event|1|||
44485389|NCT00494507|79491974|FG003|Double-Blind Phase|Adverse Event|0|||
44485390|NCT00494507|79491971|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
44485391|NCT00494507|79491972|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
44485392|NCT00494507|79491973|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
44485393|NCT00494507|79491974|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44485394|NCT00494507|79491971|FG000|Double-Blind Phase|Subject Non-compliance|0|||
44485395|NCT00494507|79491972|FG001|Double-Blind Phase|Subject Non-compliance|0|||
44485396|NCT00494507|79491973|FG002|Double-Blind Phase|Subject Non-compliance|1|||
44485397|NCT00494507|79491974|FG003|Double-Blind Phase|Subject Non-compliance|0|||
44485398|NCT00494507|79491971|FG000|Double-Blind Phase|Negative DNA test|0|||
44485399|NCT00494507|79491972|FG001|Double-Blind Phase|Negative DNA test|0|||
44485400|NCT00494507|79491973|FG002|Double-Blind Phase|Negative DNA test|0|||
44485401|NCT00494507|79491974|FG003|Double-Blind Phase|Negative DNA test|1|||
44485402|NCT00494507|79491971|FG000|Open-Label Phase|Adverse Event|0|||
44485403|NCT00494507|79491972|FG001|Open-Label Phase|Adverse Event|1|||
44485404|NCT00494507|79491973|FG002|Open-Label Phase|Adverse Event|5|||
44485405|NCT00494507|79491974|FG003|Open-Label Phase|Adverse Event|3|||
44485406|NCT00494507|79491971|FG000|Open-Label Phase|Worsening Disease|0|||
44485407|NCT00494507|79491972|FG001|Open-Label Phase|Worsening Disease|0|||
44485408|NCT00494507|79491973|FG002|Open-Label Phase|Worsening Disease|0|||
44485409|NCT00494507|79491974|FG003|Open-Label Phase|Worsening Disease|2|||
44485410|NCT00292188|79491996|FG000|Single-Blind|Adverse Event|14|||
44485411|NCT00292188|79491997|FG001|Single-Blind|Adverse Event|0|||
44485412|NCT00292188|79491998|FG002|Single-Blind|Adverse Event|0|||
44485413|NCT00292188|79491996|FG000|Single-Blind|Lack of Efficacy|2|||
44485414|NCT00292188|79491997|FG001|Single-Blind|Lack of Efficacy|0|||
44485415|NCT00292188|79491998|FG002|Single-Blind|Lack of Efficacy|0|||
44485416|NCT00292188|79491996|FG000|Single-Blind|Laboratory Abnormality|5|||
44485417|NCT00292188|79491997|FG001|Single-Blind|Laboratory Abnormality|0|||
44485418|NCT00292188|79491998|FG002|Single-Blind|Laboratory Abnormality|0|||
44485419|NCT00292188|79491996|FG000|Single-Blind|Lost to Follow-up|3|||
44485420|NCT00292188|79491997|FG001|Single-Blind|Lost to Follow-up|0|||
44485421|NCT00292188|79491998|FG002|Single-Blind|Lost to Follow-up|0|||
44485422|NCT00292188|79491996|FG000|Single-Blind|Other|77|||
44228052|NCT01951157|79035264|FG001|Overall Study|Treatment-unrelated AE|0|||
44228053|NCT01951157|79035265|FG002|Overall Study|Treatment-unrelated AE|3|||
44274273|NCT01634100|79217773|FG002|Overall Study|Withdrawal by Subject|1|||
44485423|NCT00292188|79491997|FG001|Single-Blind|Other|0|||
44228054|NCT01951157|79035263|FG000|Overall Study|Study Termination|0|||
44274274|NCT01634100|79217774|FG003|Overall Study|Withdrawal by Subject|0|||
44274275|NCT01634100|79217775|FG004|Overall Study|Withdrawal by Subject|0|||
44274276|NCT01634100|79217776|FG005|Overall Study|Withdrawal by Subject|0|||
44485424|NCT00292188|79491998|FG002|Single-Blind|Other|0|||
44485425|NCT00292188|79491996|FG000|Single-Blind|Withdrawal by Subject|12|||
44485426|NCT00292188|79491997|FG001|Single-Blind|Withdrawal by Subject|0|||
44485427|NCT00292188|79491998|FG002|Single-Blind|Withdrawal by Subject|0|||
44485428|NCT00292188|79491996|FG000|Single-Blind|Did not receive treatment|1|||
44485429|NCT00292188|79491997|FG001|Single-Blind|Did not receive treatment|0|||
44485430|NCT00292188|79491998|FG002|Single-Blind|Did not receive treatment|0|||
44485431|NCT00292188|79491996|FG000|Double-Blind|Adverse Event|0|||
44485432|NCT00292188|79491997|FG001|Double-Blind|Adverse Event|25|||
44485433|NCT00292188|79491998|FG002|Double-Blind|Adverse Event|9|||
44485434|NCT00292188|79491996|FG000|Double-Blind|Lack of Efficacy|0|||
44485435|NCT00292188|79491997|FG001|Double-Blind|Lack of Efficacy|2|||
44485436|NCT00292188|79491998|FG002|Double-Blind|Lack of Efficacy|12|||
44485437|NCT00292188|79491996|FG000|Double-Blind|Lost to Follow-up|0|||
44485438|NCT00292188|79491997|FG001|Double-Blind|Lost to Follow-up|1|||
44485439|NCT00292188|79491998|FG002|Double-Blind|Lost to Follow-up|0|||
44485440|NCT00292188|79491996|FG000|Double-Blind|Other|0|||
44485441|NCT00292188|79491997|FG001|Double-Blind|Other|3|||
44485442|NCT00292188|79491998|FG002|Double-Blind|Other|4|||
44485443|NCT00292188|79491996|FG000|Double-Blind|Withdrawal by Subject|0|||
44485444|NCT00292188|79491997|FG001|Double-Blind|Withdrawal by Subject|0|||
44485445|NCT00292188|79491998|FG002|Double-Blind|Withdrawal by Subject|3|||
44485446|NCT00292188|79491996|FG000|Double-Blind|Laboratory Abnormality|0|||
44485447|NCT00292188|79491997|FG001|Double-Blind|Laboratory Abnormality|0|||
44485448|NCT00292188|79491998|FG002|Double-Blind|Laboratory Abnormality|1|||
44485449|NCT00272844|79492005|FG000|Overall Study|Withdrawal by Subject|5|||
44485450|NCT00271596|79492011|FG000|Overall Study|Protocol Violation|1|||
44485451|NCT00271596|79492012|FG001|Overall Study|Protocol Violation|0|||
44485452|NCT00271596|79492011|FG000|Overall Study|Withdrawal by Subject|0|||
44485453|NCT00271596|79492012|FG001|Overall Study|Withdrawal by Subject|1|||
44485454|NCT00291642|79492023|FG000|Overall Study|Adverse Event|1|||
44485455|NCT00291642|79492024|FG001|Overall Study|Adverse Event|0|||
44485456|NCT00291642|79492025|FG002|Overall Study|Adverse Event|1|||
44485457|NCT00291642|79492026|FG003|Overall Study|Adverse Event|0|||
44485458|NCT00291642|79492027|FG004|Overall Study|Adverse Event|1|||
44485459|NCT00291642|79492023|FG000|Overall Study|Patient missed visit|0|||
44485460|NCT00291642|79492024|FG001|Overall Study|Patient missed visit|0|||
44485461|NCT00291642|79492025|FG002|Overall Study|Patient missed visit|1|||
44485462|NCT00291642|79492026|FG003|Overall Study|Patient missed visit|0|||
44485463|NCT00291642|79492027|FG004|Overall Study|Patient missed visit|0|||
44485464|NCT00291642|79492023|FG000|Overall Study|Intake of prohibited medication|1|||
44485465|NCT00291642|79492024|FG001|Overall Study|Intake of prohibited medication|0|||
44485466|NCT00291642|79492025|FG002|Overall Study|Intake of prohibited medication|0|||
44485467|NCT00291642|79492026|FG003|Overall Study|Intake of prohibited medication|0|||
44485468|NCT00291642|79492027|FG004|Overall Study|Intake of prohibited medication|0|||
44485469|NCT00280566|79492041|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
44485470|NCT00280566|79492042|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
44485471|NCT00280566|79492043|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
44228055|NCT01951157|79035264|FG001|Overall Study|Study Termination|0|||
44228056|NCT01951157|79035265|FG002|Overall Study|Study Termination|1|||
44485472|NCT00280566|79492041|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
44228057|NCT01951157|79035263|FG000|Overall Study|Physician Decision|5|||
44485473|NCT00280566|79492042|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
44485474|NCT00280566|79492043|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
44485475|NCT00280566|79492041|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
44485476|NCT00280566|79492042|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
44485477|NCT00280566|79492043|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
44228058|NCT01951157|79035264|FG001|Overall Study|Physician Decision|3|||
44228059|NCT01951157|79035265|FG002|Overall Study|Physician Decision|2|||
44228060|NCT01951157|79035263|FG000|Overall Study|Non-treatmentrelated death|2|||
44485478|NCT00280566|79492041|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
44485479|NCT00280566|79492042|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
44485480|NCT00280566|79492043|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
44485481|NCT00280566|79492041|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
44485482|NCT00280566|79492042|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
44485483|NCT00280566|79492043|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
44485484|NCT00280566|79492041|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
44485485|NCT00280566|79492042|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
44485486|NCT00280566|79492043|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
44485487|NCT00280566|79492041|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
44485488|NCT00280566|79492042|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
44485489|NCT00280566|79492043|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
44485490|NCT00280566|79492041|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
44485491|NCT00280566|79492042|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
44485492|NCT00280566|79492043|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
44485493|NCT00280566|79492041|FG000|Period 2 Double Blind|Adverse Event|0|||
44485494|NCT00280566|79492042|FG001|Period 2 Double Blind|Adverse Event|11|||
44485495|NCT00280566|79492043|FG002|Period 2 Double Blind|Adverse Event|15|||
44485496|NCT00280566|79492041|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
44485497|NCT00280566|79492042|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
44485498|NCT00280566|79492043|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
44228061|NCT01951157|79035264|FG001|Overall Study|Non-treatmentrelated death|2|||
44228062|NCT01951157|79035265|FG002|Overall Study|Non-treatmentrelated death|2|||
44228063|NCT01951157|79035263|FG000|Overall Study|No treated|0|||
44485499|NCT00280566|79492041|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
44485500|NCT00280566|79492042|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
44485501|NCT00280566|79492043|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
44485502|NCT00280566|79492041|FG000|Period 2 Double Blind|miscellaneous|0|||
44485503|NCT00280566|79492042|FG001|Period 2 Double Blind|miscellaneous|10|||
44485504|NCT00280566|79492043|FG002|Period 2 Double Blind|miscellaneous|5|||
44485505|NCT00270894|79492050|FG000|Overall Study|Adverse Event|1|||
44485506|NCT00270894|79492050|FG000|Overall Study|Withdrawal by Subject|1|||
44485507|NCT00317642|79492056|FG000|Overall Study|Not Received Either Study Drug|1|||
44485508|NCT00317642|79492057|FG001|Overall Study|Not Received Either Study Drug|3|||
44485509|NCT00317642|79492056|FG000|Overall Study|Physician Decision|15|||
44485510|NCT00317642|79492057|FG001|Overall Study|Physician Decision|7|||
44485511|NCT00317642|79492056|FG000|Overall Study|Participant declined treatment|14|||
44485512|NCT00317642|79492057|FG001|Overall Study|Participant declined treatment|3|||
44485513|NCT00317642|79492056|FG000|Overall Study|Adverse Event|17|||
44485514|NCT00317642|79492057|FG001|Overall Study|Adverse Event|5|||
44485515|NCT00317642|79492056|FG000|Overall Study|Treatment Failure|56|||
44485516|NCT00317642|79492057|FG001|Overall Study|Treatment Failure|102|||
44485517|NCT00317642|79492056|FG000|Overall Study|Disease Recurrence|1|||
44485518|NCT00317642|79492057|FG001|Overall Study|Disease Recurrence|2|||
44485519|NCT00317642|79492056|FG000|Overall Study|Death|14|||
44485520|NCT00317642|79492057|FG001|Overall Study|Death|7|||
44485521|NCT00317642|79492056|FG000|Overall Study|Not Continue to Consolidation|2|||
44485522|NCT00317642|79492057|FG001|Overall Study|Not Continue to Consolidation|0|||
44485523|NCT00317642|79492056|FG000|Overall Study|Withdrawal by Subject|0|||
44485524|NCT00317642|79492057|FG001|Overall Study|Withdrawal by Subject|1|||
44228064|NCT01951157|79035264|FG001|Overall Study|No treated|1|||
44485525|NCT00317642|79492056|FG000|Overall Study|Referred For Transplantation|1|||
44485526|NCT00317642|79492057|FG001|Overall Study|Referred For Transplantation|0|||
44485527|NCT00317642|79492056|FG000|Overall Study|AML Not Centrally Confirmed|1|||
44485528|NCT00317642|79492057|FG001|Overall Study|AML Not Centrally Confirmed|5|||
44485529|NCT00295022|79492073|FG000|Overall Study|Adverse Event|1|||
44485530|NCT00295022|79492074|FG001|Overall Study|Adverse Event|1|||
44485531|NCT00295022|79492075|FG002|Overall Study|Adverse Event|2|||
44485532|NCT00295022|79492073|FG000|Overall Study|Lost to Follow-up|0|||
44485533|NCT00295022|79492074|FG001|Overall Study|Lost to Follow-up|0|||
44485534|NCT00295022|79492075|FG002|Overall Study|Lost to Follow-up|1|||
44485535|NCT00295022|79492073|FG000|Overall Study|Withdrawal by Subject|0|||
44485536|NCT00295022|79492074|FG001|Overall Study|Withdrawal by Subject|0|||
44485537|NCT00295022|79492075|FG002|Overall Study|Withdrawal by Subject|2|||
44485538|NCT00303446|79492087|FG000|Overall Study|Withdrawal by Subject|2|||
44485539|NCT00303446|79492088|FG001|Overall Study|Withdrawal by Subject|2|||
44485540|NCT00303446|79492087|FG000|Overall Study|Death|0|||
44485541|NCT00303446|79492088|FG001|Overall Study|Death|1|||
44485542|NCT00303446|79492087|FG000|Overall Study|Physician Decision|0|||
44485543|NCT00303446|79492088|FG001|Overall Study|Physician Decision|1|||
44485544|NCT00316706|79492096|FG000|Overall Study|Lost to Follow-up|38|||
44485545|NCT00316706|79492097|FG001|Overall Study|Lost to Follow-up|48|||
44485546|NCT00291486|79492108|FG000|Overall Study|Adverse Event|0|||
44485547|NCT00291486|79492109|FG001|Overall Study|Adverse Event|3|||
44485548|NCT00291486|79492110|FG002|Overall Study|Adverse Event|0|||
44485549|NCT00291486|79492111|FG003|Overall Study|Adverse Event|1|||
44485550|NCT00291486|79492112|FG004|Overall Study|Adverse Event|0|||
44485551|NCT00291486|79492108|FG000|Overall Study|Withdrawal by Subject|0|||
44485552|NCT00291486|79492109|FG001|Overall Study|Withdrawal by Subject|0|||
44485553|NCT00291486|79492110|FG002|Overall Study|Withdrawal by Subject|0|||
44485554|NCT00291486|79492111|FG003|Overall Study|Withdrawal by Subject|0|||
44485555|NCT00291486|79492112|FG004|Overall Study|Withdrawal by Subject|1|||
44485556|NCT00291486|79492108|FG000|Overall Study|Disease progression|1|||
44485557|NCT00291486|79492109|FG001|Overall Study|Disease progression|0|||
44485558|NCT00291486|79492110|FG002|Overall Study|Disease progression|1|||
44485559|NCT00291486|79492111|FG003|Overall Study|Disease progression|0|||
44485560|NCT00291486|79492112|FG004|Overall Study|Disease progression|0|||
44485561|NCT00301964|79492133|FG000|Overall Study|Second primary|2|||
44485562|NCT00301964|79492133|FG000|Overall Study|Wrong primary|1|||
44485563|NCT00301964|79492133|FG000|Overall Study|Inadequate pathology|1|||
44228065|NCT01951157|79035265|FG002|Overall Study|No treated|0|||
44485564|NCT00268242|79492143|FG000|Overall Study|Death|1|||
44485565|NCT00294554|79492149|FG000|Overall Study|Lack of Efficacy|0|||
44485566|NCT00294554|79492150|FG001|Overall Study|Lack of Efficacy|1|||
44485567|NCT00294554|79492149|FG000|Overall Study|Physician Decision|0|||
44485568|NCT00294554|79492150|FG001|Overall Study|Physician Decision|1|||
44485569|NCT00294398|79492158|FG000|Overall Study|Lost to Follow-up|21|||
44485570|NCT00294398|79492159|FG001|Overall Study|Lost to Follow-up|26|||
44485571|NCT00279708|79492167|FG000|Overall Study|Withdrawal by Subject|2|||
44485572|NCT00279708|79492168|FG001|Overall Study|Withdrawal by Subject|3|||
44485573|NCT00279708|79492167|FG000|Overall Study|Adverse Event|1|||
44485574|NCT00279708|79492168|FG001|Overall Study|Adverse Event|1|||
44485575|NCT00299702|79492176|FG000|Overall Study|Death|1|||
44485576|NCT00299702|79492177|FG001|Overall Study|Death|0|||
44485577|NCT00299702|79492176|FG000|Overall Study|Adverse Event|0|||
44485578|NCT00299702|79492177|FG001|Overall Study|Adverse Event|4|||
44485579|NCT00299702|79492176|FG000|Overall Study|Lost to Follow-up|18|||
44485580|NCT00299702|79492177|FG001|Overall Study|Lost to Follow-up|10|||
44485581|NCT00299702|79492176|FG000|Overall Study|Withdrawal by Subject|25|||
44485582|NCT00299702|79492177|FG001|Overall Study|Withdrawal by Subject|23|||
44485583|NCT00299702|79492176|FG000|Overall Study|Pregnancy|0|||
44485584|NCT00299702|79492177|FG001|Overall Study|Pregnancy|1|||
44485585|NCT00299702|79492176|FG000|Overall Study|Insufficient Response|4|||
44228066|NCT01951157|79035263|FG000|Overall Study|Treatment-related AE|2|||
44228067|NCT01951157|79035264|FG001|Overall Study|Treatment-related AE|0|||
44228068|NCT01951157|79035265|FG002|Overall Study|Treatment-related AE|4|||
44228069|NCT01951157|79035263|FG000|Overall Study|Consent withdrawn by subject|0|||
44228070|NCT01951157|79035264|FG001|Overall Study|Consent withdrawn by subject|1|||
44228071|NCT01951157|79035265|FG002|Overall Study|Consent withdrawn by subject|3|||
44228072|NCT01951157|79035263|FG000|Overall Study|Treatment-related death|0|||
44228073|NCT01951157|79035264|FG001|Overall Study|Treatment-related death|2|||
44228074|NCT01951157|79035265|FG002|Overall Study|Treatment-related death|0|||
44228075|NCT01363349|79035276|FG000|Overall Study|Adverse Event|6|||
44228076|NCT01363349|79035277|FG001|Overall Study|Adverse Event|7|||
44228077|NCT01363349|79035276|FG000|Overall Study|Lack of Efficacy|3|||
44228078|NCT01363349|79035277|FG001|Overall Study|Lack of Efficacy|10|||
44228079|NCT01363349|79035276|FG000|Overall Study|Non compliance/Protocol deviations|2|||
44228080|NCT01363349|79035277|FG001|Overall Study|Non compliance/Protocol deviations|2|||
44228081|NCT01363349|79035276|FG000|Overall Study|Withdrawal by Subject|14|||
44485586|NCT00299702|79492177|FG001|Overall Study|Insufficient Response|3|||
44485587|NCT00299702|79492176|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
44485588|NCT00299702|79492177|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
44485589|NCT00291330|79492185|FG000|Overall Study|Adverse Event|47|||
44485590|NCT00291330|79492186|FG001|Overall Study|Adverse Event|40|||
44485591|NCT00291330|79492185|FG000|Overall Study|Protocol Violation|13|||
44485592|NCT00291330|79492186|FG001|Overall Study|Protocol Violation|20|||
44485593|NCT00291330|79492185|FG000|Overall Study|Lost to Follow-up|16|||
44485594|NCT00291330|79492186|FG001|Overall Study|Lost to Follow-up|11|||
44485595|NCT00291330|79492185|FG000|Overall Study|Withdrawal by Subject|22|||
44485596|NCT00291330|79492186|FG001|Overall Study|Withdrawal by Subject|25|||
44485597|NCT00291330|79492185|FG000|Overall Study|Other|3|||
44485598|NCT00291330|79492186|FG001|Overall Study|Other|1|||
44485599|NCT00267150|79492192|FG000|Overall Study|Adverse Event|1|||
44485600|NCT00278148|79492196|FG000|Phase II - Expansion Phase|Disease progression|0|||
44485601|NCT00278148|79492197|FG001|Phase II - Expansion Phase|Disease progression|0|||
44485602|NCT00278148|79492198|FG002|Phase II - Expansion Phase|Disease progression|4|||
44485603|NCT00278148|79492196|FG000|Phase II - Expansion Phase|Adverse Event|0|||
44485604|NCT00278148|79492197|FG001|Phase II - Expansion Phase|Adverse Event|0|||
44485605|NCT00278148|79492198|FG002|Phase II - Expansion Phase|Adverse Event|2|||
44485606|NCT00299546|79492208|FG000|Overall Study|Death|3|||
44485607|NCT00299546|79492209|FG001|Overall Study|Death|2|||
44485608|NCT00299546|79492210|FG002|Overall Study|Death|0|||
44485609|NCT00299546|79492208|FG000|Overall Study|Lost to Follow-up|2|||
44485610|NCT00299546|79492209|FG001|Overall Study|Lost to Follow-up|2|||
44485611|NCT00299546|79492210|FG002|Overall Study|Lost to Follow-up|5|||
44485612|NCT00299546|79492208|FG000|Overall Study|Adverse Event|37|||
44485613|NCT00299546|79492209|FG001|Overall Study|Adverse Event|22|||
44485614|NCT00299546|79492210|FG002|Overall Study|Adverse Event|27|||
44485615|NCT00299546|79492208|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
44485616|NCT00299546|79492209|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
44485617|NCT00299546|79492210|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
44485618|NCT00299546|79492208|FG000|Overall Study|Other|24|||
44485619|NCT00299546|79492209|FG001|Overall Study|Other|26|||
44485620|NCT00299546|79492210|FG002|Overall Study|Other|19|||
44485621|NCT00299546|79492208|FG000|Overall Study|Not treated|0|||
44485622|NCT00299546|79492209|FG001|Overall Study|Not treated|1|||
44485623|NCT00299546|79492210|FG002|Overall Study|Not treated|1|||
44485624|NCT00299156|79492222|FG000|Period 2 (Randomized)|Screen Failure|0|||
44228082|NCT01363349|79035277|FG001|Overall Study|Withdrawal by Subject|6|||
44228083|NCT01363349|79035276|FG000|Overall Study|Lost to Follow-up|5|||
44228084|NCT01363349|79035277|FG001|Overall Study|Lost to Follow-up|6|||
44485625|NCT00299156|79492223|FG001|Period 2 (Randomized)|Screen Failure|1|||
44485626|NCT00299156|79492224|FG002|Period 2 (Randomized)|Screen Failure|0|||
44485627|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
44485628|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
44485629|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
44485630|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
44485631|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
44485632|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
44485633|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
44485634|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
44485635|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
44485636|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
44228085|NCT01363349|79035276|FG000|Overall Study|Not reported|36|||
44228086|NCT01363349|79035277|FG001|Overall Study|Not reported|37|||
44228087|NCT01363349|79035276|FG000|Overall Study|missing|1|||
44514828|NCT03717012|79520645|FG001|Overall Study|Lung transplant|1|||
44228088|NCT01363349|79035277|FG001|Overall Study|missing|2|||
44485637|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
44485638|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
44485639|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
44485640|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
44485641|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
44485642|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
44485643|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
44485644|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
44485645|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
44485646|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
44485647|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
44485648|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
44485649|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
44485650|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
44485651|NCT00277212|79492232|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
44485652|NCT00277212|79492233|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
44485653|NCT00277212|79492234|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
44485654|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
44485655|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
44485656|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
44485657|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
44485658|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
44485659|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
44485660|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
44485661|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
44485662|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
44485663|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
44485664|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
44485665|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
44485666|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
44485667|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
44485668|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
44485669|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
44485670|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
44485671|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
44485672|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
44485673|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
44485674|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
44485675|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
44485676|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
44485677|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
44485678|NCT00277212|79492232|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
44485679|NCT00277212|79492233|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
44485680|NCT00277212|79492234|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
44485681|NCT00276744|79492242|FG000|PART A|Reason unknown|98|||
44485682|NCT00251316|79492248|FG000|Overall Study|Physician Decision|2|||
44485683|NCT00251316|79492249|FG001|Overall Study|Physician Decision|3|||
44485684|NCT00293462|79492258|FG000|Overall Study|Withdrawal by Subject|4|||
44485685|NCT00293462|79492259|FG001|Overall Study|Withdrawal by Subject|3|||
44485686|NCT00293462|79492260|FG002|Overall Study|Withdrawal by Subject|8|||
44485687|NCT00293462|79492258|FG000|Overall Study|Death|1|||
44485688|NCT00293462|79492259|FG001|Overall Study|Death|0|||
44485689|NCT00293462|79492260|FG002|Overall Study|Death|0|||
44485690|NCT00293462|79492258|FG000|Overall Study|Lost to Follow-up|0|||
44485691|NCT00293462|79492259|FG001|Overall Study|Lost to Follow-up|1|||
44485692|NCT00293462|79492260|FG002|Overall Study|Lost to Follow-up|0|||
44485693|NCT00293462|79492258|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
44485694|NCT00293462|79492259|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
44228089|NCT01933919|79035368|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
44485695|NCT00293462|79492260|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
44485696|NCT00293462|79492258|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
44485697|NCT00293462|79492259|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
44485698|NCT00293462|79492260|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
44485699|NCT00293462|79492258|FG000|Overall Study|Refuse Radiation Treatment|1|||
44485700|NCT00293462|79492259|FG001|Overall Study|Refuse Radiation Treatment|0|||
44228090|NCT01933919|79035369|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
44228091|NCT01933919|79035368|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
44228092|NCT01933919|79035369|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
44485701|NCT00293462|79492260|FG002|Overall Study|Refuse Radiation Treatment|0|||
44485702|NCT00293462|79492258|FG000|Overall Study|No Show|0|||
44485703|NCT00293462|79492259|FG001|Overall Study|No Show|0|||
44485704|NCT00293462|79492260|FG002|Overall Study|No Show|1|||
44485705|NCT00293462|79492258|FG000|Overall Study|Went back to his home country|0|||
44485706|NCT00293462|79492259|FG001|Overall Study|Went back to his home country|0|||
44485707|NCT00293462|79492260|FG002|Overall Study|Went back to his home country|1|||
44485708|NCT00293462|79492258|FG000|Overall Study|Blood clot after chemotherapy|0|||
44485709|NCT00293462|79492259|FG001|Overall Study|Blood clot after chemotherapy|0|||
44485710|NCT00293462|79492260|FG002|Overall Study|Blood clot after chemotherapy|1|||
44485711|NCT00293462|79492258|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
44485712|NCT00293462|79492259|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
44485713|NCT00293462|79492260|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
44228093|NCT01933919|79035368|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
44485714|NCT00293462|79492258|FG000|Overall Study|Possible Tracheostomy leakage|0|||
44485715|NCT00293462|79492259|FG001|Overall Study|Possible Tracheostomy leakage|1|||
44485716|NCT00293462|79492260|FG002|Overall Study|Possible Tracheostomy leakage|0|||
44485717|NCT00293462|79492258|FG000|Overall Study|Low radiation dose in oral cavity|0|||
44485718|NCT00293462|79492259|FG001|Overall Study|Low radiation dose in oral cavity|1|||
44485719|NCT00293462|79492260|FG002|Overall Study|Low radiation dose in oral cavity|0|||
44485720|NCT00293462|79492258|FG000|Overall Study|Physician Decision|0|||
44485721|NCT00293462|79492259|FG001|Overall Study|Physician Decision|1|||
44485722|NCT00293462|79492260|FG002|Overall Study|Physician Decision|0|||
44485723|NCT00316082|79492273|FG000|Overall Study|Lack of Efficacy|2|||
44485724|NCT00316082|79492274|FG001|Overall Study|Lack of Efficacy|3|||
44485725|NCT00316082|79492275|FG002|Overall Study|Lack of Efficacy|3|||
44485726|NCT00316082|79492276|FG003|Overall Study|Lack of Efficacy|4|||
44485727|NCT00316082|79492277|FG004|Overall Study|Lack of Efficacy|6|||
44485728|NCT00316082|79492273|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
44485729|NCT00316082|79492274|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
44485730|NCT00316082|79492275|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
44485731|NCT00316082|79492276|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
44485732|NCT00316082|79492277|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
44485733|NCT00316082|79492273|FG000|Overall Study|Lost to Follow-up|7|||
44485734|NCT00316082|79492274|FG001|Overall Study|Lost to Follow-up|6|||
44485735|NCT00316082|79492275|FG002|Overall Study|Lost to Follow-up|7|||
44485736|NCT00316082|79492276|FG003|Overall Study|Lost to Follow-up|8|||
44485737|NCT00316082|79492277|FG004|Overall Study|Lost to Follow-up|6|||
44485738|NCT00316082|79492273|FG000|Overall Study|Poor/noncompliance|6|||
44485739|NCT00316082|79492274|FG001|Overall Study|Poor/noncompliance|1|||
44485740|NCT00316082|79492275|FG002|Overall Study|Poor/noncompliance|4|||
44485741|NCT00316082|79492276|FG003|Overall Study|Poor/noncompliance|1|||
44485742|NCT00316082|79492277|FG004|Overall Study|Poor/noncompliance|4|||
44485743|NCT00316082|79492273|FG000|Overall Study|Adverse Event|4|||
44485744|NCT00316082|79492274|FG001|Overall Study|Adverse Event|2|||
44485745|NCT00316082|79492275|FG002|Overall Study|Adverse Event|5|||
44485746|NCT00316082|79492276|FG003|Overall Study|Adverse Event|1|||
44485747|NCT00316082|79492277|FG004|Overall Study|Adverse Event|3|||
44485748|NCT00316082|79492273|FG000|Overall Study|Subject no longer meets study criteria|3|||
44485749|NCT00316082|79492274|FG001|Overall Study|Subject no longer meets study criteria|1|||
44485750|NCT00316082|79492275|FG002|Overall Study|Subject no longer meets study criteria|2|||
44485751|NCT00316082|79492276|FG003|Overall Study|Subject no longer meets study criteria|2|||
44485752|NCT00316082|79492277|FG004|Overall Study|Subject no longer meets study criteria|1|||
44485753|NCT00316082|79492273|FG000|Overall Study|Physician Decision|1|||
44485754|NCT00316082|79492274|FG001|Overall Study|Physician Decision|1|||
44485755|NCT00316082|79492275|FG002|Overall Study|Physician Decision|2|||
44485756|NCT00316082|79492276|FG003|Overall Study|Physician Decision|1|||
44485757|NCT00316082|79492277|FG004|Overall Study|Physician Decision|1|||
44485758|NCT00316082|79492273|FG000|Overall Study|Death|0|||
44485759|NCT00316082|79492274|FG001|Overall Study|Death|0|||
44228094|NCT01933919|79035369|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
44228095|NCT01933919|79035368|FG000|Open-label Long-term Phase|Adverse Event|2|||
44485760|NCT00316082|79492275|FG002|Overall Study|Death|1|||
44485761|NCT00316082|79492276|FG003|Overall Study|Death|0|||
44485762|NCT00316082|79492277|FG004|Overall Study|Death|0|||
44485763|NCT00316082|79492273|FG000|Overall Study|Administrative reason by sponsor|0|||
44485764|NCT00316082|79492274|FG001|Overall Study|Administrative reason by sponsor|0|||
44485765|NCT00316082|79492275|FG002|Overall Study|Administrative reason by sponsor|1|||
44485766|NCT00316082|79492276|FG003|Overall Study|Administrative reason by sponsor|0|||
44485767|NCT00316082|79492277|FG004|Overall Study|Administrative reason by sponsor|0|||
44485768|NCT00316004|79492296|FG000|Overall Study|Subject was not given study fluid.|14|||
44485769|NCT00316004|79492297|FG001|Overall Study|Subject was not given study fluid.|14|||
44485770|NCT00316004|79492298|FG002|Overall Study|Subject was not given study fluid.|21|||
44485771|NCT00298766|79492306|FG000|Overall Study|Adverse Event|18|||
44485772|NCT00298766|79492306|FG000|Overall Study|Death|2|||
44485773|NCT00298766|79492306|FG000|Overall Study|Withdrawal by Subject|9|||
44485774|NCT00298766|79492306|FG000|Overall Study|Treatment ongoing|4|||
44485775|NCT00298766|79492306|FG000|Overall Study|Progression of amyloid markers|4|||
44485776|NCT00298766|79492306|FG000|Overall Study|Deterioration in KPS and organ function|1|||
44485777|NCT00298766|79492306|FG000|Overall Study|Subjects overall condition deterioration|4|||
44485778|NCT00298766|79492306|FG000|Overall Study|Other|4|||
44485779|NCT00315458|79492312|FG000|Overall Study|Administrative|0|||
44485780|NCT00315458|79492313|FG001|Overall Study|Administrative|3|||
44485781|NCT00315458|79492314|FG002|Overall Study|Administrative|8|||
44485782|NCT00315458|79492315|FG003|Overall Study|Administrative|21|||
44485783|NCT00315458|79492312|FG000|Overall Study|Adverse Event|2|||
44485784|NCT00315458|79492313|FG001|Overall Study|Adverse Event|4|||
44485785|NCT00315458|79492314|FG002|Overall Study|Adverse Event|23|||
44485786|NCT00315458|79492315|FG003|Overall Study|Adverse Event|3|||
44485787|NCT00315458|79492312|FG000|Overall Study|Lost to Follow-up|1|||
44485788|NCT00315458|79492313|FG001|Overall Study|Lost to Follow-up|2|||
44485789|NCT00315458|79492314|FG002|Overall Study|Lost to Follow-up|0|||
44485790|NCT00315458|79492315|FG003|Overall Study|Lost to Follow-up|2|||
44485791|NCT00315458|79492312|FG000|Overall Study|Withdrawal by Subject|0|||
44485792|NCT00315458|79492313|FG001|Overall Study|Withdrawal by Subject|3|||
44485793|NCT00315458|79492314|FG002|Overall Study|Withdrawal by Subject|0|||
44485794|NCT00315458|79492315|FG003|Overall Study|Withdrawal by Subject|2|||
44485795|NCT00315458|79492312|FG000|Overall Study|Lack of Efficacy|0|||
44485796|NCT00315458|79492313|FG001|Overall Study|Lack of Efficacy|0|||
44485797|NCT00315458|79492314|FG002|Overall Study|Lack of Efficacy|20|||
44485798|NCT00315458|79492315|FG003|Overall Study|Lack of Efficacy|1|||
44485799|NCT00315458|79492312|FG000|Overall Study|Did not qualify|0|||
44485800|NCT00315458|79492313|FG001|Overall Study|Did not qualify|0|||
44485801|NCT00315458|79492314|FG002|Overall Study|Did not qualify|1|||
44485802|NCT00315458|79492315|FG003|Overall Study|Did not qualify|0|||
44485803|NCT00293384|79492325|FG000|Overall Study|Non-compliance|2|||
44485804|NCT00293384|79492325|FG000|Overall Study|Missed dosage/study drug|1|||
44485805|NCT00293384|79492325|FG000|Overall Study|Ineligible|2|||
44485806|NCT00297830|79492332|FG000|6 Month Visit|Death|1|||
44485807|NCT00297830|79492333|FG001|6 Month Visit|Death|0|||
44485808|NCT00297830|79492334|FG002|6 Month Visit|Death|2|||
44485809|NCT00297830|79492332|FG000|6 Month Visit|Withdrawal by Subject|2|||
44485810|NCT00297830|79492333|FG001|6 Month Visit|Withdrawal by Subject|1|||
44485811|NCT00297830|79492334|FG002|6 Month Visit|Withdrawal by Subject|1|||
44485812|NCT00297830|79492332|FG000|6 Month Visit|Adverse Event|0|||
44485813|NCT00297830|79492333|FG001|6 Month Visit|Adverse Event|1|||
44485814|NCT00297830|79492334|FG002|6 Month Visit|Adverse Event|0|||
44485815|NCT00297830|79492332|FG000|12 Month Visit|Lost to Follow-up|1|||
44485816|NCT00297830|79492333|FG001|12 Month Visit|Lost to Follow-up|0|||
44485817|NCT00297830|79492334|FG002|12 Month Visit|Lost to Follow-up|0|||
44485818|NCT00297830|79492332|FG000|12 Month Visit|Adverse Event|0|||
44485819|NCT00297830|79492333|FG001|12 Month Visit|Adverse Event|3|||
44485820|NCT00297830|79492334|FG002|12 Month Visit|Adverse Event|0|||
44485821|NCT00297830|79492332|FG000|12 Month Visit|Withdrawal by Subject|0|||
44485822|NCT00297830|79492333|FG001|12 Month Visit|Withdrawal by Subject|3|||
44485823|NCT00297830|79492334|FG002|12 Month Visit|Withdrawal by Subject|0|||
44485824|NCT00296816|79492344|FG000|Overall Study|Disease Progression|37|||
44485825|NCT00296816|79492344|FG000|Overall Study|Adverse Event|18|||
44485826|NCT00296816|79492344|FG000|Overall Study|Investigator/Participant request|5|||
44485827|NCT00296816|79492344|FG000|Overall Study|Non-compliance|1|||
44228096|NCT01933919|79035369|FG001|Open-label Long-term Phase|Adverse Event|0|||
44485828|NCT00296816|79492344|FG000|Overall Study|Missing for end of treatment|4|||
44485829|NCT00296816|79492344|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
44228097|NCT01933919|79035368|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
44228098|NCT01933919|79035369|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
44485830|NCT00296816|79492344|FG000|Overall Study|Poor performance status|1|||
44485831|NCT00296816|79492344|FG000|Overall Study|Relocation to Florida|1|||
44485832|NCT00296816|79492344|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
44485833|NCT00296816|79492344|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
44485834|NCT00296816|79492344|FG000|Overall Study|Neuropathy/patient preference|1|||
44485835|NCT00296816|79492344|FG000|Overall Study|Proteinuria|1|||
44485836|NCT00296816|79492344|FG000|Overall Study|ineligibility due to radiation treatment|1|||
44485837|NCT00314132|79492350|FG000|Overall Study|Lost to Follow-up|3|||
44485838|NCT00314132|79492351|FG001|Overall Study|Lost to Follow-up|13|||
44485839|NCT00314132|79492350|FG000|Overall Study|Withdrawal by Subject|3|||
44485840|NCT00314132|79492351|FG001|Overall Study|Withdrawal by Subject|5|||
44485841|NCT00314132|79492350|FG000|Overall Study|Adverse Event|1|||
44485842|NCT00314132|79492351|FG001|Overall Study|Adverse Event|0|||
44485843|NCT00314132|79492350|FG000|Overall Study|Physician Decision|1|||
44485844|NCT00314132|79492351|FG001|Overall Study|Physician Decision|0|||
44485845|NCT00117988|79492359|FG000|Overall Study|Death|3|||
44485846|NCT00117988|79492359|FG000|Overall Study|Adverse Event|1|||
44485847|NCT00117676|79492365|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
44485848|NCT00117676|79492366|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
44485849|NCT00117676|79492365|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
44485850|NCT00117676|79492366|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
44485851|NCT00117676|79492365|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
44485852|NCT00117676|79492366|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
44485853|NCT00117676|79492365|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
44485854|NCT00117676|79492366|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
44485855|NCT00117676|79492365|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
44485856|NCT00117676|79492366|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
44485857|NCT00117676|79492365|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
44485858|NCT00117676|79492366|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
44485859|NCT00117676|79492365|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
44485860|NCT00117676|79492366|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
44485861|NCT00117676|79492365|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
44485862|NCT00117676|79492366|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
44485863|NCT00117676|79492365|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
44485864|NCT00117676|79492366|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
44485865|NCT00117676|79492365|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
44485866|NCT00117676|79492366|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
44485867|NCT00117676|79492365|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
44485868|NCT00117676|79492366|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
44485869|NCT00117676|79492365|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
44485870|NCT00117676|79492366|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
44485871|NCT00117676|79492365|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
44485872|NCT00117676|79492366|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
44485873|NCT00117676|79492365|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
44485874|NCT00117676|79492366|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
44485875|NCT00117676|79492365|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
44485876|NCT00117676|79492366|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
44485877|NCT00117676|79492365|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
44485878|NCT00117676|79492366|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
44485879|NCT00117676|79492365|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
44485880|NCT00117676|79492366|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
44485881|NCT00117676|79492365|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
44485882|NCT00117676|79492366|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
44485883|NCT00117676|79492365|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
44228099|NCT01933919|79035368|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
44228100|NCT01933919|79035369|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
44228101|NCT01933919|79035368|FG000|Open-label Long-term Phase|Other|1|||
44228102|NCT01933919|79035369|FG001|Open-label Long-term Phase|Other|2|||
44228103|NCT01933217|79035398|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
44228104|NCT01933217|79035399|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
44228105|NCT01933217|79035398|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
44228106|NCT01933217|79035399|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
44485884|NCT00117676|79492366|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
44485885|NCT00117676|79492365|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
44485886|NCT00117676|79492366|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
44485887|NCT00117676|79492365|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
44485888|NCT00117676|79492366|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
44485889|NCT00117676|79492365|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
44274277|NCT01633944|79217786|FG000|Open-label Titration Phase|Adverse Event|109|||
44485890|NCT00117676|79492366|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
44485891|NCT00117676|79492365|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
44485892|NCT00117676|79492366|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
44485893|NCT00117676|79492365|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
44485894|NCT00117676|79492366|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
44485895|NCT00117676|79492365|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
44485896|NCT00117676|79492366|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
44485897|NCT00117676|79492365|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
44485898|NCT00117676|79492366|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
44485899|NCT00117676|79492365|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
44485900|NCT00117676|79492366|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
44485901|NCT00117676|79492365|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
44485902|NCT00117676|79492366|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
44485903|NCT00117676|79492365|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
44485904|NCT00117676|79492366|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
44485905|NCT00117676|79492365|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
44485906|NCT00117676|79492366|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
44485907|NCT00117676|79492365|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
44485908|NCT00117676|79492366|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
44485909|NCT00117676|79492365|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
44485910|NCT00117676|79492366|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
44485911|NCT00117676|79492365|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
44485912|NCT00117676|79492366|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
44485913|NCT00117676|79492365|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
44485914|NCT00117676|79492366|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
44485915|NCT00117676|79492365|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
44485916|NCT00117676|79492366|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
44485917|NCT00251004|79492380|FG000|Overall Study|Withdrawal by Subject|23|||
44485918|NCT00251004|79492381|FG001|Overall Study|Withdrawal by Subject|16|||
44485919|NCT00251004|79492382|FG002|Overall Study|Withdrawal by Subject|14|||
44485920|NCT00251004|79492380|FG000|Overall Study|Death|9|||
44485921|NCT00251004|79492381|FG001|Overall Study|Death|10|||
44485922|NCT00251004|79492382|FG002|Overall Study|Death|8|||
44485923|NCT00251004|79492380|FG000|Overall Study|Lost to Follow-up|1|||
44485924|NCT00251004|79492381|FG001|Overall Study|Lost to Follow-up|2|||
44485925|NCT00251004|79492382|FG002|Overall Study|Lost to Follow-up|1|||
44485926|NCT00251004|79492380|FG000|Overall Study|Graft Loss|12|||
44485927|NCT00251004|79492381|FG001|Overall Study|Graft Loss|13|||
44485928|NCT00251004|79492382|FG002|Overall Study|Graft Loss|8|||
44485929|NCT00275340|79492392|FG000|Overall Study|Lost to Follow-up|2|||
44485930|NCT00275340|79492393|FG001|Overall Study|Lost to Follow-up|4|||
44485931|NCT00275262|79492399|FG000|Overall Study|Adverse Event|2|||
44485932|NCT00275262|79492400|FG001|Overall Study|Adverse Event|0|||
44485933|NCT00275262|79492399|FG000|Overall Study|Disease progression|2|||
44228107|NCT01932437|79035409|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
44228108|NCT01932437|79035410|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
44228109|NCT01932437|79035411|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
44274278|NCT01633944|79217787|FG001|Open-label Titration Phase|Adverse Event|0|||
44274279|NCT01633944|79217788|FG002|Open-label Titration Phase|Adverse Event|0|||
44485934|NCT00275262|79492400|FG001|Overall Study|Disease progression|5|||
44228110|NCT01932437|79035412|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
44274280|NCT01633944|79217786|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
44274281|NCT01633944|79217787|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
44274282|NCT01633944|79217788|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
44485935|NCT00275262|79492399|FG000|Overall Study|Lost to Follow-up|0|||
44485936|NCT00275262|79492400|FG001|Overall Study|Lost to Follow-up|2|||
44485937|NCT00275262|79492399|FG000|Overall Study|Protocol Violation|0|||
44485938|NCT00275262|79492400|FG001|Overall Study|Protocol Violation|2|||
44485939|NCT00275262|79492399|FG000|Overall Study|Death|1|||
44485940|NCT00275262|79492400|FG001|Overall Study|Death|0|||
44485941|NCT00275262|79492399|FG000|Overall Study|Started Chemotherapy|1|||
44485942|NCT00275262|79492400|FG001|Overall Study|Started Chemotherapy|0|||
44485943|NCT00275028|79492406|FG000|Overall Study|Withdrew consent before treatment began|1|||
44485944|NCT00275028|79492406|FG000|Overall Study|Withdrawal by Subject|5|||
44485945|NCT00275028|79492406|FG000|Overall Study|Adverse Event|9|||
44485946|NCT00275028|79492406|FG000|Overall Study|Progressive Disease|30|||
44485947|NCT00275028|79492406|FG000|Overall Study|Physician Decision|2|||
44485948|NCT00471497|79492413|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
44485949|NCT00471497|79492414|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
44485950|NCT00471497|79492415|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
44485951|NCT00471497|79492413|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
44485952|NCT00471497|79492414|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
44485953|NCT00471497|79492415|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
44485954|NCT00471497|79492413|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
44485955|NCT00471497|79492414|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
44485956|NCT00471497|79492415|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
44485957|NCT00471497|79492413|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
44485958|NCT00471497|79492414|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
44485959|NCT00471497|79492415|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
44485960|NCT00471497|79492413|FG000|Core Treatment Phase|Lost to Follow-up|6|||
44485961|NCT00471497|79492414|FG001|Core Treatment Phase|Lost to Follow-up|6|||
44485962|NCT00471497|79492415|FG002|Core Treatment Phase|Lost to Follow-up|3|||
44485963|NCT00471497|79492413|FG000|Core Treatment Phase|Death|3|||
44485964|NCT00471497|79492414|FG001|Core Treatment Phase|Death|9|||
44485965|NCT00471497|79492415|FG002|Core Treatment Phase|Death|3|||
44485966|NCT00471497|79492413|FG000|Core Treatment Phase|Disease Progression|10|||
44485967|NCT00471497|79492414|FG001|Core Treatment Phase|Disease Progression|2|||
44485968|NCT00471497|79492415|FG002|Core Treatment Phase|Disease Progression|4|||
44485969|NCT00471497|79492413|FG000|Core Treatment Phase|Protocol Violation|6|||
44485970|NCT00471497|79492414|FG001|Core Treatment Phase|Protocol Violation|15|||
44485971|NCT00471497|79492415|FG002|Core Treatment Phase|Protocol Violation|11|||
44485972|NCT00471497|79492413|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
44485973|NCT00471497|79492414|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
44485974|NCT00471497|79492415|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
44485975|NCT00471497|79492413|FG000|Core Treatment Phase|Administrative problems|14|||
44485976|NCT00471497|79492414|FG001|Core Treatment Phase|Administrative problems|14|||
44485977|NCT00471497|79492415|FG002|Core Treatment Phase|Administrative problems|12|||
44485978|NCT00471497|79492413|FG000|Core Treatment Phase|Adverse Event|43|||
44485979|NCT00471497|79492414|FG001|Core Treatment Phase|Adverse Event|53|||
44485980|NCT00471497|79492415|FG002|Core Treatment Phase|Adverse Event|89|||
44485981|NCT00471497|79492413|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
44485982|NCT00471497|79492414|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
44485983|NCT00471497|79492415|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
44485984|NCT00471497|79492413|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
44228111|NCT01932437|79035413|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
44485985|NCT00471497|79492414|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
44485986|NCT00471497|79492415|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
44228112|NCT01932437|79035414|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
44375660|NCT00938964|79380786|FG000|Overall Study|Lost to Follow-up|2|||
44485987|NCT00471497|79492413|FG000|Extension Phase|Adverse Event|9|||
44485988|NCT00471497|79492414|FG001|Extension Phase|Adverse Event|5|||
44485989|NCT00471497|79492415|FG002|Extension Phase|Adverse Event|1|||
44485990|NCT00471497|79492413|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
44485991|NCT00471497|79492414|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
44485992|NCT00471497|79492415|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
44485993|NCT00471497|79492413|FG000|Extension Phase|Withdrawal by Subject|3|||
44485994|NCT00471497|79492414|FG001|Extension Phase|Withdrawal by Subject|1|||
44485995|NCT00471497|79492415|FG002|Extension Phase|Withdrawal by Subject|0|||
44485996|NCT00471497|79492413|FG000|Extension Phase|Lost to Follow-up|2|||
44485997|NCT00471497|79492414|FG001|Extension Phase|Lost to Follow-up|0|||
44485998|NCT00471497|79492415|FG002|Extension Phase|Lost to Follow-up|0|||
44485999|NCT00471497|79492413|FG000|Extension Phase|Death|1|||
44486000|NCT00471497|79492414|FG001|Extension Phase|Death|0|||
44486001|NCT00471497|79492415|FG002|Extension Phase|Death|0|||
44486002|NCT00471497|79492413|FG000|Extension Phase|Disease progression|2|||
44228113|NCT01949051|79035435|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
44486003|NCT00471497|79492414|FG001|Extension Phase|Disease progression|0|||
44486004|NCT00471497|79492415|FG002|Extension Phase|Disease progression|0|||
44486005|NCT00471497|79492413|FG000|Extension Phase|Protocol Violation|2|||
44486006|NCT00471497|79492414|FG001|Extension Phase|Protocol Violation|2|||
44486007|NCT00471497|79492415|FG002|Extension Phase|Protocol Violation|0|||
44486008|NCT00493649|79492426|FG000|Overall Study|Adverse Event|44|||
44486009|NCT00493649|79492426|FG000|Overall Study|Patient Request|21|||
44486010|NCT00493649|79492426|FG000|Overall Study|Investigator Request|2|||
44228114|NCT01949051|79035436|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
44228115|NCT01949051|79035437|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
44486011|NCT00493649|79492426|FG000|Overall Study|Disease Progression|1|||
44486012|NCT00493649|79492426|FG000|Overall Study|Lost to Follow-up|1|||
44486013|NCT00493649|79492426|FG000|Overall Study|Other|13|||
44486014|NCT00471107|79492436|FG000|Overall Study|Technical problems/data loss|3|||
44486015|NCT00471107|79492437|FG001|Overall Study|Technical problems/data loss|1|||
44486016|NCT00471107|79492438|FG002|Overall Study|Technical problems/data loss|3|||
44486017|NCT00488033|79492448|FG000|Overall Study|Withdrawal by Subject|1|||
44486018|NCT00488033|79492449|FG001|Overall Study|Withdrawal by Subject|0|||
44486019|NCT00117598|79492458|FG000|Prior to Treatment Cross Over|Death|40|||
44486020|NCT00117598|79492459|FG001|Prior to Treatment Cross Over|Death|41|||
44486021|NCT00117598|79492460|FG002|Prior to Treatment Cross Over|Death|37|||
44486022|NCT00117598|79492461|FG003|Prior to Treatment Cross Over|Death|0|||
44486023|NCT00117598|79492462|FG004|Prior to Treatment Cross Over|Death|0|||
44486024|NCT00117598|79492458|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
44486025|NCT00117598|79492459|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
44486026|NCT00117598|79492460|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
44486027|NCT00117598|79492461|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
44486028|NCT00117598|79492462|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
44486029|NCT00117598|79492458|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
44486030|NCT00117598|79492459|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
44486031|NCT00117598|79492460|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
44486032|NCT00117598|79492461|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
44486033|NCT00117598|79492462|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
44486034|NCT00117598|79492458|FG000|Prior to Treatment Cross Over|Other|15|||
44486035|NCT00117598|79492459|FG001|Prior to Treatment Cross Over|Other|9|||
44486036|NCT00117598|79492460|FG002|Prior to Treatment Cross Over|Other|9|||
44486037|NCT00117598|79492461|FG003|Prior to Treatment Cross Over|Other|0|||
44486038|NCT00117598|79492462|FG004|Prior to Treatment Cross Over|Other|0|||
44486039|NCT00117598|79492458|FG000|After Treament Cross Over|Death|0|||
44486040|NCT00117598|79492459|FG001|After Treament Cross Over|Death|0|||
44486041|NCT00117598|79492460|FG002|After Treament Cross Over|Death|0|||
44486042|NCT00117598|79492461|FG003|After Treament Cross Over|Death|1|||
44486043|NCT00117598|79492462|FG004|After Treament Cross Over|Death|2|||
44486044|NCT00117598|79492458|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
44486045|NCT00117598|79492459|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
44486046|NCT00117598|79492460|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
44486047|NCT00117598|79492461|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
44486048|NCT00117598|79492462|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
44486049|NCT00117598|79492458|FG000|After Treament Cross Over|Other|0|||
44486050|NCT00117598|79492459|FG001|After Treament Cross Over|Other|0|||
44486051|NCT00117598|79492460|FG002|After Treament Cross Over|Other|0|||
44486052|NCT00117598|79492461|FG003|After Treament Cross Over|Other|1|||
44486053|NCT00117598|79492462|FG004|After Treament Cross Over|Other|2|||
44486054|NCT00469859|79492474|FG000|Overall Study|Inevaluable|0|||
44486055|NCT00469859|79492475|FG001|Overall Study|Inevaluable|2|||
44486056|NCT00093808|79492481|FG000|Overall Study|Cancel participation before receiving tx|1|||
44486057|NCT00093808|79492481|FG000|Overall Study|Protocol Violation|1|||
44486058|NCT00469079|79492488|FG000|Overall Study|Lack of Efficacy|3|||
44228116|NCT01949051|79035438|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
44228117|NCT01949051|79035439|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
44228118|NCT01949051|79035440|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
44228119|NCT01949051|79035435|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
44486059|NCT00469079|79492489|FG001|Overall Study|Lack of Efficacy|8|||
44486060|NCT00469079|79492490|FG002|Overall Study|Lack of Efficacy|5|||
44486061|NCT00469079|79492488|FG000|Overall Study|Adverse Event|1|||
44486062|NCT00469079|79492489|FG001|Overall Study|Adverse Event|3|||
44486063|NCT00469079|79492490|FG002|Overall Study|Adverse Event|2|||
44486064|NCT00469079|79492488|FG000|Overall Study|Lost to Follow-up|4|||
44486065|NCT00469079|79492489|FG001|Overall Study|Lost to Follow-up|8|||
44486066|NCT00469079|79492490|FG002|Overall Study|Lost to Follow-up|10|||
44486067|NCT00469079|79492488|FG000|Overall Study|Withdrawal by Subject|1|||
44486068|NCT00469079|79492489|FG001|Overall Study|Withdrawal by Subject|2|||
44486069|NCT00469079|79492490|FG002|Overall Study|Withdrawal by Subject|2|||
44228120|NCT01949051|79035436|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44228121|NCT01949051|79035437|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44228122|NCT01949051|79035438|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44228123|NCT01949051|79035439|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44228124|NCT01949051|79035440|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44228125|NCT01949051|79035435|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
44486070|NCT00469079|79492488|FG000|Overall Study|Ineligible|0|||
44486071|NCT00469079|79492489|FG001|Overall Study|Ineligible|1|||
44486072|NCT00469079|79492490|FG002|Overall Study|Ineligible|0|||
44486073|NCT00093496|79492506|FG000|Overall Study|Protocol Violation|1|||
44486074|NCT00093496|79492507|FG001|Overall Study|Protocol Violation|3|||
44486075|NCT00117286|79492514|FG000|Overall Study|Adverse Event|12|||
44486076|NCT00117286|79492515|FG001|Overall Study|Adverse Event|6|||
44486077|NCT00117286|79492514|FG000|Overall Study|Lost to Follow-up|2|||
44486078|NCT00117286|79492515|FG001|Overall Study|Lost to Follow-up|0|||
44228126|NCT01949051|79035436|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
44228127|NCT01949051|79035437|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
44228128|NCT01949051|79035438|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
44228129|NCT01949051|79035439|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
44228130|NCT01949051|79035440|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
44228131|NCT01949051|79035435|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
44544726|NCT03176238|79558295|FG000|Overall Study|Death|3|||
44544727|NCT03176238|79558296|FG001|Overall Study|Death|0|||
44544728|NCT03176238|79558295|FG000|Overall Study|Disease Progression|133|||
44544729|NCT03176238|79558296|FG001|Overall Study|Disease Progression|22|||
44544730|NCT03176238|79558295|FG000|Overall Study|Tx duration completed per EAP|0|||
44544731|NCT03176238|79558296|FG001|Overall Study|Tx duration completed per EAP|1|||
44544732|NCT03176238|79558295|FG000|Overall Study|Patient is switched to commercial drug|16|||
44544733|NCT03176238|79558296|FG001|Overall Study|Patient is switched to commercial drug|1|||
44544734|NCT03176238|79558295|FG000|Overall Study|Protocol Violation|1|||
44544735|NCT03176238|79558296|FG001|Overall Study|Protocol Violation|0|||
44228132|NCT01949051|79035436|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
44228133|NCT01949051|79035437|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
44228134|NCT01949051|79035438|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
44486079|NCT00117286|79492514|FG000|Overall Study|Protocol Violation|3|||
44486080|NCT00117286|79492515|FG001|Overall Study|Protocol Violation|3|||
44486081|NCT00117286|79492514|FG000|Overall Study|Withdrawal by Subject|6|||
44486082|NCT00117286|79492515|FG001|Overall Study|Withdrawal by Subject|2|||
44486083|NCT00117286|79492514|FG000|Overall Study|Physician Decision|3|||
44486084|NCT00117286|79492515|FG001|Overall Study|Physician Decision|7|||
44486085|NCT00117286|79492514|FG000|Overall Study|Lack of Efficacy|2|||
44486086|NCT00117286|79492515|FG001|Overall Study|Lack of Efficacy|1|||
44486087|NCT00117286|79492514|FG000|Overall Study|Research site closing|0|||
44486088|NCT00117286|79492515|FG001|Overall Study|Research site closing|2|||
44486089|NCT00265122|79492527|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
44486090|NCT00265122|79492528|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
44486091|NCT00265122|79492529|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
44486092|NCT00265122|79492530|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
44486093|NCT00265122|79492531|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
44486094|NCT00265122|79492532|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
44486095|NCT00265122|79492527|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
44274283|NCT01633944|79217786|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
44486096|NCT00265122|79492528|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
44544736|NCT03176238|79558295|FG000|Overall Study|Changes in the patient's condition|2|||
44228135|NCT01949051|79035439|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
44228136|NCT01949051|79035440|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
44486097|NCT00265122|79492529|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
44486098|NCT00265122|79492530|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
44486099|NCT00265122|79492531|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
44544737|NCT03176238|79558296|FG001|Overall Study|Changes in the patient's condition|1|||
44486100|NCT00265122|79492532|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
44486101|NCT00265122|79492527|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
44486102|NCT00265122|79492528|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
44486103|NCT00265122|79492529|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
44486104|NCT00265122|79492530|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
44486105|NCT00265122|79492531|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
44486106|NCT00265122|79492532|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
44486107|NCT00265122|79492527|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
44486108|NCT00265122|79492528|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
44486109|NCT00265122|79492529|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
44486110|NCT00265122|79492530|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
44486111|NCT00265122|79492531|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
44486112|NCT00265122|79492532|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
44486113|NCT00265122|79492527|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
44486114|NCT00265122|79492528|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
44486115|NCT00265122|79492529|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
44486116|NCT00265122|79492530|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
44486117|NCT00265122|79492531|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
44486118|NCT00265122|79492532|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
44486119|NCT00265122|79492527|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
44486120|NCT00265122|79492528|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
44486121|NCT00265122|79492529|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
44486122|NCT00265122|79492530|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
44486123|NCT00265122|79492531|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
44486124|NCT00265122|79492532|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
44486125|NCT00116584|79492553|FG000|Overall Study|Withdrawal by Subject|1|||
44486126|NCT00116584|79492554|FG001|Overall Study|Withdrawal by Subject|0|||
44486127|NCT00116584|79492553|FG000|Overall Study|Protocol Violation|1|||
44486128|NCT00116584|79492554|FG001|Overall Study|Protocol Violation|1|||
44486129|NCT00096538|79492560|FG000|Overall Study|Withdrawal by Subject|1|||
44486130|NCT00239928|79492564|FG000|Overall Study|Lack of Efficacy|1|||
44486131|NCT00239928|79492564|FG000|Overall Study|Adverse Event|4|||
44486132|NCT00239928|79492564|FG000|Overall Study|Not need to continue study|3|||
44486133|NCT00239928|79492564|FG000|Overall Study|Withdrawal by Subject|2|||
44486134|NCT00116428|79492570|FG000|Overall Study|Withdrawal by Subject|2|||
44486135|NCT00116428|79492571|FG001|Overall Study|Withdrawal by Subject|5|||
44486136|NCT00116428|79492570|FG000|Overall Study|Did not meet inclusion criteria|1|||
44486137|NCT00116428|79492571|FG001|Overall Study|Did not meet inclusion criteria|0|||
44486138|NCT00468845|79492583|FG000|Overall Study|Adverse Event|9|||
44486139|NCT00468845|79492584|FG001|Overall Study|Adverse Event|14|||
44486140|NCT00468845|79492585|FG002|Overall Study|Adverse Event|11|||
44486141|NCT00468845|79492583|FG000|Overall Study|Lost to Follow-up|2|||
44486142|NCT00468845|79492584|FG001|Overall Study|Lost to Follow-up|1|||
44486143|NCT00468845|79492585|FG002|Overall Study|Lost to Follow-up|2|||
44486144|NCT00468845|79492583|FG000|Overall Study|Other|4|||
44486145|NCT00468845|79492584|FG001|Overall Study|Other|9|||
44486146|NCT00468845|79492585|FG002|Overall Study|Other|5|||
44486147|NCT00468845|79492583|FG000|Overall Study|No longer willing to participate|5|||
44486148|NCT00468845|79492584|FG001|Overall Study|No longer willing to participate|6|||
44486149|NCT00468845|79492585|FG002|Overall Study|No longer willing to participate|10|||
44486150|NCT00468845|79492583|FG000|Overall Study|Randomized, not treated|1|||
44486151|NCT00468845|79492584|FG001|Overall Study|Randomized, not treated|4|||
44486152|NCT00468845|79492585|FG002|Overall Study|Randomized, not treated|2|||
44486153|NCT00468299|79492595|FG000|Overall Study|Withdrawal by Subject|0|||
44486154|NCT00468299|79492596|FG001|Overall Study|Withdrawal by Subject|1|||
44486155|NCT00468143|79492604|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
44486156|NCT00468143|79492605|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
44486157|NCT00468143|79492604|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
44274284|NCT01633944|79217787|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
44274285|NCT01633944|79217788|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
44486158|NCT00468143|79492605|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
44486159|NCT00467831|79492611|FG000|Overall Study|Death|2|||
44486160|NCT00467831|79492611|FG000|Overall Study|Withdrawal by Subject|1|||
44486161|NCT00467753|79492617|FG000|Overall Study|Lost to Follow-up|1|||
44486162|NCT00467753|79492618|FG001|Overall Study|Lost to Follow-up|2|||
44486163|NCT00467753|79492617|FG000|Overall Study|Adverse Event|2|||
44486164|NCT00467753|79492618|FG001|Overall Study|Adverse Event|0|||
44486165|NCT00467597|79492632|FG000|Overall Study|Withdrawal by Subject|2|||
44486166|NCT00467597|79492633|FG001|Overall Study|Withdrawal by Subject|0|||
44486167|NCT00115804|79492643|FG000|Overall Study|Adverse Event|2|||
44486168|NCT00467519|79492651|FG000|Overall Study|Protocol Violation|8|||
44486169|NCT00467519|79492652|FG001|Overall Study|Protocol Violation|4|||
44486170|NCT00467519|79492651|FG000|Overall Study|Lost to Follow-up|2|||
44486171|NCT00467519|79492652|FG001|Overall Study|Lost to Follow-up|9|||
44486172|NCT00467519|79492651|FG000|Overall Study|Withdrawal by Subject|4|||
44486173|NCT00467519|79492652|FG001|Overall Study|Withdrawal by Subject|10|||
44486174|NCT00264810|79492660|FG000|Baseline|Withdrawal by Subject|10|||
44486175|NCT00264810|79492661|FG001|Baseline|Withdrawal by Subject|10|||
44486176|NCT00264810|79492660|FG000|Baseline|Physician Decision|7|||
44486177|NCT00264810|79492661|FG001|Baseline|Physician Decision|8|||
44486178|NCT00264810|79492660|FG000|Baseline|Subject Compliance Failure|3|||
44486179|NCT00264810|79492661|FG001|Baseline|Subject Compliance Failure|3|||
44486180|NCT00264810|79492660|FG000|Baseline|Insufficient Seizure Frequency|2|||
44486181|NCT00264810|79492661|FG001|Baseline|Insufficient Seizure Frequency|2|||
44486182|NCT00264810|79492660|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
44486183|NCT00264810|79492661|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
44486184|NCT00264810|79492660|FG000|Baseline|Other|0|||
44486185|NCT00264810|79492661|FG001|Baseline|Other|1|||
44486186|NCT00264810|79492660|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
44486187|NCT00264810|79492661|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
44486188|NCT00264810|79492660|FG000|Stimulation Optimization Period|Death|0|||
44486189|NCT00264810|79492661|FG001|Stimulation Optimization Period|Death|1|||
44486190|NCT00264810|79492660|FG000|Blinded Evaluation Period|Explant due to infection|1|||
44486191|NCT00264810|79492661|FG001|Blinded Evaluation Period|Explant due to infection|1|||
44486192|NCT00264810|79492660|FG000|Open Label Evaluation Period|Explant due to infection|1|||
44486193|NCT00264810|79492661|FG001|Open Label Evaluation Period|Explant due to infection|1|||
44486194|NCT00264810|79492660|FG000|Open Label Evaluation Period|Death|3|||
44486195|NCT00264810|79492661|FG001|Open Label Evaluation Period|Death|2|||
44486196|NCT00264810|79492660|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
44486197|NCT00264810|79492661|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
44486198|NCT00467363|79492671|FG000|Overall Study|Lost to Follow-up|80|||
44486199|NCT00467363|79492672|FG001|Overall Study|Lost to Follow-up|70|||
44486200|NCT00091390|79492678|FG000|Overall Study|Protocol Violation|1|||
44486201|NCT00091390|79492678|FG000|Overall Study|No protocol treatment|3|||
44486202|NCT00239226|79492686|FG000|Overall Study|permAF during stabilization period|0|||
44486203|NCT00239226|79492687|FG001|Overall Study|permAF during stabilization period|0|||
44486204|NCT00239226|79492688|FG002|Overall Study|permAF during stabilization period|0|||
44486205|NCT00239226|79492689|FG003|Overall Study|permAF during stabilization period|3|||
44486206|NCT00239226|79492686|FG000|Overall Study|Lost to Follow-up|1|||
44486207|NCT00239226|79492687|FG001|Overall Study|Lost to Follow-up|0|||
44486208|NCT00239226|79492688|FG002|Overall Study|Lost to Follow-up|1|||
44486209|NCT00239226|79492689|FG003|Overall Study|Lost to Follow-up|0|||
44486210|NCT00467285|79492701|FG000|Overall Study|Lost to Follow-up|4|||
44486211|NCT00467285|79492702|FG001|Overall Study|Lost to Follow-up|4|||
44486212|NCT00264576|79492712|FG000|Overall Study|Lost to Follow-up|1|||
44486213|NCT00264576|79492713|FG001|Overall Study|Lost to Follow-up|1|||
44486214|NCT00466505|79492720|FG000|Overall Study|disease progression|13|||
44486215|NCT00466505|79492720|FG000|Overall Study|Adverse Event|4|||
44486216|NCT00467051|79492724|FG000|Overall Study|Adverse Event|2|||
44486217|NCT00264498|79492731|FG000|Randomized Treatment|Death|0|||
44486218|NCT00264498|79492732|FG001|Randomized Treatment|Death|3|||
44486219|NCT00264498|79492731|FG000|Randomized Treatment|Withdrawal by Subject|0|||
44486220|NCT00264498|79492732|FG001|Randomized Treatment|Withdrawal by Subject|1|||
44375661|NCT00938964|79380787|FG001|Overall Study|Lost to Follow-up|3|||
44486221|NCT00264498|79492731|FG000|Randomized Treatment|Objective disease Progression|13|||
44486222|NCT00264498|79492732|FG001|Randomized Treatment|Objective disease Progression|14|||
44486223|NCT00264498|79492731|FG000|Randomized Treatment|Physician Decision|1|||
44486224|NCT00264498|79492732|FG001|Randomized Treatment|Physician Decision|0|||
44486225|NCT00264498|79492731|FG000|Randomized Treatment|Incorrectly randomized|1|||
44375662|NCT00938964|79380786|FG000|Overall Study|Withdrawal by Subject|22|||
44486226|NCT00264498|79492732|FG001|Randomized Treatment|Incorrectly randomized|0|||
44274286|NCT01633944|79217786|FG000|Open-label Titration Phase|Protocol Violation|24|||
44375663|NCT00938964|79380787|FG001|Overall Study|Withdrawal by Subject|18|||
44486227|NCT00264498|79492731|FG000|Randomized Treatment|Study Closure|1|||
44486228|NCT00264498|79492732|FG001|Randomized Treatment|Study Closure|0|||
44486229|NCT00264498|79492731|FG000|Randomized Treatment|Protocol Violation|1|||
44486230|NCT00264498|79492732|FG001|Randomized Treatment|Protocol Violation|0|||
44486231|NCT00264498|79492731|FG000|Crossover Treatment|Death|1|||
44486232|NCT00264498|79492732|FG001|Crossover Treatment|Death|3|||
44375664|NCT00938964|79380786|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
44486233|NCT00264498|79492731|FG000|Crossover Treatment|Objective disease progression|4|||
44486234|NCT00264498|79492732|FG001|Crossover Treatment|Objective disease progression|5|||
44486235|NCT00264498|79492731|FG000|Crossover Treatment|Study closure|0|||
44486236|NCT00264498|79492732|FG001|Crossover Treatment|Study closure|1|||
44486237|NCT00264498|79492731|FG000|Crossover Treatment|Withdrawal by Subject|1|||
44486238|NCT00264498|79492732|FG001|Crossover Treatment|Withdrawal by Subject|0|||
44486239|NCT00466193|79492740|FG000|Overall Study|Adverse Event|0|||
44486240|NCT00466193|79492741|FG001|Overall Study|Adverse Event|1|||
44486241|NCT00466193|79492740|FG000|Overall Study|Lost to Follow-up|2|||
44486242|NCT00466193|79492741|FG001|Overall Study|Lost to Follow-up|4|||
44486243|NCT00466193|79492740|FG000|Overall Study|Physician Decision|1|||
44486244|NCT00466193|79492741|FG001|Overall Study|Physician Decision|0|||
44486245|NCT00466193|79492740|FG000|Overall Study|Protocol Violation|1|||
44486246|NCT00466193|79492741|FG001|Overall Study|Protocol Violation|1|||
44486247|NCT00466193|79492740|FG000|Overall Study|Withdrawal by Subject|7|||
44486248|NCT00466193|79492741|FG001|Overall Study|Withdrawal by Subject|2|||
44486249|NCT00466193|79492740|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
44486250|NCT00466193|79492741|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
44486251|NCT00263562|79492749|FG000|Overall Study|Protocol Violation|3|||
44486252|NCT00263562|79492750|FG001|Overall Study|Protocol Violation|0|||
44486253|NCT00454181|79492760|FG000|Overall Study|Adverse Event|1|||
44486254|NCT00454181|79492761|FG001|Overall Study|Adverse Event|1|||
44486255|NCT00454181|79492760|FG000|Overall Study|Lost to Follow-up|11|||
44486256|NCT00454181|79492761|FG001|Overall Study|Lost to Follow-up|1|||
44486257|NCT00454181|79492760|FG000|Overall Study|Protocol Violation|1|||
44486258|NCT00454181|79492761|FG001|Overall Study|Protocol Violation|1|||
44486259|NCT00454181|79492760|FG000|Overall Study|Withdrawal by Subject|2|||
44486260|NCT00454181|79492761|FG001|Overall Study|Withdrawal by Subject|0|||
44486261|NCT00237744|79492770|FG000|Overall Study|Withdrawal by Subject|3|||
44486262|NCT00237744|79492771|FG001|Overall Study|Withdrawal by Subject|1|||
44486263|NCT00237744|79492772|FG002|Overall Study|Withdrawal by Subject|0|||
44486264|NCT00237042|79492786|FG000|Treatment|Became ineligible post-randomization|0|||
44486265|NCT00237042|79492787|FG001|Treatment|Became ineligible post-randomization|1|||
44486266|NCT00237042|79492788|FG002|Treatment|Became ineligible post-randomization|16|||
44486267|NCT00237042|79492786|FG000|Treatment|Moved out of state|1|||
44486268|NCT00237042|79492787|FG001|Treatment|Moved out of state|1|||
44486269|NCT00237042|79492788|FG002|Treatment|Moved out of state|1|||
44486270|NCT00237042|79492786|FG000|Treatment|Completed no treatment|5|||
44486271|NCT00237042|79492787|FG001|Treatment|Completed no treatment|5|||
44486272|NCT00237042|79492788|FG002|Treatment|Completed no treatment|21|||
44486273|NCT00237042|79492786|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
44486274|NCT00237042|79492787|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
44486275|NCT00237042|79492788|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
44486276|NCT00237042|79492786|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
44486277|NCT00237042|79492787|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
44486278|NCT00237042|79492788|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
44486279|NCT00465647|79492800|FG000|Overall Study|Administrative|2|||
44486280|NCT00465647|79492801|FG001|Overall Study|Administrative|2|||
44486281|NCT00465647|79492802|FG002|Overall Study|Administrative|3|||
44486282|NCT00465647|79492803|FG003|Overall Study|Administrative|2|||
44486283|NCT00465647|79492800|FG000|Overall Study|Adverse Event|2|||
44486284|NCT00465647|79492801|FG001|Overall Study|Adverse Event|0|||
44486285|NCT00465647|79492802|FG002|Overall Study|Adverse Event|3|||
44486286|NCT00465647|79492803|FG003|Overall Study|Adverse Event|2|||
44486287|NCT00465647|79492800|FG000|Overall Study|Withdrawal by Subject|1|||
44486288|NCT00465647|79492801|FG001|Overall Study|Withdrawal by Subject|2|||
44486289|NCT00465647|79492802|FG002|Overall Study|Withdrawal by Subject|2|||
44486290|NCT00465647|79492803|FG003|Overall Study|Withdrawal by Subject|7|||
44486291|NCT00465647|79492800|FG000|Overall Study|"The other reasons included loss of IV"|8|||
44544738|NCT03176238|79558295|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
44544739|NCT03176238|79558296|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
44544740|NCT03565315|79558310|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
44544741|NCT03565315|79558311|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
44375665|NCT00938964|79380787|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
44544742|NCT03565315|79558312|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
44544743|NCT03565315|79558313|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
44544744|NCT03565237|79558336|FG000|Overall Study|Non-compliance of Investigational Product|1|||
44544745|NCT03565237|79558336|FG000|Overall Study|Physician Decision|1|||
44544746|NCT01345682|79558342|FG000|Overall Study|Progressive disease per RECIST|226|||
44544747|NCT01345682|79558343|FG001|Overall Study|Progressive disease per RECIST|93|||
44544748|NCT01345682|79558342|FG000|Overall Study|Worsening of underlying cancer disease|23|||
44544749|NCT01345682|79558343|FG001|Overall Study|Worsening of underlying cancer disease|12|||
44544750|NCT01345682|79558342|FG000|Overall Study|Adverse Event|51|||
44486292|NCT00465647|79492801|FG001|Overall Study|"The other reasons included loss of IV"|4|||
44486293|NCT00465647|79492802|FG002|Overall Study|"The other reasons included loss of IV"|3|||
44486294|NCT00465647|79492803|FG003|Overall Study|"The other reasons included loss of IV"|2|||
44486295|NCT00465569|79492825|FG000|Overall Study|persistent eczema during dose escalation|1|||
44486296|NCT00465569|79492826|FG001|Overall Study|persistent eczema during dose escalation|0|||
44486297|NCT00090766|79492835|FG000|Overall Study|Nephrectomy Planned|0|||
44486298|NCT00090766|79492836|FG001|Overall Study|Nephrectomy Planned|0|||
44486299|NCT00090766|79492837|FG002|Overall Study|Nephrectomy Planned|1|||
44486300|NCT00090766|79492835|FG000|Overall Study|Death|1|||
44486301|NCT00090766|79492836|FG001|Overall Study|Death|0|||
44486302|NCT00090766|79492837|FG002|Overall Study|Death|0|||
44375666|NCT00938886|79380795|FG000|Overall Study|Death|0|||
44375667|NCT00938886|79380796|FG001|Overall Study|Death|1|||
44486303|NCT00090766|79492835|FG000|Overall Study|Admin|0|||
44486304|NCT00090766|79492836|FG001|Overall Study|Admin|2|||
44486305|NCT00090766|79492837|FG002|Overall Study|Admin|0|||
44486306|NCT00090766|79492835|FG000|Overall Study|Lost to Follow-up|2|||
44486307|NCT00090766|79492836|FG001|Overall Study|Lost to Follow-up|0|||
44486308|NCT00090766|79492837|FG002|Overall Study|Lost to Follow-up|2|||
44486309|NCT00465179|79492847|FG000|Overall Study|Adverse Event|4|||
44486310|NCT00465179|79492847|FG000|Overall Study|Withdrawal by Subject|2|||
44486311|NCT00465179|79492847|FG000|Overall Study|Progression of Disease|47|||
44486312|NCT00465101|79492851|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
44486313|NCT00465101|79492851|FG000|Overall Study|Change in health precluded follow up|4|||
44486314|NCT00465101|79492851|FG000|Overall Study|Did not meet study criteria|4|||
44486315|NCT00465101|79492851|FG000|Overall Study|Lost to Follow-up|5|||
44486316|NCT00465101|79492851|FG000|Overall Study|Other|6|||
44486317|NCT00465101|79492851|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
44486318|NCT00465101|79492851|FG000|Overall Study|Patient postponed procedure|1|||
44486319|NCT00465101|79492851|FG000|Overall Study|Site closed due to IRB expiration|1|||
44486320|NCT00465101|79492851|FG000|Overall Study|Unable to obtain IRB approval|1|||
44486321|NCT00465101|79492851|FG000|Overall Study|Death|3|||
44486322|NCT00465101|79492851|FG000|Overall Study|Withdrawal by Subject|25|||
44486323|NCT00465101|79492851|FG000|Overall Study|Physician Decision|1|||
44486324|NCT00465101|79492851|FG000|Overall Study|Withdrew consent prior to procedure|3|||
44486325|NCT00084136|79492880|FG000|PI Comparison|Death|10|||
44486326|NCT00084136|79492881|FG001|PI Comparison|Death|9|||
44486327|NCT00084136|79492882|FG002|PI Comparison|Death|0|||
44486328|NCT00084136|79492880|FG000|PI Comparison|Lost to Follow-up|11|||
44486329|NCT00084136|79492881|FG001|PI Comparison|Lost to Follow-up|8|||
44486330|NCT00084136|79492882|FG002|PI Comparison|Lost to Follow-up|0|||
44486331|NCT00084136|79492880|FG000|PI Comparison|Withdrawal by Subject|33|||
44486332|NCT00084136|79492881|FG001|PI Comparison|Withdrawal by Subject|30|||
44486333|NCT00084136|79492882|FG002|PI Comparison|Withdrawal by Subject|0|||
44486334|NCT00084136|79492880|FG000|PI Comparison|Clinic site closed|1|||
44486335|NCT00084136|79492881|FG001|PI Comparison|Clinic site closed|0|||
44486336|NCT00084136|79492882|FG002|PI Comparison|Clinic site closed|0|||
44486337|NCT00084136|79492880|FG000|NRTI Comparison|Death|20|||
44486338|NCT00084136|79492881|FG001|NRTI Comparison|Death|0|||
44486339|NCT00084136|79492882|FG002|NRTI Comparison|Death|18|||
44486340|NCT00084136|79492880|FG000|NRTI Comparison|Lost to Follow-up|14|||
44486341|NCT00084136|79492881|FG001|NRTI Comparison|Lost to Follow-up|0|||
44486342|NCT00084136|79492882|FG002|NRTI Comparison|Lost to Follow-up|12|||
44486343|NCT00084136|79492880|FG000|NRTI Comparison|Withdrawal by Subject|54|||
44486344|NCT00084136|79492881|FG001|NRTI Comparison|Withdrawal by Subject|0|||
44486345|NCT00084136|79492882|FG002|NRTI Comparison|Withdrawal by Subject|38|||
44486346|NCT00084136|79492880|FG000|NRTI Comparison|Clinic site closed|12|||
44486347|NCT00084136|79492881|FG001|NRTI Comparison|Clinic site closed|0|||
44486348|NCT00084136|79492882|FG002|NRTI Comparison|Clinic site closed|14|||
44486349|NCT00084136|79492880|FG000|NRTI Comparison|Not reason above|1|||
44486350|NCT00084136|79492881|FG001|NRTI Comparison|Not reason above|0|||
44486351|NCT00084136|79492882|FG002|NRTI Comparison|Not reason above|0|||
44486352|NCT03812380|79492893|FG000|Overall Study|Protocol Violation|3|||
44228137|NCT01949051|79035435|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
44228138|NCT01949051|79035436|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
44375668|NCT00938886|79380795|FG000|Overall Study|Withdrawal by Subject|4|||
44486353|NCT03812380|79492894|FG001|Overall Study|Protocol Violation|3|||
44486354|NCT03812380|79492893|FG000|Overall Study|Withdrawal by Subject|5|||
44486355|NCT03812380|79492894|FG001|Overall Study|Withdrawal by Subject|4|||
44486356|NCT03812380|79492893|FG000|Overall Study|Early termination of study|14|||
44486357|NCT03812380|79492894|FG001|Overall Study|Early termination of study|14|||
44486358|NCT00464945|79492902|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
44486359|NCT00464945|79492903|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
44486360|NCT00464945|79492902|FG000|Infant Series|Protocol Violation|1|||
44486361|NCT00464945|79492903|FG001|Infant Series|Protocol Violation|0|||
44486362|NCT00464945|79492902|FG000|Infant Series|Lost to Follow-up|1|||
44486363|NCT00464945|79492903|FG001|Infant Series|Lost to Follow-up|0|||
44486364|NCT00464945|79492902|FG000|After Infant Series|Withdrawal by Subject|0|||
44486365|NCT00464945|79492903|FG001|After Infant Series|Withdrawal by Subject|2|||
44486366|NCT00464945|79492902|FG000|Toddler Dose|Lost to Follow-up|0|||
44486367|NCT00464945|79492903|FG001|Toddler Dose|Lost to Follow-up|1|||
44486368|NCT00464087|79492928|FG000|Overall Study|No PCI per inclusion criteria|0|||
44486369|NCT00464087|79492929|FG001|Overall Study|No PCI per inclusion criteria|0|||
44486370|NCT00464087|79492930|FG002|Overall Study|No PCI per inclusion criteria|29|||
44486371|NCT00452699|79492940|FG000|Overall Study|Adverse Event|10|||
44486372|NCT00452699|79492941|FG001|Overall Study|Adverse Event|3|||
44486373|NCT00452699|79492940|FG000|Overall Study|Lack of Efficacy|6|||
44486374|NCT00452699|79492941|FG001|Overall Study|Lack of Efficacy|4|||
44486375|NCT00452699|79492940|FG000|Overall Study|Lost to Follow-up|6|||
44486376|NCT00452699|79492941|FG001|Overall Study|Lost to Follow-up|9|||
44486377|NCT00452699|79492940|FG000|Overall Study|Protocol Violation|21|||
44486378|NCT00452699|79492941|FG001|Overall Study|Protocol Violation|25|||
44486379|NCT00452699|79492940|FG000|Overall Study|Withdrawal by Subject|26|||
44486380|NCT00452699|79492941|FG001|Overall Study|Withdrawal by Subject|25|||
44486381|NCT00452699|79492940|FG000|Overall Study|Other|12|||
44486382|NCT00452699|79492941|FG001|Overall Study|Other|7|||
44486383|NCT00069784|79492949|FG000|Overall Study|Adverse Event|105|||
44486384|NCT00069784|79492950|FG001|Overall Study|Adverse Event|0|||
44486385|NCT00069784|79492949|FG000|Overall Study|Withdrawal by Subject|1090|||
44486386|NCT00069784|79492950|FG001|Overall Study|Withdrawal by Subject|0|||
44486387|NCT00069784|79492949|FG000|Overall Study|Other|17|||
44486388|NCT00069784|79492950|FG001|Overall Study|Other|0|||
44486389|NCT00090610|79492958|FG000|Overall Study|Withdrawal by Subject|1|||
44486390|NCT00090610|79492959|FG001|Overall Study|Withdrawal by Subject|1|||
44486391|NCT00463385|79492969|FG000|Overall Study|Other|4|||
44486392|NCT00463385|79492970|FG001|Overall Study|Other|3|||
44486393|NCT00463385|79492971|FG002|Overall Study|Other|6|||
44486394|NCT00463385|79492972|FG003|Overall Study|Other|4|||
44486395|NCT00463385|79492969|FG000|Overall Study|Adverse Event|5|||
44486396|NCT00463385|79492970|FG001|Overall Study|Adverse Event|8|||
44486397|NCT00463385|79492971|FG002|Overall Study|Adverse Event|4|||
44486398|NCT00463385|79492972|FG003|Overall Study|Adverse Event|2|||
44486399|NCT00463385|79492969|FG000|Overall Study|Lack of Efficacy|6|||
44486400|NCT00463385|79492970|FG001|Overall Study|Lack of Efficacy|6|||
44486401|NCT00463385|79492971|FG002|Overall Study|Lack of Efficacy|7|||
44486402|NCT00463385|79492972|FG003|Overall Study|Lack of Efficacy|9|||
44486403|NCT00463385|79492969|FG000|Overall Study|Withdrawal by Subject|3|||
44486404|NCT00463385|79492970|FG001|Overall Study|Withdrawal by Subject|3|||
44486405|NCT00463385|79492971|FG002|Overall Study|Withdrawal by Subject|3|||
44486406|NCT00463385|79492972|FG003|Overall Study|Withdrawal by Subject|4|||
44486407|NCT00463385|79492969|FG000|Overall Study|Lost to Follow-up|0|||
44486408|NCT00463385|79492970|FG001|Overall Study|Lost to Follow-up|0|||
44486409|NCT00463385|79492971|FG002|Overall Study|Lost to Follow-up|0|||
44486410|NCT00463385|79492972|FG003|Overall Study|Lost to Follow-up|1|||
44486411|NCT00463385|79492969|FG000|Overall Study|Death|2|||
44486412|NCT00463385|79492970|FG001|Overall Study|Death|1|||
44486413|NCT00463385|79492971|FG002|Overall Study|Death|2|||
44486414|NCT00463385|79492972|FG003|Overall Study|Death|0|||
44486415|NCT00463385|79492969|FG000|Overall Study|Missing|2|||
44228139|NCT01949051|79035437|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
44228140|NCT01949051|79035438|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
44228141|NCT01949051|79035439|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
44486416|NCT00463385|79492970|FG001|Overall Study|Missing|0|||
44486417|NCT00463385|79492971|FG002|Overall Study|Missing|0|||
44486418|NCT00463385|79492972|FG003|Overall Study|Missing|2|||
44486419|NCT00463385|79492969|FG000|Overall Study|1 participant received commercial drug|0|||
44486420|NCT00463385|79492970|FG001|Overall Study|1 participant received commercial drug|1|||
44486421|NCT00463385|79492971|FG002|Overall Study|1 participant received commercial drug|0|||
44486422|NCT00463385|79492972|FG003|Overall Study|1 participant received commercial drug|0|||
44228142|NCT01949051|79035440|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
44228143|NCT01948427|79035453|FG000|Overall Study|Serious Adverse Event|3|||
44228144|NCT01948427|79035454|FG001|Overall Study|Serious Adverse Event|0|||
44486423|NCT00463229|79492992|FG000|Overall Study|Lost to Follow-up|5|||
44486424|NCT00463229|79492993|FG001|Overall Study|Lost to Follow-up|7|||
44486425|NCT00463229|79492992|FG000|Overall Study|Death|4|||
44486426|NCT00463229|79492993|FG001|Overall Study|Death|3|||
44486427|NCT03839693|79493003|FG000|Overall Study|Lost to Follow-up|0|||
44486428|NCT03839693|79493004|FG001|Overall Study|Lost to Follow-up|2|||
44486429|NCT03839693|79493005|FG002|Overall Study|Lost to Follow-up|2|||
44486430|NCT03839693|79493003|FG000|Overall Study|Withdrawal by Subject|1|||
44486431|NCT03839693|79493004|FG001|Overall Study|Withdrawal by Subject|0|||
44486432|NCT03839693|79493005|FG002|Overall Study|Withdrawal by Subject|2|||
44486433|NCT03839693|79493003|FG000|Overall Study|subject moved out of the area|1|||
44486434|NCT03839693|79493004|FG001|Overall Study|subject moved out of the area|0|||
44486435|NCT03839693|79493005|FG002|Overall Study|subject moved out of the area|0|||
44544751|NCT01345682|79558343|FG001|Overall Study|Adverse Event|41|||
44228145|NCT01948427|79035455|FG002|Overall Study|Serious Adverse Event|0|||
44486436|NCT00068692|79493018|FG000|Step 1: Registration|Disese progression/relapse|5|||
44486437|NCT00068692|79493019|FG001|Step 1: Registration|Disese progression/relapse|0|||
44486438|NCT00068692|79493020|FG002|Step 1: Registration|Disese progression/relapse|0|||
44486439|NCT00068692|79493021|FG003|Step 1: Registration|Disese progression/relapse|0|||
44486440|NCT00068692|79493022|FG004|Step 1: Registration|Disese progression/relapse|0|||
44486441|NCT00068692|79493023|FG005|Step 1: Registration|Disese progression/relapse|0|||
44486442|NCT00068692|79493024|FG006|Step 1: Registration|Disese progression/relapse|0|||
44486443|NCT00068692|79493025|FG007|Step 1: Registration|Disese progression/relapse|0|||
44486444|NCT00068692|79493018|FG000|Step 1: Registration|Adverse Event|7|||
44486445|NCT00068692|79493019|FG001|Step 1: Registration|Adverse Event|0|||
44486446|NCT00068692|79493020|FG002|Step 1: Registration|Adverse Event|0|||
44486447|NCT00068692|79493021|FG003|Step 1: Registration|Adverse Event|0|||
44486448|NCT00068692|79493022|FG004|Step 1: Registration|Adverse Event|0|||
44486449|NCT00068692|79493023|FG005|Step 1: Registration|Adverse Event|0|||
44486450|NCT00068692|79493024|FG006|Step 1: Registration|Adverse Event|0|||
44486451|NCT00068692|79493025|FG007|Step 1: Registration|Adverse Event|0|||
44486452|NCT00068692|79493018|FG000|Step 1: Registration|Death|1|||
44486453|NCT00068692|79493019|FG001|Step 1: Registration|Death|0|||
44486454|NCT00068692|79493020|FG002|Step 1: Registration|Death|0|||
44486455|NCT00068692|79493021|FG003|Step 1: Registration|Death|0|||
44486456|NCT00068692|79493022|FG004|Step 1: Registration|Death|0|||
44486457|NCT00068692|79493023|FG005|Step 1: Registration|Death|0|||
44486458|NCT00068692|79493024|FG006|Step 1: Registration|Death|0|||
44486459|NCT00068692|79493025|FG007|Step 1: Registration|Death|0|||
44486460|NCT00068692|79493018|FG000|Step 1: Registration|Withdrawal by Subject|11|||
44486461|NCT00068692|79493019|FG001|Step 1: Registration|Withdrawal by Subject|0|||
44486462|NCT00068692|79493020|FG002|Step 1: Registration|Withdrawal by Subject|0|||
44486463|NCT00068692|79493021|FG003|Step 1: Registration|Withdrawal by Subject|0|||
44486464|NCT00068692|79493022|FG004|Step 1: Registration|Withdrawal by Subject|0|||
44486465|NCT00068692|79493023|FG005|Step 1: Registration|Withdrawal by Subject|0|||
44486466|NCT00068692|79493024|FG006|Step 1: Registration|Withdrawal by Subject|0|||
44375669|NCT00938886|79380796|FG001|Overall Study|Withdrawal by Subject|7|||
44486467|NCT00068692|79493025|FG007|Step 1: Registration|Withdrawal by Subject|0|||
44486468|NCT00068692|79493018|FG000|Step 1: Registration|Alternative therapy|2|||
44486469|NCT00068692|79493019|FG001|Step 1: Registration|Alternative therapy|0|||
44486470|NCT00068692|79493020|FG002|Step 1: Registration|Alternative therapy|0|||
44486471|NCT00068692|79493021|FG003|Step 1: Registration|Alternative therapy|0|||
44486472|NCT00068692|79493022|FG004|Step 1: Registration|Alternative therapy|0|||
44486473|NCT00068692|79493023|FG005|Step 1: Registration|Alternative therapy|0|||
44486474|NCT00068692|79493024|FG006|Step 1: Registration|Alternative therapy|0|||
44486475|NCT00068692|79493025|FG007|Step 1: Registration|Alternative therapy|0|||
44486476|NCT00068692|79493018|FG000|Step 1: Registration|Complicating disease|2|||
44486477|NCT00068692|79493019|FG001|Step 1: Registration|Complicating disease|0|||
44486478|NCT00068692|79493020|FG002|Step 1: Registration|Complicating disease|0|||
44486479|NCT00068692|79493021|FG003|Step 1: Registration|Complicating disease|0|||
44486480|NCT00068692|79493022|FG004|Step 1: Registration|Complicating disease|0|||
44486481|NCT00068692|79493023|FG005|Step 1: Registration|Complicating disease|0|||
44486482|NCT00068692|79493024|FG006|Step 1: Registration|Complicating disease|0|||
44486483|NCT00068692|79493025|FG007|Step 1: Registration|Complicating disease|0|||
44486484|NCT00068692|79493018|FG000|Step 1: Registration|Protocol Violation|1|||
44486485|NCT00068692|79493019|FG001|Step 1: Registration|Protocol Violation|0|||
44486486|NCT00068692|79493020|FG002|Step 1: Registration|Protocol Violation|0|||
44486487|NCT00068692|79493021|FG003|Step 1: Registration|Protocol Violation|0|||
44486488|NCT00068692|79493022|FG004|Step 1: Registration|Protocol Violation|0|||
44375670|NCT00938886|79380795|FG000|Overall Study|Lost to Follow-up|3|||
44375671|NCT00938886|79380796|FG001|Overall Study|Lost to Follow-up|2|||
44486489|NCT00068692|79493023|FG005|Step 1: Registration|Protocol Violation|0|||
44486490|NCT00068692|79493024|FG006|Step 1: Registration|Protocol Violation|0|||
44228146|NCT01948427|79035456|FG003|Overall Study|Serious Adverse Event|0|||
44486491|NCT00068692|79493025|FG007|Step 1: Registration|Protocol Violation|0|||
44486492|NCT00068692|79493018|FG000|Step 1: Registration|Not eligible|6|||
44486493|NCT00068692|79493019|FG001|Step 1: Registration|Not eligible|0|||
44486494|NCT00068692|79493020|FG002|Step 1: Registration|Not eligible|0|||
44486495|NCT00068692|79493021|FG003|Step 1: Registration|Not eligible|0|||
44486496|NCT00068692|79493022|FG004|Step 1: Registration|Not eligible|0|||
44486497|NCT00068692|79493023|FG005|Step 1: Registration|Not eligible|0|||
44486498|NCT00068692|79493024|FG006|Step 1: Registration|Not eligible|0|||
44486499|NCT00068692|79493025|FG007|Step 1: Registration|Not eligible|0|||
44486500|NCT00068692|79493018|FG000|Step 1: Registration|Other|2|||
44486501|NCT00068692|79493019|FG001|Step 1: Registration|Other|0|||
44486502|NCT00068692|79493020|FG002|Step 1: Registration|Other|0|||
44486503|NCT00068692|79493021|FG003|Step 1: Registration|Other|0|||
44486504|NCT00068692|79493022|FG004|Step 1: Registration|Other|0|||
44486505|NCT00068692|79493023|FG005|Step 1: Registration|Other|0|||
44486506|NCT00068692|79493024|FG006|Step 1: Registration|Other|0|||
44486507|NCT00068692|79493025|FG007|Step 1: Registration|Other|0|||
44486508|NCT00068692|79493018|FG000|Step 1: Registration|Not start protocol therapy|3|||
44486509|NCT00068692|79493019|FG001|Step 1: Registration|Not start protocol therapy|0|||
44486510|NCT00068692|79493020|FG002|Step 1: Registration|Not start protocol therapy|0|||
44486511|NCT00068692|79493021|FG003|Step 1: Registration|Not start protocol therapy|0|||
44486512|NCT00068692|79493022|FG004|Step 1: Registration|Not start protocol therapy|0|||
44486513|NCT00068692|79493023|FG005|Step 1: Registration|Not start protocol therapy|0|||
44486514|NCT00068692|79493024|FG006|Step 1: Registration|Not start protocol therapy|0|||
44486515|NCT00068692|79493025|FG007|Step 1: Registration|Not start protocol therapy|0|||
44486516|NCT00068692|79493018|FG000|Step 1: Registration|Registered but not randomized|0|||
44486517|NCT00068692|79493019|FG001|Step 1: Registration|Registered but not randomized|1|||
44486518|NCT00068692|79493020|FG002|Step 1: Registration|Registered but not randomized|0|||
44486519|NCT00068692|79493021|FG003|Step 1: Registration|Registered but not randomized|0|||
44228147|NCT01948427|79035457|FG004|Overall Study|Serious Adverse Event|1|||
44486520|NCT00068692|79493022|FG004|Step 1: Registration|Registered but not randomized|0|||
44486521|NCT00068692|79493023|FG005|Step 1: Registration|Registered but not randomized|0|||
44486522|NCT00068692|79493024|FG006|Step 1: Registration|Registered but not randomized|0|||
44486523|NCT00068692|79493025|FG007|Step 1: Registration|Registered but not randomized|0|||
44486524|NCT00068692|79493018|FG000|Step 2: Randomization|Disesae progression/replase|0|||
44486525|NCT00068692|79493019|FG001|Step 2: Randomization|Disesae progression/replase|0|||
44486526|NCT00068692|79493020|FG002|Step 2: Randomization|Disesae progression/replase|1|||
44228148|NCT01948427|79035453|FG000|Overall Study|Investigator Request|0|||
44274287|NCT01633944|79217787|FG001|Open-label Titration Phase|Protocol Violation|0|||
44274288|NCT01633944|79217788|FG002|Open-label Titration Phase|Protocol Violation|0|||
44228149|NCT01948427|79035454|FG001|Overall Study|Investigator Request|8|||
44228150|NCT01948427|79035455|FG002|Overall Study|Investigator Request|0|||
44228151|NCT01948427|79035456|FG003|Overall Study|Investigator Request|0|||
44228152|NCT01948427|79035457|FG004|Overall Study|Investigator Request|6|||
44228153|NCT01948427|79035453|FG000|Overall Study|Lost to Follow-up|1|||
44228154|NCT01948427|79035454|FG001|Overall Study|Lost to Follow-up|0|||
44228155|NCT01948427|79035455|FG002|Overall Study|Lost to Follow-up|0|||
44228156|NCT01948427|79035456|FG003|Overall Study|Lost to Follow-up|0|||
44228157|NCT01948427|79035457|FG004|Overall Study|Lost to Follow-up|4|||
44228158|NCT01948427|79035453|FG000|Overall Study|Withdrawal by Subject|2|||
44228159|NCT01948427|79035454|FG001|Overall Study|Withdrawal by Subject|0|||
44228160|NCT01948427|79035455|FG002|Overall Study|Withdrawal by Subject|0|||
44228161|NCT01948427|79035456|FG003|Overall Study|Withdrawal by Subject|0|||
44228162|NCT01948427|79035457|FG004|Overall Study|Withdrawal by Subject|1|||
44228163|NCT01948427|79035453|FG000|Overall Study|Other, Not Specified|1|||
44228164|NCT01948427|79035454|FG001|Overall Study|Other, Not Specified|9|||
44228165|NCT01948427|79035455|FG002|Overall Study|Other, Not Specified|0|||
44228166|NCT01948427|79035456|FG003|Overall Study|Other, Not Specified|0|||
44228167|NCT01948427|79035457|FG004|Overall Study|Other, Not Specified|2|||
44228168|NCT01948193|79035474|FG000|Overall Study|Serious event|2|||
44228169|NCT01948193|79035474|FG000|Overall Study|Lost to Follow-up|7|||
44228170|NCT01694485|79035484|FG000|Overall Study|Withdrawal by Subject|20|||
44228171|NCT01694485|79035485|FG001|Overall Study|Withdrawal by Subject|6|||
44228172|NCT01694485|79035486|FG002|Overall Study|Withdrawal by Subject|7|||
44228173|NCT01694485|79035487|FG003|Overall Study|Withdrawal by Subject|25|||
44228174|NCT01694485|79035488|FG004|Overall Study|Withdrawal by Subject|18|||
44228175|NCT01694485|79035484|FG000|Overall Study|Sponsor Decision|3|||
44228176|NCT01694485|79035485|FG001|Overall Study|Sponsor Decision|0|||
44228177|NCT01694485|79035486|FG002|Overall Study|Sponsor Decision|0|||
44228178|NCT01694485|79035487|FG003|Overall Study|Sponsor Decision|2|||
44486527|NCT00068692|79493021|FG003|Step 2: Randomization|Disesae progression/replase|1|||
44486528|NCT00068692|79493022|FG004|Step 2: Randomization|Disesae progression/replase|0|||
44486529|NCT00068692|79493023|FG005|Step 2: Randomization|Disesae progression/replase|0|||
44486530|NCT00068692|79493024|FG006|Step 2: Randomization|Disesae progression/replase|0|||
44486531|NCT00068692|79493025|FG007|Step 2: Randomization|Disesae progression/replase|0|||
44228179|NCT01694485|79035488|FG004|Overall Study|Sponsor Decision|0|||
44228180|NCT01694485|79035484|FG000|Overall Study|Lost to Follow-up|9|||
44228181|NCT01694485|79035485|FG001|Overall Study|Lost to Follow-up|1|||
44228182|NCT01694485|79035486|FG002|Overall Study|Lost to Follow-up|6|||
44228183|NCT01694485|79035487|FG003|Overall Study|Lost to Follow-up|10|||
44228184|NCT01694485|79035488|FG004|Overall Study|Lost to Follow-up|7|||
44228185|NCT01694485|79035484|FG000|Overall Study|Death|1|||
44228186|NCT01694485|79035485|FG001|Overall Study|Death|0|||
44228187|NCT01694485|79035486|FG002|Overall Study|Death|0|||
44228188|NCT01694485|79035487|FG003|Overall Study|Death|1|||
44228189|NCT01694485|79035488|FG004|Overall Study|Death|0|||
44228190|NCT01931735|79035509|FG000|Randomized Phase|Lost to Follow-up|2|||
44228191|NCT01931735|79035510|FG001|Randomized Phase|Lost to Follow-up|2|||
44228192|NCT01931735|79035511|FG002|Randomized Phase|Lost to Follow-up|5|||
44228193|NCT01931735|79035512|FG003|Randomized Phase|Lost to Follow-up|0|||
44228194|NCT01931735|79035509|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
44228195|NCT01931735|79035510|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
44228196|NCT01931735|79035511|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
44228197|NCT01931735|79035512|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
44228198|NCT01931735|79035509|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
44486532|NCT00068692|79493018|FG000|Step 2: Randomization|Adverse Event|0|||
44486533|NCT00068692|79493019|FG001|Step 2: Randomization|Adverse Event|0|||
44486534|NCT00068692|79493020|FG002|Step 2: Randomization|Adverse Event|4|||
44486535|NCT00068692|79493021|FG003|Step 2: Randomization|Adverse Event|2|||
44486536|NCT00068692|79493022|FG004|Step 2: Randomization|Adverse Event|2|||
44486537|NCT00068692|79493023|FG005|Step 2: Randomization|Adverse Event|3|||
44486538|NCT00068692|79493024|FG006|Step 2: Randomization|Adverse Event|4|||
44486539|NCT00068692|79493025|FG007|Step 2: Randomization|Adverse Event|4|||
44486540|NCT00068692|79493018|FG000|Step 2: Randomization|Death|0|||
44486541|NCT00068692|79493019|FG001|Step 2: Randomization|Death|0|||
44486542|NCT00068692|79493020|FG002|Step 2: Randomization|Death|0|||
44486543|NCT00068692|79493021|FG003|Step 2: Randomization|Death|0|||
44486544|NCT00068692|79493022|FG004|Step 2: Randomization|Death|1|||
44486545|NCT00068692|79493023|FG005|Step 2: Randomization|Death|0|||
44486546|NCT00068692|79493024|FG006|Step 2: Randomization|Death|0|||
44486547|NCT00068692|79493025|FG007|Step 2: Randomization|Death|1|||
44486548|NCT00068692|79493018|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
44486549|NCT00068692|79493019|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
44486550|NCT00068692|79493020|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
44486551|NCT00068692|79493021|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
44486552|NCT00068692|79493022|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
44486553|NCT00068692|79493023|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
44486554|NCT00068692|79493024|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
44486555|NCT00068692|79493025|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
44486556|NCT00068692|79493018|FG000|Step 2: Randomization|alternative therapy|0|||
44486557|NCT00068692|79493019|FG001|Step 2: Randomization|alternative therapy|0|||
44486558|NCT00068692|79493020|FG002|Step 2: Randomization|alternative therapy|0|||
44486559|NCT00068692|79493021|FG003|Step 2: Randomization|alternative therapy|1|||
44486560|NCT00068692|79493022|FG004|Step 2: Randomization|alternative therapy|1|||
44486561|NCT00068692|79493023|FG005|Step 2: Randomization|alternative therapy|0|||
44486562|NCT00068692|79493024|FG006|Step 2: Randomization|alternative therapy|0|||
44486563|NCT00068692|79493025|FG007|Step 2: Randomization|alternative therapy|0|||
44486564|NCT00068692|79493018|FG000|Step 2: Randomization|Physician Decision|0|||
44486565|NCT00068692|79493019|FG001|Step 2: Randomization|Physician Decision|0|||
44228199|NCT01931735|79035510|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
44228200|NCT01931735|79035511|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
44228201|NCT01931735|79035512|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
44228202|NCT01930799|79035522|FG000|Overall Study|Withdrawal by Subject|3|||
44228203|NCT01930799|79035522|FG000|Overall Study|Lost to Follow-up|5|||
44228204|NCT01947491|79035530|FG000|Overall Study|Lost to Follow-up|5|||
44228205|NCT01947491|79035531|FG001|Overall Study|Lost to Follow-up|3|||
44486566|NCT00068692|79493020|FG002|Step 2: Randomization|Physician Decision|0|||
44274289|NCT01633944|79217786|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
44486567|NCT00068692|79493021|FG003|Step 2: Randomization|Physician Decision|1|||
44486568|NCT00068692|79493022|FG004|Step 2: Randomization|Physician Decision|1|||
44486569|NCT00068692|79493023|FG005|Step 2: Randomization|Physician Decision|0|||
44486570|NCT00068692|79493024|FG006|Step 2: Randomization|Physician Decision|0|||
44486571|NCT00068692|79493025|FG007|Step 2: Randomization|Physician Decision|0|||
44486572|NCT00068692|79493018|FG000|Step 2: Randomization|Other|0|||
44486573|NCT00068692|79493019|FG001|Step 2: Randomization|Other|0|||
44486574|NCT00068692|79493020|FG002|Step 2: Randomization|Other|0|||
44486575|NCT00068692|79493021|FG003|Step 2: Randomization|Other|1|||
44486576|NCT00068692|79493022|FG004|Step 2: Randomization|Other|0|||
44486577|NCT00068692|79493023|FG005|Step 2: Randomization|Other|1|||
44486578|NCT00068692|79493024|FG006|Step 2: Randomization|Other|0|||
44486579|NCT00068692|79493025|FG007|Step 2: Randomization|Other|0|||
44486580|NCT00068692|79493018|FG000|Step 2: Randomization|never start protocol therapy|0|||
44486581|NCT00068692|79493019|FG001|Step 2: Randomization|never start protocol therapy|0|||
44486582|NCT00068692|79493020|FG002|Step 2: Randomization|never start protocol therapy|1|||
44486583|NCT00068692|79493021|FG003|Step 2: Randomization|never start protocol therapy|0|||
44486584|NCT00068692|79493022|FG004|Step 2: Randomization|never start protocol therapy|1|||
44486585|NCT00068692|79493023|FG005|Step 2: Randomization|never start protocol therapy|0|||
44486586|NCT00068692|79493024|FG006|Step 2: Randomization|never start protocol therapy|0|||
44228206|NCT01947491|79035532|FG002|Overall Study|Lost to Follow-up|1|||
44228207|NCT01947491|79035533|FG003|Overall Study|Lost to Follow-up|2|||
44228208|NCT01947491|79035530|FG000|Overall Study|Lack of Efficacy|1|||
44228209|NCT01947491|79035531|FG001|Overall Study|Lack of Efficacy|0|||
44486587|NCT00068692|79493025|FG007|Step 2: Randomization|never start protocol therapy|0|||
44486588|NCT00463151|79493042|FG000|Overall Study|Adverse Event|0|||
44486589|NCT00463151|79493043|FG001|Overall Study|Adverse Event|0|||
44486590|NCT00463151|79493044|FG002|Overall Study|Adverse Event|1|||
44486591|NCT00463151|79493045|FG003|Overall Study|Adverse Event|0|||
44486592|NCT00463151|79493042|FG000|Overall Study|Lack of Efficacy|2|||
44486593|NCT00463151|79493043|FG001|Overall Study|Lack of Efficacy|5|||
44486594|NCT00463151|79493044|FG002|Overall Study|Lack of Efficacy|2|||
44486595|NCT00463151|79493045|FG003|Overall Study|Lack of Efficacy|5|||
44486596|NCT00463151|79493042|FG000|Overall Study|Protocol Violation|0|||
44486597|NCT00463151|79493043|FG001|Overall Study|Protocol Violation|0|||
44486598|NCT00463151|79493044|FG002|Overall Study|Protocol Violation|0|||
44486599|NCT00463151|79493045|FG003|Overall Study|Protocol Violation|1|||
44486600|NCT00463151|79493042|FG000|Overall Study|Withdrawal by Subject|0|||
44486601|NCT00463151|79493043|FG001|Overall Study|Withdrawal by Subject|0|||
44486602|NCT00463151|79493044|FG002|Overall Study|Withdrawal by Subject|0|||
44486603|NCT00463151|79493045|FG003|Overall Study|Withdrawal by Subject|1|||
44486604|NCT00068380|79493055|FG000|Overall Study|Withdrawal by Subject|3|||
44486605|NCT00068380|79493055|FG000|Overall Study|Adverse Event|2|||
44486606|NCT00067990|79493061|FG000|Overall Study|Death|5|||
44486607|NCT00067990|79493062|FG001|Overall Study|Death|7|||
44486608|NCT00067990|79493061|FG000|Overall Study|ESRD, Non IF/TA|1|||
44486609|NCT00067990|79493062|FG001|Overall Study|ESRD, Non IF/TA|3|||
44486610|NCT00067990|79493061|FG000|Overall Study|Withdrawal by Subject|4|||
44486611|NCT00067990|79493062|FG001|Overall Study|Withdrawal by Subject|12|||
44486612|NCT00090220|79493070|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
44486613|NCT00090220|79493071|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
44486614|NCT00090220|79493072|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44486615|NCT00090220|79493073|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44486616|NCT00090220|79493074|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44486617|NCT00090220|79493075|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44486618|NCT00090220|79493070|FG000|Base Study Vaccination Period|Adverse Event|6|||
44486619|NCT00090220|79493071|FG001|Base Study Vaccination Period|Adverse Event|1|||
44486620|NCT00090220|79493072|FG002|Base Study Vaccination Period|Adverse Event|0|||
44486621|NCT00090220|79493073|FG003|Base Study Vaccination Period|Adverse Event|0|||
44486622|NCT00090220|79493074|FG004|Base Study Vaccination Period|Adverse Event|0|||
44486623|NCT00090220|79493075|FG005|Base Study Vaccination Period|Adverse Event|0|||
44486624|NCT00090220|79493070|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
44486625|NCT00090220|79493071|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
44486626|NCT00090220|79493072|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
44486627|NCT00090220|79493073|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
44486628|NCT00090220|79493074|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
44486629|NCT00090220|79493075|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
44228210|NCT01947491|79035532|FG002|Overall Study|Lack of Efficacy|0|||
44228211|NCT01947491|79035533|FG003|Overall Study|Lack of Efficacy|1|||
44375672|NCT00942708|79380802|FG000|Overall Study|Withdrawal by Subject|1|||
44375673|NCT00937950|79380807|FG000|Overall Study|Withdrawal by Subject|23|||
44375674|NCT00937950|79380807|FG000|Overall Study|Migrated/moved from study area|27|||
44375675|NCT00937950|79380807|FG000|Overall Study|Lost to Follow-up|144|||
44375676|NCT00937950|79380807|FG000|Overall Study|Missing confirmed|4|||
44375677|NCT00937950|79380807|FG000|Overall Study|Other|18|||
44375678|NCT00942162|79380814|FG000|Overall Study|Death|45|||
44375679|NCT00942162|79380815|FG001|Overall Study|Death|35|||
44375680|NCT00942162|79380816|FG002|Overall Study|Death|0|||
44375681|NCT00942162|79380814|FG000|Overall Study|Withdrawal by Subject|7|||
44375682|NCT00942162|79380815|FG001|Overall Study|Withdrawal by Subject|2|||
44375683|NCT00942162|79380816|FG002|Overall Study|Withdrawal by Subject|0|||
44375684|NCT00942162|79380814|FG000|Overall Study|Lost to Follow-up|4|||
44375685|NCT00942162|79380815|FG001|Overall Study|Lost to Follow-up|0|||
44375686|NCT00942162|79380816|FG002|Overall Study|Lost to Follow-up|0|||
44228212|NCT01947491|79035530|FG000|Overall Study|Protocol Violation|1|||
44228213|NCT01947491|79035531|FG001|Overall Study|Protocol Violation|0|||
44375687|NCT00942162|79380814|FG000|Overall Study|Other|14|||
44486630|NCT00090220|79493070|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
44486631|NCT00090220|79493071|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
44486632|NCT00090220|79493072|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
44486633|NCT00090220|79493073|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
44228214|NCT01947491|79035532|FG002|Overall Study|Protocol Violation|0|||
44375688|NCT00942162|79380815|FG001|Overall Study|Other|13|||
44228215|NCT01947491|79035533|FG003|Overall Study|Protocol Violation|0|||
44274290|NCT01633944|79217787|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
44228216|NCT01947491|79035530|FG000|Overall Study|Withdrawal by Subject|1|||
44375689|NCT00942162|79380816|FG002|Overall Study|Other|2|||
44375690|NCT00942084|79380826|FG000|Overall Study|Death|2|||
44375691|NCT00941928|79380830|FG000|Overall Study|Withdrawal by Subject|1|||
44375692|NCT00941928|79380830|FG000|Overall Study|Disease Progression|1|||
44375693|NCT00937560|79380834|FG000|Initial Treatment|Death|6|||
44375694|NCT00937560|79380834|FG000|Initial Treatment|Withdraw consent|3|||
44375695|NCT00937560|79380834|FG000|Initial Treatment|Adverse Event|1|||
44375696|NCT00937560|79380834|FG000|Initial Treatment|Lost to Follow-up|1|||
44375697|NCT00937560|79380834|FG000|Initial Treatment|No end of study page|10|||
44375698|NCT00937560|79380834|FG000|Maintenance Treatment|Death|12|||
44375699|NCT00937560|79380834|FG000|Maintenance Treatment|Withdraw consent|5|||
44375700|NCT00937560|79380834|FG000|Maintenance Treatment|According to protocol|1|||
44375701|NCT00594568|79380841|FG000|Initial Treatment|Adverse Event|51|||
44486634|NCT00090220|79493074|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
44486635|NCT00090220|79493075|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
44486636|NCT00090220|79493070|FG000|Base Study Vaccination Period|Patient Moved|6|||
44486637|NCT00090220|79493071|FG001|Base Study Vaccination Period|Patient Moved|2|||
44486638|NCT00090220|79493072|FG002|Base Study Vaccination Period|Patient Moved|0|||
44375702|NCT00594568|79380842|FG001|Initial Treatment|Adverse Event|121|||
44375703|NCT00594568|79380843|FG002|Initial Treatment|Adverse Event|144|||
44375704|NCT00594568|79380841|FG000|Initial Treatment|Death|6|||
44375705|NCT00594568|79380842|FG001|Initial Treatment|Death|11|||
44375706|NCT00594568|79380843|FG002|Initial Treatment|Death|15|||
44375707|NCT00594568|79380841|FG000|Initial Treatment|Lost to Follow-up|4|||
44375708|NCT00594568|79380842|FG001|Initial Treatment|Lost to Follow-up|1|||
44375709|NCT00594568|79380843|FG002|Initial Treatment|Lost to Follow-up|4|||
44375710|NCT00594568|79380841|FG000|Initial Treatment|Physician Decision|3|||
44375711|NCT00594568|79380842|FG001|Initial Treatment|Physician Decision|2|||
44375712|NCT00594568|79380843|FG002|Initial Treatment|Physician Decision|4|||
44375713|NCT00594568|79380841|FG000|Initial Treatment|Protocol Violation|2|||
44375714|NCT00594568|79380842|FG001|Initial Treatment|Protocol Violation|2|||
44486639|NCT00090220|79493073|FG003|Base Study Vaccination Period|Patient Moved|0|||
44486640|NCT00090220|79493074|FG004|Base Study Vaccination Period|Patient Moved|0|||
44486641|NCT00090220|79493075|FG005|Base Study Vaccination Period|Patient Moved|0|||
44486642|NCT00090220|79493070|FG000|Base Study Vaccination Period|Other|4|||
44486643|NCT00090220|79493071|FG001|Base Study Vaccination Period|Other|4|||
44486644|NCT00090220|79493072|FG002|Base Study Vaccination Period|Other|0|||
44375715|NCT00594568|79380843|FG002|Initial Treatment|Protocol Violation|5|||
44375716|NCT00594568|79380841|FG000|Initial Treatment|Withdrawal by Subject|25|||
44375717|NCT00594568|79380842|FG001|Initial Treatment|Withdrawal by Subject|31|||
44375718|NCT00594568|79380843|FG002|Initial Treatment|Withdrawal by Subject|46|||
44375719|NCT00594568|79380841|FG000|Initial Treatment|Sponsor decision|193|||
44375720|NCT00594568|79380842|FG001|Initial Treatment|Sponsor decision|142|||
44375721|NCT00594568|79380843|FG002|Initial Treatment|Sponsor decision|147|||
44486645|NCT00090220|79493073|FG003|Base Study Vaccination Period|Other|0|||
44486646|NCT00090220|79493074|FG004|Base Study Vaccination Period|Other|0|||
44486647|NCT00090220|79493075|FG005|Base Study Vaccination Period|Other|0|||
44486648|NCT00090220|79493070|FG000|Base Study Follow-up Period|Adverse Event|6|||
44228217|NCT01947491|79035531|FG001|Overall Study|Withdrawal by Subject|1|||
44486649|NCT00090220|79493071|FG001|Base Study Follow-up Period|Adverse Event|1|||
44486650|NCT00090220|79493072|FG002|Base Study Follow-up Period|Adverse Event|0|||
44486651|NCT00090220|79493073|FG003|Base Study Follow-up Period|Adverse Event|0|||
44486652|NCT00090220|79493074|FG004|Base Study Follow-up Period|Adverse Event|0|||
44228218|NCT01947491|79035532|FG002|Overall Study|Withdrawal by Subject|1|||
44228219|NCT01947491|79035533|FG003|Overall Study|Withdrawal by Subject|0|||
44375722|NCT00594568|79380841|FG000|Initial Treatment|Caregiver decision|21|||
44486653|NCT00090220|79493075|FG005|Base Study Follow-up Period|Adverse Event|0|||
44486654|NCT00090220|79493070|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
44375723|NCT00594568|79380842|FG001|Initial Treatment|Caregiver decision|36|||
44375724|NCT00594568|79380843|FG002|Initial Treatment|Caregiver decision|36|||
44375725|NCT00594568|79380841|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
44486655|NCT00090220|79493071|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
44486656|NCT00090220|79493072|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
44486657|NCT00090220|79493073|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
44228220|NCT01947491|79035530|FG000|Overall Study|Worsening of condition|0|||
44486658|NCT00090220|79493074|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
44486659|NCT00090220|79493075|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
44486660|NCT00090220|79493070|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
44486661|NCT00090220|79493071|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
44486662|NCT00090220|79493072|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
44486663|NCT00090220|79493073|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
44486664|NCT00090220|79493074|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
44486665|NCT00090220|79493075|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
44486666|NCT00090220|79493070|FG000|Base Study Follow-up Period|Patient Moved|20|||
44486667|NCT00090220|79493071|FG001|Base Study Follow-up Period|Patient Moved|28|||
44486668|NCT00090220|79493072|FG002|Base Study Follow-up Period|Patient Moved|0|||
44486669|NCT00090220|79493073|FG003|Base Study Follow-up Period|Patient Moved|0|||
44486670|NCT00090220|79493074|FG004|Base Study Follow-up Period|Patient Moved|0|||
44486671|NCT00090220|79493075|FG005|Base Study Follow-up Period|Patient Moved|0|||
44486672|NCT00090220|79493070|FG000|Base Study Follow-up Period|Other|19|||
44486673|NCT00090220|79493071|FG001|Base Study Follow-up Period|Other|21|||
44486674|NCT00090220|79493072|FG002|Base Study Follow-up Period|Other|0|||
44486675|NCT00090220|79493073|FG003|Base Study Follow-up Period|Other|0|||
44486676|NCT00090220|79493074|FG004|Base Study Follow-up Period|Other|0|||
44486677|NCT00090220|79493075|FG005|Base Study Follow-up Period|Other|0|||
44486678|NCT00090220|79493070|FG000|Extension 1 (EXT1)|Adverse Event|0|||
44486679|NCT00090220|79493071|FG001|Extension 1 (EXT1)|Adverse Event|0|||
44486680|NCT00090220|79493072|FG002|Extension 1 (EXT1)|Adverse Event|4|||
44486681|NCT00090220|79493073|FG003|Extension 1 (EXT1)|Adverse Event|0|||
44486682|NCT00090220|79493074|FG004|Extension 1 (EXT1)|Adverse Event|0|||
44486683|NCT00090220|79493075|FG005|Extension 1 (EXT1)|Adverse Event|0|||
44486684|NCT00090220|79493070|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
44486685|NCT00090220|79493071|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
44486686|NCT00090220|79493072|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
44486687|NCT00090220|79493073|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
44486688|NCT00090220|79493074|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
44486689|NCT00090220|79493075|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
44486690|NCT00090220|79493070|FG000|Extension 1 (EXT1)|Moved|0|||
44486691|NCT00090220|79493071|FG001|Extension 1 (EXT1)|Moved|0|||
44486692|NCT00090220|79493072|FG002|Extension 1 (EXT1)|Moved|2|||
44486693|NCT00090220|79493073|FG003|Extension 1 (EXT1)|Moved|1|||
44486694|NCT00090220|79493074|FG004|Extension 1 (EXT1)|Moved|0|||
44486695|NCT00090220|79493075|FG005|Extension 1 (EXT1)|Moved|0|||
44486696|NCT00090220|79493070|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
44486697|NCT00090220|79493071|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
44486698|NCT00090220|79493072|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
44486699|NCT00090220|79493073|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
44486700|NCT00090220|79493074|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
44486701|NCT00090220|79493075|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
44486702|NCT00090220|79493070|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
44486703|NCT00090220|79493071|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
44486704|NCT00090220|79493072|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
44486705|NCT00090220|79493073|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
44486706|NCT00090220|79493074|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
44486707|NCT00090220|79493075|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
44486708|NCT00090220|79493070|FG000|Extension 1 (EXT1)|Other reason|0|||
44486709|NCT00090220|79493071|FG001|Extension 1 (EXT1)|Other reason|0|||
44486710|NCT00090220|79493072|FG002|Extension 1 (EXT1)|Other reason|2|||
44486711|NCT00090220|79493073|FG003|Extension 1 (EXT1)|Other reason|0|||
44486712|NCT00090220|79493074|FG004|Extension 1 (EXT1)|Other reason|0|||
44486713|NCT00090220|79493075|FG005|Extension 1 (EXT1)|Other reason|0|||
44486714|NCT00090220|79493070|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44486715|NCT00090220|79493071|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44486716|NCT00090220|79493072|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44486717|NCT00090220|79493073|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44486718|NCT00090220|79493074|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
44486719|NCT00090220|79493075|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
44486720|NCT00090220|79493070|FG000|Long-term Follow-up (EXT2)|Death|0|||
44486721|NCT00090220|79493071|FG001|Long-term Follow-up (EXT2)|Death|0|||
44486722|NCT00090220|79493072|FG002|Long-term Follow-up (EXT2)|Death|0|||
44486723|NCT00090220|79493073|FG003|Long-term Follow-up (EXT2)|Death|0|||
44486724|NCT00090220|79493074|FG004|Long-term Follow-up (EXT2)|Death|1|||
44486725|NCT00090220|79493075|FG005|Long-term Follow-up (EXT2)|Death|1|||
44486726|NCT00090220|79493070|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44486727|NCT00090220|79493071|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44486728|NCT00090220|79493072|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44486729|NCT00090220|79493073|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44486730|NCT00090220|79493074|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
44486731|NCT00090220|79493075|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
44486732|NCT00090220|79493070|FG000|Long-term Follow-up (EXT2)|Other|0|||
44486733|NCT00090220|79493071|FG001|Long-term Follow-up (EXT2)|Other|0|||
44486734|NCT00090220|79493072|FG002|Long-term Follow-up (EXT2)|Other|0|||
44486735|NCT00090220|79493073|FG003|Long-term Follow-up (EXT2)|Other|0|||
44486736|NCT00090220|79493074|FG004|Long-term Follow-up (EXT2)|Other|1|||
44486737|NCT00090220|79493075|FG005|Long-term Follow-up (EXT2)|Other|0|||
44486738|NCT00263328|79493095|FG000|Overall Study|Death|0|||
44486739|NCT00263328|79493096|FG001|Overall Study|Death|0|||
44486740|NCT00263328|79493097|FG002|Overall Study|Death|1|||
44228221|NCT01947491|79035531|FG001|Overall Study|Worsening of condition|1|||
44228222|NCT01947491|79035532|FG002|Overall Study|Worsening of condition|0|||
44486741|NCT00263328|79493095|FG000|Overall Study|Lost to Follow-up|1|||
44486742|NCT00263328|79493096|FG001|Overall Study|Lost to Follow-up|1|||
44486743|NCT00263328|79493097|FG002|Overall Study|Lost to Follow-up|0|||
44486744|NCT00263328|79493095|FG000|Overall Study|Withdrawal by Subject|3|||
44486745|NCT00263328|79493096|FG001|Overall Study|Withdrawal by Subject|0|||
44228223|NCT01947491|79035533|FG003|Overall Study|Worsening of condition|0|||
44486746|NCT00263328|79493097|FG002|Overall Study|Withdrawal by Subject|1|||
44486747|NCT00263328|79493095|FG000|Overall Study|Other|3|||
44486748|NCT00263328|79493096|FG001|Overall Study|Other|0|||
44486749|NCT00263328|79493097|FG002|Overall Study|Other|1|||
44486750|NCT00263328|79493095|FG000|Overall Study|Adverse Event|1|||
44486751|NCT00263328|79493096|FG001|Overall Study|Adverse Event|1|||
44486752|NCT00263328|79493097|FG002|Overall Study|Adverse Event|4|||
44486753|NCT00262860|79493107|FG000|Overall Study|Adverse Event|2|||
44486754|NCT00236184|79493113|FG000|Overall Study|Adverse Event|5|||
44486755|NCT00236184|79493114|FG001|Overall Study|Adverse Event|2|||
44486756|NCT00236184|79493113|FG000|Overall Study|Lack of Efficacy|0|||
44486757|NCT00236184|79493114|FG001|Overall Study|Lack of Efficacy|1|||
44486758|NCT00236184|79493113|FG000|Overall Study|Lost to Follow-up|3|||
44486759|NCT00236184|79493114|FG001|Overall Study|Lost to Follow-up|4|||
44486760|NCT00236184|79493113|FG000|Overall Study|Physician Decision|1|||
44486761|NCT00236184|79493114|FG001|Overall Study|Physician Decision|1|||
44486762|NCT00236184|79493113|FG000|Overall Study|Withdrawal by Subject|3|||
44486763|NCT00236184|79493114|FG001|Overall Study|Withdrawal by Subject|0|||
44486764|NCT00236184|79493113|FG000|Overall Study|Protocol Violation|3|||
44486765|NCT00236184|79493114|FG001|Overall Study|Protocol Violation|0|||
44486766|NCT00236184|79493113|FG000|Overall Study|non-compliance with study drug|2|||
44486767|NCT00236184|79493114|FG001|Overall Study|non-compliance with study drug|1|||
44486768|NCT00236184|79493113|FG000|Overall Study|other|1|||
44486769|NCT00236184|79493114|FG001|Overall Study|other|2|||
44228224|NCT01947491|79035530|FG000|Overall Study|Adverse Event|0|||
44228225|NCT01947491|79035531|FG001|Overall Study|Adverse Event|1|||
44228226|NCT01947491|79035532|FG002|Overall Study|Adverse Event|0|||
44228227|NCT01947491|79035533|FG003|Overall Study|Adverse Event|2|||
44228228|NCT01715857|79035543|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
44486770|NCT00296504|79493128|FG000|Interim Analysis|Withdrawal by Subject|8|||
44486771|NCT00296504|79493129|FG001|Interim Analysis|Withdrawal by Subject|0|||
44486772|NCT00296504|79493130|FG002|Interim Analysis|Withdrawal by Subject|12|||
44486773|NCT00296504|79493131|FG003|Interim Analysis|Withdrawal by Subject|0|||
44486774|NCT00296504|79493132|FG004|Interim Analysis|Withdrawal by Subject|5|||
44486775|NCT00296504|79493133|FG005|Interim Analysis|Withdrawal by Subject|5|||
44486776|NCT00296504|79493134|FG006|Interim Analysis|Withdrawal by Subject|9|||
44486777|NCT00296504|79493135|FG007|Interim Analysis|Withdrawal by Subject|3|||
44486778|NCT00296504|79493136|FG008|Interim Analysis|Withdrawal by Subject|0|||
44486779|NCT00296504|79493128|FG000|Interim Analysis|Lost to Follow-up|13|||
44228229|NCT01692301|79035549|FG000|Overall Study|Adverse Event|15|||
44228230|NCT01692301|79035550|FG001|Overall Study|Adverse Event|12|||
44486780|NCT00296504|79493129|FG001|Interim Analysis|Lost to Follow-up|3|||
44486781|NCT00296504|79493130|FG002|Interim Analysis|Lost to Follow-up|26|||
44486782|NCT00296504|79493131|FG003|Interim Analysis|Lost to Follow-up|8|||
44486783|NCT00296504|79493132|FG004|Interim Analysis|Lost to Follow-up|14|||
44486784|NCT00296504|79493133|FG005|Interim Analysis|Lost to Follow-up|4|||
44486785|NCT00296504|79493134|FG006|Interim Analysis|Lost to Follow-up|11|||
44486786|NCT00296504|79493135|FG007|Interim Analysis|Lost to Follow-up|4|||
44486787|NCT00296504|79493136|FG008|Interim Analysis|Lost to Follow-up|0|||
44486788|NCT00296504|79493128|FG000|Interim Analysis|Clinical Progression|1|||
44486789|NCT00296504|79493129|FG001|Interim Analysis|Clinical Progression|0|||
44486790|NCT00296504|79493130|FG002|Interim Analysis|Clinical Progression|1|||
44486791|NCT00296504|79493131|FG003|Interim Analysis|Clinical Progression|1|||
44486792|NCT00296504|79493132|FG004|Interim Analysis|Clinical Progression|0|||
44486793|NCT00296504|79493133|FG005|Interim Analysis|Clinical Progression|2|||
44486794|NCT00296504|79493134|FG006|Interim Analysis|Clinical Progression|1|||
44486795|NCT00296504|79493135|FG007|Interim Analysis|Clinical Progression|2|||
44486796|NCT00296504|79493136|FG008|Interim Analysis|Clinical Progression|0|||
44486797|NCT00296504|79493128|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
44486798|NCT00296504|79493129|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
44486799|NCT00296504|79493130|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
44486800|NCT00296504|79493131|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
44486801|NCT00296504|79493132|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
44486802|NCT00296504|79493133|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
44486803|NCT00296504|79493134|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
44486804|NCT00296504|79493135|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
44486805|NCT00296504|79493136|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
44486806|NCT00296504|79493128|FG000|Interim Analysis|Adverse Event|0|||
44486807|NCT00296504|79493129|FG001|Interim Analysis|Adverse Event|0|||
44486808|NCT00296504|79493130|FG002|Interim Analysis|Adverse Event|13|||
44486809|NCT00296504|79493131|FG003|Interim Analysis|Adverse Event|4|||
44486810|NCT00296504|79493132|FG004|Interim Analysis|Adverse Event|6|||
44486811|NCT00296504|79493133|FG005|Interim Analysis|Adverse Event|3|||
44486812|NCT00296504|79493134|FG006|Interim Analysis|Adverse Event|4|||
44486813|NCT00296504|79493135|FG007|Interim Analysis|Adverse Event|5|||
44486814|NCT00296504|79493136|FG008|Interim Analysis|Adverse Event|0|||
44486815|NCT00296504|79493128|FG000|Interim Analysis|Protocol Violation|0|||
44486816|NCT00296504|79493129|FG001|Interim Analysis|Protocol Violation|0|||
44486817|NCT00296504|79493130|FG002|Interim Analysis|Protocol Violation|2|||
44486818|NCT00296504|79493131|FG003|Interim Analysis|Protocol Violation|0|||
44486819|NCT00296504|79493132|FG004|Interim Analysis|Protocol Violation|1|||
44486820|NCT00296504|79493133|FG005|Interim Analysis|Protocol Violation|0|||
44486821|NCT00296504|79493134|FG006|Interim Analysis|Protocol Violation|0|||
44486822|NCT00296504|79493135|FG007|Interim Analysis|Protocol Violation|1|||
44486823|NCT00296504|79493136|FG008|Interim Analysis|Protocol Violation|0|||
44486824|NCT00296504|79493128|FG000|Interim Analysis|Insufficient CD4 Response|0|||
44486825|NCT00296504|79493129|FG001|Interim Analysis|Insufficient CD4 Response|0|||
44228231|NCT01692301|79035549|FG000|Overall Study|Death|1|||
44228232|NCT01692301|79035550|FG001|Overall Study|Death|2|||
44228233|NCT01692301|79035549|FG000|Overall Study|Lack of Efficacy|0|||
44228234|NCT01692301|79035550|FG001|Overall Study|Lack of Efficacy|5|||
44228235|NCT01692301|79035549|FG000|Overall Study|Non-compliance with study treatment|1|||
44228236|NCT01692301|79035550|FG001|Overall Study|Non-compliance with study treatment|2|||
44228237|NCT01692301|79035549|FG000|Overall Study|Protocol deviation|9|||
44228238|NCT01692301|79035550|FG001|Overall Study|Protocol deviation|2|||
44228239|NCT01692301|79035549|FG000|Overall Study|Patient/guardian decision|16|||
44228240|NCT01692301|79035550|FG001|Overall Study|Patient/guardian decision|15|||
44228241|NCT01692301|79035549|FG000|Overall Study|Technical problems|0|||
44228242|NCT01692301|79035550|FG001|Overall Study|Technical problems|1|||
44544752|NCT01345682|79558342|FG000|Overall Study|Non-compliance with protocol|0|||
44228243|NCT01692301|79035549|FG000|Overall Study|Physician Decision|2|||
44228244|NCT01692301|79035550|FG001|Overall Study|Physician Decision|2|||
44228245|NCT01692301|79035549|FG000|Overall Study|Lost to Follow-up|1|||
44228246|NCT01692301|79035550|FG001|Overall Study|Lost to Follow-up|1|||
44228247|NCT01592773|79035556|FG000|Overall Study|Study Terminated by Sponsor|582|||
44486826|NCT00296504|79493130|FG002|Interim Analysis|Insufficient CD4 Response|0|||
44486827|NCT00296504|79493131|FG003|Interim Analysis|Insufficient CD4 Response|0|||
44544753|NCT01345682|79558343|FG001|Overall Study|Non-compliance with protocol|1|||
44228248|NCT01592773|79035556|FG000|Overall Study|Withdrawal by Subject|35|||
44228249|NCT01592773|79035556|FG000|Overall Study|Lost to Follow-up|19|||
44274291|NCT01633944|79217788|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
44274292|NCT01633944|79217786|FG000|Open-label Titration Phase|Other|68|||
44486828|NCT00296504|79493132|FG004|Interim Analysis|Insufficient CD4 Response|1|||
44544754|NCT01345682|79558342|FG000|Overall Study|Lost to Follow-up|0|||
44544755|NCT01345682|79558343|FG001|Overall Study|Lost to Follow-up|1|||
44486829|NCT00296504|79493133|FG005|Interim Analysis|Insufficient CD4 Response|1|||
44544756|NCT01345682|79558342|FG000|Overall Study|Refused to continue trial medication|16|||
44228250|NCT01592773|79035556|FG000|Overall Study|Adverse Event|17|||
44228251|NCT01592773|79035556|FG000|Overall Study|Lack of Efficacy|9|||
44228252|NCT01592773|79035556|FG000|Overall Study|Protocol Violation|2|||
44228253|NCT01592773|79035556|FG000|Overall Study|Inclusion/exclusion not meet|1|||
44228254|NCT01592773|79035556|FG000|Overall Study|Other Reason|1|||
44228255|NCT01930175|79035563|FG000|Core Study|Lost to Follow-up|0|||
44228256|NCT01930175|79035564|FG001|Core Study|Lost to Follow-up|1|||
44228257|NCT01930175|79035565|FG002|Core Study|Lost to Follow-up|0|||
44228258|NCT01930175|79035563|FG000|Core Study|Adverse Event|0|||
44228259|NCT01930175|79035564|FG001|Core Study|Adverse Event|0|||
44228260|NCT01930175|79035565|FG002|Core Study|Adverse Event|1|||
44228261|NCT01592695|79035576|FG000|Overall Study|Lost to Follow-up|8|||
44228262|NCT01592695|79035577|FG001|Overall Study|Lost to Follow-up|4|||
44228263|NCT01929863|79035583|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
44228264|NCT01929863|79035584|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
44228265|NCT01929863|79035583|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
44228266|NCT01929863|79035584|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
44228267|NCT01929863|79035583|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
44228268|NCT01929863|79035584|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
44228269|NCT01918085|79035597|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
44228270|NCT01918085|79035598|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
44228271|NCT01714687|79035608|FG000|Overall Study|Withdrawal by Subject|1|||
44228272|NCT01714687|79035609|FG001|Overall Study|Withdrawal by Subject|0|||
44228273|NCT01714687|79035608|FG000|Overall Study|Lost to Follow-up|2|||
44228274|NCT01714687|79035609|FG001|Overall Study|Lost to Follow-up|4|||
44228275|NCT01714609|79035619|FG000|Overall Study|Protocol Violation|1|||
44228276|NCT01714609|79035620|FG001|Overall Study|Protocol Violation|0|||
44228277|NCT01929707|79035626|FG000|Intervention Period 1|Lost to Follow-up|0|||
44228278|NCT01929707|79035627|FG001|Intervention Period 1|Lost to Follow-up|0|||
44228279|NCT01929707|79035628|FG002|Intervention Period 1|Lost to Follow-up|0|||
44228280|NCT01929707|79035629|FG003|Intervention Period 1|Lost to Follow-up|1|||
44228281|NCT01929707|79035630|FG004|Intervention Period 1|Lost to Follow-up|0|||
44228282|NCT01929707|79035631|FG005|Intervention Period 1|Lost to Follow-up|0|||
44228283|NCT01929707|79035632|FG006|Intervention Period 1|Lost to Follow-up|0|||
44228284|NCT01929707|79035633|FG007|Intervention Period 1|Lost to Follow-up|0|||
44228285|NCT01929707|79035626|FG000|Intervention Period 1|Withdrawal by Subject|0|||
44228286|NCT01929707|79035627|FG001|Intervention Period 1|Withdrawal by Subject|0|||
44228287|NCT01929707|79035628|FG002|Intervention Period 1|Withdrawal by Subject|0|||
44228288|NCT01929707|79035629|FG003|Intervention Period 1|Withdrawal by Subject|2|||
44228289|NCT01929707|79035630|FG004|Intervention Period 1|Withdrawal by Subject|0|||
44228290|NCT01929707|79035631|FG005|Intervention Period 1|Withdrawal by Subject|0|||
44228291|NCT01929707|79035632|FG006|Intervention Period 1|Withdrawal by Subject|0|||
44228292|NCT01929707|79035633|FG007|Intervention Period 1|Withdrawal by Subject|0|||
44228293|NCT01929707|79035626|FG000|Intervention Period 2|Withdrawal by Subject|0|||
44228294|NCT01929707|79035627|FG001|Intervention Period 2|Withdrawal by Subject|0|||
44228295|NCT01929707|79035628|FG002|Intervention Period 2|Withdrawal by Subject|0|||
44228296|NCT01929707|79035629|FG003|Intervention Period 2|Withdrawal by Subject|0|||
44228297|NCT01929707|79035630|FG004|Intervention Period 2|Withdrawal by Subject|0|||
44228298|NCT01929707|79035631|FG005|Intervention Period 2|Withdrawal by Subject|2|||
44228299|NCT01929707|79035632|FG006|Intervention Period 2|Withdrawal by Subject|0|||
44228300|NCT01929707|79035633|FG007|Intervention Period 2|Withdrawal by Subject|0|||
44228301|NCT01714063|79035654|FG000|Overall Study|Equipment malfunction|2|||
44228302|NCT01929395|79035665|FG000|Overall Study|Did not complete - non-related toxicity|1|||
44228303|NCT01929395|79035666|FG001|Overall Study|Did not complete - non-related toxicity|0|||
44228304|NCT01929395|79035667|FG002|Overall Study|Did not complete - non-related toxicity|0|||
44228305|NCT01929395|79035665|FG000|Overall Study|Withdrawal by Subject|0|||
44228306|NCT01929395|79035666|FG001|Overall Study|Withdrawal by Subject|1|||
44228307|NCT01929395|79035667|FG002|Overall Study|Withdrawal by Subject|0|||
44228308|NCT01929395|79035665|FG000|Overall Study|Screen Fail|0|||
44228309|NCT01929395|79035666|FG001|Overall Study|Screen Fail|0|||
44228310|NCT01929395|79035667|FG002|Overall Study|Screen Fail|1|||
44228311|NCT01713283|79035679|FG000|Overall Study|Lack of Efficacy|10|||
44228312|NCT01713283|79035680|FG001|Overall Study|Lack of Efficacy|2|||
44228313|NCT01713283|79035679|FG000|Overall Study|Lost to Follow-up|1|||
44228314|NCT01713283|79035680|FG001|Overall Study|Lost to Follow-up|1|||
44228315|NCT01592383|79035690|FG000|Overall Study|Adverse Event|1|||
44228316|NCT01691521|79035698|FG000|Overall Study|Adverse Event|4|||
44228317|NCT01691521|79035699|FG001|Overall Study|Adverse Event|0|||
44228318|NCT01691521|79035700|FG002|Overall Study|Adverse Event|1|||
44228319|NCT01691521|79035698|FG000|Overall Study|Lack of Efficacy|1|||
44228320|NCT01691521|79035699|FG001|Overall Study|Lack of Efficacy|1|||
44228321|NCT01691521|79035700|FG002|Overall Study|Lack of Efficacy|2|||
44228322|NCT01691521|79035698|FG000|Overall Study|Protocol Violation|0|||
44228323|NCT01691521|79035699|FG001|Overall Study|Protocol Violation|3|||
44228324|NCT01691521|79035700|FG002|Overall Study|Protocol Violation|0|||
44228325|NCT01691521|79035698|FG000|Overall Study|Lost to Follow-up|0|||
44228326|NCT01691521|79035699|FG001|Overall Study|Lost to Follow-up|2|||
44228327|NCT01691521|79035700|FG002|Overall Study|Lost to Follow-up|2|||
44228328|NCT01691521|79035698|FG000|Overall Study|Physician Decision|2|||
44228329|NCT01691521|79035699|FG001|Overall Study|Physician Decision|1|||
44228330|NCT01691521|79035700|FG002|Overall Study|Physician Decision|0|||
44228331|NCT01691521|79035698|FG000|Overall Study|Withdrawal by Subject|5|||
44228332|NCT01691521|79035699|FG001|Overall Study|Withdrawal by Subject|9|||
44228333|NCT01691521|79035700|FG002|Overall Study|Withdrawal by Subject|4|||
44228334|NCT01929317|79035711|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
44544757|NCT01345682|79558343|FG001|Overall Study|Refused to continue trial medication|9|||
44544758|NCT01345682|79558342|FG000|Overall Study|Not treated|2|||
44544759|NCT01345682|79558343|FG001|Overall Study|Not treated|1|||
44544760|NCT01345682|79558342|FG000|Overall Study|Reason other than those specified above|4|||
44544761|NCT01345682|79558343|FG001|Overall Study|Reason other than those specified above|3|||
44544762|NCT03562117|79558352|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
44544763|NCT03562117|79558353|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
44544764|NCT03562117|79558354|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
44544765|NCT03561883|79558364|FG000|Overall Study|Adverse Event|10|||
44544766|NCT03561883|79558365|FG001|Overall Study|Adverse Event|13|||
44544767|NCT03561883|79558364|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44544768|NCT03561883|79558365|FG001|Overall Study|Non-Compliance With Study Drug|2|||
44544769|NCT03561883|79558364|FG000|Overall Study|Protocol Violation|2|||
44544770|NCT03561883|79558365|FG001|Overall Study|Protocol Violation|3|||
44544771|NCT03561883|79558364|FG000|Overall Study|Withdrawal by Subject|14|||
44544772|NCT03561883|79558365|FG001|Overall Study|Withdrawal by Subject|6|||
44544773|NCT03561883|79558364|FG000|Overall Study|Lost to Follow-up|2|||
44544774|NCT03561883|79558365|FG001|Overall Study|Lost to Follow-up|6|||
44544775|NCT03561883|79558364|FG000|Overall Study|Study Terminated by Sponsor|12|||
44544776|NCT03561883|79558365|FG001|Overall Study|Study Terminated by Sponsor|11|||
44544777|NCT03561883|79558364|FG000|Overall Study|Physician Decision|1|||
44544778|NCT03561883|79558365|FG001|Overall Study|Physician Decision|0|||
44544779|NCT03561883|79558364|FG000|Overall Study|Randomized by Mistake|1|||
44544780|NCT03561883|79558365|FG001|Overall Study|Randomized by Mistake|0|||
44544781|NCT03561883|79558364|FG000|Overall Study|Other, Not Specified|3|||
44544782|NCT03561883|79558365|FG001|Overall Study|Other, Not Specified|2|||
44544783|NCT03546907|79558373|FG000|Overall Study|Lack of Efficacy|1|||
44544784|NCT03546907|79558374|FG001|Overall Study|Lack of Efficacy|1|||
44544785|NCT03546907|79558373|FG000|Overall Study|Withdrawal by Subject|8|||
44544786|NCT03546907|79558374|FG001|Overall Study|Withdrawal by Subject|9|||
44544787|NCT03546907|79558373|FG000|Overall Study|Adverse events (AEs)|7|||
44544788|NCT03546907|79558374|FG001|Overall Study|Adverse events (AEs)|10|||
44544789|NCT03546907|79558373|FG000|Overall Study|Other-unspecified|1|||
44544790|NCT03546907|79558374|FG001|Overall Study|Other-unspecified|1|||
44544791|NCT01318382|79558380|FG000|Overall Study|Physician Decision|2|||
44544792|NCT01318382|79558380|FG000|Overall Study|Device Malfunction|10|||
44544793|NCT01318382|79558380|FG000|Overall Study|Protocol Violation|1|||
44544794|NCT03053180|79558398|FG000|Overall Study|Failure to Return|1|||
44544795|NCT03560869|79558402|FG000|Overall Study|Withdrawal by Subject|3|||
44544796|NCT03560869|79558403|FG001|Overall Study|Withdrawal by Subject|4|||
44544797|NCT03560869|79558402|FG000|Overall Study|Screening failure|4|||
44544798|NCT03560869|79558403|FG001|Overall Study|Screening failure|4|||
44544799|NCT03560869|79558402|FG000|Overall Study|Withdrawal by PI|0|||
44544800|NCT03560869|79558403|FG001|Overall Study|Withdrawal by PI|1|||
44228335|NCT01929317|79035712|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
44228336|NCT01929317|79035711|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
44228337|NCT01929317|79035712|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
44274293|NCT01633944|79217787|FG001|Open-label Titration Phase|Other|0|||
44274294|NCT01633944|79217788|FG002|Open-label Titration Phase|Other|0|||
44486830|NCT00296504|79493134|FG006|Interim Analysis|Insufficient CD4 Response|0|||
44486831|NCT00296504|79493135|FG007|Interim Analysis|Insufficient CD4 Response|0|||
44486832|NCT00296504|79493136|FG008|Interim Analysis|Insufficient CD4 Response|0|||
44486833|NCT00296504|79493128|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
44486834|NCT00296504|79493129|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
44486835|NCT00296504|79493130|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
44486836|NCT00296504|79493131|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
44486837|NCT00296504|79493132|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
44486838|NCT00296504|79493133|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
44486839|NCT00296504|79493134|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
44486840|NCT00296504|79493135|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
44486841|NCT00296504|79493136|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
44486842|NCT00296504|79493128|FG000|Interim Analysis|Pregnancy|4|||
44486843|NCT00296504|79493129|FG001|Interim Analysis|Pregnancy|1|||
44486844|NCT00296504|79493130|FG002|Interim Analysis|Pregnancy|4|||
44486845|NCT00296504|79493131|FG003|Interim Analysis|Pregnancy|2|||
44486846|NCT00296504|79493132|FG004|Interim Analysis|Pregnancy|0|||
44486847|NCT00296504|79493133|FG005|Interim Analysis|Pregnancy|1|||
44486848|NCT00296504|79493134|FG006|Interim Analysis|Pregnancy|1|||
44228338|NCT01929317|79035711|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
44228339|NCT01929317|79035712|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
44486849|NCT00296504|79493135|FG007|Interim Analysis|Pregnancy|1|||
44486850|NCT00296504|79493136|FG008|Interim Analysis|Pregnancy|0|||
44486851|NCT00296504|79493128|FG000|Interim Analysis|Death|1|||
44486852|NCT00296504|79493129|FG001|Interim Analysis|Death|0|||
44486853|NCT00296504|79493130|FG002|Interim Analysis|Death|3|||
44486854|NCT00296504|79493131|FG003|Interim Analysis|Death|0|||
44486855|NCT00296504|79493132|FG004|Interim Analysis|Death|0|||
44486856|NCT00296504|79493133|FG005|Interim Analysis|Death|0|||
44486857|NCT00296504|79493134|FG006|Interim Analysis|Death|0|||
44486858|NCT00296504|79493135|FG007|Interim Analysis|Death|0|||
44486859|NCT00296504|79493136|FG008|Interim Analysis|Death|0|||
44486860|NCT00296504|79493128|FG000|Interim Analysis|Participant Non-compliant|0|||
44486861|NCT00296504|79493129|FG001|Interim Analysis|Participant Non-compliant|1|||
44486862|NCT00296504|79493130|FG002|Interim Analysis|Participant Non-compliant|2|||
44486863|NCT00296504|79493131|FG003|Interim Analysis|Participant Non-compliant|1|||
44486864|NCT00296504|79493132|FG004|Interim Analysis|Participant Non-compliant|1|||
44486865|NCT00296504|79493133|FG005|Interim Analysis|Participant Non-compliant|3|||
44486866|NCT00296504|79493134|FG006|Interim Analysis|Participant Non-compliant|6|||
44486867|NCT00296504|79493135|FG007|Interim Analysis|Participant Non-compliant|2|||
44486868|NCT00296504|79493136|FG008|Interim Analysis|Participant Non-compliant|0|||
44486869|NCT00296504|79493128|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44486870|NCT00296504|79493129|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44486871|NCT00296504|79493130|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
44486872|NCT00296504|79493131|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44486873|NCT00296504|79493132|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44486874|NCT00296504|79493133|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
44486875|NCT00296504|79493134|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44486876|NCT00296504|79493135|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44228340|NCT01929317|79035711|FG000|Long-term Phase|Adverse Event|5|||
44228341|NCT01929317|79035712|FG001|Long-term Phase|Adverse Event|1|||
44228342|NCT01929317|79035711|FG000|Long-term Phase|Physician Decision|3|||
44228343|NCT01929317|79035712|FG001|Long-term Phase|Physician Decision|0|||
44228344|NCT01929317|79035711|FG000|Long-term Phase|Withdrawal by Subject|4|||
44228345|NCT01929317|79035712|FG001|Long-term Phase|Withdrawal by Subject|0|||
44228346|NCT01929317|79035711|FG000|Long-term Phase|Protocol Violation|1|||
44228347|NCT01929317|79035712|FG001|Long-term Phase|Protocol Violation|0|||
44228348|NCT01929317|79035711|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
44228349|NCT01929317|79035712|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
44228350|NCT01929317|79035711|FG000|Long-term Phase|Study Closed/Terminated|5|||
44228351|NCT01929317|79035712|FG001|Long-term Phase|Study Closed/Terminated|3|||
44228352|NCT01711879|79035726|FG000|Overall Study|Death|1|||
44228353|NCT01711879|79035727|FG001|Overall Study|Death|0|||
44486877|NCT00296504|79493136|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
44486878|NCT00296504|79493128|FG000|Interim Analysis|To Simplify Treatment|0|||
44486879|NCT00296504|79493129|FG001|Interim Analysis|To Simplify Treatment|0|||
44486880|NCT00296504|79493130|FG002|Interim Analysis|To Simplify Treatment|1|||
44486881|NCT00296504|79493131|FG003|Interim Analysis|To Simplify Treatment|0|||
44486882|NCT00296504|79493132|FG004|Interim Analysis|To Simplify Treatment|0|||
44486883|NCT00296504|79493133|FG005|Interim Analysis|To Simplify Treatment|0|||
44228354|NCT01689649|79035750|FG000|Overall Study|Lack of Efficacy|3|||
44228355|NCT01689649|79035750|FG000|Overall Study|Non-compliance|11|||
44486884|NCT00296504|79493134|FG006|Interim Analysis|To Simplify Treatment|2|||
44486885|NCT00296504|79493135|FG007|Interim Analysis|To Simplify Treatment|0|||
44228356|NCT01689649|79035750|FG000|Overall Study|Protocol Violation|3|||
44228357|NCT01689649|79035750|FG000|Overall Study|Lost to Follow-up|5|||
44486886|NCT00296504|79493136|FG008|Interim Analysis|To Simplify Treatment|0|||
44486887|NCT00296504|79493128|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
44228358|NCT01929083|79035754|FG000|Intervention 1|Lost to Follow-up|2|||
44486888|NCT00296504|79493129|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486889|NCT00296504|79493130|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
44228359|NCT01929083|79035755|FG001|Intervention 1|Lost to Follow-up|0|||
44228360|NCT01929083|79035754|FG000|Intervention 1|Nonadherent to study medications|1|||
44228361|NCT01929083|79035755|FG001|Intervention 1|Nonadherent to study medications|0|||
44228362|NCT01929083|79035754|FG000|Intervention 2|Adverse Event|0|||
44228363|NCT01929083|79035755|FG001|Intervention 2|Adverse Event|1|||
44228364|NCT01689337|79035761|FG000|Overall Study|Study Discontinuation|1|||
44228365|NCT01688635|79035767|FG000|Washout 1|Withdrawal by Subject|1|||
44228366|NCT01688635|79035768|FG001|Washout 1|Withdrawal by Subject|0|||
44228367|NCT01688635|79035767|FG000|Washout 1|Adverse Event|0|||
44228368|NCT01688635|79035768|FG001|Washout 1|Adverse Event|1|||
44228369|NCT01688635|79035767|FG000|Washout 1|Physician Decision|0|||
44228370|NCT01688635|79035768|FG001|Washout 1|Physician Decision|1|||
44228371|NCT01688635|79035767|FG000|Washout 2|Physician Decision|1|||
44228372|NCT01688635|79035768|FG001|Washout 2|Physician Decision|0|||
44228373|NCT01688635|79035767|FG000|Washout 2|Withdrawal by Subject|1|||
44228374|NCT01688635|79035768|FG001|Washout 2|Withdrawal by Subject|0|||
44274295|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Adverse Event|0|||
44544801|NCT03590743|79558411|FG000|Overall Study|Withdrawal by Subject|0|||
44544802|NCT03590743|79558412|FG001|Overall Study|Withdrawal by Subject|1|||
44544803|NCT03053102|79558418|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
44544804|NCT03053102|79558418|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
44544805|NCT03589885|79558426|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
44544806|NCT03589885|79558427|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
44544807|NCT03589885|79558428|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
44544808|NCT03589885|79558429|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
44544809|NCT03589885|79558430|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
44544810|NCT03589885|79558426|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
44544811|NCT03589885|79558427|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
44544812|NCT03589885|79558428|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
44544813|NCT03589885|79558429|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
44544814|NCT03589885|79558430|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
44544815|NCT03589885|79558426|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
44544816|NCT03589885|79558427|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
44544817|NCT03589885|79558428|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
44544818|NCT03589885|79558429|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
44544819|NCT03589885|79558430|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
44544820|NCT03589885|79558426|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
44544821|NCT03589885|79558427|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
44544822|NCT03589885|79558428|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
44544823|NCT03589885|79558429|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
44544824|NCT03589885|79558430|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
44544825|NCT03589885|79558426|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
44544826|NCT03589885|79558427|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
44544827|NCT03589885|79558428|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
44544828|NCT03589885|79558429|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
44544829|NCT03589885|79558430|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
44544830|NCT03589885|79558426|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
44544831|NCT03589885|79558427|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
44544832|NCT03589885|79558428|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
44544833|NCT03589885|79558429|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
44544834|NCT03589885|79558430|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
44544835|NCT03589885|79558426|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
44375726|NCT00594568|79380842|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
44486890|NCT00296504|79493131|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486891|NCT00296504|79493132|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486892|NCT00296504|79493133|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486893|NCT00296504|79493134|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486894|NCT00296504|79493135|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486895|NCT00296504|79493136|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
44486896|NCT00296504|79493128|FG000|Interim Analysis|Participant Moved|1|||
44486897|NCT00296504|79493129|FG001|Interim Analysis|Participant Moved|0|||
44486898|NCT00296504|79493130|FG002|Interim Analysis|Participant Moved|1|||
44486899|NCT00296504|79493131|FG003|Interim Analysis|Participant Moved|0|||
44544836|NCT03589885|79558427|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
44486900|NCT00296504|79493132|FG004|Interim Analysis|Participant Moved|0|||
44486901|NCT00296504|79493133|FG005|Interim Analysis|Participant Moved|1|||
44228375|NCT01688635|79035767|FG000|Washout 2|Sponsor Decision|1|||
44228376|NCT01688635|79035768|FG001|Washout 2|Sponsor Decision|2|||
44486902|NCT00296504|79493134|FG006|Interim Analysis|Participant Moved|1|||
44486903|NCT00296504|79493135|FG007|Interim Analysis|Participant Moved|0|||
44228377|NCT01688635|79035767|FG000|Washout 3|Withdrawal by Subject|1|||
44228378|NCT01688635|79035768|FG001|Washout 3|Withdrawal by Subject|0|||
44228379|NCT01591681|79035775|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
44544837|NCT03589885|79558428|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
44544838|NCT03589885|79558429|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
44228380|NCT01591681|79035775|FG000|Overall Study|Failed to use system during run-in|1|||
44228381|NCT01711645|79035790|FG000|Overall Study|Withdrawal by Subject|8|||
44228382|NCT01711645|79035790|FG000|Overall Study|Lost to Follow-up|6|||
44228383|NCT01711645|79035790|FG000|Overall Study|Physician Decision|5|||
44228384|NCT01590433|79035805|FG000|Overall Study|Lost to Follow-up|20|||
44228385|NCT01590433|79035806|FG001|Overall Study|Lost to Follow-up|8|||
44228386|NCT01590433|79035805|FG000|Overall Study|Withdrawal by Subject|21|||
44228387|NCT01590433|79035806|FG001|Overall Study|Withdrawal by Subject|11|||
44228388|NCT01590433|79035805|FG000|Overall Study|Adverse Event|11|||
44228389|NCT01590433|79035806|FG001|Overall Study|Adverse Event|3|||
44228390|NCT01928927|79035823|FG000|Overall Study|Lost to Follow-up|1|||
44228391|NCT01928927|79035824|FG001|Overall Study|Lost to Follow-up|0|||
44228392|NCT01928927|79035823|FG000|Overall Study|Withdrawal by Subject|1|||
44228393|NCT01928927|79035824|FG001|Overall Study|Withdrawal by Subject|1|||
44228394|NCT01710709|79035845|FG000|Overall Study|Lost to Follow-up|29|||
44228395|NCT01710709|79035845|FG000|Overall Study|Adverse Event|48|||
44228396|NCT01710709|79035845|FG000|Overall Study|Participant met withdrawal criteria|33|||
44228397|NCT01710709|79035845|FG000|Overall Study|Participant withdrawn by investigator|2|||
44228398|NCT01710709|79035845|FG000|Overall Study|Withdrawal by Subject|53|||
44228399|NCT01710709|79035845|FG000|Overall Study|Protocol Violation|5|||
44228400|NCT01710709|79035845|FG000|Overall Study|Lack of Efficacy|3|||
44228401|NCT01617629|79035850|FG000|Overall Study|Death|2|||
44228402|NCT01617629|79035850|FG000|Overall Study|Investigator's Clinical Judgement|1|||
44228403|NCT01617629|79035850|FG000|Overall Study|Reason Not Specified|1|||
44228404|NCT01617629|79035850|FG000|Overall Study|Participant Withdrew Consent|2|||
44228405|NCT01686373|79035865|FG000|Overall Study|Lost to Follow-up|3|||
44228406|NCT01686373|79035866|FG001|Overall Study|Lost to Follow-up|0|||
44228407|NCT01686373|79035865|FG000|Overall Study|Withdrawal by Subject|0|||
44228408|NCT01686373|79035866|FG001|Overall Study|Withdrawal by Subject|1|||
44375727|NCT00594568|79380843|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
44544839|NCT03589885|79558430|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
44544840|NCT03589885|79558426|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
44544841|NCT03589885|79558427|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
44544842|NCT03589885|79558428|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
44544843|NCT03589885|79558429|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
44544844|NCT03589885|79558430|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
44544845|NCT03545503|79558450|FG000|Overall Study|Protocol Violation|14|||
44544846|NCT03545503|79558451|FG001|Overall Study|Protocol Violation|16|||
44544847|NCT03545113|79558459|FG000|Overall Study|Surgery Cancelled|1|||
44544848|NCT03545113|79558460|FG001|Overall Study|Surgery Cancelled|0|||
44544849|NCT03545113|79558459|FG000|Overall Study|Death|1|||
44544850|NCT03545113|79558460|FG001|Overall Study|Death|0|||
44544851|NCT03545113|79558459|FG000|Overall Study|Adverse Event|2|||
44544852|NCT03545113|79558460|FG001|Overall Study|Adverse Event|0|||
44544853|NCT03545113|79558459|FG000|Overall Study|Received different surgery|1|||
44544854|NCT03545113|79558460|FG001|Overall Study|Received different surgery|0|||
44544855|NCT03214380|79558472|FG000|Lead-in|Adverse Event|3|||
44544856|NCT03214380|79558473|FG001|Lead-in|Adverse Event|0|||
44544857|NCT03214380|79558474|FG002|Lead-in|Adverse Event|0|||
44544858|NCT03214380|79558475|FG003|Lead-in|Adverse Event|1|||
44544859|NCT03214380|79558476|FG004|Lead-in|Adverse Event|0|||
44544860|NCT03214380|79558477|FG005|Lead-in|Adverse Event|0|||
44544861|NCT03214380|79558472|FG000|Lead-in|Lost to Follow-up|4|||
44544862|NCT03214380|79558473|FG001|Lead-in|Lost to Follow-up|0|||
44544863|NCT03214380|79558474|FG002|Lead-in|Lost to Follow-up|0|||
44544864|NCT03214380|79558475|FG003|Lead-in|Lost to Follow-up|1|||
44544865|NCT03214380|79558476|FG004|Lead-in|Lost to Follow-up|0|||
44544866|NCT03214380|79558477|FG005|Lead-in|Lost to Follow-up|0|||
44544867|NCT03214380|79558472|FG000|Lead-in|Eligibility Criteria|3|||
44544868|NCT03214380|79558473|FG001|Lead-in|Eligibility Criteria|0|||
44544869|NCT03214380|79558474|FG002|Lead-in|Eligibility Criteria|0|||
44544870|NCT03214380|79558475|FG003|Lead-in|Eligibility Criteria|0|||
44544871|NCT03214380|79558476|FG004|Lead-in|Eligibility Criteria|0|||
44544872|NCT03214380|79558477|FG005|Lead-in|Eligibility Criteria|0|||
44544873|NCT03214380|79558472|FG000|Lead-in|Physician Decision|6|||
44544874|NCT03214380|79558473|FG001|Lead-in|Physician Decision|0|||
44228409|NCT01686373|79035865|FG000|Overall Study|Adverse Event|0|||
44228410|NCT01686373|79035866|FG001|Overall Study|Adverse Event|1|||
44228411|NCT01709695|79035874|FG000|Overall Study|Withdrawal by Subject|1|||
44228412|NCT01709695|79035875|FG001|Overall Study|Withdrawal by Subject|1|||
44228413|NCT01685983|79035885|FG000|Overall Study|Adverse Event|7|||
44544875|NCT03214380|79558474|FG002|Lead-in|Physician Decision|0|||
44544876|NCT03214380|79558475|FG003|Lead-in|Physician Decision|0|||
44544877|NCT03214380|79558476|FG004|Lead-in|Physician Decision|0|||
44544878|NCT03214380|79558477|FG005|Lead-in|Physician Decision|0|||
44544879|NCT03214380|79558472|FG000|Lead-in|Protocol Deviation|7|||
44544880|NCT03214380|79558473|FG001|Lead-in|Protocol Deviation|0|||
44544881|NCT03214380|79558474|FG002|Lead-in|Protocol Deviation|0|||
44544882|NCT03214380|79558475|FG003|Lead-in|Protocol Deviation|3|||
44544883|NCT03214380|79558476|FG004|Lead-in|Protocol Deviation|0|||
44544884|NCT03214380|79558477|FG005|Lead-in|Protocol Deviation|0|||
44544885|NCT03214380|79558472|FG000|Lead-in|Withdrawal by Subject|41|||
44544886|NCT03214380|79558473|FG001|Lead-in|Withdrawal by Subject|0|||
44544887|NCT03214380|79558474|FG002|Lead-in|Withdrawal by Subject|0|||
44544888|NCT03214380|79558475|FG003|Lead-in|Withdrawal by Subject|14|||
44274296|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Adverse Event|13|||
44274297|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Adverse Event|7|||
44274298|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
44274299|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
44274300|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
44274301|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44274302|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
44274303|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
44274304|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
44274305|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
44274306|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
44274307|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
44274308|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
44274309|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
44486904|NCT00296504|79493136|FG008|Interim Analysis|Participant Moved|0|||
44486905|NCT00296504|79493128|FG000|Interim Analysis|Participant Was Incarcerated|2|||
44486906|NCT00296504|79493129|FG001|Interim Analysis|Participant Was Incarcerated|0|||
44486907|NCT00296504|79493130|FG002|Interim Analysis|Participant Was Incarcerated|1|||
44486908|NCT00296504|79493131|FG003|Interim Analysis|Participant Was Incarcerated|0|||
44486909|NCT00296504|79493132|FG004|Interim Analysis|Participant Was Incarcerated|0|||
44486910|NCT00296504|79493133|FG005|Interim Analysis|Participant Was Incarcerated|0|||
44486911|NCT00296504|79493134|FG006|Interim Analysis|Participant Was Incarcerated|0|||
44486912|NCT00296504|79493135|FG007|Interim Analysis|Participant Was Incarcerated|0|||
44486913|NCT00296504|79493136|FG008|Interim Analysis|Participant Was Incarcerated|0|||
44486914|NCT00296504|79493128|FG000|Interim Analysis|Resistance to FPV|0|||
44486915|NCT00296504|79493129|FG001|Interim Analysis|Resistance to FPV|0|||
44486916|NCT00296504|79493130|FG002|Interim Analysis|Resistance to FPV|1|||
44486917|NCT00296504|79493131|FG003|Interim Analysis|Resistance to FPV|0|||
44486918|NCT00296504|79493132|FG004|Interim Analysis|Resistance to FPV|0|||
44486919|NCT00296504|79493133|FG005|Interim Analysis|Resistance to FPV|0|||
44486920|NCT00296504|79493134|FG006|Interim Analysis|Resistance to FPV|0|||
44486921|NCT00296504|79493135|FG007|Interim Analysis|Resistance to FPV|0|||
44486922|NCT00296504|79493136|FG008|Interim Analysis|Resistance to FPV|0|||
44486923|NCT00296504|79493128|FG000|Interim Analysis|Physician Decision|0|||
44486924|NCT00296504|79493129|FG001|Interim Analysis|Physician Decision|0|||
44274310|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
44486925|NCT00296504|79493130|FG002|Interim Analysis|Physician Decision|1|||
44486926|NCT00296504|79493131|FG003|Interim Analysis|Physician Decision|0|||
44486927|NCT00296504|79493132|FG004|Interim Analysis|Physician Decision|0|||
44486928|NCT00296504|79493133|FG005|Interim Analysis|Physician Decision|0|||
44486929|NCT00296504|79493134|FG006|Interim Analysis|Physician Decision|0|||
44486930|NCT00296504|79493135|FG007|Interim Analysis|Physician Decision|0|||
44486931|NCT00296504|79493136|FG008|Interim Analysis|Physician Decision|0|||
44486932|NCT00296504|79493128|FG000|Interim Analysis|Principle Investigator Discretion|2|||
44274311|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
44274312|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
44274313|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
44375728|NCT00594568|79380841|FG000|Initial Treatment|Entry criteria exclusion|0|||
44375729|NCT00594568|79380842|FG001|Initial Treatment|Entry criteria exclusion|1|||
44486933|NCT00296504|79493129|FG001|Interim Analysis|Principle Investigator Discretion|0|||
44486934|NCT00296504|79493130|FG002|Interim Analysis|Principle Investigator Discretion|1|||
44486935|NCT00296504|79493131|FG003|Interim Analysis|Principle Investigator Discretion|1|||
44486936|NCT00296504|79493132|FG004|Interim Analysis|Principle Investigator Discretion|0|||
44486937|NCT00296504|79493133|FG005|Interim Analysis|Principle Investigator Discretion|0|||
44486938|NCT00296504|79493134|FG006|Interim Analysis|Principle Investigator Discretion|0|||
44544889|NCT03214380|79558476|FG004|Lead-in|Withdrawal by Subject|0|||
44544890|NCT03214380|79558477|FG005|Lead-in|Withdrawal by Subject|0|||
44544891|NCT03214380|79558472|FG000|Lead-in|Family Emergency|1|||
44274314|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
44274315|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
44274316|NCT01633944|79217786|FG000|Double-blind Treatment Phase|Other|0|||
44274317|NCT01633944|79217787|FG001|Double-blind Treatment Phase|Other|7|||
44274318|NCT01633944|79217788|FG002|Double-blind Treatment Phase|Other|0|||
44274319|NCT01633788|79217833|FG000|Overall Study|Adverse Event|1|||
44274320|NCT01633788|79217834|FG001|Overall Study|Adverse Event|3|||
44274321|NCT01633788|79217835|FG002|Overall Study|Adverse Event|3|||
44274322|NCT01633788|79217836|FG003|Overall Study|Adverse Event|3|||
44274323|NCT01633788|79217833|FG000|Overall Study|Lost to Follow-up|2|||
44274324|NCT01633788|79217834|FG001|Overall Study|Lost to Follow-up|2|||
44274325|NCT01633788|79217835|FG002|Overall Study|Lost to Follow-up|2|||
44274326|NCT01633788|79217836|FG003|Overall Study|Lost to Follow-up|0|||
44274327|NCT01633788|79217833|FG000|Overall Study|Personal Reasons|3|||
44274328|NCT01633788|79217834|FG001|Overall Study|Personal Reasons|1|||
44274329|NCT01633788|79217835|FG002|Overall Study|Personal Reasons|1|||
44274330|NCT01633788|79217836|FG003|Overall Study|Personal Reasons|3|||
44274331|NCT01633788|79217833|FG000|Overall Study|Protocol Violation|1|||
44274332|NCT01633788|79217834|FG001|Overall Study|Protocol Violation|0|||
44274333|NCT01633788|79217835|FG002|Overall Study|Protocol Violation|1|||
44274334|NCT01633788|79217836|FG003|Overall Study|Protocol Violation|0|||
44274335|NCT01633788|79217833|FG000|Overall Study|Other Reasons|0|||
44274336|NCT01633788|79217834|FG001|Overall Study|Other Reasons|2|||
44274337|NCT01633788|79217835|FG002|Overall Study|Other Reasons|3|||
44274338|NCT01633788|79217836|FG003|Overall Study|Other Reasons|7|||
44274339|NCT04154943|79217846|FG000|Overall Study|Study Ongoing|68|||
44544892|NCT03214380|79558473|FG001|Lead-in|Family Emergency|0|||
44544893|NCT03214380|79558474|FG002|Lead-in|Family Emergency|0|||
44544894|NCT03214380|79558475|FG003|Lead-in|Family Emergency|0|||
44544895|NCT03214380|79558476|FG004|Lead-in|Family Emergency|0|||
44544896|NCT03214380|79558477|FG005|Lead-in|Family Emergency|0|||
44544897|NCT03214380|79558472|FG000|Lead-in|Natural Disaster|9|||
44544898|NCT03214380|79558473|FG001|Lead-in|Natural Disaster|0|||
44544899|NCT03214380|79558474|FG002|Lead-in|Natural Disaster|0|||
44544900|NCT03214380|79558475|FG003|Lead-in|Natural Disaster|0|||
44544901|NCT03214380|79558476|FG004|Lead-in|Natural Disaster|0|||
44544902|NCT03214380|79558477|FG005|Lead-in|Natural Disaster|0|||
44544903|NCT03214380|79558472|FG000|Lead-in|Non Compliance|1|||
44228414|NCT01685983|79035885|FG000|Overall Study|Death|1|||
44228415|NCT01685983|79035885|FG000|Overall Study|Withdrawal by Subject|19|||
44228416|NCT01685983|79035885|FG000|Overall Study|Protocol Violation|2|||
44228417|NCT01685983|79035885|FG000|Overall Study|Physician Decision|13|||
44228418|NCT01685983|79035885|FG000|Overall Study|Other|7|||
44228419|NCT01685983|79035885|FG000|Overall Study|Progressive Disease|32|||
44228420|NCT01685983|79035885|FG000|Overall Study|Noncompliance with Study Drug|1|||
44228421|NCT01685437|79035897|FG000|Overall Study|Withdrawal by Subject|22|||
44228422|NCT01685437|79035897|FG000|Overall Study|Lost to Follow-up|3|||
44228423|NCT01685437|79035897|FG000|Overall Study|Adverse Event|1|||
44228424|NCT01685437|79035897|FG000|Overall Study|Protocol Violation|4|||
44228425|NCT01685437|79035897|FG000|Overall Study|Unable to make visits due to work|1|||
44228426|NCT01685203|79035937|FG000|Overall Study|Lost to Follow-up|3|||
44228427|NCT01685203|79035938|FG001|Overall Study|Lost to Follow-up|3|||
44228428|NCT01685203|79035939|FG002|Overall Study|Lost to Follow-up|0|||
44228429|NCT01685203|79035940|FG003|Overall Study|Lost to Follow-up|1|||
44228430|NCT01685203|79035941|FG004|Overall Study|Lost to Follow-up|0|||
44228431|NCT01685203|79035942|FG005|Overall Study|Lost to Follow-up|0|||
44228432|NCT01685203|79035943|FG006|Overall Study|Lost to Follow-up|0|||
44228433|NCT01685203|79035937|FG000|Overall Study|Adverse Event|0|||
44228434|NCT01685203|79035938|FG001|Overall Study|Adverse Event|0|||
44544904|NCT03214380|79558473|FG001|Lead-in|Non Compliance|0|||
44544905|NCT03214380|79558474|FG002|Lead-in|Non Compliance|0|||
44544906|NCT03214380|79558475|FG003|Lead-in|Non Compliance|0|||
44544907|NCT03214380|79558476|FG004|Lead-in|Non Compliance|0|||
44544908|NCT03214380|79558477|FG005|Lead-in|Non Compliance|0|||
44274340|NCT04154943|79217846|FG000|Overall Study|Lost to Follow-up|1|||
44228435|NCT01685203|79035939|FG002|Overall Study|Adverse Event|0|||
44274341|NCT04154943|79217846|FG000|Overall Study|Decision by the Investigator|1|||
44544909|NCT03214380|79558472|FG000|Lead-in|Participant Schedule|2|||
44544910|NCT03214380|79558473|FG001|Lead-in|Participant Schedule|0|||
44228436|NCT01685203|79035940|FG003|Overall Study|Adverse Event|0|||
44228437|NCT01685203|79035941|FG004|Overall Study|Adverse Event|0|||
44228438|NCT01685203|79035942|FG005|Overall Study|Adverse Event|2|||
44228439|NCT01685203|79035943|FG006|Overall Study|Adverse Event|0|||
44274342|NCT04154943|79217846|FG000|Overall Study|Death|5|||
44544911|NCT03214380|79558474|FG002|Lead-in|Participant Schedule|0|||
44544912|NCT03214380|79558475|FG003|Lead-in|Participant Schedule|0|||
44544913|NCT03214380|79558476|FG004|Lead-in|Participant Schedule|0|||
44544914|NCT03214380|79558477|FG005|Lead-in|Participant Schedule|0|||
44544915|NCT03214380|79558472|FG000|Treatment Period|Adverse Event|0|||
44544916|NCT03214380|79558473|FG001|Treatment Period|Adverse Event|1|||
44544917|NCT03214380|79558474|FG002|Treatment Period|Adverse Event|1|||
44544918|NCT03214380|79558475|FG003|Treatment Period|Adverse Event|0|||
44544919|NCT03214380|79558476|FG004|Treatment Period|Adverse Event|1|||
44544920|NCT03214380|79558477|FG005|Treatment Period|Adverse Event|0|||
44544921|NCT03214380|79558472|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
44544922|NCT03214380|79558473|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
44544923|NCT03214380|79558474|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
44544924|NCT03214380|79558475|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
44544925|NCT03214380|79558476|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
44544926|NCT03214380|79558477|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
44544927|NCT03214380|79558472|FG000|Treatment Period|Withdrawal by Subject|0|||
44544928|NCT03214380|79558473|FG001|Treatment Period|Withdrawal by Subject|10|||
44544929|NCT03214380|79558474|FG002|Treatment Period|Withdrawal by Subject|8|||
44544930|NCT03214380|79558475|FG003|Treatment Period|Withdrawal by Subject|0|||
44544931|NCT03214380|79558476|FG004|Treatment Period|Withdrawal by Subject|7|||
44544932|NCT03214380|79558477|FG005|Treatment Period|Withdrawal by Subject|11|||
44544933|NCT03214380|79558472|FG000|Treatment Period|Death|0|||
44544934|NCT03214380|79558473|FG001|Treatment Period|Death|1|||
44544935|NCT03214380|79558474|FG002|Treatment Period|Death|2|||
44544936|NCT03214380|79558475|FG003|Treatment Period|Death|0|||
44544937|NCT03214380|79558476|FG004|Treatment Period|Death|0|||
44544938|NCT03214380|79558477|FG005|Treatment Period|Death|0|||
44544939|NCT03214380|79558472|FG000|Treatment Period|Lost to Follow-up|0|||
44544940|NCT03214380|79558473|FG001|Treatment Period|Lost to Follow-up|6|||
44544941|NCT03214380|79558474|FG002|Treatment Period|Lost to Follow-up|3|||
44544942|NCT03214380|79558475|FG003|Treatment Period|Lost to Follow-up|0|||
44544943|NCT03214380|79558476|FG004|Treatment Period|Lost to Follow-up|0|||
44544944|NCT03214380|79558477|FG005|Treatment Period|Lost to Follow-up|0|||
44544945|NCT03214380|79558472|FG000|Treatment Period|Participant schedule|0|||
44544946|NCT03214380|79558473|FG001|Treatment Period|Participant schedule|0|||
44544947|NCT03214380|79558474|FG002|Treatment Period|Participant schedule|1|||
44544948|NCT03214380|79558475|FG003|Treatment Period|Participant schedule|0|||
44544949|NCT03214380|79558476|FG004|Treatment Period|Participant schedule|0|||
44544950|NCT03214380|79558477|FG005|Treatment Period|Participant schedule|0|||
44544951|NCT03214380|79558472|FG000|Treatment Period|Treatment Interruption|0|||
44544952|NCT03214380|79558473|FG001|Treatment Period|Treatment Interruption|0|||
44544953|NCT03214380|79558474|FG002|Treatment Period|Treatment Interruption|1|||
44544954|NCT03214380|79558475|FG003|Treatment Period|Treatment Interruption|0|||
44544955|NCT03214380|79558476|FG004|Treatment Period|Treatment Interruption|0|||
44544956|NCT03214380|79558477|FG005|Treatment Period|Treatment Interruption|0|||
44544957|NCT02674464|79558491|FG000|Overall Study|Death|10|||
44544958|NCT02674464|79558492|FG001|Overall Study|Death|21|||
44544959|NCT02674464|79558491|FG000|Overall Study|Withdrawal by Subject|24|||
44544960|NCT02674464|79558492|FG001|Overall Study|Withdrawal by Subject|44|||
44544961|NCT02674464|79558491|FG000|Overall Study|Lost to Follow-up|97|||
44544962|NCT02674464|79558492|FG001|Overall Study|Lost to Follow-up|92|||
44544963|NCT02674464|79558491|FG000|Overall Study|Outside survey window|6|||
44544964|NCT02674464|79558492|FG001|Overall Study|Outside survey window|3|||
44544965|NCT03172026|79558500|FG000|Overall Study|Withdrawal by Subject|1|||
44544966|NCT03172026|79558501|FG001|Overall Study|Withdrawal by Subject|0|||
44544967|NCT03172026|79558500|FG000|Overall Study|COVID restrictions|1|||
44544968|NCT03172026|79558501|FG001|Overall Study|COVID restrictions|0|||
44544969|NCT01343888|79558511|FG000|Overall Study|Adverse Event|12|||
44544970|NCT01343888|79558512|FG001|Overall Study|Adverse Event|22|||
44486939|NCT00296504|79493135|FG007|Interim Analysis|Principle Investigator Discretion|0|||
44486940|NCT00296504|79493136|FG008|Interim Analysis|Principle Investigator Discretion|0|||
44486941|NCT00296504|79493128|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
44486942|NCT00296504|79493129|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
44486943|NCT00296504|79493130|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
44486944|NCT00296504|79493131|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
44486945|NCT00296504|79493132|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
44486946|NCT00296504|79493133|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
44544971|NCT01343888|79558513|FG002|Overall Study|Adverse Event|5|||
44544972|NCT01343888|79558511|FG000|Overall Study|Lack of Efficacy|9|||
44544973|NCT01343888|79558512|FG001|Overall Study|Lack of Efficacy|9|||
44544974|NCT01343888|79558513|FG002|Overall Study|Lack of Efficacy|13|||
44544975|NCT01343888|79558511|FG000|Overall Study|Lost to Follow-up|0|||
44544976|NCT01343888|79558512|FG001|Overall Study|Lost to Follow-up|2|||
44544977|NCT01343888|79558513|FG002|Overall Study|Lost to Follow-up|1|||
44544978|NCT01343888|79558511|FG000|Overall Study|Protocol Violation|0|||
44544979|NCT01343888|79558512|FG001|Overall Study|Protocol Violation|2|||
44544980|NCT01343888|79558513|FG002|Overall Study|Protocol Violation|0|||
44544981|NCT01343888|79558511|FG000|Overall Study|Withdrawal by Subject|4|||
44544982|NCT01343888|79558512|FG001|Overall Study|Withdrawal by Subject|4|||
44544983|NCT01343888|79558513|FG002|Overall Study|Withdrawal by Subject|2|||
44228440|NCT01685203|79035937|FG000|Overall Study|Adverse event and withdrew consent|1|||
44228441|NCT01685203|79035938|FG001|Overall Study|Adverse event and withdrew consent|0|||
44228442|NCT01685203|79035939|FG002|Overall Study|Adverse event and withdrew consent|0|||
44486947|NCT00296504|79493134|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
44486948|NCT00296504|79493135|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
44486949|NCT00296504|79493136|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
44486950|NCT00296504|79493128|FG000|Interim Analysis|Non-adherence|2|||
44486951|NCT00296504|79493129|FG001|Interim Analysis|Non-adherence|0|||
44486952|NCT00296504|79493130|FG002|Interim Analysis|Non-adherence|0|||
44486953|NCT00296504|79493131|FG003|Interim Analysis|Non-adherence|0|||
44486954|NCT00296504|79493132|FG004|Interim Analysis|Non-adherence|1|||
44486955|NCT00296504|79493133|FG005|Interim Analysis|Non-adherence|0|||
44486956|NCT00296504|79493134|FG006|Interim Analysis|Non-adherence|0|||
44486957|NCT00296504|79493135|FG007|Interim Analysis|Non-adherence|1|||
44486958|NCT00296504|79493136|FG008|Interim Analysis|Non-adherence|0|||
44486959|NCT00296504|79493128|FG000|Interim Analysis|Site Closing|1|||
44486960|NCT00296504|79493129|FG001|Interim Analysis|Site Closing|0|||
44486961|NCT00296504|79493130|FG002|Interim Analysis|Site Closing|0|||
44486962|NCT00296504|79493131|FG003|Interim Analysis|Site Closing|0|||
44486963|NCT00296504|79493132|FG004|Interim Analysis|Site Closing|0|||
44486964|NCT00296504|79493133|FG005|Interim Analysis|Site Closing|1|||
44486965|NCT00296504|79493134|FG006|Interim Analysis|Site Closing|2|||
44486966|NCT00296504|79493135|FG007|Interim Analysis|Site Closing|0|||
44486967|NCT00296504|79493136|FG008|Interim Analysis|Site Closing|0|||
44486968|NCT00296504|79493128|FG000|Interim Analysis|Lack of Personnel at Site|1|||
44486969|NCT00296504|79493129|FG001|Interim Analysis|Lack of Personnel at Site|0|||
44486970|NCT00296504|79493130|FG002|Interim Analysis|Lack of Personnel at Site|0|||
44486971|NCT00296504|79493131|FG003|Interim Analysis|Lack of Personnel at Site|0|||
44486972|NCT00296504|79493132|FG004|Interim Analysis|Lack of Personnel at Site|0|||
44486973|NCT00296504|79493133|FG005|Interim Analysis|Lack of Personnel at Site|0|||
44486974|NCT00296504|79493134|FG006|Interim Analysis|Lack of Personnel at Site|0|||
44486975|NCT00296504|79493135|FG007|Interim Analysis|Lack of Personnel at Site|0|||
44486976|NCT00296504|79493136|FG008|Interim Analysis|Lack of Personnel at Site|0|||
44486977|NCT00296504|79493128|FG000|Interim Analysis|Missed Schedule Date|1|||
44486978|NCT00296504|79493129|FG001|Interim Analysis|Missed Schedule Date|0|||
44486979|NCT00296504|79493130|FG002|Interim Analysis|Missed Schedule Date|0|||
44486980|NCT00296504|79493131|FG003|Interim Analysis|Missed Schedule Date|0|||
44486981|NCT00296504|79493132|FG004|Interim Analysis|Missed Schedule Date|0|||
44486982|NCT00296504|79493133|FG005|Interim Analysis|Missed Schedule Date|0|||
44486983|NCT00296504|79493134|FG006|Interim Analysis|Missed Schedule Date|0|||
44486984|NCT00296504|79493135|FG007|Interim Analysis|Missed Schedule Date|0|||
44486985|NCT00296504|79493136|FG008|Interim Analysis|Missed Schedule Date|0|||
44486986|NCT00296504|79493128|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
44486987|NCT00296504|79493129|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
44486988|NCT00296504|79493130|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
44544984|NCT01343888|79558511|FG000|Overall Study|other than stated above|0|||
44486989|NCT00296504|79493131|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
44544985|NCT01343888|79558512|FG001|Overall Study|other than stated above|0|||
44544986|NCT01343888|79558513|FG002|Overall Study|other than stated above|1|||
44544987|NCT03589807|79558527|FG000|Overall Study|Lost to Follow-up|0|||
44486990|NCT00296504|79493132|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
44544988|NCT03589807|79558528|FG001|Overall Study|Lost to Follow-up|2|||
44486991|NCT00296504|79493133|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
44486992|NCT00296504|79493134|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
44486993|NCT00296504|79493135|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
44486994|NCT00296504|79493136|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
44486995|NCT00296504|79493128|FG000|Interim Analysis|Participant Stopped|0|||
44486996|NCT00296504|79493129|FG001|Interim Analysis|Participant Stopped|0|||
44486997|NCT00296504|79493130|FG002|Interim Analysis|Participant Stopped|0|||
44486998|NCT00296504|79493131|FG003|Interim Analysis|Participant Stopped|0|||
44486999|NCT00296504|79493132|FG004|Interim Analysis|Participant Stopped|1|||
44487000|NCT00296504|79493133|FG005|Interim Analysis|Participant Stopped|0|||
44487001|NCT00296504|79493134|FG006|Interim Analysis|Participant Stopped|0|||
44487002|NCT00296504|79493135|FG007|Interim Analysis|Participant Stopped|0|||
44487003|NCT00296504|79493136|FG008|Interim Analysis|Participant Stopped|0|||
44487004|NCT00296504|79493128|FG000|Interim Analysis|Physician and Participant Decision|0|||
44487005|NCT00296504|79493129|FG001|Interim Analysis|Physician and Participant Decision|0|||
44487006|NCT00296504|79493130|FG002|Interim Analysis|Physician and Participant Decision|0|||
44487007|NCT00296504|79493131|FG003|Interim Analysis|Physician and Participant Decision|0|||
44544989|NCT03589807|79558529|FG002|Overall Study|Lost to Follow-up|2|||
44544990|NCT03589807|79558530|FG003|Overall Study|Lost to Follow-up|3|||
44544991|NCT03589807|79558531|FG004|Overall Study|Lost to Follow-up|1|||
44544992|NCT03589807|79558532|FG005|Overall Study|Lost to Follow-up|1|||
44544993|NCT03589807|79558527|FG000|Overall Study|Withdrawal by Subject|0|||
44544994|NCT03589807|79558528|FG001|Overall Study|Withdrawal by Subject|5|||
44544995|NCT03589807|79558529|FG002|Overall Study|Withdrawal by Subject|0|||
44228443|NCT01685203|79035940|FG003|Overall Study|Adverse event and withdrew consent|0|||
44228444|NCT01685203|79035941|FG004|Overall Study|Adverse event and withdrew consent|0|||
44228445|NCT01685203|79035942|FG005|Overall Study|Adverse event and withdrew consent|0|||
44487008|NCT00296504|79493132|FG004|Interim Analysis|Physician and Participant Decision|0|||
44487009|NCT00296504|79493133|FG005|Interim Analysis|Physician and Participant Decision|1|||
44487010|NCT00296504|79493134|FG006|Interim Analysis|Physician and Participant Decision|0|||
44487011|NCT00296504|79493135|FG007|Interim Analysis|Physician and Participant Decision|0|||
44487012|NCT00296504|79493136|FG008|Interim Analysis|Physician and Participant Decision|0|||
44487013|NCT00296504|79493128|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
44487014|NCT00296504|79493129|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
44487015|NCT00296504|79493130|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
44487016|NCT00296504|79493131|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
44487017|NCT00296504|79493132|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
44487018|NCT00296504|79493133|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
44487019|NCT00296504|79493134|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
44487020|NCT00296504|79493135|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
44228446|NCT01685203|79035943|FG006|Overall Study|Adverse event and withdrew consent|0|||
44228447|NCT01685203|79035937|FG000|Overall Study|Patient's decision|0|||
44228448|NCT01685203|79035938|FG001|Overall Study|Patient's decision|0|||
44487021|NCT00296504|79493136|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
44487022|NCT00296504|79493128|FG000|Interim Analysis|Study Ended|0|||
44487023|NCT00296504|79493129|FG001|Interim Analysis|Study Ended|0|||
44487024|NCT00296504|79493130|FG002|Interim Analysis|Study Ended|0|||
44487025|NCT00296504|79493131|FG003|Interim Analysis|Study Ended|0|||
44487026|NCT00296504|79493132|FG004|Interim Analysis|Study Ended|0|||
44487027|NCT00296504|79493133|FG005|Interim Analysis|Study Ended|0|||
44487028|NCT00296504|79493134|FG006|Interim Analysis|Study Ended|1|||
44487029|NCT00296504|79493135|FG007|Interim Analysis|Study Ended|0|||
44544996|NCT03589807|79558530|FG003|Overall Study|Withdrawal by Subject|0|||
44544997|NCT03589807|79558531|FG004|Overall Study|Withdrawal by Subject|0|||
44544998|NCT03589807|79558532|FG005|Overall Study|Withdrawal by Subject|0|||
44544999|NCT03589807|79558527|FG000|Overall Study|Protocol Violation|0|||
44487030|NCT00296504|79493136|FG008|Interim Analysis|Study Ended|0|||
44487031|NCT00296504|79493128|FG000|Interim Analysis|Participant Needed Interferon|0|||
44228449|NCT01685203|79035939|FG002|Overall Study|Patient's decision|0|||
44228450|NCT01685203|79035940|FG003|Overall Study|Patient's decision|0|||
44228451|NCT01685203|79035941|FG004|Overall Study|Patient's decision|0|||
44228452|NCT01685203|79035942|FG005|Overall Study|Patient's decision|1|||
44228453|NCT01685203|79035943|FG006|Overall Study|Patient's decision|0|||
44487032|NCT00296504|79493129|FG001|Interim Analysis|Participant Needed Interferon|0|||
44487033|NCT00296504|79493130|FG002|Interim Analysis|Participant Needed Interferon|0|||
44487034|NCT00296504|79493131|FG003|Interim Analysis|Participant Needed Interferon|0|||
44487035|NCT00296504|79493132|FG004|Interim Analysis|Participant Needed Interferon|0|||
44487036|NCT00296504|79493133|FG005|Interim Analysis|Participant Needed Interferon|0|||
44487037|NCT00296504|79493134|FG006|Interim Analysis|Participant Needed Interferon|0|||
44487038|NCT00296504|79493135|FG007|Interim Analysis|Participant Needed Interferon|1|||
44487039|NCT00296504|79493136|FG008|Interim Analysis|Participant Needed Interferon|0|||
44487040|NCT00296504|79493128|FG000|Interim Analysis|Ongoing|32|||
44487041|NCT00296504|79493129|FG001|Interim Analysis|Ongoing|12|||
44487042|NCT00296504|79493130|FG002|Interim Analysis|Ongoing|16|||
44487043|NCT00296504|79493131|FG003|Interim Analysis|Ongoing|22|||
44487044|NCT00296504|79493132|FG004|Interim Analysis|Ongoing|0|||
44487045|NCT00296504|79493133|FG005|Interim Analysis|Ongoing|0|||
44487046|NCT00296504|79493134|FG006|Interim Analysis|Ongoing|30|||
44487047|NCT00296504|79493135|FG007|Interim Analysis|Ongoing|1|||
44487048|NCT00296504|79493136|FG008|Interim Analysis|Ongoing|0|||
44487049|NCT00296504|79493128|FG000|Final Analysis|Withdrawal by Subject|0|||
44487050|NCT00296504|79493129|FG001|Final Analysis|Withdrawal by Subject|0|||
44487051|NCT00296504|79493130|FG002|Final Analysis|Withdrawal by Subject|0|||
44487052|NCT00296504|79493131|FG003|Final Analysis|Withdrawal by Subject|0|||
44487053|NCT00296504|79493132|FG004|Final Analysis|Withdrawal by Subject|0|||
44487054|NCT00296504|79493133|FG005|Final Analysis|Withdrawal by Subject|0|||
44487055|NCT00296504|79493134|FG006|Final Analysis|Withdrawal by Subject|0|||
44487056|NCT00296504|79493135|FG007|Final Analysis|Withdrawal by Subject|0|||
44487057|NCT00296504|79493136|FG008|Final Analysis|Withdrawal by Subject|1|||
44487058|NCT00296504|79493128|FG000|Final Analysis|Lost to Follow-up|0|||
44487059|NCT00296504|79493129|FG001|Final Analysis|Lost to Follow-up|0|||
44487060|NCT00296504|79493130|FG002|Final Analysis|Lost to Follow-up|0|||
44487061|NCT00296504|79493131|FG003|Final Analysis|Lost to Follow-up|0|||
44487062|NCT00296504|79493132|FG004|Final Analysis|Lost to Follow-up|0|||
44487063|NCT00296504|79493133|FG005|Final Analysis|Lost to Follow-up|0|||
44487064|NCT00296504|79493134|FG006|Final Analysis|Lost to Follow-up|0|||
44487065|NCT00296504|79493135|FG007|Final Analysis|Lost to Follow-up|0|||
44487066|NCT00296504|79493136|FG008|Final Analysis|Lost to Follow-up|5|||
44487067|NCT00296504|79493128|FG000|Final Analysis|Insufficient Viral Load Response|0|||
44487068|NCT00296504|79493129|FG001|Final Analysis|Insufficient Viral Load Response|0|||
44487069|NCT00296504|79493130|FG002|Final Analysis|Insufficient Viral Load Response|0|||
44487070|NCT00296504|79493131|FG003|Final Analysis|Insufficient Viral Load Response|0|||
44487071|NCT00296504|79493132|FG004|Final Analysis|Insufficient Viral Load Response|0|||
44487072|NCT00296504|79493133|FG005|Final Analysis|Insufficient Viral Load Response|0|||
44487073|NCT00296504|79493134|FG006|Final Analysis|Insufficient Viral Load Response|0|||
44487074|NCT00296504|79493135|FG007|Final Analysis|Insufficient Viral Load Response|0|||
44487075|NCT00296504|79493136|FG008|Final Analysis|Insufficient Viral Load Response|6|||
44487076|NCT00296504|79493128|FG000|Final Analysis|Adverse Event|0|||
44487077|NCT00296504|79493129|FG001|Final Analysis|Adverse Event|0|||
44487078|NCT00296504|79493130|FG002|Final Analysis|Adverse Event|0|||
44487079|NCT00296504|79493131|FG003|Final Analysis|Adverse Event|0|||
44487080|NCT00296504|79493132|FG004|Final Analysis|Adverse Event|0|||
44487081|NCT00296504|79493133|FG005|Final Analysis|Adverse Event|0|||
44487082|NCT00296504|79493134|FG006|Final Analysis|Adverse Event|0|||
44487083|NCT00296504|79493135|FG007|Final Analysis|Adverse Event|0|||
44487084|NCT00296504|79493136|FG008|Final Analysis|Adverse Event|2|||
44487085|NCT00296504|79493128|FG000|Final Analysis|Pregnancy|0|||
44487086|NCT00296504|79493129|FG001|Final Analysis|Pregnancy|0|||
44487087|NCT00296504|79493130|FG002|Final Analysis|Pregnancy|0|||
44487088|NCT00296504|79493131|FG003|Final Analysis|Pregnancy|0|||
44487089|NCT00296504|79493132|FG004|Final Analysis|Pregnancy|0|||
44487090|NCT00296504|79493133|FG005|Final Analysis|Pregnancy|0|||
44487091|NCT00296504|79493134|FG006|Final Analysis|Pregnancy|0|||
44487092|NCT00296504|79493135|FG007|Final Analysis|Pregnancy|0|||
44487093|NCT00296504|79493136|FG008|Final Analysis|Pregnancy|4|||
44487094|NCT00296504|79493128|FG000|Final Analysis|Tuberculosis|0|||
44487095|NCT00296504|79493129|FG001|Final Analysis|Tuberculosis|0|||
44487096|NCT00296504|79493130|FG002|Final Analysis|Tuberculosis|0|||
44487097|NCT00296504|79493131|FG003|Final Analysis|Tuberculosis|0|||
44487098|NCT00296504|79493132|FG004|Final Analysis|Tuberculosis|0|||
44487099|NCT00296504|79493133|FG005|Final Analysis|Tuberculosis|0|||
44487100|NCT00296504|79493134|FG006|Final Analysis|Tuberculosis|0|||
44228454|NCT01928771|79035962|FG000|Overall Study|Adverse Event|6|||
44487101|NCT00296504|79493135|FG007|Final Analysis|Tuberculosis|0|||
44487102|NCT00296504|79493136|FG008|Final Analysis|Tuberculosis|1|||
44487103|NCT00296504|79493128|FG000|Final Analysis|Participant Moved to Another Country|0|||
44487104|NCT00296504|79493129|FG001|Final Analysis|Participant Moved to Another Country|0|||
44487105|NCT00296504|79493130|FG002|Final Analysis|Participant Moved to Another Country|0|||
44487106|NCT00296504|79493131|FG003|Final Analysis|Participant Moved to Another Country|0|||
44228455|NCT01928771|79035963|FG001|Overall Study|Adverse Event|5|||
44228456|NCT01928771|79035964|FG002|Overall Study|Adverse Event|1|||
44228457|NCT01928771|79035962|FG000|Overall Study|Death|2|||
44228458|NCT01928771|79035963|FG001|Overall Study|Death|2|||
44228459|NCT01928771|79035964|FG002|Overall Study|Death|2|||
44228460|NCT01928771|79035962|FG000|Overall Study|Lost to Follow-up|5|||
44228461|NCT01928771|79035963|FG001|Overall Study|Lost to Follow-up|6|||
44487107|NCT00296504|79493132|FG004|Final Analysis|Participant Moved to Another Country|0|||
44487108|NCT00296504|79493133|FG005|Final Analysis|Participant Moved to Another Country|0|||
44487109|NCT00296504|79493134|FG006|Final Analysis|Participant Moved to Another Country|0|||
44487110|NCT00296504|79493135|FG007|Final Analysis|Participant Moved to Another Country|0|||
44487111|NCT00296504|79493136|FG008|Final Analysis|Participant Moved to Another Country|1|||
44487112|NCT00296504|79493128|FG000|Final Analysis|Poor Adherence|0|||
44487113|NCT00296504|79493129|FG001|Final Analysis|Poor Adherence|0|||
44487114|NCT00296504|79493130|FG002|Final Analysis|Poor Adherence|0|||
44487115|NCT00296504|79493131|FG003|Final Analysis|Poor Adherence|0|||
44487116|NCT00296504|79493132|FG004|Final Analysis|Poor Adherence|0|||
44487117|NCT00296504|79493133|FG005|Final Analysis|Poor Adherence|0|||
44487118|NCT00296504|79493134|FG006|Final Analysis|Poor Adherence|0|||
44487119|NCT00296504|79493135|FG007|Final Analysis|Poor Adherence|0|||
44487120|NCT00296504|79493136|FG008|Final Analysis|Poor Adherence|1|||
44487121|NCT00313820|79493163|FG000|Assigned to Treatment|Other|1|||
44487122|NCT00313820|79493164|FG001|Assigned to Treatment|Other|0|||
44487123|NCT00313820|79493163|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
44487124|NCT00313820|79493164|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
44487125|NCT00313820|79493163|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
44487126|NCT00313820|79493164|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
44487127|NCT00313820|79493163|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
44487128|NCT00313820|79493164|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
44487129|NCT00313820|79493163|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
44487130|NCT00313820|79493164|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
44487131|NCT00313820|79493163|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
44487132|NCT00313820|79493164|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
44487133|NCT00462761|79493170|FG000|Overall Study|Adverse Event|6|||
44487134|NCT00462761|79493170|FG000|Overall Study|Withdrawal by Subject|9|||
44487135|NCT00462761|79493170|FG000|Overall Study|Physician Decision|5|||
44487136|NCT00462761|79493170|FG000|Overall Study|Disease progression|43|||
44487137|NCT00462761|79493170|FG000|Overall Study|Death|12|||
44487138|NCT00462761|79493170|FG000|Overall Study|Other|1|||
44487139|NCT00235872|79493202|FG000|Overall Study|Adverse Event|34|||
44487140|NCT00235872|79493202|FG000|Overall Study|Death|1|||
44487141|NCT00235872|79493202|FG000|Overall Study|Lost to Follow-up|1|||
44487142|NCT00235872|79493202|FG000|Overall Study|Withdrawal by Subject|50|||
44487143|NCT00235872|79493202|FG000|Overall Study|Administrative reason|61|||
44487144|NCT00461981|79493208|FG000|Overall Study|Lost to Follow-up|9|||
44487145|NCT00461981|79493209|FG001|Overall Study|Lost to Follow-up|6|||
44487146|NCT00461981|79493208|FG000|Overall Study|Withdrawal by Subject|2|||
44487147|NCT00461981|79493209|FG001|Overall Study|Withdrawal by Subject|3|||
44487148|NCT00296036|79493217|FG000|Overall Study|Withdrawal by Subject|1|||
44487149|NCT00296036|79493218|FG001|Overall Study|Withdrawal by Subject|0|||
44487150|NCT00296036|79493219|FG002|Overall Study|Withdrawal by Subject|2|||
44487151|NCT00296036|79493220|FG003|Overall Study|Withdrawal by Subject|1|||
44487152|NCT00296036|79493221|FG004|Overall Study|Withdrawal by Subject|2|||
44487153|NCT00296036|79493222|FG005|Overall Study|Withdrawal by Subject|1|||
44487154|NCT00296036|79493217|FG000|Overall Study|Protocol Violation|0|||
44487155|NCT00296036|79493218|FG001|Overall Study|Protocol Violation|0|||
44274343|NCT04154943|79217846|FG000|Overall Study|Withdrawal by Subject|4|||
44274344|NCT03476239|79217867|FG000|Overall Study|Withdrawal by Subject|10|||
44274345|NCT03476239|79217867|FG000|Overall Study|Death|80|||
44487156|NCT00296036|79493219|FG002|Overall Study|Protocol Violation|0|||
44487157|NCT00296036|79493220|FG003|Overall Study|Protocol Violation|0|||
44487158|NCT00296036|79493221|FG004|Overall Study|Protocol Violation|0|||
44545000|NCT03589807|79558528|FG001|Overall Study|Protocol Violation|0|||
44274346|NCT03476239|79217867|FG000|Overall Study|Lost to Follow-up|8|||
44487159|NCT00296036|79493222|FG005|Overall Study|Protocol Violation|3|||
44487160|NCT00089674|79493241|FG000|Overall Study|Physician Decision|4|||
44487161|NCT00089674|79493242|FG001|Overall Study|Physician Decision|2|||
44487162|NCT00089674|79493241|FG000|Overall Study|Adverse Event|23|||
44545001|NCT03589807|79558529|FG002|Overall Study|Protocol Violation|0|||
44487163|NCT00089674|79493242|FG001|Overall Study|Adverse Event|29|||
44228462|NCT01928771|79035964|FG002|Overall Study|Lost to Follow-up|3|||
44228463|NCT01928771|79035962|FG000|Overall Study|Withdrawal by Subject|20|||
44274347|NCT02678312|79217876|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
44228464|NCT01928771|79035963|FG001|Overall Study|Withdrawal by Subject|15|||
44228465|NCT01928771|79035964|FG002|Overall Study|Withdrawal by Subject|17|||
44228466|NCT01928771|79035962|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
44228467|NCT01928771|79035963|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
44228468|NCT01928771|79035964|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
44228469|NCT01928771|79035962|FG000|Overall Study|Other Reasons|9|||
44228470|NCT01928771|79035963|FG001|Overall Study|Other Reasons|9|||
44228471|NCT01928771|79035964|FG002|Overall Study|Other Reasons|14|||
44228472|NCT01928771|79035962|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
44228473|NCT01928771|79035963|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
44228474|NCT01928771|79035964|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
44228475|NCT01589653|79035974|FG000|Overall Study|Protocol Violation|3|||
44228476|NCT01589653|79035975|FG001|Overall Study|Protocol Violation|1|||
44228477|NCT01589653|79035974|FG000|Overall Study|Withdrawal criteria|4|||
44228478|NCT01589653|79035975|FG001|Overall Study|Withdrawal criteria|7|||
44228479|NCT01589653|79035974|FG000|Overall Study|Unclassified|0|||
44228480|NCT01589653|79035975|FG001|Overall Study|Unclassified|3|||
44228481|NCT01928615|79035981|FG000|Overall Study|Study Terminated by Sponsor|2|||
44228482|NCT01589497|79035990|FG000|Overall Study|Withdrawal by Subject|0|||
44228483|NCT01589497|79035991|FG001|Overall Study|Withdrawal by Subject|1|||
44487164|NCT00089674|79493241|FG000|Overall Study|Withdrawal by Subject|143|||
44487165|NCT00089674|79493242|FG001|Overall Study|Withdrawal by Subject|127|||
44487166|NCT00089674|79493241|FG000|Overall Study|Death|43|||
44487167|NCT00089674|79493242|FG001|Overall Study|Death|43|||
44487168|NCT00089674|79493241|FG000|Overall Study|Disease progression|21|||
44487169|NCT00089674|79493242|FG001|Overall Study|Disease progression|23|||
44487170|NCT00089674|79493241|FG000|Overall Study|Ineligibility determined|8|||
44487171|NCT00089674|79493242|FG001|Overall Study|Ineligibility determined|10|||
44487172|NCT00089674|79493241|FG000|Overall Study|Lost to Follow-up|21|||
44487173|NCT00089674|79493242|FG001|Overall Study|Lost to Follow-up|17|||
44487174|NCT00089674|79493241|FG000|Overall Study|Noncompliance|7|||
44487175|NCT00089674|79493242|FG001|Overall Study|Noncompliance|3|||
44487176|NCT00089674|79493241|FG000|Overall Study|Other|5|||
44487177|NCT00089674|79493242|FG001|Overall Study|Other|9|||
44487178|NCT00089674|79493241|FG000|Overall Study|Requirement for alternative therapy|14|||
44487179|NCT00089674|79493242|FG001|Overall Study|Requirement for alternative therapy|4|||
44487180|NCT00313586|79493252|FG000|Overall Study|Disease progression|14|||
44487181|NCT00313586|79493253|FG001|Overall Study|Disease progression|19|||
44487182|NCT00313586|79493254|FG002|Overall Study|Disease progression|10|||
44487183|NCT00313586|79493255|FG003|Overall Study|Disease progression|3|||
44487184|NCT00313586|79493252|FG000|Overall Study|Adverse Event|12|||
44487185|NCT00313586|79493253|FG001|Overall Study|Adverse Event|18|||
44487186|NCT00313586|79493254|FG002|Overall Study|Adverse Event|3|||
44487187|NCT00313586|79493255|FG003|Overall Study|Adverse Event|10|||
44487188|NCT00313586|79493252|FG000|Overall Study|Death|11|||
44487189|NCT00313586|79493253|FG001|Overall Study|Death|8|||
44487190|NCT00313586|79493254|FG002|Overall Study|Death|1|||
44487191|NCT00313586|79493255|FG003|Overall Study|Death|7|||
44487192|NCT00313586|79493252|FG000|Overall Study|Withdrawal by Subject|13|||
44487193|NCT00313586|79493253|FG001|Overall Study|Withdrawal by Subject|6|||
44228484|NCT01589497|79035992|FG002|Overall Study|Withdrawal by Subject|0|||
44228485|NCT01589497|79035993|FG003|Overall Study|Withdrawal by Subject|1|||
44228486|NCT01589497|79035990|FG000|Overall Study|Death|1|||
44228487|NCT01589497|79035991|FG001|Overall Study|Death|0|||
44487194|NCT00313586|79493254|FG002|Overall Study|Withdrawal by Subject|6|||
44487195|NCT00313586|79493255|FG003|Overall Study|Withdrawal by Subject|2|||
44228488|NCT01589497|79035992|FG002|Overall Study|Death|0|||
44228489|NCT01589497|79035993|FG003|Overall Study|Death|0|||
44228490|NCT01589497|79035990|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
44487196|NCT00313586|79493252|FG000|Overall Study|Alternative therapy|3|||
44487197|NCT00313586|79493253|FG001|Overall Study|Alternative therapy|6|||
44487198|NCT00313586|79493254|FG002|Overall Study|Alternative therapy|2|||
44487199|NCT00313586|79493255|FG003|Overall Study|Alternative therapy|0|||
44487200|NCT00313586|79493252|FG000|Overall Study|Other complicating disease|2|||
44228491|NCT01589497|79035991|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
44487201|NCT00313586|79493253|FG001|Overall Study|Other complicating disease|2|||
44487202|NCT00313586|79493254|FG002|Overall Study|Other complicating disease|0|||
44487203|NCT00313586|79493255|FG003|Overall Study|Other complicating disease|0|||
44228492|NCT01589497|79035992|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
44228493|NCT01589497|79035993|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
44228494|NCT01928381|79036008|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
44228495|NCT01928381|79036009|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
44228496|NCT01928381|79036010|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
44228497|NCT01928381|79036011|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
44228498|NCT01928381|79036012|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
44228499|NCT01928381|79036013|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
44228500|NCT01928381|79036014|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
44228501|NCT01928381|79036008|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
44228502|NCT01928381|79036009|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
44228503|NCT01928381|79036010|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
44228504|NCT01928381|79036011|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
44228505|NCT01928381|79036012|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
44228506|NCT01928381|79036013|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
44228507|NCT01928381|79036014|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
44228508|NCT01928381|79036008|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
44228509|NCT01928381|79036009|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
44228510|NCT01928381|79036010|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
44228511|NCT01928381|79036011|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
44228512|NCT01928381|79036012|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
44228513|NCT01928381|79036013|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
44228514|NCT01928381|79036014|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
44228515|NCT01928381|79036008|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
44228516|NCT01928381|79036009|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
44228517|NCT01928381|79036010|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
44228518|NCT01928381|79036011|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
44487204|NCT00313586|79493252|FG000|Overall Study|Did not achieve HI-major/better response|10|||
44487205|NCT00313586|79493253|FG001|Overall Study|Did not achieve HI-major/better response|7|||
44487206|NCT00313586|79493254|FG002|Overall Study|Did not achieve HI-major/better response|2|||
44487207|NCT00313586|79493255|FG003|Overall Study|Did not achieve HI-major/better response|1|||
44487208|NCT00313586|79493252|FG000|Overall Study|Physician Decision|2|||
44487209|NCT00313586|79493253|FG001|Overall Study|Physician Decision|1|||
44487210|NCT00313586|79493254|FG002|Overall Study|Physician Decision|0|||
44487211|NCT00313586|79493255|FG003|Overall Study|Physician Decision|0|||
44487212|NCT00313586|79493252|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
44487213|NCT00313586|79493253|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
44487214|NCT00313586|79493254|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
44487215|NCT00313586|79493255|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
44487216|NCT00313586|79493252|FG000|Overall Study|Lost insurance|0|||
44487217|NCT00313586|79493253|FG001|Overall Study|Lost insurance|1|||
44487218|NCT00313586|79493254|FG002|Overall Study|Lost insurance|0|||
44487219|NCT00313586|79493255|FG003|Overall Study|Lost insurance|0|||
44487220|NCT00313586|79493252|FG000|Overall Study|Moved|0|||
44487221|NCT00313586|79493253|FG001|Overall Study|Moved|1|||
44487222|NCT00313586|79493254|FG002|Overall Study|Moved|0|||
44487223|NCT00313586|79493255|FG003|Overall Study|Moved|0|||
44487224|NCT00313586|79493252|FG000|Overall Study|Death before starting treatment|1|||
44487225|NCT00313586|79493253|FG001|Overall Study|Death before starting treatment|0|||
44487226|NCT00313586|79493254|FG002|Overall Study|Death before starting treatment|0|||
44487227|NCT00313586|79493255|FG003|Overall Study|Death before starting treatment|0|||
44487228|NCT00312572|79493265|FG000|Overall Study|Adverse Event|10|||
44487229|NCT00312572|79493266|FG001|Overall Study|Adverse Event|16|||
44487230|NCT00312572|79493265|FG000|Overall Study|Lost to Follow-up|1|||
44487231|NCT00312572|79493266|FG001|Overall Study|Lost to Follow-up|1|||
44487232|NCT00312572|79493265|FG000|Overall Study|Administrative|4|||
44228519|NCT01928381|79036012|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
44228520|NCT01928381|79036013|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
44228521|NCT01928381|79036014|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
44274348|NCT02678312|79217877|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
44274349|NCT02678312|79217878|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
44487233|NCT00312572|79493266|FG001|Overall Study|Administrative|2|||
44487234|NCT00312572|79493265|FG000|Overall Study|Lack of Efficacy|1|||
44487235|NCT00312572|79493266|FG001|Overall Study|Lack of Efficacy|2|||
44487236|NCT00290888|79493276|FG000|Overall Study|Physician Decision|3|||
44228522|NCT01928381|79036008|FG000|Part 1 - Pain Training|Protocol Violation|1|||
44228523|NCT01928381|79036009|FG001|Part 1 - Pain Training|Protocol Violation|0|||
44274350|NCT02678312|79217879|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
44274351|NCT02678312|79217880|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
44487237|NCT00290888|79493277|FG001|Overall Study|Physician Decision|1|||
44228524|NCT01928381|79036010|FG002|Part 1 - Pain Training|Protocol Violation|0|||
44228525|NCT01928381|79036011|FG003|Part 1 - Pain Training|Protocol Violation|0|||
44228526|NCT01928381|79036012|FG004|Part 1 - Pain Training|Protocol Violation|0|||
44228527|NCT01928381|79036013|FG005|Part 1 - Pain Training|Protocol Violation|0|||
44228528|NCT01928381|79036014|FG006|Part 1 - Pain Training|Protocol Violation|0|||
44228529|NCT01928381|79036008|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
44228530|NCT01928381|79036009|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
44228531|NCT01928381|79036010|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
44228532|NCT01928381|79036011|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
44228533|NCT01928381|79036012|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
44228534|NCT01928381|79036013|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
44228535|NCT01928381|79036014|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
44228536|NCT01928381|79036008|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
44487238|NCT00290732|79493286|FG000|Overall Study|Inability to instill drug intraductally.|0|||
44487239|NCT00290732|79493287|FG001|Overall Study|Inability to instill drug intraductally.|1|||
44487240|NCT00290732|79493288|FG002|Overall Study|Inability to instill drug intraductally.|1|||
44487241|NCT00290732|79493289|FG003|Overall Study|Inability to instill drug intraductally.|0|||
44487242|NCT00290732|79493290|FG004|Overall Study|Inability to instill drug intraductally.|0|||
44487243|NCT00312494|79493306|FG000|Overall Study|Randomized; not treated with study drug|9|||
44487244|NCT00312494|79493307|FG001|Overall Study|Randomized; not treated with study drug|10|||
44487245|NCT00312494|79493308|FG002|Overall Study|Randomized; not treated with study drug|5|||
44487246|NCT00312494|79493306|FG000|Overall Study|Adverse Event|33|||
44228537|NCT01928381|79036009|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
44228538|NCT01928381|79036010|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
44228539|NCT01928381|79036011|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
44228540|NCT01928381|79036012|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
44228541|NCT01928381|79036013|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
44228542|NCT01928381|79036014|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
44228543|NCT01928381|79036008|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
44228544|NCT01928381|79036009|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
44228545|NCT01928381|79036010|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
44228546|NCT01928381|79036011|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
44228547|NCT01928381|79036012|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
44228548|NCT01928381|79036013|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
44228549|NCT01928381|79036014|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
44228550|NCT01928381|79036008|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
44228551|NCT01928381|79036009|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
44228552|NCT01928381|79036010|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
44228553|NCT01928381|79036011|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
44228554|NCT01928381|79036012|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
44228555|NCT01928381|79036013|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
44228556|NCT01928381|79036014|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
44228557|NCT01928381|79036008|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
44228558|NCT01928381|79036009|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
44228559|NCT01928381|79036010|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
44228560|NCT01928381|79036011|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
44545002|NCT03589807|79558530|FG003|Overall Study|Protocol Violation|1|||
44545003|NCT03589807|79558531|FG004|Overall Study|Protocol Violation|0|||
44545004|NCT03589807|79558532|FG005|Overall Study|Protocol Violation|0|||
44545005|NCT03589807|79558527|FG000|Overall Study|Enrolled but treatment not administered|0|||
44545006|NCT03589807|79558528|FG001|Overall Study|Enrolled but treatment not administered|0|||
44228561|NCT01928381|79036012|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
44228562|NCT01928381|79036013|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
44228563|NCT01928381|79036014|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
44545007|NCT03589807|79558529|FG002|Overall Study|Enrolled but treatment not administered|0|||
44545008|NCT03589807|79558530|FG003|Overall Study|Enrolled but treatment not administered|0|||
44545009|NCT03589807|79558531|FG004|Overall Study|Enrolled but treatment not administered|1|||
44545010|NCT03589807|79558532|FG005|Overall Study|Enrolled but treatment not administered|0|||
44545011|NCT03544333|79558551|FG000|Overall Study|Withdrawal by Subject|1|||
44228564|NCT01928381|79036008|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
44487247|NCT00312494|79493307|FG001|Overall Study|Adverse Event|15|||
44487248|NCT00312494|79493308|FG002|Overall Study|Adverse Event|11|||
44487249|NCT00312494|79493306|FG000|Overall Study|Lack of Efficacy|4|||
44487250|NCT00312494|79493307|FG001|Overall Study|Lack of Efficacy|6|||
44487251|NCT00312494|79493308|FG002|Overall Study|Lack of Efficacy|8|||
44487252|NCT00312494|79493306|FG000|Overall Study|Laboratory abnormality|1|||
44487253|NCT00312494|79493307|FG001|Overall Study|Laboratory abnormality|0|||
44487254|NCT00312494|79493308|FG002|Overall Study|Laboratory abnormality|0|||
44487255|NCT00312494|79493306|FG000|Overall Study|Lost to Follow-up|8|||
44487256|NCT00312494|79493307|FG001|Overall Study|Lost to Follow-up|8|||
44487257|NCT00312494|79493308|FG002|Overall Study|Lost to Follow-up|8|||
44487258|NCT00312494|79493306|FG000|Overall Study|Withdrawal by Subject|6|||
44487259|NCT00312494|79493307|FG001|Overall Study|Withdrawal by Subject|9|||
44487260|NCT00312494|79493308|FG002|Overall Study|Withdrawal by Subject|10|||
44487261|NCT00312494|79493306|FG000|Overall Study|Other|10|||
44487262|NCT00312494|79493307|FG001|Overall Study|Other|10|||
44487263|NCT00312494|79493308|FG002|Overall Study|Other|1|||
44487264|NCT00312338|79493318|FG000|Overall Study|Adverse Event|7|||
44487265|NCT00312338|79493319|FG001|Overall Study|Adverse Event|2|||
44487266|NCT00312338|79493318|FG000|Overall Study|Lost to Follow-up|9|||
44487267|NCT00312338|79493319|FG001|Overall Study|Lost to Follow-up|1|||
44487268|NCT00312338|79493318|FG000|Overall Study|Withdrawal by Subject|4|||
44487269|NCT00312338|79493319|FG001|Overall Study|Withdrawal by Subject|0|||
44487270|NCT00312338|79493318|FG000|Overall Study|Subsequent infection|2|||
44487271|NCT00312338|79493319|FG001|Overall Study|Subsequent infection|0|||
44487272|NCT00290498|79493327|FG000|Overall Study|Death|2|||
44487273|NCT00290498|79493328|FG001|Overall Study|Death|0|||
44487274|NCT00290498|79493327|FG000|Overall Study|Physician Decision|1|||
44545012|NCT03544333|79558552|FG001|Overall Study|Withdrawal by Subject|0|||
44545013|NCT03560245|79558560|FG000|Overall Study|Withdrawal by Subject|3|||
44545014|NCT03560245|79558561|FG001|Overall Study|Withdrawal by Subject|2|||
44545015|NCT03560245|79558560|FG000|Overall Study|Adverse Event|1|||
44487275|NCT00290498|79493328|FG001|Overall Study|Physician Decision|0|||
44487276|NCT00290498|79493327|FG000|Overall Study|Withdrawal by Subject|1|||
44487277|NCT00290498|79493328|FG001|Overall Study|Withdrawal by Subject|0|||
44487278|NCT00290498|79493327|FG000|Overall Study|Ineligible|3|||
44487279|NCT00290498|79493328|FG001|Overall Study|Ineligible|0|||
44487280|NCT00290498|79493327|FG000|Overall Study|Non-Compliance|1|||
44487281|NCT00290498|79493328|FG001|Overall Study|Non-Compliance|0|||
44487282|NCT00451451|79493339|FG000|Overall Study|Adverse Event|11|||
44487283|NCT00451451|79493340|FG001|Overall Study|Adverse Event|21|||
44545016|NCT03560245|79558561|FG001|Overall Study|Adverse Event|1|||
44228565|NCT01928381|79036009|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
44228566|NCT01928381|79036010|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
44487284|NCT00451451|79493341|FG002|Overall Study|Adverse Event|26|||
44545017|NCT03560245|79558560|FG000|Overall Study|Protocol Violation|1|||
44487285|NCT00451451|79493342|FG003|Overall Study|Adverse Event|10|||
44487286|NCT00451451|79493339|FG000|Overall Study|Lost to Follow-up|11|||
44487287|NCT00451451|79493340|FG001|Overall Study|Lost to Follow-up|9|||
44487288|NCT00451451|79493341|FG002|Overall Study|Lost to Follow-up|8|||
44487289|NCT00451451|79493342|FG003|Overall Study|Lost to Follow-up|11|||
44487290|NCT00451451|79493339|FG000|Overall Study|Consent Withdrawn|14|||
44487291|NCT00451451|79493340|FG001|Overall Study|Consent Withdrawn|9|||
44487292|NCT00451451|79493341|FG002|Overall Study|Consent Withdrawn|17|||
44487293|NCT00451451|79493342|FG003|Overall Study|Consent Withdrawn|17|||
44487294|NCT00451451|79493339|FG000|Overall Study|Investigator Decision|6|||
44487295|NCT00451451|79493340|FG001|Overall Study|Investigator Decision|2|||
44487296|NCT00451451|79493341|FG002|Overall Study|Investigator Decision|1|||
44487297|NCT00451451|79493342|FG003|Overall Study|Investigator Decision|2|||
44487298|NCT00451451|79493339|FG000|Overall Study|Subject Non-Compliance|8|||
44487299|NCT00451451|79493340|FG001|Overall Study|Subject Non-Compliance|4|||
44228567|NCT01928381|79036011|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
44228568|NCT01928381|79036012|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
44228569|NCT01928381|79036013|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
44487300|NCT00451451|79493341|FG002|Overall Study|Subject Non-Compliance|3|||
44487301|NCT00451451|79493342|FG003|Overall Study|Subject Non-Compliance|3|||
44487302|NCT00451451|79493339|FG000|Overall Study|Death|1|||
44487303|NCT00451451|79493340|FG001|Overall Study|Death|0|||
44487304|NCT00451451|79493341|FG002|Overall Study|Death|0|||
44487305|NCT00451451|79493342|FG003|Overall Study|Death|1|||
44487306|NCT00451451|79493339|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
44487307|NCT00451451|79493340|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
44487308|NCT00451451|79493341|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
44487309|NCT00451451|79493342|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
44487310|NCT03824912|79493357|FG000|Overall Study|Lost to Follow-up|18|||
44487311|NCT03824912|79493358|FG001|Overall Study|Lost to Follow-up|15|||
44487312|NCT03824912|79493359|FG002|Overall Study|Lost to Follow-up|8|||
44487313|NCT03824912|79493357|FG000|Overall Study|Negative Baseline Culture Result|118|||
44487314|NCT03824912|79493358|FG001|Overall Study|Negative Baseline Culture Result|112|||
44487315|NCT03824912|79493359|FG002|Overall Study|Negative Baseline Culture Result|57|||
44487316|NCT03824912|79493357|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44487317|NCT03824912|79493358|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44487318|NCT03824912|79493359|FG002|Overall Study|Non-Compliance with Study Drug|1|||
44487319|NCT03824912|79493357|FG000|Overall Study|Protocol Violation|1|||
44487320|NCT03824912|79493358|FG001|Overall Study|Protocol Violation|4|||
44487321|NCT03824912|79493359|FG002|Overall Study|Protocol Violation|1|||
44487322|NCT03824912|79493357|FG000|Overall Study|Withdrawal by Subject|3|||
44487323|NCT03824912|79493358|FG001|Overall Study|Withdrawal by Subject|2|||
44487324|NCT03824912|79493359|FG002|Overall Study|Withdrawal by Subject|1|||
44487325|NCT03824912|79493357|FG000|Overall Study|Participation in another study|0|||
44228570|NCT01928381|79036014|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
44228571|NCT01928381|79036008|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
44228572|NCT01928381|79036009|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
44228573|NCT01928381|79036010|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
44228574|NCT01928381|79036011|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
44228575|NCT01928381|79036012|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
44228576|NCT01928381|79036013|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
44228577|NCT01928381|79036014|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
44228578|NCT01928381|79036008|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
44228579|NCT01928381|79036009|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
44228580|NCT01928381|79036010|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
44228581|NCT01928381|79036011|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
44228582|NCT01928381|79036012|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
44228583|NCT01928381|79036013|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
44228584|NCT01928381|79036014|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
44228585|NCT01928381|79036008|FG000|Washout First Intervention|Protocol Violation|0|||
44487326|NCT03824912|79493358|FG001|Overall Study|Participation in another study|1|||
44487327|NCT03824912|79493359|FG002|Overall Study|Participation in another study|0|||
44487328|NCT00461123|79493369|FG000|Overall Study|Adverse Event|1|||
44487329|NCT00461123|79493370|FG001|Overall Study|Adverse Event|0|||
44487330|NCT00461123|79493369|FG000|Overall Study|Lost to Follow-up|1|||
44487331|NCT00461123|79493370|FG001|Overall Study|Lost to Follow-up|1|||
44487332|NCT00461123|79493369|FG000|Overall Study|Protocol Violation|3|||
44228586|NCT01928381|79036009|FG001|Washout First Intervention|Protocol Violation|0|||
44228587|NCT01928381|79036010|FG002|Washout First Intervention|Protocol Violation|0|||
44228588|NCT01928381|79036011|FG003|Washout First Intervention|Protocol Violation|0|||
44228589|NCT01928381|79036012|FG004|Washout First Intervention|Protocol Violation|1|||
44274352|NCT02678312|79217876|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
44274353|NCT02678312|79217877|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
44274354|NCT02678312|79217878|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
44487333|NCT00461123|79493370|FG001|Overall Study|Protocol Violation|2|||
44487334|NCT00461123|79493369|FG000|Overall Study|Withdrawal by Subject|1|||
44487335|NCT00461123|79493370|FG001|Overall Study|Withdrawal by Subject|3|||
44487336|NCT00290342|79493378|FG000|Overall Study|Other|0|||
44487337|NCT00290342|79493379|FG001|Overall Study|Other|1|||
44487338|NCT00290342|79493378|FG000|Overall Study|Withdrawal by Subject|6|||
44545018|NCT03560245|79558561|FG001|Overall Study|Protocol Violation|0|||
44487339|NCT00290342|79493379|FG001|Overall Study|Withdrawal by Subject|4|||
44487340|NCT00290342|79493378|FG000|Overall Study|Lost to Follow-up|1|||
44487341|NCT00290342|79493379|FG001|Overall Study|Lost to Follow-up|0|||
44487342|NCT00460811|79493390|FG000|Overall Study|Adverse Event|4|||
44487343|NCT00460811|79493391|FG001|Overall Study|Adverse Event|6|||
44487344|NCT00460811|79493392|FG002|Overall Study|Adverse Event|3|||
44487345|NCT00460811|79493393|FG003|Overall Study|Adverse Event|10|||
44487346|NCT00460811|79493394|FG004|Overall Study|Adverse Event|2|||
44487347|NCT00460811|79493390|FG000|Overall Study|Noncompliance|1|||
44487348|NCT00460811|79493391|FG001|Overall Study|Noncompliance|0|||
44487349|NCT00460811|79493392|FG002|Overall Study|Noncompliance|0|||
44487350|NCT00460811|79493393|FG003|Overall Study|Noncompliance|2|||
44487351|NCT00460811|79493394|FG004|Overall Study|Noncompliance|1|||
44487352|NCT00460811|79493390|FG000|Overall Study|Withdrawal by Subject|7|||
44487353|NCT00460811|79493391|FG001|Overall Study|Withdrawal by Subject|7|||
44487354|NCT00460811|79493392|FG002|Overall Study|Withdrawal by Subject|6|||
44487355|NCT00460811|79493393|FG003|Overall Study|Withdrawal by Subject|3|||
44487356|NCT00460811|79493394|FG004|Overall Study|Withdrawal by Subject|11|||
44487357|NCT00460811|79493390|FG000|Overall Study|Physician Decision|1|||
44487358|NCT00460811|79493391|FG001|Overall Study|Physician Decision|0|||
44487359|NCT00460811|79493392|FG002|Overall Study|Physician Decision|0|||
44487360|NCT00460811|79493393|FG003|Overall Study|Physician Decision|0|||
44487361|NCT00460811|79493394|FG004|Overall Study|Physician Decision|0|||
44487362|NCT00460811|79493390|FG000|Overall Study|Lost to Follow-up|3|||
44487363|NCT00460811|79493391|FG001|Overall Study|Lost to Follow-up|2|||
44487364|NCT00460811|79493392|FG002|Overall Study|Lost to Follow-up|5|||
44487365|NCT00460811|79493393|FG003|Overall Study|Lost to Follow-up|3|||
44487366|NCT00460811|79493394|FG004|Overall Study|Lost to Follow-up|6|||
44487367|NCT00290186|79493413|FG000|Overall Study|Adverse Event|1|||
44487368|NCT00290186|79493414|FG001|Overall Study|Adverse Event|1|||
44487369|NCT00290186|79493413|FG000|Overall Study|Lost to Follow-up|3|||
44487370|NCT00290186|79493414|FG001|Overall Study|Lost to Follow-up|2|||
44487371|NCT00290186|79493413|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
44487372|NCT00290186|79493414|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
44487373|NCT00290186|79493413|FG000|Overall Study|Withdrawal by Subject|0|||
44487374|NCT00290186|79493414|FG001|Overall Study|Withdrawal by Subject|1|||
44487375|NCT00460655|79493424|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
44487376|NCT00460655|79493425|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44487377|NCT00460655|79493426|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44487378|NCT00460655|79493427|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44487379|NCT00460655|79493424|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
44487380|NCT00460655|79493425|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44487381|NCT00460655|79493426|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44487382|NCT00460655|79493427|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44487383|NCT00460655|79493424|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
44487384|NCT00460655|79493425|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
44487385|NCT00460655|79493426|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
44487386|NCT00460655|79493427|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
44228590|NCT01928381|79036013|FG005|Washout First Intervention|Protocol Violation|0|||
44487387|NCT00460655|79493424|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44487388|NCT00460655|79493425|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44487389|NCT00460655|79493426|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
44487390|NCT00460655|79493427|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
44487391|NCT00460655|79493424|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44487392|NCT00460655|79493425|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44487393|NCT00460655|79493426|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
44228591|NCT01928381|79036014|FG006|Washout First Intervention|Protocol Violation|0|||
44228592|NCT01928381|79036008|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
44228593|NCT01928381|79036009|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
44228594|NCT01928381|79036010|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
44228595|NCT01928381|79036011|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
44228596|NCT01928381|79036012|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
44228597|NCT01928381|79036013|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
44228598|NCT01928381|79036014|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
44228599|NCT01928381|79036008|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
44228600|NCT01928381|79036009|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
44228601|NCT01928381|79036010|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
44228602|NCT01928381|79036011|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
44487394|NCT00460655|79493427|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
44487395|NCT00460655|79493424|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
44487396|NCT00460655|79493425|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
44487397|NCT00460655|79493426|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
44487398|NCT00460655|79493427|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
44487399|NCT00460577|79493439|FG000|Overall Study|Protocol Violation|2|||
44487400|NCT00460577|79493440|FG001|Overall Study|Protocol Violation|6|||
44487401|NCT00289016|79493446|FG000|Overall Study|Disease Progression|29|||
44487402|NCT00289016|79493446|FG000|Overall Study|Death|2|||
44487403|NCT00289016|79493446|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
44487404|NCT00289016|79493446|FG000|Overall Study|Withdrawal by Subject|2|||
44487405|NCT00289016|79493446|FG000|Overall Study|Adverse Event|1|||
44487406|NCT00289016|79493446|FG000|Overall Study|Other|1|||
44487407|NCT00288860|79493452|FG000|Overall Study|Did not complete intake|4|||
44487408|NCT00288860|79493453|FG001|Overall Study|Did not complete intake|8|||
44487409|NCT00288860|79493452|FG000|Overall Study|Death|4|||
44487410|NCT00288860|79493453|FG001|Overall Study|Death|3|||
44487411|NCT00288860|79493452|FG000|Overall Study|Withdrawal by Subject|20|||
44487412|NCT00288860|79493453|FG001|Overall Study|Withdrawal by Subject|15|||
44487413|NCT00288860|79493452|FG000|Overall Study|Lost to Follow-up|74|||
44487414|NCT00288860|79493453|FG001|Overall Study|Lost to Follow-up|71|||
44487415|NCT00288704|79493465|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
44487416|NCT00288704|79493466|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
44487417|NCT00288704|79493467|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
44487418|NCT00288704|79493465|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
44487419|NCT00288704|79493466|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
44487420|NCT00288704|79493467|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
44487421|NCT00288704|79493465|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
44487422|NCT00288704|79493466|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
44487423|NCT00288704|79493467|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
44487424|NCT00288704|79493465|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
44228603|NCT01928381|79036012|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
44228604|NCT01928381|79036013|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
44228605|NCT01928381|79036014|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
44228606|NCT01928225|79036026|FG000|Overall Study|Pregnancy|1|||
44228607|NCT01928225|79036027|FG001|Overall Study|Pregnancy|0|||
44274355|NCT02678312|79217879|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
44487425|NCT00288704|79493466|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
44487426|NCT00288704|79493467|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
44487427|NCT00288704|79493465|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
44487428|NCT00288704|79493466|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
44487429|NCT00288704|79493467|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
44487430|NCT00288704|79493465|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
44487431|NCT00288704|79493466|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
44487432|NCT00288704|79493467|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
44487433|NCT00288704|79493465|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
44487434|NCT00288704|79493466|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
44487435|NCT00288704|79493467|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
44487436|NCT00288626|79493474|FG000|Overall Study|Death|3|||
44487437|NCT00288626|79493474|FG000|Overall Study|Withdrawal by Subject|4|||
44487438|NCT00087490|79493482|FG000|Overall Study|Death|6|||
44487439|NCT00087490|79493483|FG001|Overall Study|Death|4|||
44487440|NCT00087490|79493482|FG000|Overall Study|Adverse Event|3|||
44228608|NCT01928225|79036026|FG000|Overall Study|basaloid cervical cancer|1|||
44487441|NCT00087490|79493483|FG001|Overall Study|Adverse Event|8|||
44228609|NCT01928225|79036027|FG001|Overall Study|basaloid cervical cancer|0|||
44228610|NCT01928225|79036026|FG000|Overall Study|Lost to Follow-up|1|||
44228611|NCT01928225|79036027|FG001|Overall Study|Lost to Follow-up|3|||
44228612|NCT01927757|79036034|FG000|Overall Study|Withdrawal by Subject|14|||
44228613|NCT01927757|79036034|FG000|Overall Study|Lost to Follow-up|2|||
44228614|NCT01927757|79036034|FG000|Overall Study|Decision by Sponsor|2|||
44228615|NCT01927757|79036034|FG000|Overall Study|Other|1|||
44228616|NCT01927757|79036034|FG000|Overall Study|Ethical Reasons|4|||
44228617|NCT01927367|79036044|FG000|Overall Study|Withdrawal by Subject|7|||
44228618|NCT01927367|79036045|FG001|Overall Study|Withdrawal by Subject|4|||
44228619|NCT01927367|79036044|FG000|Overall Study|No baseline data|0|||
44228620|NCT01927367|79036045|FG001|Overall Study|No baseline data|1|||
44228621|NCT01913639|79036051|FG000|Overall Study|Not Eligible|3|||
44228622|NCT01913483|79036057|FG000|Overall Study|Withdrawal by Subject|1|||
44228623|NCT01913483|79036058|FG001|Overall Study|Withdrawal by Subject|2|||
44228624|NCT01913483|79036057|FG000|Overall Study|Lost to Follow-up|6|||
44228625|NCT01913483|79036058|FG001|Overall Study|Lost to Follow-up|3|||
44228626|NCT01913483|79036057|FG000|Overall Study|Death|14|||
44228627|NCT01913483|79036058|FG001|Overall Study|Death|17|||
44228628|NCT01913405|79036064|FG000|Overall Study|Withdrawal by Subject|1|||
44228629|NCT01913405|79036064|FG000|Overall Study|Adverse Event|1|||
44228630|NCT01927055|79036084|FG000|Open-label|Adverse Event|6|||
44228631|NCT01927055|79036085|FG001|Open-label|Adverse Event|0|||
44228632|NCT01927055|79036086|FG002|Open-label|Adverse Event|0|||
44228633|NCT01927055|79036084|FG000|Open-label|Withdrawal by Subject|1|||
44228634|NCT01927055|79036085|FG001|Open-label|Withdrawal by Subject|0|||
44228635|NCT01927055|79036086|FG002|Open-label|Withdrawal by Subject|0|||
44228636|NCT01927055|79036084|FG000|Open-label|Study Stopped|4|||
44228637|NCT01927055|79036085|FG001|Open-label|Study Stopped|0|||
44228638|NCT01927055|79036086|FG002|Open-label|Study Stopped|0|||
44228639|NCT01927055|79036084|FG000|Open-label|Supine Hypertension|4|||
44228640|NCT01927055|79036085|FG001|Open-label|Supine Hypertension|0|||
44228641|NCT01927055|79036086|FG002|Open-label|Supine Hypertension|0|||
44228642|NCT01927055|79036084|FG000|Open-label|Difficulty attending study visits|1|||
44228643|NCT01927055|79036085|FG001|Open-label|Difficulty attending study visits|0|||
44228644|NCT01927055|79036086|FG002|Open-label|Difficulty attending study visits|0|||
44228645|NCT01927055|79036084|FG000|Double-Blind|Adverse Event|0|||
44228646|NCT01927055|79036085|FG001|Double-Blind|Adverse Event|1|||
44375730|NCT00594568|79380843|FG002|Initial Treatment|Entry criteria exclusion|1|||
44487442|NCT00087490|79493482|FG000|Overall Study|Lack of Efficacy|0|||
44487443|NCT00087490|79493483|FG001|Overall Study|Lack of Efficacy|2|||
44487444|NCT00087490|79493482|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
44487445|NCT00087490|79493483|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
44487446|NCT00087490|79493482|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
44487447|NCT00087490|79493483|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
44487448|NCT00087490|79493482|FG000|Overall Study|Randomized but not treated|7|||
44487449|NCT00087490|79493483|FG001|Overall Study|Randomized but not treated|18|||
44487450|NCT00087178|79493491|FG000|Overall Study|No follow up data|5|||
44487451|NCT00087178|79493492|FG001|Overall Study|No follow up data|15|||
44487452|NCT00087178|79493491|FG000|Overall Study|No clinical assessment|1|||
44487453|NCT00087178|79493492|FG001|Overall Study|No clinical assessment|2|||
44228647|NCT01927055|79036086|FG002|Double-Blind|Adverse Event|1|||
44228648|NCT01927055|79036084|FG000|Double-Blind|Protocol Violation|0|||
44228649|NCT01927055|79036085|FG001|Double-Blind|Protocol Violation|0|||
44228650|NCT01927055|79036086|FG002|Double-Blind|Protocol Violation|1|||
44228651|NCT01927055|79036084|FG000|Double-Blind|Withdrawal by Subject|0|||
44228652|NCT01927055|79036085|FG001|Double-Blind|Withdrawal by Subject|2|||
44228653|NCT01927055|79036086|FG002|Double-Blind|Withdrawal by Subject|3|||
44228654|NCT01927055|79036084|FG000|Double-Blind|Study Stopped|0|||
44228655|NCT01927055|79036085|FG001|Double-Blind|Study Stopped|7|||
44228656|NCT01927055|79036086|FG002|Double-Blind|Study Stopped|7|||
44487454|NCT00087178|79493491|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
44487455|NCT00087178|79493492|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
44487456|NCT00288080|79493500|FG000|Overall Study|Withdrawal by Subject|1|||
44487457|NCT00288080|79493501|FG001|Overall Study|Withdrawal by Subject|3|||
44487458|NCT00288080|79493500|FG000|Overall Study|Protocol Violation|25|||
44487459|NCT00288080|79493501|FG001|Overall Study|Protocol Violation|20|||
44487460|NCT00287690|79493509|FG000|Overall Study|Protocol Violation|20|||
44487461|NCT00287690|79493510|FG001|Overall Study|Protocol Violation|26|||
44487462|NCT00286754|79493519|FG000|Overall Study|Adverse Event|2|||
44487463|NCT00286754|79493520|FG001|Overall Study|Adverse Event|2|||
44487464|NCT00286754|79493521|FG002|Overall Study|Adverse Event|3|||
44487465|NCT00286754|79493519|FG000|Overall Study|Withdrawal by Subject|6|||
44487466|NCT00286754|79493520|FG001|Overall Study|Withdrawal by Subject|2|||
44487467|NCT00286754|79493521|FG002|Overall Study|Withdrawal by Subject|0|||
44487468|NCT00286754|79493519|FG000|Overall Study|Lost to Follow-up|12|||
44487469|NCT00286754|79493520|FG001|Overall Study|Lost to Follow-up|14|||
44487470|NCT00286754|79493521|FG002|Overall Study|Lost to Follow-up|6|||
44487471|NCT00286754|79493519|FG000|Overall Study|Moved out of state|0|||
44487472|NCT00286754|79493520|FG001|Overall Study|Moved out of state|0|||
44487473|NCT00286754|79493521|FG002|Overall Study|Moved out of state|1|||
44487474|NCT00066742|79493535|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
44487475|NCT00066742|79493535|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
44228657|NCT01927055|79036084|FG000|Double-Blind|Supine Hypertension|0|||
44228658|NCT01927055|79036085|FG001|Double-Blind|Supine Hypertension|0|||
44228659|NCT01927055|79036086|FG002|Double-Blind|Supine Hypertension|1|||
44228660|NCT01927055|79036084|FG000|Double-Blind|Extended Vacation|0|||
44228661|NCT01927055|79036085|FG001|Double-Blind|Extended Vacation|1|||
44228662|NCT01927055|79036086|FG002|Double-Blind|Extended Vacation|0|||
44228663|NCT01913327|79036095|FG000|Overall Study|Withdrawal by Subject|0|||
44228664|NCT01913327|79036096|FG001|Overall Study|Withdrawal by Subject|1|||
44228665|NCT01926509|79036106|FG000|Overall Study|vital sign met discontinuation criteria|1|||
44228666|NCT01926509|79036107|FG001|Overall Study|vital sign met discontinuation criteria|0|||
44274356|NCT02678312|79217880|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
44274357|NCT02678312|79217876|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
44274358|NCT02678312|79217877|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
44487476|NCT00066742|79493535|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
44487477|NCT00066742|79493535|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
44487478|NCT00066742|79493535|FG000|Induction Chemoradiotherapy|Ineligible|3|||
44228667|NCT01926509|79036108|FG002|Overall Study|vital sign met discontinuation criteria|0|||
44228668|NCT01926509|79036109|FG003|Overall Study|vital sign met discontinuation criteria|0|||
44228669|NCT01926119|79036119|FG000|Overall Study|Withdrawal by Subject|1|||
44228670|NCT01912781|79036125|FG000|Overall Study|Withdrawal by Subject|2|||
44228671|NCT01912781|79036126|FG001|Overall Study|Withdrawal by Subject|0|||
44228672|NCT01925417|79036133|FG000|Overall Study|Withdrawal by Subject|2|||
44228673|NCT01925417|79036133|FG000|Overall Study|Death|1|||
44228674|NCT01911845|79036138|FG000|Overall Study|Adverse Event|2|||
44228675|NCT01911845|79036138|FG000|Overall Study|Lost to Follow-up|1|||
44228676|NCT01911845|79036138|FG000|Overall Study|Other (not specified)|3|||
44228677|NCT01925183|79036146|FG000|Overall Study|Adverse Event|1|||
44228678|NCT01925183|79036147|FG001|Overall Study|Adverse Event|0|||
44228679|NCT01910519|79036155|FG000|Overall Study|Withdrawal by Subject|2|||
44228680|NCT01910519|79036156|FG001|Overall Study|Withdrawal by Subject|0|||
44228681|NCT01910519|79036155|FG000|Overall Study|Adverse Event|2|||
44228682|NCT01910519|79036156|FG001|Overall Study|Adverse Event|0|||
44274359|NCT02678312|79217878|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
44274360|NCT02678312|79217879|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
44274361|NCT02678312|79217880|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
44274362|NCT02678312|79217876|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
44545019|NCT03560245|79558560|FG000|Overall Study|Death|0|||
44545020|NCT03560245|79558561|FG001|Overall Study|Death|1|||
44274363|NCT02678312|79217877|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
44487479|NCT00066742|79493535|FG000|Consolidation Chemotherapy|not protocol specified|1|||
44487480|NCT00066742|79493535|FG000|Consolidation Chemotherapy|Ineligible|2|||
44487481|NCT00460265|79493543|FG000|Overall Study|Lost to Follow-up|14|||
44487482|NCT00460265|79493544|FG001|Overall Study|Lost to Follow-up|15|||
44487483|NCT00460265|79493543|FG000|Overall Study|Physician Decision|1|||
44487484|NCT00460265|79493544|FG001|Overall Study|Physician Decision|2|||
44545021|NCT03560245|79558560|FG000|Overall Study|Lost to Follow-up|0|||
44545022|NCT03560245|79558561|FG001|Overall Study|Lost to Follow-up|1|||
44228683|NCT01910441|79036164|FG000|Overall Study|Sponsor decision|0|||
44228684|NCT01910441|79036165|FG001|Overall Study|Sponsor decision|2|||
44228685|NCT01910441|79036164|FG000|Overall Study|Lost to Follow-up|6|||
44228686|NCT01910441|79036165|FG001|Overall Study|Lost to Follow-up|5|||
44228687|NCT01910441|79036164|FG000|Overall Study|Withdrawal by Subject|0|||
44228688|NCT01910441|79036165|FG001|Overall Study|Withdrawal by Subject|1|||
44274364|NCT02678312|79217878|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
44545023|NCT03560245|79558560|FG000|Overall Study|Physician Decision|0|||
44545024|NCT03560245|79558561|FG001|Overall Study|Physician Decision|1|||
44545025|NCT03560245|79558560|FG000|Overall Study|Other|0|||
44545026|NCT03560245|79558561|FG001|Overall Study|Other|1|||
44545027|NCT00707434|79558569|FG000|Overall Study|Adverse Event|1|||
44545028|NCT03054428|79558576|FG000|Overall Study|Physician Decision|0|||
44545029|NCT03054428|79558577|FG001|Overall Study|Physician Decision|1|||
44545030|NCT03054428|79558578|FG002|Overall Study|Physician Decision|1|||
44545031|NCT03054428|79558576|FG000|Overall Study|Lack of Efficacy|3|||
44545032|NCT03054428|79558577|FG001|Overall Study|Lack of Efficacy|1|||
44545033|NCT03054428|79558578|FG002|Overall Study|Lack of Efficacy|0|||
44545034|NCT03054428|79558576|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
44545035|NCT03054428|79558577|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
44545036|NCT03054428|79558578|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
44545037|NCT03054428|79558576|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
44545038|NCT03054428|79558577|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
44545039|NCT03054428|79558578|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
44545040|NCT03054428|79558576|FG000|Overall Study|Transitioned to OLE study|76|||
44545041|NCT03054428|79558577|FG001|Overall Study|Transitioned to OLE study|76|||
44545042|NCT03054428|79558578|FG002|Overall Study|Transitioned to OLE study|73|||
44545043|NCT03054428|79558576|FG000|Overall Study|Withdrawal by Subject|3|||
44228689|NCT01910441|79036164|FG000|Overall Study|Non-compliance|0|||
44545044|NCT03054428|79558577|FG001|Overall Study|Withdrawal by Subject|2|||
44545045|NCT03054428|79558578|FG002|Overall Study|Withdrawal by Subject|3|||
44545046|NCT03054428|79558576|FG000|Overall Study|Lost to Follow-up|0|||
44545047|NCT03054428|79558577|FG001|Overall Study|Lost to Follow-up|0|||
44545048|NCT03054428|79558578|FG002|Overall Study|Lost to Follow-up|1|||
44545049|NCT03558997|79558590|FG000|Overall Study|Adverse Event|0|||
44545050|NCT03558997|79558591|FG001|Overall Study|Adverse Event|2|||
44545051|NCT03558997|79558592|FG002|Overall Study|Adverse Event|5|||
44228690|NCT01910441|79036165|FG001|Overall Study|Non-compliance|1|||
44228691|NCT01910441|79036164|FG000|Overall Study|Adverse Event|1|||
44228692|NCT01910441|79036165|FG001|Overall Study|Adverse Event|0|||
44228693|NCT01910441|79036164|FG000|Overall Study|Physician Decision|0|||
44545052|NCT03558997|79558593|FG003|Overall Study|Adverse Event|1|||
44545053|NCT03558997|79558590|FG000|Overall Study|Physician Decision|0|||
44545054|NCT03558997|79558591|FG001|Overall Study|Physician Decision|0|||
44545055|NCT03558997|79558592|FG002|Overall Study|Physician Decision|1|||
44545056|NCT03558997|79558593|FG003|Overall Study|Physician Decision|0|||
44545057|NCT03558997|79558590|FG000|Overall Study|Withdrawal by Subject|1|||
44545058|NCT03558997|79558591|FG001|Overall Study|Withdrawal by Subject|0|||
44545059|NCT03558997|79558592|FG002|Overall Study|Withdrawal by Subject|1|||
44487485|NCT00460265|79493543|FG000|Overall Study|Withdrawal by Subject|10|||
44487486|NCT00460265|79493544|FG001|Overall Study|Withdrawal by Subject|25|||
44487487|NCT00460265|79493543|FG000|Overall Study|Ongoing|60|||
44487488|NCT00460265|79493544|FG001|Overall Study|Ongoing|47|||
44487489|NCT00460109|79493550|FG000|Overall Study|Death|1|||
44487490|NCT00065260|79493556|FG000|Overall Study|Death|0|||
44487491|NCT00065260|79493557|FG001|Overall Study|Death|1|||
44487492|NCT00460031|79493563|FG000|Overall Study|Adverse Event|5|||
44487493|NCT00460031|79493563|FG000|Overall Study|Withdrawal by Subject|5|||
44487494|NCT00460031|79493563|FG000|Overall Study|Death|1|||
44545060|NCT03558997|79558593|FG003|Overall Study|Withdrawal by Subject|1|||
44545061|NCT03558997|79558590|FG000|Overall Study|Lost to Follow-up|0|||
44545062|NCT03558997|79558591|FG001|Overall Study|Lost to Follow-up|0|||
44545063|NCT03558997|79558592|FG002|Overall Study|Lost to Follow-up|1|||
44545064|NCT03558997|79558593|FG003|Overall Study|Lost to Follow-up|0|||
44545065|NCT03052400|79558608|FG000|Overall Study|Lost to Follow-up|1|||
44545066|NCT03052400|79558609|FG001|Overall Study|Lost to Follow-up|0|||
44545067|NCT03052400|79558608|FG000|Overall Study|Withdrawal by Subject|0|||
44545068|NCT03052400|79558609|FG001|Overall Study|Withdrawal by Subject|1|||
44545069|NCT03538951|79558617|FG000|Overall Study|Withdrawal by Subject|1|||
44228694|NCT01910441|79036165|FG001|Overall Study|Physician Decision|1|||
44487495|NCT00451217|79493571|FG000|Overall Study|Lost to Follow-up|0|||
44487496|NCT00451217|79493572|FG001|Overall Study|Lost to Follow-up|1|||
44545070|NCT03538951|79558618|FG001|Overall Study|Withdrawal by Subject|2|||
44545071|NCT03052322|79558626|FG000|Overall Study|Other un-specified|1|||
44545072|NCT03052322|79558627|FG001|Overall Study|Other un-specified|2|||
44545073|NCT03052322|79558626|FG000|Overall Study|Withdrawal by Subject|10|||
44545074|NCT03052322|79558627|FG001|Overall Study|Withdrawal by Subject|9|||
44545075|NCT03052322|79558626|FG000|Overall Study|Death|0|||
44545076|NCT03052322|79558627|FG001|Overall Study|Death|2|||
44545077|NCT03052322|79558626|FG000|Overall Study|Lack of Efficacy|1|||
44545078|NCT03052322|79558627|FG001|Overall Study|Lack of Efficacy|2|||
44545079|NCT03052322|79558626|FG000|Overall Study|Protocol Violation|1|||
44545080|NCT03052322|79558627|FG001|Overall Study|Protocol Violation|0|||
44545081|NCT03052322|79558626|FG000|Overall Study|Lost to Follow-up|2|||
44545082|NCT03052322|79558627|FG001|Overall Study|Lost to Follow-up|4|||
44545083|NCT03052322|79558626|FG000|Overall Study|Adverse Event|6|||
44545084|NCT03052322|79558627|FG001|Overall Study|Adverse Event|13|||
44545085|NCT03521791|79558635|FG000|Overall Study|Protocol Violation|7|||
44545086|NCT03521791|79558636|FG001|Overall Study|Protocol Violation|17|||
44545087|NCT03521635|79558644|FG000|Overall Study|Adverse Event|1|||
44545088|NCT03521635|79558645|FG001|Overall Study|Adverse Event|1|||
44545089|NCT03521635|79558644|FG000|Overall Study|Refused to complete study visit|1|||
44545090|NCT03521635|79558645|FG001|Overall Study|Refused to complete study visit|0|||
44545091|NCT03521635|79558644|FG000|Overall Study|Refused to continue trial medication|2|||
44545092|NCT03521635|79558645|FG001|Overall Study|Refused to continue trial medication|2|||
44228695|NCT01923467|79036171|FG000|Overall Study|Lost to Follow-up|62|||
44545093|NCT03521635|79558644|FG000|Overall Study|Lost to Follow-up|0|||
44545094|NCT03521635|79558645|FG001|Overall Study|Lost to Follow-up|1|||
44545095|NCT03521635|79558644|FG000|Overall Study|Meet exclusion criteria|0|||
44545096|NCT03521635|79558645|FG001|Overall Study|Meet exclusion criteria|1|||
44545097|NCT03521635|79558644|FG000|Overall Study|Patient not taken study medicine|0|||
44545098|NCT03521635|79558645|FG001|Overall Study|Patient not taken study medicine|1|||
44545099|NCT03170544|79558663|FG000|Part 1|Lost to Follow-up|1|||
44545100|NCT03170544|79558664|FG001|Part 1|Lost to Follow-up|0|||
44545101|NCT03170544|79558665|FG002|Part 1|Lost to Follow-up|0|||
44545102|NCT03170544|79558666|FG003|Part 1|Lost to Follow-up|0|||
44545103|NCT03170544|79558667|FG004|Part 1|Lost to Follow-up|0|||
44545104|NCT03170544|79558668|FG005|Part 1|Lost to Follow-up|0|||
44545105|NCT03170544|79558669|FG006|Part 1|Lost to Follow-up|0|||
44545106|NCT03170544|79558670|FG007|Part 1|Lost to Follow-up|0|||
44545107|NCT03170544|79558671|FG008|Part 1|Lost to Follow-up|0|||
44545108|NCT03170544|79558672|FG009|Part 1|Lost to Follow-up|0|||
44545109|NCT03170544|79558673|FG010|Part 1|Lost to Follow-up|0|||
44228696|NCT01923467|79036171|FG000|Overall Study|Subject non-interest|479|||
44228697|NCT01910129|79036177|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
44228698|NCT01910129|79036178|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
44228699|NCT01910129|79036179|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
44228700|NCT01910129|79036177|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
44228701|NCT01910129|79036178|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
44228702|NCT01910129|79036179|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
44228703|NCT01909973|79036199|FG000|Overall Study|Lost to Follow-up|1|||
44228704|NCT01909973|79036200|FG001|Overall Study|Lost to Follow-up|0|||
44228705|NCT01617005|79036206|FG000|Overall Study|Pregnancy|1|||
44228706|NCT01617005|79036206|FG000|Overall Study|Lack of motivation for treatment|1|||
44228707|NCT01925339|79036212|FG000|Overall Study|Adverse Event|2|||
44228708|NCT01925339|79036213|FG001|Overall Study|Adverse Event|0|||
44487497|NCT00451217|79493573|FG002|Overall Study|Lost to Follow-up|1|||
44487498|NCT00451217|79493574|FG003|Overall Study|Lost to Follow-up|1|||
44487499|NCT00451217|79493571|FG000|Overall Study|Withdrawal by Subject|1|||
44487500|NCT00451217|79493572|FG001|Overall Study|Withdrawal by Subject|0|||
44487501|NCT00451217|79493573|FG002|Overall Study|Withdrawal by Subject|0|||
44487502|NCT00451217|79493574|FG003|Overall Study|Withdrawal by Subject|0|||
44487503|NCT00451217|79493571|FG000|Overall Study|Not Treated|1|||
44487504|NCT00451217|79493572|FG001|Overall Study|Not Treated|1|||
44487505|NCT00451217|79493573|FG002|Overall Study|Not Treated|3|||
44487506|NCT00451217|79493574|FG003|Overall Study|Not Treated|4|||
44487507|NCT00459953|79493586|FG000|Overall Study|not analyzed-household member in study|1|||
44545110|NCT03170544|79558674|FG011|Part 1|Lost to Follow-up|0|||
44545111|NCT03170544|79558663|FG000|Part 1|Not treated|0|||
44545112|NCT03170544|79558664|FG001|Part 1|Not treated|0|||
44545113|NCT03170544|79558665|FG002|Part 1|Not treated|0|||
44545114|NCT03170544|79558666|FG003|Part 1|Not treated|1|||
44545115|NCT03170544|79558667|FG004|Part 1|Not treated|0|||
44545116|NCT03170544|79558668|FG005|Part 1|Not treated|0|||
44545117|NCT03170544|79558669|FG006|Part 1|Not treated|0|||
44545118|NCT03170544|79558670|FG007|Part 1|Not treated|0|||
44545119|NCT03170544|79558671|FG008|Part 1|Not treated|0|||
44545120|NCT03170544|79558672|FG009|Part 1|Not treated|0|||
44545121|NCT03170544|79558673|FG010|Part 1|Not treated|0|||
44228709|NCT01908803|79036221|FG000|Overall Study|Adverse Event|1|||
44228710|NCT01908803|79036222|FG001|Overall Study|Adverse Event|0|||
44228711|NCT01908803|79036221|FG000|Overall Study|Physician Decision|0|||
44228712|NCT01908803|79036222|FG001|Overall Study|Physician Decision|1|||
44487508|NCT00459953|79493587|FG001|Overall Study|not analyzed-household member in study|1|||
44545122|NCT03170544|79558674|FG011|Part 1|Not treated|0|||
44545123|NCT03582943|79558759|FG000|Allocated to Groups|Withdrawal by Subject|1|||
44545124|NCT03582943|79558760|FG001|Allocated to Groups|Withdrawal by Subject|1|||
44545125|NCT03582943|79558759|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
44487509|NCT00459875|79493593|FG000|Overall Study|Ineligible participant|1|||
44487510|NCT00459875|79493593|FG000|Overall Study|Adverse Event|2|||
44487511|NCT00311402|79493599|FG000|Overall Study|Adverse Event|118|||
44487512|NCT00311402|79493600|FG001|Overall Study|Adverse Event|105|||
44487513|NCT00311402|79493599|FG000|Overall Study|Lost to Follow-up|0|||
44487514|NCT00311402|79493600|FG001|Overall Study|Lost to Follow-up|3|||
44487515|NCT00311402|79493599|FG000|Overall Study|Withdrawal by Subject|17|||
44487516|NCT00311402|79493600|FG001|Overall Study|Withdrawal by Subject|18|||
44487517|NCT00311402|79493599|FG000|Overall Study|Lack of Efficacy|58|||
44545126|NCT03582943|79558760|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
44545127|NCT03582943|79558759|FG000|Analyzed|Protocol Violation|4|||
44487518|NCT00311402|79493600|FG001|Overall Study|Lack of Efficacy|42|||
44487519|NCT00311402|79493599|FG000|Overall Study|Protocol Violation|7|||
44487520|NCT00311402|79493600|FG001|Overall Study|Protocol Violation|6|||
44487521|NCT00311402|79493599|FG000|Overall Study|IRB's rejection etc.|10|||
44545128|NCT03582943|79558760|FG001|Analyzed|Protocol Violation|1|||
44545129|NCT03532009|79558768|FG000|Overall Study|Other|1|||
44487522|NCT00311402|79493600|FG001|Overall Study|IRB's rejection etc.|3|||
44487523|NCT00450749|79493609|FG000|Overall Study|Withdrawal by Subject|0|||
44545130|NCT03532009|79558769|FG001|Overall Study|Other|1|||
44545131|NCT03532009|79558768|FG000|Overall Study|Death|1|||
44487524|NCT00450749|79493610|FG001|Overall Study|Withdrawal by Subject|0|||
44487525|NCT00450749|79493611|FG002|Overall Study|Withdrawal by Subject|2|||
44487526|NCT00450749|79493609|FG000|Overall Study|Noncompliant|0|||
44487527|NCT00450749|79493610|FG001|Overall Study|Noncompliant|1|||
44487528|NCT00450749|79493611|FG002|Overall Study|Noncompliant|0|||
44545132|NCT03532009|79558769|FG001|Overall Study|Death|1|||
44375731|NCT00594568|79380841|FG000|Delayed Start|Death|0|||
44487529|NCT00292370|79493622|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
44487530|NCT00292370|79493623|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
44487531|NCT00292370|79493624|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
44487532|NCT00292370|79493622|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
44487533|NCT00292370|79493623|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
44487534|NCT00292370|79493624|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
44487535|NCT00292370|79493622|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
44487536|NCT00292370|79493623|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
44487537|NCT00292370|79493624|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
44487538|NCT00292370|79493622|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
44487539|NCT00292370|79493623|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
44487540|NCT00292370|79493624|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
44487541|NCT00292370|79493622|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
44487542|NCT00292370|79493623|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
44487543|NCT00292370|79493624|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
44487544|NCT00292370|79493622|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
44487545|NCT00292370|79493623|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
44487546|NCT00292370|79493624|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
44487547|NCT00065182|79493633|FG000|Overall Study|Adverse Event|24|||
44487548|NCT00065182|79493634|FG001|Overall Study|Adverse Event|17|||
44487549|NCT00065182|79493633|FG000|Overall Study|Lost to Follow-up|0|||
44487550|NCT00065182|79493634|FG001|Overall Study|Lost to Follow-up|4|||
44487551|NCT00065182|79493633|FG000|Overall Study|Protocol Violation|3|||
44487552|NCT00065182|79493634|FG001|Overall Study|Protocol Violation|4|||
44487553|NCT00065182|79493633|FG000|Overall Study|Serious adverse events (SAE)|1|||
44487554|NCT00065182|79493634|FG001|Overall Study|Serious adverse events (SAE)|0|||
44487555|NCT00065182|79493633|FG000|Overall Study|Sponsor Decision|11|||
44487556|NCT00065182|79493634|FG001|Overall Study|Sponsor Decision|7|||
44487557|NCT00065182|79493633|FG000|Overall Study|Withdrawal by Subject|8|||
44545133|NCT03532009|79558768|FG000|Overall Study|Withdrawal by Patient|0|||
44545134|NCT03532009|79558769|FG001|Overall Study|Withdrawal by Patient|2|||
44487558|NCT00065182|79493634|FG001|Overall Study|Withdrawal by Subject|3|||
44487559|NCT00065182|79493633|FG000|Overall Study|No clinical benefit|1|||
44487560|NCT00065182|79493634|FG001|Overall Study|No clinical benefit|0|||
44375732|NCT00594568|79380842|FG001|Delayed Start|Death|0|||
44487561|NCT00065182|79493633|FG000|Overall Study|Death|0|||
44487562|NCT00065182|79493634|FG001|Overall Study|Death|1|||
44487563|NCT00065182|79493633|FG000|Overall Study|Decline in Status|0|||
44545135|NCT03520387|79558780|FG000|Pre-Randomization|Withdrawal by Subject|1|||
44545136|NCT03520387|79558781|FG001|Pre-Randomization|Withdrawal by Subject|0|||
44487564|NCT00065182|79493634|FG001|Overall Study|Decline in Status|1|||
44487565|NCT00064792|79493642|FG000|Overall Study|Withdrawal by Subject|2|||
44487566|NCT00064792|79493643|FG001|Overall Study|Withdrawal by Subject|0|||
44487567|NCT00064792|79493642|FG000|Overall Study|Adverse Event|3|||
44487568|NCT00064792|79493643|FG001|Overall Study|Adverse Event|0|||
44487569|NCT00450437|79493651|FG000|Overall Study|Withdrawal by Subject|10|||
44487570|NCT00450437|79493652|FG001|Overall Study|Withdrawal by Subject|2|||
44545137|NCT03520387|79558782|FG002|Pre-Randomization|Withdrawal by Subject|0|||
44487571|NCT00450437|79493653|FG002|Overall Study|Withdrawal by Subject|0|||
44487572|NCT00450437|79493654|FG003|Overall Study|Withdrawal by Subject|1|||
44487573|NCT00450437|79493651|FG000|Overall Study|Lost to Follow-up|31|||
44487574|NCT00450437|79493652|FG001|Overall Study|Lost to Follow-up|12|||
44487575|NCT00450437|79493653|FG002|Overall Study|Lost to Follow-up|19|||
44487576|NCT00450437|79493654|FG003|Overall Study|Lost to Follow-up|9|||
44487577|NCT00450437|79493651|FG000|Overall Study|Protocol Violation|0|||
44487578|NCT00450437|79493652|FG001|Overall Study|Protocol Violation|1|||
44487579|NCT00450437|79493653|FG002|Overall Study|Protocol Violation|0|||
44487580|NCT00450437|79493654|FG003|Overall Study|Protocol Violation|1|||
44487581|NCT00450437|79493651|FG000|Overall Study|Inappropriate enrollment|4|||
44487582|NCT00450437|79493652|FG001|Overall Study|Inappropriate enrollment|1|||
44487583|NCT00450437|79493653|FG002|Overall Study|Inappropriate enrollment|3|||
44545138|NCT03520387|79558783|FG003|Pre-Randomization|Withdrawal by Subject|0|||
44545139|NCT03520387|79558784|FG004|Pre-Randomization|Withdrawal by Subject|0|||
44545140|NCT03520387|79558780|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
44545141|NCT03520387|79558781|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
44545142|NCT03520387|79558782|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
44545143|NCT03520387|79558783|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
44545144|NCT03520387|79558784|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
44545145|NCT03170232|79558797|FG000|Overall Study|Adverse Event|0|||
44545146|NCT03170232|79558798|FG001|Overall Study|Adverse Event|1|||
44545147|NCT03170232|79558797|FG000|Overall Study|Protocol Violation|0|||
44545148|NCT03170232|79558798|FG001|Overall Study|Protocol Violation|1|||
44545149|NCT03170232|79558797|FG000|Overall Study|Lack of Efficacy|0|||
44545150|NCT03170232|79558798|FG001|Overall Study|Lack of Efficacy|1|||
44545151|NCT03170232|79558797|FG000|Overall Study|Study closed/terminated|26|||
44545152|NCT03170232|79558798|FG001|Overall Study|Study closed/terminated|23|||
44545153|NCT03170232|79558797|FG000|Overall Study|Lost to Follow-up|1|||
44545154|NCT03170232|79558798|FG001|Overall Study|Lost to Follow-up|0|||
44545155|NCT03170232|79558797|FG000|Overall Study|Withdrawal by Subject|0|||
44545156|NCT03170232|79558798|FG001|Overall Study|Withdrawal by Subject|1|||
44545157|NCT03519919|79558804|FG000|Overall Study|Withdrawal by Subject|1|||
44545158|NCT03519919|79558804|FG000|Overall Study|Lack of Efficacy|1|||
44545159|NCT03519919|79558804|FG000|Overall Study|Screen Failure|1|||
44545160|NCT03478969|79558837|FG000|Overall Study|Withdrawal by Subject|4|||
44545161|NCT03478969|79558838|FG001|Overall Study|Withdrawal by Subject|7|||
44545162|NCT03478969|79558839|FG002|Overall Study|Withdrawal by Subject|6|||
44545163|NCT03478969|79558837|FG000|Overall Study|Adverse Event|2|||
44545164|NCT03478969|79558838|FG001|Overall Study|Adverse Event|0|||
44545165|NCT03478969|79558839|FG002|Overall Study|Adverse Event|1|||
44545166|NCT03478969|79558837|FG000|Overall Study|Pregnancy|1|||
44545167|NCT03478969|79558838|FG001|Overall Study|Pregnancy|0|||
44545168|NCT03478969|79558839|FG002|Overall Study|Pregnancy|0|||
44545169|NCT03478969|79558837|FG000|Overall Study|Personal Reasons|1|||
44545170|NCT03478969|79558838|FG001|Overall Study|Personal Reasons|0|||
44545171|NCT03478969|79558839|FG002|Overall Study|Personal Reasons|1|||
44545172|NCT03478969|79558837|FG000|Overall Study|Covid-19|1|||
44545173|NCT03478969|79558838|FG001|Overall Study|Covid-19|4|||
44545174|NCT03478969|79558839|FG002|Overall Study|Covid-19|3|||
44545175|NCT03478969|79558837|FG000|Overall Study|Multiple Reasons|0|||
44545176|NCT03478969|79558838|FG001|Overall Study|Multiple Reasons|1|||
44545177|NCT03478969|79558839|FG002|Overall Study|Multiple Reasons|1|||
44545178|NCT03478969|79558837|FG000|Overall Study|Eligibility Criteria|0|||
44487584|NCT00450437|79493654|FG003|Overall Study|Inappropriate enrollment|0|||
44487585|NCT00450437|79493651|FG000|Overall Study|Administrative reason|0|||
44545179|NCT03478969|79558838|FG001|Overall Study|Eligibility Criteria|0|||
44545180|NCT03478969|79558839|FG002|Overall Study|Eligibility Criteria|5|||
44487586|NCT00450437|79493652|FG001|Overall Study|Administrative reason|0|||
44487587|NCT00450437|79493653|FG002|Overall Study|Administrative reason|1|||
44487588|NCT00450437|79493654|FG003|Overall Study|Administrative reason|0|||
44487589|NCT00450437|79493651|FG000|Overall Study|Unable to Classify|1|||
44487590|NCT00450437|79493652|FG001|Overall Study|Unable to Classify|0|||
44487591|NCT00450437|79493653|FG002|Overall Study|Unable to Classify|1|||
44545181|NCT03478969|79558837|FG000|Overall Study|Lost to Follow-up|0|||
44545182|NCT03478969|79558838|FG001|Overall Study|Lost to Follow-up|0|||
44545183|NCT03478969|79558839|FG002|Overall Study|Lost to Follow-up|1|||
44545184|NCT04823949|79558870|FG000|Overall Study|Withdrawal by Subject|0|||
44545185|NCT04823949|79558871|FG001|Overall Study|Withdrawal by Subject|4|||
44487592|NCT00450437|79493654|FG003|Overall Study|Unable to Classify|0|||
44487593|NCT00286442|79493671|FG000|Overall Study|Hyperglycemic Rescue|19|||
44487594|NCT00286442|79493672|FG001|Overall Study|Hyperglycemic Rescue|17|||
44487595|NCT00286442|79493673|FG002|Overall Study|Hyperglycemic Rescue|25|||
44487596|NCT00286442|79493671|FG000|Overall Study|Adverse Event|7|||
44487597|NCT00286442|79493672|FG001|Overall Study|Adverse Event|6|||
44487598|NCT00286442|79493673|FG002|Overall Study|Adverse Event|1|||
44487599|NCT00286442|79493671|FG000|Overall Study|Protocol Violation|2|||
44487600|NCT00286442|79493672|FG001|Overall Study|Protocol Violation|4|||
44487601|NCT00286442|79493673|FG002|Overall Study|Protocol Violation|2|||
44487602|NCT00286442|79493671|FG000|Overall Study|Lost to Follow-up|5|||
44487603|NCT00286442|79493672|FG001|Overall Study|Lost to Follow-up|2|||
44487604|NCT00286442|79493673|FG002|Overall Study|Lost to Follow-up|1|||
44487605|NCT00286442|79493671|FG000|Overall Study|Physician Decision|1|||
44487606|NCT00286442|79493672|FG001|Overall Study|Physician Decision|1|||
44487607|NCT00286442|79493673|FG002|Overall Study|Physician Decision|1|||
44487608|NCT00286442|79493671|FG000|Overall Study|Administrative Error|1|||
44487609|NCT00286442|79493672|FG001|Overall Study|Administrative Error|1|||
44487610|NCT00286442|79493673|FG002|Overall Study|Administrative Error|0|||
44487611|NCT00286442|79493671|FG000|Overall Study|Withdrawal by Subject|2|||
44487612|NCT00286442|79493672|FG001|Overall Study|Withdrawal by Subject|14|||
44487613|NCT00286442|79493673|FG002|Overall Study|Withdrawal by Subject|2|||
44274365|NCT02678312|79217879|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
44274366|NCT02678312|79217880|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
44274367|NCT02678312|79217876|FG000|Part 2 Double Blind Epoch|Death|0|||
44274368|NCT02678312|79217877|FG001|Part 2 Double Blind Epoch|Death|0|||
44274369|NCT02678312|79217878|FG002|Part 2 Double Blind Epoch|Death|0|||
44274370|NCT02678312|79217879|FG003|Part 2 Double Blind Epoch|Death|8|||
44274371|NCT02678312|79217880|FG004|Part 2 Double Blind Epoch|Death|12|||
44487614|NCT00063934|79493681|FG000|Overall Study|Ineligible|1|||
44487615|NCT00458783|79493687|FG000|Overall Study|Protocol Violation|1228|||
44487616|NCT00458783|79493688|FG001|Overall Study|Protocol Violation|1220|||
44487617|NCT00063154|79493694|FG000|Overall Study|Disease progression|27|||
44487618|NCT00063154|79493694|FG000|Overall Study|Adverse Event|2|||
44487619|NCT00063154|79493694|FG000|Overall Study|Physician Decision|10|||
44487620|NCT00063154|79493694|FG000|Overall Study|Death|3|||
44487621|NCT00063154|79493694|FG000|Overall Study|Reason unspecified|1|||
44487622|NCT00063154|79493694|FG000|Overall Study|Did not receive treatment|8|||
44487623|NCT00311168|79493700|FG000|First Intervention|Withdrawal by Subject|2|||
44487624|NCT00311168|79493701|FG001|First Intervention|Withdrawal by Subject|2|||
44487625|NCT00311168|79493700|FG000|First Intervention|Lost to Follow-up|1|||
44487626|NCT00311168|79493701|FG001|First Intervention|Lost to Follow-up|1|||
44487627|NCT00311168|79493700|FG000|First Intervention|Protocol Violation|1|||
44487628|NCT00311168|79493701|FG001|First Intervention|Protocol Violation|1|||
44487629|NCT00311168|79493700|FG000|First Intervention|Adverse Event|1|||
44487630|NCT00311168|79493701|FG001|First Intervention|Adverse Event|0|||
44487631|NCT00311168|79493700|FG000|First Intervention|Other|2|||
44487632|NCT00311168|79493701|FG001|First Intervention|Other|2|||
44487633|NCT00311168|79493700|FG000|Second Intervention|Lost to Follow-up|9|||
44487634|NCT00311168|79493701|FG001|Second Intervention|Lost to Follow-up|2|||
44487635|NCT00311168|79493700|FG000|Second Intervention|Withdrawal by Subject|0|||
44487636|NCT00311168|79493701|FG001|Second Intervention|Withdrawal by Subject|1|||
44487637|NCT00311168|79493700|FG000|Second Intervention|Other|1|||
44487638|NCT00311168|79493701|FG001|Second Intervention|Other|1|||
44487639|NCT00458705|79493709|FG000|Overall Study|Adverse Event|4|||
44487640|NCT00458705|79493709|FG000|Overall Study|Not Treated|1|||
44487641|NCT00062374|79493713|FG000|Overall Study|Not treated|12|||
44487642|NCT00285818|79493719|FG000|Overall Study|Withdrawal by Subject|3|||
44487643|NCT00285818|79493720|FG001|Overall Study|Withdrawal by Subject|2|||
44274372|NCT02678312|79217876|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
44274373|NCT02678312|79217877|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
44487644|NCT00285818|79493719|FG000|Overall Study|Lost to Follow-up|1|||
44487645|NCT00285818|79493720|FG001|Overall Study|Lost to Follow-up|0|||
44487646|NCT04761627|79493824|FG000|Run-in Period|Death|1|||
44487647|NCT04761627|79493825|FG001|Run-in Period|Death|0|||
44487648|NCT04761627|79493826|FG002|Run-in Period|Death|0|||
44274374|NCT02678312|79217878|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
44487649|NCT04761627|79493824|FG000|Run-in Period|Required alternative therapy|2|||
44487650|NCT04761627|79493825|FG001|Run-in Period|Required alternative therapy|0|||
44487651|NCT04761627|79493826|FG002|Run-in Period|Required alternative therapy|0|||
44487652|NCT04761627|79493824|FG000|Run-in Period|Lost to Follow-up|2|||
44487653|NCT04761627|79493825|FG001|Run-in Period|Lost to Follow-up|0|||
44487654|NCT04761627|79493826|FG002|Run-in Period|Lost to Follow-up|0|||
44487655|NCT04761627|79493824|FG000|Run-in Period|Protocol Violation|3|||
44487656|NCT04761627|79493825|FG001|Run-in Period|Protocol Violation|0|||
44487657|NCT04761627|79493826|FG002|Run-in Period|Protocol Violation|0|||
44487658|NCT04761627|79493824|FG000|Run-in Period|Abnormal liver function|1|||
44487659|NCT04761627|79493825|FG001|Run-in Period|Abnormal liver function|0|||
44487660|NCT04761627|79493826|FG002|Run-in Period|Abnormal liver function|0|||
44487661|NCT04761627|79493824|FG000|Run-in Period|Adverse Event|6|||
44487662|NCT04761627|79493825|FG001|Run-in Period|Adverse Event|0|||
44487663|NCT04761627|79493826|FG002|Run-in Period|Adverse Event|0|||
44487664|NCT04761627|79493824|FG000|Run-in Period|Withdrawal by Subject|7|||
44487665|NCT04761627|79493825|FG001|Run-in Period|Withdrawal by Subject|0|||
44487666|NCT04761627|79493826|FG002|Run-in Period|Withdrawal by Subject|0|||
44487667|NCT04761627|79493824|FG000|Run-in Period|Did not meet PASI 50|15|||
44545186|NCT04823949|79558870|FG000|Overall Study|Physician Decision|0|||
44487668|NCT04761627|79493825|FG001|Run-in Period|Did not meet PASI 50|0|||
44487669|NCT04761627|79493826|FG002|Run-in Period|Did not meet PASI 50|0|||
44487670|NCT04761627|79493824|FG000|Run-in Period|Study site closure|2|||
44487671|NCT04761627|79493825|FG001|Run-in Period|Study site closure|0|||
44487672|NCT04761627|79493826|FG002|Run-in Period|Study site closure|0|||
44545187|NCT04823949|79558871|FG001|Overall Study|Physician Decision|1|||
44545188|NCT04499482|79558886|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
44545189|NCT04408794|79558905|FG000|Overall Study|Adverse Event|43|||
44545190|NCT04408794|79558905|FG000|Overall Study|Infrequent study drug usage|43|||
44545191|NCT04408794|79558905|FG000|Overall Study|Lack of Efficacy|61|||
44545192|NCT04408794|79558905|FG000|Overall Study|Lost to Follow-up|33|||
44545193|NCT04408794|79558905|FG000|Overall Study|Non-compliance|6|||
44545194|NCT04408794|79558905|FG000|Overall Study|Physician Decision|1|||
44545195|NCT04408794|79558905|FG000|Overall Study|Pregnancy|6|||
44545196|NCT04408794|79558905|FG000|Overall Study|Protocol Deviation|9|||
44545197|NCT04408794|79558905|FG000|Overall Study|Sheehan-STS Result|1|||
44545198|NCT04408794|79558905|FG000|Overall Study|Withdrawal by Subject|57|||
44545199|NCT04408794|79558905|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
44545200|NCT04408794|79558905|FG000|Overall Study|Never Treated Migraine|5|||
44545201|NCT04354168|79558938|FG000|Overall Study|Lost to Follow-up|22|||
44545202|NCT04305405|79558944|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44545203|NCT04305405|79558945|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44545204|NCT03543410|79558963|FG000|Overall Study|Adverse Event|10|||
44545205|NCT03543410|79558964|FG001|Overall Study|Adverse Event|8|||
44375733|NCT00594568|79380843|FG002|Delayed Start|Death|1|||
44487673|NCT04761627|79493824|FG000|Run-in Period|Pregnancy|2|||
44487674|NCT04761627|79493825|FG001|Run-in Period|Pregnancy|0|||
44487675|NCT04761627|79493826|FG002|Run-in Period|Pregnancy|0|||
44487676|NCT04761627|79493824|FG000|Post-randomization Period|Military service|0|||
44487677|NCT04761627|79493825|FG001|Post-randomization Period|Military service|1|||
44487678|NCT04761627|79493826|FG002|Post-randomization Period|Military service|0|||
44487679|NCT04761627|79493824|FG000|Post-randomization Period|Adverse Event|0|||
44487680|NCT04761627|79493825|FG001|Post-randomization Period|Adverse Event|4|||
44487681|NCT04761627|79493826|FG002|Post-randomization Period|Adverse Event|2|||
44487682|NCT04761627|79493824|FG000|Post-randomization Period|Lost to Follow-up|0|||
44487683|NCT04761627|79493825|FG001|Post-randomization Period|Lost to Follow-up|6|||
44487684|NCT04761627|79493826|FG002|Post-randomization Period|Lost to Follow-up|6|||
44487685|NCT04761627|79493824|FG000|Post-randomization Period|Withdrawal by Subject|0|||
44487686|NCT04761627|79493825|FG001|Post-randomization Period|Withdrawal by Subject|7|||
44487687|NCT04761627|79493826|FG002|Post-randomization Period|Withdrawal by Subject|6|||
44545206|NCT03543410|79558965|FG002|Overall Study|Adverse Event|2|||
44545207|NCT03543410|79558963|FG000|Overall Study|Lack of Efficacy|0|||
44487688|NCT04761627|79493824|FG000|Post-randomization Period|Pregnancy|0|||
44487689|NCT04761627|79493825|FG001|Post-randomization Period|Pregnancy|0|||
44487690|NCT04761627|79493826|FG002|Post-randomization Period|Pregnancy|1|||
44487691|NCT04761627|79493824|FG000|Post-randomization Period|Study site closure|0|||
44487692|NCT04761627|79493825|FG001|Post-randomization Period|Study site closure|0|||
44487693|NCT04761627|79493826|FG002|Post-randomization Period|Study site closure|1|||
44487694|NCT04761627|79493824|FG000|Post-randomization Period|Family planning|0|||
44487695|NCT04761627|79493825|FG001|Post-randomization Period|Family planning|1|||
44487696|NCT04761627|79493826|FG002|Post-randomization Period|Family planning|0|||
44487697|NCT04621786|79493843|FG000|Overall Study|Lost to Follow-up|9|||
44487698|NCT04621786|79493843|FG000|Overall Study|Protocol Violation|3|||
44487699|NCT04025710|79493860|FG000|Overall Study|Death|3|||
44487700|NCT04025710|79493860|FG000|Overall Study|Lost to Follow-up|5|||
44487701|NCT04025710|79493860|FG000|Overall Study|Withdrawal by Subject|1|||
44487702|NCT04025710|79493860|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
44487703|NCT04025710|79493860|FG000|Overall Study|Drop-out according to protocol|34|||
44487704|NCT03147287|79493940|FG000|Overall Study|Randomized Not Treated|2|||
44487705|NCT03147287|79493941|FG001|Overall Study|Randomized Not Treated|1|||
44487706|NCT03147287|79493942|FG002|Overall Study|Randomized Not Treated|1|||
44487707|NCT03147287|79493940|FG000|Overall Study|Progressive Disease RECIST|31|||
44487708|NCT03147287|79493941|FG001|Overall Study|Progressive Disease RECIST|72|||
44487709|NCT03147287|79493942|FG002|Overall Study|Progressive Disease RECIST|32|||
44487710|NCT03147287|79493940|FG000|Overall Study|Progressive Disease not RECIST|13|||
44487711|NCT03147287|79493941|FG001|Overall Study|Progressive Disease not RECIST|21|||
44487712|NCT03147287|79493942|FG002|Overall Study|Progressive Disease not RECIST|13|||
44487713|NCT03147287|79493940|FG000|Overall Study|Physician Decision|1|||
44487714|NCT03147287|79493941|FG001|Overall Study|Physician Decision|2|||
44487715|NCT03147287|79493942|FG002|Overall Study|Physician Decision|1|||
44487716|NCT03147287|79493940|FG000|Overall Study|Intercurrent illness|0|||
44487717|NCT03147287|79493941|FG001|Overall Study|Intercurrent illness|1|||
44487718|NCT03147287|79493942|FG002|Overall Study|Intercurrent illness|0|||
44487719|NCT03147287|79493940|FG000|Overall Study|Withdrawal by Subject|2|||
44487720|NCT03147287|79493941|FG001|Overall Study|Withdrawal by Subject|3|||
44487721|NCT03147287|79493942|FG002|Overall Study|Withdrawal by Subject|2|||
44487722|NCT03147287|79493940|FG000|Overall Study|Patient Non-Compliance|0|||
44487723|NCT03147287|79493941|FG001|Overall Study|Patient Non-Compliance|2|||
44487724|NCT03147287|79493942|FG002|Overall Study|Patient Non-Compliance|0|||
44487725|NCT03147287|79493940|FG000|Overall Study|Patient moved|0|||
44487726|NCT03147287|79493941|FG001|Overall Study|Patient moved|1|||
44487727|NCT03147287|79493942|FG002|Overall Study|Patient moved|0|||
44487728|NCT03147287|79493940|FG000|Overall Study|Arm A crossover without PD|1|||
44487729|NCT03147287|79493941|FG001|Overall Study|Arm A crossover without PD|0|||
44487730|NCT03147287|79493942|FG002|Overall Study|Arm A crossover without PD|0|||
44487731|NCT03147287|79493940|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
44487732|NCT03147287|79493941|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
44487733|NCT03147287|79493942|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
44487734|NCT02865135|79493953|FG000|Overall Study|Death|0|||
44487735|NCT02865135|79493954|FG001|Overall Study|Death|1|||
44487736|NCT02865135|79493955|FG002|Overall Study|Death|0|||
44487737|NCT02865135|79493953|FG000|Overall Study|Progression|6|||
44487738|NCT02865135|79493954|FG001|Overall Study|Progression|2|||
44487739|NCT02865135|79493955|FG002|Overall Study|Progression|2|||
44487740|NCT02709720|79493973|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
44487741|NCT02709720|79493973|FG000|Overall Study|Protocol Violation|1|||
44487742|NCT02709720|79493973|FG000|Overall Study|Not take study medication|1|||
44487743|NCT02364557|79493996|FG000|Overall Study|Protocol Violation|3|||
44487744|NCT02364557|79493997|FG001|Overall Study|Protocol Violation|1|||
44487745|NCT01774487|79494012|FG000|Overall Study|Did not tolerate taste|4|||
44487746|NCT01774487|79494013|FG001|Overall Study|Did not tolerate taste|4|||
44487747|NCT00905645|79494051|FG000|Overall Study|Death (not device related)|10|||
44487748|NCT00905645|79494052|FG001|Overall Study|Death (not device related)|4|||
44487749|NCT00905645|79494053|FG002|Overall Study|Death (not device related)|15|||
44487750|NCT00905645|79494054|FG003|Overall Study|Death (not device related)|8|||
44487751|NCT00905645|79494051|FG000|Overall Study|Explantation of study device(s)|78|||
44487752|NCT00905645|79494052|FG001|Overall Study|Explantation of study device(s)|47|||
44487753|NCT00905645|79494053|FG002|Overall Study|Explantation of study device(s)|28|||
44487754|NCT00905645|79494054|FG003|Overall Study|Explantation of study device(s)|21|||
44487755|NCT00905645|79494051|FG000|Overall Study|Subject Request|41|||
44487756|NCT00905645|79494052|FG001|Overall Study|Subject Request|17|||
44487757|NCT00905645|79494053|FG002|Overall Study|Subject Request|13|||
44487758|NCT00905645|79494054|FG003|Overall Study|Subject Request|11|||
44487759|NCT00905645|79494051|FG000|Overall Study|Lost to Follow-up|299|||
44487760|NCT00905645|79494052|FG001|Overall Study|Lost to Follow-up|103|||
44487761|NCT00905645|79494053|FG002|Overall Study|Lost to Follow-up|51|||
44487762|NCT00905645|79494054|FG003|Overall Study|Lost to Follow-up|12|||
44487763|NCT00285584|79494066|FG000|Month 3|Lost to Follow-up|3|||
44487764|NCT00285584|79494067|FG001|Month 3|Lost to Follow-up|3|||
44487765|NCT00285584|79494066|FG000|Month 3|Withdrawal by Subject|1|||
44487766|NCT00285584|79494067|FG001|Month 3|Withdrawal by Subject|0|||
44487767|NCT00285584|79494066|FG000|Month 6|Lost to Follow-up|0|||
44487768|NCT00285584|79494067|FG001|Month 6|Lost to Follow-up|1|||
44487769|NCT03807700|79494079|FG000|Overall Study|Withdrawal by Subject|2|||
44487770|NCT03807700|79494080|FG001|Overall Study|Withdrawal by Subject|1|||
44487771|NCT00291668|79494090|FG000|Overall Study|Lack of Efficacy|1|||
44487772|NCT00291668|79494091|FG001|Overall Study|Lack of Efficacy|0|||
44487773|NCT00291668|79494092|FG002|Overall Study|Lack of Efficacy|0|||
44487774|NCT00291668|79494090|FG000|Overall Study|SAE, non-fatal|1|||
44487775|NCT00291668|79494091|FG001|Overall Study|SAE, non-fatal|1|||
44487776|NCT00291668|79494092|FG002|Overall Study|SAE, non-fatal|1|||
44487777|NCT00291668|79494090|FG000|Overall Study|AE, non-serious non-fatal|1|||
44487778|NCT00291668|79494091|FG001|Overall Study|AE, non-serious non-fatal|0|||
44487779|NCT00291668|79494092|FG002|Overall Study|AE, non-serious non-fatal|0|||
44487780|NCT00291668|79494090|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44487781|NCT00291668|79494091|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
44487782|NCT00291668|79494092|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
44487783|NCT00458393|79494102|FG000|Overall Study|Withdrawal by Subject|67|||
44487784|NCT00458393|79494103|FG001|Overall Study|Withdrawal by Subject|80|||
44487785|NCT00458393|79494102|FG000|Overall Study|Physician Decision|31|||
44487786|NCT00458393|79494103|FG001|Overall Study|Physician Decision|22|||
44487787|NCT00458393|79494102|FG000|Overall Study|Relocated|77|||
44487788|NCT00458393|79494103|FG001|Overall Study|Relocated|81|||
44487789|NCT00458393|79494102|FG000|Overall Study|Lost to Follow-up|115|||
44487790|NCT00458393|79494103|FG001|Overall Study|Lost to Follow-up|92|||
44487791|NCT00458393|79494102|FG000|Overall Study|Sites marked other on the form.|19|||
44487792|NCT00458393|79494103|FG001|Overall Study|Sites marked other on the form.|20|||
44487793|NCT00310856|79494114|FG000|Overall Study|Withdrawal by Subject|2|||
44545208|NCT03543410|79558964|FG001|Overall Study|Lack of Efficacy|1|||
44487794|NCT00310856|79494115|FG001|Overall Study|Withdrawal by Subject|2|||
44487795|NCT00310856|79494116|FG002|Overall Study|Withdrawal by Subject|2|||
44487796|NCT00310856|79494114|FG000|Overall Study|Lost to Follow-up|1|||
44487797|NCT00310856|79494115|FG001|Overall Study|Lost to Follow-up|2|||
44487798|NCT00310856|79494116|FG002|Overall Study|Lost to Follow-up|6|||
44487799|NCT00310856|79494114|FG000|Overall Study|Inappropriate enrollment|1|||
44487800|NCT00310856|79494115|FG001|Overall Study|Inappropriate enrollment|1|||
44487801|NCT00310856|79494116|FG002|Overall Study|Inappropriate enrollment|0|||
44487802|NCT00310856|79494114|FG000|Overall Study|Unable to classify|1|||
44487803|NCT00310856|79494115|FG001|Overall Study|Unable to classify|0|||
44487804|NCT00310856|79494116|FG002|Overall Study|Unable to classify|0|||
44487805|NCT00283712|79494127|FG000|Overall Study|Death|0|||
44487806|NCT00283712|79494128|FG001|Overall Study|Death|1|||
44487807|NCT00048724|79494136|FG000|Overall Study|Adverse Event|53|||
44487808|NCT00048724|79494137|FG001|Overall Study|Adverse Event|12|||
44487809|NCT00048724|79494136|FG000|Overall Study|Withdrawal by Subject|34|||
44487810|NCT00048724|79494137|FG001|Overall Study|Withdrawal by Subject|54|||
44487811|NCT00048724|79494136|FG000|Overall Study|Lost to Follow-up|5|||
44487812|NCT00048724|79494137|FG001|Overall Study|Lost to Follow-up|5|||
44487813|NCT00048724|79494136|FG000|Overall Study|Protocol-defined Clinical Event|17|||
44487814|NCT00048724|79494137|FG001|Overall Study|Protocol-defined Clinical Event|32|||
44487815|NCT00048724|79494136|FG000|Overall Study|Noncompliance With Protocol|4|||
44487816|NCT00048724|79494137|FG001|Overall Study|Noncompliance With Protocol|12|||
44487817|NCT00048724|79494136|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
44487818|NCT00048724|79494137|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
44487819|NCT00048724|79494136|FG000|Overall Study|Administrative|1|||
44487820|NCT00048724|79494137|FG001|Overall Study|Administrative|1|||
44487821|NCT00449033|79494145|FG000|Treatment Period|Adverse Event|117|||
44487822|NCT00449033|79494146|FG001|Treatment Period|Adverse Event|83|||
44487823|NCT00449033|79494145|FG000|Treatment Period|Death|21|||
44487824|NCT00449033|79494146|FG001|Treatment Period|Death|12|||
44487825|NCT00449033|79494145|FG000|Treatment Period|Lost to Follow-up|0|||
44487826|NCT00449033|79494146|FG001|Treatment Period|Lost to Follow-up|2|||
44487827|NCT00449033|79494145|FG000|Treatment Period|Physician Decision|4|||
44487828|NCT00449033|79494146|FG001|Treatment Period|Physician Decision|5|||
44487829|NCT00449033|79494145|FG000|Treatment Period|Protocol Violation|8|||
44487830|NCT00449033|79494146|FG001|Treatment Period|Protocol Violation|7|||
44487831|NCT00449033|79494145|FG000|Treatment Period|Disease Progression|231|||
44487832|NCT00449033|79494146|FG001|Treatment Period|Disease Progression|288|||
44487833|NCT00449033|79494145|FG000|Treatment Period|Consent Withdrawn|36|||
44487834|NCT00449033|79494146|FG001|Treatment Period|Consent Withdrawn|20|||
44375734|NCT00594568|79380841|FG000|Delayed Start|Adverse Event|12|||
44375735|NCT00594568|79380842|FG001|Delayed Start|Adverse Event|2|||
44487835|NCT00449033|79494145|FG000|Treatment Period|Amended Protocol Criteria|22|||
44487836|NCT00449033|79494146|FG001|Treatment Period|Amended Protocol Criteria|18|||
44487837|NCT00449033|79494145|FG000|Treatment Period|Non-compliance|7|||
44487838|NCT00449033|79494146|FG001|Treatment Period|Non-compliance|8|||
44487839|NCT00449033|79494145|FG000|Treatment Period|Second Malignancy|0|||
44487840|NCT00449033|79494146|FG001|Treatment Period|Second Malignancy|1|||
44487841|NCT00449033|79494145|FG000|Treatment Period|Reason Missing|0|||
44487842|NCT00449033|79494146|FG001|Treatment Period|Reason Missing|4|||
44487843|NCT00449033|79494145|FG000|Treatment Period|Treatment Ongoing|6|||
44487844|NCT00449033|79494146|FG001|Treatment Period|Treatment Ongoing|4|||
44487845|NCT00449033|79494145|FG000|Follow-up Period|Death|299|||
44545209|NCT03543410|79558965|FG002|Overall Study|Lack of Efficacy|0|||
44545210|NCT03543410|79558963|FG000|Overall Study|Lost to Follow-up|0|||
44545211|NCT03543410|79558964|FG001|Overall Study|Lost to Follow-up|1|||
44545212|NCT03543410|79558965|FG002|Overall Study|Lost to Follow-up|0|||
44545213|NCT03543410|79558963|FG000|Overall Study|Withdrawal by Subject|5|||
44545214|NCT03543410|79558964|FG001|Overall Study|Withdrawal by Subject|2|||
44545215|NCT03543410|79558965|FG002|Overall Study|Withdrawal by Subject|8|||
44545216|NCT03543410|79558963|FG000|Overall Study|Protocol Violation|0|||
44545217|NCT03543410|79558964|FG001|Overall Study|Protocol Violation|1|||
44545218|NCT03543410|79558965|FG002|Overall Study|Protocol Violation|0|||
44545219|NCT03543410|79558963|FG000|Overall Study|Due to COVID-19|4|||
44545220|NCT03543410|79558964|FG001|Overall Study|Due to COVID-19|0|||
44545221|NCT03543410|79558965|FG002|Overall Study|Due to COVID-19|2|||
44545222|NCT03543410|79558963|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
44545223|NCT03543410|79558964|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
44545224|NCT03543410|79558965|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
44545225|NCT03543410|79558963|FG000|Overall Study|Not Due to COVID-19|2|||
44228713|NCT01908803|79036221|FG000|Overall Study|Withdrawal by Subject|1|||
44228714|NCT01908803|79036222|FG001|Overall Study|Withdrawal by Subject|0|||
44545226|NCT03543410|79558964|FG001|Overall Study|Not Due to COVID-19|0|||
44545227|NCT03543410|79558965|FG002|Overall Study|Not Due to COVID-19|1|||
44545228|NCT02908074|79558979|FG000|Overall Study|sponsor/ICON decision|0|||
44545229|NCT02908074|79558980|FG001|Overall Study|sponsor/ICON decision|0|||
44545230|NCT02908074|79558981|FG002|Overall Study|sponsor/ICON decision|1|||
44545231|NCT02908074|79558982|FG003|Overall Study|sponsor/ICON decision|0|||
44545232|NCT02908074|79558983|FG004|Overall Study|sponsor/ICON decision|0|||
44545233|NCT02908074|79558984|FG005|Overall Study|sponsor/ICON decision|0|||
44545234|NCT02908074|79558979|FG000|Overall Study|Protocol Violation|0|||
44228715|NCT01908803|79036221|FG000|Overall Study|Randomization Error|1|||
44228716|NCT01908803|79036222|FG001|Overall Study|Randomization Error|0|||
44228717|NCT01908803|79036221|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
44228718|NCT01908803|79036222|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
44228719|NCT01908101|79036229|FG000|Overall Study|Physician Decision|1|||
44487846|NCT00449033|79494146|FG001|Follow-up Period|Death|311|||
44487847|NCT00449033|79494145|FG000|Follow-up Period|Lost to Follow-up|6|||
44487848|NCT00449033|79494146|FG001|Follow-up Period|Lost to Follow-up|10|||
44487849|NCT00449033|79494145|FG000|Follow-up Period|Reason Missing|120|||
44228720|NCT01908101|79036229|FG000|Overall Study|Withdrawal by Subject|1|||
44228721|NCT01908101|79036229|FG000|Overall Study|Incorrect Diagnosis|2|||
44228722|NCT01908101|79036229|FG000|Overall Study|Incorrect Starting Dose|1|||
44228723|NCT01908101|79036229|FG000|Overall Study|Did not complete the first cycle|4|||
44228724|NCT01923389|79036235|FG000|Overall Study|Protocol Violation|1|||
44228725|NCT01923389|79036236|FG001|Overall Study|Protocol Violation|0|||
44228726|NCT01907087|79036243|FG000|Overall Study|Withdrawal by Subject|1|||
44228727|NCT01616771|79036247|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
44228728|NCT01589185|79036261|FG000|Overall Study|Death|1|||
44228729|NCT01589185|79036262|FG001|Overall Study|Death|2|||
44487850|NCT00449033|79494146|FG001|Follow-up Period|Reason Missing|113|||
44487851|NCT00448019|79494152|FG000|Overall Study|Withdrawal by Subject|3|||
44487852|NCT00448019|79494152|FG000|Overall Study|Disease progression|1|||
44487853|NCT00448019|79494152|FG000|Overall Study|Death|2|||
44487854|NCT00448019|79494152|FG000|Overall Study|Insurance Issues|1|||
44487855|NCT00457691|79494158|FG000|Overall Study|Adverse Event|4|||
44545235|NCT02908074|79558980|FG001|Overall Study|Protocol Violation|1|||
44545236|NCT02908074|79558981|FG002|Overall Study|Protocol Violation|0|||
44545237|NCT02908074|79558982|FG003|Overall Study|Protocol Violation|0|||
44545238|NCT02908074|79558983|FG004|Overall Study|Protocol Violation|0|||
44545239|NCT02908074|79558984|FG005|Overall Study|Protocol Violation|0|||
44545240|NCT02908074|79558979|FG000|Overall Study|Adverse Event|5|||
44545241|NCT02908074|79558980|FG001|Overall Study|Adverse Event|2|||
44545242|NCT02908074|79558981|FG002|Overall Study|Adverse Event|0|||
44228730|NCT01589185|79036263|FG002|Overall Study|Death|2|||
44228731|NCT01589185|79036264|FG003|Overall Study|Death|0|||
44487856|NCT00457691|79494159|FG001|Overall Study|Adverse Event|1|||
44487857|NCT00457691|79494158|FG000|Overall Study|Death|163|||
44487858|NCT00457691|79494159|FG001|Overall Study|Death|148|||
44228732|NCT01589185|79036265|FG004|Overall Study|Death|1|||
44545243|NCT02908074|79558982|FG003|Overall Study|Adverse Event|0|||
44545244|NCT02908074|79558983|FG004|Overall Study|Adverse Event|1|||
44545245|NCT02908074|79558984|FG005|Overall Study|Adverse Event|0|||
44545246|NCT02908074|79558979|FG000|Overall Study|AESI|1|||
44545247|NCT02908074|79558980|FG001|Overall Study|AESI|0|||
44545248|NCT02908074|79558981|FG002|Overall Study|AESI|1|||
44545249|NCT02908074|79558982|FG003|Overall Study|AESI|0|||
44545250|NCT02908074|79558983|FG004|Overall Study|AESI|1|||
44545251|NCT02908074|79558984|FG005|Overall Study|AESI|0|||
44545252|NCT02908074|79558979|FG000|Overall Study|Discontinuation criteria per protocol|0|||
44545253|NCT02908074|79558980|FG001|Overall Study|Discontinuation criteria per protocol|0|||
44545254|NCT02908074|79558981|FG002|Overall Study|Discontinuation criteria per protocol|1|||
44545255|NCT02908074|79558982|FG003|Overall Study|Discontinuation criteria per protocol|0|||
44545256|NCT02908074|79558983|FG004|Overall Study|Discontinuation criteria per protocol|0|||
44545257|NCT02908074|79558984|FG005|Overall Study|Discontinuation criteria per protocol|1|||
44545258|NCT02908074|79558979|FG000|Overall Study|Withdrawal by Subject|3|||
44545259|NCT02908074|79558980|FG001|Overall Study|Withdrawal by Subject|2|||
44545260|NCT02908074|79558981|FG002|Overall Study|Withdrawal by Subject|2|||
44545261|NCT02908074|79558982|FG003|Overall Study|Withdrawal by Subject|2|||
44545262|NCT02908074|79558983|FG004|Overall Study|Withdrawal by Subject|2|||
44545263|NCT02908074|79558984|FG005|Overall Study|Withdrawal by Subject|2|||
44545264|NCT02908074|79558979|FG000|Overall Study|Lost to Follow-up|0|||
44545265|NCT02908074|79558980|FG001|Overall Study|Lost to Follow-up|1|||
44545266|NCT02908074|79558981|FG002|Overall Study|Lost to Follow-up|1|||
44545267|NCT02908074|79558982|FG003|Overall Study|Lost to Follow-up|1|||
44545268|NCT02908074|79558983|FG004|Overall Study|Lost to Follow-up|0|||
44545269|NCT02908074|79558984|FG005|Overall Study|Lost to Follow-up|1|||
44545270|NCT02907359|79559003|FG000|Overall Study|Death|234|||
44545271|NCT02907359|79559004|FG001|Overall Study|Death|117|||
44545272|NCT02907359|79559003|FG000|Overall Study|Withdrawal by Subject|6|||
44545273|NCT02907359|79559004|FG001|Overall Study|Withdrawal by Subject|11|||
44545274|NCT02907359|79559003|FG000|Overall Study|Lost to Follow-up|1|||
44545275|NCT02907359|79559004|FG001|Overall Study|Lost to Follow-up|0|||
44545276|NCT02714205|79559012|FG000|Overall Study|Cannot tolerate medication|1|||
44545277|NCT02714205|79559013|FG001|Overall Study|Cannot tolerate medication|0|||
44545278|NCT02714205|79559012|FG000|Overall Study|Adverse Event|2|||
44545279|NCT02714205|79559013|FG001|Overall Study|Adverse Event|0|||
44545280|NCT02714205|79559012|FG000|Overall Study|Too busy|1|||
44487859|NCT00457691|79494158|FG000|Overall Study|Protocol Violation|1|||
44487860|NCT00457691|79494159|FG001|Overall Study|Protocol Violation|3|||
44487861|NCT00457691|79494158|FG000|Overall Study|Lost to Follow-up|23|||
44487862|NCT00457691|79494159|FG001|Overall Study|Lost to Follow-up|14|||
44487863|NCT00457691|79494158|FG000|Overall Study|Study terminated by Sponsor|1|||
44487864|NCT00457691|79494159|FG001|Overall Study|Study terminated by Sponsor|1|||
44487865|NCT00457691|79494158|FG000|Overall Study|Subject refused (reason other than AE)|14|||
44487866|NCT00457691|79494159|FG001|Overall Study|Subject refused (reason other than AE)|19|||
44487867|NCT00457691|79494158|FG000|Overall Study|Disease progression, study terminated|180|||
44487868|NCT00457691|79494159|FG001|Overall Study|Disease progression, study terminated|196|||
44487869|NCT00457301|79494167|FG000|Overall Study|Withdrawal by Subject|3|||
44487870|NCT00457301|79494168|FG001|Overall Study|Withdrawal by Subject|3|||
44487871|NCT00457301|79494167|FG000|Overall Study|Censored out of the study|15|||
44487872|NCT00457301|79494168|FG001|Overall Study|Censored out of the study|14|||
44487873|NCT00457301|79494167|FG000|Overall Study|Death|5|||
44487874|NCT00457301|79494168|FG001|Overall Study|Death|7|||
44487875|NCT00456755|79494176|FG000|Overall Study|Lost to Follow-up|2|||
44545281|NCT02714205|79559013|FG001|Overall Study|Too busy|0|||
44487876|NCT00456755|79494177|FG001|Overall Study|Lost to Follow-up|1|||
44487877|NCT00447005|79494183|FG000|Overall Study|Adverse Event|1|||
44487878|NCT00447005|79494183|FG000|Overall Study|Lack of Efficacy|11|||
44487879|NCT00446849|79494187|FG000|Acute Phase|Lack of Efficacy|64|||
44545282|NCT02714205|79559012|FG000|Overall Study|Incomplete outcome data|0|||
44545283|NCT02714205|79559013|FG001|Overall Study|Incomplete outcome data|1|||
44545284|NCT00583752|79559037|FG000|Overall Study|Lost to Follow-up|5|||
44545285|NCT00583752|79559038|FG001|Overall Study|Lost to Follow-up|5|||
44545286|NCT03170154|79559056|FG000|Overall Study|Lost to Follow-up|4|||
44487880|NCT00446849|79494187|FG000|Acute Phase|Protocol Violation|10|||
44228733|NCT01589185|79036261|FG000|Overall Study|Lost to Follow-up|1|||
44487881|NCT00446849|79494187|FG000|Acute Phase|Consent withdrawn|4|||
44487882|NCT00446849|79494187|FG000|Acute Phase|Lost to Follow-up|2|||
44487883|NCT00446849|79494187|FG000|Acute Phase|Physician Decision|1|||
44487884|NCT00446849|79494187|FG000|Acute Phase|noncompliance|1|||
44487885|NCT00446849|79494187|FG000|Maintenance Phase|Lack of Efficacy|40|||
44487886|NCT00446849|79494187|FG000|Maintenance Phase|Protocol Violation|7|||
44487887|NCT00446849|79494187|FG000|Maintenance Phase|Adverse Event|6|||
44487888|NCT00446849|79494187|FG000|Maintenance Phase|Consent withdrawn|5|||
44487889|NCT00446849|79494187|FG000|Maintenance Phase|Lost to Follow-up|3|||
44487890|NCT00446849|79494187|FG000|Maintenance Phase|Pregnancy|1|||
44487891|NCT00446849|79494187|FG000|Maintenance Phase|noncompliance|2|||
44487892|NCT00446849|79494187|FG000|Maintenance Phase|prohibited medication use|2|||
44487893|NCT00446849|79494187|FG000|Maintenance Phase|antibiotic use|1|||
44487894|NCT00446849|79494187|FG000|Maintenance Phase|study closure|1|||
44487895|NCT00446849|79494187|FG000|Maintenance Phase|hydrocodone use|1|||
44487896|NCT00446849|79494187|FG000|Maintenance Phase|concomitant medication use|1|||
44487897|NCT00446459|79494192|FG000|8 Months|Protocol Violation|12|||
44487898|NCT00446459|79494192|FG000|12 Months|Protocol Violation|4|||
44487899|NCT00446459|79494192|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
44487900|NCT00456599|79494196|FG000|Overall Study|Non-compliance|1|||
44487901|NCT00456599|79494196|FG000|Overall Study|Withdrawal by Subject|2|||
44487902|NCT00456521|79494202|FG000|Overall Study|Adverse Event|150|||
44487903|NCT00456521|79494203|FG001|Overall Study|Adverse Event|25|||
44487904|NCT00456521|79494202|FG000|Overall Study|Withdrawal by Subject|43|||
44487905|NCT00456521|79494203|FG001|Overall Study|Withdrawal by Subject|24|||
44487906|NCT00456521|79494202|FG000|Overall Study|Lost to Follow-up|22|||
44487907|NCT00456521|79494203|FG001|Overall Study|Lost to Follow-up|17|||
44487908|NCT00456521|79494202|FG000|Overall Study|Lack of Efficacy|3|||
44487909|NCT00456521|79494203|FG001|Overall Study|Lack of Efficacy|6|||
44487910|NCT00456521|79494202|FG000|Overall Study|Protocol Violation|4|||
44487911|NCT00456521|79494203|FG001|Overall Study|Protocol Violation|0|||
44487912|NCT00456521|79494202|FG000|Overall Study|Pregnancy|1|||
44487913|NCT00456521|79494203|FG001|Overall Study|Pregnancy|1|||
44487914|NCT00456521|79494202|FG000|Overall Study|Drug non-compliance, moved, other|26|||
44487915|NCT00456521|79494203|FG001|Overall Study|Drug non-compliance, moved, other|11|||
44487916|NCT00456365|79494212|FG000|Overall Study|Lost to Follow-up|1|||
44487917|NCT00456365|79494213|FG001|Overall Study|Lost to Follow-up|3|||
44487918|NCT00456365|79494212|FG000|Overall Study|Withdrawal by Subject|4|||
44487919|NCT00456365|79494213|FG001|Overall Study|Withdrawal by Subject|7|||
44487920|NCT00456365|79494212|FG000|Overall Study|Pregnancy|1|||
44487921|NCT00456365|79494213|FG001|Overall Study|Pregnancy|1|||
44487922|NCT00456365|79494212|FG000|Overall Study|oncologic diagnosis|1|||
44487923|NCT00456365|79494213|FG001|Overall Study|oncologic diagnosis|1|||
44487924|NCT00455741|79494223|FG000|Overall Study|Physician Decision|0|||
44487925|NCT00455741|79494224|FG001|Overall Study|Physician Decision|1|||
44487926|NCT00445679|79494244|FG000|Overall Study|Adverse Event|22|||
44487927|NCT00445679|79494245|FG001|Overall Study|Adverse Event|12|||
44487928|NCT00445679|79494246|FG002|Overall Study|Adverse Event|30|||
44487929|NCT00445679|79494247|FG003|Overall Study|Adverse Event|19|||
44487930|NCT00445679|79494244|FG000|Overall Study|Failed to return|1|||
44487931|NCT00445679|79494245|FG001|Overall Study|Failed to return|3|||
44487932|NCT00445679|79494246|FG002|Overall Study|Failed to return|2|||
44487933|NCT00445679|79494247|FG003|Overall Study|Failed to return|2|||
44487934|NCT00445679|79494244|FG000|Overall Study|Physician Decision|0|||
44487935|NCT00445679|79494245|FG001|Overall Study|Physician Decision|0|||
44487936|NCT00445679|79494246|FG002|Overall Study|Physician Decision|1|||
44487937|NCT00445679|79494247|FG003|Overall Study|Physician Decision|0|||
44487938|NCT00445679|79494244|FG000|Overall Study|Lost to Follow-up|10|||
44487939|NCT00445679|79494245|FG001|Overall Study|Lost to Follow-up|6|||
44487940|NCT00445679|79494246|FG002|Overall Study|Lost to Follow-up|6|||
44487941|NCT00445679|79494247|FG003|Overall Study|Lost to Follow-up|5|||
44487942|NCT00445679|79494244|FG000|Overall Study|Compliance|3|||
44487943|NCT00445679|79494245|FG001|Overall Study|Compliance|2|||
44487944|NCT00445679|79494246|FG002|Overall Study|Compliance|1|||
44487945|NCT00445679|79494247|FG003|Overall Study|Compliance|2|||
44487946|NCT00445679|79494244|FG000|Overall Study|Withdrawal of Informed Consent|0|||
44487947|NCT00445679|79494245|FG001|Overall Study|Withdrawal of Informed Consent|0|||
44487948|NCT00445679|79494246|FG002|Overall Study|Withdrawal of Informed Consent|1|||
44487949|NCT00445679|79494247|FG003|Overall Study|Withdrawal of Informed Consent|0|||
44487950|NCT00445679|79494244|FG000|Overall Study|Protocol Violation|2|||
44487951|NCT00445679|79494245|FG001|Overall Study|Protocol Violation|3|||
44487952|NCT00445679|79494246|FG002|Overall Study|Protocol Violation|3|||
44487953|NCT00445679|79494247|FG003|Overall Study|Protocol Violation|1|||
44487954|NCT00445679|79494244|FG000|Overall Study|Withdrawal by Subject|8|||
44487955|NCT00445679|79494245|FG001|Overall Study|Withdrawal by Subject|14|||
44487956|NCT00445679|79494246|FG002|Overall Study|Withdrawal by Subject|20|||
44487957|NCT00445679|79494247|FG003|Overall Study|Withdrawal by Subject|18|||
44487958|NCT00445679|79494244|FG000|Overall Study|Lack of Efficacy|2|||
44487959|NCT00445679|79494245|FG001|Overall Study|Lack of Efficacy|6|||
44487960|NCT00445679|79494246|FG002|Overall Study|Lack of Efficacy|2|||
44487961|NCT00445679|79494247|FG003|Overall Study|Lack of Efficacy|0|||
44487962|NCT00455429|79494261|FG000|Overall Study|Study Terminated by Sponsor|0|||
44487963|NCT00455429|79494262|FG001|Overall Study|Study Terminated by Sponsor|0|||
44487964|NCT00455429|79494263|FG002|Overall Study|Study Terminated by Sponsor|0|||
44487965|NCT00455429|79494264|FG003|Overall Study|Study Terminated by Sponsor|3|||
44487966|NCT00455429|79494261|FG000|Overall Study|Lost to Follow-up|1|||
44487967|NCT00455429|79494262|FG001|Overall Study|Lost to Follow-up|0|||
44487968|NCT00455429|79494263|FG002|Overall Study|Lost to Follow-up|0|||
44487969|NCT00455429|79494264|FG003|Overall Study|Lost to Follow-up|3|||
44487970|NCT00455429|79494261|FG000|Overall Study|Withdrawal by Subject|0|||
44487971|NCT00455429|79494262|FG001|Overall Study|Withdrawal by Subject|1|||
44487972|NCT00455429|79494263|FG002|Overall Study|Withdrawal by Subject|1|||
44487973|NCT00455429|79494264|FG003|Overall Study|Withdrawal by Subject|0|||
44487974|NCT00455429|79494261|FG000|Overall Study|Lack of Efficacy|0|||
44487975|NCT00455429|79494262|FG001|Overall Study|Lack of Efficacy|1|||
44487976|NCT00455429|79494263|FG002|Overall Study|Lack of Efficacy|0|||
44487977|NCT00455429|79494264|FG003|Overall Study|Lack of Efficacy|1|||
44487978|NCT00455429|79494261|FG000|Overall Study|Adverse Event|0|||
44487979|NCT00455429|79494262|FG001|Overall Study|Adverse Event|1|||
44487980|NCT00455429|79494263|FG002|Overall Study|Adverse Event|0|||
44487981|NCT00455429|79494264|FG003|Overall Study|Adverse Event|3|||
44487982|NCT00455429|79494261|FG000|Overall Study|Randomly assigned but not treated|0|||
44487983|NCT00455429|79494262|FG001|Overall Study|Randomly assigned but not treated|0|||
44487984|NCT00455429|79494263|FG002|Overall Study|Randomly assigned but not treated|0|||
44487985|NCT00455429|79494264|FG003|Overall Study|Randomly assigned but not treated|2|||
44487986|NCT00455429|79494261|FG000|Overall Study|Personal Reason|1|||
44487987|NCT00455429|79494262|FG001|Overall Study|Personal Reason|0|||
44487988|NCT00455429|79494263|FG002|Overall Study|Personal Reason|0|||
44487989|NCT00455429|79494264|FG003|Overall Study|Personal Reason|0|||
44487990|NCT00455429|79494261|FG000|Overall Study|Non-compliance|0|||
44487991|NCT00455429|79494262|FG001|Overall Study|Non-compliance|0|||
44487992|NCT00455429|79494263|FG002|Overall Study|Non-compliance|0|||
44487993|NCT00455429|79494264|FG003|Overall Study|Non-compliance|1|||
44487994|NCT00455429|79494261|FG000|Overall Study|Other|0|||
44487995|NCT00455429|79494262|FG001|Overall Study|Other|2|||
44487996|NCT00455429|79494263|FG002|Overall Study|Other|0|||
44487997|NCT00455429|79494264|FG003|Overall Study|Other|1|||
44487998|NCT00445601|79494279|FG000|Overall Study|Withdrawal by Subject|11|||
44487999|NCT00445601|79494280|FG001|Overall Study|Withdrawal by Subject|11|||
44488000|NCT00445601|79494279|FG000|Overall Study|TURBT Complication|12|||
44488001|NCT00445601|79494280|FG001|Overall Study|TURBT Complication|8|||
44488002|NCT00445601|79494279|FG000|Overall Study|Incorrect Disease Status|6|||
44488003|NCT00445601|79494280|FG001|Overall Study|Incorrect Disease Status|6|||
44545287|NCT03170154|79559056|FG000|Overall Study|Death|2|||
44545288|NCT03170154|79559056|FG000|Overall Study|Withdrawal by Subject|2|||
44375736|NCT00594568|79380843|FG002|Delayed Start|Adverse Event|2|||
44375737|NCT00594568|79380841|FG000|Delayed Start|Withdrawal by Subject|4|||
44488004|NCT00445601|79494279|FG000|Overall Study|Drug Delivery Issue|2|||
44488005|NCT00445601|79494280|FG001|Overall Study|Drug Delivery Issue|2|||
44488006|NCT00445601|79494279|FG000|Overall Study|Adverse Event|2|||
44488007|NCT00445601|79494280|FG001|Overall Study|Adverse Event|0|||
44488008|NCT00445601|79494279|FG000|Overall Study|Death prior to TURBT|0|||
44488009|NCT00445601|79494280|FG001|Overall Study|Death prior to TURBT|1|||
44488010|NCT00444587|79494292|FG000|Overall Study|Death|2|||
44488011|NCT00444587|79494293|FG001|Overall Study|Death|1|||
44488012|NCT00444587|79494292|FG000|Overall Study|Progression of the disease|73|||
44488013|NCT00444587|79494293|FG001|Overall Study|Progression of the disease|8|||
44488014|NCT00444587|79494292|FG000|Overall Study|Refused treatment/did not cooperate|4|||
44488015|NCT00444587|79494293|FG001|Overall Study|Refused treatment/did not cooperate|1|||
44488016|NCT00444587|79494292|FG000|Overall Study|Investigator decision|3|||
44488017|NCT00444587|79494293|FG001|Overall Study|Investigator decision|0|||
44488018|NCT00444587|79494292|FG000|Overall Study|Protocol Violation|1|||
44488019|NCT00444587|79494293|FG001|Overall Study|Protocol Violation|0|||
44488020|NCT00444587|79494292|FG000|Overall Study|Missing|0|||
44488021|NCT00444587|79494293|FG001|Overall Study|Missing|5|||
44488022|NCT00455195|79494303|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
44488023|NCT00455195|79494304|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
44488024|NCT00455195|79494303|FG000|Double-blind Study AGLU02704|Death|1|||
44488025|NCT00455195|79494304|FG001|Double-blind Study AGLU02704|Death|0|||
44488026|NCT00455195|79494303|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
44488027|NCT00455195|79494304|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
44488028|NCT00455195|79494303|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
44488029|NCT00455195|79494304|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
44488030|NCT00235716|79494314|FG000|Overall Study|Death|26|||
44488031|NCT00235716|79494315|FG001|Overall Study|Death|39|||
44488032|NCT00235716|79494316|FG002|Overall Study|Death|32|||
44488033|NCT00235716|79494317|FG003|Overall Study|Death|31|||
44488034|NCT00235716|79494314|FG000|Overall Study|Withdrawal by Subject|23|||
44488035|NCT00235716|79494315|FG001|Overall Study|Withdrawal by Subject|19|||
44488036|NCT00235716|79494316|FG002|Overall Study|Withdrawal by Subject|17|||
44488037|NCT00235716|79494317|FG003|Overall Study|Withdrawal by Subject|18|||
44488038|NCT00235716|79494314|FG000|Overall Study|Lost to Follow-up|12|||
44488039|NCT00235716|79494315|FG001|Overall Study|Lost to Follow-up|7|||
44488040|NCT00235716|79494316|FG002|Overall Study|Lost to Follow-up|14|||
44488041|NCT00235716|79494317|FG003|Overall Study|Lost to Follow-up|10|||
44488042|NCT00235716|79494314|FG000|Overall Study|Adverse Event|1|||
44488043|NCT00235716|79494315|FG001|Overall Study|Adverse Event|1|||
44488044|NCT00235716|79494316|FG002|Overall Study|Adverse Event|1|||
44488045|NCT00235716|79494317|FG003|Overall Study|Adverse Event|0|||
44488046|NCT00235716|79494314|FG000|Overall Study|Physician Decision|0|||
44488047|NCT00235716|79494315|FG001|Overall Study|Physician Decision|1|||
44488048|NCT00235716|79494316|FG002|Overall Study|Physician Decision|1|||
44488049|NCT00235716|79494317|FG003|Overall Study|Physician Decision|3|||
44488050|NCT00274742|79494333|FG000|Overall Study|Adverse Event|0|||
44488051|NCT00274742|79494334|FG001|Overall Study|Adverse Event|4|||
44488052|NCT00274742|79494335|FG002|Overall Study|Adverse Event|1|||
44228734|NCT01589185|79036262|FG001|Overall Study|Lost to Follow-up|0|||
44228735|NCT01589185|79036263|FG002|Overall Study|Lost to Follow-up|2|||
44228736|NCT01589185|79036264|FG003|Overall Study|Lost to Follow-up|3|||
44375738|NCT00594568|79380842|FG001|Delayed Start|Withdrawal by Subject|3|||
44375739|NCT00594568|79380843|FG002|Delayed Start|Withdrawal by Subject|0|||
44375740|NCT00594568|79380841|FG000|Delayed Start|Physician Decision|0|||
44488053|NCT00274742|79494336|FG003|Overall Study|Adverse Event|4|||
44488054|NCT00274742|79494337|FG004|Overall Study|Adverse Event|12|||
44375741|NCT00594568|79380842|FG001|Delayed Start|Physician Decision|0|||
44375742|NCT00594568|79380843|FG002|Delayed Start|Physician Decision|1|||
44375743|NCT00594568|79380841|FG000|Delayed Start|Lost to Follow-up|0|||
44375744|NCT00594568|79380842|FG001|Delayed Start|Lost to Follow-up|0|||
44375745|NCT00594568|79380843|FG002|Delayed Start|Lost to Follow-up|1|||
44375746|NCT00594568|79380841|FG000|Delayed Start|Caregiver Decision|5|||
44375747|NCT00594568|79380842|FG001|Delayed Start|Caregiver Decision|6|||
44375748|NCT00594568|79380843|FG002|Delayed Start|Caregiver Decision|2|||
44375749|NCT00594568|79380841|FG000|Delayed Start|Sponsor Decision|77|||
44375750|NCT00594568|79380842|FG001|Delayed Start|Sponsor Decision|66|||
44375751|NCT00594568|79380843|FG002|Delayed Start|Sponsor Decision|59|||
44375752|NCT00594568|79380841|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
44375753|NCT00594568|79380842|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
44375754|NCT00594568|79380843|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
44375755|NCT00594568|79380841|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
44375756|NCT00594568|79380842|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
44375757|NCT00594568|79380843|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
44375758|NCT00594568|79380841|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
44375759|NCT00594568|79380842|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
44375760|NCT00594568|79380843|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
44375761|NCT00594568|79380841|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
44375762|NCT00594568|79380842|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
44375763|NCT00594568|79380843|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
44375764|NCT00594568|79380841|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
44488055|NCT00274742|79494338|FG005|Overall Study|Adverse Event|3|||
44488056|NCT00274742|79494333|FG000|Overall Study|Lost to Follow-up|0|||
44488057|NCT00274742|79494334|FG001|Overall Study|Lost to Follow-up|0|||
44488058|NCT00274742|79494335|FG002|Overall Study|Lost to Follow-up|0|||
44488059|NCT00274742|79494336|FG003|Overall Study|Lost to Follow-up|0|||
44488060|NCT00274742|79494337|FG004|Overall Study|Lost to Follow-up|1|||
44488061|NCT00274742|79494338|FG005|Overall Study|Lost to Follow-up|0|||
44488062|NCT00274742|79494333|FG000|Overall Study|End of Study|0|||
44488063|NCT00274742|79494334|FG001|Overall Study|End of Study|0|||
44488064|NCT00274742|79494335|FG002|Overall Study|End of Study|0|||
44488065|NCT00274742|79494336|FG003|Overall Study|End of Study|1|||
44488066|NCT00274742|79494337|FG004|Overall Study|End of Study|0|||
44488067|NCT00274742|79494338|FG005|Overall Study|End of Study|0|||
44488068|NCT00274742|79494333|FG000|Overall Study|Disease Progression|0|||
44375765|NCT00594568|79380842|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
44375766|NCT00594568|79380843|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
44375767|NCT00594568|79380841|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
44488069|NCT00274742|79494334|FG001|Overall Study|Disease Progression|1|||
44488070|NCT00274742|79494335|FG002|Overall Study|Disease Progression|1|||
44488071|NCT00274742|79494336|FG003|Overall Study|Disease Progression|0|||
44488072|NCT00274742|79494337|FG004|Overall Study|Disease Progression|1|||
44488073|NCT00274742|79494338|FG005|Overall Study|Disease Progression|0|||
44488074|NCT00274742|79494333|FG000|Overall Study|Other|0|||
44488075|NCT00274742|79494334|FG001|Overall Study|Other|3|||
44488076|NCT00274742|79494335|FG002|Overall Study|Other|0|||
44488077|NCT00274742|79494336|FG003|Overall Study|Other|0|||
44488078|NCT00274742|79494337|FG004|Overall Study|Other|2|||
44488079|NCT00274742|79494338|FG005|Overall Study|Other|0|||
44488080|NCT00262314|79494358|FG000|Overall Study|Changing physicians|38|||
44488081|NCT00262314|79494358|FG000|Overall Study|Death|12|||
44488082|NCT00262314|79494358|FG000|Overall Study|Patient's decision|92|||
44488083|NCT00262314|79494358|FG000|Overall Study|Other|95|||
44488084|NCT00262314|79494358|FG000|Overall Study|Lost to Follow-up|70|||
44488085|NCT00262314|79494358|FG000|Overall Study|Administrative withdrawal|30|||
44488086|NCT00283400|79494366|FG000|Overall Study|Withdrawal by Subject|1|||
44488087|NCT00283400|79494367|FG001|Overall Study|Withdrawal by Subject|1|||
44488088|NCT00283400|79494368|FG002|Overall Study|Withdrawal by Subject|0|||
44488089|NCT00283400|79494369|FG003|Overall Study|Withdrawal by Subject|0|||
44488090|NCT00283400|79494366|FG000|Overall Study|Death|1|||
44488091|NCT00283400|79494367|FG001|Overall Study|Death|0|||
44488092|NCT00283400|79494368|FG002|Overall Study|Death|1|||
44488093|NCT00283400|79494369|FG003|Overall Study|Death|0|||
44488094|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
44488095|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
44488096|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
44488097|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
44488098|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
44488099|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
44488100|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
44488101|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
44488102|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
44488103|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
44488104|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Adverse Event|0|||
44488105|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Adverse Event|0|||
44488106|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Adverse Event|3|||
44488107|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Adverse Event|2|||
44488108|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Adverse Event|13|||
44488109|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
44488110|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
44488111|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
44488112|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
44488113|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
44488114|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Patient's wish|0|||
44488115|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Patient's wish|0|||
44488116|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Patient's wish|19|||
44488117|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Patient's wish|9|||
44488118|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Patient's wish|20|||
44488119|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
44488120|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
44488121|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
44375768|NCT00594568|79380842|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
44488122|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
44488123|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
44488124|NCT00444275|79494382|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
44488125|NCT00444275|79494383|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
44488126|NCT00444275|79494384|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
44488127|NCT00444275|79494385|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
44488128|NCT00444275|79494386|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
44488129|NCT00454805|79494403|FG000|Overall Study|Withdrawal by Subject|9|||
44488130|NCT00454805|79494404|FG001|Overall Study|Withdrawal by Subject|2|||
44488131|NCT00454805|79494403|FG000|Overall Study|Death|0|||
44488132|NCT00454805|79494404|FG001|Overall Study|Death|2|||
44488133|NCT00454805|79494403|FG000|Overall Study|Disease progression|16|||
44488134|NCT00454805|79494404|FG001|Overall Study|Disease progression|19|||
44488135|NCT00454805|79494403|FG000|Overall Study|In order to begin radiotherapy|1|||
44488136|NCT00454805|79494404|FG001|Overall Study|In order to begin radiotherapy|0|||
44488137|NCT00283244|79494413|FG000|Overall Study|Adverse Event|0|||
44488138|NCT00283244|79494414|FG001|Overall Study|Adverse Event|8|||
44488139|NCT00283244|79494415|FG002|Overall Study|Adverse Event|11|||
44488140|NCT00283244|79494413|FG000|Overall Study|Death|4|||
44488141|NCT00283244|79494414|FG001|Overall Study|Death|3|||
44488142|NCT00283244|79494415|FG002|Overall Study|Death|2|||
44488143|NCT00283244|79494413|FG000|Overall Study|Lack of Efficacy|8|||
44488144|NCT00283244|79494414|FG001|Overall Study|Lack of Efficacy|32|||
44488145|NCT00283244|79494415|FG002|Overall Study|Lack of Efficacy|26|||
44488146|NCT00283244|79494413|FG000|Overall Study|Withdrawal by Subject|1|||
44488147|NCT00283244|79494414|FG001|Overall Study|Withdrawal by Subject|2|||
44488148|NCT00283244|79494415|FG002|Overall Study|Withdrawal by Subject|2|||
44488149|NCT00283244|79494413|FG000|Overall Study|Physician Decision|0|||
44488150|NCT00283244|79494414|FG001|Overall Study|Physician Decision|0|||
44488151|NCT00283244|79494415|FG002|Overall Study|Physician Decision|1|||
44488152|NCT00283244|79494413|FG000|Overall Study|Medical illness (other complicating dz)|4|||
44488153|NCT00283244|79494414|FG001|Overall Study|Medical illness (other complicating dz)|3|||
44488154|NCT00283244|79494415|FG002|Overall Study|Medical illness (other complicating dz)|6|||
44488155|NCT00283244|79494413|FG000|Overall Study|Clinical deterioration|1|||
44488156|NCT00283244|79494414|FG001|Overall Study|Clinical deterioration|3|||
44488157|NCT00283244|79494415|FG002|Overall Study|Clinical deterioration|3|||
44488158|NCT00282464|79494426|FG000|Overall Study|Adverse Event|26|||
44488159|NCT00282464|79494427|FG001|Overall Study|Adverse Event|20|||
44488160|NCT00282464|79494426|FG000|Overall Study|Lack of Efficacy|8|||
44488161|NCT00282464|79494427|FG001|Overall Study|Lack of Efficacy|8|||
44488162|NCT00282464|79494426|FG000|Overall Study|Lost to Follow-up|10|||
44488163|NCT00282464|79494427|FG001|Overall Study|Lost to Follow-up|10|||
44488164|NCT00282464|79494426|FG000|Overall Study|Withdrawal by Subject|24|||
44488165|NCT00282464|79494427|FG001|Overall Study|Withdrawal by Subject|10|||
44488166|NCT00282464|79494426|FG000|Overall Study|laboratory abnormality|1|||
44488167|NCT00282464|79494427|FG001|Overall Study|laboratory abnormality|2|||
44488168|NCT00282464|79494426|FG000|Overall Study|Protocol Violation|0|||
44488169|NCT00282464|79494427|FG001|Overall Study|Protocol Violation|7|||
44488170|NCT00282464|79494426|FG000|Overall Study|Patient moved|1|||
44488171|NCT00282464|79494427|FG001|Overall Study|Patient moved|0|||
44488172|NCT00282464|79494426|FG000|Overall Study|patient non-compliant|3|||
44488173|NCT00282464|79494427|FG001|Overall Study|patient non-compliant|0|||
44488174|NCT00282464|79494426|FG000|Overall Study|patient no show|0|||
44488175|NCT00282464|79494427|FG001|Overall Study|patient no show|1|||
44488176|NCT00282464|79494426|FG000|Overall Study|patient incarcerated|0|||
44488177|NCT00282464|79494427|FG001|Overall Study|patient incarcerated|1|||
44488178|NCT00282464|79494426|FG000|Overall Study|family crisis|0|||
44488179|NCT00282464|79494427|FG001|Overall Study|family crisis|1|||
44488180|NCT00282464|79494426|FG000|Overall Study|dispensed wrong kit|0|||
44488181|NCT00282464|79494427|FG001|Overall Study|dispensed wrong kit|1|||
44488182|NCT00282464|79494426|FG000|Overall Study|dropped due to missed visits|0|||
44228737|NCT01589185|79036265|FG004|Overall Study|Lost to Follow-up|0|||
44488183|NCT00282464|79494427|FG001|Overall Study|dropped due to missed visits|1|||
44488184|NCT00273182|79494433|FG000|Overall Study|Death|450|||
44488185|NCT00273182|79494433|FG000|Overall Study|Lost to Follow-up|88|||
44488186|NCT00273182|79494433|FG000|Overall Study|Withdrawal by Subject|257|||
44488187|NCT00273182|79494433|FG000|Overall Study|Device/System Explant|154|||
44488188|NCT00273182|79494433|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
44488189|NCT00209274|79494440|FG000|Overall Study|Missed visit|3|||
44488190|NCT00209274|79494441|FG001|Overall Study|Missed visit|2|||
44488191|NCT00209274|79494440|FG000|Overall Study|Death|32|||
44488192|NCT00209274|79494441|FG001|Overall Study|Death|15|||
44488193|NCT00209274|79494440|FG000|Overall Study|Withdrawal by Subject|30|||
44375769|NCT00594568|79380843|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
44375770|NCT00875056|79380871|FG000|Overall Study|Adverse Event|6|||
44375771|NCT00875056|79380872|FG001|Overall Study|Adverse Event|1|||
44488194|NCT00209274|79494441|FG001|Overall Study|Withdrawal by Subject|15|||
44488195|NCT00209274|79494440|FG000|Overall Study|Randomized not treated (RNT)|6|||
44488196|NCT00209274|79494441|FG001|Overall Study|Randomized not treated (RNT)|15|||
44488197|NCT03841331|79494449|FG000|Overall Study|Withdrawal by Subject|4|||
44488198|NCT03841331|79494450|FG001|Overall Study|Withdrawal by Subject|9|||
44488199|NCT03841331|79494449|FG000|Overall Study|Lost to Follow-up|5|||
44488200|NCT03841331|79494450|FG001|Overall Study|Lost to Follow-up|1|||
44488201|NCT00262080|79494459|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
44488202|NCT00262080|79494460|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
44488203|NCT00262080|79494461|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
44488204|NCT00262080|79494459|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
44488205|NCT00262080|79494460|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
44375772|NCT00875056|79380873|FG002|Overall Study|Adverse Event|2|||
44375773|NCT00875056|79380871|FG000|Overall Study|Progressive Disease|14|||
44375774|NCT00875056|79380872|FG001|Overall Study|Progressive Disease|8|||
44375775|NCT00875056|79380873|FG002|Overall Study|Progressive Disease|3|||
44488206|NCT00262080|79494461|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
44488207|NCT00262080|79494459|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
44488208|NCT00262080|79494460|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
44488209|NCT00262080|79494461|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
44488210|NCT00262080|79494459|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
44488211|NCT00262080|79494460|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
44488212|NCT00262080|79494461|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
44488213|NCT00262080|79494459|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
44488214|NCT00262080|79494460|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
44488215|NCT00262080|79494461|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
44488216|NCT00262080|79494459|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
44488217|NCT00262080|79494460|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
44488218|NCT00262080|79494461|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
44488219|NCT00282308|79494471|FG000|Treatment Period|Lost to Follow-up|1|||
44488220|NCT00282308|79494472|FG001|Treatment Period|Lost to Follow-up|0|||
44488221|NCT00282308|79494473|FG002|Treatment Period|Lost to Follow-up|0|||
44488222|NCT00282308|79494471|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
44488223|NCT00282308|79494472|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
44488224|NCT00282308|79494473|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
44488225|NCT00282308|79494471|FG000|Treatment Period|Adverse Event|0|||
44488226|NCT00282308|79494472|FG001|Treatment Period|Adverse Event|2|||
44488227|NCT00282308|79494473|FG002|Treatment Period|Adverse Event|0|||
44488228|NCT00282308|79494471|FG000|Treatment Period|Not Treated with Study Drug|1|||
44488229|NCT00282308|79494472|FG001|Treatment Period|Not Treated with Study Drug|0|||
44488230|NCT00282308|79494473|FG002|Treatment Period|Not Treated with Study Drug|0|||
44488231|NCT00282308|79494471|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
44488232|NCT00282308|79494472|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
44488233|NCT00282308|79494473|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
44488234|NCT00282308|79494471|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
44488235|NCT00282308|79494472|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
44488236|NCT00282308|79494473|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
44488237|NCT00282308|79494471|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
44488238|NCT00282308|79494472|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
44488239|NCT00282308|79494473|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
44488240|NCT00282308|79494471|FG000|Safety Follow-up Period|Adverse Event|0|||
44375776|NCT00875056|79380871|FG000|Overall Study|Withdrawal by Subject|3|||
44375777|NCT00875056|79380872|FG001|Overall Study|Withdrawal by Subject|0|||
44375778|NCT00875056|79380873|FG002|Overall Study|Withdrawal by Subject|1|||
44375779|NCT00940602|79380883|FG000|Overall Study|Administrative problems|1|||
44375780|NCT00940602|79380884|FG001|Overall Study|Administrative problems|1|||
44375781|NCT00940602|79380883|FG000|Overall Study|Patient/guardian decision|13|||
44488241|NCT00282308|79494472|FG001|Safety Follow-up Period|Adverse Event|0|||
44488242|NCT00282308|79494473|FG002|Safety Follow-up Period|Adverse Event|1|||
44488243|NCT00282308|79494471|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
44488244|NCT00282308|79494472|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
44488245|NCT00282308|79494473|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
44488246|NCT00282308|79494471|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
44488247|NCT00282308|79494472|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
44488248|NCT00282308|79494473|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
44488249|NCT00282308|79494471|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
44488250|NCT00282308|79494472|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
44488251|NCT00282308|79494473|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
44488252|NCT00282152|79494485|FG000|Overall Study|Withdrawal by Subject|1|||
44488253|NCT00282152|79494486|FG001|Overall Study|Withdrawal by Subject|0|||
44488254|NCT00281840|79494493|FG000|Overall Study|Adverse Event|12|||
44488255|NCT00281840|79494493|FG000|Overall Study|Physician Decision|6|||
44488256|NCT00281840|79494493|FG000|Overall Study|Withdrawal by Subject|3|||
44488257|NCT00281840|79494493|FG000|Overall Study|Disease Progression|2|||
44488258|NCT00281840|79494493|FG000|Overall Study|exceed maximum delay in treatment|1|||
44488259|NCT00281840|79494493|FG000|Overall Study|Complicating Disease|1|||
44488260|NCT00281684|79494502|FG000|Overall Study|Lost to Follow-up|0|||
44488261|NCT00281684|79494503|FG001|Overall Study|Lost to Follow-up|0|||
44488262|NCT00281684|79494504|FG002|Overall Study|Lost to Follow-up|1|||
44488263|NCT00281684|79494505|FG003|Overall Study|Lost to Follow-up|0|||
44488264|NCT00281684|79494502|FG000|Overall Study|Withdrawal by Subject|1|||
44488265|NCT00281684|79494503|FG001|Overall Study|Withdrawal by Subject|0|||
44488266|NCT00281684|79494504|FG002|Overall Study|Withdrawal by Subject|0|||
44488267|NCT00281684|79494505|FG003|Overall Study|Withdrawal by Subject|0|||
44488268|NCT00272792|79494519|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
44488269|NCT00272792|79494520|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
44488270|NCT00272792|79494519|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
44488271|NCT00272792|79494520|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
44488272|NCT00272792|79494519|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
44488273|NCT00272792|79494520|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
44488274|NCT00272792|79494519|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
44488275|NCT00272792|79494520|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
44488276|NCT00048568|79494528|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
44488277|NCT00048568|79494529|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
44488278|NCT00048568|79494530|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
44488279|NCT00048568|79494528|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
44488280|NCT00048568|79494529|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
44488281|NCT00048568|79494530|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
44488282|NCT00048568|79494528|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
44488283|NCT00048568|79494529|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
44488284|NCT00048568|79494530|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
44488285|NCT00048568|79494528|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
44488286|NCT00048568|79494529|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
44488287|NCT00048568|79494530|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
44488288|NCT00048568|79494528|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
44488289|NCT00048568|79494529|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
44488290|NCT00048568|79494530|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
44488291|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|Death|1|||
44488292|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|Death|1|||
44488293|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|Death|0|||
44488294|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
44488295|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
44488296|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
44488297|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
44488298|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
44488299|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
44488300|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
44488301|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
44488302|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
44488303|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
44488304|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
44488305|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
44488306|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
44488307|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
44488308|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
44488309|NCT00048568|79494528|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
44488310|NCT00048568|79494529|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
44488311|NCT00048568|79494530|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
44488312|NCT00048568|79494528|FG000|Open-Label Period|Death|0|||
44488313|NCT00048568|79494529|FG001|Open-Label Period|Death|0|||
44488314|NCT00048568|79494530|FG002|Open-Label Period|Death|13|||
44488315|NCT00048568|79494528|FG000|Open-Label Period|Adverse Event|0|||
44488316|NCT00048568|79494529|FG001|Open-Label Period|Adverse Event|0|||
44488317|NCT00048568|79494530|FG002|Open-Label Period|Adverse Event|49|||
44488318|NCT00048568|79494528|FG000|Open-Label Period|Lack of Efficacy|0|||
44488319|NCT00048568|79494529|FG001|Open-Label Period|Lack of Efficacy|0|||
44488320|NCT00048568|79494530|FG002|Open-Label Period|Lack of Efficacy|32|||
44488321|NCT00048568|79494528|FG000|Open-Label Period|Withdrawal by Subject|0|||
44488322|NCT00048568|79494529|FG001|Open-Label Period|Withdrawal by Subject|0|||
44488323|NCT00048568|79494530|FG002|Open-Label Period|Withdrawal by Subject|26|||
44488324|NCT00048568|79494528|FG000|Open-Label Period|Pregnancy|0|||
44488325|NCT00048568|79494529|FG001|Open-Label Period|Pregnancy|0|||
44488326|NCT00048568|79494530|FG002|Open-Label Period|Pregnancy|5|||
44488327|NCT00048568|79494528|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
44488328|NCT00048568|79494529|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
44488329|NCT00048568|79494530|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
44488330|NCT00048568|79494528|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
44488331|NCT00048568|79494529|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
44488332|NCT00048568|79494530|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
44488333|NCT00048568|79494528|FG000|Open-Label Period|Unknown Reasons|0|||
44488334|NCT00048568|79494529|FG001|Open-Label Period|Unknown Reasons|0|||
44488335|NCT00048568|79494530|FG002|Open-Label Period|Unknown Reasons|25|||
44488336|NCT00048568|79494528|FG000|Open-Label Period|Lost to Follow-up|0|||
44488337|NCT00048568|79494529|FG001|Open-Label Period|Lost to Follow-up|0|||
44488338|NCT00048568|79494530|FG002|Open-Label Period|Lost to Follow-up|7|||
44488339|NCT00262002|79494558|FG000|Overall Study|Adverse Event|2|||
44488340|NCT00262002|79494559|FG001|Overall Study|Adverse Event|1|||
44488341|NCT00262002|79494560|FG002|Overall Study|Adverse Event|0|||
44488342|NCT00262002|79494561|FG003|Overall Study|Adverse Event|0|||
44488343|NCT00262002|79494562|FG004|Overall Study|Adverse Event|0|||
44488344|NCT00262002|79494563|FG005|Overall Study|Adverse Event|1|||
44488345|NCT00262002|79494564|FG006|Overall Study|Adverse Event|0|||
44488346|NCT00262002|79494558|FG000|Overall Study|Withdrawal by Subject|4|||
44488347|NCT00262002|79494559|FG001|Overall Study|Withdrawal by Subject|2|||
44488348|NCT00262002|79494560|FG002|Overall Study|Withdrawal by Subject|0|||
44488349|NCT00262002|79494561|FG003|Overall Study|Withdrawal by Subject|1|||
44488350|NCT00262002|79494562|FG004|Overall Study|Withdrawal by Subject|2|||
44488351|NCT00262002|79494563|FG005|Overall Study|Withdrawal by Subject|2|||
44488352|NCT00262002|79494564|FG006|Overall Study|Withdrawal by Subject|2|||
44488353|NCT00262002|79494558|FG000|Overall Study|Lost to Follow-up|2|||
44488354|NCT00262002|79494559|FG001|Overall Study|Lost to Follow-up|0|||
44488355|NCT00262002|79494560|FG002|Overall Study|Lost to Follow-up|0|||
44488356|NCT00262002|79494561|FG003|Overall Study|Lost to Follow-up|2|||
44488357|NCT00262002|79494562|FG004|Overall Study|Lost to Follow-up|0|||
44488358|NCT00262002|79494563|FG005|Overall Study|Lost to Follow-up|1|||
44488359|NCT00262002|79494564|FG006|Overall Study|Lost to Follow-up|0|||
44488360|NCT00262002|79494558|FG000|Overall Study|Inapropriate enrollment|0|||
44488361|NCT00262002|79494559|FG001|Overall Study|Inapropriate enrollment|1|||
44488362|NCT00262002|79494560|FG002|Overall Study|Inapropriate enrollment|0|||
44488363|NCT00262002|79494561|FG003|Overall Study|Inapropriate enrollment|0|||
44488364|NCT00262002|79494562|FG004|Overall Study|Inapropriate enrollment|0|||
44488365|NCT00262002|79494563|FG005|Overall Study|Inapropriate enrollment|0|||
44545289|NCT03518125|79559071|FG000|Overall Study|Lost to Follow-up|0|||
44488366|NCT00262002|79494564|FG006|Overall Study|Inapropriate enrollment|0|||
44488367|NCT00262002|79494558|FG000|Overall Study|Protocol Violation|3|||
44488368|NCT00262002|79494559|FG001|Overall Study|Protocol Violation|2|||
44488369|NCT00262002|79494560|FG002|Overall Study|Protocol Violation|0|||
44488370|NCT00262002|79494561|FG003|Overall Study|Protocol Violation|2|||
44488371|NCT00262002|79494562|FG004|Overall Study|Protocol Violation|5|||
44488372|NCT00262002|79494563|FG005|Overall Study|Protocol Violation|3|||
44488373|NCT00262002|79494564|FG006|Overall Study|Protocol Violation|2|||
44488374|NCT00262002|79494558|FG000|Overall Study|Unable to classify|0|||
44488375|NCT00262002|79494559|FG001|Overall Study|Unable to classify|0|||
44488376|NCT00262002|79494560|FG002|Overall Study|Unable to classify|0|||
44488377|NCT00262002|79494561|FG003|Overall Study|Unable to classify|0|||
44488378|NCT00262002|79494562|FG004|Overall Study|Unable to classify|0|||
44488379|NCT00262002|79494563|FG005|Overall Study|Unable to classify|0|||
44488380|NCT00262002|79494564|FG006|Overall Study|Unable to classify|2|||
44488381|NCT00281528|79494632|FG000|Overall Study|Progressive Disease|28|||
44488382|NCT00281528|79494633|FG001|Overall Study|Progressive Disease|18|||
44488383|NCT00281528|79494634|FG002|Overall Study|Progressive Disease|27|||
44488384|NCT00281528|79494632|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
44488385|NCT00281528|79494633|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
44488386|NCT00281528|79494634|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
44488387|NCT00281528|79494632|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
44488388|NCT00281528|79494633|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
44488389|NCT00281528|79494634|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
44488390|NCT00281528|79494632|FG000|Overall Study|Physician Decision|11|||
44488391|NCT00281528|79494633|FG001|Overall Study|Physician Decision|4|||
44488392|NCT00281528|79494634|FG002|Overall Study|Physician Decision|5|||
44488393|NCT00281528|79494632|FG000|Overall Study|Protocol Violation|1|||
44488394|NCT00281528|79494633|FG001|Overall Study|Protocol Violation|0|||
44488395|NCT00281528|79494634|FG002|Overall Study|Protocol Violation|1|||
44488396|NCT00281528|79494632|FG000|Overall Study|Withdrawal by Subject|5|||
44488397|NCT00281528|79494633|FG001|Overall Study|Withdrawal by Subject|5|||
44488398|NCT00281528|79494634|FG002|Overall Study|Withdrawal by Subject|7|||
44488399|NCT00281528|79494632|FG000|Overall Study|Other|6|||
44488400|NCT00281528|79494633|FG001|Overall Study|Other|3|||
44488401|NCT00281528|79494634|FG002|Overall Study|Other|5|||
44488402|NCT00280748|79494642|FG000|Overall Study|Decline in performance|3|||
44488403|NCT00280748|79494642|FG000|Overall Study|Extra-cranial disease progression|1|||
44488404|NCT00271856|79494648|FG000|Overall Study|Withdrawal by Subject|1|||
44488405|NCT00271856|79494649|FG001|Overall Study|Withdrawal by Subject|7|||
44488406|NCT00271856|79494648|FG000|Overall Study|Lost to Follow-up|10|||
44488407|NCT00271856|79494649|FG001|Overall Study|Lost to Follow-up|11|||
44488408|NCT00061048|79494655|FG000|Overall Study|Adverse Event|2|||
44488409|NCT00061048|79494655|FG000|Overall Study|disease progression|20|||
44488410|NCT00270998|79494662|FG000|3 Month Follow-up|Adverse Event|1|||
44488411|NCT00270998|79494663|FG001|3 Month Follow-up|Adverse Event|0|||
44488412|NCT00270998|79494664|FG002|3 Month Follow-up|Adverse Event|0|||
44488413|NCT00270998|79494662|FG000|3 Month Follow-up|Lack of Efficacy|1|||
44488414|NCT00270998|79494663|FG001|3 Month Follow-up|Lack of Efficacy|2|||
44488415|NCT00270998|79494664|FG002|3 Month Follow-up|Lack of Efficacy|1|||
44488416|NCT00270998|79494662|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
44488417|NCT00270998|79494663|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
44488418|NCT00270998|79494664|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
44488419|NCT00270998|79494662|FG000|3 Month Follow-up|Pessary did not fit|12|||
44488420|NCT00270998|79494663|FG001|3 Month Follow-up|Pessary did not fit|0|||
44488421|NCT00270998|79494664|FG002|3 Month Follow-up|Pessary did not fit|0|||
44488422|NCT00270998|79494662|FG000|3 Month Follow-up|Personal/family health|1|||
44488423|NCT00270998|79494663|FG001|3 Month Follow-up|Personal/family health|1|||
44488424|NCT00270998|79494664|FG002|3 Month Follow-up|Personal/family health|0|||
44488425|NCT00270998|79494662|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
44488426|NCT00270998|79494663|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
44488427|NCT00270998|79494664|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
44488428|NCT00270998|79494662|FG000|12 Month Follow-up|Lack of Efficacy|5|||
44488429|NCT00270998|79494663|FG001|12 Month Follow-up|Lack of Efficacy|4|||
44488430|NCT00270998|79494664|FG002|12 Month Follow-up|Lack of Efficacy|3|||
44488431|NCT00270998|79494662|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
44488432|NCT00270998|79494663|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
44488433|NCT00270998|79494664|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
44488434|NCT00270998|79494662|FG000|12 Month Follow-up|Pessary did not fit|1|||
44488435|NCT00270998|79494663|FG001|12 Month Follow-up|Pessary did not fit|0|||
44488436|NCT00270998|79494664|FG002|12 Month Follow-up|Pessary did not fit|0|||
44488437|NCT00270998|79494662|FG000|12 Month Follow-up|Personal/family health|0|||
44488438|NCT00270998|79494663|FG001|12 Month Follow-up|Personal/family health|5|||
44488439|NCT00270998|79494664|FG002|12 Month Follow-up|Personal/family health|1|||
44488440|NCT00270998|79494662|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
44488441|NCT00270998|79494663|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
44488442|NCT00270998|79494664|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
44488443|NCT00279812|79494680|FG000|Overall Study|Protocol Violation|1|||
44488444|NCT00279812|79494681|FG001|Overall Study|Protocol Violation|1|||
44488445|NCT00279812|79494682|FG002|Overall Study|Protocol Violation|0|||
44488446|NCT00279812|79494683|FG003|Overall Study|Protocol Violation|0|||
44488447|NCT00279812|79494684|FG004|Overall Study|Protocol Violation|1|||
44488448|NCT00279812|79494685|FG005|Overall Study|Protocol Violation|0|||
44488449|NCT00279812|79494680|FG000|Overall Study|Withdrawal by Subject|0|||
44488450|NCT00279812|79494681|FG001|Overall Study|Withdrawal by Subject|4|||
44488451|NCT00279812|79494682|FG002|Overall Study|Withdrawal by Subject|2|||
44488452|NCT00279812|79494683|FG003|Overall Study|Withdrawal by Subject|0|||
44488453|NCT00279812|79494684|FG004|Overall Study|Withdrawal by Subject|0|||
44488454|NCT00279812|79494685|FG005|Overall Study|Withdrawal by Subject|0|||
44488455|NCT00279812|79494680|FG000|Overall Study|Adverse Event|0|||
44488456|NCT00279812|79494681|FG001|Overall Study|Adverse Event|1|||
44488457|NCT00279812|79494682|FG002|Overall Study|Adverse Event|1|||
44488458|NCT00279812|79494683|FG003|Overall Study|Adverse Event|0|||
44488459|NCT00279812|79494684|FG004|Overall Study|Adverse Event|2|||
44488460|NCT00279812|79494685|FG005|Overall Study|Adverse Event|1|||
44488461|NCT00207714|79494704|FG000|Overall Study|Adverse Event|6|||
44488462|NCT00207714|79494705|FG001|Overall Study|Adverse Event|2|||
44488463|NCT00207714|79494706|FG002|Overall Study|Adverse Event|4|||
44488464|NCT00207714|79494707|FG003|Overall Study|Adverse Event|3|||
44488465|NCT00207714|79494708|FG004|Overall Study|Adverse Event|1|||
44488466|NCT00207714|79494704|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
44488467|NCT00207714|79494705|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44488468|NCT00207714|79494706|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
44488469|NCT00207714|79494707|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
44488470|NCT00207714|79494708|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
44488471|NCT00207714|79494704|FG000|Overall Study|Other|3|||
44488472|NCT00207714|79494705|FG001|Overall Study|Other|2|||
44488473|NCT00207714|79494706|FG002|Overall Study|Other|5|||
44488474|NCT00207714|79494707|FG003|Overall Study|Other|1|||
44488475|NCT00207714|79494708|FG004|Overall Study|Other|0|||
44488476|NCT00207090|79494727|FG000|Overall Study|Study drug toxicity|3|||
44488477|NCT00207090|79494727|FG000|Overall Study|Chest wall mass larger|1|||
44488478|NCT00207090|79494727|FG000|Overall Study|Disease progression/relapse|2|||
44488479|NCT00207090|79494727|FG000|Overall Study|Physician Decision|1|||
44488480|NCT00059332|79494738|FG000|Overall Study|Withdrawal by Subject|2|||
44488481|NCT00059332|79494739|FG001|Overall Study|Withdrawal by Subject|1|||
44488482|NCT00059332|79494738|FG000|Overall Study|Lost to Follow-up|1|||
44488483|NCT00059332|79494739|FG001|Overall Study|Lost to Follow-up|1|||
44488484|NCT00233454|79494745|FG000|Overall Study|Death|6|||
44488485|NCT00047320|79494749|FG000|Overall Study|Lack of Efficacy|8|||
44488486|NCT00047320|79494749|FG000|Overall Study|Lost to Follow-up|1|||
44488487|NCT00047320|79494749|FG000|Overall Study|Physician Decision|8|||
44488488|NCT00047320|79494749|FG000|Overall Study|Withdrawal by Subject|9|||
44488489|NCT00047320|79494749|FG000|Overall Study|Ineligible|2|||
44488490|NCT00233064|79494755|FG000|Overall Study|Lost to Follow-up|7|||
44488491|NCT00233064|79494756|FG001|Overall Study|Lost to Follow-up|7|||
44488492|NCT00233064|79494755|FG000|Overall Study|Withdrawal by Subject|5|||
44488493|NCT00233064|79494756|FG001|Overall Study|Withdrawal by Subject|3|||
44488494|NCT00233064|79494755|FG000|Overall Study|Death|0|||
44488495|NCT00233064|79494756|FG001|Overall Study|Death|1|||
44488496|NCT00233064|79494755|FG000|Overall Study|Relocation|0|||
44488497|NCT00233064|79494756|FG001|Overall Study|Relocation|1|||
44488498|NCT00233064|79494755|FG000|Overall Study|Protocol Violation|1|||
44488499|NCT00233064|79494756|FG001|Overall Study|Protocol Violation|0|||
44488500|NCT00233064|79494755|FG000|Overall Study|Moved to Dom. Republic|1|||
44488501|NCT00233064|79494756|FG001|Overall Study|Moved to Dom. Republic|0|||
44488502|NCT00268892|79494766|FG000|Overall Study|Adverse Event|14|||
44488503|NCT00268892|79494767|FG001|Overall Study|Adverse Event|17|||
44488504|NCT00268892|79494768|FG002|Overall Study|Adverse Event|20|||
44488505|NCT00268892|79494766|FG000|Overall Study|Lack of Efficacy|1|||
44488506|NCT00268892|79494767|FG001|Overall Study|Lack of Efficacy|3|||
44488507|NCT00268892|79494768|FG002|Overall Study|Lack of Efficacy|0|||
44488508|NCT00268892|79494766|FG000|Overall Study|Withdrawal by Subject|14|||
44488509|NCT00268892|79494767|FG001|Overall Study|Withdrawal by Subject|15|||
44488510|NCT00268892|79494768|FG002|Overall Study|Withdrawal by Subject|13|||
44488511|NCT00268892|79494766|FG000|Overall Study|Physician Decision|0|||
44488512|NCT00268892|79494767|FG001|Overall Study|Physician Decision|1|||
44488513|NCT00268892|79494768|FG002|Overall Study|Physician Decision|0|||
44488514|NCT00268892|79494766|FG000|Overall Study|Lost to Follow-up|5|||
44488515|NCT00268892|79494767|FG001|Overall Study|Lost to Follow-up|2|||
44488516|NCT00268892|79494768|FG002|Overall Study|Lost to Follow-up|4|||
44488517|NCT00268892|79494766|FG000|Overall Study|Protocol Violation|0|||
44545290|NCT03518125|79559072|FG001|Overall Study|Lost to Follow-up|2|||
44488518|NCT00268892|79494767|FG001|Overall Study|Protocol Violation|1|||
44488519|NCT00268892|79494768|FG002|Overall Study|Protocol Violation|0|||
44488520|NCT00268892|79494766|FG000|Overall Study|Disease Progression|1|||
44488521|NCT00268892|79494767|FG001|Overall Study|Disease Progression|1|||
44488522|NCT00268892|79494768|FG002|Overall Study|Disease Progression|0|||
44488523|NCT00268892|79494766|FG000|Overall Study|Trial Site Closed|4|||
44488524|NCT00268892|79494767|FG001|Overall Study|Trial Site Closed|2|||
44488525|NCT00268892|79494768|FG002|Overall Study|Trial Site Closed|2|||
44488526|NCT00206076|79494778|FG000|Overall Study|Physician Decision|2|||
44488527|NCT00206076|79494779|FG001|Overall Study|Physician Decision|0|||
44488528|NCT00206076|79494778|FG000|Overall Study|Withdrawal by Subject|1|||
44488529|NCT00206076|79494779|FG001|Overall Study|Withdrawal by Subject|1|||
44488530|NCT00278954|79494787|FG000|Overall Study|Adverse Event|3|||
44488531|NCT00278954|79494787|FG000|Overall Study|Lost to Follow-up|1|||
44488532|NCT00278954|79494787|FG000|Overall Study|Withdrawal by Subject|1|||
44488533|NCT00278564|79494791|FG000|Overall Study|Lack of Efficacy|4|||
44488534|NCT00268346|79494797|FG000|Overall Study|Adverse Event|0|||
44488535|NCT00268346|79494798|FG001|Overall Study|Adverse Event|1|||
44488536|NCT00268346|79494797|FG000|Overall Study|Death|0|||
44488537|NCT00268346|79494798|FG001|Overall Study|Death|1|||
44488538|NCT00268346|79494797|FG000|Overall Study|Withdrawal by Subject|0|||
44488539|NCT00268346|79494798|FG001|Overall Study|Withdrawal by Subject|1|||
44488540|NCT00203892|79494807|FG000|Overall Study|Physician Decision|1|||
44488541|NCT00203892|79494808|FG001|Overall Study|Physician Decision|2|||
44488542|NCT00203892|79494809|FG002|Overall Study|Physician Decision|0|||
44488543|NCT00203892|79494807|FG000|Overall Study|Death|1|||
44488544|NCT00203892|79494808|FG001|Overall Study|Death|0|||
44488545|NCT00203892|79494809|FG002|Overall Study|Death|0|||
44488546|NCT00250718|79494817|FG000|Overall Study|Death|1|||
44488547|NCT00250718|79494817|FG000|Overall Study|Adverse Event|1|||
44488548|NCT00250718|79494817|FG000|Overall Study|Withdrawal by Subject|1|||
44488549|NCT00276614|79494821|FG000|Overall Study|Progression of disease under study|3|||
44488550|NCT00276458|79494827|FG000|Overall Study|Adverse Event|0|||
44488551|NCT00276458|79494828|FG001|Overall Study|Adverse Event|2|||
44488552|NCT00276458|79494827|FG000|Overall Study|Lost to Follow-up|2|||
44488553|NCT00276458|79494828|FG001|Overall Study|Lost to Follow-up|2|||
44488554|NCT00276458|79494827|FG000|Overall Study|Protocol Violation|4|||
44488555|NCT00276458|79494828|FG001|Overall Study|Protocol Violation|3|||
44488556|NCT00276380|79494836|FG000|Overall Study|Adverse Event|5|||
44488557|NCT00276380|79494837|FG001|Overall Study|Adverse Event|3|||
44488558|NCT00276380|79494836|FG000|Overall Study|Lost to Follow-up|1|||
44488559|NCT00276380|79494837|FG001|Overall Study|Lost to Follow-up|1|||
44375782|NCT00940602|79380884|FG001|Overall Study|Patient/guardian decision|28|||
44488560|NCT00276380|79494836|FG000|Overall Study|Withdrawal by Subject|3|||
44488561|NCT00276380|79494837|FG001|Overall Study|Withdrawal by Subject|6|||
44488562|NCT00276380|79494836|FG000|Overall Study|Death|5|||
44488563|NCT00276380|79494837|FG001|Overall Study|Death|3|||
44488564|NCT00276380|79494836|FG000|Overall Study|Abnormal aPPT Levels|0|||
44488565|NCT00276380|79494837|FG001|Overall Study|Abnormal aPPT Levels|1|||
44514829|NCT03078556|79520658|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
44514830|NCT03078556|79520659|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
44488566|NCT00267956|79494846|FG000|Controlled Period|Adverse Event|4|||
44488567|NCT00267956|79494847|FG001|Controlled Period|Adverse Event|1|||
44488568|NCT00267956|79494848|FG002|Controlled Period|Adverse Event|0|||
44488569|NCT00267956|79494849|FG003|Controlled Period|Adverse Event|0|||
44488570|NCT00267956|79494846|FG000|Controlled Period|Lack of Efficacy|4|||
44488571|NCT00267956|79494847|FG001|Controlled Period|Lack of Efficacy|2|||
44488572|NCT00267956|79494848|FG002|Controlled Period|Lack of Efficacy|0|||
44488573|NCT00267956|79494849|FG003|Controlled Period|Lack of Efficacy|0|||
44488574|NCT00267956|79494846|FG000|Controlled Period|Lost to Follow-up|2|||
44488575|NCT00267956|79494847|FG001|Controlled Period|Lost to Follow-up|0|||
44488576|NCT00267956|79494848|FG002|Controlled Period|Lost to Follow-up|0|||
44488577|NCT00267956|79494849|FG003|Controlled Period|Lost to Follow-up|0|||
44488578|NCT00267956|79494846|FG000|Controlled Period|Withdrew consent|3|||
44488579|NCT00267956|79494847|FG001|Controlled Period|Withdrew consent|1|||
44488580|NCT00267956|79494848|FG002|Controlled Period|Withdrew consent|0|||
44488581|NCT00267956|79494849|FG003|Controlled Period|Withdrew consent|0|||
44488582|NCT00267956|79494846|FG000|After Controlled Period|Adverse Event|0|||
44488583|NCT00267956|79494847|FG001|After Controlled Period|Adverse Event|0|||
44488584|NCT00267956|79494848|FG002|After Controlled Period|Adverse Event|2|||
44488585|NCT00267956|79494849|FG003|After Controlled Period|Adverse Event|1|||
44488586|NCT00267956|79494846|FG000|After Controlled Period|Lack of Efficacy|0|||
44488587|NCT00267956|79494847|FG001|After Controlled Period|Lack of Efficacy|0|||
44488588|NCT00267956|79494848|FG002|After Controlled Period|Lack of Efficacy|1|||
44488589|NCT00267956|79494849|FG003|After Controlled Period|Lack of Efficacy|1|||
44488590|NCT00267956|79494846|FG000|After Controlled Period|Lost to Follow-up|0|||
44488591|NCT00267956|79494847|FG001|After Controlled Period|Lost to Follow-up|0|||
44488592|NCT00267956|79494848|FG002|After Controlled Period|Lost to Follow-up|1|||
44488593|NCT00267956|79494849|FG003|After Controlled Period|Lost to Follow-up|0|||
44488594|NCT00267956|79494846|FG000|After Controlled Period|Withdrew consent|0|||
44488595|NCT00267956|79494847|FG001|After Controlled Period|Withdrew consent|0|||
44488596|NCT00267956|79494848|FG002|After Controlled Period|Withdrew consent|1|||
44488597|NCT00267956|79494849|FG003|After Controlled Period|Withdrew consent|0|||
44488598|NCT00267488|79494857|FG000|Overall Study|Sponsor Terminated Study|9|||
44488599|NCT00267488|79494857|FG000|Overall Study|Protocol Violation|1|||
44488600|NCT00267488|79494857|FG000|Overall Study|Other (Disease Progression)|1|||
44488601|NCT00058552|79494863|FG000|Overall Study|Died prior to receiving treatment|4|||
44488602|NCT00058552|79494864|FG001|Overall Study|Died prior to receiving treatment|2|||
44488603|NCT00058552|79494863|FG000|Overall Study|Disease progression|52|||
44488604|NCT00058552|79494864|FG001|Overall Study|Disease progression|44|||
44488605|NCT00058552|79494863|FG000|Overall Study|Adverse Event|4|||
44488606|NCT00058552|79494864|FG001|Overall Study|Adverse Event|2|||
44488607|NCT00058552|79494863|FG000|Overall Study|Withdrawal by Subject|3|||
44488608|NCT00058552|79494864|FG001|Overall Study|Withdrawal by Subject|5|||
44488609|NCT00058552|79494863|FG000|Overall Study|Physician Decision|2|||
44488610|NCT00058552|79494864|FG001|Overall Study|Physician Decision|5|||
44488611|NCT00058552|79494863|FG000|Overall Study|Clinical disease progression|0|||
44488612|NCT00058552|79494864|FG001|Overall Study|Clinical disease progression|4|||
44488613|NCT00044512|79494872|FG000|Follow Up|Lost to Follow-up|2|||
44488614|NCT03805438|79494876|FG000|Overall Study|Lack of Efficacy|1|||
44488615|NCT03805438|79494876|FG000|Overall Study|Protocol Violation|1|||
44488616|NCT05369806|79494889|FG000|Overall Study|Lost to Follow-up|1|||
44488617|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
44488618|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
44488619|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
44488620|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
44488621|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
44488622|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
44488623|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
44488624|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
44488625|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44488626|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
44488627|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44488628|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
44488629|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
44488630|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44488631|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
44488632|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
44488633|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
44488634|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
44488635|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
44488636|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
44488637|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
44488638|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
44488639|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
44488640|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
44488641|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
44488642|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
44488643|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
44488644|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
44488645|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
44488646|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
44488647|NCT05195528|79494900|FG000|Placebo-controlled Treatment Period|Other|0|||
44488648|NCT05195528|79494901|FG001|Placebo-controlled Treatment Period|Other|0|||
44488649|NCT05195528|79494902|FG002|Placebo-controlled Treatment Period|Other|1|||
44488650|NCT05195528|79494903|FG003|Placebo-controlled Treatment Period|Other|0|||
44488651|NCT05195528|79494904|FG004|Placebo-controlled Treatment Period|Other|0|||
44488652|NCT05195528|79494900|FG000|Extension Period|PTE or AE or SAE|0|||
44488653|NCT05195528|79494901|FG001|Extension Period|PTE or AE or SAE|4|||
44488654|NCT05195528|79494902|FG002|Extension Period|PTE or AE or SAE|5|||
44488655|NCT05195528|79494903|FG003|Extension Period|PTE or AE or SAE|4|||
44488656|NCT05195528|79494904|FG004|Extension Period|PTE or AE or SAE|4|||
44488657|NCT05195528|79494900|FG000|Extension Period|Protocol Violation|0|||
44488658|NCT05195528|79494901|FG001|Extension Period|Protocol Violation|2|||
44488659|NCT05195528|79494902|FG002|Extension Period|Protocol Violation|1|||
44488660|NCT05195528|79494903|FG003|Extension Period|Protocol Violation|0|||
44488661|NCT05195528|79494904|FG004|Extension Period|Protocol Violation|1|||
44488662|NCT05195528|79494900|FG000|Extension Period|Lost to Follow-up|0|||
44488663|NCT05195528|79494901|FG001|Extension Period|Lost to Follow-up|6|||
44488664|NCT05195528|79494902|FG002|Extension Period|Lost to Follow-up|13|||
44375783|NCT00940602|79380883|FG000|Overall Study|Physician Decision|8|||
44375784|NCT00940602|79380884|FG001|Overall Study|Physician Decision|5|||
44488665|NCT05195528|79494903|FG003|Extension Period|Lost to Follow-up|3|||
44488666|NCT05195528|79494904|FG004|Extension Period|Lost to Follow-up|7|||
44488667|NCT05195528|79494900|FG000|Extension Period|Withdrawal by Subject|0|||
44488668|NCT05195528|79494901|FG001|Extension Period|Withdrawal by Subject|12|||
44488669|NCT05195528|79494902|FG002|Extension Period|Withdrawal by Subject|9|||
44488670|NCT05195528|79494903|FG003|Extension Period|Withdrawal by Subject|6|||
44488671|NCT05195528|79494904|FG004|Extension Period|Withdrawal by Subject|5|||
44488672|NCT05195528|79494900|FG000|Extension Period|Lack of Efficacy|0|||
44488673|NCT05195528|79494901|FG001|Extension Period|Lack of Efficacy|3|||
44488674|NCT05195528|79494902|FG002|Extension Period|Lack of Efficacy|0|||
44488675|NCT05195528|79494903|FG003|Extension Period|Lack of Efficacy|0|||
44488676|NCT05195528|79494904|FG004|Extension Period|Lack of Efficacy|2|||
44488677|NCT05195528|79494900|FG000|Extension Period|Not Treated|0|||
44488678|NCT05195528|79494901|FG001|Extension Period|Not Treated|0|||
44488679|NCT05195528|79494902|FG002|Extension Period|Not Treated|2|||
44488680|NCT05195528|79494903|FG003|Extension Period|Not Treated|3|||
44488681|NCT05195528|79494904|FG004|Extension Period|Not Treated|0|||
44488682|NCT05195528|79494900|FG000|Extension Period|Other|0|||
44488683|NCT05195528|79494901|FG001|Extension Period|Other|1|||
44488684|NCT05195528|79494902|FG002|Extension Period|Other|1|||
44488685|NCT05195528|79494903|FG003|Extension Period|Other|0|||
44488686|NCT05195528|79494904|FG004|Extension Period|Other|0|||
44488687|NCT05135156|79494918|FG000|Overall Study|Lost to Follow-up|0|||
44488688|NCT05135156|79494919|FG001|Overall Study|Lost to Follow-up|0|||
44488689|NCT05135156|79494920|FG002|Overall Study|Lost to Follow-up|2|||
44488690|NCT04956666|79494927|FG000|Overall Study|Adverse Event|18|||
44488691|NCT04956666|79494927|FG000|Overall Study|Physician Decision|5|||
44488692|NCT04738318|79494933|FG000|Overall Study|Protocol Violation|1|||
44488693|NCT04738318|79494934|FG001|Overall Study|Protocol Violation|0|||
44488694|NCT04726709|79494942|FG000|Overall Study|Withdrawal by Subject|2|||
44488695|NCT04726709|79494943|FG001|Overall Study|Withdrawal by Subject|2|||
44488696|NCT04684420|79494956|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
44488697|NCT04684420|79494957|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
44488698|NCT04684420|79494958|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
44488699|NCT04684420|79494959|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
44488700|NCT04684420|79494956|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
44488701|NCT04684420|79494957|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
44488702|NCT04684420|79494958|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
44488703|NCT04684420|79494959|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
44488704|NCT04352101|79494972|FG000|Overall Study|Physician Decision|2|||
44488705|NCT04352101|79494973|FG001|Overall Study|Physician Decision|1|||
44488706|NCT04208087|79494984|FG000|Overall Study|Adverse Event|1|||
44488707|NCT04208087|79494985|FG001|Overall Study|Adverse Event|0|||
44488708|NCT04208087|79494986|FG002|Overall Study|Adverse Event|0|||
44488709|NCT04208087|79494987|FG003|Overall Study|Adverse Event|0|||
44488710|NCT04208087|79494988|FG004|Overall Study|Adverse Event|0|||
44488711|NCT04208087|79494984|FG000|Overall Study|Withdrawal by Subject|0|||
44488712|NCT04208087|79494985|FG001|Overall Study|Withdrawal by Subject|0|||
44488713|NCT04208087|79494986|FG002|Overall Study|Withdrawal by Subject|1|||
44488714|NCT04208087|79494987|FG003|Overall Study|Withdrawal by Subject|0|||
44488715|NCT04208087|79494988|FG004|Overall Study|Withdrawal by Subject|0|||
44488716|NCT04208087|79494984|FG000|Overall Study|Other|0|||
44488717|NCT04208087|79494985|FG001|Overall Study|Other|0|||
44488718|NCT04208087|79494986|FG002|Overall Study|Other|0|||
44488719|NCT04208087|79494987|FG003|Overall Study|Other|0|||
44488720|NCT04208087|79494988|FG004|Overall Study|Other|1|||
44488721|NCT04140227|79494999|FG000|Overall Study|Withdrawal by Subject|26|||
44488722|NCT04140227|79494999|FG000|Overall Study|Lost to Follow-up|8|||
44488723|NCT04140227|79494999|FG000|Overall Study|Adverse Event|8|||
44488724|NCT04140227|79494999|FG000|Overall Study|Death|1|||
44488725|NCT04140227|79494999|FG000|Overall Study|Other|3|||
44488726|NCT04140227|79494999|FG000|Overall Study|Protocol Violation|2|||
44545291|NCT03518125|79559073|FG002|Overall Study|Lost to Follow-up|0|||
44545292|NCT03518125|79559074|FG003|Overall Study|Lost to Follow-up|0|||
44545293|NCT03518125|79559075|FG004|Overall Study|Lost to Follow-up|3|||
44375785|NCT00940602|79380883|FG000|Overall Study|Pregnancy|1|||
44375786|NCT00940602|79380884|FG001|Overall Study|Pregnancy|0|||
44375787|NCT00940602|79380883|FG000|Overall Study|Protocol Deviation (untreated)|1|||
44375788|NCT00940602|79380884|FG001|Overall Study|Protocol Deviation (untreated)|0|||
44375789|NCT00940602|79380883|FG000|Overall Study|Disease progression|8|||
44375790|NCT00940602|79380884|FG001|Overall Study|Disease progression|2|||
44375791|NCT00940602|79380883|FG000|Overall Study|Death|38|||
44375792|NCT00940602|79380884|FG001|Overall Study|Death|19|||
44375793|NCT00940602|79380883|FG000|Overall Study|Lost to Follow-up|3|||
44375794|NCT00940602|79380884|FG001|Overall Study|Lost to Follow-up|1|||
44375795|NCT00940602|79380883|FG000|Overall Study|Patient withdrew consent|26|||
44375796|NCT00940602|79380884|FG001|Overall Study|Patient withdrew consent|13|||
44375797|NCT00940602|79380883|FG000|Overall Study|Adverse Event|7|||
44375798|NCT00940602|79380884|FG001|Overall Study|Adverse Event|2|||
44375799|NCT00940602|79380883|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
44375800|NCT00940602|79380884|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
44375801|NCT00875524|79380893|FG000|Overall Study|Serious adverse event|0|||
44375802|NCT00875524|79380894|FG001|Overall Study|Serious adverse event|1|||
44375803|NCT00875524|79380893|FG000|Overall Study|Protocol Violation|4|||
44375804|NCT00875524|79380894|FG001|Overall Study|Protocol Violation|0|||
44488727|NCT03782259|79495005|FG000|Overall Study|Lost to Follow-up|1|||
44488728|NCT03782259|79495006|FG001|Overall Study|Lost to Follow-up|1|||
44488729|NCT03782259|79495005|FG000|Overall Study|Moved out of state|0|||
44488730|NCT03782259|79495006|FG001|Overall Study|Moved out of state|2|||
44488731|NCT03782259|79495005|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
44545294|NCT03518125|79559076|FG005|Overall Study|Lost to Follow-up|5|||
44488732|NCT03782259|79495006|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
44488733|NCT03782259|79495005|FG000|Overall Study|Subject discontinued intervention|1|||
44488734|NCT03782259|79495006|FG001|Overall Study|Subject discontinued intervention|0|||
44488735|NCT03743194|79495019|FG000|Overall Study|Protocol Violation|7|||
44488736|NCT03743194|79495020|FG001|Overall Study|Protocol Violation|7|||
44488737|NCT03743194|79495019|FG000|Overall Study|Physician Decision|0|||
44488738|NCT03743194|79495020|FG001|Overall Study|Physician Decision|2|||
44488739|NCT03461146|79495035|FG000|Overall Study|Adverse Event|2|||
44488740|NCT03461146|79495035|FG000|Overall Study|Physician Decision|1|||
44488741|NCT03460704|79495041|FG000|Overall Study|Withdrawal by Subject|11|||
44488742|NCT03460704|79495042|FG001|Overall Study|Withdrawal by Subject|14|||
44488743|NCT03460704|79495041|FG000|Overall Study|Study terminated by the Sponsor|29|||
44488744|NCT03460704|79495042|FG001|Overall Study|Study terminated by the Sponsor|19|||
44488745|NCT03460704|79495041|FG000|Overall Study|Adverse Event|10|||
44488746|NCT03460704|79495042|FG001|Overall Study|Adverse Event|5|||
44488747|NCT03460704|79495041|FG000|Overall Study|Death|3|||
44488748|NCT03460704|79495042|FG001|Overall Study|Death|2|||
44488749|NCT03460704|79495041|FG000|Overall Study|Non-Compliance with Study Drug|3|||
44488750|NCT03460704|79495042|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44488751|NCT03460704|79495041|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44488752|NCT03460704|79495042|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
44488753|NCT03460704|79495041|FG000|Overall Study|Other|2|||
44488754|NCT03460704|79495042|FG001|Overall Study|Other|1|||
44488755|NCT03430843|79495050|FG000|Overall Study|Death|233|||
44488756|NCT03430843|79495051|FG001|Overall Study|Death|233|||
44488757|NCT03430843|79495050|FG000|Overall Study|Sponsor Decision|17|||
44488758|NCT03430843|79495051|FG001|Overall Study|Sponsor Decision|6|||
44488759|NCT03430843|79495050|FG000|Overall Study|Withdrawal by Subject|5|||
44488760|NCT03430843|79495051|FG001|Overall Study|Withdrawal by Subject|14|||
44488761|NCT03430843|79495050|FG000|Overall Study|Lost to Follow-up|1|||
44488762|NCT03430843|79495051|FG001|Overall Study|Lost to Follow-up|3|||
44488763|NCT03382600|79495068|FG000|Overall Study|Adverse Event|3|||
44488764|NCT03382600|79495069|FG001|Overall Study|Adverse Event|3|||
44488765|NCT03382600|79495068|FG000|Overall Study|Clinical Disease Progression|2|||
44488766|NCT03382600|79495069|FG001|Overall Study|Clinical Disease Progression|4|||
44488767|NCT03382600|79495068|FG000|Overall Study|Radiological Progression|40|||
44488768|NCT03382600|79495069|FG001|Overall Study|Radiological Progression|31|||
44488769|NCT03382600|79495068|FG000|Overall Study|Withdrawal by Subject|0|||
44488770|NCT03382600|79495069|FG001|Overall Study|Withdrawal by Subject|1|||
44488771|NCT03382600|79495068|FG000|Overall Study|Other|9|||
44488772|NCT03382600|79495069|FG001|Overall Study|Other|7|||
44488773|NCT03207009|79495084|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
44488774|NCT02759861|79495088|FG000|Overall Study|Death|1|||
44488775|NCT02141074|79495118|FG000|Pre-prophylaxis|Adverse Event|3|||
44488776|NCT02141074|79495119|FG001|Pre-prophylaxis|Adverse Event|0|||
44488777|NCT02141074|79495118|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
44488778|NCT02141074|79495119|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
44488779|NCT02141074|79495118|FG000|Prophylaxis|Adverse Event|0|||
44488780|NCT02141074|79495119|FG001|Prophylaxis|Adverse Event|4|||
44488781|NCT02141074|79495118|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
44488782|NCT02141074|79495119|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
44488783|NCT02141074|79495118|FG000|Prophylaxis|Withdrawal by Subject|0|||
44488784|NCT02141074|79495119|FG001|Prophylaxis|Withdrawal by Subject|1|||
44488785|NCT01524705|79495129|FG000|Overall Study|Adverse Event|2|||
44488786|NCT01524705|79495130|FG001|Overall Study|Adverse Event|0|||
44488787|NCT01524705|79495129|FG000|Overall Study|Death|1|||
44488788|NCT01524705|79495130|FG001|Overall Study|Death|0|||
44488789|NCT01524705|79495129|FG000|Overall Study|Lost to Follow-up|0|||
44488790|NCT01524705|79495130|FG001|Overall Study|Lost to Follow-up|1|||
44488791|NCT01524705|79495129|FG000|Overall Study|Withdrawal by Subject|0|||
44488792|NCT01524705|79495130|FG001|Overall Study|Withdrawal by Subject|1|||
44488793|NCT01524705|79495129|FG000|Overall Study|Pancreatic Cancer|0|||
44488794|NCT01524705|79495130|FG001|Overall Study|Pancreatic Cancer|1|||
44488795|NCT01072539|79495142|FG000|Overall Study|Treated prior to the Site Initiation|1|||
44488796|NCT01072539|79495142|FG000|Overall Study|Protocol Violation|2|||
44488797|NCT00147537|79495150|FG000|Phase 1b|Death|0|||
44488798|NCT00147537|79495151|FG001|Phase 1b|Death|1|||
44488799|NCT00147537|79495152|FG002|Phase 1b|Death|2|||
44488800|NCT00147537|79495153|FG003|Phase 1b|Death|1|||
44488801|NCT00147537|79495154|FG004|Phase 1b|Death|2|||
44488802|NCT00147537|79495155|FG005|Phase 1b|Death|2|||
44488803|NCT00147537|79495156|FG006|Phase 1b|Death|1|||
44488804|NCT00147537|79495157|FG007|Phase 1b|Death|3|||
44488805|NCT00147537|79495158|FG008|Phase 1b|Death|9|||
44488806|NCT00147537|79495159|FG009|Phase 1b|Death|0|||
44488807|NCT00147537|79495160|FG010|Phase 1b|Death|0|||
44488808|NCT00147537|79495150|FG000|Phase 1b|Lost to Follow-up|2|||
44488809|NCT00147537|79495151|FG001|Phase 1b|Lost to Follow-up|1|||
44488810|NCT00147537|79495152|FG002|Phase 1b|Lost to Follow-up|0|||
44488811|NCT00147537|79495153|FG003|Phase 1b|Lost to Follow-up|0|||
44488812|NCT00147537|79495154|FG004|Phase 1b|Lost to Follow-up|0|||
44488813|NCT00147537|79495155|FG005|Phase 1b|Lost to Follow-up|0|||
44488814|NCT00147537|79495156|FG006|Phase 1b|Lost to Follow-up|2|||
44488815|NCT00147537|79495157|FG007|Phase 1b|Lost to Follow-up|0|||
44488816|NCT00147537|79495158|FG008|Phase 1b|Lost to Follow-up|1|||
44488817|NCT00147537|79495159|FG009|Phase 1b|Lost to Follow-up|0|||
44488818|NCT00147537|79495160|FG010|Phase 1b|Lost to Follow-up|0|||
44488819|NCT00147537|79495150|FG000|Phase 1b|Other|0|||
44488820|NCT00147537|79495151|FG001|Phase 1b|Other|0|||
44488821|NCT00147537|79495152|FG002|Phase 1b|Other|2|||
44488822|NCT00147537|79495153|FG003|Phase 1b|Other|1|||
44488823|NCT00147537|79495154|FG004|Phase 1b|Other|1|||
44488824|NCT00147537|79495155|FG005|Phase 1b|Other|1|||
44488825|NCT00147537|79495156|FG006|Phase 1b|Other|14|||
44488826|NCT00147537|79495157|FG007|Phase 1b|Other|4|||
44488827|NCT00147537|79495158|FG008|Phase 1b|Other|4|||
44488828|NCT00147537|79495159|FG009|Phase 1b|Other|0|||
44488829|NCT00147537|79495160|FG010|Phase 1b|Other|0|||
44488830|NCT00147537|79495150|FG000|Phase 1b|Withdrawal by Subject|0|||
44488831|NCT00147537|79495151|FG001|Phase 1b|Withdrawal by Subject|0|||
44488832|NCT00147537|79495152|FG002|Phase 1b|Withdrawal by Subject|0|||
44488833|NCT00147537|79495153|FG003|Phase 1b|Withdrawal by Subject|0|||
44488834|NCT00147537|79495154|FG004|Phase 1b|Withdrawal by Subject|0|||
44488835|NCT00147537|79495155|FG005|Phase 1b|Withdrawal by Subject|0|||
44488836|NCT00147537|79495156|FG006|Phase 1b|Withdrawal by Subject|0|||
44488837|NCT00147537|79495157|FG007|Phase 1b|Withdrawal by Subject|0|||
44488838|NCT00147537|79495158|FG008|Phase 1b|Withdrawal by Subject|2|||
44488839|NCT00147537|79495159|FG009|Phase 1b|Withdrawal by Subject|0|||
44488840|NCT00147537|79495160|FG010|Phase 1b|Withdrawal by Subject|0|||
44488841|NCT00147537|79495150|FG000|Phase 1b|Randomized but not treated|0|||
44488842|NCT00147537|79495151|FG001|Phase 1b|Randomized but not treated|0|||
44488843|NCT00147537|79495152|FG002|Phase 1b|Randomized but not treated|0|||
44488844|NCT00147537|79495153|FG003|Phase 1b|Randomized but not treated|0|||
44488845|NCT00147537|79495154|FG004|Phase 1b|Randomized but not treated|0|||
44488846|NCT00147537|79495155|FG005|Phase 1b|Randomized but not treated|0|||
44488847|NCT00147537|79495156|FG006|Phase 1b|Randomized but not treated|1|||
44488848|NCT00147537|79495157|FG007|Phase 1b|Randomized but not treated|0|||
44488849|NCT00147537|79495158|FG008|Phase 1b|Randomized but not treated|1|||
44488850|NCT00147537|79495159|FG009|Phase 1b|Randomized but not treated|0|||
44488851|NCT00147537|79495160|FG010|Phase 1b|Randomized but not treated|0|||
44488852|NCT00147537|79495150|FG000|Phase 2|Death|0|||
44488853|NCT00147537|79495151|FG001|Phase 2|Death|0|||
44488854|NCT00147537|79495152|FG002|Phase 2|Death|0|||
44488855|NCT00147537|79495153|FG003|Phase 2|Death|0|||
44488856|NCT00147537|79495154|FG004|Phase 2|Death|0|||
44488857|NCT00147537|79495155|FG005|Phase 2|Death|0|||
44488858|NCT00147537|79495156|FG006|Phase 2|Death|0|||
44488859|NCT00147537|79495157|FG007|Phase 2|Death|0|||
44488860|NCT00147537|79495158|FG008|Phase 2|Death|0|||
44488861|NCT00147537|79495159|FG009|Phase 2|Death|85|||
44488862|NCT00147537|79495160|FG010|Phase 2|Death|31|||
44488863|NCT00147537|79495150|FG000|Phase 2|Lost to Follow-up|0|||
44488864|NCT00147537|79495151|FG001|Phase 2|Lost to Follow-up|0|||
44488865|NCT00147537|79495152|FG002|Phase 2|Lost to Follow-up|0|||
44488866|NCT00147537|79495153|FG003|Phase 2|Lost to Follow-up|0|||
44488867|NCT00147537|79495154|FG004|Phase 2|Lost to Follow-up|0|||
44488868|NCT00147537|79495155|FG005|Phase 2|Lost to Follow-up|0|||
44488869|NCT00147537|79495156|FG006|Phase 2|Lost to Follow-up|0|||
44488870|NCT00147537|79495157|FG007|Phase 2|Lost to Follow-up|0|||
44488871|NCT00147537|79495158|FG008|Phase 2|Lost to Follow-up|0|||
44488872|NCT00147537|79495159|FG009|Phase 2|Lost to Follow-up|12|||
44488873|NCT00147537|79495160|FG010|Phase 2|Lost to Follow-up|4|||
44488874|NCT00147537|79495150|FG000|Phase 2|Other|0|||
44488875|NCT00147537|79495151|FG001|Phase 2|Other|0|||
44488876|NCT00147537|79495152|FG002|Phase 2|Other|0|||
44488877|NCT00147537|79495153|FG003|Phase 2|Other|0|||
44488878|NCT00147537|79495154|FG004|Phase 2|Other|0|||
44488879|NCT00147537|79495155|FG005|Phase 2|Other|0|||
44488880|NCT00147537|79495156|FG006|Phase 2|Other|0|||
44488881|NCT00147537|79495157|FG007|Phase 2|Other|0|||
44488882|NCT00147537|79495158|FG008|Phase 2|Other|0|||
44488883|NCT00147537|79495159|FG009|Phase 2|Other|47|||
44488884|NCT00147537|79495160|FG010|Phase 2|Other|12|||
44488885|NCT00147537|79495150|FG000|Phase 2|Withdrawal by Subject|0|||
44488886|NCT00147537|79495151|FG001|Phase 2|Withdrawal by Subject|0|||
44488887|NCT00147537|79495152|FG002|Phase 2|Withdrawal by Subject|0|||
44488888|NCT00147537|79495153|FG003|Phase 2|Withdrawal by Subject|0|||
44488889|NCT00147537|79495154|FG004|Phase 2|Withdrawal by Subject|0|||
44488890|NCT00147537|79495155|FG005|Phase 2|Withdrawal by Subject|0|||
44488891|NCT00147537|79495156|FG006|Phase 2|Withdrawal by Subject|0|||
44488892|NCT00147537|79495157|FG007|Phase 2|Withdrawal by Subject|0|||
44488893|NCT00147537|79495158|FG008|Phase 2|Withdrawal by Subject|0|||
44488894|NCT00147537|79495159|FG009|Phase 2|Withdrawal by Subject|16|||
44488895|NCT00147537|79495160|FG010|Phase 2|Withdrawal by Subject|4|||
44488896|NCT00147537|79495150|FG000|Phase 2|Randomized but not treated|0|||
44488897|NCT00147537|79495151|FG001|Phase 2|Randomized but not treated|0|||
44488898|NCT00147537|79495152|FG002|Phase 2|Randomized but not treated|0|||
44488899|NCT00147537|79495153|FG003|Phase 2|Randomized but not treated|0|||
44488900|NCT00147537|79495154|FG004|Phase 2|Randomized but not treated|0|||
44488901|NCT00147537|79495155|FG005|Phase 2|Randomized but not treated|0|||
44488902|NCT00147537|79495156|FG006|Phase 2|Randomized but not treated|0|||
44488903|NCT00147537|79495157|FG007|Phase 2|Randomized but not treated|0|||
44488904|NCT00147537|79495158|FG008|Phase 2|Randomized but not treated|0|||
44488905|NCT00147537|79495159|FG009|Phase 2|Randomized but not treated|1|||
44488906|NCT00147537|79495160|FG010|Phase 2|Randomized but not treated|1|||
44488907|NCT00222729|79495205|FG000|Overall Study|Adverse Event|3|||
44488908|NCT00147225|79495215|FG000|Overall Study|Withdrawal by Subject|1|||
44488909|NCT00147225|79495216|FG001|Overall Study|Withdrawal by Subject|0|||
44488910|NCT00147225|79495217|FG002|Overall Study|Withdrawal by Subject|1|||
44488911|NCT00147225|79495218|FG003|Overall Study|Withdrawal by Subject|0|||
44488912|NCT00147225|79495219|FG004|Overall Study|Withdrawal by Subject|0|||
44488913|NCT00147225|79495220|FG005|Overall Study|Withdrawal by Subject|1|||
44488914|NCT00147225|79495215|FG000|Overall Study|Adverse Event|0|||
44488915|NCT00147225|79495216|FG001|Overall Study|Adverse Event|0|||
44375805|NCT00875524|79380893|FG000|Overall Study|Lost to Follow-up|1|||
44375806|NCT00875524|79380894|FG001|Overall Study|Lost to Follow-up|0|||
44375807|NCT00875524|79380893|FG000|Overall Study|Withdrawal by Subject|3|||
44488916|NCT00147225|79495217|FG002|Overall Study|Adverse Event|1|||
44488917|NCT00147225|79495218|FG003|Overall Study|Adverse Event|1|||
44488918|NCT00147225|79495219|FG004|Overall Study|Adverse Event|0|||
44488919|NCT00147225|79495220|FG005|Overall Study|Adverse Event|0|||
44488920|NCT00147225|79495215|FG000|Overall Study|Screen Failure|0|||
44488921|NCT00147225|79495216|FG001|Overall Study|Screen Failure|0|||
44488922|NCT00147225|79495217|FG002|Overall Study|Screen Failure|0|||
44488923|NCT00147225|79495218|FG003|Overall Study|Screen Failure|0|||
44488924|NCT00147225|79495219|FG004|Overall Study|Screen Failure|1|||
44488925|NCT00147225|79495220|FG005|Overall Study|Screen Failure|0|||
44488926|NCT00147225|79495215|FG000|Overall Study|Chemotherapy Changed|0|||
44488927|NCT00147225|79495216|FG001|Overall Study|Chemotherapy Changed|0|||
44488928|NCT00147225|79495217|FG002|Overall Study|Chemotherapy Changed|0|||
44488929|NCT00147225|79495218|FG003|Overall Study|Chemotherapy Changed|0|||
44488930|NCT00147225|79495219|FG004|Overall Study|Chemotherapy Changed|0|||
44488931|NCT00147225|79495220|FG005|Overall Study|Chemotherapy Changed|1|||
44488932|NCT00222105|79495234|FG000|Overall Study|Removed due to wrong diagnosis|1|||
44488933|NCT00222105|79495234|FG000|Overall Study|Withdrawal by Subject|1|||
44488934|NCT00222105|79495234|FG000|Overall Study|Adverse Event|8|||
44488935|NCT00222105|79495234|FG000|Overall Study|Treatment delays|2|||
44488936|NCT00222105|79495234|FG000|Overall Study|Death|2|||
44488937|NCT00146757|79495238|FG000|Overall Study|Death|1|||
44488938|NCT00146757|79495239|FG001|Overall Study|Death|0|||
44488939|NCT00146757|79495238|FG000|Overall Study|Adverse Event|1|||
44488940|NCT00146757|79495239|FG001|Overall Study|Adverse Event|0|||
44488941|NCT00267098|79495253|FG000|Overall Study|Death|0|||
44488942|NCT00267098|79495254|FG001|Overall Study|Death|0|||
44488943|NCT00267098|79495255|FG002|Overall Study|Death|57|||
44488944|NCT00267098|79495256|FG003|Overall Study|Death|66|||
44488945|NCT00267098|79495257|FG004|Overall Study|Death|14|||
44488946|NCT00267098|79495258|FG005|Overall Study|Death|23|||
44488947|NCT00267098|79495259|FG006|Overall Study|Death|28|||
44488948|NCT00267098|79495260|FG007|Overall Study|Death|9|||
44488949|NCT00267098|79495253|FG000|Overall Study|Lost to Follow-up|0|||
44488950|NCT00267098|79495254|FG001|Overall Study|Lost to Follow-up|0|||
44488951|NCT00267098|79495255|FG002|Overall Study|Lost to Follow-up|6|||
44488952|NCT00267098|79495256|FG003|Overall Study|Lost to Follow-up|5|||
44488953|NCT00267098|79495257|FG004|Overall Study|Lost to Follow-up|2|||
44488954|NCT00267098|79495258|FG005|Overall Study|Lost to Follow-up|3|||
44488955|NCT00267098|79495259|FG006|Overall Study|Lost to Follow-up|1|||
44375808|NCT00875524|79380894|FG001|Overall Study|Withdrawal by Subject|5|||
44488956|NCT00267098|79495260|FG007|Overall Study|Lost to Follow-up|1|||
44488957|NCT00267098|79495253|FG000|Overall Study|Withdrawal by Subject|8|||
44488958|NCT00267098|79495254|FG001|Overall Study|Withdrawal by Subject|0|||
44488959|NCT00267098|79495255|FG002|Overall Study|Withdrawal by Subject|24|||
44488960|NCT00267098|79495256|FG003|Overall Study|Withdrawal by Subject|21|||
44545295|NCT03518125|79559071|FG000|Overall Study|Physician Decision|0|||
44488961|NCT00267098|79495257|FG004|Overall Study|Withdrawal by Subject|12|||
44488962|NCT00267098|79495258|FG005|Overall Study|Withdrawal by Subject|9|||
44488963|NCT00267098|79495259|FG006|Overall Study|Withdrawal by Subject|12|||
44488964|NCT00267098|79495260|FG007|Overall Study|Withdrawal by Subject|5|||
44488965|NCT00267098|79495253|FG000|Overall Study|Physician Decision|5|||
44488966|NCT00267098|79495254|FG001|Overall Study|Physician Decision|0|||
44488967|NCT00267098|79495255|FG002|Overall Study|Physician Decision|7|||
44488968|NCT00267098|79495256|FG003|Overall Study|Physician Decision|11|||
44488969|NCT00267098|79495257|FG004|Overall Study|Physician Decision|5|||
44488970|NCT00267098|79495258|FG005|Overall Study|Physician Decision|4|||
44488971|NCT00267098|79495259|FG006|Overall Study|Physician Decision|3|||
44488972|NCT00267098|79495260|FG007|Overall Study|Physician Decision|0|||
44488973|NCT00267098|79495253|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
44488974|NCT00267098|79495254|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44488975|NCT00267098|79495255|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44488976|NCT00267098|79495256|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44488977|NCT00267098|79495257|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
44488978|NCT00267098|79495258|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44488979|NCT00267098|79495259|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44488980|NCT00267098|79495260|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44488981|NCT00267098|79495253|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488982|NCT00267098|79495254|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
44488983|NCT00267098|79495255|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488984|NCT00267098|79495256|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488985|NCT00267098|79495257|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488986|NCT00267098|79495258|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488987|NCT00267098|79495259|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488988|NCT00267098|79495260|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
44488989|NCT00267098|79495253|FG000|Overall Study|Site closure|0|||
44488990|NCT00267098|79495254|FG001|Overall Study|Site closure|0|||
44488991|NCT00267098|79495255|FG002|Overall Study|Site closure|0|||
44488992|NCT00267098|79495256|FG003|Overall Study|Site closure|1|||
44488993|NCT00267098|79495257|FG004|Overall Study|Site closure|0|||
44488994|NCT00267098|79495258|FG005|Overall Study|Site closure|1|||
44488995|NCT00267098|79495259|FG006|Overall Study|Site closure|1|||
44488996|NCT00267098|79495260|FG007|Overall Study|Site closure|0|||
44488997|NCT00267098|79495253|FG000|Overall Study|Explanted Medtronic device|0|||
44488998|NCT00267098|79495254|FG001|Overall Study|Explanted Medtronic device|0|||
44488999|NCT00267098|79495255|FG002|Overall Study|Explanted Medtronic device|0|||
44489000|NCT00267098|79495256|FG003|Overall Study|Explanted Medtronic device|1|||
44489001|NCT00267098|79495257|FG004|Overall Study|Explanted Medtronic device|0|||
44489002|NCT00267098|79495258|FG005|Overall Study|Explanted Medtronic device|0|||
44489003|NCT00267098|79495259|FG006|Overall Study|Explanted Medtronic device|0|||
44489004|NCT00267098|79495260|FG007|Overall Study|Explanted Medtronic device|0|||
44489005|NCT00267098|79495253|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489006|NCT00267098|79495254|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489007|NCT00267098|79495255|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489008|NCT00267098|79495256|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489009|NCT00267098|79495257|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
44489010|NCT00267098|79495258|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489011|NCT00267098|79495259|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489012|NCT00267098|79495260|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
44489013|NCT00267098|79495253|FG000|Overall Study|Subject listed for heart transplant|0|||
44489014|NCT00267098|79495254|FG001|Overall Study|Subject listed for heart transplant|0|||
44489015|NCT00267098|79495255|FG002|Overall Study|Subject listed for heart transplant|0|||
44489016|NCT00267098|79495256|FG003|Overall Study|Subject listed for heart transplant|0|||
44489017|NCT00267098|79495257|FG004|Overall Study|Subject listed for heart transplant|0|||
44489018|NCT00267098|79495258|FG005|Overall Study|Subject listed for heart transplant|0|||
44489019|NCT00267098|79495259|FG006|Overall Study|Subject listed for heart transplant|1|||
44489020|NCT00267098|79495260|FG007|Overall Study|Subject listed for heart transplant|0|||
44375809|NCT01094288|79380908|FG000|Overall Study|Adverse Event|0|||
44489021|NCT00267098|79495253|FG000|Overall Study|Sponsor withdrew subject|0|||
44489022|NCT00267098|79495254|FG001|Overall Study|Sponsor withdrew subject|0|||
44489023|NCT00267098|79495255|FG002|Overall Study|Sponsor withdrew subject|0|||
44489024|NCT00267098|79495256|FG003|Overall Study|Sponsor withdrew subject|1|||
44489025|NCT00267098|79495257|FG004|Overall Study|Sponsor withdrew subject|0|||
44489026|NCT00267098|79495258|FG005|Overall Study|Sponsor withdrew subject|0|||
44489027|NCT00267098|79495259|FG006|Overall Study|Sponsor withdrew subject|0|||
44489028|NCT00267098|79495260|FG007|Overall Study|Sponsor withdrew subject|0|||
44489029|NCT00247676|79495283|FG000|Overall Study|Death|5|||
44489030|NCT00247676|79495283|FG000|Overall Study|Adverse Event|11|||
44489031|NCT00247676|79495283|FG000|Overall Study|Lack of Efficacy|15|||
44489032|NCT00247676|79495283|FG000|Overall Study|Other|3|||
44489033|NCT00247676|79495283|FG000|Overall Study|Withdrawal by Subject|2|||
44489034|NCT00267020|79495289|FG000|Overall Study|Adverse Event|22|||
44489035|NCT00267020|79495290|FG001|Overall Study|Adverse Event|5|||
44489036|NCT00267020|79495289|FG000|Overall Study|Death|2|||
44489037|NCT00267020|79495290|FG001|Overall Study|Death|1|||
44489038|NCT00267020|79495289|FG000|Overall Study|Withdrawal by Subject|17|||
44489039|NCT00267020|79495290|FG001|Overall Study|Withdrawal by Subject|7|||
44489040|NCT00267020|79495289|FG000|Overall Study|Physician Decision|3|||
44489041|NCT00267020|79495290|FG001|Overall Study|Physician Decision|2|||
44489042|NCT00267020|79495289|FG000|Overall Study|Disease Progression|39|||
44489043|NCT00267020|79495290|FG001|Overall Study|Disease Progression|25|||
44489044|NCT00267020|79495289|FG000|Overall Study|Unrelated Complication|1|||
44489045|NCT00267020|79495290|FG001|Overall Study|Unrelated Complication|1|||
44489046|NCT00267020|79495289|FG000|Overall Study|Sponsor Request|1|||
44489047|NCT00267020|79495290|FG001|Overall Study|Sponsor Request|0|||
44489048|NCT00267020|79495289|FG000|Overall Study|Other|1|||
44489049|NCT00267020|79495290|FG001|Overall Study|Other|2|||
44489050|NCT00242216|79495298|FG000|Overall Study|Lost to Follow-up|12|||
44489051|NCT00242216|79495299|FG001|Overall Study|Lost to Follow-up|17|||
44489052|NCT00242216|79495298|FG000|Overall Study|Death|4|||
44489053|NCT00242216|79495299|FG001|Overall Study|Death|2|||
44489054|NCT00242216|79495298|FG000|Overall Study|Lack of Efficacy|1|||
44489055|NCT00242216|79495299|FG001|Overall Study|Lack of Efficacy|2|||
44489056|NCT00242216|79495298|FG000|Overall Study|no medicaiton dispensed|1|||
44489057|NCT00242216|79495299|FG001|Overall Study|no medicaiton dispensed|1|||
44489058|NCT00240110|79495307|FG000|Overall Study|Lost to Follow-up|6|||
44489059|NCT00240110|79495308|FG001|Overall Study|Lost to Follow-up|7|||
44489060|NCT00239720|79495318|FG000|Overall Study|Adverse Event|1|||
44489061|NCT00239720|79495319|FG001|Overall Study|Adverse Event|0|||
44489062|NCT00239720|79495318|FG000|Overall Study|Lost to Follow-up|0|||
44489063|NCT00239720|79495319|FG001|Overall Study|Lost to Follow-up|1|||
44489064|NCT00266864|79495327|FG000|Overall Study|Lost to Follow-up|4|||
44489065|NCT00266864|79495328|FG001|Overall Study|Lost to Follow-up|1|||
44489066|NCT00266864|79495327|FG000|Overall Study|Withdrawal by Subject|1|||
44489067|NCT00266864|79495328|FG001|Overall Study|Withdrawal by Subject|1|||
44489068|NCT00266708|79495336|FG000|Overall Study|No renal function|1|||
44489069|NCT00266708|79495337|FG001|Overall Study|No renal function|1|||
44489070|NCT00266708|79495336|FG000|Overall Study|Refused biopsy|3|||
44489071|NCT00266708|79495337|FG001|Overall Study|Refused biopsy|6|||
44489072|NCT00266708|79495336|FG000|Overall Study|Asthma|0|||
44489073|NCT00266708|79495337|FG001|Overall Study|Asthma|2|||
44489074|NCT00266630|79495345|FG000|Overall Study|Adverse Event|8|||
44489075|NCT00266630|79495346|FG001|Overall Study|Adverse Event|6|||
44489076|NCT00266630|79495345|FG000|Overall Study|Lack of Efficacy|1|||
44489077|NCT00266630|79495346|FG001|Overall Study|Lack of Efficacy|4|||
44489078|NCT00266630|79495345|FG000|Overall Study|Entry Criteria not met|1|||
44489079|NCT00266630|79495346|FG001|Overall Study|Entry Criteria not met|0|||
44489080|NCT00266630|79495345|FG000|Overall Study|Protocol Violation|1|||
44489081|NCT00266630|79495346|FG001|Overall Study|Protocol Violation|3|||
44489082|NCT00266630|79495345|FG000|Overall Study|Physician Decision|1|||
44489083|NCT00266630|79495346|FG001|Overall Study|Physician Decision|2|||
44489084|NCT00266630|79495345|FG000|Overall Study|Withdrawal by Subject|10|||
44489085|NCT00266630|79495346|FG001|Overall Study|Withdrawal by Subject|2|||
44489086|NCT00266630|79495345|FG000|Overall Study|Lost to Follow-up|1|||
44489087|NCT00266630|79495346|FG001|Overall Study|Lost to Follow-up|0|||
44489088|NCT00266630|79495345|FG000|Overall Study|Other|19|||
44489089|NCT00266630|79495346|FG001|Overall Study|Other|11|||
44489090|NCT00129129|79495357|FG000|Primary Phase|Adverse Event|2|||
44489091|NCT00129129|79495358|FG001|Primary Phase|Adverse Event|1|||
44489092|NCT00129129|79495359|FG002|Primary Phase|Adverse Event|0|||
44489093|NCT00129129|79495360|FG003|Primary Phase|Adverse Event|0|||
44489094|NCT00129129|79495361|FG004|Primary Phase|Adverse Event|0|||
44489095|NCT00129129|79495357|FG000|Primary Phase|Withdrawal by Subject|12|||
44274375|NCT02678312|79217879|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
44274376|NCT02678312|79217880|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
44274377|NCT02678312|79217876|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
44274378|NCT02678312|79217877|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
44274379|NCT02678312|79217878|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
44489096|NCT00129129|79495358|FG001|Primary Phase|Withdrawal by Subject|10|||
44489097|NCT00129129|79495359|FG002|Primary Phase|Withdrawal by Subject|0|||
44489098|NCT00129129|79495360|FG003|Primary Phase|Withdrawal by Subject|0|||
44489099|NCT00129129|79495361|FG004|Primary Phase|Withdrawal by Subject|0|||
44489100|NCT00129129|79495357|FG000|Primary Phase|Migration from study area|1|||
44489101|NCT00129129|79495358|FG001|Primary Phase|Migration from study area|3|||
44228738|NCT01588951|79036281|FG000|Overall Study|Ineligible in retrospect|0|||
44228739|NCT01588951|79036282|FG001|Overall Study|Ineligible in retrospect|0|||
44228740|NCT01588951|79036283|FG002|Overall Study|Ineligible in retrospect|1|||
44228741|NCT01709383|79036293|FG000|Overall Study|Lost to Follow-up|1|||
44228742|NCT01709383|79036294|FG001|Overall Study|Lost to Follow-up|0|||
44228743|NCT01588405|79036302|FG000|Overall Study|Adverse Event|1|||
44228744|NCT01588405|79036302|FG000|Overall Study|Clinical Worsening|1|||
44228745|NCT01923311|79036311|FG000|Overall Study|Pregnancy|1|||
44228746|NCT01923311|79036312|FG001|Overall Study|Pregnancy|0|||
44228747|NCT01923311|79036311|FG000|Overall Study|Investigator's Discretion|1|||
44489102|NCT00129129|79495359|FG002|Primary Phase|Migration from study area|0|||
44228748|NCT01923311|79036312|FG001|Overall Study|Investigator's Discretion|0|||
44228749|NCT01923311|79036311|FG000|Overall Study|Non-Compliance with Study Drug|2|||
44274380|NCT02678312|79217879|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
44489103|NCT00129129|79495360|FG003|Primary Phase|Migration from study area|0|||
44489104|NCT00129129|79495361|FG004|Primary Phase|Migration from study area|0|||
44489105|NCT00129129|79495357|FG000|Primary Phase|Lost to Follow-up|8|||
44489106|NCT00129129|79495358|FG001|Primary Phase|Lost to Follow-up|6|||
44489107|NCT00129129|79495359|FG002|Primary Phase|Lost to Follow-up|0|||
44489108|NCT00129129|79495360|FG003|Primary Phase|Lost to Follow-up|0|||
44489109|NCT00129129|79495361|FG004|Primary Phase|Lost to Follow-up|0|||
44489110|NCT00129129|79495357|FG000|Primary Phase|Other|2|||
44489111|NCT00129129|79495358|FG001|Primary Phase|Other|5|||
44489112|NCT00129129|79495359|FG002|Primary Phase|Other|0|||
44489113|NCT00129129|79495360|FG003|Primary Phase|Other|0|||
44489114|NCT00129129|79495361|FG004|Primary Phase|Other|0|||
44489115|NCT00129129|79495357|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
44489116|NCT00129129|79495358|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
44489117|NCT00129129|79495359|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
44489118|NCT00129129|79495360|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
44489119|NCT00129129|79495361|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
44489120|NCT00129129|79495357|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
44489121|NCT00129129|79495358|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
44489122|NCT00129129|79495359|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
44489123|NCT00129129|79495360|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
44489124|NCT00129129|79495361|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
44489125|NCT00129129|79495357|FG000|Fourth Dose Phase|Migration from study area|0|||
44489126|NCT00129129|79495358|FG001|Fourth Dose Phase|Migration from study area|0|||
44489127|NCT00129129|79495359|FG002|Fourth Dose Phase|Migration from study area|0|||
44489128|NCT00129129|79495360|FG003|Fourth Dose Phase|Migration from study area|0|||
44489129|NCT00129129|79495361|FG004|Fourth Dose Phase|Migration from study area|2|||
44489130|NCT00129129|79495357|FG000|Fourth Dose Phase|Other|0|||
44489131|NCT00129129|79495358|FG001|Fourth Dose Phase|Other|0|||
44489132|NCT00129129|79495359|FG002|Fourth Dose Phase|Other|0|||
44489133|NCT00129129|79495360|FG003|Fourth Dose Phase|Other|1|||
44489134|NCT00129129|79495361|FG004|Fourth Dose Phase|Other|1|||
44489135|NCT00129129|79495357|FG000|Fourth Dose Phase|Protocol Violation|0|||
44489136|NCT00129129|79495358|FG001|Fourth Dose Phase|Protocol Violation|0|||
44489137|NCT00129129|79495359|FG002|Fourth Dose Phase|Protocol Violation|0|||
44489138|NCT00129129|79495360|FG003|Fourth Dose Phase|Protocol Violation|1|||
44274381|NCT02678312|79217880|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
44489139|NCT00129129|79495361|FG004|Fourth Dose Phase|Protocol Violation|0|||
44489140|NCT00221403|79495384|FG000|Overall Study|Protocol Violation|1|||
44489141|NCT00221403|79495385|FG001|Overall Study|Protocol Violation|0|||
44489142|NCT00221403|79495386|FG002|Overall Study|Protocol Violation|0|||
44489143|NCT00221403|79495384|FG000|Overall Study|Physician Decision|1|||
44274382|NCT02678312|79217876|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
44489144|NCT00221403|79495385|FG001|Overall Study|Physician Decision|0|||
44489145|NCT00221403|79495386|FG002|Overall Study|Physician Decision|0|||
44489146|NCT00221403|79495384|FG000|Overall Study|Withdrawal by Subject|0|||
44489147|NCT00221403|79495385|FG001|Overall Study|Withdrawal by Subject|3|||
44489148|NCT00221403|79495386|FG002|Overall Study|Withdrawal by Subject|0|||
44489149|NCT00221403|79495384|FG000|Overall Study|Lack of Efficacy|0|||
44489150|NCT00221403|79495385|FG001|Overall Study|Lack of Efficacy|1|||
44489151|NCT00221403|79495386|FG002|Overall Study|Lack of Efficacy|0|||
44489152|NCT00221403|79495384|FG000|Overall Study|Adverse Event|0|||
44489153|NCT00221403|79495385|FG001|Overall Study|Adverse Event|1|||
44489154|NCT00221403|79495386|FG002|Overall Study|Adverse Event|0|||
44489155|NCT00145977|79495396|FG000|Overall Study|Lack of Efficacy|0|||
44489156|NCT00145977|79495397|FG001|Overall Study|Lack of Efficacy|4|||
44489157|NCT00145977|79495396|FG000|Overall Study|Lost to Follow-up|1|||
44489158|NCT00145977|79495397|FG001|Overall Study|Lost to Follow-up|0|||
44489159|NCT00145977|79495396|FG000|Overall Study|Withdrawal by Subject|1|||
44489160|NCT00145977|79495397|FG001|Overall Study|Withdrawal by Subject|0|||
44489161|NCT00238238|79495406|FG000|Overall Study|Withdrawal by Subject|0|||
44489162|NCT00238238|79495407|FG001|Overall Study|Withdrawal by Subject|3|||
44489163|NCT00238238|79495408|FG002|Overall Study|Withdrawal by Subject|0|||
44489164|NCT00128661|79495418|FG000|Overall Study|Adverse Event|14|||
44375810|NCT01094288|79380909|FG001|Overall Study|Adverse Event|3|||
44375811|NCT01094288|79380910|FG002|Overall Study|Adverse Event|1|||
44375812|NCT01094288|79380911|FG003|Overall Study|Adverse Event|1|||
44375813|NCT01094288|79380912|FG004|Overall Study|Adverse Event|0|||
44375814|NCT01094288|79380913|FG005|Overall Study|Adverse Event|0|||
44375815|NCT01094288|79380914|FG006|Overall Study|Adverse Event|0|||
44375816|NCT01094288|79380915|FG007|Overall Study|Adverse Event|0|||
44489165|NCT00128661|79495419|FG001|Overall Study|Adverse Event|11|||
44489166|NCT00128661|79495418|FG000|Overall Study|Lost to Follow-up|10|||
44375817|NCT01094288|79380908|FG000|Overall Study|Withdrawal by Subject|0|||
44375818|NCT01094288|79380909|FG001|Overall Study|Withdrawal by Subject|1|||
44375819|NCT01094288|79380910|FG002|Overall Study|Withdrawal by Subject|2|||
44375820|NCT01094288|79380911|FG003|Overall Study|Withdrawal by Subject|0|||
44489167|NCT00128661|79495419|FG001|Overall Study|Lost to Follow-up|7|||
44489168|NCT00128661|79495418|FG000|Overall Study|Withdrawal by Subject|243|||
44489169|NCT00128661|79495419|FG001|Overall Study|Withdrawal by Subject|232|||
44489170|NCT00128661|79495418|FG000|Overall Study|Other|7|||
44489171|NCT00128661|79495419|FG001|Overall Study|Other|8|||
44489172|NCT00145509|79495427|FG000|Overall Study|Adverse Event|10|||
44489173|NCT00145509|79495428|FG001|Overall Study|Adverse Event|3|||
44489174|NCT00145509|79495427|FG000|Overall Study|Lack of Efficacy|3|||
44375821|NCT01094288|79380912|FG004|Overall Study|Withdrawal by Subject|0|||
44375822|NCT01094288|79380913|FG005|Overall Study|Withdrawal by Subject|0|||
44375823|NCT01094288|79380914|FG006|Overall Study|Withdrawal by Subject|0|||
44489175|NCT00145509|79495428|FG001|Overall Study|Lack of Efficacy|1|||
44489176|NCT00145509|79495427|FG000|Overall Study|Lost to Follow-up|5|||
44489177|NCT00145509|79495428|FG001|Overall Study|Lost to Follow-up|9|||
44489178|NCT00145509|79495427|FG000|Overall Study|Withdrew Consent|2|||
44489179|NCT00145509|79495428|FG001|Overall Study|Withdrew Consent|7|||
44489180|NCT00145509|79495427|FG000|Overall Study|Reason not provided|2|||
44489181|NCT00145509|79495428|FG001|Overall Study|Reason not provided|1|||
44489182|NCT00145119|79495434|FG000|Overall Study|Death|45|||
44489183|NCT00220779|79495441|FG000|Overall Study|Adverse Event|1|||
44489184|NCT00220779|79495442|FG001|Overall Study|Adverse Event|0|||
44489185|NCT00220779|79495443|FG002|Overall Study|Adverse Event|0|||
44489186|NCT00220779|79495441|FG000|Overall Study|Withdrawal by Subject|1|||
44375824|NCT01094288|79380915|FG007|Overall Study|Withdrawal by Subject|2|||
44375825|NCT01094288|79380908|FG000|Overall Study|Initiation of Alternative Therapy|0|||
44375826|NCT01094288|79380909|FG001|Overall Study|Initiation of Alternative Therapy|0|||
44375827|NCT01094288|79380910|FG002|Overall Study|Initiation of Alternative Therapy|1|||
44375828|NCT01094288|79380911|FG003|Overall Study|Initiation of Alternative Therapy|0|||
44375829|NCT01094288|79380912|FG004|Overall Study|Initiation of Alternative Therapy|0|||
44375830|NCT01094288|79380913|FG005|Overall Study|Initiation of Alternative Therapy|0|||
44375831|NCT01094288|79380914|FG006|Overall Study|Initiation of Alternative Therapy|0|||
44489187|NCT00220779|79495442|FG001|Overall Study|Withdrawal by Subject|4|||
44489188|NCT00220779|79495443|FG002|Overall Study|Withdrawal by Subject|1|||
44489189|NCT00220779|79495441|FG000|Overall Study|Non-compliance|1|||
44489190|NCT00220779|79495442|FG001|Overall Study|Non-compliance|0|||
44489191|NCT00220779|79495443|FG002|Overall Study|Non-compliance|0|||
44489192|NCT00220779|79495441|FG000|Overall Study|Too time consuming|1|||
44489193|NCT00220779|79495442|FG001|Overall Study|Too time consuming|0|||
44489194|NCT00220779|79495443|FG002|Overall Study|Too time consuming|0|||
44489195|NCT00220779|79495441|FG000|Overall Study|Pregnancy|0|||
44489196|NCT00220779|79495442|FG001|Overall Study|Pregnancy|0|||
44489197|NCT00220779|79495443|FG002|Overall Study|Pregnancy|2|||
44489198|NCT00220779|79495441|FG000|Overall Study|Lack of Efficacy|3|||
44489199|NCT00220779|79495442|FG001|Overall Study|Lack of Efficacy|0|||
44489200|NCT00220779|79495443|FG002|Overall Study|Lack of Efficacy|1|||
44489201|NCT00207740|79495455|FG000|Overall Study|Adverse Event|4|||
44489202|NCT00207740|79495456|FG001|Overall Study|Adverse Event|14|||
44489203|NCT00207740|79495457|FG002|Overall Study|Adverse Event|14|||
44489204|NCT00207740|79495458|FG003|Overall Study|Adverse Event|11|||
44489205|NCT00207740|79495455|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44489206|NCT00207740|79495456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44489207|NCT00207740|79495457|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44489208|NCT00207740|79495458|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
44489209|NCT00207740|79495455|FG000|Overall Study|Lost to Follow-up|0|||
44489210|NCT00207740|79495456|FG001|Overall Study|Lost to Follow-up|2|||
44489211|NCT00207740|79495457|FG002|Overall Study|Lost to Follow-up|1|||
44489212|NCT00207740|79495458|FG003|Overall Study|Lost to Follow-up|1|||
44489213|NCT00207740|79495455|FG000|Overall Study|Death|0|||
44489214|NCT00207740|79495456|FG001|Overall Study|Death|0|||
44489215|NCT00207740|79495457|FG002|Overall Study|Death|0|||
44489216|NCT00207740|79495458|FG003|Overall Study|Death|1|||
44489217|NCT00207740|79495455|FG000|Overall Study|Sponsor Directive|22|||
44489218|NCT00207740|79495456|FG001|Overall Study|Sponsor Directive|15|||
44489219|NCT00207740|79495457|FG002|Overall Study|Sponsor Directive|16|||
44489220|NCT00207740|79495458|FG003|Overall Study|Sponsor Directive|21|||
44489221|NCT00207740|79495455|FG000|Overall Study|Other|2|||
44489222|NCT00207740|79495456|FG001|Overall Study|Other|10|||
44489223|NCT00207740|79495457|FG002|Overall Study|Other|7|||
44489224|NCT00207740|79495458|FG003|Overall Study|Other|5|||
44489225|NCT00265382|79495472|FG000|Overall Study|Adverse Event|21|||
44489226|NCT00265382|79495472|FG000|Overall Study|Laboratory Abnormality|1|||
44375832|NCT01094288|79380915|FG007|Overall Study|Initiation of Alternative Therapy|0|||
44489227|NCT00265382|79495472|FG000|Overall Study|Lost to Follow-up|3|||
44489228|NCT00265382|79495472|FG000|Overall Study|Lack of Efficacy|6|||
44489229|NCT00265382|79495472|FG000|Overall Study|Miscellaneous|6|||
44489230|NCT00265382|79495472|FG000|Overall Study|Withdrawal by Subject|13|||
44489231|NCT00265382|79495472|FG000|Overall Study|Study terminated by sponsor|94|||
44489232|NCT00265382|79495472|FG000|Overall Study|Death|1|||
44489233|NCT00206726|79495476|FG000|Overall Study|Delayed recovery of blood counts|1|||
44489234|NCT00206726|79495476|FG000|Overall Study|Progressive disease or relapsed disease|18|||
44489235|NCT00206726|79495476|FG000|Overall Study|Placed on new protocol|1|||
44489236|NCT00206726|79495476|FG000|Overall Study|Bone marrow transplant|1|||
44489237|NCT00206726|79495476|FG000|Overall Study|Adverse Event|17|||
44489238|NCT00206726|79495476|FG000|Overall Study|Death|4|||
44489239|NCT00206726|79495476|FG000|Overall Study|Protocol Violation|1|||
44489240|NCT00206726|79495476|FG000|Overall Study|Withdrawal by Subject|8|||
44489241|NCT00237692|79495484|FG000|Overall Study|Lost to Follow-up|9|||
44489242|NCT00237692|79495485|FG001|Overall Study|Lost to Follow-up|3|||
44489243|NCT00237692|79495486|FG002|Overall Study|Lost to Follow-up|5|||
44489244|NCT00237692|79495487|FG003|Overall Study|Lost to Follow-up|3|||
44489245|NCT00237692|79495484|FG000|Overall Study|Death|1|||
44489246|NCT00237692|79495485|FG001|Overall Study|Death|2|||
44489247|NCT00237692|79495486|FG002|Overall Study|Death|2|||
44489248|NCT00237692|79495487|FG003|Overall Study|Death|3|||
44489249|NCT00237692|79495484|FG000|Overall Study|Excluded - did not meet criteria|4|||
44489250|NCT00237692|79495485|FG001|Overall Study|Excluded - did not meet criteria|3|||
44489251|NCT00237692|79495486|FG002|Overall Study|Excluded - did not meet criteria|5|||
44489252|NCT00237692|79495487|FG003|Overall Study|Excluded - did not meet criteria|9|||
44489253|NCT00237692|79495484|FG000|Overall Study|Withdrawal by Subject|4|||
44489254|NCT00237692|79495485|FG001|Overall Study|Withdrawal by Subject|6|||
44489255|NCT00237692|79495486|FG002|Overall Study|Withdrawal by Subject|10|||
44489256|NCT00237692|79495487|FG003|Overall Study|Withdrawal by Subject|4|||
44489257|NCT00237458|79495497|FG000|Overall Study|Lack of Efficacy|1|||
44489258|NCT00237458|79495497|FG000|Overall Study|Adverse Event|1|||
44489259|NCT00237458|79495497|FG000|Overall Study|Withdrawal by Subject|1|||
44489260|NCT00265148|79495503|FG000|Overall Study|Adverse Event|2|||
44489261|NCT00265148|79495504|FG001|Overall Study|Adverse Event|2|||
44274383|NCT02678312|79217877|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
44274384|NCT02678312|79217878|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
44489262|NCT00265148|79495503|FG000|Overall Study|Lack of Efficacy|0|||
44489263|NCT00265148|79495504|FG001|Overall Study|Lack of Efficacy|2|||
44489264|NCT00265148|79495503|FG000|Overall Study|Protocol Violation|3|||
44489265|NCT00265148|79495504|FG001|Overall Study|Protocol Violation|2|||
44489266|NCT00265148|79495503|FG000|Overall Study|Lost to Follow-up|0|||
44489267|NCT00265148|79495504|FG001|Overall Study|Lost to Follow-up|1|||
44274385|NCT02678312|79217879|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
44274386|NCT02678312|79217880|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
44274387|NCT02256631|79218118|FG000|Overall Study|Lost to Follow-up|1|||
44489268|NCT00265148|79495503|FG000|Overall Study|Withdrawal by Subject|2|||
44489269|NCT00265148|79495504|FG001|Overall Study|Withdrawal by Subject|1|||
44489270|NCT00265148|79495503|FG000|Overall Study|Physician Decision|1|||
44489271|NCT00265148|79495504|FG001|Overall Study|Physician Decision|0|||
44489272|NCT00265148|79495503|FG000|Overall Study|Increasing frailty|0|||
44489273|NCT00265148|79495504|FG001|Overall Study|Increasing frailty|1|||
44489274|NCT00265148|79495503|FG000|Overall Study|Subject chose to change of the dose|1|||
44489275|NCT00265148|79495504|FG001|Overall Study|Subject chose to change of the dose|0|||
44489276|NCT00043186|79495520|FG000|Overall Study|Physician Decision|0|||
44489277|NCT00043186|79495521|FG001|Overall Study|Physician Decision|0|||
44489278|NCT00043186|79495522|FG002|Overall Study|Physician Decision|3|||
44489279|NCT00043186|79495523|FG003|Overall Study|Physician Decision|0|||
44489280|NCT00043186|79495524|FG004|Overall Study|Physician Decision|1|||
44489281|NCT00043186|79495525|FG005|Overall Study|Physician Decision|0|||
44489282|NCT00043186|79495526|FG006|Overall Study|Physician Decision|0|||
44489283|NCT00043186|79495527|FG007|Overall Study|Physician Decision|1|||
44489284|NCT00043186|79495528|FG008|Overall Study|Physician Decision|1|||
44489285|NCT00043186|79495520|FG000|Overall Study|Adverse Event|2|||
44489286|NCT00043186|79495521|FG001|Overall Study|Adverse Event|2|||
44489287|NCT00043186|79495522|FG002|Overall Study|Adverse Event|2|||
44228750|NCT01923311|79036312|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44489288|NCT00043186|79495523|FG003|Overall Study|Adverse Event|3|||
44228751|NCT01923311|79036311|FG000|Overall Study|Withdrew Consent|1|||
44489289|NCT00043186|79495524|FG004|Overall Study|Adverse Event|2|||
44489290|NCT00043186|79495525|FG005|Overall Study|Adverse Event|1|||
44489291|NCT00043186|79495526|FG006|Overall Study|Adverse Event|2|||
44489292|NCT00043186|79495527|FG007|Overall Study|Adverse Event|1|||
44489293|NCT00043186|79495528|FG008|Overall Study|Adverse Event|3|||
44489294|NCT00043186|79495520|FG000|Overall Study|Withdrawal by Subject|11|||
44489295|NCT00043186|79495521|FG001|Overall Study|Withdrawal by Subject|8|||
44489296|NCT00043186|79495522|FG002|Overall Study|Withdrawal by Subject|11|||
44489297|NCT00043186|79495523|FG003|Overall Study|Withdrawal by Subject|13|||
44489298|NCT00043186|79495524|FG004|Overall Study|Withdrawal by Subject|14|||
44489299|NCT00043186|79495525|FG005|Overall Study|Withdrawal by Subject|6|||
44489300|NCT00043186|79495526|FG006|Overall Study|Withdrawal by Subject|12|||
44489301|NCT00043186|79495527|FG007|Overall Study|Withdrawal by Subject|9|||
44489302|NCT00043186|79495528|FG008|Overall Study|Withdrawal by Subject|10|||
44489303|NCT00043186|79495520|FG000|Overall Study|Death|0|||
44489304|NCT00043186|79495521|FG001|Overall Study|Death|0|||
44489305|NCT00043186|79495522|FG002|Overall Study|Death|1|||
44489306|NCT00043186|79495523|FG003|Overall Study|Death|0|||
44489307|NCT00043186|79495524|FG004|Overall Study|Death|0|||
44489308|NCT00043186|79495525|FG005|Overall Study|Death|0|||
44489309|NCT00043186|79495526|FG006|Overall Study|Death|2|||
44489310|NCT00043186|79495527|FG007|Overall Study|Death|0|||
44489311|NCT00043186|79495528|FG008|Overall Study|Death|0|||
44489312|NCT00043186|79495520|FG000|Overall Study|Disease progression|1|||
44489313|NCT00043186|79495521|FG001|Overall Study|Disease progression|0|||
44489314|NCT00043186|79495522|FG002|Overall Study|Disease progression|0|||
44489315|NCT00043186|79495523|FG003|Overall Study|Disease progression|3|||
44489316|NCT00043186|79495524|FG004|Overall Study|Disease progression|0|||
44489317|NCT00043186|79495525|FG005|Overall Study|Disease progression|0|||
44489318|NCT00043186|79495526|FG006|Overall Study|Disease progression|0|||
44489319|NCT00043186|79495527|FG007|Overall Study|Disease progression|4|||
44489320|NCT00043186|79495528|FG008|Overall Study|Disease progression|0|||
44489321|NCT00043186|79495520|FG000|Overall Study|Ineligibility determined|0|||
44489322|NCT00043186|79495521|FG001|Overall Study|Ineligibility determined|0|||
44489323|NCT00043186|79495522|FG002|Overall Study|Ineligibility determined|0|||
44489324|NCT00043186|79495523|FG003|Overall Study|Ineligibility determined|0|||
44489325|NCT00043186|79495524|FG004|Overall Study|Ineligibility determined|0|||
44489326|NCT00043186|79495525|FG005|Overall Study|Ineligibility determined|0|||
44489327|NCT00043186|79495526|FG006|Overall Study|Ineligibility determined|0|||
44489328|NCT00043186|79495527|FG007|Overall Study|Ineligibility determined|0|||
44489329|NCT00043186|79495528|FG008|Overall Study|Ineligibility determined|1|||
44489330|NCT00043186|79495520|FG000|Overall Study|Lost to Follow-up|3|||
44489331|NCT00043186|79495521|FG001|Overall Study|Lost to Follow-up|5|||
44489332|NCT00043186|79495522|FG002|Overall Study|Lost to Follow-up|1|||
44489333|NCT00043186|79495523|FG003|Overall Study|Lost to Follow-up|1|||
44489334|NCT00043186|79495524|FG004|Overall Study|Lost to Follow-up|1|||
44489335|NCT00043186|79495525|FG005|Overall Study|Lost to Follow-up|1|||
44489336|NCT00043186|79495526|FG006|Overall Study|Lost to Follow-up|1|||
44489337|NCT00043186|79495527|FG007|Overall Study|Lost to Follow-up|1|||
44489338|NCT00043186|79495528|FG008|Overall Study|Lost to Follow-up|2|||
44489339|NCT00043186|79495520|FG000|Overall Study|Noncompliance|0|||
44489340|NCT00043186|79495521|FG001|Overall Study|Noncompliance|0|||
44489341|NCT00043186|79495522|FG002|Overall Study|Noncompliance|1|||
44489342|NCT00043186|79495523|FG003|Overall Study|Noncompliance|1|||
44489343|NCT00043186|79495524|FG004|Overall Study|Noncompliance|0|||
44489344|NCT00043186|79495525|FG005|Overall Study|Noncompliance|0|||
44274388|NCT02256631|79218119|FG001|Overall Study|Lost to Follow-up|1|||
44489345|NCT00043186|79495526|FG006|Overall Study|Noncompliance|0|||
44489346|NCT00043186|79495527|FG007|Overall Study|Noncompliance|0|||
44489347|NCT00043186|79495528|FG008|Overall Study|Noncompliance|0|||
44489348|NCT00043186|79495520|FG000|Overall Study|Other|0|||
44489349|NCT00043186|79495521|FG001|Overall Study|Other|0|||
44489350|NCT00043186|79495522|FG002|Overall Study|Other|1|||
44489351|NCT00043186|79495523|FG003|Overall Study|Other|1|||
44489352|NCT00043186|79495524|FG004|Overall Study|Other|0|||
44489353|NCT00043186|79495525|FG005|Overall Study|Other|0|||
44489354|NCT00043186|79495526|FG006|Overall Study|Other|0|||
44489355|NCT00043186|79495527|FG007|Overall Study|Other|0|||
44489356|NCT00043186|79495528|FG008|Overall Study|Other|0|||
44489357|NCT00041470|79495549|FG000|Overall Study|Loss of Funding|38|||
44489358|NCT00206102|79495555|FG000|Overall Study|Adverse Event|119|||
44489359|NCT00206102|79495556|FG001|Overall Study|Adverse Event|82|||
44489360|NCT00206102|79495555|FG000|Overall Study|Protocol Violation|0|||
44489361|NCT00206102|79495556|FG001|Overall Study|Protocol Violation|2|||
44489362|NCT00206102|79495555|FG000|Overall Study|Lack of therapeutic response|16|||
44489363|NCT00206102|79495556|FG001|Overall Study|Lack of therapeutic response|11|||
44489364|NCT00206102|79495555|FG000|Overall Study|Lost to Follow-up|95|||
44489365|NCT00206102|79495556|FG001|Overall Study|Lost to Follow-up|66|||
44489366|NCT00206102|79495555|FG000|Overall Study|Withdrawal by Subject|118|||
44489367|NCT00206102|79495556|FG001|Overall Study|Withdrawal by Subject|101|||
44489368|NCT00206102|79495555|FG000|Overall Study|Study-specific discontinuation criteria|18|||
44489369|NCT00206102|79495556|FG001|Overall Study|Study-specific discontinuation criteria|17|||
44489370|NCT00206102|79495555|FG000|Overall Study|None of those categories|42|||
44489371|NCT00206102|79495556|FG001|Overall Study|None of those categories|36|||
44489372|NCT00041080|79495564|FG000|Overall Study|Adverse Event|21|||
44489373|NCT00041080|79495565|FG001|Overall Study|Adverse Event|1|||
44489374|NCT00041080|79495564|FG000|Overall Study|Withdrawal by Subject|6|||
44489375|NCT00041080|79495565|FG001|Overall Study|Withdrawal by Subject|6|||
44489376|NCT00041080|79495564|FG000|Overall Study|Concommitant Illness/Other|1|||
44489377|NCT00041080|79495565|FG001|Overall Study|Concommitant Illness/Other|2|||
44489378|NCT00041080|79495564|FG000|Overall Study|Did not start therapy|1|||
44489379|NCT00041080|79495565|FG001|Overall Study|Did not start therapy|1|||
44489380|NCT00041080|79495564|FG000|Overall Study|Ineligible|1|||
44489381|NCT00041080|79495565|FG001|Overall Study|Ineligible|0|||
44489382|NCT00205712|79495573|FG000|Overall Study|Lost to Follow-up|0|||
44489383|NCT00205712|79495574|FG001|Overall Study|Lost to Follow-up|1|||
44489384|NCT00203294|79495584|FG000|Overall Study|Withdrawal by Subject|8|||
44489385|NCT00203294|79495585|FG001|Overall Study|Withdrawal by Subject|13|||
44489386|NCT00264290|79495593|FG000|Intervention (8 Weeks)|Adverse Event|1|||
44489387|NCT00264290|79495594|FG001|Intervention (8 Weeks)|Adverse Event|0|||
44489388|NCT00234494|79495604|FG000|Overall Study|Protocol Violation|2|||
44489389|NCT00234104|79495612|FG000|Overall Study|Adverse Event|4|||
44489390|NCT00234104|79495613|FG001|Overall Study|Adverse Event|0|||
44489391|NCT00234104|79495614|FG002|Overall Study|Adverse Event|3|||
44489392|NCT00234104|79495615|FG003|Overall Study|Adverse Event|5|||
44489393|NCT00234104|79495612|FG000|Overall Study|Protocol Violation|0|||
44489394|NCT00234104|79495613|FG001|Overall Study|Protocol Violation|0|||
44489395|NCT00234104|79495614|FG002|Overall Study|Protocol Violation|0|||
44489396|NCT00234104|79495615|FG003|Overall Study|Protocol Violation|1|||
44489397|NCT00234104|79495612|FG000|Overall Study|Physician Decision|0|||
44489398|NCT00234104|79495613|FG001|Overall Study|Physician Decision|1|||
44489399|NCT00234104|79495614|FG002|Overall Study|Physician Decision|2|||
44489400|NCT00234104|79495615|FG003|Overall Study|Physician Decision|2|||
44489401|NCT00263666|79495627|FG000|Overall Study|Adverse Event|6|||
44489402|NCT00263666|79495628|FG001|Overall Study|Adverse Event|8|||
44489403|NCT00263666|79495627|FG000|Overall Study|Lost to Follow-up|1|||
44489404|NCT00263666|79495628|FG001|Overall Study|Lost to Follow-up|2|||
44489405|NCT00263666|79495627|FG000|Overall Study|Withdrawal by Subject|0|||
44489406|NCT00263666|79495628|FG001|Overall Study|Withdrawal by Subject|1|||
44489407|NCT00195338|79495634|FG000|Overall Study|Lost to Follow-up|2|||
44489408|NCT00195338|79495634|FG000|Overall Study|Adverse Event|5|||
44489409|NCT00195338|79495634|FG000|Overall Study|Lack of Efficacy|1|||
44489410|NCT00195338|79495634|FG000|Overall Study|Early closure of the site|4|||
44489411|NCT00035932|79495641|FG000|Overall Study|Adverse Event|10|||
44489412|NCT00035932|79495642|FG001|Overall Study|Adverse Event|9|||
44489413|NCT00035932|79495643|FG002|Overall Study|Adverse Event|9|||
44489414|NCT00035932|79495641|FG000|Overall Study|Death|0|||
44489415|NCT00035932|79495642|FG001|Overall Study|Death|0|||
44489416|NCT00035932|79495643|FG002|Overall Study|Death|1|||
44489417|NCT00035932|79495641|FG000|Overall Study|Disease Progression / Relapse|1|||
44489418|NCT00035932|79495642|FG001|Overall Study|Disease Progression / Relapse|1|||
44489419|NCT00035932|79495643|FG002|Overall Study|Disease Progression / Relapse|0|||
44489420|NCT00035932|79495641|FG000|Overall Study|Lost to Follow-up|4|||
44489421|NCT00035932|79495642|FG001|Overall Study|Lost to Follow-up|4|||
44489422|NCT00035932|79495643|FG002|Overall Study|Lost to Follow-up|3|||
44489423|NCT00035932|79495641|FG000|Overall Study|Noncompliance|6|||
44489424|NCT00035932|79495642|FG001|Overall Study|Noncompliance|7|||
44489425|NCT00035932|79495643|FG002|Overall Study|Noncompliance|6|||
44489426|NCT00035932|79495641|FG000|Overall Study|Protocol Violation While on Study|0|||
44489427|NCT00035932|79495642|FG001|Overall Study|Protocol Violation While on Study|1|||
44489428|NCT00035932|79495643|FG002|Overall Study|Protocol Violation While on Study|2|||
44489429|NCT00035932|79495641|FG000|Overall Study|Withdrawal by Subject|1|||
44489430|NCT00035932|79495642|FG001|Overall Study|Withdrawal by Subject|5|||
44489431|NCT00035932|79495643|FG002|Overall Study|Withdrawal by Subject|0|||
44489432|NCT00035932|79495641|FG000|Overall Study|Study Termination by Sponsor|1|||
44489433|NCT00035932|79495642|FG001|Overall Study|Study Termination by Sponsor|0|||
44489434|NCT00035932|79495643|FG002|Overall Study|Study Termination by Sponsor|0|||
44489435|NCT00035932|79495641|FG000|Overall Study|Lack of Efficacy|33|||
44489436|NCT00035932|79495642|FG001|Overall Study|Lack of Efficacy|33|||
44489437|NCT00035932|79495643|FG002|Overall Study|Lack of Efficacy|28|||
44489438|NCT00022516|79495658|FG000|Overall Study|Adverse Event|0|||
44489439|NCT00022516|79495659|FG001|Overall Study|Adverse Event|59|||
44489440|NCT00022516|79495658|FG000|Overall Study|Lack of Efficacy|0|||
44489441|NCT00022516|79495659|FG001|Overall Study|Lack of Efficacy|27|||
44489442|NCT00022516|79495658|FG000|Overall Study|Physician Decision|0|||
44489443|NCT00022516|79495659|FG001|Overall Study|Physician Decision|1|||
44489444|NCT00022516|79495658|FG000|Overall Study|Protocol Violation|1|||
44489445|NCT00022516|79495659|FG001|Overall Study|Protocol Violation|3|||
44489446|NCT00022516|79495658|FG000|Overall Study|Withdrawal by Subject|2|||
44489447|NCT00022516|79495659|FG001|Overall Study|Withdrawal by Subject|113|||
44489448|NCT00022516|79495658|FG000|Overall Study|Incomplete documentation|0|||
44489449|NCT00022516|79495659|FG001|Overall Study|Incomplete documentation|27|||
44489450|NCT00033514|79495667|FG000|Overall Study|Lost to Follow-up|1|||
44489451|NCT00033514|79495668|FG001|Overall Study|Lost to Follow-up|1|||
44489452|NCT00033514|79495667|FG000|Overall Study|Withdrawal by Subject|0|||
44489453|NCT00033514|79495668|FG001|Overall Study|Withdrawal by Subject|3|||
44489454|NCT00006916|79495675|FG000|Overall Study|Device not inserted|4|||
44489455|NCT00006916|79495675|FG000|Overall Study|Complication of device insertion|1|||
44489456|NCT00454649|79495689|FG000|Overall Study|Lack of Efficacy|2|||
44489457|NCT00454649|79495690|FG001|Overall Study|Lack of Efficacy|2|||
44489458|NCT00454649|79495691|FG002|Overall Study|Lack of Efficacy|10|||
44489459|NCT00454649|79495692|FG003|Overall Study|Lack of Efficacy|3|||
44489460|NCT00454649|79495693|FG004|Overall Study|Lack of Efficacy|0|||
44489461|NCT00454649|79495694|FG005|Overall Study|Lack of Efficacy|4|||
44489462|NCT00454649|79495695|FG006|Overall Study|Lack of Efficacy|5|||
44489463|NCT00454649|79495696|FG007|Overall Study|Lack of Efficacy|13|||
44489464|NCT00454649|79495697|FG008|Overall Study|Lack of Efficacy|10|||
44489465|NCT00454649|79495698|FG009|Overall Study|Lack of Efficacy|2|||
44489466|NCT00454649|79495689|FG000|Overall Study|Adverse Event|0|||
44489467|NCT00454649|79495690|FG001|Overall Study|Adverse Event|1|||
44489468|NCT00454649|79495691|FG002|Overall Study|Adverse Event|3|||
44489469|NCT00454649|79495692|FG003|Overall Study|Adverse Event|0|||
44489470|NCT00454649|79495693|FG004|Overall Study|Adverse Event|1|||
44489471|NCT00454649|79495694|FG005|Overall Study|Adverse Event|2|||
44489472|NCT00454649|79495695|FG006|Overall Study|Adverse Event|3|||
44489473|NCT00454649|79495696|FG007|Overall Study|Adverse Event|4|||
44489474|NCT00454649|79495697|FG008|Overall Study|Adverse Event|6|||
44489475|NCT00454649|79495698|FG009|Overall Study|Adverse Event|2|||
44489476|NCT00454649|79495689|FG000|Overall Study|Lost to Follow-up|0|||
44489477|NCT00454649|79495690|FG001|Overall Study|Lost to Follow-up|0|||
44489478|NCT00454649|79495691|FG002|Overall Study|Lost to Follow-up|1|||
44489479|NCT00454649|79495692|FG003|Overall Study|Lost to Follow-up|0|||
44489480|NCT00454649|79495693|FG004|Overall Study|Lost to Follow-up|0|||
44489481|NCT00454649|79495694|FG005|Overall Study|Lost to Follow-up|0|||
44489482|NCT00454649|79495695|FG006|Overall Study|Lost to Follow-up|1|||
44489483|NCT00454649|79495696|FG007|Overall Study|Lost to Follow-up|0|||
44489484|NCT00454649|79495697|FG008|Overall Study|Lost to Follow-up|0|||
44489485|NCT00454649|79495698|FG009|Overall Study|Lost to Follow-up|0|||
44489486|NCT00454649|79495689|FG000|Overall Study|Other|1|||
44489487|NCT00454649|79495690|FG001|Overall Study|Other|1|||
44489488|NCT00454649|79495691|FG002|Overall Study|Other|5|||
44489489|NCT00454649|79495692|FG003|Overall Study|Other|3|||
44489490|NCT00454649|79495693|FG004|Overall Study|Other|0|||
44489491|NCT00454649|79495694|FG005|Overall Study|Other|0|||
44489492|NCT00454649|79495695|FG006|Overall Study|Other|0|||
44489493|NCT00454649|79495696|FG007|Overall Study|Other|0|||
44489494|NCT00454649|79495697|FG008|Overall Study|Other|3|||
44489495|NCT00454649|79495698|FG009|Overall Study|Other|1|||
44489496|NCT00454649|79495689|FG000|Overall Study|Withdrawal by Subject|0|||
44489497|NCT00454649|79495690|FG001|Overall Study|Withdrawal by Subject|0|||
44274389|NCT02256631|79218120|FG002|Overall Study|Lost to Follow-up|0|||
44274390|NCT02256631|79218121|FG003|Overall Study|Lost to Follow-up|2|||
44274391|NCT02256631|79218122|FG004|Overall Study|Lost to Follow-up|0|||
44274392|NCT02256631|79218123|FG005|Overall Study|Lost to Follow-up|4|||
44489498|NCT00454649|79495691|FG002|Overall Study|Withdrawal by Subject|0|||
44489499|NCT00454649|79495692|FG003|Overall Study|Withdrawal by Subject|0|||
44489500|NCT00454649|79495693|FG004|Overall Study|Withdrawal by Subject|0|||
44489501|NCT00454649|79495694|FG005|Overall Study|Withdrawal by Subject|1|||
44489502|NCT00454649|79495695|FG006|Overall Study|Withdrawal by Subject|0|||
44489503|NCT00454649|79495696|FG007|Overall Study|Withdrawal by Subject|2|||
44489504|NCT00454649|79495697|FG008|Overall Study|Withdrawal by Subject|1|||
44489505|NCT00454649|79495698|FG009|Overall Study|Withdrawal by Subject|0|||
44489506|NCT00454571|79495741|FG000|Overall Study|Adverse Event|2|||
44489507|NCT00454571|79495742|FG001|Overall Study|Adverse Event|0|||
44489508|NCT00454571|79495741|FG000|Overall Study|Physician Decision|0|||
44489509|NCT00454571|79495742|FG001|Overall Study|Physician Decision|1|||
44489510|NCT00454571|79495741|FG000|Overall Study|Protocol Violation|1|||
44489511|NCT00454571|79495742|FG001|Overall Study|Protocol Violation|0|||
44489512|NCT00454571|79495741|FG000|Overall Study|Withdrawal by Subject|10|||
44489513|NCT00454571|79495742|FG001|Overall Study|Withdrawal by Subject|5|||
44489514|NCT03837743|79495748|FG000|Overall Study|Adverse Event|1|||
44489515|NCT03837743|79495748|FG000|Overall Study|Withdrawal by Subject|2|||
44489516|NCT03836729|79495756|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
44489517|NCT00443729|79495766|FG000|Overall Study|Never Treated|0|||
44489518|NCT00443729|79495767|FG001|Overall Study|Never Treated|1|||
44489519|NCT00443729|79495766|FG000|Overall Study|Lack of Efficacy|4|||
44489520|NCT00443729|79495767|FG001|Overall Study|Lack of Efficacy|2|||
44489521|NCT00443729|79495766|FG000|Overall Study|Lost to Follow-up|0|||
44489522|NCT00443729|79495767|FG001|Overall Study|Lost to Follow-up|1|||
44489523|NCT00443729|79495766|FG000|Overall Study|Physician Decision|2|||
44489524|NCT00443729|79495767|FG001|Overall Study|Physician Decision|1|||
44489525|NCT00443729|79495766|FG000|Overall Study|Protocol Violation|1|||
44489526|NCT00443729|79495767|FG001|Overall Study|Protocol Violation|1|||
44489527|NCT00443729|79495766|FG000|Overall Study|Withdrawal by Subject|3|||
44489528|NCT00443729|79495767|FG001|Overall Study|Withdrawal by Subject|1|||
44489529|NCT00443651|79495775|FG000|Overall Study|Death|1|||
44489530|NCT00443651|79495776|FG001|Overall Study|Death|5|||
44489531|NCT00443651|79495775|FG000|Overall Study|Adverse Event|5|||
44489532|NCT00443651|79495776|FG001|Overall Study|Adverse Event|6|||
44489533|NCT00443651|79495775|FG000|Overall Study|Lost to Follow-up|18|||
44489534|NCT00443651|79495776|FG001|Overall Study|Lost to Follow-up|12|||
44489535|NCT00443651|79495775|FG000|Overall Study|Patient's/Guardian's Decision|58|||
44489536|NCT00443651|79495776|FG001|Overall Study|Patient's/Guardian's Decision|30|||
44489537|NCT00443651|79495775|FG000|Overall Study|Physician Decision|13|||
44489538|NCT00443651|79495776|FG001|Overall Study|Physician Decision|4|||
44489539|NCT00443651|79495775|FG000|Overall Study|Pregnancy|0|||
44489540|NCT00443651|79495776|FG001|Overall Study|Pregnancy|1|||
44489541|NCT00443261|79495782|FG000|Overall Study|Death|1|||
44489542|NCT00439517|79495788|FG000|Overall Study|Subject on treatment|1|||
44489543|NCT00439517|79495789|FG001|Overall Study|Subject on treatment|0|||
44489544|NCT00439517|79495788|FG000|Overall Study|Subject in survival follow-up|1|||
44489545|NCT00439517|79495789|FG001|Overall Study|Subject in survival follow-up|0|||
44489546|NCT00438815|79495795|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
44489547|NCT00438815|79495795|FG000|Overall Study|3-month follow-up no longer required|12|||
44489548|NCT00438815|79495795|FG000|Overall Study|Noncompliance with protocol requirements|9|||
44489549|NCT00438815|79495795|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
44489550|NCT00438815|79495795|FG000|Overall Study|Lost to Follow-up|6|||
44489551|NCT00438815|79495795|FG000|Overall Study|Withdrawal by Subject|6|||
44489552|NCT00438815|79495795|FG000|Overall Study|Death|1|||
44489553|NCT00438659|79495801|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
44489554|NCT00438659|79495802|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
44489555|NCT00438659|79495801|FG000|Overall Study|Cancel|5|||
44489556|NCT00438659|79495802|FG001|Overall Study|Cancel|2|||
44489557|NCT00437645|79495811|FG000|Overall Study|Adverse Event|15|||
44489558|NCT00437645|79495812|FG001|Overall Study|Adverse Event|84|||
44489559|NCT00437645|79495811|FG000|Overall Study|Withdrawal by Subject|10|||
44489560|NCT00437645|79495812|FG001|Overall Study|Withdrawal by Subject|22|||
44489561|NCT00437645|79495811|FG000|Overall Study|Protocol Violation|3|||
44489562|NCT00437645|79495812|FG001|Overall Study|Protocol Violation|3|||
44489563|NCT00437645|79495811|FG000|Overall Study|Lost to Follow-up|2|||
44489564|NCT00437645|79495812|FG001|Overall Study|Lost to Follow-up|3|||
44489565|NCT00437645|79495811|FG000|Overall Study|Administrative problems|2|||
44489566|NCT00437645|79495812|FG001|Overall Study|Administrative problems|1|||
44489567|NCT00437645|79495811|FG000|Overall Study|Lack of Efficacy|2|||
44489568|NCT00437645|79495812|FG001|Overall Study|Lack of Efficacy|1|||
44489569|NCT00437645|79495811|FG000|Overall Study|Condition no longer requires study drug|1|||
44489570|NCT00437645|79495812|FG001|Overall Study|Condition no longer requires study drug|1|||
44489571|NCT00437489|79495820|FG000|Overall Study|Study terminated by sponsor|23|||
44489572|NCT00437489|79495821|FG001|Overall Study|Study terminated by sponsor|21|||
44489573|NCT00437489|79495820|FG000|Overall Study|Lost to Follow-up|0|||
44489574|NCT00437489|79495821|FG001|Overall Study|Lost to Follow-up|1|||
44489575|NCT00442559|79495829|FG000|Overall Study|Lost to Follow-up|32|||
44489576|NCT00442559|79495830|FG001|Overall Study|Lost to Follow-up|34|||
44489577|NCT00442559|79495829|FG000|Overall Study|Protocol Violation|1|||
44489578|NCT00442559|79495830|FG001|Overall Study|Protocol Violation|1|||
44489579|NCT00442559|79495829|FG000|Overall Study|Withdrawal by Subject|1|||
44489580|NCT00442559|79495830|FG001|Overall Study|Withdrawal by Subject|0|||
44489581|NCT00441701|79495852|FG000|Overall Study|Adverse Event|3|||
44489582|NCT00441701|79495853|FG001|Overall Study|Adverse Event|2|||
44489583|NCT00441701|79495854|FG002|Overall Study|Adverse Event|1|||
44489584|NCT00441701|79495855|FG003|Overall Study|Adverse Event|0|||
44489585|NCT00441701|79495856|FG004|Overall Study|Adverse Event|2|||
44489586|NCT00441701|79495857|FG005|Overall Study|Adverse Event|2|||
44489587|NCT00441701|79495858|FG006|Overall Study|Adverse Event|0|||
44489588|NCT00441701|79495859|FG007|Overall Study|Adverse Event|0|||
44489589|NCT00441701|79495860|FG008|Overall Study|Adverse Event|0|||
44489590|NCT00441701|79495861|FG009|Overall Study|Adverse Event|0|||
44489591|NCT00441701|79495852|FG000|Overall Study|Lack of Efficacy|2|||
44489592|NCT00441701|79495853|FG001|Overall Study|Lack of Efficacy|0|||
44489593|NCT00441701|79495854|FG002|Overall Study|Lack of Efficacy|2|||
44489594|NCT00441701|79495855|FG003|Overall Study|Lack of Efficacy|2|||
44489595|NCT00441701|79495856|FG004|Overall Study|Lack of Efficacy|0|||
44489596|NCT00441701|79495857|FG005|Overall Study|Lack of Efficacy|1|||
44489597|NCT00441701|79495858|FG006|Overall Study|Lack of Efficacy|0|||
44489598|NCT00441701|79495859|FG007|Overall Study|Lack of Efficacy|0|||
44489599|NCT00441701|79495860|FG008|Overall Study|Lack of Efficacy|0|||
44489600|NCT00441701|79495861|FG009|Overall Study|Lack of Efficacy|0|||
44489601|NCT00441701|79495852|FG000|Overall Study|Withdrawal by Subject|0|||
44489602|NCT00441701|79495853|FG001|Overall Study|Withdrawal by Subject|2|||
44489603|NCT00441701|79495854|FG002|Overall Study|Withdrawal by Subject|1|||
44489604|NCT00441701|79495855|FG003|Overall Study|Withdrawal by Subject|1|||
44489605|NCT00441701|79495856|FG004|Overall Study|Withdrawal by Subject|0|||
44489606|NCT00441701|79495857|FG005|Overall Study|Withdrawal by Subject|0|||
44489607|NCT00441701|79495858|FG006|Overall Study|Withdrawal by Subject|0|||
44489608|NCT00441701|79495859|FG007|Overall Study|Withdrawal by Subject|0|||
44489609|NCT00441701|79495860|FG008|Overall Study|Withdrawal by Subject|0|||
44489610|NCT00441701|79495861|FG009|Overall Study|Withdrawal by Subject|0|||
44489611|NCT00441545|79495879|FG000|First Intervention|Adverse Event|6|||
44489612|NCT00441545|79495880|FG001|First Intervention|Adverse Event|5|||
44489613|NCT00441545|79495879|FG000|First Intervention|Protocol Violation|2|||
44489614|NCT00441545|79495880|FG001|First Intervention|Protocol Violation|2|||
44489615|NCT00441545|79495879|FG000|First Intervention|Withdrawal by Subject|3|||
44489616|NCT00441545|79495880|FG001|First Intervention|Withdrawal by Subject|3|||
44489617|NCT00441545|79495879|FG000|First Intervention|Kidney transplant|1|||
44489618|NCT00441545|79495880|FG001|First Intervention|Kidney transplant|1|||
44489619|NCT00441545|79495879|FG000|First Intervention|Lack of Efficacy|2|||
44489620|NCT00441545|79495880|FG001|First Intervention|Lack of Efficacy|0|||
44489621|NCT00441545|79495879|FG000|First Intervention|Subject exceeded safety criteria|0|||
44489622|NCT00441545|79495880|FG001|First Intervention|Subject exceeded safety criteria|1|||
44489623|NCT00441545|79495879|FG000|First Intervention|Subject met an exclusionary criteria|1|||
44489624|NCT00441545|79495880|FG001|First Intervention|Subject met an exclusionary criteria|0|||
44489625|NCT00441545|79495879|FG000|First Intervention|Extended hospitalization|1|||
44489626|NCT00441545|79495880|FG001|First Intervention|Extended hospitalization|0|||
44489627|NCT00441545|79495879|FG000|First Intervention|Site error|1|||
44489628|NCT00441545|79495880|FG001|First Intervention|Site error|0|||
44489629|NCT00441545|79495879|FG000|First Intervention|Sponsor's request|1|||
44489630|NCT00441545|79495880|FG001|First Intervention|Sponsor's request|0|||
44489631|NCT00441545|79495879|FG000|Second Intervention|Adverse Event|5|||
44489632|NCT00441545|79495880|FG001|Second Intervention|Adverse Event|2|||
44489633|NCT00441545|79495879|FG000|Second Intervention|Protocol Violation|4|||
44489634|NCT00441545|79495880|FG001|Second Intervention|Protocol Violation|1|||
44489635|NCT00441545|79495879|FG000|Second Intervention|Withdrawal by Subject|1|||
44489636|NCT00441545|79495880|FG001|Second Intervention|Withdrawal by Subject|1|||
44489637|NCT00441545|79495879|FG000|Second Intervention|Kidney Transplant|1|||
44489638|NCT00441545|79495880|FG001|Second Intervention|Kidney Transplant|1|||
44489639|NCT00441545|79495879|FG000|Second Intervention|Lack of Efficacy|0|||
44489640|NCT00441545|79495880|FG001|Second Intervention|Lack of Efficacy|1|||
44489641|NCT00441545|79495879|FG000|Second Intervention|Subject exceeded safety criteria|1|||
44489642|NCT00441545|79495880|FG001|Second Intervention|Subject exceeded safety criteria|0|||
44489643|NCT00441545|79495879|FG000|Second Intervention|Subject moved|0|||
44489644|NCT00441545|79495880|FG001|Second Intervention|Subject moved|1|||
44489645|NCT00436553|79495889|FG000|Overall Study|Adverse Event|4|||
44489646|NCT00436553|79495890|FG001|Overall Study|Adverse Event|3|||
44228752|NCT01923311|79036312|FG001|Overall Study|Withdrew Consent|0|||
44228753|NCT01923311|79036311|FG000|Overall Study|Study Terminated by Sponsor|12|||
44228754|NCT01923311|79036312|FG001|Overall Study|Study Terminated by Sponsor|0|||
44228755|NCT01603615|79036319|FG000|Overall Study|Did not Receive Treatment|7|||
44228756|NCT01603615|79036319|FG000|Overall Study|Lost to Follow-up|9|||
44228757|NCT01603615|79036319|FG000|Overall Study|Personal Reasons|17|||
44228758|NCT01603615|79036319|FG000|Overall Study|Other Miscellaneous|1|||
44228759|NCT01685047|79036323|FG000|Overall Study|Withdrawal by Subject|20|||
44489647|NCT00436553|79495891|FG002|Overall Study|Adverse Event|4|||
44489648|NCT00436553|79495889|FG000|Overall Study|Death|3|||
44489649|NCT00436553|79495890|FG001|Overall Study|Death|1|||
44489650|NCT00436553|79495891|FG002|Overall Study|Death|3|||
44489651|NCT00436553|79495889|FG000|Overall Study|Lost to Follow-up|0|||
44489652|NCT00436553|79495890|FG001|Overall Study|Lost to Follow-up|2|||
44489653|NCT00436553|79495891|FG002|Overall Study|Lost to Follow-up|0|||
44489654|NCT00436553|79495889|FG000|Overall Study|Protocol Violation|1|||
44489655|NCT00436553|79495890|FG001|Overall Study|Protocol Violation|0|||
44489656|NCT00436553|79495891|FG002|Overall Study|Protocol Violation|0|||
44489657|NCT00436553|79495889|FG000|Overall Study|Withdrawal by Subject|5|||
44489658|NCT00436553|79495890|FG001|Overall Study|Withdrawal by Subject|6|||
44489659|NCT00436553|79495891|FG002|Overall Study|Withdrawal by Subject|3|||
44489660|NCT00441467|79495899|FG000|Overall Study|Adverse Event|6|||
44489661|NCT00441467|79495899|FG000|Overall Study|Withdrawal by Subject|3|||
44489662|NCT00441467|79495899|FG000|Overall Study|Progressive disease|9|||
44489663|NCT00436163|79495903|FG000|Overall Study|Lost to Follow-up|2|||
44489664|NCT00436163|79495903|FG000|Overall Study|Adverse Event|1|||
44489665|NCT00006604|79495915|FG000|Overall Study|Met study objective - no further FU|1|||
44489666|NCT00006604|79495916|FG001|Overall Study|Met study objective - no further FU|0|||
44489667|NCT00006604|79495917|FG002|Overall Study|Met study objective - no further FU|0|||
44489668|NCT00006604|79495918|FG003|Overall Study|Met study objective - no further FU|0|||
44489669|NCT00006604|79495919|FG004|Overall Study|Met study objective - no further FU|0|||
44489670|NCT00006604|79495920|FG005|Overall Study|Met study objective - no further FU|0|||
44489671|NCT00006604|79495921|FG006|Overall Study|Met study objective - no further FU|0|||
44489672|NCT00006604|79495922|FG007|Overall Study|Met study objective - no further FU|0|||
44489673|NCT00006604|79495923|FG008|Overall Study|Met study objective - no further FU|0|||
44489674|NCT00006604|79495924|FG009|Overall Study|Met study objective - no further FU|0|||
44489675|NCT00006604|79495925|FG010|Overall Study|Met study objective - no further FU|0|||
44489676|NCT00006604|79495926|FG011|Overall Study|Met study objective - no further FU|0|||
44489677|NCT00006604|79495927|FG012|Overall Study|Met study objective - no further FU|0|||
44489678|NCT00006604|79495928|FG013|Overall Study|Met study objective - no further FU|0|||
44489679|NCT00006604|79495929|FG014|Overall Study|Met study objective - no further FU|1|||
44489680|NCT00006604|79495930|FG015|Overall Study|Met study objective - no further FU|1|||
44489681|NCT00006604|79495931|FG016|Overall Study|Met study objective - no further FU|0|||
44489682|NCT00006604|79495915|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
44489683|NCT00006604|79495916|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
44489684|NCT00006604|79495917|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
44489685|NCT00006604|79495918|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
44489686|NCT00006604|79495919|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
44489687|NCT00006604|79495920|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
44489688|NCT00006604|79495921|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
44489689|NCT00006604|79495922|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
44489690|NCT00006604|79495923|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
44489691|NCT00006604|79495924|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
44489692|NCT00006604|79495925|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
44489693|NCT00006604|79495926|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
44489694|NCT00006604|79495927|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
44489695|NCT00006604|79495928|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
44489696|NCT00006604|79495929|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
44489697|NCT00006604|79495930|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
44489698|NCT00006604|79495931|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
44489699|NCT00006604|79495915|FG000|Overall Study|Death|0|||
44489700|NCT00006604|79495916|FG001|Overall Study|Death|0|||
44489701|NCT00006604|79495917|FG002|Overall Study|Death|0|||
44489702|NCT00006604|79495918|FG003|Overall Study|Death|0|||
44489703|NCT00006604|79495919|FG004|Overall Study|Death|0|||
44489704|NCT00006604|79495920|FG005|Overall Study|Death|0|||
44489705|NCT00006604|79495921|FG006|Overall Study|Death|0|||
44489706|NCT00006604|79495922|FG007|Overall Study|Death|0|||
44228760|NCT01685047|79036323|FG000|Overall Study|Death|26|||
44228761|NCT01685047|79036323|FG000|Overall Study|Lost to Follow-up|8|||
44489707|NCT00006604|79495923|FG008|Overall Study|Death|0|||
44489708|NCT00006604|79495924|FG009|Overall Study|Death|1|||
44489709|NCT00006604|79495925|FG010|Overall Study|Death|1|||
44489710|NCT00006604|79495926|FG011|Overall Study|Death|1|||
44228762|NCT01685047|79036323|FG000|Overall Study|Physician Decision|25|||
44489711|NCT00006604|79495927|FG012|Overall Study|Death|0|||
44489712|NCT00006604|79495928|FG013|Overall Study|Death|0|||
44489713|NCT00006604|79495929|FG014|Overall Study|Death|0|||
44489714|NCT00006604|79495930|FG015|Overall Study|Death|0|||
44489715|NCT00006604|79495931|FG016|Overall Study|Death|0|||
44489716|NCT00006604|79495915|FG000|Overall Study|Severe debilitation, unable to continue|0|||
44489717|NCT00006604|79495916|FG001|Overall Study|Severe debilitation, unable to continue|0|||
44489718|NCT00006604|79495917|FG002|Overall Study|Severe debilitation, unable to continue|0|||
44489719|NCT00006604|79495918|FG003|Overall Study|Severe debilitation, unable to continue|0|||
44489720|NCT00006604|79495919|FG004|Overall Study|Severe debilitation, unable to continue|0|||
44489721|NCT00006604|79495920|FG005|Overall Study|Severe debilitation, unable to continue|0|||
44489722|NCT00006604|79495921|FG006|Overall Study|Severe debilitation, unable to continue|3|||
44489723|NCT00006604|79495922|FG007|Overall Study|Severe debilitation, unable to continue|0|||
44489724|NCT00006604|79495923|FG008|Overall Study|Severe debilitation, unable to continue|0|||
44489725|NCT00006604|79495924|FG009|Overall Study|Severe debilitation, unable to continue|5|||
44489726|NCT00006604|79495925|FG010|Overall Study|Severe debilitation, unable to continue|0|||
44489727|NCT00006604|79495926|FG011|Overall Study|Severe debilitation, unable to continue|2|||
44489728|NCT00006604|79495927|FG012|Overall Study|Severe debilitation, unable to continue|1|||
44489729|NCT00006604|79495928|FG013|Overall Study|Severe debilitation, unable to continue|0|||
44489730|NCT00006604|79495929|FG014|Overall Study|Severe debilitation, unable to continue|2|||
44489731|NCT00006604|79495930|FG015|Overall Study|Severe debilitation, unable to continue|0|||
44489732|NCT00006604|79495931|FG016|Overall Study|Severe debilitation, unable to continue|0|||
44489733|NCT00006604|79495915|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
44489734|NCT00006604|79495916|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
44489735|NCT00006604|79495917|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
44489736|NCT00006604|79495918|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
44489737|NCT00006604|79495919|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
44489738|NCT00006604|79495920|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
44489739|NCT00006604|79495921|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
44489740|NCT00006604|79495922|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
44489741|NCT00006604|79495923|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
44489742|NCT00006604|79495924|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
44489743|NCT00006604|79495925|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
44489744|NCT00006604|79495926|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
44489745|NCT00006604|79495927|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
44489746|NCT00006604|79495928|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
44489747|NCT00006604|79495929|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
44489748|NCT00006604|79495930|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
44489749|NCT00006604|79495931|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
44489750|NCT00006604|79495915|FG000|Overall Study|Site closing|0|||
44489751|NCT00006604|79495916|FG001|Overall Study|Site closing|0|||
44489752|NCT00006604|79495917|FG002|Overall Study|Site closing|1|||
44489753|NCT00006604|79495918|FG003|Overall Study|Site closing|1|||
44489754|NCT00006604|79495919|FG004|Overall Study|Site closing|0|||
44489755|NCT00006604|79495920|FG005|Overall Study|Site closing|0|||
44489756|NCT00006604|79495921|FG006|Overall Study|Site closing|0|||
44489757|NCT00006604|79495922|FG007|Overall Study|Site closing|1|||
44489758|NCT00006604|79495923|FG008|Overall Study|Site closing|0|||
44489759|NCT00006604|79495924|FG009|Overall Study|Site closing|0|||
44489760|NCT00006604|79495925|FG010|Overall Study|Site closing|0|||
44489761|NCT00006604|79495926|FG011|Overall Study|Site closing|1|||
44489762|NCT00006604|79495927|FG012|Overall Study|Site closing|1|||
44489763|NCT00006604|79495928|FG013|Overall Study|Site closing|1|||
44489764|NCT00006604|79495929|FG014|Overall Study|Site closing|0|||
44489765|NCT00006604|79495930|FG015|Overall Study|Site closing|0|||
44489766|NCT00006604|79495931|FG016|Overall Study|Site closing|1|||
44489767|NCT00006604|79495915|FG000|Overall Study|Withdrawal by Subject|1|||
44489768|NCT00006604|79495916|FG001|Overall Study|Withdrawal by Subject|0|||
44489769|NCT00006604|79495917|FG002|Overall Study|Withdrawal by Subject|2|||
44489770|NCT00006604|79495918|FG003|Overall Study|Withdrawal by Subject|0|||
44489771|NCT00006604|79495919|FG004|Overall Study|Withdrawal by Subject|1|||
44489772|NCT00006604|79495920|FG005|Overall Study|Withdrawal by Subject|2|||
44489773|NCT00006604|79495921|FG006|Overall Study|Withdrawal by Subject|2|||
44489774|NCT00006604|79495922|FG007|Overall Study|Withdrawal by Subject|0|||
44489775|NCT00006604|79495923|FG008|Overall Study|Withdrawal by Subject|1|||
44489776|NCT00006604|79495924|FG009|Overall Study|Withdrawal by Subject|3|||
44489777|NCT00006604|79495925|FG010|Overall Study|Withdrawal by Subject|2|||
44489778|NCT00006604|79495926|FG011|Overall Study|Withdrawal by Subject|0|||
44489779|NCT00006604|79495927|FG012|Overall Study|Withdrawal by Subject|1|||
44489780|NCT00006604|79495928|FG013|Overall Study|Withdrawal by Subject|2|||
44489781|NCT00006604|79495929|FG014|Overall Study|Withdrawal by Subject|1|||
44489782|NCT00006604|79495930|FG015|Overall Study|Withdrawal by Subject|0|||
44489783|NCT00006604|79495931|FG016|Overall Study|Withdrawal by Subject|1|||
44489784|NCT00006604|79495915|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
44489785|NCT00006604|79495916|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
44489786|NCT00006604|79495917|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
44489787|NCT00006604|79495918|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
44489788|NCT00006604|79495919|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
44489789|NCT00006604|79495920|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
44489790|NCT00006604|79495921|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
44489791|NCT00006604|79495922|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
44489792|NCT00006604|79495923|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
44489793|NCT00006604|79495924|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
44489794|NCT00006604|79495925|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
44489795|NCT00006604|79495926|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
44489796|NCT00006604|79495927|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
44489797|NCT00006604|79495928|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
44489798|NCT00006604|79495929|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
44489799|NCT00006604|79495930|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
44489800|NCT00006604|79495931|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
44489801|NCT00006604|79495915|FG000|Overall Study|Lost to Follow-up|0|||
44489802|NCT00006604|79495916|FG001|Overall Study|Lost to Follow-up|0|||
44489803|NCT00006604|79495917|FG002|Overall Study|Lost to Follow-up|0|||
44489804|NCT00006604|79495918|FG003|Overall Study|Lost to Follow-up|0|||
44489805|NCT00006604|79495919|FG004|Overall Study|Lost to Follow-up|0|||
44489806|NCT00006604|79495920|FG005|Overall Study|Lost to Follow-up|0|||
44489807|NCT00006604|79495921|FG006|Overall Study|Lost to Follow-up|0|||
44489808|NCT00006604|79495922|FG007|Overall Study|Lost to Follow-up|1|||
44489809|NCT00006604|79495923|FG008|Overall Study|Lost to Follow-up|0|||
44489810|NCT00006604|79495924|FG009|Overall Study|Lost to Follow-up|2|||
44489811|NCT00006604|79495925|FG010|Overall Study|Lost to Follow-up|0|||
44489812|NCT00006604|79495926|FG011|Overall Study|Lost to Follow-up|0|||
44489813|NCT00006604|79495927|FG012|Overall Study|Lost to Follow-up|0|||
44489814|NCT00006604|79495928|FG013|Overall Study|Lost to Follow-up|0|||
44489815|NCT00006604|79495929|FG014|Overall Study|Lost to Follow-up|0|||
44489816|NCT00006604|79495930|FG015|Overall Study|Lost to Follow-up|1|||
44489817|NCT00006604|79495931|FG016|Overall Study|Lost to Follow-up|3|||
44489818|NCT00006604|79495915|FG000|Overall Study|Other Reason|0|||
44489819|NCT00006604|79495916|FG001|Overall Study|Other Reason|0|||
44489820|NCT00006604|79495917|FG002|Overall Study|Other Reason|0|||
44375833|NCT01094288|79380908|FG000|Overall Study|Reason not Specified|2|||
44489821|NCT00006604|79495918|FG003|Overall Study|Other Reason|0|||
44489822|NCT00006604|79495919|FG004|Overall Study|Other Reason|0|||
44489823|NCT00006604|79495920|FG005|Overall Study|Other Reason|1|||
44489824|NCT00006604|79495921|FG006|Overall Study|Other Reason|0|||
44489825|NCT00006604|79495922|FG007|Overall Study|Other Reason|0|||
44489826|NCT00006604|79495923|FG008|Overall Study|Other Reason|0|||
44489827|NCT00006604|79495924|FG009|Overall Study|Other Reason|1|||
44489828|NCT00006604|79495925|FG010|Overall Study|Other Reason|0|||
44489829|NCT00006604|79495926|FG011|Overall Study|Other Reason|0|||
44489830|NCT00006604|79495927|FG012|Overall Study|Other Reason|0|||
44489831|NCT00006604|79495928|FG013|Overall Study|Other Reason|0|||
44489832|NCT00006604|79495929|FG014|Overall Study|Other Reason|0|||
44489833|NCT00006604|79495930|FG015|Overall Study|Other Reason|0|||
44489834|NCT00006604|79495931|FG016|Overall Study|Other Reason|0|||
44489835|NCT00436007|79495957|FG000|Overall Study|Withdrawal by Subject|5|||
44489836|NCT00436007|79495958|FG001|Overall Study|Withdrawal by Subject|3|||
44489837|NCT00436007|79495959|FG002|Overall Study|Withdrawal by Subject|4|||
44489838|NCT00436007|79495957|FG000|Overall Study|Lost to Follow-up|14|||
44489839|NCT00436007|79495958|FG001|Overall Study|Lost to Follow-up|10|||
44489840|NCT00436007|79495959|FG002|Overall Study|Lost to Follow-up|13|||
44489841|NCT00436007|79495957|FG000|Overall Study|Physician Decision|0|||
44489842|NCT00436007|79495958|FG001|Overall Study|Physician Decision|0|||
44489843|NCT00436007|79495959|FG002|Overall Study|Physician Decision|2|||
44489844|NCT00436007|79495957|FG000|Overall Study|Death|0|||
44489845|NCT00436007|79495958|FG001|Overall Study|Death|1|||
44489846|NCT00436007|79495959|FG002|Overall Study|Death|3|||
44489847|NCT00436007|79495957|FG000|Overall Study|Other|0|||
44489848|NCT00436007|79495958|FG001|Overall Study|Other|0|||
44489849|NCT00436007|79495959|FG002|Overall Study|Other|1|||
44489850|NCT00435461|79495975|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
44489851|NCT00435461|79495976|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
44489852|NCT00435461|79495977|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
44489853|NCT00435461|79495975|FG000|Overall Study|Protocol Violation|6|||
44489854|NCT00435461|79495976|FG001|Overall Study|Protocol Violation|9|||
44489855|NCT00435461|79495977|FG002|Overall Study|Protocol Violation|10|||
44489856|NCT00435461|79495975|FG000|Overall Study|Participant randomized(inadequate score)|1|||
44489857|NCT00435461|79495976|FG001|Overall Study|Participant randomized(inadequate score)|0|||
44489858|NCT00435461|79495977|FG002|Overall Study|Participant randomized(inadequate score)|0|||
44489859|NCT00435461|79495975|FG000|Overall Study|Compliance less than 80 percent|1|||
44489860|NCT00435461|79495976|FG001|Overall Study|Compliance less than 80 percent|0|||
44489861|NCT00435461|79495977|FG002|Overall Study|Compliance less than 80 percent|0|||
44489862|NCT00435461|79495975|FG000|Overall Study|In error, two study medications switched|1|||
44489863|NCT00435461|79495976|FG001|Overall Study|In error, two study medications switched|0|||
44489864|NCT00435461|79495977|FG002|Overall Study|In error, two study medications switched|0|||
44489865|NCT00435461|79495975|FG000|Overall Study|Lack of Efficacy|2|||
44489866|NCT00435461|79495976|FG001|Overall Study|Lack of Efficacy|1|||
44489867|NCT00435461|79495977|FG002|Overall Study|Lack of Efficacy|0|||
44489868|NCT00435461|79495975|FG000|Overall Study|Withdrawal by Subject|1|||
44489869|NCT00435461|79495976|FG001|Overall Study|Withdrawal by Subject|0|||
44489870|NCT00435461|79495977|FG002|Overall Study|Withdrawal by Subject|2|||
44489871|NCT00435461|79495975|FG000|Overall Study|Randomized in error|1|||
44489872|NCT00435461|79495976|FG001|Overall Study|Randomized in error|0|||
44489873|NCT00435461|79495977|FG002|Overall Study|Randomized in error|0|||
44489874|NCT00435461|79495975|FG000|Overall Study|Participant could not tolerate symptoms|0|||
44489875|NCT00435461|79495976|FG001|Overall Study|Participant could not tolerate symptoms|0|||
44489876|NCT00435461|79495977|FG002|Overall Study|Participant could not tolerate symptoms|1|||
44489877|NCT00435461|79495975|FG000|Overall Study|Participant could not swallow capsule|0|||
44489878|NCT00435461|79495976|FG001|Overall Study|Participant could not swallow capsule|0|||
44489879|NCT00435461|79495977|FG002|Overall Study|Participant could not swallow capsule|1|||
44489880|NCT00435461|79495975|FG000|Overall Study|Pregnancy|2|||
44489881|NCT00435461|79495976|FG001|Overall Study|Pregnancy|0|||
44489882|NCT00435461|79495977|FG002|Overall Study|Pregnancy|0|||
44489883|NCT00435461|79495975|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
44489884|NCT00435461|79495976|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
44489885|NCT00435461|79495977|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
44489886|NCT00435461|79495975|FG000|Overall Study|Participant ended study one day early|1|||
44489887|NCT00435461|79495976|FG001|Overall Study|Participant ended study one day early|0|||
44489888|NCT00435461|79495977|FG002|Overall Study|Participant ended study one day early|0|||
44489889|NCT00435461|79495975|FG000|Overall Study|Noncompliance with study requirements|1|||
44489890|NCT00435461|79495976|FG001|Overall Study|Noncompliance with study requirements|1|||
44489891|NCT00435461|79495977|FG002|Overall Study|Noncompliance with study requirements|1|||
44489892|NCT00435461|79495975|FG000|Overall Study|Adverse Event|1|||
44489893|NCT00435461|79495976|FG001|Overall Study|Adverse Event|2|||
44489894|NCT00435461|79495977|FG002|Overall Study|Adverse Event|6|||
44489895|NCT00435461|79495975|FG000|Overall Study|Non-Compliance of diary|2|||
44489896|NCT00435461|79495976|FG001|Overall Study|Non-Compliance of diary|0|||
44489897|NCT00435461|79495977|FG002|Overall Study|Non-Compliance of diary|1|||
44489898|NCT00435461|79495975|FG000|Overall Study|Lost to Follow-up|1|||
44489899|NCT00435461|79495976|FG001|Overall Study|Lost to Follow-up|1|||
44489900|NCT00435461|79495977|FG002|Overall Study|Lost to Follow-up|2|||
44489901|NCT00434759|79495987|FG000|Overall Study|Lack of Efficacy|5|||
44489902|NCT00434759|79495988|FG001|Overall Study|Lack of Efficacy|4|||
44489903|NCT00434759|79495987|FG000|Overall Study|Withdrawal by Subject|17|||
44489904|NCT00434759|79495988|FG001|Overall Study|Withdrawal by Subject|1|||
44489905|NCT00434759|79495987|FG000|Overall Study|family affairs|2|||
44489906|NCT00434759|79495988|FG001|Overall Study|family affairs|0|||
44489907|NCT00440999|79495998|FG000|Overall Study|Adverse Event|0|||
44489908|NCT00440999|79495999|FG001|Overall Study|Adverse Event|2|||
44489909|NCT00440999|79495998|FG000|Overall Study|Lack of Efficacy|6|||
44489910|NCT00440999|79495999|FG001|Overall Study|Lack of Efficacy|7|||
44489911|NCT00440999|79495998|FG000|Overall Study|Lost to Follow-up|19|||
44489912|NCT00440999|79495999|FG001|Overall Study|Lost to Follow-up|12|||
44489913|NCT00440999|79495998|FG000|Overall Study|Protocol Violation|1|||
44489914|NCT00440999|79495999|FG001|Overall Study|Protocol Violation|0|||
44489915|NCT00440999|79495998|FG000|Overall Study|Withdrawal by Subject|2|||
44489916|NCT00440999|79495999|FG001|Overall Study|Withdrawal by Subject|5|||
44489917|NCT00440999|79495998|FG000|Overall Study|Subjets missed the visit|1|||
44489918|NCT00440999|79495999|FG001|Overall Study|Subjets missed the visit|0|||
44489919|NCT00440999|79495998|FG000|Overall Study|Mixed infection at entry|1|||
44489920|NCT00440999|79495999|FG001|Overall Study|Mixed infection at entry|0|||
44489921|NCT00440999|79495998|FG000|Overall Study|P. falciparum malaria|5|||
44489922|NCT00440999|79495999|FG001|Overall Study|P. falciparum malaria|14|||
44489923|NCT00440999|79495998|FG000|Overall Study|Subj left hosp without inform staff|0|||
44489924|NCT00440999|79495999|FG001|Overall Study|Subj left hosp without inform staff|1|||
44489925|NCT00434213|79496007|FG000|Overall Study|Adverse Event|12|||
44489926|NCT00434213|79496007|FG000|Overall Study|Lack of Efficacy|9|||
44489927|NCT00434213|79496007|FG000|Overall Study|Lost to Follow-up|14|||
44489928|NCT00434213|79496007|FG000|Overall Study|Withdrawal by Subject|7|||
44489929|NCT00434213|79496007|FG000|Overall Study|Protocol Violation|3|||
44489930|NCT00434213|79496007|FG000|Overall Study|Unable to comply with study visit window|2|||
44489931|NCT00434213|79496007|FG000|Overall Study|Application site reaction|1|||
44489932|NCT00434213|79496007|FG000|Overall Study|Non-compliant to study schedule|1|||
44489933|NCT00006184|79496013|FG000|Overall Study|Death|1|||
44489934|NCT00006184|79496014|FG001|Overall Study|Death|0|||
44489935|NCT00434057|79496020|FG000|Overall Study|Withdrawal by Subject|1|||
44489936|NCT00433199|79496026|FG000|Double-Blind Period|Adverse Event|0|||
44489937|NCT00433199|79496027|FG001|Double-Blind Period|Adverse Event|25|||
44228763|NCT01685047|79036323|FG000|Overall Study|Adverse Event|5|||
44489938|NCT00433199|79496026|FG000|Double-Blind Period|Lack of Efficacy|0|||
44489939|NCT00433199|79496027|FG001|Double-Blind Period|Lack of Efficacy|2|||
44489940|NCT00433199|79496026|FG000|Double-Blind Period|Lost to Follow-up|2|||
44489941|NCT00433199|79496027|FG001|Double-Blind Period|Lost to Follow-up|5|||
44489942|NCT00433199|79496026|FG000|Double-Blind Period|Withdrawal by Subject|8|||
44489943|NCT00433199|79496027|FG001|Double-Blind Period|Withdrawal by Subject|19|||
44489944|NCT00433199|79496026|FG000|Double-Blind Period|Protocol Violation|1|||
44489945|NCT00433199|79496027|FG001|Double-Blind Period|Protocol Violation|10|||
44489946|NCT00433199|79496026|FG000|Double-Blind Period|Administrative|1|||
44489947|NCT00433199|79496027|FG001|Double-Blind Period|Administrative|5|||
44489948|NCT00433199|79496026|FG000|Open-Label Period|Adverse Event|0|||
44489949|NCT00433199|79496027|FG001|Open-Label Period|Adverse Event|19|||
44489950|NCT00433199|79496026|FG000|Open-Label Period|Lack of Efficacy|0|||
44489951|NCT00433199|79496027|FG001|Open-Label Period|Lack of Efficacy|2|||
44489952|NCT00433199|79496026|FG000|Open-Label Period|Lost to Follow-up|0|||
44489953|NCT00433199|79496027|FG001|Open-Label Period|Lost to Follow-up|3|||
44489954|NCT00433199|79496026|FG000|Open-Label Period|Withdrawal by Subject|0|||
44489955|NCT00433199|79496027|FG001|Open-Label Period|Withdrawal by Subject|7|||
44489956|NCT00433199|79496026|FG000|Open-Label Period|Protocol Violation|0|||
44489957|NCT00433199|79496027|FG001|Open-Label Period|Protocol Violation|2|||
44489958|NCT00433199|79496026|FG000|Open-Label Period|Administrative|0|||
44489959|NCT00433199|79496027|FG001|Open-Label Period|Administrative|1|||
44489960|NCT00005908|79496038|FG000|Overall Study|Withdrawal by Subject|1|||
44489961|NCT00005908|79496039|FG001|Overall Study|Withdrawal by Subject|0|||
44489962|NCT00432965|79496050|FG000|Overall Study|Lost to Follow-up|22|||
44489963|NCT00432965|79496051|FG001|Overall Study|Lost to Follow-up|19|||
44489964|NCT00432965|79496050|FG000|Overall Study|Withdrawal by Subject|13|||
44489965|NCT00432965|79496051|FG001|Overall Study|Withdrawal by Subject|13|||
44489966|NCT00432965|79496050|FG000|Overall Study|Physician Decision|14|||
44489967|NCT00432965|79496051|FG001|Overall Study|Physician Decision|13|||
44489968|NCT00432965|79496050|FG000|Overall Study|Lack of Efficacy|8|||
44489969|NCT00432965|79496051|FG001|Overall Study|Lack of Efficacy|13|||
44489970|NCT00432965|79496050|FG000|Overall Study|Non-compliance|7|||
44489971|NCT00432965|79496051|FG001|Overall Study|Non-compliance|0|||
44489972|NCT00432965|79496050|FG000|Overall Study|Adverse Event|22|||
44489973|NCT00432965|79496051|FG001|Overall Study|Adverse Event|19|||
44489974|NCT00432965|79496050|FG000|Overall Study|Death|3|||
44489975|NCT00432965|79496051|FG001|Overall Study|Death|4|||
44489976|NCT00432965|79496050|FG000|Overall Study|Exclusionary Methods|1|||
44489977|NCT00432965|79496051|FG001|Overall Study|Exclusionary Methods|2|||
44489978|NCT00432965|79496050|FG000|Overall Study|Incomplete Data|4|||
44489979|NCT00432965|79496051|FG001|Overall Study|Incomplete Data|3|||
44489980|NCT00440297|79496059|FG000|Overall Study|Adverse Event|8|||
44489981|NCT00440297|79496060|FG001|Overall Study|Adverse Event|5|||
44489982|NCT00440297|79496059|FG000|Overall Study|Lost to Follow-up|1|||
44489983|NCT00440297|79496060|FG001|Overall Study|Lost to Follow-up|0|||
44489984|NCT00440297|79496059|FG000|Overall Study|Physician Decision|1|||
44489985|NCT00440297|79496060|FG001|Overall Study|Physician Decision|0|||
44489986|NCT00440297|79496059|FG000|Overall Study|Protocol Violation|11|||
44489987|NCT00440297|79496060|FG001|Overall Study|Protocol Violation|7|||
44489988|NCT00440297|79496059|FG000|Overall Study|Withdrawal by Subject|1|||
44489989|NCT00440297|79496060|FG001|Overall Study|Withdrawal by Subject|6|||
44489990|NCT00440297|79496059|FG000|Overall Study|Randomized by mistake|1|||
44489991|NCT00440297|79496060|FG001|Overall Study|Randomized by mistake|0|||
44489992|NCT00432809|79496069|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
44489993|NCT00432809|79496070|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
44489994|NCT00432809|79496071|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
44489995|NCT00432809|79496069|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
44489996|NCT00432809|79496070|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
44489997|NCT00432809|79496071|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
44489998|NCT00431951|79496083|FG000|Overall Study|Inability to follow study procedures|1|||
44489999|NCT00431951|79496084|FG001|Overall Study|Inability to follow study procedures|0|||
44490000|NCT00431951|79496085|FG002|Overall Study|Inability to follow study procedures|1|||
44490001|NCT00431951|79496086|FG003|Overall Study|Inability to follow study procedures|2|||
44490002|NCT00431951|79496083|FG000|Overall Study|Lost to Follow-up|0|||
44490003|NCT00431951|79496084|FG001|Overall Study|Lost to Follow-up|1|||
44490004|NCT00431951|79496085|FG002|Overall Study|Lost to Follow-up|0|||
44490005|NCT00431951|79496086|FG003|Overall Study|Lost to Follow-up|0|||
44490006|NCT00431951|79496083|FG000|Overall Study|Withdrawal by Subject|0|||
44490007|NCT00431951|79496084|FG001|Overall Study|Withdrawal by Subject|1|||
44490008|NCT00431951|79496085|FG002|Overall Study|Withdrawal by Subject|0|||
44490009|NCT00431951|79496086|FG003|Overall Study|Withdrawal by Subject|0|||
44490010|NCT00431951|79496083|FG000|Overall Study|Adverse Event|0|||
44490011|NCT00431951|79496084|FG001|Overall Study|Adverse Event|0|||
44490012|NCT00431951|79496085|FG002|Overall Study|Adverse Event|1|||
44490013|NCT00431951|79496086|FG003|Overall Study|Adverse Event|0|||
44490014|NCT00004978|79496102|FG000|Overall Study|Death|107|||
44490015|NCT00004978|79496103|FG001|Overall Study|Death|116|||
44490016|NCT00004978|79496102|FG000|Overall Study|Lost to Follow-up|101|||
44490017|NCT00004978|79496103|FG001|Overall Study|Lost to Follow-up|108|||
44490018|NCT00004978|79496102|FG000|Overall Study|Withdrawal by Subject|17|||
44545296|NCT03518125|79559072|FG001|Overall Study|Physician Decision|1|||
44490019|NCT00004978|79496103|FG001|Overall Study|Withdrawal by Subject|26|||
44490020|NCT00004978|79496102|FG000|Overall Study|site closure - not in analysis cohort|19|||
44490021|NCT00004978|79496103|FG001|Overall Study|site closure - not in analysis cohort|20|||
44490022|NCT00430937|79496111|FG000|Overall Study|Adverse Event|3|||
44490023|NCT00430937|79496112|FG001|Overall Study|Adverse Event|8|||
44490024|NCT00430937|79496111|FG000|Overall Study|Death|0|||
44490025|NCT00430937|79496112|FG001|Overall Study|Death|1|||
44490026|NCT00430937|79496111|FG000|Overall Study|Lost to Follow-up|6|||
44490027|NCT00430937|79496112|FG001|Overall Study|Lost to Follow-up|6|||
44490028|NCT00430937|79496111|FG000|Overall Study|Withdrawal by Subject|5|||
44490029|NCT00430937|79496112|FG001|Overall Study|Withdrawal by Subject|2|||
44490030|NCT00430937|79496111|FG000|Overall Study|Protocol Violation|3|||
44490031|NCT00430937|79496112|FG001|Overall Study|Protocol Violation|2|||
44490032|NCT00430937|79496111|FG000|Overall Study|Lack of Efficacy|6|||
44490033|NCT00430937|79496112|FG001|Overall Study|Lack of Efficacy|5|||
44490034|NCT00430937|79496111|FG000|Overall Study|Inappropriate enrollment|2|||
44490035|NCT00430937|79496112|FG001|Overall Study|Inappropriate enrollment|1|||
44490036|NCT00430937|79496111|FG000|Overall Study|Administrative reasons|1|||
44490037|NCT00430937|79496112|FG001|Overall Study|Administrative reasons|0|||
44490038|NCT00430937|79496111|FG000|Overall Study|Protocol discontinuation criteria met|1|||
44490039|NCT00430937|79496112|FG001|Overall Study|Protocol discontinuation criteria met|2|||
44490040|NCT00430937|79496111|FG000|Overall Study|Unable to classify|0|||
44490041|NCT00430937|79496112|FG001|Overall Study|Unable to classify|1|||
44490042|NCT00004888|79496120|FG000|Overall Study|Adverse Event|5|||
44490043|NCT00004888|79496121|FG001|Overall Study|Adverse Event|10|||
44490044|NCT00004888|79496120|FG000|Overall Study|Withdrawal by Subject|0|||
44490045|NCT00004888|79496121|FG001|Overall Study|Withdrawal by Subject|3|||
44490046|NCT00004888|79496120|FG000|Overall Study|Physician Decision|1|||
44490047|NCT00004888|79496121|FG001|Overall Study|Physician Decision|1|||
44490048|NCT00004888|79496120|FG000|Overall Study|Progressive Disease|4|||
44490049|NCT00004888|79496121|FG001|Overall Study|Progressive Disease|9|||
44490050|NCT00004888|79496120|FG000|Overall Study|Death without progressive disease|0|||
44490051|NCT00004888|79496121|FG001|Overall Study|Death without progressive disease|1|||
44490052|NCT00004888|79496120|FG000|Overall Study|Toxic death|1|||
44490053|NCT00004888|79496121|FG001|Overall Study|Toxic death|0|||
44490054|NCT00004732|79496129|FG000|Overall Study|Withdrawal by Subject|36|||
44490055|NCT00004732|79496130|FG001|Overall Study|Withdrawal by Subject|64|||
44490056|NCT00004732|79496129|FG000|Overall Study|Lost to Follow-up|33|||
44490057|NCT00004732|79496130|FG001|Overall Study|Lost to Follow-up|47|||
44490058|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
44490059|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
44490060|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
44490061|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
44490062|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
44490063|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
44490064|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
44490065|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
44490066|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
44490067|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
44490068|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
44490069|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
44490070|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
44490071|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
44490072|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
44490073|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
44490074|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
44490075|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
44490076|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Death|0|||
44490077|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Death|1|||
44490078|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Death|0|||
44490079|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
44490080|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
44490081|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
44490082|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
44490083|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
44490084|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
44490085|NCT00430781|79496141|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
44490086|NCT00430781|79496142|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
44490087|NCT00430781|79496143|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
44490088|NCT00430781|79496141|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
44490089|NCT00430781|79496142|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
44490090|NCT00430781|79496143|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
44490091|NCT00430781|79496141|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
44490092|NCT00430781|79496142|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
44490093|NCT00430781|79496143|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
44490094|NCT00430781|79496141|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
44490095|NCT00430781|79496142|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
44490096|NCT00430781|79496143|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
44490097|NCT00430781|79496141|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
44490098|NCT00430781|79496142|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
44490099|NCT00430781|79496143|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
44490100|NCT00430781|79496141|FG000|Final Analysis; 31 July 2008|Other|0|||
44490101|NCT00430781|79496142|FG001|Final Analysis; 31 July 2008|Other|1|||
44490102|NCT00430781|79496143|FG002|Final Analysis; 31 July 2008|Other|0|||
44490103|NCT00430781|79496141|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
44490104|NCT00430781|79496142|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
44490105|NCT00430781|79496143|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
44490106|NCT00430781|79496141|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
44490107|NCT00430781|79496142|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
44228764|NCT01685047|79036323|FG000|Overall Study|patient withdrawn by sponsor|1|||
44375834|NCT01094288|79380909|FG001|Overall Study|Reason not Specified|3|||
44375835|NCT01094288|79380910|FG002|Overall Study|Reason not Specified|0|||
44375836|NCT01094288|79380911|FG003|Overall Study|Reason not Specified|1|||
44375837|NCT01094288|79380912|FG004|Overall Study|Reason not Specified|0|||
44375838|NCT01094288|79380913|FG005|Overall Study|Reason not Specified|0|||
44375839|NCT01094288|79380914|FG006|Overall Study|Reason not Specified|0|||
44375840|NCT01094288|79380915|FG007|Overall Study|Reason not Specified|0|||
44228765|NCT01905683|79036327|FG000|Overall Study|Protocol Violation|1|||
44228766|NCT01905683|79036327|FG000|Overall Study|Re-injection criteria not met; others|13|||
44228767|NCT01905683|79036327|FG000|Overall Study|Physician Decision|1|||
44228768|NCT01905683|79036327|FG000|Overall Study|Lack of Efficacy|8|||
44228769|NCT01905683|79036327|FG000|Overall Study|Withdrawal by Subject|20|||
44228770|NCT01905683|79036327|FG000|Overall Study|Adverse Event|4|||
44228771|NCT01905683|79036327|FG000|Overall Study|Lost to Follow-up|4|||
44228772|NCT01921829|79036333|FG000|Overall Study|Withdrawal by Subject|0|||
44228773|NCT01921829|79036334|FG001|Overall Study|Withdrawal by Subject|1|||
44228774|NCT01904903|79036340|FG000|Overall Study|Withdrawal by Subject|1|||
44228775|NCT01921517|79036346|FG000|Overall Study|Lost to Follow-up|5|||
44228776|NCT01921517|79036347|FG001|Overall Study|Lost to Follow-up|0|||
44228777|NCT01921517|79036346|FG000|Overall Study|Newly diagnosed health concern|2|||
44228778|NCT01921517|79036347|FG001|Overall Study|Newly diagnosed health concern|0|||
44228779|NCT01921517|79036346|FG000|Overall Study|Physician Decision|0|||
44228780|NCT01921517|79036347|FG001|Overall Study|Physician Decision|2|||
44228781|NCT01921517|79036346|FG000|Overall Study|Withdrawal by Subject|7|||
44228782|NCT01921517|79036347|FG001|Overall Study|Withdrawal by Subject|3|||
44228783|NCT01921517|79036346|FG000|Overall Study|Subject missed final imaging|1|||
44228784|NCT01921517|79036347|FG001|Overall Study|Subject missed final imaging|4|||
44228785|NCT01921205|79036355|FG000|Overall Study|Adverse Event|12|||
44228786|NCT01921205|79036356|FG001|Overall Study|Adverse Event|7|||
44228787|NCT01921205|79036355|FG000|Overall Study|Lack of Efficacy|1|||
44375841|NCT01094288|79380908|FG000|Overall Study|Ongoing Participants|0|||
44375842|NCT01094288|79380909|FG001|Overall Study|Ongoing Participants|3|||
44375843|NCT01094288|79380910|FG002|Overall Study|Ongoing Participants|0|||
44375844|NCT01094288|79380911|FG003|Overall Study|Ongoing Participants|0|||
44490108|NCT00430781|79496143|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
44490109|NCT00430781|79496141|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
44545297|NCT03518125|79559073|FG002|Overall Study|Physician Decision|0|||
44228788|NCT01921205|79036356|FG001|Overall Study|Lack of Efficacy|0|||
44228789|NCT01921205|79036355|FG000|Overall Study|Protocol Violation|1|||
44228790|NCT01921205|79036356|FG001|Overall Study|Protocol Violation|3|||
44228791|NCT01921205|79036355|FG000|Overall Study|Lost to Follow-up|1|||
44228792|NCT01921205|79036356|FG001|Overall Study|Lost to Follow-up|1|||
44375845|NCT01094288|79380912|FG004|Overall Study|Ongoing Participants|0|||
44375846|NCT01094288|79380913|FG005|Overall Study|Ongoing Participants|0|||
44375847|NCT01094288|79380914|FG006|Overall Study|Ongoing Participants|0|||
44228793|NCT01921205|79036355|FG000|Overall Study|Withdrawal by Subject|6|||
44228794|NCT01921205|79036356|FG001|Overall Study|Withdrawal by Subject|5|||
44228795|NCT01921205|79036355|FG000|Overall Study|Use Of Prohibited Medication|0|||
44228796|NCT01921205|79036356|FG001|Overall Study|Use Of Prohibited Medication|1|||
44228797|NCT01921205|79036355|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
44228798|NCT01921205|79036356|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
44228799|NCT01921205|79036355|FG000|Overall Study|Non Compliance Of The Parent|0|||
44228800|NCT01921205|79036356|FG001|Overall Study|Non Compliance Of The Parent|1|||
44228801|NCT01921205|79036355|FG000|Overall Study|Non Compliance Of Child|0|||
44228802|NCT01921205|79036356|FG001|Overall Study|Non Compliance Of Child|1|||
44228803|NCT01920893|79036364|FG000|Overall Study|Adverse Event|5|||
44228804|NCT01920893|79036365|FG001|Overall Study|Adverse Event|2|||
44228805|NCT01920893|79036364|FG000|Overall Study|Lack of Efficacy|2|||
44228806|NCT01920893|79036365|FG001|Overall Study|Lack of Efficacy|0|||
44228807|NCT01709305|79036372|FG000|Phase 1|Clinical Adverse Event|80|||
44228808|NCT01709305|79036373|FG001|Phase 1|Clinical Adverse Event|0|||
44228809|NCT01709305|79036374|FG002|Phase 1|Clinical Adverse Event|0|||
44228810|NCT01709305|79036375|FG003|Phase 1|Clinical Adverse Event|0|||
44228811|NCT01709305|79036376|FG004|Phase 1|Clinical Adverse Event|0|||
44490110|NCT00430781|79496142|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
44490111|NCT00430781|79496143|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
44490112|NCT00430781|79496141|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
44490113|NCT00430781|79496142|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
44490114|NCT00430781|79496143|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
44490115|NCT00430781|79496141|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
44490116|NCT00430781|79496142|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
44490117|NCT00430781|79496143|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
44490118|NCT00430781|79496141|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
44490119|NCT00430781|79496142|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
44490120|NCT00430781|79496143|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
44490121|NCT00430781|79496141|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
44490122|NCT00430781|79496142|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
44490123|NCT00430781|79496143|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
44490124|NCT00429299|79496157|FG000|Overall Study|Disease Progression|1|||
44490125|NCT00429299|79496158|FG001|Overall Study|Disease Progression|1|||
44490126|NCT00429299|79496159|FG002|Overall Study|Disease Progression|0|||
44490127|NCT00429299|79496157|FG000|Overall Study|Adverse Event|2|||
44490128|NCT00429299|79496158|FG001|Overall Study|Adverse Event|5|||
44490129|NCT00429299|79496159|FG002|Overall Study|Adverse Event|1|||
44490130|NCT00429299|79496157|FG000|Overall Study|Protocol Violation|1|||
44490131|NCT00429299|79496158|FG001|Overall Study|Protocol Violation|0|||
44490132|NCT00429299|79496159|FG002|Overall Study|Protocol Violation|0|||
44490133|NCT00429299|79496157|FG000|Overall Study|Withdrawal by Subject|0|||
44490134|NCT00429299|79496158|FG001|Overall Study|Withdrawal by Subject|1|||
44490135|NCT00429299|79496159|FG002|Overall Study|Withdrawal by Subject|3|||
44490136|NCT00428597|79496169|FG000|Overall Study|Randomized but not treated|3|||
44490137|NCT00428597|79496170|FG001|Overall Study|Randomized but not treated|3|||
44490138|NCT00428597|79496169|FG000|Overall Study|Objective Progression or Relapse|19|||
44490139|NCT00428597|79496170|FG001|Overall Study|Objective Progression or Relapse|47|||
44490140|NCT00428597|79496169|FG000|Overall Study|Study Terminated by Sponsor|41|||
44490141|NCT00428597|79496170|FG001|Overall Study|Study Terminated by Sponsor|16|||
44490142|NCT00428597|79496169|FG000|Overall Study|Adverse Event|15|||
44490143|NCT00428597|79496170|FG001|Overall Study|Adverse Event|7|||
44490144|NCT00428597|79496169|FG000|Overall Study|Global Deterioration of Health Status|1|||
44490145|NCT00428597|79496170|FG001|Overall Study|Global Deterioration of Health Status|5|||
44490146|NCT00428597|79496169|FG000|Overall Study|Protocol Violation|2|||
44490147|NCT00428597|79496170|FG001|Overall Study|Protocol Violation|1|||
44490148|NCT00428597|79496169|FG000|Overall Study|Withdrawal by Subject|2|||
44490149|NCT00428597|79496170|FG001|Overall Study|Withdrawal by Subject|1|||
44490150|NCT00428597|79496169|FG000|Overall Study|Other|1|||
44490151|NCT00428597|79496170|FG001|Overall Study|Other|1|||
44228812|NCT01709305|79036372|FG000|Phase 1|Death|2|||
44228813|NCT01709305|79036373|FG001|Phase 1|Death|0|||
44228814|NCT01709305|79036374|FG002|Phase 1|Death|0|||
44274393|NCT02256631|79218124|FG006|Overall Study|Lost to Follow-up|1|||
44490152|NCT00428597|79496169|FG000|Overall Study|Lost to Follow-up|0|||
44490153|NCT00428597|79496170|FG001|Overall Study|Lost to Follow-up|1|||
44228815|NCT01709305|79036375|FG003|Phase 1|Death|0|||
44228816|NCT01709305|79036376|FG004|Phase 1|Death|0|||
44228817|NCT01709305|79036372|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
44228818|NCT01709305|79036373|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
44228819|NCT01709305|79036374|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
44228820|NCT01709305|79036375|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
44228821|NCT01709305|79036376|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
44274394|NCT02256631|79218118|FG000|Overall Study|Withdrawal by Subject|0|||
44490154|NCT00428597|79496169|FG000|Overall Study|Pregnancy|1|||
44228822|NCT01709305|79036372|FG000|Phase 1|Laboratory Adverse Event|16|||
44228823|NCT01709305|79036373|FG001|Phase 1|Laboratory Adverse Event|0|||
44228824|NCT01709305|79036374|FG002|Phase 1|Laboratory Adverse Event|0|||
44228825|NCT01709305|79036375|FG003|Phase 1|Laboratory Adverse Event|0|||
44228826|NCT01709305|79036376|FG004|Phase 1|Laboratory Adverse Event|0|||
44228827|NCT01709305|79036372|FG000|Phase 1|Lost to Follow-up|147|||
44228828|NCT01709305|79036373|FG001|Phase 1|Lost to Follow-up|0|||
44228829|NCT01709305|79036374|FG002|Phase 1|Lost to Follow-up|0|||
44228830|NCT01709305|79036375|FG003|Phase 1|Lost to Follow-up|0|||
44228831|NCT01709305|79036376|FG004|Phase 1|Lost to Follow-up|0|||
44228832|NCT01709305|79036372|FG000|Phase 1|Travel, moving, etc.|30|||
44228833|NCT01709305|79036373|FG001|Phase 1|Travel, moving, etc.|0|||
44228834|NCT01709305|79036374|FG002|Phase 1|Travel, moving, etc.|0|||
44228835|NCT01709305|79036375|FG003|Phase 1|Travel, moving, etc.|0|||
44228836|NCT01709305|79036376|FG004|Phase 1|Travel, moving, etc.|0|||
44228837|NCT01709305|79036372|FG000|Phase 1|Physician Decision|13|||
44228838|NCT01709305|79036373|FG001|Phase 1|Physician Decision|0|||
44228839|NCT01709305|79036374|FG002|Phase 1|Physician Decision|0|||
44228840|NCT01709305|79036375|FG003|Phase 1|Physician Decision|0|||
44228841|NCT01709305|79036376|FG004|Phase 1|Physician Decision|0|||
44228842|NCT01709305|79036372|FG000|Phase 1|Protocol Violation|118|||
44228843|NCT01709305|79036373|FG001|Phase 1|Protocol Violation|0|||
44228844|NCT01709305|79036374|FG002|Phase 1|Protocol Violation|0|||
44228845|NCT01709305|79036375|FG003|Phase 1|Protocol Violation|0|||
44228846|NCT01709305|79036376|FG004|Phase 1|Protocol Violation|0|||
44228847|NCT01709305|79036372|FG000|Phase 1|Withdrawal by Subject|218|||
44228848|NCT01709305|79036373|FG001|Phase 1|Withdrawal by Subject|0|||
44228849|NCT01709305|79036374|FG002|Phase 1|Withdrawal by Subject|0|||
44228850|NCT01709305|79036375|FG003|Phase 1|Withdrawal by Subject|0|||
44228851|NCT01709305|79036376|FG004|Phase 1|Withdrawal by Subject|0|||
44228852|NCT01709305|79036372|FG000|Phase 2|Clinical Adverse Event|0|||
44490155|NCT00428597|79496170|FG001|Overall Study|Pregnancy|0|||
44490156|NCT00428597|79496169|FG000|Overall Study|Death|1|||
44490157|NCT00428597|79496170|FG001|Overall Study|Death|3|||
44490158|NCT00428441|79496176|FG000|Overall Study|Lost to Follow-up|1|||
44490159|NCT00144339|79496182|FG000|Overall Study|Adverse Event|746|||
44490160|NCT00144339|79496183|FG001|Overall Study|Adverse Event|627|||
44490161|NCT00144339|79496182|FG000|Overall Study|Protocol Violation|75|||
44490162|NCT00144339|79496183|FG001|Overall Study|Protocol Violation|48|||
44490163|NCT00144339|79496182|FG000|Overall Study|Withdrawal by Subject|403|||
44490164|NCT00144339|79496183|FG001|Overall Study|Withdrawal by Subject|300|||
44490165|NCT00144339|79496182|FG000|Overall Study|Lost to Follow-up|76|||
44490166|NCT00144339|79496183|FG001|Overall Study|Lost to Follow-up|64|||
44490167|NCT00144339|79496182|FG000|Overall Study|Other|58|||
44490168|NCT00144339|79496183|FG001|Overall Study|Other|60|||
44490169|NCT00144027|79496191|FG000|Overall Study|Lost to Follow-up|1|||
44490170|NCT00144027|79496192|FG001|Overall Study|Lost to Follow-up|3|||
44490171|NCT00144027|79496191|FG000|Overall Study|Withdrawal by Subject|2|||
44490172|NCT00144027|79496192|FG001|Overall Study|Withdrawal by Subject|2|||
44490173|NCT00144027|79496191|FG000|Overall Study|did not complete baseline assessment|0|||
44490174|NCT00144027|79496192|FG001|Overall Study|did not complete baseline assessment|6|||
44490175|NCT00127803|79496202|FG000|Overall Study|Adverse Event|2|||
44490176|NCT00127803|79496203|FG001|Overall Study|Adverse Event|0|||
44490177|NCT00127803|79496204|FG002|Overall Study|Adverse Event|0|||
44490178|NCT00127803|79496205|FG003|Overall Study|Adverse Event|0|||
44490179|NCT00127803|79496202|FG000|Overall Study|Withdrawal by Subject|1|||
44490180|NCT00127803|79496203|FG001|Overall Study|Withdrawal by Subject|0|||
44228853|NCT01709305|79036373|FG001|Phase 2|Clinical Adverse Event|10|||
44228854|NCT01709305|79036374|FG002|Phase 2|Clinical Adverse Event|10|||
44228855|NCT01709305|79036375|FG003|Phase 2|Clinical Adverse Event|6|||
44228856|NCT01709305|79036376|FG004|Phase 2|Clinical Adverse Event|11|||
44228857|NCT01709305|79036372|FG000|Phase 2|Death|0|||
44490181|NCT00127803|79496204|FG002|Overall Study|Withdrawal by Subject|0|||
44490182|NCT00127803|79496205|FG003|Overall Study|Withdrawal by Subject|0|||
44490183|NCT00127803|79496202|FG000|Overall Study|Lost to Follow-up|0|||
44490184|NCT00127803|79496203|FG001|Overall Study|Lost to Follow-up|0|||
44490185|NCT00127803|79496204|FG002|Overall Study|Lost to Follow-up|0|||
44490186|NCT00127803|79496205|FG003|Overall Study|Lost to Follow-up|1|||
44490187|NCT00127413|79496219|FG000|Overall Study|Lost to Follow-up|6|||
44490188|NCT00127413|79496220|FG001|Overall Study|Lost to Follow-up|4|||
44490189|NCT00127413|79496221|FG002|Overall Study|Lost to Follow-up|8|||
44228858|NCT01709305|79036373|FG001|Phase 2|Death|0|||
44228859|NCT01709305|79036374|FG002|Phase 2|Death|1|||
44228860|NCT01709305|79036375|FG003|Phase 2|Death|0|||
44274395|NCT02256631|79218119|FG001|Overall Study|Withdrawal by Subject|0|||
44490190|NCT00127413|79496222|FG003|Overall Study|Lost to Follow-up|2|||
44228861|NCT01709305|79036376|FG004|Phase 2|Death|0|||
44228862|NCT01709305|79036372|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
44228863|NCT01709305|79036373|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
44490191|NCT00143403|79496234|FG000|Overall Study|Adverse Event|3|||
44490192|NCT00143403|79496235|FG001|Overall Study|Adverse Event|8|||
44490193|NCT00143403|79496234|FG000|Overall Study|Death|1|||
44490194|NCT00143403|79496235|FG001|Overall Study|Death|0|||
44490195|NCT00143403|79496234|FG000|Overall Study|Withdrawal by Subject|3|||
44490196|NCT00143403|79496235|FG001|Overall Study|Withdrawal by Subject|12|||
44490197|NCT00143403|79496234|FG000|Overall Study|Relapse|15|||
44490198|NCT00143403|79496235|FG001|Overall Study|Relapse|7|||
44490199|NCT00143403|79496234|FG000|Overall Study|Protocol Violation|2|||
44490200|NCT00143403|79496235|FG001|Overall Study|Protocol Violation|2|||
44490201|NCT00143403|79496234|FG000|Overall Study|specified by site|4|||
44490202|NCT00143403|79496235|FG001|Overall Study|specified by site|9|||
44490203|NCT00143403|79496234|FG000|Overall Study|Randomized Not Treated|7|||
44490204|NCT00143403|79496235|FG001|Overall Study|Randomized Not Treated|8|||
44490205|NCT00220701|79496243|FG000|Overall Study|Lost to Follow-up|5|||
44490206|NCT00220701|79496244|FG001|Overall Study|Lost to Follow-up|4|||
44490207|NCT00127101|79496256|FG000|Base Protocol|Adverse Event|0|||
44490208|NCT00127101|79496257|FG001|Base Protocol|Adverse Event|2|||
44490209|NCT00127101|79496258|FG002|Base Protocol|Adverse Event|1|||
44490210|NCT00127101|79496259|FG003|Base Protocol|Adverse Event|0|||
44490211|NCT00127101|79496260|FG004|Base Protocol|Adverse Event|0|||
44490212|NCT00127101|79496261|FG005|Base Protocol|Adverse Event|0|||
44490213|NCT00127101|79496256|FG000|Base Protocol|Lack of Efficacy|1|||
44490214|NCT00127101|79496257|FG001|Base Protocol|Lack of Efficacy|0|||
44490215|NCT00127101|79496258|FG002|Base Protocol|Lack of Efficacy|0|||
44490216|NCT00127101|79496259|FG003|Base Protocol|Lack of Efficacy|0|||
44490217|NCT00127101|79496260|FG004|Base Protocol|Lack of Efficacy|2|||
44490218|NCT00127101|79496261|FG005|Base Protocol|Lack of Efficacy|0|||
44490219|NCT00127101|79496256|FG000|Base Protocol|Withdrawal by Subject|1|||
44490220|NCT00127101|79496257|FG001|Base Protocol|Withdrawal by Subject|2|||
44490221|NCT00127101|79496258|FG002|Base Protocol|Withdrawal by Subject|1|||
44490222|NCT00127101|79496259|FG003|Base Protocol|Withdrawal by Subject|0|||
44490223|NCT00127101|79496260|FG004|Base Protocol|Withdrawal by Subject|0|||
44490224|NCT00127101|79496261|FG005|Base Protocol|Withdrawal by Subject|1|||
44490225|NCT00127101|79496256|FG000|Continuation Phase|Adverse Event|0|||
44490226|NCT00127101|79496257|FG001|Continuation Phase|Adverse Event|0|||
44490227|NCT00127101|79496258|FG002|Continuation Phase|Adverse Event|0|||
44490228|NCT00127101|79496259|FG003|Continuation Phase|Adverse Event|0|||
44490229|NCT00127101|79496260|FG004|Continuation Phase|Adverse Event|1|||
44490230|NCT00127101|79496261|FG005|Continuation Phase|Adverse Event|1|||
44490231|NCT00127101|79496256|FG000|Continuation Phase|Lack of Efficacy|0|||
44490232|NCT00127101|79496257|FG001|Continuation Phase|Lack of Efficacy|0|||
44490233|NCT00127101|79496258|FG002|Continuation Phase|Lack of Efficacy|0|||
44490234|NCT00127101|79496259|FG003|Continuation Phase|Lack of Efficacy|0|||
44490235|NCT00127101|79496260|FG004|Continuation Phase|Lack of Efficacy|0|||
44490236|NCT00127101|79496261|FG005|Continuation Phase|Lack of Efficacy|1|||
44490237|NCT00127101|79496256|FG000|Continuation Phase|Withdrawal by Subject|0|||
44490238|NCT00127101|79496257|FG001|Continuation Phase|Withdrawal by Subject|0|||
44490239|NCT00127101|79496258|FG002|Continuation Phase|Withdrawal by Subject|1|||
44490240|NCT00127101|79496259|FG003|Continuation Phase|Withdrawal by Subject|0|||
44490241|NCT00127101|79496260|FG004|Continuation Phase|Withdrawal by Subject|2|||
44490242|NCT00127101|79496261|FG005|Continuation Phase|Withdrawal by Subject|1|||
44490243|NCT00126555|79496275|FG000|Overall Study|Withdrawal by Subject|1|||
44490244|NCT00126555|79496275|FG000|Overall Study|Adverse Event|2|||
44490245|NCT00126555|79496275|FG000|Overall Study|Progressive Disease|3|||
44490246|NCT00004228|79496298|FG000|Overall Study|Adverse Event|0|||
44490247|NCT00004228|79496299|FG001|Overall Study|Adverse Event|1|||
44490248|NCT00004228|79496300|FG002|Overall Study|Adverse Event|0|||
44490249|NCT00004228|79496301|FG003|Overall Study|Adverse Event|0|||
44490250|NCT00004228|79496302|FG004|Overall Study|Adverse Event|1|||
44490251|NCT00004228|79496303|FG005|Overall Study|Adverse Event|0|||
44490252|NCT00004228|79496304|FG006|Overall Study|Adverse Event|0|||
44490253|NCT00004228|79496298|FG000|Overall Study|Death|0|||
44490254|NCT00004228|79496299|FG001|Overall Study|Death|1|||
44490255|NCT00004228|79496300|FG002|Overall Study|Death|2|||
44490256|NCT00004228|79496301|FG003|Overall Study|Death|0|||
44490257|NCT00004228|79496302|FG004|Overall Study|Death|1|||
44490258|NCT00004228|79496303|FG005|Overall Study|Death|0|||
44490259|NCT00004228|79496304|FG006|Overall Study|Death|0|||
44375848|NCT01094288|79380915|FG007|Overall Study|Ongoing Participants|0|||
44490260|NCT00004228|79496298|FG000|Overall Study|Lack of Efficacy|1|||
44490261|NCT00004228|79496299|FG001|Overall Study|Lack of Efficacy|6|||
44490262|NCT00004228|79496300|FG002|Overall Study|Lack of Efficacy|5|||
44490263|NCT00004228|79496301|FG003|Overall Study|Lack of Efficacy|3|||
44490264|NCT00004228|79496302|FG004|Overall Study|Lack of Efficacy|9|||
44375849|NCT00874120|79380939|FG000|First Intervention|Adverse Event|0|||
44490265|NCT00004228|79496303|FG005|Overall Study|Lack of Efficacy|8|||
44490266|NCT00004228|79496304|FG006|Overall Study|Lack of Efficacy|4|||
44490267|NCT00004228|79496298|FG000|Overall Study|Lost to Follow-up|0|||
44490268|NCT00004228|79496299|FG001|Overall Study|Lost to Follow-up|0|||
44490269|NCT00004228|79496300|FG002|Overall Study|Lost to Follow-up|1|||
44490270|NCT00004228|79496301|FG003|Overall Study|Lost to Follow-up|0|||
44490271|NCT00004228|79496302|FG004|Overall Study|Lost to Follow-up|0|||
44375850|NCT00874120|79380940|FG001|First Intervention|Adverse Event|1|||
44375851|NCT00874120|79380939|FG000|First Intervention|Withdrawal by Subject|2|||
44375852|NCT00874120|79380940|FG001|First Intervention|Withdrawal by Subject|0|||
44375853|NCT00874120|79380939|FG000|First Intervention|Lost to Follow-up|0|||
44375854|NCT00874120|79380940|FG001|First Intervention|Lost to Follow-up|1|||
44375855|NCT00874120|79380939|FG000|First Intervention|Protocol Violation|3|||
44375856|NCT00874120|79380940|FG001|First Intervention|Protocol Violation|0|||
44375857|NCT00874120|79380939|FG000|First Intervention|positive drug test|1|||
44375858|NCT00874120|79380940|FG001|First Intervention|positive drug test|0|||
44375859|NCT00874120|79380939|FG000|Second Intervention|Withdrawal by Subject|1|||
44375860|NCT00874120|79380940|FG001|Second Intervention|Withdrawal by Subject|0|||
44375861|NCT00874120|79380939|FG000|Second Intervention|Protocol Violation|1|||
44375862|NCT00874120|79380940|FG001|Second Intervention|Protocol Violation|0|||
44375863|NCT00939822|79380948|FG000|Overall Study|Lost to Follow-up|1|||
44375864|NCT00939822|79380949|FG001|Overall Study|Lost to Follow-up|0|||
44375865|NCT00939822|79380948|FG000|Overall Study|withdrew from study due to busy schedule|1|||
44375866|NCT00939822|79380949|FG001|Overall Study|withdrew from study due to busy schedule|1|||
44375867|NCT00939822|79380948|FG000|Overall Study|Mental health issues|0|||
44228864|NCT01709305|79036374|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
44274396|NCT02256631|79218120|FG002|Overall Study|Withdrawal by Subject|0|||
44274397|NCT02256631|79218121|FG003|Overall Study|Withdrawal by Subject|1|||
44274398|NCT02256631|79218122|FG004|Overall Study|Withdrawal by Subject|1|||
44274399|NCT02256631|79218123|FG005|Overall Study|Withdrawal by Subject|0|||
44375868|NCT00939822|79380949|FG001|Overall Study|Mental health issues|2|||
44375869|NCT00939510|79380955|FG000|Overall Study|Withdrawal by Subject|1|||
44375870|NCT01098266|79380961|FG000|Overall Study|Physician Decision|1|||
44228865|NCT01709305|79036375|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
44228866|NCT01709305|79036376|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
44228867|NCT01709305|79036372|FG000|Phase 2|Laboratory Adverse Event|0|||
44228868|NCT01709305|79036373|FG001|Phase 2|Laboratory Adverse Event|1|||
44228869|NCT01709305|79036374|FG002|Phase 2|Laboratory Adverse Event|0|||
44228870|NCT01709305|79036375|FG003|Phase 2|Laboratory Adverse Event|1|||
44228871|NCT01709305|79036376|FG004|Phase 2|Laboratory Adverse Event|1|||
44228872|NCT01709305|79036372|FG000|Phase 2|Lost to Follow-up|0|||
44228873|NCT01709305|79036373|FG001|Phase 2|Lost to Follow-up|10|||
44228874|NCT01709305|79036374|FG002|Phase 2|Lost to Follow-up|6|||
44228875|NCT01709305|79036375|FG003|Phase 2|Lost to Follow-up|9|||
44228876|NCT01709305|79036376|FG004|Phase 2|Lost to Follow-up|5|||
44228877|NCT01709305|79036372|FG000|Phase 2|Travel, moving, etc.|0|||
44228878|NCT01709305|79036373|FG001|Phase 2|Travel, moving, etc.|2|||
44228879|NCT01709305|79036374|FG002|Phase 2|Travel, moving, etc.|3|||
44228880|NCT01709305|79036375|FG003|Phase 2|Travel, moving, etc.|3|||
44228881|NCT01709305|79036376|FG004|Phase 2|Travel, moving, etc.|5|||
44228882|NCT01709305|79036372|FG000|Phase 2|Physician Decision|0|||
44228883|NCT01709305|79036373|FG001|Phase 2|Physician Decision|2|||
44228884|NCT01709305|79036374|FG002|Phase 2|Physician Decision|0|||
44228885|NCT01709305|79036375|FG003|Phase 2|Physician Decision|1|||
44228886|NCT01709305|79036376|FG004|Phase 2|Physician Decision|2|||
44228887|NCT01709305|79036372|FG000|Phase 2|Protocol Violation|0|||
44228888|NCT01709305|79036373|FG001|Phase 2|Protocol Violation|19|||
44228889|NCT01709305|79036374|FG002|Phase 2|Protocol Violation|19|||
44228890|NCT01709305|79036375|FG003|Phase 2|Protocol Violation|13|||
44228891|NCT01709305|79036376|FG004|Phase 2|Protocol Violation|9|||
44228892|NCT01709305|79036372|FG000|Phase 2|Withdrawal by Subject|0|||
44228893|NCT01709305|79036373|FG001|Phase 2|Withdrawal by Subject|8|||
44228894|NCT01709305|79036374|FG002|Phase 2|Withdrawal by Subject|6|||
44228895|NCT01709305|79036375|FG003|Phase 2|Withdrawal by Subject|15|||
44228896|NCT01709305|79036376|FG004|Phase 2|Withdrawal by Subject|12|||
44228897|NCT01684423|79036396|FG000|Overall Study|Withdrawal by Subject|0|||
44375871|NCT01098266|79380962|FG001|Overall Study|Physician Decision|0|||
44375872|NCT01098266|79380961|FG000|Overall Study|Death|3|||
44375873|NCT01098266|79380962|FG001|Overall Study|Death|2|||
44375874|NCT01098266|79380961|FG000|Overall Study|Withdrawal by Subject|3|||
44375875|NCT01098266|79380962|FG001|Overall Study|Withdrawal by Subject|5|||
44375876|NCT00935532|79380970|FG000|Overall Study|Adverse Event|11|||
44375877|NCT00935532|79380971|FG001|Overall Study|Adverse Event|6|||
44375878|NCT00935532|79380970|FG000|Overall Study|Death|1|||
44375879|NCT00935532|79380971|FG001|Overall Study|Death|0|||
44375880|NCT00935532|79380970|FG000|Overall Study|Lost to Follow-up|1|||
44375881|NCT00935532|79380971|FG001|Overall Study|Lost to Follow-up|0|||
44375882|NCT00935532|79380970|FG000|Overall Study|Physician Decision|1|||
44228898|NCT01684423|79036397|FG001|Overall Study|Withdrawal by Subject|0|||
44228899|NCT01684423|79036398|FG002|Overall Study|Withdrawal by Subject|1|||
44228900|NCT01684423|79036399|FG003|Overall Study|Withdrawal by Subject|0|||
44228901|NCT01684423|79036400|FG004|Overall Study|Withdrawal by Subject|0|||
44228902|NCT01709227|79036416|FG000|Overall Study|Physician Decision|1|||
44228903|NCT01709227|79036417|FG001|Overall Study|Physician Decision|0|||
44228904|NCT01709227|79036416|FG000|Overall Study|Pleural Peritoneal communication|0|||
44228905|NCT01709227|79036417|FG001|Overall Study|Pleural Peritoneal communication|9|||
44375883|NCT00935532|79380971|FG001|Overall Study|Physician Decision|2|||
44375884|NCT00935532|79380970|FG000|Overall Study|Protocol Violation|2|||
44375885|NCT00935532|79380971|FG001|Overall Study|Protocol Violation|1|||
44375886|NCT00935532|79380970|FG000|Overall Study|Subject Decision|2|||
44375887|NCT00935532|79380971|FG001|Overall Study|Subject Decision|1|||
44375888|NCT00935532|79380970|FG000|Overall Study|Sponsor Decision|0|||
44375889|NCT00935532|79380971|FG001|Overall Study|Sponsor Decision|1|||
44375890|NCT00935532|79380970|FG000|Overall Study|Loss Glucose Control|4|||
44375891|NCT00935532|79380971|FG001|Overall Study|Loss Glucose Control|0|||
44375892|NCT01093586|79380977|FG000|Overall Study|Failed to engraft|3|||
44375893|NCT00937404|79380981|FG000|Overall Study|Protocol Violation|1|||
44375894|NCT00937404|79380981|FG000|Overall Study|Withdrawal by Subject|1|||
44375895|NCT01098110|79380988|FG000|Overall Study|Withdrawal by Subject|14|||
44228906|NCT01684033|79036424|FG000|Period 1, First 30 Days|Adverse Event|1|||
44228907|NCT01684033|79036425|FG001|Period 1, First 30 Days|Adverse Event|1|||
44228908|NCT01684033|79036424|FG000|Period 1, First 30 Days|Noncompliance|1|||
44228909|NCT01684033|79036425|FG001|Period 1, First 30 Days|Noncompliance|0|||
44228910|NCT01684033|79036424|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
44228911|NCT01684033|79036425|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
44228912|NCT01684033|79036424|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
44228913|NCT01684033|79036425|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
44228914|NCT01684033|79036424|FG000|Period 2, Second 30 Days|Adverse Event|1|||
44228915|NCT01684033|79036425|FG001|Period 2, Second 30 Days|Adverse Event|0|||
44228916|NCT01903811|79036466|FG000|Overall Study|No measurable disease|1|||
44228917|NCT01903811|79036467|FG001|Overall Study|No measurable disease|1|||
44228918|NCT01903811|79036466|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
44228919|NCT01903811|79036467|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
44228920|NCT01903811|79036466|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
44228921|NCT01903811|79036467|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
44228922|NCT01903811|79036466|FG000|Overall Study|Withdrawal by Subject|0|||
44375896|NCT01098110|79380989|FG001|Overall Study|Withdrawal by Subject|24|||
44375897|NCT01098110|79380990|FG002|Overall Study|Withdrawal by Subject|19|||
44375898|NCT01098110|79380988|FG000|Overall Study|Adverse Event|30|||
44375899|NCT01098110|79380989|FG001|Overall Study|Adverse Event|32|||
44375900|NCT01098110|79380990|FG002|Overall Study|Adverse Event|43|||
44228923|NCT01903811|79036467|FG001|Overall Study|Withdrawal by Subject|1|||
44228924|NCT01709149|79036484|FG000|Open-label Lead-in Phase|Adverse Event|109|||
44228925|NCT01709149|79036485|FG001|Open-label Lead-in Phase|Adverse Event|0|||
44228926|NCT01709149|79036486|FG002|Open-label Lead-in Phase|Adverse Event|0|||
44228927|NCT01709149|79036484|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
44228928|NCT01709149|79036485|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
44228929|NCT01709149|79036486|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
44228930|NCT01709149|79036484|FG000|Open-label Lead-in Phase|Death|1|||
44228931|NCT01709149|79036485|FG001|Open-label Lead-in Phase|Death|0|||
44228932|NCT01709149|79036486|FG002|Open-label Lead-in Phase|Death|0|||
44228933|NCT01709149|79036484|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
44228934|NCT01709149|79036485|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
44375901|NCT01098110|79380988|FG000|Overall Study|Lack of Efficacy|13|||
44375902|NCT01098110|79380989|FG001|Overall Study|Lack of Efficacy|9|||
44375903|NCT01098110|79380990|FG002|Overall Study|Lack of Efficacy|27|||
44375904|NCT01098110|79380988|FG000|Overall Study|Other|4|||
44375905|NCT01098110|79380989|FG001|Overall Study|Other|7|||
44375906|NCT01098110|79380990|FG002|Overall Study|Other|5|||
44375907|NCT01098110|79380988|FG000|Overall Study|Untreated|1|||
44375908|NCT01098110|79380989|FG001|Overall Study|Untreated|1|||
44375909|NCT01098110|79380990|FG002|Overall Study|Untreated|0|||
44375910|NCT01092728|79381000|FG000|Overall Study|Withdrawal by Subject|2|||
44228935|NCT01709149|79036486|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
44228936|NCT01709149|79036484|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
44228937|NCT01709149|79036485|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
44228938|NCT01709149|79036486|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
44375911|NCT01092728|79381001|FG001|Overall Study|Withdrawal by Subject|0|||
44375912|NCT01092728|79381000|FG000|Overall Study|Adverse Event|0|||
44375913|NCT01092728|79381001|FG001|Overall Study|Adverse Event|1|||
44375914|NCT01092728|79381000|FG000|Overall Study|Disease Progression|1|||
44375915|NCT01092728|79381001|FG001|Overall Study|Disease Progression|13|||
44375916|NCT01092728|79381000|FG000|Overall Study|Prohibited Concomitant Medications|1|||
44228939|NCT01709149|79036484|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
44228940|NCT01709149|79036485|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
44375917|NCT01092728|79381001|FG001|Overall Study|Prohibited Concomitant Medications|0|||
44228941|NCT01709149|79036486|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
44375918|NCT01096550|79381009|FG000|Overall Study|discontinued site|10|||
44375919|NCT01096550|79381010|FG001|Overall Study|discontinued site|11|||
44490272|NCT00004228|79496303|FG005|Overall Study|Lost to Follow-up|0|||
44490273|NCT00004228|79496304|FG006|Overall Study|Lost to Follow-up|0|||
44490274|NCT00004228|79496298|FG000|Overall Study|Physician Decision|1|||
44490275|NCT00004228|79496299|FG001|Overall Study|Physician Decision|0|||
44490276|NCT00004228|79496300|FG002|Overall Study|Physician Decision|3|||
44490277|NCT00004228|79496301|FG003|Overall Study|Physician Decision|2|||
44490278|NCT00004228|79496302|FG004|Overall Study|Physician Decision|1|||
44375920|NCT01096550|79381009|FG000|Overall Study|non-regular treatment track at clinic|1|||
44375921|NCT01096550|79381010|FG001|Overall Study|non-regular treatment track at clinic|1|||
44375922|NCT01096550|79381009|FG000|Overall Study|clinic readmission|1|||
44375923|NCT01096550|79381010|FG001|Overall Study|clinic readmission|1|||
44375924|NCT01096550|79381009|FG000|Overall Study|Withdrawal by Subject|0|||
44375925|NCT01096550|79381010|FG001|Overall Study|Withdrawal by Subject|1|||
44375926|NCT01096550|79381009|FG000|Overall Study|non-African American participant|13|||
44375927|NCT01096550|79381010|FG001|Overall Study|non-African American participant|6|||
44228942|NCT01709149|79036484|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
44228943|NCT01709149|79036485|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
44228944|NCT01709149|79036486|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
44375928|NCT01096550|79381009|FG000|Overall Study|Lost to Follow-up|12|||
44375929|NCT01096550|79381010|FG001|Overall Study|Lost to Follow-up|9|||
44375930|NCT01101542|79381016|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
44375931|NCT01101542|79381016|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
44375932|NCT01101542|79381016|FG000|Year 4 Surveillance Period|Other|287|||
44375933|NCT01101542|79381016|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
44375934|NCT01101542|79381016|FG000|Year 5 Surveillance Period|Pregnancy|1|||
44375935|NCT01101542|79381016|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
44375936|NCT01101542|79381016|FG000|Year 6 Surveillance Period|Pregnancy|1|||
44375937|NCT01101542|79381016|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
44375938|NCT00937326|79381025|FG000|Overall Study|Adverse Event|0|||
44375939|NCT00937326|79381026|FG001|Overall Study|Adverse Event|3|||
44375940|NCT00937326|79381027|FG002|Overall Study|Adverse Event|1|||
44375941|NCT00937326|79381028|FG003|Overall Study|Adverse Event|1|||
44375942|NCT00937326|79381029|FG004|Overall Study|Adverse Event|2|||
44490279|NCT00004228|79496303|FG005|Overall Study|Physician Decision|1|||
44490280|NCT00004228|79496304|FG006|Overall Study|Physician Decision|1|||
44490281|NCT00004228|79496298|FG000|Overall Study|Protocol Violation|0|||
44490282|NCT00004228|79496299|FG001|Overall Study|Protocol Violation|5|||
44490283|NCT00004228|79496300|FG002|Overall Study|Protocol Violation|2|||
44490284|NCT00004228|79496301|FG003|Overall Study|Protocol Violation|1|||
44490285|NCT00004228|79496302|FG004|Overall Study|Protocol Violation|1|||
44490286|NCT00004228|79496303|FG005|Overall Study|Protocol Violation|2|||
44490287|NCT00004228|79496304|FG006|Overall Study|Protocol Violation|0|||
44490288|NCT00004228|79496298|FG000|Overall Study|Withdrawal by Subject|3|||
44490289|NCT00004228|79496299|FG001|Overall Study|Withdrawal by Subject|0|||
44490290|NCT00004228|79496300|FG002|Overall Study|Withdrawal by Subject|1|||
44490291|NCT00004228|79496301|FG003|Overall Study|Withdrawal by Subject|0|||
44490292|NCT00004228|79496302|FG004|Overall Study|Withdrawal by Subject|2|||
44490293|NCT00004228|79496303|FG005|Overall Study|Withdrawal by Subject|1|||
44490294|NCT00004228|79496304|FG006|Overall Study|Withdrawal by Subject|2|||
44490295|NCT00004228|79496298|FG000|Overall Study|Other|0|||
44490296|NCT00004228|79496299|FG001|Overall Study|Other|0|||
44490297|NCT00004228|79496300|FG002|Overall Study|Other|1|||
44490298|NCT00004228|79496301|FG003|Overall Study|Other|0|||
44490299|NCT00004228|79496302|FG004|Overall Study|Other|0|||
44490300|NCT00004228|79496303|FG005|Overall Study|Other|0|||
44490301|NCT00004228|79496304|FG006|Overall Study|Other|0|||
44490302|NCT00004228|79496298|FG000|Overall Study|ineligible|4|||
44490303|NCT00004228|79496299|FG001|Overall Study|ineligible|2|||
44490304|NCT00004228|79496300|FG002|Overall Study|ineligible|4|||
44490305|NCT00004228|79496301|FG003|Overall Study|ineligible|1|||
44375943|NCT00937326|79381025|FG000|Overall Study|Death|0|||
44490306|NCT00004228|79496302|FG004|Overall Study|ineligible|1|||
44490307|NCT00004228|79496303|FG005|Overall Study|ineligible|2|||
44490308|NCT00004228|79496304|FG006|Overall Study|ineligible|5|||
44375944|NCT00937326|79381026|FG001|Overall Study|Death|0|||
44375945|NCT00937326|79381027|FG002|Overall Study|Death|1|||
44490309|NCT00003526|79496321|FG000|Overall Study|Not evaluable|6|||
44375946|NCT00937326|79381028|FG003|Overall Study|Death|0|||
44490310|NCT00195260|79496327|FG000|Part 1: Dose Escalation|Adverse Event|0|||
44490311|NCT00195260|79496328|FG001|Part 1: Dose Escalation|Adverse Event|1|||
44490312|NCT00195260|79496329|FG002|Part 1: Dose Escalation|Adverse Event|0|||
44375947|NCT00937326|79381029|FG004|Overall Study|Death|0|||
44490313|NCT00195260|79496330|FG003|Part 1: Dose Escalation|Adverse Event|1|||
44490314|NCT00195260|79496331|FG004|Part 1: Dose Escalation|Adverse Event|1|||
44490315|NCT00195260|79496332|FG005|Part 1: Dose Escalation|Adverse Event|0|||
44490316|NCT00195260|79496333|FG006|Part 1: Dose Escalation|Adverse Event|3|||
44490317|NCT00195260|79496334|FG007|Part 1: Dose Escalation|Adverse Event|0|||
44490318|NCT00195260|79496335|FG008|Part 1: Dose Escalation|Adverse Event|0|||
44490319|NCT00195260|79496336|FG009|Part 1: Dose Escalation|Adverse Event|0|||
44490320|NCT00195260|79496337|FG010|Part 1: Dose Escalation|Adverse Event|0|||
44490321|NCT00195260|79496327|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490322|NCT00195260|79496328|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490323|NCT00195260|79496329|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490324|NCT00195260|79496330|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490325|NCT00195260|79496331|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
44490326|NCT00195260|79496332|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490327|NCT00195260|79496333|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490328|NCT00195260|79496334|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
44490329|NCT00195260|79496335|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490330|NCT00195260|79496336|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490331|NCT00195260|79496337|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44490332|NCT00195260|79496327|FG000|Part 1: Dose Escalation|Death|0|||
44490333|NCT00195260|79496328|FG001|Part 1: Dose Escalation|Death|0|||
44490334|NCT00195260|79496329|FG002|Part 1: Dose Escalation|Death|0|||
44490335|NCT00195260|79496330|FG003|Part 1: Dose Escalation|Death|0|||
44490336|NCT00195260|79496331|FG004|Part 1: Dose Escalation|Death|0|||
44490337|NCT00195260|79496332|FG005|Part 1: Dose Escalation|Death|0|||
44490338|NCT00195260|79496333|FG006|Part 1: Dose Escalation|Death|0|||
44490339|NCT00195260|79496334|FG007|Part 1: Dose Escalation|Death|1|||
44490340|NCT00195260|79496335|FG008|Part 1: Dose Escalation|Death|0|||
44490341|NCT00195260|79496336|FG009|Part 1: Dose Escalation|Death|0|||
44490342|NCT00195260|79496337|FG010|Part 1: Dose Escalation|Death|0|||
44490343|NCT00195260|79496327|FG000|Part 1: Dose Escalation|Disease Progression|3|||
44490344|NCT00195260|79496328|FG001|Part 1: Dose Escalation|Disease Progression|2|||
44490345|NCT00195260|79496329|FG002|Part 1: Dose Escalation|Disease Progression|5|||
44490346|NCT00195260|79496330|FG003|Part 1: Dose Escalation|Disease Progression|6|||
44490347|NCT00195260|79496331|FG004|Part 1: Dose Escalation|Disease Progression|4|||
44490348|NCT00195260|79496332|FG005|Part 1: Dose Escalation|Disease Progression|6|||
44490349|NCT00195260|79496333|FG006|Part 1: Dose Escalation|Disease Progression|7|||
44490350|NCT00195260|79496334|FG007|Part 1: Dose Escalation|Disease Progression|4|||
44490351|NCT00195260|79496335|FG008|Part 1: Dose Escalation|Disease Progression|0|||
44490352|NCT00195260|79496336|FG009|Part 1: Dose Escalation|Disease Progression|0|||
44490353|NCT00195260|79496337|FG010|Part 1: Dose Escalation|Disease Progression|0|||
44490354|NCT00195260|79496327|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
44490355|NCT00195260|79496328|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
44490356|NCT00195260|79496329|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
44490357|NCT00195260|79496330|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490358|NCT00195260|79496331|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490359|NCT00195260|79496332|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
44490360|NCT00195260|79496333|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490361|NCT00195260|79496334|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490362|NCT00195260|79496335|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490363|NCT00195260|79496336|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490364|NCT00195260|79496337|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
44490365|NCT00195260|79496327|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490366|NCT00195260|79496328|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490367|NCT00195260|79496329|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490368|NCT00195260|79496330|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490369|NCT00195260|79496331|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490370|NCT00195260|79496332|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490371|NCT00195260|79496333|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44490372|NCT00195260|79496334|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
44228945|NCT01709149|79036484|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
44375948|NCT00937326|79381025|FG000|Overall Study|Withdrawal by Subject|3|||
44490373|NCT00195260|79496335|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
44490374|NCT00195260|79496336|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
44490375|NCT00195260|79496337|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
44490376|NCT00195260|79496327|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490377|NCT00195260|79496328|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490378|NCT00195260|79496329|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490379|NCT00195260|79496330|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490380|NCT00195260|79496331|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44228946|NCT01709149|79036485|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
44228947|NCT01709149|79036486|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
44228948|NCT01709149|79036484|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
44228949|NCT01709149|79036485|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
44228950|NCT01709149|79036486|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
44228951|NCT01709149|79036484|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44228952|NCT01709149|79036485|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
44228953|NCT01709149|79036486|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
44228954|NCT01568593|79036495|FG000|Overall Study|Lack of Efficacy|4|||
44490381|NCT00195260|79496332|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490382|NCT00195260|79496333|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490383|NCT00195260|79496334|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
44490384|NCT00195260|79496335|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
44490385|NCT00195260|79496336|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
44490386|NCT00195260|79496337|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
44490387|NCT00195260|79496327|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490388|NCT00195260|79496328|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490389|NCT00195260|79496329|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490390|NCT00195260|79496330|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490391|NCT00195260|79496331|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490392|NCT00195260|79496332|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490393|NCT00195260|79496333|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490394|NCT00195260|79496334|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
44490395|NCT00195260|79496335|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
44490396|NCT00195260|79496336|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
44490397|NCT00195260|79496337|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
44490398|NCT00195260|79496327|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490399|NCT00195260|79496328|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490400|NCT00195260|79496329|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490401|NCT00195260|79496330|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490402|NCT00195260|79496331|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490403|NCT00195260|79496332|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490404|NCT00195260|79496333|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490405|NCT00195260|79496334|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
44490406|NCT00195260|79496335|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
44490407|NCT00195260|79496336|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
44490408|NCT00195260|79496337|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
44490409|NCT00031486|79496367|FG000|Overall Study|Adverse Event|1|||
44490410|NCT00031486|79496368|FG001|Overall Study|Adverse Event|0|||
44490411|NCT00031486|79496367|FG000|Overall Study|Lost to Follow-up|0|||
44490412|NCT00031486|79496368|FG001|Overall Study|Lost to Follow-up|1|||
44490413|NCT00031486|79496367|FG000|Overall Study|Withdrawal by Subject|3|||
44490414|NCT00031486|79496368|FG001|Overall Study|Withdrawal by Subject|2|||
44490415|NCT00031486|79496367|FG000|Overall Study|Death|0|||
44490416|NCT00031486|79496368|FG001|Overall Study|Death|3|||
44490417|NCT00031486|79496367|FG000|Overall Study|Non-compliant|0|||
44490418|NCT00031486|79496368|FG001|Overall Study|Non-compliant|4|||
44490419|NCT00031486|79496367|FG000|Overall Study|Did not meet eligibility requirement|2|||
44490420|NCT00031486|79496368|FG001|Overall Study|Did not meet eligibility requirement|1|||
44490421|NCT00031486|79496367|FG000|Overall Study|Other|1|||
44490422|NCT00031486|79496368|FG001|Overall Study|Other|1|||
44490423|NCT00003508|79496376|FG000|Overall Study|Not evaluable|5|||
44228955|NCT01568593|79036496|FG001|Overall Study|Lack of Efficacy|1|||
44228956|NCT01568593|79036495|FG000|Overall Study|Adverse Event|3|||
44228957|NCT01568593|79036496|FG001|Overall Study|Adverse Event|2|||
44490424|NCT00003472|79496380|FG000|Overall Study|Not evaluable|3|||
44490425|NCT00003298|79496384|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
44228958|NCT01683565|79036504|FG000|Overall Study|Lost to Follow-up|2|||
44490426|NCT00003298|79496384|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
44490427|NCT00003298|79496384|FG000|Surgery|Unresectable at surgery|3|||
44228959|NCT01683565|79036505|FG001|Overall Study|Lost to Follow-up|0|||
44228960|NCT01683565|79036504|FG000|Overall Study|Discontinued Intervention|1|||
44228961|NCT01683565|79036505|FG001|Overall Study|Discontinued Intervention|1|||
44228962|NCT01903031|79036529|FG000|Overall Study|Not Able to Attend Clinic|1|||
44228963|NCT01903031|79036530|FG001|Overall Study|Not Able to Attend Clinic|1|||
44228964|NCT01903031|79036531|FG002|Overall Study|Not Able to Attend Clinic|0|||
44490428|NCT00003298|79496384|FG000|Surgery|Progression before surgery|2|||
44490429|NCT00003298|79496384|FG000|Surgery|Unevaluable and off study|2|||
44490430|NCT00003298|79496384|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
44490431|NCT00003298|79496384|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
44490432|NCT00003298|79496384|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
44490433|NCT00003298|79496384|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
44490434|NCT00003298|79496384|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
44490435|NCT00003298|79496384|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
44490436|NCT00003298|79496384|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
44490437|NCT00003298|79496384|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
44490438|NCT00003298|79496384|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
44490439|NCT00003298|79496384|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
44490440|NCT00002842|79496389|FG000|Overall Study|ineligible for surgical resection|27|||
44490441|NCT00143247|79496393|FG000|Overall Study|Death|8|||
44490442|NCT00143247|79496393|FG000|Overall Study|Adverse Event|19|||
44490443|NCT00143247|79496393|FG000|Overall Study|Lack of Efficacy|3|||
44490444|NCT00143247|79496393|FG000|Overall Study|Withdrawal by Subject|55|||
44490445|NCT00143247|79496393|FG000|Overall Study|Study terminated by sponsor|31|||
44490446|NCT00143247|79496393|FG000|Overall Study|Protocol Violation|15|||
44490447|NCT00143247|79496393|FG000|Overall Study|Lost to Follow-up|12|||
44490448|NCT00143247|79496393|FG000|Overall Study|following inaccurate lab adverse event|1|||
44490449|NCT00143247|79496393|FG000|Overall Study|Other|12|||
44490450|NCT00125853|79496397|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
44490451|NCT00125853|79496398|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
44490452|NCT00219141|79496407|FG000|Overall Study|Adverse Event|4|||
44490453|NCT00219141|79496408|FG001|Overall Study|Adverse Event|10|||
44490454|NCT00219141|79496409|FG002|Overall Study|Adverse Event|5|||
44490455|NCT00219141|79496407|FG000|Overall Study|Lack of Efficacy|3|||
44490456|NCT00219141|79496408|FG001|Overall Study|Lack of Efficacy|2|||
44490457|NCT00219141|79496409|FG002|Overall Study|Lack of Efficacy|0|||
44490458|NCT00219141|79496407|FG000|Overall Study|Administrative problems|0|||
44490459|NCT00219141|79496408|FG001|Overall Study|Administrative problems|1|||
44490460|NCT00219141|79496409|FG002|Overall Study|Administrative problems|0|||
44490461|NCT00219141|79496407|FG000|Overall Study|Lost to Follow-up|2|||
44490462|NCT00219141|79496408|FG001|Overall Study|Lost to Follow-up|4|||
44490463|NCT00219141|79496409|FG002|Overall Study|Lost to Follow-up|1|||
44490464|NCT00219141|79496407|FG000|Overall Study|Protocol Violation|3|||
44490465|NCT00219141|79496408|FG001|Overall Study|Protocol Violation|1|||
44490466|NCT00219141|79496409|FG002|Overall Study|Protocol Violation|1|||
44490467|NCT00219141|79496407|FG000|Overall Study|Withdrawal by Subject|1|||
44490468|NCT00219141|79496408|FG001|Overall Study|Withdrawal by Subject|3|||
44490469|NCT00219141|79496409|FG002|Overall Study|Withdrawal by Subject|5|||
44490470|NCT00219141|79496407|FG000|Overall Study|Condition no longer requires study drug|1|||
44490471|NCT00219141|79496408|FG001|Overall Study|Condition no longer requires study drug|0|||
44490472|NCT00219141|79496409|FG002|Overall Study|Condition no longer requires study drug|0|||
44490473|NCT00142935|79496420|FG000|Overall Study|Other reason|1|||
44490474|NCT00142935|79496421|FG001|Overall Study|Other reason|1|||
44490475|NCT00142935|79496422|FG002|Overall Study|Other reason|1|||
44490476|NCT00142935|79496420|FG000|Overall Study|Lost to Follow-up|2|||
44490477|NCT00142935|79496421|FG001|Overall Study|Lost to Follow-up|5|||
44490478|NCT00142935|79496422|FG002|Overall Study|Lost to Follow-up|5|||
44490479|NCT00142935|79496420|FG000|Overall Study|Death|0|||
44228965|NCT01903031|79036529|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
44228966|NCT01903031|79036530|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
44490480|NCT00142935|79496421|FG001|Overall Study|Death|2|||
44490481|NCT00142935|79496422|FG002|Overall Study|Death|1|||
44490482|NCT00233948|79496436|FG000|Overall Study|Adverse Event|1|||
44490483|NCT00233948|79496437|FG001|Overall Study|Adverse Event|0|||
44490484|NCT00233948|79496438|FG002|Overall Study|Adverse Event|0|||
44490485|NCT00233948|79496439|FG003|Overall Study|Adverse Event|0|||
44490486|NCT00233948|79496440|FG004|Overall Study|Adverse Event|0|||
44490487|NCT00233948|79496441|FG005|Overall Study|Adverse Event|0|||
44490488|NCT00233480|79496458|FG000|Overall Study|Underwent status II heart transplant|0|||
44490489|NCT00233480|79496459|FG001|Overall Study|Underwent status II heart transplant|1|||
44490490|NCT03801928|79496473|FG000|Overall Study|Adverse Event|1|||
44490491|NCT03801928|79496474|FG001|Overall Study|Adverse Event|0|||
44490492|NCT03801928|79496475|FG002|Overall Study|Adverse Event|1|||
44490493|NCT03801928|79496476|FG003|Overall Study|Adverse Event|2|||
44490494|NCT03801928|79496477|FG004|Overall Study|Adverse Event|0|||
44490495|NCT03801928|79496478|FG005|Overall Study|Adverse Event|2|||
44490496|NCT03801928|79496473|FG000|Overall Study|Lack of Efficacy|0|||
44490497|NCT03801928|79496474|FG001|Overall Study|Lack of Efficacy|0|||
44490498|NCT03801928|79496475|FG002|Overall Study|Lack of Efficacy|1|||
44490499|NCT03801928|79496476|FG003|Overall Study|Lack of Efficacy|0|||
44490500|NCT03801928|79496477|FG004|Overall Study|Lack of Efficacy|0|||
44490501|NCT03801928|79496478|FG005|Overall Study|Lack of Efficacy|0|||
44490502|NCT03801928|79496473|FG000|Overall Study|Lost to Follow-up|5|||
44490503|NCT03801928|79496474|FG001|Overall Study|Lost to Follow-up|1|||
44490504|NCT03801928|79496475|FG002|Overall Study|Lost to Follow-up|1|||
44490505|NCT03801928|79496476|FG003|Overall Study|Lost to Follow-up|4|||
44490506|NCT03801928|79496477|FG004|Overall Study|Lost to Follow-up|4|||
44490507|NCT03801928|79496478|FG005|Overall Study|Lost to Follow-up|2|||
44490508|NCT03801928|79496473|FG000|Overall Study|Withdrawal by Subject|0|||
44490509|NCT03801928|79496474|FG001|Overall Study|Withdrawal by Subject|0|||
44490510|NCT03801928|79496475|FG002|Overall Study|Withdrawal by Subject|2|||
44490511|NCT03801928|79496476|FG003|Overall Study|Withdrawal by Subject|1|||
44490512|NCT03801928|79496477|FG004|Overall Study|Withdrawal by Subject|0|||
44490513|NCT03801928|79496478|FG005|Overall Study|Withdrawal by Subject|0|||
44490514|NCT03801928|79496473|FG000|Overall Study|Other|0|||
44490515|NCT03801928|79496474|FG001|Overall Study|Other|2|||
44490516|NCT03801928|79496475|FG002|Overall Study|Other|0|||
44490517|NCT03801928|79496476|FG003|Overall Study|Other|1|||
44490518|NCT03801928|79496477|FG004|Overall Study|Other|0|||
44228967|NCT01903031|79036531|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
44228968|NCT01903031|79036529|FG000|Overall Study|Adverse Event|0|||
44490519|NCT03801928|79496478|FG005|Overall Study|Other|1|||
44228969|NCT01903031|79036530|FG001|Overall Study|Adverse Event|1|||
44490520|NCT00263588|79496497|FG000|Overall Study|Death|54|||
44490521|NCT00263588|79496498|FG001|Overall Study|Death|90|||
44490522|NCT00263588|79496497|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
44490523|NCT00263588|79496498|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
44490524|NCT00263588|79496497|FG000|Overall Study|Lost to Follow-up|7|||
44490525|NCT00263588|79496498|FG001|Overall Study|Lost to Follow-up|10|||
44228970|NCT01903031|79036531|FG002|Overall Study|Adverse Event|0|||
44228971|NCT01903031|79036529|FG000|Overall Study|Withdrawal by Subject|0|||
44228972|NCT01903031|79036530|FG001|Overall Study|Withdrawal by Subject|1|||
44228973|NCT01903031|79036531|FG002|Overall Study|Withdrawal by Subject|1|||
44228974|NCT01903031|79036529|FG000|Overall Study|Protocol Violation|0|||
44228975|NCT01903031|79036530|FG001|Overall Study|Protocol Violation|0|||
44228976|NCT01903031|79036531|FG002|Overall Study|Protocol Violation|2|||
44228977|NCT01903031|79036529|FG000|Overall Study|Lost to Follow-up|0|||
44228978|NCT01903031|79036530|FG001|Overall Study|Lost to Follow-up|0|||
44228979|NCT01903031|79036531|FG002|Overall Study|Lost to Follow-up|1|||
44228980|NCT01903031|79036529|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
44228981|NCT01903031|79036530|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
44228982|NCT01903031|79036531|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
44228983|NCT01616693|79036563|FG000|Evaluated for Safety|Physician Decision|1|||
44228984|NCT01616693|79036564|FG001|Evaluated for Safety|Physician Decision|0|||
44490526|NCT00263588|79496497|FG000|Overall Study|Withdrawal by Subject|3|||
44490527|NCT00263588|79496498|FG001|Overall Study|Withdrawal by Subject|4|||
44490528|NCT00263588|79496497|FG000|Overall Study|Protocol Violation|0|||
44490529|NCT00263588|79496498|FG001|Overall Study|Protocol Violation|1|||
44490530|NCT00263588|79496497|FG000|Overall Study|Investigator decision|7|||
44490531|NCT00263588|79496498|FG001|Overall Study|Investigator decision|15|||
44490532|NCT00263588|79496497|FG000|Overall Study|Sponsor terminated study|0|||
44490533|NCT00263588|79496498|FG001|Overall Study|Sponsor terminated study|1|||
44490534|NCT00213135|79496508|FG000|Overall Study|Adverse Event|9|||
44228985|NCT01616693|79036565|FG002|Evaluated for Safety|Physician Decision|1|||
44228986|NCT01616693|79036566|FG003|Evaluated for Safety|Physician Decision|0|||
44228987|NCT01616693|79036563|FG000|Received Both Vaccines|Adverse Event|2|||
44490535|NCT00213135|79496509|FG001|Overall Study|Adverse Event|5|||
44490536|NCT00213135|79496510|FG002|Overall Study|Adverse Event|5|||
44490537|NCT00213135|79496508|FG000|Overall Study|Lost to Follow-up|11|||
44490538|NCT00213135|79496509|FG001|Overall Study|Lost to Follow-up|8|||
44490539|NCT00213135|79496510|FG002|Overall Study|Lost to Follow-up|4|||
44490540|NCT00213135|79496508|FG000|Overall Study|Protocol Violation|4|||
44228988|NCT01616693|79036564|FG001|Received Both Vaccines|Adverse Event|0|||
44228989|NCT01616693|79036565|FG002|Received Both Vaccines|Adverse Event|0|||
44228990|NCT01616693|79036566|FG003|Received Both Vaccines|Adverse Event|0|||
44228991|NCT01616693|79036563|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
44228992|NCT01616693|79036564|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
44228993|NCT01616693|79036565|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
44228994|NCT01616693|79036566|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
44228995|NCT01616693|79036563|FG000|Received Both Vaccines|Lost to Follow-up|4|||
44228996|NCT01616693|79036564|FG001|Received Both Vaccines|Lost to Follow-up|3|||
44228997|NCT01616693|79036565|FG002|Received Both Vaccines|Lost to Follow-up|4|||
44228998|NCT01616693|79036566|FG003|Received Both Vaccines|Lost to Follow-up|4|||
44490541|NCT00213135|79496509|FG001|Overall Study|Protocol Violation|4|||
44228999|NCT01616693|79036563|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
44229000|NCT01616693|79036564|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
44490542|NCT00213135|79496510|FG002|Overall Study|Protocol Violation|10|||
44490543|NCT00213135|79496508|FG000|Overall Study|Death|1|||
44490544|NCT00213135|79496509|FG001|Overall Study|Death|1|||
44490545|NCT00213135|79496510|FG002|Overall Study|Death|2|||
44490546|NCT00213135|79496508|FG000|Overall Study|Disease progression|4|||
44490547|NCT00213135|79496509|FG001|Overall Study|Disease progression|5|||
44490548|NCT00213135|79496510|FG002|Overall Study|Disease progression|21|||
44490549|NCT00213135|79496508|FG000|Overall Study|Other|21|||
44490550|NCT00213135|79496509|FG001|Overall Study|Other|12|||
44490551|NCT00213135|79496510|FG002|Overall Study|Other|15|||
44490552|NCT00077974|79496518|FG000|Overall Study|Adverse Event|22|||
44490553|NCT00077974|79496518|FG000|Overall Study|Protocol Violation|1|||
44490554|NCT00077974|79496518|FG000|Overall Study|Withdrawal by Subject|3|||
44490555|NCT00077974|79496518|FG000|Overall Study|Lack of Efficacy|76|||
44490556|NCT00077974|79496518|FG000|Overall Study|Decision of Sponsor|2|||
44490557|NCT00124917|79496522|FG000|Overall Study|Physician Decision|3|||
44490558|NCT00141921|79496527|FG000|Overall Study|Remain on Study|28|||
44490559|NCT00141921|79496527|FG000|Overall Study|Withdrawal by Subject|42|||
44490560|NCT00141921|79496527|FG000|Overall Study|Lost to Follow-up|19|||
44490561|NCT00141921|79496527|FG000|Overall Study|Noncompliance|17|||
44490562|NCT00141921|79496527|FG000|Overall Study|Disease Progression|7|||
44490563|NCT00141921|79496527|FG000|Overall Study|Protocol Deviation|7|||
44490564|NCT00141921|79496527|FG000|Overall Study|Adverse Event|5|||
44229001|NCT01616693|79036565|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
44229002|NCT01616693|79036566|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
44229003|NCT01616459|79036673|FG000|Overall Study|Adverse Event|1|||
44490565|NCT00141921|79496527|FG000|Overall Study|Administrative Decision|2|||
44490566|NCT00141921|79496527|FG000|Overall Study|Pregnancy|4|||
44490567|NCT00141921|79496527|FG000|Overall Study|Ineligibility Determined|2|||
44490568|NCT00141921|79496527|FG000|Overall Study|Other|8|||
44490569|NCT00029146|79496533|FG000|Overall Study|Lost to Follow-up|2|||
44229004|NCT01616459|79036674|FG001|Overall Study|Adverse Event|1|||
44229005|NCT01616459|79036675|FG002|Overall Study|Adverse Event|2|||
44490570|NCT00029146|79496534|FG001|Overall Study|Lost to Follow-up|1|||
44490571|NCT00026494|79496544|FG000|Overall Study|Withdrawal by Subject|1|||
44490572|NCT00026494|79496545|FG001|Overall Study|Withdrawal by Subject|0|||
44490573|NCT00026494|79496546|FG002|Overall Study|Withdrawal by Subject|1|||
44490574|NCT00026494|79496547|FG003|Overall Study|Withdrawal by Subject|0|||
44490575|NCT00026494|79496544|FG000|Overall Study|Patient non-compliance|1|||
44490576|NCT00026494|79496545|FG001|Overall Study|Patient non-compliance|0|||
44490577|NCT00026494|79496546|FG002|Overall Study|Patient non-compliance|0|||
44274400|NCT02256631|79218124|FG006|Overall Study|Withdrawal by Subject|1|||
44274401|NCT02256631|79218118|FG000|Overall Study|Unable to get to clinic|0|||
44490578|NCT00026494|79496547|FG003|Overall Study|Patient non-compliance|0|||
44490579|NCT00026494|79496544|FG000|Overall Study|Patient not treated|0|||
44490580|NCT00026494|79496545|FG001|Overall Study|Patient not treated|0|||
44490581|NCT00026494|79496546|FG002|Overall Study|Patient not treated|2|||
44490582|NCT00026494|79496547|FG003|Overall Study|Patient not treated|0|||
44490583|NCT00026494|79496544|FG000|Overall Study|Clinical progression|0|||
44490584|NCT00026494|79496545|FG001|Overall Study|Clinical progression|0|||
44490585|NCT00026494|79496546|FG002|Overall Study|Clinical progression|3|||
44490586|NCT00026494|79496547|FG003|Overall Study|Clinical progression|0|||
44490587|NCT00023764|79496557|FG000|Overall Study|Other|1|||
44490588|NCT00023764|79496557|FG000|Overall Study|Adverse Event|4|||
44490589|NCT00023764|79496557|FG000|Overall Study|Withdrawal by Subject|1|||
44490590|NCT00023764|79496557|FG000|Overall Study|Progression of disease|6|||
44490591|NCT00023764|79496557|FG000|Overall Study|patient received other treatment|1|||
44490592|NCT00023764|79496557|FG000|Overall Study|delay in obtaining staging images|1|||
44490593|NCT00189488|79496564|FG000|Overall Study|Ineligibility determined|1|||
44490594|NCT00189488|79496565|FG001|Overall Study|Ineligibility determined|0|||
44490595|NCT00189488|79496564|FG000|Overall Study|Protocol deviation|2|||
44490596|NCT00189488|79496565|FG001|Overall Study|Protocol deviation|1|||
44490597|NCT00189488|79496564|FG000|Overall Study|Adverse Event|2|||
44490598|NCT00189488|79496565|FG001|Overall Study|Adverse Event|1|||
44490599|NCT00189488|79496564|FG000|Overall Study|Withdrawal by Subject|2|||
44490600|NCT00189488|79496565|FG001|Overall Study|Withdrawal by Subject|6|||
44490601|NCT00189488|79496564|FG000|Overall Study|Disease progression|2|||
44490602|NCT00189488|79496565|FG001|Overall Study|Disease progression|4|||
44490603|NCT00189488|79496564|FG000|Overall Study|Administrative Decision|0|||
44490604|NCT00189488|79496565|FG001|Overall Study|Administrative Decision|2|||
44490605|NCT00189488|79496564|FG000|Overall Study|Death|5|||
44490606|NCT00189488|79496565|FG001|Overall Study|Death|8|||
44490607|NCT00189488|79496564|FG000|Overall Study|Other|1|||
44490608|NCT00189488|79496565|FG001|Overall Study|Other|0|||
44490609|NCT00233402|79496574|FG000|Overall Study|No pathology data|12|||
44490610|NCT00233402|79496575|FG001|Overall Study|No pathology data|9|||
44490611|NCT00233402|79496574|FG000|Overall Study|No Ta/T1|89|||
44490612|NCT00233402|79496575|FG001|Overall Study|No Ta/T1|94|||
44490613|NCT00233402|79496574|FG000|Overall Study|Lost to follow up etc|3|||
44490614|NCT00233402|79496575|FG001|Overall Study|Lost to follow up etc|21|||
44490615|NCT00233324|79496587|FG000|Main Study|Death|68|||
44490616|NCT00233324|79496588|FG001|Main Study|Death|60|||
44490617|NCT00233324|79496589|FG002|Main Study|Death|62|||
44490618|NCT00233324|79496590|FG003|Main Study|Death|47|||
44490619|NCT00233324|79496587|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
44490620|NCT00233324|79496588|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
44490621|NCT00233324|79496589|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
44490622|NCT00233324|79496590|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
44545298|NCT03518125|79559074|FG003|Overall Study|Physician Decision|0|||
44545299|NCT03518125|79559075|FG004|Overall Study|Physician Decision|0|||
44545300|NCT03518125|79559076|FG005|Overall Study|Physician Decision|0|||
44545301|NCT03518125|79559071|FG000|Overall Study|Withdrawal by Subject|1|||
44545302|NCT03518125|79559072|FG001|Overall Study|Withdrawal by Subject|1|||
44545303|NCT03518125|79559073|FG002|Overall Study|Withdrawal by Subject|0|||
44545304|NCT03518125|79559074|FG003|Overall Study|Withdrawal by Subject|1|||
44545305|NCT03518125|79559075|FG004|Overall Study|Withdrawal by Subject|1|||
44490623|NCT00233324|79496587|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
44490624|NCT00233324|79496588|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
44490625|NCT00233324|79496589|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
44490626|NCT00233324|79496590|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
44490627|NCT00023452|79496609|FG000|Overall Study|Ineligible for Study|163|||
44490628|NCT00023452|79496610|FG001|Overall Study|Ineligible for Study|159|||
44490629|NCT00023452|79496609|FG000|Overall Study|Out of Window|129|||
44490630|NCT00023452|79496610|FG001|Overall Study|Out of Window|69|||
44490631|NCT00023452|79496609|FG000|Overall Study|Death|2|||
44490632|NCT00023452|79496610|FG001|Overall Study|Death|0|||
44490633|NCT00023452|79496609|FG000|Overall Study|Withdrawal by Subject|66|||
44490634|NCT00023452|79496610|FG001|Overall Study|Withdrawal by Subject|54|||
44490635|NCT00023452|79496609|FG000|Overall Study|Adverse Event|139|||
44490636|NCT00023452|79496610|FG001|Overall Study|Adverse Event|196|||
44490637|NCT00023452|79496609|FG000|Overall Study|Lost to Follow-up|293|||
44490638|NCT00023452|79496610|FG001|Overall Study|Lost to Follow-up|60|||
44490639|NCT00023452|79496609|FG000|Overall Study|Physician Decision|49|||
44490640|NCT00023452|79496610|FG001|Overall Study|Physician Decision|21|||
44490641|NCT00023452|79496609|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
44490642|NCT00023452|79496610|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
44490643|NCT00023452|79496609|FG000|Overall Study|Pregnant|53|||
44490644|NCT00023452|79496610|FG001|Overall Study|Pregnant|20|||
44490645|NCT00023452|79496609|FG000|Overall Study|Other|204|||
44490646|NCT00023452|79496610|FG001|Overall Study|Other|69|||
44490647|NCT00022672|79496622|FG000|Main Phase: 24 Months|Adverse Event|6|||
44490648|NCT00022672|79496623|FG001|Main Phase: 24 Months|Adverse Event|0|||
44490649|NCT00022672|79496622|FG000|Main Phase: 24 Months|Death|0|||
44490650|NCT00022672|79496623|FG001|Main Phase: 24 Months|Death|3|||
44490651|NCT00022672|79496622|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
44490652|NCT00022672|79496623|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
44490653|NCT00022672|79496622|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
44490654|NCT00022672|79496623|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
44490655|NCT00022672|79496622|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
44490656|NCT00022672|79496623|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
44490657|NCT00022672|79496622|FG000|Main Phase: 24 Months|Refused Treatment|3|||
44490658|NCT00022672|79496623|FG001|Main Phase: 24 Months|Refused Treatment|4|||
44490659|NCT00022672|79496622|FG000|Main Phase: 24 Months|Failure to Return|1|||
44490660|NCT00022672|79496623|FG001|Main Phase: 24 Months|Failure to Return|1|||
44490661|NCT00022672|79496622|FG000|Main Phase: 24 Months|Other|1|||
44490662|NCT00022672|79496623|FG001|Main Phase: 24 Months|Other|0|||
44490663|NCT00022672|79496622|FG000|Extension Phase|Adverse Event|1|||
44490664|NCT00022672|79496623|FG001|Extension Phase|Adverse Event|3|||
44490665|NCT00022672|79496622|FG000|Extension Phase|Death|0|||
44490666|NCT00022672|79496623|FG001|Extension Phase|Death|1|||
44490667|NCT00022672|79496622|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
44490668|NCT00022672|79496623|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
44490669|NCT00022672|79496622|FG000|Extension Phase|Refused Treatment|0|||
44490670|NCT00022672|79496623|FG001|Extension Phase|Refused Treatment|2|||
44490671|NCT00022672|79496622|FG000|Extension Phase|Other|1|||
44229006|NCT01616459|79036676|FG003|Overall Study|Adverse Event|0|||
44229007|NCT01616459|79036673|FG000|Overall Study|Lost to Follow-up|1|||
44229008|NCT01616459|79036674|FG001|Overall Study|Lost to Follow-up|11|||
44229009|NCT01616459|79036675|FG002|Overall Study|Lost to Follow-up|3|||
44229010|NCT01616459|79036676|FG003|Overall Study|Lost to Follow-up|2|||
44229011|NCT01616459|79036673|FG000|Overall Study|Protocol Violation|0|||
44229012|NCT01616459|79036674|FG001|Overall Study|Protocol Violation|0|||
44229013|NCT01616459|79036675|FG002|Overall Study|Protocol Violation|0|||
44375949|NCT00937326|79381026|FG001|Overall Study|Withdrawal by Subject|4|||
44375950|NCT00937326|79381027|FG002|Overall Study|Withdrawal by Subject|1|||
44490672|NCT00022672|79496623|FG001|Extension Phase|Other|1|||
44490673|NCT00076804|79496632|FG000|Overall Study|Death|9|||
44490674|NCT00076804|79496633|FG001|Overall Study|Death|20|||
44490675|NCT00076804|79496632|FG000|Overall Study|Lost to Follow-up|9|||
44490676|NCT00076804|79496633|FG001|Overall Study|Lost to Follow-up|9|||
44490677|NCT00076804|79496632|FG000|Overall Study|Withdrawal by Subject|10|||
44490678|NCT00076804|79496633|FG001|Overall Study|Withdrawal by Subject|8|||
44490679|NCT00076804|79496632|FG000|Overall Study|Early study Closure|32|||
44490680|NCT00076804|79496633|FG001|Overall Study|Early study Closure|32|||
44490681|NCT00141453|79496641|FG000|Overall Study|Protocol Violation|6|||
44490682|NCT00141453|79496642|FG001|Overall Study|Protocol Violation|5|||
44490683|NCT00076570|79496650|FG000|Overall Study|Drug intolerance|8|||
44490684|NCT00076570|79496651|FG001|Overall Study|Drug intolerance|8|||
44490685|NCT00124449|79496659|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
44490686|NCT00124449|79496660|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
44490687|NCT00124449|79496659|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
44490688|NCT00124449|79496660|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
44490689|NCT00124449|79496659|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
44490690|NCT00124449|79496660|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
44490691|NCT00124449|79496659|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
44490692|NCT00124449|79496660|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
44229014|NCT01616459|79036676|FG003|Overall Study|Protocol Violation|2|||
44229015|NCT01616459|79036673|FG000|Overall Study|Withdrawal by Subject|2|||
44490693|NCT00124449|79496659|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
44490694|NCT00124449|79496660|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
44490695|NCT00124449|79496659|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
44490696|NCT00124449|79496660|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
44490697|NCT00124449|79496659|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
44490698|NCT00124449|79496660|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
44490699|NCT00124449|79496659|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
44490700|NCT00124449|79496660|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
44490701|NCT00124449|79496659|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
44490702|NCT00124449|79496660|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
44490703|NCT00124449|79496659|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
44490704|NCT00124449|79496660|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
44490705|NCT00124449|79496659|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
44490706|NCT00124449|79496660|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
44490707|NCT00124449|79496659|FG000|18-Month Untreated Observation Period|Relocated|1|||
44490708|NCT00124449|79496660|FG001|18-Month Untreated Observation Period|Relocated|0|||
44490709|NCT00076336|79496669|FG000|Overall Study|Death|13|||
44490710|NCT00076336|79496670|FG001|Overall Study|Death|17|||
44490711|NCT00076336|79496669|FG000|Overall Study|Adverse Event|4|||
44490712|NCT00076336|79496670|FG001|Overall Study|Adverse Event|4|||
44490713|NCT00076336|79496669|FG000|Overall Study|Lost to Follow-up|4|||
44490714|NCT00076336|79496670|FG001|Overall Study|Lost to Follow-up|4|||
44490715|NCT00076336|79496669|FG000|Overall Study|Non-Compliance|2|||
44490716|NCT00076336|79496670|FG001|Overall Study|Non-Compliance|0|||
44490717|NCT00076336|79496669|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
44490718|NCT00076336|79496670|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
44490719|NCT00076336|79496669|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
44490720|NCT00076336|79496670|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
44490721|NCT00076336|79496669|FG000|Overall Study|Liver Transplantation|3|||
44490722|NCT00076336|79496670|FG001|Overall Study|Liver Transplantation|3|||
44490723|NCT00076336|79496669|FG000|Overall Study|Virologic Breakthrough|14|||
44490724|NCT00076336|79496670|FG001|Overall Study|Virologic Breakthrough|16|||
44490725|NCT00076336|79496669|FG000|Overall Study|Treatment failure|4|||
44490726|NCT00076336|79496670|FG001|Overall Study|Treatment failure|5|||
44490727|NCT00185588|79496680|FG000|Overall Study|Adverse Event|3|||
44490728|NCT00185588|79496681|FG001|Overall Study|Adverse Event|1|||
44490729|NCT00185588|79496682|FG002|Overall Study|Adverse Event|4|||
44490730|NCT00185588|79496683|FG003|Overall Study|Adverse Event|2|||
44490731|NCT00185588|79496680|FG000|Overall Study|Lost to Follow-up|0|||
44490732|NCT00185588|79496681|FG001|Overall Study|Lost to Follow-up|0|||
44490733|NCT00185588|79496682|FG002|Overall Study|Lost to Follow-up|1|||
44490734|NCT00185588|79496683|FG003|Overall Study|Lost to Follow-up|2|||
44490735|NCT00185588|79496680|FG000|Overall Study|Withdrawal by Subject|0|||
44490736|NCT00185588|79496681|FG001|Overall Study|Withdrawal by Subject|1|||
44490737|NCT00185588|79496682|FG002|Overall Study|Withdrawal by Subject|0|||
44490738|NCT00185588|79496683|FG003|Overall Study|Withdrawal by Subject|0|||
44490739|NCT00185588|79496680|FG000|Overall Study|Physician Decision|0|||
44490740|NCT00185588|79496681|FG001|Overall Study|Physician Decision|0|||
44490741|NCT00185588|79496682|FG002|Overall Study|Physician Decision|1|||
44490742|NCT00185588|79496683|FG003|Overall Study|Physician Decision|0|||
44229016|NCT01616459|79036674|FG001|Overall Study|Withdrawal by Subject|4|||
44490743|NCT00232544|79496695|FG000|Overall Study|Lost to Follow-up|20|||
44490744|NCT00232544|79496696|FG001|Overall Study|Lost to Follow-up|15|||
44490745|NCT00231842|79496702|FG000|Overall Study|Withdrawal by Subject|3|||
44490746|NCT00231842|79496702|FG000|Overall Study|Did not complete the last 3 cycle|8|||
44490747|NCT00076102|79496707|FG000|Overall Study|Clinical progression|1|||
44490748|NCT00076102|79496707|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
44490749|NCT00076102|79496707|FG000|Overall Study|plexiform neurofibroma surgery|1|||
44490750|NCT00076102|79496707|FG000|Overall Study|refusal of further therapy|2|||
44229017|NCT01616459|79036675|FG002|Overall Study|Withdrawal by Subject|4|||
44490751|NCT00231062|79496721|FG000|Overall Study|Physician Decision|6|||
44490752|NCT00184028|79496725|FG000|Overall Study|Death|1|||
44490753|NCT00184028|79496725|FG000|Overall Study|Lack of Efficacy|4|||
44490754|NCT00184028|79496725|FG000|Overall Study|Adverse Event|2|||
44490755|NCT00184028|79496725|FG000|Overall Study|Withdrawal by Subject|1|||
44490756|NCT00184028|79496725|FG000|Overall Study|Non-compliance|2|||
44490757|NCT00183872|79496730|FG000|Overall Study|Death|3|||
44490758|NCT00183872|79496730|FG000|Overall Study|Adverse Event|9|||
44490759|NCT00183872|79496730|FG000|Overall Study|Withdrawal by Subject|2|||
44490760|NCT00183872|79496730|FG000|Overall Study|Drug delayed more than 28 days|2|||
44490761|NCT03815175|79496734|FG000|Overall Study|Subject Lost to Follow-up|6|||
44490762|NCT03815175|79496734|FG000|Overall Study|Subject Withdrew Consent|48|||
44490763|NCT03815175|79496734|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
44490764|NCT03815175|79496734|FG000|Overall Study|Death|86|||
44490765|NCT03815175|79496734|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
44490766|NCT03815175|79496734|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
44490767|NCT03815175|79496734|FG000|Overall Study|Other Status Change Reason|1|||
44490768|NCT03815175|79496734|FG000|Overall Study|Missed Visit|12|||
44490769|NCT00262028|79496747|FG000|Overall Study|Withdrawal by Subject|6|||
44490770|NCT00262028|79496748|FG001|Overall Study|Withdrawal by Subject|3|||
44490771|NCT00262028|79496749|FG002|Overall Study|Withdrawal by Subject|6|||
44490772|NCT00262028|79496750|FG003|Overall Study|Withdrawal by Subject|5|||
44490773|NCT00262028|79496751|FG004|Overall Study|Withdrawal by Subject|2|||
44490774|NCT00262028|79496752|FG005|Overall Study|Withdrawal by Subject|3|||
44490775|NCT00262028|79496753|FG006|Overall Study|Withdrawal by Subject|5|||
44490776|NCT00262028|79496754|FG007|Overall Study|Withdrawal by Subject|7|||
44490777|NCT00262028|79496755|FG008|Overall Study|Withdrawal by Subject|2|||
44490778|NCT00262028|79496747|FG000|Overall Study|Lost to Follow-up|7|||
44490779|NCT00262028|79496748|FG001|Overall Study|Lost to Follow-up|7|||
44490780|NCT00262028|79496749|FG002|Overall Study|Lost to Follow-up|5|||
44490781|NCT00262028|79496750|FG003|Overall Study|Lost to Follow-up|5|||
44490782|NCT00262028|79496751|FG004|Overall Study|Lost to Follow-up|4|||
44490783|NCT00262028|79496752|FG005|Overall Study|Lost to Follow-up|3|||
44490784|NCT00262028|79496753|FG006|Overall Study|Lost to Follow-up|3|||
44490785|NCT00262028|79496754|FG007|Overall Study|Lost to Follow-up|5|||
44490786|NCT00262028|79496755|FG008|Overall Study|Lost to Follow-up|6|||
44490787|NCT00262028|79496747|FG000|Overall Study|Administrative Reason|11|||
44490788|NCT00262028|79496748|FG001|Overall Study|Administrative Reason|14|||
44490789|NCT00262028|79496749|FG002|Overall Study|Administrative Reason|9|||
44490790|NCT00262028|79496750|FG003|Overall Study|Administrative Reason|12|||
44490791|NCT00262028|79496751|FG004|Overall Study|Administrative Reason|6|||
44490792|NCT00262028|79496752|FG005|Overall Study|Administrative Reason|7|||
44490793|NCT00262028|79496753|FG006|Overall Study|Administrative Reason|4|||
44490794|NCT00262028|79496754|FG007|Overall Study|Administrative Reason|6|||
44229018|NCT01616459|79036676|FG003|Overall Study|Withdrawal by Subject|4|||
44229019|NCT01616459|79036673|FG000|Overall Study|Other reason|0|||
44229020|NCT01616459|79036674|FG001|Overall Study|Other reason|1|||
44229021|NCT01616459|79036675|FG002|Overall Study|Other reason|1|||
44229022|NCT01616459|79036676|FG003|Overall Study|Other reason|0|||
44229023|NCT01919801|79036693|FG000|Overall Study|Withdrawal by Subject|1|||
44490795|NCT00262028|79496755|FG008|Overall Study|Administrative Reason|10|||
44490796|NCT00262028|79496747|FG000|Overall Study|Protocol Violation|0|||
44490797|NCT00262028|79496748|FG001|Overall Study|Protocol Violation|0|||
44490798|NCT00262028|79496749|FG002|Overall Study|Protocol Violation|0|||
44490799|NCT00262028|79496750|FG003|Overall Study|Protocol Violation|1|||
44229024|NCT01919801|79036694|FG001|Overall Study|Withdrawal by Subject|0|||
44229025|NCT01919801|79036693|FG000|Overall Study|Physician Decision|0|||
44490800|NCT00262028|79496751|FG004|Overall Study|Protocol Violation|0|||
44490801|NCT00262028|79496752|FG005|Overall Study|Protocol Violation|0|||
44490802|NCT00262028|79496753|FG006|Overall Study|Protocol Violation|0|||
44229026|NCT01919801|79036694|FG001|Overall Study|Physician Decision|1|||
44229027|NCT01919801|79036693|FG000|Overall Study|Lost to Follow-up|0|||
44229028|NCT01919801|79036694|FG001|Overall Study|Lost to Follow-up|1|||
44229029|NCT01919801|79036693|FG000|Overall Study|Other|0|||
44229030|NCT01919801|79036694|FG001|Overall Study|Other|1|||
44229031|NCT01919723|79036702|FG000|Overall Study|Blood Samples Hemolyzed|2|||
44229032|NCT01919723|79036703|FG001|Overall Study|Blood Samples Hemolyzed|2|||
44490803|NCT00262028|79496754|FG007|Overall Study|Protocol Violation|0|||
44490804|NCT00262028|79496755|FG008|Overall Study|Protocol Violation|0|||
44490805|NCT00262028|79496747|FG000|Overall Study|Unable to classify|0|||
44490806|NCT00262028|79496748|FG001|Overall Study|Unable to classify|3|||
44490807|NCT00262028|79496749|FG002|Overall Study|Unable to classify|0|||
44490808|NCT00262028|79496750|FG003|Overall Study|Unable to classify|0|||
44490809|NCT00262028|79496751|FG004|Overall Study|Unable to classify|0|||
44490810|NCT00262028|79496752|FG005|Overall Study|Unable to classify|0|||
44490811|NCT00262028|79496753|FG006|Overall Study|Unable to classify|0|||
44490812|NCT00262028|79496754|FG007|Overall Study|Unable to classify|0|||
44490813|NCT00262028|79496755|FG008|Overall Study|Unable to classify|1|||
44490814|NCT00183248|79496799|FG000|Overall Study|Lost to Follow-up|0|||
44490815|NCT00183248|79496800|FG001|Overall Study|Lost to Follow-up|1|||
44490816|NCT00183248|79496799|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
44490817|NCT00183248|79496800|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
44490818|NCT00183170|79496808|FG000|First Intervention|Did not complete study|1|||
44490819|NCT00183170|79496809|FG001|First Intervention|Did not complete study|0|||
44490820|NCT00183170|79496808|FG000|First Intervention|Did not meet targeted BrAC|1|||
44490821|NCT00183170|79496809|FG001|First Intervention|Did not meet targeted BrAC|0|||
44490822|NCT00183170|79496808|FG000|Washout 1 Week|Did not complete study|6|||
44490823|NCT00183170|79496809|FG001|Washout 1 Week|Did not complete study|8|||
44490824|NCT00183170|79496808|FG000|Second Intervention|Did not complete study|1|||
44490825|NCT00183170|79496809|FG001|Second Intervention|Did not complete study|0|||
44490826|NCT00183170|79496808|FG000|Second Intervention|Did not meet targeted BrAC|0|||
44490827|NCT00183170|79496809|FG001|Second Intervention|Did not meet targeted BrAC|2|||
44490828|NCT00230282|79496815|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
44490829|NCT00230282|79496815|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
44490830|NCT00230282|79496815|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
44490831|NCT00230282|79496815|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
44490832|NCT00261950|79496819|FG000|Overall Study|Lost to Follow-up|2|||
44490833|NCT00261950|79496819|FG000|Overall Study|Death|6|||
44490834|NCT00261950|79496819|FG000|Overall Study|Withdrawal by Subject|5|||
44490835|NCT00261950|79496819|FG000|Overall Study|Other|1|||
44490836|NCT00261950|79496819|FG000|Overall Study|Physician Decision|1|||
44490837|NCT00261950|79496819|FG000|Overall Study|Protocol specified Criteria|11|||
44490838|NCT00230048|79496825|FG000|Overall Study|Lost to Follow-up|13|||
44490839|NCT00230048|79496826|FG001|Overall Study|Lost to Follow-up|18|||
44490840|NCT00229658|79496836|FG000|Overall Study|Administrative|2|||
44490841|NCT00229658|79496837|FG001|Overall Study|Administrative|1|||
44490842|NCT00229658|79496836|FG000|Overall Study|Investigator decision|13|||
44490843|NCT00229658|79496837|FG001|Overall Study|Investigator decision|10|||
44490844|NCT00229658|79496836|FG000|Overall Study|Other|80|||
44545306|NCT03518125|79559076|FG005|Overall Study|Withdrawal by Subject|3|||
44545307|NCT03518125|79559071|FG000|Overall Study|Missed Day 394 Visit|1|||
44545308|NCT03518125|79559072|FG001|Overall Study|Missed Day 394 Visit|0|||
44545309|NCT03518125|79559073|FG002|Overall Study|Missed Day 394 Visit|0|||
44545310|NCT03518125|79559074|FG003|Overall Study|Missed Day 394 Visit|0|||
44545311|NCT03518125|79559075|FG004|Overall Study|Missed Day 394 Visit|0|||
44545312|NCT03518125|79559076|FG005|Overall Study|Missed Day 394 Visit|0|||
44490845|NCT00229658|79496837|FG001|Overall Study|Other|60|||
44490846|NCT00229658|79496836|FG000|Overall Study|Lost to Follow-up|82|||
44490847|NCT00229658|79496837|FG001|Overall Study|Lost to Follow-up|55|||
44490848|NCT00229658|79496836|FG000|Overall Study|Serious Adverse Event|2|||
44490849|NCT00229658|79496837|FG001|Overall Study|Serious Adverse Event|2|||
44490850|NCT00229658|79496836|FG000|Overall Study|Withdrawal of consent|46|||
44545313|NCT03169530|79559093|FG000|Overall Study|Study ended by NIH|15|||
44490851|NCT00229658|79496837|FG001|Overall Study|Withdrawal of consent|39|||
44490852|NCT00182078|79496845|FG000|Overall Study|Withdrawal by Subject|1|||
44490853|NCT00182078|79496846|FG001|Overall Study|Withdrawal by Subject|0|||
44490854|NCT00181844|79496852|FG000|Signed Consent|Withdrawal by Subject|5|||
44490855|NCT00181844|79496852|FG000|Signed Consent|Did not meet entrance criteria|7|||
44490856|NCT00181844|79496852|FG000|Exposed to Study Medication|Adverse Event|10|||
44490857|NCT00181844|79496852|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
44490858|NCT00181844|79496852|FG000|Exposed to Study Medication|Non-compliance|2|||
44490859|NCT00181844|79496852|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
44490860|NCT00181844|79496852|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
44490861|NCT00181766|79496856|FG000|Overall Study|Lost to Follow-up|6|||
44490862|NCT00181766|79496856|FG000|Overall Study|Adverse Event|4|||
44490863|NCT00181766|79496856|FG000|Overall Study|non-compliance|2|||
44490864|NCT00180674|79496860|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
44490865|NCT00180674|79496860|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
44490866|NCT00076024|79496871|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
44490867|NCT00076024|79496872|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
44490868|NCT00076024|79496873|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
44490869|NCT00076024|79496874|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
44490870|NCT00076024|79496871|FG000|Phase 1, Lead-in|Adverse Event|1|||
44490871|NCT00076024|79496872|FG001|Phase 1, Lead-in|Adverse Event|0|||
44490872|NCT00076024|79496873|FG002|Phase 1, Lead-in|Adverse Event|0|||
44490873|NCT00076024|79496874|FG003|Phase 1, Lead-in|Adverse Event|0|||
44490874|NCT00076024|79496871|FG000|Phase 1, Lead-in|Clinical progression|1|||
44490875|NCT00076024|79496872|FG001|Phase 1, Lead-in|Clinical progression|0|||
44490876|NCT00076024|79496873|FG002|Phase 1, Lead-in|Clinical progression|0|||
44490877|NCT00076024|79496874|FG003|Phase 1, Lead-in|Clinical progression|0|||
44490878|NCT00076024|79496871|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
44490879|NCT00076024|79496872|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
44490880|NCT00076024|79496873|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
44490881|NCT00076024|79496874|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
44490882|NCT00076024|79496871|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
44490883|NCT00076024|79496872|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
44490884|NCT00076024|79496873|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
44490885|NCT00076024|79496874|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
44490886|NCT00076024|79496871|FG000|Phase 2, Double-blind|Adverse Event|0|||
44490887|NCT00076024|79496872|FG001|Phase 2, Double-blind|Adverse Event|25|||
44490888|NCT00076024|79496873|FG002|Phase 2, Double-blind|Adverse Event|6|||
44490889|NCT00076024|79496874|FG003|Phase 2, Double-blind|Adverse Event|0|||
44490890|NCT00076024|79496871|FG000|Phase 2, Double-blind|Un-specified|0|||
44490891|NCT00076024|79496872|FG001|Phase 2, Double-blind|Un-specified|14|||
44490892|NCT00076024|79496873|FG002|Phase 2, Double-blind|Un-specified|6|||
44490893|NCT00076024|79496874|FG003|Phase 2, Double-blind|Un-specified|0|||
44490894|NCT00076024|79496871|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
44490895|NCT00076024|79496872|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
44490896|NCT00076024|79496873|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
44490897|NCT00076024|79496874|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
44490898|NCT00076024|79496871|FG000|Phase 2, Open-label|Adverse Event|0|||
44490899|NCT00076024|79496872|FG001|Phase 2, Open-label|Adverse Event|0|||
44490900|NCT00076024|79496873|FG002|Phase 2, Open-label|Adverse Event|0|||
44229033|NCT01919489|79036711|FG000|Overall Study|Rejected the need of injections|4|||
44229034|NCT01919489|79036712|FG001|Overall Study|Rejected the need of injections|7|||
44375951|NCT00937326|79381028|FG003|Overall Study|Withdrawal by Subject|4|||
44375952|NCT00937326|79381029|FG004|Overall Study|Withdrawal by Subject|3|||
44375953|NCT00937326|79381025|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
44375954|NCT00937326|79381026|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
44375955|NCT00937326|79381027|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
44490901|NCT00076024|79496874|FG003|Phase 2, Open-label|Adverse Event|2|||
44490902|NCT00076024|79496871|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
44490903|NCT00076024|79496872|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
44490904|NCT00076024|79496873|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
44490905|NCT00076024|79496874|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
44490906|NCT00076024|79496871|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
44490907|NCT00076024|79496872|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
44490908|NCT00076024|79496873|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
44490909|NCT00076024|79496874|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
44490910|NCT00076024|79496871|FG000|Phase 2, Open-label|Other|0|||
44490911|NCT00076024|79496872|FG001|Phase 2, Open-label|Other|0|||
44490912|NCT00076024|79496873|FG002|Phase 2, Open-label|Other|0|||
44490913|NCT00076024|79496874|FG003|Phase 2, Open-label|Other|2|||
44490914|NCT00075478|79496885|FG000|Overall Study|not eligible|1|||
44490915|NCT00075478|79496886|FG001|Overall Study|not eligible|0|||
44490916|NCT00075478|79496885|FG000|Overall Study|Physician Decision|0|||
44490917|NCT00075478|79496886|FG001|Overall Study|Physician Decision|1|||
44490918|NCT00175916|79496892|FG000|Overall Study|Death|19|||
44490919|NCT00175916|79496892|FG000|Overall Study|Adverse Event|81|||
44490920|NCT00175916|79496892|FG000|Overall Study|Lack of Efficacy|354|||
44490921|NCT00175916|79496892|FG000|Overall Study|Lost to Follow-up|17|||
44490922|NCT00175916|79496892|FG000|Overall Study|Subject Choice|98|||
44490923|NCT00175916|79496892|FG000|Overall Study|Lack of compliance|8|||
44490924|NCT00175916|79496892|FG000|Overall Study|Patient cannot record seizures|1|||
44490925|NCT00175916|79496892|FG000|Overall Study|Sponsor decision|17|||
44490926|NCT00175916|79496892|FG000|Overall Study|Vigabatrin intake|1|||
44490927|NCT00175916|79496892|FG000|Overall Study|Suicidal behaviour|1|||
44490928|NCT00175916|79496892|FG000|Overall Study|Withdrawal by Subject|1|||
44490929|NCT00175916|79496892|FG000|Overall Study|Seizure - free|4|||
44490930|NCT00175916|79496892|FG000|Overall Study|Administrative reason|1|||
44490931|NCT00175916|79496892|FG000|Overall Study|Pregnancy|1|||
44490932|NCT00175916|79496892|FG000|Overall Study|Patient's request|2|||
44490933|NCT00175916|79496892|FG000|Overall Study|Treating physiciant's choice|1|||
44490934|NCT00175916|79496892|FG000|Overall Study|Moved overseas|1|||
44490935|NCT00175916|79496892|FG000|Overall Study|Loss of job and economic burden|1|||
44490936|NCT00175916|79496892|FG000|Overall Study|Site was closed|9|||
44490937|NCT00175916|79496892|FG000|Overall Study|Patient went to prison|1|||
44490938|NCT00075400|79496897|FG000|Overall Study|Ineligible: wrong primary|1|||
44490939|NCT00075400|79496897|FG000|Overall Study|Never treated|2|||
44490940|NCT00228566|79496906|FG000|Overall Study|Adverse Event|31|||
44490941|NCT00228566|79496906|FG000|Overall Study|Lack of Efficacy|14|||
44490942|NCT00228566|79496906|FG000|Overall Study|Lost to Follow-up|16|||
44490943|NCT00228566|79496906|FG000|Overall Study|Physician Decision|5|||
44490944|NCT00228566|79496906|FG000|Overall Study|Withdrawal by Subject|4|||
44490945|NCT00228566|79496906|FG000|Overall Study|Miscellaneous|1|||
44490946|NCT00074152|79496912|FG000|Overall Study|Death|21|||
44490947|NCT00074152|79496913|FG001|Overall Study|Death|9|||
44490948|NCT00074152|79496912|FG000|Overall Study|Lack of Efficacy|34|||
44490949|NCT00074152|79496913|FG001|Overall Study|Lack of Efficacy|24|||
44490950|NCT00261846|79496929|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
44490951|NCT00261846|79496930|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
44229035|NCT01919489|79036711|FG000|Overall Study|Adverse Event|10|||
44229036|NCT01919489|79036712|FG001|Overall Study|Adverse Event|0|||
44229037|NCT01919489|79036711|FG000|Overall Study|Hospital readmission|2|||
44490952|NCT00261846|79496931|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
44490953|NCT00261846|79496932|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490954|NCT00261846|79496933|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490955|NCT00261846|79496934|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490956|NCT00261846|79496935|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44229038|NCT01919489|79036712|FG001|Overall Study|Hospital readmission|9|||
44490957|NCT00261846|79496936|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490958|NCT00261846|79496937|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490959|NCT00261846|79496938|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490960|NCT00261846|79496939|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490961|NCT00261846|79496940|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
44490962|NCT00261846|79496929|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490963|NCT00261846|79496930|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490964|NCT00261846|79496931|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490965|NCT00261846|79496932|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
44490966|NCT00261846|79496933|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490967|NCT00261846|79496934|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490968|NCT00261846|79496935|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490969|NCT00261846|79496936|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490970|NCT00261846|79496937|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
44490971|NCT00261846|79496938|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490972|NCT00261846|79496939|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490973|NCT00261846|79496940|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
44490974|NCT00261846|79496929|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
44490975|NCT00261846|79496930|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
44490976|NCT00261846|79496931|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
44490977|NCT00261846|79496932|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
44490978|NCT00261846|79496933|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
44490979|NCT00261846|79496934|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
44490980|NCT00261846|79496935|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
44490981|NCT00261846|79496936|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
44490982|NCT00261846|79496937|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
44490983|NCT00261846|79496938|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
44490984|NCT00261846|79496939|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
44490985|NCT00261846|79496940|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
44490986|NCT00261846|79496929|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
44490987|NCT00261846|79496930|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
44490988|NCT00261846|79496931|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
44490989|NCT00261846|79496932|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
44490990|NCT00261846|79496933|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
44490991|NCT00261846|79496934|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
44490992|NCT00261846|79496935|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
44490993|NCT00261846|79496936|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
44490994|NCT00261846|79496937|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
44490995|NCT00261846|79496938|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
44490996|NCT00261846|79496939|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
44490997|NCT00261846|79496940|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
44490998|NCT00261846|79496929|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
44490999|NCT00261846|79496930|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
44491000|NCT00261846|79496931|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
44491001|NCT00261846|79496932|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
44491002|NCT00261846|79496933|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
44491003|NCT00261846|79496934|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
44491004|NCT00261846|79496935|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
44491005|NCT00261846|79496936|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
44491006|NCT00261846|79496937|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
44491007|NCT00261846|79496938|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
44491008|NCT00261846|79496939|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
44491009|NCT00261846|79496940|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
44491010|NCT00261846|79496929|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
44491011|NCT00261846|79496930|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
44229039|NCT01919489|79036711|FG000|Overall Study|Death|2|||
44229040|NCT01919489|79036712|FG001|Overall Study|Death|1|||
44229041|NCT01919489|79036711|FG000|Overall Study|Lost to Follow-up|38|||
44229042|NCT01919489|79036712|FG001|Overall Study|Lost to Follow-up|27|||
44491012|NCT00261846|79496931|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
44229043|NCT01919411|79036720|FG000|Overall Study|Lost to Follow-up|2|||
44229044|NCT01919411|79036721|FG001|Overall Study|Lost to Follow-up|4|||
44229045|NCT01919411|79036720|FG000|Overall Study|Physician Decision|1|||
44491013|NCT00261846|79496932|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
44491014|NCT00261846|79496933|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
44491015|NCT00261846|79496934|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
44491016|NCT00261846|79496935|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
44491017|NCT00261846|79496936|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
44491018|NCT00261846|79496937|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
44491019|NCT00261846|79496938|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
44491020|NCT00261846|79496939|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
44491021|NCT00261846|79496940|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
44491022|NCT00261846|79496929|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
44491023|NCT00261846|79496930|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
44491024|NCT00261846|79496931|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
44491025|NCT00261846|79496932|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
44491026|NCT00261846|79496933|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
44491027|NCT00261846|79496934|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
44491028|NCT00261846|79496935|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
44491029|NCT00261846|79496936|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
44491030|NCT00261846|79496937|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
44491031|NCT00261846|79496938|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
44491032|NCT00261846|79496939|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
44491033|NCT00261846|79496940|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
44491034|NCT00169442|79496985|FG000|Overall Study|Withdrawal by Subject|0|||
44491035|NCT00169442|79496986|FG001|Overall Study|Withdrawal by Subject|0|||
44491036|NCT00169442|79496987|FG002|Overall Study|Withdrawal by Subject|1|||
44491037|NCT00169442|79496988|FG003|Overall Study|Withdrawal by Subject|0|||
44491038|NCT00169442|79496989|FG004|Overall Study|Withdrawal by Subject|0|||
44491039|NCT00169442|79496990|FG005|Overall Study|Withdrawal by Subject|0|||
44491040|NCT00169442|79496985|FG000|Overall Study|Migrated/moved from study area|0|||
44491041|NCT00169442|79496986|FG001|Overall Study|Migrated/moved from study area|0|||
44491042|NCT00169442|79496987|FG002|Overall Study|Migrated/moved from study area|0|||
44491043|NCT00169442|79496988|FG003|Overall Study|Migrated/moved from study area|0|||
44491044|NCT00169442|79496989|FG004|Overall Study|Migrated/moved from study area|0|||
44491045|NCT00169442|79496990|FG005|Overall Study|Migrated/moved from study area|2|||
44491046|NCT00169442|79496985|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
44491047|NCT00169442|79496986|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
44491048|NCT00169442|79496987|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
44491049|NCT00169442|79496988|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
44491050|NCT00169442|79496989|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
44491051|NCT00169442|79496990|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
44491052|NCT00169442|79496985|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
44491053|NCT00169442|79496986|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
44491054|NCT00169442|79496987|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
44491055|NCT00169442|79496988|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
44491056|NCT00169442|79496989|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
44491057|NCT00169442|79496990|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
44491058|NCT00261716|79497008|FG000|Overall Study|Withdrawal by Subject|6|||
44491059|NCT00261716|79497009|FG001|Overall Study|Withdrawal by Subject|8|||
44491060|NCT00261716|79497008|FG000|Overall Study|Lost to Follow-up|0|||
44491061|NCT00261716|79497009|FG001|Overall Study|Lost to Follow-up|2|||
44491062|NCT03809104|79497019|FG000|Overall Study|Withdrawal by Subject|3|||
44491063|NCT00203502|79497023|FG000|Overall Study|Death|1|||
44491064|NCT03799198|79497029|FG000|Overall Study|Lost to Follow-up|4|||
44491065|NCT03799198|79497030|FG001|Overall Study|Lost to Follow-up|8|||
44491066|NCT03799198|79497029|FG000|Overall Study|Death|0|||
44491067|NCT03799198|79497030|FG001|Overall Study|Death|1|||
44491068|NCT00232596|79497038|FG000|6-Week Titration Phase|Adverse Event|6|||
44491069|NCT00232596|79497039|FG001|6-Week Titration Phase|Adverse Event|19|||
44491070|NCT00232596|79497038|FG000|6-Week Titration Phase|Failed to Return|2|||
44491071|NCT00232596|79497039|FG001|6-Week Titration Phase|Failed to Return|1|||
44491072|NCT00232596|79497038|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
44491073|NCT00232596|79497039|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
44491074|NCT00232596|79497038|FG000|6-Week Titration Phase|Protocol Violation|1|||
44229046|NCT01919411|79036721|FG001|Overall Study|Physician Decision|0|||
44229047|NCT01919411|79036720|FG000|Overall Study|Protocol Violation|2|||
44229048|NCT01919411|79036721|FG001|Overall Study|Protocol Violation|1|||
44375956|NCT00937326|79381028|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
44375957|NCT00937326|79381029|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
44375958|NCT00873730|79381048|FG000|Overall Study|Protocol Deviation|5|||
44491075|NCT00232596|79497039|FG001|6-Week Titration Phase|Protocol Violation|3|||
44491076|NCT00232596|79497038|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
44491077|NCT00232596|79497039|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
44491078|NCT00232596|79497038|FG000|6-Week Titration Phase|Other|3|||
44491079|NCT00232596|79497039|FG001|6-Week Titration Phase|Other|3|||
44491080|NCT00232596|79497038|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
44491081|NCT00232596|79497039|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
44491082|NCT00232596|79497038|FG000|12-Week Maintenance Phase|Adverse Event|7|||
44229049|NCT01901393|79036729|FG000|Overall Study|Adverse Event|1|||
44375959|NCT00873730|79381049|FG001|Overall Study|Protocol Deviation|2|||
44491083|NCT00232596|79497039|FG001|12-Week Maintenance Phase|Adverse Event|22|||
44491084|NCT00232596|79497038|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
44491085|NCT00232596|79497039|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
44491086|NCT00232596|79497038|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
44491087|NCT00232596|79497039|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
44491088|NCT00232596|79497038|FG000|12-Week Maintenance Phase|Other|1|||
44491089|NCT00232596|79497039|FG001|12-Week Maintenance Phase|Other|3|||
44491090|NCT00073918|79497057|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
44491091|NCT00073918|79497057|FG000|Overall Study|Rapid disease progression|2|||
44491092|NCT00073918|79497057|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
44491093|NCT00231894|79497063|FG000|Overall Study|Withdrawal by Subject|1|||
44491094|NCT00231894|79497064|FG001|Overall Study|Withdrawal by Subject|1|||
44491095|NCT00203424|79497076|FG000|Treatment Period|Withdrawal by Subject|4|||
44491096|NCT00203424|79497076|FG000|Treatment Period|Adverse Event|5|||
44491097|NCT00203424|79497076|FG000|Treatment Period|progressive disease|2|||
44491098|NCT00203424|79497076|FG000|Follow-up Period|Withdrawal by Subject|1|||
44491099|NCT00203424|79497076|FG000|Follow-up Period|progressive disease|4|||
44491100|NCT00203424|79497076|FG000|Follow-up Period|Lost to Follow-up|1|||
44491101|NCT00203268|79497080|FG000|Early Treatment|only treated one headache|2|||
44491102|NCT00203268|79497080|FG000|Early Treatment|Lost to Follow-up|1|||
44491103|NCT00203268|79497080|FG000|Early Treatment|Withdrawal by Subject|1|||
44491104|NCT00168818|79497089|FG000|Overall Study|Adverse Event|23|||
44491105|NCT00168818|79497090|FG001|Overall Study|Adverse Event|29|||
44491106|NCT00168818|79497091|FG002|Overall Study|Adverse Event|31|||
44491107|NCT00168818|79497089|FG000|Overall Study|Protocol Violation|16|||
44491108|NCT00168818|79497090|FG001|Overall Study|Protocol Violation|11|||
44491109|NCT00168818|79497091|FG002|Overall Study|Protocol Violation|11|||
44491110|NCT00168818|79497089|FG000|Overall Study|Lost to Follow-up|13|||
44491111|NCT00168818|79497090|FG001|Overall Study|Lost to Follow-up|4|||
44491112|NCT00168818|79497091|FG002|Overall Study|Lost to Follow-up|15|||
44491113|NCT00168818|79497089|FG000|Overall Study|Withdrawal by Subject|43|||
44491114|NCT00168818|79497090|FG001|Overall Study|Withdrawal by Subject|41|||
44491115|NCT00168818|79497091|FG002|Overall Study|Withdrawal by Subject|37|||
44491116|NCT00168818|79497089|FG000|Overall Study|Other|22|||
44491117|NCT00168818|79497090|FG001|Overall Study|Other|24|||
44491118|NCT00168818|79497091|FG002|Overall Study|Other|30|||
44491119|NCT00168818|79497089|FG000|Treatment|Adverse Event|77|||
44491120|NCT00168818|79497090|FG001|Treatment|Adverse Event|89|||
44491121|NCT00168818|79497091|FG002|Treatment|Adverse Event|68|||
44491122|NCT00168818|79497089|FG000|Treatment|Protocol Violation|8|||
44491123|NCT00168818|79497090|FG001|Treatment|Protocol Violation|11|||
44491124|NCT00168818|79497091|FG002|Treatment|Protocol Violation|11|||
44491125|NCT00168818|79497089|FG000|Treatment|Lost to Follow-up|0|||
44491126|NCT00168818|79497090|FG001|Treatment|Lost to Follow-up|2|||
44491127|NCT00168818|79497091|FG002|Treatment|Lost to Follow-up|1|||
44491128|NCT00168818|79497089|FG000|Treatment|Withdrawal by Subject|25|||
44491129|NCT00168818|79497090|FG001|Treatment|Withdrawal by Subject|20|||
44491130|NCT00168818|79497091|FG002|Treatment|Withdrawal by Subject|22|||
44491131|NCT00168818|79497089|FG000|Treatment|Other|23|||
44491132|NCT00168818|79497090|FG001|Treatment|Other|29|||
44491133|NCT00168818|79497091|FG002|Treatment|Other|31|||
44491134|NCT00260832|79497101|FG000|Overall Study|Adverse Event|26|||
44491135|NCT00260832|79497102|FG001|Overall Study|Adverse Event|19|||
44491136|NCT00260832|79497101|FG000|Overall Study|Progression|116|||
44491137|NCT00260832|79497102|FG001|Overall Study|Progression|96|||
44491138|NCT00260832|79497101|FG000|Overall Study|Withdrawal by Subject|15|||
44491139|NCT00260832|79497102|FG001|Overall Study|Withdrawal by Subject|17|||
44491140|NCT00260832|79497101|FG000|Overall Study|Physician Decision|15|||
44491141|NCT00260832|79497102|FG001|Overall Study|Physician Decision|9|||
44491142|NCT00260832|79497101|FG000|Overall Study|Death|43|||
44491143|NCT00260832|79497102|FG001|Overall Study|Death|62|||
44491144|NCT00260832|79497101|FG000|Overall Study|Other|10|||
44491145|NCT00260832|79497102|FG001|Overall Study|Other|7|||
44491146|NCT00260832|79497101|FG000|Overall Study|Protocol Violation|3|||
44491147|NCT00260832|79497102|FG001|Overall Study|Protocol Violation|1|||
44491148|NCT00168038|79497108|FG000|Overall Study|Adverse Event|1|||
44491149|NCT00168038|79497108|FG000|Overall Study|Therapy failure|1|||
44491150|NCT00167414|79497112|FG000|Overall Study|Death|10|||
44491151|NCT00166712|79497118|FG000|Overall Study|Death|0|||
44491152|NCT00166712|79497119|FG001|Overall Study|Death|1|||
44491153|NCT00166712|79497118|FG000|Overall Study|Adverse Event|1|||
44491154|NCT00166712|79497119|FG001|Overall Study|Adverse Event|0|||
44491155|NCT00166712|79497118|FG000|Overall Study|Withdrawal by Subject|1|||
44491156|NCT00166712|79497119|FG001|Overall Study|Withdrawal by Subject|2|||
44491157|NCT00166712|79497118|FG000|Overall Study|Physician Decision|0|||
44491158|NCT00166712|79497119|FG001|Overall Study|Physician Decision|2|||
44491159|NCT00073528|79497131|FG000|Overall Study|Death|488|||
44491160|NCT00073528|79497132|FG001|Overall Study|Death|473|||
44491161|NCT00073528|79497131|FG000|Overall Study|Lost to Follow-up|52|||
44491162|NCT00073528|79497132|FG001|Overall Study|Lost to Follow-up|45|||
44491163|NCT00073528|79497131|FG000|Overall Study|Withdrawal by Subject|50|||
44491164|NCT00073528|79497132|FG001|Overall Study|Withdrawal by Subject|45|||
44491165|NCT00073528|79497131|FG000|Overall Study|Study terminated by Sponsor|10|||
44491166|NCT00073528|79497132|FG001|Overall Study|Study terminated by Sponsor|29|||
44491167|NCT00073528|79497131|FG000|Overall Study|Other|18|||
44491168|NCT00073528|79497132|FG001|Overall Study|Other|19|||
44491169|NCT00073528|79497131|FG000|Overall Study|Other|9|||
44491170|NCT00073528|79497132|FG001|Overall Study|Other|12|||
44491171|NCT00073528|79497131|FG000|Overall Study|Protocol Violation|3|||
44491172|NCT00073528|79497132|FG001|Overall Study|Protocol Violation|5|||
44491173|NCT03801148|79497142|FG000|Period 1 (2 Days)|Adverse Event|1|||
44491174|NCT03801148|79497143|FG001|Period 1 (2 Days)|Adverse Event|1|||
44229050|NCT01901393|79036730|FG001|Overall Study|Adverse Event|0|||
44229051|NCT01890707|79036738|FG000|Overall Study|Lost to Follow-up|1|||
44229052|NCT01890707|79036739|FG001|Overall Study|Lost to Follow-up|1|||
44229053|NCT01900691|79036745|FG000|Overall Study|Death|7|||
44375960|NCT00873730|79381048|FG000|Overall Study|Adverse Event|0|||
44375961|NCT00873730|79381049|FG001|Overall Study|Adverse Event|2|||
44375962|NCT00873730|79381048|FG000|Overall Study|Withdrawal by Subject|0|||
44375963|NCT00873730|79381049|FG001|Overall Study|Withdrawal by Subject|1|||
44375964|NCT00873730|79381048|FG000|Overall Study|Sponsor decision|1|||
44375965|NCT00873730|79381049|FG001|Overall Study|Sponsor decision|0|||
44375966|NCT00874432|79381059|FG000|Overall Study|Withdrawal by Subject|1|||
44375967|NCT00874432|79381060|FG001|Overall Study|Withdrawal by Subject|0|||
44375968|NCT00874432|79381061|FG002|Overall Study|Withdrawal by Subject|0|||
44375969|NCT00874432|79381062|FG003|Overall Study|Withdrawal by Subject|0|||
44375970|NCT00874432|79381059|FG000|Overall Study|Physician Decision|1|||
44375971|NCT00874432|79381060|FG001|Overall Study|Physician Decision|0|||
44375972|NCT00874432|79381061|FG002|Overall Study|Physician Decision|0|||
44375973|NCT00874432|79381062|FG003|Overall Study|Physician Decision|0|||
44375974|NCT00874432|79381059|FG000|Overall Study|Other|1|||
44375975|NCT00874432|79381060|FG001|Overall Study|Other|2|||
44375976|NCT00874432|79381061|FG002|Overall Study|Other|8|||
44375977|NCT00874432|79381062|FG003|Overall Study|Other|3|||
44375978|NCT00935220|79381074|FG000|Overall Study|Adverse Event|1|||
44375979|NCT00935220|79381074|FG000|Overall Study|Other reason (not specified)|1|||
44375980|NCT00874276|79381080|FG000|Overall Study|Withdrawal by Subject|1|||
44375981|NCT00874276|79381081|FG001|Overall Study|Withdrawal by Subject|1|||
44375982|NCT00594958|79381092|FG000|Overall Study|Withdrawal by Subject|1|||
44375983|NCT00594958|79381093|FG001|Overall Study|Withdrawal by Subject|0|||
44491175|NCT03801148|79497144|FG002|Period 1 (2 Days)|Adverse Event|0|||
44491176|NCT03801148|79497145|FG003|Period 1 (2 Days)|Adverse Event|0|||
44375984|NCT00594958|79381094|FG002|Overall Study|Withdrawal by Subject|1|||
44375985|NCT00594958|79381092|FG000|Overall Study|Adverse Event|4|||
44375986|NCT00594958|79381093|FG001|Overall Study|Adverse Event|1|||
44375987|NCT00594958|79381094|FG002|Overall Study|Adverse Event|2|||
44491177|NCT03801148|79497142|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
44229054|NCT01900691|79036745|FG000|Overall Study|Lost to Follow-up|4|||
44229055|NCT01900691|79036745|FG000|Overall Study|Study Device Not Placed|3|||
44229056|NCT01900691|79036745|FG000|Overall Study|Non study stent placed|2|||
44375988|NCT00594958|79381092|FG000|Overall Study|Pregnancy|0|||
44375989|NCT00594958|79381093|FG001|Overall Study|Pregnancy|2|||
44375990|NCT00594958|79381094|FG002|Overall Study|Pregnancy|0|||
44491178|NCT03801148|79497143|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
44491179|NCT03801148|79497144|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
44491180|NCT03801148|79497145|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
44229057|NCT01900691|79036745|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
44375991|NCT00594958|79381092|FG000|Overall Study|Protocol Violation|1|||
44491181|NCT03801148|79497142|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44375992|NCT00594958|79381093|FG001|Overall Study|Protocol Violation|0|||
44375993|NCT00594958|79381094|FG002|Overall Study|Protocol Violation|2|||
44375994|NCT00594958|79381092|FG000|Overall Study|Lost to Follow-up|5|||
44375995|NCT00594958|79381093|FG001|Overall Study|Lost to Follow-up|0|||
44375996|NCT00594958|79381094|FG002|Overall Study|Lost to Follow-up|3|||
44375997|NCT00594958|79381092|FG000|Overall Study|administrative|3|||
44375998|NCT00594958|79381093|FG001|Overall Study|administrative|0|||
44491182|NCT03801148|79497143|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44491183|NCT03801148|79497144|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
44491184|NCT03801148|79497145|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44491185|NCT03801148|79497142|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
44491186|NCT03801148|79497143|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
44491187|NCT03801148|79497144|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
44491188|NCT03801148|79497145|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
44491189|NCT00072280|79497157|FG000|Treatment|Found ineligible|1|||
44491190|NCT00072280|79497158|FG001|Treatment|Found ineligible|2|||
44491191|NCT00072280|79497157|FG000|Follow-up|Early termination of study|2|||
44491192|NCT00072280|79497158|FG001|Follow-up|Early termination of study|2|||
44491193|NCT00071812|79497167|FG000|24-Week Double-Blind Period|Adverse Event|2|||
44491194|NCT00071812|79497168|FG001|24-Week Double-Blind Period|Adverse Event|3|||
44491195|NCT00071812|79497169|FG002|24-Week Double-Blind Period|Adverse Event|4|||
44491196|NCT00071812|79497170|FG003|24-Week Double-Blind Period|Adverse Event|4|||
44491197|NCT00071812|79497167|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
44491198|NCT00071812|79497168|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
44491199|NCT00071812|79497169|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
44491200|NCT00071812|79497170|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
44491201|NCT00071812|79497167|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
44491202|NCT00071812|79497168|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
44491203|NCT00071812|79497169|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
44491204|NCT00071812|79497170|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
44491205|NCT00071812|79497167|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
44491206|NCT00071812|79497168|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
44491207|NCT00071812|79497169|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
44491208|NCT00071812|79497170|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
44491209|NCT00071812|79497167|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
44491210|NCT00071812|79497168|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
44491211|NCT00071812|79497169|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
44491212|NCT00071812|79497170|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
44491213|NCT00071812|79497167|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
44491214|NCT00071812|79497168|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
44491215|NCT00071812|79497169|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
44491216|NCT00071812|79497170|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
44491217|NCT00071812|79497167|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
44491218|NCT00071812|79497168|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
44491219|NCT00071812|79497169|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
44491220|NCT00071812|79497170|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
44491221|NCT00071812|79497167|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
44491222|NCT00071812|79497168|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
44491223|NCT00071812|79497169|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
44229058|NCT01900691|79036745|FG000|Overall Study|Complete stent migration through digestive tract|1|||
44375999|NCT00594958|79381094|FG002|Overall Study|administrative|2|||
44376000|NCT00594880|79381104|FG000|Overall Study|Withdrawal by Subject|1|||
44491224|NCT00071812|79497170|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
44491225|NCT00071812|79497167|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
44491226|NCT00071812|79497168|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
44491227|NCT00071812|79497169|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
44491228|NCT00071812|79497170|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
44491229|NCT00071812|79497167|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
44376001|NCT00594880|79381105|FG001|Overall Study|Withdrawal by Subject|1|||
44376002|NCT00594880|79381104|FG000|Overall Study|Lost to Follow-up|1|||
44491230|NCT00071812|79497168|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
44491231|NCT00071812|79497169|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
44491232|NCT00071812|79497170|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
44491233|NCT00071110|79497184|FG000|Overall Study|Protocol Violation|0|||
44491234|NCT00071110|79497185|FG001|Overall Study|Protocol Violation|4|||
44491235|NCT00071032|79497193|FG000|Overall Study|Lost to Follow-up|1|||
44491236|NCT00071032|79497194|FG001|Overall Study|Lost to Follow-up|1|||
44491237|NCT00071032|79497193|FG000|Overall Study|Withdrawal by Subject|8|||
44491238|NCT00071032|79497194|FG001|Overall Study|Withdrawal by Subject|6|||
44491239|NCT00071032|79497193|FG000|Overall Study|Missing Primary Outcome|0|||
44491240|NCT00071032|79497194|FG001|Overall Study|Missing Primary Outcome|1|||
44491241|NCT00259610|79497205|FG000|Overall Study|Withdrawal by Subject|33|||
44491242|NCT00259610|79497206|FG001|Overall Study|Withdrawal by Subject|25|||
44491243|NCT00259610|79497207|FG002|Overall Study|Withdrawal by Subject|29|||
44491244|NCT00259610|79497208|FG003|Overall Study|Withdrawal by Subject|19|||
44491245|NCT00259610|79497205|FG000|Overall Study|Lost to Follow-up|19|||
44491246|NCT00259610|79497206|FG001|Overall Study|Lost to Follow-up|8|||
44491247|NCT00259610|79497207|FG002|Overall Study|Lost to Follow-up|18|||
44491248|NCT00259610|79497208|FG003|Overall Study|Lost to Follow-up|15|||
44491249|NCT00259610|79497205|FG000|Overall Study|Physician Decision|6|||
44491250|NCT00259610|79497206|FG001|Overall Study|Physician Decision|4|||
44491251|NCT00259610|79497207|FG002|Overall Study|Physician Decision|7|||
44491252|NCT00259610|79497208|FG003|Overall Study|Physician Decision|2|||
44491253|NCT00259610|79497205|FG000|Overall Study|Death|1|||
44491254|NCT00259610|79497206|FG001|Overall Study|Death|1|||
44491255|NCT00259610|79497207|FG002|Overall Study|Death|2|||
44491256|NCT00259610|79497208|FG003|Overall Study|Death|0|||
44491257|NCT00259610|79497205|FG000|Overall Study|non medical reason|6|||
44491258|NCT00259610|79497206|FG001|Overall Study|non medical reason|2|||
44491259|NCT00259610|79497207|FG002|Overall Study|non medical reason|10|||
44491260|NCT00259610|79497208|FG003|Overall Study|non medical reason|3|||
44491261|NCT00259610|79497205|FG000|Overall Study|Adverse Event|3|||
44491262|NCT00259610|79497206|FG001|Overall Study|Adverse Event|4|||
44491263|NCT00259610|79497207|FG002|Overall Study|Adverse Event|5|||
44491264|NCT00259610|79497208|FG003|Overall Study|Adverse Event|2|||
44491265|NCT00259610|79497205|FG000|Overall Study|Serious Adverse Event|8|||
44491266|NCT00259610|79497206|FG001|Overall Study|Serious Adverse Event|2|||
44491267|NCT00259610|79497207|FG002|Overall Study|Serious Adverse Event|2|||
44491268|NCT00259610|79497208|FG003|Overall Study|Serious Adverse Event|2|||
44491269|NCT00165776|79497222|FG000|Overall Study|Lack of Efficacy|0|||
44491270|NCT00165776|79497223|FG001|Overall Study|Lack of Efficacy|0|||
44491271|NCT00165776|79497224|FG002|Overall Study|Lack of Efficacy|0|||
44491272|NCT00165776|79497225|FG003|Overall Study|Lack of Efficacy|1|||
44491273|NCT00165776|79497222|FG000|Overall Study|Withdrawal by Subject|4|||
44491274|NCT00165776|79497223|FG001|Overall Study|Withdrawal by Subject|1|||
44491275|NCT00165776|79497224|FG002|Overall Study|Withdrawal by Subject|2|||
44229059|NCT01890473|79036752|FG000|Overall Study|Lost to Follow-up|1|||
44229060|NCT01890473|79036753|FG001|Overall Study|Lost to Follow-up|0|||
44229061|NCT01890473|79036752|FG000|Overall Study|Poor/non-compliance|1|||
44229062|NCT01890473|79036753|FG001|Overall Study|Poor/non-compliance|0|||
44229063|NCT01889069|79036763|FG000|Overall Study|Death|18|||
44229064|NCT01889069|79036763|FG000|Overall Study|Progression of Disease|14|||
44229065|NCT01889069|79036763|FG000|Overall Study|Lost to Follow-up|6|||
44229066|NCT01889069|79036763|FG000|Overall Study|Other|4|||
44229067|NCT01889069|79036763|FG000|Overall Study|Consent Withdrawal|3|||
44229068|NCT02533180|79036775|FG000|Overall Study|Death|0|||
44229069|NCT02533180|79036776|FG001|Overall Study|Death|2|||
44229070|NCT02533180|79036775|FG000|Overall Study|Lost to Follow-up|0|||
44229071|NCT02533180|79036776|FG001|Overall Study|Lost to Follow-up|1|||
44229072|NCT02533180|79036775|FG000|Overall Study|Physician Decision|0|||
44229073|NCT02533180|79036776|FG001|Overall Study|Physician Decision|1|||
44491276|NCT00165776|79497225|FG003|Overall Study|Withdrawal by Subject|0|||
44491277|NCT00165776|79497222|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
44491278|NCT00165776|79497223|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
44229074|NCT02533180|79036775|FG000|Overall Study|Withdrawal by Subject|2|||
44229075|NCT02533180|79036776|FG001|Overall Study|Withdrawal by Subject|5|||
44229076|NCT02533180|79036775|FG000|Overall Study|Screen Failure|37|||
44376003|NCT00594880|79381105|FG001|Overall Study|Lost to Follow-up|0|||
44376004|NCT00871858|79381117|FG000|Overall Study|Protocol Violation|3|||
44491279|NCT00165776|79497224|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
44491280|NCT00165776|79497225|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
44491281|NCT00165698|79497237|FG000|Overall Study|Adverse Event|2|||
44491282|NCT00165698|79497238|FG001|Overall Study|Adverse Event|10|||
44491283|NCT00165698|79497237|FG000|Overall Study|Lost to Follow-up|2|||
44491284|NCT00165698|79497238|FG001|Overall Study|Lost to Follow-up|2|||
44491285|NCT00165698|79497237|FG000|Overall Study|Withdrawal by Subject|2|||
44491286|NCT00165698|79497238|FG001|Overall Study|Withdrawal by Subject|1|||
44229077|NCT02533180|79036776|FG001|Overall Study|Screen Failure|0|||
44229078|NCT02533180|79036775|FG000|Overall Study|Protocol Deviation|0|||
44491287|NCT00165698|79497237|FG000|Overall Study|Protocol Violation|1|||
44491288|NCT00165698|79497238|FG001|Overall Study|Protocol Violation|0|||
44491289|NCT00165698|79497237|FG000|Overall Study|Not Taken/Lost the medicine|1|||
44229079|NCT02533180|79036776|FG001|Overall Study|Protocol Deviation|1|||
44491290|NCT00165698|79497238|FG001|Overall Study|Not Taken/Lost the medicine|2|||
44491291|NCT00225758|79497244|FG000|Overall Study|Adverse Event|4|||
44491292|NCT00259298|79497250|FG000|Overall Study|Withdrawal by Subject|1|||
44491293|NCT00259298|79497250|FG000|Overall Study|Physician Decision|2|||
44491294|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
44491295|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
44491296|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
44491297|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
44491298|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
44491299|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
44491300|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
44491301|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
44229080|NCT02533180|79036775|FG000|Overall Study|Non-compliance|0|||
44491302|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
44491303|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
44491304|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
44491305|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
44491306|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
44491307|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
44491308|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
44491309|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
44491310|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
44491311|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
44491312|NCT03789292|79497256|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
44491313|NCT03789292|79497257|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
44491314|NCT03789292|79497258|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
44491315|NCT03789292|79497256|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
44491316|NCT03789292|79497257|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
44491317|NCT03789292|79497258|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
44491318|NCT03789292|79497256|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
44491319|NCT03789292|79497257|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
44229081|NCT02533180|79036776|FG001|Overall Study|Non-compliance|1|||
44229082|NCT01739348|79036814|FG000|Part I (Base Study)|Adverse Event|41|||
44229083|NCT01739348|79036815|FG001|Part I (Base Study)|Adverse Event|52|||
44229084|NCT01739348|79036816|FG002|Part I (Base Study)|Adverse Event|8|||
44491320|NCT03789292|79497258|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
44491321|NCT03789292|79497256|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
44491322|NCT03789292|79497257|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
44491323|NCT03789292|79497258|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
44491324|NCT03789292|79497256|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
44491325|NCT03789292|79497257|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
44491326|NCT03789292|79497258|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
44491327|NCT03789292|79497256|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
44491328|NCT03789292|79497257|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
44491329|NCT03789292|79497258|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
44491330|NCT03789292|79497256|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
44491331|NCT03789292|79497257|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
44491332|NCT03789292|79497258|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
44491333|NCT03781336|79497274|FG000|Overall Study|Withdrawal by Subject|2|||
44491334|NCT03781336|79497275|FG001|Overall Study|Withdrawal by Subject|2|||
44491335|NCT03780400|79497281|FG000|Overall Study|Lost to Follow-up|5|||
44491336|NCT03780400|79497281|FG000|Overall Study|Withdrawal by Subject|2|||
44491337|NCT03780244|79497287|FG000|Overall Study|Lost to Follow-up|1|||
44491338|NCT03780244|79497288|FG001|Overall Study|Lost to Follow-up|0|||
44491339|NCT03785548|79497296|FG000|Overall Study|age > 80|1|||
44491340|NCT03785548|79497297|FG001|Overall Study|age > 80|0|||
44491341|NCT03785548|79497296|FG000|Overall Study|no Postop queries|1|||
44491342|NCT03785548|79497297|FG001|Overall Study|no Postop queries|0|||
44491343|NCT00141297|79497305|FG000|Overall Study|Adverse Event|0|||
44491344|NCT00141297|79497306|FG001|Overall Study|Adverse Event|0|||
44491345|NCT00141297|79497307|FG002|Overall Study|Adverse Event|1|||
44491346|NCT00141297|79497308|FG003|Overall Study|Adverse Event|0|||
44491347|NCT00141297|79497309|FG004|Overall Study|Adverse Event|1|||
44491348|NCT00141297|79497310|FG005|Overall Study|Adverse Event|1|||
44229085|NCT01739348|79036817|FG003|Part I (Base Study)|Adverse Event|33|||
44491349|NCT00141297|79497311|FG006|Overall Study|Adverse Event|0|||
44491350|NCT00141297|79497312|FG007|Overall Study|Adverse Event|1|||
44491351|NCT00141297|79497313|FG008|Overall Study|Adverse Event|1|||
44491352|NCT00141297|79497314|FG009|Overall Study|Adverse Event|0|||
44491353|NCT00141297|79497305|FG000|Overall Study|Death|1|||
44491354|NCT00141297|79497306|FG001|Overall Study|Death|0|||
44491355|NCT00141297|79497307|FG002|Overall Study|Death|0|||
44491356|NCT00141297|79497308|FG003|Overall Study|Death|0|||
44491357|NCT00141297|79497309|FG004|Overall Study|Death|0|||
44491358|NCT00141297|79497310|FG005|Overall Study|Death|0|||
44491359|NCT00141297|79497311|FG006|Overall Study|Death|0|||
44229086|NCT01739348|79036814|FG000|Part I (Base Study)|Death|10|||
44229087|NCT01739348|79036815|FG001|Part I (Base Study)|Death|7|||
44229088|NCT01739348|79036816|FG002|Part I (Base Study)|Death|2|||
44229089|NCT01739348|79036817|FG003|Part I (Base Study)|Death|8|||
44229090|NCT01739348|79036814|FG000|Part I (Base Study)|Lack of Efficacy|3|||
44229091|NCT01739348|79036815|FG001|Part I (Base Study)|Lack of Efficacy|8|||
44229092|NCT01739348|79036816|FG002|Part I (Base Study)|Lack of Efficacy|0|||
44229093|NCT01739348|79036817|FG003|Part I (Base Study)|Lack of Efficacy|7|||
44229094|NCT01739348|79036814|FG000|Part I (Base Study)|Lost to Follow-up|4|||
44229095|NCT01739348|79036815|FG001|Part I (Base Study)|Lost to Follow-up|2|||
44229096|NCT01739348|79036816|FG002|Part I (Base Study)|Lost to Follow-up|4|||
44229097|NCT01739348|79036817|FG003|Part I (Base Study)|Lost to Follow-up|4|||
44229098|NCT01739348|79036814|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
44229099|NCT01739348|79036815|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
44229100|NCT01739348|79036816|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
44229101|NCT01739348|79036817|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
44229102|NCT01739348|79036814|FG000|Part I (Base Study)|Physician Decision|10|||
44229103|NCT01739348|79036815|FG001|Part I (Base Study)|Physician Decision|7|||
44229104|NCT01739348|79036816|FG002|Part I (Base Study)|Physician Decision|1|||
44229105|NCT01739348|79036817|FG003|Part I (Base Study)|Physician Decision|4|||
44229106|NCT01739348|79036814|FG000|Part I (Base Study)|Protocol Violation|2|||
44229107|NCT01739348|79036815|FG001|Part I (Base Study)|Protocol Violation|0|||
44229108|NCT01739348|79036816|FG002|Part I (Base Study)|Protocol Violation|1|||
44229109|NCT01739348|79036817|FG003|Part I (Base Study)|Protocol Violation|2|||
44229110|NCT01739348|79036814|FG000|Part I (Base Study)|Screen Failure|2|||
44229111|NCT01739348|79036815|FG001|Part I (Base Study)|Screen Failure|0|||
44229112|NCT01739348|79036816|FG002|Part I (Base Study)|Screen Failure|0|||
44229113|NCT01739348|79036817|FG003|Part I (Base Study)|Screen Failure|0|||
44229114|NCT01739348|79036814|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
44229115|NCT01739348|79036815|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
44229116|NCT01739348|79036816|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
44229117|NCT01739348|79036817|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
44229118|NCT01739348|79036814|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
44229119|NCT01739348|79036815|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
44229120|NCT01739348|79036816|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
44229121|NCT01739348|79036817|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
44229122|NCT01739348|79036814|FG000|Part I (Base Study)|Participant Moved|4|||
44229123|NCT01739348|79036815|FG001|Part I (Base Study)|Participant Moved|3|||
44229124|NCT01739348|79036816|FG002|Part I (Base Study)|Participant Moved|1|||
44491360|NCT00141297|79497312|FG007|Overall Study|Death|0|||
44491361|NCT00141297|79497313|FG008|Overall Study|Death|1|||
44491362|NCT00141297|79497314|FG009|Overall Study|Death|0|||
44491363|NCT00141297|79497305|FG000|Overall Study|Withdrawal by Subject|0|||
44491364|NCT00141297|79497306|FG001|Overall Study|Withdrawal by Subject|0|||
44545314|NCT03169530|79559094|FG001|Overall Study|Study ended by NIH|17|||
44545315|NCT03478891|79559112|FG000|Overall Study|Enrolled, but product never administered|0|||
44545316|NCT03478891|79559113|FG001|Overall Study|Enrolled, but product never administered|0|||
44545317|NCT03478891|79559114|FG002|Overall Study|Enrolled, but product never administered|1|||
44545318|NCT03478891|79559112|FG000|Overall Study|Moved from area|0|||
44545319|NCT03478891|79559113|FG001|Overall Study|Moved from area|0|||
44545320|NCT03478891|79559114|FG002|Overall Study|Moved from area|1|||
44545321|NCT03478891|79559112|FG000|Overall Study|Lost to Follow-up|1|||
44545322|NCT03478891|79559113|FG001|Overall Study|Lost to Follow-up|0|||
44545323|NCT03478891|79559114|FG002|Overall Study|Lost to Follow-up|1|||
44545324|NCT01585103|79559126|FG000|Overall Study|Unable to swallow Cytosponge|6|||
44545325|NCT03168906|79559132|FG000|Overall Study|Lack of Efficacy|6|||
44545326|NCT03168906|79559133|FG001|Overall Study|Lack of Efficacy|6|||
44491365|NCT00141297|79497307|FG002|Overall Study|Withdrawal by Subject|0|||
44491366|NCT00141297|79497308|FG003|Overall Study|Withdrawal by Subject|0|||
44491367|NCT00141297|79497309|FG004|Overall Study|Withdrawal by Subject|0|||
44491368|NCT00141297|79497310|FG005|Overall Study|Withdrawal by Subject|0|||
44229125|NCT01739348|79036817|FG003|Part I (Base Study)|Participant Moved|7|||
44229126|NCT01739348|79036814|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
44229127|NCT01739348|79036815|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
44229128|NCT01739348|79036816|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
44376005|NCT00871858|79381118|FG001|Overall Study|Protocol Violation|4|||
44376006|NCT00871858|79381117|FG000|Overall Study|Adverse Event|1|||
44376007|NCT00871858|79381118|FG001|Overall Study|Adverse Event|1|||
44376008|NCT00871858|79381117|FG000|Overall Study|Withdrawal by Subject|1|||
44376009|NCT00871858|79381118|FG001|Overall Study|Withdrawal by Subject|1|||
44376010|NCT00871858|79381117|FG000|Overall Study|Lost to Follow-up|0|||
44376011|NCT00871858|79381118|FG001|Overall Study|Lost to Follow-up|1|||
44376012|NCT00871780|79381124|FG000|Overall Study|Enrolled But Not Treated|6|||
44376013|NCT00871780|79381124|FG000|Overall Study|Withdrawal by Subject|9|||
44376014|NCT00871780|79381124|FG000|Overall Study|Adverse Event|6|||
44376015|NCT00871780|79381124|FG000|Overall Study|Voluntary Discontinuation|4|||
44376016|NCT00871780|79381124|FG000|Overall Study|Death|1|||
44376017|NCT00871780|79381124|FG000|Overall Study|Physician Decision|1|||
44376018|NCT00594178|79381131|FG000|Overall Study|Physician Decision|5|||
44376019|NCT00933270|79381135|FG000|Overall Study|Withdrawal by Subject|26|||
44376020|NCT00933270|79381135|FG000|Overall Study|Insufficient Follow-up|10|||
44376021|NCT00933270|79381135|FG000|Overall Study|Lost to Follow-up|14|||
44376022|NCT00933270|79381135|FG000|Overall Study|Adverse Event|1|||
44376023|NCT00933270|79381135|FG000|Overall Study|Missed Visit|2|||
44376024|NCT00933270|79381135|FG000|Overall Study|Death|24|||
44376025|NCT00933270|79381135|FG000|Overall Study|Moved or would not return|10|||
44376026|NCT00936858|79381140|FG000|Overall Study|Death|3|||
44376027|NCT00936858|79381140|FG000|Overall Study|Progression|29|||
44376028|NCT00936858|79381140|FG000|Overall Study|Withdrawal by Subject|5|||
44376029|NCT00936858|79381140|FG000|Overall Study|Adverse Event|1|||
44376030|NCT00936858|79381140|FG000|Overall Study|Physician Decision|7|||
44376031|NCT00936858|79381140|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
44376032|NCT00936858|79381140|FG000|Overall Study|Lost to Follow-up|1|||
44376033|NCT00872170|79381147|FG000|Overall Study|Adverse Event|1|||
44376034|NCT00872170|79381148|FG001|Overall Study|Adverse Event|0|||
44376035|NCT00936702|79381153|FG000|Overall Study|Disease progression|34|||
44376036|NCT00936702|79381153|FG000|Overall Study|Adverse Event|8|||
44376037|NCT00936702|79381153|FG000|Overall Study|Withdrawal by Subject|2|||
44376038|NCT00936702|79381153|FG000|Overall Study|Alternative Treatment|1|||
44376039|NCT00936702|79381153|FG000|Overall Study|Other|1|||
44376040|NCT00594100|79381157|FG000|Procedure|Technical Failure|9|||
44376041|NCT00594100|79381157|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
44376042|NCT00594100|79381157|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
44376043|NCT00594100|79381157|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
44376044|NCT01092182|79381164|FG000|Overall Study|Death|0|||
44376045|NCT01092182|79381165|FG001|Overall Study|Death|5|||
44376046|NCT01092182|79381166|FG002|Overall Study|Death|3|||
44376047|NCT01092182|79381164|FG000|Overall Study|participant safety|1|||
44376048|NCT01092182|79381165|FG001|Overall Study|participant safety|2|||
44376049|NCT01092182|79381166|FG002|Overall Study|participant safety|0|||
44376050|NCT01092182|79381164|FG000|Overall Study|Physician Decision|0|||
44376051|NCT01092182|79381165|FG001|Overall Study|Physician Decision|6|||
44376052|NCT01092182|79381166|FG002|Overall Study|Physician Decision|0|||
44376053|NCT01092182|79381164|FG000|Overall Study|Did not meet criteria|0|||
44376054|NCT01092182|79381165|FG001|Overall Study|Did not meet criteria|0|||
44376055|NCT01092182|79381166|FG002|Overall Study|Did not meet criteria|25|||
44376056|NCT01092182|79381164|FG000|Overall Study|Non-compliance|0|||
44376057|NCT01092182|79381165|FG001|Overall Study|Non-compliance|3|||
44376058|NCT01092182|79381166|FG002|Overall Study|Non-compliance|0|||
44376059|NCT01092182|79381164|FG000|Overall Study|Participant refused follow-up|0|||
44376060|NCT01092182|79381165|FG001|Overall Study|Participant refused follow-up|2|||
44376061|NCT01092182|79381166|FG002|Overall Study|Participant refused follow-up|0|||
44376062|NCT00932646|79381174|FG000|Overall Study|Adverse Event|2|||
44376063|NCT00932646|79381175|FG001|Overall Study|Adverse Event|1|||
44376064|NCT00932646|79381176|FG002|Overall Study|Adverse Event|1|||
44376065|NCT00932646|79381177|FG003|Overall Study|Adverse Event|1|||
44491369|NCT00141297|79497311|FG006|Overall Study|Withdrawal by Subject|0|||
44491370|NCT00141297|79497312|FG007|Overall Study|Withdrawal by Subject|0|||
44491371|NCT00141297|79497313|FG008|Overall Study|Withdrawal by Subject|1|||
44491372|NCT00141297|79497314|FG009|Overall Study|Withdrawal by Subject|0|||
44491373|NCT00141297|79497305|FG000|Overall Study|Other|0|||
44491374|NCT00141297|79497306|FG001|Overall Study|Other|0|||
44491375|NCT00141297|79497307|FG002|Overall Study|Other|0|||
44491376|NCT00141297|79497308|FG003|Overall Study|Other|1|||
44491377|NCT00141297|79497309|FG004|Overall Study|Other|5|||
44491378|NCT00141297|79497310|FG005|Overall Study|Other|0|||
44491379|NCT00141297|79497311|FG006|Overall Study|Other|0|||
44491380|NCT00141297|79497312|FG007|Overall Study|Other|0|||
44491381|NCT00141297|79497313|FG008|Overall Study|Other|2|||
44491382|NCT00141297|79497314|FG009|Overall Study|Other|0|||
44491383|NCT00141297|79497305|FG000|Overall Study|Progressive Disease|2|||
44491384|NCT00141297|79497306|FG001|Overall Study|Progressive Disease|3|||
44491385|NCT00141297|79497307|FG002|Overall Study|Progressive Disease|6|||
44491386|NCT00141297|79497308|FG003|Overall Study|Progressive Disease|2|||
44491387|NCT00141297|79497309|FG004|Overall Study|Progressive Disease|15|||
44491388|NCT00141297|79497310|FG005|Overall Study|Progressive Disease|2|||
44491389|NCT00141297|79497311|FG006|Overall Study|Progressive Disease|3|||
44491390|NCT00141297|79497312|FG007|Overall Study|Progressive Disease|3|||
44491391|NCT00141297|79497313|FG008|Overall Study|Progressive Disease|15|||
44491392|NCT00141297|79497314|FG009|Overall Study|Progressive Disease|6|||
44491393|NCT00141297|79497305|FG000|Overall Study|Transitioned|0|||
44491394|NCT00141297|79497306|FG001|Overall Study|Transitioned|0|||
44491395|NCT00141297|79497307|FG002|Overall Study|Transitioned|0|||
44491396|NCT00141297|79497308|FG003|Overall Study|Transitioned|0|||
44491397|NCT00141297|79497309|FG004|Overall Study|Transitioned|1|||
44491398|NCT00141297|79497310|FG005|Overall Study|Transitioned|0|||
44491399|NCT00141297|79497311|FG006|Overall Study|Transitioned|0|||
44491400|NCT00141297|79497312|FG007|Overall Study|Transitioned|0|||
44491401|NCT00141297|79497313|FG008|Overall Study|Transitioned|0|||
44491402|NCT00141297|79497314|FG009|Overall Study|Transitioned|0|||
44491403|NCT00141219|79497349|FG000|Overall Study|Protocol violations|5|||
44491404|NCT00141219|79497350|FG001|Overall Study|Protocol violations|4|||
44491405|NCT00141219|79497349|FG000|Overall Study|Adverse Event|8|||
44491406|NCT00141219|79497350|FG001|Overall Study|Adverse Event|6|||
44491407|NCT00141219|79497349|FG000|Overall Study|Lack of Efficacy|5|||
44491408|NCT00141219|79497350|FG001|Overall Study|Lack of Efficacy|4|||
44491409|NCT00141219|79497349|FG000|Overall Study|Withdrawal by Subject|6|||
44491410|NCT00141219|79497350|FG001|Overall Study|Withdrawal by Subject|2|||
44491411|NCT00162266|79497359|FG000|Double-Blind Period|Adverse Event|5|||
44545327|NCT00706966|79559140|FG000|Overall Study|Adverse Event|1|||
44545328|NCT03478657|79559174|FG000|Overall Study|Withdrawal by Subject|0|||
44376066|NCT00932646|79381174|FG000|Overall Study|Lost to Follow-up|2|||
44376067|NCT00932646|79381175|FG001|Overall Study|Lost to Follow-up|1|||
44376068|NCT00932646|79381176|FG002|Overall Study|Lost to Follow-up|0|||
44376069|NCT00932646|79381177|FG003|Overall Study|Lost to Follow-up|0|||
44376070|NCT00932646|79381174|FG000|Overall Study|Withdrawal by Subject|1|||
44376071|NCT00932646|79381175|FG001|Overall Study|Withdrawal by Subject|1|||
44376072|NCT00932646|79381176|FG002|Overall Study|Withdrawal by Subject|3|||
44491412|NCT00162266|79497360|FG001|Double-Blind Period|Adverse Event|9|||
44491413|NCT00162266|79497361|FG002|Double-Blind Period|Adverse Event|11|||
44491414|NCT00162266|79497362|FG003|Double-Blind Period|Adverse Event|0|||
44491415|NCT00162266|79497359|FG000|Double-Blind Period|Death|0|||
44491416|NCT00162266|79497360|FG001|Double-Blind Period|Death|1|||
44491417|NCT00162266|79497361|FG002|Double-Blind Period|Death|0|||
44491418|NCT00162266|79497362|FG003|Double-Blind Period|Death|0|||
44491419|NCT00162266|79497359|FG000|Double-Blind Period|Lost to Follow-up|1|||
44491420|NCT00162266|79497360|FG001|Double-Blind Period|Lost to Follow-up|2|||
44491421|NCT00162266|79497361|FG002|Double-Blind Period|Lost to Follow-up|0|||
44491422|NCT00162266|79497362|FG003|Double-Blind Period|Lost to Follow-up|0|||
44491423|NCT00162266|79497359|FG000|Double-Blind Period|Other Reason|1|||
44491424|NCT00162266|79497360|FG001|Double-Blind Period|Other Reason|0|||
44491425|NCT00162266|79497361|FG002|Double-Blind Period|Other Reason|1|||
44491426|NCT00162266|79497362|FG003|Double-Blind Period|Other Reason|0|||
44491427|NCT00162266|79497359|FG000|Double-Blind Period|Lack of Efficacy|13|||
44491428|NCT00162266|79497360|FG001|Double-Blind Period|Lack of Efficacy|17|||
44491429|NCT00162266|79497361|FG002|Double-Blind Period|Lack of Efficacy|30|||
44491430|NCT00162266|79497362|FG003|Double-Blind Period|Lack of Efficacy|0|||
44491431|NCT00162266|79497359|FG000|Double-Blind Period|Withdrawal by Subject|5|||
44491432|NCT00162266|79497360|FG001|Double-Blind Period|Withdrawal by Subject|2|||
44491433|NCT00162266|79497361|FG002|Double-Blind Period|Withdrawal by Subject|6|||
44491434|NCT00162266|79497362|FG003|Double-Blind Period|Withdrawal by Subject|0|||
44491435|NCT00162266|79497359|FG000|Open-Label Period|Death|0|||
44491436|NCT00162266|79497360|FG001|Open-Label Period|Death|0|||
44491437|NCT00162266|79497361|FG002|Open-Label Period|Death|0|||
44491438|NCT00162266|79497362|FG003|Open-Label Period|Death|7|||
44491439|NCT00162266|79497359|FG000|Open-Label Period|Adverse Event|0|||
44491440|NCT00162266|79497360|FG001|Open-Label Period|Adverse Event|0|||
44491441|NCT00162266|79497361|FG002|Open-Label Period|Adverse Event|0|||
44491442|NCT00162266|79497362|FG003|Open-Label Period|Adverse Event|46|||
44491443|NCT00162266|79497359|FG000|Open-Label Period|Lack of Efficacy|0|||
44491444|NCT00162266|79497360|FG001|Open-Label Period|Lack of Efficacy|0|||
44491445|NCT00162266|79497361|FG002|Open-Label Period|Lack of Efficacy|0|||
44491446|NCT00162266|79497362|FG003|Open-Label Period|Lack of Efficacy|26|||
44491447|NCT00162266|79497359|FG000|Open-Label Period|Lost to Follow-up|0|||
44491448|NCT00162266|79497360|FG001|Open-Label Period|Lost to Follow-up|0|||
44491449|NCT00162266|79497361|FG002|Open-Label Period|Lost to Follow-up|0|||
44491450|NCT00162266|79497362|FG003|Open-Label Period|Lost to Follow-up|3|||
44491451|NCT00162266|79497359|FG000|Open-Label Period|Withdrawal by Subject|0|||
44491452|NCT00162266|79497360|FG001|Open-Label Period|Withdrawal by Subject|0|||
44491453|NCT00162266|79497361|FG002|Open-Label Period|Withdrawal by Subject|0|||
44491454|NCT00162266|79497362|FG003|Open-Label Period|Withdrawal by Subject|31|||
44491455|NCT00162266|79497359|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
44491456|NCT00162266|79497360|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
44491457|NCT00162266|79497361|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
44491458|NCT00162266|79497362|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
44491459|NCT00162266|79497359|FG000|Open-Label Period|Other Reasons|0|||
44491460|NCT00162266|79497360|FG001|Open-Label Period|Other Reasons|0|||
44491461|NCT00162266|79497361|FG002|Open-Label Period|Other Reasons|0|||
44491462|NCT00162266|79497362|FG003|Open-Label Period|Other Reasons|15|||
44491463|NCT00225212|79497414|FG000|Overall Study|Disease progression|2|||
44491464|NCT00225212|79497414|FG000|Overall Study|Death|1|||
44491465|NCT00225212|79497414|FG000|Overall Study|Adverse Event|2|||
44491466|NCT00225212|79497414|FG000|Overall Study|Intercurrent illness|1|||
44491467|NCT00162032|79497420|FG000|Overall Study|Lost to Follow-up|4|||
44491468|NCT00162032|79497421|FG001|Overall Study|Lost to Follow-up|2|||
44491469|NCT00162032|79497420|FG000|Overall Study|Reason not specified|1|||
44491470|NCT00162032|79497421|FG001|Overall Study|Reason not specified|0|||
44491471|NCT00258674|79497435|FG000|Overall Study|Death|32|||
44491472|NCT00258674|79497436|FG001|Overall Study|Death|53|||
44491473|NCT00258674|79497437|FG002|Overall Study|Death|34|||
44491474|NCT00258440|79497448|FG000|Overall Study|Withdrawal by Subject|0|||
44491475|NCT00258440|79497449|FG001|Overall Study|Withdrawal by Subject|0|||
44376073|NCT00932646|79381177|FG003|Overall Study|Withdrawal by Subject|0|||
44376074|NCT00871234|79381191|FG000|Overall Study|Adverse Event|2|||
44491476|NCT00258440|79497450|FG002|Overall Study|Withdrawal by Subject|1|||
44491477|NCT00224120|79497460|FG000|Overall Study|Adverse Event|10|||
44491478|NCT00224120|79497461|FG001|Overall Study|Adverse Event|4|||
44491479|NCT00224120|79497460|FG000|Overall Study|Protocol Violation|1|||
44376075|NCT00871234|79381191|FG000|Overall Study|Lost to Follow-up|3|||
44376076|NCT01091246|79381198|FG000|Overall Study|Lost to Follow-up|23|||
44491480|NCT00224120|79497461|FG001|Overall Study|Protocol Violation|0|||
44491481|NCT00224120|79497460|FG000|Overall Study|Withdrawal by Subject|5|||
44376077|NCT01091246|79381199|FG001|Overall Study|Lost to Follow-up|11|||
44491482|NCT00224120|79497461|FG001|Overall Study|Withdrawal by Subject|10|||
44491483|NCT00224120|79497460|FG000|Overall Study|Lack of Efficacy|0|||
44491484|NCT00224120|79497461|FG001|Overall Study|Lack of Efficacy|2|||
44491485|NCT00224120|79497460|FG000|Overall Study|Lost to Follow-up|2|||
44491486|NCT00224120|79497461|FG001|Overall Study|Lost to Follow-up|3|||
44491487|NCT00224120|79497460|FG000|Overall Study|Other|4|||
44491488|NCT00224120|79497461|FG001|Overall Study|Other|5|||
44491489|NCT00257660|79497469|FG000|Overall Study|Lack of Efficacy|5|||
44229129|NCT01739348|79036817|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
44229130|NCT01739348|79036814|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
44229131|NCT01739348|79036815|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
44491490|NCT00257660|79497470|FG001|Overall Study|Lack of Efficacy|23|||
44376078|NCT01091246|79381200|FG002|Overall Study|Lost to Follow-up|7|||
44376079|NCT01091246|79381198|FG000|Overall Study|Adverse Event|1|||
44376080|NCT01091246|79381199|FG001|Overall Study|Adverse Event|0|||
44376081|NCT01091246|79381200|FG002|Overall Study|Adverse Event|1|||
44491491|NCT00257660|79497469|FG000|Overall Study|Withdrawal by Subject|2|||
44491492|NCT00257660|79497470|FG001|Overall Study|Withdrawal by Subject|0|||
44491493|NCT00257660|79497469|FG000|Overall Study|Lost to Follow-up|1|||
44491494|NCT00257660|79497470|FG001|Overall Study|Lost to Follow-up|0|||
44491495|NCT00257660|79497469|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
44491496|NCT00257660|79497470|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
44491497|NCT00257660|79497469|FG000|Overall Study|No longer wanted to do blood draws|1|||
44491498|NCT00257660|79497470|FG001|Overall Study|No longer wanted to do blood draws|0|||
44491499|NCT00224042|79497478|FG000|Overall Study|Adverse Event|2|||
44491500|NCT00224042|79497479|FG001|Overall Study|Adverse Event|1|||
44491501|NCT00224042|79497478|FG000|Overall Study|Protocol Violation|0|||
44491502|NCT00224042|79497479|FG001|Overall Study|Protocol Violation|1|||
44491503|NCT00224042|79497478|FG000|Overall Study|Physician Decision|0|||
44491504|NCT00224042|79497479|FG001|Overall Study|Physician Decision|1|||
44491505|NCT00224042|79497478|FG000|Overall Study|Did not meet lab incusion criteria|2|||
44491506|NCT00224042|79497479|FG001|Overall Study|Did not meet lab incusion criteria|3|||
44491507|NCT00224042|79497478|FG000|Overall Study|Other|2|||
44491508|NCT00224042|79497479|FG001|Overall Study|Other|0|||
44491509|NCT00160706|79497485|FG000|Overall Study|Adverse Event|53|||
44491510|NCT00160706|79497485|FG000|Overall Study|Adverse Event and Other Reason|105|||
44491511|NCT00160706|79497485|FG000|Overall Study|Protocol Violation|3|||
44491512|NCT00160706|79497485|FG000|Overall Study|Withdrawal by Subject|41|||
44491513|NCT00160706|79497485|FG000|Overall Study|Withdrawal by Subject and Other|12|||
44491514|NCT00160706|79497485|FG000|Overall Study|Physician Decision|10|||
44491515|NCT00160706|79497485|FG000|Overall Study|Physician Decision and Other|3|||
44491516|NCT00160706|79497485|FG000|Overall Study|Lost to Follow-up|4|||
44491517|NCT00160706|79497485|FG000|Overall Study|Lost to Follow-up and Other|1|||
44491518|NCT00160706|79497485|FG000|Overall Study|Lack of Efficacy|42|||
44491519|NCT00160706|79497485|FG000|Overall Study|Lack of Efficacy and Other|1|||
44491520|NCT00160706|79497485|FG000|Overall Study|Other Reason|11|||
44491521|NCT00257192|79497491|FG000|Overall Study|Adverse Event|21|||
44491522|NCT00257192|79497492|FG001|Overall Study|Adverse Event|10|||
44491523|NCT00257192|79497491|FG000|Overall Study|Laboratory abnormality|1|||
44491524|NCT00257192|79497492|FG001|Overall Study|Laboratory abnormality|1|||
44491525|NCT00257192|79497491|FG000|Overall Study|Lost to Follow-up|3|||
44491526|NCT00257192|79497492|FG001|Overall Study|Lost to Follow-up|3|||
44491527|NCT00257192|79497491|FG000|Overall Study|Insufficient clinical response|18|||
44229132|NCT01739348|79036816|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
44229133|NCT01739348|79036817|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
44229134|NCT01739348|79036814|FG000|Part II (Extension Study)|Adverse Event|10|||
44229135|NCT01739348|79036815|FG001|Part II (Extension Study)|Adverse Event|11|||
44229136|NCT01739348|79036816|FG002|Part II (Extension Study)|Adverse Event|7|||
44229137|NCT01739348|79036817|FG003|Part II (Extension Study)|Adverse Event|26|||
44229138|NCT01739348|79036814|FG000|Part II (Extension Study)|Death|3|||
44229139|NCT01739348|79036815|FG001|Part II (Extension Study)|Death|3|||
44229140|NCT01739348|79036816|FG002|Part II (Extension Study)|Death|2|||
44229141|NCT01739348|79036817|FG003|Part II (Extension Study)|Death|6|||
44229142|NCT01739348|79036814|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
44229143|NCT01739348|79036815|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
44229144|NCT01739348|79036816|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
44229145|NCT01739348|79036817|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
44229146|NCT01739348|79036814|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
44229147|NCT01739348|79036815|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
44229148|NCT01739348|79036816|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
44229149|NCT01739348|79036817|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
44229150|NCT01739348|79036814|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
44229151|NCT01739348|79036815|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
44229152|NCT01739348|79036816|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
44229153|NCT01739348|79036817|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
44229154|NCT01739348|79036814|FG000|Part II (Extension Study)|Physician Decision|7|||
44229155|NCT01739348|79036815|FG001|Part II (Extension Study)|Physician Decision|11|||
44229156|NCT01739348|79036816|FG002|Part II (Extension Study)|Physician Decision|6|||
44229157|NCT01739348|79036817|FG003|Part II (Extension Study)|Physician Decision|12|||
44376082|NCT01091246|79381198|FG000|Overall Study|Withdrawal by Subject|9|||
44491528|NCT00257192|79497492|FG001|Overall Study|Insufficient clinical response|18|||
44491529|NCT00257192|79497491|FG000|Overall Study|Withdrawal by Subject|14|||
44491530|NCT00257192|79497492|FG001|Overall Study|Withdrawal by Subject|2|||
44491531|NCT00257192|79497491|FG000|Overall Study|Randomized but not treated|0|||
44491532|NCT00257192|79497492|FG001|Overall Study|Randomized but not treated|1|||
44491533|NCT00257192|79497491|FG000|Overall Study|Study terminated by sponsor|1|||
44491534|NCT00257192|79497492|FG001|Overall Study|Study terminated by sponsor|0|||
44491535|NCT00257192|79497491|FG000|Overall Study|Miscellaneous|0|||
44491536|NCT00257192|79497492|FG001|Overall Study|Miscellaneous|4|||
44491537|NCT00256724|79497500|FG000|Overall Study|Physician Decision|2|||
44491538|NCT00256724|79497501|FG001|Overall Study|Physician Decision|5|||
44491539|NCT00256724|79497500|FG000|Overall Study|Protocol Violation|3|||
44491540|NCT00256724|79497501|FG001|Overall Study|Protocol Violation|3|||
44491541|NCT00157820|79497510|FG000|Randomized|Physician Decision|4|||
44491542|NCT00157820|79497511|FG001|Randomized|Physician Decision|2|||
44491543|NCT00157820|79497512|FG002|Randomized|Physician Decision|3|||
44491544|NCT00157820|79497510|FG000|Randomized|Withdrawal by Subject|1|||
44491545|NCT00157820|79497511|FG001|Randomized|Withdrawal by Subject|2|||
44491546|NCT00157820|79497512|FG002|Randomized|Withdrawal by Subject|3|||
44491547|NCT00157820|79497510|FG000|Randomized|Protocol Violation|2|||
44491548|NCT00157820|79497511|FG001|Randomized|Protocol Violation|1|||
44491549|NCT00157820|79497512|FG002|Randomized|Protocol Violation|2|||
44491550|NCT00157820|79497510|FG000|1st 8 Month|Death|7|||
44491551|NCT00157820|79497511|FG001|1st 8 Month|Death|8|||
44491552|NCT00157820|79497512|FG002|1st 8 Month|Death|3|||
44491553|NCT00157820|79497510|FG000|1st 8 Month|Lost to Follow-up|1|||
44491554|NCT00157820|79497511|FG001|1st 8 Month|Lost to Follow-up|2|||
44491555|NCT00157820|79497512|FG002|1st 8 Month|Lost to Follow-up|1|||
44491556|NCT00157820|79497510|FG000|1st 8 Month|Premature cross-over|0|||
44491557|NCT00157820|79497511|FG001|1st 8 Month|Premature cross-over|2|||
44491558|NCT00157820|79497512|FG002|1st 8 Month|Premature cross-over|2|||
44491559|NCT00157820|79497510|FG000|2nd 8 Months|Death|3|||
44491560|NCT00157820|79497511|FG001|2nd 8 Months|Death|1|||
44491561|NCT00157820|79497512|FG002|2nd 8 Months|Death|3|||
44491562|NCT00157820|79497510|FG000|2nd 8 Months|Lost to Follow-up|1|||
44491563|NCT00157820|79497511|FG001|2nd 8 Months|Lost to Follow-up|5|||
44491564|NCT00157820|79497512|FG002|2nd 8 Months|Lost to Follow-up|2|||
44491565|NCT00157820|79497510|FG000|2nd 8 Months|Premature cross-over|1|||
44491566|NCT00157820|79497511|FG001|2nd 8 Months|Premature cross-over|7|||
44491567|NCT00157820|79497512|FG002|2nd 8 Months|Premature cross-over|9|||
44491568|NCT00223808|79497524|FG000|Overall Study|<5 hrs therapy before discharge|3|||
44491569|NCT00223808|79497525|FG001|Overall Study|<5 hrs therapy before discharge|5|||
44491570|NCT00223808|79497526|FG002|Overall Study|<5 hrs therapy before discharge|5|||
44491571|NCT00154310|79497536|FG000|Overall Study|Adverse Event|19|||
44491572|NCT00154310|79497537|FG001|Overall Study|Adverse Event|9|||
44491573|NCT00154310|79497536|FG000|Overall Study|Lack of Efficacy|5|||
44491574|NCT00154310|79497537|FG001|Overall Study|Lack of Efficacy|4|||
44491575|NCT00154310|79497536|FG000|Overall Study|Protocol Violation|4|||
44491576|NCT00154310|79497537|FG001|Overall Study|Protocol Violation|2|||
44491577|NCT00154310|79497536|FG000|Overall Study|Withdrawal by Subject|9|||
44491578|NCT00154310|79497537|FG001|Overall Study|Withdrawal by Subject|3|||
44491579|NCT00154310|79497536|FG000|Overall Study|Lost to Follow-up|0|||
44491580|NCT00154310|79497537|FG001|Overall Study|Lost to Follow-up|8|||
44491581|NCT00154310|79497536|FG000|Overall Study|Administrative problems|0|||
44491582|NCT00154310|79497537|FG001|Overall Study|Administrative problems|1|||
44491583|NCT00154310|79497536|FG000|Overall Study|Death|0|||
44491584|NCT00154310|79497537|FG001|Overall Study|Death|1|||
44491585|NCT03771352|79497543|FG000|Overall Study|Screen failure|2|||
44491586|NCT03771352|79497543|FG000|Overall Study|Withdrawal by Subject|2|||
44491587|NCT03770728|79497551|FG000|Overall Study|Adverse Event|1|||
44491588|NCT03770728|79497552|FG001|Overall Study|Adverse Event|0|||
44491589|NCT03770728|79497553|FG002|Overall Study|Adverse Event|1|||
44274402|NCT02256631|79218119|FG001|Overall Study|Unable to get to clinic|2|||
44274403|NCT02256631|79218120|FG002|Overall Study|Unable to get to clinic|0|||
44274404|NCT02256631|79218121|FG003|Overall Study|Unable to get to clinic|1|||
44491590|NCT03770728|79497554|FG003|Overall Study|Adverse Event|0|||
44491591|NCT03770728|79497551|FG000|Overall Study|Poor compliance to protocol|0|||
44491592|NCT03770728|79497552|FG001|Overall Study|Poor compliance to protocol|0|||
44491593|NCT03770728|79497553|FG002|Overall Study|Poor compliance to protocol|1|||
44491594|NCT03770728|79497554|FG003|Overall Study|Poor compliance to protocol|0|||
44491595|NCT03770728|79497551|FG000|Overall Study|Withdrawal by Subject|13|||
44491596|NCT03770728|79497552|FG001|Overall Study|Withdrawal by Subject|8|||
44491597|NCT03770728|79497553|FG002|Overall Study|Withdrawal by Subject|9|||
44491598|NCT03770728|79497554|FG003|Overall Study|Withdrawal by Subject|13|||
44274405|NCT02256631|79218122|FG004|Overall Study|Unable to get to clinic|0|||
44274406|NCT02256631|79218123|FG005|Overall Study|Unable to get to clinic|1|||
44491599|NCT03770728|79497551|FG000|Overall Study|Other than specified|24|||
44491600|NCT03770728|79497552|FG001|Overall Study|Other than specified|23|||
44491601|NCT03770728|79497553|FG002|Overall Study|Other than specified|21|||
44491602|NCT03770728|79497554|FG003|Overall Study|Other than specified|22|||
44491603|NCT03769090|79497569|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
44491604|NCT03769090|79497570|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
44491605|NCT03769090|79497571|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
44491606|NCT03769090|79497569|FG000|Overall Study|Withdrawal by Subject|52|||
44491607|NCT03769090|79497570|FG001|Overall Study|Withdrawal by Subject|62|||
44491608|NCT03769090|79497571|FG002|Overall Study|Withdrawal by Subject|74|||
44491609|NCT03769090|79497569|FG000|Overall Study|Death|4|||
44491610|NCT03769090|79497570|FG001|Overall Study|Death|2|||
44491611|NCT03769090|79497571|FG002|Overall Study|Death|2|||
44491612|NCT03769090|79497569|FG000|Overall Study|Adverse Event|7|||
44491613|NCT03769090|79497570|FG001|Overall Study|Adverse Event|7|||
44491614|NCT03769090|79497571|FG002|Overall Study|Adverse Event|8|||
44491615|NCT03769090|79497569|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
44491616|NCT03769090|79497570|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
44491617|NCT03769090|79497571|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
44491618|NCT03769090|79497569|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
44491619|NCT03769090|79497570|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
44491620|NCT03769090|79497571|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
44491621|NCT03769090|79497569|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
44491622|NCT03769090|79497570|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
44491623|NCT03769090|79497571|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
44491624|NCT03769090|79497569|FG000|Overall Study|Protocol Violation|5|||
44491625|NCT03769090|79497570|FG001|Overall Study|Protocol Violation|6|||
44491626|NCT03769090|79497571|FG002|Overall Study|Protocol Violation|8|||
44491627|NCT03769090|79497569|FG000|Overall Study|Pregnancy|1|||
44491628|NCT03769090|79497570|FG001|Overall Study|Pregnancy|0|||
44491629|NCT03769090|79497571|FG002|Overall Study|Pregnancy|3|||
44491630|NCT03769090|79497569|FG000|Overall Study|Lost to Follow-up|19|||
44491631|NCT03769090|79497570|FG001|Overall Study|Lost to Follow-up|25|||
44491632|NCT03769090|79497571|FG002|Overall Study|Lost to Follow-up|21|||
44491633|NCT03769090|79497569|FG000|Overall Study|Condition under investigation worsened|2|||
44491634|NCT03769090|79497570|FG001|Overall Study|Condition under investigation worsened|0|||
44376083|NCT01091246|79381199|FG001|Overall Study|Withdrawal by Subject|5|||
44491635|NCT03769090|79497571|FG002|Overall Study|Condition under investigation worsened|1|||
44491636|NCT03769090|79497569|FG000|Overall Study|Lack of Efficacy|1|||
44491637|NCT03769090|79497570|FG001|Overall Study|Lack of Efficacy|2|||
44491638|NCT03769090|79497571|FG002|Overall Study|Lack of Efficacy|2|||
44376084|NCT01091246|79381200|FG002|Overall Study|Withdrawal by Subject|4|||
44376085|NCT01091246|79381198|FG000|Overall Study|Subject not dosed|2|||
44376086|NCT01091246|79381199|FG001|Overall Study|Subject not dosed|0|||
44376087|NCT01091246|79381200|FG002|Overall Study|Subject not dosed|1|||
44376088|NCT01097330|79381212|FG000|Overall Study|Study terminated early|7|||
44376089|NCT01097330|79381213|FG001|Overall Study|Study terminated early|5|||
44376090|NCT00934440|79381219|FG000|Overall Study|Lost to Follow-up|1|||
44376091|NCT00934362|79381226|FG000|Overall Study|Adverse Event|1|||
44376092|NCT00934362|79381227|FG001|Overall Study|Adverse Event|0|||
44376093|NCT00934128|79381235|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
44376094|NCT00934128|79381236|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
44376095|NCT00934128|79381235|FG000|First Intervention (2 Hours)|Adverse Event|4|||
44376096|NCT00934128|79381236|FG001|First Intervention (2 Hours)|Adverse Event|1|||
44376097|NCT00934128|79381235|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
44376098|NCT00934128|79381236|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
44376099|NCT00934128|79381235|FG000|Washout Period (1 Hour)|Patient preference|1|||
44376100|NCT00934128|79381236|FG001|Washout Period (1 Hour)|Patient preference|3|||
44376101|NCT00934128|79381235|FG000|Washout Period (1 Hour)|Pain|1|||
44376102|NCT00934128|79381236|FG001|Washout Period (1 Hour)|Pain|0|||
44376103|NCT00934128|79381235|FG000|Washout Period (1 Hour)|Too tired|1|||
44376104|NCT00934128|79381236|FG001|Washout Period (1 Hour)|Too tired|0|||
44376105|NCT00934128|79381235|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
44376106|NCT00934128|79381236|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
44376107|NCT00934128|79381235|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
44376108|NCT00934128|79381236|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
44376109|NCT00871000|79381244|FG000|Overall Study|Withdrawal by Subject|1|||
44376110|NCT00871000|79381245|FG001|Overall Study|Withdrawal by Subject|0|||
44491639|NCT03769090|79497569|FG000|Overall Study|Other reasons|8|||
44491640|NCT03769090|79497570|FG001|Overall Study|Other reasons|12|||
44491641|NCT03769090|79497571|FG002|Overall Study|Other reasons|15|||
44491642|NCT03559270|79497595|FG000|Overall Study|Adverse Event|6|||
44491643|NCT03559270|79497596|FG001|Overall Study|Adverse Event|5|||
44545329|NCT03478657|79559175|FG001|Overall Study|Withdrawal by Subject|1|||
44376111|NCT01096784|79381253|FG000|Overall Study|Withdrawal by Subject|2|||
44376112|NCT01096784|79381254|FG001|Overall Study|Withdrawal by Subject|1|||
44376113|NCT01096784|79381253|FG000|Overall Study|Adverse Event|11|||
44376114|NCT01096784|79381254|FG001|Overall Study|Adverse Event|9|||
44491644|NCT03559270|79497597|FG002|Overall Study|Adverse Event|3|||
44491645|NCT03559270|79497598|FG003|Overall Study|Adverse Event|0|||
44376115|NCT01096784|79381253|FG000|Overall Study|Protocol Deviation|2|||
44376116|NCT01096784|79381254|FG001|Overall Study|Protocol Deviation|2|||
44376117|NCT01096784|79381253|FG000|Overall Study|Administrative Decision|0|||
44376118|NCT01096784|79381254|FG001|Overall Study|Administrative Decision|1|||
44376119|NCT01096784|79381253|FG000|Overall Study|Other Unspecified|0|||
44376120|NCT01096784|79381254|FG001|Overall Study|Other Unspecified|1|||
44376121|NCT00934050|79381268|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
44376122|NCT00934050|79381269|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
44376123|NCT00934050|79381270|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
44376124|NCT00934050|79381271|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
44376125|NCT00934050|79381272|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
44376126|NCT00934050|79381273|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
44376127|NCT00934050|79381268|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
44376128|NCT00934050|79381269|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
44376129|NCT00934050|79381270|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
44376130|NCT00934050|79381271|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
44376131|NCT00934050|79381272|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
44491646|NCT03559270|79497595|FG000|Overall Study|Lack of Efficacy|34|||
44491647|NCT03559270|79497596|FG001|Overall Study|Lack of Efficacy|52|||
44376132|NCT00934050|79381273|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
44376133|NCT00934050|79381268|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
44376134|NCT00934050|79381269|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
44376135|NCT00934050|79381270|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
44376136|NCT00934050|79381271|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
44376137|NCT00934050|79381272|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
44376138|NCT00934050|79381273|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
44376139|NCT00934050|79381268|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
44376140|NCT00934050|79381269|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
44376141|NCT00934050|79381270|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
44491648|NCT03559270|79497597|FG002|Overall Study|Lack of Efficacy|37|||
44491649|NCT03559270|79497598|FG003|Overall Study|Lack of Efficacy|2|||
44491650|NCT03559270|79497595|FG000|Overall Study|Death|0|||
44491651|NCT03559270|79497596|FG001|Overall Study|Death|2|||
44491652|NCT03559270|79497597|FG002|Overall Study|Death|0|||
44491653|NCT03559270|79497598|FG003|Overall Study|Death|0|||
44491654|NCT03559270|79497595|FG000|Overall Study|Lost to Follow-up|16|||
44491655|NCT03559270|79497596|FG001|Overall Study|Lost to Follow-up|4|||
44491656|NCT03559270|79497597|FG002|Overall Study|Lost to Follow-up|12|||
44491657|NCT03559270|79497598|FG003|Overall Study|Lost to Follow-up|3|||
44491658|NCT03559270|79497595|FG000|Overall Study|Sponsor Decision|38|||
44491659|NCT03559270|79497596|FG001|Overall Study|Sponsor Decision|31|||
44491660|NCT03559270|79497597|FG002|Overall Study|Sponsor Decision|35|||
44491661|NCT03559270|79497598|FG003|Overall Study|Sponsor Decision|18|||
44491662|NCT03559270|79497595|FG000|Overall Study|Withdrawal by Subject|19|||
44491663|NCT03559270|79497596|FG001|Overall Study|Withdrawal by Subject|21|||
44491664|NCT03559270|79497597|FG002|Overall Study|Withdrawal by Subject|18|||
44491665|NCT03559270|79497598|FG003|Overall Study|Withdrawal by Subject|7|||
44491666|NCT03559270|79497595|FG000|Overall Study|Physician Decision|3|||
44491667|NCT03559270|79497596|FG001|Overall Study|Physician Decision|2|||
44491668|NCT03559270|79497597|FG002|Overall Study|Physician Decision|1|||
44491669|NCT03559270|79497598|FG003|Overall Study|Physician Decision|0|||
44491670|NCT03559270|79497595|FG000|Overall Study|Pregnancy|0|||
44491671|NCT03559270|79497596|FG001|Overall Study|Pregnancy|1|||
44491672|NCT03559270|79497597|FG002|Overall Study|Pregnancy|0|||
44491673|NCT03559270|79497598|FG003|Overall Study|Pregnancy|0|||
44491674|NCT03559270|79497595|FG000|Overall Study|Protocol Violation|1|||
44491675|NCT03559270|79497596|FG001|Overall Study|Protocol Violation|0|||
44491676|NCT03559270|79497597|FG002|Overall Study|Protocol Violation|2|||
44491677|NCT03559270|79497598|FG003|Overall Study|Protocol Violation|0|||
44491678|NCT00114777|79497653|FG000|Randomization to Month 36|Death|10|||
44376142|NCT00934050|79381271|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
44376143|NCT00934050|79381272|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
44376144|NCT00934050|79381273|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
44376145|NCT00934050|79381268|FG000|Enrolled After 15 Dec 2009|Death|0|||
44376146|NCT00934050|79381269|FG001|Enrolled After 15 Dec 2009|Death|0|||
44376147|NCT00934050|79381270|FG002|Enrolled After 15 Dec 2009|Death|0|||
44376148|NCT00934050|79381271|FG003|Enrolled After 15 Dec 2009|Death|0|||
44491679|NCT00114777|79497654|FG001|Randomization to Month 36|Death|4|||
44491680|NCT00114777|79497655|FG002|Randomization to Month 36|Death|3|||
44491681|NCT00114777|79497653|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
44491682|NCT00114777|79497654|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
44376149|NCT00934050|79381272|FG004|Enrolled After 15 Dec 2009|Death|0|||
44491683|NCT00114777|79497655|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
44491684|NCT00114777|79497653|FG000|Randomization to Month 36|Lack of Efficacy|19|||
44491685|NCT00114777|79497654|FG001|Randomization to Month 36|Lack of Efficacy|15|||
44491686|NCT00114777|79497655|FG002|Randomization to Month 36|Lack of Efficacy|17|||
44491687|NCT00114777|79497653|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
44491688|NCT00114777|79497654|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
44491689|NCT00114777|79497655|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
44491690|NCT00114777|79497653|FG000|Randomization to Month 36|Adverse Event|34|||
44491691|NCT00114777|79497654|FG001|Randomization to Month 36|Adverse Event|35|||
44491692|NCT00114777|79497655|FG002|Randomization to Month 36|Adverse Event|44|||
44491693|NCT00114777|79497653|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
44491694|NCT00114777|79497654|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
44491695|NCT00114777|79497655|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
44491696|NCT00114777|79497653|FG000|Randomization to Month 36|Other|9|||
44491697|NCT00114777|79497654|FG001|Randomization to Month 36|Other|3|||
44491698|NCT00114777|79497655|FG002|Randomization to Month 36|Other|12|||
44491699|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Death|8|||
44491700|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Death|13|||
44491701|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Death|7|||
44491702|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
44491703|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
44491704|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
44491705|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
44491706|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
44491707|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
44491708|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
44491709|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
44491710|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
44491711|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
44491712|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
44491713|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
44491714|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
44491715|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
44491716|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
44491717|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
44491718|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
44491719|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
44491720|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
44491721|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
44491722|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
44491723|NCT00114777|79497653|FG000|Long-Term Extension to Month 84|Other|2|||
44491724|NCT00114777|79497654|FG001|Long-Term Extension to Month 84|Other|0|||
44491725|NCT00114777|79497655|FG002|Long-Term Extension to Month 84|Other|2|||
44491726|NCT00139737|79497664|FG000|Overall Study|Withdrawal by Subject|190|||
44491727|NCT00139737|79497664|FG000|Overall Study|Adverse Event|58|||
44491728|NCT00139737|79497664|FG000|Overall Study|Lack of Efficacy|40|||
44491729|NCT00139737|79497664|FG000|Overall Study|Lost to Follow-up|8|||
44491730|NCT00139737|79497664|FG000|Overall Study|Death|3|||
44491731|NCT00139737|79497664|FG000|Overall Study|Laboratory Abnormality|2|||
44491732|NCT00139737|79497664|FG000|Overall Study|Protocol Violation|18|||
44491733|NCT00139737|79497664|FG000|Overall Study|Withdrew During Screening Phase|8|||
44491734|NCT00139737|79497664|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
44491735|NCT00139737|79497664|FG000|Overall Study|Screened, Not Treated|13|||
44491736|NCT00122187|79497670|FG000|Overall Study|Withdrew because of resource limitations|2|||
44491737|NCT00122187|79497671|FG001|Overall Study|Withdrew because of resource limitations|2|||
44491738|NCT00139659|79497681|FG000|Overall Study|Adverse Event|12|||
44491739|NCT00139659|79497682|FG001|Overall Study|Adverse Event|1|||
44491740|NCT00139659|79497681|FG000|Overall Study|Lack of Efficacy|1|||
44491741|NCT00139659|79497682|FG001|Overall Study|Lack of Efficacy|1|||
44491742|NCT00139659|79497681|FG000|Overall Study|Lost to Follow-up|7|||
44491743|NCT00139659|79497682|FG001|Overall Study|Lost to Follow-up|3|||
44491744|NCT00139659|79497681|FG000|Overall Study|Reason not Specified|6|||
44491745|NCT00139659|79497682|FG001|Overall Study|Reason not Specified|3|||
44491746|NCT00139659|79497681|FG000|Overall Study|Withdrawal by Subject|14|||
44491747|NCT00139659|79497682|FG001|Overall Study|Withdrawal by Subject|10|||
44491748|NCT00137631|79497694|FG000|Overall Study|Lost to Follow-up|37|||
44491749|NCT00137631|79497695|FG001|Overall Study|Lost to Follow-up|41|||
44491750|NCT00114231|79497703|FG000|Overall Study|No consent|2|||
44491751|NCT00114231|79497704|FG001|Overall Study|No consent|0|||
44491752|NCT00114231|79497703|FG000|Overall Study|QARC requirement not met|1|||
44491753|NCT00114231|79497704|FG001|Overall Study|QARC requirement not met|0|||
44491754|NCT00114231|79497703|FG000|Overall Study|Suspected metastatic disease|1|||
44491755|NCT00114231|79497704|FG001|Overall Study|Suspected metastatic disease|0|||
44491756|NCT00114231|79497703|FG000|Overall Study|No adenocarcinoma|1|||
44491757|NCT00114231|79497704|FG001|Overall Study|No adenocarcinoma|0|||
44491758|NCT00114231|79497703|FG000|Overall Study|Low creatinine clearance|0|||
44491759|NCT00114231|79497704|FG001|Overall Study|Low creatinine clearance|1|||
44491760|NCT00114231|79497703|FG000|Overall Study|Tumor size > 4cm|1|||
44491761|NCT00114231|79497704|FG001|Overall Study|Tumor size > 4cm|0|||
44491762|NCT00114231|79497703|FG000|Overall Study|Tumor fixed on digital exam|0|||
44491763|NCT00114231|79497704|FG001|Overall Study|Tumor fixed on digital exam|1|||
44491764|NCT00114231|79497703|FG000|Overall Study|No Absolute Neutrophil Count|2|||
44491765|NCT00114231|79497704|FG001|Overall Study|No Absolute Neutrophil Count|0|||
44491766|NCT00114231|79497703|FG000|Overall Study|Biopsy done after registration|1|||
44491767|NCT00114231|79497704|FG001|Overall Study|Biopsy done after registration|0|||
44491768|NCT00113919|79497709|FG000|Overall Study|Physician Decision|8|||
44491769|NCT00113919|79497709|FG000|Overall Study|Death|6|||
44491770|NCT00113841|79497715|FG000|Overall Study|Disease progression|0|||
44491771|NCT00113841|79497716|FG001|Overall Study|Disease progression|2|||
44491772|NCT00113841|79497715|FG000|Overall Study|Non-compliant|1|||
44491773|NCT00113841|79497716|FG001|Overall Study|Non-compliant|0|||
44491774|NCT00113607|79497724|FG000|Overall Study|Adverse Event|40|||
44491775|NCT00113607|79497725|FG001|Overall Study|Adverse Event|71|||
44491776|NCT00113607|79497724|FG000|Overall Study|Death|8|||
44491777|NCT00113607|79497725|FG001|Overall Study|Death|8|||
44491778|NCT00113607|79497724|FG000|Overall Study|Withdrawal by Subject|50|||
44491779|NCT00113607|79497725|FG001|Overall Study|Withdrawal by Subject|58|||
44491780|NCT00113607|79497724|FG000|Overall Study|Lost to Follow-up|0|||
44491781|NCT00113607|79497725|FG001|Overall Study|Lost to Follow-up|2|||
44491782|NCT00113607|79497724|FG000|Overall Study|Disease Progression|180|||
44491783|NCT00113607|79497725|FG001|Overall Study|Disease Progression|142|||
44491784|NCT00113607|79497724|FG000|Overall Study|Complete Response (Confirmed)|14|||
44491785|NCT00113607|79497725|FG001|Overall Study|Complete Response (Confirmed)|24|||
44491786|NCT00113607|79497724|FG000|Overall Study|Other|43|||
44491787|NCT00113607|79497725|FG001|Overall Study|Other|32|||
44491788|NCT00113529|79497732|FG000|Overall Study|Adverse Event|4|||
44491789|NCT00113529|79497732|FG000|Overall Study|Lack of Efficacy|20|||
44491790|NCT00113529|79497732|FG000|Overall Study|Decision of sponsor|6|||
44491791|NCT00113529|79497732|FG000|Overall Study|Withdrawal by Subject|4|||
44491792|NCT00134901|79497738|FG000|Overall Study|Lost to Follow-up|5|||
44491793|NCT00134901|79497739|FG001|Overall Study|Lost to Follow-up|5|||
44491794|NCT00134901|79497738|FG000|Overall Study|discontinued intervention|12|||
44491795|NCT00134901|79497739|FG001|Overall Study|discontinued intervention|10|||
44491796|NCT00122109|79497749|FG000|Overall Study|Did not meet criteria|6|||
44491797|NCT00122109|79497750|FG001|Overall Study|Did not meet criteria|7|||
44545330|NCT03018288|79559185|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
44491798|NCT00113373|79497759|FG000|Overall Study|Ineligible: wrong primary|1|||
44491799|NCT00113373|79497759|FG000|Overall Study|Ineligible: second primary|1|||
44491800|NCT00113373|79497759|FG000|Overall Study|Never Treated|1|||
44491801|NCT00113295|79497770|FG000|Overall Study|Adverse Event|4|||
44491802|NCT00113295|79497771|FG001|Overall Study|Adverse Event|1|||
44491803|NCT00113295|79497770|FG000|Overall Study|Unrelated Medical Illness|1|||
44491804|NCT00113295|79497771|FG001|Overall Study|Unrelated Medical Illness|0|||
44491805|NCT00112905|79497779|FG000|Overall Study|Adverse Event|4|||
44491806|NCT00112905|79497779|FG000|Overall Study|Death|1|||
44376150|NCT00934050|79381273|FG005|Enrolled After 15 Dec 2009|Death|1|||
44376151|NCT00934050|79381268|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
44376152|NCT00934050|79381269|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
44376153|NCT00934050|79381270|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
44491807|NCT00112905|79497779|FG000|Overall Study|Ineligibility|5|||
44491808|NCT00112905|79497779|FG000|Overall Study|Alternative treatment|1|||
44491809|NCT00112905|79497779|FG000|Overall Study|performance status was deteiorating|1|||
44491810|NCT00427895|79497787|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491811|NCT00427895|79497788|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491812|NCT00427895|79497789|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491813|NCT00427895|79497790|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
44491814|NCT00427895|79497791|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491815|NCT00427895|79497792|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491816|NCT00427895|79497793|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491817|NCT00427895|79497794|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
44491818|NCT00427895|79497787|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491819|NCT00427895|79497788|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491820|NCT00427895|79497789|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491821|NCT00427895|79497790|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491822|NCT00427895|79497791|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491823|NCT00427895|79497792|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491824|NCT00427895|79497793|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
44491825|NCT00427895|79497794|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
44491826|NCT00427895|79497787|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491827|NCT00427895|79497788|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491828|NCT00427895|79497789|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491829|NCT00427895|79497790|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491830|NCT00427895|79497791|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491831|NCT00427895|79497792|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491832|NCT00427895|79497793|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
44491833|NCT00427895|79497794|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
44491834|NCT00427895|79497787|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
44491835|NCT00427895|79497788|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
44491836|NCT00427895|79497789|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
44491837|NCT00427895|79497790|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
44491838|NCT00427895|79497791|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
44491839|NCT00427895|79497792|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
44491840|NCT00427895|79497793|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
44491841|NCT00427895|79497794|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
44491842|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
44491843|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
44491844|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
44491845|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
44491846|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
44491847|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
44491848|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
44491849|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
44491850|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
44491851|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
44491852|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
44491853|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
44491854|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
44491855|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
44491856|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
44491857|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
44491858|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
44491859|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
44491860|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
44491861|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
44491862|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
44491863|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
44376154|NCT00934050|79381271|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
44376155|NCT00934050|79381272|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
44376156|NCT00934050|79381273|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
44376157|NCT00934050|79381268|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
44376158|NCT00934050|79381269|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
44376159|NCT00934050|79381270|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
44376160|NCT00934050|79381271|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
44376161|NCT00934050|79381272|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
44376162|NCT00934050|79381273|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
44376163|NCT01091168|79381285|FG000|Overall Study|Progressive disease|250|||
44491864|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
44491865|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
44491866|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
44491867|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
44491868|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
44491869|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
44491870|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
44491871|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
44491872|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
44491873|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
44491874|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491875|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491876|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491877|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
44491878|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491879|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491880|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491881|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
44491882|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
44491883|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
44491884|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
44376164|NCT01091168|79381286|FG001|Overall Study|Progressive disease|234|||
44376165|NCT01091168|79381285|FG000|Overall Study|Adverse Event|21|||
44376166|NCT01091168|79381286|FG001|Overall Study|Adverse Event|24|||
44376167|NCT01091168|79381285|FG000|Overall Study|Lost to Follow-up|0|||
44376168|NCT01091168|79381286|FG001|Overall Study|Lost to Follow-up|1|||
44376169|NCT01091168|79381285|FG000|Overall Study|Physician, patient's decision, other|27|||
44376170|NCT01091168|79381286|FG001|Overall Study|Physician, patient's decision, other|37|||
44376171|NCT00864916|79381294|FG000|Overall Study|Lost to Follow-up|4|||
44376172|NCT00864916|79381295|FG001|Overall Study|Lost to Follow-up|4|||
44376173|NCT00864916|79381294|FG000|Overall Study|Protocol Violation|1|||
44376174|NCT00864916|79381295|FG001|Overall Study|Protocol Violation|0|||
44376175|NCT00864916|79381294|FG000|Overall Study|Withdrawal by Subject|1|||
44376176|NCT00864916|79381295|FG001|Overall Study|Withdrawal by Subject|0|||
44376177|NCT00864682|79381304|FG000|Overall Study|Protocol Violation|2|||
44376178|NCT00864682|79381305|FG001|Overall Study|Protocol Violation|1|||
44376179|NCT00864682|79381306|FG002|Overall Study|Protocol Violation|2|||
44376180|NCT00931944|79381314|FG000|Overall Study|Adverse Event|4|||
44376181|NCT00931944|79381314|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
44491885|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
44491886|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
44491887|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
44491888|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
44491889|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
44491890|NCT00427895|79497787|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
44491891|NCT00427895|79497788|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
44376182|NCT00931944|79381314|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
44376183|NCT00931944|79381314|FG000|Overall Study|Death|28|||
44376184|NCT00931944|79381314|FG000|Overall Study|Other|2|||
44376185|NCT00929994|79381318|FG000|Overall Study|Withdrawal by Subject|1|||
44376186|NCT00929994|79381318|FG000|Overall Study|medical issue unrelated to intervention|4|||
44376187|NCT00929994|79381318|FG000|Overall Study|employment|1|||
44491892|NCT00427895|79497789|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
44491893|NCT00427895|79497790|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
44491894|NCT00427895|79497791|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
44491895|NCT00427895|79497792|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
44491896|NCT00427895|79497793|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
44491897|NCT00427895|79497794|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
44491898|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
44491899|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
44491900|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
44491901|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
44491902|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
44491903|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
44491904|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
44491905|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
44491906|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
44491907|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
44491908|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
44491909|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
44491910|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
44491911|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
44491912|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
44491913|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
44491914|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
44491915|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
44491916|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
44491917|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
44491918|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
44491919|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
44491920|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
44491921|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
44491922|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491923|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
44491924|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491925|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491926|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491927|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491928|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491929|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
44491930|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Death|1|||
44491931|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Death|0|||
44491932|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Death|0|||
44491933|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Death|0|||
44491934|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Death|0|||
44491935|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Death|0|||
44491936|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Death|0|||
44491937|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Death|0|||
44491938|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
44491939|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
44491940|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
44491941|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
44491942|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
44491943|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
44491944|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
44491945|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
44491946|NCT00427895|79497787|FG000|Vax 1/Year 1 Follow-up|Other|0|||
44491947|NCT00427895|79497788|FG001|Vax 1/Year 1 Follow-up|Other|0|||
44491948|NCT00427895|79497789|FG002|Vax 1/Year 1 Follow-up|Other|0|||
44491949|NCT00427895|79497790|FG003|Vax 1/Year 1 Follow-up|Other|2|||
44491950|NCT00427895|79497791|FG004|Vax 1/Year 1 Follow-up|Other|0|||
44491951|NCT00427895|79497792|FG005|Vax 1/Year 1 Follow-up|Other|0|||
44491952|NCT00427895|79497793|FG006|Vax 1/Year 1 Follow-up|Other|0|||
44491953|NCT00427895|79497794|FG007|Vax 1/Year 1 Follow-up|Other|0|||
44491954|NCT00427895|79497787|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
44491955|NCT00427895|79497788|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
44491956|NCT00427895|79497789|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
44491957|NCT00427895|79497790|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
44491958|NCT00427895|79497791|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
44491959|NCT00427895|79497792|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
44491960|NCT00427895|79497793|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
44491961|NCT00427895|79497794|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
44491962|NCT00425945|79497835|FG000|Overall Study|Concern about Supplement|2|||
44491963|NCT00425945|79497836|FG001|Overall Study|Concern about Supplement|0|||
44491964|NCT00425945|79497835|FG000|Overall Study|Inconvenience|0|||
44491965|NCT00425945|79497836|FG001|Overall Study|Inconvenience|2|||
44491966|NCT00425945|79497835|FG000|Overall Study|Lost to Follow-up|0|||
44491967|NCT00425945|79497836|FG001|Overall Study|Lost to Follow-up|2|||
44491968|NCT00425945|79497835|FG000|Overall Study|Began hypertension medication|1|||
44491969|NCT00425945|79497836|FG001|Overall Study|Began hypertension medication|0|||
44491970|NCT00425945|79497835|FG000|Overall Study|Began cancer treatments|1|||
44491971|NCT00425945|79497836|FG001|Overall Study|Began cancer treatments|0|||
44491972|NCT00425945|79497835|FG000|Overall Study|Moved from area|0|||
44491973|NCT00425945|79497836|FG001|Overall Study|Moved from area|1|||
44491974|NCT00416195|79497846|FG000|Overall Study|Adverse Event|1|||
44491975|NCT00416195|79497847|FG001|Overall Study|Adverse Event|2|||
44491976|NCT00416195|79497846|FG000|Overall Study|Protocol Violation|1|||
44491977|NCT00416195|79497847|FG001|Overall Study|Protocol Violation|1|||
44491978|NCT00416195|79497846|FG000|Overall Study|Other|0|||
44491979|NCT00416195|79497847|FG001|Overall Study|Other|1|||
44491980|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
44491981|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
44491982|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
44491983|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
44491984|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
44491985|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
44491986|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
44491987|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
44491988|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
44491989|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
44376188|NCT01090310|79381329|FG000|Core Study|Adverse Event|2|||
44491990|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
44491991|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
44491992|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
44491993|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
44491994|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
44491995|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
44491996|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
44491997|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
44491998|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
44491999|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
44492000|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
44492001|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
44376189|NCT01090310|79381330|FG001|Core Study|Adverse Event|2|||
44376190|NCT01090310|79381331|FG002|Core Study|Adverse Event|1|||
44376191|NCT01090310|79381332|FG003|Core Study|Adverse Event|1|||
44376192|NCT01090310|79381329|FG000|Core Study|Subject withdrew consent|0|||
44376193|NCT01090310|79381330|FG001|Core Study|Subject withdrew consent|3|||
44376194|NCT01090310|79381331|FG002|Core Study|Subject withdrew consent|1|||
44376195|NCT01090310|79381332|FG003|Core Study|Subject withdrew consent|1|||
44376196|NCT01090310|79381329|FG000|Core Study|Abnormal test procedure result|0|||
44376197|NCT01090310|79381330|FG001|Core Study|Abnormal test procedure result|0|||
44376198|NCT01090310|79381331|FG002|Core Study|Abnormal test procedure result|1|||
44376199|NCT01090310|79381332|FG003|Core Study|Abnormal test procedure result|0|||
44376200|NCT01090310|79381329|FG000|Core Study|Administrative reasons|5|||
44376201|NCT01090310|79381330|FG001|Core Study|Administrative reasons|6|||
44376202|NCT01090310|79381331|FG002|Core Study|Administrative reasons|4|||
44376203|NCT01090310|79381332|FG003|Core Study|Administrative reasons|4|||
44376204|NCT01090310|79381329|FG000|Core Study|Protocol deviation|1|||
44376205|NCT01090310|79381330|FG001|Core Study|Protocol deviation|0|||
44376206|NCT01090310|79381331|FG002|Core Study|Protocol deviation|0|||
44376207|NCT01090310|79381332|FG003|Core Study|Protocol deviation|1|||
44376208|NCT01090310|79381329|FG000|Extension Study|Aministrative problems|13|||
44376209|NCT01090310|79381330|FG001|Extension Study|Aministrative problems|15|||
44376210|NCT01090310|79381331|FG002|Extension Study|Aministrative problems|14|||
44376211|NCT01090310|79381332|FG003|Extension Study|Aministrative problems|18|||
44376212|NCT01090310|79381329|FG000|Extension Study|Adverse Event|0|||
44376213|NCT01090310|79381330|FG001|Extension Study|Adverse Event|0|||
44376214|NCT01090310|79381331|FG002|Extension Study|Adverse Event|0|||
44376215|NCT01090310|79381332|FG003|Extension Study|Adverse Event|1|||
44376216|NCT01090310|79381329|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
44492002|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
44376217|NCT01090310|79381330|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
44376218|NCT01090310|79381331|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
44376219|NCT01090310|79381332|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
44376220|NCT01090310|79381329|FG000|Extension Study|Subject withdrew consent|0|||
44376221|NCT01090310|79381330|FG001|Extension Study|Subject withdrew consent|1|||
44376222|NCT01090310|79381331|FG002|Extension Study|Subject withdrew consent|0|||
44376223|NCT01090310|79381332|FG003|Extension Study|Subject withdrew consent|0|||
44376224|NCT01090076|79381344|FG000|Overall Study|Death|1|||
44376225|NCT01090076|79381345|FG001|Overall Study|Death|1|||
44376226|NCT01090076|79381344|FG000|Overall Study|Withdrawal by Subject|0|||
44376227|NCT01090076|79381345|FG001|Overall Study|Withdrawal by Subject|1|||
44376228|NCT00869050|79381353|FG000|Overall Study|Screen Failure|3|||
44376229|NCT00927186|79381359|FG000|12 Months Primary Study|Adverse Event|5|||
44376230|NCT00927186|79381360|FG001|12 Months Primary Study|Adverse Event|2|||
44376231|NCT00927186|79381359|FG000|12 Months Primary Study|Lost to Follow-up|1|||
44376232|NCT00927186|79381360|FG001|12 Months Primary Study|Lost to Follow-up|0|||
44376233|NCT00927186|79381359|FG000|12 Months Primary Study|Protocol Violation|0|||
44376234|NCT00927186|79381360|FG001|12 Months Primary Study|Protocol Violation|1|||
44376235|NCT00927186|79381359|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
44376236|NCT00927186|79381360|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
44376237|NCT00593554|79381371|FG000|Overall Study|Death|1|||
44376238|NCT00593554|79381372|FG001|Overall Study|Death|2|||
44376239|NCT00593554|79381371|FG000|Overall Study|Physician Decision|0|||
44376240|NCT00593554|79381372|FG001|Overall Study|Physician Decision|1|||
44376241|NCT00593554|79381371|FG000|Overall Study|Withdrawal by Subject|1|||
44376242|NCT00593554|79381372|FG001|Overall Study|Withdrawal by Subject|0|||
44376243|NCT00593554|79381371|FG000|Overall Study|Disease Progression|1|||
44376244|NCT00593554|79381372|FG001|Overall Study|Disease Progression|2|||
44376245|NCT01101308|79381378|FG000|Period 1|Adverse Event|2|||
44376246|NCT01101308|79381379|FG001|Period 1|Adverse Event|1|||
44376247|NCT01101308|79381378|FG000|Period 1|Positive for cotinine|1|||
44376248|NCT01101308|79381379|FG001|Period 1|Positive for cotinine|0|||
44376249|NCT00926796|79381388|FG000|Overall Study|Did not receive randomized treatment|4|||
44376250|NCT00926796|79381389|FG001|Overall Study|Did not receive randomized treatment|7|||
44376251|NCT00926796|79381388|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
44376252|NCT00926796|79381389|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
44376253|NCT00926796|79381388|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
44376254|NCT00926796|79381389|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
44376255|NCT00926796|79381388|FG000|Overall Study|Adverse Event|7|||
44376256|NCT00926796|79381389|FG001|Overall Study|Adverse Event|14|||
44376257|NCT00926796|79381388|FG000|Overall Study|Lost to Follow-up|22|||
44376258|NCT00926796|79381389|FG001|Overall Study|Lost to Follow-up|13|||
44376259|NCT00926796|79381388|FG000|Overall Study|Protocol Violation|15|||
44376260|NCT00926796|79381389|FG001|Overall Study|Protocol Violation|11|||
44376261|NCT00926796|79381388|FG000|Overall Study|Withdrawal by Subject|1|||
44376262|NCT00926796|79381389|FG001|Overall Study|Withdrawal by Subject|0|||
44376263|NCT01087736|79381399|FG000|Overall Study|Lost to Follow-up|1|||
44376264|NCT01087736|79381400|FG001|Overall Study|Lost to Follow-up|0|||
44376265|NCT01087736|79381399|FG000|Overall Study|Death|0|||
44376266|NCT01087736|79381400|FG001|Overall Study|Death|1|||
44376267|NCT01087736|79381399|FG000|Overall Study|Withdrawal by Subject|0|||
44376268|NCT01087736|79381400|FG001|Overall Study|Withdrawal by Subject|1|||
44376269|NCT01079936|79381410|FG000|Phase I: MTD|First Remission Status|2|||
44376270|NCT01079936|79381411|FG001|Phase I: MTD|First Remission Status|0|||
44376271|NCT01079936|79381412|FG002|Phase I: MTD|First Remission Status|0|||
44376272|NCT01079936|79381413|FG003|Phase I: MTD|First Remission Status|0|||
44376273|NCT01079936|79381414|FG004|Phase I: MTD|First Remission Status|0|||
44376274|NCT01079936|79381410|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
44376275|NCT01079936|79381411|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
44376276|NCT01079936|79381412|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
44376277|NCT01079936|79381413|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
44376278|NCT01079936|79381414|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
44376279|NCT01079936|79381410|FG000|Phase II|Adverse Event|0|||
44376280|NCT01079936|79381411|FG001|Phase II|Adverse Event|0|||
44376281|NCT01079936|79381412|FG002|Phase II|Adverse Event|1|||
44376282|NCT01079936|79381413|FG003|Phase II|Adverse Event|0|||
44376283|NCT01079936|79381414|FG004|Phase II|Adverse Event|0|||
44492003|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
44492004|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
44492005|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
44492006|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
44492007|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
44376284|NCT01079936|79381410|FG000|Phase II|Insurance Issue|0|||
44492008|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
44376285|NCT01079936|79381411|FG001|Phase II|Insurance Issue|0|||
44376286|NCT01079936|79381412|FG002|Phase II|Insurance Issue|0|||
44376287|NCT01079936|79381413|FG003|Phase II|Insurance Issue|0|||
44376288|NCT01079936|79381414|FG004|Phase II|Insurance Issue|1|||
44376289|NCT00931710|79381427|FG000|Overall Study|Adverse Event|16|||
44376290|NCT00931710|79381428|FG001|Overall Study|Adverse Event|10|||
44376291|NCT00931710|79381427|FG000|Overall Study|Abnormal test procedure results|2|||
44376292|NCT00931710|79381428|FG001|Overall Study|Abnormal test procedure results|0|||
44376293|NCT00931710|79381427|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
44376294|NCT00931710|79381428|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
44376295|NCT00931710|79381427|FG000|Overall Study|Patient withdrew consent|4|||
44376296|NCT00931710|79381428|FG001|Overall Study|Patient withdrew consent|9|||
44376297|NCT00931710|79381427|FG000|Overall Study|Lost to Follow-up|6|||
44492009|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
44492010|NCT00121641|79497857|FG000|24-week Short-term Treatment Period|Other Reason|1|||
44492011|NCT00121641|79497858|FG001|24-week Short-term Treatment Period|Other Reason|0|||
44492012|NCT00121641|79497859|FG002|24-week Short-term Treatment Period|Other Reason|0|||
44492013|NCT00121641|79497860|FG003|24-week Short-term Treatment Period|Other Reason|0|||
44492014|NCT00121641|79497861|FG004|24-week Short-term Treatment Period|Other Reason|0|||
44492015|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
44376298|NCT00931710|79381428|FG001|Overall Study|Lost to Follow-up|5|||
44492016|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
44492017|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
44492018|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
44492019|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
44492020|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
44492021|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
44492022|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
44492023|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
44492024|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
44492025|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
44492026|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
44492027|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
44492028|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
44492029|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
44492030|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
44492031|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
44492032|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
44492033|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
44492034|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
44492035|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
44492036|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
44492037|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
44492038|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
44492039|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
44492040|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
44492041|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
44492042|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
44492043|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
44492044|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
44492045|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
44492046|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
44492047|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
44492048|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
44492049|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
44492050|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
44492051|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
44492052|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
44492053|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
44492054|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
44492055|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Death|0|||
44492056|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Death|0|||
44492057|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Death|0|||
44492058|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Death|1|||
44492059|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Death|0|||
44492060|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Missing|0|||
44492061|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Missing|0|||
44492062|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Missing|1|||
44492063|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Missing|0|||
44492064|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Missing|0|||
44376299|NCT00931710|79381427|FG000|Overall Study|Protocol deviation|1|||
44376300|NCT00931710|79381428|FG001|Overall Study|Protocol deviation|2|||
44376301|NCT01100528|79381434|FG000|Overall Study|Death|1|||
44376302|NCT01100528|79381434|FG000|Overall Study|Withdrawal by Subject|2|||
44376303|NCT01079234|79381441|FG000|Main: Week 0 to 26|Adverse Event|5|||
44492065|NCT00121641|79497857|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
44492066|NCT00121641|79497858|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
44492067|NCT00121641|79497859|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
44492068|NCT00121641|79497860|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
44492069|NCT00121641|79497861|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
44492070|NCT00425555|79497877|FG000|Overall Study|Withdrawal by Subject|11|||
44492071|NCT00425555|79497878|FG001|Overall Study|Withdrawal by Subject|8|||
44492072|NCT00425555|79497877|FG000|Overall Study|Lost to Follow-up|0|||
44492073|NCT00425555|79497878|FG001|Overall Study|Lost to Follow-up|1|||
44492074|NCT00425555|79497877|FG000|Overall Study|Administrative problems|3|||
44492075|NCT00425555|79497878|FG001|Overall Study|Administrative problems|0|||
44492076|NCT00425555|79497877|FG000|Overall Study|Death|1|||
44492077|NCT00425555|79497878|FG001|Overall Study|Death|2|||
44492078|NCT00425555|79497877|FG000|Overall Study|New cancer therapy|2|||
44492079|NCT00425555|79497878|FG001|Overall Study|New cancer therapy|1|||
44492080|NCT00425555|79497877|FG000|Overall Study|Disease progression|36|||
44492081|NCT00425555|79497878|FG001|Overall Study|Disease progression|33|||
44492082|NCT00425555|79497877|FG000|Overall Study|Adverse Event|25|||
44492083|NCT00425555|79497878|FG001|Overall Study|Adverse Event|15|||
44492084|NCT00425555|79497877|FG000|Overall Study|Protocol Violation|1|||
44492085|NCT00425555|79497878|FG001|Overall Study|Protocol Violation|0|||
44492086|NCT00424775|79497887|FG000|Overall Study|Adverse Event|2|||
44492087|NCT00424775|79497888|FG001|Overall Study|Adverse Event|0|||
44492088|NCT00424775|79497887|FG000|Overall Study|Lack of Efficacy|1|||
44492089|NCT00424775|79497888|FG001|Overall Study|Lack of Efficacy|0|||
44492090|NCT00121485|79497894|FG000|Overall Study|Not implanted|1|||
44492091|NCT00121485|79497895|FG001|Overall Study|Not implanted|5|||
44376304|NCT01079234|79381442|FG001|Main: Week 0 to 26|Adverse Event|4|||
44376305|NCT01079234|79381443|FG002|Main: Week 0 to 26|Adverse Event|1|||
44376306|NCT01079234|79381444|FG003|Main: Week 0 to 26|Adverse Event|0|||
44376307|NCT01079234|79381441|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
44376308|NCT01079234|79381442|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
44492092|NCT00121485|79497894|FG000|Overall Study|Crossover|0|||
44492093|NCT00121485|79497895|FG001|Overall Study|Crossover|2|||
44492094|NCT01763866|79497926|FG000|Overall Study|Withdrawal by Subject|2|||
44492095|NCT01763866|79497927|FG001|Overall Study|Withdrawal by Subject|1|||
44492096|NCT01763866|79497928|FG002|Overall Study|Withdrawal by Subject|4|||
44492097|NCT01763866|79497929|FG003|Overall Study|Withdrawal by Subject|0|||
44492098|NCT01763866|79497930|FG004|Overall Study|Withdrawal by Subject|0|||
44492099|NCT01763866|79497931|FG005|Overall Study|Withdrawal by Subject|3|||
44492100|NCT01763866|79497932|FG006|Overall Study|Withdrawal by Subject|4|||
44492101|NCT01763866|79497933|FG007|Overall Study|Withdrawal by Subject|0|||
44492102|NCT01763866|79497934|FG008|Overall Study|Withdrawal by Subject|1|||
44492103|NCT01763866|79497935|FG009|Overall Study|Withdrawal by Subject|1|||
44492104|NCT01763866|79497936|FG010|Overall Study|Withdrawal by Subject|2|||
44492105|NCT01763866|79497937|FG011|Overall Study|Withdrawal by Subject|2|||
44492106|NCT01763866|79497938|FG012|Overall Study|Withdrawal by Subject|2|||
44545331|NCT03018288|79559186|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
44545332|NCT03018288|79559187|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
44545333|NCT03018288|79559188|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
44545334|NCT03018288|79559185|FG000|Overall Study|Participant withdrew consent.|0|||
44545335|NCT03018288|79559186|FG001|Overall Study|Participant withdrew consent.|0|||
44545336|NCT03018288|79559187|FG002|Overall Study|Participant withdrew consent.|1|||
44545337|NCT03018288|79559188|FG003|Overall Study|Participant withdrew consent.|0|||
44545338|NCT03018288|79559185|FG000|Overall Study|Switched to alternative treatment.|0|||
44545339|NCT03018288|79559186|FG001|Overall Study|Switched to alternative treatment.|0|||
44545340|NCT03018288|79559187|FG002|Overall Study|Switched to alternative treatment.|1|||
44545341|NCT03018288|79559188|FG003|Overall Study|Switched to alternative treatment.|0|||
44376309|NCT01079234|79381443|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
44376310|NCT01079234|79381444|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
44376311|NCT01079234|79381441|FG000|Main: Week 0 to 26|Protocol Violation|6|||
44376312|NCT01079234|79381442|FG001|Main: Week 0 to 26|Protocol Violation|2|||
44376313|NCT01079234|79381443|FG002|Main: Week 0 to 26|Protocol Violation|4|||
44376314|NCT01079234|79381444|FG003|Main: Week 0 to 26|Protocol Violation|0|||
44492107|NCT01763866|79497939|FG013|Overall Study|Withdrawal by Subject|0|||
44492108|NCT01763866|79497940|FG014|Overall Study|Withdrawal by Subject|6|||
44492109|NCT01763866|79497941|FG015|Overall Study|Withdrawal by Subject|3|||
44492110|NCT01763866|79497942|FG016|Overall Study|Withdrawal by Subject|0|||
44492111|NCT01763866|79497943|FG017|Overall Study|Withdrawal by Subject|1|||
44492112|NCT01763866|79497944|FG018|Overall Study|Withdrawal by Subject|1|||
44492113|NCT01763866|79497945|FG019|Overall Study|Withdrawal by Subject|1|||
44492114|NCT01763866|79497946|FG020|Overall Study|Withdrawal by Subject|2|||
44492115|NCT01763866|79497947|FG021|Overall Study|Withdrawal by Subject|1|||
44545342|NCT03018288|79559185|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
44545343|NCT03018288|79559186|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
44545344|NCT03018288|79559187|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
44545345|NCT03018288|79559188|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
44545346|NCT03018288|79559185|FG000|Overall Study|Screen failures|0|||
44545347|NCT03018288|79559186|FG001|Overall Study|Screen failures|0|||
44545348|NCT03018288|79559187|FG002|Overall Study|Screen failures|0|||
44545349|NCT03018288|79559188|FG003|Overall Study|Screen failures|51|||
44545350|NCT03018288|79559185|FG000|Overall Study|Chose treatment outside of UNC|0|||
44545351|NCT03018288|79559186|FG001|Overall Study|Chose treatment outside of UNC|0|||
44545352|NCT03018288|79559187|FG002|Overall Study|Chose treatment outside of UNC|0|||
44545353|NCT03018288|79559188|FG003|Overall Study|Chose treatment outside of UNC|1|||
44545354|NCT03018288|79559185|FG000|Overall Study|Unable to comply with protocol requirements|1|||
44545355|NCT03018288|79559186|FG001|Overall Study|Unable to comply with protocol requirements|1|||
44545356|NCT03018288|79559187|FG002|Overall Study|Unable to comply with protocol requirements|0|||
44545357|NCT03018288|79559188|FG003|Overall Study|Unable to comply with protocol requirements|1|||
44545358|NCT03018288|79559185|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
44545359|NCT03018288|79559186|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
44545360|NCT03018288|79559187|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
44545361|NCT03018288|79559188|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
44545362|NCT03018288|79559185|FG000|Overall Study|Physician Decision|0|||
44545363|NCT03018288|79559186|FG001|Overall Study|Physician Decision|0|||
44545364|NCT03018288|79559187|FG002|Overall Study|Physician Decision|0|||
44545365|NCT03018288|79559188|FG003|Overall Study|Physician Decision|1|||
44545366|NCT03515941|79559205|FG000|Overall Study|Adverse Event|1|||
44545367|NCT03515941|79559206|FG001|Overall Study|Adverse Event|0|||
44545368|NCT03011034|79559214|FG000|Overall Study|Adverse Event|1|||
44545369|NCT03011034|79559215|FG001|Overall Study|Adverse Event|0|||
44545370|NCT03515629|79559223|FG000|Overall Study|Death|0|||
44545371|NCT03515629|79559224|FG001|Overall Study|Death|1|||
44545372|NCT03515629|79559225|FG002|Overall Study|Death|1|||
44545373|NCT03515629|79559223|FG000|Overall Study|Progressive disease|0|||
44545374|NCT03515629|79559224|FG001|Overall Study|Progressive disease|1|||
44545375|NCT03515629|79559225|FG002|Overall Study|Progressive disease|0|||
44545376|NCT03512353|79559234|FG000|Overall Study|Sponsor Decision|3|||
44545377|NCT03512353|79559234|FG000|Overall Study|Death|1|||
44545378|NCT03512275|79559242|FG000|Overall Study|Withdrawal by Subject|1|||
44545379|NCT03512275|79559243|FG001|Overall Study|Withdrawal by Subject|3|||
44545380|NCT03512275|79559242|FG000|Overall Study|Physician Decision|0|||
44545381|NCT03512275|79559243|FG001|Overall Study|Physician Decision|1|||
44545382|NCT03512275|79559242|FG000|Overall Study|Lost to Follow-up|0|||
44545383|NCT03512275|79559243|FG001|Overall Study|Lost to Follow-up|3|||
44545384|NCT03512275|79559242|FG000|Overall Study|Other|1|||
44545385|NCT03512275|79559243|FG001|Overall Study|Other|0|||
44545386|NCT03473197|79559249|FG000|Overall Study|Adverse Event|4|||
44545387|NCT03473197|79559249|FG000|Overall Study|Lost to Follow-up|1|||
44545388|NCT03473197|79559249|FG000|Overall Study|Withdrawal by Subject|5|||
44545389|NCT03511105|79559255|FG000|Overall Study|Adverse Event|1|||
44492116|NCT01763866|79497948|FG022|Overall Study|Withdrawal by Subject|2|||
44492117|NCT01763866|79497949|FG023|Overall Study|Withdrawal by Subject|1|||
44492118|NCT01763866|79497926|FG000|Overall Study|Decision by sponsor|0|||
44492119|NCT01763866|79497927|FG001|Overall Study|Decision by sponsor|0|||
44492120|NCT01763866|79497928|FG002|Overall Study|Decision by sponsor|1|||
44492121|NCT01763866|79497929|FG003|Overall Study|Decision by sponsor|0|||
44492122|NCT01763866|79497930|FG004|Overall Study|Decision by sponsor|2|||
44492123|NCT01763866|79497931|FG005|Overall Study|Decision by sponsor|0|||
44492124|NCT01763866|79497932|FG006|Overall Study|Decision by sponsor|2|||
44492125|NCT01763866|79497933|FG007|Overall Study|Decision by sponsor|0|||
44492126|NCT01763866|79497934|FG008|Overall Study|Decision by sponsor|2|||
44492127|NCT01763866|79497935|FG009|Overall Study|Decision by sponsor|0|||
44492128|NCT01763866|79497936|FG010|Overall Study|Decision by sponsor|6|||
44492129|NCT01763866|79497937|FG011|Overall Study|Decision by sponsor|0|||
44492130|NCT01763866|79497938|FG012|Overall Study|Decision by sponsor|1|||
44492131|NCT01763866|79497939|FG013|Overall Study|Decision by sponsor|0|||
44492132|NCT01763866|79497940|FG014|Overall Study|Decision by sponsor|5|||
44492133|NCT01763866|79497941|FG015|Overall Study|Decision by sponsor|0|||
44545390|NCT03511105|79559256|FG001|Overall Study|Adverse Event|0|||
44545391|NCT03511105|79559255|FG000|Overall Study|Withdrew consent|1|||
44545392|NCT03511105|79559256|FG001|Overall Study|Withdrew consent|0|||
44545393|NCT03510715|79559276|FG000|Overall Study|Adverse Event|1|||
44492134|NCT01763866|79497942|FG016|Overall Study|Decision by sponsor|0|||
44492135|NCT01763866|79497943|FG017|Overall Study|Decision by sponsor|0|||
44545394|NCT03510715|79559277|FG001|Overall Study|Adverse Event|0|||
44545395|NCT03508843|79559284|FG000|Overall Study|Withdrawal by Subject|1|||
44492136|NCT01763866|79497944|FG018|Overall Study|Decision by sponsor|4|||
44492137|NCT01763866|79497945|FG019|Overall Study|Decision by sponsor|0|||
44492138|NCT01763866|79497946|FG020|Overall Study|Decision by sponsor|2|||
44492139|NCT01763866|79497947|FG021|Overall Study|Decision by sponsor|0|||
44492140|NCT01763866|79497948|FG022|Overall Study|Decision by sponsor|1|||
44545396|NCT03508843|79559284|FG000|Overall Study|technical difficulties|2|||
44545397|NCT03508609|79559288|FG000|Overall Study|Withdrawal by Subject|1|||
44545398|NCT03054350|79559298|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
44545399|NCT03054350|79559299|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
44545400|NCT03054350|79559300|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
44545401|NCT03054350|79559301|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
44545402|NCT03054350|79559302|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
44545403|NCT03054350|79559303|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
44545404|NCT03054350|79559298|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
44545405|NCT03054350|79559299|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
44545406|NCT03054350|79559300|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
44545407|NCT03054350|79559301|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
44545408|NCT03054350|79559302|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
44545409|NCT03054350|79559303|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
44545410|NCT03054350|79559298|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
44545411|NCT03054350|79559299|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
44545412|NCT03054350|79559300|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
44545413|NCT03054350|79559301|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
44545414|NCT03054350|79559302|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
44545415|NCT03054350|79559303|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
44545416|NCT03054350|79559298|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
44545417|NCT03054350|79559299|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
44545418|NCT03054350|79559300|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
44545419|NCT03054350|79559301|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
44545420|NCT03054350|79559302|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
44545421|NCT03054350|79559303|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
44545422|NCT03528577|79559334|FG000|Sequence 1|Failed Spirometry|1|||
44545423|NCT03528577|79559334|FG000|Sequence 1|Restricted medication|1|||
44545424|NCT03528577|79559334|FG000|Sequence 2|Adverse Event|1|||
44545425|NCT03528577|79559334|FG000|Sequence 2|Withdrawal by Subject|1|||
44229158|NCT01739348|79036814|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
44229159|NCT01739348|79036815|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
44229160|NCT01739348|79036816|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
44229161|NCT01739348|79036817|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
44492141|NCT01763866|79497949|FG023|Overall Study|Decision by sponsor|0|||
44229162|NCT01739348|79036814|FG000|Part II (Extension Study)|Participant Moved|3|||
44229163|NCT01739348|79036815|FG001|Part II (Extension Study)|Participant Moved|3|||
44229164|NCT01739348|79036816|FG002|Part II (Extension Study)|Participant Moved|0|||
44229165|NCT01739348|79036817|FG003|Part II (Extension Study)|Participant Moved|3|||
44229166|NCT01739348|79036814|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
44229167|NCT01739348|79036815|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
44229168|NCT01739348|79036816|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
44229169|NCT01739348|79036817|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
44229170|NCT01739348|79036814|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
44229171|NCT01739348|79036815|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
44229172|NCT01739348|79036816|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
44229173|NCT01739348|79036817|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
44229174|NCT01738646|79036849|FG000|Overall Study|Still Receiving Treatment|2|||
44229175|NCT01716104|79036856|FG000|Overall Study|Do not meet inclusion criteria|6|||
44229176|NCT01716104|79036857|FG001|Overall Study|Do not meet inclusion criteria|7|||
44229177|NCT04426695|79036937|FG000|Overall Study|Death|2|||
44229178|NCT04426695|79036938|FG001|Overall Study|Death|0|||
44229179|NCT04426695|79036939|FG002|Overall Study|Death|1|||
44229180|NCT04426695|79036940|FG003|Overall Study|Death|27|||
44229181|NCT04426695|79036941|FG004|Overall Study|Death|25|||
44229182|NCT04426695|79036942|FG005|Overall Study|Death|21|||
44229183|NCT04426695|79036943|FG006|Overall Study|Death|42|||
44492142|NCT01763866|79497926|FG000|Overall Study|Lost to Follow-up|0|||
44492143|NCT01763866|79497927|FG001|Overall Study|Lost to Follow-up|0|||
44492144|NCT01763866|79497928|FG002|Overall Study|Lost to Follow-up|0|||
44492145|NCT01763866|79497929|FG003|Overall Study|Lost to Follow-up|0|||
44492146|NCT01763866|79497930|FG004|Overall Study|Lost to Follow-up|0|||
44492147|NCT01763866|79497931|FG005|Overall Study|Lost to Follow-up|0|||
44492148|NCT01763866|79497932|FG006|Overall Study|Lost to Follow-up|1|||
44229184|NCT04426695|79036944|FG007|Overall Study|Death|23|||
44229185|NCT04426695|79036945|FG008|Overall Study|Death|37|||
44229186|NCT04426695|79036946|FG009|Overall Study|Death|14|||
44376315|NCT01079234|79381441|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
44492149|NCT01763866|79497933|FG007|Overall Study|Lost to Follow-up|0|||
44229187|NCT04426695|79036947|FG010|Overall Study|Death|8|||
44229188|NCT04426695|79036948|FG011|Overall Study|Death|7|||
44229189|NCT04426695|79036949|FG012|Overall Study|Death|13|||
44229190|NCT04426695|79036950|FG013|Overall Study|Death|25|||
44229191|NCT04426695|79036951|FG014|Overall Study|Death|19|||
44545426|NCT03528577|79559334|FG000|Sequence 2|Failed Spirometry|1|||
44545427|NCT03528577|79559334|FG000|Sequence 3|Failed Spirometry|1|||
44545428|NCT03528577|79559334|FG000|Sequence 4|Failed Spirometry|2|||
44545429|NCT03528577|79559334|FG000|Sequence 4|Adverse Event|1|||
44545430|NCT00706654|79559344|FG000|Conversion Phase|Lost to Follow-up|4|||
44545431|NCT00706654|79559345|FG001|Conversion Phase|Lost to Follow-up|0|||
44545432|NCT00706654|79559346|FG002|Conversion Phase|Lost to Follow-up|0|||
44545433|NCT00706654|79559347|FG003|Conversion Phase|Lost to Follow-up|0|||
44545434|NCT00706654|79559344|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
44545435|NCT00706654|79559345|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
44545436|NCT00706654|79559346|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
44545437|NCT00706654|79559347|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
44545438|NCT00706654|79559344|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
44545439|NCT00706654|79559345|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
44545440|NCT00706654|79559346|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
44545441|NCT00706654|79559347|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
44545442|NCT00706654|79559344|FG000|Conversion Phase|Withdrawn by Investigator|14|||
44545443|NCT00706654|79559345|FG001|Conversion Phase|Withdrawn by Investigator|0|||
44545444|NCT00706654|79559346|FG002|Conversion Phase|Withdrawn by Investigator|0|||
44545445|NCT00706654|79559347|FG003|Conversion Phase|Withdrawn by Investigator|0|||
44545446|NCT00706654|79559344|FG000|Conversion Phase|Withdrew Consent|38|||
44545447|NCT00706654|79559345|FG001|Conversion Phase|Withdrew Consent|0|||
44545448|NCT00706654|79559346|FG002|Conversion Phase|Withdrew Consent|0|||
44545449|NCT00706654|79559347|FG003|Conversion Phase|Withdrew Consent|0|||
44545450|NCT00706654|79559344|FG000|Conversion Phase|Adverse Event|18|||
44545451|NCT00706654|79559345|FG001|Conversion Phase|Adverse Event|0|||
44545452|NCT00706654|79559346|FG002|Conversion Phase|Adverse Event|0|||
44545453|NCT00706654|79559347|FG003|Conversion Phase|Adverse Event|0|||
44545454|NCT00706654|79559344|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
44545455|NCT00706654|79559345|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
44545456|NCT00706654|79559346|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
44545457|NCT00706654|79559347|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
44545458|NCT00706654|79559344|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
44545459|NCT00706654|79559345|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
44545460|NCT00706654|79559346|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
44545461|NCT00706654|79559347|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
44545462|NCT00706654|79559344|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
44545463|NCT00706654|79559345|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
44545464|NCT00706654|79559346|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
44545465|NCT00706654|79559347|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
44545466|NCT00706654|79559344|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
44545467|NCT00706654|79559345|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
44545468|NCT00706654|79559346|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
44545469|NCT00706654|79559347|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
44545470|NCT00706654|79559344|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
44545471|NCT00706654|79559345|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
44545472|NCT00706654|79559346|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
44545473|NCT00706654|79559347|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
44545474|NCT00706654|79559344|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
44545475|NCT00706654|79559345|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
44545476|NCT00706654|79559346|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
44545477|NCT00706654|79559347|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
44545478|NCT00706654|79559344|FG000|Oral Stabilization Phase|Withdrew consent|55|||
44545479|NCT00706654|79559345|FG001|Oral Stabilization Phase|Withdrew consent|0|||
44545480|NCT00706654|79559346|FG002|Oral Stabilization Phase|Withdrew consent|0|||
44545481|NCT00706654|79559347|FG003|Oral Stabilization Phase|Withdrew consent|0|||
44545482|NCT00706654|79559344|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
44545483|NCT00706654|79559345|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
44545484|NCT00706654|79559346|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
44545485|NCT00706654|79559347|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
44545486|NCT00706654|79559344|FG000|Oral Stabilization Phase|Adverse Event|21|||
44545487|NCT00706654|79559345|FG001|Oral Stabilization Phase|Adverse Event|0|||
44545488|NCT00706654|79559346|FG002|Oral Stabilization Phase|Adverse Event|0|||
44545489|NCT00706654|79559347|FG003|Oral Stabilization Phase|Adverse Event|0|||
44545490|NCT00706654|79559344|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
44545491|NCT00706654|79559345|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44229192|NCT04426695|79036952|FG015|Overall Study|Death|7|||
44229193|NCT04426695|79036953|FG016|Overall Study|Death|8|||
44545492|NCT00706654|79559346|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44545493|NCT00706654|79559347|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44545494|NCT00706654|79559344|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
44545495|NCT00706654|79559345|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44545496|NCT00706654|79559346|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44545497|NCT00706654|79559347|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44545498|NCT00706654|79559344|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
44545499|NCT00706654|79559345|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
44545500|NCT00706654|79559346|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
44545501|NCT00706654|79559347|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
44545502|NCT00706654|79559344|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
44545503|NCT00706654|79559345|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
44545504|NCT00706654|79559346|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
44545505|NCT00706654|79559347|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
44545506|NCT00706654|79559344|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
44545507|NCT00706654|79559345|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
44545508|NCT00706654|79559346|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
44545509|NCT00706654|79559347|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
44545510|NCT00706654|79559344|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
44545511|NCT00706654|79559345|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
44545512|NCT00706654|79559346|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
44545513|NCT00706654|79559347|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
44545514|NCT00706654|79559344|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
44545515|NCT00706654|79559345|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
44545516|NCT00706654|79559346|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
44545517|NCT00706654|79559347|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
44545518|NCT00706654|79559344|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
44545519|NCT00706654|79559345|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
44545520|NCT00706654|79559346|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
44545521|NCT00706654|79559347|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
44545522|NCT00706654|79559344|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
44545523|NCT00706654|79559345|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
44545524|NCT00706654|79559346|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
44545525|NCT00706654|79559347|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
44545526|NCT00706654|79559344|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
44545527|NCT00706654|79559345|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
44545528|NCT00706654|79559346|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
44545529|NCT00706654|79559347|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
44545530|NCT03471871|79559359|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
44545531|NCT03471871|79559360|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
44545532|NCT03471871|79559361|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
44229194|NCT04426695|79036954|FG017|Overall Study|Death|4|||
44229195|NCT04426695|79036937|FG000|Overall Study|Lost to Follow-up|2|||
44229196|NCT04426695|79036938|FG001|Overall Study|Lost to Follow-up|4|||
44229197|NCT04426695|79036939|FG002|Overall Study|Lost to Follow-up|1|||
44229198|NCT04426695|79036940|FG003|Overall Study|Lost to Follow-up|19|||
44229199|NCT04426695|79036941|FG004|Overall Study|Lost to Follow-up|10|||
44229200|NCT04426695|79036942|FG005|Overall Study|Lost to Follow-up|14|||
44229201|NCT04426695|79036943|FG006|Overall Study|Lost to Follow-up|5|||
44229202|NCT04426695|79036944|FG007|Overall Study|Lost to Follow-up|14|||
44376316|NCT01079234|79381442|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
44376317|NCT01079234|79381443|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
44492150|NCT01763866|79497934|FG008|Overall Study|Lost to Follow-up|0|||
44492151|NCT01763866|79497935|FG009|Overall Study|Lost to Follow-up|0|||
44492152|NCT01763866|79497936|FG010|Overall Study|Lost to Follow-up|0|||
44492153|NCT01763866|79497937|FG011|Overall Study|Lost to Follow-up|0|||
44492154|NCT01763866|79497938|FG012|Overall Study|Lost to Follow-up|1|||
44492155|NCT01763866|79497939|FG013|Overall Study|Lost to Follow-up|0|||
44492156|NCT01763866|79497940|FG014|Overall Study|Lost to Follow-up|1|||
44492157|NCT01763866|79497941|FG015|Overall Study|Lost to Follow-up|0|||
44492158|NCT01763866|79497942|FG016|Overall Study|Lost to Follow-up|0|||
44492159|NCT01763866|79497943|FG017|Overall Study|Lost to Follow-up|0|||
44492160|NCT01763866|79497944|FG018|Overall Study|Lost to Follow-up|1|||
44492161|NCT01763866|79497945|FG019|Overall Study|Lost to Follow-up|1|||
44492162|NCT01763866|79497946|FG020|Overall Study|Lost to Follow-up|0|||
44376318|NCT01079234|79381444|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
44492163|NCT01763866|79497947|FG021|Overall Study|Lost to Follow-up|0|||
44545533|NCT03471871|79559362|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
44229203|NCT04426695|79036945|FG008|Overall Study|Lost to Follow-up|10|||
44229204|NCT04426695|79036946|FG009|Overall Study|Lost to Follow-up|11|||
44492164|NCT01763866|79497948|FG022|Overall Study|Lost to Follow-up|0|||
44545534|NCT03471871|79559363|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
44545535|NCT03471871|79559359|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
44545536|NCT03471871|79559360|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
44545537|NCT03471871|79559361|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
44545538|NCT03471871|79559362|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
44545539|NCT03471871|79559363|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
44545540|NCT03471871|79559359|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
44545541|NCT03471871|79559360|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
44545542|NCT03471871|79559361|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
44545543|NCT03471871|79559362|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
44545544|NCT03471871|79559363|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
44545545|NCT03471871|79559359|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
44545546|NCT03471871|79559360|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
44545547|NCT03471871|79559361|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
44545548|NCT03471871|79559362|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
44545549|NCT03471871|79559363|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
44492165|NCT01763866|79497949|FG023|Overall Study|Lost to Follow-up|1|||
44492166|NCT01763866|79497926|FG000|Overall Study|Death|0|||
44492167|NCT01763866|79497927|FG001|Overall Study|Death|0|||
44492168|NCT01763866|79497928|FG002|Overall Study|Death|0|||
44492169|NCT01763866|79497929|FG003|Overall Study|Death|0|||
44492170|NCT01763866|79497930|FG004|Overall Study|Death|0|||
44492171|NCT01763866|79497931|FG005|Overall Study|Death|0|||
44229205|NCT04426695|79036947|FG010|Overall Study|Lost to Follow-up|12|||
44492172|NCT01763866|79497932|FG006|Overall Study|Death|0|||
44492173|NCT01763866|79497933|FG007|Overall Study|Death|0|||
44492174|NCT01763866|79497934|FG008|Overall Study|Death|0|||
44492175|NCT01763866|79497935|FG009|Overall Study|Death|0|||
44492176|NCT01763866|79497936|FG010|Overall Study|Death|0|||
44492177|NCT01763866|79497937|FG011|Overall Study|Death|0|||
44492178|NCT01763866|79497938|FG012|Overall Study|Death|0|||
44492179|NCT01763866|79497939|FG013|Overall Study|Death|0|||
44492180|NCT01763866|79497940|FG014|Overall Study|Death|0|||
44492181|NCT01763866|79497941|FG015|Overall Study|Death|0|||
44492182|NCT01763866|79497942|FG016|Overall Study|Death|1|||
44492183|NCT01763866|79497943|FG017|Overall Study|Death|0|||
44492184|NCT01763866|79497944|FG018|Overall Study|Death|0|||
44492185|NCT01763866|79497945|FG019|Overall Study|Death|0|||
44492186|NCT01763866|79497946|FG020|Overall Study|Death|0|||
44492187|NCT01763866|79497947|FG021|Overall Study|Death|0|||
44492188|NCT01763866|79497948|FG022|Overall Study|Death|0|||
44492189|NCT01763866|79497949|FG023|Overall Study|Death|0|||
44492190|NCT00132873|79497999|FG000|Overall Study|Adverse Event|3|||
44492191|NCT00132873|79497999|FG000|Overall Study|Lost to Follow-up|1|||
44492192|NCT00132873|79497999|FG000|Overall Study|Lack of Efficacy|1|||
44492193|NCT00132873|79497999|FG000|Overall Study|Withdrawal by Subject|3|||
44492194|NCT00132873|79497999|FG000|Overall Study|Planned Pregnancy|1|||
44492195|NCT00120627|79498005|FG000|Overall Study|Withdrawal by Subject|5|||
44492196|NCT00120627|79498006|FG001|Overall Study|Withdrawal by Subject|5|||
44492197|NCT03762616|79498021|FG000|Overall Study|Protocol Violation|2|||
44492198|NCT04246996|79498029|FG000|Overall Study|Physician Decision|1|||
44492199|NCT04246996|79498030|FG001|Overall Study|Physician Decision|1|||
44492200|NCT04246996|79498029|FG000|Overall Study|Did not meet eligibility criteria|1|||
44492201|NCT04246996|79498030|FG001|Overall Study|Did not meet eligibility criteria|4|||
44492202|NCT00424463|79498039|FG000|Overall Study|Adverse Event|2|||
44492203|NCT00424463|79498040|FG001|Overall Study|Adverse Event|3|||
44492204|NCT00424463|79498041|FG002|Overall Study|Adverse Event|2|||
44492205|NCT00424463|79498039|FG000|Overall Study|Physician Decision|0|||
44492206|NCT00424463|79498040|FG001|Overall Study|Physician Decision|2|||
44492207|NCT00424463|79498041|FG002|Overall Study|Physician Decision|2|||
44492208|NCT00424463|79498039|FG000|Overall Study|Withdrawal by Subject|4|||
44492209|NCT00424463|79498040|FG001|Overall Study|Withdrawal by Subject|2|||
44492210|NCT00424463|79498041|FG002|Overall Study|Withdrawal by Subject|5|||
44492211|NCT00424463|79498039|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
44492212|NCT00424463|79498040|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
44492213|NCT00424463|79498041|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
44492214|NCT00424463|79498039|FG000|Overall Study|Patient's convenience|0|||
44545550|NCT03471871|79559359|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
44545551|NCT03471871|79559360|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
44492215|NCT00424463|79498040|FG001|Overall Study|Patient's convenience|0|||
44492216|NCT00424463|79498041|FG002|Overall Study|Patient's convenience|1|||
44492217|NCT00424385|79498049|FG000|Cohort 0|Withdrawal by Subject|5|||
44492218|NCT00424385|79498049|FG000|Cohort 0|Physician Decision|1|||
44492219|NCT00424385|79498049|FG000|Cohort 1|Withdrawal by Subject|1|||
44492220|NCT00423917|79498055|FG000|Overall Study|Cancel|2|||
44492221|NCT00423917|79498055|FG000|Overall Study|Ineligible|1|||
44545552|NCT03471871|79559361|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
44545553|NCT03471871|79559362|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
44545554|NCT03471871|79559363|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
44545555|NCT01957176|79559381|FG000|Overall Study|Adverse Event|2|||
44545556|NCT01957176|79559382|FG001|Overall Study|Adverse Event|0|||
44545557|NCT01957176|79559381|FG000|Overall Study|Physician Decision|2|||
44545558|NCT01957176|79559382|FG001|Overall Study|Physician Decision|1|||
44545559|NCT01957176|79559381|FG000|Overall Study|Withdrawal by Subject|1|||
44545560|NCT01957176|79559382|FG001|Overall Study|Withdrawal by Subject|0|||
44545561|NCT03527173|79559391|FG000|Overall Study|Lost to Follow-up|4|||
44545562|NCT03527173|79559392|FG001|Overall Study|Lost to Follow-up|2|||
44545563|NCT03527173|79559391|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
44545564|NCT03527173|79559392|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
44492222|NCT00845026|79498061|FG000|Study Period III|Adverse Event|23|||
44492223|NCT00845026|79498062|FG001|Study Period III|Adverse Event|19|||
44492224|NCT00845026|79498061|FG000|Study Period III|Perceived lack of efficacy|27|||
44492225|NCT00845026|79498062|FG001|Study Period III|Perceived lack of efficacy|15|||
44492226|NCT00845026|79498061|FG000|Study Period III|Withdrawal by Subject|19|||
44492227|NCT00845026|79498062|FG001|Study Period III|Withdrawal by Subject|15|||
44492228|NCT00845026|79498061|FG000|Study Period III|Entry Criteria not met|8|||
44492229|NCT00845026|79498062|FG001|Study Period III|Entry Criteria not met|11|||
44492230|NCT00845026|79498061|FG000|Study Period III|Lost to Follow-up|4|||
44492231|NCT00845026|79498062|FG001|Study Period III|Lost to Follow-up|5|||
44492232|NCT00845026|79498061|FG000|Study Period III|Protocol Violation|8|||
44492233|NCT00845026|79498062|FG001|Study Period III|Protocol Violation|1|||
44376319|NCT01079234|79381441|FG000|Main: Week 0 to 26|Unclassified|7|||
44376320|NCT01079234|79381442|FG001|Main: Week 0 to 26|Unclassified|13|||
44376321|NCT01079234|79381443|FG002|Main: Week 0 to 26|Unclassified|4|||
44376322|NCT01079234|79381444|FG003|Main: Week 0 to 26|Unclassified|0|||
44376323|NCT01079234|79381441|FG000|Extension: Week 27 to 52|Adverse Event|0|||
44376324|NCT01079234|79381442|FG001|Extension: Week 27 to 52|Adverse Event|0|||
44376325|NCT01079234|79381443|FG002|Extension: Week 27 to 52|Adverse Event|1|||
44376326|NCT01079234|79381444|FG003|Extension: Week 27 to 52|Adverse Event|0|||
44376327|NCT01079234|79381441|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
44376328|NCT01079234|79381442|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
44376329|NCT01079234|79381443|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
44376330|NCT01079234|79381444|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
44376331|NCT01079234|79381441|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
44376332|NCT01079234|79381442|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
44376333|NCT01079234|79381443|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
44492234|NCT00845026|79498061|FG000|Study Period III|Scheduled conflict|3|||
44492235|NCT00845026|79498062|FG001|Study Period III|Scheduled conflict|1|||
44545565|NCT03527173|79559391|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
44545566|NCT03527173|79559392|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
44545567|NCT03527173|79559391|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
44545568|NCT03527173|79559392|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44545569|NCT00707980|79559398|FG000|Overall Study|Adverse Event|49|||
44545570|NCT00707980|79559398|FG000|Overall Study|Lack of Efficacy|35|||
44545571|NCT00707980|79559398|FG000|Overall Study|Non-Compliance with Study Drug|28|||
44545572|NCT00707980|79559398|FG000|Overall Study|Protocol Deviations|19|||
44274407|NCT02256631|79218124|FG006|Overall Study|Unable to get to clinic|2|||
44274408|NCT02279745|79218234|FG000|Overall Study|Adverse Event|7|||
44274409|NCT02279745|79218234|FG000|Overall Study|Death|6|||
44274410|NCT02279745|79218234|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
44492236|NCT00845026|79498061|FG000|Study Period III|Subject is moving or has moved|2|||
44492237|NCT00845026|79498062|FG001|Study Period III|Subject is moving or has moved|4|||
44492238|NCT00845026|79498061|FG000|Study Period III|Transportation issues|1|||
44492239|NCT00845026|79498062|FG001|Study Period III|Transportation issues|1|||
44274411|NCT02279745|79218234|FG000|Overall Study|Withdrawal by Subject|2|||
44376334|NCT01079234|79381444|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
44376335|NCT01079234|79381441|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
44274412|NCT02279745|79218234|FG000|Overall Study|Pregnancy|1|||
44274413|NCT02279745|79218234|FG000|Overall Study|Study Non-compliance|1|||
44274414|NCT02279745|79218234|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
44274415|NCT01761877|79218273|FG000|Overall Study|Adverse Event|7|||
44274416|NCT01761877|79218274|FG001|Overall Study|Adverse Event|0|||
44274417|NCT01761877|79218273|FG000|Overall Study|Withdrawal by Subject|6|||
44274418|NCT01761877|79218274|FG001|Overall Study|Withdrawal by Subject|4|||
44274419|NCT01761877|79218273|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
44274420|NCT01761877|79218274|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
44274421|NCT01761877|79218273|FG000|Overall Study|Death|0|||
44274422|NCT01761877|79218274|FG001|Overall Study|Death|1|||
44274423|NCT01761877|79218273|FG000|Overall Study|MRI intolerant|1|||
44274424|NCT01761877|79218274|FG001|Overall Study|MRI intolerant|6|||
44274425|NCT00588523|79218354|FG000|Overall Study|Not treated|3|||
44274426|NCT03093259|79218528|FG000|Overall Study|Adverse Event|1|||
44274427|NCT03093259|79218529|FG001|Overall Study|Adverse Event|0|||
44545573|NCT00707980|79559398|FG000|Overall Study|Withdrawal of Consent|81|||
44545574|NCT00707980|79559398|FG000|Overall Study|Lost to Follow-up|59|||
44545575|NCT00707980|79559398|FG000|Overall Study|Other|39|||
44545576|NCT03506425|79559405|FG000|Overall Study|Adverse Event|1|||
44229206|NCT04426695|79036948|FG011|Overall Study|Lost to Follow-up|6|||
44545577|NCT03506425|79559406|FG001|Overall Study|Adverse Event|3|||
44545578|NCT03506425|79559407|FG002|Overall Study|Adverse Event|0|||
44545579|NCT03506425|79559405|FG000|Overall Study|Death|1|||
44545580|NCT03506425|79559406|FG001|Overall Study|Death|0|||
44545581|NCT03506425|79559407|FG002|Overall Study|Death|0|||
44545582|NCT03506425|79559405|FG000|Overall Study|Withdrawal by Subject|0|||
44545583|NCT03506425|79559406|FG001|Overall Study|Withdrawal by Subject|0|||
44545584|NCT03506425|79559407|FG002|Overall Study|Withdrawal by Subject|1|||
44545585|NCT03051620|79559416|FG000|Overall Study|Lost to Follow-up|6|||
44545586|NCT03051620|79559416|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
44545587|NCT03053492|79559422|FG000|Overall Study|Adverse Event|1|||
44545588|NCT03053492|79559423|FG001|Overall Study|Adverse Event|1|||
44229207|NCT04426695|79036949|FG012|Overall Study|Lost to Follow-up|2|||
44229208|NCT04426695|79036950|FG013|Overall Study|Lost to Follow-up|2|||
44229209|NCT04426695|79036951|FG014|Overall Study|Lost to Follow-up|2|||
44229210|NCT04426695|79036952|FG015|Overall Study|Lost to Follow-up|0|||
44229211|NCT04426695|79036953|FG016|Overall Study|Lost to Follow-up|0|||
44229212|NCT04426695|79036954|FG017|Overall Study|Lost to Follow-up|0|||
44545589|NCT03053492|79559422|FG000|Overall Study|Withdrawal by Subject|7|||
44545590|NCT03053492|79559423|FG001|Overall Study|Withdrawal by Subject|5|||
44545591|NCT03801707|79559429|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
44545592|NCT04239872|79559433|FG000|Overall Study|Lost to Follow-up|0|||
44545593|NCT04239872|79559434|FG001|Overall Study|Lost to Follow-up|1|||
44545594|NCT03164772|79559442|FG000|Overall Study|Death|4|||
44545595|NCT03164772|79559443|FG001|Overall Study|Death|2|||
44229213|NCT04426695|79036937|FG000|Overall Study|Participant Decision|1|||
44545596|NCT03164772|79559442|FG000|Overall Study|Adverse Event|1|||
44545597|NCT03164772|79559443|FG001|Overall Study|Adverse Event|4|||
44545598|NCT03164772|79559442|FG000|Overall Study|Progressive Disease|11|||
44545599|NCT03164772|79559443|FG001|Overall Study|Progressive Disease|21|||
44229214|NCT04426695|79036938|FG001|Overall Study|Participant Decision|2|||
44274428|NCT03093259|79218528|FG000|Overall Study|Withdrawal by Subject|1|||
44274429|NCT03093259|79218529|FG001|Overall Study|Withdrawal by Subject|0|||
44492240|NCT00845026|79498061|FG000|Study Period IV|Adverse Event|4|||
44492241|NCT00845026|79498062|FG001|Study Period IV|Adverse Event|0|||
44492242|NCT00845026|79498061|FG000|Study Period IV|Perceived lack of efficacy|2|||
44492243|NCT00845026|79498062|FG001|Study Period IV|Perceived lack of efficacy|1|||
44492244|NCT00845026|79498061|FG000|Study Period IV|Protocol Violation|3|||
44492245|NCT00845026|79498062|FG001|Study Period IV|Protocol Violation|1|||
44492246|NCT00845026|79498061|FG000|Study Period IV|Lost to Follow-up|1|||
44492247|NCT00845026|79498062|FG001|Study Period IV|Lost to Follow-up|0|||
44492248|NCT00845026|79498061|FG000|Study Period IV|Withdrawal by Subject|4|||
44492249|NCT00845026|79498062|FG001|Study Period IV|Withdrawal by Subject|1|||
44492250|NCT00845026|79498061|FG000|Study Period IV|Entry Criteria Not Met|1|||
44492251|NCT00845026|79498062|FG001|Study Period IV|Entry Criteria Not Met|0|||
44492252|NCT00845026|79498061|FG000|Study Period IV|Subject is moving or has moved|0|||
44492253|NCT00845026|79498062|FG001|Study Period IV|Subject is moving or has moved|1|||
44492254|NCT00845026|79498061|FG000|Study Period IV|Scheduling conflict|1|||
44492255|NCT00845026|79498062|FG001|Study Period IV|Scheduling conflict|0|||
44492256|NCT00691678|79498070|FG000|Overall Study|Adverse Event|5|||
44492257|NCT00691678|79498070|FG000|Overall Study|life events, pain|11|||
44492258|NCT00423605|79498074|FG000|Overall Study|Adverse Event|129|||
44492259|NCT00423605|79498074|FG000|Overall Study|Withdrawal by Subject|36|||
44492260|NCT00423605|79498074|FG000|Overall Study|Lost to Follow-up|15|||
44492261|NCT00423605|79498074|FG000|Overall Study|Lack of Efficacy|38|||
44492262|NCT00423605|79498074|FG000|Overall Study|Sponsor Decision|3|||
44492263|NCT00423605|79498074|FG000|Overall Study|Physician Decision|8|||
44492264|NCT00423605|79498074|FG000|Overall Study|Protocol Violation|7|||
44492265|NCT00423605|79498074|FG000|Overall Study|Not one of the pre-specified options|5|||
44492266|NCT00423449|79498078|FG000|Overall Study|Clinical Adverse Event|1|||
44492267|NCT00423449|79498079|FG001|Overall Study|Clinical Adverse Event|0|||
44492268|NCT00423449|79498080|FG002|Overall Study|Clinical Adverse Event|1|||
44492269|NCT00423449|79498081|FG003|Overall Study|Clinical Adverse Event|8|||
44492270|NCT00423449|79498082|FG004|Overall Study|Clinical Adverse Event|2|||
44492271|NCT00423449|79498078|FG000|Overall Study|Death|1|||
44492272|NCT00423449|79498079|FG001|Overall Study|Death|0|||
44492273|NCT00423449|79498080|FG002|Overall Study|Death|2|||
44545600|NCT03164772|79559442|FG000|Overall Study|Physician Decision|2|||
44545601|NCT03164772|79559443|FG001|Overall Study|Physician Decision|0|||
44545602|NCT03164772|79559442|FG000|Overall Study|Withdrawal by Subject|0|||
44545603|NCT03164772|79559443|FG001|Overall Study|Withdrawal by Subject|4|||
44545604|NCT03050450|79559466|FG000|Overall Study|Physician Decision|1|||
44545605|NCT03050450|79559467|FG001|Overall Study|Physician Decision|0|||
44545606|NCT03050450|79559468|FG002|Overall Study|Physician Decision|0|||
44545607|NCT03050450|79559469|FG003|Overall Study|Physician Decision|0|||
44545608|NCT03050450|79559470|FG004|Overall Study|Physician Decision|0|||
44545609|NCT03505021|79559484|FG000|Overall Study|Protocol Violation|1|||
44492274|NCT00423449|79498081|FG003|Overall Study|Death|1|||
44492275|NCT00423449|79498082|FG004|Overall Study|Death|1|||
44545610|NCT03505021|79559485|FG001|Overall Study|Protocol Violation|0|||
44545611|NCT03505021|79559484|FG000|Overall Study|Death|9|||
44545612|NCT03505021|79559485|FG001|Overall Study|Death|8|||
44545613|NCT03505021|79559484|FG000|Overall Study|Consent withdrawn by subject|6|||
44492276|NCT00423449|79498078|FG000|Overall Study|Progressive Disease|1|||
44492277|NCT00423449|79498079|FG001|Overall Study|Progressive Disease|3|||
44492278|NCT00423449|79498080|FG002|Overall Study|Progressive Disease|8|||
44545614|NCT03505021|79559485|FG001|Overall Study|Consent withdrawn by subject|1|||
44545615|NCT03505021|79559484|FG000|Overall Study|Lost to Follow-up|5|||
44545616|NCT03505021|79559485|FG001|Overall Study|Lost to Follow-up|3|||
44545617|NCT03505021|79559484|FG000|Overall Study|Adverse Event|26|||
44492279|NCT00423449|79498081|FG003|Overall Study|Progressive Disease|11|||
44492280|NCT00423449|79498082|FG004|Overall Study|Progressive Disease|4|||
44492281|NCT00423449|79498078|FG000|Overall Study|Laboratory Adverse Event|0|||
44229215|NCT04426695|79036939|FG002|Overall Study|Participant Decision|2|||
44492282|NCT00423449|79498079|FG001|Overall Study|Laboratory Adverse Event|1|||
44545618|NCT03505021|79559485|FG001|Overall Study|Adverse Event|9|||
44545619|NCT03505021|79559484|FG000|Overall Study|Disease progression|33|||
44229216|NCT04426695|79036940|FG003|Overall Study|Participant Decision|12|||
44492283|NCT00423449|79498080|FG002|Overall Study|Laboratory Adverse Event|2|||
44492284|NCT00423449|79498081|FG003|Overall Study|Laboratory Adverse Event|0|||
44492285|NCT00423449|79498082|FG004|Overall Study|Laboratory Adverse Event|0|||
44492286|NCT00423449|79498078|FG000|Overall Study|Other|0|||
44545620|NCT03505021|79559485|FG001|Overall Study|Disease progression|17|||
44545621|NCT03505021|79559484|FG000|Overall Study|Other|11|||
44545622|NCT03505021|79559485|FG001|Overall Study|Other|5|||
44545623|NCT03505021|79559484|FG000|Overall Study|Personal reason|21|||
44545624|NCT03505021|79559485|FG001|Overall Study|Personal reason|12|||
44545625|NCT03050372|79559491|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
44545626|NCT03050372|79559492|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
44545627|NCT03050372|79559491|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
44545628|NCT03050372|79559492|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
44545629|NCT03470545|79559499|FG000|Overall Study|Death|0|||
44545630|NCT03470545|79559500|FG001|Overall Study|Death|1|||
44545631|NCT03470545|79559499|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
44545632|NCT03470545|79559500|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
44545633|NCT03470545|79559499|FG000|Overall Study|Adverse Event|2|||
44229217|NCT04426695|79036941|FG004|Overall Study|Participant Decision|18|||
44229218|NCT04426695|79036942|FG005|Overall Study|Participant Decision|22|||
44229219|NCT04426695|79036943|FG006|Overall Study|Participant Decision|13|||
44229220|NCT04426695|79036944|FG007|Overall Study|Participant Decision|13|||
44545634|NCT03470545|79559500|FG001|Overall Study|Adverse Event|0|||
44545635|NCT03470545|79559499|FG000|Overall Study|Withdrawal by Subject|1|||
44545636|NCT03470545|79559500|FG001|Overall Study|Withdrawal by Subject|1|||
44545637|NCT03470545|79559499|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
44545638|NCT03470545|79559500|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
44545639|NCT03163446|79559509|FG000|Overall Study|Unable to return for Day 180 visit|2|||
44545640|NCT03163446|79559510|FG001|Overall Study|Unable to return for Day 180 visit|0|||
44545641|NCT03163446|79559509|FG000|Overall Study|Withdrawal by Subject|2|||
44545642|NCT03163446|79559510|FG001|Overall Study|Withdrawal by Subject|6|||
44545643|NCT03163446|79559509|FG000|Overall Study|Death|16|||
44545644|NCT03163446|79559510|FG001|Overall Study|Death|5|||
44545645|NCT03163446|79559509|FG000|Overall Study|Lost to Follow-up|6|||
44545646|NCT03163446|79559510|FG001|Overall Study|Lost to Follow-up|5|||
44545647|NCT03163446|79559509|FG000|Overall Study|Physician Decision|1|||
44545648|NCT03163446|79559510|FG001|Overall Study|Physician Decision|1|||
44545649|NCT03163446|79559509|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
44545650|NCT03163446|79559510|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
44229221|NCT04426695|79036945|FG008|Overall Study|Participant Decision|10|||
44492287|NCT00423449|79498079|FG001|Overall Study|Other|0|||
44545651|NCT03722485|79559524|FG000|Overall Study|Withdrawal by Subject|1|||
44492288|NCT00423449|79498080|FG002|Overall Study|Other|0|||
44492289|NCT00423449|79498081|FG003|Overall Study|Other|1|||
44492290|NCT00423449|79498082|FG004|Overall Study|Other|0|||
44492291|NCT00423449|79498078|FG000|Overall Study|Protocol Violation|0|||
44492292|NCT00423449|79498079|FG001|Overall Study|Protocol Violation|0|||
44492293|NCT00423449|79498080|FG002|Overall Study|Protocol Violation|2|||
44492294|NCT00423449|79498081|FG003|Overall Study|Protocol Violation|1|||
44492295|NCT00423449|79498082|FG004|Overall Study|Protocol Violation|0|||
44492296|NCT00423293|79498095|FG000|Overall Study|Ineligible / No protocol treatment|11|||
44492297|NCT00423137|79498103|FG000|Overall Study|Lost to Follow-up|0|||
44492298|NCT00423137|79498104|FG001|Overall Study|Lost to Follow-up|0|||
44492299|NCT00423137|79498105|FG002|Overall Study|Lost to Follow-up|1|||
44492300|NCT00423137|79498106|FG003|Overall Study|Lost to Follow-up|0|||
44492301|NCT00423137|79498103|FG000|Overall Study|Protocol Violation|0|||
44492302|NCT00423137|79498104|FG001|Overall Study|Protocol Violation|0|||
44492303|NCT00423137|79498105|FG002|Overall Study|Protocol Violation|0|||
44492304|NCT00423137|79498106|FG003|Overall Study|Protocol Violation|1|||
44545652|NCT03722485|79559525|FG001|Overall Study|Withdrawal by Subject|0|||
44545653|NCT03722485|79559524|FG000|Overall Study|Adverse Event|0|||
44545654|NCT03722485|79559525|FG001|Overall Study|Adverse Event|2|||
44545655|NCT03722485|79559524|FG000|Overall Study|subject discharged prior to study completion|1|||
44545656|NCT03722485|79559525|FG001|Overall Study|subject discharged prior to study completion|5|||
44545657|NCT03722485|79559524|FG000|Overall Study|eligibility criteria not met|2|||
44545658|NCT03722485|79559525|FG001|Overall Study|eligibility criteria not met|0|||
44545659|NCT03047720|79559559|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
44545660|NCT03047720|79559560|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
44545661|NCT03626168|79559585|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
44229222|NCT04426695|79036946|FG009|Overall Study|Participant Decision|15|||
44229223|NCT04426695|79036947|FG010|Overall Study|Participant Decision|16|||
44492305|NCT00423137|79498103|FG000|Overall Study|Adverse Event Study disease worse|1|||
44492306|NCT00423137|79498104|FG001|Overall Study|Adverse Event Study disease worse|0|||
44492307|NCT00423137|79498105|FG002|Overall Study|Adverse Event Study disease worse|3|||
44492308|NCT00423137|79498106|FG003|Overall Study|Adverse Event Study disease worse|1|||
44545662|NCT03626168|79559586|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
44545663|NCT03626168|79559585|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
44545664|NCT03626168|79559586|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
44545665|NCT03626168|79559585|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
44545666|NCT03626168|79559586|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
44545667|NCT02966873|79559594|FG000|Overall Study|Lost to Follow-up|16|||
44545668|NCT02966873|79559595|FG001|Overall Study|Lost to Follow-up|15|||
44545669|NCT01389024|79559603|FG000|Overall Study|Withdrawal by Subject|0|||
44545670|NCT01389024|79559604|FG001|Overall Study|Withdrawal by Subject|1|||
44545671|NCT01389024|79559603|FG000|Overall Study|Lost to Follow-up|1|||
44545672|NCT01389024|79559604|FG001|Overall Study|Lost to Follow-up|0|||
44545673|NCT03050060|79559614|FG000|Overall Study|Adverse Event|7|||
44545674|NCT03050060|79559614|FG000|Overall Study|Withdrawal by Subject|1|||
44545675|NCT03050060|79559614|FG000|Overall Study|Progression|7|||
44545676|NCT00706342|79559627|FG000|Overall Study|Adverse Event|3|||
44545677|NCT00706342|79559627|FG000|Overall Study|Not responding to treatment|2|||
44545678|NCT00706342|79559627|FG000|Overall Study|Withdrawn due to failure to respond|1|||
44545679|NCT00706342|79559627|FG000|Overall Study|Death|1|||
44545680|NCT00706342|79559627|FG000|Overall Study|Withdrew from the study on his own.|1|||
44545681|NCT00706342|79559627|FG000|Overall Study|Investigator discretion|2|||
44545682|NCT00706342|79559627|FG000|Overall Study|Non-responder Week 12|1|||
44545683|NCT00706342|79559627|FG000|Overall Study|Ongoing|6|||
44545684|NCT00706342|79559627|FG000|Overall Study|WIthdrawal of consent|1|||
44545685|NCT03049748|79559633|FG000|Overall Study|Lost to Follow-up|1|||
44545686|NCT03049748|79559634|FG001|Overall Study|Lost to Follow-up|0|||
44545687|NCT03049748|79559633|FG000|Overall Study|Death|3|||
44545688|NCT03049748|79559634|FG001|Overall Study|Death|0|||
44545689|NCT03049748|79559633|FG000|Overall Study|Withdrawal by Subject|0|||
44545690|NCT03049748|79559634|FG001|Overall Study|Withdrawal by Subject|3|||
44545691|NCT03049748|79559633|FG000|Overall Study|Protocol Violation|0|||
44545692|NCT03049748|79559634|FG001|Overall Study|Protocol Violation|2|||
44545693|NCT03049748|79559633|FG000|Overall Study|Moved out of state (relocation)|0|||
44545694|NCT03049748|79559634|FG001|Overall Study|Moved out of state (relocation)|1|||
44545695|NCT03501277|79559648|FG000|Intervention Period 1 (4 Days)|Other|0|||
44545696|NCT03501277|79559649|FG001|Intervention Period 1 (4 Days)|Other|0|||
44545697|NCT03501277|79559650|FG002|Intervention Period 1 (4 Days)|Other|1|||
44545698|NCT03501277|79559651|FG003|Intervention Period 1 (4 Days)|Other|0|||
44545699|NCT03501277|79559648|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
44545700|NCT03501277|79559649|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
44545701|NCT03501277|79559650|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
44545702|NCT03501277|79559651|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
44545703|NCT03501277|79559648|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
44545704|NCT03501277|79559649|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
44545705|NCT03501277|79559650|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
44545706|NCT03501277|79559651|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
44545707|NCT03501277|79559648|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
44545708|NCT03501277|79559649|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
44545709|NCT03501277|79559650|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
44545710|NCT03501277|79559651|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
44545711|NCT03500419|79559663|FG000|Overall Study|Withdrawal by Subject|2|||
44545712|NCT03500419|79559664|FG001|Overall Study|Withdrawal by Subject|25|||
44229224|NCT04426695|79036948|FG011|Overall Study|Participant Decision|17|||
44229225|NCT04426695|79036949|FG012|Overall Study|Participant Decision|2|||
44492309|NCT00423137|79498103|FG000|Overall Study|Adverse Event Other|0|||
44492310|NCT00423137|79498104|FG001|Overall Study|Adverse Event Other|0|||
44492311|NCT00423137|79498105|FG002|Overall Study|Adverse Event Other|2|||
44492312|NCT00423137|79498106|FG003|Overall Study|Adverse Event Other|0|||
44492313|NCT00422903|79498121|FG000|Overall Study|Disease Progression|3|||
44492314|NCT00422903|79498122|FG001|Overall Study|Disease Progression|1|||
44492315|NCT00422903|79498121|FG000|Overall Study|Adverse Event|0|||
44492316|NCT00422903|79498122|FG001|Overall Study|Adverse Event|2|||
44492317|NCT00422903|79498121|FG000|Overall Study|Informed Consent Withdrawn|1|||
44492318|NCT00422903|79498122|FG001|Overall Study|Informed Consent Withdrawn|2|||
44492319|NCT00422669|79498131|FG000|Overall Study|The study was terminated early.|98|||
44229226|NCT04426695|79036950|FG013|Overall Study|Participant Decision|1|||
44229227|NCT04426695|79036951|FG014|Overall Study|Participant Decision|2|||
44229228|NCT04426695|79036952|FG015|Overall Study|Participant Decision|0|||
44492320|NCT00422669|79498132|FG001|Overall Study|The study was terminated early.|100|||
44545713|NCT03500341|79559670|FG000|Overall Study|Withdrawn prior to Completion|2|||
44545714|NCT01316900|79559691|FG000|Overall Study|Adverse Event|10|||
44229229|NCT04426695|79036953|FG016|Overall Study|Participant Decision|0|||
44229230|NCT04426695|79036954|FG017|Overall Study|Participant Decision|0|||
44492321|NCT00422669|79498133|FG002|Overall Study|The study was terminated early.|7|||
44492322|NCT00422591|79498139|FG000|Overall Study|Physician Decision|4|||
44545715|NCT01316900|79559692|FG001|Overall Study|Adverse Event|10|||
44545716|NCT01316900|79559693|FG002|Overall Study|Adverse Event|15|||
44492323|NCT00422591|79498139|FG000|Overall Study|Withdrawal by Subject|2|||
44492324|NCT00422513|79498145|FG000|Overall Study|Lack of Efficacy|4|||
44492325|NCT00422513|79498146|FG001|Overall Study|Lack of Efficacy|5|||
44492326|NCT00422513|79498145|FG000|Overall Study|Protocol Violation|23|||
44492327|NCT00422513|79498146|FG001|Overall Study|Protocol Violation|7|||
44492328|NCT00422513|79498145|FG000|Overall Study|Refused Treatment|4|||
44492329|NCT00422513|79498146|FG001|Overall Study|Refused Treatment|2|||
44492330|NCT00422513|79498145|FG000|Overall Study|Withdrawal by Subject|2|||
44492331|NCT00422513|79498146|FG001|Overall Study|Withdrawal by Subject|1|||
44492332|NCT00422513|79498145|FG000|Overall Study|early termination of the study|67|||
44492333|NCT00422513|79498146|FG001|Overall Study|early termination of the study|80|||
44492334|NCT00422513|79498145|FG000|Overall Study|Adverse Event|4|||
44492335|NCT00422513|79498146|FG001|Overall Study|Adverse Event|4|||
44492336|NCT00422513|79498145|FG000|Overall Study|Death|3|||
44492337|NCT00422513|79498146|FG001|Overall Study|Death|7|||
44492338|NCT00202878|79498154|FG000|Overall Study|Death|964|||
44492339|NCT00202878|79498155|FG001|Overall Study|Death|968|||
44492340|NCT00202878|79498154|FG000|Overall Study|Only Vital Status Known|357|||
44492341|NCT00202878|79498155|FG001|Overall Study|Only Vital Status Known|356|||
44492342|NCT00202878|79498154|FG000|Overall Study|Lost to Follow-up|44|||
44492343|NCT00202878|79498155|FG001|Overall Study|Lost to Follow-up|49|||
44492344|NCT00202878|79498154|FG000|Overall Study|Site Closure|39|||
44492345|NCT00202878|79498155|FG001|Overall Study|Site Closure|36|||
44492346|NCT00202878|79498154|FG000|Overall Study|Withdrawal by Subject|795|||
44492347|NCT00202878|79498155|FG001|Overall Study|Withdrawal by Subject|808|||
44492348|NCT00414011|79498161|FG000|Overall Study|Physician Decision|3|||
44492349|NCT00414011|79498161|FG000|Overall Study|Withdrawal by Subject|2|||
44492350|NCT00231816|79498168|FG000|Overall Study|Adverse Event|1|||
44492351|NCT00231816|79498169|FG001|Overall Study|Adverse Event|0|||
44492352|NCT00231816|79498168|FG000|Overall Study|Lost to Follow-up|8|||
44492353|NCT00231816|79498169|FG001|Overall Study|Lost to Follow-up|5|||
44492354|NCT00231816|79498168|FG000|Overall Study|Protocol Violation|2|||
44492355|NCT00231816|79498169|FG001|Overall Study|Protocol Violation|3|||
44492356|NCT00231816|79498168|FG000|Overall Study|Withdrawal by Subject|3|||
44492357|NCT00231816|79498169|FG001|Overall Study|Withdrawal by Subject|3|||
44492358|NCT00231816|79498168|FG000|Overall Study|Other|2|||
44492359|NCT00231816|79498169|FG001|Overall Study|Other|1|||
44492360|NCT00260208|79498178|FG000|Overall Study|Subject withdrew consent|11|||
44492361|NCT00260208|79498179|FG001|Overall Study|Subject withdrew consent|7|||
44492362|NCT00260208|79498178|FG000|Overall Study|Lost to Follow-up|6|||
44492363|NCT00260208|79498179|FG001|Overall Study|Lost to Follow-up|1|||
44492364|NCT00260208|79498178|FG000|Overall Study|Death|12|||
44492365|NCT00260208|79498179|FG001|Overall Study|Death|10|||
44492366|NCT00260208|79498178|FG000|Overall Study|Missing|18|||
44492367|NCT00260208|79498179|FG001|Overall Study|Missing|16|||
44492368|NCT00202644|79498187|FG000|Overall Study|Adverse Event|12|||
44492369|NCT00202644|79498188|FG001|Overall Study|Adverse Event|13|||
44492370|NCT00202644|79498187|FG000|Overall Study|Withdrawal by Subject|8|||
44492371|NCT00202644|79498188|FG001|Overall Study|Withdrawal by Subject|6|||
44492372|NCT00202644|79498187|FG000|Overall Study|Lack of Efficacy|6|||
44492373|NCT00202644|79498188|FG001|Overall Study|Lack of Efficacy|6|||
44492374|NCT00202644|79498187|FG000|Overall Study|Lost to Follow-up|0|||
44492375|NCT00202644|79498188|FG001|Overall Study|Lost to Follow-up|1|||
44492376|NCT00202644|79498187|FG000|Overall Study|Other|9|||
44492377|NCT00202644|79498188|FG001|Overall Study|Other|1|||
44492378|NCT01235962|79498198|FG000|Overall Study|Withdrawal by Subject|20|||
44492379|NCT01235962|79498199|FG001|Overall Study|Withdrawal by Subject|19|||
44492380|NCT01235962|79498200|FG002|Overall Study|Withdrawal by Subject|62|||
44492381|NCT01235962|79498201|FG003|Overall Study|Withdrawal by Subject|49|||
44492382|NCT01235962|79498198|FG000|Overall Study|Lost to Follow-up|21|||
44545717|NCT01316900|79559694|FG003|Overall Study|Adverse Event|9|||
44545718|NCT01316900|79559691|FG000|Overall Study|Lack of Efficacy|17|||
44492383|NCT01235962|79498199|FG001|Overall Study|Lost to Follow-up|16|||
44492384|NCT01235962|79498200|FG002|Overall Study|Lost to Follow-up|47|||
44545719|NCT01316900|79559692|FG001|Overall Study|Lack of Efficacy|9|||
44492385|NCT01235962|79498201|FG003|Overall Study|Lost to Follow-up|32|||
44492386|NCT01235962|79498198|FG000|Overall Study|Physician Decision|5|||
44492387|NCT01235962|79498199|FG001|Overall Study|Physician Decision|0|||
44492388|NCT01235962|79498200|FG002|Overall Study|Physician Decision|9|||
44492389|NCT01235962|79498201|FG003|Overall Study|Physician Decision|5|||
44492390|NCT00259740|79498221|FG000|Overall Study|Physician Decision|1|||
44492391|NCT00259740|79498222|FG001|Overall Study|Physician Decision|1|||
44376336|NCT01079234|79381442|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
44492392|NCT00259740|79498221|FG000|Overall Study|Adverse Event|0|||
44545720|NCT01316900|79559693|FG002|Overall Study|Lack of Efficacy|5|||
44492393|NCT00259740|79498222|FG001|Overall Study|Adverse Event|2|||
44492394|NCT00259740|79498221|FG000|Overall Study|Withdrawal by Subject|2|||
44492395|NCT00259740|79498222|FG001|Overall Study|Withdrawal by Subject|6|||
44545721|NCT01316900|79559694|FG003|Overall Study|Lack of Efficacy|7|||
44274430|NCT02997865|79218821|FG000|Overall Study|Death|2|||
44274431|NCT02997865|79218822|FG001|Overall Study|Death|1|||
44274432|NCT02997865|79218821|FG000|Overall Study|Lost to Follow-up|6|||
44274433|NCT02997865|79218822|FG001|Overall Study|Lost to Follow-up|3|||
44274434|NCT02997865|79218821|FG000|Overall Study|Withdrawal by Subject|5|||
44274435|NCT02997865|79218822|FG001|Overall Study|Withdrawal by Subject|0|||
44274436|NCT02253654|79220151|FG000|Overall Study|Withdrawal by Subject|12|||
44274437|NCT02253654|79220152|FG001|Overall Study|Withdrawal by Subject|4|||
44274438|NCT02253654|79220151|FG000|Overall Study|Decision by Sponsor|1|||
44274439|NCT02253654|79220152|FG001|Overall Study|Decision by Sponsor|1|||
44492396|NCT00259740|79498221|FG000|Overall Study|Death|1|||
44492397|NCT00259740|79498222|FG001|Overall Study|Death|1|||
44492398|NCT00259740|79498221|FG000|Overall Study|Disease progression|19|||
44545722|NCT01316900|79559691|FG000|Overall Study|Protocol Violation|7|||
44545723|NCT01316900|79559692|FG001|Overall Study|Protocol Violation|1|||
44545724|NCT01316900|79559693|FG002|Overall Study|Protocol Violation|4|||
44545725|NCT01316900|79559694|FG003|Overall Study|Protocol Violation|0|||
44545726|NCT01316900|79559691|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
44545727|NCT01316900|79559692|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
44274440|NCT02253654|79220151|FG000|Overall Study|Lost to Follow-up|2|||
44274441|NCT02253654|79220152|FG001|Overall Study|Lost to Follow-up|5|||
44274442|NCT02253654|79220151|FG000|Overall Study|Death|4|||
44492399|NCT00259740|79498222|FG001|Overall Study|Disease progression|36|||
44492400|NCT00259740|79498221|FG000|Overall Study|Ongoing|17|||
44492401|NCT00259740|79498222|FG001|Overall Study|Ongoing|3|||
44492402|NCT00259740|79498221|FG000|Overall Study|Other|3|||
44492403|NCT00259740|79498222|FG001|Overall Study|Other|0|||
44492404|NCT00259740|79498221|FG000|Overall Study|Requirement for alternative therapy|0|||
44492405|NCT00259740|79498222|FG001|Overall Study|Requirement for alternative therapy|4|||
44492406|NCT00201006|79498231|FG000|Overall Study|Withdrawal by Subject|7|||
44492407|NCT00201006|79498232|FG001|Overall Study|Withdrawal by Subject|2|||
44492408|NCT00201006|79498233|FG002|Overall Study|Withdrawal by Subject|3|||
44492409|NCT00201006|79498231|FG000|Overall Study|Adverse Event|1|||
44492410|NCT00201006|79498232|FG001|Overall Study|Adverse Event|0|||
44492411|NCT00201006|79498233|FG002|Overall Study|Adverse Event|1|||
44492412|NCT00200850|79498244|FG000|Overall Study|relocation|1|||
44492413|NCT00200850|79498245|FG001|Overall Study|relocation|0|||
44492414|NCT00200850|79498246|FG002|Overall Study|relocation|1|||
44492415|NCT00200850|79498244|FG000|Overall Study|too busy|1|||
44492416|NCT00200850|79498245|FG001|Overall Study|too busy|0|||
44492417|NCT00200850|79498246|FG002|Overall Study|too busy|0|||
44492418|NCT00200850|79498244|FG000|Overall Study|Pregnancy|0|||
44492419|NCT00200850|79498245|FG001|Overall Study|Pregnancy|0|||
44492420|NCT00200850|79498246|FG002|Overall Study|Pregnancy|1|||
44492421|NCT00200850|79498244|FG000|Overall Study|Poor adherence|0|||
44492422|NCT00200850|79498245|FG001|Overall Study|Poor adherence|0|||
44274443|NCT02253654|79220152|FG001|Overall Study|Death|7|||
44274444|NCT02253654|79220151|FG000|Overall Study|Did Not Receive Study Treatment|4|||
44492423|NCT00200850|79498246|FG002|Overall Study|Poor adherence|1|||
44492424|NCT00200850|79498244|FG000|Overall Study|optic neuritis|0|||
44492425|NCT00200850|79498245|FG001|Overall Study|optic neuritis|0|||
44492426|NCT00200850|79498246|FG002|Overall Study|optic neuritis|1|||
44274445|NCT02253654|79220152|FG001|Overall Study|Did Not Receive Study Treatment|1|||
44274446|NCT02252406|79220160|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
44492427|NCT00200850|79498244|FG000|Overall Study|Adverse Event|1|||
44492428|NCT00200850|79498245|FG001|Overall Study|Adverse Event|1|||
44492429|NCT00200850|79498246|FG002|Overall Study|Adverse Event|2|||
44492430|NCT00231114|79498256|FG000|Randomized|Withdrawal by Subject|6|||
44492431|NCT00231114|79498257|FG001|Randomized|Withdrawal by Subject|3|||
44492432|NCT00231114|79498256|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
44492433|NCT00231114|79498257|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
44492434|NCT00231114|79498256|FG000|Post-Treatment Period|Lost to Follow-up|6|||
44545728|NCT01316900|79559693|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
44545729|NCT01316900|79559694|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
44545730|NCT01316900|79559691|FG000|Overall Study|Lost to Follow-up|1|||
44545731|NCT01316900|79559692|FG001|Overall Study|Lost to Follow-up|0|||
44545732|NCT01316900|79559693|FG002|Overall Study|Lost to Follow-up|1|||
44545733|NCT01316900|79559694|FG003|Overall Study|Lost to Follow-up|1|||
44545734|NCT01316900|79559691|FG000|Overall Study|Withdrawal by Subject|7|||
44545735|NCT01316900|79559692|FG001|Overall Study|Withdrawal by Subject|8|||
44545736|NCT01316900|79559693|FG002|Overall Study|Withdrawal by Subject|6|||
44545737|NCT01316900|79559694|FG003|Overall Study|Withdrawal by Subject|9|||
44545738|NCT03499873|79559707|FG000|Overall Study|Withdrawal by Subject|4|||
44545739|NCT03499873|79559708|FG001|Overall Study|Withdrawal by Subject|6|||
44545740|NCT03499873|79559709|FG002|Overall Study|Withdrawal by Subject|1|||
44545741|NCT03499873|79559707|FG000|Overall Study|Subjects condition worsened|0|||
44545742|NCT03499873|79559708|FG001|Overall Study|Subjects condition worsened|3|||
44545743|NCT03499873|79559709|FG002|Overall Study|Subjects condition worsened|11|||
44545744|NCT03499873|79559707|FG000|Overall Study|Adverse Event|8|||
44545745|NCT03499873|79559708|FG001|Overall Study|Adverse Event|3|||
44545746|NCT03499873|79559709|FG002|Overall Study|Adverse Event|6|||
44545747|NCT03499873|79559707|FG000|Overall Study|Physician Decision|1|||
44545748|NCT03499873|79559708|FG001|Overall Study|Physician Decision|0|||
44545749|NCT03499873|79559709|FG002|Overall Study|Physician Decision|0|||
44545750|NCT03499873|79559707|FG000|Overall Study|Administrative reasons|0|||
44545751|NCT03499873|79559708|FG001|Overall Study|Administrative reasons|1|||
44545752|NCT03499873|79559709|FG002|Overall Study|Administrative reasons|0|||
44492435|NCT00231114|79498257|FG001|Post-Treatment Period|Lost to Follow-up|1|||
44492436|NCT00231114|79498256|FG000|Post-Treatment Period|Physician Decision|1|||
44492437|NCT00231114|79498257|FG001|Post-Treatment Period|Physician Decision|0|||
44492438|NCT00231114|79498256|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
44492439|NCT00231114|79498257|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
44492440|NCT03543046|79498267|FG000|Overall Study|Adverse Event|1|||
44492441|NCT03543046|79498268|FG001|Overall Study|Adverse Event|1|||
44492442|NCT03543046|79498267|FG000|Overall Study|Physician Decision|1|||
44492443|NCT03543046|79498268|FG001|Overall Study|Physician Decision|1|||
44492444|NCT03543046|79498267|FG000|Overall Study|Protocol Violation|1|||
44492445|NCT03543046|79498268|FG001|Overall Study|Protocol Violation|0|||
44492446|NCT00259272|79498287|FG000|Overall Study|Adverse Event|2|||
44492447|NCT00259272|79498288|FG001|Overall Study|Adverse Event|1|||
44492448|NCT00259272|79498289|FG002|Overall Study|Adverse Event|0|||
44492449|NCT00259272|79498290|FG003|Overall Study|Adverse Event|3|||
44492450|NCT00259272|79498287|FG000|Overall Study|Lack of Efficacy|5|||
44492451|NCT00259272|79498288|FG001|Overall Study|Lack of Efficacy|1|||
44492452|NCT00259272|79498289|FG002|Overall Study|Lack of Efficacy|2|||
44492453|NCT00259272|79498290|FG003|Overall Study|Lack of Efficacy|6|||
44492454|NCT00259272|79498287|FG000|Overall Study|Physician Decision|1|||
44492455|NCT00259272|79498288|FG001|Overall Study|Physician Decision|2|||
44492456|NCT00259272|79498289|FG002|Overall Study|Physician Decision|1|||
44492457|NCT00259272|79498290|FG003|Overall Study|Physician Decision|3|||
44545753|NCT03499873|79559707|FG000|Overall Study|Concomitant therapy|5|||
44545754|NCT03499873|79559708|FG001|Overall Study|Concomitant therapy|4|||
44545755|NCT03499873|79559709|FG002|Overall Study|Concomitant therapy|7|||
44545756|NCT03499873|79559707|FG000|Overall Study|Miscellaneous|1|||
44545757|NCT03499873|79559708|FG001|Overall Study|Miscellaneous|2|||
44545758|NCT03499873|79559709|FG002|Overall Study|Miscellaneous|2|||
44545759|NCT03499873|79559707|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
44545760|NCT03499873|79559708|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
44545761|NCT03499873|79559709|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
44492458|NCT00259272|79498287|FG000|Overall Study|Protocol Violation|2|||
44492459|NCT00259272|79498288|FG001|Overall Study|Protocol Violation|0|||
44492460|NCT00259272|79498289|FG002|Overall Study|Protocol Violation|0|||
44492461|NCT00259272|79498290|FG003|Overall Study|Protocol Violation|1|||
44492462|NCT00259272|79498287|FG000|Overall Study|Sponsor Decision|0|||
44492463|NCT00259272|79498288|FG001|Overall Study|Sponsor Decision|1|||
44492464|NCT00259272|79498289|FG002|Overall Study|Sponsor Decision|0|||
44492465|NCT00259272|79498290|FG003|Overall Study|Sponsor Decision|0|||
44492466|NCT00259272|79498287|FG000|Overall Study|Withdrawal by Subject|4|||
44492467|NCT00259272|79498288|FG001|Overall Study|Withdrawal by Subject|2|||
44492468|NCT00259272|79498289|FG002|Overall Study|Withdrawal by Subject|2|||
44492469|NCT00259272|79498290|FG003|Overall Study|Withdrawal by Subject|7|||
44492470|NCT00259272|79498287|FG000|Overall Study|Lost to Follow-up|1|||
44492471|NCT00259272|79498288|FG001|Overall Study|Lost to Follow-up|0|||
44492472|NCT00259272|79498289|FG002|Overall Study|Lost to Follow-up|0|||
44492473|NCT00259272|79498290|FG003|Overall Study|Lost to Follow-up|1|||
44492474|NCT00421889|79498323|FG000|Overall Study|Adverse Event|1|||
44545762|NCT03467971|79559719|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44545763|NCT03467971|79559720|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44545764|NCT03049280|79559736|FG000|Overall Study|Physician Decision|1|||
44545765|NCT03048500|79559742|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
44545766|NCT03048500|79559742|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
44545767|NCT03048500|79559742|FG000|Reached 1st Response/Continued Treatment|Death|1|||
44545768|NCT03048500|79559742|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
44545769|NCT03048500|79559742|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
44545770|NCT03048500|79559742|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
44545771|NCT03048500|79559742|FG000|Follow up for 3 Years|Death|12|||
44545772|NCT00908076|79559748|FG000|Overall Study|Lack of Efficacy|1|||
44545773|NCT00908076|79559749|FG001|Overall Study|Lack of Efficacy|1|||
44545774|NCT03467425|79559757|FG000|Overall Study|Adverse Event|9|||
44545775|NCT03467425|79559758|FG001|Overall Study|Adverse Event|9|||
44545776|NCT03467425|79559757|FG000|Overall Study|Lack of Efficacy|3|||
44545777|NCT03467425|79559758|FG001|Overall Study|Lack of Efficacy|1|||
44545778|NCT03467425|79559757|FG000|Overall Study|Protocol Violation|0|||
44545779|NCT03467425|79559758|FG001|Overall Study|Protocol Violation|1|||
44545780|NCT03467425|79559757|FG000|Overall Study|Lost to Follow-up|18|||
44545781|NCT03467425|79559758|FG001|Overall Study|Lost to Follow-up|25|||
44229231|NCT04426695|79036937|FG000|Overall Study|Adverse Event|0|||
44229232|NCT04426695|79036938|FG001|Overall Study|Adverse Event|0|||
44229233|NCT04426695|79036939|FG002|Overall Study|Adverse Event|0|||
44229234|NCT04426695|79036940|FG003|Overall Study|Adverse Event|0|||
44229235|NCT04426695|79036941|FG004|Overall Study|Adverse Event|0|||
44229236|NCT04426695|79036942|FG005|Overall Study|Adverse Event|0|||
44229237|NCT04426695|79036943|FG006|Overall Study|Adverse Event|0|||
44229238|NCT04426695|79036944|FG007|Overall Study|Adverse Event|1|||
44545782|NCT03467425|79559757|FG000|Overall Study|Physician Decision|2|||
44545783|NCT03467425|79559758|FG001|Overall Study|Physician Decision|1|||
44545784|NCT03467425|79559757|FG000|Overall Study|Withdrawal by Subject|15|||
44545785|NCT03467425|79559758|FG001|Overall Study|Withdrawal by Subject|17|||
44545786|NCT02886702|79559767|FG000|Overall Study|Other|4|||
44545787|NCT02886702|79559768|FG001|Overall Study|Other|3|||
44545788|NCT02886702|79559769|FG002|Overall Study|Other|9|||
44545789|NCT02886702|79559767|FG000|Overall Study|Withdrawal by Subject|24|||
44545790|NCT02886702|79559768|FG001|Overall Study|Withdrawal by Subject|18|||
44492475|NCT00421889|79498324|FG001|Overall Study|Adverse Event|0|||
44492476|NCT00421889|79498325|FG002|Overall Study|Adverse Event|1|||
44492477|NCT00421889|79498326|FG003|Overall Study|Adverse Event|1|||
44492478|NCT00421889|79498327|FG004|Overall Study|Adverse Event|1|||
44492479|NCT00421889|79498328|FG005|Overall Study|Adverse Event|4|||
44492480|NCT00421889|79498329|FG006|Overall Study|Adverse Event|1|||
44545791|NCT02886702|79559769|FG002|Overall Study|Withdrawal by Subject|22|||
44545792|NCT02886702|79559767|FG000|Overall Study|Significant Worsening of Condition|0|||
44545793|NCT02886702|79559768|FG001|Overall Study|Significant Worsening of Condition|1|||
44545794|NCT02886702|79559769|FG002|Overall Study|Significant Worsening of Condition|0|||
44545795|NCT02886702|79559767|FG000|Overall Study|Protocol Violation|2|||
44545796|NCT02886702|79559768|FG001|Overall Study|Protocol Violation|2|||
44545797|NCT02886702|79559769|FG002|Overall Study|Protocol Violation|1|||
44229239|NCT04426695|79036945|FG008|Overall Study|Adverse Event|0|||
44229240|NCT04426695|79036946|FG009|Overall Study|Adverse Event|0|||
44274447|NCT02252406|79220161|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
44545798|NCT02886702|79559767|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44545799|NCT02886702|79559768|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44545800|NCT02886702|79559769|FG002|Overall Study|Non-Compliance With Study Drug|4|||
44229241|NCT04426695|79036947|FG010|Overall Study|Adverse Event|1|||
44229242|NCT04426695|79036948|FG011|Overall Study|Adverse Event|1|||
44492481|NCT00421889|79498330|FG007|Overall Study|Adverse Event|0|||
44492482|NCT00421889|79498331|FG008|Overall Study|Adverse Event|2|||
44492483|NCT00421889|79498323|FG000|Overall Study|Withdrawal by Subject|1|||
44492484|NCT00421889|79498324|FG001|Overall Study|Withdrawal by Subject|3|||
44492485|NCT00421889|79498325|FG002|Overall Study|Withdrawal by Subject|0|||
44492486|NCT00421889|79498326|FG003|Overall Study|Withdrawal by Subject|0|||
44545801|NCT02886702|79559767|FG000|Overall Study|Lost to Follow-up|11|||
44545802|NCT02886702|79559768|FG001|Overall Study|Lost to Follow-up|13|||
44492487|NCT00421889|79498327|FG004|Overall Study|Withdrawal by Subject|2|||
44492488|NCT00421889|79498328|FG005|Overall Study|Withdrawal by Subject|0|||
44492489|NCT00421889|79498329|FG006|Overall Study|Withdrawal by Subject|0|||
44492490|NCT00421889|79498330|FG007|Overall Study|Withdrawal by Subject|0|||
44492491|NCT00421889|79498331|FG008|Overall Study|Withdrawal by Subject|0|||
44492492|NCT00421889|79498323|FG000|Overall Study|Death|0|||
44492493|NCT00421889|79498324|FG001|Overall Study|Death|0|||
44492494|NCT00421889|79498325|FG002|Overall Study|Death|0|||
44492495|NCT00421889|79498326|FG003|Overall Study|Death|0|||
44492496|NCT00421889|79498327|FG004|Overall Study|Death|1|||
44492497|NCT00421889|79498328|FG005|Overall Study|Death|1|||
44492498|NCT00421889|79498329|FG006|Overall Study|Death|0|||
44492499|NCT00421889|79498330|FG007|Overall Study|Death|0|||
44492500|NCT00421889|79498331|FG008|Overall Study|Death|0|||
44545803|NCT02886702|79559769|FG002|Overall Study|Lost to Follow-up|8|||
44545804|NCT02886702|79559767|FG000|Overall Study|Lack of Efficacy|3|||
44492501|NCT00421889|79498323|FG000|Overall Study|Progressive disease|3|||
44545805|NCT02886702|79559768|FG001|Overall Study|Lack of Efficacy|4|||
44545806|NCT02886702|79559769|FG002|Overall Study|Lack of Efficacy|5|||
44545807|NCT02886702|79559767|FG000|Overall Study|Adverse Event|4|||
44545808|NCT02886702|79559768|FG001|Overall Study|Adverse Event|9|||
44545809|NCT02886702|79559769|FG002|Overall Study|Adverse Event|3|||
44545810|NCT02886702|79559767|FG000|Overall Study|Administrative Reasons|0|||
44545811|NCT02886702|79559768|FG001|Overall Study|Administrative Reasons|0|||
44545812|NCT02886702|79559769|FG002|Overall Study|Administrative Reasons|1|||
44545813|NCT03498313|79559783|FG000|Experimental Period 1|Adverse Event|1|||
44545814|NCT03498313|79559784|FG001|Experimental Period 1|Adverse Event|0|||
44545815|NCT03498313|79559785|FG002|Experimental Period 1|Adverse Event|0|||
44545816|NCT03498313|79559786|FG003|Experimental Period 1|Adverse Event|1|||
44545817|NCT03498313|79559787|FG004|Experimental Period 1|Adverse Event|0|||
44545818|NCT03498313|79559788|FG005|Experimental Period 1|Adverse Event|0|||
44545819|NCT03498313|79559783|FG000|Experimental Period 1|Withdrawal by Subject|0|||
44545820|NCT03498313|79559784|FG001|Experimental Period 1|Withdrawal by Subject|1|||
44545821|NCT03498313|79559785|FG002|Experimental Period 1|Withdrawal by Subject|0|||
44545822|NCT03498313|79559786|FG003|Experimental Period 1|Withdrawal by Subject|0|||
44545823|NCT03498313|79559787|FG004|Experimental Period 1|Withdrawal by Subject|0|||
44545824|NCT03498313|79559788|FG005|Experimental Period 1|Withdrawal by Subject|0|||
44545825|NCT03498313|79559783|FG000|Washout Period 1|Anovulation|1|||
44545826|NCT03498313|79559784|FG001|Washout Period 1|Anovulation|0|||
44545827|NCT03498313|79559785|FG002|Washout Period 1|Anovulation|0|||
44545828|NCT03498313|79559786|FG003|Washout Period 1|Anovulation|0|||
44545829|NCT03498313|79559787|FG004|Washout Period 1|Anovulation|0|||
44545830|NCT03498313|79559788|FG005|Washout Period 1|Anovulation|0|||
44545831|NCT03498313|79559783|FG000|Washout Period 1|Withdrawal by Subject|0|||
44545832|NCT03498313|79559784|FG001|Washout Period 1|Withdrawal by Subject|3|||
44545833|NCT03498313|79559785|FG002|Washout Period 1|Withdrawal by Subject|0|||
44545834|NCT03498313|79559786|FG003|Washout Period 1|Withdrawal by Subject|1|||
44545835|NCT03498313|79559787|FG004|Washout Period 1|Withdrawal by Subject|0|||
44545836|NCT03498313|79559788|FG005|Washout Period 1|Withdrawal by Subject|1|||
44545837|NCT03498313|79559783|FG000|Experimental Period 2|Adverse Event|0|||
44545838|NCT03498313|79559784|FG001|Experimental Period 2|Adverse Event|0|||
44545839|NCT03498313|79559785|FG002|Experimental Period 2|Adverse Event|0|||
44545840|NCT03498313|79559786|FG003|Experimental Period 2|Adverse Event|0|||
44229243|NCT04426695|79036949|FG012|Overall Study|Adverse Event|0|||
44545841|NCT03498313|79559787|FG004|Experimental Period 2|Adverse Event|1|||
44492502|NCT00421889|79498324|FG001|Overall Study|Progressive disease|2|||
44545842|NCT03498313|79559788|FG005|Experimental Period 2|Adverse Event|2|||
44545843|NCT03498313|79559783|FG000|Washout Period 2|Physician Decision|1|||
44545844|NCT03498313|79559784|FG001|Washout Period 2|Physician Decision|0|||
44229244|NCT04426695|79036950|FG013|Overall Study|Adverse Event|0|||
44229245|NCT04426695|79036951|FG014|Overall Study|Adverse Event|0|||
44229246|NCT04426695|79036952|FG015|Overall Study|Adverse Event|0|||
44229247|NCT04426695|79036953|FG016|Overall Study|Adverse Event|0|||
44492503|NCT00421889|79498325|FG002|Overall Study|Progressive disease|2|||
44545845|NCT03498313|79559785|FG002|Washout Period 2|Physician Decision|0|||
44229248|NCT04426695|79036954|FG017|Overall Study|Adverse Event|0|||
44545846|NCT03498313|79559786|FG003|Washout Period 2|Physician Decision|1|||
44545847|NCT03498313|79559787|FG004|Washout Period 2|Physician Decision|0|||
44545848|NCT03498313|79559788|FG005|Washout Period 2|Physician Decision|1|||
44229249|NCT04426695|79036937|FG000|Overall Study|Sponsor Request|0|||
44492504|NCT00421889|79498326|FG003|Overall Study|Progressive disease|3|||
44492505|NCT00421889|79498327|FG004|Overall Study|Progressive disease|2|||
44492506|NCT00421889|79498328|FG005|Overall Study|Progressive disease|21|||
44492507|NCT00421889|79498329|FG006|Overall Study|Progressive disease|3|||
44492508|NCT00421889|79498330|FG007|Overall Study|Progressive disease|1|||
44545849|NCT03498313|79559783|FG000|Washout Period 2|Withdrawal by Subject|3|||
44545850|NCT03498313|79559784|FG001|Washout Period 2|Withdrawal by Subject|2|||
44545851|NCT03498313|79559785|FG002|Washout Period 2|Withdrawal by Subject|0|||
44545852|NCT03498313|79559786|FG003|Washout Period 2|Withdrawal by Subject|0|||
44545853|NCT03498313|79559787|FG004|Washout Period 2|Withdrawal by Subject|2|||
44545854|NCT03498313|79559788|FG005|Washout Period 2|Withdrawal by Subject|0|||
44545855|NCT03498313|79559783|FG000|Washout Period 2|Anovulation|0|||
44545856|NCT03498313|79559784|FG001|Washout Period 2|Anovulation|0|||
44545857|NCT03498313|79559785|FG002|Washout Period 2|Anovulation|0|||
44545858|NCT03498313|79559786|FG003|Washout Period 2|Anovulation|0|||
44545859|NCT03498313|79559787|FG004|Washout Period 2|Anovulation|0|||
44545860|NCT03498313|79559788|FG005|Washout Period 2|Anovulation|1|||
44545861|NCT02601014|79559798|FG000|Overall Study|Adverse Event|3|||
44545862|NCT02601014|79559799|FG001|Overall Study|Adverse Event|3|||
44545863|NCT02601014|79559798|FG000|Overall Study|Death|3|||
44545864|NCT02601014|79559799|FG001|Overall Study|Death|1|||
44545865|NCT02601014|79559798|FG000|Overall Study|Disease progression|4|||
44545866|NCT02601014|79559799|FG001|Overall Study|Disease progression|8|||
44545867|NCT01307046|79559807|FG000|Overall Study|Adverse Event|3|||
44545868|NCT01307046|79559808|FG001|Overall Study|Adverse Event|3|||
44545869|NCT01307046|79559807|FG000|Overall Study|Lack of Efficacy|0|||
44545870|NCT01307046|79559808|FG001|Overall Study|Lack of Efficacy|2|||
44545871|NCT01307046|79559807|FG000|Overall Study|Physician Decision|2|||
44545872|NCT01307046|79559808|FG001|Overall Study|Physician Decision|0|||
44545873|NCT01307046|79559807|FG000|Overall Study|Withdrawal by Subject|1|||
44545874|NCT01307046|79559808|FG001|Overall Study|Withdrawal by Subject|1|||
44545875|NCT01307046|79559807|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
44545876|NCT01307046|79559808|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
44545877|NCT01307046|79559807|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
44545878|NCT01307046|79559808|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
44545879|NCT03495817|79559814|FG000|26 Week Open Label|Adverse Event|3|||
44545880|NCT03495817|79559814|FG000|26 Week Open Label|Withdrawal by Subject|4|||
44545881|NCT03495817|79559814|FG000|26 Week Open Label|Lost to Follow-up|1|||
44545882|NCT03495817|79559814|FG000|26 Week Extension|Lost to Follow-up|2|||
44545883|NCT02886624|79559818|FG000|12-week Post Treatment Follow-up|Death|1|||
44229250|NCT04426695|79036938|FG001|Overall Study|Sponsor Request|0|||
44229251|NCT04426695|79036939|FG002|Overall Study|Sponsor Request|0|||
44229252|NCT04426695|79036940|FG003|Overall Study|Sponsor Request|0|||
44274448|NCT02252406|79220160|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
44376337|NCT01079234|79381443|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
44492509|NCT00421889|79498331|FG008|Overall Study|Progressive disease|5|||
44492510|NCT00421889|79498323|FG000|Overall Study|Patient/Investigator request|0|||
44492511|NCT00421889|79498324|FG001|Overall Study|Patient/Investigator request|0|||
44492512|NCT00421889|79498325|FG002|Overall Study|Patient/Investigator request|0|||
44492513|NCT00421889|79498326|FG003|Overall Study|Patient/Investigator request|0|||
44492514|NCT00421889|79498327|FG004|Overall Study|Patient/Investigator request|0|||
44492515|NCT00421889|79498328|FG005|Overall Study|Patient/Investigator request|9|||
44492516|NCT00421889|79498329|FG006|Overall Study|Patient/Investigator request|0|||
44492517|NCT00421889|79498330|FG007|Overall Study|Patient/Investigator request|1|||
44492518|NCT00421889|79498331|FG008|Overall Study|Patient/Investigator request|3|||
44492519|NCT00421889|79498323|FG000|Overall Study|Lost to Follow-up|0|||
44492520|NCT00421889|79498324|FG001|Overall Study|Lost to Follow-up|0|||
44492521|NCT00421889|79498325|FG002|Overall Study|Lost to Follow-up|0|||
44492522|NCT00421889|79498326|FG003|Overall Study|Lost to Follow-up|0|||
44492523|NCT00421889|79498327|FG004|Overall Study|Lost to Follow-up|0|||
44492524|NCT00421889|79498328|FG005|Overall Study|Lost to Follow-up|0|||
44492525|NCT00421889|79498329|FG006|Overall Study|Lost to Follow-up|0|||
44545884|NCT02886624|79559818|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
44545885|NCT02963766|79559825|FG000|Double-Blind Period|Adverse Event|1|||
44545886|NCT02963766|79559826|FG001|Double-Blind Period|Adverse Event|0|||
44492526|NCT00421889|79498330|FG007|Overall Study|Lost to Follow-up|0|||
44492527|NCT00421889|79498331|FG008|Overall Study|Lost to Follow-up|1|||
44545887|NCT02963766|79559827|FG002|Double-Blind Period|Adverse Event|1|||
44545888|NCT02963766|79559825|FG000|Double-Blind Period|Physician Decision|1|||
44545889|NCT02963766|79559826|FG001|Double-Blind Period|Physician Decision|0|||
44545890|NCT02963766|79559827|FG002|Double-Blind Period|Physician Decision|0|||
44545891|NCT02963766|79559825|FG000|Double-Blind Period|Withdrawal by Subject|1|||
44545892|NCT02963766|79559826|FG001|Double-Blind Period|Withdrawal by Subject|1|||
44545893|NCT02963766|79559827|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44545894|NCT02963766|79559825|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
44545895|NCT02963766|79559826|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
44545896|NCT02963766|79559827|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
44545897|NCT02963766|79559825|FG000|Double-Blind Period|Protocol Violation|1|||
44545898|NCT02963766|79559826|FG001|Double-Blind Period|Protocol Violation|0|||
44545899|NCT02963766|79559827|FG002|Double-Blind Period|Protocol Violation|0|||
44545900|NCT02963766|79559825|FG000|Double-Blind Period|Lost to Follow-up|0|||
44545901|NCT02963766|79559826|FG001|Double-Blind Period|Lost to Follow-up|1|||
44545902|NCT02963766|79559827|FG002|Double-Blind Period|Lost to Follow-up|0|||
44545903|NCT02963766|79559825|FG000|Open Label Extension (OLE)|Physician Decision|1|||
44545904|NCT02963766|79559826|FG001|Open Label Extension (OLE)|Physician Decision|2|||
44545905|NCT02963766|79559827|FG002|Open Label Extension (OLE)|Physician Decision|2|||
44545906|NCT02963766|79559825|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
44545907|NCT02963766|79559826|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
44545908|NCT02963766|79559827|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
44545909|NCT04839965|79559847|FG000|Overall Study|Death|6|||
44545910|NCT04839965|79559848|FG001|Overall Study|Death|6|||
44545911|NCT04839965|79559847|FG000|Overall Study|Lost to Follow-up|1|||
44545912|NCT04839965|79559848|FG001|Overall Study|Lost to Follow-up|0|||
44545913|NCT03466099|79559857|FG000|Overall Study|Adverse Event|1|||
44545914|NCT03466099|79559858|FG001|Overall Study|Adverse Event|1|||
44545915|NCT03466099|79559859|FG002|Overall Study|Adverse Event|1|||
44545916|NCT03466099|79559857|FG000|Overall Study|Withdrawal by Subject|2|||
44545917|NCT03466099|79559858|FG001|Overall Study|Withdrawal by Subject|3|||
44545918|NCT03466099|79559859|FG002|Overall Study|Withdrawal by Subject|1|||
44545919|NCT03466099|79559857|FG000|Overall Study|Use of rescue medication|8|||
44545920|NCT03466099|79559858|FG001|Overall Study|Use of rescue medication|9|||
44545921|NCT03466099|79559859|FG002|Overall Study|Use of rescue medication|13|||
44545922|NCT03466099|79559857|FG000|Overall Study|Rescued without meeting criteria|4|||
44545923|NCT03466099|79559858|FG001|Overall Study|Rescued without meeting criteria|1|||
44545924|NCT03466099|79559859|FG002|Overall Study|Rescued without meeting criteria|1|||
44545925|NCT03466099|79559857|FG000|Overall Study|Subject compliance|2|||
44229253|NCT04426695|79036941|FG004|Overall Study|Sponsor Request|0|||
44229254|NCT04426695|79036942|FG005|Overall Study|Sponsor Request|0|||
44229255|NCT04426695|79036943|FG006|Overall Study|Sponsor Request|1|||
44229256|NCT04426695|79036944|FG007|Overall Study|Sponsor Request|0|||
44229257|NCT04426695|79036945|FG008|Overall Study|Sponsor Request|0|||
44229258|NCT04426695|79036946|FG009|Overall Study|Sponsor Request|0|||
44229259|NCT04426695|79036947|FG010|Overall Study|Sponsor Request|0|||
44229260|NCT04426695|79036948|FG011|Overall Study|Sponsor Request|0|||
44229261|NCT04426695|79036949|FG012|Overall Study|Sponsor Request|0|||
44492528|NCT00421733|79498358|FG000|Overall Study|Adverse Event|4|||
44492529|NCT00421733|79498359|FG001|Overall Study|Adverse Event|9|||
44492530|NCT00421733|79498360|FG002|Overall Study|Adverse Event|2|||
44492531|NCT00421733|79498358|FG000|Overall Study|Lost to Follow-up|1|||
44492532|NCT00421733|79498359|FG001|Overall Study|Lost to Follow-up|2|||
44492533|NCT00421733|79498360|FG002|Overall Study|Lost to Follow-up|4|||
44492534|NCT00421733|79498358|FG000|Overall Study|Withdrawal by Subject|1|||
44492535|NCT00421733|79498359|FG001|Overall Study|Withdrawal by Subject|2|||
44492536|NCT00421733|79498360|FG002|Overall Study|Withdrawal by Subject|7|||
44492537|NCT00421733|79498358|FG000|Overall Study|Death|0|||
44492538|NCT00421733|79498359|FG001|Overall Study|Death|3|||
44492539|NCT00421733|79498360|FG002|Overall Study|Death|0|||
44492540|NCT00421733|79498358|FG000|Overall Study|Required dialysis|1|||
44492541|NCT00421733|79498359|FG001|Overall Study|Required dialysis|0|||
44492542|NCT00421733|79498360|FG002|Overall Study|Required dialysis|0|||
44492543|NCT00421733|79498358|FG000|Overall Study|Administrative|2|||
44492544|NCT00421733|79498359|FG001|Overall Study|Administrative|0|||
44492545|NCT00421733|79498360|FG002|Overall Study|Administrative|0|||
44492546|NCT00421733|79498358|FG000|Overall Study|Did not satisfy entry criteria|1|||
44229262|NCT04426695|79036950|FG013|Overall Study|Sponsor Request|0|||
44492547|NCT00421733|79498359|FG001|Overall Study|Did not satisfy entry criteria|3|||
44492548|NCT00421733|79498360|FG002|Overall Study|Did not satisfy entry criteria|2|||
44492549|NCT00421733|79498358|FG000|Overall Study|Sponsor request|1|||
44492550|NCT00421733|79498359|FG001|Overall Study|Sponsor request|0|||
44545926|NCT03466099|79559858|FG001|Overall Study|Subject compliance|0|||
44545927|NCT03466099|79559859|FG002|Overall Study|Subject compliance|0|||
44545928|NCT03466099|79559857|FG000|Overall Study|Worsening disease|0|||
44229263|NCT04426695|79036951|FG014|Overall Study|Sponsor Request|0|||
44229264|NCT04426695|79036952|FG015|Overall Study|Sponsor Request|0|||
44229265|NCT04426695|79036953|FG016|Overall Study|Sponsor Request|0|||
44229266|NCT04426695|79036954|FG017|Overall Study|Sponsor Request|0|||
44229267|NCT04426695|79036937|FG000|Overall Study|Physician Decision|0|||
44229268|NCT04426695|79036938|FG001|Overall Study|Physician Decision|0|||
44229269|NCT04426695|79036939|FG002|Overall Study|Physician Decision|0|||
44229270|NCT04426695|79036940|FG003|Overall Study|Physician Decision|0|||
44229271|NCT04426695|79036941|FG004|Overall Study|Physician Decision|0|||
44229272|NCT04426695|79036942|FG005|Overall Study|Physician Decision|0|||
44229273|NCT04426695|79036943|FG006|Overall Study|Physician Decision|0|||
44229274|NCT04426695|79036944|FG007|Overall Study|Physician Decision|0|||
44229275|NCT04426695|79036945|FG008|Overall Study|Physician Decision|0|||
44229276|NCT04426695|79036946|FG009|Overall Study|Physician Decision|1|||
44229277|NCT04426695|79036947|FG010|Overall Study|Physician Decision|0|||
44229278|NCT04426695|79036948|FG011|Overall Study|Physician Decision|0|||
44229279|NCT04426695|79036949|FG012|Overall Study|Physician Decision|1|||
44229280|NCT04426695|79036950|FG013|Overall Study|Physician Decision|0|||
44229281|NCT04426695|79036951|FG014|Overall Study|Physician Decision|0|||
44229282|NCT04426695|79036952|FG015|Overall Study|Physician Decision|0|||
44229283|NCT04426695|79036953|FG016|Overall Study|Physician Decision|0|||
44229284|NCT04426695|79036954|FG017|Overall Study|Physician Decision|0|||
44229285|NCT04426695|79036937|FG000|Overall Study|Randomized but Never Treated|3|||
44229286|NCT04426695|79036938|FG001|Overall Study|Randomized but Never Treated|1|||
44229287|NCT04426695|79036939|FG002|Overall Study|Randomized but Never Treated|0|||
44229288|NCT04426695|79036940|FG003|Overall Study|Randomized but Never Treated|4|||
44229289|NCT04426695|79036941|FG004|Overall Study|Randomized but Never Treated|5|||
44229290|NCT04426695|79036942|FG005|Overall Study|Randomized but Never Treated|5|||
44229291|NCT04426695|79036943|FG006|Overall Study|Randomized but Never Treated|4|||
44229292|NCT04426695|79036944|FG007|Overall Study|Randomized but Never Treated|6|||
44229293|NCT04426695|79036945|FG008|Overall Study|Randomized but Never Treated|6|||
44229294|NCT04426695|79036946|FG009|Overall Study|Randomized but Never Treated|3|||
44229295|NCT04426695|79036947|FG010|Overall Study|Randomized but Never Treated|3|||
44229296|NCT04426695|79036948|FG011|Overall Study|Randomized but Never Treated|6|||
44229297|NCT04426695|79036949|FG012|Overall Study|Randomized but Never Treated|1|||
44229298|NCT04426695|79036950|FG013|Overall Study|Randomized but Never Treated|2|||
44229299|NCT04426695|79036951|FG014|Overall Study|Randomized but Never Treated|0|||
44229300|NCT04426695|79036952|FG015|Overall Study|Randomized but Never Treated|0|||
44229301|NCT04426695|79036953|FG016|Overall Study|Randomized but Never Treated|0|||
44229302|NCT04426695|79036954|FG017|Overall Study|Randomized but Never Treated|0|||
44229303|NCT01838200|79037031|FG000|Overall Study|Adverse Event|0|||
44229304|NCT01838200|79037032|FG001|Overall Study|Adverse Event|2|||
44229305|NCT01838200|79037031|FG000|Overall Study|Progressive disease|3|||
44229306|NCT01838200|79037032|FG001|Overall Study|Progressive disease|0|||
44229307|NCT03219034|79037075|FG000|Overall Study|Lost to Follow-up|9|||
44229308|NCT03219034|79037076|FG001|Overall Study|Lost to Follow-up|13|||
44229309|NCT03219034|79037075|FG000|Overall Study|Additional dental work needed|1|||
44229310|NCT03219034|79037076|FG001|Overall Study|Additional dental work needed|0|||
44492551|NCT00421733|79498360|FG002|Overall Study|Sponsor request|3|||
44492552|NCT00421733|79498358|FG000|Overall Study|Protocol deviation|4|||
44492553|NCT00421733|79498359|FG001|Overall Study|Protocol deviation|7|||
44492554|NCT00421733|79498360|FG002|Overall Study|Protocol deviation|2|||
44492555|NCT00421343|79498372|FG000|Overall Study|Death|1|||
44492556|NCT00421343|79498372|FG000|Overall Study|Withdrawal by Subject|2|||
44492557|NCT00421343|79498372|FG000|Overall Study|Lost to Follow-up|3|||
44492558|NCT00230178|79498379|FG000|Overall Study|Adverse Event|1|||
44492559|NCT00230178|79498380|FG001|Overall Study|Adverse Event|5|||
44229311|NCT03219034|79037075|FG000|Overall Study|UPPP Surgery|1|||
44229312|NCT03219034|79037076|FG001|Overall Study|UPPP Surgery|0|||
44229313|NCT03219034|79037075|FG000|Overall Study|Dental sensitivity|0|||
44229314|NCT03219034|79037076|FG001|Overall Study|Dental sensitivity|1|||
44229315|NCT03219034|79037075|FG000|Overall Study|Death in family|0|||
44229316|NCT03219034|79037076|FG001|Overall Study|Death in family|1|||
44229317|NCT01706198|79037100|FG000|Overall Study|Adverse Event|12|||
44229318|NCT01706198|79037101|FG001|Overall Study|Adverse Event|15|||
44229319|NCT01706198|79037100|FG000|Overall Study|Protocol Violation|7|||
44229320|NCT01706198|79037101|FG001|Overall Study|Protocol Violation|5|||
44229321|NCT01706198|79037100|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
44229322|NCT01706198|79037101|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
44229323|NCT01706198|79037100|FG000|Overall Study|Lost to Follow-up|97|||
44492560|NCT00230178|79498381|FG002|Overall Study|Adverse Event|2|||
44229324|NCT01706198|79037101|FG001|Overall Study|Lost to Follow-up|93|||
44492561|NCT00230178|79498379|FG000|Overall Study|Withdrawal by Subject|0|||
44492562|NCT00230178|79498380|FG001|Overall Study|Withdrawal by Subject|0|||
44545929|NCT03466099|79559858|FG001|Overall Study|Worsening disease|0|||
44545930|NCT03466099|79559859|FG002|Overall Study|Worsening disease|1|||
44545931|NCT00739674|79559869|FG000|Overall Study|Screening failures|19|||
44545932|NCT00739674|79559870|FG001|Overall Study|Screening failures|17|||
44545933|NCT00739674|79559869|FG000|Overall Study|Site 212 removal|19|||
44545934|NCT00739674|79559870|FG001|Overall Study|Site 212 removal|13|||
44545935|NCT00739674|79559869|FG000|Overall Study|No follow-up data|33|||
44545936|NCT00739674|79559870|FG001|Overall Study|No follow-up data|18|||
44545937|NCT00739674|79559869|FG000|Overall Study|Dietician consultation >30 days|1|||
44545938|NCT00739674|79559870|FG001|Overall Study|Dietician consultation >30 days|9|||
44545939|NCT00739674|79559869|FG000|Overall Study|Adverse Event|22|||
44545940|NCT00739674|79559870|FG001|Overall Study|Adverse Event|13|||
44545941|NCT00739674|79559869|FG000|Overall Study|Death|1|||
44545942|NCT00739674|79559870|FG001|Overall Study|Death|0|||
44545943|NCT00739674|79559869|FG000|Overall Study|Lack of Efficacy|1|||
44545944|NCT00739674|79559870|FG001|Overall Study|Lack of Efficacy|0|||
44545945|NCT00739674|79559869|FG000|Overall Study|Lost to Follow-up|52|||
44545946|NCT00739674|79559870|FG001|Overall Study|Lost to Follow-up|30|||
44545947|NCT00739674|79559869|FG000|Overall Study|Protocol Violation|5|||
44545948|NCT00739674|79559870|FG001|Overall Study|Protocol Violation|5|||
44545949|NCT00739674|79559869|FG000|Overall Study|Withdrawal by Subject|9|||
44545950|NCT00739674|79559870|FG001|Overall Study|Withdrawal by Subject|9|||
44545951|NCT00739674|79559869|FG000|Overall Study|Reason missing|2|||
44545952|NCT00739674|79559870|FG001|Overall Study|Reason missing|0|||
44545953|NCT00739674|79559869|FG000|Overall Study|Clinic closed|6|||
44545954|NCT00739674|79559870|FG001|Overall Study|Clinic closed|4|||
44545955|NCT00739674|79559869|FG000|Overall Study|Patient moved|3|||
44545956|NCT00739674|79559870|FG001|Overall Study|Patient moved|2|||
44545957|NCT00739674|79559869|FG000|Overall Study|Non compliant|4|||
44545958|NCT00739674|79559870|FG001|Overall Study|Non compliant|0|||
44545959|NCT00739674|79559869|FG000|Overall Study|Unable to attend visit|3|||
44545960|NCT00739674|79559870|FG001|Overall Study|Unable to attend visit|1|||
44545961|NCT00739674|79559869|FG000|Overall Study|Home monitoring off meds|1|||
44545962|NCT00739674|79559870|FG001|Overall Study|Home monitoring off meds|0|||
44545963|NCT00739674|79559869|FG000|Overall Study|Erectile dysfunction|0|||
44545964|NCT00739674|79559870|FG001|Overall Study|Erectile dysfunction|1|||
44545965|NCT03494725|79559878|FG000|Overall Study|Withdrawal by Subject|0|||
44545966|NCT03494725|79559879|FG001|Overall Study|Withdrawal by Subject|2|||
44545967|NCT03494725|79559878|FG000|Overall Study|Antibiotic use|1|||
44545968|NCT03494725|79559879|FG001|Overall Study|Antibiotic use|0|||
44545969|NCT00705718|79559893|FG000|Overall Study|Death|6|||
44545970|NCT00705718|79559894|FG001|Overall Study|Death|6|||
44545971|NCT00705718|79559893|FG000|Overall Study|Not due for Visit|0|||
44545972|NCT00705718|79559894|FG001|Overall Study|Not due for Visit|12|||
44545973|NCT00705718|79559893|FG000|Overall Study|Follow up not done|1|||
44545974|NCT00705718|79559894|FG001|Overall Study|Follow up not done|4|||
44545975|NCT03435211|79559900|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
44545976|NCT03465709|79559913|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
44545977|NCT03465709|79559913|FG000|Overall Study|Withdrawal by Subject|3|||
44545978|NCT03435055|79559919|FG000|Screening|Physician Decision|2|||
44545979|NCT03435055|79559919|FG000|Received Intervention|Did not complete nitrous administration|3|||
44545980|NCT03434977|79559932|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
44545981|NCT03434977|79559933|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
44545982|NCT03434119|79559941|FG000|Overall Study|Randomized but not treated|1|||
44545983|NCT03434119|79559942|FG001|Overall Study|Randomized but not treated|0|||
44545984|NCT03434119|79559941|FG000|Overall Study|Adverse Event|1|||
44545985|NCT03434119|79559942|FG001|Overall Study|Adverse Event|0|||
44545986|NCT03434119|79559941|FG000|Overall Study|Poor Compliance to Protocol|0|||
44545987|NCT03434119|79559942|FG001|Overall Study|Poor Compliance to Protocol|1|||
44545988|NCT03434119|79559941|FG000|Overall Study|Study Terminated by Sponsor|91|||
44545989|NCT03434119|79559942|FG001|Overall Study|Study Terminated by Sponsor|102|||
44545990|NCT03434119|79559941|FG000|Overall Study|Withdrawal by Subject|7|||
44545991|NCT03434119|79559942|FG001|Overall Study|Withdrawal by Subject|5|||
44545992|NCT03434119|79559941|FG000|Overall Study|Other than specified|7|||
44545993|NCT03434119|79559942|FG001|Overall Study|Other than specified|5|||
44545994|NCT00378378|79559951|FG000|Overall Study|Withdrawal by Subject|0|||
44545995|NCT00378378|79559952|FG001|Overall Study|Withdrawal by Subject|1|||
44545996|NCT00378378|79559953|FG002|Overall Study|Withdrawal by Subject|0|||
44545997|NCT00378378|79559951|FG000|Overall Study|Treatment Failure|0|||
44545998|NCT00378378|79559952|FG001|Overall Study|Treatment Failure|0|||
44545999|NCT00378378|79559953|FG002|Overall Study|Treatment Failure|1|||
44546000|NCT00378378|79559951|FG000|Overall Study|Non-compliance with protocol|0|||
44546001|NCT00378378|79559952|FG001|Overall Study|Non-compliance with protocol|0|||
44546002|NCT00378378|79559953|FG002|Overall Study|Non-compliance with protocol|1|||
44546003|NCT03490981|79559963|FG000|Overall Study|Lost to Follow-up|1|||
44546004|NCT03490981|79559964|FG001|Overall Study|Lost to Follow-up|2|||
44546005|NCT03160716|79559970|FG000|Overall Study|Lost to Follow-up|1|||
44546006|NCT03713021|79559974|FG000|Overall Study|Did not have CT sim scan available|6|||
44546007|NCT03713021|79559974|FG000|Overall Study|Not eligible|4|||
44546008|NCT03713021|79559974|FG000|Overall Study|Issues with TraceIT markers|5|||
44546009|NCT03160560|79559982|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
44546010|NCT03160560|79559983|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44546011|NCT03160560|79559984|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44546012|NCT03160560|79559985|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
44546013|NCT03160560|79559982|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
44546014|NCT03160560|79559983|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
44546015|NCT03160560|79559984|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
44546016|NCT03160560|79559985|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
44546017|NCT03489343|79560002|FG000|Overall Study|Documented progressive disease|1|||
44546018|NCT03489343|79560003|FG001|Overall Study|Documented progressive disease|0|||
44546019|NCT03489343|79560004|FG002|Overall Study|Documented progressive disease|3|||
44546020|NCT03489343|79560005|FG003|Overall Study|Documented progressive disease|1|||
44546021|NCT03489343|79560006|FG004|Overall Study|Documented progressive disease|3|||
44546022|NCT03489343|79560007|FG005|Overall Study|Documented progressive disease|5|||
44546023|NCT03489343|79560008|FG006|Overall Study|Documented progressive disease|4|||
44546024|NCT03489343|79560002|FG000|Overall Study|Adverse Event|0|||
44546025|NCT03489343|79560003|FG001|Overall Study|Adverse Event|1|||
44546026|NCT03489343|79560004|FG002|Overall Study|Adverse Event|0|||
44546027|NCT03489343|79560005|FG003|Overall Study|Adverse Event|0|||
44546028|NCT03489343|79560006|FG004|Overall Study|Adverse Event|0|||
44546029|NCT03489343|79560007|FG005|Overall Study|Adverse Event|1|||
44546030|NCT03489343|79560008|FG006|Overall Study|Adverse Event|0|||
44229325|NCT01706198|79037100|FG000|Overall Study|Physician Decision|23|||
44229326|NCT01706198|79037101|FG001|Overall Study|Physician Decision|37|||
44229327|NCT01706198|79037100|FG000|Overall Study|Withdrawal by Subject|23|||
44229328|NCT01706198|79037101|FG001|Overall Study|Withdrawal by Subject|31|||
44546031|NCT03489343|79560002|FG000|Overall Study|Withdrawal by Subject|0|||
44546032|NCT03489343|79560003|FG001|Overall Study|Withdrawal by Subject|0|||
44546033|NCT03489343|79560004|FG002|Overall Study|Withdrawal by Subject|0|||
44546034|NCT03489343|79560005|FG003|Overall Study|Withdrawal by Subject|1|||
44546035|NCT03489343|79560006|FG004|Overall Study|Withdrawal by Subject|0|||
44546036|NCT03489343|79560007|FG005|Overall Study|Withdrawal by Subject|1|||
44546037|NCT03489343|79560008|FG006|Overall Study|Withdrawal by Subject|1|||
44546038|NCT03489343|79560002|FG000|Overall Study|Clinical progression|0|||
44546039|NCT03489343|79560003|FG001|Overall Study|Clinical progression|0|||
44546040|NCT03489343|79560004|FG002|Overall Study|Clinical progression|0|||
44229329|NCT01705730|79037107|FG000|Overall Study|Lack of Efficacy|1|||
44229330|NCT01705730|79037107|FG000|Overall Study|Adverse Event|3|||
44229331|NCT01705730|79037107|FG000|Overall Study|Lost to Follow-up|1|||
44229332|NCT01705730|79037107|FG000|Overall Study|Reason not Specified|4|||
44546041|NCT03489343|79560005|FG003|Overall Study|Clinical progression|1|||
44229333|NCT01705652|79037113|FG000|Overall Study|Adverse Event|1|||
44229334|NCT01705652|79037114|FG001|Overall Study|Adverse Event|0|||
44229335|NCT01705652|79037113|FG000|Overall Study|Withdrawal by Subject|1|||
44229336|NCT01705652|79037114|FG001|Overall Study|Withdrawal by Subject|2|||
44229337|NCT01705652|79037113|FG000|Overall Study|non-compliance|1|||
44229338|NCT01705652|79037114|FG001|Overall Study|non-compliance|1|||
44229339|NCT01705574|79037142|FG000|Double-Blind Phase|Lost to Follow-up|12|||
44229340|NCT01705574|79037143|FG001|Double-Blind Phase|Lost to Follow-up|16|||
44492563|NCT00230178|79498381|FG002|Overall Study|Withdrawal by Subject|1|||
44492564|NCT00230178|79498379|FG000|Overall Study|Various other reasons|3|||
44492565|NCT00230178|79498380|FG001|Overall Study|Various other reasons|2|||
44492566|NCT00230178|79498381|FG002|Overall Study|Various other reasons|4|||
44492567|NCT00413777|79498391|FG000|Fixed-dose Period|Lost to Follow-up|1|||
44492568|NCT00413777|79498392|FG001|Fixed-dose Period|Lost to Follow-up|1|||
44492569|NCT00413777|79498391|FG000|Fixed-dose Period|Adverse Event|2|||
44492570|NCT00413777|79498392|FG001|Fixed-dose Period|Adverse Event|1|||
44492571|NCT00413777|79498391|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
44492572|NCT00413777|79498392|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
44492573|NCT00413777|79498391|FG000|Fixed-dose Period|Withdrew Consent|0|||
44492574|NCT00413777|79498392|FG001|Fixed-dose Period|Withdrew Consent|1|||
44492575|NCT00197028|79498400|FG000|Overall Study|Adverse Event|2|||
44492576|NCT00197028|79498401|FG001|Overall Study|Adverse Event|2|||
44492577|NCT00197028|79498400|FG000|Overall Study|Protocol Violation|2|||
44492578|NCT00197028|79498401|FG001|Overall Study|Protocol Violation|1|||
44492579|NCT00197028|79498400|FG000|Overall Study|Withdrawal by Subject|8|||
44492580|NCT00197028|79498401|FG001|Overall Study|Withdrawal by Subject|12|||
44492581|NCT00197028|79498400|FG000|Overall Study|Lost to Follow-up|1|||
44492582|NCT00197028|79498401|FG001|Overall Study|Lost to Follow-up|0|||
44492583|NCT00197028|79498400|FG000|Overall Study|Other|3|||
44546042|NCT03489343|79560006|FG004|Overall Study|Clinical progression|0|||
44492584|NCT00197028|79498401|FG001|Overall Study|Other|6|||
44546043|NCT03489343|79560007|FG005|Overall Study|Clinical progression|0|||
44546044|NCT03489343|79560008|FG006|Overall Study|Clinical progression|1|||
44546045|NCT03489109|79560026|FG000|Overall Study|Lost to Follow-up|1|||
44229341|NCT01705574|79037144|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44229342|NCT01705574|79037145|FG003|Double-Blind Phase|Lost to Follow-up|0|||
44229343|NCT01705574|79037142|FG000|Double-Blind Phase|Adverse Event|3|||
44229344|NCT01705574|79037143|FG001|Double-Blind Phase|Adverse Event|10|||
44229345|NCT01705574|79037144|FG002|Double-Blind Phase|Adverse Event|0|||
44229346|NCT01705574|79037145|FG003|Double-Blind Phase|Adverse Event|0|||
44229347|NCT01705574|79037142|FG000|Double-Blind Phase|Withdrew Consent|8|||
44229348|NCT01705574|79037143|FG001|Double-Blind Phase|Withdrew Consent|5|||
44229349|NCT01705574|79037144|FG002|Double-Blind Phase|Withdrew Consent|0|||
44229350|NCT01705574|79037145|FG003|Double-Blind Phase|Withdrew Consent|0|||
44229351|NCT01705574|79037142|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
44229352|NCT01705574|79037143|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
44229353|NCT01705574|79037144|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
44229354|NCT01705574|79037145|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
44229355|NCT01705574|79037142|FG000|Double-Blind Phase|Pregnancy|1|||
44229356|NCT01705574|79037143|FG001|Double-Blind Phase|Pregnancy|1|||
44229357|NCT01705574|79037144|FG002|Double-Blind Phase|Pregnancy|0|||
44229358|NCT01705574|79037145|FG003|Double-Blind Phase|Pregnancy|0|||
44229359|NCT01705574|79037142|FG000|Double-Blind Phase|Protocol Violation|1|||
44229360|NCT01705574|79037143|FG001|Double-Blind Phase|Protocol Violation|0|||
44546046|NCT03489109|79560027|FG001|Overall Study|Lost to Follow-up|2|||
44546047|NCT03709823|79560039|FG000|Overall Study|Adverse Event|0|||
44546048|NCT03709823|79560040|FG001|Overall Study|Adverse Event|0|||
44546049|NCT03709823|79560041|FG002|Overall Study|Adverse Event|1|||
44546050|NCT03709823|79560042|FG003|Overall Study|Adverse Event|0|||
44546051|NCT03709823|79560043|FG004|Overall Study|Adverse Event|0|||
44546052|NCT03709823|79560044|FG005|Overall Study|Adverse Event|0|||
44546053|NCT03709823|79560039|FG000|Overall Study|Lost to Follow-up|2|||
44546054|NCT03709823|79560040|FG001|Overall Study|Lost to Follow-up|2|||
44546055|NCT03709823|79560041|FG002|Overall Study|Lost to Follow-up|2|||
44546056|NCT03709823|79560042|FG003|Overall Study|Lost to Follow-up|1|||
44546057|NCT03709823|79560043|FG004|Overall Study|Lost to Follow-up|1|||
44546058|NCT03709823|79560044|FG005|Overall Study|Lost to Follow-up|0|||
44546059|NCT03709823|79560039|FG000|Overall Study|Withdrawal by Subject|1|||
44546060|NCT03709823|79560040|FG001|Overall Study|Withdrawal by Subject|3|||
44546061|NCT03709823|79560041|FG002|Overall Study|Withdrawal by Subject|0|||
44546062|NCT03709823|79560042|FG003|Overall Study|Withdrawal by Subject|0|||
44546063|NCT03709823|79560043|FG004|Overall Study|Withdrawal by Subject|0|||
44229361|NCT01705574|79037144|FG002|Double-Blind Phase|Protocol Violation|0|||
44229362|NCT01705574|79037145|FG003|Double-Blind Phase|Protocol Violation|0|||
44229363|NCT01705574|79037142|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
44229364|NCT01705574|79037143|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
44229365|NCT01705574|79037144|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
44229366|NCT01705574|79037145|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
44229367|NCT01705574|79037142|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
44229368|NCT01705574|79037143|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
44229369|NCT01705574|79037144|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
44229370|NCT01705574|79037145|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
44229371|NCT01705574|79037142|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
44229372|NCT01705574|79037143|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
44229373|NCT01705574|79037144|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
44546064|NCT03709823|79560044|FG005|Overall Study|Withdrawal by Subject|0|||
44546065|NCT03709823|79560039|FG000|Overall Study|Other, Not Specified|0|||
44546066|NCT03709823|79560040|FG001|Overall Study|Other, Not Specified|0|||
44546067|NCT03709823|79560041|FG002|Overall Study|Other, Not Specified|0|||
44546068|NCT03709823|79560042|FG003|Overall Study|Other, Not Specified|1|||
44546069|NCT03709823|79560043|FG004|Overall Study|Other, Not Specified|0|||
44546070|NCT03709823|79560044|FG005|Overall Study|Other, Not Specified|0|||
44546071|NCT03488563|79560064|FG000|Overall Study|Lost to Follow-up|7|||
44546072|NCT03488563|79560065|FG001|Overall Study|Lost to Follow-up|6|||
44546073|NCT03488563|79560066|FG002|Overall Study|Lost to Follow-up|7|||
44546074|NCT03488563|79560064|FG000|Overall Study|Withdrawal by Subject|8|||
44546075|NCT03488563|79560065|FG001|Overall Study|Withdrawal by Subject|7|||
44546076|NCT03488563|79560066|FG002|Overall Study|Withdrawal by Subject|7|||
44546077|NCT03488563|79560064|FG000|Overall Study|Physician Decision|0|||
44274449|NCT02252406|79220161|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
44274450|NCT02252406|79220160|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
44274451|NCT02252406|79220161|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
44274452|NCT02252406|79220160|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
44274453|NCT02252406|79220161|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
44274454|NCT02252406|79220160|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
44492585|NCT00420641|79498410|FG000|Overall Study|Adverse Event|3|||
44492586|NCT00420641|79498411|FG001|Overall Study|Adverse Event|25|||
44546078|NCT03488563|79560065|FG001|Overall Study|Physician Decision|0|||
44546079|NCT03488563|79560066|FG002|Overall Study|Physician Decision|1|||
44546080|NCT03488563|79560064|FG000|Overall Study|Protocol Violation|3|||
44546081|NCT03488563|79560065|FG001|Overall Study|Protocol Violation|2|||
44546082|NCT03488563|79560066|FG002|Overall Study|Protocol Violation|6|||
44546083|NCT03488563|79560064|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
44546084|NCT03488563|79560065|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
44546085|NCT03488563|79560066|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
44546086|NCT03488563|79560064|FG000|Overall Study|Use of prohibited medication|2|||
44546087|NCT03488563|79560065|FG001|Overall Study|Use of prohibited medication|0|||
44546088|NCT03488563|79560066|FG002|Overall Study|Use of prohibited medication|0|||
44492587|NCT00420641|79498412|FG002|Overall Study|Adverse Event|10|||
44492588|NCT00420641|79498410|FG000|Overall Study|Lost to Follow-up|2|||
44492589|NCT00420641|79498411|FG001|Overall Study|Lost to Follow-up|4|||
44492590|NCT00420641|79498412|FG002|Overall Study|Lost to Follow-up|2|||
44492591|NCT00420641|79498410|FG000|Overall Study|Protocol Violation|8|||
44492592|NCT00420641|79498411|FG001|Overall Study|Protocol Violation|8|||
44492593|NCT00420641|79498412|FG002|Overall Study|Protocol Violation|7|||
44492594|NCT00420641|79498410|FG000|Overall Study|Withdrawal by Subject|15|||
44492595|NCT00420641|79498411|FG001|Overall Study|Withdrawal by Subject|21|||
44492596|NCT00420641|79498412|FG002|Overall Study|Withdrawal by Subject|14|||
44492597|NCT00420641|79498410|FG000|Overall Study|Lack of Efficacy|6|||
44492598|NCT00420641|79498411|FG001|Overall Study|Lack of Efficacy|5|||
44492599|NCT00420641|79498412|FG002|Overall Study|Lack of Efficacy|4|||
44492600|NCT00420641|79498410|FG000|Overall Study|Non-compliance|7|||
44492601|NCT00420641|79498411|FG001|Overall Study|Non-compliance|5|||
44492602|NCT00420641|79498412|FG002|Overall Study|Non-compliance|4|||
44546089|NCT03488563|79560064|FG000|Overall Study|Adverse Event|1|||
44274455|NCT02252406|79220161|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
44492603|NCT00420641|79498410|FG000|Overall Study|Other|4|||
44492604|NCT00420641|79498411|FG001|Overall Study|Other|4|||
44546090|NCT03488563|79560065|FG001|Overall Study|Adverse Event|0|||
44546091|NCT03488563|79560066|FG002|Overall Study|Adverse Event|1|||
44546092|NCT03488563|79560064|FG000|Overall Study|Subject returned for ET visit|0|||
44546093|NCT03488563|79560065|FG001|Overall Study|Subject returned for ET visit|1|||
44546094|NCT03488563|79560066|FG002|Overall Study|Subject returned for ET visit|0|||
44546095|NCT03488563|79560064|FG000|Overall Study|Sponsor's decision|0|||
44492605|NCT00420641|79498412|FG002|Overall Study|Other|3|||
44546096|NCT03488563|79560065|FG001|Overall Study|Sponsor's decision|0|||
44546097|NCT03488563|79560066|FG002|Overall Study|Sponsor's decision|1|||
44546098|NCT00706030|79560080|FG000|Overall Study|Disease Progression|4|||
44546099|NCT00706030|79560081|FG001|Overall Study|Disease Progression|6|||
44546100|NCT00706030|79560082|FG002|Overall Study|Disease Progression|46|||
44546101|NCT00706030|79560083|FG003|Overall Study|Disease Progression|12|||
44546102|NCT00706030|79560080|FG000|Overall Study|Adverse Event|1|||
44274456|NCT02246478|79220171|FG000|Multiple-dose Phase|Protocol Violation|1|||
44274457|NCT02246478|79220172|FG001|Multiple-dose Phase|Protocol Violation|0|||
44274458|NCT02246478|79220173|FG002|Multiple-dose Phase|Protocol Violation|0|||
44274459|NCT02246478|79220174|FG003|Multiple-dose Phase|Protocol Violation|1|||
44274460|NCT02252016|79220193|FG000|Overall Study|Lost to Follow-up|2|||
44274461|NCT02252016|79220194|FG001|Overall Study|Lost to Follow-up|1|||
44546103|NCT00706030|79560081|FG001|Overall Study|Adverse Event|0|||
44546104|NCT00706030|79560082|FG002|Overall Study|Adverse Event|4|||
44546105|NCT00706030|79560083|FG003|Overall Study|Adverse Event|2|||
44546106|NCT00706030|79560080|FG000|Overall Study|Withdrawal by Subject|1|||
44274462|NCT02252016|79220193|FG000|Overall Study|Physician Decision|1|||
44274463|NCT02252016|79220194|FG001|Overall Study|Physician Decision|0|||
44274464|NCT02252016|79220193|FG000|Overall Study|Withdrawal by Subject|0|||
44274465|NCT02252016|79220194|FG001|Overall Study|Withdrawal by Subject|2|||
44274466|NCT02249832|79220200|FG000|Overall Study|Withdrawal by Subject|3|||
44274467|NCT02249832|79220200|FG000|Overall Study|Lost to Follow-up|10|||
44546107|NCT00706030|79560081|FG001|Overall Study|Withdrawal by Subject|0|||
44546108|NCT00706030|79560082|FG002|Overall Study|Withdrawal by Subject|2|||
44546109|NCT00706030|79560083|FG003|Overall Study|Withdrawal by Subject|0|||
44546110|NCT00706030|79560080|FG000|Overall Study|Physician Decision|0|||
44546111|NCT00706030|79560081|FG001|Overall Study|Physician Decision|0|||
44546112|NCT00706030|79560082|FG002|Overall Study|Physician Decision|2|||
44546113|NCT00706030|79560083|FG003|Overall Study|Physician Decision|0|||
44546114|NCT00706030|79560080|FG000|Overall Study|Not recorded|0|||
44546115|NCT00706030|79560081|FG001|Overall Study|Not recorded|0|||
44546116|NCT00706030|79560082|FG002|Overall Study|Not recorded|2|||
44546117|NCT00706030|79560083|FG003|Overall Study|Not recorded|0|||
44546118|NCT00706030|79560080|FG000|Overall Study|Protocol Violation|0|||
44546119|NCT00706030|79560081|FG001|Overall Study|Protocol Violation|0|||
44546120|NCT00706030|79560082|FG002|Overall Study|Protocol Violation|1|||
44229374|NCT01705574|79037145|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
44229375|NCT01705574|79037142|FG000|Open-Label Extension Phase|Adverse Event|3|||
44229376|NCT01705574|79037143|FG001|Open-Label Extension Phase|Adverse Event|0|||
44274468|NCT02248974|79220211|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
44274469|NCT02248974|79220212|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
44274470|NCT02248974|79220211|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
44274471|NCT02248974|79220212|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
44274472|NCT02248974|79220211|FG000|1-Day Follow-Up|Enrolled in another study|1|||
44274473|NCT02248974|79220212|FG001|1-Day Follow-Up|Enrolled in another study|0|||
44274474|NCT02248974|79220211|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
44274475|NCT02248974|79220212|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
44274476|NCT02248974|79220211|FG000|1-Week Follow-Up|Enrolled in another study|1|||
44274477|NCT02248974|79220212|FG001|1-Week Follow-Up|Enrolled in another study|1|||
44274478|NCT02248974|79220211|FG000|1-Week Follow-Up|Transferred to another facility|1|||
44274479|NCT02248974|79220212|FG001|1-Week Follow-Up|Transferred to another facility|0|||
44274480|NCT02248974|79220211|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
44546121|NCT00706030|79560083|FG003|Overall Study|Protocol Violation|1|||
44229377|NCT01705574|79037144|FG002|Open-Label Extension Phase|Adverse Event|0|||
44229378|NCT01705574|79037145|FG003|Open-Label Extension Phase|Adverse Event|1|||
44229379|NCT01705574|79037142|FG000|Open-Label Extension Phase|Death|2|||
44229380|NCT01705574|79037143|FG001|Open-Label Extension Phase|Death|0|||
44229381|NCT01705574|79037144|FG002|Open-Label Extension Phase|Death|1|||
44229382|NCT01705574|79037145|FG003|Open-Label Extension Phase|Death|0|||
44229383|NCT01705574|79037142|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
44229384|NCT01705574|79037143|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
44546122|NCT00706030|79560080|FG000|Overall Study|Failed to return|0|||
44229385|NCT01705574|79037144|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
44229386|NCT01705574|79037145|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
44229387|NCT01705574|79037142|FG000|Open-Label Extension Phase|Physician Decision|0|||
44229388|NCT01705574|79037143|FG001|Open-Label Extension Phase|Physician Decision|0|||
44229389|NCT01705574|79037144|FG002|Open-Label Extension Phase|Physician Decision|2|||
44274481|NCT02248974|79220212|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
44274482|NCT02248974|79220211|FG000|1-Week Follow-Up|Death|1|||
44546123|NCT00706030|79560081|FG001|Overall Study|Failed to return|0|||
44546124|NCT00706030|79560082|FG002|Overall Study|Failed to return|1|||
44546125|NCT00706030|79560083|FG003|Overall Study|Failed to return|0|||
44546126|NCT00706030|79560080|FG000|Overall Study|Symptomatic Deterioration|0|||
44546127|NCT00706030|79560081|FG001|Overall Study|Symptomatic Deterioration|0|||
44546128|NCT00706030|79560082|FG002|Overall Study|Symptomatic Deterioration|1|||
44546129|NCT00706030|79560083|FG003|Overall Study|Symptomatic Deterioration|0|||
44546130|NCT00706030|79560080|FG000|Overall Study|No treatment received|0|||
44546131|NCT00706030|79560081|FG001|Overall Study|No treatment received|0|||
44546132|NCT00706030|79560082|FG002|Overall Study|No treatment received|0|||
44546133|NCT00706030|79560083|FG003|Overall Study|No treatment received|1|||
44546134|NCT00706030|79560080|FG000|Overall Study|Death|0|||
44546135|NCT00706030|79560081|FG001|Overall Study|Death|0|||
44546136|NCT00706030|79560082|FG002|Overall Study|Death|1|||
44546137|NCT00706030|79560083|FG003|Overall Study|Death|0|||
44546138|NCT03488251|79560098|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
44546139|NCT03488251|79560099|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
44546140|NCT03488251|79560100|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
44546141|NCT03488251|79560101|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
44546142|NCT03488251|79560098|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
44546143|NCT03488251|79560099|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
44546144|NCT03488251|79560100|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
44546145|NCT03488251|79560101|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
44546146|NCT03488251|79560098|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
44546147|NCT03488251|79560099|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
44546148|NCT03488251|79560100|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
44546149|NCT03488251|79560101|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
44546150|NCT03488251|79560098|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
44546151|NCT03488251|79560099|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
44546152|NCT03488251|79560100|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
44546153|NCT03488251|79560101|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
44546154|NCT03488251|79560098|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
44546155|NCT03488251|79560099|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
44546156|NCT03488251|79560100|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
44546157|NCT03488251|79560101|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
44546158|NCT02727322|79560114|FG000|Overall Study|Withdrawal by Subject|1|||
44546159|NCT02727322|79560115|FG001|Overall Study|Withdrawal by Subject|1|||
44546160|NCT02727322|79560114|FG000|Overall Study|Protocol Violation|1|||
44546161|NCT02727322|79560115|FG001|Overall Study|Protocol Violation|0|||
44546162|NCT03431857|79560125|FG000|Overall Study|Death|6|||
44546163|NCT03431857|79560125|FG000|Overall Study|Lost to Follow-up|41|||
44546164|NCT03431857|79560125|FG000|Overall Study|Adverse Event|6|||
44546165|NCT03431857|79560125|FG000|Overall Study|Withdrawal by Subject|1|||
44546166|NCT03487549|79560131|FG000|Overall Study|Protocol Violation|0|||
44546167|NCT03487549|79560132|FG001|Overall Study|Protocol Violation|1|||
44546168|NCT03487549|79560131|FG000|Overall Study|Lost to Follow-up|2|||
44546169|NCT03487549|79560132|FG001|Overall Study|Lost to Follow-up|1|||
44546170|NCT03487549|79560131|FG000|Overall Study|Withdrawal by Subject|2|||
44546171|NCT03487549|79560132|FG001|Overall Study|Withdrawal by Subject|0|||
44546172|NCT03464383|79560141|FG000|Overall Study|Lost to Follow-up|1|||
44546173|NCT03464383|79560142|FG001|Overall Study|Lost to Follow-up|0|||
44546174|NCT03464383|79560143|FG002|Overall Study|Lost to Follow-up|0|||
44546175|NCT03464383|79560141|FG000|Overall Study|Withdrawal by Subject|0|||
44546176|NCT03464383|79560142|FG001|Overall Study|Withdrawal by Subject|1|||
44546177|NCT03464383|79560143|FG002|Overall Study|Withdrawal by Subject|0|||
44229390|NCT01705574|79037145|FG003|Open-Label Extension Phase|Physician Decision|0|||
44229391|NCT01705574|79037142|FG000|Open-Label Extension Phase|Pregnancy|0|||
44229392|NCT01705574|79037143|FG001|Open-Label Extension Phase|Pregnancy|0|||
44229393|NCT01705574|79037144|FG002|Open-Label Extension Phase|Pregnancy|1|||
44229394|NCT01705574|79037145|FG003|Open-Label Extension Phase|Pregnancy|1|||
44229395|NCT01737710|79037166|FG000|Overall Study|Lost to Follow-up|0|||
44229396|NCT01737710|79037167|FG001|Overall Study|Lost to Follow-up|2|||
44229397|NCT01737710|79037168|FG002|Overall Study|Lost to Follow-up|2|||
44229398|NCT01737710|79037169|FG003|Overall Study|Lost to Follow-up|0|||
44229399|NCT01737710|79037170|FG004|Overall Study|Lost to Follow-up|0|||
44229400|NCT01737710|79037166|FG000|Overall Study|Withdrawal by Subject|1|||
44229401|NCT01737710|79037167|FG001|Overall Study|Withdrawal by Subject|1|||
44229402|NCT01737710|79037168|FG002|Overall Study|Withdrawal by Subject|1|||
44229403|NCT01737710|79037169|FG003|Overall Study|Withdrawal by Subject|0|||
44229404|NCT01737710|79037170|FG004|Overall Study|Withdrawal by Subject|0|||
44229405|NCT01737710|79037166|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
44229406|NCT01737710|79037167|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
44546178|NCT01444092|79560152|FG000|Overall Study|Adverse Event|8|||
44546179|NCT01444092|79560152|FG000|Overall Study|Protocol Violation|1|||
44229407|NCT01737710|79037168|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
44546180|NCT01444092|79560152|FG000|Overall Study|Withdrawal by Subject|1|||
44546181|NCT01444092|79560152|FG000|Overall Study|Other Eligibility criteria|7|||
44546182|NCT01265784|79560159|FG000|Overall Study|Lost to Follow-up|5|||
44229408|NCT01737710|79037169|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
44229409|NCT01737710|79037170|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
44229410|NCT01682876|79037185|FG000|Overall Study|Administrative reason|4|||
44229411|NCT01682876|79037186|FG001|Overall Study|Administrative reason|4|||
44229412|NCT01682876|79037187|FG002|Overall Study|Administrative reason|0|||
44229413|NCT01682876|79037188|FG003|Overall Study|Administrative reason|3|||
44274483|NCT02248974|79220212|FG001|1-Week Follow-Up|Death|1|||
44274484|NCT02248974|79220211|FG000|1-Week Follow-Up|Excluded because of age|0|||
44274485|NCT02248974|79220212|FG001|1-Week Follow-Up|Excluded because of age|1|||
44274486|NCT02248974|79220211|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
44492606|NCT00257556|79498422|FG000|Overall Study|Adverse Event|1|||
44492607|NCT00257556|79498423|FG001|Overall Study|Adverse Event|4|||
44492608|NCT00257556|79498422|FG000|Overall Study|Physician Decision|6|||
44492609|NCT00257556|79498423|FG001|Overall Study|Physician Decision|0|||
44492610|NCT00257556|79498422|FG000|Overall Study|Did not meet hCG criterion|3|||
44492611|NCT00257556|79498423|FG001|Overall Study|Did not meet hCG criterion|0|||
44492612|NCT00257556|79498422|FG000|Overall Study|other reason|4|||
44492613|NCT00257556|79498423|FG001|Overall Study|other reason|6|||
44492614|NCT00228384|79498431|FG000|Overall Study|Death|9|||
44492615|NCT00228384|79498432|FG001|Overall Study|Death|3|||
44492616|NCT00228384|79498431|FG000|Overall Study|Lost to Follow-up|6|||
44492617|NCT00228384|79498432|FG001|Overall Study|Lost to Follow-up|10|||
44492618|NCT00228384|79498431|FG000|Overall Study|Surgical Intervention (bypass)|5|||
44492619|NCT00228384|79498432|FG001|Overall Study|Surgical Intervention (bypass)|5|||
44492620|NCT00228384|79498431|FG000|Overall Study|Withdrawal by Subject|9|||
44492621|NCT00228384|79498432|FG001|Overall Study|Withdrawal by Subject|10|||
44492622|NCT00228384|79498431|FG000|Overall Study|Physician Decision|0|||
44229414|NCT01682876|79037185|FG000|Overall Study|Adverse Event|0|||
44229415|NCT01682876|79037186|FG001|Overall Study|Adverse Event|0|||
44229416|NCT01682876|79037187|FG002|Overall Study|Adverse Event|0|||
44229417|NCT01682876|79037188|FG003|Overall Study|Adverse Event|1|||
44229418|NCT01682876|79037185|FG000|Overall Study|Lost to Follow-up|11|||
44229419|NCT01682876|79037186|FG001|Overall Study|Lost to Follow-up|15|||
44229420|NCT01682876|79037187|FG002|Overall Study|Lost to Follow-up|9|||
44229421|NCT01682876|79037188|FG003|Overall Study|Lost to Follow-up|11|||
44229422|NCT01682876|79037185|FG000|Overall Study|Protocol Violation|1|||
44229423|NCT01682876|79037186|FG001|Overall Study|Protocol Violation|1|||
44229424|NCT01682876|79037187|FG002|Overall Study|Protocol Violation|1|||
44274487|NCT02248974|79220212|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
44274488|NCT02248974|79220211|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
44492623|NCT00228384|79498432|FG001|Overall Study|Physician Decision|1|||
44492624|NCT00257166|79498440|FG000|Overall Study|Adverse Event|18|||
44492625|NCT00257166|79498441|FG001|Overall Study|Adverse Event|13|||
44229425|NCT01682876|79037188|FG003|Overall Study|Protocol Violation|1|||
44229426|NCT01682876|79037185|FG000|Overall Study|Withdrawal by Subject|4|||
44546183|NCT01265784|79560160|FG001|Overall Study|Lost to Follow-up|3|||
44546184|NCT01265784|79560161|FG002|Overall Study|Lost to Follow-up|2|||
44546185|NCT01265784|79560159|FG000|Overall Study|Withdrawal by Subject|0|||
44546186|NCT01265784|79560160|FG001|Overall Study|Withdrawal by Subject|5|||
44546187|NCT01265784|79560161|FG002|Overall Study|Withdrawal by Subject|0|||
44546188|NCT01265784|79560159|FG000|Overall Study|Physician Decision|1|||
44546189|NCT01265784|79560160|FG001|Overall Study|Physician Decision|0|||
44546190|NCT01265784|79560161|FG002|Overall Study|Physician Decision|1|||
44546191|NCT01265784|79560159|FG000|Overall Study|Adverse Event|1|||
44546192|NCT01265784|79560160|FG001|Overall Study|Adverse Event|0|||
44546193|NCT01265784|79560161|FG002|Overall Study|Adverse Event|0|||
44546194|NCT01265784|79560159|FG000|Overall Study|Death|3|||
44546195|NCT01265784|79560160|FG001|Overall Study|Death|0|||
44546196|NCT01265784|79560161|FG002|Overall Study|Death|0|||
44546197|NCT01265784|79560159|FG000|Overall Study|Protocol Violation|2|||
44546198|NCT01265784|79560160|FG001|Overall Study|Protocol Violation|0|||
44546199|NCT01265784|79560161|FG002|Overall Study|Protocol Violation|0|||
44546200|NCT01265784|79560159|FG000|Overall Study|Incorrectly Randomized|0|||
44546201|NCT01265784|79560160|FG001|Overall Study|Incorrectly Randomized|0|||
44546202|NCT01265784|79560161|FG002|Overall Study|Incorrectly Randomized|1|||
44546203|NCT03156504|79560169|FG000|Overall Study|Withdrawal by Subject|1|||
44546204|NCT03159468|79560179|FG000|Overall Study|Withdrawal by Subject|0|||
44546205|NCT03159468|79560180|FG001|Overall Study|Withdrawal by Subject|0|||
44546206|NCT03159468|79560181|FG002|Overall Study|Withdrawal by Subject|3|||
44546207|NCT03159468|79560182|FG003|Overall Study|Withdrawal by Subject|0|||
44546208|NCT03159468|79560183|FG004|Overall Study|Withdrawal by Subject|0|||
44546209|NCT03159468|79560184|FG005|Overall Study|Withdrawal by Subject|0|||
44546210|NCT03430063|79560201|FG000|Overall Study|Adverse Event|0|||
44229427|NCT01682876|79037186|FG001|Overall Study|Withdrawal by Subject|0|||
44229428|NCT01682876|79037187|FG002|Overall Study|Withdrawal by Subject|0|||
44546211|NCT03430063|79560202|FG001|Overall Study|Adverse Event|1|||
44546212|NCT03430063|79560203|FG002|Overall Study|Adverse Event|0|||
44546213|NCT03430063|79560201|FG000|Overall Study|Death|3|||
44546214|NCT03430063|79560202|FG001|Overall Study|Death|2|||
44546215|NCT03430063|79560203|FG002|Overall Study|Death|3|||
44546216|NCT03430063|79560201|FG000|Overall Study|Lost to Follow-up|0|||
44546217|NCT03430063|79560202|FG001|Overall Study|Lost to Follow-up|1|||
44546218|NCT03430063|79560203|FG002|Overall Study|Lost to Follow-up|0|||
44546219|NCT03430063|79560201|FG000|Overall Study|Withdrawal by Subject|0|||
44546220|NCT03430063|79560202|FG001|Overall Study|Withdrawal by Subject|0|||
44546221|NCT03430063|79560203|FG002|Overall Study|Withdrawal by Subject|1|||
44546222|NCT03430063|79560201|FG000|Overall Study|Withdrawal of consent|3|||
44546223|NCT03430063|79560202|FG001|Overall Study|Withdrawal of consent|1|||
44546224|NCT03430063|79560203|FG002|Overall Study|Withdrawal of consent|2|||
44546225|NCT03430063|79560201|FG000|Overall Study|Progressive disease|1|||
44546226|NCT03430063|79560202|FG001|Overall Study|Progressive disease|2|||
44229429|NCT01682876|79037188|FG003|Overall Study|Withdrawal by Subject|2|||
44229430|NCT01682876|79037185|FG000|Overall Study|Other|1|||
44229431|NCT01682876|79037186|FG001|Overall Study|Other|0|||
44229432|NCT01682876|79037187|FG002|Overall Study|Other|1|||
44229433|NCT01682876|79037188|FG003|Overall Study|Other|1|||
44229434|NCT01682720|79037205|FG000|Overall Study|Randomized but Not Treated|0|||
44229435|NCT01682720|79037206|FG001|Overall Study|Randomized but Not Treated|1|||
44229436|NCT01682720|79037207|FG002|Overall Study|Randomized but Not Treated|1|||
44546227|NCT03430063|79560203|FG002|Overall Study|Progressive disease|1|||
44546228|NCT03430063|79560201|FG000|Overall Study|Other un-specified|1|||
44546229|NCT03430063|79560202|FG001|Overall Study|Other un-specified|1|||
44546230|NCT03430063|79560203|FG002|Overall Study|Other un-specified|0|||
44546231|NCT03430063|79560201|FG000|Overall Study|Randomized, but never treated|0|||
44546232|NCT03430063|79560202|FG001|Overall Study|Randomized, but never treated|0|||
44546233|NCT03430063|79560203|FG002|Overall Study|Randomized, but never treated|1|||
44546234|NCT03158220|79560214|FG000|Overall Study|Screen Failure|0|||
44546235|NCT03158220|79560215|FG001|Overall Study|Screen Failure|1|||
44546236|NCT03158220|79560214|FG000|Overall Study|Withdrawal by Subject|8|||
44546237|NCT03158220|79560215|FG001|Overall Study|Withdrawal by Subject|9|||
44546238|NCT03158220|79560214|FG000|Overall Study|Status unknown|0|||
44546239|NCT03158220|79560215|FG001|Overall Study|Status unknown|1|||
44546240|NCT03158220|79560214|FG000|Overall Study|Lost to Follow-up|8|||
44546241|NCT03158220|79560215|FG001|Overall Study|Lost to Follow-up|5|||
44546242|NCT03158220|79560214|FG000|Overall Study|Physician Decision|1|||
44546243|NCT03158220|79560215|FG001|Overall Study|Physician Decision|0|||
44546244|NCT03156270|79560221|FG000|Overall Study|Failed pre-treatment screening|1|||
44546245|NCT03156270|79560221|FG000|Overall Study|Lost to Follow-up|1|||
44546246|NCT03429049|79560229|FG000|Overall Study|Adverse Event|2|||
44546247|NCT03429049|79560230|FG001|Overall Study|Adverse Event|3|||
44546248|NCT03429049|79560229|FG000|Overall Study|Death|0|||
44546249|NCT03429049|79560230|FG001|Overall Study|Death|1|||
44546250|NCT03429049|79560229|FG000|Overall Study|Lack of Efficacy|4|||
44229437|NCT01682720|79037208|FG003|Overall Study|Randomized but Not Treated|0|||
44229438|NCT01682720|79037205|FG000|Overall Study|Terminated by Sponsor|83|||
44229439|NCT01682720|79037206|FG001|Overall Study|Terminated by Sponsor|0|||
44229440|NCT01682720|79037207|FG002|Overall Study|Terminated by Sponsor|0|||
44492626|NCT00257166|79498440|FG000|Overall Study|Laboratory abnormality|1|||
44492627|NCT00257166|79498441|FG001|Overall Study|Laboratory abnormality|0|||
44492628|NCT00257166|79498440|FG000|Overall Study|Lost to Follow-up|8|||
44492629|NCT00257166|79498441|FG001|Overall Study|Lost to Follow-up|1|||
44492630|NCT00257166|79498440|FG000|Overall Study|Withdrawal by Subject|9|||
44492631|NCT00257166|79498441|FG001|Overall Study|Withdrawal by Subject|2|||
44229441|NCT01682720|79037208|FG003|Overall Study|Terminated by Sponsor|0|||
44229442|NCT01682720|79037205|FG000|Overall Study|Efficacy Failure|0|||
44229443|NCT01682720|79037206|FG001|Overall Study|Efficacy Failure|3|||
44229444|NCT01682720|79037207|FG002|Overall Study|Efficacy Failure|3|||
44229445|NCT01682720|79037208|FG003|Overall Study|Efficacy Failure|30|||
44229446|NCT01682720|79037205|FG000|Overall Study|Lost to Follow-up|1|||
44229447|NCT01682720|79037206|FG001|Overall Study|Lost to Follow-up|1|||
44229448|NCT01682720|79037207|FG002|Overall Study|Lost to Follow-up|0|||
44229449|NCT01682720|79037208|FG003|Overall Study|Lost to Follow-up|6|||
44492632|NCT00257166|79498440|FG000|Overall Study|Other|16|||
44492633|NCT00257166|79498441|FG001|Overall Study|Other|21|||
44492634|NCT00257166|79498440|FG000|Overall Study|Randomized, but not treated|1|||
44492635|NCT00257166|79498441|FG001|Overall Study|Randomized, but not treated|0|||
44492636|NCT00227370|79498449|FG000|Overall Study|Withdrawal by Subject|1|||
44492637|NCT00227370|79498450|FG001|Overall Study|Withdrawal by Subject|2|||
44492638|NCT00227370|79498449|FG000|Overall Study|Death|3|||
44492639|NCT00227370|79498450|FG001|Overall Study|Death|4|||
44492640|NCT00227370|79498449|FG000|Overall Study|Adverse Event|6|||
44492641|NCT00227370|79498450|FG001|Overall Study|Adverse Event|11|||
44492642|NCT00227370|79498449|FG000|Overall Study|Physician Decision|9|||
44492643|NCT00227370|79498450|FG001|Overall Study|Physician Decision|6|||
44492644|NCT00227370|79498449|FG000|Overall Study|Other reasons|2|||
44492645|NCT00227370|79498450|FG001|Overall Study|Other reasons|1|||
44492646|NCT00191100|79498458|FG000|Overall Study|Adverse Event|18|||
44492647|NCT00191100|79498459|FG001|Overall Study|Adverse Event|1|||
44492648|NCT00191100|79498458|FG000|Overall Study|Lost to Follow-up|2|||
44492649|NCT00191100|79498459|FG001|Overall Study|Lost to Follow-up|0|||
44492650|NCT00191100|79498458|FG000|Overall Study|Patient Moved|0|||
44492651|NCT00191100|79498459|FG001|Overall Study|Patient Moved|1|||
44492652|NCT00191100|79498458|FG000|Overall Study|Withdrawal by Subject|9|||
44492653|NCT00191100|79498459|FG001|Overall Study|Withdrawal by Subject|3|||
44492654|NCT00191100|79498458|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
44492655|NCT00191100|79498459|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
44492656|NCT00191100|79498458|FG000|Overall Study|Clinical Relapse|2|||
44492657|NCT00191100|79498459|FG001|Overall Study|Clinical Relapse|1|||
44492658|NCT00191100|79498458|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
44492659|NCT00191100|79498459|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
44492660|NCT00191100|79498458|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
44492661|NCT00191100|79498459|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
44492662|NCT00191100|79498458|FG000|Overall Study|Physician Decision|3|||
44492663|NCT00191100|79498459|FG001|Overall Study|Physician Decision|1|||
44492664|NCT00191100|79498458|FG000|Overall Study|Death from Study Drug Toxicity|2|||
44492665|NCT00191100|79498459|FG001|Overall Study|Death from Study Drug Toxicity|0|||
44492666|NCT00191100|79498458|FG000|Overall Study|Protocol Violation|1|||
44492667|NCT00191100|79498459|FG001|Overall Study|Protocol Violation|1|||
44546251|NCT03429049|79560230|FG001|Overall Study|Lack of Efficacy|2|||
44546252|NCT03429049|79560229|FG000|Overall Study|Lost to Follow-up|9|||
44546253|NCT03429049|79560230|FG001|Overall Study|Lost to Follow-up|8|||
44546254|NCT03429049|79560229|FG000|Overall Study|Physician Decision|1|||
44546255|NCT03429049|79560230|FG001|Overall Study|Physician Decision|0|||
44546256|NCT03429049|79560229|FG000|Overall Study|Protocol Violation|3|||
44546257|NCT03429049|79560230|FG001|Overall Study|Protocol Violation|0|||
44546258|NCT03429049|79560229|FG000|Overall Study|Sponsor Decision|2|||
44546259|NCT03429049|79560230|FG001|Overall Study|Sponsor Decision|0|||
44546260|NCT03429049|79560229|FG000|Overall Study|Withdrawal by Subject|4|||
44546261|NCT03429049|79560230|FG001|Overall Study|Withdrawal by Subject|20|||
44546262|NCT03429049|79560229|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
44546263|NCT03429049|79560230|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
44376338|NCT01079234|79381444|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
44492668|NCT00191100|79498458|FG000|Overall Study|Death from Other Cause|1|||
44492669|NCT00191100|79498459|FG001|Overall Study|Death from Other Cause|0|||
44492670|NCT00191100|79498458|FG000|Overall Study|Reason Not Specified|0|||
44492671|NCT00191100|79498459|FG001|Overall Study|Reason Not Specified|1|||
44546264|NCT03428815|79560238|FG000|Overall Study|Lost to Follow-up|2|||
44546265|NCT03428815|79560239|FG001|Overall Study|Lost to Follow-up|2|||
44546266|NCT03428815|79560238|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
44546267|NCT03428815|79560239|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
44546268|NCT03428815|79560238|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
44546269|NCT03428815|79560239|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
44229450|NCT01682720|79037205|FG000|Overall Study|Subject Withdrew Consent|0|||
44229451|NCT01682720|79037206|FG001|Overall Study|Subject Withdrew Consent|0|||
44229452|NCT01682720|79037207|FG002|Overall Study|Subject Withdrew Consent|2|||
44229453|NCT01682720|79037208|FG003|Overall Study|Subject Withdrew Consent|2|||
44229454|NCT01682720|79037205|FG000|Overall Study|Adverse Event|1|||
44229455|NCT01682720|79037206|FG001|Overall Study|Adverse Event|0|||
44229456|NCT01682720|79037207|FG002|Overall Study|Adverse Event|1|||
44229457|NCT01682720|79037208|FG003|Overall Study|Adverse Event|1|||
44229458|NCT01714544|79037227|FG000|Overall Study|Lost to Follow-up|1|||
44229459|NCT01714544|79037227|FG000|Overall Study|Physician Decision|1|||
44229460|NCT01714544|79037227|FG000|Overall Study|Withdrawal by Subject|1|||
44229461|NCT01703858|79037234|FG000|Overall Study|Withdrawal by Subject|0|||
44229462|NCT01703858|79037235|FG001|Overall Study|Withdrawal by Subject|1|||
44274489|NCT02248974|79220212|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
44274490|NCT02248974|79220211|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
44274491|NCT02248974|79220212|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
44274492|NCT02248974|79220211|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
44274493|NCT02248974|79220212|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
44274494|NCT02248974|79220211|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
44274495|NCT02248974|79220212|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
44274496|NCT02246166|79220220|FG000|Overall Study|Protocol Violation|1|||
44274497|NCT02246166|79220221|FG001|Overall Study|Protocol Violation|0|||
44274498|NCT02706847|79220230|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
44274499|NCT02706847|79220231|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
44274500|NCT02706847|79220232|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
44274501|NCT02706847|79220233|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
44274502|NCT02706847|79220230|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
44274503|NCT02706847|79220231|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
44274504|NCT02706847|79220232|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
44274505|NCT02706847|79220233|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
44274506|NCT02706847|79220230|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
44274507|NCT02706847|79220231|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
44274508|NCT02706847|79220232|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
44274509|NCT02706847|79220233|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
44274510|NCT02706847|79220230|FG000|Period 1: Day 1 to Week 12|Other|4|||
44274511|NCT02706847|79220231|FG001|Period 1: Day 1 to Week 12|Other|4|||
44274512|NCT02706847|79220232|FG002|Period 1: Day 1 to Week 12|Other|2|||
44274513|NCT02706847|79220233|FG003|Period 1: Day 1 to Week 12|Other|2|||
44274514|NCT02706847|79220230|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
44274515|NCT02706847|79220231|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
44274516|NCT02706847|79220232|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
44492672|NCT00189540|79498467|FG000|Overall Study|Withdrawal by Subject|3|||
44492673|NCT00189540|79498468|FG001|Overall Study|Withdrawal by Subject|0|||
44492674|NCT00189540|79498467|FG000|Overall Study|Death|4|||
44229463|NCT01703858|79037236|FG002|Overall Study|Withdrawal by Subject|0|||
44229464|NCT01714310|79037252|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
44229465|NCT01714310|79037253|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
44229466|NCT01714310|79037254|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
44492675|NCT00189540|79498468|FG001|Overall Study|Death|1|||
44492676|NCT00257010|79498474|FG000|Overall Study|Lack of Efficacy|11|||
44492677|NCT00257010|79498474|FG000|Overall Study|Lost to Follow-up|53|||
44492678|NCT00257010|79498474|FG000|Overall Study|Withdrawal by Subject|34|||
44492679|NCT00257010|79498474|FG000|Overall Study|Adverse Event|10|||
44492680|NCT00257010|79498474|FG000|Overall Study|various|11|||
44492681|NCT00257010|79498474|FG000|Overall Study|no headache reported|9|||
44492682|NCT00256854|79498484|FG000|Overall Study|Withdrawal by Subject|2|||
44492683|NCT00256854|79498485|FG001|Overall Study|Withdrawal by Subject|3|||
44274517|NCT02706847|79220233|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
44274518|NCT02706847|79220230|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
44492684|NCT00256854|79498486|FG002|Overall Study|Withdrawal by Subject|0|||
44546270|NCT03155724|79560245|FG000|Overall Study|Death|3|||
44229467|NCT01714310|79037252|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
44229468|NCT01714310|79037253|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
44229469|NCT01714310|79037254|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
44492685|NCT00256854|79498487|FG003|Overall Study|Withdrawal by Subject|0|||
44274519|NCT02706847|79220231|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
44274520|NCT02706847|79220232|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
44274521|NCT02706847|79220233|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
44274522|NCT02706847|79220230|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
44274523|NCT02706847|79220231|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
44274524|NCT02706847|79220232|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
44492686|NCT00256854|79498488|FG004|Overall Study|Withdrawal by Subject|0|||
44492687|NCT00256854|79498489|FG005|Overall Study|Withdrawal by Subject|0|||
44492688|NCT00256854|79498484|FG000|Overall Study|Lack of Efficacy|1|||
44492689|NCT00256854|79498485|FG001|Overall Study|Lack of Efficacy|0|||
44492690|NCT00256854|79498486|FG002|Overall Study|Lack of Efficacy|0|||
44492691|NCT00256854|79498487|FG003|Overall Study|Lack of Efficacy|0|||
44492692|NCT00256854|79498488|FG004|Overall Study|Lack of Efficacy|0|||
44492693|NCT00256854|79498489|FG005|Overall Study|Lack of Efficacy|0|||
44492694|NCT00256854|79498484|FG000|Overall Study|Protocol Violation|0|||
44492695|NCT00256854|79498485|FG001|Overall Study|Protocol Violation|1|||
44546271|NCT03155724|79560245|FG000|Overall Study|Physician Decision|1|||
44274525|NCT02706847|79220233|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
44274526|NCT02706847|79220230|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
44274527|NCT02706847|79220231|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
44274528|NCT02706847|79220232|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
44274529|NCT02706847|79220233|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
44274530|NCT02706847|79220230|FG000|Period 1: Week 12 to Week 24|Other|1|||
44274531|NCT02706847|79220231|FG001|Period 1: Week 12 to Week 24|Other|0|||
44274532|NCT02706847|79220232|FG002|Period 1: Week 12 to Week 24|Other|1|||
44274533|NCT02706847|79220233|FG003|Period 1: Week 12 to Week 24|Other|4|||
44274534|NCT02706847|79220230|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
44274535|NCT02706847|79220231|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
44274536|NCT02706847|79220232|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
44274537|NCT02706847|79220233|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
44274538|NCT02706847|79220230|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
44274539|NCT02706847|79220231|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
44274540|NCT02706847|79220232|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
44274541|NCT02706847|79220233|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
44274542|NCT02706847|79220230|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
44274543|NCT02706847|79220231|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
44274544|NCT02706847|79220232|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
44274545|NCT02706847|79220233|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
44546272|NCT03155724|79560245|FG000|Overall Study|Study closure|7|||
44546273|NCT03426787|79560249|FG000|Overall Study|Withdrawal by Subject|6|||
44546274|NCT03426787|79560249|FG000|Overall Study|Lost to Follow-up|7|||
44546275|NCT03426787|79560249|FG000|Overall Study|Unrelated to intervention death|1|||
44546276|NCT03426631|79560259|FG000|Overall Study|Lost to Follow-up|0|||
44546277|NCT03426631|79560260|FG001|Overall Study|Lost to Follow-up|1|||
44546278|NCT03484429|79560268|FG000|Overall Study|Withdrawal by Subject|1|||
44229470|NCT01714310|79037252|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
44229471|NCT01714310|79037253|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
44229472|NCT01714310|79037254|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
44229473|NCT01714310|79037252|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
44229474|NCT01714310|79037253|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
44229475|NCT01714310|79037254|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
44229476|NCT01713998|79037275|FG000|Overall Study|Lost to Follow-up|2|||
44229477|NCT01713998|79037276|FG001|Overall Study|Lost to Follow-up|0|||
44229478|NCT01713998|79037277|FG002|Overall Study|Lost to Follow-up|2|||
44229479|NCT01713998|79037275|FG000|Overall Study|Withdrawal by Subject|1|||
44229480|NCT01713998|79037276|FG001|Overall Study|Withdrawal by Subject|0|||
44229481|NCT01713998|79037277|FG002|Overall Study|Withdrawal by Subject|0|||
44229482|NCT01681628|79037287|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
44229483|NCT01681628|79037288|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
44229484|NCT01681628|79037287|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
44274546|NCT02706847|79220230|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
44274547|NCT02706847|79220231|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
44274548|NCT02706847|79220232|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
44274549|NCT02706847|79220233|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
44492696|NCT00256854|79498486|FG002|Overall Study|Protocol Violation|1|||
44546279|NCT03484429|79560269|FG001|Overall Study|Withdrawal by Subject|0|||
44274550|NCT02706847|79220230|FG000|Period 2: Week 24 to Week 260|Other|8|||
44274551|NCT02706847|79220231|FG001|Period 2: Week 24 to Week 260|Other|5|||
44546280|NCT03484429|79560268|FG000|Overall Study|Adverse Event|2|||
44229485|NCT01681628|79037288|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
44229486|NCT01681628|79037287|FG000|19 Months Follow-up|Death|1|||
44546281|NCT03484429|79560269|FG001|Overall Study|Adverse Event|0|||
44492697|NCT00256854|79498487|FG003|Overall Study|Protocol Violation|1|||
44492698|NCT00256854|79498488|FG004|Overall Study|Protocol Violation|0|||
44492699|NCT00256854|79498489|FG005|Overall Study|Protocol Violation|0|||
44492700|NCT00256854|79498484|FG000|Overall Study|Adverse Event|0|||
44492701|NCT00256854|79498485|FG001|Overall Study|Adverse Event|0|||
44492702|NCT00256854|79498486|FG002|Overall Study|Adverse Event|2|||
44492703|NCT00256854|79498487|FG003|Overall Study|Adverse Event|2|||
44546282|NCT03484273|79560275|FG000|Overall Study|Equipment Malfunction|1|||
44546283|NCT03484273|79560275|FG000|Overall Study|Data excluded from analysis|1|||
44546284|NCT02724592|79560289|FG000|Overall Study|Lost to Follow-up|4|||
44492704|NCT00256854|79498488|FG004|Overall Study|Adverse Event|0|||
44492705|NCT00256854|79498489|FG005|Overall Study|Adverse Event|1|||
44492706|NCT00256854|79498484|FG000|Overall Study|Not compliant with the study drug|0|||
44492707|NCT00256854|79498485|FG001|Overall Study|Not compliant with the study drug|0|||
44492708|NCT00256854|79498486|FG002|Overall Study|Not compliant with the study drug|0|||
44492709|NCT00256854|79498487|FG003|Overall Study|Not compliant with the study drug|0|||
44492710|NCT00256854|79498488|FG004|Overall Study|Not compliant with the study drug|1|||
44492711|NCT00256854|79498489|FG005|Overall Study|Not compliant with the study drug|0|||
44492712|NCT00189462|79498506|FG000|Overall Study|Lack of Efficacy|5|||
44492713|NCT00189462|79498507|FG001|Overall Study|Lack of Efficacy|1|||
44492714|NCT00189462|79498506|FG000|Overall Study|Lost to Follow-up|18|||
44492715|NCT00189462|79498507|FG001|Overall Study|Lost to Follow-up|20|||
44492716|NCT00256698|79498515|FG000|Overall Study|Withdrawal by Subject|7|||
44492717|NCT00256698|79498516|FG001|Overall Study|Withdrawal by Subject|7|||
44492718|NCT00256698|79498515|FG000|Overall Study|Adverse Event|13|||
44492719|NCT00256698|79498516|FG001|Overall Study|Adverse Event|6|||
44492720|NCT00256698|79498515|FG000|Overall Study|Protocol Violation|6|||
44492721|NCT00256698|79498516|FG001|Overall Study|Protocol Violation|5|||
44492722|NCT00256698|79498515|FG000|Overall Study|Lost to Follow-up|1|||
44546285|NCT02724592|79560290|FG001|Overall Study|Lost to Follow-up|1|||
44546286|NCT03154476|79560298|FG000|Overall Study|Lost to Follow-up|4|||
44546287|NCT03154476|79560299|FG001|Overall Study|Lost to Follow-up|4|||
44546288|NCT02726074|79560305|FG000|Overall Study|Withdrawal by Subject|4|||
44546289|NCT02726074|79560305|FG000|Overall Study|Adverse Event|14|||
44546290|NCT02726074|79560305|FG000|Overall Study|Protocol Violation|3|||
44546291|NCT02726074|79560305|FG000|Overall Study|Lost to Follow-up|2|||
44546292|NCT02726074|79560305|FG000|Overall Study|Others|3|||
44546293|NCT03482635|79560313|FG000|Overall Study|Lack of Efficacy|0|||
44546294|NCT03482635|79560314|FG001|Overall Study|Lack of Efficacy|0|||
44546295|NCT03482635|79560315|FG002|Overall Study|Lack of Efficacy|1|||
44546296|NCT03482635|79560316|FG003|Overall Study|Lack of Efficacy|3|||
44546297|NCT03482635|79560313|FG000|Overall Study|Adverse Event|2|||
44546298|NCT03482635|79560314|FG001|Overall Study|Adverse Event|2|||
44546299|NCT03482635|79560315|FG002|Overall Study|Adverse Event|0|||
44492723|NCT00256698|79498516|FG001|Overall Study|Lost to Follow-up|3|||
44492724|NCT00256698|79498515|FG000|Overall Study|disease progression|97|||
44492725|NCT00256698|79498516|FG001|Overall Study|disease progression|105|||
44492726|NCT00256698|79498515|FG000|Overall Study|still ongoing at data cut-off|41|||
44492727|NCT00256698|79498516|FG001|Overall Study|still ongoing at data cut-off|46|||
44492728|NCT00256698|79498515|FG000|Overall Study|withdrawn due to osteoporosis|1|||
44492729|NCT00256698|79498516|FG001|Overall Study|withdrawn due to osteoporosis|0|||
44546300|NCT03482635|79560316|FG003|Overall Study|Adverse Event|3|||
44546301|NCT03482635|79560313|FG000|Overall Study|Withdrawal by Subject|2|||
44546302|NCT03482635|79560314|FG001|Overall Study|Withdrawal by Subject|1|||
44546303|NCT03482635|79560315|FG002|Overall Study|Withdrawal by Subject|0|||
44546304|NCT03482635|79560316|FG003|Overall Study|Withdrawal by Subject|1|||
44546305|NCT03482635|79560313|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
44546306|NCT03482635|79560314|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
44546307|NCT03482635|79560315|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
44546308|NCT03482635|79560316|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
44546309|NCT03482635|79560313|FG000|Overall Study|Not treated|0|||
44546310|NCT03482635|79560314|FG001|Overall Study|Not treated|0|||
44546311|NCT03482635|79560315|FG002|Overall Study|Not treated|0|||
44546312|NCT03482635|79560316|FG003|Overall Study|Not treated|1|||
44546313|NCT03712787|79560330|FG000|Overall Study|Adverse Event|2|||
44546314|NCT03712787|79560331|FG001|Overall Study|Adverse Event|3|||
44546315|NCT03712787|79560332|FG002|Overall Study|Adverse Event|0|||
44546316|NCT03712787|79560333|FG003|Overall Study|Adverse Event|4|||
44546317|NCT03712787|79560330|FG000|Overall Study|Withdrawal by Subject|4|||
44546318|NCT03712787|79560331|FG001|Overall Study|Withdrawal by Subject|14|||
44546319|NCT03712787|79560332|FG002|Overall Study|Withdrawal by Subject|12|||
44546320|NCT03712787|79560333|FG003|Overall Study|Withdrawal by Subject|8|||
44546321|NCT03712787|79560330|FG000|Overall Study|Lost to Follow-up|1|||
44546322|NCT03712787|79560331|FG001|Overall Study|Lost to Follow-up|1|||
44546323|NCT03712787|79560332|FG002|Overall Study|Lost to Follow-up|2|||
44546324|NCT03712787|79560333|FG003|Overall Study|Lost to Follow-up|1|||
44546325|NCT03712787|79560330|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
44546326|NCT03712787|79560331|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
44546327|NCT03712787|79560332|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
44546328|NCT03712787|79560333|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
44546329|NCT03712787|79560330|FG000|Overall Study|COVID-19 Infection|0|||
44546330|NCT03712787|79560331|FG001|Overall Study|COVID-19 Infection|1|||
44546331|NCT03712787|79560332|FG002|Overall Study|COVID-19 Infection|0|||
44546332|NCT03712787|79560333|FG003|Overall Study|COVID-19 Infection|0|||
44546333|NCT03712787|79560330|FG000|Overall Study|Other, Not Specified|79|||
44546334|NCT03712787|79560331|FG001|Overall Study|Other, Not Specified|77|||
44546335|NCT03712787|79560332|FG002|Overall Study|Other, Not Specified|74|||
44546336|NCT03712787|79560333|FG003|Overall Study|Other, Not Specified|78|||
44546337|NCT03048422|79560365|FG000|Overall Study|Death|1|||
44546338|NCT03048422|79560366|FG001|Overall Study|Death|0|||
44546339|NCT03048422|79560367|FG002|Overall Study|Death|0|||
44546340|NCT03048422|79560365|FG000|Overall Study|Lost to Follow-up|5|||
44546341|NCT03048422|79560366|FG001|Overall Study|Lost to Follow-up|0|||
44546342|NCT03048422|79560367|FG002|Overall Study|Lost to Follow-up|1|||
44546343|NCT03048422|79560365|FG000|Overall Study|Withdrawal by Subject|5|||
44546344|NCT03048422|79560366|FG001|Overall Study|Withdrawal by Subject|7|||
44546345|NCT03048422|79560367|FG002|Overall Study|Withdrawal by Subject|4|||
44546346|NCT03048422|79560365|FG000|Overall Study|Moved|3|||
44229487|NCT01681628|79037288|FG001|19 Months Follow-up|Death|0|||
44546347|NCT03048422|79560366|FG001|Overall Study|Moved|2|||
44546348|NCT03048422|79560367|FG002|Overall Study|Moved|2|||
44546349|NCT03048422|79560365|FG000|Overall Study|Noncompliant with Study Requirements|2|||
44546350|NCT03048422|79560366|FG001|Overall Study|Noncompliant with Study Requirements|1|||
44546351|NCT03048422|79560367|FG002|Overall Study|Noncompliant with Study Requirements|2|||
44546352|NCT03048422|79560365|FG000|Overall Study|Not Able to Get to Clinic|1|||
44546353|NCT03048422|79560366|FG001|Overall Study|Not Able to Get to Clinic|0|||
44546354|NCT03048422|79560367|FG002|Overall Study|Not Able to Get to Clinic|0|||
44492730|NCT00256698|79498515|FG000|Overall Study|Prematurely Discontinued|1|||
44492731|NCT00256698|79498516|FG001|Overall Study|Prematurely Discontinued|0|||
44492732|NCT00189306|79498522|FG000|Treatment Period|Withdrawal by Subject|2|||
44492733|NCT00189306|79498522|FG000|Treatment Period|Adverse Event|2|||
44492734|NCT00189306|79498522|FG000|Treatment Period|Protocol Violation|1|||
44492735|NCT00189306|79498522|FG000|Posttreatment Period|Death|1|||
44492736|NCT00189306|79498522|FG000|Posttreatment Period|Withdrawal by Subject|2|||
44492737|NCT00189306|79498522|FG000|Posttreatment Period|Noncompliance|1|||
44492738|NCT00189306|79498522|FG000|Posttreatment Period|Target lesion excised|1|||
44492739|NCT00189306|79498522|FG000|Posttreatment Period|Protocol Violation|1|||
44492740|NCT00189306|79498522|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
44492741|NCT00189306|79498522|FG000|Posttreatment Period|Local skin reaction/sign|1|||
44229488|NCT01681628|79037287|FG000|19 Months Follow-up|Lost to Follow-up|61|||
44229489|NCT01681628|79037288|FG001|19 Months Follow-up|Lost to Follow-up|43|||
44229490|NCT00016354|79037310|FG000|Overall Study|Lack of Efficacy|0|||
44274552|NCT02706847|79220232|FG002|Period 2: Week 24 to Week 260|Other|15|||
44229491|NCT00016354|79037311|FG001|Overall Study|Lack of Efficacy|0|||
44492742|NCT00189306|79498522|FG000|Long-Term Follow-up|Adverse Event|2|||
44492743|NCT00189306|79498522|FG000|Long-Term Follow-up|Death|4|||
44492744|NCT00189306|79498522|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
44492745|NCT00189306|79498522|FG000|Long-Term Follow-up|Intercurrent disease|2|||
44492746|NCT00189306|79498522|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
44492747|NCT00189306|79498522|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
44492748|NCT00187278|79498528|FG000|Overall Study|Protocol Violation|10|||
44492749|NCT00187278|79498529|FG001|Overall Study|Protocol Violation|13|||
44492750|NCT00256308|79498537|FG000|Overall Study|Death|2|||
44492751|NCT00255840|79498543|FG000|Overall Study|Lost to Follow-up|10|||
44492752|NCT00255840|79498544|FG001|Overall Study|Lost to Follow-up|14|||
44492753|NCT00255840|79498543|FG000|Overall Study|Discontinued intervention|53|||
44492754|NCT00255840|79498544|FG001|Overall Study|Discontinued intervention|56|||
44492755|NCT00224874|79498554|FG000|Overall Study|Withdrawal by Subject|0|||
44492756|NCT00224874|79498555|FG001|Overall Study|Withdrawal by Subject|0|||
44492757|NCT00224874|79498556|FG002|Overall Study|Withdrawal by Subject|1|||
44492758|NCT00224874|79498557|FG003|Overall Study|Withdrawal by Subject|0|||
44492759|NCT00186186|79498567|FG000|Overall Study|Lack of Efficacy|3|||
44492760|NCT00186186|79498567|FG000|Overall Study|Withdrawal by Subject|3|||
44492761|NCT00186186|79498567|FG000|Overall Study|Not reported as to reason|2|||
44229492|NCT00016354|79037312|FG002|Overall Study|Lack of Efficacy|0|||
44229493|NCT00016354|79037313|FG003|Overall Study|Lack of Efficacy|0|||
44229494|NCT00016354|79037314|FG004|Overall Study|Lack of Efficacy|0|||
44229495|NCT00016354|79037315|FG005|Overall Study|Lack of Efficacy|0|||
44229496|NCT00016354|79037316|FG006|Overall Study|Lack of Efficacy|0|||
44492762|NCT00185640|79498572|FG000|Overall Study|Not Eligible|4|||
44492763|NCT00185640|79498572|FG000|Overall Study|Withdrawal by Subject|3|||
44492764|NCT00185640|79498572|FG000|Overall Study|Death|138|||
44492765|NCT03760666|79498579|FG000|Overall Study|Adverse Event|2|||
44492766|NCT03760666|79498580|FG001|Overall Study|Adverse Event|4|||
44492767|NCT03760666|79498581|FG002|Overall Study|Adverse Event|1|||
44492768|NCT03760666|79498579|FG000|Overall Study|AML Disease Progression|3|||
44492769|NCT03760666|79498580|FG001|Overall Study|AML Disease Progression|3|||
44492770|NCT03760666|79498581|FG002|Overall Study|AML Disease Progression|0|||
44492771|NCT03760666|79498579|FG000|Overall Study|Physician Decision|0|||
44492772|NCT03760666|79498580|FG001|Overall Study|Physician Decision|3|||
44274553|NCT02706847|79220233|FG003|Period 2: Week 24 to Week 260|Other|15|||
44274554|NCT02245620|79220246|FG000|Overall Study|Physician Decision|1|||
44274555|NCT02245620|79220247|FG001|Overall Study|Physician Decision|1|||
44546355|NCT04664855|79560387|FG000|Overall Study|Withdrawal by Subject|0|||
44546356|NCT04664855|79560388|FG001|Overall Study|Withdrawal by Subject|2|||
44492773|NCT03760666|79498581|FG002|Overall Study|Physician Decision|0|||
44492774|NCT03760666|79498579|FG000|Overall Study|Withdrawal by Subject|0|||
44492775|NCT03760666|79498580|FG001|Overall Study|Withdrawal by Subject|1|||
44492776|NCT03760666|79498581|FG002|Overall Study|Withdrawal by Subject|0|||
44492777|NCT03760510|79498594|FG000|Overall Study|Not ventilated for 24 hours|105|||
44492778|NCT03760510|79498595|FG001|Overall Study|Not ventilated for 24 hours|97|||
44492779|NCT00224484|79498604|FG000|Overall Study|Serious Adverse Event|1|||
44492780|NCT00224484|79498605|FG001|Overall Study|Serious Adverse Event|1|||
44229497|NCT00016354|79037317|FG007|Overall Study|Lack of Efficacy|1|||
44229498|NCT01681472|79037325|FG000|Overall Study|Adverse Event|0|||
44492781|NCT00224484|79498606|FG002|Overall Study|Serious Adverse Event|0|||
44492782|NCT00224484|79498604|FG000|Overall Study|Non-Serious Adverse Event|5|||
44492783|NCT00224484|79498605|FG001|Overall Study|Non-Serious Adverse Event|7|||
44492784|NCT00224484|79498606|FG002|Overall Study|Non-Serious Adverse Event|3|||
44492785|NCT00224484|79498604|FG000|Overall Study|Protocol Violation|2|||
44492786|NCT00224484|79498605|FG001|Overall Study|Protocol Violation|2|||
44492787|NCT00224484|79498606|FG002|Overall Study|Protocol Violation|0|||
44492788|NCT00224484|79498604|FG000|Overall Study|Withdrawal by Subject|49|||
44492789|NCT00224484|79498605|FG001|Overall Study|Withdrawal by Subject|18|||
44492790|NCT00224484|79498606|FG002|Overall Study|Withdrawal by Subject|16|||
44492791|NCT00224484|79498604|FG000|Overall Study|Migrated/moved from study area|18|||
44492792|NCT00224484|79498605|FG001|Overall Study|Migrated/moved from study area|5|||
44492793|NCT00224484|79498606|FG002|Overall Study|Migrated/moved from study area|5|||
44492794|NCT00224484|79498604|FG000|Overall Study|Lost to Follow-up|66|||
44492795|NCT00224484|79498605|FG001|Overall Study|Lost to Follow-up|28|||
44546357|NCT04664153|79560398|FG000|Overall Study|Lack of Efficacy|0|||
44546358|NCT04664153|79560399|FG001|Overall Study|Lack of Efficacy|0|||
44546359|NCT04664153|79560400|FG002|Overall Study|Lack of Efficacy|1|||
44546360|NCT04664153|79560401|FG003|Overall Study|Lack of Efficacy|0|||
44546361|NCT04664153|79560398|FG000|Overall Study|Physician Decision|0|||
44546362|NCT04664153|79560399|FG001|Overall Study|Physician Decision|0|||
44546363|NCT04664153|79560400|FG002|Overall Study|Physician Decision|1|||
44546364|NCT04664153|79560401|FG003|Overall Study|Physician Decision|0|||
44546365|NCT04664153|79560398|FG000|Overall Study|Withdrawal by Subject|3|||
44546366|NCT04664153|79560399|FG001|Overall Study|Withdrawal by Subject|2|||
44546367|NCT04664153|79560400|FG002|Overall Study|Withdrawal by Subject|1|||
44546368|NCT04664153|79560401|FG003|Overall Study|Withdrawal by Subject|2|||
44546369|NCT04664153|79560398|FG000|Overall Study|Other|0|||
44546370|NCT04664153|79560399|FG001|Overall Study|Other|1|||
44546371|NCT04664153|79560400|FG002|Overall Study|Other|0|||
44546372|NCT04664153|79560401|FG003|Overall Study|Other|0|||
44546373|NCT04664153|79560398|FG000|Overall Study|Adverse Event|4|||
44546374|NCT04664153|79560399|FG001|Overall Study|Adverse Event|0|||
44546375|NCT04664153|79560400|FG002|Overall Study|Adverse Event|1|||
44546376|NCT04664153|79560401|FG003|Overall Study|Adverse Event|0|||
44546377|NCT04663295|79560413|FG000|Run-in Period|Withdrawal by Subject|3|||
44546378|NCT04663295|79560413|FG000|Overall Study Period|Pregnancy|1|||
44546379|NCT04663295|79560413|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
44546380|NCT04228445|79560424|FG000|Overall Study|Lost to Follow-up|1|||
44546381|NCT04228445|79560425|FG001|Overall Study|Lost to Follow-up|1|||
44546382|NCT04228445|79560424|FG000|Overall Study|Physician Decision|1|||
44546383|NCT04228445|79560425|FG001|Overall Study|Physician Decision|2|||
44546384|NCT04228445|79560424|FG000|Overall Study|Withdrawal by Subject|0|||
44546385|NCT04228445|79560425|FG001|Overall Study|Withdrawal by Subject|1|||
44546386|NCT04228445|79560424|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
44229499|NCT01681472|79037326|FG001|Overall Study|Adverse Event|1|||
44229500|NCT01681472|79037327|FG002|Overall Study|Adverse Event|0|||
44229501|NCT01681472|79037328|FG003|Overall Study|Adverse Event|0|||
44229502|NCT01049308|79037357|FG000|Pill Counts|Withdrawal by Subject|83|||
44229503|NCT01713686|79037364|FG000|Overall Study|Lost to Follow-up|9|||
44229504|NCT01713686|79037364|FG000|Overall Study|Withdrawal by Subject|6|||
44229505|NCT01047436|79037370|FG000|Overall Study|Protocol Violation|1|||
44229506|NCT01047436|79037371|FG001|Overall Study|Protocol Violation|0|||
44229507|NCT01681004|79037379|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
44229508|NCT01681004|79037380|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
44492796|NCT00224484|79498606|FG002|Overall Study|Lost to Follow-up|36|||
44492797|NCT00224484|79498604|FG000|Overall Study|Reason not specified|5|||
44492798|NCT00224484|79498605|FG001|Overall Study|Reason not specified|4|||
44274556|NCT02244996|79220255|FG000|Overall Study|Lack of Efficacy|2|||
44492799|NCT00224484|79498606|FG002|Overall Study|Reason not specified|2|||
44492800|NCT00254982|79498619|FG000|Overall Study|Other|2|||
44546387|NCT04228445|79560425|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
44546388|NCT04641299|79560437|FG000|Overall Study|Adverse Event|0|||
44546389|NCT04641299|79560438|FG001|Overall Study|Adverse Event|0|||
44546390|NCT04641299|79560439|FG002|Overall Study|Adverse Event|2|||
44546391|NCT04641299|79560440|FG003|Overall Study|Adverse Event|0|||
44546392|NCT04641299|79560437|FG000|Overall Study|Lost to Follow-up|0|||
44546393|NCT04641299|79560438|FG001|Overall Study|Lost to Follow-up|1|||
44546394|NCT04641299|79560439|FG002|Overall Study|Lost to Follow-up|0|||
44376339|NCT01079234|79381441|FG000|Extension: Week 27 to 52|Unclassified|0|||
44376340|NCT01079234|79381442|FG001|Extension: Week 27 to 52|Unclassified|0|||
44376341|NCT01079234|79381443|FG002|Extension: Week 27 to 52|Unclassified|4|||
44376342|NCT01079234|79381444|FG003|Extension: Week 27 to 52|Unclassified|7|||
44376343|NCT00931632|79381455|FG000|Overall Study|Withdrawal by Subject|2|||
44376344|NCT00931632|79381456|FG001|Overall Study|Withdrawal by Subject|3|||
44376345|NCT00931632|79381455|FG000|Overall Study|Adverse Event|19|||
44376346|NCT00931632|79381456|FG001|Overall Study|Adverse Event|15|||
44376347|NCT01078922|79381462|FG000|Overall Study|Adverse Event|1|||
44376348|NCT00863746|79381469|FG000|Treatment|Not treated|4|||
44376349|NCT00863746|79381470|FG001|Treatment|Not treated|2|||
44376350|NCT00863746|79381469|FG000|Treatment|Adverse Event|41|||
44376351|NCT00863746|79381470|FG001|Treatment|Adverse Event|16|||
44492801|NCT00254982|79498620|FG001|Overall Study|Other|1|||
44492802|NCT00254982|79498619|FG000|Overall Study|Lack of Efficacy|5|||
44492803|NCT00254982|79498620|FG001|Overall Study|Lack of Efficacy|3|||
44492804|NCT00254982|79498619|FG000|Overall Study|Lost to Follow-up|5|||
44492805|NCT00254982|79498620|FG001|Overall Study|Lost to Follow-up|3|||
44492806|NCT00254982|79498619|FG000|Overall Study|Adverse Event|18|||
44229509|NCT01681004|79037379|FG000|Study Completion|Lost to Follow-up|8|||
44229510|NCT01681004|79037380|FG001|Study Completion|Lost to Follow-up|3|||
44546395|NCT04641299|79560440|FG003|Overall Study|Lost to Follow-up|0|||
44546396|NCT04641299|79560437|FG000|Overall Study|Withdrawal by Subject|1|||
44546397|NCT04641299|79560438|FG001|Overall Study|Withdrawal by Subject|0|||
44546398|NCT04641299|79560439|FG002|Overall Study|Withdrawal by Subject|0|||
44546399|NCT04641299|79560440|FG003|Overall Study|Withdrawal by Subject|0|||
44546400|NCT04641299|79560437|FG000|Overall Study|Reason not given|1|||
44492807|NCT00254982|79498620|FG001|Overall Study|Adverse Event|16|||
44492808|NCT00254982|79498619|FG000|Overall Study|Withdrawal by Subject|1|||
44546401|NCT04641299|79560438|FG001|Overall Study|Reason not given|0|||
44546402|NCT04641299|79560439|FG002|Overall Study|Reason not given|0|||
44546403|NCT04641299|79560440|FG003|Overall Study|Reason not given|0|||
44546404|NCT03703817|79560456|FG000|Overall Study|Not meeting eligibility criteria|7|||
44546405|NCT03703817|79560457|FG001|Overall Study|Not meeting eligibility criteria|4|||
44546406|NCT03698591|79560465|FG000|Overall Study|Withdrawal by Subject|2|||
44546407|NCT03698591|79560466|FG001|Overall Study|Withdrawal by Subject|2|||
44546408|NCT03698591|79560465|FG000|Overall Study|Failed drug screen|1|||
44376352|NCT00863746|79381469|FG000|Treatment|non-compliant with study medication|4|||
44376353|NCT00863746|79381470|FG001|Treatment|non-compliant with study medication|0|||
44376354|NCT00863746|79381469|FG000|Treatment|Consent withdrawn|15|||
44492809|NCT00254982|79498620|FG001|Overall Study|Withdrawal by Subject|1|||
44492810|NCT00254982|79498619|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
44229511|NCT01681004|79037379|FG000|Study Completion|Physician Decision|1|||
44229512|NCT01681004|79037380|FG001|Study Completion|Physician Decision|3|||
44376355|NCT00863746|79381470|FG001|Treatment|Consent withdrawn|14|||
44492811|NCT00254982|79498620|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
44546409|NCT03698591|79560466|FG001|Overall Study|Failed drug screen|1|||
44546410|NCT03698591|79560465|FG000|Overall Study|Failed health screen|0|||
44546411|NCT03698591|79560466|FG001|Overall Study|Failed health screen|1|||
44546412|NCT03698591|79560465|FG000|Overall Study|Ineligible for financial compensation|1|||
44492812|NCT00254982|79498619|FG000|Overall Study|Protocol deviation|1|||
44492813|NCT00254982|79498620|FG001|Overall Study|Protocol deviation|1|||
44546413|NCT03698591|79560466|FG001|Overall Study|Ineligible for financial compensation|0|||
44546414|NCT03698591|79560465|FG000|Overall Study|Equipment Error|1|||
44546415|NCT03698591|79560466|FG001|Overall Study|Equipment Error|0|||
44546416|NCT03698591|79560465|FG000|Overall Study|Could not establish TMS dosage|0|||
44546417|NCT03698591|79560466|FG001|Overall Study|Could not establish TMS dosage|1|||
44546418|NCT04606199|79560472|FG000|Overall Study|Withdrawal by Subject|2|||
44229513|NCT01681004|79037379|FG000|Study Completion|Site Termination|2|||
44229514|NCT01681004|79037380|FG001|Study Completion|Site Termination|1|||
44229515|NCT01681004|79037379|FG000|Study Completion|Death|1|||
44229516|NCT01681004|79037380|FG001|Study Completion|Death|1|||
44492814|NCT00254982|79498619|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
44492815|NCT00254982|79498620|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
44229517|NCT01046110|79037392|FG000|Overall Study|Adverse Event|9|||
44492816|NCT00254982|79498619|FG000|Overall Study|Malignancy|0|||
44492817|NCT00254982|79498620|FG001|Overall Study|Malignancy|2|||
44492818|NCT00254982|79498619|FG000|Overall Study|Opportunistic infection|1|||
44492819|NCT00254982|79498620|FG001|Overall Study|Opportunistic infection|0|||
44492820|NCT00254982|79498619|FG000|Overall Study|Abnormal liver function tests|2|||
44492821|NCT00254982|79498620|FG001|Overall Study|Abnormal liver function tests|1|||
44492822|NCT03759340|79498626|FG000|Overall Study|Adverse Event|2|||
44492823|NCT03759340|79498626|FG000|Overall Study|Lost to Follow-up|1|||
44492824|NCT03759340|79498626|FG000|Overall Study|Withdrawal by Subject|15|||
44492825|NCT03759340|79498626|FG000|Overall Study|Study Terminated by Sponsor|38|||
44492826|NCT00224016|79498632|FG000|Titration Period|Withdrawal by Subject|0|||
44229518|NCT01046110|79037393|FG001|Overall Study|Adverse Event|2|||
44229519|NCT01046110|79037392|FG000|Overall Study|Lack of Efficacy|0|||
44492827|NCT00224016|79498633|FG001|Titration Period|Withdrawal by Subject|1|||
44492828|NCT00224016|79498632|FG000|Titration Period|Lost to Follow-up|1|||
44492829|NCT00224016|79498633|FG001|Titration Period|Lost to Follow-up|0|||
44546419|NCT05085665|79560478|FG000|Overall Study|Physician Decision|2|||
44546420|NCT05017493|79560484|FG000|Overall Study|Withdrawal by Subject|26|||
44492830|NCT00224016|79498632|FG000|Maintenance Period|Withdrawal by Subject|2|||
44492831|NCT00224016|79498633|FG001|Maintenance Period|Withdrawal by Subject|0|||
44492832|NCT00224016|79498632|FG000|Maintenance Period|Lost to Follow-up|0|||
44229520|NCT01046110|79037393|FG001|Overall Study|Lack of Efficacy|1|||
44229521|NCT01046110|79037392|FG000|Overall Study|Protocol Violation|7|||
44229522|NCT01046110|79037393|FG001|Overall Study|Protocol Violation|12|||
44229523|NCT01046110|79037392|FG000|Overall Study|Withdrawal Criteria|3|||
44229524|NCT01046110|79037393|FG001|Overall Study|Withdrawal Criteria|5|||
44229525|NCT01046110|79037392|FG000|Overall Study|Unclassified|36|||
44229526|NCT01046110|79037393|FG001|Overall Study|Unclassified|35|||
44229527|NCT01713530|79037401|FG000|Overall Study|Adverse Event|0|||
44229528|NCT01713530|79037402|FG001|Overall Study|Adverse Event|5|||
44229529|NCT01713530|79037401|FG000|Overall Study|Withdrawal criteria|21|||
44229530|NCT01713530|79037402|FG001|Overall Study|Withdrawal criteria|12|||
44229531|NCT01713530|79037401|FG000|Overall Study|Unclassified|4|||
44229532|NCT01713530|79037402|FG001|Overall Study|Unclassified|2|||
44229533|NCT01045798|79037410|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
44229534|NCT01045798|79037411|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
44229535|NCT01045798|79037410|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
44229536|NCT01045798|79037411|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
44229537|NCT01045798|79037410|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
44229538|NCT01045798|79037411|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
44229539|NCT01045798|79037410|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
44229540|NCT01045798|79037411|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
44229541|NCT01712984|79037424|FG000|Overall Study|Adverse Event|0|||
44229542|NCT01712984|79037425|FG001|Overall Study|Adverse Event|0|||
44229543|NCT01712984|79037426|FG002|Overall Study|Adverse Event|1|||
44229544|NCT01712984|79037424|FG000|Overall Study|Protocol Violation|2|||
44229545|NCT01712984|79037425|FG001|Overall Study|Protocol Violation|0|||
44229546|NCT01712984|79037426|FG002|Overall Study|Protocol Violation|1|||
44229547|NCT01712984|79037424|FG000|Overall Study|Lost to Follow-up|8|||
44229548|NCT01712984|79037425|FG001|Overall Study|Lost to Follow-up|10|||
44229549|NCT01712984|79037426|FG002|Overall Study|Lost to Follow-up|1|||
44229550|NCT01712984|79037424|FG000|Overall Study|Withdrawal by Subject|6|||
44229551|NCT01712984|79037425|FG001|Overall Study|Withdrawal by Subject|6|||
44229552|NCT01712984|79037426|FG002|Overall Study|Withdrawal by Subject|7|||
44229553|NCT01042678|79037437|FG000|Overall Study|Physician Decision|1|||
44229554|NCT01042678|79037438|FG001|Overall Study|Physician Decision|0|||
44229555|NCT01042678|79037439|FG002|Overall Study|Physician Decision|0|||
44229556|NCT01042678|79037440|FG003|Overall Study|Physician Decision|0|||
44229557|NCT01042678|79037441|FG004|Overall Study|Physician Decision|0|||
44229558|NCT01042678|79037442|FG005|Overall Study|Physician Decision|0|||
44492833|NCT00224016|79498633|FG001|Maintenance Period|Lost to Follow-up|1|||
44492834|NCT03757234|79498644|FG000|Overall Study|Adverse Event|0|||
44492835|NCT03757234|79498645|FG001|Overall Study|Adverse Event|0|||
44492836|NCT03757234|79498646|FG002|Overall Study|Adverse Event|0|||
44492837|NCT03757234|79498647|FG003|Overall Study|Adverse Event|0|||
44492838|NCT03757234|79498648|FG004|Overall Study|Adverse Event|1|||
44492839|NCT03757234|79498644|FG000|Overall Study|Lost to Follow-up|1|||
44492840|NCT03757234|79498645|FG001|Overall Study|Lost to Follow-up|0|||
44492841|NCT03757234|79498646|FG002|Overall Study|Lost to Follow-up|0|||
44492842|NCT03757234|79498647|FG003|Overall Study|Lost to Follow-up|0|||
44492843|NCT03757234|79498648|FG004|Overall Study|Lost to Follow-up|1|||
44492844|NCT03757234|79498644|FG000|Overall Study|Withdrawal by Subject|1|||
44492845|NCT03757234|79498645|FG001|Overall Study|Withdrawal by Subject|1|||
44492846|NCT03757234|79498646|FG002|Overall Study|Withdrawal by Subject|0|||
44492847|NCT03757234|79498647|FG003|Overall Study|Withdrawal by Subject|1|||
44492848|NCT03757234|79498648|FG004|Overall Study|Withdrawal by Subject|2|||
44492849|NCT03757234|79498644|FG000|Overall Study|Other|1|||
44492850|NCT03757234|79498645|FG001|Overall Study|Other|1|||
44492851|NCT03757234|79498646|FG002|Overall Study|Other|0|||
44492852|NCT03757234|79498647|FG003|Overall Study|Other|0|||
44492853|NCT03757234|79498648|FG004|Overall Study|Other|0|||
44492854|NCT00223080|79498662|FG000|Overall Study|Withdrawal by Subject|253|||
44229559|NCT01042600|79037452|FG000|Overall Study|Ineligible|1|||
44229560|NCT01042600|79037453|FG001|Overall Study|Ineligible|0|||
44229561|NCT01041976|79037462|FG000|Overall Study|Withdrawal by Subject|3|||
44492855|NCT00223080|79498663|FG001|Overall Study|Withdrawal by Subject|232|||
44492856|NCT00223080|79498662|FG000|Overall Study|Required contraindicated med|0|||
44492857|NCT00223080|79498663|FG001|Overall Study|Required contraindicated med|1|||
44492858|NCT00223080|79498662|FG000|Overall Study|Non-compliant|7|||
44492859|NCT00223080|79498663|FG001|Overall Study|Non-compliant|7|||
44492860|NCT00223080|79498662|FG000|Overall Study|Moved from study area|37|||
44492861|NCT00223080|79498663|FG001|Overall Study|Moved from study area|47|||
44492862|NCT00223080|79498662|FG000|Overall Study|Lost to Follow-up|259|||
44229562|NCT01041976|79037463|FG001|Overall Study|Withdrawal by Subject|0|||
44229563|NCT01041976|79037462|FG000|Overall Study|Incarceration|2|||
44229564|NCT01041976|79037463|FG001|Overall Study|Incarceration|0|||
44229565|NCT01041976|79037462|FG000|Overall Study|Death|0|||
44229566|NCT01041976|79037463|FG001|Overall Study|Death|4|||
44229567|NCT01712516|79037489|FG000|Overall Study|Technical problems|0|||
44492863|NCT00223080|79498663|FG001|Overall Study|Lost to Follow-up|284|||
44229568|NCT01712516|79037490|FG001|Overall Study|Technical problems|0|||
44229569|NCT01712516|79037491|FG002|Overall Study|Technical problems|0|||
44229570|NCT01712516|79037492|FG003|Overall Study|Technical problems|2|||
44229571|NCT01712516|79037489|FG000|Overall Study|Lost to Follow-up|0|||
44229572|NCT01712516|79037490|FG001|Overall Study|Lost to Follow-up|0|||
44229573|NCT01712516|79037491|FG002|Overall Study|Lost to Follow-up|2|||
44229574|NCT01712516|79037492|FG003|Overall Study|Lost to Follow-up|1|||
44492864|NCT00223080|79498662|FG000|Overall Study|Death|85|||
44492865|NCT00223080|79498663|FG001|Overall Study|Death|74|||
44492866|NCT00223080|79498662|FG000|Overall Study|Other|14|||
44492867|NCT00223080|79498663|FG001|Overall Study|Other|11|||
44492868|NCT00223080|79498662|FG000|Overall Study|Reason not provided|141|||
44492869|NCT00223080|79498663|FG001|Overall Study|Reason not provided|140|||
44492870|NCT00223080|79498662|FG000|Overall Study|Adverse Event|0|||
44492871|NCT00223080|79498663|FG001|Overall Study|Adverse Event|1|||
44492872|NCT00220740|79498671|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
44492873|NCT00220740|79498672|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
44492874|NCT00220740|79498671|FG000|Efficacy Period|Adverse Event|1|||
44492875|NCT00220740|79498672|FG001|Efficacy Period|Adverse Event|1|||
44492876|NCT00220740|79498671|FG000|Efficacy Period|Withdrawal by Subject|1|||
44492877|NCT00220740|79498672|FG001|Efficacy Period|Withdrawal by Subject|0|||
44492878|NCT00220740|79498671|FG000|Efficacy Period|Protocol Violation|1|||
44492879|NCT00220740|79498672|FG001|Efficacy Period|Protocol Violation|0|||
44229575|NCT01712516|79037489|FG000|Overall Study|Death|0|||
44229576|NCT01712516|79037490|FG001|Overall Study|Death|1|||
44229577|NCT01712516|79037491|FG002|Overall Study|Death|0|||
44229578|NCT01712516|79037492|FG003|Overall Study|Death|0|||
44229579|NCT01712516|79037489|FG000|Overall Study|Protocol deviation|1|||
44229580|NCT01712516|79037490|FG001|Overall Study|Protocol deviation|0|||
44229581|NCT01712516|79037491|FG002|Overall Study|Protocol deviation|1|||
44229582|NCT01712516|79037492|FG003|Overall Study|Protocol deviation|0|||
44229583|NCT01712516|79037489|FG000|Overall Study|Physician Decision|2|||
44229584|NCT01712516|79037490|FG001|Overall Study|Physician Decision|0|||
44229585|NCT01712516|79037491|FG002|Overall Study|Physician Decision|0|||
44229586|NCT01712516|79037492|FG003|Overall Study|Physician Decision|1|||
44229587|NCT01712516|79037489|FG000|Overall Study|Withdrawal by Subject|3|||
44229588|NCT01712516|79037490|FG001|Overall Study|Withdrawal by Subject|9|||
44229589|NCT01712516|79037491|FG002|Overall Study|Withdrawal by Subject|3|||
44229590|NCT01712516|79037492|FG003|Overall Study|Withdrawal by Subject|9|||
44229591|NCT01703000|79037502|FG000|Overall Study|Death|1|||
44229592|NCT01040728|79037506|FG000|Overall Study|Adverse Event|4|||
44229593|NCT01040728|79037507|FG001|Overall Study|Adverse Event|8|||
44492880|NCT00220740|79498671|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
44492881|NCT00220740|79498672|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
44492882|NCT00184002|79498680|FG000|Overall Study|Adverse Event|9|||
44492883|NCT00184002|79498680|FG000|Overall Study|Death|3|||
44492884|NCT00184002|79498680|FG000|Overall Study|Physician Decision|1|||
44492885|NCT00184002|79498680|FG000|Overall Study|Withdrawal by Subject|4|||
44492886|NCT00165672|79498686|FG000|Overall Study|Adverse Event|0|||
44229594|NCT01040728|79037508|FG002|Overall Study|Adverse Event|0|||
44229595|NCT01040728|79037509|FG003|Overall Study|Adverse Event|4|||
44229596|NCT01040728|79037506|FG000|Overall Study|Withdrawal by Subject|0|||
44229597|NCT01040728|79037507|FG001|Overall Study|Withdrawal by Subject|1|||
44229598|NCT01040728|79037508|FG002|Overall Study|Withdrawal by Subject|1|||
44229599|NCT01040728|79037509|FG003|Overall Study|Withdrawal by Subject|0|||
44229600|NCT01040728|79037506|FG000|Overall Study|Protocol Violation|0|||
44229601|NCT01040728|79037507|FG001|Overall Study|Protocol Violation|0|||
44229602|NCT01040728|79037508|FG002|Overall Study|Protocol Violation|0|||
44229603|NCT01040728|79037509|FG003|Overall Study|Protocol Violation|1|||
44229604|NCT01040728|79037506|FG000|Overall Study|Lack of Efficacy|0|||
44229605|NCT01040728|79037507|FG001|Overall Study|Lack of Efficacy|1|||
44229606|NCT01040728|79037508|FG002|Overall Study|Lack of Efficacy|0|||
44229607|NCT01040728|79037509|FG003|Overall Study|Lack of Efficacy|1|||
44229608|NCT01040728|79037506|FG000|Overall Study|Other reasons not listed above|0|||
44229609|NCT01040728|79037507|FG001|Overall Study|Other reasons not listed above|1|||
44229610|NCT01040728|79037508|FG002|Overall Study|Other reasons not listed above|0|||
44229611|NCT01040728|79037509|FG003|Overall Study|Other reasons not listed above|0|||
44229612|NCT01593020|79037527|FG000|Overall Study|Adverse Event|1|||
44229613|NCT01593020|79037528|FG001|Overall Study|Adverse Event|1|||
44229614|NCT01593020|79037527|FG000|Overall Study|Death|0|||
44229615|NCT01593020|79037528|FG001|Overall Study|Death|1|||
44229616|NCT01593020|79037527|FG000|Overall Study|Ineligible|1|||
44492887|NCT00165672|79498687|FG001|Overall Study|Adverse Event|1|||
44492888|NCT00180414|79498695|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
44492889|NCT00180414|79498696|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
44492890|NCT00174252|79498702|FG000|Overall Study|Protocol Violation|2|||
44229617|NCT01593020|79037528|FG001|Overall Study|Ineligible|0|||
44229618|NCT01040260|79037536|FG000|Overall Study|Withdrawal by Subject|12|||
44229619|NCT01040260|79037537|FG001|Overall Study|Withdrawal by Subject|6|||
44229620|NCT01040260|79037536|FG000|Overall Study|Lost to Follow-up|3|||
44229621|NCT01040260|79037537|FG001|Overall Study|Lost to Follow-up|5|||
44229622|NCT01712438|79037543|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
44229623|NCT01712438|79037543|FG000|Overall Study|Ongoing ITI treatment|6|||
44229624|NCT01712438|79037543|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
44229625|NCT01712438|79037543|FG000|Overall Study|Prematurely Discontinued|25|||
44229626|NCT01712204|79037554|FG000|Overall Study|Adverse Event|3|||
44229627|NCT01712204|79037555|FG001|Overall Study|Adverse Event|1|||
44229628|NCT01712204|79037554|FG000|Overall Study|Withdrawal by Subject|3|||
44229629|NCT01712204|79037555|FG001|Overall Study|Withdrawal by Subject|3|||
44229630|NCT01712204|79037554|FG000|Overall Study|Lost to Follow-up|1|||
44492891|NCT00169104|79498710|FG000|Overall Study|Withdrawal by Subject|2|||
44492892|NCT00169104|79498711|FG001|Overall Study|Withdrawal by Subject|0|||
44492893|NCT00169104|79498710|FG000|Overall Study|Protocol Violation|0|||
44492894|NCT00169104|79498711|FG001|Overall Study|Protocol Violation|1|||
44492895|NCT00169104|79498710|FG000|Overall Study|Physician Decision|0|||
44229631|NCT01712204|79037555|FG001|Overall Study|Lost to Follow-up|0|||
44229632|NCT01712204|79037554|FG000|Overall Study|Protocol Violation|1|||
44229633|NCT01712204|79037555|FG001|Overall Study|Protocol Violation|1|||
44229634|NCT01592864|79037563|FG000|Overall Study|Withdrawal by Subject|0|||
44229635|NCT01592864|79037564|FG001|Overall Study|Withdrawal by Subject|1|||
44229636|NCT01592786|79037570|FG000|Overall Study|Adverse Event|60|||
44229637|NCT01592786|79037570|FG000|Overall Study|Lack of Efficacy|19|||
44229638|NCT01592786|79037570|FG000|Overall Study|Protocol Violation|14|||
44229639|NCT01592786|79037570|FG000|Overall Study|Withdrawal by Subject|23|||
44229640|NCT01592786|79037570|FG000|Overall Study|Lost to Follow-up|19|||
44229641|NCT01592786|79037570|FG000|Overall Study|Other|3|||
44229642|NCT01711736|79037576|FG000|Overall Study|Lost to Follow-up|4|||
44229643|NCT01711736|79037577|FG001|Overall Study|Lost to Follow-up|1|||
44229644|NCT01711736|79037576|FG000|Overall Study|Withdrawal by Subject|6|||
44229645|NCT01711736|79037577|FG001|Overall Study|Withdrawal by Subject|6|||
44229646|NCT01711736|79037576|FG000|Overall Study|Migrated/moved from study area|2|||
44229647|NCT01711736|79037577|FG001|Overall Study|Migrated/moved from study area|1|||
44229648|NCT01592708|79037586|FG000|Overall Study|Protocol Violation|3|||
44229649|NCT01592708|79037587|FG001|Overall Study|Protocol Violation|0|||
44229650|NCT01042522|79037598|FG000|Overall Study|Adverse Event|1|||
44229651|NCT01042522|79037599|FG001|Overall Study|Adverse Event|2|||
44229652|NCT01042522|79037598|FG000|Overall Study|Disease Progression|5|||
44229653|NCT01042522|79037599|FG001|Overall Study|Disease Progression|0|||
44229654|NCT01042522|79037598|FG000|Overall Study|Death|1|||
44229655|NCT01042522|79037599|FG001|Overall Study|Death|0|||
44492896|NCT00169104|79498711|FG001|Overall Study|Physician Decision|1|||
44229656|NCT01042522|79037598|FG000|Overall Study|Patient Refused|0|||
44229657|NCT01042522|79037599|FG001|Overall Study|Patient Refused|3|||
44229658|NCT01042522|79037598|FG000|Overall Study|Withdrawal by Subject|1|||
44229659|NCT01042522|79037599|FG001|Overall Study|Withdrawal by Subject|1|||
44229660|NCT01702844|79037605|FG000|Overall Study|Adverse Event|9|||
44229661|NCT01702844|79037605|FG000|Overall Study|Death|1|||
44229662|NCT01702844|79037605|FG000|Overall Study|Withdrawal by Subject|3|||
44229663|NCT01702844|79037605|FG000|Overall Study|Physician Decision|6|||
44229664|NCT01702532|79037611|FG000|Overall Study|Adverse Event|0|||
44229665|NCT01702532|79037612|FG001|Overall Study|Adverse Event|1|||
44229666|NCT01702454|79037621|FG000|Overall Study|Consent withdrawal|0|||
44229667|NCT01702454|79037622|FG001|Overall Study|Consent withdrawal|1|||
44229668|NCT01702454|79037621|FG000|Overall Study|Migrated/moved from study area|0|||
44229669|NCT01702454|79037622|FG001|Overall Study|Migrated/moved from study area|1|||
44229670|NCT01702454|79037621|FG000|Overall Study|Lost to Follow-up|3|||
44229671|NCT01702454|79037622|FG001|Overall Study|Lost to Follow-up|6|||
44274557|NCT02244996|79220256|FG001|Overall Study|Lack of Efficacy|6|||
44274558|NCT02243280|79220291|FG000|Treated|Adverse Event|1|||
44229672|NCT01702298|79037635|FG000|Overall Study|Withdrawal by Subject|1|||
44229673|NCT01701362|79037641|FG000|Overall Study|Adverse events not related to study drug|1|||
44229674|NCT01701362|79037642|FG001|Overall Study|Adverse events not related to study drug|6|||
44274559|NCT02243280|79220292|FG001|Treated|Adverse Event|0|||
44274560|NCT02243280|79220293|FG002|Treated|Adverse Event|0|||
44274561|NCT02243280|79220294|FG003|Treated|Adverse Event|0|||
44274562|NCT02243280|79220295|FG004|Treated|Adverse Event|0|||
44274563|NCT02243280|79220296|FG005|Treated|Adverse Event|0|||
44274564|NCT02243280|79220297|FG006|Treated|Adverse Event|0|||
44274565|NCT02243280|79220298|FG007|Treated|Adverse Event|0|||
44274566|NCT02243280|79220299|FG008|Treated|Adverse Event|0|||
44274567|NCT02243280|79220300|FG009|Treated|Adverse Event|0|||
44229675|NCT01701362|79037641|FG000|Overall Study|Adverse events related to study drug|12|||
44229676|NCT01701362|79037642|FG001|Overall Study|Adverse events related to study drug|10|||
44274568|NCT02243280|79220301|FG010|Treated|Adverse Event|1|||
44274569|NCT02243280|79220291|FG000|Treated|Lost to Follow-up|0|||
44274570|NCT02243280|79220292|FG001|Treated|Lost to Follow-up|0|||
44229677|NCT01701362|79037641|FG000|Overall Study|Protocol Violation|5|||
44274571|NCT02243280|79220293|FG002|Treated|Lost to Follow-up|0|||
44274572|NCT02243280|79220294|FG003|Treated|Lost to Follow-up|0|||
44229678|NCT01701362|79037642|FG001|Overall Study|Protocol Violation|3|||
44274573|NCT02243280|79220295|FG004|Treated|Lost to Follow-up|0|||
44274574|NCT02243280|79220296|FG005|Treated|Lost to Follow-up|0|||
44274575|NCT02243280|79220297|FG006|Treated|Lost to Follow-up|0|||
44274576|NCT02243280|79220298|FG007|Treated|Lost to Follow-up|0|||
44229679|NCT01701362|79037641|FG000|Overall Study|No longer willing to participate|8|||
44229680|NCT01701362|79037642|FG001|Overall Study|No longer willing to participate|14|||
44229681|NCT01701362|79037641|FG000|Overall Study|Lost to Follow-up|6|||
44229682|NCT01701362|79037642|FG001|Overall Study|Lost to Follow-up|9|||
44229683|NCT01701362|79037641|FG000|Overall Study|Insufficient clinical response|6|||
44229684|NCT01701362|79037642|FG001|Overall Study|Insufficient clinical response|6|||
44229685|NCT01701362|79037641|FG000|Overall Study|Death|0|||
44229686|NCT01701362|79037642|FG001|Overall Study|Death|1|||
44229687|NCT01701362|79037641|FG000|Overall Study|Randomized but not treated|1|||
44229688|NCT01701362|79037642|FG001|Overall Study|Randomized but not treated|2|||
44229689|NCT01701362|79037641|FG000|Overall Study|Reasons other than those mentioned above|3|||
44274577|NCT02243280|79220299|FG008|Treated|Lost to Follow-up|1|||
44376356|NCT00863746|79381469|FG000|Treatment|Lost to Follow-up|1|||
44274578|NCT02243280|79220300|FG009|Treated|Lost to Follow-up|0|||
44274579|NCT02243280|79220301|FG010|Treated|Lost to Follow-up|2|||
44376357|NCT00863746|79381470|FG001|Treatment|Lost to Follow-up|0|||
44376358|NCT00863746|79381469|FG000|Treatment|Protocol Violation|5|||
44376359|NCT00863746|79381470|FG001|Treatment|Protocol Violation|3|||
44376360|NCT00863746|79381469|FG000|Treatment|Other|1|||
44376361|NCT00863746|79381470|FG001|Treatment|Other|0|||
44376362|NCT00863746|79381469|FG000|Survival Follow up|Death|244|||
44376363|NCT00863746|79381470|FG001|Survival Follow up|Death|271|||
44376364|NCT00863746|79381469|FG000|Survival Follow up|Lost to Follow-up|2|||
44376365|NCT00863746|79381470|FG001|Survival Follow up|Lost to Follow-up|1|||
44376366|NCT00863746|79381469|FG000|Survival Follow up|Consent Withdrawn|7|||
44376367|NCT00863746|79381470|FG001|Survival Follow up|Consent Withdrawn|8|||
44376368|NCT00926328|79381478|FG000|Overall Study|Lost to Follow-up|12|||
44376369|NCT00926328|79381479|FG001|Overall Study|Lost to Follow-up|14|||
44376370|NCT00863512|79381487|FG000|Overall Study|Adverse Event|2|||
44376371|NCT00863512|79381488|FG001|Overall Study|Adverse Event|0|||
44376372|NCT00863512|79381487|FG000|Overall Study|Withdrawal by Subject|11|||
44376373|NCT00863512|79381488|FG001|Overall Study|Withdrawal by Subject|0|||
44376374|NCT00863512|79381487|FG000|Overall Study|Physician Decision|1|||
44376375|NCT00863512|79381488|FG001|Overall Study|Physician Decision|0|||
44376376|NCT00868192|79381494|FG000|Overall Study|Ineligible|4|||
44376377|NCT00930930|79381500|FG000|Overall Study|Death|1|||
44376378|NCT00930930|79381501|FG001|Overall Study|Death|0|||
44376379|NCT00930930|79381500|FG000|Overall Study|Physician Decision|1|||
44376380|NCT00930930|79381501|FG001|Overall Study|Physician Decision|0|||
44376381|NCT00930930|79381500|FG000|Overall Study|Adverse Event|13|||
44376382|NCT00930930|79381501|FG001|Overall Study|Adverse Event|3|||
44376383|NCT00930930|79381500|FG000|Overall Study|Withdrawal by Subject|3|||
44274580|NCT02248818|79220359|FG000|Screening|Protocol Violation|0|||
44376384|NCT00930930|79381501|FG001|Overall Study|Withdrawal by Subject|1|||
44376385|NCT00930930|79381500|FG000|Overall Study|Disease progression|2|||
44376386|NCT00930930|79381501|FG001|Overall Study|Disease progression|3|||
44376387|NCT00930930|79381500|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
44376388|NCT00930930|79381501|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
44376389|NCT00930930|79381500|FG000|Overall Study|patients not compliant|1|||
44376390|NCT00930930|79381501|FG001|Overall Study|patients not compliant|1|||
44376391|NCT00862654|79381511|FG000|Overall Study|Lack of Efficacy|1|||
44492897|NCT00163020|79498720|FG000|Overall Study|Lost to Follow-up|0|||
44492898|NCT00163020|79498721|FG001|Overall Study|Lost to Follow-up|2|||
44492899|NCT00252720|79498731|FG000|Overall Study|Withdrawal by Subject|95|||
44229690|NCT01701362|79037642|FG001|Overall Study|Reasons other than those mentioned above|5|||
44229691|NCT01710800|79037671|FG000|Overall Study|Withdrawal by Subject|21|||
44492900|NCT00252720|79498732|FG001|Overall Study|Withdrawal by Subject|97|||
44492901|NCT00252720|79498731|FG000|Overall Study|Death|7|||
44492902|NCT00252720|79498732|FG001|Overall Study|Death|8|||
44492903|NCT00252720|79498731|FG000|Overall Study|Moving|23|||
44492904|NCT00252720|79498732|FG001|Overall Study|Moving|42|||
44229692|NCT01710800|79037671|FG000|Overall Study|Protocol Violation|1|||
44229693|NCT01710020|79037677|FG000|Period 1|Protocol Violation|1|||
44229694|NCT01700348|79037683|FG000|Overall Study|Withdrawal by Subject|22|||
44229695|NCT01700348|79037683|FG000|Overall Study|Lost to Follow-up|1|||
44229696|NCT01700192|79037691|FG000|Overall Study|Adverse Event|73|||
44229697|NCT01700192|79037692|FG001|Overall Study|Adverse Event|18|||
44229698|NCT01700192|79037691|FG000|Overall Study|Lack of Efficacy|1|||
44229699|NCT01700192|79037692|FG001|Overall Study|Lack of Efficacy|0|||
44229700|NCT01700192|79037691|FG000|Overall Study|Lost to Follow-up|42|||
44229701|NCT01700192|79037692|FG001|Overall Study|Lost to Follow-up|29|||
44229702|NCT01700192|79037691|FG000|Overall Study|Noncompliance with study drug|0|||
44229703|NCT01700192|79037692|FG001|Overall Study|Noncompliance with study drug|5|||
44229704|NCT01700192|79037691|FG000|Overall Study|Physician Decision|2|||
44229705|NCT01700192|79037692|FG001|Overall Study|Physician Decision|3|||
44229706|NCT01700192|79037691|FG000|Overall Study|Pregnancy|1|||
44229707|NCT01700192|79037692|FG001|Overall Study|Pregnancy|4|||
44229708|NCT01700192|79037691|FG000|Overall Study|Progressive disease|1|||
44229709|NCT01700192|79037692|FG001|Overall Study|Progressive disease|0|||
44229710|NCT01700192|79037691|FG000|Overall Study|Protocol Violation|3|||
44229711|NCT01700192|79037692|FG001|Overall Study|Protocol Violation|4|||
44229712|NCT01700192|79037691|FG000|Overall Study|Technical problems|0|||
44229713|NCT01700192|79037692|FG001|Overall Study|Technical problems|1|||
44229714|NCT01700192|79037691|FG000|Overall Study|Withdrawal by Subject|56|||
44229715|NCT01700192|79037692|FG001|Overall Study|Withdrawal by Subject|64|||
44229716|NCT01700192|79037691|FG000|Overall Study|Never received study drug|1|||
44229717|NCT01700192|79037692|FG001|Overall Study|Never received study drug|0|||
44229718|NCT01709864|79037709|FG000|Overall Study|Physician Decision|0|||
44229719|NCT01709864|79037710|FG001|Overall Study|Physician Decision|1|||
44229720|NCT01709864|79037709|FG000|Overall Study|subject/guardian decision|5|||
44229721|NCT01709864|79037710|FG001|Overall Study|subject/guardian decision|6|||
44229722|NCT01709864|79037709|FG000|Overall Study|Lost to Follow-up|1|||
44229723|NCT01709864|79037710|FG001|Overall Study|Lost to Follow-up|0|||
44229724|NCT01709864|79037709|FG000|Overall Study|non-compliance with study treatment|1|||
44229725|NCT01709864|79037710|FG001|Overall Study|non-compliance with study treatment|1|||
44229726|NCT01709864|79037709|FG000|Overall Study|Adverse Event|0|||
44229727|NCT01709864|79037710|FG001|Overall Study|Adverse Event|2|||
44229728|NCT01709864|79037709|FG000|Overall Study|Death|0|||
44229729|NCT01709864|79037710|FG001|Overall Study|Death|1|||
44492905|NCT00252720|79498731|FG000|Overall Study|Mainly patients lost to follow-up|7|||
44492906|NCT00252720|79498732|FG001|Overall Study|Mainly patients lost to follow-up|18|||
44492907|NCT00167778|79498738|FG000|Overall Study|Withdrawal by Subject|1|||
44492908|NCT00167310|79498745|FG000|Overall Study|Protocol Violation|5|||
44229730|NCT01709708|79037718|FG000|Overall Study|Protocol Violation|1|||
44229731|NCT01709708|79037719|FG001|Overall Study|Protocol Violation|2|||
44229732|NCT01709318|79037742|FG000|Overall Study|Adverse Event|3|||
44492909|NCT00167310|79498746|FG001|Overall Study|Protocol Violation|3|||
44229733|NCT01709318|79037743|FG001|Overall Study|Adverse Event|4|||
44229734|NCT01709318|79037744|FG002|Overall Study|Adverse Event|2|||
44229735|NCT01709318|79037745|FG003|Overall Study|Adverse Event|2|||
44229736|NCT01709318|79037746|FG004|Overall Study|Adverse Event|0|||
44229737|NCT01709318|79037747|FG005|Overall Study|Adverse Event|1|||
44492910|NCT00167310|79498745|FG000|Overall Study|Withdrawal by Subject|3|||
44229738|NCT01709318|79037748|FG006|Overall Study|Adverse Event|2|||
44229739|NCT01709318|79037742|FG000|Overall Study|Lost to Follow-up|2|||
44229740|NCT01709318|79037743|FG001|Overall Study|Lost to Follow-up|0|||
44229741|NCT01709318|79037744|FG002|Overall Study|Lost to Follow-up|0|||
44492911|NCT00167310|79498746|FG001|Overall Study|Withdrawal by Subject|7|||
44492912|NCT03754582|79498752|FG000|Treatment Phase|Adverse Event|0|||
44492913|NCT03754582|79498753|FG001|Treatment Phase|Adverse Event|1|||
44492914|NCT03754582|79498754|FG002|Treatment Phase|Adverse Event|0|||
44229742|NCT01709318|79037745|FG003|Overall Study|Lost to Follow-up|0|||
44229743|NCT01709318|79037746|FG004|Overall Study|Lost to Follow-up|1|||
44229744|NCT01709318|79037747|FG005|Overall Study|Lost to Follow-up|1|||
44229745|NCT01709318|79037748|FG006|Overall Study|Lost to Follow-up|1|||
44229746|NCT01709318|79037742|FG000|Overall Study|Non-compliance with Study Drug|0|||
44229747|NCT01709318|79037743|FG001|Overall Study|Non-compliance with Study Drug|2|||
44492915|NCT03754582|79498752|FG000|Follow-up Phase|Other|0|||
44492916|NCT03754582|79498753|FG001|Follow-up Phase|Other|0|||
44492917|NCT03754582|79498754|FG002|Follow-up Phase|Other|1|||
44492918|NCT00161616|79498772|FG000|Overall Study|Withdrawal by Subject|6|||
44492919|NCT00161616|79498773|FG001|Overall Study|Withdrawal by Subject|5|||
44492920|NCT00161616|79498772|FG000|Overall Study|Physician Decision|1|||
44492921|NCT00161616|79498773|FG001|Overall Study|Physician Decision|0|||
44492922|NCT00161616|79498772|FG000|Overall Study|Death|1|||
44492923|NCT00161616|79498773|FG001|Overall Study|Death|1|||
44492924|NCT00161616|79498772|FG000|Overall Study|Lost to Follow-up|17|||
44492925|NCT00161616|79498773|FG001|Overall Study|Lost to Follow-up|13|||
44492926|NCT00161616|79498772|FG000|Overall Study|Protocol deviation|1|||
44492927|NCT00161616|79498773|FG001|Overall Study|Protocol deviation|0|||
44492928|NCT00252564|79498781|FG000|Overall Study|Adverse Event|17|||
44492929|NCT00252564|79498782|FG001|Overall Study|Adverse Event|13|||
44492930|NCT00252564|79498781|FG000|Overall Study|Unrelated Complication|2|||
44492931|NCT00252564|79498782|FG001|Overall Study|Unrelated Complication|1|||
44492932|NCT00252564|79498781|FG000|Overall Study|Disease Progression|14|||
44492933|NCT00252564|79498782|FG001|Overall Study|Disease Progression|20|||
44492934|NCT00252564|79498781|FG000|Overall Study|Death|0|||
44492935|NCT00252564|79498782|FG001|Overall Study|Death|3|||
44492936|NCT00252564|79498781|FG000|Overall Study|Physician Decision|1|||
44492937|NCT00252564|79498782|FG001|Overall Study|Physician Decision|0|||
44492938|NCT00252564|79498781|FG000|Overall Study|Lost to Follow-up|1|||
44492939|NCT00252564|79498782|FG001|Overall Study|Lost to Follow-up|0|||
44492940|NCT00252564|79498781|FG000|Overall Study|Patient Request|4|||
44492941|NCT00252564|79498782|FG001|Overall Study|Patient Request|5|||
44492942|NCT00252564|79498781|FG000|Overall Study|Withdrawal by Subject|0|||
44492943|NCT00252564|79498782|FG001|Overall Study|Withdrawal by Subject|2|||
44492944|NCT00166296|79498790|FG000|Overall Study|Withdrawal by Subject|1|||
44492945|NCT00166296|79498791|FG001|Overall Study|Withdrawal by Subject|3|||
44492946|NCT00166296|79498790|FG000|Overall Study|Adverse Event|2|||
44492947|NCT00166296|79498791|FG001|Overall Study|Adverse Event|4|||
44492948|NCT00166296|79498790|FG000|Overall Study|Lost to Follow-up|4|||
44492949|NCT00166296|79498791|FG001|Overall Study|Lost to Follow-up|2|||
44492950|NCT00252174|79498800|FG000|Overall Study|Withdrawal by Subject|0|||
44492951|NCT00252174|79498801|FG001|Overall Study|Withdrawal by Subject|1|||
44492952|NCT00252174|79498802|FG002|Overall Study|Withdrawal by Subject|0|||
44492953|NCT00165984|79498810|FG000|Overall Study|Death|15|||
44492954|NCT00160524|79498817|FG000|Overall Study|Adverse Event|119|||
44492955|NCT00160524|79498817|FG000|Overall Study|Adverse Event and Other|94|||
44492956|NCT00160524|79498817|FG000|Overall Study|Protocol Violation|16|||
44492957|NCT00160524|79498817|FG000|Overall Study|Protocol Violation and Other|2|||
44492958|NCT00160524|79498817|FG000|Overall Study|Withdrawal by Subject|141|||
44492959|NCT00160524|79498817|FG000|Overall Study|Withdrawal by Subject and Other|17|||
44492960|NCT00160524|79498817|FG000|Overall Study|Physician Decision|27|||
44492961|NCT00160524|79498817|FG000|Overall Study|Physician Decision and Other|6|||
44492962|NCT00160524|79498817|FG000|Overall Study|Lost to Follow-up|13|||
44492963|NCT00160524|79498817|FG000|Overall Study|Lost to Follow-up and Other|1|||
44492964|NCT00160524|79498817|FG000|Overall Study|Lack of Efficacy|21|||
44492965|NCT00160524|79498817|FG000|Overall Study|Lack of Efficacy and Other|1|||
44492966|NCT00160524|79498817|FG000|Overall Study|Other|20|||
44274581|NCT02248818|79220360|FG001|Screening|Protocol Violation|0|||
44274582|NCT02248818|79220361|FG002|Screening|Protocol Violation|0|||
44492967|NCT00159822|79498821|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
44492968|NCT00159822|79498821|FG000|Voriconazole Treatment Period|Adverse Event|9|||
44492969|NCT00159822|79498821|FG000|Voriconazole Treatment Period|Death|4|||
44492970|NCT00159822|79498821|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
44492971|NCT00159822|79498821|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
44492972|NCT00159822|79498821|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
44492973|NCT00159822|79498821|FG000|Post-treatment Follow-up Period|Death|1|||
44492974|NCT00159822|79498821|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
44229748|NCT01709318|79037744|FG002|Overall Study|Non-compliance with Study Drug|1|||
44229749|NCT01709318|79037745|FG003|Overall Study|Non-compliance with Study Drug|1|||
44229750|NCT01709318|79037746|FG004|Overall Study|Non-compliance with Study Drug|0|||
44229751|NCT01709318|79037747|FG005|Overall Study|Non-compliance with Study Drug|0|||
44229752|NCT01709318|79037748|FG006|Overall Study|Non-compliance with Study Drug|2|||
44229753|NCT01709318|79037742|FG000|Overall Study|Physician Decision|0|||
44229754|NCT01709318|79037743|FG001|Overall Study|Physician Decision|0|||
44229755|NCT01709318|79037744|FG002|Overall Study|Physician Decision|0|||
44229756|NCT01709318|79037745|FG003|Overall Study|Physician Decision|0|||
44229757|NCT01709318|79037746|FG004|Overall Study|Physician Decision|0|||
44229758|NCT01709318|79037747|FG005|Overall Study|Physician Decision|0|||
44229759|NCT01709318|79037748|FG006|Overall Study|Physician Decision|1|||
44229760|NCT01709318|79037742|FG000|Overall Study|Pregnancy|0|||
44229761|NCT01709318|79037743|FG001|Overall Study|Pregnancy|0|||
44229762|NCT01709318|79037744|FG002|Overall Study|Pregnancy|0|||
44229763|NCT01709318|79037745|FG003|Overall Study|Pregnancy|0|||
44229764|NCT01709318|79037746|FG004|Overall Study|Pregnancy|1|||
44229765|NCT01709318|79037747|FG005|Overall Study|Pregnancy|0|||
44376392|NCT00862654|79381512|FG001|Overall Study|Lack of Efficacy|0|||
44376393|NCT00862654|79381513|FG002|Overall Study|Lack of Efficacy|1|||
44546421|NCT05017493|79560485|FG001|Overall Study|Withdrawal by Subject|0|||
44546422|NCT05017493|79560484|FG000|Overall Study|Physician Decision|15|||
44546423|NCT05017493|79560485|FG001|Overall Study|Physician Decision|0|||
44546424|NCT05017493|79560484|FG000|Overall Study|Protocol Violation|81|||
44546425|NCT05017493|79560485|FG001|Overall Study|Protocol Violation|0|||
44546426|NCT04599803|79560491|FG000|Overall Study|Withdrawal by Subject|5|||
44546427|NCT04599803|79560491|FG000|Overall Study|Lost to Follow-up|26|||
44546428|NCT05002985|79560495|FG000|Overall Study|Withdrawal by Subject|1|||
44546429|NCT04580303|79560501|FG000|Overall Study|Adverse Event|0|||
44546430|NCT04580303|79560502|FG001|Overall Study|Adverse Event|1|||
44546431|NCT04580303|79560503|FG002|Overall Study|Adverse Event|0|||
44546432|NCT04580303|79560504|FG003|Overall Study|Adverse Event|0|||
44546433|NCT04580303|79560501|FG000|Overall Study|Withdrawal by Subject|0|||
44546434|NCT04580303|79560502|FG001|Overall Study|Withdrawal by Subject|0|||
44546435|NCT04580303|79560503|FG002|Overall Study|Withdrawal by Subject|1|||
44546436|NCT04580303|79560504|FG003|Overall Study|Withdrawal by Subject|0|||
44546437|NCT04577183|79560514|FG000|Overall Study|Death|1|||
44546438|NCT04577183|79560514|FG000|Overall Study|Withdrawal by Subject|3|||
44376394|NCT00862654|79381514|FG003|Overall Study|Lack of Efficacy|0|||
44376395|NCT00862654|79381511|FG000|Overall Study|Lost to Follow-up|1|||
44376396|NCT00862654|79381512|FG001|Overall Study|Lost to Follow-up|2|||
44376397|NCT00862654|79381513|FG002|Overall Study|Lost to Follow-up|1|||
44376398|NCT00862654|79381514|FG003|Overall Study|Lost to Follow-up|3|||
44376399|NCT00862654|79381511|FG000|Overall Study|Adverse Event|0|||
44376400|NCT00862654|79381512|FG001|Overall Study|Adverse Event|1|||
44376401|NCT00862654|79381513|FG002|Overall Study|Adverse Event|1|||
44376402|NCT00862654|79381514|FG003|Overall Study|Adverse Event|0|||
44492975|NCT00159822|79498821|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
44492976|NCT00158262|79498827|FG000|Overall Study|Lost to Follow-up|1|||
44492977|NCT00158262|79498828|FG001|Overall Study|Lost to Follow-up|1|||
44492978|NCT00157950|79498836|FG000|Overall Study|Death|1|||
44492979|NCT00157950|79498837|FG001|Overall Study|Death|0|||
44492980|NCT03745768|79498845|FG000|Overall Study|discontinued study|2|||
44492981|NCT03745768|79498846|FG001|Overall Study|discontinued study|0|||
44492982|NCT03745222|79498855|FG000|Overall Study|Withdrawal by Subject|0|||
44546439|NCT04577183|79560514|FG000|Overall Study|Early termination|2|||
44546440|NCT04574999|79560520|FG000|Overall Study|Adverse Event|1|||
44376403|NCT00862654|79381511|FG000|Overall Study|Pregnancy|1|||
44546441|NCT04574999|79560521|FG001|Overall Study|Adverse Event|0|||
44546442|NCT04574999|79560520|FG000|Overall Study|Lack of Efficacy|2|||
44229766|NCT01709318|79037748|FG006|Overall Study|Pregnancy|0|||
44492983|NCT03745222|79498856|FG001|Overall Study|Withdrawal by Subject|1|||
44229767|NCT01709318|79037742|FG000|Overall Study|Protocol Violation|0|||
44229768|NCT01709318|79037743|FG001|Overall Study|Protocol Violation|0|||
44376404|NCT00862654|79381512|FG001|Overall Study|Pregnancy|1|||
44492984|NCT03745222|79498857|FG002|Overall Study|Withdrawal by Subject|0|||
44546443|NCT04574999|79560521|FG001|Overall Study|Lack of Efficacy|3|||
44546444|NCT04574999|79560520|FG000|Overall Study|Protocol Violation|1|||
44376405|NCT00862654|79381513|FG002|Overall Study|Pregnancy|0|||
44546445|NCT04574999|79560521|FG001|Overall Study|Protocol Violation|0|||
44546446|NCT04574999|79560520|FG000|Overall Study|Withdrawal by Subject|2|||
44546447|NCT04574999|79560521|FG001|Overall Study|Withdrawal by Subject|2|||
44229769|NCT01709318|79037744|FG002|Overall Study|Protocol Violation|0|||
44229770|NCT01709318|79037745|FG003|Overall Study|Protocol Violation|0|||
44229771|NCT01709318|79037746|FG004|Overall Study|Protocol Violation|2|||
44229772|NCT01709318|79037747|FG005|Overall Study|Protocol Violation|0|||
44492985|NCT03743038|79498865|FG000|Overall Study|Physician Decision|1|||
44492986|NCT00153816|79498877|FG000|Overall Study|Death|6|||
44492987|NCT00153816|79498878|FG001|Overall Study|Death|5|||
44492988|NCT00153816|79498879|FG002|Overall Study|Death|4|||
44492989|NCT00153816|79498880|FG003|Overall Study|Death|6|||
44492990|NCT00153816|79498881|FG004|Overall Study|Death|0|||
44492991|NCT00153816|79498882|FG005|Overall Study|Death|2|||
44492992|NCT00153816|79498877|FG000|Overall Study|Lost to Follow-up|7|||
44492993|NCT00153816|79498878|FG001|Overall Study|Lost to Follow-up|8|||
44492994|NCT00153816|79498879|FG002|Overall Study|Lost to Follow-up|5|||
44492995|NCT00153816|79498880|FG003|Overall Study|Lost to Follow-up|8|||
44492996|NCT00153816|79498881|FG004|Overall Study|Lost to Follow-up|7|||
44492997|NCT00153816|79498882|FG005|Overall Study|Lost to Follow-up|9|||
44492998|NCT00153816|79498877|FG000|Overall Study|Withdrawal by Subject|9|||
44492999|NCT00153816|79498878|FG001|Overall Study|Withdrawal by Subject|9|||
44493000|NCT00153816|79498879|FG002|Overall Study|Withdrawal by Subject|9|||
44493001|NCT00153816|79498880|FG003|Overall Study|Withdrawal by Subject|4|||
44493002|NCT00153816|79498881|FG004|Overall Study|Withdrawal by Subject|1|||
44493003|NCT00153816|79498882|FG005|Overall Study|Withdrawal by Subject|5|||
44493004|NCT00153816|79498877|FG000|Overall Study|Follow-up exam not done|8|||
44493005|NCT00153816|79498878|FG001|Overall Study|Follow-up exam not done|7|||
44493006|NCT00153816|79498879|FG002|Overall Study|Follow-up exam not done|11|||
44493007|NCT00153816|79498880|FG003|Overall Study|Follow-up exam not done|10|||
44493008|NCT00153816|79498881|FG004|Overall Study|Follow-up exam not done|8|||
44493009|NCT00153816|79498882|FG005|Overall Study|Follow-up exam not done|9|||
44493010|NCT00153816|79498877|FG000|Overall Study|Follow-up exam done, histology missing|2|||
44493011|NCT00153816|79498878|FG001|Overall Study|Follow-up exam done, histology missing|3|||
44493012|NCT00153816|79498879|FG002|Overall Study|Follow-up exam done, histology missing|3|||
44493013|NCT00153816|79498880|FG003|Overall Study|Follow-up exam done, histology missing|3|||
44493014|NCT00153816|79498881|FG004|Overall Study|Follow-up exam done, histology missing|1|||
44493015|NCT00153816|79498882|FG005|Overall Study|Follow-up exam done, histology missing|2|||
44493016|NCT00151476|79498899|FG000|FAP Identified Subjects|Protocol Violation|0|||
44493017|NCT00151476|79498900|FG001|FAP Identified Subjects|Protocol Violation|1|||
44493018|NCT00151476|79498899|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
44493019|NCT00151476|79498900|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
44493020|NCT00151476|79498899|FG000|FAP Analyzed Subjects|Other study participation|0|||
44493021|NCT00151476|79498900|FG001|FAP Analyzed Subjects|Other study participation|1|||
44546448|NCT04574999|79560520|FG000|Overall Study|Lost to Follow-up|1|||
44546449|NCT04574999|79560521|FG001|Overall Study|Lost to Follow-up|0|||
44546450|NCT04574999|79560520|FG000|Overall Study|Personal problems|1|||
44546451|NCT04574999|79560521|FG001|Overall Study|Personal problems|0|||
44546452|NCT04574999|79560520|FG000|Overall Study|Previous planned surgery|1|||
44546453|NCT04574999|79560521|FG001|Overall Study|Previous planned surgery|0|||
44546454|NCT04565249|79560531|FG000|Overall Study|Death|0|||
44546455|NCT04565249|79560532|FG001|Overall Study|Death|0|||
44546456|NCT04565249|79560533|FG002|Overall Study|Death|0|||
44546457|NCT04565249|79560534|FG003|Overall Study|Death|1|||
44546458|NCT04942925|79560546|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
44546459|NCT04942925|79560547|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
44546460|NCT04942925|79560546|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
44546461|NCT04942925|79560547|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
44546462|NCT04854707|79560559|FG000|Overall Study|Lack of Efficacy|78|||
44546463|NCT04854707|79560560|FG001|Overall Study|Lack of Efficacy|59|||
44546464|NCT04854707|79560561|FG002|Overall Study|Lack of Efficacy|30|||
44546465|NCT04557371|79560576|FG000|Overall Study|Covid-19-related|0|||
44546466|NCT04557371|79560577|FG001|Overall Study|Covid-19-related|1|||
44546467|NCT04557371|79560578|FG002|Overall Study|Covid-19-related|0|||
44546468|NCT04557371|79560576|FG000|Overall Study|Withdrawal by Subject|0|||
44546469|NCT04557371|79560577|FG001|Overall Study|Withdrawal by Subject|1|||
44546470|NCT04557371|79560578|FG002|Overall Study|Withdrawal by Subject|0|||
44546471|NCT04557371|79560576|FG000|Overall Study|Adverse Event|1|||
44546472|NCT04557371|79560577|FG001|Overall Study|Adverse Event|0|||
44546473|NCT04557371|79560578|FG002|Overall Study|Adverse Event|0|||
44546474|NCT04821245|79560586|FG000|Overall Study|Withdrawal by Subject|3|||
44546475|NCT04821245|79560586|FG000|Overall Study|Physician Decision|1|||
44546476|NCT04821245|79560586|FG000|Overall Study|Protocol Violation|5|||
44546477|NCT04539275|79560594|FG000|Overall Study|Death|2|||
44546478|NCT04539275|79560595|FG001|Overall Study|Death|4|||
44546479|NCT04539275|79560594|FG000|Overall Study|Lost to Follow-up|1|||
44546480|NCT04539275|79560595|FG001|Overall Study|Lost to Follow-up|1|||
44546481|NCT04539275|79560594|FG000|Overall Study|Withdrawal by Subject|3|||
44546482|NCT04539275|79560595|FG001|Overall Study|Withdrawal by Subject|0|||
44546483|NCT04784897|79560604|FG000|Overall Study|Death|4|||
44546484|NCT04784897|79560605|FG001|Overall Study|Death|2|||
44546485|NCT04784897|79560606|FG002|Overall Study|Death|1|||
44546486|NCT04784897|79560604|FG000|Overall Study|Withdrawal by Subject|0|||
44546487|NCT04784897|79560605|FG001|Overall Study|Withdrawal by Subject|0|||
44546488|NCT04784897|79560606|FG002|Overall Study|Withdrawal by Subject|1|||
44546489|NCT04532099|79560620|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
44546490|NCT04532099|79560621|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
44546491|NCT04532099|79560622|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
44546492|NCT03041792|79560636|FG000|Overall Study|Adverse Event|4|||
44546493|NCT03041792|79560637|FG001|Overall Study|Adverse Event|0|||
44546494|NCT03041792|79560636|FG000|Overall Study|Death in the family|0|||
44546495|NCT03041792|79560637|FG001|Overall Study|Death in the family|2|||
44546496|NCT03041792|79560636|FG000|Overall Study|Randomized but not treated|0|||
44546497|NCT03041792|79560637|FG001|Overall Study|Randomized but not treated|1|||
44546498|NCT04507763|79560643|FG000|Overall Study|Participants did not meet entrance criteria|201|||
44493022|NCT00149994|79498909|FG000|Overall Study|Administrative problems:|1|||
44493023|NCT00149994|79498910|FG001|Overall Study|Administrative problems:|0|||
44493024|NCT00149994|79498909|FG000|Overall Study|Protocol Violation|0|||
44493025|NCT00149994|79498910|FG001|Overall Study|Protocol Violation|1|||
44493026|NCT00149214|79498918|FG000|Overall Study|Adverse Event|12|||
44493027|NCT00149214|79498919|FG001|Overall Study|Adverse Event|9|||
44493028|NCT00149214|79498918|FG000|Overall Study|Withdrawal by Subject|4|||
44493029|NCT00149214|79498919|FG001|Overall Study|Withdrawal by Subject|1|||
44493030|NCT00149214|79498918|FG000|Overall Study|Physician Decision|3|||
44493031|NCT00149214|79498919|FG001|Overall Study|Physician Decision|3|||
44493032|NCT00149214|79498918|FG000|Overall Study|Sponsor Decision|0|||
44493033|NCT00149214|79498919|FG001|Overall Study|Sponsor Decision|1|||
44493034|NCT00149214|79498918|FG000|Overall Study|Progressive Disease|7|||
44546499|NCT03045302|79560650|FG000|Overall Study|Pre-treatment adverse event|1|||
44546500|NCT00705484|79560656|FG000|Overall Study|Adverse Event|28|||
44546501|NCT00705484|79560657|FG001|Overall Study|Adverse Event|27|||
44546502|NCT00705484|79560656|FG000|Overall Study|Lost to Follow-up|169|||
44546503|NCT00705484|79560657|FG001|Overall Study|Lost to Follow-up|250|||
44546504|NCT00705484|79560656|FG000|Overall Study|Withdrawal by Subject|96|||
44546505|NCT00705484|79560657|FG001|Overall Study|Withdrawal by Subject|72|||
44546506|NCT00705484|79560656|FG000|Overall Study|Administrative|89|||
44546507|NCT00705484|79560657|FG001|Overall Study|Administrative|59|||
44493035|NCT00149214|79498919|FG001|Overall Study|Progressive Disease|3|||
44493036|NCT00114972|79498936|FG000|Overall Study|Withdrawal by Subject|40|||
44546508|NCT04523831|79560667|FG000|Overall Study|Lost to Follow-up|15|||
44546509|NCT04523831|79560668|FG001|Overall Study|Lost to Follow-up|17|||
44546510|NCT04523831|79560667|FG000|Overall Study|Death|0|||
44546511|NCT04523831|79560668|FG001|Overall Study|Death|3|||
44546512|NCT04523831|79560667|FG000|Overall Study|Adverse Event|2|||
44546513|NCT04523831|79560668|FG001|Overall Study|Adverse Event|0|||
44546514|NCT04707664|79560679|FG000|Overall Study|Adverse Event|2|||
44546515|NCT04707664|79560680|FG001|Overall Study|Adverse Event|0|||
44546516|NCT04707664|79560679|FG000|Overall Study|Death|1|||
44546517|NCT04707664|79560680|FG001|Overall Study|Death|2|||
44546518|NCT04707664|79560679|FG000|Overall Study|Withdrawal by Subject|13|||
44546519|NCT04707664|79560680|FG001|Overall Study|Withdrawal by Subject|21|||
44546520|NCT04707664|79560679|FG000|Overall Study|Lost to Follow-up|11|||
44546521|NCT04707664|79560680|FG001|Overall Study|Lost to Follow-up|13|||
44546522|NCT04707664|79560679|FG000|Overall Study|Not treated|2|||
44546523|NCT04707664|79560680|FG001|Overall Study|Not treated|0|||
44546524|NCT01316276|79560686|FG000|Overall Study|Death|1|||
44546525|NCT01316276|79560686|FG000|Overall Study|Adverse Event|19|||
44546526|NCT01316276|79560686|FG000|Overall Study|Withdrawal of consent|24|||
44546527|NCT01316276|79560686|FG000|Overall Study|Lost to Follow-up|1|||
44546528|NCT01316276|79560686|FG000|Overall Study|Other|22|||
44546529|NCT04668989|79560691|FG000|First Intervention|Covid-19 related self-isolation|0|||
44546530|NCT04668989|79560692|FG001|First Intervention|Covid-19 related self-isolation|1|||
44546531|NCT04668989|79560691|FG000|Second Intervention|Adverse Event|0|||
44546532|NCT04668989|79560692|FG001|Second Intervention|Adverse Event|1|||
44546533|NCT03700385|79560698|FG000|Overall Study|Lost to Follow-up|1|||
44546534|NCT04498403|79560704|FG000|Overall Study|Adverse Event|1|||
44546535|NCT04498403|79560705|FG001|Overall Study|Adverse Event|0|||
44546536|NCT04498403|79560704|FG000|Overall Study|Study Terminated By Sponsor|29|||
44546537|NCT04498403|79560705|FG001|Overall Study|Study Terminated By Sponsor|10|||
44546538|NCT04362137|79560713|FG000|Overall Study|Death|9|||
44546539|NCT04362137|79560714|FG001|Overall Study|Death|3|||
44546540|NCT04362137|79560713|FG000|Overall Study|Patient decision|6|||
44546541|NCT04362137|79560714|FG001|Overall Study|Patient decision|3|||
44546542|NCT04362137|79560713|FG000|Overall Study|Adverse Event|1|||
44546543|NCT04362137|79560714|FG001|Overall Study|Adverse Event|0|||
44546544|NCT04362137|79560713|FG000|Overall Study|Lost to Follow-up|1|||
44546545|NCT04362137|79560714|FG001|Overall Study|Lost to Follow-up|0|||
44546546|NCT04362137|79560713|FG000|Overall Study|Protocol deviation|1|||
44546547|NCT04362137|79560714|FG001|Overall Study|Protocol deviation|0|||
44546548|NCT05099380|79560722|FG000|Overall Study|Subject enrolled in error|1|||
44546549|NCT05099380|79560723|FG001|Overall Study|Subject enrolled in error|0|||
44546550|NCT05099380|79560722|FG000|Overall Study|Study Procedure|1|||
44546551|NCT05099380|79560723|FG001|Overall Study|Study Procedure|0|||
44546552|NCT05099380|79560722|FG000|Overall Study|Protocol Violation|1|||
44546553|NCT05099380|79560723|FG001|Overall Study|Protocol Violation|0|||
44546554|NCT05099380|79560722|FG000|Overall Study|Adverse Event|1|||
44546555|NCT05099380|79560723|FG001|Overall Study|Adverse Event|1|||
44546556|NCT05099380|79560722|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
44493037|NCT00114972|79498937|FG001|Overall Study|Withdrawal by Subject|7|||
44493038|NCT00114972|79498936|FG000|Overall Study|Lost to Follow-up|8|||
44493039|NCT00114972|79498937|FG001|Overall Study|Lost to Follow-up|5|||
44493040|NCT00129402|79498945|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
44493041|NCT00129402|79498946|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
44493042|NCT00129402|79498947|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
44493043|NCT00129402|79498948|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
44493044|NCT00129402|79498949|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
44493045|NCT00129402|79498950|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
44493046|NCT00129402|79498951|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
44493047|NCT00129402|79498945|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
44493048|NCT00129402|79498946|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
44493049|NCT00129402|79498947|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
44493050|NCT00129402|79498948|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
44493051|NCT00129402|79498949|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
44546557|NCT05099380|79560723|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
44546558|NCT03614728|79560733|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
44546559|NCT03614728|79560734|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
44546560|NCT03614728|79560735|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
44546561|NCT03614728|79560736|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
44546562|NCT03614728|79560733|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
44229773|NCT01709318|79037748|FG006|Overall Study|Protocol Violation|1|||
44493052|NCT00129402|79498950|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
44546563|NCT03614728|79560734|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
44546564|NCT03614728|79560735|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
44546565|NCT03614728|79560736|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
44546566|NCT03154086|79560759|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546567|NCT03154086|79560760|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546568|NCT03154086|79560761|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546569|NCT03154086|79560762|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
44546570|NCT03154086|79560763|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546571|NCT03154086|79560764|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546572|NCT03154086|79560765|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546573|NCT03154086|79560766|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546574|NCT03154086|79560767|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546575|NCT03154086|79560768|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546576|NCT03154086|79560769|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546577|NCT03154086|79560770|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546578|NCT03154086|79560771|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546579|NCT03154086|79560772|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546580|NCT03154086|79560773|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
44546581|NCT03154086|79560759|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546582|NCT03154086|79560760|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
44546583|NCT03154086|79560761|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546584|NCT03154086|79560762|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546585|NCT03154086|79560763|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546586|NCT03154086|79560764|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546587|NCT03154086|79560765|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546588|NCT03154086|79560766|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546589|NCT03154086|79560767|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546590|NCT03154086|79560768|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546591|NCT03154086|79560769|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546592|NCT03154086|79560770|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546593|NCT03154086|79560771|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546594|NCT03154086|79560772|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546595|NCT03154086|79560773|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
44546596|NCT03154086|79560759|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546597|NCT03154086|79560760|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546598|NCT03154086|79560761|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
44546599|NCT03154086|79560762|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546600|NCT03154086|79560763|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546601|NCT03154086|79560764|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546602|NCT03154086|79560765|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546603|NCT03154086|79560766|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546604|NCT03154086|79560767|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546605|NCT03154086|79560768|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546606|NCT03154086|79560769|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546607|NCT03154086|79560770|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546608|NCT03154086|79560771|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546609|NCT03154086|79560772|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546610|NCT03154086|79560773|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
44546611|NCT03154086|79560759|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
44493053|NCT00129402|79498951|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
44493054|NCT00129402|79498945|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
44493055|NCT00129402|79498946|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
44493056|NCT00129402|79498947|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
44493057|NCT00129402|79498948|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
44493058|NCT00129402|79498949|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
44493059|NCT00129402|79498950|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
44493060|NCT00129402|79498951|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
44493061|NCT00129402|79498945|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
44493062|NCT00129402|79498946|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
44493063|NCT00129402|79498947|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
44493064|NCT00129402|79498948|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
44493065|NCT00129402|79498949|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
44546612|NCT03154086|79560760|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44229774|NCT01709318|79037742|FG000|Overall Study|Technical Problems|1|||
44229775|NCT01709318|79037743|FG001|Overall Study|Technical Problems|0|||
44493066|NCT00129402|79498950|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
44493067|NCT00129402|79498951|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
44546613|NCT03154086|79560761|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546614|NCT03154086|79560762|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546615|NCT03154086|79560763|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546616|NCT03154086|79560764|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546617|NCT03154086|79560765|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546618|NCT03154086|79560766|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546619|NCT03154086|79560767|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546620|NCT03154086|79560768|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546621|NCT03154086|79560769|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546622|NCT03154086|79560770|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546623|NCT03154086|79560771|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546624|NCT03154086|79560772|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546625|NCT03154086|79560773|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
44546626|NCT03154086|79560759|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546627|NCT03154086|79560760|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546628|NCT03154086|79560761|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546629|NCT03154086|79560762|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546630|NCT03154086|79560763|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546631|NCT03154086|79560764|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546632|NCT03154086|79560765|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546633|NCT03154086|79560766|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546634|NCT03154086|79560767|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
44546635|NCT03154086|79560768|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546636|NCT03154086|79560769|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546637|NCT03154086|79560770|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546638|NCT03154086|79560771|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546639|NCT03154086|79560772|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546640|NCT03154086|79560773|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
44546641|NCT03154086|79560759|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546642|NCT03154086|79560760|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546643|NCT03154086|79560761|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546644|NCT03154086|79560762|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546645|NCT03154086|79560763|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546646|NCT03154086|79560764|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546647|NCT03154086|79560765|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546648|NCT03154086|79560766|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
44546649|NCT03154086|79560767|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546650|NCT03154086|79560768|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546651|NCT03154086|79560769|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546652|NCT03154086|79560770|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546653|NCT03154086|79560771|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546654|NCT03154086|79560772|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546655|NCT03154086|79560773|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
44546656|NCT03154086|79560759|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
44546657|NCT03154086|79560760|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
44546658|NCT03154086|79560761|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
44546659|NCT03154086|79560762|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
44546660|NCT03154086|79560763|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
44546661|NCT03154086|79560764|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
44546662|NCT03154086|79560765|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
44546663|NCT03154086|79560766|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
44546664|NCT03154086|79560767|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
44546665|NCT03154086|79560768|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
44546666|NCT03154086|79560769|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
44546667|NCT03154086|79560770|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
44546668|NCT03154086|79560771|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
44546669|NCT03154086|79560772|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
44546670|NCT03154086|79560773|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
44546671|NCT02723344|79560831|FG000|Overall Study|Lost to Follow-up|0|||
44546672|NCT02723344|79560832|FG001|Overall Study|Lost to Follow-up|4|||
44546673|NCT02723188|79560841|FG000|Overall Study|Withdrawal by Subject|1|||
44546674|NCT02723188|79560842|FG001|Overall Study|Withdrawal by Subject|0|||
44546675|NCT02723188|79560843|FG002|Overall Study|Withdrawal by Subject|0|||
44546676|NCT00705406|79560853|FG000|Overall Study|Lost to Follow-up|3|||
44546677|NCT00705406|79560854|FG001|Overall Study|Lost to Follow-up|3|||
44546678|NCT00705406|79560853|FG000|Overall Study|Did not receive study drug|1|||
44546679|NCT00705406|79560854|FG001|Overall Study|Did not receive study drug|2|||
44546680|NCT03155178|79560865|FG000|Overall Study|Did not meet treatment day baseline|7|||
44546681|NCT03155178|79560866|FG001|Overall Study|Did not meet treatment day baseline|7|||
44546682|NCT03155178|79560867|FG002|Overall Study|Did not meet treatment day baseline|7|||
44546683|NCT03155178|79560868|FG003|Overall Study|Did not meet treatment day baseline|7|||
44546684|NCT00705250|79560892|FG000|Overall Study|Withdrawal by Subject|1|||
44546685|NCT00705250|79560892|FG000|Overall Study|Patient died in car accident|1|||
44546686|NCT05553600|79560898|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
44546687|NCT05553600|79560899|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
44546688|NCT05553600|79560900|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
44546689|NCT05553600|79560901|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
44546690|NCT05553600|79560898|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
44546691|NCT05553600|79560899|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
44546692|NCT05553600|79560900|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
44546693|NCT05553600|79560901|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
44546694|NCT05553600|79560898|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
44546695|NCT05553600|79560899|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
44546696|NCT05553600|79560900|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
44546697|NCT05553600|79560901|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
44546698|NCT05553600|79560898|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
44546699|NCT05553600|79560899|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
44546700|NCT05553600|79560900|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
44546701|NCT05553600|79560901|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
44546702|NCT05553600|79560898|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
44546703|NCT05553600|79560899|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
44229776|NCT01709318|79037744|FG002|Overall Study|Technical Problems|0|||
44376406|NCT00862654|79381514|FG003|Overall Study|Pregnancy|0|||
44376407|NCT00862654|79381511|FG000|Overall Study|Withdrawal by Subject|2|||
44376408|NCT00862654|79381512|FG001|Overall Study|Withdrawal by Subject|2|||
44376409|NCT00862654|79381513|FG002|Overall Study|Withdrawal by Subject|2|||
44376410|NCT00862654|79381514|FG003|Overall Study|Withdrawal by Subject|3|||
44376411|NCT00862654|79381511|FG000|Overall Study|Subject mistake|0|||
44493068|NCT00129402|79498945|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
44493069|NCT00129402|79498946|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
44493070|NCT00129402|79498947|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
44493071|NCT00129402|79498948|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
44493072|NCT00129402|79498949|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
44493073|NCT00129402|79498950|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
44493074|NCT00129402|79498951|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
44493075|NCT00129402|79498945|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
44493076|NCT00129402|79498946|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
44493077|NCT00129402|79498947|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
44493078|NCT00129402|79498948|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
44493079|NCT00129402|79498949|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
44493080|NCT00129402|79498950|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
44493081|NCT00129402|79498951|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
44493082|NCT00129402|79498945|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
44546704|NCT05553600|79560900|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
44546705|NCT05553600|79560901|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
44376412|NCT00862654|79381512|FG001|Overall Study|Subject mistake|1|||
44376413|NCT00862654|79381513|FG002|Overall Study|Subject mistake|0|||
44376414|NCT00862654|79381514|FG003|Overall Study|Subject mistake|0|||
44376415|NCT00862654|79381511|FG000|Overall Study|Familly constraint|0|||
44376416|NCT00862654|79381512|FG001|Overall Study|Familly constraint|1|||
44546706|NCT05553600|79560898|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
44546707|NCT05553600|79560899|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
44546708|NCT05553600|79560900|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
44376417|NCT00862654|79381513|FG002|Overall Study|Familly constraint|0|||
44376418|NCT00862654|79381514|FG003|Overall Study|Familly constraint|0|||
44376419|NCT00862654|79381511|FG000|Overall Study|Never used study drugs|1|||
44376420|NCT00862654|79381512|FG001|Overall Study|Never used study drugs|0|||
44376421|NCT00862654|79381513|FG002|Overall Study|Never used study drugs|0|||
44376422|NCT00862654|79381514|FG003|Overall Study|Never used study drugs|0|||
44376423|NCT00862654|79381511|FG000|Overall Study|Included after end of inclusions|0|||
44376424|NCT00862654|79381512|FG001|Overall Study|Included after end of inclusions|0|||
44376425|NCT00862654|79381513|FG002|Overall Study|Included after end of inclusions|1|||
44376426|NCT00862654|79381514|FG003|Overall Study|Included after end of inclusions|0|||
44376427|NCT00867490|79381524|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
44376428|NCT00867490|79381524|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
44376429|NCT00867490|79381524|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
44376430|NCT00867490|79381524|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
44376431|NCT00867490|79381524|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
44493083|NCT00129402|79498946|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
44493084|NCT00129402|79498947|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
44493085|NCT00129402|79498948|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
44546709|NCT05553600|79560901|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
44546710|NCT05553600|79560898|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
44546711|NCT05553600|79560899|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
44546712|NCT05553600|79560900|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
44546713|NCT05553600|79560901|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
44546714|NCT05553600|79560898|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
44546715|NCT05553600|79560899|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
44546716|NCT05553600|79560900|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
44546717|NCT05553600|79560901|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
44546718|NCT05553600|79560898|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
44546719|NCT05553600|79560899|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
44546720|NCT05553600|79560900|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
44546721|NCT05553600|79560901|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
44546722|NCT05553600|79560898|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
44546723|NCT05553600|79560899|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
44376432|NCT00930774|79381535|FG000|Overall Study|Withdrawal by Subject|1|||
44376433|NCT00930774|79381536|FG001|Overall Study|Withdrawal by Subject|9|||
44376434|NCT00930774|79381537|FG002|Overall Study|Withdrawal by Subject|2|||
44493086|NCT00129402|79498949|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
44493087|NCT00129402|79498950|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
44493088|NCT00129402|79498951|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
44493089|NCT00129402|79498945|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
44493090|NCT00129402|79498946|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
44493091|NCT00129402|79498947|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
44493092|NCT00129402|79498948|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
44493093|NCT00129402|79498949|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
44493094|NCT00129402|79498950|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
44493095|NCT00129402|79498951|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
44493096|NCT00129402|79498945|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
44493097|NCT00129402|79498946|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
44493098|NCT00129402|79498947|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
44493099|NCT00129402|79498948|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
44493100|NCT00129402|79498949|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
44493101|NCT00129402|79498950|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
44493102|NCT00129402|79498951|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
44493103|NCT00129402|79498945|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
44493104|NCT00129402|79498946|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
44493105|NCT00129402|79498947|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
44546724|NCT05553600|79560900|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
44274583|NCT02248818|79220362|FG003|Screening|Protocol Violation|0|||
44376435|NCT00930774|79381538|FG003|Overall Study|Withdrawal by Subject|0|||
44546725|NCT05553600|79560901|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
44546726|NCT05553600|79560898|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
44546727|NCT05553600|79560899|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
44546728|NCT05553600|79560900|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
44546729|NCT05553600|79560901|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
44229777|NCT01709318|79037745|FG003|Overall Study|Technical Problems|0|||
44229778|NCT01709318|79037746|FG004|Overall Study|Technical Problems|0|||
44229779|NCT01709318|79037747|FG005|Overall Study|Technical Problems|0|||
44546730|NCT05553600|79560898|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
44546731|NCT05553600|79560899|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
44546732|NCT05553600|79560900|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
44546733|NCT05553600|79560901|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
44546734|NCT05451329|79560915|FG000|Overall Study|Adverse Event|1|||
44546735|NCT05451329|79560916|FG001|Overall Study|Adverse Event|1|||
44546736|NCT05451329|79560917|FG002|Overall Study|Adverse Event|0|||
44546737|NCT05451329|79560915|FG000|Overall Study|Withdrawal by Subject|1|||
44546738|NCT05451329|79560916|FG001|Overall Study|Withdrawal by Subject|0|||
44546739|NCT05451329|79560917|FG002|Overall Study|Withdrawal by Subject|0|||
44546740|NCT05451329|79560915|FG000|Overall Study|Investigational Product Lot exchange|1|||
44546741|NCT05451329|79560916|FG001|Overall Study|Investigational Product Lot exchange|1|||
44546742|NCT05451329|79560917|FG002|Overall Study|Investigational Product Lot exchange|0|||
44546743|NCT05013905|79560945|FG000|Overall Study|Adverse Event|1|||
44546744|NCT05013905|79560945|FG000|Overall Study|Lack of Efficacy|1|||
44546745|NCT04887506|79560955|FG000|Overall Study|Death|1|||
44546746|NCT04887506|79560956|FG001|Overall Study|Death|1|||
44546747|NCT04887506|79560955|FG000|Overall Study|Withdrawal by Subject|0|||
44546748|NCT04887506|79560956|FG001|Overall Study|Withdrawal by Subject|3|||
44546749|NCT04887506|79560955|FG000|Overall Study|Adverse Event|4|||
44546750|NCT04887506|79560956|FG001|Overall Study|Adverse Event|3|||
44546751|NCT04887506|79560955|FG000|Overall Study|Other - Not Reported|1|||
44546752|NCT04887506|79560956|FG001|Overall Study|Other - Not Reported|1|||
44546753|NCT04872569|79560966|FG000|Overall Study|Withdrawal by Subject|2|||
44546754|NCT04871776|79560974|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
44546755|NCT04871776|79560975|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
44546756|NCT04871776|79560976|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
44546757|NCT04871776|79560974|FG000|Overall Study|Did not meet eligibility criteria|1|||
44546758|NCT04871776|79560975|FG001|Overall Study|Did not meet eligibility criteria|1|||
44546759|NCT04871776|79560976|FG002|Overall Study|Did not meet eligibility criteria|1|||
44546760|NCT04854642|79560984|FG000|Overall Study|Adverse Event|1|||
44546761|NCT04854642|79560985|FG001|Overall Study|Adverse Event|2|||
44546762|NCT04854642|79560984|FG000|Overall Study|Withdrawal by Subject|0|||
44546763|NCT04854642|79560985|FG001|Overall Study|Withdrawal by Subject|1|||
44546764|NCT04832971|79560997|FG000|Overall Study|Death|1|||
44546765|NCT04832971|79560998|FG001|Overall Study|Death|0|||
44546766|NCT04832971|79560999|FG002|Overall Study|Death|0|||
44546767|NCT04832971|79561000|FG003|Overall Study|Death|0|||
44546768|NCT04832971|79560997|FG000|Overall Study|Lost to Follow-up|1|||
44546769|NCT04832971|79560998|FG001|Overall Study|Lost to Follow-up|1|||
44546770|NCT04832971|79560999|FG002|Overall Study|Lost to Follow-up|1|||
44546771|NCT04832971|79561000|FG003|Overall Study|Lost to Follow-up|0|||
44546772|NCT04832971|79560997|FG000|Overall Study|Withdrawal by Subject|1|||
44546773|NCT04832971|79560998|FG001|Overall Study|Withdrawal by Subject|3|||
44229780|NCT01709318|79037748|FG006|Overall Study|Technical Problems|0|||
44229781|NCT01709318|79037742|FG000|Overall Study|Withdrawal by Subject|3|||
44229782|NCT01709318|79037743|FG001|Overall Study|Withdrawal by Subject|0|||
44546774|NCT04832971|79560999|FG002|Overall Study|Withdrawal by Subject|2|||
44546775|NCT04832971|79561000|FG003|Overall Study|Withdrawal by Subject|2|||
44546776|NCT04832971|79560997|FG000|Overall Study|Other, Not Specified|0|||
44546777|NCT04832971|79560998|FG001|Overall Study|Other, Not Specified|0|||
44546778|NCT04832971|79560999|FG002|Overall Study|Other, Not Specified|1|||
44546779|NCT04832971|79561000|FG003|Overall Study|Other, Not Specified|0|||
44546780|NCT04824521|79561012|FG000|Overall Study|Lost to Follow-up|1|||
44546781|NCT04706091|79561018|FG000|Treatment 2|Withdrawal by Subject|1|||
44546782|NCT04706091|79561019|FG001|Treatment 2|Withdrawal by Subject|0|||
44546783|NCT04669691|79561031|FG000|Overall Study|Death|0|||
44546784|NCT04669691|79561032|FG001|Overall Study|Death|1|||
44546785|NCT04669691|79561033|FG002|Overall Study|Death|0|||
44546786|NCT04669691|79561034|FG003|Overall Study|Death|0|||
44546787|NCT04669691|79561035|FG004|Overall Study|Death|0|||
44546788|NCT04669691|79561036|FG005|Overall Study|Death|0|||
44546789|NCT04610580|79561050|FG000|Two-way Crossover Period|Adverse Event|1|||
44546790|NCT04610580|79561051|FG001|Two-way Crossover Period|Adverse Event|0|||
44546791|NCT04610580|79561052|FG002|Two-way Crossover Period|Adverse Event|0|||
44546792|NCT04610580|79561053|FG003|Two-way Crossover Period|Adverse Event|0|||
44229783|NCT01709318|79037744|FG002|Overall Study|Withdrawal by Subject|3|||
44229784|NCT01709318|79037745|FG003|Overall Study|Withdrawal by Subject|3|||
44229785|NCT01709318|79037746|FG004|Overall Study|Withdrawal by Subject|0|||
44229786|NCT01709318|79037747|FG005|Overall Study|Withdrawal by Subject|2|||
44546793|NCT04610580|79561054|FG004|Two-way Crossover Period|Adverse Event|0|||
44546794|NCT04610580|79561055|FG005|Two-way Crossover Period|Adverse Event|0|||
44229787|NCT01709318|79037748|FG006|Overall Study|Withdrawal by Subject|4|||
44229788|NCT01709318|79037742|FG000|Overall Study|Other Protocol Specified Criteria|0|||
44229789|NCT01709318|79037743|FG001|Overall Study|Other Protocol Specified Criteria|1|||
44229790|NCT01709318|79037744|FG002|Overall Study|Other Protocol Specified Criteria|0|||
44229791|NCT01709318|79037745|FG003|Overall Study|Other Protocol Specified Criteria|0|||
44229792|NCT01709318|79037746|FG004|Overall Study|Other Protocol Specified Criteria|0|||
44229793|NCT01709318|79037747|FG005|Overall Study|Other Protocol Specified Criteria|0|||
44229794|NCT01709318|79037748|FG006|Overall Study|Other Protocol Specified Criteria|0|||
44229795|NCT01699178|79037766|FG000|Overall Study|Adverse Event|1|||
44229796|NCT01699178|79037767|FG001|Overall Study|Adverse Event|5|||
44229797|NCT01699178|79037766|FG000|Overall Study|Lost to Follow-up|1|||
44493106|NCT00129402|79498948|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
44493107|NCT00129402|79498949|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
44229798|NCT01699178|79037767|FG001|Overall Study|Lost to Follow-up|6|||
44229799|NCT01699178|79037766|FG000|Overall Study|Non-compliance with Study Drug|3|||
44229800|NCT01699178|79037767|FG001|Overall Study|Non-compliance with Study Drug|1|||
44229801|NCT01699178|79037766|FG000|Overall Study|Physician Decision|1|||
44229802|NCT01699178|79037767|FG001|Overall Study|Physician Decision|0|||
44229803|NCT01699178|79037766|FG000|Overall Study|Withdrawal by Subject|4|||
44229804|NCT01699178|79037767|FG001|Overall Study|Withdrawal by Subject|12|||
44229805|NCT01699178|79037766|FG000|Overall Study|Hematocrit >54%|1|||
44229806|NCT01699178|79037767|FG001|Overall Study|Hematocrit >54%|1|||
44229807|NCT01699178|79037766|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
44229808|NCT01699178|79037767|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
44229809|NCT01699178|79037766|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
44229810|NCT01699178|79037767|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
44229811|NCT01683409|79037778|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
44229812|NCT01683409|79037779|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
44229813|NCT01683409|79037780|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
44229814|NCT01683409|79037781|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
44229815|NCT01683409|79037782|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
44493108|NCT00129402|79498950|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
44493109|NCT00129402|79498951|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
44229816|NCT01683409|79037778|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
44229817|NCT01683409|79037779|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
44229818|NCT01683409|79037780|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
44229819|NCT01683409|79037781|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
44229820|NCT01683409|79037782|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
44229821|NCT01683409|79037778|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
44229822|NCT01683409|79037779|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
44229823|NCT01683409|79037780|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
44229824|NCT01683409|79037781|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
44229825|NCT01683409|79037782|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
44229826|NCT01683409|79037778|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
44229827|NCT01683409|79037779|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
44229828|NCT01683409|79037780|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
44229829|NCT01683409|79037781|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
44229830|NCT01683409|79037782|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
44229831|NCT01683409|79037778|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
44493110|NCT00129402|79498945|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
44493111|NCT00129402|79498946|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
44546795|NCT04610580|79561050|FG000|Two-way Crossover Period|Physician Decision|1|||
44546796|NCT04610580|79561051|FG001|Two-way Crossover Period|Physician Decision|0|||
44229832|NCT01683409|79037779|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
44493112|NCT00129402|79498947|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
44493113|NCT00129402|79498948|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
44493114|NCT00129402|79498949|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
44493115|NCT00129402|79498950|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
44493116|NCT00129402|79498951|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
44493117|NCT00129402|79498945|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
44493118|NCT00129402|79498946|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
44493119|NCT00129402|79498947|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
44546797|NCT04610580|79561052|FG002|Two-way Crossover Period|Physician Decision|0|||
44546798|NCT04610580|79561053|FG003|Two-way Crossover Period|Physician Decision|0|||
44546799|NCT04610580|79561054|FG004|Two-way Crossover Period|Physician Decision|0|||
44546800|NCT04610580|79561055|FG005|Two-way Crossover Period|Physician Decision|0|||
44546801|NCT04610580|79561050|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
44546802|NCT04610580|79561051|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
44546803|NCT04610580|79561052|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
44546804|NCT04610580|79561053|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
44546805|NCT04610580|79561054|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
44546806|NCT04610580|79561055|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
44546807|NCT04610580|79561050|FG000|Two-way Crossover Period|Other than specified|0|||
44546808|NCT04610580|79561051|FG001|Two-way Crossover Period|Other than specified|1|||
44546809|NCT04610580|79561052|FG002|Two-way Crossover Period|Other than specified|0|||
44546810|NCT04610580|79561053|FG003|Two-way Crossover Period|Other than specified|0|||
44546811|NCT04610580|79561054|FG004|Two-way Crossover Period|Other than specified|0|||
44546812|NCT04610580|79561055|FG005|Two-way Crossover Period|Other than specified|0|||
44546813|NCT04610580|79561050|FG000|Washout Before Extension Period|Other than specified|0|||
44546814|NCT04610580|79561051|FG001|Washout Before Extension Period|Other than specified|1|||
44546815|NCT04610580|79561052|FG002|Washout Before Extension Period|Other than specified|0|||
44546816|NCT04610580|79561053|FG003|Washout Before Extension Period|Other than specified|0|||
44546817|NCT04610580|79561054|FG004|Washout Before Extension Period|Other than specified|0|||
44546818|NCT04610580|79561055|FG005|Washout Before Extension Period|Other than specified|0|||
44546819|NCT04610580|79561050|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
44546820|NCT04610580|79561051|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
44546821|NCT04610580|79561052|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
44546822|NCT04610580|79561053|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
44546823|NCT04610580|79561054|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
44546824|NCT04610580|79561055|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
44546825|NCT04610580|79561050|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
44546826|NCT04610580|79561051|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
44546827|NCT04610580|79561052|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
44546828|NCT04610580|79561053|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
44546829|NCT04610580|79561054|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
44546830|NCT04610580|79561055|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
44546831|NCT04359758|79561108|FG000|Overall Study|Protocol Violation|3|||
44546832|NCT04359758|79561109|FG001|Overall Study|Protocol Violation|2|||
44546833|NCT04186871|79561132|FG000|Overall Study|Lack of Efficacy|0|||
44546834|NCT04186871|79561133|FG001|Overall Study|Lack of Efficacy|1|||
44546835|NCT04186871|79561134|FG002|Overall Study|Lack of Efficacy|0|||
44546836|NCT04186871|79561135|FG003|Overall Study|Lack of Efficacy|0|||
44376436|NCT00867334|79381551|FG000|Overall Study|Withdrawal by Subject|0|||
44376437|NCT00867334|79381552|FG001|Overall Study|Withdrawal by Subject|1|||
44376438|NCT00867334|79381551|FG000|Overall Study|Withdrawal by Subject|1|||
44546837|NCT04186871|79561136|FG004|Overall Study|Lack of Efficacy|1|||
44546838|NCT04186871|79561137|FG005|Overall Study|Lack of Efficacy|1|||
44376439|NCT00867334|79381552|FG001|Overall Study|Withdrawal by Subject|0|||
44376440|NCT00867334|79381551|FG000|Overall Study|Withdrawal by Subject|1|||
44546839|NCT04186871|79561132|FG000|Overall Study|Adverse Event|1|||
44493120|NCT00129402|79498948|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
44274584|NCT02248818|79220363|FG004|Screening|Protocol Violation|0|||
44274585|NCT02248818|79220364|FG005|Screening|Protocol Violation|0|||
44274586|NCT02248818|79220365|FG006|Screening|Protocol Violation|0|||
44274587|NCT02248818|79220366|FG007|Screening|Protocol Violation|0|||
44274588|NCT02248818|79220367|FG008|Screening|Protocol Violation|7|||
44493121|NCT00129402|79498949|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
44493122|NCT00129402|79498950|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
44493123|NCT00129402|79498951|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
44493124|NCT00129402|79498945|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
44493125|NCT00129402|79498946|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
44493126|NCT00129402|79498947|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
44493127|NCT00129402|79498948|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
44493128|NCT00129402|79498949|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
44493129|NCT00129402|79498950|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
44493130|NCT00129402|79498951|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
44493131|NCT03739528|79498961|FG000|Overall Study|Not treated|8|||
44493132|NCT03739528|79498962|FG001|Overall Study|Not treated|12|||
44493133|NCT03739528|79498961|FG000|Overall Study|Treatment and study discontinued|6|||
44493134|NCT03739528|79498962|FG001|Overall Study|Treatment and study discontinued|2|||
44493135|NCT03739528|79498961|FG000|Overall Study|Treatment discontinued + study completed|1|||
44493136|NCT03739528|79498962|FG001|Overall Study|Treatment discontinued + study completed|3|||
44493137|NCT00114738|79498971|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
44493138|NCT00114738|79498972|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
44493139|NCT00114738|79498973|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
44493140|NCT00114738|79498971|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
44493141|NCT00114738|79498972|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
44493142|NCT00114738|79498973|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
44493143|NCT00114738|79498971|FG000|Screening for Randomization|Neuropathy|17|||
44493144|NCT00114738|79498972|FG001|Screening for Randomization|Neuropathy|0|||
44493145|NCT00114738|79498973|FG002|Screening for Randomization|Neuropathy|0|||
44493146|NCT00114738|79498971|FG000|Screening for Randomization|Progressive disease|2|||
44493147|NCT00114738|79498972|FG001|Screening for Randomization|Progressive disease|0|||
44493148|NCT00114738|79498973|FG002|Screening for Randomization|Progressive disease|0|||
44493149|NCT00114738|79498971|FG000|Screening for Randomization|CNS Hemorrhage|1|||
44493150|NCT00114738|79498972|FG001|Screening for Randomization|CNS Hemorrhage|0|||
44493151|NCT00114738|79498973|FG002|Screening for Randomization|CNS Hemorrhage|0|||
44493152|NCT00114738|79498971|FG000|Screening for Randomization|Other|1|||
44493153|NCT00114738|79498972|FG001|Screening for Randomization|Other|0|||
44493154|NCT00114738|79498973|FG002|Screening for Randomization|Other|0|||
44493155|NCT00148122|79498980|FG000|Overall Study|Withdrawal by Subject|2|||
44493156|NCT00147498|79498988|FG000|Overall Study|Adverse Event|1|||
44493157|NCT00147498|79498989|FG001|Overall Study|Adverse Event|6|||
44493158|NCT00147498|79498990|FG002|Overall Study|Adverse Event|7|||
44493159|NCT00147498|79498991|FG003|Overall Study|Adverse Event|3|||
44493160|NCT00147498|79498988|FG000|Overall Study|Lack of Efficacy|1|||
44493161|NCT00147498|79498989|FG001|Overall Study|Lack of Efficacy|1|||
44493162|NCT00147498|79498990|FG002|Overall Study|Lack of Efficacy|1|||
44493163|NCT00147498|79498991|FG003|Overall Study|Lack of Efficacy|8|||
44493164|NCT00147498|79498988|FG000|Overall Study|Laboratory abnormality|0|||
44493165|NCT00147498|79498989|FG001|Overall Study|Laboratory abnormality|0|||
44493166|NCT00147498|79498990|FG002|Overall Study|Laboratory abnormality|2|||
44493167|NCT00147498|79498991|FG003|Overall Study|Laboratory abnormality|0|||
44493168|NCT00147498|79498988|FG000|Overall Study|Participant defaulted|0|||
44493169|NCT00147498|79498989|FG001|Overall Study|Participant defaulted|1|||
44493170|NCT00147498|79498990|FG002|Overall Study|Participant defaulted|4|||
44493171|NCT00147498|79498991|FG003|Overall Study|Participant defaulted|3|||
44493172|NCT00147498|79498988|FG000|Overall Study|Other|1|||
44493173|NCT00147498|79498989|FG001|Overall Study|Other|1|||
44493174|NCT00147498|79498990|FG002|Overall Study|Other|3|||
44493175|NCT00147498|79498991|FG003|Overall Study|Other|3|||
44493176|NCT00113568|79499001|FG000|Overall Study|Adverse Event|97|||
44493177|NCT00113568|79499001|FG000|Overall Study|Death|1|||
44493178|NCT00113568|79499001|FG000|Overall Study|Lack of Efficacy|30|||
44493179|NCT00113568|79499001|FG000|Overall Study|Lost to Follow-up|156|||
44493180|NCT00113568|79499001|FG000|Overall Study|Protocol Violation|32|||
44493181|NCT00113568|79499001|FG000|Overall Study|Withdrawal by Subject|117|||
44274589|NCT02248818|79220359|FG000|Screening|Study fully enrolled|0|||
44493182|NCT00113568|79499001|FG000|Overall Study|Other|112|||
44493183|NCT00113490|79499007|FG000|Overall Study|Withdrawal by Subject|1|||
44493184|NCT00113490|79499008|FG001|Overall Study|Withdrawal by Subject|3|||
44546840|NCT04186871|79561133|FG001|Overall Study|Adverse Event|1|||
44546841|NCT04186871|79561134|FG002|Overall Study|Adverse Event|0|||
44546842|NCT04186871|79561135|FG003|Overall Study|Adverse Event|0|||
44546843|NCT04186871|79561136|FG004|Overall Study|Adverse Event|0|||
44546844|NCT04186871|79561137|FG005|Overall Study|Adverse Event|2|||
44546845|NCT04186871|79561132|FG000|Overall Study|Study terminated by sponsor|1|||
44546846|NCT04186871|79561133|FG001|Overall Study|Study terminated by sponsor|2|||
44546847|NCT04186871|79561134|FG002|Overall Study|Study terminated by sponsor|0|||
44546848|NCT04186871|79561135|FG003|Overall Study|Study terminated by sponsor|1|||
44546849|NCT04186871|79561136|FG004|Overall Study|Study terminated by sponsor|0|||
44546850|NCT04186871|79561137|FG005|Overall Study|Study terminated by sponsor|0|||
44546851|NCT04186871|79561132|FG000|Overall Study|Other reasons|0|||
44546852|NCT04186871|79561133|FG001|Overall Study|Other reasons|0|||
44546853|NCT04186871|79561134|FG002|Overall Study|Other reasons|0|||
44546854|NCT04186871|79561135|FG003|Overall Study|Other reasons|0|||
44546855|NCT04186871|79561136|FG004|Overall Study|Other reasons|0|||
44546856|NCT04186871|79561137|FG005|Overall Study|Other reasons|1|||
44546857|NCT04186871|79561132|FG000|Overall Study|Withdrawal by Subject|0|||
44546858|NCT04186871|79561133|FG001|Overall Study|Withdrawal by Subject|0|||
44546859|NCT04186871|79561134|FG002|Overall Study|Withdrawal by Subject|0|||
44546860|NCT04186871|79561135|FG003|Overall Study|Withdrawal by Subject|0|||
44546861|NCT04186871|79561136|FG004|Overall Study|Withdrawal by Subject|0|||
44546862|NCT04186871|79561137|FG005|Overall Study|Withdrawal by Subject|1|||
44546863|NCT04186871|79561132|FG000|Overall Study|Lost to Follow-up|0|||
44546864|NCT04186871|79561133|FG001|Overall Study|Lost to Follow-up|0|||
44546865|NCT04186871|79561134|FG002|Overall Study|Lost to Follow-up|0|||
44546866|NCT04186871|79561135|FG003|Overall Study|Lost to Follow-up|0|||
44546867|NCT04186871|79561136|FG004|Overall Study|Lost to Follow-up|0|||
44546868|NCT04186871|79561137|FG005|Overall Study|Lost to Follow-up|1|||
44546869|NCT04058366|79561152|FG000|Overall Study|Adverse Event|14|||
44493185|NCT00113490|79499007|FG000|Overall Study|Lost to Follow-up|1|||
44493186|NCT00113490|79499008|FG001|Overall Study|Lost to Follow-up|0|||
44493187|NCT00146640|79499016|FG000|Overall Study|Adverse Event|12|||
44493188|NCT00146640|79499017|FG001|Overall Study|Adverse Event|10|||
44493189|NCT00146640|79499016|FG000|Overall Study|Medical Reasons|3|||
44493190|NCT00146640|79499017|FG001|Overall Study|Medical Reasons|0|||
44493191|NCT00146640|79499016|FG000|Overall Study|Non-Medical Reasons|8|||
44493192|NCT00146640|79499017|FG001|Overall Study|Non-Medical Reasons|4|||
44546870|NCT04058366|79561152|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
44493193|NCT00146328|79499035|FG000|Overall Study|Adverse Event|39|||
44546871|NCT04058366|79561152|FG000|Overall Study|Commercial drug is available for participants|6|||
44493194|NCT00146328|79499036|FG001|Overall Study|Adverse Event|48|||
44493195|NCT00146328|79499037|FG002|Overall Study|Adverse Event|79|||
44493196|NCT00146328|79499035|FG000|Overall Study|Protocol Violation|11|||
44493197|NCT00146328|79499036|FG001|Overall Study|Protocol Violation|6|||
44493198|NCT00146328|79499037|FG002|Overall Study|Protocol Violation|12|||
44493199|NCT00146328|79499035|FG000|Overall Study|Lost to Follow-up|7|||
44493200|NCT00146328|79499036|FG001|Overall Study|Lost to Follow-up|4|||
44493201|NCT00146328|79499037|FG002|Overall Study|Lost to Follow-up|7|||
44493202|NCT00146328|79499035|FG000|Overall Study|Withdrawal by Subject|16|||
44493203|NCT00146328|79499036|FG001|Overall Study|Withdrawal by Subject|16|||
44546872|NCT04058366|79561152|FG000|Overall Study|Death|1|||
44546873|NCT04058366|79561152|FG000|Overall Study|Other non-compliance|2|||
44546874|NCT04058366|79561152|FG000|Overall Study|Other|6|||
44493204|NCT00146328|79499037|FG002|Overall Study|Withdrawal by Subject|22|||
44493205|NCT00146328|79499035|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
44493206|NCT00146328|79499036|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
44546875|NCT03840902|79561211|FG000|Overall Study|Randomized but not treated|1|||
44546876|NCT03840902|79561212|FG001|Overall Study|Randomized but not treated|1|||
44546877|NCT03820986|79561220|FG000|Overall Study|Death|177|||
44546878|NCT03820986|79561221|FG001|Overall Study|Death|156|||
44546879|NCT03820986|79561220|FG000|Overall Study|Lost to Follow-up|0|||
44229833|NCT01683409|79037780|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
44493207|NCT00146328|79499037|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
44493208|NCT00146328|79499035|FG000|Overall Study|Trial ended/site closed|8|||
44546880|NCT03820986|79561221|FG001|Overall Study|Lost to Follow-up|1|||
44546881|NCT03820986|79561220|FG000|Overall Study|Withdrawal by Subject|8|||
44546882|NCT03820986|79561221|FG001|Overall Study|Withdrawal by Subject|3|||
44546883|NCT03820986|79561220|FG000|Overall Study|Ongoing|149|||
44493209|NCT00146328|79499036|FG001|Overall Study|Trial ended/site closed|2|||
44493210|NCT00146328|79499037|FG002|Overall Study|Trial ended/site closed|19|||
44493211|NCT00146328|79499035|FG000|Overall Study|Patient decision to end|0|||
44493212|NCT00146328|79499036|FG001|Overall Study|Patient decision to end|1|||
44493213|NCT00146328|79499037|FG002|Overall Study|Patient decision to end|6|||
44493214|NCT00146328|79499035|FG000|Overall Study|Enroll into other trial|2|||
44493215|NCT00146328|79499036|FG001|Overall Study|Enroll into other trial|4|||
44493216|NCT00146328|79499037|FG002|Overall Study|Enroll into other trial|2|||
44493217|NCT00146328|79499035|FG000|Overall Study|Death|0|||
44493218|NCT00146328|79499036|FG001|Overall Study|Death|1|||
44493219|NCT00146328|79499037|FG002|Overall Study|Death|1|||
44493220|NCT00146328|79499035|FG000|Overall Study|Moved|2|||
44493221|NCT00146328|79499036|FG001|Overall Study|Moved|0|||
44493222|NCT00146328|79499037|FG002|Overall Study|Moved|0|||
44493223|NCT00146328|79499035|FG000|Overall Study|Interaction with other medication|2|||
44493224|NCT00146328|79499036|FG001|Overall Study|Interaction with other medication|0|||
44493225|NCT00146328|79499037|FG002|Overall Study|Interaction with other medication|1|||
44493226|NCT03733444|79499048|FG000|Overall Study|Adverse Event|8|||
44493227|NCT03733444|79499049|FG001|Overall Study|Adverse Event|10|||
44493228|NCT03733444|79499050|FG002|Overall Study|Adverse Event|5|||
44493229|NCT03733444|79499048|FG000|Overall Study|Death|20|||
44493230|NCT03733444|79499049|FG001|Overall Study|Death|19|||
44493231|NCT03733444|79499050|FG002|Overall Study|Death|11|||
44493232|NCT03733444|79499048|FG000|Overall Study|Lost to Follow-up|3|||
44493233|NCT03733444|79499049|FG001|Overall Study|Lost to Follow-up|0|||
44493234|NCT03733444|79499050|FG002|Overall Study|Lost to Follow-up|1|||
44493235|NCT03733444|79499048|FG000|Overall Study|Lack of Efficacy|0|||
44493236|NCT03733444|79499049|FG001|Overall Study|Lack of Efficacy|1|||
44493237|NCT03733444|79499050|FG002|Overall Study|Lack of Efficacy|1|||
44493238|NCT03733444|79499048|FG000|Overall Study|Physician Decision|2|||
44493239|NCT03733444|79499049|FG001|Overall Study|Physician Decision|1|||
44493240|NCT03733444|79499050|FG002|Overall Study|Physician Decision|0|||
44493241|NCT03733444|79499048|FG000|Overall Study|Protocol Violation|2|||
44493242|NCT03733444|79499049|FG001|Overall Study|Protocol Violation|1|||
44493243|NCT03733444|79499050|FG002|Overall Study|Protocol Violation|0|||
44493244|NCT03733444|79499048|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
44493245|NCT03733444|79499049|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
44493246|NCT03733444|79499050|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
44493247|NCT03733444|79499048|FG000|Overall Study|Study Terminated by Sponsor|203|||
44493248|NCT03733444|79499049|FG001|Overall Study|Study Terminated by Sponsor|209|||
44493249|NCT03733444|79499050|FG002|Overall Study|Study Terminated by Sponsor|221|||
44493250|NCT03733444|79499048|FG000|Overall Study|Withdrawal by Subject|19|||
44493251|NCT03733444|79499049|FG001|Overall Study|Withdrawal by Subject|18|||
44493252|NCT03733444|79499050|FG002|Overall Study|Withdrawal by Subject|16|||
44493253|NCT03733444|79499048|FG000|Overall Study|Miscellaneous|1|||
44493254|NCT03733444|79499049|FG001|Overall Study|Miscellaneous|0|||
44493255|NCT03733444|79499050|FG002|Overall Study|Miscellaneous|1|||
44493256|NCT03733444|79499048|FG000|Overall Study|Not Treated|1|||
44493257|NCT03733444|79499049|FG001|Overall Study|Not Treated|2|||
44493258|NCT03733444|79499050|FG002|Overall Study|Not Treated|1|||
44493259|NCT03731182|79499070|FG000|Overall Study|Lost to Follow-up|2|||
44493260|NCT03731182|79499071|FG001|Overall Study|Lost to Follow-up|0|||
44493261|NCT03731182|79499070|FG000|Overall Study|Physician Decision|1|||
44493262|NCT03731182|79499071|FG001|Overall Study|Physician Decision|0|||
44493263|NCT03731182|79499070|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
44493264|NCT03731182|79499071|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
44493265|NCT03730012|79499080|FG000|Overall Study|Adverse Event|0|||
44493266|NCT03730012|79499081|FG001|Overall Study|Adverse Event|1|||
44493267|NCT03730012|79499080|FG000|Overall Study|Lack of Efficacy|1|||
44493268|NCT03730012|79499081|FG001|Overall Study|Lack of Efficacy|5|||
44493269|NCT03730012|79499080|FG000|Overall Study|Withdrawal by Subject|0|||
44493270|NCT03730012|79499081|FG001|Overall Study|Withdrawal by Subject|1|||
44493271|NCT03730012|79499080|FG000|Overall Study|Miscellaneous|2|||
44493272|NCT03730012|79499081|FG001|Overall Study|Miscellaneous|1|||
44493273|NCT03728140|79499092|FG000|Overall Study|Abnormal embryo transfer operation|10|||
44493274|NCT03728140|79499093|FG001|Overall Study|Abnormal embryo transfer operation|7|||
44493275|NCT03725722|79499118|FG000|Overall Study|Lack of Efficacy|2|||
44493276|NCT03725722|79499119|FG001|Overall Study|Lack of Efficacy|1|||
44493277|NCT03725722|79499120|FG002|Overall Study|Lack of Efficacy|2|||
44493278|NCT03725722|79499121|FG003|Overall Study|Lack of Efficacy|0|||
44493279|NCT03725722|79499122|FG004|Overall Study|Lack of Efficacy|2|||
44493280|NCT03725722|79499118|FG000|Overall Study|Adverse Event|2|||
44493281|NCT03725722|79499119|FG001|Overall Study|Adverse Event|2|||
44493282|NCT03725722|79499120|FG002|Overall Study|Adverse Event|1|||
44493283|NCT03725722|79499121|FG003|Overall Study|Adverse Event|0|||
44546884|NCT03820986|79561221|FG001|Overall Study|Ongoing|180|||
44493284|NCT03725722|79499122|FG004|Overall Study|Adverse Event|6|||
44493285|NCT03725722|79499118|FG000|Overall Study|Withdrawal by Subject|4|||
44493286|NCT03725722|79499119|FG001|Overall Study|Withdrawal by Subject|1|||
44493287|NCT03725722|79499120|FG002|Overall Study|Withdrawal by Subject|0|||
44493288|NCT03725722|79499121|FG003|Overall Study|Withdrawal by Subject|4|||
44493289|NCT03725722|79499122|FG004|Overall Study|Withdrawal by Subject|4|||
44493290|NCT03725722|79499118|FG000|Overall Study|Lost to Follow-up|3|||
44493291|NCT03725722|79499119|FG001|Overall Study|Lost to Follow-up|1|||
44493292|NCT03725722|79499120|FG002|Overall Study|Lost to Follow-up|2|||
44493293|NCT03725722|79499121|FG003|Overall Study|Lost to Follow-up|2|||
44493294|NCT03725722|79499122|FG004|Overall Study|Lost to Follow-up|1|||
44493295|NCT03725722|79499118|FG000|Overall Study|Personal reasons|0|||
44493296|NCT03725722|79499119|FG001|Overall Study|Personal reasons|0|||
44493297|NCT03725722|79499120|FG002|Overall Study|Personal reasons|1|||
44493298|NCT03725722|79499121|FG003|Overall Study|Personal reasons|0|||
44493299|NCT03725722|79499122|FG004|Overall Study|Personal reasons|1|||
44493300|NCT03725722|79499118|FG000|Overall Study|COVID-19 situation|0|||
44493301|NCT03725722|79499119|FG001|Overall Study|COVID-19 situation|1|||
44493302|NCT03725722|79499120|FG002|Overall Study|COVID-19 situation|0|||
44493303|NCT03725722|79499121|FG003|Overall Study|COVID-19 situation|0|||
44493304|NCT03725722|79499122|FG004|Overall Study|COVID-19 situation|0|||
44493305|NCT02966314|79499136|FG000|Overall Study|Lost to Follow-up|1|||
44493306|NCT02966314|79499137|FG001|Overall Study|Lost to Follow-up|0|||
44493307|NCT03723070|79499143|FG000|Overall Study|Lost to Follow-up|2|||
44493308|NCT03723070|79499143|FG000|Overall Study|Physician Decision|1|||
44493309|NCT03723070|79499143|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
44493310|NCT03722524|79499151|FG000|Overall Study|Protocol Violation|86|||
44493311|NCT03722524|79499151|FG000|Overall Study|Adverse Event|7|||
44493312|NCT03722524|79499151|FG000|Overall Study|Lost to Follow-up|1|||
44493313|NCT03722524|79499151|FG000|Overall Study|Reason is not stated|1|||
44493314|NCT03722524|79499151|FG000|Overall Study|Physician Decision|1|||
44493315|NCT03722524|79499151|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
44493316|NCT03722446|79499157|FG000|Overall Study|Protocol Violation|15|||
44493317|NCT03722446|79499158|FG001|Overall Study|Protocol Violation|2|||
44493318|NCT00146172|79499172|FG000|Overall Study|Adverse Event|0|||
44493319|NCT00146172|79499173|FG001|Overall Study|Adverse Event|0|||
44493320|NCT00146172|79499174|FG002|Overall Study|Adverse Event|1|||
44493321|NCT00146172|79499175|FG003|Overall Study|Adverse Event|1|||
44493322|NCT00146172|79499176|FG004|Overall Study|Adverse Event|0|||
44493323|NCT00146172|79499177|FG005|Overall Study|Adverse Event|2|||
44493324|NCT00146172|79499178|FG006|Overall Study|Adverse Event|3|||
44493325|NCT00146172|79499179|FG007|Overall Study|Adverse Event|10|||
44493326|NCT00146172|79499172|FG000|Overall Study|Lost to Follow-up|0|||
44493327|NCT00146172|79499173|FG001|Overall Study|Lost to Follow-up|0|||
44493328|NCT00146172|79499174|FG002|Overall Study|Lost to Follow-up|0|||
44493329|NCT00146172|79499175|FG003|Overall Study|Lost to Follow-up|0|||
44493330|NCT00146172|79499176|FG004|Overall Study|Lost to Follow-up|0|||
44493331|NCT00146172|79499177|FG005|Overall Study|Lost to Follow-up|0|||
44493332|NCT00146172|79499178|FG006|Overall Study|Lost to Follow-up|0|||
44493333|NCT00146172|79499179|FG007|Overall Study|Lost to Follow-up|1|||
44546885|NCT03775486|79561231|FG000|Initial Therapy Phase|Other reason provided|0|||
44546886|NCT03775486|79561232|FG001|Initial Therapy Phase|Other reason provided|15|||
44546887|NCT03775486|79561231|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
44546888|NCT03775486|79561232|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
44546889|NCT03775486|79561231|FG000|Initial Therapy Phase|Protocol Violation|0|||
44546890|NCT03775486|79561232|FG001|Initial Therapy Phase|Protocol Violation|2|||
44546891|NCT03775486|79561231|FG000|Initial Therapy Phase|Adverse Event|0|||
44546892|NCT03775486|79561232|FG001|Initial Therapy Phase|Adverse Event|34|||
44546893|NCT03775486|79561231|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
44546894|NCT03775486|79561232|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
44546895|NCT03775486|79561231|FG000|Maintenance Phase|Withdrawal by Subject|13|||
44546896|NCT03775486|79561232|FG001|Maintenance Phase|Withdrawal by Subject|12|||
44546897|NCT03775486|79561231|FG000|Maintenance Phase|Death|44|||
44229834|NCT01683409|79037781|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
44546898|NCT03775486|79561232|FG001|Maintenance Phase|Death|45|||
44546899|NCT03675737|79561250|FG000|Overall Study|Death|593|||
44546900|NCT03675737|79561251|FG001|Overall Study|Death|660|||
44546901|NCT03675737|79561250|FG000|Overall Study|Lost to Follow-up|1|||
44493334|NCT00146172|79499172|FG000|Overall Study|Disease Progression|2|||
44493335|NCT00146172|79499173|FG001|Overall Study|Disease Progression|4|||
44493336|NCT00146172|79499174|FG002|Overall Study|Disease Progression|2|||
44493337|NCT00146172|79499175|FG003|Overall Study|Disease Progression|5|||
44546902|NCT03675737|79561251|FG001|Overall Study|Lost to Follow-up|5|||
44229835|NCT01683409|79037782|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
44229836|NCT01683409|79037778|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
44493338|NCT00146172|79499176|FG004|Overall Study|Disease Progression|2|||
44493339|NCT00146172|79499177|FG005|Overall Study|Disease Progression|2|||
44493340|NCT00146172|79499178|FG006|Overall Study|Disease Progression|1|||
44493341|NCT00146172|79499179|FG007|Overall Study|Disease Progression|22|||
44493342|NCT00146172|79499172|FG000|Overall Study|Death|0|||
44546903|NCT03675737|79561250|FG000|Overall Study|Physician Decision|1|||
44546904|NCT03675737|79561251|FG001|Overall Study|Physician Decision|0|||
44546905|NCT03675737|79561250|FG000|Overall Study|Withdrawal by Subject|14|||
44546906|NCT03675737|79561251|FG001|Overall Study|Withdrawal by Subject|12|||
44546907|NCT03675737|79561250|FG000|Overall Study|Ongoing in Study|181|||
44546908|NCT03675737|79561251|FG001|Overall Study|Ongoing in Study|112|||
44546909|NCT03643562|79561260|FG000|Overall Study|Adverse Event|1|||
44546910|NCT03643562|79561261|FG001|Overall Study|Adverse Event|0|||
44546911|NCT03643562|79561260|FG000|Overall Study|Lack of Efficacy|0|||
44546912|NCT03643562|79561261|FG001|Overall Study|Lack of Efficacy|1|||
44546913|NCT03643562|79561260|FG000|Overall Study|Physician Decision|0|||
44546914|NCT03643562|79561261|FG001|Overall Study|Physician Decision|1|||
44493343|NCT00146172|79499173|FG001|Overall Study|Death|0|||
44493344|NCT00146172|79499174|FG002|Overall Study|Death|0|||
44493345|NCT00146172|79499175|FG003|Overall Study|Death|0|||
44493346|NCT00146172|79499176|FG004|Overall Study|Death|0|||
44493347|NCT00146172|79499177|FG005|Overall Study|Death|0|||
44493348|NCT00146172|79499178|FG006|Overall Study|Death|1|||
44493349|NCT00146172|79499179|FG007|Overall Study|Death|0|||
44493350|NCT00146172|79499172|FG000|Overall Study|Physician Decision|0|||
44546915|NCT03643562|79561260|FG000|Overall Study|Study Terminated by Sponsor|2|||
44546916|NCT03643562|79561261|FG001|Overall Study|Study Terminated by Sponsor|10|||
44546917|NCT03643562|79561260|FG000|Overall Study|Withdrawal by Subject|2|||
44546918|NCT03643562|79561261|FG001|Overall Study|Withdrawal by Subject|2|||
44546919|NCT03643562|79561260|FG000|Overall Study|Other than specified|3|||
44546920|NCT03643562|79561261|FG001|Overall Study|Other than specified|2|||
44546921|NCT03635567|79561269|FG000|Overall Study|Lost to Follow-up|0|||
44546922|NCT03635567|79561270|FG001|Overall Study|Lost to Follow-up|2|||
44546923|NCT03635567|79561269|FG000|Overall Study|Withdrawal by Subject|9|||
44546924|NCT03635567|79561270|FG001|Overall Study|Withdrawal by Subject|10|||
44546925|NCT03635567|79561269|FG000|Overall Study|Ongoing in Study|125|||
44546926|NCT03635567|79561270|FG001|Overall Study|Ongoing in Study|76|||
44546927|NCT03635567|79561269|FG000|Overall Study|Death|174|||
44546928|NCT03635567|79561270|FG001|Overall Study|Death|221|||
44546929|NCT03606486|79561277|FG000|Overall Study|Unable to collect sample|5|||
44546930|NCT03578536|79561281|FG000|Overall Study|Lost to Follow-up|1|||
44546931|NCT03564496|79561288|FG000|Overall Study|Withdrawal by Subject|1|||
44546932|NCT03564496|79561289|FG001|Overall Study|Withdrawal by Subject|1|||
44546933|NCT03564496|79561290|FG002|Overall Study|Withdrawal by Subject|0|||
44546934|NCT03564496|79561288|FG000|Overall Study|Screen failure|0|||
44546935|NCT03564496|79561289|FG001|Overall Study|Screen failure|3|||
44546936|NCT03564496|79561290|FG002|Overall Study|Screen failure|0|||
44546937|NCT03562247|79561305|FG000|Overall Study|Lost to Follow-up|3|||
44546938|NCT03562247|79561306|FG001|Overall Study|Lost to Follow-up|1|||
44546939|NCT03562247|79561307|FG002|Overall Study|Lost to Follow-up|1|||
44546940|NCT03515837|79561317|FG000|Overall Study|Death|214|||
44546941|NCT03515837|79561318|FG001|Overall Study|Death|221|||
44546942|NCT03515837|79561317|FG000|Overall Study|Lost to Follow-up|0|||
44546943|NCT03515837|79561318|FG001|Overall Study|Lost to Follow-up|1|||
44546944|NCT03515837|79561317|FG000|Overall Study|Ongoing|31|||
44546945|NCT03515837|79561318|FG001|Overall Study|Ongoing|21|||
44546946|NCT03515837|79561317|FG000|Overall Study|Withdrawal by Subject|0|||
44546947|NCT03515837|79561318|FG001|Overall Study|Withdrawal by Subject|4|||
44546948|NCT03443973|79561331|FG000|Double-blind Treatment Period|Adverse Event|5|||
44546949|NCT03443973|79561332|FG001|Double-blind Treatment Period|Adverse Event|19|||
44546950|NCT03443973|79561333|FG002|Double-blind Treatment Period|Adverse Event|0|||
44546951|NCT03443973|79561334|FG003|Double-blind Treatment Period|Adverse Event|0|||
44546952|NCT03443973|79561331|FG000|Double-blind Treatment Period|Death|5|||
44546953|NCT03443973|79561332|FG001|Double-blind Treatment Period|Death|7|||
44546954|NCT03443973|79561333|FG002|Double-blind Treatment Period|Death|0|||
44546955|NCT03443973|79561334|FG003|Double-blind Treatment Period|Death|0|||
44546956|NCT03443973|79561331|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
44546957|NCT03443973|79561332|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
44546958|NCT03443973|79561333|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
44546959|NCT03443973|79561334|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
44229837|NCT01683409|79037779|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
44229838|NCT01683409|79037780|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
44493351|NCT00146172|79499173|FG001|Overall Study|Physician Decision|0|||
44546960|NCT03443973|79561331|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44546961|NCT03443973|79561332|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
44546962|NCT03443973|79561333|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
44546963|NCT03443973|79561334|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
44493352|NCT00146172|79499174|FG002|Overall Study|Physician Decision|0|||
44493353|NCT00146172|79499175|FG003|Overall Study|Physician Decision|0|||
44493354|NCT00146172|79499176|FG004|Overall Study|Physician Decision|0|||
44546964|NCT03443973|79561331|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
44546965|NCT03443973|79561332|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
44546966|NCT03443973|79561333|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
44546967|NCT03443973|79561334|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
44546968|NCT03443973|79561331|FG000|Double-blind Treatment Period|Physician Decision|5|||
44546969|NCT03443973|79561332|FG001|Double-blind Treatment Period|Physician Decision|6|||
44546970|NCT03443973|79561333|FG002|Double-blind Treatment Period|Physician Decision|0|||
44546971|NCT03443973|79561334|FG003|Double-blind Treatment Period|Physician Decision|0|||
44546972|NCT03443973|79561331|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
44546973|NCT03443973|79561332|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
44546974|NCT03443973|79561333|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
44546975|NCT03443973|79561334|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
44546976|NCT03443973|79561331|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
44546977|NCT03443973|79561332|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
44546978|NCT03443973|79561333|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44546979|NCT03443973|79561334|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
44546980|NCT03443973|79561331|FG000|Open-label Extension Period|Reason Not Specified|0|||
44546981|NCT03443973|79561332|FG001|Open-label Extension Period|Reason Not Specified|0|||
44546982|NCT03443973|79561333|FG002|Open-label Extension Period|Reason Not Specified|3|||
44546983|NCT03443973|79561334|FG003|Open-label Extension Period|Reason Not Specified|0|||
44546984|NCT03443973|79561331|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
44546985|NCT03443973|79561332|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
44546986|NCT03443973|79561333|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
44546987|NCT03443973|79561334|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
44546988|NCT03361306|79561398|FG000|Overall Study|Death|5|||
44546989|NCT03361306|79561398|FG000|Overall Study|Still On Study (on study treatment)|3|||
44546990|NCT03361306|79561398|FG000|Overall Study|Still On Study (in follow up)|7|||
44546991|NCT03325439|79561402|FG000|Overall Study|Ineligibility|3|||
44546992|NCT03246347|79561414|FG000|Overall Study|On Study|23|||
44546993|NCT03141177|79561421|FG000|Overall Study|Death|62|||
44546994|NCT03141177|79561422|FG001|Overall Study|Death|13|||
44546995|NCT03141177|79561423|FG002|Overall Study|Death|84|||
44229839|NCT01683409|79037781|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
44229840|NCT01683409|79037782|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
44229841|NCT01683409|79037778|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
44229842|NCT01683409|79037779|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
44229843|NCT01683409|79037780|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
44229844|NCT01683409|79037781|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
44229845|NCT01683409|79037782|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
44229846|NCT01683409|79037778|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
44229847|NCT01683409|79037779|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
44229848|NCT01683409|79037780|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
44229849|NCT01683409|79037781|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
44229850|NCT01683409|79037782|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
44229851|NCT01683409|79037778|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
44229852|NCT01683409|79037779|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
44229853|NCT01683409|79037780|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
44229854|NCT01683409|79037781|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
44229855|NCT01683409|79037782|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
44229856|NCT01683409|79037778|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
44229857|NCT01683409|79037779|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
44229858|NCT01683409|79037780|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
44229859|NCT01683409|79037781|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
44229860|NCT01683409|79037782|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
44229861|NCT01683409|79037778|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
44229862|NCT01683409|79037779|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
44229863|NCT01683409|79037780|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
44229864|NCT01683409|79037781|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
44229865|NCT01683409|79037782|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
44229866|NCT01699022|79037808|FG000|Overall Study|Early discontinuation from the study|3|||
44229867|NCT01683019|79037816|FG000|Overall Study|Withdrawal by Subject|2|||
44229868|NCT01683019|79037817|FG001|Overall Study|Withdrawal by Subject|1|||
44229869|NCT01683019|79037818|FG002|Overall Study|Withdrawal by Subject|4|||
44229870|NCT01709162|79037828|FG000|Overall Study|Disease progression|3|||
44229871|NCT01709162|79037829|FG001|Overall Study|Disease progression|3|||
44229872|NCT01709162|79037828|FG000|Overall Study|Study drug toxicity|2|||
44229873|NCT01709162|79037829|FG001|Overall Study|Study drug toxicity|0|||
44229874|NCT01709162|79037828|FG000|Overall Study|Administrative reason by sponsor|0|||
44274590|NCT02248818|79220360|FG001|Screening|Study fully enrolled|0|||
44546996|NCT03141177|79561421|FG000|Overall Study|Participant withdrew consent|9|||
44546997|NCT03141177|79561422|FG001|Overall Study|Participant withdrew consent|2|||
44229875|NCT01709162|79037829|FG001|Overall Study|Administrative reason by sponsor|1|||
44229876|NCT01709162|79037828|FG000|Overall Study|Other|1|||
44229877|NCT01709162|79037829|FG001|Overall Study|Other|0|||
44229878|NCT01709162|79037828|FG000|Overall Study|Withdrawal by Subject|0|||
44229879|NCT01709162|79037829|FG001|Overall Study|Withdrawal by Subject|1|||
44229880|NCT01698554|79037839|FG000|Overall Study|Adverse Event|2|||
44229881|NCT01698554|79037840|FG001|Overall Study|Adverse Event|5|||
44229882|NCT01698554|79037841|FG002|Overall Study|Adverse Event|0|||
44229883|NCT01698554|79037842|FG003|Overall Study|Adverse Event|1|||
44229884|NCT01698554|79037839|FG000|Overall Study|Lost to Follow-up|1|||
44229885|NCT01698554|79037840|FG001|Overall Study|Lost to Follow-up|0|||
44229886|NCT01698554|79037841|FG002|Overall Study|Lost to Follow-up|0|||
44493355|NCT00146172|79499177|FG005|Overall Study|Physician Decision|0|||
44493356|NCT00146172|79499178|FG006|Overall Study|Physician Decision|0|||
44493357|NCT00146172|79499179|FG007|Overall Study|Physician Decision|1|||
44493358|NCT00146172|79499172|FG000|Overall Study|Withdrawal by Subject|0|||
44546998|NCT03141177|79561423|FG002|Overall Study|Participant withdrew consent|13|||
44546999|NCT03141177|79561421|FG000|Overall Study|Not reported|1|||
44547000|NCT03141177|79561422|FG001|Overall Study|Not reported|0|||
44547001|NCT03141177|79561423|FG002|Overall Study|Not reported|1|||
44547002|NCT03141177|79561421|FG000|Overall Study|Lost to Follow-up|2|||
44547003|NCT03141177|79561422|FG001|Overall Study|Lost to Follow-up|1|||
44547004|NCT03141177|79561423|FG002|Overall Study|Lost to Follow-up|1|||
44547005|NCT03141177|79561421|FG000|Overall Study|Other reasons|4|||
44547006|NCT03141177|79561422|FG001|Overall Study|Other reasons|0|||
44547007|NCT03141177|79561423|FG002|Overall Study|Other reasons|11|||
44547008|NCT03141177|79561421|FG000|Overall Study|Participants did not start treatment period|3|||
44547009|NCT03141177|79561422|FG001|Overall Study|Participants did not start treatment period|0|||
44493359|NCT00146172|79499173|FG001|Overall Study|Withdrawal by Subject|0|||
44493360|NCT00146172|79499174|FG002|Overall Study|Withdrawal by Subject|0|||
44493361|NCT00146172|79499175|FG003|Overall Study|Withdrawal by Subject|0|||
44493362|NCT00146172|79499176|FG004|Overall Study|Withdrawal by Subject|0|||
44493363|NCT00146172|79499177|FG005|Overall Study|Withdrawal by Subject|1|||
44493364|NCT00146172|79499178|FG006|Overall Study|Withdrawal by Subject|1|||
44493365|NCT00146172|79499179|FG007|Overall Study|Withdrawal by Subject|4|||
44493366|NCT00146172|79499172|FG000|Overall Study|Symptomatic Deterioration|1|||
44493367|NCT00146172|79499173|FG001|Overall Study|Symptomatic Deterioration|0|||
44493368|NCT00146172|79499174|FG002|Overall Study|Symptomatic Deterioration|1|||
44493369|NCT00146172|79499175|FG003|Overall Study|Symptomatic Deterioration|0|||
44547010|NCT03141177|79561423|FG002|Overall Study|Participants did not start treatment period|8|||
44547011|NCT03035864|79561434|FG000|Treatment Period|Adverse Event|1|||
44547012|NCT03035864|79561435|FG001|Treatment Period|Adverse Event|0|||
44547013|NCT03035864|79561434|FG000|Treatment Period|Other|3|||
44229887|NCT01698554|79037842|FG003|Overall Study|Lost to Follow-up|0|||
44229888|NCT01698554|79037839|FG000|Overall Study|Personal Reasons|0|||
44229889|NCT01698554|79037840|FG001|Overall Study|Personal Reasons|5|||
44229890|NCT01698554|79037841|FG002|Overall Study|Personal Reasons|1|||
44547014|NCT03035864|79561435|FG001|Treatment Period|Other|1|||
44547015|NCT03035864|79561434|FG000|Follow-up Period|Adverse Event|1|||
44493370|NCT00146172|79499176|FG004|Overall Study|Symptomatic Deterioration|1|||
44493371|NCT00146172|79499177|FG005|Overall Study|Symptomatic Deterioration|2|||
44493372|NCT00146172|79499178|FG006|Overall Study|Symptomatic Deterioration|0|||
44547016|NCT03035864|79561435|FG001|Follow-up Period|Adverse Event|0|||
44547017|NCT03035864|79561434|FG000|Follow-up Period|Lost to Follow-up|6|||
44547018|NCT03035864|79561435|FG001|Follow-up Period|Lost to Follow-up|2|||
44547019|NCT03035864|79561434|FG000|Follow-up Period|Physician Decision|1|||
44547020|NCT03035864|79561435|FG001|Follow-up Period|Physician Decision|0|||
44547021|NCT03035864|79561434|FG000|Follow-up Period|Other|3|||
44547022|NCT03035864|79561435|FG001|Follow-up Period|Other|2|||
44547023|NCT02889809|79561447|FG000|Overall Study|Withdrawal by Subject|30|||
44547024|NCT02889809|79561448|FG001|Overall Study|Withdrawal by Subject|21|||
44547025|NCT02889809|79561447|FG000|Overall Study|Lost to Follow-up|1|||
44547026|NCT02889809|79561448|FG001|Overall Study|Lost to Follow-up|1|||
44547027|NCT02889809|79561447|FG000|Overall Study|Site Closed|12|||
44547028|NCT02889809|79561448|FG001|Overall Study|Site Closed|11|||
44547029|NCT02759107|79561472|FG000|Overall Study|Adverse Event|0|||
44547030|NCT02759107|79561473|FG001|Overall Study|Adverse Event|0|||
44547031|NCT02759107|79561474|FG002|Overall Study|Adverse Event|0|||
44547032|NCT02759107|79561475|FG003|Overall Study|Adverse Event|0|||
44547033|NCT02759107|79561476|FG004|Overall Study|Adverse Event|0|||
44547034|NCT02759107|79561477|FG005|Overall Study|Adverse Event|0|||
44547035|NCT02759107|79561478|FG006|Overall Study|Adverse Event|0|||
44547036|NCT02759107|79561479|FG007|Overall Study|Adverse Event|0|||
44547037|NCT02759107|79561480|FG008|Overall Study|Adverse Event|0|||
44547038|NCT02759107|79561481|FG009|Overall Study|Adverse Event|0|||
44547039|NCT02759107|79561482|FG010|Overall Study|Adverse Event|0|||
44547040|NCT02759107|79561483|FG011|Overall Study|Adverse Event|0|||
44547041|NCT02759107|79561484|FG012|Overall Study|Adverse Event|2|||
44547042|NCT02759107|79561485|FG013|Overall Study|Adverse Event|0|||
44547043|NCT02759107|79561486|FG014|Overall Study|Adverse Event|0|||
44547044|NCT02759107|79561487|FG015|Overall Study|Adverse Event|1|||
44547045|NCT02759107|79561488|FG016|Overall Study|Adverse Event|0|||
44547046|NCT02759107|79561489|FG017|Overall Study|Adverse Event|2|||
44547047|NCT02759107|79561472|FG000|Overall Study|Scheduling Conflict|0|||
44547048|NCT02759107|79561473|FG001|Overall Study|Scheduling Conflict|0|||
44547049|NCT02759107|79561474|FG002|Overall Study|Scheduling Conflict|0|||
44547050|NCT02759107|79561475|FG003|Overall Study|Scheduling Conflict|0|||
44547051|NCT02759107|79561476|FG004|Overall Study|Scheduling Conflict|0|||
44547052|NCT02759107|79561477|FG005|Overall Study|Scheduling Conflict|0|||
44547053|NCT02759107|79561478|FG006|Overall Study|Scheduling Conflict|0|||
44547054|NCT02759107|79561479|FG007|Overall Study|Scheduling Conflict|0|||
44547055|NCT02759107|79561480|FG008|Overall Study|Scheduling Conflict|0|||
44547056|NCT02759107|79561481|FG009|Overall Study|Scheduling Conflict|1|||
44547057|NCT02759107|79561482|FG010|Overall Study|Scheduling Conflict|0|||
44547058|NCT02759107|79561483|FG011|Overall Study|Scheduling Conflict|0|||
44547059|NCT02759107|79561484|FG012|Overall Study|Scheduling Conflict|0|||
44547060|NCT02759107|79561485|FG013|Overall Study|Scheduling Conflict|0|||
44547061|NCT02759107|79561486|FG014|Overall Study|Scheduling Conflict|0|||
44547062|NCT02759107|79561487|FG015|Overall Study|Scheduling Conflict|0|||
44547063|NCT02759107|79561488|FG016|Overall Study|Scheduling Conflict|0|||
44547064|NCT02759107|79561489|FG017|Overall Study|Scheduling Conflict|0|||
44547065|NCT02658968|79561535|FG000|Received Rituximab|Adverse Event|0|||
44547066|NCT02658968|79561536|FG001|Received Rituximab|Adverse Event|0|||
44229891|NCT01698554|79037842|FG003|Overall Study|Personal Reasons|1|||
44229892|NCT01698554|79037839|FG000|Overall Study|Protocol Violation|2|||
44547067|NCT02658968|79561537|FG002|Received Rituximab|Adverse Event|0|||
44547068|NCT02658968|79561538|FG003|Received Rituximab|Adverse Event|0|||
44547069|NCT02658968|79561539|FG004|Received Rituximab|Adverse Event|1|||
44547070|NCT02658968|79561535|FG000|Received Rituximab|Progressive disease|0|||
44547071|NCT02658968|79561536|FG001|Received Rituximab|Progressive disease|0|||
44547072|NCT02658968|79561537|FG002|Received Rituximab|Progressive disease|0|||
44547073|NCT02658968|79561538|FG003|Received Rituximab|Progressive disease|0|||
44547074|NCT02658968|79561539|FG004|Received Rituximab|Progressive disease|1|||
44547075|NCT02658968|79561535|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
44547076|NCT02658968|79561536|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
44547077|NCT02658968|79561537|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
44547078|NCT02658968|79561538|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
44547079|NCT02658968|79561539|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
44547080|NCT02658968|79561535|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
44547081|NCT02658968|79561536|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
44547082|NCT02658968|79561537|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
44547083|NCT02658968|79561538|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
44547084|NCT02658968|79561539|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
44547085|NCT02658968|79561535|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
44547086|NCT02658968|79561536|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
44547087|NCT02658968|79561537|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
44547088|NCT02658968|79561538|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
44229893|NCT01698554|79037840|FG001|Overall Study|Protocol Violation|0|||
44229894|NCT01698554|79037841|FG002|Overall Study|Protocol Violation|1|||
44229895|NCT01698554|79037842|FG003|Overall Study|Protocol Violation|0|||
44493373|NCT00146172|79499179|FG007|Overall Study|Symptomatic Deterioration|2|||
44493374|NCT00145626|79499207|FG000|Overall Study|Did not have NK infusions|2|||
44493375|NCT00145626|79499207|FG000|Overall Study|Turned 2 years old before treatment|1|||
44493376|NCT00145626|79499207|FG000|Overall Study|Death|1|||
44493377|NCT00145626|79499207|FG000|Overall Study|Withdrawal by Subject|1|||
44493378|NCT00153062|79499231|FG000|Overall Study|Death|360|||
44547089|NCT02658968|79561539|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
44547090|NCT02658968|79561535|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
44547091|NCT02658968|79561536|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
44493379|NCT00153062|79499232|FG001|Overall Study|Death|352|||
44493380|NCT00153062|79499233|FG002|Overall Study|Death|369|||
44493381|NCT00153062|79499234|FG003|Overall Study|Death|365|||
44493382|NCT00153062|79499231|FG000|Overall Study|Withdrawal by Subject|14|||
44493383|NCT00153062|79499232|FG001|Overall Study|Withdrawal by Subject|30|||
44493384|NCT00153062|79499233|FG002|Overall Study|Withdrawal by Subject|27|||
44229896|NCT01698554|79037839|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44229897|NCT01698554|79037840|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44493385|NCT00153062|79499234|FG003|Overall Study|Withdrawal by Subject|28|||
44493386|NCT00153062|79499231|FG000|Overall Study|Lost to Follow-up|12|||
44493387|NCT00153062|79499232|FG001|Overall Study|Lost to Follow-up|20|||
44493388|NCT00153062|79499233|FG002|Overall Study|Lost to Follow-up|15|||
44229898|NCT01698554|79037841|FG002|Overall Study|Other Miscellaneous Reasons|0|||
44493389|NCT00153062|79499234|FG003|Overall Study|Lost to Follow-up|16|||
44493390|NCT00153062|79499231|FG000|Overall Study|Adverse Event|0|||
44493391|NCT00153062|79499232|FG001|Overall Study|Adverse Event|1|||
44493392|NCT00153062|79499233|FG002|Overall Study|Adverse Event|1|||
44493393|NCT00153062|79499234|FG003|Overall Study|Adverse Event|0|||
44493394|NCT00153062|79499231|FG000|Overall Study|Protocol Violation|0|||
44493395|NCT00153062|79499232|FG001|Overall Study|Protocol Violation|2|||
44493396|NCT00153062|79499233|FG002|Overall Study|Protocol Violation|1|||
44493397|NCT00153062|79499234|FG003|Overall Study|Protocol Violation|1|||
44493398|NCT00153062|79499231|FG000|Overall Study|No disposition data available|1|||
44493399|NCT00153062|79499232|FG001|Overall Study|No disposition data available|1|||
44493400|NCT00153062|79499233|FG002|Overall Study|No disposition data available|1|||
44493401|NCT00153062|79499234|FG003|Overall Study|No disposition data available|1|||
44547092|NCT02658968|79561537|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
44547093|NCT02658968|79561538|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
44547094|NCT02658968|79561539|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
44493402|NCT00153062|79499231|FG000|Overall Study|Other|0|||
44493403|NCT00153062|79499232|FG001|Overall Study|Other|0|||
44493404|NCT00153062|79499233|FG002|Overall Study|Other|1|||
44493405|NCT00153062|79499234|FG003|Overall Study|Other|0|||
44493406|NCT00145470|79499246|FG000|Overall Study|Adverse Event|19|||
44493407|NCT00145470|79499247|FG001|Overall Study|Adverse Event|25|||
44493408|NCT00145470|79499246|FG000|Overall Study|Lack of Efficacy|27|||
44493409|NCT00145470|79499247|FG001|Overall Study|Lack of Efficacy|13|||
44493410|NCT00145470|79499246|FG000|Overall Study|Withdrawal by Subject|36|||
44493411|NCT00145470|79499247|FG001|Overall Study|Withdrawal by Subject|34|||
44493412|NCT00145470|79499246|FG000|Overall Study|Lost to Follow-up|21|||
44493413|NCT00145470|79499247|FG001|Overall Study|Lost to Follow-up|17|||
44493414|NCT00145470|79499246|FG000|Overall Study|Reason Not Reported|9|||
44547095|NCT02658968|79561535|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
44547096|NCT02658968|79561536|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
44547097|NCT02658968|79561537|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
44547098|NCT02658968|79561538|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
44547099|NCT02658968|79561539|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
44547100|NCT02385110|79561574|FG000|Overall Study|Early Death|1|||
44547101|NCT02385110|79561575|FG001|Overall Study|Early Death|0|||
44547102|NCT02138110|79561581|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
44547103|NCT02138110|79561581|FG000|Overall Scaffold Implantation|Death|3|||
44547104|NCT01898793|79561592|FG000|Overall Study|Death|2|||
44547105|NCT01898793|79561593|FG001|Overall Study|Death|1|||
44547106|NCT01898793|79561594|FG002|Overall Study|Death|4|||
44547107|NCT01898793|79561595|FG003|Overall Study|Death|0|||
44547108|NCT01898793|79561596|FG004|Overall Study|Death|0|||
44547109|NCT01898793|79561597|FG005|Overall Study|Death|0|||
44547110|NCT01898793|79561598|FG006|Overall Study|Death|0|||
44547111|NCT01857934|79561617|FG000|Overall Study|Relapse or progression|2|||
44547112|NCT01857934|79561617|FG000|Overall Study|Unacceptable toxicity|3|||
44547113|NCT01857934|79561617|FG000|Overall Study|Unwillingness or inability to comply|2|||
44547114|NCT01857934|79561617|FG000|Overall Study|Physician Decision|3|||
44547115|NCT01757665|79561643|FG000|Overall Study|Still on Study - Visit Completed|240|||
44547116|NCT01757665|79561644|FG001|Overall Study|Still on Study - Visit Completed|30|||
44547117|NCT01757665|79561643|FG000|Overall Study|Still on Study - Visit Pending|398|||
44547118|NCT01757665|79561644|FG001|Overall Study|Still on Study - Visit Pending|40|||
44547119|NCT01757665|79561643|FG000|Overall Study|Still on Study - Missed Visit|14|||
44547120|NCT01757665|79561644|FG001|Overall Study|Still on Study - Missed Visit|1|||
44547121|NCT01757665|79561643|FG000|Overall Study|Death|25|||
44547122|NCT01757665|79561644|FG001|Overall Study|Death|8|||
44229899|NCT01698554|79037842|FG003|Overall Study|Other Miscellaneous Reasons|0|||
44229900|NCT01698320|79037854|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
44229901|NCT01698320|79037855|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
44229902|NCT01698320|79037856|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
44274591|NCT02248818|79220361|FG002|Screening|Study fully enrolled|0|||
44376441|NCT00867334|79381552|FG001|Overall Study|Withdrawal by Subject|0|||
44493415|NCT00145470|79499247|FG001|Overall Study|Reason Not Reported|9|||
44547123|NCT01757665|79561643|FG000|Overall Study|Explant|1|||
44547124|NCT01757665|79561644|FG001|Overall Study|Explant|2|||
44547125|NCT01757665|79561643|FG000|Overall Study|Withdrawal by Subject|10|||
44547126|NCT01757665|79561644|FG001|Overall Study|Withdrawal by Subject|0|||
44547127|NCT01757665|79561643|FG000|Overall Study|Lost to Follow-up|1|||
44547128|NCT01757665|79561644|FG001|Overall Study|Lost to Follow-up|1|||
44547129|NCT01757665|79561643|FG000|Overall Study|Not Implanted with Device|5|||
44547130|NCT01757665|79561644|FG001|Overall Study|Not Implanted with Device|1|||
44143809|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
44143810|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
44376442|NCT00925704|79381564|FG000|First Intervention|Withdrew consent|0|||
44493416|NCT00152516|79499253|FG000|Overall Study|Adverse Event|18|||
44493417|NCT00152516|79499253|FG000|Overall Study|Lack and Loss of Efficacy|30|||
44143811|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
44143812|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
44493418|NCT00152516|79499253|FG000|Overall Study|Lost to Follow-up|5|||
44493419|NCT00152516|79499253|FG000|Overall Study|Withdrawal by Subject|8|||
44547131|NCT01459497|79561680|FG000|Overall Study|Inability to meet trial constraints.|1|||
44547132|NCT01459497|79561681|FG001|Overall Study|Inability to meet trial constraints.|0|||
44547133|NCT01459497|79561680|FG000|Overall Study|Physician Decision|1|||
44547134|NCT01459497|79561681|FG001|Overall Study|Physician Decision|1|||
44547135|NCT01459497|79561680|FG000|Overall Study|Hospitalization.|0|||
44547136|NCT01459497|79561681|FG001|Overall Study|Hospitalization.|3|||
44547137|NCT01459497|79561680|FG000|Overall Study|Disease progression.|0|||
44547138|NCT01459497|79561681|FG001|Overall Study|Disease progression.|1|||
44547139|NCT01063751|79561687|FG000|Overall Study|Site terminated|45|||
44547140|NCT01063751|79561687|FG000|Overall Study|Lost to Follow-up|28|||
44547141|NCT01063751|79561687|FG000|Overall Study|Withdrawal by Subject|25|||
44547142|NCT01063751|79561687|FG000|Overall Study|Revision|6|||
44547143|NCT01063751|79561687|FG000|Overall Study|Death|12|||
44547144|NCT01063751|79561687|FG000|Overall Study|Physician Decision|4|||
44547145|NCT01063751|79561687|FG000|Overall Study|Active|91|||
44547146|NCT00680901|79561694|FG000|Overall Study|Lost to Follow-up|8|||
44547147|NCT00680901|79561695|FG001|Overall Study|Lost to Follow-up|8|||
44547148|NCT00680901|79561694|FG000|Overall Study|Withdrawal by Subject|4|||
44547149|NCT00680901|79561695|FG001|Overall Study|Withdrawal by Subject|13|||
44493420|NCT00152516|79499253|FG000|Overall Study|Protocol Violation|3|||
44493421|NCT00152516|79499253|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
44493422|NCT00152516|79499253|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
44493423|NCT00152516|79499253|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
44493424|NCT00152516|79499253|FG000|Overall Study|Other: Non-Compliance|2|||
44493425|NCT00152516|79499253|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
44547150|NCT00680901|79561694|FG000|Overall Study|Physician Decision|0|||
44547151|NCT00680901|79561695|FG001|Overall Study|Physician Decision|1|||
44547152|NCT00680901|79561694|FG000|Overall Study|Ongoing: On Study Treatment|16|||
44547153|NCT00680901|79561695|FG001|Overall Study|Ongoing: On Study Treatment|13|||
44547154|NCT00680901|79561694|FG000|Overall Study|Ongoing: In Follow Up|45|||
44547155|NCT00680901|79561695|FG001|Overall Study|Ongoing: In Follow Up|41|||
44547156|NCT00557193|79561701|FG000|Induction|Adverse Event|2|||
44547157|NCT00557193|79561702|FG001|Induction|Adverse Event|0|||
44547158|NCT00557193|79561703|FG002|Induction|Adverse Event|0|||
44547159|NCT00557193|79561704|FG003|Induction|Adverse Event|0|||
44547160|NCT00557193|79561705|FG004|Induction|Adverse Event|0|||
44547161|NCT00557193|79561706|FG005|Induction|Adverse Event|0|||
44547162|NCT00557193|79561701|FG000|Induction|Death|6|||
44547163|NCT00557193|79561702|FG001|Induction|Death|0|||
44547164|NCT00557193|79561703|FG002|Induction|Death|0|||
44547165|NCT00557193|79561704|FG003|Induction|Death|0|||
44547166|NCT00557193|79561705|FG004|Induction|Death|0|||
44547167|NCT00557193|79561706|FG005|Induction|Death|0|||
44547168|NCT00557193|79561701|FG000|Induction|Physician Decision|3|||
44229903|NCT01698320|79037854|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
44229904|NCT01698320|79037855|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
44229905|NCT01698320|79037856|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
44229906|NCT01698320|79037854|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
44493426|NCT00152516|79499253|FG000|Overall Study|Other: Moved Out Of State|1|||
44493427|NCT00152516|79499253|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
44493428|NCT00152516|79499253|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
44493429|NCT00145158|79499259|FG000|Overall Study|premature withdrawal|2|||
44493430|NCT00145158|79499260|FG001|Overall Study|premature withdrawal|3|||
44493431|NCT00150800|79499267|FG000|Overall Study|Adverse Event|89|||
44547169|NCT00557193|79561702|FG001|Induction|Physician Decision|0|||
44547170|NCT00557193|79561703|FG002|Induction|Physician Decision|0|||
44547171|NCT00557193|79561704|FG003|Induction|Physician Decision|0|||
44547172|NCT00557193|79561705|FG004|Induction|Physician Decision|0|||
44547173|NCT00557193|79561706|FG005|Induction|Physician Decision|0|||
44547174|NCT00557193|79561701|FG000|Induction|Withdrawal by Subject|1|||
44547175|NCT00557193|79561702|FG001|Induction|Withdrawal by Subject|0|||
44547176|NCT00557193|79561703|FG002|Induction|Withdrawal by Subject|0|||
44547177|NCT00557193|79561704|FG003|Induction|Withdrawal by Subject|0|||
44547178|NCT00557193|79561705|FG004|Induction|Withdrawal by Subject|0|||
44547179|NCT00557193|79561706|FG005|Induction|Withdrawal by Subject|0|||
44547180|NCT00557193|79561701|FG000|Induction|Refusal of Further Protocol Therapy|2|||
44547181|NCT00557193|79561702|FG001|Induction|Refusal of Further Protocol Therapy|0|||
44547182|NCT00557193|79561703|FG002|Induction|Refusal of Further Protocol Therapy|0|||
44547183|NCT00557193|79561704|FG003|Induction|Refusal of Further Protocol Therapy|0|||
44547184|NCT00557193|79561705|FG004|Induction|Refusal of Further Protocol Therapy|0|||
44547185|NCT00557193|79561706|FG005|Induction|Refusal of Further Protocol Therapy|0|||
44547186|NCT00557193|79561701|FG000|Induction|Ineligible|8|||
44547187|NCT00557193|79561702|FG001|Induction|Ineligible|0|||
44229907|NCT01698320|79037855|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
44229908|NCT01698320|79037856|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
44229909|NCT01698320|79037854|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
44229910|NCT01698320|79037855|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
44229911|NCT01698320|79037856|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
44229912|NCT01698320|79037854|FG000|12-Week Double-Blind Period|Adverse Event|0|||
44229913|NCT01698320|79037855|FG001|12-Week Double-Blind Period|Adverse Event|1|||
44229914|NCT01698320|79037856|FG002|12-Week Double-Blind Period|Adverse Event|1|||
44229915|NCT01698320|79037854|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
44229916|NCT01698320|79037855|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
44229917|NCT01698320|79037856|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
44547188|NCT00557193|79561703|FG002|Induction|Ineligible|0|||
44547189|NCT00557193|79561704|FG003|Induction|Ineligible|0|||
44547190|NCT00557193|79561705|FG004|Induction|Ineligible|0|||
44547191|NCT00557193|79561706|FG005|Induction|Ineligible|0|||
44547192|NCT00557193|79561701|FG000|Induction|Inevaluable for post Induction|2|||
44547193|NCT00557193|79561702|FG001|Induction|Inevaluable for post Induction|0|||
44547194|NCT00557193|79561703|FG002|Induction|Inevaluable for post Induction|0|||
44547195|NCT00557193|79561704|FG003|Induction|Inevaluable for post Induction|0|||
44547196|NCT00557193|79561705|FG004|Induction|Inevaluable for post Induction|0|||
44547197|NCT00557193|79561706|FG005|Induction|Inevaluable for post Induction|0|||
44547198|NCT00557193|79561701|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
44547199|NCT00557193|79561702|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
44547200|NCT00557193|79561703|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
44547201|NCT00557193|79561704|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
44547202|NCT00557193|79561705|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
44547203|NCT00557193|79561706|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
44547204|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
44547205|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
44547206|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
44547207|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
44547208|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
44547209|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
44547210|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
44547211|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
44547212|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
44547213|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
44547214|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
44547215|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
44547216|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
44547217|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
44547218|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
44547219|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
44547220|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
44547221|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
44547222|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
44547223|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
44547224|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
44547225|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
44547226|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
44547227|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
44547228|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
44547229|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
44229918|NCT01698320|79037854|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
44229919|NCT01698320|79037855|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
44547230|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
44547231|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
44376443|NCT00925704|79381565|FG001|First Intervention|Withdrew consent|0|||
44493432|NCT00150800|79499267|FG000|Overall Study|Death|18|||
44493433|NCT00150800|79499267|FG000|Overall Study|Lack of Efficacy|166|||
44493434|NCT00150800|79499267|FG000|Overall Study|Lost to Follow-up|58|||
44493435|NCT00150800|79499267|FG000|Overall Study|Subject's choice|90|||
44493436|NCT00150800|79499267|FG000|Overall Study|No compliance|18|||
44493437|NCT00150800|79499267|FG000|Overall Study|IP misshandling|1|||
44493438|NCT00150800|79499267|FG000|Overall Study|Site closure|24|||
44376444|NCT00925704|79381566|FG002|First Intervention|Withdrew consent|0|||
44493439|NCT00150800|79499267|FG000|Overall Study|Protocol non-adherence|2|||
44493440|NCT00150800|79499267|FG000|Overall Study|Nobody to accompany patient|1|||
44493441|NCT00150800|79499267|FG000|Overall Study|Distance too long for patient|1|||
44229920|NCT01698320|79037856|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
44229921|NCT01698320|79037854|FG000|12-Week Double-Blind Period|Pregnancy|0|||
44229922|NCT01698320|79037855|FG001|12-Week Double-Blind Period|Pregnancy|1|||
44229923|NCT01698320|79037856|FG002|12-Week Double-Blind Period|Pregnancy|1|||
44547232|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
44547233|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
44547234|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
44229924|NCT01698320|79037854|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
44229925|NCT01698320|79037855|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
44547235|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
44547236|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
44547237|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
44547238|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
44547239|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
44547240|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
44547241|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
44547242|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
44547243|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
44547244|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
44547245|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
44547246|NCT00557193|79561701|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
44547247|NCT00557193|79561702|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
44547248|NCT00557193|79561703|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
44547249|NCT00557193|79561704|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
44547250|NCT00557193|79561705|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
44376445|NCT00925704|79381567|FG003|First Intervention|Withdrew consent|1|||
44547251|NCT00557193|79561706|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
44493442|NCT00150800|79499267|FG000|Overall Study|Neurosurgery|2|||
44493443|NCT00150800|79499267|FG000|Overall Study|BRV monotherapy|1|||
44493444|NCT00150800|79499267|FG000|Overall Study|Visit refusal|3|||
44493445|NCT00150800|79499267|FG000|Overall Study|Sponsor's request|2|||
44547252|NCT00186888|79561759|FG000|Overall Study|Toxicity|0|||
44229926|NCT01698320|79037856|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
44229927|NCT01698320|79037854|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
44229928|NCT01698320|79037855|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
44493446|NCT00150800|79499267|FG000|Overall Study|Generalized Epilepsy|1|||
44493447|NCT00150800|79499267|FG000|Overall Study|Moved from area/country|8|||
44493448|NCT00150800|79499267|FG000|Overall Study|PI retiring|2|||
44493449|NCT00150800|79499267|FG000|Overall Study|PI leaving site|2|||
44493450|NCT00150800|79499267|FG000|Overall Study|Patient insurance|1|||
44547253|NCT00186888|79561760|FG001|Overall Study|Toxicity|1|||
44229929|NCT01698320|79037856|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
44493451|NCT00150800|79499267|FG000|Overall Study|Surgical intervention|4|||
44493452|NCT00150800|79499267|FG000|Overall Study|Pregnancy planned|1|||
44493453|NCT00150800|79499267|FG000|Overall Study|PI discontinuation request|1|||
44547254|NCT00186888|79561761|FG002|Overall Study|Toxicity|0|||
44547255|NCT00186888|79561759|FG000|Overall Study|Relapse or progression of disease|4|||
44274592|NCT02248818|79220362|FG003|Screening|Study fully enrolled|0|||
44493454|NCT00144300|79499274|FG000|Overall Study|Adverse Event|18|||
44493455|NCT00144300|79499275|FG001|Overall Study|Adverse Event|16|||
44493456|NCT00144300|79499274|FG000|Overall Study|Protocol Violation|1|||
44493457|NCT00144300|79499275|FG001|Overall Study|Protocol Violation|3|||
44493458|NCT00144300|79499274|FG000|Overall Study|Lost to Follow-up|3|||
44493459|NCT00144300|79499275|FG001|Overall Study|Lost to Follow-up|0|||
44493460|NCT00144300|79499274|FG000|Overall Study|Withdrawal by Subject|6|||
44493461|NCT00144300|79499275|FG001|Overall Study|Withdrawal by Subject|6|||
44493462|NCT00144300|79499274|FG000|Overall Study|Other reason (not specified)|1|||
44493463|NCT00144300|79499275|FG001|Overall Study|Other reason (not specified)|3|||
44493464|NCT00149630|79499283|FG000|Overall Study|Incarceration|2|||
44493465|NCT00149630|79499284|FG001|Overall Study|Incarceration|0|||
44493466|NCT00149630|79499283|FG000|Overall Study|Treatment Programs|4|||
44493467|NCT00149630|79499284|FG001|Overall Study|Treatment Programs|5|||
44493468|NCT00149630|79499283|FG000|Overall Study|Adverse Event|2|||
44493469|NCT00149630|79499284|FG001|Overall Study|Adverse Event|0|||
44493470|NCT00127842|79499294|FG000|Overall Study|Adverse Event|15|||
44493471|NCT00127842|79499294|FG000|Overall Study|Withdrawal by Subject|3|||
44493472|NCT00127842|79499294|FG000|Overall Study|Lost to Follow-up|1|||
44547256|NCT00186888|79561760|FG001|Overall Study|Relapse or progression of disease|2|||
44547257|NCT00186888|79561761|FG002|Overall Study|Relapse or progression of disease|0|||
44547258|NCT03078192|79561798|FG000|Overall Study|Withdrawal by Subject|2|||
44547259|NCT03078192|79561799|FG001|Overall Study|Withdrawal by Subject|1|||
44376446|NCT00925704|79381568|FG004|First Intervention|Withdrew consent|1|||
44376447|NCT00925704|79381569|FG005|First Intervention|Withdrew consent|0|||
44274593|NCT02248818|79220363|FG004|Screening|Study fully enrolled|0|||
44274594|NCT02248818|79220364|FG005|Screening|Study fully enrolled|0|||
44493473|NCT00127842|79499294|FG000|Overall Study|Lack of Efficacy|12|||
44493474|NCT00127842|79499294|FG000|Overall Study|Noncompliance|2|||
44547260|NCT03078192|79561798|FG000|Overall Study|screen failure|0|||
44547261|NCT03078192|79561799|FG001|Overall Study|screen failure|3|||
44547262|NCT00703846|79561805|FG000|Overall Study|Adverse Event|8|||
44547263|NCT00703846|79561805|FG000|Overall Study|Lost to Follow-up|55|||
44547264|NCT00703846|79561805|FG000|Overall Study|Lack of Efficacy|15|||
44547265|NCT00703846|79561805|FG000|Overall Study|Noncompliance with Study Treatment|2|||
44547266|NCT00703846|79561805|FG000|Overall Study|Withdrawal by Subject|40|||
44547267|NCT00703846|79561805|FG000|Overall Study|Death|1|||
44547268|NCT00703846|79561805|FG000|Overall Study|Other|14|||
44547269|NCT00703846|79561805|FG000|Overall Study|Did Not Receive Study Drug|2|||
44547270|NCT05372575|79561815|FG000|Overall Study|Protocol Violation|7|||
44547271|NCT05372575|79561816|FG001|Overall Study|Protocol Violation|16|||
44547272|NCT05132127|79561827|FG000|Overall Study|Adverse Event|1|||
44547273|NCT04969276|79561854|FG000|Overall Study|Protocol Deviation|0|||
44547274|NCT04969276|79561855|FG001|Overall Study|Protocol Deviation|1|||
44547275|NCT04969276|79561856|FG002|Overall Study|Protocol Deviation|0|||
44547276|NCT04969276|79561854|FG000|Overall Study|Withdrawal by Subject|1|||
44547277|NCT04969276|79561855|FG001|Overall Study|Withdrawal by Subject|10|||
44547278|NCT04969276|79561856|FG002|Overall Study|Withdrawal by Subject|0|||
44547279|NCT04969276|79561854|FG000|Overall Study|Lost to Follow-up|0|||
44547280|NCT04969276|79561855|FG001|Overall Study|Lost to Follow-up|1|||
44547281|NCT04969276|79561856|FG002|Overall Study|Lost to Follow-up|0|||
44547282|NCT04969224|79561864|FG000|Overall Study|Adverse Event|1|||
44547283|NCT04969224|79561864|FG000|Overall Study|Enrolled but never dosed|1|||
44547284|NCT04507126|79561890|FG000|Overall Study|Withdrawal by Subject|1|||
44547285|NCT04507126|79561890|FG000|Overall Study|Protocol Violation|2|||
44547286|NCT04507126|79561890|FG000|Overall Study|Physician Decision|1|||
44547287|NCT04498832|79561897|FG000|Overall Study|Adverse Event|1|||
44547288|NCT04498832|79561898|FG001|Overall Study|Adverse Event|3|||
44547289|NCT04498832|79561897|FG000|Overall Study|Withdrawal by Subject|0|||
44547290|NCT04498832|79561898|FG001|Overall Study|Withdrawal by Subject|1|||
44376448|NCT00925704|79381564|FG000|Second Intervention|Withdrawal by Subject|1|||
44547291|NCT04490018|79561907|FG000|Overall Study|Protocol Violation|0|||
44547292|NCT04490018|79561908|FG001|Overall Study|Protocol Violation|2|||
44547293|NCT04490018|79561909|FG002|Overall Study|Protocol Violation|1|||
44547294|NCT04490018|79561907|FG000|Overall Study|Lost to Follow-up|2|||
44547295|NCT04490018|79561908|FG001|Overall Study|Lost to Follow-up|2|||
44547296|NCT04490018|79561909|FG002|Overall Study|Lost to Follow-up|0|||
44493475|NCT00127842|79499294|FG000|Overall Study|Protocol Violation|1|||
44493476|NCT00127842|79499294|FG000|Overall Study|Other|5|||
44493477|NCT03720652|79499300|FG000|Overall Study|Withdrawal by Subject|2|||
44493478|NCT03720652|79499301|FG001|Overall Study|Withdrawal by Subject|7|||
44493479|NCT03720652|79499300|FG000|Overall Study|Lost to Follow-up|0|||
44547297|NCT04490018|79561907|FG000|Overall Study|Withdrawal by Subject|2|||
44547298|NCT04490018|79561908|FG001|Overall Study|Withdrawal by Subject|1|||
44547299|NCT04490018|79561909|FG002|Overall Study|Withdrawal by Subject|0|||
44547300|NCT04490018|79561907|FG000|Overall Study|Withdrawal by parent/guardian|2|||
44547301|NCT04490018|79561908|FG001|Overall Study|Withdrawal by parent/guardian|3|||
44547302|NCT04490018|79561909|FG002|Overall Study|Withdrawal by parent/guardian|0|||
44547303|NCT03672461|79561960|FG000|Overall Study|COVID Related|4|||
44547304|NCT03672461|79561961|FG001|Overall Study|COVID Related|2|||
44547305|NCT03672461|79561960|FG000|Overall Study|Adverse Event|2|||
44547306|NCT03672461|79561961|FG001|Overall Study|Adverse Event|0|||
44547307|NCT03672461|79561960|FG000|Overall Study|Serious Adverse Event|0|||
44547308|NCT03672461|79561961|FG001|Overall Study|Serious Adverse Event|1|||
44547309|NCT03672461|79561960|FG000|Overall Study|Too Busy|3|||
44547310|NCT03672461|79561961|FG001|Overall Study|Too Busy|1|||
44547311|NCT03672461|79561960|FG000|Overall Study|Lost to Follow-up|1|||
44547312|NCT03672461|79561961|FG001|Overall Study|Lost to Follow-up|2|||
44547313|NCT03672461|79561960|FG000|Overall Study|Family|2|||
44547314|NCT03672461|79561961|FG001|Overall Study|Family|2|||
44547315|NCT03672461|79561960|FG000|Overall Study|No remote technology access|0|||
44547316|NCT03672461|79561961|FG001|Overall Study|No remote technology access|1|||
44547317|NCT03672461|79561960|FG000|Overall Study|Withdrawal by Subject|1|||
44547318|NCT03672461|79561961|FG001|Overall Study|Withdrawal by Subject|0|||
44547319|NCT03672461|79561960|FG000|Overall Study|Cannot tolerate intervention|1|||
44547320|NCT03672461|79561961|FG001|Overall Study|Cannot tolerate intervention|0|||
44547321|NCT03672461|79561960|FG000|Overall Study|Incomplete outcome data|6|||
44547322|NCT03672461|79561961|FG001|Overall Study|Incomplete outcome data|1|||
44547323|NCT03611556|79561974|FG000|Overall Study|Death|7|||
44547324|NCT03611556|79561975|FG001|Overall Study|Death|7|||
44547325|NCT03611556|79561976|FG002|Overall Study|Death|3|||
44547326|NCT03611556|79561977|FG003|Overall Study|Death|8|||
44547327|NCT03611556|79561978|FG004|Overall Study|Death|47|||
44547328|NCT03611556|79561979|FG005|Overall Study|Death|32|||
44547329|NCT03611556|79561980|FG006|Overall Study|Death|53|||
44547330|NCT03611556|79561974|FG000|Overall Study|Withdrawal by Subject|0|||
44229930|NCT01698320|79037854|FG000|40-Week Open-Label Period|Adverse Event|0|||
44493480|NCT03720652|79499301|FG001|Overall Study|Lost to Follow-up|4|||
44493481|NCT00112866|79499311|FG000|Overall Study|Protocol Violation|1|||
44493482|NCT00112866|79499312|FG001|Overall Study|Protocol Violation|0|||
44493483|NCT00112866|79499311|FG000|Overall Study|did not start treatment post-op|1|||
44493484|NCT00112866|79499312|FG001|Overall Study|did not start treatment post-op|2|||
44493485|NCT00127608|79499326|FG000|Overall Study|VZV DNA negative|1|||
44493486|NCT00149396|79499330|FG000|Overall Study|Death|15|||
44493487|NCT00149396|79499330|FG000|Overall Study|Withdrawal by Subject|1|||
44493488|NCT00149396|79499330|FG000|Overall Study|Subject noncompliance|2|||
44493489|NCT00149396|79499330|FG000|Overall Study|other treatment|5|||
44493490|NCT00223496|79499341|FG000|Overall Study|screen failure|9|||
44493491|NCT00223496|79499341|FG000|Overall Study|Lost to Follow-up|4|||
44493492|NCT00223496|79499341|FG000|Overall Study|Lack of Efficacy|6|||
44493493|NCT00223496|79499341|FG000|Overall Study|Withdrawal by Subject|1|||
44493494|NCT00223496|79499341|FG000|Overall Study|Physician Decision|2|||
44493495|NCT00255944|79499347|FG000|Overall Study|Lost to Follow-up|797|||
44493496|NCT00255944|79499348|FG001|Overall Study|Lost to Follow-up|834|||
44493497|NCT00143598|79499356|FG000|Overall Study|Lost to Follow-up|23|||
44493498|NCT00143598|79499357|FG001|Overall Study|Lost to Follow-up|21|||
44493499|NCT00143598|79499356|FG000|Overall Study|Withdrawal by Subject|33|||
44493500|NCT00143598|79499357|FG001|Overall Study|Withdrawal by Subject|37|||
44493501|NCT00143598|79499356|FG000|Overall Study|Death|36|||
44493502|NCT00143598|79499357|FG001|Overall Study|Death|36|||
44493503|NCT00126672|79499363|FG000|Overall Study|Adverse Event|4|||
44493504|NCT00126672|79499363|FG000|Overall Study|Lost to Follow-up|4|||
44547331|NCT03611556|79561975|FG001|Overall Study|Withdrawal by Subject|0|||
44547332|NCT03611556|79561976|FG002|Overall Study|Withdrawal by Subject|0|||
44547333|NCT03611556|79561977|FG003|Overall Study|Withdrawal by Subject|0|||
44547334|NCT03611556|79561978|FG004|Overall Study|Withdrawal by Subject|4|||
44229931|NCT01698320|79037855|FG001|40-Week Open-Label Period|Adverse Event|3|||
44274595|NCT02248818|79220365|FG006|Screening|Study fully enrolled|0|||
44493505|NCT00145574|79499370|FG000|Double Blind|Adverse Event|0|||
44493506|NCT00145574|79499371|FG001|Double Blind|Adverse Event|3|||
44493507|NCT00145574|79499372|FG002|Double Blind|Adverse Event|1|||
44493508|NCT00145574|79499370|FG000|Double Blind|Withdrawal by Subject|1|||
44493509|NCT00145574|79499371|FG001|Double Blind|Withdrawal by Subject|1|||
44493510|NCT00145574|79499372|FG002|Double Blind|Withdrawal by Subject|1|||
44493511|NCT00145574|79499370|FG000|Double Blind|required restricted medicine|0|||
44547335|NCT03611556|79561979|FG005|Overall Study|Withdrawal by Subject|2|||
44547336|NCT03611556|79561980|FG006|Overall Study|Withdrawal by Subject|4|||
44547337|NCT03611556|79561974|FG000|Overall Study|Sponsor decision|0|||
44547338|NCT03611556|79561975|FG001|Overall Study|Sponsor decision|0|||
44547339|NCT03611556|79561976|FG002|Overall Study|Sponsor decision|0|||
44547340|NCT03611556|79561977|FG003|Overall Study|Sponsor decision|0|||
44547341|NCT03611556|79561978|FG004|Overall Study|Sponsor decision|9|||
44547342|NCT03611556|79561979|FG005|Overall Study|Sponsor decision|4|||
44547343|NCT03611556|79561980|FG006|Overall Study|Sponsor decision|12|||
44547344|NCT03611556|79561974|FG000|Overall Study|Reasons|0|||
44547345|NCT03611556|79561975|FG001|Overall Study|Reasons|0|||
44547346|NCT03611556|79561976|FG002|Overall Study|Reasons|0|||
44547347|NCT03611556|79561977|FG003|Overall Study|Reasons|0|||
44547348|NCT03611556|79561978|FG004|Overall Study|Reasons|2|||
44547349|NCT03611556|79561979|FG005|Overall Study|Reasons|0|||
44547350|NCT03611556|79561980|FG006|Overall Study|Reasons|1|||
44547351|NCT03309813|79562031|FG000|Main Randomized Study|Withdrawal by Subject|1|||
44547352|NCT03309813|79562032|FG001|Main Randomized Study|Withdrawal by Subject|0|||
44229932|NCT01698320|79037856|FG002|40-Week Open-Label Period|Adverse Event|2|||
44229933|NCT01698320|79037854|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
44229934|NCT01698320|79037855|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
44229935|NCT01698320|79037856|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
44229936|NCT01698320|79037854|FG000|40-Week Open-Label Period|Pregnancy|0|||
44229937|NCT01698320|79037855|FG001|40-Week Open-Label Period|Pregnancy|2|||
44229938|NCT01698320|79037856|FG002|40-Week Open-Label Period|Pregnancy|1|||
44229939|NCT01698320|79037854|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
44229940|NCT01698320|79037855|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
44229941|NCT01698320|79037856|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
44229942|NCT01698320|79037854|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
44229943|NCT01698320|79037855|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
44229944|NCT01698320|79037856|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
44229945|NCT01697696|79037874|FG000|Overall Study|Study terminated by sponsor|0|||
44229946|NCT01697696|79037875|FG001|Overall Study|Study terminated by sponsor|3|||
44229947|NCT01697696|79037874|FG000|Overall Study|Protocol deviation|1|||
44229948|NCT01697696|79037875|FG001|Overall Study|Protocol deviation|0|||
44229949|NCT01697696|79037874|FG000|Overall Study|Physician Decision|1|||
44229950|NCT01697696|79037875|FG001|Overall Study|Physician Decision|0|||
44229951|NCT01697696|79037874|FG000|Overall Study|Death|4|||
44493512|NCT00145574|79499371|FG001|Double Blind|required restricted medicine|1|||
44229952|NCT01697696|79037875|FG001|Overall Study|Death|2|||
44229953|NCT01697696|79037874|FG000|Overall Study|Lost to Follow-up|10|||
44493513|NCT00145574|79499372|FG002|Double Blind|required restricted medicine|0|||
44493514|NCT00145574|79499370|FG000|Open Label Long-term Extension|Adverse Event|0|||
44493515|NCT00145574|79499371|FG001|Open Label Long-term Extension|Adverse Event|0|||
44493516|NCT00145574|79499372|FG002|Open Label Long-term Extension|Adverse Event|5|||
44493517|NCT00145574|79499370|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
44493518|NCT00145574|79499371|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
44547353|NCT02273388|79562085|FG000|Overall Study|Adverse Event|0|||
44547354|NCT02273388|79562086|FG001|Overall Study|Adverse Event|0|||
44547355|NCT02273388|79562087|FG002|Overall Study|Adverse Event|0|||
44547356|NCT02273388|79562088|FG003|Overall Study|Adverse Event|0|||
44547357|NCT02273388|79562089|FG004|Overall Study|Adverse Event|0|||
44547358|NCT02273388|79562090|FG005|Overall Study|Adverse Event|0|||
44493519|NCT00145574|79499372|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
44547359|NCT02273388|79562091|FG006|Overall Study|Adverse Event|1|||
44547360|NCT02273388|79562092|FG007|Overall Study|Adverse Event|2|||
44547361|NCT02273388|79562093|FG008|Overall Study|Adverse Event|0|||
44547362|NCT02273388|79562094|FG009|Overall Study|Adverse Event|0|||
44547363|NCT02273388|79562095|FG010|Overall Study|Adverse Event|0|||
44547364|NCT02273388|79562096|FG011|Overall Study|Adverse Event|0|||
44547365|NCT02273388|79562085|FG000|Overall Study|Adverse Event study disease worse|4|||
44547366|NCT02273388|79562086|FG001|Overall Study|Adverse Event study disease worse|3|||
44547367|NCT02273388|79562087|FG002|Overall Study|Adverse Event study disease worse|3|||
44547368|NCT02273388|79562088|FG003|Overall Study|Adverse Event study disease worse|2|||
44547369|NCT02273388|79562089|FG004|Overall Study|Adverse Event study disease worse|4|||
44547370|NCT02273388|79562090|FG005|Overall Study|Adverse Event study disease worse|3|||
44547371|NCT02273388|79562091|FG006|Overall Study|Adverse Event study disease worse|14|||
44547372|NCT02273388|79562092|FG007|Overall Study|Adverse Event study disease worse|6|||
44547373|NCT02273388|79562093|FG008|Overall Study|Adverse Event study disease worse|6|||
44547374|NCT02273388|79562094|FG009|Overall Study|Adverse Event study disease worse|5|||
44547375|NCT02273388|79562095|FG010|Overall Study|Adverse Event study disease worse|10|||
44547376|NCT02273388|79562096|FG011|Overall Study|Adverse Event study disease worse|1|||
44547377|NCT02273388|79562085|FG000|Overall Study|Sponsor decision|0|||
44547378|NCT02273388|79562086|FG001|Overall Study|Sponsor decision|0|||
44547379|NCT02273388|79562087|FG002|Overall Study|Sponsor decision|0|||
44547380|NCT02273388|79562088|FG003|Overall Study|Sponsor decision|0|||
44547381|NCT02273388|79562089|FG004|Overall Study|Sponsor decision|0|||
44547382|NCT02273388|79562090|FG005|Overall Study|Sponsor decision|0|||
44547383|NCT02273388|79562091|FG006|Overall Study|Sponsor decision|0|||
44547384|NCT02273388|79562092|FG007|Overall Study|Sponsor decision|0|||
44547385|NCT02273388|79562093|FG008|Overall Study|Sponsor decision|0|||
44547386|NCT02273388|79562094|FG009|Overall Study|Sponsor decision|0|||
44547387|NCT02273388|79562095|FG010|Overall Study|Sponsor decision|0|||
44547388|NCT02273388|79562096|FG011|Overall Study|Sponsor decision|1|||
44547389|NCT02272790|79562131|FG000|Overall Study|Physician Decision|0|||
44547390|NCT02272790|79562132|FG001|Overall Study|Physician Decision|1|||
44547391|NCT02272790|79562133|FG002|Overall Study|Physician Decision|0|||
44547392|NCT02272790|79562134|FG003|Overall Study|Physician Decision|0|||
44547393|NCT02272790|79562135|FG004|Overall Study|Physician Decision|0|||
44547394|NCT02272790|79562136|FG005|Overall Study|Physician Decision|0|||
44547395|NCT02100956|79562158|FG000|At Least One Week Between Injections|Adverse Event|0|||
44547396|NCT02100956|79562159|FG001|At Least One Week Between Injections|Adverse Event|1|||
44547397|NCT01438411|79562165|FG000|Overall Study|Adverse Event|8|||
44547398|NCT01438411|79562165|FG000|Overall Study|Lost to Follow-up|1|||
44547399|NCT01438411|79562165|FG000|Overall Study|Lack of Efficacy|1|||
44547400|NCT01438411|79562165|FG000|Overall Study|Withdrawal by Subject|3|||
44547401|NCT01302834|79562171|FG000|Overall Study|Protocol Violation|17|||
44547402|NCT01302834|79562172|FG001|Overall Study|Protocol Violation|23|||
44547403|NCT01302834|79562171|FG000|Overall Study|HIV positive|1|||
44547404|NCT01302834|79562172|FG001|Overall Study|HIV positive|3|||
44547405|NCT01153698|79562178|FG000|Overall Study|Adverse Event|12|||
44547406|NCT01153698|79562178|FG000|Overall Study|Lost to Follow-up|4|||
44547407|NCT01153698|79562178|FG000|Overall Study|Withdrawal by Subject|2|||
44547408|NCT01153698|79562178|FG000|Overall Study|Switch to other anticoagulants|4|||
44547409|NCT01153698|79562178|FG000|Overall Study|Other|2|||
44547410|NCT01153698|79562178|FG000|Overall Study|Not treated with Pradaxa|5|||
44547411|NCT00804856|79562211|FG000|Overall Study|Progressive Disease|3|||
44547412|NCT00804856|79562212|FG001|Overall Study|Progressive Disease|2|||
44547413|NCT00804856|79562213|FG002|Overall Study|Progressive Disease|4|||
44547414|NCT00804856|79562214|FG003|Overall Study|Progressive Disease|6|||
44547415|NCT00804856|79562215|FG004|Overall Study|Progressive Disease|4|||
44547416|NCT00804856|79562216|FG005|Overall Study|Progressive Disease|1|||
44547417|NCT00804856|79562217|FG006|Overall Study|Progressive Disease|8|||
44547418|NCT00804856|79562218|FG007|Overall Study|Progressive Disease|2|||
44547419|NCT00804856|79562219|FG008|Overall Study|Progressive Disease|4|||
44547420|NCT00804856|79562220|FG009|Overall Study|Progressive Disease|5|||
44547421|NCT00804856|79562221|FG010|Overall Study|Progressive Disease|12|||
44547422|NCT00804856|79562222|FG011|Overall Study|Progressive Disease|2|||
44547423|NCT00804856|79562223|FG012|Overall Study|Progressive Disease|2|||
44547424|NCT00804856|79562224|FG013|Overall Study|Progressive Disease|26|||
44547425|NCT00804856|79562225|FG014|Overall Study|Progressive Disease|20|||
44547426|NCT00804856|79562211|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547427|NCT00804856|79562212|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547428|NCT00804856|79562213|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547429|NCT00804856|79562214|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547430|NCT00804856|79562215|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44547431|NCT00804856|79562216|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547432|NCT00804856|79562217|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547433|NCT00804856|79562218|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547434|NCT00804856|79562219|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547435|NCT00804856|79562220|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547436|NCT00804856|79562221|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547437|NCT00804856|79562222|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547438|NCT00804856|79562223|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547439|NCT00804856|79562224|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44547440|NCT00804856|79562225|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44547441|NCT00804856|79562211|FG000|Overall Study|Other Adverse Event|1|||
44547442|NCT00804856|79562212|FG001|Overall Study|Other Adverse Event|1|||
44547443|NCT00804856|79562213|FG002|Overall Study|Other Adverse Event|1|||
44547444|NCT00804856|79562214|FG003|Overall Study|Other Adverse Event|2|||
44547445|NCT00804856|79562215|FG004|Overall Study|Other Adverse Event|2|||
44547446|NCT00804856|79562216|FG005|Overall Study|Other Adverse Event|1|||
44547447|NCT00804856|79562217|FG006|Overall Study|Other Adverse Event|3|||
44547448|NCT00804856|79562218|FG007|Overall Study|Other Adverse Event|0|||
44547449|NCT00804856|79562219|FG008|Overall Study|Other Adverse Event|0|||
44547450|NCT00804856|79562220|FG009|Overall Study|Other Adverse Event|1|||
44547451|NCT00804856|79562221|FG010|Overall Study|Other Adverse Event|5|||
44547452|NCT00804856|79562222|FG011|Overall Study|Other Adverse Event|2|||
44547453|NCT00804856|79562223|FG012|Overall Study|Other Adverse Event|0|||
44547454|NCT00804856|79562224|FG013|Overall Study|Other Adverse Event|6|||
44547455|NCT00804856|79562225|FG014|Overall Study|Other Adverse Event|13|||
44547456|NCT00804856|79562211|FG000|Overall Study|Non compliance with protocol|0|||
44547457|NCT00804856|79562212|FG001|Overall Study|Non compliance with protocol|0|||
44547458|NCT00804856|79562213|FG002|Overall Study|Non compliance with protocol|0|||
44547459|NCT00804856|79562214|FG003|Overall Study|Non compliance with protocol|0|||
44547460|NCT00804856|79562215|FG004|Overall Study|Non compliance with protocol|0|||
44547461|NCT00804856|79562216|FG005|Overall Study|Non compliance with protocol|0|||
44547462|NCT00804856|79562217|FG006|Overall Study|Non compliance with protocol|0|||
44547463|NCT00804856|79562218|FG007|Overall Study|Non compliance with protocol|0|||
44547464|NCT00804856|79562219|FG008|Overall Study|Non compliance with protocol|0|||
44547465|NCT00804856|79562220|FG009|Overall Study|Non compliance with protocol|0|||
44547466|NCT00804856|79562221|FG010|Overall Study|Non compliance with protocol|0|||
44493520|NCT00145574|79499370|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
44493521|NCT00145574|79499371|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
44493522|NCT00145574|79499372|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
44493523|NCT00145574|79499370|FG000|Open Label Long-term Extension|required restricted medicine|0|||
44493524|NCT00145574|79499371|FG001|Open Label Long-term Extension|required restricted medicine|0|||
44493525|NCT00145574|79499372|FG002|Open Label Long-term Extension|required restricted medicine|1|||
44493526|NCT00145496|79499387|FG000|Overall Study|Adverse Event|42|||
44493527|NCT00145496|79499388|FG001|Overall Study|Adverse Event|30|||
44493528|NCT00145496|79499387|FG000|Overall Study|Lack of Efficacy|12|||
44493529|NCT00145496|79499388|FG001|Overall Study|Lack of Efficacy|7|||
44493530|NCT00145496|79499387|FG000|Overall Study|Withdrawal by Subject|32|||
44493531|NCT00145496|79499388|FG001|Overall Study|Withdrawal by Subject|26|||
44493532|NCT00145496|79499387|FG000|Overall Study|Lost to Follow-up|12|||
44547467|NCT00804856|79562222|FG011|Overall Study|Non compliance with protocol|0|||
44547468|NCT00804856|79562223|FG012|Overall Study|Non compliance with protocol|0|||
44493533|NCT00145496|79499388|FG001|Overall Study|Lost to Follow-up|5|||
44547469|NCT00804856|79562224|FG013|Overall Study|Non compliance with protocol|2|||
44547470|NCT00804856|79562225|FG014|Overall Study|Non compliance with protocol|0|||
44547471|NCT00804856|79562211|FG000|Overall Study|Refused to continue medication|0|||
44547472|NCT00804856|79562212|FG001|Overall Study|Refused to continue medication|0|||
44547473|NCT00804856|79562213|FG002|Overall Study|Refused to continue medication|0|||
44547474|NCT00804856|79562214|FG003|Overall Study|Refused to continue medication|1|||
44547475|NCT00804856|79562215|FG004|Overall Study|Refused to continue medication|1|||
44547476|NCT00804856|79562216|FG005|Overall Study|Refused to continue medication|0|||
44547477|NCT00804856|79562217|FG006|Overall Study|Refused to continue medication|0|||
44547478|NCT00804856|79562218|FG007|Overall Study|Refused to continue medication|0|||
44547479|NCT00804856|79562219|FG008|Overall Study|Refused to continue medication|0|||
44547480|NCT00804856|79562220|FG009|Overall Study|Refused to continue medication|0|||
44547481|NCT00804856|79562221|FG010|Overall Study|Refused to continue medication|3|||
44547482|NCT00804856|79562222|FG011|Overall Study|Refused to continue medication|0|||
44547483|NCT00804856|79562223|FG012|Overall Study|Refused to continue medication|1|||
44547484|NCT00804856|79562224|FG013|Overall Study|Refused to continue medication|1|||
44547485|NCT00804856|79562225|FG014|Overall Study|Refused to continue medication|5|||
44547486|NCT00804856|79562211|FG000|Overall Study|Other reason than listed above|0|||
44547487|NCT00804856|79562212|FG001|Overall Study|Other reason than listed above|0|||
44547488|NCT00804856|79562213|FG002|Overall Study|Other reason than listed above|0|||
44547489|NCT00804856|79562214|FG003|Overall Study|Other reason than listed above|0|||
44547490|NCT00804856|79562215|FG004|Overall Study|Other reason than listed above|0|||
44547491|NCT00804856|79562216|FG005|Overall Study|Other reason than listed above|1|||
44547492|NCT00804856|79562217|FG006|Overall Study|Other reason than listed above|0|||
44547493|NCT00804856|79562218|FG007|Overall Study|Other reason than listed above|0|||
44547494|NCT00804856|79562219|FG008|Overall Study|Other reason than listed above|1|||
44547495|NCT00804856|79562220|FG009|Overall Study|Other reason than listed above|0|||
44547496|NCT00804856|79562221|FG010|Overall Study|Other reason than listed above|3|||
44493534|NCT00145496|79499387|FG000|Overall Study|Other|25|||
44547497|NCT00804856|79562222|FG011|Overall Study|Other reason than listed above|1|||
44547498|NCT00804856|79562223|FG012|Overall Study|Other reason than listed above|1|||
44547499|NCT00804856|79562224|FG013|Overall Study|Other reason than listed above|10|||
44547500|NCT00804856|79562225|FG014|Overall Study|Other reason than listed above|3|||
44547501|NCT01314872|79562313|FG000|Treatment Period 1|Protocol Violation|2|||
44547502|NCT01314872|79562314|FG001|Treatment Period 1|Protocol Violation|1|||
44547503|NCT01314872|79562315|FG002|Treatment Period 1|Protocol Violation|1|||
44547504|NCT01314872|79562316|FG003|Treatment Period 1|Protocol Violation|0|||
44547505|NCT01314872|79562317|FG004|Treatment Period 1|Protocol Violation|1|||
44547506|NCT01314872|79562318|FG005|Treatment Period 1|Protocol Violation|0|||
44547507|NCT01314872|79562319|FG006|Treatment Period 1|Protocol Violation|0|||
44547508|NCT01314872|79562320|FG007|Treatment Period 1|Protocol Violation|0|||
44547509|NCT01314872|79562321|FG008|Treatment Period 1|Protocol Violation|0|||
44547510|NCT01314872|79562322|FG009|Treatment Period 1|Protocol Violation|1|||
44547511|NCT01314872|79562323|FG010|Treatment Period 1|Protocol Violation|1|||
44493535|NCT00145496|79499388|FG001|Overall Study|Other|13|||
44493536|NCT00255164|79499397|FG000|Overall Study|Adverse Event|10|||
44493537|NCT00255164|79499398|FG001|Overall Study|Adverse Event|6|||
44493538|NCT00255164|79499399|FG002|Overall Study|Adverse Event|9|||
44493539|NCT00255164|79499397|FG000|Overall Study|Lost to Follow-up|4|||
44493540|NCT00255164|79499398|FG001|Overall Study|Lost to Follow-up|3|||
44493541|NCT00255164|79499399|FG002|Overall Study|Lost to Follow-up|4|||
44493542|NCT00255164|79499397|FG000|Overall Study|Withdrawal by Subject|18|||
44493543|NCT00255164|79499398|FG001|Overall Study|Withdrawal by Subject|17|||
44493544|NCT00255164|79499399|FG002|Overall Study|Withdrawal by Subject|8|||
44493545|NCT00255164|79499397|FG000|Overall Study|Noncompliance|0|||
44547512|NCT01314872|79562324|FG011|Treatment Period 1|Protocol Violation|0|||
44547513|NCT01314872|79562325|FG012|Treatment Period 1|Protocol Violation|0|||
44547514|NCT01314872|79562326|FG013|Treatment Period 1|Protocol Violation|0|||
44547515|NCT01314872|79562327|FG014|Treatment Period 1|Protocol Violation|0|||
44547516|NCT01314872|79562313|FG000|Treatment Period 1|Physician Decision|0|||
44547517|NCT01314872|79562314|FG001|Treatment Period 1|Physician Decision|1|||
44547518|NCT01314872|79562315|FG002|Treatment Period 1|Physician Decision|0|||
44547519|NCT01314872|79562316|FG003|Treatment Period 1|Physician Decision|1|||
44547520|NCT01314872|79562317|FG004|Treatment Period 1|Physician Decision|0|||
44547521|NCT01314872|79562318|FG005|Treatment Period 1|Physician Decision|0|||
44493546|NCT00255164|79499398|FG001|Overall Study|Noncompliance|1|||
44493547|NCT00255164|79499399|FG002|Overall Study|Noncompliance|2|||
44493548|NCT00255164|79499397|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
44547522|NCT01314872|79562319|FG006|Treatment Period 1|Physician Decision|0|||
44547523|NCT01314872|79562320|FG007|Treatment Period 1|Physician Decision|0|||
44547524|NCT01314872|79562321|FG008|Treatment Period 1|Physician Decision|0|||
44547525|NCT01314872|79562322|FG009|Treatment Period 1|Physician Decision|1|||
44547526|NCT01314872|79562323|FG010|Treatment Period 1|Physician Decision|0|||
44547527|NCT01314872|79562324|FG011|Treatment Period 1|Physician Decision|0|||
44547528|NCT01314872|79562325|FG012|Treatment Period 1|Physician Decision|0|||
44547529|NCT01314872|79562326|FG013|Treatment Period 1|Physician Decision|0|||
44547530|NCT01314872|79562327|FG014|Treatment Period 1|Physician Decision|0|||
44547531|NCT01314872|79562313|FG000|Treatment Period 1|Lack of Efficacy|1|||
44547532|NCT01314872|79562314|FG001|Treatment Period 1|Lack of Efficacy|0|||
44547533|NCT01314872|79562315|FG002|Treatment Period 1|Lack of Efficacy|0|||
44547534|NCT01314872|79562316|FG003|Treatment Period 1|Lack of Efficacy|0|||
44547535|NCT01314872|79562317|FG004|Treatment Period 1|Lack of Efficacy|0|||
44547536|NCT01314872|79562318|FG005|Treatment Period 1|Lack of Efficacy|1|||
44547537|NCT01314872|79562319|FG006|Treatment Period 1|Lack of Efficacy|0|||
44547538|NCT01314872|79562320|FG007|Treatment Period 1|Lack of Efficacy|2|||
44547539|NCT01314872|79562321|FG008|Treatment Period 1|Lack of Efficacy|0|||
44547540|NCT01314872|79562322|FG009|Treatment Period 1|Lack of Efficacy|0|||
44547541|NCT01314872|79562323|FG010|Treatment Period 1|Lack of Efficacy|0|||
44547542|NCT01314872|79562324|FG011|Treatment Period 1|Lack of Efficacy|0|||
44547543|NCT01314872|79562325|FG012|Treatment Period 1|Lack of Efficacy|0|||
44547544|NCT01314872|79562326|FG013|Treatment Period 1|Lack of Efficacy|0|||
44547545|NCT01314872|79562327|FG014|Treatment Period 1|Lack of Efficacy|0|||
44547546|NCT01314872|79562313|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
44547547|NCT01314872|79562314|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
44547548|NCT01314872|79562315|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
44547549|NCT01314872|79562316|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
44547550|NCT01314872|79562317|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
44547551|NCT01314872|79562318|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
44547552|NCT01314872|79562319|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
44547553|NCT01314872|79562320|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
44547554|NCT01314872|79562321|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
44547555|NCT01314872|79562322|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
44547556|NCT01314872|79562323|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
44547557|NCT01314872|79562324|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
44547558|NCT01314872|79562325|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
44547559|NCT01314872|79562326|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
44547560|NCT01314872|79562327|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
44547561|NCT01314872|79562313|FG000|Treatment Period 1|Withdrawal by Subject|3|||
44547562|NCT01314872|79562314|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44547563|NCT01314872|79562315|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44547564|NCT01314872|79562316|FG003|Treatment Period 1|Withdrawal by Subject|2|||
44547565|NCT01314872|79562317|FG004|Treatment Period 1|Withdrawal by Subject|3|||
44547566|NCT01314872|79562318|FG005|Treatment Period 1|Withdrawal by Subject|1|||
44547567|NCT01314872|79562319|FG006|Treatment Period 1|Withdrawal by Subject|3|||
44547568|NCT01314872|79562320|FG007|Treatment Period 1|Withdrawal by Subject|2|||
44547569|NCT01314872|79562321|FG008|Treatment Period 1|Withdrawal by Subject|2|||
44547570|NCT01314872|79562322|FG009|Treatment Period 1|Withdrawal by Subject|2|||
44547571|NCT01314872|79562323|FG010|Treatment Period 1|Withdrawal by Subject|1|||
44547572|NCT01314872|79562324|FG011|Treatment Period 1|Withdrawal by Subject|0|||
44547573|NCT01314872|79562325|FG012|Treatment Period 1|Withdrawal by Subject|0|||
44547574|NCT01314872|79562326|FG013|Treatment Period 1|Withdrawal by Subject|0|||
44547575|NCT01314872|79562327|FG014|Treatment Period 1|Withdrawal by Subject|0|||
44547576|NCT01314872|79562313|FG000|Treatment Period 1|Lost to Follow-up|0|||
44547577|NCT01314872|79562314|FG001|Treatment Period 1|Lost to Follow-up|1|||
44547578|NCT01314872|79562315|FG002|Treatment Period 1|Lost to Follow-up|2|||
44547579|NCT01314872|79562316|FG003|Treatment Period 1|Lost to Follow-up|2|||
44547580|NCT01314872|79562317|FG004|Treatment Period 1|Lost to Follow-up|1|||
44547581|NCT01314872|79562318|FG005|Treatment Period 1|Lost to Follow-up|1|||
44547582|NCT01314872|79562319|FG006|Treatment Period 1|Lost to Follow-up|1|||
44547583|NCT01314872|79562320|FG007|Treatment Period 1|Lost to Follow-up|1|||
44547584|NCT01314872|79562321|FG008|Treatment Period 1|Lost to Follow-up|1|||
44547585|NCT01314872|79562322|FG009|Treatment Period 1|Lost to Follow-up|0|||
44547586|NCT01314872|79562323|FG010|Treatment Period 1|Lost to Follow-up|0|||
44547587|NCT01314872|79562324|FG011|Treatment Period 1|Lost to Follow-up|0|||
44547588|NCT01314872|79562325|FG012|Treatment Period 1|Lost to Follow-up|0|||
44547589|NCT01314872|79562326|FG013|Treatment Period 1|Lost to Follow-up|0|||
44547590|NCT01314872|79562327|FG014|Treatment Period 1|Lost to Follow-up|0|||
44547591|NCT01314872|79562313|FG000|Period 2|Protocol Violation|0|||
44547592|NCT01314872|79562314|FG001|Period 2|Protocol Violation|0|||
44547593|NCT01314872|79562315|FG002|Period 2|Protocol Violation|0|||
44547594|NCT01314872|79562316|FG003|Period 2|Protocol Violation|0|||
44547595|NCT01314872|79562317|FG004|Period 2|Protocol Violation|0|||
44547596|NCT01314872|79562318|FG005|Period 2|Protocol Violation|0|||
44547597|NCT01314872|79562319|FG006|Period 2|Protocol Violation|0|||
44547598|NCT01314872|79562320|FG007|Period 2|Protocol Violation|0|||
44547599|NCT01314872|79562321|FG008|Period 2|Protocol Violation|0|||
44547600|NCT01314872|79562322|FG009|Period 2|Protocol Violation|0|||
44547601|NCT01314872|79562323|FG010|Period 2|Protocol Violation|0|||
44547602|NCT01314872|79562324|FG011|Period 2|Protocol Violation|3|||
44547603|NCT01314872|79562325|FG012|Period 2|Protocol Violation|3|||
44547604|NCT01314872|79562326|FG013|Period 2|Protocol Violation|2|||
44547605|NCT01314872|79562327|FG014|Period 2|Protocol Violation|0|||
44547606|NCT01314872|79562313|FG000|Period 2|Non-compliance with study drug|0|||
44547607|NCT01314872|79562314|FG001|Period 2|Non-compliance with study drug|0|||
44547608|NCT01314872|79562315|FG002|Period 2|Non-compliance with study drug|0|||
44547609|NCT01314872|79562316|FG003|Period 2|Non-compliance with study drug|0|||
44547610|NCT01314872|79562317|FG004|Period 2|Non-compliance with study drug|0|||
44547611|NCT01314872|79562318|FG005|Period 2|Non-compliance with study drug|0|||
44547612|NCT01314872|79562319|FG006|Period 2|Non-compliance with study drug|0|||
44547613|NCT01314872|79562320|FG007|Period 2|Non-compliance with study drug|0|||
44547614|NCT01314872|79562321|FG008|Period 2|Non-compliance with study drug|0|||
44547615|NCT01314872|79562322|FG009|Period 2|Non-compliance with study drug|0|||
44547616|NCT01314872|79562323|FG010|Period 2|Non-compliance with study drug|0|||
44547617|NCT01314872|79562324|FG011|Period 2|Non-compliance with study drug|3|||
44547618|NCT01314872|79562325|FG012|Period 2|Non-compliance with study drug|3|||
44547619|NCT01314872|79562326|FG013|Period 2|Non-compliance with study drug|1|||
44547620|NCT01314872|79562327|FG014|Period 2|Non-compliance with study drug|2|||
44547621|NCT01314872|79562313|FG000|Period 2|Lack of Efficacy|0|||
44547622|NCT01314872|79562314|FG001|Period 2|Lack of Efficacy|0|||
44547623|NCT01314872|79562315|FG002|Period 2|Lack of Efficacy|0|||
44547624|NCT01314872|79562316|FG003|Period 2|Lack of Efficacy|0|||
44547625|NCT01314872|79562317|FG004|Period 2|Lack of Efficacy|0|||
44547626|NCT01314872|79562318|FG005|Period 2|Lack of Efficacy|0|||
44547627|NCT01314872|79562319|FG006|Period 2|Lack of Efficacy|0|||
44547628|NCT01314872|79562320|FG007|Period 2|Lack of Efficacy|0|||
44547629|NCT01314872|79562321|FG008|Period 2|Lack of Efficacy|0|||
44547630|NCT01314872|79562322|FG009|Period 2|Lack of Efficacy|0|||
44547631|NCT01314872|79562323|FG010|Period 2|Lack of Efficacy|0|||
44547632|NCT01314872|79562324|FG011|Period 2|Lack of Efficacy|7|||
44547633|NCT01314872|79562325|FG012|Period 2|Lack of Efficacy|12|||
44547634|NCT01314872|79562326|FG013|Period 2|Lack of Efficacy|9|||
44547635|NCT01314872|79562327|FG014|Period 2|Lack of Efficacy|2|||
44547636|NCT01314872|79562313|FG000|Period 2|Pregnancy|0|||
44547637|NCT01314872|79562314|FG001|Period 2|Pregnancy|0|||
44547638|NCT01314872|79562315|FG002|Period 2|Pregnancy|0|||
44547639|NCT01314872|79562316|FG003|Period 2|Pregnancy|0|||
44547640|NCT01314872|79562317|FG004|Period 2|Pregnancy|0|||
44547641|NCT01314872|79562318|FG005|Period 2|Pregnancy|0|||
44547642|NCT01314872|79562319|FG006|Period 2|Pregnancy|0|||
44547643|NCT01314872|79562320|FG007|Period 2|Pregnancy|0|||
44547644|NCT01314872|79562321|FG008|Period 2|Pregnancy|0|||
44547645|NCT01314872|79562322|FG009|Period 2|Pregnancy|0|||
44547646|NCT01314872|79562323|FG010|Period 2|Pregnancy|0|||
44547647|NCT01314872|79562324|FG011|Period 2|Pregnancy|0|||
44547648|NCT01314872|79562325|FG012|Period 2|Pregnancy|0|||
44547649|NCT01314872|79562326|FG013|Period 2|Pregnancy|0|||
44547650|NCT01314872|79562327|FG014|Period 2|Pregnancy|1|||
44547651|NCT01314872|79562313|FG000|Period 2|Study terminated by Sponsor|0|||
44547652|NCT01314872|79562314|FG001|Period 2|Study terminated by Sponsor|0|||
44547653|NCT01314872|79562315|FG002|Period 2|Study terminated by Sponsor|0|||
44547654|NCT01314872|79562316|FG003|Period 2|Study terminated by Sponsor|0|||
44547655|NCT01314872|79562317|FG004|Period 2|Study terminated by Sponsor|0|||
44547656|NCT01314872|79562318|FG005|Period 2|Study terminated by Sponsor|0|||
44547657|NCT01314872|79562319|FG006|Period 2|Study terminated by Sponsor|0|||
44547658|NCT01314872|79562320|FG007|Period 2|Study terminated by Sponsor|0|||
44547659|NCT01314872|79562321|FG008|Period 2|Study terminated by Sponsor|0|||
44547660|NCT01314872|79562322|FG009|Period 2|Study terminated by Sponsor|0|||
44547661|NCT01314872|79562323|FG010|Period 2|Study terminated by Sponsor|0|||
44547662|NCT01314872|79562324|FG011|Period 2|Study terminated by Sponsor|2|||
44547663|NCT01314872|79562325|FG012|Period 2|Study terminated by Sponsor|2|||
44547664|NCT01314872|79562326|FG013|Period 2|Study terminated by Sponsor|3|||
44547665|NCT01314872|79562327|FG014|Period 2|Study terminated by Sponsor|0|||
44547666|NCT01314872|79562313|FG000|Period 2|Adverse event, non-fatal|0|||
44547667|NCT01314872|79562314|FG001|Period 2|Adverse event, non-fatal|0|||
44547668|NCT01314872|79562315|FG002|Period 2|Adverse event, non-fatal|0|||
44547669|NCT01314872|79562316|FG003|Period 2|Adverse event, non-fatal|0|||
44547670|NCT01314872|79562317|FG004|Period 2|Adverse event, non-fatal|0|||
44547671|NCT01314872|79562318|FG005|Period 2|Adverse event, non-fatal|0|||
44547672|NCT01314872|79562319|FG006|Period 2|Adverse event, non-fatal|0|||
44547673|NCT01314872|79562320|FG007|Period 2|Adverse event, non-fatal|0|||
44547674|NCT01314872|79562321|FG008|Period 2|Adverse event, non-fatal|0|||
44547675|NCT01314872|79562322|FG009|Period 2|Adverse event, non-fatal|0|||
44547676|NCT01314872|79562323|FG010|Period 2|Adverse event, non-fatal|0|||
44229954|NCT01697696|79037875|FG001|Overall Study|Lost to Follow-up|7|||
44229955|NCT01697696|79037874|FG000|Overall Study|Subject/guardian decision|31|||
44376449|NCT00925704|79381565|FG001|Second Intervention|Withdrawal by Subject|0|||
44376450|NCT00925704|79381566|FG002|Second Intervention|Withdrawal by Subject|0|||
44376451|NCT00925704|79381567|FG003|Second Intervention|Withdrawal by Subject|0|||
44376452|NCT00925704|79381568|FG004|Second Intervention|Withdrawal by Subject|1|||
44493549|NCT00255164|79499398|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
44493550|NCT00255164|79499399|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
44493551|NCT00255164|79499397|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
44493552|NCT00255164|79499398|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
44493553|NCT00255164|79499399|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
44493554|NCT00255164|79499397|FG000|Overall Study|Possible Barrett's Esophagus|1|||
44493555|NCT00255164|79499398|FG001|Overall Study|Possible Barrett's Esophagus|3|||
44493556|NCT00255164|79499399|FG002|Overall Study|Possible Barrett's Esophagus|8|||
44493557|NCT00255164|79499397|FG000|Overall Study|Esophageal Stricture|0|||
44493558|NCT00255164|79499398|FG001|Overall Study|Esophageal Stricture|0|||
44493559|NCT00255164|79499399|FG002|Overall Study|Esophageal Stricture|1|||
44493560|NCT00255164|79499397|FG000|Overall Study|Therapeutic Failure|11|||
44493561|NCT00255164|79499398|FG001|Overall Study|Therapeutic Failure|2|||
44493562|NCT00255164|79499399|FG002|Overall Study|Therapeutic Failure|3|||
44493563|NCT00126594|79499409|FG000|Overall Study|Ineligible|2|||
44493564|NCT00126594|79499410|FG001|Overall Study|Ineligible|0|||
44493565|NCT00126594|79499409|FG000|Overall Study|Withdrawal by Subject|0|||
44493566|NCT00126594|79499410|FG001|Overall Study|Withdrawal by Subject|4|||
44493567|NCT00126594|79499409|FG000|Overall Study|Physician Decision|1|||
44493568|NCT00126594|79499410|FG001|Overall Study|Physician Decision|3|||
44493569|NCT00126594|79499409|FG000|Overall Study|Adverse Event|7|||
44493570|NCT00126594|79499410|FG001|Overall Study|Adverse Event|5|||
44493571|NCT00126594|79499409|FG000|Overall Study|Non-compliance|0|||
44493572|NCT00126594|79499410|FG001|Overall Study|Non-compliance|1|||
44493573|NCT00126594|79499409|FG000|Overall Study|Disease Progression|29|||
44493574|NCT00126594|79499410|FG001|Overall Study|Disease Progression|24|||
44493575|NCT00126438|79499419|FG000|Overall Study|Withdrawal due to adverse event|1|||
44493576|NCT00126438|79499420|FG001|Overall Study|Withdrawal due to adverse event|0|||
44493577|NCT00126438|79499419|FG000|Overall Study|Lost to Follow-up|22|||
44493578|NCT00126438|79499420|FG001|Overall Study|Lost to Follow-up|0|||
44493579|NCT00126438|79499419|FG000|Overall Study|Protocol Violation|8|||
44493580|NCT00126438|79499420|FG001|Overall Study|Protocol Violation|8|||
44229956|NCT01697696|79037875|FG001|Overall Study|Subject/guardian decision|35|||
44229957|NCT01569152|79037883|FG000|Phase IIa, Period 1|Early Escape|5|||
44376453|NCT00925704|79381569|FG005|Second Intervention|Withdrawal by Subject|0|||
44493581|NCT00126438|79499419|FG000|Overall Study|Withdrawal by Subject|3|||
44229958|NCT01569152|79037884|FG001|Phase IIa, Period 1|Early Escape|22|||
44493582|NCT00126438|79499420|FG001|Overall Study|Withdrawal by Subject|2|||
44493583|NCT00142584|79499428|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
44493584|NCT00142584|79499429|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
44493585|NCT00142584|79499428|FG000|Overall Study|Withdrawal by Subject|30|||
44493586|NCT00142584|79499429|FG001|Overall Study|Withdrawal by Subject|16|||
44493587|NCT00142584|79499428|FG000|Overall Study|Lost to Follow-up|22|||
44493588|NCT00142584|79499429|FG001|Overall Study|Lost to Follow-up|12|||
44493589|NCT00142584|79499428|FG000|Overall Study|Adverse Event|14|||
44493590|NCT00142584|79499429|FG001|Overall Study|Adverse Event|5|||
44493591|NCT00142584|79499428|FG000|Overall Study|Protocol Violation|4|||
44493592|NCT00142584|79499429|FG001|Overall Study|Protocol Violation|7|||
44493593|NCT00142584|79499428|FG000|Overall Study|Treatment Failure|2|||
44493594|NCT00142584|79499429|FG001|Overall Study|Treatment Failure|0|||
44493595|NCT00126126|79499439|FG000|Overall Study|Lost to Follow-up|0|||
44493596|NCT00126126|79499440|FG001|Overall Study|Lost to Follow-up|2|||
44493597|NCT00125268|79499448|FG000|Overall Study|Withdrawal by Subject|1|||
44493598|NCT00125268|79499449|FG001|Overall Study|Withdrawal by Subject|1|||
44493599|NCT00125190|79499455|FG000|Overall Study|Subject/Parent Decision|7|||
44493600|NCT00125190|79499455|FG000|Overall Study|Non-compliance|2|||
44493601|NCT00125190|79499455|FG000|Overall Study|Adverse Event|1|||
44493602|NCT00125190|79499455|FG000|Overall Study|Other|1|||
44493603|NCT00125190|79499455|FG000|Overall Study|Lost to Follow-up|4|||
44493604|NCT00141726|79499460|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
44493605|NCT00111228|79499467|FG000|Overall Study|Withdrawal by Subject|5|||
44493606|NCT00111228|79499468|FG001|Overall Study|Withdrawal by Subject|1|||
44493607|NCT00111228|79499469|FG002|Overall Study|Withdrawal by Subject|0|||
44493608|NCT00110994|79499479|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
44493609|NCT00110994|79499480|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
44493610|NCT00110994|79499479|FG000|Double-blind (DB) Treatment|Death|1|||
44493611|NCT00110994|79499480|FG001|Double-blind (DB) Treatment|Death|0|||
44493612|NCT00110994|79499479|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
44493613|NCT00110994|79499480|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
44493614|NCT00110994|79499479|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
44493615|NCT00110994|79499480|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
44493616|NCT00110994|79499479|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
44493617|NCT00110994|79499480|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
44493618|NCT00110994|79499479|FG000|Double-blind (DB) Treatment|other reasons|2|||
44493619|NCT00110994|79499480|FG001|Double-blind (DB) Treatment|other reasons|3|||
44493620|NCT00110994|79499479|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
44493621|NCT00110994|79499480|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
44493622|NCT00110994|79499479|FG000|Active Follow-up|Other reasons|0|||
44493623|NCT00110994|79499480|FG001|Active Follow-up|Other reasons|2|||
44493624|NCT00110994|79499479|FG000|Long Term Follow-up|Death|19|||
44493625|NCT00110994|79499480|FG001|Long Term Follow-up|Death|17|||
44493626|NCT00144170|79499488|FG000|Overall Study|Adverse Event|84|||
44493627|NCT00144170|79499489|FG001|Overall Study|Adverse Event|41|||
44493628|NCT00144170|79499488|FG000|Overall Study|Protocol Violation|23|||
44493629|NCT00144170|79499489|FG001|Overall Study|Protocol Violation|16|||
44493630|NCT00144170|79499488|FG000|Overall Study|Lost to Follow-up|5|||
44493631|NCT00144170|79499489|FG001|Overall Study|Lost to Follow-up|10|||
44493632|NCT00144170|79499488|FG000|Overall Study|Withdrawal by Subject|29|||
44493633|NCT00144170|79499489|FG001|Overall Study|Withdrawal by Subject|13|||
44493634|NCT00144170|79499488|FG000|Overall Study|Other reason not defined above|211|||
44493635|NCT00144170|79499489|FG001|Overall Study|Other reason not defined above|316|||
44493636|NCT00255086|79499497|FG000|Overall Study|Adverse Event|1|||
44493637|NCT00255086|79499498|FG001|Overall Study|Adverse Event|1|||
44493638|NCT00255086|79499497|FG000|Overall Study|Protocol Violation|1|||
44493639|NCT00255086|79499498|FG001|Overall Study|Protocol Violation|1|||
44493640|NCT00110214|79499507|FG000|Overall Study|Never started treatment|21|||
44493641|NCT00110214|79499508|FG001|Overall Study|Never started treatment|20|||
44493642|NCT00110214|79499507|FG000|Overall Study|Disease progression or death|260|||
44493643|NCT00110214|79499508|FG001|Overall Study|Disease progression or death|151|||
44493644|NCT00110214|79499507|FG000|Overall Study|Adverse Event|115|||
44493645|NCT00110214|79499508|FG001|Overall Study|Adverse Event|192|||
44493646|NCT00110214|79499507|FG000|Overall Study|Refused further treatment|52|||
44493647|NCT00110214|79499508|FG001|Overall Study|Refused further treatment|65|||
44493648|NCT00110214|79499507|FG000|Overall Study|Other (not specified)|61|||
44493649|NCT00110214|79499508|FG001|Overall Study|Other (not specified)|75|||
44493650|NCT00124020|79499516|FG000|Overall Study|Death|67|||
44493651|NCT00124020|79499517|FG001|Overall Study|Death|71|||
44547677|NCT01314872|79562324|FG011|Period 2|Adverse event, non-fatal|13|||
44547678|NCT01314872|79562325|FG012|Period 2|Adverse event, non-fatal|16|||
44547679|NCT01314872|79562326|FG013|Period 2|Adverse event, non-fatal|24|||
44547680|NCT01314872|79562327|FG014|Period 2|Adverse event, non-fatal|9|||
44229959|NCT01569152|79037885|FG002|Phase IIa, Period 1|Early Escape|0|||
44229960|NCT01569152|79037883|FG000|Phase IIa, Period 1|Adverse Event|4|||
44229961|NCT01569152|79037884|FG001|Phase IIa, Period 1|Adverse Event|0|||
44229962|NCT01569152|79037885|FG002|Phase IIa, Period 1|Adverse Event|0|||
44229963|NCT01569152|79037883|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
44229964|NCT01569152|79037884|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
44376454|NCT00925704|79381564|FG000|Third Intervention|Withdrew consent|0|||
44493652|NCT00124020|79499516|FG000|Overall Study|Withdrawal by Subject|13|||
44493653|NCT00124020|79499517|FG001|Overall Study|Withdrawal by Subject|11|||
44493654|NCT00124020|79499516|FG000|Overall Study|Lost to Follow-up|5|||
44493655|NCT00124020|79499517|FG001|Overall Study|Lost to Follow-up|8|||
44493656|NCT00124020|79499516|FG000|Overall Study|Other|1|||
44493657|NCT00124020|79499517|FG001|Overall Study|Other|1|||
44493658|NCT00124020|79499516|FG000|Overall Study|Transfer to another hospital|2|||
44493659|NCT00124020|79499517|FG001|Overall Study|Transfer to another hospital|0|||
44493660|NCT00215540|79499526|FG000|Overall Study|Withdrew from study medication|1|||
44493661|NCT00215540|79499527|FG001|Overall Study|Withdrew from study medication|0|||
44493662|NCT00215540|79499528|FG002|Overall Study|Withdrew from study medication|0|||
44493663|NCT00143390|79499538|FG000|Overall Study|Death|2|||
44493664|NCT00143390|79499539|FG001|Overall Study|Death|0|||
44493665|NCT00143390|79499538|FG000|Overall Study|Not meeting entry criteria|2|||
44493666|NCT00143390|79499539|FG001|Overall Study|Not meeting entry criteria|5|||
44493667|NCT00143390|79499538|FG000|Overall Study|Withdrawal by Subject|4|||
44493668|NCT00143390|79499539|FG001|Overall Study|Withdrawal by Subject|4|||
44547681|NCT01314872|79562313|FG000|Period 2|Withdrawal by Subject|0|||
44547682|NCT01314872|79562314|FG001|Period 2|Withdrawal by Subject|0|||
44547683|NCT01314872|79562315|FG002|Period 2|Withdrawal by Subject|0|||
44547684|NCT01314872|79562316|FG003|Period 2|Withdrawal by Subject|0|||
44547685|NCT01314872|79562317|FG004|Period 2|Withdrawal by Subject|0|||
44547686|NCT01314872|79562318|FG005|Period 2|Withdrawal by Subject|0|||
44547687|NCT01314872|79562319|FG006|Period 2|Withdrawal by Subject|0|||
44547688|NCT01314872|79562320|FG007|Period 2|Withdrawal by Subject|0|||
44547689|NCT01314872|79562321|FG008|Period 2|Withdrawal by Subject|0|||
44547690|NCT01314872|79562322|FG009|Period 2|Withdrawal by Subject|0|||
44547691|NCT01314872|79562323|FG010|Period 2|Withdrawal by Subject|0|||
44547692|NCT01314872|79562324|FG011|Period 2|Withdrawal by Subject|14|||
44547693|NCT01314872|79562325|FG012|Period 2|Withdrawal by Subject|17|||
44547694|NCT01314872|79562326|FG013|Period 2|Withdrawal by Subject|12|||
44547695|NCT01314872|79562327|FG014|Period 2|Withdrawal by Subject|4|||
44547696|NCT01314872|79562313|FG000|Period 2|Lost to Follow-up|0|||
44547697|NCT01314872|79562314|FG001|Period 2|Lost to Follow-up|0|||
44547698|NCT01314872|79562315|FG002|Period 2|Lost to Follow-up|0|||
44547699|NCT01314872|79562316|FG003|Period 2|Lost to Follow-up|0|||
44547700|NCT01314872|79562317|FG004|Period 2|Lost to Follow-up|0|||
44547701|NCT01314872|79562318|FG005|Period 2|Lost to Follow-up|0|||
44547702|NCT01314872|79562319|FG006|Period 2|Lost to Follow-up|0|||
44493669|NCT00143390|79499538|FG000|Overall Study|Progressive disease|119|||
44493670|NCT00143390|79499539|FG001|Overall Study|Progressive disease|115|||
44493671|NCT00143390|79499538|FG000|Overall Study|Protocol Violation|2|||
44493672|NCT00143390|79499539|FG001|Overall Study|Protocol Violation|0|||
44493673|NCT00143390|79499538|FG000|Overall Study|Study termination|10|||
44493674|NCT00143390|79499539|FG001|Overall Study|Study termination|15|||
44493675|NCT00143390|79499538|FG000|Overall Study|Adverse Event|9|||
44493676|NCT00143390|79499539|FG001|Overall Study|Adverse Event|8|||
44493677|NCT00143390|79499538|FG000|Overall Study|Other|1|||
44493678|NCT00143390|79499539|FG001|Overall Study|Other|2|||
44493679|NCT00141102|79499547|FG000|Overall Study|Adverse Event|233|||
44493680|NCT00141102|79499548|FG001|Overall Study|Adverse Event|305|||
44493681|NCT00141102|79499547|FG000|Overall Study|Laboratory Abnormality|9|||
44493682|NCT00141102|79499548|FG001|Overall Study|Laboratory Abnormality|33|||
44493683|NCT00141102|79499547|FG000|Overall Study|Lack of Efficacy|21|||
44493684|NCT00141102|79499548|FG001|Overall Study|Lack of Efficacy|26|||
44493685|NCT00141102|79499547|FG000|Overall Study|Lost to Follow-up|29|||
44493686|NCT00141102|79499548|FG001|Overall Study|Lost to Follow-up|32|||
44493687|NCT00141102|79499547|FG000|Overall Study|Other|87|||
44547703|NCT01314872|79562320|FG007|Period 2|Lost to Follow-up|0|||
44547704|NCT01314872|79562321|FG008|Period 2|Lost to Follow-up|0|||
44376455|NCT00925704|79381565|FG001|Third Intervention|Withdrew consent|0|||
44493688|NCT00141102|79499548|FG001|Overall Study|Other|76|||
44493689|NCT00141102|79499547|FG000|Overall Study|Withdrawal by Subject|112|||
44493690|NCT00141102|79499548|FG001|Overall Study|Withdrawal by Subject|142|||
44493691|NCT00141102|79499547|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
44493692|NCT00141102|79499548|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
44493693|NCT00141102|79499547|FG000|Overall Study|Death|2|||
44547705|NCT01314872|79562322|FG009|Period 2|Lost to Follow-up|0|||
44547706|NCT01314872|79562323|FG010|Period 2|Lost to Follow-up|0|||
44229965|NCT01569152|79037885|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
44229966|NCT01569152|79037883|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
44229967|NCT01569152|79037884|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
44229968|NCT01569152|79037885|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
44229969|NCT01569152|79037883|FG000|Phase IIa, Period 1|Protocol Violation|0|||
44229970|NCT01569152|79037884|FG001|Phase IIa, Period 1|Protocol Violation|1|||
44547707|NCT01314872|79562324|FG011|Period 2|Lost to Follow-up|6|||
44376456|NCT00925704|79381566|FG002|Third Intervention|Withdrew consent|0|||
44376457|NCT00925704|79381567|FG003|Third Intervention|Withdrew consent|0|||
44376458|NCT00925704|79381568|FG004|Third Intervention|Withdrew consent|0|||
44376459|NCT00925704|79381569|FG005|Third Intervention|Withdrew consent|1|||
44376460|NCT01076192|79381580|FG000|Overall Study|Other|197|||
44547708|NCT01314872|79562325|FG012|Period 2|Lost to Follow-up|7|||
44547709|NCT01314872|79562326|FG013|Period 2|Lost to Follow-up|2|||
44547710|NCT01314872|79562327|FG014|Period 2|Lost to Follow-up|6|||
44547711|NCT00703924|79562361|FG000|Overall Study|Withdrawal by Subject|1|||
44229971|NCT01569152|79037885|FG002|Phase IIa, Period 1|Protocol Violation|0|||
44229972|NCT01569152|79037883|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
44229973|NCT01569152|79037884|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
44229974|NCT01569152|79037885|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
44229975|NCT01569152|79037883|FG000|Safety Extension, Period 3|Adverse Event|0|||
44229976|NCT01569152|79037884|FG001|Safety Extension, Period 3|Adverse Event|0|||
44229977|NCT01569152|79037885|FG002|Safety Extension, Period 3|Adverse Event|4|||
44229978|NCT01569152|79037883|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
44229979|NCT01569152|79037884|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
44229980|NCT01569152|79037885|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
44229981|NCT01569152|79037883|FG000|Safety Extension, Period 3|Physician Decision|0|||
44229982|NCT01569152|79037884|FG001|Safety Extension, Period 3|Physician Decision|0|||
44229983|NCT01569152|79037885|FG002|Safety Extension, Period 3|Physician Decision|2|||
44229984|NCT01569152|79037883|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
44229985|NCT01569152|79037884|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
44229986|NCT01569152|79037885|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
44229987|NCT01569074|79037910|FG000|Overall Study|Study stopped|6|||
44229988|NCT01569074|79037911|FG001|Overall Study|Study stopped|6|||
44229989|NCT01569074|79037912|FG002|Overall Study|Study stopped|8|||
44229990|NCT01569074|79037913|FG003|Overall Study|Study stopped|7|||
44229991|NCT01569074|79037914|FG004|Overall Study|Study stopped|7|||
44229992|NCT01569074|79037910|FG000|Overall Study|Study-specific discontinuation criteria|0|||
44229993|NCT01569074|79037911|FG001|Overall Study|Study-specific discontinuation criteria|1|||
44229994|NCT01569074|79037912|FG002|Overall Study|Study-specific discontinuation criteria|0|||
44229995|NCT01569074|79037913|FG003|Overall Study|Study-specific discontinuation criteria|0|||
44229996|NCT01569074|79037914|FG004|Overall Study|Study-specific discontinuation criteria|0|||
44229997|NCT01569074|79037910|FG000|Overall Study|Severe non-compliance to protocol|0|||
44229998|NCT01569074|79037911|FG001|Overall Study|Severe non-compliance to protocol|0|||
44229999|NCT01569074|79037912|FG002|Overall Study|Severe non-compliance to protocol|1|||
44230000|NCT01569074|79037913|FG003|Overall Study|Severe non-compliance to protocol|0|||
44230001|NCT01569074|79037914|FG004|Overall Study|Severe non-compliance to protocol|0|||
44230002|NCT01569074|79037910|FG000|Overall Study|eg change in circumstances|0|||
44230003|NCT01569074|79037911|FG001|Overall Study|eg change in circumstances|2|||
44230004|NCT01569074|79037912|FG002|Overall Study|eg change in circumstances|0|||
44493694|NCT00141102|79499548|FG001|Overall Study|Death|2|||
44493695|NCT00255008|79499559|FG000|Overall Study|Adverse Event|1|||
44493696|NCT00255008|79499560|FG001|Overall Study|Adverse Event|1|||
44493697|NCT00255008|79499561|FG002|Overall Study|Adverse Event|2|||
44547712|NCT00703924|79562362|FG001|Overall Study|Withdrawal by Subject|1|||
44547713|NCT03152526|79562374|FG000|Overall Study|Withdrawal by Subject|0|||
44547714|NCT03152526|79562375|FG001|Overall Study|Withdrawal by Subject|1|||
44230005|NCT01569074|79037913|FG003|Overall Study|eg change in circumstances|1|||
44547715|NCT03149328|79562383|FG000|Overall Study|Withdrawal by Subject|30|||
44547716|NCT03149328|79562384|FG001|Overall Study|Withdrawal by Subject|26|||
44547717|NCT03149328|79562383|FG000|Overall Study|Changed Dialysis Modality|18|||
44547718|NCT03149328|79562384|FG001|Overall Study|Changed Dialysis Modality|1|||
44547719|NCT03149328|79562383|FG000|Overall Study|Transplant|9|||
44547720|NCT03149328|79562384|FG001|Overall Study|Transplant|1|||
44547721|NCT03149328|79562383|FG000|Overall Study|Lost to Follow-up|25|||
44547722|NCT03149328|79562384|FG001|Overall Study|Lost to Follow-up|16|||
44547723|NCT03149328|79562383|FG000|Overall Study|Left Study Site|1|||
44547724|NCT03149328|79562384|FG001|Overall Study|Left Study Site|2|||
44230006|NCT01569074|79037914|FG004|Overall Study|eg change in circumstances|1|||
44547725|NCT03149328|79562383|FG000|Overall Study|Language Barrier|1|||
44547726|NCT03149328|79562384|FG001|Overall Study|Language Barrier|0|||
44547727|NCT04296942|79562433|FG000|Overall Study|Study closure by sponsor|1|||
44547728|NCT04296942|79562434|FG001|Overall Study|Study closure by sponsor|0|||
44547729|NCT04296942|79562435|FG002|Overall Study|Study closure by sponsor|0|||
44547730|NCT01315028|79562491|FG000|Overall Study|Lost to Follow-up|1|||
44547731|NCT01315028|79562492|FG001|Overall Study|Lost to Follow-up|0|||
44547732|NCT01315028|79562491|FG000|Overall Study|Death|0|||
44547733|NCT01315028|79562492|FG001|Overall Study|Death|1|||
44547734|NCT02720536|79562498|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
44230007|NCT01569074|79037910|FG000|Overall Study|Adverse Event|1|||
44230008|NCT01569074|79037911|FG001|Overall Study|Adverse Event|0|||
44230009|NCT01569074|79037912|FG002|Overall Study|Adverse Event|3|||
44230010|NCT01569074|79037913|FG003|Overall Study|Adverse Event|0|||
44230011|NCT01569074|79037914|FG004|Overall Study|Adverse Event|0|||
44230012|NCT01604408|79037932|FG000|Treatment Period 1|Protocol Violation|0|||
44230013|NCT01604408|79037933|FG001|Treatment Period 1|Protocol Violation|1|||
44230014|NCT01604408|79037932|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44230015|NCT01604408|79037933|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44230016|NCT01604408|79037932|FG000|Treatment Period 2|Protocol Violation|1|||
44230017|NCT01604408|79037933|FG001|Treatment Period 2|Protocol Violation|0|||
44230018|NCT01604408|79037932|FG000|Treatment Period 2|Adverse Event|0|||
44230019|NCT01604408|79037933|FG001|Treatment Period 2|Adverse Event|1|||
44230020|NCT01604408|79037932|FG000|Treatment Period 3|Protocol Violation|1|||
44230021|NCT01604408|79037933|FG001|Treatment Period 3|Protocol Violation|1|||
44230022|NCT01604408|79037932|FG000|Treatment Period 3|Adverse Event|0|||
44230023|NCT01604408|79037933|FG001|Treatment Period 3|Adverse Event|3|||
44230024|NCT01604408|79037932|FG000|Treatment Period 3|Withdrawal by Subject|3|||
44230025|NCT01604408|79037933|FG001|Treatment Period 3|Withdrawal by Subject|1|||
44230026|NCT01604408|79037932|FG000|Treatment Period 3|Sponsor Decision|1|||
44230027|NCT01604408|79037933|FG001|Treatment Period 3|Sponsor Decision|0|||
44230028|NCT01604408|79037932|FG000|Treatment Period 4|Death|1|||
44230029|NCT01604408|79037933|FG001|Treatment Period 4|Death|0|||
44230030|NCT01604408|79037932|FG000|Treatment Period 4|Withdrawal by Subject|2|||
44230031|NCT01604408|79037933|FG001|Treatment Period 4|Withdrawal by Subject|1|||
44230032|NCT01604408|79037932|FG000|Treatment Period 4|Adverse Event|0|||
44230033|NCT01604408|79037933|FG001|Treatment Period 4|Adverse Event|1|||
44230034|NCT01604408|79037932|FG000|Treatment Period 5|Adverse Event|4|||
44230035|NCT01604408|79037933|FG001|Treatment Period 5|Adverse Event|0|||
44230036|NCT01604408|79037932|FG000|Treatment Period 6|Lost to Follow-up|0|||
44230037|NCT01604408|79037933|FG001|Treatment Period 6|Lost to Follow-up|1|||
44230038|NCT01604408|79037932|FG000|Treatment Period 6|Adverse Event|2|||
44230039|NCT01604408|79037933|FG001|Treatment Period 6|Adverse Event|0|||
44547735|NCT02720536|79562498|FG000|Overall Study|PR - pregnancy|2|||
44230040|NCT01604408|79037932|FG000|Treatment Period 6|Sponsor decision|0|||
44230041|NCT01604408|79037933|FG001|Treatment Period 6|Sponsor decision|1|||
44230042|NCT01604408|79037932|FG000|Observation Period|Adverse Event|1|||
44547736|NCT02720536|79562498|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
44230043|NCT01604408|79037933|FG001|Observation Period|Adverse Event|1|||
44230044|NCT01604408|79037932|FG000|Observation Period|Withdrawal by Subject|0|||
44230045|NCT01604408|79037933|FG001|Observation Period|Withdrawal by Subject|2|||
44230046|NCT01567826|79037941|FG000|Overall Study|Lost to Follow-up|3|||
44230047|NCT01567826|79037942|FG001|Overall Study|Lost to Follow-up|2|||
44230048|NCT01697462|79037950|FG000|Overall Study|Disease Progression|1|||
44547737|NCT02720536|79562498|FG000|Overall Study|PR - death|1|||
44547738|NCT02720536|79562498|FG000|Overall Study|PR - adverse event|1|||
44547739|NCT02720536|79562498|FG000|Overall Study|PR - abnormal lab value(s)|1|||
44547740|NCT02720536|79562498|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
44547741|NCT03168438|79562510|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
44547742|NCT03168438|79562511|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
44547743|NCT03137784|79562518|FG000|Overall Study|Adverse Event|1|||
44547744|NCT03137784|79562519|FG001|Overall Study|Adverse Event|1|||
44547745|NCT03137784|79562520|FG002|Overall Study|Adverse Event|0|||
44547746|NCT03137784|79562521|FG003|Overall Study|Adverse Event|0|||
44547747|NCT03137784|79562522|FG004|Overall Study|Adverse Event|0|||
44547748|NCT03137784|79562523|FG005|Overall Study|Adverse Event|0|||
44547749|NCT03137784|79562518|FG000|Overall Study|Subject/guardian decision|1|||
44547750|NCT03137784|79562519|FG001|Overall Study|Subject/guardian decision|0|||
44547751|NCT03137784|79562520|FG002|Overall Study|Subject/guardian decision|0|||
44547752|NCT03137784|79562521|FG003|Overall Study|Subject/guardian decision|0|||
44547753|NCT03137784|79562522|FG004|Overall Study|Subject/guardian decision|0|||
44547754|NCT03137784|79562523|FG005|Overall Study|Subject/guardian decision|0|||
44547755|NCT03137784|79562518|FG000|Overall Study|Non-compliance with study treatment|0|||
44547756|NCT03137784|79562519|FG001|Overall Study|Non-compliance with study treatment|0|||
44547757|NCT03137784|79562520|FG002|Overall Study|Non-compliance with study treatment|0|||
44547758|NCT03137784|79562521|FG003|Overall Study|Non-compliance with study treatment|0|||
44547759|NCT03137784|79562522|FG004|Overall Study|Non-compliance with study treatment|1|||
44547760|NCT03137784|79562523|FG005|Overall Study|Non-compliance with study treatment|0|||
44547761|NCT01314716|79562533|FG000|Double-Blind Phase|Randomized but not treated|1|||
44547762|NCT01314716|79562534|FG001|Double-Blind Phase|Randomized but not treated|1|||
44547763|NCT01314716|79562533|FG000|Double-Blind Phase|Adverse Event|10|||
44547764|NCT01314716|79562534|FG001|Double-Blind Phase|Adverse Event|4|||
44547765|NCT01314716|79562533|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
44547766|NCT01314716|79562534|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
44547767|NCT01314716|79562533|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44547768|NCT01314716|79562534|FG001|Double-Blind Phase|Lost to Follow-up|1|||
44547769|NCT01314716|79562533|FG000|Double-Blind Phase|Sponsor request|1|||
44547770|NCT01314716|79562534|FG001|Double-Blind Phase|Sponsor request|2|||
44547771|NCT01314716|79562533|FG000|Double-Blind Phase|Physician Decision|0|||
44547772|NCT01314716|79562534|FG001|Double-Blind Phase|Physician Decision|1|||
44547773|NCT01314716|79562533|FG000|Open-Label Phase|Adverse Event|4|||
44547774|NCT01314716|79562534|FG001|Open-Label Phase|Adverse Event|6|||
44230049|NCT01697462|79037950|FG000|Overall Study|Adverse Event|6|||
44493698|NCT00255008|79499562|FG003|Overall Study|Adverse Event|0|||
44493699|NCT00255008|79499559|FG000|Overall Study|Lost to Follow-up|1|||
44493700|NCT00255008|79499560|FG001|Overall Study|Lost to Follow-up|0|||
44493701|NCT00255008|79499561|FG002|Overall Study|Lost to Follow-up|1|||
44493702|NCT00255008|79499562|FG003|Overall Study|Lost to Follow-up|2|||
44493703|NCT00255008|79499559|FG000|Overall Study|Did not meet viral reduction criteria|4|||
44493704|NCT00255008|79499560|FG001|Overall Study|Did not meet viral reduction criteria|5|||
44493705|NCT00255008|79499561|FG002|Overall Study|Did not meet viral reduction criteria|0|||
44493706|NCT00255008|79499562|FG003|Overall Study|Did not meet viral reduction criteria|1|||
44493707|NCT00255008|79499559|FG000|Overall Study|Withdrew consent|0|||
44493708|NCT00255008|79499560|FG001|Overall Study|Withdrew consent|0|||
44493709|NCT00255008|79499561|FG002|Overall Study|Withdrew consent|2|||
44493710|NCT00255008|79499562|FG003|Overall Study|Withdrew consent|0|||
44493711|NCT00255008|79499559|FG000|Overall Study|Sponsor request|18|||
44493712|NCT00255008|79499560|FG001|Overall Study|Sponsor request|3|||
44493713|NCT00255008|79499561|FG002|Overall Study|Sponsor request|8|||
44493714|NCT00255008|79499562|FG003|Overall Study|Sponsor request|17|||
44493715|NCT00255008|79499559|FG000|Overall Study|Adverse lab experience|1|||
44493716|NCT00255008|79499560|FG001|Overall Study|Adverse lab experience|0|||
44493717|NCT00255008|79499561|FG002|Overall Study|Adverse lab experience|0|||
44493718|NCT00255008|79499562|FG003|Overall Study|Adverse lab experience|0|||
44493719|NCT00255008|79499559|FG000|Overall Study|Other|7|||
44493720|NCT00255008|79499560|FG001|Overall Study|Other|0|||
44547775|NCT01314716|79562533|FG000|Open-Label Phase|Withdrawal by Subject|1|||
44547776|NCT01314716|79562534|FG001|Open-Label Phase|Withdrawal by Subject|2|||
44547777|NCT01314716|79562533|FG000|Open-Label Phase|Physician Decision|5|||
44547778|NCT01314716|79562534|FG001|Open-Label Phase|Physician Decision|4|||
44547779|NCT03144180|79562544|FG000|Overall Study|STAT Delivery|1|||
44547780|NCT03144180|79562545|FG001|Overall Study|STAT Delivery|1|||
44547781|NCT03144180|79562544|FG000|Overall Study|Provider forgot to fill out forms|1|||
44493721|NCT00255008|79499561|FG002|Overall Study|Other|3|||
44493722|NCT00255008|79499562|FG003|Overall Study|Other|2|||
44493723|NCT03714022|79499574|FG000|Overall Study|Adverse Event|1|||
44493724|NCT03714022|79499575|FG001|Overall Study|Adverse Event|0|||
44493725|NCT03714022|79499574|FG000|Overall Study|Consent withdrawal|0|||
44493726|NCT03714022|79499575|FG001|Overall Study|Consent withdrawal|1|||
44547782|NCT03144180|79562545|FG001|Overall Study|Provider forgot to fill out forms|3|||
44547783|NCT03144180|79562544|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
44547784|NCT03144180|79562545|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
44547785|NCT03144180|79562544|FG000|Overall Study|Scrub tech removed tube cap|0|||
44547786|NCT03144180|79562545|FG001|Overall Study|Scrub tech removed tube cap|1|||
44547787|NCT01465334|79562555|FG000|Overall Study|Disease Progression|1|||
44547788|NCT01465334|79562556|FG001|Overall Study|Disease Progression|0|||
44547789|NCT01465334|79562555|FG000|Overall Study|Adverse Event|1|||
44547790|NCT01465334|79562556|FG001|Overall Study|Adverse Event|0|||
44230050|NCT01697462|79037950|FG000|Overall Study|Lost to Follow-up|21|||
44230051|NCT01697462|79037950|FG000|Overall Study|Withdrawal by Subject|12|||
44230052|NCT01697462|79037950|FG000|Overall Study|Investigator Decision|21|||
44493727|NCT03714022|79499574|FG000|Overall Study|Lost to Follow-up|3|||
44493728|NCT03714022|79499575|FG001|Overall Study|Lost to Follow-up|2|||
44493729|NCT00143312|79499581|FG000|Overall Study|Death|11|||
44547791|NCT01465334|79562555|FG000|Overall Study|Richter's transformation|0|||
44547792|NCT01465334|79562556|FG001|Overall Study|Richter's transformation|3|||
44547793|NCT01465334|79562555|FG000|Overall Study|Refractory Disease|0|||
44547794|NCT01465334|79562556|FG001|Overall Study|Refractory Disease|3|||
44547795|NCT00702208|79562562|FG000|Overall Study|Lost to Follow-up|28|||
44493730|NCT00143312|79499581|FG000|Overall Study|Adverse Event|2|||
44493731|NCT00143312|79499581|FG000|Overall Study|Lost to Follow-up|1|||
44493732|NCT00143312|79499581|FG000|Overall Study|Other|1|||
44547796|NCT00702208|79562562|FG000|Overall Study|Did not self-lavage|1|||
44547797|NCT00702208|79562562|FG000|Overall Study|Unsatisfactory colposcopy|2|||
44547798|NCT02718898|79562579|FG000|Blinded Treatment Period|Adverse Event|5|||
44547799|NCT02718898|79562580|FG001|Blinded Treatment Period|Adverse Event|1|||
44547800|NCT02718898|79562581|FG002|Blinded Treatment Period|Adverse Event|0|||
44547801|NCT02718898|79562582|FG003|Blinded Treatment Period|Adverse Event|0|||
44547802|NCT02718898|79562583|FG004|Blinded Treatment Period|Adverse Event|0|||
44547803|NCT02718898|79562584|FG005|Blinded Treatment Period|Adverse Event|0|||
44547804|NCT02718898|79562585|FG006|Blinded Treatment Period|Adverse Event|0|||
44547805|NCT02718898|79562579|FG000|Blinded Treatment Period|Physician Decision|1|||
44547806|NCT02718898|79562580|FG001|Blinded Treatment Period|Physician Decision|0|||
44547807|NCT02718898|79562581|FG002|Blinded Treatment Period|Physician Decision|0|||
44547808|NCT02718898|79562582|FG003|Blinded Treatment Period|Physician Decision|0|||
44547809|NCT02718898|79562583|FG004|Blinded Treatment Period|Physician Decision|0|||
44547810|NCT02718898|79562584|FG005|Blinded Treatment Period|Physician Decision|0|||
44547811|NCT02718898|79562585|FG006|Blinded Treatment Period|Physician Decision|0|||
44547812|NCT02718898|79562579|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
44547813|NCT02718898|79562580|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
44547814|NCT02718898|79562581|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
44493733|NCT00143312|79499581|FG000|Overall Study|Withdrawal by Subject|1|||
44493734|NCT00254540|79499587|FG000|Overall Study|Adverse Event|6|||
44493735|NCT00254540|79499588|FG001|Overall Study|Adverse Event|7|||
44493736|NCT00254540|79499587|FG000|Overall Study|Lack of Efficacy|13|||
44493737|NCT00254540|79499588|FG001|Overall Study|Lack of Efficacy|13|||
44493738|NCT00254540|79499587|FG000|Overall Study|Death|0|||
44493739|NCT00254540|79499588|FG001|Overall Study|Death|1|||
44493740|NCT00254540|79499587|FG000|Overall Study|Laboratory Test Abnormality|0|||
44493741|NCT00254540|79499588|FG001|Overall Study|Laboratory Test Abnormality|1|||
44493742|NCT00139776|79499614|FG000|Period I|Did not enter Period II|575|||
44493743|NCT00139776|79499615|FG001|Period I|Did not enter Period II|0|||
44547815|NCT02718898|79562582|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
44547816|NCT02718898|79562583|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
44230053|NCT01697462|79037950|FG000|Overall Study|Death|1|||
44230054|NCT01697462|79037950|FG000|Overall Study|Other|10|||
44230055|NCT01697462|79037950|FG000|Overall Study|Missing|5|||
44493744|NCT00139776|79499616|FG002|Period I|Did not enter Period II|0|||
44493745|NCT00139776|79499617|FG003|Period I|Did not enter Period II|0|||
44493746|NCT00139776|79499614|FG000|Period II|Not Randomized into Period III|0|||
44493747|NCT00139776|79499615|FG001|Period II|Not Randomized into Period III|322|||
44493748|NCT00139776|79499616|FG002|Period II|Not Randomized into Period III|0|||
44547817|NCT02718898|79562584|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
44547818|NCT02718898|79562585|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
44547819|NCT02718898|79562579|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
44493749|NCT00139776|79499617|FG003|Period II|Not Randomized into Period III|0|||
44493750|NCT00139776|79499614|FG000|Period III|Adverse Event|0|||
44493751|NCT00139776|79499615|FG001|Period III|Adverse Event|0|||
44493752|NCT00139776|79499616|FG002|Period III|Adverse Event|22|||
44493753|NCT00139776|79499617|FG003|Period III|Adverse Event|23|||
44493754|NCT00139776|79499614|FG000|Period III|Other|0|||
44493755|NCT00139776|79499615|FG001|Period III|Other|0|||
44493756|NCT00139776|79499616|FG002|Period III|Other|23|||
44493757|NCT00139776|79499617|FG003|Period III|Other|34|||
44493758|NCT00139776|79499614|FG000|Period III|Lack of Efficacy|0|||
44493759|NCT00139776|79499615|FG001|Period III|Lack of Efficacy|0|||
44493760|NCT00139776|79499616|FG002|Period III|Lack of Efficacy|10|||
44493761|NCT00139776|79499617|FG003|Period III|Lack of Efficacy|24|||
44493762|NCT00139776|79499614|FG000|Period III|Lost to Follow-up|0|||
44493763|NCT00139776|79499615|FG001|Period III|Lost to Follow-up|0|||
44493764|NCT00139776|79499616|FG002|Period III|Lost to Follow-up|5|||
44493765|NCT00139776|79499617|FG003|Period III|Lost to Follow-up|4|||
44230056|NCT01592240|79038106|FG000|Overall Study|Adverse Event|1|||
44493766|NCT00139776|79499614|FG000|Period III|Withdrawal by Subject|0|||
44493767|NCT00139776|79499615|FG001|Period III|Withdrawal by Subject|0|||
44493768|NCT00139776|79499616|FG002|Period III|Withdrawal by Subject|16|||
44493769|NCT00139776|79499617|FG003|Period III|Withdrawal by Subject|21|||
44493770|NCT00413699|79499626|FG000|Initial Period|Death|25|||
44493771|NCT00413699|79499627|FG001|Initial Period|Death|30|||
44493772|NCT00413699|79499628|FG002|Initial Period|Death|0|||
44493773|NCT00413699|79499626|FG000|Initial Period|Lack of Efficacy|59|||
44493774|NCT00413699|79499627|FG001|Initial Period|Lack of Efficacy|115|||
44493775|NCT00413699|79499628|FG002|Initial Period|Lack of Efficacy|0|||
44493776|NCT00413699|79499626|FG000|Initial Period|Lost to Follow-up|31|||
44493777|NCT00413699|79499627|FG001|Initial Period|Lost to Follow-up|101|||
44493778|NCT00413699|79499628|FG002|Initial Period|Lost to Follow-up|0|||
44493779|NCT00413699|79499626|FG000|Initial Period|Protocol Violation|38|||
44493780|NCT00413699|79499627|FG001|Initial Period|Protocol Violation|89|||
44493781|NCT00413699|79499628|FG002|Initial Period|Protocol Violation|0|||
44493782|NCT00413699|79499626|FG000|Initial Period|Pregnancy|10|||
44493783|NCT00413699|79499627|FG001|Initial Period|Pregnancy|8|||
44493784|NCT00413699|79499628|FG002|Initial Period|Pregnancy|0|||
44493785|NCT00413699|79499626|FG000|Initial Period|Did not meet entrance criteria|2|||
44493786|NCT00413699|79499627|FG001|Initial Period|Did not meet entrance criteria|2|||
44493787|NCT00413699|79499628|FG002|Initial Period|Did not meet entrance criteria|0|||
44493788|NCT00413699|79499626|FG000|Initial Period|Medication error without adverse event|0|||
44493789|NCT00413699|79499627|FG001|Initial Period|Medication error without adverse event|1|||
44493790|NCT00413699|79499628|FG002|Initial Period|Medication error without adverse event|0|||
44493791|NCT00413699|79499626|FG000|Initial Period|Study terminated by Sponsor|0|||
44493792|NCT00413699|79499627|FG001|Initial Period|Study terminated by Sponsor|1|||
44493793|NCT00413699|79499628|FG002|Initial Period|Study terminated by Sponsor|0|||
44493794|NCT00413699|79499626|FG000|Initial Period|Other|67|||
44493795|NCT00413699|79499627|FG001|Initial Period|Other|211|||
44493796|NCT00413699|79499628|FG002|Initial Period|Other|0|||
44493797|NCT00413699|79499626|FG000|Initial Period|Adverse event related to study drug|178|||
44493798|NCT00413699|79499627|FG001|Initial Period|Adverse event related to study drug|527|||
44493799|NCT00413699|79499628|FG002|Initial Period|Adverse event related to study drug|0|||
44493800|NCT00413699|79499626|FG000|Initial Period|Adverse event not related to study drug|113|||
44493801|NCT00413699|79499627|FG001|Initial Period|Adverse event not related to study drug|248|||
44493802|NCT00413699|79499628|FG002|Initial Period|Adverse event not related to study drug|0|||
44493803|NCT00413699|79499626|FG000|Initial Period|Missing end of study page|0|||
44493804|NCT00413699|79499627|FG001|Initial Period|Missing end of study page|4|||
44547820|NCT02718898|79562580|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
44547821|NCT02718898|79562581|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
44547822|NCT02718898|79562582|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
44547823|NCT02718898|79562583|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
44547824|NCT02718898|79562584|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
44547825|NCT02718898|79562585|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
44547826|NCT02718898|79562579|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
44547827|NCT02718898|79562580|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
44547828|NCT02718898|79562581|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
44547829|NCT02718898|79562582|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
44547830|NCT02718898|79562583|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
44547831|NCT02718898|79562584|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
44547832|NCT02718898|79562585|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
44547833|NCT02718898|79562579|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
44547834|NCT02718898|79562580|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
44547835|NCT02718898|79562581|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
44547836|NCT02718898|79562582|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
44547837|NCT02718898|79562583|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
44547838|NCT02718898|79562584|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
44547839|NCT02718898|79562585|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
44547840|NCT02718898|79562579|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44547841|NCT02718898|79562580|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44547842|NCT02718898|79562581|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
44547843|NCT02718898|79562582|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
44547844|NCT02718898|79562583|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44547845|NCT02718898|79562584|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44547846|NCT02718898|79562585|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44547847|NCT02718898|79562579|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
44547848|NCT02718898|79562580|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
44547849|NCT02718898|79562581|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
44547850|NCT02718898|79562582|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
44547851|NCT02718898|79562583|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
44547852|NCT02718898|79562584|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
44547853|NCT02718898|79562585|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
44547854|NCT02718898|79562579|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
44547855|NCT02718898|79562580|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
44547856|NCT02718898|79562581|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
44547857|NCT02718898|79562582|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
44547858|NCT02718898|79562583|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
44547859|NCT02718898|79562584|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
44547860|NCT02718898|79562585|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
44547861|NCT02718898|79562579|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
44547862|NCT02718898|79562580|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
44230057|NCT01592240|79038107|FG001|Overall Study|Adverse Event|0|||
44230058|NCT01592240|79038108|FG002|Overall Study|Adverse Event|0|||
44230059|NCT01592240|79038109|FG003|Overall Study|Adverse Event|1|||
44230060|NCT01592240|79038110|FG004|Overall Study|Adverse Event|1|||
44230061|NCT01592240|79038111|FG005|Overall Study|Adverse Event|0|||
44230062|NCT01592240|79038112|FG006|Overall Study|Adverse Event|0|||
44230063|NCT01592240|79038106|FG000|Overall Study|Death|0|||
44230064|NCT01592240|79038107|FG001|Overall Study|Death|1|||
44230065|NCT01592240|79038108|FG002|Overall Study|Death|0|||
44230066|NCT01592240|79038109|FG003|Overall Study|Death|0|||
44230067|NCT01592240|79038110|FG004|Overall Study|Death|0|||
44230068|NCT01592240|79038111|FG005|Overall Study|Death|0|||
44230069|NCT01592240|79038112|FG006|Overall Study|Death|0|||
44230070|NCT01592240|79038106|FG000|Overall Study|Lost to Follow-up|1|||
44230071|NCT01592240|79038107|FG001|Overall Study|Lost to Follow-up|3|||
44230072|NCT01592240|79038108|FG002|Overall Study|Lost to Follow-up|1|||
44230073|NCT01592240|79038109|FG003|Overall Study|Lost to Follow-up|0|||
44547863|NCT02718898|79562581|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
44547864|NCT02718898|79562582|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
44230074|NCT01592240|79038110|FG004|Overall Study|Lost to Follow-up|3|||
44230075|NCT01592240|79038111|FG005|Overall Study|Lost to Follow-up|2|||
44230076|NCT01592240|79038112|FG006|Overall Study|Lost to Follow-up|0|||
44230077|NCT01592240|79038106|FG000|Overall Study|Protocol Violation|0|||
44230078|NCT01592240|79038107|FG001|Overall Study|Protocol Violation|0|||
44230079|NCT01592240|79038108|FG002|Overall Study|Protocol Violation|0|||
44547865|NCT02718898|79562583|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
44547866|NCT02718898|79562584|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
44547867|NCT02718898|79562585|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
44547868|NCT02718898|79562579|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
44547869|NCT02718898|79562580|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
44230080|NCT01592240|79038109|FG003|Overall Study|Protocol Violation|0|||
44230081|NCT01592240|79038110|FG004|Overall Study|Protocol Violation|0|||
44230082|NCT01592240|79038111|FG005|Overall Study|Protocol Violation|1|||
44547870|NCT02718898|79562581|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
44230083|NCT01592240|79038112|FG006|Overall Study|Protocol Violation|0|||
44547871|NCT02718898|79562582|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
44547872|NCT02718898|79562583|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
44547873|NCT02718898|79562584|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
44547874|NCT02718898|79562585|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
44547875|NCT02718898|79562579|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
44547876|NCT02718898|79562580|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
44547877|NCT02718898|79562581|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
44547878|NCT02718898|79562582|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
44547879|NCT02718898|79562583|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
44547880|NCT02718898|79562584|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
44547881|NCT02718898|79562585|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
44547882|NCT02718898|79562579|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44547883|NCT02718898|79562580|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44547884|NCT02718898|79562581|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44547885|NCT02718898|79562582|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44547886|NCT02718898|79562583|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44547887|NCT02718898|79562584|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
44547888|NCT02718898|79562585|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
44547889|NCT03143166|79562602|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
44547890|NCT02879994|79562608|FG000|Overall Study|off treatment early|7|||
44547891|NCT02879994|79562608|FG000|Overall Study|Adverse Event|2|||
44547892|NCT02879994|79562608|FG000|Overall Study|Death|2|||
44547893|NCT03142932|79562614|FG000|Overall Study|Lost to Follow-up|2|||
44547894|NCT03142932|79562615|FG001|Overall Study|Lost to Follow-up|11|||
44547895|NCT00702052|79562621|FG000|Overall Study|Adverse Event|23|||
44547896|NCT00702052|79562621|FG000|Overall Study|Disease Progression|30|||
44547897|NCT00702052|79562621|FG000|Overall Study|Withdrawal by Subject|5|||
44547898|NCT03140280|79562625|FG000|Overall Study|Physician Decision|5|||
44547899|NCT03136380|79562631|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44547900|NCT03136380|79562632|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
44547901|NCT03136380|79562633|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44547902|NCT03136380|79562634|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44547903|NCT03136380|79562635|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44547904|NCT03136068|79562655|FG000|Overall Study|Lost to Follow-up|1|||
44547905|NCT03136068|79562656|FG001|Overall Study|Lost to Follow-up|1|||
44547906|NCT03136068|79562655|FG000|Overall Study|Protocol Violation|1|||
44547907|NCT03136068|79562656|FG001|Overall Study|Protocol Violation|0|||
44547908|NCT02585232|79562664|FG000|Overall Study|Lost to Follow-up|8|||
44547909|NCT02585232|79562665|FG001|Overall Study|Lost to Follow-up|8|||
44547910|NCT02585232|79562664|FG000|Overall Study|Withdrawal by Subject|4|||
44547911|NCT02585232|79562665|FG001|Overall Study|Withdrawal by Subject|8|||
44547912|NCT03377790|79562694|FG000|Overall Study|Withdrawal by Subject|1|||
44547913|NCT03377790|79562695|FG001|Overall Study|Withdrawal by Subject|0|||
44547914|NCT03377790|79562694|FG000|Overall Study|Adverse Event|1|||
44230084|NCT01592240|79038106|FG000|Overall Study|Withdrawal by Subject|0|||
44230085|NCT01592240|79038107|FG001|Overall Study|Withdrawal by Subject|4|||
44547915|NCT03377790|79562695|FG001|Overall Study|Adverse Event|0|||
44547916|NCT03377790|79562694|FG000|Overall Study|Lost to Follow-up|0|||
44547917|NCT03377790|79562695|FG001|Overall Study|Lost to Follow-up|2|||
44547918|NCT03377790|79562694|FG000|Overall Study|Randomized but not treated|1|||
44547919|NCT03377790|79562695|FG001|Overall Study|Randomized but not treated|0|||
44547920|NCT03377790|79562694|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
44547921|NCT03377790|79562695|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
44547922|NCT02717494|79562704|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
44493805|NCT00413699|79499628|FG002|Initial Period|Missing end of study page|0|||
44493806|NCT00413699|79499626|FG000|Initial Period|No longer willing to participate|116|||
44547923|NCT02717494|79562705|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
44547924|NCT02717494|79562706|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
44547925|NCT02717494|79562704|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
44547926|NCT02717494|79562705|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
44274596|NCT02248818|79220366|FG007|Screening|Study fully enrolled|0|||
44493807|NCT00413699|79499627|FG001|Initial Period|No longer willing to participate|368|||
44493808|NCT00413699|79499628|FG002|Initial Period|No longer willing to participate|0|||
44493809|NCT00413699|79499626|FG000|Extension Period|No Longer Willing to Participate|0|||
44493810|NCT00413699|79499627|FG001|Extension Period|No Longer Willing to Participate|0|||
44493811|NCT00413699|79499628|FG002|Extension Period|No Longer Willing to Participate|2|||
44493812|NCT00413699|79499626|FG000|Extension Period|Protocol Violation|0|||
44493813|NCT00413699|79499627|FG001|Extension Period|Protocol Violation|0|||
44274597|NCT02248818|79220367|FG008|Screening|Study fully enrolled|14|||
44274598|NCT02248818|79220359|FG000|Screening|Physician Decision|0|||
44274599|NCT02248818|79220360|FG001|Screening|Physician Decision|0|||
44274600|NCT02248818|79220361|FG002|Screening|Physician Decision|0|||
44274601|NCT02248818|79220362|FG003|Screening|Physician Decision|0|||
44274602|NCT02248818|79220363|FG004|Screening|Physician Decision|0|||
44274603|NCT02248818|79220364|FG005|Screening|Physician Decision|0|||
44274604|NCT02248818|79220365|FG006|Screening|Physician Decision|0|||
44274605|NCT02248818|79220366|FG007|Screening|Physician Decision|0|||
44274606|NCT02248818|79220367|FG008|Screening|Physician Decision|73|||
44274607|NCT02248818|79220359|FG000|Screening|Withdrawal by Subject|0|||
44274608|NCT02248818|79220360|FG001|Screening|Withdrawal by Subject|0|||
44274609|NCT02248818|79220361|FG002|Screening|Withdrawal by Subject|0|||
44274610|NCT02248818|79220362|FG003|Screening|Withdrawal by Subject|0|||
44274611|NCT02248818|79220363|FG004|Screening|Withdrawal by Subject|0|||
44274612|NCT02248818|79220364|FG005|Screening|Withdrawal by Subject|0|||
44274613|NCT02248818|79220365|FG006|Screening|Withdrawal by Subject|0|||
44274614|NCT02248818|79220366|FG007|Screening|Withdrawal by Subject|0|||
44274615|NCT02248818|79220367|FG008|Screening|Withdrawal by Subject|6|||
44274616|NCT02248818|79220359|FG000|Screening|Lost to Follow-up|0|||
44493814|NCT00413699|79499628|FG002|Extension Period|Protocol Violation|1|||
44493815|NCT00413699|79499626|FG000|Extension Period|Adverse Event|0|||
44493816|NCT00413699|79499627|FG001|Extension Period|Adverse Event|0|||
44493817|NCT00413699|79499628|FG002|Extension Period|Adverse Event|2|||
44493818|NCT03713320|79499656|FG000|Randomized Period|Adverse Event|1|||
44493819|NCT03713320|79499657|FG001|Randomized Period|Adverse Event|5|||
44493820|NCT03713320|79499658|FG002|Randomized Period|Adverse Event|0|||
44493821|NCT03713320|79499656|FG000|Randomized Period|Physician Decision|1|||
44493822|NCT03713320|79499657|FG001|Randomized Period|Physician Decision|1|||
44493823|NCT03713320|79499658|FG002|Randomized Period|Physician Decision|0|||
44493824|NCT03713320|79499656|FG000|Randomized Period|Withdrawal by Subject|4|||
44493825|NCT03713320|79499657|FG001|Randomized Period|Withdrawal by Subject|0|||
44493826|NCT03713320|79499658|FG002|Randomized Period|Withdrawal by Subject|0|||
44493827|NCT03713320|79499656|FG000|Randomized Period|Participant decision|3|||
44493828|NCT03713320|79499657|FG001|Randomized Period|Participant decision|1|||
44493829|NCT03713320|79499658|FG002|Randomized Period|Participant decision|0|||
44493830|NCT03713320|79499656|FG000|Randomized Period|Study terminated by sponsor|6|||
44493831|NCT03713320|79499657|FG001|Randomized Period|Study terminated by sponsor|3|||
44493832|NCT03713320|79499658|FG002|Randomized Period|Study terminated by sponsor|0|||
44547927|NCT02717494|79562706|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
44274617|NCT02248818|79220360|FG001|Screening|Lost to Follow-up|0|||
44274618|NCT02248818|79220361|FG002|Screening|Lost to Follow-up|0|||
44493833|NCT03713320|79499656|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
44493834|NCT03713320|79499657|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
44493835|NCT03713320|79499658|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
44493836|NCT03713320|79499656|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
44493837|NCT03713320|79499657|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
44493838|NCT03713320|79499658|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
44547928|NCT02717494|79562704|FG000|First Intervention (Step 1)|Death|0|||
44274619|NCT02248818|79220362|FG003|Screening|Lost to Follow-up|0|||
44274620|NCT02248818|79220363|FG004|Screening|Lost to Follow-up|0|||
44274621|NCT02248818|79220364|FG005|Screening|Lost to Follow-up|0|||
44274622|NCT02248818|79220365|FG006|Screening|Lost to Follow-up|0|||
44274623|NCT02248818|79220366|FG007|Screening|Lost to Follow-up|0|||
44274624|NCT02248818|79220367|FG008|Screening|Lost to Follow-up|7|||
44547929|NCT02717494|79562705|FG001|First Intervention (Step 1)|Death|0|||
44547930|NCT02717494|79562706|FG002|First Intervention (Step 1)|Death|1|||
44547931|NCT02717494|79562704|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
44547932|NCT02717494|79562705|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
44547933|NCT02717494|79562706|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
44230086|NCT01592240|79038108|FG002|Overall Study|Withdrawal by Subject|4|||
44274625|NCT02248818|79220359|FG000|Randomised Study|Administrative - randomization error|0|||
44274626|NCT02248818|79220360|FG001|Randomised Study|Administrative - randomization error|0|||
44274627|NCT02248818|79220361|FG002|Randomised Study|Administrative - randomization error|0|||
44274628|NCT02248818|79220362|FG003|Randomised Study|Administrative - randomization error|0|||
44274629|NCT02248818|79220363|FG004|Randomised Study|Administrative - randomization error|0|||
44274630|NCT02248818|79220364|FG005|Randomised Study|Administrative - randomization error|8|||
44274631|NCT02248818|79220365|FG006|Randomised Study|Administrative - randomization error|0|||
44274632|NCT02248818|79220366|FG007|Randomised Study|Administrative - randomization error|0|||
44274633|NCT02248818|79220367|FG008|Randomised Study|Administrative - randomization error|0|||
44274634|NCT02247960|79220396|FG000|Patient Consent and Randomization|Physician Decision|2|||
44274635|NCT02247960|79220397|FG001|Patient Consent and Randomization|Physician Decision|2|||
44274636|NCT02247960|79220396|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
44493839|NCT03712930|79499665|FG000|Overall Study|Death|7|||
44493840|NCT03712930|79499665|FG000|Overall Study|Physician Decision|1|||
44493841|NCT03712930|79499665|FG000|Overall Study|Study Terminated by Sponsor|3|||
44493842|NCT03712930|79499665|FG000|Overall Study|Progressive Disease|2|||
44493843|NCT00420407|79499671|FG000|Overall Study|Lost to Follow-up|0|||
44493844|NCT00420407|79499672|FG001|Overall Study|Lost to Follow-up|3|||
44493845|NCT00420407|79499671|FG000|Overall Study|Physician Decision|2|||
44493846|NCT00420407|79499672|FG001|Overall Study|Physician Decision|1|||
44493847|NCT00420407|79499671|FG000|Overall Study|subject identified as detainee|1|||
44493848|NCT00420407|79499672|FG001|Overall Study|subject identified as detainee|0|||
44493849|NCT00420407|79499671|FG000|Overall Study|subject identified as Jehovah's witness|1|||
44493850|NCT00420407|79499672|FG001|Overall Study|subject identified as Jehovah's witness|0|||
44493851|NCT00420407|79499671|FG000|Overall Study|Withdrawal by Subject|0|||
44493852|NCT00420407|79499672|FG001|Overall Study|Withdrawal by Subject|2|||
44493853|NCT00420095|79499681|FG000|Overall Study|Adverse Event|1|||
44493854|NCT00420095|79499682|FG001|Overall Study|Adverse Event|0|||
44493855|NCT00420095|79499681|FG000|Overall Study|Protocol Violation|1|||
44493856|NCT00420095|79499682|FG001|Overall Study|Protocol Violation|1|||
44493857|NCT00420095|79499681|FG000|Overall Study|Lost to Follow-up|1|||
44493858|NCT00420095|79499682|FG001|Overall Study|Lost to Follow-up|0|||
44493859|NCT00419393|79499688|FG000|Overall Study|Adverse Event|5|||
44493860|NCT00419393|79499688|FG000|Overall Study|Protocol Violation|5|||
44493861|NCT00419393|79499688|FG000|Overall Study|Withdrawal by Subject|7|||
44493862|NCT00419393|79499688|FG000|Overall Study|Other: Sponsor request|3|||
44493863|NCT00419393|79499688|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
44493864|NCT00419393|79499688|FG000|Overall Study|Other: Site closure|1|||
44493865|NCT00419393|79499688|FG000|Overall Study|Other: Other health problems|1|||
44493866|NCT00419393|79499688|FG000|Overall Study|Other: Investigator decision|1|||
44493867|NCT00419159|79499694|FG000|Overall Study|Adverse Event|7|||
44493868|NCT00419159|79499695|FG001|Overall Study|Adverse Event|15|||
44230087|NCT01592240|79038109|FG003|Overall Study|Withdrawal by Subject|1|||
44230088|NCT01592240|79038110|FG004|Overall Study|Withdrawal by Subject|3|||
44230089|NCT01592240|79038111|FG005|Overall Study|Withdrawal by Subject|0|||
44230090|NCT01592240|79038112|FG006|Overall Study|Withdrawal by Subject|2|||
44230091|NCT01592240|79038106|FG000|Overall Study|Other|0|||
44230092|NCT01592240|79038107|FG001|Overall Study|Other|3|||
44230093|NCT01592240|79038108|FG002|Overall Study|Other|1|||
44230094|NCT01592240|79038109|FG003|Overall Study|Other|1|||
44230095|NCT01592240|79038110|FG004|Overall Study|Other|0|||
44230096|NCT01592240|79038111|FG005|Overall Study|Other|0|||
44230097|NCT01592240|79038112|FG006|Overall Study|Other|1|||
44493869|NCT00419159|79499694|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44493870|NCT00419159|79499695|FG001|Overall Study|Abnormal laboratory value(s)|2|||
44493871|NCT00419159|79499694|FG000|Overall Study|Subject's no longer requires study drug|0|||
44493872|NCT00419159|79499695|FG001|Overall Study|Subject's no longer requires study drug|1|||
44493873|NCT00419159|79499694|FG000|Overall Study|Protocol Violation|1|||
44230098|NCT01592240|79038106|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
44274637|NCT02247960|79220397|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
44274638|NCT02247960|79220396|FG000|Catheter Removed|Lost to Follow-up|7|||
44274639|NCT02247960|79220397|FG001|Catheter Removed|Lost to Follow-up|10|||
44493874|NCT00419159|79499695|FG001|Overall Study|Protocol Violation|0|||
44274640|NCT02247804|79220486|FG000|Treatment Period 1|Adverse Event|9|||
44274641|NCT02247804|79220487|FG001|Treatment Period 1|Adverse Event|2|||
44274642|NCT02247804|79220488|FG002|Treatment Period 1|Adverse Event|0|||
44274643|NCT02247804|79220486|FG000|Treatment Period 1|Lack of Efficacy|0|||
44274644|NCT02247804|79220487|FG001|Treatment Period 1|Lack of Efficacy|0|||
44274645|NCT02247804|79220488|FG002|Treatment Period 1|Lack of Efficacy|2|||
44493875|NCT00419159|79499694|FG000|Overall Study|Withdrawal by Subject|10|||
44493876|NCT00419159|79499695|FG001|Overall Study|Withdrawal by Subject|3|||
44493877|NCT00419159|79499694|FG000|Overall Study|Lost to Follow-up|0|||
44493878|NCT00419159|79499695|FG001|Overall Study|Lost to Follow-up|1|||
44493879|NCT00419159|79499694|FG000|Overall Study|Death|2|||
44493880|NCT00419159|79499695|FG001|Overall Study|Death|2|||
44493881|NCT00419159|79499694|FG000|Overall Study|Disease progression|79|||
44493882|NCT00419159|79499695|FG001|Overall Study|Disease progression|76|||
44493883|NCT03717064|79499709|FG000|Period 2|Adverse Event|1|||
44493884|NCT03716050|79499721|FG000|Overall Study|Lost to Follow-up|0|||
44493885|NCT03716050|79499722|FG001|Overall Study|Lost to Follow-up|0|||
44493886|NCT03716050|79499723|FG002|Overall Study|Lost to Follow-up|1|||
44493887|NCT03716050|79499724|FG003|Overall Study|Lost to Follow-up|0|||
44493888|NCT03716050|79499725|FG004|Overall Study|Lost to Follow-up|0|||
44493889|NCT03716050|79499726|FG005|Overall Study|Lost to Follow-up|0|||
44493890|NCT03716050|79499727|FG006|Overall Study|Lost to Follow-up|0|||
44493891|NCT03716050|79499728|FG007|Overall Study|Lost to Follow-up|0|||
44493892|NCT03716050|79499721|FG000|Overall Study|Physician Decision|0|||
44493893|NCT03716050|79499722|FG001|Overall Study|Physician Decision|0|||
44493894|NCT03716050|79499723|FG002|Overall Study|Physician Decision|0|||
44230099|NCT01592240|79038107|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
44230100|NCT01592240|79038108|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
44230101|NCT01592240|79038109|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
44230102|NCT01592240|79038110|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
44230103|NCT01592240|79038111|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
44493895|NCT03716050|79499724|FG003|Overall Study|Physician Decision|1|||
44493896|NCT03716050|79499725|FG004|Overall Study|Physician Decision|0|||
44493897|NCT03716050|79499726|FG005|Overall Study|Physician Decision|0|||
44493898|NCT03716050|79499727|FG006|Overall Study|Physician Decision|0|||
44493899|NCT03716050|79499728|FG007|Overall Study|Physician Decision|0|||
44493900|NCT03716050|79499721|FG000|Overall Study|Protocol Violation|0|||
44493901|NCT03716050|79499722|FG001|Overall Study|Protocol Violation|0|||
44493902|NCT03716050|79499723|FG002|Overall Study|Protocol Violation|0|||
44493903|NCT03716050|79499724|FG003|Overall Study|Protocol Violation|1|||
44493904|NCT03716050|79499725|FG004|Overall Study|Protocol Violation|0|||
44493905|NCT03716050|79499726|FG005|Overall Study|Protocol Violation|0|||
44493906|NCT03716050|79499727|FG006|Overall Study|Protocol Violation|0|||
44493907|NCT03716050|79499728|FG007|Overall Study|Protocol Violation|2|||
44493908|NCT00413231|79499745|FG000|0 to 30-day Post Treatment|Death|5|||
44230104|NCT01592240|79038112|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
44230105|NCT01591616|79038155|FG000|Overall Study|Withdrawal by Subject|1|||
44230106|NCT01591460|79038311|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
44230107|NCT01591460|79038311|FG000|Overall Study|Futility Rule (Week 12)|7|||
44230108|NCT01591460|79038311|FG000|Overall Study|Futility Rule (Week 24)|3|||
44230109|NCT01591460|79038311|FG000|Overall Study|Rebound or Breakthrough|3|||
44493909|NCT00413231|79499745|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
44493910|NCT00413231|79499745|FG000|30-day to 365-day Post Treatment|Death|13|||
44493911|NCT00413231|79499745|FG000|365-day to 60-month Post Treatment|Death|36|||
44493912|NCT00413231|79499745|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
44493913|NCT00413231|79499745|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
44493914|NCT00413231|79499745|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
44493915|NCT00413153|79499765|FG000|Overall Study|Withdrawal by Subject|1|||
44230110|NCT01591460|79038311|FG000|Overall Study|Treatment Discontinued by Error|1|||
44274646|NCT02247804|79220486|FG000|Treatment Period 1|Lost to Follow-up|1|||
44274647|NCT02247804|79220487|FG001|Treatment Period 1|Lost to Follow-up|0|||
44493916|NCT00413153|79499766|FG001|Overall Study|Withdrawal by Subject|1|||
44493917|NCT00413153|79499765|FG000|Overall Study|Adverse Event|1|||
44493918|NCT00413153|79499766|FG001|Overall Study|Adverse Event|0|||
44493919|NCT00412607|79499772|FG000|Overall Study|Withdrawal by Subject|9|||
44493920|NCT00412607|79499772|FG000|Overall Study|Lost to Follow-up|19|||
44493921|NCT00412607|79499772|FG000|Overall Study|Death|61|||
44493922|NCT00412607|79499772|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
44493923|NCT00419003|79499781|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
44274648|NCT02247804|79220488|FG002|Treatment Period 1|Lost to Follow-up|2|||
44493924|NCT00419003|79499782|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
44493925|NCT00419003|79499781|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
44547934|NCT01844856|79562734|FG000|Overall Study|Lost to Follow-up|15|||
44547935|NCT01844856|79562735|FG001|Overall Study|Lost to Follow-up|3|||
44274649|NCT02247804|79220486|FG000|Treatment Period 1|Personal Reasons|7|||
44274650|NCT02247804|79220487|FG001|Treatment Period 1|Personal Reasons|1|||
44274651|NCT02247804|79220488|FG002|Treatment Period 1|Personal Reasons|2|||
44274652|NCT02247804|79220486|FG000|Treatment Period 1|Protocol Deviation|0|||
44274653|NCT02247804|79220487|FG001|Treatment Period 1|Protocol Deviation|0|||
44274654|NCT02247804|79220488|FG002|Treatment Period 1|Protocol Deviation|1|||
44274655|NCT02247804|79220486|FG000|Treatment Period 1|Randomized but not Treated|5|||
44274656|NCT02247804|79220487|FG001|Treatment Period 1|Randomized but not Treated|1|||
44547936|NCT01844856|79562734|FG000|Overall Study|Adverse Event|3|||
44274657|NCT02247804|79220488|FG002|Treatment Period 1|Randomized but not Treated|1|||
44274658|NCT02247804|79220486|FG000|Treatment Period 2|Adverse Event|6|||
44274659|NCT02247804|79220487|FG001|Treatment Period 2|Adverse Event|3|||
44274660|NCT02247804|79220488|FG002|Treatment Period 2|Adverse Event|3|||
44274661|NCT02247804|79220486|FG000|Treatment Period 2|Lack of Efficacy|0|||
44274662|NCT02247804|79220487|FG001|Treatment Period 2|Lack of Efficacy|0|||
44274663|NCT02247804|79220488|FG002|Treatment Period 2|Lack of Efficacy|1|||
44274664|NCT02247804|79220486|FG000|Treatment Period 2|Lost to Follow-up|0|||
44274665|NCT02247804|79220487|FG001|Treatment Period 2|Lost to Follow-up|1|||
44274666|NCT02247804|79220488|FG002|Treatment Period 2|Lost to Follow-up|1|||
44274667|NCT02247804|79220486|FG000|Treatment Period 2|Personal Reasons|2|||
44274668|NCT02247804|79220487|FG001|Treatment Period 2|Personal Reasons|1|||
44274669|NCT02247804|79220488|FG002|Treatment Period 2|Personal Reasons|1|||
44274670|NCT02247804|79220486|FG000|Treatment Period 2|Reason not Specified|0|||
44274671|NCT02247804|79220487|FG001|Treatment Period 2|Reason not Specified|0|||
44274672|NCT02247804|79220488|FG002|Treatment Period 2|Reason not Specified|2|||
44274673|NCT02247804|79220486|FG000|Treatment Period 3|Adverse Event|4|||
44274674|NCT02247804|79220487|FG001|Treatment Period 3|Adverse Event|3|||
44493926|NCT00419003|79499782|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
44547937|NCT01844856|79562735|FG001|Overall Study|Adverse Event|6|||
44547938|NCT01844856|79562734|FG000|Overall Study|Withdrawal by Subject|3|||
44547939|NCT01844856|79562735|FG001|Overall Study|Withdrawal by Subject|2|||
44547940|NCT01844856|79562734|FG000|Overall Study|Noncompliance|2|||
44547941|NCT01844856|79562735|FG001|Overall Study|Noncompliance|3|||
44547942|NCT01844856|79562734|FG000|Overall Study|Enterococcus Resistant|0|||
44547943|NCT01844856|79562735|FG001|Overall Study|Enterococcus Resistant|1|||
44547944|NCT01844856|79562734|FG000|Overall Study|Inadvertently Not Scheduled|1|||
44547945|NCT01844856|79562735|FG001|Overall Study|Inadvertently Not Scheduled|0|||
44547946|NCT01844856|79562734|FG000|Overall Study|Randomized but was a Screen Failure|0|||
44547947|NCT01844856|79562735|FG001|Overall Study|Randomized but was a Screen Failure|1|||
44547948|NCT03135210|79562771|FG000|Overall Study|Death|0|||
44547949|NCT03135210|79562772|FG001|Overall Study|Death|1|||
44230111|NCT01591460|79038311|FG000|Overall Study|Lost to Follow-up|1|||
44230112|NCT01591460|79038311|FG000|Overall Study|Noncompliance|1|||
44230113|NCT01591460|79038311|FG000|Overall Study|Participant Refusal|3|||
44230114|NCT01591460|79038311|FG000|Overall Study|Withdrawal by Subject|1|||
44230115|NCT01591460|79038311|FG000|Overall Study|Protocol Violation|1|||
44230116|NCT01591382|79038334|FG000|Overall Study|Discharged Prior to Study Completion|2|||
44230117|NCT01591382|79038335|FG001|Overall Study|Discharged Prior to Study Completion|1|||
44230118|NCT01591382|79038334|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
44230119|NCT01591382|79038335|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
44230120|NCT01696214|79038353|FG000|Overall Study|Lost to Follow-up|1|||
44230121|NCT01696214|79038354|FG001|Overall Study|Lost to Follow-up|0|||
44493927|NCT00418691|79499794|FG000|Overall Study|Lost to Follow-up|1|||
44493928|NCT00418691|79499795|FG001|Overall Study|Lost to Follow-up|2|||
44493929|NCT00418691|79499796|FG002|Overall Study|Lost to Follow-up|3|||
44493930|NCT00418691|79499794|FG000|Overall Study|Started new medication voiding entry|0|||
44493931|NCT00418691|79499795|FG001|Overall Study|Started new medication voiding entry|0|||
44493932|NCT00418691|79499796|FG002|Overall Study|Started new medication voiding entry|1|||
44493933|NCT00418691|79499794|FG000|Overall Study|Progressive Disease|1|||
44547950|NCT00701662|79562778|FG000|Overall Study|Lack of Efficacy|1|||
44547951|NCT02878590|79562782|FG000|Overall Study|Withdrawal by Subject|2|||
44493934|NCT00418691|79499795|FG001|Overall Study|Progressive Disease|0|||
44547952|NCT04634409|79562813|FG000|Overall Study|Death|0|||
44547953|NCT04634409|79562814|FG001|Overall Study|Death|0|||
44547954|NCT04634409|79562815|FG002|Overall Study|Death|0|||
44230122|NCT01696214|79038355|FG002|Overall Study|Lost to Follow-up|0|||
44274675|NCT02247804|79220488|FG002|Treatment Period 3|Adverse Event|3|||
44493935|NCT00418691|79499796|FG002|Overall Study|Progressive Disease|1|||
44274676|NCT02247804|79220486|FG000|Treatment Period 3|Lack of Efficacy|0|||
44274677|NCT02247804|79220487|FG001|Treatment Period 3|Lack of Efficacy|1|||
44274678|NCT02247804|79220488|FG002|Treatment Period 3|Lack of Efficacy|0|||
44547955|NCT04634409|79562816|FG003|Overall Study|Death|0|||
44547956|NCT04634409|79562817|FG004|Overall Study|Death|0|||
44547957|NCT04634409|79562818|FG005|Overall Study|Death|0|||
44547958|NCT04634409|79562819|FG006|Overall Study|Death|0|||
44547959|NCT04634409|79562820|FG007|Overall Study|Death|0|||
44547960|NCT04634409|79562821|FG008|Overall Study|Death|0|||
44493936|NCT00412373|79499806|FG000|Overall Study|Adverse Event|8|||
44493937|NCT00412373|79499807|FG001|Overall Study|Adverse Event|13|||
44493938|NCT00412373|79499806|FG000|Overall Study|Lack of Efficacy|16|||
44493939|NCT00412373|79499807|FG001|Overall Study|Lack of Efficacy|22|||
44493940|NCT00412373|79499806|FG000|Overall Study|Lost to Follow-up|7|||
44493941|NCT00412373|79499807|FG001|Overall Study|Lost to Follow-up|13|||
44493942|NCT00412373|79499806|FG000|Overall Study|Withdrawal by Subject|8|||
44547961|NCT04634409|79562822|FG009|Overall Study|Death|0|||
44547962|NCT04634409|79562823|FG010|Overall Study|Death|1|||
44547963|NCT04634409|79562824|FG011|Overall Study|Death|0|||
44547964|NCT04634409|79562825|FG012|Overall Study|Death|1|||
44547965|NCT04634409|79562826|FG013|Overall Study|Death|0|||
44547966|NCT04634409|79562827|FG014|Overall Study|Death|0|||
44547967|NCT04634409|79562828|FG015|Overall Study|Death|0|||
44547968|NCT04634409|79562829|FG016|Overall Study|Death|0|||
44547969|NCT04634409|79562830|FG017|Overall Study|Death|0|||
44547970|NCT04634409|79562831|FG018|Overall Study|Death|0|||
44547971|NCT04634409|79562832|FG019|Overall Study|Death|0|||
44493943|NCT00412373|79499807|FG001|Overall Study|Withdrawal by Subject|27|||
44493944|NCT00412373|79499806|FG000|Overall Study|Other|2|||
44493945|NCT00412373|79499807|FG001|Overall Study|Other|2|||
44493946|NCT00418379|79499816|FG000|Year 1|Adverse Event|9|||
44493947|NCT00418379|79499817|FG001|Year 1|Adverse Event|15|||
44547972|NCT04634409|79562833|FG020|Overall Study|Death|0|||
44493948|NCT00418379|79499818|FG002|Year 1|Adverse Event|3|||
44493949|NCT00418379|79499816|FG000|Year 1|Withdrawal by Subject|7|||
44493950|NCT00418379|79499817|FG001|Year 1|Withdrawal by Subject|8|||
44547973|NCT04634409|79562834|FG021|Overall Study|Death|0|||
44547974|NCT04634409|79562835|FG022|Overall Study|Death|0|||
44547975|NCT04634409|79562836|FG023|Overall Study|Death|0|||
44547976|NCT04634409|79562837|FG024|Overall Study|Death|0|||
44547977|NCT04634409|79562838|FG025|Overall Study|Death|0|||
44547978|NCT04634409|79562839|FG026|Overall Study|Death|0|||
44547979|NCT04634409|79562813|FG000|Overall Study|Adverse Event|0|||
44547980|NCT04634409|79562814|FG001|Overall Study|Adverse Event|0|||
44547981|NCT04634409|79562815|FG002|Overall Study|Adverse Event|1|||
44230123|NCT01696214|79038356|FG003|Overall Study|Lost to Follow-up|0|||
44547982|NCT04634409|79562816|FG003|Overall Study|Adverse Event|0|||
44547983|NCT04634409|79562817|FG004|Overall Study|Adverse Event|0|||
44547984|NCT04634409|79562818|FG005|Overall Study|Adverse Event|1|||
44547985|NCT04634409|79562819|FG006|Overall Study|Adverse Event|0|||
44547986|NCT04634409|79562820|FG007|Overall Study|Adverse Event|0|||
44547987|NCT04634409|79562821|FG008|Overall Study|Adverse Event|0|||
44547988|NCT04634409|79562822|FG009|Overall Study|Adverse Event|0|||
44547989|NCT04634409|79562823|FG010|Overall Study|Adverse Event|0|||
44547990|NCT04634409|79562824|FG011|Overall Study|Adverse Event|0|||
44547991|NCT04634409|79562825|FG012|Overall Study|Adverse Event|0|||
44547992|NCT04634409|79562826|FG013|Overall Study|Adverse Event|0|||
44547993|NCT04634409|79562827|FG014|Overall Study|Adverse Event|0|||
44547994|NCT04634409|79562828|FG015|Overall Study|Adverse Event|0|||
44547995|NCT04634409|79562829|FG016|Overall Study|Adverse Event|0|||
44547996|NCT04634409|79562830|FG017|Overall Study|Adverse Event|0|||
44547997|NCT04634409|79562831|FG018|Overall Study|Adverse Event|0|||
44547998|NCT04634409|79562832|FG019|Overall Study|Adverse Event|0|||
44547999|NCT04634409|79562833|FG020|Overall Study|Adverse Event|0|||
44548000|NCT04634409|79562834|FG021|Overall Study|Adverse Event|0|||
44548001|NCT04634409|79562835|FG022|Overall Study|Adverse Event|0|||
44548002|NCT04634409|79562836|FG023|Overall Study|Adverse Event|0|||
44548003|NCT04634409|79562837|FG024|Overall Study|Adverse Event|0|||
44548004|NCT04634409|79562838|FG025|Overall Study|Adverse Event|0|||
44230124|NCT01543087|79038389|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
44493951|NCT00418379|79499818|FG002|Year 1|Withdrawal by Subject|5|||
44493952|NCT00418379|79499816|FG000|Year 1|Any other reason not above-mentioned|2|||
44493953|NCT00418379|79499817|FG001|Year 1|Any other reason not above-mentioned|5|||
44493954|NCT00418379|79499818|FG002|Year 1|Any other reason not above-mentioned|7|||
44548005|NCT04634409|79562839|FG026|Overall Study|Adverse Event|0|||
44548006|NCT04634409|79562813|FG000|Overall Study|Lost to Follow-up|3|||
44548007|NCT04634409|79562814|FG001|Overall Study|Lost to Follow-up|1|||
44548008|NCT04634409|79562815|FG002|Overall Study|Lost to Follow-up|1|||
44548009|NCT04634409|79562816|FG003|Overall Study|Lost to Follow-up|3|||
44548010|NCT04634409|79562817|FG004|Overall Study|Lost to Follow-up|1|||
44548011|NCT04634409|79562818|FG005|Overall Study|Lost to Follow-up|1|||
44548012|NCT04634409|79562819|FG006|Overall Study|Lost to Follow-up|1|||
44493955|NCT00418379|79499816|FG000|Year 2|Adverse Event|5|||
44493956|NCT00418379|79499817|FG001|Year 2|Adverse Event|2|||
44493957|NCT00418379|79499818|FG002|Year 2|Adverse Event|1|||
44493958|NCT00418379|79499816|FG000|Year 2|Withdrawal by Subject|1|||
44493959|NCT00418379|79499817|FG001|Year 2|Withdrawal by Subject|1|||
44493960|NCT00418379|79499818|FG002|Year 2|Withdrawal by Subject|3|||
44548013|NCT04634409|79562820|FG007|Overall Study|Lost to Follow-up|3|||
44548014|NCT04634409|79562821|FG008|Overall Study|Lost to Follow-up|3|||
44548015|NCT04634409|79562822|FG009|Overall Study|Lost to Follow-up|11|||
44548016|NCT04634409|79562823|FG010|Overall Study|Lost to Follow-up|8|||
44493961|NCT00418379|79499816|FG000|Year 2|Any other reason not above-mentioned|2|||
44493962|NCT00418379|79499817|FG001|Year 2|Any other reason not above-mentioned|1|||
44548017|NCT04634409|79562824|FG011|Overall Study|Lost to Follow-up|15|||
44548018|NCT04634409|79562825|FG012|Overall Study|Lost to Follow-up|3|||
44548019|NCT04634409|79562826|FG013|Overall Study|Lost to Follow-up|2|||
44548020|NCT04634409|79562827|FG014|Overall Study|Lost to Follow-up|7|||
44548021|NCT04634409|79562828|FG015|Overall Study|Lost to Follow-up|0|||
44548022|NCT04634409|79562829|FG016|Overall Study|Lost to Follow-up|0|||
44548023|NCT04634409|79562830|FG017|Overall Study|Lost to Follow-up|0|||
44548024|NCT04634409|79562831|FG018|Overall Study|Lost to Follow-up|0|||
44548025|NCT04634409|79562832|FG019|Overall Study|Lost to Follow-up|0|||
44548026|NCT04634409|79562833|FG020|Overall Study|Lost to Follow-up|0|||
44548027|NCT04634409|79562834|FG021|Overall Study|Lost to Follow-up|0|||
44548028|NCT04634409|79562835|FG022|Overall Study|Lost to Follow-up|0|||
44548029|NCT04634409|79562836|FG023|Overall Study|Lost to Follow-up|0|||
44548030|NCT04634409|79562837|FG024|Overall Study|Lost to Follow-up|0|||
44548031|NCT04634409|79562838|FG025|Overall Study|Lost to Follow-up|0|||
44548032|NCT04634409|79562839|FG026|Overall Study|Lost to Follow-up|0|||
44548033|NCT04634409|79562813|FG000|Overall Study|Withdrawal by Subject|3|||
44548034|NCT04634409|79562814|FG001|Overall Study|Withdrawal by Subject|1|||
44548035|NCT04634409|79562815|FG002|Overall Study|Withdrawal by Subject|6|||
44548036|NCT04634409|79562816|FG003|Overall Study|Withdrawal by Subject|4|||
44548037|NCT04634409|79562817|FG004|Overall Study|Withdrawal by Subject|2|||
44548038|NCT04634409|79562818|FG005|Overall Study|Withdrawal by Subject|0|||
44548039|NCT04634409|79562819|FG006|Overall Study|Withdrawal by Subject|0|||
44548040|NCT04634409|79562820|FG007|Overall Study|Withdrawal by Subject|2|||
44548041|NCT04634409|79562821|FG008|Overall Study|Withdrawal by Subject|3|||
44548042|NCT04634409|79562822|FG009|Overall Study|Withdrawal by Subject|2|||
44548043|NCT04634409|79562823|FG010|Overall Study|Withdrawal by Subject|3|||
44548044|NCT04634409|79562824|FG011|Overall Study|Withdrawal by Subject|2|||
44548045|NCT04634409|79562825|FG012|Overall Study|Withdrawal by Subject|2|||
44548046|NCT04634409|79562826|FG013|Overall Study|Withdrawal by Subject|1|||
44548047|NCT04634409|79562827|FG014|Overall Study|Withdrawal by Subject|5|||
44548048|NCT04634409|79562828|FG015|Overall Study|Withdrawal by Subject|0|||
44548049|NCT04634409|79562829|FG016|Overall Study|Withdrawal by Subject|0|||
44548050|NCT04634409|79562830|FG017|Overall Study|Withdrawal by Subject|1|||
44548051|NCT04634409|79562831|FG018|Overall Study|Withdrawal by Subject|0|||
44548052|NCT04634409|79562832|FG019|Overall Study|Withdrawal by Subject|0|||
44548053|NCT04634409|79562833|FG020|Overall Study|Withdrawal by Subject|0|||
44548054|NCT04634409|79562834|FG021|Overall Study|Withdrawal by Subject|0|||
44548055|NCT04634409|79562835|FG022|Overall Study|Withdrawal by Subject|0|||
44548056|NCT04634409|79562836|FG023|Overall Study|Withdrawal by Subject|1|||
44548057|NCT04634409|79562837|FG024|Overall Study|Withdrawal by Subject|0|||
44548058|NCT04634409|79562838|FG025|Overall Study|Withdrawal by Subject|0|||
44548059|NCT04634409|79562839|FG026|Overall Study|Withdrawal by Subject|0|||
44548060|NCT04634409|79562813|FG000|Overall Study|Other - As reported by Investigator|1|||
44548061|NCT04634409|79562814|FG001|Overall Study|Other - As reported by Investigator|0|||
44548062|NCT04634409|79562815|FG002|Overall Study|Other - As reported by Investigator|0|||
44548063|NCT04634409|79562816|FG003|Overall Study|Other - As reported by Investigator|0|||
44548064|NCT04634409|79562817|FG004|Overall Study|Other - As reported by Investigator|0|||
44548065|NCT04634409|79562818|FG005|Overall Study|Other - As reported by Investigator|0|||
44548066|NCT04634409|79562819|FG006|Overall Study|Other - As reported by Investigator|0|||
44548067|NCT04634409|79562820|FG007|Overall Study|Other - As reported by Investigator|6|||
44230125|NCT01543087|79038390|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
44493963|NCT00418379|79499818|FG002|Year 2|Any other reason not above-mentioned|6|||
44493964|NCT00418379|79499816|FG000|Year 3|Withdrawal by Subject|1|||
44493965|NCT00418379|79499817|FG001|Year 3|Withdrawal by Subject|1|||
44493966|NCT00418379|79499818|FG002|Year 3|Withdrawal by Subject|2|||
44493967|NCT00418379|79499816|FG000|Year 3|Any other reason not above-mentioned|2|||
44493968|NCT00418379|79499817|FG001|Year 3|Any other reason not above-mentioned|1|||
44493969|NCT00418379|79499818|FG002|Year 3|Any other reason not above-mentioned|1|||
44493970|NCT00418379|79499816|FG000|Year 4|Adverse Event|0|||
44493971|NCT00418379|79499817|FG001|Year 4|Adverse Event|1|||
44548068|NCT04634409|79562821|FG008|Overall Study|Other - As reported by Investigator|4|||
44548069|NCT04634409|79562822|FG009|Overall Study|Other - As reported by Investigator|0|||
44548070|NCT04634409|79562823|FG010|Overall Study|Other - As reported by Investigator|1|||
44548071|NCT04634409|79562824|FG011|Overall Study|Other - As reported by Investigator|2|||
44548072|NCT04634409|79562825|FG012|Overall Study|Other - As reported by Investigator|2|||
44548073|NCT04634409|79562826|FG013|Overall Study|Other - As reported by Investigator|1|||
44493972|NCT00418379|79499818|FG002|Year 4|Adverse Event|0|||
44493973|NCT00418379|79499816|FG000|Year 4|Withdrawal by Subject|2|||
44376461|NCT01076036|79381585|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
44493974|NCT00418379|79499817|FG001|Year 4|Withdrawal by Subject|3|||
44548074|NCT04634409|79562827|FG014|Overall Study|Other - As reported by Investigator|0|||
44548075|NCT04634409|79562828|FG015|Overall Study|Other - As reported by Investigator|0|||
44548076|NCT04634409|79562829|FG016|Overall Study|Other - As reported by Investigator|0|||
44548077|NCT04634409|79562830|FG017|Overall Study|Other - As reported by Investigator|0|||
44548078|NCT04634409|79562831|FG018|Overall Study|Other - As reported by Investigator|0|||
44548079|NCT04634409|79562832|FG019|Overall Study|Other - As reported by Investigator|0|||
44548080|NCT04634409|79562833|FG020|Overall Study|Other - As reported by Investigator|0|||
44548081|NCT04634409|79562834|FG021|Overall Study|Other - As reported by Investigator|0|||
44548082|NCT04634409|79562835|FG022|Overall Study|Other - As reported by Investigator|0|||
44548083|NCT04634409|79562836|FG023|Overall Study|Other - As reported by Investigator|0|||
44548084|NCT04634409|79562837|FG024|Overall Study|Other - As reported by Investigator|0|||
44548085|NCT04634409|79562838|FG025|Overall Study|Other - As reported by Investigator|0|||
44548086|NCT04634409|79562839|FG026|Overall Study|Other - As reported by Investigator|0|||
44548087|NCT00005780|79562917|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
44548088|NCT01978938|79562926|FG000|Overall Study|Lost to Follow-up|12|||
44548089|NCT01978938|79562927|FG001|Overall Study|Lost to Follow-up|6|||
44548090|NCT01978938|79562926|FG000|Overall Study|Withdrawal by Subject|8|||
44548091|NCT01978938|79562927|FG001|Overall Study|Withdrawal by Subject|4|||
44548092|NCT01978938|79562926|FG000|Overall Study|Adverse Event, non-fatal|2|||
44548093|NCT01978938|79562927|FG001|Overall Study|Adverse Event, non-fatal|1|||
44548094|NCT01978938|79562926|FG000|Overall Study|Participant noncompliance|1|||
44548095|NCT01978938|79562927|FG001|Overall Study|Participant noncompliance|1|||
44548096|NCT01978938|79562926|FG000|Overall Study|Did not meet inclusion criteria|0|||
44548097|NCT01978938|79562927|FG001|Overall Study|Did not meet inclusion criteria|1|||
44548098|NCT01978938|79562926|FG000|Overall Study|Previously scheduled procedure|0|||
44548099|NCT01978938|79562927|FG001|Overall Study|Previously scheduled procedure|1|||
44548100|NCT03041090|79562935|FG000|Overall Study|technical error|0|||
44548101|NCT03041090|79562936|FG001|Overall Study|technical error|3|||
44548102|NCT00116142|79562944|FG000|Overall Study|Adverse Event|8|||
44548103|NCT00116142|79562945|FG001|Overall Study|Adverse Event|7|||
44548104|NCT00116142|79562944|FG000|Overall Study|Protocol Violation|2|||
44548105|NCT00116142|79562945|FG001|Overall Study|Protocol Violation|1|||
44548106|NCT00116142|79562944|FG000|Overall Study|Withdrawal by Subject|5|||
44548107|NCT00116142|79562945|FG001|Overall Study|Withdrawal by Subject|5|||
44548108|NCT00116142|79562944|FG000|Overall Study|Physician Decision|3|||
44548109|NCT00116142|79562945|FG001|Overall Study|Physician Decision|1|||
44548110|NCT00116142|79562944|FG000|Overall Study|Delayed Radiation Therapy|1|||
44548111|NCT00116142|79562945|FG001|Overall Study|Delayed Radiation Therapy|0|||
44548112|NCT00116142|79562944|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
44548113|NCT00116142|79562945|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
44548114|NCT00116142|79562944|FG000|Overall Study|Patient stopped due to depression|0|||
44548115|NCT00116142|79562945|FG001|Overall Study|Patient stopped due to depression|1|||
44548116|NCT00116142|79562944|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
44548117|NCT00116142|79562945|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
44493975|NCT00418379|79499818|FG002|Year 4|Withdrawal by Subject|2|||
44493976|NCT00418379|79499816|FG000|Year 4|Any other reason not above-mentioned|1|||
44493977|NCT00418379|79499817|FG001|Year 4|Any other reason not above-mentioned|1|||
44493978|NCT00418379|79499818|FG002|Year 4|Any other reason not above-mentioned|0|||
44493979|NCT00418379|79499816|FG000|Year 5|Adverse Event|0|||
44493980|NCT00418379|79499817|FG001|Year 5|Adverse Event|1|||
44493981|NCT00418379|79499818|FG002|Year 5|Adverse Event|0|||
44493982|NCT00418379|79499816|FG000|Year 5|Any other reason not above-mentioned|2|||
44493983|NCT00418379|79499817|FG001|Year 5|Any other reason not above-mentioned|4|||
44493984|NCT00418379|79499818|FG002|Year 5|Any other reason not above-mentioned|3|||
44548118|NCT00116142|79562944|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
44548119|NCT00116142|79562945|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
44548120|NCT00116142|79562944|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
44548121|NCT00116142|79562945|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
44548122|NCT03135522|79562956|FG000|Overall Study|Adverse Event|1|||
44548123|NCT03135522|79562957|FG001|Overall Study|Adverse Event|0|||
44548124|NCT02875080|79562980|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
44376462|NCT01075958|79381589|FG000|Overall Study|Blood sample could not be obtained|44|||
44548125|NCT02875080|79562981|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
44376463|NCT01096316|79381595|FG000|Overall Study|Lost to Follow-up|15|||
44493985|NCT00418145|79499826|FG000|Overall Study|study terminated|6|||
44493986|NCT00417989|79499834|FG000|Overall Study|Withdrawal by Subject|13|||
44548126|NCT02875080|79562982|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
44548127|NCT03129360|79562993|FG000|Overall Study|Did not meet entry criteria|0|||
44548128|NCT03129360|79562994|FG001|Overall Study|Did not meet entry criteria|2|||
44548129|NCT03129360|79562995|FG002|Overall Study|Did not meet entry criteria|1|||
44548130|NCT03129360|79562993|FG000|Overall Study|Excluded due to motion in scanner|1|||
44548131|NCT03129360|79562994|FG001|Overall Study|Excluded due to motion in scanner|0|||
44548132|NCT03129360|79562995|FG002|Overall Study|Excluded due to motion in scanner|0|||
44548133|NCT03165045|79563003|FG000|Visit 1|No registration after visit 1|9|||
44548134|NCT03165045|79563003|FG000|Visit 1|No treatment documented|10|||
44548135|NCT03165045|79563003|FG000|Visit 1|No visit 1|10|||
44548136|NCT03165045|79563003|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
44548137|NCT03165045|79563003|FG000|Visit 2|No available total CCQ score at all|29|||
44548138|NCT03165045|79563003|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
44548139|NCT01928199|79563011|FG000|Overall Study|Lost to Follow-up|2|||
44548140|NCT01928199|79563012|FG001|Overall Study|Lost to Follow-up|1|||
44548141|NCT01928199|79563011|FG000|Overall Study|Withdrawal by Subject|3|||
44548142|NCT01928199|79563012|FG001|Overall Study|Withdrawal by Subject|5|||
44548143|NCT03128892|79563018|FG000|Overall Study|Withdrawal by Subject|2|||
44548144|NCT03128892|79563018|FG000|Overall Study|Physician Decision|1|||
44548145|NCT03039686|79563034|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
44548146|NCT03039686|79563035|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
44548147|NCT03039686|79563036|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
44548148|NCT03039686|79563034|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
44548149|NCT03039686|79563035|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
44548150|NCT03039686|79563036|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
44548151|NCT03039686|79563034|FG000|Double-blind Period|Withdrawal by Subject|2|||
44548152|NCT03039686|79563035|FG001|Double-blind Period|Withdrawal by Subject|2|||
44548153|NCT03039686|79563036|FG002|Double-blind Period|Withdrawal by Subject|1|||
44548154|NCT03039686|79563034|FG000|Double-blind Period|Death|0|||
44548155|NCT03039686|79563035|FG001|Double-blind Period|Death|0|||
44548156|NCT03039686|79563036|FG002|Double-blind Period|Death|1|||
44548157|NCT03039686|79563034|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
44548158|NCT03039686|79563035|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
44548159|NCT03039686|79563036|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
44548160|NCT03039686|79563034|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
44548161|NCT03039686|79563035|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
44548162|NCT03039686|79563036|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
44548163|NCT03039686|79563034|FG000|Open Label Period|Withdrawal by Subject|0|||
44548164|NCT03039686|79563035|FG001|Open Label Period|Withdrawal by Subject|3|||
44548165|NCT03039686|79563036|FG002|Open Label Period|Withdrawal by Subject|1|||
44548166|NCT01822275|79563054|FG000|Overall Study|Withdrawal by Subject|3|||
44548167|NCT01822275|79563054|FG000|Overall Study|Adverse Event|3|||
44548168|NCT01822275|79563054|FG000|Overall Study|Progression|14|||
44548169|NCT01822275|79563054|FG000|Overall Study|Physician Decision|2|||
44548170|NCT01656434|79563066|FG000|Overall Study|Adverse Event|199|||
44548171|NCT01656434|79563067|FG001|Overall Study|Adverse Event|63|||
44548172|NCT01656434|79563066|FG000|Overall Study|Enrollment terminated at trial site|2|||
44548173|NCT01656434|79563067|FG001|Overall Study|Enrollment terminated at trial site|0|||
44493987|NCT00417989|79499835|FG001|Overall Study|Withdrawal by Subject|13|||
44493988|NCT00417989|79499834|FG000|Overall Study|Lost to Follow-up|1|||
44493989|NCT00417989|79499835|FG001|Overall Study|Lost to Follow-up|6|||
44493990|NCT00417989|79499834|FG000|Overall Study|Protocol Violation|1|||
44493991|NCT00417989|79499835|FG001|Overall Study|Protocol Violation|0|||
44493992|NCT00417989|79499834|FG000|Overall Study|Death|0|||
44493993|NCT00417989|79499835|FG001|Overall Study|Death|1|||
44493994|NCT00417989|79499834|FG000|Overall Study|Physician Decision|5|||
44493995|NCT00417989|79499835|FG001|Overall Study|Physician Decision|2|||
44493996|NCT00412217|79499845|FG000|Overall Study|Insufficient Data Available|8|||
44493997|NCT00412217|79499846|FG001|Overall Study|Insufficient Data Available|3|||
44493998|NCT00412217|79499845|FG000|Overall Study|Death|5|||
44493999|NCT00412217|79499846|FG001|Overall Study|Death|4|||
44494000|NCT00412217|79499845|FG000|Overall Study|Disease Progression|2|||
44494001|NCT00412217|79499846|FG001|Overall Study|Disease Progression|3|||
44494002|NCT00412217|79499845|FG000|Overall Study|Investigator Decision|1|||
44548174|NCT01656434|79563066|FG000|Overall Study|Lost to Follow-up|309|||
44548175|NCT01656434|79563067|FG001|Overall Study|Lost to Follow-up|76|||
44548176|NCT01656434|79563066|FG000|Overall Study|Site discontinued study participation|24|||
44494003|NCT00412217|79499846|FG001|Overall Study|Investigator Decision|0|||
44494004|NCT00412217|79499845|FG000|Overall Study|Withdrawal by Subject|2|||
44548177|NCT01656434|79563067|FG001|Overall Study|Site discontinued study participation|9|||
44376464|NCT01096316|79381596|FG001|Overall Study|Lost to Follow-up|9|||
44494005|NCT00412217|79499846|FG001|Overall Study|Withdrawal by Subject|0|||
44494006|NCT00412217|79499845|FG000|Overall Study|Lost to Follow-up|1|||
44494007|NCT00412217|79499846|FG001|Overall Study|Lost to Follow-up|4|||
44230126|NCT01543087|79038391|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
44230127|NCT01543087|79038392|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
44230128|NCT01543087|79038393|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
44230129|NCT01543087|79038394|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
44230130|NCT01543087|79038389|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
44548178|NCT01656434|79563066|FG000|Overall Study|Screen failure|2|||
44230131|NCT01543087|79038390|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
44230132|NCT01543087|79038391|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
44230133|NCT01543087|79038392|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
44230134|NCT01543087|79038393|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
44230135|NCT01543087|79038394|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
44230136|NCT01543087|79038389|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
44230137|NCT01543087|79038390|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
44230138|NCT01543087|79038391|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
44230139|NCT01543087|79038392|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
44230140|NCT01543087|79038393|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
44230141|NCT01543087|79038394|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
44230142|NCT01543087|79038389|FG000|Stage 1 (48 Months)|Other than specified|5|||
44230143|NCT01543087|79038390|FG001|Stage 1 (48 Months)|Other than specified|0|||
44230144|NCT01543087|79038391|FG002|Stage 1 (48 Months)|Other than specified|9|||
44230145|NCT01543087|79038392|FG003|Stage 1 (48 Months)|Other than specified|0|||
44230146|NCT01543087|79038393|FG004|Stage 1 (48 Months)|Other than specified|0|||
44230147|NCT01543087|79038394|FG005|Stage 1 (48 Months)|Other than specified|0|||
44230148|NCT01543087|79038389|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
44230149|NCT01543087|79038390|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
44230150|NCT01543087|79038391|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
44230151|NCT01543087|79038392|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
44230152|NCT01543087|79038393|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
44230153|NCT01543087|79038394|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
44230154|NCT01543087|79038389|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
44230155|NCT01543087|79038390|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
44230156|NCT01543087|79038391|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
44230157|NCT01543087|79038392|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
44230158|NCT01543087|79038393|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
44494008|NCT00412217|79499845|FG000|Overall Study|Study Terminated by Sponsor|26|||
44494009|NCT00412217|79499846|FG001|Overall Study|Study Terminated by Sponsor|33|||
44494010|NCT00412217|79499845|FG000|Overall Study|Other|1|||
44494011|NCT00412217|79499846|FG001|Overall Study|Other|1|||
44494012|NCT05000164|79499852|FG000|Overall Study|Adverse Event|1|||
44494013|NCT05000164|79499852|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
44494014|NCT05000164|79499852|FG000|Overall Study|Lens Discomfort|3|||
44494015|NCT05000164|79499852|FG000|Overall Study|Withdrew Consent during Study|2|||
44494016|NCT05000164|79499852|FG000|Overall Study|Subject Withdrawn by PI|2|||
44494017|NCT05000164|79499852|FG000|Overall Study|Other Fractured Test Article|1|||
44494018|NCT00123474|79499860|FG000|Randomized to Treatment|Randomized, never treated|1|||
44494019|NCT00123474|79499861|FG001|Randomized to Treatment|Randomized, never treated|4|||
44494020|NCT00123474|79499862|FG002|Randomized to Treatment|Randomized, never treated|2|||
44494021|NCT00123474|79499863|FG003|Randomized to Treatment|Randomized, never treated|1|||
44494022|NCT00123474|79499860|FG000|As Treated at Study Closure|not reported when site closed|1|||
44494023|NCT00123474|79499861|FG001|As Treated at Study Closure|not reported when site closed|0|||
44494024|NCT00123474|79499862|FG002|As Treated at Study Closure|not reported when site closed|1|||
44494025|NCT00123474|79499863|FG003|As Treated at Study Closure|not reported when site closed|0|||
44494026|NCT00123474|79499860|FG000|As Treated at Study Closure|Adverse Event|10|||
44494027|NCT00123474|79499861|FG001|As Treated at Study Closure|Adverse Event|4|||
44494028|NCT00123474|79499862|FG002|As Treated at Study Closure|Adverse Event|10|||
44494029|NCT00123474|79499863|FG003|As Treated at Study Closure|Adverse Event|8|||
44494030|NCT00123474|79499860|FG000|As Treated at Study Closure|Disease Progression|35|||
44494031|NCT00123474|79499861|FG001|As Treated at Study Closure|Disease Progression|42|||
44548179|NCT01656434|79563067|FG001|Overall Study|Screen failure|0|||
44548180|NCT01656434|79563066|FG000|Overall Study|Protocol Violation|7|||
44230159|NCT01543087|79038394|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
44230160|NCT01543087|79038389|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
44230161|NCT01543087|79038390|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
44494032|NCT00123474|79499862|FG002|As Treated at Study Closure|Disease Progression|29|||
44494033|NCT00123474|79499863|FG003|As Treated at Study Closure|Disease Progression|27|||
44548181|NCT01656434|79563067|FG001|Overall Study|Protocol Violation|0|||
44548182|NCT01656434|79563066|FG000|Overall Study|Pregnancy wish|18|||
44230162|NCT01543087|79038391|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
44230163|NCT01543087|79038392|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
44230164|NCT01543087|79038393|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
44494034|NCT00123474|79499860|FG000|As Treated at Study Closure|Investigator Request|12|||
44494035|NCT00123474|79499861|FG001|As Treated at Study Closure|Investigator Request|6|||
44548183|NCT01656434|79563067|FG001|Overall Study|Pregnancy wish|6|||
44548184|NCT01656434|79563066|FG000|Overall Study|Pregnancy|45|||
44548185|NCT01656434|79563067|FG001|Overall Study|Pregnancy|10|||
44548186|NCT01656434|79563066|FG000|Overall Study|Physician Decision|7|||
44548187|NCT01656434|79563067|FG001|Overall Study|Physician Decision|2|||
44548188|NCT01656434|79563066|FG000|Overall Study|Non-compliance with study drug|48|||
44548189|NCT01656434|79563067|FG001|Overall Study|Non-compliance with study drug|9|||
44548190|NCT01656434|79563066|FG000|Overall Study|Study terminated by sponsor|1501|||
44548191|NCT01656434|79563067|FG001|Overall Study|Study terminated by sponsor|348|||
44548192|NCT01656434|79563066|FG000|Overall Study|Participant discontinued; drug related|13|||
44548193|NCT01656434|79563067|FG001|Overall Study|Participant discontinued; drug related|4|||
44548194|NCT01656434|79563066|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
44548195|NCT01656434|79563067|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
44548196|NCT01656434|79563066|FG000|Overall Study|Non-compliance with protocol|39|||
44548197|NCT01656434|79563067|FG001|Overall Study|Non-compliance with protocol|15|||
44548198|NCT01656434|79563066|FG000|Overall Study|Participant moved|40|||
44548199|NCT01656434|79563067|FG001|Overall Study|Participant moved|12|||
44548200|NCT01656434|79563066|FG000|Overall Study|Participant withdrew consent|28|||
44548201|NCT01656434|79563067|FG001|Overall Study|Participant withdrew consent|9|||
44494036|NCT00123474|79499862|FG002|As Treated at Study Closure|Investigator Request|7|||
44494037|NCT00123474|79499863|FG003|As Treated at Study Closure|Investigator Request|5|||
44494038|NCT00123474|79499860|FG000|As Treated at Study Closure|non-specified|54|||
44548202|NCT01656434|79563066|FG000|Overall Study|Withdrawal by Subject|64|||
44548203|NCT01656434|79563067|FG001|Overall Study|Withdrawal by Subject|7|||
44548204|NCT02931396|79563075|FG000|Overall Study|Lost to Follow-up|3|||
44548205|NCT02931396|79563076|FG001|Overall Study|Lost to Follow-up|0|||
44548206|NCT02931396|79563075|FG000|Overall Study|Withdrawal by Subject|2|||
44548207|NCT02931396|79563076|FG001|Overall Study|Withdrawal by Subject|0|||
44548208|NCT03037580|79563084|FG000|Overall Study|Withdrawal by Subject|3|||
44548209|NCT03037580|79563085|FG001|Overall Study|Withdrawal by Subject|0|||
44548210|NCT03037580|79563084|FG000|Overall Study|Adverse Event|1|||
44548211|NCT03037580|79563085|FG001|Overall Study|Adverse Event|0|||
44548212|NCT03037580|79563084|FG000|Overall Study|Study Terminated by Sponsor|12|||
44548213|NCT03037580|79563085|FG001|Overall Study|Study Terminated by Sponsor|15|||
44548214|NCT03037580|79563084|FG000|Overall Study|Death|0|||
44548215|NCT03037580|79563085|FG001|Overall Study|Death|1|||
44548216|NCT00897104|79563094|FG000|Overall Study|Lost to Follow-up|12|||
44548217|NCT00897104|79563095|FG001|Overall Study|Lost to Follow-up|17|||
44548218|NCT00897104|79563096|FG002|Overall Study|Lost to Follow-up|2|||
44548219|NCT00897104|79563094|FG000|Overall Study|Pregnancy|0|||
44548220|NCT00897104|79563095|FG001|Overall Study|Pregnancy|1|||
44548221|NCT00897104|79563096|FG002|Overall Study|Pregnancy|0|||
44548222|NCT00897104|79563094|FG000|Overall Study|Protocol Violation|0|||
44548223|NCT00897104|79563095|FG001|Overall Study|Protocol Violation|1|||
44548224|NCT00897104|79563096|FG002|Overall Study|Protocol Violation|0|||
44548225|NCT00897104|79563094|FG000|Overall Study|Withdrawal by Subject|23|||
44548226|NCT00897104|79563095|FG001|Overall Study|Withdrawal by Subject|27|||
44548227|NCT00897104|79563096|FG002|Overall Study|Withdrawal by Subject|3|||
44548228|NCT00897104|79563094|FG000|Overall Study|Abnormal Prestudy Labs|2|||
44548229|NCT00897104|79563095|FG001|Overall Study|Abnormal Prestudy Labs|0|||
44548230|NCT00897104|79563096|FG002|Overall Study|Abnormal Prestudy Labs|0|||
44548231|NCT00897104|79563094|FG000|Overall Study|Abnormal Baseline ECG|2|||
44494039|NCT00123474|79499861|FG001|As Treated at Study Closure|non-specified|47|||
44494040|NCT00123474|79499862|FG002|As Treated at Study Closure|non-specified|57|||
44548232|NCT00897104|79563095|FG001|Overall Study|Abnormal Baseline ECG|2|||
44548233|NCT00897104|79563096|FG002|Overall Study|Abnormal Baseline ECG|0|||
44548234|NCT00897104|79563094|FG000|Overall Study|Need for Concom. Med.|0|||
44548235|NCT00897104|79563095|FG001|Overall Study|Need for Concom. Med.|1|||
44548236|NCT00897104|79563096|FG002|Overall Study|Need for Concom. Med.|1|||
44548237|NCT00897104|79563094|FG000|Overall Study|Lack of Migraine Attack|20|||
44548238|NCT00897104|79563095|FG001|Overall Study|Lack of Migraine Attack|22|||
44548239|NCT00897104|79563096|FG002|Overall Study|Lack of Migraine Attack|1|||
44548240|NCT00897104|79563094|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
44548241|NCT00897104|79563095|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44548242|NCT00897104|79563096|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44548243|NCT00897104|79563094|FG000|Overall Study|Other|3|||
44494041|NCT00123474|79499863|FG003|As Treated at Study Closure|non-specified|60|||
44230165|NCT01543087|79038394|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
44548244|NCT00897104|79563095|FG001|Overall Study|Other|0|||
44548245|NCT00897104|79563096|FG002|Overall Study|Other|0|||
44548246|NCT00897104|79563094|FG000|Overall Study|Protocol Violation|1|||
44548247|NCT00897104|79563095|FG001|Overall Study|Protocol Violation|0|||
44548248|NCT00897104|79563096|FG002|Overall Study|Protocol Violation|0|||
44548249|NCT00897104|79563094|FG000|Overall Study|Withdrawal by Subject|0|||
44548250|NCT00897104|79563095|FG001|Overall Study|Withdrawal by Subject|0|||
44548251|NCT00897104|79563096|FG002|Overall Study|Withdrawal by Subject|1|||
44548252|NCT01339689|79563106|FG000|Overall Study|Adverse Event|1|||
44548253|NCT01339689|79563107|FG001|Overall Study|Adverse Event|2|||
44548254|NCT01339689|79563106|FG000|Overall Study|Lost to Follow-up|9|||
44548255|NCT01339689|79563107|FG001|Overall Study|Lost to Follow-up|3|||
44548256|NCT01339689|79563106|FG000|Overall Study|Withdrawal by Subject|3|||
44548257|NCT01339689|79563107|FG001|Overall Study|Withdrawal by Subject|0|||
44548258|NCT01339689|79563106|FG000|Overall Study|Noncompliance|1|||
44548259|NCT01339689|79563107|FG001|Overall Study|Noncompliance|0|||
44548260|NCT01339689|79563106|FG000|Overall Study|Relocated out of area|0|||
44548261|NCT01339689|79563107|FG001|Overall Study|Relocated out of area|1|||
44548262|NCT01339689|79563106|FG000|Overall Study|Other|2|||
44548263|NCT01339689|79563107|FG001|Overall Study|Other|2|||
44548264|NCT01339689|79563106|FG000|Overall Study|multiple reasons|1|||
44548265|NCT01339689|79563107|FG001|Overall Study|multiple reasons|1|||
44548266|NCT03038126|79563115|FG000|Overall Study|Death|1|||
44548267|NCT03038126|79563116|FG001|Overall Study|Death|1|||
44548268|NCT03038126|79563115|FG000|Overall Study|Withdrawal by Subject|5|||
44548269|NCT03038126|79563116|FG001|Overall Study|Withdrawal by Subject|0|||
44548270|NCT03038126|79563115|FG000|Overall Study|Lost to Follow-up|0|||
44548271|NCT03038126|79563116|FG001|Overall Study|Lost to Follow-up|1|||
44548272|NCT03038126|79563115|FG000|Overall Study|Long Term Hospitalization|2|||
44548273|NCT03038126|79563116|FG001|Overall Study|Long Term Hospitalization|0|||
44548274|NCT03038126|79563115|FG000|Overall Study|Too Ill to Participate|1|||
44548275|NCT03038126|79563116|FG001|Overall Study|Too Ill to Participate|2|||
44548276|NCT00696878|79563122|FG000|Overall Study|Adverse Event|8|||
44548277|NCT00696878|79563122|FG000|Overall Study|Withdrawal by Subject|87|||
44548278|NCT00696878|79563122|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
44548279|NCT00696878|79563122|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
44548280|NCT00696878|79563122|FG000|Overall Study|Trial stopped|32|||
44548281|NCT00696878|79563122|FG000|Overall Study|Other reason (not specified)|55|||
44548282|NCT00696800|79563128|FG000|Overall Study|Adverse Event|16|||
44548283|NCT00696800|79563129|FG001|Overall Study|Adverse Event|3|||
44548284|NCT00696800|79563128|FG000|Overall Study|Insufficient compliance with medication|2|||
44548285|NCT00696800|79563129|FG001|Overall Study|Insufficient compliance with medication|1|||
44548286|NCT00696800|79563128|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
44548287|NCT00696800|79563129|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
44548288|NCT00696800|79563128|FG000|Overall Study|Insufficient ovarian response|4|||
44548289|NCT00696800|79563129|FG001|Overall Study|Insufficient ovarian response|1|||
44548290|NCT00696800|79563128|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
44548291|NCT00696800|79563129|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
44548292|NCT00696800|79563128|FG000|Overall Study|Too high ovarian response|6|||
44548293|NCT00696800|79563129|FG001|Overall Study|Too high ovarian response|1|||
44548294|NCT00696800|79563128|FG000|Overall Study|No/too few/bad quality oocytes|4|||
44548295|NCT00696800|79563129|FG001|Overall Study|No/too few/bad quality oocytes|3|||
44548296|NCT00696800|79563128|FG000|Overall Study|No/abnormal fertilization|11|||
44548297|NCT00696800|79563129|FG001|Overall Study|No/abnormal fertilization|13|||
44548298|NCT00696800|79563128|FG000|Overall Study|No/too few/bad quality embryos|24|||
44548299|NCT00696800|79563129|FG001|Overall Study|No/too few/bad quality embryos|18|||
44548300|NCT00696800|79563128|FG000|Overall Study|Other Reasons|5|||
44548301|NCT00696800|79563129|FG001|Overall Study|Other Reasons|3|||
44548302|NCT00696800|79563128|FG000|Overall Study|Not treated|1|||
44548303|NCT00696800|79563129|FG001|Overall Study|Not treated|2|||
44548304|NCT00289874|79563137|FG000|Overall Study|Adverse Event|1|||
44548305|NCT00289874|79563138|FG001|Overall Study|Adverse Event|5|||
44230166|NCT01696058|79038432|FG000|Overall Study|Adverse Event|21|||
44230167|NCT01696058|79038433|FG001|Overall Study|Adverse Event|11|||
44230168|NCT01696058|79038432|FG000|Overall Study|Lack of Efficacy|2|||
44230169|NCT01696058|79038433|FG001|Overall Study|Lack of Efficacy|3|||
44230170|NCT01696058|79038432|FG000|Overall Study|Protocol Violation|9|||
44548306|NCT00289874|79563137|FG000|Overall Study|Lost to Follow-up|1|||
44548307|NCT00289874|79563138|FG001|Overall Study|Lost to Follow-up|1|||
44548308|NCT00289874|79563137|FG000|Overall Study|Protocol Violation|3|||
44548309|NCT00289874|79563138|FG001|Overall Study|Protocol Violation|2|||
44548310|NCT00289874|79563137|FG000|Overall Study|Did not meet eligibility|1|||
44548311|NCT00289874|79563138|FG001|Overall Study|Did not meet eligibility|0|||
44376465|NCT00925548|79381604|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
44376466|NCT00925548|79381605|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
44376467|NCT00866788|79381616|FG000|Overall Study|Adverse Event|0|||
44376468|NCT00866788|79381617|FG001|Overall Study|Adverse Event|2|||
44548312|NCT00245570|79563144|FG000|Washout Between Periods III and IV|Adverse Event|0|||
44548313|NCT00245570|79563145|FG001|Washout Between Periods III and IV|Adverse Event|1|||
44548314|NCT00245570|79563146|FG002|Washout Between Periods III and IV|Adverse Event|0|||
44548315|NCT00245570|79563147|FG003|Washout Between Periods III and IV|Adverse Event|0|||
44548316|NCT00245570|79563148|FG004|Washout Between Periods III and IV|Adverse Event|0|||
44548317|NCT00245570|79563149|FG005|Washout Between Periods III and IV|Adverse Event|0|||
44548318|NCT04638660|79563185|FG000|Overall Study|Withdrawal by Subject|2|||
44548319|NCT04638660|79563186|FG001|Overall Study|Withdrawal by Subject|0|||
44548320|NCT04638660|79563185|FG000|Overall Study|Lost to Follow-up|1|||
44548321|NCT04638660|79563186|FG001|Overall Study|Lost to Follow-up|0|||
44548322|NCT04367480|79563195|FG000|Overall Study|Adverse Event|1|||
44548323|NCT04367480|79563196|FG001|Overall Study|Adverse Event|1|||
44548324|NCT04367480|79563195|FG000|Overall Study|Death|1|||
44548325|NCT04367480|79563196|FG001|Overall Study|Death|0|||
44548326|NCT04367480|79563195|FG000|Overall Study|Lost to Follow-up|1|||
44548327|NCT04367480|79563196|FG001|Overall Study|Lost to Follow-up|1|||
44548328|NCT04367480|79563195|FG000|Overall Study|Withdrawal by Subject|0|||
44548329|NCT04367480|79563196|FG001|Overall Study|Withdrawal by Subject|3|||
44548330|NCT04367480|79563195|FG000|Overall Study|App glitch during the study|1|||
44548331|NCT04367480|79563196|FG001|Overall Study|App glitch during the study|0|||
44548332|NCT04367480|79563195|FG000|Overall Study|Device Distribution Error|0|||
44548333|NCT04367480|79563196|FG001|Overall Study|Device Distribution Error|2|||
44548334|NCT04367480|79563195|FG000|Overall Study|Ineligible after Randomization|0|||
44548335|NCT04367480|79563196|FG001|Overall Study|Ineligible after Randomization|1|||
44548336|NCT04367480|79563195|FG000|Overall Study|Other Medical Reasons|0|||
44548337|NCT04367480|79563196|FG001|Overall Study|Other Medical Reasons|2|||
44548338|NCT04137731|79563219|FG000|Overall Study|Surgery Cancellation|1|||
44548339|NCT04137731|79563220|FG001|Overall Study|Surgery Cancellation|2|||
44548340|NCT04137731|79563219|FG000|Overall Study|Withdrawal by Subject|2|||
44548341|NCT04137731|79563220|FG001|Overall Study|Withdrawal by Subject|0|||
44548342|NCT04137731|79563219|FG000|Overall Study|Protocol Violation|0|||
44548343|NCT04137731|79563220|FG001|Overall Study|Protocol Violation|1|||
44548344|NCT04088760|79563235|FG000|Overall Study|Physician Decision|1|||
44548345|NCT03813238|79563254|FG000|Overall Study|Adverse Event|0|||
44548346|NCT03813238|79563255|FG001|Overall Study|Adverse Event|6|||
44548347|NCT03813238|79563254|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44548348|NCT03813238|79563255|FG001|Overall Study|Withdrawal by parent/guardian|2|||
44548349|NCT03813238|79563254|FG000|Overall Study|Lost to Follow-up|0|||
44548350|NCT03813238|79563255|FG001|Overall Study|Lost to Follow-up|1|||
44548351|NCT03813238|79563254|FG000|Overall Study|Other than specified|1|||
44548352|NCT03813238|79563255|FG001|Overall Study|Other than specified|2|||
44548353|NCT03737240|79563263|FG000|Overall Study|Lost to Follow-up|16|||
44548354|NCT03737240|79563264|FG001|Overall Study|Lost to Follow-up|15|||
44548355|NCT03532178|79563272|FG000|First Period|Withdrawal by Subject|1|||
44548356|NCT03532178|79563273|FG001|First Period|Withdrawal by Subject|3|||
44548357|NCT03532178|79563272|FG000|First Period|technical issues in data collection Technical issues|0|||
44548358|NCT03532178|79563273|FG001|First Period|technical issues in data collection Technical issues|1|||
44548359|NCT03532178|79563272|FG000|Second Period|Withdrawal by Subject|1|||
44548360|NCT03532178|79563273|FG001|Second Period|Withdrawal by Subject|1|||
44548361|NCT03532178|79563272|FG000|Second Period|Technical issues|0|||
44548362|NCT03532178|79563273|FG001|Second Period|Technical issues|1|||
44548363|NCT03526549|79563281|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
44548364|NCT03526549|79563282|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
44548365|NCT03526549|79563281|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
44548366|NCT03526549|79563282|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
44548367|NCT03526549|79563281|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
44548368|NCT03526549|79563282|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
44548369|NCT03526549|79563281|FG000|Open-label Phase|Adverse Event|4|||
44548370|NCT03526549|79563282|FG001|Open-label Phase|Adverse Event|0|||
44548371|NCT03526549|79563281|FG000|Open-label Phase|Withdrawal by Subject|54|||
44548372|NCT03526549|79563282|FG001|Open-label Phase|Withdrawal by Subject|0|||
44548373|NCT03526549|79563281|FG000|Open-label Phase|Lost to Follow-up|35|||
44230171|NCT01696058|79038433|FG001|Overall Study|Protocol Violation|3|||
44230172|NCT01696058|79038432|FG000|Overall Study|Lost to Follow-up|2|||
44230173|NCT01696058|79038433|FG001|Overall Study|Lost to Follow-up|5|||
44548374|NCT03526549|79563282|FG001|Open-label Phase|Lost to Follow-up|0|||
44548375|NCT03526549|79563281|FG000|Open-label Phase|Other than Specified|5|||
44548376|NCT03526549|79563282|FG001|Open-label Phase|Other than Specified|0|||
44548377|NCT03449901|79563296|FG000|Overall Study|Progression|57|||
44548378|NCT03449901|79563297|FG001|Overall Study|Progression|12|||
44548379|NCT03449901|79563296|FG000|Overall Study|Adverse Event|3|||
44548380|NCT03449901|79563297|FG001|Overall Study|Adverse Event|0|||
44548381|NCT03449901|79563296|FG000|Overall Study|Death|6|||
44548382|NCT03449901|79563297|FG001|Overall Study|Death|2|||
44548383|NCT03449901|79563296|FG000|Overall Study|Withdrawal by Subject|12|||
44548384|NCT03449901|79563297|FG001|Overall Study|Withdrawal by Subject|1|||
44548385|NCT03449901|79563296|FG000|Overall Study|Physician Decision|1|||
44548386|NCT03449901|79563297|FG001|Overall Study|Physician Decision|0|||
44548387|NCT03449901|79563296|FG000|Overall Study|Patient elected for surgical intervention|1|||
44548388|NCT03449901|79563297|FG001|Overall Study|Patient elected for surgical intervention|0|||
44548389|NCT03449901|79563296|FG000|Overall Study|Patient off for other complicating disease|1|||
44548390|NCT03449901|79563297|FG001|Overall Study|Patient off for other complicating disease|0|||
44548391|NCT03435380|79563312|FG000|Overall Study|Death|1|||
44548392|NCT03435380|79563313|FG001|Overall Study|Death|2|||
44548393|NCT03435380|79563314|FG002|Overall Study|Death|1|||
44548394|NCT03435380|79563312|FG000|Overall Study|Lost to Follow-up|12|||
44548395|NCT03435380|79563313|FG001|Overall Study|Lost to Follow-up|8|||
44548396|NCT03435380|79563314|FG002|Overall Study|Lost to Follow-up|6|||
44548397|NCT03435380|79563312|FG000|Overall Study|Physician Decision|1|||
44230174|NCT01696058|79038432|FG000|Overall Study|Withdrawal by Subject|4|||
44230175|NCT01696058|79038433|FG001|Overall Study|Withdrawal by Subject|6|||
44230176|NCT01696058|79038432|FG000|Overall Study|Other reason prematurely discontinued|5|||
44376469|NCT00866788|79381618|FG002|Overall Study|Adverse Event|0|||
44376470|NCT00866788|79381619|FG003|Overall Study|Adverse Event|1|||
44230177|NCT01696058|79038433|FG001|Overall Study|Other reason prematurely discontinued|3|||
44376471|NCT00866788|79381616|FG000|Overall Study|Lost to Follow-up|1|||
44494042|NCT00123474|79499860|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
44494043|NCT00123474|79499861|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
44494044|NCT00123474|79499862|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
44494045|NCT00123474|79499863|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
44494046|NCT00123474|79499860|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
44494047|NCT00123474|79499861|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
44494048|NCT00123474|79499862|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
44494049|NCT00123474|79499863|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
44376472|NCT00866788|79381617|FG001|Overall Study|Lost to Follow-up|1|||
44494050|NCT00142298|79499904|FG000|Overall Study|Adverse Event|10|||
44494051|NCT00142298|79499905|FG001|Overall Study|Adverse Event|10|||
44494052|NCT00142298|79499906|FG002|Overall Study|Adverse Event|1|||
44548398|NCT03435380|79563313|FG001|Overall Study|Physician Decision|0|||
44548399|NCT03435380|79563314|FG002|Overall Study|Physician Decision|0|||
44548400|NCT03435380|79563312|FG000|Overall Study|Withdrawal by Subject|0|||
44548401|NCT03435380|79563313|FG001|Overall Study|Withdrawal by Subject|1|||
44548402|NCT03435380|79563314|FG002|Overall Study|Withdrawal by Subject|1|||
44494053|NCT00142298|79499907|FG003|Overall Study|Adverse Event|5|||
44494054|NCT00142298|79499908|FG004|Overall Study|Adverse Event|2|||
44494055|NCT00142298|79499909|FG005|Overall Study|Adverse Event|2|||
44494056|NCT00142298|79499910|FG006|Overall Study|Adverse Event|0|||
44494057|NCT00142298|79499911|FG007|Overall Study|Adverse Event|0|||
44494058|NCT00142298|79499912|FG008|Overall Study|Adverse Event|0|||
44494059|NCT00142298|79499913|FG009|Overall Study|Adverse Event|0|||
44494060|NCT00142298|79499904|FG000|Overall Study|Clinical disease progression|1|||
44494061|NCT00142298|79499905|FG001|Overall Study|Clinical disease progression|0|||
44494062|NCT00142298|79499906|FG002|Overall Study|Clinical disease progression|0|||
44494063|NCT00142298|79499907|FG003|Overall Study|Clinical disease progression|0|||
44494064|NCT00142298|79499908|FG004|Overall Study|Clinical disease progression|0|||
44494065|NCT00142298|79499909|FG005|Overall Study|Clinical disease progression|0|||
44548403|NCT03435380|79563312|FG000|Overall Study|Ineligible|0|||
44548404|NCT03435380|79563313|FG001|Overall Study|Ineligible|1|||
44548405|NCT03435380|79563314|FG002|Overall Study|Ineligible|1|||
44548406|NCT03363659|79563322|FG000|Overall Study|Adverse Event|1|||
44548407|NCT03363659|79563322|FG000|Overall Study|Screen fail|1|||
44548408|NCT03363659|79563322|FG000|Overall Study|Withdrawal by Subject|1|||
44548409|NCT03299166|79563328|FG000|Overall Study|Adverse Event|9|||
44548410|NCT03299166|79563329|FG001|Overall Study|Adverse Event|4|||
44548411|NCT03299166|79563328|FG000|Overall Study|Withdrawal by Subject|6|||
44548412|NCT03299166|79563329|FG001|Overall Study|Withdrawal by Subject|5|||
44548413|NCT03299166|79563328|FG000|Overall Study|Physician Decision|1|||
44548414|NCT03299166|79563329|FG001|Overall Study|Physician Decision|1|||
44548415|NCT03299166|79563328|FG000|Overall Study|Sponsor Decision|3|||
44548416|NCT03299166|79563329|FG001|Overall Study|Sponsor Decision|0|||
44548417|NCT03299166|79563328|FG000|Overall Study|Lost to Follow-up|2|||
44548418|NCT03299166|79563329|FG001|Overall Study|Lost to Follow-up|4|||
44548419|NCT03299166|79563328|FG000|Overall Study|Randomization Error|0|||
44548420|NCT03299166|79563329|FG001|Overall Study|Randomization Error|1|||
44548421|NCT03299166|79563328|FG000|Overall Study|Subject unable to return due to COVID|1|||
44548422|NCT03299166|79563329|FG001|Overall Study|Subject unable to return due to COVID|0|||
44548423|NCT03299166|79563328|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
44548424|NCT03299166|79563329|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
44548425|NCT03204812|79563335|FG000|Overall Study|Adverse Event|3|||
44548426|NCT03201250|79563342|FG000|Overall Study|screen failures|3|||
44548427|NCT03201250|79563343|FG001|Overall Study|screen failures|0|||
44548428|NCT03201250|79563344|FG002|Overall Study|screen failures|0|||
44548429|NCT03149029|79563355|FG000|Overall Study|Adverse Event|2|||
44230178|NCT01695746|79038439|FG000|Overall Study|Adverse Event|1|||
44230179|NCT01695746|79038439|FG000|Overall Study|Non-compliance by the participant|3|||
44230180|NCT01695746|79038439|FG000|Overall Study|Protocol Violation|5|||
44230181|NCT01695746|79038439|FG000|Overall Study|Participant not willing to participate|3|||
44548430|NCT03149029|79563356|FG001|Overall Study|Adverse Event|0|||
44548431|NCT02853305|79563366|FG000|Overall Study|Death|287|||
44548432|NCT02853305|79563367|FG001|Overall Study|Death|249|||
44548433|NCT02853305|79563368|FG002|Overall Study|Death|300|||
44548434|NCT02853305|79563366|FG000|Overall Study|Withdrawal by Subject|2|||
44548435|NCT02853305|79563367|FG001|Overall Study|Withdrawal by Subject|8|||
44548436|NCT02853305|79563368|FG002|Overall Study|Withdrawal by Subject|3|||
44548437|NCT02853305|79563366|FG000|Overall Study|Transferred to Extension Study|46|||
44548438|NCT02853305|79563367|FG001|Overall Study|Transferred to Extension Study|30|||
44548439|NCT02853305|79563368|FG002|Overall Study|Transferred to Extension Study|25|||
44548440|NCT02853305|79563366|FG000|Overall Study|Did Not Continue on Extension Study|16|||
44548441|NCT02853305|79563367|FG001|Overall Study|Did Not Continue on Extension Study|20|||
44548442|NCT02853305|79563368|FG002|Overall Study|Did Not Continue on Extension Study|24|||
44548443|NCT02524275|79563378|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
44548444|NCT02499120|79563384|FG000|Overall Study|Death|52|||
44548445|NCT02499120|79563385|FG001|Overall Study|Death|43|||
44548446|NCT02499120|79563384|FG000|Overall Study|Lost to Follow-up|1|||
44548447|NCT02499120|79563385|FG001|Overall Study|Lost to Follow-up|2|||
44548448|NCT02499120|79563384|FG000|Overall Study|Participant refused further follow-up|1|||
44548449|NCT02499120|79563385|FG001|Overall Study|Participant refused further follow-up|0|||
44548450|NCT02499120|79563384|FG000|Overall Study|Withdrawal by Subject|2|||
44230182|NCT01694420|79038450|FG000|Overall Study|Lost to Follow-up|3|||
44230183|NCT01675479|79038621|FG000|Overall Study|Lost to Follow-up|11|||
44230184|NCT00089973|79038752|FG000|Overall Study|Adverse Event|3|||
44230185|NCT00089973|79038752|FG000|Overall Study|Withdrawal by Subject|1|||
44548451|NCT02499120|79563385|FG001|Overall Study|Withdrawal by Subject|5|||
44548452|NCT02499120|79563384|FG000|Overall Study|Other|9|||
44548453|NCT02499120|79563385|FG001|Overall Study|Other|10|||
44548454|NCT02227992|79563393|FG000|Overall Study|Lost to Follow-up|1|||
44548455|NCT02227992|79563394|FG001|Overall Study|Lost to Follow-up|1|||
44548456|NCT01027143|79563406|FG000|Overall Study|Lost to Follow-up|9|||
44548457|NCT01027143|79563407|FG001|Overall Study|Lost to Follow-up|4|||
44548458|NCT00981656|79563413|FG000|Overall Study|Protocol Violation|1|||
44548459|NCT00981656|79563413|FG000|Overall Study|Did not start protocol treatment|2|||
44548460|NCT00895622|79563420|FG000|Overall Study|Protocol Violation|5|||
44548461|NCT00895622|79563421|FG001|Overall Study|Protocol Violation|4|||
44548462|NCT00895622|79563422|FG002|Overall Study|Protocol Violation|4|||
44548463|NCT00847535|79563438|FG000|Overall Study|Withdrawal by Subject|2|||
44548464|NCT00847535|79563439|FG001|Overall Study|Withdrawal by Subject|1|||
44548465|NCT00847535|79563440|FG002|Overall Study|Withdrawal by Subject|1|||
44548466|NCT00847535|79563438|FG000|Overall Study|Lost to Follow-up|0|||
44548467|NCT00847535|79563439|FG001|Overall Study|Lost to Follow-up|1|||
44548468|NCT00847535|79563440|FG002|Overall Study|Lost to Follow-up|0|||
44548469|NCT00539591|79563452|FG000|Overall Study|Toxicity|3|||
44548470|NCT00539591|79563453|FG001|Overall Study|Toxicity|0|||
44548471|NCT00539591|79563454|FG002|Overall Study|Toxicity|0|||
44548472|NCT00539591|79563452|FG000|Overall Study|Disease progression|2|||
44548473|NCT00539591|79563453|FG001|Overall Study|Disease progression|2|||
44548474|NCT00539591|79563454|FG002|Overall Study|Disease progression|3|||
44548475|NCT03512210|79563494|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
44548476|NCT03512210|79563494|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
44548477|NCT03512210|79563494|FG000|Step 2:Post-MINMON|Death|2|||
44548478|NCT03512210|79563494|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
44548479|NCT03512210|79563494|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
44548480|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
44548481|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
44548482|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
44548483|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
44548484|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
44548485|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
44548486|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
44548487|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
44548488|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
44548489|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
44548490|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
44548491|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
44548492|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
44548493|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
44548494|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
44548495|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
44548496|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
44548497|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
44494066|NCT00142298|79499910|FG006|Overall Study|Clinical disease progression|0|||
44494067|NCT00142298|79499911|FG007|Overall Study|Clinical disease progression|0|||
44548498|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
44548499|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
44548500|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
44548501|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
44548502|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
44548503|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
44548504|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
44548505|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
44548506|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
44548507|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
44548508|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
44548509|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
44548510|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
44548511|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
44494068|NCT00142298|79499912|FG008|Overall Study|Clinical disease progression|0|||
44494069|NCT00142298|79499913|FG009|Overall Study|Clinical disease progression|0|||
44494070|NCT00142298|79499904|FG000|Overall Study|Death|1|||
44548512|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
44548513|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
44230186|NCT00089973|79038752|FG000|Overall Study|Disease progression|45|||
44230187|NCT00089973|79038752|FG000|Overall Study|Death|1|||
44230188|NCT00089661|79038770|FG000|Overall Study|Adverse Event|0|||
44230189|NCT00089661|79038771|FG001|Overall Study|Adverse Event|2|||
44230190|NCT00089661|79038770|FG000|Overall Study|Death|1|||
44230191|NCT00089661|79038771|FG001|Overall Study|Death|0|||
44494071|NCT00142298|79499905|FG001|Overall Study|Death|1|||
44494072|NCT00142298|79499906|FG002|Overall Study|Death|1|||
44494073|NCT00142298|79499907|FG003|Overall Study|Death|0|||
44494074|NCT00142298|79499908|FG004|Overall Study|Death|0|||
44494075|NCT00142298|79499909|FG005|Overall Study|Death|6|||
44494076|NCT00142298|79499910|FG006|Overall Study|Death|0|||
44494077|NCT00142298|79499911|FG007|Overall Study|Death|0|||
44494078|NCT00142298|79499912|FG008|Overall Study|Death|0|||
44548514|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
44548515|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
44548516|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
44230192|NCT00089661|79038770|FG000|Overall Study|Lost to Follow-up|0|||
44230193|NCT00089661|79038771|FG001|Overall Study|Lost to Follow-up|3|||
44230194|NCT00089661|79038770|FG000|Overall Study|Withdrawal by Subject|11|||
44494079|NCT00142298|79499913|FG009|Overall Study|Death|0|||
44494080|NCT00142298|79499904|FG000|Overall Study|Lack of Efficacy|44|||
44548517|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
44548518|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
44548519|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
44548520|NCT00383721|79563503|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
44548521|NCT00383721|79563504|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
44548522|NCT00383721|79563505|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
44548523|NCT00383721|79563506|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
44548524|NCT00383721|79563507|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
44548525|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
44548526|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
44548527|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
44548528|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
44548529|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
44548530|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
44548531|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
44548532|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
44548533|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
44548534|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
44548535|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
44548536|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
44548537|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
44548538|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
44548539|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
44548540|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
44548541|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
44548542|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
44548543|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
44548544|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
44548545|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
44548546|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
44548547|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
44548548|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
44548549|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
44548550|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
44548551|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
44548552|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
44548553|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
44548554|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
44548555|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
44548556|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
44548557|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
44548558|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
44548559|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
44548560|NCT00383721|79563503|FG000|26-Week Treatment Safety Extension|Administrative|1|||
44274679|NCT02247804|79220486|FG000|Treatment Period 3|Lost to Follow-up|1|||
44376473|NCT00866788|79381618|FG002|Overall Study|Lost to Follow-up|0|||
44494081|NCT00142298|79499905|FG001|Overall Study|Lack of Efficacy|62|||
44494082|NCT00142298|79499906|FG002|Overall Study|Lack of Efficacy|9|||
44494083|NCT00142298|79499907|FG003|Overall Study|Lack of Efficacy|12|||
44494084|NCT00142298|79499908|FG004|Overall Study|Lack of Efficacy|1|||
44494085|NCT00142298|79499909|FG005|Overall Study|Lack of Efficacy|0|||
44494086|NCT00142298|79499910|FG006|Overall Study|Lack of Efficacy|0|||
44494087|NCT00142298|79499911|FG007|Overall Study|Lack of Efficacy|1|||
44494088|NCT00142298|79499912|FG008|Overall Study|Lack of Efficacy|0|||
44494089|NCT00142298|79499913|FG009|Overall Study|Lack of Efficacy|0|||
44494090|NCT00142298|79499904|FG000|Overall Study|Non-compliance|15|||
44494091|NCT00142298|79499905|FG001|Overall Study|Non-compliance|13|||
44494092|NCT00142298|79499906|FG002|Overall Study|Non-compliance|0|||
44494093|NCT00142298|79499907|FG003|Overall Study|Non-compliance|6|||
44494094|NCT00142298|79499908|FG004|Overall Study|Non-compliance|1|||
44494095|NCT00142298|79499909|FG005|Overall Study|Non-compliance|0|||
44494096|NCT00142298|79499910|FG006|Overall Study|Non-compliance|0|||
44494097|NCT00142298|79499911|FG007|Overall Study|Non-compliance|3|||
44494098|NCT00142298|79499912|FG008|Overall Study|Non-compliance|3|||
44494099|NCT00142298|79499913|FG009|Overall Study|Non-compliance|0|||
44494100|NCT00142298|79499904|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
44494101|NCT00142298|79499905|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
44494102|NCT00142298|79499906|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
44548561|NCT00383721|79563504|FG001|26-Week Treatment Safety Extension|Administrative|2|||
44548562|NCT00383721|79563505|FG002|26-Week Treatment Safety Extension|Administrative|3|||
44548563|NCT00383721|79563506|FG003|26-Week Treatment Safety Extension|Administrative|1|||
44548564|NCT00383721|79563507|FG004|26-Week Treatment Safety Extension|Administrative|0|||
44548565|NCT03035942|79563535|FG000|Overall Study|Adverse Event|8|||
44548566|NCT03035942|79563536|FG001|Overall Study|Adverse Event|4|||
44548567|NCT03035942|79563537|FG002|Overall Study|Adverse Event|5|||
44548568|NCT02616146|79563549|FG000|Overall Study|Adverse Event|64|||
44548569|NCT02616146|79563550|FG001|Overall Study|Adverse Event|24|||
44548570|NCT02616146|79563549|FG000|Overall Study|Lost to Follow-up|23|||
44548571|NCT02616146|79563550|FG001|Overall Study|Lost to Follow-up|13|||
44548572|NCT02616146|79563549|FG000|Overall Study|Non-compliance with study protocol|2|||
44548573|NCT02616146|79563550|FG001|Overall Study|Non-compliance with study protocol|0|||
44548574|NCT02616146|79563549|FG000|Overall Study|Non-compliance with study drug|4|||
44548575|NCT02616146|79563550|FG001|Overall Study|Non-compliance with study drug|2|||
44548576|NCT02616146|79563549|FG000|Overall Study|Pregnancy|2|||
44548577|NCT02616146|79563550|FG001|Overall Study|Pregnancy|2|||
44548578|NCT02616146|79563549|FG000|Overall Study|Pregnancy wish|3|||
44548579|NCT02616146|79563550|FG001|Overall Study|Pregnancy wish|0|||
44548580|NCT02616146|79563549|FG000|Overall Study|Protocol Violation|6|||
44548581|NCT02616146|79563550|FG001|Overall Study|Protocol Violation|3|||
44548582|NCT02616146|79563549|FG000|Overall Study|Study terminated by sponsor|1372|||
44548583|NCT02616146|79563550|FG001|Overall Study|Study terminated by sponsor|432|||
44548584|NCT02616146|79563549|FG000|Overall Study|Participant moved|4|||
44548585|NCT02616146|79563550|FG001|Overall Study|Participant moved|3|||
44548586|NCT02616146|79563549|FG000|Overall Study|Withdrawal by Subject|30|||
44548587|NCT02616146|79563550|FG001|Overall Study|Withdrawal by Subject|24|||
44548588|NCT02616146|79563549|FG000|Overall Study|Physician Decision|2|||
44548589|NCT02616146|79563550|FG001|Overall Study|Physician Decision|1|||
44548590|NCT04850313|79563558|FG000|Overall Study|Withdrawal by Subject|0|||
44548591|NCT04850313|79563559|FG001|Overall Study|Withdrawal by Subject|1|||
44548592|NCT02885181|79563577|FG000|Overall Study|Investigator's Discretion|0|||
44548593|NCT02885181|79563578|FG001|Overall Study|Investigator's Discretion|1|||
44548594|NCT02885181|79563579|FG002|Overall Study|Investigator's Discretion|0|||
44548595|NCT02885181|79563580|FG003|Overall Study|Investigator's Discretion|1|||
44548596|NCT02885181|79563577|FG000|Overall Study|Adverse Event|0|||
44548597|NCT02885181|79563578|FG001|Overall Study|Adverse Event|0|||
44548598|NCT02885181|79563579|FG002|Overall Study|Adverse Event|0|||
44548599|NCT02885181|79563580|FG003|Overall Study|Adverse Event|1|||
44548600|NCT02885181|79563577|FG000|Overall Study|Withdrawal by Subject|0|||
44548601|NCT02885181|79563578|FG001|Overall Study|Withdrawal by Subject|0|||
44548602|NCT02885181|79563579|FG002|Overall Study|Withdrawal by Subject|0|||
44548603|NCT02885181|79563580|FG003|Overall Study|Withdrawal by Subject|1|||
44548604|NCT02884089|79563594|FG000|Period 1|Dosing error|2|||
44548605|NCT02884089|79563595|FG001|Period 1|Dosing error|2|||
44548606|NCT02884089|79563596|FG002|Period 1|Dosing error|0|||
44548607|NCT02884089|79563597|FG003|Period 1|Dosing error|0|||
44376474|NCT00866788|79381619|FG003|Overall Study|Lost to Follow-up|2|||
44494103|NCT00142298|79499907|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
44494104|NCT00142298|79499908|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
44494105|NCT00142298|79499909|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
44494106|NCT00142298|79499910|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
44494107|NCT00142298|79499911|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
44494108|NCT00142298|79499912|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
44494109|NCT00142298|79499913|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
44494110|NCT00142298|79499904|FG000|Overall Study|Pregnancy|4|||
44494111|NCT00142298|79499905|FG001|Overall Study|Pregnancy|4|||
44494112|NCT00142298|79499906|FG002|Overall Study|Pregnancy|2|||
44494113|NCT00142298|79499907|FG003|Overall Study|Pregnancy|3|||
44494114|NCT00142298|79499908|FG004|Overall Study|Pregnancy|0|||
44494115|NCT00142298|79499909|FG005|Overall Study|Pregnancy|0|||
44494116|NCT00142298|79499910|FG006|Overall Study|Pregnancy|0|||
44494117|NCT00142298|79499911|FG007|Overall Study|Pregnancy|0|||
44494118|NCT00142298|79499912|FG008|Overall Study|Pregnancy|1|||
44494119|NCT00142298|79499913|FG009|Overall Study|Pregnancy|0|||
44548608|NCT02884089|79563594|FG000|Washout Period 1|Lost to Follow-up|0|||
44548609|NCT02884089|79563595|FG001|Washout Period 1|Lost to Follow-up|1|||
44548610|NCT02884089|79563596|FG002|Washout Period 1|Lost to Follow-up|0|||
44548611|NCT02884089|79563597|FG003|Washout Period 1|Lost to Follow-up|1|||
44548612|NCT02884089|79563594|FG000|Washout Period 1|Withdrawal by Subject|0|||
44548613|NCT02884089|79563595|FG001|Washout Period 1|Withdrawal by Subject|1|||
44548614|NCT02884089|79563596|FG002|Washout Period 1|Withdrawal by Subject|0|||
44548615|NCT02884089|79563597|FG003|Washout Period 1|Withdrawal by Subject|0|||
44548616|NCT02884089|79563594|FG000|Period 2|Adverse Event|1|||
44548617|NCT02884089|79563595|FG001|Period 2|Adverse Event|0|||
44548618|NCT02884089|79563596|FG002|Period 2|Adverse Event|0|||
44548619|NCT02884089|79563597|FG003|Period 2|Adverse Event|0|||
44494120|NCT00142298|79499904|FG000|Overall Study|Virologic breakthrough|19|||
44494121|NCT00142298|79499905|FG001|Overall Study|Virologic breakthrough|23|||
44494122|NCT00142298|79499906|FG002|Overall Study|Virologic breakthrough|9|||
44494123|NCT00142298|79499907|FG003|Overall Study|Virologic breakthrough|7|||
44494124|NCT00142298|79499908|FG004|Overall Study|Virologic breakthrough|2|||
44494125|NCT00142298|79499909|FG005|Overall Study|Virologic breakthrough|3|||
44494126|NCT00142298|79499910|FG006|Overall Study|Virologic breakthrough|3|||
44494127|NCT00142298|79499911|FG007|Overall Study|Virologic breakthrough|0|||
44494128|NCT00142298|79499912|FG008|Overall Study|Virologic breakthrough|0|||
44494129|NCT00142298|79499913|FG009|Overall Study|Virologic breakthrough|0|||
44494130|NCT00142298|79499904|FG000|Overall Study|Other- not specified|0|||
44494131|NCT00142298|79499905|FG001|Overall Study|Other- not specified|3|||
44494132|NCT00142298|79499906|FG002|Overall Study|Other- not specified|0|||
44494133|NCT00142298|79499907|FG003|Overall Study|Other- not specified|1|||
44494134|NCT00142298|79499908|FG004|Overall Study|Other- not specified|0|||
44494135|NCT00142298|79499909|FG005|Overall Study|Other- not specified|0|||
44494136|NCT00142298|79499910|FG006|Overall Study|Other- not specified|0|||
44494137|NCT00142298|79499911|FG007|Overall Study|Other- not specified|0|||
44494138|NCT00142298|79499912|FG008|Overall Study|Other- not specified|0|||
44494139|NCT00142298|79499913|FG009|Overall Study|Other- not specified|0|||
44494140|NCT00142298|79499904|FG000|Overall Study|Lost to Follow-up|0|||
44494141|NCT00142298|79499905|FG001|Overall Study|Lost to Follow-up|0|||
44494142|NCT00142298|79499906|FG002|Overall Study|Lost to Follow-up|0|||
44494143|NCT00142298|79499907|FG003|Overall Study|Lost to Follow-up|0|||
44494144|NCT00142298|79499908|FG004|Overall Study|Lost to Follow-up|0|||
44494145|NCT00142298|79499909|FG005|Overall Study|Lost to Follow-up|0|||
44494146|NCT00142298|79499910|FG006|Overall Study|Lost to Follow-up|2|||
44494147|NCT00142298|79499911|FG007|Overall Study|Lost to Follow-up|0|||
44494148|NCT00142298|79499912|FG008|Overall Study|Lost to Follow-up|0|||
44494149|NCT00142298|79499913|FG009|Overall Study|Lost to Follow-up|0|||
44494150|NCT00142298|79499904|FG000|Overall Study|Treatment Failure|0|||
44494151|NCT00142298|79499905|FG001|Overall Study|Treatment Failure|0|||
44494152|NCT00142298|79499906|FG002|Overall Study|Treatment Failure|0|||
44494153|NCT00142298|79499907|FG003|Overall Study|Treatment Failure|0|||
44494154|NCT00142298|79499908|FG004|Overall Study|Treatment Failure|0|||
44230195|NCT00089661|79038771|FG001|Overall Study|Withdrawal by Subject|9|||
44230196|NCT00089661|79038770|FG000|Overall Study|Disease progression|1|||
44230197|NCT00089661|79038771|FG001|Overall Study|Disease progression|3|||
44230198|NCT00089661|79038770|FG000|Overall Study|Ineligibility determined|4|||
44230199|NCT00089661|79038771|FG001|Overall Study|Ineligibility determined|4|||
44230200|NCT00089661|79038770|FG000|Overall Study|Noncompliance|2|||
44230201|NCT00089661|79038771|FG001|Overall Study|Noncompliance|4|||
44230202|NCT00089661|79038770|FG000|Overall Study|Other|2|||
44230203|NCT00089661|79038771|FG001|Overall Study|Other|1|||
44230204|NCT00089583|79038788|FG000|Overall Study|Adverse Event|0|||
44230205|NCT00089583|79038789|FG001|Overall Study|Adverse Event|3|||
44230206|NCT00089583|79038788|FG000|Overall Study|Insufficient Viral Load Response|5|||
44230207|NCT00089583|79038789|FG001|Overall Study|Insufficient Viral Load Response|5|||
44230208|NCT00089583|79038788|FG000|Overall Study|Withdrawal by Subject|0|||
44230209|NCT00089583|79038789|FG001|Overall Study|Withdrawal by Subject|4|||
44230210|NCT00089583|79038788|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
44230211|NCT00089583|79038789|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
44230212|NCT00089583|79038788|FG000|Overall Study|Participant Refused Study Medication|0|||
44230213|NCT00089583|79038789|FG001|Overall Study|Participant Refused Study Medication|2|||
44230214|NCT00089583|79038788|FG000|Overall Study|Non-Compliance|0|||
44230215|NCT00089583|79038789|FG001|Overall Study|Non-Compliance|4|||
44494155|NCT00142298|79499909|FG005|Overall Study|Treatment Failure|2|||
44494156|NCT00142298|79499910|FG006|Overall Study|Treatment Failure|2|||
44494157|NCT00142298|79499911|FG007|Overall Study|Treatment Failure|0|||
44494158|NCT00142298|79499912|FG008|Overall Study|Treatment Failure|0|||
44494159|NCT00142298|79499913|FG009|Overall Study|Treatment Failure|0|||
44494160|NCT03709654|79499937|FG000|Overall Study|Lost to Follow-up|1|||
44494161|NCT03709654|79499938|FG001|Overall Study|Lost to Follow-up|1|||
44494162|NCT03709654|79499937|FG000|Overall Study|Withdrawal by Subject|1|||
44494163|NCT03709654|79499938|FG001|Overall Study|Withdrawal by Subject|1|||
44494164|NCT03709654|79499937|FG000|Overall Study|Adverse Event|1|||
44494165|NCT03709654|79499938|FG001|Overall Study|Adverse Event|0|||
44230216|NCT00089583|79038788|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
44230217|NCT00089583|79038789|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
44494166|NCT00412061|79499946|FG000|Double Blind Phase|Disease Progression|101|||
44494167|NCT00412061|79499947|FG001|Double Blind Phase|Disease Progression|154|||
44494168|NCT00412061|79499946|FG000|Double Blind Phase|Adverse Event|61|||
44494169|NCT00412061|79499947|FG001|Double Blind Phase|Adverse Event|16|||
44494170|NCT00412061|79499946|FG000|Double Blind Phase|Final Primary Analysis|26|||
44494171|NCT00412061|79499947|FG001|Double Blind Phase|Final Primary Analysis|14|||
44230218|NCT00089583|79038788|FG000|Overall Study|Participant Management Criteria Met|0|||
44230219|NCT00089583|79038789|FG001|Overall Study|Participant Management Criteria Met|1|||
44274680|NCT02247804|79220487|FG001|Treatment Period 3|Lost to Follow-up|2|||
44274681|NCT02247804|79220488|FG002|Treatment Period 3|Lost to Follow-up|2|||
44274682|NCT02247804|79220486|FG000|Treatment Period 3|Personal Reasons|4|||
44274683|NCT02247804|79220487|FG001|Treatment Period 3|Personal Reasons|3|||
44274684|NCT02247804|79220488|FG002|Treatment Period 3|Personal Reasons|2|||
44274685|NCT02247804|79220486|FG000|Treatment Period 3|Reason not Specified|2|||
44274686|NCT02247804|79220487|FG001|Treatment Period 3|Reason not Specified|1|||
44274687|NCT02247804|79220488|FG002|Treatment Period 3|Reason not Specified|3|||
44274688|NCT02243202|79220513|FG000|Overall Study|Adverse Event|5|||
44494172|NCT00412061|79499946|FG000|Double Blind Phase|Withdrawal by Subject|18|||
44494173|NCT00412061|79499947|FG001|Double Blind Phase|Withdrawal by Subject|20|||
44494174|NCT00412061|79499946|FG000|Double Blind Phase|Death|6|||
44494175|NCT00412061|79499947|FG001|Double Blind Phase|Death|3|||
44494176|NCT00412061|79499946|FG000|Double Blind Phase|Protocol Violation|3|||
44494177|NCT00412061|79499947|FG001|Double Blind Phase|Protocol Violation|4|||
44494178|NCT00412061|79499946|FG000|Double Blind Phase|New Cander Therapy|1|||
44494179|NCT00412061|79499947|FG001|Double Blind Phase|New Cander Therapy|1|||
44494180|NCT00412061|79499946|FG000|Double Blind Phase|Lost to Follow-up|0|||
44494181|NCT00412061|79499947|FG001|Double Blind Phase|Lost to Follow-up|1|||
44494182|NCT00412061|79499946|FG000|Open Label Phase|Disease Progression|0|||
44494183|NCT00412061|79499947|FG001|Open Label Phase|Disease Progression|86|||
44494184|NCT00412061|79499946|FG000|Open Label Phase|Adverse Event|0|||
44494185|NCT00412061|79499947|FG001|Open Label Phase|Adverse Event|46|||
44494186|NCT00412061|79499946|FG000|Open Label Phase|Withdrawal by Subject|0|||
44494187|NCT00412061|79499947|FG001|Open Label Phase|Withdrawal by Subject|15|||
44494188|NCT00412061|79499946|FG000|Open Label Phase|Administrative Problems|0|||
44494189|NCT00412061|79499947|FG001|Open Label Phase|Administrative Problems|13|||
44494190|NCT00412061|79499946|FG000|Open Label Phase|Death|0|||
44494191|NCT00412061|79499947|FG001|Open Label Phase|Death|7|||
44494192|NCT00412061|79499946|FG000|Open Label Phase|Lost to Follow-up|0|||
44494193|NCT00412061|79499947|FG001|Open Label Phase|Lost to Follow-up|2|||
44494194|NCT00412061|79499946|FG000|Open Label Phase|New Cancer Therapy|0|||
44494195|NCT00412061|79499947|FG001|Open Label Phase|New Cancer Therapy|1|||
44494196|NCT00411671|79499965|FG000|Overall Study|Adverse Event|15|||
44494197|NCT00411671|79499965|FG000|Overall Study|Death|2|||
44494198|NCT00411671|79499965|FG000|Overall Study|Lost to Follow-up|3|||
44494199|NCT03835481|79499974|FG000|Double-blind Period|Other not stated below|0|||
44494200|NCT03835481|79499975|FG001|Double-blind Period|Other not stated below|0|||
44494201|NCT03835481|79499976|FG002|Double-blind Period|Other not stated below|0|||
44494202|NCT03835481|79499977|FG003|Double-blind Period|Other not stated below|1|||
44494203|NCT03835481|79499978|FG004|Double-blind Period|Other not stated below|1|||
44494204|NCT03835481|79499974|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
44494205|NCT03835481|79499975|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
44494206|NCT03835481|79499976|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
44494207|NCT03835481|79499977|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
44494208|NCT03835481|79499978|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
44494209|NCT03835481|79499974|FG000|Double-blind Period|Withdrawal by Subject|0|||
44494210|NCT03835481|79499975|FG001|Double-blind Period|Withdrawal by Subject|0|||
44494211|NCT03835481|79499976|FG002|Double-blind Period|Withdrawal by Subject|1|||
44494212|NCT03835481|79499977|FG003|Double-blind Period|Withdrawal by Subject|0|||
44230220|NCT00089583|79038788|FG000|Overall Study|Reason Not Provided|0|||
44230221|NCT00089583|79038789|FG001|Overall Study|Reason Not Provided|1|||
44230222|NCT00089583|79038788|FG000|Overall Study|Protocol Violation|0|||
44230223|NCT00089583|79038789|FG001|Overall Study|Protocol Violation|3|||
44230224|NCT00089583|79038788|FG000|Overall Study|Principal Investigator Decision|0|||
44230225|NCT00089583|79038789|FG001|Overall Study|Principal Investigator Decision|10|||
44230226|NCT00089583|79038788|FG000|Overall Study|Start of Disallowed Medication|0|||
44230227|NCT00089583|79038789|FG001|Overall Study|Start of Disallowed Medication|1|||
44230228|NCT00089583|79038788|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
44230229|NCT00089583|79038789|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
44230230|NCT00089583|79038788|FG000|Overall Study|Participant Incarcerated|0|||
44230231|NCT00089583|79038789|FG001|Overall Study|Participant Incarcerated|1|||
44230232|NCT00088881|79038801|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
44376475|NCT00866788|79381616|FG000|Overall Study|Withdrawal by Subject|2|||
44494213|NCT03835481|79499978|FG004|Double-blind Period|Withdrawal by Subject|5|||
44494214|NCT03835481|79499974|FG000|Double-blind Period|Lost to Follow-up|0|||
44494215|NCT03835481|79499975|FG001|Double-blind Period|Lost to Follow-up|0|||
44494216|NCT03835481|79499976|FG002|Double-blind Period|Lost to Follow-up|0|||
44494217|NCT03835481|79499977|FG003|Double-blind Period|Lost to Follow-up|1|||
44494218|NCT03835481|79499978|FG004|Double-blind Period|Lost to Follow-up|0|||
44230233|NCT00088881|79038801|FG000|Step 1 - R-CHOP|Adverse Event|1|||
44230234|NCT00088881|79038801|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
44548620|NCT02884089|79563594|FG000|Period 3|Withdrawal by Subject|0|||
44548621|NCT02884089|79563595|FG001|Period 3|Withdrawal by Subject|0|||
44548622|NCT02884089|79563596|FG002|Period 3|Withdrawal by Subject|1|||
44548623|NCT02884089|79563597|FG003|Period 3|Withdrawal by Subject|0|||
44548624|NCT02884089|79563594|FG000|Washout Period 3|Withdrawal by Subject|0|||
44548625|NCT02884089|79563595|FG001|Washout Period 3|Withdrawal by Subject|0|||
44548626|NCT02884089|79563596|FG002|Washout Period 3|Withdrawal by Subject|1|||
44548627|NCT02884089|79563597|FG003|Washout Period 3|Withdrawal by Subject|0|||
44548628|NCT02884089|79563594|FG000|Washout Period 3|Lost to Follow-up|0|||
44548629|NCT02884089|79563595|FG001|Washout Period 3|Lost to Follow-up|0|||
44548630|NCT02884089|79563596|FG002|Washout Period 3|Lost to Follow-up|0|||
44548631|NCT02884089|79563597|FG003|Washout Period 3|Lost to Follow-up|1|||
44548632|NCT02884089|79563594|FG000|Period 4|Withdrawal by Subject|0|||
44548633|NCT02884089|79563595|FG001|Period 4|Withdrawal by Subject|1|||
44548634|NCT02884089|79563596|FG002|Period 4|Withdrawal by Subject|0|||
44548635|NCT02884089|79563597|FG003|Period 4|Withdrawal by Subject|0|||
44548636|NCT02884089|79563594|FG000|Period 4|Lost to Follow-up|1|||
44548637|NCT02884089|79563595|FG001|Period 4|Lost to Follow-up|0|||
44548638|NCT02884089|79563596|FG002|Period 4|Lost to Follow-up|0|||
44230235|NCT00088881|79038801|FG000|Step 1 - R-CHOP|Physician Decision|1|||
44230236|NCT00088881|79038801|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
44274689|NCT02243202|79220514|FG001|Overall Study|Adverse Event|6|||
44274690|NCT02243202|79220515|FG002|Overall Study|Adverse Event|10|||
44230237|NCT00088881|79038801|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
44230238|NCT00088881|79038801|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
44230239|NCT00087555|79038849|FG000|Overall Study|Adverse Event|3|||
44230240|NCT00087555|79038850|FG001|Overall Study|Adverse Event|6|||
44230241|NCT00087555|79038851|FG002|Overall Study|Adverse Event|14|||
44230242|NCT00087555|79038849|FG000|Overall Study|Lost to Follow-up|0|||
44230243|NCT00087555|79038850|FG001|Overall Study|Lost to Follow-up|1|||
44230244|NCT00087555|79038851|FG002|Overall Study|Lost to Follow-up|1|||
44230245|NCT00087555|79038849|FG000|Overall Study|Non - Compliance|1|||
44274691|NCT02243202|79220516|FG003|Overall Study|Adverse Event|4|||
44274692|NCT02243202|79220513|FG000|Overall Study|Lost to Follow-up|9|||
44274693|NCT02243202|79220514|FG001|Overall Study|Lost to Follow-up|9|||
44376476|NCT00866788|79381617|FG001|Overall Study|Withdrawal by Subject|1|||
44274694|NCT02243202|79220515|FG002|Overall Study|Lost to Follow-up|14|||
44376477|NCT00866788|79381618|FG002|Overall Study|Withdrawal by Subject|0|||
44494219|NCT03835481|79499974|FG000|Double-blind Period|Protocol Violation|0|||
44494220|NCT03835481|79499975|FG001|Double-blind Period|Protocol Violation|2|||
44494221|NCT03835481|79499976|FG002|Double-blind Period|Protocol Violation|0|||
44494222|NCT03835481|79499977|FG003|Double-blind Period|Protocol Violation|1|||
44494223|NCT03835481|79499978|FG004|Double-blind Period|Protocol Violation|0|||
44494224|NCT03835481|79499974|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
44494225|NCT03835481|79499975|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
44494226|NCT03835481|79499976|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
44494227|NCT03835481|79499977|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
44494228|NCT03835481|79499978|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
44494229|NCT03835481|79499974|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
44548639|NCT02884089|79563597|FG003|Period 4|Lost to Follow-up|0|||
44274695|NCT02243202|79220516|FG003|Overall Study|Lost to Follow-up|11|||
44230246|NCT00087555|79038850|FG001|Overall Study|Non - Compliance|0|||
44274696|NCT02243202|79220513|FG000|Overall Study|Protocol Violation|3|||
44548640|NCT02884089|79563594|FG000|Follow-up Visit|Withdrawal by Subject|1|||
44548641|NCT02884089|79563595|FG001|Follow-up Visit|Withdrawal by Subject|0|||
44548642|NCT02884089|79563596|FG002|Follow-up Visit|Withdrawal by Subject|0|||
44548643|NCT02884089|79563597|FG003|Follow-up Visit|Withdrawal by Subject|1|||
44548644|NCT02809677|79563607|FG000|Overall Study|Withdrawal by Subject|8|||
44548645|NCT02881047|79563612|FG000|Overall Study|Adverse Event|1|||
44548646|NCT02881047|79563612|FG000|Overall Study|Withdrawal by Subject|1|||
44548647|NCT03157089|79563618|FG000|Overall Study|Treated only with pembrolizumab|1|||
44548648|NCT03157089|79563619|FG001|Overall Study|Treated only with pembrolizumab|0|||
44548649|NCT03157089|79563618|FG000|Overall Study|Adverse Event|5|||
44548650|NCT03157089|79563619|FG001|Overall Study|Adverse Event|4|||
44548651|NCT03157089|79563618|FG000|Overall Study|Progressive disease|6|||
44548652|NCT03157089|79563619|FG001|Overall Study|Progressive disease|8|||
44548653|NCT03158727|79563628|FG000|Overall Study|Withdrawal by Subject|2|||
44548654|NCT03158727|79563629|FG001|Overall Study|Withdrawal by Subject|6|||
44548655|NCT03158727|79563628|FG000|Overall Study|Death|11|||
44548656|NCT03158727|79563629|FG001|Overall Study|Death|12|||
44548657|NCT03158727|79563628|FG000|Overall Study|Lost to Follow-up|1|||
44548658|NCT03158727|79563629|FG001|Overall Study|Lost to Follow-up|0|||
44548659|NCT03158727|79563628|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
44548660|NCT03158727|79563629|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
44548661|NCT03158727|79563628|FG000|Overall Study|Visit 11 not done by mistake|0|||
44548662|NCT03158727|79563629|FG001|Overall Study|Visit 11 not done by mistake|1|||
44548663|NCT03158727|79563628|FG000|Overall Study|Enrolled, not treated|1|||
44548664|NCT03158727|79563629|FG001|Overall Study|Enrolled, not treated|0|||
44548665|NCT00089895|79563637|FG000|Overall Study|Consent Withdrawn|11|||
44548666|NCT00089895|79563638|FG001|Overall Study|Consent Withdrawn|14|||
44548667|NCT00089895|79563637|FG000|Overall Study|Technical reason|7|||
44548668|NCT00089895|79563638|FG001|Overall Study|Technical reason|2|||
44548669|NCT00089895|79563637|FG000|Overall Study|Surgery|0|||
44548670|NCT00089895|79563638|FG001|Overall Study|Surgery|1|||
44548671|NCT00089895|79563637|FG000|Overall Study|Bleeding|0|||
44548672|NCT00089895|79563638|FG001|Overall Study|Bleeding|2|||
44548673|NCT00089895|79563637|FG000|Overall Study|Physician Decision|3|||
44548674|NCT00089895|79563638|FG001|Overall Study|Physician Decision|7|||
44548675|NCT00089895|79563637|FG000|Overall Study|Exclusion criteria met|6|||
44548676|NCT00089895|79563638|FG001|Overall Study|Exclusion criteria met|6|||
44548677|NCT00089895|79563637|FG000|Overall Study|Not otherwise specified|4|||
44548678|NCT00089895|79563638|FG001|Overall Study|Not otherwise specified|8|||
44548679|NCT00089895|79563637|FG000|Overall Study|Missing|4|||
44548680|NCT00089895|79563638|FG001|Overall Study|Missing|2|||
44548681|NCT02714218|79563647|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44548682|NCT02714218|79563648|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44548683|NCT02714218|79563649|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44548684|NCT02714218|79563647|FG000|Pre-Treatment Period|Other reasons|0|||
44548685|NCT02714218|79563648|FG001|Pre-Treatment Period|Other reasons|1|||
44548686|NCT02714218|79563649|FG002|Pre-Treatment Period|Other reasons|0|||
44548687|NCT02714218|79563647|FG000|Treatment Period|Disease Progression|55|||
44548688|NCT02714218|79563648|FG001|Treatment Period|Disease Progression|52|||
44548689|NCT02714218|79563649|FG002|Treatment Period|Disease Progression|14|||
44548690|NCT02714218|79563647|FG000|Treatment Period|Study drug toxicity|46|||
44548691|NCT02714218|79563648|FG001|Treatment Period|Study drug toxicity|70|||
44548692|NCT02714218|79563649|FG002|Treatment Period|Study drug toxicity|6|||
44548693|NCT02714218|79563647|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
44548694|NCT02714218|79563648|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
44548695|NCT02714218|79563649|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
44548696|NCT02714218|79563647|FG000|Treatment Period|Request to discontinue treatment|1|||
44548697|NCT02714218|79563648|FG001|Treatment Period|Request to discontinue treatment|4|||
44548698|NCT02714218|79563649|FG002|Treatment Period|Request to discontinue treatment|1|||
44548699|NCT02714218|79563647|FG000|Treatment Period|Participant withdrew consent|2|||
44548700|NCT02714218|79563648|FG001|Treatment Period|Participant withdrew consent|2|||
44548701|NCT02714218|79563649|FG002|Treatment Period|Participant withdrew consent|0|||
44548702|NCT02714218|79563647|FG000|Treatment Period|Maximum clinical benefit|4|||
44548703|NCT02714218|79563648|FG001|Treatment Period|Maximum clinical benefit|2|||
44548704|NCT02714218|79563649|FG002|Treatment Period|Maximum clinical benefit|0|||
44548705|NCT02714218|79563647|FG000|Treatment Period|Administrative reason by sponsor|2|||
44230247|NCT00087555|79038851|FG002|Overall Study|Non - Compliance|0|||
44230248|NCT00087555|79038849|FG000|Overall Study|Protocol Violation|0|||
44230249|NCT00087555|79038850|FG001|Overall Study|Protocol Violation|0|||
44548706|NCT02714218|79563648|FG001|Treatment Period|Administrative reason by sponsor|1|||
44548707|NCT02714218|79563649|FG002|Treatment Period|Administrative reason by sponsor|0|||
44548708|NCT02714218|79563647|FG000|Treatment Period|Other reasons|6|||
44548709|NCT02714218|79563648|FG001|Treatment Period|Other reasons|6|||
44548710|NCT02714218|79563649|FG002|Treatment Period|Other reasons|0|||
44548711|NCT02714218|79563647|FG000|Treatment Period|Completed treatment as per protocol|36|||
44548712|NCT02714218|79563648|FG001|Treatment Period|Completed treatment as per protocol|27|||
44548713|NCT02714218|79563649|FG002|Treatment Period|Completed treatment as per protocol|3|||
44548714|NCT02714218|79563647|FG000|Treatment Period|Not reported|9|||
44376478|NCT00866788|79381619|FG003|Overall Study|Withdrawal by Subject|1|||
44376479|NCT00866788|79381616|FG000|Overall Study|Pregnancy|0|||
44376480|NCT00866788|79381617|FG001|Overall Study|Pregnancy|1|||
44494230|NCT03835481|79499975|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
44548715|NCT02714218|79563648|FG001|Treatment Period|Not reported|6|||
44548716|NCT02714218|79563649|FG002|Treatment Period|Not reported|0|||
44548717|NCT03154047|79563656|FG000|Overall Study|Death|1|||
44548718|NCT03154047|79563656|FG000|Overall Study|Study terminated by sponsor|76|||
44548719|NCT03154047|79563656|FG000|Overall Study|Withdrawal by Subject|3|||
44548720|NCT03156621|79563662|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
44548721|NCT03156621|79563663|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
44548722|NCT03156621|79563662|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
44548723|NCT03156621|79563663|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
44548724|NCT03156543|79563674|FG000|Overall Study|Withdrawal by Subject|1|||
44548725|NCT03156543|79563675|FG001|Overall Study|Withdrawal by Subject|0|||
44548726|NCT02713594|79563683|FG000|Overall Study|Withdrawal by Subject|32|||
44548727|NCT02713594|79563684|FG001|Overall Study|Withdrawal by Subject|22|||
44548728|NCT02713594|79563683|FG000|Overall Study|Lost to Follow-up|358|||
44548729|NCT02713594|79563684|FG001|Overall Study|Lost to Follow-up|374|||
44548730|NCT03152019|79563694|FG000|Overall Study|Adverse Event|0|||
44548731|NCT03152019|79563695|FG001|Overall Study|Adverse Event|1|||
44548732|NCT02714062|79563708|FG000|Overall Study|Adverse Event|0|||
44548733|NCT02714062|79563709|FG001|Overall Study|Adverse Event|0|||
44548734|NCT02714062|79563710|FG002|Overall Study|Adverse Event|2|||
44548735|NCT02714062|79563708|FG000|Overall Study|Withdrawal by Subject|1|||
44548736|NCT02714062|79563709|FG001|Overall Study|Withdrawal by Subject|0|||
44548737|NCT02714062|79563710|FG002|Overall Study|Withdrawal by Subject|1|||
44548738|NCT02714062|79563708|FG000|Overall Study|Protocol Violation|0|||
44230250|NCT00087555|79038851|FG002|Overall Study|Protocol Violation|2|||
44548739|NCT02714062|79563709|FG001|Overall Study|Protocol Violation|1|||
44548740|NCT02714062|79563710|FG002|Overall Study|Protocol Violation|0|||
44548741|NCT03151395|79563720|FG000|Overall Study|Adverse Event|2|||
44548742|NCT03151395|79563720|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
44548743|NCT03151395|79563720|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
44548744|NCT03151395|79563720|FG000|Overall Study|Unspecified reason|4|||
44548745|NCT02713828|79563726|FG000|Overall Study|Death|2|||
44230251|NCT00087555|79038849|FG000|Overall Study|Screen Failure|1|||
44230252|NCT00087555|79038850|FG001|Overall Study|Screen Failure|1|||
44230253|NCT00087555|79038851|FG002|Overall Study|Screen Failure|0|||
44230254|NCT00087555|79038849|FG000|Overall Study|Pregnancy|0|||
44230255|NCT00087555|79038850|FG001|Overall Study|Pregnancy|1|||
44230256|NCT00087555|79038851|FG002|Overall Study|Pregnancy|1|||
44230257|NCT00087555|79038849|FG000|Overall Study|Withdrawal by Subject|3|||
44230258|NCT00087555|79038850|FG001|Overall Study|Withdrawal by Subject|2|||
44230259|NCT00087555|79038851|FG002|Overall Study|Withdrawal by Subject|1|||
44274697|NCT02243202|79220514|FG001|Overall Study|Protocol Violation|1|||
44274698|NCT02243202|79220515|FG002|Overall Study|Protocol Violation|2|||
44274699|NCT02243202|79220516|FG003|Overall Study|Protocol Violation|1|||
44274700|NCT02243202|79220513|FG000|Overall Study|Withdrawal by Subject|7|||
44376481|NCT00866788|79381618|FG002|Overall Study|Pregnancy|0|||
44494231|NCT03835481|79499976|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
44494232|NCT03835481|79499977|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
44494233|NCT03835481|79499978|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
44494234|NCT03835481|79499974|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
44494235|NCT03835481|79499975|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
44494236|NCT03835481|79499976|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
44494237|NCT03835481|79499977|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
44494238|NCT03835481|79499978|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
44494239|NCT03835481|79499974|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
44494240|NCT03835481|79499975|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
44494241|NCT03835481|79499976|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
44548746|NCT02713828|79563727|FG001|Overall Study|Death|0|||
44548747|NCT02713828|79563726|FG000|Overall Study|Withdrawal by Subject|1|||
44230260|NCT00087555|79038849|FG000|Overall Study|Lack of Efficacy|2|||
44230261|NCT00087555|79038850|FG001|Overall Study|Lack of Efficacy|0|||
44376482|NCT00866788|79381619|FG003|Overall Study|Pregnancy|0|||
44230262|NCT00087555|79038851|FG002|Overall Study|Lack of Efficacy|1|||
44548748|NCT02713828|79563727|FG001|Overall Study|Withdrawal by Subject|0|||
44548749|NCT02713828|79563726|FG000|Overall Study|study terminated but patient allowed to|2|||
44548750|NCT02713828|79563727|FG001|Overall Study|study terminated but patient allowed to|0|||
44548751|NCT02875860|79563734|FG000|Overall Study|Withdrawal by Subject|0|||
44548752|NCT02875860|79563735|FG001|Overall Study|Withdrawal by Subject|1|||
44548753|NCT02875392|79563743|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
44548754|NCT02875392|79563744|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
44548755|NCT03127644|79563753|FG000|Overall Study|Study-specific withdrawal criteria|0|||
44548756|NCT03127644|79563754|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44548757|NCT03127644|79563755|FG002|Overall Study|Study-specific withdrawal criteria|2|||
44548758|NCT03965962|79563769|FG000|Overall Study|Adverse Event|1|||
44548759|NCT03965962|79563770|FG001|Overall Study|Adverse Event|0|||
44548760|NCT03965962|79563771|FG002|Overall Study|Adverse Event|0|||
44548761|NCT03965962|79563772|FG003|Overall Study|Adverse Event|0|||
44548762|NCT03965962|79563769|FG000|Overall Study|Protocol Violation|21|||
44548763|NCT03965962|79563770|FG001|Overall Study|Protocol Violation|4|||
44548764|NCT03965962|79563771|FG002|Overall Study|Protocol Violation|10|||
44548765|NCT03965962|79563772|FG003|Overall Study|Protocol Violation|5|||
44548766|NCT03965962|79563769|FG000|Overall Study|Lost to Follow-up|0|||
44548767|NCT03965962|79563770|FG001|Overall Study|Lost to Follow-up|1|||
44548768|NCT03965962|79563771|FG002|Overall Study|Lost to Follow-up|0|||
44548769|NCT03965962|79563772|FG003|Overall Study|Lost to Follow-up|0|||
44548770|NCT03965962|79563769|FG000|Overall Study|Withdrawal by Subject|3|||
44548771|NCT03965962|79563770|FG001|Overall Study|Withdrawal by Subject|0|||
44548772|NCT03965962|79563771|FG002|Overall Study|Withdrawal by Subject|0|||
44548773|NCT03965962|79563772|FG003|Overall Study|Withdrawal by Subject|1|||
44548774|NCT03151551|79563784|FG000|Open-Label Treatment Period|Adverse Event|0|||
44548775|NCT03151551|79563785|FG001|Open-Label Treatment Period|Adverse Event|2|||
44548776|NCT03151551|79563784|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
44548777|NCT03151551|79563785|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
44548778|NCT03151551|79563784|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
44548779|NCT03151551|79563785|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
44548780|NCT03151551|79563784|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
44548781|NCT03151551|79563785|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
44548782|NCT03151551|79563784|FG000|Open-Label Treatment Period|Physician Decision|3|||
44548783|NCT03151551|79563785|FG001|Open-Label Treatment Period|Physician Decision|0|||
44548784|NCT03151551|79563784|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
44548785|NCT03151551|79563785|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
44548786|NCT03151551|79563784|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
44548787|NCT03151551|79563785|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
44548788|NCT03151551|79563784|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
44548789|NCT03151551|79563785|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
44548790|NCT03151551|79563784|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
44548791|NCT03151551|79563785|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
44548792|NCT03151551|79563784|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
44548793|NCT03151551|79563785|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
44548794|NCT03147495|79563795|FG000|Overall Study|Physician Decision|0|||
44230263|NCT00087555|79038849|FG000|Overall Study|Non Compliance|0|||
44230264|NCT00087555|79038850|FG001|Overall Study|Non Compliance|0|||
44548795|NCT03147495|79563796|FG001|Overall Study|Physician Decision|6|||
44548796|NCT03126786|79563804|FG000|Overall Study|Adverse Event|3|||
44548797|NCT03126786|79563805|FG001|Overall Study|Adverse Event|0|||
44230265|NCT00087555|79038851|FG002|Overall Study|Non Compliance|1|||
44230266|NCT00087555|79038849|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
44230267|NCT00087555|79038850|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
44230268|NCT00087555|79038851|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
44548798|NCT03126786|79563804|FG000|Overall Study|Lost to Follow-up|0|||
44548799|NCT03126786|79563805|FG001|Overall Study|Lost to Follow-up|1|||
44548800|NCT03126786|79563804|FG000|Overall Study|Withdrawal by Subject|3|||
44548801|NCT03126786|79563805|FG001|Overall Study|Withdrawal by Subject|1|||
44548802|NCT03146403|79563813|FG000|Overall Study|Withdrawal by Subject|0|||
44548803|NCT03146403|79563814|FG001|Overall Study|Withdrawal by Subject|3|||
44548804|NCT03146403|79563813|FG000|Overall Study|Lost to Follow-up|2|||
44274701|NCT02243202|79220514|FG001|Overall Study|Withdrawal by Subject|6|||
44548805|NCT03146403|79563814|FG001|Overall Study|Lost to Follow-up|0|||
44548806|NCT02713204|79563823|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
44548807|NCT02713204|79563824|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
44548808|NCT02713204|79563825|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
44548809|NCT02713204|79563826|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
44548810|NCT02713204|79563827|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
44548811|NCT02713204|79563828|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
44548812|NCT02713204|79563829|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
44548813|NCT02713204|79563830|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
44548814|NCT02713204|79563823|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548815|NCT02713204|79563824|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548816|NCT02713204|79563825|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
44548817|NCT02713204|79563826|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548818|NCT02713204|79563827|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548819|NCT02713204|79563828|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548820|NCT02713204|79563829|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548821|NCT02713204|79563830|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44548822|NCT02713204|79563823|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548823|NCT02713204|79563824|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
44548824|NCT02713204|79563825|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548825|NCT02713204|79563826|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548826|NCT02713204|79563827|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548827|NCT02713204|79563828|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548828|NCT02713204|79563829|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548829|NCT02713204|79563830|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44548830|NCT02713204|79563823|FG000|From Week 12 up to Week 36|Adverse Event|1|||
44548831|NCT02713204|79563824|FG001|From Week 12 up to Week 36|Adverse Event|0|||
44548832|NCT02713204|79563825|FG002|From Week 12 up to Week 36|Adverse Event|0|||
44548833|NCT02713204|79563826|FG003|From Week 12 up to Week 36|Adverse Event|1|||
44548834|NCT02713204|79563827|FG004|From Week 12 up to Week 36|Adverse Event|1|||
44548835|NCT02713204|79563828|FG005|From Week 12 up to Week 36|Adverse Event|0|||
44548836|NCT02713204|79563829|FG006|From Week 12 up to Week 36|Adverse Event|2|||
44548837|NCT02713204|79563830|FG007|From Week 12 up to Week 36|Adverse Event|1|||
44548838|NCT02713204|79563823|FG000|From Week 12 up to Week 36|Death|0|||
44548839|NCT02713204|79563824|FG001|From Week 12 up to Week 36|Death|0|||
44548840|NCT02713204|79563825|FG002|From Week 12 up to Week 36|Death|0|||
44548841|NCT02713204|79563826|FG003|From Week 12 up to Week 36|Death|1|||
44548842|NCT02713204|79563827|FG004|From Week 12 up to Week 36|Death|0|||
44548843|NCT02713204|79563828|FG005|From Week 12 up to Week 36|Death|1|||
44548844|NCT02713204|79563829|FG006|From Week 12 up to Week 36|Death|0|||
44548845|NCT02713204|79563830|FG007|From Week 12 up to Week 36|Death|3|||
44548846|NCT02713204|79563823|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548847|NCT02713204|79563824|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548848|NCT02713204|79563825|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548849|NCT02713204|79563826|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
44548850|NCT02713204|79563827|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548851|NCT02713204|79563828|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548852|NCT02713204|79563829|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548853|NCT02713204|79563830|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
44548854|NCT02713204|79563823|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
44548855|NCT02713204|79563824|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
44548856|NCT02713204|79563825|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
44548857|NCT02713204|79563826|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
44548858|NCT02713204|79563827|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
44548859|NCT02713204|79563828|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
44548860|NCT02713204|79563829|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
44548861|NCT02713204|79563830|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
44548862|NCT03695172|79563850|FG000|Overall Study|Withdrawal by Subject|1|||
44548863|NCT03695172|79563851|FG001|Overall Study|Withdrawal by Subject|1|||
44548864|NCT03695172|79563852|FG002|Overall Study|Withdrawal by Subject|0|||
44548865|NCT03721107|79563864|FG000|Overall Study|Adverse Event|1|||
44548866|NCT03721107|79563865|FG001|Overall Study|Adverse Event|1|||
44548867|NCT03721107|79563866|FG002|Overall Study|Adverse Event|6|||
44548868|NCT03721107|79563867|FG003|Overall Study|Adverse Event|5|||
44548869|NCT03721107|79563864|FG000|Overall Study|Lost to Follow-up|2|||
44548870|NCT03721107|79563865|FG001|Overall Study|Lost to Follow-up|0|||
44548871|NCT03721107|79563866|FG002|Overall Study|Lost to Follow-up|3|||
44548872|NCT03721107|79563867|FG003|Overall Study|Lost to Follow-up|0|||
44548873|NCT03721107|79563864|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
44548874|NCT03721107|79563865|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
44376483|NCT00866788|79381616|FG000|Overall Study|Disease progression|3|||
44376484|NCT00866788|79381617|FG001|Overall Study|Disease progression|1|||
44548875|NCT03721107|79563866|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
44548876|NCT03721107|79563867|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
44548877|NCT03721107|79563864|FG000|Overall Study|Physician Decision|0|||
44548878|NCT03721107|79563865|FG001|Overall Study|Physician Decision|1|||
44548879|NCT03721107|79563866|FG002|Overall Study|Physician Decision|0|||
44548880|NCT03721107|79563867|FG003|Overall Study|Physician Decision|0|||
44548881|NCT03721107|79563864|FG000|Overall Study|Pregnancy|0|||
44548882|NCT03721107|79563865|FG001|Overall Study|Pregnancy|0|||
44548883|NCT03721107|79563866|FG002|Overall Study|Pregnancy|1|||
44548884|NCT03721107|79563867|FG003|Overall Study|Pregnancy|0|||
44548885|NCT03721107|79563864|FG000|Overall Study|Withdrawal by Subject|1|||
44548886|NCT03721107|79563865|FG001|Overall Study|Withdrawal by Subject|1|||
44548887|NCT03721107|79563866|FG002|Overall Study|Withdrawal by Subject|5|||
44548888|NCT03721107|79563867|FG003|Overall Study|Withdrawal by Subject|5|||
44548889|NCT03721107|79563864|FG000|Overall Study|Other|1|||
44548890|NCT03721107|79563865|FG001|Overall Study|Other|0|||
44548891|NCT03721107|79563866|FG002|Overall Study|Other|0|||
44548892|NCT03721107|79563867|FG003|Overall Study|Other|1|||
44548893|NCT03052920|79563886|FG000|Overall Study|Withdrawal by Subject|1|||
44548894|NCT02930226|79563896|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
44548895|NCT02930226|79563897|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
44548896|NCT02930226|79563898|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
44548897|NCT02930226|79563899|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
44548898|NCT02930226|79563900|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
44548899|NCT02930226|79563901|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
44548900|NCT02722434|79563938|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
44548901|NCT02722434|79563939|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
44548902|NCT02722434|79563938|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
44548903|NCT02722434|79563939|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
44548904|NCT03539601|79563949|FG000|Overall Study|Withdraw by parent/guardian|1|||
44548905|NCT03539601|79563950|FG001|Overall Study|Withdraw by parent/guardian|0|||
44548906|NCT03539601|79563951|FG002|Overall Study|Withdraw by parent/guardian|1|||
44548907|NCT03539601|79563952|FG003|Overall Study|Withdraw by parent/guardian|0|||
44548908|NCT03539601|79563949|FG000|Overall Study|Adverse Event|0|||
44548909|NCT03539601|79563950|FG001|Overall Study|Adverse Event|2|||
44548910|NCT03539601|79563951|FG002|Overall Study|Adverse Event|0|||
44548911|NCT03539601|79563952|FG003|Overall Study|Adverse Event|0|||
44548912|NCT03539601|79563949|FG000|Overall Study|Lost to Follow-up|2|||
44548913|NCT03539601|79563950|FG001|Overall Study|Lost to Follow-up|4|||
44548914|NCT03539601|79563951|FG002|Overall Study|Lost to Follow-up|5|||
44548915|NCT03539601|79563952|FG003|Overall Study|Lost to Follow-up|0|||
44548916|NCT03539601|79563949|FG000|Overall Study|Withdrawal by Subject|2|||
44548917|NCT03539601|79563950|FG001|Overall Study|Withdrawal by Subject|0|||
44548918|NCT03539601|79563951|FG002|Overall Study|Withdrawal by Subject|0|||
44548919|NCT03539601|79563952|FG003|Overall Study|Withdrawal by Subject|1|||
44548920|NCT03539601|79563949|FG000|Overall Study|Randomized but not treated|1|||
44548921|NCT03539601|79563950|FG001|Overall Study|Randomized but not treated|1|||
44548922|NCT03539601|79563951|FG002|Overall Study|Randomized but not treated|0|||
44548923|NCT03539601|79563952|FG003|Overall Study|Randomized but not treated|0|||
44548924|NCT00700804|79563972|FG000|Overall Study|Withdrawal by Subject|1|||
44548925|NCT00700804|79563973|FG001|Overall Study|Withdrawal by Subject|2|||
44548926|NCT00700804|79563972|FG000|Overall Study|Protocol Violation|1|||
44548927|NCT00700804|79563973|FG001|Overall Study|Protocol Violation|1|||
44548928|NCT00700804|79563972|FG000|Overall Study|Loose Stools|1|||
44548929|NCT00700804|79563973|FG001|Overall Study|Loose Stools|1|||
44548930|NCT02903823|79563979|FG000|Overall Study|Physician Decision|5|||
44548931|NCT02903823|79563979|FG000|Overall Study|Could not advance catheter|1|||
44548932|NCT02903823|79563979|FG000|Overall Study|Catheter dislodgement|1|||
44548933|NCT00832455|79564008|FG000|Overall Study|Adverse Event|13|||
44548934|NCT00832455|79564008|FG000|Overall Study|Lost to Follow-up|26|||
44548935|NCT00832455|79564008|FG000|Overall Study|Protocol Violation|4|||
44548936|NCT00832455|79564008|FG000|Overall Study|Withdrawal by Subject|17|||
44548937|NCT00832455|79564008|FG000|Overall Study|Screening Failure|2|||
44548938|NCT00832455|79564008|FG000|Overall Study|Stopped Medication|4|||
44548939|NCT00832455|79564008|FG000|Overall Study|Parent misunderstood study|1|||
44548940|NCT00832455|79564008|FG000|Overall Study|Parent dissatisfied|1|||
44548941|NCT00832455|79564008|FG000|Overall Study|No improvement|3|||
44548942|NCT00832455|79564008|FG000|Overall Study|Patient moved|1|||
44548943|NCT00687531|79564021|FG000|Overall Study|Did not meet protocol eligibility|104|||
44548944|NCT00687531|79564021|FG000|Overall Study|Adverse Event|5|||
44548945|NCT00687531|79564021|FG000|Overall Study|Lost to Follow-up|26|||
44548946|NCT00423579|79564027|FG000|Overall Study|Lost to Follow-up|3|||
44548947|NCT00423579|79564028|FG001|Overall Study|Lost to Follow-up|0|||
44548948|NCT00423579|79564027|FG000|Overall Study|Protocol Violation|1|||
44548949|NCT00423579|79564028|FG001|Overall Study|Protocol Violation|3|||
44548950|NCT00423579|79564027|FG000|Overall Study|Diagnosis of diabetes|0|||
44548951|NCT00423579|79564028|FG001|Overall Study|Diagnosis of diabetes|1|||
44548952|NCT03268005|79564041|FG000|Overall Study|Death|2|||
44548953|NCT03268005|79564042|FG001|Overall Study|Death|1|||
44548954|NCT03268005|79564041|FG000|Overall Study|Lost to Follow-up|2|||
44548955|NCT03268005|79564042|FG001|Overall Study|Lost to Follow-up|2|||
44548956|NCT03268005|79564041|FG000|Overall Study|Withdrawal by Subject|11|||
44548957|NCT03268005|79564042|FG001|Overall Study|Withdrawal by Subject|11|||
44548958|NCT03149055|79564048|FG000|Overall Study|Not treated|4|||
44548959|NCT03137121|79564063|FG000|Overall Study|Withdrawal by Subject|0|||
44548960|NCT03137121|79564064|FG001|Overall Study|Withdrawal by Subject|1|||
44548961|NCT00700570|79564107|FG000|Overall Study|Adverse Event|2|||
44548962|NCT00700570|79564108|FG001|Overall Study|Adverse Event|6|||
44548963|NCT00700570|79564107|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
44548964|NCT00700570|79564108|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
44548965|NCT00700570|79564107|FG000|Overall Study|Disease Progression|8|||
44548966|NCT00700570|79564108|FG001|Overall Study|Disease Progression|11|||
44548967|NCT00700570|79564107|FG000|Overall Study|Withdrawal by Subject|1|||
44548968|NCT00700570|79564108|FG001|Overall Study|Withdrawal by Subject|6|||
44548969|NCT02874924|79564126|FG000|Overall Study|Adverse Event|2|||
44548970|NCT02874924|79564127|FG001|Overall Study|Adverse Event|0|||
44548971|NCT02874924|79564128|FG002|Overall Study|Adverse Event|0|||
44548972|NCT02874924|79564126|FG000|Overall Study|Withdrawal by Subject|1|||
44548973|NCT02874924|79564127|FG001|Overall Study|Withdrawal by Subject|0|||
44548974|NCT02874924|79564128|FG002|Overall Study|Withdrawal by Subject|0|||
44548975|NCT04425863|79564139|FG000|Overall Study|Death|0|||
44548976|NCT04425863|79564140|FG001|Overall Study|Death|0|||
44548977|NCT04425863|79564141|FG002|Overall Study|Death|1|||
44548978|NCT04360187|79564163|FG000|Double-Blind Treatment|Adverse Event|9|||
44548979|NCT04360187|79564164|FG001|Double-Blind Treatment|Adverse Event|11|||
44548980|NCT04360187|79564163|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
44548981|NCT04360187|79564164|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
44548982|NCT04360187|79564163|FG000|Double-Blind Treatment|Physician Decision|1|||
44548983|NCT04360187|79564164|FG001|Double-Blind Treatment|Physician Decision|0|||
44548984|NCT04360187|79564163|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
44548985|NCT04360187|79564164|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
44548986|NCT04360187|79564163|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
44548987|NCT04360187|79564164|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
44548988|NCT04360187|79564163|FG000|Follow-Up|Lost to Follow-up|1|||
44376485|NCT00866788|79381618|FG002|Overall Study|Disease progression|1|||
44548989|NCT04360187|79564164|FG001|Follow-Up|Lost to Follow-up|0|||
44548990|NCT04498169|79564172|FG000|Study Completion|Adverse Event|1|||
44548991|NCT04498169|79564173|FG001|Study Completion|Adverse Event|1|||
44548992|NCT03695393|79564181|FG000|Overall Study|Death|3|||
44548993|NCT03695393|79564182|FG001|Overall Study|Death|1|||
44548994|NCT03695393|79564181|FG000|Overall Study|Lost to Follow-up|0|||
44548995|NCT03695393|79564182|FG001|Overall Study|Lost to Follow-up|1|||
44548996|NCT03694925|79564191|FG000|Overall Study|Inadequate laboratory testing|0|||
44548997|NCT03694925|79564192|FG001|Overall Study|Inadequate laboratory testing|3|||
44548998|NCT03694925|79564193|FG002|Overall Study|Inadequate laboratory testing|0|||
44548999|NCT04258020|79564205|FG000|Overall Study|Withdrawal by Subject|1|||
44549000|NCT04258020|79564206|FG001|Overall Study|Withdrawal by Subject|0|||
44549001|NCT04495283|79564215|FG000|Overall Study|Physician Decision|0|||
44549002|NCT04495283|79564216|FG001|Overall Study|Physician Decision|0|||
44549003|NCT04495283|79564217|FG002|Overall Study|Physician Decision|1|||
44549004|NCT04495283|79564215|FG000|Overall Study|Withdrawal by Subject|0|||
44549005|NCT04495283|79564216|FG001|Overall Study|Withdrawal by Subject|1|||
44549006|NCT04495283|79564217|FG002|Overall Study|Withdrawal by Subject|1|||
44549007|NCT04495283|79564215|FG000|Overall Study|Other|1|||
44549008|NCT04495283|79564216|FG001|Overall Study|Other|0|||
44549009|NCT04495283|79564217|FG002|Overall Study|Other|1|||
44549010|NCT03117738|79564230|FG000|Overall Study|Withdrawal by Subject|3|||
44549011|NCT03117738|79564231|FG001|Overall Study|Withdrawal by Subject|1|||
44549012|NCT03117738|79564230|FG000|Overall Study|Lost to Follow-up|1|||
44549013|NCT03117738|79564231|FG001|Overall Study|Lost to Follow-up|4|||
44549014|NCT04234464|79564239|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
44549015|NCT04234464|79564240|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
44549016|NCT03123588|79564248|FG000|Overall Study|Study Terminated by Sponsor|2|||
44549017|NCT03123588|79564249|FG001|Overall Study|Study Terminated by Sponsor|5|||
44549018|NCT03123588|79564248|FG000|Overall Study|Withdrawal by Subject|1|||
44549019|NCT03123588|79564249|FG001|Overall Study|Withdrawal by Subject|0|||
44549020|NCT03123588|79564248|FG000|Overall Study|Adverse Event|1|||
44549021|NCT03123588|79564249|FG001|Overall Study|Adverse Event|0|||
44549022|NCT03123588|79564248|FG000|Overall Study|Physician Decision|2|||
44549023|NCT03123588|79564249|FG001|Overall Study|Physician Decision|1|||
44549024|NCT03123354|79564256|FG000|Overall Study|Physician Decision|6|||
44549025|NCT04421027|79564262|FG000|Treatment Period|Adverse Event|5|||
44549026|NCT04421027|79564263|FG001|Treatment Period|Adverse Event|3|||
44549027|NCT04421027|79564264|FG002|Treatment Period|Adverse Event|0|||
44549028|NCT04421027|79564265|FG003|Treatment Period|Adverse Event|0|||
44549029|NCT04421027|79564262|FG000|Treatment Period|Death|98|||
44549030|NCT04421027|79564263|FG001|Treatment Period|Death|61|||
44549031|NCT04421027|79564264|FG002|Treatment Period|Death|0|||
44549032|NCT04421027|79564265|FG003|Treatment Period|Death|0|||
44549033|NCT04421027|79564262|FG000|Treatment Period|Lost to Follow-up|22|||
44549034|NCT04421027|79564263|FG001|Treatment Period|Lost to Follow-up|20|||
44549035|NCT04421027|79564264|FG002|Treatment Period|Lost to Follow-up|0|||
44549036|NCT04421027|79564265|FG003|Treatment Period|Lost to Follow-up|0|||
44549037|NCT04421027|79564262|FG000|Treatment Period|Other-Unknown|15|||
44549038|NCT04421027|79564263|FG001|Treatment Period|Other-Unknown|9|||
44549039|NCT04421027|79564264|FG002|Treatment Period|Other-Unknown|0|||
44549040|NCT04421027|79564265|FG003|Treatment Period|Other-Unknown|0|||
44549041|NCT04421027|79564262|FG000|Treatment Period|Physician Decision|1|||
44549042|NCT04421027|79564263|FG001|Treatment Period|Physician Decision|1|||
44549043|NCT04421027|79564264|FG002|Treatment Period|Physician Decision|0|||
44549044|NCT04421027|79564265|FG003|Treatment Period|Physician Decision|0|||
44549045|NCT04421027|79564262|FG000|Treatment Period|Withdrawal by Subject|7|||
44549046|NCT04421027|79564263|FG001|Treatment Period|Withdrawal by Subject|12|||
44549047|NCT04421027|79564264|FG002|Treatment Period|Withdrawal by Subject|0|||
44549048|NCT04421027|79564265|FG003|Treatment Period|Withdrawal by Subject|0|||
44549049|NCT04421027|79564262|FG000|Treatment Period|Randomized Not Dosed|9|||
44549050|NCT04421027|79564263|FG001|Treatment Period|Randomized Not Dosed|14|||
44549051|NCT04421027|79564264|FG002|Treatment Period|Randomized Not Dosed|0|||
44549052|NCT04421027|79564265|FG003|Treatment Period|Randomized Not Dosed|0|||
44549053|NCT04421027|79564262|FG000|Follow-Up Period|Adverse Event|0|||
44549054|NCT04421027|79564263|FG001|Follow-Up Period|Adverse Event|0|||
44549055|NCT04421027|79564264|FG002|Follow-Up Period|Adverse Event|0|||
44549056|NCT04421027|79564265|FG003|Follow-Up Period|Adverse Event|3|||
44549057|NCT04421027|79564262|FG000|Follow-Up Period|Death|0|||
44549058|NCT04421027|79564263|FG001|Follow-Up Period|Death|0|||
44549059|NCT04421027|79564264|FG002|Follow-Up Period|Death|16|||
44549060|NCT04421027|79564265|FG003|Follow-Up Period|Death|17|||
44549061|NCT04421027|79564262|FG000|Follow-Up Period|Lost to Follow-up|0|||
44549062|NCT04421027|79564263|FG001|Follow-Up Period|Lost to Follow-up|0|||
44549063|NCT04421027|79564264|FG002|Follow-Up Period|Lost to Follow-up|7|||
44549064|NCT04421027|79564265|FG003|Follow-Up Period|Lost to Follow-up|7|||
44549065|NCT04421027|79564262|FG000|Follow-Up Period|Protocol Deviation|0|||
44549066|NCT04421027|79564263|FG001|Follow-Up Period|Protocol Deviation|0|||
44549067|NCT04421027|79564264|FG002|Follow-Up Period|Protocol Deviation|1|||
44549068|NCT04421027|79564265|FG003|Follow-Up Period|Protocol Deviation|0|||
44549069|NCT04421027|79564262|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
44549070|NCT04421027|79564263|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
44549071|NCT04421027|79564264|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
44549072|NCT04421027|79564265|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
44549073|NCT04421027|79564262|FG000|Follow-Up Period|Left message, participant did not call back|0|||
44549074|NCT04421027|79564263|FG001|Follow-Up Period|Left message, participant did not call back|0|||
44549075|NCT04421027|79564264|FG002|Follow-Up Period|Left message, participant did not call back|0|||
44549076|NCT04421027|79564265|FG003|Follow-Up Period|Left message, participant did not call back|1|||
44549077|NCT04421027|79564262|FG000|Follow-Up Period|Participant died|0|||
44549078|NCT04421027|79564263|FG001|Follow-Up Period|Participant died|0|||
44549079|NCT04421027|79564264|FG002|Follow-Up Period|Participant died|0|||
44549080|NCT04421027|79564265|FG003|Follow-Up Period|Participant died|1|||
44549081|NCT04421027|79564262|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
44549082|NCT04421027|79564263|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
44549083|NCT04421027|79564264|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
44549084|NCT04421027|79564265|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
44549085|NCT04419311|79564275|FG000|Overall Study|Lost to Follow-up|1|||
44549086|NCT04419311|79564276|FG001|Overall Study|Lost to Follow-up|0|||
44549087|NCT04411667|79564286|FG000|Overall Study|Physician Decision|1|||
44549088|NCT04411667|79564287|FG001|Overall Study|Physician Decision|0|||
44549089|NCT04358549|79564295|FG000|Overall Study|Adverse Event|0|||
44549090|NCT04358549|79564296|FG001|Overall Study|Adverse Event|1|||
44549091|NCT04358549|79564295|FG000|Overall Study|Death|1|||
44549092|NCT04358549|79564296|FG001|Overall Study|Death|0|||
44549093|NCT04358549|79564295|FG000|Overall Study|Lost to Follow-up|2|||
44549094|NCT04358549|79564296|FG001|Overall Study|Lost to Follow-up|1|||
44549095|NCT04358549|79564295|FG000|Overall Study|Withdrawal by Subject|6|||
44549096|NCT04358549|79564296|FG001|Overall Study|Withdrawal by Subject|6|||
44549097|NCT04358549|79564295|FG000|Overall Study|Start remdesivir|1|||
44549098|NCT04358549|79564296|FG001|Overall Study|Start remdesivir|0|||
44549099|NCT00700180|79564304|FG000|Overall Study|Death|99|||
44549100|NCT00700180|79564305|FG001|Overall Study|Death|114|||
44549101|NCT00700180|79564304|FG000|Overall Study|Alive on treatment|5|||
44549102|NCT00700180|79564305|FG001|Overall Study|Alive on treatment|3|||
44549103|NCT00700180|79564304|FG000|Overall Study|Alive in follow-up|46|||
44549104|NCT00700180|79564305|FG001|Overall Study|Alive in follow-up|27|||
44549105|NCT00700180|79564304|FG000|Overall Study|Lost to Follow-up|4|||
44549106|NCT00700180|79564305|FG001|Overall Study|Lost to Follow-up|5|||
44549107|NCT00238420|79564313|FG000|Overall Study|Protocol Violation|1|||
44549108|NCT00238420|79564314|FG001|Overall Study|Protocol Violation|1|||
44549109|NCT04492475|79564322|FG000|Overall Study|Enrolled but not treated|8|||
44549110|NCT04492475|79564323|FG001|Overall Study|Enrolled but not treated|8|||
44549111|NCT04492475|79564322|FG000|Overall Study|Withdrawal by Subject|4|||
44549112|NCT04492475|79564323|FG001|Overall Study|Withdrawal by Subject|0|||
44549113|NCT04492475|79564322|FG000|Overall Study|Became ineligible after enrollment|2|||
44549114|NCT04492475|79564323|FG001|Overall Study|Became ineligible after enrollment|0|||
44549115|NCT04486235|79564338|FG000|Overall Study|Pregnancy|1|||
44549116|NCT04486235|79564339|FG001|Overall Study|Pregnancy|0|||
44549117|NCT04486235|79564338|FG000|Overall Study|Lost to Follow-up|1|||
44549118|NCT04486235|79564339|FG001|Overall Study|Lost to Follow-up|0|||
44549119|NCT04358081|79564349|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
44549120|NCT04358081|79564350|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
44549121|NCT04358081|79564351|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
44549122|NCT04358081|79564349|FG000|Treatment Phase of Study|Adverse Event|1|||
44549123|NCT04358081|79564350|FG001|Treatment Phase of Study|Adverse Event|0|||
44549124|NCT04358081|79564351|FG002|Treatment Phase of Study|Adverse Event|1|||
44549125|NCT04358081|79564349|FG000|Treatment Phase of Study|Physician Decision|2|||
44549126|NCT04358081|79564350|FG001|Treatment Phase of Study|Physician Decision|0|||
44549127|NCT04358081|79564351|FG002|Treatment Phase of Study|Physician Decision|1|||
44549128|NCT04358081|79564349|FG000|Treatment Phase of Study|Protocol Violation|1|||
44549129|NCT04358081|79564350|FG001|Treatment Phase of Study|Protocol Violation|0|||
44549130|NCT04358081|79564351|FG002|Treatment Phase of Study|Protocol Violation|0|||
44549131|NCT04358081|79564349|FG000|Study Completion Phase|Death|0|||
44549132|NCT04358081|79564350|FG001|Study Completion Phase|Death|0|||
44549133|NCT04358081|79564351|FG002|Study Completion Phase|Death|1|||
44549134|NCT04358081|79564349|FG000|Study Completion Phase|Lost to Follow-up|1|||
44549135|NCT04358081|79564350|FG001|Study Completion Phase|Lost to Follow-up|0|||
44549136|NCT04358081|79564351|FG002|Study Completion Phase|Lost to Follow-up|1|||
44549137|NCT04355663|79564364|FG000|Overall Study|Physician Decision|2|||
44549138|NCT04355663|79564365|FG001|Overall Study|Physician Decision|7|||
44549139|NCT04355663|79564366|FG002|Overall Study|Physician Decision|0|||
44549140|NCT04355663|79564364|FG000|Overall Study|Adverse Event|0|||
44549141|NCT04355663|79564365|FG001|Overall Study|Adverse Event|0|||
44549142|NCT04355663|79564366|FG002|Overall Study|Adverse Event|1|||
44549143|NCT04355663|79564364|FG000|Overall Study|Withdrawal by Subject|0|||
44549144|NCT04355663|79564365|FG001|Overall Study|Withdrawal by Subject|8|||
44549145|NCT04355663|79564366|FG002|Overall Study|Withdrawal by Subject|3|||
44549146|NCT04345367|79564376|FG000|Overall Study|Other|3|||
44549147|NCT04345367|79564377|FG001|Overall Study|Other|4|||
44549148|NCT04345367|79564376|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
44549149|NCT04345367|79564377|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
44549150|NCT04345367|79564376|FG000|Overall Study|Withdrawal by Subject|11|||
44549151|NCT04345367|79564377|FG001|Overall Study|Withdrawal by Subject|11|||
44549152|NCT04345367|79564376|FG000|Overall Study|Protocol Violation|4|||
44549153|NCT04345367|79564377|FG001|Overall Study|Protocol Violation|3|||
44549154|NCT04345367|79564376|FG000|Overall Study|Lost to Follow-up|2|||
44549155|NCT04345367|79564377|FG001|Overall Study|Lost to Follow-up|4|||
44549156|NCT04345367|79564376|FG000|Overall Study|Lack of Efficacy|2|||
44549157|NCT04345367|79564377|FG001|Overall Study|Lack of Efficacy|0|||
44549158|NCT04345367|79564376|FG000|Overall Study|Death|2|||
44549159|NCT04345367|79564377|FG001|Overall Study|Death|0|||
44549160|NCT04345367|79564376|FG000|Overall Study|Adverse Event|10|||
44376486|NCT00866788|79381619|FG003|Overall Study|Disease progression|0|||
44376487|NCT00866788|79381616|FG000|Overall Study|Physician Decision|0|||
44549161|NCT04345367|79564377|FG001|Overall Study|Adverse Event|9|||
44549162|NCT04404725|79564383|FG000|First Intervention|Withdrawal by Subject|0|||
44549163|NCT04404725|79564384|FG001|First Intervention|Withdrawal by Subject|2|||
44549164|NCT04404725|79564383|FG000|Second Intervention|Adverse Event|1|||
44549165|NCT04404725|79564384|FG001|Second Intervention|Adverse Event|1|||
44549166|NCT04404725|79564383|FG000|Second Intervention|Withdrawal by Subject|0|||
44549167|NCT04404725|79564384|FG001|Second Intervention|Withdrawal by Subject|1|||
44549168|NCT04343261|79564390|FG000|Overall Study|Adverse Event|1|||
44549169|NCT04343261|79564390|FG000|Overall Study|received inadequate amount of antibodies|7|||
44549170|NCT04336475|79564396|FG000|Overall Study|pain|1|||
44549171|NCT04336475|79564397|FG001|Overall Study|pain|0|||
44549172|NCT04336475|79564396|FG000|Overall Study|upper respiratory infection|1|||
44549173|NCT04336475|79564397|FG001|Overall Study|upper respiratory infection|0|||
44549174|NCT04336475|79564396|FG000|Overall Study|Lost to Follow-up|0|||
44376488|NCT00866788|79381617|FG001|Overall Study|Physician Decision|0|||
44549175|NCT04336475|79564397|FG001|Overall Study|Lost to Follow-up|2|||
44549176|NCT04335929|79564403|FG000|Overall Study|Lost to Follow-up|10|||
44549177|NCT04333199|79564410|FG000|Evaluated Patients|Lost to Follow-up|0|||
44549178|NCT04333199|79564411|FG001|Evaluated Patients|Lost to Follow-up|1|||
44549179|NCT04333199|79564412|FG002|Evaluated Patients|Lost to Follow-up|2|||
44549180|NCT04332419|79564421|FG000|Overall Study|Withdrawal by Subject|1|||
44549181|NCT04330157|79564425|FG000|Overall Study|Protocol Violation|4|||
44549182|NCT04330157|79564425|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
44549183|NCT04329923|79564440|FG000|Overall Study|Withdrawal by Subject|1|||
44549184|NCT04329923|79564441|FG001|Overall Study|Withdrawal by Subject|4|||
44549185|NCT04329923|79564442|FG002|Overall Study|Withdrawal by Subject|1|||
44549186|NCT04329923|79564443|FG003|Overall Study|Withdrawal by Subject|1|||
44549187|NCT04329923|79564444|FG004|Overall Study|Withdrawal by Subject|1|||
44549188|NCT04329923|79564445|FG005|Overall Study|Withdrawal by Subject|1|||
44494242|NCT03835481|79499977|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
44494243|NCT03835481|79499978|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
44376489|NCT00866788|79381618|FG002|Overall Study|Physician Decision|1|||
44494244|NCT03835481|79499974|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
44549189|NCT04329923|79564440|FG000|Overall Study|early termination of study|0|||
44549190|NCT04329923|79564441|FG001|Overall Study|early termination of study|0|||
44549191|NCT04329923|79564442|FG002|Overall Study|early termination of study|0|||
44549192|NCT04329923|79564443|FG003|Overall Study|early termination of study|0|||
44549193|NCT04329923|79564444|FG004|Overall Study|early termination of study|1|||
44549194|NCT04329923|79564445|FG005|Overall Study|early termination of study|2|||
44549195|NCT04329923|79564440|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
44549196|NCT04329923|79564441|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
44549197|NCT04329923|79564442|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
44549198|NCT04329923|79564443|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
44549199|NCT04329923|79564444|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
44549200|NCT04329923|79564445|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
44549201|NCT04403399|79564461|FG000|Period 2|Physician Decision|0|||
44549202|NCT04403399|79564462|FG001|Period 2|Physician Decision|1|||
44549203|NCT04401293|79564470|FG000|Overall Study|Withdrawal by Subject|1|||
44549204|NCT04401293|79564471|FG001|Overall Study|Withdrawal by Subject|3|||
44549205|NCT04319159|79564479|FG000|Overall Study|Screening failure|13|||
44549206|NCT04319159|79564479|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
44549207|NCT04319159|79564479|FG000|Overall Study|Withdrawal by Subject|1|||
44549208|NCT04318535|79564485|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
44494245|NCT03835481|79499975|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
44494246|NCT03835481|79499976|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
44494247|NCT03835481|79499977|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
44494248|NCT03835481|79499978|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
44494249|NCT03835481|79499974|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
44494250|NCT03835481|79499975|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
44494251|NCT03835481|79499976|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
44494252|NCT03835481|79499977|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
44494253|NCT03835481|79499978|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
44494254|NCT03709576|79500025|FG000|Overall Study|progression prior to enrollment|1|||
44494255|NCT00122460|79500032|FG000|Overall Study|investigational study phase ongoing|7|||
44494256|NCT00122460|79500033|FG001|Overall Study|investigational study phase ongoing|1|||
44494257|NCT00137436|79500039|FG000|Overall Study|Adverse Event|13|||
44494258|NCT00137436|79500039|FG000|Overall Study|Death|2|||
44494259|NCT00137436|79500039|FG000|Overall Study|Lack of Efficacy|17|||
44494260|NCT00137436|79500039|FG000|Overall Study|Withdrawal by Subject|6|||
44494261|NCT00137436|79500039|FG000|Overall Study|Other|5|||
44494262|NCT03834623|79500045|FG000|Overall Study|Progression|0|||
44494263|NCT03834623|79500046|FG001|Overall Study|Progression|1|||
44549209|NCT04318535|79564486|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
44549210|NCT04318535|79564487|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
44549211|NCT04454567|79564498|FG000|Overall Study|Study Terminated by Sponsor|1|||
44549212|NCT04454567|79564499|FG001|Overall Study|Study Terminated by Sponsor|1|||
44549213|NCT04449341|79564507|FG000|Overall Study|Protocol Violation|1|||
44549214|NCT04449341|79564508|FG001|Overall Study|Protocol Violation|0|||
44549215|NCT04448561|79564516|FG000|Overall Study|Noncompliance|1|||
44549216|NCT04448561|79564517|FG001|Overall Study|Noncompliance|0|||
44549217|NCT04308239|79564533|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
44549218|NCT04308239|79564534|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
44376490|NCT00866788|79381619|FG003|Overall Study|Physician Decision|1|||
44230269|NCT00087555|79038849|FG000|Overall Study|Patient wanted to go back on Med|1|||
44230270|NCT00087555|79038850|FG001|Overall Study|Patient wanted to go back on Med|0|||
44230271|NCT00087555|79038851|FG002|Overall Study|Patient wanted to go back on Med|0|||
44230272|NCT00086619|79038874|FG000|Overall Study|Withdrawal by Subject|6|||
44230273|NCT00086619|79038875|FG001|Overall Study|Withdrawal by Subject|6|||
44230274|NCT00086619|79038874|FG000|Overall Study|Adverse Event|8|||
44230275|NCT00086619|79038875|FG001|Overall Study|Adverse Event|10|||
44230276|NCT00086619|79038874|FG000|Overall Study|Protocol Violation|1|||
44230277|NCT00086619|79038875|FG001|Overall Study|Protocol Violation|1|||
44230278|NCT00085917|79038888|FG000|Overall Study|Adverse Event|4|||
44230279|NCT00085917|79038889|FG001|Overall Study|Adverse Event|3|||
44230280|NCT00084747|79038895|FG000|Overall Study|Relapsed|8|||
44230281|NCT00084747|79038895|FG000|Overall Study|Death|3|||
44230282|NCT00084747|79038895|FG000|Overall Study|Withdrawal by Subject|2|||
44230283|NCT00081159|79038930|FG000|Overall Study|Withdrawal by Subject|0|||
44230284|NCT00081159|79038931|FG001|Overall Study|Withdrawal by Subject|3|||
44230285|NCT00081159|79038930|FG000|Overall Study|Myelosuppression prior to treatment|0|||
44230286|NCT00081159|79038931|FG001|Overall Study|Myelosuppression prior to treatment|1|||
44230287|NCT00081159|79038930|FG000|Overall Study|Lost to Follow-up|2|||
44230288|NCT00081159|79038931|FG001|Overall Study|Lost to Follow-up|1|||
44230289|NCT00080223|79038946|FG000|Overall Study|Adverse Event|23|||
44230290|NCT00080223|79038946|FG000|Overall Study|Death|21|||
44230291|NCT00080223|79038946|FG000|Overall Study|Withdrawal by Subject|13|||
44230292|NCT00080223|79038946|FG000|Overall Study|Lung Transplantation|9|||
44230293|NCT00080223|79038946|FG000|Overall Study|Non-compliance With Study Treatment|7|||
44230294|NCT00080223|79038946|FG000|Overall Study|Participant unwilling to continue|2|||
44230295|NCT00080223|79038946|FG000|Overall Study|Physician Decision|1|||
44230296|NCT01899053|79039557|FG000|Overall Study|Progressive Disease|4|||
44230297|NCT01899053|79039558|FG001|Overall Study|Progressive Disease|0|||
44230298|NCT01899053|79039559|FG002|Overall Study|Progressive Disease|3|||
44230299|NCT01899053|79039560|FG003|Overall Study|Progressive Disease|0|||
44230300|NCT01899053|79039561|FG004|Overall Study|Progressive Disease|3|||
44230301|NCT01899053|79039562|FG005|Overall Study|Progressive Disease|1|||
44230302|NCT01899053|79039563|FG006|Overall Study|Progressive Disease|1|||
44230303|NCT01899053|79039564|FG007|Overall Study|Progressive Disease|1|||
44230304|NCT01899053|79039565|FG008|Overall Study|Progressive Disease|4|||
44230305|NCT01899053|79039566|FG009|Overall Study|Progressive Disease|3|||
44230306|NCT01899053|79039567|FG010|Overall Study|Progressive Disease|12|||
44230307|NCT01899053|79039568|FG011|Overall Study|Progressive Disease|5|||
44230308|NCT01899053|79039569|FG012|Overall Study|Progressive Disease|8|||
44230309|NCT01899053|79039570|FG013|Overall Study|Progressive Disease|17|||
44376491|NCT00860470|79381634|FG000|Overall Study|Death|6|||
44230310|NCT01899053|79039557|FG000|Overall Study|Adverse Event|1|||
44230311|NCT01899053|79039558|FG001|Overall Study|Adverse Event|1|||
44230312|NCT01899053|79039559|FG002|Overall Study|Adverse Event|1|||
44549219|NCT04308239|79564533|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
44549220|NCT04308239|79564534|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
44549221|NCT04308239|79564533|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
44549222|NCT04308239|79564534|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
44549223|NCT04308239|79564533|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
44549224|NCT04308239|79564534|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
44549225|NCT04302545|79564546|FG000|Overall Study|Lost to Follow-up|3|||
44549226|NCT04302545|79564547|FG001|Overall Study|Lost to Follow-up|4|||
44549227|NCT04297241|79564564|FG000|Overall Study|Withdrawal by Subject|1|||
44549228|NCT04297241|79564564|FG000|Overall Study|Adverse Event|1|||
44549229|NCT04297241|79564564|FG000|Overall Study|Physician Decision|3|||
44549230|NCT04292171|79564580|FG000|Overall Study|Pharmacy error|2|||
44549231|NCT04292171|79564581|FG001|Overall Study|Pharmacy error|0|||
44549232|NCT04292171|79564580|FG000|Overall Study|Delivered prior to procedure|0|||
44549233|NCT04292171|79564581|FG001|Overall Study|Delivered prior to procedure|1|||
44549234|NCT04393493|79564589|FG000|First 4 Days of Intervention|Early improvement|5|||
44549235|NCT04393493|79564590|FG001|First 4 Days of Intervention|Early improvement|7|||
44549236|NCT04280705|79564600|FG000|Overall Study|Enrolled but not treated|4|||
44549237|NCT04280705|79564601|FG001|Overall Study|Enrolled but not treated|10|||
44549238|NCT04280705|79564600|FG000|Overall Study|Physician Decision|1|||
44549239|NCT04280705|79564601|FG001|Overall Study|Physician Decision|0|||
44549240|NCT04280705|79564600|FG000|Overall Study|Withdrawal by Subject|7|||
44549241|NCT04280705|79564601|FG001|Overall Study|Withdrawal by Subject|9|||
44549242|NCT04280705|79564600|FG000|Overall Study|Adverse Event|0|||
44549243|NCT04280705|79564601|FG001|Overall Study|Adverse Event|4|||
44549244|NCT04280705|79564600|FG000|Overall Study|Transferred to another hospital|1|||
44549245|NCT04280705|79564601|FG001|Overall Study|Transferred to another hospital|1|||
44549246|NCT02077166|79564614|FG000|Overall Study|Death|6|||
44549247|NCT02077166|79564615|FG001|Overall Study|Death|7|||
44549248|NCT02077166|79564616|FG002|Overall Study|Death|5|||
44549249|NCT02077166|79564617|FG003|Overall Study|Death|6|||
44549250|NCT02077166|79564618|FG004|Overall Study|Death|4|||
44549251|NCT02077166|79564619|FG005|Overall Study|Death|32|||
44549252|NCT02077166|79564620|FG006|Overall Study|Death|22|||
44549253|NCT02077166|79564614|FG000|Overall Study|Study Closure by Sponsor|3|||
44549254|NCT02077166|79564615|FG001|Overall Study|Study Closure by Sponsor|0|||
44549255|NCT02077166|79564616|FG002|Overall Study|Study Closure by Sponsor|2|||
44549256|NCT02077166|79564617|FG003|Overall Study|Study Closure by Sponsor|2|||
44549257|NCT02077166|79564618|FG004|Overall Study|Study Closure by Sponsor|2|||
44549258|NCT02077166|79564619|FG005|Overall Study|Study Closure by Sponsor|12|||
44549259|NCT02077166|79564620|FG006|Overall Study|Study Closure by Sponsor|4|||
44549260|NCT02077166|79564614|FG000|Overall Study|Lost to Follow-up|0|||
44549261|NCT02077166|79564615|FG001|Overall Study|Lost to Follow-up|0|||
44549262|NCT02077166|79564616|FG002|Overall Study|Lost to Follow-up|0|||
44549263|NCT02077166|79564617|FG003|Overall Study|Lost to Follow-up|0|||
44549264|NCT02077166|79564618|FG004|Overall Study|Lost to Follow-up|0|||
44549265|NCT02077166|79564619|FG005|Overall Study|Lost to Follow-up|1|||
44549266|NCT02077166|79564620|FG006|Overall Study|Lost to Follow-up|0|||
44230313|NCT01899053|79039560|FG003|Overall Study|Adverse Event|3|||
44230314|NCT01899053|79039561|FG004|Overall Study|Adverse Event|1|||
44230315|NCT01899053|79039562|FG005|Overall Study|Adverse Event|1|||
44230316|NCT01899053|79039563|FG006|Overall Study|Adverse Event|1|||
44494264|NCT00410813|79500054|FG000|Overall Study|Adverse Event|6|||
44549267|NCT02077166|79564614|FG000|Overall Study|Withdrawal by Subject|3|||
44230317|NCT01899053|79039564|FG007|Overall Study|Adverse Event|0|||
44494265|NCT00410813|79500055|FG001|Overall Study|Adverse Event|11|||
44494266|NCT00410813|79500054|FG000|Overall Study|Progression|32|||
44494267|NCT00410813|79500055|FG001|Overall Study|Progression|21|||
44494268|NCT00410813|79500054|FG000|Overall Study|Not protocol specified|3|||
44494269|NCT00410813|79500055|FG001|Overall Study|Not protocol specified|4|||
44494270|NCT00410813|79500054|FG000|Overall Study|Ineligible|2|||
44494271|NCT00410813|79500055|FG001|Overall Study|Ineligible|4|||
44494272|NCT00410813|79500054|FG000|Overall Study|Death|0|||
44549268|NCT02077166|79564615|FG001|Overall Study|Withdrawal by Subject|0|||
44549269|NCT02077166|79564616|FG002|Overall Study|Withdrawal by Subject|1|||
44549270|NCT02077166|79564617|FG003|Overall Study|Withdrawal by Subject|1|||
44549271|NCT02077166|79564618|FG004|Overall Study|Withdrawal by Subject|1|||
44549272|NCT02077166|79564619|FG005|Overall Study|Withdrawal by Subject|3|||
44549273|NCT02077166|79564620|FG006|Overall Study|Withdrawal by Subject|0|||
44230318|NCT01899053|79039565|FG008|Overall Study|Adverse Event|2|||
44549274|NCT02077166|79564614|FG000|Overall Study|Other, Not Specified|0|||
44230319|NCT01899053|79039566|FG009|Overall Study|Adverse Event|0|||
44230320|NCT01899053|79039567|FG010|Overall Study|Adverse Event|3|||
44230321|NCT01899053|79039568|FG011|Overall Study|Adverse Event|1|||
44230322|NCT01899053|79039569|FG012|Overall Study|Adverse Event|2|||
44230323|NCT01899053|79039570|FG013|Overall Study|Adverse Event|2|||
44494273|NCT00410813|79500055|FG001|Overall Study|Death|2|||
44494274|NCT00405821|79500086|FG000|Overall Study|Death|5|||
44494275|NCT00405821|79500087|FG001|Overall Study|Death|7|||
44494276|NCT00405821|79500086|FG000|Overall Study|Lost to Follow-up|7|||
44494277|NCT00405821|79500087|FG001|Overall Study|Lost to Follow-up|7|||
44494278|NCT00405821|79500086|FG000|Overall Study|Protocol Violation|1|||
44494279|NCT00405821|79500087|FG001|Overall Study|Protocol Violation|0|||
44494280|NCT00405821|79500086|FG000|Overall Study|initiated ART|9|||
44494281|NCT00405821|79500087|FG001|Overall Study|initiated ART|8|||
44494282|NCT01446016|79500093|FG000|Overall Study|Lost to Follow-up|3|||
44494283|NCT01446016|79500093|FG000|Overall Study|Withdrawal by Subject|1|||
44494284|NCT01446016|79500093|FG000|Overall Study|Toxicity|3|||
44494285|NCT00137046|79500099|FG000|Overall Study|Death|2|||
44494286|NCT00137046|79500100|FG001|Overall Study|Death|1|||
44494287|NCT00137046|79500099|FG000|Overall Study|Adverse Event|16|||
44494288|NCT00137046|79500100|FG001|Overall Study|Adverse Event|5|||
44494289|NCT00137046|79500099|FG000|Overall Study|Laboratory Abnormality|2|||
44494290|NCT00137046|79500100|FG001|Overall Study|Laboratory Abnormality|0|||
44494291|NCT00137046|79500099|FG000|Overall Study|Lack of Efficacy|13|||
44494292|NCT00137046|79500100|FG001|Overall Study|Lack of Efficacy|1|||
44494293|NCT00137046|79500099|FG000|Overall Study|Lost to Follow-up|8|||
44494294|NCT00137046|79500100|FG001|Overall Study|Lost to Follow-up|24|||
44494295|NCT00137046|79500099|FG000|Overall Study|Other|23|||
44494296|NCT00137046|79500100|FG001|Overall Study|Other|19|||
44494297|NCT00137046|79500099|FG000|Overall Study|Withdrawal by Subject|33|||
44494298|NCT00137046|79500100|FG001|Overall Study|Withdrawal by Subject|42|||
44494299|NCT00137046|79500099|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
44494300|NCT00137046|79500100|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
44494301|NCT00137046|79500099|FG000|Overall Study|Withdrew prior to study treatment|1|||
44549275|NCT02077166|79564615|FG001|Overall Study|Other, Not Specified|0|||
44549276|NCT02077166|79564616|FG002|Overall Study|Other, Not Specified|1|||
44230324|NCT01899053|79039557|FG000|Overall Study|Reason Not Specified|0|||
44230325|NCT01899053|79039558|FG001|Overall Study|Reason Not Specified|0|||
44494302|NCT00137046|79500100|FG001|Overall Study|Withdrew prior to study treatment|1|||
44494303|NCT00122382|79500112|FG000|Double-Blind Study|Adverse Event|9|||
44494304|NCT00122382|79500113|FG001|Double-Blind Study|Adverse Event|11|||
44494305|NCT00122382|79500114|FG002|Double-Blind Study|Adverse Event|0|||
44494306|NCT00122382|79500112|FG000|Double-Blind Study|Death|2|||
44230326|NCT01899053|79039559|FG002|Overall Study|Reason Not Specified|0|||
44376492|NCT00860470|79381635|FG001|Overall Study|Death|10|||
44549277|NCT02077166|79564617|FG003|Overall Study|Other, Not Specified|0|||
44549278|NCT02077166|79564618|FG004|Overall Study|Other, Not Specified|1|||
44549279|NCT02077166|79564619|FG005|Overall Study|Other, Not Specified|7|||
44549280|NCT02077166|79564620|FG006|Overall Study|Other, Not Specified|8|||
44549281|NCT04273217|79564647|FG000|Overall Study|Lost to Follow-up|0|||
44549282|NCT04273217|79564648|FG001|Overall Study|Lost to Follow-up|0|||
44549283|NCT04273217|79564649|FG002|Overall Study|Lost to Follow-up|0|||
44549284|NCT04273217|79564650|FG003|Overall Study|Lost to Follow-up|0|||
44549285|NCT04273217|79564651|FG004|Overall Study|Lost to Follow-up|0|||
44549286|NCT04273217|79564652|FG005|Overall Study|Lost to Follow-up|1|||
44549287|NCT04273217|79564647|FG000|Overall Study|Participant non-compliance|0|||
44549288|NCT04273217|79564648|FG001|Overall Study|Participant non-compliance|0|||
44549289|NCT04273217|79564649|FG002|Overall Study|Participant non-compliance|0|||
44549290|NCT04273217|79564650|FG003|Overall Study|Participant non-compliance|0|||
44549291|NCT04273217|79564651|FG004|Overall Study|Participant non-compliance|1|||
44549292|NCT04273217|79564652|FG005|Overall Study|Participant non-compliance|0|||
44549293|NCT04273217|79564647|FG000|Overall Study|Positive urine drug screen|1|||
44549294|NCT04273217|79564648|FG001|Overall Study|Positive urine drug screen|0|||
44549295|NCT04273217|79564649|FG002|Overall Study|Positive urine drug screen|1|||
44549296|NCT04273217|79564650|FG003|Overall Study|Positive urine drug screen|0|||
44549297|NCT04273217|79564651|FG004|Overall Study|Positive urine drug screen|0|||
44549298|NCT04273217|79564652|FG005|Overall Study|Positive urine drug screen|1|||
44549299|NCT04384523|79564672|FG000|Overall Study|Lost to Follow-up|0|||
44549300|NCT04384523|79564673|FG001|Overall Study|Lost to Follow-up|0|||
44549301|NCT04384523|79564674|FG002|Overall Study|Lost to Follow-up|0|||
44549302|NCT04384523|79564675|FG003|Overall Study|Lost to Follow-up|0|||
44549303|NCT04384523|79564676|FG004|Overall Study|Lost to Follow-up|0|||
44549304|NCT04384523|79564677|FG005|Overall Study|Lost to Follow-up|1|||
44549305|NCT04384523|79564672|FG000|Overall Study|Protocol Violation|0|||
44549306|NCT04384523|79564673|FG001|Overall Study|Protocol Violation|1|||
44549307|NCT04384523|79564674|FG002|Overall Study|Protocol Violation|0|||
44549308|NCT04384523|79564675|FG003|Overall Study|Protocol Violation|0|||
44549309|NCT04384523|79564676|FG004|Overall Study|Protocol Violation|0|||
44549310|NCT04384523|79564677|FG005|Overall Study|Protocol Violation|0|||
44494307|NCT00122382|79500113|FG001|Double-Blind Study|Death|2|||
44494308|NCT00122382|79500114|FG002|Double-Blind Study|Death|0|||
44494309|NCT00122382|79500112|FG000|Double-Blind Study|Lack of Efficacy|0|||
44494310|NCT00122382|79500113|FG001|Double-Blind Study|Lack of Efficacy|8|||
44494311|NCT00122382|79500114|FG002|Double-Blind Study|Lack of Efficacy|0|||
44494312|NCT00122382|79500112|FG000|Double-Blind Study|Lost to Follow-up|2|||
44494313|NCT00122382|79500113|FG001|Double-Blind Study|Lost to Follow-up|1|||
44494314|NCT00122382|79500114|FG002|Double-Blind Study|Lost to Follow-up|0|||
44549311|NCT04384523|79564672|FG000|Overall Study|Withdrawal by Subject|1|||
44549312|NCT04384523|79564673|FG001|Overall Study|Withdrawal by Subject|0|||
44549313|NCT04384523|79564674|FG002|Overall Study|Withdrawal by Subject|0|||
44549314|NCT04384523|79564675|FG003|Overall Study|Withdrawal by Subject|0|||
44549315|NCT04384523|79564676|FG004|Overall Study|Withdrawal by Subject|0|||
44549316|NCT04384523|79564677|FG005|Overall Study|Withdrawal by Subject|0|||
44549317|NCT04382651|79564712|FG000|Overall Study|Death|26|||
44549318|NCT04382651|79564713|FG001|Overall Study|Death|23|||
44549319|NCT04382651|79564712|FG000|Overall Study|Lost to Follow-up|3|||
44549320|NCT04382651|79564713|FG001|Overall Study|Lost to Follow-up|4|||
44549321|NCT04382651|79564712|FG000|Overall Study|Withdrawal by Subject|2|||
44549322|NCT04382651|79564713|FG001|Overall Study|Withdrawal by Subject|0|||
44549323|NCT04382651|79564712|FG000|Overall Study|Physician Decision|0|||
44549324|NCT04382651|79564713|FG001|Overall Study|Physician Decision|1|||
44549325|NCT03442088|79564725|FG000|Overall Study|Adverse Event|1|||
44549326|NCT03442088|79564725|FG000|Overall Study|Lack of Efficacy|2|||
44549327|NCT03442088|79564725|FG000|Overall Study|Lost to Follow-up|2|||
44549328|NCT04223687|79564731|FG000|Overall Study|Missing primary outcome|1|||
44549329|NCT04223687|79564732|FG001|Overall Study|Missing primary outcome|0|||
44549330|NCT03722576|79564738|FG000|Overall Study|Withdrawal by Subject|3|||
44549331|NCT03722576|79564738|FG000|Overall Study|Adverse Event|2|||
44549332|NCT03722576|79564738|FG000|Overall Study|Physician Decision|1|||
44549333|NCT03722576|79564738|FG000|Overall Study|Lost to Follow-up|1|||
44549334|NCT03693989|79564744|FG000|Overall Study|Protocol Violation|3|||
44549335|NCT03693989|79564745|FG001|Overall Study|Protocol Violation|4|||
44549336|NCT04206293|79564751|FG000|Overall Study|Consent withdrawal|1|||
44549337|NCT02727998|79564758|FG000|Overall Study|Lost to Follow-up|3|||
44549338|NCT02727998|79564759|FG001|Overall Study|Lost to Follow-up|3|||
44549339|NCT02727998|79564758|FG000|Overall Study|Withdrawal by Subject|0|||
44230327|NCT01899053|79039560|FG003|Overall Study|Reason Not Specified|0|||
44494315|NCT00122382|79500112|FG000|Double-Blind Study|Pregnancy|2|||
44494316|NCT00122382|79500113|FG001|Double-Blind Study|Pregnancy|0|||
44494317|NCT00122382|79500114|FG002|Double-Blind Study|Pregnancy|0|||
44494318|NCT00122382|79500112|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
44494319|NCT00122382|79500113|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
44494320|NCT00122382|79500114|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
44494321|NCT00122382|79500112|FG000|Double-Blind Study|Withdrawal of Consent|7|||
44494322|NCT00122382|79500113|FG001|Double-Blind Study|Withdrawal of Consent|3|||
44494323|NCT00122382|79500114|FG002|Double-Blind Study|Withdrawal of Consent|0|||
44494324|NCT00122382|79500112|FG000|Double-Blind Study|Protocol Violation|1|||
44494325|NCT00122382|79500113|FG001|Double-Blind Study|Protocol Violation|0|||
44494326|NCT00122382|79500114|FG002|Double-Blind Study|Protocol Violation|0|||
44494327|NCT00122382|79500112|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
44494328|NCT00122382|79500113|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
44494329|NCT00122382|79500114|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
44494330|NCT00122382|79500112|FG000|Double-Blind Study|Randomized but not treated|0|||
44494331|NCT00122382|79500113|FG001|Double-Blind Study|Randomized but not treated|2|||
44494332|NCT00122382|79500114|FG002|Double-Blind Study|Randomized but not treated|0|||
44494333|NCT00122382|79500112|FG000|Open-Label Study|Adverse Event|0|||
44494334|NCT00122382|79500113|FG001|Open-Label Study|Adverse Event|0|||
44494335|NCT00122382|79500114|FG002|Open-Label Study|Adverse Event|11|||
44494336|NCT00122382|79500112|FG000|Open-Label Study|Death|0|||
44494337|NCT00122382|79500113|FG001|Open-Label Study|Death|0|||
44494338|NCT00122382|79500114|FG002|Open-Label Study|Death|2|||
44494339|NCT00122382|79500112|FG000|Open-Label Study|Lack of Efficacy|0|||
44494340|NCT00122382|79500113|FG001|Open-Label Study|Lack of Efficacy|0|||
44494341|NCT00122382|79500114|FG002|Open-Label Study|Lack of Efficacy|3|||
44494342|NCT00122382|79500112|FG000|Open-Label Study|Lost to Follow-up|0|||
44494343|NCT00122382|79500113|FG001|Open-Label Study|Lost to Follow-up|0|||
44494344|NCT00122382|79500114|FG002|Open-Label Study|Lost to Follow-up|3|||
44494345|NCT00122382|79500112|FG000|Open-Label Study|Pregnancy|0|||
44494346|NCT00122382|79500113|FG001|Open-Label Study|Pregnancy|0|||
44230328|NCT01899053|79039561|FG004|Overall Study|Reason Not Specified|0|||
44549340|NCT02727998|79564759|FG001|Overall Study|Withdrawal by Subject|1|||
44549341|NCT02636270|79564768|FG000|Overall Study|Adverse Event|1|||
44549342|NCT02636270|79564769|FG001|Overall Study|Adverse Event|0|||
44549343|NCT02636270|79564770|FG002|Overall Study|Adverse Event|0|||
44549344|NCT02636270|79564768|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
44494347|NCT00122382|79500114|FG002|Open-Label Study|Pregnancy|2|||
44494348|NCT00122382|79500112|FG000|Open-Label Study|Poor/Non-Compliance|0|||
44494349|NCT00122382|79500113|FG001|Open-Label Study|Poor/Non-Compliance|0|||
44494350|NCT00122382|79500114|FG002|Open-Label Study|Poor/Non-Compliance|1|||
44494351|NCT00122382|79500112|FG000|Open-Label Study|Withdrawal of Consent|0|||
44494352|NCT00122382|79500113|FG001|Open-Label Study|Withdrawal of Consent|0|||
44494353|NCT00122382|79500114|FG002|Open-Label Study|Withdrawal of Consent|4|||
44494354|NCT01028716|79500132|FG000|Overall Study|Physician Decision|1|||
44494355|NCT00106704|79500139|FG000|Overall Study|Adverse Event|10|||
44494356|NCT00106704|79500140|FG001|Overall Study|Adverse Event|7|||
44494357|NCT00106704|79500139|FG000|Overall Study|Death|2|||
44494358|NCT00106704|79500140|FG001|Overall Study|Death|1|||
44494359|NCT00106704|79500139|FG000|Overall Study|Lack of Efficacy|67|||
44494360|NCT00106704|79500140|FG001|Overall Study|Lack of Efficacy|69|||
44494361|NCT00106704|79500139|FG000|Overall Study|Lost to Follow-up|7|||
44494362|NCT00106704|79500140|FG001|Overall Study|Lost to Follow-up|3|||
44494363|NCT00106704|79500139|FG000|Overall Study|Pregnancy|1|||
44494364|NCT00106704|79500140|FG001|Overall Study|Pregnancy|0|||
44494365|NCT00106704|79500139|FG000|Overall Study|Protocol Violation|4|||
44494366|NCT00106704|79500140|FG001|Overall Study|Protocol Violation|7|||
44549345|NCT02636270|79564769|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
44549346|NCT02636270|79564770|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
44549347|NCT04366349|79564810|FG000|Overall Study|Withdrawal by Subject|1|||
44549348|NCT04366349|79564811|FG001|Overall Study|Withdrawal by Subject|0|||
44549349|NCT04366349|79564812|FG002|Overall Study|Withdrawal by Subject|0|||
44549350|NCT04366349|79564813|FG003|Overall Study|Withdrawal by Subject|0|||
44549351|NCT04366349|79564814|FG004|Overall Study|Withdrawal by Subject|0|||
44549352|NCT04366349|79564815|FG005|Overall Study|Withdrawal by Subject|0|||
44549353|NCT04179461|79564833|FG000|Overall Study|Lost to Follow-up|4|||
44549354|NCT04017611|79564837|FG000|Overall Study|Withdrawn prior to completion|1|||
44549355|NCT04172831|79564852|FG000|Overall Study|Adverse Event|21|||
44549356|NCT04172831|79564853|FG001|Overall Study|Adverse Event|9|||
44549357|NCT04172831|79564852|FG000|Overall Study|Lack of Efficacy|2|||
44549358|NCT04172831|79564853|FG001|Overall Study|Lack of Efficacy|8|||
44549359|NCT04172831|79564852|FG000|Overall Study|Physician Decision|0|||
44549360|NCT04172831|79564853|FG001|Overall Study|Physician Decision|1|||
44549361|NCT04172831|79564852|FG000|Overall Study|Withdrawal by Subject|12|||
44549362|NCT04172831|79564853|FG001|Overall Study|Withdrawal by Subject|11|||
44549363|NCT04172831|79564852|FG000|Overall Study|Lost to Follow-up|4|||
44549364|NCT04172831|79564853|FG001|Overall Study|Lost to Follow-up|9|||
44549365|NCT04172831|79564852|FG000|Overall Study|COVID-19 related crisis|3|||
44549366|NCT04172831|79564853|FG001|Overall Study|COVID-19 related crisis|3|||
44549367|NCT04172831|79564852|FG000|Overall Study|Subject non-compliance|1|||
44549368|NCT04172831|79564853|FG001|Overall Study|Subject non-compliance|1|||
44549369|NCT04172831|79564852|FG000|Overall Study|Family emergency|1|||
44549370|NCT04172831|79564853|FG001|Overall Study|Family emergency|0|||
44549371|NCT04165031|79564870|FG000|Overall Study|Adverse Event|1|||
44549372|NCT04165031|79564871|FG001|Overall Study|Adverse Event|1|||
44549373|NCT04165031|79564872|FG002|Overall Study|Adverse Event|0|||
44549374|NCT04165031|79564873|FG003|Overall Study|Adverse Event|0|||
44549375|NCT04165031|79564874|FG004|Overall Study|Adverse Event|0|||
44549376|NCT04165031|79564875|FG005|Overall Study|Adverse Event|0|||
44549377|NCT04165031|79564870|FG000|Overall Study|Withdrawal by Subject|0|||
44549378|NCT04165031|79564871|FG001|Overall Study|Withdrawal by Subject|0|||
44549379|NCT04165031|79564872|FG002|Overall Study|Withdrawal by Subject|1|||
44549380|NCT04165031|79564873|FG003|Overall Study|Withdrawal by Subject|0|||
44549381|NCT04165031|79564874|FG004|Overall Study|Withdrawal by Subject|0|||
44549382|NCT04165031|79564875|FG005|Overall Study|Withdrawal by Subject|0|||
44549383|NCT02712424|79564892|FG000|Overall Study|Lost to Follow-up|34|||
44549384|NCT02712424|79564893|FG001|Overall Study|Lost to Follow-up|32|||
44549385|NCT03034772|79564901|FG000|Overall Study|Adverse Event|0|||
44549386|NCT03034772|79564902|FG001|Overall Study|Adverse Event|1|||
44549387|NCT03034772|79564901|FG000|Overall Study|Withdrawal by Subject|0|||
44549388|NCT03034772|79564902|FG001|Overall Study|Withdrawal by Subject|1|||
44549389|NCT03032198|79564908|FG000|Overall Study|Screen Fail|1|||
44549390|NCT02431364|79564917|FG000|Overall Study|Adverse Event|0|||
44549391|NCT02431364|79564918|FG001|Overall Study|Adverse Event|1|||
44549392|NCT02431364|79564919|FG002|Overall Study|Adverse Event|0|||
44549393|NCT02431364|79564920|FG003|Overall Study|Adverse Event|0|||
44549394|NCT02431364|79564921|FG004|Overall Study|Adverse Event|0|||
44549395|NCT02431364|79564917|FG000|Overall Study|Randomized but never treated|0|||
44549396|NCT02431364|79564918|FG001|Overall Study|Randomized but never treated|0|||
44549397|NCT02431364|79564919|FG002|Overall Study|Randomized but never treated|0|||
44549398|NCT02431364|79564920|FG003|Overall Study|Randomized but never treated|1|||
44549399|NCT02431364|79564921|FG004|Overall Study|Randomized but never treated|0|||
44549400|NCT03034460|79564939|FG000|Overall Study|Adverse Event|0|||
44549401|NCT03034460|79564940|FG001|Overall Study|Adverse Event|1|||
44549402|NCT03034460|79564939|FG000|Overall Study|Withdrawal by Subject|2|||
44376493|NCT00860470|79381634|FG000|Overall Study|Moved away|8|||
44549403|NCT03034460|79564940|FG001|Overall Study|Withdrawal by Subject|2|||
44549404|NCT03034460|79564939|FG000|Overall Study|Personal Reasons|1|||
44549405|NCT03034460|79564940|FG001|Overall Study|Personal Reasons|0|||
44549406|NCT04162769|79564953|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
44549407|NCT04162769|79564954|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
44549408|NCT04162769|79564955|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
44549409|NCT04162769|79564956|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
44549410|NCT04162769|79564953|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
44549411|NCT04162769|79564954|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
44549412|NCT04162769|79564955|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
44549413|NCT04162769|79564956|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
44549414|NCT04162769|79564953|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
44549415|NCT04162769|79564954|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
44549416|NCT04162769|79564955|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
44549417|NCT04162769|79564956|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
44549418|NCT04162769|79564953|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
44549419|NCT04162769|79564954|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
44549420|NCT04162769|79564955|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
44549421|NCT04162769|79564956|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
44549422|NCT04162769|79564953|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
44549423|NCT04162769|79564954|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
44549424|NCT04162769|79564955|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
44549425|NCT04162769|79564956|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
44549426|NCT04162769|79564953|FG000|Double-blind Treatment (12-Week)|Other|0|||
44549427|NCT04162769|79564954|FG001|Double-blind Treatment (12-Week)|Other|1|||
44549428|NCT04162769|79564955|FG002|Double-blind Treatment (12-Week)|Other|1|||
44549429|NCT04162769|79564956|FG003|Double-blind Treatment (12-Week)|Other|0|||
44549430|NCT04162769|79564953|FG000|OLE Period (52-Week)|Adverse Event|0|||
44549431|NCT04162769|79564954|FG001|OLE Period (52-Week)|Adverse Event|0|||
44549432|NCT04162769|79564955|FG002|OLE Period (52-Week)|Adverse Event|0|||
44549433|NCT04162769|79564956|FG003|OLE Period (52-Week)|Adverse Event|5|||
44549434|NCT04162769|79564953|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
44549435|NCT04162769|79564954|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
44549436|NCT04162769|79564955|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
44549437|NCT04162769|79564956|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
44549438|NCT04162769|79564953|FG000|OLE Period (52-Week)|Physician Decision|0|||
44549439|NCT04162769|79564954|FG001|OLE Period (52-Week)|Physician Decision|0|||
44549440|NCT04162769|79564955|FG002|OLE Period (52-Week)|Physician Decision|0|||
44549441|NCT04162769|79564956|FG003|OLE Period (52-Week)|Physician Decision|1|||
44549442|NCT04162769|79564953|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
44549443|NCT04162769|79564954|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
44549444|NCT04162769|79564955|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
44549445|NCT04162769|79564956|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
44549446|NCT04162769|79564953|FG000|OLE Period (52-Week)|Protocol deviation|0|||
44549447|NCT04162769|79564954|FG001|OLE Period (52-Week)|Protocol deviation|0|||
44549448|NCT04162769|79564955|FG002|OLE Period (52-Week)|Protocol deviation|0|||
44549449|NCT04162769|79564956|FG003|OLE Period (52-Week)|Protocol deviation|2|||
44549450|NCT04161131|79564967|FG000|Overall Study|Ineligible|2|||
44549451|NCT04161131|79564967|FG000|Overall Study|Lost to Follow-up|4|||
44549452|NCT04155047|79564973|FG000|Overall Study|Adverse Event|1|||
44549453|NCT04155047|79564974|FG001|Overall Study|Adverse Event|0|||
44549454|NCT04155047|79564973|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
44274702|NCT02243202|79220515|FG002|Overall Study|Withdrawal by Subject|4|||
44494367|NCT00106704|79500139|FG000|Overall Study|Withdrawal by Subject|14|||
44494368|NCT00106704|79500140|FG001|Overall Study|Withdrawal by Subject|21|||
44494369|NCT00106704|79500139|FG000|Overall Study|Patient moved|1|||
44494370|NCT00106704|79500140|FG001|Overall Study|Patient moved|0|||
44494371|NCT00106704|79500139|FG000|Overall Study|Site terminated|0|||
44494372|NCT00106704|79500140|FG001|Overall Study|Site terminated|1|||
44494373|NCT00106704|79500139|FG000|Overall Study|Planned major surgery|1|||
44494374|NCT00106704|79500140|FG001|Overall Study|Planned major surgery|0|||
44494375|NCT00106704|79500139|FG000|Overall Study|Patient Received Glycemic Medication|22|||
44494376|NCT00106704|79500140|FG001|Overall Study|Patient Received Glycemic Medication|41|||
44494377|NCT00106704|79500139|FG000|Overall Study|Unable to re-enter US|1|||
44494378|NCT00106704|79500140|FG001|Overall Study|Unable to re-enter US|0|||
44494379|NCT00106704|79500139|FG000|Overall Study|Laboratory test|1|||
44494380|NCT00106704|79500140|FG001|Overall Study|Laboratory test|1|||
44494381|NCT00105066|79500148|FG000|Overall Study|Adverse Event|2|||
44494382|NCT00105066|79500149|FG001|Overall Study|Adverse Event|5|||
44494383|NCT00104520|79500157|FG000|Overall Study|Unrelated adverse event|34|||
44494384|NCT00104520|79500158|FG001|Overall Study|Unrelated adverse event|47|||
44494385|NCT00104520|79500157|FG000|Overall Study|Study drug intolerance|0|||
44494386|NCT00104520|79500158|FG001|Overall Study|Study drug intolerance|1|||
44549455|NCT04155047|79564974|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
44549456|NCT04152083|79564982|FG000|Overall Study|Lost to Follow-up|2|||
44376494|NCT00860470|79381635|FG001|Overall Study|Moved away|10|||
44549457|NCT04152083|79564983|FG001|Overall Study|Lost to Follow-up|1|||
44549458|NCT04152083|79564982|FG000|Overall Study|Adverse Event|1|||
44549459|NCT04152083|79564983|FG001|Overall Study|Adverse Event|0|||
44549460|NCT04152083|79564982|FG000|Overall Study|Randomized but not treated|3|||
44549461|NCT04152083|79564983|FG001|Overall Study|Randomized but not treated|2|||
44549462|NCT02711956|79565004|FG000|Overall Study|Adverse Event|0|||
44549463|NCT02711956|79565005|FG001|Overall Study|Adverse Event|0|||
44549464|NCT02711956|79565006|FG002|Overall Study|Adverse Event|0|||
44549465|NCT02711956|79565007|FG003|Overall Study|Adverse Event|1|||
44230329|NCT01899053|79039562|FG005|Overall Study|Reason Not Specified|0|||
44230330|NCT01899053|79039563|FG006|Overall Study|Reason Not Specified|1|||
44230331|NCT01899053|79039564|FG007|Overall Study|Reason Not Specified|0|||
44230332|NCT01899053|79039565|FG008|Overall Study|Reason Not Specified|0|||
44230333|NCT01899053|79039566|FG009|Overall Study|Reason Not Specified|0|||
44230334|NCT01899053|79039567|FG010|Overall Study|Reason Not Specified|0|||
44230335|NCT01899053|79039568|FG011|Overall Study|Reason Not Specified|0|||
44230336|NCT01899053|79039569|FG012|Overall Study|Reason Not Specified|1|||
44230337|NCT01899053|79039570|FG013|Overall Study|Reason Not Specified|0|||
44230338|NCT01899053|79039557|FG000|Overall Study|Withdrawal by Subject|1|||
44230339|NCT01899053|79039558|FG001|Overall Study|Withdrawal by Subject|1|||
44230340|NCT01899053|79039559|FG002|Overall Study|Withdrawal by Subject|2|||
44230341|NCT01899053|79039560|FG003|Overall Study|Withdrawal by Subject|0|||
44230342|NCT01899053|79039561|FG004|Overall Study|Withdrawal by Subject|2|||
44230343|NCT01899053|79039562|FG005|Overall Study|Withdrawal by Subject|0|||
44230344|NCT01899053|79039563|FG006|Overall Study|Withdrawal by Subject|0|||
44230345|NCT01899053|79039564|FG007|Overall Study|Withdrawal by Subject|1|||
44230346|NCT01899053|79039565|FG008|Overall Study|Withdrawal by Subject|0|||
44230347|NCT01899053|79039566|FG009|Overall Study|Withdrawal by Subject|0|||
44230348|NCT01899053|79039567|FG010|Overall Study|Withdrawal by Subject|0|||
44230349|NCT01899053|79039568|FG011|Overall Study|Withdrawal by Subject|0|||
44230350|NCT01899053|79039569|FG012|Overall Study|Withdrawal by Subject|1|||
44230351|NCT01899053|79039570|FG013|Overall Study|Withdrawal by Subject|1|||
44230352|NCT01899053|79039557|FG000|Overall Study|Protocol Violation|0|||
44230353|NCT01899053|79039558|FG001|Overall Study|Protocol Violation|0|||
44230354|NCT01899053|79039559|FG002|Overall Study|Protocol Violation|1|||
44230355|NCT01899053|79039560|FG003|Overall Study|Protocol Violation|0|||
44230356|NCT01899053|79039561|FG004|Overall Study|Protocol Violation|0|||
44230357|NCT01899053|79039562|FG005|Overall Study|Protocol Violation|0|||
44230358|NCT01899053|79039563|FG006|Overall Study|Protocol Violation|0|||
44230359|NCT01899053|79039564|FG007|Overall Study|Protocol Violation|0|||
44230360|NCT01899053|79039565|FG008|Overall Study|Protocol Violation|0|||
44230361|NCT01899053|79039566|FG009|Overall Study|Protocol Violation|0|||
44230362|NCT01899053|79039567|FG010|Overall Study|Protocol Violation|0|||
44230363|NCT01899053|79039568|FG011|Overall Study|Protocol Violation|0|||
44230364|NCT01899053|79039569|FG012|Overall Study|Protocol Violation|0|||
44230365|NCT01899053|79039570|FG013|Overall Study|Protocol Violation|0|||
44230366|NCT01899053|79039557|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
44230367|NCT01899053|79039558|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
44230368|NCT01899053|79039559|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230369|NCT01899053|79039560|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230370|NCT01899053|79039561|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230371|NCT01899053|79039562|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230372|NCT01899053|79039563|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230373|NCT01899053|79039564|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230374|NCT01899053|79039565|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230375|NCT01899053|79039566|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230376|NCT01899053|79039567|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
44230377|NCT01899053|79039568|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230378|NCT01899053|79039569|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230379|NCT01899053|79039570|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
44230380|NCT01899053|79039557|FG000|Overall Study|Symptomatic Deterioration|0|||
44230381|NCT01899053|79039558|FG001|Overall Study|Symptomatic Deterioration|0|||
44230382|NCT01899053|79039559|FG002|Overall Study|Symptomatic Deterioration|0|||
44230383|NCT01899053|79039560|FG003|Overall Study|Symptomatic Deterioration|0|||
44230384|NCT01899053|79039561|FG004|Overall Study|Symptomatic Deterioration|0|||
44549466|NCT02711956|79565008|FG004|Overall Study|Adverse Event|2|||
44549467|NCT02711956|79565009|FG005|Overall Study|Adverse Event|0|||
44549468|NCT02711956|79565010|FG006|Overall Study|Adverse Event|0|||
44230385|NCT01899053|79039562|FG005|Overall Study|Symptomatic Deterioration|1|||
44230386|NCT01899053|79039563|FG006|Overall Study|Symptomatic Deterioration|0|||
44549469|NCT02711956|79565011|FG007|Overall Study|Adverse Event|1|||
44549470|NCT02711956|79565012|FG008|Overall Study|Adverse Event|1|||
44230387|NCT01899053|79039564|FG007|Overall Study|Symptomatic Deterioration|1|||
44230388|NCT01899053|79039565|FG008|Overall Study|Symptomatic Deterioration|0|||
44549471|NCT02711956|79565013|FG009|Overall Study|Adverse Event|1|||
44549472|NCT02711956|79565014|FG010|Overall Study|Adverse Event|1|||
44549473|NCT02711956|79565015|FG011|Overall Study|Adverse Event|0|||
44549474|NCT02711956|79565016|FG012|Overall Study|Adverse Event|0|||
44549475|NCT02711956|79565017|FG013|Overall Study|Adverse Event|0|||
44549476|NCT02711956|79565018|FG014|Overall Study|Adverse Event|2|||
44549477|NCT02711956|79565004|FG000|Overall Study|Physician Decision|0|||
44494387|NCT00104520|79500157|FG000|Overall Study|Related adverse event|13|||
44494388|NCT00104520|79500158|FG001|Overall Study|Related adverse event|15|||
44494389|NCT00104520|79500157|FG000|Overall Study|Lost to Follow-up|1|||
44494390|NCT00104520|79500158|FG001|Overall Study|Lost to Follow-up|0|||
44230389|NCT01899053|79039566|FG009|Overall Study|Symptomatic Deterioration|0|||
44494391|NCT00104520|79500157|FG000|Overall Study|Noncompliance|0|||
44494392|NCT00104520|79500158|FG001|Overall Study|Noncompliance|2|||
44494393|NCT00104520|79500157|FG000|Overall Study|Personal/administrative|1|||
44494394|NCT00104520|79500158|FG001|Overall Study|Personal/administrative|1|||
44494395|NCT00104520|79500157|FG000|Overall Study|Other|1|||
44494396|NCT00104520|79500158|FG001|Overall Study|Other|5|||
44494397|NCT00135330|79500167|FG000|Overall Study|Adverse Event|2|||
44494398|NCT00135330|79500168|FG001|Overall Study|Adverse Event|5|||
44494399|NCT00135330|79500169|FG002|Overall Study|Adverse Event|1|||
44494400|NCT00135330|79500167|FG000|Overall Study|Lost to Follow-up|0|||
44494401|NCT00135330|79500168|FG001|Overall Study|Lost to Follow-up|2|||
44494402|NCT00135330|79500169|FG002|Overall Study|Lost to Follow-up|3|||
44494403|NCT00135330|79500167|FG000|Overall Study|Physician Decision|1|||
44494404|NCT00135330|79500168|FG001|Overall Study|Physician Decision|1|||
44494405|NCT00135330|79500169|FG002|Overall Study|Physician Decision|0|||
44494406|NCT00135330|79500167|FG000|Overall Study|Protocol Violation|4|||
44494407|NCT00135330|79500168|FG001|Overall Study|Protocol Violation|3|||
44494408|NCT00135330|79500169|FG002|Overall Study|Protocol Violation|3|||
44494409|NCT00135330|79500167|FG000|Overall Study|Patient Decision|5|||
44494410|NCT00135330|79500168|FG001|Overall Study|Patient Decision|1|||
44494411|NCT00135330|79500169|FG002|Overall Study|Patient Decision|4|||
44494412|NCT00135330|79500167|FG000|Overall Study|Sponsor Decision|0|||
44494413|NCT00135330|79500168|FG001|Overall Study|Sponsor Decision|1|||
44494414|NCT00135330|79500169|FG002|Overall Study|Sponsor Decision|0|||
44494415|NCT00134784|79500181|FG000|Overall Study|Withdrawal by Subject|2|||
44494416|NCT00134784|79500182|FG001|Overall Study|Withdrawal by Subject|2|||
44494417|NCT00134784|79500183|FG002|Overall Study|Withdrawal by Subject|2|||
44494418|NCT00134784|79500184|FG003|Overall Study|Withdrawal by Subject|1|||
44494419|NCT00134082|79500191|FG000|Overall Study|Adverse Event|2|||
44494420|NCT00134082|79500191|FG000|Overall Study|Death|1|||
44494421|NCT03703336|79500197|FG000|Overall Study|Parent withdrew consent|29|||
44494422|NCT03703336|79500198|FG001|Overall Study|Parent withdrew consent|8|||
44549478|NCT02711956|79565005|FG001|Overall Study|Physician Decision|0|||
44549479|NCT02711956|79565006|FG002|Overall Study|Physician Decision|0|||
44549480|NCT02711956|79565007|FG003|Overall Study|Physician Decision|2|||
44549481|NCT02711956|79565008|FG004|Overall Study|Physician Decision|0|||
44549482|NCT02711956|79565009|FG005|Overall Study|Physician Decision|0|||
44549483|NCT02711956|79565010|FG006|Overall Study|Physician Decision|0|||
44549484|NCT02711956|79565011|FG007|Overall Study|Physician Decision|0|||
44549485|NCT02711956|79565012|FG008|Overall Study|Physician Decision|0|||
44549486|NCT02711956|79565013|FG009|Overall Study|Physician Decision|0|||
44549487|NCT02711956|79565014|FG010|Overall Study|Physician Decision|0|||
44549488|NCT02711956|79565015|FG011|Overall Study|Physician Decision|0|||
44549489|NCT02711956|79565016|FG012|Overall Study|Physician Decision|0|||
44494423|NCT03703336|79500197|FG000|Overall Study|Migration|3|||
44494424|NCT03703336|79500198|FG001|Overall Study|Migration|3|||
44494425|NCT03703336|79500197|FG000|Overall Study|Protocol Violation|3|||
44494426|NCT03703336|79500198|FG001|Overall Study|Protocol Violation|1|||
44494427|NCT03703336|79500197|FG000|Overall Study|Physician Decision|2|||
44494428|NCT03703336|79500198|FG001|Overall Study|Physician Decision|0|||
44494429|NCT03703336|79500197|FG000|Overall Study|Adverse Event|0|||
44549490|NCT02711956|79565017|FG013|Overall Study|Physician Decision|0|||
44549491|NCT02711956|79565018|FG014|Overall Study|Physician Decision|0|||
44549492|NCT02711956|79565004|FG000|Overall Study|Withdrawal by Subject|0|||
44549493|NCT02711956|79565005|FG001|Overall Study|Withdrawal by Subject|0|||
44549494|NCT02711956|79565006|FG002|Overall Study|Withdrawal by Subject|0|||
44549495|NCT02711956|79565007|FG003|Overall Study|Withdrawal by Subject|0|||
44549496|NCT02711956|79565008|FG004|Overall Study|Withdrawal by Subject|0|||
44549497|NCT02711956|79565009|FG005|Overall Study|Withdrawal by Subject|0|||
44549498|NCT02711956|79565010|FG006|Overall Study|Withdrawal by Subject|1|||
44549499|NCT02711956|79565011|FG007|Overall Study|Withdrawal by Subject|0|||
44549500|NCT02711956|79565012|FG008|Overall Study|Withdrawal by Subject|0|||
44549501|NCT02711956|79565013|FG009|Overall Study|Withdrawal by Subject|0|||
44549502|NCT02711956|79565014|FG010|Overall Study|Withdrawal by Subject|0|||
44549503|NCT02711956|79565015|FG011|Overall Study|Withdrawal by Subject|1|||
44376495|NCT00860470|79381634|FG000|Overall Study|Lost to Follow-up|34|||
44376496|NCT00860470|79381635|FG001|Overall Study|Lost to Follow-up|39|||
44376497|NCT00923364|79381641|FG000|Overall Study|Death|3|||
44376498|NCT00923364|79381642|FG001|Overall Study|Death|0|||
44376499|NCT00923364|79381641|FG000|Overall Study|Did not go to transplant|1|||
44376500|NCT00923364|79381642|FG001|Overall Study|Did not go to transplant|0|||
44376501|NCT01096160|79381657|FG000|Overall Study|Adverse Event|0|||
44376502|NCT01096160|79381658|FG001|Overall Study|Adverse Event|0|||
44376503|NCT01096160|79381659|FG002|Overall Study|Adverse Event|1|||
44376504|NCT01096160|79381660|FG003|Overall Study|Adverse Event|0|||
44376505|NCT01096160|79381661|FG004|Overall Study|Adverse Event|0|||
44494430|NCT03703336|79500198|FG001|Overall Study|Adverse Event|2|||
44494431|NCT03703336|79500197|FG000|Overall Study|Lost to Follow-up|1|||
44494432|NCT03703336|79500198|FG001|Overall Study|Lost to Follow-up|0|||
44549504|NCT02711956|79565016|FG012|Overall Study|Withdrawal by Subject|6|||
44549505|NCT02711956|79565017|FG013|Overall Study|Withdrawal by Subject|0|||
44549506|NCT02711956|79565018|FG014|Overall Study|Withdrawal by Subject|1|||
44549507|NCT02711956|79565004|FG000|Overall Study|Clinical progression|1|||
44549508|NCT02711956|79565005|FG001|Overall Study|Clinical progression|0|||
44549509|NCT02711956|79565006|FG002|Overall Study|Clinical progression|0|||
44549510|NCT02711956|79565007|FG003|Overall Study|Clinical progression|0|||
44549511|NCT02711956|79565008|FG004|Overall Study|Clinical progression|0|||
44549512|NCT02711956|79565009|FG005|Overall Study|Clinical progression|0|||
44549513|NCT02711956|79565010|FG006|Overall Study|Clinical progression|1|||
44549514|NCT02711956|79565011|FG007|Overall Study|Clinical progression|0|||
44549515|NCT02711956|79565012|FG008|Overall Study|Clinical progression|1|||
44549516|NCT02711956|79565013|FG009|Overall Study|Clinical progression|0|||
44549517|NCT02711956|79565014|FG010|Overall Study|Clinical progression|0|||
44549518|NCT02711956|79565015|FG011|Overall Study|Clinical progression|2|||
44549519|NCT02711956|79565016|FG012|Overall Study|Clinical progression|4|||
44230390|NCT01899053|79039567|FG010|Overall Study|Symptomatic Deterioration|0|||
44230391|NCT01899053|79039568|FG011|Overall Study|Symptomatic Deterioration|1|||
44230392|NCT01899053|79039569|FG012|Overall Study|Symptomatic Deterioration|2|||
44549520|NCT02711956|79565017|FG013|Overall Study|Clinical progression|1|||
44549521|NCT02711956|79565018|FG014|Overall Study|Clinical progression|1|||
44549522|NCT02711956|79565004|FG000|Overall Study|Radiographic progression|1|||
44549523|NCT02711956|79565005|FG001|Overall Study|Radiographic progression|1|||
44549524|NCT02711956|79565006|FG002|Overall Study|Radiographic progression|2|||
44549525|NCT02711956|79565007|FG003|Overall Study|Radiographic progression|0|||
44549526|NCT02711956|79565008|FG004|Overall Study|Radiographic progression|1|||
44549527|NCT02711956|79565009|FG005|Overall Study|Radiographic progression|0|||
44494433|NCT03702166|79500204|FG000|Overall Study|Lost to Follow-up|1|||
44494434|NCT03702166|79500204|FG000|Overall Study|Withdrawal by Subject|1|||
44494435|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
44494436|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
44494437|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
44494438|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
44494439|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
44494440|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
44494441|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
44494442|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
44494443|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
44376506|NCT01096160|79381662|FG005|Overall Study|Adverse Event|0|||
44549528|NCT02711956|79565010|FG006|Overall Study|Radiographic progression|0|||
44549529|NCT02711956|79565011|FG007|Overall Study|Radiographic progression|0|||
44549530|NCT02711956|79565012|FG008|Overall Study|Radiographic progression|2|||
44549531|NCT02711956|79565013|FG009|Overall Study|Radiographic progression|1|||
44549532|NCT02711956|79565014|FG010|Overall Study|Radiographic progression|0|||
44549533|NCT02711956|79565015|FG011|Overall Study|Radiographic progression|5|||
44230393|NCT01899053|79039570|FG013|Overall Study|Symptomatic Deterioration|0|||
44549534|NCT02711956|79565016|FG012|Overall Study|Radiographic progression|3|||
44549535|NCT02711956|79565017|FG013|Overall Study|Radiographic progression|0|||
44376507|NCT01096160|79381663|FG006|Overall Study|Adverse Event|0|||
44376508|NCT01096160|79381664|FG007|Overall Study|Adverse Event|0|||
44549536|NCT02711956|79565018|FG014|Overall Study|Radiographic progression|1|||
44549537|NCT02711956|79565004|FG000|Overall Study|PSA progression with clinical progression|0|||
44549538|NCT02711956|79565005|FG001|Overall Study|PSA progression with clinical progression|0|||
44549539|NCT02711956|79565006|FG002|Overall Study|PSA progression with clinical progression|0|||
44549540|NCT02711956|79565007|FG003|Overall Study|PSA progression with clinical progression|0|||
44549541|NCT02711956|79565008|FG004|Overall Study|PSA progression with clinical progression|1|||
44549542|NCT02711956|79565009|FG005|Overall Study|PSA progression with clinical progression|0|||
44549543|NCT02711956|79565010|FG006|Overall Study|PSA progression with clinical progression|0|||
44549544|NCT02711956|79565011|FG007|Overall Study|PSA progression with clinical progression|0|||
44549545|NCT02711956|79565012|FG008|Overall Study|PSA progression with clinical progression|0|||
44549546|NCT02711956|79565013|FG009|Overall Study|PSA progression with clinical progression|0|||
44549547|NCT02711956|79565014|FG010|Overall Study|PSA progression with clinical progression|0|||
44549548|NCT02711956|79565015|FG011|Overall Study|PSA progression with clinical progression|0|||
44549549|NCT02711956|79565016|FG012|Overall Study|PSA progression with clinical progression|1|||
44549550|NCT02711956|79565017|FG013|Overall Study|PSA progression with clinical progression|1|||
44549551|NCT02711956|79565018|FG014|Overall Study|PSA progression with clinical progression|0|||
44549552|NCT02711956|79565004|FG000|Overall Study|PSA progression with radiographic progression|0|||
44549553|NCT02711956|79565005|FG001|Overall Study|PSA progression with radiographic progression|1|||
44549554|NCT02711956|79565006|FG002|Overall Study|PSA progression with radiographic progression|0|||
44549555|NCT02711956|79565007|FG003|Overall Study|PSA progression with radiographic progression|0|||
44549556|NCT02711956|79565008|FG004|Overall Study|PSA progression with radiographic progression|0|||
44549557|NCT02711956|79565009|FG005|Overall Study|PSA progression with radiographic progression|2|||
44549558|NCT02711956|79565010|FG006|Overall Study|PSA progression with radiographic progression|2|||
44549559|NCT02711956|79565011|FG007|Overall Study|PSA progression with radiographic progression|1|||
44549560|NCT02711956|79565012|FG008|Overall Study|PSA progression with radiographic progression|0|||
44549561|NCT02711956|79565013|FG009|Overall Study|PSA progression with radiographic progression|1|||
44549562|NCT02711956|79565014|FG010|Overall Study|PSA progression with radiographic progression|0|||
44549563|NCT02711956|79565015|FG011|Overall Study|PSA progression with radiographic progression|1|||
44549564|NCT02711956|79565016|FG012|Overall Study|PSA progression with radiographic progression|2|||
44549565|NCT02711956|79565017|FG013|Overall Study|PSA progression with radiographic progression|3|||
44549566|NCT02711956|79565018|FG014|Overall Study|PSA progression with radiographic progression|3|||
44549567|NCT04149353|79565059|FG000|Overall Study|Study terminated|1|||
44549568|NCT02711800|79565064|FG000|Overall Study|Lost to Follow-up|1|||
44549569|NCT02711800|79565064|FG000|Overall Study|Withdrawal by Subject|1|||
44549570|NCT03031496|79565068|FG000|Period 1|Adverse Event|2|||
44549571|NCT03031496|79565069|FG001|Period 1|Adverse Event|0|||
44549572|NCT03031496|79565068|FG000|Period 1|Withdrawal by Subject|0|||
44549573|NCT03031496|79565069|FG001|Period 1|Withdrawal by Subject|2|||
44549574|NCT02659020|79565082|FG000|Overall Study|Adverse Event|0|||
44549575|NCT02659020|79565083|FG001|Overall Study|Adverse Event|0|||
44549576|NCT02659020|79565084|FG002|Overall Study|Adverse Event|0|||
44549577|NCT02659020|79565085|FG003|Overall Study|Adverse Event|2|||
44549578|NCT02659020|79565086|FG004|Overall Study|Adverse Event|0|||
44549579|NCT02659020|79565087|FG005|Overall Study|Adverse Event|0|||
44549580|NCT02659020|79565088|FG006|Overall Study|Adverse Event|2|||
44549581|NCT02659020|79565082|FG000|Overall Study|Lost to Follow-up|1|||
44549582|NCT02659020|79565083|FG001|Overall Study|Lost to Follow-up|2|||
44549583|NCT02659020|79565084|FG002|Overall Study|Lost to Follow-up|1|||
44549584|NCT02659020|79565085|FG003|Overall Study|Lost to Follow-up|6|||
44549585|NCT02659020|79565086|FG004|Overall Study|Lost to Follow-up|1|||
44549586|NCT02659020|79565087|FG005|Overall Study|Lost to Follow-up|5|||
44549587|NCT02659020|79565088|FG006|Overall Study|Lost to Follow-up|0|||
44549588|NCT02659020|79565082|FG000|Overall Study|Physician Decision|0|||
44230394|NCT01888367|79039675|FG000|Overall Study|Physician Decision|3|||
44230395|NCT01888367|79039676|FG001|Overall Study|Physician Decision|4|||
44549589|NCT02659020|79565083|FG001|Overall Study|Physician Decision|0|||
44549590|NCT02659020|79565084|FG002|Overall Study|Physician Decision|0|||
44549591|NCT02659020|79565085|FG003|Overall Study|Physician Decision|1|||
44549592|NCT02659020|79565086|FG004|Overall Study|Physician Decision|1|||
44549593|NCT02659020|79565087|FG005|Overall Study|Physician Decision|0|||
44549594|NCT02659020|79565088|FG006|Overall Study|Physician Decision|1|||
44230396|NCT01888367|79039677|FG002|Overall Study|Physician Decision|2|||
44549595|NCT02659020|79565082|FG000|Overall Study|Withdrawal by Subject|2|||
44549596|NCT02659020|79565083|FG001|Overall Study|Withdrawal by Subject|1|||
44549597|NCT02659020|79565084|FG002|Overall Study|Withdrawal by Subject|0|||
44549598|NCT02659020|79565085|FG003|Overall Study|Withdrawal by Subject|3|||
44494444|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
44494445|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
44494446|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
44549599|NCT02659020|79565086|FG004|Overall Study|Withdrawal by Subject|3|||
44549600|NCT02659020|79565087|FG005|Overall Study|Withdrawal by Subject|6|||
44549601|NCT02659020|79565088|FG006|Overall Study|Withdrawal by Subject|3|||
44549602|NCT02659020|79565082|FG000|Overall Study|Progressive Disease|0|||
44494447|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
44494448|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
44494449|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
44494450|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
44494451|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
44494452|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
44549603|NCT02659020|79565083|FG001|Overall Study|Progressive Disease|0|||
44549604|NCT02659020|79565084|FG002|Overall Study|Progressive Disease|0|||
44549605|NCT02659020|79565085|FG003|Overall Study|Progressive Disease|4|||
44549606|NCT02659020|79565086|FG004|Overall Study|Progressive Disease|1|||
44549607|NCT02659020|79565087|FG005|Overall Study|Progressive Disease|0|||
44549608|NCT02659020|79565088|FG006|Overall Study|Progressive Disease|2|||
44549609|NCT03482011|79565113|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
44549610|NCT03482011|79565114|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
44549611|NCT03482011|79565115|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
44549612|NCT03482011|79565116|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
44549613|NCT03482011|79565117|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
44549614|NCT03482011|79565118|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
44549615|NCT03482011|79565119|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
44549616|NCT03482011|79565120|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
44549617|NCT03482011|79565113|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
44549618|NCT03482011|79565114|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
44549619|NCT03482011|79565115|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44549620|NCT03482011|79565116|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44494453|NCT00132678|79500211|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
44494454|NCT00132678|79500212|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
44494455|NCT00132678|79500213|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
44494456|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Death|2|||
44494457|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Death|0|||
44494458|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Death|0|||
44494459|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
44494460|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
44494461|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
44494462|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
44494463|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
44494464|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
44494465|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
44494466|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
44494467|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
44494468|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
44549621|NCT03482011|79565117|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44549622|NCT03482011|79565118|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44549623|NCT03482011|79565119|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44494469|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
44494470|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
44549624|NCT03482011|79565120|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44549625|NCT03482011|79565113|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44549626|NCT03482011|79565114|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
44549627|NCT03482011|79565115|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44549628|NCT03482011|79565116|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44549629|NCT03482011|79565117|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44549630|NCT03482011|79565118|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44376509|NCT01096160|79381665|FG008|Overall Study|Adverse Event|0|||
44494471|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
44494472|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
44494473|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
44549631|NCT03482011|79565119|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44549632|NCT03482011|79565120|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
44549633|NCT03482011|79565113|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
44549634|NCT03482011|79565114|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
44549635|NCT03482011|79565115|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
44549636|NCT03482011|79565116|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
44549637|NCT03482011|79565117|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
44549638|NCT03482011|79565118|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
44549639|NCT03482011|79565119|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
44549640|NCT03482011|79565120|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
44549641|NCT03482011|79565113|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
44549642|NCT03482011|79565114|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
44549643|NCT03482011|79565115|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44549644|NCT03482011|79565116|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44549645|NCT03482011|79565117|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44549646|NCT03482011|79565118|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44549647|NCT03482011|79565119|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44549648|NCT03482011|79565120|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44549649|NCT03482011|79565113|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
44549650|NCT03482011|79565114|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
44494474|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
44494475|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
44494476|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
44494477|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
44494478|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
44494479|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
44549651|NCT03482011|79565115|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
44549652|NCT03482011|79565116|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
44549653|NCT03482011|79565117|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
44549654|NCT03482011|79565118|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
44549655|NCT03482011|79565119|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
44549656|NCT03482011|79565120|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
44549657|NCT03482011|79565113|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
44549658|NCT03482011|79565114|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
44549659|NCT03482011|79565115|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
44549660|NCT03482011|79565116|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
44549661|NCT03482011|79565117|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
44549662|NCT03482011|79565118|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
44549663|NCT03482011|79565119|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
44549664|NCT03482011|79565120|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
44549665|NCT03482011|79565113|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44549666|NCT03482011|79565114|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44549667|NCT03482011|79565115|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44549668|NCT03482011|79565116|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44549669|NCT03482011|79565117|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
44549670|NCT03482011|79565118|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44549671|NCT03482011|79565119|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44549672|NCT03482011|79565120|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
44549673|NCT03482011|79565113|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
44549674|NCT03482011|79565114|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
44549675|NCT03482011|79565115|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
44549676|NCT03482011|79565116|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
44549677|NCT03482011|79565117|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
44549678|NCT03482011|79565118|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
44376510|NCT01096160|79381666|FG009|Overall Study|Adverse Event|1|||
44376511|NCT01096160|79381657|FG000|Overall Study|Met stopping criteria per protocol|0|||
44376512|NCT01096160|79381658|FG001|Overall Study|Met stopping criteria per protocol|0|||
44376513|NCT01096160|79381659|FG002|Overall Study|Met stopping criteria per protocol|0|||
44376514|NCT01096160|79381660|FG003|Overall Study|Met stopping criteria per protocol|0|||
44376515|NCT01096160|79381661|FG004|Overall Study|Met stopping criteria per protocol|1|||
44376516|NCT01096160|79381662|FG005|Overall Study|Met stopping criteria per protocol|0|||
44494480|NCT00132678|79500211|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
44494481|NCT00132678|79500212|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
44549679|NCT03482011|79565119|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
44549680|NCT03482011|79565120|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
44549681|NCT03482011|79565113|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44549682|NCT03482011|79565114|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44549683|NCT03482011|79565115|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44549684|NCT03482011|79565116|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
44549685|NCT03482011|79565117|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
44376517|NCT01096160|79381663|FG006|Overall Study|Met stopping criteria per protocol|2|||
44376518|NCT01096160|79381664|FG007|Overall Study|Met stopping criteria per protocol|0|||
44376519|NCT01096160|79381665|FG008|Overall Study|Met stopping criteria per protocol|2|||
44494482|NCT00132678|79500213|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
44494483|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
44494484|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
44494485|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
44494486|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
44494487|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
44494488|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
44494489|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
44494490|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
44494491|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
44494492|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
44494493|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
44494494|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
44494495|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
44494496|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
44549686|NCT03482011|79565118|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
44494497|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
44494498|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
44230397|NCT01888367|79039675|FG000|Overall Study|Death|2|||
44549687|NCT03482011|79565119|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
44549688|NCT03482011|79565120|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
44549689|NCT03482011|79565113|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44549690|NCT03482011|79565114|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44549691|NCT03482011|79565115|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44549692|NCT03482011|79565116|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
44549693|NCT03482011|79565117|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44549694|NCT03482011|79565118|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
44494499|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
44494500|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
44494501|NCT00132678|79500211|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
44494502|NCT00132678|79500212|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
44549695|NCT03482011|79565119|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
44549696|NCT03482011|79565120|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
44549697|NCT03482011|79565113|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
44230398|NCT01888367|79039676|FG001|Overall Study|Death|0|||
44230399|NCT01888367|79039677|FG002|Overall Study|Death|1|||
44230400|NCT01888367|79039675|FG000|Overall Study|Withdrawal by Subject|1|||
44230401|NCT01888367|79039676|FG001|Overall Study|Withdrawal by Subject|0|||
44230402|NCT01888367|79039677|FG002|Overall Study|Withdrawal by Subject|1|||
44230403|NCT01888367|79039675|FG000|Overall Study|Lost to Follow-up|1|||
44230404|NCT01888367|79039676|FG001|Overall Study|Lost to Follow-up|1|||
44494503|NCT00132678|79500213|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
44494504|NCT00101868|79500223|FG000|Overall Study|Death|10|||
44494505|NCT00101868|79500224|FG001|Overall Study|Death|10|||
44494506|NCT00101868|79500223|FG000|Overall Study|Withdrawal by Subject|8|||
44549698|NCT03482011|79565114|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
44549699|NCT03482011|79565115|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
44549700|NCT03482011|79565116|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
44549701|NCT03482011|79565117|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
44549702|NCT03482011|79565118|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
44549703|NCT03482011|79565119|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
44549704|NCT03482011|79565120|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
44549705|NCT03482011|79565113|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
44549706|NCT03482011|79565114|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
44549707|NCT03482011|79565115|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
44549708|NCT03482011|79565116|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
44549709|NCT03482011|79565117|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
44549710|NCT03482011|79565118|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
44549711|NCT03482011|79565119|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
44549712|NCT03482011|79565120|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
44549713|NCT03482011|79565113|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549714|NCT03482011|79565114|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549715|NCT03482011|79565115|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549716|NCT03482011|79565116|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549717|NCT03482011|79565117|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549718|NCT03482011|79565118|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549719|NCT03482011|79565119|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
44549720|NCT03482011|79565120|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
44549721|NCT03482011|79565113|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549722|NCT03482011|79565114|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549723|NCT03482011|79565115|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549724|NCT03482011|79565116|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549725|NCT03482011|79565117|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549726|NCT03482011|79565118|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549727|NCT03482011|79565119|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
44549728|NCT03482011|79565120|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
44549729|NCT03481309|79565151|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
44494507|NCT00101868|79500224|FG001|Overall Study|Withdrawal by Subject|9|||
44494508|NCT00101868|79500223|FG000|Overall Study|Protocol Violation|3|||
44494509|NCT00101868|79500224|FG001|Overall Study|Protocol Violation|0|||
44494510|NCT00101868|79500223|FG000|Overall Study|Lost to Follow-up|8|||
44549730|NCT03481309|79565152|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
44549731|NCT03481309|79565153|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
44494511|NCT00101868|79500224|FG001|Overall Study|Lost to Follow-up|13|||
44494512|NCT00101400|79500232|FG000|Survival Follow-Up|Alive|7|||
44494513|NCT03821064|79500236|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
44494514|NCT00141518|79500243|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
44230405|NCT01888367|79039677|FG002|Overall Study|Lost to Follow-up|0|||
44230406|NCT01888367|79039675|FG000|Overall Study|Protocol Violation|0|||
44549732|NCT03481309|79565154|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
44549733|NCT03481309|79565155|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
44549734|NCT03481309|79565156|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
44549735|NCT03480841|79565164|FG000|Overall Study|Lost to Follow-up|2|||
44549736|NCT02709538|79565171|FG000|Overall Study|Adverse Event|13|||
44549737|NCT02709538|79565172|FG001|Overall Study|Adverse Event|2|||
44549738|NCT02709538|79565173|FG002|Overall Study|Adverse Event|3|||
44549739|NCT02709538|79565171|FG000|Overall Study|Lack of Efficacy|1|||
44549740|NCT02709538|79565172|FG001|Overall Study|Lack of Efficacy|0|||
44549741|NCT02709538|79565173|FG002|Overall Study|Lack of Efficacy|0|||
44549742|NCT02709538|79565171|FG000|Overall Study|Lost to Follow-up|24|||
44549743|NCT02709538|79565172|FG001|Overall Study|Lost to Follow-up|8|||
44549744|NCT02709538|79565173|FG002|Overall Study|Lost to Follow-up|4|||
44549745|NCT02709538|79565171|FG000|Overall Study|Physician Decision|1|||
44549746|NCT02709538|79565172|FG001|Overall Study|Physician Decision|0|||
44549747|NCT02709538|79565173|FG002|Overall Study|Physician Decision|0|||
44549748|NCT02709538|79565171|FG000|Overall Study|Withdrawal by Subject|40|||
44549749|NCT02709538|79565172|FG001|Overall Study|Withdrawal by Subject|7|||
44549750|NCT02709538|79565173|FG002|Overall Study|Withdrawal by Subject|4|||
44549751|NCT02709538|79565171|FG000|Overall Study|Non-compliance with study procedures|5|||
44549752|NCT02709538|79565172|FG001|Overall Study|Non-compliance with study procedures|0|||
44549753|NCT02709538|79565173|FG002|Overall Study|Non-compliance with study procedures|0|||
44549754|NCT02709538|79565171|FG000|Overall Study|Non-compliance with study drug|2|||
44549755|NCT02709538|79565172|FG001|Overall Study|Non-compliance with study drug|0|||
44549756|NCT02709538|79565173|FG002|Overall Study|Non-compliance with study drug|0|||
44549757|NCT02709538|79565171|FG000|Overall Study|Protocol deviation|10|||
44549758|NCT02709538|79565172|FG001|Overall Study|Protocol deviation|4|||
44549759|NCT02709538|79565173|FG002|Overall Study|Protocol deviation|4|||
44549760|NCT02709538|79565171|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
44549761|NCT02709538|79565172|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
44549762|NCT02709538|79565173|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
44549763|NCT02709538|79565171|FG000|Overall Study|Other|16|||
44549764|NCT02709538|79565172|FG001|Overall Study|Other|7|||
44549765|NCT02709538|79565173|FG002|Overall Study|Other|5|||
44549766|NCT03789318|79565186|FG000|Overall Study|Adverse Event|0|||
44549767|NCT03789318|79565187|FG001|Overall Study|Adverse Event|0|||
44549768|NCT03789318|79565188|FG002|Overall Study|Adverse Event|1|||
44549769|NCT03789318|79565189|FG003|Overall Study|Adverse Event|1|||
44494515|NCT00141518|79500244|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
44494516|NCT00141518|79500245|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
44494517|NCT00141518|79500243|FG000|Overall Study|Adverse Event|7|||
44494518|NCT00141518|79500244|FG001|Overall Study|Adverse Event|5|||
44494519|NCT00141518|79500245|FG002|Overall Study|Adverse Event|2|||
44494520|NCT00141518|79500243|FG000|Overall Study|Withdrawal by Subject|2|||
44494521|NCT00141518|79500244|FG001|Overall Study|Withdrawal by Subject|0|||
44494522|NCT00141518|79500245|FG002|Overall Study|Withdrawal by Subject|2|||
44494523|NCT00141518|79500243|FG000|Overall Study|Protocol Violation|1|||
44494524|NCT00141518|79500244|FG001|Overall Study|Protocol Violation|1|||
44494525|NCT00141518|79500245|FG002|Overall Study|Protocol Violation|2|||
44494526|NCT00141518|79500243|FG000|Overall Study|Lack of Efficacy|5|||
44494527|NCT00141518|79500244|FG001|Overall Study|Lack of Efficacy|0|||
44494528|NCT00141518|79500245|FG002|Overall Study|Lack of Efficacy|0|||
44494529|NCT00253448|79500255|FG000|Overall Study|Withdrawal by Subject|1|||
44494530|NCT00098748|79500262|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
44494531|NCT00098748|79500263|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
44494532|NCT00098748|79500264|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
44494533|NCT00098748|79500262|FG000|Received Study Treatment|Death|2|||
44494534|NCT00098748|79500263|FG001|Received Study Treatment|Death|1|||
44494535|NCT00098748|79500264|FG002|Received Study Treatment|Death|2|||
44494536|NCT00098748|79500262|FG000|Received Study Treatment|Adverse Event|1|||
44549770|NCT03789318|79565190|FG004|Overall Study|Adverse Event|0|||
44549771|NCT03789318|79565186|FG000|Overall Study|Lost to Follow-up|0|||
44549772|NCT03789318|79565187|FG001|Overall Study|Lost to Follow-up|0|||
44549773|NCT03789318|79565188|FG002|Overall Study|Lost to Follow-up|1|||
44549774|NCT03789318|79565189|FG003|Overall Study|Lost to Follow-up|0|||
44494537|NCT00098748|79500263|FG001|Received Study Treatment|Adverse Event|2|||
44494538|NCT00098748|79500264|FG002|Received Study Treatment|Adverse Event|5|||
44494539|NCT00098748|79500262|FG000|Received Study Treatment|Lack of Efficacy|40|||
44549775|NCT03789318|79565190|FG004|Overall Study|Lost to Follow-up|0|||
44549776|NCT03789318|79565186|FG000|Overall Study|Withdrawal by Subject|0|||
44549777|NCT03789318|79565187|FG001|Overall Study|Withdrawal by Subject|0|||
44549778|NCT03789318|79565188|FG002|Overall Study|Withdrawal by Subject|1|||
44549779|NCT03789318|79565189|FG003|Overall Study|Withdrawal by Subject|0|||
44494540|NCT00098748|79500263|FG001|Received Study Treatment|Lack of Efficacy|27|||
44494541|NCT00098748|79500264|FG002|Received Study Treatment|Lack of Efficacy|27|||
44494542|NCT00098748|79500262|FG000|Received Study Treatment|Other|2|||
44549780|NCT03789318|79565190|FG004|Overall Study|Withdrawal by Subject|0|||
44230407|NCT01888367|79039676|FG001|Overall Study|Protocol Violation|0|||
44230408|NCT01888367|79039677|FG002|Overall Study|Protocol Violation|1|||
44230409|NCT01888367|79039675|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
44230410|NCT01888367|79039676|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
44230411|NCT01888367|79039677|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
44230412|NCT01898195|79039703|FG000|Smoking Abstinence|Did not have good measurements|35|||
44230413|NCT01898195|79039704|FG001|Smoking Abstinence|Did not have good measurements|38|||
44230414|NCT01898195|79039705|FG002|Smoking Abstinence|Did not have good measurements|36|||
44230415|NCT01897727|79039719|FG000|Overall Study|Exclusion: central sleep apnea|0|||
44230416|NCT01897727|79039720|FG001|Overall Study|Exclusion: central sleep apnea|1|||
44230417|NCT01897493|79039726|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
44230418|NCT01887353|79039735|FG000|Overall Study|Study stopped early|4|||
44230419|NCT01887353|79039736|FG001|Overall Study|Study stopped early|3|||
44230420|NCT01896869|79039758|FG000|Overall Study|Withdrawal by Subject|0|||
44230421|NCT01896869|79039759|FG001|Overall Study|Withdrawal by Subject|6|||
44230422|NCT01896869|79039758|FG000|Overall Study|Lost to Follow-up|1|||
44494543|NCT00098748|79500263|FG001|Received Study Treatment|Other|2|||
44494544|NCT00098748|79500264|FG002|Received Study Treatment|Other|6|||
44494545|NCT00098748|79500262|FG000|Received Study Treatment|Subject defaulted|3|||
44494546|NCT00098748|79500263|FG001|Received Study Treatment|Subject defaulted|4|||
44494547|NCT00098748|79500264|FG002|Received Study Treatment|Subject defaulted|4|||
44494548|NCT00098748|79500262|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
44494549|NCT00098748|79500263|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
44494550|NCT00098748|79500264|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
44494551|NCT00098748|79500262|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
44494552|NCT00098748|79500263|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
44494553|NCT00098748|79500264|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
44494554|NCT00098748|79500262|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
44494555|NCT00098748|79500263|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
44494556|NCT00098748|79500264|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
44494557|NCT00098748|79500262|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
44494558|NCT00098748|79500263|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
44494559|NCT00098748|79500264|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
44494560|NCT00098748|79500262|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
44494561|NCT00098748|79500263|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
44494562|NCT00098748|79500264|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
44494563|NCT00130520|79500272|FG000|Overall Study|Adverse Event|11|||
44494564|NCT00130520|79500272|FG000|Overall Study|Death|1|||
44494565|NCT00130520|79500272|FG000|Overall Study|Physician Decision|1|||
44230423|NCT01896869|79039759|FG001|Overall Study|Lost to Follow-up|0|||
44494566|NCT00130520|79500272|FG000|Overall Study|Withdrawal by Subject|1|||
44494567|NCT00130520|79500272|FG000|Overall Study|Disease Progression|23|||
44230424|NCT01896557|79039769|FG000|Clopidogrel Alone|Adverse Event|1|||
44230425|NCT01896557|79039770|FG001|Clopidogrel Alone|Adverse Event|0|||
44230426|NCT01896557|79039769|FG000|Clopidogrel + GI Protector|low adherence|1|||
44230427|NCT01896557|79039770|FG001|Clopidogrel + GI Protector|low adherence|1|||
44230428|NCT01896557|79039769|FG000|Clopidogrel + GI Protector|Reading error|1|||
44549781|NCT00511134|79565208|FG000|Overall Study|Withdrawal by Subject|0|||
44549782|NCT00511134|79565209|FG001|Overall Study|Withdrawal by Subject|2|||
44549783|NCT01372384|79565215|FG000|Overall Study|Progression of disease|3|||
44549784|NCT03115476|79565222|FG000|LP0084-1369|Death|1|||
44549785|NCT03115476|79565223|FG001|LP0084-1369|Death|0|||
44549786|NCT03115476|79565224|FG002|LP0084-1369|Death|2|||
44549787|NCT03115476|79565222|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
44549788|NCT03115476|79565223|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
44549789|NCT03115476|79565224|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
44549790|NCT03480763|79565234|FG000|Overall Study|Withdrawal by Subject|18|||
44549791|NCT03480763|79565235|FG001|Overall Study|Withdrawal by Subject|10|||
44549792|NCT03480763|79565234|FG000|Overall Study|Lost to Follow-up|4|||
44549793|NCT03480763|79565235|FG001|Overall Study|Lost to Follow-up|7|||
44549794|NCT03480763|79565234|FG000|Overall Study|non-study pneumococcal vaccine|1|||
44549795|NCT03480763|79565235|FG001|Overall Study|non-study pneumococcal vaccine|0|||
44549796|NCT03480763|79565234|FG000|Overall Study|oncological treatment|0|||
44549797|NCT03480763|79565235|FG001|Overall Study|oncological treatment|2|||
44549798|NCT03480763|79565234|FG000|Overall Study|pain with vaccination|1|||
44549799|NCT03480763|79565235|FG001|Overall Study|pain with vaccination|0|||
44549800|NCT03123120|79565249|FG000|Overall Study|Lost to Follow-up|0|||
44549801|NCT03123120|79565250|FG001|Overall Study|Lost to Follow-up|1|||
44549802|NCT03123120|79565249|FG000|Overall Study|Withdrawal by Subject|0|||
44549803|NCT03123120|79565250|FG001|Overall Study|Withdrawal by Subject|1|||
44549804|NCT01319994|79565260|FG000|Overall Study|Protocol Violation|7|||
44549805|NCT01319994|79565261|FG001|Overall Study|Protocol Violation|6|||
44549806|NCT03453151|79565271|FG000|Overall Study|Withdrawal by Subject|1|||
44549807|NCT03453151|79565271|FG000|Overall Study|Physician Decision|3|||
44549808|NCT03452527|79565277|FG000|Overall Study|Withdrawal by Subject|1|||
44549809|NCT03452527|79565278|FG001|Overall Study|Withdrawal by Subject|1|||
44549810|NCT03452527|79565277|FG000|Overall Study|Study Terminated|2|||
44549811|NCT03452527|79565278|FG001|Overall Study|Study Terminated|3|||
44549812|NCT03028142|79565284|FG000|Overall Study|Adverse Event|1|||
44549813|NCT03028142|79565285|FG001|Overall Study|Adverse Event|1|||
44549814|NCT03028142|79565286|FG002|Overall Study|Adverse Event|0|||
44549815|NCT03028142|79565287|FG003|Overall Study|Adverse Event|0|||
44549816|NCT03028142|79565288|FG004|Overall Study|Adverse Event|0|||
44230429|NCT01896557|79039770|FG001|Clopidogrel + GI Protector|Reading error|3|||
44549817|NCT03028142|79565289|FG005|Overall Study|Adverse Event|1|||
44549818|NCT03028142|79565284|FG000|Overall Study|Withdrawal by Subject|0|||
44549819|NCT03028142|79565285|FG001|Overall Study|Withdrawal by Subject|0|||
44549820|NCT03028142|79565286|FG002|Overall Study|Withdrawal by Subject|0|||
44549821|NCT03028142|79565287|FG003|Overall Study|Withdrawal by Subject|0|||
44230430|NCT01886105|79039785|FG000|Overall Study|Lack of Efficacy|3|||
44230431|NCT01895777|79039814|FG000|Overall Study|Adverse Event|1|||
44230432|NCT01895777|79039815|FG001|Overall Study|Adverse Event|2|||
44230433|NCT01895777|79039814|FG000|Overall Study|Lost to Follow-up|2|||
44230434|NCT01895777|79039815|FG001|Overall Study|Lost to Follow-up|0|||
44230435|NCT01895777|79039814|FG000|Overall Study|Not treated|1|||
44494568|NCT00130520|79500272|FG000|Overall Study|Protocol non-compliance|1|||
44494569|NCT00130520|79500272|FG000|Overall Study|Did not meet re-treatment criteria|1|||
44494570|NCT00132132|79500278|FG000|Overall Study|Lost to Follow-up|7|||
44494571|NCT00132132|79500279|FG001|Overall Study|Lost to Follow-up|2|||
44494572|NCT00130442|79500287|FG000|Overall Study|Withdrawal by Subject|0|||
44494573|NCT00130442|79500288|FG001|Overall Study|Withdrawal by Subject|1|||
44494574|NCT00130442|79500287|FG000|Overall Study|did not meet criteria|1|||
44494575|NCT00130442|79500288|FG001|Overall Study|did not meet criteria|1|||
44494576|NCT00130208|79500298|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
44494577|NCT00130208|79500299|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
44494578|NCT00130208|79500298|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
44494579|NCT00130208|79500299|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
44494580|NCT00130208|79500298|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
44494581|NCT00130208|79500299|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
44549822|NCT03028142|79565288|FG004|Overall Study|Withdrawal by Subject|1|||
44549823|NCT03028142|79565289|FG005|Overall Study|Withdrawal by Subject|0|||
44549824|NCT02708524|79565302|FG000|Overall Study|Adverse Event|0|||
44549825|NCT02708524|79565303|FG001|Overall Study|Adverse Event|1|||
44549826|NCT02708524|79565304|FG002|Overall Study|Adverse Event|0|||
44549827|NCT02708524|79565305|FG003|Overall Study|Adverse Event|0|||
44549828|NCT02708524|79565302|FG000|Overall Study|Lens Discomfort|1|||
44549829|NCT02708524|79565303|FG001|Overall Study|Lens Discomfort|0|||
44549830|NCT02708524|79565304|FG002|Overall Study|Lens Discomfort|1|||
44549831|NCT02708524|79565305|FG003|Overall Study|Lens Discomfort|0|||
44549832|NCT02708524|79565302|FG000|Overall Study|Lost to Follow-up|1|||
44549833|NCT02708524|79565303|FG001|Overall Study|Lost to Follow-up|1|||
44549834|NCT02708524|79565304|FG002|Overall Study|Lost to Follow-up|1|||
44549835|NCT02708524|79565305|FG003|Overall Study|Lost to Follow-up|0|||
44549836|NCT02708524|79565302|FG000|Overall Study|Protocol Violation|0|||
44549837|NCT02708524|79565303|FG001|Overall Study|Protocol Violation|1|||
44549838|NCT02708524|79565304|FG002|Overall Study|Protocol Violation|0|||
44549839|NCT02708524|79565305|FG003|Overall Study|Protocol Violation|0|||
44549840|NCT02708524|79565302|FG000|Overall Study|Withdrawal by Subject|1|||
44549841|NCT02708524|79565303|FG001|Overall Study|Withdrawal by Subject|1|||
44549842|NCT02708524|79565304|FG002|Overall Study|Withdrawal by Subject|0|||
44549843|NCT02708524|79565305|FG003|Overall Study|Withdrawal by Subject|0|||
44549844|NCT02708524|79565302|FG000|Overall Study|Dispensed incorrect study lens|0|||
44549845|NCT02708524|79565303|FG001|Overall Study|Dispensed incorrect study lens|1|||
44549846|NCT02708524|79565304|FG002|Overall Study|Dispensed incorrect study lens|1|||
44549847|NCT02708524|79565305|FG003|Overall Study|Dispensed incorrect study lens|0|||
44549848|NCT02708524|79565302|FG000|Overall Study|Did not wear lens at final visit|0|||
44549849|NCT02708524|79565303|FG001|Overall Study|Did not wear lens at final visit|1|||
44549850|NCT02708524|79565304|FG002|Overall Study|Did not wear lens at final visit|0|||
44549851|NCT02708524|79565305|FG003|Overall Study|Did not wear lens at final visit|0|||
44549852|NCT02708524|79565302|FG000|Overall Study|Subject lost study lens|1|||
44549853|NCT02708524|79565303|FG001|Overall Study|Subject lost study lens|0|||
44549854|NCT02708524|79565304|FG002|Overall Study|Subject lost study lens|0|||
44549855|NCT02708524|79565305|FG003|Overall Study|Subject lost study lens|0|||
44549856|NCT03418675|79565317|FG000|Overall Study|Lost to Follow-up|13|||
44549857|NCT03418675|79565318|FG001|Overall Study|Lost to Follow-up|10|||
44549858|NCT03418675|79565317|FG000|Overall Study|Adverse Event|2|||
44549859|NCT03418675|79565318|FG001|Overall Study|Adverse Event|0|||
44549860|NCT03417505|79565335|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
44549861|NCT03417505|79565336|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
44549862|NCT02953639|79565345|FG000|Overall Study|Adverse Event|2|||
44549863|NCT02953639|79565346|FG001|Overall Study|Adverse Event|0|||
44549864|NCT02953639|79565347|FG002|Overall Study|Adverse Event|1|||
44549865|NCT02953639|79565345|FG000|Overall Study|Lost to Follow-up|8|||
44549866|NCT02953639|79565346|FG001|Overall Study|Lost to Follow-up|4|||
44549867|NCT02953639|79565347|FG002|Overall Study|Lost to Follow-up|3|||
44549868|NCT02953639|79565345|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44549869|NCT02953639|79565346|FG001|Overall Study|Non-Compliance With Study Drug|2|||
44549870|NCT02953639|79565347|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44549871|NCT02953639|79565345|FG000|Overall Study|Multiple Reasons|1|||
44549872|NCT02953639|79565346|FG001|Overall Study|Multiple Reasons|0|||
44549873|NCT02953639|79565347|FG002|Overall Study|Multiple Reasons|1|||
44549874|NCT02953639|79565345|FG000|Overall Study|Physician Decision|1|||
44549875|NCT02953639|79565346|FG001|Overall Study|Physician Decision|0|||
44549876|NCT02953639|79565347|FG002|Overall Study|Physician Decision|0|||
44549877|NCT02953639|79565345|FG000|Overall Study|Withdrawal by Subject|7|||
44549878|NCT02953639|79565346|FG001|Overall Study|Withdrawal by Subject|8|||
44549879|NCT02953639|79565347|FG002|Overall Study|Withdrawal by Subject|10|||
44549880|NCT02953639|79565345|FG000|Overall Study|Completed or Discontinued information is missing|1|||
44549881|NCT02953639|79565346|FG001|Overall Study|Completed or Discontinued information is missing|0|||
44549882|NCT02953639|79565347|FG002|Overall Study|Completed or Discontinued information is missing|0|||
44549883|NCT04147715|79565369|FG000|Overall Study|Adverse Event|0|||
44549884|NCT04147715|79565370|FG001|Overall Study|Adverse Event|0|||
44549885|NCT04147715|79565371|FG002|Overall Study|Adverse Event|0|||
44549886|NCT04147715|79565372|FG003|Overall Study|Adverse Event|0|||
44549887|NCT04147715|79565373|FG004|Overall Study|Adverse Event|0|||
44549888|NCT04147715|79565374|FG005|Overall Study|Adverse Event|0|||
44549889|NCT04147715|79565375|FG006|Overall Study|Adverse Event|0|||
44549890|NCT04147715|79565376|FG007|Overall Study|Adverse Event|2|||
44549891|NCT04147715|79565377|FG008|Overall Study|Adverse Event|1|||
44549892|NCT04147715|79565378|FG009|Overall Study|Adverse Event|0|||
44549893|NCT04147715|79565379|FG010|Overall Study|Adverse Event|0|||
44549894|NCT04147715|79565380|FG011|Overall Study|Adverse Event|0|||
44549895|NCT02452554|79565467|FG000|Overall Study|Death|2|||
44549896|NCT02452554|79565468|FG001|Overall Study|Death|1|||
44549897|NCT02452554|79565469|FG002|Overall Study|Death|0|||
44549898|NCT02452554|79565470|FG003|Overall Study|Death|0|||
44549899|NCT02452554|79565471|FG004|Overall Study|Death|0|||
44549900|NCT02452554|79565472|FG005|Overall Study|Death|0|||
44549901|NCT02452554|79565467|FG000|Overall Study|Lack of Efficacy|13|||
44549902|NCT02452554|79565468|FG001|Overall Study|Lack of Efficacy|14|||
44549903|NCT02452554|79565469|FG002|Overall Study|Lack of Efficacy|9|||
44549904|NCT02452554|79565470|FG003|Overall Study|Lack of Efficacy|1|||
44549905|NCT02452554|79565471|FG004|Overall Study|Lack of Efficacy|5|||
44549906|NCT02452554|79565472|FG005|Overall Study|Lack of Efficacy|8|||
44549907|NCT02452554|79565467|FG000|Overall Study|Physician Decision|0|||
44549908|NCT02452554|79565468|FG001|Overall Study|Physician Decision|1|||
44549909|NCT02452554|79565469|FG002|Overall Study|Physician Decision|0|||
44549910|NCT02452554|79565470|FG003|Overall Study|Physician Decision|0|||
44549911|NCT02452554|79565471|FG004|Overall Study|Physician Decision|0|||
44549912|NCT02452554|79565472|FG005|Overall Study|Physician Decision|0|||
44549913|NCT02452554|79565467|FG000|Overall Study|Withdrawal by Subject|1|||
44549914|NCT02452554|79565468|FG001|Overall Study|Withdrawal by Subject|0|||
44549915|NCT02452554|79565469|FG002|Overall Study|Withdrawal by Subject|2|||
44549916|NCT02452554|79565470|FG003|Overall Study|Withdrawal by Subject|0|||
44549917|NCT02452554|79565471|FG004|Overall Study|Withdrawal by Subject|0|||
44230436|NCT01895777|79039815|FG001|Overall Study|Not treated|0|||
44230437|NCT01895777|79039814|FG000|Overall Study|Other reasons|3|||
44494582|NCT00130208|79500298|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
44494583|NCT00130208|79500299|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
44494584|NCT00130208|79500298|FG000|Maintenance Period (26 Weeks)|Other|1|||
44494585|NCT00130208|79500299|FG001|Maintenance Period (26 Weeks)|Other|1|||
44494586|NCT00130208|79500298|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
44494587|NCT00130208|79500299|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
44494588|NCT00130208|79500298|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
44494589|NCT00130208|79500299|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
44494590|NCT00130208|79500298|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
44494591|NCT00130208|79500299|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
44494592|NCT00130208|79500298|FG000|Washout Period (8 Weeks)|Other|1|||
44494593|NCT00130208|79500299|FG001|Washout Period (8 Weeks)|Other|1|||
44494594|NCT00253370|79500305|FG000|Overall Study|Adverse Event|18|||
44494595|NCT00253370|79500305|FG000|Overall Study|Disease progression|13|||
44494596|NCT00253370|79500305|FG000|Overall Study|Death|2|||
44494597|NCT00253370|79500305|FG000|Overall Study|Withdrawal by Subject|6|||
44494598|NCT00253370|79500305|FG000|Overall Study|Non-protocol therapy|1|||
44494599|NCT00253370|79500305|FG000|Overall Study|Physician Decision|1|||
44494600|NCT00253370|79500305|FG000|Overall Study|Protocol Violation|1|||
44494601|NCT00253370|79500305|FG000|Overall Study|Abdominal pain due to disease|1|||
44494602|NCT00140426|79500312|FG000|Overall Study|Withdrawal by Subject|0|||
44494603|NCT00140426|79500313|FG001|Overall Study|Withdrawal by Subject|3|||
44494604|NCT00121134|79500328|FG000|Overall Study|Progression of Disease|5|||
44494605|NCT00121134|79500329|FG001|Overall Study|Progression of Disease|3|||
44549918|NCT02452554|79565472|FG005|Overall Study|Withdrawal by Subject|1|||
44494606|NCT00121134|79500330|FG002|Overall Study|Progression of Disease|4|||
44549919|NCT02452554|79565467|FG000|Overall Study|Ineligible|0|||
44549920|NCT02452554|79565468|FG001|Overall Study|Ineligible|1|||
44549921|NCT02452554|79565469|FG002|Overall Study|Ineligible|0|||
44549922|NCT02452554|79565470|FG003|Overall Study|Ineligible|0|||
44494607|NCT00121134|79500331|FG003|Overall Study|Progression of Disease|2|||
44549923|NCT02452554|79565471|FG004|Overall Study|Ineligible|0|||
44549924|NCT02452554|79565472|FG005|Overall Study|Ineligible|0|||
44549925|NCT02452554|79565467|FG000|Overall Study|Never Received Treatment|1|||
44549926|NCT02452554|79565468|FG001|Overall Study|Never Received Treatment|0|||
44549927|NCT02452554|79565469|FG002|Overall Study|Never Received Treatment|0|||
44549928|NCT02452554|79565470|FG003|Overall Study|Never Received Treatment|0|||
44549929|NCT02452554|79565471|FG004|Overall Study|Never Received Treatment|0|||
44549930|NCT02452554|79565472|FG005|Overall Study|Never Received Treatment|0|||
44549931|NCT04009577|79565491|FG000|Core Study|Adverse Event|1|||
44549932|NCT04009577|79565492|FG001|Core Study|Adverse Event|0|||
44549933|NCT04009577|79565493|FG002|Core Study|Adverse Event|2|||
44549934|NCT04009577|79565494|FG003|Core Study|Adverse Event|4|||
44549935|NCT04009577|79565491|FG000|Core Study|Withdrawal by Subject|0|||
44549936|NCT04009577|79565492|FG001|Core Study|Withdrawal by Subject|0|||
44549937|NCT04009577|79565493|FG002|Core Study|Withdrawal by Subject|2|||
44549938|NCT04009577|79565494|FG003|Core Study|Withdrawal by Subject|0|||
44549939|NCT04009577|79565491|FG000|Core Study|Other|0|||
44549940|NCT04009577|79565492|FG001|Core Study|Other|0|||
44549941|NCT04009577|79565493|FG002|Core Study|Other|0|||
44549942|NCT04009577|79565494|FG003|Core Study|Other|1|||
44549943|NCT04009577|79565491|FG000|Extension Phase|Adverse Event|0|||
44549944|NCT04009577|79565492|FG001|Extension Phase|Adverse Event|0|||
44549945|NCT04009577|79565493|FG002|Extension Phase|Adverse Event|0|||
44549946|NCT04009577|79565494|FG003|Extension Phase|Adverse Event|1|||
44549947|NCT04009577|79565491|FG000|Extension Phase|Inadequate therapeutic effect|0|||
44549948|NCT04009577|79565492|FG001|Extension Phase|Inadequate therapeutic effect|0|||
44549949|NCT04009577|79565493|FG002|Extension Phase|Inadequate therapeutic effect|1|||
44549950|NCT04009577|79565494|FG003|Extension Phase|Inadequate therapeutic effect|0|||
44549951|NCT04009577|79565491|FG000|Extension Phase|Withdrawal by Subject|0|||
44549952|NCT04009577|79565492|FG001|Extension Phase|Withdrawal by Subject|0|||
44549953|NCT04009577|79565493|FG002|Extension Phase|Withdrawal by Subject|1|||
44549954|NCT04009577|79565494|FG003|Extension Phase|Withdrawal by Subject|0|||
44549955|NCT04009577|79565491|FG000|Extension Phase|Not Treated|0|||
44549956|NCT04009577|79565492|FG001|Extension Phase|Not Treated|0|||
44549957|NCT04009577|79565493|FG002|Extension Phase|Not Treated|2|||
44549958|NCT04009577|79565494|FG003|Extension Phase|Not Treated|0|||
44549959|NCT04146467|79565522|FG000|Overall Study|Adverse Event|0|||
44549960|NCT04146467|79565523|FG001|Overall Study|Adverse Event|1|||
44549961|NCT04146467|79565522|FG000|Overall Study|Lost to Follow-up|0|||
44549962|NCT04146467|79565523|FG001|Overall Study|Lost to Follow-up|2|||
44549963|NCT02705716|79565534|FG000|Overall Study|Adverse Event|0|||
44549964|NCT02705716|79565535|FG001|Overall Study|Adverse Event|1|||
44549965|NCT02705716|79565534|FG000|Overall Study|Protocol Violation|3|||
44549966|NCT02705716|79565535|FG001|Overall Study|Protocol Violation|0|||
44549967|NCT02705716|79565534|FG000|Overall Study|Withdrawal of Consent|1|||
44549968|NCT02705716|79565535|FG001|Overall Study|Withdrawal of Consent|1|||
44549969|NCT04138043|79565543|FG000|Overall Study|Withdrawal by Subject|0|||
44549970|NCT04138043|79565544|FG001|Overall Study|Withdrawal by Subject|1|||
44549971|NCT03443713|79565563|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
44549972|NCT03443713|79565564|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
44549973|NCT03443713|79565565|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
44549974|NCT04133519|79565579|FG000|Overall Study|Withdrawal by Subject|5|||
44549975|NCT04133519|79565580|FG001|Overall Study|Withdrawal by Subject|4|||
44549976|NCT04133519|79565579|FG000|Overall Study|Protocol Violation|0|||
44549977|NCT04133519|79565580|FG001|Overall Study|Protocol Violation|1|||
44494608|NCT00121134|79500328|FG000|Overall Study|Toxicity|4|||
44494609|NCT00121134|79500329|FG001|Overall Study|Toxicity|7|||
44494610|NCT00121134|79500330|FG002|Overall Study|Toxicity|13|||
44494611|NCT00121134|79500331|FG003|Overall Study|Toxicity|5|||
44494612|NCT00121134|79500328|FG000|Overall Study|Physician Decision|6|||
44494613|NCT00121134|79500329|FG001|Overall Study|Physician Decision|4|||
44494614|NCT00121134|79500330|FG002|Overall Study|Physician Decision|4|||
44494615|NCT00121134|79500331|FG003|Overall Study|Physician Decision|1|||
44549978|NCT04133519|79565579|FG000|Overall Study|Never started treatment|1|||
44549979|NCT04133519|79565580|FG001|Overall Study|Never started treatment|1|||
44549980|NCT04007159|79565586|FG000|Induction Phase|(missed study visits)|16|||
44549981|NCT04007159|79565586|FG000|Induction Phase|Withdrawal by Subject|4|||
44549982|NCT04007159|79565586|FG000|Induction Phase|Adverse Event|2|||
44549983|NCT04007159|79565586|FG000|Challenge Phase|missed study visits|3|||
44230438|NCT01895777|79039815|FG001|Overall Study|Other reasons|2|||
44230439|NCT01895777|79039814|FG000|Overall Study|Non-compliance with the CTP|2|||
44549984|NCT03119688|79565597|FG000|Overall Study|Adverse Event|4|||
44549985|NCT03389893|79565616|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
44494616|NCT00121134|79500328|FG000|Overall Study|Treatment Delay|1|||
44549986|NCT03389893|79565617|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
44549987|NCT03389893|79565618|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
44549988|NCT03389893|79565619|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
44549989|NCT03389893|79565616|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
44549990|NCT03389893|79565617|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
44549991|NCT03389893|79565618|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
44549992|NCT03389893|79565619|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
44549993|NCT03389893|79565616|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
44549994|NCT03389893|79565617|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
44549995|NCT03389893|79565618|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
44549996|NCT03389893|79565619|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
44549997|NCT03389893|79565616|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
44549998|NCT03389893|79565617|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
44549999|NCT03389893|79565618|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
44550000|NCT03389893|79565619|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
44550001|NCT04128293|79565629|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
44550002|NCT04128293|79565630|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
44550003|NCT04128293|79565631|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
44550004|NCT04128293|79565632|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
44550005|NCT00787176|79565651|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
44550006|NCT00787176|79565652|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
44550007|NCT00787176|79565653|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
44550008|NCT00787176|79565654|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
44550009|NCT03691571|79565667|FG000|Overall Study|Withdrawal by Subject|9|||
44550010|NCT03691571|79565668|FG001|Overall Study|Withdrawal by Subject|2|||
44550011|NCT03113916|79565677|FG000|Overall Study|Withdrawal by Subject|9|||
44550012|NCT03113916|79565678|FG001|Overall Study|Withdrawal by Subject|7|||
44550013|NCT03113916|79565677|FG000|Overall Study|Pregnancy|1|||
44550014|NCT03113916|79565678|FG001|Overall Study|Pregnancy|3|||
44550015|NCT03113916|79565677|FG000|Overall Study|Lost to Follow-up|1|||
44550016|NCT03113916|79565678|FG001|Overall Study|Lost to Follow-up|2|||
44550017|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
44550018|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
44550019|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
44550020|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
44550021|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
44550022|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
44550023|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
44550024|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
44230440|NCT01895777|79039815|FG001|Overall Study|Non-compliance with the CTP|1|||
44230441|NCT01885559|79039843|FG000|Overall Study|Lost to Follow-up|15|||
44230442|NCT01885559|79039844|FG001|Overall Study|Lost to Follow-up|16|||
44230443|NCT01885559|79039843|FG000|Overall Study|Less than full participation|9|||
44230444|NCT01885559|79039844|FG001|Overall Study|Less than full participation|19|||
44494617|NCT00121134|79500329|FG001|Overall Study|Treatment Delay|0|||
44494618|NCT00121134|79500330|FG002|Overall Study|Treatment Delay|0|||
44494619|NCT00121134|79500331|FG003|Overall Study|Treatment Delay|0|||
44494620|NCT00121134|79500328|FG000|Overall Study|Intercurrent Illness|0|||
44494621|NCT00121134|79500329|FG001|Overall Study|Intercurrent Illness|0|||
44494622|NCT00121134|79500330|FG002|Overall Study|Intercurrent Illness|0|||
44494623|NCT00121134|79500331|FG003|Overall Study|Intercurrent Illness|1|||
44494624|NCT00121134|79500328|FG000|Overall Study|Patient Personal Reasons|0|||
44494625|NCT00121134|79500329|FG001|Overall Study|Patient Personal Reasons|1|||
44494626|NCT00121134|79500330|FG002|Overall Study|Patient Personal Reasons|0|||
44494627|NCT00121134|79500331|FG003|Overall Study|Patient Personal Reasons|0|||
44494628|NCT00119262|79500343|FG000|Overall Study|Lack of Efficacy|0|||
44494629|NCT00119262|79500344|FG001|Overall Study|Lack of Efficacy|3|||
44494630|NCT00119262|79500343|FG000|Overall Study|Withdrawal by Subject|12|||
44494631|NCT00119262|79500344|FG001|Overall Study|Withdrawal by Subject|11|||
44494632|NCT00119262|79500343|FG000|Overall Study|Adverse Event|33|||
44550025|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Other|1|||
44230445|NCT01885559|79039843|FG000|Overall Study|Protocol Violation|0|||
44230446|NCT01885559|79039844|FG001|Overall Study|Protocol Violation|1|||
44494633|NCT00119262|79500344|FG001|Overall Study|Adverse Event|35|||
44550026|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Other|4|||
44494634|NCT00119262|79500343|FG000|Overall Study|other disease|0|||
44494635|NCT00119262|79500344|FG001|Overall Study|other disease|2|||
44494636|NCT00119262|79500343|FG000|Overall Study|ineligble|1|||
44494637|NCT00119262|79500344|FG001|Overall Study|ineligble|2|||
44550027|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Other|3|||
44550028|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Other|6|||
44550029|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
44550030|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
44550031|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
44550032|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
44550033|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
44550034|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
44550035|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
44274703|NCT02243202|79220516|FG003|Overall Study|Withdrawal by Subject|4|||
44494638|NCT00119262|79500343|FG000|Overall Study|others|0|||
44494639|NCT00119262|79500344|FG001|Overall Study|others|5|||
44494640|NCT03703882|79500352|FG000|Overall Study|Adverse Event|1|||
44494641|NCT03703882|79500353|FG001|Overall Study|Adverse Event|0|||
44494642|NCT03703882|79500352|FG000|Overall Study|Lost to Follow-up|0|||
44494643|NCT03703882|79500353|FG001|Overall Study|Lost to Follow-up|2|||
44494644|NCT03703882|79500352|FG000|Overall Study|Non-compliance with study drug|0|||
44494645|NCT03703882|79500353|FG001|Overall Study|Non-compliance with study drug|1|||
44494646|NCT03703882|79500352|FG000|Overall Study|Physician Decision|0|||
44550036|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
44274704|NCT02243202|79220513|FG000|Overall Study|Other|1|||
44494647|NCT03703882|79500353|FG001|Overall Study|Physician Decision|1|||
44494648|NCT03703882|79500352|FG000|Overall Study|Progressive disease|1|||
44494649|NCT03703882|79500353|FG001|Overall Study|Progressive disease|0|||
44494650|NCT03703882|79500352|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44494651|NCT03703882|79500353|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44494652|NCT03703882|79500352|FG000|Overall Study|Starting another treatment|0|||
44494653|NCT03703882|79500353|FG001|Overall Study|Starting another treatment|1|||
44494654|NCT03703882|79500352|FG000|Overall Study|noncompliance with study procedures|0|||
44494655|NCT03703882|79500353|FG001|Overall Study|noncompliance with study procedures|1|||
44494656|NCT00131664|79500362|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
44494657|NCT00131664|79500363|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
44494658|NCT00131664|79500364|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
44494659|NCT00131664|79500365|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
44494660|NCT00131664|79500366|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
44494661|NCT00131664|79500367|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
44494662|NCT00131664|79500362|FG000|First Period (First 6 Months)|Death|0|||
44494663|NCT00131664|79500363|FG001|First Period (First 6 Months)|Death|1|||
44494664|NCT00131664|79500364|FG002|First Period (First 6 Months)|Death|0|||
44494665|NCT00131664|79500365|FG003|First Period (First 6 Months)|Death|0|||
44494666|NCT00131664|79500366|FG004|First Period (First 6 Months)|Death|0|||
44494667|NCT00131664|79500367|FG005|First Period (First 6 Months)|Death|0|||
44494668|NCT00131664|79500362|FG000|First Period (First 6 Months)|Protocol Violation|2|||
44494669|NCT00131664|79500363|FG001|First Period (First 6 Months)|Protocol Violation|2|||
44494670|NCT00131664|79500364|FG002|First Period (First 6 Months)|Protocol Violation|1|||
44230447|NCT01884545|79039854|FG000|Overall Study|Lost to Follow-up|6|||
44230448|NCT01884545|79039855|FG001|Overall Study|Lost to Follow-up|4|||
44230449|NCT01884545|79039856|FG002|Overall Study|Lost to Follow-up|9|||
44230450|NCT01884545|79039857|FG003|Overall Study|Lost to Follow-up|4|||
44494671|NCT00131664|79500365|FG003|First Period (First 6 Months)|Protocol Violation|0|||
44494672|NCT00131664|79500366|FG004|First Period (First 6 Months)|Protocol Violation|0|||
44494673|NCT00131664|79500367|FG005|First Period (First 6 Months)|Protocol Violation|0|||
44494674|NCT00131664|79500362|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
44494675|NCT00131664|79500363|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
44494676|NCT00131664|79500364|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
44230451|NCT01884545|79039854|FG000|Overall Study|Patient withdrawn|7|||
44230452|NCT01884545|79039855|FG001|Overall Study|Patient withdrawn|12|||
44494677|NCT00131664|79500365|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
44230453|NCT01884545|79039856|FG002|Overall Study|Patient withdrawn|5|||
44230454|NCT01884545|79039857|FG003|Overall Study|Patient withdrawn|5|||
44230455|NCT01884545|79039854|FG000|Overall Study|Non-adherence|0|||
44230456|NCT01884545|79039855|FG001|Overall Study|Non-adherence|2|||
44230457|NCT01884545|79039856|FG002|Overall Study|Non-adherence|0|||
44230458|NCT01884545|79039857|FG003|Overall Study|Non-adherence|0|||
44230459|NCT01895543|79039867|FG000|Overall Study|Withdrawal by Subject|43|||
44230460|NCT01895543|79039867|FG000|Overall Study|Lost to Follow-up|25|||
44230461|NCT01895543|79039867|FG000|Overall Study|Adverse Event|28|||
44230462|NCT01895543|79039867|FG000|Overall Study|Subject's substantial non-compliance|6|||
44230463|NCT01895543|79039867|FG000|Overall Study|Protocol Violation|1|||
44230464|NCT01895543|79039867|FG000|Overall Study|Physician Decision|2|||
44230465|NCT01895543|79039867|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
44230466|NCT04828161|79039964|FG000|Overall Study|Withdrawal by Subject|0|||
44230467|NCT04828161|79039965|FG001|Overall Study|Withdrawal by Subject|3|||
44494678|NCT00131664|79500366|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
44494679|NCT00131664|79500367|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
44494680|NCT00131664|79500362|FG000|First Period (First 6 Months)|Adverse Event|9|||
44494681|NCT00131664|79500363|FG001|First Period (First 6 Months)|Adverse Event|4|||
44494682|NCT00131664|79500364|FG002|First Period (First 6 Months)|Adverse Event|5|||
44494683|NCT00131664|79500365|FG003|First Period (First 6 Months)|Adverse Event|0|||
44494684|NCT00131664|79500366|FG004|First Period (First 6 Months)|Adverse Event|0|||
44494685|NCT00131664|79500367|FG005|First Period (First 6 Months)|Adverse Event|0|||
44494686|NCT00131664|79500362|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
44514831|NCT03078556|79520660|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
44230468|NCT04828161|79039966|FG002|Overall Study|Withdrawal by Subject|3|||
44230469|NCT04828161|79039967|FG003|Overall Study|Withdrawal by Subject|4|||
44230470|NCT04828161|79039964|FG000|Overall Study|Lost to Follow-up|1|||
44230471|NCT04828161|79039965|FG001|Overall Study|Lost to Follow-up|4|||
44230472|NCT04828161|79039966|FG002|Overall Study|Lost to Follow-up|2|||
44274705|NCT02243202|79220514|FG001|Overall Study|Other|3|||
44274706|NCT02243202|79220515|FG002|Overall Study|Other|1|||
44514832|NCT03078556|79520661|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
44514833|NCT03078556|79520658|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
44514834|NCT03078556|79520659|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
44514835|NCT03078556|79520660|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
44514836|NCT03078556|79520661|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
44514837|NCT03078556|79520658|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
44514838|NCT03078556|79520659|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
44514839|NCT03078556|79520660|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
44514840|NCT03078556|79520661|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
44514841|NCT03078556|79520658|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
44514842|NCT03078556|79520659|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
44514843|NCT03078556|79520660|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
44514844|NCT03078556|79520661|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
44514845|NCT03714672|79520690|FG000|Overall Study|Adverse Event|0|||
44514846|NCT03714672|79520691|FG001|Overall Study|Adverse Event|0|||
44514847|NCT03714672|79520692|FG002|Overall Study|Adverse Event|3|||
44514848|NCT03714672|79520693|FG003|Overall Study|Adverse Event|0|||
44514849|NCT03714672|79520690|FG000|Overall Study|Physician Decision|0|||
44514850|NCT03714672|79520691|FG001|Overall Study|Physician Decision|1|||
44514851|NCT03714672|79520692|FG002|Overall Study|Physician Decision|0|||
44514852|NCT03714672|79520693|FG003|Overall Study|Physician Decision|0|||
44514853|NCT03714672|79520690|FG000|Overall Study|Other Reason|1|||
44230473|NCT04828161|79039967|FG003|Overall Study|Lost to Follow-up|2|||
44230474|NCT04828161|79039964|FG000|Overall Study|Other|2|||
44274707|NCT02243202|79220516|FG003|Overall Study|Other|2|||
44494687|NCT00131664|79500363|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
44494688|NCT00131664|79500364|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
44494689|NCT00131664|79500365|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
44494690|NCT00131664|79500366|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
44494691|NCT00131664|79500367|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
44494692|NCT00131664|79500362|FG000|First Period (First 6 Months)|Administrative reasons|2|||
44494693|NCT00131664|79500363|FG001|First Period (First 6 Months)|Administrative reasons|0|||
44494694|NCT00131664|79500364|FG002|First Period (First 6 Months)|Administrative reasons|5|||
44494695|NCT00131664|79500365|FG003|First Period (First 6 Months)|Administrative reasons|0|||
44494696|NCT00131664|79500366|FG004|First Period (First 6 Months)|Administrative reasons|0|||
44494697|NCT00131664|79500367|FG005|First Period (First 6 Months)|Administrative reasons|0|||
44494698|NCT00131664|79500362|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
44494699|NCT00131664|79500363|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
44494700|NCT00131664|79500364|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
44494701|NCT00131664|79500365|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
44494702|NCT00131664|79500366|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
44494703|NCT00131664|79500367|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
44494704|NCT00131664|79500362|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
44494705|NCT00131664|79500363|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
44494706|NCT00131664|79500364|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
44494707|NCT00131664|79500365|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
44494708|NCT00131664|79500366|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
44494709|NCT00131664|79500367|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
44494710|NCT00131664|79500362|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
44494711|NCT00131664|79500363|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
44494712|NCT00131664|79500364|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
44494713|NCT00131664|79500365|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
44494714|NCT00131664|79500366|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
44494715|NCT00131664|79500367|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
44550037|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
44550038|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
44550039|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
44230475|NCT04828161|79039965|FG001|Overall Study|Other|0|||
44550040|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
44550041|NCT02925494|79565693|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
44550042|NCT02925494|79565694|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
44550043|NCT02925494|79565695|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
44550044|NCT02925494|79565696|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
44550045|NCT04006145|79565709|FG000|Overall Study|Lost to Follow-up|0|||
44550046|NCT04006145|79565710|FG001|Overall Study|Lost to Follow-up|1|||
44550047|NCT04006145|79565709|FG000|Overall Study|Other|1|||
44550048|NCT04006145|79565710|FG001|Overall Study|Other|2|||
44550049|NCT03386773|79565718|FG000|Overall Study|Lost to Follow-up|24|||
44550050|NCT03386773|79565719|FG001|Overall Study|Lost to Follow-up|33|||
44550051|NCT03386773|79565718|FG000|Overall Study|Withdrawal by Subject|3|||
44550052|NCT03386773|79565719|FG001|Overall Study|Withdrawal by Subject|2|||
44550053|NCT04126343|79565731|FG000|Overall Study|Adverse Event|0|||
44550054|NCT04126343|79565732|FG001|Overall Study|Adverse Event|0|||
44550055|NCT04126343|79565733|FG002|Overall Study|Adverse Event|0|||
44550056|NCT04126343|79565734|FG003|Overall Study|Adverse Event|0|||
44550057|NCT04126343|79565735|FG004|Overall Study|Adverse Event|0|||
44550058|NCT04126343|79565736|FG005|Overall Study|Adverse Event|1|||
44550059|NCT04126343|79565731|FG000|Overall Study|Withdrawal by Subject|0|||
44550060|NCT04126343|79565732|FG001|Overall Study|Withdrawal by Subject|0|||
44550061|NCT04126343|79565733|FG002|Overall Study|Withdrawal by Subject|0|||
44550062|NCT04126343|79565734|FG003|Overall Study|Withdrawal by Subject|1|||
44550063|NCT04126343|79565735|FG004|Overall Study|Withdrawal by Subject|0|||
44550064|NCT04126343|79565736|FG005|Overall Study|Withdrawal by Subject|0|||
44550065|NCT04126343|79565731|FG000|Overall Study|Related to COVID-19 pandemic|3|||
44550066|NCT04126343|79565732|FG001|Overall Study|Related to COVID-19 pandemic|4|||
44550067|NCT04126343|79565733|FG002|Overall Study|Related to COVID-19 pandemic|3|||
44550068|NCT04126343|79565734|FG003|Overall Study|Related to COVID-19 pandemic|3|||
44550069|NCT04126343|79565735|FG004|Overall Study|Related to COVID-19 pandemic|3|||
44550070|NCT04126343|79565736|FG005|Overall Study|Related to COVID-19 pandemic|3|||
44550071|NCT02952313|79565751|FG000|Primary Endpoint|Lost to Follow-up|4|||
44550072|NCT02952313|79565751|FG000|Primary Endpoint|Withdrawal by Subject|1|||
44550073|NCT02952313|79565751|FG000|Primary Endpoint|Lack of Efficacy|1|||
44550074|NCT02952313|79565751|FG000|Primary Endpoint|Missed visit|1|||
44550075|NCT02952313|79565751|FG000|Long-term Follow-up|Lost to Follow-up|12|||
44550076|NCT02952313|79565751|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
44550077|NCT02952313|79565751|FG000|Long-term Follow-up|Lack of Efficacy|6|||
44550078|NCT02952313|79565751|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
44550079|NCT02952313|79565751|FG000|Long-term Follow-up|Physician Decision|1|||
44550080|NCT02952313|79565751|FG000|Long-term Follow-up|Death|1|||
44550081|NCT03119610|79565758|FG000|Overall Study|Adverse Event|1|||
44550082|NCT03119610|79565759|FG001|Overall Study|Adverse Event|0|||
44550083|NCT03119610|79565758|FG000|Overall Study|Lost to Follow-up|0|||
44550084|NCT03119610|79565759|FG001|Overall Study|Lost to Follow-up|1|||
44550085|NCT04005755|79565765|FG000|Overall Study|Adverse Event|6|||
44550086|NCT04005755|79565765|FG000|Overall Study|Physician Decision|3|||
44550087|NCT04005755|79565765|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
44550088|NCT04005755|79565765|FG000|Overall Study|Withdrawal by Subject|3|||
44550089|NCT04005755|79565765|FG000|Overall Study|Lost to Follow-up|1|||
44550090|NCT03442777|79565772|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
44550091|NCT03442777|79565773|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
44550092|NCT03442777|79565774|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
44550093|NCT03401749|79565783|FG000|Overall Study|Lost to Follow-up|20|||
44550094|NCT03401749|79565784|FG001|Overall Study|Lost to Follow-up|16|||
44550095|NCT03401749|79565785|FG002|Overall Study|Lost to Follow-up|26|||
44550096|NCT03029624|79565793|FG000|Overall Study|Adverse Event|1|||
44550097|NCT03029624|79565793|FG000|Overall Study|Withdrawal by Subject|1|||
44550098|NCT03029624|79565793|FG000|Overall Study|Lack of Efficacy|1|||
44550099|NCT03029624|79565793|FG000|Overall Study|MRI need|2|||
44550100|NCT02952001|79565801|FG000|Overall Study|Adverse Event|3|||
44550101|NCT02952001|79565802|FG001|Overall Study|Adverse Event|0|||
44550102|NCT02952001|79565801|FG000|Overall Study|Prohibited therapy|10|||
44550103|NCT02952001|79565802|FG001|Overall Study|Prohibited therapy|3|||
44550104|NCT02952001|79565801|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
44550105|NCT02952001|79565802|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
44550106|NCT04123067|79565811|FG000|Overall Study|Lost to Follow-up|0|||
44550107|NCT04123067|79565812|FG001|Overall Study|Lost to Follow-up|1|||
44550108|NCT04117607|79565821|FG000|Overall Study|Early Termination|0|||
44550109|NCT04117607|79565822|FG001|Overall Study|Early Termination|1|||
44550110|NCT04117607|79565823|FG002|Overall Study|Early Termination|0|||
44550111|NCT04117607|79565824|FG003|Overall Study|Early Termination|0|||
44550112|NCT04117607|79565825|FG004|Overall Study|Early Termination|0|||
44550113|NCT04117607|79565826|FG005|Overall Study|Early Termination|0|||
44550114|NCT04117607|79565827|FG006|Overall Study|Early Termination|1|||
44550115|NCT04117607|79565828|FG007|Overall Study|Early Termination|0|||
44550116|NCT04117607|79565829|FG008|Overall Study|Early Termination|0|||
44550117|NCT04117607|79565830|FG009|Overall Study|Early Termination|0|||
44550118|NCT04117607|79565831|FG010|Overall Study|Early Termination|0|||
44550119|NCT04117607|79565832|FG011|Overall Study|Early Termination|0|||
44550120|NCT04117607|79565833|FG012|Overall Study|Early Termination|0|||
44550121|NCT04117607|79565834|FG013|Overall Study|Early Termination|0|||
44550122|NCT04112303|79565850|FG000|Overall Study|Death|1|||
44230476|NCT04828161|79039966|FG002|Overall Study|Other|2|||
44230477|NCT04828161|79039967|FG003|Overall Study|Other|0|||
44230478|NCT04828161|79039964|FG000|Overall Study|Death|0|||
44230479|NCT04828161|79039965|FG001|Overall Study|Death|0|||
44230480|NCT04828161|79039966|FG002|Overall Study|Death|0|||
44230481|NCT04828161|79039967|FG003|Overall Study|Death|2|||
44550123|NCT03998189|79565856|FG000|Overall Study|Lack of Efficacy|0|||
44550124|NCT03998189|79565857|FG001|Overall Study|Lack of Efficacy|1|||
44550125|NCT04099277|79565863|FG000|Overall Study|Physician Decision|1|||
44550126|NCT04099277|79565863|FG000|Overall Study|Withdrawal by Subject|1|||
44550127|NCT03990389|79565869|FG000|Overall Study|Lost to Follow-up|3|||
44550128|NCT03990389|79565870|FG001|Overall Study|Lost to Follow-up|0|||
44550129|NCT03988907|79565878|FG000|Overall Study|Unable to complete visit|0|||
44550130|NCT03988907|79565879|FG001|Overall Study|Unable to complete visit|1|||
44550131|NCT03987191|79565893|FG000|Overall Study|COVID-19 related research disruption|0|||
44550132|NCT03987191|79565894|FG001|Overall Study|COVID-19 related research disruption|2|||
44550133|NCT04098809|79565902|FG000|Overall Study|Withdrawal by Subject|1|||
44550134|NCT04098809|79565903|FG001|Overall Study|Withdrawal by Subject|3|||
44550135|NCT04098809|79565902|FG000|Overall Study|Physician Decision|2|||
44550136|NCT04098809|79565903|FG001|Overall Study|Physician Decision|1|||
44550137|NCT03122184|79565911|FG000|Overall Study|Lost to Follow-up|4|||
44550138|NCT03122184|79565912|FG001|Overall Study|Lost to Follow-up|6|||
44550139|NCT03122184|79565911|FG000|Overall Study|Withdrawal by Subject|3|||
44550140|NCT03122184|79565912|FG001|Overall Study|Withdrawal by Subject|0|||
44550141|NCT03122184|79565911|FG000|Overall Study|Terminated due to cognitive problem|1|||
44550142|NCT03122184|79565912|FG001|Overall Study|Terminated due to cognitive problem|0|||
44550143|NCT04091087|79565937|FG000|Overall Study|Not treated|1|||
44550144|NCT04091087|79565938|FG001|Overall Study|Not treated|0|||
44550145|NCT04091087|79565937|FG000|Overall Study|Adverse Event|4|||
44550146|NCT04091087|79565938|FG001|Overall Study|Adverse Event|4|||
44550147|NCT04091087|79565937|FG000|Overall Study|Protocol Violation|0|||
44550148|NCT04091087|79565938|FG001|Overall Study|Protocol Violation|1|||
44550149|NCT04091087|79565937|FG000|Overall Study|Withdrawal by Subject|5|||
44550150|NCT04091087|79565938|FG001|Overall Study|Withdrawal by Subject|2|||
44550151|NCT03400033|79565956|FG000|Overall Study|Withdrawal by Subject|1|||
44550152|NCT03400033|79565957|FG001|Overall Study|Withdrawal by Subject|2|||
44550153|NCT04089761|79565972|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
44550154|NCT04089761|79565972|FG000|"Run In Phase"|Lost to Follow-up|1|||
44550155|NCT04089761|79565972|FG000|"Treatment Phase"|No evaluable data|5|||
44550156|NCT04089761|79565972|FG000|"Treatment Phase"|Lost to Follow-up|1|||
44550157|NCT03118518|79565978|FG000|Overall Study|Early Exit after treatment|2|||
44550158|NCT03118518|79565979|FG001|Overall Study|Early Exit after treatment|8|||
44550159|NCT03118518|79565978|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
44550160|NCT03118518|79565979|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
44550161|NCT03984305|79565987|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
44550162|NCT03984305|79565988|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
44550163|NCT03984305|79565987|FG000|Overall Study|Withdrawal by Subject|3|||
44550164|NCT03984305|79565988|FG001|Overall Study|Withdrawal by Subject|3|||
44550165|NCT03984305|79565987|FG000|Overall Study|Lost to Follow-up|1|||
44550166|NCT03984305|79565988|FG001|Overall Study|Lost to Follow-up|0|||
44550167|NCT03397771|79565996|FG000|Overall Study|2 erroneously randomized, never treated|3|||
44550168|NCT03397771|79565997|FG001|Overall Study|2 erroneously randomized, never treated|1|||
44550169|NCT03397771|79565996|FG000|Overall Study|Withdrawal by Subject|1|||
44550170|NCT03397771|79565997|FG001|Overall Study|Withdrawal by Subject|3|||
44550171|NCT03397771|79565996|FG000|Overall Study|Protocol Violation|2|||
44550172|NCT03397771|79565997|FG001|Overall Study|Protocol Violation|2|||
44230482|NCT01895309|79040065|FG000|Overall Study|Adverse Event|13|||
44550173|NCT03397771|79565996|FG000|Overall Study|Adverse Event|2|||
44550174|NCT03397771|79565997|FG001|Overall Study|Adverse Event|1|||
44550175|NCT02876835|79566005|FG000|Treatment Period (51.1 Month)|Other|1|||
44550176|NCT02876835|79566006|FG001|Treatment Period (51.1 Month)|Other|0|||
44550177|NCT02876835|79566005|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
44550178|NCT02876835|79566006|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
44550179|NCT02876835|79566005|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
44550180|NCT02876835|79566006|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
44230483|NCT01895309|79040066|FG001|Overall Study|Adverse Event|17|||
44230484|NCT01895309|79040065|FG000|Overall Study|Protocol Violation|1|||
44230485|NCT01895309|79040066|FG001|Overall Study|Protocol Violation|0|||
44494716|NCT00131664|79500362|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
44494717|NCT00131664|79500363|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
44494718|NCT00131664|79500364|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
44494719|NCT00131664|79500365|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
44494720|NCT00131664|79500366|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
44494721|NCT00131664|79500367|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
44494722|NCT00131664|79500362|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
44494723|NCT00131664|79500363|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
44494724|NCT00131664|79500364|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
44494725|NCT00131664|79500365|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
44494726|NCT00131664|79500366|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
44514854|NCT03714672|79520691|FG001|Overall Study|Other Reason|2|||
44514855|NCT03714672|79520692|FG002|Overall Study|Other Reason|1|||
44376520|NCT01096160|79381666|FG009|Overall Study|Met stopping criteria per protocol|0|||
44376521|NCT00860158|79381701|FG000|Overall Study|Study Terminated|1|||
44514856|NCT03714672|79520693|FG003|Overall Study|Other Reason|1|||
44514857|NCT03714672|79520690|FG000|Overall Study|Lost to Follow-up|1|||
44514858|NCT03714672|79520691|FG001|Overall Study|Lost to Follow-up|1|||
44514859|NCT03714672|79520692|FG002|Overall Study|Lost to Follow-up|0|||
44514860|NCT03714672|79520693|FG003|Overall Study|Lost to Follow-up|0|||
44514861|NCT03083470|79520709|FG000|Overall Study|Lost to Follow-up|0|||
44514862|NCT03083470|79520710|FG001|Overall Study|Lost to Follow-up|0|||
44514863|NCT03083470|79520711|FG002|Overall Study|Lost to Follow-up|0|||
44514864|NCT03083470|79520712|FG003|Overall Study|Lost to Follow-up|0|||
44514865|NCT03083470|79520713|FG004|Overall Study|Lost to Follow-up|1|||
44514866|NCT03083470|79520709|FG000|Overall Study|Withdrawal by Subject|0|||
44514867|NCT03083470|79520710|FG001|Overall Study|Withdrawal by Subject|0|||
44514868|NCT03083470|79520711|FG002|Overall Study|Withdrawal by Subject|0|||
44514869|NCT03083470|79520712|FG003|Overall Study|Withdrawal by Subject|0|||
44514870|NCT03083470|79520713|FG004|Overall Study|Withdrawal by Subject|1|||
44514871|NCT05405244|79520725|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
44514872|NCT05405244|79520726|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
44514873|NCT05405244|79520725|FG000|Washout (2 Weeks)|Adverse Event|2|||
44514874|NCT05405244|79520726|FG001|Washout (2 Weeks)|Adverse Event|0|||
44514875|NCT05405244|79520725|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
44514876|NCT05405244|79520726|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
44514877|NCT03074500|79520739|FG000|Overall Study|Lost to Follow-up|1|||
44514878|NCT03074500|79520740|FG001|Overall Study|Lost to Follow-up|0|||
44550181|NCT02876835|79566005|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
44550182|NCT02876835|79566006|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
44550183|NCT04086641|79566015|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
44550184|NCT04086641|79566016|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
44550185|NCT03503318|79566025|FG000|Overall Study|Death|1|||
44550186|NCT03503318|79566026|FG001|Overall Study|Death|0|||
44550187|NCT03503318|79566027|FG002|Overall Study|Death|4|||
44550188|NCT03503318|79566025|FG000|Overall Study|Adverse Event|3|||
44550189|NCT03503318|79566026|FG001|Overall Study|Adverse Event|4|||
44550190|NCT03503318|79566027|FG002|Overall Study|Adverse Event|2|||
44550191|NCT03503318|79566025|FG000|Overall Study|Withdrawal by Subject|12|||
44550192|NCT03503318|79566026|FG001|Overall Study|Withdrawal by Subject|17|||
44550193|NCT03503318|79566027|FG002|Overall Study|Withdrawal by Subject|16|||
44550194|NCT03503318|79566025|FG000|Overall Study|Protocol Violation|5|||
44550195|NCT03503318|79566026|FG001|Overall Study|Protocol Violation|0|||
44550196|NCT03503318|79566027|FG002|Overall Study|Protocol Violation|3|||
44550197|NCT03503318|79566025|FG000|Overall Study|Lost to Follow-up|17|||
44550198|NCT03503318|79566026|FG001|Overall Study|Lost to Follow-up|15|||
44550199|NCT03503318|79566027|FG002|Overall Study|Lost to Follow-up|12|||
44550200|NCT03503318|79566025|FG000|Overall Study|Other than specified|1|||
44550201|NCT03503318|79566026|FG001|Overall Study|Other than specified|3|||
44550202|NCT03503318|79566027|FG002|Overall Study|Other than specified|3|||
44550203|NCT03396913|79566037|FG000|Overall Study|Lost to Follow-up|0|||
44550204|NCT03396913|79566038|FG001|Overall Study|Lost to Follow-up|6|||
44550205|NCT03982433|79566044|FG000|Overall Study|Lost to Follow-up|1|||
44550206|NCT03396835|79566048|FG000|Overall Study|Withdrawn prior to completion|1|||
44550207|NCT03396835|79566048|FG000|Overall Study|Did not meet criteria for data analysis|1|||
44550208|NCT03121950|79566054|FG000|Overall Study|Withdrawal by Subject|11|||
44550209|NCT03121950|79566055|FG001|Overall Study|Withdrawal by Subject|2|||
44550210|NCT03395353|79566063|FG000|Overall Study|Adverse Event|20|||
44550211|NCT03395353|79566063|FG000|Overall Study|Protocol Violation|1|||
44550212|NCT03395353|79566063|FG000|Overall Study|Lack of Efficacy|3|||
44550213|NCT03395353|79566063|FG000|Overall Study|Withdrawal by Subject|24|||
44550214|NCT03395353|79566063|FG000|Overall Study|Discontinued visit|1|||
44230486|NCT01895309|79040065|FG000|Overall Study|Lack of Efficacy|1|||
44230487|NCT01895309|79040066|FG001|Overall Study|Lack of Efficacy|3|||
44230488|NCT01895309|79040065|FG000|Overall Study|Lost to Follow-up|1|||
44230489|NCT01895309|79040066|FG001|Overall Study|Lost to Follow-up|3|||
44230490|NCT01895309|79040065|FG000|Overall Study|Physician Decision|15|||
44230491|NCT01895309|79040066|FG001|Overall Study|Physician Decision|10|||
44230492|NCT01895309|79040065|FG000|Overall Study|Withdrawal by Subject|9|||
44230493|NCT01895309|79040066|FG001|Overall Study|Withdrawal by Subject|18|||
44230494|NCT01884311|79040076|FG000|Overall Study|Withdrawal by Subject|3|||
44230495|NCT01884311|79040076|FG000|Overall Study|withdrew consent due to AEs|1|||
44230496|NCT01884311|79040076|FG000|Overall Study|Precautionary measure|1|||
44230497|NCT01884077|79040116|FG000|Overall Study|screen fail|0|||
44230498|NCT01884077|79040117|FG001|Overall Study|screen fail|2|||
44230499|NCT01884077|79040116|FG000|Overall Study|canceled surgery|2|||
44230500|NCT01884077|79040117|FG001|Overall Study|canceled surgery|0|||
44230501|NCT01884077|79040116|FG000|Overall Study|Lost to Follow-up|0|||
44230502|NCT01884077|79040117|FG001|Overall Study|Lost to Follow-up|4|||
44230503|NCT01884077|79040116|FG000|Overall Study|study closed|6|||
44230504|NCT01884077|79040117|FG001|Overall Study|study closed|4|||
44230505|NCT01894919|79040136|FG000|Overall Study|Withdrawal by Subject|1|||
44230506|NCT01894919|79040137|FG001|Overall Study|Withdrawal by Subject|0|||
44550215|NCT03395353|79566063|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
44550216|NCT03395353|79566063|FG000|Overall Study|Physician Decision|4|||
44550217|NCT03395353|79566063|FG000|Overall Study|Early termination of overall study|33|||
44550218|NCT04082663|79566071|FG000|Overall Study|Adverse Event|6|||
44550219|NCT04082663|79566071|FG000|Overall Study|Lost to Follow-up|1|||
44550220|NCT03682367|79566077|FG000|Overall Study|Protocol Violation|2|||
44550221|NCT03682367|79566078|FG001|Overall Study|Protocol Violation|1|||
44550222|NCT03682367|79566077|FG000|Overall Study|Closed Study Early|0|||
44550223|NCT03682367|79566078|FG001|Overall Study|Closed Study Early|3|||
44550224|NCT03681353|79566084|FG000|Overall Study|Lost to Follow-up|2|||
44550225|NCT03681353|79566084|FG000|Overall Study|Withdrawal by Subject|3|||
44550226|NCT03681353|79566084|FG000|Overall Study|withdrawn by PI|2|||
44550227|NCT03394885|79566088|FG000|Overall Study|Adverse Event|4|||
44550228|NCT03394885|79566088|FG000|Overall Study|Lack of Efficacy|1|||
44550229|NCT03394885|79566088|FG000|Overall Study|Physician Decision|1|||
44550230|NCT03394885|79566088|FG000|Overall Study|Withdrawal by Subject|8|||
44550231|NCT03394885|79566088|FG000|Overall Study|Alternative Therapy|1|||
44550232|NCT02877927|79566094|FG000|Overall Study|Adverse Event|1|||
44550233|NCT02877927|79566095|FG001|Overall Study|Adverse Event|0|||
44550234|NCT02877927|79566094|FG000|Overall Study|Lost to Follow-up|37|||
44550235|NCT02877927|79566095|FG001|Overall Study|Lost to Follow-up|38|||
44550236|NCT02877927|79566094|FG000|Overall Study|Withdrawal by Subject|11|||
44550237|NCT02877927|79566095|FG001|Overall Study|Withdrawal by Subject|12|||
44550238|NCT02877927|79566094|FG000|Overall Study|Physician Decision|0|||
44550239|NCT02877927|79566095|FG001|Overall Study|Physician Decision|1|||
44550240|NCT02877927|79566094|FG000|Overall Study|Missed EOT/PTE Visit|5|||
44514879|NCT03074500|79520741|FG002|Overall Study|Lost to Follow-up|0|||
44514880|NCT03074500|79520739|FG000|Overall Study|Lack of Efficacy|0|||
44514881|NCT03074500|79520740|FG001|Overall Study|Lack of Efficacy|1|||
44514882|NCT03074500|79520741|FG002|Overall Study|Lack of Efficacy|0|||
44514883|NCT03074500|79520739|FG000|Overall Study|Adverse Event|0|||
44514884|NCT03074500|79520740|FG001|Overall Study|Adverse Event|0|||
44514885|NCT03074500|79520741|FG002|Overall Study|Adverse Event|1|||
44514886|NCT03715530|79520754|FG000|Overall Study|Lost to Follow-up|3|||
44514887|NCT03715530|79520755|FG001|Overall Study|Lost to Follow-up|1|||
44514888|NCT03715530|79520756|FG002|Overall Study|Lost to Follow-up|2|||
44514889|NCT03077698|79520766|FG000|Progestin Monotherapy|Stable Disease|8|||
44514890|NCT03077698|79520767|FG001|Progestin Monotherapy|Stable Disease|0|||
44514891|NCT03077698|79520766|FG000|Progestin Monotherapy|Adverse Event|1|||
44514892|NCT03077698|79520767|FG001|Progestin Monotherapy|Adverse Event|0|||
44514893|NCT03077698|79520766|FG000|Progestin Monotherapy|Death|1|||
44514894|NCT03077698|79520767|FG001|Progestin Monotherapy|Death|0|||
44514895|NCT03077698|79520766|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
44514896|NCT03077698|79520767|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
44514897|NCT03077698|79520766|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
44550241|NCT02877927|79566095|FG001|Overall Study|Missed EOT/PTE Visit|6|||
44550242|NCT02706886|79566110|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
44550243|NCT02706886|79566111|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
44550244|NCT02706886|79566112|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
44550245|NCT02706886|79566113|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
44550246|NCT02706886|79566114|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
44550247|NCT02706886|79566115|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
44550248|NCT02706886|79566116|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
44550249|NCT02706886|79566117|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
44550250|NCT02706886|79566118|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
44550251|NCT04069715|79566172|FG000|Overall Study|Lost to Follow-up|1|||
44550252|NCT04069715|79566173|FG001|Overall Study|Lost to Follow-up|1|||
44550253|NCT04069715|79566172|FG000|Overall Study|Physician Decision|1|||
44550254|NCT04069715|79566173|FG001|Overall Study|Physician Decision|1|||
44550255|NCT04069715|79566172|FG000|Overall Study|Withdrawal by Subject|3|||
44550256|NCT04069715|79566173|FG001|Overall Study|Withdrawal by Subject|3|||
44550257|NCT03681119|79566181|FG000|Overall Study|No specific reason|4|||
44550258|NCT03681119|79566182|FG001|Overall Study|No specific reason|0|||
44550259|NCT03681119|79566181|FG000|Overall Study|Sickness|2|||
44550260|NCT03681119|79566182|FG001|Overall Study|Sickness|0|||
44550261|NCT03111108|79566188|FG000|Overall Study|Death|0|||
44550262|NCT03111108|79566189|FG001|Overall Study|Death|1|||
44550263|NCT03111108|79566188|FG000|Overall Study|Withdrawal by Subject|1|||
44550264|NCT03111108|79566189|FG001|Overall Study|Withdrawal by Subject|0|||
44550265|NCT03677375|79566195|FG000|Overall Study|Incomplete procedure|8|||
44550266|NCT03677375|79566195|FG000|Overall Study|Adverse Event|3|||
44550267|NCT03677375|79566195|FG000|Overall Study|Physician Decision|1|||
44550268|NCT00702520|79566201|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
44550269|NCT00702520|79566202|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
44550270|NCT00702520|79566203|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
44550271|NCT00702520|79566204|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
44550272|NCT00702520|79566201|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
44550273|NCT00702520|79566202|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
44550274|NCT00702520|79566203|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
44550275|NCT00702520|79566204|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
44550276|NCT00702520|79566201|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
44550277|NCT00702520|79566202|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
44550278|NCT00702520|79566203|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
44550279|NCT00702520|79566204|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
44550280|NCT04067141|79566214|FG000|First Intervention|Withdrawal by Subject|0|||
44550281|NCT04067141|79566215|FG001|First Intervention|Withdrawal by Subject|1|||
44550282|NCT04067141|79566214|FG000|Second Intervention|Adverse Event|0|||
44550283|NCT04067141|79566215|FG001|Second Intervention|Adverse Event|2|||
44550284|NCT02876601|79566225|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
44550285|NCT02876601|79566226|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
44550286|NCT02876601|79566227|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
44550287|NCT02876601|79566228|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
44550288|NCT04054193|79566273|FG000|Cycle 1|Physician Decision|1|||
44550289|NCT04054193|79566273|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
44550290|NCT04054193|79566273|FG000|Cycle 1|Allocated but not treated|3|||
44550291|NCT04054193|79566273|FG000|Cycles 2-3|Physician Decision|2|||
44550292|NCT04054193|79566273|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
44550293|NCT04054193|79566273|FG000|Cycles 2-3|Various reasons|17|||
44550294|NCT03394027|79566281|FG000|Overall Study|Ineligible|3|||
44550295|NCT03394027|79566282|FG001|Overall Study|Ineligible|1|||
44550296|NCT03394027|79566283|FG002|Overall Study|Ineligible|3|||
44550297|NCT03394027|79566281|FG000|Overall Study|Participant declined to participate before treatment started|0|||
44550298|NCT03394027|79566282|FG001|Overall Study|Participant declined to participate before treatment started|0|||
44550299|NCT03394027|79566283|FG002|Overall Study|Participant declined to participate before treatment started|1|||
44550300|NCT03136107|79566309|FG000|Overall Study|Other (Not specified)|1|||
44550301|NCT02916056|79566317|FG000|Overall Study|Adverse Event|6|||
44230507|NCT01894919|79040138|FG002|Overall Study|Withdrawal by Subject|0|||
44230508|NCT01894919|79040139|FG003|Overall Study|Withdrawal by Subject|0|||
44230509|NCT01894919|79040140|FG004|Overall Study|Withdrawal by Subject|1|||
44376522|NCT00929526|79381707|FG000|Overall Study|Withdrawal by Subject|1|||
44550302|NCT02916056|79566317|FG000|Overall Study|Lost to Follow-up|1|||
44550303|NCT02916056|79566317|FG000|Overall Study|Other|12|||
44550304|NCT02916056|79566317|FG000|Overall Study|Protocol Violation|1|||
44550305|NCT02916056|79566317|FG000|Overall Study|Withdrawal by Subject|8|||
44550306|NCT02916056|79566317|FG000|Overall Study|Study Terminated by Sponsor|269|||
44550307|NCT03384745|79566327|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
44550308|NCT03384745|79566328|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
44550309|NCT03384745|79566329|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
44376523|NCT00929526|79381708|FG001|Overall Study|Withdrawal by Subject|11|||
44376524|NCT00929526|79381707|FG000|Overall Study|Lost to Follow-up|8|||
44550310|NCT03384745|79566330|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
44550311|NCT03384745|79566331|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
44550312|NCT03384745|79566332|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
44550313|NCT03384745|79566327|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
44550314|NCT03384745|79566328|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
44550315|NCT03384745|79566329|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
44550316|NCT03384745|79566330|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
44550317|NCT03384745|79566331|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
44550318|NCT03384745|79566332|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
44550319|NCT03384745|79566327|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
44550320|NCT03384745|79566328|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
44550321|NCT03384745|79566329|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
44550322|NCT03384745|79566330|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
44550323|NCT03384745|79566331|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
44550324|NCT03384745|79566332|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
44550325|NCT03384745|79566327|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
44550326|NCT03384745|79566328|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
44550327|NCT03384745|79566329|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
44550328|NCT03384745|79566330|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
44550329|NCT03384745|79566331|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
44550330|NCT03384745|79566332|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
44550331|NCT03384745|79566327|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
44550332|NCT03384745|79566328|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
44550333|NCT03384745|79566329|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
44550334|NCT03384745|79566330|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
44550335|NCT03384745|79566331|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
44550336|NCT03384745|79566332|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
44550337|NCT03384745|79566327|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
44550338|NCT03384745|79566328|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
44550339|NCT03384745|79566329|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
44550340|NCT03384745|79566330|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
44550341|NCT03384745|79566331|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
44550342|NCT03384745|79566332|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
44550343|NCT03384745|79566327|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
44550344|NCT03384745|79566328|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
44550345|NCT03384745|79566329|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
44550346|NCT03384745|79566330|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
44550347|NCT03384745|79566331|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
44550348|NCT03384745|79566332|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
44550349|NCT03384745|79566327|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
44494727|NCT00131664|79500367|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
44494728|NCT00131664|79500362|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
44494729|NCT00131664|79500363|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
44494730|NCT00131664|79500364|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
44494731|NCT00131664|79500365|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
44494732|NCT00131664|79500366|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
44494733|NCT00131664|79500367|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
44494734|NCT00131508|79500380|FG000|Overall Study|Disease progression|0|||
44494735|NCT00131508|79500381|FG001|Overall Study|Disease progression|2|||
44494736|NCT00131508|79500380|FG000|Overall Study|Non-Compliance|2|||
44494737|NCT00131508|79500381|FG001|Overall Study|Non-Compliance|4|||
44494738|NCT00131508|79500380|FG000|Overall Study|Withdrawal by Subject|1|||
44494739|NCT00131508|79500381|FG001|Overall Study|Withdrawal by Subject|2|||
44494740|NCT05050318|79500390|FG000|Overall Study|Protocol Deviation|1|||
44494741|NCT05050318|79500391|FG001|Overall Study|Protocol Deviation|0|||
44494742|NCT05050318|79500392|FG002|Overall Study|Protocol Deviation|0|||
44494743|NCT03699124|79500403|FG000|Overall Study|Adverse Event|6|||
44494744|NCT03699124|79500404|FG001|Overall Study|Adverse Event|5|||
44494745|NCT03699124|79500405|FG002|Overall Study|Adverse Event|2|||
44494746|NCT03699124|79500403|FG000|Overall Study|Death|0|||
44494747|NCT03699124|79500404|FG001|Overall Study|Death|2|||
44494748|NCT03699124|79500405|FG002|Overall Study|Death|0|||
44494749|NCT03699124|79500403|FG000|Overall Study|Lost to Follow-up|20|||
44550350|NCT03384745|79566328|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
44550351|NCT03384745|79566329|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
44550352|NCT03384745|79566330|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
44550353|NCT03384745|79566331|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
44550354|NCT03384745|79566332|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
44550355|NCT03384745|79566327|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
44550356|NCT03384745|79566328|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
44550357|NCT03384745|79566329|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
44550358|NCT03384745|79566330|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
44550359|NCT03384745|79566331|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
44550360|NCT03384745|79566332|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
44550361|NCT03384745|79566327|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
44550362|NCT03384745|79566328|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
44550363|NCT03384745|79566329|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
44550364|NCT03384745|79566330|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
44550365|NCT03384745|79566331|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
44550366|NCT03384745|79566332|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
44550367|NCT03384745|79566327|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
44550368|NCT03384745|79566328|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
44550369|NCT03384745|79566329|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
44550370|NCT03384745|79566330|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
44550371|NCT03384745|79566331|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
44550372|NCT03384745|79566332|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
44550373|NCT03383887|79566352|FG000|Overall Study|Lost to Follow-up|0|||
44550374|NCT03383887|79566353|FG001|Overall Study|Lost to Follow-up|1|||
44550375|NCT03379753|79566361|FG000|Overall Study|Withdrawal by Subject|2|||
44550376|NCT03379753|79566362|FG001|Overall Study|Withdrawal by Subject|1|||
44550377|NCT03379753|79566361|FG000|Overall Study|not having correct procedure|1|||
44550378|NCT03379753|79566362|FG001|Overall Study|not having correct procedure|2|||
44550379|NCT03379753|79566361|FG000|Overall Study|No primary outcome|12|||
44494750|NCT03699124|79500404|FG001|Overall Study|Lost to Follow-up|16|||
44494751|NCT03699124|79500405|FG002|Overall Study|Lost to Follow-up|15|||
44494752|NCT03699124|79500403|FG000|Overall Study|Protocol Violation|1|||
44550380|NCT03379753|79566362|FG001|Overall Study|No primary outcome|22|||
44550381|NCT03379675|79566371|FG000|Overall Study|Lost to Follow-up|0|||
44550382|NCT03379675|79566372|FG001|Overall Study|Lost to Follow-up|1|||
44550383|NCT03379675|79566373|FG002|Overall Study|Lost to Follow-up|0|||
44550384|NCT03379675|79566371|FG000|Overall Study|Adverse Event|2|||
44550385|NCT03379675|79566372|FG001|Overall Study|Adverse Event|0|||
44550386|NCT03379675|79566373|FG002|Overall Study|Adverse Event|0|||
44550387|NCT03379675|79566371|FG000|Overall Study|Withdrawal by Subject|2|||
44550388|NCT03379675|79566372|FG001|Overall Study|Withdrawal by Subject|1|||
44550389|NCT03379675|79566373|FG002|Overall Study|Withdrawal by Subject|2|||
44230510|NCT01894919|79040141|FG005|Overall Study|Withdrawal by Subject|0|||
44230511|NCT01894919|79040142|FG006|Overall Study|Withdrawal by Subject|0|||
44230512|NCT01894919|79040143|FG007|Overall Study|Withdrawal by Subject|0|||
44230513|NCT01894919|79040144|FG008|Overall Study|Withdrawal by Subject|0|||
44230514|NCT01894919|79040145|FG009|Overall Study|Withdrawal by Subject|1|||
44230515|NCT01894919|79040146|FG010|Overall Study|Withdrawal by Subject|1|||
44230516|NCT01894919|79040147|FG011|Overall Study|Withdrawal by Subject|0|||
44230517|NCT01894919|79040148|FG012|Overall Study|Withdrawal by Subject|0|||
44230518|NCT01894919|79040136|FG000|Overall Study|Adverse Event|0|||
44230519|NCT01894919|79040137|FG001|Overall Study|Adverse Event|0|||
44230520|NCT01894919|79040138|FG002|Overall Study|Adverse Event|0|||
44230521|NCT01894919|79040139|FG003|Overall Study|Adverse Event|0|||
44230522|NCT01894919|79040140|FG004|Overall Study|Adverse Event|0|||
44230523|NCT01894919|79040141|FG005|Overall Study|Adverse Event|0|||
44494753|NCT03699124|79500404|FG001|Overall Study|Protocol Violation|0|||
44494754|NCT03699124|79500405|FG002|Overall Study|Protocol Violation|0|||
44494755|NCT03699124|79500403|FG000|Overall Study|Withdrawal by Subject|13|||
44494756|NCT03699124|79500404|FG001|Overall Study|Withdrawal by Subject|14|||
44494757|NCT03699124|79500405|FG002|Overall Study|Withdrawal by Subject|13|||
44230524|NCT01894919|79040142|FG006|Overall Study|Adverse Event|0|||
44230525|NCT01894919|79040143|FG007|Overall Study|Adverse Event|0|||
44230526|NCT01894919|79040144|FG008|Overall Study|Adverse Event|0|||
44494758|NCT03699124|79500403|FG000|Overall Study|Other reasons|5|||
44230527|NCT01894919|79040145|FG009|Overall Study|Adverse Event|0|||
44494759|NCT03699124|79500404|FG001|Overall Study|Other reasons|3|||
44494760|NCT03699124|79500405|FG002|Overall Study|Other reasons|10|||
44494761|NCT05002972|79500413|FG000|Overall Study|Withdrawal by Subject|2|||
44494762|NCT04651114|79500417|FG000|Overall Study|Withdrawal by Subject|8|||
44494763|NCT04980040|79500421|FG000|Overall Study|Violated the Inclusion Criteria|260|||
44494764|NCT04980040|79500421|FG000|Overall Study|Violated the Administration & Dosage|225|||
44494765|NCT04980040|79500421|FG000|Overall Study|Lost to Safety-Follow-up|4|||
44494766|NCT04980040|79500421|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
44550390|NCT02930889|79566381|FG000|Overall Study|Lost to Follow-up|2|||
44550391|NCT02930889|79566381|FG000|Overall Study|Withdrawal by Subject|6|||
44230528|NCT01894919|79040146|FG010|Overall Study|Adverse Event|1|||
44494767|NCT00131352|79500427|FG000|Initial Treatment Period|Adverse Event|1|||
44494768|NCT00131352|79500428|FG001|Initial Treatment Period|Adverse Event|3|||
44494769|NCT00131352|79500427|FG000|Initial Treatment Period|Non-compliant|1|||
44494770|NCT00131352|79500428|FG001|Initial Treatment Period|Non-compliant|2|||
44494771|NCT00131352|79500427|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
44550392|NCT02930889|79566381|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
44550393|NCT02875977|79566387|FG000|Overall Study|Lost to Follow-up|42|||
44550394|NCT02875977|79566388|FG001|Overall Study|Lost to Follow-up|29|||
44550395|NCT02703532|79566407|FG000|Overall Study|Withdrawal by Subject|0|||
44550396|NCT02703532|79566408|FG001|Overall Study|Withdrawal by Subject|1|||
44550397|NCT02703532|79566409|FG002|Overall Study|Withdrawal by Subject|0|||
44550398|NCT02703532|79566410|FG003|Overall Study|Withdrawal by Subject|1|||
44550399|NCT02703532|79566407|FG000|Overall Study|Lost to Follow-up|2|||
44550400|NCT02703532|79566408|FG001|Overall Study|Lost to Follow-up|0|||
44230529|NCT01894919|79040147|FG011|Overall Study|Adverse Event|0|||
44230530|NCT01894919|79040148|FG012|Overall Study|Adverse Event|0|||
44230531|NCT01894919|79040136|FG000|Overall Study|Other-Unspecified|1|||
44230532|NCT01894919|79040137|FG001|Overall Study|Other-Unspecified|0|||
44230533|NCT01894919|79040138|FG002|Overall Study|Other-Unspecified|0|||
44230534|NCT01894919|79040139|FG003|Overall Study|Other-Unspecified|0|||
44230535|NCT01894919|79040140|FG004|Overall Study|Other-Unspecified|0|||
44230536|NCT01894919|79040141|FG005|Overall Study|Other-Unspecified|0|||
44230537|NCT01894919|79040142|FG006|Overall Study|Other-Unspecified|0|||
44230538|NCT01894919|79040143|FG007|Overall Study|Other-Unspecified|0|||
44230539|NCT01894919|79040144|FG008|Overall Study|Other-Unspecified|0|||
44230540|NCT01894919|79040145|FG009|Overall Study|Other-Unspecified|0|||
44230541|NCT01894919|79040146|FG010|Overall Study|Other-Unspecified|0|||
44230542|NCT01894919|79040147|FG011|Overall Study|Other-Unspecified|0|||
44230543|NCT01894919|79040148|FG012|Overall Study|Other-Unspecified|0|||
44230544|NCT01894919|79040136|FG000|Overall Study|Lost to Follow-up|0|||
44230545|NCT01894919|79040137|FG001|Overall Study|Lost to Follow-up|0|||
44230546|NCT01894919|79040138|FG002|Overall Study|Lost to Follow-up|0|||
44230547|NCT01894919|79040139|FG003|Overall Study|Lost to Follow-up|0|||
44230548|NCT01894919|79040140|FG004|Overall Study|Lost to Follow-up|2|||
44230549|NCT01894919|79040141|FG005|Overall Study|Lost to Follow-up|0|||
44494772|NCT00131352|79500428|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
44494773|NCT00131352|79500427|FG000|Initial Treatment Period|Lack of Efficacy|6|||
44494774|NCT00131352|79500428|FG001|Initial Treatment Period|Lack of Efficacy|4|||
44494775|NCT00131352|79500427|FG000|Initial Treatment Period|Other|0|||
44494776|NCT00131352|79500428|FG001|Initial Treatment Period|Other|2|||
44494777|NCT00131352|79500427|FG000|Repeat Treatment Period|Adverse Event|1|||
44494778|NCT00131352|79500428|FG001|Repeat Treatment Period|Adverse Event|0|||
44494779|NCT00131352|79500427|FG000|Repeat Treatment Period|Other|1|||
44494780|NCT00131352|79500428|FG001|Repeat Treatment Period|Other|0|||
44550401|NCT02703532|79566409|FG002|Overall Study|Lost to Follow-up|2|||
44230550|NCT01894919|79040142|FG006|Overall Study|Lost to Follow-up|0|||
44230551|NCT01894919|79040143|FG007|Overall Study|Lost to Follow-up|0|||
44230552|NCT01894919|79040144|FG008|Overall Study|Lost to Follow-up|0|||
44230553|NCT01894919|79040145|FG009|Overall Study|Lost to Follow-up|0|||
44230554|NCT01894919|79040146|FG010|Overall Study|Lost to Follow-up|0|||
44230555|NCT01894919|79040147|FG011|Overall Study|Lost to Follow-up|0|||
44550402|NCT02703532|79566410|FG003|Overall Study|Lost to Follow-up|0|||
44230556|NCT01894919|79040148|FG012|Overall Study|Lost to Follow-up|0|||
44230557|NCT01894841|79040192|FG000|Overall Study|Withdrawal by Subject|9|||
44550403|NCT02930343|79566443|FG000|Overall Study|Lost to Follow-up|9|||
44230558|NCT01894841|79040193|FG001|Overall Study|Withdrawal by Subject|4|||
44494781|NCT04633642|79500438|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
44494782|NCT04633642|79500439|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
44230559|NCT01894841|79040192|FG000|Overall Study|Withdrawn by investigator|2|||
44550404|NCT02930343|79566444|FG001|Overall Study|Lost to Follow-up|7|||
44550405|NCT02703454|79566452|FG000|Overall Study|Not treated|1|||
44550406|NCT02703454|79566453|FG001|Overall Study|Not treated|3|||
44550407|NCT02703454|79566452|FG000|Overall Study|Withdrawal by Subject|4|||
44550408|NCT02703454|79566453|FG001|Overall Study|Withdrawal by Subject|3|||
44550409|NCT02703454|79566452|FG000|Overall Study|Lost to Follow-up|1|||
44550410|NCT02703454|79566453|FG001|Overall Study|Lost to Follow-up|2|||
44550411|NCT02703454|79566452|FG000|Overall Study|Study discontinuation|5|||
44550412|NCT02703454|79566453|FG001|Overall Study|Study discontinuation|8|||
44550413|NCT03103542|79566459|FG000|Overall Study|Physician Decision|2|||
44550414|NCT03103542|79566459|FG000|Overall Study|Adverse Event|2|||
44550415|NCT03103542|79566459|FG000|Overall Study|Other|2|||
44550416|NCT03103542|79566459|FG000|Overall Study|Withdrawal by Subject|1|||
44550417|NCT03376321|79566486|FG000|Overall Study|Other|5|||
44550418|NCT03376321|79566487|FG001|Overall Study|Other|1|||
44550419|NCT03376321|79566486|FG000|Overall Study|Withdrawal by Subject|8|||
44550420|NCT03376321|79566487|FG001|Overall Study|Withdrawal by Subject|14|||
44550421|NCT03376321|79566486|FG000|Overall Study|Lost to Follow-up|1|||
44550422|NCT03376321|79566487|FG001|Overall Study|Lost to Follow-up|7|||
44550423|NCT03376321|79566486|FG000|Overall Study|Death|4|||
44550424|NCT03376321|79566487|FG001|Overall Study|Death|0|||
44550425|NCT03376321|79566486|FG000|Overall Study|Randomized, not treated|5|||
44550426|NCT03376321|79566487|FG001|Overall Study|Randomized, not treated|3|||
44550427|NCT03374995|79566495|FG000|Overall Study|Withdrawal by Subject|0|||
44550428|NCT03374995|79566496|FG001|Overall Study|Withdrawal by Subject|1|||
44550429|NCT02828982|79566502|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44550430|NCT02828982|79566503|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44550431|NCT03133767|79566513|FG000|Overall Study|Lost to Follow-up|38|||
44550432|NCT03133767|79566514|FG001|Overall Study|Lost to Follow-up|24|||
44550433|NCT03133767|79566513|FG000|Overall Study|Protocol Violation|0|||
44550434|NCT03133767|79566514|FG001|Overall Study|Protocol Violation|1|||
44550435|NCT03391765|79566524|FG000|Overall Study|Adverse Event|2|||
44550436|NCT03391765|79566525|FG001|Overall Study|Adverse Event|0|||
44550437|NCT03391765|79566526|FG002|Overall Study|Adverse Event|0|||
44550438|NCT03391765|79566527|FG003|Overall Study|Adverse Event|2|||
44550439|NCT03391765|79566524|FG000|Overall Study|Withdrew consent|5|||
44550440|NCT03391765|79566525|FG001|Overall Study|Withdrew consent|7|||
44550441|NCT03391765|79566526|FG002|Overall Study|Withdrew consent|2|||
44230560|NCT01894841|79040193|FG001|Overall Study|Withdrawn by investigator|2|||
44230561|NCT01894841|79040192|FG000|Overall Study|Lost to Follow-up|7|||
44230562|NCT01894841|79040193|FG001|Overall Study|Lost to Follow-up|3|||
44230563|NCT01894607|79040203|FG000|Overall Study|Ineligible|1|||
44230564|NCT01883453|79040209|FG000|Overall Study|No episode of common cold|25|||
44230565|NCT01883453|79040210|FG001|Overall Study|No episode of common cold|23|||
44494783|NCT00136916|79500447|FG000|Overall Study|Never received study treatment|3|||
44494784|NCT00136916|79500448|FG001|Overall Study|Never received study treatment|5|||
44494785|NCT00136916|79500447|FG000|Overall Study|Death|1|||
44494786|NCT00136916|79500448|FG001|Overall Study|Death|3|||
44494787|NCT00136916|79500447|FG000|Overall Study|Adverse Event|27|||
44494788|NCT00136916|79500448|FG001|Overall Study|Adverse Event|8|||
44494789|NCT00136916|79500447|FG000|Overall Study|Laboratory abnormality|0|||
44494790|NCT00136916|79500448|FG001|Overall Study|Laboratory abnormality|1|||
44494791|NCT00136916|79500447|FG000|Overall Study|Lack of Efficacy|13|||
44494792|NCT00136916|79500448|FG001|Overall Study|Lack of Efficacy|3|||
44494793|NCT00136916|79500447|FG000|Overall Study|Lost to Follow-up|12|||
44494794|NCT00136916|79500448|FG001|Overall Study|Lost to Follow-up|14|||
44494795|NCT00136916|79500447|FG000|Overall Study|Withdrawal by Subject|44|||
44550442|NCT03391765|79566527|FG003|Overall Study|Withdrew consent|5|||
44550443|NCT03391765|79566524|FG000|Overall Study|Other, not specified|44|||
44550444|NCT03391765|79566525|FG001|Overall Study|Other, not specified|38|||
44550445|NCT03391765|79566526|FG002|Overall Study|Other, not specified|21|||
44550446|NCT03391765|79566527|FG003|Overall Study|Other, not specified|16|||
44550447|NCT02802228|79566539|FG000|Overall Study|Withdrawal by Subject|2|||
44550448|NCT02802228|79566540|FG001|Overall Study|Withdrawal by Subject|0|||
44550449|NCT02802228|79566539|FG000|Overall Study|Lost to Follow-up|1|||
44550450|NCT02802228|79566540|FG001|Overall Study|Lost to Follow-up|0|||
44550451|NCT02802228|79566539|FG000|Overall Study|Adverse Event|1|||
44550452|NCT02802228|79566540|FG001|Overall Study|Adverse Event|0|||
44550453|NCT02802228|79566539|FG000|Overall Study|Physician Decision|1|||
44550454|NCT02802228|79566540|FG001|Overall Study|Physician Decision|0|||
44550455|NCT03130257|79566549|FG000|Overall Study|Withdrawal by Subject|1|||
44550456|NCT03130257|79566550|FG001|Overall Study|Withdrawal by Subject|0|||
44550457|NCT03130257|79566551|FG002|Overall Study|Withdrawal by Subject|2|||
44550458|NCT03674177|79566563|FG000|Overall Study|Lost to Follow-up|2|||
44494796|NCT00136916|79500448|FG001|Overall Study|Withdrawal by Subject|46|||
44494797|NCT00136916|79500447|FG000|Overall Study|Other|22|||
44494798|NCT00136916|79500448|FG001|Overall Study|Other|24|||
44494799|NCT00136916|79500447|FG000|Overall Study|Discontinued in follow up period|3|||
44550459|NCT03674177|79566564|FG001|Overall Study|Lost to Follow-up|1|||
44550460|NCT03674177|79566565|FG002|Overall Study|Lost to Follow-up|0|||
44550461|NCT03674177|79566566|FG003|Overall Study|Lost to Follow-up|2|||
44550462|NCT03354637|79566592|FG000|Double-blind Period|Protocol Violation|2|||
44550463|NCT03354637|79566593|FG001|Double-blind Period|Protocol Violation|0|||
44550464|NCT03354637|79566594|FG002|Double-blind Period|Protocol Violation|0|||
44550465|NCT03354637|79566592|FG000|Double-blind Period|Adverse Event|1|||
44550466|NCT03354637|79566593|FG001|Double-blind Period|Adverse Event|2|||
44550467|NCT03354637|79566594|FG002|Double-blind Period|Adverse Event|0|||
44550468|NCT03354637|79566592|FG000|Double-blind Period|Lost to Follow-up|3|||
44550469|NCT03354637|79566593|FG001|Double-blind Period|Lost to Follow-up|4|||
44550470|NCT03354637|79566594|FG002|Double-blind Period|Lost to Follow-up|3|||
44550471|NCT03354637|79566592|FG000|Double-blind Period|Withdrawal by Subject|10|||
44550472|NCT03354637|79566593|FG001|Double-blind Period|Withdrawal by Subject|6|||
44550473|NCT03354637|79566594|FG002|Double-blind Period|Withdrawal by Subject|4|||
44550474|NCT03354637|79566592|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
44550475|NCT03354637|79566593|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
44550476|NCT03354637|79566594|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
44550477|NCT03354637|79566592|FG000|Open Label Extension|Adverse Event|0|||
44550478|NCT03354637|79566593|FG001|Open Label Extension|Adverse Event|0|||
44550479|NCT03354637|79566594|FG002|Open Label Extension|Adverse Event|1|||
44550480|NCT03354637|79566592|FG000|Open Label Extension|Lost to Follow-up|0|||
44550481|NCT03354637|79566593|FG001|Open Label Extension|Lost to Follow-up|0|||
44550482|NCT03354637|79566594|FG002|Open Label Extension|Lost to Follow-up|2|||
44550483|NCT03354637|79566592|FG000|Open Label Extension|Withdrawal by Subject|0|||
44550484|NCT03354637|79566593|FG001|Open Label Extension|Withdrawal by Subject|0|||
44550485|NCT03354637|79566594|FG002|Open Label Extension|Withdrawal by Subject|5|||
44550486|NCT03354637|79566592|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
44550487|NCT03354637|79566593|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
44230566|NCT01882985|79040244|FG000|Overall Study|Lost to Follow-up|1|||
44230567|NCT01882985|79040244|FG000|Overall Study|Withdrawal by Subject|1|||
44230568|NCT01893905|79040257|FG000|Overall Study|Withdrawal by Subject|1|||
44230569|NCT01893905|79040258|FG001|Overall Study|Withdrawal by Subject|0|||
44230570|NCT01893905|79040257|FG000|Overall Study|Adverse Event|9|||
44230571|NCT01893905|79040258|FG001|Overall Study|Adverse Event|3|||
44230572|NCT01893905|79040257|FG000|Overall Study|Lack of Efficacy|5|||
44230573|NCT01893905|79040258|FG001|Overall Study|Lack of Efficacy|7|||
44230574|NCT01893905|79040257|FG000|Overall Study|Lost to Follow-up|1|||
44230575|NCT01893905|79040258|FG001|Overall Study|Lost to Follow-up|0|||
44230576|NCT01893905|79040257|FG000|Overall Study|Protocol Violation|6|||
44230577|NCT01893905|79040258|FG001|Overall Study|Protocol Violation|1|||
44274708|NCT02243202|79220513|FG000|Overall Study|Randomized but not received treatment|0|||
44274709|NCT02243202|79220514|FG001|Overall Study|Randomized but not received treatment|0|||
44274710|NCT02243202|79220515|FG002|Overall Study|Randomized but not received treatment|0|||
44274711|NCT02243202|79220516|FG003|Overall Study|Randomized but not received treatment|1|||
44274712|NCT02243046|79220529|FG000|Overall Study|Lost to Follow-up|1|||
44494800|NCT00136916|79500448|FG001|Overall Study|Discontinued in follow up period|0|||
44494801|NCT04633564|79500458|FG000|Period 1|Adverse Event|28|||
44494802|NCT04633564|79500459|FG001|Period 1|Adverse Event|19|||
44494803|NCT04633564|79500458|FG000|Period 1|Death|8|||
44494804|NCT04633564|79500459|FG001|Period 1|Death|7|||
44494805|NCT04633564|79500458|FG000|Period 1|Lost to Follow-up|3|||
44494806|NCT04633564|79500459|FG001|Period 1|Lost to Follow-up|5|||
44494807|NCT04633564|79500458|FG000|Period 1|Physician Decision|4|||
44550488|NCT03354637|79566594|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
44550489|NCT03354637|79566592|FG000|Open Label Extension|Subject Noncompliance|0|||
44550490|NCT03354637|79566593|FG001|Open Label Extension|Subject Noncompliance|0|||
44550491|NCT03354637|79566594|FG002|Open Label Extension|Subject Noncompliance|1|||
44550492|NCT03354637|79566592|FG000|Open Label Extension|Lack of Efficacy|0|||
44550493|NCT03354637|79566593|FG001|Open Label Extension|Lack of Efficacy|0|||
44550494|NCT03354637|79566594|FG002|Open Label Extension|Lack of Efficacy|1|||
44550495|NCT03354637|79566592|FG000|Open Label Extension|Physician Decision|0|||
44550496|NCT03354637|79566593|FG001|Open Label Extension|Physician Decision|0|||
44274713|NCT02243046|79220530|FG001|Overall Study|Lost to Follow-up|1|||
44494808|NCT04633564|79500459|FG001|Period 1|Physician Decision|12|||
44550497|NCT03354637|79566594|FG002|Open Label Extension|Physician Decision|1|||
44550498|NCT04053023|79566605|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
44550499|NCT04053023|79566606|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
44550500|NCT03352453|79566618|FG000|Overall Study|Miscellaneous Reasons|1|||
44550501|NCT03352453|79566619|FG001|Overall Study|Miscellaneous Reasons|2|||
44550502|NCT03352453|79566618|FG000|Overall Study|Lack of Efficacy|1|||
44550503|NCT03352453|79566619|FG001|Overall Study|Lack of Efficacy|0|||
44550504|NCT03352453|79566618|FG000|Overall Study|Withdrawal by Subject|8|||
44550505|NCT03352453|79566619|FG001|Overall Study|Withdrawal by Subject|14|||
44230578|NCT01893905|79040257|FG000|Overall Study|Lack of adherence to treatment|2|||
44230579|NCT01893905|79040258|FG001|Overall Study|Lack of adherence to treatment|0|||
44230580|NCT01893905|79040257|FG000|Overall Study|Other reason|1|||
44230581|NCT01893905|79040258|FG001|Overall Study|Other reason|3|||
44230582|NCT01893827|79040271|FG000|Overall Study|Lost to Follow-up|19|||
44230583|NCT01893827|79040272|FG001|Overall Study|Lost to Follow-up|26|||
44230584|NCT01882907|79040280|FG000|Overall Study|Adverse Event|3|||
44230585|NCT01882907|79040281|FG001|Overall Study|Adverse Event|1|||
44230586|NCT01882907|79040280|FG000|Overall Study|Lack of Efficacy|0|||
44550506|NCT03352453|79566618|FG000|Overall Study|Study Terminated by Sponsor|2|||
44550507|NCT03352453|79566619|FG001|Overall Study|Study Terminated by Sponsor|1|||
44550508|NCT03352453|79566618|FG000|Overall Study|Protocol Deviation|1|||
44550509|NCT03352453|79566619|FG001|Overall Study|Protocol Deviation|0|||
44550510|NCT03352453|79566618|FG000|Overall Study|Lost to Follow-up|7|||
44550511|NCT03352453|79566619|FG001|Overall Study|Lost to Follow-up|6|||
44550512|NCT03352453|79566618|FG000|Overall Study|Adverse Event|2|||
44550513|NCT03352453|79566619|FG001|Overall Study|Adverse Event|9|||
44230587|NCT01882907|79040281|FG001|Overall Study|Lack of Efficacy|3|||
44230588|NCT01882907|79040280|FG000|Overall Study|Lost to Follow-up|1|||
44230589|NCT01882907|79040281|FG001|Overall Study|Lost to Follow-up|4|||
44230590|NCT01882907|79040280|FG000|Overall Study|Protocol Violation|10|||
44230591|NCT01882907|79040281|FG001|Overall Study|Protocol Violation|14|||
44230592|NCT01882907|79040280|FG000|Overall Study|Withdrawal by Subject|0|||
44230593|NCT01882907|79040281|FG001|Overall Study|Withdrawal by Subject|6|||
44230594|NCT01893281|79040303|FG000|Overall Study|Adverse Event|1|||
44230595|NCT01893281|79040303|FG000|Overall Study|Protocol Violation|1|||
44230596|NCT01893281|79040303|FG000|Overall Study|Withdrawal by Subject|1|||
44230597|NCT01893203|79040307|FG000|Overall Study|Withdrawal by Subject|1|||
44230598|NCT01882829|79040311|FG000|Overall Study|Adverse Event|4|||
44230599|NCT01882829|79040311|FG000|Overall Study|Protocol Violation|1|||
44230600|NCT01882829|79040311|FG000|Overall Study|Withdrawal by Subject|1|||
44230601|NCT01882439|79040395|FG000|Overall Study|Adverse event related to study drug|3|||
44230602|NCT01882439|79040396|FG001|Overall Study|Adverse event related to study drug|8|||
44230603|NCT01882439|79040397|FG002|Overall Study|Adverse event related to study drug|1|||
44230604|NCT01882439|79040398|FG003|Overall Study|Adverse event related to study drug|2|||
44230605|NCT01882439|79040395|FG000|Overall Study|Pregnancy|0|||
44230606|NCT01882439|79040396|FG001|Overall Study|Pregnancy|1|||
44230607|NCT01882439|79040397|FG002|Overall Study|Pregnancy|0|||
44230608|NCT01882439|79040398|FG003|Overall Study|Pregnancy|0|||
44230609|NCT01882439|79040395|FG000|Overall Study|Protocol Violation|2|||
44230610|NCT01882439|79040396|FG001|Overall Study|Protocol Violation|2|||
44230611|NCT01882439|79040397|FG002|Overall Study|Protocol Violation|0|||
44230612|NCT01882439|79040398|FG003|Overall Study|Protocol Violation|1|||
44230613|NCT01882439|79040395|FG000|Overall Study|No longer willing to participate|1|||
44230614|NCT01882439|79040396|FG001|Overall Study|No longer willing to participate|4|||
44230615|NCT01882439|79040397|FG002|Overall Study|No longer willing to participate|2|||
44230616|NCT01882439|79040398|FG003|Overall Study|No longer willing to participate|3|||
44230617|NCT01882439|79040395|FG000|Overall Study|Medication error with no associated AE|0|||
44230618|NCT01882439|79040396|FG001|Overall Study|Medication error with no associated AE|0|||
44230619|NCT01882439|79040397|FG002|Overall Study|Medication error with no associated AE|2|||
44230620|NCT01882439|79040398|FG003|Overall Study|Medication error with no associated AE|0|||
44230621|NCT01882439|79040395|FG000|Overall Study|Insufficient clinical response|1|||
44230622|NCT01882439|79040396|FG001|Overall Study|Insufficient clinical response|4|||
44230623|NCT01882439|79040397|FG002|Overall Study|Insufficient clinical response|4|||
44230624|NCT01882439|79040398|FG003|Overall Study|Insufficient clinical response|2|||
44230625|NCT01882439|79040395|FG000|Overall Study|Adverse event unrelated to study drug|2|||
44230626|NCT01882439|79040396|FG001|Overall Study|Adverse event unrelated to study drug|2|||
44550514|NCT03128931|79566625|FG000|Overall Study|Physician Decision|1|||
44550515|NCT03128931|79566625|FG000|Overall Study|Equipment Issues|3|||
44550516|NCT03107052|79566632|FG000|Overall Study|Adverse Event|6|||
44550517|NCT03107052|79566633|FG001|Overall Study|Adverse Event|1|||
44550518|NCT03107052|79566634|FG002|Overall Study|Adverse Event|2|||
44550519|NCT03107052|79566632|FG000|Overall Study|Withdrawal by Subject|9|||
44550520|NCT03107052|79566633|FG001|Overall Study|Withdrawal by Subject|5|||
44550521|NCT03107052|79566634|FG002|Overall Study|Withdrawal by Subject|8|||
44550522|NCT03107052|79566632|FG000|Overall Study|Protocol Violation|6|||
44550523|NCT03107052|79566633|FG001|Overall Study|Protocol Violation|0|||
44550524|NCT03107052|79566634|FG002|Overall Study|Protocol Violation|3|||
44550525|NCT03107052|79566632|FG000|Overall Study|Lost to Follow-up|4|||
44550526|NCT03107052|79566633|FG001|Overall Study|Lost to Follow-up|0|||
44550527|NCT03107052|79566634|FG002|Overall Study|Lost to Follow-up|1|||
44550528|NCT03107052|79566632|FG000|Overall Study|Lack of Efficacy|23|||
44550529|NCT03107052|79566633|FG001|Overall Study|Lack of Efficacy|7|||
44550530|NCT03107052|79566634|FG002|Overall Study|Lack of Efficacy|4|||
44550531|NCT03107052|79566632|FG000|Overall Study|Other than specified|4|||
44230627|NCT01882439|79040397|FG002|Overall Study|Adverse event unrelated to study drug|1|||
44230628|NCT01882439|79040398|FG003|Overall Study|Adverse event unrelated to study drug|1|||
44230629|NCT01892657|79040445|FG000|Overall Study|Withdrawal by Subject|6|||
44230630|NCT01892657|79040445|FG000|Overall Study|Protocol Violation|12|||
44230631|NCT01881737|79040472|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
44230632|NCT01881737|79040472|FG000|Overall Study|Withdrawal by Subject|1|||
44230633|NCT01881737|79040472|FG000|Overall Study|Worsening of baseline behavior|1|||
44230634|NCT01892501|79040508|FG000|Overall Study|Protocol Violation|2|||
44230635|NCT01892501|79040508|FG000|Overall Study|Puncture not carried out|9|||
44230636|NCT01892501|79040508|FG000|Overall Study|Radiological monitoring not carried out|5|||
44230637|NCT01892501|79040508|FG000|Overall Study|Non-contributory histological result|12|||
44230638|NCT01892345|79040523|FG000|Overall Study|Adverse Event|0|||
44230639|NCT01892345|79040524|FG001|Overall Study|Adverse Event|2|||
44230640|NCT01892345|79040523|FG000|Overall Study|Death|1|||
44230641|NCT01892345|79040524|FG001|Overall Study|Death|0|||
44230642|NCT01892345|79040523|FG000|Overall Study|Lost to Follow-up|3|||
44230643|NCT01892345|79040524|FG001|Overall Study|Lost to Follow-up|0|||
44230644|NCT01892345|79040523|FG000|Overall Study|Withdrawal by Subject|12|||
44230645|NCT01892345|79040524|FG001|Overall Study|Withdrawal by Subject|1|||
44249729|NCT01504412|79083923|FG000|Overall Study|Withdrawal by Subject|2|||
44274714|NCT02243046|79220531|FG002|Overall Study|Lost to Follow-up|4|||
44494809|NCT04633564|79500458|FG000|Period 1|Protocol Violation|0|||
44494810|NCT04633564|79500459|FG001|Period 1|Protocol Violation|1|||
44494811|NCT04633564|79500458|FG000|Period 1|Withdrawal by Subject|10|||
44494812|NCT04633564|79500459|FG001|Period 1|Withdrawal by Subject|8|||
44494813|NCT04633564|79500458|FG000|Period 1|Progressive disease|47|||
44494814|NCT04633564|79500459|FG001|Period 1|Progressive disease|51|||
44494815|NCT04633564|79500458|FG000|Period 1|Terminated by Sponsor|8|||
44494816|NCT04633564|79500459|FG001|Period 1|Terminated by Sponsor|6|||
44494817|NCT04633564|79500458|FG000|Period 2|Adverse Event|3|||
44494818|NCT04633564|79500459|FG001|Period 2|Adverse Event|4|||
44550532|NCT03107052|79566633|FG001|Overall Study|Other than specified|2|||
44550533|NCT03107052|79566634|FG002|Overall Study|Other than specified|0|||
44550534|NCT03107052|79566632|FG000|Overall Study|Study terminated due to futility|67|||
44550535|NCT03107052|79566633|FG001|Overall Study|Study terminated due to futility|31|||
44550536|NCT03107052|79566634|FG002|Overall Study|Study terminated due to futility|23|||
44249730|NCT01504412|79083924|FG001|Overall Study|Withdrawal by Subject|1|||
44249731|NCT01504412|79083925|FG002|Overall Study|Withdrawal by Subject|1|||
44274715|NCT02207946|79220541|FG000|Overall Study|Lost to Follow-up|1|||
44494819|NCT04633564|79500458|FG000|Period 2|Death|0|||
44494820|NCT04633564|79500459|FG001|Period 2|Death|2|||
44494821|NCT04633564|79500458|FG000|Period 2|Lost to Follow-up|0|||
44550537|NCT04050371|79566644|FG000|Overall Study|Withdrawal by Subject|1|||
44550538|NCT04050371|79566645|FG001|Overall Study|Withdrawal by Subject|0|||
44550539|NCT04447287|79566654|FG000|Period 1: Run-in Period|Adverse Event|3|||
44550540|NCT04447287|79566655|FG001|Period 1: Run-in Period|Adverse Event|0|||
44550541|NCT04447287|79566656|FG002|Period 1: Run-in Period|Adverse Event|0|||
44550542|NCT04447287|79566654|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
44550543|NCT04447287|79566655|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
44550544|NCT04447287|79566656|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
44550545|NCT04447287|79566654|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
44550546|NCT04447287|79566655|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
44550547|NCT04447287|79566656|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
44550548|NCT01879319|79566677|FG000|Overall Study|Withdrawal by Subject|1|||
44550549|NCT01879319|79566678|FG001|Overall Study|Withdrawal by Subject|0|||
44550550|NCT01879319|79566677|FG000|Overall Study|Lost to Follow-up|1|||
44550551|NCT01879319|79566678|FG001|Overall Study|Lost to Follow-up|5|||
44550552|NCT03102918|79566686|FG000|Overall Study|Protocol Violation|1|||
44550553|NCT03102918|79566687|FG001|Overall Study|Protocol Violation|0|||
44550554|NCT03128307|79566693|FG000|Overall Study|Lost to Follow-up|29|||
44550555|NCT03128307|79566693|FG000|Overall Study|Withdrawal by Subject|5|||
44550556|NCT03102762|79566699|FG000|Overall Study|Lost to Follow-up|1|||
44550557|NCT03102762|79566700|FG001|Overall Study|Lost to Follow-up|0|||
44550558|NCT01346475|79566713|FG000|First Intervention|Lost to Follow-up|4|||
44550559|NCT01346475|79566714|FG001|First Intervention|Lost to Follow-up|3|||
44550560|NCT01338636|79566720|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
44550561|NCT00322218|79566726|FG000|Overall Study|Death|3|||
44550562|NCT00322218|79566727|FG001|Overall Study|Death|6|||
44550563|NCT02873754|79566733|FG000|Overall Study|Lost to Follow-up|5|||
44550564|NCT02873754|79566733|FG000|Overall Study|Couldn't complete study procedures|1|||
44550565|NCT03287414|79566739|FG000|Treatment Epoch|Adverse Event|0|||
44550566|NCT03287414|79566740|FG001|Treatment Epoch|Adverse Event|1|||
44550567|NCT03287414|79566739|FG000|Treatment Epoch|Study terminated by sponsor|2|||
44550568|NCT03287414|79566740|FG001|Treatment Epoch|Study terminated by sponsor|2|||
44550569|NCT03287414|79566739|FG000|Treatment Epoch|Subject/Guardian decision|4|||
44550570|NCT03287414|79566740|FG001|Treatment Epoch|Subject/Guardian decision|0|||
44550571|NCT03287414|79566739|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
44550572|NCT03287414|79566740|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
44550573|NCT03287414|79566739|FG000|Treatment Epoch|Withdrawal by Subject|1|||
44550574|NCT03287414|79566740|FG001|Treatment Epoch|Withdrawal by Subject|0|||
44550575|NCT03287414|79566739|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
44550576|NCT03287414|79566740|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
44550577|NCT03287414|79566739|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
44550578|NCT03287414|79566740|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
44550579|NCT03101592|79566770|FG000|Overall Study|participant files could not be located|111|||
44550580|NCT03101592|79566771|FG001|Overall Study|participant files could not be located|170|||
44550581|NCT03101592|79566772|FG002|Overall Study|participant files could not be located|118|||
44550582|NCT04046939|79566790|FG000|Primary Assessment Period|Adverse Event|1|||
44550583|NCT04046939|79566791|FG001|Primary Assessment Period|Adverse Event|0|||
44550584|NCT04046939|79566792|FG002|Primary Assessment Period|Adverse Event|0|||
44550585|NCT04046939|79566793|FG003|Primary Assessment Period|Adverse Event|0|||
44550586|NCT04046939|79566790|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
44550587|NCT04046939|79566791|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
44274716|NCT02207946|79220542|FG001|Overall Study|Lost to Follow-up|0|||
44494822|NCT04633564|79500459|FG001|Period 2|Lost to Follow-up|1|||
44494823|NCT04633564|79500458|FG000|Period 2|Physician Decision|2|||
44494824|NCT04633564|79500459|FG001|Period 2|Physician Decision|4|||
44494825|NCT04633564|79500458|FG000|Period 2|Withdrawal by Subject|5|||
44494826|NCT04633564|79500459|FG001|Period 2|Withdrawal by Subject|1|||
44494827|NCT04633564|79500458|FG000|Period 2|Progressive Disease|74|||
44494828|NCT04633564|79500459|FG001|Period 2|Progressive Disease|82|||
44550588|NCT04046939|79566792|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
44550589|NCT04046939|79566793|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
44550590|NCT04046939|79566790|FG000|Primary Assessment Period|Physician Decision|0|||
44550591|NCT04046939|79566791|FG001|Primary Assessment Period|Physician Decision|0|||
44550592|NCT04046939|79566792|FG002|Primary Assessment Period|Physician Decision|1|||
44550593|NCT04046939|79566793|FG003|Primary Assessment Period|Physician Decision|0|||
44550594|NCT04046939|79566790|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
44550595|NCT04046939|79566791|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
44550596|NCT04046939|79566792|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
44550597|NCT04046939|79566793|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
44550598|NCT04042103|79566809|FG000|Overall Study|Lost to Follow-up|1|||
44494829|NCT04633564|79500458|FG000|Period 2|Terminated by Sponsor|9|||
44550599|NCT04042103|79566809|FG000|Overall Study|Withdrawal by Subject|1|||
44550600|NCT02955797|79566817|FG000|Overall Study|Protocol Violation|1|||
44550601|NCT02955797|79566818|FG001|Overall Study|Protocol Violation|0|||
44550602|NCT02955797|79566819|FG002|Overall Study|Protocol Violation|0|||
44550603|NCT02955797|79566820|FG003|Overall Study|Protocol Violation|1|||
44550604|NCT02955797|79566817|FG000|Overall Study|Withdrawal by Subject|2|||
44550605|NCT02955797|79566818|FG001|Overall Study|Withdrawal by Subject|2|||
44550606|NCT02955797|79566819|FG002|Overall Study|Withdrawal by Subject|0|||
44550607|NCT02955797|79566820|FG003|Overall Study|Withdrawal by Subject|1|||
44550608|NCT02955797|79566817|FG000|Overall Study|Lost to Follow-up|0|||
44550609|NCT02955797|79566818|FG001|Overall Study|Lost to Follow-up|1|||
44550610|NCT02955797|79566819|FG002|Overall Study|Lost to Follow-up|0|||
44550611|NCT02955797|79566820|FG003|Overall Study|Lost to Follow-up|0|||
44550612|NCT03101514|79566833|FG000|Overall Study|Withdrawal by Subject|4|||
44550613|NCT03101514|79566833|FG000|Overall Study|Protocol Violation|2|||
44550614|NCT03101514|79566833|FG000|Overall Study|patient's information was incomplete|1|||
44550615|NCT02702518|79566839|FG000|Overall Study|Lost to Follow-up|3|||
44550616|NCT02702518|79566840|FG001|Overall Study|Lost to Follow-up|4|||
44550617|NCT04039503|79566850|FG000|Overall Study|Adverse Event|3|||
44550618|NCT04039503|79566851|FG001|Overall Study|Adverse Event|0|||
44550619|NCT04039503|79566852|FG002|Overall Study|Adverse Event|2|||
44550620|NCT04039503|79566853|FG003|Overall Study|Adverse Event|0|||
44550621|NCT04039503|79566850|FG000|Overall Study|Lost to Follow-up|0|||
44550622|NCT04039503|79566851|FG001|Overall Study|Lost to Follow-up|0|||
44550623|NCT04039503|79566852|FG002|Overall Study|Lost to Follow-up|1|||
44550624|NCT04039503|79566853|FG003|Overall Study|Lost to Follow-up|0|||
44550625|NCT04039503|79566850|FG000|Overall Study|Protocol Violation|0|||
44550626|NCT04039503|79566851|FG001|Overall Study|Protocol Violation|1|||
44550627|NCT04039503|79566852|FG002|Overall Study|Protocol Violation|2|||
44550628|NCT04039503|79566853|FG003|Overall Study|Protocol Violation|1|||
44550629|NCT04039503|79566850|FG000|Overall Study|Withdrawal by Subject|4|||
44494830|NCT04633564|79500459|FG001|Period 2|Terminated by Sponsor|3|||
44494831|NCT04960228|79500467|FG000|Overall Study|Withdrawal by Subject|216|||
44494832|NCT04960228|79500468|FG001|Overall Study|Withdrawal by Subject|35|||
44494833|NCT04960228|79500467|FG000|Overall Study|Failed attention check|69|||
44494834|NCT04960228|79500468|FG001|Overall Study|Failed attention check|148|||
44494835|NCT04960228|79500467|FG000|Overall Study|Flagged for response quality by Dynata|3|||
44494836|NCT04960228|79500468|FG001|Overall Study|Flagged for response quality by Dynata|3|||
44494837|NCT04619992|79500476|FG000|Overall Study|Withdrawal by Subject|1|||
44494838|NCT04619992|79500477|FG001|Overall Study|Withdrawal by Subject|0|||
44494839|NCT00136604|79500488|FG000|Overall Study|Lost to Follow-up|1|||
44494840|NCT00136604|79500489|FG001|Overall Study|Lost to Follow-up|0|||
44494841|NCT00136604|79500490|FG002|Overall Study|Lost to Follow-up|0|||
44494842|NCT00136604|79500491|FG003|Overall Study|Lost to Follow-up|0|||
44494843|NCT00136604|79500492|FG004|Overall Study|Lost to Follow-up|1|||
44494844|NCT00136604|79500488|FG000|Overall Study|Migrated/moved from study area|0|||
44494845|NCT00136604|79500489|FG001|Overall Study|Migrated/moved from study area|1|||
44494846|NCT00136604|79500490|FG002|Overall Study|Migrated/moved from study area|0|||
44494847|NCT00136604|79500491|FG003|Overall Study|Migrated/moved from study area|0|||
44494848|NCT00136604|79500492|FG004|Overall Study|Migrated/moved from study area|0|||
44494849|NCT00135512|79500508|FG000|Overall Study|Adverse Event|56|||
44494850|NCT00135512|79500508|FG000|Overall Study|Lack of Efficacy|25|||
44494851|NCT00135512|79500508|FG000|Overall Study|Other|42|||
44494852|NCT00130728|79500514|FG000|Overall Study|Death|258|||
44494853|NCT00130728|79500515|FG001|Overall Study|Death|258|||
44494854|NCT00130728|79500514|FG000|Overall Study|Lost to Follow-up|4|||
44494855|NCT00130728|79500515|FG001|Overall Study|Lost to Follow-up|0|||
44550630|NCT04039503|79566851|FG001|Overall Study|Withdrawal by Subject|3|||
44550631|NCT04039503|79566852|FG002|Overall Study|Withdrawal by Subject|5|||
44550632|NCT04039503|79566853|FG003|Overall Study|Withdrawal by Subject|2|||
44550633|NCT03131895|79566890|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
44550634|NCT03131895|79566891|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
44550635|NCT03131895|79566892|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
44550636|NCT03131895|79566893|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
44550637|NCT03131895|79566890|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
44494856|NCT00130728|79500514|FG000|Overall Study|Withdrawal by Subject|0|||
44494857|NCT00130728|79500515|FG001|Overall Study|Withdrawal by Subject|2|||
44494858|NCT00129974|79500521|FG000|Overall Study|Other|1|||
44494859|NCT04947436|79500528|FG000|Overall Study|Lost to Follow-up|3|||
44494860|NCT04947436|79500529|FG001|Overall Study|Lost to Follow-up|7|||
44494861|NCT04947436|79500530|FG002|Overall Study|Lost to Follow-up|5|||
44494862|NCT04947436|79500528|FG000|Overall Study|Death|1|||
44550638|NCT03131895|79566891|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
44550639|NCT03131895|79566892|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
44550640|NCT03131895|79566893|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
44550641|NCT03131895|79566890|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44550642|NCT03131895|79566891|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
44550643|NCT03131895|79566892|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44550644|NCT03131895|79566893|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
44550645|NCT03131895|79566890|FG000|Washout Period (at Least 5 Days)|Other|0|||
44550646|NCT03131895|79566891|FG001|Washout Period (at Least 5 Days)|Other|0|||
44550647|NCT03131895|79566892|FG002|Washout Period (at Least 5 Days)|Other|2|||
44550648|NCT03131895|79566893|FG003|Washout Period (at Least 5 Days)|Other|0|||
44550649|NCT03131895|79566890|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
44550650|NCT03131895|79566891|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
44274717|NCT02207946|79220541|FG000|Overall Study|Adverse Event|0|||
44274718|NCT02207946|79220542|FG001|Overall Study|Adverse Event|1|||
44274719|NCT03976076|79220549|FG000|Overall Study|Withdrawal by Subject|2|||
44274720|NCT03551210|79220748|FG000|Overall Study|Adverse Event|5|||
44274721|NCT03551210|79220749|FG001|Overall Study|Adverse Event|6|||
44274722|NCT03551210|79220748|FG000|Overall Study|Withdrawal by Subject|1|||
44274723|NCT03551210|79220749|FG001|Overall Study|Withdrawal by Subject|7|||
44274724|NCT03551210|79220748|FG000|Overall Study|Needed in other antibiotic treatment|2|||
44274725|NCT03551210|79220749|FG001|Overall Study|Needed in other antibiotic treatment|5|||
44274726|NCT03551210|79220748|FG000|Overall Study|Lost to Follow-up|1|||
44274727|NCT03551210|79220749|FG001|Overall Study|Lost to Follow-up|1|||
44274728|NCT03551210|79220748|FG000|Overall Study|Absence of visit 4 and 5|1|||
44274729|NCT03551210|79220749|FG001|Overall Study|Absence of visit 4 and 5|0|||
44274730|NCT03551210|79220748|FG000|Overall Study|No drug for dispensing|0|||
44274731|NCT03551210|79220749|FG001|Overall Study|No drug for dispensing|1|||
44274732|NCT02207634|79220886|FG000|Overall Study|Withdrawal by Subject|21|||
44274733|NCT02207634|79220887|FG001|Overall Study|Withdrawal by Subject|31|||
44274734|NCT02207634|79220886|FG000|Overall Study|Lost to Follow-up|1|||
44274735|NCT02207634|79220887|FG001|Overall Study|Lost to Follow-up|0|||
44230646|NCT01892189|79040601|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
44230647|NCT01892189|79040602|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
44230648|NCT01892189|79040603|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
44230649|NCT01892189|79040604|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
44230650|NCT01892189|79040605|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
44230651|NCT01892189|79040606|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
44274736|NCT03452228|79220919|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
44274737|NCT03452228|79220920|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
44376525|NCT00929526|79381708|FG001|Overall Study|Lost to Follow-up|12|||
44376526|NCT00929526|79381707|FG000|Overall Study|Other|8|||
44376527|NCT00929526|79381708|FG001|Overall Study|Other|6|||
44376528|NCT00859456|79381714|FG000|Overall Study|Adverse Event|3|||
44494863|NCT04947436|79500529|FG001|Overall Study|Death|1|||
44494864|NCT04947436|79500530|FG002|Overall Study|Death|1|||
44494865|NCT00119106|79500540|FG000|Overall Study|HIV infected at baseline|179|||
44494866|NCT00119106|79500541|FG001|Overall Study|HIV infected at baseline|178|||
44494867|NCT00135356|79500557|FG000|Overall Study|Adverse Event|6|||
44494868|NCT00135356|79500558|FG001|Overall Study|Adverse Event|2|||
44494869|NCT00135356|79500557|FG000|Overall Study|Lack of Efficacy|2|||
44494870|NCT00135356|79500558|FG001|Overall Study|Lack of Efficacy|0|||
44494871|NCT00135356|79500557|FG000|Overall Study|Lost to Follow-up|3|||
44274738|NCT03452228|79220921|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
44274739|NCT03452228|79220919|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
44274740|NCT03452228|79220920|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
44274741|NCT03452228|79220921|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
44274742|NCT03452228|79220919|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
44274743|NCT03452228|79220920|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
44274744|NCT03452228|79220921|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
44274745|NCT03452228|79220919|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
44274746|NCT03452228|79220920|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
44274747|NCT03452228|79220921|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
44274748|NCT02207556|79220984|FG000|Overall Study|Physician Decision|1|||
44274749|NCT02207556|79220985|FG001|Overall Study|Physician Decision|0|||
44274750|NCT02207556|79220984|FG000|Overall Study|Withdrawal by Subject|1|||
44274751|NCT02207556|79220985|FG001|Overall Study|Withdrawal by Subject|0|||
44274752|NCT02207556|79220984|FG000|Overall Study|Death|0|||
44550651|NCT03131895|79566892|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
44376529|NCT00859456|79381714|FG000|Overall Study|Progressive disease|2|||
44376530|NCT00859456|79381714|FG000|Overall Study|Non-compliance|3|||
44494872|NCT00135356|79500558|FG001|Overall Study|Lost to Follow-up|1|||
44230652|NCT01892189|79040607|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
44230653|NCT01892189|79040608|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
44494873|NCT00135356|79500557|FG000|Overall Study|Surgery for abdominal fat|1|||
44230654|NCT01892189|79040609|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
44230655|NCT01892189|79040601|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44230656|NCT01892189|79040602|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44230657|NCT01892189|79040603|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
44230658|NCT01892189|79040604|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
44230659|NCT01892189|79040605|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44230660|NCT01892189|79040606|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44230661|NCT01892189|79040607|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
44230662|NCT01892189|79040608|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44230663|NCT01892189|79040609|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
44230664|NCT01892189|79040601|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230665|NCT01892189|79040602|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230666|NCT01892189|79040603|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230667|NCT01892189|79040604|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230668|NCT01892189|79040605|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230669|NCT01892189|79040606|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
44230670|NCT01892189|79040607|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230671|NCT01892189|79040608|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230672|NCT01892189|79040609|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
44230673|NCT01881425|79040640|FG000|Overall Study|Death|5|||
44230674|NCT01881425|79040641|FG001|Overall Study|Death|1|||
44230675|NCT01881425|79040640|FG000|Overall Study|Withdrawal by Subject|8|||
44230676|NCT01881425|79040641|FG001|Overall Study|Withdrawal by Subject|3|||
44230677|NCT01881425|79040640|FG000|Overall Study|Physician Decision|2|||
44230678|NCT01881425|79040641|FG001|Overall Study|Physician Decision|1|||
44230679|NCT01881425|79040640|FG000|Overall Study|Adverse Event|3|||
44230680|NCT01881425|79040641|FG001|Overall Study|Adverse Event|0|||
44230681|NCT01881425|79040640|FG000|Overall Study|General Anesthesia panic attack|0|||
44230682|NCT01881425|79040641|FG001|Overall Study|General Anesthesia panic attack|1|||
44230683|NCT01881425|79040640|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
44230684|NCT01881425|79040641|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
44230685|NCT01881425|79040640|FG000|Overall Study|Lost to Follow-up|7|||
44230686|NCT01881425|79040641|FG001|Overall Study|Lost to Follow-up|2|||
44230687|NCT01891721|79040660|FG000|Overall Study|Lost to Follow-up|10|||
44230688|NCT01891721|79040661|FG001|Overall Study|Lost to Follow-up|5|||
44230689|NCT01891721|79040662|FG002|Overall Study|Lost to Follow-up|1|||
44230690|NCT01880957|79040681|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
44230691|NCT01880957|79040682|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
44230692|NCT01880957|79040681|FG000|Overall Study|Lost to Follow-up|11|||
44230693|NCT01880957|79040682|FG001|Overall Study|Lost to Follow-up|0|||
44230694|NCT01880957|79040681|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
44230695|NCT01880957|79040682|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
44230696|NCT04152837|79040697|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
44376531|NCT01075646|79381722|FG000|Overall Study|Lost to Follow-up|4|||
44376532|NCT01075646|79381723|FG001|Overall Study|Lost to Follow-up|3|||
44376533|NCT01075646|79381724|FG002|Overall Study|Lost to Follow-up|1|||
44376534|NCT01075646|79381725|FG003|Overall Study|Lost to Follow-up|2|||
44376535|NCT01075412|79381737|FG000|Overall Study|Withdrawal by Subject|0|||
44376536|NCT01075412|79381738|FG001|Overall Study|Withdrawal by Subject|1|||
44376537|NCT00799903|79381745|FG000|Overall Study|Investigator Site Closed|25|||
44494874|NCT00135356|79500558|FG001|Overall Study|Surgery for abdominal fat|0|||
44376538|NCT00799903|79381746|FG001|Overall Study|Investigator Site Closed|23|||
44376539|NCT00799903|79381745|FG000|Overall Study|Withdrawal by Subject|179|||
44274753|NCT02207556|79220985|FG001|Overall Study|Death|5|||
44274754|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
44274755|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
44274756|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
44376540|NCT00799903|79381746|FG001|Overall Study|Withdrawal by Subject|175|||
44376541|NCT00799903|79381745|FG000|Overall Study|Lost to Follow-up|69|||
44376542|NCT00799903|79381746|FG001|Overall Study|Lost to Follow-up|80|||
44376543|NCT01075256|79381755|FG000|Overall Study|Withdrawal by Subject|1|||
44494875|NCT00135356|79500557|FG000|Overall Study|Change in antiviral regimen|0|||
44494876|NCT00135356|79500558|FG001|Overall Study|Change in antiviral regimen|1|||
44494877|NCT00135356|79500557|FG000|Overall Study|Poor/noncompliance|1|||
44494878|NCT00135356|79500558|FG001|Overall Study|Poor/noncompliance|1|||
44274757|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
44376544|NCT01075256|79381756|FG001|Overall Study|Withdrawal by Subject|0|||
44494879|NCT00135356|79500557|FG000|Overall Study|No longer meets study criteria|2|||
44274758|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
44274759|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
44230697|NCT04152837|79040697|FG000|Maintenance Period|Adverse Event|1|||
44230698|NCT04152837|79040697|FG000|Maintenance Period|Withdrawal by Subject|1|||
44230699|NCT04152837|79040697|FG000|Maintenance Period|Sponsor Termination of Study|2|||
44230700|NCT01879553|79040716|FG000|Overall Study|Withdrawal by Subject|1|||
44230701|NCT01879553|79040717|FG001|Overall Study|Withdrawal by Subject|0|||
44230702|NCT01890785|79040738|FG000|Third Intervention|Withdrawal by Subject|0|||
44230703|NCT01890785|79040739|FG001|Third Intervention|Withdrawal by Subject|1|||
44230704|NCT01890785|79040740|FG002|Third Intervention|Withdrawal by Subject|0|||
44230705|NCT01890785|79040741|FG003|Third Intervention|Withdrawal by Subject|0|||
44230706|NCT01890785|79040742|FG004|Third Intervention|Withdrawal by Subject|0|||
44230707|NCT01890785|79040743|FG005|Third Intervention|Withdrawal by Subject|0|||
44230708|NCT01878383|79040767|FG000|Overall Study|Lost to Follow-up|0|||
44230709|NCT01878383|79040768|FG001|Overall Study|Lost to Follow-up|1499|||
44230710|NCT01878149|79040776|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
44230711|NCT01878149|79040777|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
44230712|NCT01863953|79040799|FG000|Overall Study|Adverse Event|0|||
44230713|NCT01863953|79040800|FG001|Overall Study|Adverse Event|0|||
44230714|NCT01863953|79040801|FG002|Overall Study|Adverse Event|1|||
44376545|NCT01075256|79381757|FG002|Overall Study|Withdrawal by Subject|0|||
44376546|NCT00923130|79381770|FG000|Overall Study|Stopped treatment due to progression|17|||
44274760|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
44274761|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
44274762|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
44274763|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
44274764|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
44274765|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
44376547|NCT00923130|79381770|FG000|Overall Study|Death|1|||
44494880|NCT00135356|79500558|FG001|Overall Study|No longer meets study criteria|0|||
44494881|NCT00135356|79500557|FG000|Overall Study|Withdrawal by Subject|2|||
44494882|NCT00135356|79500558|FG001|Overall Study|Withdrawal by Subject|4|||
44494883|NCT00118716|79500566|FG000|Overall Study|Adverse Event|2|||
44494884|NCT00118716|79500567|FG001|Overall Study|Adverse Event|7|||
44494885|NCT00118716|79500566|FG000|Overall Study|Protocol Violation|5|||
44494886|NCT00118716|79500567|FG001|Overall Study|Protocol Violation|4|||
44230715|NCT03049449|79041077|FG000|Overall Study|Did not receive treatment.|0|||
44230716|NCT03049449|79041078|FG001|Overall Study|Did not receive treatment.|0|||
44230717|NCT03049449|79041079|FG002|Overall Study|Did not receive treatment.|0|||
44230718|NCT03049449|79041080|FG003|Overall Study|Did not receive treatment.|0|||
44274766|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
44494887|NCT00118716|79500566|FG000|Overall Study|Withdrawal by Subject|0|||
44376548|NCT00923130|79381770|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
44550652|NCT03131895|79566893|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
44550653|NCT03131895|79566890|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
44550654|NCT03131895|79566891|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
44550655|NCT03131895|79566892|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
44550656|NCT03131895|79566893|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
44550657|NCT04039919|79566908|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44550658|NCT04039919|79566909|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44550659|NCT04039919|79566910|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44550660|NCT04039919|79566911|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44550661|NCT04039919|79566912|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44550662|NCT04039919|79566908|FG000|Treatment Period 1|Sponsor's decision|0|||
44550663|NCT04039919|79566909|FG001|Treatment Period 1|Sponsor's decision|0|||
44550664|NCT04039919|79566910|FG002|Treatment Period 1|Sponsor's decision|0|||
44550665|NCT04039919|79566911|FG003|Treatment Period 1|Sponsor's decision|0|||
44550666|NCT04039919|79566912|FG004|Treatment Period 1|Sponsor's decision|16|||
44550667|NCT04039919|79566908|FG000|Treatment Period 5|Withdrawal by Subject|1|||
44550668|NCT04039919|79566909|FG001|Treatment Period 5|Withdrawal by Subject|0|||
44550669|NCT04039919|79566910|FG002|Treatment Period 5|Withdrawal by Subject|0|||
44550670|NCT04039919|79566911|FG003|Treatment Period 5|Withdrawal by Subject|0|||
44550671|NCT04039919|79566912|FG004|Treatment Period 5|Withdrawal by Subject|0|||
44550672|NCT04035473|79566948|FG000|Screening/Baseline|Death|0|||
44550673|NCT04035473|79566949|FG001|Screening/Baseline|Death|1|||
44550674|NCT04035473|79566948|FG000|Screening/Baseline|Adverse Event|0|||
44550675|NCT04035473|79566949|FG001|Screening/Baseline|Adverse Event|1|||
44550676|NCT04035473|79566948|FG000|Follow-up Period|Adverse Event|2|||
44550677|NCT04035473|79566949|FG001|Follow-up Period|Adverse Event|0|||
44550678|NCT04032977|79566957|FG000|Overall Study|Withdrawal by Subject|6|||
44550679|NCT04032977|79566958|FG001|Overall Study|Withdrawal by Subject|1|||
44550680|NCT04032977|79566957|FG000|Overall Study|Lost to Follow-up|2|||
44550681|NCT04032977|79566958|FG001|Overall Study|Lost to Follow-up|7|||
44550682|NCT04032977|79566957|FG000|Overall Study|Pregnancy|1|||
44550683|NCT04032977|79566958|FG001|Overall Study|Pregnancy|0|||
44550684|NCT04030247|79566964|FG000|Overall Study|Withdrawal by Subject|4|||
44550685|NCT04030247|79566964|FG000|Overall Study|Lost to Follow-up|13|||
44550686|NCT02915978|79566971|FG000|Overall Study|Adverse Event|2|||
44550687|NCT02915978|79566972|FG001|Overall Study|Adverse Event|1|||
44550688|NCT02915978|79566973|FG002|Overall Study|Adverse Event|0|||
44550689|NCT02701192|79566981|FG000|Overall Study|Protocol Violation|2|||
44550690|NCT02701192|79566981|FG000|Overall Study|Lost to Follow-up|4|||
44550691|NCT03101358|79566989|FG000|Overall Study|Non-compliance with study schedule|1|||
44550692|NCT03101358|79566990|FG001|Overall Study|Non-compliance with study schedule|0|||
44550693|NCT03101358|79566991|FG002|Overall Study|Non-compliance with study schedule|0|||
44550694|NCT03101358|79566992|FG003|Overall Study|Non-compliance with study schedule|1|||
44550695|NCT03101358|79566989|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
44550696|NCT03101358|79566990|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
44550697|NCT03101358|79566991|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
44550698|NCT03101358|79566992|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
44550699|NCT03101358|79566989|FG000|Overall Study|Physician Decision|1|||
44550700|NCT03101358|79566990|FG001|Overall Study|Physician Decision|0|||
44550701|NCT03101358|79566991|FG002|Overall Study|Physician Decision|0|||
44550702|NCT03101358|79566992|FG003|Overall Study|Physician Decision|3|||
44550703|NCT03101358|79566989|FG000|Overall Study|Adverse Event|0|||
44550704|NCT03101358|79566990|FG001|Overall Study|Adverse Event|0|||
44550705|NCT03101358|79566991|FG002|Overall Study|Adverse Event|1|||
44550706|NCT03101358|79566992|FG003|Overall Study|Adverse Event|0|||
44550707|NCT03101358|79566989|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
44550708|NCT03101358|79566990|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
44550709|NCT03101358|79566991|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
44550710|NCT03101358|79566992|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
44550711|NCT03101358|79566989|FG000|Overall Study|Lost to Follow-up|1|||
44550712|NCT03101358|79566990|FG001|Overall Study|Lost to Follow-up|0|||
44550713|NCT03101358|79566991|FG002|Overall Study|Lost to Follow-up|0|||
44550714|NCT03101358|79566992|FG003|Overall Study|Lost to Follow-up|1|||
44550715|NCT03657095|79567005|FG000|Overall Study|Withdrawal by Subject|1|||
44550716|NCT03657095|79567006|FG001|Overall Study|Withdrawal by Subject|1|||
44550717|NCT03657095|79567005|FG000|Overall Study|Adverse Event|0|||
44550718|NCT03657095|79567006|FG001|Overall Study|Adverse Event|3|||
44550719|NCT03657095|79567005|FG000|Overall Study|Study Terminated by Sponsor|58|||
44550720|NCT03657095|79567006|FG001|Overall Study|Study Terminated by Sponsor|49|||
44550721|NCT03100344|79567016|FG000|Overall Study|Adverse Event|0|||
44550722|NCT03100344|79567017|FG001|Overall Study|Adverse Event|3|||
44550723|NCT03100344|79567018|FG002|Overall Study|Adverse Event|2|||
44550724|NCT03100344|79567019|FG003|Overall Study|Adverse Event|3|||
44550725|NCT03100344|79567016|FG000|Overall Study|Lack of Efficacy|2|||
44550726|NCT03100344|79567017|FG001|Overall Study|Lack of Efficacy|0|||
44550727|NCT03100344|79567018|FG002|Overall Study|Lack of Efficacy|0|||
44550728|NCT03100344|79567019|FG003|Overall Study|Lack of Efficacy|0|||
44550729|NCT03100344|79567016|FG000|Overall Study|Protocol Violation|1|||
44550730|NCT03100344|79567017|FG001|Overall Study|Protocol Violation|0|||
44550731|NCT03100344|79567018|FG002|Overall Study|Protocol Violation|0|||
44550732|NCT03100344|79567019|FG003|Overall Study|Protocol Violation|0|||
44550733|NCT03100344|79567016|FG000|Overall Study|Withdrawal by Subject|10|||
44550734|NCT03100344|79567017|FG001|Overall Study|Withdrawal by Subject|7|||
44550735|NCT03100344|79567018|FG002|Overall Study|Withdrawal by Subject|4|||
44550736|NCT03100344|79567019|FG003|Overall Study|Withdrawal by Subject|8|||
44550737|NCT03100344|79567016|FG000|Overall Study|Lost to Follow-up|1|||
44550738|NCT03100344|79567017|FG001|Overall Study|Lost to Follow-up|1|||
44550739|NCT03100344|79567018|FG002|Overall Study|Lost to Follow-up|1|||
44550740|NCT03100344|79567019|FG003|Overall Study|Lost to Follow-up|1|||
44550741|NCT02951533|79567032|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
44550742|NCT02951533|79567033|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
44550743|NCT02951533|79567034|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
44550744|NCT02951533|79567032|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
44550745|NCT02951533|79567033|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
44550746|NCT02951533|79567034|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
44550747|NCT02951533|79567032|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
44550748|NCT02951533|79567033|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
44550749|NCT02951533|79567034|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
44550750|NCT02951533|79567032|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
44550751|NCT02951533|79567033|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
44550752|NCT02951533|79567034|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
44550753|NCT02951533|79567032|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
44550754|NCT02951533|79567033|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
44550755|NCT02951533|79567034|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
44550756|NCT02951533|79567032|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
44550757|NCT02951533|79567033|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
44550758|NCT02951533|79567034|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
44550759|NCT02951533|79567032|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
44550760|NCT02951533|79567033|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
44550761|NCT02951533|79567034|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
44550762|NCT02951533|79567032|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
44550763|NCT02951533|79567033|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
44550764|NCT02951533|79567034|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
44550765|NCT02951533|79567032|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
44550766|NCT02951533|79567033|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
44550767|NCT02951533|79567034|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
44550768|NCT02951533|79567032|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
44550769|NCT02951533|79567033|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
44550770|NCT02951533|79567034|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
44550771|NCT02951533|79567032|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
44230719|NCT03049449|79041081|FG004|Overall Study|Did not receive treatment.|0|||
44230720|NCT03049449|79041082|FG005|Overall Study|Did not receive treatment.|0|||
44230721|NCT03049449|79041083|FG006|Overall Study|Did not receive treatment.|0|||
44550772|NCT02951533|79567033|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
44550773|NCT02951533|79567034|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
44550774|NCT02700412|79567051|FG000|Overall Study|Adverse Event|6|||
44550775|NCT02700412|79567051|FG000|Overall Study|Death|1|||
44550776|NCT02700412|79567051|FG000|Overall Study|Lack of Efficacy|19|||
44550777|NCT02700412|79567051|FG000|Overall Study|Protocol Violation|5|||
44550778|NCT02700412|79567051|FG000|Overall Study|Withdrawal by Subject|2|||
44550779|NCT03665441|79567057|FG000|Overall Study|survival follow up ongoing|23|||
44550780|NCT03665441|79567058|FG001|Overall Study|survival follow up ongoing|0|||
44550781|NCT03665441|79567057|FG000|Overall Study|Patients ongoing on treatment|9|||
44550782|NCT03665441|79567058|FG001|Overall Study|Patients ongoing on treatment|6|||
44550783|NCT03665441|79567057|FG000|Overall Study|Randomized but not treated|7|||
44550784|NCT03665441|79567058|FG001|Overall Study|Randomized but not treated|11|||
44550785|NCT02699866|79567064|FG000|Overall Study|Withdrawal by Subject|3|||
44550786|NCT02699866|79567064|FG000|Overall Study|Physician Decision|2|||
44550787|NCT02699866|79567064|FG000|Overall Study|Adverse Event|3|||
44550788|NCT03663569|79567068|FG000|Overall Study|Discontinuation of study|11|||
44550789|NCT03663569|79567068|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
44550790|NCT03663569|79567068|FG000|Overall Study|Deceased patient|6|||
44550791|NCT03663569|79567068|FG000|Overall Study|Lost to Follow-up|18|||
44230722|NCT03049449|79041084|FG007|Overall Study|Did not receive treatment.|0|||
44230723|NCT03049449|79041085|FG008|Overall Study|Did not receive treatment.|1|||
44230724|NCT03049449|79041086|FG009|Overall Study|Did not receive treatment.|0|||
44230725|NCT03049449|79041077|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
44230726|NCT03049449|79041078|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
44230727|NCT03049449|79041079|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
44230728|NCT03049449|79041080|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
44230729|NCT03049449|79041081|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
44550792|NCT03663569|79567068|FG000|Overall Study|Withdrawal of consent|5|||
44550793|NCT03663569|79567068|FG000|Overall Study|Patient's request|11|||
44550794|NCT03663569|79567068|FG000|Overall Study|Adverse Event|4|||
44230730|NCT03049449|79041082|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
44230731|NCT03049449|79041083|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
44230732|NCT03049449|79041084|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
44494888|NCT00118716|79500567|FG001|Overall Study|Withdrawal by Subject|1|||
44550795|NCT03663569|79567068|FG000|Overall Study|Not come to second visit|3|||
44550796|NCT03663569|79567068|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
44550797|NCT03663569|79567068|FG000|Overall Study|Serious adverse event|1|||
44550798|NCT03596762|79567077|FG000|Overall Study|Protocol Violation|0|||
44550799|NCT03596762|79567078|FG001|Overall Study|Protocol Violation|0|||
44550800|NCT03596762|79567079|FG002|Overall Study|Protocol Violation|0|||
44550801|NCT03596762|79567080|FG003|Overall Study|Protocol Violation|0|||
44550802|NCT03596762|79567081|FG004|Overall Study|Protocol Violation|1|||
44550803|NCT03596762|79567077|FG000|Overall Study|Adverse Event|2|||
44550804|NCT03596762|79567078|FG001|Overall Study|Adverse Event|0|||
44550805|NCT03596762|79567079|FG002|Overall Study|Adverse Event|1|||
44494889|NCT00118716|79500566|FG000|Overall Study|Exacerbation|2|||
44494890|NCT00118716|79500567|FG001|Overall Study|Exacerbation|2|||
44494891|NCT00118716|79500566|FG000|Overall Study|Discontinued by sponsor|1|||
44494892|NCT00118716|79500567|FG001|Overall Study|Discontinued by sponsor|1|||
44494893|NCT00118716|79500566|FG000|Overall Study|Non-compliance|1|||
44494894|NCT00118716|79500567|FG001|Overall Study|Non-compliance|3|||
44494895|NCT00118716|79500566|FG000|Overall Study|misrandomized|1|||
44494896|NCT00118716|79500567|FG001|Overall Study|misrandomized|1|||
44494897|NCT00118716|79500566|FG000|Overall Study|Expired drug use|1|||
44494898|NCT00118716|79500567|FG001|Overall Study|Expired drug use|2|||
44494899|NCT00118716|79500566|FG000|Overall Study|Investigator discretion|0|||
44494900|NCT00118716|79500567|FG001|Overall Study|Investigator discretion|1|||
44494901|NCT04584346|79500575|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
44494902|NCT04584346|79500576|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
44494903|NCT00118482|79500586|FG000|Overall Study|Lost to Follow-up|7|||
44494904|NCT00118482|79500587|FG001|Overall Study|Lost to Follow-up|7|||
44494905|NCT00118482|79500586|FG000|Overall Study|Withdrawal by Subject|23|||
44494906|NCT00118482|79500587|FG001|Overall Study|Withdrawal by Subject|22|||
44494907|NCT00129272|79500595|FG000|Overall Study|Lost to Follow-up|12|||
44494908|NCT00129272|79500596|FG001|Overall Study|Lost to Follow-up|11|||
44494909|NCT00129272|79500595|FG000|Overall Study|Withdrawal by Subject|5|||
44494910|NCT00129272|79500596|FG001|Overall Study|Withdrawal by Subject|11|||
44550806|NCT03596762|79567080|FG003|Overall Study|Adverse Event|0|||
44550807|NCT03596762|79567081|FG004|Overall Study|Adverse Event|5|||
44550808|NCT03596762|79567077|FG000|Overall Study|Withdrawal by Subject|2|||
44550809|NCT03596762|79567078|FG001|Overall Study|Withdrawal by Subject|1|||
44550810|NCT03596762|79567079|FG002|Overall Study|Withdrawal by Subject|0|||
44550811|NCT03596762|79567080|FG003|Overall Study|Withdrawal by Subject|1|||
44550812|NCT03596762|79567081|FG004|Overall Study|Withdrawal by Subject|1|||
44550813|NCT03663179|79567099|FG000|Overall Study|Withdrawal by Subject|2|||
44550814|NCT03663179|79567100|FG001|Overall Study|Withdrawal by Subject|0|||
44550815|NCT03663179|79567099|FG000|Overall Study|Lost to Follow-up|1|||
44550816|NCT03663179|79567100|FG001|Overall Study|Lost to Follow-up|1|||
44550817|NCT03663179|79567099|FG000|Overall Study|Revealed exclusionary condition|1|||
44550818|NCT03663179|79567100|FG001|Overall Study|Revealed exclusionary condition|0|||
44550819|NCT03662789|79567108|FG000|Overall Study|Lost to Follow-up|1|||
44550820|NCT03662789|79567109|FG001|Overall Study|Lost to Follow-up|2|||
44550821|NCT03662789|79567108|FG000|Overall Study|Could not perform treadmill test|4|||
44550822|NCT03662789|79567109|FG001|Overall Study|Could not perform treadmill test|4|||
44550823|NCT03662789|79567108|FG000|Overall Study|Death|0|||
44550824|NCT03662789|79567109|FG001|Overall Study|Death|1|||
44550825|NCT03658889|79567117|FG000|Overall Study|Protocol Violation|2|||
44550826|NCT03658889|79567118|FG001|Overall Study|Protocol Violation|0|||
44550827|NCT03655691|79567126|FG000|Overall Study|Adverse Event|0|||
44550828|NCT03655691|79567127|FG001|Overall Study|Adverse Event|0|||
44550829|NCT03655691|79567128|FG002|Overall Study|Adverse Event|1|||
44550830|NCT03655691|79567126|FG000|Overall Study|Lost to Follow-up|1|||
44550831|NCT03655691|79567127|FG001|Overall Study|Lost to Follow-up|1|||
44550832|NCT03655691|79567128|FG002|Overall Study|Lost to Follow-up|2|||
44550833|NCT03655691|79567126|FG000|Overall Study|Protocol Violation|0|||
44550834|NCT03655691|79567127|FG001|Overall Study|Protocol Violation|1|||
44550835|NCT03655691|79567128|FG002|Overall Study|Protocol Violation|0|||
44550836|NCT03655691|79567126|FG000|Overall Study|Withdrawal by Subject|1|||
44550837|NCT03655691|79567127|FG001|Overall Study|Withdrawal by Subject|1|||
44550838|NCT03655691|79567128|FG002|Overall Study|Withdrawal by Subject|0|||
44550839|NCT03658811|79567136|FG000|Overall Study|Lost to Follow-up|3|||
44550840|NCT03631355|79567146|FG000|Overall Study|Lost to Follow-up|1|||
44550841|NCT03631355|79567147|FG001|Overall Study|Lost to Follow-up|2|||
44550842|NCT03629249|79567156|FG000|Overall Study|Study terminated by sponsor|197|||
44550843|NCT03629249|79567157|FG001|Overall Study|Study terminated by sponsor|197|||
44550844|NCT03629249|79567158|FG002|Overall Study|Study terminated by sponsor|194|||
44550845|NCT03629249|79567156|FG000|Overall Study|Protocol deviation|0|||
44550846|NCT03629249|79567157|FG001|Overall Study|Protocol deviation|2|||
44230733|NCT03049449|79041085|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
44494911|NCT04899232|79500605|FG000|Screening Period|Physician Decision|1|||
44494912|NCT04899232|79500606|FG001|Screening Period|Physician Decision|0|||
44494913|NCT04899232|79500607|FG002|Screening Period|Physician Decision|0|||
44494914|NCT04899232|79500605|FG000|Screening Period|Withdrawal by Subject|1|||
44494915|NCT04899232|79500606|FG001|Screening Period|Withdrawal by Subject|0|||
44494916|NCT04899232|79500607|FG002|Screening Period|Withdrawal by Subject|0|||
44494917|NCT04899232|79500605|FG000|Screening Period|Participant discharged before receiving intervention|3|||
44494918|NCT04899232|79500606|FG001|Screening Period|Participant discharged before receiving intervention|0|||
44494919|NCT04899232|79500607|FG002|Screening Period|Participant discharged before receiving intervention|0|||
44494920|NCT04559698|79500626|FG000|Overall Study|Lost to Follow-up|14|||
44494921|NCT04559698|79500627|FG001|Overall Study|Lost to Follow-up|15|||
44494922|NCT04559698|79500626|FG000|Overall Study|Withdrawal by Subject|0|||
44494923|NCT04559698|79500627|FG001|Overall Study|Withdrawal by Subject|1|||
44494924|NCT00133952|79500635|FG000|Overall Study|Adverse Event|1|||
44494925|NCT00133952|79500636|FG001|Overall Study|Adverse Event|2|||
44494926|NCT00133952|79500635|FG000|Overall Study|Death|3|||
44494927|NCT00133952|79500636|FG001|Overall Study|Death|2|||
44494928|NCT00133952|79500635|FG000|Overall Study|Lost to Follow-up|9|||
44494929|NCT00133952|79500636|FG001|Overall Study|Lost to Follow-up|14|||
44494930|NCT00133952|79500635|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
44494931|NCT00133952|79500636|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
44494932|NCT00133952|79500635|FG000|Overall Study|Protocol Violation|1|||
44494933|NCT00133952|79500636|FG001|Overall Study|Protocol Violation|1|||
44494934|NCT00133952|79500635|FG000|Overall Study|Withdrawal by Subject|20|||
44494935|NCT00133952|79500636|FG001|Overall Study|Withdrawal by Subject|4|||
44494936|NCT00133952|79500635|FG000|Overall Study|Physician Decision|4|||
44494937|NCT00133952|79500636|FG001|Overall Study|Physician Decision|3|||
44494938|NCT00133952|79500635|FG000|Overall Study|Sponsor Decision|0|||
44494939|NCT00133952|79500636|FG001|Overall Study|Sponsor Decision|1|||
44494940|NCT00118092|79500642|FG000|Overall Study|Withdrawal by Subject|1|||
44494941|NCT00118092|79500642|FG000|Overall Study|Protocol Violation|1|||
44494942|NCT04555096|79500649|FG000|Overall Study|Death|4|||
44494943|NCT04555096|79500650|FG001|Overall Study|Death|4|||
44494944|NCT04555096|79500649|FG000|Overall Study|Withdrawal by Subject|1|||
44494945|NCT04555096|79500650|FG001|Overall Study|Withdrawal by Subject|0|||
44550847|NCT03629249|79567158|FG002|Overall Study|Protocol deviation|5|||
44550848|NCT03629249|79567156|FG000|Overall Study|Subject decision|1|||
44550849|NCT03629249|79567157|FG001|Overall Study|Subject decision|1|||
44494946|NCT04555096|79500649|FG000|Overall Study|Other|0|||
44494947|NCT04555096|79500650|FG001|Overall Study|Other|1|||
44494948|NCT00097500|79500658|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
44494949|NCT00097500|79500659|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
44494950|NCT00097500|79500658|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
44494951|NCT00097500|79500659|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
44550850|NCT03629249|79567158|FG002|Overall Study|Subject decision|3|||
44550851|NCT03629249|79567156|FG000|Overall Study|Adverse Event|1|||
44550852|NCT03629249|79567157|FG001|Overall Study|Adverse Event|1|||
44550853|NCT03629249|79567158|FG002|Overall Study|Adverse Event|0|||
44550854|NCT03629249|79567156|FG000|Overall Study|Death|1|||
44550855|NCT03629249|79567157|FG001|Overall Study|Death|0|||
44550856|NCT03629249|79567158|FG002|Overall Study|Death|0|||
44550857|NCT03629249|79567156|FG000|Overall Study|Physician Decision|1|||
44550858|NCT03629249|79567157|FG001|Overall Study|Physician Decision|0|||
44550859|NCT03629249|79567158|FG002|Overall Study|Physician Decision|0|||
44550860|NCT03628781|79567168|FG000|Overall Study|Lost to Follow-up|16|||
44550861|NCT03628781|79567169|FG001|Overall Study|Lost to Follow-up|8|||
44550862|NCT03628781|79567168|FG000|Overall Study|Withdrawal by Subject|16|||
44550863|NCT03628781|79567169|FG001|Overall Study|Withdrawal by Subject|1|||
44550864|NCT03371251|79567181|FG000|Overall Study|Withdrawal by Subject|1|||
44230734|NCT03049449|79041086|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
44230735|NCT03049449|79041077|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44550865|NCT03371251|79567182|FG001|Overall Study|Withdrawal by Subject|0|||
44550866|NCT03371251|79567183|FG002|Overall Study|Withdrawal by Subject|1|||
44550867|NCT03371251|79567184|FG003|Overall Study|Withdrawal by Subject|0|||
44550868|NCT03371251|79567185|FG004|Overall Study|Withdrawal by Subject|2|||
44550869|NCT03371251|79567186|FG005|Overall Study|Withdrawal by Subject|2|||
44550870|NCT03371251|79567181|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
44550871|NCT03371251|79567182|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
44550872|NCT03371251|79567183|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
44550873|NCT03371251|79567184|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
44550874|NCT03371251|79567185|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
44550875|NCT03371251|79567186|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
44550876|NCT03371251|79567181|FG000|Overall Study|Adverse Event|0|||
44550877|NCT03371251|79567182|FG001|Overall Study|Adverse Event|0|||
44550878|NCT03371251|79567183|FG002|Overall Study|Adverse Event|0|||
44550879|NCT03371251|79567184|FG003|Overall Study|Adverse Event|0|||
44550880|NCT03371251|79567185|FG004|Overall Study|Adverse Event|1|||
44550881|NCT03371251|79567186|FG005|Overall Study|Adverse Event|0|||
44550882|NCT03371251|79567181|FG000|Overall Study|Decision by Sponsor|0|||
44550883|NCT03371251|79567182|FG001|Overall Study|Decision by Sponsor|0|||
44550884|NCT03371251|79567183|FG002|Overall Study|Decision by Sponsor|0|||
44550885|NCT03371251|79567184|FG003|Overall Study|Decision by Sponsor|0|||
44550886|NCT03371251|79567185|FG004|Overall Study|Decision by Sponsor|2|||
44550887|NCT03371251|79567186|FG005|Overall Study|Decision by Sponsor|0|||
44550888|NCT03370471|79567205|FG000|Overall Study|Withdrawal by Subject|6|||
44550889|NCT03370471|79567206|FG001|Overall Study|Withdrawal by Subject|1|||
44550890|NCT03370471|79567205|FG000|Overall Study|Unable to access veins for blood draw|0|||
44550891|NCT03370471|79567206|FG001|Overall Study|Unable to access veins for blood draw|1|||
44550892|NCT03370471|79567205|FG000|Overall Study|Screen fail|1|||
44550893|NCT03370471|79567206|FG001|Overall Study|Screen fail|0|||
44550894|NCT03349645|79567214|FG000|Overall Study|Sponsor Terminated Study|75|||
44550895|NCT03349645|79567214|FG000|Overall Study|Withdrawal by Subject|4|||
44550896|NCT03349645|79567214|FG000|Overall Study|Protocol Violation|1|||
44550897|NCT03349645|79567214|FG000|Overall Study|Other|2|||
44550898|NCT03349333|79567218|FG000|Overall Study|Progression of Disease|36|||
44550899|NCT03349333|79567218|FG000|Overall Study|Adverse Event|11|||
44550900|NCT03349333|79567218|FG000|Overall Study|Other|6|||
44550901|NCT03349333|79567218|FG000|Overall Study|Withdrawal by Subject|5|||
44550902|NCT03349333|79567218|FG000|Overall Study|Conditions interfere with participation|2|||
44550903|NCT03349333|79567218|FG000|Overall Study|Physician Decision|2|||
44550904|NCT03349333|79567218|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
44550905|NCT03349333|79567218|FG000|Overall Study|Patients in treatment less than 24 month|8|||
44550906|NCT03349099|79567224|FG000|Overall Study|Physician Decision|3|||
44550907|NCT03349099|79567225|FG001|Overall Study|Physician Decision|4|||
44550908|NCT03349099|79567224|FG000|Overall Study|Stone migrated from the kidney|1|||
44550909|NCT03349099|79567225|FG001|Overall Study|Stone migrated from the kidney|0|||
44550910|NCT03348163|79567233|FG000|Overall Study|Withdrawal by Subject|2|||
44550911|NCT03348163|79567234|FG001|Overall Study|Withdrawal by Subject|0|||
44550912|NCT03347695|79567242|FG000|Overall Study|Death|0|||
44550913|NCT03347695|79567243|FG001|Overall Study|Death|4|||
44550914|NCT03347695|79567242|FG000|Overall Study|Lost to Follow-up|0|||
44230736|NCT03049449|79041078|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44550915|NCT03347695|79567243|FG001|Overall Study|Lost to Follow-up|1|||
44550916|NCT02892019|79567253|FG000|Overall Study|randomized but not treated|0|||
44550917|NCT02892019|79567254|FG001|Overall Study|randomized but not treated|1|||
44550918|NCT02892019|79567253|FG000|Overall Study|Withdrawal by Subject|0|||
44550919|NCT02892019|79567254|FG001|Overall Study|Withdrawal by Subject|1|||
44550920|NCT02892019|79567253|FG000|Overall Study|Adverse Event|1|||
44550921|NCT02892019|79567254|FG001|Overall Study|Adverse Event|1|||
44550922|NCT03365791|79567260|FG000|Overall Study|Adverse Event|5|||
44550923|NCT03365791|79567260|FG000|Overall Study|Death|1|||
44550924|NCT03365791|79567260|FG000|Overall Study|Lost to Follow-up|1|||
44550925|NCT03365791|79567260|FG000|Overall Study|Physician Decision|9|||
44550926|NCT03365791|79567260|FG000|Overall Study|Progressive disease|51|||
44550927|NCT03365791|79567260|FG000|Overall Study|Subject/guardian decision|5|||
44550928|NCT03365011|79567267|FG000|Overall Study|Withdrawal by Subject|1|||
44550929|NCT03365011|79567268|FG001|Overall Study|Withdrawal by Subject|2|||
44550930|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
44550931|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
44550932|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
44550933|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
44550934|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
44550935|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
44550936|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
44550937|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
44550938|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
44550939|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
44550940|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
44550941|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
44550942|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
44550943|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
44550944|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
44550945|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
44550946|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
44550947|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
44550948|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
44550949|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
44550950|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
44550951|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
44550952|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
44550953|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
44550954|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
44550955|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
44550956|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
44550957|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
44230737|NCT03049449|79041079|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44550958|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
44550959|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
44550960|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
44550961|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
44550962|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
44550963|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
44550964|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
44550965|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
44550966|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
44550967|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
44550968|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
44550969|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
44550970|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
44550971|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
44376549|NCT00923130|79381770|FG000|Overall Study|Switched to alternative treatment|2|||
44376550|NCT00923130|79381770|FG000|Overall Study|Refused further treatment|2|||
44376551|NCT03253627|79381776|FG000|Overall Study|Lost to Follow-up|1|||
44376552|NCT03253627|79381777|FG001|Overall Study|Lost to Follow-up|2|||
44376553|NCT03253627|79381776|FG000|Overall Study|Withdrawal by Subject|0|||
44376554|NCT03253627|79381777|FG001|Overall Study|Withdrawal by Subject|2|||
44376555|NCT03253627|79381776|FG000|Overall Study|Inability to complete MRI|1|||
44376556|NCT03253627|79381777|FG001|Overall Study|Inability to complete MRI|0|||
44550972|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
44550973|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
44230738|NCT03049449|79041080|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44230739|NCT03049449|79041081|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44550974|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
44550975|NCT03627767|79567277|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
44550976|NCT03627767|79567278|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
44550977|NCT03627767|79567279|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
44230740|NCT03049449|79041082|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44230741|NCT03049449|79041083|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44230742|NCT03049449|79041084|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
44230743|NCT03049449|79041085|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
44230744|NCT03049449|79041086|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
44376557|NCT01075178|79381785|FG000|Subject Matching|eligible but not matched|130|||
44550978|NCT03627767|79567280|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
44550979|NCT03627767|79567281|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
44550980|NCT03627767|79567277|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
44550981|NCT03627767|79567278|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
44550982|NCT03627767|79567279|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
44550983|NCT03627767|79567280|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
44550984|NCT03627767|79567281|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
44376558|NCT01075178|79381786|FG001|Subject Matching|eligible but not matched|403|||
44550985|NCT03627767|79567277|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
44550986|NCT03627767|79567278|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
44550987|NCT03627767|79567279|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
44550988|NCT03627767|79567280|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
44550989|NCT03627767|79567281|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
44550990|NCT03627767|79567277|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
44550991|NCT03627767|79567278|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
44550992|NCT03627767|79567279|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
44550993|NCT03627767|79567280|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
44550994|NCT03627767|79567281|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
44550995|NCT03627767|79567277|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
44550996|NCT03627767|79567278|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
44550997|NCT03627767|79567279|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
44550998|NCT03627767|79567280|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
44550999|NCT03627767|79567281|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
44551000|NCT03627767|79567277|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
44551001|NCT03627767|79567278|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
44551002|NCT03627767|79567279|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
44230745|NCT02989857|79041209|FG000|Randomization Phase|Not Treated|3|||
44230746|NCT02989857|79041210|FG001|Randomization Phase|Not Treated|2|||
44230747|NCT02989857|79041211|FG002|Randomization Phase|Not Treated|0|||
44551003|NCT03627767|79567280|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
44551004|NCT03627767|79567281|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
44551005|NCT03627767|79567277|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
44551006|NCT03627767|79567278|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
44551007|NCT03627767|79567279|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
44551008|NCT03627767|79567280|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
44551009|NCT03627767|79567281|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
44551010|NCT03627767|79567277|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
44551011|NCT03627767|79567278|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
44551012|NCT03627767|79567279|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
44551013|NCT03627767|79567280|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
44551014|NCT03627767|79567281|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
44551015|NCT03627767|79567277|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
44551016|NCT03627767|79567278|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
44551017|NCT03627767|79567279|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
44230748|NCT01877915|79041222|FG000|Overall Study|Lost to Follow-up|10|||
44230749|NCT01877915|79041223|FG001|Overall Study|Lost to Follow-up|9|||
44230750|NCT01877915|79041222|FG000|Overall Study|Withdrawal by Subject|42|||
44230751|NCT01877915|79041223|FG001|Overall Study|Withdrawal by Subject|55|||
44230752|NCT01877915|79041222|FG000|Overall Study|Other|2|||
44230753|NCT01877915|79041223|FG001|Overall Study|Other|4|||
44230754|NCT01876979|79041231|FG000|Overall Study|Physician Decision|2|||
44230755|NCT01876979|79041232|FG001|Overall Study|Physician Decision|3|||
44494952|NCT00097500|79500658|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
44494953|NCT00097500|79500659|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
44494954|NCT00097500|79500658|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
44494955|NCT00097500|79500659|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
44494956|NCT00097500|79500658|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
44494957|NCT00097500|79500659|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
44494958|NCT00097500|79500658|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
44494959|NCT00097500|79500659|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
44494960|NCT00097500|79500658|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
44494961|NCT00097500|79500659|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
44494962|NCT04551898|79500669|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
44494963|NCT04551898|79500670|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
44494964|NCT04551898|79500671|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
44551018|NCT03627767|79567280|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
44230756|NCT01860989|79041238|FG000|Overall Study|Unsatisfactory therapeutic|5|||
44230757|NCT01860677|79041254|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
44551019|NCT03627767|79567281|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
44551020|NCT03627767|79567277|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
44551021|NCT03627767|79567278|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
44551022|NCT03627767|79567279|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
44551023|NCT03627767|79567280|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
44551024|NCT03627767|79567281|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
44551025|NCT03627767|79567277|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
44551026|NCT03627767|79567278|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
44551027|NCT03627767|79567279|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
44551028|NCT03627767|79567280|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
44551029|NCT03627767|79567281|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
44551030|NCT03627065|79567292|FG000|Overall Study|Study Terminated by sponsor|1|||
44551031|NCT03627065|79567292|FG000|Overall Study|Withdrawal by Subject|2|||
44551032|NCT02142738|79567298|FG000|Overall Study|Adverse Event|13|||
44551033|NCT02142738|79567299|FG001|Overall Study|Adverse Event|9|||
44551034|NCT02142738|79567298|FG000|Overall Study|Death|92|||
44551035|NCT02142738|79567299|FG001|Overall Study|Death|112|||
44551036|NCT02142738|79567298|FG000|Overall Study|Lost to Follow-up|0|||
44551037|NCT02142738|79567299|FG001|Overall Study|Lost to Follow-up|3|||
44494965|NCT04551898|79500672|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
44494966|NCT04551898|79500669|FG000|Overall Study|Withdrawal by Subject|5|||
44494967|NCT04551898|79500670|FG001|Overall Study|Withdrawal by Subject|1|||
44494968|NCT04551898|79500671|FG002|Overall Study|Withdrawal by Subject|2|||
44494969|NCT04551898|79500672|FG003|Overall Study|Withdrawal by Subject|2|||
44494970|NCT04551898|79500669|FG000|Overall Study|Lost to Follow-up|2|||
44494971|NCT04551898|79500670|FG001|Overall Study|Lost to Follow-up|1|||
44494972|NCT04551898|79500671|FG002|Overall Study|Lost to Follow-up|2|||
44494973|NCT04551898|79500672|FG003|Overall Study|Lost to Follow-up|2|||
44494974|NCT04551898|79500669|FG000|Overall Study|Death|1|||
44494975|NCT04551898|79500670|FG001|Overall Study|Death|0|||
44494976|NCT04551898|79500671|FG002|Overall Study|Death|0|||
44551038|NCT02142738|79567298|FG000|Overall Study|Withdrawal by Subject|6|||
44551039|NCT02142738|79567299|FG001|Overall Study|Withdrawal by Subject|7|||
44551040|NCT02142738|79567298|FG000|Overall Study|Follow up ended by sponsor|43|||
44551041|NCT02142738|79567299|FG001|Overall Study|Follow up ended by sponsor|20|||
44551042|NCT03617861|79567310|FG000|Second Intervention (1 Day)|Adverse Event|0|||
44551043|NCT03617861|79567311|FG001|Second Intervention (1 Day)|Adverse Event|0|||
44551044|NCT03617861|79567312|FG002|Second Intervention (1 Day)|Adverse Event|1|||
44551045|NCT03617861|79567313|FG003|Second Intervention (1 Day)|Adverse Event|0|||
44551046|NCT03614975|79567325|FG000|Overall Study|Physician Decision|7|||
44551047|NCT03614975|79567326|FG001|Overall Study|Physician Decision|5|||
44551048|NCT03614975|79567325|FG000|Overall Study|Withdrawal by Subject|2|||
44551049|NCT03614975|79567326|FG001|Overall Study|Withdrawal by Subject|2|||
44551050|NCT03614975|79567325|FG000|Overall Study|Specimens not in lab batch shipment|1|||
44551051|NCT03614975|79567326|FG001|Overall Study|Specimens not in lab batch shipment|1|||
44551052|NCT03613649|79567344|FG000|Second Treatment|Lost to Follow-up|0|||
44551053|NCT03613649|79567345|FG001|Second Treatment|Lost to Follow-up|0|||
44551054|NCT03613649|79567346|FG002|Second Treatment|Lost to Follow-up|1|||
44551055|NCT03613649|79567347|FG003|Second Treatment|Lost to Follow-up|0|||
44551056|NCT03613649|79567348|FG004|Second Treatment|Lost to Follow-up|0|||
44494977|NCT04551898|79500672|FG003|Overall Study|Death|0|||
44230758|NCT01860677|79041255|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
44376559|NCT01075178|79381785|FG000|Subject Chart Review|died before chart review period|0|||
44376560|NCT01075178|79381786|FG001|Subject Chart Review|died before chart review period|2|||
44376561|NCT01075178|79381785|FG000|Subject Chart Review|no data collected due to site closure|3|||
44376562|NCT01075178|79381786|FG001|Subject Chart Review|no data collected due to site closure|4|||
44376563|NCT01075178|79381785|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
44376564|NCT01075178|79381786|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
44376565|NCT00799825|79381792|FG000|Overall Study|Adverse Event|1|||
44376566|NCT00799825|79381792|FG000|Overall Study|Withdrawal by Subject|6|||
44376567|NCT00799825|79381792|FG000|Overall Study|Lost to Follow-up|38|||
44376568|NCT00799825|79381792|FG000|Overall Study|Pregnancy|3|||
44376569|NCT00799591|79381796|FG000|Overall Study|De-escalation of doses|20|||
44230759|NCT01876901|79041273|FG000|Overall Study|Protocol Violation|10|||
44230760|NCT01876901|79041274|FG001|Overall Study|Protocol Violation|2|||
44230761|NCT01876901|79041273|FG000|Overall Study|No or other surgical intervention|7|||
44230762|NCT01876901|79041274|FG001|Overall Study|No or other surgical intervention|5|||
44230763|NCT01876823|79041281|FG000|Overall Study|Withdrawal by Subject|5|||
44230764|NCT01876823|79041281|FG000|Overall Study|Physician Decision|2|||
44376570|NCT00799591|79381796|FG000|Overall Study|Death|14|||
44376571|NCT00799591|79381796|FG000|Overall Study|Technical failure|12|||
44376572|NCT00799591|79381796|FG000|Overall Study|Resistant germ|11|||
44376573|NCT00799591|79381796|FG000|Overall Study|New infection|4|||
44494978|NCT04551898|79500669|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
44494979|NCT04551898|79500670|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
44230765|NCT01876823|79041281|FG000|Overall Study|Patients moved|2|||
44230766|NCT01876511|79041288|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
44230767|NCT01876511|79041289|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
44230768|NCT01876511|79041290|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
44230769|NCT01876511|79041288|FG000|Overall Study|Death (unrelated)|3|||
44376574|NCT00799591|79381796|FG000|Overall Study|Resistance germ and technical failure|2|||
44376575|NCT00799591|79381796|FG000|Overall Study|Persistance of fever undetermined origin|1|||
44274767|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
44230770|NCT01876511|79041289|FG001|Overall Study|Death (unrelated)|0|||
44376576|NCT00799591|79381796|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
44376577|NCT00799591|79381796|FG000|Overall Study|Infectious origin not probable|1|||
44376578|NCT01075100|79381802|FG000|Overall Study|Adverse Event|15|||
44551057|NCT03613649|79567349|FG005|Second Treatment|Lost to Follow-up|0|||
44551058|NCT03613649|79567350|FG006|Second Treatment|Lost to Follow-up|0|||
44551059|NCT03613649|79567351|FG007|Second Treatment|Lost to Follow-up|0|||
44551060|NCT03613649|79567352|FG008|Second Treatment|Lost to Follow-up|0|||
44551061|NCT03613649|79567353|FG009|Second Treatment|Lost to Follow-up|0|||
44551062|NCT03613649|79567354|FG010|Second Treatment|Lost to Follow-up|0|||
44551063|NCT03613649|79567355|FG011|Second Treatment|Lost to Follow-up|0|||
44551064|NCT03613649|79567344|FG000|Second Treatment|Withdrawal by Subject|0|||
44551065|NCT03613649|79567345|FG001|Second Treatment|Withdrawal by Subject|0|||
44551066|NCT03613649|79567346|FG002|Second Treatment|Withdrawal by Subject|0|||
44551067|NCT03613649|79567347|FG003|Second Treatment|Withdrawal by Subject|0|||
44551068|NCT03613649|79567348|FG004|Second Treatment|Withdrawal by Subject|1|||
44551069|NCT03613649|79567349|FG005|Second Treatment|Withdrawal by Subject|0|||
44551070|NCT03613649|79567350|FG006|Second Treatment|Withdrawal by Subject|0|||
44230771|NCT01876511|79041290|FG002|Overall Study|Death (unrelated)|2|||
44230772|NCT01876511|79041288|FG000|Overall Study|Drug-related Toxicity|5|||
44230773|NCT01876511|79041289|FG001|Overall Study|Drug-related Toxicity|1|||
44230774|NCT01876511|79041290|FG002|Overall Study|Drug-related Toxicity|6|||
44230775|NCT01876511|79041288|FG000|Overall Study|Patient Decision|3|||
44230776|NCT01876511|79041289|FG001|Overall Study|Patient Decision|0|||
44230777|NCT01876511|79041290|FG002|Overall Study|Patient Decision|6|||
44230778|NCT01876511|79041288|FG000|Overall Study|Physician Decision|1|||
44230779|NCT01876511|79041289|FG001|Overall Study|Physician Decision|0|||
44230780|NCT01876511|79041290|FG002|Overall Study|Physician Decision|1|||
44494980|NCT04551898|79500671|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
44494981|NCT04551898|79500672|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
44494982|NCT04849780|79500690|FG000|Period 1|Covid-19 Related|1|||
44494983|NCT04849780|79500691|FG001|Period 1|Covid-19 Related|0|||
44494984|NCT04849780|79500690|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
44494985|NCT04849780|79500691|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
44494986|NCT04849780|79500690|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
44494987|NCT04849780|79500691|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
44494988|NCT04823494|79500705|FG000|Overall Study|Programming software malfunction.|1|||
44494989|NCT04823494|79500706|FG001|Overall Study|Programming software malfunction.|0|||
44494990|NCT04823494|79500705|FG000|Overall Study|Withdrawal by Subject|1|||
44494991|NCT04823494|79500706|FG001|Overall Study|Withdrawal by Subject|0|||
44494992|NCT04823494|79500705|FG000|Overall Study|Devices lost|0|||
44494993|NCT04823494|79500706|FG001|Overall Study|Devices lost|1|||
44494994|NCT04542694|79500716|FG000|Overall Study|The need for prohibited therapy|2|||
44494995|NCT04542694|79500717|FG001|Overall Study|The need for prohibited therapy|0|||
44494996|NCT04542694|79500716|FG000|Overall Study|Adverse Event|1|||
44494997|NCT04542694|79500717|FG001|Overall Study|Adverse Event|0|||
44494998|NCT04542694|79500716|FG000|Overall Study|Protocol Violation|1|||
44494999|NCT04542694|79500717|FG001|Overall Study|Protocol Violation|0|||
44495000|NCT00117312|79500727|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
44495001|NCT00117312|79500728|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
44495002|NCT00117312|79500729|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
44495003|NCT00117312|79500730|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
44495004|NCT00117312|79500727|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
44495005|NCT00117312|79500728|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
44495006|NCT00117312|79500729|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
44495007|NCT00117312|79500730|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
44495008|NCT00117312|79500727|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
44495009|NCT00117312|79500728|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
44495010|NCT00117312|79500729|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
44495011|NCT00117312|79500730|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
44495012|NCT00117312|79500727|FG000|Overall Study|Other|0|||
44495013|NCT00117312|79500728|FG001|Overall Study|Other|1|||
44495014|NCT00117312|79500729|FG002|Overall Study|Other|3|||
44495015|NCT00117312|79500730|FG003|Overall Study|Other|1|||
44495016|NCT00117312|79500727|FG000|Overall Study|Patient choice|0|||
44495017|NCT00117312|79500728|FG001|Overall Study|Patient choice|0|||
44495018|NCT00117312|79500729|FG002|Overall Study|Patient choice|2|||
44495019|NCT00117312|79500730|FG003|Overall Study|Patient choice|1|||
44495020|NCT00117312|79500727|FG000|Overall Study|Adverse Event|0|||
44376579|NCT01075100|79381803|FG001|Overall Study|Adverse Event|18|||
44495021|NCT00117312|79500728|FG001|Overall Study|Adverse Event|2|||
44551071|NCT03613649|79567351|FG007|Second Treatment|Withdrawal by Subject|0|||
44551072|NCT03613649|79567352|FG008|Second Treatment|Withdrawal by Subject|0|||
44230781|NCT01993719|79041305|FG000|First Drug Administration|Not treated|1|||
44230782|NCT01993719|79041306|FG001|First Drug Administration|Not treated|0|||
44230783|NCT01993719|79041307|FG002|First Drug Administration|Not treated|0|||
44551073|NCT03613649|79567353|FG009|Second Treatment|Withdrawal by Subject|0|||
44230784|NCT01993719|79041308|FG003|First Drug Administration|Not treated|0|||
44230785|NCT01993719|79041309|FG004|First Drug Administration|Not treated|0|||
44230786|NCT00638235|79041351|FG000|Overall Study|Lost to Follow-up|31|||
44230787|NCT00638235|79041352|FG001|Overall Study|Lost to Follow-up|3|||
44230788|NCT00638235|79041353|FG002|Overall Study|Lost to Follow-up|18|||
44230789|NCT00638235|79041354|FG003|Overall Study|Lost to Follow-up|10|||
44551074|NCT03613649|79567354|FG010|Second Treatment|Withdrawal by Subject|0|||
44551075|NCT03613649|79567355|FG011|Second Treatment|Withdrawal by Subject|0|||
44551076|NCT03613649|79567344|FG000|Third Treatment|Lost to Follow-up|0|||
44551077|NCT03613649|79567345|FG001|Third Treatment|Lost to Follow-up|0|||
44551078|NCT03613649|79567346|FG002|Third Treatment|Lost to Follow-up|0|||
44551079|NCT03613649|79567347|FG003|Third Treatment|Lost to Follow-up|0|||
44551080|NCT03613649|79567348|FG004|Third Treatment|Lost to Follow-up|1|||
44551081|NCT03613649|79567349|FG005|Third Treatment|Lost to Follow-up|0|||
44551082|NCT03613649|79567350|FG006|Third Treatment|Lost to Follow-up|0|||
44551083|NCT03613649|79567351|FG007|Third Treatment|Lost to Follow-up|0|||
44551084|NCT03613649|79567352|FG008|Third Treatment|Lost to Follow-up|0|||
44551085|NCT03613649|79567353|FG009|Third Treatment|Lost to Follow-up|0|||
44551086|NCT03613649|79567354|FG010|Third Treatment|Lost to Follow-up|0|||
44551087|NCT03613649|79567355|FG011|Third Treatment|Lost to Follow-up|1|||
44551088|NCT03613649|79567344|FG000|Third Treatment|Protocol Violation|0|||
44551089|NCT03613649|79567345|FG001|Third Treatment|Protocol Violation|0|||
44551090|NCT03613649|79567346|FG002|Third Treatment|Protocol Violation|0|||
44551091|NCT03613649|79567347|FG003|Third Treatment|Protocol Violation|0|||
44551092|NCT03613649|79567348|FG004|Third Treatment|Protocol Violation|0|||
44551093|NCT03613649|79567349|FG005|Third Treatment|Protocol Violation|0|||
44551094|NCT03613649|79567350|FG006|Third Treatment|Protocol Violation|1|||
44551095|NCT03613649|79567351|FG007|Third Treatment|Protocol Violation|0|||
44551096|NCT03613649|79567352|FG008|Third Treatment|Protocol Violation|0|||
44551097|NCT03613649|79567353|FG009|Third Treatment|Protocol Violation|0|||
44551098|NCT03613649|79567354|FG010|Third Treatment|Protocol Violation|0|||
44551099|NCT03613649|79567355|FG011|Third Treatment|Protocol Violation|1|||
44551100|NCT03613649|79567344|FG000|Fourth Treatment|Protocol Violation|1|||
44551101|NCT03613649|79567345|FG001|Fourth Treatment|Protocol Violation|0|||
44230790|NCT00638235|79041355|FG004|Overall Study|Lost to Follow-up|13|||
44230791|NCT00638235|79041356|FG005|Overall Study|Lost to Follow-up|26|||
44551102|NCT03613649|79567346|FG002|Fourth Treatment|Protocol Violation|0|||
44551103|NCT03613649|79567347|FG003|Fourth Treatment|Protocol Violation|0|||
44551104|NCT03613649|79567348|FG004|Fourth Treatment|Protocol Violation|1|||
44551105|NCT03613649|79567349|FG005|Fourth Treatment|Protocol Violation|0|||
44551106|NCT03613649|79567350|FG006|Fourth Treatment|Protocol Violation|0|||
44551107|NCT03613649|79567351|FG007|Fourth Treatment|Protocol Violation|0|||
44551108|NCT03613649|79567352|FG008|Fourth Treatment|Protocol Violation|0|||
44551109|NCT03613649|79567353|FG009|Fourth Treatment|Protocol Violation|0|||
44551110|NCT03613649|79567354|FG010|Fourth Treatment|Protocol Violation|0|||
44551111|NCT03613649|79567355|FG011|Fourth Treatment|Protocol Violation|0|||
44551112|NCT03613649|79567344|FG000|Fourth Treatment|Physician Decision|0|||
44551113|NCT03613649|79567345|FG001|Fourth Treatment|Physician Decision|0|||
44230792|NCT00638235|79041357|FG006|Overall Study|Lost to Follow-up|0|||
44230793|NCT00638235|79041358|FG007|Overall Study|Lost to Follow-up|1|||
44551114|NCT03613649|79567346|FG002|Fourth Treatment|Physician Decision|0|||
44551115|NCT03613649|79567347|FG003|Fourth Treatment|Physician Decision|0|||
44551116|NCT03613649|79567348|FG004|Fourth Treatment|Physician Decision|0|||
44551117|NCT03613649|79567349|FG005|Fourth Treatment|Physician Decision|0|||
44551118|NCT03613649|79567350|FG006|Fourth Treatment|Physician Decision|1|||
44230794|NCT00638235|79041359|FG008|Overall Study|Lost to Follow-up|18|||
44230795|NCT00638157|79041388|FG000|Overall Study|Adverse Event|0|||
44230796|NCT00638157|79041389|FG001|Overall Study|Adverse Event|1|||
44230797|NCT00638157|79041388|FG000|Overall Study|Clinical (symptomatic) failure|1|||
44230798|NCT00638157|79041389|FG001|Overall Study|Clinical (symptomatic) failure|1|||
44230799|NCT00638157|79041388|FG000|Overall Study|Microbiological failure|1|||
44230800|NCT00638157|79041389|FG001|Overall Study|Microbiological failure|0|||
44495022|NCT00117312|79500729|FG002|Overall Study|Adverse Event|0|||
44495023|NCT00117312|79500730|FG003|Overall Study|Adverse Event|0|||
44495024|NCT00117312|79500727|FG000|Overall Study|Protocol Violation|0|||
44495025|NCT00117312|79500728|FG001|Overall Study|Protocol Violation|1|||
44495026|NCT00117312|79500729|FG002|Overall Study|Protocol Violation|3|||
44495027|NCT00117312|79500730|FG003|Overall Study|Protocol Violation|0|||
44495028|NCT00117312|79500727|FG000|Overall Study|PSA decrease <=50%|0|||
44495029|NCT00117312|79500728|FG001|Overall Study|PSA decrease <=50%|2|||
44495030|NCT00117312|79500729|FG002|Overall Study|PSA decrease <=50%|2|||
44495031|NCT00117312|79500730|FG003|Overall Study|PSA decrease <=50%|4|||
44551119|NCT03613649|79567351|FG007|Fourth Treatment|Physician Decision|0|||
44551120|NCT03613649|79567352|FG008|Fourth Treatment|Physician Decision|0|||
44230801|NCT00638157|79041388|FG000|Overall Study|Lost to Follow-up|1|||
44230802|NCT00638157|79041389|FG001|Overall Study|Lost to Follow-up|0|||
44230803|NCT00638157|79041388|FG000|Overall Study|Physician Decision|1|||
44230804|NCT00638157|79041389|FG001|Overall Study|Physician Decision|0|||
44230805|NCT00638157|79041388|FG000|Overall Study|Other|1|||
44230806|NCT00638157|79041389|FG001|Overall Study|Other|2|||
44230807|NCT00638157|79041388|FG000|Overall Study|Randomized, not treated|2|||
44230808|NCT00638157|79041389|FG001|Overall Study|Randomized, not treated|0|||
44230809|NCT00637377|79041400|FG000|Overall Study|Adverse Event|2|||
44230810|NCT00637377|79041401|FG001|Overall Study|Adverse Event|6|||
44230811|NCT00637377|79041402|FG002|Overall Study|Adverse Event|8|||
44551121|NCT03613649|79567353|FG009|Fourth Treatment|Physician Decision|0|||
44551122|NCT03613649|79567354|FG010|Fourth Treatment|Physician Decision|0|||
44551123|NCT03613649|79567355|FG011|Fourth Treatment|Physician Decision|0|||
44230812|NCT00637377|79041403|FG003|Overall Study|Adverse Event|9|||
44230813|NCT00637377|79041400|FG000|Overall Study|Death|1|||
44230814|NCT00637377|79041401|FG001|Overall Study|Death|3|||
44230815|NCT00637377|79041402|FG002|Overall Study|Death|2|||
44230816|NCT00637377|79041403|FG003|Overall Study|Death|1|||
44230817|NCT00637377|79041400|FG000|Overall Study|Lack of Efficacy|0|||
44230818|NCT00637377|79041401|FG001|Overall Study|Lack of Efficacy|0|||
44230819|NCT00637377|79041402|FG002|Overall Study|Lack of Efficacy|1|||
44230820|NCT00637377|79041403|FG003|Overall Study|Lack of Efficacy|1|||
44230821|NCT00637377|79041400|FG000|Overall Study|Lost to Follow-up|4|||
44230822|NCT00637377|79041401|FG001|Overall Study|Lost to Follow-up|1|||
44495032|NCT00117312|79500727|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
44495033|NCT00117312|79500728|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
44495034|NCT00117312|79500729|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
44551124|NCT03096288|79567377|FG000|Overall Study|Withdrawal by Subject|0|||
44551125|NCT03096288|79567378|FG001|Overall Study|Withdrawal by Subject|1|||
44551126|NCT03096288|79567379|FG002|Overall Study|Withdrawal by Subject|0|||
44551127|NCT03096288|79567380|FG003|Overall Study|Withdrawal by Subject|1|||
44551128|NCT03611075|79567399|FG000|Overall Study|Physician Decision|0|||
44551129|NCT03611075|79567400|FG001|Overall Study|Physician Decision|1|||
44551130|NCT03611075|79567401|FG002|Overall Study|Physician Decision|1|||
44551131|NCT03611075|79567402|FG003|Overall Study|Physician Decision|0|||
44495035|NCT00117312|79500730|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
44495036|NCT00117312|79500727|FG000|Overall Study|Hepatic abnormality|0|||
44495037|NCT00117312|79500728|FG001|Overall Study|Hepatic abnormality|1|||
44551132|NCT03611075|79567403|FG004|Overall Study|Physician Decision|0|||
44551133|NCT03611075|79567404|FG005|Overall Study|Physician Decision|0|||
44551134|NCT03611075|79567405|FG006|Overall Study|Physician Decision|0|||
44551135|NCT03611075|79567406|FG007|Overall Study|Physician Decision|0|||
44551136|NCT03611075|79567407|FG008|Overall Study|Physician Decision|0|||
44551137|NCT03611075|79567399|FG000|Overall Study|Lost to Follow-up|1|||
44551138|NCT03611075|79567400|FG001|Overall Study|Lost to Follow-up|0|||
44551139|NCT03611075|79567401|FG002|Overall Study|Lost to Follow-up|0|||
44551140|NCT03611075|79567402|FG003|Overall Study|Lost to Follow-up|2|||
44551141|NCT03611075|79567403|FG004|Overall Study|Lost to Follow-up|0|||
44551142|NCT03611075|79567404|FG005|Overall Study|Lost to Follow-up|0|||
44551143|NCT03611075|79567405|FG006|Overall Study|Lost to Follow-up|0|||
44551144|NCT03611075|79567406|FG007|Overall Study|Lost to Follow-up|0|||
44495038|NCT00117312|79500729|FG002|Overall Study|Hepatic abnormality|0|||
44495039|NCT00117312|79500730|FG003|Overall Study|Hepatic abnormality|1|||
44495040|NCT00117312|79500727|FG000|Overall Study|Withdrawal by Subject|0|||
44495041|NCT00117312|79500728|FG001|Overall Study|Withdrawal by Subject|2|||
44495042|NCT00117312|79500729|FG002|Overall Study|Withdrawal by Subject|0|||
44551145|NCT03611075|79567407|FG008|Overall Study|Lost to Follow-up|0|||
44551146|NCT03611075|79567399|FG000|Overall Study|Withdrawal by Subject|0|||
44551147|NCT03611075|79567400|FG001|Overall Study|Withdrawal by Subject|1|||
44551148|NCT03611075|79567401|FG002|Overall Study|Withdrawal by Subject|1|||
44551149|NCT03611075|79567402|FG003|Overall Study|Withdrawal by Subject|1|||
44551150|NCT03611075|79567403|FG004|Overall Study|Withdrawal by Subject|0|||
44551151|NCT03611075|79567404|FG005|Overall Study|Withdrawal by Subject|0|||
44551152|NCT03611075|79567405|FG006|Overall Study|Withdrawal by Subject|1|||
44551153|NCT03611075|79567406|FG007|Overall Study|Withdrawal by Subject|0|||
44551154|NCT03611075|79567407|FG008|Overall Study|Withdrawal by Subject|0|||
44551155|NCT03611075|79567399|FG000|Overall Study|Reason unknown|0|||
44551156|NCT03611075|79567400|FG001|Overall Study|Reason unknown|0|||
44551157|NCT03611075|79567401|FG002|Overall Study|Reason unknown|0|||
44230823|NCT00637377|79041402|FG002|Overall Study|Lost to Follow-up|2|||
44230824|NCT00637377|79041403|FG003|Overall Study|Lost to Follow-up|2|||
44230825|NCT00637377|79041400|FG000|Overall Study|Protocol Violation|2|||
44230826|NCT00637377|79041401|FG001|Overall Study|Protocol Violation|1|||
44230827|NCT00637377|79041402|FG002|Overall Study|Protocol Violation|1|||
44495043|NCT00117312|79500730|FG003|Overall Study|Withdrawal by Subject|0|||
44551158|NCT03611075|79567402|FG003|Overall Study|Reason unknown|1|||
44230828|NCT00637377|79041403|FG003|Overall Study|Protocol Violation|0|||
44230829|NCT00637377|79041400|FG000|Overall Study|Withdrawal by Subject|11|||
44551159|NCT03611075|79567403|FG004|Overall Study|Reason unknown|0|||
44230830|NCT00637377|79041401|FG001|Overall Study|Withdrawal by Subject|15|||
44551160|NCT03611075|79567404|FG005|Overall Study|Reason unknown|0|||
44551161|NCT03611075|79567405|FG006|Overall Study|Reason unknown|1|||
44551162|NCT03611075|79567406|FG007|Overall Study|Reason unknown|0|||
44551163|NCT03611075|79567407|FG008|Overall Study|Reason unknown|0|||
44551164|NCT03095508|79567452|FG000|Overall Study|Adverse Event|0|||
44551165|NCT03095508|79567453|FG001|Overall Study|Adverse Event|1|||
44230831|NCT00637377|79041402|FG002|Overall Study|Withdrawal by Subject|13|||
44230832|NCT00637377|79041403|FG003|Overall Study|Withdrawal by Subject|11|||
44551166|NCT03607487|79567463|FG000|Overall Study|Withdrawal by Subject|2|||
44551167|NCT03607487|79567464|FG001|Overall Study|Withdrawal by Subject|0|||
44551168|NCT03607487|79567465|FG002|Overall Study|Withdrawal by Subject|0|||
44551169|NCT03607487|79567466|FG003|Overall Study|Withdrawal by Subject|1|||
44551170|NCT03605693|79567480|FG000|Overall Study|Lost to Follow-up|4|||
44551171|NCT03605693|79567481|FG001|Overall Study|Lost to Follow-up|0|||
44551172|NCT03605693|79567480|FG000|Overall Study|Physician Decision|1|||
44551173|NCT03605693|79567481|FG001|Overall Study|Physician Decision|0|||
44551174|NCT03605303|79567487|FG000|Period 1|Study Terminated|2|||
44551175|NCT03605303|79567488|FG001|Period 1|Study Terminated|1|||
44551176|NCT03604523|79567496|FG000|Overall Study|Physician Decision|1|||
44551177|NCT03604523|79567497|FG001|Overall Study|Physician Decision|0|||
44551178|NCT03602339|79567503|FG000|Overall Study|Withdrawal by Subject|9|||
44551179|NCT03602339|79567503|FG000|Overall Study|Physician Decision|2|||
44551180|NCT03602339|79567503|FG000|Overall Study|Other reason|4|||
44551181|NCT03653429|79567512|FG000|Overall Study|Physician Decision|4|||
44551182|NCT03653429|79567513|FG001|Overall Study|Physician Decision|10|||
44551183|NCT03601715|79567522|FG000|Second Intervention|Lost to Follow-up|1|||
44551184|NCT03601715|79567523|FG001|Second Intervention|Lost to Follow-up|1|||
44230833|NCT00637377|79041400|FG000|Overall Study|Other (no further information available)|7|||
44230834|NCT00637377|79041401|FG001|Overall Study|Other (no further information available)|6|||
44230835|NCT00637377|79041402|FG002|Overall Study|Other (no further information available)|10|||
44230836|NCT00637377|79041403|FG003|Overall Study|Other (no further information available)|5|||
44230837|NCT00636987|79041413|FG000|Overall Study|Death|44|||
44551185|NCT03601715|79567524|FG002|Second Intervention|Lost to Follow-up|0|||
44551186|NCT03594227|79567540|FG000|Overall Study|Adverse Event|2|||
44551187|NCT03594227|79567541|FG001|Overall Study|Adverse Event|1|||
44551188|NCT03594227|79567542|FG002|Overall Study|Adverse Event|0|||
44551189|NCT03594227|79567543|FG003|Overall Study|Adverse Event|2|||
44551190|NCT03594227|79567540|FG000|Overall Study|Lost to Follow-up|1|||
44551191|NCT03594227|79567541|FG001|Overall Study|Lost to Follow-up|1|||
44230838|NCT00636987|79041413|FG000|Overall Study|Explanted|13|||
44230839|NCT00636987|79041413|FG000|Overall Study|Lost to Follow-up|63|||
44551192|NCT03594227|79567542|FG002|Overall Study|Lost to Follow-up|1|||
44551193|NCT03594227|79567543|FG003|Overall Study|Lost to Follow-up|0|||
44551194|NCT03594227|79567540|FG000|Overall Study|Withdrawal by Subject|1|||
44551195|NCT03594227|79567541|FG001|Overall Study|Withdrawal by Subject|1|||
44230840|NCT00636987|79041413|FG000|Overall Study|5 year visit window not complete|69|||
44230841|NCT00636441|79041568|FG000|Overall Study|Adverse Event|0|||
44230842|NCT00636441|79041569|FG001|Overall Study|Adverse Event|1|||
44230843|NCT00636441|79041570|FG002|Overall Study|Adverse Event|1|||
44230844|NCT00636441|79041571|FG003|Overall Study|Adverse Event|0|||
44230845|NCT00636441|79041572|FG004|Overall Study|Adverse Event|0|||
44230846|NCT00636441|79041573|FG005|Overall Study|Adverse Event|1|||
44230847|NCT00636441|79041574|FG006|Overall Study|Adverse Event|0|||
44495044|NCT00129116|79500745|FG000|Primary Phase|Lost to Follow-up|1|||
44495045|NCT00129116|79500746|FG001|Primary Phase|Lost to Follow-up|1|||
44495046|NCT00129116|79500747|FG002|Primary Phase|Lost to Follow-up|0|||
44495047|NCT00129116|79500748|FG003|Primary Phase|Lost to Follow-up|1|||
44495048|NCT00129116|79500749|FG004|Primary Phase|Lost to Follow-up|1|||
44495049|NCT00129116|79500745|FG000|Primary Phase|Protocol Violation|0|||
44495050|NCT00129116|79500746|FG001|Primary Phase|Protocol Violation|1|||
44495051|NCT00129116|79500747|FG002|Primary Phase|Protocol Violation|0|||
44551196|NCT03594227|79567542|FG002|Overall Study|Withdrawal by Subject|1|||
44551197|NCT03594227|79567543|FG003|Overall Study|Withdrawal by Subject|1|||
44551198|NCT03594227|79567540|FG000|Overall Study|Pregnancy|0|||
44551199|NCT03594227|79567541|FG001|Overall Study|Pregnancy|1|||
44551200|NCT03594227|79567542|FG002|Overall Study|Pregnancy|0|||
44551201|NCT03594227|79567543|FG003|Overall Study|Pregnancy|0|||
44551202|NCT03594227|79567540|FG000|Overall Study|Sponsor Decision|0|||
44551203|NCT03594227|79567541|FG001|Overall Study|Sponsor Decision|0|||
44551204|NCT03594227|79567542|FG002|Overall Study|Sponsor Decision|0|||
44551205|NCT03594227|79567543|FG003|Overall Study|Sponsor Decision|1|||
44495052|NCT00129116|79500748|FG003|Primary Phase|Protocol Violation|0|||
44551206|NCT03594227|79567540|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
44551207|NCT03594227|79567541|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
44230848|NCT00636441|79041568|FG000|Overall Study|Late, ineligible|0|||
44230849|NCT00636441|79041569|FG001|Overall Study|Late, ineligible|0|||
44230850|NCT00636441|79041570|FG002|Overall Study|Late, ineligible|0|||
44551208|NCT03594227|79567542|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
44551209|NCT03594227|79567543|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
44551210|NCT03098550|79567567|FG000|Overall Study|Disease Progression|30|||
44551211|NCT03098550|79567568|FG001|Overall Study|Disease Progression|19|||
44551212|NCT03098550|79567569|FG002|Overall Study|Disease Progression|41|||
44551213|NCT03098550|79567567|FG000|Overall Study|Study Drug Toxicity|2|||
44551214|NCT03098550|79567568|FG001|Overall Study|Study Drug Toxicity|1|||
44551215|NCT03098550|79567569|FG002|Overall Study|Study Drug Toxicity|0|||
44230851|NCT00636441|79041571|FG003|Overall Study|Late, ineligible|0|||
44230852|NCT00636441|79041572|FG004|Overall Study|Late, ineligible|0|||
44230853|NCT00636441|79041573|FG005|Overall Study|Late, ineligible|0|||
44230854|NCT00636441|79041574|FG006|Overall Study|Late, ineligible|1|||
44551216|NCT03098550|79567567|FG000|Overall Study|Death|1|||
44551217|NCT03098550|79567568|FG001|Overall Study|Death|0|||
44551218|NCT03098550|79567569|FG002|Overall Study|Death|0|||
44551219|NCT03098550|79567567|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
44551220|NCT03098550|79567568|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
44551221|NCT03098550|79567569|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
44551222|NCT03098550|79567567|FG000|Overall Study|Administrative reason by sponsor|0|||
44551223|NCT03098550|79567568|FG001|Overall Study|Administrative reason by sponsor|0|||
44551224|NCT03098550|79567569|FG002|Overall Study|Administrative reason by sponsor|1|||
44230855|NCT00636441|79041568|FG000|Overall Study|Screen Failure|0|||
44230856|NCT00636441|79041569|FG001|Overall Study|Screen Failure|0|||
44230857|NCT00636441|79041570|FG002|Overall Study|Screen Failure|0|||
44230858|NCT00636441|79041571|FG003|Overall Study|Screen Failure|0|||
44230859|NCT00636441|79041572|FG004|Overall Study|Screen Failure|0|||
44230860|NCT00636441|79041573|FG005|Overall Study|Screen Failure|0|||
44230861|NCT00636441|79041574|FG006|Overall Study|Screen Failure|17|||
44230862|NCT00636363|79041597|FG000|Overall Study|Conjunctivitis|0|||
44230863|NCT00636363|79041598|FG001|Overall Study|Conjunctivitis|0|||
44230864|NCT00636363|79041599|FG002|Overall Study|Conjunctivitis|1|||
44230865|NCT00636363|79041597|FG000|Overall Study|Adverse Event|0|||
44274768|NCT03732638|79221000|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
44274769|NCT03732638|79221001|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
44274770|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
44495053|NCT00129116|79500749|FG004|Primary Phase|Protocol Violation|0|||
44495054|NCT00129116|79500745|FG000|Primary Phase|Adverse Event|1|||
44495055|NCT00129116|79500746|FG001|Primary Phase|Adverse Event|1|||
44495056|NCT00129116|79500747|FG002|Primary Phase|Adverse Event|0|||
44495057|NCT00129116|79500748|FG003|Primary Phase|Adverse Event|0|||
44495058|NCT00129116|79500749|FG004|Primary Phase|Adverse Event|0|||
44495059|NCT00129116|79500745|FG000|Primary Phase|Withdrawal by Subject|0|||
44495060|NCT00129116|79500746|FG001|Primary Phase|Withdrawal by Subject|1|||
44495061|NCT00129116|79500747|FG002|Primary Phase|Withdrawal by Subject|0|||
44495062|NCT00129116|79500748|FG003|Primary Phase|Withdrawal by Subject|0|||
44495063|NCT00129116|79500749|FG004|Primary Phase|Withdrawal by Subject|0|||
44495064|NCT00129116|79500745|FG000|Primary Phase|Other|0|||
44495065|NCT00129116|79500746|FG001|Primary Phase|Other|0|||
44495066|NCT00129116|79500747|FG002|Primary Phase|Other|1|||
44495067|NCT00129116|79500748|FG003|Primary Phase|Other|0|||
44495068|NCT00129116|79500749|FG004|Primary Phase|Other|0|||
44495069|NCT00129116|79500745|FG000|Booster Phase|Lost to Follow-up|2|||
44495070|NCT00129116|79500746|FG001|Booster Phase|Lost to Follow-up|0|||
44495071|NCT00129116|79500747|FG002|Booster Phase|Lost to Follow-up|0|||
44495072|NCT00129116|79500748|FG003|Booster Phase|Lost to Follow-up|0|||
44495073|NCT00129116|79500749|FG004|Booster Phase|Lost to Follow-up|1|||
44495074|NCT00117156|79500761|FG000|Overall Study|Adverse Event|9|||
44495075|NCT00117156|79500761|FG000|Overall Study|Physician Decision|1|||
44495076|NCT00117156|79500761|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
44495077|NCT00096954|79500767|FG000|Overall Study|Adverse Event|3|||
44495078|NCT00096954|79500768|FG001|Overall Study|Adverse Event|1|||
44551225|NCT03098550|79567567|FG000|Overall Study|Other reasons|2|||
44551226|NCT03098550|79567568|FG001|Overall Study|Other reasons|0|||
44274771|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
44495079|NCT00096954|79500767|FG000|Overall Study|Withdrawal by Subject|9|||
44495080|NCT00096954|79500768|FG001|Overall Study|Withdrawal by Subject|8|||
44495081|NCT00096954|79500767|FG000|Overall Study|Physician Decision|1|||
44495082|NCT00096954|79500768|FG001|Overall Study|Physician Decision|1|||
44551227|NCT03098550|79567569|FG002|Overall Study|Other reasons|0|||
44274772|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
44495083|NCT00096954|79500767|FG000|Overall Study|Sponsors Decision|1|||
44495084|NCT00096954|79500768|FG001|Overall Study|Sponsors Decision|1|||
44551228|NCT03095118|79567581|FG000|Overall Study|Adverse Event|1|||
44551229|NCT03095118|79567581|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
44551230|NCT03594071|79567585|FG000|Overall Study|Re-operation|3|||
44551231|NCT03594071|79567585|FG000|Overall Study|Missed visit|2|||
44551232|NCT02696902|79567592|FG000|Overall Study|Lost to Follow-up|0|||
44230866|NCT00636363|79041598|FG001|Overall Study|Adverse Event|0|||
44230867|NCT00636363|79041599|FG002|Overall Study|Adverse Event|1|||
44230868|NCT00636363|79041597|FG000|Overall Study|Positive slit lamp finding|0|||
44230869|NCT00636363|79041598|FG001|Overall Study|Positive slit lamp finding|2|||
44230870|NCT00636363|79041599|FG002|Overall Study|Positive slit lamp finding|1|||
44230871|NCT00636363|79041597|FG000|Overall Study|Study related symptoms/complaints|8|||
44230872|NCT00636363|79041598|FG001|Overall Study|Study related symptoms/complaints|7|||
44230873|NCT00636363|79041599|FG002|Overall Study|Study related symptoms/complaints|4|||
44230874|NCT00636363|79041597|FG000|Overall Study|Met ineligibility criteria|0|||
44551233|NCT02696902|79567593|FG001|Overall Study|Lost to Follow-up|1|||
44551234|NCT02696902|79567594|FG002|Overall Study|Lost to Follow-up|1|||
44230875|NCT00636363|79041598|FG001|Overall Study|Met ineligibility criteria|0|||
44230876|NCT00636363|79041599|FG002|Overall Study|Met ineligibility criteria|3|||
44230877|NCT00636363|79041597|FG000|Overall Study|Missed > 1 visit|0|||
44230878|NCT00636363|79041598|FG001|Overall Study|Missed > 1 visit|1|||
44230879|NCT00636363|79041599|FG002|Overall Study|Missed > 1 visit|3|||
44230880|NCT00636363|79041597|FG000|Overall Study|Lack of motivation|1|||
44230881|NCT00636363|79041598|FG001|Overall Study|Lack of motivation|0|||
44230882|NCT00636363|79041599|FG002|Overall Study|Lack of motivation|1|||
44230883|NCT00636363|79041597|FG000|Overall Study|Protocol Violation|0|||
44230884|NCT00636363|79041598|FG001|Overall Study|Protocol Violation|3|||
44230885|NCT00636363|79041599|FG002|Overall Study|Protocol Violation|0|||
44230886|NCT00636363|79041597|FG000|Overall Study|Lost to Follow-up|3|||
44230887|NCT00636363|79041598|FG001|Overall Study|Lost to Follow-up|4|||
44230888|NCT00636363|79041599|FG002|Overall Study|Lost to Follow-up|2|||
44230889|NCT00636363|79041597|FG000|Overall Study|Withdrawal by Subject|1|||
44230890|NCT00636363|79041598|FG001|Overall Study|Withdrawal by Subject|3|||
44495085|NCT00096954|79500767|FG000|Overall Study|Pregnancy|1|||
44495086|NCT00096954|79500768|FG001|Overall Study|Pregnancy|1|||
44495087|NCT00096954|79500767|FG000|Overall Study|Initiation of immunotherapy|1|||
44230891|NCT00636363|79041599|FG002|Overall Study|Withdrawal by Subject|2|||
44230892|NCT00636207|79041641|FG000|Overall Study|Adverse Event|1|||
44230893|NCT00636207|79041642|FG001|Overall Study|Adverse Event|0|||
44230894|NCT00636207|79041643|FG002|Overall Study|Adverse Event|0|||
44230895|NCT00636207|79041644|FG003|Overall Study|Adverse Event|0|||
44230896|NCT00636207|79041645|FG004|Overall Study|Adverse Event|0|||
44230897|NCT00636207|79041646|FG005|Overall Study|Adverse Event|0|||
44230898|NCT00636207|79041647|FG006|Overall Study|Adverse Event|0|||
44230899|NCT00636207|79041641|FG000|Overall Study|Withdrawal by Subject|0|||
44230900|NCT00636207|79041642|FG001|Overall Study|Withdrawal by Subject|1|||
44495088|NCT00096954|79500768|FG001|Overall Study|Initiation of immunotherapy|0|||
44495089|NCT00096954|79500767|FG000|Overall Study|Non-compliance|0|||
44495090|NCT00096954|79500768|FG001|Overall Study|Non-compliance|3|||
44495091|NCT00096954|79500767|FG000|Overall Study|Lost to Follow-up|8|||
44495092|NCT00096954|79500768|FG001|Overall Study|Lost to Follow-up|5|||
44495093|NCT00096486|79500778|FG000|Overall Study|Withdrawal by Subject|0|||
44495094|NCT00096486|79500779|FG001|Overall Study|Withdrawal by Subject|0|||
44495095|NCT00096486|79500780|FG002|Overall Study|Withdrawal by Subject|1|||
44495096|NCT00096486|79500781|FG003|Overall Study|Withdrawal by Subject|1|||
44495097|NCT00096486|79500778|FG000|Overall Study|Not Treated|0|||
44495098|NCT00096486|79500779|FG001|Overall Study|Not Treated|0|||
44495099|NCT00096486|79500780|FG002|Overall Study|Not Treated|1|||
44495100|NCT00096486|79500781|FG003|Overall Study|Not Treated|1|||
44495101|NCT00116844|79500793|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
44495102|NCT00116844|79500794|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
44495103|NCT00116844|79500793|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
44495104|NCT00116844|79500794|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
44230901|NCT00636207|79041643|FG002|Overall Study|Withdrawal by Subject|0|||
44230902|NCT00636207|79041644|FG003|Overall Study|Withdrawal by Subject|0|||
44230903|NCT00636207|79041645|FG004|Overall Study|Withdrawal by Subject|1|||
44495105|NCT00116844|79500793|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
44551235|NCT02696902|79567592|FG000|Overall Study|Withdrawal by Subject|0|||
44230904|NCT00636207|79041646|FG005|Overall Study|Withdrawal by Subject|0|||
44230905|NCT00636207|79041647|FG006|Overall Study|Withdrawal by Subject|0|||
44230906|NCT00635661|79041668|FG000|Overall Study|Withdrawal by Subject|4|||
44230907|NCT00635427|79041757|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
44230908|NCT00635427|79041758|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
44230909|NCT00635427|79041759|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
44230910|NCT00635427|79041760|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
44230911|NCT00635427|79041761|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
44230912|NCT00635427|79041757|FG000|Overall Study|Death|0|||
44230913|NCT00635427|79041758|FG001|Overall Study|Death|0|||
44551236|NCT02696902|79567593|FG001|Overall Study|Withdrawal by Subject|0|||
44551237|NCT02696902|79567594|FG002|Overall Study|Withdrawal by Subject|1|||
44551238|NCT02696902|79567592|FG000|Overall Study|Death|19|||
44551239|NCT02696902|79567593|FG001|Overall Study|Death|3|||
44551240|NCT02696902|79567594|FG002|Overall Study|Death|24|||
44230914|NCT00635427|79041759|FG002|Overall Study|Death|0|||
44230915|NCT00635427|79041760|FG003|Overall Study|Death|1|||
44230916|NCT00635427|79041761|FG004|Overall Study|Death|0|||
44230917|NCT00635427|79041757|FG000|Overall Study|Termination Of Study By Sponsor|12|||
44230918|NCT00635427|79041758|FG001|Overall Study|Termination Of Study By Sponsor|6|||
44230919|NCT00635427|79041759|FG002|Overall Study|Termination Of Study By Sponsor|10|||
44274773|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
44274774|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
44376580|NCT01075100|79381802|FG000|Overall Study|Patient Request|4|||
44376581|NCT01075100|79381803|FG001|Overall Study|Patient Request|4|||
44376582|NCT01075100|79381802|FG000|Overall Study|Investigator Request|2|||
44376583|NCT01075100|79381803|FG001|Overall Study|Investigator Request|1|||
44495106|NCT00116844|79500794|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
44495107|NCT00116844|79500793|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
44495108|NCT00116844|79500794|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
44495109|NCT00116844|79500793|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
44495110|NCT00116844|79500794|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
44495111|NCT00116844|79500793|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
44495112|NCT00116844|79500794|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
44495113|NCT00116844|79500793|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
44495114|NCT00116844|79500794|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
44495115|NCT00116844|79500793|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
44495116|NCT00116844|79500794|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
44495117|NCT00116844|79500793|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
44495118|NCT00116844|79500794|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
44495119|NCT00128492|79500802|FG000|Overall Study|AE unrelated to study|2|||
44376584|NCT01075100|79381802|FG000|Overall Study|Disease Progression|25|||
44376585|NCT01075100|79381803|FG001|Overall Study|Disease Progression|29|||
44376586|NCT01075100|79381802|FG000|Overall Study|Other|3|||
44376587|NCT01075100|79381803|FG001|Overall Study|Other|1|||
44376588|NCT00803023|79381815|FG000|Overall Study|Adverse Event|5|||
44376589|NCT00803023|79381816|FG001|Overall Study|Adverse Event|4|||
44376590|NCT00803023|79381817|FG002|Overall Study|Adverse Event|8|||
44376591|NCT00803023|79381818|FG003|Overall Study|Adverse Event|6|||
44376592|NCT00803023|79381815|FG000|Overall Study|Withdrawal by Subject|0|||
44376593|NCT00803023|79381816|FG001|Overall Study|Withdrawal by Subject|2|||
44376594|NCT00803023|79381817|FG002|Overall Study|Withdrawal by Subject|0|||
44495120|NCT00128492|79500803|FG001|Overall Study|AE unrelated to study|9|||
44495121|NCT00128492|79500802|FG000|Overall Study|Study drug intolerance (AE)|2|||
44495122|NCT00128492|79500803|FG001|Overall Study|Study drug intolerance (AE)|8|||
44495123|NCT00128492|79500802|FG000|Overall Study|AE related to study|1|||
44495124|NCT00128492|79500803|FG001|Overall Study|AE related to study|4|||
44495125|NCT00128492|79500802|FG000|Overall Study|Death|1|||
44495126|NCT00128492|79500803|FG001|Overall Study|Death|0|||
44495127|NCT00128492|79500802|FG000|Overall Study|Lost to Follow-up|1|||
44495128|NCT00128492|79500803|FG001|Overall Study|Lost to Follow-up|5|||
44495129|NCT00128492|79500802|FG000|Overall Study|Noncompliance|0|||
44551241|NCT02696902|79567592|FG000|Overall Study|Participant not fit post-randomization|0|||
44551242|NCT02696902|79567593|FG001|Overall Study|Participant not fit post-randomization|0|||
44551243|NCT02696902|79567594|FG002|Overall Study|Participant not fit post-randomization|1|||
44230920|NCT00635427|79041760|FG003|Overall Study|Termination Of Study By Sponsor|6|||
44495130|NCT00128492|79500803|FG001|Overall Study|Noncompliance|5|||
44495131|NCT00128492|79500802|FG000|Overall Study|Personal or administrative|10|||
44495132|NCT00128492|79500803|FG001|Overall Study|Personal or administrative|22|||
44551244|NCT02696902|79567592|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
44376595|NCT00803023|79381818|FG003|Overall Study|Withdrawal by Subject|0|||
44230921|NCT00635427|79041761|FG004|Overall Study|Termination Of Study By Sponsor|6|||
44230922|NCT00635427|79041757|FG000|Overall Study|Withdrawal Of Consent|0|||
44376596|NCT00803023|79381815|FG000|Overall Study|Lost to Follow-up|0|||
44230923|NCT00635427|79041758|FG001|Overall Study|Withdrawal Of Consent|0|||
44230924|NCT00635427|79041759|FG002|Overall Study|Withdrawal Of Consent|0|||
44230925|NCT00635427|79041760|FG003|Overall Study|Withdrawal Of Consent|2|||
44230926|NCT00635427|79041761|FG004|Overall Study|Withdrawal Of Consent|2|||
44230927|NCT00635349|79041773|FG000|Overall Study|Other|8|||
44230928|NCT00635349|79041774|FG001|Overall Study|Other|6|||
44230929|NCT00635349|79041773|FG000|Overall Study|Protocol Violation|18|||
44230930|NCT00635349|79041774|FG001|Overall Study|Protocol Violation|22|||
44230931|NCT00635349|79041773|FG000|Overall Study|Withdrawal by Subject|3|||
44230932|NCT00635349|79041774|FG001|Overall Study|Withdrawal by Subject|8|||
44230933|NCT00635349|79041773|FG000|Overall Study|Lost to Follow-up|4|||
44230934|NCT00635349|79041774|FG001|Overall Study|Lost to Follow-up|3|||
44230935|NCT00635349|79041773|FG000|Overall Study|Adverse Event|11|||
44230936|NCT00635349|79041774|FG001|Overall Study|Adverse Event|9|||
44230937|NCT00634803|79041783|FG000|Overall Study|Lost to Follow-up|6|||
44230938|NCT00634803|79041784|FG001|Overall Study|Lost to Follow-up|7|||
44230939|NCT00634803|79041785|FG002|Overall Study|Lost to Follow-up|7|||
44230940|NCT01217385|79041801|FG000|Overall Study|Withdrawal by Subject|3|||
44230941|NCT01217385|79041801|FG000|Overall Study|DOSI not performed/not eval|12|||
44230942|NCT01217385|79041801|FG000|Overall Study|Central Path not Available|1|||
44230943|NCT01217385|79041801|FG000|Overall Study|Normal Breast TOI not available|10|||
44230944|NCT01378104|79042153|FG000|Overall Study|Adverse Event|8|||
44230945|NCT01378104|79042154|FG001|Overall Study|Adverse Event|8|||
44230946|NCT01378104|79042153|FG000|Overall Study|Lack of Efficacy|7|||
44230947|NCT01378104|79042154|FG001|Overall Study|Lack of Efficacy|5|||
44230948|NCT01378104|79042153|FG000|Overall Study|Withdrawal by Subject|12|||
44230949|NCT01378104|79042154|FG001|Overall Study|Withdrawal by Subject|13|||
44230950|NCT01379274|79042195|FG000|Overall Study|funding withdrawn|1|||
44230951|NCT00634569|79042396|FG000|Overall Study|Withdrawal by Subject|0|||
44230952|NCT00634569|79042397|FG001|Overall Study|Withdrawal by Subject|4|||
44230953|NCT00634569|79042396|FG000|Overall Study|Physician Decision|0|||
44230954|NCT00634569|79042397|FG001|Overall Study|Physician Decision|1|||
44230955|NCT00634179|79042442|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
44230956|NCT03877926|79042517|FG000|Overall Study|Adverse Event|1|||
44230957|NCT03877926|79042518|FG001|Overall Study|Adverse Event|0|||
44230958|NCT03877926|79042519|FG002|Overall Study|Adverse Event|0|||
44230959|NCT03877926|79042520|FG003|Overall Study|Adverse Event|0|||
44230960|NCT03877926|79042517|FG000|Overall Study|Death|2|||
44230961|NCT03877926|79042518|FG001|Overall Study|Death|2|||
44230962|NCT03877926|79042519|FG002|Overall Study|Death|2|||
44230963|NCT03877926|79042520|FG003|Overall Study|Death|0|||
44230964|NCT03877926|79042517|FG000|Overall Study|Lost to Follow-up|41|||
44230965|NCT03877926|79042518|FG001|Overall Study|Lost to Follow-up|52|||
44230966|NCT03877926|79042519|FG002|Overall Study|Lost to Follow-up|45|||
44230967|NCT03877926|79042520|FG003|Overall Study|Lost to Follow-up|17|||
44230968|NCT03877926|79042517|FG000|Overall Study|Physician Decision|2|||
44230969|NCT03877926|79042518|FG001|Overall Study|Physician Decision|0|||
44230970|NCT03877926|79042519|FG002|Overall Study|Physician Decision|2|||
44230971|NCT03877926|79042520|FG003|Overall Study|Physician Decision|0|||
44230972|NCT03877926|79042517|FG000|Overall Study|Withdrawal by Subject|18|||
44495133|NCT00128492|79500802|FG000|Overall Study|Withdrawal by Subject|3|||
44495134|NCT00128492|79500803|FG001|Overall Study|Withdrawal by Subject|5|||
44495135|NCT00128492|79500802|FG000|Overall Study|Pregnancy|0|||
44495136|NCT00128492|79500803|FG001|Overall Study|Pregnancy|1|||
44495137|NCT00132314|79500811|FG000|Overall Study|Lost to Follow-up|70|||
44495138|NCT00132314|79500812|FG001|Overall Study|Lost to Follow-up|62|||
44495139|NCT00132314|79500811|FG000|Overall Study|Lacked SSN|1|||
44495140|NCT00132314|79500812|FG001|Overall Study|Lacked SSN|3|||
44495141|NCT00132314|79500811|FG000|Overall Study|Refused intervention at baseline|2|||
44495142|NCT00132314|79500812|FG001|Overall Study|Refused intervention at baseline|7|||
44495143|NCT04539262|79500826|FG000|Overall Study|Adverse Event|0|||
44495144|NCT04539262|79500827|FG001|Overall Study|Adverse Event|0|||
44230973|NCT03877926|79042518|FG001|Overall Study|Withdrawal by Subject|21|||
44230974|NCT03877926|79042519|FG002|Overall Study|Withdrawal by Subject|12|||
44230975|NCT03877926|79042520|FG003|Overall Study|Withdrawal by Subject|4|||
44230976|NCT03877926|79042517|FG000|Overall Study|Other - Various|4|||
44230977|NCT03877926|79042518|FG001|Overall Study|Other - Various|1|||
44230978|NCT03877926|79042519|FG002|Overall Study|Other - Various|1|||
44230979|NCT03877926|79042520|FG003|Overall Study|Other - Various|0|||
44230980|NCT03877926|79042517|FG000|Overall Study|Not Treated|3|||
44230981|NCT03877926|79042518|FG001|Overall Study|Not Treated|1|||
44230982|NCT03877926|79042519|FG002|Overall Study|Not Treated|1|||
44230983|NCT03877926|79042520|FG003|Overall Study|Not Treated|0|||
44230984|NCT02874144|79042732|FG000|Overall Study|Lost to Follow-up|3|||
44230985|NCT02874144|79042733|FG001|Overall Study|Lost to Follow-up|5|||
44230986|NCT02611830|79042763|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
44230987|NCT02611830|79042764|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
44230988|NCT02611830|79042765|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
44376597|NCT00803023|79381816|FG001|Overall Study|Lost to Follow-up|1|||
44230989|NCT02611830|79042766|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
44230990|NCT02611830|79042763|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
44230991|NCT02611830|79042764|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
44230992|NCT02611830|79042765|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
44230993|NCT02611830|79042766|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
44230994|NCT02611830|79042763|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
44230995|NCT02611830|79042764|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
44230996|NCT02611830|79042765|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
44230997|NCT02611830|79042766|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
44230998|NCT02611830|79042763|FG000|OL Induction Phase|Lack of Efficacy|9|||
44230999|NCT02611830|79042764|FG001|OL Induction Phase|Lack of Efficacy|0|||
44231000|NCT02611830|79042765|FG002|OL Induction Phase|Lack of Efficacy|0|||
44231001|NCT02611830|79042766|FG003|OL Induction Phase|Lack of Efficacy|0|||
44231002|NCT02611830|79042763|FG000|OL Induction Phase|Reason not specified|3|||
44231003|NCT02611830|79042764|FG001|OL Induction Phase|Reason not specified|0|||
44231004|NCT02611830|79042765|FG002|OL Induction Phase|Reason not specified|0|||
44231005|NCT02611830|79042766|FG003|OL Induction Phase|Reason not specified|0|||
44231006|NCT02611830|79042763|FG000|Maintenance Phase|Lack of Efficacy|0|||
44231007|NCT02611830|79042764|FG001|Maintenance Phase|Lack of Efficacy|29|||
44231008|NCT02611830|79042765|FG002|Maintenance Phase|Lack of Efficacy|18|||
44231009|NCT02611830|79042766|FG003|Maintenance Phase|Lack of Efficacy|6|||
44231010|NCT02611830|79042763|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
44274775|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
44495145|NCT04539262|79500828|FG002|Overall Study|Adverse Event|1|||
44495146|NCT04539262|79500829|FG003|Overall Study|Adverse Event|0|||
44495147|NCT04539262|79500830|FG004|Overall Study|Adverse Event|0|||
44495148|NCT04539262|79500831|FG005|Overall Study|Adverse Event|0|||
44495149|NCT04539262|79500832|FG006|Overall Study|Adverse Event|0|||
44495150|NCT04539262|79500833|FG007|Overall Study|Adverse Event|0|||
44495151|NCT04539262|79500826|FG000|Overall Study|Withdrew Consent|0|||
44495152|NCT04539262|79500827|FG001|Overall Study|Withdrew Consent|0|||
44495153|NCT04539262|79500828|FG002|Overall Study|Withdrew Consent|0|||
44495154|NCT04539262|79500829|FG003|Overall Study|Withdrew Consent|1|||
44495155|NCT04539262|79500830|FG004|Overall Study|Withdrew Consent|0|||
44495156|NCT04539262|79500831|FG005|Overall Study|Withdrew Consent|0|||
44495157|NCT04539262|79500832|FG006|Overall Study|Withdrew Consent|0|||
44274776|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
44495158|NCT04539262|79500833|FG007|Overall Study|Withdrew Consent|0|||
44495159|NCT04539262|79500826|FG000|Overall Study|Randomized, Not treated|0|||
44495160|NCT04539262|79500827|FG001|Overall Study|Randomized, Not treated|1|||
44495161|NCT04539262|79500828|FG002|Overall Study|Randomized, Not treated|0|||
44495162|NCT04539262|79500829|FG003|Overall Study|Randomized, Not treated|0|||
44495163|NCT04539262|79500830|FG004|Overall Study|Randomized, Not treated|0|||
44231011|NCT02611830|79042764|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
44231012|NCT02611830|79042765|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
44231013|NCT02611830|79042766|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
44231014|NCT02611830|79042763|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
44274777|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
44495164|NCT04539262|79500831|FG005|Overall Study|Randomized, Not treated|0|||
44551245|NCT02696902|79567593|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
44551246|NCT02696902|79567594|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
44551247|NCT02696902|79567592|FG000|Overall Study|Principal investigator's decision|1|||
44551248|NCT02696902|79567593|FG001|Overall Study|Principal investigator's decision|0|||
44551249|NCT02696902|79567594|FG002|Overall Study|Principal investigator's decision|0|||
44551250|NCT02696902|79567592|FG000|Overall Study|Sponsor's decision|1|||
44551251|NCT02696902|79567593|FG001|Overall Study|Sponsor's decision|0|||
44551252|NCT02696902|79567594|FG002|Overall Study|Sponsor's decision|0|||
44551253|NCT02696902|79567592|FG000|Overall Study|Transferred to other hospital|1|||
44551254|NCT02696902|79567593|FG001|Overall Study|Transferred to other hospital|0|||
44551255|NCT02696902|79567594|FG002|Overall Study|Transferred to other hospital|0|||
44551256|NCT02694562|79567604|FG000|Overall Study|Death|8|||
44551257|NCT02694562|79567604|FG000|Overall Study|Protocol Violation|4|||
44551258|NCT02694562|79567604|FG000|Overall Study|Lost to Follow-up|3|||
44551259|NCT02694562|79567604|FG000|Overall Study|Screen Failure|2|||
44551260|NCT02694562|79567604|FG000|Overall Study|Physician Decision|1|||
44551261|NCT02874534|79567610|FG000|Overall Study|Withdrawal by Subject|5|||
44551262|NCT02874534|79567611|FG001|Overall Study|Withdrawal by Subject|8|||
44551263|NCT02874534|79567610|FG000|Overall Study|Lost to Follow-up|2|||
44551264|NCT02874534|79567611|FG001|Overall Study|Lost to Follow-up|2|||
44551265|NCT02874534|79567610|FG000|Overall Study|Ongoing in study|1|||
44551266|NCT02874534|79567611|FG001|Overall Study|Ongoing in study|1|||
44551267|NCT03097614|79567617|FG000|Overall Study|Adverse Event|3|||
44551268|NCT03364309|79567624|FG000|Induction Period|Adverse Event|4|||
44551269|NCT03364309|79567625|FG001|Induction Period|Adverse Event|0|||
44551270|NCT03364309|79567626|FG002|Induction Period|Adverse Event|1|||
44551271|NCT03364309|79567627|FG003|Induction Period|Adverse Event|0|||
44551272|NCT03364309|79567628|FG004|Induction Period|Adverse Event|0|||
44551273|NCT03364309|79567629|FG005|Induction Period|Adverse Event|0|||
44551274|NCT03364309|79567630|FG006|Induction Period|Adverse Event|0|||
44551275|NCT03364309|79567631|FG007|Induction Period|Adverse Event|0|||
44551276|NCT03364309|79567632|FG008|Induction Period|Adverse Event|0|||
44551277|NCT03364309|79567633|FG009|Induction Period|Adverse Event|0|||
44551278|NCT03364309|79567634|FG010|Induction Period|Adverse Event|0|||
44551279|NCT03364309|79567635|FG011|Induction Period|Adverse Event|0|||
44551280|NCT03364309|79567636|FG012|Induction Period|Adverse Event|0|||
44551281|NCT03364309|79567637|FG013|Induction Period|Adverse Event|0|||
44551282|NCT03364309|79567638|FG014|Induction Period|Adverse Event|0|||
44551283|NCT03364309|79567639|FG015|Induction Period|Adverse Event|0|||
44551284|NCT03364309|79567640|FG016|Induction Period|Adverse Event|0|||
44376598|NCT00803023|79381817|FG002|Overall Study|Lost to Follow-up|2|||
44376599|NCT00803023|79381818|FG003|Overall Study|Lost to Follow-up|1|||
44376600|NCT00803023|79381815|FG000|Overall Study|Lack of Efficacy|0|||
44376601|NCT00803023|79381816|FG001|Overall Study|Lack of Efficacy|1|||
44376602|NCT00803023|79381817|FG002|Overall Study|Lack of Efficacy|1|||
44376603|NCT00803023|79381818|FG003|Overall Study|Lack of Efficacy|1|||
44376604|NCT00859222|79381831|FG000|Overall Study|Adverse Event|2|||
44376605|NCT00859222|79381832|FG001|Overall Study|Adverse Event|3|||
44495165|NCT04539262|79500832|FG006|Overall Study|Randomized, Not treated|1|||
44495166|NCT04539262|79500833|FG007|Overall Study|Randomized, Not treated|0|||
44495167|NCT03702010|79500856|FG000|Follow-up (30days)|Lack of Efficacy|2|||
44495168|NCT03702010|79500857|FG001|Follow-up (30days)|Lack of Efficacy|2|||
44495169|NCT04538170|79500871|FG000|Overall Study|Withdrawal by Subject|104|||
44495170|NCT04538170|79500872|FG001|Overall Study|Withdrawal by Subject|210|||
44495171|NCT04537234|79500884|FG000|Overall Study|Withdrawal by Subject|2|||
44495172|NCT04537234|79500885|FG001|Overall Study|Withdrawal by Subject|0|||
44495173|NCT04537078|79500893|FG000|Overall Study|Protocol Violation|3|||
44495174|NCT04537078|79500894|FG001|Overall Study|Protocol Violation|2|||
44495175|NCT04537078|79500893|FG000|Overall Study|Lost to Follow-up|1|||
44495176|NCT04537078|79500894|FG001|Overall Study|Lost to Follow-up|0|||
44551285|NCT03364309|79567641|FG017|Induction Period|Adverse Event|0|||
44551286|NCT03364309|79567642|FG018|Induction Period|Adverse Event|0|||
44551287|NCT03364309|79567624|FG000|Induction Period|Withdrawal by Subject|1|||
44551288|NCT03364309|79567625|FG001|Induction Period|Withdrawal by Subject|3|||
44376606|NCT00859222|79381833|FG002|Overall Study|Adverse Event|6|||
44376607|NCT00859222|79381834|FG003|Overall Study|Adverse Event|24|||
44376608|NCT00859222|79381835|FG004|Overall Study|Adverse Event|15|||
44551289|NCT03364309|79567626|FG002|Induction Period|Withdrawal by Subject|0|||
44551290|NCT03364309|79567627|FG003|Induction Period|Withdrawal by Subject|0|||
44551291|NCT03364309|79567628|FG004|Induction Period|Withdrawal by Subject|0|||
44551292|NCT03364309|79567629|FG005|Induction Period|Withdrawal by Subject|0|||
44551293|NCT03364309|79567630|FG006|Induction Period|Withdrawal by Subject|0|||
44376609|NCT00859222|79381831|FG000|Overall Study|DLT|1|||
44376610|NCT00859222|79381832|FG001|Overall Study|DLT|0|||
44376611|NCT00859222|79381833|FG002|Overall Study|DLT|0|||
44376612|NCT00859222|79381834|FG003|Overall Study|DLT|0|||
44376613|NCT00859222|79381835|FG004|Overall Study|DLT|0|||
44376614|NCT01072448|79381852|FG000|Overall Study|Adverse Event|9|||
44376615|NCT01072448|79381853|FG001|Overall Study|Adverse Event|10|||
44376616|NCT01072448|79381852|FG000|Overall Study|Subject withdrew consent|4|||
44376617|NCT01072448|79381853|FG001|Overall Study|Subject withdrew consent|9|||
44376618|NCT01072448|79381852|FG000|Overall Study|Protocol deviation|3|||
44376619|NCT01072448|79381853|FG001|Overall Study|Protocol deviation|4|||
44376620|NCT01072448|79381852|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44231015|NCT02611830|79042764|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
44495177|NCT04537078|79500893|FG000|Overall Study|Withdrawal by Subject|0|||
44495178|NCT04537078|79500894|FG001|Overall Study|Withdrawal by Subject|1|||
44495179|NCT04532164|79500907|FG000|Overall Study|Adverse Event|1|||
44495180|NCT04532164|79500907|FG000|Overall Study|Protocol Violation|5|||
44495181|NCT04532164|79500907|FG000|Overall Study|Lost to Follow-up|1|||
44495182|NCT04532164|79500907|FG000|Overall Study|Found to be Ineligible|3|||
44231016|NCT02611830|79042765|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
44231017|NCT02611830|79042766|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
44231018|NCT02611830|79042763|FG000|Maintenance Phase|Lost to Follow-up|0|||
44231019|NCT02611830|79042764|FG001|Maintenance Phase|Lost to Follow-up|0|||
44231020|NCT02611830|79042765|FG002|Maintenance Phase|Lost to Follow-up|0|||
44231021|NCT02611830|79042766|FG003|Maintenance Phase|Lost to Follow-up|1|||
44231022|NCT02611830|79042763|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
44231023|NCT02611830|79042764|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
44274778|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
44495183|NCT04532164|79500907|FG000|Overall Study|Withdrawal by Subject|14|||
44495184|NCT00116688|79500914|FG000|Overall Study|Protocol deviation|1|||
44495185|NCT00116688|79500915|FG001|Overall Study|Protocol deviation|0|||
44495186|NCT00116688|79500914|FG000|Overall Study|Noncompliance|3|||
44495187|NCT00116688|79500915|FG001|Overall Study|Noncompliance|1|||
44495188|NCT00116688|79500914|FG000|Overall Study|Adverse Event|11|||
44231024|NCT02611830|79042765|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
44274779|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
44274780|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
44495189|NCT00116688|79500915|FG001|Overall Study|Adverse Event|0|||
44495190|NCT00116688|79500914|FG000|Overall Study|Withdrawal by Subject|26|||
44495191|NCT00116688|79500915|FG001|Overall Study|Withdrawal by Subject|2|||
44495192|NCT00116688|79500914|FG000|Overall Study|Requirement for alternative therapy|11|||
44495193|NCT00116688|79500915|FG001|Overall Study|Requirement for alternative therapy|1|||
44495194|NCT00116688|79500914|FG000|Overall Study|Physician Decision|7|||
44495195|NCT00116688|79500915|FG001|Overall Study|Physician Decision|0|||
44495196|NCT00116688|79500914|FG000|Overall Study|Lost to Follow-up|3|||
44495197|NCT00116688|79500915|FG001|Overall Study|Lost to Follow-up|0|||
44495198|NCT00116688|79500914|FG000|Overall Study|Death|15|||
44495199|NCT00116688|79500915|FG001|Overall Study|Death|0|||
44495200|NCT00116688|79500914|FG000|Overall Study|Protocol-specified criteria|3|||
44495201|NCT00116688|79500915|FG001|Overall Study|Protocol-specified criteria|0|||
44495202|NCT00116688|79500914|FG000|Overall Study|Pregnancy|1|||
44495203|NCT00116688|79500915|FG001|Overall Study|Pregnancy|0|||
44495204|NCT00116688|79500914|FG000|Overall Study|Other|11|||
44495205|NCT00116688|79500915|FG001|Overall Study|Other|0|||
44495206|NCT04531540|79500921|FG000|Overall Study|Adverse Event|1|||
44495207|NCT04531540|79500921|FG000|Overall Study|Protocol Violation|3|||
44495208|NCT04531540|79500921|FG000|Overall Study|Withdrawal by Subject|4|||
44495209|NCT04531540|79500921|FG000|Overall Study|Found to be Ineligible|1|||
44495210|NCT04799782|79500925|FG000|Washout|Physician Decision|2|||
44495211|NCT04799782|79500926|FG001|Washout|Physician Decision|0|||
44495212|NCT04799782|79500925|FG000|Washout|Withdrawal by Subject|0|||
44376621|NCT01072448|79381853|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44376622|NCT01072448|79381852|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44495213|NCT04799782|79500926|FG001|Washout|Withdrawal by Subject|2|||
44495214|NCT04799782|79500925|FG000|Washout|Lost to Follow-up|0|||
44495215|NCT04799782|79500926|FG001|Washout|Lost to Follow-up|1|||
44495216|NCT03697252|79500934|FG000|Overall Study|Adverse Event|3|||
44376623|NCT01072448|79381853|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44495217|NCT03697252|79500935|FG001|Overall Study|Adverse Event|2|||
44551294|NCT03364309|79567631|FG007|Induction Period|Withdrawal by Subject|0|||
44551295|NCT03364309|79567632|FG008|Induction Period|Withdrawal by Subject|0|||
44551296|NCT03364309|79567633|FG009|Induction Period|Withdrawal by Subject|0|||
44551297|NCT03364309|79567634|FG010|Induction Period|Withdrawal by Subject|0|||
44551298|NCT03364309|79567635|FG011|Induction Period|Withdrawal by Subject|0|||
44551299|NCT03364309|79567636|FG012|Induction Period|Withdrawal by Subject|0|||
44551300|NCT03364309|79567637|FG013|Induction Period|Withdrawal by Subject|0|||
44551301|NCT03364309|79567638|FG014|Induction Period|Withdrawal by Subject|0|||
44551302|NCT03364309|79567639|FG015|Induction Period|Withdrawal by Subject|0|||
44551303|NCT03364309|79567640|FG016|Induction Period|Withdrawal by Subject|0|||
44551304|NCT03364309|79567641|FG017|Induction Period|Withdrawal by Subject|0|||
44551305|NCT03364309|79567642|FG018|Induction Period|Withdrawal by Subject|0|||
44551306|NCT03364309|79567624|FG000|Induction Period|Lost to Follow-up|1|||
44551307|NCT03364309|79567625|FG001|Induction Period|Lost to Follow-up|0|||
44551308|NCT03364309|79567626|FG002|Induction Period|Lost to Follow-up|0|||
44551309|NCT03364309|79567627|FG003|Induction Period|Lost to Follow-up|0|||
44551310|NCT03364309|79567628|FG004|Induction Period|Lost to Follow-up|0|||
44551311|NCT03364309|79567629|FG005|Induction Period|Lost to Follow-up|0|||
44551312|NCT03364309|79567630|FG006|Induction Period|Lost to Follow-up|0|||
44551313|NCT03364309|79567631|FG007|Induction Period|Lost to Follow-up|0|||
44551314|NCT03364309|79567632|FG008|Induction Period|Lost to Follow-up|0|||
44551315|NCT03364309|79567633|FG009|Induction Period|Lost to Follow-up|0|||
44551316|NCT03364309|79567634|FG010|Induction Period|Lost to Follow-up|0|||
44551317|NCT03364309|79567635|FG011|Induction Period|Lost to Follow-up|0|||
44495218|NCT03697252|79500934|FG000|Overall Study|Withdrawal by Subject|14|||
44551318|NCT03364309|79567636|FG012|Induction Period|Lost to Follow-up|0|||
44551319|NCT03364309|79567637|FG013|Induction Period|Lost to Follow-up|0|||
44551320|NCT03364309|79567638|FG014|Induction Period|Lost to Follow-up|0|||
44551321|NCT03364309|79567639|FG015|Induction Period|Lost to Follow-up|0|||
44551322|NCT03364309|79567640|FG016|Induction Period|Lost to Follow-up|0|||
44551323|NCT03364309|79567641|FG017|Induction Period|Lost to Follow-up|0|||
44551324|NCT03364309|79567642|FG018|Induction Period|Lost to Follow-up|0|||
44551325|NCT03364309|79567624|FG000|Induction Period|Physician Decision|0|||
44551326|NCT03364309|79567625|FG001|Induction Period|Physician Decision|1|||
44551327|NCT03364309|79567626|FG002|Induction Period|Physician Decision|0|||
44551328|NCT03364309|79567627|FG003|Induction Period|Physician Decision|0|||
44551329|NCT03364309|79567628|FG004|Induction Period|Physician Decision|0|||
44551330|NCT03364309|79567629|FG005|Induction Period|Physician Decision|0|||
44551331|NCT03364309|79567630|FG006|Induction Period|Physician Decision|0|||
44551332|NCT03364309|79567631|FG007|Induction Period|Physician Decision|0|||
44551333|NCT03364309|79567632|FG008|Induction Period|Physician Decision|0|||
44551334|NCT03364309|79567633|FG009|Induction Period|Physician Decision|0|||
44551335|NCT03364309|79567634|FG010|Induction Period|Physician Decision|0|||
44551336|NCT03364309|79567635|FG011|Induction Period|Physician Decision|0|||
44495219|NCT03697252|79500935|FG001|Overall Study|Withdrawal by Subject|14|||
44495220|NCT03697252|79500934|FG000|Overall Study|Lost to Follow-up|0|||
44495221|NCT03697252|79500935|FG001|Overall Study|Lost to Follow-up|1|||
44495222|NCT03697252|79500934|FG000|Overall Study|Physician Decision|1|||
44495223|NCT03697252|79500935|FG001|Overall Study|Physician Decision|1|||
44495224|NCT03697252|79500934|FG000|Overall Study|Other|0|||
44495225|NCT03697252|79500935|FG001|Overall Study|Other|1|||
44495226|NCT03701074|79500943|FG000|Overall Study|Physician Decision|1|||
44495227|NCT03701074|79500944|FG001|Overall Study|Physician Decision|0|||
44495228|NCT04728802|79500952|FG000|Overall Study|Withdrawal by Subject|4|||
44551337|NCT03364309|79567636|FG012|Induction Period|Physician Decision|0|||
44551338|NCT03364309|79567637|FG013|Induction Period|Physician Decision|0|||
44551339|NCT03364309|79567638|FG014|Induction Period|Physician Decision|0|||
44551340|NCT03364309|79567639|FG015|Induction Period|Physician Decision|0|||
44551341|NCT03364309|79567640|FG016|Induction Period|Physician Decision|0|||
44551342|NCT03364309|79567641|FG017|Induction Period|Physician Decision|0|||
44551343|NCT03364309|79567642|FG018|Induction Period|Physician Decision|0|||
44551344|NCT03364309|79567624|FG000|Maintenance Period|Withdrawal by Subject|0|||
44551345|NCT03364309|79567625|FG001|Maintenance Period|Withdrawal by Subject|0|||
44551346|NCT03364309|79567626|FG002|Maintenance Period|Withdrawal by Subject|0|||
44551347|NCT03364309|79567627|FG003|Maintenance Period|Withdrawal by Subject|1|||
44551348|NCT03364309|79567628|FG004|Maintenance Period|Withdrawal by Subject|3|||
44551349|NCT03364309|79567629|FG005|Maintenance Period|Withdrawal by Subject|1|||
44551350|NCT03364309|79567630|FG006|Maintenance Period|Withdrawal by Subject|3|||
44551351|NCT03364309|79567631|FG007|Maintenance Period|Withdrawal by Subject|0|||
44551352|NCT03364309|79567632|FG008|Maintenance Period|Withdrawal by Subject|1|||
44551353|NCT03364309|79567633|FG009|Maintenance Period|Withdrawal by Subject|1|||
44551354|NCT03364309|79567634|FG010|Maintenance Period|Withdrawal by Subject|2|||
44551355|NCT03364309|79567635|FG011|Maintenance Period|Withdrawal by Subject|0|||
44551356|NCT03364309|79567636|FG012|Maintenance Period|Withdrawal by Subject|0|||
44551357|NCT03364309|79567637|FG013|Maintenance Period|Withdrawal by Subject|0|||
44551358|NCT03364309|79567638|FG014|Maintenance Period|Withdrawal by Subject|0|||
44551359|NCT03364309|79567639|FG015|Maintenance Period|Withdrawal by Subject|0|||
44551360|NCT03364309|79567640|FG016|Maintenance Period|Withdrawal by Subject|0|||
44551361|NCT03364309|79567641|FG017|Maintenance Period|Withdrawal by Subject|0|||
44551362|NCT03364309|79567642|FG018|Maintenance Period|Withdrawal by Subject|0|||
44551363|NCT03364309|79567624|FG000|Maintenance Period|Adverse Event|0|||
44551364|NCT03364309|79567625|FG001|Maintenance Period|Adverse Event|0|||
44551365|NCT03364309|79567626|FG002|Maintenance Period|Adverse Event|0|||
44551366|NCT03364309|79567627|FG003|Maintenance Period|Adverse Event|0|||
44551367|NCT03364309|79567628|FG004|Maintenance Period|Adverse Event|2|||
44551368|NCT03364309|79567629|FG005|Maintenance Period|Adverse Event|0|||
44551369|NCT03364309|79567630|FG006|Maintenance Period|Adverse Event|3|||
44551370|NCT03364309|79567631|FG007|Maintenance Period|Adverse Event|0|||
44551371|NCT03364309|79567632|FG008|Maintenance Period|Adverse Event|1|||
44551372|NCT03364309|79567633|FG009|Maintenance Period|Adverse Event|0|||
44551373|NCT03364309|79567634|FG010|Maintenance Period|Adverse Event|2|||
44551374|NCT03364309|79567635|FG011|Maintenance Period|Adverse Event|0|||
44551375|NCT03364309|79567636|FG012|Maintenance Period|Adverse Event|0|||
44551376|NCT03364309|79567637|FG013|Maintenance Period|Adverse Event|0|||
44551377|NCT03364309|79567638|FG014|Maintenance Period|Adverse Event|0|||
44551378|NCT03364309|79567639|FG015|Maintenance Period|Adverse Event|0|||
44551379|NCT03364309|79567640|FG016|Maintenance Period|Adverse Event|0|||
44551380|NCT03364309|79567641|FG017|Maintenance Period|Adverse Event|0|||
44551381|NCT03364309|79567642|FG018|Maintenance Period|Adverse Event|0|||
44551382|NCT03364309|79567624|FG000|Maintenance Period|Relapsed|0|||
44551383|NCT03364309|79567625|FG001|Maintenance Period|Relapsed|0|||
44551384|NCT03364309|79567626|FG002|Maintenance Period|Relapsed|0|||
44551385|NCT03364309|79567627|FG003|Maintenance Period|Relapsed|43|||
44551386|NCT03364309|79567628|FG004|Maintenance Period|Relapsed|7|||
44551387|NCT03364309|79567629|FG005|Maintenance Period|Relapsed|45|||
44551388|NCT03364309|79567630|FG006|Maintenance Period|Relapsed|10|||
44551389|NCT03364309|79567631|FG007|Maintenance Period|Relapsed|2|||
44551390|NCT03364309|79567632|FG008|Maintenance Period|Relapsed|0|||
44551391|NCT03364309|79567633|FG009|Maintenance Period|Relapsed|0|||
44495229|NCT04728802|79500953|FG001|Overall Study|Withdrawal by Subject|20|||
44495230|NCT04728802|79500952|FG000|Overall Study|Physician Decision|7|||
44495231|NCT04728802|79500953|FG001|Overall Study|Physician Decision|7|||
44495232|NCT04728802|79500952|FG000|Overall Study|Protocol Violation|10|||
44495233|NCT04728802|79500953|FG001|Overall Study|Protocol Violation|4|||
44495234|NCT04728802|79500952|FG000|Overall Study|Transfer|1|||
44495235|NCT04728802|79500953|FG001|Overall Study|Transfer|0|||
44495236|NCT04728802|79500952|FG000|Overall Study|Death|4|||
44495237|NCT04728802|79500953|FG001|Overall Study|Death|5|||
44495238|NCT04728802|79500952|FG000|Overall Study|Other|3|||
44495239|NCT04728802|79500953|FG001|Overall Study|Other|0|||
44495240|NCT04715932|79500961|FG000|Overall Study|Lost to Follow-up|1|||
44495241|NCT04715932|79500962|FG001|Overall Study|Lost to Follow-up|0|||
44495242|NCT00130832|79500970|FG000|Overall Study|Adverse Event|1|||
44495243|NCT00130832|79500971|FG001|Overall Study|Adverse Event|1|||
44551392|NCT03364309|79567634|FG010|Maintenance Period|Relapsed|0|||
44551393|NCT03364309|79567635|FG011|Maintenance Period|Relapsed|0|||
44274781|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
44274782|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
44495244|NCT00130832|79500970|FG000|Overall Study|Lost to Follow-up|1|||
44495245|NCT00130832|79500971|FG001|Overall Study|Lost to Follow-up|2|||
44495246|NCT00130832|79500970|FG000|Overall Study|Protocol Violation|6|||
44495247|NCT00130832|79500971|FG001|Overall Study|Protocol Violation|8|||
44495248|NCT00130832|79500970|FG000|Overall Study|Withdrawal by Subject|6|||
44495249|NCT00130832|79500971|FG001|Overall Study|Withdrawal by Subject|1|||
44551394|NCT03364309|79567636|FG012|Maintenance Period|Relapsed|0|||
44551395|NCT03364309|79567637|FG013|Maintenance Period|Relapsed|0|||
44551396|NCT03364309|79567638|FG014|Maintenance Period|Relapsed|0|||
44551397|NCT03364309|79567639|FG015|Maintenance Period|Relapsed|0|||
44551398|NCT03364309|79567640|FG016|Maintenance Period|Relapsed|0|||
44551399|NCT03364309|79567641|FG017|Maintenance Period|Relapsed|0|||
44551400|NCT03364309|79567642|FG018|Maintenance Period|Relapsed|0|||
44551401|NCT03364309|79567624|FG000|Maintenance Period|Lack of Efficacy|0|||
44551402|NCT03364309|79567625|FG001|Maintenance Period|Lack of Efficacy|0|||
44551403|NCT03364309|79567626|FG002|Maintenance Period|Lack of Efficacy|0|||
44551404|NCT03364309|79567627|FG003|Maintenance Period|Lack of Efficacy|0|||
44551405|NCT03364309|79567628|FG004|Maintenance Period|Lack of Efficacy|0|||
44551406|NCT03364309|79567629|FG005|Maintenance Period|Lack of Efficacy|0|||
44551407|NCT03364309|79567630|FG006|Maintenance Period|Lack of Efficacy|0|||
44551408|NCT03364309|79567631|FG007|Maintenance Period|Lack of Efficacy|0|||
44551409|NCT03364309|79567632|FG008|Maintenance Period|Lack of Efficacy|1|||
44551410|NCT03364309|79567633|FG009|Maintenance Period|Lack of Efficacy|3|||
44551411|NCT03364309|79567634|FG010|Maintenance Period|Lack of Efficacy|2|||
44551412|NCT03364309|79567635|FG011|Maintenance Period|Lack of Efficacy|0|||
44551413|NCT03364309|79567636|FG012|Maintenance Period|Lack of Efficacy|0|||
44551414|NCT03364309|79567637|FG013|Maintenance Period|Lack of Efficacy|0|||
44551415|NCT03364309|79567638|FG014|Maintenance Period|Lack of Efficacy|0|||
44551416|NCT03364309|79567639|FG015|Maintenance Period|Lack of Efficacy|0|||
44551417|NCT03364309|79567640|FG016|Maintenance Period|Lack of Efficacy|0|||
44551418|NCT03364309|79567641|FG017|Maintenance Period|Lack of Efficacy|0|||
44551419|NCT03364309|79567642|FG018|Maintenance Period|Lack of Efficacy|0|||
44551420|NCT03364309|79567624|FG000|Maintenance Period|Death|0|||
44551421|NCT03364309|79567625|FG001|Maintenance Period|Death|0|||
44551422|NCT03364309|79567626|FG002|Maintenance Period|Death|0|||
44551423|NCT03364309|79567627|FG003|Maintenance Period|Death|0|||
44551424|NCT03364309|79567628|FG004|Maintenance Period|Death|0|||
44551425|NCT03364309|79567629|FG005|Maintenance Period|Death|0|||
44551426|NCT03364309|79567630|FG006|Maintenance Period|Death|0|||
44551427|NCT03364309|79567631|FG007|Maintenance Period|Death|0|||
44551428|NCT03364309|79567632|FG008|Maintenance Period|Death|1|||
44551429|NCT03364309|79567633|FG009|Maintenance Period|Death|0|||
44551430|NCT03364309|79567634|FG010|Maintenance Period|Death|0|||
44551431|NCT03364309|79567635|FG011|Maintenance Period|Death|0|||
44551432|NCT03364309|79567636|FG012|Maintenance Period|Death|0|||
44551433|NCT03364309|79567637|FG013|Maintenance Period|Death|0|||
44551434|NCT03364309|79567638|FG014|Maintenance Period|Death|0|||
44551435|NCT03364309|79567639|FG015|Maintenance Period|Death|0|||
44551436|NCT03364309|79567640|FG016|Maintenance Period|Death|0|||
44551437|NCT03364309|79567641|FG017|Maintenance Period|Death|0|||
44551438|NCT03364309|79567642|FG018|Maintenance Period|Death|0|||
44551439|NCT03364309|79567624|FG000|Maintenance Period|Lost to Follow-up|0|||
44551440|NCT03364309|79567625|FG001|Maintenance Period|Lost to Follow-up|0|||
44551441|NCT03364309|79567626|FG002|Maintenance Period|Lost to Follow-up|0|||
44551442|NCT03364309|79567627|FG003|Maintenance Period|Lost to Follow-up|0|||
44551443|NCT03364309|79567628|FG004|Maintenance Period|Lost to Follow-up|0|||
44551444|NCT03364309|79567629|FG005|Maintenance Period|Lost to Follow-up|0|||
44376624|NCT01072448|79381852|FG000|Overall Study|Lost to Follow-up|1|||
44376625|NCT01072448|79381853|FG001|Overall Study|Lost to Follow-up|1|||
44376626|NCT01072448|79381852|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44376627|NCT01072448|79381853|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44376628|NCT01072448|79381852|FG000|Overall Study|Death|0|||
44495250|NCT00130832|79500970|FG000|Overall Study|Moved|2|||
44495251|NCT00130832|79500971|FG001|Overall Study|Moved|2|||
44495252|NCT00130832|79500970|FG000|Overall Study|Other|0|||
44495253|NCT00130832|79500971|FG001|Overall Study|Other|3|||
44495254|NCT00096018|79500979|FG000|Overall Study|Became Ineligible (not treated)|0|||
44495255|NCT00096018|79500980|FG001|Overall Study|Became Ineligible (not treated)|3|||
44495256|NCT00096018|79500979|FG000|Overall Study|Miscellaneous (not treated)|0|||
44495257|NCT00096018|79500980|FG001|Overall Study|Miscellaneous (not treated)|2|||
44495258|NCT00096018|79500979|FG000|Overall Study|Adverse Event|0|||
44495259|NCT00096018|79500980|FG001|Overall Study|Adverse Event|5|||
44495260|NCT00096018|79500979|FG000|Overall Study|Death|0|||
44551445|NCT03364309|79567630|FG006|Maintenance Period|Lost to Follow-up|0|||
44551446|NCT03364309|79567631|FG007|Maintenance Period|Lost to Follow-up|0|||
44551447|NCT03364309|79567632|FG008|Maintenance Period|Lost to Follow-up|1|||
44551448|NCT03364309|79567633|FG009|Maintenance Period|Lost to Follow-up|0|||
44551449|NCT03364309|79567634|FG010|Maintenance Period|Lost to Follow-up|0|||
44551450|NCT03364309|79567635|FG011|Maintenance Period|Lost to Follow-up|0|||
44376629|NCT01072448|79381853|FG001|Overall Study|Death|2|||
44495261|NCT00096018|79500980|FG001|Overall Study|Death|1|||
44551451|NCT03364309|79567636|FG012|Maintenance Period|Lost to Follow-up|0|||
44551452|NCT03364309|79567637|FG013|Maintenance Period|Lost to Follow-up|0|||
44376630|NCT00922974|79381862|FG000|Phase II Component|Protocol Violation|2|||
44376631|NCT00922974|79381863|FG001|Phase II Component|Protocol Violation|0|||
44551453|NCT03364309|79567638|FG014|Maintenance Period|Lost to Follow-up|0|||
44495262|NCT00096018|79500979|FG000|Overall Study|Withdrawal by Subject|0|||
44495263|NCT00096018|79500980|FG001|Overall Study|Withdrawal by Subject|2|||
44551454|NCT03364309|79567639|FG015|Maintenance Period|Lost to Follow-up|0|||
44551455|NCT03364309|79567640|FG016|Maintenance Period|Lost to Follow-up|0|||
44551456|NCT03364309|79567641|FG017|Maintenance Period|Lost to Follow-up|0|||
44551457|NCT03364309|79567642|FG018|Maintenance Period|Lost to Follow-up|0|||
44551458|NCT03364309|79567624|FG000|Maintenance Period|Miscellaneous|0|||
44551459|NCT03364309|79567625|FG001|Maintenance Period|Miscellaneous|0|||
44551460|NCT03364309|79567626|FG002|Maintenance Period|Miscellaneous|0|||
44551461|NCT03364309|79567627|FG003|Maintenance Period|Miscellaneous|0|||
44551462|NCT03364309|79567628|FG004|Maintenance Period|Miscellaneous|0|||
44551463|NCT03364309|79567629|FG005|Maintenance Period|Miscellaneous|0|||
44551464|NCT03364309|79567630|FG006|Maintenance Period|Miscellaneous|0|||
44551465|NCT03364309|79567631|FG007|Maintenance Period|Miscellaneous|0|||
44551466|NCT03364309|79567632|FG008|Maintenance Period|Miscellaneous|1|||
44551467|NCT03364309|79567633|FG009|Maintenance Period|Miscellaneous|0|||
44551468|NCT03364309|79567634|FG010|Maintenance Period|Miscellaneous|0|||
44551469|NCT03364309|79567635|FG011|Maintenance Period|Miscellaneous|0|||
44551470|NCT03364309|79567636|FG012|Maintenance Period|Miscellaneous|0|||
44551471|NCT03364309|79567637|FG013|Maintenance Period|Miscellaneous|0|||
44551472|NCT03364309|79567638|FG014|Maintenance Period|Miscellaneous|0|||
44551473|NCT03364309|79567639|FG015|Maintenance Period|Miscellaneous|0|||
44551474|NCT03364309|79567640|FG016|Maintenance Period|Miscellaneous|0|||
44551475|NCT03364309|79567641|FG017|Maintenance Period|Miscellaneous|0|||
44551476|NCT03364309|79567642|FG018|Maintenance Period|Miscellaneous|0|||
44551477|NCT03364309|79567624|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551478|NCT03364309|79567625|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551479|NCT03364309|79567626|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551480|NCT03364309|79567627|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551481|NCT03364309|79567628|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551482|NCT03364309|79567629|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551483|NCT03364309|79567630|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551484|NCT03364309|79567631|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551485|NCT03364309|79567632|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44376632|NCT00922974|79381862|FG000|Phase II Component|Not evaluable for treatment review|5|||
44376633|NCT00922974|79381863|FG001|Phase II Component|Not evaluable for treatment review|0|||
44495264|NCT00096018|79500979|FG000|Overall Study|Miscellaneous|2|||
44495265|NCT00096018|79500980|FG001|Overall Study|Miscellaneous|1|||
44495266|NCT04713748|79500986|FG000|Overall Study|Not enough kits allocated|35|||
44495267|NCT04702984|79500990|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
44495268|NCT04701658|79500996|FG000|Overall Study|Lost to Follow-up|6|||
44495269|NCT00128102|79501002|FG000|Overall Study|Site Discontinued|3|||
44495270|NCT00128102|79501003|FG001|Overall Study|Site Discontinued|6|||
44495271|NCT00128102|79501002|FG000|Overall Study|Other|0|||
44495272|NCT00128102|79501003|FG001|Overall Study|Other|1|||
44551486|NCT03364309|79567633|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551487|NCT03364309|79567634|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551488|NCT03364309|79567635|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44495273|NCT00128102|79501002|FG000|Overall Study|Progressive Disease|255|||
44495274|NCT00128102|79501003|FG001|Overall Study|Progressive Disease|285|||
44495275|NCT00128102|79501002|FG000|Overall Study|Adverse Event|34|||
44376634|NCT00922974|79381862|FG000|Phase III Component|Protocol Violation|8|||
44551489|NCT03364309|79567636|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551490|NCT03364309|79567637|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
44551491|NCT03364309|79567638|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
44551492|NCT03364309|79567639|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
44551493|NCT03364309|79567640|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551494|NCT03364309|79567641|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551495|NCT03364309|79567642|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
44551496|NCT03364309|79567624|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551497|NCT03364309|79567625|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551498|NCT03364309|79567626|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551499|NCT03364309|79567627|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551500|NCT03364309|79567628|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551501|NCT03364309|79567629|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551502|NCT03364309|79567630|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551503|NCT03364309|79567631|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551504|NCT03364309|79567632|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551505|NCT03364309|79567633|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551506|NCT03364309|79567634|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551507|NCT03364309|79567635|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551508|NCT03364309|79567636|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551509|NCT03364309|79567637|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551510|NCT03364309|79567638|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
44551511|NCT03364309|79567639|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551512|NCT03364309|79567640|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551513|NCT03364309|79567641|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551514|NCT03364309|79567642|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
44551515|NCT03364309|79567624|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
44551516|NCT03364309|79567625|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
44551517|NCT03364309|79567626|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
44551518|NCT03364309|79567627|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
44551519|NCT03364309|79567628|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
44551520|NCT03364309|79567629|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
44551521|NCT03364309|79567630|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
44551522|NCT03364309|79567631|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
44551523|NCT03364309|79567632|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
44551524|NCT03364309|79567633|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
44551525|NCT03364309|79567634|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
44551526|NCT03364309|79567635|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
44551527|NCT03364309|79567636|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
44551528|NCT03364309|79567637|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
44551529|NCT03364309|79567638|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
44551530|NCT03364309|79567639|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
44551531|NCT03364309|79567640|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
44551532|NCT03364309|79567641|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
44551533|NCT03364309|79567642|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
44551534|NCT03364309|79567624|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551535|NCT03364309|79567625|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551536|NCT03364309|79567626|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551537|NCT03364309|79567627|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551538|NCT03364309|79567628|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551539|NCT03364309|79567629|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551540|NCT03364309|79567630|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551541|NCT03364309|79567631|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551542|NCT03364309|79567632|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551543|NCT03364309|79567633|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551544|NCT03364309|79567634|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551545|NCT03364309|79567635|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551546|NCT03364309|79567636|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551547|NCT03364309|79567637|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551548|NCT03364309|79567638|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551549|NCT03364309|79567639|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44551550|NCT03364309|79567640|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
44551551|NCT03364309|79567641|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
44551552|NCT03364309|79567642|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
44551553|NCT03364309|79567624|FG000|Post-Treatment Followup Period|Adverse Event|0|||
44551554|NCT03364309|79567625|FG001|Post-Treatment Followup Period|Adverse Event|0|||
44551555|NCT03364309|79567626|FG002|Post-Treatment Followup Period|Adverse Event|0|||
44551556|NCT03364309|79567627|FG003|Post-Treatment Followup Period|Adverse Event|0|||
44551557|NCT03364309|79567628|FG004|Post-Treatment Followup Period|Adverse Event|0|||
44551558|NCT03364309|79567629|FG005|Post-Treatment Followup Period|Adverse Event|0|||
44551559|NCT03364309|79567630|FG006|Post-Treatment Followup Period|Adverse Event|0|||
44551560|NCT03364309|79567631|FG007|Post-Treatment Followup Period|Adverse Event|0|||
44551561|NCT03364309|79567632|FG008|Post-Treatment Followup Period|Adverse Event|0|||
44551562|NCT03364309|79567633|FG009|Post-Treatment Followup Period|Adverse Event|0|||
44551563|NCT03364309|79567634|FG010|Post-Treatment Followup Period|Adverse Event|0|||
44551564|NCT03364309|79567635|FG011|Post-Treatment Followup Period|Adverse Event|0|||
44551565|NCT03364309|79567636|FG012|Post-Treatment Followup Period|Adverse Event|0|||
44551566|NCT03364309|79567637|FG013|Post-Treatment Followup Period|Adverse Event|0|||
44551567|NCT03364309|79567638|FG014|Post-Treatment Followup Period|Adverse Event|0|||
44551568|NCT03364309|79567639|FG015|Post-Treatment Followup Period|Adverse Event|0|||
44551569|NCT03364309|79567640|FG016|Post-Treatment Followup Period|Adverse Event|2|||
44551570|NCT03364309|79567641|FG017|Post-Treatment Followup Period|Adverse Event|6|||
44551571|NCT03364309|79567642|FG018|Post-Treatment Followup Period|Adverse Event|1|||
44551572|NCT03364309|79567624|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551573|NCT03364309|79567625|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551574|NCT03364309|79567626|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551575|NCT03364309|79567627|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551576|NCT03364309|79567628|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551577|NCT03364309|79567629|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551578|NCT03364309|79567630|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551579|NCT03364309|79567631|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551580|NCT03364309|79567632|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551581|NCT03364309|79567633|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551582|NCT03364309|79567634|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551583|NCT03364309|79567635|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551584|NCT03364309|79567636|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551585|NCT03364309|79567637|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551586|NCT03364309|79567638|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551587|NCT03364309|79567639|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551588|NCT03364309|79567640|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551589|NCT03364309|79567641|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
44551590|NCT03364309|79567642|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
44551591|NCT03364309|79567624|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
44551592|NCT03364309|79567625|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
44551593|NCT03364309|79567626|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
44551594|NCT03364309|79567627|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
44551595|NCT03364309|79567628|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
44551596|NCT03364309|79567629|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
44551597|NCT03364309|79567630|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
44551598|NCT03364309|79567631|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
44551599|NCT03364309|79567632|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
44551600|NCT03364309|79567633|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
44551601|NCT03364309|79567634|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
44551602|NCT03364309|79567635|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
44231025|NCT02611830|79042766|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
44231026|NCT02611830|79042763|FG000|Maintenance Phase|Pregnancy|0|||
44231027|NCT02611830|79042764|FG001|Maintenance Phase|Pregnancy|0|||
44231028|NCT02611830|79042765|FG002|Maintenance Phase|Pregnancy|1|||
44231029|NCT02611830|79042766|FG003|Maintenance Phase|Pregnancy|0|||
44231030|NCT02611830|79042763|FG000|Maintenance Phase|Reason not specified|0|||
44376635|NCT00922974|79381863|FG001|Phase III Component|Protocol Violation|6|||
44495276|NCT00128102|79501003|FG001|Overall Study|Adverse Event|11|||
44495277|NCT00128102|79501002|FG000|Overall Study|Death|12|||
44495278|NCT00128102|79501003|FG001|Overall Study|Death|13|||
44231031|NCT02611830|79042764|FG001|Maintenance Phase|Reason not specified|1|||
44495279|NCT00128102|79501002|FG000|Overall Study|Physician Decision|3|||
44495280|NCT00128102|79501003|FG001|Overall Study|Physician Decision|3|||
44495281|NCT00128102|79501002|FG000|Overall Study|Withdrawal by Subject|19|||
44495282|NCT00128102|79501003|FG001|Overall Study|Withdrawal by Subject|11|||
44495283|NCT00128102|79501002|FG000|Overall Study|Protocol Violation|2|||
44495284|NCT00128102|79501003|FG001|Overall Study|Protocol Violation|2|||
44495285|NCT04668274|79501009|FG000|Part 1 Study Period 1|Adverse Event|3|||
44495286|NCT04668274|79501010|FG001|Part 1 Study Period 1|Adverse Event|0|||
44231032|NCT02611830|79042765|FG002|Maintenance Phase|Reason not specified|4|||
44495287|NCT04668274|79501011|FG002|Part 1 Study Period 1|Adverse Event|0|||
44495288|NCT04668274|79501012|FG003|Part 1 Study Period 1|Adverse Event|0|||
44551603|NCT03364309|79567636|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
44551604|NCT03364309|79567637|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
44551605|NCT03364309|79567638|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
44551606|NCT03364309|79567639|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
44551607|NCT03364309|79567640|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
44551608|NCT03364309|79567641|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
44551609|NCT03364309|79567642|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
44551610|NCT03334903|79567668|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
44551611|NCT03334903|79567669|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
44551612|NCT03334903|79567668|FG000|Overall Study|Protocol Violation|1|||
44551613|NCT03334903|79567669|FG001|Overall Study|Protocol Violation|3|||
44551614|NCT03334903|79567668|FG000|Overall Study|Surgery postponed|1|||
44551615|NCT03334903|79567669|FG001|Overall Study|Surgery postponed|0|||
44551616|NCT03334903|79567668|FG000|Overall Study|Adverse Event|1|||
44551617|NCT03334903|79567669|FG001|Overall Study|Adverse Event|1|||
44551618|NCT03334903|79567668|FG000|Overall Study|Withdrawal by Subject|0|||
44551619|NCT03334903|79567669|FG001|Overall Study|Withdrawal by Subject|1|||
44551620|NCT01353664|79567675|FG000|Overall Study|Other|3|||
44551621|NCT01353664|79567675|FG000|Overall Study|Disease Progression|16|||
44551622|NCT02694328|79567681|FG000|Overall Study|Adverse Event|27|||
44551623|NCT02694328|79567682|FG001|Overall Study|Adverse Event|33|||
44551624|NCT02694328|79567681|FG000|Overall Study|Withdrawal by Subject|27|||
44551625|NCT02694328|79567682|FG001|Overall Study|Withdrawal by Subject|23|||
44551626|NCT02694328|79567681|FG000|Overall Study|Lost to Follow-up|26|||
44551627|NCT02694328|79567682|FG001|Overall Study|Lost to Follow-up|22|||
44551628|NCT02694328|79567681|FG000|Overall Study|Noncompliant with study drug|11|||
44551629|NCT02694328|79567682|FG001|Overall Study|Noncompliant with study drug|8|||
44551630|NCT02694328|79567681|FG000|Overall Study|Incarceration|1|||
44551631|NCT02694328|79567682|FG001|Overall Study|Incarceration|1|||
44551632|NCT02694328|79567681|FG000|Overall Study|Lack of Efficacy|1|||
44551633|NCT02694328|79567682|FG001|Overall Study|Lack of Efficacy|2|||
44551634|NCT02694328|79567681|FG000|Overall Study|Pregnancy|1|||
44551635|NCT02694328|79567682|FG001|Overall Study|Pregnancy|1|||
44551636|NCT02694328|79567681|FG000|Overall Study|Protocol Violation|6|||
44551637|NCT02694328|79567682|FG001|Overall Study|Protocol Violation|5|||
44551638|NCT02694328|79567681|FG000|Overall Study|Abnormal Laboratory Value|0|||
44551639|NCT02694328|79567682|FG001|Overall Study|Abnormal Laboratory Value|3|||
44551640|NCT03334747|79567697|FG000|Treatment Phase|Technical problems|0|||
44551641|NCT03334747|79567698|FG001|Treatment Phase|Technical problems|0|||
44551642|NCT03334747|79567699|FG002|Treatment Phase|Technical problems|0|||
44551643|NCT03334747|79567700|FG003|Treatment Phase|Technical problems|0|||
44551644|NCT03334747|79567701|FG004|Treatment Phase|Technical problems|1|||
44551645|NCT03334747|79567702|FG005|Treatment Phase|Technical problems|0|||
44551646|NCT03334747|79567703|FG006|Treatment Phase|Technical problems|0|||
44551647|NCT03334747|79567704|FG007|Treatment Phase|Technical problems|0|||
44551648|NCT03334747|79567705|FG008|Treatment Phase|Technical problems|0|||
44376636|NCT00858988|79381873|FG000|Analysis|Lactulose unable to be detected in urine|2|||
44551649|NCT03334747|79567697|FG000|Treatment Phase|Subject/guardian decision|1|||
44551650|NCT03334747|79567698|FG001|Treatment Phase|Subject/guardian decision|0|||
44551651|NCT03334747|79567699|FG002|Treatment Phase|Subject/guardian decision|0|||
44551652|NCT03334747|79567700|FG003|Treatment Phase|Subject/guardian decision|0|||
44551653|NCT03334747|79567701|FG004|Treatment Phase|Subject/guardian decision|0|||
44551654|NCT03334747|79567702|FG005|Treatment Phase|Subject/guardian decision|1|||
44551655|NCT03334747|79567703|FG006|Treatment Phase|Subject/guardian decision|0|||
44551656|NCT03334747|79567704|FG007|Treatment Phase|Subject/guardian decision|0|||
44551657|NCT03334747|79567705|FG008|Treatment Phase|Subject/guardian decision|0|||
44551658|NCT03334747|79567697|FG000|Follow-Up Phase|Subject/guardian decision|0|||
44551659|NCT03334747|79567698|FG001|Follow-Up Phase|Subject/guardian decision|0|||
44551660|NCT03334747|79567699|FG002|Follow-Up Phase|Subject/guardian decision|0|||
44551661|NCT03334747|79567700|FG003|Follow-Up Phase|Subject/guardian decision|0|||
44551662|NCT03334747|79567701|FG004|Follow-Up Phase|Subject/guardian decision|0|||
44551663|NCT03334747|79567702|FG005|Follow-Up Phase|Subject/guardian decision|0|||
44551664|NCT03334747|79567703|FG006|Follow-Up Phase|Subject/guardian decision|1|||
44551665|NCT03334747|79567704|FG007|Follow-Up Phase|Subject/guardian decision|0|||
44376637|NCT00858988|79381874|FG001|Analysis|Lactulose unable to be detected in urine|1|||
44551666|NCT03334747|79567705|FG008|Follow-Up Phase|Subject/guardian decision|1|||
44551667|NCT03346759|79567727|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
44551668|NCT03346759|79567728|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
44551669|NCT03346759|79567727|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
44551670|NCT03346759|79567728|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
44551671|NCT03346759|79567727|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
44551672|NCT03346759|79567728|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
44551673|NCT03361423|79567737|FG000|Overall Study|Withdrawal by Subject|4|||
44551674|NCT03361423|79567738|FG001|Overall Study|Withdrawal by Subject|3|||
44551675|NCT03361423|79567737|FG000|Overall Study|Did not treat|19|||
44551676|NCT03361423|79567738|FG001|Overall Study|Did not treat|18|||
44551677|NCT03361423|79567737|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
44551678|NCT03361423|79567738|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
44551679|NCT03361423|79567737|FG000|Overall Study|Missing data|4|||
44551680|NCT03361423|79567738|FG001|Overall Study|Missing data|1|||
44551681|NCT02693002|79567746|FG000|Overall Study|Withdrawal by Subject|1|||
44551682|NCT02693002|79567747|FG001|Overall Study|Withdrawal by Subject|0|||
44551683|NCT03093870|79567756|FG000|Overall Study|Withdrawal by Subject|2|||
44551684|NCT03093870|79567757|FG001|Overall Study|Withdrawal by Subject|6|||
44551685|NCT03093870|79567758|FG002|Overall Study|Withdrawal by Subject|5|||
44551686|NCT03093870|79567756|FG000|Overall Study|Death|1|||
44551687|NCT03093870|79567757|FG001|Overall Study|Death|35|||
44551688|NCT03093870|79567758|FG002|Overall Study|Death|35|||
44551689|NCT03093870|79567756|FG000|Overall Study|Radiographic disease progression|10|||
44551690|NCT03093870|79567757|FG001|Overall Study|Radiographic disease progression|0|||
44551691|NCT03093870|79567758|FG002|Overall Study|Radiographic disease progression|0|||
44551692|NCT03093870|79567756|FG000|Overall Study|Clinical disease progression|1|||
44551693|NCT03093870|79567757|FG001|Overall Study|Clinical disease progression|0|||
44231033|NCT02611830|79042766|FG003|Maintenance Phase|Reason not specified|0|||
44231034|NCT01328574|79042952|FG000|Overall Study|Refused further treatment|1|||
44231035|NCT01328496|79043074|FG000|Overall Study|Significant Change in Health Status|1|||
44231036|NCT01328496|79043075|FG001|Overall Study|Significant Change in Health Status|0|||
44231037|NCT02734212|79043195|FG000|Overall Study|Lost to Follow-up|5|||
44231038|NCT02734212|79043196|FG001|Overall Study|Lost to Follow-up|10|||
44231039|NCT03786432|79043242|FG000|Overall Study|Screen Failure after consent|1|||
44231040|NCT03786432|79043242|FG000|Overall Study|Lost to Follow-up|4|||
44231041|NCT03786432|79043242|FG000|Overall Study|did not complete 12 month CT scan|1|||
44231042|NCT04604184|79043278|FG000|Overall Study|Adverse Event|5|||
44231043|NCT04604184|79043279|FG001|Overall Study|Adverse Event|5|||
44231044|NCT04604184|79043278|FG000|Overall Study|Death|2|||
44231045|NCT04604184|79043279|FG001|Overall Study|Death|1|||
44231046|NCT04604184|79043278|FG000|Overall Study|Withdrawal by Subject|1|||
44231047|NCT04604184|79043279|FG001|Overall Study|Withdrawal by Subject|3|||
44231048|NCT04604184|79043278|FG000|Overall Study|Not treated|2|||
44231049|NCT04604184|79043279|FG001|Overall Study|Not treated|2|||
44231050|NCT04604184|79043278|FG000|Overall Study|Due to sponsor decision|9|||
44231051|NCT04604184|79043279|FG001|Overall Study|Due to sponsor decision|7|||
44231052|NCT04604184|79043278|FG000|Overall Study|Physician Decision|0|||
44231053|NCT04604184|79043279|FG001|Overall Study|Physician Decision|1|||
44231054|NCT04604184|79043278|FG000|Overall Study|Transfer to healthcare|1|||
44231055|NCT04604184|79043279|FG001|Overall Study|Transfer to healthcare|0|||
44231056|NCT01859741|79043450|FG000|Overall Study|Death|3|||
44551694|NCT03093870|79567758|FG002|Overall Study|Clinical disease progression|0|||
44551695|NCT03093870|79567756|FG000|Overall Study|Physician Decision|2|||
44231057|NCT01859741|79043451|FG001|Overall Study|Death|2|||
44231058|NCT01859741|79043452|FG002|Overall Study|Death|4|||
44231059|NCT01859741|79043453|FG003|Overall Study|Death|3|||
44376638|NCT00858832|79381882|FG000|Overall Study|became ineligible: delivered vaginally|1|||
44551696|NCT03093870|79567757|FG001|Overall Study|Physician Decision|0|||
44551697|NCT03093870|79567758|FG002|Overall Study|Physician Decision|0|||
44551698|NCT03093870|79567756|FG000|Overall Study|Adverse Event|7|||
44551699|NCT03093870|79567757|FG001|Overall Study|Adverse Event|0|||
44551700|NCT03093870|79567758|FG002|Overall Study|Adverse Event|0|||
44551701|NCT03093870|79567756|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
44551702|NCT03093870|79567757|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
44231060|NCT01859741|79043454|FG004|Overall Study|Death|5|||
44231061|NCT01859741|79043455|FG005|Overall Study|Death|4|||
44231062|NCT01859741|79043456|FG006|Overall Study|Death|51|||
44231063|NCT01859741|79043457|FG007|Overall Study|Death|51|||
44231064|NCT01859741|79043450|FG000|Overall Study|Lost to Follow-up|0|||
44231065|NCT01859741|79043451|FG001|Overall Study|Lost to Follow-up|0|||
44231066|NCT01859741|79043452|FG002|Overall Study|Lost to Follow-up|0|||
44231067|NCT01859741|79043453|FG003|Overall Study|Lost to Follow-up|0|||
44551703|NCT03093870|79567758|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
44551704|NCT03093870|79567756|FG000|Overall Study|Lost to Follow-up|0|||
44551705|NCT03093870|79567757|FG001|Overall Study|Lost to Follow-up|0|||
44495289|NCT04668274|79501009|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
44495290|NCT04668274|79501010|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
44495291|NCT04668274|79501011|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
44495292|NCT04668274|79501012|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
44495293|NCT04668274|79501009|FG000|Part 1 Study Period 2|Other|0|||
44495294|NCT04668274|79501010|FG001|Part 1 Study Period 2|Other|1|||
44495295|NCT04668274|79501011|FG002|Part 1 Study Period 2|Other|0|||
44495296|NCT04668274|79501012|FG003|Part 1 Study Period 2|Other|0|||
44495297|NCT04668274|79501009|FG000|Part 1 Study Period 3|Adverse Event|0|||
44495298|NCT04668274|79501010|FG001|Part 1 Study Period 3|Adverse Event|0|||
44551706|NCT03093870|79567758|FG002|Overall Study|Lost to Follow-up|1|||
44551707|NCT03346057|79567781|FG000|Overall Study|Death|1|||
44551708|NCT03346057|79567782|FG001|Overall Study|Death|2|||
44551709|NCT03346057|79567783|FG002|Overall Study|Death|0|||
44551710|NCT03346057|79567784|FG003|Overall Study|Death|0|||
44551711|NCT03346057|79567781|FG000|Overall Study|Lost to Follow-up|0|||
44551712|NCT03346057|79567782|FG001|Overall Study|Lost to Follow-up|2|||
44551713|NCT03346057|79567783|FG002|Overall Study|Lost to Follow-up|1|||
44551714|NCT03346057|79567784|FG003|Overall Study|Lost to Follow-up|0|||
44551715|NCT03346057|79567781|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
44551716|NCT03346057|79567782|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
44551717|NCT03346057|79567783|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
44376639|NCT00858832|79381883|FG001|Overall Study|became ineligible: delivered vaginally|0|||
44376640|NCT00858832|79381882|FG000|Overall Study|Adverse Event|0|||
44376641|NCT00858832|79381883|FG001|Overall Study|Adverse Event|1|||
44376642|NCT01071512|79381889|FG000|Overall Study|Adverse Event|1|||
44376643|NCT01071512|79381889|FG000|Overall Study|Development of antibodies to drug|2|||
44231068|NCT01859741|79043454|FG004|Overall Study|Lost to Follow-up|0|||
44231069|NCT01859741|79043455|FG005|Overall Study|Lost to Follow-up|1|||
44376644|NCT01071512|79381889|FG000|Overall Study|positive anti-JC virus antibody test|2|||
44376645|NCT00858442|79381895|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
44376646|NCT00858442|79381896|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
44376647|NCT01071278|79381903|FG000|Overall Study|Premature Discontinuation|254|||
44495299|NCT04668274|79501011|FG002|Part 1 Study Period 3|Adverse Event|1|||
44551718|NCT03346057|79567784|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
44551719|NCT03346057|79567781|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
44551720|NCT03346057|79567782|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
44551721|NCT03346057|79567783|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
44551722|NCT03346057|79567784|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
44551723|NCT03346057|79567781|FG000|Overall Study|Physician Decision|3|||
44551724|NCT03346057|79567782|FG001|Overall Study|Physician Decision|2|||
44551725|NCT03346057|79567783|FG002|Overall Study|Physician Decision|0|||
44551726|NCT03346057|79567784|FG003|Overall Study|Physician Decision|2|||
44551727|NCT03346057|79567781|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
44551728|NCT03346057|79567782|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
44551729|NCT03346057|79567783|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
44551730|NCT03346057|79567784|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
44551731|NCT03346057|79567781|FG000|Overall Study|Withdrawal by Subject|1|||
44551732|NCT03346057|79567782|FG001|Overall Study|Withdrawal by Subject|0|||
44551733|NCT03346057|79567783|FG002|Overall Study|Withdrawal by Subject|0|||
44551734|NCT03346057|79567784|FG003|Overall Study|Withdrawal by Subject|0|||
44231070|NCT01859741|79043456|FG006|Overall Study|Lost to Follow-up|0|||
44231071|NCT01859741|79043457|FG007|Overall Study|Lost to Follow-up|4|||
44231072|NCT01859741|79043450|FG000|Overall Study|Withdrawal by Subject|0|||
44231073|NCT01859741|79043451|FG001|Overall Study|Withdrawal by Subject|1|||
44231074|NCT01859741|79043452|FG002|Overall Study|Withdrawal by Subject|2|||
44231075|NCT01859741|79043453|FG003|Overall Study|Withdrawal by Subject|0|||
44376648|NCT01071278|79381903|FG000|Overall Study|Completion Status Unknown|459|||
44551735|NCT03345979|79567796|FG000|Overall Study|Withdrawal by Subject|20|||
44551736|NCT03345979|79567797|FG001|Overall Study|Withdrawal by Subject|31|||
44551737|NCT03345979|79567796|FG000|Overall Study|Adverse Event|10|||
44231076|NCT01859741|79043454|FG004|Overall Study|Withdrawal by Subject|0|||
44231077|NCT01859741|79043455|FG005|Overall Study|Withdrawal by Subject|1|||
44551738|NCT03345979|79567797|FG001|Overall Study|Adverse Event|11|||
44551739|NCT03345979|79567796|FG000|Overall Study|Lost to Follow-up|8|||
44551740|NCT03345979|79567797|FG001|Overall Study|Lost to Follow-up|9|||
44551741|NCT03345979|79567796|FG000|Overall Study|Lack of Efficacy|4|||
44551742|NCT03345979|79567797|FG001|Overall Study|Lack of Efficacy|2|||
44551743|NCT03345979|79567796|FG000|Overall Study|Protocol Violation|1|||
44551744|NCT03345979|79567797|FG001|Overall Study|Protocol Violation|3|||
44551745|NCT03345979|79567796|FG000|Overall Study|Physician Decision|0|||
44551746|NCT03345979|79567797|FG001|Overall Study|Physician Decision|2|||
44551747|NCT02696434|79567805|FG000|Overall Study|Adverse Event|3|||
44551748|NCT02696434|79567806|FG001|Overall Study|Adverse Event|1|||
44231078|NCT01859741|79043456|FG006|Overall Study|Withdrawal by Subject|1|||
44231079|NCT01859741|79043457|FG007|Overall Study|Withdrawal by Subject|1|||
44231080|NCT01859741|79043450|FG000|Overall Study|Study Terminated by Sponsor|0|||
44231081|NCT01859741|79043451|FG001|Overall Study|Study Terminated by Sponsor|0|||
44231082|NCT01859741|79043452|FG002|Overall Study|Study Terminated by Sponsor|0|||
44231083|NCT01859741|79043453|FG003|Overall Study|Study Terminated by Sponsor|0|||
44231084|NCT01859741|79043454|FG004|Overall Study|Study Terminated by Sponsor|1|||
44231085|NCT01859741|79043455|FG005|Overall Study|Study Terminated by Sponsor|0|||
44231086|NCT01859741|79043456|FG006|Overall Study|Study Terminated by Sponsor|16|||
44231087|NCT01859741|79043457|FG007|Overall Study|Study Terminated by Sponsor|14|||
44231088|NCT01859741|79043450|FG000|Overall Study|Other|0|||
44231089|NCT01859741|79043451|FG001|Overall Study|Other|0|||
44551749|NCT02696434|79567805|FG000|Overall Study|Lost to Follow-up|5|||
44551750|NCT02696434|79567806|FG001|Overall Study|Lost to Follow-up|4|||
44551751|NCT02696434|79567805|FG000|Overall Study|Withdrawal by Subject|14|||
44551752|NCT02696434|79567806|FG001|Overall Study|Withdrawal by Subject|12|||
44551753|NCT02696434|79567805|FG000|Overall Study|Physician Decision|0|||
44551754|NCT02696434|79567806|FG001|Overall Study|Physician Decision|1|||
44551755|NCT03345901|79567812|FG000|Overall Study|The study was terminated|18|||
44551756|NCT02950831|79567817|FG000|Overall Study|Lost to Follow-up|1|||
44551757|NCT02950831|79567817|FG000|Overall Study|Withdrawal by Subject|3|||
44551758|NCT02950831|79567817|FG000|Overall Study|stimulation trail failure|5|||
44551759|NCT03593681|79567821|FG000|Overall Study|Inadequate sample collected|12|||
44551760|NCT03593681|79567821|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
44551761|NCT03593681|79567821|FG000|Overall Study|Protocol Violation|3|||
44231090|NCT01859741|79043452|FG002|Overall Study|Other|0|||
44231091|NCT01859741|79043453|FG003|Overall Study|Other|0|||
44231092|NCT01859741|79043454|FG004|Overall Study|Other|0|||
44551762|NCT03593681|79567821|FG000|Overall Study|Withdrawal by Subject|3|||
44551763|NCT03593681|79567821|FG000|Overall Study|Procedure not attempted|3|||
44551764|NCT03593681|79567821|FG000|Overall Study|Adverse Event|2|||
44551765|NCT03593681|79567821|FG000|Overall Study|Physician Decision|1|||
44551766|NCT03592745|79567844|FG000|Overall Study|Adverse Event|0|||
44551767|NCT03592745|79567845|FG001|Overall Study|Adverse Event|2|||
44231093|NCT01859741|79043455|FG005|Overall Study|Other|0|||
44231094|NCT01859741|79043456|FG006|Overall Study|Other|2|||
44231095|NCT01859741|79043457|FG007|Overall Study|Other|0|||
44231096|NCT01859507|79043503|FG000|Overall Study|left the country|4|||
44231097|NCT01876043|79043508|FG000|Overall Study|Death|1|||
44231098|NCT01876043|79043508|FG000|Overall Study|Withdrawal by Subject|1|||
44231099|NCT01875731|79043514|FG000|Overall Study|Fail to obtain lab sample|1|||
44231100|NCT01875731|79043515|FG001|Overall Study|Fail to obtain lab sample|0|||
44231101|NCT01873859|79043523|FG000|Overall Study|Withdrawal by Subject|0|||
44231102|NCT01873859|79043524|FG001|Overall Study|Withdrawal by Subject|4|||
44231103|NCT01857869|79043541|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
44495300|NCT04668274|79501012|FG003|Part 1 Study Period 3|Adverse Event|0|||
44495301|NCT04668274|79501009|FG000|Part 1 Study Period 3|Other|0|||
44495302|NCT04668274|79501010|FG001|Part 1 Study Period 3|Other|0|||
44495303|NCT04668274|79501011|FG002|Part 1 Study Period 3|Other|2|||
44495304|NCT04668274|79501012|FG003|Part 1 Study Period 3|Other|0|||
44495305|NCT04668274|79501009|FG000|Part 2 Study Period 4|Other|0|||
44495306|NCT04668274|79501010|FG001|Part 2 Study Period 4|Other|0|||
44495307|NCT04668274|79501011|FG002|Part 2 Study Period 4|Other|0|||
44495308|NCT04668274|79501012|FG003|Part 2 Study Period 4|Other|1|||
44495309|NCT04406194|79501027|FG000|Period 1|Withdrawal by Subject|0|||
44495310|NCT04406194|79501028|FG001|Period 1|Withdrawal by Subject|1|||
44495311|NCT03822884|79501043|FG000|Overall Study|Withdrawal by Subject|0|||
44495312|NCT03822884|79501044|FG001|Overall Study|Withdrawal by Subject|0|||
44495313|NCT03822884|79501045|FG002|Overall Study|Withdrawal by Subject|0|||
44231104|NCT01857869|79043542|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
44231105|NCT01857869|79043543|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
44231106|NCT01857869|79043544|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
44231107|NCT01857869|79043545|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
44231108|NCT01857869|79043546|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
44495314|NCT03822884|79501046|FG003|Overall Study|Withdrawal by Subject|0|||
44495315|NCT03822884|79501047|FG004|Overall Study|Withdrawal by Subject|1|||
44551768|NCT03592745|79567844|FG000|Overall Study|Lost to Follow-up|2|||
44551769|NCT03592745|79567845|FG001|Overall Study|Lost to Follow-up|0|||
44551770|NCT03592745|79567844|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
44551771|NCT03592745|79567845|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
44551772|NCT03592277|79567853|FG000|Overall Study|Withdrawal by Subject|6|||
44551773|NCT03592277|79567854|FG001|Overall Study|Withdrawal by Subject|8|||
44551774|NCT03401112|79567865|FG000|Overall Study|Adverse Event|1|||
44551775|NCT03401112|79567866|FG001|Overall Study|Adverse Event|2|||
44551776|NCT03401112|79567867|FG002|Overall Study|Adverse Event|3|||
44551777|NCT03401112|79567868|FG003|Overall Study|Adverse Event|2|||
44551778|NCT03401112|79567869|FG004|Overall Study|Adverse Event|0|||
44231109|NCT01857869|79043547|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
44231110|NCT01857869|79043548|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
44231111|NCT01857869|79043549|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
44551779|NCT03401112|79567865|FG000|Overall Study|Lost to Follow-up|1|||
44551780|NCT03401112|79567866|FG001|Overall Study|Lost to Follow-up|0|||
44551781|NCT03401112|79567867|FG002|Overall Study|Lost to Follow-up|0|||
44551782|NCT03401112|79567868|FG003|Overall Study|Lost to Follow-up|0|||
44551783|NCT03401112|79567869|FG004|Overall Study|Lost to Follow-up|0|||
44551784|NCT03401112|79567865|FG000|Overall Study|Noncompliance|1|||
44551785|NCT03401112|79567866|FG001|Overall Study|Noncompliance|2|||
44551786|NCT03401112|79567867|FG002|Overall Study|Noncompliance|3|||
44551787|NCT03401112|79567868|FG003|Overall Study|Noncompliance|0|||
44551788|NCT03401112|79567869|FG004|Overall Study|Noncompliance|0|||
44551789|NCT03401112|79567865|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
44551790|NCT03401112|79567866|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
44551791|NCT03401112|79567867|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
44551792|NCT03401112|79567868|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
44551793|NCT03401112|79567869|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
44551794|NCT03401112|79567865|FG000|Overall Study|Withdrawal by Subject|0|||
44551795|NCT03401112|79567866|FG001|Overall Study|Withdrawal by Subject|3|||
44551796|NCT03401112|79567867|FG002|Overall Study|Withdrawal by Subject|2|||
44551797|NCT03401112|79567868|FG003|Overall Study|Withdrawal by Subject|1|||
44551798|NCT03401112|79567869|FG004|Overall Study|Withdrawal by Subject|0|||
44551799|NCT03401112|79567865|FG000|Overall Study|Physician Decision|0|||
44551800|NCT03401112|79567866|FG001|Overall Study|Physician Decision|0|||
44551801|NCT03401112|79567867|FG002|Overall Study|Physician Decision|0|||
44551802|NCT03401112|79567868|FG003|Overall Study|Physician Decision|2|||
44551803|NCT03401112|79567869|FG004|Overall Study|Physician Decision|0|||
44551804|NCT03401112|79567865|FG000|Overall Study|Study was Terminated by Sponsor|0|||
44551805|NCT03401112|79567866|FG001|Overall Study|Study was Terminated by Sponsor|0|||
44551806|NCT03401112|79567867|FG002|Overall Study|Study was Terminated by Sponsor|0|||
44551807|NCT03401112|79567868|FG003|Overall Study|Study was Terminated by Sponsor|1|||
44551808|NCT03401112|79567869|FG004|Overall Study|Study was Terminated by Sponsor|0|||
44551809|NCT03401112|79567865|FG000|Overall Study|Day 1 Assessment not Done|1|||
44551810|NCT03401112|79567866|FG001|Overall Study|Day 1 Assessment not Done|0|||
44551811|NCT03401112|79567867|FG002|Overall Study|Day 1 Assessment not Done|0|||
44551812|NCT03401112|79567868|FG003|Overall Study|Day 1 Assessment not Done|0|||
44551813|NCT03401112|79567869|FG004|Overall Study|Day 1 Assessment not Done|0|||
44551814|NCT03401112|79567865|FG000|Overall Study|Not Dosed|0|||
44551815|NCT03401112|79567866|FG001|Overall Study|Not Dosed|0|||
44551816|NCT03401112|79567867|FG002|Overall Study|Not Dosed|1|||
44551817|NCT03401112|79567868|FG003|Overall Study|Not Dosed|0|||
44551818|NCT03401112|79567869|FG004|Overall Study|Not Dosed|0|||
44551819|NCT03401112|79567865|FG000|Overall Study|Missed Clinical Visit|0|||
44551820|NCT03401112|79567866|FG001|Overall Study|Missed Clinical Visit|0|||
44551821|NCT03401112|79567867|FG002|Overall Study|Missed Clinical Visit|1|||
44551822|NCT03401112|79567868|FG003|Overall Study|Missed Clinical Visit|0|||
44551823|NCT03401112|79567869|FG004|Overall Study|Missed Clinical Visit|0|||
44551824|NCT03401112|79567865|FG000|Overall Study|Missed Doses|0|||
44551825|NCT03401112|79567866|FG001|Overall Study|Missed Doses|0|||
44551826|NCT03401112|79567867|FG002|Overall Study|Missed Doses|1|||
44551827|NCT03401112|79567868|FG003|Overall Study|Missed Doses|0|||
44551828|NCT03401112|79567869|FG004|Overall Study|Missed Doses|0|||
44551829|NCT02697916|79567898|FG000|Overall Study|Death|357|||
44551830|NCT02697916|79567899|FG001|Overall Study|Death|315|||
44551831|NCT02697916|79567898|FG000|Overall Study|Withdrawal by Subject|221|||
44551832|NCT02697916|79567899|FG001|Overall Study|Withdrawal by Subject|393|||
44551833|NCT03359473|79567918|FG000|Overall Study|Adverse Event|0|||
44551834|NCT03359473|79567919|FG001|Overall Study|Adverse Event|2|||
44551835|NCT03359473|79567920|FG002|Overall Study|Adverse Event|5|||
44551836|NCT03359473|79567921|FG003|Overall Study|Adverse Event|3|||
44551837|NCT03359473|79567918|FG000|Overall Study|Lost to Follow-up|0|||
44231112|NCT01857869|79043550|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
44231113|NCT01857869|79043541|FG000|Primary/Challenge Phase|Pregnancy|1|||
44231114|NCT01857869|79043542|FG001|Primary/Challenge Phase|Pregnancy|0|||
44231115|NCT01857869|79043543|FG002|Primary/Challenge Phase|Pregnancy|0|||
44551838|NCT03359473|79567919|FG001|Overall Study|Lost to Follow-up|1|||
44551839|NCT03359473|79567920|FG002|Overall Study|Lost to Follow-up|0|||
44551840|NCT03359473|79567921|FG003|Overall Study|Lost to Follow-up|0|||
44551841|NCT03359473|79567918|FG000|Overall Study|Physician Decision|0|||
44551842|NCT03359473|79567919|FG001|Overall Study|Physician Decision|1|||
44551843|NCT03359473|79567920|FG002|Overall Study|Physician Decision|0|||
44551844|NCT03359473|79567921|FG003|Overall Study|Physician Decision|1|||
44231116|NCT01857869|79043544|FG003|Primary/Challenge Phase|Pregnancy|0|||
44231117|NCT01857869|79043545|FG004|Primary/Challenge Phase|Pregnancy|0|||
44231118|NCT01857869|79043546|FG005|Primary/Challenge Phase|Pregnancy|0|||
44231119|NCT01857869|79043547|FG006|Primary/Challenge Phase|Pregnancy|0|||
44231120|NCT01857869|79043548|FG007|Primary/Challenge Phase|Pregnancy|0|||
44231121|NCT01857869|79043549|FG008|Primary/Challenge Phase|Pregnancy|0|||
44231122|NCT01857869|79043550|FG009|Primary/Challenge Phase|Pregnancy|0|||
44231123|NCT01857869|79043541|FG000|Primary/Challenge Phase|Protocol Violation|1|||
44551845|NCT03359473|79567918|FG000|Overall Study|Withdrawal by Subject|1|||
44231124|NCT01857869|79043542|FG001|Primary/Challenge Phase|Protocol Violation|0|||
44551846|NCT03359473|79567919|FG001|Overall Study|Withdrawal by Subject|2|||
44551847|NCT03359473|79567920|FG002|Overall Study|Withdrawal by Subject|1|||
44551848|NCT03359473|79567921|FG003|Overall Study|Withdrawal by Subject|0|||
44551849|NCT03359473|79567918|FG000|Overall Study|Protocol-defined stopping criteria|1|||
44551850|NCT03359473|79567919|FG001|Overall Study|Protocol-defined stopping criteria|0|||
44551851|NCT03359473|79567920|FG002|Overall Study|Protocol-defined stopping criteria|0|||
44551852|NCT03359473|79567921|FG003|Overall Study|Protocol-defined stopping criteria|1|||
44551853|NCT03589469|79567934|FG000|Overall Study|Withdrawal by Subject|8|||
44551854|NCT03589469|79567934|FG000|Overall Study|Physician Decision|20|||
44551855|NCT03589469|79567934|FG000|Overall Study|Death|97|||
44551856|NCT03589469|79567934|FG000|Overall Study|Lost to Follow-up|8|||
44231125|NCT01857869|79043543|FG002|Primary/Challenge Phase|Protocol Violation|0|||
44231126|NCT01857869|79043544|FG003|Primary/Challenge Phase|Protocol Violation|0|||
44231127|NCT01857869|79043545|FG004|Primary/Challenge Phase|Protocol Violation|0|||
44376649|NCT00858208|79381909|FG000|Overall Study|Adverse Event|3|||
44551857|NCT03589469|79567934|FG000|Overall Study|Miscellaneous|1|||
44551858|NCT03359395|79567940|FG000|First Intervention A / B|Withdrawal by Subject|1|||
44231128|NCT01857869|79043546|FG005|Primary/Challenge Phase|Protocol Violation|0|||
44551859|NCT03359395|79567941|FG001|First Intervention A / B|Withdrawal by Subject|0|||
44551860|NCT03359395|79567940|FG000|First Intervention A / B|Lost to Follow-up|2|||
44551861|NCT03359395|79567941|FG001|First Intervention A / B|Lost to Follow-up|3|||
44551862|NCT03359395|79567940|FG000|Second Intervention B/A|Exclusion criteria|0|||
44551863|NCT03359395|79567941|FG001|Second Intervention B/A|Exclusion criteria|1|||
44551864|NCT03359395|79567940|FG000|Second Intervention B/A|Lost to Follow-up|3|||
44551865|NCT03359395|79567941|FG001|Second Intervention B/A|Lost to Follow-up|2|||
44551866|NCT03586427|79567952|FG000|Overall Study|Lost to Follow-up|0|||
44551867|NCT03586427|79567953|FG001|Overall Study|Lost to Follow-up|3|||
44551868|NCT03586427|79567954|FG002|Overall Study|Lost to Follow-up|1|||
44551869|NCT03586427|79567955|FG003|Overall Study|Lost to Follow-up|3|||
44551870|NCT03586427|79567956|FG004|Overall Study|Lost to Follow-up|3|||
44551871|NCT03586427|79567952|FG000|Overall Study|Withdrawal by Subject|0|||
44551872|NCT03586427|79567953|FG001|Overall Study|Withdrawal by Subject|1|||
44551873|NCT03586427|79567954|FG002|Overall Study|Withdrawal by Subject|2|||
44551874|NCT03586427|79567955|FG003|Overall Study|Withdrawal by Subject|1|||
44551875|NCT03586427|79567956|FG004|Overall Study|Withdrawal by Subject|1|||
44551876|NCT03586427|79567952|FG000|Overall Study|Adverse Event|0|||
44551877|NCT03586427|79567953|FG001|Overall Study|Adverse Event|0|||
44551878|NCT03586427|79567954|FG002|Overall Study|Adverse Event|1|||
44551879|NCT03586427|79567955|FG003|Overall Study|Adverse Event|0|||
44551880|NCT03586427|79567956|FG004|Overall Study|Adverse Event|0|||
44551881|NCT03586427|79567952|FG000|Overall Study|Protocol Violation|0|||
44551882|NCT03586427|79567953|FG001|Overall Study|Protocol Violation|0|||
44551883|NCT03586427|79567954|FG002|Overall Study|Protocol Violation|1|||
44551884|NCT03586427|79567955|FG003|Overall Study|Protocol Violation|0|||
44551885|NCT03586427|79567956|FG004|Overall Study|Protocol Violation|1|||
44551886|NCT03586427|79567952|FG000|Overall Study|Noncompliance with study drug|0|||
44551887|NCT03586427|79567953|FG001|Overall Study|Noncompliance with study drug|0|||
44551888|NCT03586427|79567954|FG002|Overall Study|Noncompliance with study drug|1|||
44551889|NCT03586427|79567955|FG003|Overall Study|Noncompliance with study drug|0|||
44551890|NCT03586427|79567956|FG004|Overall Study|Noncompliance with study drug|0|||
44551891|NCT03648983|79567973|FG000|Overall Study|Study was terminated due to PI departure|95|||
44551892|NCT02695420|79567982|FG000|Overall Study|Death|0|||
44551893|NCT02695420|79567983|FG001|Overall Study|Death|1|||
44551894|NCT02695420|79567984|FG002|Overall Study|Death|0|||
44551895|NCT02695420|79567985|FG003|Overall Study|Death|0|||
44551896|NCT03358147|79568003|FG000|Overall Study|Withdrawal by Subject|13|||
44551897|NCT03358147|79568004|FG001|Overall Study|Withdrawal by Subject|19|||
44551898|NCT03358147|79568005|FG002|Overall Study|Withdrawal by Subject|16|||
44551899|NCT03358147|79568006|FG003|Overall Study|Withdrawal by Subject|10|||
44551900|NCT03358147|79568007|FG004|Overall Study|Withdrawal by Subject|5|||
44551901|NCT03358147|79568003|FG000|Overall Study|Adverse Event|3|||
44551902|NCT03358147|79568004|FG001|Overall Study|Adverse Event|9|||
44551903|NCT03358147|79568005|FG002|Overall Study|Adverse Event|7|||
44551904|NCT03358147|79568006|FG003|Overall Study|Adverse Event|5|||
44495316|NCT03822884|79501048|FG005|Overall Study|Withdrawal by Subject|0|||
44495317|NCT03822416|79501058|FG000|Overall Study|Lost to Follow-up|1|||
44495318|NCT03822416|79501059|FG001|Overall Study|Lost to Follow-up|0|||
44495319|NCT03822416|79501058|FG000|Overall Study|Withdrawal by Subject|0|||
44495320|NCT03822416|79501059|FG001|Overall Study|Withdrawal by Subject|1|||
44495321|NCT04405570|79501069|FG000|Overall Study|Adverse Event|0|||
44495322|NCT04405570|79501070|FG001|Overall Study|Adverse Event|1|||
44495323|NCT04405570|79501071|FG002|Overall Study|Adverse Event|1|||
44495324|NCT04405570|79501072|FG003|Overall Study|Adverse Event|1|||
44495325|NCT04405570|79501069|FG000|Overall Study|Lost to Follow-up|0|||
44495326|NCT04405570|79501070|FG001|Overall Study|Lost to Follow-up|1|||
44495327|NCT04405570|79501071|FG002|Overall Study|Lost to Follow-up|0|||
44495328|NCT04405570|79501072|FG003|Overall Study|Lost to Follow-up|0|||
44495329|NCT04405570|79501069|FG000|Overall Study|Physician Decision|0|||
44495330|NCT04405570|79501070|FG001|Overall Study|Physician Decision|0|||
44495331|NCT04405570|79501071|FG002|Overall Study|Physician Decision|1|||
44551905|NCT03358147|79568007|FG004|Overall Study|Adverse Event|2|||
44551906|NCT03358147|79568003|FG000|Overall Study|Lost to Follow-up|4|||
44551907|NCT03358147|79568004|FG001|Overall Study|Lost to Follow-up|3|||
44551908|NCT03358147|79568005|FG002|Overall Study|Lost to Follow-up|7|||
44231129|NCT01857869|79043547|FG006|Primary/Challenge Phase|Protocol Violation|0|||
44231130|NCT01857869|79043548|FG007|Primary/Challenge Phase|Protocol Violation|0|||
44551909|NCT03358147|79568006|FG003|Overall Study|Lost to Follow-up|6|||
44551910|NCT03358147|79568007|FG004|Overall Study|Lost to Follow-up|4|||
44551911|NCT03358147|79568003|FG000|Overall Study|Major Protocol Deviation|11|||
44551912|NCT03358147|79568004|FG001|Overall Study|Major Protocol Deviation|3|||
44495332|NCT04405570|79501072|FG003|Overall Study|Physician Decision|0|||
44495333|NCT04405570|79501069|FG000|Overall Study|Withdrawal by Subject|0|||
44495334|NCT04405570|79501070|FG001|Overall Study|Withdrawal by Subject|1|||
44495335|NCT04405570|79501071|FG002|Overall Study|Withdrawal by Subject|1|||
44551913|NCT03358147|79568005|FG002|Overall Study|Major Protocol Deviation|2|||
44551914|NCT03358147|79568006|FG003|Overall Study|Major Protocol Deviation|3|||
44551915|NCT03358147|79568007|FG004|Overall Study|Major Protocol Deviation|1|||
44551916|NCT03358147|79568003|FG000|Overall Study|Protocol specified criteria|2|||
44551917|NCT03358147|79568004|FG001|Overall Study|Protocol specified criteria|3|||
44551918|NCT03358147|79568005|FG002|Overall Study|Protocol specified criteria|0|||
44551919|NCT03358147|79568006|FG003|Overall Study|Protocol specified criteria|3|||
44551920|NCT03358147|79568007|FG004|Overall Study|Protocol specified criteria|1|||
44551921|NCT03358147|79568003|FG000|Overall Study|Physician Decision|1|||
44551922|NCT03358147|79568004|FG001|Overall Study|Physician Decision|0|||
44551923|NCT03358147|79568005|FG002|Overall Study|Physician Decision|1|||
44551924|NCT03358147|79568006|FG003|Overall Study|Physician Decision|6|||
44551925|NCT03358147|79568007|FG004|Overall Study|Physician Decision|1|||
44551926|NCT03358147|79568003|FG000|Overall Study|Administrative reasons|0|||
44551927|NCT03358147|79568004|FG001|Overall Study|Administrative reasons|1|||
44551928|NCT03358147|79568005|FG002|Overall Study|Administrative reasons|0|||
44551929|NCT03358147|79568006|FG003|Overall Study|Administrative reasons|3|||
44551930|NCT03358147|79568007|FG004|Overall Study|Administrative reasons|0|||
44551931|NCT03358147|79568003|FG000|Overall Study|Lack of Efficacy|0|||
44551932|NCT03358147|79568004|FG001|Overall Study|Lack of Efficacy|1|||
44551933|NCT03358147|79568005|FG002|Overall Study|Lack of Efficacy|1|||
44551934|NCT03358147|79568006|FG003|Overall Study|Lack of Efficacy|0|||
44551935|NCT03358147|79568007|FG004|Overall Study|Lack of Efficacy|0|||
44551936|NCT03093402|79568023|FG000|Overall Study|Lost to Follow-up|1|||
44551937|NCT03093402|79568024|FG001|Overall Study|Lost to Follow-up|0|||
44551938|NCT03093402|79568025|FG002|Overall Study|Lost to Follow-up|0|||
44551939|NCT03093402|79568026|FG003|Overall Study|Lost to Follow-up|0|||
44551940|NCT03093402|79568023|FG000|Overall Study|Withdrawal by Subject|3|||
44551941|NCT03093402|79568024|FG001|Overall Study|Withdrawal by Subject|3|||
44551942|NCT03093402|79568025|FG002|Overall Study|Withdrawal by Subject|0|||
44551943|NCT03093402|79568026|FG003|Overall Study|Withdrawal by Subject|1|||
44551944|NCT03093402|79568023|FG000|Overall Study|Withdrew prior to dosing|2|||
44551945|NCT03093402|79568024|FG001|Overall Study|Withdrew prior to dosing|1|||
44551946|NCT03093402|79568025|FG002|Overall Study|Withdrew prior to dosing|2|||
44551947|NCT03093402|79568026|FG003|Overall Study|Withdrew prior to dosing|3|||
44551948|NCT03093402|79568023|FG000|Overall Study|Ineligible for study|1|||
44551949|NCT03093402|79568024|FG001|Overall Study|Ineligible for study|0|||
44551950|NCT03093402|79568025|FG002|Overall Study|Ineligible for study|0|||
44551951|NCT03093402|79568026|FG003|Overall Study|Ineligible for study|0|||
44551952|NCT03093402|79568023|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
44231131|NCT01857869|79043549|FG008|Primary/Challenge Phase|Protocol Violation|0|||
44231132|NCT01857869|79043550|FG009|Primary/Challenge Phase|Protocol Violation|0|||
44231133|NCT01857869|79043541|FG000|Primary/Challenge Phase|Other|1|||
44231134|NCT01857869|79043542|FG001|Primary/Challenge Phase|Other|1|||
44231135|NCT01857869|79043543|FG002|Primary/Challenge Phase|Other|0|||
44231136|NCT01857869|79043544|FG003|Primary/Challenge Phase|Other|0|||
44231137|NCT01857869|79043545|FG004|Primary/Challenge Phase|Other|0|||
44231138|NCT01857869|79043546|FG005|Primary/Challenge Phase|Other|0|||
44231139|NCT01857869|79043547|FG006|Primary/Challenge Phase|Other|0|||
44231140|NCT01857869|79043548|FG007|Primary/Challenge Phase|Other|0|||
44231141|NCT01857869|79043549|FG008|Primary/Challenge Phase|Other|0|||
44231142|NCT01857869|79043550|FG009|Primary/Challenge Phase|Other|0|||
44231143|NCT01857869|79043541|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231144|NCT01857869|79043542|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44551953|NCT03093402|79568024|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
44231145|NCT01857869|79043543|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231146|NCT01857869|79043544|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
44551954|NCT03093402|79568025|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
44551955|NCT03093402|79568026|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
44551956|NCT03585959|79568036|FG000|Overall Study|Physician Decision|1|||
44551957|NCT03585959|79568036|FG000|Overall Study|Unsuccessful Procedure|2|||
44551958|NCT03584789|79568045|FG000|Overall Study|refused EHR permission|19|||
44551959|NCT03584789|79568046|FG001|Overall Study|refused EHR permission|28|||
44551960|NCT03584789|79568047|FG002|Overall Study|refused EHR permission|23|||
44551961|NCT03584789|79568045|FG000|Overall Study|patients tied to a provider who retired|0|||
44551962|NCT03584789|79568046|FG001|Overall Study|patients tied to a provider who retired|0|||
44551963|NCT03584789|79568047|FG002|Overall Study|patients tied to a provider who retired|3|||
44231147|NCT01857869|79043545|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231148|NCT01857869|79043546|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231149|NCT01857869|79043547|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231150|NCT01857869|79043548|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231151|NCT01857869|79043549|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231152|NCT01857869|79043550|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
44231153|NCT01857869|79043541|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231154|NCT01857869|79043542|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231155|NCT01857869|79043543|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231156|NCT01857869|79043544|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
44231157|NCT01857869|79043545|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231158|NCT01857869|79043546|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231159|NCT01857869|79043547|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231160|NCT01857869|79043548|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231161|NCT01857869|79043549|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44231162|NCT01857869|79043550|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
44495336|NCT04405570|79501072|FG003|Overall Study|Withdrawal by Subject|0|||
44495337|NCT04405570|79501069|FG000|Overall Study|Randomized not dosed|0|||
44495338|NCT04405570|79501070|FG001|Overall Study|Randomized not dosed|2|||
44495339|NCT04405570|79501071|FG002|Overall Study|Randomized not dosed|0|||
44495340|NCT04405570|79501072|FG003|Overall Study|Randomized not dosed|0|||
44495341|NCT00127712|79501087|FG000|Overall Study|Adverse Event|3|||
44495342|NCT00127712|79501088|FG001|Overall Study|Adverse Event|0|||
44495343|NCT00127712|79501087|FG000|Overall Study|Lack of GI access to continue|2|||
44495344|NCT00127712|79501088|FG001|Overall Study|Lack of GI access to continue|0|||
44495345|NCT04404010|79501096|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
44495346|NCT04404010|79501097|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
44495347|NCT04401202|79501107|FG000|Overall Study|Lost to Follow-up|2|||
44495348|NCT04401202|79501108|FG001|Overall Study|Lost to Follow-up|2|||
44495349|NCT04401202|79501107|FG000|Overall Study|Adverse Event|0|||
44495350|NCT04401202|79501108|FG001|Overall Study|Adverse Event|1|||
44495351|NCT04401202|79501107|FG000|Overall Study|Hospitalized|4|||
44495352|NCT04401202|79501108|FG001|Overall Study|Hospitalized|1|||
44495353|NCT00096356|79501117|FG000|Overall Study|Adverse Event|11|||
44495354|NCT00096356|79501118|FG001|Overall Study|Adverse Event|9|||
44495355|NCT00096356|79501117|FG000|Overall Study|Physician Decision|5|||
44495356|NCT00096356|79501118|FG001|Overall Study|Physician Decision|3|||
44495357|NCT00096356|79501117|FG000|Overall Study|Withdrawal by Subject|17|||
44495358|NCT00096356|79501118|FG001|Overall Study|Withdrawal by Subject|23|||
44495359|NCT00096356|79501117|FG000|Overall Study|Lack of Efficacy|1|||
44495360|NCT00096356|79501118|FG001|Overall Study|Lack of Efficacy|0|||
44495361|NCT00096356|79501117|FG000|Overall Study|multiple reasons|10|||
44495362|NCT00096356|79501118|FG001|Overall Study|multiple reasons|18|||
44495363|NCT04358068|79501127|FG000|Overall Study|Did not initiate study treatment|2|||
44495364|NCT04358068|79501128|FG001|Overall Study|Did not initiate study treatment|2|||
44495365|NCT03694210|79501134|FG000|Overall Study|Death|1|||
44495366|NCT03694210|79501134|FG000|Overall Study|Screen Failure|7|||
44495367|NCT04339972|79501142|FG000|Overall Study|Scheduling Issues|3|||
44495368|NCT04339972|79501143|FG001|Overall Study|Scheduling Issues|3|||
44274783|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
44274784|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
44274785|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
44274786|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
44274787|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
44274788|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
44274789|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
44274790|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
44274791|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
44274792|NCT03732638|79221000|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
44274793|NCT03732638|79221001|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
44274794|NCT03732638|79221000|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
44274795|NCT03732638|79221001|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
44274796|NCT03732638|79221000|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
44274797|NCT03732638|79221001|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
44274798|NCT03732638|79221000|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
44274799|NCT03732638|79221001|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
44274800|NCT03732638|79221000|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
44274801|NCT03732638|79221001|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
44274802|NCT03266588|79221040|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
44274803|NCT03266588|79221041|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
44274804|NCT03266588|79221042|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
44274805|NCT03266588|79221040|FG000|Observational Period|Withdrawal by Subject|44|||
44376650|NCT00858208|79381909|FG000|Overall Study|Lost to Follow-up|26|||
44376651|NCT00858208|79381909|FG000|Overall Study|Participant refused|40|||
44495369|NCT04339972|79501142|FG000|Overall Study|dropout|1|||
44551964|NCT03343639|79568057|FG000|Overall Study|Withdrawal by Subject|10|||
44551965|NCT03343639|79568058|FG001|Overall Study|Withdrawal by Subject|6|||
44551966|NCT03343639|79568057|FG000|Overall Study|Lost to Follow-up|4|||
44551967|NCT03343639|79568058|FG001|Overall Study|Lost to Follow-up|5|||
44551968|NCT03343639|79568057|FG000|Overall Study|Protocol Violation|0|||
44551969|NCT03343639|79568058|FG001|Overall Study|Protocol Violation|1|||
44231163|NCT04452318|79043638|FG000|Overall Study|Physician Decision|1|||
44231164|NCT04452318|79043639|FG001|Overall Study|Physician Decision|2|||
44231165|NCT04452318|79043640|FG002|Overall Study|Physician Decision|0|||
44231166|NCT04452318|79043641|FG003|Overall Study|Physician Decision|2|||
44231167|NCT04452318|79043642|FG004|Overall Study|Physician Decision|0|||
44231168|NCT04452318|79043643|FG005|Overall Study|Physician Decision|2|||
44231169|NCT04452318|79043644|FG006|Overall Study|Physician Decision|5|||
44231170|NCT04452318|79043638|FG000|Overall Study|Death|2|||
44231171|NCT04452318|79043639|FG001|Overall Study|Death|3|||
44231172|NCT04452318|79043640|FG002|Overall Study|Death|0|||
44231173|NCT04452318|79043641|FG003|Overall Study|Death|0|||
44231174|NCT04452318|79043642|FG004|Overall Study|Death|0|||
44231175|NCT04452318|79043643|FG005|Overall Study|Death|0|||
44231176|NCT04452318|79043644|FG006|Overall Study|Death|0|||
44231177|NCT04452318|79043638|FG000|Overall Study|Lost to Follow-up|38|||
44231178|NCT04452318|79043639|FG001|Overall Study|Lost to Follow-up|28|||
44231179|NCT04452318|79043640|FG002|Overall Study|Lost to Follow-up|0|||
44274806|NCT03266588|79221041|FG001|Observational Period|Withdrawal by Subject|22|||
44495370|NCT04339972|79501143|FG001|Overall Study|dropout|1|||
44495371|NCT04339972|79501142|FG000|Overall Study|Technical issues|1|||
44495372|NCT04339972|79501143|FG001|Overall Study|Technical issues|0|||
44495373|NCT04339972|79501142|FG000|Overall Study|Claustraphobia|0|||
44495374|NCT04339972|79501143|FG001|Overall Study|Claustraphobia|1|||
44495375|NCT00096278|79501151|FG000|Overall Study|No follow-up data|15|||
44495376|NCT00096278|79501152|FG001|Overall Study|No follow-up data|18|||
44495377|NCT00096278|79501151|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
44495378|NCT00096278|79501152|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
44495379|NCT00095940|79501167|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
44495380|NCT00095940|79501168|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
44551970|NCT03647267|79568066|FG000|Overall Study|Lost to Follow-up|1|||
44551971|NCT03647267|79568067|FG001|Overall Study|Lost to Follow-up|0|||
44551972|NCT03356977|79568075|FG000|Overall Study|Lost to Follow-up|3|||
44551973|NCT03356977|79568075|FG000|Overall Study|Withdrawal by parent/guardian|2|||
44274807|NCT03266588|79221042|FG002|Observational Period|Withdrawal by Subject|13|||
44376652|NCT00858208|79381909|FG000|Overall Study|Other|10|||
44495381|NCT00095940|79501169|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
44495382|NCT00095940|79501170|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
44495383|NCT00095940|79501171|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
44551974|NCT02690974|79568079|FG000|Overall Study|Adverse Event|16|||
44231180|NCT04452318|79043641|FG003|Overall Study|Lost to Follow-up|3|||
44231181|NCT04452318|79043642|FG004|Overall Study|Lost to Follow-up|3|||
44231182|NCT04452318|79043643|FG005|Overall Study|Lost to Follow-up|2|||
44551975|NCT02690974|79568079|FG000|Overall Study|Death|9|||
44551976|NCT02690974|79568079|FG000|Overall Study|Subject/guardian decision|4|||
44551977|NCT02690974|79568079|FG000|Overall Study|Lost to Follow-up|3|||
44551978|NCT02690974|79568079|FG000|Overall Study|Withdrawal of Informed Consent|3|||
44551979|NCT02690974|79568079|FG000|Overall Study|Physician Decision|2|||
44551980|NCT02690974|79568079|FG000|Overall Study|Non-compliance with study treatment|1|||
44551981|NCT02690974|79568079|FG000|Overall Study|Protocol-defined stopping criteria|1|||
44551982|NCT02690974|79568079|FG000|Overall Study|Protocol Deviation|1|||
44551983|NCT03093324|79568085|FG000|Overall Study|Adverse Event|4|||
44551984|NCT03093324|79568086|FG001|Overall Study|Adverse Event|15|||
44551985|NCT03093324|79568085|FG000|Overall Study|Lost to Follow-up|1|||
44551986|NCT03093324|79568086|FG001|Overall Study|Lost to Follow-up|0|||
44551987|NCT03093324|79568085|FG000|Overall Study|Protocol Deviation|2|||
44551988|NCT03093324|79568086|FG001|Overall Study|Protocol Deviation|2|||
44551989|NCT03093324|79568085|FG000|Overall Study|Withdrawal by Subject|2|||
44551990|NCT03093324|79568086|FG001|Overall Study|Withdrawal by Subject|2|||
44551991|NCT03584009|79568094|FG000|Overall Study|Death|25|||
44551992|NCT03584009|79568095|FG001|Overall Study|Death|18|||
44551993|NCT03584009|79568094|FG000|Overall Study|Lost to Follow-up|0|||
44231183|NCT04452318|79043644|FG006|Overall Study|Lost to Follow-up|1|||
44231184|NCT04452318|79043638|FG000|Overall Study|Withdrawal by Subject|46|||
44231185|NCT04452318|79043639|FG001|Overall Study|Withdrawal by Subject|40|||
44231186|NCT04452318|79043640|FG002|Overall Study|Withdrawal by Subject|0|||
44231187|NCT04452318|79043641|FG003|Overall Study|Withdrawal by Subject|18|||
44231188|NCT04452318|79043642|FG004|Overall Study|Withdrawal by Subject|6|||
44495384|NCT00095940|79501172|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
44495385|NCT00095940|79501173|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
44495386|NCT00095940|79501174|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
44231189|NCT04452318|79043643|FG005|Overall Study|Withdrawal by Subject|8|||
44231190|NCT04452318|79043644|FG006|Overall Study|Withdrawal by Subject|6|||
44231191|NCT00634101|79043821|FG000|Overall Study|Study Terminated|3|||
44495387|NCT00095940|79501175|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
44495388|NCT00095940|79501167|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
44495389|NCT00095940|79501168|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
44495390|NCT00095940|79501169|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
44495391|NCT00095940|79501170|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
44495392|NCT00095940|79501171|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
44495393|NCT00095940|79501172|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
44495394|NCT00095940|79501173|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
44495395|NCT00095940|79501174|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
44495396|NCT00095940|79501175|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
44495397|NCT00095940|79501167|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
44495398|NCT00095940|79501168|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
44495399|NCT00095940|79501169|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
44495400|NCT00095940|79501170|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
44495401|NCT00095940|79501171|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
44551994|NCT03584009|79568095|FG001|Overall Study|Lost to Follow-up|1|||
44551995|NCT03584009|79568094|FG000|Overall Study|Physician Decision|1|||
44231192|NCT00634101|79043822|FG001|Overall Study|Study Terminated|3|||
44495402|NCT00095940|79501172|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
44551996|NCT03584009|79568095|FG001|Overall Study|Physician Decision|1|||
44551997|NCT03584009|79568094|FG000|Overall Study|Study Terminated by Sponsor|22|||
44551998|NCT03584009|79568095|FG001|Overall Study|Study Terminated by Sponsor|30|||
44551999|NCT03584009|79568094|FG000|Overall Study|Withdrawal by Subject|3|||
44552000|NCT03584009|79568095|FG001|Overall Study|Withdrawal by Subject|2|||
44552001|NCT04167462|79568106|FG000|Overall Study|Other reasons|3|||
44552002|NCT04167462|79568107|FG001|Overall Study|Other reasons|2|||
44552003|NCT04167462|79568106|FG000|Overall Study|Withdrawal by Subject|6|||
44552004|NCT04167462|79568107|FG001|Overall Study|Withdrawal by Subject|7|||
44552005|NCT04167462|79568106|FG000|Overall Study|Adverse Event|4|||
44231193|NCT00634101|79043821|FG000|Overall Study|Lost to Follow-up|2|||
44552006|NCT04167462|79568107|FG001|Overall Study|Adverse Event|0|||
44552007|NCT04167462|79568106|FG000|Overall Study|Pregnancy|1|||
44552008|NCT04167462|79568107|FG001|Overall Study|Pregnancy|0|||
44552009|NCT04167462|79568106|FG000|Overall Study|Lack of Efficacy|0|||
44552010|NCT04167462|79568107|FG001|Overall Study|Lack of Efficacy|1|||
44552011|NCT03583385|79568114|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44552012|NCT03583385|79568115|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44552013|NCT03583385|79568114|FG000|Treatment Period 2|Adverse Event|1|||
44231194|NCT00634101|79043822|FG001|Overall Study|Lost to Follow-up|0|||
44231195|NCT00633477|79043839|FG000|Overall Study|Death|1|||
44231196|NCT00633477|79043840|FG001|Overall Study|Death|0|||
44231197|NCT00633477|79043839|FG000|Overall Study|Randomized but not treated|1|||
44231198|NCT00633477|79043840|FG001|Overall Study|Randomized but not treated|0|||
44231199|NCT00331773|79043865|FG000|Overall Study|Withdrawal by Subject|6|||
44274808|NCT03266588|79221040|FG000|Observational Period|Non-compliance|18|||
44274809|NCT03266588|79221041|FG001|Observational Period|Non-compliance|12|||
44376653|NCT01071200|79381915|FG000|Overall Study|Lack of ovarian response|1|||
44552014|NCT03583385|79568115|FG001|Treatment Period 2|Adverse Event|0|||
44552015|NCT04350372|79568121|FG000|Overall Study|Death|1|||
44552016|NCT02949973|79568125|FG000|Overall Study|Physician Decision|1|||
44552017|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
44552018|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
44552019|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Adverse Event|2|||
44552020|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Adverse Event|5|||
44552021|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
44552022|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
44552023|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
44552024|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
44552025|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Randomized by error|0|||
44552026|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Randomized by error|5|||
44552027|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
44552028|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
44552029|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
44552030|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
44552031|NCT02948959|79568131|FG000|52 Weeks Treatment Period|Change of residence location|0|||
44552032|NCT02948959|79568132|FG001|52 Weeks Treatment Period|Change of residence location|1|||
44552033|NCT02948959|79568131|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
44552034|NCT02948959|79568132|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
44552035|NCT02948959|79568131|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
44552036|NCT02948959|79568132|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
44552037|NCT02948959|79568131|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
44552038|NCT02948959|79568132|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
44552039|NCT02948959|79568131|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
44552040|NCT02948959|79568132|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
44552041|NCT02948959|79568131|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
44552042|NCT02948959|79568132|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
44552043|NCT02948959|79568131|FG000|12 Weeks Follow-up Period|Study site closure|1|||
44552044|NCT02948959|79568132|FG001|12 Weeks Follow-up Period|Study site closure|0|||
44274810|NCT03266588|79221042|FG002|Observational Period|Non-compliance|10|||
44552045|NCT03582215|79568154|FG000|Overall Study|Adverse Event|1|||
44552046|NCT03582215|79568155|FG001|Overall Study|Adverse Event|0|||
44552047|NCT03582215|79568156|FG002|Overall Study|Adverse Event|0|||
44231200|NCT00331773|79043866|FG001|Overall Study|Withdrawal by Subject|4|||
44274811|NCT03266588|79221040|FG000|Observational Period|Lost to Follow-up|8|||
44552048|NCT03582215|79568157|FG003|Overall Study|Adverse Event|0|||
44231201|NCT00331773|79043865|FG000|Overall Study|Protocol Violation|10|||
44552049|NCT03582215|79568158|FG004|Overall Study|Adverse Event|0|||
44552050|NCT03582215|79568159|FG005|Overall Study|Adverse Event|0|||
44552051|NCT03582215|79568160|FG006|Overall Study|Adverse Event|2|||
44552052|NCT03582215|79568161|FG007|Overall Study|Adverse Event|2|||
44552053|NCT03089580|79568190|FG000|Overall Study|Lost to Follow-up|2|||
44552054|NCT03645395|79568200|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
44552055|NCT03645395|79568201|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
44552056|NCT03645395|79568202|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
44552057|NCT03645395|79568203|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
44552058|NCT03645395|79568200|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
44552059|NCT03645395|79568201|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
44552060|NCT03645395|79568202|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
44552061|NCT03645395|79568203|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
44552062|NCT03645395|79568200|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
44552063|NCT03645395|79568201|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
44552064|NCT03645395|79568202|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
44552065|NCT03645395|79568203|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
44552066|NCT03645395|79568200|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
44552067|NCT03645395|79568201|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
44552068|NCT03645395|79568202|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
44552069|NCT03645395|79568203|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
44552070|NCT03342469|79568216|FG000|Overall Study|Withdrawal by Subject|0|||
44552071|NCT03342469|79568217|FG001|Overall Study|Withdrawal by Subject|1|||
44552072|NCT03342469|79568218|FG002|Overall Study|Withdrawal by Subject|0|||
44552073|NCT03342469|79568219|FG003|Overall Study|Withdrawal by Subject|0|||
44552074|NCT03581825|79568230|FG000|Period 1|Lens Discomfort|1|||
44552075|NCT03581825|79568231|FG001|Period 1|Lens Discomfort|0|||
44495403|NCT00095940|79501173|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
44495404|NCT00095940|79501174|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
44495405|NCT00095940|79501175|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
44495406|NCT00114218|79501193|FG000|Overall Study|Wrong Cell Type|2|||
44495407|NCT00114218|79501193|FG000|Overall Study|Wrong Primary|1|||
44495408|NCT00114218|79501193|FG000|Overall Study|Never Treated|1|||
44495409|NCT00095628|79501197|FG000|Overall Study|Disease progression prior to treatment|1|||
44495410|NCT04380142|79501203|FG000|LD/CD Stabilization Period|Adverse Event|3|||
44495411|NCT04380142|79501204|FG001|LD/CD Stabilization Period|Adverse Event|0|||
44552076|NCT03581825|79568230|FG000|Period 2|Unsatisfactory Vision to Test|0|||
44552077|NCT03581825|79568231|FG001|Period 2|Unsatisfactory Vision to Test|1|||
44552078|NCT03342001|79568237|FG000|Overall Study|Adverse Event|1|||
44552079|NCT03342001|79568237|FG000|Overall Study|Lost to Follow-up|1|||
44552080|NCT03341923|79568241|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
44495412|NCT04380142|79501205|FG002|LD/CD Stabilization Period|Adverse Event|0|||
44552081|NCT03341923|79568242|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
44552082|NCT03579719|79568250|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
44552083|NCT03341533|79568256|FG000|Overall Study|Withdrawal by Subject|1|||
44552084|NCT03341533|79568257|FG001|Overall Study|Withdrawal by Subject|1|||
44552085|NCT03341533|79568256|FG000|Overall Study|Not eligible after randomization|2|||
44552086|NCT03341533|79568257|FG001|Overall Study|Not eligible after randomization|1|||
44552087|NCT02688088|79568263|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
44552088|NCT02688088|79568264|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
44552089|NCT02688088|79568265|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
44552090|NCT02688088|79568266|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
44552091|NCT02688088|79568267|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
44552092|NCT02688088|79568263|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
44552093|NCT02688088|79568264|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
44552094|NCT02688088|79568265|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
44552095|NCT02688088|79568266|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
44552096|NCT02688088|79568267|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
44552097|NCT02688088|79568263|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
44552098|NCT02688088|79568264|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
44552099|NCT02688088|79568265|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
44552100|NCT02688088|79568266|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
44552101|NCT02688088|79568267|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
44552102|NCT02688088|79568263|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
44552103|NCT02688088|79568264|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
44552104|NCT02688088|79568265|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
44552105|NCT02688088|79568266|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
44552106|NCT02688088|79568267|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
44552107|NCT02688088|79568263|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
44552108|NCT02688088|79568264|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
44552109|NCT02688088|79568265|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
44552110|NCT02688088|79568266|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
44552111|NCT02688088|79568267|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
44552112|NCT02688088|79568263|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
44552113|NCT02688088|79568264|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
44552114|NCT02688088|79568265|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
44552115|NCT02688088|79568266|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
44552116|NCT02688088|79568267|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
44552117|NCT02688088|79568263|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
44552118|NCT02688088|79568264|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
44552119|NCT02688088|79568265|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
44552120|NCT02688088|79568266|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
44552121|NCT02688088|79568267|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
44552122|NCT02688088|79568263|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
44231202|NCT00331773|79043866|FG001|Overall Study|Protocol Violation|3|||
44231203|NCT00633243|79043899|FG000|Overall Study|Withdrawal by Subject|0|||
44231204|NCT00633243|79043900|FG001|Overall Study|Withdrawal by Subject|1|||
44231205|NCT00633243|79043899|FG000|Overall Study|incarceration|0|||
44231206|NCT00633243|79043900|FG001|Overall Study|incarceration|2|||
44231207|NCT00633243|79043899|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
44231208|NCT00633243|79043900|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
44231209|NCT00633243|79043899|FG000|Overall Study|Not comfortable with self-injecting|0|||
44231210|NCT00633243|79043900|FG001|Overall Study|Not comfortable with self-injecting|1|||
44231211|NCT00633243|79043899|FG000|Overall Study|Mental Health--Depression|0|||
44231212|NCT00633243|79043900|FG001|Overall Study|Mental Health--Depression|1|||
44231213|NCT00633243|79043899|FG000|Overall Study|Couldn't tolerate side-effects|1|||
44231214|NCT00633243|79043900|FG001|Overall Study|Couldn't tolerate side-effects|1|||
44231215|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
44231216|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
44231217|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
44231218|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
44231219|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
44231220|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
44231221|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
44231222|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
44231223|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
44552123|NCT02688088|79568264|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
44552124|NCT02688088|79568265|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
44552125|NCT02688088|79568266|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
44552126|NCT02688088|79568267|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
44552127|NCT02688088|79568263|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
44552128|NCT02688088|79568264|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
44552129|NCT02688088|79568265|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
44552130|NCT02688088|79568266|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
44552131|NCT02688088|79568267|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
44552132|NCT03641651|79568292|FG000|Overall Study|organizational issues at one study site|1|||
44552133|NCT03341299|79568296|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
44552134|NCT03341299|79568297|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
44552135|NCT03341299|79568298|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
44552136|NCT03341299|79568299|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
44552137|NCT02949271|79568313|FG000|Overall Study|Lack of Efficacy|5|||
44552138|NCT02949271|79568314|FG001|Overall Study|Lack of Efficacy|4|||
44552139|NCT02949271|79568313|FG000|Overall Study|Lost to Follow-up|3|||
44552140|NCT02949271|79568314|FG001|Overall Study|Lost to Follow-up|6|||
44552141|NCT02949271|79568313|FG000|Overall Study|Physician Decision|5|||
44552142|NCT02949271|79568314|FG001|Overall Study|Physician Decision|5|||
44552143|NCT02949271|79568313|FG000|Overall Study|Protocol Violation|6|||
44552144|NCT02949271|79568314|FG001|Overall Study|Protocol Violation|3|||
44552145|NCT02949271|79568313|FG000|Overall Study|Withdrawal by Subject|1|||
44552146|NCT02949271|79568314|FG001|Overall Study|Withdrawal by Subject|0|||
44552147|NCT02949271|79568313|FG000|Overall Study|Delivered prior to intervention|7|||
44552148|NCT02949271|79568314|FG001|Overall Study|Delivered prior to intervention|9|||
44552149|NCT02949271|79568313|FG000|Overall Study|Outside the window for cervical dilation|2|||
44552150|NCT02949271|79568314|FG001|Overall Study|Outside the window for cervical dilation|3|||
44552151|NCT03640559|79568322|FG000|Overall Study|Physician Decision|1|||
44552152|NCT03640559|79568323|FG001|Overall Study|Physician Decision|1|||
44552153|NCT03640559|79568322|FG000|Overall Study|Withdrawal by Subject|1|||
44552154|NCT03640559|79568323|FG001|Overall Study|Withdrawal by Subject|0|||
44552155|NCT03339583|79568331|FG000|First Intervention (14 Days)|Adverse Event|1|||
44552156|NCT03339583|79568332|FG001|First Intervention (14 Days)|Adverse Event|0|||
44552157|NCT03339583|79568331|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
44552158|NCT03339583|79568332|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
44552159|NCT03339583|79568331|FG000|Second Intervention (14 Days)|Adverse Event|0|||
44552160|NCT03339583|79568332|FG001|Second Intervention (14 Days)|Adverse Event|1|||
44552161|NCT03339583|79568331|FG000|Follow-up (14 Days)|Physician Decision|6|||
44552162|NCT03339583|79568332|FG001|Follow-up (14 Days)|Physician Decision|3|||
44552163|NCT03639779|79568340|FG000|Overall Study|Lost to Follow-up|1|||
44552164|NCT03575975|79568349|FG000|Overall Study|Lost to Follow-up|1|||
44552165|NCT03575975|79568350|FG001|Overall Study|Lost to Follow-up|0|||
44552166|NCT03575975|79568351|FG002|Overall Study|Lost to Follow-up|0|||
44552167|NCT03636893|79568359|FG000|Overall Study|Death|0|||
44552168|NCT03636893|79568360|FG001|Overall Study|Death|1|||
44552169|NCT03636893|79568359|FG000|Overall Study|Protocol Violation|0|||
44552170|NCT03636893|79568360|FG001|Overall Study|Protocol Violation|3|||
44552171|NCT03636893|79568359|FG000|Overall Study|Withdrawal by Subject|1|||
44552172|NCT03636893|79568360|FG001|Overall Study|Withdrawal by Subject|2|||
44552173|NCT03636893|79568359|FG000|Overall Study|Refusal to surgery|4|||
44552174|NCT03636893|79568360|FG001|Overall Study|Refusal to surgery|3|||
44552175|NCT03636893|79568359|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
44552176|NCT03636893|79568360|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
44552177|NCT03636893|79568359|FG000|Overall Study|Adverse Event|1|||
44552178|NCT03636893|79568360|FG001|Overall Study|Adverse Event|1|||
44552179|NCT01353586|79568368|FG000|Overall Study|Procedure terminated prior to ablation|3|||
44552180|NCT01353586|79568369|FG001|Overall Study|Procedure terminated prior to ablation|0|||
44552181|NCT01353586|79568368|FG000|Overall Study|Never had insertion of study catheter|4|||
44552182|NCT01353586|79568369|FG001|Overall Study|Never had insertion of study catheter|1|||
44552183|NCT01353586|79568368|FG000|Overall Study|Neurological exam not done|0|||
44552184|NCT01353586|79568369|FG001|Overall Study|Neurological exam not done|1|||
44552185|NCT03091920|79568381|FG000|Overall Study|Adverse Event|0|||
44552186|NCT03091920|79568382|FG001|Overall Study|Adverse Event|1|||
44552187|NCT03091920|79568383|FG002|Overall Study|Adverse Event|0|||
44552188|NCT03338569|79568399|FG000|Overall Study|Physician Decision|8|||
44552189|NCT03338569|79568400|FG001|Overall Study|Physician Decision|3|||
44552190|NCT03338569|79568399|FG000|Overall Study|Withdrawal by Subject|0|||
44552191|NCT03338569|79568400|FG001|Overall Study|Withdrawal by Subject|1|||
44552192|NCT03338569|79568399|FG000|Overall Study|Lost to Follow-up|0|||
44552193|NCT03338569|79568400|FG001|Overall Study|Lost to Follow-up|1|||
44552194|NCT03338023|79568408|FG000|Overall Study|Withdrawal by Subject|3|||
44552195|NCT03338023|79568409|FG001|Overall Study|Withdrawal by Subject|4|||
44552196|NCT03338023|79568408|FG000|Overall Study|Protocol Violation|3|||
44552197|NCT03338023|79568409|FG001|Overall Study|Protocol Violation|3|||
44552198|NCT03338023|79568408|FG000|Overall Study|Lost to Follow-up|2|||
44552199|NCT03338023|79568409|FG001|Overall Study|Lost to Follow-up|1|||
44552200|NCT03338023|79568408|FG000|Overall Study|Physician Decision|1|||
44552201|NCT03338023|79568409|FG001|Overall Study|Physician Decision|2|||
44552202|NCT03337477|79568417|FG000|Overall Study|not categorized into the listed ones|11|||
44552203|NCT03337477|79568418|FG001|Overall Study|not categorized into the listed ones|9|||
44552204|NCT03337477|79568417|FG000|Overall Study|Withdrawal by Subject|0|||
44552205|NCT03337477|79568418|FG001|Overall Study|Withdrawal by Subject|1|||
44552206|NCT03337477|79568417|FG000|Overall Study|Death|0|||
44552207|NCT03337477|79568418|FG001|Overall Study|Death|1|||
44552208|NCT03337477|79568417|FG000|Overall Study|Lost to Follow-up|0|||
44552209|NCT03337477|79568418|FG001|Overall Study|Lost to Follow-up|2|||
44552210|NCT02687542|79568431|FG000|Overall Study|Medication error without associated AEs|0|||
44552211|NCT02687542|79568432|FG001|Overall Study|Medication error without associated AEs|0|||
44552212|NCT02687542|79568433|FG002|Overall Study|Medication error without associated AEs|0|||
44552213|NCT02687542|79568434|FG003|Overall Study|Medication error without associated AEs|0|||
44552214|NCT02687542|79568435|FG004|Overall Study|Medication error without associated AEs|1|||
44552215|NCT02687542|79568431|FG000|Overall Study|Lost to Follow-up|0|||
44552216|NCT02687542|79568432|FG001|Overall Study|Lost to Follow-up|0|||
44552217|NCT02687542|79568433|FG002|Overall Study|Lost to Follow-up|0|||
44552218|NCT02687542|79568434|FG003|Overall Study|Lost to Follow-up|0|||
44552219|NCT02687542|79568435|FG004|Overall Study|Lost to Follow-up|1|||
44552220|NCT02687542|79568431|FG000|Overall Study|Protocol Violation|0|||
44231224|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
44231225|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
44552221|NCT02687542|79568432|FG001|Overall Study|Protocol Violation|1|||
44552222|NCT02687542|79568433|FG002|Overall Study|Protocol Violation|0|||
44552223|NCT02687542|79568434|FG003|Overall Study|Protocol Violation|0|||
44552224|NCT02687542|79568435|FG004|Overall Study|Protocol Violation|0|||
44552225|NCT02687542|79568431|FG000|Overall Study|Other|5|||
44552226|NCT02687542|79568432|FG001|Overall Study|Other|9|||
44552227|NCT02687542|79568433|FG002|Overall Study|Other|10|||
44495413|NCT04380142|79501203|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
44495414|NCT04380142|79501204|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
44495415|NCT04380142|79501205|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
44495416|NCT04380142|79501203|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
44495417|NCT04380142|79501204|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
44495418|NCT04380142|79501205|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
44495419|NCT04380142|79501203|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
44495420|NCT04380142|79501204|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
44495421|NCT04380142|79501205|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
44495422|NCT04380142|79501203|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
44495423|NCT04380142|79501204|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
44495424|NCT04380142|79501205|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
44495425|NCT04380142|79501203|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
44495426|NCT04380142|79501204|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
44495427|NCT04380142|79501205|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
44495428|NCT04380142|79501203|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44495429|NCT04380142|79501204|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44495430|NCT04380142|79501205|FG002|Double-Blind Treatment Period|Adverse Event|14|||
44495431|NCT04380142|79501203|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
44495432|NCT04380142|79501204|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
44495433|NCT04380142|79501205|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
44495434|NCT04380142|79501203|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
44495435|NCT04380142|79501204|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
44495436|NCT04380142|79501205|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
44495437|NCT04380142|79501203|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
44495438|NCT04380142|79501204|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
44495439|NCT04380142|79501205|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
44495440|NCT04380142|79501203|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
44495441|NCT04380142|79501204|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
44495442|NCT04380142|79501205|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
44495443|NCT04380142|79501203|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
44495444|NCT04380142|79501204|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
44495445|NCT04380142|79501205|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
44495446|NCT04335136|79501215|FG000|Overall Study|Death|8|||
44495447|NCT04335136|79501216|FG001|Overall Study|Death|4|||
44495448|NCT04335136|79501215|FG000|Overall Study|Lost to Follow-up|2|||
44495449|NCT04335136|79501216|FG001|Overall Study|Lost to Follow-up|0|||
44495450|NCT04335136|79501215|FG000|Overall Study|Protocol Violation|1|||
44495451|NCT04335136|79501216|FG001|Overall Study|Protocol Violation|0|||
44495452|NCT04335136|79501215|FG000|Overall Study|Withdrawal by Subject|1|||
44495453|NCT04335136|79501216|FG001|Overall Study|Withdrawal by Subject|1|||
44495454|NCT04335136|79501215|FG000|Overall Study|Health-threatening condition|0|||
44495455|NCT04335136|79501216|FG001|Overall Study|Health-threatening condition|1|||
44495456|NCT04335136|79501215|FG000|Overall Study|Adverse Event|0|||
44495457|NCT04335136|79501216|FG001|Overall Study|Adverse Event|1|||
44495458|NCT04335136|79501215|FG000|Overall Study|Erroneously randomized|2|||
44552228|NCT02687542|79568434|FG003|Overall Study|Other|6|||
44552229|NCT02687542|79568435|FG004|Overall Study|Other|5|||
44552230|NCT02687542|79568431|FG000|Overall Study|Adverse Event|3|||
44552231|NCT02687542|79568432|FG001|Overall Study|Adverse Event|1|||
44552232|NCT02687542|79568433|FG002|Overall Study|Adverse Event|3|||
44231226|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
44231227|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
44231228|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
44552233|NCT02687542|79568434|FG003|Overall Study|Adverse Event|2|||
44552234|NCT02687542|79568435|FG004|Overall Study|Adverse Event|9|||
44552235|NCT02687542|79568431|FG000|Overall Study|Withdrawal by Subject|0|||
44552236|NCT02687542|79568432|FG001|Overall Study|Withdrawal by Subject|1|||
44552237|NCT02687542|79568433|FG002|Overall Study|Withdrawal by Subject|1|||
44552238|NCT02687542|79568434|FG003|Overall Study|Withdrawal by Subject|2|||
44552239|NCT02687542|79568435|FG004|Overall Study|Withdrawal by Subject|4|||
44552240|NCT03336619|79568449|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
44552241|NCT03336619|79568450|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
44552242|NCT03336619|79568449|FG000|Overall Study|Withdrawal by Subject|17|||
44552243|NCT03336619|79568450|FG001|Overall Study|Withdrawal by Subject|16|||
44552244|NCT03336619|79568449|FG000|Overall Study|Adverse Event|2|||
44552245|NCT03336619|79568450|FG001|Overall Study|Adverse Event|5|||
44552246|NCT03336619|79568449|FG000|Overall Study|Physician Decision|3|||
44552247|NCT03336619|79568450|FG001|Overall Study|Physician Decision|0|||
44552248|NCT01353508|79568472|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
44552249|NCT01353508|79568473|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
44552250|NCT01353508|79568474|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
44552251|NCT01353508|79568475|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
44552252|NCT01353508|79568472|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
44552253|NCT01353508|79568473|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
44552254|NCT01353508|79568474|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
44552255|NCT01353508|79568475|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
44552256|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
44552257|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
44552258|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
44552259|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
44552260|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
44552261|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
44552262|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
44552263|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
44552264|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
44552265|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
44552266|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
44552267|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
44552268|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Other|6|||
44552269|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Other|3|||
44552270|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Other|0|||
44552271|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
44231229|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
44495459|NCT04335136|79501216|FG001|Overall Study|Erroneously randomized|0|||
44495460|NCT04171414|79501222|FG000|Overall Study|Death|1|||
44495461|NCT04171414|79501222|FG000|Overall Study|Withdrawal by Subject|1|||
44495462|NCT04167670|79501229|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
44495463|NCT04167670|79501230|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
44495464|NCT04167670|79501231|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
44495465|NCT04167670|79501229|FG000|Overall Study|Significant protocol deviation|3|||
44495466|NCT04167670|79501230|FG001|Overall Study|Significant protocol deviation|1|||
44495467|NCT04167670|79501231|FG002|Overall Study|Significant protocol deviation|0|||
44495468|NCT04167670|79501229|FG000|Overall Study|Lost to Follow-up|0|||
44495469|NCT04167670|79501230|FG001|Overall Study|Lost to Follow-up|3|||
44495470|NCT04167670|79501231|FG002|Overall Study|Lost to Follow-up|3|||
44495471|NCT04167670|79501229|FG000|Overall Study|Voluntary Withdrawal|0|||
44495472|NCT04167670|79501230|FG001|Overall Study|Voluntary Withdrawal|1|||
44495473|NCT04167670|79501231|FG002|Overall Study|Voluntary Withdrawal|1|||
44495474|NCT04167670|79501229|FG000|Overall Study|Withdrawal of Consent|4|||
44495475|NCT04167670|79501230|FG001|Overall Study|Withdrawal of Consent|1|||
44552272|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
44552273|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
44552274|NCT03636269|79568487|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
44552275|NCT03636269|79568488|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
44495476|NCT04167670|79501231|FG002|Overall Study|Withdrawal of Consent|3|||
44495477|NCT04167670|79501229|FG000|Overall Study|Miscellaneous|7|||
44552276|NCT03636269|79568489|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
44552277|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Adverse Event|0|||
44552278|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Adverse Event|0|||
44552279|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Adverse Event|21|||
44552280|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
44552281|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
44231230|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
44231231|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
44376654|NCT01071200|79381916|FG001|Overall Study|Lack of ovarian response|1|||
44552282|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
44552283|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
44552284|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
44552285|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
44552286|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
44552287|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
44552288|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
44552289|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Administrative|0|||
44552290|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Administrative|0|||
44552291|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Administrative|36|||
44552292|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Other|0|||
44552293|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Other|0|||
44552294|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Other|9|||
44552295|NCT03636269|79568487|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
44552296|NCT03636269|79568488|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
44552297|NCT03636269|79568489|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
44552298|NCT02685202|79568498|FG000|Overall Study|Lost to Follow-up|9|||
44552299|NCT03087786|79568504|FG000|Overall Study|Withdrawal by Subject|2|||
44552300|NCT03087786|79568505|FG001|Overall Study|Withdrawal by Subject|0|||
44552301|NCT03635957|79568511|FG000|Run-In Period|Lost to Follow-up|1|||
44552302|NCT03635957|79568511|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
44552303|NCT01353274|79568516|FG000|Overall Study|No case report form (CRF) collected|28|||
44552304|NCT02690194|79568523|FG000|Overall Study|Withdrawal by Subject|1|||
44552305|NCT02690194|79568524|FG001|Overall Study|Withdrawal by Subject|4|||
44552306|NCT02690194|79568525|FG002|Overall Study|Withdrawal by Subject|0|||
44552307|NCT02684344|79568535|FG000|Overall Study|Withdrawal by Subject|0|||
44552308|NCT02684344|79568536|FG001|Overall Study|Withdrawal by Subject|1|||
44552309|NCT02683876|79568544|FG000|Overall Study|samples damaged during shipping|2|||
44552310|NCT02683876|79568545|FG001|Overall Study|samples damaged during shipping|0|||
44552311|NCT03974100|79568555|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
44552312|NCT03974100|79568556|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
44552313|NCT03974100|79568557|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
44552314|NCT03974100|79568558|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
44552315|NCT03974100|79568559|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
44552316|NCT03974100|79568555|FG000|TP1 - Day 1 to Week 52|Death|1|||
44552317|NCT03974100|79568556|FG001|TP1 - Day 1 to Week 52|Death|0|||
44552318|NCT03974100|79568557|FG002|TP1 - Day 1 to Week 52|Death|0|||
44552319|NCT03974100|79568558|FG003|TP1 - Day 1 to Week 52|Death|0|||
44552320|NCT03974100|79568559|FG004|TP1 - Day 1 to Week 52|Death|0|||
44552321|NCT03974100|79568555|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
44552322|NCT03974100|79568556|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
44552323|NCT03974100|79568557|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
44552324|NCT03974100|79568558|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
44552325|NCT03974100|79568559|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
44552326|NCT03974100|79568555|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
44552327|NCT03974100|79568556|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
44552328|NCT03974100|79568557|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
44552329|NCT03974100|79568558|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
44552330|NCT03974100|79568559|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
44552331|NCT03974100|79568555|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
44552332|NCT03974100|79568556|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
44552333|NCT03974100|79568557|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
44552334|NCT03974100|79568558|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
44552335|NCT03974100|79568559|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
44552336|NCT03974100|79568555|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
44552337|NCT03974100|79568556|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
44552338|NCT03974100|79568557|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
44552339|NCT03974100|79568558|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
44552340|NCT03974100|79568559|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
44552341|NCT03974100|79568555|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
44552342|NCT03974100|79568556|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
44552343|NCT03974100|79568557|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
44552344|NCT03974100|79568558|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
44552345|NCT03974100|79568559|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
44552346|NCT02689804|79568573|FG000|Overall Study|Withdrawal by Subject|2|||
44552347|NCT02689804|79568574|FG001|Overall Study|Withdrawal by Subject|0|||
44552348|NCT02946931|79568583|FG000|Overall Study|Did not require collection of CRFs|588|||
44552349|NCT02946931|79568583|FG000|Overall Study|Other than listed|37|||
44552350|NCT02946931|79568583|FG000|Overall Study|Discharge from hospital|118|||
44552351|NCT02946931|79568583|FG000|Overall Study|Adverse Event|81|||
44552352|NCT02946931|79568583|FG000|Overall Study|CRFs not valid|1|||
44552353|NCT02946931|79568583|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
44552354|NCT02689492|79568587|FG000|Overall Study|Lost to Follow-up|61|||
44552355|NCT02689492|79568587|FG000|Overall Study|Withdrawal by Subject|11|||
44552356|NCT02689492|79568587|FG000|Overall Study|Death|9|||
44552357|NCT02689492|79568587|FG000|Overall Study|Physician Decision|2|||
44552358|NCT02689492|79568587|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
44552359|NCT02689492|79568587|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
44552360|NCT02689492|79568587|FG000|Overall Study|Other than listed|1|||
44552361|NCT01374568|79568605|FG000|Overall Study|Lab unable to analyze BTM|0|||
44552362|NCT01374568|79568606|FG001|Overall Study|Lab unable to analyze BTM|2|||
44552363|NCT02682784|79568616|FG000|Overall Study|Withdrawal by Subject|0|||
44552364|NCT02682784|79568617|FG001|Overall Study|Withdrawal by Subject|2|||
44552365|NCT02682784|79568618|FG002|Overall Study|Withdrawal by Subject|1|||
44552366|NCT02682784|79568619|FG003|Overall Study|Withdrawal by Subject|2|||
44552367|NCT02682784|79568616|FG000|Overall Study|Physician Decision|1|||
44552368|NCT02682784|79568617|FG001|Overall Study|Physician Decision|0|||
44552369|NCT02682784|79568618|FG002|Overall Study|Physician Decision|1|||
44552370|NCT02682784|79568619|FG003|Overall Study|Physician Decision|1|||
44552371|NCT03387852|79568633|FG000|Overall Study|Adverse event (AE)|3|||
44552372|NCT03387852|79568634|FG001|Overall Study|Adverse event (AE)|0|||
44552373|NCT03387852|79568635|FG002|Overall Study|Adverse event (AE)|2|||
44552374|NCT03387852|79568636|FG003|Overall Study|Adverse event (AE)|0|||
44552375|NCT03387852|79568633|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
44552376|NCT03387852|79568634|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
44552377|NCT03387852|79568635|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
44552378|NCT03387852|79568636|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
44552379|NCT03387852|79568633|FG000|Overall Study|Withdrawal by participant|1|||
44552380|NCT03387852|79568634|FG001|Overall Study|Withdrawal by participant|1|||
44552381|NCT03387852|79568635|FG002|Overall Study|Withdrawal by participant|3|||
44552382|NCT03387852|79568636|FG003|Overall Study|Withdrawal by participant|2|||
44552383|NCT03387852|79568633|FG000|Overall Study|Other- Unspecified|1|||
44552384|NCT03387852|79568634|FG001|Overall Study|Other- Unspecified|1|||
44552385|NCT03387852|79568635|FG002|Overall Study|Other- Unspecified|2|||
44552386|NCT03387852|79568636|FG003|Overall Study|Other- Unspecified|1|||
44552387|NCT03387852|79568633|FG000|Overall Study|Poor compliance to protocol|0|||
44552388|NCT03387852|79568634|FG001|Overall Study|Poor compliance to protocol|0|||
44552389|NCT03387852|79568635|FG002|Overall Study|Poor compliance to protocol|0|||
44552390|NCT03387852|79568636|FG003|Overall Study|Poor compliance to protocol|1|||
44552391|NCT03387852|79568633|FG000|Overall Study|Randomized and not treated|0|||
44552392|NCT03387852|79568634|FG001|Overall Study|Randomized and not treated|0|||
44552393|NCT03387852|79568635|FG002|Overall Study|Randomized and not treated|0|||
44552394|NCT03387852|79568636|FG003|Overall Study|Randomized and not treated|1|||
44552395|NCT02679274|79568649|FG000|Overall Study|Withdrawal by Subject|1|||
44552396|NCT02679274|79568650|FG001|Overall Study|Withdrawal by Subject|0|||
44552397|NCT04969861|79568658|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
44552398|NCT04969861|79568659|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
44552399|NCT02678416|79568667|FG000|Part 1|Withdrawal by Subject|1|||
44552400|NCT02678416|79568667|FG000|Part 2|Adverse Event|2|||
44552401|NCT02678416|79568667|FG000|Part 2|Withdrawal by Subject|1|||
44552402|NCT02680834|79568687|FG000|Overall Study|Physician Decision|5|||
44552403|NCT02680834|79568688|FG001|Overall Study|Physician Decision|2|||
44552404|NCT02680834|79568687|FG000|Overall Study|Withdrawal by Subject|6|||
44552405|NCT02680834|79568688|FG001|Overall Study|Withdrawal by Subject|0|||
44552406|NCT02680834|79568687|FG000|Overall Study|Lost to Follow-up|0|||
44552407|NCT02680834|79568688|FG001|Overall Study|Lost to Follow-up|1|||
44552408|NCT03343704|79568696|FG000|Overall Study|Refused to complete follow up|0|||
44552409|NCT03343704|79568697|FG001|Overall Study|Refused to complete follow up|1|||
44552410|NCT03343704|79568696|FG000|Overall Study|Death|0|||
44552411|NCT03343704|79568697|FG001|Overall Study|Death|1|||
44552412|NCT03343704|79568696|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
44552413|NCT03343704|79568697|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
44495478|NCT04167670|79501230|FG001|Overall Study|Miscellaneous|5|||
44552414|NCT02680756|79568707|FG000|Overall Study|Adverse Event|10|||
44552415|NCT02680756|79568708|FG001|Overall Study|Adverse Event|2|||
44552416|NCT02680756|79568707|FG000|Overall Study|Lost to Follow-up|7|||
44552417|NCT02680756|79568708|FG001|Overall Study|Lost to Follow-up|6|||
44552418|NCT02680756|79568707|FG000|Overall Study|Withdrawal by Subject|5|||
44552419|NCT02680756|79568708|FG001|Overall Study|Withdrawal by Subject|5|||
44552420|NCT02680756|79568707|FG000|Overall Study|Physician Decision|4|||
44552421|NCT02680756|79568708|FG001|Overall Study|Physician Decision|1|||
44552422|NCT02680756|79568707|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
44552423|NCT02680756|79568708|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
44552424|NCT02680756|79568707|FG000|Overall Study|Blood transfusion for any reason|0|||
44552425|NCT02680756|79568708|FG001|Overall Study|Blood transfusion for any reason|1|||
44552426|NCT02680756|79568707|FG000|Overall Study|Death|1|||
44552427|NCT02680756|79568708|FG001|Overall Study|Death|0|||
44552428|NCT02680756|79568707|FG000|Overall Study|Protocol Violation|1|||
44552429|NCT02680756|79568708|FG001|Overall Study|Protocol Violation|0|||
44552430|NCT02680756|79568707|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
44552431|NCT02680756|79568708|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
44552432|NCT02680756|79568707|FG000|Overall Study|None of above or not recorded|3|||
44552433|NCT02680756|79568708|FG001|Overall Study|None of above or not recorded|2|||
44552434|NCT03086460|79568714|FG000|Study Participants|Lost to Follow-up|2|||
44552435|NCT03086460|79568714|FG000|Study Participants|Protocol Violation|1|||
44552436|NCT03086460|79568714|FG000|Study Participants|Withdrawal by Subject|6|||
44552437|NCT03086460|79568714|FG000|Treatment A|Lost to Follow-up|1|||
44552438|NCT03086460|79568714|FG000|Treatment A|Protocol Violation|1|||
44552439|NCT03086460|79568714|FG000|Treatment A|Withdrawal by Subject|2|||
44552440|NCT03086460|79568714|FG000|Treatment C|Withdrawal by Subject|2|||
44552441|NCT03086460|79568714|FG000|Treatment E|Lost to Follow-up|1|||
44552442|NCT03086460|79568714|FG000|Treatment E|Withdrawal by Subject|3|||
44552443|NCT02677714|79568740|FG000|Overall Study|Withdrawal by Subject|2|||
44552444|NCT02677714|79568741|FG001|Overall Study|Withdrawal by Subject|0|||
44552445|NCT02677324|79568747|FG000|Overall Study|Disease Progression|6|||
44552446|NCT02677324|79568747|FG000|Overall Study|Inability to Swallow pills|1|||
44552447|NCT02677324|79568747|FG000|Overall Study|Non-compliance|1|||
44552448|NCT02677324|79568747|FG000|Overall Study|Lack of Efficacy|1|||
44552449|NCT02677324|79568747|FG000|Overall Study|Medical insurance coverage|1|||
44552450|NCT02677324|79568747|FG000|Overall Study|Adverse Event|1|||
44552451|NCT02677324|79568747|FG000|Overall Study|IgM Myeloma diagnosis|1|||
44552452|NCT01971008|79568755|FG000|Overall Study|Protocol Violation|2|||
44552453|NCT01971008|79568756|FG001|Overall Study|Protocol Violation|1|||
44552454|NCT01374178|79568765|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
44552455|NCT01374178|79568766|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
44552456|NCT01374178|79568765|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
44552457|NCT01374178|79568766|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
44552458|NCT03025542|79568774|FG000|Overall Study|Adverse Event|0|||
44552459|NCT03025542|79568775|FG001|Overall Study|Adverse Event|2|||
44552460|NCT03025542|79568774|FG000|Overall Study|Lost to Follow-up|1|||
44552461|NCT03025542|79568775|FG001|Overall Study|Lost to Follow-up|0|||
44552462|NCT03025542|79568774|FG000|Overall Study|Withdrawal by Subject|1|||
44552463|NCT03025542|79568775|FG001|Overall Study|Withdrawal by Subject|0|||
44495479|NCT04167670|79501231|FG002|Overall Study|Miscellaneous|3|||
44495480|NCT00113516|79501239|FG000|Part 1|Adverse Event|6|||
44495481|NCT00113516|79501240|FG001|Part 1|Adverse Event|0|||
44495482|NCT00113516|79501239|FG000|Part 1|Death|3|||
44495483|NCT00113516|79501240|FG001|Part 1|Death|0|||
44495484|NCT00113516|79501239|FG000|Part 1|Other|3|||
44495485|NCT00113516|79501240|FG001|Part 1|Other|0|||
44495486|NCT00113516|79501239|FG000|Part 1|Withdrawal by Subject|2|||
44495487|NCT00113516|79501240|FG001|Part 1|Withdrawal by Subject|0|||
44495488|NCT00113516|79501239|FG000|Part 1|Lack of Efficacy|2|||
44495489|NCT00113516|79501240|FG001|Part 1|Lack of Efficacy|0|||
44552464|NCT03022370|79568789|FG000|Overall Study|Death|6|||
44552465|NCT03022370|79568790|FG001|Overall Study|Death|12|||
44552466|NCT03022370|79568789|FG000|Overall Study|Lost to Follow-up|174|||
44552467|NCT03022370|79568790|FG001|Overall Study|Lost to Follow-up|109|||
44552468|NCT03021668|79568802|FG000|Overall Study|Physician Decision|0|||
44552469|NCT03021668|79568803|FG001|Overall Study|Physician Decision|1|||
44552470|NCT03020888|79568809|FG000|Overall Study|Physician Decision|4|||
44552471|NCT03020888|79568809|FG000|Overall Study|Withdrawal by Subject|6|||
44552472|NCT03020888|79568809|FG000|Overall Study|Insurance coverage|2|||
44552473|NCT03020888|79568809|FG000|Overall Study|Lost to Follow-up|1|||
44552474|NCT02250300|79568817|FG000|Expansion Phase|Death|6|||
44552475|NCT02250300|79568818|FG001|Expansion Phase|Death|7|||
44552476|NCT02250300|79568819|FG002|Expansion Phase|Death|0|||
44552477|NCT02250300|79568820|FG003|Expansion Phase|Death|0|||
44552478|NCT03020966|79568833|FG000|Overall Study|Withdrawal by Subject|2|||
44552479|NCT03020966|79568834|FG001|Overall Study|Withdrawal by Subject|0|||
44552480|NCT03020576|79568842|FG000|Overall Study|Withdrawal by Subject|1|||
44552481|NCT03020576|79568843|FG001|Overall Study|Withdrawal by Subject|2|||
44552482|NCT03017612|79568849|FG000|Overall Study|Adverse Event|2|||
44552483|NCT03635099|79568861|FG000|Period 1|Adverse Event|1|||
44552484|NCT03635099|79568862|FG001|Period 1|Adverse Event|0|||
44552485|NCT03635099|79568863|FG002|Period 1|Adverse Event|0|||
44552486|NCT03635099|79568864|FG003|Period 1|Adverse Event|1|||
44552487|NCT03635099|79568865|FG004|Period 1|Adverse Event|0|||
44231232|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
44231233|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
44231234|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
44231235|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
44231236|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
44231237|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
44231238|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
44231239|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
44231240|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
44231241|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
44231242|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
44231243|NCT01872689|79043910|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
44231244|NCT01872689|79043911|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
44231245|NCT01872689|79043912|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
44231246|NCT01872689|79043913|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
44231247|NCT01872689|79043910|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
44231248|NCT01872689|79043911|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
44231249|NCT01872689|79043912|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
44495490|NCT00113516|79501239|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
44495491|NCT00113516|79501240|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
44495492|NCT00113516|79501239|FG000|Part 1|Laboratory Abnormality|1|||
44495493|NCT00113516|79501240|FG001|Part 1|Laboratory Abnormality|0|||
44495494|NCT00113516|79501239|FG000|Part 1|Ongoing|1|||
44495495|NCT00113516|79501240|FG001|Part 1|Ongoing|0|||
44495496|NCT00113516|79501239|FG000|Part 1|Missing|65|||
44495497|NCT00113516|79501240|FG001|Part 1|Missing|0|||
44495498|NCT00113516|79501239|FG000|Part 2|Adverse Event|0|||
44495499|NCT00113516|79501240|FG001|Part 2|Adverse Event|16|||
44495500|NCT00113516|79501239|FG000|Part 2|Death|0|||
44495501|NCT00113516|79501240|FG001|Part 2|Death|5|||
44495502|NCT00113516|79501239|FG000|Part 2|Lack of Efficacy|0|||
44495503|NCT00113516|79501240|FG001|Part 2|Lack of Efficacy|37|||
44495504|NCT00113516|79501239|FG000|Part 2|Withdrawal by Subject|0|||
44495505|NCT00113516|79501240|FG001|Part 2|Withdrawal by Subject|3|||
44495506|NCT00113516|79501239|FG000|Part 2|Other|0|||
44495507|NCT00113516|79501240|FG001|Part 2|Other|3|||
44495508|NCT00113516|79501239|FG000|Part 2|Laboratory Abnormality|0|||
44495509|NCT00113516|79501240|FG001|Part 2|Laboratory Abnormality|1|||
44495510|NCT00113516|79501239|FG000|Part 2|Ongoing|0|||
44495511|NCT00113516|79501240|FG001|Part 2|Ongoing|1|||
44495512|NCT04140292|79501261|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
44495513|NCT04140292|79501262|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
44495514|NCT04138810|79501271|FG000|Overall Study|Withdrawal by Subject|0|||
44495515|NCT04138810|79501272|FG001|Overall Study|Withdrawal by Subject|1|||
44495516|NCT04138810|79501271|FG000|Overall Study|Subject cancelled surgery|1|||
44495517|NCT04138810|79501272|FG001|Overall Study|Subject cancelled surgery|0|||
44495518|NCT00127166|79501280|FG000|Period I|Protocol Violation|0|||
44231250|NCT01872689|79043913|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
44231251|NCT01872689|79043910|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
44231252|NCT01872689|79043911|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
44231253|NCT01872689|79043912|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
44231254|NCT01872689|79043913|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
44274812|NCT03266588|79221041|FG001|Observational Period|Lost to Follow-up|12|||
44274813|NCT03266588|79221042|FG002|Observational Period|Lost to Follow-up|4|||
44495519|NCT00127166|79501281|FG001|Period I|Protocol Violation|2|||
44495520|NCT00127166|79501280|FG000|Period I|Withdrawal by Subject|2|||
44495521|NCT00127166|79501281|FG001|Period I|Withdrawal by Subject|0|||
44495522|NCT00127166|79501280|FG000|Period I|Patient did not meet inclusion criteria|1|||
44495523|NCT00127166|79501281|FG001|Period I|Patient did not meet inclusion criteria|0|||
44495524|NCT00127166|79501280|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
44552488|NCT03635099|79568866|FG005|Period 1|Adverse Event|0|||
44552489|NCT03635099|79568867|FG006|Period 1|Adverse Event|0|||
44552490|NCT03635099|79568868|FG007|Period 1|Adverse Event|0|||
44552491|NCT03635099|79568861|FG000|Period 1|Protocol Violation|0|||
44552492|NCT03635099|79568862|FG001|Period 1|Protocol Violation|0|||
44552493|NCT03635099|79568863|FG002|Period 1|Protocol Violation|1|||
44552494|NCT03635099|79568864|FG003|Period 1|Protocol Violation|0|||
44552495|NCT03635099|79568865|FG004|Period 1|Protocol Violation|0|||
44552496|NCT03635099|79568866|FG005|Period 1|Protocol Violation|0|||
44552497|NCT03635099|79568867|FG006|Period 1|Protocol Violation|0|||
44552498|NCT03635099|79568868|FG007|Period 1|Protocol Violation|0|||
44552499|NCT03635099|79568861|FG000|Period 1|Lost to Follow-up|0|||
44552500|NCT03635099|79568862|FG001|Period 1|Lost to Follow-up|0|||
44552501|NCT03635099|79568863|FG002|Period 1|Lost to Follow-up|1|||
44552502|NCT03635099|79568864|FG003|Period 1|Lost to Follow-up|2|||
44552503|NCT03635099|79568865|FG004|Period 1|Lost to Follow-up|1|||
44552504|NCT03635099|79568866|FG005|Period 1|Lost to Follow-up|0|||
44552505|NCT03635099|79568867|FG006|Period 1|Lost to Follow-up|1|||
44552506|NCT03635099|79568868|FG007|Period 1|Lost to Follow-up|2|||
44552507|NCT03635099|79568861|FG000|Period 1|Withdrawal by Subject|3|||
44552508|NCT03635099|79568862|FG001|Period 1|Withdrawal by Subject|3|||
44231255|NCT01872689|79043910|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
44231256|NCT01872689|79043911|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
44552509|NCT03635099|79568863|FG002|Period 1|Withdrawal by Subject|5|||
44552510|NCT03635099|79568864|FG003|Period 1|Withdrawal by Subject|2|||
44552511|NCT03635099|79568865|FG004|Period 1|Withdrawal by Subject|2|||
44552512|NCT03635099|79568866|FG005|Period 1|Withdrawal by Subject|0|||
44552513|NCT03635099|79568867|FG006|Period 1|Withdrawal by Subject|3|||
44552514|NCT03635099|79568868|FG007|Period 1|Withdrawal by Subject|0|||
44552515|NCT03635099|79568861|FG000|Period 1|History of suicidal ideation|0|||
44552516|NCT03635099|79568862|FG001|Period 1|History of suicidal ideation|0|||
44552517|NCT03635099|79568863|FG002|Period 1|History of suicidal ideation|1|||
44552518|NCT03635099|79568864|FG003|Period 1|History of suicidal ideation|0|||
44552519|NCT03635099|79568865|FG004|Period 1|History of suicidal ideation|0|||
44552520|NCT03635099|79568866|FG005|Period 1|History of suicidal ideation|0|||
44552521|NCT03635099|79568867|FG006|Period 1|History of suicidal ideation|0|||
44552522|NCT03635099|79568868|FG007|Period 1|History of suicidal ideation|0|||
44552523|NCT03635099|79568861|FG000|Period 1|pursue other treatment options|0|||
44231257|NCT01872689|79043912|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
44231258|NCT01872689|79043913|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
44495525|NCT00127166|79501281|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
44495526|NCT00127166|79501280|FG000|Period II|Withdrawal by Subject|2|||
44495527|NCT00127166|79501281|FG001|Period II|Withdrawal by Subject|0|||
44495528|NCT00127166|79501280|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
44495529|NCT00127166|79501281|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
44552524|NCT03635099|79568862|FG001|Period 1|pursue other treatment options|0|||
44552525|NCT03635099|79568863|FG002|Period 1|pursue other treatment options|0|||
44552526|NCT03635099|79568864|FG003|Period 1|pursue other treatment options|0|||
44552527|NCT03635099|79568865|FG004|Period 1|pursue other treatment options|0|||
44552528|NCT03635099|79568866|FG005|Period 1|pursue other treatment options|1|||
44552529|NCT03635099|79568867|FG006|Period 1|pursue other treatment options|0|||
44552530|NCT03635099|79568868|FG007|Period 1|pursue other treatment options|0|||
44552531|NCT03635099|79568861|FG000|Not Eligible for Period 2|Pregnancy|0|||
44552532|NCT03635099|79568862|FG001|Not Eligible for Period 2|Pregnancy|0|||
44552533|NCT03635099|79568863|FG002|Not Eligible for Period 2|Pregnancy|0|||
44552534|NCT03635099|79568864|FG003|Not Eligible for Period 2|Pregnancy|1|||
44495530|NCT00125138|79501291|FG000|Overall Study|Adverse Event|1|||
44495531|NCT00125138|79501292|FG001|Overall Study|Adverse Event|0|||
44495532|NCT00125138|79501293|FG002|Overall Study|Adverse Event|3|||
44495533|NCT00125138|79501294|FG003|Overall Study|Adverse Event|2|||
44495534|NCT00125138|79501291|FG000|Overall Study|Withdrawal by Subject|2|||
44495535|NCT00125138|79501292|FG001|Overall Study|Withdrawal by Subject|3|||
44495536|NCT00125138|79501293|FG002|Overall Study|Withdrawal by Subject|1|||
44495537|NCT00125138|79501294|FG003|Overall Study|Withdrawal by Subject|1|||
44495538|NCT00125138|79501291|FG000|Overall Study|Lack of Efficacy|0|||
44495539|NCT00125138|79501292|FG001|Overall Study|Lack of Efficacy|0|||
44495540|NCT00125138|79501293|FG002|Overall Study|Lack of Efficacy|0|||
44495541|NCT00125138|79501294|FG003|Overall Study|Lack of Efficacy|1|||
44495542|NCT00125138|79501291|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
44495543|NCT00125138|79501292|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
44231259|NCT01872689|79043910|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
44376655|NCT01071200|79381915|FG000|Overall Study|No fertilization|4|||
44552535|NCT03635099|79568865|FG004|Not Eligible for Period 2|Pregnancy|0|||
44552536|NCT03635099|79568866|FG005|Not Eligible for Period 2|Pregnancy|0|||
44495544|NCT00125138|79501293|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
44552537|NCT03635099|79568867|FG006|Not Eligible for Period 2|Pregnancy|0|||
44552538|NCT03635099|79568868|FG007|Not Eligible for Period 2|Pregnancy|0|||
44552539|NCT03635099|79568861|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
44552540|NCT03635099|79568862|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
44552541|NCT03635099|79568863|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
44495545|NCT00125138|79501294|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
44495546|NCT04132336|79501311|FG000|Overall Study|Investigator Decision|0|||
44495547|NCT04132336|79501312|FG001|Overall Study|Investigator Decision|1|||
44495548|NCT04132336|79501313|FG002|Overall Study|Investigator Decision|0|||
44495549|NCT04132336|79501314|FG003|Overall Study|Investigator Decision|0|||
44495550|NCT04132336|79501315|FG004|Overall Study|Investigator Decision|0|||
44495551|NCT04132336|79501316|FG005|Overall Study|Investigator Decision|0|||
44495552|NCT04132336|79501317|FG006|Overall Study|Investigator Decision|0|||
44495553|NCT04131556|79501333|FG000|Overall Study|Adverse Event|1|||
44495554|NCT04131556|79501333|FG000|Overall Study|Withdrawal by Subject|1|||
44495555|NCT04295356|79501342|FG000|Overall Study|Physician Decision|1|||
44495556|NCT04295356|79501343|FG001|Overall Study|Physician Decision|0|||
44495557|NCT04295356|79501342|FG000|Overall Study|Lost to Follow-up|0|||
44495558|NCT04295356|79501343|FG001|Overall Study|Lost to Follow-up|3|||
44495559|NCT04295356|79501342|FG000|Overall Study|Protocol Violation|0|||
44495560|NCT04295356|79501343|FG001|Overall Study|Protocol Violation|1|||
44495561|NCT03691948|79501351|FG000|Overall Study|Lost to Follow-up|1|||
44495562|NCT03691948|79501352|FG001|Overall Study|Lost to Follow-up|3|||
44495563|NCT04126174|79501359|FG000|Overall Study|Lost to Follow-up|3|||
44495564|NCT04126174|79501360|FG001|Overall Study|Lost to Follow-up|3|||
44552542|NCT03635099|79568864|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
44552543|NCT03635099|79568865|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
44552544|NCT03635099|79568866|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
44552545|NCT03635099|79568867|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
44552546|NCT03635099|79568868|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
44376656|NCT01071200|79381916|FG001|Overall Study|No fertilization|0|||
44495565|NCT04124926|79501368|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
44552547|NCT03635099|79568861|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
44552548|NCT03635099|79568862|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
44552549|NCT03635099|79568863|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
44552550|NCT03635099|79568864|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
44552551|NCT03635099|79568865|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
44552552|NCT03635099|79568866|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
44552553|NCT03635099|79568867|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
44552554|NCT03635099|79568868|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
44552555|NCT03635099|79568861|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
44552556|NCT03635099|79568862|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
44552557|NCT03635099|79568863|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
44552558|NCT03635099|79568864|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
44552559|NCT03635099|79568865|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
44552560|NCT03635099|79568866|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
44552561|NCT03635099|79568867|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
44552562|NCT03635099|79568868|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
44552563|NCT03635099|79568861|FG000|Period 2|Adverse Event|0|||
44552564|NCT03635099|79568862|FG001|Period 2|Adverse Event|0|||
44552565|NCT03635099|79568863|FG002|Period 2|Adverse Event|1|||
44552566|NCT03635099|79568864|FG003|Period 2|Adverse Event|0|||
44552567|NCT03635099|79568865|FG004|Period 2|Adverse Event|1|||
44552568|NCT03635099|79568866|FG005|Period 2|Adverse Event|0|||
44552569|NCT03635099|79568867|FG006|Period 2|Adverse Event|0|||
44552570|NCT03635099|79568868|FG007|Period 2|Adverse Event|0|||
44552571|NCT03635099|79568861|FG000|Period 2|Lost to Follow-up|0|||
44552572|NCT03635099|79568862|FG001|Period 2|Lost to Follow-up|0|||
44231260|NCT01872689|79043911|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
44552573|NCT03635099|79568863|FG002|Period 2|Lost to Follow-up|1|||
44552574|NCT03635099|79568864|FG003|Period 2|Lost to Follow-up|0|||
44552575|NCT03635099|79568865|FG004|Period 2|Lost to Follow-up|4|||
44552576|NCT03635099|79568866|FG005|Period 2|Lost to Follow-up|0|||
44552577|NCT03635099|79568867|FG006|Period 2|Lost to Follow-up|0|||
44552578|NCT03635099|79568868|FG007|Period 2|Lost to Follow-up|0|||
44552579|NCT03635099|79568861|FG000|Period 2|Withdrawal by Subject|0|||
44552580|NCT03635099|79568862|FG001|Period 2|Withdrawal by Subject|0|||
44552581|NCT03635099|79568863|FG002|Period 2|Withdrawal by Subject|7|||
44231261|NCT01872689|79043912|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
44231262|NCT01872689|79043913|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
44552582|NCT03635099|79568864|FG003|Period 2|Withdrawal by Subject|4|||
44552583|NCT03635099|79568865|FG004|Period 2|Withdrawal by Subject|7|||
44552584|NCT03635099|79568866|FG005|Period 2|Withdrawal by Subject|0|||
44376657|NCT01071200|79381915|FG000|Overall Study|No oocytes retrieved|1|||
44495566|NCT04124926|79501369|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
44495567|NCT04124926|79501370|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
44495568|NCT04124926|79501371|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
44552585|NCT03635099|79568867|FG006|Period 2|Withdrawal by Subject|0|||
44552586|NCT03635099|79568868|FG007|Period 2|Withdrawal by Subject|0|||
44552587|NCT02108652|79568894|FG000|Overall Study|Death|226|||
44552588|NCT02108652|79568894|FG000|Overall Study|Lost to Follow-up|2|||
44552589|NCT02108652|79568894|FG000|Overall Study|Withdrawal by Subject|8|||
44552590|NCT02108652|79568894|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
44552591|NCT03634085|79568900|FG000|Overall Study|Adverse Event|1|||
44552592|NCT03634085|79568901|FG001|Overall Study|Adverse Event|0|||
44552593|NCT03634085|79568900|FG000|Overall Study|Withdrawal by Subject|0|||
44552594|NCT03634085|79568901|FG001|Overall Study|Withdrawal by Subject|2|||
44552595|NCT02676778|79568917|FG000|Overall Study|Disease Progression|7|||
44552596|NCT02676778|79568918|FG001|Overall Study|Disease Progression|3|||
44552597|NCT02676778|79568919|FG002|Overall Study|Disease Progression|1|||
44552598|NCT02676778|79568917|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
44552599|NCT02676778|79568918|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
44552600|NCT02676778|79568919|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
44552601|NCT02676778|79568917|FG000|Overall Study|Withdrawal by Subject|3|||
44552602|NCT02676778|79568918|FG001|Overall Study|Withdrawal by Subject|2|||
44552603|NCT02676778|79568919|FG002|Overall Study|Withdrawal by Subject|0|||
44552604|NCT02676778|79568917|FG000|Overall Study|Other|4|||
44552605|NCT02676778|79568918|FG001|Overall Study|Other|3|||
44552606|NCT02676778|79568919|FG002|Overall Study|Other|0|||
44552607|NCT02676778|79568917|FG000|Overall Study|Adverse Event|2|||
44552608|NCT02676778|79568918|FG001|Overall Study|Adverse Event|3|||
44552609|NCT02676778|79568919|FG002|Overall Study|Adverse Event|0|||
44552610|NCT02946385|79568934|FG000|Overall Study|Lost to Follow-up|0|||
44552611|NCT02946385|79568935|FG001|Overall Study|Lost to Follow-up|0|||
44552612|NCT02946385|79568936|FG002|Overall Study|Lost to Follow-up|3|||
44552613|NCT02946385|79568937|FG003|Overall Study|Lost to Follow-up|0|||
44552614|NCT02946385|79568938|FG004|Overall Study|Lost to Follow-up|2|||
44552615|NCT02946385|79568939|FG005|Overall Study|Lost to Follow-up|1|||
44552616|NCT02694718|79568959|FG000|Overall Study|Death|1|||
44552617|NCT02694718|79568959|FG000|Overall Study|Withdrawal by Subject|1|||
44495569|NCT04124926|79501372|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
44495570|NCT04124926|79501368|FG000|Healing Phase|Protocol Violation|0|||
44495571|NCT04124926|79501369|FG001|Healing Phase|Protocol Violation|1|||
44495572|NCT04124926|79501370|FG002|Healing Phase|Protocol Violation|0|||
44495573|NCT04124926|79501371|FG003|Healing Phase|Protocol Violation|0|||
44495574|NCT04124926|79501372|FG004|Healing Phase|Protocol Violation|0|||
44495575|NCT04124926|79501368|FG000|Healing Phase|Lost to Follow-up|5|||
44495576|NCT04124926|79501369|FG001|Healing Phase|Lost to Follow-up|4|||
44495577|NCT04124926|79501370|FG002|Healing Phase|Lost to Follow-up|0|||
44495578|NCT04124926|79501371|FG003|Healing Phase|Lost to Follow-up|0|||
44495579|NCT04124926|79501372|FG004|Healing Phase|Lost to Follow-up|0|||
44495580|NCT04124926|79501368|FG000|Healing Phase|Voluntary Withdrawal|10|||
44495581|NCT04124926|79501369|FG001|Healing Phase|Voluntary Withdrawal|7|||
44495582|NCT04124926|79501370|FG002|Healing Phase|Voluntary Withdrawal|0|||
44495583|NCT04124926|79501371|FG003|Healing Phase|Voluntary Withdrawal|0|||
44495584|NCT04124926|79501372|FG004|Healing Phase|Voluntary Withdrawal|0|||
44495585|NCT04124926|79501368|FG000|Healing Phase|Withdrawal of Consent|5|||
44495586|NCT04124926|79501369|FG001|Healing Phase|Withdrawal of Consent|3|||
44495587|NCT04124926|79501370|FG002|Healing Phase|Withdrawal of Consent|0|||
44495588|NCT04124926|79501371|FG003|Healing Phase|Withdrawal of Consent|0|||
44552618|NCT02944513|79568965|FG000|Overall Study|Withdrawal by Subject|4|||
44231263|NCT01872689|79043910|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
44231264|NCT01872689|79043911|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
44231265|NCT01872689|79043912|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
44495589|NCT04124926|79501372|FG004|Healing Phase|Withdrawal of Consent|0|||
44495590|NCT04124926|79501368|FG000|Healing Phase|Miscellaneous|8|||
44552619|NCT02944513|79568966|FG001|Overall Study|Withdrawal by Subject|1|||
44552620|NCT03018938|79568994|FG000|Overall Study|Death|0|||
44552621|NCT03018938|79568995|FG001|Overall Study|Death|1|||
44552622|NCT03018938|79568994|FG000|Overall Study|Lost to Follow-up|21|||
44552623|NCT03018938|79568995|FG001|Overall Study|Lost to Follow-up|32|||
44552624|NCT03018938|79568994|FG000|Overall Study|Withdrawal by Subject|38|||
44231266|NCT01872689|79043913|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
44231267|NCT01872689|79043910|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
44495591|NCT04124926|79501369|FG001|Healing Phase|Miscellaneous|7|||
44552625|NCT03018938|79568995|FG001|Overall Study|Withdrawal by Subject|45|||
44552626|NCT03018938|79568994|FG000|Overall Study|Physician Decision|3|||
44552627|NCT03018938|79568995|FG001|Overall Study|Physician Decision|2|||
44552628|NCT03018938|79568994|FG000|Overall Study|Sponsor Decision|0|||
44552629|NCT03018938|79568995|FG001|Overall Study|Sponsor Decision|1|||
44552630|NCT03018938|79568994|FG000|Overall Study|Screen failure-After randomization|4|||
44552631|NCT03018938|79568995|FG001|Overall Study|Screen failure-After randomization|2|||
44552632|NCT03018938|79568994|FG000|Overall Study|Not recorded|0|||
44552633|NCT03018938|79568995|FG001|Overall Study|Not recorded|2|||
44552634|NCT02943577|79569003|FG000|Overall Study|Protocol Violation|0|||
44495592|NCT04124926|79501370|FG002|Healing Phase|Miscellaneous|0|||
44495593|NCT04124926|79501371|FG003|Healing Phase|Miscellaneous|0|||
44495594|NCT04124926|79501372|FG004|Healing Phase|Miscellaneous|0|||
44495595|NCT04124926|79501368|FG000|Healing Phase|Randomized but not Treated|0|||
44495596|NCT04124926|79501369|FG001|Healing Phase|Randomized but not Treated|3|||
44495597|NCT04124926|79501370|FG002|Healing Phase|Randomized but not Treated|0|||
44495598|NCT04124926|79501371|FG003|Healing Phase|Randomized but not Treated|0|||
44495599|NCT04124926|79501372|FG004|Healing Phase|Randomized but not Treated|0|||
44495600|NCT04124926|79501368|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
44495601|NCT04124926|79501369|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
44495602|NCT04124926|79501370|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
44552635|NCT02943577|79569004|FG001|Overall Study|Protocol Violation|1|||
44552636|NCT02943577|79569003|FG000|Overall Study|Adverse Event|3|||
44552637|NCT02943577|79569004|FG001|Overall Study|Adverse Event|2|||
44552638|NCT02943577|79569003|FG000|Overall Study|Lost to Follow-up|0|||
44552639|NCT02943577|79569004|FG001|Overall Study|Lost to Follow-up|1|||
44552640|NCT02943577|79569003|FG000|Overall Study|Withdrawal by Subject|1|||
44552641|NCT02943577|79569004|FG001|Overall Study|Withdrawal by Subject|1|||
44552642|NCT02943577|79569003|FG000|Overall Study|Pregnancy|1|||
44552643|NCT02943577|79569004|FG001|Overall Study|Pregnancy|0|||
44552644|NCT03016598|79569012|FG000|Overall Study|Lost to Follow-up|0|||
44552645|NCT03016598|79569013|FG001|Overall Study|Lost to Follow-up|2|||
44552646|NCT03017846|79569019|FG000|Overall Study|Lost to Follow-up|3|||
44552647|NCT03017846|79569019|FG000|Overall Study|Adverse Event|2|||
44552648|NCT03014180|79569025|FG000|Overall Study|Protocol Violation|2|||
44552649|NCT03011840|79569035|FG000|Overall Study|Not received PIL in post PIL phase|0|||
44552650|NCT03011840|79569036|FG001|Overall Study|Not received PIL in post PIL phase|21|||
44552651|NCT02942485|79569044|FG000|Overall Study|Lost to Follow-up|1|||
44552652|NCT02942485|79569045|FG001|Overall Study|Lost to Follow-up|0|||
44552653|NCT02942407|79569053|FG000|Overall Study|Lost to Follow-up|3|||
44552654|NCT02942407|79569054|FG001|Overall Study|Lost to Follow-up|2|||
44552655|NCT02942407|79569053|FG000|Overall Study|Withdrawal by Subject|7|||
44552656|NCT02942407|79569054|FG001|Overall Study|Withdrawal by Subject|9|||
44552657|NCT02942407|79569053|FG000|Overall Study|Death|16|||
44552658|NCT02942407|79569054|FG001|Overall Study|Death|13|||
44552659|NCT03009344|79569068|FG000|Overall Study|Lack of Efficacy|5|||
44552660|NCT03009344|79569068|FG000|Overall Study|Withdrawal by Subject|1|||
44552661|NCT03009344|79569068|FG000|Overall Study|Adverse Event|1|||
44552662|NCT03322423|79569072|FG000|Period 1|Subject no longer eligible|0|||
44552663|NCT03322423|79569073|FG001|Period 1|Subject no longer eligible|1|||
44552664|NCT03322423|79569072|FG000|Period 1|Withdrawal by Subject|0|||
44552665|NCT03322423|79569073|FG001|Period 1|Withdrawal by Subject|1|||
44552666|NCT03322423|79569072|FG000|Period 1|Incorrect Lens Dispensed|1|||
44552667|NCT03322423|79569073|FG001|Period 1|Incorrect Lens Dispensed|0|||
44552668|NCT03322423|79569072|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
44552669|NCT03322423|79569073|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
44495603|NCT04124926|79501371|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
44552670|NCT03322423|79569072|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
44552671|NCT03322423|79569073|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
44552672|NCT03322423|79569072|FG000|Period 2|Protocol Violation|1|||
44495604|NCT04124926|79501372|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
44495605|NCT04124926|79501368|FG000|Maintenance Phase|Protocol Violation|0|||
44552673|NCT03322423|79569073|FG001|Period 2|Protocol Violation|0|||
44552674|NCT03322423|79569072|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
44552675|NCT03322423|79569073|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
44552676|NCT03007472|79569079|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
44376658|NCT01071200|79381916|FG001|Overall Study|No oocytes retrieved|1|||
44495606|NCT04124926|79501369|FG001|Maintenance Phase|Protocol Violation|0|||
44495607|NCT04124926|79501370|FG002|Maintenance Phase|Protocol Violation|3|||
44495608|NCT04124926|79501371|FG003|Maintenance Phase|Protocol Violation|0|||
44495609|NCT04124926|79501372|FG004|Maintenance Phase|Protocol Violation|0|||
44495610|NCT04124926|79501368|FG000|Maintenance Phase|Lost to Follow-up|0|||
44495611|NCT04124926|79501369|FG001|Maintenance Phase|Lost to Follow-up|0|||
44495612|NCT04124926|79501370|FG002|Maintenance Phase|Lost to Follow-up|7|||
44495613|NCT04124926|79501371|FG003|Maintenance Phase|Lost to Follow-up|8|||
44495614|NCT04124926|79501372|FG004|Maintenance Phase|Lost to Follow-up|9|||
44495615|NCT04124926|79501368|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
44495616|NCT04124926|79501369|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
44495617|NCT04124926|79501370|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
44495618|NCT04124926|79501371|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
44495619|NCT04124926|79501372|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
44495620|NCT04124926|79501368|FG000|Maintenance Phase|Pregnancy|0|||
44495621|NCT04124926|79501369|FG001|Maintenance Phase|Pregnancy|0|||
44495622|NCT04124926|79501370|FG002|Maintenance Phase|Pregnancy|0|||
44495623|NCT04124926|79501371|FG003|Maintenance Phase|Pregnancy|1|||
44495624|NCT04124926|79501372|FG004|Maintenance Phase|Pregnancy|0|||
44495625|NCT04124926|79501368|FG000|Maintenance Phase|Lack of Efficacy|0|||
44495626|NCT04124926|79501369|FG001|Maintenance Phase|Lack of Efficacy|0|||
44495627|NCT04124926|79501370|FG002|Maintenance Phase|Lack of Efficacy|0|||
44495628|NCT04124926|79501371|FG003|Maintenance Phase|Lack of Efficacy|0|||
44495629|NCT04124926|79501372|FG004|Maintenance Phase|Lack of Efficacy|1|||
44495630|NCT04124926|79501368|FG000|Maintenance Phase|Withdrawal of Consent|0|||
44495631|NCT04124926|79501369|FG001|Maintenance Phase|Withdrawal of Consent|0|||
44495632|NCT04124926|79501370|FG002|Maintenance Phase|Withdrawal of Consent|5|||
44495633|NCT04124926|79501371|FG003|Maintenance Phase|Withdrawal of Consent|5|||
44495634|NCT04124926|79501372|FG004|Maintenance Phase|Withdrawal of Consent|5|||
44495635|NCT04124926|79501368|FG000|Maintenance Phase|Miscellaneous|0|||
44495636|NCT04124926|79501369|FG001|Maintenance Phase|Miscellaneous|0|||
44495637|NCT04124926|79501370|FG002|Maintenance Phase|Miscellaneous|1|||
44495638|NCT04124926|79501371|FG003|Maintenance Phase|Miscellaneous|2|||
44495639|NCT04124926|79501372|FG004|Maintenance Phase|Miscellaneous|4|||
44495640|NCT04124926|79501368|FG000|Maintenance Phase|Randomized but not Treated|0|||
44495641|NCT04124926|79501369|FG001|Maintenance Phase|Randomized but not Treated|0|||
44495642|NCT04124926|79501370|FG002|Maintenance Phase|Randomized but not Treated|2|||
44495643|NCT04124926|79501371|FG003|Maintenance Phase|Randomized but not Treated|2|||
44495644|NCT04124926|79501372|FG004|Maintenance Phase|Randomized but not Treated|0|||
44495645|NCT04274686|79501384|FG000|Overall Study|Physician Decision|1|||
44495646|NCT04274686|79501385|FG001|Overall Study|Physician Decision|0|||
44495647|NCT04113694|79501393|FG000|Overall Study|Adverse Event|2|||
44495648|NCT04113694|79501393|FG000|Overall Study|Lost to Follow-up|2|||
44495649|NCT04113694|79501393|FG000|Overall Study|Withdrawal by Subject|6|||
44495650|NCT04113694|79501393|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
44495651|NCT04105972|79501402|FG000|Overall Study|Adverse Event|2|||
44495652|NCT04105972|79501403|FG001|Overall Study|Adverse Event|1|||
44552677|NCT03007472|79569079|FG000|Overall Study|Death|2|||
44552678|NCT03007472|79569079|FG000|Overall Study|Loss to Follow Up|1|||
44552679|NCT03321721|79569086|FG000|Overall Study|Lost to Follow-up|4|||
44552680|NCT03321721|79569087|FG001|Overall Study|Lost to Follow-up|8|||
44231268|NCT01872689|79043911|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
44376659|NCT01071200|79381915|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
44376660|NCT01071200|79381916|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
44376661|NCT01071200|79381915|FG000|Overall Study|No viable embryos|0|||
44376662|NCT01071200|79381916|FG001|Overall Study|No viable embryos|1|||
44376663|NCT02207569|79381922|FG000|1-Month|Death|6|||
44376664|NCT02207569|79381922|FG000|1-Month|Withdrawal by Subject|2|||
44376665|NCT02207569|79381922|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
44376666|NCT02207569|79381922|FG000|6-Month|Death|8|||
44376667|NCT02207569|79381922|FG000|6-Month|Withdrawal by Subject|2|||
44376668|NCT02207569|79381922|FG000|12-Month|Death|14|||
44376669|NCT02207569|79381922|FG000|12-Month|Withdrawal by Subject|2|||
44376670|NCT02207569|79381922|FG000|24-Month|Death|23|||
44376671|NCT02207569|79381922|FG000|24-Month|Withdrawal by Subject|3|||
44376672|NCT02207569|79381922|FG000|36-Month|Death|23|||
44495653|NCT04102540|79501409|FG000|Overall Study|Withdrawn by PI|2|||
44495654|NCT04102540|79501409|FG000|Overall Study|Lost to Follow-up|6|||
44495655|NCT00124982|79501415|FG000|Short-term Period|Death|1|||
44495656|NCT00124982|79501416|FG001|Short-term Period|Death|1|||
44495657|NCT00124982|79501417|FG002|Short-term Period|Death|0|||
44495658|NCT00124982|79501415|FG000|Short-term Period|Adverse Event|17|||
44495659|NCT00124982|79501416|FG001|Short-term Period|Adverse Event|22|||
44552681|NCT03321721|79569088|FG002|Overall Study|Lost to Follow-up|11|||
44552682|NCT03015116|79569100|FG000|Overall Study|Lost to Follow-up|3|||
44552683|NCT03015116|79569101|FG001|Overall Study|Lost to Follow-up|0|||
44552684|NCT03015116|79569102|FG002|Overall Study|Lost to Follow-up|2|||
44552685|NCT03015116|79569100|FG000|Overall Study|Withdrawal by Subject|3|||
44552686|NCT03015116|79569101|FG001|Overall Study|Withdrawal by Subject|1|||
44552687|NCT03015116|79569102|FG002|Overall Study|Withdrawal by Subject|0|||
44552688|NCT03015116|79569100|FG000|Overall Study|Subject has New Medical Status|1|||
44552689|NCT03015116|79569101|FG001|Overall Study|Subject has New Medical Status|0|||
44552690|NCT03015116|79569102|FG002|Overall Study|Subject has New Medical Status|0|||
44552691|NCT03015116|79569100|FG000|Overall Study|Physician Decision|0|||
44552692|NCT03015116|79569101|FG001|Overall Study|Physician Decision|1|||
44552693|NCT03015116|79569102|FG002|Overall Study|Physician Decision|0|||
44552694|NCT03006458|79569112|FG000|First Intervention|Unsatisfied Vision|0|||
44552695|NCT03006458|79569113|FG001|First Intervention|Unsatisfied Vision|3|||
44552696|NCT03320941|79569124|FG000|Overall Study|subject/guardian decision|0|||
44552697|NCT03320941|79569125|FG001|Overall Study|subject/guardian decision|0|||
44552698|NCT03320941|79569126|FG002|Overall Study|subject/guardian decision|0|||
44552699|NCT03320941|79569127|FG003|Overall Study|subject/guardian decision|1|||
44552700|NCT03320941|79569128|FG004|Overall Study|subject/guardian decision|0|||
44552701|NCT03005288|79569142|FG000|Overall Study|Withdrawal by Subject|7|||
44552702|NCT03005288|79569143|FG001|Overall Study|Withdrawal by Subject|5|||
44552703|NCT03005288|79569142|FG000|Overall Study|Lost to Follow-up|0|||
44552704|NCT03005288|79569143|FG001|Overall Study|Lost to Follow-up|1|||
44552705|NCT03005288|79569142|FG000|Overall Study|Adverse Event|5|||
44552706|NCT03005288|79569143|FG001|Overall Study|Adverse Event|0|||
44376673|NCT02207569|79381922|FG000|36-Month|Withdrawal by Subject|4|||
44376674|NCT02207569|79381922|FG000|48-Month|Death|25|||
44376675|NCT02207569|79381922|FG000|48-Month|Withdrawal by Subject|2|||
44376676|NCT02207569|79381922|FG000|48-Month|Lost to Follow-up|4|||
44376677|NCT02207569|79381922|FG000|60-Month|Death|1|||
44376678|NCT02207569|79381922|FG000|60-Month|Lost to Follow-up|1|||
44376679|NCT02207569|79381922|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
44376680|NCT02207569|79381922|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
44495660|NCT00124982|79501417|FG002|Short-term Period|Adverse Event|0|||
44495661|NCT00124982|79501415|FG000|Short-term Period|Lack of Efficacy|32|||
44495662|NCT00124982|79501416|FG001|Short-term Period|Lack of Efficacy|73|||
44495663|NCT00124982|79501417|FG002|Short-term Period|Lack of Efficacy|0|||
44495664|NCT00124982|79501415|FG000|Short-term Period|Lost to Follow-up|8|||
44495665|NCT00124982|79501416|FG001|Short-term Period|Lost to Follow-up|5|||
44495666|NCT00124982|79501417|FG002|Short-term Period|Lost to Follow-up|0|||
44495667|NCT00124982|79501415|FG000|Short-term Period|Withdrawal of Consent|7|||
44495668|NCT00124982|79501416|FG001|Short-term Period|Withdrawal of Consent|9|||
44495669|NCT00124982|79501417|FG002|Short-term Period|Withdrawal of Consent|0|||
44495670|NCT00124982|79501415|FG000|Short-term Period|Poor/Non-compliance|3|||
44495671|NCT00124982|79501416|FG001|Short-term Period|Poor/Non-compliance|1|||
44495672|NCT00124982|79501417|FG002|Short-term Period|Poor/Non-compliance|0|||
44495673|NCT00124982|79501415|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
44495674|NCT00124982|79501416|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
44495675|NCT00124982|79501417|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
44552707|NCT03005288|79569142|FG000|Overall Study|Protocol deviation|0|||
44552708|NCT03005288|79569143|FG001|Overall Study|Protocol deviation|1|||
44552709|NCT03005288|79569142|FG000|Overall Study|Physician Decision|0|||
44552710|NCT03005288|79569143|FG001|Overall Study|Physician Decision|1|||
44231269|NCT01872689|79043912|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
44495676|NCT00124982|79501415|FG000|Short-term Period|Participant Decision|1|||
44495677|NCT00124982|79501416|FG001|Short-term Period|Participant Decision|0|||
44495678|NCT00124982|79501417|FG002|Short-term Period|Participant Decision|0|||
44552711|NCT03003494|79569149|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
44495679|NCT00124982|79501415|FG000|Short-term Period|Participant Chose Own Doctor|0|||
44495680|NCT00124982|79501416|FG001|Short-term Period|Participant Chose Own Doctor|1|||
44495681|NCT00124982|79501417|FG002|Short-term Period|Participant Chose Own Doctor|0|||
44495682|NCT00124982|79501415|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
44495683|NCT00124982|79501416|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
44495684|NCT00124982|79501417|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
44552712|NCT03559699|79569153|FG000|Overall Study|Withdrawal by Subject|6|||
44552713|NCT03559699|79569153|FG000|Overall Study|Lost to Follow-up|1|||
44552714|NCT03935880|79569169|FG000|Overall Study|Lost to Follow-up|0|||
44552715|NCT03935880|79569170|FG001|Overall Study|Lost to Follow-up|1|||
44495685|NCT00124982|79501415|FG000|Short-term Period|Participant Had Lymphopenia|1|||
44495686|NCT00124982|79501416|FG001|Short-term Period|Participant Had Lymphopenia|0|||
44495687|NCT00124982|79501417|FG002|Short-term Period|Participant Had Lymphopenia|0|||
44495688|NCT00124982|79501415|FG000|Long-term Period|Death|0|||
44495689|NCT00124982|79501416|FG001|Long-term Period|Death|0|||
44495690|NCT00124982|79501417|FG002|Long-term Period|Death|1|||
44495691|NCT00124982|79501415|FG000|Long-term Period|Adverse Event|0|||
44495692|NCT00124982|79501416|FG001|Long-term Period|Adverse Event|0|||
44495693|NCT00124982|79501417|FG002|Long-term Period|Adverse Event|17|||
44495694|NCT00124982|79501415|FG000|Long-term Period|Lack of Efficacy|0|||
44552716|NCT03315793|79569178|FG000|Overall Study|Adverse Event|4|||
44552717|NCT03315793|79569179|FG001|Overall Study|Adverse Event|2|||
44552718|NCT03315793|79569178|FG000|Overall Study|Protocol Deviation|1|||
44552719|NCT03315793|79569179|FG001|Overall Study|Protocol Deviation|0|||
44552720|NCT03315793|79569178|FG000|Overall Study|Difficult for regular visit|0|||
44552721|NCT03315793|79569179|FG001|Overall Study|Difficult for regular visit|1|||
44552722|NCT02676466|79569195|FG000|Overall Study|Death|0|||
44552723|NCT02676466|79569196|FG001|Overall Study|Death|2|||
44552724|NCT02676466|79569197|FG002|Overall Study|Death|1|||
44552725|NCT02676466|79569198|FG003|Overall Study|Death|0|||
44552726|NCT02676466|79569199|FG004|Overall Study|Death|0|||
44552727|NCT02676466|79569200|FG005|Overall Study|Death|0|||
44552728|NCT02676466|79569201|FG006|Overall Study|Death|0|||
44552729|NCT02676466|79569202|FG007|Overall Study|Death|0|||
44552730|NCT02676466|79569195|FG000|Overall Study|Withdrawal by Subject|4|||
44552731|NCT02676466|79569196|FG001|Overall Study|Withdrawal by Subject|3|||
44552732|NCT02676466|79569197|FG002|Overall Study|Withdrawal by Subject|1|||
44552733|NCT02676466|79569198|FG003|Overall Study|Withdrawal by Subject|0|||
44552734|NCT02676466|79569199|FG004|Overall Study|Withdrawal by Subject|3|||
44231270|NCT01872689|79043913|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
44231271|NCT00632931|79043926|FG000|Part 1, Period 1|Protocol Violation|1|||
44231272|NCT00632931|79043927|FG001|Part 1, Period 1|Protocol Violation|0|||
44231273|NCT00632931|79043928|FG002|Part 1, Period 1|Protocol Violation|0|||
44231274|NCT00632931|79043926|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
44231275|NCT00632931|79043927|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
44231276|NCT00632931|79043928|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
44231277|NCT00632931|79043926|FG000|Part 2|Adverse Event|0|||
44231278|NCT00632931|79043927|FG001|Part 2|Adverse Event|0|||
44231279|NCT00632931|79043928|FG002|Part 2|Adverse Event|3|||
44231280|NCT00632931|79043926|FG000|Part 2|Death|0|||
44231281|NCT00632931|79043927|FG001|Part 2|Death|0|||
44231282|NCT00632931|79043928|FG002|Part 2|Death|1|||
44231283|NCT00632931|79043926|FG000|Part 2|Lack of Efficacy|0|||
44231284|NCT00632931|79043927|FG001|Part 2|Lack of Efficacy|0|||
44231285|NCT00632931|79043928|FG002|Part 2|Lack of Efficacy|17|||
44274814|NCT03266588|79221040|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
44274815|NCT03266588|79221041|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
44274816|NCT03266588|79221042|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
44274817|NCT03266588|79221040|FG000|Observational Period|Protocol Deviation|1|||
44274818|NCT03266588|79221041|FG001|Observational Period|Protocol Deviation|0|||
44274819|NCT03266588|79221042|FG002|Observational Period|Protocol Deviation|0|||
44274820|NCT03266588|79221040|FG000|Observational Period|Other Reasons|3|||
44274821|NCT03266588|79221041|FG001|Observational Period|Other Reasons|0|||
44274822|NCT03266588|79221042|FG002|Observational Period|Other Reasons|1|||
44495695|NCT00124982|79501416|FG001|Long-term Period|Lack of Efficacy|0|||
44495696|NCT00124982|79501417|FG002|Long-term Period|Lack of Efficacy|46|||
44552735|NCT02676466|79569200|FG005|Overall Study|Withdrawal by Subject|1|||
44552736|NCT02676466|79569201|FG006|Overall Study|Withdrawal by Subject|1|||
44231286|NCT00632931|79043926|FG000|Part 2|Withdrawal by Subject|0|||
44231287|NCT00632931|79043927|FG001|Part 2|Withdrawal by Subject|0|||
44231288|NCT00632931|79043928|FG002|Part 2|Withdrawal by Subject|3|||
44231289|NCT01857323|79043933|FG000|Overall Study|Adverse Event|1|||
44274823|NCT03266588|79221040|FG000|Long-term Treatment Period|Adverse Event|33|||
44495697|NCT00124982|79501415|FG000|Long-term Period|Lost to Follow-up|0|||
44495698|NCT00124982|79501416|FG001|Long-term Period|Lost to Follow-up|0|||
44552737|NCT02676466|79569202|FG007|Overall Study|Withdrawal by Subject|1|||
44552738|NCT03633695|79569226|FG000|Overall Study|Lost to Follow-up|4|||
44231290|NCT01857323|79043933|FG000|Overall Study|Withdrawal by Subject|3|||
44231291|NCT01857323|79043933|FG000|Overall Study|Non-compliance|1|||
44231292|NCT01857323|79043933|FG000|Overall Study|Protocol Violation|6|||
44231293|NCT01857323|79043933|FG000|Overall Study|Lost to Follow-up|1|||
44231294|NCT01857323|79043933|FG000|Overall Study|Other|4|||
44231295|NCT01857323|79043933|FG000|Overall Study|Did not complete 180 doses|48|||
44231296|NCT00632541|79043937|FG000|Overall Study|Adverse Event|7|||
44231297|NCT01872611|79043943|FG000|Overall Study|Adverse Event|3|||
44231298|NCT01872611|79043944|FG001|Overall Study|Adverse Event|1|||
44231299|NCT01872611|79043943|FG000|Overall Study|Adverse Event, prior to treatment|0|||
44231300|NCT01872611|79043944|FG001|Overall Study|Adverse Event, prior to treatment|1|||
44231301|NCT01872611|79043943|FG000|Overall Study|Death|0|||
44231302|NCT01872611|79043944|FG001|Overall Study|Death|1|||
44231303|NCT01872611|79043943|FG000|Overall Study|Death, prior to treatment|0|||
44231304|NCT01872611|79043944|FG001|Overall Study|Death, prior to treatment|1|||
44231305|NCT01872611|79043943|FG000|Overall Study|Lost to Follow-up|8|||
44495699|NCT00124982|79501417|FG002|Long-term Period|Lost to Follow-up|4|||
44552739|NCT03633695|79569227|FG001|Overall Study|Lost to Follow-up|5|||
44495700|NCT00124982|79501415|FG000|Long-term Period|Withdrawal by Subject|0|||
44495701|NCT00124982|79501416|FG001|Long-term Period|Withdrawal by Subject|0|||
44495702|NCT00124982|79501417|FG002|Long-term Period|Withdrawal by Subject|16|||
44495703|NCT00124982|79501415|FG000|Long-term Period|Pregnancy|0|||
44495704|NCT00124982|79501416|FG001|Long-term Period|Pregnancy|0|||
44552740|NCT03633695|79569226|FG000|Overall Study|Discontinued|8|||
44552741|NCT03633695|79569227|FG001|Overall Study|Discontinued|4|||
44552742|NCT03314233|79569249|FG000|Overall Study|No longer eligible at time of delivery|1|||
44552743|NCT02675998|79569257|FG000|8-Week Treatment Period|Adverse Event|6|||
44552744|NCT02675998|79569258|FG001|8-Week Treatment Period|Adverse Event|5|||
44552745|NCT02675998|79569259|FG002|8-Week Treatment Period|Adverse Event|6|||
44552746|NCT02675998|79569260|FG003|8-Week Treatment Period|Adverse Event|0|||
44552747|NCT02675998|79569257|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
44552748|NCT02675998|79569258|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
44552749|NCT02675998|79569259|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
44552750|NCT02675998|79569260|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
44552751|NCT02675998|79569257|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
44552752|NCT02675998|79569258|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
44552753|NCT02675998|79569259|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
44552754|NCT02675998|79569260|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
44552755|NCT02675998|79569257|FG000|8-Week Treatment Period|Physician Decision|1|||
44552756|NCT02675998|79569258|FG001|8-Week Treatment Period|Physician Decision|0|||
44552757|NCT02675998|79569259|FG002|8-Week Treatment Period|Physician Decision|2|||
44552758|NCT02675998|79569260|FG003|8-Week Treatment Period|Physician Decision|0|||
44552759|NCT02675998|79569257|FG000|8-Week Treatment Period|GI side Effects|1|||
44552760|NCT02675998|79569258|FG001|8-Week Treatment Period|GI side Effects|4|||
44552761|NCT02675998|79569259|FG002|8-Week Treatment Period|GI side Effects|2|||
44552762|NCT02675998|79569260|FG003|8-Week Treatment Period|GI side Effects|0|||
44552763|NCT02675998|79569257|FG000|8-Week Treatment Period|Protocol Violation|1|||
44552764|NCT02675998|79569258|FG001|8-Week Treatment Period|Protocol Violation|1|||
44552765|NCT02675998|79569259|FG002|8-Week Treatment Period|Protocol Violation|1|||
44552766|NCT02675998|79569260|FG003|8-Week Treatment Period|Protocol Violation|0|||
44552767|NCT02675998|79569257|FG000|8-Week Treatment Period|Other|3|||
44552768|NCT02675998|79569258|FG001|8-Week Treatment Period|Other|1|||
44552769|NCT02675998|79569259|FG002|8-Week Treatment Period|Other|2|||
44552770|NCT02675998|79569260|FG003|8-Week Treatment Period|Other|0|||
44552771|NCT02675998|79569257|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
44231306|NCT01872611|79043944|FG001|Overall Study|Lost to Follow-up|1|||
44231307|NCT01872611|79043943|FG000|Overall Study|Physician Decision|1|||
44231308|NCT01872611|79043944|FG001|Overall Study|Physician Decision|0|||
44495705|NCT00124982|79501417|FG002|Long-term Period|Pregnancy|1|||
44231309|NCT01872611|79043943|FG000|Overall Study|Withdrawal by Subject|6|||
44495706|NCT00124982|79501415|FG000|Long-term Period|Poor/Non-compliance|0|||
44495707|NCT00124982|79501416|FG001|Long-term Period|Poor/Non-compliance|0|||
44495708|NCT00124982|79501417|FG002|Long-term Period|Poor/Non-compliance|2|||
44495709|NCT00124982|79501415|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
44495710|NCT00124982|79501416|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
44495711|NCT00124982|79501417|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
44495712|NCT00124982|79501415|FG000|Long-term Period|Neurologist Recommendation|0|||
44495713|NCT00124982|79501416|FG001|Long-term Period|Neurologist Recommendation|0|||
44495714|NCT00124982|79501417|FG002|Long-term Period|Neurologist Recommendation|1|||
44231310|NCT01872611|79043944|FG001|Overall Study|Withdrawal by Subject|1|||
44231311|NCT01872611|79043943|FG000|Overall Study|Reason not provided|6|||
44231312|NCT01872611|79043944|FG001|Overall Study|Reason not provided|6|||
44495715|NCT04263142|79501431|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
44495716|NCT04263142|79501432|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
44495717|NCT04263142|79501433|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
44552772|NCT02675998|79569258|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
44552773|NCT02675998|79569259|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
44552774|NCT02675998|79569260|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
44552775|NCT02675998|79569257|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
44552776|NCT02675998|79569258|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
44552777|NCT02675998|79569259|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
44552778|NCT02675998|79569260|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
44552779|NCT02675998|79569257|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
44552780|NCT02675998|79569258|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
44552781|NCT02675998|79569259|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
44552782|NCT02675998|79569260|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
44552783|NCT02675998|79569257|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
44552784|NCT02675998|79569258|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
44552785|NCT02675998|79569259|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
44552786|NCT02675998|79569260|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
44552787|NCT02675998|79569257|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
44552788|NCT02675998|79569258|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
44552789|NCT02675998|79569259|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
44552790|NCT02675998|79569260|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
44552791|NCT02674204|79569276|FG000|Overall Study|Adverse Event|1|||
44552792|NCT02674204|79569277|FG001|Overall Study|Adverse Event|0|||
44552793|NCT02941627|79569283|FG000|Overall Study|Death|1|||
44552794|NCT02941627|79569283|FG000|Overall Study|Surgical failure|1|||
44552795|NCT02941627|79569283|FG000|Overall Study|cholesteatoma prevented implantation|1|||
44552796|NCT03521934|79569295|FG000|Overall Study|Death|65|||
44552797|NCT03521934|79569296|FG001|Overall Study|Death|73|||
44552798|NCT03521934|79569295|FG000|Overall Study|Withdrawal by Subject|18|||
44552799|NCT03521934|79569296|FG001|Overall Study|Withdrawal by Subject|23|||
44552800|NCT03521934|79569295|FG000|Overall Study|Site Terminated by Sponsor|39|||
44552801|NCT03521934|79569296|FG001|Overall Study|Site Terminated by Sponsor|35|||
44552802|NCT03521934|79569295|FG000|Overall Study|Study Terminated by Sponsor|483|||
44552803|NCT03521934|79569296|FG001|Overall Study|Study Terminated by Sponsor|477|||
44552804|NCT03521934|79569295|FG000|Overall Study|Reason not Specified|3|||
44552805|NCT03521934|79569296|FG001|Overall Study|Reason not Specified|6|||
44552806|NCT03434353|79569307|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
44552807|NCT03434353|79569308|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
44552808|NCT03434353|79569309|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
44552809|NCT03434353|79569310|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
44552810|NCT03434353|79569311|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
44552811|NCT03434353|79569307|FG000|Overall Study|Withdrew consent|1|||
44552812|NCT03434353|79569308|FG001|Overall Study|Withdrew consent|0|||
44552813|NCT03434353|79569309|FG002|Overall Study|Withdrew consent|3|||
44495718|NCT04263142|79501434|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
44495719|NCT04263142|79501435|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
44495720|NCT04263142|79501431|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
44495721|NCT04263142|79501432|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
44495722|NCT04263142|79501433|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
44495723|NCT04263142|79501434|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
44495724|NCT04263142|79501435|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
44495725|NCT04095286|79501448|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495726|NCT04095286|79501449|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
44495727|NCT04095286|79501450|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495728|NCT04095286|79501451|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495729|NCT04095286|79501452|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495730|NCT04095286|79501453|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495731|NCT04095286|79501448|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
44495732|NCT04095286|79501449|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
44495733|NCT04095286|79501450|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
44495734|NCT04095286|79501451|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
44495735|NCT04095286|79501452|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
44495736|NCT04095286|79501453|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
44495737|NCT04095286|79501448|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
44495738|NCT04095286|79501449|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
44552814|NCT03434353|79569310|FG003|Overall Study|Withdrew consent|0|||
44552815|NCT03434353|79569311|FG004|Overall Study|Withdrew consent|0|||
44552816|NCT03434353|79569307|FG000|Overall Study|Adverse Event|1|||
44552817|NCT03434353|79569308|FG001|Overall Study|Adverse Event|0|||
44552818|NCT03434353|79569309|FG002|Overall Study|Adverse Event|0|||
44552819|NCT03434353|79569310|FG003|Overall Study|Adverse Event|0|||
44552820|NCT03434353|79569311|FG004|Overall Study|Adverse Event|1|||
44552821|NCT03434353|79569307|FG000|Overall Study|Lost to Follow-up|2|||
44552822|NCT03434353|79569308|FG001|Overall Study|Lost to Follow-up|0|||
44552823|NCT03434353|79569309|FG002|Overall Study|Lost to Follow-up|0|||
44552824|NCT03434353|79569310|FG003|Overall Study|Lost to Follow-up|0|||
44552825|NCT03434353|79569311|FG004|Overall Study|Lost to Follow-up|0|||
44552826|NCT02914184|79569327|FG000|Overall Study|Lost to Follow-up|7|||
44552827|NCT02914184|79569328|FG001|Overall Study|Lost to Follow-up|10|||
44552828|NCT02914184|79569329|FG002|Overall Study|Lost to Follow-up|8|||
44552829|NCT02914184|79569330|FG003|Overall Study|Lost to Follow-up|7|||
44552830|NCT02914184|79569327|FG000|Overall Study|Withdrawal by Subject|4|||
44552831|NCT02914184|79569328|FG001|Overall Study|Withdrawal by Subject|2|||
44552832|NCT02914184|79569329|FG002|Overall Study|Withdrawal by Subject|7|||
44552833|NCT02914184|79569330|FG003|Overall Study|Withdrawal by Subject|3|||
44552834|NCT02914184|79569327|FG000|Overall Study|Other|1|||
44552835|NCT02914184|79569328|FG001|Overall Study|Other|0|||
44552836|NCT02914184|79569329|FG002|Overall Study|Other|0|||
44552837|NCT02914184|79569330|FG003|Overall Study|Other|0|||
44552838|NCT02914184|79569327|FG000|Overall Study|Migrated/moved from the study area|2|||
44552839|NCT02914184|79569328|FG001|Overall Study|Migrated/moved from the study area|1|||
44552840|NCT02914184|79569329|FG002|Overall Study|Migrated/moved from the study area|2|||
44552841|NCT02914184|79569330|FG003|Overall Study|Migrated/moved from the study area|1|||
44552842|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
44552843|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
44552844|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Death|2|||
44552845|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Death|1|||
44552846|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
44552847|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
44552848|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
44552849|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
44552850|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
44552851|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
44552852|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
44552853|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
44552854|NCT03633227|79569344|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
44552855|NCT03633227|79569345|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
44552856|NCT03633227|79569344|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
44552857|NCT03633227|79569345|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
44552858|NCT03633227|79569344|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
44495739|NCT04095286|79501450|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
44495740|NCT04095286|79501451|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
44495741|NCT04095286|79501452|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
44495742|NCT04095286|79501453|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
44495743|NCT04095286|79501448|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495744|NCT04095286|79501449|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44552859|NCT03633227|79569345|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
44552860|NCT03633227|79569344|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
44552861|NCT03633227|79569345|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
44552862|NCT03633227|79569344|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
44552863|NCT03633227|79569345|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
44552864|NCT03633227|79569344|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
44231313|NCT03089853|79043954|FG000|Overall Study|Lost to Follow-up|2|||
44231314|NCT03089853|79043955|FG001|Overall Study|Lost to Follow-up|1|||
44231315|NCT03086967|79043963|FG000|Overall Study|Screen Failure|2|||
44231316|NCT03086967|79043964|FG001|Overall Study|Screen Failure|2|||
44231317|NCT01856543|79043972|FG000|Overall Study|Treatment discontinued|6|||
44495745|NCT04095286|79501450|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
44495746|NCT04095286|79501451|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495747|NCT04095286|79501452|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44495748|NCT04095286|79501453|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
44552865|NCT03633227|79569345|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
44552866|NCT02913326|79569358|FG000|Overall Study|Reason not listed|0|||
44552867|NCT02913326|79569359|FG001|Overall Study|Reason not listed|1|||
44552868|NCT02913326|79569358|FG000|Overall Study|Lost to Follow-up|0|||
44552869|NCT02913326|79569359|FG001|Overall Study|Lost to Follow-up|1|||
44552870|NCT02913326|79569358|FG000|Overall Study|Adverse Event|1|||
44552871|NCT02913326|79569359|FG001|Overall Study|Adverse Event|0|||
44231318|NCT01856543|79043973|FG001|Overall Study|Treatment discontinued|3|||
44231319|NCT01856543|79043972|FG000|Overall Study|Withdrawn before start|7|||
44552872|NCT02912468|79569367|FG000|Overall Study|Adverse Event|3|||
44552873|NCT02912468|79569368|FG001|Overall Study|Adverse Event|2|||
44552874|NCT02912468|79569367|FG000|Overall Study|Withdrawal by Subject|6|||
44552875|NCT02912468|79569368|FG001|Overall Study|Withdrawal by Subject|2|||
44552876|NCT02912468|79569367|FG000|Overall Study|Randomized and not treated|0|||
44552877|NCT02912468|79569368|FG001|Overall Study|Randomized and not treated|1|||
44552878|NCT04438499|79569375|FG000|Overall Study|Lack of Efficacy|2|||
44552879|NCT00002874|79569381|FG000|Overall Study|Withdrawal by Subject|1|||
44552880|NCT00002874|79569382|FG001|Overall Study|Withdrawal by Subject|1|||
44495749|NCT04095286|79501448|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
44495750|NCT04095286|79501449|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
44495751|NCT04095286|79501450|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
44495752|NCT04095286|79501451|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
44495753|NCT04095286|79501452|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
44495754|NCT04095286|79501453|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
44495755|NCT04093414|79501463|FG000|3 Month Follow up|Physician Decision|0|||
44495756|NCT04093414|79501464|FG001|3 Month Follow up|Physician Decision|1|||
44495757|NCT04093414|79501463|FG000|6month Follow up|Physician Decision|1|||
44495758|NCT04093414|79501464|FG001|6month Follow up|Physician Decision|3|||
44495759|NCT04093258|79501470|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
44495760|NCT04093258|79501471|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
44552881|NCT00002874|79569381|FG000|Overall Study|Protocol Violation|44|||
44552882|NCT00002874|79569382|FG001|Overall Study|Protocol Violation|34|||
44552883|NCT03001076|79569390|FG000|Overall Study|Withdrawal by patient|2|||
44552884|NCT03001076|79569391|FG001|Overall Study|Withdrawal by patient|0|||
44552885|NCT03001076|79569390|FG000|Overall Study|Other|1|||
44552886|NCT03001076|79569391|FG001|Overall Study|Other|0|||
44552887|NCT03001076|79569390|FG000|Overall Study|Adverse Event|3|||
44552888|NCT03001076|79569391|FG001|Overall Study|Adverse Event|3|||
44552889|NCT03001076|79569390|FG000|Overall Study|Sponsor decision|1|||
44552890|NCT03001076|79569391|FG001|Overall Study|Sponsor decision|0|||
44552891|NCT03001076|79569390|FG000|Overall Study|Lost to Follow-up|0|||
44552892|NCT03001076|79569391|FG001|Overall Study|Lost to Follow-up|2|||
44552893|NCT03555305|79569397|FG000|Period 1|Physician Decision|0|||
44552894|NCT03555305|79569398|FG001|Period 1|Physician Decision|1|||
44552895|NCT03555305|79569397|FG000|Period 1|Adverse Event|0|||
44552896|NCT03555305|79569398|FG001|Period 1|Adverse Event|1|||
44552897|NCT03553823|79569406|FG000|Overall Study|Physician Decision|0|||
44552898|NCT03553823|79569407|FG001|Overall Study|Physician Decision|1|||
44552899|NCT03000686|79569415|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
44552900|NCT03000686|79569416|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
44552901|NCT03000686|79569417|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
44552902|NCT03000686|79569418|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
44552903|NCT02493660|79569436|FG000|Overall Study|Physician Decision|0|||
44552904|NCT02493660|79569437|FG001|Overall Study|Physician Decision|1|||
44552905|NCT02493660|79569436|FG000|Overall Study|Adverse Event|4|||
44552906|NCT02493660|79569437|FG001|Overall Study|Adverse Event|2|||
44552907|NCT02493660|79569436|FG000|Overall Study|Withdrawal by Subject|2|||
44552908|NCT02493660|79569437|FG001|Overall Study|Withdrawal by Subject|3|||
44552909|NCT02493660|79569436|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
44552910|NCT02493660|79569437|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
44552911|NCT02493660|79569436|FG000|Overall Study|Protocol Violation|0|||
44552912|NCT02493660|79569437|FG001|Overall Study|Protocol Violation|1|||
44552913|NCT02493660|79569436|FG000|Overall Study|Death|0|||
44552914|NCT02493660|79569437|FG001|Overall Study|Death|1|||
44552915|NCT02493660|79569436|FG000|Overall Study|Lost to Follow-up|2|||
44552916|NCT02493660|79569437|FG001|Overall Study|Lost to Follow-up|4|||
44552917|NCT03552029|79569447|FG000|Overall Study|Death|3|||
44552918|NCT03552029|79569448|FG001|Overall Study|Death|0|||
44552919|NCT03552029|79569447|FG000|Overall Study|Adverse Event|1|||
44552920|NCT03552029|79569448|FG001|Overall Study|Adverse Event|0|||
44552921|NCT03552029|79569447|FG000|Overall Study|Lack of Efficacy|0|||
44552922|NCT03552029|79569448|FG001|Overall Study|Lack of Efficacy|2|||
44552923|NCT03552029|79569447|FG000|Overall Study|Physician Decision|0|||
44552924|NCT03552029|79569448|FG001|Overall Study|Physician Decision|1|||
44552925|NCT03552029|79569447|FG000|Overall Study|Study terminated by Sponsor|0|||
44552926|NCT03552029|79569448|FG001|Overall Study|Study terminated by Sponsor|1|||
44552927|NCT03552029|79569447|FG000|Overall Study|Other|0|||
44552928|NCT03552029|79569448|FG001|Overall Study|Other|2|||
44552929|NCT05395104|79569454|FG000|Overall Study|Met Liver Stopping Criteria|1|||
44552930|NCT05395104|79569454|FG000|Overall Study|Withdrawal by Subject|1|||
44552931|NCT05327491|79569460|FG000|Periods 1 & 2|Miscellaneous|0|||
44552932|NCT05327491|79569461|FG001|Periods 1 & 2|Miscellaneous|1|||
44552933|NCT05327491|79569462|FG002|Periods 1 & 2|Miscellaneous|0|||
44552934|NCT05327491|79569463|FG003|Periods 1 & 2|Miscellaneous|0|||
44552935|NCT05327491|79569460|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
44552936|NCT05327491|79569461|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
44552937|NCT05327491|79569462|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
44552938|NCT05327491|79569463|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
44552939|NCT05299892|79569481|FG000|Overall Study|Withdrawal by Subject|2|||
44552940|NCT04983940|79569486|FG000|Overall Study|Lost to Follow-up|14|||
44552941|NCT04983940|79569486|FG000|Overall Study|Lack of Efficacy|2|||
44552942|NCT04966910|79569494|FG000|Baseline|Participant did not complete measure|0|||
44231320|NCT01856543|79043973|FG001|Overall Study|Withdrawn before start|3|||
44231321|NCT00632463|79043983|FG000|Overall Study|Adverse Event|0|||
44231322|NCT00632463|79043984|FG001|Overall Study|Adverse Event|1|||
44231323|NCT00632463|79043985|FG002|Overall Study|Adverse Event|0|||
44231324|NCT00632229|79043995|FG000|Overall Study|Adverse Event|6|||
44231325|NCT00632229|79043996|FG001|Overall Study|Adverse Event|0|||
44231326|NCT00632229|79043995|FG000|Overall Study|Lost to Follow-up|0|||
44231327|NCT00632229|79043996|FG001|Overall Study|Lost to Follow-up|3|||
44231328|NCT00632229|79043995|FG000|Overall Study|Lack of Efficacy|0|||
44231329|NCT00632229|79043996|FG001|Overall Study|Lack of Efficacy|2|||
44231330|NCT00632229|79043995|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
44231331|NCT00632229|79043996|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
44231332|NCT00631137|79044004|FG000|Overall Study|Withdrawal by Subject|1|||
44495761|NCT04253236|79501479|FG000|Overall Study|Adverse Event|1|||
44495762|NCT04253236|79501480|FG001|Overall Study|Adverse Event|0|||
44495763|NCT04253236|79501479|FG000|Overall Study|Safety Concerns|1|||
44495764|NCT04253236|79501480|FG001|Overall Study|Safety Concerns|0|||
44495765|NCT04253236|79501479|FG000|Overall Study|Study Terminated by Sponsor|1|||
44495766|NCT04253236|79501480|FG001|Overall Study|Study Terminated by Sponsor|0|||
44495767|NCT04087720|79501486|FG000|Overall Study|Withdrawal by Subject|2|||
44495768|NCT04087720|79501486|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
44495769|NCT04086472|79501495|FG000|Overall Study|Lost to Follow-up|1|||
44495770|NCT04086472|79501496|FG001|Overall Study|Lost to Follow-up|0|||
44231333|NCT00631137|79044005|FG001|Overall Study|Withdrawal by Subject|0|||
44231334|NCT00630825|79044024|FG000|Overall Study|Adverse Event|4|||
44231335|NCT00630825|79044025|FG001|Overall Study|Adverse Event|4|||
44495771|NCT04086472|79501497|FG002|Overall Study|Lost to Follow-up|0|||
44495772|NCT04086472|79501498|FG003|Overall Study|Lost to Follow-up|0|||
44495773|NCT04086472|79501499|FG004|Overall Study|Lost to Follow-up|1|||
44231336|NCT00630825|79044026|FG002|Overall Study|Adverse Event|3|||
44552943|NCT04966910|79569495|FG001|Baseline|Participant did not complete measure|0|||
44552944|NCT04966910|79569496|FG002|Baseline|Participant did not complete measure|1|||
44552945|NCT04966910|79569497|FG003|Baseline|Participant did not complete measure|0|||
44552946|NCT04966910|79569494|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
44495774|NCT04086472|79501495|FG000|Overall Study|Physician Decision|0|||
44552947|NCT04966910|79569495|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
44552948|NCT04966910|79569496|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
44552949|NCT04966910|79569497|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
44552950|NCT04966910|79569494|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
44552951|NCT04966910|79569495|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
44552952|NCT04966910|79569496|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
44552953|NCT04966910|79569497|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
44552954|NCT04966910|79569494|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
44231337|NCT00630825|79044027|FG003|Overall Study|Adverse Event|1|||
44231338|NCT00630825|79044024|FG000|Overall Study|Entry Criteria Not Met|1|||
44552955|NCT04966910|79569495|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
44231339|NCT00630825|79044025|FG001|Overall Study|Entry Criteria Not Met|0|||
44231340|NCT00630825|79044026|FG002|Overall Study|Entry Criteria Not Met|2|||
44495775|NCT04086472|79501496|FG001|Overall Study|Physician Decision|1|||
44495776|NCT04086472|79501497|FG002|Overall Study|Physician Decision|1|||
44552956|NCT04966910|79569496|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
44552957|NCT04966910|79569497|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
44552958|NCT04900038|79569513|FG000|Overall Study|Adverse Event|1|||
44552959|NCT04900038|79569514|FG001|Overall Study|Adverse Event|0|||
44552960|NCT04900038|79569515|FG002|Overall Study|Adverse Event|1|||
44552961|NCT04900038|79569516|FG003|Overall Study|Adverse Event|1|||
44552962|NCT04900038|79569513|FG000|Overall Study|Withdrawal by Subject|0|||
44552963|NCT04900038|79569514|FG001|Overall Study|Withdrawal by Subject|1|||
44552964|NCT04900038|79569515|FG002|Overall Study|Withdrawal by Subject|0|||
44552965|NCT04900038|79569516|FG003|Overall Study|Withdrawal by Subject|0|||
44495777|NCT04086472|79501498|FG003|Overall Study|Physician Decision|0|||
44552966|NCT04900038|79569513|FG000|Overall Study|Study terminated by sponsor|18|||
44552967|NCT04900038|79569514|FG001|Overall Study|Study terminated by sponsor|15|||
44552968|NCT04900038|79569515|FG002|Overall Study|Study terminated by sponsor|17|||
44552969|NCT04900038|79569516|FG003|Overall Study|Study terminated by sponsor|14|||
44552970|NCT04900038|79569513|FG000|Overall Study|Protocol Deviation|1|||
44552971|NCT04900038|79569514|FG001|Overall Study|Protocol Deviation|1|||
44552972|NCT04900038|79569515|FG002|Overall Study|Protocol Deviation|0|||
44552973|NCT04900038|79569516|FG003|Overall Study|Protocol Deviation|0|||
44552974|NCT04900038|79569513|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
44552975|NCT04900038|79569514|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
44552976|NCT04900038|79569515|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
44231341|NCT00630825|79044027|FG003|Overall Study|Entry Criteria Not Met|1|||
44495778|NCT04086472|79501499|FG004|Overall Study|Physician Decision|0|||
44495779|NCT04086472|79501495|FG000|Overall Study|Withdrawal by Subject|1|||
44495780|NCT04086472|79501496|FG001|Overall Study|Withdrawal by Subject|1|||
44495781|NCT04086472|79501497|FG002|Overall Study|Withdrawal by Subject|1|||
44495782|NCT04086472|79501498|FG003|Overall Study|Withdrawal by Subject|0|||
44495783|NCT04086472|79501499|FG004|Overall Study|Withdrawal by Subject|0|||
44495784|NCT04086472|79501495|FG000|Overall Study|Various reasons|2|||
44495785|NCT04086472|79501496|FG001|Overall Study|Various reasons|0|||
44495786|NCT04086472|79501497|FG002|Overall Study|Various reasons|0|||
44495787|NCT04086472|79501498|FG003|Overall Study|Various reasons|3|||
44495788|NCT04086472|79501499|FG004|Overall Study|Various reasons|1|||
44495789|NCT04249336|79501515|FG000|Overall Study|Lost to Follow-up|3|||
44495790|NCT04249336|79501516|FG001|Overall Study|Lost to Follow-up|3|||
44495791|NCT04249336|79501517|FG002|Overall Study|Lost to Follow-up|3|||
44495792|NCT04249336|79501518|FG003|Overall Study|Lost to Follow-up|3|||
44495793|NCT04245202|79501530|FG000|Overall Study|Lack of Efficacy|10|||
44495794|NCT04245202|79501531|FG001|Overall Study|Lack of Efficacy|1|||
44231342|NCT00630825|79044024|FG000|Overall Study|Lost to Follow-up|1|||
44231343|NCT00630825|79044025|FG001|Overall Study|Lost to Follow-up|1|||
44231344|NCT00630825|79044026|FG002|Overall Study|Lost to Follow-up|1|||
44495795|NCT04079842|79501538|FG000|Overall Study|Request of subject|2|||
44495796|NCT04079842|79501538|FG000|Overall Study|Unable to draw Arterial samples|1|||
44495797|NCT04078126|79501542|FG000|Washout|Study put on hold due to COVID-19|0|||
44495798|NCT04078126|79501543|FG001|Washout|Study put on hold due to COVID-19|2|||
44552977|NCT04900038|79569516|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
44552978|NCT04900038|79569513|FG000|Overall Study|Lost to Follow-up|0|||
44552979|NCT04900038|79569514|FG001|Overall Study|Lost to Follow-up|0|||
44552980|NCT04900038|79569515|FG002|Overall Study|Lost to Follow-up|0|||
44376681|NCT01070966|79381926|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
44376682|NCT01070966|79381926|FG000|Participants for Safety Evaluation|Off-label use|9|||
44376683|NCT01070966|79381926|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
44376684|NCT01070966|79381926|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
44495799|NCT04078126|79501542|FG000|Period 2|Study put on hold due to COVID-19|1|||
44495800|NCT04078126|79501543|FG001|Period 2|Study put on hold due to COVID-19|1|||
44231345|NCT00630825|79044027|FG003|Overall Study|Lost to Follow-up|1|||
44231346|NCT00630825|79044024|FG000|Overall Study|Physician Decision|1|||
44231347|NCT00630825|79044025|FG001|Overall Study|Physician Decision|0|||
44231348|NCT00630825|79044026|FG002|Overall Study|Physician Decision|0|||
44231349|NCT00630825|79044027|FG003|Overall Study|Physician Decision|0|||
44231350|NCT00630825|79044024|FG000|Overall Study|Withdrawal by Subject|2|||
44231351|NCT00630825|79044025|FG001|Overall Study|Withdrawal by Subject|2|||
44231352|NCT00630825|79044026|FG002|Overall Study|Withdrawal by Subject|2|||
44495801|NCT04073368|79501553|FG000|Overall Study|Adverse Event|2|||
44495802|NCT04073368|79501554|FG001|Overall Study|Adverse Event|0|||
44552981|NCT04900038|79569516|FG003|Overall Study|Lost to Follow-up|1|||
44552982|NCT04880642|79569528|FG000|Randomization|Withdrawal by Subject|2|||
44552983|NCT04880642|79569529|FG001|Randomization|Withdrawal by Subject|3|||
44552984|NCT04880642|79569528|FG000|Treatment Period|Adverse Event|0|||
44552985|NCT04880642|79569529|FG001|Treatment Period|Adverse Event|1|||
44552986|NCT04880642|79569528|FG000|Treatment Period|Death|6|||
44495803|NCT04073368|79501555|FG002|Overall Study|Adverse Event|1|||
44495804|NCT04073368|79501556|FG003|Overall Study|Adverse Event|1|||
44552987|NCT04880642|79569529|FG001|Treatment Period|Death|6|||
44552988|NCT04880642|79569528|FG000|Treatment Period|Lost to Follow-up|1|||
44552989|NCT04880642|79569529|FG001|Treatment Period|Lost to Follow-up|0|||
44552990|NCT04880642|79569528|FG000|Treatment Period|Protocol Violation|0|||
44552991|NCT04880642|79569529|FG001|Treatment Period|Protocol Violation|1|||
44552992|NCT04880642|79569528|FG000|Treatment Period|Withdrawal by Subject|5|||
44552993|NCT04880642|79569529|FG001|Treatment Period|Withdrawal by Subject|3|||
44552994|NCT04880642|79569528|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
44552995|NCT04880642|79569529|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
44552996|NCT04880642|79569528|FG000|Follow-up|Death|4|||
44552997|NCT04880642|79569529|FG001|Follow-up|Death|3|||
44552998|NCT04880642|79569528|FG000|Follow-up|Withdrawal by Subject|1|||
44552999|NCT04880642|79569529|FG001|Follow-up|Withdrawal by Subject|0|||
44553000|NCT04578535|79569541|FG000|Overall Study|Lost to Follow-up|1|||
44553001|NCT04578535|79569542|FG001|Overall Study|Lost to Follow-up|0|||
44553002|NCT04578535|79569543|FG002|Overall Study|Lost to Follow-up|0|||
44495805|NCT04073368|79501553|FG000|Overall Study|Withdrawal by Subject|2|||
44495806|NCT04073368|79501554|FG001|Overall Study|Withdrawal by Subject|2|||
44495807|NCT04073368|79501555|FG002|Overall Study|Withdrawal by Subject|1|||
44495808|NCT04073368|79501556|FG003|Overall Study|Withdrawal by Subject|1|||
44495809|NCT04073368|79501553|FG000|Overall Study|Lost to Follow-up|1|||
44495810|NCT04073368|79501554|FG001|Overall Study|Lost to Follow-up|1|||
44495811|NCT04073368|79501555|FG002|Overall Study|Lost to Follow-up|1|||
44495812|NCT04073368|79501556|FG003|Overall Study|Lost to Follow-up|0|||
44495813|NCT04073368|79501553|FG000|Overall Study|Protocol Violation|0|||
44495814|NCT04073368|79501554|FG001|Overall Study|Protocol Violation|1|||
44495815|NCT04073368|79501555|FG002|Overall Study|Protocol Violation|0|||
44495816|NCT04073368|79501556|FG003|Overall Study|Protocol Violation|0|||
44495817|NCT04073368|79501553|FG000|Overall Study|Subject noncompliance|7|||
44553003|NCT04578535|79569544|FG003|Overall Study|Lost to Follow-up|1|||
44553004|NCT04578535|79569545|FG004|Overall Study|Lost to Follow-up|0|||
44231353|NCT00630825|79044027|FG003|Overall Study|Withdrawal by Subject|3|||
44231354|NCT04075734|79044324|FG000|Overall Study|Lost to Follow-up|1|||
44231355|NCT04075734|79044325|FG001|Overall Study|Lost to Follow-up|1|||
44231356|NCT04075734|79044326|FG002|Overall Study|Lost to Follow-up|0|||
44495818|NCT04073368|79501554|FG001|Overall Study|Subject noncompliance|4|||
44553005|NCT04578535|79569546|FG005|Overall Study|Lost to Follow-up|2|||
44553006|NCT04578535|79569541|FG000|Overall Study|Pregnancy|1|||
44553007|NCT04578535|79569542|FG001|Overall Study|Pregnancy|0|||
44553008|NCT04578535|79569543|FG002|Overall Study|Pregnancy|0|||
44553009|NCT04578535|79569544|FG003|Overall Study|Pregnancy|0|||
44553010|NCT04578535|79569545|FG004|Overall Study|Pregnancy|0|||
44553011|NCT04578535|79569546|FG005|Overall Study|Pregnancy|0|||
44231357|NCT04075734|79044324|FG000|Overall Study|Withdrawal by Subject|3|||
44495819|NCT04073368|79501555|FG002|Overall Study|Subject noncompliance|0|||
44495820|NCT04073368|79501556|FG003|Overall Study|Subject noncompliance|0|||
44553012|NCT04578535|79569541|FG000|Overall Study|Withdrawal by Subject|0|||
44553013|NCT04578535|79569542|FG001|Overall Study|Withdrawal by Subject|0|||
44553014|NCT04578535|79569543|FG002|Overall Study|Withdrawal by Subject|0|||
44553015|NCT04578535|79569544|FG003|Overall Study|Withdrawal by Subject|1|||
44553016|NCT04578535|79569545|FG004|Overall Study|Withdrawal by Subject|1|||
44553017|NCT04578535|79569546|FG005|Overall Study|Withdrawal by Subject|5|||
44553018|NCT04578535|79569541|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
44553019|NCT04578535|79569542|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
44553020|NCT04578535|79569543|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
44553021|NCT04578535|79569544|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
44553022|NCT04578535|79569545|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
44553023|NCT04578535|79569546|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
44553024|NCT04574362|79569566|FG000|Overall Study|Other|0|||
44553025|NCT04574362|79569567|FG001|Overall Study|Other|5|||
44553026|NCT04574362|79569566|FG000|Overall Study|COVID-19|0|||
44553027|NCT04574362|79569567|FG001|Overall Study|COVID-19|1|||
44553028|NCT04574362|79569566|FG000|Overall Study|Adverse Event|1|||
44553029|NCT04574362|79569567|FG001|Overall Study|Adverse Event|1|||
44553030|NCT04574362|79569566|FG000|Overall Study|Withdrawal by Subject|2|||
44553031|NCT04574362|79569567|FG001|Overall Study|Withdrawal by Subject|4|||
44553032|NCT04574362|79569566|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
44553033|NCT04574362|79569567|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
44553034|NCT04574362|79569566|FG000|Overall Study|Participant refused to come to the hospital|1|||
44553035|NCT04574362|79569567|FG001|Overall Study|Participant refused to come to the hospital|0|||
44553036|NCT04574362|79569566|FG000|Overall Study|Participant refused the visit|1|||
44553037|NCT04574362|79569567|FG001|Overall Study|Participant refused the visit|0|||
44553038|NCT04574362|79569566|FG000|Overall Study|Participant quit early because of business trip|1|||
44553039|NCT04574362|79569567|FG001|Overall Study|Participant quit early because of business trip|0|||
44553040|NCT04470908|79569573|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
44553041|NCT04399837|79569587|FG000|Overall Study|Other than listed|0|||
44553042|NCT04399837|79569588|FG001|Overall Study|Other than listed|2|||
44553043|NCT04399837|79569589|FG002|Overall Study|Other than listed|2|||
44553044|NCT04399837|79569590|FG003|Overall Study|Other than listed|3|||
44553045|NCT04399837|79569587|FG000|Overall Study|Withdrawal by Subject|1|||
44553046|NCT04399837|79569588|FG001|Overall Study|Withdrawal by Subject|2|||
44553047|NCT04399837|79569589|FG002|Overall Study|Withdrawal by Subject|1|||
44553048|NCT04399837|79569590|FG003|Overall Study|Withdrawal by Subject|1|||
44553049|NCT04364269|79569613|FG000|Overall Study|Adverse Event|1|||
44553050|NCT04364269|79569614|FG001|Overall Study|Adverse Event|0|||
44553051|NCT04364269|79569615|FG002|Overall Study|Adverse Event|0|||
44553052|NCT04364269|79569613|FG000|Overall Study|Withdrawal by Subject|0|||
44553053|NCT04364269|79569614|FG001|Overall Study|Withdrawal by Subject|1|||
44553054|NCT04364269|79569615|FG002|Overall Study|Withdrawal by Subject|0|||
44553055|NCT04299048|79569623|FG000|Overall Study|Death|1|||
44553056|NCT04299048|79569623|FG000|Overall Study|Global deterioration of health status|2|||
44553057|NCT04299048|79569623|FG000|Overall Study|Enrolled and not treated|1|||
44553058|NCT03673462|79569655|FG000|Overall Study|Adverse Event|11|||
44553059|NCT03673462|79569656|FG001|Overall Study|Adverse Event|1|||
44553060|NCT03673462|79569655|FG000|Overall Study|Protocol Violation|25|||
44553061|NCT03673462|79569656|FG001|Overall Study|Protocol Violation|11|||
44553062|NCT03673462|79569655|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
44553063|NCT03673462|79569656|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
44553064|NCT03673462|79569655|FG000|Overall Study|Lost to Follow-up|102|||
44553065|NCT03673462|79569656|FG001|Overall Study|Lost to Follow-up|19|||
44553066|NCT03432364|79569665|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
44553067|NCT03307785|79569681|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
44553068|NCT03307785|79569682|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
44553069|NCT03307785|79569683|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
44231358|NCT04075734|79044325|FG001|Overall Study|Withdrawal by Subject|0|||
44231359|NCT04075734|79044326|FG002|Overall Study|Withdrawal by Subject|0|||
44231360|NCT00989781|79044371|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
44376685|NCT01070966|79381926|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
44553070|NCT03307785|79569684|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
44553071|NCT03307785|79569685|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
44553072|NCT03307785|79569686|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
44553073|NCT03307785|79569687|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
44553074|NCT03307785|79569688|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
44553075|NCT03307785|79569689|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
44553076|NCT03307785|79569690|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
44553077|NCT03307785|79569691|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
44553078|NCT03307785|79569681|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
44553079|NCT03307785|79569682|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
44553080|NCT03307785|79569683|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553081|NCT03307785|79569684|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553082|NCT03307785|79569685|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553083|NCT03307785|79569686|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553084|NCT03307785|79569687|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553085|NCT03307785|79569688|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553086|NCT03307785|79569689|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553087|NCT03307785|79569690|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553088|NCT03307785|79569691|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
44553089|NCT03307785|79569681|FG000|Part A: Up to 28.5 Months|Death|4|||
44553090|NCT03307785|79569682|FG001|Part A: Up to 28.5 Months|Death|4|||
44553091|NCT03307785|79569683|FG002|Part A: Up to 28.5 Months|Death|0|||
44553092|NCT03307785|79569684|FG003|Part A: Up to 28.5 Months|Death|0|||
44553093|NCT03307785|79569685|FG004|Part A: Up to 28.5 Months|Death|0|||
44553094|NCT03307785|79569686|FG005|Part A: Up to 28.5 Months|Death|0|||
44553095|NCT03307785|79569687|FG006|Part A: Up to 28.5 Months|Death|0|||
44553096|NCT03307785|79569688|FG007|Part A: Up to 28.5 Months|Death|0|||
44553097|NCT03307785|79569689|FG008|Part A: Up to 28.5 Months|Death|0|||
44553098|NCT03307785|79569690|FG009|Part A: Up to 28.5 Months|Death|0|||
44553099|NCT03307785|79569691|FG010|Part A: Up to 28.5 Months|Death|0|||
44553100|NCT03307785|79569681|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
44553101|NCT03307785|79569682|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
44553102|NCT03307785|79569683|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
44553103|NCT03307785|79569684|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
44553104|NCT03307785|79569685|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
44553105|NCT03307785|79569686|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
44553106|NCT03307785|79569687|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
44553107|NCT03307785|79569688|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
44553108|NCT03307785|79569689|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
44553109|NCT03307785|79569690|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
44553110|NCT03307785|79569691|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
44553111|NCT03307785|79569681|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
44553112|NCT03307785|79569682|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
44274824|NCT03266588|79221041|FG001|Long-term Treatment Period|Adverse Event|17|||
44495821|NCT04380688|79501568|FG000|Overall Study|Death|2|||
44553113|NCT03307785|79569683|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
44553114|NCT03307785|79569684|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
44553115|NCT03307785|79569685|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
44553116|NCT03307785|79569686|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
44553117|NCT03307785|79569687|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
44274825|NCT03266588|79221042|FG002|Long-term Treatment Period|Adverse Event|8|||
44274826|NCT03266588|79221040|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
44274827|NCT03266588|79221041|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
44495822|NCT04380688|79501569|FG001|Overall Study|Death|2|||
44495823|NCT04380688|79501568|FG000|Overall Study|Lost to Follow-up|2|||
44495824|NCT04380688|79501569|FG001|Overall Study|Lost to Follow-up|4|||
44495825|NCT04380688|79501568|FG000|Overall Study|Withdrawal by Subject|3|||
44495826|NCT04380688|79501569|FG001|Overall Study|Withdrawal by Subject|3|||
44495827|NCT00124748|79501577|FG000|Overall Study|Adverse Event|8|||
44495828|NCT00124748|79501578|FG001|Overall Study|Adverse Event|39|||
44553118|NCT03307785|79569688|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
44553119|NCT03307785|79569689|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
44553120|NCT03307785|79569690|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
44553121|NCT03307785|79569691|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
44553122|NCT03307785|79569681|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
44553123|NCT03307785|79569682|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
44553124|NCT03307785|79569683|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
44553125|NCT03307785|79569684|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
44553126|NCT03307785|79569685|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
44553127|NCT03307785|79569686|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
44553128|NCT03307785|79569687|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
44495829|NCT00124748|79501577|FG000|Overall Study|Abnormal laboratory Value|2|||
44553129|NCT03307785|79569688|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
44553130|NCT03307785|79569689|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
44553131|NCT03307785|79569690|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
44553132|NCT03307785|79569691|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
44553133|NCT03307785|79569681|FG000|Part B: Up to 28.5 Months|Death|0|||
44553134|NCT03307785|79569682|FG001|Part B: Up to 28.5 Months|Death|0|||
44553135|NCT03307785|79569683|FG002|Part B: Up to 28.5 Months|Death|7|||
44553136|NCT03307785|79569684|FG003|Part B: Up to 28.5 Months|Death|0|||
44553137|NCT03307785|79569685|FG004|Part B: Up to 28.5 Months|Death|0|||
44553138|NCT03307785|79569686|FG005|Part B: Up to 28.5 Months|Death|0|||
44553139|NCT03307785|79569687|FG006|Part B: Up to 28.5 Months|Death|0|||
44553140|NCT03307785|79569688|FG007|Part B: Up to 28.5 Months|Death|0|||
44553141|NCT03307785|79569689|FG008|Part B: Up to 28.5 Months|Death|0|||
44553142|NCT03307785|79569690|FG009|Part B: Up to 28.5 Months|Death|0|||
44553143|NCT03307785|79569691|FG010|Part B: Up to 28.5 Months|Death|0|||
44553144|NCT03307785|79569681|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553145|NCT03307785|79569682|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553146|NCT03307785|79569683|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
44553147|NCT03307785|79569684|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553148|NCT03307785|79569685|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553149|NCT03307785|79569686|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553150|NCT03307785|79569687|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553151|NCT03307785|79569688|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553152|NCT03307785|79569689|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553153|NCT03307785|79569690|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553154|NCT03307785|79569691|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
44553155|NCT03307785|79569681|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553156|NCT03307785|79569682|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553157|NCT03307785|79569683|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
44553158|NCT03307785|79569684|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553159|NCT03307785|79569685|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553160|NCT03307785|79569686|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553161|NCT03307785|79569687|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553162|NCT03307785|79569688|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553163|NCT03307785|79569689|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553164|NCT03307785|79569690|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553165|NCT03307785|79569691|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
44553166|NCT03307785|79569681|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
44553167|NCT03307785|79569682|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
44553168|NCT03307785|79569683|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
44553169|NCT03307785|79569684|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
44553170|NCT03307785|79569685|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
44553171|NCT03307785|79569686|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
44553172|NCT03307785|79569687|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
44553173|NCT03307785|79569688|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
44553174|NCT03307785|79569689|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
44553175|NCT03307785|79569690|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
44553176|NCT03307785|79569691|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
44553177|NCT03307785|79569681|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
44553178|NCT03307785|79569682|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
44553179|NCT03307785|79569683|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
44553180|NCT03307785|79569684|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
44553181|NCT03307785|79569685|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
44553182|NCT03307785|79569686|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
44553183|NCT03307785|79569687|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
44553184|NCT03307785|79569688|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
44553185|NCT03307785|79569689|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
44553186|NCT03307785|79569690|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
44231361|NCT00989781|79044372|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
44231362|NCT00989235|79044413|FG000|Overall Study|Death|0|||
44231363|NCT00989235|79044414|FG001|Overall Study|Death|1|||
44231364|NCT00989235|79044413|FG000|Overall Study|Adverse Event|0|||
44231365|NCT00989235|79044414|FG001|Overall Study|Adverse Event|1|||
44231366|NCT00989235|79044413|FG000|Overall Study|Lack of Efficacy|1|||
44231367|NCT00989235|79044414|FG001|Overall Study|Lack of Efficacy|0|||
44231368|NCT00989235|79044413|FG000|Overall Study|Withdrawal of Consent|1|||
44495830|NCT00124748|79501578|FG001|Overall Study|Abnormal laboratory Value|2|||
44495831|NCT00124748|79501577|FG000|Overall Study|Abnormal Procedure|0|||
44495832|NCT00124748|79501578|FG001|Overall Study|Abnormal Procedure|1|||
44495833|NCT00124748|79501577|FG000|Overall Study|Lack of Efficacy|20|||
44495834|NCT00124748|79501578|FG001|Overall Study|Lack of Efficacy|41|||
44495835|NCT00124748|79501577|FG000|Overall Study|No longer requires study drug|1|||
44231369|NCT00989235|79044414|FG001|Overall Study|Withdrawal of Consent|1|||
44274828|NCT03266588|79221042|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
44274829|NCT03266588|79221040|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
44274830|NCT03266588|79221041|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
44274831|NCT03266588|79221042|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
44376686|NCT01070966|79381926|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
44376687|NCT01070966|79381926|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
44495836|NCT00124748|79501578|FG001|Overall Study|No longer requires study drug|1|||
44495837|NCT00124748|79501577|FG000|Overall Study|Protocol Violation|3|||
44495838|NCT00124748|79501578|FG001|Overall Study|Protocol Violation|1|||
44231370|NCT00989235|79044413|FG000|Overall Study|Desire to Become Pregnant|1|||
44231371|NCT00989235|79044414|FG001|Overall Study|Desire to Become Pregnant|0|||
44231372|NCT00989235|79044413|FG000|Overall Study|Randomized by Mistake|0|||
44553187|NCT03307785|79569691|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
44553188|NCT03307785|79569681|FG000|Part C: Up to 22.5 Months|Death|0|||
44553189|NCT03307785|79569682|FG001|Part C: Up to 22.5 Months|Death|0|||
44553190|NCT03307785|79569683|FG002|Part C: Up to 22.5 Months|Death|0|||
44553191|NCT03307785|79569684|FG003|Part C: Up to 22.5 Months|Death|1|||
44553192|NCT03307785|79569685|FG004|Part C: Up to 22.5 Months|Death|4|||
44553193|NCT03307785|79569686|FG005|Part C: Up to 22.5 Months|Death|0|||
44553194|NCT03307785|79569687|FG006|Part C: Up to 22.5 Months|Death|0|||
44553195|NCT03307785|79569688|FG007|Part C: Up to 22.5 Months|Death|0|||
44553196|NCT03307785|79569689|FG008|Part C: Up to 22.5 Months|Death|0|||
44553197|NCT03307785|79569690|FG009|Part C: Up to 22.5 Months|Death|0|||
44553198|NCT03307785|79569691|FG010|Part C: Up to 22.5 Months|Death|0|||
44553199|NCT03307785|79569681|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553200|NCT03307785|79569682|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553201|NCT03307785|79569683|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553202|NCT03307785|79569684|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
44553203|NCT03307785|79569685|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553204|NCT03307785|79569686|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553205|NCT03307785|79569687|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553206|NCT03307785|79569688|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553207|NCT03307785|79569689|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553208|NCT03307785|79569690|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553209|NCT03307785|79569691|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
44553210|NCT03307785|79569681|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553211|NCT03307785|79569682|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553212|NCT03307785|79569683|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553213|NCT03307785|79569684|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
44553214|NCT03307785|79569685|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
44553215|NCT03307785|79569686|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553216|NCT03307785|79569687|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44231373|NCT00989235|79044414|FG001|Overall Study|Randomized by Mistake|2|||
44231374|NCT00989235|79044413|FG000|Overall Study|Lost to Follow-up|0|||
44231375|NCT00989235|79044414|FG001|Overall Study|Lost to Follow-up|1|||
44231376|NCT04969198|79044434|FG000|Overall Study|Withdrawal by Subject|20|||
44231377|NCT04969198|79044434|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
44231378|NCT04969198|79044434|FG000|Overall Study|Lost to Follow-up|20|||
44231379|NCT04778059|79044461|FG000|Overall Study|Death|2|||
44231380|NCT04778059|79044462|FG001|Overall Study|Death|2|||
44231381|NCT04778059|79044463|FG002|Overall Study|Death|1|||
44231382|NCT04778059|79044464|FG003|Overall Study|Death|1|||
44231383|NCT04778059|79044465|FG004|Overall Study|Death|1|||
44231384|NCT04778059|79044461|FG000|Overall Study|Lost to Follow-up|0|||
44231385|NCT04778059|79044462|FG001|Overall Study|Lost to Follow-up|0|||
44231386|NCT04778059|79044463|FG002|Overall Study|Lost to Follow-up|0|||
44231387|NCT04778059|79044464|FG003|Overall Study|Lost to Follow-up|0|||
44231388|NCT04778059|79044465|FG004|Overall Study|Lost to Follow-up|1|||
44553217|NCT03307785|79569688|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553218|NCT03307785|79569689|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553219|NCT03307785|79569690|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44231389|NCT04778059|79044461|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
44231390|NCT04778059|79044462|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
44231391|NCT04778059|79044463|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
44553220|NCT03307785|79569691|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
44553221|NCT03307785|79569681|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
44553222|NCT03307785|79569682|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
44553223|NCT03307785|79569683|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
44553224|NCT03307785|79569684|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
44553225|NCT03307785|79569685|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
44553226|NCT03307785|79569686|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
44553227|NCT03307785|79569687|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
44553228|NCT03307785|79569688|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
44553229|NCT03307785|79569689|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
44553230|NCT03307785|79569690|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
44553231|NCT03307785|79569691|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
44553232|NCT03307785|79569681|FG000|Part D: Up to 9.5 Months|Death|0|||
44553233|NCT03307785|79569682|FG001|Part D: Up to 9.5 Months|Death|0|||
44553234|NCT03307785|79569683|FG002|Part D: Up to 9.5 Months|Death|0|||
44553235|NCT03307785|79569684|FG003|Part D: Up to 9.5 Months|Death|0|||
44553236|NCT03307785|79569685|FG004|Part D: Up to 9.5 Months|Death|0|||
44553237|NCT03307785|79569686|FG005|Part D: Up to 9.5 Months|Death|1|||
44553238|NCT03307785|79569687|FG006|Part D: Up to 9.5 Months|Death|0|||
44553239|NCT03307785|79569688|FG007|Part D: Up to 9.5 Months|Death|0|||
44553240|NCT03307785|79569689|FG008|Part D: Up to 9.5 Months|Death|0|||
44553241|NCT03307785|79569690|FG009|Part D: Up to 9.5 Months|Death|0|||
44553242|NCT03307785|79569691|FG010|Part D: Up to 9.5 Months|Death|0|||
44553243|NCT03307785|79569681|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553244|NCT03307785|79569682|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553245|NCT03307785|79569683|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44231392|NCT04778059|79044464|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
44553246|NCT03307785|79569684|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553247|NCT03307785|79569685|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553248|NCT03307785|79569686|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
44553249|NCT03307785|79569687|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553250|NCT03307785|79569688|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553251|NCT03307785|79569689|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553252|NCT03307785|79569690|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553253|NCT03307785|79569691|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
44553254|NCT03307785|79569681|FG000|Part E: Up to 4.4 Months|Death|0|||
44553255|NCT03307785|79569682|FG001|Part E: Up to 4.4 Months|Death|0|||
44553256|NCT03307785|79569683|FG002|Part E: Up to 4.4 Months|Death|0|||
44553257|NCT03307785|79569684|FG003|Part E: Up to 4.4 Months|Death|0|||
44553258|NCT03307785|79569685|FG004|Part E: Up to 4.4 Months|Death|0|||
44553259|NCT03307785|79569686|FG005|Part E: Up to 4.4 Months|Death|0|||
44553260|NCT03307785|79569687|FG006|Part E: Up to 4.4 Months|Death|1|||
44553261|NCT03307785|79569688|FG007|Part E: Up to 4.4 Months|Death|0|||
44553262|NCT03307785|79569689|FG008|Part E: Up to 4.4 Months|Death|0|||
44553263|NCT03307785|79569690|FG009|Part E: Up to 4.4 Months|Death|0|||
44553264|NCT03307785|79569691|FG010|Part E: Up to 4.4 Months|Death|0|||
44553265|NCT03307785|79569681|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
44553266|NCT03307785|79569682|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
44553267|NCT03307785|79569683|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
44553268|NCT03307785|79569684|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
44553269|NCT03307785|79569685|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
44553270|NCT03307785|79569686|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
44553271|NCT03307785|79569687|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
44231393|NCT04778059|79044465|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
44231394|NCT04621227|79044477|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
44231395|NCT04621227|79044477|FG000|Period 3 (29 Days)|Adverse Event|1|||
44553272|NCT03307785|79569688|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
44553273|NCT03307785|79569689|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
44553274|NCT03307785|79569690|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
44553275|NCT03307785|79569691|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
44553276|NCT03307785|79569681|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
44553277|NCT03307785|79569682|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
44553278|NCT03307785|79569683|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
44553279|NCT03307785|79569684|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
44553280|NCT03307785|79569685|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
44553281|NCT03307785|79569686|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
44553282|NCT03307785|79569687|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
44553283|NCT03307785|79569688|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
44553284|NCT03307785|79569689|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
44553285|NCT03307785|79569690|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
44553286|NCT03307785|79569691|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
44553287|NCT03199040|79569714|FG000|Overall Study|Lack of Efficacy|2|||
44553288|NCT03199040|79569715|FG001|Overall Study|Lack of Efficacy|0|||
44553289|NCT03199040|79569714|FG000|Overall Study|Withdrawal by Subject|2|||
44553290|NCT03199040|79569715|FG001|Overall Study|Withdrawal by Subject|0|||
44553291|NCT03199040|79569714|FG000|Overall Study|Adverse Event|0|||
44553292|NCT03199040|79569715|FG001|Overall Study|Adverse Event|1|||
44553293|NCT03072238|79569723|FG000|Overall Study|Withdrawal by Subject|30|||
44553294|NCT03072238|79569724|FG001|Overall Study|Withdrawal by Subject|51|||
44553295|NCT03072238|79569723|FG000|Overall Study|Lost to Follow-up|7|||
44553296|NCT03072238|79569724|FG001|Overall Study|Lost to Follow-up|4|||
44553297|NCT03072238|79569723|FG000|Overall Study|Physician Decision|1|||
44553298|NCT03072238|79569724|FG001|Overall Study|Physician Decision|3|||
44553299|NCT03072238|79569723|FG000|Overall Study|Death|139|||
44553300|NCT03072238|79569724|FG001|Overall Study|Death|121|||
44553301|NCT03072238|79569723|FG000|Overall Study|Other|0|||
44553302|NCT03072238|79569724|FG001|Overall Study|Other|1|||
44553303|NCT03072238|79569723|FG000|Overall Study|Ongoing on study|377|||
44553304|NCT03072238|79569724|FG001|Overall Study|Ongoing on study|367|||
44553305|NCT02970318|79569733|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
44553306|NCT02970318|79569734|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
44553307|NCT02970318|79569735|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
44553308|NCT02970318|79569736|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
44553309|NCT02970318|79569733|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
44553310|NCT02970318|79569734|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
44553311|NCT02970318|79569735|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
44553312|NCT02970318|79569736|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
44553313|NCT02970318|79569733|FG000|Overall for Arm A & Main for Arm B|Death|41|||
44553314|NCT02970318|79569734|FG001|Overall for Arm A & Main for Arm B|Death|33|||
44553315|NCT02970318|79569735|FG002|Overall for Arm A & Main for Arm B|Death|0|||
44553316|NCT02970318|79569736|FG003|Overall for Arm A & Main for Arm B|Death|0|||
44553317|NCT02970318|79569733|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
44553318|NCT02970318|79569734|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
44553319|NCT02970318|79569735|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
44553320|NCT02970318|79569736|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
44553321|NCT02970318|79569733|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
44553322|NCT02970318|79569734|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
44553323|NCT02970318|79569735|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
44553324|NCT02970318|79569736|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
44553325|NCT02970318|79569733|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
44553326|NCT02970318|79569734|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
44553327|NCT02970318|79569735|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
44553328|NCT02970318|79569736|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
44553329|NCT02970318|79569733|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
44553330|NCT02970318|79569734|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
44553331|NCT02970318|79569735|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
44553332|NCT02970318|79569736|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
44553333|NCT02408549|79569870|FG000|Overall Study|Adverse Event|15|||
44553334|NCT02408549|79569870|FG000|Overall Study|Death|4|||
44553335|NCT02408549|79569870|FG000|Overall Study|Lack of Efficacy|17|||
44553336|NCT02408549|79569870|FG000|Overall Study|Protocol Violation|4|||
44553337|NCT02408549|79569870|FG000|Overall Study|Lost to Follow-up|6|||
44553338|NCT02408549|79569870|FG000|Overall Study|Consent withdrawn|30|||
44553339|NCT02408549|79569870|FG000|Overall Study|Neurology research program closing at site|1|||
44553340|NCT02408549|79569870|FG000|Overall Study|Site closure|1|||
44553341|NCT02408549|79569870|FG000|Overall Study|Pregnancy|1|||
44553342|NCT02408549|79569870|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
44553343|NCT02408549|79569870|FG000|Overall Study|Subject moved to another place, far from site|1|||
44553344|NCT02408549|79569870|FG000|Overall Study|Study terminated at site|1|||
44553345|NCT02242942|79569877|FG000|Overall Study|Death|17|||
44553346|NCT02242942|79569878|FG001|Overall Study|Death|20|||
44553347|NCT02242942|79569879|FG002|Overall Study|Death|2|||
44553348|NCT02242942|79569877|FG000|Overall Study|Physician Decision|1|||
44553349|NCT02242942|79569878|FG001|Overall Study|Physician Decision|0|||
44553350|NCT02242942|79569879|FG002|Overall Study|Physician Decision|0|||
44553351|NCT02242942|79569877|FG000|Overall Study|Withdrawal by Subject|8|||
44553352|NCT02242942|79569878|FG001|Overall Study|Withdrawal by Subject|10|||
44553353|NCT02242942|79569879|FG002|Overall Study|Withdrawal by Subject|0|||
44553354|NCT02242942|79569877|FG000|Overall Study|On-going in Study|190|||
44553355|NCT02242942|79569878|FG001|Overall Study|On-going in Study|186|||
44553356|NCT02242942|79569879|FG002|Overall Study|On-going in Study|11|||
44553357|NCT01523002|79569900|FG000|Period 1|Withdrawal by Subject|1|||
44553358|NCT01523002|79569901|FG001|Period 1|Withdrawal by Subject|3|||
44553359|NCT01523002|79569900|FG000|Period 1|Lost to Follow-up|1|||
44553360|NCT01523002|79569901|FG001|Period 1|Lost to Follow-up|0|||
44553361|NCT01523002|79569900|FG000|Period 1|Adverse Event|0|||
44553362|NCT01523002|79569901|FG001|Period 1|Adverse Event|8|||
44553363|NCT01523002|79569900|FG000|Period 2|Withdrawal by Subject|4|||
44553364|NCT01523002|79569901|FG001|Period 2|Withdrawal by Subject|1|||
44553365|NCT01523002|79569900|FG000|Period 2|Adverse Event|2|||
44553366|NCT01523002|79569901|FG001|Period 2|Adverse Event|5|||
44553367|NCT01523002|79569900|FG000|Period 3|Withdrawal by Subject|1|||
44553368|NCT01523002|79569901|FG001|Period 3|Withdrawal by Subject|0|||
44553369|NCT01523002|79569900|FG000|Period 3|Adverse Event|3|||
44553370|NCT01523002|79569901|FG001|Period 3|Adverse Event|0|||
44553371|NCT00489307|79569909|FG000|Overall Study|Death|1|||
44553372|NCT00489307|79569910|FG001|Overall Study|Death|1|||
44553373|NCT00489307|79569909|FG000|Overall Study|Lost to Follow-up|2|||
44553374|NCT00489307|79569910|FG001|Overall Study|Lost to Follow-up|2|||
44553375|NCT00489307|79569909|FG000|Overall Study|Physician Decision|1|||
44553376|NCT00489307|79569910|FG001|Overall Study|Physician Decision|0|||
44553377|NCT00489307|79569909|FG000|Overall Study|Withdrawal by Subject|2|||
44553378|NCT00489307|79569910|FG001|Overall Study|Withdrawal by Subject|4|||
44553379|NCT00489307|79569909|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
44553380|NCT00489307|79569910|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
44553381|NCT00489307|79569909|FG000|Overall Study|Surgery after assignment|1|||
44553382|NCT00489307|79569910|FG001|Overall Study|Surgery after assignment|0|||
44553383|NCT00489307|79569909|FG000|Overall Study|Did not fill up the forms|2|||
44553384|NCT00489307|79569910|FG001|Overall Study|Did not fill up the forms|1|||
44553385|NCT00489307|79569909|FG000|Overall Study|Patient or family refusal|5|||
44553386|NCT00489307|79569910|FG001|Overall Study|Patient or family refusal|9|||
44553387|NCT03521141|79569919|FG000|Overall Study|Death|1|||
44495839|NCT00124748|79501577|FG000|Overall Study|Withdrawal by Subject|5|||
44495840|NCT00124748|79501578|FG001|Overall Study|Withdrawal by Subject|15|||
44495841|NCT00124748|79501577|FG000|Overall Study|Lost to Follow-up|2|||
44495842|NCT00124748|79501578|FG001|Overall Study|Lost to Follow-up|7|||
44495843|NCT00124748|79501577|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
44495844|NCT00124748|79501578|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
44495845|NCT00124748|79501577|FG000|Overall Study|Death|1|||
44495846|NCT00124748|79501578|FG001|Overall Study|Death|3|||
44553388|NCT03521141|79569920|FG001|Overall Study|Death|0|||
44495847|NCT04070326|79501586|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
44553389|NCT03521141|79569921|FG002|Overall Study|Death|1|||
44553390|NCT02997176|79569933|FG000|Overall Study|Adverse Event|0|||
44553391|NCT02997176|79569934|FG001|Overall Study|Adverse Event|0|||
44553392|NCT02997176|79569935|FG002|Overall Study|Adverse Event|0|||
44553393|NCT02997176|79569936|FG003|Overall Study|Adverse Event|8|||
44553394|NCT02997176|79569933|FG000|Overall Study|Progressive Disease|1|||
44553395|NCT02997176|79569934|FG001|Overall Study|Progressive Disease|0|||
44553396|NCT02997176|79569935|FG002|Overall Study|Progressive Disease|1|||
44495848|NCT04070326|79501587|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
44553397|NCT02997176|79569936|FG003|Overall Study|Progressive Disease|1|||
44553398|NCT02997176|79569933|FG000|Overall Study|Death|0|||
44553399|NCT02997176|79569934|FG001|Overall Study|Death|0|||
44553400|NCT02997176|79569935|FG002|Overall Study|Death|1|||
44553401|NCT02997176|79569936|FG003|Overall Study|Death|1|||
44553402|NCT02997176|79569933|FG000|Overall Study|Withdrawal by Subject|0|||
44553403|NCT02997176|79569934|FG001|Overall Study|Withdrawal by Subject|2|||
44553404|NCT02997176|79569935|FG002|Overall Study|Withdrawal by Subject|0|||
44553405|NCT02997176|79569936|FG003|Overall Study|Withdrawal by Subject|1|||
44553406|NCT03000452|79569946|FG000|Treatment Period|Death|1|||
44553407|NCT03000452|79569946|FG000|Treatment Period|Progressive Disease (PD)|14|||
44553408|NCT03000452|79569946|FG000|Treatment Period|Physician Decision|1|||
44231396|NCT04621227|79044477|FG000|Period 8 (2 Days)|Adverse Event|1|||
44231397|NCT04597918|79044501|FG000|Overall Study|Withdrawal by Subject|6|||
44231398|NCT04597918|79044501|FG000|Overall Study|Lost to Follow-up|3|||
44231399|NCT04597918|79044501|FG000|Overall Study|Death|1|||
44231400|NCT04317586|79044505|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
44231401|NCT04317586|79044505|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
44231402|NCT04102098|79044511|FG000|Main Study Period|Ongoing in study|302|||
44231403|NCT04102098|79044512|FG001|Main Study Period|Ongoing in study|291|||
44231404|NCT04102098|79044511|FG000|Main Study Period|Death|20|||
44231405|NCT04102098|79044512|FG001|Main Study Period|Death|27|||
44231406|NCT04102098|79044511|FG000|Main Study Period|Lost to Follow-up|1|||
44231407|NCT04102098|79044512|FG001|Main Study Period|Lost to Follow-up|1|||
44231408|NCT04102098|79044511|FG000|Main Study Period|Physician Decision|0|||
44231409|NCT04102098|79044512|FG001|Main Study Period|Physician Decision|1|||
44231410|NCT04102098|79044511|FG000|Main Study Period|Withdrawal by Subject|11|||
44231411|NCT04102098|79044512|FG001|Main Study Period|Withdrawal by Subject|14|||
44231412|NCT04102098|79044511|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
44495849|NCT03689452|79501597|FG000|Overall Study|Lost to Follow-up|1|||
44495850|NCT03689452|79501598|FG001|Overall Study|Lost to Follow-up|1|||
44495851|NCT04067050|79501606|FG000|One Month|Lost to Follow-up|4|||
44495852|NCT04067050|79501607|FG001|One Month|Lost to Follow-up|0|||
44495853|NCT04067050|79501606|FG000|Two Month|Lost to Follow-up|1|||
44495854|NCT04067050|79501607|FG001|Two Month|Lost to Follow-up|0|||
44495855|NCT04067050|79501606|FG000|Two Month|Adverse Event|1|||
44553409|NCT03000452|79569946|FG000|Treatment Period|Miscellaneous|2|||
44553410|NCT03000452|79569946|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
44553411|NCT03000452|79569946|FG000|Follow-Up Period|Death|3|||
44553412|NCT03000452|79569946|FG000|Follow-Up Period|Withdrawal by Subject|3|||
44553413|NCT01373164|79569955|FG000|Overall Study|Lost to Follow-up|0|||
44553414|NCT01373164|79569956|FG001|Overall Study|Lost to Follow-up|0|||
44553415|NCT01373164|79569957|FG002|Overall Study|Lost to Follow-up|1|||
44553416|NCT01373164|79569958|FG003|Overall Study|Lost to Follow-up|2|||
44553417|NCT01373164|79569959|FG004|Overall Study|Lost to Follow-up|0|||
44553418|NCT01373164|79569955|FG000|Overall Study|Withdrawal by Subject|0|||
44553419|NCT01373164|79569956|FG001|Overall Study|Withdrawal by Subject|1|||
44553420|NCT01373164|79569957|FG002|Overall Study|Withdrawal by Subject|0|||
44553421|NCT01373164|79569958|FG003|Overall Study|Withdrawal by Subject|10|||
44553422|NCT01373164|79569959|FG004|Overall Study|Withdrawal by Subject|2|||
44553423|NCT02999984|79569974|FG000|Overall Study|Treatment Failure|1|||
44553424|NCT03550313|79569981|FG000|Overall Study|Adverse Event|0|||
44495856|NCT04067050|79501607|FG001|Two Month|Adverse Event|0|||
44495857|NCT04060654|79501613|FG000|Overall Study|Withdrawal by Subject|1|||
44495858|NCT04060654|79501613|FG000|Overall Study|Lost to Follow-up|5|||
44495859|NCT00096200|79501620|FG000|Overall Study|Adverse Event|0|||
44553425|NCT03550313|79569982|FG001|Overall Study|Adverse Event|1|||
44553426|NCT03550313|79569983|FG002|Overall Study|Adverse Event|0|||
44553427|NCT03550313|79569981|FG000|Overall Study|Lost to Follow-up|5|||
44231413|NCT04102098|79044512|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
44553428|NCT03550313|79569982|FG001|Overall Study|Lost to Follow-up|7|||
44553429|NCT03550313|79569983|FG002|Overall Study|Lost to Follow-up|12|||
44495860|NCT00096200|79501621|FG001|Overall Study|Adverse Event|4|||
44553430|NCT03550313|79569981|FG000|Overall Study|Study terminated by sponsor|44|||
44553431|NCT03550313|79569982|FG001|Overall Study|Study terminated by sponsor|37|||
44553432|NCT03550313|79569983|FG002|Overall Study|Study terminated by sponsor|48|||
44553433|NCT03550313|79569981|FG000|Overall Study|No longer met eligibility criteria|3|||
44553434|NCT03550313|79569982|FG001|Overall Study|No longer met eligibility criteria|5|||
44553435|NCT03550313|79569983|FG002|Overall Study|No longer met eligibility criteria|6|||
44553436|NCT03550313|79569981|FG000|Overall Study|Withdrawal by parent/guardian|20|||
44553437|NCT03550313|79569982|FG001|Overall Study|Withdrawal by parent/guardian|18|||
44553438|NCT03550313|79569983|FG002|Overall Study|Withdrawal by parent/guardian|26|||
44553439|NCT03550313|79569981|FG000|Overall Study|Other|4|||
44553440|NCT03550313|79569982|FG001|Overall Study|Other|2|||
44553441|NCT03550313|79569983|FG002|Overall Study|Other|2|||
44553442|NCT03550313|79569981|FG000|Overall Study|Randomized but not vaccinated|3|||
44553443|NCT03550313|79569982|FG001|Overall Study|Randomized but not vaccinated|23|||
44553444|NCT03550313|79569983|FG002|Overall Study|Randomized but not vaccinated|2|||
44553445|NCT03550313|79569981|FG000|Overall Study|Sites terminated due to quality issues|18|||
44553446|NCT03550313|79569982|FG001|Overall Study|Sites terminated due to quality issues|17|||
44553447|NCT03550313|79569983|FG002|Overall Study|Sites terminated due to quality issues|18|||
44553448|NCT03312907|79569995|FG000|Overall Study|Adverse Event|1|||
44553449|NCT03312907|79569996|FG001|Overall Study|Adverse Event|6|||
44553450|NCT03312907|79569997|FG002|Overall Study|Adverse Event|1|||
44553451|NCT03312907|79569995|FG000|Overall Study|Protocol Violation|2|||
44231414|NCT04102098|79044511|FG000|Crossover: AS Who Crossed Over|Death|11|||
44231415|NCT04102098|79044512|FG001|Crossover: AS Who Crossed Over|Death|0|||
44495861|NCT00096200|79501622|FG002|Overall Study|Adverse Event|0|||
44495862|NCT00096200|79501620|FG000|Overall Study|Withdrawal by Subject|1|||
44495863|NCT00096200|79501621|FG001|Overall Study|Withdrawal by Subject|2|||
44495864|NCT00096200|79501622|FG002|Overall Study|Withdrawal by Subject|0|||
44495865|NCT00096200|79501620|FG000|Overall Study|Ineligible pathology|0|||
44495866|NCT00096200|79501621|FG001|Overall Study|Ineligible pathology|1|||
44495867|NCT00096200|79501622|FG002|Overall Study|Ineligible pathology|0|||
44231416|NCT04102098|79044511|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
44231417|NCT04102098|79044512|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
44231418|NCT03964493|79044522|FG000|Overall Study|Withdrawal by Subject|4|||
44231419|NCT03964493|79044523|FG001|Overall Study|Withdrawal by Subject|1|||
44231420|NCT03964493|79044522|FG000|Overall Study|Lost to Follow-up|13|||
44231421|NCT03964493|79044523|FG001|Overall Study|Lost to Follow-up|4|||
44231422|NCT03846804|79044542|FG000|Overall Study|Refused blood draw|1|||
44231423|NCT03846804|79044542|FG000|Overall Study|Protocol Violation|1|||
44231424|NCT03807440|79044551|FG000|Overall Study|No documentation of index date 2|320|||
44231425|NCT03807440|79044551|FG000|Overall Study|No informed consent for index date 2|117|||
44231426|NCT03746522|79044628|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
44231427|NCT03746522|79044629|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
44231428|NCT03746522|79044630|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
44231429|NCT03746522|79044628|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
44231430|NCT03746522|79044629|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
44231431|NCT03746522|79044630|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
44231432|NCT03746522|79044628|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
44231433|NCT03746522|79044629|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
44231434|NCT03746522|79044630|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
44231435|NCT03746522|79044628|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
44231436|NCT03746522|79044629|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
44231437|NCT03746522|79044630|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
44231438|NCT03746522|79044628|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
44495868|NCT04059094|79501635|FG000|Overall Study|Adverse Event|0|||
44495869|NCT04059094|79501636|FG001|Overall Study|Adverse Event|0|||
44495870|NCT04059094|79501637|FG002|Overall Study|Adverse Event|0|||
44495871|NCT04059094|79501638|FG003|Overall Study|Adverse Event|0|||
44495872|NCT04059094|79501639|FG004|Overall Study|Adverse Event|1|||
44495873|NCT04059094|79501635|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
44495874|NCT04059094|79501636|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
44231439|NCT03746522|79044629|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
44231440|NCT03746522|79044630|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
44231441|NCT03710161|79044638|FG000|Overall Study|Study halted due to COVID pandemic|3|||
44231442|NCT03710161|79044639|FG001|Overall Study|Study halted due to COVID pandemic|2|||
44231443|NCT03478956|79044657|FG000|Overall Study|Adverse Event|1|||
44231444|NCT03478956|79044658|FG001|Overall Study|Adverse Event|0|||
44231445|NCT03478956|79044657|FG000|Overall Study|Withdrawal by Subject|0|||
44231446|NCT03478956|79044658|FG001|Overall Study|Withdrawal by Subject|1|||
44231447|NCT03478956|79044657|FG000|Overall Study|Ongoing in the Study|11|||
44231448|NCT03478956|79044658|FG001|Overall Study|Ongoing in the Study|11|||
44495875|NCT04059094|79501637|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
44495876|NCT04059094|79501638|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
44495877|NCT04059094|79501639|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
44495878|NCT00096044|79501655|FG000|Overall Study|Withdrawal by Subject|9|||
44495879|NCT00096044|79501655|FG000|Overall Study|Adverse Event|21|||
44495880|NCT00096044|79501655|FG000|Overall Study|Disease Progression|4|||
44495881|NCT03689374|79501661|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
44495882|NCT03689374|79501662|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
44495883|NCT03689374|79501663|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
44495884|NCT03689374|79501661|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
44495885|NCT03689374|79501662|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
44495886|NCT03689374|79501663|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
44495887|NCT03689374|79501661|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
44495888|NCT03689374|79501662|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
44376688|NCT01070966|79381926|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
44231449|NCT03347110|79044664|FG000|Overall Study|Other (Participant is incarcerated)|1|||
44231450|NCT03347110|79044664|FG000|Overall Study|Withdrawal by Subject|9|||
44495889|NCT03689374|79501663|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
44495890|NCT03689374|79501661|FG000|Treatment Period (Week 0 to 52)|Death|0|||
44495891|NCT03689374|79501662|FG001|Treatment Period (Week 0 to 52)|Death|11|||
44495892|NCT03689374|79501663|FG002|Treatment Period (Week 0 to 52)|Death|1|||
44495893|NCT00123734|79501669|FG000|Overall Study|Death|3|||
44495894|NCT00123734|79501669|FG000|Overall Study|Lost to Follow-up|3|||
44495895|NCT00123734|79501669|FG000|Overall Study|Dropout|1|||
44495896|NCT00123734|79501669|FG000|Overall Study|Withdrawal by Subject|1|||
44495897|NCT00112736|79501679|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
44495898|NCT00112736|79501680|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
44495899|NCT00123422|79501695|FG000|Overall Study|Physician Decision|2|||
44495900|NCT00123422|79501696|FG001|Overall Study|Physician Decision|2|||
44495901|NCT00123422|79501697|FG002|Overall Study|Physician Decision|6|||
44495902|NCT00123422|79501695|FG000|Overall Study|Withdrawal by Subject|1|||
44495903|NCT00123422|79501696|FG001|Overall Study|Withdrawal by Subject|2|||
44495904|NCT00123422|79501697|FG002|Overall Study|Withdrawal by Subject|2|||
44495905|NCT00123422|79501695|FG000|Overall Study|Lost to Follow-up|1|||
44495906|NCT00123422|79501696|FG001|Overall Study|Lost to Follow-up|2|||
44495907|NCT00123422|79501697|FG002|Overall Study|Lost to Follow-up|2|||
44495908|NCT04052620|79501707|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
44495909|NCT04052620|79501708|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
44495910|NCT04052620|79501707|FG000|Overall Study|Withdrawal by Subject|1|||
44495911|NCT04052620|79501708|FG001|Overall Study|Withdrawal by Subject|0|||
44495912|NCT04052620|79501707|FG000|Overall Study|Lost to Follow-up|1|||
44495913|NCT04052620|79501708|FG001|Overall Study|Lost to Follow-up|1|||
44495914|NCT04052620|79501707|FG000|Overall Study|Adverse Event|1|||
44495915|NCT04052620|79501708|FG001|Overall Study|Adverse Event|0|||
44495916|NCT04052620|79501707|FG000|Overall Study|Subject did not meet study Criteria|0|||
44495917|NCT04052620|79501708|FG001|Overall Study|Subject did not meet study Criteria|1|||
44495918|NCT04052620|79501707|FG000|Overall Study|Screened failure, randomized by mistake|0|||
44495919|NCT04052620|79501708|FG001|Overall Study|Screened failure, randomized by mistake|1|||
44495920|NCT04052620|79501707|FG000|Overall Study|Personal reasons|2|||
44495921|NCT04052620|79501708|FG001|Overall Study|Personal reasons|4|||
44495922|NCT04052620|79501707|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
44495923|NCT04052620|79501708|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
44495924|NCT00112580|79501716|FG000|Overall Study|Adverse Event|1|||
44495925|NCT00112580|79501717|FG001|Overall Study|Adverse Event|2|||
44495926|NCT00112580|79501716|FG000|Overall Study|Disease progression|5|||
44495927|NCT00112580|79501717|FG001|Overall Study|Disease progression|16|||
44495928|NCT00112580|79501716|FG000|Overall Study|Participant withdrew consent|2|||
44495929|NCT00112580|79501717|FG001|Overall Study|Participant withdrew consent|1|||
44495930|NCT04238650|79501724|FG000|Overall Study|Withdrawal by Subject|0|||
44495931|NCT04238650|79501725|FG001|Overall Study|Withdrawal by Subject|1|||
44495932|NCT00095576|79501733|FG000|Overall Study|Adverse Event|5|||
44495933|NCT00095576|79501734|FG001|Overall Study|Adverse Event|3|||
44495934|NCT00095576|79501733|FG000|Overall Study|Lost to Follow-up|233|||
44495935|NCT00095576|79501734|FG001|Overall Study|Lost to Follow-up|229|||
44495936|NCT00095576|79501733|FG000|Overall Study|Protocol Violation|1|||
44495937|NCT00095576|79501734|FG001|Overall Study|Protocol Violation|0|||
44495938|NCT00095576|79501733|FG000|Overall Study|Withdrawal by Subject|34|||
44495939|NCT00095576|79501734|FG001|Overall Study|Withdrawal by Subject|47|||
44495940|NCT00095576|79501733|FG000|Overall Study|Option to switch to a rollover study|1097|||
44495941|NCT00095576|79501734|FG001|Overall Study|Option to switch to a rollover study|1099|||
44495942|NCT00095576|79501733|FG000|Overall Study|Site terminated|75|||
44495943|NCT00095576|79501734|FG001|Overall Study|Site terminated|67|||
44495944|NCT00095576|79501733|FG000|Overall Study|Subject moved|30|||
44495945|NCT00095576|79501734|FG001|Overall Study|Subject moved|36|||
44495946|NCT04049578|79501740|FG000|Overall Study|Physician Decision|1|||
44495947|NCT04044352|79501744|FG000|Overall Study|Lost to Follow-up|9|||
44495948|NCT04044352|79501744|FG000|Overall Study|Withdrawal by Subject|2|||
44495949|NCT04043962|79501749|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
44495950|NCT04043962|79501749|FG000|Post-Treatment|Withdrawal by Subject|5|||
44495951|NCT04043962|79501749|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
44495952|NCT04043728|79501756|FG000|Overall Study|Lost to Follow-up|1|||
44495953|NCT04043728|79501757|FG001|Overall Study|Lost to Follow-up|2|||
44495954|NCT04043728|79501758|FG002|Overall Study|Lost to Follow-up|0|||
44495955|NCT04043416|79501768|FG000|Washout|Change in health condition|0|||
44553452|NCT03312907|79569996|FG001|Overall Study|Protocol Violation|3|||
44553453|NCT03312907|79569997|FG002|Overall Study|Protocol Violation|4|||
44553454|NCT03312907|79569995|FG000|Overall Study|Lost to Follow-up|2|||
44553455|NCT03312907|79569996|FG001|Overall Study|Lost to Follow-up|3|||
44553456|NCT03312907|79569997|FG002|Overall Study|Lost to Follow-up|2|||
44553457|NCT03312907|79569995|FG000|Overall Study|Physician Decision|3|||
44553458|NCT03312907|79569996|FG001|Overall Study|Physician Decision|4|||
44553459|NCT03312907|79569997|FG002|Overall Study|Physician Decision|2|||
44553460|NCT03312907|79569995|FG000|Overall Study|Withdrawal by Subject|9|||
44553461|NCT03312907|79569996|FG001|Overall Study|Withdrawal by Subject|14|||
44553462|NCT03312907|79569997|FG002|Overall Study|Withdrawal by Subject|10|||
44553463|NCT02999672|79570007|FG000|Overall Study|Death|0|||
44553464|NCT02999672|79570008|FG001|Overall Study|Death|1|||
44553465|NCT02999672|79570007|FG000|Overall Study|Study Terminated by Sponsor|0|||
44553466|NCT02999672|79570008|FG001|Overall Study|Study Terminated by Sponsor|1|||
44553467|NCT02999672|79570007|FG000|Overall Study|Progressive Disease|9|||
44553468|NCT02999672|79570008|FG001|Overall Study|Progressive Disease|5|||
44553469|NCT02999672|79570007|FG000|Overall Study|Adverse Event|4|||
44553470|NCT02999672|79570008|FG001|Overall Study|Adverse Event|0|||
44553471|NCT01911676|79570018|FG000|Period 1 of Study|Withdrawal by Subject|4|||
44553472|NCT01911676|79570019|FG001|Period 1 of Study|Withdrawal by Subject|2|||
44553473|NCT01911676|79570020|FG002|Period 1 of Study|Withdrawal by Subject|1|||
44553474|NCT01911676|79570021|FG003|Period 1 of Study|Withdrawal by Subject|2|||
44553475|NCT01911676|79570018|FG000|Period 1 of Study|Physician Decision|2|||
44553476|NCT01911676|79570019|FG001|Period 1 of Study|Physician Decision|0|||
44553477|NCT01911676|79570020|FG002|Period 1 of Study|Physician Decision|0|||
44553478|NCT01911676|79570021|FG003|Period 1 of Study|Physician Decision|1|||
44553479|NCT01911676|79570018|FG000|Period 2 of Study|Physician Decision|2|||
44553480|NCT01911676|79570019|FG001|Period 2 of Study|Physician Decision|0|||
44553481|NCT01911676|79570020|FG002|Period 2 of Study|Physician Decision|0|||
44553482|NCT01911676|79570021|FG003|Period 2 of Study|Physician Decision|1|||
44553483|NCT01911676|79570018|FG000|Period 2 of Study|Lost to Follow-up|0|||
44553484|NCT01911676|79570019|FG001|Period 2 of Study|Lost to Follow-up|0|||
44553485|NCT01911676|79570020|FG002|Period 2 of Study|Lost to Follow-up|0|||
44553486|NCT01911676|79570021|FG003|Period 2 of Study|Lost to Follow-up|1|||
44553487|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
44553488|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
44553489|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
44553490|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
44553491|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
44553492|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
44553493|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
44553494|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
44553495|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
44553496|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
44553497|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
44553498|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
44553499|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
44553500|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
44553501|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
44553502|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
44553503|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
44553504|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
44553505|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
44553506|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
44553507|NCT03573323|79570038|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
44553508|NCT03573323|79570039|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
44553509|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
44553510|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
44553511|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
44376689|NCT01070888|79381939|FG000|First Intervention (14 Days)|Adverse Event|0|||
44376690|NCT01070888|79381940|FG001|First Intervention (14 Days)|Adverse Event|1|||
44553512|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
44553513|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
44553514|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
44553515|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
44553516|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
44553517|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
44553518|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
44553519|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
44553520|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
44553521|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
44553522|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
44553523|NCT03573323|79570038|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
44553524|NCT03573323|79570039|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
44553525|NCT03306043|79570065|FG000|Overall Study|Adverse Event|1|||
44553526|NCT03306043|79570065|FG000|Overall Study|Lost to Follow-up|1|||
44553527|NCT03306043|79570065|FG000|Overall Study|Withdrawal by Subject|2|||
44553528|NCT01069172|79570069|FG000|Overall Study|Withdrawal by Subject|1|||
44553529|NCT01069172|79570070|FG001|Overall Study|Withdrawal by Subject|0|||
44553530|NCT02911688|79570079|FG000|Washout|Lost to Follow-up|1|||
44553531|NCT02911688|79570080|FG001|Washout|Lost to Follow-up|1|||
44553532|NCT02911688|79570079|FG000|Washout|Withdrawal by Subject|0|||
44553533|NCT02911688|79570080|FG001|Washout|Withdrawal by Subject|1|||
44553534|NCT02670928|79570090|FG000|Overall Study|Adverse Event|3|||
44376691|NCT01070888|79381939|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
44376692|NCT01070888|79381940|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
44553535|NCT02670928|79570091|FG001|Overall Study|Adverse Event|1|||
44553536|NCT02670928|79570090|FG000|Overall Study|Withdrawal by Subject|4|||
44553537|NCT02670928|79570091|FG001|Overall Study|Withdrawal by Subject|0|||
44553538|NCT02670928|79570090|FG000|Overall Study|Lost to Follow-up|1|||
44553539|NCT02670928|79570091|FG001|Overall Study|Lost to Follow-up|0|||
44553540|NCT02670928|79570090|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
44553541|NCT02670928|79570091|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
44495956|NCT04043416|79501769|FG001|Washout|Change in health condition|1|||
44495957|NCT00095498|79501781|FG000|Overall Study|Physician Decision|9|||
44495958|NCT00095498|79501782|FG001|Overall Study|Physician Decision|10|||
44553542|NCT03305809|79570101|FG000|Overall Study|Adverse Event|2|||
44553543|NCT03305809|79570102|FG001|Overall Study|Adverse Event|2|||
44553544|NCT03305809|79570103|FG002|Overall Study|Adverse Event|6|||
44553545|NCT03305809|79570104|FG003|Overall Study|Adverse Event|6|||
44553546|NCT03305809|79570101|FG000|Overall Study|Death|0|||
44553547|NCT03305809|79570102|FG001|Overall Study|Death|0|||
44553548|NCT03305809|79570103|FG002|Overall Study|Death|1|||
44553549|NCT03305809|79570104|FG003|Overall Study|Death|1|||
44553550|NCT03305809|79570101|FG000|Overall Study|Lost to Follow-up|1|||
44553551|NCT03305809|79570102|FG001|Overall Study|Lost to Follow-up|2|||
44553552|NCT03305809|79570103|FG002|Overall Study|Lost to Follow-up|0|||
44553553|NCT03305809|79570104|FG003|Overall Study|Lost to Follow-up|0|||
44553554|NCT03305809|79570101|FG000|Overall Study|Sponsor Decision|1|||
44553555|NCT03305809|79570102|FG001|Overall Study|Sponsor Decision|0|||
44553556|NCT03305809|79570103|FG002|Overall Study|Sponsor Decision|1|||
44553557|NCT03305809|79570104|FG003|Overall Study|Sponsor Decision|8|||
44553558|NCT03305809|79570101|FG000|Overall Study|Physician Decision|0|||
44495959|NCT00095498|79501783|FG002|Overall Study|Physician Decision|8|||
44495960|NCT00095498|79501781|FG000|Overall Study|Adverse Event|1|||
44495961|NCT00095498|79501782|FG001|Overall Study|Adverse Event|0|||
44495962|NCT00095498|79501783|FG002|Overall Study|Adverse Event|1|||
44495963|NCT00095498|79501781|FG000|Overall Study|Withdrawal by Subject|15|||
44495964|NCT00095498|79501782|FG001|Overall Study|Withdrawal by Subject|16|||
44495965|NCT00095498|79501783|FG002|Overall Study|Withdrawal by Subject|15|||
44553559|NCT03305809|79570102|FG001|Overall Study|Physician Decision|0|||
44553560|NCT03305809|79570103|FG002|Overall Study|Physician Decision|2|||
44553561|NCT03305809|79570104|FG003|Overall Study|Physician Decision|4|||
44553562|NCT03305809|79570101|FG000|Overall Study|Progressive Disease|0|||
44553563|NCT03305809|79570102|FG001|Overall Study|Progressive Disease|0|||
44553564|NCT03305809|79570103|FG002|Overall Study|Progressive Disease|1|||
44553565|NCT03305809|79570104|FG003|Overall Study|Progressive Disease|0|||
44553566|NCT03305809|79570101|FG000|Overall Study|Protocol Violation|1|||
44553567|NCT03305809|79570102|FG001|Overall Study|Protocol Violation|0|||
44553568|NCT03305809|79570103|FG002|Overall Study|Protocol Violation|2|||
44553569|NCT03305809|79570104|FG003|Overall Study|Protocol Violation|3|||
44553570|NCT03305809|79570101|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
44553571|NCT03305809|79570102|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
44553572|NCT03305809|79570103|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
44553573|NCT03305809|79570104|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
44553574|NCT03305809|79570101|FG000|Overall Study|Withdrawal by Subject|2|||
44553575|NCT03305809|79570102|FG001|Overall Study|Withdrawal by Subject|4|||
44553576|NCT03305809|79570103|FG002|Overall Study|Withdrawal by Subject|5|||
44553577|NCT03305809|79570104|FG003|Overall Study|Withdrawal by Subject|2|||
44553578|NCT03305809|79570101|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
44553579|NCT03305809|79570102|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
44553580|NCT03305809|79570103|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
44553581|NCT03305809|79570104|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
44553582|NCT02994056|79570117|FG000|Overall Study|Death|8|||
44553583|NCT02994056|79570117|FG000|Overall Study|Withdrew Consent|1|||
44553584|NCT03548051|79570136|FG000|Overall Study|Death|1|||
44553585|NCT03548051|79570137|FG001|Overall Study|Death|1|||
44553586|NCT03548051|79570136|FG000|Overall Study|Withdrawal by Subject|1|||
44553587|NCT03548051|79570137|FG001|Overall Study|Withdrawal by Subject|0|||
44553588|NCT03305731|79570143|FG000|Overall Study|Protocol Violation|1|||
44553589|NCT03305575|79570149|FG000|Overall Study|Physician Decision|1|||
44553590|NCT03305575|79570150|FG001|Overall Study|Physician Decision|0|||
44553591|NCT02993822|79570160|FG000|Overall Study|Lack of Efficacy|1|||
44553592|NCT02993822|79570161|FG001|Overall Study|Lack of Efficacy|1|||
44553593|NCT02993822|79570162|FG002|Overall Study|Lack of Efficacy|0|||
44553594|NCT02993822|79570163|FG003|Overall Study|Lack of Efficacy|0|||
44553595|NCT02993822|79570160|FG000|Overall Study|Protocol Violation|1|||
44495966|NCT00095498|79501781|FG000|Overall Study|Disease progression|0|||
44495967|NCT00095498|79501782|FG001|Overall Study|Disease progression|1|||
44495968|NCT00095498|79501783|FG002|Overall Study|Disease progression|1|||
44495969|NCT00095498|79501781|FG000|Overall Study|Ineligibility determined|3|||
44553596|NCT02993822|79570161|FG001|Overall Study|Protocol Violation|0|||
44553597|NCT02993822|79570162|FG002|Overall Study|Protocol Violation|0|||
44553598|NCT02993822|79570163|FG003|Overall Study|Protocol Violation|0|||
44231451|NCT03347110|79044664|FG000|Overall Study|Lost to Follow-up|1|||
44231452|NCT03347110|79044664|FG000|Overall Study|Lack of Efficacy|2|||
44231453|NCT03347110|79044664|FG000|Overall Study|Adverse Event, non-fatal|9|||
44553599|NCT02993822|79570160|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
44553600|NCT02993822|79570161|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
44553601|NCT02993822|79570162|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
44553602|NCT02993822|79570163|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
44495970|NCT00095498|79501782|FG001|Overall Study|Ineligibility determined|0|||
44495971|NCT00095498|79501783|FG002|Overall Study|Ineligibility determined|2|||
44495972|NCT00095498|79501781|FG000|Overall Study|Lost to Follow-up|1|||
44495973|NCT00095498|79501782|FG001|Overall Study|Lost to Follow-up|1|||
44495974|NCT00095498|79501783|FG002|Overall Study|Lost to Follow-up|2|||
44495975|NCT00095498|79501781|FG000|Overall Study|Noncompliance|1|||
44495976|NCT00095498|79501782|FG001|Overall Study|Noncompliance|0|||
44495977|NCT00095498|79501783|FG002|Overall Study|Noncompliance|1|||
44495978|NCT00095498|79501781|FG000|Overall Study|Other|6|||
44495979|NCT00095498|79501782|FG001|Overall Study|Other|7|||
44495980|NCT00095498|79501783|FG002|Overall Study|Other|6|||
44495981|NCT00095498|79501781|FG000|Overall Study|Protocol Violation|0|||
44495982|NCT00095498|79501782|FG001|Overall Study|Protocol Violation|0|||
44495983|NCT00095498|79501783|FG002|Overall Study|Protocol Violation|1|||
44495984|NCT00095498|79501781|FG000|Overall Study|Requirement for alternative therapy|1|||
44495985|NCT00095498|79501782|FG001|Overall Study|Requirement for alternative therapy|0|||
44495986|NCT00095498|79501783|FG002|Overall Study|Requirement for alternative therapy|2|||
44495987|NCT04237792|79501797|FG000|Treatment (Day 1)|Adverse Event|1|||
44495988|NCT04237792|79501798|FG001|Treatment (Day 1)|Adverse Event|0|||
44495989|NCT04237792|79501799|FG002|Treatment (Day 1)|Adverse Event|0|||
44495990|NCT04237792|79501800|FG003|Treatment (Day 1)|Adverse Event|0|||
44495991|NCT04237792|79501801|FG004|Treatment (Day 1)|Adverse Event|1|||
44553603|NCT02993822|79570160|FG000|Overall Study|Adverse Event|3|||
44553604|NCT02993822|79570161|FG001|Overall Study|Adverse Event|1|||
44553605|NCT02993822|79570162|FG002|Overall Study|Adverse Event|7|||
44553606|NCT02993822|79570163|FG003|Overall Study|Adverse Event|0|||
44553607|NCT02993822|79570160|FG000|Overall Study|Withdrawal by Subject|4|||
44553608|NCT02993822|79570161|FG001|Overall Study|Withdrawal by Subject|2|||
44553609|NCT02993822|79570162|FG002|Overall Study|Withdrawal by Subject|2|||
44553610|NCT02993822|79570163|FG003|Overall Study|Withdrawal by Subject|3|||
44231454|NCT02688400|79044685|FG000|Overall Study|Protocol Violation|2|||
44231455|NCT02688400|79044686|FG001|Overall Study|Protocol Violation|5|||
44231456|NCT02688400|79044685|FG000|Overall Study|Lack of Efficacy|7|||
44231457|NCT02688400|79044686|FG001|Overall Study|Lack of Efficacy|7|||
44231458|NCT02688400|79044685|FG000|Overall Study|Adverse Event|21|||
44231459|NCT02688400|79044686|FG001|Overall Study|Adverse Event|12|||
44231460|NCT02688400|79044685|FG000|Overall Study|Withdrawal by Subject|15|||
44231461|NCT02688400|79044686|FG001|Overall Study|Withdrawal by Subject|13|||
44231462|NCT02688400|79044685|FG000|Overall Study|No study medication intake|1|||
44231463|NCT02688400|79044686|FG001|Overall Study|No study medication intake|4|||
44231464|NCT02688400|79044685|FG000|Overall Study|Lost to Follow-up|0|||
44231465|NCT02688400|79044686|FG001|Overall Study|Lost to Follow-up|3|||
44231466|NCT02039843|79044699|FG000|Randomization and Observation Period|Adverse Event|2|||
44231467|NCT02039843|79044700|FG001|Randomization and Observation Period|Adverse Event|0|||
44231468|NCT02039843|79044699|FG000|Randomization and Observation Period|Death|1|||
44231469|NCT02039843|79044700|FG001|Randomization and Observation Period|Death|0|||
44231470|NCT02039843|79044699|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
44231471|NCT02039843|79044700|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
44231472|NCT02039843|79044699|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
44231473|NCT02039843|79044700|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
44231474|NCT02039843|79044699|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
44231475|NCT02039843|79044700|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
44231476|NCT02039843|79044699|FG000|Pairing With a Study Dog|Death|1|||
44231477|NCT02039843|79044700|FG001|Pairing With a Study Dog|Death|0|||
44231478|NCT02039843|79044699|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
44231479|NCT02039843|79044700|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
44495992|NCT04237792|79501802|FG005|Treatment (Day 1)|Adverse Event|1|||
44495993|NCT04237792|79501797|FG000|Treatment (Day 1)|Other|0|||
44495994|NCT04237792|79501798|FG001|Treatment (Day 1)|Other|0|||
44495995|NCT04237792|79501799|FG002|Treatment (Day 1)|Other|1|||
44495996|NCT04237792|79501800|FG003|Treatment (Day 1)|Other|0|||
44495997|NCT04237792|79501801|FG004|Treatment (Day 1)|Other|0|||
44495998|NCT04237792|79501802|FG005|Treatment (Day 1)|Other|1|||
44231480|NCT02039843|79044699|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
44495999|NCT04237792|79501797|FG000|Treatment (Day 1)|Not treated|1|||
44496000|NCT04237792|79501798|FG001|Treatment (Day 1)|Not treated|1|||
44496001|NCT04237792|79501799|FG002|Treatment (Day 1)|Not treated|2|||
44496002|NCT04237792|79501800|FG003|Treatment (Day 1)|Not treated|1|||
44496003|NCT04237792|79501801|FG004|Treatment (Day 1)|Not treated|0|||
44496004|NCT04237792|79501802|FG005|Treatment (Day 1)|Not treated|1|||
44496005|NCT00122954|79501833|FG000|Overall Study|Withdrawal by Subject|2|||
44496006|NCT00122954|79501834|FG001|Overall Study|Withdrawal by Subject|2|||
44496007|NCT00122954|79501833|FG000|Overall Study|Protocol Violation|0|||
44496008|NCT00122954|79501834|FG001|Overall Study|Protocol Violation|1|||
44496009|NCT04491994|79501842|FG000|Overall Study|Withdrawal by Subject|10|||
44496010|NCT04491994|79501843|FG001|Overall Study|Withdrawal by Subject|5|||
44496011|NCT04491994|79501842|FG000|Overall Study|developed fever > 3 days|4|||
44496012|NCT04491994|79501843|FG001|Overall Study|developed fever > 3 days|1|||
44496013|NCT04491994|79501842|FG000|Overall Study|Protocol Violation|11|||
44496014|NCT04491994|79501843|FG001|Overall Study|Protocol Violation|2|||
44496015|NCT04491994|79501842|FG000|Overall Study|Lost to Follow-up|4|||
44496016|NCT04491994|79501843|FG001|Overall Study|Lost to Follow-up|3|||
44496017|NCT04041700|79501849|FG000|Overall Study|Pregnancy|1|||
44496018|NCT04041700|79501849|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
44553611|NCT02993822|79570160|FG000|Overall Study|Lost to Follow-up|1|||
44553612|NCT02993822|79570161|FG001|Overall Study|Lost to Follow-up|0|||
44553613|NCT02993822|79570162|FG002|Overall Study|Lost to Follow-up|1|||
44553614|NCT02993822|79570163|FG003|Overall Study|Lost to Follow-up|0|||
44553615|NCT01068860|79570183|FG000|Overall Study|Withdrawal by Subject|0|||
44553616|NCT01068860|79570184|FG001|Overall Study|Withdrawal by Subject|0|||
44553617|NCT01068860|79570185|FG002|Overall Study|Withdrawal by Subject|0|||
44553618|NCT01068860|79570186|FG003|Overall Study|Withdrawal by Subject|0|||
44553619|NCT01068860|79570187|FG004|Overall Study|Withdrawal by Subject|0|||
44553620|NCT01068860|79570188|FG005|Overall Study|Withdrawal by Subject|2|||
44553621|NCT01068860|79570189|FG006|Overall Study|Withdrawal by Subject|0|||
44553622|NCT01068860|79570190|FG007|Overall Study|Withdrawal by Subject|0|||
44553623|NCT01068860|79570191|FG008|Overall Study|Withdrawal by Subject|0|||
44553624|NCT01068860|79570192|FG009|Overall Study|Withdrawal by Subject|3|||
44553625|NCT01068860|79570183|FG000|Overall Study|Administrative problems; misrandomized|0|||
44553626|NCT01068860|79570184|FG001|Overall Study|Administrative problems; misrandomized|0|||
44553627|NCT01068860|79570185|FG002|Overall Study|Administrative problems; misrandomized|0|||
44553628|NCT01068860|79570186|FG003|Overall Study|Administrative problems; misrandomized|1|||
44553629|NCT01068860|79570187|FG004|Overall Study|Administrative problems; misrandomized|0|||
44553630|NCT01068860|79570188|FG005|Overall Study|Administrative problems; misrandomized|0|||
44553631|NCT01068860|79570189|FG006|Overall Study|Administrative problems; misrandomized|0|||
44553632|NCT01068860|79570190|FG007|Overall Study|Administrative problems; misrandomized|0|||
44553633|NCT01068860|79570191|FG008|Overall Study|Administrative problems; misrandomized|0|||
44553634|NCT01068860|79570192|FG009|Overall Study|Administrative problems; misrandomized|1|||
44553635|NCT01068860|79570183|FG000|Overall Study|Lost to Follow-up|0|||
44553636|NCT01068860|79570184|FG001|Overall Study|Lost to Follow-up|1|||
44553637|NCT01068860|79570185|FG002|Overall Study|Lost to Follow-up|0|||
44553638|NCT01068860|79570186|FG003|Overall Study|Lost to Follow-up|0|||
44553639|NCT01068860|79570187|FG004|Overall Study|Lost to Follow-up|0|||
44553640|NCT01068860|79570188|FG005|Overall Study|Lost to Follow-up|0|||
44553641|NCT01068860|79570189|FG006|Overall Study|Lost to Follow-up|0|||
44553642|NCT01068860|79570190|FG007|Overall Study|Lost to Follow-up|0|||
44231481|NCT02039843|79044700|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
44231482|NCT02039843|79044699|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
44231483|NCT02039843|79044700|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
44376693|NCT01070888|79381939|FG000|Washout (14 Days)|Physician Decision|1|||
44376694|NCT01070888|79381940|FG001|Washout (14 Days)|Physician Decision|0|||
44376695|NCT00857896|79381946|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
44376696|NCT00857818|79381953|FG000|Overall Study|Lack of Efficacy|1|||
44376697|NCT00857818|79381954|FG001|Overall Study|Lack of Efficacy|0|||
44553643|NCT01068860|79570191|FG008|Overall Study|Lost to Follow-up|0|||
44231484|NCT02004275|79044714|FG000|Phase 1|Ineligible|0|||
44231485|NCT02004275|79044715|FG001|Phase 1|Ineligible|0|||
44376698|NCT00857818|79381953|FG000|Overall Study|Adverse Event|3|||
44376699|NCT00857818|79381954|FG001|Overall Study|Adverse Event|0|||
44496019|NCT04227340|79501855|FG000|Overall Study|Withdrawal by Subject|3|||
44496020|NCT04033432|79501862|FG000|Overall Study|Progressive Disease|8|||
44553644|NCT01068860|79570192|FG009|Overall Study|Lost to Follow-up|0|||
44553645|NCT02989610|79570214|FG000|Overall Study|Withdrawal/Other reasons|39|||
44553646|NCT01372774|79570220|FG000|Overall Study|Withdrawal prior to treatment|4|||
44496021|NCT04033432|79501862|FG000|Overall Study|Adverse Event|4|||
44496022|NCT04033432|79501862|FG000|Overall Study|Death|1|||
44496023|NCT04223830|79501867|FG000|Overall Study|Lost to Follow-up|9|||
44496024|NCT04223830|79501867|FG000|Overall Study|Adverse Event|1|||
44496025|NCT04032652|79501874|FG000|Overall Study|The study was terminated and the PI has|1|||
44496026|NCT04032652|79501875|FG001|Overall Study|The study was terminated and the PI has|1|||
44496027|NCT04031404|79501881|FG000|Baseline|Lost to Follow-up|0|||
44496028|NCT04031404|79501882|FG001|Baseline|Lost to Follow-up|1|||
44496029|NCT04031404|79501881|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
44496030|NCT04031404|79501882|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
44496031|NCT04031404|79501881|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
44496032|NCT04031404|79501882|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
44496033|NCT04031404|79501881|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
44496034|NCT04031404|79501882|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
44496035|NCT04031404|79501881|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
44496036|NCT04031404|79501882|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
44496037|NCT04476784|79501898|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
44496038|NCT04476784|79501899|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
44496039|NCT04026568|79501910|FG000|Overall Study|study terminated|0|||
44496040|NCT04026568|79501911|FG001|Overall Study|study terminated|1|||
44496041|NCT04025632|79501919|FG000|Overall Study|Adverse Event|1|||
44496042|NCT04025632|79501920|FG001|Overall Study|Adverse Event|1|||
44496043|NCT04025632|79501919|FG000|Overall Study|Withdrawal by Subject|1|||
44496044|NCT04025632|79501920|FG001|Overall Study|Withdrawal by Subject|1|||
44496045|NCT04025632|79501919|FG000|Overall Study|Study Terminated by Sponsor|10|||
44496046|NCT04025632|79501920|FG001|Overall Study|Study Terminated by Sponsor|9|||
44496047|NCT04025632|79501919|FG000|Overall Study|Physician Decision|3|||
44496048|NCT04025632|79501920|FG001|Overall Study|Physician Decision|1|||
44496049|NCT04024228|79501931|FG000|Overall Study|Adverse Event|1|||
44496050|NCT04024228|79501932|FG001|Overall Study|Adverse Event|0|||
44496051|NCT04024228|79501931|FG000|Overall Study|Protocol Deviation|0|||
44496052|NCT04024228|79501932|FG001|Overall Study|Protocol Deviation|2|||
44496053|NCT04024228|79501931|FG000|Overall Study|Withdrawal by Subject|3|||
44496054|NCT04024228|79501932|FG001|Overall Study|Withdrawal by Subject|4|||
44496055|NCT04023994|79501946|FG000|Overall Study|Lost to Follow-up|0|||
44496056|NCT04023994|79501947|FG001|Overall Study|Lost to Follow-up|1|||
44496057|NCT04023994|79501948|FG002|Overall Study|Lost to Follow-up|2|||
44496058|NCT04023994|79501949|FG003|Overall Study|Lost to Follow-up|0|||
44496059|NCT04023994|79501950|FG004|Overall Study|Lost to Follow-up|0|||
44496060|NCT04023994|79501951|FG005|Overall Study|Lost to Follow-up|0|||
44496061|NCT04023994|79501946|FG000|Overall Study|Withdrawal by Subject|0|||
44496062|NCT04023994|79501947|FG001|Overall Study|Withdrawal by Subject|0|||
44496063|NCT04023994|79501948|FG002|Overall Study|Withdrawal by Subject|0|||
44496064|NCT04023994|79501949|FG003|Overall Study|Withdrawal by Subject|1|||
44496065|NCT04023994|79501950|FG004|Overall Study|Withdrawal by Subject|0|||
44496066|NCT04023994|79501951|FG005|Overall Study|Withdrawal by Subject|0|||
44496067|NCT04023682|79501970|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
44496068|NCT04018612|79501981|FG000|Overall Study|Withdrawal by Subject|1|||
44496069|NCT04018612|79501982|FG001|Overall Study|Withdrawal by Subject|0|||
44496070|NCT04018612|79501983|FG002|Overall Study|Withdrawal by Subject|1|||
44496071|NCT04209400|79501993|FG000|Overall Study|Withdrawal by Subject|0|||
44496072|NCT04209400|79501994|FG001|Overall Study|Withdrawal by Subject|1|||
44496073|NCT04207840|79502000|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
44496074|NCT04207840|79502001|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
44496075|NCT04207840|79502002|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
44496076|NCT04207840|79502000|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
44496077|NCT04207840|79502001|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
44496078|NCT04207840|79502002|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
44496079|NCT04006366|79502010|FG000|Overall Study|Withdrawal by Subject|1|||
44496080|NCT04191148|79502016|FG000|Overall Study|Withdrawal by Subject|1|||
44496081|NCT04191148|79502017|FG001|Overall Study|Withdrawal by Subject|0|||
44496082|NCT04191148|79502016|FG000|Overall Study|Adverse Event|1|||
44496083|NCT04191148|79502017|FG001|Overall Study|Adverse Event|0|||
44496084|NCT04004260|79502027|FG000|Overall Study|Withdrawal by Subject|7|||
44496085|NCT04004260|79502028|FG001|Overall Study|Withdrawal by Subject|3|||
44496086|NCT04004260|79502027|FG000|Overall Study|Lost to Follow-up|22|||
44496087|NCT04004260|79502028|FG001|Overall Study|Lost to Follow-up|12|||
44496088|NCT04004260|79502027|FG000|Overall Study|Did not engage in intervention|13|||
44496089|NCT04004260|79502028|FG001|Overall Study|Did not engage in intervention|17|||
44496090|NCT04470622|79502036|FG000|Overall Study|Withdrawal by Subject|0|||
44553647|NCT01372774|79570221|FG001|Overall Study|Withdrawal prior to treatment|5|||
44553648|NCT02670538|79570232|FG000|Overall Study|Withdrawal of Consent|8|||
44553649|NCT02670538|79570233|FG001|Overall Study|Withdrawal of Consent|6|||
44553650|NCT02670538|79570234|FG002|Overall Study|Withdrawal of Consent|5|||
44553651|NCT02670538|79570232|FG000|Overall Study|Lost to Follow-up|8|||
44553652|NCT02670538|79570233|FG001|Overall Study|Lost to Follow-up|12|||
44553653|NCT02670538|79570234|FG002|Overall Study|Lost to Follow-up|7|||
44553654|NCT02670538|79570232|FG000|Overall Study|Adverse Event|5|||
44553655|NCT02670538|79570233|FG001|Overall Study|Adverse Event|5|||
44553656|NCT02670538|79570234|FG002|Overall Study|Adverse Event|11|||
44553657|NCT02670538|79570232|FG000|Overall Study|Lack of Efficacy|7|||
44553658|NCT02670538|79570233|FG001|Overall Study|Lack of Efficacy|1|||
44553659|NCT02670538|79570234|FG002|Overall Study|Lack of Efficacy|2|||
44553660|NCT02670538|79570232|FG000|Overall Study|Protocol Violation|3|||
44553661|NCT02670538|79570233|FG001|Overall Study|Protocol Violation|4|||
44553662|NCT02670538|79570234|FG002|Overall Study|Protocol Violation|1|||
44553663|NCT02670538|79570232|FG000|Overall Study|Noncompliance with Study Drug|1|||
44553664|NCT02670538|79570233|FG001|Overall Study|Noncompliance with Study Drug|3|||
44553665|NCT02670538|79570234|FG002|Overall Study|Noncompliance with Study Drug|2|||
44553666|NCT02670538|79570232|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44553667|NCT02670538|79570233|FG001|Overall Study|Other Miscellaneous Reasons|1|||
44553668|NCT02670538|79570234|FG002|Overall Study|Other Miscellaneous Reasons|2|||
44553669|NCT03547583|79570245|FG000|Overall Study|Adverse Event|16|||
44553670|NCT03547583|79570246|FG001|Overall Study|Adverse Event|11|||
44553671|NCT03547583|79570247|FG002|Overall Study|Adverse Event|10|||
44553672|NCT03547583|79570245|FG000|Overall Study|Death|11|||
44553673|NCT03547583|79570246|FG001|Overall Study|Death|7|||
44553674|NCT03547583|79570247|FG002|Overall Study|Death|4|||
44553675|NCT03547583|79570245|FG000|Overall Study|Lost to Follow-up|1|||
44553676|NCT03547583|79570246|FG001|Overall Study|Lost to Follow-up|0|||
44553677|NCT03547583|79570247|FG002|Overall Study|Lost to Follow-up|0|||
44553678|NCT03547583|79570245|FG000|Overall Study|Non-compliance with study drug|0|||
44553679|NCT03547583|79570246|FG001|Overall Study|Non-compliance with study drug|0|||
44553680|NCT03547583|79570247|FG002|Overall Study|Non-compliance with study drug|1|||
44553681|NCT03547583|79570245|FG000|Overall Study|Physician Decision|1|||
44553682|NCT03547583|79570246|FG001|Overall Study|Physician Decision|0|||
44231486|NCT02004275|79044716|FG002|Phase 1|Ineligible|0|||
44274832|NCT03266588|79221040|FG000|Long-term Treatment Period|Non-Compliance|126|||
44274833|NCT03266588|79221041|FG001|Long-term Treatment Period|Non-Compliance|57|||
44376700|NCT00857818|79381953|FG000|Overall Study|Withdrawal by Subject|0|||
44376701|NCT00857818|79381954|FG001|Overall Study|Withdrawal by Subject|4|||
44496091|NCT04470622|79502037|FG001|Overall Study|Withdrawal by Subject|1|||
44496092|NCT04470622|79502036|FG000|Overall Study|Screen Failure|0|||
44496093|NCT04470622|79502037|FG001|Overall Study|Screen Failure|1|||
44496094|NCT04470622|79502036|FG000|Overall Study|Death|0|||
44496095|NCT04470622|79502037|FG001|Overall Study|Death|1|||
44496096|NCT04465630|79502043|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
44496097|NCT04465630|79502043|FG000|Overall Study|Screen failure|8|||
44496098|NCT04465630|79502043|FG000|Overall Study|Baseline failure|16|||
44496099|NCT04182880|79502050|FG000|Overall Study|Pregnancy|1|||
44496100|NCT04182880|79502051|FG001|Overall Study|Pregnancy|0|||
44496101|NCT04465396|79502061|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
44496102|NCT04465396|79502062|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
44496103|NCT04465396|79502063|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
44496104|NCT04465396|79502064|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
44496105|NCT03999892|79502089|FG000|Overall Study|Lost to Follow-up|1|||
44496106|NCT03996694|79502093|FG000|First Washout (7 Days)|positive urine drug screen|0|||
44496107|NCT03996694|79502094|FG001|First Washout (7 Days)|positive urine drug screen|0|||
44496108|NCT03996694|79502095|FG002|First Washout (7 Days)|positive urine drug screen|1|||
44496109|NCT03996694|79502096|FG003|First Washout (7 Days)|positive urine drug screen|0|||
44496110|NCT03996694|79502097|FG004|First Washout (7 Days)|positive urine drug screen|0|||
44496111|NCT03996694|79502098|FG005|First Washout (7 Days)|positive urine drug screen|0|||
44496112|NCT03996694|79502093|FG000|First Washout (7 Days)|Adverse Event|0|||
44496113|NCT03996694|79502094|FG001|First Washout (7 Days)|Adverse Event|1|||
44496114|NCT03996694|79502095|FG002|First Washout (7 Days)|Adverse Event|0|||
44496115|NCT03996694|79502096|FG003|First Washout (7 Days)|Adverse Event|0|||
44496116|NCT03996694|79502097|FG004|First Washout (7 Days)|Adverse Event|0|||
44553683|NCT03547583|79570247|FG002|Overall Study|Physician Decision|3|||
44553684|NCT03547583|79570245|FG000|Overall Study|Protocol Violation|2|||
44553685|NCT03547583|79570246|FG001|Overall Study|Protocol Violation|1|||
44553686|NCT03547583|79570247|FG002|Overall Study|Protocol Violation|1|||
44553687|NCT03547583|79570245|FG000|Overall Study|Withdrawal by Subject|12|||
44496117|NCT03996694|79502098|FG005|First Washout (7 Days)|Adverse Event|0|||
44553688|NCT03547583|79570246|FG001|Overall Study|Withdrawal by Subject|19|||
44553689|NCT03547583|79570247|FG002|Overall Study|Withdrawal by Subject|10|||
44553690|NCT03547583|79570245|FG000|Overall Study|Other|2|||
44553691|NCT03547583|79570246|FG001|Overall Study|Other|2|||
44553692|NCT03547583|79570247|FG002|Overall Study|Other|3|||
44553693|NCT02670382|79570258|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
44553694|NCT02670382|79570259|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
44553695|NCT02991482|79570269|FG000|Overall Study|Disease progression|56|||
44553696|NCT02991482|79570270|FG001|Overall Study|Disease progression|47|||
44553697|NCT02991482|79570269|FG000|Overall Study|Death|4|||
44553698|NCT02991482|79570270|FG001|Overall Study|Death|4|||
44553699|NCT02991482|79570269|FG000|Overall Study|Adverse Event|1|||
44553700|NCT02991482|79570270|FG001|Overall Study|Adverse Event|6|||
44553701|NCT02991482|79570269|FG000|Overall Study|Patient decision|1|||
44553702|NCT02991482|79570270|FG001|Overall Study|Patient decision|1|||
44553703|NCT02991482|79570269|FG000|Overall Study|Physician Decision|0|||
44553704|NCT02991482|79570270|FG001|Overall Study|Physician Decision|6|||
44553705|NCT02991482|79570269|FG000|Overall Study|Clinical deterioration|1|||
44553706|NCT02991482|79570270|FG001|Overall Study|Clinical deterioration|0|||
44553707|NCT02991482|79570269|FG000|Overall Study|Patient feeling too unwell|1|||
44553708|NCT02991482|79570270|FG001|Overall Study|Patient feeling too unwell|0|||
44553709|NCT02991482|79570269|FG000|Overall Study|Worsening of performance status|0|||
44553710|NCT02991482|79570270|FG001|Overall Study|Worsening of performance status|1|||
44553711|NCT02991482|79570269|FG000|Overall Study|Death prior to study drug initiation|1|||
44553712|NCT02991482|79570270|FG001|Overall Study|Death prior to study drug initiation|0|||
44553713|NCT02991482|79570269|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
44553714|NCT02991482|79570270|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
44496118|NCT03996694|79502093|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
44496119|NCT03996694|79502094|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
44496120|NCT03996694|79502095|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
44496121|NCT03996694|79502096|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
44496122|NCT03996694|79502097|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
44496123|NCT03996694|79502098|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
44496124|NCT03996694|79502093|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
44496125|NCT03996694|79502094|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
44496126|NCT03996694|79502095|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
44496127|NCT03996694|79502096|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
44496128|NCT03996694|79502097|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
44496129|NCT03996694|79502098|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
44496130|NCT04179838|79502114|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
44496131|NCT04179838|79502115|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
44496132|NCT04179838|79502114|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
44496133|NCT04179838|79502115|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
44496134|NCT03994120|79502123|FG000|Overall Study|Lost to Follow-up|3|||
44496135|NCT03994120|79502124|FG001|Overall Study|Lost to Follow-up|1|||
44496136|NCT04178590|79502130|FG000|Overall Study|Pregnancy|1|||
44496137|NCT04178590|79502130|FG000|Overall Study|Lost to Follow-up|1|||
44496138|NCT04175392|79502158|FG000|Overall Study|Withdrawal by Subject|3|||
44496139|NCT04175392|79502159|FG001|Overall Study|Withdrawal by Subject|2|||
44496140|NCT03986866|79502167|FG000|Overall Study|Withdrawal by Subject|0|||
44496141|NCT03986866|79502168|FG001|Overall Study|Withdrawal by Subject|3|||
44496142|NCT03986866|79502167|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
44496143|NCT03986866|79502168|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
44496144|NCT03980938|79502176|FG000|Treatment Period 1|Study Terminated|1|||
44496145|NCT03980938|79502177|FG001|Treatment Period 1|Study Terminated|1|||
44496146|NCT03980938|79502176|FG000|Treatment Period 2|Study Terminated|2|||
44496147|NCT03980938|79502177|FG001|Treatment Period 2|Study Terminated|2|||
44496148|NCT03656692|79502183|FG000|Overall Study|Worsening of disease activity|2|||
44496149|NCT03656692|79502183|FG000|Overall Study|Physician Decision|1|||
44496150|NCT04439266|79502187|FG000|Overall Study|Ineligible|1|||
44496151|NCT04439266|79502187|FG000|Overall Study|Adverse Event|1|||
44553715|NCT02674750|79570279|FG000|Overall Study|Death|4|||
44231487|NCT02004275|79044717|FG003|Phase 1|Ineligible|1|||
44496152|NCT04439266|79502187|FG000|Overall Study|Death|1|||
44553716|NCT02674750|79570280|FG001|Overall Study|Death|5|||
44553717|NCT02674750|79570281|FG002|Overall Study|Death|8|||
44553718|NCT02674750|79570279|FG000|Overall Study|Lost to Follow-up|0|||
44553719|NCT02674750|79570280|FG001|Overall Study|Lost to Follow-up|8|||
44231488|NCT02004275|79044718|FG004|Phase 1|Ineligible|1|||
44553720|NCT02674750|79570281|FG002|Overall Study|Lost to Follow-up|0|||
44553721|NCT02674750|79570279|FG000|Overall Study|Lack of Efficacy|1|||
44553722|NCT02674750|79570280|FG001|Overall Study|Lack of Efficacy|17|||
44553723|NCT02674750|79570281|FG002|Overall Study|Lack of Efficacy|3|||
44553724|NCT02674750|79570279|FG000|Overall Study|Withdrawal by Subject|0|||
44553725|NCT02674750|79570280|FG001|Overall Study|Withdrawal by Subject|7|||
44553726|NCT02674750|79570281|FG002|Overall Study|Withdrawal by Subject|1|||
44553727|NCT02674750|79570279|FG000|Overall Study|Other|0|||
44553728|NCT02674750|79570280|FG001|Overall Study|Other|8|||
44553729|NCT02674750|79570281|FG002|Overall Study|Other|0|||
44553730|NCT02987972|79570310|FG000|Overall Study|Adverse Event|1|||
44553731|NCT02987972|79570311|FG001|Overall Study|Adverse Event|1|||
44553732|NCT02987972|79570312|FG002|Overall Study|Adverse Event|0|||
44553733|NCT02987972|79570310|FG000|Overall Study|Death|1|||
44553734|NCT02987972|79570311|FG001|Overall Study|Death|0|||
44553735|NCT02987972|79570312|FG002|Overall Study|Death|0|||
44553736|NCT02987972|79570310|FG000|Overall Study|Lack of Efficacy|9|||
44553737|NCT02987972|79570311|FG001|Overall Study|Lack of Efficacy|12|||
44553738|NCT02987972|79570312|FG002|Overall Study|Lack of Efficacy|12|||
44553739|NCT02987972|79570310|FG000|Overall Study|Lost to Follow-up|7|||
44553740|NCT02987972|79570311|FG001|Overall Study|Lost to Follow-up|8|||
44553741|NCT02987972|79570312|FG002|Overall Study|Lost to Follow-up|4|||
44553742|NCT02987972|79570310|FG000|Overall Study|Physician Decision|1|||
44553743|NCT02987972|79570311|FG001|Overall Study|Physician Decision|6|||
44553744|NCT02987972|79570312|FG002|Overall Study|Physician Decision|0|||
44553745|NCT02987972|79570310|FG000|Overall Study|Protocol Violation|2|||
44553746|NCT02987972|79570311|FG001|Overall Study|Protocol Violation|1|||
44553747|NCT02987972|79570312|FG002|Overall Study|Protocol Violation|5|||
44553748|NCT02987972|79570310|FG000|Overall Study|Withdrawal by Subject|22|||
44553749|NCT02987972|79570311|FG001|Overall Study|Withdrawal by Subject|17|||
44553750|NCT02987972|79570312|FG002|Overall Study|Withdrawal by Subject|21|||
44274834|NCT03266588|79221042|FG002|Long-term Treatment Period|Non-Compliance|7|||
44274835|NCT03266588|79221040|FG000|Long-term Treatment Period|Pregnancy|11|||
44274836|NCT03266588|79221041|FG001|Long-term Treatment Period|Pregnancy|5|||
44274837|NCT03266588|79221042|FG002|Long-term Treatment Period|Pregnancy|0|||
44274838|NCT03266588|79221040|FG000|Long-term Treatment Period|Protocol Deviation|17|||
44274839|NCT03266588|79221041|FG001|Long-term Treatment Period|Protocol Deviation|10|||
44553751|NCT01372618|79570320|FG000|Overall Study|PI Died. Study Terminated|9|||
44553752|NCT03304873|79570326|FG000|Overall Study|Lost to Follow-up|1|||
44553753|NCT03304873|79570327|FG001|Overall Study|Lost to Follow-up|8|||
44553754|NCT02669758|79570333|FG000|Overall Study|Withdrawal by Subject|43|||
44553755|NCT02669758|79570333|FG000|Overall Study|Lost to Follow-up|19|||
44274840|NCT03266588|79221042|FG002|Long-term Treatment Period|Protocol Deviation|4|||
44553756|NCT02669758|79570333|FG000|Overall Study|Adverse Event|16|||
44553757|NCT02669758|79570333|FG000|Overall Study|Non-Compliance with Study Drug|8|||
44553758|NCT02669758|79570333|FG000|Overall Study|Lack of Efficacy|5|||
44553759|NCT02669758|79570333|FG000|Overall Study|Pregnancy|1|||
44553760|NCT02669758|79570333|FG000|Overall Study|Study noncompliance|1|||
44553761|NCT02669758|79570333|FG000|Overall Study|Protocol Violation|1|||
44553762|NCT02987660|79570339|FG000|Overall Study|Study terminated by sponsor|10|||
44553763|NCT02987660|79570340|FG001|Overall Study|Study terminated by sponsor|10|||
44553764|NCT04528069|79570346|FG000|Overall Study|Adverse Event|1|||
44553765|NCT04528069|79570346|FG000|Overall Study|Lost to Follow-up|1|||
44553766|NCT04528069|79570346|FG000|Overall Study|Patient Unable to Come|1|||
44553767|NCT04528069|79570346|FG000|Overall Study|Patient Unable to Attend|1|||
44553768|NCT03303469|79570362|FG000|Overall Study|Lost to Follow-up|2|||
44553769|NCT02990000|79570368|FG000|Overall Study|Failed to provide data beyond baseline|36|||
44553770|NCT02990000|79570369|FG001|Overall Study|Failed to provide data beyond baseline|34|||
44553771|NCT01068626|79570377|FG000|Overall Study|Adverse Event|3|||
44553772|NCT01068626|79570378|FG001|Overall Study|Adverse Event|0|||
44553773|NCT01068626|79570377|FG000|Overall Study|Withdrawal by Subject|0|||
44553774|NCT01068626|79570378|FG001|Overall Study|Withdrawal by Subject|2|||
44553775|NCT02921750|79570386|FG000|Overall Study|Adverse Event|1|||
44553776|NCT02921750|79570387|FG001|Overall Study|Adverse Event|2|||
44553777|NCT02921750|79570386|FG000|Overall Study|Withdrawal by Subject|1|||
44553778|NCT02921750|79570387|FG001|Overall Study|Withdrawal by Subject|1|||
44553779|NCT02921750|79570386|FG000|Overall Study|Lost to Follow-up|3|||
44553780|NCT02921750|79570387|FG001|Overall Study|Lost to Follow-up|3|||
44553781|NCT02921750|79570386|FG000|Overall Study|Wound healed|3|||
44553782|NCT02921750|79570387|FG001|Overall Study|Wound healed|3|||
44553783|NCT02921750|79570386|FG000|Overall Study|Serious Adverse Event|1|||
44553784|NCT02921750|79570387|FG001|Overall Study|Serious Adverse Event|2|||
44553785|NCT02920970|79570396|FG000|First Intervention|Protocol Violation|0|||
44553786|NCT02920970|79570397|FG001|First Intervention|Protocol Violation|1|||
44553787|NCT02920970|79570396|FG000|First Intervention|Adverse Event|0|||
44553788|NCT02920970|79570397|FG001|First Intervention|Adverse Event|1|||
44553789|NCT02920970|79570396|FG000|Second Intervention|Poor Lens Fit|1|||
44553790|NCT02920970|79570397|FG001|Second Intervention|Poor Lens Fit|0|||
44553791|NCT01068158|79570407|FG000|Overall Study|Withdrawal by Subject|1|||
44553792|NCT01068158|79570408|FG001|Overall Study|Withdrawal by Subject|2|||
44553793|NCT01068158|79570407|FG000|Overall Study|Lost to Follow-up|7|||
44553794|NCT01068158|79570408|FG001|Overall Study|Lost to Follow-up|0|||
44553795|NCT01068158|79570407|FG000|Overall Study|Protocol Violation|0|||
44553796|NCT01068158|79570408|FG001|Overall Study|Protocol Violation|2|||
44231489|NCT02004275|79044719|FG005|Phase 1|Ineligible|0|||
44231490|NCT02004275|79044714|FG000|Phase 1|Protocol Violation|0|||
44231491|NCT02004275|79044715|FG001|Phase 1|Protocol Violation|0|||
44496153|NCT04439266|79502187|FG000|Overall Study|Disease progression|1|||
44496154|NCT04439266|79502187|FG000|Overall Study|Still on treatment|1|||
44496155|NCT03682120|79502195|FG000|Overall Study|Lost to Follow-up|11|||
44496156|NCT03682120|79502196|FG001|Overall Study|Lost to Follow-up|4|||
44496157|NCT03682120|79502197|FG002|Overall Study|Lost to Follow-up|5|||
44496158|NCT03682120|79502198|FG003|Overall Study|Lost to Follow-up|2|||
44496159|NCT03682120|79502195|FG000|Overall Study|Physician Decision|1|||
44496160|NCT03682120|79502196|FG001|Overall Study|Physician Decision|0|||
44496161|NCT03682120|79502197|FG002|Overall Study|Physician Decision|0|||
44496162|NCT03682120|79502198|FG003|Overall Study|Physician Decision|0|||
44496163|NCT03682120|79502195|FG000|Overall Study|Withdrawal by Subject|1|||
44496164|NCT03682120|79502196|FG001|Overall Study|Withdrawal by Subject|2|||
44553797|NCT03303079|79570417|FG000|Overall Study|Adverse Event|0|||
44553798|NCT03303079|79570418|FG001|Overall Study|Adverse Event|1|||
44553799|NCT03303079|79570419|FG002|Overall Study|Adverse Event|3|||
44496165|NCT03682120|79502197|FG002|Overall Study|Withdrawal by Subject|3|||
44496166|NCT03682120|79502198|FG003|Overall Study|Withdrawal by Subject|0|||
44496167|NCT03682120|79502195|FG000|Overall Study|Death|0|||
44553800|NCT03303079|79570417|FG000|Overall Study|Protocol Violation|5|||
44553801|NCT03303079|79570418|FG001|Overall Study|Protocol Violation|4|||
44553802|NCT03303079|79570419|FG002|Overall Study|Protocol Violation|7|||
44553803|NCT03303079|79570417|FG000|Overall Study|Withdrawal by Subject|2|||
44553804|NCT03303079|79570418|FG001|Overall Study|Withdrawal by Subject|4|||
44553805|NCT03303079|79570419|FG002|Overall Study|Withdrawal by Subject|2|||
44553806|NCT03303079|79570417|FG000|Overall Study|Other than specified|0|||
44553807|NCT03303079|79570418|FG001|Overall Study|Other than specified|2|||
44553808|NCT03303079|79570419|FG002|Overall Study|Other than specified|0|||
44553809|NCT01067846|79570429|FG000|Overall Study|Lost to Follow-up|17|||
44553810|NCT01067846|79570430|FG001|Overall Study|Lost to Follow-up|19|||
44553811|NCT01067846|79570429|FG000|Overall Study|Withdrawal by Subject|1|||
44553812|NCT01067846|79570430|FG001|Overall Study|Withdrawal by Subject|0|||
44553813|NCT01067846|79570429|FG000|Overall Study|participation in other tx study|1|||
44553814|NCT01067846|79570430|FG001|Overall Study|participation in other tx study|0|||
44553815|NCT03311659|79570436|FG000|Overall Study|Protocol Violation|1|||
44553816|NCT03874234|79570453|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553817|NCT03874234|79570454|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553818|NCT03874234|79570455|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553819|NCT03874234|79570456|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
44553820|NCT03874234|79570457|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553821|NCT03874234|79570458|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553822|NCT03874234|79570459|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553823|NCT03874234|79570460|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553824|NCT03874234|79570461|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553825|NCT03874234|79570462|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553826|NCT03874234|79570463|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553827|NCT03874234|79570464|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553828|NCT03874234|79570465|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
44553829|NCT03874234|79570453|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
44553830|NCT03874234|79570454|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553831|NCT03874234|79570455|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553832|NCT03874234|79570456|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553833|NCT03874234|79570457|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553834|NCT03874234|79570458|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553835|NCT03874234|79570459|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553836|NCT03874234|79570460|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553837|NCT03874234|79570461|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553838|NCT03874234|79570462|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553839|NCT03874234|79570463|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553840|NCT03874234|79570464|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553841|NCT03874234|79570465|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
44553842|NCT03874234|79570453|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553843|NCT03874234|79570454|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553844|NCT03874234|79570455|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553845|NCT03874234|79570456|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
44553846|NCT03874234|79570457|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553847|NCT03874234|79570458|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553848|NCT03874234|79570459|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44231492|NCT02004275|79044716|FG002|Phase 1|Protocol Violation|0|||
44231493|NCT02004275|79044717|FG003|Phase 1|Protocol Violation|1|||
44496168|NCT03682120|79502196|FG001|Overall Study|Death|1|||
44496169|NCT03682120|79502197|FG002|Overall Study|Death|0|||
44496170|NCT03682120|79502198|FG003|Overall Study|Death|0|||
44496171|NCT03682120|79502195|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
44231494|NCT02004275|79044718|FG004|Phase 1|Protocol Violation|0|||
44496172|NCT03682120|79502196|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
44496173|NCT03682120|79502197|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
44496174|NCT03682120|79502198|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
44496175|NCT04428502|79502210|FG000|Overall Study|Did not meet entrance criteria|14|||
44496176|NCT04428424|79502215|FG000|Overall Study|Does not meet entrance criteria|132|||
44496177|NCT04428424|79502215|FG000|Overall Study|Lost to Follow-up|115|||
44496178|NCT03655756|79502219|FG000|Overall Study|Death|1|||
44496179|NCT00095238|79502225|FG000|Overall Study|Lack of Efficacy|9|||
44496180|NCT00095238|79502226|FG001|Overall Study|Lack of Efficacy|9|||
44496181|NCT00095238|79502225|FG000|Overall Study|Adverse Event|331|||
44496182|NCT00095238|79502226|FG001|Overall Study|Adverse Event|287|||
44496183|NCT00095238|79502225|FG000|Overall Study|Subject Withdrew Consent|208|||
44496184|NCT00095238|79502226|FG001|Overall Study|Subject Withdrew Consent|223|||
44496185|NCT00095238|79502225|FG000|Overall Study|Death|154|||
44496186|NCT00095238|79502226|FG001|Overall Study|Death|170|||
44553849|NCT03874234|79570460|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553850|NCT03874234|79570461|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553851|NCT03874234|79570462|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553852|NCT03874234|79570463|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44231495|NCT02004275|79044719|FG005|Phase 1|Protocol Violation|5|||
44496187|NCT00095238|79502225|FG000|Overall Study|Lost to Follow-up|19|||
44496188|NCT00095238|79502226|FG001|Overall Study|Lost to Follow-up|24|||
44553853|NCT03874234|79570464|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553854|NCT03874234|79570465|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
44553855|NCT03874234|79570453|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553856|NCT03874234|79570454|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553857|NCT03874234|79570455|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553858|NCT03874234|79570456|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553859|NCT03874234|79570457|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
44553860|NCT03874234|79570458|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553861|NCT03874234|79570459|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553862|NCT03874234|79570460|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553863|NCT03874234|79570461|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553864|NCT03874234|79570462|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553865|NCT03874234|79570463|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553866|NCT03874234|79570464|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553867|NCT03874234|79570465|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
44553868|NCT03874234|79570453|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553869|NCT03874234|79570454|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553870|NCT03874234|79570455|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553871|NCT03874234|79570456|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553872|NCT03874234|79570457|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553873|NCT03874234|79570458|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553874|NCT03874234|79570459|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553875|NCT03874234|79570460|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
44553876|NCT03874234|79570461|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553877|NCT03874234|79570462|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553878|NCT03874234|79570463|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553879|NCT03874234|79570464|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553880|NCT03874234|79570465|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
44553881|NCT03874234|79570453|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553882|NCT03874234|79570454|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553883|NCT03874234|79570455|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553884|NCT03874234|79570456|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553885|NCT03874234|79570457|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
44553886|NCT03874234|79570458|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
44553887|NCT03874234|79570459|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553888|NCT03874234|79570460|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553889|NCT03874234|79570461|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553890|NCT03874234|79570462|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44496189|NCT00095238|79502225|FG000|Overall Study|Noncompliance|44|||
44496190|NCT00095238|79502226|FG001|Overall Study|Noncompliance|45|||
44496191|NCT00095238|79502225|FG000|Overall Study|No longer met study criteria|4|||
44496192|NCT00095238|79502226|FG001|Overall Study|No longer met study criteria|5|||
44496193|NCT00095238|79502225|FG000|Overall Study|Study terminated by sponsor|0|||
44496194|NCT00095238|79502226|FG001|Overall Study|Study terminated by sponsor|1|||
44496195|NCT00095238|79502225|FG000|Overall Study|Missing|1|||
44496196|NCT00095238|79502226|FG001|Overall Study|Missing|0|||
44496197|NCT00095238|79502225|FG000|Overall Study|Other Reasons|87|||
44496198|NCT00095238|79502226|FG001|Overall Study|Other Reasons|88|||
44496199|NCT00082368|79502264|FG000|Overall Study|Not treated-pt had poor IV access|1|||
44553891|NCT03874234|79570463|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553892|NCT03874234|79570464|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44496200|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
44553893|NCT03874234|79570465|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
44553894|NCT03874234|79570453|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553895|NCT03874234|79570454|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553896|NCT03874234|79570455|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553897|NCT03874234|79570456|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553898|NCT03874234|79570457|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553899|NCT03874234|79570458|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553900|NCT03874234|79570459|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
44553901|NCT03874234|79570460|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553902|NCT03874234|79570461|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553903|NCT03874234|79570462|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553904|NCT03874234|79570463|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553905|NCT03874234|79570464|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553906|NCT03874234|79570465|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
44553907|NCT03874234|79570453|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553908|NCT03874234|79570454|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553909|NCT03874234|79570455|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553910|NCT03874234|79570456|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553911|NCT03874234|79570457|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
44553912|NCT03874234|79570458|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553913|NCT03874234|79570459|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553914|NCT03874234|79570460|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553915|NCT03874234|79570461|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553916|NCT03874234|79570462|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553917|NCT03874234|79570463|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553918|NCT03874234|79570464|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553919|NCT03874234|79570465|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
44553920|NCT02985398|79570501|FG000|Overall Study|Adverse Event|1|||
44553921|NCT02985398|79570501|FG000|Overall Study|Lost to Follow-up|4|||
44553922|NCT02985398|79570501|FG000|Overall Study|Withdrawal by Subject|8|||
44274841|NCT03266588|79221040|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
44496201|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
44553923|NCT02985398|79570501|FG000|Overall Study|Study Burden|9|||
44553924|NCT03310723|79570507|FG000|Overall Study|Withdrawal by Subject|0|||
44553925|NCT03310723|79570508|FG001|Overall Study|Withdrawal by Subject|1|||
44553926|NCT03310723|79570507|FG000|Overall Study|Protocol Violation|0|||
44553927|NCT03310723|79570508|FG001|Overall Study|Protocol Violation|2|||
44553928|NCT02663674|79570516|FG000|Overall Study|Lost to Follow-up|5|||
44553929|NCT02663674|79570517|FG001|Overall Study|Lost to Follow-up|4|||
44553930|NCT02663674|79570516|FG000|Overall Study|Withdrawal by Subject|1|||
44553931|NCT02663674|79570517|FG001|Overall Study|Withdrawal by Subject|4|||
44553932|NCT02663674|79570516|FG000|Overall Study|Physician Decision|1|||
44553933|NCT02663674|79570517|FG001|Overall Study|Physician Decision|1|||
44553934|NCT02663674|79570516|FG000|Overall Study|Other Event (Health Related)|0|||
44274842|NCT03266588|79221041|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
44496202|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
44496203|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
44496204|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
44496205|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
44496206|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
44496207|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
44496208|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
44496209|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
44496210|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
44553935|NCT02663674|79570517|FG001|Overall Study|Other Event (Health Related)|1|||
44553936|NCT02908880|79570523|FG000|Overall Study|Lost to Follow-up|4|||
44553937|NCT02908880|79570523|FG000|Overall Study|Explantation of the device|1|||
44553938|NCT02908880|79570523|FG000|Overall Study|Withdrawal by Subject|17|||
44553939|NCT02908880|79570523|FG000|Overall Study|Death|5|||
44553940|NCT03310411|79570527|FG000|Period 1|Adverse Event|0|||
44553941|NCT03310411|79570528|FG001|Period 1|Adverse Event|0|||
44553942|NCT03310411|79570529|FG002|Period 1|Adverse Event|0|||
44553943|NCT03310411|79570530|FG003|Period 1|Adverse Event|1|||
44553944|NCT03301831|79570548|FG000|Overall Study|Lost to Follow-up|5|||
44553945|NCT03301831|79570549|FG001|Overall Study|Lost to Follow-up|3|||
44553946|NCT03301831|79570548|FG000|Overall Study|Protocol Violation|4|||
44553947|NCT03301831|79570549|FG001|Overall Study|Protocol Violation|0|||
44553948|NCT03301831|79570548|FG000|Overall Study|Withdrawal by Subject|11|||
44553949|NCT03301831|79570549|FG001|Overall Study|Withdrawal by Subject|0|||
44496211|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
44496212|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
44496213|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
44496214|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
44496215|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
44496216|NCT00094770|79502270|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
44496217|NCT00094770|79502271|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
44496218|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
44496219|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
44496220|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
44496221|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
44496222|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
44553950|NCT02909504|79570555|FG000|Overall Study|Adverse Event|2|||
44553951|NCT02909504|79570555|FG000|Overall Study|Lack of Efficacy|3|||
44553952|NCT02909504|79570555|FG000|Overall Study|Withdrawal by Subject|4|||
44553953|NCT02909504|79570555|FG000|Overall Study|Pregnancy|1|||
44553954|NCT02909504|79570555|FG000|Overall Study|Subject moved|1|||
44553955|NCT02909504|79570555|FG000|Overall Study|Lost to Follow-up|1|||
44553956|NCT02199691|79570564|FG000|Overall Study|Protocol Violation|3|||
44553957|NCT02199691|79570565|FG001|Overall Study|Protocol Violation|3|||
44553958|NCT02199691|79570566|FG002|Overall Study|Protocol Violation|6|||
44553959|NCT02199691|79570567|FG003|Overall Study|Protocol Violation|7|||
44553960|NCT02199691|79570564|FG000|Overall Study|Withdrawal by Subject|5|||
44553961|NCT02199691|79570565|FG001|Overall Study|Withdrawal by Subject|3|||
44553962|NCT02199691|79570566|FG002|Overall Study|Withdrawal by Subject|12|||
44553963|NCT02199691|79570567|FG003|Overall Study|Withdrawal by Subject|13|||
44553964|NCT02199691|79570564|FG000|Overall Study|Lost to Follow-up|2|||
44553965|NCT02199691|79570565|FG001|Overall Study|Lost to Follow-up|1|||
44553966|NCT02199691|79570566|FG002|Overall Study|Lost to Follow-up|9|||
44553967|NCT02199691|79570567|FG003|Overall Study|Lost to Follow-up|10|||
44553968|NCT03299881|79570581|FG000|Overall Study|Study Termination|17|||
44553969|NCT03299881|79570582|FG001|Overall Study|Study Termination|13|||
44553970|NCT03299101|79570588|FG000|Overall Study|Lost to Follow-up|1|||
44553971|NCT03299101|79570588|FG000|Overall Study|Withdrawal by Subject|5|||
44553972|NCT03299101|79570588|FG000|Overall Study|Surgery was changed|3|||
44553973|NCT03299101|79570588|FG000|Overall Study|Not enough time to complete prehab|1|||
44553974|NCT02663128|79570594|FG000|Period 2|Physician Decision|0|||
44553975|NCT02663128|79570595|FG001|Period 2|Physician Decision|0|||
44553976|NCT02663128|79570596|FG002|Period 2|Physician Decision|0|||
44496223|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
44496224|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
44496225|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
44496226|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
44496227|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
44496228|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
44553977|NCT02663128|79570597|FG003|Period 2|Physician Decision|0|||
44553978|NCT02663128|79570598|FG004|Period 2|Physician Decision|1|||
44553979|NCT02663128|79570599|FG005|Period 2|Physician Decision|0|||
44496229|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
44496230|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
44496231|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
44553980|NCT03298867|79570610|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
44553981|NCT03298867|79570611|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
44553982|NCT03298867|79570610|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
44553983|NCT03298867|79570611|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
44553984|NCT03298867|79570610|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
44553985|NCT03298867|79570611|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
44553986|NCT03298867|79570610|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
44553987|NCT03298867|79570611|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
44553988|NCT03298867|79570610|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
44553989|NCT03298867|79570611|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
44553990|NCT03298867|79570610|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
44553991|NCT03298867|79570611|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
44553992|NCT03298867|79570610|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
44553993|NCT03298867|79570611|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
44553994|NCT03298867|79570610|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
44553995|NCT03298867|79570611|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
44553996|NCT03298867|79570610|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
44553997|NCT03298867|79570611|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
44553998|NCT02906930|79570621|FG000|Overall Study|Withdrawal by Subject|0|||
44553999|NCT02906930|79570622|FG001|Overall Study|Withdrawal by Subject|5|||
44554000|NCT02906930|79570623|FG002|Overall Study|Withdrawal by Subject|5|||
44554001|NCT02906930|79570624|FG003|Overall Study|Withdrawal by Subject|4|||
44554002|NCT02906930|79570621|FG000|Overall Study|Lost to Follow-up|5|||
44554003|NCT02906930|79570622|FG001|Overall Study|Lost to Follow-up|7|||
44554004|NCT02906930|79570623|FG002|Overall Study|Lost to Follow-up|5|||
44554005|NCT02906930|79570624|FG003|Overall Study|Lost to Follow-up|2|||
44554006|NCT02906930|79570621|FG000|Overall Study|Death|0|||
44554007|NCT02906930|79570622|FG001|Overall Study|Death|0|||
44554008|NCT02906930|79570623|FG002|Overall Study|Death|1|||
44554009|NCT02906930|79570624|FG003|Overall Study|Death|0|||
44554010|NCT02906930|79570621|FG000|Overall Study|Other|1|||
44554011|NCT02906930|79570622|FG001|Overall Study|Other|2|||
44554012|NCT02906930|79570623|FG002|Overall Study|Other|1|||
44554013|NCT02906930|79570624|FG003|Overall Study|Other|2|||
44554014|NCT02983604|79570638|FG000|Overall Study|Enrolled but not Treated|0|||
44554015|NCT02983604|79570639|FG001|Overall Study|Enrolled but not Treated|0|||
44554016|NCT02983604|79570640|FG002|Overall Study|Enrolled but not Treated|1|||
44554017|NCT02983604|79570641|FG003|Overall Study|Enrolled but not Treated|0|||
44554018|NCT02662582|79570653|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
44554019|NCT02662582|79570654|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
44554020|NCT02662582|79570653|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
44554021|NCT02662582|79570654|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
44554022|NCT02662582|79570653|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
44554023|NCT02662582|79570654|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
44554024|NCT02662582|79570653|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44554025|NCT02662582|79570654|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44554026|NCT02908100|79570664|FG000|Overall Study|Adverse Event|7|||
44554027|NCT02908100|79570665|FG001|Overall Study|Adverse Event|6|||
44554028|NCT02908100|79570666|FG002|Overall Study|Adverse Event|9|||
44554029|NCT02908100|79570664|FG000|Overall Study|Death|2|||
44231496|NCT02004275|79044714|FG000|Phase 2 Part 1|Ineligible|6|||
44231497|NCT02004275|79044715|FG001|Phase 2 Part 1|Ineligible|9|||
44496232|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
44496233|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
44496234|NCT00094770|79502270|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
44496235|NCT00094770|79502271|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
44496236|NCT00069576|79502279|FG000|Original Trial|Lost to Follow-up|25|||
44496237|NCT00069576|79502280|FG001|Original Trial|Lost to Follow-up|33|||
44496238|NCT00069576|79502279|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
44496239|NCT00069576|79502280|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
44554030|NCT02908100|79570665|FG001|Overall Study|Death|0|||
44554031|NCT02908100|79570666|FG002|Overall Study|Death|0|||
44554032|NCT02908100|79570664|FG000|Overall Study|Lack of Efficacy|2|||
44554033|NCT02908100|79570665|FG001|Overall Study|Lack of Efficacy|3|||
44554034|NCT02908100|79570666|FG002|Overall Study|Lack of Efficacy|3|||
44554035|NCT02908100|79570664|FG000|Overall Study|Lost to Follow-up|0|||
44554036|NCT02908100|79570665|FG001|Overall Study|Lost to Follow-up|1|||
44554037|NCT02908100|79570666|FG002|Overall Study|Lost to Follow-up|2|||
44554038|NCT02908100|79570664|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44554039|NCT02908100|79570665|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44554040|NCT02908100|79570666|FG002|Overall Study|Non-Compliance With Study Drug|2|||
44231498|NCT02004275|79044716|FG002|Phase 2 Part 1|Ineligible|0|||
44496240|NCT00069264|79502286|FG000|Overall Study|Adverse Event|3|||
44496241|NCT00069264|79502286|FG000|Overall Study|Progressive Disease|23|||
44496242|NCT00069264|79502286|FG000|Overall Study|Withdrawal by Subject|3|||
44496243|NCT00069264|79502286|FG000|Overall Study|Discon Therapy|3|||
44554041|NCT02908100|79570664|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
44554042|NCT02908100|79570665|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
44554043|NCT02908100|79570666|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
44554044|NCT02908100|79570664|FG000|Overall Study|Physician Decision|0|||
44554045|NCT02908100|79570665|FG001|Overall Study|Physician Decision|1|||
44554046|NCT02908100|79570666|FG002|Overall Study|Physician Decision|0|||
44554047|NCT02908100|79570664|FG000|Overall Study|Pregnancy|1|||
44554048|NCT02908100|79570665|FG001|Overall Study|Pregnancy|2|||
44554049|NCT02908100|79570666|FG002|Overall Study|Pregnancy|0|||
44554050|NCT02908100|79570664|FG000|Overall Study|Withdrawal by Subject|8|||
44554051|NCT02908100|79570665|FG001|Overall Study|Withdrawal by Subject|7|||
44554052|NCT02908100|79570666|FG002|Overall Study|Withdrawal by Subject|5|||
44554053|NCT02908100|79570664|FG000|Overall Study|Randomised in Error|1|||
44554054|NCT02908100|79570665|FG001|Overall Study|Randomised in Error|0|||
44554055|NCT02908100|79570666|FG002|Overall Study|Randomised in Error|0|||
44554056|NCT02982590|79570690|FG000|Overall Study|Lost to Follow-up|0|||
44554057|NCT02982590|79570691|FG001|Overall Study|Lost to Follow-up|1|||
44554058|NCT02982590|79570690|FG000|Overall Study|Death|4|||
44554059|NCT02982590|79570691|FG001|Overall Study|Death|0|||
44554060|NCT03310021|79570717|FG000|Overall Study|Withdrawal by Subject|0|||
44554061|NCT03310021|79570718|FG001|Overall Study|Withdrawal by Subject|0|||
44554062|NCT03310021|79570719|FG002|Overall Study|Withdrawal by Subject|0|||
44554063|NCT03310021|79570720|FG003|Overall Study|Withdrawal by Subject|0|||
44554064|NCT03310021|79570721|FG004|Overall Study|Withdrawal by Subject|0|||
44554065|NCT03310021|79570722|FG005|Overall Study|Withdrawal by Subject|0|||
44554066|NCT03310021|79570723|FG006|Overall Study|Withdrawal by Subject|1|||
44554067|NCT03310021|79570724|FG007|Overall Study|Withdrawal by Subject|0|||
44554068|NCT03310021|79570725|FG008|Overall Study|Withdrawal by Subject|0|||
44554069|NCT03310021|79570726|FG009|Overall Study|Withdrawal by Subject|0|||
44554070|NCT03310021|79570727|FG010|Overall Study|Withdrawal by Subject|0|||
44231499|NCT02004275|79044717|FG003|Phase 2 Part 1|Ineligible|0|||
44231500|NCT02004275|79044718|FG004|Phase 2 Part 1|Ineligible|0|||
44231501|NCT02004275|79044719|FG005|Phase 2 Part 1|Ineligible|0|||
44231502|NCT02004275|79044714|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
44376702|NCT00857818|79381953|FG000|Overall Study|Sponsor terminated study|6|||
44376703|NCT00857818|79381954|FG001|Overall Study|Sponsor terminated study|4|||
44376704|NCT00857818|79381953|FG000|Overall Study|Investigator decision|1|||
44376705|NCT00857818|79381954|FG001|Overall Study|Investigator decision|0|||
44376706|NCT01074944|79381960|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
44376707|NCT01074944|79381961|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
44376708|NCT01074944|79381962|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
44376709|NCT01074944|79381963|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
44376710|NCT01074944|79381964|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
44376711|NCT01074944|79381960|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
44376712|NCT01074944|79381961|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
44376713|NCT01074944|79381962|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
44376714|NCT01074944|79381963|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
44376715|NCT01074944|79381964|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
44376716|NCT01074944|79381960|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
44376717|NCT01074944|79381961|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
44376718|NCT01074944|79381962|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
44376719|NCT01074944|79381963|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
44496244|NCT00069108|79502292|FG000|Overall Study|Withdrawal by Subject|5|||
44496245|NCT00069108|79502293|FG001|Overall Study|Withdrawal by Subject|9|||
44496246|NCT00069108|79502292|FG000|Overall Study|Adverse Event|64|||
44496247|NCT00069108|79502293|FG001|Overall Study|Adverse Event|42|||
44496248|NCT00069108|79502292|FG000|Overall Study|Death|6|||
44496249|NCT00069108|79502293|FG001|Overall Study|Death|6|||
44496250|NCT00069108|79502292|FG000|Overall Study|Administration|15|||
44554071|NCT03310021|79570728|FG011|Overall Study|Withdrawal by Subject|0|||
44554072|NCT03310021|79570729|FG012|Overall Study|Withdrawal by Subject|0|||
44554073|NCT03310021|79570730|FG013|Overall Study|Withdrawal by Subject|0|||
44554074|NCT03310021|79570731|FG014|Overall Study|Withdrawal by Subject|0|||
44554075|NCT03310021|79570732|FG015|Overall Study|Withdrawal by Subject|0|||
44554076|NCT03310021|79570733|FG016|Overall Study|Withdrawal by Subject|0|||
44554077|NCT03310021|79570734|FG017|Overall Study|Withdrawal by Subject|0|||
44554078|NCT03310021|79570735|FG018|Overall Study|Withdrawal by Subject|0|||
44554079|NCT03310021|79570736|FG019|Overall Study|Withdrawal by Subject|0|||
44554080|NCT03310021|79570717|FG000|Overall Study|Lost to Follow-up|0|||
44231503|NCT02004275|79044715|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
44376720|NCT01074944|79381964|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
44376721|NCT01074944|79381960|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
44496251|NCT00069108|79502293|FG001|Overall Study|Administration|4|||
44496252|NCT00069108|79502292|FG000|Overall Study|Insufficient therapy|117|||
44496253|NCT00069108|79502293|FG001|Overall Study|Insufficient therapy|144|||
44496254|NCT00069108|79502292|FG000|Overall Study|Violation criteria|1|||
44496255|NCT00069108|79502293|FG001|Overall Study|Violation criteria|4|||
44376722|NCT01074944|79381961|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
44376723|NCT01074944|79381962|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
44376724|NCT01074944|79381963|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
44376725|NCT01074944|79381964|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
44376726|NCT01074944|79381960|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
44376727|NCT01074944|79381961|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
44376728|NCT01074944|79381962|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
44376729|NCT01074944|79381963|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
44496256|NCT00069108|79502292|FG000|Overall Study|Refused treatment|5|||
44496257|NCT00069108|79502293|FG001|Overall Study|Refused treatment|10|||
44496258|NCT00094536|79502300|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
44496259|NCT00094536|79502300|FG000|Treatment and Follow-up|Adverse Event|4|||
44554081|NCT03310021|79570718|FG001|Overall Study|Lost to Follow-up|0|||
44496260|NCT00094536|79502300|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
44496261|NCT00094536|79502300|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
44496262|NCT00094536|79502300|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
44496263|NCT00094536|79502300|FG000|Treatment and Follow-up|Subject non-compliance|9|||
44496264|NCT00094536|79502300|FG000|Treatment and Follow-up|Unable to attend visits|1|||
44496265|NCT00405587|79502308|FG000|Overall Study|Death|0|||
44496266|NCT00405587|79502309|FG001|Overall Study|Death|0|||
44496267|NCT00405587|79502310|FG002|Overall Study|Death|0|||
44496268|NCT00405587|79502311|FG003|Overall Study|Death|1|||
44496269|NCT00405587|79502308|FG000|Overall Study|Disease Progression|22|||
44496270|NCT00405587|79502309|FG001|Overall Study|Disease Progression|23|||
44496271|NCT00405587|79502310|FG002|Overall Study|Disease Progression|21|||
44496272|NCT00405587|79502311|FG003|Overall Study|Disease Progression|17|||
44496273|NCT00405587|79502308|FG000|Overall Study|Physician Decision|3|||
44496274|NCT00405587|79502309|FG001|Overall Study|Physician Decision|2|||
44496275|NCT00405587|79502310|FG002|Overall Study|Physician Decision|0|||
44496276|NCT00405587|79502311|FG003|Overall Study|Physician Decision|0|||
44496277|NCT00405587|79502308|FG000|Overall Study|Adverse Event|1|||
44554082|NCT03310021|79570719|FG002|Overall Study|Lost to Follow-up|0|||
44554083|NCT03310021|79570720|FG003|Overall Study|Lost to Follow-up|0|||
44554084|NCT03310021|79570721|FG004|Overall Study|Lost to Follow-up|0|||
44554085|NCT03310021|79570722|FG005|Overall Study|Lost to Follow-up|0|||
44554086|NCT03310021|79570723|FG006|Overall Study|Lost to Follow-up|0|||
44554087|NCT03310021|79570724|FG007|Overall Study|Lost to Follow-up|0|||
44554088|NCT03310021|79570725|FG008|Overall Study|Lost to Follow-up|0|||
44554089|NCT03310021|79570726|FG009|Overall Study|Lost to Follow-up|0|||
44554090|NCT03310021|79570727|FG010|Overall Study|Lost to Follow-up|1|||
44554091|NCT03310021|79570728|FG011|Overall Study|Lost to Follow-up|0|||
44554092|NCT03310021|79570729|FG012|Overall Study|Lost to Follow-up|0|||
44554093|NCT03310021|79570730|FG013|Overall Study|Lost to Follow-up|0|||
44554094|NCT03310021|79570731|FG014|Overall Study|Lost to Follow-up|0|||
44554095|NCT03310021|79570732|FG015|Overall Study|Lost to Follow-up|0|||
44554096|NCT03310021|79570733|FG016|Overall Study|Lost to Follow-up|0|||
44554097|NCT03310021|79570734|FG017|Overall Study|Lost to Follow-up|0|||
44554098|NCT03310021|79570735|FG018|Overall Study|Lost to Follow-up|0|||
44554099|NCT03310021|79570736|FG019|Overall Study|Lost to Follow-up|0|||
44554100|NCT03333109|79570781|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
44554101|NCT03333109|79570782|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
44554102|NCT03333109|79570783|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
44554103|NCT03333109|79570781|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44554104|NCT03333109|79570782|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44554105|NCT03333109|79570783|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
44554106|NCT03333109|79570781|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
44554107|NCT03333109|79570782|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
44496278|NCT00405587|79502309|FG001|Overall Study|Adverse Event|0|||
44496279|NCT00405587|79502310|FG002|Overall Study|Adverse Event|0|||
44554108|NCT03333109|79570783|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
44231504|NCT02004275|79044716|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
44496280|NCT00405587|79502311|FG003|Overall Study|Adverse Event|0|||
44496281|NCT00405587|79502308|FG000|Overall Study|Lost to Follow-up|0|||
44496282|NCT00405587|79502309|FG001|Overall Study|Lost to Follow-up|1|||
44496283|NCT00405587|79502310|FG002|Overall Study|Lost to Follow-up|1|||
44496284|NCT00405587|79502311|FG003|Overall Study|Lost to Follow-up|0|||
44554109|NCT03333109|79570781|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
44554110|NCT03333109|79570782|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
44554111|NCT03333109|79570783|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
44554112|NCT03333109|79570781|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
44554113|NCT03333109|79570782|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
44231505|NCT02004275|79044717|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
44496285|NCT00405587|79502308|FG000|Overall Study|Radiation induced necrosis|0|||
44496286|NCT00405587|79502309|FG001|Overall Study|Radiation induced necrosis|1|||
44496287|NCT00405587|79502310|FG002|Overall Study|Radiation induced necrosis|0|||
44554114|NCT03333109|79570783|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
44554115|NCT03333109|79570781|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
44554116|NCT03333109|79570782|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
44554117|NCT03333109|79570783|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
44554118|NCT03333109|79570781|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
44554119|NCT03333109|79570782|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
44554120|NCT03333109|79570783|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
44554121|NCT03333109|79570781|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
44554122|NCT03333109|79570782|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
44554123|NCT03333109|79570783|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
44554124|NCT02940223|79570793|FG000|Overall Study|Failed Requirement|2|||
44554125|NCT02940223|79570794|FG001|Overall Study|Failed Requirement|0|||
44554126|NCT03295201|79570802|FG000|Overall Study|Lost to Follow-up|1|||
44554127|NCT03295201|79570803|FG001|Overall Study|Lost to Follow-up|1|||
44554128|NCT03295201|79570802|FG000|Overall Study|Hospital admission|0|||
44554129|NCT03295201|79570803|FG001|Overall Study|Hospital admission|1|||
44554130|NCT03293485|79570809|FG000|Overall Study|Death|1|||
44554131|NCT03293485|79570809|FG000|Overall Study|Screen Failure|2|||
44554132|NCT03293485|79570809|FG000|Overall Study|Withdrawal by Subject|2|||
44554133|NCT03309943|79570817|FG000|Overall Study|Withdrawal by Subject|0|||
44554134|NCT03309943|79570818|FG001|Overall Study|Withdrawal by Subject|1|||
44554135|NCT03309943|79570817|FG000|Overall Study|Inappropriate behavior towards staff|0|||
44554136|NCT03309943|79570818|FG001|Overall Study|Inappropriate behavior towards staff|1|||
44554137|NCT01732627|79570826|FG000|Overall Study|Withdrawal by Subject|1|||
44554138|NCT01732627|79570827|FG001|Overall Study|Withdrawal by Subject|0|||
44554139|NCT03307837|79570839|FG000|Overall Study|Withdrawal by Subject|0|||
44554140|NCT03307837|79570840|FG001|Overall Study|Withdrawal by Subject|0|||
44554141|NCT03307837|79570841|FG002|Overall Study|Withdrawal by Subject|1|||
44554142|NCT03307837|79570842|FG003|Overall Study|Withdrawal by Subject|0|||
44554143|NCT03307837|79570843|FG004|Overall Study|Withdrawal by Subject|0|||
44554144|NCT03307837|79570844|FG005|Overall Study|Withdrawal by Subject|1|||
44554145|NCT03307837|79570839|FG000|Overall Study|Lost to Follow-up|1|||
44554146|NCT03307837|79570840|FG001|Overall Study|Lost to Follow-up|1|||
44554147|NCT03307837|79570841|FG002|Overall Study|Lost to Follow-up|0|||
44554148|NCT03307837|79570842|FG003|Overall Study|Lost to Follow-up|0|||
44554149|NCT03307837|79570843|FG004|Overall Study|Lost to Follow-up|0|||
44554150|NCT03307837|79570844|FG005|Overall Study|Lost to Follow-up|1|||
44554151|NCT03331315|79570865|FG000|Overall Study|Physician Decision|18|||
44554152|NCT03331315|79570866|FG001|Overall Study|Physician Decision|14|||
44554153|NCT03329989|79570874|FG000|Overall Study|Withdrawal by Subject|9|||
44554154|NCT03329989|79570874|FG000|Overall Study|Lost to Follow-up|8|||
44554155|NCT03329989|79570874|FG000|Overall Study|Adverse Event|5|||
44554156|NCT03329989|79570874|FG000|Overall Study|Protocol Violation|1|||
44554157|NCT03287869|79570880|FG000|Overall Study|Adverse Event|14|||
44554158|NCT03287869|79570881|FG001|Overall Study|Adverse Event|12|||
44554159|NCT03287869|79570880|FG000|Overall Study|Lack of Efficacy|1|||
44554160|NCT03287869|79570881|FG001|Overall Study|Lack of Efficacy|0|||
44376730|NCT01074944|79381964|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
44496288|NCT00405587|79502311|FG003|Overall Study|Radiation induced necrosis|0|||
44496289|NCT00405587|79502308|FG000|Overall Study|Withdrawal by Subject|0|||
44496290|NCT00405587|79502309|FG001|Overall Study|Withdrawal by Subject|0|||
44496291|NCT00405587|79502310|FG002|Overall Study|Withdrawal by Subject|0|||
44496292|NCT00405587|79502311|FG003|Overall Study|Withdrawal by Subject|2|||
44496293|NCT00405587|79502308|FG000|Overall Study|Participant not dosed|0|||
44496294|NCT00405587|79502309|FG001|Overall Study|Participant not dosed|1|||
44496295|NCT00405587|79502310|FG002|Overall Study|Participant not dosed|0|||
44496296|NCT00405587|79502311|FG003|Overall Study|Participant not dosed|0|||
44554161|NCT03287869|79570880|FG000|Overall Study|Lost to Follow-up|13|||
44554162|NCT03287869|79570881|FG001|Overall Study|Lost to Follow-up|19|||
44554163|NCT03287869|79570880|FG000|Overall Study|Non-Compliance With Study Drug|5|||
44554164|NCT03287869|79570881|FG001|Overall Study|Non-Compliance With Study Drug|9|||
44554165|NCT03287869|79570880|FG000|Overall Study|Progressive Disease|1|||
44554166|NCT03287869|79570881|FG001|Overall Study|Progressive Disease|0|||
44554167|NCT03287869|79570880|FG000|Overall Study|Protocol Deviation|2|||
44554168|NCT03287869|79570881|FG001|Overall Study|Protocol Deviation|1|||
44554169|NCT03287869|79570880|FG000|Overall Study|Withdrawal by Subject|36|||
44554170|NCT03287869|79570881|FG001|Overall Study|Withdrawal by Subject|43|||
44554171|NCT03287869|79570880|FG000|Overall Study|Early Closure of the Site|0|||
44554172|NCT03287869|79570881|FG001|Overall Study|Early Closure of the Site|1|||
44554173|NCT03287869|79570880|FG000|Overall Study|Physician Decision|5|||
44554174|NCT03287869|79570881|FG001|Overall Study|Physician Decision|5|||
44554175|NCT03287869|79570880|FG000|Overall Study|Reason not Specified|6|||
44554176|NCT03287869|79570881|FG001|Overall Study|Reason not Specified|3|||
44496297|NCT00405275|79502349|FG000|Overall Study|Death|1|||
44496298|NCT00405275|79502350|FG001|Overall Study|Death|0|||
44496299|NCT00405275|79502349|FG000|Overall Study|Lost to Follow-up|5|||
44554177|NCT02661490|79570892|FG000|Overall Study|Lost to Follow-up|0|||
44496300|NCT00405275|79502350|FG001|Overall Study|Lost to Follow-up|1|||
44496301|NCT00405275|79502349|FG000|Overall Study|Withdrawal by Subject|7|||
44554178|NCT02661490|79570893|FG001|Overall Study|Lost to Follow-up|1|||
44554179|NCT02661490|79570894|FG002|Overall Study|Lost to Follow-up|0|||
44554180|NCT02661490|79570895|FG003|Overall Study|Lost to Follow-up|0|||
44554181|NCT02661490|79570896|FG004|Overall Study|Lost to Follow-up|2|||
44554182|NCT02661490|79570892|FG000|Overall Study|Withdrawal by Subject|2|||
44554183|NCT02661490|79570893|FG001|Overall Study|Withdrawal by Subject|0|||
44554184|NCT02661490|79570894|FG002|Overall Study|Withdrawal by Subject|2|||
44554185|NCT02661490|79570895|FG003|Overall Study|Withdrawal by Subject|0|||
44554186|NCT02661490|79570896|FG004|Overall Study|Withdrawal by Subject|0|||
44554187|NCT02661490|79570892|FG000|Overall Study|Death|1|||
44554188|NCT02661490|79570893|FG001|Overall Study|Death|1|||
44554189|NCT02661490|79570894|FG002|Overall Study|Death|0|||
44496302|NCT00405275|79502350|FG001|Overall Study|Withdrawal by Subject|9|||
44496303|NCT00405275|79502349|FG000|Overall Study|Unwilling to continue|10|||
44496304|NCT00405275|79502350|FG001|Overall Study|Unwilling to continue|9|||
44496305|NCT00404651|79502360|FG000|Overall Study|Serious Adverse Event|0|||
44496306|NCT00404651|79502361|FG001|Overall Study|Serious Adverse Event|0|||
44496307|NCT00404651|79502362|FG002|Overall Study|Serious Adverse Event|2|||
44496308|NCT00404651|79502363|FG003|Overall Study|Serious Adverse Event|0|||
44496309|NCT00404651|79502360|FG000|Overall Study|Protocol Violation|10|||
44554190|NCT02661490|79570895|FG003|Overall Study|Death|1|||
44554191|NCT02661490|79570896|FG004|Overall Study|Death|0|||
44554192|NCT02661490|79570892|FG000|Overall Study|Reason not Specified|0|||
44554193|NCT02661490|79570893|FG001|Overall Study|Reason not Specified|0|||
44554194|NCT02661490|79570894|FG002|Overall Study|Reason not Specified|0|||
44554195|NCT02661490|79570895|FG003|Overall Study|Reason not Specified|0|||
44554196|NCT02661490|79570896|FG004|Overall Study|Reason not Specified|1|||
44554197|NCT03287791|79570911|FG000|Overall Study|Insufficient Therapeutic Response|0|||
44554198|NCT03287791|79570912|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44554199|NCT03287791|79570913|FG002|Overall Study|Insufficient Therapeutic Response|1|||
44554200|NCT03287791|79570911|FG000|Overall Study|Adverse Event|0|||
44496310|NCT00404651|79502361|FG001|Overall Study|Protocol Violation|5|||
44496311|NCT00404651|79502362|FG002|Overall Study|Protocol Violation|14|||
44496312|NCT00404651|79502363|FG003|Overall Study|Protocol Violation|5|||
44496313|NCT00404651|79502360|FG000|Overall Study|Lost to Follow-up|15|||
44554201|NCT03287791|79570912|FG001|Overall Study|Adverse Event|4|||
44554202|NCT03287791|79570913|FG002|Overall Study|Adverse Event|3|||
44554203|NCT03287791|79570911|FG000|Overall Study|Withdrawal by Subject|12|||
44554204|NCT03287791|79570912|FG001|Overall Study|Withdrawal by Subject|12|||
44554205|NCT03287791|79570913|FG002|Overall Study|Withdrawal by Subject|17|||
44554206|NCT03287791|79570911|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
44554207|NCT03287791|79570912|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
44554208|NCT03287791|79570913|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
44554209|NCT03287791|79570911|FG000|Overall Study|Lost to Follow-up|8|||
44554210|NCT03287791|79570912|FG001|Overall Study|Lost to Follow-up|14|||
44554211|NCT03287791|79570913|FG002|Overall Study|Lost to Follow-up|11|||
44554212|NCT03287791|79570911|FG000|Overall Study|Protocol Violation|7|||
44554213|NCT03287791|79570912|FG001|Overall Study|Protocol Violation|2|||
44554214|NCT03287791|79570913|FG002|Overall Study|Protocol Violation|1|||
44554215|NCT03287791|79570911|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
44554216|NCT03287791|79570912|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
44554217|NCT03287791|79570913|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
44554218|NCT03287791|79570911|FG000|Overall Study|Too much time between 2 visits|0|||
44554219|NCT03287791|79570912|FG001|Overall Study|Too much time between 2 visits|1|||
44554220|NCT03287791|79570913|FG002|Overall Study|Too much time between 2 visits|0|||
44554221|NCT03287791|79570911|FG000|Overall Study|Non-compliance|0|||
44554222|NCT03287791|79570912|FG001|Overall Study|Non-compliance|1|||
44554223|NCT03287791|79570913|FG002|Overall Study|Non-compliance|0|||
44554224|NCT03287791|79570911|FG000|Overall Study|Did not meet inclusion criteria|1|||
44554225|NCT03287791|79570912|FG001|Overall Study|Did not meet inclusion criteria|0|||
44554226|NCT03287791|79570913|FG002|Overall Study|Did not meet inclusion criteria|0|||
44554227|NCT03287635|79570921|FG000|Overall Study|Lost to Follow-up|5|||
44554228|NCT03287635|79570921|FG000|Overall Study|Withdrawal by Subject|1|||
44554229|NCT03287635|79570921|FG000|Overall Study|Physician Decision|1|||
44554230|NCT03287089|79570927|FG000|Overall Study|Lost to Follow-up|0|||
44554231|NCT03287089|79570928|FG001|Overall Study|Lost to Follow-up|2|||
44554232|NCT03287089|79570927|FG000|Overall Study|Physician Decision|0|||
44554233|NCT03287089|79570928|FG001|Overall Study|Physician Decision|2|||
44554234|NCT03287089|79570927|FG000|Overall Study|Withdrawal by Subject|0|||
44554235|NCT03287089|79570928|FG001|Overall Study|Withdrawal by Subject|2|||
44554236|NCT03286543|79570936|FG000|Consented|Screen failure before randomization|2|||
44554237|NCT03286543|79570937|FG001|Consented|Screen failure before randomization|0|||
44554238|NCT03286543|79570938|FG002|Consented|Screen failure before randomization|0|||
44554239|NCT03286543|79570936|FG000|Consented|Screen failure before enrollment|4|||
44554240|NCT03286543|79570937|FG001|Consented|Screen failure before enrollment|0|||
44554241|NCT03286543|79570938|FG002|Consented|Screen failure before enrollment|0|||
44554242|NCT03286543|79570936|FG000|Consented|TKA cancelled after enrollment|1|||
44554243|NCT03286543|79570937|FG001|Consented|TKA cancelled after enrollment|0|||
44554244|NCT03286543|79570938|FG002|Consented|TKA cancelled after enrollment|0|||
44554245|NCT03286543|79570936|FG000|Consented|Withdrawn from study|12|||
44376731|NCT01074944|79381960|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
44376732|NCT01074944|79381961|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
44376733|NCT01074944|79381962|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
44376734|NCT01074944|79381963|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
44554246|NCT03286543|79570937|FG001|Consented|Withdrawn from study|0|||
44554247|NCT03286543|79570938|FG002|Consented|Withdrawn from study|0|||
44554248|NCT03286543|79570936|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
44554249|NCT03286543|79570937|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
44554250|NCT03286543|79570938|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
44554251|NCT03286543|79570936|FG000|Study Enrollment|Withdrawn from study|0|||
44554252|NCT03286543|79570937|FG001|Study Enrollment|Withdrawn from study|6|||
44554253|NCT03286543|79570938|FG002|Study Enrollment|Withdrawn from study|6|||
44554254|NCT03306433|79570944|FG000|Overall Study|Lost to Follow-up|3|||
44554255|NCT03306433|79570944|FG000|Overall Study|Patient did not have teeth extracted|1|||
44554256|NCT03306433|79570944|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
44376735|NCT01074944|79381964|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
44554257|NCT02940691|79570952|FG000|Overall Study|Lost to Follow-up|5|||
44554258|NCT02940691|79570952|FG000|Overall Study|Incarceration|1|||
44554259|NCT03306277|79570990|FG000|Overall Study|Death|1|||
44554260|NCT03306277|79570990|FG000|Overall Study|Adverse Event|1|||
44554261|NCT03306277|79570990|FG000|Overall Study|Withdrawal by Subject|1|||
44554262|NCT03130959|79571004|FG000|Overall Study|Disease progression|19|||
44554263|NCT03130959|79571005|FG001|Overall Study|Disease progression|7|||
44554264|NCT03130959|79571006|FG002|Overall Study|Disease progression|12|||
44554265|NCT03130959|79571007|FG003|Overall Study|Disease progression|7|||
44554266|NCT03130959|79571008|FG004|Overall Study|Disease progression|12|||
44554267|NCT03130959|79571009|FG005|Overall Study|Disease progression|3|||
44554268|NCT03130959|79571010|FG006|Overall Study|Disease progression|6|||
44554269|NCT03130959|79571011|FG007|Overall Study|Disease progression|3|||
44554270|NCT03130959|79571012|FG008|Overall Study|Disease progression|15|||
44554271|NCT03130959|79571013|FG009|Overall Study|Disease progression|8|||
44554272|NCT03130959|79571004|FG000|Overall Study|Study drug toxicity|2|||
44554273|NCT03130959|79571005|FG001|Overall Study|Study drug toxicity|2|||
44554274|NCT03130959|79571006|FG002|Overall Study|Study drug toxicity|1|||
44554275|NCT03130959|79571007|FG003|Overall Study|Study drug toxicity|2|||
44554276|NCT03130959|79571008|FG004|Overall Study|Study drug toxicity|1|||
44554277|NCT03130959|79571009|FG005|Overall Study|Study drug toxicity|1|||
44554278|NCT03130959|79571010|FG006|Overall Study|Study drug toxicity|3|||
44554279|NCT03130959|79571011|FG007|Overall Study|Study drug toxicity|0|||
44554280|NCT03130959|79571012|FG008|Overall Study|Study drug toxicity|3|||
44554281|NCT03130959|79571013|FG009|Overall Study|Study drug toxicity|3|||
44554282|NCT03130959|79571004|FG000|Overall Study|Other reasons|0|||
44554283|NCT03130959|79571005|FG001|Overall Study|Other reasons|0|||
44554284|NCT03130959|79571006|FG002|Overall Study|Other reasons|0|||
44554285|NCT03130959|79571007|FG003|Overall Study|Other reasons|0|||
44554286|NCT03130959|79571008|FG004|Overall Study|Other reasons|0|||
44554287|NCT03130959|79571009|FG005|Overall Study|Other reasons|1|||
44554288|NCT03130959|79571010|FG006|Overall Study|Other reasons|1|||
44554289|NCT03130959|79571011|FG007|Overall Study|Other reasons|0|||
44554290|NCT03130959|79571012|FG008|Overall Study|Other reasons|0|||
44554291|NCT03130959|79571013|FG009|Overall Study|Other reasons|0|||
44496314|NCT00404651|79502361|FG001|Overall Study|Lost to Follow-up|11|||
44496315|NCT00404651|79502362|FG002|Overall Study|Lost to Follow-up|13|||
44496316|NCT00404651|79502363|FG003|Overall Study|Lost to Follow-up|10|||
44496317|NCT00404651|79502360|FG000|Overall Study|Withdrawal by Subject|14|||
44496318|NCT00404651|79502361|FG001|Overall Study|Withdrawal by Subject|12|||
44496319|NCT00404651|79502362|FG002|Overall Study|Withdrawal by Subject|16|||
44496320|NCT00404651|79502363|FG003|Overall Study|Withdrawal by Subject|6|||
44496321|NCT00404495|79502375|FG000|Overall Study|Death|37|||
44496322|NCT00404495|79502376|FG001|Overall Study|Death|11|||
44496323|NCT00404495|79502375|FG000|Overall Study|Lost to Follow-up|5|||
44554292|NCT03130959|79571004|FG000|Overall Study|Subject request to discontinue therapy|0|||
44554293|NCT03130959|79571005|FG001|Overall Study|Subject request to discontinue therapy|0|||
44554294|NCT03130959|79571006|FG002|Overall Study|Subject request to discontinue therapy|1|||
44554295|NCT03130959|79571007|FG003|Overall Study|Subject request to discontinue therapy|1|||
44554296|NCT03130959|79571008|FG004|Overall Study|Subject request to discontinue therapy|0|||
44496324|NCT00404495|79502376|FG001|Overall Study|Lost to Follow-up|0|||
44496325|NCT00404495|79502375|FG000|Overall Study|Other|1|||
44496326|NCT00404495|79502376|FG001|Overall Study|Other|0|||
44496327|NCT00404495|79502375|FG000|Overall Study|Withdrawal by Subject|1|||
44496328|NCT00404495|79502376|FG001|Overall Study|Withdrawal by Subject|0|||
44496329|NCT00409409|79502384|FG000|Overall Study|Adverse Event|7|||
44496330|NCT00409409|79502385|FG001|Overall Study|Adverse Event|2|||
44496331|NCT00409409|79502384|FG000|Overall Study|Withdrawal by Subject|1|||
44496332|NCT00409409|79502385|FG001|Overall Study|Withdrawal by Subject|1|||
44554297|NCT03130959|79571009|FG005|Overall Study|Subject request to discontinue therapy|0|||
44554298|NCT03130959|79571010|FG006|Overall Study|Subject request to discontinue therapy|1|||
44554299|NCT03130959|79571011|FG007|Overall Study|Subject request to discontinue therapy|1|||
44554300|NCT03130959|79571012|FG008|Overall Study|Subject request to discontinue therapy|0|||
44496333|NCT00409409|79502384|FG000|Overall Study|Any other reason not above-mentioned|0|||
44496334|NCT00409409|79502385|FG001|Overall Study|Any other reason not above-mentioned|1|||
44496335|NCT00409331|79502391|FG000|Overall Study|Physician Decision|1|||
44554301|NCT03130959|79571013|FG009|Overall Study|Subject request to discontinue therapy|0|||
44496336|NCT00409175|79502397|FG000|Overall Study|Adverse Event|4|||
44496337|NCT00409175|79502398|FG001|Overall Study|Adverse Event|3|||
44376736|NCT01074944|79381960|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
44376737|NCT01074944|79381961|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
44376738|NCT01074944|79381962|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
44376739|NCT01074944|79381963|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
44376740|NCT01074944|79381964|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
44376741|NCT01074944|79381960|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
44376742|NCT01074944|79381961|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
44376743|NCT01074944|79381962|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
44496338|NCT00409175|79502397|FG000|Overall Study|Withdrawal by Subject|1|||
44496339|NCT00409175|79502398|FG001|Overall Study|Withdrawal by Subject|2|||
44496340|NCT00409175|79502397|FG000|Overall Study|Negative genotype|0|||
44496341|NCT00409175|79502398|FG001|Overall Study|Negative genotype|1|||
44496342|NCT00409175|79502397|FG000|Overall Study|Liver transplantation|13|||
44496343|NCT00409175|79502398|FG001|Overall Study|Liver transplantation|13|||
44496344|NCT00408629|79502406|FG000|Overall Study|Adverse Event|13|||
44496345|NCT00408629|79502407|FG001|Overall Study|Adverse Event|27|||
44496346|NCT00408629|79502406|FG000|Overall Study|Withdrawal by Subject|8|||
44496347|NCT00408629|79502407|FG001|Overall Study|Withdrawal by Subject|4|||
44496348|NCT00408629|79502406|FG000|Overall Study|Lost to Follow-up|1|||
44496349|NCT00408629|79502407|FG001|Overall Study|Lost to Follow-up|1|||
44496350|NCT00408629|79502406|FG000|Overall Study|Lack of Efficacy|63|||
44496351|NCT00408629|79502407|FG001|Overall Study|Lack of Efficacy|73|||
44496352|NCT00408629|79502406|FG000|Overall Study|Protocol Violation|1|||
44496353|NCT00408629|79502407|FG001|Overall Study|Protocol Violation|5|||
44496354|NCT00408629|79502406|FG000|Overall Study|Miscellaneous|11|||
44496355|NCT00408629|79502407|FG001|Overall Study|Miscellaneous|15|||
44496356|NCT00408317|79502414|FG000|First Intervention Period|Adverse Event|0|||
44496357|NCT00408317|79502415|FG001|First Intervention Period|Adverse Event|1|||
44496358|NCT00408317|79502414|FG000|Second Intervention Period|Adverse Event|2|||
44496359|NCT00408317|79502415|FG001|Second Intervention Period|Adverse Event|0|||
44496360|NCT00408317|79502414|FG000|Second Intervention Period|Protocol Violation|0|||
44496361|NCT00408317|79502415|FG001|Second Intervention Period|Protocol Violation|1|||
44496362|NCT00408317|79502414|FG000|Second Intervention Period|Withdrawal of consent|0|||
44496363|NCT00408317|79502415|FG001|Second Intervention Period|Withdrawal of consent|1|||
44496364|NCT00112502|79502429|FG000|Overall Study|Withdrawal by Subject|0|||
44496365|NCT00112502|79502430|FG001|Overall Study|Withdrawal by Subject|1|||
44496366|NCT00112502|79502431|FG002|Overall Study|Withdrawal by Subject|1|||
44496367|NCT00112502|79502432|FG003|Overall Study|Withdrawal by Subject|4|||
44496368|NCT00112502|79502433|FG004|Overall Study|Withdrawal by Subject|2|||
44496369|NCT00112502|79502434|FG005|Overall Study|Withdrawal by Subject|5|||
44496370|NCT00112502|79502435|FG006|Overall Study|Withdrawal by Subject|3|||
44496371|NCT00112502|79502436|FG007|Overall Study|Withdrawal by Subject|7|||
44496372|NCT03822182|79502467|FG000|Overall Study|Protocol Violation|0|||
44496373|NCT03822182|79502468|FG001|Overall Study|Protocol Violation|1|||
44496374|NCT03822182|79502469|FG002|Overall Study|Protocol Violation|1|||
44496375|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
44496376|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
44496377|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
44496378|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
44496379|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
44496380|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
44496381|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
44496382|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
44496383|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
44496384|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
44496385|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
44554302|NCT03130959|79571004|FG000|Overall Study|Not reported|0|||
44496386|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
44496387|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
44231506|NCT02004275|79044718|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
44231507|NCT02004275|79044719|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
44231508|NCT01559129|79044745|FG000|Treatment Phase|Adverse Event|0|||
44231509|NCT01559129|79044746|FG001|Treatment Phase|Adverse Event|2|||
44554303|NCT03130959|79571005|FG001|Overall Study|Not reported|0|||
44554304|NCT03130959|79571006|FG002|Overall Study|Not reported|0|||
44554305|NCT03130959|79571007|FG003|Overall Study|Not reported|1|||
44554306|NCT03130959|79571008|FG004|Overall Study|Not reported|0|||
44554307|NCT03130959|79571009|FG005|Overall Study|Not reported|1|||
44554308|NCT03130959|79571010|FG006|Overall Study|Not reported|0|||
44554309|NCT03130959|79571011|FG007|Overall Study|Not reported|0|||
44554310|NCT03130959|79571012|FG008|Overall Study|Not reported|0|||
44554311|NCT03130959|79571013|FG009|Overall Study|Not reported|1|||
44554312|NCT03130959|79571004|FG000|Overall Study|Adverse Event unrelated to drug|0|||
44554313|NCT03130959|79571005|FG001|Overall Study|Adverse Event unrelated to drug|0|||
44554314|NCT03130959|79571006|FG002|Overall Study|Adverse Event unrelated to drug|1|||
44554315|NCT03130959|79571007|FG003|Overall Study|Adverse Event unrelated to drug|1|||
44554316|NCT03130959|79571008|FG004|Overall Study|Adverse Event unrelated to drug|1|||
44554317|NCT03130959|79571009|FG005|Overall Study|Adverse Event unrelated to drug|0|||
44554318|NCT03130959|79571010|FG006|Overall Study|Adverse Event unrelated to drug|1|||
44554319|NCT03130959|79571011|FG007|Overall Study|Adverse Event unrelated to drug|0|||
44554320|NCT03130959|79571012|FG008|Overall Study|Adverse Event unrelated to drug|1|||
44554321|NCT03130959|79571013|FG009|Overall Study|Adverse Event unrelated to drug|1|||
44554322|NCT03130959|79571004|FG000|Overall Study|Participant withdrew consent|0|||
44554323|NCT03130959|79571005|FG001|Overall Study|Participant withdrew consent|1|||
44554324|NCT03130959|79571006|FG002|Overall Study|Participant withdrew consent|0|||
44554325|NCT03130959|79571007|FG003|Overall Study|Participant withdrew consent|2|||
44554326|NCT03130959|79571008|FG004|Overall Study|Participant withdrew consent|1|||
44554327|NCT03130959|79571009|FG005|Overall Study|Participant withdrew consent|0|||
44554328|NCT03130959|79571010|FG006|Overall Study|Participant withdrew consent|0|||
44554329|NCT03130959|79571011|FG007|Overall Study|Participant withdrew consent|0|||
44554330|NCT03130959|79571012|FG008|Overall Study|Participant withdrew consent|0|||
44554331|NCT03130959|79571013|FG009|Overall Study|Participant withdrew consent|2|||
44554332|NCT03130959|79571004|FG000|Overall Study|Administrative reason by sponsor|1|||
44554333|NCT03130959|79571005|FG001|Overall Study|Administrative reason by sponsor|0|||
44554334|NCT03130959|79571006|FG002|Overall Study|Administrative reason by sponsor|1|||
44554335|NCT03130959|79571007|FG003|Overall Study|Administrative reason by sponsor|0|||
44554336|NCT03130959|79571008|FG004|Overall Study|Administrative reason by sponsor|0|||
44554337|NCT03130959|79571009|FG005|Overall Study|Administrative reason by sponsor|0|||
44554338|NCT03130959|79571010|FG006|Overall Study|Administrative reason by sponsor|0|||
44554339|NCT03130959|79571011|FG007|Overall Study|Administrative reason by sponsor|0|||
44554340|NCT03130959|79571012|FG008|Overall Study|Administrative reason by sponsor|0|||
44554341|NCT03130959|79571013|FG009|Overall Study|Administrative reason by sponsor|0|||
44554342|NCT03130959|79571004|FG000|Overall Study|Lost to Follow-up|1|||
44554343|NCT03130959|79571005|FG001|Overall Study|Lost to Follow-up|0|||
44554344|NCT03130959|79571006|FG002|Overall Study|Lost to Follow-up|0|||
44554345|NCT03130959|79571007|FG003|Overall Study|Lost to Follow-up|0|||
44554346|NCT03130959|79571008|FG004|Overall Study|Lost to Follow-up|0|||
44554347|NCT03130959|79571009|FG005|Overall Study|Lost to Follow-up|0|||
44554348|NCT03130959|79571010|FG006|Overall Study|Lost to Follow-up|0|||
44376744|NCT01074944|79381963|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
44376745|NCT01074944|79381964|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
44496388|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
44496389|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
44496390|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
44496391|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
44496392|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
44496393|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
44496394|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
44496395|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
44496396|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
44496397|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
44554349|NCT03130959|79571011|FG007|Overall Study|Lost to Follow-up|0|||
44554350|NCT03130959|79571012|FG008|Overall Study|Lost to Follow-up|0|||
44554351|NCT03130959|79571013|FG009|Overall Study|Lost to Follow-up|0|||
44554352|NCT03124407|79571052|FG000|Overall Study|Lost to Follow-up|1|||
44554353|NCT03124407|79571053|FG001|Overall Study|Lost to Follow-up|0|||
44554354|NCT03124407|79571054|FG002|Overall Study|Lost to Follow-up|0|||
44554355|NCT03124407|79571055|FG003|Overall Study|Lost to Follow-up|0|||
44554356|NCT03124407|79571052|FG000|Overall Study|Adverse Event|0|||
44554357|NCT03124407|79571053|FG001|Overall Study|Adverse Event|0|||
44554358|NCT03124407|79571054|FG002|Overall Study|Adverse Event|1|||
44554359|NCT03124407|79571055|FG003|Overall Study|Adverse Event|0|||
44554360|NCT02929407|79571069|FG000|Overall Study|Adverse Event|1|||
44554361|NCT03123939|79571073|FG000|Overall Study|Lack of Efficacy|6|||
44554362|NCT03123939|79571073|FG000|Overall Study|Death|5|||
44554363|NCT03123939|79571073|FG000|Overall Study|Physician Decision|2|||
44554364|NCT03123939|79571073|FG000|Overall Study|Subject/guardian decision|2|||
44554365|NCT03123939|79571073|FG000|Overall Study|Lost to Follow-up|1|||
44554366|NCT03123939|79571073|FG000|Overall Study|New therapy for study indication|1|||
44554367|NCT03123939|79571073|FG000|Overall Study|Protocol deviation|1|||
44554368|NCT03123939|79571073|FG000|Overall Study|Progressive disease|18|||
44554369|NCT03123939|79571073|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
44554370|NCT03123939|79571073|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
44554371|NCT03123861|79571088|FG000|Overall Study|Protocol Violation|1|||
44554372|NCT03123861|79571089|FG001|Overall Study|Protocol Violation|1|||
44554373|NCT03123861|79571088|FG000|Overall Study|Withdrawal by Subject|2|||
44554374|NCT03123861|79571089|FG001|Overall Study|Withdrawal by Subject|2|||
44554375|NCT03123471|79571097|FG000|Placebo-controlled Phase|Adverse Event|3|||
44554376|NCT03123471|79571098|FG001|Placebo-controlled Phase|Adverse Event|8|||
44554377|NCT03123471|79571097|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
44554378|NCT03123471|79571098|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
44554379|NCT03123471|79571097|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
44554380|NCT03123471|79571098|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
44231510|NCT01559129|79044745|FG000|Treatment Phase|Progressive Disease|1|||
44231511|NCT01559129|79044746|FG001|Treatment Phase|Progressive Disease|1|||
44231512|NCT01559129|79044745|FG000|Treatment Phase|Lack of Efficacy|0|||
44231513|NCT01559129|79044746|FG001|Treatment Phase|Lack of Efficacy|1|||
44231514|NCT01559129|79044745|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
44231515|NCT01559129|79044746|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
44231516|NCT01559129|79044745|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
44231517|NCT01559129|79044746|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
44231518|NCT01559129|79044745|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
44231519|NCT01559129|79044746|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
44231520|NCT01559129|79044745|FG000|Open-label Extension Period|Adverse Event|1|||
44231521|NCT01559129|79044746|FG001|Open-label Extension Period|Adverse Event|0|||
44231522|NCT01559129|79044745|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
44231523|NCT01559129|79044746|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
44231524|NCT00355238|79044771|FG000|Overall Study|Adverse event unrelated to study drug|2|||
44231525|NCT00355238|79044772|FG001|Overall Study|Adverse event unrelated to study drug|2|||
44231526|NCT00355238|79044773|FG002|Overall Study|Adverse event unrelated to study drug|0|||
44231527|NCT00355238|79044774|FG003|Overall Study|Adverse event unrelated to study drug|1|||
44231528|NCT00355238|79044771|FG000|Overall Study|Death|1|||
44231529|NCT00355238|79044772|FG001|Overall Study|Death|0|||
44231530|NCT00355238|79044773|FG002|Overall Study|Death|0|||
44231531|NCT00355238|79044774|FG003|Overall Study|Death|0|||
44231532|NCT00355238|79044771|FG000|Overall Study|Disease progression|37|||
44231533|NCT00355238|79044772|FG001|Overall Study|Disease progression|36|||
44231534|NCT00355238|79044773|FG002|Overall Study|Disease progression|16|||
44231535|NCT00355238|79044774|FG003|Overall Study|Disease progression|11|||
44231536|NCT00355238|79044771|FG000|Overall Study|Study drug toxicity|11|||
44231537|NCT00355238|79044772|FG001|Overall Study|Study drug toxicity|7|||
44231538|NCT00355238|79044773|FG002|Overall Study|Study drug toxicity|5|||
44554381|NCT03123471|79571097|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
44554382|NCT03123471|79571098|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
44554383|NCT03123471|79571097|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
44554384|NCT03123471|79571098|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
44231539|NCT00355238|79044774|FG003|Overall Study|Study drug toxicity|2|||
44231540|NCT00355238|79044771|FG000|Overall Study|Participant withdrew consent|3|||
44231541|NCT00355238|79044772|FG001|Overall Study|Participant withdrew consent|1|||
44231542|NCT00355238|79044773|FG002|Overall Study|Participant withdrew consent|0|||
44231543|NCT00355238|79044774|FG003|Overall Study|Participant withdrew consent|0|||
44231544|NCT00355238|79044771|FG000|Overall Study|Participant request to discontinue study treatment|1|||
44231545|NCT00355238|79044772|FG001|Overall Study|Participant request to discontinue study treatment|0|||
44231546|NCT00355238|79044773|FG002|Overall Study|Participant request to discontinue study treatment|1|||
44496398|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
44496399|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
44496400|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
44496401|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
44496402|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
44496403|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
44496404|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
44496405|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44496406|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
44496407|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
44496408|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
44496409|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44231547|NCT00355238|79044774|FG003|Overall Study|Participant request to discontinue study treatment|0|||
44231548|NCT00303303|79044789|FG000|Overall Study|Withdrawal by Subject|0|||
44231549|NCT00303303|79044790|FG001|Overall Study|Withdrawal by Subject|0|||
44554385|NCT03123471|79571097|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
44554386|NCT03123471|79571098|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
44554387|NCT03123471|79571097|FG000|Placebo-controlled Phase|Miscellaneous|0|||
44554388|NCT03123471|79571098|FG001|Placebo-controlled Phase|Miscellaneous|1|||
44554389|NCT03123471|79571097|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
44554390|NCT03123471|79571098|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
44554391|NCT03123471|79571097|FG000|Apremilast Extension Phase|Adverse Event|1|||
44554392|NCT03123471|79571098|FG001|Apremilast Extension Phase|Adverse Event|5|||
44554393|NCT03123471|79571097|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
44554394|NCT03123471|79571098|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
44554395|NCT03123471|79571097|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
44554396|NCT03123471|79571098|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
44554397|NCT02661178|79571125|FG000|Part 1|Protocol Violation|1|||
44554398|NCT02661178|79571126|FG001|Part 1|Protocol Violation|0|||
44554399|NCT02661178|79571127|FG002|Part 1|Protocol Violation|0|||
44554400|NCT02661178|79571128|FG003|Part 1|Protocol Violation|0|||
44554401|NCT02661178|79571129|FG004|Part 1|Protocol Violation|0|||
44554402|NCT02661178|79571130|FG005|Part 1|Protocol Violation|0|||
44554403|NCT02661178|79571131|FG006|Part 1|Protocol Violation|0|||
44554404|NCT02661178|79571132|FG007|Part 1|Protocol Violation|0|||
44554405|NCT02661178|79571133|FG008|Part 1|Protocol Violation|0|||
44554406|NCT02661178|79571134|FG009|Part 1|Protocol Violation|0|||
44554407|NCT02661178|79571135|FG010|Part 1|Protocol Violation|0|||
44554408|NCT02661178|79571136|FG011|Part 1|Protocol Violation|0|||
44554409|NCT02661178|79571137|FG012|Part 1|Protocol Violation|0|||
44554410|NCT02661178|79571138|FG013|Part 1|Protocol Violation|0|||
44554411|NCT02661178|79571139|FG014|Part 1|Protocol Violation|0|||
44554412|NCT02660944|79571191|FG000|Overall Study|Adverse Event|3|||
44554413|NCT02660944|79571192|FG001|Overall Study|Adverse Event|4|||
44554414|NCT02660944|79571191|FG000|Overall Study|Physician Decision|3|||
44554415|NCT02660944|79571192|FG001|Overall Study|Physician Decision|1|||
44554416|NCT02660944|79571191|FG000|Overall Study|Withdrawal by Subject|5|||
44554417|NCT02660944|79571192|FG001|Overall Study|Withdrawal by Subject|3|||
44554418|NCT02660944|79571191|FG000|Overall Study|Lost to Follow-up|4|||
44554419|NCT02660944|79571192|FG001|Overall Study|Lost to Follow-up|1|||
44554420|NCT02660944|79571191|FG000|Overall Study|Subject schedule|0|||
44554421|NCT02660944|79571192|FG001|Overall Study|Subject schedule|1|||
44554422|NCT02660944|79571191|FG000|Overall Study|Exclusion criteria met|2|||
44554423|NCT02660944|79571192|FG001|Overall Study|Exclusion criteria met|0|||
44554424|NCT02975336|79571202|FG000|DBPC (52 Weeks)|Adverse Event|16|||
44554425|NCT02975336|79571203|FG001|DBPC (52 Weeks)|Adverse Event|17|||
44554426|NCT02975336|79571204|FG002|DBPC (52 Weeks)|Adverse Event|13|||
44554427|NCT02975336|79571205|FG003|DBPC (52 Weeks)|Adverse Event|18|||
44554428|NCT02975336|79571206|FG004|DBPC (52 Weeks)|Adverse Event|0|||
44554429|NCT02975336|79571207|FG005|DBPC (52 Weeks)|Adverse Event|0|||
44554430|NCT02975336|79571208|FG006|DBPC (52 Weeks)|Adverse Event|0|||
44554431|NCT02975336|79571209|FG007|DBPC (52 Weeks)|Adverse Event|0|||
44554432|NCT02975336|79571202|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
44554433|NCT02975336|79571203|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
44231550|NCT00303303|79044791|FG002|Overall Study|Withdrawal by Subject|1|||
44231551|NCT00988533|79044836|FG000|Overall Study|Lost to Follow-up|3|||
44231552|NCT03633396|79044868|FG000|Overall Study|Withdrawal by Subject|4|||
44231553|NCT03633396|79044869|FG001|Overall Study|Withdrawal by Subject|4|||
44231554|NCT03633396|79044868|FG000|Overall Study|Adverse Event|1|||
44554434|NCT02975336|79571204|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
44554435|NCT02975336|79571205|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
44554436|NCT02975336|79571206|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
44554437|NCT02975336|79571207|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
44554438|NCT02975336|79571208|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
44554439|NCT02975336|79571209|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
44554440|NCT02975336|79571202|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
44231555|NCT03633396|79044869|FG001|Overall Study|Adverse Event|1|||
44554441|NCT02975336|79571203|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
44554442|NCT02975336|79571204|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
44554443|NCT02975336|79571205|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
44554444|NCT02975336|79571206|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
44554445|NCT02975336|79571207|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
44554446|NCT02975336|79571208|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
44554447|NCT02975336|79571209|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
44231556|NCT03633396|79044868|FG000|Overall Study|Lack of Efficacy|1|||
44231557|NCT03633396|79044869|FG001|Overall Study|Lack of Efficacy|0|||
44231558|NCT03633396|79044868|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
44231559|NCT03633396|79044869|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
44231560|NCT00988065|79044882|FG000|Overall Study|Adverse Event|4|||
44231561|NCT00988065|79044883|FG001|Overall Study|Adverse Event|10|||
44231562|NCT00988065|79044884|FG002|Overall Study|Adverse Event|2|||
44231563|NCT00988065|79044882|FG000|Overall Study|Lost to Follow-up|1|||
44231564|NCT00988065|79044883|FG001|Overall Study|Lost to Follow-up|2|||
44231565|NCT00988065|79044884|FG002|Overall Study|Lost to Follow-up|2|||
44231566|NCT00988065|79044882|FG000|Overall Study|Subject withdrew consent|3|||
44231567|NCT00988065|79044883|FG001|Overall Study|Subject withdrew consent|5|||
44231568|NCT00988065|79044884|FG002|Overall Study|Subject withdrew consent|2|||
44231569|NCT00988065|79044882|FG000|Overall Study|Noncompliance with protocol|5|||
44231570|NCT00988065|79044883|FG001|Overall Study|Noncompliance with protocol|6|||
44231571|NCT00988065|79044884|FG002|Overall Study|Noncompliance with protocol|9|||
44231572|NCT00987831|79044908|FG000|Overall Study|Never flared in 12 months|1|||
44231573|NCT00987831|79044909|FG001|Overall Study|Never flared in 12 months|0|||
44231574|NCT00987831|79044910|FG002|Overall Study|Never flared in 12 months|0|||
44231575|NCT00987831|79044908|FG000|Overall Study|Lost to Follow-up|0|||
44231576|NCT00987831|79044909|FG001|Overall Study|Lost to Follow-up|3|||
44231577|NCT00987831|79044910|FG002|Overall Study|Lost to Follow-up|0|||
44376746|NCT01074944|79381960|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
44376747|NCT01074944|79381961|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
44376748|NCT01074944|79381962|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
44496410|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
44496411|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
44496412|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
44496413|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
44496414|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
44496415|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
44496416|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
44496417|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
44496418|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
44496419|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
44496420|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
44496421|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
44496422|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
44496423|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
44496424|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
44496425|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
44496426|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
44496427|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
44496428|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
44496429|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
44496430|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
44496431|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
44496432|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
44496433|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
44496434|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
44496435|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
44496436|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
44496437|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
44514898|NCT03077698|79520767|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
44554448|NCT02975336|79571202|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
44231578|NCT00986973|79044941|FG000|Overall Study|Withdrawn by study team|1|||
44231579|NCT00986427|79044948|FG000|Overall Study|Lost to Follow-up|2|||
44554449|NCT02975336|79571203|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
44554450|NCT02975336|79571204|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
44554451|NCT02975336|79571205|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
44554452|NCT02975336|79571206|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
44554453|NCT02975336|79571207|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
44554454|NCT02975336|79571208|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
44554455|NCT02975336|79571209|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
44554456|NCT02975336|79571202|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
44554457|NCT02975336|79571203|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
44554458|NCT02975336|79571204|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
44554459|NCT02975336|79571205|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
44554460|NCT02975336|79571206|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
44554461|NCT02975336|79571207|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
44554462|NCT02975336|79571208|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
44554463|NCT02975336|79571209|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
44554464|NCT02975336|79571202|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
44554465|NCT02975336|79571203|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
44554466|NCT02975336|79571204|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
44554467|NCT02975336|79571205|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
44554468|NCT02975336|79571206|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
44554469|NCT02975336|79571207|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
44554470|NCT02975336|79571208|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
44554471|NCT02975336|79571209|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
44554472|NCT02975336|79571202|FG000|LTE (104 Weeks)|Adverse Event|0|||
44554473|NCT02975336|79571203|FG001|LTE (104 Weeks)|Adverse Event|0|||
44554474|NCT02975336|79571204|FG002|LTE (104 Weeks)|Adverse Event|0|||
44554475|NCT02975336|79571205|FG003|LTE (104 Weeks)|Adverse Event|0|||
44554476|NCT02975336|79571206|FG004|LTE (104 Weeks)|Adverse Event|7|||
44554477|NCT02975336|79571207|FG005|LTE (104 Weeks)|Adverse Event|4|||
44496438|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
44496439|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
44496440|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
44496441|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
44496442|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
44496443|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
44496444|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
44496445|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
44496446|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
44496447|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
44496448|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
44496449|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
44496450|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
44496451|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
44496452|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
44496453|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
44496454|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
44496455|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
44554478|NCT02975336|79571208|FG006|LTE (104 Weeks)|Adverse Event|2|||
44554479|NCT02975336|79571209|FG007|LTE (104 Weeks)|Adverse Event|0|||
44554480|NCT02975336|79571202|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
44554481|NCT02975336|79571203|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
44554482|NCT02975336|79571204|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
44554483|NCT02975336|79571205|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
44554484|NCT02975336|79571206|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
44554485|NCT02975336|79571207|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
44554486|NCT02975336|79571208|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
44554487|NCT02975336|79571209|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
44554488|NCT02975336|79571202|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
44554489|NCT02975336|79571203|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
44554490|NCT02975336|79571204|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
44554491|NCT02975336|79571205|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
44554492|NCT02975336|79571206|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
44554493|NCT02975336|79571207|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
44554494|NCT02975336|79571208|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
44554495|NCT02975336|79571209|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
44554496|NCT02975336|79571202|FG000|LTE (104 Weeks)|Other|0|||
44554497|NCT02975336|79571203|FG001|LTE (104 Weeks)|Other|0|||
44554498|NCT02975336|79571204|FG002|LTE (104 Weeks)|Other|0|||
44554499|NCT02975336|79571205|FG003|LTE (104 Weeks)|Other|0|||
44554500|NCT02975336|79571206|FG004|LTE (104 Weeks)|Other|55|||
44554501|NCT02975336|79571207|FG005|LTE (104 Weeks)|Other|63|||
44554502|NCT02975336|79571208|FG006|LTE (104 Weeks)|Other|76|||
44554503|NCT02975336|79571209|FG007|LTE (104 Weeks)|Other|72|||
44554504|NCT03124563|79571225|FG000|Overall Study|Lost to Follow-up|1|||
44554505|NCT03124563|79571226|FG001|Overall Study|Lost to Follow-up|1|||
44554506|NCT03124563|79571225|FG000|Overall Study|Withdrawal by Subject|1|||
44554507|NCT03124563|79571226|FG001|Overall Study|Withdrawal by Subject|1|||
44554508|NCT03079869|79571234|FG000|Overall Study|Adverse Event|6|||
44554509|NCT03079869|79571235|FG001|Overall Study|Adverse Event|8|||
44554510|NCT03079869|79571234|FG000|Overall Study|Withdrawal by Subject|4|||
44554511|NCT03079869|79571235|FG001|Overall Study|Withdrawal by Subject|1|||
44554512|NCT03079869|79571234|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
44554513|NCT03079869|79571235|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
44554514|NCT03085914|79571248|FG000|Overall Study|Death|6|||
44554515|NCT03085914|79571249|FG001|Overall Study|Death|6|||
44554516|NCT03085914|79571250|FG002|Overall Study|Death|4|||
44554517|NCT03085914|79571251|FG003|Overall Study|Death|1|||
44554518|NCT03085914|79571252|FG004|Overall Study|Death|5|||
44554519|NCT03085914|79571253|FG005|Overall Study|Death|2|||
44554520|NCT03085914|79571254|FG006|Overall Study|Death|2|||
44554521|NCT03085914|79571248|FG000|Overall Study|Withdrawal by Subject|1|||
44554522|NCT03085914|79571249|FG001|Overall Study|Withdrawal by Subject|1|||
44554523|NCT03085914|79571250|FG002|Overall Study|Withdrawal by Subject|2|||
44554524|NCT03085914|79571251|FG003|Overall Study|Withdrawal by Subject|2|||
44554525|NCT03085914|79571252|FG004|Overall Study|Withdrawal by Subject|2|||
44554526|NCT03085914|79571253|FG005|Overall Study|Withdrawal by Subject|0|||
44554527|NCT03085914|79571254|FG006|Overall Study|Withdrawal by Subject|1|||
44554528|NCT03085914|79571248|FG000|Overall Study|Lost to Follow-up|0|||
44554529|NCT03085914|79571249|FG001|Overall Study|Lost to Follow-up|0|||
44554530|NCT03085914|79571250|FG002|Overall Study|Lost to Follow-up|1|||
44554531|NCT03085914|79571251|FG003|Overall Study|Lost to Follow-up|0|||
44554532|NCT03085914|79571252|FG004|Overall Study|Lost to Follow-up|0|||
44554533|NCT03085914|79571253|FG005|Overall Study|Lost to Follow-up|1|||
44554534|NCT03085914|79571254|FG006|Overall Study|Lost to Follow-up|1|||
44554535|NCT03085914|79571248|FG000|Overall Study|Reason was not specified,|2|||
44554536|NCT03085914|79571249|FG001|Overall Study|Reason was not specified,|2|||
44554537|NCT03085914|79571250|FG002|Overall Study|Reason was not specified,|2|||
44554538|NCT03085914|79571251|FG003|Overall Study|Reason was not specified,|3|||
44554539|NCT03085914|79571252|FG004|Overall Study|Reason was not specified,|3|||
44554540|NCT03085914|79571253|FG005|Overall Study|Reason was not specified,|3|||
44554541|NCT03085914|79571254|FG006|Overall Study|Reason was not specified,|6|||
44554542|NCT03085914|79571248|FG000|Overall Study|Progressive Disease|0|||
44554543|NCT03085914|79571249|FG001|Overall Study|Progressive Disease|0|||
44554544|NCT03085914|79571250|FG002|Overall Study|Progressive Disease|2|||
44554545|NCT03085914|79571251|FG003|Overall Study|Progressive Disease|2|||
44554546|NCT03085914|79571252|FG004|Overall Study|Progressive Disease|1|||
44554547|NCT03085914|79571253|FG005|Overall Study|Progressive Disease|1|||
44554548|NCT03085914|79571254|FG006|Overall Study|Progressive Disease|1|||
44554549|NCT03085914|79571248|FG000|Overall Study|Study Terminated by the Sponsor|0|||
44554550|NCT03085914|79571249|FG001|Overall Study|Study Terminated by the Sponsor|0|||
44554551|NCT03085914|79571250|FG002|Overall Study|Study Terminated by the Sponsor|0|||
44554552|NCT03085914|79571251|FG003|Overall Study|Study Terminated by the Sponsor|1|||
44554553|NCT03085914|79571252|FG004|Overall Study|Study Terminated by the Sponsor|2|||
44554554|NCT03085914|79571253|FG005|Overall Study|Study Terminated by the Sponsor|1|||
44554555|NCT03085914|79571254|FG006|Overall Study|Study Terminated by the Sponsor|0|||
44554556|NCT03078582|79571282|FG000|Overall Study|Adverse Event|0|||
44554557|NCT03078582|79571283|FG001|Overall Study|Adverse Event|8|||
44554558|NCT03077724|79571291|FG000|Overall Study|Lost to Follow-up|5|||
44554559|NCT03077724|79571292|FG001|Overall Study|Lost to Follow-up|1|||
44554560|NCT03077724|79571291|FG000|Overall Study|Withdrawal by Subject|3|||
44554561|NCT03077724|79571292|FG001|Overall Study|Withdrawal by Subject|1|||
44554562|NCT00979212|79571300|FG000|Overall Study|Protocol Violation|1|||
44554563|NCT00979212|79571301|FG001|Overall Study|Protocol Violation|8|||
44554564|NCT00979212|79571300|FG000|Overall Study|No protocol therapy received|1|||
44554565|NCT00979212|79571301|FG001|Overall Study|No protocol therapy received|0|||
44554566|NCT03080454|79571307|FG000|Baseline|Adverse Event|2|||
44554567|NCT03080454|79571307|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
44554568|NCT03080454|79571307|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
44554569|NCT02981342|79571331|FG000|Overall Study|Adverse Event|0|||
44554570|NCT02981342|79571332|FG001|Overall Study|Adverse Event|0|||
44554571|NCT02981342|79571333|FG002|Overall Study|Adverse Event|0|||
44554572|NCT02981342|79571334|FG003|Overall Study|Adverse Event|1|||
44554573|NCT02981342|79571331|FG000|Overall Study|Death|0|||
44554574|NCT02981342|79571332|FG001|Overall Study|Death|9|||
44554575|NCT02981342|79571333|FG002|Overall Study|Death|9|||
44554576|NCT02981342|79571334|FG003|Overall Study|Death|4|||
44554577|NCT02981342|79571331|FG000|Overall Study|Withdrawal by Subject|0|||
44554578|NCT02981342|79571332|FG001|Overall Study|Withdrawal by Subject|0|||
44554579|NCT02981342|79571333|FG002|Overall Study|Withdrawal by Subject|3|||
44554580|NCT02981342|79571334|FG003|Overall Study|Withdrawal by Subject|1|||
44554581|NCT02981342|79571331|FG000|Overall Study|Study closed by sponsor|0|||
44554582|NCT02981342|79571332|FG001|Overall Study|Study closed by sponsor|0|||
44554583|NCT02981342|79571333|FG002|Overall Study|Study closed by sponsor|1|||
44554584|NCT02981342|79571334|FG003|Overall Study|Study closed by sponsor|1|||
44554585|NCT02981342|79571331|FG000|Overall Study|Randomized, Never Treated|0|||
44554586|NCT02981342|79571332|FG001|Overall Study|Randomized, Never Treated|1|||
44554587|NCT02981342|79571333|FG002|Overall Study|Randomized, Never Treated|0|||
44231580|NCT00986427|79044949|FG001|Overall Study|Lost to Follow-up|0|||
44231581|NCT00986427|79044948|FG000|Overall Study|Lack of Efficacy|1|||
44231582|NCT00986427|79044949|FG001|Overall Study|Lack of Efficacy|0|||
44231583|NCT00986427|79044948|FG000|Overall Study|Withdrawal by Subject|1|||
44231584|NCT00986427|79044949|FG001|Overall Study|Withdrawal by Subject|0|||
44496456|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
44496457|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
44496458|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
44496459|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
44496460|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
44496461|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
44496462|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
44496463|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
44496464|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
44496465|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
44496466|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
44496467|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
44496468|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
44496469|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
44496470|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
44496471|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
44496472|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
44496473|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
44496474|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
44496475|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
44496476|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
44496477|NCT00111800|79502484|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
44496478|NCT00111800|79502485|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
44496479|NCT00111800|79502486|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
44496480|NCT00111800|79502487|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
44496481|NCT00111800|79502488|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
44496482|NCT00111800|79502489|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
44496483|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
44496484|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
44496485|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
44554588|NCT02981342|79571334|FG003|Overall Study|Randomized, Never Treated|7|||
44554589|NCT02981342|79571331|FG000|Overall Study|Lost to Follow-up|0|||
44554590|NCT02981342|79571332|FG001|Overall Study|Lost to Follow-up|1|||
44554591|NCT02981342|79571333|FG002|Overall Study|Lost to Follow-up|0|||
44554592|NCT02981342|79571334|FG003|Overall Study|Lost to Follow-up|0|||
44231585|NCT00986349|79044959|FG000|Overall Study|Unsuccessful implant procedure|3|||
44554593|NCT02794246|79571346|FG000|Overall Study|Withdrawal by Subject|2|||
44554594|NCT02794246|79571346|FG000|Overall Study|Physician Decision|4|||
44554595|NCT03428100|79571354|FG000|Overall Study|Adverse Event|1|||
44554596|NCT03428100|79571355|FG001|Overall Study|Adverse Event|0|||
44554597|NCT03428100|79571356|FG002|Overall Study|Adverse Event|3|||
44554598|NCT03428100|79571357|FG003|Overall Study|Adverse Event|1|||
44554599|NCT03428100|79571354|FG000|Overall Study|Lack of Efficacy|16|||
44554600|NCT03428100|79571355|FG001|Overall Study|Lack of Efficacy|10|||
44554601|NCT03428100|79571356|FG002|Overall Study|Lack of Efficacy|7|||
44554602|NCT03428100|79571357|FG003|Overall Study|Lack of Efficacy|6|||
44554603|NCT03428100|79571354|FG000|Overall Study|Protocol Deviation|0|||
44554604|NCT03428100|79571355|FG001|Overall Study|Protocol Deviation|2|||
44554605|NCT03428100|79571356|FG002|Overall Study|Protocol Deviation|2|||
44554606|NCT03428100|79571357|FG003|Overall Study|Protocol Deviation|0|||
44554607|NCT03428100|79571354|FG000|Overall Study|Withdrawal by Subject|4|||
44554608|NCT03428100|79571355|FG001|Overall Study|Withdrawal by Subject|0|||
44554609|NCT03428100|79571356|FG002|Overall Study|Withdrawal by Subject|0|||
44554610|NCT03428100|79571357|FG003|Overall Study|Withdrawal by Subject|0|||
44554611|NCT03428100|79571354|FG000|Overall Study|Physician Decision|0|||
44554612|NCT03428100|79571355|FG001|Overall Study|Physician Decision|1|||
44554613|NCT03428100|79571356|FG002|Overall Study|Physician Decision|0|||
44554614|NCT03428100|79571357|FG003|Overall Study|Physician Decision|0|||
44554615|NCT02980874|79571379|FG000|Overall Study|Adverse Event|2|||
44554616|NCT02980874|79571380|FG001|Overall Study|Adverse Event|7|||
44554617|NCT02980874|79571379|FG000|Overall Study|Withdrawal by Subject|7|||
44554618|NCT02980874|79571380|FG001|Overall Study|Withdrawal by Subject|2|||
44554619|NCT02980874|79571379|FG000|Overall Study|Lost to Follow-up|5|||
44554620|NCT02980874|79571380|FG001|Overall Study|Lost to Follow-up|5|||
44554621|NCT02980874|79571379|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
44554622|NCT02980874|79571380|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
44554623|NCT02980874|79571379|FG000|Overall Study|Unknown study completion status|1|||
44554624|NCT02980874|79571380|FG001|Overall Study|Unknown study completion status|0|||
44554625|NCT01066052|79571388|FG000|Overall Study|Enrolled But Not Treated|3|||
44554626|NCT01066052|79571389|FG001|Overall Study|Enrolled But Not Treated|0|||
44554627|NCT03077646|79571397|FG000|Overall Study|Lost to Follow-up|29|||
44496486|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
44496487|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
44496488|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
44496489|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
44496490|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
44496491|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
44496492|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
44496493|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
44496494|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
44496495|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
44496496|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
44554628|NCT03077646|79571398|FG001|Overall Study|Lost to Follow-up|30|||
44554629|NCT03077646|79571399|FG002|Overall Study|Lost to Follow-up|31|||
44554630|NCT02892149|79571409|FG000|Overall Study|Death|262|||
44554631|NCT02892149|79571410|FG001|Overall Study|Death|278|||
44554632|NCT02892149|79571409|FG000|Overall Study|Withdrawal by Subject|53|||
44554633|NCT02892149|79571410|FG001|Overall Study|Withdrawal by Subject|47|||
44554634|NCT02892149|79571409|FG000|Overall Study|Lost to Follow-up|37|||
44554635|NCT02892149|79571410|FG001|Overall Study|Lost to Follow-up|31|||
44554636|NCT04187092|79571418|FG000|Overall Study|Lost to Follow-up|1|||
44554637|NCT04187092|79571419|FG001|Overall Study|Lost to Follow-up|1|||
44554638|NCT04187092|79571418|FG000|Overall Study|Withdrawal by Subject|1|||
44554639|NCT04187092|79571419|FG001|Overall Study|Withdrawal by Subject|1|||
44554640|NCT04187092|79571418|FG000|Overall Study|Adverse Event|0|||
44554641|NCT04187092|79571419|FG001|Overall Study|Adverse Event|1|||
44554642|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Adverse Event|9|||
44554643|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Adverse Event|2|||
44554644|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
44554645|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
44554646|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
44554647|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
44554648|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Physician Decision|1|||
44554649|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Physician Decision|1|||
44554650|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Pregnancy|2|||
44554651|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Pregnancy|0|||
44554652|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
44554653|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
44554654|NCT02896127|79571427|FG000|COMPLETED WEEK 52|Technical problems|1|||
44554655|NCT02896127|79571428|FG001|COMPLETED WEEK 52|Technical problems|0|||
44554656|NCT02896127|79571427|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
44554657|NCT02896127|79571428|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
44554658|NCT02896127|79571427|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
44554659|NCT02896127|79571428|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
44554660|NCT02896127|79571427|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
44554661|NCT02896127|79571428|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
44554662|NCT02896127|79571427|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
44554663|NCT02896127|79571428|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
44554664|NCT02896127|79571427|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
44554665|NCT02896127|79571428|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
44554666|NCT03546647|79571434|FG000|Overall Study|Adverse Event|1|||
44554667|NCT03546647|79571435|FG001|Overall Study|Adverse Event|0|||
44554668|NCT03077412|79571444|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
44554669|NCT03077412|79571445|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
44554670|NCT03077412|79571446|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
44554671|NCT03077412|79571444|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
44554672|NCT03077412|79571445|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
44554673|NCT03077412|79571446|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
44554674|NCT03077412|79571444|FG000|Overall Study|Adverse Event|1|||
44496497|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
44496498|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
44496499|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
44496500|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
44496501|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
44496502|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
44496503|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
44496504|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
44496505|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
44496506|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
44496507|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44496508|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44496509|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
44496510|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44554675|NCT03077412|79571445|FG001|Overall Study|Adverse Event|2|||
44554676|NCT03077412|79571446|FG002|Overall Study|Adverse Event|2|||
44554677|NCT03077412|79571444|FG000|Overall Study|Investigator's Discretion|0|||
44554678|NCT03077412|79571445|FG001|Overall Study|Investigator's Discretion|1|||
44554679|NCT03077412|79571446|FG002|Overall Study|Investigator's Discretion|1|||
44554680|NCT03077412|79571444|FG000|Overall Study|Withdrew Consent|0|||
44554681|NCT03077412|79571445|FG001|Overall Study|Withdrew Consent|2|||
44554682|NCT03077412|79571446|FG002|Overall Study|Withdrew Consent|0|||
44554683|NCT03544229|79571458|FG000|Overall Study|Adverse Event|1|||
44554684|NCT03544229|79571459|FG001|Overall Study|Adverse Event|0|||
44554685|NCT03544229|79571460|FG002|Overall Study|Adverse Event|1|||
44554686|NCT03544229|79571461|FG003|Overall Study|Adverse Event|0|||
44554687|NCT03544229|79571458|FG000|Overall Study|Protocol Deviation|0|||
44554688|NCT03544229|79571459|FG001|Overall Study|Protocol Deviation|0|||
44554689|NCT03544229|79571460|FG002|Overall Study|Protocol Deviation|1|||
44554690|NCT03544229|79571461|FG003|Overall Study|Protocol Deviation|0|||
44554691|NCT03544229|79571458|FG000|Overall Study|Lost to Follow-up|3|||
44554692|NCT03544229|79571459|FG001|Overall Study|Lost to Follow-up|0|||
44554693|NCT03544229|79571460|FG002|Overall Study|Lost to Follow-up|0|||
44554694|NCT03544229|79571461|FG003|Overall Study|Lost to Follow-up|2|||
44554695|NCT03544229|79571458|FG000|Overall Study|Voluntary Withdrawal|2|||
44554696|NCT03544229|79571459|FG001|Overall Study|Voluntary Withdrawal|1|||
44554697|NCT03544229|79571460|FG002|Overall Study|Voluntary Withdrawal|3|||
44554698|NCT03544229|79571461|FG003|Overall Study|Voluntary Withdrawal|0|||
44554699|NCT03544229|79571458|FG000|Overall Study|Lack of Efficacy|0|||
44554700|NCT03544229|79571459|FG001|Overall Study|Lack of Efficacy|1|||
44554701|NCT03544229|79571460|FG002|Overall Study|Lack of Efficacy|0|||
44554702|NCT03544229|79571461|FG003|Overall Study|Lack of Efficacy|0|||
44554703|NCT03078816|79571471|FG000|Overall Study|Withdrawal by Subject|1|||
44554704|NCT03510455|79571475|FG000|Overall Study|Physician Decision|1|||
44554705|NCT03509675|79571483|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
44554706|NCT03509675|79571484|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
44554707|NCT03509675|79571483|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
44554708|NCT03509675|79571484|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
44554709|NCT03509675|79571483|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
44554710|NCT03509675|79571484|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
44554711|NCT03509675|79571483|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
44554712|NCT03509675|79571484|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
44554713|NCT03509207|79571490|FG000|Overall Study|Death|2|||
44554714|NCT03543137|79571494|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
44554715|NCT03543137|79571495|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
44554716|NCT03543137|79571494|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
44554717|NCT03543137|79571495|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
44554718|NCT03543137|79571494|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
44554719|NCT03543137|79571495|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
44554720|NCT02895347|79571505|FG000|Overall Study|Withdrawal by Subject|3|||
44554721|NCT02895347|79571506|FG001|Overall Study|Withdrawal by Subject|1|||
44554722|NCT03539549|79571513|FG000|Overall Study|Adverse Event|12|||
44554723|NCT03539549|79571513|FG000|Overall Study|Lost to Follow-up|1|||
44554724|NCT03539549|79571513|FG000|Overall Study|Death|2|||
44554725|NCT03539549|79571513|FG000|Overall Study|Progressive Disease|1|||
44554726|NCT03539549|79571513|FG000|Overall Study|Reason not Specified|1|||
44554727|NCT03506477|79571519|FG000|Overall Study|Withdrawal by Subject|1|||
44554728|NCT03506477|79571520|FG001|Overall Study|Withdrawal by Subject|0|||
44554729|NCT03073980|79571529|FG000|Overall Study|Lost to Follow-up|10|||
44554730|NCT03073980|79571530|FG001|Overall Study|Lost to Follow-up|2|||
44554731|NCT03073980|79571531|FG002|Overall Study|Lost to Follow-up|9|||
44554732|NCT03073980|79571529|FG000|Overall Study|No post-procedure data|0|||
44554733|NCT03073980|79571530|FG001|Overall Study|No post-procedure data|0|||
44554734|NCT03073980|79571531|FG002|Overall Study|No post-procedure data|2|||
44554735|NCT03930186|79571543|FG000|Weeks 0 to 16|Adverse Event|6|||
44496511|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44496512|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
44496513|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
44496514|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
44496515|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
44496516|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
44496517|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
44496518|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
44496519|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
44554736|NCT03930186|79571543|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
44554737|NCT03930186|79571543|FG000|Weeks 16 to 32|Adverse Event|1|||
44554738|NCT03930186|79571543|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
44554739|NCT03504917|79571549|FG000|Blinded Treatment Period|Protocol Violation|1|||
44554740|NCT03504917|79571550|FG001|Blinded Treatment Period|Protocol Violation|0|||
44554741|NCT03504917|79571549|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
44554742|NCT03504917|79571550|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
44554743|NCT03504917|79571549|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
44554744|NCT03504917|79571550|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
44554745|NCT03504917|79571549|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
44554746|NCT03504917|79571550|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
44554747|NCT03504917|79571549|FG000|Blinded Treatment Period|Adverse Event|4|||
44554748|NCT03504917|79571550|FG001|Blinded Treatment Period|Adverse Event|4|||
44554749|NCT03504917|79571549|FG000|Blinded Treatment Period|Physician Decision|1|||
44554750|NCT03504917|79571550|FG001|Blinded Treatment Period|Physician Decision|0|||
44554751|NCT03504917|79571549|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
44554752|NCT03504917|79571550|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
44554753|NCT03504917|79571549|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
44554754|NCT03504917|79571550|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
44554755|NCT03504917|79571549|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
44554756|NCT03504917|79571550|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
44554757|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
44554758|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
44554759|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
44554760|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
44554761|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
44554762|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
44554763|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
44554764|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
44554765|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
44554766|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
44554767|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
44554768|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
44554769|NCT03504917|79571549|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
44554770|NCT03504917|79571550|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
44554771|NCT03536663|79571562|FG000|Endexo|Protocol Violation|1|||
44554772|NCT03565211|79571571|FG000|Overall Study|Withdrawal by Subject|2|||
44554773|NCT03565211|79571571|FG000|Overall Study|Lost to Follow-up|1|||
44554774|NCT03565211|79571571|FG000|Overall Study|Adverse Event|44|||
44554775|NCT03565211|79571571|FG000|Overall Study|Personal issues|1|||
44554776|NCT03531905|79571578|FG000|Overall Study|Withdrawal by Subject|3|||
44554777|NCT03531905|79571579|FG001|Overall Study|Withdrawal by Subject|3|||
44554778|NCT03531905|79571580|FG002|Overall Study|Withdrawal by Subject|2|||
44554779|NCT03531905|79571578|FG000|Overall Study|Lost to Follow-up|2|||
44554780|NCT03531905|79571579|FG001|Overall Study|Lost to Follow-up|2|||
44554781|NCT03531905|79571580|FG002|Overall Study|Lost to Follow-up|1|||
44554782|NCT03531905|79571578|FG000|Overall Study|Participant was out of town|1|||
44554783|NCT03531905|79571579|FG001|Overall Study|Participant was out of town|0|||
44554784|NCT03531905|79571580|FG002|Overall Study|Participant was out of town|0|||
44496520|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
44496521|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
44496522|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
44496523|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
44496524|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
44496525|NCT00111800|79502484|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
44496526|NCT00111800|79502485|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
44496527|NCT00111800|79502486|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
44496528|NCT00111800|79502487|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
44496529|NCT00111800|79502488|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
44496530|NCT00111800|79502489|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
44496531|NCT00094328|79502512|FG000|Overall Study|Lost to Follow-up|1|||
44496532|NCT00094172|79502518|FG000|Overall Study|Adverse Event|0|||
44496533|NCT00094172|79502519|FG001|Overall Study|Adverse Event|1|||
44496534|NCT00094172|79502518|FG000|Overall Study|Lost to Follow-up|2|||
44496535|NCT00094172|79502519|FG001|Overall Study|Lost to Follow-up|0|||
44496536|NCT00094172|79502518|FG000|Overall Study|Protocol Violation|0|||
44496537|NCT00094172|79502519|FG001|Overall Study|Protocol Violation|1|||
44496538|NCT00094172|79502518|FG000|Overall Study|Withdrawal by Subject|10|||
44496539|NCT00094172|79502519|FG001|Overall Study|Withdrawal by Subject|5|||
44496540|NCT00094172|79502518|FG000|Overall Study|Primary endpoint met.|1|||
44496541|NCT00094172|79502519|FG001|Overall Study|Primary endpoint met.|0|||
44496542|NCT00094172|79502518|FG000|Overall Study|Started other MS therapy due to disease|1|||
44554785|NCT03531905|79571578|FG000|Overall Study|Could not speak with the participant|1|||
44554786|NCT03531905|79571579|FG001|Overall Study|Could not speak with the participant|0|||
44554787|NCT03531905|79571580|FG002|Overall Study|Could not speak with the participant|0|||
44554788|NCT03531827|79571590|FG000|Overall Study|Adverse Event|2|||
44554789|NCT03531827|79571591|FG001|Overall Study|Adverse Event|0|||
44554790|NCT03531827|79571590|FG000|Overall Study|Progressive disease|1|||
44554791|NCT03531827|79571591|FG001|Overall Study|Progressive disease|0|||
44554792|NCT03530345|79571620|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
44554793|NCT03530345|79571621|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
44231586|NCT00986349|79044959|FG000|Overall Study|Adverse Event|2|||
44496543|NCT00094172|79502519|FG001|Overall Study|Started other MS therapy due to disease|0|||
44496544|NCT00094094|79502525|FG000|Overall Study|Death|2|||
44496545|NCT00094094|79502525|FG000|Overall Study|Lack of Efficacy|23|||
44496546|NCT00094094|79502525|FG000|Overall Study|Adverse Event|7|||
44496547|NCT00110396|79502529|FG000|Overall Study|Adverse Event|15|||
44496548|NCT00110396|79502529|FG000|Overall Study|Lost to Follow-up|1|||
44554794|NCT03530345|79571620|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
44554795|NCT03530345|79571621|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
44554796|NCT03530345|79571620|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
44554797|NCT03530345|79571621|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
44554798|NCT03530345|79571620|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
44554799|NCT03530345|79571621|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
44554800|NCT03500159|79571635|FG000|Overall Study|Study Terminated|2|||
44554801|NCT03500159|79571636|FG001|Overall Study|Study Terminated|1|||
44554802|NCT03785340|79571644|FG000|Overall Study|Lost to Follow-up|2|||
44554803|NCT03785340|79571645|FG001|Overall Study|Lost to Follow-up|0|||
44554804|NCT03785340|79571644|FG000|Overall Study|Adverse Event|1|||
44554805|NCT03785340|79571645|FG001|Overall Study|Adverse Event|0|||
44554806|NCT03499067|79571651|FG000|First Intervention|Physician Decision|2|||
44554807|NCT03499067|79571652|FG001|First Intervention|Physician Decision|1|||
44554808|NCT03499067|79571651|FG000|First Intervention|Withdrawal by Subject|3|||
44554809|NCT03499067|79571652|FG001|First Intervention|Withdrawal by Subject|6|||
44554810|NCT03562481|79571660|FG000|First Intervention|Lost to Follow-up|1|||
44554811|NCT03562481|79571661|FG001|First Intervention|Lost to Follow-up|0|||
44554812|NCT03529409|79571687|FG000|Randomized|Lost to Follow-up|0|||
44554813|NCT03529409|79571688|FG001|Randomized|Lost to Follow-up|0|||
44554814|NCT03529409|79571689|FG002|Randomized|Lost to Follow-up|4|||
44554815|NCT03529409|79571687|FG000|Randomized|Excluded|0|||
44554816|NCT03529409|79571688|FG001|Randomized|Excluded|0|||
44554817|NCT03529409|79571689|FG002|Randomized|Excluded|1|||
44554818|NCT03529409|79571687|FG000|Post-treatment Assessment|Death|1|||
44554819|NCT03529409|79571688|FG001|Post-treatment Assessment|Death|0|||
44554820|NCT03529409|79571689|FG002|Post-treatment Assessment|Death|0|||
44231587|NCT00986349|79044959|FG000|Overall Study|Physician Decision|1|||
44496549|NCT00110396|79502529|FG000|Overall Study|Administration of plasmapheresis|1|||
44496550|NCT00110396|79502529|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
44496551|NCT00110396|79502529|FG000|Overall Study|Lack of Efficacy|1|||
44554821|NCT03529409|79571687|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
44554822|NCT03529409|79571688|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
44554823|NCT03529409|79571689|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
44554824|NCT03529409|79571687|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
44554825|NCT03529409|79571688|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
44554826|NCT03529409|79571689|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
44231588|NCT00986349|79044959|FG000|Overall Study|device migration|1|||
44231589|NCT00985959|79044982|FG000|Overall Study|Adverse Event|0|||
44231590|NCT00985959|79044983|FG001|Overall Study|Adverse Event|0|||
44231591|NCT00985959|79044984|FG002|Overall Study|Adverse Event|19|||
44231592|NCT00985959|79044982|FG000|Overall Study|Withdrawal by Subject|0|||
44231593|NCT00985959|79044983|FG001|Overall Study|Withdrawal by Subject|0|||
44231594|NCT00985959|79044984|FG002|Overall Study|Withdrawal by Subject|8|||
44231595|NCT00985959|79044982|FG000|Overall Study|Progressive disease|1|||
44231596|NCT00985959|79044983|FG001|Overall Study|Progressive disease|2|||
44231597|NCT00985959|79044984|FG002|Overall Study|Progressive disease|8|||
44231598|NCT00985959|79044982|FG000|Overall Study|Unrecovered toxicity|0|||
44231599|NCT00985959|79044983|FG001|Overall Study|Unrecovered toxicity|0|||
44231600|NCT00985959|79044984|FG002|Overall Study|Unrecovered toxicity|7|||
44231601|NCT00985959|79044982|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
44231602|NCT00985959|79044983|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
44231603|NCT00985959|79044984|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
44231604|NCT00985959|79044982|FG000|Overall Study|Complete response observed over 2 cycles|0|||
44231605|NCT00985959|79044983|FG001|Overall Study|Complete response observed over 2 cycles|1|||
44231606|NCT00985959|79044984|FG002|Overall Study|Complete response observed over 2 cycles|4|||
44231607|NCT00985959|79044982|FG000|Overall Study|Other|0|||
44231608|NCT00985959|79044983|FG001|Overall Study|Other|0|||
44231609|NCT00985959|79044984|FG002|Overall Study|Other|11|||
44231610|NCT00985725|79045000|FG000|Overall Study|Adverse Event|4|||
44231611|NCT00985725|79045001|FG001|Overall Study|Adverse Event|1|||
44231612|NCT00985725|79045000|FG000|Overall Study|Protocol Violation|1|||
44231613|NCT00985725|79045001|FG001|Overall Study|Protocol Violation|3|||
44231614|NCT00985725|79045000|FG000|Overall Study|Withdrawal by Subject|4|||
44274843|NCT03266588|79221042|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
44274844|NCT03266588|79221040|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
44274845|NCT03266588|79221041|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
44554827|NCT03529409|79571687|FG000|Follow-up Assessment|Death|1|||
44554828|NCT03529409|79571688|FG001|Follow-up Assessment|Death|0|||
44554829|NCT03529409|79571689|FG002|Follow-up Assessment|Death|0|||
44554830|NCT03529409|79571687|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
44554831|NCT03529409|79571688|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
44554832|NCT03529409|79571689|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
44554833|NCT03498287|79571698|FG000|Overall Study|Withdrawal by Subject|3|||
44231615|NCT00985725|79045001|FG001|Overall Study|Withdrawal by Subject|4|||
44231616|NCT00985725|79045000|FG000|Overall Study|Lost to Follow-up|1|||
44231617|NCT00985725|79045001|FG001|Overall Study|Lost to Follow-up|1|||
44274846|NCT03266588|79221042|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
44274847|NCT03266588|79221040|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
44554834|NCT03498287|79571699|FG001|Overall Study|Withdrawal by Subject|0|||
44554835|NCT03498287|79571698|FG000|Overall Study|Protocol Violation|0|||
44554836|NCT03498287|79571699|FG001|Overall Study|Protocol Violation|4|||
44554837|NCT03498287|79571698|FG000|Overall Study|Adverse Event|0|||
44554838|NCT03498287|79571699|FG001|Overall Study|Adverse Event|1|||
44554839|NCT03497429|79571707|FG000|Overall Study|Progressive disease|3|||
44554840|NCT03497429|79571708|FG001|Overall Study|Progressive disease|4|||
44554841|NCT03497429|79571707|FG000|Overall Study|Adverse Event|0|||
44554842|NCT03497429|79571708|FG001|Overall Study|Adverse Event|2|||
44554843|NCT03497039|79571716|FG000|Overall Study|Withdrawal by Subject|1|||
44554844|NCT03497039|79571717|FG001|Overall Study|Withdrawal by Subject|0|||
44554845|NCT03497039|79571716|FG000|Overall Study|Protocol Violation|0|||
44554846|NCT03497039|79571717|FG001|Overall Study|Protocol Violation|1|||
44554847|NCT03495869|79571736|FG000|Overall Study|Lost to Follow-up|4|||
44554848|NCT03495869|79571737|FG001|Overall Study|Lost to Follow-up|17|||
44554849|NCT03495869|79571738|FG002|Overall Study|Lost to Follow-up|8|||
44231618|NCT00985725|79045000|FG000|Overall Study|Lack of Efficacy|0|||
44231619|NCT00985725|79045001|FG001|Overall Study|Lack of Efficacy|1|||
44231620|NCT00985725|79045000|FG000|Overall Study|Non-compliance|1|||
44554850|NCT03495869|79571739|FG003|Overall Study|Lost to Follow-up|14|||
44231621|NCT00985725|79045001|FG001|Overall Study|Non-compliance|2|||
44231622|NCT00985725|79045000|FG000|Overall Study|Out-of-window visits|0|||
44231623|NCT00985725|79045001|FG001|Overall Study|Out-of-window visits|1|||
44231624|NCT00985491|79045016|FG000|Overall Study|Adverse Event|8|||
44231625|NCT00985491|79045016|FG000|Overall Study|device migration|7|||
44231626|NCT00985491|79045016|FG000|Overall Study|Withdrawal by Subject|1|||
44231627|NCT00985491|79045016|FG000|Overall Study|implant failure|3|||
44231628|NCT00984867|79045051|FG000|Overall Study|Adverse Event|3|||
44496552|NCT00110396|79502529|FG000|Overall Study|Decided not to continue treatment|1|||
44231629|NCT00984867|79045052|FG001|Overall Study|Adverse Event|7|||
44231630|NCT00984867|79045051|FG000|Overall Study|Death|1|||
44231631|NCT00984867|79045052|FG001|Overall Study|Death|0|||
44231632|NCT00984867|79045051|FG000|Overall Study|Withdrawal by Subject|13|||
44496553|NCT00110396|79502529|FG000|Overall Study|Patient non-compliance|1|||
44496554|NCT00110396|79502529|FG000|Overall Study|Patient refused to continue|1|||
44496555|NCT00110396|79502529|FG000|Overall Study|Patient refused to participate|1|||
44496556|NCT00110396|79502529|FG000|Overall Study|Patient will|1|||
44274848|NCT03266588|79221041|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
44274849|NCT03266588|79221042|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
44274850|NCT03266588|79221040|FG000|Long-term Treatment Period|Other Reasons|5|||
44496557|NCT00110396|79502529|FG000|Overall Study|Patient's decision|1|||
44231633|NCT00984867|79045052|FG001|Overall Study|Withdrawal by Subject|4|||
44231634|NCT00984867|79045051|FG000|Overall Study|Lost to Follow-up|3|||
44231635|NCT00984867|79045052|FG001|Overall Study|Lost to Follow-up|4|||
44231636|NCT00984867|79045051|FG000|Overall Study|Poor/non-compliance|0|||
44231637|NCT00984867|79045052|FG001|Overall Study|Poor/non-compliance|1|||
44231638|NCT00984867|79045051|FG000|Overall Study|Subject no longer meets study criteria|1|||
44231639|NCT00984867|79045052|FG001|Overall Study|Subject no longer meets study criteria|1|||
44231640|NCT00984867|79045051|FG000|Overall Study|site closing|1|||
44231641|NCT00984867|79045052|FG001|Overall Study|site closing|0|||
44231642|NCT00984867|79045051|FG000|Overall Study|lack of efficacy and subject compliance|1|||
44231643|NCT00984867|79045052|FG001|Overall Study|lack of efficacy and subject compliance|0|||
44231644|NCT00984009|79045092|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
44231645|NCT00983931|79045099|FG000|14 Day Washout Period|Physician Decision|1|||
44231646|NCT00983853|79045111|FG000|Overall Study|Lost to Follow-up|1|||
44231647|NCT00983853|79045112|FG001|Overall Study|Lost to Follow-up|1|||
44231648|NCT00983853|79045113|FG002|Overall Study|Lost to Follow-up|2|||
44231649|NCT00983853|79045114|FG003|Overall Study|Lost to Follow-up|2|||
44231650|NCT00983853|79045115|FG004|Overall Study|Lost to Follow-up|2|||
44231651|NCT00983853|79045116|FG005|Overall Study|Lost to Follow-up|1|||
44231652|NCT00983853|79045111|FG000|Overall Study|Withdrawal by Subject|0|||
44231653|NCT00983853|79045112|FG001|Overall Study|Withdrawal by Subject|0|||
44231654|NCT00983853|79045113|FG002|Overall Study|Withdrawal by Subject|1|||
44231655|NCT00983853|79045114|FG003|Overall Study|Withdrawal by Subject|0|||
44496558|NCT00110396|79502529|FG000|Overall Study|Participation in MS vaccine study|1|||
44496559|NCT00110396|79502529|FG000|Overall Study|Pregnancy|1|||
44231656|NCT00983853|79045115|FG004|Overall Study|Withdrawal by Subject|1|||
44231657|NCT00983853|79045116|FG005|Overall Study|Withdrawal by Subject|0|||
44496560|NCT00110396|79502529|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
44496561|NCT00110396|79502529|FG000|Overall Study|Protocol Violation|2|||
44496562|NCT00110396|79502529|FG000|Overall Study|Patient refused to come back|1|||
44496563|NCT00110396|79502529|FG000|Overall Study|The patient has refused|2|||
44496564|NCT00110396|79502529|FG000|Overall Study|The patient has refused to visit site|1|||
44496565|NCT00110396|79502529|FG000|Overall Study|Patient is to be administered copaxone|1|||
44496566|NCT03819218|79502533|FG000|Overall Study|Protocol Violation|1|||
44496567|NCT00093470|79502539|FG000|Overall Study|Disease progression|39|||
44554851|NCT03495869|79571736|FG000|Overall Study|Withdrawal by Subject|0|||
44496568|NCT00093470|79502540|FG001|Overall Study|Disease progression|0|||
44554852|NCT03495869|79571737|FG001|Overall Study|Withdrawal by Subject|3|||
44496569|NCT00093470|79502539|FG000|Overall Study|Adverse Event|15|||
44496570|NCT00093470|79502540|FG001|Overall Study|Adverse Event|0|||
44496571|NCT00093470|79502539|FG000|Overall Study|Death|2|||
44496572|NCT00093470|79502540|FG001|Overall Study|Death|0|||
44496573|NCT00093470|79502539|FG000|Overall Study|Withdrawal by Subject|8|||
44496574|NCT00093470|79502540|FG001|Overall Study|Withdrawal by Subject|0|||
44496575|NCT00093470|79502539|FG000|Overall Study|Alternative therapy|2|||
44496576|NCT00093470|79502540|FG001|Overall Study|Alternative therapy|0|||
44496577|NCT00093470|79502539|FG000|Overall Study|Other complicating disease|3|||
44496578|NCT00093470|79502540|FG001|Overall Study|Other complicating disease|0|||
44496579|NCT00093470|79502539|FG000|Overall Study|Physician Decision|2|||
44496580|NCT00093470|79502540|FG001|Overall Study|Physician Decision|0|||
44496581|NCT00093470|79502539|FG000|Overall Study|Never started treatment|1|||
44496582|NCT00093470|79502540|FG001|Overall Study|Never started treatment|0|||
44496583|NCT00093470|79502539|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
44496584|NCT00093470|79502540|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
44554853|NCT03495869|79571738|FG002|Overall Study|Withdrawal by Subject|0|||
44554854|NCT03495869|79571739|FG003|Overall Study|Withdrawal by Subject|3|||
44496585|NCT00407537|79502548|FG000|Overall Study|Death|5|||
44496586|NCT00407537|79502549|FG001|Overall Study|Death|2|||
44496587|NCT00407537|79502548|FG000|Overall Study|Adverse Event|36|||
44496588|NCT00407537|79502549|FG001|Overall Study|Adverse Event|0|||
44554855|NCT03495869|79571736|FG000|Overall Study|Dropped from study|0|||
44496589|NCT00407537|79502548|FG000|Overall Study|Lost to Follow-up|12|||
44496590|NCT00407537|79502549|FG001|Overall Study|Lost to Follow-up|19|||
44496591|NCT00407537|79502548|FG000|Overall Study|Other|6|||
44231658|NCT00983853|79045111|FG000|Overall Study|Unable to come to study follow-up visits|0|||
44554856|NCT03495869|79571737|FG001|Overall Study|Dropped from study|7|||
44554857|NCT03495869|79571738|FG002|Overall Study|Dropped from study|2|||
44231659|NCT00983853|79045112|FG001|Overall Study|Unable to come to study follow-up visits|1|||
44231660|NCT00983853|79045113|FG002|Overall Study|Unable to come to study follow-up visits|0|||
44231661|NCT00983853|79045114|FG003|Overall Study|Unable to come to study follow-up visits|0|||
44231662|NCT00983853|79045115|FG004|Overall Study|Unable to come to study follow-up visits|0|||
44554858|NCT03495869|79571739|FG003|Overall Study|Dropped from study|4|||
44554859|NCT03071094|79571760|FG000|Overall Study|Death|1|||
44554860|NCT03071094|79571761|FG001|Overall Study|Death|1|||
44554861|NCT03071094|79571760|FG000|Overall Study|Adverse Event|1|||
44554862|NCT03071094|79571761|FG001|Overall Study|Adverse Event|0|||
44554863|NCT03559517|79571770|FG000|Overall Study|Withdrawal by Subject|1|||
44554864|NCT03559517|79571771|FG001|Overall Study|Withdrawal by Subject|0|||
44554865|NCT03559517|79571772|FG002|Overall Study|Withdrawal by Subject|0|||
44231663|NCT00983853|79045116|FG005|Overall Study|Unable to come to study follow-up visits|0|||
44231664|NCT00983073|79045132|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
44554866|NCT02509494|79571789|FG000|Overall Study|Lost to Follow-up|8|||
44376749|NCT01074944|79381963|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
44376750|NCT01074944|79381964|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
44376751|NCT01074944|79381960|FG000|Long Term Treatment|Adverse Event|0|||
44376752|NCT01074944|79381961|FG001|Long Term Treatment|Adverse Event|0|||
44376753|NCT01074944|79381962|FG002|Long Term Treatment|Adverse Event|0|||
44376754|NCT01074944|79381963|FG003|Long Term Treatment|Adverse Event|3|||
44376755|NCT01074944|79381964|FG004|Long Term Treatment|Adverse Event|0|||
44496592|NCT00407537|79502549|FG001|Overall Study|Other|7|||
44231665|NCT00983073|79045132|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
44231666|NCT00983073|79045132|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
44231667|NCT00983073|79045132|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
44231668|NCT00983073|79045132|FG000|Titration and Optimal Dose Period|Other reason|4|||
44231669|NCT00983073|79045132|FG000|Maintenance Period|Adverse Event|5|||
44231670|NCT00983073|79045132|FG000|Maintenance Period|Withdrawal by Subject|2|||
44231671|NCT00983073|79045132|FG000|Maintenance Period|Lack of Efficacy|2|||
44376756|NCT01074944|79381960|FG000|Long Term Treatment|Lost to Follow-up|0|||
44376757|NCT01074944|79381961|FG001|Long Term Treatment|Lost to Follow-up|0|||
44554867|NCT02509494|79571790|FG001|Overall Study|Lost to Follow-up|47|||
44554868|NCT02509494|79571791|FG002|Overall Study|Lost to Follow-up|19|||
44231672|NCT00983073|79045132|FG000|Maintenance Period|Other Reason|7|||
44231673|NCT00982137|79045141|FG000|Overall Study|Lost to Follow-up|0|||
44231674|NCT00982137|79045142|FG001|Overall Study|Lost to Follow-up|0|||
44231675|NCT00982137|79045143|FG002|Overall Study|Lost to Follow-up|0|||
44231676|NCT00982137|79045144|FG003|Overall Study|Lost to Follow-up|1|||
44231677|NCT00982137|79045141|FG000|Overall Study|Withdrawal by Subject|0|||
44231678|NCT00982137|79045142|FG001|Overall Study|Withdrawal by Subject|1|||
44231679|NCT00982137|79045143|FG002|Overall Study|Withdrawal by Subject|0|||
44554869|NCT02509494|79571792|FG003|Overall Study|Lost to Follow-up|6|||
44231680|NCT00982137|79045144|FG003|Overall Study|Withdrawal by Subject|0|||
44231681|NCT00981747|79045161|FG000|Losartan|Withdrawal by Subject|1|||
44231682|NCT00981747|79045161|FG000|Losartan|Death|1|||
44231683|NCT00981747|79045161|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
44231684|NCT01856309|79045316|FG000|Overall Study|Death|4|||
44231685|NCT01856309|79045317|FG001|Overall Study|Death|6|||
44231686|NCT01856309|79045318|FG002|Overall Study|Death|11|||
44231687|NCT01856309|79045319|FG003|Overall Study|Death|6|||
44231688|NCT01856309|79045316|FG000|Overall Study|Lost to Follow-up|6|||
44231689|NCT01856309|79045317|FG001|Overall Study|Lost to Follow-up|2|||
44554870|NCT02509494|79571793|FG004|Overall Study|Lost to Follow-up|3|||
44554871|NCT02509494|79571794|FG005|Overall Study|Lost to Follow-up|3|||
44554872|NCT02509494|79571795|FG006|Overall Study|Lost to Follow-up|1|||
44554873|NCT02509494|79571796|FG007|Overall Study|Lost to Follow-up|3|||
44554874|NCT02509494|79571797|FG008|Overall Study|Lost to Follow-up|1|||
44554875|NCT02509494|79571789|FG000|Overall Study|Physician Decision|2|||
44554876|NCT02509494|79571790|FG001|Overall Study|Physician Decision|1|||
44554877|NCT02509494|79571791|FG002|Overall Study|Physician Decision|0|||
44554878|NCT02509494|79571792|FG003|Overall Study|Physician Decision|0|||
44554879|NCT02509494|79571793|FG004|Overall Study|Physician Decision|0|||
44554880|NCT02509494|79571794|FG005|Overall Study|Physician Decision|0|||
44554881|NCT02509494|79571795|FG006|Overall Study|Physician Decision|0|||
44554882|NCT02509494|79571796|FG007|Overall Study|Physician Decision|0|||
44554883|NCT02509494|79571797|FG008|Overall Study|Physician Decision|0|||
44554884|NCT02509494|79571789|FG000|Overall Study|Withdrawal by Subject|4|||
44554885|NCT02509494|79571790|FG001|Overall Study|Withdrawal by Subject|17|||
44554886|NCT02509494|79571791|FG002|Overall Study|Withdrawal by Subject|7|||
44554887|NCT02509494|79571792|FG003|Overall Study|Withdrawal by Subject|5|||
44554888|NCT02509494|79571793|FG004|Overall Study|Withdrawal by Subject|0|||
44554889|NCT02509494|79571794|FG005|Overall Study|Withdrawal by Subject|6|||
44554890|NCT02509494|79571795|FG006|Overall Study|Withdrawal by Subject|1|||
44554891|NCT02509494|79571796|FG007|Overall Study|Withdrawal by Subject|2|||
44554892|NCT02509494|79571797|FG008|Overall Study|Withdrawal by Subject|1|||
44554893|NCT02509494|79571789|FG000|Overall Study|Death|0|||
44554894|NCT02509494|79571790|FG001|Overall Study|Death|1|||
44554895|NCT02509494|79571791|FG002|Overall Study|Death|0|||
44554896|NCT02509494|79571792|FG003|Overall Study|Death|0|||
44554897|NCT02509494|79571793|FG004|Overall Study|Death|1|||
44554898|NCT02509494|79571794|FG005|Overall Study|Death|0|||
44554899|NCT02509494|79571795|FG006|Overall Study|Death|0|||
44554900|NCT02509494|79571796|FG007|Overall Study|Death|1|||
44554901|NCT02509494|79571797|FG008|Overall Study|Death|0|||
44554902|NCT02509494|79571789|FG000|Overall Study|Other|0|||
44554903|NCT02509494|79571790|FG001|Overall Study|Other|4|||
44554904|NCT02509494|79571791|FG002|Overall Study|Other|5|||
44554905|NCT02509494|79571792|FG003|Overall Study|Other|0|||
44554906|NCT02509494|79571793|FG004|Overall Study|Other|0|||
44554907|NCT02509494|79571794|FG005|Overall Study|Other|0|||
44554908|NCT02509494|79571795|FG006|Overall Study|Other|0|||
44554909|NCT02509494|79571796|FG007|Overall Study|Other|0|||
44554910|NCT02509494|79571797|FG008|Overall Study|Other|0|||
44554911|NCT02509494|79571789|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44554912|NCT02509494|79571790|FG001|Overall Study|Non-Compliance With Study Drug|11|||
44496593|NCT00407537|79502548|FG000|Overall Study|Withdrawal by Subject|34|||
44496594|NCT00407537|79502549|FG001|Overall Study|Withdrawal by Subject|16|||
44496595|NCT00094458|79502558|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
44496596|NCT00094458|79502559|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
44496597|NCT00094458|79502560|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
44496598|NCT00094458|79502561|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
44496599|NCT00094458|79502562|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
44496600|NCT00094458|79502563|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
44496601|NCT00094458|79502558|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
44231690|NCT01856309|79045318|FG002|Overall Study|Lost to Follow-up|4|||
44231691|NCT01856309|79045319|FG003|Overall Study|Lost to Follow-up|8|||
44496602|NCT00094458|79502559|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
44496603|NCT00094458|79502560|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
44554913|NCT02509494|79571791|FG002|Overall Study|Non-Compliance With Study Drug|7|||
44554914|NCT02509494|79571792|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44554915|NCT02509494|79571793|FG004|Overall Study|Non-Compliance With Study Drug|1|||
44554916|NCT02509494|79571794|FG005|Overall Study|Non-Compliance With Study Drug|2|||
44554917|NCT02509494|79571795|FG006|Overall Study|Non-Compliance With Study Drug|1|||
44554918|NCT02509494|79571796|FG007|Overall Study|Non-Compliance With Study Drug|1|||
44554919|NCT02509494|79571797|FG008|Overall Study|Non-Compliance With Study Drug|0|||
44554920|NCT03493451|79571834|FG000|Overall Study|Death|11|||
44554921|NCT03493451|79571835|FG001|Overall Study|Death|26|||
44554922|NCT03493451|79571836|FG002|Overall Study|Death|3|||
44231692|NCT01856309|79045316|FG000|Overall Study|Withdrawal by Subject|11|||
44231693|NCT01856309|79045317|FG001|Overall Study|Withdrawal by Subject|13|||
44554923|NCT03493451|79571834|FG000|Overall Study|Lost to Follow-up|1|||
44554924|NCT03493451|79571835|FG001|Overall Study|Lost to Follow-up|4|||
44554925|NCT03493451|79571836|FG002|Overall Study|Lost to Follow-up|1|||
44554926|NCT03493451|79571834|FG000|Overall Study|Withdrawal by Subject|1|||
44554927|NCT03493451|79571835|FG001|Overall Study|Withdrawal by Subject|1|||
44554928|NCT03493451|79571836|FG002|Overall Study|Withdrawal by Subject|2|||
44554929|NCT03493451|79571834|FG000|Overall Study|Progressive Disease|1|||
44554930|NCT03493451|79571835|FG001|Overall Study|Progressive Disease|0|||
44554931|NCT03493451|79571836|FG002|Overall Study|Progressive Disease|0|||
44554932|NCT03493451|79571834|FG000|Overall Study|Transferred to long term extension study|8|||
44554933|NCT03493451|79571835|FG001|Overall Study|Transferred to long term extension study|13|||
44554934|NCT03493451|79571836|FG002|Overall Study|Transferred to long term extension study|5|||
44231694|NCT01856309|79045318|FG002|Overall Study|Withdrawal by Subject|28|||
44231695|NCT01856309|79045319|FG003|Overall Study|Withdrawal by Subject|26|||
44231696|NCT01856309|79045316|FG000|Overall Study|Other|227|||
44554935|NCT03492281|79571847|FG000|Overall Study|Withdrawal by Subject|21|||
44554936|NCT03492281|79571848|FG001|Overall Study|Withdrawal by Subject|14|||
44554937|NCT03492281|79571849|FG002|Overall Study|Withdrawal by Subject|13|||
44554938|NCT03492281|79571847|FG000|Overall Study|Lost to Follow-up|14|||
44554939|NCT03492281|79571848|FG001|Overall Study|Lost to Follow-up|15|||
44554940|NCT03492281|79571849|FG002|Overall Study|Lost to Follow-up|10|||
44554941|NCT03492281|79571847|FG000|Overall Study|Adverse Event|6|||
44554942|NCT03492281|79571848|FG001|Overall Study|Adverse Event|8|||
44554943|NCT03492281|79571849|FG002|Overall Study|Adverse Event|13|||
44554944|NCT03492281|79571847|FG000|Overall Study|Lack of Efficacy|3|||
44554945|NCT03492281|79571848|FG001|Overall Study|Lack of Efficacy|0|||
44554946|NCT03492281|79571849|FG002|Overall Study|Lack of Efficacy|1|||
44554947|NCT03492281|79571847|FG000|Overall Study|Physician Decision|1|||
44554948|NCT03492281|79571848|FG001|Overall Study|Physician Decision|0|||
44554949|NCT03492281|79571849|FG002|Overall Study|Physician Decision|3|||
44554950|NCT03492281|79571847|FG000|Overall Study|Protocol Violation|0|||
44554951|NCT03492281|79571848|FG001|Overall Study|Protocol Violation|2|||
44554952|NCT03492281|79571849|FG002|Overall Study|Protocol Violation|1|||
44554953|NCT03492281|79571847|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
44554954|NCT03492281|79571848|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
44554955|NCT03492281|79571849|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
44554956|NCT03492281|79571847|FG000|Overall Study|Death|0|||
44554957|NCT03492281|79571848|FG001|Overall Study|Death|0|||
44554958|NCT03492281|79571849|FG002|Overall Study|Death|1|||
44554959|NCT03492281|79571847|FG000|Overall Study|Captured as Other in Database|8|||
44554960|NCT03492281|79571848|FG001|Overall Study|Captured as Other in Database|6|||
44554961|NCT03492281|79571849|FG002|Overall Study|Captured as Other in Database|3|||
44554962|NCT03070782|79571866|FG000|Overall Study|Adverse Event|3|||
44554963|NCT03070782|79571867|FG001|Overall Study|Adverse Event|0|||
44554964|NCT03070782|79571868|FG002|Overall Study|Adverse Event|3|||
44554965|NCT03070782|79571869|FG003|Overall Study|Adverse Event|1|||
44231697|NCT01856309|79045317|FG001|Overall Study|Other|225|||
44231698|NCT01856309|79045318|FG002|Overall Study|Other|447|||
44231699|NCT01856309|79045319|FG003|Overall Study|Other|469|||
44231700|NCT01856309|79045316|FG000|Overall Study|Lack of Efficacy|14|||
44231701|NCT01856309|79045317|FG001|Overall Study|Lack of Efficacy|9|||
44554966|NCT03070782|79571870|FG004|Overall Study|Adverse Event|6|||
44554967|NCT03070782|79571871|FG005|Overall Study|Adverse Event|2|||
44554968|NCT03070782|79571866|FG000|Overall Study|Withdrawal by Subject|2|||
44554969|NCT03070782|79571867|FG001|Overall Study|Withdrawal by Subject|1|||
44554970|NCT03070782|79571868|FG002|Overall Study|Withdrawal by Subject|1|||
44554971|NCT03070782|79571869|FG003|Overall Study|Withdrawal by Subject|0|||
44554972|NCT03070782|79571870|FG004|Overall Study|Withdrawal by Subject|4|||
44554973|NCT03070782|79571871|FG005|Overall Study|Withdrawal by Subject|3|||
44554974|NCT03070782|79571866|FG000|Overall Study|Reason Not Specified|2|||
44554975|NCT03070782|79571867|FG001|Overall Study|Reason Not Specified|0|||
44554976|NCT03070782|79571868|FG002|Overall Study|Reason Not Specified|0|||
44554977|NCT03070782|79571869|FG003|Overall Study|Reason Not Specified|1|||
44554978|NCT03070782|79571870|FG004|Overall Study|Reason Not Specified|2|||
44554979|NCT03070782|79571871|FG005|Overall Study|Reason Not Specified|1|||
44554980|NCT03070782|79571866|FG000|Overall Study|Ineligibility|0|||
44554981|NCT03070782|79571867|FG001|Overall Study|Ineligibility|0|||
44554982|NCT03070782|79571868|FG002|Overall Study|Ineligibility|0|||
44554983|NCT03070782|79571869|FG003|Overall Study|Ineligibility|1|||
44554984|NCT03070782|79571870|FG004|Overall Study|Ineligibility|0|||
44554985|NCT03070782|79571871|FG005|Overall Study|Ineligibility|1|||
44554986|NCT03070782|79571866|FG000|Overall Study|Pregnancy|0|||
44554987|NCT03070782|79571867|FG001|Overall Study|Pregnancy|0|||
44554988|NCT03070782|79571868|FG002|Overall Study|Pregnancy|0|||
44554989|NCT03070782|79571869|FG003|Overall Study|Pregnancy|1|||
44554990|NCT03070782|79571870|FG004|Overall Study|Pregnancy|0|||
44554991|NCT03070782|79571871|FG005|Overall Study|Pregnancy|0|||
44554992|NCT03070782|79571866|FG000|Overall Study|Investigator Judgement|0|||
44554993|NCT03070782|79571867|FG001|Overall Study|Investigator Judgement|0|||
44554994|NCT03070782|79571868|FG002|Overall Study|Investigator Judgement|0|||
44554995|NCT03070782|79571869|FG003|Overall Study|Investigator Judgement|1|||
44554996|NCT03070782|79571870|FG004|Overall Study|Investigator Judgement|0|||
44554997|NCT03070782|79571871|FG005|Overall Study|Investigator Judgement|0|||
44554998|NCT03525119|79571907|FG000|Overall Study|Adverse Event|0|||
44231702|NCT01856309|79045318|FG002|Overall Study|Lack of Efficacy|40|||
44231703|NCT01856309|79045319|FG003|Overall Study|Lack of Efficacy|25|||
44231704|NCT01856309|79045316|FG000|Overall Study|Adverse Event|31|||
44231705|NCT01856309|79045317|FG001|Overall Study|Adverse Event|31|||
44231706|NCT01856309|79045318|FG002|Overall Study|Adverse Event|55|||
44231707|NCT01856309|79045319|FG003|Overall Study|Adverse Event|65|||
44231708|NCT01856309|79045316|FG000|Overall Study|Pregnancy|0|||
44231709|NCT01856309|79045317|FG001|Overall Study|Pregnancy|0|||
44231710|NCT01856309|79045318|FG002|Overall Study|Pregnancy|0|||
44231711|NCT01856309|79045319|FG003|Overall Study|Pregnancy|1|||
44231712|NCT01856309|79045316|FG000|Overall Study|Physician Decision|6|||
44231713|NCT01856309|79045317|FG001|Overall Study|Physician Decision|1|||
44231714|NCT01856309|79045318|FG002|Overall Study|Physician Decision|6|||
44231715|NCT01856309|79045319|FG003|Overall Study|Physician Decision|8|||
44231716|NCT01856309|79045316|FG000|Overall Study|Noncompliance With Study Drug|0|||
44231717|NCT01856309|79045317|FG001|Overall Study|Noncompliance With Study Drug|1|||
44231718|NCT01856309|79045318|FG002|Overall Study|Noncompliance With Study Drug|4|||
44231719|NCT01856309|79045319|FG003|Overall Study|Noncompliance With Study Drug|1|||
44231720|NCT01855919|79045517|FG000|Overall Study|Adverse Event|16|||
44231721|NCT01855919|79045518|FG001|Overall Study|Adverse Event|8|||
44554999|NCT03525119|79571908|FG001|Overall Study|Adverse Event|1|||
44231722|NCT01855919|79045517|FG000|Overall Study|Lack of Efficacy|1|||
44231723|NCT01855919|79045518|FG001|Overall Study|Lack of Efficacy|3|||
44231724|NCT01855919|79045517|FG000|Overall Study|Withdrawal by Subject|4|||
44496604|NCT00094458|79502561|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
44496605|NCT00094458|79502562|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
44496606|NCT00094458|79502563|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
44496607|NCT00094458|79502558|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
44496608|NCT00094458|79502559|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
44496609|NCT00094458|79502560|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
44496610|NCT00094458|79502561|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
44496611|NCT00094458|79502562|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
44496612|NCT00094458|79502563|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
44496613|NCT00094458|79502558|FG000|Main Study: Through Week 30|Adverse Event|38|||
44496614|NCT00094458|79502559|FG001|Main Study: Through Week 30|Adverse Event|20|||
44496615|NCT00094458|79502560|FG002|Main Study: Through Week 30|Adverse Event|28|||
44496616|NCT00094458|79502561|FG003|Main Study: Through Week 30|Adverse Event|0|||
44496617|NCT00094458|79502562|FG004|Main Study: Through Week 30|Adverse Event|0|||
44555000|NCT03525119|79571909|FG002|Overall Study|Adverse Event|0|||
44231725|NCT01855919|79045518|FG001|Overall Study|Withdrawal by Subject|10|||
44555001|NCT03525119|79571907|FG000|Overall Study|Lost to Follow-up|32|||
44555002|NCT03525119|79571908|FG001|Overall Study|Lost to Follow-up|33|||
44555003|NCT03525119|79571909|FG002|Overall Study|Lost to Follow-up|37|||
44555004|NCT03525119|79571907|FG000|Overall Study|Withdrawal by Subject|5|||
44231726|NCT01855919|79045517|FG000|Overall Study|Entry Criteria Not Met|1|||
44231727|NCT01855919|79045518|FG001|Overall Study|Entry Criteria Not Met|1|||
44231728|NCT01855919|79045517|FG000|Overall Study|Protocol Violation|1|||
44496618|NCT00094458|79502563|FG005|Main Study: Through Week 30|Adverse Event|0|||
44555005|NCT03525119|79571908|FG001|Overall Study|Withdrawal by Subject|4|||
44231729|NCT01855919|79045518|FG001|Overall Study|Protocol Violation|4|||
44496619|NCT00094458|79502558|FG000|Main Study: Through Week 30|Death|1|||
44555006|NCT03525119|79571909|FG002|Overall Study|Withdrawal by Subject|2|||
44231730|NCT01871519|79045534|FG000|Overall Study|Death|26|||
44231731|NCT01871519|79045534|FG000|Overall Study|Lost to Follow-up|15|||
44231732|NCT01871519|79045534|FG000|Overall Study|Withdrawal by Subject|49|||
44555007|NCT03525119|79571907|FG000|Overall Study|Reason not Specified|2|||
44555008|NCT03525119|79571908|FG001|Overall Study|Reason not Specified|1|||
44555009|NCT03525119|79571909|FG002|Overall Study|Reason not Specified|2|||
44555010|NCT03525119|79571907|FG000|Overall Study|Randomized but not Vaccinated|1|||
44555011|NCT03525119|79571908|FG001|Overall Study|Randomized but not Vaccinated|0|||
44555012|NCT03525119|79571909|FG002|Overall Study|Randomized but not Vaccinated|2|||
44555013|NCT03558503|79571917|FG000|Overall Study|Adverse Event|1|||
44555014|NCT03558503|79571917|FG000|Overall Study|Death|1|||
44555015|NCT03558503|79571917|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
44555016|NCT03489863|79571923|FG000|Overall Study|Withdrawal by Subject|0|||
44555017|NCT03489863|79571924|FG001|Overall Study|Withdrawal by Subject|1|||
44555018|NCT03489551|79571930|FG000|Overall Study|Withdrawal by Subject|2|||
44555019|NCT03557801|79571937|FG000|Overall Study|Protocol Violation|1|||
44555020|NCT03557801|79571938|FG001|Overall Study|Protocol Violation|0|||
44555021|NCT03557801|79571939|FG002|Overall Study|Protocol Violation|0|||
44231733|NCT01871285|79045541|FG000|First Intervention (1 Day)|Adverse Event|1|||
44231734|NCT01871285|79045542|FG001|First Intervention (1 Day)|Adverse Event|0|||
44555022|NCT03557801|79571937|FG000|Overall Study|Withdrawal by Subject|1|||
44555023|NCT03557801|79571938|FG001|Overall Study|Withdrawal by Subject|0|||
44231735|NCT01871285|79045543|FG002|First Intervention (1 Day)|Adverse Event|0|||
44231736|NCT01871285|79045544|FG003|First Intervention (1 Day)|Adverse Event|0|||
44231737|NCT01871285|79045541|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
44231738|NCT01871285|79045542|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
44231739|NCT01871285|79045543|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
44231740|NCT01871285|79045544|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
44555024|NCT03557801|79571939|FG002|Overall Study|Withdrawal by Subject|3|||
44555025|NCT03557801|79571937|FG000|Overall Study|Lost to Follow-up|0|||
44555026|NCT03557801|79571938|FG001|Overall Study|Lost to Follow-up|1|||
44555027|NCT03557801|79571939|FG002|Overall Study|Lost to Follow-up|0|||
44555028|NCT04210180|79571947|FG000|Overall Study|Withdrawal by Subject|2|||
44555029|NCT03523871|79571951|FG000|Overall Study|Death|1|||
44555030|NCT03523715|79571957|FG000|Overall Study|Lost to Follow-up|11|||
44555031|NCT03523715|79571958|FG001|Overall Study|Lost to Follow-up|14|||
44555032|NCT03523715|79571957|FG000|Overall Study|Did not meet inclusion criteria|1|||
44555033|NCT03523715|79571958|FG001|Overall Study|Did not meet inclusion criteria|0|||
44555034|NCT03523715|79571957|FG000|Overall Study|Internally inconsistent reporting|0|||
44555035|NCT03523715|79571958|FG001|Overall Study|Internally inconsistent reporting|2|||
44555036|NCT03980730|79571966|FG000|Overall Study|Study Terminated by Sponsor|0|||
44555037|NCT03980730|79571967|FG001|Overall Study|Study Terminated by Sponsor|3|||
44555038|NCT03980730|79571966|FG000|Overall Study|Adverse Event|2|||
44555039|NCT03980730|79571967|FG001|Overall Study|Adverse Event|0|||
44555040|NCT03980730|79571966|FG000|Overall Study|Sponsor Request|0|||
44555041|NCT03980730|79571967|FG001|Overall Study|Sponsor Request|1|||
44555042|NCT03523091|79571975|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
44555043|NCT03523091|79571976|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
44555044|NCT03523091|79571975|FG000|Overall Study|Withdrawal by Subject|0|||
44555045|NCT03523091|79571976|FG001|Overall Study|Withdrawal by Subject|3|||
44555046|NCT03523091|79571975|FG000|Overall Study|Increase Botox dose|0|||
44555047|NCT03523091|79571976|FG001|Overall Study|Increase Botox dose|1|||
44555048|NCT03438383|79571997|FG000|Overall Study|Protocol Violation|9|||
44555049|NCT03438383|79571998|FG001|Overall Study|Protocol Violation|3|||
44231741|NCT01870973|79045570|FG000|Overall Study|Lost to Follow-up|10|||
44231742|NCT01870973|79045571|FG001|Overall Study|Lost to Follow-up|3|||
44231743|NCT01854827|79045590|FG000|Overall Study|Death|1|||
44231744|NCT01854047|79045733|FG000|Overall Study|Lack of Efficacy|1|||
44496620|NCT00094458|79502559|FG001|Main Study: Through Week 30|Death|0|||
44496621|NCT00094458|79502560|FG002|Main Study: Through Week 30|Death|0|||
44496622|NCT00094458|79502561|FG003|Main Study: Through Week 30|Death|0|||
44496623|NCT00094458|79502562|FG004|Main Study: Through Week 30|Death|0|||
44496624|NCT00094458|79502563|FG005|Main Study: Through Week 30|Death|0|||
44496625|NCT00094458|79502558|FG000|Main Study: Through Week 30|Other|19|||
44555050|NCT03478787|79572006|FG000|Overall Study|Adverse Event|5|||
44555051|NCT03478787|79572007|FG001|Overall Study|Adverse Event|1|||
44555052|NCT03478787|79572006|FG000|Overall Study|Protocol Violation|3|||
44231745|NCT01854047|79045734|FG001|Overall Study|Lack of Efficacy|0|||
44231746|NCT01854047|79045735|FG002|Overall Study|Lack of Efficacy|0|||
44231747|NCT01854047|79045736|FG003|Overall Study|Lack of Efficacy|0|||
44496626|NCT00094458|79502559|FG001|Main Study: Through Week 30|Other|16|||
44496627|NCT00094458|79502560|FG002|Main Study: Through Week 30|Other|9|||
44496628|NCT00094458|79502561|FG003|Main Study: Through Week 30|Other|0|||
44555053|NCT03478787|79572007|FG001|Overall Study|Protocol Violation|0|||
44555054|NCT03478787|79572006|FG000|Overall Study|Lack of Efficacy|7|||
44555055|NCT03478787|79572007|FG001|Overall Study|Lack of Efficacy|1|||
44555056|NCT03478787|79572006|FG000|Overall Study|Lost to Follow-up|9|||
44555057|NCT03478787|79572007|FG001|Overall Study|Lost to Follow-up|5|||
44555058|NCT03478787|79572006|FG000|Overall Study|Withdrawal by Subject|2|||
44555059|NCT03478787|79572007|FG001|Overall Study|Withdrawal by Subject|6|||
44555060|NCT03478787|79572006|FG000|Overall Study|Other, Not Specified|3|||
44555061|NCT03478787|79572007|FG001|Overall Study|Other, Not Specified|0|||
44555062|NCT03488927|79572016|FG000|Overall Study|Withdrawal by Subject|44|||
44555063|NCT03488927|79572017|FG001|Overall Study|Withdrawal by Subject|118|||
44555064|NCT03488927|79572018|FG002|Overall Study|Withdrawal by Subject|217|||
44555065|NCT03437447|79572029|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44555066|NCT03437447|79572030|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44555067|NCT03437447|79572031|FG002|Treatment Period 1|Withdrawal by Subject|1|||
44555068|NCT03487445|79572054|FG000|Randomization|Not treated for administrative reasons|1|||
44555069|NCT03487445|79572055|FG001|Randomization|Not treated for administrative reasons|0|||
44555070|NCT02109172|79572061|FG000|Overall Study|Withdrawal by Subject|1|||
44555071|NCT02109172|79572062|FG001|Overall Study|Withdrawal by Subject|0|||
44555072|NCT02109172|79572063|FG002|Overall Study|Withdrawal by Subject|0|||
44555073|NCT02109172|79572064|FG003|Overall Study|Withdrawal by Subject|1|||
44555074|NCT02109172|79572065|FG004|Overall Study|Withdrawal by Subject|0|||
44555075|NCT02109172|79572066|FG005|Overall Study|Withdrawal by Subject|0|||
44555076|NCT02109172|79572061|FG000|Overall Study|Adverse Event|0|||
44555077|NCT02109172|79572062|FG001|Overall Study|Adverse Event|0|||
44555078|NCT02109172|79572063|FG002|Overall Study|Adverse Event|1|||
44555079|NCT02109172|79572064|FG003|Overall Study|Adverse Event|0|||
44555080|NCT02109172|79572065|FG004|Overall Study|Adverse Event|0|||
44555081|NCT02109172|79572066|FG005|Overall Study|Adverse Event|1|||
44555082|NCT02109172|79572061|FG000|Overall Study|Death|0|||
44555083|NCT02109172|79572062|FG001|Overall Study|Death|0|||
44555084|NCT02109172|79572063|FG002|Overall Study|Death|0|||
44555085|NCT02109172|79572064|FG003|Overall Study|Death|0|||
44555086|NCT02109172|79572065|FG004|Overall Study|Death|1|||
44555087|NCT02109172|79572066|FG005|Overall Study|Death|0|||
44555088|NCT02974868|79572077|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
44555089|NCT02974868|79572078|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
44555090|NCT02974868|79572079|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
44555091|NCT02974868|79572080|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
44555092|NCT02974868|79572077|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
44555093|NCT02974868|79572078|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
44555094|NCT02974868|79572079|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
44555095|NCT02974868|79572080|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
44555096|NCT02974868|79572077|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
44555097|NCT02974868|79572078|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
44555098|NCT02974868|79572079|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
44555099|NCT02974868|79572080|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
44555100|NCT02974868|79572077|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
44555101|NCT02974868|79572078|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
44555102|NCT02974868|79572079|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
44555103|NCT02974868|79572080|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
44555104|NCT03486899|79572125|FG000|Overall Study|Lost to Follow-up|4|||
44555105|NCT03486899|79572126|FG001|Overall Study|Lost to Follow-up|1|||
44555106|NCT03486899|79572127|FG002|Overall Study|Lost to Follow-up|4|||
44555107|NCT03486899|79572128|FG003|Overall Study|Lost to Follow-up|3|||
44555108|NCT03486899|79572125|FG000|Overall Study|Death|1|||
44555109|NCT03486899|79572126|FG001|Overall Study|Death|0|||
44555110|NCT03486899|79572127|FG002|Overall Study|Death|0|||
44555111|NCT03486899|79572128|FG003|Overall Study|Death|1|||
44555112|NCT03486899|79572125|FG000|Overall Study|Adverse Event|0|||
44555113|NCT03486899|79572126|FG001|Overall Study|Adverse Event|2|||
44555114|NCT03486899|79572127|FG002|Overall Study|Adverse Event|0|||
44231748|NCT01854047|79045737|FG004|Overall Study|Lack of Efficacy|0|||
44555115|NCT03486899|79572128|FG003|Overall Study|Adverse Event|2|||
44555116|NCT03486899|79572125|FG000|Overall Study|Withdrawal by Subject|3|||
44555117|NCT03486899|79572126|FG001|Overall Study|Withdrawal by Subject|7|||
44555118|NCT03486899|79572127|FG002|Overall Study|Withdrawal by Subject|4|||
44555119|NCT03486899|79572128|FG003|Overall Study|Withdrawal by Subject|3|||
44555120|NCT03486899|79572125|FG000|Overall Study|Other Reasons|0|||
44555121|NCT03486899|79572126|FG001|Overall Study|Other Reasons|1|||
44555122|NCT03486899|79572127|FG002|Overall Study|Other Reasons|0|||
44231749|NCT01854047|79045733|FG000|Overall Study|Poor compliance to protocol|3|||
44231750|NCT01854047|79045734|FG001|Overall Study|Poor compliance to protocol|0|||
44231751|NCT01854047|79045735|FG002|Overall Study|Poor compliance to protocol|2|||
44555123|NCT03486899|79572128|FG003|Overall Study|Other Reasons|1|||
44555124|NCT02918552|79572140|FG000|Overall Study|Failed Pharmacokinetics|1|||
44555125|NCT02918552|79572141|FG001|Overall Study|Failed Pharmacokinetics|0|||
44555126|NCT02918552|79572140|FG000|Overall Study|Withdrawal by Subject|0|||
44555127|NCT02918552|79572141|FG001|Overall Study|Withdrawal by Subject|1|||
44231752|NCT01854047|79045736|FG003|Overall Study|Poor compliance to protocol|0|||
44496629|NCT00094458|79502562|FG004|Main Study: Through Week 30|Other|0|||
44496630|NCT00094458|79502563|FG005|Main Study: Through Week 30|Other|0|||
44496631|NCT00094458|79502558|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
44231753|NCT01854047|79045737|FG004|Overall Study|Poor compliance to protocol|0|||
44231754|NCT01854047|79045733|FG000|Overall Study|Adverse Event|5|||
44496632|NCT00094458|79502559|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
44496633|NCT00094458|79502560|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
44496634|NCT00094458|79502561|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
44496635|NCT00094458|79502562|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
44496636|NCT00094458|79502563|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
44496637|NCT00094458|79502558|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
44231755|NCT01854047|79045734|FG001|Overall Study|Adverse Event|4|||
44555128|NCT02918552|79572140|FG000|Overall Study|Lost to Follow-up|0|||
44555129|NCT02918552|79572141|FG001|Overall Study|Lost to Follow-up|1|||
44555130|NCT03485495|79572149|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
44555131|NCT03485495|79572150|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
44555132|NCT01065818|79572156|FG000|Overall Study|Withdrawal by Subject|1|||
44555133|NCT01065818|79572156|FG000|Overall Study|Not a candidate for surgery|1|||
44555134|NCT03483623|79572160|FG000|Overall Study|43 complete sets achieved|1|||
44555135|NCT02318277|79572172|FG000|Overall Study|Physician Decision|0|||
44555136|NCT02318277|79572173|FG001|Overall Study|Physician Decision|0|||
44555137|NCT02318277|79572174|FG002|Overall Study|Physician Decision|0|||
44555138|NCT02318277|79572175|FG003|Overall Study|Physician Decision|0|||
44555139|NCT02318277|79572176|FG004|Overall Study|Physician Decision|0|||
44496638|NCT00094458|79502559|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
44496639|NCT00094458|79502560|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
44496640|NCT00094458|79502561|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
44496641|NCT00094458|79502562|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
44496642|NCT00094458|79502563|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
44496643|NCT00094458|79502558|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
44496644|NCT00094458|79502559|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
44496645|NCT00094458|79502560|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
44555140|NCT02318277|79572177|FG005|Overall Study|Physician Decision|0|||
44555141|NCT02318277|79572178|FG006|Overall Study|Physician Decision|0|||
44555142|NCT02318277|79572179|FG007|Overall Study|Physician Decision|1|||
44555143|NCT02318277|79572172|FG000|Overall Study|Other|0|||
44555144|NCT02318277|79572173|FG001|Overall Study|Other|0|||
44555145|NCT02318277|79572174|FG002|Overall Study|Other|0|||
44555146|NCT02318277|79572175|FG003|Overall Study|Other|0|||
44555147|NCT02318277|79572176|FG004|Overall Study|Other|0|||
44555148|NCT02318277|79572177|FG005|Overall Study|Other|0|||
44555149|NCT02318277|79572178|FG006|Overall Study|Other|1|||
44555150|NCT02318277|79572179|FG007|Overall Study|Other|0|||
44555151|NCT02318277|79572172|FG000|Overall Study|Withdrawal by Subject|0|||
44555152|NCT02318277|79572173|FG001|Overall Study|Withdrawal by Subject|0|||
44555153|NCT02318277|79572174|FG002|Overall Study|Withdrawal by Subject|1|||
44555154|NCT02318277|79572175|FG003|Overall Study|Withdrawal by Subject|0|||
44555155|NCT02318277|79572176|FG004|Overall Study|Withdrawal by Subject|1|||
44496646|NCT00094458|79502561|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
44496647|NCT00094458|79502562|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
44496648|NCT00094458|79502563|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
44496649|NCT00094458|79502558|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
44496650|NCT00094458|79502559|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
44496651|NCT00094458|79502560|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
44496652|NCT00094458|79502561|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
44496653|NCT00094458|79502562|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
44496654|NCT00094458|79502563|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
44496655|NCT00094458|79502558|FG000|OLE: Open-Label Extension|Adverse Event|0|||
44496656|NCT00094458|79502559|FG001|OLE: Open-Label Extension|Adverse Event|0|||
44555156|NCT02318277|79572177|FG005|Overall Study|Withdrawal by Subject|1|||
44555157|NCT02318277|79572178|FG006|Overall Study|Withdrawal by Subject|6|||
44555158|NCT02318277|79572179|FG007|Overall Study|Withdrawal by Subject|14|||
44555159|NCT02318277|79572172|FG000|Overall Study|Participant trial terminated by sponsor|0|||
44555160|NCT02318277|79572173|FG001|Overall Study|Participant trial terminated by sponsor|0|||
44555161|NCT02318277|79572174|FG002|Overall Study|Participant trial terminated by sponsor|1|||
44555162|NCT02318277|79572175|FG003|Overall Study|Participant trial terminated by sponsor|0|||
44555163|NCT02318277|79572176|FG004|Overall Study|Participant trial terminated by sponsor|1|||
44555164|NCT02318277|79572177|FG005|Overall Study|Participant trial terminated by sponsor|2|||
44555165|NCT02318277|79572178|FG006|Overall Study|Participant trial terminated by sponsor|5|||
44555166|NCT02318277|79572179|FG007|Overall Study|Participant trial terminated by sponsor|16|||
44555167|NCT02318277|79572172|FG000|Overall Study|Lost to Follow-up|1|||
44555168|NCT02318277|79572173|FG001|Overall Study|Lost to Follow-up|0|||
44555169|NCT02318277|79572174|FG002|Overall Study|Lost to Follow-up|1|||
44555170|NCT02318277|79572175|FG003|Overall Study|Lost to Follow-up|0|||
44555171|NCT02318277|79572176|FG004|Overall Study|Lost to Follow-up|0|||
44555172|NCT02318277|79572177|FG005|Overall Study|Lost to Follow-up|0|||
44555173|NCT02318277|79572178|FG006|Overall Study|Lost to Follow-up|3|||
44555174|NCT02318277|79572179|FG007|Overall Study|Lost to Follow-up|4|||
44555175|NCT02318277|79572172|FG000|Overall Study|Death|5|||
44555176|NCT02318277|79572173|FG001|Overall Study|Death|3|||
44555177|NCT02318277|79572174|FG002|Overall Study|Death|1|||
44555178|NCT02318277|79572175|FG003|Overall Study|Death|4|||
44555179|NCT02318277|79572176|FG004|Overall Study|Death|6|||
44555180|NCT02318277|79572177|FG005|Overall Study|Death|5|||
44555181|NCT02318277|79572178|FG006|Overall Study|Death|34|||
44555182|NCT02318277|79572179|FG007|Overall Study|Death|58|||
44555183|NCT02318277|79572172|FG000|Overall Study|Transitioned to Hospice|0|||
44555184|NCT02318277|79572173|FG001|Overall Study|Transitioned to Hospice|0|||
44555185|NCT02318277|79572174|FG002|Overall Study|Transitioned to Hospice|0|||
44555186|NCT02318277|79572175|FG003|Overall Study|Transitioned to Hospice|0|||
44555187|NCT02318277|79572176|FG004|Overall Study|Transitioned to Hospice|0|||
44555188|NCT02318277|79572177|FG005|Overall Study|Transitioned to Hospice|1|||
44555189|NCT02318277|79572178|FG006|Overall Study|Transitioned to Hospice|0|||
44555190|NCT02318277|79572179|FG007|Overall Study|Transitioned to Hospice|0|||
44555191|NCT01063868|79572224|FG000|Overall Study|Adverse Event|9|||
44555192|NCT01063868|79572225|FG001|Overall Study|Adverse Event|7|||
44555193|NCT01063868|79572224|FG000|Overall Study|Withdrawal by Subject|3|||
44555194|NCT01063868|79572225|FG001|Overall Study|Withdrawal by Subject|1|||
44555195|NCT01063868|79572224|FG000|Overall Study|Study Terminated By Sponsor|23|||
44555196|NCT01063868|79572225|FG001|Overall Study|Study Terminated By Sponsor|4|||
44555197|NCT02974088|79572233|FG000|Overall Study|Lost to Follow-up|0|||
44555198|NCT02974088|79572234|FG001|Overall Study|Lost to Follow-up|2|||
44555199|NCT02974088|79572233|FG000|Overall Study|Adverse Event|0|||
44555200|NCT02974088|79572234|FG001|Overall Study|Adverse Event|1|||
44555201|NCT02385045|79572240|FG000|Overall Study|Endoscopy could not be completed|4|||
44555202|NCT02974010|79572248|FG000|Overall Study|Lost to Follow-up|3|||
44555203|NCT02974010|79572249|FG001|Overall Study|Lost to Follow-up|1|||
44555204|NCT02974010|79572250|FG002|Overall Study|Lost to Follow-up|0|||
44555205|NCT02974010|79572251|FG003|Overall Study|Lost to Follow-up|0|||
44555206|NCT02974010|79572248|FG000|Overall Study|Withdrawal by Subject|2|||
44555207|NCT02974010|79572249|FG001|Overall Study|Withdrawal by Subject|1|||
44555208|NCT02974010|79572250|FG002|Overall Study|Withdrawal by Subject|0|||
44555209|NCT02974010|79572251|FG003|Overall Study|Withdrawal by Subject|0|||
44555210|NCT02974010|79572248|FG000|Overall Study|Adverse Event|0|||
44555211|NCT02974010|79572249|FG001|Overall Study|Adverse Event|1|||
44555212|NCT02974010|79572250|FG002|Overall Study|Adverse Event|0|||
44555213|NCT02974010|79572251|FG003|Overall Study|Adverse Event|0|||
44555214|NCT02974010|79572248|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
44555215|NCT02974010|79572249|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
44555216|NCT02974010|79572250|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
44555217|NCT02974010|79572251|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
44555218|NCT02974010|79572248|FG000|Overall Study|Lack of Efficacy|0|||
44555219|NCT02974010|79572249|FG001|Overall Study|Lack of Efficacy|0|||
44555220|NCT02974010|79572250|FG002|Overall Study|Lack of Efficacy|1|||
44555221|NCT02974010|79572251|FG003|Overall Study|Lack of Efficacy|0|||
44555222|NCT02030938|79572261|FG000|Overall Study|Lost to Follow-up|4|||
44555223|NCT02030938|79572261|FG000|Overall Study|Withdrawal by Subject|1|||
44555224|NCT03122535|79572269|FG000|Overall Study|Lost to Follow-up|68|||
44555225|NCT03122535|79572270|FG001|Overall Study|Lost to Follow-up|68|||
44555226|NCT03122535|79572269|FG000|Overall Study|Physician Decision|3|||
44555227|NCT03122535|79572270|FG001|Overall Study|Physician Decision|3|||
44555228|NCT03122535|79572269|FG000|Overall Study|Withdrawal by Subject|2|||
44555229|NCT03122535|79572270|FG001|Overall Study|Withdrawal by Subject|2|||
44555230|NCT01061606|79572276|FG000|Overall Study|Adverse Event|1|||
44555231|NCT01061606|79572276|FG000|Overall Study|Death|1|||
44555232|NCT01061606|79572276|FG000|Overall Study|Disease Progression|4|||
44555233|NCT01061606|79572276|FG000|Overall Study|alternative therapy|2|||
44555234|NCT03122457|79572280|FG000|Overall Study|Withdrawal by Subject|6|||
44555235|NCT03482453|79572296|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555236|NCT03482453|79572297|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555237|NCT03482453|79572298|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555238|NCT03482453|79572299|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555239|NCT03482453|79572300|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555240|NCT03482453|79572301|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555241|NCT03482453|79572302|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555242|NCT03482453|79572303|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555243|NCT03482453|79572304|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555244|NCT03482453|79572305|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555245|NCT03482453|79572306|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
44555246|NCT03482453|79572307|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
44555247|NCT03480425|79572343|FG000|Overall Study|Force transducer technical failure|1|||
44555248|NCT03472547|79572347|FG000|Overall Study|Withdrawal by Subject|30|||
44555249|NCT00799396|79572351|FG000|Clopidogrel Treatment|Adverse Event|6|||
44555250|NCT00799396|79572351|FG000|Clopidogrel Treatment|Physician Decision|5|||
44555251|NCT00799396|79572351|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
44555252|NCT00799396|79572351|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
44555253|NCT00799396|79572351|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
44555254|NCT03469349|79572357|FG000|Overall Study|Withdrawal by Subject|1|||
44555255|NCT03469349|79572358|FG001|Overall Study|Withdrawal by Subject|3|||
44555256|NCT03469349|79572357|FG000|Overall Study|Progressive Disease|0|||
44555257|NCT03469349|79572358|FG001|Overall Study|Progressive Disease|1|||
44555258|NCT03469349|79572357|FG000|Overall Study|Lost to Follow-up|2|||
44555259|NCT03469349|79572358|FG001|Overall Study|Lost to Follow-up|2|||
44555260|NCT03469349|79572357|FG000|Overall Study|Adverse Event|2|||
44231756|NCT01854047|79045735|FG002|Overall Study|Adverse Event|6|||
44555261|NCT03469349|79572358|FG001|Overall Study|Adverse Event|4|||
44555262|NCT03467945|79572368|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44555263|NCT03467945|79572369|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44555264|NCT03467945|79572370|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44555265|NCT03467945|79572371|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44555266|NCT03467945|79572368|FG000|Treatment Period 3|Withdrawal by Subject|1|||
44231757|NCT01854047|79045736|FG003|Overall Study|Adverse Event|10|||
44231758|NCT01854047|79045737|FG004|Overall Study|Adverse Event|7|||
44231759|NCT01854047|79045733|FG000|Overall Study|Randomized but not treated|0|||
44231760|NCT01854047|79045734|FG001|Overall Study|Randomized but not treated|1|||
44231761|NCT01854047|79045735|FG002|Overall Study|Randomized but not treated|2|||
44496657|NCT00094458|79502560|FG002|OLE: Open-Label Extension|Adverse Event|0|||
44496658|NCT00094458|79502561|FG003|OLE: Open-Label Extension|Adverse Event|0|||
44496659|NCT00094458|79502562|FG004|OLE: Open-Label Extension|Adverse Event|3|||
44496660|NCT00094458|79502563|FG005|OLE: Open-Label Extension|Adverse Event|4|||
44496661|NCT00094458|79502558|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
44496662|NCT00094458|79502559|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
44496663|NCT00094458|79502560|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
44496664|NCT00094458|79502561|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
44496665|NCT00094458|79502562|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
44496666|NCT00094458|79502563|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
44496667|NCT00094458|79502558|FG000|OLE: Open-Label Extension|Patient decision|0|||
44496668|NCT00094458|79502559|FG001|OLE: Open-Label Extension|Patient decision|0|||
44496669|NCT00094458|79502560|FG002|OLE: Open-Label Extension|Patient decision|0|||
44496670|NCT00094458|79502561|FG003|OLE: Open-Label Extension|Patient decision|0|||
44496671|NCT00094458|79502562|FG004|OLE: Open-Label Extension|Patient decision|1|||
44496672|NCT00094458|79502563|FG005|OLE: Open-Label Extension|Patient decision|0|||
44496673|NCT00406367|79502579|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
44496674|NCT00406367|79502580|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
44496675|NCT00406367|79502579|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
44496676|NCT00406367|79502580|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
44496677|NCT00406367|79502579|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
44496678|NCT00406367|79502580|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
44496679|NCT00406367|79502579|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
44496680|NCT00406367|79502580|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
44496681|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
44555267|NCT03467945|79572369|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44231762|NCT01854047|79045736|FG003|Overall Study|Randomized but not treated|0|||
44496682|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
44555268|NCT03467945|79572370|FG002|Treatment Period 3|Withdrawal by Subject|2|||
44555269|NCT03467945|79572371|FG003|Treatment Period 3|Withdrawal by Subject|1|||
44555270|NCT00069238|79572382|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
44555271|NCT00069238|79572383|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
44231763|NCT01854047|79045737|FG004|Overall Study|Randomized but not treated|4|||
44496683|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
44555272|NCT00069238|79572384|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
44555273|NCT00069238|79572382|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
44555274|NCT00069238|79572383|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
44555275|NCT00069238|79572384|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
44555276|NCT00069238|79572382|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
44555277|NCT00069238|79572383|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
44555278|NCT00069238|79572384|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
44555279|NCT03435497|79572391|FG000|Overall Study|Lost to Follow-up|1|||
44555280|NCT03435497|79572392|FG001|Overall Study|Lost to Follow-up|0|||
44555281|NCT03435497|79572391|FG000|Overall Study|Death|1|||
44555282|NCT03435497|79572392|FG001|Overall Study|Death|0|||
44555283|NCT03435497|79572391|FG000|Overall Study|Withdrawal by Subject|0|||
44555284|NCT03435497|79572392|FG001|Overall Study|Withdrawal by Subject|4|||
44555285|NCT03435497|79572391|FG000|Overall Study|Wrong survey administered|0|||
44555286|NCT03435497|79572392|FG001|Overall Study|Wrong survey administered|2|||
44555287|NCT03073200|79572401|FG000|Double Blind Treatment Period|Protocol Violation|1|||
44555288|NCT03073200|79572402|FG001|Double Blind Treatment Period|Protocol Violation|0|||
44555289|NCT03073200|79572403|FG002|Double Blind Treatment Period|Protocol Violation|0|||
44555290|NCT03073200|79572404|FG003|Double Blind Treatment Period|Protocol Violation|0|||
44555291|NCT03073200|79572405|FG004|Double Blind Treatment Period|Protocol Violation|0|||
44555292|NCT03073200|79572406|FG005|Double Blind Treatment Period|Protocol Violation|0|||
44555293|NCT03073200|79572407|FG006|Double Blind Treatment Period|Protocol Violation|0|||
44555294|NCT03073200|79572408|FG007|Double Blind Treatment Period|Protocol Violation|0|||
44555295|NCT03073200|79572409|FG008|Double Blind Treatment Period|Protocol Violation|0|||
44555296|NCT03073200|79572410|FG009|Double Blind Treatment Period|Protocol Violation|0|||
44555297|NCT03073200|79572411|FG010|Double Blind Treatment Period|Protocol Violation|0|||
44555298|NCT03073200|79572412|FG011|Double Blind Treatment Period|Protocol Violation|0|||
44555299|NCT03073200|79572413|FG012|Double Blind Treatment Period|Protocol Violation|0|||
44555300|NCT03073200|79572414|FG013|Double Blind Treatment Period|Protocol Violation|0|||
44555301|NCT03073200|79572415|FG014|Double Blind Treatment Period|Protocol Violation|0|||
44555302|NCT03073200|79572401|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555303|NCT03073200|79572402|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
44555304|NCT03073200|79572403|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555305|NCT03073200|79572404|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555306|NCT03073200|79572405|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555307|NCT03073200|79572406|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555308|NCT03073200|79572407|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555309|NCT03073200|79572408|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555310|NCT03073200|79572409|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555311|NCT03073200|79572410|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555312|NCT03073200|79572411|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555313|NCT03073200|79572412|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555314|NCT03073200|79572413|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555315|NCT03073200|79572414|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555316|NCT03073200|79572415|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
44555317|NCT03073200|79572401|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
44555318|NCT03073200|79572402|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555319|NCT03073200|79572403|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555320|NCT03073200|79572404|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555321|NCT03073200|79572405|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
44496684|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
44496685|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
44496686|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
44496687|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
44496688|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
44496689|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
44496690|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
44496691|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
44555322|NCT03073200|79572406|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555323|NCT03073200|79572407|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555324|NCT03073200|79572408|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555325|NCT03073200|79572409|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555326|NCT03073200|79572410|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555327|NCT03073200|79572411|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555328|NCT03073200|79572412|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555329|NCT03073200|79572413|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555330|NCT03073200|79572414|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555331|NCT03073200|79572415|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
44555332|NCT03073200|79572401|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555333|NCT03073200|79572402|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555334|NCT03073200|79572403|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555335|NCT03073200|79572404|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
44555336|NCT03073200|79572405|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
44555337|NCT03073200|79572406|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555338|NCT03073200|79572407|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555339|NCT03073200|79572408|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555340|NCT03073200|79572409|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555341|NCT03073200|79572410|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555342|NCT03073200|79572411|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555343|NCT03073200|79572412|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555344|NCT03073200|79572413|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555345|NCT03073200|79572414|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555346|NCT03073200|79572415|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
44555347|NCT03073200|79572401|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
44555348|NCT03073200|79572402|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
44555349|NCT03073200|79572403|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
44555350|NCT03073200|79572404|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
44555351|NCT03073200|79572405|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
44555352|NCT03073200|79572406|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
44555353|NCT03073200|79572407|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
44555354|NCT03073200|79572408|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
44555355|NCT03073200|79572409|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
44231764|NCT01854047|79045733|FG000|Overall Study|Other than specified above|3|||
44231765|NCT01854047|79045734|FG001|Overall Study|Other than specified above|3|||
44555356|NCT03073200|79572410|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
44555357|NCT03073200|79572411|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
44555358|NCT03073200|79572412|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
44555359|NCT03073200|79572413|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
44555360|NCT03073200|79572414|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
44555361|NCT03073200|79572415|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
44555362|NCT03073200|79572401|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555363|NCT03073200|79572402|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555364|NCT03073200|79572403|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555365|NCT03073200|79572404|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555366|NCT03073200|79572405|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
44555367|NCT03073200|79572406|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555368|NCT03073200|79572407|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555369|NCT03073200|79572408|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
44231766|NCT01854047|79045735|FG002|Overall Study|Other than specified above|3|||
44231767|NCT01854047|79045736|FG003|Overall Study|Other than specified above|5|||
44231768|NCT01854047|79045737|FG004|Overall Study|Other than specified above|8|||
44231769|NCT01870739|79045783|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
44231770|NCT01870739|79045784|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
44231771|NCT01870739|79045783|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
44231772|NCT01870739|79045784|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
44231773|NCT01870739|79045783|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
44231774|NCT01870739|79045784|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
44231775|NCT01870739|79045783|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
44231776|NCT01870739|79045784|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
44231777|NCT01870739|79045783|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
44231778|NCT01870739|79045784|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
44231779|NCT01870739|79045783|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
44231780|NCT01870739|79045784|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
44231781|NCT01870739|79045783|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
44555370|NCT03073200|79572409|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555371|NCT03073200|79572410|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555372|NCT03073200|79572411|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555373|NCT03073200|79572412|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555374|NCT03073200|79572413|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555375|NCT03073200|79572414|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555376|NCT03073200|79572415|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
44555377|NCT03073200|79572401|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555378|NCT03073200|79572402|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555379|NCT03073200|79572403|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555380|NCT03073200|79572404|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
44555381|NCT03073200|79572405|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
44555382|NCT03073200|79572406|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555383|NCT03073200|79572407|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555384|NCT03073200|79572408|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555385|NCT03073200|79572409|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555386|NCT03073200|79572410|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555387|NCT03073200|79572411|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555388|NCT03073200|79572412|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555389|NCT03073200|79572413|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555390|NCT03073200|79572414|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555391|NCT03073200|79572415|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
44555392|NCT03073200|79572401|FG000|Extension Period|Lost to Follow-up|0|||
44555393|NCT03073200|79572402|FG001|Extension Period|Lost to Follow-up|0|||
44555394|NCT03073200|79572403|FG002|Extension Period|Lost to Follow-up|0|||
44555395|NCT03073200|79572404|FG003|Extension Period|Lost to Follow-up|0|||
44555396|NCT03073200|79572405|FG004|Extension Period|Lost to Follow-up|0|||
44555397|NCT03073200|79572406|FG005|Extension Period|Lost to Follow-up|0|||
44555398|NCT03073200|79572407|FG006|Extension Period|Lost to Follow-up|1|||
44555399|NCT03073200|79572408|FG007|Extension Period|Lost to Follow-up|1|||
44555400|NCT03073200|79572409|FG008|Extension Period|Lost to Follow-up|0|||
44555401|NCT03073200|79572410|FG009|Extension Period|Lost to Follow-up|0|||
44555402|NCT03073200|79572411|FG010|Extension Period|Lost to Follow-up|0|||
44555403|NCT03073200|79572412|FG011|Extension Period|Lost to Follow-up|0|||
44555404|NCT03073200|79572413|FG012|Extension Period|Lost to Follow-up|0|||
44555405|NCT03073200|79572414|FG013|Extension Period|Lost to Follow-up|0|||
44555406|NCT03073200|79572415|FG014|Extension Period|Lost to Follow-up|0|||
44555407|NCT03073200|79572401|FG000|Extension Period|Sponsor Decision|0|||
44555408|NCT03073200|79572402|FG001|Extension Period|Sponsor Decision|0|||
44555409|NCT03073200|79572403|FG002|Extension Period|Sponsor Decision|0|||
44555410|NCT03073200|79572404|FG003|Extension Period|Sponsor Decision|0|||
44555411|NCT03073200|79572405|FG004|Extension Period|Sponsor Decision|0|||
44555412|NCT03073200|79572406|FG005|Extension Period|Sponsor Decision|0|||
44555413|NCT03073200|79572407|FG006|Extension Period|Sponsor Decision|0|||
44555414|NCT03073200|79572408|FG007|Extension Period|Sponsor Decision|0|||
44555415|NCT03073200|79572409|FG008|Extension Period|Sponsor Decision|1|||
44555416|NCT03073200|79572410|FG009|Extension Period|Sponsor Decision|0|||
44555417|NCT03073200|79572411|FG010|Extension Period|Sponsor Decision|0|||
44555418|NCT03073200|79572412|FG011|Extension Period|Sponsor Decision|0|||
44555419|NCT03073200|79572413|FG012|Extension Period|Sponsor Decision|0|||
44555420|NCT03073200|79572414|FG013|Extension Period|Sponsor Decision|0|||
44555421|NCT03073200|79572415|FG014|Extension Period|Sponsor Decision|0|||
44555422|NCT03073200|79572401|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
44555423|NCT03073200|79572402|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
44555424|NCT03073200|79572403|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
44555425|NCT03073200|79572404|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
44555426|NCT03073200|79572405|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
44555427|NCT03073200|79572406|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
44274851|NCT03266588|79221041|FG001|Long-term Treatment Period|Other Reasons|0|||
44274852|NCT03266588|79221042|FG002|Long-term Treatment Period|Other Reasons|0|||
44555428|NCT03073200|79572407|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
44555429|NCT03073200|79572408|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
44555430|NCT03073200|79572409|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
44555431|NCT03073200|79572410|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
44555432|NCT03073200|79572411|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
44555433|NCT03073200|79572412|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
44231782|NCT01870739|79045784|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
44231783|NCT01613417|79045811|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
44231784|NCT01613417|79045812|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
44231785|NCT01870583|79045840|FG000|Overall Study|Protocol Violation|0|||
44231786|NCT01870583|79045841|FG001|Overall Study|Protocol Violation|5|||
44231787|NCT01870583|79045842|FG002|Overall Study|Protocol Violation|3|||
44231788|NCT01870583|79045840|FG000|Overall Study|Lost to Follow-up|11|||
44231789|NCT01870583|79045841|FG001|Overall Study|Lost to Follow-up|13|||
44231790|NCT01870583|79045842|FG002|Overall Study|Lost to Follow-up|5|||
44231791|NCT01869959|79045900|FG000|Randomization Period|Physician Decision|0|||
44231792|NCT01869959|79045901|FG001|Randomization Period|Physician Decision|0|||
44231793|NCT01869959|79045902|FG002|Randomization Period|Physician Decision|0|||
44231794|NCT01869959|79045903|FG003|Randomization Period|Physician Decision|0|||
44231795|NCT01869959|79045904|FG004|Randomization Period|Physician Decision|1|||
44231796|NCT01869959|79045900|FG000|Treatment Period|Adverse Event|1|||
44231797|NCT01869959|79045901|FG001|Treatment Period|Adverse Event|0|||
44231798|NCT01869959|79045902|FG002|Treatment Period|Adverse Event|3|||
44231799|NCT01869959|79045903|FG003|Treatment Period|Adverse Event|1|||
44231800|NCT01869959|79045904|FG004|Treatment Period|Adverse Event|0|||
44231801|NCT01869959|79045900|FG000|Treatment Period|Sponsor decision|0|||
44231802|NCT01869959|79045901|FG001|Treatment Period|Sponsor decision|1|||
44231803|NCT01869959|79045902|FG002|Treatment Period|Sponsor decision|0|||
44231804|NCT01869959|79045903|FG003|Treatment Period|Sponsor decision|1|||
44231805|NCT01869959|79045904|FG004|Treatment Period|Sponsor decision|0|||
44231806|NCT01869959|79045900|FG000|Treatment Period|Withdrawal by Subject|0|||
44231807|NCT01869959|79045901|FG001|Treatment Period|Withdrawal by Subject|1|||
44231808|NCT01869959|79045902|FG002|Treatment Period|Withdrawal by Subject|0|||
44231809|NCT01869959|79045903|FG003|Treatment Period|Withdrawal by Subject|0|||
44231810|NCT01869959|79045904|FG004|Treatment Period|Withdrawal by Subject|0|||
44231811|NCT01613027|79045965|FG000|Overall Study|Lost to Follow-up|5|||
44231812|NCT01613027|79045965|FG000|Overall Study|Switched Physician|1|||
44231813|NCT01613027|79045965|FG000|Overall Study|Lack of Efficacy|1|||
44231814|NCT01613027|79045965|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
44231815|NCT01869725|79045983|FG000|Overall Study|ineligible after registration|1|||
44231816|NCT01869725|79045983|FG000|Overall Study|Death|1|||
44231817|NCT01869725|79045983|FG000|Overall Study|Lost to Follow-up|2|||
44231818|NCT01851863|79046004|FG000|Overall Study|Did not receive study medication|2|||
44274853|NCT03266588|79221040|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
44231819|NCT01851863|79046005|FG001|Overall Study|Did not receive study medication|5|||
44231820|NCT01851863|79046006|FG002|Overall Study|Did not receive study medication|3|||
44231821|NCT01851863|79046007|FG003|Overall Study|Did not receive study medication|0|||
44274854|NCT03266588|79221041|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
44274855|NCT03266588|79221042|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
44274856|NCT03019640|79221112|FG000|Overall Study|Screen Failures|4|||
44274857|NCT03019640|79221112|FG000|Overall Study|Adverse Event|3|||
44274858|NCT03019640|79221112|FG000|Overall Study|Participant Relapsed|1|||
44274859|NCT02240706|79221180|FG000|Overall Study|Lack of Efficacy|2|||
44274860|NCT02240706|79221181|FG001|Overall Study|Lack of Efficacy|2|||
44274861|NCT02240706|79221182|FG002|Overall Study|Lack of Efficacy|2|||
44274862|NCT02240706|79221183|FG003|Overall Study|Lack of Efficacy|2|||
44274863|NCT02240706|79221184|FG004|Overall Study|Lack of Efficacy|5|||
44274864|NCT02240706|79221185|FG005|Overall Study|Lack of Efficacy|0|||
44555434|NCT03073200|79572413|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
44555435|NCT03073200|79572414|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
44555436|NCT03073200|79572415|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
44555437|NCT03073200|79572401|FG000|Extension Period|Withdrawal by Subject|0|||
44555438|NCT03073200|79572402|FG001|Extension Period|Withdrawal by Subject|0|||
44555439|NCT03073200|79572403|FG002|Extension Period|Withdrawal by Subject|0|||
44555440|NCT03073200|79572404|FG003|Extension Period|Withdrawal by Subject|0|||
44555441|NCT03073200|79572405|FG004|Extension Period|Withdrawal by Subject|0|||
44555442|NCT03073200|79572406|FG005|Extension Period|Withdrawal by Subject|0|||
44555443|NCT03073200|79572407|FG006|Extension Period|Withdrawal by Subject|1|||
44555444|NCT03073200|79572408|FG007|Extension Period|Withdrawal by Subject|2|||
44555445|NCT03073200|79572409|FG008|Extension Period|Withdrawal by Subject|0|||
44555446|NCT03073200|79572410|FG009|Extension Period|Withdrawal by Subject|0|||
44231822|NCT01851863|79046004|FG000|Overall Study|Lost to Follow-up|3|||
44231823|NCT01851863|79046005|FG001|Overall Study|Lost to Follow-up|4|||
44231824|NCT01851863|79046006|FG002|Overall Study|Lost to Follow-up|2|||
44231825|NCT01851863|79046007|FG003|Overall Study|Lost to Follow-up|3|||
44231826|NCT01850615|79046035|FG000|Overall Study|Protocol Violation|4|||
44231827|NCT01850615|79046036|FG001|Overall Study|Protocol Violation|1|||
44274865|NCT02240706|79221186|FG006|Overall Study|Lack of Efficacy|0|||
44274866|NCT02240706|79221180|FG000|Overall Study|Adverse Event|1|||
44274867|NCT02240706|79221181|FG001|Overall Study|Adverse Event|0|||
44555447|NCT03073200|79572411|FG010|Extension Period|Withdrawal by Subject|0|||
44555448|NCT03073200|79572412|FG011|Extension Period|Withdrawal by Subject|0|||
44555449|NCT03073200|79572413|FG012|Extension Period|Withdrawal by Subject|0|||
44555450|NCT03073200|79572414|FG013|Extension Period|Withdrawal by Subject|0|||
44555451|NCT03073200|79572415|FG014|Extension Period|Withdrawal by Subject|0|||
44555452|NCT03073200|79572401|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555453|NCT03073200|79572402|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555454|NCT03073200|79572403|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555455|NCT03073200|79572404|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555456|NCT03073200|79572405|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555457|NCT03073200|79572406|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555458|NCT03073200|79572407|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555459|NCT03073200|79572408|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555460|NCT03073200|79572409|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555461|NCT03073200|79572410|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555462|NCT03073200|79572411|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555463|NCT03073200|79572412|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
44555464|NCT03073200|79572413|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555465|NCT03073200|79572414|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555466|NCT03073200|79572415|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
44555467|NCT03073200|79572401|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555468|NCT03073200|79572402|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555469|NCT03073200|79572403|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555470|NCT03073200|79572404|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555471|NCT03073200|79572405|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555472|NCT03073200|79572406|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555473|NCT03073200|79572407|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555474|NCT03073200|79572408|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555475|NCT03073200|79572409|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555476|NCT03073200|79572410|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44231828|NCT01850615|79046035|FG000|Overall Study|Adverse Event|2|||
44231829|NCT01850615|79046036|FG001|Overall Study|Adverse Event|1|||
44496692|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
44496693|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
44496694|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
44496695|NCT00406367|79502579|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
44496696|NCT00406367|79502580|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
44496697|NCT00394589|79502589|FG000|Overall Study|Adverse Event|2|||
44496698|NCT00394589|79502590|FG001|Overall Study|Adverse Event|1|||
44496699|NCT00394589|79502591|FG002|Overall Study|Adverse Event|2|||
44496700|NCT00394589|79502589|FG000|Overall Study|Lack of Efficacy|2|||
44496701|NCT00394589|79502590|FG001|Overall Study|Lack of Efficacy|2|||
44496702|NCT00394589|79502591|FG002|Overall Study|Lack of Efficacy|3|||
44496703|NCT00394589|79502589|FG000|Overall Study|Protocol Violation|4|||
44496704|NCT00394589|79502590|FG001|Overall Study|Protocol Violation|0|||
44496705|NCT00394589|79502591|FG002|Overall Study|Protocol Violation|2|||
44496706|NCT00068406|79502599|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
44496707|NCT00068406|79502599|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
44496708|NCT00403559|79502605|FG000|Overall Study|Adverse Event|0|||
44496709|NCT00403559|79502606|FG001|Overall Study|Adverse Event|1|||
44496710|NCT00403559|79502605|FG000|Overall Study|Lost to Follow-up|3|||
44496711|NCT00403559|79502606|FG001|Overall Study|Lost to Follow-up|3|||
44496712|NCT00403559|79502605|FG000|Overall Study|Withdrawal by Subject|1|||
44496713|NCT00403559|79502606|FG001|Overall Study|Withdrawal by Subject|0|||
44496714|NCT00403481|79502614|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
44496715|NCT00403481|79502614|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
44496716|NCT00403481|79502614|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
44496717|NCT00403481|79502614|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
44496718|NCT00403481|79502614|FG000|Olm 40 mg|Adverse Event|2|||
44496719|NCT00403481|79502614|FG000|Olm 40 mg|Protocol Violation|1|||
44496720|NCT00403481|79502614|FG000|Olm 40 mg|Withdrawal by Subject|1|||
44496721|NCT00403481|79502614|FG000|Olm 40 mg|Other|1|||
44496722|NCT00403481|79502614|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
44231830|NCT01850615|79046035|FG000|Overall Study|Withdrawal by Subject|3|||
44231831|NCT01850615|79046036|FG001|Overall Study|Withdrawal by Subject|1|||
44496723|NCT00403481|79502614|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
44496724|NCT00403481|79502614|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
44496725|NCT00403481|79502614|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
44496726|NCT00403481|79502614|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
44231832|NCT01850615|79046035|FG000|Overall Study|Lost to Follow-up|0|||
44555477|NCT03073200|79572411|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555478|NCT03073200|79572412|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
44555479|NCT03073200|79572413|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555480|NCT03073200|79572414|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555481|NCT03073200|79572415|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
44555482|NCT03073200|79572401|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555483|NCT03073200|79572402|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555484|NCT03073200|79572403|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555485|NCT03073200|79572404|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555486|NCT03073200|79572405|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555487|NCT03073200|79572406|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555488|NCT03073200|79572407|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555489|NCT03073200|79572408|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555490|NCT03073200|79572409|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555491|NCT03073200|79572410|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555492|NCT03073200|79572411|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
44555493|NCT03073200|79572412|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
44555494|NCT03073200|79572413|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555495|NCT03073200|79572414|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555496|NCT03073200|79572415|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44555497|NCT03073200|79572401|FG000|Randomized Withdrawal Period|Adverse Event|0|||
44555498|NCT03073200|79572402|FG001|Randomized Withdrawal Period|Adverse Event|0|||
44555499|NCT03073200|79572403|FG002|Randomized Withdrawal Period|Adverse Event|0|||
44555500|NCT03073200|79572404|FG003|Randomized Withdrawal Period|Adverse Event|0|||
44496727|NCT00403481|79502614|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
44496728|NCT00402779|79502623|FG000|Overall Study|Screen Failure|77|||
44496729|NCT00402779|79502624|FG001|Overall Study|Screen Failure|76|||
44496730|NCT00394433|79502630|FG000|Overall Study|Adverse Event|2|||
44496731|NCT00394433|79502630|FG000|Overall Study|Alternative Therapy|1|||
44496732|NCT00092534|79502636|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
44496733|NCT00092534|79502637|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
44496734|NCT00092534|79502638|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44496735|NCT00092534|79502639|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44496736|NCT00092534|79502640|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
44496737|NCT00092534|79502636|FG000|Base Study Vaccination Period|Adverse Event|3|||
44496738|NCT00092534|79502637|FG001|Base Study Vaccination Period|Adverse Event|1|||
44496739|NCT00092534|79502638|FG002|Base Study Vaccination Period|Adverse Event|0|||
44496740|NCT00092534|79502639|FG003|Base Study Vaccination Period|Adverse Event|0|||
44496741|NCT00092534|79502640|FG004|Base Study Vaccination Period|Adverse Event|0|||
44496742|NCT00092534|79502636|FG000|Base Study Vaccination Period|Death|5|||
44496743|NCT00092534|79502637|FG001|Base Study Vaccination Period|Death|4|||
44555501|NCT03073200|79572405|FG004|Randomized Withdrawal Period|Adverse Event|0|||
44555502|NCT03073200|79572406|FG005|Randomized Withdrawal Period|Adverse Event|0|||
44555503|NCT03073200|79572407|FG006|Randomized Withdrawal Period|Adverse Event|0|||
44555504|NCT03073200|79572408|FG007|Randomized Withdrawal Period|Adverse Event|0|||
44555505|NCT03073200|79572409|FG008|Randomized Withdrawal Period|Adverse Event|0|||
44555506|NCT03073200|79572410|FG009|Randomized Withdrawal Period|Adverse Event|0|||
44555507|NCT03073200|79572411|FG010|Randomized Withdrawal Period|Adverse Event|1|||
44555508|NCT03073200|79572412|FG011|Randomized Withdrawal Period|Adverse Event|0|||
44555509|NCT03073200|79572413|FG012|Randomized Withdrawal Period|Adverse Event|0|||
44555510|NCT03073200|79572414|FG013|Randomized Withdrawal Period|Adverse Event|0|||
44555511|NCT03073200|79572415|FG014|Randomized Withdrawal Period|Adverse Event|0|||
44555512|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555513|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555514|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555515|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555516|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555517|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555518|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555519|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555520|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555521|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
44274868|NCT02240706|79221182|FG002|Overall Study|Adverse Event|1|||
44496744|NCT00092534|79502638|FG002|Base Study Vaccination Period|Death|0|||
44496745|NCT00092534|79502639|FG003|Base Study Vaccination Period|Death|0|||
44496746|NCT00092534|79502640|FG004|Base Study Vaccination Period|Death|0|||
44555522|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555523|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555524|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
44231833|NCT01850615|79046036|FG001|Overall Study|Lost to Follow-up|1|||
44231834|NCT01850615|79046035|FG000|Overall Study|Unclassified|0|||
44231835|NCT01850615|79046036|FG001|Overall Study|Unclassified|1|||
44231836|NCT01868477|79046121|FG000|Overall Study|Adverse Event|2|||
44231837|NCT01868477|79046122|FG001|Overall Study|Adverse Event|4|||
44231838|NCT01868477|79046121|FG000|Overall Study|Disease progression|1|||
44231839|NCT01868477|79046122|FG001|Overall Study|Disease progression|1|||
44231840|NCT01868477|79046121|FG000|Overall Study|Withdrawal by Subject|1|||
44231841|NCT01868477|79046122|FG001|Overall Study|Withdrawal by Subject|0|||
44231842|NCT01849289|79046137|FG000|Overall Study|Adverse Event|3|||
44231843|NCT01849289|79046138|FG001|Overall Study|Adverse Event|3|||
44231844|NCT01849289|79046137|FG000|Overall Study|Protocol Violation|3|||
44231845|NCT01849289|79046138|FG001|Overall Study|Protocol Violation|3|||
44231846|NCT01849289|79046137|FG000|Overall Study|Withdrawal criteria|1|||
44231847|NCT01849289|79046138|FG001|Overall Study|Withdrawal criteria|0|||
44231848|NCT01849289|79046137|FG000|Overall Study|Unclassified|25|||
44231849|NCT01849289|79046138|FG001|Overall Study|Unclassified|18|||
44231850|NCT01868243|79046146|FG000|Overall Study|Death|0|||
44231851|NCT01868243|79046147|FG001|Overall Study|Death|1|||
44231852|NCT01611935|79046155|FG000|Overall Study|Family Declined Participation|1|||
44496747|NCT00092534|79502636|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
44496748|NCT00092534|79502637|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
44496749|NCT00092534|79502638|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
44496750|NCT00092534|79502639|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
44496751|NCT00092534|79502640|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
44496752|NCT00092534|79502636|FG000|Base Study Vaccination Period|Physician Decision|1|||
44496753|NCT00092534|79502637|FG001|Base Study Vaccination Period|Physician Decision|0|||
44496754|NCT00092534|79502638|FG002|Base Study Vaccination Period|Physician Decision|0|||
44496755|NCT00092534|79502639|FG003|Base Study Vaccination Period|Physician Decision|0|||
44496756|NCT00092534|79502640|FG004|Base Study Vaccination Period|Physician Decision|0|||
44496757|NCT00092534|79502636|FG000|Base Study Vaccination Period|Pregnancy|9|||
44496758|NCT00092534|79502637|FG001|Base Study Vaccination Period|Pregnancy|7|||
44496759|NCT00092534|79502638|FG002|Base Study Vaccination Period|Pregnancy|0|||
44496760|NCT00092534|79502639|FG003|Base Study Vaccination Period|Pregnancy|0|||
44496761|NCT00092534|79502640|FG004|Base Study Vaccination Period|Pregnancy|0|||
44496762|NCT00092534|79502636|FG000|Base Study Vaccination Period|Protocol Violation|2|||
44496763|NCT00092534|79502637|FG001|Base Study Vaccination Period|Protocol Violation|1|||
44496764|NCT00092534|79502638|FG002|Base Study Vaccination Period|Protocol Violation|0|||
44496765|NCT00092534|79502639|FG003|Base Study Vaccination Period|Protocol Violation|0|||
44496766|NCT00092534|79502640|FG004|Base Study Vaccination Period|Protocol Violation|0|||
44496767|NCT00092534|79502636|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
44496768|NCT00092534|79502637|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
44496769|NCT00092534|79502638|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
44496770|NCT00092534|79502639|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
44496771|NCT00092534|79502640|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
44496772|NCT00092534|79502636|FG000|Base Study Vaccination Period|Moved|14|||
44496773|NCT00092534|79502637|FG001|Base Study Vaccination Period|Moved|12|||
44496774|NCT00092534|79502638|FG002|Base Study Vaccination Period|Moved|0|||
44496775|NCT00092534|79502639|FG003|Base Study Vaccination Period|Moved|0|||
44496776|NCT00092534|79502640|FG004|Base Study Vaccination Period|Moved|0|||
44496777|NCT00092534|79502636|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
44496778|NCT00092534|79502637|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
44496779|NCT00092534|79502638|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
44496780|NCT00092534|79502639|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
44496781|NCT00092534|79502640|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
44496782|NCT00092534|79502636|FG000|Base Study Vaccination Period|Travel|1|||
44496783|NCT00092534|79502637|FG001|Base Study Vaccination Period|Travel|0|||
44496784|NCT00092534|79502638|FG002|Base Study Vaccination Period|Travel|0|||
44496785|NCT00092534|79502639|FG003|Base Study Vaccination Period|Travel|0|||
44231853|NCT01611935|79046156|FG001|Overall Study|Family Declined Participation|0|||
44231854|NCT01868165|79046162|FG000|Overall Study|Withdrawal by Subject|36|||
44231855|NCT01868165|79046162|FG000|Overall Study|Physician Decision|2|||
44231856|NCT01868165|79046162|FG000|Overall Study|Lost to Follow-up|3|||
44231857|NCT01868165|79046162|FG000|Overall Study|Death|4|||
44555525|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
44274869|NCT02240706|79221183|FG003|Overall Study|Adverse Event|0|||
44274870|NCT02240706|79221184|FG004|Overall Study|Adverse Event|2|||
44274871|NCT02240706|79221185|FG005|Overall Study|Adverse Event|0|||
44274872|NCT02240706|79221186|FG006|Overall Study|Adverse Event|0|||
44274873|NCT02240706|79221180|FG000|Overall Study|Progressive disease|0|||
44274874|NCT02240706|79221181|FG001|Overall Study|Progressive disease|0|||
44274875|NCT02240706|79221182|FG002|Overall Study|Progressive disease|0|||
44274876|NCT02240706|79221183|FG003|Overall Study|Progressive disease|0|||
44274877|NCT02240706|79221184|FG004|Overall Study|Progressive disease|1|||
44231858|NCT01868009|79046201|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
44231859|NCT01868009|79046202|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
44231860|NCT01868009|79046201|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
44231861|NCT01868009|79046202|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
44231862|NCT01868009|79046201|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
44231863|NCT01868009|79046202|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
44231864|NCT01849055|79046256|FG000|Overall Study|Withdrawal by Subject|0|||
44231865|NCT01849055|79046257|FG001|Overall Study|Withdrawal by Subject|0|||
44231866|NCT01849055|79046258|FG002|Overall Study|Withdrawal by Subject|1|||
44231867|NCT01849055|79046259|FG003|Overall Study|Withdrawal by Subject|0|||
44231868|NCT01849055|79046260|FG004|Overall Study|Withdrawal by Subject|0|||
44231869|NCT01849055|79046261|FG005|Overall Study|Withdrawal by Subject|0|||
44231870|NCT01848353|79046287|FG000|Phase 1|Withdrawal by Subject|3|||
44231871|NCT01848353|79046288|FG001|Phase 1|Withdrawal by Subject|1|||
44231872|NCT01848353|79046289|FG002|Phase 1|Withdrawal by Subject|0|||
44231873|NCT01848353|79046290|FG003|Phase 1|Withdrawal by Subject|0|||
44231874|NCT01848353|79046287|FG000|Phase 2|Withdrawal by Subject|3|||
44231875|NCT01848353|79046288|FG001|Phase 2|Withdrawal by Subject|2|||
44231876|NCT01848353|79046289|FG002|Phase 2|Withdrawal by Subject|0|||
44231877|NCT01848353|79046290|FG003|Phase 2|Withdrawal by Subject|0|||
44231878|NCT01848353|79046287|FG000|Phase 3|Withdrawal by Subject|1|||
44231879|NCT01848353|79046288|FG001|Phase 3|Withdrawal by Subject|1|||
44231880|NCT01848353|79046289|FG002|Phase 3|Withdrawal by Subject|0|||
44231881|NCT01848353|79046290|FG003|Phase 3|Withdrawal by Subject|0|||
44231882|NCT01847885|79046319|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
44231883|NCT01847885|79046320|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
44231884|NCT01847885|79046321|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
44231885|NCT01847885|79046319|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
44231886|NCT01847885|79046320|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
44231887|NCT01847885|79046321|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
44231888|NCT01847885|79046319|FG000|Initial Enrollment (Consented)|Screen failure|39|||
44274878|NCT02240706|79221185|FG005|Overall Study|Progressive disease|0|||
44274879|NCT02240706|79221186|FG006|Overall Study|Progressive disease|0|||
44555526|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
44555527|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555528|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555529|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555530|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555531|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555532|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555533|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555534|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555535|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555536|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555537|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44231889|NCT01847885|79046320|FG001|Initial Enrollment (Consented)|Screen failure|0|||
44496786|NCT00092534|79502640|FG004|Base Study Vaccination Period|Travel|0|||
44496787|NCT00092534|79502636|FG000|Base Study Vaccination Period|Site Closed|0|||
44496788|NCT00092534|79502637|FG001|Base Study Vaccination Period|Site Closed|1|||
44496789|NCT00092534|79502638|FG002|Base Study Vaccination Period|Site Closed|0|||
44496790|NCT00092534|79502639|FG003|Base Study Vaccination Period|Site Closed|0|||
44496791|NCT00092534|79502640|FG004|Base Study Vaccination Period|Site Closed|0|||
44496792|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Adverse Event|2|||
44496793|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Adverse Event|4|||
44496794|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Adverse Event|0|||
44496795|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Adverse Event|0|||
44496796|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Adverse Event|0|||
44496797|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Death|2|||
44496798|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Death|1|||
44555538|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44231890|NCT01847885|79046321|FG002|Initial Enrollment (Consented)|Screen failure|0|||
44231891|NCT01847885|79046319|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
44274880|NCT02240706|79221180|FG000|Overall Study|Dose limiting toxicity|0|||
44555539|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555540|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
44555541|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44555542|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555543|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555544|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555545|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555546|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555547|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555548|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555549|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555550|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555551|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555552|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555553|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555554|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555555|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
44555556|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
44555557|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555558|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555559|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555560|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555561|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555562|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555563|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555564|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555565|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555566|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555567|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555568|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555569|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44496799|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Death|0|||
44496800|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Death|0|||
44496801|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Death|0|||
44496802|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
44496803|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
44496804|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
44496805|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
44496806|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
44496807|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Pregnancy|6|||
44496808|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Pregnancy|10|||
44496809|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Pregnancy|0|||
44496810|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Pregnancy|0|||
44496811|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Pregnancy|0|||
44496812|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
44496813|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
44496814|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
44496815|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
44496816|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
44496817|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
44496818|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
44496819|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
44496820|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
44555570|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
44555571|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44555572|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555573|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555574|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555575|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555576|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555577|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555578|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555579|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555580|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555581|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555582|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555583|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555584|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555585|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
44555586|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
44555587|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555588|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555589|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555590|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555591|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555592|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555593|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555594|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555595|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555596|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555597|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555598|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44231892|NCT01847885|79046320|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
44231893|NCT01847885|79046321|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
44496821|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
44496822|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Moved|62|||
44496823|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Moved|58|||
44496824|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Moved|0|||
44496825|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Moved|0|||
44555599|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44555600|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
44555601|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
44231894|NCT01847885|79046319|FG000|Randomization|Protocol Violation|0|||
44496826|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Moved|0|||
44496827|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Travel|10|||
44496828|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Travel|7|||
44231895|NCT01847885|79046320|FG001|Randomization|Protocol Violation|1|||
44231896|NCT01847885|79046321|FG002|Randomization|Protocol Violation|0|||
44496829|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Travel|0|||
44231897|NCT01847885|79046319|FG000|Randomization|Withdrawal by Subject|0|||
44555602|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555603|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555604|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555605|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555606|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555607|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555608|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555609|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555610|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555611|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555612|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555613|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555614|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555615|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
44555616|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44555617|NCT03073200|79572401|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555618|NCT03073200|79572402|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555619|NCT03073200|79572403|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555620|NCT03073200|79572404|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555621|NCT03073200|79572405|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555622|NCT03073200|79572406|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555623|NCT03073200|79572407|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44496830|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Travel|0|||
44496831|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Travel|0|||
44496832|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Site Closed|0|||
44496833|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Site Closed|2|||
44496834|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Site Closed|0|||
44496835|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Site Closed|0|||
44496836|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Site Closed|0|||
44496837|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
44496838|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
44496839|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
44496840|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
44496841|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
44496842|NCT00092534|79502636|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
44496843|NCT00092534|79502637|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
44496844|NCT00092534|79502638|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
44496845|NCT00092534|79502639|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
44496846|NCT00092534|79502640|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
44496847|NCT00092534|79502636|FG000|Base Study EXT|Lost to Follow-up|0|||
44496848|NCT00092534|79502637|FG001|Base Study EXT|Lost to Follow-up|0|||
44496849|NCT00092534|79502638|FG002|Base Study EXT|Lost to Follow-up|41|||
44496850|NCT00092534|79502639|FG003|Base Study EXT|Lost to Follow-up|0|||
44496851|NCT00092534|79502640|FG004|Base Study EXT|Lost to Follow-up|0|||
44496852|NCT00092534|79502636|FG000|Base Study EXT|Physician Decision|0|||
44496853|NCT00092534|79502637|FG001|Base Study EXT|Physician Decision|0|||
44496854|NCT00092534|79502638|FG002|Base Study EXT|Physician Decision|1|||
44496855|NCT00092534|79502639|FG003|Base Study EXT|Physician Decision|0|||
44496856|NCT00092534|79502640|FG004|Base Study EXT|Physician Decision|0|||
44496857|NCT00092534|79502636|FG000|Base Study EXT|Pregnancy|0|||
44496858|NCT00092534|79502637|FG001|Base Study EXT|Pregnancy|0|||
44496859|NCT00092534|79502638|FG002|Base Study EXT|Pregnancy|12|||
44496860|NCT00092534|79502639|FG003|Base Study EXT|Pregnancy|0|||
44496861|NCT00092534|79502640|FG004|Base Study EXT|Pregnancy|0|||
44496862|NCT00092534|79502636|FG000|Base Study EXT|Withdrawal by Subject|0|||
44496863|NCT00092534|79502637|FG001|Base Study EXT|Withdrawal by Subject|0|||
44496864|NCT00092534|79502638|FG002|Base Study EXT|Withdrawal by Subject|18|||
44496865|NCT00092534|79502639|FG003|Base Study EXT|Withdrawal by Subject|0|||
44496866|NCT00092534|79502640|FG004|Base Study EXT|Withdrawal by Subject|0|||
44496867|NCT00092534|79502636|FG000|Base Study EXT|Participant moved|0|||
44555624|NCT03073200|79572408|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555625|NCT03073200|79572409|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44496868|NCT00092534|79502637|FG001|Base Study EXT|Participant moved|0|||
44496869|NCT00092534|79502638|FG002|Base Study EXT|Participant moved|6|||
44231898|NCT01847885|79046320|FG001|Randomization|Withdrawal by Subject|0|||
44496870|NCT00092534|79502639|FG003|Base Study EXT|Participant moved|0|||
44496871|NCT00092534|79502640|FG004|Base Study EXT|Participant moved|0|||
44496872|NCT00092534|79502636|FG000|Base Study EXT|Travel|0|||
44496873|NCT00092534|79502637|FG001|Base Study EXT|Travel|0|||
44496874|NCT00092534|79502638|FG002|Base Study EXT|Travel|2|||
44496875|NCT00092534|79502639|FG003|Base Study EXT|Travel|0|||
44496876|NCT00092534|79502640|FG004|Base Study EXT|Travel|0|||
44555626|NCT03073200|79572410|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555627|NCT03073200|79572411|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555628|NCT03073200|79572412|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555629|NCT03073200|79572413|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555630|NCT03073200|79572414|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
44555631|NCT03073200|79572415|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
44555632|NCT03290781|79572444|FG000|Overall Study|Adverse Event|5|||
44555633|NCT03290781|79572445|FG001|Overall Study|Adverse Event|7|||
44555634|NCT03290781|79572446|FG002|Overall Study|Adverse Event|4|||
44555635|NCT03290781|79572447|FG003|Overall Study|Adverse Event|1|||
44555636|NCT03290781|79572448|FG004|Overall Study|Adverse Event|0|||
44555637|NCT03290781|79572449|FG005|Overall Study|Adverse Event|0|||
44555638|NCT03290781|79572450|FG006|Overall Study|Adverse Event|0|||
44555639|NCT03290781|79572444|FG000|Overall Study|Death|0|||
44555640|NCT03290781|79572445|FG001|Overall Study|Death|0|||
44555641|NCT03290781|79572446|FG002|Overall Study|Death|1|||
44555642|NCT03290781|79572447|FG003|Overall Study|Death|0|||
44555643|NCT03290781|79572448|FG004|Overall Study|Death|1|||
44555644|NCT03290781|79572449|FG005|Overall Study|Death|0|||
44555645|NCT03290781|79572450|FG006|Overall Study|Death|0|||
44555646|NCT03290781|79572444|FG000|Overall Study|Withdrawal by Subject|6|||
44555647|NCT03290781|79572445|FG001|Overall Study|Withdrawal by Subject|5|||
44555648|NCT03290781|79572446|FG002|Overall Study|Withdrawal by Subject|9|||
44555649|NCT03290781|79572447|FG003|Overall Study|Withdrawal by Subject|10|||
44555650|NCT03290781|79572448|FG004|Overall Study|Withdrawal by Subject|1|||
44555651|NCT03290781|79572449|FG005|Overall Study|Withdrawal by Subject|2|||
44496877|NCT00092534|79502636|FG000|Base Study EXT|Site closed|0|||
44496878|NCT00092534|79502637|FG001|Base Study EXT|Site closed|0|||
44496879|NCT00092534|79502638|FG002|Base Study EXT|Site closed|21|||
44496880|NCT00092534|79502639|FG003|Base Study EXT|Site closed|0|||
44496881|NCT00092534|79502640|FG004|Base Study EXT|Site closed|0|||
44496882|NCT00092534|79502636|FG000|Base Study EXT|Study ended|0|||
44496883|NCT00092534|79502637|FG001|Base Study EXT|Study ended|0|||
44496884|NCT00092534|79502638|FG002|Base Study EXT|Study ended|29|||
44496885|NCT00092534|79502639|FG003|Base Study EXT|Study ended|0|||
44496886|NCT00092534|79502640|FG004|Base Study EXT|Study ended|0|||
44496887|NCT00092534|79502636|FG000|Base Study EXT|Protocol Violation|0|||
44496888|NCT00092534|79502637|FG001|Base Study EXT|Protocol Violation|0|||
44496889|NCT00092534|79502638|FG002|Base Study EXT|Protocol Violation|15|||
44496890|NCT00092534|79502639|FG003|Base Study EXT|Protocol Violation|0|||
44496891|NCT00092534|79502640|FG004|Base Study EXT|Protocol Violation|0|||
44496892|NCT00092534|79502636|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
44496893|NCT00092534|79502637|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
44496894|NCT00092534|79502638|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
44496895|NCT00092534|79502639|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
44496896|NCT00092534|79502640|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
44496897|NCT00068250|79502653|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
44496898|NCT00068250|79502654|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
44496899|NCT00068250|79502655|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
44496900|NCT00068250|79502656|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
44496901|NCT00393887|79502666|FG000|Overall Study|Physician Decision|5|||
44496902|NCT00393887|79502667|FG001|Overall Study|Physician Decision|0|||
44496903|NCT00393887|79502666|FG000|Overall Study|Lost to Follow-up|11|||
44496904|NCT00393887|79502667|FG001|Overall Study|Lost to Follow-up|9|||
44496905|NCT00393029|79502675|FG000|Overall Study|Not treated|0|||
44496906|NCT00393029|79502676|FG001|Overall Study|Not treated|1|||
44496907|NCT00402233|79502687|FG000|Overall Study|Adverse Event|1|||
44496908|NCT00402233|79502688|FG001|Overall Study|Adverse Event|7|||
44496909|NCT00402233|79502689|FG002|Overall Study|Adverse Event|9|||
44496910|NCT00402233|79502690|FG003|Overall Study|Adverse Event|9|||
44496911|NCT00402233|79502687|FG000|Overall Study|Protocol Violation|0|||
44496912|NCT00402233|79502688|FG001|Overall Study|Protocol Violation|1|||
44496913|NCT00402233|79502689|FG002|Overall Study|Protocol Violation|0|||
44555652|NCT03290781|79572450|FG006|Overall Study|Withdrawal by Subject|0|||
44555653|NCT03290781|79572444|FG000|Overall Study|Physician Decision|0|||
44555654|NCT03290781|79572445|FG001|Overall Study|Physician Decision|1|||
44555655|NCT03290781|79572446|FG002|Overall Study|Physician Decision|0|||
44496914|NCT00402233|79502690|FG003|Overall Study|Protocol Violation|0|||
44496915|NCT00402233|79502687|FG000|Overall Study|Withdrawal by Subject|2|||
44496916|NCT00402233|79502688|FG001|Overall Study|Withdrawal by Subject|1|||
44496917|NCT00402233|79502689|FG002|Overall Study|Withdrawal by Subject|2|||
44496918|NCT00402233|79502690|FG003|Overall Study|Withdrawal by Subject|2|||
44496919|NCT00402233|79502687|FG000|Overall Study|Worsening of disease under study|2|||
44555656|NCT03290781|79572447|FG003|Overall Study|Physician Decision|0|||
44555657|NCT03290781|79572448|FG004|Overall Study|Physician Decision|0|||
44555658|NCT03290781|79572449|FG005|Overall Study|Physician Decision|0|||
44555659|NCT03290781|79572450|FG006|Overall Study|Physician Decision|0|||
44555660|NCT03290781|79572444|FG000|Overall Study|Site Terminated by Sponsor|1|||
44555661|NCT03290781|79572445|FG001|Overall Study|Site Terminated by Sponsor|0|||
44555662|NCT03290781|79572446|FG002|Overall Study|Site Terminated by Sponsor|2|||
44555663|NCT03290781|79572447|FG003|Overall Study|Site Terminated by Sponsor|1|||
44555664|NCT03290781|79572448|FG004|Overall Study|Site Terminated by Sponsor|0|||
44555665|NCT03290781|79572449|FG005|Overall Study|Site Terminated by Sponsor|0|||
44555666|NCT03290781|79572450|FG006|Overall Study|Site Terminated by Sponsor|0|||
44555667|NCT03290781|79572444|FG000|Overall Study|Lost to Follow-up|0|||
44555668|NCT03290781|79572445|FG001|Overall Study|Lost to Follow-up|0|||
44555669|NCT03290781|79572446|FG002|Overall Study|Lost to Follow-up|0|||
44555670|NCT03290781|79572447|FG003|Overall Study|Lost to Follow-up|1|||
44555671|NCT03290781|79572448|FG004|Overall Study|Lost to Follow-up|0|||
44555672|NCT03290781|79572449|FG005|Overall Study|Lost to Follow-up|0|||
44555673|NCT03290781|79572450|FG006|Overall Study|Lost to Follow-up|0|||
44555674|NCT03290781|79572444|FG000|Overall Study|Protocol Deviation|2|||
44555675|NCT03290781|79572445|FG001|Overall Study|Protocol Deviation|0|||
44555676|NCT03290781|79572446|FG002|Overall Study|Protocol Deviation|0|||
44555677|NCT03290781|79572447|FG003|Overall Study|Protocol Deviation|1|||
44555678|NCT03290781|79572448|FG004|Overall Study|Protocol Deviation|0|||
44555679|NCT03290781|79572449|FG005|Overall Study|Protocol Deviation|0|||
44555680|NCT03290781|79572450|FG006|Overall Study|Protocol Deviation|0|||
44555681|NCT03290781|79572444|FG000|Overall Study|Disease Relapse|32|||
44555682|NCT03290781|79572445|FG001|Overall Study|Disease Relapse|5|||
44555683|NCT03290781|79572446|FG002|Overall Study|Disease Relapse|38|||
44555684|NCT03290781|79572447|FG003|Overall Study|Disease Relapse|7|||
44555685|NCT03290781|79572448|FG004|Overall Study|Disease Relapse|3|||
44555686|NCT03290781|79572449|FG005|Overall Study|Disease Relapse|1|||
44555687|NCT03290781|79572450|FG006|Overall Study|Disease Relapse|4|||
44555688|NCT03290781|79572444|FG000|Overall Study|Other|3|||
44555689|NCT03290781|79572445|FG001|Overall Study|Other|0|||
44555690|NCT03290781|79572446|FG002|Overall Study|Other|2|||
44555691|NCT03290781|79572447|FG003|Overall Study|Other|2|||
44555692|NCT03290781|79572448|FG004|Overall Study|Other|0|||
44555693|NCT03290781|79572449|FG005|Overall Study|Other|0|||
44555694|NCT03290781|79572450|FG006|Overall Study|Other|0|||
44555695|NCT03466073|79572479|FG000|Overall Study|Death|1|||
44555696|NCT03466073|79572480|FG001|Overall Study|Death|0|||
44555697|NCT03466073|79572481|FG002|Overall Study|Death|0|||
44555698|NCT03466073|79572482|FG003|Overall Study|Death|0|||
44555699|NCT03466073|79572483|FG004|Overall Study|Death|0|||
44555700|NCT03466073|79572484|FG005|Overall Study|Death|1|||
44555701|NCT03412019|79572507|FG000|Overall Study|Withdrawal by Subject|1|||
44496920|NCT00402233|79502688|FG001|Overall Study|Worsening of disease under study|0|||
44496921|NCT00402233|79502689|FG002|Overall Study|Worsening of disease under study|0|||
44496922|NCT00402233|79502690|FG003|Overall Study|Worsening of disease under study|0|||
44496923|NCT00402233|79502687|FG000|Overall Study|Worsening of other pre-existing disease|0|||
44496924|NCT00402233|79502688|FG001|Overall Study|Worsening of other pre-existing disease|1|||
44496925|NCT00402233|79502689|FG002|Overall Study|Worsening of other pre-existing disease|0|||
44496926|NCT00402233|79502690|FG003|Overall Study|Worsening of other pre-existing disease|0|||
44496927|NCT00092456|79502704|FG000|Overall Study|Adverse Event|0|||
44496928|NCT00092456|79502705|FG001|Overall Study|Adverse Event|0|||
44496929|NCT00092456|79502706|FG002|Overall Study|Adverse Event|1|||
44496930|NCT00092456|79502707|FG003|Overall Study|Adverse Event|1|||
44496931|NCT00092456|79502704|FG000|Overall Study|Lost to Follow-up|2|||
44496932|NCT00092456|79502705|FG001|Overall Study|Lost to Follow-up|2|||
44496933|NCT00092456|79502706|FG002|Overall Study|Lost to Follow-up|1|||
44496934|NCT00092456|79502707|FG003|Overall Study|Lost to Follow-up|2|||
44496935|NCT00092456|79502704|FG000|Overall Study|Protocol Violation|5|||
44496936|NCT00092456|79502705|FG001|Overall Study|Protocol Violation|7|||
44496937|NCT00092456|79502706|FG002|Overall Study|Protocol Violation|8|||
44496938|NCT00092456|79502707|FG003|Overall Study|Protocol Violation|6|||
44555702|NCT03412019|79572508|FG001|Overall Study|Withdrawal by Subject|1|||
44555703|NCT03070002|79572514|FG000|Follow up for 2 Years|Death|1|||
44555704|NCT02918318|79572522|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
44555705|NCT02918318|79572523|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
44555706|NCT02918318|79572524|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
44555707|NCT02918318|79572525|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
44555708|NCT02918318|79572526|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
44555709|NCT02918318|79572522|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
44555710|NCT02918318|79572523|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
44555711|NCT02918318|79572524|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
44555712|NCT02918318|79572525|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
44555713|NCT02918318|79572526|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
44555714|NCT02918318|79572522|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
44496939|NCT00092456|79502704|FG000|Overall Study|Withdrawal by Subject|13|||
44555715|NCT02918318|79572523|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
44555716|NCT02918318|79572524|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
44231899|NCT01847885|79046321|FG002|Randomization|Withdrawal by Subject|2|||
44231900|NCT01847885|79046319|FG000|Randomization|Screen Failure|0|||
44231901|NCT01847885|79046320|FG001|Randomization|Screen Failure|3|||
44231902|NCT01847885|79046321|FG002|Randomization|Screen Failure|0|||
44231903|NCT01867307|79046359|FG000|Overall Study|Protocol Violation|2|||
44231904|NCT01867307|79046360|FG001|Overall Study|Protocol Violation|0|||
44231905|NCT01867307|79046359|FG000|Overall Study|Other Adverse Event|1|||
44231906|NCT01867307|79046360|FG001|Overall Study|Other Adverse Event|3|||
44231907|NCT01845077|79046369|FG000|Washout Period|Lost to Follow-up|0|||
44231908|NCT01845077|79046370|FG001|Washout Period|Lost to Follow-up|1|||
44231909|NCT01845077|79046371|FG002|Washout Period|Lost to Follow-up|0|||
44231910|NCT01845077|79046372|FG003|Washout Period|Lost to Follow-up|1|||
44231911|NCT01845077|79046373|FG004|Washout Period|Lost to Follow-up|0|||
44231912|NCT01845077|79046374|FG005|Washout Period|Lost to Follow-up|1|||
44231913|NCT01845077|79046369|FG000|Washout Period|Adverse Event|1|||
44274881|NCT02240706|79221181|FG001|Overall Study|Dose limiting toxicity|0|||
44274882|NCT02240706|79221182|FG002|Overall Study|Dose limiting toxicity|0|||
44274883|NCT02240706|79221183|FG003|Overall Study|Dose limiting toxicity|0|||
44274884|NCT02240706|79221184|FG004|Overall Study|Dose limiting toxicity|1|||
44274885|NCT02240706|79221185|FG005|Overall Study|Dose limiting toxicity|0|||
44274886|NCT02240706|79221186|FG006|Overall Study|Dose limiting toxicity|0|||
44231914|NCT01845077|79046370|FG001|Washout Period|Adverse Event|0|||
44274887|NCT02240706|79221180|FG000|Overall Study|Refused to continue taking medication|0|||
44274888|NCT02240706|79221181|FG001|Overall Study|Refused to continue taking medication|1|||
44274889|NCT02240706|79221182|FG002|Overall Study|Refused to continue taking medication|3|||
44274890|NCT02240706|79221183|FG003|Overall Study|Refused to continue taking medication|1|||
44274891|NCT02240706|79221184|FG004|Overall Study|Refused to continue taking medication|2|||
44274892|NCT02240706|79221185|FG005|Overall Study|Refused to continue taking medication|0|||
44274893|NCT02240706|79221186|FG006|Overall Study|Refused to continue taking medication|0|||
44376758|NCT01074944|79381962|FG002|Long Term Treatment|Lost to Follow-up|0|||
44496940|NCT00092456|79502705|FG001|Overall Study|Withdrawal by Subject|5|||
44496941|NCT00092456|79502706|FG002|Overall Study|Withdrawal by Subject|16|||
44496942|NCT00092456|79502707|FG003|Overall Study|Withdrawal by Subject|6|||
44496943|NCT00092456|79502704|FG000|Overall Study|Moved|1|||
44496944|NCT00092456|79502705|FG001|Overall Study|Moved|1|||
44496945|NCT00092456|79502706|FG002|Overall Study|Moved|0|||
44496946|NCT00092456|79502707|FG003|Overall Study|Moved|1|||
44496947|NCT00092456|79502704|FG000|Overall Study|Other|4|||
44496948|NCT00092456|79502705|FG001|Overall Study|Other|2|||
44496949|NCT00092456|79502706|FG002|Overall Study|Other|3|||
44376759|NCT01074944|79381963|FG003|Long Term Treatment|Lost to Follow-up|2|||
44376760|NCT01074944|79381964|FG004|Long Term Treatment|Lost to Follow-up|0|||
44496950|NCT00092456|79502707|FG003|Overall Study|Other|0|||
44496951|NCT00067470|79502719|FG000|Overall Study|Withdrawal by Subject|0|||
44496952|NCT00067470|79502720|FG001|Overall Study|Withdrawal by Subject|1|||
44496953|NCT00401843|79502729|FG000|Overall Study|Achieved Complete Response|1|||
44496954|NCT00401843|79502730|FG001|Overall Study|Achieved Complete Response|5|||
44496955|NCT00401843|79502731|FG002|Overall Study|Achieved Complete Response|11|||
44496956|NCT00401843|79502729|FG000|Overall Study|Adverse Event|7|||
44496957|NCT00401843|79502730|FG001|Overall Study|Adverse Event|26|||
44496958|NCT00401843|79502731|FG002|Overall Study|Adverse Event|27|||
44496959|NCT00401843|79502729|FG000|Overall Study|Death|0|||
44496960|NCT00401843|79502730|FG001|Overall Study|Death|8|||
44496961|NCT00401843|79502731|FG002|Overall Study|Death|10|||
44496962|NCT00401843|79502729|FG000|Overall Study|Disease progression|10|||
44496963|NCT00401843|79502730|FG001|Overall Study|Disease progression|60|||
44231915|NCT01845077|79046371|FG002|Washout Period|Adverse Event|0|||
44231916|NCT01845077|79046372|FG003|Washout Period|Adverse Event|0|||
44274894|NCT02240706|79221180|FG000|Overall Study|Insurance billing concerns|0|||
44274895|NCT02240706|79221181|FG001|Overall Study|Insurance billing concerns|0|||
44496964|NCT00401843|79502731|FG002|Overall Study|Disease progression|49|||
44496965|NCT00401843|79502729|FG000|Overall Study|End of Study|1|||
44496966|NCT00401843|79502730|FG001|Overall Study|End of Study|1|||
44496967|NCT00401843|79502731|FG002|Overall Study|End of Study|2|||
44496968|NCT00401843|79502729|FG000|Overall Study|Lost to Follow-up|0|||
44555717|NCT02918318|79572525|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
44555718|NCT02918318|79572526|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
44555719|NCT02918318|79572522|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
44555720|NCT02918318|79572523|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
44555721|NCT02918318|79572524|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
44555722|NCT02918318|79572525|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
44555723|NCT02918318|79572526|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
44555724|NCT02918318|79572522|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
44555725|NCT02918318|79572523|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
44555726|NCT02918318|79572524|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
44555727|NCT02918318|79572525|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
44555728|NCT02918318|79572526|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
44555729|NCT02918318|79572522|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
44555730|NCT02918318|79572523|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
44555731|NCT02918318|79572524|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
44555732|NCT02918318|79572525|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
44555733|NCT02918318|79572526|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
44555734|NCT02918318|79572522|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
44555735|NCT02918318|79572523|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
44555736|NCT02918318|79572524|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
44555737|NCT02918318|79572525|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
44555738|NCT02918318|79572526|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
44555739|NCT02918318|79572522|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
44555740|NCT02918318|79572523|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
44555741|NCT02918318|79572524|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
44555742|NCT02918318|79572525|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
44555743|NCT02918318|79572526|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
44555744|NCT02918318|79572522|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
44555745|NCT02918318|79572523|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
44555746|NCT02918318|79572524|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
44555747|NCT02918318|79572525|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
44555748|NCT02918318|79572526|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
44555749|NCT02918318|79572522|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
44555750|NCT02918318|79572523|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
44555751|NCT02918318|79572524|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
44555752|NCT02918318|79572525|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
44555753|NCT02918318|79572526|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
44555754|NCT02918318|79572522|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
44555755|NCT02918318|79572523|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
44555756|NCT02918318|79572524|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
44555757|NCT02918318|79572525|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
44555758|NCT02918318|79572526|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
44231917|NCT01845077|79046373|FG004|Washout Period|Adverse Event|0|||
44231918|NCT01845077|79046374|FG005|Washout Period|Adverse Event|0|||
44231919|NCT01845077|79046369|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
44231920|NCT01845077|79046370|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
44231921|NCT01845077|79046371|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
44231922|NCT01845077|79046372|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
44231923|NCT01845077|79046373|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
44231924|NCT01845077|79046374|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
44231925|NCT01845077|79046369|FG000|Washout Period|Protocol Violation|0|||
44231926|NCT01845077|79046370|FG001|Washout Period|Protocol Violation|0|||
44231927|NCT01845077|79046371|FG002|Washout Period|Protocol Violation|0|||
44231928|NCT01845077|79046372|FG003|Washout Period|Protocol Violation|1|||
44231929|NCT01845077|79046373|FG004|Washout Period|Protocol Violation|1|||
44231930|NCT01845077|79046374|FG005|Washout Period|Protocol Violation|0|||
44274896|NCT02240706|79221182|FG002|Overall Study|Insurance billing concerns|0|||
44496969|NCT00401843|79502730|FG001|Overall Study|Lost to Follow-up|0|||
44496970|NCT00401843|79502731|FG002|Overall Study|Lost to Follow-up|2|||
44496971|NCT00401843|79502729|FG000|Overall Study|Other Unspecified|0|||
44496972|NCT00401843|79502730|FG001|Overall Study|Other Unspecified|3|||
44496973|NCT00401843|79502731|FG002|Overall Study|Other Unspecified|5|||
44496974|NCT00401843|79502729|FG000|Overall Study|Physician Decision|0|||
44496975|NCT00401843|79502730|FG001|Overall Study|Physician Decision|16|||
44231931|NCT01866917|79046391|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
44231932|NCT01866917|79046392|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
44496976|NCT00401843|79502731|FG002|Overall Study|Physician Decision|10|||
44496977|NCT00401843|79502729|FG000|Overall Study|Protocol Violation|0|||
44555759|NCT02918318|79572522|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
44555760|NCT02918318|79572523|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
44555761|NCT02918318|79572524|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
44555762|NCT02918318|79572525|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
44555763|NCT02918318|79572526|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
44231933|NCT01844765|79046527|FG000|Overall Study|Adverse Event|6|||
44231934|NCT01844765|79046528|FG001|Overall Study|Adverse Event|8|||
44231935|NCT01844765|79046527|FG000|Overall Study|Withdrawal by Subject|2|||
44231936|NCT01844765|79046528|FG001|Overall Study|Withdrawal by Subject|3|||
44231937|NCT01844765|79046527|FG000|Overall Study|Disease progression|1|||
44231938|NCT01844765|79046528|FG001|Overall Study|Disease progression|0|||
44231939|NCT01844765|79046527|FG000|Overall Study|Administrative problems|3|||
44231940|NCT01844765|79046528|FG001|Overall Study|Administrative problems|4|||
44231941|NCT01844765|79046527|FG000|Overall Study|Protocol deviation|2|||
44231942|NCT01844765|79046528|FG001|Overall Study|Protocol deviation|0|||
44231943|NCT01844765|79046527|FG000|Overall Study|Untreated|1|||
44231944|NCT01844765|79046528|FG001|Overall Study|Untreated|0|||
44231945|NCT01866293|79046543|FG000|Overall Study|Adverse Event|2|||
44231946|NCT01844687|79046547|FG000|Visit 1|Protocol Violation|3|||
44231947|NCT01844687|79046547|FG000|Visit 1|Lost to Follow-up|5|||
44231948|NCT01844687|79046547|FG000|Visit 2|Withdrawal by Subject|1|||
44231949|NCT01844687|79046547|FG000|Visit 2|Protocol Violation|1|||
44231950|NCT01844687|79046547|FG000|Visit 3|Lost to Follow-up|1|||
44231951|NCT01844687|79046547|FG000|Visit 3|Withdrawal by Subject|3|||
44231952|NCT01844687|79046547|FG000|Visit 3|child care problems|1|||
44231953|NCT01844687|79046547|FG000|Visit 4|Pregnancy|1|||
44231954|NCT01844687|79046547|FG000|Visit 4|Lost to Follow-up|1|||
44274897|NCT02240706|79221183|FG003|Overall Study|Insurance billing concerns|1|||
44496978|NCT00401843|79502730|FG001|Overall Study|Protocol Violation|0|||
44496979|NCT00401843|79502731|FG002|Overall Study|Protocol Violation|1|||
44496980|NCT00401843|79502729|FG000|Overall Study|Withdrawal by Subject|1|||
44496981|NCT00401843|79502730|FG001|Overall Study|Withdrawal by Subject|5|||
44496982|NCT00401843|79502731|FG002|Overall Study|Withdrawal by Subject|5|||
44496983|NCT00401843|79502729|FG000|Overall Study|Withdrawal of consent to study agent|1|||
44496984|NCT00401843|79502730|FG001|Overall Study|Withdrawal of consent to study agent|15|||
44496985|NCT00401843|79502731|FG002|Overall Study|Withdrawal of consent to study agent|17|||
44496986|NCT00401843|79502729|FG000|Overall Study|Randomized but not Treated|0|||
44496987|NCT00401843|79502730|FG001|Overall Study|Randomized but not Treated|2|||
44496988|NCT00401843|79502731|FG002|Overall Study|Randomized but not Treated|3|||
44496989|NCT00401843|79502729|FG000|Overall Study|Received incorrect treatment|0|||
44496990|NCT00401843|79502730|FG001|Overall Study|Received incorrect treatment|3|||
44496991|NCT00401843|79502731|FG002|Overall Study|Received incorrect treatment|0|||
44496992|NCT00401531|79502743|FG000|Overall Study|Adverse Event|2|||
44496993|NCT00401531|79502744|FG001|Overall Study|Adverse Event|0|||
44496994|NCT00401531|79502743|FG000|Overall Study|Protocol Violation|3|||
44496995|NCT00401531|79502744|FG001|Overall Study|Protocol Violation|7|||
44496996|NCT00401531|79502743|FG000|Overall Study|Lost to Follow-up|1|||
44496997|NCT00401531|79502744|FG001|Overall Study|Lost to Follow-up|1|||
44496998|NCT00401531|79502743|FG000|Overall Study|Withdrawal by Subject|3|||
44496999|NCT00401531|79502744|FG001|Overall Study|Withdrawal by Subject|2|||
44497000|NCT00401375|79502753|FG000|Overall Study|Protocol Violation|2|||
44497001|NCT00401375|79502754|FG001|Overall Study|Protocol Violation|2|||
44497002|NCT00401375|79502755|FG002|Overall Study|Protocol Violation|1|||
44497003|NCT00401375|79502753|FG000|Overall Study|Adverse Event|6|||
44497004|NCT00401375|79502754|FG001|Overall Study|Adverse Event|11|||
44497005|NCT00401375|79502755|FG002|Overall Study|Adverse Event|10|||
44497006|NCT00401375|79502753|FG000|Overall Study|Withdrawal by Subject|9|||
44497007|NCT00401375|79502754|FG001|Overall Study|Withdrawal by Subject|7|||
44497008|NCT00401375|79502755|FG002|Overall Study|Withdrawal by Subject|7|||
44497009|NCT00401375|79502753|FG000|Overall Study|Lost to Follow-up|0|||
44497010|NCT00401375|79502754|FG001|Overall Study|Lost to Follow-up|1|||
44497011|NCT00401375|79502755|FG002|Overall Study|Lost to Follow-up|1|||
44497012|NCT00401375|79502753|FG000|Overall Study|Other than specified|2|||
44231955|NCT01844687|79046547|FG000|Visit 4|Withdrawal by Subject|2|||
44497013|NCT00401375|79502754|FG001|Overall Study|Other than specified|1|||
44497014|NCT00401375|79502755|FG002|Overall Study|Other than specified|3|||
44497015|NCT00401375|79502753|FG000|Overall Study|Randomized but not treated|3|||
44497016|NCT00401375|79502754|FG001|Overall Study|Randomized but not treated|3|||
44497017|NCT00401375|79502755|FG002|Overall Study|Randomized but not treated|3|||
44555764|NCT03411863|79572571|FG000|Overall Study|Withdrawal by Subject|3|||
44231956|NCT01844531|79046573|FG000|Overall Study|Withdrawal by Subject|0|||
44231957|NCT01844531|79046574|FG001|Overall Study|Withdrawal by Subject|1|||
44231958|NCT01844531|79046575|FG002|Overall Study|Withdrawal by Subject|0|||
44231959|NCT01844531|79046576|FG003|Overall Study|Withdrawal by Subject|0|||
44231960|NCT01844375|79046588|FG000|Overall Study|Protocol Violation|1|||
44497018|NCT00400985|79502763|FG000|Overall Study|Withdrawal by Subject|5|||
44497019|NCT00400985|79502763|FG000|Overall Study|system modification|8|||
44497020|NCT00400985|79502763|FG000|Overall Study|Death|30|||
44555765|NCT03411863|79572572|FG001|Overall Study|Withdrawal by Subject|1|||
44555766|NCT03411863|79572571|FG000|Overall Study|Physician Decision|0|||
44555767|NCT03411863|79572572|FG001|Overall Study|Physician Decision|1|||
44555768|NCT01065350|79572581|FG000|Overall Study|Received incorrect drug allocation|0|||
44555769|NCT01065350|79572582|FG001|Overall Study|Received incorrect drug allocation|1|||
44555770|NCT03434249|79572590|FG000|Overall Study|Adverse Event|1|||
44555771|NCT03434249|79572591|FG001|Overall Study|Adverse Event|0|||
44555772|NCT03434249|79572590|FG000|Overall Study|Lost to Follow-up|0|||
44555773|NCT03434249|79572591|FG001|Overall Study|Lost to Follow-up|1|||
44555774|NCT03434249|79572590|FG000|Overall Study|Non-compliance of family|2|||
44555775|NCT03434249|79572591|FG001|Overall Study|Non-compliance of family|1|||
44555776|NCT03434249|79572590|FG000|Overall Study|Difficulties in completing daily diary|2|||
44555777|NCT03434249|79572591|FG001|Overall Study|Difficulties in completing daily diary|1|||
44555778|NCT03114969|79572606|FG000|Overall Study|Lost to Follow-up|0|||
44555779|NCT03114969|79572607|FG001|Overall Study|Lost to Follow-up|0|||
44555780|NCT03114969|79572608|FG002|Overall Study|Lost to Follow-up|3|||
44555781|NCT03114969|79572609|FG003|Overall Study|Lost to Follow-up|2|||
44555782|NCT03114969|79572610|FG004|Overall Study|Lost to Follow-up|0|||
44555783|NCT03114969|79572611|FG005|Overall Study|Lost to Follow-up|0|||
44555784|NCT03114969|79572612|FG006|Overall Study|Lost to Follow-up|0|||
44555785|NCT03114969|79572613|FG007|Overall Study|Lost to Follow-up|0|||
44555786|NCT03114969|79572614|FG008|Overall Study|Lost to Follow-up|0|||
44555787|NCT03114969|79572606|FG000|Overall Study|Adverse Event|0|||
44555788|NCT03114969|79572607|FG001|Overall Study|Adverse Event|0|||
44555789|NCT03114969|79572608|FG002|Overall Study|Adverse Event|1|||
44555790|NCT03114969|79572609|FG003|Overall Study|Adverse Event|0|||
44555791|NCT03114969|79572610|FG004|Overall Study|Adverse Event|0|||
44555792|NCT03114969|79572611|FG005|Overall Study|Adverse Event|1|||
44555793|NCT03114969|79572612|FG006|Overall Study|Adverse Event|1|||
44555794|NCT03114969|79572613|FG007|Overall Study|Adverse Event|0|||
44555795|NCT03114969|79572614|FG008|Overall Study|Adverse Event|2|||
44555796|NCT02046096|79572643|FG000|Overall Study|Death|28|||
44555797|NCT02046096|79572644|FG001|Overall Study|Death|45|||
44555798|NCT02046096|79572643|FG000|Overall Study|Lost to Follow-up|9|||
44555799|NCT02046096|79572644|FG001|Overall Study|Lost to Follow-up|20|||
44555800|NCT02046096|79572643|FG000|Overall Study|Withdrawal by Subject|5|||
44555801|NCT02046096|79572644|FG001|Overall Study|Withdrawal by Subject|17|||
44555802|NCT02046096|79572643|FG000|Overall Study|Other endpoint|2|||
44555803|NCT02046096|79572644|FG001|Overall Study|Other endpoint|19|||
44555804|NCT03463577|79572658|FG000|Overall Study|Lost to Follow-up|238|||
44555805|NCT03463577|79572659|FG001|Overall Study|Lost to Follow-up|435|||
44555806|NCT03463577|79572660|FG002|Overall Study|Lost to Follow-up|0|||
44555807|NCT03463577|79572661|FG003|Overall Study|Lost to Follow-up|0|||
44555808|NCT03463577|79572662|FG004|Overall Study|Lost to Follow-up|0|||
44555809|NCT03463577|79572663|FG005|Overall Study|Lost to Follow-up|0|||
44555810|NCT03463577|79572658|FG000|Overall Study|With unknown pregnancy outcome|0|||
44555811|NCT03463577|79572659|FG001|Overall Study|With unknown pregnancy outcome|5|||
44555812|NCT03463577|79572660|FG002|Overall Study|With unknown pregnancy outcome|0|||
44555813|NCT03463577|79572661|FG003|Overall Study|With unknown pregnancy outcome|0|||
44555814|NCT03463577|79572662|FG004|Overall Study|With unknown pregnancy outcome|0|||
44555815|NCT03463577|79572663|FG005|Overall Study|With unknown pregnancy outcome|0|||
44555816|NCT03463577|79572658|FG000|Overall Study|Maternal death|2|||
44555817|NCT03463577|79572659|FG001|Overall Study|Maternal death|0|||
44555818|NCT03463577|79572660|FG002|Overall Study|Maternal death|0|||
44555819|NCT03463577|79572661|FG003|Overall Study|Maternal death|0|||
44555820|NCT03463577|79572662|FG004|Overall Study|Maternal death|0|||
44555821|NCT03463577|79572663|FG005|Overall Study|Maternal death|0|||
44555822|NCT03463577|79572658|FG000|Overall Study|Neonatal death|0|||
44555823|NCT03463577|79572659|FG001|Overall Study|Neonatal death|0|||
44555824|NCT03463577|79572660|FG002|Overall Study|Neonatal death|0|||
44555825|NCT03463577|79572661|FG003|Overall Study|Neonatal death|15|||
44555826|NCT03463577|79572662|FG004|Overall Study|Neonatal death|17|||
44231961|NCT01844375|79046589|FG001|Overall Study|Protocol Violation|1|||
44231962|NCT02367456|79046598|FG000|Overall Study|Death|8|||
44555827|NCT03463577|79572663|FG005|Overall Study|Neonatal death|0|||
44555828|NCT03122145|79572679|FG000|Overall Study|Concurrent respiratory disease|3|||
44555829|NCT03122145|79572680|FG001|Overall Study|Concurrent respiratory disease|0|||
44555830|NCT03114657|79572688|FG000|Overall Study|Adverse Event|9|||
44555831|NCT03114657|79572689|FG001|Overall Study|Adverse Event|6|||
44555832|NCT03114657|79572688|FG000|Overall Study|Death|4|||
44555833|NCT03114657|79572689|FG001|Overall Study|Death|0|||
44555834|NCT03114657|79572688|FG000|Overall Study|Multiple Reasons|1|||
44555835|NCT03114657|79572689|FG001|Overall Study|Multiple Reasons|2|||
44555836|NCT03114657|79572688|FG000|Overall Study|Physician Decision|2|||
44231963|NCT02367456|79046599|FG001|Overall Study|Death|24|||
44555837|NCT03114657|79572689|FG001|Overall Study|Physician Decision|2|||
44555838|NCT03114657|79572688|FG000|Overall Study|Study Terminated By Sponsor|355|||
44555839|NCT03114657|79572689|FG001|Overall Study|Study Terminated By Sponsor|374|||
44555840|NCT03114657|79572688|FG000|Overall Study|Symptomatic Deterioration|0|||
44555841|NCT03114657|79572689|FG001|Overall Study|Symptomatic Deterioration|1|||
44497021|NCT00400985|79502763|FG000|Overall Study|Lost to Follow-up|9|||
44497022|NCT00400517|79502767|FG000|Overall Study|Withdrawal by Subject|1|||
44555842|NCT03114657|79572688|FG000|Overall Study|Withdrawal by Subject|28|||
44555843|NCT03114657|79572689|FG001|Overall Study|Withdrawal by Subject|22|||
44555844|NCT02926950|79572698|FG000|Overall Study|Adverse Event|4|||
44555845|NCT02926950|79572699|FG001|Overall Study|Adverse Event|6|||
44555846|NCT02926950|79572698|FG000|Overall Study|At the participant's own request|21|||
44555847|NCT02926950|79572699|FG001|Overall Study|At the participant's own request|25|||
44555848|NCT02926950|79572698|FG000|Overall Study|Reason not Specified|17|||
44555849|NCT02926950|79572699|FG001|Overall Study|Reason not Specified|9|||
44555850|NCT02926950|79572698|FG000|Overall Study|Lost to Follow-up|7|||
44555851|NCT02926950|79572699|FG001|Overall Study|Lost to Follow-up|8|||
44231964|NCT02367456|79046600|FG002|Overall Study|Death|17|||
44231965|NCT02367456|79046598|FG000|Overall Study|Lost to Follow-up|1|||
44231966|NCT02367456|79046599|FG001|Overall Study|Lost to Follow-up|3|||
44231967|NCT02367456|79046600|FG002|Overall Study|Lost to Follow-up|1|||
44231968|NCT02367456|79046598|FG000|Overall Study|Other reason|3|||
44231969|NCT02367456|79046599|FG001|Overall Study|Other reason|3|||
44231970|NCT02367456|79046600|FG002|Overall Study|Other reason|9|||
44231971|NCT02367456|79046598|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
44231972|NCT02367456|79046599|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
44231973|NCT02367456|79046600|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
44231974|NCT01865747|79046631|FG000|Overall Study (ITT)|Adverse Event|32|||
44231975|NCT01865747|79046632|FG001|Overall Study (ITT)|Adverse Event|31|||
44274898|NCT02240706|79221184|FG004|Overall Study|Insurance billing concerns|0|||
44274899|NCT02240706|79221185|FG005|Overall Study|Insurance billing concerns|0|||
44274900|NCT02240706|79221186|FG006|Overall Study|Insurance billing concerns|0|||
44274901|NCT01600092|79221211|FG000|Overall Study|Adverse Event|2|||
44274902|NCT01600092|79221212|FG001|Overall Study|Adverse Event|0|||
44497023|NCT00400517|79502767|FG000|Overall Study|Physician Decision|1|||
44497024|NCT00392171|79502771|FG000|Overall Study|Did not meet inclusion criteria|4|||
44497025|NCT00392171|79502771|FG000|Overall Study|Disease progression|101|||
44497026|NCT00391625|79502775|FG000|Month 14|Withdrawal by Subject|1|||
44497027|NCT00391625|79502775|FG000|Month 50|Physician Decision|1|||
44497028|NCT00091832|79502808|FG000|Overall Study|Physician Decision|1|||
44497029|NCT00091832|79502809|FG001|Overall Study|Physician Decision|0|||
44497030|NCT00091832|79502810|FG002|Overall Study|Physician Decision|0|||
44497031|NCT00091832|79502811|FG003|Overall Study|Physician Decision|0|||
44497032|NCT00091832|79502812|FG004|Overall Study|Physician Decision|0|||
44497033|NCT00091832|79502813|FG005|Overall Study|Physician Decision|0|||
44274903|NCT01600092|79221211|FG000|Overall Study|Lost to Follow-up|4|||
44274904|NCT01600092|79221212|FG001|Overall Study|Lost to Follow-up|6|||
44274905|NCT01600092|79221211|FG000|Overall Study|Withdrawal by parent/guardian|8|||
44274906|NCT01600092|79221212|FG001|Overall Study|Withdrawal by parent/guardian|6|||
44274907|NCT01600092|79221211|FG000|Overall Study|Physician Decision|1|||
44274908|NCT01600092|79221212|FG001|Overall Study|Physician Decision|1|||
44274909|NCT01600092|79221211|FG000|Overall Study|Randomized but not vaccinated|3|||
44497034|NCT00091832|79502808|FG000|Overall Study|Adverse Event|0|||
44497035|NCT00091832|79502809|FG001|Overall Study|Adverse Event|0|||
44497036|NCT00091832|79502810|FG002|Overall Study|Adverse Event|0|||
44497037|NCT00091832|79502811|FG003|Overall Study|Adverse Event|1|||
44555852|NCT03410693|79572708|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
44555853|NCT03410693|79572709|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
44555854|NCT03410693|79572708|FG000|Overall Study|Disc trt: Lost to follow up|0|||
44231976|NCT01865747|79046631|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
44231977|NCT01865747|79046632|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
44497038|NCT00091832|79502812|FG004|Overall Study|Adverse Event|3|||
44497039|NCT00091832|79502813|FG005|Overall Study|Adverse Event|0|||
44497040|NCT00091832|79502808|FG000|Overall Study|Withdrawal by Subject|4|||
44497041|NCT00091832|79502809|FG001|Overall Study|Withdrawal by Subject|5|||
44497042|NCT00091832|79502810|FG002|Overall Study|Withdrawal by Subject|0|||
44555855|NCT03410693|79572709|FG001|Overall Study|Disc trt: Lost to follow up|1|||
44555856|NCT03410693|79572708|FG000|Overall Study|Disc trt: radiological progression|58|||
44555857|NCT03410693|79572709|FG001|Overall Study|Disc trt: radiological progression|50|||
44555858|NCT03410693|79572708|FG000|Overall Study|Disc trt: Other|1|||
44555859|NCT03410693|79572709|FG001|Overall Study|Disc trt: Other|0|||
44555860|NCT03410693|79572708|FG000|Overall Study|Study drug never administered|1|||
44555861|NCT03410693|79572709|FG001|Overall Study|Study drug never administered|6|||
44555862|NCT03410693|79572708|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
44555863|NCT03410693|79572709|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
44555864|NCT03410693|79572708|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
44555865|NCT03410693|79572709|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
44555866|NCT03410693|79572708|FG000|Overall Study|Disc trt: Physician decision|0|||
44555867|NCT03410693|79572709|FG001|Overall Study|Disc trt: Physician decision|5|||
44555868|NCT03410693|79572708|FG000|Overall Study|Disc trt: clinical progression|1|||
44555869|NCT03410693|79572709|FG001|Overall Study|Disc trt: clinical progression|5|||
44555870|NCT03410693|79572708|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
44555871|NCT03410693|79572709|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
44555872|NCT01064414|79572724|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
44555873|NCT01064414|79572725|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
44555874|NCT01064414|79572726|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
44555875|NCT01064414|79572724|FG000|Core Period: Baseline to Week 26|Death|0|||
44555876|NCT01064414|79572725|FG001|Core Period: Baseline to Week 26|Death|1|||
44555877|NCT01064414|79572726|FG002|Core Period: Baseline to Week 26|Death|0|||
44555878|NCT01064414|79572724|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
44555879|NCT01064414|79572725|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
44555880|NCT01064414|79572726|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
44555881|NCT01064414|79572724|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
44555882|NCT01064414|79572725|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
44555883|NCT01064414|79572726|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
44555884|NCT01064414|79572724|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44555885|NCT01064414|79572725|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
44555886|NCT01064414|79572726|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44555887|NCT01064414|79572724|FG000|Core Period: Baseline to Week 26|Other|4|||
44555888|NCT01064414|79572725|FG001|Core Period: Baseline to Week 26|Other|7|||
44555889|NCT01064414|79572726|FG002|Core Period: Baseline to Week 26|Other|2|||
44555890|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
44555891|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
44555892|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
44555893|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Death|0|||
44555894|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Death|1|||
44555895|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Death|0|||
44555896|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
44555897|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44555898|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44555899|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
44555900|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44555901|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44555902|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44555903|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
44555904|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44555905|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
44555906|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
44555907|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
44555908|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
44555909|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
44555910|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
44555911|NCT01064414|79572724|FG000|Extension Period: Week 26 to Week 52|Other|5|||
44555912|NCT01064414|79572725|FG001|Extension Period: Week 26 to Week 52|Other|2|||
44555913|NCT01064414|79572726|FG002|Extension Period: Week 26 to Week 52|Other|1|||
44231978|NCT01865747|79046631|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
44231979|NCT01865747|79046632|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
44231980|NCT01865747|79046631|FG000|Overall Study (ITT)|Protocol Violation|1|||
44231981|NCT01865747|79046632|FG001|Overall Study (ITT)|Protocol Violation|1|||
44231982|NCT01865747|79046631|FG000|Overall Study (ITT)|Physician Decision|5|||
44231983|NCT01865747|79046632|FG001|Overall Study (ITT)|Physician Decision|2|||
44555914|NCT03433703|79572737|FG000|Overall Study|Study terminated by Sponsor|2|||
44231984|NCT01865747|79046631|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
44555915|NCT03463031|79572747|FG000|Overall Study|Withdrawal by Subject|4|||
44231985|NCT01865747|79046632|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
44555916|NCT03463031|79572748|FG001|Overall Study|Withdrawal by Subject|2|||
44555917|NCT03463031|79572747|FG000|Overall Study|Investigator/Sponsor Decision|0|||
44555918|NCT03463031|79572748|FG001|Overall Study|Investigator/Sponsor Decision|1|||
44555919|NCT03463031|79572747|FG000|Overall Study|Lost to Follow-up|1|||
44555920|NCT03463031|79572748|FG001|Overall Study|Lost to Follow-up|1|||
44555921|NCT03463031|79572747|FG000|Overall Study|Adverse Event|4|||
44555922|NCT03463031|79572748|FG001|Overall Study|Adverse Event|1|||
44555923|NCT03463031|79572747|FG000|Overall Study|Use of prohibited medication by subject|1|||
44555924|NCT03463031|79572748|FG001|Overall Study|Use of prohibited medication by subject|0|||
44555925|NCT03462641|79572756|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
44555926|NCT03462641|79572757|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
44555927|NCT03462641|79572756|FG000|Visit 2|Withdrawal by Subject|0|||
44555928|NCT03462641|79572757|FG001|Visit 2|Withdrawal by Subject|1|||
44555929|NCT02974634|79572767|FG000|Overall Study|Advanced disease|12|||
44555930|NCT02974634|79572768|FG001|Overall Study|Advanced disease|3|||
44555931|NCT02974634|79572767|FG000|Overall Study|Noncompliance|3|||
44555932|NCT02974634|79572768|FG001|Overall Study|Noncompliance|7|||
44555933|NCT02974634|79572767|FG000|Overall Study|intervention technology related issues|5|||
44555934|NCT02974634|79572768|FG001|Overall Study|intervention technology related issues|0|||
44555935|NCT02974634|79572767|FG000|Overall Study|Death|8|||
44555936|NCT02974634|79572768|FG001|Overall Study|Death|11|||
44555937|NCT01060670|79572777|FG000|Run In|screen failure|0|||
44555938|NCT01060670|79572778|FG001|Run In|screen failure|238|||
44555939|NCT02971670|79572790|FG000|Overall Study|Withdrawal by Subject|4|||
44555940|NCT02971670|79572791|FG001|Overall Study|Withdrawal by Subject|1|||
44555941|NCT02971670|79572792|FG002|Overall Study|Withdrawal by Subject|1|||
44555942|NCT02971670|79572793|FG003|Overall Study|Withdrawal by Subject|2|||
44231986|NCT01865747|79046631|FG000|Overall Study (ITT)|Sponsor Decision|0|||
44555943|NCT02971202|79572806|FG000|Overall Study|Pregnancy|1|||
44555944|NCT02971202|79572807|FG001|Overall Study|Pregnancy|0|||
44555945|NCT02971202|79572808|FG002|Overall Study|Pregnancy|0|||
44555946|NCT02971202|79572806|FG000|Overall Study|screen fail after consent|1|||
44555947|NCT02971202|79572807|FG001|Overall Study|screen fail after consent|0|||
44555948|NCT02971202|79572808|FG002|Overall Study|screen fail after consent|1|||
44555949|NCT02926638|79572818|FG000|Overall Study|Progression|2|||
44555950|NCT02926638|79572819|FG001|Overall Study|Progression|5|||
44555951|NCT02926638|79572818|FG000|Overall Study|Ineligible|1|||
44555952|NCT02926638|79572819|FG001|Overall Study|Ineligible|0|||
44555953|NCT02926638|79572818|FG000|Overall Study|Not protocol specified|1|||
44555954|NCT02926638|79572819|FG001|Overall Study|Not protocol specified|0|||
44555955|NCT02903030|79572827|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
44555956|NCT02903030|79572828|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
44555957|NCT02969408|79572837|FG000|Overall Study|Adverse Event|2|||
44555958|NCT02969408|79572837|FG000|Overall Study|Withdrawal by Subject|8|||
44555959|NCT02969408|79572837|FG000|Overall Study|Lost to Follow-up|4|||
44555960|NCT02969408|79572837|FG000|Overall Study|Protocol Violation|1|||
44555961|NCT02969408|79572837|FG000|Overall Study|Other than specified|1|||
44555962|NCT03462563|79572843|FG000|Overall Study|Death|1|||
44555963|NCT03462563|79572844|FG001|Overall Study|Death|1|||
44555964|NCT03462563|79572843|FG000|Overall Study|Termination of study|2|||
44231987|NCT01865747|79046632|FG001|Overall Study (ITT)|Sponsor Decision|1|||
44231988|NCT01865747|79046631|FG000|Overall Study (ITT)|Progressive Disease|122|||
44231989|NCT01865747|79046632|FG001|Overall Study (ITT)|Progressive Disease|158|||
44231990|NCT01865747|79046631|FG000|Overall Study (ITT)|Reason Not Provided|0|||
44231991|NCT01865747|79046632|FG001|Overall Study (ITT)|Reason Not Provided|1|||
44231992|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
44231993|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
44231994|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
44231995|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
44231996|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
44231997|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
44231998|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
44231999|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
44232000|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
44232001|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
44555965|NCT03462563|79572844|FG001|Overall Study|Termination of study|1|||
44555966|NCT03462563|79572843|FG000|Overall Study|Adverse Event|1|||
44555967|NCT03462563|79572844|FG001|Overall Study|Adverse Event|3|||
44555968|NCT03462563|79572843|FG000|Overall Study|Unspecified reason|10|||
44555969|NCT03462563|79572844|FG001|Overall Study|Unspecified reason|12|||
44555970|NCT03462563|79572843|FG000|Overall Study|Physician Decision|1|||
44555971|NCT03462563|79572844|FG001|Overall Study|Physician Decision|0|||
44555972|NCT01060124|79572850|FG000|Overall Study|Other|16|||
44555973|NCT01060124|79572850|FG000|Overall Study|Adverse Event|14|||
44555974|NCT01060124|79572850|FG000|Overall Study|Withdrawal by Subject|7|||
44555975|NCT03461003|79572856|FG000|Overall Study|Lost to Follow-up|2|||
44555976|NCT03461003|79572857|FG001|Overall Study|Lost to Follow-up|2|||
44232002|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
44232003|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
44232004|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
44232005|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
44232006|NCT01865747|79046631|FG000|Primary Intent to Treat (PITT)|Other|0|||
44232007|NCT01865747|79046632|FG001|Primary Intent to Treat (PITT)|Other|1|||
44232008|NCT01843673|79046673|FG000|Overall Study|Lack of Efficacy|2|||
44232009|NCT01843673|79046673|FG000|Overall Study|Withdrawal by Subject|4|||
44232010|NCT01843205|79046692|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
44232011|NCT01843205|79046693|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
44232012|NCT01835015|79046780|FG000|Overall Study|Adverse Event|0|||
44232013|NCT01835015|79046781|FG001|Overall Study|Adverse Event|0|||
44232014|NCT01835015|79046782|FG002|Overall Study|Adverse Event|1|||
44232015|NCT01835015|79046783|FG003|Overall Study|Adverse Event|0|||
44232016|NCT01835015|79046784|FG004|Overall Study|Adverse Event|0|||
44232017|NCT01842581|79046812|FG000|Overall Study|Adverse Event|6|||
44232018|NCT01842581|79046813|FG001|Overall Study|Adverse Event|4|||
44232019|NCT01842581|79046812|FG000|Overall Study|HE breakthrough|26|||
44232020|NCT01842581|79046813|FG001|Overall Study|HE breakthrough|13|||
44232021|NCT01842581|79046812|FG000|Overall Study|Liver transplant|2|||
44232022|NCT01842581|79046813|FG001|Overall Study|Liver transplant|0|||
44232023|NCT01842581|79046812|FG000|Overall Study|Lost to Follow-up|2|||
44232024|NCT01842581|79046813|FG001|Overall Study|Lost to Follow-up|5|||
44232025|NCT01842581|79046812|FG000|Overall Study|Withdrawal by Subject|5|||
44232026|NCT01842581|79046813|FG001|Overall Study|Withdrawal by Subject|7|||
44274910|NCT01600092|79221212|FG001|Overall Study|Randomized but not vaccinated|3|||
44497043|NCT00091832|79502811|FG003|Overall Study|Withdrawal by Subject|1|||
44497044|NCT00091832|79502812|FG004|Overall Study|Withdrawal by Subject|3|||
44497045|NCT00091832|79502813|FG005|Overall Study|Withdrawal by Subject|1|||
44497046|NCT00091832|79502808|FG000|Overall Study|Death|6|||
44274911|NCT02240628|79221224|FG000|Overall Study|Physician Decision|6|||
44274912|NCT02240628|79221225|FG001|Overall Study|Physician Decision|5|||
44497047|NCT00091832|79502809|FG001|Overall Study|Death|4|||
44497048|NCT00091832|79502810|FG002|Overall Study|Death|5|||
44497049|NCT00091832|79502811|FG003|Overall Study|Death|8|||
44497050|NCT00091832|79502812|FG004|Overall Study|Death|5|||
44497051|NCT00091832|79502813|FG005|Overall Study|Death|6|||
44497052|NCT00091832|79502808|FG000|Overall Study|Disease Progression|2|||
44497053|NCT00091832|79502809|FG001|Overall Study|Disease Progression|0|||
44497054|NCT00091832|79502810|FG002|Overall Study|Disease Progression|0|||
44497055|NCT00091832|79502811|FG003|Overall Study|Disease Progression|1|||
44497056|NCT00091832|79502812|FG004|Overall Study|Disease Progression|1|||
44497057|NCT00091832|79502813|FG005|Overall Study|Disease Progression|2|||
44555977|NCT03461003|79572856|FG000|Overall Study|Withdrawal by Subject|3|||
44555978|NCT03461003|79572857|FG001|Overall Study|Withdrawal by Subject|1|||
44555979|NCT02904902|79572863|FG000|Overall Study|Withdrawal by Subject|1|||
44555980|NCT04425720|79572869|FG000|Overall Study|Withdrawal by Subject|0|||
44555981|NCT04425720|79572870|FG001|Overall Study|Withdrawal by Subject|20|||
44555982|NCT02904512|79572879|FG000|Overall Study|Withdrawal by Subject|1|||
44555983|NCT02904512|79572880|FG001|Overall Study|Withdrawal by Subject|0|||
44555984|NCT02904512|79572879|FG000|Overall Study|Transferred to ICU|1|||
44555985|NCT02904512|79572880|FG001|Overall Study|Transferred to ICU|0|||
44555986|NCT02904512|79572879|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
44555987|NCT02904512|79572880|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
44555988|NCT02904200|79572886|FG000|Overall Study|Withdrawal by Subject|1|||
44555989|NCT02904200|79572887|FG001|Overall Study|Withdrawal by Subject|0|||
44555990|NCT03432533|79572893|FG000|Overall Study|Lost to Follow-up|1|||
44555991|NCT03432533|79572894|FG001|Overall Study|Lost to Follow-up|2|||
44555992|NCT03432533|79572893|FG000|Overall Study|Withdrawal by Subject|14|||
44555993|NCT03432533|79572894|FG001|Overall Study|Withdrawal by Subject|9|||
44555994|NCT02901548|79572900|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
44232027|NCT01842581|79046812|FG000|Overall Study|Other than specified|3|||
44232028|NCT01842581|79046813|FG001|Overall Study|Other than specified|1|||
44232029|NCT01833533|79046821|FG000|Overall Study|Adverse Event|0|||
44274913|NCT02207400|79221247|FG000|Overall Study|Adverse Event|1|||
44274914|NCT02207400|79221248|FG001|Overall Study|Adverse Event|1|||
44274915|NCT02207400|79221247|FG000|Overall Study|Lost to Follow-up|6|||
44274916|NCT02207400|79221248|FG001|Overall Study|Lost to Follow-up|7|||
44555995|NCT02903966|79572906|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
44555996|NCT02903966|79572907|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
44555997|NCT02903966|79572906|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
44555998|NCT02903966|79572907|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
44497058|NCT00091832|79502808|FG000|Overall Study|Ineligibility Determined|0|||
44497059|NCT00091832|79502809|FG001|Overall Study|Ineligibility Determined|0|||
44497060|NCT00091832|79502810|FG002|Overall Study|Ineligibility Determined|1|||
44497061|NCT00091832|79502811|FG003|Overall Study|Ineligibility Determined|0|||
44497062|NCT00091832|79502812|FG004|Overall Study|Ineligibility Determined|1|||
44555999|NCT02903966|79572906|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
44556000|NCT02903966|79572907|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
44556001|NCT03457727|79572923|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
44556002|NCT03457727|79572924|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
44556003|NCT03457727|79572925|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
44556004|NCT03457727|79572926|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
44556005|NCT03431441|79572958|FG000|Overall Study|Withdrawal by Subject|2|||
44556006|NCT03431441|79572958|FG000|Overall Study|Adverse Event|2|||
44556007|NCT03431441|79572958|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
44556008|NCT03457103|79572964|FG000|Overall Study|illness/hospitalization|4|||
44556009|NCT03457103|79572965|FG001|Overall Study|illness/hospitalization|2|||
44556010|NCT03457103|79572964|FG000|Overall Study|Lost to Follow-up|2|||
44556011|NCT03457103|79572965|FG001|Overall Study|Lost to Follow-up|1|||
44556012|NCT03457103|79572964|FG000|Overall Study|Withdrawal by Subject|1|||
44556013|NCT03457103|79572965|FG001|Overall Study|Withdrawal by Subject|2|||
44556014|NCT03457103|79572964|FG000|Overall Study|financial/ insurance issues|1|||
44556015|NCT03457103|79572965|FG001|Overall Study|financial/ insurance issues|1|||
44556016|NCT03455543|79572973|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
44556017|NCT03455543|79572974|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
44556018|NCT03455543|79572975|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
44556019|NCT03455543|79572973|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
44556020|NCT03455543|79572974|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
44556021|NCT03455543|79572975|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
44556022|NCT03455543|79572973|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
44556023|NCT03455543|79572974|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
44556024|NCT03455543|79572975|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
44556025|NCT03455543|79572973|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
44556026|NCT03455543|79572974|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
44556027|NCT03455543|79572975|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
44556028|NCT03455543|79572973|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
44556029|NCT03455543|79572974|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
44556030|NCT03455543|79572975|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
44556031|NCT03455543|79572973|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
44556032|NCT03455543|79572974|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
44556033|NCT03455543|79572975|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
44556034|NCT03455543|79572973|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
44556035|NCT03455543|79572974|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
44556036|NCT03455543|79572975|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
44556037|NCT03455543|79572973|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
44556038|NCT03455543|79572974|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
44556039|NCT03455543|79572975|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
44556040|NCT03455543|79572973|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
44556041|NCT03455543|79572974|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
44556042|NCT03455543|79572975|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
44556043|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
44556044|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
44556045|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
44556046|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
44556047|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Death|2|||
44556048|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Death|2|||
44556049|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Death|0|||
44556050|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Death|0|||
44556051|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
44556052|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
44556053|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
44556054|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
44556055|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
44274917|NCT02207400|79221247|FG000|Overall Study|Protocol Violation|1|||
44497063|NCT00091832|79502813|FG005|Overall Study|Ineligibility Determined|0|||
44497064|NCT00091832|79502808|FG000|Overall Study|Lost to Follow-up|1|||
44497065|NCT00091832|79502809|FG001|Overall Study|Lost to Follow-up|0|||
44497066|NCT00091832|79502810|FG002|Overall Study|Lost to Follow-up|3|||
44497067|NCT00091832|79502811|FG003|Overall Study|Lost to Follow-up|3|||
44497068|NCT00091832|79502812|FG004|Overall Study|Lost to Follow-up|2|||
44497069|NCT00091832|79502813|FG005|Overall Study|Lost to Follow-up|1|||
44497070|NCT00091832|79502808|FG000|Overall Study|Noncompliance|0|||
44497071|NCT00091832|79502809|FG001|Overall Study|Noncompliance|1|||
44497072|NCT00091832|79502810|FG002|Overall Study|Noncompliance|0|||
44556056|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
44556057|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
44556058|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
44556059|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
44556060|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
44556061|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
44556062|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
44556063|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
44556064|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
44556065|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
44556066|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
44556067|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
44556068|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
44556069|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
44556070|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
44556071|NCT03068754|79572985|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
44556072|NCT03068754|79572986|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
44556073|NCT03068754|79572987|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
44556074|NCT03068754|79572988|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
44376761|NCT01074944|79381960|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
44376762|NCT01074944|79381961|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
44376763|NCT01074944|79381962|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
44376764|NCT01074944|79381963|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
44376765|NCT01074944|79381964|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
44376766|NCT01074944|79381960|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
44556075|NCT03068754|79572985|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
44556076|NCT03068754|79572986|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
44556077|NCT03068754|79572987|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
44556078|NCT03068754|79572988|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
44556079|NCT03068754|79572985|FG000|Open Label Extension Period (OLE)|Death|0|||
44556080|NCT03068754|79572986|FG001|Open Label Extension Period (OLE)|Death|0|||
44556081|NCT03068754|79572987|FG002|Open Label Extension Period (OLE)|Death|0|||
44556082|NCT03068754|79572988|FG003|Open Label Extension Period (OLE)|Death|1|||
44556083|NCT03068754|79572985|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
44556084|NCT03068754|79572986|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
44556085|NCT03068754|79572987|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
44556086|NCT03068754|79572988|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
44556087|NCT03068754|79572985|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
44556088|NCT03068754|79572986|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
44556089|NCT03068754|79572987|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
44556090|NCT03068754|79572988|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
44556091|NCT03068754|79572985|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
44556092|NCT03068754|79572986|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
44556093|NCT03068754|79572987|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
44556094|NCT03068754|79572988|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
44556095|NCT03068754|79572985|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
44556096|NCT03068754|79572986|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
44556097|NCT03068754|79572987|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
44376767|NCT01074944|79381961|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
44497073|NCT00091832|79502811|FG003|Overall Study|Noncompliance|0|||
44497074|NCT00091832|79502812|FG004|Overall Study|Noncompliance|0|||
44497075|NCT00091832|79502813|FG005|Overall Study|Noncompliance|0|||
44497076|NCT00091832|79502808|FG000|Overall Study|Other|0|||
44497077|NCT00091832|79502809|FG001|Overall Study|Other|1|||
44497078|NCT00091832|79502810|FG002|Overall Study|Other|2|||
44497079|NCT00091832|79502811|FG003|Overall Study|Other|0|||
44497080|NCT00091832|79502812|FG004|Overall Study|Other|0|||
44497081|NCT00091832|79502813|FG005|Overall Study|Other|0|||
44497082|NCT00091832|79502808|FG000|Overall Study|Protocol Violation|0|||
44497083|NCT00091832|79502809|FG001|Overall Study|Protocol Violation|0|||
44497084|NCT00091832|79502810|FG002|Overall Study|Protocol Violation|1|||
44497085|NCT00091832|79502811|FG003|Overall Study|Protocol Violation|0|||
44376768|NCT01074944|79381962|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
44376769|NCT01074944|79381963|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
44497086|NCT00091832|79502812|FG004|Overall Study|Protocol Violation|0|||
44497087|NCT00091832|79502813|FG005|Overall Study|Protocol Violation|1|||
44497088|NCT00391391|79502831|FG000|Overall Study|Adverse Event|0|||
44556098|NCT03068754|79572988|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
44556099|NCT02965820|79572998|FG000|Period 2, Second 30 Days|Adverse Event|1|||
44556100|NCT02965820|79572999|FG001|Period 2, Second 30 Days|Adverse Event|1|||
44556101|NCT03430895|79573005|FG000|Overall Study|Not Treated|2|||
44556102|NCT03452189|79573009|FG000|First Intervention (3 Months)|Adverse Event|1|||
44556103|NCT03452189|79573010|FG001|First Intervention (3 Months)|Adverse Event|0|||
44556104|NCT03452189|79573009|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
44556105|NCT03452189|79573010|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
44556106|NCT03451721|79573016|FG000|Overall Study|Death|1|||
44556107|NCT00603954|79573022|FG000|Overall Study|Protocol Violation|1|||
44556108|NCT00603954|79573023|FG001|Overall Study|Protocol Violation|2|||
44556109|NCT03427619|79573030|FG000|Overall Study|Physician Decision|3|||
44556110|NCT03427619|79573030|FG000|Overall Study|Withdrawal by Subject|4|||
44556111|NCT03427619|79573030|FG000|Overall Study|Lost to Follow-up|5|||
44556112|NCT03427619|79573030|FG000|Overall Study|Administrative|4|||
44556113|NCT03427619|79573030|FG000|Overall Study|Other|2|||
44556114|NCT03427619|79573030|FG000|Overall Study|Unknown or Missing Completion Status|48|||
44556115|NCT03407729|79573036|FG000|Overall Study|Lost to Follow-up|2|||
44556116|NCT03407729|79573037|FG001|Overall Study|Lost to Follow-up|0|||
44556117|NCT03407729|79573036|FG000|Overall Study|Unable to schedule|0|||
44556118|NCT03407729|79573037|FG001|Overall Study|Unable to schedule|3|||
44556119|NCT02435433|79573048|FG000|Overall Study|Withdrawal by Subject|2|||
44556120|NCT02435433|79573049|FG001|Overall Study|Withdrawal by Subject|3|||
44556121|NCT02435433|79573050|FG002|Overall Study|Withdrawal by Subject|1|||
44556122|NCT02435433|79573051|FG003|Overall Study|Withdrawal by Subject|0|||
44556123|NCT02435433|79573052|FG004|Overall Study|Withdrawal by Subject|0|||
44556124|NCT02435433|79573048|FG000|Overall Study|Lost to Follow-up|2|||
44556125|NCT02435433|79573049|FG001|Overall Study|Lost to Follow-up|2|||
44556126|NCT02435433|79573050|FG002|Overall Study|Lost to Follow-up|4|||
44556127|NCT02435433|79573051|FG003|Overall Study|Lost to Follow-up|1|||
44556128|NCT02435433|79573052|FG004|Overall Study|Lost to Follow-up|0|||
44556129|NCT03120351|79573065|FG000|Overall Study|Physician Decision|1|||
44556130|NCT03120351|79573066|FG001|Overall Study|Physician Decision|1|||
44556131|NCT02354703|79573076|FG000|Overall Study|Withdrawal by Subject|1|||
44556132|NCT02354703|79573077|FG001|Overall Study|Withdrawal by Subject|1|||
44556133|NCT02354703|79573078|FG002|Overall Study|Withdrawal by Subject|1|||
44556134|NCT02354703|79573079|FG003|Overall Study|Withdrawal by Subject|1|||
44556135|NCT02354703|79573076|FG000|Overall Study|Lost to Follow-up|2|||
44556136|NCT02354703|79573077|FG001|Overall Study|Lost to Follow-up|7|||
44556137|NCT02354703|79573078|FG002|Overall Study|Lost to Follow-up|9|||
44556138|NCT02354703|79573079|FG003|Overall Study|Lost to Follow-up|2|||
44274918|NCT02207400|79221248|FG001|Overall Study|Protocol Violation|1|||
44274919|NCT02207400|79221247|FG000|Overall Study|Withdrawal by Subject|8|||
44274920|NCT02207400|79221248|FG001|Overall Study|Withdrawal by Subject|4|||
44274921|NCT02207400|79221247|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
44274922|NCT02207400|79221248|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
44497089|NCT00391391|79502832|FG001|Overall Study|Adverse Event|0|||
44497090|NCT00391391|79502833|FG002|Overall Study|Adverse Event|0|||
44497091|NCT00391391|79502834|FG003|Overall Study|Adverse Event|1|||
44497092|NCT00391391|79502831|FG000|Overall Study|Lost to Follow-up|1|||
44497093|NCT00391391|79502832|FG001|Overall Study|Lost to Follow-up|3|||
44497094|NCT00391391|79502833|FG002|Overall Study|Lost to Follow-up|7|||
44497095|NCT00391391|79502834|FG003|Overall Study|Lost to Follow-up|4|||
44497096|NCT00391391|79502831|FG000|Overall Study|Protocol Violation|2|||
44497097|NCT00391391|79502832|FG001|Overall Study|Protocol Violation|3|||
44497098|NCT00391391|79502833|FG002|Overall Study|Protocol Violation|6|||
44497099|NCT00391391|79502834|FG003|Overall Study|Protocol Violation|7|||
44497100|NCT00391391|79502831|FG000|Overall Study|Withdrawal by Subject|6|||
44497101|NCT00391391|79502832|FG001|Overall Study|Withdrawal by Subject|4|||
44497102|NCT00391391|79502833|FG002|Overall Study|Withdrawal by Subject|10|||
44556139|NCT02354703|79573076|FG000|Overall Study|Adverse Event|0|||
44556140|NCT02354703|79573077|FG001|Overall Study|Adverse Event|0|||
44556141|NCT02354703|79573078|FG002|Overall Study|Adverse Event|1|||
44556142|NCT02354703|79573079|FG003|Overall Study|Adverse Event|0|||
44556143|NCT00384111|79573095|FG000|Overall Study|Disease Progression|3|||
44556144|NCT00384111|79573095|FG000|Overall Study|Adverse Event|1|||
44497103|NCT00391391|79502834|FG003|Overall Study|Withdrawal by Subject|7|||
44556145|NCT00384111|79573095|FG000|Overall Study|Investigator Decision|3|||
44556146|NCT00384111|79573095|FG000|Overall Study|Study Terminated by the Sponsor|19|||
44497104|NCT00091442|79502846|FG000|Overall Study|Progressive Disease|220|||
44497105|NCT00091442|79502847|FG001|Overall Study|Progressive Disease|189|||
44497106|NCT00091442|79502846|FG000|Overall Study|Physician Decision|61|||
44497107|NCT00091442|79502847|FG001|Overall Study|Physician Decision|58|||
44497108|NCT00091442|79502846|FG000|Overall Study|Withdrawal by Subject|38|||
44376770|NCT01074944|79381964|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
44497109|NCT00091442|79502847|FG001|Overall Study|Withdrawal by Subject|46|||
44497110|NCT00091442|79502846|FG000|Overall Study|Adverse Event|29|||
44232030|NCT01833533|79046822|FG001|Overall Study|Adverse Event|1|||
44232031|NCT01833533|79046821|FG000|Overall Study|Lost to Follow-up|4|||
44232032|NCT01833533|79046822|FG001|Overall Study|Lost to Follow-up|9|||
44232033|NCT01833533|79046821|FG000|Overall Study|To Enter an Extension Study|0|||
44232034|NCT01833533|79046822|FG001|Overall Study|To Enter an Extension Study|4|||
44232035|NCT01833533|79046821|FG000|Overall Study|Other|2|||
44232036|NCT01833533|79046822|FG001|Overall Study|Other|7|||
44232037|NCT01833455|79046830|FG000|Overall Study|Withdrawal by Subject|1|||
44232038|NCT01833455|79046831|FG001|Overall Study|Withdrawal by Subject|0|||
44497111|NCT00091442|79502847|FG001|Overall Study|Adverse Event|48|||
44497112|NCT00091442|79502846|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
44497113|NCT00091442|79502847|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
44497114|NCT00091442|79502846|FG000|Overall Study|Death|9|||
44497115|NCT00091442|79502847|FG001|Overall Study|Death|7|||
44497116|NCT00091442|79502846|FG000|Overall Study|Lost to Follow-up|1|||
44497117|NCT00091442|79502847|FG001|Overall Study|Lost to Follow-up|3|||
44497118|NCT00091442|79502846|FG000|Overall Study|Other|2|||
44497119|NCT00091442|79502847|FG001|Overall Study|Other|6|||
44497120|NCT00390689|79502856|FG000|Overall Study|Adverse Event|2|||
44497121|NCT00390689|79502857|FG001|Overall Study|Adverse Event|5|||
44497122|NCT00390689|79502858|FG002|Overall Study|Adverse Event|2|||
44497123|NCT00390689|79502856|FG000|Overall Study|Lack of Efficacy|0|||
44497124|NCT00390689|79502857|FG001|Overall Study|Lack of Efficacy|0|||
44497125|NCT00390689|79502858|FG002|Overall Study|Lack of Efficacy|1|||
44497126|NCT00390689|79502856|FG000|Overall Study|Protocol Violation|1|||
44497127|NCT00390689|79502857|FG001|Overall Study|Protocol Violation|0|||
44497128|NCT00390689|79502858|FG002|Overall Study|Protocol Violation|0|||
44232039|NCT01833143|79046849|FG000|Overall Study|Not Treated|1|||
44232040|NCT01841567|79046853|FG000|Overall Study|Adverse Event|3|||
44232041|NCT01833065|79046860|FG000|Overall Study|Adverse Event|6|||
44232042|NCT01833065|79046861|FG001|Overall Study|Adverse Event|1|||
44232043|NCT01833065|79046862|FG002|Overall Study|Adverse Event|0|||
44232044|NCT01833065|79046863|FG003|Overall Study|Adverse Event|2|||
44232045|NCT01833065|79046864|FG004|Overall Study|Adverse Event|3|||
44232046|NCT01833065|79046860|FG000|Overall Study|Protocol Violation|1|||
44497129|NCT00390689|79502856|FG000|Overall Study|Investigator's judgement|2|||
44497130|NCT00390689|79502857|FG001|Overall Study|Investigator's judgement|0|||
44497131|NCT00390689|79502858|FG002|Overall Study|Investigator's judgement|0|||
44497132|NCT00121238|79502875|FG000|Overall Study|disease progression before intervention|1|||
44497133|NCT00121238|79502875|FG000|Overall Study|Protocol Violation|2|||
44497134|NCT00390455|79502881|FG000|Overall Study|Adverse Event|17|||
44497135|NCT00390455|79502882|FG001|Overall Study|Adverse Event|3|||
44497136|NCT00390455|79502881|FG000|Overall Study|Withdrawal by Subject|8|||
44497137|NCT00390455|79502882|FG001|Overall Study|Withdrawal by Subject|8|||
44497138|NCT00390455|79502881|FG000|Overall Study|Alternate Treatment|0|||
44497139|NCT00390455|79502882|FG001|Overall Study|Alternate Treatment|1|||
44497140|NCT00390455|79502881|FG000|Overall Study|Other Medical Reasons|7|||
44497141|NCT00390455|79502882|FG001|Overall Study|Other Medical Reasons|11|||
44497142|NCT03812510|79502888|FG000|Overall Study|Lost to Follow-up|39|||
44497143|NCT03812510|79502888|FG000|Overall Study|Withdrawal by Subject|42|||
44497144|NCT03812510|79502888|FG000|Overall Study|Physician Decision|2|||
44497145|NCT03812510|79502888|FG000|Overall Study|Study Terminated by Sponsor|9|||
44497146|NCT03812510|79502888|FG000|Overall Study|Did Not Start Study Medication|55|||
44497147|NCT03812510|79502888|FG000|Overall Study|Adverse Event|5|||
44232047|NCT01833065|79046861|FG001|Overall Study|Protocol Violation|0|||
44497148|NCT00390299|79502898|FG000|Overall Study|Cancellation|1|||
44497149|NCT00390299|79502899|FG001|Overall Study|Cancellation|0|||
44497150|NCT00390299|79502900|FG002|Overall Study|Cancellation|0|||
44497151|NCT00390299|79502901|FG003|Overall Study|Cancellation|0|||
44497152|NCT00390299|79502902|FG004|Overall Study|Cancellation|0|||
44497153|NCT00119678|79502918|FG000|Double-blind Treatment Period|Death|1|||
44497154|NCT00119678|79502919|FG001|Double-blind Treatment Period|Death|0|||
44497155|NCT00119678|79502918|FG000|Double-blind Treatment Period|Adverse Event|7|||
44232048|NCT01833065|79046862|FG002|Overall Study|Protocol Violation|0|||
44232049|NCT01833065|79046863|FG003|Overall Study|Protocol Violation|0|||
44497156|NCT00119678|79502919|FG001|Double-blind Treatment Period|Adverse Event|1|||
44232050|NCT01833065|79046864|FG004|Overall Study|Protocol Violation|2|||
44497157|NCT00119678|79502918|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
44497158|NCT00119678|79502919|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
44274923|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
44274924|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
44274925|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
44274926|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44497159|NCT00119678|79502918|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
44497160|NCT00119678|79502919|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
44497161|NCT00119678|79502918|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
44497162|NCT00119678|79502919|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
44497163|NCT00119678|79502918|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
44497164|NCT00119678|79502919|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
44497165|NCT00119678|79502918|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
44274927|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44274928|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44376771|NCT01074944|79381960|FG000|Long Term Treatment|Withdrawal by Subject|0|||
44497166|NCT00119678|79502919|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
44274929|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44497167|NCT00119678|79502918|FG000|Double-blind Treatment Period|Pregnancy|0|||
44497168|NCT00119678|79502919|FG001|Double-blind Treatment Period|Pregnancy|2|||
44497169|NCT00119678|79502918|FG000|Double-blind Treatment Period|Not treated|1|||
44497170|NCT00119678|79502919|FG001|Double-blind Treatment Period|Not treated|2|||
44497171|NCT00119678|79502918|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
44497172|NCT00119678|79502919|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
44232051|NCT01833065|79046860|FG000|Overall Study|Lost to Follow-up|1|||
44497173|NCT00119678|79502918|FG000|Open-label Treatment Period|Death|1|||
44497174|NCT00119678|79502919|FG001|Open-label Treatment Period|Death|0|||
44497175|NCT00119678|79502918|FG000|Open-label Treatment Period|Adverse Event|3|||
44556147|NCT03113409|79573099|FG000|Overall Study|Withdrawal by Subject|5|||
44556148|NCT03113409|79573100|FG001|Overall Study|Withdrawal by Subject|0|||
44556149|NCT03113409|79573101|FG002|Overall Study|Withdrawal by Subject|0|||
44556150|NCT01319877|79573107|FG000|Overall Study|Lost to Follow-up|100|||
44556151|NCT01319877|79573108|FG001|Overall Study|Lost to Follow-up|37|||
44556152|NCT01319877|79573107|FG000|Overall Study|Physician Decision|2|||
44556153|NCT01319877|79573108|FG001|Overall Study|Physician Decision|0|||
44556154|NCT01319877|79573107|FG000|Overall Study|Disease Progression|2|||
44556155|NCT01319877|79573108|FG001|Overall Study|Disease Progression|2|||
44556156|NCT01319877|79573107|FG000|Overall Study|Withdrawal by Subject|0|||
44556157|NCT01319877|79573108|FG001|Overall Study|Withdrawal by Subject|1|||
44556158|NCT01319877|79573107|FG000|Overall Study|Reason Not Specified|4|||
44556159|NCT01319877|79573108|FG001|Overall Study|Reason Not Specified|5|||
44556160|NCT03427073|79573121|FG000|Overall Study|Disease Progression|1|||
44556161|NCT03427073|79573122|FG001|Overall Study|Disease Progression|1|||
44556162|NCT03427073|79573123|FG002|Overall Study|Disease Progression|1|||
44556163|NCT03427073|79573124|FG003|Overall Study|Disease Progression|3|||
44556164|NCT03427073|79573125|FG004|Overall Study|Disease Progression|3|||
44556165|NCT03427073|79573126|FG005|Overall Study|Disease Progression|4|||
44556166|NCT03427073|79573127|FG006|Overall Study|Disease Progression|2|||
44556167|NCT03427073|79573128|FG007|Overall Study|Disease Progression|3|||
44556168|NCT03427073|79573121|FG000|Overall Study|Physician Decision|0|||
44556169|NCT03427073|79573122|FG001|Overall Study|Physician Decision|0|||
44556170|NCT03427073|79573123|FG002|Overall Study|Physician Decision|0|||
44556171|NCT03427073|79573124|FG003|Overall Study|Physician Decision|0|||
44556172|NCT03427073|79573125|FG004|Overall Study|Physician Decision|0|||
44556173|NCT03427073|79573126|FG005|Overall Study|Physician Decision|0|||
44556174|NCT03427073|79573127|FG006|Overall Study|Physician Decision|1|||
44556175|NCT03427073|79573128|FG007|Overall Study|Physician Decision|1|||
44556176|NCT03066804|79573148|FG000|Overall Study|Physician Decision|0|||
44232052|NCT01833065|79046861|FG001|Overall Study|Lost to Follow-up|0|||
44232053|NCT01833065|79046862|FG002|Overall Study|Lost to Follow-up|0|||
44232054|NCT01833065|79046863|FG003|Overall Study|Lost to Follow-up|0|||
44232055|NCT01833065|79046864|FG004|Overall Study|Lost to Follow-up|3|||
44232056|NCT01833065|79046860|FG000|Overall Study|Withdrawal by Subject|6|||
44232057|NCT01833065|79046861|FG001|Overall Study|Withdrawal by Subject|2|||
44232058|NCT01833065|79046862|FG002|Overall Study|Withdrawal by Subject|4|||
44274930|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44497176|NCT00119678|79502919|FG001|Open-label Treatment Period|Adverse Event|0|||
44556177|NCT03066804|79573149|FG001|Overall Study|Physician Decision|4|||
44556178|NCT03066804|79573148|FG000|Overall Study|Death|23|||
44556179|NCT03066804|79573149|FG001|Overall Study|Death|17|||
44556180|NCT03066804|79573148|FG000|Overall Study|Withdrawal by Subject|19|||
44556181|NCT03066804|79573149|FG001|Overall Study|Withdrawal by Subject|25|||
44556182|NCT03066804|79573148|FG000|Overall Study|Lost to Follow-up|2|||
44556183|NCT03066804|79573149|FG001|Overall Study|Lost to Follow-up|0|||
44556184|NCT03066804|79573148|FG000|Overall Study|Adverse Event|2|||
44232059|NCT01833065|79046863|FG003|Overall Study|Withdrawal by Subject|3|||
44556185|NCT03066804|79573149|FG001|Overall Study|Adverse Event|3|||
44556186|NCT03066804|79573148|FG000|Overall Study|Technical problems|5|||
44556187|NCT03066804|79573149|FG001|Overall Study|Technical problems|1|||
44556188|NCT02954237|79573156|FG000|Overall Study|Withdrawal by Subject|25|||
44556189|NCT02954237|79573156|FG000|Overall Study|Missed visit|16|||
44556190|NCT02954237|79573156|FG000|Overall Study|Death|2|||
44556191|NCT04250337|79573162|FG000|Overall Study|Adverse Event|0|||
44556192|NCT04250337|79573163|FG001|Overall Study|Adverse Event|3|||
44556193|NCT04250337|79573162|FG000|Overall Study|Lack of Efficacy|1|||
44556194|NCT04250337|79573163|FG001|Overall Study|Lack of Efficacy|3|||
44556195|NCT04250337|79573162|FG000|Overall Study|Physician Decision|1|||
44556196|NCT04250337|79573163|FG001|Overall Study|Physician Decision|0|||
44556197|NCT04250337|79573162|FG000|Overall Study|Protocol Deviation|2|||
44556198|NCT04250337|79573163|FG001|Overall Study|Protocol Deviation|2|||
44556199|NCT04250337|79573162|FG000|Overall Study|Withdrawal by Subject|4|||
44556200|NCT04250337|79573163|FG001|Overall Study|Withdrawal by Subject|3|||
44556201|NCT03118947|79573170|FG000|Overall Study|Adverse Event|7|||
44556202|NCT03118947|79573170|FG000|Overall Study|Death|3|||
44556203|NCT03118947|79573170|FG000|Overall Study|Lack of Efficacy|4|||
44556204|NCT03118947|79573170|FG000|Overall Study|Non-compliance with study drug|1|||
44556205|NCT03118947|79573170|FG000|Overall Study|Protocol Violation|2|||
44556206|NCT03118947|79573170|FG000|Overall Study|Withdrawal by Subject|3|||
44556207|NCT03118947|79573170|FG000|Overall Study|Withdrawal by caregiver|3|||
44556208|NCT03118947|79573170|FG000|Overall Study|Change in patient's living situation|4|||
44556209|NCT03118947|79573170|FG000|Overall Study|Lost to Follow-up|2|||
44556210|NCT03953079|79573177|FG000|Core Study|Withdrawal by Subject|1|||
44556211|NCT03953079|79573178|FG001|Core Study|Withdrawal by Subject|2|||
44556212|NCT03953079|79573179|FG002|Core Study|Withdrawal by Subject|1|||
44556213|NCT03953079|79573177|FG000|Core Study|COVID-19|0|||
44556214|NCT03953079|79573178|FG001|Core Study|COVID-19|1|||
44556215|NCT03953079|79573179|FG002|Core Study|COVID-19|0|||
44556216|NCT03953079|79573177|FG000|Core Study|Difficulties leaving the house|0|||
44556217|NCT03953079|79573178|FG001|Core Study|Difficulties leaving the house|1|||
44556218|NCT03953079|79573179|FG002|Core Study|Difficulties leaving the house|0|||
44556219|NCT03953079|79573177|FG000|Extension Study|Withdrawal by Subject|1|||
44556220|NCT03953079|79573178|FG001|Extension Study|Withdrawal by Subject|0|||
44232060|NCT01833065|79046864|FG004|Overall Study|Withdrawal by Subject|11|||
44232061|NCT01833065|79046860|FG000|Overall Study|Subject's substantial non-compliance|0|||
44232062|NCT01833065|79046861|FG001|Overall Study|Subject's substantial non-compliance|1|||
44232063|NCT01833065|79046862|FG002|Overall Study|Subject's substantial non-compliance|0|||
44232064|NCT01833065|79046863|FG003|Overall Study|Subject's substantial non-compliance|0|||
44232065|NCT01833065|79046864|FG004|Overall Study|Subject's substantial non-compliance|0|||
44232066|NCT01833065|79046860|FG000|Overall Study|Trial terminated by sponsor|8|||
44232067|NCT01833065|79046861|FG001|Overall Study|Trial terminated by sponsor|8|||
44232068|NCT01833065|79046862|FG002|Overall Study|Trial terminated by sponsor|7|||
44232069|NCT01833065|79046863|FG003|Overall Study|Trial terminated by sponsor|3|||
44232070|NCT01833065|79046864|FG004|Overall Study|Trial terminated by sponsor|13|||
44232071|NCT01833065|79046860|FG000|Overall Study|Others|2|||
44232072|NCT01833065|79046861|FG001|Overall Study|Others|1|||
44497177|NCT00119678|79502918|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
44497178|NCT00119678|79502919|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
44497179|NCT00119678|79502918|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
44497180|NCT00119678|79502919|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
44497181|NCT00119678|79502918|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
44497182|NCT00119678|79502919|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
44497183|NCT00119678|79502918|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
44497184|NCT00119678|79502919|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
44497185|NCT00119678|79502918|FG000|Open-label Treatment Period|Pregnancy|1|||
44497186|NCT00119678|79502919|FG001|Open-label Treatment Period|Pregnancy|0|||
44497187|NCT00119678|79502918|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
44497188|NCT00119678|79502919|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
44497189|NCT00110084|79502927|FG000|Overall Study|Adverse Event|9|||
44556221|NCT03953079|79573179|FG002|Extension Study|Withdrawal by Subject|0|||
44556222|NCT03953079|79573177|FG000|Extension Study|Received Rescue Treatment|5|||
44556223|NCT03953079|79573178|FG001|Extension Study|Received Rescue Treatment|6|||
44232073|NCT01833065|79046862|FG002|Overall Study|Others|1|||
44232074|NCT01833065|79046863|FG003|Overall Study|Others|1|||
44376772|NCT01074944|79381961|FG001|Long Term Treatment|Withdrawal by Subject|0|||
44497190|NCT00110084|79502927|FG000|Overall Study|Death|1|||
44497191|NCT00110084|79502927|FG000|Overall Study|Patient Refusal|10|||
44497192|NCT00110084|79502927|FG000|Overall Study|Alternate Therapy|5|||
44556224|NCT03953079|79573179|FG002|Extension Study|Received Rescue Treatment|5|||
44556225|NCT03885999|79573192|FG000|Overall Study|Adverse Event|1|||
44556226|NCT03108027|79573206|FG000|Period 1|Subject/Guardian Decision|0|||
44232075|NCT01833065|79046864|FG004|Overall Study|Others|4|||
44232076|NCT01831817|79046878|FG000|Overall Study|Lost to Follow-up|1|||
44556227|NCT03108027|79573207|FG001|Period 1|Subject/Guardian Decision|0|||
44556228|NCT03108027|79573208|FG002|Period 1|Subject/Guardian Decision|0|||
44556229|NCT03108027|79573209|FG003|Period 1|Subject/Guardian Decision|2|||
44556230|NCT03108027|79573210|FG004|Period 1|Subject/Guardian Decision|0|||
44556231|NCT03108027|79573211|FG005|Period 1|Subject/Guardian Decision|0|||
44556232|NCT03108027|79573206|FG000|Period 3|Adverse Event|0|||
44556233|NCT03108027|79573207|FG001|Period 3|Adverse Event|1|||
44556234|NCT03108027|79573208|FG002|Period 3|Adverse Event|0|||
44556235|NCT03108027|79573209|FG003|Period 3|Adverse Event|0|||
44556236|NCT03108027|79573210|FG004|Period 3|Adverse Event|0|||
44556237|NCT03108027|79573211|FG005|Period 3|Adverse Event|0|||
44556238|NCT03107715|79573227|FG000|Overall Study|did not deliver at the home hospital|4|||
44556239|NCT03107715|79573228|FG001|Overall Study|did not deliver at the home hospital|6|||
44556240|NCT03107715|79573227|FG000|Overall Study|infant stillborn|0|||
44556241|NCT03107715|79573228|FG001|Overall Study|infant stillborn|1|||
44556242|NCT03567057|79573237|FG000|Overall Study|Adverse Event|56|||
44556243|NCT03567057|79573238|FG001|Overall Study|Adverse Event|53|||
44556244|NCT03567057|79573239|FG002|Overall Study|Adverse Event|28|||
44556245|NCT03567057|79573237|FG000|Overall Study|Withdrawal by Subject|22|||
44556246|NCT03567057|79573238|FG001|Overall Study|Withdrawal by Subject|24|||
44556247|NCT03567057|79573239|FG002|Overall Study|Withdrawal by Subject|13|||
44556248|NCT03567057|79573237|FG000|Overall Study|Lost to Follow-up|3|||
44556249|NCT03567057|79573238|FG001|Overall Study|Lost to Follow-up|5|||
44556250|NCT03567057|79573239|FG002|Overall Study|Lost to Follow-up|2|||
44556251|NCT03567057|79573237|FG000|Overall Study|COVID-19 pandemic|4|||
44556252|NCT03567057|79573238|FG001|Overall Study|COVID-19 pandemic|3|||
44556253|NCT03567057|79573239|FG002|Overall Study|COVID-19 pandemic|0|||
44556254|NCT03567057|79573237|FG000|Overall Study|Non-compliance with study drug|4|||
44556255|NCT03567057|79573238|FG001|Overall Study|Non-compliance with study drug|2|||
44556256|NCT03567057|79573239|FG002|Overall Study|Non-compliance with study drug|0|||
44556257|NCT03567057|79573237|FG000|Overall Study|Lack of Efficacy|3|||
44556258|NCT03567057|79573238|FG001|Overall Study|Lack of Efficacy|0|||
44556259|NCT03567057|79573239|FG002|Overall Study|Lack of Efficacy|1|||
44556260|NCT03567057|79573237|FG000|Overall Study|Death|1|||
44556261|NCT03567057|79573238|FG001|Overall Study|Death|0|||
44556262|NCT03567057|79573239|FG002|Overall Study|Death|0|||
44556263|NCT03567057|79573237|FG000|Overall Study|Physician Decision|1|||
44556264|NCT03567057|79573238|FG001|Overall Study|Physician Decision|0|||
44556265|NCT03567057|79573239|FG002|Overall Study|Physician Decision|0|||
44556266|NCT03567057|79573237|FG000|Overall Study|Unstable medical condition|1|||
44232077|NCT01831817|79046879|FG001|Overall Study|Lost to Follow-up|0|||
44232078|NCT01831817|79046880|FG002|Overall Study|Lost to Follow-up|0|||
44232079|NCT01831817|79046881|FG003|Overall Study|Lost to Follow-up|0|||
44497193|NCT00110084|79502927|FG000|Overall Study|Intercurrent Illness|1|||
44497194|NCT00110084|79502927|FG000|Overall Study|Other|2|||
44497195|NCT00390221|79502934|FG000|Overall Study|Lost to Follow-up|0|||
44497196|NCT00390221|79502935|FG001|Overall Study|Lost to Follow-up|3|||
44497197|NCT00390221|79502936|FG002|Overall Study|Lost to Follow-up|0|||
44497198|NCT00390221|79502934|FG000|Overall Study|Adverse Event|1|||
44497199|NCT00390221|79502935|FG001|Overall Study|Adverse Event|4|||
44497200|NCT00390221|79502936|FG002|Overall Study|Adverse Event|3|||
44497201|NCT00390221|79502934|FG000|Overall Study|Investigator Decision|0|||
44497202|NCT00390221|79502935|FG001|Overall Study|Investigator Decision|0|||
44497203|NCT00390221|79502936|FG002|Overall Study|Investigator Decision|1|||
44497204|NCT00390221|79502934|FG000|Overall Study|Withdrawal by Subject|13|||
44497205|NCT00390221|79502935|FG001|Overall Study|Withdrawal by Subject|9|||
44497206|NCT00390221|79502936|FG002|Overall Study|Withdrawal by Subject|7|||
44497207|NCT00390221|79502934|FG000|Overall Study|Subject Non-compliance|1|||
44556267|NCT03567057|79573238|FG001|Overall Study|Unstable medical condition|0|||
44556268|NCT03567057|79573239|FG002|Overall Study|Unstable medical condition|0|||
44556269|NCT03567057|79573237|FG000|Overall Study|Medical history event|0|||
44556270|NCT03567057|79573238|FG001|Overall Study|Medical history event|0|||
44556271|NCT03567057|79573239|FG002|Overall Study|Medical history event|1|||
44556272|NCT03567057|79573237|FG000|Overall Study|Other|0|||
44232080|NCT01831817|79046878|FG000|Overall Study|Withdrawl of Consent|3|||
44232081|NCT01831817|79046879|FG001|Overall Study|Withdrawl of Consent|0|||
44232082|NCT01831817|79046880|FG002|Overall Study|Withdrawl of Consent|0|||
44232083|NCT01831817|79046881|FG003|Overall Study|Withdrawl of Consent|0|||
44497208|NCT00390221|79502935|FG001|Overall Study|Subject Non-compliance|0|||
44497209|NCT00390221|79502936|FG002|Overall Study|Subject Non-compliance|2|||
44497210|NCT00390221|79502934|FG000|Overall Study|Other|3|||
44497211|NCT00390221|79502935|FG001|Overall Study|Other|4|||
44556273|NCT03567057|79573238|FG001|Overall Study|Other|0|||
44556274|NCT03567057|79573239|FG002|Overall Study|Other|1|||
44556275|NCT04388787|79573247|FG000|Blinded Period|Patient could not follow instructions|1|||
44556276|NCT04388787|79573247|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
44556277|NCT03057600|79573259|FG000|Overall Study|Adverse Event|0|||
44556278|NCT03057600|79573260|FG001|Overall Study|Adverse Event|0|||
44556279|NCT03057600|79573261|FG002|Overall Study|Adverse Event|4|||
44556280|NCT03057600|79573262|FG003|Overall Study|Adverse Event|0|||
44556281|NCT03057600|79573259|FG000|Overall Study|Radiologic Disease Progression|8|||
44556282|NCT03057600|79573260|FG001|Overall Study|Radiologic Disease Progression|7|||
44556283|NCT03057600|79573261|FG002|Overall Study|Radiologic Disease Progression|13|||
44556284|NCT03057600|79573262|FG003|Overall Study|Radiologic Disease Progression|10|||
44556285|NCT03057600|79573259|FG000|Overall Study|Symptomatic Deterioration|0|||
44556286|NCT03057600|79573260|FG001|Overall Study|Symptomatic Deterioration|1|||
44556287|NCT03057600|79573261|FG002|Overall Study|Symptomatic Deterioration|1|||
44556288|NCT03057600|79573262|FG003|Overall Study|Symptomatic Deterioration|0|||
44556289|NCT03057600|79573259|FG000|Overall Study|Investigator Decision|0|||
44556290|NCT03057600|79573260|FG001|Overall Study|Investigator Decision|0|||
44556291|NCT03057600|79573261|FG002|Overall Study|Investigator Decision|1|||
44556292|NCT03057600|79573262|FG003|Overall Study|Investigator Decision|0|||
44556293|NCT03057600|79573259|FG000|Overall Study|Study Termination by Sponsor|0|||
44556294|NCT03057600|79573260|FG001|Overall Study|Study Termination by Sponsor|0|||
44556295|NCT03057600|79573261|FG002|Overall Study|Study Termination by Sponsor|0|||
44556296|NCT03057600|79573262|FG003|Overall Study|Study Termination by Sponsor|2|||
44556297|NCT03057600|79573259|FG000|Overall Study|Withdrawal by Subject|0|||
44556298|NCT03057600|79573260|FG001|Overall Study|Withdrawal by Subject|1|||
44556299|NCT03057600|79573261|FG002|Overall Study|Withdrawal by Subject|0|||
44556300|NCT03057600|79573262|FG003|Overall Study|Withdrawal by Subject|0|||
44556301|NCT03057600|79573259|FG000|Overall Study|Other, Not Specified|1|||
44556302|NCT03057600|79573260|FG001|Overall Study|Other, Not Specified|1|||
44556303|NCT03057600|79573261|FG002|Overall Study|Other, Not Specified|1|||
44556304|NCT03057600|79573262|FG003|Overall Study|Other, Not Specified|1|||
44556305|NCT03371823|79573292|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
44556306|NCT03371823|79573293|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
44556307|NCT02966301|79573308|FG000|Overall Study|Death|2|||
44556308|NCT02966301|79573308|FG000|Overall Study|Withdrawal by Subject|1|||
44556309|NCT03107091|79573312|FG000|Overall Study|Physician Decision|1|||
44556310|NCT03065400|79573326|FG000|Overall Study|Adverse Event|1|||
44556311|NCT03065400|79573326|FG000|Overall Study|Physician Decision|3|||
44556312|NCT03065400|79573326|FG000|Overall Study|Withdrawal by Subject|1|||
44556313|NCT03065400|79573326|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
44556314|NCT03085095|79573332|FG000|Overall Study|Adverse Event|23|||
44556315|NCT03085095|79573333|FG001|Overall Study|Adverse Event|8|||
44556316|NCT03085095|79573332|FG000|Overall Study|Protocol Violation|0|||
44556317|NCT03085095|79573333|FG001|Overall Study|Protocol Violation|1|||
44497212|NCT00390221|79502936|FG002|Overall Study|Other|2|||
44497213|NCT00389831|79502947|FG000|Overall Study|Lack of Efficacy|0|||
44497214|NCT00389831|79502948|FG001|Overall Study|Lack of Efficacy|2|||
44497215|NCT00389831|79502947|FG000|Overall Study|Did not receive treatment.|0|||
44497216|NCT00389831|79502948|FG001|Overall Study|Did not receive treatment.|2|||
44497217|NCT00389831|79502947|FG000|Overall Study|Other reasons|0|||
44497218|NCT00389831|79502948|FG001|Overall Study|Other reasons|2|||
44497219|NCT00389831|79502947|FG000|Overall Study|Lost to Follow-up|0|||
44497220|NCT00389831|79502948|FG001|Overall Study|Lost to Follow-up|1|||
44556318|NCT03085095|79573332|FG000|Overall Study|Lost to Follow-up|2|||
44556319|NCT03085095|79573333|FG001|Overall Study|Lost to Follow-up|1|||
44556320|NCT03085095|79573332|FG000|Overall Study|Withdrawal by Subject|17|||
44497221|NCT00389597|79502970|FG000|Overall Study|Lost to Follow-up|8|||
44497222|NCT00389597|79502971|FG001|Overall Study|Lost to Follow-up|6|||
44556321|NCT03085095|79573333|FG001|Overall Study|Withdrawal by Subject|6|||
44556322|NCT03085095|79573332|FG000|Overall Study|Physician Decision|9|||
44556323|NCT03085095|79573333|FG001|Overall Study|Physician Decision|3|||
44556324|NCT03085095|79573332|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
44556325|NCT03085095|79573333|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
44556326|NCT03085095|79573332|FG000|Overall Study|Did not Receive Study Drug|2|||
44497223|NCT00389597|79502972|FG002|Overall Study|Lost to Follow-up|4|||
44497224|NCT00389597|79502973|FG003|Overall Study|Lost to Follow-up|6|||
44556327|NCT03085095|79573333|FG001|Overall Study|Did not Receive Study Drug|2|||
44556328|NCT03085095|79573332|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
44556329|NCT03085095|79573333|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
44556330|NCT04097301|79573342|FG000|Overall Study|Death|1|||
44556331|NCT04097301|79573342|FG000|Overall Study|Withdrawal by Subject|1|||
44556332|NCT04097301|79573342|FG000|Overall Study|Screening Failure|5|||
44556333|NCT02276547|79573348|FG000|Overall Study|Death|2|||
44556334|NCT02276547|79573348|FG000|Overall Study|Explant|2|||
44556335|NCT02966834|79573358|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
44556336|NCT02966834|79573359|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
44556337|NCT02966834|79573360|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
44556338|NCT02966834|79573361|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
44556339|NCT02966834|79573362|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
44556340|NCT02966834|79573363|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
44556341|NCT02966834|79573358|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
44556342|NCT02966834|79573359|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
44556343|NCT02966834|79573360|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
44556344|NCT02966834|79573361|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
44556345|NCT02966834|79573362|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
44556346|NCT02966834|79573363|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
44556347|NCT02966834|79573358|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
44556348|NCT02966834|79573359|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
44232084|NCT01840943|79046906|FG000|Overall Study|Withdrawal by Subject|5|||
44232085|NCT01840943|79046907|FG001|Overall Study|Withdrawal by Subject|6|||
44232086|NCT01840943|79046906|FG000|Overall Study|Physician Decision|4|||
44232087|NCT01840943|79046907|FG001|Overall Study|Physician Decision|2|||
44232088|NCT01840943|79046906|FG000|Overall Study|Lost to Follow-up|4|||
44232089|NCT01840943|79046907|FG001|Overall Study|Lost to Follow-up|4|||
44232090|NCT01840163|79046915|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
44232091|NCT01840163|79046916|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
44232092|NCT01840163|79046915|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
44232093|NCT01840163|79046916|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
44232094|NCT01840163|79046915|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
44232095|NCT01840163|79046916|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
44232096|NCT01831427|79047069|FG000|Overall Study|Adverse Event|0|||
44232097|NCT01831427|79047070|FG001|Overall Study|Adverse Event|1|||
44232098|NCT01831427|79047071|FG002|Overall Study|Adverse Event|0|||
44232099|NCT01831427|79047072|FG003|Overall Study|Adverse Event|0|||
44232100|NCT01831427|79047073|FG004|Overall Study|Adverse Event|0|||
44232101|NCT01831427|79047074|FG005|Overall Study|Adverse Event|1|||
44232102|NCT01831427|79047075|FG006|Overall Study|Adverse Event|0|||
44232103|NCT01831427|79047076|FG007|Overall Study|Adverse Event|1|||
44232104|NCT01831427|79047077|FG008|Overall Study|Adverse Event|0|||
44232105|NCT01831427|79047078|FG009|Overall Study|Adverse Event|0|||
44232106|NCT01831427|79047079|FG010|Overall Study|Adverse Event|2|||
44232107|NCT01831427|79047069|FG000|Overall Study|Investigator's Discretion|0|||
44232108|NCT01831427|79047070|FG001|Overall Study|Investigator's Discretion|0|||
44232109|NCT01831427|79047071|FG002|Overall Study|Investigator's Discretion|0|||
44232110|NCT01831427|79047072|FG003|Overall Study|Investigator's Discretion|1|||
44232111|NCT01831427|79047073|FG004|Overall Study|Investigator's Discretion|0|||
44232112|NCT01831427|79047074|FG005|Overall Study|Investigator's Discretion|0|||
44232113|NCT01831427|79047075|FG006|Overall Study|Investigator's Discretion|0|||
44232114|NCT01831427|79047076|FG007|Overall Study|Investigator's Discretion|0|||
44232115|NCT01831427|79047077|FG008|Overall Study|Investigator's Discretion|0|||
44274931|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44376773|NCT01074944|79381962|FG002|Long Term Treatment|Withdrawal by Subject|0|||
44376774|NCT01074944|79381963|FG003|Long Term Treatment|Withdrawal by Subject|2|||
44497225|NCT00389519|79502987|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
44497226|NCT00389519|79502988|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
44497227|NCT00389519|79502989|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
44497228|NCT00389519|79502990|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
44497229|NCT00389519|79502987|FG000|Placebo Run-In|Withdrawal by Subject|19|||
44497230|NCT00389519|79502988|FG001|Placebo Run-In|Withdrawal by Subject|0|||
44497231|NCT00389519|79502989|FG002|Placebo Run-In|Withdrawal by Subject|0|||
44497232|NCT00389519|79502990|FG003|Placebo Run-In|Withdrawal by Subject|0|||
44232116|NCT01831427|79047078|FG009|Overall Study|Investigator's Discretion|0|||
44232117|NCT01831427|79047079|FG010|Overall Study|Investigator's Discretion|0|||
44232118|NCT01831427|79047069|FG000|Overall Study|Withdrew Consent|0|||
44232119|NCT01831427|79047070|FG001|Overall Study|Withdrew Consent|0|||
44232120|NCT01831427|79047071|FG002|Overall Study|Withdrew Consent|0|||
44232121|NCT01831427|79047072|FG003|Overall Study|Withdrew Consent|0|||
44232122|NCT01831427|79047073|FG004|Overall Study|Withdrew Consent|0|||
44232123|NCT01831427|79047074|FG005|Overall Study|Withdrew Consent|0|||
44232124|NCT01831427|79047075|FG006|Overall Study|Withdrew Consent|2|||
44232125|NCT01831427|79047076|FG007|Overall Study|Withdrew Consent|0|||
44232126|NCT01831427|79047077|FG008|Overall Study|Withdrew Consent|0|||
44232127|NCT01831427|79047078|FG009|Overall Study|Withdrew Consent|1|||
44556349|NCT02966834|79573360|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
44556350|NCT02966834|79573361|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
44556351|NCT02966834|79573362|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
44232128|NCT01831427|79047079|FG010|Overall Study|Withdrew Consent|1|||
44232129|NCT01830881|79047125|FG000|Overall Study|Changed decision to have an abortion|0|||
44232130|NCT01830881|79047126|FG001|Overall Study|Changed decision to have an abortion|1|||
44232131|NCT01838681|79047162|FG000|Period A|Adverse Event|39|||
44274932|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44274933|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
44232132|NCT01838681|79047163|FG001|Period A|Adverse Event|0|||
44232133|NCT01838681|79047164|FG002|Period A|Adverse Event|0|||
44274934|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
44274935|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274936|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
44274937|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44497233|NCT00389519|79502987|FG000|Placebo Run-In|Reason not specified|40|||
44497234|NCT00389519|79502988|FG001|Placebo Run-In|Reason not specified|0|||
44497235|NCT00389519|79502989|FG002|Placebo Run-In|Reason not specified|0|||
44497236|NCT00389519|79502990|FG003|Placebo Run-In|Reason not specified|0|||
44497237|NCT00389519|79502987|FG000|Randomized|Did not receive study drug|2|||
44497238|NCT00389519|79502988|FG001|Randomized|Did not receive study drug|0|||
44497239|NCT00389519|79502989|FG002|Randomized|Did not receive study drug|0|||
44497240|NCT00389519|79502990|FG003|Randomized|Did not receive study drug|0|||
44497241|NCT00389519|79502987|FG000|Treated|Adverse Event|1|||
44497242|NCT00389519|79502988|FG001|Treated|Adverse Event|0|||
44497243|NCT00389519|79502989|FG002|Treated|Adverse Event|0|||
44497244|NCT00389519|79502990|FG003|Treated|Adverse Event|2|||
44497245|NCT00389519|79502987|FG000|Treated|Reason not specified|1|||
44497246|NCT00389519|79502988|FG001|Treated|Reason not specified|1|||
44497247|NCT00389519|79502989|FG002|Treated|Reason not specified|0|||
44497248|NCT00389519|79502990|FG003|Treated|Reason not specified|2|||
44497249|NCT00389441|79503000|FG000|Overall Study|Adverse Event|7|||
44497250|NCT00389441|79503000|FG000|Overall Study|Death|4|||
44497251|NCT00389441|79503000|FG000|Overall Study|Lost to Follow-up|2|||
44497252|NCT00389441|79503000|FG000|Overall Study|Withdrawal by Subject|4|||
44497253|NCT00389441|79503000|FG000|Overall Study|Physician Decision|1|||
44497254|NCT00389441|79503000|FG000|Overall Study|Protocol Violation|1|||
44497255|NCT00389441|79503000|FG000|Overall Study|Global deterioration of health status|4|||
44497256|NCT00389441|79503000|FG000|Overall Study|Objective progression or relapse|26|||
44497257|NCT00389441|79503000|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
44497258|NCT00389441|79503000|FG000|Overall Study|Clinical progression|1|||
44497259|NCT00118898|79503008|FG000|Overall Study|Death|6|||
44497260|NCT00118898|79503009|FG001|Overall Study|Death|11|||
44497261|NCT00118898|79503010|FG002|Overall Study|Death|6|||
44497262|NCT00118898|79503011|FG003|Overall Study|Death|8|||
44497263|NCT00118898|79503008|FG000|Overall Study|Lost to Follow-up|26|||
44497264|NCT00118898|79503009|FG001|Overall Study|Lost to Follow-up|34|||
44497265|NCT00118898|79503010|FG002|Overall Study|Lost to Follow-up|33|||
44497266|NCT00118898|79503011|FG003|Overall Study|Lost to Follow-up|33|||
44497267|NCT00118898|79503008|FG000|Overall Study|Withdrawal by Subject|10|||
44497268|NCT00118898|79503009|FG001|Overall Study|Withdrawal by Subject|5|||
44497269|NCT00118898|79503010|FG002|Overall Study|Withdrawal by Subject|8|||
44497270|NCT00118898|79503011|FG003|Overall Study|Withdrawal by Subject|8|||
44497271|NCT00118898|79503008|FG000|Overall Study|Site Closure|33|||
44497272|NCT00118898|79503009|FG001|Overall Study|Site Closure|31|||
44497273|NCT00118898|79503010|FG002|Overall Study|Site Closure|28|||
44497274|NCT00118898|79503011|FG003|Overall Study|Site Closure|37|||
44497275|NCT00118898|79503008|FG000|Overall Study|Severe debilitation|1|||
44497276|NCT00118898|79503009|FG001|Overall Study|Severe debilitation|4|||
44497277|NCT00118898|79503010|FG002|Overall Study|Severe debilitation|6|||
44497278|NCT00118898|79503011|FG003|Overall Study|Severe debilitation|4|||
44497279|NCT00118898|79503008|FG000|Overall Study|Not compliant with requirements|11|||
44497280|NCT00118898|79503009|FG001|Overall Study|Not compliant with requirements|13|||
44232134|NCT01838681|79047165|FG003|Period A|Adverse Event|0|||
44232135|NCT01838681|79047162|FG000|Period A|Lack of Efficacy|21|||
44232136|NCT01838681|79047163|FG001|Period A|Lack of Efficacy|0|||
44232137|NCT01838681|79047164|FG002|Period A|Lack of Efficacy|0|||
44232138|NCT01838681|79047165|FG003|Period A|Lack of Efficacy|0|||
44232139|NCT01838681|79047162|FG000|Period A|Early response|148|||
44556352|NCT02966834|79573363|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
44556353|NCT02966834|79573358|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
44556354|NCT02966834|79573359|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
44556355|NCT02966834|79573360|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
44556356|NCT02966834|79573361|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
44556357|NCT02966834|79573362|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
44556358|NCT02966834|79573363|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
44556359|NCT02966834|79573358|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
44556360|NCT02966834|79573359|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
44556361|NCT02966834|79573360|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
44556362|NCT02966834|79573361|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
44556363|NCT02966834|79573362|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
44556364|NCT02966834|79573363|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
44556365|NCT02966834|79573358|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
44556366|NCT02966834|79573359|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
44556367|NCT02966834|79573360|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
44556368|NCT02966834|79573361|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
44556369|NCT02966834|79573362|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
44556370|NCT02966834|79573363|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
44274938|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274939|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274940|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274941|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274942|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274943|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44274944|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
44556371|NCT03106077|79573412|FG000|Overall Study|Screen Failure|94|||
44556372|NCT03106077|79573413|FG001|Overall Study|Screen Failure|0|||
44556373|NCT03105297|79573418|FG000|Baseline Phase (Day 1)|Other|21|||
44556374|NCT03105297|79573418|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
44556375|NCT03105297|79573418|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
44556376|NCT03426995|79573460|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556377|NCT03426995|79573461|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556378|NCT03426995|79573462|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
44556379|NCT03426995|79573463|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556380|NCT03426995|79573464|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556381|NCT03426995|79573465|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556382|NCT03426995|79573466|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556383|NCT03426995|79573467|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556384|NCT03426995|79573468|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556385|NCT03426995|79573469|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556386|NCT03426995|79573470|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556387|NCT03426995|79573471|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556388|NCT03426995|79573472|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556389|NCT03426995|79573473|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556390|NCT03426995|79573474|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556391|NCT03426995|79573475|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556392|NCT03426995|79573476|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556393|NCT03426995|79573477|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556394|NCT03426995|79573478|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
44556395|NCT03426995|79573460|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556396|NCT03426995|79573461|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556397|NCT03426995|79573462|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44232140|NCT01838681|79047163|FG001|Period A|Early response|0|||
44232141|NCT01838681|79047164|FG002|Period A|Early response|0|||
44232142|NCT01838681|79047165|FG003|Period A|Early response|0|||
44232143|NCT01838681|79047162|FG000|Period A|Withdrawal by Subject|70|||
44232144|NCT01838681|79047163|FG001|Period A|Withdrawal by Subject|0|||
44232145|NCT01838681|79047164|FG002|Period A|Withdrawal by Subject|0|||
44232146|NCT01838681|79047165|FG003|Period A|Withdrawal by Subject|0|||
44232147|NCT01838681|79047162|FG000|Period A|Protocol Violation|16|||
44232148|NCT01838681|79047163|FG001|Period A|Protocol Violation|0|||
44232149|NCT01838681|79047164|FG002|Period A|Protocol Violation|0|||
44232150|NCT01838681|79047165|FG003|Period A|Protocol Violation|0|||
44232151|NCT01838681|79047162|FG000|Period A|Non-compliance with IMP|6|||
44232152|NCT01838681|79047163|FG001|Period A|Non-compliance with IMP|0|||
44232153|NCT01838681|79047164|FG002|Period A|Non-compliance with IMP|0|||
44556398|NCT03426995|79573463|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556399|NCT03426995|79573464|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556400|NCT03426995|79573465|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
44556401|NCT03426995|79573466|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556402|NCT03426995|79573467|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556403|NCT03426995|79573468|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556404|NCT03426995|79573469|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556405|NCT03426995|79573470|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556406|NCT03426995|79573471|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556407|NCT03426995|79573472|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556408|NCT03426995|79573473|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556409|NCT03426995|79573474|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556410|NCT03426995|79573475|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556411|NCT03426995|79573476|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556412|NCT03426995|79573477|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556413|NCT03426995|79573478|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
44556414|NCT03426995|79573460|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556415|NCT03426995|79573461|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556416|NCT03426995|79573462|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556417|NCT03426995|79573463|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556418|NCT03426995|79573464|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
44556419|NCT03426995|79573465|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
44556420|NCT03426995|79573466|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556421|NCT03426995|79573467|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556422|NCT03426995|79573468|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556423|NCT03426995|79573469|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556424|NCT03426995|79573470|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556425|NCT03426995|79573471|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556426|NCT03426995|79573472|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556427|NCT03426995|79573473|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556428|NCT03426995|79573474|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556429|NCT03426995|79573475|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556430|NCT03426995|79573476|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556431|NCT03426995|79573477|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556432|NCT03426995|79573478|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
44556433|NCT03426995|79573460|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556434|NCT03426995|79573461|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556435|NCT03426995|79573462|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556436|NCT03426995|79573463|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556437|NCT03426995|79573464|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556438|NCT03426995|79573465|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556439|NCT03426995|79573466|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556440|NCT03426995|79573467|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556441|NCT03426995|79573468|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44232154|NCT01838681|79047165|FG003|Period A|Non-compliance with IMP|0|||
44232155|NCT01838681|79047162|FG000|Period A|Lost to Follow-up|4|||
44232156|NCT01838681|79047163|FG001|Period A|Lost to Follow-up|0|||
44274945|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
44497281|NCT00118898|79503010|FG002|Overall Study|Not compliant with requirements|11|||
44497282|NCT00118898|79503011|FG003|Overall Study|Not compliant with requirements|11|||
44497283|NCT00118898|79503008|FG000|Overall Study|Not able to get to clinic|34|||
44497284|NCT00118898|79503009|FG001|Overall Study|Not able to get to clinic|43|||
44497285|NCT00118898|79503010|FG002|Overall Study|Not able to get to clinic|31|||
44497286|NCT00118898|79503011|FG003|Overall Study|Not able to get to clinic|40|||
44497287|NCT00118430|79503024|FG000|Overall Study|Withdrawal by Subject|6|||
44497288|NCT00118430|79503025|FG001|Overall Study|Withdrawal by Subject|2|||
44497289|NCT00118430|79503026|FG002|Overall Study|Withdrawal by Subject|0|||
44497290|NCT00118430|79503024|FG000|Overall Study|Lost to Follow-up|15|||
44497291|NCT00118430|79503025|FG001|Overall Study|Lost to Follow-up|22|||
44497292|NCT00118430|79503026|FG002|Overall Study|Lost to Follow-up|28|||
44497293|NCT00090584|79503035|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
44556442|NCT03426995|79573469|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556443|NCT03426995|79573470|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
44556444|NCT03426995|79573471|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44497294|NCT00090584|79503036|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
44556445|NCT03426995|79573472|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556446|NCT03426995|79573473|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556447|NCT03426995|79573474|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556448|NCT03426995|79573475|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556449|NCT03426995|79573476|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556450|NCT03426995|79573477|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556451|NCT03426995|79573478|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
44556452|NCT03426995|79573460|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556453|NCT03426995|79573461|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556454|NCT03426995|79573462|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556455|NCT03426995|79573463|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556456|NCT03426995|79573464|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556457|NCT03426995|79573465|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556458|NCT03426995|79573466|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556459|NCT03426995|79573467|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
44556460|NCT03426995|79573468|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556461|NCT03426995|79573469|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556462|NCT03426995|79573470|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556463|NCT03426995|79573471|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556464|NCT03426995|79573472|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556465|NCT03426995|79573473|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556466|NCT03426995|79573474|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556467|NCT03426995|79573475|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556468|NCT03426995|79573476|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556469|NCT03426995|79573477|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556470|NCT03426995|79573478|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
44556471|NCT03426995|79573460|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556472|NCT03426995|79573461|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556473|NCT03426995|79573462|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556474|NCT03426995|79573463|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556475|NCT03426995|79573464|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556476|NCT03426995|79573465|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556477|NCT03426995|79573466|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556478|NCT03426995|79573467|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556479|NCT03426995|79573468|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556480|NCT03426995|79573469|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556481|NCT03426995|79573470|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556482|NCT03426995|79573471|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556483|NCT03426995|79573472|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556484|NCT03426995|79573473|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556485|NCT03426995|79573474|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
44556486|NCT03426995|79573475|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
44556487|NCT03426995|79573476|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556488|NCT03426995|79573477|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556489|NCT03426995|79573478|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
44556490|NCT03426995|79573460|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556491|NCT03426995|79573461|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556492|NCT03426995|79573462|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556493|NCT03426995|79573463|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556494|NCT03426995|79573464|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556495|NCT03426995|79573465|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556496|NCT03426995|79573466|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556497|NCT03426995|79573467|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556498|NCT03426995|79573468|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556499|NCT03426995|79573469|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556500|NCT03426995|79573470|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556501|NCT03426995|79573471|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556502|NCT03426995|79573472|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556503|NCT03426995|79573473|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556504|NCT03426995|79573474|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
44556505|NCT03426995|79573475|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
44556506|NCT03426995|79573476|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556507|NCT03426995|79573477|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556508|NCT03426995|79573478|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
44556509|NCT03424265|79573527|FG000|Overall Study|screening failure|1|||
44556510|NCT03424265|79573528|FG001|Overall Study|screening failure|0|||
44556511|NCT03424265|79573527|FG000|Overall Study|Withdrawal by Subject|0|||
44556512|NCT03424265|79573528|FG001|Overall Study|Withdrawal by Subject|2|||
44556513|NCT03322566|79573537|FG000|Overall Study|Death|34|||
44556514|NCT03322566|79573538|FG001|Overall Study|Death|35|||
44556515|NCT03322566|79573539|FG002|Overall Study|Death|23|||
44556516|NCT03322566|79573537|FG000|Overall Study|Physician Decision|6|||
44556517|NCT03322566|79573538|FG001|Overall Study|Physician Decision|7|||
44556518|NCT03322566|79573539|FG002|Overall Study|Physician Decision|2|||
44556519|NCT03322566|79573537|FG000|Overall Study|Withdrawal by Subject|4|||
44556520|NCT03322566|79573538|FG001|Overall Study|Withdrawal by Subject|3|||
44556521|NCT03322566|79573539|FG002|Overall Study|Withdrawal by Subject|6|||
44556522|NCT03322566|79573537|FG000|Overall Study|Lost to Follow-up|0|||
44556523|NCT03322566|79573538|FG001|Overall Study|Lost to Follow-up|0|||
44556524|NCT03322566|79573539|FG002|Overall Study|Lost to Follow-up|1|||
44556525|NCT03322566|79573537|FG000|Overall Study|Study terminated by sponsor|1|||
44497295|NCT00090584|79503035|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
44497296|NCT00090584|79503036|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
44497297|NCT03670810|79503056|FG000|Main Study|Adverse Event|37|||
44497298|NCT03670810|79503057|FG001|Main Study|Adverse Event|38|||
44497299|NCT03670810|79503058|FG002|Main Study|Adverse Event|3|||
44497300|NCT03670810|79503059|FG003|Main Study|Adverse Event|4|||
44497301|NCT03670810|79503060|FG004|Main Study|Adverse Event|4|||
44497302|NCT03670810|79503061|FG005|Main Study|Adverse Event|5|||
44497303|NCT03670810|79503062|FG006|Main Study|Adverse Event|0|||
44497304|NCT03670810|79503063|FG007|Main Study|Adverse Event|0|||
44497305|NCT03670810|79503064|FG008|Main Study|Adverse Event|0|||
44497306|NCT03670810|79503056|FG000|Main Study|Lack of Efficacy|8|||
44497307|NCT03670810|79503057|FG001|Main Study|Lack of Efficacy|9|||
44497308|NCT03670810|79503058|FG002|Main Study|Lack of Efficacy|3|||
44497309|NCT03670810|79503059|FG003|Main Study|Lack of Efficacy|4|||
44497310|NCT03670810|79503060|FG004|Main Study|Lack of Efficacy|0|||
44497311|NCT03670810|79503061|FG005|Main Study|Lack of Efficacy|0|||
44497312|NCT03670810|79503062|FG006|Main Study|Lack of Efficacy|0|||
44497313|NCT03670810|79503063|FG007|Main Study|Lack of Efficacy|0|||
44497314|NCT03670810|79503064|FG008|Main Study|Lack of Efficacy|0|||
44497315|NCT03670810|79503056|FG000|Main Study|Lost to Follow-up|9|||
44497316|NCT03670810|79503057|FG001|Main Study|Lost to Follow-up|7|||
44497317|NCT03670810|79503058|FG002|Main Study|Lost to Follow-up|4|||
44497318|NCT03670810|79503059|FG003|Main Study|Lost to Follow-up|6|||
44497319|NCT03670810|79503060|FG004|Main Study|Lost to Follow-up|1|||
44497320|NCT03670810|79503061|FG005|Main Study|Lost to Follow-up|0|||
44497321|NCT03670810|79503062|FG006|Main Study|Lost to Follow-up|0|||
44497322|NCT03670810|79503063|FG007|Main Study|Lost to Follow-up|0|||
44497323|NCT03670810|79503064|FG008|Main Study|Lost to Follow-up|0|||
44497324|NCT03670810|79503056|FG000|Main Study|Non-compliance with Study Drug|0|||
44497325|NCT03670810|79503057|FG001|Main Study|Non-compliance with Study Drug|2|||
44497326|NCT03670810|79503058|FG002|Main Study|Non-compliance with Study Drug|3|||
44497327|NCT03670810|79503059|FG003|Main Study|Non-compliance with Study Drug|0|||
44497328|NCT03670810|79503060|FG004|Main Study|Non-compliance with Study Drug|0|||
44497329|NCT03670810|79503061|FG005|Main Study|Non-compliance with Study Drug|0|||
44497330|NCT03670810|79503062|FG006|Main Study|Non-compliance with Study Drug|0|||
44497331|NCT03670810|79503063|FG007|Main Study|Non-compliance with Study Drug|1|||
44497332|NCT03670810|79503064|FG008|Main Study|Non-compliance with Study Drug|0|||
44497333|NCT03670810|79503056|FG000|Main Study|Physician Decision|3|||
44556526|NCT03322566|79573538|FG001|Overall Study|Study terminated by sponsor|0|||
44556527|NCT03322566|79573539|FG002|Overall Study|Study terminated by sponsor|1|||
44556528|NCT02969018|79573555|FG000|Overall Study|Adverse Event|2|||
44556529|NCT02969018|79573556|FG001|Overall Study|Adverse Event|4|||
44497334|NCT03670810|79503057|FG001|Main Study|Physician Decision|0|||
44497335|NCT03670810|79503058|FG002|Main Study|Physician Decision|1|||
44497336|NCT03670810|79503059|FG003|Main Study|Physician Decision|0|||
44497337|NCT03670810|79503060|FG004|Main Study|Physician Decision|0|||
44497338|NCT03670810|79503061|FG005|Main Study|Physician Decision|0|||
44556530|NCT02969018|79573557|FG002|Overall Study|Adverse Event|1|||
44497339|NCT03670810|79503062|FG006|Main Study|Physician Decision|1|||
44497340|NCT03670810|79503063|FG007|Main Study|Physician Decision|1|||
44497341|NCT03670810|79503064|FG008|Main Study|Physician Decision|0|||
44497342|NCT03670810|79503056|FG000|Main Study|Pregnancy|1|||
44497343|NCT03670810|79503057|FG001|Main Study|Pregnancy|2|||
44497344|NCT03670810|79503058|FG002|Main Study|Pregnancy|0|||
44497345|NCT03670810|79503059|FG003|Main Study|Pregnancy|0|||
44497346|NCT03670810|79503060|FG004|Main Study|Pregnancy|0|||
44497347|NCT03670810|79503061|FG005|Main Study|Pregnancy|0|||
44497348|NCT03670810|79503062|FG006|Main Study|Pregnancy|0|||
44497349|NCT03670810|79503063|FG007|Main Study|Pregnancy|0|||
44497350|NCT03670810|79503064|FG008|Main Study|Pregnancy|0|||
44497351|NCT03670810|79503056|FG000|Main Study|Protocol Deviation|2|||
44497352|NCT03670810|79503057|FG001|Main Study|Protocol Deviation|12|||
44497353|NCT03670810|79503058|FG002|Main Study|Protocol Deviation|8|||
44497354|NCT03670810|79503059|FG003|Main Study|Protocol Deviation|4|||
44497355|NCT03670810|79503060|FG004|Main Study|Protocol Deviation|0|||
44497356|NCT03670810|79503061|FG005|Main Study|Protocol Deviation|0|||
44497357|NCT03670810|79503062|FG006|Main Study|Protocol Deviation|0|||
44497358|NCT03670810|79503063|FG007|Main Study|Protocol Deviation|0|||
44497359|NCT03670810|79503064|FG008|Main Study|Protocol Deviation|0|||
44497360|NCT03670810|79503056|FG000|Main Study|Withdrawal by Subject|21|||
44497361|NCT03670810|79503057|FG001|Main Study|Withdrawal by Subject|21|||
44497362|NCT03670810|79503058|FG002|Main Study|Withdrawal by Subject|8|||
44497363|NCT03670810|79503059|FG003|Main Study|Withdrawal by Subject|9|||
44497364|NCT03670810|79503060|FG004|Main Study|Withdrawal by Subject|5|||
44497365|NCT03670810|79503061|FG005|Main Study|Withdrawal by Subject|2|||
44497366|NCT03670810|79503062|FG006|Main Study|Withdrawal by Subject|1|||
44497367|NCT03670810|79503063|FG007|Main Study|Withdrawal by Subject|1|||
44497368|NCT03670810|79503064|FG008|Main Study|Withdrawal by Subject|0|||
44497369|NCT03670810|79503056|FG000|Main Study|Participant did not want to take the three other treatments|1|||
44497370|NCT03670810|79503057|FG001|Main Study|Participant did not want to take the three other treatments|0|||
44497371|NCT03670810|79503058|FG002|Main Study|Participant did not want to take the three other treatments|0|||
44497372|NCT03670810|79503059|FG003|Main Study|Participant did not want to take the three other treatments|0|||
44497373|NCT03670810|79503060|FG004|Main Study|Participant did not want to take the three other treatments|0|||
44497374|NCT03670810|79503061|FG005|Main Study|Participant did not want to take the three other treatments|0|||
44497375|NCT03670810|79503062|FG006|Main Study|Participant did not want to take the three other treatments|0|||
44497376|NCT03670810|79503063|FG007|Main Study|Participant did not want to take the three other treatments|0|||
44497377|NCT03670810|79503064|FG008|Main Study|Participant did not want to take the three other treatments|0|||
44497378|NCT03670810|79503056|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497379|NCT03670810|79503057|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
44497380|NCT03670810|79503058|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497381|NCT03670810|79503059|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497382|NCT03670810|79503060|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497383|NCT03670810|79503061|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497384|NCT03670810|79503062|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497385|NCT03670810|79503063|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497386|NCT03670810|79503064|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
44497387|NCT03670810|79503056|FG000|Main Study|Travel and Coronavirus issues|0|||
44497388|NCT03670810|79503057|FG001|Main Study|Travel and Coronavirus issues|0|||
44497389|NCT03670810|79503058|FG002|Main Study|Travel and Coronavirus issues|0|||
44232157|NCT01838681|79047164|FG002|Period A|Lost to Follow-up|0|||
44232158|NCT01838681|79047165|FG003|Period A|Lost to Follow-up|0|||
44232159|NCT01838681|79047162|FG000|Period A|Withdrawal before treatment|4|||
44232160|NCT01838681|79047163|FG001|Period A|Withdrawal before treatment|0|||
44232161|NCT01838681|79047164|FG002|Period A|Withdrawal before treatment|0|||
44232162|NCT01838681|79047165|FG003|Period A|Withdrawal before treatment|0|||
44232163|NCT01838681|79047162|FG000|Period A|Administrative or other reasons|17|||
44232164|NCT01838681|79047163|FG001|Period A|Administrative or other reasons|0|||
44232165|NCT01838681|79047164|FG002|Period A|Administrative or other reasons|0|||
44232166|NCT01838681|79047165|FG003|Period A|Administrative or other reasons|0|||
44232167|NCT01838681|79047162|FG000|Period B/A+|Adverse Event|0|||
44232168|NCT01838681|79047163|FG001|Period B/A+|Adverse Event|13|||
44274946|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
44376775|NCT01074944|79381964|FG004|Long Term Treatment|Withdrawal by Subject|0|||
44376776|NCT01074944|79381960|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
44376777|NCT01074944|79381961|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
44497390|NCT03670810|79503059|FG003|Main Study|Travel and Coronavirus issues|1|||
44232169|NCT01838681|79047164|FG002|Period B/A+|Adverse Event|27|||
44497391|NCT03670810|79503060|FG004|Main Study|Travel and Coronavirus issues|0|||
44497392|NCT03670810|79503061|FG005|Main Study|Travel and Coronavirus issues|0|||
44497393|NCT03670810|79503062|FG006|Main Study|Travel and Coronavirus issues|0|||
44497394|NCT03670810|79503063|FG007|Main Study|Travel and Coronavirus issues|0|||
44497395|NCT03670810|79503064|FG008|Main Study|Travel and Coronavirus issues|0|||
44497396|NCT03670810|79503056|FG000|Open Label Extension|Protocol Deviation|0|||
44497397|NCT03670810|79503057|FG001|Open Label Extension|Protocol Deviation|0|||
44497398|NCT03670810|79503058|FG002|Open Label Extension|Protocol Deviation|0|||
44497399|NCT03670810|79503059|FG003|Open Label Extension|Protocol Deviation|0|||
44497400|NCT03670810|79503060|FG004|Open Label Extension|Protocol Deviation|0|||
44497401|NCT03670810|79503061|FG005|Open Label Extension|Protocol Deviation|0|||
44556531|NCT02969018|79573558|FG003|Overall Study|Adverse Event|2|||
44556532|NCT02969018|79573559|FG004|Overall Study|Adverse Event|0|||
44556533|NCT02969018|79573560|FG005|Overall Study|Adverse Event|1|||
44556534|NCT02969018|79573561|FG006|Overall Study|Adverse Event|2|||
44556535|NCT02969018|79573562|FG007|Overall Study|Adverse Event|0|||
44556536|NCT02969018|79573555|FG000|Overall Study|Lack of Efficacy|0|||
44556537|NCT02969018|79573556|FG001|Overall Study|Lack of Efficacy|1|||
44556538|NCT02969018|79573557|FG002|Overall Study|Lack of Efficacy|0|||
44556539|NCT02969018|79573558|FG003|Overall Study|Lack of Efficacy|0|||
44556540|NCT02969018|79573559|FG004|Overall Study|Lack of Efficacy|1|||
44556541|NCT02969018|79573560|FG005|Overall Study|Lack of Efficacy|1|||
44556542|NCT02969018|79573561|FG006|Overall Study|Lack of Efficacy|1|||
44556543|NCT02969018|79573562|FG007|Overall Study|Lack of Efficacy|1|||
44556544|NCT02969018|79573555|FG000|Overall Study|Lost to Follow-up|1|||
44556545|NCT02969018|79573556|FG001|Overall Study|Lost to Follow-up|2|||
44232170|NCT01838681|79047165|FG003|Period B/A+|Adverse Event|16|||
44232171|NCT01838681|79047162|FG000|Period B/A+|Lack of Efficacy|0|||
44232172|NCT01838681|79047163|FG001|Period B/A+|Lack of Efficacy|9|||
44232173|NCT01838681|79047164|FG002|Period B/A+|Lack of Efficacy|11|||
44497402|NCT03670810|79503062|FG006|Open Label Extension|Protocol Deviation|0|||
44497403|NCT03670810|79503063|FG007|Open Label Extension|Protocol Deviation|0|||
44497404|NCT03670810|79503064|FG008|Open Label Extension|Protocol Deviation|5|||
44497405|NCT03670810|79503056|FG000|Open Label Extension|Death|0|||
44497406|NCT03670810|79503057|FG001|Open Label Extension|Death|0|||
44497407|NCT03670810|79503058|FG002|Open Label Extension|Death|0|||
44497408|NCT03670810|79503059|FG003|Open Label Extension|Death|0|||
44497409|NCT03670810|79503060|FG004|Open Label Extension|Death|0|||
44497410|NCT03670810|79503061|FG005|Open Label Extension|Death|0|||
44497411|NCT03670810|79503062|FG006|Open Label Extension|Death|0|||
44497412|NCT03670810|79503063|FG007|Open Label Extension|Death|0|||
44497413|NCT03670810|79503064|FG008|Open Label Extension|Death|1|||
44497414|NCT03670810|79503056|FG000|Open Label Extension|COVID-19|0|||
44497415|NCT03670810|79503057|FG001|Open Label Extension|COVID-19|0|||
44497416|NCT03670810|79503058|FG002|Open Label Extension|COVID-19|0|||
44497417|NCT03670810|79503059|FG003|Open Label Extension|COVID-19|0|||
44497418|NCT03670810|79503060|FG004|Open Label Extension|COVID-19|0|||
44497419|NCT03670810|79503061|FG005|Open Label Extension|COVID-19|0|||
44497420|NCT03670810|79503062|FG006|Open Label Extension|COVID-19|0|||
44497421|NCT03670810|79503063|FG007|Open Label Extension|COVID-19|0|||
44497422|NCT03670810|79503064|FG008|Open Label Extension|COVID-19|1|||
44497423|NCT03670810|79503056|FG000|Open Label Extension|Lack of Efficacy|0|||
44497424|NCT03670810|79503057|FG001|Open Label Extension|Lack of Efficacy|0|||
44497425|NCT03670810|79503058|FG002|Open Label Extension|Lack of Efficacy|0|||
44556546|NCT02969018|79573557|FG002|Overall Study|Lost to Follow-up|2|||
44556547|NCT02969018|79573558|FG003|Overall Study|Lost to Follow-up|0|||
44556548|NCT02969018|79573559|FG004|Overall Study|Lost to Follow-up|1|||
44556549|NCT02969018|79573560|FG005|Overall Study|Lost to Follow-up|1|||
44556550|NCT02969018|79573561|FG006|Overall Study|Lost to Follow-up|0|||
44232174|NCT01838681|79047165|FG003|Period B/A+|Lack of Efficacy|6|||
44232175|NCT01838681|79047162|FG000|Period B/A+|Withdrawal by Subject|0|||
44232176|NCT01838681|79047163|FG001|Period B/A+|Withdrawal by Subject|28|||
44232177|NCT01838681|79047164|FG002|Period B/A+|Withdrawal by Subject|35|||
44232178|NCT01838681|79047165|FG003|Period B/A+|Withdrawal by Subject|47|||
44232179|NCT01838681|79047162|FG000|Period B/A+|Protocol Violation|0|||
44232180|NCT01838681|79047163|FG001|Period B/A+|Protocol Violation|1|||
44497426|NCT03670810|79503059|FG003|Open Label Extension|Lack of Efficacy|0|||
44497427|NCT03670810|79503060|FG004|Open Label Extension|Lack of Efficacy|0|||
44497428|NCT03670810|79503061|FG005|Open Label Extension|Lack of Efficacy|0|||
44556551|NCT02969018|79573562|FG007|Overall Study|Lost to Follow-up|1|||
44556552|NCT02969018|79573555|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44556553|NCT02969018|79573556|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44556554|NCT02969018|79573557|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
44232181|NCT01838681|79047164|FG002|Period B/A+|Protocol Violation|4|||
44232182|NCT01838681|79047165|FG003|Period B/A+|Protocol Violation|6|||
44232183|NCT01838681|79047162|FG000|Period B/A+|Non-compliance with IMP|0|||
44497429|NCT03670810|79503062|FG006|Open Label Extension|Lack of Efficacy|0|||
44497430|NCT03670810|79503063|FG007|Open Label Extension|Lack of Efficacy|0|||
44497431|NCT03670810|79503064|FG008|Open Label Extension|Lack of Efficacy|39|||
44556555|NCT02969018|79573558|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
44556556|NCT02969018|79573559|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
44556557|NCT02969018|79573560|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
44556558|NCT02969018|79573561|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
44556559|NCT02969018|79573562|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
44556560|NCT02969018|79573555|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44556561|NCT02969018|79573556|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44556562|NCT02969018|79573557|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44556563|NCT02969018|79573558|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44556564|NCT02969018|79573559|FG004|Overall Study|Non-Compliance With Study Drug|0|||
44232184|NCT01838681|79047163|FG001|Period B/A+|Non-compliance with IMP|2|||
44232185|NCT01838681|79047164|FG002|Period B/A+|Non-compliance with IMP|3|||
44232186|NCT01838681|79047165|FG003|Period B/A+|Non-compliance with IMP|3|||
44232187|NCT01838681|79047162|FG000|Period B/A+|Lost to Follow-up|0|||
44232188|NCT01838681|79047163|FG001|Period B/A+|Lost to Follow-up|2|||
44232189|NCT01838681|79047164|FG002|Period B/A+|Lost to Follow-up|5|||
44232190|NCT01838681|79047165|FG003|Period B/A+|Lost to Follow-up|11|||
44232191|NCT01838681|79047162|FG000|Period B/A+|Withdrawal before treatment|0|||
44232192|NCT01838681|79047163|FG001|Period B/A+|Withdrawal before treatment|1|||
44232193|NCT01838681|79047164|FG002|Period B/A+|Withdrawal before treatment|0|||
44232194|NCT01838681|79047165|FG003|Period B/A+|Withdrawal before treatment|0|||
44232195|NCT01838681|79047162|FG000|Period B/A+|Administrative or other reasons|0|||
44497432|NCT03670810|79503056|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
44497433|NCT03670810|79503057|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
44497434|NCT03670810|79503058|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
44497435|NCT03670810|79503059|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
44497436|NCT03670810|79503060|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
44497437|NCT03670810|79503061|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
44497438|NCT03670810|79503062|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
44497439|NCT03670810|79503063|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
44497440|NCT03670810|79503064|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
44497441|NCT03670810|79503056|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497442|NCT03670810|79503057|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497443|NCT03670810|79503058|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497444|NCT03670810|79503059|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497445|NCT03670810|79503060|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497446|NCT03670810|79503061|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497447|NCT03670810|79503062|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497448|NCT03670810|79503063|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
44497449|NCT03670810|79503064|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
44497450|NCT03670810|79503056|FG000|Open Label Extension|Withdrawal by Subject|0|||
44497451|NCT03670810|79503057|FG001|Open Label Extension|Withdrawal by Subject|0|||
44497452|NCT03670810|79503058|FG002|Open Label Extension|Withdrawal by Subject|0|||
44497453|NCT03670810|79503059|FG003|Open Label Extension|Withdrawal by Subject|0|||
44497454|NCT03670810|79503060|FG004|Open Label Extension|Withdrawal by Subject|0|||
44497455|NCT03670810|79503061|FG005|Open Label Extension|Withdrawal by Subject|0|||
44497456|NCT03670810|79503062|FG006|Open Label Extension|Withdrawal by Subject|0|||
44497457|NCT03670810|79503063|FG007|Open Label Extension|Withdrawal by Subject|0|||
44497458|NCT03670810|79503064|FG008|Open Label Extension|Withdrawal by Subject|46|||
44497459|NCT03670810|79503056|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497460|NCT03670810|79503057|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497461|NCT03670810|79503058|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497462|NCT03670810|79503059|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497463|NCT03670810|79503060|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497464|NCT03670810|79503061|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44556565|NCT02969018|79573560|FG005|Overall Study|Non-Compliance With Study Drug|0|||
44556566|NCT02969018|79573561|FG006|Overall Study|Non-Compliance With Study Drug|0|||
44232196|NCT01838681|79047163|FG001|Period B/A+|Administrative or other reasons|6|||
44232197|NCT01838681|79047164|FG002|Period B/A+|Administrative or other reasons|10|||
44232198|NCT01838681|79047165|FG003|Period B/A+|Administrative or other reasons|28|||
44556567|NCT02969018|79573562|FG007|Overall Study|Non-Compliance With Study Drug|0|||
44556568|NCT02969018|79573555|FG000|Overall Study|Other|0|||
44556569|NCT02969018|79573556|FG001|Overall Study|Other|0|||
44556570|NCT02969018|79573557|FG002|Overall Study|Other|0|||
44556571|NCT02969018|79573558|FG003|Overall Study|Other|1|||
44556572|NCT02969018|79573559|FG004|Overall Study|Other|0|||
44556573|NCT02969018|79573560|FG005|Overall Study|Other|0|||
44556574|NCT02969018|79573561|FG006|Overall Study|Other|0|||
44556575|NCT02969018|79573562|FG007|Overall Study|Other|2|||
44556576|NCT02969018|79573555|FG000|Overall Study|Pregnancy|0|||
44556577|NCT02969018|79573556|FG001|Overall Study|Pregnancy|0|||
44556578|NCT02969018|79573557|FG002|Overall Study|Pregnancy|0|||
44556579|NCT02969018|79573558|FG003|Overall Study|Pregnancy|0|||
44556580|NCT02969018|79573559|FG004|Overall Study|Pregnancy|0|||
44556581|NCT02969018|79573560|FG005|Overall Study|Pregnancy|1|||
44556582|NCT02969018|79573561|FG006|Overall Study|Pregnancy|0|||
44556583|NCT02969018|79573562|FG007|Overall Study|Pregnancy|0|||
44556584|NCT02969018|79573555|FG000|Overall Study|Protocol Violation|0|||
44556585|NCT02969018|79573556|FG001|Overall Study|Protocol Violation|0|||
44556586|NCT02969018|79573557|FG002|Overall Study|Protocol Violation|1|||
44556587|NCT02969018|79573558|FG003|Overall Study|Protocol Violation|1|||
44556588|NCT02969018|79573559|FG004|Overall Study|Protocol Violation|0|||
44556589|NCT02969018|79573560|FG005|Overall Study|Protocol Violation|0|||
44497465|NCT03670810|79503062|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497466|NCT03670810|79503063|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
44497467|NCT03670810|79503064|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
44497468|NCT03670810|79503056|FG000|Open Label Extension|Physician Decision|0|||
44497469|NCT03670810|79503057|FG001|Open Label Extension|Physician Decision|0|||
44497470|NCT03670810|79503058|FG002|Open Label Extension|Physician Decision|0|||
44497471|NCT03670810|79503059|FG003|Open Label Extension|Physician Decision|0|||
44232199|NCT01611857|79047223|FG000|Overall Study|Withdrawal by Subject|0|||
44376778|NCT01074944|79381962|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
44497472|NCT03670810|79503060|FG004|Open Label Extension|Physician Decision|0|||
44497473|NCT03670810|79503061|FG005|Open Label Extension|Physician Decision|0|||
44497474|NCT03670810|79503062|FG006|Open Label Extension|Physician Decision|0|||
44497475|NCT03670810|79503063|FG007|Open Label Extension|Physician Decision|0|||
44497476|NCT03670810|79503064|FG008|Open Label Extension|Physician Decision|2|||
44556590|NCT02969018|79573561|FG006|Overall Study|Protocol Violation|0|||
44556591|NCT02969018|79573562|FG007|Overall Study|Protocol Violation|0|||
44556592|NCT02969018|79573555|FG000|Overall Study|Withdrawal by Subject|0|||
44556593|NCT02969018|79573556|FG001|Overall Study|Withdrawal by Subject|1|||
44556594|NCT02969018|79573557|FG002|Overall Study|Withdrawal by Subject|2|||
44143813|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
44556595|NCT02969018|79573558|FG003|Overall Study|Withdrawal by Subject|1|||
44556596|NCT02969018|79573559|FG004|Overall Study|Withdrawal by Subject|0|||
44556597|NCT02969018|79573560|FG005|Overall Study|Withdrawal by Subject|4|||
44556598|NCT02969018|79573561|FG006|Overall Study|Withdrawal by Subject|4|||
44556599|NCT02969018|79573562|FG007|Overall Study|Withdrawal by Subject|3|||
44556600|NCT01319721|79573585|FG000|Overall Study|Lost to Follow-up|1|||
44556601|NCT01319721|79573586|FG001|Overall Study|Lost to Follow-up|6|||
44556602|NCT02905032|79573595|FG000|Overall Study|Withdrawal by Subject|2|||
44556603|NCT02905032|79573596|FG001|Overall Study|Withdrawal by Subject|0|||
44556604|NCT02905032|79573597|FG002|Overall Study|Withdrawal by Subject|0|||
44556605|NCT02905032|79573595|FG000|Overall Study|Protocol Violation|6|||
44556606|NCT02905032|79573596|FG001|Overall Study|Protocol Violation|12|||
44556607|NCT02905032|79573597|FG002|Overall Study|Protocol Violation|0|||
44556608|NCT03259425|79573604|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
44556609|NCT03101241|79573610|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
44556610|NCT03101241|79573611|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
44556611|NCT03101241|79573610|FG000|Overall Study|Participant withdrew consent|3|||
44556612|NCT03101241|79573611|FG001|Overall Study|Participant withdrew consent|1|||
44556613|NCT03101241|79573610|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
44556614|NCT03101241|79573611|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
44556615|NCT03101241|79573610|FG000|Overall Study|Lost to Follow-up|2|||
44556616|NCT03101241|79573611|FG001|Overall Study|Lost to Follow-up|0|||
44556617|NCT03101241|79573610|FG000|Overall Study|Lack of Efficacy|0|||
44556618|NCT03101241|79573611|FG001|Overall Study|Lack of Efficacy|1|||
44556619|NCT03101241|79573610|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
44556620|NCT03101241|79573611|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
44556621|NCT03061188|79573621|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
44556622|NCT03061188|79573622|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
44556623|NCT03061188|79573623|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
44556624|NCT03061188|79573624|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
44556625|NCT03061188|79573621|FG000|On Follow-up for 3 Years|Death|0|||
44556626|NCT03061188|79573622|FG001|On Follow-up for 3 Years|Death|3|||
44232200|NCT01611857|79047224|FG001|Overall Study|Withdrawal by Subject|2|||
44232201|NCT01829477|79047247|FG000|Overall Study|Study Terminated by Sponsor|15|||
44232202|NCT01829477|79047248|FG001|Overall Study|Study Terminated by Sponsor|15|||
44232203|NCT01829477|79047247|FG000|Overall Study|Withdrawal by Subject|1|||
44497477|NCT03670810|79503056|FG000|Open Label Extension|Non-compliance with study drug|0|||
44497478|NCT03670810|79503057|FG001|Open Label Extension|Non-compliance with study drug|0|||
44497479|NCT03670810|79503058|FG002|Open Label Extension|Non-compliance with study drug|0|||
44497480|NCT03670810|79503059|FG003|Open Label Extension|Non-compliance with study drug|0|||
44497481|NCT03670810|79503060|FG004|Open Label Extension|Non-compliance with study drug|0|||
44497482|NCT03670810|79503061|FG005|Open Label Extension|Non-compliance with study drug|0|||
44497483|NCT03670810|79503062|FG006|Open Label Extension|Non-compliance with study drug|0|||
44497484|NCT03670810|79503063|FG007|Open Label Extension|Non-compliance with study drug|0|||
44497485|NCT03670810|79503064|FG008|Open Label Extension|Non-compliance with study drug|5|||
44497486|NCT03670810|79503056|FG000|Open Label Extension|Pregnancy|0|||
44497487|NCT03670810|79503057|FG001|Open Label Extension|Pregnancy|0|||
44497488|NCT03670810|79503058|FG002|Open Label Extension|Pregnancy|0|||
44497489|NCT03670810|79503059|FG003|Open Label Extension|Pregnancy|0|||
44497490|NCT03670810|79503060|FG004|Open Label Extension|Pregnancy|0|||
44497491|NCT03670810|79503061|FG005|Open Label Extension|Pregnancy|0|||
44497492|NCT03670810|79503062|FG006|Open Label Extension|Pregnancy|0|||
44497493|NCT03670810|79503063|FG007|Open Label Extension|Pregnancy|0|||
44556627|NCT03061188|79573623|FG002|On Follow-up for 3 Years|Death|5|||
44556628|NCT03061188|79573624|FG003|On Follow-up for 3 Years|Death|2|||
44556629|NCT03061188|79573621|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
44556630|NCT03061188|79573622|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
44556631|NCT03061188|79573623|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
44556632|NCT03061188|79573624|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
44556633|NCT03449147|79573642|FG000|52-week Treatment Period|Death|0|||
44556634|NCT03449147|79573643|FG001|52-week Treatment Period|Death|1|||
44556635|NCT03449147|79573644|FG002|52-week Treatment Period|Death|0|||
44556636|NCT03449147|79573642|FG000|52-week Treatment Period|Lost to Follow-up|6|||
44556637|NCT03449147|79573643|FG001|52-week Treatment Period|Lost to Follow-up|2|||
44556638|NCT03449147|79573644|FG002|52-week Treatment Period|Lost to Follow-up|5|||
44556639|NCT03449147|79573642|FG000|52-week Treatment Period|Other|0|||
44556640|NCT03449147|79573643|FG001|52-week Treatment Period|Other|1|||
44556641|NCT03449147|79573644|FG002|52-week Treatment Period|Other|2|||
44556642|NCT03449147|79573642|FG000|52-week Treatment Period|Physician Decision|1|||
44556643|NCT03449147|79573643|FG001|52-week Treatment Period|Physician Decision|0|||
44556644|NCT03449147|79573644|FG002|52-week Treatment Period|Physician Decision|3|||
44556645|NCT03449147|79573642|FG000|52-week Treatment Period|Screen Failure|1|||
44556646|NCT03449147|79573643|FG001|52-week Treatment Period|Screen Failure|2|||
44556647|NCT03449147|79573644|FG002|52-week Treatment Period|Screen Failure|0|||
44556648|NCT03449147|79573642|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
44556649|NCT03449147|79573643|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
44556650|NCT03449147|79573644|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
44556651|NCT03449147|79573642|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
44556652|NCT03449147|79573643|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
44556653|NCT03449147|79573644|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
44556654|NCT03449147|79573642|FG000|12-Week Off-Treatment Durability Period|Other|0|||
44556655|NCT03449147|79573643|FG001|12-Week Off-Treatment Durability Period|Other|1|||
44556656|NCT03449147|79573644|FG002|12-Week Off-Treatment Durability Period|Other|0|||
44556657|NCT03423173|79573669|FG000|Overall Study|Randomized but not vaccinated|1|||
44232204|NCT01829477|79047248|FG001|Overall Study|Withdrawal by Subject|0|||
44232205|NCT01611155|79047264|FG000|Overall Study|Adverse Event|1|||
44232206|NCT01611155|79047265|FG001|Overall Study|Adverse Event|1|||
44232207|NCT01611155|79047264|FG000|Overall Study|Refused further treatment|6|||
44232208|NCT01611155|79047265|FG001|Overall Study|Refused further treatment|4|||
44232209|NCT01611155|79047264|FG000|Overall Study|Disease progression|1|||
44232210|NCT01611155|79047265|FG001|Overall Study|Disease progression|0|||
44232211|NCT01611155|79047264|FG000|Overall Study|Withdrawal by Subject|1|||
44232212|NCT01611155|79047265|FG001|Overall Study|Withdrawal by Subject|0|||
44232213|NCT01611155|79047264|FG000|Overall Study|Alternative treatment|0|||
44274947|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
44274948|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274949|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274950|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274951|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274952|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44376779|NCT01074944|79381963|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
44376780|NCT01074944|79381964|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
44497494|NCT03670810|79503064|FG008|Open Label Extension|Pregnancy|3|||
44497495|NCT03670810|79503056|FG000|Open Label Extension|Adverse Event|0|||
44497496|NCT03670810|79503057|FG001|Open Label Extension|Adverse Event|0|||
44497497|NCT03670810|79503058|FG002|Open Label Extension|Adverse Event|0|||
44497498|NCT03670810|79503059|FG003|Open Label Extension|Adverse Event|0|||
44497499|NCT03670810|79503060|FG004|Open Label Extension|Adverse Event|0|||
44497500|NCT03670810|79503061|FG005|Open Label Extension|Adverse Event|0|||
44497501|NCT03670810|79503062|FG006|Open Label Extension|Adverse Event|0|||
44497502|NCT03670810|79503063|FG007|Open Label Extension|Adverse Event|0|||
44497503|NCT03670810|79503064|FG008|Open Label Extension|Adverse Event|24|||
44497504|NCT03670810|79503056|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
44497505|NCT03670810|79503057|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
44497506|NCT03670810|79503058|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
44497507|NCT03670810|79503059|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
44497508|NCT03670810|79503060|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
44497509|NCT03670810|79503061|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
44497510|NCT03670810|79503062|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
44556658|NCT03423173|79573670|FG001|Overall Study|Randomized but not vaccinated|0|||
44556659|NCT03423173|79573671|FG002|Overall Study|Randomized but not vaccinated|2|||
44556660|NCT03423173|79573672|FG003|Overall Study|Randomized but not vaccinated|1|||
44556661|NCT03423173|79573669|FG000|Overall Study|Adverse Event|1|||
44556662|NCT03423173|79573670|FG001|Overall Study|Adverse Event|1|||
44556663|NCT03423173|79573671|FG002|Overall Study|Adverse Event|1|||
44556664|NCT03423173|79573672|FG003|Overall Study|Adverse Event|1|||
44556665|NCT03423173|79573669|FG000|Overall Study|Lost to Follow-up|10|||
44232214|NCT01611155|79047265|FG001|Overall Study|Alternative treatment|1|||
44232215|NCT01611155|79047264|FG000|Overall Study|Ineligible patient|0|||
44274953|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274954|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274955|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
44274956|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
44274957|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
44274958|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274959|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44232216|NCT01611155|79047265|FG001|Overall Study|Ineligible patient|1|||
44232217|NCT01829243|79047280|FG000|First Intervention|Screen Failure|4|||
44232218|NCT01829243|79047281|FG001|First Intervention|Screen Failure|2|||
44232219|NCT01838447|79047291|FG000|Overall Study|Change in surgical plan|1|||
44232220|NCT01838447|79047292|FG001|Overall Study|Change in surgical plan|2|||
44232221|NCT01838447|79047291|FG000|Overall Study|Withdrawal by Subject|1|||
44232222|NCT01838447|79047292|FG001|Overall Study|Withdrawal by Subject|1|||
44232223|NCT01829165|79047300|FG000|Overall Study|Did not complete intervention|2|||
44232224|NCT01829165|79047301|FG001|Overall Study|Did not complete intervention|0|||
44232225|NCT01838213|79047309|FG000|Overall Study|Ineligible|166|||
44232226|NCT01838213|79047310|FG001|Overall Study|Ineligible|191|||
44232227|NCT01837823|79047316|FG000|Overall Study|Lost to Follow-up|6|||
44232228|NCT01828073|79047326|FG000|Overall Study|Lost to Follow-up|1|||
44232229|NCT01828073|79047327|FG001|Overall Study|Lost to Follow-up|2|||
44232230|NCT03819114|79047347|FG000|Overall Study|Protocol Violation|0|||
44232231|NCT03819114|79047348|FG001|Overall Study|Protocol Violation|1|||
44232232|NCT03819114|79047349|FG002|Overall Study|Protocol Violation|1|||
44232233|NCT03819114|79047350|FG003|Overall Study|Protocol Violation|0|||
44232234|NCT03819114|79047347|FG000|Overall Study|Lost to Follow-up|0|||
44232235|NCT03819114|79047348|FG001|Overall Study|Lost to Follow-up|0|||
44232236|NCT03819114|79047349|FG002|Overall Study|Lost to Follow-up|1|||
44274960|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274961|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44232237|NCT03819114|79047350|FG003|Overall Study|Lost to Follow-up|0|||
44232238|NCT01827839|79047362|FG000|Overall Study|Adverse Event|1|||
44232239|NCT01827839|79047362|FG000|Overall Study|Consent Withdrawal|2|||
44232240|NCT01827371|79047377|FG000|Overall Study|Adverse Event|0|||
44232241|NCT01827371|79047378|FG001|Overall Study|Adverse Event|0|||
44232242|NCT01827371|79047379|FG002|Overall Study|Adverse Event|4|||
44232243|NCT01827371|79047380|FG003|Overall Study|Adverse Event|2|||
44232244|NCT01827371|79047377|FG000|Overall Study|Lost to Follow-up|0|||
44232245|NCT01827371|79047378|FG001|Overall Study|Lost to Follow-up|2|||
44232246|NCT01827371|79047379|FG002|Overall Study|Lost to Follow-up|0|||
44232247|NCT01827371|79047380|FG003|Overall Study|Lost to Follow-up|4|||
44274962|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274963|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274964|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274965|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274966|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
44274967|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
44274968|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
44274969|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
44274970|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274971|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44376781|NCT01074944|79381960|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
44376782|NCT01074944|79381961|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
44376783|NCT01074944|79381962|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
44376784|NCT01074944|79381963|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
44376785|NCT01074944|79381964|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
44497511|NCT03670810|79503063|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
44497512|NCT03670810|79503064|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
44497513|NCT03670810|79503056|FG000|Open Label Extension|Lost to Follow-up|0|||
44497514|NCT03670810|79503057|FG001|Open Label Extension|Lost to Follow-up|0|||
44497515|NCT03670810|79503058|FG002|Open Label Extension|Lost to Follow-up|0|||
44497516|NCT03670810|79503059|FG003|Open Label Extension|Lost to Follow-up|0|||
44497517|NCT03670810|79503060|FG004|Open Label Extension|Lost to Follow-up|0|||
44497518|NCT03670810|79503061|FG005|Open Label Extension|Lost to Follow-up|0|||
44232248|NCT01827371|79047377|FG000|Overall Study|Protocol Violation|1|||
44232249|NCT01827371|79047378|FG001|Overall Study|Protocol Violation|0|||
44232250|NCT01827371|79047379|FG002|Overall Study|Protocol Violation|0|||
44232251|NCT01827371|79047380|FG003|Overall Study|Protocol Violation|0|||
44232252|NCT01827371|79047377|FG000|Overall Study|Withdrawal by Subject|1|||
44232253|NCT01827371|79047378|FG001|Overall Study|Withdrawal by Subject|2|||
44274972|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274973|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274974|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274975|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274976|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274977|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
44274978|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274979|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
44274980|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
44274981|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274982|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274983|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274984|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44232254|NCT01827371|79047379|FG002|Overall Study|Withdrawal by Subject|2|||
44232255|NCT01827371|79047380|FG003|Overall Study|Withdrawal by Subject|3|||
44274985|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274986|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274987|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274988|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
44274989|NCT02207244|79221607|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274990|NCT02207244|79221608|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
44274991|NCT02207244|79221609|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274992|NCT02207244|79221610|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274993|NCT02207244|79221611|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274994|NCT02207244|79221612|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274995|NCT02207244|79221613|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274996|NCT02207244|79221614|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274997|NCT02207244|79221615|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274998|NCT02207244|79221616|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
44274999|NCT02207244|79221617|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
44275000|NCT02207244|79221607|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275001|NCT02207244|79221608|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275002|NCT02207244|79221609|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275003|NCT02207244|79221610|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275004|NCT02207244|79221611|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
44275005|NCT02207244|79221612|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
44275006|NCT02207244|79221613|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275007|NCT02207244|79221614|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275008|NCT02207244|79221615|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275009|NCT02207244|79221616|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275010|NCT02207244|79221617|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
44275011|NCT02207244|79221607|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275012|NCT02207244|79221608|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275013|NCT02207244|79221609|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44232256|NCT01827371|79047377|FG000|Overall Study|Physician Decision|0|||
44232257|NCT01827371|79047378|FG001|Overall Study|Physician Decision|1|||
44232258|NCT01827371|79047379|FG002|Overall Study|Physician Decision|0|||
44232259|NCT01827371|79047380|FG003|Overall Study|Physician Decision|1|||
44232260|NCT01827371|79047377|FG000|Overall Study|Temporary study halt to vaccinations|11|||
44232261|NCT01827371|79047378|FG001|Overall Study|Temporary study halt to vaccinations|2|||
44232262|NCT01827371|79047379|FG002|Overall Study|Temporary study halt to vaccinations|5|||
44232263|NCT01827371|79047380|FG003|Overall Study|Temporary study halt to vaccinations|13|||
44232264|NCT04409262|79047559|FG000|Overall Study|Adverse Event|0|||
44232265|NCT04409262|79047560|FG001|Overall Study|Adverse Event|2|||
44232266|NCT04409262|79047559|FG000|Overall Study|Death|55|||
44232267|NCT04409262|79047560|FG001|Overall Study|Death|97|||
44232268|NCT04409262|79047559|FG000|Overall Study|Lost to Follow-up|12|||
44232269|NCT04409262|79047560|FG001|Overall Study|Lost to Follow-up|23|||
44232270|NCT04409262|79047559|FG000|Overall Study|Lack of Staff|0|||
44232271|NCT04409262|79047560|FG001|Overall Study|Lack of Staff|1|||
44232272|NCT04409262|79047559|FG000|Overall Study|Protocol Violation|3|||
44232273|NCT04409262|79047560|FG001|Overall Study|Protocol Violation|1|||
44275014|NCT02207244|79221610|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275015|NCT02207244|79221611|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275016|NCT02207244|79221612|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
44376786|NCT00802945|79381974|FG000|Overall Study|Death|27|||
44232274|NCT04409262|79047559|FG000|Overall Study|Withdrawal by Subject|5|||
44232275|NCT04409262|79047560|FG001|Overall Study|Withdrawal by Subject|10|||
44376787|NCT00802945|79381975|FG001|Overall Study|Death|23|||
44232276|NCT04305912|79047604|FG000|First Intervention|COVID-19 Suspension|2|||
44275017|NCT02207244|79221613|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275018|NCT02207244|79221614|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275019|NCT02207244|79221615|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275020|NCT02207244|79221616|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275021|NCT02207244|79221617|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
44275022|NCT02207244|79221607|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275023|NCT02207244|79221608|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275024|NCT02207244|79221609|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275025|NCT02207244|79221610|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
44275026|NCT02207244|79221611|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
44275027|NCT02207244|79221612|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
44275028|NCT02207244|79221613|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275029|NCT02207244|79221614|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275030|NCT02207244|79221615|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275031|NCT02207244|79221616|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275032|NCT02207244|79221617|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
44275033|NCT02207244|79221607|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275034|NCT02207244|79221608|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275035|NCT02207244|79221609|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275036|NCT02207244|79221610|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
44275037|NCT02207244|79221611|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
44275038|NCT02207244|79221612|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
44275039|NCT02207244|79221613|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275040|NCT02207244|79221614|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275041|NCT02207244|79221615|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275042|NCT02207244|79221616|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275043|NCT02207244|79221617|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
44275044|NCT02207244|79221607|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275045|NCT02207244|79221608|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275046|NCT02207244|79221609|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275047|NCT02207244|79221610|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
44275048|NCT02207244|79221611|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275049|NCT02207244|79221612|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
44275050|NCT02207244|79221613|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275051|NCT02207244|79221614|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275052|NCT02207244|79221615|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275053|NCT02207244|79221616|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275054|NCT02207244|79221617|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
44275055|NCT02207244|79221607|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275056|NCT02207244|79221608|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275057|NCT02207244|79221609|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275058|NCT02207244|79221610|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
44275059|NCT02207244|79221611|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275060|NCT02207244|79221612|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275061|NCT02207244|79221613|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
44232277|NCT04305912|79047605|FG001|First Intervention|COVID-19 Suspension|0|||
44232278|NCT04305912|79047604|FG000|First Intervention|Withdrawal by Subject|0|||
44232279|NCT04305912|79047605|FG001|First Intervention|Withdrawal by Subject|1|||
44232280|NCT04305912|79047604|FG000|Second Intervention|Adverse Event|0|||
44232281|NCT04305912|79047605|FG001|Second Intervention|Adverse Event|1|||
44232282|NCT00782184|79047834|FG000|Overall Study|Adverse Event|1|||
44232283|NCT00782184|79047835|FG001|Overall Study|Adverse Event|2|||
44232284|NCT00782184|79047834|FG000|Overall Study|Protocol Violation|0|||
44232285|NCT00782184|79047835|FG001|Overall Study|Protocol Violation|1|||
44232286|NCT00782184|79047834|FG000|Overall Study|Withdrawal by Subject|3|||
44232287|NCT00782184|79047835|FG001|Overall Study|Withdrawal by Subject|2|||
44232288|NCT02731638|79047871|FG000|Overall Study|Lost to Follow-up|6|||
44275062|NCT02207244|79221614|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275063|NCT02207244|79221615|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
44556666|NCT03423173|79573670|FG001|Overall Study|Lost to Follow-up|19|||
44232289|NCT02731638|79047872|FG001|Overall Study|Lost to Follow-up|9|||
44275064|NCT02207244|79221616|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275065|NCT02207244|79221617|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
44275066|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275067|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275068|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275069|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275070|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275071|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275072|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
44275073|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
44275074|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
44275075|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
44275076|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
44275077|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275078|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275079|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275080|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275081|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44232290|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
44232291|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
44232292|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
44232293|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
44232294|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
44232295|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
44275082|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275083|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275084|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
44275085|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275086|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275087|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
44275088|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275089|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275090|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275091|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275092|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275093|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275094|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
44275095|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
44275096|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
44275097|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
44232296|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
44232297|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
44232298|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Death|6|||
44232299|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Death|2|||
44232300|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Death|2|||
44232301|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Death|9|||
44232302|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
44232303|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
44232304|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
44275098|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
44275099|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275100|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275101|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275102|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275103|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44497519|NCT03670810|79503062|FG006|Open Label Extension|Lost to Follow-up|0|||
44497520|NCT03670810|79503063|FG007|Open Label Extension|Lost to Follow-up|0|||
44497521|NCT03670810|79503064|FG008|Open Label Extension|Lost to Follow-up|23|||
44497522|NCT00089648|79503078|FG000|Overall Study|Adverse Event|7|||
44497523|NCT00089648|79503078|FG000|Overall Study|Withdrawal by Subject|1|||
44232305|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
44232306|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
44232307|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
44232308|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
44275104|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275105|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
44275106|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
44275107|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275108|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
44275109|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
44275110|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275111|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275112|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275113|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275114|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275115|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275116|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
44275117|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
44275118|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
44275119|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
44275120|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
44275121|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275122|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275123|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275124|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275125|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275126|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275127|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275128|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
44275129|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
44275130|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275131|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
44275132|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275133|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275134|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275135|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275136|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275137|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275138|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275139|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275140|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
44275141|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275142|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
44275143|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275144|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275145|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275146|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275147|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275148|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275149|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275150|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
44275151|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275152|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275153|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
44275154|NCT02207244|79221607|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275155|NCT02207244|79221608|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275156|NCT02207244|79221609|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275157|NCT02207244|79221610|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44497524|NCT00089648|79503078|FG000|Overall Study|Lack of Efficacy|33|||
44232309|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
44232310|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
44232311|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
44232312|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
44232313|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
44232314|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
44232315|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
44232316|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
44232317|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
44232318|NCT03730662|79048308|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
44232319|NCT03730662|79048309|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
44232320|NCT03730662|79048310|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
44232321|NCT03730662|79048311|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
44275158|NCT02207244|79221611|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275159|NCT02207244|79221612|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275160|NCT02207244|79221613|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
44275161|NCT02207244|79221614|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275162|NCT02207244|79221615|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275163|NCT02207244|79221616|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44232322|NCT03730662|79048308|FG000|Variable Treatment Period|Adverse Event|1|||
44232323|NCT03730662|79048309|FG001|Variable Treatment Period|Adverse Event|2|||
44232324|NCT03730662|79048310|FG002|Variable Treatment Period|Adverse Event|0|||
44232325|NCT03730662|79048311|FG003|Variable Treatment Period|Adverse Event|7|||
44232326|NCT03730662|79048308|FG000|Variable Treatment Period|Death|9|||
44232327|NCT03730662|79048309|FG001|Variable Treatment Period|Death|0|||
44232328|NCT03730662|79048310|FG002|Variable Treatment Period|Death|6|||
44232329|NCT03730662|79048311|FG003|Variable Treatment Period|Death|26|||
44232330|NCT03730662|79048308|FG000|Variable Treatment Period|Lost to Follow-up|2|||
44232331|NCT03730662|79048309|FG001|Variable Treatment Period|Lost to Follow-up|1|||
44232332|NCT03730662|79048310|FG002|Variable Treatment Period|Lost to Follow-up|4|||
44232333|NCT03730662|79048311|FG003|Variable Treatment Period|Lost to Follow-up|11|||
44232334|NCT03730662|79048308|FG000|Variable Treatment Period|Personal Reason|0|||
44232335|NCT03730662|79048309|FG001|Variable Treatment Period|Personal Reason|2|||
44232336|NCT03730662|79048310|FG002|Variable Treatment Period|Personal Reason|1|||
44232337|NCT03730662|79048311|FG003|Variable Treatment Period|Personal Reason|6|||
44275164|NCT02207244|79221617|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
44275165|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275166|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275167|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275168|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275169|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275170|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275171|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275172|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275173|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
44275174|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
44275175|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
44275176|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275177|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275178|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275179|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275180|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275181|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275182|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44232338|NCT03730662|79048308|FG000|Variable Treatment Period|Physician Decision|0|||
44232339|NCT03730662|79048309|FG001|Variable Treatment Period|Physician Decision|0|||
44232340|NCT03730662|79048310|FG002|Variable Treatment Period|Physician Decision|0|||
44232341|NCT03730662|79048311|FG003|Variable Treatment Period|Physician Decision|3|||
44232342|NCT03730662|79048308|FG000|Variable Treatment Period|Protocol Violation|0|||
44232343|NCT03730662|79048309|FG001|Variable Treatment Period|Protocol Violation|1|||
44232344|NCT03730662|79048310|FG002|Variable Treatment Period|Protocol Violation|1|||
44232345|NCT03730662|79048311|FG003|Variable Treatment Period|Protocol Violation|1|||
44275183|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275184|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
44232346|NCT03730662|79048308|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
44232347|NCT03730662|79048309|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
44232348|NCT03730662|79048310|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
44232349|NCT03730662|79048311|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
44232350|NCT03185832|79048409|FG000|Overall Study|Death|9|||
44232351|NCT03185832|79048410|FG001|Overall Study|Death|14|||
44232352|NCT03185832|79048411|FG002|Overall Study|Death|9|||
44232353|NCT03185832|79048412|FG003|Overall Study|Death|7|||
44232354|NCT03185832|79048409|FG000|Overall Study|Withdrawn - vital status available|0|||
44232355|NCT03185832|79048410|FG001|Overall Study|Withdrawn - vital status available|1|||
44232356|NCT03185832|79048411|FG002|Overall Study|Withdrawn - vital status available|1|||
44232357|NCT03185832|79048412|FG003|Overall Study|Withdrawn - vital status available|4|||
44232358|NCT04569786|79048464|FG000|Overall Study|Lost to Follow-up|1|||
44275185|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
44275186|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
44275187|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275188|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275189|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275190|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275191|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275192|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275193|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275194|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275195|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
44275196|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
44275197|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
44275198|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275199|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275200|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275201|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275202|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275203|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275204|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275205|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275206|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
44275207|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
44275208|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
44275209|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
44275210|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
44497525|NCT00118040|79503085|FG000|Overall Study|Adverse Event|0|||
44497526|NCT00118040|79503086|FG001|Overall Study|Adverse Event|1|||
44497527|NCT00118040|79503087|FG002|Overall Study|Adverse Event|0|||
44497528|NCT00118040|79503085|FG000|Overall Study|Withdrawal by Subject|0|||
44497529|NCT00118040|79503086|FG001|Overall Study|Withdrawal by Subject|0|||
44497530|NCT00118040|79503087|FG002|Overall Study|Withdrawal by Subject|2|||
44497531|NCT00118040|79503085|FG000|Overall Study|Medical Contraindication|0|||
44497532|NCT00118040|79503086|FG001|Overall Study|Medical Contraindication|0|||
44275211|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
44275212|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
44275213|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
44275214|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
44275215|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
44497533|NCT00118040|79503087|FG002|Overall Study|Medical Contraindication|1|||
44497534|NCT00118040|79503085|FG000|Overall Study|Non-Compliant Participant|1|||
44497535|NCT00118040|79503086|FG001|Overall Study|Non-Compliant Participant|1|||
44497536|NCT00118040|79503087|FG002|Overall Study|Non-Compliant Participant|2|||
44497537|NCT00118040|79503085|FG000|Overall Study|Other|0|||
44497538|NCT00118040|79503086|FG001|Overall Study|Other|0|||
44497539|NCT00118040|79503087|FG002|Overall Study|Other|1|||
44497540|NCT00389207|79503103|FG000|Overall Study|Adverse Event|26|||
44497541|NCT00389207|79503104|FG001|Overall Study|Adverse Event|32|||
44497542|NCT00389207|79503105|FG002|Overall Study|Adverse Event|10|||
44497543|NCT00389207|79503103|FG000|Overall Study|Protocol Violation|3|||
44497544|NCT00389207|79503104|FG001|Overall Study|Protocol Violation|1|||
44497545|NCT00389207|79503105|FG002|Overall Study|Protocol Violation|4|||
44497546|NCT00389207|79503103|FG000|Overall Study|Lost to Follow-up|12|||
44497547|NCT00389207|79503104|FG001|Overall Study|Lost to Follow-up|9|||
44497548|NCT00389207|79503105|FG002|Overall Study|Lost to Follow-up|7|||
44497549|NCT00389207|79503103|FG000|Overall Study|Withdrawal by Subject|5|||
44497550|NCT00389207|79503104|FG001|Overall Study|Withdrawal by Subject|7|||
44497551|NCT00389207|79503105|FG002|Overall Study|Withdrawal by Subject|11|||
44497552|NCT00389207|79503103|FG000|Overall Study|Other|17|||
44497553|NCT00389207|79503104|FG001|Overall Study|Other|23|||
44497554|NCT00389207|79503105|FG002|Overall Study|Other|9|||
44497555|NCT00388973|79503120|FG000|Overall Study|Adverse Event|16|||
44497556|NCT00388973|79503121|FG001|Overall Study|Adverse Event|6|||
44497557|NCT00388973|79503120|FG000|Overall Study|Lack of Efficacy|1|||
44497558|NCT00388973|79503121|FG001|Overall Study|Lack of Efficacy|12|||
44497559|NCT00388973|79503120|FG000|Overall Study|Protocol Violation|3|||
44497560|NCT00388973|79503121|FG001|Overall Study|Protocol Violation|0|||
44497561|NCT00388973|79503120|FG000|Overall Study|Withdrawal by Subject|14|||
44497562|NCT00388973|79503121|FG001|Overall Study|Withdrawal by Subject|17|||
44497563|NCT00388973|79503120|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
44497564|NCT00388973|79503121|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
44497565|NCT00388973|79503120|FG000|Overall Study|Did not complete 61 days of treatment|5|||
44497566|NCT00388973|79503121|FG001|Overall Study|Did not complete 61 days of treatment|4|||
44497567|NCT00388973|79503120|FG000|Overall Study|Left region|0|||
44556667|NCT03423173|79573671|FG002|Overall Study|Lost to Follow-up|17|||
44556668|NCT03423173|79573672|FG003|Overall Study|Lost to Follow-up|22|||
44556669|NCT03423173|79573669|FG000|Overall Study|Withdrawal of consent|4|||
44556670|NCT03423173|79573670|FG001|Overall Study|Withdrawal of consent|10|||
44556671|NCT03423173|79573671|FG002|Overall Study|Withdrawal of consent|4|||
44556672|NCT03423173|79573672|FG003|Overall Study|Withdrawal of consent|5|||
44556673|NCT03423173|79573669|FG000|Overall Study|Death|1|||
44556674|NCT03423173|79573670|FG001|Overall Study|Death|0|||
44556675|NCT03423173|79573671|FG002|Overall Study|Death|0|||
44556676|NCT03423173|79573672|FG003|Overall Study|Death|0|||
44556677|NCT03423173|79573669|FG000|Overall Study|Reason not Specified|2|||
44556678|NCT03423173|79573670|FG001|Overall Study|Reason not Specified|5|||
44556679|NCT03423173|79573671|FG002|Overall Study|Reason not Specified|3|||
44556680|NCT03423173|79573672|FG003|Overall Study|Reason not Specified|1|||
44556681|NCT03447821|79573685|FG000|Overall Study|Withdrawal by Subject|1|||
44556682|NCT03447821|79573686|FG001|Overall Study|Withdrawal by Subject|1|||
44556683|NCT03447821|79573687|FG002|Overall Study|Withdrawal by Subject|0|||
44556684|NCT03447821|79573685|FG000|Overall Study|Lost to Follow-up|0|||
44556685|NCT03447821|79573686|FG001|Overall Study|Lost to Follow-up|0|||
44556686|NCT03447821|79573687|FG002|Overall Study|Lost to Follow-up|1|||
44556687|NCT03447353|79573701|FG000|Overall Study|Failure at Screening Visit|2|||
44556688|NCT03447353|79573701|FG000|Overall Study|Lost to Follow-up|4|||
44556689|NCT03447353|79573701|FG000|Overall Study|Scheduling Conflicts|3|||
44556690|NCT03447353|79573701|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
44556691|NCT03446885|79573711|FG000|Overall Study|Lost to Follow-up|1|||
44556692|NCT03446885|79573712|FG001|Overall Study|Lost to Follow-up|0|||
44556693|NCT03446885|79573711|FG000|Overall Study|Did not complete entire visit|1|||
44556694|NCT03446885|79573712|FG001|Overall Study|Did not complete entire visit|0|||
44556695|NCT00710970|79573720|FG000|Overall Study|Never took drug|3|||
44556696|NCT03421379|79573726|FG000|Period 1|Withdrawal by Subject|0|||
44556697|NCT03421379|79573727|FG001|Period 1|Withdrawal by Subject|1|||
44556698|NCT03421379|79573726|FG000|Period 1|Physician Decision|1|||
44556699|NCT03421379|79573727|FG001|Period 1|Physician Decision|1|||
44556700|NCT03421379|79573726|FG000|Period 1|Did not receive treatment|1|||
44556701|NCT03421379|79573727|FG001|Period 1|Did not receive treatment|2|||
44556702|NCT02900378|79573735|FG000|Randomization (Visit 2)|Adverse Event|14|||
44232359|NCT04569786|79048465|FG001|Overall Study|Lost to Follow-up|0|||
44497568|NCT00388973|79503121|FG001|Overall Study|Left region|1|||
44497569|NCT00388973|79503120|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
44497570|NCT00388973|79503121|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
44497571|NCT00388583|79503129|FG000|Overall Study|Protocol Violation|1|||
44497572|NCT00388583|79503130|FG001|Overall Study|Protocol Violation|0|||
44497573|NCT00388583|79503129|FG000|Overall Study|Withdrawal by Subject|3|||
44497574|NCT00388583|79503130|FG001|Overall Study|Withdrawal by Subject|3|||
44497575|NCT00388583|79503129|FG000|Overall Study|Serious Adverse Event|2|||
44497576|NCT00388583|79503130|FG001|Overall Study|Serious Adverse Event|0|||
44497577|NCT00388583|79503129|FG000|Overall Study|Did not receive vaccine|0|||
44497578|NCT00388583|79503130|FG001|Overall Study|Did not receive vaccine|1|||
44497579|NCT00117572|79503138|FG000|Overall Study|Site withdrew before starting treatment|2|||
44497580|NCT00117572|79503139|FG001|Overall Study|Site withdrew before starting treatment|3|||
44497581|NCT00117572|79503138|FG000|Overall Study|Withdrawal by Subject|3|||
44497582|NCT00117572|79503139|FG001|Overall Study|Withdrawal by Subject|3|||
44497583|NCT00117572|79503138|FG000|Overall Study|Protocol Violation|1|||
44497584|NCT00117572|79503139|FG001|Overall Study|Protocol Violation|0|||
44497585|NCT00388505|79503147|FG000|Overall Study|Adverse Event or Death|43|||
44497586|NCT00388505|79503148|FG001|Overall Study|Adverse Event or Death|17|||
44497587|NCT00388505|79503147|FG000|Overall Study|Withdrawal by Subject|24|||
44497588|NCT00388505|79503148|FG001|Overall Study|Withdrawal by Subject|9|||
44556703|NCT02900378|79573736|FG001|Randomization (Visit 2)|Adverse Event|11|||
44556704|NCT02900378|79573735|FG000|Randomization (Visit 2)|Death|1|||
44556705|NCT02900378|79573736|FG001|Randomization (Visit 2)|Death|4|||
44556706|NCT02900378|79573735|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
44556707|NCT02900378|79573736|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
44556708|NCT02900378|79573735|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
44556709|NCT02900378|79573736|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
44556710|NCT02900378|79573735|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
44497589|NCT00388505|79503147|FG000|Overall Study|Lost to Follow-up|5|||
44556711|NCT02900378|79573736|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
44556712|NCT02900378|79573735|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
44556713|NCT02900378|79573736|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
44556714|NCT02900378|79573735|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
44556715|NCT02900378|79573736|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
44556716|NCT03058692|79573744|FG000|Overall Study|Lost to Follow-up|2|||
44556717|NCT03058692|79573745|FG001|Overall Study|Lost to Follow-up|1|||
44556718|NCT03058692|79573744|FG000|Overall Study|Withdrawal by Subject|1|||
44556719|NCT03058692|79573745|FG001|Overall Study|Withdrawal by Subject|1|||
44556720|NCT02964338|79573755|FG000|Overall Study|Sponsor terminated study for futility|12|||
44556721|NCT02964338|79573756|FG001|Overall Study|Sponsor terminated study for futility|15|||
44556722|NCT02964338|79573757|FG002|Overall Study|Sponsor terminated study for futility|14|||
44556723|NCT02964338|79573755|FG000|Overall Study|Lack of Efficacy|0|||
44556724|NCT02964338|79573756|FG001|Overall Study|Lack of Efficacy|3|||
44556725|NCT02964338|79573757|FG002|Overall Study|Lack of Efficacy|0|||
44556726|NCT02964338|79573755|FG000|Overall Study|Lost to Follow-up|1|||
44556727|NCT02964338|79573756|FG001|Overall Study|Lost to Follow-up|0|||
44556728|NCT02964338|79573757|FG002|Overall Study|Lost to Follow-up|3|||
44556729|NCT02964338|79573755|FG000|Overall Study|Protocol Violation|0|||
44556730|NCT02964338|79573756|FG001|Overall Study|Protocol Violation|1|||
44556731|NCT02964338|79573757|FG002|Overall Study|Protocol Violation|0|||
44556732|NCT02964338|79573755|FG000|Overall Study|Withdrawal by Subject|1|||
44556733|NCT02964338|79573756|FG001|Overall Study|Withdrawal by Subject|3|||
44556734|NCT02964338|79573757|FG002|Overall Study|Withdrawal by Subject|1|||
44556735|NCT02964338|79573755|FG000|Overall Study|Adverse Event|2|||
44556736|NCT02964338|79573756|FG001|Overall Study|Adverse Event|1|||
44556737|NCT02964338|79573757|FG002|Overall Study|Adverse Event|1|||
44556738|NCT02964338|79573755|FG000|Overall Study|Non-compliant with e-diary|0|||
44556739|NCT02964338|79573756|FG001|Overall Study|Non-compliant with e-diary|1|||
44556740|NCT02964338|79573757|FG002|Overall Study|Non-compliant with e-diary|0|||
44556741|NCT02964338|79573755|FG000|Overall Study|Did not meet criteria|1|||
44556742|NCT02964338|79573756|FG001|Overall Study|Did not meet criteria|0|||
44556743|NCT02964338|79573757|FG002|Overall Study|Did not meet criteria|0|||
44556744|NCT03056352|79573765|FG000|Overall Study|Lost to Follow-up|1|||
44232360|NCT04569786|79048466|FG002|Overall Study|Lost to Follow-up|4|||
44556745|NCT02898662|79573771|FG000|Overall Study|Adverse Event|1|||
44556746|NCT02898662|79573772|FG001|Overall Study|Adverse Event|0|||
44556747|NCT02898662|79573771|FG000|Overall Study|Loss of asthma control|23|||
44556748|NCT02898662|79573772|FG001|Overall Study|Loss of asthma control|24|||
44556749|NCT02898662|79573771|FG000|Overall Study|Withdrawal by Subject|4|||
44556750|NCT02898662|79573772|FG001|Overall Study|Withdrawal by Subject|1|||
44556751|NCT02898662|79573771|FG000|Overall Study|Technical issue|0|||
44556752|NCT02898662|79573772|FG001|Overall Study|Technical issue|1|||
44556753|NCT02898662|79573771|FG000|Overall Study|Randomized in error|0|||
44556754|NCT02898662|79573772|FG001|Overall Study|Randomized in error|1|||
44556755|NCT02898662|79573771|FG000|Overall Study|Subject decision|1|||
44556756|NCT02898662|79573772|FG001|Overall Study|Subject decision|0|||
44556757|NCT02898662|79573771|FG000|Overall Study|Other|0|||
44556758|NCT02898662|79573772|FG001|Overall Study|Other|1|||
44556759|NCT03055338|79573781|FG000|Overall Study|Lost to Follow-up|9|||
44556760|NCT03055338|79573782|FG001|Overall Study|Lost to Follow-up|2|||
44556761|NCT03055338|79573783|FG002|Overall Study|Lost to Follow-up|3|||
44556762|NCT03055338|79573781|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
44556763|NCT03055338|79573782|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
44556764|NCT03055338|79573783|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
44556765|NCT03055338|79573781|FG000|Overall Study|Physician Decision|0|||
44556766|NCT03055338|79573782|FG001|Overall Study|Physician Decision|0|||
44556767|NCT03055338|79573783|FG002|Overall Study|Physician Decision|2|||
44556768|NCT03055338|79573781|FG000|Overall Study|Withdrawal by Subject|9|||
44556769|NCT03055338|79573782|FG001|Overall Study|Withdrawal by Subject|8|||
44556770|NCT03055338|79573783|FG002|Overall Study|Withdrawal by Subject|7|||
44556771|NCT03913130|79573791|FG000|Overall Study|Sponsor Decision|1|||
44556772|NCT03419741|79573797|FG000|Overall Study|Adverse Event|1|||
44556773|NCT03419741|79573798|FG001|Overall Study|Adverse Event|0|||
44556774|NCT03419741|79573797|FG000|Overall Study|Withdrawal by Subject|1|||
44232361|NCT04569786|79048467|FG003|Overall Study|Lost to Follow-up|1|||
44232362|NCT04569786|79048468|FG004|Overall Study|Lost to Follow-up|0|||
44556775|NCT03419741|79573798|FG001|Overall Study|Withdrawal by Subject|2|||
44232363|NCT04569786|79048464|FG000|Overall Study|Withdrawal by Subject|0|||
44556776|NCT02896400|79573820|FG000|1 Month Follow-up|Lost to Follow-up|7|||
44556777|NCT02896400|79573821|FG001|1 Month Follow-up|Lost to Follow-up|7|||
44556778|NCT02896400|79573822|FG002|1 Month Follow-up|Lost to Follow-up|5|||
44232364|NCT04569786|79048465|FG001|Overall Study|Withdrawal by Subject|0|||
44556779|NCT02896400|79573823|FG003|1 Month Follow-up|Lost to Follow-up|8|||
44556780|NCT02896400|79573824|FG004|1 Month Follow-up|Lost to Follow-up|9|||
44556781|NCT02896400|79573825|FG005|1 Month Follow-up|Lost to Follow-up|6|||
44556782|NCT02896400|79573826|FG006|1 Month Follow-up|Lost to Follow-up|5|||
44556783|NCT02896400|79573827|FG007|1 Month Follow-up|Lost to Follow-up|6|||
44556784|NCT02896400|79573828|FG008|1 Month Follow-up|Lost to Follow-up|4|||
44556785|NCT02896400|79573829|FG009|1 Month Follow-up|Lost to Follow-up|7|||
44556786|NCT02896400|79573830|FG010|1 Month Follow-up|Lost to Follow-up|5|||
44556787|NCT02896400|79573831|FG011|1 Month Follow-up|Lost to Follow-up|5|||
44556788|NCT02896400|79573832|FG012|1 Month Follow-up|Lost to Follow-up|3|||
44556789|NCT02896400|79573833|FG013|1 Month Follow-up|Lost to Follow-up|4|||
44556790|NCT02896400|79573834|FG014|1 Month Follow-up|Lost to Follow-up|1|||
44556791|NCT02896400|79573835|FG015|1 Month Follow-up|Lost to Follow-up|2|||
44556792|NCT02896400|79573820|FG000|1 Month Follow-up|Death|0|||
44556793|NCT02896400|79573821|FG001|1 Month Follow-up|Death|0|||
44556794|NCT02896400|79573822|FG002|1 Month Follow-up|Death|0|||
44556795|NCT02896400|79573823|FG003|1 Month Follow-up|Death|0|||
44556796|NCT02896400|79573824|FG004|1 Month Follow-up|Death|0|||
44556797|NCT02896400|79573825|FG005|1 Month Follow-up|Death|0|||
44556798|NCT02896400|79573826|FG006|1 Month Follow-up|Death|0|||
44556799|NCT02896400|79573827|FG007|1 Month Follow-up|Death|0|||
44556800|NCT02896400|79573828|FG008|1 Month Follow-up|Death|0|||
44556801|NCT02896400|79573829|FG009|1 Month Follow-up|Death|0|||
44556802|NCT02896400|79573830|FG010|1 Month Follow-up|Death|0|||
44556803|NCT02896400|79573831|FG011|1 Month Follow-up|Death|0|||
44556804|NCT02896400|79573832|FG012|1 Month Follow-up|Death|0|||
44556805|NCT02896400|79573833|FG013|1 Month Follow-up|Death|0|||
44556806|NCT02896400|79573834|FG014|1 Month Follow-up|Death|0|||
44556807|NCT02896400|79573835|FG015|1 Month Follow-up|Death|1|||
44556808|NCT02896400|79573820|FG000|3 Month Follow-up|Lost to Follow-up|6|||
44556809|NCT02896400|79573821|FG001|3 Month Follow-up|Lost to Follow-up|3|||
44556810|NCT02896400|79573822|FG002|3 Month Follow-up|Lost to Follow-up|6|||
44556811|NCT02896400|79573823|FG003|3 Month Follow-up|Lost to Follow-up|11|||
44556812|NCT02896400|79573824|FG004|3 Month Follow-up|Lost to Follow-up|12|||
44556813|NCT02896400|79573825|FG005|3 Month Follow-up|Lost to Follow-up|6|||
44556814|NCT02896400|79573826|FG006|3 Month Follow-up|Lost to Follow-up|4|||
44556815|NCT02896400|79573827|FG007|3 Month Follow-up|Lost to Follow-up|3|||
44556816|NCT02896400|79573828|FG008|3 Month Follow-up|Lost to Follow-up|6|||
44556817|NCT02896400|79573829|FG009|3 Month Follow-up|Lost to Follow-up|5|||
44556818|NCT02896400|79573830|FG010|3 Month Follow-up|Lost to Follow-up|6|||
44556819|NCT02896400|79573831|FG011|3 Month Follow-up|Lost to Follow-up|6|||
44556820|NCT02896400|79573832|FG012|3 Month Follow-up|Lost to Follow-up|3|||
44556821|NCT02896400|79573833|FG013|3 Month Follow-up|Lost to Follow-up|5|||
44556822|NCT02896400|79573834|FG014|3 Month Follow-up|Lost to Follow-up|3|||
44556823|NCT02896400|79573835|FG015|3 Month Follow-up|Lost to Follow-up|2|||
44556824|NCT02896400|79573820|FG000|3 Month Follow-up|Death|0|||
44556825|NCT02896400|79573821|FG001|3 Month Follow-up|Death|0|||
44556826|NCT02896400|79573822|FG002|3 Month Follow-up|Death|0|||
44556827|NCT02896400|79573823|FG003|3 Month Follow-up|Death|0|||
44556828|NCT02896400|79573824|FG004|3 Month Follow-up|Death|0|||
44556829|NCT02896400|79573825|FG005|3 Month Follow-up|Death|0|||
44556830|NCT02896400|79573826|FG006|3 Month Follow-up|Death|0|||
44556831|NCT02896400|79573827|FG007|3 Month Follow-up|Death|0|||
44556832|NCT02896400|79573828|FG008|3 Month Follow-up|Death|0|||
44556833|NCT02896400|79573829|FG009|3 Month Follow-up|Death|0|||
44556834|NCT02896400|79573830|FG010|3 Month Follow-up|Death|0|||
44232365|NCT04569786|79048466|FG002|Overall Study|Withdrawal by Subject|0|||
44232366|NCT04569786|79048467|FG003|Overall Study|Withdrawal by Subject|5|||
44232367|NCT04569786|79048468|FG004|Overall Study|Withdrawal by Subject|1|||
44556835|NCT02896400|79573831|FG011|3 Month Follow-up|Death|0|||
44556836|NCT02896400|79573832|FG012|3 Month Follow-up|Death|0|||
44556837|NCT02896400|79573833|FG013|3 Month Follow-up|Death|1|||
44556838|NCT02896400|79573834|FG014|3 Month Follow-up|Death|1|||
44232368|NCT04569786|79048464|FG000|Overall Study|Physician Decision|0|||
44556839|NCT02896400|79573835|FG015|3 Month Follow-up|Death|0|||
44556840|NCT02896400|79573820|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556841|NCT02896400|79573821|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
44556842|NCT02896400|79573822|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556843|NCT02896400|79573823|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556844|NCT02896400|79573824|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
44556845|NCT02896400|79573825|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556846|NCT02896400|79573826|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
44556847|NCT02896400|79573827|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
44556848|NCT02896400|79573828|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556849|NCT02896400|79573829|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556850|NCT02896400|79573830|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
44376788|NCT00802945|79381974|FG000|Overall Study|Terminated by sponsor|8|||
44376789|NCT00802945|79381975|FG001|Overall Study|Terminated by sponsor|12|||
44376790|NCT01074554|79381985|FG000|Overall Study|Adverse Event|3|||
44556851|NCT02896400|79573831|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
44556852|NCT02896400|79573832|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556853|NCT02896400|79573833|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
44556854|NCT02896400|79573834|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
44556855|NCT02896400|79573835|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
44556856|NCT02896400|79573820|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
44556857|NCT02896400|79573821|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
44556858|NCT02896400|79573822|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
44556859|NCT02896400|79573823|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
44556860|NCT02896400|79573824|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
44556861|NCT02896400|79573825|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
44556862|NCT02896400|79573826|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
44556863|NCT02896400|79573827|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
44556864|NCT02896400|79573828|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
44556865|NCT02896400|79573829|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
44556866|NCT02896400|79573830|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
44556867|NCT02896400|79573831|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
44556868|NCT02896400|79573832|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
44556869|NCT02896400|79573833|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
44556870|NCT02896400|79573834|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
44556871|NCT02896400|79573835|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
44556872|NCT03405935|79573861|FG000|Overall Study|Adverse Event|3|||
44556873|NCT03405935|79573861|FG000|Overall Study|Death|2|||
44556874|NCT03405935|79573861|FG000|Overall Study|Withdrawal by Subject|1|||
44556875|NCT03405935|79573861|FG000|Overall Study|Lost to Follow-up|2|||
44275216|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
44275217|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
44556876|NCT03055260|79573867|FG000|Overall Study|Withdrawal by Subject|1|||
44556877|NCT03055260|79573868|FG001|Overall Study|Withdrawal by Subject|0|||
44376791|NCT01074554|79381986|FG001|Overall Study|Adverse Event|3|||
44376792|NCT01074554|79381985|FG000|Overall Study|Lost to Follow-up|0|||
44376793|NCT01074554|79381986|FG001|Overall Study|Lost to Follow-up|1|||
44376794|NCT00857584|79381994|FG000|Overall Study|Lack of Efficacy|1|||
44376795|NCT00857584|79381995|FG001|Overall Study|Lack of Efficacy|2|||
44275218|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
44275219|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
44376796|NCT00857584|79381994|FG000|Overall Study|Adverse Event|2|||
44376797|NCT00857584|79381995|FG001|Overall Study|Adverse Event|2|||
44556878|NCT03404843|79573876|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
44556879|NCT03404843|79573877|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
44556880|NCT03444155|79573901|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
44556881|NCT03444155|79573902|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
44556882|NCT02898116|79573908|FG000|Overall Study|Adverse Event|1|||
44556883|NCT02898116|79573908|FG000|Overall Study|Progressive disease|1|||
44497590|NCT00388505|79503148|FG001|Overall Study|Lost to Follow-up|3|||
44497591|NCT00388505|79503147|FG000|Overall Study|Inappropriate Enrollment|0|||
44497592|NCT00388505|79503148|FG001|Overall Study|Inappropriate Enrollment|1|||
44497593|NCT00388505|79503147|FG000|Overall Study|Administrative Reason|1|||
44497594|NCT00388505|79503148|FG001|Overall Study|Administrative Reason|0|||
44497595|NCT00388505|79503147|FG000|Overall Study|Protocol Violation|6|||
44497596|NCT00388505|79503148|FG001|Overall Study|Protocol Violation|5|||
44556884|NCT03658304|79573912|FG000|Overall Study|participants still on follow up|8|||
44556885|NCT03422159|79573918|FG000|Overall Study|Exclusion due to terminal disease|2|||
44497597|NCT00388505|79503147|FG000|Overall Study|Unable to classify|4|||
44497598|NCT00388505|79503148|FG001|Overall Study|Unable to classify|3|||
44497599|NCT00388349|79503154|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
44556886|NCT03422159|79573919|FG001|Overall Study|Exclusion due to terminal disease|1|||
44556887|NCT03403751|79573929|FG000|Overall Study|Death|5|||
44275220|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
44275221|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
44556888|NCT03403751|79573930|FG001|Overall Study|Death|6|||
44556889|NCT03403751|79573929|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
44556890|NCT03403751|79573930|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
44556891|NCT02297412|79573940|FG000|Overall Study|Canceled|1|||
44556892|NCT02297412|79573941|FG001|Overall Study|Canceled|1|||
44497600|NCT00388349|79503155|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
44556893|NCT03418727|79573950|FG000|Overall Study|Adverse Event|1|||
44232369|NCT04569786|79048465|FG001|Overall Study|Physician Decision|0|||
44497601|NCT00117338|79503165|FG000|Overall Study|Adverse Event|0|||
44497602|NCT00117338|79503166|FG001|Overall Study|Adverse Event|1|||
44497603|NCT00117338|79503165|FG000|Overall Study|Protocol Violation|3|||
44497604|NCT00117338|79503166|FG001|Overall Study|Protocol Violation|2|||
44497605|NCT00117338|79503165|FG000|Overall Study|Withdrawal by Subject|1|||
44497606|NCT00117338|79503166|FG001|Overall Study|Withdrawal by Subject|0|||
44497607|NCT00117338|79503165|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
44497608|NCT00117338|79503166|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
44556894|NCT03418727|79573951|FG001|Overall Study|Adverse Event|2|||
44556895|NCT03418727|79573952|FG002|Overall Study|Adverse Event|0|||
44556896|NCT03418727|79573950|FG000|Overall Study|Withdrawal by Subject|0|||
44556897|NCT03418727|79573951|FG001|Overall Study|Withdrawal by Subject|0|||
44556898|NCT03418727|79573952|FG002|Overall Study|Withdrawal by Subject|2|||
44556899|NCT03418571|79573962|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
44556900|NCT03418571|79573963|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
44556901|NCT03402893|79573969|FG000|Overall Study|Withdrawal by Subject|1|||
44556902|NCT03442985|79573977|FG000|Overall Study|Sponsor Request|55|||
44556903|NCT03442985|79573978|FG001|Overall Study|Sponsor Request|60|||
44556904|NCT03442985|79573979|FG002|Overall Study|Sponsor Request|54|||
44556905|NCT03442985|79573977|FG000|Overall Study|Lost to Follow-up|5|||
44556906|NCT03442985|79573978|FG001|Overall Study|Lost to Follow-up|2|||
44556907|NCT03442985|79573979|FG002|Overall Study|Lost to Follow-up|7|||
44556908|NCT03442985|79573977|FG000|Overall Study|Withdrawal by Subject|2|||
44556909|NCT03442985|79573978|FG001|Overall Study|Withdrawal by Subject|3|||
44556910|NCT03442985|79573979|FG002|Overall Study|Withdrawal by Subject|4|||
44556911|NCT03442985|79573977|FG000|Overall Study|Adverse Event|0|||
44556912|NCT03442985|79573978|FG001|Overall Study|Adverse Event|1|||
44556913|NCT03442985|79573979|FG002|Overall Study|Adverse Event|0|||
44556914|NCT01318122|79573991|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44556915|NCT01318122|79573992|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44556916|NCT01318122|79573993|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
44556917|NCT01318122|79573994|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
44556918|NCT01318122|79573991|FG000|Enrolled - Long-Term Extension Study|Other|1|||
44556919|NCT01318122|79573992|FG001|Enrolled - Long-Term Extension Study|Other|0|||
44556920|NCT01318122|79573993|FG002|Enrolled - Long-Term Extension Study|Other|0|||
44556921|NCT01318122|79573994|FG003|Enrolled - Long-Term Extension Study|Other|0|||
44556922|NCT01318122|79573991|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
44556923|NCT01318122|79573992|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
44556924|NCT01318122|79573993|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
44556925|NCT01318122|79573994|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
44556926|NCT01318122|79573991|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
44556927|NCT01318122|79573992|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44556928|NCT01318122|79573993|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44556929|NCT01318122|79573994|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44556930|NCT01318122|79573991|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44556931|NCT01318122|79573992|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
44556932|NCT01318122|79573993|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44556933|NCT01318122|79573994|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44556934|NCT01318122|79573991|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
44556935|NCT01318122|79573992|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
44556936|NCT01318122|79573993|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
44556937|NCT01318122|79573994|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
44556938|NCT02954159|79574002|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
44556939|NCT02954159|79574003|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
44556940|NCT02954159|79574002|FG000|Overall Study|Withdrawal by Subject|0|||
44556941|NCT02954159|79574003|FG001|Overall Study|Withdrawal by Subject|1|||
44556942|NCT03442829|79574011|FG000|Overall Study|Scheduling clash|3|||
44232370|NCT04569786|79048466|FG002|Overall Study|Physician Decision|0|||
44497609|NCT00117338|79503165|FG000|Overall Study|Lack of Efficacy|0|||
44497610|NCT00117338|79503166|FG001|Overall Study|Lack of Efficacy|1|||
44497611|NCT00388037|79503172|FG000|Overall Study|Protocol Violation|1|||
44497612|NCT00387881|79503178|FG000|Overall Study|Lost to Follow-up|23|||
44497613|NCT00387881|79503179|FG001|Overall Study|Lost to Follow-up|23|||
44497614|NCT00387881|79503178|FG000|Overall Study|Protocol Violation|2|||
44497615|NCT00387881|79503179|FG001|Overall Study|Protocol Violation|12|||
44232371|NCT04569786|79048467|FG003|Overall Study|Physician Decision|1|||
44232372|NCT04569786|79048468|FG004|Overall Study|Physician Decision|0|||
44497616|NCT00387881|79503178|FG000|Overall Study|Withdrawal by Subject|15|||
44497617|NCT00387881|79503179|FG001|Overall Study|Withdrawal by Subject|18|||
44556943|NCT03442829|79574012|FG001|Overall Study|Scheduling clash|1|||
44556944|NCT03442829|79574011|FG000|Overall Study|Illness unrelated to study|1|||
44556945|NCT03442829|79574012|FG001|Overall Study|Illness unrelated to study|1|||
44556946|NCT03442595|79574020|FG000|Overall Study|Lost to Follow-up|94|||
44556947|NCT03442595|79574021|FG001|Overall Study|Lost to Follow-up|0|||
44556948|NCT03440411|79574030|FG000|Overall Study|Adverse Event|0|||
44556949|NCT03440411|79574031|FG001|Overall Study|Adverse Event|0|||
44497618|NCT00387881|79503178|FG000|Overall Study|Sponsor terminated Study|0|||
44497619|NCT00387881|79503179|FG001|Overall Study|Sponsor terminated Study|1|||
44556950|NCT03440411|79574032|FG002|Overall Study|Adverse Event|1|||
44556951|NCT03440411|79574033|FG003|Overall Study|Adverse Event|0|||
44556952|NCT03440411|79574030|FG000|Overall Study|PD|2|||
44556953|NCT03440411|79574031|FG001|Overall Study|PD|1|||
44556954|NCT03440411|79574032|FG002|Overall Study|PD|1|||
44497620|NCT00387881|79503178|FG000|Overall Study|Not eligible|6|||
44232373|NCT03125382|79048558|FG000|Randomization|screening failure|1|||
44232374|NCT03125382|79048559|FG001|Randomization|screening failure|4|||
44232375|NCT03125382|79048560|FG002|Randomization|screening failure|2|||
44232376|NCT03125382|79048561|FG003|Randomization|screening failure|0|||
44232377|NCT03125382|79048558|FG000|Follow-up|Death|1|||
44232378|NCT03125382|79048559|FG001|Follow-up|Death|2|||
44232379|NCT03125382|79048560|FG002|Follow-up|Death|1|||
44232380|NCT03125382|79048561|FG003|Follow-up|Death|2|||
44232381|NCT03125382|79048558|FG000|Follow-up|Lost to Follow-up|1|||
44232382|NCT03125382|79048559|FG001|Follow-up|Lost to Follow-up|4|||
44232383|NCT03125382|79048560|FG002|Follow-up|Lost to Follow-up|3|||
44232384|NCT03125382|79048561|FG003|Follow-up|Lost to Follow-up|1|||
44275222|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
44275223|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
44497621|NCT00387881|79503179|FG001|Overall Study|Not eligible|7|||
44497622|NCT00387881|79503178|FG000|Overall Study|No opportunity to treat headache|32|||
44497623|NCT00387881|79503179|FG001|Overall Study|No opportunity to treat headache|34|||
44497624|NCT00387881|79503178|FG000|Overall Study|Not otherwise specified|11|||
44497625|NCT00387881|79503179|FG001|Overall Study|Not otherwise specified|7|||
44497626|NCT00084656|79503188|FG000|Overall Study|Other reasons|0|||
44497627|NCT00084656|79503189|FG001|Overall Study|Other reasons|12|||
44497628|NCT00084656|79503190|FG002|Overall Study|Other reasons|11|||
44497629|NCT00084656|79503188|FG000|Overall Study|Withdrawal by Subject|15|||
44497630|NCT00084656|79503189|FG001|Overall Study|Withdrawal by Subject|4|||
44497631|NCT00084656|79503190|FG002|Overall Study|Withdrawal by Subject|4|||
44497632|NCT00084656|79503188|FG000|Overall Study|Disease relapse|0|||
44497633|NCT00084656|79503189|FG001|Overall Study|Disease relapse|9|||
44497634|NCT00084656|79503190|FG002|Overall Study|Disease relapse|10|||
44497635|NCT00084656|79503188|FG000|Overall Study|Disease progression|9|||
44497636|NCT00084656|79503189|FG001|Overall Study|Disease progression|0|||
44497637|NCT00084656|79503190|FG002|Overall Study|Disease progression|0|||
44497638|NCT00084656|79503188|FG000|Overall Study|Lost to Follow-up|1|||
44497639|NCT00084656|79503189|FG001|Overall Study|Lost to Follow-up|0|||
44497640|NCT00084656|79503190|FG002|Overall Study|Lost to Follow-up|1|||
44497641|NCT00387725|79503204|FG000|Overall Study|Adverse Event|0|||
44497642|NCT00387725|79503205|FG001|Overall Study|Adverse Event|0|||
44497643|NCT00387725|79503206|FG002|Overall Study|Adverse Event|0|||
44497644|NCT00387725|79503207|FG003|Overall Study|Adverse Event|1|||
44497645|NCT00387725|79503204|FG000|Overall Study|Protocol Violation|0|||
44497646|NCT00387725|79503205|FG001|Overall Study|Protocol Violation|1|||
44497647|NCT00387725|79503206|FG002|Overall Study|Protocol Violation|0|||
44497648|NCT00387725|79503207|FG003|Overall Study|Protocol Violation|0|||
44497649|NCT00387725|79503204|FG000|Overall Study|Withdrawal by Subject|1|||
44497650|NCT00387725|79503205|FG001|Overall Study|Withdrawal by Subject|0|||
44497651|NCT00387725|79503206|FG002|Overall Study|Withdrawal by Subject|1|||
44497652|NCT00387725|79503207|FG003|Overall Study|Withdrawal by Subject|0|||
44497653|NCT00387725|79503204|FG000|Overall Study|Parent/legal guardian request|0|||
44497654|NCT00387725|79503205|FG001|Overall Study|Parent/legal guardian request|0|||
44497655|NCT00387725|79503206|FG002|Overall Study|Parent/legal guardian request|1|||
44497656|NCT00387725|79503207|FG003|Overall Study|Parent/legal guardian request|1|||
44497657|NCT00102596|79503217|FG000|Part A|Screen failures|6|||
44497658|NCT00102596|79503218|FG001|Part A|Screen failures|0|||
44497659|NCT00102596|79503217|FG000|Part A|Adverse Event|1|||
44497660|NCT00102596|79503218|FG001|Part A|Adverse Event|0|||
44497661|NCT00387647|79503225|FG000|Overall Study|Death|18|||
44497662|NCT00386009|79503231|FG000|Overall Study|Adverse Event|0|||
44497663|NCT00386009|79503232|FG001|Overall Study|Adverse Event|2|||
44497664|NCT00386009|79503231|FG000|Overall Study|Death|1|||
44497665|NCT00386009|79503232|FG001|Overall Study|Death|0|||
44497666|NCT00386009|79503231|FG000|Overall Study|Entry Criteria Not Met|0|||
44497667|NCT00386009|79503232|FG001|Overall Study|Entry Criteria Not Met|2|||
44497668|NCT00386009|79503231|FG000|Overall Study|Lost to Follow-up|1|||
44497669|NCT00386009|79503232|FG001|Overall Study|Lost to Follow-up|1|||
44497670|NCT00386009|79503231|FG000|Overall Study|Protocol Violation|1|||
44497671|NCT00386009|79503232|FG001|Overall Study|Protocol Violation|0|||
44497672|NCT00386009|79503231|FG000|Overall Study|Sponsor Decision|1|||
44556955|NCT03440411|79574033|FG003|Overall Study|PD|1|||
44232385|NCT01826981|79048667|FG000|Overall Study|Lack of Efficacy|0|||
44232386|NCT01826981|79048668|FG001|Overall Study|Lack of Efficacy|1|||
44497673|NCT00386009|79503232|FG001|Overall Study|Sponsor Decision|1|||
44497674|NCT00386009|79503231|FG000|Overall Study|Withdrawal by Subject|5|||
44497675|NCT00386009|79503232|FG001|Overall Study|Withdrawal by Subject|4|||
44497676|NCT00373685|79503240|FG000|Overall Study|Death|2|||
44556956|NCT03440411|79574030|FG000|Overall Study|Withdrawal by Subject|1|||
44556957|NCT03440411|79574031|FG001|Overall Study|Withdrawal by Subject|0|||
44556958|NCT03440411|79574032|FG002|Overall Study|Withdrawal by Subject|0|||
44556959|NCT03440411|79574033|FG003|Overall Study|Withdrawal by Subject|0|||
44556960|NCT03440411|79574030|FG000|Overall Study|Closed study by sponsor|0|||
44556961|NCT03440411|79574031|FG001|Overall Study|Closed study by sponsor|0|||
44556962|NCT03440411|79574032|FG002|Overall Study|Closed study by sponsor|0|||
44556963|NCT03440411|79574033|FG003|Overall Study|Closed study by sponsor|1|||
44556964|NCT03438539|79574054|FG000|Overall Study|Lost to Follow-up|8|||
44556965|NCT03438539|79574055|FG001|Overall Study|Lost to Follow-up|4|||
44497677|NCT00373685|79503241|FG001|Overall Study|Death|1|||
44497678|NCT00373685|79503240|FG000|Overall Study|Adverse Event|278|||
44497679|NCT00373685|79503241|FG001|Overall Study|Adverse Event|253|||
44497680|NCT00373685|79503240|FG000|Overall Study|Insufficient clinical response|169|||
44497681|NCT00373685|79503241|FG001|Overall Study|Insufficient clinical response|119|||
44497682|NCT00373685|79503240|FG000|Overall Study|Did not meet entrance criteria|167|||
44497683|NCT00373685|79503241|FG001|Overall Study|Did not meet entrance criteria|184|||
44497684|NCT00373685|79503240|FG000|Overall Study|Lost to follow up|83|||
44497685|NCT00373685|79503241|FG001|Overall Study|Lost to follow up|103|||
44497686|NCT00373685|79503240|FG000|Overall Study|No longer willing to participate|337|||
44497687|NCT00373685|79503241|FG001|Overall Study|No longer willing to participate|352|||
44497688|NCT00373685|79503240|FG000|Overall Study|Other|149|||
44497689|NCT00373685|79503241|FG001|Overall Study|Other|146|||
44497690|NCT00373685|79503240|FG000|Overall Study|Protocol Violation|191|||
44497691|NCT00373685|79503241|FG001|Overall Study|Protocol Violation|182|||
44497692|NCT00373685|79503240|FG000|Overall Study|Final Status Unknown|12|||
44497693|NCT00373685|79503241|FG001|Overall Study|Final Status Unknown|4|||
44497694|NCT00373685|79503240|FG000|Overall Study|Randomized, not treated|51|||
44497695|NCT00373685|79503241|FG001|Overall Study|Randomized, not treated|77|||
44497696|NCT00373529|79503247|FG000|Overall Study|Physician Decision|19|||
44497697|NCT00373529|79503247|FG000|Overall Study|Withdrawal by Subject|7|||
44497698|NCT00373529|79503247|FG000|Overall Study|Adverse Event|7|||
44497699|NCT00373529|79503247|FG000|Overall Study|Treatment failure|36|||
44497700|NCT00373529|79503247|FG000|Overall Study|Disease recurrence|10|||
44497701|NCT00373529|79503247|FG000|Overall Study|Death|16|||
44497702|NCT00373529|79503247|FG000|Overall Study|Need for treatment prohibited by study|1|||
44497703|NCT00373529|79503247|FG000|Overall Study|Other|8|||
44497704|NCT00373529|79503247|FG000|Overall Study|Failed independent confirmation of AML|3|||
44497705|NCT00373529|79503247|FG000|Overall Study|Consent violation|1|||
44497706|NCT00373295|79503251|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
44497707|NCT00373295|79503252|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
44497708|NCT00373295|79503253|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
44497709|NCT00373295|79503254|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
44497710|NCT00373295|79503255|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
44497711|NCT00373295|79503256|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
44497712|NCT00385541|79503266|FG000|Overall Study|severe pain, clinician requested unblind|0|||
44497713|NCT00385541|79503267|FG001|Overall Study|severe pain, clinician requested unblind|1|||
44497714|NCT00392015|79503279|FG000|Overall Study|Lost to Follow-up|2|||
44497715|NCT00392015|79503280|FG001|Overall Study|Lost to Follow-up|0|||
44497716|NCT00392015|79503281|FG002|Overall Study|Lost to Follow-up|2|||
44497717|NCT00392015|79503282|FG003|Overall Study|Lost to Follow-up|1|||
44497718|NCT00392015|79503283|FG004|Overall Study|Lost to Follow-up|1|||
44497719|NCT00392015|79503284|FG005|Overall Study|Lost to Follow-up|0|||
44497720|NCT00392015|79503279|FG000|Overall Study|Withdrawal by Subject|0|||
44497721|NCT00392015|79503280|FG001|Overall Study|Withdrawal by Subject|0|||
44497722|NCT00392015|79503281|FG002|Overall Study|Withdrawal by Subject|2|||
44497723|NCT00392015|79503282|FG003|Overall Study|Withdrawal by Subject|0|||
44497724|NCT00392015|79503283|FG004|Overall Study|Withdrawal by Subject|0|||
44497725|NCT00392015|79503284|FG005|Overall Study|Withdrawal by Subject|0|||
44497726|NCT00392015|79503279|FG000|Overall Study|Adverse Event|0|||
44497727|NCT00392015|79503280|FG001|Overall Study|Adverse Event|0|||
44497728|NCT00392015|79503281|FG002|Overall Study|Adverse Event|0|||
44275224|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
44275225|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
44497729|NCT00392015|79503282|FG003|Overall Study|Adverse Event|0|||
44497730|NCT00392015|79503283|FG004|Overall Study|Adverse Event|1|||
44497731|NCT00392015|79503284|FG005|Overall Study|Adverse Event|0|||
44497732|NCT00392015|79503279|FG000|Overall Study|Previous trial recipient|0|||
44497733|NCT00392015|79503280|FG001|Overall Study|Previous trial recipient|0|||
44556966|NCT03438539|79574056|FG002|Overall Study|Lost to Follow-up|10|||
44556967|NCT03438539|79574057|FG003|Overall Study|Lost to Follow-up|9|||
44556968|NCT03438539|79574058|FG004|Overall Study|Lost to Follow-up|3|||
44556969|NCT03438539|79574059|FG005|Overall Study|Lost to Follow-up|8|||
44556970|NCT03400787|79574075|FG000|Overall Study|Lost to Follow-up|1|||
44556971|NCT03400787|79574076|FG001|Overall Study|Lost to Follow-up|0|||
44556972|NCT03400787|79574075|FG000|Overall Study|Death|1|||
44556973|NCT03400787|79574076|FG001|Overall Study|Death|0|||
44556974|NCT03400787|79574075|FG000|Overall Study|Protocol Violation|0|||
44556975|NCT03400787|79574076|FG001|Overall Study|Protocol Violation|2|||
44556976|NCT03400787|79574075|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
44556977|NCT03400787|79574076|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
44556978|NCT03417245|79574084|FG000|Overall Study|Adverse Event|1|||
44556979|NCT03417245|79574085|FG001|Overall Study|Adverse Event|0|||
44556980|NCT03417245|79574084|FG000|Overall Study|Protocol Violation|1|||
44556981|NCT03417245|79574085|FG001|Overall Study|Protocol Violation|0|||
44556982|NCT03417245|79574084|FG000|Overall Study|Withdrawal by Subject|1|||
44556983|NCT03417245|79574085|FG001|Overall Study|Withdrawal by Subject|1|||
44556984|NCT03389555|79574093|FG000|Overall Study|Protocol Violation|1|||
44556985|NCT03389555|79574094|FG001|Overall Study|Protocol Violation|3|||
44556986|NCT03389555|79574093|FG000|Overall Study|Death|1|||
44556987|NCT03389555|79574094|FG001|Overall Study|Death|0|||
44556988|NCT03395639|79574102|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
44556989|NCT03395639|79574103|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
44556990|NCT03395639|79574104|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
44497734|NCT00392015|79503281|FG002|Overall Study|Previous trial recipient|0|||
44497735|NCT00392015|79503282|FG003|Overall Study|Previous trial recipient|0|||
44556991|NCT03395639|79574102|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
44556992|NCT03395639|79574103|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
44556993|NCT03395639|79574104|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
44556994|NCT03395639|79574102|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
44556995|NCT03395639|79574103|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
44556996|NCT03395639|79574104|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
44556997|NCT03395639|79574102|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
44556998|NCT03395639|79574103|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
44556999|NCT03395639|79574104|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
44557000|NCT03395639|79574102|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
44557001|NCT03395639|79574103|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
44557002|NCT03395639|79574104|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
44557003|NCT03353922|79574111|FG000|Overall Study|Withdrawal by Subject|1|||
44557004|NCT03353922|79574112|FG001|Overall Study|Withdrawal by Subject|0|||
44557005|NCT03353922|79574113|FG002|Overall Study|Withdrawal by Subject|1|||
44557006|NCT03353922|79574114|FG003|Overall Study|Withdrawal by Subject|1|||
44557007|NCT03353922|79574115|FG004|Overall Study|Withdrawal by Subject|0|||
44557008|NCT03353922|79574116|FG005|Overall Study|Withdrawal by Subject|0|||
44557009|NCT03353922|79574111|FG000|Overall Study|Adverse Event|0|||
44557010|NCT03353922|79574112|FG001|Overall Study|Adverse Event|1|||
44557011|NCT03353922|79574113|FG002|Overall Study|Adverse Event|0|||
44497736|NCT00392015|79503283|FG004|Overall Study|Previous trial recipient|1|||
44497737|NCT00392015|79503284|FG005|Overall Study|Previous trial recipient|0|||
44497738|NCT00094302|79503305|FG000|Overall Study|Lost to Follow-up|43|||
44497739|NCT00094302|79503306|FG001|Overall Study|Lost to Follow-up|41|||
44497740|NCT00094302|79503305|FG000|Overall Study|Physician Decision|5|||
44497741|NCT00094302|79503306|FG001|Overall Study|Physician Decision|8|||
44497742|NCT00094302|79503305|FG000|Overall Study|Withdrawal by Subject|103|||
44497743|NCT00094302|79503306|FG001|Overall Study|Withdrawal by Subject|111|||
44557012|NCT03353922|79574114|FG003|Overall Study|Adverse Event|0|||
44557013|NCT03353922|79574115|FG004|Overall Study|Adverse Event|0|||
44557014|NCT03353922|79574116|FG005|Overall Study|Adverse Event|0|||
44557015|NCT03387683|79574129|FG000|Overall Study|In receipt of disallowed medication|1|||
44376798|NCT00857584|79381994|FG000|Overall Study|Physician Decision|1|||
44497744|NCT00094302|79503305|FG000|Overall Study|Death|266|||
44497745|NCT00094302|79503306|FG001|Overall Study|Death|246|||
44557016|NCT03387683|79574130|FG001|Overall Study|In receipt of disallowed medication|0|||
44557017|NCT03387683|79574129|FG000|Overall Study|Did not receive treatment|1|||
44557018|NCT03387683|79574130|FG001|Overall Study|Did not receive treatment|0|||
44557019|NCT03387059|79574138|FG000|Overall Study|Study termination|5|||
44557020|NCT03387059|79574139|FG001|Overall Study|Study termination|4|||
44557021|NCT02942004|79574148|FG000|Overall Study|Withdrawal by Subject|0|||
44557022|NCT02942004|79574149|FG001|Overall Study|Withdrawal by Subject|2|||
44557023|NCT02942004|79574150|FG002|Overall Study|Withdrawal by Subject|3|||
44557024|NCT02942004|79574148|FG000|Overall Study|Lost to Follow-up|1|||
44557025|NCT02942004|79574149|FG001|Overall Study|Lost to Follow-up|1|||
44557026|NCT02942004|79574150|FG002|Overall Study|Lost to Follow-up|2|||
44557027|NCT02942004|79574148|FG000|Overall Study|Randomized but not dosed|3|||
44557028|NCT02942004|79574149|FG001|Overall Study|Randomized but not dosed|9|||
44557029|NCT02942004|79574150|FG002|Overall Study|Randomized but not dosed|4|||
44557030|NCT03394391|79574160|FG000|Overall Study|Lost to Follow-up|1|||
44557031|NCT03394391|79574161|FG001|Overall Study|Lost to Follow-up|2|||
44557032|NCT03386435|79574169|FG000|Overall Study|Protocol Violation|5|||
44557033|NCT03386435|79574170|FG001|Overall Study|Protocol Violation|7|||
44557034|NCT02726880|79574178|FG000|Overall Study|Withdrawal by Subject|2|||
44557035|NCT02726880|79574179|FG001|Overall Study|Withdrawal by Subject|0|||
44557036|NCT02726880|79574178|FG000|Overall Study|Lost to Follow-up|1|||
44557037|NCT02726880|79574179|FG001|Overall Study|Lost to Follow-up|3|||
44557038|NCT03275389|79574196|FG000|Overall Study|Lost to Follow-up|10|||
44557039|NCT03275389|79574197|FG001|Overall Study|Lost to Follow-up|10|||
44557040|NCT03275389|79574198|FG002|Overall Study|Lost to Follow-up|19|||
44557041|NCT03275389|79574199|FG003|Overall Study|Lost to Follow-up|12|||
44557042|NCT03275389|79574200|FG004|Overall Study|Lost to Follow-up|11|||
44557043|NCT03275389|79574201|FG005|Overall Study|Lost to Follow-up|12|||
44557044|NCT03275389|79574202|FG006|Overall Study|Lost to Follow-up|21|||
44557045|NCT03275389|79574203|FG007|Overall Study|Lost to Follow-up|15|||
44557046|NCT03275389|79574204|FG008|Overall Study|Lost to Follow-up|12|||
44557047|NCT03275389|79574205|FG009|Overall Study|Lost to Follow-up|14|||
44557048|NCT03275389|79574196|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557049|NCT03275389|79574197|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557050|NCT03275389|79574198|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557051|NCT03275389|79574199|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557052|NCT03275389|79574200|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557053|NCT03275389|79574201|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
44557054|NCT03275389|79574202|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557055|NCT03275389|79574203|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557056|NCT03275389|79574204|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
44557057|NCT03275389|79574205|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
44557058|NCT03275389|79574196|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
44557059|NCT03275389|79574197|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44557060|NCT03275389|79574198|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44557061|NCT03275389|79574199|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
44557062|NCT03275389|79574200|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
44557063|NCT03275389|79574201|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
44557064|NCT03275389|79574202|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
44557065|NCT03275389|79574203|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
44557066|NCT03275389|79574204|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
44557067|NCT03275389|79574205|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
44557068|NCT03275389|79574196|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44232387|NCT01826981|79048669|FG002|Overall Study|Lack of Efficacy|0|||
44557069|NCT03275389|79574197|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
44557070|NCT03275389|79574198|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44557071|NCT03275389|79574199|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
44557072|NCT03275389|79574200|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44557073|NCT03275389|79574201|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44232388|NCT01826981|79048670|FG003|Overall Study|Lack of Efficacy|0|||
44376799|NCT00857584|79381995|FG001|Overall Study|Physician Decision|1|||
44557074|NCT03275389|79574202|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44557075|NCT03275389|79574203|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44557076|NCT03275389|79574204|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44557077|NCT03275389|79574205|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44557078|NCT03275389|79574196|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44497746|NCT00372905|79503312|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
44497747|NCT00372905|79503313|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
44557079|NCT03275389|79574197|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557080|NCT03275389|79574198|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
44557081|NCT03275389|79574199|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557082|NCT03275389|79574200|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557083|NCT03275389|79574201|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557084|NCT03275389|79574202|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557085|NCT03275389|79574203|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557086|NCT03275389|79574204|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44557087|NCT03275389|79574205|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
44557088|NCT03275389|79574196|FG000|Overall Study|Other|0|||
44557089|NCT03275389|79574197|FG001|Overall Study|Other|4|||
44557090|NCT03275389|79574198|FG002|Overall Study|Other|3|||
44557091|NCT03275389|79574199|FG003|Overall Study|Other|2|||
44557092|NCT03275389|79574200|FG004|Overall Study|Other|2|||
44557093|NCT03275389|79574201|FG005|Overall Study|Other|2|||
44557094|NCT03275389|79574202|FG006|Overall Study|Other|0|||
44557095|NCT03275389|79574203|FG007|Overall Study|Other|0|||
44557096|NCT03275389|79574204|FG008|Overall Study|Other|1|||
44557097|NCT03275389|79574205|FG009|Overall Study|Other|0|||
44557098|NCT03414359|79574229|FG000|Overall Study|Lack of Efficacy|1|||
44557099|NCT03414359|79574230|FG001|Overall Study|Lack of Efficacy|1|||
44557100|NCT03414359|79574229|FG000|Overall Study|Protocol Violation|0|||
44557101|NCT03414359|79574230|FG001|Overall Study|Protocol Violation|1|||
44557102|NCT03285295|79574241|FG000|Alinity s HBsAg|Protocol Violation|11|||
44557103|NCT03285295|79574242|FG001|Alinity s HBsAg|Protocol Violation|0|||
44557104|NCT03285295|79574243|FG002|Alinity s HBsAg|Protocol Violation|0|||
44557105|NCT03285295|79574244|FG003|Alinity s HBsAg|Protocol Violation|0|||
44557106|NCT03285295|79574245|FG004|Alinity s HBsAg|Protocol Violation|0|||
44557107|NCT03285295|79574241|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
44557108|NCT03285295|79574242|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
44232389|NCT01826981|79048671|FG004|Overall Study|Lack of Efficacy|5|||
44232390|NCT01826981|79048672|FG005|Overall Study|Lack of Efficacy|0|||
44557109|NCT03285295|79574243|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
44557110|NCT03285295|79574244|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
44557111|NCT03285295|79574245|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
44557112|NCT03285295|79574241|FG000|Alinity s HBsAg|No Results Generated|74|||
44557113|NCT03285295|79574242|FG001|Alinity s HBsAg|No Results Generated|6|||
44557114|NCT03285295|79574243|FG002|Alinity s HBsAg|No Results Generated|0|||
44557115|NCT03285295|79574244|FG003|Alinity s HBsAg|No Results Generated|0|||
44557116|NCT03285295|79574245|FG004|Alinity s HBsAg|No Results Generated|0|||
44557117|NCT03285295|79574241|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
44232391|NCT01826981|79048673|FG006|Overall Study|Lack of Efficacy|0|||
44232392|NCT01826981|79048674|FG007|Overall Study|Lack of Efficacy|8|||
44232393|NCT01826981|79048675|FG008|Overall Study|Lack of Efficacy|7|||
44232394|NCT01826981|79048676|FG009|Overall Study|Lack of Efficacy|0|||
44232395|NCT01826981|79048677|FG010|Overall Study|Lack of Efficacy|1|||
44232396|NCT01826981|79048678|FG011|Overall Study|Lack of Efficacy|0|||
44497748|NCT00372905|79503314|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
44232397|NCT01826981|79048679|FG012|Overall Study|Lack of Efficacy|0|||
44232398|NCT01826981|79048680|FG013|Overall Study|Lack of Efficacy|3|||
44497749|NCT00372905|79503315|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
44497750|NCT00372905|79503312|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
44497751|NCT00372905|79503313|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
44497752|NCT00372905|79503314|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
44557118|NCT03285295|79574242|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
44557119|NCT03285295|79574243|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
44557120|NCT03285295|79574244|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
44557121|NCT03285295|79574245|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
44557122|NCT03285295|79574241|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
44232399|NCT01826981|79048681|FG014|Overall Study|Lack of Efficacy|0|||
44232400|NCT01826981|79048667|FG000|Overall Study|Lost to Follow-up|0|||
44232401|NCT01826981|79048668|FG001|Overall Study|Lost to Follow-up|0|||
44557123|NCT03285295|79574242|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
44557124|NCT03285295|79574243|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
44557125|NCT03285295|79574244|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
44557126|NCT03285295|79574245|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
44557127|NCT03285295|79574241|FG000|Alinity s HTLV I/II|No Results Generated|70|||
44557128|NCT03285295|79574242|FG001|Alinity s HTLV I/II|No Results Generated|0|||
44557129|NCT03285295|79574243|FG002|Alinity s HTLV I/II|No Results Generated|0|||
44557130|NCT03285295|79574244|FG003|Alinity s HTLV I/II|No Results Generated|0|||
44557131|NCT03285295|79574245|FG004|Alinity s HTLV I/II|No Results Generated|0|||
44557132|NCT03285295|79574241|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
44557133|NCT03285295|79574242|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
44557134|NCT03285295|79574243|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
44557135|NCT03285295|79574244|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
44557136|NCT03285295|79574245|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
44557137|NCT03285295|79574241|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
44232402|NCT01826981|79048669|FG002|Overall Study|Lost to Follow-up|0|||
44232403|NCT01826981|79048670|FG003|Overall Study|Lost to Follow-up|0|||
44232404|NCT01826981|79048671|FG004|Overall Study|Lost to Follow-up|1|||
44232405|NCT01826981|79048672|FG005|Overall Study|Lost to Follow-up|1|||
44232406|NCT01826981|79048673|FG006|Overall Study|Lost to Follow-up|0|||
44557138|NCT03285295|79574242|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
44557139|NCT03285295|79574243|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
44557140|NCT03285295|79574244|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
44557141|NCT03285295|79574245|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
44557142|NCT03285295|79574241|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
44557143|NCT03285295|79574242|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
44557144|NCT03285295|79574243|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
44557145|NCT03285295|79574244|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
44557146|NCT03285295|79574245|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
44557147|NCT03285295|79574241|FG000|Alinity s Anti-HCV|No Results Generated|71|||
44557148|NCT03285295|79574242|FG001|Alinity s Anti-HCV|No Results Generated|0|||
44557149|NCT03285295|79574243|FG002|Alinity s Anti-HCV|No Results Generated|0|||
44557150|NCT03285295|79574244|FG003|Alinity s Anti-HCV|No Results Generated|0|||
44557151|NCT03285295|79574245|FG004|Alinity s Anti-HCV|No Results Generated|0|||
44557152|NCT03285295|79574241|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
44557153|NCT03285295|79574242|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
44557154|NCT03285295|79574243|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
44557155|NCT03285295|79574244|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
44557156|NCT03285295|79574245|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
44557157|NCT03285295|79574241|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
44557158|NCT03285295|79574242|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
44557159|NCT03285295|79574243|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
44557160|NCT03285295|79574244|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
44557161|NCT03285295|79574245|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
44557162|NCT03285295|79574241|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
44557163|NCT03285295|79574242|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
44557164|NCT03285295|79574243|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
44557165|NCT03285295|79574244|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
44557166|NCT03285295|79574245|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
44557167|NCT03285295|79574241|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
44557168|NCT03285295|79574242|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
44557169|NCT03285295|79574243|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
44557170|NCT03285295|79574244|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
44557171|NCT03285295|79574245|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
44557172|NCT03285295|79574241|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
44557173|NCT03285295|79574242|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
44232407|NCT01826981|79048674|FG007|Overall Study|Lost to Follow-up|1|||
44232408|NCT01826981|79048675|FG008|Overall Study|Lost to Follow-up|0|||
44232409|NCT01826981|79048676|FG009|Overall Study|Lost to Follow-up|1|||
44232410|NCT01826981|79048677|FG010|Overall Study|Lost to Follow-up|1|||
44557174|NCT03285295|79574243|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
44557175|NCT03285295|79574244|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
44557176|NCT03285295|79574245|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
44557177|NCT03285295|79574241|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
44557178|NCT03285295|79574242|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
44376800|NCT00798967|79382003|FG000|Overall Study|Adverse Event|2|||
44376801|NCT00798967|79382004|FG001|Overall Study|Adverse Event|3|||
44376802|NCT00798967|79382003|FG000|Overall Study|Withdrawal by Subject|0|||
44376803|NCT00798967|79382004|FG001|Overall Study|Withdrawal by Subject|1|||
44376804|NCT00798967|79382003|FG000|Overall Study|Physician Decision|1|||
44376805|NCT00798967|79382004|FG001|Overall Study|Physician Decision|0|||
44376806|NCT00798967|79382003|FG000|Overall Study|Randomized in error by site|1|||
44376807|NCT00798967|79382004|FG001|Overall Study|Randomized in error by site|0|||
44376808|NCT01074242|79382011|FG000|Overall Study|Case report before date of contract|40|||
44376809|NCT01074242|79382011|FG000|Overall Study|Lost to Follow-up|1|||
44376810|NCT01074242|79382011|FG000|Overall Study|Case report unclear|6|||
44376811|NCT01074242|79382011|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
44376812|NCT01074242|79382011|FG000|Overall Study|Duplicate Case Report Form|5|||
44376813|NCT00798889|79382015|FG000|Overall Study|Adverse Event|53|||
44376814|NCT00798889|79382015|FG000|Overall Study|Protocol Violation|2|||
44376815|NCT00798889|79382015|FG000|Overall Study|Withdrawal by Subject|31|||
44376816|NCT00798889|79382015|FG000|Overall Study|Lost to Follow-up|1|||
44376817|NCT00798889|79382015|FG000|Overall Study|Lack of Efficacy|213|||
44376818|NCT00798889|79382015|FG000|Overall Study|Decision of Sponsor|11|||
44376819|NCT00798889|79382015|FG000|Overall Study|Enrolled, Not treated|3|||
44376820|NCT00796861|79382019|FG000|Overall Study|Withdrawal by Subject|2|||
44376821|NCT00796861|79382019|FG000|Overall Study|Death|2|||
44376822|NCT00802867|79382023|FG000|Overall Study|Lost to Follow-up|6|||
44376823|NCT00802867|79382023|FG000|Overall Study|Protocol Violation|6|||
44376824|NCT00802867|79382023|FG000|Overall Study|Withdrawal by Subject|1|||
44376825|NCT00798655|79382027|FG000|Overall Study|Did not receive at least one dose of pan|2|||
44376826|NCT00796549|79382031|FG000|Overall Study|Adverse Event|11|||
44376827|NCT00796549|79382031|FG000|Overall Study|not entered|149|||
44376828|NCT00796549|79382031|FG000|Overall Study|Other|2|||
44376829|NCT00796549|79382031|FG000|Overall Study|Progressive disease|56|||
44376830|NCT00856492|79382040|FG000|Overall Study|Ineligible or withdrew consent|1|||
44376831|NCT00856492|79382041|FG001|Overall Study|Ineligible or withdrew consent|1|||
44376832|NCT00856492|79382042|FG002|Overall Study|Ineligible or withdrew consent|2|||
44376833|NCT00856180|79382053|FG000|Overall Study|Adverse Event|4|||
44376834|NCT00856180|79382053|FG000|Overall Study|Progressive Disease|16|||
44376835|NCT00900627|79382065|FG000|Overall Study|Condition under investigation worsened|4|||
44376836|NCT00900627|79382066|FG001|Overall Study|Condition under investigation worsened|0|||
44376837|NCT00900627|79382067|FG002|Overall Study|Condition under investigation worsened|5|||
44557179|NCT03285295|79574243|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
44557180|NCT03285295|79574244|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
44557181|NCT03285295|79574245|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
44557182|NCT03285295|79574241|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
44557183|NCT03285295|79574242|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
44557184|NCT03285295|79574243|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
44557185|NCT03285295|79574244|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
44557186|NCT03285295|79574245|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
44557187|NCT03285295|79574241|FG000|Alinity s Anti-HBc|No Results Generated|70|||
44557188|NCT03285295|79574242|FG001|Alinity s Anti-HBc|No Results Generated|0|||
44275226|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
44376838|NCT00900627|79382068|FG003|Overall Study|Condition under investigation worsened|3|||
44376839|NCT00900627|79382069|FG004|Overall Study|Condition under investigation worsened|0|||
44376840|NCT00900627|79382070|FG005|Overall Study|Condition under investigation worsened|0|||
44497753|NCT00372905|79503315|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
44497754|NCT00372905|79503312|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
44497755|NCT00372905|79503313|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
44497756|NCT00372905|79503314|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
44497757|NCT00372905|79503315|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
44497758|NCT00372905|79503312|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
44497759|NCT00372905|79503313|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
44497760|NCT00372905|79503314|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
44497761|NCT00372905|79503315|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
44497762|NCT00372905|79503312|FG000|Follow up Until Relapse or Progression|Study closed|0|||
44497763|NCT00372905|79503313|FG001|Follow up Until Relapse or Progression|Study closed|0|||
44497764|NCT00372905|79503314|FG002|Follow up Until Relapse or Progression|Study closed|0|||
44557189|NCT03285295|79574243|FG002|Alinity s Anti-HBc|No Results Generated|0|||
44557190|NCT03285295|79574244|FG003|Alinity s Anti-HBc|No Results Generated|0|||
44376841|NCT00900627|79382065|FG000|Overall Study|Withdrawal by Subject|1|||
44557191|NCT03285295|79574245|FG004|Alinity s Anti-HBc|No Results Generated|0|||
44497765|NCT00372905|79503315|FG003|Follow up Until Relapse or Progression|Study closed|3|||
44497766|NCT00372905|79503312|FG000|Follow up Until Relapse or Progression|Other|0|||
44497767|NCT00372905|79503313|FG001|Follow up Until Relapse or Progression|Other|1|||
44497768|NCT00372905|79503314|FG002|Follow up Until Relapse or Progression|Other|0|||
44497769|NCT00372905|79503315|FG003|Follow up Until Relapse or Progression|Other|0|||
44497770|NCT00384839|79503325|FG000|Overall Study|Adverse Event|4|||
44497771|NCT00384839|79503325|FG000|Overall Study|Investigator Request|1|||
44497772|NCT00384839|79503325|FG000|Overall Study|Patient Request|1|||
44497773|NCT00384839|79503325|FG000|Overall Study|Ineligible|2|||
44497774|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
44497775|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
44497776|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
44497777|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
44497778|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
44497779|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
44497780|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
44497781|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
44497782|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
44497783|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
44497784|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
44497785|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
44497786|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
44497787|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
44497788|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
44497789|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
44497790|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
44497791|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
44497792|NCT00384293|79503331|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
44497793|NCT00384293|79503332|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
44497794|NCT00384293|79503333|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
44497795|NCT00384293|79503331|FG000|Post-randomization Period|Adverse Event|0|||
44497796|NCT00384293|79503332|FG001|Post-randomization Period|Adverse Event|23|||
44497797|NCT00384293|79503333|FG002|Post-randomization Period|Adverse Event|7|||
44497798|NCT00384293|79503331|FG000|Post-randomization Period|Lost to Follow-up|0|||
44497799|NCT00384293|79503332|FG001|Post-randomization Period|Lost to Follow-up|2|||
44497800|NCT00384293|79503333|FG002|Post-randomization Period|Lost to Follow-up|1|||
44497801|NCT00384293|79503331|FG000|Post-randomization Period|Protocol Violation|0|||
44497802|NCT00384293|79503332|FG001|Post-randomization Period|Protocol Violation|1|||
44557192|NCT03285295|79574241|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
44557193|NCT03285295|79574242|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
44557194|NCT03285295|79574243|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
44557195|NCT03285295|79574244|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
44557196|NCT03285295|79574245|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
44557197|NCT03285295|79574241|FG000|Alinity s Chagas|Protocol Violation|76|||
44557198|NCT03285295|79574242|FG001|Alinity s Chagas|Protocol Violation|0|||
44557199|NCT03285295|79574243|FG002|Alinity s Chagas|Protocol Violation|0|||
44557200|NCT03285295|79574244|FG003|Alinity s Chagas|Protocol Violation|0|||
44557201|NCT03285295|79574245|FG004|Alinity s Chagas|Protocol Violation|0|||
44376842|NCT00900627|79382066|FG001|Overall Study|Withdrawal by Subject|0|||
44376843|NCT00900627|79382067|FG002|Overall Study|Withdrawal by Subject|1|||
44376844|NCT00900627|79382068|FG003|Overall Study|Withdrawal by Subject|0|||
44376845|NCT00900627|79382069|FG004|Overall Study|Withdrawal by Subject|1|||
44376846|NCT00900627|79382070|FG005|Overall Study|Withdrawal by Subject|2|||
44376847|NCT00900627|79382065|FG000|Overall Study|Adverse Event|1|||
44376848|NCT00900627|79382066|FG001|Overall Study|Adverse Event|2|||
44376849|NCT00900627|79382067|FG002|Overall Study|Adverse Event|0|||
44376850|NCT00900627|79382068|FG003|Overall Study|Adverse Event|3|||
44376851|NCT00900627|79382069|FG004|Overall Study|Adverse Event|0|||
44376852|NCT00900627|79382070|FG005|Overall Study|Adverse Event|0|||
44376853|NCT00900627|79382065|FG000|Overall Study|Death|0|||
44376854|NCT00900627|79382066|FG001|Overall Study|Death|0|||
44376855|NCT00900627|79382067|FG002|Overall Study|Death|0|||
44376856|NCT00900627|79382068|FG003|Overall Study|Death|0|||
44376857|NCT00900627|79382069|FG004|Overall Study|Death|28|||
44497803|NCT00384293|79503333|FG002|Post-randomization Period|Protocol Violation|0|||
44557202|NCT03285295|79574241|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
44557203|NCT03285295|79574242|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
44557204|NCT03285295|79574243|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
44557205|NCT03285295|79574244|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
44557206|NCT03285295|79574245|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
44557207|NCT03285295|79574241|FG000|Alinity s Chagas|No Results Generated|105|||
44557208|NCT03285295|79574242|FG001|Alinity s Chagas|No Results Generated|0|||
44557209|NCT03285295|79574243|FG002|Alinity s Chagas|No Results Generated|0|||
44557210|NCT03285295|79574244|FG003|Alinity s Chagas|No Results Generated|0|||
44557211|NCT03285295|79574245|FG004|Alinity s Chagas|No Results Generated|0|||
44557212|NCT03285295|79574241|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
44557213|NCT03285295|79574242|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
44557214|NCT03285295|79574243|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
44557215|NCT03285295|79574244|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
44557216|NCT03285295|79574245|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
44497804|NCT00384293|79503331|FG000|Post-randomization Period|Withdrawal by Subject|0|||
44497805|NCT00384293|79503332|FG001|Post-randomization Period|Withdrawal by Subject|8|||
44497806|NCT00384293|79503333|FG002|Post-randomization Period|Withdrawal by Subject|6|||
44497807|NCT00384293|79503331|FG000|Post-randomization Period|Trial Termination|0|||
44497808|NCT00384293|79503332|FG001|Post-randomization Period|Trial Termination|180|||
44497809|NCT00384293|79503333|FG002|Post-randomization Period|Trial Termination|204|||
44497810|NCT00384293|79503331|FG000|Post-randomization Period|Patient Randomized in Error|0|||
44497811|NCT00384293|79503332|FG001|Post-randomization Period|Patient Randomized in Error|0|||
44497812|NCT00384293|79503333|FG002|Post-randomization Period|Patient Randomized in Error|1|||
44497813|NCT00067002|79503343|FG000|Overall Study|Early Death|1|||
44497814|NCT00067002|79503344|FG001|Overall Study|Early Death|2|||
44557217|NCT02583048|79574277|FG000|Overall Study|Withdrawal by Subject|0|||
44557218|NCT02583048|79574278|FG001|Overall Study|Withdrawal by Subject|1|||
44376858|NCT00900627|79382070|FG005|Overall Study|Death|24|||
44497815|NCT00067002|79503343|FG000|Overall Study|Delayed|1|||
44497816|NCT00067002|79503344|FG001|Overall Study|Delayed|1|||
44497817|NCT00067002|79503343|FG000|Overall Study|Graft Failure|5|||
44497818|NCT00067002|79503344|FG001|Overall Study|Graft Failure|6|||
44557219|NCT02583048|79574279|FG002|Overall Study|Withdrawal by Subject|0|||
44376859|NCT00866320|79382084|FG000|Overall Study|Withdrawal by Subject|4|||
44376860|NCT00866320|79382084|FG000|Overall Study|Death|2|||
44557220|NCT02583048|79574277|FG000|Overall Study|Failed to meet eligibility criterion|0|||
44557221|NCT02583048|79574278|FG001|Overall Study|Failed to meet eligibility criterion|0|||
44557222|NCT02583048|79574279|FG002|Overall Study|Failed to meet eligibility criterion|1|||
44557223|NCT02939599|79574292|FG000|Overall Study|Adverse Event|1|||
44557224|NCT02939599|79574293|FG001|Overall Study|Adverse Event|0|||
44557225|NCT02939599|79574292|FG000|Overall Study|Study Terminated By Sponsor|2|||
44557226|NCT02939599|79574293|FG001|Overall Study|Study Terminated By Sponsor|2|||
44557227|NCT01318512|79574300|FG000|Maintenance Period (6 Months)|Death|2|||
44557228|NCT01318512|79574300|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
44557229|NCT03274687|79574321|FG000|Overall Study|Protocol Violation|1|||
44557230|NCT03274687|79574322|FG001|Overall Study|Protocol Violation|1|||
44557231|NCT04651218|79574328|FG000|Overall Study|Withdrawal by Subject|0|||
44557232|NCT04651218|79574329|FG001|Overall Study|Withdrawal by Subject|2|||
44557233|NCT03274453|79574339|FG000|Overall Study|Lost to Follow-up|2|||
44557234|NCT03274453|79574340|FG001|Overall Study|Lost to Follow-up|5|||
44557235|NCT03274453|79574341|FG002|Overall Study|Lost to Follow-up|4|||
44557236|NCT03274453|79574342|FG003|Overall Study|Lost to Follow-up|1|||
44557237|NCT03274453|79574339|FG000|Overall Study|Physician Decision|2|||
44557238|NCT03274453|79574340|FG001|Overall Study|Physician Decision|0|||
44557239|NCT03274453|79574341|FG002|Overall Study|Physician Decision|0|||
44557240|NCT03274453|79574342|FG003|Overall Study|Physician Decision|3|||
44557241|NCT03274453|79574339|FG000|Overall Study|Surgery Cancelled|0|||
44557242|NCT03274453|79574340|FG001|Overall Study|Surgery Cancelled|1|||
44557243|NCT03274453|79574341|FG002|Overall Study|Surgery Cancelled|0|||
44557244|NCT03274453|79574342|FG003|Overall Study|Surgery Cancelled|0|||
44557245|NCT00659646|79574368|FG000|Overall Study|Protocol Violation|12|||
44557246|NCT00659646|79574369|FG001|Overall Study|Protocol Violation|8|||
44557247|NCT00659646|79574368|FG000|Overall Study|Adverse Event|1|||
44557248|NCT00659646|79574369|FG001|Overall Study|Adverse Event|0|||
44557249|NCT00659646|79574368|FG000|Overall Study|Lost to Follow-up|1|||
44557250|NCT00659646|79574369|FG001|Overall Study|Lost to Follow-up|0|||
44557251|NCT00659646|79574368|FG000|Overall Study|protocol noncompliance after randomized|1|||
44557252|NCT00659646|79574369|FG001|Overall Study|protocol noncompliance after randomized|0|||
44557253|NCT02236572|79574377|FG000|Overall Study|Withdrawal by Subject|1|||
44557254|NCT02236572|79574377|FG000|Overall Study|Protocol Violation|1|||
44557255|NCT02236572|79574377|FG000|Overall Study|Lost to Follow-up|1|||
44557256|NCT03054870|79574381|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
44557257|NCT03054870|79574381|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
44557258|NCT03414047|79574400|FG000|Overall Study|Adverse Event|0|||
44557259|NCT03414047|79574401|FG001|Overall Study|Adverse Event|0|||
44557260|NCT03414047|79574402|FG002|Overall Study|Adverse Event|1|||
44557261|NCT03414047|79574403|FG003|Overall Study|Adverse Event|1|||
44557262|NCT03414047|79574400|FG000|Overall Study|Physician Decision|1|||
44557263|NCT03414047|79574401|FG001|Overall Study|Physician Decision|0|||
44557264|NCT03414047|79574402|FG002|Overall Study|Physician Decision|0|||
44557265|NCT03414047|79574403|FG003|Overall Study|Physician Decision|1|||
44557266|NCT03414047|79574400|FG000|Overall Study|Withdrawal by Subject|1|||
44557267|NCT03414047|79574401|FG001|Overall Study|Withdrawal by Subject|0|||
44557268|NCT03414047|79574402|FG002|Overall Study|Withdrawal by Subject|2|||
44557269|NCT03414047|79574403|FG003|Overall Study|Withdrawal by Subject|0|||
44557270|NCT03351335|79574417|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
44557271|NCT03351335|79574418|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
44557272|NCT03351335|79574419|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
44557273|NCT03055806|79574431|FG000|Overall Study|Adverse Event|0|||
44557274|NCT03055806|79574432|FG001|Overall Study|Adverse Event|0|||
44557275|NCT03055806|79574433|FG002|Overall Study|Adverse Event|1|||
44557276|NCT03055806|79574434|FG003|Overall Study|Adverse Event|1|||
44557277|NCT03055806|79574431|FG000|Overall Study|Lost to Follow-up|0|||
44557278|NCT03055806|79574432|FG001|Overall Study|Lost to Follow-up|3|||
44557279|NCT03055806|79574433|FG002|Overall Study|Lost to Follow-up|6|||
44557280|NCT03055806|79574434|FG003|Overall Study|Lost to Follow-up|7|||
44557281|NCT03055806|79574431|FG000|Overall Study|Physician Decision|1|||
44557282|NCT03055806|79574432|FG001|Overall Study|Physician Decision|0|||
44557283|NCT03055806|79574433|FG002|Overall Study|Physician Decision|0|||
44557284|NCT03055806|79574434|FG003|Overall Study|Physician Decision|1|||
44557285|NCT03055806|79574431|FG000|Overall Study|Protocol Violation|1|||
44557286|NCT03055806|79574432|FG001|Overall Study|Protocol Violation|0|||
44557287|NCT03055806|79574433|FG002|Overall Study|Protocol Violation|0|||
44557288|NCT03055806|79574434|FG003|Overall Study|Protocol Violation|0|||
44557289|NCT03055806|79574431|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
44557290|NCT03055806|79574432|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
44557291|NCT03055806|79574433|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
44557292|NCT03055806|79574434|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
44557293|NCT03055806|79574431|FG000|Overall Study|Withdrawal of consent to continue study|2|||
44557294|NCT03055806|79574432|FG001|Overall Study|Withdrawal of consent to continue study|3|||
44557295|NCT03055806|79574433|FG002|Overall Study|Withdrawal of consent to continue study|4|||
44557296|NCT03055806|79574434|FG003|Overall Study|Withdrawal of consent to continue study|6|||
44557297|NCT03055806|79574431|FG000|Overall Study|Partner not willing to try intercourse|1|||
44557298|NCT03055806|79574432|FG001|Overall Study|Partner not willing to try intercourse|0|||
44557299|NCT03055806|79574433|FG002|Overall Study|Partner not willing to try intercourse|0|||
44557300|NCT03055806|79574434|FG003|Overall Study|Partner not willing to try intercourse|0|||
44557301|NCT04620798|79574446|FG000|Overall Study|Lost to Follow-up|126|||
44557302|NCT04620798|79574447|FG001|Overall Study|Lost to Follow-up|138|||
44557303|NCT03052764|79574455|FG000|Double-Blind Treatment Period|Adverse Event|2|||
44376861|NCT00869518|79382092|FG000|Overall Study|Lost to Follow-up|1|||
44557304|NCT03052764|79574456|FG001|Double-Blind Treatment Period|Adverse Event|0|||
44557305|NCT03052764|79574455|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
44557306|NCT03052764|79574456|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
44557307|NCT03052764|79574455|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
44275227|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
44232411|NCT01826981|79048678|FG011|Overall Study|Lost to Follow-up|1|||
44232412|NCT01826981|79048679|FG012|Overall Study|Lost to Follow-up|1|||
44232413|NCT01826981|79048680|FG013|Overall Study|Lost to Follow-up|0|||
44232414|NCT01826981|79048681|FG014|Overall Study|Lost to Follow-up|0|||
44497819|NCT00091572|79503352|FG000|Overall Study|Lost to Follow-up|1|||
44497820|NCT00091572|79503353|FG001|Overall Study|Lost to Follow-up|1|||
44497821|NCT00091572|79503352|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
44497822|NCT00091572|79503353|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
44497823|NCT00091572|79503352|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
44497824|NCT00091572|79503353|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
44497825|NCT00091572|79503352|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
44497826|NCT00091572|79503353|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
44497827|NCT00091572|79503352|FG000|Overall Study|Other Reason|6|||
44497828|NCT00091572|79503353|FG001|Overall Study|Other Reason|13|||
44497829|NCT00091572|79503352|FG000|Overall Study|Ongoing (still on treatment)|8|||
44497830|NCT00091572|79503353|FG001|Overall Study|Ongoing (still on treatment)|12|||
44497831|NCT00091572|79503352|FG000|Overall Study|Major Protocol Violation|2|||
44497832|NCT00091572|79503353|FG001|Overall Study|Major Protocol Violation|0|||
44497833|NCT00091572|79503352|FG000|Overall Study|Toxicity (Related AE)|53|||
44497834|NCT00091572|79503353|FG001|Overall Study|Toxicity (Related AE)|9|||
44497835|NCT00084266|79503361|FG000|Overall Study|Death|42|||
44497836|NCT00084266|79503362|FG001|Overall Study|Death|39|||
44497837|NCT00084266|79503361|FG000|Overall Study|Adverse Event|8|||
44497838|NCT00084266|79503362|FG001|Overall Study|Adverse Event|5|||
44497839|NCT00084266|79503361|FG000|Overall Study|Lack of Efficacy|2|||
44497840|NCT00084266|79503362|FG001|Overall Study|Lack of Efficacy|4|||
44497841|NCT00084266|79503361|FG000|Overall Study|Lost to Follow-up|5|||
44497842|NCT00084266|79503362|FG001|Overall Study|Lost to Follow-up|3|||
44497843|NCT00084266|79503361|FG000|Overall Study|Participant not willing to participate|3|||
44497844|NCT00084266|79503362|FG001|Overall Study|Participant not willing to participate|8|||
44497845|NCT00084266|79503361|FG000|Overall Study|Other|360|||
44497846|NCT00084266|79503362|FG001|Overall Study|Other|344|||
44497847|NCT00084266|79503361|FG000|Overall Study|Randomized not treated|21|||
44497848|NCT00084266|79503362|FG001|Overall Study|Randomized not treated|20|||
44497849|NCT00091026|79503370|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
44497850|NCT00091026|79503371|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
44497851|NCT00091026|79503370|FG000|Overall Study|Patient withdrew and never received trea|0|||
44497852|NCT00091026|79503371|FG001|Overall Study|Patient withdrew and never received trea|2|||
44497853|NCT00091026|79503370|FG000|Overall Study|Unknown-never received treatment|0|||
44497854|NCT00091026|79503371|FG001|Overall Study|Unknown-never received treatment|1|||
44497855|NCT00116558|79503380|FG000|Overall Study|Death|11|||
44497856|NCT00116558|79503381|FG001|Overall Study|Death|5|||
44497857|NCT00116558|79503382|FG002|Overall Study|Death|3|||
44497858|NCT00116558|79503380|FG000|Overall Study|Withdrawal by Subject|17|||
44497859|NCT00116558|79503381|FG001|Overall Study|Withdrawal by Subject|3|||
44497860|NCT00116558|79503382|FG002|Overall Study|Withdrawal by Subject|12|||
44497861|NCT00116558|79503380|FG000|Overall Study|disease progression|3|||
44497862|NCT00116558|79503381|FG001|Overall Study|disease progression|7|||
44497863|NCT00116558|79503382|FG002|Overall Study|disease progression|18|||
44497864|NCT00116168|79503393|FG000|Overall Study|Lost to Follow-up|6|||
44232415|NCT01826981|79048667|FG000|Overall Study|Withdrew Consent|0|||
44497865|NCT00116168|79503394|FG001|Overall Study|Lost to Follow-up|5|||
44497866|NCT00116168|79503395|FG002|Overall Study|Lost to Follow-up|0|||
44497867|NCT00116168|79503396|FG003|Overall Study|Lost to Follow-up|0|||
44497868|NCT00115934|79503408|FG000|Overall Study|Lost to Follow-up|1|||
44232416|NCT01826981|79048668|FG001|Overall Study|Withdrew Consent|0|||
44557308|NCT03052764|79574456|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
44557309|NCT03052764|79574455|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
44557310|NCT03052764|79574456|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44557311|NCT03052764|79574455|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
44557312|NCT03052764|79574456|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
44557313|NCT02951819|79574466|FG000|Overall Study|Death|9|||
44232417|NCT01826981|79048669|FG002|Overall Study|Withdrew Consent|0|||
44232418|NCT01826981|79048670|FG003|Overall Study|Withdrew Consent|0|||
44232419|NCT01826981|79048671|FG004|Overall Study|Withdrew Consent|0|||
44232420|NCT01826981|79048672|FG005|Overall Study|Withdrew Consent|0|||
44232421|NCT01826981|79048673|FG006|Overall Study|Withdrew Consent|1|||
44232422|NCT01826981|79048674|FG007|Overall Study|Withdrew Consent|1|||
44232423|NCT01826981|79048675|FG008|Overall Study|Withdrew Consent|0|||
44232424|NCT01826981|79048676|FG009|Overall Study|Withdrew Consent|0|||
44232425|NCT01826981|79048677|FG010|Overall Study|Withdrew Consent|0|||
44232426|NCT01826981|79048678|FG011|Overall Study|Withdrew Consent|1|||
44232427|NCT01826981|79048679|FG012|Overall Study|Withdrew Consent|0|||
44232428|NCT01826981|79048680|FG013|Overall Study|Withdrew Consent|1|||
44232429|NCT01826981|79048681|FG014|Overall Study|Withdrew Consent|0|||
44232430|NCT01826981|79048667|FG000|Overall Study|Adverse Event|0|||
44232431|NCT01826981|79048668|FG001|Overall Study|Adverse Event|0|||
44232432|NCT01826981|79048669|FG002|Overall Study|Adverse Event|0|||
44232433|NCT01826981|79048670|FG003|Overall Study|Adverse Event|0|||
44232434|NCT01826981|79048671|FG004|Overall Study|Adverse Event|1|||
44232435|NCT01826981|79048672|FG005|Overall Study|Adverse Event|0|||
44275228|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
44497869|NCT00115934|79503409|FG001|Overall Study|Lost to Follow-up|0|||
44497870|NCT00115934|79503408|FG000|Overall Study|Did not receive intervention|3|||
44497871|NCT00115934|79503409|FG001|Overall Study|Did not receive intervention|2|||
44497872|NCT00115778|79503415|FG000|Overall Study|Withdrawal by Subject|0|||
44497873|NCT00115778|79503416|FG001|Overall Study|Withdrawal by Subject|1|||
44497874|NCT00100178|79503425|FG000|Overall Study|Lost to Follow-up|0|||
44497875|NCT00100178|79503426|FG001|Overall Study|Lost to Follow-up|6|||
44497876|NCT00100178|79503427|FG002|Overall Study|Lost to Follow-up|5|||
44497877|NCT00100178|79503425|FG000|Overall Study|Adverse Event|2|||
44497878|NCT00100178|79503426|FG001|Overall Study|Adverse Event|2|||
44497879|NCT00100178|79503427|FG002|Overall Study|Adverse Event|1|||
44497880|NCT00100178|79503425|FG000|Overall Study|Withdrawal by Subject|1|||
44497881|NCT00100178|79503426|FG001|Overall Study|Withdrawal by Subject|1|||
44497882|NCT00100178|79503427|FG002|Overall Study|Withdrawal by Subject|1|||
44497883|NCT00100178|79503425|FG000|Overall Study|Physician Decision|6|||
44497884|NCT00100178|79503426|FG001|Overall Study|Physician Decision|1|||
44497885|NCT00100178|79503427|FG002|Overall Study|Physician Decision|3|||
44497886|NCT00099632|79503441|FG000|Overall Study|Lost to Follow-up|1|||
44497887|NCT00099632|79503442|FG001|Overall Study|Lost to Follow-up|0|||
44497888|NCT00099632|79503443|FG002|Overall Study|Lost to Follow-up|3|||
44497889|NCT00099632|79503444|FG003|Overall Study|Lost to Follow-up|1|||
44497890|NCT00099632|79503445|FG004|Overall Study|Lost to Follow-up|1|||
44497891|NCT00099632|79503446|FG005|Overall Study|Lost to Follow-up|0|||
44275229|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
44497892|NCT00099632|79503441|FG000|Overall Study|Withdrawal by Subject|0|||
44497893|NCT00099632|79503442|FG001|Overall Study|Withdrawal by Subject|1|||
44497894|NCT00099632|79503443|FG002|Overall Study|Withdrawal by Subject|0|||
44497895|NCT00099632|79503444|FG003|Overall Study|Withdrawal by Subject|0|||
44497896|NCT00099632|79503445|FG004|Overall Study|Withdrawal by Subject|0|||
44232436|NCT01826981|79048673|FG006|Overall Study|Adverse Event|0|||
44232437|NCT01826981|79048674|FG007|Overall Study|Adverse Event|0|||
44232438|NCT01826981|79048675|FG008|Overall Study|Adverse Event|0|||
44497897|NCT00099632|79503446|FG005|Overall Study|Withdrawal by Subject|1|||
44232439|NCT01826981|79048676|FG009|Overall Study|Adverse Event|0|||
44232440|NCT01826981|79048677|FG010|Overall Study|Adverse Event|0|||
44232441|NCT01826981|79048678|FG011|Overall Study|Adverse Event|0|||
44232442|NCT01826981|79048679|FG012|Overall Study|Adverse Event|0|||
44232443|NCT01826981|79048680|FG013|Overall Study|Adverse Event|0|||
44557314|NCT02951819|79574467|FG001|Overall Study|Death|7|||
44557315|NCT02951819|79574466|FG000|Overall Study|Withdrawal by Subject|3|||
44557316|NCT02951819|79574467|FG001|Overall Study|Withdrawal by Subject|0|||
44557317|NCT02951819|79574466|FG000|Overall Study|Adverse Event|1|||
44557318|NCT02951819|79574467|FG001|Overall Study|Adverse Event|0|||
44557319|NCT02951819|79574466|FG000|Overall Study|Lack of Efficacy|4|||
44557320|NCT02951819|79574467|FG001|Overall Study|Lack of Efficacy|0|||
44557321|NCT02951819|79574466|FG000|Overall Study|Lost to Follow-up|1|||
44557322|NCT02951819|79574467|FG001|Overall Study|Lost to Follow-up|0|||
44557323|NCT02951819|79574466|FG000|Overall Study|Progressive Disease|1|||
44557324|NCT02951819|79574467|FG001|Overall Study|Progressive Disease|0|||
44557325|NCT02951819|79574466|FG000|Overall Study|Other|9|||
44557326|NCT02951819|79574467|FG001|Overall Study|Other|0|||
44557327|NCT03383783|79574473|FG000|Overall Study|Withdrawal by Subject|2|||
44557328|NCT03334721|79574491|FG000|Overall Study|Withdrawal by Subject|1|||
44557329|NCT03334721|79574492|FG001|Overall Study|Withdrawal by Subject|0|||
44557330|NCT03334721|79574491|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
44557331|NCT03334721|79574492|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
44557332|NCT03515551|79574505|FG000|Overall Study|Death|4|||
44557333|NCT03515551|79574506|FG001|Overall Study|Death|1|||
44557334|NCT03515551|79574507|FG002|Overall Study|Death|2|||
44557335|NCT03515551|79574508|FG003|Overall Study|Death|2|||
44557336|NCT03515551|79574509|FG004|Overall Study|Death|2|||
44557337|NCT03515551|79574510|FG005|Overall Study|Death|4|||
44557338|NCT03515551|79574511|FG006|Overall Study|Death|1|||
44557339|NCT03515551|79574505|FG000|Overall Study|Lost to Follow-up|0|||
44557340|NCT03515551|79574506|FG001|Overall Study|Lost to Follow-up|0|||
44557341|NCT03515551|79574507|FG002|Overall Study|Lost to Follow-up|1|||
44557342|NCT03515551|79574508|FG003|Overall Study|Lost to Follow-up|0|||
44557343|NCT03515551|79574509|FG004|Overall Study|Lost to Follow-up|0|||
44557344|NCT03515551|79574510|FG005|Overall Study|Lost to Follow-up|0|||
44557345|NCT03515551|79574511|FG006|Overall Study|Lost to Follow-up|0|||
44557346|NCT03515551|79574505|FG000|Overall Study|Withdrawal by Subject|0|||
44557347|NCT03515551|79574506|FG001|Overall Study|Withdrawal by Subject|1|||
44557348|NCT03515551|79574507|FG002|Overall Study|Withdrawal by Subject|0|||
44557349|NCT03515551|79574508|FG003|Overall Study|Withdrawal by Subject|0|||
44557350|NCT03515551|79574509|FG004|Overall Study|Withdrawal by Subject|0|||
44557351|NCT03515551|79574510|FG005|Overall Study|Withdrawal by Subject|0|||
44557352|NCT03515551|79574511|FG006|Overall Study|Withdrawal by Subject|1|||
44497898|NCT00099632|79503441|FG000|Overall Study|Protocol Violation|0|||
44497899|NCT00099632|79503442|FG001|Overall Study|Protocol Violation|0|||
44557353|NCT03515551|79574505|FG000|Overall Study|Study ended by sponsor|0|||
44557354|NCT03515551|79574506|FG001|Overall Study|Study ended by sponsor|0|||
44557355|NCT03515551|79574507|FG002|Overall Study|Study ended by sponsor|2|||
44557356|NCT03515551|79574508|FG003|Overall Study|Study ended by sponsor|1|||
44557357|NCT03515551|79574509|FG004|Overall Study|Study ended by sponsor|3|||
44497900|NCT00099632|79503443|FG002|Overall Study|Protocol Violation|0|||
44497901|NCT00099632|79503444|FG003|Overall Study|Protocol Violation|0|||
44497902|NCT00099632|79503445|FG004|Overall Study|Protocol Violation|0|||
44497903|NCT00099632|79503446|FG005|Overall Study|Protocol Violation|1|||
44497904|NCT00098774|79503460|FG000|Overall Study|Adverse Event|2|||
44497905|NCT00098774|79503460|FG000|Overall Study|Disease Progression|9|||
44497906|NCT00098774|79503460|FG000|Overall Study|Withdrawal by Subject|1|||
44497907|NCT00098774|79503460|FG000|Overall Study|Failed (to respond) during induction|4|||
44497908|NCT00098774|79503460|FG000|Overall Study|Physician Decision|2|||
44497909|NCT00384059|79503466|FG000|Infant Series|Not consented|2|||
44557358|NCT03515551|79574510|FG005|Overall Study|Study ended by sponsor|0|||
44557359|NCT03515551|79574511|FG006|Overall Study|Study ended by sponsor|3|||
44557360|NCT03515551|79574505|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
44497910|NCT00384059|79503467|FG001|Infant Series|Not consented|6|||
44497911|NCT00384059|79503466|FG000|Infant Series|Withdrawal by Subject|2|||
44497912|NCT00384059|79503467|FG001|Infant Series|Withdrawal by Subject|2|||
44497913|NCT00384059|79503466|FG000|Infant Series|Adverse Event|1|||
44497914|NCT00384059|79503467|FG001|Infant Series|Adverse Event|2|||
44497915|NCT00384059|79503466|FG000|Infant Series|Protocol Violation|1|||
44497916|NCT00384059|79503467|FG001|Infant Series|Protocol Violation|2|||
44497917|NCT00384059|79503466|FG000|Infant Series|Lost to Follow-up|0|||
44557361|NCT03515551|79574506|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
44557362|NCT03515551|79574507|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
44557363|NCT03515551|79574508|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
44557364|NCT03515551|79574509|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
44557365|NCT03515551|79574510|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
44557366|NCT03515551|79574511|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
44557367|NCT03380429|79574537|FG000|Overall Study|Physician Decision|0|||
44557368|NCT03380429|79574538|FG001|Overall Study|Physician Decision|1|||
44557369|NCT03380429|79574539|FG002|Overall Study|Physician Decision|0|||
44557370|NCT03380429|79574540|FG003|Overall Study|Physician Decision|1|||
44232444|NCT01826981|79048681|FG014|Overall Study|Adverse Event|0|||
44232445|NCT01826981|79048667|FG000|Overall Study|Upper G-I Haemorrhage|0|||
44232446|NCT01826981|79048668|FG001|Overall Study|Upper G-I Haemorrhage|0|||
44232447|NCT01826981|79048669|FG002|Overall Study|Upper G-I Haemorrhage|0|||
44232448|NCT01826981|79048670|FG003|Overall Study|Upper G-I Haemorrhage|0|||
44232449|NCT01826981|79048671|FG004|Overall Study|Upper G-I Haemorrhage|0|||
44232450|NCT01826981|79048672|FG005|Overall Study|Upper G-I Haemorrhage|0|||
44232451|NCT01826981|79048673|FG006|Overall Study|Upper G-I Haemorrhage|0|||
44497918|NCT00384059|79503467|FG001|Infant Series|Lost to Follow-up|1|||
44497919|NCT00384059|79503466|FG000|After Infant Series|Protocol Violation|2|||
44497920|NCT00384059|79503467|FG001|After Infant Series|Protocol Violation|3|||
44497921|NCT00384059|79503466|FG000|After Infant Series|Withdrawal by Subject|2|||
44497922|NCT00384059|79503467|FG001|After Infant Series|Withdrawal by Subject|2|||
44497923|NCT00384059|79503466|FG000|After Infant Series|Failed to Return|0|||
44497924|NCT00384059|79503467|FG001|After Infant Series|Failed to Return|2|||
44497925|NCT00384059|79503466|FG000|After Infant Series|Adverse Event|0|||
44497926|NCT00384059|79503467|FG001|After Infant Series|Adverse Event|1|||
44497927|NCT00384059|79503466|FG000|After Infant Series|Physician Decision|0|||
44497928|NCT00384059|79503467|FG001|After Infant Series|Physician Decision|1|||
44497929|NCT00384059|79503466|FG000|After Infant Series|Lost to Follow-up|0|||
44497930|NCT00384059|79503467|FG001|After Infant Series|Lost to Follow-up|1|||
44497931|NCT00384059|79503466|FG000|Toddler Dose|Lost to Follow-up|1|||
44497932|NCT00384059|79503467|FG001|Toddler Dose|Lost to Follow-up|1|||
44497933|NCT00384059|79503466|FG000|Toddler Dose|Failed to return|0|||
44497934|NCT00384059|79503467|FG001|Toddler Dose|Failed to return|1|||
44497935|NCT00383123|79503496|FG000|Overall Study|Adverse Event|1|||
44497936|NCT00383123|79503497|FG001|Overall Study|Adverse Event|0|||
44497937|NCT00383123|79503496|FG000|Overall Study|Lost to Follow-up|68|||
44497938|NCT00383123|79503497|FG001|Overall Study|Lost to Follow-up|61|||
44497939|NCT00383123|79503496|FG000|Overall Study|Protocol Violation|5|||
44497940|NCT00383123|79503497|FG001|Overall Study|Protocol Violation|1|||
44497941|NCT00383123|79503496|FG000|Overall Study|Withdrawal by Subject|27|||
44497942|NCT00383123|79503497|FG001|Overall Study|Withdrawal by Subject|18|||
44497943|NCT00383123|79503496|FG000|Overall Study|Other reason|10|||
44497944|NCT00383123|79503497|FG001|Overall Study|Other reason|6|||
44497945|NCT00382967|79503505|FG000|Overall Study|Protocol Violation|1|||
44497946|NCT00382967|79503506|FG001|Overall Study|Protocol Violation|1|||
44497947|NCT00858364|79503514|FG000|Overall Study|Administrative Decision|3|||
44497948|NCT00858364|79503515|FG001|Overall Study|Administrative Decision|2|||
44497949|NCT00858364|79503514|FG000|Overall Study|Adverse Event|5|||
44497950|NCT00858364|79503515|FG001|Overall Study|Adverse Event|2|||
44497951|NCT00858364|79503514|FG000|Overall Study|Withdrawal by Subject|44|||
44497952|NCT00858364|79503515|FG001|Overall Study|Withdrawal by Subject|118|||
44497953|NCT00858364|79503514|FG000|Overall Study|Ineligibility Determined|1|||
44497954|NCT00858364|79503515|FG001|Overall Study|Ineligibility Determined|10|||
44497955|NCT00858364|79503514|FG000|Overall Study|Lost to Follow-up|24|||
44497956|NCT00858364|79503515|FG001|Overall Study|Lost to Follow-up|54|||
44497957|NCT00858364|79503514|FG000|Overall Study|Noncompliance|3|||
44497958|NCT00858364|79503515|FG001|Overall Study|Noncompliance|4|||
44497959|NCT00858364|79503514|FG000|Overall Study|Protocol Deviation|0|||
44497960|NCT00858364|79503515|FG001|Overall Study|Protocol Deviation|2|||
44497961|NCT00858364|79503514|FG000|Overall Study|Other|9|||
44497962|NCT00858364|79503515|FG001|Overall Study|Other|17|||
44497963|NCT00858364|79503514|FG000|Overall Study|Missing|1|||
44497964|NCT00858364|79503515|FG001|Overall Study|Missing|1|||
44497965|NCT00858364|79503514|FG000|Overall Study|Still on-study|114|||
44497966|NCT00858364|79503515|FG001|Overall Study|Still on-study|247|||
44497967|NCT00382733|79503521|FG000|Overall Study|Withdrawal by Subject|0|||
44497968|NCT00382733|79503522|FG001|Overall Study|Withdrawal by Subject|1|||
44497969|NCT00382733|79503523|FG002|Overall Study|Withdrawal by Subject|0|||
44497970|NCT00382733|79503524|FG003|Overall Study|Withdrawal by Subject|0|||
44497971|NCT00382733|79503525|FG004|Overall Study|Withdrawal by Subject|0|||
44497972|NCT03631732|79503540|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
44497973|NCT03631732|79503541|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
44497974|NCT03631732|79503540|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
44232452|NCT01826981|79048674|FG007|Overall Study|Upper G-I Haemorrhage|0|||
44232453|NCT01826981|79048675|FG008|Overall Study|Upper G-I Haemorrhage|0|||
44232454|NCT01826981|79048676|FG009|Overall Study|Upper G-I Haemorrhage|0|||
44497975|NCT03631732|79503541|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
44497976|NCT03631732|79503540|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
44497977|NCT03631732|79503541|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
44497978|NCT03631732|79503540|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
44497979|NCT03631732|79503541|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
44497980|NCT03631732|79503540|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
44497981|NCT03631732|79503541|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
44497982|NCT03631732|79503540|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
44557371|NCT03380429|79574541|FG004|Overall Study|Physician Decision|1|||
44232455|NCT01826981|79048677|FG010|Overall Study|Upper G-I Haemorrhage|0|||
44232456|NCT01826981|79048678|FG011|Overall Study|Upper G-I Haemorrhage|0|||
44232457|NCT01826981|79048679|FG012|Overall Study|Upper G-I Haemorrhage|0|||
44232458|NCT01826981|79048680|FG013|Overall Study|Upper G-I Haemorrhage|1|||
44232459|NCT01826981|79048681|FG014|Overall Study|Upper G-I Haemorrhage|0|||
44232460|NCT01826981|79048667|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232461|NCT01826981|79048668|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232462|NCT01826981|79048669|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232463|NCT01826981|79048670|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
44557372|NCT03380429|79574537|FG000|Overall Study|Withdrawal by Subject|3|||
44557373|NCT03380429|79574538|FG001|Overall Study|Withdrawal by Subject|3|||
44557374|NCT03380429|79574539|FG002|Overall Study|Withdrawal by Subject|5|||
44557375|NCT03380429|79574540|FG003|Overall Study|Withdrawal by Subject|2|||
44557376|NCT03380429|79574541|FG004|Overall Study|Withdrawal by Subject|1|||
44557377|NCT03380429|79574537|FG000|Overall Study|Lost to Follow-up|0|||
44557378|NCT03380429|79574538|FG001|Overall Study|Lost to Follow-up|2|||
44557379|NCT03380429|79574539|FG002|Overall Study|Lost to Follow-up|4|||
44557380|NCT03380429|79574540|FG003|Overall Study|Lost to Follow-up|3|||
44557381|NCT03380429|79574541|FG004|Overall Study|Lost to Follow-up|1|||
44557382|NCT03380429|79574537|FG000|Overall Study|Protocol Violation|1|||
44557383|NCT03380429|79574538|FG001|Overall Study|Protocol Violation|0|||
44557384|NCT03380429|79574539|FG002|Overall Study|Protocol Violation|1|||
44557385|NCT03380429|79574540|FG003|Overall Study|Protocol Violation|0|||
44557386|NCT03380429|79574541|FG004|Overall Study|Protocol Violation|1|||
44557387|NCT03380429|79574537|FG000|Overall Study|Lack of Efficacy|0|||
44557388|NCT03380429|79574538|FG001|Overall Study|Lack of Efficacy|0|||
44557389|NCT03380429|79574539|FG002|Overall Study|Lack of Efficacy|0|||
44557390|NCT03380429|79574540|FG003|Overall Study|Lack of Efficacy|2|||
44557391|NCT03380429|79574541|FG004|Overall Study|Lack of Efficacy|1|||
44557392|NCT03380429|79574537|FG000|Overall Study|Adverse Event|1|||
44557393|NCT03380429|79574538|FG001|Overall Study|Adverse Event|1|||
44557394|NCT03380429|79574539|FG002|Overall Study|Adverse Event|1|||
44557395|NCT03380429|79574540|FG003|Overall Study|Adverse Event|2|||
44557396|NCT03380429|79574541|FG004|Overall Study|Adverse Event|0|||
44557397|NCT03280615|79574560|FG000|Overall Study|Lost to Follow-up|1|||
44557398|NCT03280615|79574561|FG001|Overall Study|Lost to Follow-up|2|||
44557399|NCT03280615|79574560|FG000|Overall Study|Adverse Event|1|||
44232464|NCT01826981|79048671|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
44557400|NCT03280615|79574561|FG001|Overall Study|Adverse Event|1|||
44557401|NCT03280615|79574560|FG000|Overall Study|Withdrawal by Subject|2|||
44557402|NCT03280615|79574561|FG001|Overall Study|Withdrawal by Subject|2|||
44557403|NCT03280537|79574569|FG000|Overall Study|Withdrawal by Subject|2|||
44557404|NCT03280537|79574570|FG001|Overall Study|Withdrawal by Subject|4|||
44557405|NCT03280381|79574578|FG000|Overall Study|Physician Decision|0|||
44557406|NCT03280381|79574579|FG001|Overall Study|Physician Decision|2|||
44557407|NCT03270085|79574588|FG000|Overall Study|Withdrawal by Subject|1|||
44557408|NCT03270085|79574589|FG001|Overall Study|Withdrawal by Subject|0|||
44557409|NCT03267511|79574599|FG000|Overall Study|Lost to Follow-up|0|||
44557410|NCT03267511|79574600|FG001|Overall Study|Lost to Follow-up|0|||
44557411|NCT03267511|79574601|FG002|Overall Study|Lost to Follow-up|0|||
44557412|NCT03267511|79574602|FG003|Overall Study|Lost to Follow-up|1|||
44557413|NCT03379259|79574629|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
44557414|NCT03379259|79574630|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
44557415|NCT03379259|79574631|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
44557416|NCT03379259|79574632|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
44557417|NCT03379259|79574633|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
44557418|NCT03379259|79574634|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
44557419|NCT03379259|79574629|FG000|Overall Study|Death|0|||
44557420|NCT03379259|79574630|FG001|Overall Study|Death|1|||
44557421|NCT03379259|79574631|FG002|Overall Study|Death|2|||
44557422|NCT03379259|79574632|FG003|Overall Study|Death|1|||
44557423|NCT03379259|79574633|FG004|Overall Study|Death|4|||
44557424|NCT03379259|79574634|FG005|Overall Study|Death|2|||
44557425|NCT03379259|79574629|FG000|Overall Study|Withdrawal by Subject|0|||
44557426|NCT03379259|79574630|FG001|Overall Study|Withdrawal by Subject|0|||
44232465|NCT01826981|79048672|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232466|NCT01826981|79048673|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232467|NCT01826981|79048674|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
44232468|NCT01826981|79048675|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232469|NCT01826981|79048676|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
44376862|NCT00869518|79382093|FG001|Overall Study|Lost to Follow-up|1|||
44557427|NCT03379259|79574631|FG002|Overall Study|Withdrawal by Subject|1|||
44557428|NCT03379259|79574632|FG003|Overall Study|Withdrawal by Subject|0|||
44557429|NCT03379259|79574633|FG004|Overall Study|Withdrawal by Subject|2|||
44557430|NCT03379259|79574634|FG005|Overall Study|Withdrawal by Subject|0|||
44557431|NCT03379259|79574629|FG000|Overall Study|Study terminated by sponsor|0|||
44557432|NCT03379259|79574630|FG001|Overall Study|Study terminated by sponsor|0|||
44557433|NCT03379259|79574631|FG002|Overall Study|Study terminated by sponsor|0|||
44557434|NCT03379259|79574632|FG003|Overall Study|Study terminated by sponsor|1|||
44557435|NCT03379259|79574633|FG004|Overall Study|Study terminated by sponsor|1|||
44557436|NCT03379259|79574634|FG005|Overall Study|Study terminated by sponsor|4|||
44557437|NCT03379259|79574629|FG000|Overall Study|Disease progression|0|||
44557438|NCT03379259|79574630|FG001|Overall Study|Disease progression|0|||
44557439|NCT03379259|79574631|FG002|Overall Study|Disease progression|0|||
44557440|NCT03379259|79574632|FG003|Overall Study|Disease progression|1|||
44557441|NCT03379259|79574633|FG004|Overall Study|Disease progression|0|||
44557442|NCT03379259|79574634|FG005|Overall Study|Disease progression|1|||
44557443|NCT03379259|79574629|FG000|Overall Study|Lost to Follow-up|0|||
44557444|NCT03379259|79574630|FG001|Overall Study|Lost to Follow-up|0|||
44557445|NCT03379259|79574631|FG002|Overall Study|Lost to Follow-up|0|||
44557446|NCT03379259|79574632|FG003|Overall Study|Lost to Follow-up|0|||
44557447|NCT03379259|79574633|FG004|Overall Study|Lost to Follow-up|1|||
44557448|NCT03379259|79574634|FG005|Overall Study|Lost to Follow-up|0|||
44557449|NCT03379259|79574629|FG000|Overall Study|Deteriorating condition|0|||
44557450|NCT03379259|79574630|FG001|Overall Study|Deteriorating condition|0|||
44557451|NCT03379259|79574631|FG002|Overall Study|Deteriorating condition|0|||
44557452|NCT03379259|79574632|FG003|Overall Study|Deteriorating condition|0|||
44557453|NCT03379259|79574633|FG004|Overall Study|Deteriorating condition|1|||
44557454|NCT03379259|79574634|FG005|Overall Study|Deteriorating condition|0|||
44557455|NCT03328897|79574654|FG000|Randomized-treatment Epoch|Adverse Event|4|||
44232470|NCT01826981|79048677|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232471|NCT01826981|79048678|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
44497983|NCT03631732|79503541|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
44497984|NCT03631732|79503540|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
44497985|NCT03631732|79503541|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
44497986|NCT03631732|79503540|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
44497987|NCT03631732|79503541|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
44557456|NCT03328897|79574655|FG001|Randomized-treatment Epoch|Adverse Event|1|||
44232472|NCT01826981|79048679|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
44232473|NCT01826981|79048680|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
44497988|NCT03631732|79503540|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
44497989|NCT03631732|79503541|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
44232474|NCT01826981|79048681|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
44497990|NCT03631732|79503540|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
44557457|NCT03328897|79574656|FG002|Randomized-treatment Epoch|Adverse Event|1|||
44557458|NCT03328897|79574654|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
44557459|NCT03328897|79574655|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
44557460|NCT03328897|79574656|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
44557461|NCT03328897|79574654|FG000|Randomized-treatment Epoch|Pregnancy|3|||
44557462|NCT03328897|79574655|FG001|Randomized-treatment Epoch|Pregnancy|0|||
44557463|NCT03328897|79574656|FG002|Randomized-treatment Epoch|Pregnancy|0|||
44557464|NCT03328897|79574654|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
44557465|NCT03328897|79574655|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
44557466|NCT03328897|79574656|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
44557467|NCT03328897|79574654|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
44557468|NCT03328897|79574655|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
44557469|NCT03328897|79574656|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
44557470|NCT03328897|79574654|FG000|Follow-up Epoch|Adverse Event|4|||
44557471|NCT03328897|79574655|FG001|Follow-up Epoch|Adverse Event|0|||
44557472|NCT03328897|79574656|FG002|Follow-up Epoch|Adverse Event|1|||
44557473|NCT03328897|79574654|FG000|Follow-up Epoch|Lack of Efficacy|1|||
44557474|NCT03328897|79574655|FG001|Follow-up Epoch|Lack of Efficacy|1|||
44557475|NCT03328897|79574656|FG002|Follow-up Epoch|Lack of Efficacy|1|||
44557476|NCT03328897|79574654|FG000|Follow-up Epoch|Lost to Follow-up|0|||
44557477|NCT03328897|79574655|FG001|Follow-up Epoch|Lost to Follow-up|1|||
44557478|NCT03328897|79574656|FG002|Follow-up Epoch|Lost to Follow-up|0|||
44557479|NCT03328897|79574654|FG000|Follow-up Epoch|Pregnancy|1|||
44557480|NCT03328897|79574655|FG001|Follow-up Epoch|Pregnancy|0|||
44557481|NCT03328897|79574656|FG002|Follow-up Epoch|Pregnancy|0|||
44557482|NCT03328897|79574654|FG000|Follow-up Epoch|Patient/guardian decision|2|||
44557483|NCT03328897|79574655|FG001|Follow-up Epoch|Patient/guardian decision|1|||
44557484|NCT03328897|79574656|FG002|Follow-up Epoch|Patient/guardian decision|0|||
44557485|NCT03266107|79574664|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
44557486|NCT03266107|79574664|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
44557487|NCT03266107|79574664|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
44557488|NCT03266107|79574664|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
44557489|NCT03378635|79574673|FG000|Overall Study|Adverse Event|1|||
44557490|NCT03378635|79574674|FG001|Overall Study|Adverse Event|0|||
44557491|NCT03378635|79574675|FG002|Overall Study|Adverse Event|0|||
44557492|NCT03378635|79574673|FG000|Overall Study|Withdrawal by Subject|1|||
44557493|NCT03378635|79574674|FG001|Overall Study|Withdrawal by Subject|0|||
44557494|NCT03378635|79574675|FG002|Overall Study|Withdrawal by Subject|0|||
44557495|NCT03326869|79574686|FG000|Overall Study|Study data has been lost to natural disa|1|||
44497991|NCT03631732|79503541|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
44497992|NCT03630016|79503551|FG000|Overall Study|Poor Sensor Placement|1|||
44497993|NCT03628924|79503558|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
44497994|NCT03628924|79503559|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
44497995|NCT03628924|79503560|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
44497996|NCT03628924|79503561|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
44497997|NCT03628924|79503562|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
44497998|NCT03628924|79503563|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
44497999|NCT03628924|79503564|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
44498000|NCT03628924|79503558|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44498001|NCT03628924|79503559|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44498002|NCT03628924|79503560|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
44557496|NCT03326869|79574687|FG001|Overall Study|Study data has been lost to natural disa|1|||
44557497|NCT03334409|79574699|FG000|Overall Study|Did not meet inclusion criteria|1|||
44557498|NCT03334409|79574700|FG001|Overall Study|Did not meet inclusion criteria|0|||
44557499|NCT02891915|79574708|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
44557500|NCT02891915|79574709|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
44557501|NCT02891915|79574708|FG000|Overall Study|Withdrawal by Subject|3|||
44557502|NCT02891915|79574709|FG001|Overall Study|Withdrawal by Subject|3|||
44557503|NCT02891915|79574708|FG000|Overall Study|Became Ineligible After Enrollment|2|||
44498003|NCT03628924|79503561|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44557504|NCT02891915|79574709|FG001|Overall Study|Became Ineligible After Enrollment|1|||
44557505|NCT02891915|79574708|FG000|Overall Study|Lost to Follow-up|1|||
44557506|NCT02891915|79574709|FG001|Overall Study|Lost to Follow-up|4|||
44557507|NCT02891915|79574708|FG000|Overall Study|Physician Decision|1|||
44557508|NCT02891915|79574709|FG001|Overall Study|Physician Decision|0|||
44557509|NCT02891681|79574718|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
44557510|NCT02891681|79574719|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
44557511|NCT02891681|79574720|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
44557512|NCT02891681|79574718|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
44557513|NCT02891681|79574719|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
44557514|NCT02891681|79574720|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
44557515|NCT02891681|79574718|FG000|Overall Study|Taken off study after first imaging appointment|1|||
44557516|NCT02891681|79574719|FG001|Overall Study|Taken off study after first imaging appointment|0|||
44557517|NCT02891681|79574720|FG002|Overall Study|Taken off study after first imaging appointment|0|||
44557518|NCT04671342|79574728|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
44557519|NCT04671342|79574728|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
44557520|NCT04671342|79574728|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
44557521|NCT04671342|79574728|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
44557522|NCT04671342|79574728|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
44557523|NCT04671342|79574728|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
44557524|NCT03051217|79574735|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
44498004|NCT03628924|79503562|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44498005|NCT03628924|79503563|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44498006|NCT03628924|79503564|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44498007|NCT03628924|79503558|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
44498008|NCT03628924|79503559|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
44498009|NCT03628924|79503560|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
44498010|NCT03628924|79503561|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
44498011|NCT03628924|79503562|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
44498012|NCT03628924|79503563|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
44498013|NCT03628924|79503564|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
44498014|NCT03628924|79503558|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44498015|NCT03628924|79503559|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
44498016|NCT03628924|79503560|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44498017|NCT03628924|79503561|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44557525|NCT03051217|79574736|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44557526|NCT03051217|79574737|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
44557527|NCT03051217|79574738|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44143814|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
44557528|NCT03051217|79574739|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44557529|NCT03051217|79574740|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44557530|NCT03051217|79574741|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
44557531|NCT03051217|79574735|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
44557532|NCT03051217|79574736|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
44557533|NCT03051217|79574737|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
44557534|NCT03051217|79574738|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
44557535|NCT03051217|79574739|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
44557536|NCT03051217|79574740|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
44557537|NCT03051217|79574741|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
44557538|NCT03051217|79574735|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
44557539|NCT03051217|79574736|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
44557540|NCT03051217|79574737|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
44557541|NCT03051217|79574738|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44557542|NCT03051217|79574739|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44557543|NCT03051217|79574740|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44557544|NCT03051217|79574741|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
44557545|NCT03051217|79574735|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
44557546|NCT03051217|79574736|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
44557547|NCT03051217|79574737|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
44557548|NCT03051217|79574738|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
44557549|NCT03051217|79574739|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
44557550|NCT03051217|79574740|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
44557551|NCT03051217|79574741|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
44557552|NCT03051217|79574735|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
44557553|NCT03051217|79574736|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
44557554|NCT03051217|79574737|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
44557555|NCT03051217|79574738|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
44557556|NCT03051217|79574739|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
44557557|NCT03051217|79574740|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
44557558|NCT03051217|79574741|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
44557559|NCT03051217|79574735|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
44557560|NCT03051217|79574736|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
44557561|NCT03051217|79574737|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
44557562|NCT03051217|79574738|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
44557563|NCT03051217|79574739|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
44557564|NCT03051217|79574740|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
44557565|NCT03051217|79574741|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
44557566|NCT03051217|79574735|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
44557567|NCT03051217|79574736|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
44557568|NCT03051217|79574737|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
44557569|NCT03051217|79574738|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
44557570|NCT03051217|79574739|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
44557571|NCT03051217|79574740|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
44557572|NCT03051217|79574741|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
44557573|NCT03051217|79574735|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
44232475|NCT01804049|79048753|FG000|Overall Study|Adverse Event|2|||
44498018|NCT03628924|79503562|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44498019|NCT03628924|79503563|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44498020|NCT03628924|79503564|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44498021|NCT03628924|79503558|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
44498022|NCT03628924|79503559|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
44498023|NCT03628924|79503560|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
44498024|NCT03628924|79503561|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
44498025|NCT03628924|79503562|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
44498026|NCT03628924|79503563|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
44498027|NCT03628924|79503564|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
44498028|NCT03628924|79503558|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
44498029|NCT03628924|79503559|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
44498030|NCT03628924|79503560|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
44498031|NCT03628924|79503561|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
44498032|NCT03628924|79503562|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
44498033|NCT03628924|79503563|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
44232476|NCT01804049|79048754|FG001|Overall Study|Adverse Event|10|||
44232477|NCT01804049|79048753|FG000|Overall Study|Lost to Follow-up|2|||
44232478|NCT01804049|79048754|FG001|Overall Study|Lost to Follow-up|1|||
44232479|NCT01804049|79048753|FG000|Overall Study|Decreased interest/personal|4|||
44232480|NCT01804049|79048754|FG001|Overall Study|Decreased interest/personal|5|||
44232481|NCT01804049|79048753|FG000|Overall Study|Other health concerns|2|||
44232482|NCT01804049|79048754|FG001|Overall Study|Other health concerns|7|||
44232483|NCT01804049|79048753|FG000|Overall Study|Moved out of area|0|||
44275230|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
44275231|NCT02207244|79221607|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44275232|NCT02207244|79221608|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44275233|NCT02207244|79221609|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44498034|NCT03628924|79503564|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
44498035|NCT03628924|79503558|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
44498036|NCT03628924|79503559|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
44498037|NCT03628924|79503560|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
44498038|NCT03628924|79503561|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
44498039|NCT03628924|79503562|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
44498040|NCT03628924|79503563|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
44498041|NCT03628924|79503564|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
44498042|NCT03628924|79503558|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
44498043|NCT03628924|79503559|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
44498044|NCT03628924|79503560|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
44498045|NCT03628924|79503561|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
44498046|NCT03628924|79503562|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
44498047|NCT03628924|79503563|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
44498048|NCT03628924|79503564|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
44498049|NCT03628924|79503558|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
44498050|NCT03628924|79503559|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
44498051|NCT03628924|79503560|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
44498052|NCT03628924|79503561|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
44498053|NCT03628924|79503562|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
44498054|NCT03628924|79503563|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
44498055|NCT03628924|79503564|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
44498056|NCT03628924|79503558|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
44498057|NCT03628924|79503559|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
44498058|NCT03628924|79503560|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
44498059|NCT03628924|79503561|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
44498060|NCT03628924|79503562|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
44498061|NCT03628924|79503563|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
44498062|NCT03628924|79503564|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
44498063|NCT03627832|79503578|FG000|Overall Study|Withdrawal by Subject|10|||
44498064|NCT03627832|79503579|FG001|Overall Study|Withdrawal by Subject|1|||
44498065|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
44498066|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
44498067|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
44498068|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
44498069|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
44498070|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498071|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498072|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498073|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498074|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498075|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498076|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498077|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498078|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498079|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498080|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498081|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498082|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498083|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498084|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498085|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498086|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
44232484|NCT01804049|79048754|FG001|Overall Study|Moved out of area|7|||
44232485|NCT01804049|79048753|FG000|Overall Study|other MD recommended|1|||
44232486|NCT01804049|79048754|FG001|Overall Study|other MD recommended|1|||
44232487|NCT01804049|79048753|FG000|Overall Study|Enrollment in dual studies|0|||
44232488|NCT01804049|79048754|FG001|Overall Study|Enrollment in dual studies|1|||
44557574|NCT03051217|79574736|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
44557575|NCT03051217|79574737|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
44557576|NCT03051217|79574738|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
44557577|NCT03051217|79574739|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
44557578|NCT03051217|79574740|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
44557579|NCT03051217|79574741|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
44557580|NCT03046056|79574767|FG000|Overall Study|Non-responder at Week 10|6|||
44557581|NCT03046056|79574768|FG001|Overall Study|Non-responder at Week 10|6|||
44557582|NCT03046056|79574769|FG002|Overall Study|Non-responder at Week 10|4|||
44557583|NCT03046056|79574767|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
44557584|NCT03046056|79574768|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
44557585|NCT03046056|79574769|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
44557586|NCT03046056|79574767|FG000|Overall Study|Adverse Event|1|||
44557587|NCT03046056|79574768|FG001|Overall Study|Adverse Event|5|||
44557588|NCT03046056|79574769|FG002|Overall Study|Adverse Event|0|||
44557589|NCT03046056|79574767|FG000|Overall Study|Non-compliance With Study Drug|0|||
44557590|NCT03046056|79574768|FG001|Overall Study|Non-compliance With Study Drug|0|||
44557591|NCT03046056|79574769|FG002|Overall Study|Non-compliance With Study Drug|2|||
44557592|NCT03046056|79574767|FG000|Overall Study|Protocol Violation|1|||
44557593|NCT03046056|79574768|FG001|Overall Study|Protocol Violation|1|||
44557594|NCT03046056|79574769|FG002|Overall Study|Protocol Violation|0|||
44557595|NCT03046056|79574767|FG000|Overall Study|Investigator's Discretion|0|||
44557596|NCT03046056|79574768|FG001|Overall Study|Investigator's Discretion|1|||
44557597|NCT03046056|79574769|FG002|Overall Study|Investigator's Discretion|0|||
44557598|NCT03046056|79574767|FG000|Overall Study|Withdrew Consent|1|||
44557599|NCT03046056|79574768|FG001|Overall Study|Withdrew Consent|0|||
44557600|NCT03046056|79574769|FG002|Overall Study|Withdrew Consent|0|||
44557601|NCT02849587|79574780|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
44557602|NCT02849587|79574781|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
44557603|NCT02849587|79574782|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
44557604|NCT02849587|79574780|FG000|Overall Study|Withdrawal by Subject|0|||
44557605|NCT02849587|79574781|FG001|Overall Study|Withdrawal by Subject|1|||
44557606|NCT02849587|79574782|FG002|Overall Study|Withdrawal by Subject|0|||
44557607|NCT03347279|79574796|FG000|Overall Study|Withdrawal by Subject|8|||
44557608|NCT03347279|79574797|FG001|Overall Study|Withdrawal by Subject|15|||
44557609|NCT03347279|79574796|FG000|Overall Study|Death|0|||
44557610|NCT03347279|79574797|FG001|Overall Study|Death|2|||
44557611|NCT03347279|79574796|FG000|Overall Study|Lost to Follow-up|5|||
44557612|NCT03347279|79574797|FG001|Overall Study|Lost to Follow-up|2|||
44557613|NCT03347279|79574796|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
44557614|NCT03347279|79574797|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
44557615|NCT03262441|79574803|FG000|Overall Study|Withdrawal by Subject|1|||
44557616|NCT04580394|79574807|FG000|First Intervention|Incorrectly Randomized|1|||
44557617|NCT04580394|79574807|FG000|First Intervention|Physician Decision|1|||
44557618|NCT04580394|79574807|FG000|First Intervention|Lost to Follow-up|1|||
44557619|NCT04580394|79574807|FG000|Washout (One Week)|Withdrawal by Subject|1|||
44557620|NCT04580394|79574807|FG000|Washout (One Week)|Adverse Event|1|||
44557621|NCT04580394|79574807|FG000|Washout (One Week)|Withdrawal by Subject|2|||
44557622|NCT04580394|79574807|FG000|Third Intervention|Adverse Event|1|||
44557623|NCT04580394|79574807|FG000|Third Intervention|Withdrawal by Subject|1|||
44557624|NCT04580394|79574807|FG000|Washout (One Week)|Withdrawal by Subject|2|||
44557625|NCT02781727|79574819|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
44557626|NCT02781727|79574820|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
44557627|NCT02781727|79574819|FG000|Treatment Period|Withdrawal by Subject|1|||
44557628|NCT02781727|79574820|FG001|Treatment Period|Withdrawal by Subject|0|||
44557629|NCT02781727|79574819|FG000|Treatment Period|Lost to Follow-up|0|||
44557630|NCT02781727|79574820|FG001|Treatment Period|Lost to Follow-up|1|||
44557631|NCT01343082|79574826|FG000|The run-in Period|Not meeting criteria|3|||
44557632|NCT01343082|79574827|FG001|The run-in Period|Not meeting criteria|4|||
44557633|NCT01343082|79574828|FG002|The run-in Period|Not meeting criteria|5|||
44557634|NCT01343082|79574826|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
44557635|NCT01343082|79574827|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
44557636|NCT01343082|79574828|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
44557637|NCT01343082|79574826|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
44376863|NCT00797563|79382099|FG000|Overall Study|Adverse Event|1|||
44557638|NCT01343082|79574827|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
44557639|NCT01343082|79574828|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
44232489|NCT01826825|79048764|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
44232490|NCT01826825|79048765|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
44232491|NCT01803737|79048775|FG000|Overall Study|Lack of Time|1|||
44232492|NCT01803737|79048776|FG001|Overall Study|Lack of Time|0|||
44232493|NCT01803737|79048775|FG000|Overall Study|Medical Reason|0|||
44232494|NCT01803737|79048776|FG001|Overall Study|Medical Reason|1|||
44232495|NCT01803737|79048775|FG000|Overall Study|Lost to Follow-up|0|||
44232496|NCT01803737|79048776|FG001|Overall Study|Lost to Follow-up|2|||
44498087|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498088|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498089|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498090|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
44498091|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498092|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
44498093|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498094|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498095|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498096|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498097|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498098|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498099|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498100|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498101|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498102|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498103|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498104|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498105|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498106|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498107|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498108|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498109|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498110|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498111|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498112|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498113|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498114|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498115|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498116|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
44498117|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498118|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
44498119|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498120|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498121|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498122|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498123|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498124|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498125|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44557640|NCT01343082|79574826|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
44557641|NCT01343082|79574827|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
44232497|NCT01826201|79048782|FG000|Overall Study|Non compliance with protocol|4|||
44232498|NCT01803269|79048813|FG000|Overall Study|Withdrawal by Subject|3|||
44232499|NCT01803269|79048814|FG001|Overall Study|Withdrawal by Subject|0|||
44232500|NCT01803269|79048815|FG002|Overall Study|Withdrawal by Subject|0|||
44232501|NCT01802879|79048823|FG000|Overall Study|Administrative problems|2|||
44232502|NCT01802879|79048823|FG000|Overall Study|Disease progression|6|||
44232503|NCT01825577|79048827|FG000|Overall Study|Physician Decision|2|||
44232504|NCT01825577|79048827|FG000|Overall Study|Withdrawal by Subject|1|||
44232505|NCT01825577|79048827|FG000|Overall Study|Withdrawn by family members|2|||
44232506|NCT01825577|79048827|FG000|Overall Study|Lack of Efficacy|3|||
44232507|NCT01802411|79048833|FG000|Overall Study|Death|2|||
44232508|NCT01802411|79048834|FG001|Overall Study|Death|1|||
44232509|NCT01802411|79048833|FG000|Overall Study|Adverse Event|2|||
44232510|NCT01802411|79048834|FG001|Overall Study|Adverse Event|7|||
44232511|NCT01802411|79048833|FG000|Overall Study|Lack of Efficacy|8|||
44232512|NCT01802411|79048834|FG001|Overall Study|Lack of Efficacy|10|||
44232513|NCT01802411|79048833|FG000|Overall Study|Withdrawal by Subject|0|||
44232514|NCT01802411|79048834|FG001|Overall Study|Withdrawal by Subject|2|||
44232515|NCT01802411|79048833|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
44232516|NCT01802411|79048834|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
44275234|NCT02207244|79221610|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44557642|NCT01343082|79574828|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
44557643|NCT01343082|79574826|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
44557644|NCT01343082|79574827|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
44557645|NCT01343082|79574828|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
44557646|NCT03374189|79574834|FG000|Overall Study|Lost to Follow-up|1|||
44557647|NCT03374189|79574835|FG001|Overall Study|Lost to Follow-up|0|||
44557648|NCT03261037|79574845|FG000|Overall Study|Withdrawal by Subject|2|||
44557649|NCT03261037|79574846|FG001|Overall Study|Withdrawal by Subject|13|||
44557650|NCT03261037|79574847|FG002|Overall Study|Withdrawal by Subject|0|||
44557651|NCT03261037|79574848|FG003|Overall Study|Withdrawal by Subject|18|||
44557652|NCT03261037|79574845|FG000|Overall Study|Non-compliance with study procedures|0|||
44557653|NCT03261037|79574846|FG001|Overall Study|Non-compliance with study procedures|2|||
44557654|NCT03261037|79574847|FG002|Overall Study|Non-compliance with study procedures|0|||
44557655|NCT03261037|79574848|FG003|Overall Study|Non-compliance with study procedures|6|||
44557656|NCT03261037|79574845|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
44557657|NCT03261037|79574846|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
44557658|NCT03261037|79574847|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
44557659|NCT03261037|79574848|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
44557660|NCT03261037|79574845|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
44557661|NCT03261037|79574846|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
44557662|NCT03261037|79574847|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
44557663|NCT03261037|79574848|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
44557664|NCT03261037|79574845|FG000|Overall Study|Diagnosed but protocol deviation|1|||
44557665|NCT03261037|79574846|FG001|Overall Study|Diagnosed but protocol deviation|0|||
44557666|NCT03261037|79574847|FG002|Overall Study|Diagnosed but protocol deviation|0|||
44557667|NCT03261037|79574848|FG003|Overall Study|Diagnosed but protocol deviation|0|||
44557668|NCT03261037|79574845|FG000|Overall Study|Participant did not want to continue the study|0|||
44557669|NCT03261037|79574846|FG001|Overall Study|Participant did not want to continue the study|1|||
44557670|NCT03261037|79574847|FG002|Overall Study|Participant did not want to continue the study|0|||
44557671|NCT03261037|79574848|FG003|Overall Study|Participant did not want to continue the study|0|||
44557672|NCT03261037|79574845|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
44557673|NCT03261037|79574846|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
44557674|NCT03261037|79574847|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
44275235|NCT02207244|79221611|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44275236|NCT02207244|79221612|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44275237|NCT02207244|79221613|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44498126|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498127|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498128|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498129|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498130|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498131|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498132|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498133|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498134|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44232517|NCT01802411|79048833|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
44232518|NCT01802411|79048834|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
44232519|NCT01802411|79048833|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
44232520|NCT01802411|79048834|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
44249732|NCT01504412|79083926|FG003|Overall Study|Withdrawal by Subject|5|||
44557675|NCT03261037|79574848|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
44557676|NCT03261037|79574845|FG000|Overall Study|Participant presented clinical improvement|0|||
44557677|NCT03261037|79574846|FG001|Overall Study|Participant presented clinical improvement|2|||
44557678|NCT03261037|79574847|FG002|Overall Study|Participant presented clinical improvement|0|||
44557679|NCT03261037|79574848|FG003|Overall Study|Participant presented clinical improvement|0|||
44557680|NCT03261037|79574845|FG000|Overall Study|Technical difficulties|0|||
44557681|NCT03261037|79574846|FG001|Overall Study|Technical difficulties|0|||
44557682|NCT03261037|79574847|FG002|Overall Study|Technical difficulties|0|||
44557683|NCT03261037|79574848|FG003|Overall Study|Technical difficulties|1|||
44557684|NCT03261037|79574845|FG000|Overall Study|Equipment failed to work|0|||
44557685|NCT03261037|79574846|FG001|Overall Study|Equipment failed to work|0|||
44557686|NCT03261037|79574847|FG002|Overall Study|Equipment failed to work|0|||
44557687|NCT03261037|79574848|FG003|Overall Study|Equipment failed to work|1|||
44557688|NCT03261037|79574845|FG000|Overall Study|End of study for participant and no follow up|0|||
44557689|NCT03261037|79574846|FG001|Overall Study|End of study for participant and no follow up|0|||
44557690|NCT03261037|79574847|FG002|Overall Study|End of study for participant and no follow up|0|||
44557691|NCT03261037|79574848|FG003|Overall Study|End of study for participant and no follow up|1|||
44557692|NCT03261037|79574845|FG000|Overall Study|Participant was too weak to continue in study|1|||
44557693|NCT03261037|79574846|FG001|Overall Study|Participant was too weak to continue in study|0|||
44557694|NCT03261037|79574847|FG002|Overall Study|Participant was too weak to continue in study|0|||
44557695|NCT03261037|79574848|FG003|Overall Study|Participant was too weak to continue in study|0|||
44557696|NCT03372551|79574859|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
44557697|NCT03372551|79574860|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
44557698|NCT03326323|79574873|FG000|Overall Study|Unable to receive ANH protocol|3|||
44557699|NCT03259789|79574884|FG000|Overall Study|Adverse Event|3|||
44557700|NCT03259789|79574885|FG001|Overall Study|Adverse Event|2|||
44557701|NCT03259789|79574886|FG002|Overall Study|Adverse Event|1|||
44232521|NCT02963610|79048875|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
44232522|NCT01802333|79049096|FG000|Overall Study|Ineligible|2|||
44232523|NCT01802333|79049097|FG001|Overall Study|Ineligible|6|||
44232524|NCT01802333|79049098|FG002|Overall Study|Ineligible|8|||
44498135|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498136|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498137|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498138|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498139|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498140|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498141|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498142|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
44498143|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
44498144|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498145|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
44498146|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
44498147|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
44498148|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498149|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498150|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498151|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498152|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498153|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498154|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498155|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498156|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498157|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498158|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498159|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498160|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498161|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498162|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498163|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498164|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498165|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44557702|NCT03259789|79574884|FG000|Overall Study|Withdrawal by Subject|9|||
44557703|NCT03259789|79574885|FG001|Overall Study|Withdrawal by Subject|5|||
44557704|NCT03259789|79574886|FG002|Overall Study|Withdrawal by Subject|1|||
44557705|NCT03259789|79574884|FG000|Overall Study|Lost to Follow-up|5|||
44557706|NCT03259789|79574885|FG001|Overall Study|Lost to Follow-up|9|||
44232525|NCT01802333|79049096|FG000|Overall Study|Adverse Event|1|||
44498166|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44232526|NCT01802333|79049097|FG001|Overall Study|Adverse Event|8|||
44557707|NCT03259789|79574886|FG002|Overall Study|Lost to Follow-up|4|||
44557708|NCT03259789|79574884|FG000|Overall Study|Physician Decision|0|||
44557709|NCT03259789|79574885|FG001|Overall Study|Physician Decision|1|||
44557710|NCT03259789|79574886|FG002|Overall Study|Physician Decision|0|||
44557711|NCT03259555|79574897|FG000|Overall Study|Adverse Event|6|||
44557712|NCT03259555|79574898|FG001|Overall Study|Adverse Event|4|||
44557713|NCT03259555|79574897|FG000|Overall Study|Lack of Efficacy|6|||
44557714|NCT03259555|79574898|FG001|Overall Study|Lack of Efficacy|4|||
44557715|NCT03259555|79574897|FG000|Overall Study|Lost to Follow-up|0|||
44557716|NCT03259555|79574898|FG001|Overall Study|Lost to Follow-up|2|||
44557717|NCT03259555|79574897|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44557718|NCT03259555|79574898|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44557719|NCT03259555|79574897|FG000|Overall Study|Progressive Disease|0|||
44557720|NCT03259555|79574898|FG001|Overall Study|Progressive Disease|2|||
44557721|NCT03259555|79574897|FG000|Overall Study|Withdrawal by Subject|19|||
44557722|NCT03259555|79574898|FG001|Overall Study|Withdrawal by Subject|16|||
44557723|NCT03259555|79574897|FG000|Overall Study|Physician Decision|1|||
44557724|NCT03259555|79574898|FG001|Overall Study|Physician Decision|2|||
44557725|NCT03259555|79574897|FG000|Overall Study|Other|1|||
44557726|NCT03259555|79574898|FG001|Overall Study|Other|0|||
44557727|NCT03259087|79574909|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
44557728|NCT03259087|79574910|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
44557729|NCT03259087|79574911|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
44557730|NCT03259087|79574912|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
44557731|NCT03259087|79574913|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
44557732|NCT03259087|79574909|FG000|Period 2 of Part 2|Adverse Event|0|||
44557733|NCT03259087|79574910|FG001|Period 2 of Part 2|Adverse Event|0|||
44557734|NCT03259087|79574911|FG002|Period 2 of Part 2|Adverse Event|0|||
44557735|NCT03259087|79574912|FG003|Period 2 of Part 2|Adverse Event|0|||
44557736|NCT03259087|79574913|FG004|Period 2 of Part 2|Adverse Event|1|||
44557737|NCT03257995|79574935|FG000|Overall Study|Adverse Event|0|||
44557738|NCT03257995|79574936|FG001|Overall Study|Adverse Event|1|||
44557739|NCT03257995|79574937|FG002|Overall Study|Adverse Event|0|||
44557740|NCT03257995|79574938|FG003|Overall Study|Adverse Event|0|||
44557741|NCT03257995|79574939|FG004|Overall Study|Adverse Event|0|||
44557742|NCT03257995|79574940|FG005|Overall Study|Adverse Event|0|||
44557743|NCT03257995|79574935|FG000|Overall Study|Protocol deviation|0|||
44557744|NCT03257995|79574936|FG001|Overall Study|Protocol deviation|0|||
44557745|NCT03257995|79574937|FG002|Overall Study|Protocol deviation|0|||
44557746|NCT03257995|79574938|FG003|Overall Study|Protocol deviation|0|||
44557747|NCT03257995|79574939|FG004|Overall Study|Protocol deviation|0|||
44557748|NCT03257995|79574940|FG005|Overall Study|Protocol deviation|2|||
44557749|NCT03049488|79574958|FG000|Overall Study|Lost to Follow-up|1|||
44557750|NCT03049488|79574959|FG001|Overall Study|Lost to Follow-up|1|||
44557751|NCT03049488|79574960|FG002|Overall Study|Lost to Follow-up|0|||
44557752|NCT03049488|79574961|FG003|Overall Study|Lost to Follow-up|0|||
44557753|NCT03049488|79574962|FG004|Overall Study|Lost to Follow-up|0|||
44557754|NCT03049488|79574963|FG005|Overall Study|Lost to Follow-up|0|||
44557755|NCT03049488|79574958|FG000|Overall Study|Moved from Area|1|||
44557756|NCT03049488|79574959|FG001|Overall Study|Moved from Area|0|||
44557757|NCT03049488|79574960|FG002|Overall Study|Moved from Area|0|||
44557758|NCT03049488|79574961|FG003|Overall Study|Moved from Area|1|||
44557759|NCT03049488|79574962|FG004|Overall Study|Moved from Area|1|||
44557760|NCT03049488|79574963|FG005|Overall Study|Moved from Area|0|||
44557761|NCT03049488|79574958|FG000|Overall Study|Physician Decision|0|||
44557762|NCT03049488|79574959|FG001|Overall Study|Physician Decision|1|||
44557763|NCT03049488|79574960|FG002|Overall Study|Physician Decision|0|||
44557764|NCT03049488|79574961|FG003|Overall Study|Physician Decision|0|||
44557765|NCT03049488|79574962|FG004|Overall Study|Physician Decision|0|||
44557766|NCT03049488|79574963|FG005|Overall Study|Physician Decision|0|||
44557767|NCT03049488|79574958|FG000|Overall Study|Withdrawal by Subject|0|||
44557768|NCT03049488|79574959|FG001|Overall Study|Withdrawal by Subject|0|||
44557769|NCT03049488|79574960|FG002|Overall Study|Withdrawal by Subject|0|||
44557770|NCT03049488|79574961|FG003|Overall Study|Withdrawal by Subject|1|||
44557771|NCT03049488|79574962|FG004|Overall Study|Withdrawal by Subject|1|||
44557772|NCT03049488|79574963|FG005|Overall Study|Withdrawal by Subject|0|||
44557773|NCT03257371|79574978|FG000|Overall Study|Lost to Follow-up|1|||
44557774|NCT03242863|79574982|FG000|Study Week 1|Withdrawal by Subject|0|||
44557775|NCT03242863|79574983|FG001|Study Week 1|Withdrawal by Subject|1|||
44557776|NCT03242863|79574984|FG002|Study Week 1|Withdrawal by Subject|0|||
44557777|NCT03242863|79574985|FG003|Study Week 1|Withdrawal by Subject|0|||
44557778|NCT03242863|79574986|FG004|Study Week 1|Withdrawal by Subject|3|||
44557779|NCT03242863|79574987|FG005|Study Week 1|Withdrawal by Subject|0|||
44557780|NCT03044106|79574995|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
44557781|NCT03044106|79574996|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
44557782|NCT03043560|79575022|FG000|Overall Study|Discontinued Intervention|1|||
44232527|NCT01802333|79049098|FG002|Overall Study|Adverse Event|8|||
44232528|NCT01802333|79049096|FG000|Overall Study|Withdrawal by Subject|6|||
44232529|NCT01802333|79049097|FG001|Overall Study|Withdrawal by Subject|6|||
44232530|NCT01802333|79049098|FG002|Overall Study|Withdrawal by Subject|5|||
44498167|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498168|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
44498169|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
44498170|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
44498171|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
44498172|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
44498173|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
44498174|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498175|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498176|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498177|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498178|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498179|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498180|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498181|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498182|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498183|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498184|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498185|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498186|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498187|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498188|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498189|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498190|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498191|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498192|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498193|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498194|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
44498195|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|moved|0|||
44498196|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|moved|1|||
44498197|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|moved|1|||
44498198|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|moved|0|||
44498199|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|moved|0|||
44498200|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|moved|0|||
44498201|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|moved|0|||
44498202|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|moved|0|||
44498203|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|moved|0|||
44498204|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|moved|0|||
44498205|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|moved|0|||
44498206|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|moved|0|||
44498207|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|moved|0|||
44498208|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|moved|0|||
44498209|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|moved|0|||
44498210|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|moved|0|||
44498211|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|moved|0|||
44498212|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|moved|0|||
44498213|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|moved|0|||
44498214|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|moved|0|||
44498215|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|moved|0|||
44498216|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|moved|0|||
44498217|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|moved|0|||
44498218|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|moved|0|||
44498219|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|moved|0|||
44498220|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|moved|0|||
44498221|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498222|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498223|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44232531|NCT01802333|79049096|FG000|Overall Study|Progression/relapse|1|||
44232532|NCT01802333|79049097|FG001|Overall Study|Progression/relapse|3|||
44232533|NCT01802333|79049098|FG002|Overall Study|Progression/relapse|0|||
44232534|NCT01802333|79049096|FG000|Overall Study|Death|7|||
44498224|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
44498225|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498226|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498227|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498228|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498229|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498230|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498231|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498232|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498233|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498234|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498235|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498236|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498237|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498238|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498239|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498240|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498241|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498242|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498243|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498244|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498245|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498246|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
44498247|NCT00112437|79503590|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498248|NCT00112437|79503591|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498249|NCT00112437|79503592|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44557783|NCT03043560|79575023|FG001|Overall Study|Discontinued Intervention|2|||
44557784|NCT03043560|79575022|FG000|Overall Study|Lost to Follow-up|0|||
44557785|NCT03043560|79575023|FG001|Overall Study|Lost to Follow-up|1|||
44557786|NCT03255733|79575049|FG000|Overall Study|Lost to Follow-up|4|||
44557787|NCT03255655|79575055|FG000|Overall Study|Lost to Follow-up|7|||
44557788|NCT03255655|79575056|FG001|Overall Study|Lost to Follow-up|4|||
44275238|NCT02207244|79221614|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44275239|NCT02207244|79221615|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44557789|NCT02899988|79575066|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
44557790|NCT02899988|79575067|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
44498250|NCT00112437|79503593|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498251|NCT00112437|79503594|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
44498252|NCT00112437|79503595|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498253|NCT00112437|79503596|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44557791|NCT02899988|79575068|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557792|NCT02899988|79575069|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557793|NCT02899988|79575070|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557794|NCT02899988|79575071|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557795|NCT02899988|79575072|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557796|NCT02899988|79575073|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557797|NCT02899988|79575074|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557798|NCT02899988|79575075|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557799|NCT02899988|79575076|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44557800|NCT02899988|79575066|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
44557801|NCT02899988|79575067|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
44557802|NCT02899988|79575068|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
44498254|NCT00112437|79503597|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498255|NCT00112437|79503598|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498256|NCT00112437|79503599|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498257|NCT00112437|79503600|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498258|NCT00112437|79503601|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498259|NCT00112437|79503602|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498260|NCT00112437|79503603|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498261|NCT00112437|79503604|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498262|NCT00112437|79503605|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498263|NCT00112437|79503606|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44557803|NCT02899988|79575069|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
44557804|NCT02899988|79575070|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
44557805|NCT02899988|79575071|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
44557806|NCT02899988|79575072|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
44557807|NCT02899988|79575073|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
44557808|NCT02899988|79575074|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
44557809|NCT02899988|79575075|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
44557810|NCT02899988|79575076|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
44557811|NCT02899988|79575066|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
44557812|NCT02899988|79575067|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
44557813|NCT02899988|79575068|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
44557814|NCT02899988|79575069|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
44557815|NCT02899988|79575070|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
44557816|NCT02899988|79575071|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
44557817|NCT02899988|79575072|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
44557818|NCT02899988|79575073|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
44557819|NCT02899988|79575074|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
44557820|NCT02899988|79575075|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
44557821|NCT02899988|79575076|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
44557822|NCT02899988|79575066|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
44557823|NCT02899988|79575067|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
44557824|NCT02899988|79575068|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
44557825|NCT02899988|79575069|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
44557826|NCT02899988|79575070|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
44557827|NCT02899988|79575071|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
44557828|NCT02899988|79575072|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
44557829|NCT02899988|79575073|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
44557830|NCT02899988|79575074|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
44557831|NCT02899988|79575075|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
44557832|NCT02899988|79575076|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
44557833|NCT02899988|79575066|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557834|NCT02899988|79575067|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557835|NCT02899988|79575068|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557836|NCT02899988|79575069|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557837|NCT02899988|79575070|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557838|NCT02899988|79575071|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
44557839|NCT02899988|79575072|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557840|NCT02899988|79575073|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
44557841|NCT02899988|79575074|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557842|NCT02899988|79575075|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557843|NCT02899988|79575076|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
44557844|NCT02899988|79575066|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
44557845|NCT02899988|79575067|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
44557846|NCT02899988|79575068|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
44557847|NCT02899988|79575069|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
44557848|NCT02899988|79575070|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
44557849|NCT02899988|79575071|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
44557850|NCT02899988|79575072|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
44557851|NCT02899988|79575073|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
44557852|NCT02899988|79575074|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
44557853|NCT02899988|79575075|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
44557854|NCT02899988|79575076|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
44557855|NCT02939131|79575110|FG000|Overall Study|Unable to get to clinic|6|||
44557856|NCT02939131|79575111|FG001|Overall Study|Unable to get to clinic|4|||
44557857|NCT02939131|79575110|FG000|Overall Study|Lost to Follow-up|2|||
44557858|NCT02939131|79575111|FG001|Overall Study|Lost to Follow-up|4|||
44557859|NCT02939131|79575110|FG000|Overall Study|severe debilitation|1|||
44557860|NCT02939131|79575111|FG001|Overall Study|severe debilitation|0|||
44557861|NCT02939131|79575110|FG000|Overall Study|Other|0|||
44557862|NCT02939131|79575111|FG001|Overall Study|Other|1|||
44557863|NCT02939131|79575110|FG000|Overall Study|not willing to adhere to protocol|2|||
44557864|NCT02939131|79575111|FG001|Overall Study|not willing to adhere to protocol|0|||
44557865|NCT03345407|79575125|FG000|Overall Study|Withdrawal by Subject|11|||
44557866|NCT03345407|79575126|FG001|Overall Study|Withdrawal by Subject|1|||
44557867|NCT03345407|79575127|FG002|Overall Study|Withdrawal by Subject|5|||
44557868|NCT03345407|79575128|FG003|Overall Study|Withdrawal by Subject|6|||
44275240|NCT02207244|79221616|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
44557869|NCT03345407|79575129|FG004|Overall Study|Withdrawal by Subject|3|||
44557870|NCT03345407|79575130|FG005|Overall Study|Withdrawal by Subject|6|||
44557871|NCT03345407|79575131|FG006|Overall Study|Withdrawal by Subject|16|||
44557872|NCT03345407|79575125|FG000|Overall Study|Physician Decision|3|||
44557873|NCT03345407|79575126|FG001|Overall Study|Physician Decision|1|||
44557874|NCT03345407|79575127|FG002|Overall Study|Physician Decision|0|||
44557875|NCT03345407|79575128|FG003|Overall Study|Physician Decision|0|||
44557876|NCT03345407|79575129|FG004|Overall Study|Physician Decision|1|||
44557877|NCT03345407|79575130|FG005|Overall Study|Physician Decision|2|||
44557878|NCT03345407|79575131|FG006|Overall Study|Physician Decision|3|||
44557879|NCT03345407|79575125|FG000|Overall Study|Lost to Follow-up|2|||
44557880|NCT03345407|79575126|FG001|Overall Study|Lost to Follow-up|0|||
44557881|NCT03345407|79575127|FG002|Overall Study|Lost to Follow-up|1|||
44557882|NCT03345407|79575128|FG003|Overall Study|Lost to Follow-up|0|||
44557883|NCT03345407|79575129|FG004|Overall Study|Lost to Follow-up|1|||
44557884|NCT03345407|79575130|FG005|Overall Study|Lost to Follow-up|2|||
44557885|NCT03345407|79575131|FG006|Overall Study|Lost to Follow-up|3|||
44557886|NCT03345407|79575125|FG000|Overall Study|Protocol-defined stopping criteria|9|||
44557887|NCT03345407|79575126|FG001|Overall Study|Protocol-defined stopping criteria|0|||
44557888|NCT03345407|79575127|FG002|Overall Study|Protocol-defined stopping criteria|0|||
44557889|NCT03345407|79575128|FG003|Overall Study|Protocol-defined stopping criteria|0|||
44557890|NCT03345407|79575129|FG004|Overall Study|Protocol-defined stopping criteria|2|||
44557891|NCT03345407|79575130|FG005|Overall Study|Protocol-defined stopping criteria|1|||
44557892|NCT03345407|79575131|FG006|Overall Study|Protocol-defined stopping criteria|1|||
44557893|NCT03345407|79575125|FG000|Overall Study|Protocol Violation|2|||
44557894|NCT03345407|79575126|FG001|Overall Study|Protocol Violation|0|||
44557895|NCT03345407|79575127|FG002|Overall Study|Protocol Violation|0|||
44557896|NCT03345407|79575128|FG003|Overall Study|Protocol Violation|0|||
44557897|NCT03345407|79575129|FG004|Overall Study|Protocol Violation|1|||
44557898|NCT03345407|79575130|FG005|Overall Study|Protocol Violation|0|||
44557899|NCT03345407|79575131|FG006|Overall Study|Protocol Violation|3|||
44557900|NCT03345407|79575125|FG000|Overall Study|Lack of Efficacy|1|||
44557901|NCT03345407|79575126|FG001|Overall Study|Lack of Efficacy|1|||
44557902|NCT03345407|79575127|FG002|Overall Study|Lack of Efficacy|1|||
44557903|NCT03345407|79575128|FG003|Overall Study|Lack of Efficacy|1|||
44557904|NCT03345407|79575129|FG004|Overall Study|Lack of Efficacy|1|||
44557905|NCT03345407|79575130|FG005|Overall Study|Lack of Efficacy|0|||
44557906|NCT03345407|79575131|FG006|Overall Study|Lack of Efficacy|3|||
44557907|NCT03345407|79575125|FG000|Overall Study|Adverse Event|4|||
44557908|NCT03345407|79575126|FG001|Overall Study|Adverse Event|0|||
44557909|NCT03345407|79575127|FG002|Overall Study|Adverse Event|5|||
44557910|NCT03345407|79575128|FG003|Overall Study|Adverse Event|4|||
44557911|NCT03345407|79575129|FG004|Overall Study|Adverse Event|6|||
44557912|NCT03345407|79575130|FG005|Overall Study|Adverse Event|5|||
44557913|NCT03345407|79575131|FG006|Overall Study|Adverse Event|16|||
44557914|NCT03255187|79575155|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
44557915|NCT03255187|79575156|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
44557916|NCT03255187|79575155|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
44557917|NCT03255187|79575156|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
44557918|NCT02929329|79575164|FG000|Overall Study|Withdrawal by Subject|24|||
44557919|NCT02929329|79575165|FG001|Overall Study|Withdrawal by Subject|21|||
44557920|NCT02929329|79575164|FG000|Overall Study|Lost to Follow-up|26|||
44557921|NCT02929329|79575165|FG001|Overall Study|Lost to Follow-up|20|||
44557922|NCT02929329|79575164|FG000|Overall Study|Death|1054|||
44376864|NCT00869440|79382107|FG000|Overall Study|Withdrawal by Subject|1|||
44498264|NCT00112437|79503607|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498265|NCT00112437|79503608|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498266|NCT00112437|79503609|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498267|NCT00112437|79503610|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498268|NCT00112437|79503611|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498269|NCT00112437|79503612|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498270|NCT00112437|79503613|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498271|NCT00112437|79503614|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498272|NCT00112437|79503615|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
44498273|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
44498274|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
44498275|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
44498276|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
44498277|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
44498278|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
44498279|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
44498280|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
44498281|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
44498282|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
44557923|NCT02929329|79575165|FG001|Overall Study|Death|1051|||
44557924|NCT03240133|79575178|FG000|Overall Study|Withdrawal by Subject|0|||
44557925|NCT03240133|79575179|FG001|Overall Study|Withdrawal by Subject|1|||
44557926|NCT03240133|79575180|FG002|Overall Study|Withdrawal by Subject|0|||
44557927|NCT03240133|79575178|FG000|Overall Study|Adverse Event|1|||
44557928|NCT03240133|79575179|FG001|Overall Study|Adverse Event|1|||
44557929|NCT03240133|79575180|FG002|Overall Study|Adverse Event|0|||
44557930|NCT03240133|79575178|FG000|Overall Study|Rash|1|||
44557931|NCT03240133|79575179|FG001|Overall Study|Rash|0|||
44557932|NCT03240133|79575180|FG002|Overall Study|Rash|0|||
44557933|NCT03240133|79575178|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
44557934|NCT03240133|79575179|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
44557935|NCT03240133|79575180|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
44557936|NCT03240133|79575178|FG000|Overall Study|Intercurrent illness.|0|||
44557937|NCT03240133|79575179|FG001|Overall Study|Intercurrent illness.|1|||
44557938|NCT03240133|79575180|FG002|Overall Study|Intercurrent illness.|0|||
44557939|NCT03240133|79575178|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
44557940|NCT03240133|79575179|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
44557941|NCT03240133|79575180|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
44557942|NCT03372083|79575204|FG000|Overall Study|Adverse Event|3|||
44557943|NCT03372083|79575204|FG000|Overall Study|Physician Decision|1|||
44557944|NCT03372083|79575204|FG000|Overall Study|Withdrawal by Subject|1|||
44557945|NCT03044886|79575211|FG000|Overall Study|Lost to Follow-up|15|||
44557946|NCT03044886|79575212|FG001|Overall Study|Lost to Follow-up|10|||
44557947|NCT03044886|79575213|FG002|Overall Study|Lost to Follow-up|12|||
44557948|NCT02961764|79575223|FG000|Overall Study|Protocol Violation|0|||
44557949|NCT02961764|79575224|FG001|Overall Study|Protocol Violation|1|||
44557950|NCT02961764|79575223|FG000|Overall Study|Death|2|||
44557951|NCT02961764|79575224|FG001|Overall Study|Death|0|||
44557952|NCT02961764|79575223|FG000|Overall Study|Lost to Follow-up|35|||
44557953|NCT02961764|79575224|FG001|Overall Study|Lost to Follow-up|24|||
44557954|NCT02961764|79575223|FG000|Overall Study|Withdrawal by Subject|2|||
44557955|NCT02961764|79575224|FG001|Overall Study|Withdrawal by Subject|0|||
44557956|NCT03371459|79575230|FG000|Washout|Lost to Follow-up|0|||
44557957|NCT03371459|79575231|FG001|Washout|Lost to Follow-up|1|||
44557958|NCT02961920|79575239|FG000|Overall Study|did not achive stydy protocol schedule|1|||
44557959|NCT02961920|79575240|FG001|Overall Study|did not achive stydy protocol schedule|1|||
44557960|NCT03371381|79575246|FG000|Overall Study|Death|5|||
44557961|NCT03371381|79575246|FG000|Overall Study|Study terminated by sponsor|3|||
44557962|NCT03371381|79575246|FG000|Overall Study|Other|4|||
44557963|NCT03044730|79575250|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
44557964|NCT03044730|79575250|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
44557965|NCT03044730|79575250|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
44557966|NCT03044730|79575250|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
44557967|NCT03044730|79575250|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
44557968|NCT03044730|79575250|FG000|Cycles 4 and Beyond|Adverse Event|1|||
44557969|NCT03044730|79575250|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
44557970|NCT03044730|79575250|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
44557971|NCT03044730|79575250|FG000|On Follow-up for 2 Years|Death|17|||
44557972|NCT02961374|79575255|FG000|Overall Study|Adverse Event|4|||
44557973|NCT02951429|79575261|FG000|Overall Study|Adverse Event|3|||
44557974|NCT02951429|79575262|FG001|Overall Study|Adverse Event|7|||
44557975|NCT02951429|79575261|FG000|Overall Study|Death|28|||
44557976|NCT02951429|79575262|FG001|Overall Study|Death|36|||
44557977|NCT02951429|79575261|FG000|Overall Study|Lack of Efficacy|0|||
44557978|NCT02951429|79575262|FG001|Overall Study|Lack of Efficacy|1|||
44557979|NCT02951429|79575261|FG000|Overall Study|Lost to Follow-up|0|||
44557980|NCT02951429|79575262|FG001|Overall Study|Lost to Follow-up|1|||
44498283|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
44557981|NCT02951429|79575261|FG000|Overall Study|Lung Transplantation|9|||
44557982|NCT02951429|79575262|FG001|Overall Study|Lung Transplantation|6|||
44557983|NCT02951429|79575261|FG000|Overall Study|Other|1|||
44557984|NCT02951429|79575262|FG001|Overall Study|Other|3|||
44557985|NCT02951429|79575261|FG000|Overall Study|Progressive Disease|1|||
44557986|NCT02951429|79575262|FG001|Overall Study|Progressive Disease|1|||
44557987|NCT02951429|79575261|FG000|Overall Study|Withdrawal by Subject|7|||
44498284|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
44498285|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
44498286|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
44498287|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
44498288|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
44498289|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
44557988|NCT02951429|79575262|FG001|Overall Study|Withdrawal by Subject|11|||
44557989|NCT02951429|79575261|FG000|Overall Study|Participant ongoing in the study|23|||
44498290|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
44498291|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
44557990|NCT02951429|79575262|FG001|Overall Study|Participant ongoing in the study|17|||
44557991|NCT03343067|79575275|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
44557992|NCT03343067|79575276|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
44557993|NCT03343067|79575277|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
44557994|NCT03103503|79575285|FG000|Overall Study|Death|64|||
44557995|NCT03103503|79575285|FG000|Overall Study|Physician Decision|57|||
44557996|NCT03103503|79575285|FG000|Overall Study|Withdrawal by Subject|10|||
44557997|NCT03103503|79575285|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
44557998|NCT03103503|79575285|FG000|Overall Study|Lost to Follow-up|3|||
44557999|NCT03103503|79575285|FG000|Overall Study|Study Closure|757|||
44558000|NCT02961218|79575291|FG000|Overall Study|Lost to Follow-up|0|||
44558001|NCT02961218|79575292|FG001|Overall Study|Lost to Follow-up|2|||
44558002|NCT02961218|79575291|FG000|Overall Study|Physician Decision|0|||
44558003|NCT02961218|79575292|FG001|Overall Study|Physician Decision|2|||
44558004|NCT02961218|79575291|FG000|Overall Study|Subject/Guardian Decision|3|||
44558005|NCT02961218|79575292|FG001|Overall Study|Subject/Guardian Decision|1|||
44558006|NCT02949947|79575302|FG000|Overall Study|Non Compliance|0|||
44558007|NCT02949947|79575303|FG001|Overall Study|Non Compliance|1|||
44558008|NCT02949947|79575302|FG000|Overall Study|Insurance change|1|||
44558009|NCT02949947|79575303|FG001|Overall Study|Insurance change|0|||
44558010|NCT03341507|79575309|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
44558011|NCT01345058|79575315|FG000|Overall Study|Withdrawal by Subject|1|||
44558012|NCT01345058|79575316|FG001|Overall Study|Withdrawal by Subject|0|||
44558013|NCT01345058|79575315|FG000|Overall Study|Participant Reported Increase in Events|1|||
44558014|NCT01345058|79575316|FG001|Overall Study|Participant Reported Increase in Events|0|||
44558015|NCT01345058|79575315|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
44558016|NCT01345058|79575316|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
44558017|NCT01345058|79575315|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
44558018|NCT01345058|79575316|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
44558019|NCT01345058|79575315|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
44558020|NCT01345058|79575316|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
44558021|NCT01345292|79575325|FG000|Overall Study|Withdrawal by Subject|2|||
44558022|NCT01345292|79575326|FG001|Overall Study|Withdrawal by Subject|0|||
44558023|NCT01345292|79575327|FG002|Overall Study|Withdrawal by Subject|1|||
44558024|NCT03340961|79575339|FG000|Overall Study|Adverse Event|1|||
44558025|NCT03340961|79575340|FG001|Overall Study|Adverse Event|3|||
44558026|NCT03340961|79575341|FG002|Overall Study|Adverse Event|2|||
44558027|NCT03340961|79575342|FG003|Overall Study|Adverse Event|4|||
44558028|NCT03340961|79575339|FG000|Overall Study|Lost to Follow-up|0|||
44558029|NCT03340961|79575340|FG001|Overall Study|Lost to Follow-up|1|||
44558030|NCT03340961|79575341|FG002|Overall Study|Lost to Follow-up|0|||
44558031|NCT03340961|79575342|FG003|Overall Study|Lost to Follow-up|1|||
44558032|NCT03340961|79575339|FG000|Overall Study|Withdrawal by Subject|3|||
44558033|NCT03340961|79575340|FG001|Overall Study|Withdrawal by Subject|2|||
44558034|NCT03340961|79575341|FG002|Overall Study|Withdrawal by Subject|4|||
44558035|NCT03340961|79575342|FG003|Overall Study|Withdrawal by Subject|7|||
44558036|NCT03340961|79575339|FG000|Overall Study|Use of prohibited treatment|0|||
44558037|NCT03340961|79575340|FG001|Overall Study|Use of prohibited treatment|3|||
44558038|NCT03340961|79575341|FG002|Overall Study|Use of prohibited treatment|2|||
44558039|NCT03340961|79575342|FG003|Overall Study|Use of prohibited treatment|4|||
44558040|NCT03340961|79575339|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
44558041|NCT03340961|79575340|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
44558042|NCT03340961|79575341|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
44558043|NCT03340961|79575342|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
44558044|NCT03340961|79575339|FG000|Overall Study|Subject developed an exclusion criterion|0|||
44558045|NCT03340961|79575340|FG001|Overall Study|Subject developed an exclusion criterion|1|||
44558046|NCT03340961|79575341|FG002|Overall Study|Subject developed an exclusion criterion|0|||
44558047|NCT03340961|79575342|FG003|Overall Study|Subject developed an exclusion criterion|0|||
44558048|NCT03340961|79575339|FG000|Overall Study|Protocol Violation|1|||
44558049|NCT03340961|79575340|FG001|Overall Study|Protocol Violation|0|||
44558050|NCT03340961|79575341|FG002|Overall Study|Protocol Violation|1|||
44558051|NCT03340961|79575342|FG003|Overall Study|Protocol Violation|0|||
44558052|NCT03340961|79575339|FG000|Overall Study|Adverse Event|1|||
44558053|NCT03340961|79575340|FG001|Overall Study|Adverse Event|1|||
44558054|NCT03340961|79575341|FG002|Overall Study|Adverse Event|0|||
44558055|NCT03340961|79575342|FG003|Overall Study|Adverse Event|0|||
44558056|NCT03340961|79575339|FG000|Overall Study|Lack of Efficacy|0|||
44558057|NCT03340961|79575340|FG001|Overall Study|Lack of Efficacy|0|||
44558058|NCT03340961|79575341|FG002|Overall Study|Lack of Efficacy|0|||
44558059|NCT03340961|79575342|FG003|Overall Study|Lack of Efficacy|1|||
44558060|NCT03340025|79575354|FG000|Overall Study|Lost to Follow-up|2|||
44558061|NCT03340025|79575355|FG001|Overall Study|Lost to Follow-up|2|||
44558062|NCT03339713|79575363|FG000|Overall Study|Lost to Follow-up|2|||
44558063|NCT03339713|79575364|FG001|Overall Study|Lost to Follow-up|1|||
44558064|NCT03339713|79575363|FG000|Overall Study|Protocol Violation|1|||
44558065|NCT03339713|79575364|FG001|Overall Study|Protocol Violation|0|||
44558066|NCT03339713|79575363|FG000|Overall Study|Withdrawal by Subject|1|||
44558067|NCT03339713|79575364|FG001|Overall Study|Withdrawal by Subject|1|||
44558068|NCT03254485|79575376|FG000|Overall Study|Adverse Event|3|||
44558069|NCT03254485|79575377|FG001|Overall Study|Adverse Event|0|||
44558070|NCT03254485|79575378|FG002|Overall Study|Adverse Event|0|||
44558071|NCT03254485|79575379|FG003|Overall Study|Adverse Event|6|||
44558072|NCT03254485|79575376|FG000|Overall Study|Protocol Violation|6|||
44558073|NCT03254485|79575377|FG001|Overall Study|Protocol Violation|0|||
44558074|NCT03254485|79575378|FG002|Overall Study|Protocol Violation|0|||
44558075|NCT03254485|79575379|FG003|Overall Study|Protocol Violation|2|||
44558076|NCT03254485|79575376|FG000|Overall Study|Withdrawal by Subject|1|||
44558077|NCT03254485|79575377|FG001|Overall Study|Withdrawal by Subject|0|||
44558078|NCT03254485|79575378|FG002|Overall Study|Withdrawal by Subject|0|||
44558079|NCT03254485|79575379|FG003|Overall Study|Withdrawal by Subject|4|||
44558080|NCT03254485|79575376|FG000|Overall Study|Death|0|||
44558081|NCT03254485|79575377|FG001|Overall Study|Death|0|||
44558082|NCT03254485|79575378|FG002|Overall Study|Death|0|||
44558083|NCT03254485|79575379|FG003|Overall Study|Death|1|||
44558084|NCT03254485|79575376|FG000|Overall Study|Lost to Follow-up|1|||
44558085|NCT03254485|79575377|FG001|Overall Study|Lost to Follow-up|0|||
44558086|NCT03254485|79575378|FG002|Overall Study|Lost to Follow-up|0|||
44558087|NCT03254485|79575379|FG003|Overall Study|Lost to Follow-up|0|||
44558088|NCT03254485|79575376|FG000|Overall Study|Other|1|||
44558089|NCT03254485|79575377|FG001|Overall Study|Other|0|||
44558090|NCT03254485|79575378|FG002|Overall Study|Other|0|||
44558091|NCT03254485|79575379|FG003|Overall Study|Other|2|||
44558092|NCT03339401|79575392|FG000|Overall Study|Death|2|||
44498292|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
44498293|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
44498294|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
44498295|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
44498296|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
44498297|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
44558093|NCT03339401|79575393|FG001|Overall Study|Death|1|||
44558094|NCT03339401|79575392|FG000|Overall Study|Withdrawal by Subject|2|||
44558095|NCT03339401|79575393|FG001|Overall Study|Withdrawal by Subject|0|||
44376865|NCT00869440|79382108|FG001|Overall Study|Withdrawal by Subject|0|||
44558096|NCT03339401|79575392|FG000|Overall Study|Study terminated|4|||
44558097|NCT03339401|79575393|FG001|Overall Study|Study terminated|3|||
44558098|NCT03339401|79575392|FG000|Overall Study|Investigator Decision|1|||
44558099|NCT03339401|79575393|FG001|Overall Study|Investigator Decision|0|||
44498298|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
44498299|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44558100|NCT03370289|79575399|FG000|Overall Study|Screen Failure|1|||
44558101|NCT03370289|79575399|FG000|Overall Study|Sample Size Sufficient|4|||
44558102|NCT01344824|79575403|FG000|Overall Study|Adverse Event|15|||
44558103|NCT01344824|79575403|FG000|Overall Study|Withdrawal by Subject|6|||
44558104|NCT01344824|79575403|FG000|Overall Study|Other complicating disease|1|||
44558105|NCT01344824|79575403|FG000|Overall Study|Progression|15|||
44558106|NCT03339245|79575410|FG000|Overall Study|Adverse Event|1|||
44558107|NCT03339245|79575411|FG001|Overall Study|Adverse Event|1|||
44558108|NCT03339245|79575410|FG000|Overall Study|Withdrawal by Subject|1|||
44558109|NCT03339245|79575411|FG001|Overall Study|Withdrawal by Subject|0|||
44558110|NCT03044574|79575419|FG000|Overall Study|Lost to Follow-up|37|||
44558111|NCT03044574|79575420|FG001|Overall Study|Lost to Follow-up|45|||
44558112|NCT02959892|79575428|FG000|Overall Study|PET tracer synthesis failure|1|||
44558113|NCT02959892|79575429|FG001|Overall Study|PET tracer synthesis failure|0|||
44558114|NCT02959892|79575428|FG000|Overall Study|Study termination|0|||
44558115|NCT02959892|79575429|FG001|Overall Study|Study termination|1|||
44558116|NCT03252145|79575437|FG000|Overall Study|Withdrawal by Subject|1|||
44558117|NCT03252145|79575438|FG001|Overall Study|Withdrawal by Subject|0|||
44558118|NCT03252145|79575437|FG000|Overall Study|Complicating Disease|1|||
44558119|NCT03252145|79575438|FG001|Overall Study|Complicating Disease|2|||
44558120|NCT02959814|79575444|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
44558121|NCT02959814|79575444|FG000|Overall Study|Excluded based on anatomical criteria|2|||
44558122|NCT02959814|79575444|FG000|Overall Study|Protocol Violation|7|||
44558123|NCT02959814|79575444|FG000|Overall Study|FFR not measured|2|||
44558124|NCT02959814|79575444|FG000|Overall Study|In-procedure QFR not computed|6|||
44558125|NCT02959814|79575444|FG000|Overall Study|Excluded by FFR core-lab|24|||
44558126|NCT03666624|79575451|FG000|Overall Study|participant grieving over recent death of parent|1|||
44558127|NCT03666624|79575452|FG001|Overall Study|participant grieving over recent death of parent|0|||
44558128|NCT03368807|79575458|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
44558129|NCT03368807|79575458|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
44558130|NCT03368807|79575458|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
44558131|NCT03368807|79575458|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
44558132|NCT03338855|79575466|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
44558133|NCT03338855|79575467|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
44558134|NCT03367793|79575479|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
44558135|NCT03367793|79575480|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
44558136|NCT03367793|79575481|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
44558137|NCT03367793|79575482|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
44558138|NCT03367793|79575483|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
44558139|NCT03367793|79575484|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
44558140|NCT01347307|79575506|FG000|Overall Study|Death|0|||
44558141|NCT01347307|79575507|FG001|Overall Study|Death|4|||
44558142|NCT01347307|79575506|FG000|Overall Study|Physician Decision|0|||
44558143|NCT01347307|79575507|FG001|Overall Study|Physician Decision|1|||
44558144|NCT03247543|79575564|FG000|Overall Study|Adverse Event|3|||
44558145|NCT03247543|79575565|FG001|Overall Study|Adverse Event|6|||
44558146|NCT03247543|79575566|FG002|Overall Study|Adverse Event|4|||
44558147|NCT03247543|79575564|FG000|Overall Study|Lost to Follow-up|10|||
44558148|NCT03247543|79575565|FG001|Overall Study|Lost to Follow-up|7|||
44558149|NCT03247543|79575566|FG002|Overall Study|Lost to Follow-up|8|||
44558150|NCT03247543|79575564|FG000|Overall Study|Consent withdrawn by caregiver|2|||
44558151|NCT03247543|79575565|FG001|Overall Study|Consent withdrawn by caregiver|2|||
44558152|NCT03247543|79575566|FG002|Overall Study|Consent withdrawn by caregiver|9|||
44558153|NCT03247543|79575564|FG000|Overall Study|Withdrawal by Subject|0|||
44558154|NCT03247543|79575565|FG001|Overall Study|Withdrawal by Subject|0|||
44558155|NCT03247543|79575566|FG002|Overall Study|Withdrawal by Subject|1|||
44558156|NCT03247543|79575564|FG000|Overall Study|Failure to Follow study procedures|1|||
44558157|NCT03247543|79575565|FG001|Overall Study|Failure to Follow study procedures|3|||
44498300|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498301|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498302|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498303|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498304|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
44498305|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
44498306|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498307|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498308|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
44498309|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44558158|NCT03247543|79575566|FG002|Overall Study|Failure to Follow study procedures|1|||
44558159|NCT03247543|79575564|FG000|Overall Study|Lack of Efficacy|1|||
44558160|NCT03247543|79575565|FG001|Overall Study|Lack of Efficacy|0|||
44558161|NCT03247543|79575566|FG002|Overall Study|Lack of Efficacy|0|||
44558162|NCT03247543|79575564|FG000|Overall Study|Non-compliance with study visits|0|||
44558163|NCT03247543|79575565|FG001|Overall Study|Non-compliance with study visits|1|||
44558164|NCT03247543|79575566|FG002|Overall Study|Non-compliance with study visits|0|||
44558165|NCT01347073|79575576|FG000|Overall Study|Adverse Event|1|||
44558166|NCT01347073|79575576|FG000|Overall Study|Liver Transplant|1|||
44498310|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498311|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498312|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498313|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498314|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498315|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498316|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498317|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498318|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498319|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498320|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498321|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498322|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498323|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498324|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
44498325|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498326|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498327|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498328|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498329|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498330|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498331|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498332|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498333|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
44498334|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498335|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498336|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498337|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498338|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498339|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498340|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498341|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498342|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498343|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498344|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498345|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498346|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498347|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498348|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498349|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498350|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
44498351|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498352|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498353|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498354|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498355|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498356|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498357|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498358|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498359|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
44498360|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498361|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498362|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498363|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498364|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498365|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498366|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498367|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498368|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
44558167|NCT01315236|79575588|FG000|Double-blind Phase|Death|1|||
44498369|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498370|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498371|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498372|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498373|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498374|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498375|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
44498376|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
44558168|NCT01315236|79575589|FG001|Double-blind Phase|Death|0|||
44558169|NCT01315236|79575588|FG000|Double-blind Phase|Adverse Event|1|||
44558170|NCT01315236|79575589|FG001|Double-blind Phase|Adverse Event|0|||
44558171|NCT01315236|79575588|FG000|Double-blind Phase|Withdrawal of Consent|1|||
44558172|NCT01315236|79575589|FG001|Double-blind Phase|Withdrawal of Consent|0|||
44558173|NCT01315236|79575588|FG000|Double-blind Phase|Lost to Follow-up|1|||
44558174|NCT01315236|79575589|FG001|Double-blind Phase|Lost to Follow-up|0|||
44558175|NCT01315236|79575588|FG000|Open-label Phase|Death|1|||
44558176|NCT01315236|79575589|FG001|Open-label Phase|Death|0|||
44558177|NCT01315236|79575588|FG000|Open-label Phase|Adverse Event|0|||
44558178|NCT01315236|79575589|FG001|Open-label Phase|Adverse Event|1|||
44558179|NCT01315236|79575588|FG000|Open-label Phase|Other|0|||
44558180|NCT01315236|79575589|FG001|Open-label Phase|Other|1|||
44558181|NCT01315236|79575588|FG000|12-Month Follow-up Period|Death|0|||
44558182|NCT01315236|79575589|FG001|12-Month Follow-up Period|Death|1|||
44558183|NCT01315236|79575588|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
44558184|NCT01315236|79575589|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
44558185|NCT03232567|79575601|FG000|Overall Study|Withdrawal by Subject|0|||
44558186|NCT03232567|79575602|FG001|Overall Study|Withdrawal by Subject|1|||
44558187|NCT03232567|79575603|FG002|Overall Study|Withdrawal by Subject|0|||
44558188|NCT03232567|79575604|FG003|Overall Study|Withdrawal by Subject|0|||
44558189|NCT01348490|79575614|FG000|Overall Study|Death|1|||
44558190|NCT01348490|79575614|FG000|Overall Study|Adverse Event|3|||
44558191|NCT01348490|79575614|FG000|Overall Study|Consent withdrawn|7|||
44558192|NCT01348490|79575614|FG000|Overall Study|Disease progression|3|||
44558193|NCT01348490|79575614|FG000|Overall Study|Lost to Follow-up|1|||
44558194|NCT01348490|79575614|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
44558195|NCT01348490|79575614|FG000|Overall Study|Other Unspecified|8|||
44498377|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498378|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498379|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44558196|NCT03040674|79575635|FG000|Overall Study|Lost to Follow-up|225|||
44232535|NCT01802333|79049097|FG001|Overall Study|Death|14|||
44498380|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498381|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498382|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
44558197|NCT03040674|79575635|FG000|Overall Study|Death|23|||
44558198|NCT03232333|79575640|FG000|Overall Study|Infection or Osteomyelitis|9|||
44558199|NCT03232333|79575640|FG000|Overall Study|Lost to Follow-up|4|||
44498383|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
44376866|NCT00869440|79382109|FG002|Overall Study|Withdrawal by Subject|0|||
44558200|NCT03232333|79575640|FG000|Overall Study|Withdrawal by Subject|2|||
44558201|NCT03364049|79575648|FG000|Overall Study|Death|6|||
44558202|NCT03364049|79575649|FG001|Overall Study|Death|4|||
44558203|NCT03364049|79575650|FG002|Overall Study|Death|5|||
44558204|NCT03364049|79575651|FG003|Overall Study|Death|14|||
44558205|NCT03364049|79575648|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
44558206|NCT03364049|79575649|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
44558207|NCT03364049|79575650|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
44558208|NCT03364049|79575651|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
44558209|NCT03364049|79575648|FG000|Overall Study|Withdrawal by Subject|0|||
44558210|NCT03364049|79575649|FG001|Overall Study|Withdrawal by Subject|1|||
44558211|NCT03364049|79575650|FG002|Overall Study|Withdrawal by Subject|1|||
44558212|NCT03364049|79575651|FG003|Overall Study|Withdrawal by Subject|1|||
44558213|NCT03238963|79575663|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
44558214|NCT03238963|79575664|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
44558215|NCT03238963|79575663|FG000|Overall Study|Withdrawal by Subject|1|||
44558216|NCT03238963|79575664|FG001|Overall Study|Withdrawal by Subject|1|||
44558217|NCT03238963|79575663|FG000|Overall Study|Lost to Follow-up|1|||
44558218|NCT03238963|79575664|FG001|Overall Study|Lost to Follow-up|0|||
44558219|NCT03238963|79575663|FG000|Overall Study|Protocol Violation|1|||
44558220|NCT03238963|79575664|FG001|Overall Study|Protocol Violation|1|||
44558221|NCT03238963|79575663|FG000|Overall Study|Adverse Event|1|||
44558222|NCT03238963|79575664|FG001|Overall Study|Adverse Event|0|||
44558223|NCT03337139|79575672|FG000|Phase I|Withdrawal by Subject|10|||
44558224|NCT03337139|79575673|FG001|Phase I|Withdrawal by Subject|0|||
44558225|NCT03042312|79575681|FG000|Overall Study|Administrative Reason|1|||
44558226|NCT03042312|79575682|FG001|Overall Study|Administrative Reason|1|||
44558227|NCT03042312|79575681|FG000|Overall Study|Adverse Event|0|||
44558228|NCT03042312|79575682|FG001|Overall Study|Adverse Event|1|||
44558229|NCT03042312|79575681|FG000|Overall Study|Lost to Follow-up|1|||
44558230|NCT03042312|79575682|FG001|Overall Study|Lost to Follow-up|3|||
44558231|NCT03042312|79575681|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
44558232|NCT03042312|79575682|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
44558233|NCT03042312|79575681|FG000|Overall Study|Withdrawal by Subject|4|||
44558234|NCT03042312|79575682|FG001|Overall Study|Withdrawal by Subject|5|||
44558235|NCT03360071|79575690|FG000|Overall Study|Lost to Follow-up|1|||
44498384|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
44498385|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
44498386|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
44498387|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498388|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498389|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498390|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498391|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498392|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498393|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498394|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44558236|NCT03360071|79575691|FG001|Overall Study|Lost to Follow-up|0|||
44558237|NCT02949011|79575700|FG000|Overall Study|Adverse Event|6|||
44558238|NCT02949011|79575701|FG001|Overall Study|Adverse Event|7|||
44558239|NCT02949011|79575702|FG002|Overall Study|Adverse Event|3|||
44558240|NCT02949011|79575700|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
44558241|NCT02949011|79575701|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
44558242|NCT02949011|79575702|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
44498395|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44558243|NCT02949011|79575700|FG000|Overall Study|Protocol Deviation|5|||
44558244|NCT02949011|79575701|FG001|Overall Study|Protocol Deviation|3|||
44558245|NCT02949011|79575702|FG002|Overall Study|Protocol Deviation|3|||
44558246|NCT02949011|79575700|FG000|Overall Study|Lack of Efficacy|0|||
44558247|NCT02949011|79575701|FG001|Overall Study|Lack of Efficacy|2|||
44558248|NCT02949011|79575702|FG002|Overall Study|Lack of Efficacy|0|||
44558249|NCT02949011|79575700|FG000|Overall Study|Withdrawal by Subject|13|||
44558250|NCT02949011|79575701|FG001|Overall Study|Withdrawal by Subject|13|||
44558251|NCT02949011|79575702|FG002|Overall Study|Withdrawal by Subject|21|||
44558252|NCT02949011|79575700|FG000|Overall Study|Lost to Follow-up|7|||
44558253|NCT02949011|79575701|FG001|Overall Study|Lost to Follow-up|5|||
44558254|NCT02949011|79575702|FG002|Overall Study|Lost to Follow-up|5|||
44558255|NCT02949011|79575700|FG000|Overall Study|Death|0|||
44558256|NCT02949011|79575701|FG001|Overall Study|Death|0|||
44558257|NCT02949011|79575702|FG002|Overall Study|Death|1|||
44558258|NCT02949011|79575700|FG000|Overall Study|Miscellaneous|2|||
44558259|NCT02949011|79575701|FG001|Overall Study|Miscellaneous|4|||
44558260|NCT02949011|79575702|FG002|Overall Study|Miscellaneous|6|||
44558261|NCT03357731|79575714|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
44558262|NCT03357731|79575715|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
44558263|NCT03357731|79575716|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
44558264|NCT03357731|79575717|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
44558265|NCT03357731|79575718|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
44558266|NCT03357731|79575719|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
44558267|NCT03357731|79575714|FG000|Overall Study|Acute bradycardia and hypotension|0|||
44558268|NCT03357731|79575715|FG001|Overall Study|Acute bradycardia and hypotension|0|||
44558269|NCT03357731|79575716|FG002|Overall Study|Acute bradycardia and hypotension|0|||
44558270|NCT03357731|79575717|FG003|Overall Study|Acute bradycardia and hypotension|1|||
44558271|NCT03357731|79575718|FG004|Overall Study|Acute bradycardia and hypotension|0|||
44558272|NCT03357731|79575719|FG005|Overall Study|Acute bradycardia and hypotension|0|||
44558273|NCT03357731|79575714|FG000|Overall Study|Adverse Event|0|||
44558274|NCT03357731|79575715|FG001|Overall Study|Adverse Event|0|||
44558275|NCT03357731|79575716|FG002|Overall Study|Adverse Event|0|||
44558276|NCT03357731|79575717|FG003|Overall Study|Adverse Event|0|||
44558277|NCT03357731|79575718|FG004|Overall Study|Adverse Event|0|||
44558278|NCT03357731|79575719|FG005|Overall Study|Adverse Event|1|||
44558279|NCT03357731|79575714|FG000|Overall Study|Hypotension|0|||
44558280|NCT03357731|79575715|FG001|Overall Study|Hypotension|0|||
44558281|NCT03357731|79575716|FG002|Overall Study|Hypotension|1|||
44558282|NCT03357731|79575717|FG003|Overall Study|Hypotension|1|||
44558283|NCT03357731|79575718|FG004|Overall Study|Hypotension|0|||
44558284|NCT03357731|79575719|FG005|Overall Study|Hypotension|0|||
44558285|NCT03357731|79575714|FG000|Overall Study|Lost to Follow-up|0|||
44558286|NCT03357731|79575715|FG001|Overall Study|Lost to Follow-up|0|||
44558287|NCT03357731|79575716|FG002|Overall Study|Lost to Follow-up|0|||
44558288|NCT03357731|79575717|FG003|Overall Study|Lost to Follow-up|1|||
44558289|NCT03357731|79575718|FG004|Overall Study|Lost to Follow-up|0|||
44558290|NCT03357731|79575719|FG005|Overall Study|Lost to Follow-up|0|||
44558291|NCT03357341|79575729|FG000|Overall Study|Withdrawal by Subject|3|||
44558292|NCT03357341|79575730|FG001|Overall Study|Withdrawal by Subject|6|||
44558293|NCT03357341|79575729|FG000|Overall Study|Lost to Follow-up|4|||
44558294|NCT03357341|79575730|FG001|Overall Study|Lost to Follow-up|5|||
44558295|NCT03357341|79575729|FG000|Overall Study|Death|0|||
44558296|NCT03357341|79575730|FG001|Overall Study|Death|1|||
44558297|NCT03039738|79575739|FG000|Overall Study|Incomplete data sets|54|||
44558298|NCT03039738|79575740|FG001|Overall Study|Incomplete data sets|0|||
44558299|NCT03036852|79575771|FG000|Overall Study|Death|2|||
44558300|NCT03036852|79575771|FG000|Overall Study|Lack of Efficacy|2|||
44558301|NCT03036852|79575771|FG000|Overall Study|Adverse Event|1|||
44558302|NCT03036852|79575771|FG000|Overall Study|Lost to Follow-up|1|||
44558303|NCT02945657|79575782|FG000|Overall Study|Adverse Event|1|||
44275241|NCT02207244|79221617|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
44558304|NCT02945657|79575782|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
44558305|NCT02948777|79575787|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
44558306|NCT03324581|79575795|FG000|Overall Study|Adverse Event|18|||
44558307|NCT03324581|79575796|FG001|Overall Study|Adverse Event|11|||
44558308|NCT03324581|79575797|FG002|Overall Study|Adverse Event|7|||
44558309|NCT03324581|79575795|FG000|Overall Study|Lack of Efficacy|0|||
44558310|NCT03324581|79575796|FG001|Overall Study|Lack of Efficacy|1|||
44558311|NCT03324581|79575797|FG002|Overall Study|Lack of Efficacy|0|||
44558312|NCT03324581|79575795|FG000|Overall Study|Lost to Follow-up|5|||
44558313|NCT03324581|79575796|FG001|Overall Study|Lost to Follow-up|3|||
44558314|NCT03324581|79575797|FG002|Overall Study|Lost to Follow-up|6|||
44558315|NCT03324581|79575795|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
44558316|NCT03324581|79575796|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
44558317|NCT03324581|79575797|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
44558318|NCT03324581|79575795|FG000|Overall Study|Physician Decision|0|||
44558319|NCT03324581|79575796|FG001|Overall Study|Physician Decision|1|||
44558320|NCT03324581|79575797|FG002|Overall Study|Physician Decision|2|||
44558321|NCT03324581|79575795|FG000|Overall Study|Protocol Deviation|8|||
44558322|NCT03324581|79575796|FG001|Overall Study|Protocol Deviation|9|||
44558323|NCT03324581|79575797|FG002|Overall Study|Protocol Deviation|4|||
44558324|NCT03324581|79575795|FG000|Overall Study|Withdrawal by Subject|6|||
44558325|NCT03324581|79575796|FG001|Overall Study|Withdrawal by Subject|8|||
44558326|NCT03324581|79575797|FG002|Overall Study|Withdrawal by Subject|6|||
44558327|NCT03324581|79575795|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
44558328|NCT03324581|79575796|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
44558329|NCT03324581|79575797|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
44558330|NCT02943473|79575805|FG000|Overall Study|enrolled but not dosed|1|||
44558331|NCT02943473|79575805|FG000|Overall Study|screen failure|1|||
44558332|NCT02943473|79575805|FG000|Overall Study|Physician Decision|4|||
44558333|NCT03320369|79575809|FG000|Overall Study|Adverse Event|1|||
44558334|NCT03320369|79575809|FG000|Overall Study|Withdrawal by Subject|2|||
44558335|NCT02650895|79575819|FG000|Overall Study|Withdrawal by Subject|0|||
44558336|NCT02650895|79575820|FG001|Overall Study|Withdrawal by Subject|1|||
44558337|NCT02650895|79575821|FG002|Overall Study|Withdrawal by Subject|0|||
44558338|NCT02650895|79575822|FG003|Overall Study|Withdrawal by Subject|0|||
44558339|NCT02650895|79575823|FG004|Overall Study|Withdrawal by Subject|0|||
44558340|NCT02650895|79575824|FG005|Overall Study|Withdrawal by Subject|0|||
44558341|NCT03320057|79575843|FG000|Overall Study|Lost to Follow-up|4|||
44558342|NCT03320057|79575844|FG001|Overall Study|Lost to Follow-up|17|||
44558343|NCT03320057|79575843|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
44558344|NCT03320057|79575844|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
44558345|NCT03316547|79575852|FG000|Overall Study|Death|3|||
44558346|NCT03316547|79575853|FG001|Overall Study|Death|1|||
44558347|NCT03316547|79575852|FG000|Overall Study|Lost to Follow-up|6|||
44558348|NCT03316547|79575853|FG001|Overall Study|Lost to Follow-up|6|||
44558349|NCT03316547|79575852|FG000|Overall Study|Withdrawal by Subject|3|||
44558350|NCT03316547|79575853|FG001|Overall Study|Withdrawal by Subject|2|||
44558351|NCT03316547|79575852|FG000|Overall Study|Transfer to another hospital|6|||
44558352|NCT03316547|79575853|FG001|Overall Study|Transfer to another hospital|4|||
44558353|NCT03315689|79575876|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
44558354|NCT03315689|79575877|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
44558355|NCT03315689|79575876|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
44232536|NCT01802333|79049098|FG002|Overall Study|Death|13|||
44558356|NCT03315689|79575877|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
44558357|NCT03315689|79575876|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
44558358|NCT03315689|79575877|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
44558359|NCT03314519|79575887|FG000|Overall Study|Protocol Violation|3|||
44558360|NCT03314519|79575888|FG001|Overall Study|Protocol Violation|2|||
44558361|NCT03313037|79575900|FG000|Overall Study|Protocol Violation|4|||
44558362|NCT03313037|79575901|FG001|Overall Study|Protocol Violation|1|||
44558363|NCT03313037|79575900|FG000|Overall Study|Other|1|||
44558364|NCT03313037|79575901|FG001|Overall Study|Other|1|||
44558365|NCT03313037|79575900|FG000|Overall Study|Withdrawal by Subject|4|||
44558366|NCT03313037|79575901|FG001|Overall Study|Withdrawal by Subject|3|||
44558367|NCT03313037|79575900|FG000|Overall Study|No longer meets eligibility criteria|1|||
44558368|NCT03313037|79575901|FG001|Overall Study|No longer meets eligibility criteria|7|||
44558369|NCT03313037|79575900|FG000|Overall Study|Lost to Follow-up|9|||
44558370|NCT03313037|79575901|FG001|Overall Study|Lost to Follow-up|8|||
44558371|NCT03313037|79575900|FG000|Overall Study|Randomized but not treated|1|||
44558372|NCT03313037|79575901|FG001|Overall Study|Randomized but not treated|0|||
44558373|NCT02420795|79575910|FG000|Overall Study|Withdrawal by Subject|1|||
44558374|NCT02420795|79575911|FG001|Overall Study|Withdrawal by Subject|0|||
44558375|NCT02420795|79575912|FG002|Overall Study|Withdrawal by Subject|0|||
44558376|NCT02420795|79575910|FG000|Overall Study|Adverse Event|1|||
44558377|NCT02420795|79575911|FG001|Overall Study|Adverse Event|0|||
44558378|NCT02420795|79575912|FG002|Overall Study|Adverse Event|0|||
44558379|NCT02420795|79575910|FG000|Overall Study|Progressive disease|2|||
44558380|NCT02420795|79575911|FG001|Overall Study|Progressive disease|2|||
44558381|NCT02420795|79575912|FG002|Overall Study|Progressive disease|4|||
44558382|NCT02420795|79575910|FG000|Overall Study|Death|0|||
44558383|NCT02420795|79575911|FG001|Overall Study|Death|0|||
44558384|NCT02420795|79575912|FG002|Overall Study|Death|1|||
44558385|NCT03334175|79575924|FG000|Overall Study|Lost to Follow-up|0|||
44558386|NCT03334175|79575925|FG001|Overall Study|Lost to Follow-up|1|||
44558387|NCT02942771|79575936|FG000|Overall Study|Adverse Event|1|||
44558388|NCT02942771|79575937|FG001|Overall Study|Adverse Event|0|||
44558389|NCT02942771|79575938|FG002|Overall Study|Adverse Event|0|||
44558390|NCT02942771|79575939|FG003|Overall Study|Adverse Event|0|||
44558391|NCT02942771|79575940|FG004|Overall Study|Adverse Event|2|||
44558392|NCT02942771|79575936|FG000|Overall Study|Lost to Follow-up|1|||
44558393|NCT02942771|79575937|FG001|Overall Study|Lost to Follow-up|0|||
44558394|NCT02942771|79575938|FG002|Overall Study|Lost to Follow-up|0|||
44558395|NCT02942771|79575939|FG003|Overall Study|Lost to Follow-up|0|||
44558396|NCT02942771|79575940|FG004|Overall Study|Lost to Follow-up|0|||
44558397|NCT02942771|79575936|FG000|Overall Study|Withdrawal by Subject|1|||
44558398|NCT02942771|79575937|FG001|Overall Study|Withdrawal by Subject|0|||
44558399|NCT02942771|79575938|FG002|Overall Study|Withdrawal by Subject|0|||
44558400|NCT02942771|79575939|FG003|Overall Study|Withdrawal by Subject|0|||
44558401|NCT02942771|79575940|FG004|Overall Study|Withdrawal by Subject|2|||
44558402|NCT03036150|79575954|FG000|Overall Study|Withdrawal by Subject|8|||
44558403|NCT03036150|79575955|FG001|Overall Study|Withdrawal by Subject|3|||
44558404|NCT03036150|79575954|FG000|Overall Study|Lost to Follow-up|2|||
44558405|NCT03036150|79575955|FG001|Overall Study|Lost to Follow-up|2|||
44558406|NCT03332771|79575965|FG000|Overall Study|Adverse Event|6|||
44558407|NCT03332771|79575966|FG001|Overall Study|Adverse Event|4|||
44558408|NCT03332771|79575967|FG002|Overall Study|Adverse Event|1|||
44558409|NCT03332771|79575968|FG003|Overall Study|Adverse Event|3|||
44558410|NCT03332771|79575965|FG000|Overall Study|Poor Compliance to Protocol|0|||
44558411|NCT03332771|79575966|FG001|Overall Study|Poor Compliance to Protocol|1|||
44558412|NCT03332771|79575967|FG002|Overall Study|Poor Compliance to Protocol|0|||
44558413|NCT03332771|79575968|FG003|Overall Study|Poor Compliance to Protocol|1|||
44558414|NCT03332771|79575965|FG000|Overall Study|Lost to Follow-up|2|||
44558415|NCT03332771|79575966|FG001|Overall Study|Lost to Follow-up|2|||
44558416|NCT03332771|79575967|FG002|Overall Study|Lost to Follow-up|1|||
44558417|NCT03332771|79575968|FG003|Overall Study|Lost to Follow-up|2|||
44558418|NCT03332771|79575965|FG000|Overall Study|At the Participant's own request|20|||
44558419|NCT03332771|79575966|FG001|Overall Study|At the Participant's own request|26|||
44558420|NCT03332771|79575967|FG002|Overall Study|At the Participant's own request|14|||
44558421|NCT03332771|79575968|FG003|Overall Study|At the Participant's own request|23|||
44558422|NCT03332771|79575965|FG000|Overall Study|Reason Not Specified|6|||
44558423|NCT03332771|79575966|FG001|Overall Study|Reason Not Specified|18|||
44558424|NCT03332771|79575967|FG002|Overall Study|Reason Not Specified|16|||
44558425|NCT03332771|79575968|FG003|Overall Study|Reason Not Specified|19|||
44558426|NCT03310775|79575980|FG000|Overall Study|Lost to Follow-up|2|||
44558427|NCT03310775|79575981|FG001|Overall Study|Lost to Follow-up|3|||
44558428|NCT03310775|79575980|FG000|Overall Study|aggravation of depression|0|||
44558429|NCT03310775|79575981|FG001|Overall Study|aggravation of depression|1|||
44558430|NCT03330119|79575993|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
44558431|NCT03330119|79575994|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
44558432|NCT03040986|79576002|FG000|Overall Study|Hospice|1|||
44558433|NCT03040986|79576003|FG001|Overall Study|Hospice|0|||
44558434|NCT03040986|79576002|FG000|Overall Study|Adverse Event|2|||
44558435|NCT03040986|79576003|FG001|Overall Study|Adverse Event|1|||
44558436|NCT03040986|79576002|FG000|Overall Study|Disease progression on study|3|||
44558437|NCT03040986|79576003|FG001|Overall Study|Disease progression on study|1|||
44558438|NCT03039192|79576013|FG000|Overall Study|Lost to Follow-up|4|||
44558439|NCT03039192|79576014|FG001|Overall Study|Lost to Follow-up|4|||
44558440|NCT03039192|79576013|FG000|Overall Study|Adverse event, serious fatal|0|||
44558441|NCT03039192|79576014|FG001|Overall Study|Adverse event, serious fatal|1|||
44558442|NCT03039192|79576013|FG000|Overall Study|Adverse event, non-fatal|0|||
44558443|NCT03039192|79576014|FG001|Overall Study|Adverse event, non-fatal|2|||
44558444|NCT03039192|79576013|FG000|Overall Study|Withdrawal by Subject|6|||
44558445|NCT03039192|79576014|FG001|Overall Study|Withdrawal by Subject|9|||
44558446|NCT03039192|79576013|FG000|Overall Study|Discontinued from treatment phase|19|||
44558447|NCT03039192|79576014|FG001|Overall Study|Discontinued from treatment phase|12|||
44558448|NCT03039192|79576013|FG000|Overall Study|Other|3|||
44558449|NCT03039192|79576014|FG001|Overall Study|Other|2|||
44558450|NCT03698279|79576026|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44558451|NCT03698279|79576027|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44558452|NCT03698279|79576028|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44558453|NCT03698279|79576029|FG003|Overall Study|Withdrawal by parent/guardian|1|||
44558454|NCT03698279|79576030|FG004|Overall Study|Withdrawal by parent/guardian|0|||
44558455|NCT03698279|79576031|FG005|Overall Study|Withdrawal by parent/guardian|0|||
44558456|NCT03698279|79576026|FG000|Overall Study|Protocol deviation|1|||
44558457|NCT03698279|79576027|FG001|Overall Study|Protocol deviation|0|||
44558458|NCT03698279|79576028|FG002|Overall Study|Protocol deviation|1|||
44558459|NCT03698279|79576029|FG003|Overall Study|Protocol deviation|0|||
44558460|NCT03698279|79576030|FG004|Overall Study|Protocol deviation|0|||
44558461|NCT03698279|79576031|FG005|Overall Study|Protocol deviation|0|||
44558462|NCT03698279|79576026|FG000|Overall Study|Withdrawal by Subject|0|||
44558463|NCT03698279|79576027|FG001|Overall Study|Withdrawal by Subject|0|||
44558464|NCT03698279|79576028|FG002|Overall Study|Withdrawal by Subject|1|||
44558465|NCT03698279|79576029|FG003|Overall Study|Withdrawal by Subject|0|||
44558466|NCT03698279|79576030|FG004|Overall Study|Withdrawal by Subject|0|||
44558467|NCT03698279|79576031|FG005|Overall Study|Withdrawal by Subject|0|||
44558468|NCT03698279|79576026|FG000|Overall Study|Lost to Follow-up|3|||
44558469|NCT03698279|79576027|FG001|Overall Study|Lost to Follow-up|1|||
44558470|NCT03698279|79576028|FG002|Overall Study|Lost to Follow-up|4|||
44558471|NCT03698279|79576029|FG003|Overall Study|Lost to Follow-up|5|||
44558472|NCT03698279|79576030|FG004|Overall Study|Lost to Follow-up|0|||
44558473|NCT03698279|79576031|FG005|Overall Study|Lost to Follow-up|0|||
44498396|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498397|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498398|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498399|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498400|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498401|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498402|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
44498403|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498404|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498405|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558474|NCT01529034|79576050|FG000|Overall Study|Discontinued prior to study treatment|14|||
44558475|NCT01529034|79576050|FG000|Overall Study|Site closure|62|||
44498406|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558476|NCT01529034|79576050|FG000|Overall Study|Study termination|29|||
44498407|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558477|NCT01529034|79576050|FG000|Overall Study|Withdrawal by Subject|25|||
44558478|NCT01529034|79576050|FG000|Overall Study|No treated SCs within protocol window|13|||
44558479|NCT01529034|79576050|FG000|Overall Study|Noncompliance|8|||
44558480|NCT01529034|79576050|FG000|Overall Study|Caregiver no longer available|7|||
44558481|NCT01529034|79576050|FG000|Overall Study|Adverse Event|4|||
44558482|NCT01529034|79576050|FG000|Overall Study|Protocol Violation|4|||
44558483|NCT01529034|79576050|FG000|Overall Study|Lack of Efficacy|4|||
44558484|NCT01529034|79576050|FG000|Overall Study|Investigator no longer available|2|||
44558485|NCT01529034|79576050|FG000|Overall Study|Study drug not available|2|||
44558486|NCT03036072|79576057|FG000|Overall Study|Death|0|||
44558487|NCT03036072|79576058|FG001|Overall Study|Death|1|||
44558488|NCT03036072|79576057|FG000|Overall Study|Withdrawal by Subject|0|||
44558489|NCT03036072|79576058|FG001|Overall Study|Withdrawal by Subject|1|||
44558490|NCT03036072|79576057|FG000|Overall Study|Physician Decision|0|||
44558491|NCT03036072|79576058|FG001|Overall Study|Physician Decision|1|||
44275242|NCT02207088|79221670|FG000|Overall Study|Adverse Event|2|||
44275243|NCT02206620|79221685|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
44498408|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498409|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558492|NCT03038880|79576067|FG000|Overall Study|Death|1|||
44558493|NCT03038880|79576068|FG001|Overall Study|Death|2|||
44558494|NCT03038880|79576069|FG002|Overall Study|Death|0|||
44558495|NCT03038880|79576067|FG000|Overall Study|Physician Decision|2|||
44558496|NCT03038880|79576068|FG001|Overall Study|Physician Decision|1|||
44558497|NCT03038880|79576069|FG002|Overall Study|Physician Decision|0|||
44558498|NCT03035916|79576080|FG000|Overall Study|Puncture failed|0|||
44558499|NCT03035916|79576081|FG001|Overall Study|Puncture failed|2|||
44558500|NCT03035916|79576082|FG002|Overall Study|Puncture failed|0|||
44558501|NCT01702571|79576092|FG000|Overall Study|Death|1067|||
44558502|NCT01702571|79576093|FG001|Overall Study|Death|76|||
44558503|NCT01702571|79576092|FG000|Overall Study|Lost to Follow-up|144|||
44498410|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558504|NCT01702571|79576093|FG001|Overall Study|Lost to Follow-up|10|||
44558505|NCT01702571|79576092|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
44558506|NCT01702571|79576093|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
44558507|NCT01702571|79576092|FG000|Overall Study|Investigator Decision|5|||
44558508|NCT01702571|79576093|FG001|Overall Study|Investigator Decision|0|||
44558509|NCT01702571|79576092|FG000|Overall Study|Not Classifiable|1|||
44558510|NCT01702571|79576093|FG001|Overall Study|Not Classifiable|0|||
44558511|NCT01702571|79576092|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
44558512|NCT01702571|79576093|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
44558513|NCT01702571|79576092|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
44558514|NCT01702571|79576093|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
44558515|NCT01702571|79576092|FG000|Overall Study|Progressive Disease|3|||
44558516|NCT01702571|79576093|FG001|Overall Study|Progressive Disease|0|||
44558517|NCT01702571|79576092|FG000|Overall Study|Protocol Violation|2|||
44558518|NCT01702571|79576093|FG001|Overall Study|Protocol Violation|0|||
44558519|NCT01702571|79576092|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
44558520|NCT01702571|79576093|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
44558521|NCT01702571|79576092|FG000|Overall Study|Termination By Sponsor|4|||
44558522|NCT01702571|79576093|FG001|Overall Study|Termination By Sponsor|0|||
44558523|NCT01702571|79576092|FG000|Overall Study|Withdrawal by Subject|177|||
44558524|NCT01702571|79576093|FG001|Overall Study|Withdrawal by Subject|29|||
44498411|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498412|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
44498413|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498414|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498415|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498416|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498417|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498418|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558525|NCT03231943|79576116|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558526|NCT03231943|79576117|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
44558527|NCT03231943|79576118|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
44558528|NCT03231943|79576119|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558529|NCT03231943|79576120|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558530|NCT03231943|79576121|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558531|NCT03231943|79576122|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558532|NCT03231943|79576123|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558533|NCT03231943|79576124|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558534|NCT03231943|79576125|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558535|NCT03231943|79576126|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558536|NCT03231943|79576127|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558537|NCT03231943|79576128|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
44558538|NCT03231943|79576116|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558539|NCT03231943|79576117|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
44558540|NCT03231943|79576118|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558541|NCT03231943|79576119|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558542|NCT03231943|79576120|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558543|NCT03231943|79576121|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558544|NCT03231943|79576122|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558545|NCT03231943|79576123|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558546|NCT03231943|79576124|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558547|NCT03231943|79576125|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558548|NCT03231943|79576126|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558549|NCT03231943|79576127|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558550|NCT03231943|79576128|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
44558551|NCT03231943|79576116|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
44558552|NCT03231943|79576117|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558553|NCT03231943|79576118|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558554|NCT03231943|79576119|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558555|NCT03231943|79576120|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558556|NCT03231943|79576121|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558557|NCT03231943|79576122|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558558|NCT03231943|79576123|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558559|NCT03231943|79576124|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558560|NCT03231943|79576125|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558561|NCT03231943|79576126|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558562|NCT03231943|79576127|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558563|NCT03231943|79576128|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
44558564|NCT03231943|79576116|FG000|Part 2|Adverse Event|0|||
44558565|NCT03231943|79576117|FG001|Part 2|Adverse Event|0|||
44558566|NCT03231943|79576118|FG002|Part 2|Adverse Event|0|||
44558567|NCT03231943|79576119|FG003|Part 2|Adverse Event|0|||
44558568|NCT03231943|79576120|FG004|Part 2|Adverse Event|0|||
44558569|NCT03231943|79576121|FG005|Part 2|Adverse Event|0|||
44558570|NCT03231943|79576122|FG006|Part 2|Adverse Event|0|||
44558571|NCT03231943|79576123|FG007|Part 2|Adverse Event|0|||
44558572|NCT03231943|79576124|FG008|Part 2|Adverse Event|0|||
44558573|NCT03231943|79576125|FG009|Part 2|Adverse Event|0|||
44558574|NCT03231943|79576126|FG010|Part 2|Adverse Event|1|||
44558575|NCT03231943|79576127|FG011|Part 2|Adverse Event|0|||
44558576|NCT03231943|79576128|FG012|Part 2|Adverse Event|0|||
44558577|NCT03231943|79576116|FG000|Part 2|Withdrawal by Subject|0|||
44558578|NCT03231943|79576117|FG001|Part 2|Withdrawal by Subject|0|||
44558579|NCT03231943|79576118|FG002|Part 2|Withdrawal by Subject|0|||
44558580|NCT03231943|79576119|FG003|Part 2|Withdrawal by Subject|0|||
44558581|NCT03231943|79576120|FG004|Part 2|Withdrawal by Subject|0|||
44558582|NCT03231943|79576121|FG005|Part 2|Withdrawal by Subject|0|||
44558583|NCT03231943|79576122|FG006|Part 2|Withdrawal by Subject|0|||
44558584|NCT03231943|79576123|FG007|Part 2|Withdrawal by Subject|0|||
44558585|NCT03231943|79576124|FG008|Part 2|Withdrawal by Subject|0|||
44558586|NCT03231943|79576125|FG009|Part 2|Withdrawal by Subject|0|||
44558587|NCT03231943|79576126|FG010|Part 2|Withdrawal by Subject|0|||
44558588|NCT03231943|79576127|FG011|Part 2|Withdrawal by Subject|1|||
44558589|NCT03231943|79576128|FG012|Part 2|Withdrawal by Subject|0|||
44558590|NCT01578239|79576160|FG000|Treatment Period|Progressive Disease|19|||
44558591|NCT01578239|79576161|FG001|Treatment Period|Progressive Disease|64|||
44558592|NCT01578239|79576160|FG000|Treatment Period|Physician Decision|17|||
44558593|NCT01578239|79576161|FG001|Treatment Period|Physician Decision|17|||
44558594|NCT01578239|79576160|FG000|Treatment Period|Adverse Event|13|||
44558595|NCT01578239|79576161|FG001|Treatment Period|Adverse Event|10|||
44558596|NCT01578239|79576160|FG000|Treatment Period|Non-compliance|2|||
44558597|NCT01578239|79576161|FG001|Treatment Period|Non-compliance|0|||
44558598|NCT01578239|79576160|FG000|Treatment Period|Withdrawal by Subject|10|||
44558599|NCT01578239|79576161|FG001|Treatment Period|Withdrawal by Subject|9|||
44558600|NCT01578239|79576160|FG000|Treatment Period|Other|6|||
44558601|NCT01578239|79576161|FG001|Treatment Period|Other|1|||
44558602|NCT01578239|79576160|FG000|Long-term Follow-Up Period|Death|69|||
44558603|NCT01578239|79576161|FG001|Long-term Follow-Up Period|Death|64|||
44558604|NCT01578239|79576160|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
44558605|NCT01578239|79576161|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
44558606|NCT01578239|79576160|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
44558607|NCT01578239|79576161|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
44558608|NCT01578239|79576160|FG000|Long-term Follow-Up Period|Other|2|||
44558609|NCT01578239|79576161|FG001|Long-term Follow-Up Period|Other|2|||
44558610|NCT03241927|79576167|FG000|Overall Study|study terminated|1|||
44558611|NCT03241927|79576168|FG001|Overall Study|study terminated|0|||
44558612|NCT03329885|79576180|FG000|Overall Study|Sponsor discontinued the study early|0|||
44558613|NCT03329885|79576181|FG001|Overall Study|Sponsor discontinued the study early|0|||
44558614|NCT03329885|79576182|FG002|Overall Study|Sponsor discontinued the study early|0|||
44558615|NCT03329885|79576183|FG003|Overall Study|Sponsor discontinued the study early|0|||
44558616|NCT03329885|79576184|FG004|Overall Study|Sponsor discontinued the study early|0|||
44558617|NCT03329885|79576185|FG005|Overall Study|Sponsor discontinued the study early|0|||
44558618|NCT03329885|79576186|FG006|Overall Study|Sponsor discontinued the study early|1|||
44558619|NCT03329885|79576187|FG007|Overall Study|Sponsor discontinued the study early|1|||
44558620|NCT03329885|79576188|FG008|Overall Study|Sponsor discontinued the study early|0|||
44558621|NCT02941523|79576210|FG000|Monotherapy|Withdrawal by Subject|0|||
44558622|NCT02941523|79576211|FG001|Monotherapy|Withdrawal by Subject|1|||
44558623|NCT02941523|79576210|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
44558624|NCT02941523|79576211|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
44558625|NCT02941523|79576210|FG000|Carboplatin Combination Therapy|Death|1|||
44558626|NCT02941523|79576211|FG001|Carboplatin Combination Therapy|Death|2|||
44558627|NCT02941523|79576210|FG000|Carboplatin Combination Therapy|Disease progression|2|||
44558628|NCT02941523|79576211|FG001|Carboplatin Combination Therapy|Disease progression|0|||
44558629|NCT02941523|79576210|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
44558630|NCT02941523|79576211|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
44558631|NCT02938585|79576229|FG000|Overall Study|Withdrawal by parent or guardian|0|||
44558632|NCT02938585|79576230|FG001|Overall Study|Withdrawal by parent or guardian|1|||
44558633|NCT02938585|79576231|FG002|Overall Study|Withdrawal by parent or guardian|0|||
44558634|NCT02938585|79576232|FG003|Overall Study|Withdrawal by parent or guardian|0|||
44558635|NCT02938585|79576229|FG000|Overall Study|Withdrawal by Subject|0|||
44558636|NCT02938585|79576230|FG001|Overall Study|Withdrawal by Subject|0|||
44558637|NCT02938585|79576231|FG002|Overall Study|Withdrawal by Subject|0|||
44498419|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498420|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498421|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498422|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498423|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498424|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498425|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558638|NCT02938585|79576232|FG003|Overall Study|Withdrawal by Subject|5|||
44558639|NCT03229759|79576256|FG000|Overall Study|Screen Failure|30|||
44558640|NCT03228433|79576268|FG000|Overall Study|Lost to Follow-up|1|||
44558641|NCT03228433|79576269|FG001|Overall Study|Lost to Follow-up|0|||
44232537|NCT01802333|79049096|FG000|Overall Study|Other - not protocol specified|32|||
44232538|NCT01802333|79049097|FG001|Overall Study|Other - not protocol specified|22|||
44558642|NCT03228433|79576270|FG002|Overall Study|Lost to Follow-up|0|||
44558643|NCT03228433|79576271|FG003|Overall Study|Lost to Follow-up|0|||
44498426|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44558644|NCT03228433|79576272|FG004|Overall Study|Lost to Follow-up|0|||
44558645|NCT03228433|79576273|FG005|Overall Study|Lost to Follow-up|0|||
44558646|NCT03228433|79576268|FG000|Overall Study|Positive alcohol test|0|||
44558647|NCT03228433|79576269|FG001|Overall Study|Positive alcohol test|0|||
44558648|NCT03228433|79576270|FG002|Overall Study|Positive alcohol test|0|||
44558649|NCT03228433|79576271|FG003|Overall Study|Positive alcohol test|1|||
44558650|NCT03228433|79576272|FG004|Overall Study|Positive alcohol test|0|||
44558651|NCT03228433|79576273|FG005|Overall Study|Positive alcohol test|0|||
44558652|NCT01496118|79576303|FG000|Overall Study|Disease progression|3|||
44558653|NCT01496118|79576304|FG001|Overall Study|Disease progression|2|||
44558654|NCT01496118|79576305|FG002|Overall Study|Disease progression|3|||
44558655|NCT01496118|79576306|FG003|Overall Study|Disease progression|1|||
44558656|NCT01496118|79576307|FG004|Overall Study|Disease progression|2|||
44558657|NCT01496118|79576308|FG005|Overall Study|Disease progression|2|||
44498427|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498428|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
44498429|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498430|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
44558658|NCT01496118|79576309|FG006|Overall Study|Disease progression|14|||
44558659|NCT01496118|79576310|FG007|Overall Study|Disease progression|10|||
44558660|NCT01496118|79576303|FG000|Overall Study|Physician Decision|0|||
44558661|NCT01496118|79576304|FG001|Overall Study|Physician Decision|0|||
44558662|NCT01496118|79576305|FG002|Overall Study|Physician Decision|0|||
44558663|NCT01496118|79576306|FG003|Overall Study|Physician Decision|0|||
44558664|NCT01496118|79576307|FG004|Overall Study|Physician Decision|1|||
44558665|NCT01496118|79576308|FG005|Overall Study|Physician Decision|0|||
44498431|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498432|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498433|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498434|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498435|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498436|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498437|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498438|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
44498439|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498440|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498441|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498442|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498443|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498444|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
44558666|NCT01496118|79576309|FG006|Overall Study|Physician Decision|3|||
44558667|NCT01496118|79576310|FG007|Overall Study|Physician Decision|6|||
44558668|NCT01496118|79576303|FG000|Overall Study|Adverse Event|1|||
44558669|NCT01496118|79576304|FG001|Overall Study|Adverse Event|1|||
44558670|NCT01496118|79576305|FG002|Overall Study|Adverse Event|0|||
44558671|NCT01496118|79576306|FG003|Overall Study|Adverse Event|0|||
44558672|NCT01496118|79576307|FG004|Overall Study|Adverse Event|0|||
44558673|NCT01496118|79576308|FG005|Overall Study|Adverse Event|0|||
44558674|NCT01496118|79576309|FG006|Overall Study|Adverse Event|6|||
44558675|NCT01496118|79576310|FG007|Overall Study|Adverse Event|10|||
44558676|NCT01496118|79576303|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558677|NCT01496118|79576304|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558678|NCT01496118|79576305|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558679|NCT01496118|79576306|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558680|NCT01496118|79576307|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558681|NCT01496118|79576308|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558682|NCT01496118|79576309|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
44558683|NCT01496118|79576310|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
44558684|NCT01496118|79576303|FG000|Overall Study|Death|0|||
44558685|NCT01496118|79576304|FG001|Overall Study|Death|0|||
44558686|NCT01496118|79576305|FG002|Overall Study|Death|0|||
44558687|NCT01496118|79576306|FG003|Overall Study|Death|0|||
44558688|NCT01496118|79576307|FG004|Overall Study|Death|0|||
44558689|NCT01496118|79576308|FG005|Overall Study|Death|0|||
44558690|NCT01496118|79576309|FG006|Overall Study|Death|1|||
44558691|NCT01496118|79576310|FG007|Overall Study|Death|1|||
44558692|NCT01496118|79576303|FG000|Overall Study|Withdrawal by Subject|0|||
44558693|NCT01496118|79576304|FG001|Overall Study|Withdrawal by Subject|0|||
44558694|NCT01496118|79576305|FG002|Overall Study|Withdrawal by Subject|0|||
44558695|NCT01496118|79576306|FG003|Overall Study|Withdrawal by Subject|2|||
44558696|NCT01496118|79576307|FG004|Overall Study|Withdrawal by Subject|0|||
44558697|NCT01496118|79576308|FG005|Overall Study|Withdrawal by Subject|1|||
44558698|NCT01496118|79576309|FG006|Overall Study|Withdrawal by Subject|6|||
44558699|NCT01496118|79576310|FG007|Overall Study|Withdrawal by Subject|3|||
44558700|NCT02936869|79576330|FG000|Overall Study|Lost to Follow-up|1|||
44558701|NCT02936869|79576331|FG001|Overall Study|Lost to Follow-up|3|||
44558702|NCT02936869|79576330|FG000|Overall Study|Death|0|||
44558703|NCT02936869|79576331|FG001|Overall Study|Death|1|||
44558704|NCT02936869|79576330|FG000|Overall Study|Legal Case|0|||
44558705|NCT02936869|79576331|FG001|Overall Study|Legal Case|1|||
44558706|NCT02936869|79576330|FG000|Overall Study|Protocol Violation|1|||
44558707|NCT02936869|79576331|FG001|Overall Study|Protocol Violation|0|||
44558708|NCT03309605|79576346|FG000|Overall Study|Adverse Event|0|||
44558709|NCT03309605|79576347|FG001|Overall Study|Adverse Event|0|||
44558710|NCT03309605|79576348|FG002|Overall Study|Adverse Event|0|||
44558711|NCT03309605|79576349|FG003|Overall Study|Adverse Event|1|||
44558712|NCT03309605|79576350|FG004|Overall Study|Adverse Event|0|||
44558713|NCT03309605|79576351|FG005|Overall Study|Adverse Event|0|||
44558714|NCT03309605|79576352|FG006|Overall Study|Adverse Event|2|||
44558715|NCT03309605|79576353|FG007|Overall Study|Adverse Event|1|||
44558716|NCT03309605|79576346|FG000|Overall Study|Withdrawal by Subject|0|||
44558717|NCT03309605|79576347|FG001|Overall Study|Withdrawal by Subject|0|||
44558718|NCT03309605|79576348|FG002|Overall Study|Withdrawal by Subject|0|||
44558719|NCT03309605|79576349|FG003|Overall Study|Withdrawal by Subject|0|||
44558720|NCT03309605|79576350|FG004|Overall Study|Withdrawal by Subject|1|||
44558721|NCT03309605|79576351|FG005|Overall Study|Withdrawal by Subject|0|||
44558722|NCT03309605|79576352|FG006|Overall Study|Withdrawal by Subject|1|||
44558723|NCT03309605|79576353|FG007|Overall Study|Withdrawal by Subject|1|||
44498445|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498446|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498447|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498448|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498449|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498450|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498451|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498452|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498453|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498454|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
44498455|NCT00112437|79503590|FG000|Year 2 (12-Month Extension)|Moved|0|||
44498456|NCT00112437|79503591|FG001|Year 2 (12-Month Extension)|Moved|0|||
44498457|NCT00112437|79503592|FG002|Year 2 (12-Month Extension)|Moved|0|||
44498458|NCT00112437|79503593|FG003|Year 2 (12-Month Extension)|Moved|0|||
44498459|NCT00112437|79503594|FG004|Year 2 (12-Month Extension)|Moved|0|||
44498460|NCT00112437|79503595|FG005|Year 2 (12-Month Extension)|Moved|0|||
44275244|NCT02206620|79221686|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
44275245|NCT02206620|79221685|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
44275246|NCT02206620|79221686|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
44275247|NCT02239926|79221700|FG000|Overall Study|Withdrawal by Subject|0|||
44275248|NCT02239926|79221701|FG001|Overall Study|Withdrawal by Subject|1|||
44498461|NCT00112437|79503596|FG006|Year 2 (12-Month Extension)|Moved|0|||
44558724|NCT02936635|79576369|FG000|Overall Study|Adverse Event|43|||
44558725|NCT02936635|79576370|FG001|Overall Study|Adverse Event|25|||
44558726|NCT02936635|79576369|FG000|Overall Study|Progressive Disease|10|||
44558727|NCT02936635|79576370|FG001|Overall Study|Progressive Disease|18|||
44558728|NCT02936635|79576369|FG000|Overall Study|Sponsor Discretion|10|||
44558729|NCT02936635|79576370|FG001|Overall Study|Sponsor Discretion|16|||
44498462|NCT00112437|79503597|FG007|Year 2 (12-Month Extension)|Moved|0|||
44498463|NCT00112437|79503598|FG008|Year 2 (12-Month Extension)|Moved|0|||
44498464|NCT00112437|79503599|FG009|Year 2 (12-Month Extension)|Moved|1|||
44498465|NCT00112437|79503600|FG010|Year 2 (12-Month Extension)|Moved|0|||
44498466|NCT00112437|79503601|FG011|Year 2 (12-Month Extension)|Moved|0|||
44498467|NCT00112437|79503602|FG012|Year 2 (12-Month Extension)|Moved|0|||
44498468|NCT00112437|79503603|FG013|Year 2 (12-Month Extension)|Moved|0|||
44498469|NCT00112437|79503604|FG014|Year 2 (12-Month Extension)|Moved|0|||
44498470|NCT00112437|79503605|FG015|Year 2 (12-Month Extension)|Moved|0|||
44498471|NCT00112437|79503606|FG016|Year 2 (12-Month Extension)|Moved|0|||
44498472|NCT00112437|79503607|FG017|Year 2 (12-Month Extension)|Moved|0|||
44498473|NCT00112437|79503608|FG018|Year 2 (12-Month Extension)|Moved|0|||
44558730|NCT02936635|79576369|FG000|Overall Study|Death|9|||
44558731|NCT02936635|79576370|FG001|Overall Study|Death|15|||
44558732|NCT02936635|79576369|FG000|Overall Study|Withdrawal by Subject|8|||
44558733|NCT02936635|79576370|FG001|Overall Study|Withdrawal by Subject|15|||
44558734|NCT02936635|79576369|FG000|Overall Study|Physician Decision|2|||
44558735|NCT02936635|79576370|FG001|Overall Study|Physician Decision|9|||
44558736|NCT02936635|79576369|FG000|Overall Study|Lost to Follow-up|1|||
44498474|NCT00112437|79503609|FG019|Year 2 (12-Month Extension)|Moved|0|||
44558737|NCT02936635|79576370|FG001|Overall Study|Lost to Follow-up|2|||
44558738|NCT02936635|79576369|FG000|Overall Study|Protocol Violation|1|||
44558739|NCT02936635|79576370|FG001|Overall Study|Protocol Violation|0|||
44558740|NCT02936635|79576369|FG000|Overall Study|Lack of effect/Entry into other study|31|||
44558741|NCT02936635|79576370|FG001|Overall Study|Lack of effect/Entry into other study|65|||
44558742|NCT03227029|79576379|FG000|Overall Study|Child Wheezed (no treatment)|0|||
44558743|NCT03227029|79576380|FG001|Overall Study|Child Wheezed (no treatment)|1|||
44558744|NCT03227029|79576381|FG002|Overall Study|Child Wheezed (no treatment)|0|||
44558745|NCT03227029|79576379|FG000|Overall Study|No post RSV season visit due to COVID|3|||
44558746|NCT03227029|79576380|FG001|Overall Study|No post RSV season visit due to COVID|3|||
44558747|NCT03227029|79576381|FG002|Overall Study|No post RSV season visit due to COVID|2|||
44558748|NCT03227029|79576379|FG000|Overall Study|Not able to get to clinic|0|||
44558749|NCT03227029|79576380|FG001|Overall Study|Not able to get to clinic|0|||
44558750|NCT03227029|79576381|FG002|Overall Study|Not able to get to clinic|1|||
44558751|NCT03227029|79576379|FG000|Overall Study|Withdrawal by Subject|1|||
44558752|NCT03227029|79576380|FG001|Overall Study|Withdrawal by Subject|0|||
44558753|NCT03227029|79576381|FG002|Overall Study|Withdrawal by Subject|0|||
44558754|NCT03227029|79576379|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
44558755|NCT03227029|79576380|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
44558756|NCT03227029|79576381|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
44558757|NCT03329573|79576393|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
44558758|NCT03329573|79576394|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
44558759|NCT03329573|79576395|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
44558760|NCT03329573|79576396|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
44558761|NCT03329573|79576393|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
44558762|NCT03329573|79576394|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
44558763|NCT03329573|79576395|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44558764|NCT03329573|79576396|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
44558765|NCT03329573|79576393|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
44558766|NCT03329573|79576394|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
44558767|NCT03329573|79576395|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
44558768|NCT03329573|79576396|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
44558769|NCT03329573|79576393|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
44558770|NCT03329573|79576394|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
44558771|NCT03329573|79576395|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
44558772|NCT03329573|79576396|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
44498475|NCT00112437|79503610|FG020|Year 2 (12-Month Extension)|Moved|0|||
44498476|NCT00112437|79503611|FG021|Year 2 (12-Month Extension)|Moved|0|||
44498477|NCT00112437|79503612|FG022|Year 2 (12-Month Extension)|Moved|0|||
44498478|NCT00112437|79503613|FG023|Year 2 (12-Month Extension)|Moved|0|||
44498479|NCT00112437|79503614|FG024|Year 2 (12-Month Extension)|Moved|0|||
44498480|NCT00112437|79503615|FG025|Year 2 (12-Month Extension)|Moved|0|||
44498481|NCT00112437|79503590|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
44498482|NCT00112437|79503591|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
44498483|NCT00112437|79503592|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
44498484|NCT00112437|79503593|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
44498485|NCT00112437|79503594|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
44498486|NCT00112437|79503595|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
44498487|NCT00112437|79503596|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
44498488|NCT00112437|79503597|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
44498489|NCT00112437|79503598|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
44498490|NCT00112437|79503599|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
44498491|NCT00112437|79503600|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
44498492|NCT00112437|79503601|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
44498493|NCT00112437|79503602|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
44498494|NCT00112437|79503603|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
44498495|NCT00112437|79503604|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
44498496|NCT00112437|79503605|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
44498497|NCT00112437|79503606|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
44232539|NCT01802333|79049098|FG002|Overall Study|Other - not protocol specified|24|||
44498498|NCT00112437|79503607|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
44232540|NCT01802333|79049096|FG000|Overall Study|Did not start treatment|0|||
44498499|NCT00112437|79503608|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
44498500|NCT00112437|79503609|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
44558773|NCT03308825|79576427|FG000|Overall Study|Lost to Follow-up|2|||
44558774|NCT03308825|79576428|FG001|Overall Study|Lost to Follow-up|2|||
44558775|NCT03308825|79576429|FG002|Overall Study|Lost to Follow-up|1|||
44558776|NCT03308825|79576430|FG003|Overall Study|Lost to Follow-up|0|||
44558777|NCT03308825|79576427|FG000|Overall Study|Protocol Violation|0|||
44558778|NCT03308825|79576428|FG001|Overall Study|Protocol Violation|2|||
44558779|NCT03308825|79576429|FG002|Overall Study|Protocol Violation|0|||
44558780|NCT03308825|79576430|FG003|Overall Study|Protocol Violation|0|||
44558781|NCT03328325|79576444|FG000|Overall Study|Lost to Follow-up|4|||
44558782|NCT03328325|79576444|FG000|Overall Study|Physician Decision|1|||
44558783|NCT03328325|79576444|FG000|Overall Study|Withdrawal by Subject|3|||
44558784|NCT03328325|79576444|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
44558785|NCT03305081|79576454|FG000|Overall Study|Lost to Follow-up|10|||
44558786|NCT03305081|79576455|FG001|Overall Study|Lost to Follow-up|15|||
44558787|NCT03325673|79576473|FG000|Overall Study|Adverse Event|4|||
44558788|NCT03325673|79576474|FG001|Overall Study|Adverse Event|0|||
44558789|NCT03223909|79576483|FG000|Overall Study|Protocol Violation|48|||
44558790|NCT03223909|79576484|FG001|Overall Study|Protocol Violation|45|||
44558791|NCT03223909|79576485|FG002|Overall Study|Protocol Violation|16|||
44558792|NCT03733925|79576493|FG000|Overall Study|Lost to Follow-up|1|||
44558793|NCT03733925|79576493|FG000|Overall Study|Withdrawal by Subject|2|||
44558794|NCT03733925|79576493|FG000|Overall Study|Adverse Event|2|||
44558795|NCT03733925|79576493|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44558796|NCT03649711|79576500|FG000|Overall Study|Adverse Event|0|||
44558797|NCT03649711|79576501|FG001|Overall Study|Adverse Event|1|||
44558798|NCT03649711|79576502|FG002|Overall Study|Adverse Event|0|||
44558799|NCT03649711|79576500|FG000|Overall Study|Kidney Transplant|1|||
44558800|NCT03649711|79576501|FG001|Overall Study|Kidney Transplant|0|||
44558801|NCT03649711|79576502|FG002|Overall Study|Kidney Transplant|0|||
44558802|NCT03303521|79576512|FG000|Overall Study|Withdrawal by Subject|2|||
44558803|NCT03303521|79576513|FG001|Overall Study|Withdrawal by Subject|0|||
44558804|NCT03303521|79576512|FG000|Overall Study|Death|1|||
44558805|NCT03303521|79576513|FG001|Overall Study|Death|0|||
44558806|NCT03303521|79576512|FG000|Overall Study|Kidney transplantation|0|||
44558807|NCT03303521|79576513|FG001|Overall Study|Kidney transplantation|1|||
44558808|NCT03303521|79576512|FG000|Overall Study|Investigational product discontinuation|0|||
44558809|NCT03303521|79576513|FG001|Overall Study|Investigational product discontinuation|1|||
44558810|NCT03303521|79576512|FG000|Overall Study|Transferred to non-study dialysis center|1|||
44558811|NCT03303521|79576513|FG001|Overall Study|Transferred to non-study dialysis center|0|||
44558812|NCT03303521|79576512|FG000|Overall Study|Non-comliance to study protocol|0|||
44558813|NCT03303521|79576513|FG001|Overall Study|Non-comliance to study protocol|1|||
44558814|NCT03303521|79576512|FG000|Overall Study|Adverse Event|1|||
44558815|NCT03303521|79576513|FG001|Overall Study|Adverse Event|0|||
44558816|NCT03214081|79576519|FG000|Overall Study|Case Report Forms Uncollected|9|||
44498501|NCT00112437|79503610|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
44498502|NCT00112437|79503611|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
44498503|NCT00112437|79503612|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
44498504|NCT00112437|79503613|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
44498505|NCT00112437|79503614|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
44498506|NCT00112437|79503615|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
44498507|NCT00112437|79503590|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498508|NCT00112437|79503591|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498509|NCT00112437|79503592|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44558817|NCT03214081|79576519|FG000|Overall Study|Protocol Deviation|54|||
44558818|NCT02888171|79576525|FG000|Overall Study|Lost to Follow-up|2|||
44558819|NCT02888171|79576526|FG001|Overall Study|Lost to Follow-up|1|||
44558820|NCT02888171|79576525|FG000|Overall Study|Withdrawal by Subject|3|||
44558821|NCT02888171|79576526|FG001|Overall Study|Withdrawal by Subject|2|||
44558822|NCT02888171|79576525|FG000|Overall Study|Adverse Event|0|||
44558823|NCT02888171|79576526|FG001|Overall Study|Adverse Event|1|||
44558824|NCT02932891|79576532|FG000|Overall Study|Lost to Follow-up|2|||
44558825|NCT02932891|79576532|FG000|Overall Study|HPA Suppress|2|||
44558826|NCT03302975|79576536|FG000|Overall Study|Lost to Follow-up|4|||
44558827|NCT03212521|79576540|FG000|Overall Study|Adverse Event|1|||
44558828|NCT03212521|79576540|FG000|Overall Study|Lost to Follow-up|4|||
44558829|NCT03212521|79576540|FG000|Overall Study|Withdrawal by Subject|1|||
44558830|NCT03212521|79576540|FG000|Overall Study|Other|1|||
44558831|NCT03212365|79576546|FG000|Overall Study|Discharged prior to Xa level|12|||
44558832|NCT03212365|79576547|FG001|Overall Study|Discharged prior to Xa level|8|||
44558833|NCT03212365|79576546|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
44558834|NCT03212365|79576547|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
44558835|NCT03212365|79576546|FG000|Overall Study|Refused study medication|3|||
44558836|NCT03212365|79576547|FG001|Overall Study|Refused study medication|0|||
44558837|NCT03212365|79576546|FG000|Overall Study|Initiated heparin infusion on floor|1|||
44558838|NCT03212365|79576547|FG001|Overall Study|Initiated heparin infusion on floor|1|||
44558839|NCT03212365|79576546|FG000|Overall Study|Unexpected return to OR|1|||
44558840|NCT03212365|79576547|FG001|Overall Study|Unexpected return to OR|1|||
44558841|NCT03212365|79576546|FG000|Overall Study|Medication distribution error|1|||
44558842|NCT03212365|79576547|FG001|Overall Study|Medication distribution error|0|||
44558843|NCT03212365|79576546|FG000|Overall Study|Required epidural placement|1|||
44558844|NCT03212365|79576547|FG001|Overall Study|Required epidural placement|0|||
44558845|NCT03212365|79576546|FG000|Overall Study|Withdrawal by Subject|0|||
44558846|NCT03212365|79576547|FG001|Overall Study|Withdrawal by Subject|1|||
44558847|NCT03212365|79576546|FG000|Overall Study|developed acute renal failure|0|||
44558848|NCT03212365|79576547|FG001|Overall Study|developed acute renal failure|1|||
44558849|NCT03273257|79576555|FG000|Overall Study|Death|0|||
44558850|NCT03273257|79576556|FG001|Overall Study|Death|1|||
44558851|NCT03273257|79576555|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
44558852|NCT03273257|79576556|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
44558853|NCT03273257|79576555|FG000|Overall Study|Study terminated|3|||
44558854|NCT03273257|79576556|FG001|Overall Study|Study terminated|2|||
44558855|NCT04316741|79576564|FG000|Baseline Enrollment|Lost to Follow-up|1|||
44558856|NCT04316741|79576565|FG001|Baseline Enrollment|Lost to Follow-up|1|||
44558857|NCT04316741|79576564|FG000|Immediate Post-Test|Lost to Follow-up|5|||
44558858|NCT04316741|79576565|FG001|Immediate Post-Test|Lost to Follow-up|1|||
44558859|NCT04316741|79576564|FG000|1-month Post-test|Lost to Follow-up|7|||
44558860|NCT04316741|79576565|FG001|1-month Post-test|Lost to Follow-up|2|||
44558861|NCT04316741|79576564|FG000|3-month Follow-up|Lost to Follow-up|10|||
44558862|NCT04316741|79576565|FG001|3-month Follow-up|Lost to Follow-up|2|||
44558863|NCT03271307|79576575|FG000|Overall Study|Lost to Follow-up|0|||
44558864|NCT03271307|79576576|FG001|Overall Study|Lost to Follow-up|0|||
44558865|NCT03271307|79576577|FG002|Overall Study|Lost to Follow-up|0|||
44558866|NCT03271307|79576578|FG003|Overall Study|Lost to Follow-up|28|||
44558867|NCT03271307|79576579|FG004|Overall Study|Lost to Follow-up|91|||
44558868|NCT03271151|79576596|FG000|Overall Study|Lost to Follow-up|1|||
44558869|NCT03271151|79576597|FG001|Overall Study|Lost to Follow-up|3|||
44558870|NCT03271151|79576596|FG000|Overall Study|Withdrawal by Subject|1|||
44558871|NCT03271151|79576597|FG001|Overall Study|Withdrawal by Subject|0|||
44558872|NCT03245723|79576605|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
44558873|NCT03245723|79576606|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
44558874|NCT03245723|79576605|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
44558875|NCT03245723|79576606|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
44558876|NCT03245723|79576605|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
44558877|NCT03245723|79576606|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
44558878|NCT03245723|79576605|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
44558879|NCT03245723|79576606|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
44558880|NCT03301649|79576615|FG000|Overall Study|Need alternate therapy due to live lice|17|||
44558881|NCT03301649|79576616|FG001|Overall Study|Need alternate therapy due to live lice|25|||
44558882|NCT03301649|79576617|FG002|Overall Study|Need alternate therapy due to live lice|81|||
44558883|NCT03301649|79576615|FG000|Overall Study|Lost to Follow-up|11|||
44558884|NCT03301649|79576616|FG001|Overall Study|Lost to Follow-up|11|||
44558885|NCT03301649|79576617|FG002|Overall Study|Lost to Follow-up|3|||
44558886|NCT03301649|79576615|FG000|Overall Study|Protocol Violation|0|||
44558887|NCT03301649|79576616|FG001|Overall Study|Protocol Violation|1|||
44558888|NCT03301649|79576617|FG002|Overall Study|Protocol Violation|1|||
44558889|NCT03301649|79576615|FG000|Overall Study|Withdrawal by Subject|10|||
44558890|NCT03301649|79576616|FG001|Overall Study|Withdrawal by Subject|4|||
44558891|NCT03301649|79576617|FG002|Overall Study|Withdrawal by Subject|0|||
44558892|NCT03301649|79576615|FG000|Overall Study|Other than specified|5|||
44558893|NCT03301649|79576616|FG001|Overall Study|Other than specified|3|||
44558894|NCT03301649|79576617|FG002|Overall Study|Other than specified|0|||
44558895|NCT03222973|79576627|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
44558896|NCT03222973|79576628|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
44558897|NCT03222973|79576629|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
44558898|NCT03222973|79576630|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
44558899|NCT03222973|79576627|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
44558900|NCT03222973|79576628|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
44558901|NCT03222973|79576629|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
44558902|NCT03222973|79576630|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
44558903|NCT03222973|79576627|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
44558904|NCT03222973|79576628|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
44558905|NCT03222973|79576629|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
44558906|NCT03222973|79576630|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
44558907|NCT03222973|79576627|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
44558908|NCT03222973|79576628|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
44558909|NCT03222973|79576629|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
44558910|NCT03222973|79576630|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
44558911|NCT03222973|79576627|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
44558912|NCT03222973|79576628|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
44558913|NCT03222973|79576629|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
44558914|NCT03222973|79576630|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
44558915|NCT03222973|79576627|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
44558916|NCT03222973|79576628|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
44558917|NCT03222973|79576629|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
44558918|NCT03222973|79576630|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
44558919|NCT03222973|79576627|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
44558920|NCT03222973|79576628|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
44558921|NCT03222973|79576629|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
44558922|NCT03222973|79576630|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
44558923|NCT03222973|79576627|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
44498510|NCT00112437|79503593|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44558924|NCT03222973|79576628|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
44558925|NCT03222973|79576629|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
44558926|NCT03222973|79576630|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
44558927|NCT03222973|79576627|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
44558928|NCT03222973|79576628|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
44558929|NCT03222973|79576629|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
44558930|NCT03222973|79576630|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
44558931|NCT03222973|79576627|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
44558932|NCT03222973|79576628|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
44558933|NCT03222973|79576629|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
44558934|NCT03222973|79576630|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
44558935|NCT03222973|79576627|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
44558936|NCT03222973|79576628|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
44558937|NCT03222973|79576629|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
44558938|NCT03222973|79576630|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
44558939|NCT03222973|79576627|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
44232541|NCT01802333|79049097|FG001|Overall Study|Did not start treatment|2|||
44232542|NCT01802333|79049098|FG002|Overall Study|Did not start treatment|5|||
44498511|NCT00112437|79503594|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498512|NCT00112437|79503595|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498513|NCT00112437|79503596|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498514|NCT00112437|79503597|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498515|NCT00112437|79503598|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498516|NCT00112437|79503599|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498517|NCT00112437|79503600|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498518|NCT00112437|79503601|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
44498519|NCT00112437|79503602|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498520|NCT00112437|79503603|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
44498521|NCT00112437|79503604|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498522|NCT00112437|79503605|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
44498523|NCT00112437|79503606|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498524|NCT00112437|79503607|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498525|NCT00112437|79503608|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
44498526|NCT00112437|79503609|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498527|NCT00112437|79503610|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498528|NCT00112437|79503611|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498529|NCT00112437|79503612|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498530|NCT00112437|79503613|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498531|NCT00112437|79503614|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498532|NCT00112437|79503615|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
44498533|NCT00112437|79503590|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498534|NCT00112437|79503591|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498535|NCT00112437|79503592|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498536|NCT00112437|79503593|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498537|NCT00112437|79503594|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498538|NCT00112437|79503595|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498539|NCT00112437|79503596|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498540|NCT00112437|79503597|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498541|NCT00112437|79503598|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44558940|NCT03222973|79576628|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
44232543|NCT00980655|79049143|FG000|Overall Study|Adverse Event|13|||
44232544|NCT00980655|79049144|FG001|Overall Study|Adverse Event|31|||
44232545|NCT00980655|79049143|FG000|Overall Study|Death|0|||
44232546|NCT00980655|79049144|FG001|Overall Study|Death|7|||
44498542|NCT00112437|79503599|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44558941|NCT03222973|79576629|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
44558942|NCT03222973|79576630|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
44558943|NCT01144416|79576642|FG000|Intervention Period|Adverse Event|5|||
44558944|NCT01144416|79576643|FG001|Intervention Period|Adverse Event|6|||
44558945|NCT01144416|79576642|FG000|Intervention Period|Insufficient ovarian response|11|||
44558946|NCT01144416|79576643|FG001|Intervention Period|Insufficient ovarian response|17|||
44558947|NCT01144416|79576642|FG000|Intervention Period|Risk of OHSS|0|||
44558948|NCT01144416|79576643|FG001|Intervention Period|Risk of OHSS|1|||
44558949|NCT01144416|79576642|FG000|Intervention Period|Too high ovarian response|4|||
44558950|NCT01144416|79576643|FG001|Intervention Period|Too high ovarian response|2|||
44558951|NCT01144416|79576642|FG000|Intervention Period|No/too few/bad oocytes|7|||
44558952|NCT01144416|79576643|FG001|Intervention Period|No/too few/bad oocytes|5|||
44558953|NCT01144416|79576642|FG000|Intervention Period|No or abnormal fertilization|25|||
44558954|NCT01144416|79576643|FG001|Intervention Period|No or abnormal fertilization|10|||
44558955|NCT01144416|79576642|FG000|Intervention Period|No/too few/bad quality embryos|3|||
44558956|NCT01144416|79576643|FG001|Intervention Period|No/too few/bad quality embryos|3|||
44558957|NCT01144416|79576642|FG000|Intervention Period|Other|7|||
44558958|NCT01144416|79576643|FG001|Intervention Period|Other|5|||
44558959|NCT00335777|79576653|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
44558960|NCT00335777|79576653|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
44558961|NCT00335777|79576653|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
44558962|NCT00335777|79576653|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
44558963|NCT00335777|79576653|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
44558964|NCT01140048|79576658|FG000|Overall Study|Physician Decision|1|||
44558965|NCT01140048|79576658|FG000|Overall Study|Withdrawal by Subject|13|||
44558966|NCT01140048|79576658|FG000|Overall Study|Lost to Follow-up|31|||
44558967|NCT00972738|79576669|FG000|Overall Study|Adverse Event|7|||
44558968|NCT00972738|79576670|FG001|Overall Study|Adverse Event|1|||
44558969|NCT00972738|79576671|FG002|Overall Study|Adverse Event|8|||
44558970|NCT00972738|79576669|FG000|Overall Study|Protocol Violation|2|||
44558971|NCT00972738|79576670|FG001|Overall Study|Protocol Violation|1|||
44558972|NCT00972738|79576671|FG002|Overall Study|Protocol Violation|3|||
44558973|NCT00972738|79576669|FG000|Overall Study|Lost to Follow-up|1|||
44558974|NCT00972738|79576670|FG001|Overall Study|Lost to Follow-up|0|||
44558975|NCT00972738|79576671|FG002|Overall Study|Lost to Follow-up|1|||
44558976|NCT00972738|79576669|FG000|Overall Study|Lack of Efficacy|5|||
44558977|NCT00972738|79576670|FG001|Overall Study|Lack of Efficacy|1|||
44558978|NCT00972738|79576671|FG002|Overall Study|Lack of Efficacy|11|||
44558979|NCT00972738|79576669|FG000|Overall Study|Withdrawal by Subject|5|||
44558980|NCT00972738|79576670|FG001|Overall Study|Withdrawal by Subject|1|||
44558981|NCT00972738|79576671|FG002|Overall Study|Withdrawal by Subject|4|||
44558982|NCT00972738|79576669|FG000|Overall Study|Moved|0|||
44558983|NCT00972738|79576670|FG001|Overall Study|Moved|0|||
44558984|NCT00972738|79576671|FG002|Overall Study|Moved|1|||
44558985|NCT00972738|79576669|FG000|Overall Study|Other|1|||
44558986|NCT00972738|79576670|FG001|Overall Study|Other|2|||
44558987|NCT00972738|79576671|FG002|Overall Study|Other|1|||
44558988|NCT03243305|79576679|FG000|Overall Study|Lost to Follow-up|250|||
44232547|NCT00980655|79049143|FG000|Overall Study|Protocol Violation|2|||
44232548|NCT00980655|79049144|FG001|Overall Study|Protocol Violation|7|||
44232549|NCT00980655|79049143|FG000|Overall Study|Withdrawal by Subject|0|||
44232550|NCT00980655|79049144|FG001|Overall Study|Withdrawal by Subject|4|||
44232551|NCT00980655|79049143|FG000|Overall Study|Lost to Follow-up|0|||
44232552|NCT00980655|79049144|FG001|Overall Study|Lost to Follow-up|1|||
44232553|NCT00980655|79049143|FG000|Overall Study|Parent/legal guardian request|1|||
44232554|NCT00980655|79049144|FG001|Overall Study|Parent/legal guardian request|0|||
44232555|NCT00980655|79049143|FG000|Overall Study|Other|0|||
44232556|NCT00980655|79049144|FG001|Overall Study|Other|1|||
44232557|NCT01801865|79049186|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
44232558|NCT01801865|79049186|FG000|Overall Study|Physician Decision|7|||
44232559|NCT00980343|79049196|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
44232560|NCT00980343|79049197|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
44558989|NCT03243305|79576679|FG000|Overall Study|Withdrawal by Subject|170|||
44558990|NCT03243305|79576679|FG000|Overall Study|Pregnancy|104|||
44558991|NCT03243305|79576679|FG000|Overall Study|Non-Compliance with Study Drug|38|||
44558992|NCT03243305|79576679|FG000|Overall Study|Adverse Event|23|||
44558993|NCT03243305|79576679|FG000|Overall Study|No sexually active|26|||
44232561|NCT01801475|79049207|FG000|Overall Study|Withdrawal by Subject|0|||
44232562|NCT01801475|79049208|FG001|Overall Study|Withdrawal by Subject|0|||
44232563|NCT01801475|79049209|FG002|Overall Study|Withdrawal by Subject|0|||
44558994|NCT03243305|79576679|FG000|Overall Study|Physician Decision|22|||
44232564|NCT01801475|79049210|FG003|Overall Study|Withdrawal by Subject|0|||
44232565|NCT01801475|79049211|FG004|Overall Study|Withdrawal by Subject|1|||
44232566|NCT01822925|79049270|FG000|Overall Study|Adverse Event|1|||
44232567|NCT01822925|79049271|FG001|Overall Study|Adverse Event|1|||
44232568|NCT01822925|79049272|FG002|Overall Study|Adverse Event|1|||
44232569|NCT01822925|79049273|FG003|Overall Study|Adverse Event|1|||
44232570|NCT01822925|79049270|FG000|Overall Study|Lost to Follow-up|0|||
44232571|NCT01822925|79049271|FG001|Overall Study|Lost to Follow-up|1|||
44232572|NCT01822925|79049272|FG002|Overall Study|Lost to Follow-up|0|||
44232573|NCT01822925|79049273|FG003|Overall Study|Lost to Follow-up|0|||
44232574|NCT01822925|79049270|FG000|Overall Study|Protocol Violation|1|||
44232575|NCT01822925|79049271|FG001|Overall Study|Protocol Violation|0|||
44232576|NCT01822925|79049272|FG002|Overall Study|Protocol Violation|0|||
44232577|NCT01822925|79049273|FG003|Overall Study|Protocol Violation|1|||
44232578|NCT01822925|79049270|FG000|Overall Study|Withdrawal by Subject|2|||
44232579|NCT01822925|79049271|FG001|Overall Study|Withdrawal by Subject|0|||
44232580|NCT01822925|79049272|FG002|Overall Study|Withdrawal by Subject|2|||
44232581|NCT01822925|79049273|FG003|Overall Study|Withdrawal by Subject|2|||
44232582|NCT01822925|79049270|FG000|Overall Study|Taking prohibited medication|2|||
44232583|NCT01822925|79049271|FG001|Overall Study|Taking prohibited medication|0|||
44232584|NCT01822925|79049272|FG002|Overall Study|Taking prohibited medication|0|||
44232585|NCT01822925|79049273|FG003|Overall Study|Taking prohibited medication|1|||
44232586|NCT01801007|79049306|FG000|Overall Study|Adverse Event|2|||
44558995|NCT03243305|79576679|FG000|Overall Study|Protocol Violation|22|||
44558996|NCT03243305|79576679|FG000|Overall Study|Study method no longer primary method|12|||
44558997|NCT03243305|79576679|FG000|Overall Study|Study Terminated by Sponsor|1|||
44558998|NCT03243305|79576679|FG000|Overall Study|Early terminations|267|||
44558999|NCT03222583|79576685|FG000|Overall Study|Withdrawal by Subject|3|||
44559000|NCT03222583|79576686|FG001|Overall Study|Withdrawal by Subject|3|||
44559001|NCT03222583|79576685|FG000|Overall Study|Lost to Follow-up|1|||
44559002|NCT03222583|79576686|FG001|Overall Study|Lost to Follow-up|0|||
44559003|NCT03222583|79576685|FG000|Overall Study|Other|1|||
44559004|NCT03222583|79576686|FG001|Overall Study|Other|3|||
44559005|NCT03295721|79576695|FG000|Overall Study|Adverse Event|1|||
44559006|NCT03295721|79576696|FG001|Overall Study|Adverse Event|0|||
44559007|NCT03295721|79576697|FG002|Overall Study|Adverse Event|0|||
44559008|NCT03295721|79576695|FG000|Overall Study|Lost to Follow-up|1|||
44559009|NCT03295721|79576696|FG001|Overall Study|Lost to Follow-up|1|||
44559010|NCT03295721|79576697|FG002|Overall Study|Lost to Follow-up|1|||
44559011|NCT03295721|79576695|FG000|Overall Study|Withdrawal by Subject|1|||
44559012|NCT03295721|79576696|FG001|Overall Study|Withdrawal by Subject|0|||
44559013|NCT03295721|79576697|FG002|Overall Study|Withdrawal by Subject|1|||
44559014|NCT03295721|79576695|FG000|Overall Study|Death|0|||
44232587|NCT01801007|79049306|FG000|Overall Study|Lost to Follow-up|4|||
44232588|NCT01801007|79049306|FG000|Overall Study|Withdrawal by Subject|5|||
44232589|NCT01822691|79049310|FG000|Overall Study|Withdrawal by Subject|2|||
44232590|NCT01822535|79049316|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
44498543|NCT00112437|79503600|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498544|NCT00112437|79503601|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498545|NCT00112437|79503602|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498546|NCT00112437|79503603|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498547|NCT00112437|79503604|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498548|NCT00112437|79503605|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
44498549|NCT00112437|79503606|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498550|NCT00112437|79503607|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498551|NCT00112437|79503608|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44559015|NCT03295721|79576696|FG001|Overall Study|Death|0|||
44559016|NCT03295721|79576697|FG002|Overall Study|Death|1|||
44559017|NCT00803790|79576708|FG000|Period 1|Adverse Event|0|||
44232591|NCT01822535|79049317|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
44559018|NCT00803790|79576709|FG001|Period 1|Adverse Event|1|||
44232592|NCT01822535|79049316|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
44559019|NCT00803790|79576710|FG002|Period 1|Adverse Event|0|||
44559020|NCT00803790|79576711|FG003|Period 1|Adverse Event|0|||
44559021|NCT00803790|79576708|FG000|Period 1|Lost to Follow-up|1|||
44559022|NCT00803790|79576709|FG001|Period 1|Lost to Follow-up|2|||
44559023|NCT00803790|79576710|FG002|Period 1|Lost to Follow-up|0|||
44559024|NCT00803790|79576711|FG003|Period 1|Lost to Follow-up|0|||
44559025|NCT00803790|79576708|FG000|Period 1|Withdrawal by Subject|8|||
44559026|NCT00803790|79576709|FG001|Period 1|Withdrawal by Subject|6|||
44559027|NCT00803790|79576710|FG002|Period 1|Withdrawal by Subject|0|||
44559028|NCT00803790|79576711|FG003|Period 1|Withdrawal by Subject|0|||
44559029|NCT00803790|79576708|FG000|Period 1|positive drug screen or personal reasons|0|||
44559030|NCT00803790|79576709|FG001|Period 1|positive drug screen or personal reasons|3|||
44559031|NCT00803790|79576710|FG002|Period 1|positive drug screen or personal reasons|0|||
44559032|NCT00803790|79576711|FG003|Period 1|positive drug screen or personal reasons|4|||
44559033|NCT00803790|79576708|FG000|Period 1|Protocol Violation|0|||
44559034|NCT00803790|79576709|FG001|Period 1|Protocol Violation|0|||
44559035|NCT00803790|79576710|FG002|Period 1|Protocol Violation|1|||
44559036|NCT00803790|79576711|FG003|Period 1|Protocol Violation|0|||
44559037|NCT00803790|79576708|FG000|Period 2|Adverse Event|0|||
44559038|NCT00803790|79576709|FG001|Period 2|Adverse Event|0|||
44559039|NCT00803790|79576710|FG002|Period 2|Adverse Event|1|||
44559040|NCT00803790|79576711|FG003|Period 2|Adverse Event|1|||
44559041|NCT00803790|79576708|FG000|Period 2|Withdrawal by Subject|1|||
44559042|NCT00803790|79576709|FG001|Period 2|Withdrawal by Subject|0|||
44559043|NCT00803790|79576710|FG002|Period 2|Withdrawal by Subject|0|||
44559044|NCT00803790|79576711|FG003|Period 2|Withdrawal by Subject|0|||
44559045|NCT00803790|79576708|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
44559046|NCT00803790|79576709|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
44559047|NCT00803790|79576710|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
44232593|NCT01822535|79049317|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
44559048|NCT00803790|79576711|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
44559049|NCT00250458|79576759|FG000|Overall Study|Lost to Follow-up|4|||
44559050|NCT00250458|79576760|FG001|Overall Study|Lost to Follow-up|2|||
44559051|NCT00250458|79576759|FG000|Overall Study|Protocol Violation|0|||
44559052|NCT00250458|79576760|FG001|Overall Study|Protocol Violation|1|||
44559053|NCT00250458|79576759|FG000|Overall Study|Withdrawal by Subject|4|||
44559054|NCT00250458|79576760|FG001|Overall Study|Withdrawal by Subject|2|||
44559055|NCT00250458|79576759|FG000|Overall Study|Lack of Migraine Attack|20|||
44559056|NCT00250458|79576760|FG001|Overall Study|Lack of Migraine Attack|9|||
44559057|NCT00250458|79576759|FG000|Overall Study|Qualifying migraine but did not treat|3|||
44559058|NCT00250458|79576760|FG001|Overall Study|Qualifying migraine but did not treat|3|||
44559059|NCT00250458|79576759|FG000|Overall Study|Other|1|||
44559060|NCT00250458|79576760|FG001|Overall Study|Other|0|||
44559061|NCT01667133|79576778|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
44559062|NCT01667133|79576779|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
44559063|NCT01667133|79576780|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
44559064|NCT01667133|79576781|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
44498552|NCT00112437|79503609|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498553|NCT00112437|79503610|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498554|NCT00112437|79503611|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498555|NCT00112437|79503612|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498556|NCT00112437|79503613|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498557|NCT00112437|79503614|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498558|NCT00112437|79503615|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
44498559|NCT00112437|79503590|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498560|NCT00112437|79503591|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
44559065|NCT01667133|79576782|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
44559066|NCT01667133|79576783|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
44559067|NCT01667133|79576784|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
44559068|NCT01667133|79576785|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
44232594|NCT01822535|79049316|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
44559069|NCT01667133|79576786|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
44559070|NCT01667133|79576787|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
44559071|NCT01667133|79576788|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
44232595|NCT01822535|79049317|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
44559072|NCT01667133|79576789|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
44559073|NCT01667133|79576778|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44498561|NCT00112437|79503592|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498562|NCT00112437|79503593|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498563|NCT00112437|79503594|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498564|NCT00112437|79503595|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498565|NCT00112437|79503596|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498566|NCT00112437|79503597|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498567|NCT00112437|79503598|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498568|NCT00112437|79503599|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498569|NCT00112437|79503600|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498570|NCT00112437|79503601|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498571|NCT00112437|79503602|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498572|NCT00112437|79503603|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498573|NCT00112437|79503604|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498574|NCT00112437|79503605|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
44498575|NCT00112437|79503606|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498576|NCT00112437|79503607|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498577|NCT00112437|79503608|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498578|NCT00112437|79503609|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498579|NCT00112437|79503610|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498580|NCT00112437|79503611|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498581|NCT00112437|79503612|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498582|NCT00112437|79503613|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498583|NCT00112437|79503614|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498584|NCT00112437|79503615|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
44498585|NCT00112437|79503590|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498586|NCT00112437|79503591|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498587|NCT00112437|79503592|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498588|NCT00112437|79503593|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498589|NCT00112437|79503594|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498590|NCT00112437|79503595|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498591|NCT00112437|79503596|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498592|NCT00112437|79503597|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498593|NCT00112437|79503598|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498594|NCT00112437|79503599|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498595|NCT00112437|79503600|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498596|NCT00112437|79503601|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
44498597|NCT00112437|79503602|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498598|NCT00112437|79503603|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498599|NCT00112437|79503604|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
44498600|NCT00112437|79503605|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498601|NCT00112437|79503606|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498602|NCT00112437|79503607|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498603|NCT00112437|79503608|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498604|NCT00112437|79503609|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498605|NCT00112437|79503610|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498606|NCT00112437|79503611|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498607|NCT00112437|79503612|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498608|NCT00112437|79503613|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498609|NCT00112437|79503614|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498610|NCT00112437|79503615|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
44498611|NCT00112437|79503590|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498612|NCT00112437|79503591|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498613|NCT00112437|79503592|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498614|NCT00112437|79503593|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44232596|NCT01799993|79049403|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
44559074|NCT01667133|79576779|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559075|NCT01667133|79576780|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
44559076|NCT01667133|79576781|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559077|NCT01667133|79576782|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559078|NCT01667133|79576783|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559079|NCT01667133|79576784|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559080|NCT01667133|79576785|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559081|NCT01667133|79576786|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559082|NCT01667133|79576787|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559083|NCT01667133|79576788|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559084|NCT01667133|79576789|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
44559085|NCT01667133|79576778|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
44559086|NCT01667133|79576779|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
44559087|NCT01667133|79576780|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
44559088|NCT01667133|79576781|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
44559089|NCT01667133|79576782|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
44559090|NCT01667133|79576783|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
44559091|NCT01667133|79576784|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
44559092|NCT01667133|79576785|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
44559093|NCT01667133|79576786|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
44559094|NCT01667133|79576787|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
44559095|NCT01667133|79576788|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
44559096|NCT01667133|79576789|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
44559097|NCT01667133|79576778|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559098|NCT01667133|79576779|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559099|NCT01667133|79576780|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559100|NCT01667133|79576781|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
44559101|NCT01667133|79576782|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559102|NCT01667133|79576783|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559103|NCT01667133|79576784|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559104|NCT01667133|79576785|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559105|NCT01667133|79576786|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559106|NCT01667133|79576787|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559107|NCT01667133|79576788|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44275249|NCT02239692|79221709|FG000|Overall Study|Incomplete colonoscopy|1|||
44275250|NCT02239692|79221710|FG001|Overall Study|Incomplete colonoscopy|2|||
44559108|NCT01667133|79576789|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
44559109|NCT01667133|79576778|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
44559110|NCT01667133|79576779|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
44559111|NCT01667133|79576780|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
44559112|NCT01667133|79576781|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
44559113|NCT01667133|79576782|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
44559114|NCT01667133|79576783|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
44559115|NCT01667133|79576784|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
44559116|NCT01667133|79576785|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
44275251|NCT02239692|79221709|FG000|Overall Study|Adverse Event|0|||
44559117|NCT01667133|79576786|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
44559118|NCT01667133|79576787|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
44559119|NCT01667133|79576788|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
44275252|NCT02239692|79221710|FG001|Overall Study|Adverse Event|1|||
44498615|NCT00112437|79503594|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498616|NCT00112437|79503595|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498617|NCT00112437|79503596|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498618|NCT00112437|79503597|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498619|NCT00112437|79503598|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498620|NCT00112437|79503599|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498621|NCT00112437|79503600|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
44498622|NCT00112437|79503601|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
44498623|NCT00112437|79503602|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498624|NCT00112437|79503603|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498625|NCT00112437|79503604|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498626|NCT00112437|79503605|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498627|NCT00112437|79503606|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498628|NCT00112437|79503607|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498629|NCT00112437|79503608|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498630|NCT00112437|79503609|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498631|NCT00112437|79503610|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498632|NCT00112437|79503611|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498633|NCT00112437|79503612|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498634|NCT00112437|79503613|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498635|NCT00112437|79503614|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498636|NCT00112437|79503615|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
44498637|NCT00112437|79503590|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498638|NCT00112437|79503591|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498639|NCT00112437|79503592|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498640|NCT00112437|79503593|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498641|NCT00112437|79503594|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498642|NCT00112437|79503595|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498643|NCT00112437|79503596|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498644|NCT00112437|79503597|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498645|NCT00112437|79503598|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498646|NCT00112437|79503599|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44559120|NCT01667133|79576789|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
44559121|NCT01667133|79576778|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559122|NCT01667133|79576779|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559123|NCT01667133|79576780|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559124|NCT01667133|79576781|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559125|NCT01667133|79576782|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559126|NCT01667133|79576783|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559127|NCT01667133|79576784|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559128|NCT01667133|79576785|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559129|NCT01667133|79576786|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559130|NCT01667133|79576787|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
44559131|NCT01667133|79576788|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559132|NCT01667133|79576789|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
44559133|NCT01667133|79576778|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
44559134|NCT01667133|79576779|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
44559135|NCT01667133|79576780|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
44559136|NCT01667133|79576781|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
44559137|NCT01667133|79576782|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
44559138|NCT01667133|79576783|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
44559139|NCT01667133|79576784|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
44559140|NCT01667133|79576785|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
44559141|NCT01667133|79576786|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
44559142|NCT01667133|79576787|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
44559143|NCT01667133|79576788|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
44559144|NCT01667133|79576789|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
44559145|NCT01667133|79576778|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559146|NCT01667133|79576779|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559147|NCT01667133|79576780|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559148|NCT01667133|79576781|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44498647|NCT00112437|79503600|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498648|NCT00112437|79503601|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498649|NCT00112437|79503602|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498650|NCT00112437|79503603|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498651|NCT00112437|79503604|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498652|NCT00112437|79503605|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498653|NCT00112437|79503606|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498654|NCT00112437|79503607|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498655|NCT00112437|79503608|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498656|NCT00112437|79503609|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498657|NCT00112437|79503610|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
44498658|NCT00112437|79503611|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
44498659|NCT00112437|79503612|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498660|NCT00112437|79503613|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498661|NCT00112437|79503614|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498662|NCT00112437|79503615|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
44498663|NCT00112437|79503590|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498664|NCT00112437|79503591|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498665|NCT00112437|79503592|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498666|NCT00112437|79503593|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498667|NCT00112437|79503594|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498668|NCT00112437|79503595|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498669|NCT00112437|79503596|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498670|NCT00112437|79503597|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44559149|NCT01667133|79576782|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559150|NCT01667133|79576783|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559151|NCT01667133|79576784|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44498671|NCT00112437|79503598|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498672|NCT00112437|79503599|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498673|NCT00112437|79503600|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498674|NCT00112437|79503601|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498675|NCT00112437|79503602|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498676|NCT00112437|79503603|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498677|NCT00112437|79503604|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498678|NCT00112437|79503605|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498679|NCT00112437|79503606|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498680|NCT00112437|79503607|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498681|NCT00112437|79503608|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498682|NCT00112437|79503609|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44559152|NCT01667133|79576785|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559153|NCT01667133|79576786|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559154|NCT01667133|79576787|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
44559155|NCT01667133|79576788|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559156|NCT01667133|79576789|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
44559157|NCT01667133|79576778|FG000|Phase 2: Dose-expansion|Death|0|||
44559158|NCT01667133|79576779|FG001|Phase 2: Dose-expansion|Death|0|||
44559159|NCT01667133|79576780|FG002|Phase 2: Dose-expansion|Death|0|||
44559160|NCT01667133|79576781|FG003|Phase 2: Dose-expansion|Death|0|||
44559161|NCT01667133|79576782|FG004|Phase 2: Dose-expansion|Death|0|||
44559162|NCT01667133|79576783|FG005|Phase 2: Dose-expansion|Death|0|||
44559163|NCT01667133|79576784|FG006|Phase 2: Dose-expansion|Death|0|||
44559164|NCT01667133|79576785|FG007|Phase 2: Dose-expansion|Death|0|||
44559165|NCT01667133|79576786|FG008|Phase 2: Dose-expansion|Death|0|||
44559166|NCT01667133|79576787|FG009|Phase 2: Dose-expansion|Death|1|||
44559167|NCT01667133|79576788|FG010|Phase 2: Dose-expansion|Death|0|||
44559168|NCT01667133|79576789|FG011|Phase 2: Dose-expansion|Death|0|||
44559169|NCT01667133|79576778|FG000|Phase 2: Dose-expansion|Other|0|||
44559170|NCT01667133|79576779|FG001|Phase 2: Dose-expansion|Other|0|||
44559171|NCT01667133|79576780|FG002|Phase 2: Dose-expansion|Other|0|||
44559172|NCT01667133|79576781|FG003|Phase 2: Dose-expansion|Other|0|||
44559173|NCT01667133|79576782|FG004|Phase 2: Dose-expansion|Other|0|||
44232597|NCT01799993|79049404|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
44232598|NCT01799993|79049403|FG000|Overall Study|Death|61|||
44232599|NCT01799993|79049404|FG001|Overall Study|Death|45|||
44232600|NCT01799993|79049403|FG000|Overall Study|Withdrawal by Subject|23|||
44232601|NCT01799993|79049404|FG001|Overall Study|Withdrawal by Subject|24|||
44498683|NCT00112437|79503610|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
44498684|NCT00112437|79503611|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498685|NCT00112437|79503612|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498686|NCT00112437|79503613|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498687|NCT00112437|79503614|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498688|NCT00112437|79503615|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
44498689|NCT00112437|79503590|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498690|NCT00112437|79503591|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498691|NCT00112437|79503592|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498692|NCT00112437|79503593|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498693|NCT00112437|79503594|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498694|NCT00112437|79503595|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498695|NCT00112437|79503596|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498696|NCT00112437|79503597|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498697|NCT00112437|79503598|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498698|NCT00112437|79503599|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498699|NCT00112437|79503600|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498700|NCT00112437|79503601|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498701|NCT00112437|79503602|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498702|NCT00112437|79503603|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498703|NCT00112437|79503604|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498704|NCT00112437|79503605|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498705|NCT00112437|79503606|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44559174|NCT01667133|79576783|FG005|Phase 2: Dose-expansion|Other|0|||
44559175|NCT01667133|79576784|FG006|Phase 2: Dose-expansion|Other|0|||
44559176|NCT01667133|79576785|FG007|Phase 2: Dose-expansion|Other|0|||
44559177|NCT01667133|79576786|FG008|Phase 2: Dose-expansion|Other|0|||
44232602|NCT01799993|79049403|FG000|Overall Study|Lost to Follow-up|5|||
44559178|NCT01667133|79576787|FG009|Phase 2: Dose-expansion|Other|0|||
44559179|NCT01667133|79576788|FG010|Phase 2: Dose-expansion|Other|0|||
44559180|NCT01667133|79576789|FG011|Phase 2: Dose-expansion|Other|1|||
44559181|NCT01181778|79576850|FG000|Overall Study|Physician Decision|48|||
44559182|NCT00092118|79576858|FG000|Overall Study|Adverse Event|35|||
44559183|NCT00092118|79576859|FG001|Overall Study|Adverse Event|32|||
44559184|NCT00092118|79576858|FG000|Overall Study|Lack of Efficacy|12|||
44559185|NCT00092118|79576859|FG001|Overall Study|Lack of Efficacy|14|||
44559186|NCT00092118|79576858|FG000|Overall Study|Lost to Follow-up|4|||
44559187|NCT00092118|79576859|FG001|Overall Study|Lost to Follow-up|3|||
44559188|NCT00092118|79576858|FG000|Overall Study|Protocol Violation|23|||
44559189|NCT00092118|79576859|FG001|Overall Study|Protocol Violation|25|||
44559190|NCT00092118|79576858|FG000|Overall Study|Withdrawal by Subject|4|||
44559191|NCT00092118|79576859|FG001|Overall Study|Withdrawal by Subject|10|||
44559192|NCT00092118|79576858|FG000|Overall Study|Other|6|||
44559193|NCT00092118|79576859|FG001|Overall Study|Other|5|||
44559194|NCT03261947|79576870|FG000|Overall Study|Death|10|||
44559195|NCT03261947|79576871|FG001|Overall Study|Death|13|||
44559196|NCT03261947|79576872|FG002|Overall Study|Death|17|||
44559197|NCT03261947|79576873|FG003|Overall Study|Death|12|||
44559198|NCT03261947|79576874|FG004|Overall Study|Death|8|||
44559199|NCT03261947|79576870|FG000|Overall Study|Lost to Follow-up|0|||
44559200|NCT03261947|79576871|FG001|Overall Study|Lost to Follow-up|0|||
44559201|NCT03261947|79576872|FG002|Overall Study|Lost to Follow-up|2|||
44559202|NCT03261947|79576873|FG003|Overall Study|Lost to Follow-up|1|||
44559203|NCT03261947|79576874|FG004|Overall Study|Lost to Follow-up|0|||
44559204|NCT03261947|79576870|FG000|Overall Study|Withdrawal by Subject|0|||
44559205|NCT03261947|79576871|FG001|Overall Study|Withdrawal by Subject|0|||
44559206|NCT03261947|79576872|FG002|Overall Study|Withdrawal by Subject|3|||
44559207|NCT03261947|79576873|FG003|Overall Study|Withdrawal by Subject|0|||
44559208|NCT03261947|79576874|FG004|Overall Study|Withdrawal by Subject|1|||
44559209|NCT03261947|79576870|FG000|Overall Study|Site Terminated by Sponsor|0|||
44559210|NCT03261947|79576871|FG001|Overall Study|Site Terminated by Sponsor|0|||
44559211|NCT03261947|79576872|FG002|Overall Study|Site Terminated by Sponsor|4|||
44559212|NCT03261947|79576873|FG003|Overall Study|Site Terminated by Sponsor|7|||
44559213|NCT03261947|79576874|FG004|Overall Study|Site Terminated by Sponsor|5|||
44559214|NCT03261947|79576870|FG000|Overall Study|Reason not Specified|2|||
44559215|NCT03261947|79576871|FG001|Overall Study|Reason not Specified|0|||
44559216|NCT03261947|79576872|FG002|Overall Study|Reason not Specified|4|||
44559217|NCT03261947|79576873|FG003|Overall Study|Reason not Specified|1|||
44559218|NCT03261947|79576874|FG004|Overall Study|Reason not Specified|3|||
44559219|NCT03098979|79576905|FG000|Overall Study|Adverse Event|1|||
44559220|NCT03098979|79576906|FG001|Overall Study|Adverse Event|0|||
44559221|NCT03098979|79576907|FG002|Overall Study|Adverse Event|1|||
44559222|NCT03098979|79576908|FG003|Overall Study|Adverse Event|4|||
44559223|NCT03098979|79576909|FG004|Overall Study|Adverse Event|6|||
44559224|NCT03098979|79576910|FG005|Overall Study|Adverse Event|1|||
44559225|NCT03098979|79576905|FG000|Overall Study|Withdrawal by Subject|2|||
44559226|NCT03098979|79576906|FG001|Overall Study|Withdrawal by Subject|1|||
44559227|NCT03098979|79576907|FG002|Overall Study|Withdrawal by Subject|1|||
44559228|NCT03098979|79576908|FG003|Overall Study|Withdrawal by Subject|1|||
44559229|NCT03098979|79576909|FG004|Overall Study|Withdrawal by Subject|2|||
44559230|NCT03098979|79576910|FG005|Overall Study|Withdrawal by Subject|1|||
44559231|NCT03098979|79576905|FG000|Overall Study|Death|1|||
44559232|NCT03098979|79576906|FG001|Overall Study|Death|0|||
44559233|NCT03098979|79576907|FG002|Overall Study|Death|2|||
44559234|NCT03098979|79576908|FG003|Overall Study|Death|0|||
44559235|NCT03098979|79576909|FG004|Overall Study|Death|1|||
44559236|NCT03098979|79576910|FG005|Overall Study|Death|0|||
44559237|NCT03098979|79576905|FG000|Overall Study|Physician Decision|2|||
44559238|NCT03098979|79576906|FG001|Overall Study|Physician Decision|1|||
44559239|NCT03098979|79576907|FG002|Overall Study|Physician Decision|0|||
44559240|NCT03098979|79576908|FG003|Overall Study|Physician Decision|0|||
44559241|NCT03098979|79576909|FG004|Overall Study|Physician Decision|0|||
44559242|NCT03098979|79576910|FG005|Overall Study|Physician Decision|0|||
44559243|NCT03098979|79576905|FG000|Overall Study|Non-compliance|0|||
44559244|NCT03098979|79576906|FG001|Overall Study|Non-compliance|0|||
44559245|NCT03098979|79576907|FG002|Overall Study|Non-compliance|0|||
44559246|NCT03098979|79576908|FG003|Overall Study|Non-compliance|0|||
44559247|NCT03098979|79576909|FG004|Overall Study|Non-compliance|0|||
44559248|NCT03098979|79576910|FG005|Overall Study|Non-compliance|1|||
44559249|NCT03098979|79576905|FG000|Overall Study|Protocol Violation|0|||
44559250|NCT03098979|79576906|FG001|Overall Study|Protocol Violation|0|||
44559251|NCT03098979|79576907|FG002|Overall Study|Protocol Violation|0|||
44559252|NCT03098979|79576908|FG003|Overall Study|Protocol Violation|0|||
44559253|NCT03098979|79576909|FG004|Overall Study|Protocol Violation|0|||
44559254|NCT03098979|79576910|FG005|Overall Study|Protocol Violation|1|||
44559255|NCT03261167|79576926|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
44559256|NCT03261167|79576927|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
44559257|NCT03261167|79576926|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
44559258|NCT03261167|79576927|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
44559259|NCT03261167|79576926|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
44559260|NCT03261167|79576927|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
44559261|NCT03261167|79576926|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
44559262|NCT03261167|79576927|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
44559263|NCT03261167|79576926|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
44559264|NCT03261167|79576927|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
44559265|NCT03294941|79576941|FG000|Overall Study|Withdrawal by Subject|0|||
44559266|NCT03294941|79576942|FG001|Overall Study|Withdrawal by Subject|2|||
44559267|NCT03098433|79576949|FG000|Overall Study|Withdrawal by Subject|10|||
44559268|NCT03294317|79576954|FG000|Overall Study|Physician Decision|1|||
44232603|NCT01799993|79049404|FG001|Overall Study|Lost to Follow-up|8|||
44232604|NCT01799993|79049403|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
44232605|NCT01799993|79049404|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
44232606|NCT01799993|79049403|FG000|Overall Study|Protocol driven decision point|0|||
44232607|NCT01799993|79049404|FG001|Overall Study|Protocol driven decision point|3|||
44232608|NCT01799993|79049403|FG000|Overall Study|Protocol Violation|1|||
44232609|NCT01799993|79049404|FG001|Overall Study|Protocol Violation|1|||
44232610|NCT01799993|79049403|FG000|Overall Study|Deterioration of general conditions|2|||
44232611|NCT01799993|79049404|FG001|Overall Study|Deterioration of general conditions|0|||
44232612|NCT01799993|79049403|FG000|Overall Study|Screen failure|0|||
44232613|NCT01799993|79049404|FG001|Overall Study|Screen failure|1|||
44232614|NCT01799993|79049403|FG000|Overall Study|Adverse Event|1|||
44232615|NCT01799993|79049404|FG001|Overall Study|Adverse Event|0|||
44232616|NCT01799993|79049403|FG000|Overall Study|Lack of Efficacy|1|||
44232617|NCT01799993|79049404|FG001|Overall Study|Lack of Efficacy|0|||
44232618|NCT01799993|79049403|FG000|Overall Study|Recovery|0|||
44232619|NCT01799993|79049404|FG001|Overall Study|Recovery|1|||
44232620|NCT01799993|79049403|FG000|Overall Study|Logistical difficulties|1|||
44232621|NCT01799993|79049404|FG001|Overall Study|Logistical difficulties|0|||
44559269|NCT03294317|79576954|FG000|Overall Study|Withdrawal by Subject|6|||
44559270|NCT03294317|79576954|FG000|Overall Study|Lost to Follow-up|1|||
44559271|NCT03294317|79576954|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
44559272|NCT03294317|79576954|FG000|Overall Study|Failed HB lead implant|8|||
44559273|NCT03294317|79576954|FG000|Overall Study|Received CRT instead|1|||
44559274|NCT03294317|79576954|FG000|Overall Study|Exited after lead revision|2|||
44559275|NCT03292913|79576960|FG000|Overall Study|Death|9|||
44559276|NCT03292913|79576961|FG001|Overall Study|Death|3|||
44559277|NCT03292913|79576960|FG000|Overall Study|Lost to Follow-up|49|||
44559278|NCT03292913|79576961|FG001|Overall Study|Lost to Follow-up|49|||
44559279|NCT03292913|79576960|FG000|Overall Study|Withdrawal by Subject|2|||
44559280|NCT03292913|79576961|FG001|Overall Study|Withdrawal by Subject|0|||
44232622|NCT01799993|79049403|FG000|Overall Study|Protocol deviation|1|||
44232623|NCT01799993|79049404|FG001|Overall Study|Protocol deviation|0|||
44232624|NCT01799993|79049403|FG000|Overall Study|Non-compliance with medical device|1|||
44559281|NCT03292913|79576960|FG000|Overall Study|Clinic closed due to COVID|22|||
44559282|NCT03292913|79576961|FG001|Overall Study|Clinic closed due to COVID|36|||
44559283|NCT03291587|79576973|FG000|Overall Study|Lost to Follow-up|62|||
44559284|NCT03291587|79576974|FG001|Overall Study|Lost to Follow-up|43|||
44232625|NCT01799993|79049404|FG001|Overall Study|Non-compliance with medical device|0|||
44559285|NCT03291587|79576973|FG000|Overall Study|Refused to Answer|5|||
44559286|NCT03291587|79576974|FG001|Overall Study|Refused to Answer|2|||
44232626|NCT01799993|79049403|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44232627|NCT01799993|79049404|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44232628|NCT01799993|79049403|FG000|Overall Study|Other|1|||
44232629|NCT01799993|79049404|FG001|Overall Study|Other|0|||
44232630|NCT01799993|79049403|FG000|Overall Study|Subject didn't return for follow-up|0|||
44232631|NCT01799993|79049404|FG001|Overall Study|Subject didn't return for follow-up|1|||
44232632|NCT01822223|79049421|FG000|Overall Study|Death|0|||
44232633|NCT01822223|79049422|FG001|Overall Study|Death|1|||
44232634|NCT02228382|79049508|FG000|Overall Study|Death|5|||
44232635|NCT02228382|79049509|FG001|Overall Study|Death|7|||
44232636|NCT02228382|79049510|FG002|Overall Study|Death|5|||
44232637|NCT02228382|79049511|FG003|Overall Study|Death|0|||
44232638|NCT02228382|79049512|FG004|Overall Study|Death|2|||
44232639|NCT02228382|79049508|FG000|Overall Study|Participant refused further follow-up|0|||
44232640|NCT02228382|79049509|FG001|Overall Study|Participant refused further follow-up|0|||
44232641|NCT02228382|79049510|FG002|Overall Study|Participant refused further follow-up|1|||
44232642|NCT02228382|79049511|FG003|Overall Study|Participant refused further follow-up|0|||
44232643|NCT02228382|79049512|FG004|Overall Study|Participant refused further follow-up|0|||
44232644|NCT02228382|79049508|FG000|Overall Study|Study terminated by sponsor|3|||
44232645|NCT02228382|79049509|FG001|Overall Study|Study terminated by sponsor|5|||
44232646|NCT02228382|79049510|FG002|Overall Study|Study terminated by sponsor|7|||
44232647|NCT02228382|79049511|FG003|Overall Study|Study terminated by sponsor|0|||
44232648|NCT02228382|79049512|FG004|Overall Study|Study terminated by sponsor|0|||
44232649|NCT02228382|79049508|FG000|Overall Study|Lost to Follow-up|0|||
44232650|NCT02228382|79049509|FG001|Overall Study|Lost to Follow-up|0|||
44232651|NCT02228382|79049510|FG002|Overall Study|Lost to Follow-up|3|||
44232652|NCT02228382|79049511|FG003|Overall Study|Lost to Follow-up|1|||
44232653|NCT02228382|79049512|FG004|Overall Study|Lost to Follow-up|0|||
44232654|NCT02228382|79049508|FG000|Overall Study|Withdrawal by Subject|0|||
44232655|NCT02228382|79049509|FG001|Overall Study|Withdrawal by Subject|3|||
44232656|NCT02228382|79049510|FG002|Overall Study|Withdrawal by Subject|2|||
44232657|NCT02228382|79049511|FG003|Overall Study|Withdrawal by Subject|1|||
44232658|NCT02228382|79049512|FG004|Overall Study|Withdrawal by Subject|0|||
44232659|NCT02228382|79049508|FG000|Overall Study|Other|2|||
44232660|NCT02228382|79049509|FG001|Overall Study|Other|3|||
44232661|NCT02228382|79049510|FG002|Overall Study|Other|3|||
44232662|NCT02228382|79049511|FG003|Overall Study|Other|0|||
44232663|NCT02228382|79049512|FG004|Overall Study|Other|0|||
44232664|NCT01900002|79049556|FG000|Overall Study|Withdrawal by Subject|2|||
44232665|NCT01900002|79049556|FG000|Overall Study|ineligible for Y-90|4|||
44232666|NCT01377012|79049586|FG000|Core Study|Study terminated by Sponsor|47|||
44232667|NCT01377012|79049587|FG001|Core Study|Study terminated by Sponsor|54|||
44232668|NCT01377012|79049588|FG002|Core Study|Study terminated by Sponsor|46|||
44232669|NCT01377012|79049586|FG000|Core Study|Technical problems|1|||
44232670|NCT01377012|79049587|FG001|Core Study|Technical problems|0|||
44232671|NCT01377012|79049588|FG002|Core Study|Technical problems|0|||
44232672|NCT01377012|79049586|FG000|Core Study|Withdrawal by Subject|15|||
44232673|NCT01377012|79049587|FG001|Core Study|Withdrawal by Subject|23|||
44232674|NCT01377012|79049588|FG002|Core Study|Withdrawal by Subject|18|||
44559287|NCT03291587|79576973|FG000|Overall Study|Death|2|||
44232675|NCT01377012|79049586|FG000|Core Study|Protocol Violation|7|||
44232676|NCT01377012|79049587|FG001|Core Study|Protocol Violation|3|||
44232677|NCT01377012|79049588|FG002|Core Study|Protocol Violation|2|||
44232678|NCT01377012|79049586|FG000|Core Study|Pregnancy|0|||
44232679|NCT01377012|79049587|FG001|Core Study|Pregnancy|0|||
44559288|NCT03291587|79576974|FG001|Overall Study|Death|4|||
44559289|NCT03291587|79576973|FG000|Overall Study|Not interested in participating|8|||
44559290|NCT03291587|79576974|FG001|Overall Study|Not interested in participating|6|||
44559291|NCT03291587|79576973|FG000|Overall Study|Too busy to participate|4|||
44559292|NCT03291587|79576974|FG001|Overall Study|Too busy to participate|2|||
44559293|NCT03210961|79577005|FG000|Overall Study|Adverse Event|0|||
44559294|NCT03210961|79577006|FG001|Overall Study|Adverse Event|0|||
44559295|NCT03210961|79577007|FG002|Overall Study|Adverse Event|0|||
44559296|NCT03210961|79577008|FG003|Overall Study|Adverse Event|0|||
44559297|NCT03210961|79577009|FG004|Overall Study|Adverse Event|0|||
44559298|NCT03210961|79577010|FG005|Overall Study|Adverse Event|0|||
44559299|NCT03210961|79577011|FG006|Overall Study|Adverse Event|0|||
44559300|NCT03210961|79577012|FG007|Overall Study|Adverse Event|0|||
44559301|NCT03210961|79577013|FG008|Overall Study|Adverse Event|0|||
44559302|NCT03210961|79577014|FG009|Overall Study|Adverse Event|0|||
44559303|NCT03210961|79577015|FG010|Overall Study|Adverse Event|0|||
44559304|NCT03210961|79577016|FG011|Overall Study|Adverse Event|0|||
44559305|NCT03210961|79577017|FG012|Overall Study|Adverse Event|0|||
44559306|NCT03210961|79577018|FG013|Overall Study|Adverse Event|1|||
44559307|NCT03210961|79577019|FG014|Overall Study|Adverse Event|0|||
44559308|NCT03210961|79577005|FG000|Overall Study|Lost to Follow-up|0|||
44559309|NCT03210961|79577006|FG001|Overall Study|Lost to Follow-up|0|||
44559310|NCT03210961|79577007|FG002|Overall Study|Lost to Follow-up|0|||
44559311|NCT03210961|79577008|FG003|Overall Study|Lost to Follow-up|0|||
44559312|NCT03210961|79577009|FG004|Overall Study|Lost to Follow-up|0|||
44559313|NCT03210961|79577010|FG005|Overall Study|Lost to Follow-up|0|||
44559314|NCT03210961|79577011|FG006|Overall Study|Lost to Follow-up|0|||
44559315|NCT03210961|79577012|FG007|Overall Study|Lost to Follow-up|0|||
44559316|NCT03210961|79577013|FG008|Overall Study|Lost to Follow-up|0|||
44559317|NCT03210961|79577014|FG009|Overall Study|Lost to Follow-up|0|||
44559318|NCT03210961|79577015|FG010|Overall Study|Lost to Follow-up|0|||
44559319|NCT03210961|79577016|FG011|Overall Study|Lost to Follow-up|0|||
44232680|NCT01377012|79049588|FG002|Core Study|Pregnancy|1|||
44232681|NCT01377012|79049586|FG000|Core Study|Physician Decision|5|||
44232682|NCT01377012|79049587|FG001|Core Study|Physician Decision|4|||
44232683|NCT01377012|79049588|FG002|Core Study|Physician Decision|10|||
44232684|NCT01377012|79049586|FG000|Core Study|Non-Compliant with study treatment|0|||
44232685|NCT01377012|79049587|FG001|Core Study|Non-Compliant with study treatment|0|||
44232686|NCT01377012|79049588|FG002|Core Study|Non-Compliant with study treatment|1|||
44232687|NCT01377012|79049586|FG000|Core Study|No Longer require treatment|0|||
44232688|NCT01377012|79049587|FG001|Core Study|No Longer require treatment|0|||
44232689|NCT01377012|79049588|FG002|Core Study|No Longer require treatment|1|||
44232690|NCT01377012|79049586|FG000|Core Study|Lost to Follow-up|7|||
44232691|NCT01377012|79049587|FG001|Core Study|Lost to Follow-up|5|||
44232692|NCT01377012|79049588|FG002|Core Study|Lost to Follow-up|4|||
44232693|NCT01377012|79049586|FG000|Core Study|Lack of Efficacy|41|||
44232694|NCT01377012|79049587|FG001|Core Study|Lack of Efficacy|28|||
44232695|NCT01377012|79049588|FG002|Core Study|Lack of Efficacy|37|||
44232696|NCT01377012|79049586|FG000|Core Study|Death|1|||
44232697|NCT01377012|79049587|FG001|Core Study|Death|1|||
44232698|NCT01377012|79049588|FG002|Core Study|Death|1|||
44498706|NCT00112437|79503607|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498707|NCT00112437|79503608|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498708|NCT00112437|79503609|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498709|NCT00112437|79503610|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498710|NCT00112437|79503611|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
44498711|NCT00112437|79503612|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498712|NCT00112437|79503613|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498713|NCT00112437|79503614|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498714|NCT00112437|79503615|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
44498715|NCT00112437|79503590|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498716|NCT00112437|79503591|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498717|NCT00112437|79503592|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498718|NCT00112437|79503593|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498719|NCT00112437|79503594|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498720|NCT00112437|79503595|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
44559320|NCT03210961|79577017|FG012|Overall Study|Lost to Follow-up|0|||
44559321|NCT03210961|79577018|FG013|Overall Study|Lost to Follow-up|0|||
44559322|NCT03210961|79577019|FG014|Overall Study|Lost to Follow-up|1|||
44559323|NCT03210961|79577005|FG000|Overall Study|Withdrawal by Subject|0|||
44559324|NCT03210961|79577006|FG001|Overall Study|Withdrawal by Subject|0|||
44559325|NCT03210961|79577007|FG002|Overall Study|Withdrawal by Subject|0|||
44559326|NCT03210961|79577008|FG003|Overall Study|Withdrawal by Subject|0|||
44559327|NCT03210961|79577009|FG004|Overall Study|Withdrawal by Subject|0|||
44559328|NCT03210961|79577010|FG005|Overall Study|Withdrawal by Subject|0|||
44232699|NCT01377012|79049586|FG000|Core Study|Adverse Event|10|||
44559329|NCT03210961|79577011|FG006|Overall Study|Withdrawal by Subject|0|||
44559330|NCT03210961|79577012|FG007|Overall Study|Withdrawal by Subject|0|||
44559331|NCT03210961|79577013|FG008|Overall Study|Withdrawal by Subject|0|||
44559332|NCT03210961|79577014|FG009|Overall Study|Withdrawal by Subject|0|||
44559333|NCT03210961|79577015|FG010|Overall Study|Withdrawal by Subject|0|||
44559334|NCT03210961|79577016|FG011|Overall Study|Withdrawal by Subject|0|||
44559335|NCT03210961|79577017|FG012|Overall Study|Withdrawal by Subject|0|||
44559336|NCT03210961|79577018|FG013|Overall Study|Withdrawal by Subject|0|||
44559337|NCT03210961|79577019|FG014|Overall Study|Withdrawal by Subject|1|||
44559338|NCT03210961|79577005|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559339|NCT03210961|79577006|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559340|NCT03210961|79577007|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559341|NCT03210961|79577008|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559342|NCT03210961|79577009|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559343|NCT03210961|79577010|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559344|NCT03210961|79577011|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559345|NCT03210961|79577012|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559346|NCT03210961|79577013|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
44232700|NCT01377012|79049587|FG001|Core Study|Adverse Event|14|||
44232701|NCT01377012|79049588|FG002|Core Study|Adverse Event|13|||
44232702|NCT01377012|79049586|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
44232703|NCT01377012|79049587|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
44232704|NCT01377012|79049588|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
44232705|NCT01377012|79049586|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
44232706|NCT01377012|79049587|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
44232707|NCT01377012|79049588|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
44232708|NCT01377012|79049586|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
44232709|NCT01377012|79049587|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
44232710|NCT01377012|79049588|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
44232711|NCT01377012|79049586|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
44232712|NCT01377012|79049587|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
44232713|NCT01377012|79049588|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
44498721|NCT00112437|79503596|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498722|NCT00112437|79503597|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498723|NCT00112437|79503598|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498724|NCT00112437|79503599|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498725|NCT00112437|79503600|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498726|NCT00112437|79503601|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498727|NCT00112437|79503602|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498728|NCT00112437|79503603|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498729|NCT00112437|79503604|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498730|NCT00112437|79503605|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498731|NCT00112437|79503606|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498732|NCT00112437|79503607|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498733|NCT00112437|79503608|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498734|NCT00112437|79503609|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
44559347|NCT03210961|79577014|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559348|NCT03210961|79577015|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559349|NCT03210961|79577016|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559350|NCT03210961|79577017|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559351|NCT03210961|79577018|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
44559352|NCT03210961|79577019|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
44559353|NCT03210961|79577005|FG000|Overall Study|Other|0|||
44559354|NCT03210961|79577006|FG001|Overall Study|Other|0|||
44559355|NCT03210961|79577007|FG002|Overall Study|Other|0|||
44232714|NCT01377012|79049586|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
44559356|NCT03210961|79577008|FG003|Overall Study|Other|1|||
44559357|NCT03210961|79577009|FG004|Overall Study|Other|0|||
44559358|NCT03210961|79577010|FG005|Overall Study|Other|0|||
44559359|NCT03210961|79577011|FG006|Overall Study|Other|1|||
44559360|NCT03210961|79577012|FG007|Overall Study|Other|0|||
44559361|NCT03210961|79577013|FG008|Overall Study|Other|0|||
44559362|NCT03210961|79577014|FG009|Overall Study|Other|0|||
44559363|NCT03210961|79577015|FG010|Overall Study|Other|1|||
44559364|NCT03210961|79577016|FG011|Overall Study|Other|0|||
44559365|NCT03210961|79577017|FG012|Overall Study|Other|2|||
44559366|NCT03210961|79577018|FG013|Overall Study|Other|2|||
44559367|NCT03210961|79577019|FG014|Overall Study|Other|0|||
44559368|NCT03242759|79577072|FG000|Overall Study|Adverse Event|5|||
44559369|NCT03242759|79577073|FG001|Overall Study|Adverse Event|1|||
44559370|NCT03242759|79577072|FG000|Overall Study|Withdrawal by Subject|4|||
44232715|NCT01377012|79049587|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
44232716|NCT01377012|79049588|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
44232717|NCT01377012|79049586|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
44232718|NCT01377012|79049587|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
44232719|NCT01377012|79049588|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
44232720|NCT01376310|79049837|FG000|Overall Study|Study closed/terminated|1|||
44498735|NCT00112437|79503610|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498736|NCT00112437|79503611|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
44498737|NCT00112437|79503612|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498738|NCT00112437|79503613|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498739|NCT00112437|79503614|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498740|NCT00112437|79503615|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
44498741|NCT00112437|79503590|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44559371|NCT03242759|79577073|FG001|Overall Study|Withdrawal by Subject|3|||
44559372|NCT03242759|79577072|FG000|Overall Study|Lost to Follow-up|3|||
44559373|NCT03242759|79577073|FG001|Overall Study|Lost to Follow-up|1|||
44559374|NCT03242759|79577072|FG000|Overall Study|Administrative problems|1|||
44559375|NCT03242759|79577073|FG001|Overall Study|Administrative problems|1|||
44559376|NCT03242759|79577072|FG000|Overall Study|Death|22|||
44498742|NCT00112437|79503591|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498743|NCT00112437|79503592|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498744|NCT00112437|79503593|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498745|NCT00112437|79503594|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498746|NCT00112437|79503595|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498747|NCT00112437|79503596|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498748|NCT00112437|79503597|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498749|NCT00112437|79503598|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498750|NCT00112437|79503599|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498751|NCT00112437|79503600|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498752|NCT00112437|79503601|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498753|NCT00112437|79503602|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44559377|NCT03242759|79577073|FG001|Overall Study|Death|0|||
44559378|NCT03242759|79577072|FG000|Overall Study|Change visit schedule|0|||
44559379|NCT03242759|79577073|FG001|Overall Study|Change visit schedule|1|||
44559380|NCT03097029|79577079|FG000|Overall Study|Withdrawal by Subject|1|||
44232721|NCT01376310|79049838|FG001|Overall Study|Study closed/terminated|2|||
44498754|NCT00112437|79503603|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44559381|NCT03257813|79577085|FG000|Overall Study|Protocol Violation|6|||
44559382|NCT03257813|79577086|FG001|Overall Study|Protocol Violation|3|||
44559383|NCT03210259|79577097|FG000|12-Week Run-in Period|Adverse Event|1|||
44559384|NCT03210259|79577098|FG001|12-Week Run-in Period|Adverse Event|0|||
44559385|NCT03210259|79577099|FG002|12-Week Run-in Period|Adverse Event|0|||
44559386|NCT03210259|79577097|FG000|12-Week Run-in Period|Death|1|||
44559387|NCT03210259|79577098|FG001|12-Week Run-in Period|Death|0|||
44559388|NCT03210259|79577099|FG002|12-Week Run-in Period|Death|0|||
44559389|NCT03210259|79577097|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
44559390|NCT03210259|79577098|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
44559391|NCT03210259|79577099|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
44559392|NCT03210259|79577097|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
44559393|NCT03210259|79577098|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
44559394|NCT03210259|79577099|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
44559395|NCT03210259|79577097|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
44559396|NCT03210259|79577098|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
44559397|NCT03210259|79577099|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
44559398|NCT03210259|79577097|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
44559399|NCT03210259|79577098|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
44559400|NCT03210259|79577099|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
44559401|NCT03210259|79577097|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
44559402|NCT03210259|79577098|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
44559403|NCT03210259|79577099|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
44559404|NCT03210259|79577097|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
44559405|NCT03210259|79577098|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
44559406|NCT03210259|79577099|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
44559407|NCT03210259|79577097|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
44559408|NCT03210259|79577098|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
44559409|NCT03210259|79577099|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
44559410|NCT03210259|79577097|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
44559411|NCT03210259|79577098|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
44559412|NCT03210259|79577099|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
44559413|NCT03210259|79577097|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
44559414|NCT03210259|79577098|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
44559415|NCT03210259|79577099|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
44559416|NCT03257657|79577108|FG000|Overall Study|Lost to Follow-up|0|||
44559417|NCT03257657|79577109|FG001|Overall Study|Lost to Follow-up|3|||
44559418|NCT03257657|79577108|FG000|Overall Study|Withdrawn|0|||
44559419|NCT03257657|79577109|FG001|Overall Study|Withdrawn|1|||
44559420|NCT03257657|79577108|FG000|Overall Study|Noted not eligible right after enrolled|0|||
44498755|NCT00112437|79503604|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498756|NCT00112437|79503605|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498757|NCT00112437|79503606|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498758|NCT00112437|79503607|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498759|NCT00112437|79503608|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498760|NCT00112437|79503609|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498761|NCT00112437|79503610|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
44498762|NCT00112437|79503611|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
44498763|NCT00112437|79503612|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498764|NCT00112437|79503613|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498765|NCT00112437|79503614|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498766|NCT00112437|79503615|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
44498767|NCT00112437|79503590|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498768|NCT00112437|79503591|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498769|NCT00112437|79503592|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498770|NCT00112437|79503593|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498771|NCT00112437|79503594|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498772|NCT00112437|79503595|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498773|NCT00112437|79503596|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498774|NCT00112437|79503597|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498775|NCT00112437|79503598|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498776|NCT00112437|79503599|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44559421|NCT03257657|79577109|FG001|Overall Study|Noted not eligible right after enrolled|1|||
44498777|NCT00112437|79503600|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498778|NCT00112437|79503601|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44559422|NCT02496611|79577118|FG000|Overall Study|Lost to Follow-up|2|||
44559423|NCT02496611|79577119|FG001|Overall Study|Lost to Follow-up|1|||
44559424|NCT02496611|79577118|FG000|Overall Study|Withdrawal by Subject|5|||
44498779|NCT00112437|79503602|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44559425|NCT02496611|79577119|FG001|Overall Study|Withdrawal by Subject|2|||
44559426|NCT03237481|79577129|FG000|Overall Study|Lost to Follow-up|1|||
44559427|NCT03237481|79577130|FG001|Overall Study|Lost to Follow-up|0|||
44559428|NCT03237481|79577131|FG002|Overall Study|Lost to Follow-up|0|||
44559429|NCT03237481|79577129|FG000|Overall Study|Protocol Violation|1|||
44559430|NCT03237481|79577130|FG001|Overall Study|Protocol Violation|0|||
44559431|NCT03237481|79577131|FG002|Overall Study|Protocol Violation|0|||
44559432|NCT03237481|79577129|FG000|Overall Study|Withdrawal by Subject|3|||
44559433|NCT03237481|79577130|FG001|Overall Study|Withdrawal by Subject|2|||
44559434|NCT03237481|79577131|FG002|Overall Study|Withdrawal by Subject|1|||
44232722|NCT01376310|79049837|FG000|Overall Study|Withdrawal by Subject|8|||
44498780|NCT00112437|79503603|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498781|NCT00112437|79503604|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498782|NCT00112437|79503605|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498783|NCT00112437|79503606|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498784|NCT00112437|79503607|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44559435|NCT03222349|79577139|FG000|Overall Study|Treatment B not done|5|||
44559436|NCT03222349|79577140|FG001|Overall Study|Treatment B not done|0|||
44559437|NCT03222349|79577139|FG000|Overall Study|Lost to Follow-up|1|||
44559438|NCT03222349|79577140|FG001|Overall Study|Lost to Follow-up|2|||
44559439|NCT03222349|79577139|FG000|Overall Study|Withdrawal by Subject|1|||
44559440|NCT03222349|79577140|FG001|Overall Study|Withdrawal by Subject|0|||
44559441|NCT03222349|79577139|FG000|Overall Study|Treatment A not done|0|||
44559442|NCT03222349|79577140|FG001|Overall Study|Treatment A not done|5|||
44559443|NCT03222349|79577139|FG000|Overall Study|Study terminated by sponsor|1|||
44559444|NCT03222349|79577140|FG001|Overall Study|Study terminated by sponsor|0|||
44559445|NCT02927925|79577153|FG000|Overall Study|Death|16|||
44559446|NCT02927925|79577153|FG000|Overall Study|Physician Decision|1|||
44559447|NCT02927925|79577153|FG000|Overall Study|Withdrawal by Subject|11|||
44559448|NCT02927925|79577153|FG000|Overall Study|Other|3|||
44559449|NCT02927925|79577153|FG000|Overall Study|Disease progression at clinical cutoff|1|||
44559450|NCT03208933|79577157|FG000|Overall Study|Death|3|||
44559451|NCT03208933|79577157|FG000|Overall Study|Withdrawal by Subject|3|||
44559452|NCT03208933|79577157|FG000|Overall Study|Adverse Event|1|||
44559453|NCT03208933|79577157|FG000|Overall Study|Lost to Follow-up|2|||
44559454|NCT03208933|79577157|FG000|Overall Study|Physician Decision|3|||
44559455|NCT03208933|79577157|FG000|Overall Study|Protocol Violation|1|||
44559456|NCT03207763|79577163|FG000|Overall Study|Lost to Follow-up|1|||
44559457|NCT03207763|79577164|FG001|Overall Study|Lost to Follow-up|0|||
44559458|NCT04766034|79577183|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
44559459|NCT04766034|79577184|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
44559460|NCT04766034|79577185|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
44559461|NCT04766034|79577186|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
44559462|NCT04766034|79577187|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
44559463|NCT04766034|79577183|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
44559464|NCT04766034|79577184|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
44559465|NCT04766034|79577185|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
44559466|NCT04766034|79577186|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
44559467|NCT04766034|79577187|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
44559468|NCT04766034|79577183|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
44559469|NCT04766034|79577184|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
44559470|NCT04766034|79577185|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
44559471|NCT04766034|79577186|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
44559472|NCT04766034|79577187|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
44559473|NCT04766034|79577183|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
44232723|NCT01376310|79049838|FG001|Overall Study|Withdrawal by Subject|2|||
44498785|NCT00112437|79503608|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498786|NCT00112437|79503609|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498787|NCT00112437|79503610|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498788|NCT00112437|79503611|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498789|NCT00112437|79503612|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
44498790|NCT00112437|79503613|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
44498791|NCT00112437|79503614|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
44498792|NCT00112437|79503615|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
44559474|NCT04766034|79577184|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
44559475|NCT04766034|79577185|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
44559476|NCT04766034|79577186|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
44559477|NCT04766034|79577187|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
44559478|NCT03237013|79577202|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
44559479|NCT03237013|79577203|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
44559480|NCT03237013|79577204|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
44559481|NCT03236779|79577214|FG000|Overall Study|Lost to Follow-up|13|||
44559482|NCT03236779|79577215|FG001|Overall Study|Lost to Follow-up|21|||
44559483|NCT03096483|79577223|FG000|Overall Study|Withdrawal by site|1|||
44559484|NCT02932579|79577229|FG000|Overall Study|Withdrawal by Subject|4|||
44559485|NCT02932579|79577230|FG001|Overall Study|Withdrawal by Subject|1|||
44559486|NCT03207451|79577240|FG000|Overall Study|scheduling conflict|1|||
44559487|NCT03207451|79577241|FG001|Overall Study|scheduling conflict|0|||
44559488|NCT03207451|79577242|FG002|Overall Study|scheduling conflict|2|||
44559489|NCT03207451|79577243|FG003|Overall Study|scheduling conflict|2|||
44559490|NCT03207451|79577240|FG000|Overall Study|Adverse Event|0|||
44559491|NCT03207451|79577241|FG001|Overall Study|Adverse Event|0|||
44559492|NCT03207451|79577242|FG002|Overall Study|Adverse Event|0|||
44559493|NCT03207451|79577243|FG003|Overall Study|Adverse Event|1|||
44559494|NCT03350503|79577270|FG000|Overall Study|Adverse Event|5|||
44559495|NCT03350503|79577270|FG000|Overall Study|Withdrawal by Subject|5|||
44559496|NCT03350503|79577270|FG000|Overall Study|Continuation impossible due to move|4|||
44559497|NCT03350503|79577270|FG000|Overall Study|Physician Decision|3|||
44559498|NCT03288779|79577293|FG000|Overall Study|Withdrawal by Subject|3|||
44559499|NCT03206749|79577300|FG000|Overall Study|Withdrawal of consent|5|||
44559500|NCT03206749|79577301|FG001|Overall Study|Withdrawal of consent|3|||
44559501|NCT03206749|79577302|FG002|Overall Study|Withdrawal of consent|6|||
44559502|NCT03206749|79577300|FG000|Overall Study|Lost to Follow-up|0|||
44559503|NCT03206749|79577301|FG001|Overall Study|Lost to Follow-up|0|||
44559504|NCT03206749|79577302|FG002|Overall Study|Lost to Follow-up|1|||
44559505|NCT03255941|79577322|FG000|Overall Study|Not eligible or refused injection|37|||
44559506|NCT03255941|79577323|FG001|Overall Study|Not eligible or refused injection|44|||
44559507|NCT03255941|79577324|FG002|Overall Study|Not eligible or refused injection|5|||
44559508|NCT03255941|79577325|FG003|Overall Study|Not eligible or refused injection|6|||
44559509|NCT03255941|79577322|FG000|Overall Study|Did not complete exit interview|1|||
44559510|NCT03255941|79577323|FG001|Overall Study|Did not complete exit interview|2|||
44559511|NCT03255941|79577324|FG002|Overall Study|Did not complete exit interview|0|||
44559512|NCT03255941|79577325|FG003|Overall Study|Did not complete exit interview|0|||
44559513|NCT03255629|79577347|FG000|Overall Study|Adverse Event|1|||
44559514|NCT03255629|79577348|FG001|Overall Study|Adverse Event|0|||
44559515|NCT03255629|79577347|FG000|Overall Study|did not experience hypoglycemia|2|||
44559516|NCT03255629|79577348|FG001|Overall Study|did not experience hypoglycemia|1|||
44498793|NCT00112437|79503590|FG000|Years 6-10 (60-Month Extension)|Death|0|||
44498794|NCT00112437|79503591|FG001|Years 6-10 (60-Month Extension)|Death|0|||
44498795|NCT00112437|79503592|FG002|Years 6-10 (60-Month Extension)|Death|0|||
44498796|NCT00112437|79503593|FG003|Years 6-10 (60-Month Extension)|Death|0|||
44498797|NCT00112437|79503594|FG004|Years 6-10 (60-Month Extension)|Death|0|||
44498798|NCT00112437|79503595|FG005|Years 6-10 (60-Month Extension)|Death|0|||
44498799|NCT00112437|79503596|FG006|Years 6-10 (60-Month Extension)|Death|0|||
44498800|NCT00112437|79503597|FG007|Years 6-10 (60-Month Extension)|Death|0|||
44498801|NCT00112437|79503598|FG008|Years 6-10 (60-Month Extension)|Death|0|||
44498802|NCT00112437|79503599|FG009|Years 6-10 (60-Month Extension)|Death|0|||
44498803|NCT00112437|79503600|FG010|Years 6-10 (60-Month Extension)|Death|0|||
44559517|NCT03031938|79577357|FG000|Overall Study|Death|1|||
44498804|NCT00112437|79503601|FG011|Years 6-10 (60-Month Extension)|Death|0|||
44498805|NCT00112437|79503602|FG012|Years 6-10 (60-Month Extension)|Death|0|||
44559518|NCT03031938|79577358|FG001|Overall Study|Death|0|||
44559519|NCT01137773|79577366|FG000|Overall Study|Death|3|||
44559520|NCT01137773|79577367|FG001|Overall Study|Death|3|||
44559521|NCT01137773|79577366|FG000|Overall Study|Lost to Follow-up|6|||
44559522|NCT01137773|79577367|FG001|Overall Study|Lost to Follow-up|0|||
44498806|NCT00112437|79503603|FG013|Years 6-10 (60-Month Extension)|Death|0|||
44498807|NCT00112437|79503604|FG014|Years 6-10 (60-Month Extension)|Death|0|||
44498808|NCT00112437|79503605|FG015|Years 6-10 (60-Month Extension)|Death|0|||
44559523|NCT03094611|79577375|FG000|Overall Study|Lack of Efficacy|1|||
44559524|NCT03094611|79577375|FG000|Overall Study|Stem Cell Transplant|1|||
44559525|NCT04105725|79577399|FG000|Primary Intervention|Lost to Follow-up|0|||
44559526|NCT04105725|79577400|FG001|Primary Intervention|Lost to Follow-up|2|||
44559527|NCT04105725|79577399|FG000|Primary Intervention|Withdrawal by Subject|0|||
44559528|NCT04105725|79577400|FG001|Primary Intervention|Withdrawal by Subject|1|||
44559529|NCT04066023|79577409|FG000|Overall Study|Adverse Event|0|||
44559530|NCT04066023|79577410|FG001|Overall Study|Adverse Event|0|||
44559531|NCT04066023|79577411|FG002|Overall Study|Adverse Event|1|||
44559532|NCT04066023|79577409|FG000|Overall Study|Sponsor decision|3|||
44559533|NCT04066023|79577410|FG001|Overall Study|Sponsor decision|6|||
44559534|NCT04066023|79577411|FG002|Overall Study|Sponsor decision|2|||
44559535|NCT04066023|79577409|FG000|Overall Study|Physician Decision|0|||
44559536|NCT04066023|79577410|FG001|Overall Study|Physician Decision|0|||
44559537|NCT04066023|79577411|FG002|Overall Study|Physician Decision|1|||
44559538|NCT04066023|79577409|FG000|Overall Study|Lost to Follow-up|0|||
44559539|NCT04066023|79577410|FG001|Overall Study|Lost to Follow-up|1|||
44559540|NCT04066023|79577411|FG002|Overall Study|Lost to Follow-up|1|||
44559541|NCT04066023|79577409|FG000|Overall Study|Noncompliance|0|||
44559542|NCT04066023|79577410|FG001|Overall Study|Noncompliance|1|||
44559543|NCT04066023|79577411|FG002|Overall Study|Noncompliance|1|||
44559544|NCT03106987|79577423|FG000|Overall Study|Death|37|||
44559545|NCT03106987|79577424|FG001|Overall Study|Death|22|||
44559546|NCT03106987|79577425|FG002|Overall Study|Death|12|||
44559547|NCT03106987|79577426|FG003|Overall Study|Death|8|||
44559548|NCT03106987|79577423|FG000|Overall Study|Lost to Follow-up|2|||
44559549|NCT03106987|79577424|FG001|Overall Study|Lost to Follow-up|0|||
44559550|NCT03106987|79577425|FG002|Overall Study|Lost to Follow-up|2|||
44559551|NCT03106987|79577426|FG003|Overall Study|Lost to Follow-up|2|||
44559552|NCT03106987|79577423|FG000|Overall Study|Withdrawal by Subject|5|||
44559553|NCT03106987|79577424|FG001|Overall Study|Withdrawal by Subject|1|||
44559554|NCT03106987|79577425|FG002|Overall Study|Withdrawal by Subject|4|||
44559555|NCT03106987|79577426|FG003|Overall Study|Withdrawal by Subject|1|||
44559556|NCT02932267|79577436|FG000|Overall Study|Withdrawal by Subject|3|||
44559557|NCT02932267|79577436|FG000|Overall Study|Lost to Follow-up|4|||
44559558|NCT02932267|79577436|FG000|Overall Study|Pregnancy|1|||
44559559|NCT03217591|79577443|FG000|Overall Study|Adverse Event|1|||
44559560|NCT03217591|79577444|FG001|Overall Study|Adverse Event|2|||
44559561|NCT03217591|79577445|FG002|Overall Study|Adverse Event|6|||
44559562|NCT03217591|79577443|FG000|Overall Study|Withdrawal by Subject|0|||
44559563|NCT03217591|79577444|FG001|Overall Study|Withdrawal by Subject|1|||
44559564|NCT03217591|79577445|FG002|Overall Study|Withdrawal by Subject|3|||
44559565|NCT03217591|79577443|FG000|Overall Study|Lost to Follow-up|1|||
44559566|NCT03217591|79577444|FG001|Overall Study|Lost to Follow-up|0|||
44559567|NCT03217591|79577445|FG002|Overall Study|Lost to Follow-up|0|||
44559568|NCT03217591|79577443|FG000|Overall Study|Protocol Violation|1|||
44559569|NCT03217591|79577444|FG001|Overall Study|Protocol Violation|0|||
44559570|NCT03217591|79577445|FG002|Overall Study|Protocol Violation|1|||
44559571|NCT03031782|79577454|FG000|Treatment Period 1|Lack of Efficacy|3|||
44559572|NCT03031782|79577455|FG001|Treatment Period 1|Lack of Efficacy|0|||
44559573|NCT03031782|79577456|FG002|Treatment Period 1|Lack of Efficacy|0|||
44559574|NCT03031782|79577457|FG003|Treatment Period 1|Lack of Efficacy|0|||
44559575|NCT03031782|79577458|FG004|Treatment Period 1|Lack of Efficacy|0|||
44559576|NCT03031782|79577454|FG000|Treatment Period 2|Physician Decision|0|||
44559577|NCT03031782|79577455|FG001|Treatment Period 2|Physician Decision|1|||
44559578|NCT03031782|79577456|FG002|Treatment Period 2|Physician Decision|0|||
44559579|NCT03031782|79577457|FG003|Treatment Period 2|Physician Decision|0|||
44559580|NCT03031782|79577458|FG004|Treatment Period 2|Physician Decision|3|||
44559581|NCT03031782|79577454|FG000|Treatment Period 2|Lack of Efficacy|0|||
44559582|NCT03031782|79577455|FG001|Treatment Period 2|Lack of Efficacy|1|||
44559583|NCT03031782|79577456|FG002|Treatment Period 2|Lack of Efficacy|0|||
44559584|NCT03031782|79577457|FG003|Treatment Period 2|Lack of Efficacy|0|||
44559585|NCT03031782|79577458|FG004|Treatment Period 2|Lack of Efficacy|1|||
44559586|NCT03031782|79577454|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44559587|NCT03031782|79577455|FG001|Treatment Period 2|Withdrawal by Subject|3|||
44559588|NCT03031782|79577456|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44559589|NCT03031782|79577457|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44559590|NCT03031782|79577458|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44559591|NCT03031782|79577454|FG000|Treatment Period 2|Adverse Event|0|||
44559592|NCT03031782|79577455|FG001|Treatment Period 2|Adverse Event|1|||
44559593|NCT03031782|79577456|FG002|Treatment Period 2|Adverse Event|2|||
44559594|NCT03031782|79577457|FG003|Treatment Period 2|Adverse Event|0|||
44559595|NCT03031782|79577458|FG004|Treatment Period 2|Adverse Event|0|||
44559596|NCT03031782|79577454|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44559597|NCT03031782|79577455|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44559598|NCT03031782|79577456|FG002|Treatment Period 3|Withdrawal by Subject|0|||
44559599|NCT03031782|79577457|FG003|Treatment Period 3|Withdrawal by Subject|1|||
44559600|NCT03031782|79577458|FG004|Treatment Period 3|Withdrawal by Subject|0|||
44559601|NCT03216265|79577475|FG000|Overall Study|Adverse Event|2|||
44559602|NCT03216265|79577476|FG001|Overall Study|Adverse Event|0|||
44559603|NCT03216265|79577477|FG002|Overall Study|Adverse Event|2|||
44559604|NCT03216265|79577475|FG000|Overall Study|Lost to Follow-up|0|||
44559605|NCT03216265|79577476|FG001|Overall Study|Lost to Follow-up|1|||
44559606|NCT03216265|79577477|FG002|Overall Study|Lost to Follow-up|0|||
44559607|NCT03216265|79577475|FG000|Overall Study|Withdrawal by Subject|0|||
44559608|NCT03216265|79577476|FG001|Overall Study|Withdrawal by Subject|0|||
44559609|NCT03216265|79577477|FG002|Overall Study|Withdrawal by Subject|1|||
44559610|NCT04486950|79577508|FG000|Overall Study|Lost to Follow-up|0|||
44559611|NCT04486950|79577509|FG001|Overall Study|Lost to Follow-up|0|||
44559612|NCT04486950|79577510|FG002|Overall Study|Lost to Follow-up|0|||
44559613|NCT04486950|79577511|FG003|Overall Study|Lost to Follow-up|0|||
44232724|NCT01376310|79049837|FG000|Overall Study|Physician Decision|26|||
44559614|NCT04486950|79577512|FG004|Overall Study|Lost to Follow-up|0|||
44559615|NCT04486950|79577513|FG005|Overall Study|Lost to Follow-up|1|||
44559616|NCT04486950|79577514|FG006|Overall Study|Lost to Follow-up|0|||
44559617|NCT04693416|79577536|FG000|Overall Study|Lost to Follow-up|13|||
44559618|NCT04693416|79577537|FG001|Overall Study|Lost to Follow-up|0|||
44559619|NCT00265941|79577545|FG000|Overall Study|Protocol Violation|22|||
44559620|NCT00265941|79577546|FG001|Overall Study|Protocol Violation|25|||
44559621|NCT00265941|79577545|FG000|Overall Study|Lost to Follow-up|1|||
44559622|NCT00265941|79577546|FG001|Overall Study|Lost to Follow-up|1|||
44559623|NCT03882957|79577560|FG000|Overall Study|Did not complete all three arms|1|||
44559624|NCT03201211|79577572|FG000|Overall Study|Adverse Event|1|||
44559625|NCT03201211|79577573|FG001|Overall Study|Adverse Event|0|||
44559626|NCT03201211|79577574|FG002|Overall Study|Adverse Event|0|||
44232725|NCT01376310|79049838|FG001|Overall Study|Physician Decision|7|||
44232726|NCT01376310|79049837|FG000|Overall Study|Lost to Follow-up|1|||
44232727|NCT01376310|79049838|FG001|Overall Study|Lost to Follow-up|0|||
44232728|NCT01949506|79049844|FG000|Overall Study|Physician Decision|1|||
44232729|NCT00709098|79049941|FG000|Double-blind Period|Withdrawal of consent|3|||
44232730|NCT00709098|79049942|FG001|Double-blind Period|Withdrawal of consent|3|||
44232731|NCT00709098|79049943|FG002|Double-blind Period|Withdrawal of consent|0|||
44232732|NCT00709098|79049941|FG000|Double-blind Period|Administrative reason|1|||
44232733|NCT00709098|79049942|FG001|Double-blind Period|Administrative reason|3|||
44232734|NCT00709098|79049943|FG002|Double-blind Period|Administrative reason|0|||
44232735|NCT00709098|79049941|FG000|Double-blind Period|Death|1|||
44498809|NCT00112437|79503606|FG016|Years 6-10 (60-Month Extension)|Death|0|||
44498810|NCT00112437|79503607|FG017|Years 6-10 (60-Month Extension)|Death|0|||
44498811|NCT00112437|79503608|FG018|Years 6-10 (60-Month Extension)|Death|0|||
44498812|NCT00112437|79503609|FG019|Years 6-10 (60-Month Extension)|Death|0|||
44498813|NCT00112437|79503610|FG020|Years 6-10 (60-Month Extension)|Death|0|||
44498814|NCT00112437|79503611|FG021|Years 6-10 (60-Month Extension)|Death|0|||
44498815|NCT00112437|79503612|FG022|Years 6-10 (60-Month Extension)|Death|0|||
44498816|NCT00112437|79503613|FG023|Years 6-10 (60-Month Extension)|Death|2|||
44498817|NCT00112437|79503614|FG024|Years 6-10 (60-Month Extension)|Death|0|||
44498818|NCT00112437|79503615|FG025|Years 6-10 (60-Month Extension)|Death|0|||
44498819|NCT00112437|79503590|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498820|NCT00112437|79503591|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498821|NCT00112437|79503592|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498822|NCT00112437|79503593|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498823|NCT00112437|79503594|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498824|NCT00112437|79503595|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498825|NCT00112437|79503596|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498826|NCT00112437|79503597|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498827|NCT00112437|79503598|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498828|NCT00112437|79503599|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498829|NCT00112437|79503600|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498830|NCT00112437|79503601|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44232736|NCT00709098|79049942|FG001|Double-blind Period|Death|1|||
44498831|NCT00112437|79503602|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498832|NCT00112437|79503603|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498833|NCT00112437|79503604|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44559627|NCT03201211|79577572|FG000|Overall Study|Protocol Violation|1|||
44559628|NCT03201211|79577573|FG001|Overall Study|Protocol Violation|0|||
44559629|NCT03201211|79577574|FG002|Overall Study|Protocol Violation|0|||
44559630|NCT03201211|79577572|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44559631|NCT03201211|79577573|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44559632|NCT03201211|79577574|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
44559633|NCT03201211|79577572|FG000|Overall Study|OTHER unknown reasons|0|||
44559634|NCT03201211|79577573|FG001|Overall Study|OTHER unknown reasons|1|||
44559635|NCT03201211|79577574|FG002|Overall Study|OTHER unknown reasons|0|||
44559636|NCT04633837|79577584|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
44559637|NCT04633837|79577585|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
44559638|NCT03029832|79577593|FG000|Overall Study|Safety Follow-Up Completed|2|||
44559639|NCT03029832|79577594|FG001|Overall Study|Safety Follow-Up Completed|0|||
44559640|NCT03029832|79577593|FG000|Overall Study|Death due to Disease Progression|1|||
44559641|NCT03029832|79577594|FG001|Overall Study|Death due to Disease Progression|0|||
44559642|NCT03029832|79577593|FG000|Overall Study|Study Terminated By Sponsor|1|||
44498834|NCT00112437|79503605|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498835|NCT00112437|79503606|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44559643|NCT03029832|79577594|FG001|Overall Study|Study Terminated By Sponsor|1|||
44559644|NCT03089697|79577602|FG000|Overall Study|Adverse Event|1|||
44559645|NCT03089697|79577603|FG001|Overall Study|Adverse Event|2|||
44559646|NCT03089697|79577602|FG000|Overall Study|Withdrawal by Subject|1|||
44559647|NCT03089697|79577603|FG001|Overall Study|Withdrawal by Subject|0|||
44559648|NCT03199963|79577611|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
44559649|NCT03199963|79577612|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
44559650|NCT03199963|79577611|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
44559651|NCT03199963|79577612|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
44559652|NCT03199963|79577611|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
44559653|NCT03199963|79577612|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
44559654|NCT03199963|79577611|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
44559655|NCT03199963|79577612|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
44559656|NCT03199963|79577611|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
44559657|NCT03199963|79577612|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
44559658|NCT03199963|79577611|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
44559659|NCT03199963|79577612|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
44559660|NCT03883581|79577624|FG000|Overall Study|Withdrawal by Subject|4|||
44559661|NCT03029208|79577630|FG000|Overall Study|Withdrawal by Subject|2|||
44559662|NCT03029208|79577631|FG001|Overall Study|Withdrawal by Subject|3|||
44559663|NCT03029208|79577630|FG000|Overall Study|Lost to Follow-up|0|||
44559664|NCT03029208|79577631|FG001|Overall Study|Lost to Follow-up|1|||
44559665|NCT03198715|79577651|FG000|Overall Study|Death|0|||
44559666|NCT03198715|79577652|FG001|Overall Study|Death|0|||
44559667|NCT03198715|79577653|FG002|Overall Study|Death|1|||
44559668|NCT03198715|79577654|FG003|Overall Study|Death|0|||
44559669|NCT03198715|79577655|FG004|Overall Study|Death|2|||
44559670|NCT03198715|79577651|FG000|Overall Study|Other|0|||
44559671|NCT03198715|79577652|FG001|Overall Study|Other|1|||
44559672|NCT03198715|79577653|FG002|Overall Study|Other|1|||
44559673|NCT03198715|79577654|FG003|Overall Study|Other|0|||
44559674|NCT03198715|79577655|FG004|Overall Study|Other|0|||
44559675|NCT03088917|79577676|FG000|Overall Study|In care/cured elsewhere|15|||
44559676|NCT03088917|79577676|FG000|Overall Study|Refuse re-evaluation|13|||
44498836|NCT00112437|79503607|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498837|NCT00112437|79503608|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498838|NCT00112437|79503609|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498839|NCT00112437|79503610|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498840|NCT00112437|79503611|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498841|NCT00112437|79503612|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498842|NCT00112437|79503613|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498843|NCT00112437|79503614|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
44498844|NCT00112437|79503615|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
44498845|NCT00112437|79503590|FG000|Years 6-10 (60-Month Extension)|Other|0|||
44498846|NCT00112437|79503591|FG001|Years 6-10 (60-Month Extension)|Other|0|||
44559677|NCT03088917|79577676|FG000|Overall Study|Contact not established|13|||
44498847|NCT00112437|79503592|FG002|Years 6-10 (60-Month Extension)|Other|0|||
44232737|NCT00709098|79049943|FG002|Double-blind Period|Death|0|||
44559678|NCT03088917|79577676|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
44559679|NCT03088917|79577676|FG000|Overall Study|Moved outside study region|50|||
44559680|NCT03087513|79577682|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
44232738|NCT00709098|79049941|FG000|Double-blind Period|Lost to Follow-up|1|||
44232739|NCT00709098|79049942|FG001|Double-blind Period|Lost to Follow-up|1|||
44232740|NCT00709098|79049943|FG002|Double-blind Period|Lost to Follow-up|0|||
44232741|NCT00709098|79049941|FG000|Open-label Period|Withdrawal of consent|0|||
44232742|NCT00709098|79049942|FG001|Open-label Period|Withdrawal of consent|0|||
44232743|NCT00709098|79049943|FG002|Open-label Period|Withdrawal of consent|7|||
44232744|NCT00709098|79049941|FG000|Open-label Period|Administrative reason|0|||
44232745|NCT00709098|79049942|FG001|Open-label Period|Administrative reason|0|||
44232746|NCT00709098|79049943|FG002|Open-label Period|Administrative reason|5|||
44232747|NCT00709098|79049941|FG000|Open-label Period|Death|0|||
44232748|NCT00709098|79049942|FG001|Open-label Period|Death|0|||
44232749|NCT00709098|79049943|FG002|Open-label Period|Death|1|||
44232750|NCT00709098|79049941|FG000|Open-label Period|Lost to Follow-up|0|||
44232751|NCT00709098|79049942|FG001|Open-label Period|Lost to Follow-up|0|||
44232752|NCT00709098|79049943|FG002|Open-label Period|Lost to Follow-up|1|||
44232753|NCT01376700|79049952|FG000|Overall Study|Sponsor terminated study early|8|||
44232754|NCT01376700|79049952|FG000|Overall Study|Low or high titer inhibitor|8|||
44232755|NCT01797965|79049963|FG000|Overall Study|Adverse Event|104|||
44232756|NCT01797965|79049964|FG001|Overall Study|Adverse Event|129|||
44232757|NCT01797965|79049965|FG002|Overall Study|Adverse Event|4|||
44232758|NCT01797965|79049966|FG003|Overall Study|Adverse Event|21|||
44498848|NCT00112437|79503593|FG003|Years 6-10 (60-Month Extension)|Other|0|||
44498849|NCT00112437|79503594|FG004|Years 6-10 (60-Month Extension)|Other|0|||
44498850|NCT00112437|79503595|FG005|Years 6-10 (60-Month Extension)|Other|0|||
44498851|NCT00112437|79503596|FG006|Years 6-10 (60-Month Extension)|Other|0|||
44498852|NCT00112437|79503597|FG007|Years 6-10 (60-Month Extension)|Other|0|||
44498853|NCT00112437|79503598|FG008|Years 6-10 (60-Month Extension)|Other|0|||
44498854|NCT00112437|79503599|FG009|Years 6-10 (60-Month Extension)|Other|0|||
44498855|NCT00112437|79503600|FG010|Years 6-10 (60-Month Extension)|Other|0|||
44498856|NCT00112437|79503601|FG011|Years 6-10 (60-Month Extension)|Other|0|||
44498857|NCT00112437|79503602|FG012|Years 6-10 (60-Month Extension)|Other|0|||
44498858|NCT00112437|79503603|FG013|Years 6-10 (60-Month Extension)|Other|0|||
44498859|NCT00112437|79503604|FG014|Years 6-10 (60-Month Extension)|Other|0|||
44498860|NCT00112437|79503605|FG015|Years 6-10 (60-Month Extension)|Other|0|||
44498861|NCT00112437|79503606|FG016|Years 6-10 (60-Month Extension)|Other|0|||
44498862|NCT00112437|79503607|FG017|Years 6-10 (60-Month Extension)|Other|0|||
44498863|NCT00112437|79503608|FG018|Years 6-10 (60-Month Extension)|Other|0|||
44498864|NCT00112437|79503609|FG019|Years 6-10 (60-Month Extension)|Other|0|||
44498865|NCT00112437|79503610|FG020|Years 6-10 (60-Month Extension)|Other|0|||
44498866|NCT00112437|79503611|FG021|Years 6-10 (60-Month Extension)|Other|0|||
44498867|NCT00112437|79503612|FG022|Years 6-10 (60-Month Extension)|Other|0|||
44498868|NCT00112437|79503613|FG023|Years 6-10 (60-Month Extension)|Other|0|||
44498869|NCT00112437|79503614|FG024|Years 6-10 (60-Month Extension)|Other|1|||
44498870|NCT00112437|79503615|FG025|Years 6-10 (60-Month Extension)|Other|0|||
44498871|NCT00112437|79503590|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498872|NCT00112437|79503591|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498873|NCT00112437|79503592|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498874|NCT00112437|79503593|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498875|NCT00112437|79503594|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498876|NCT00112437|79503595|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498877|NCT00112437|79503596|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498878|NCT00112437|79503597|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498879|NCT00112437|79503598|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498880|NCT00112437|79503599|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498881|NCT00112437|79503600|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498882|NCT00112437|79503601|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498883|NCT00112437|79503602|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498884|NCT00112437|79503603|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498885|NCT00112437|79503604|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498886|NCT00112437|79503605|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44232759|NCT01797965|79049963|FG000|Overall Study|Lost to Follow-up|9|||
44559681|NCT02917629|79577697|FG000|Overall Study|Withdrawal by Subject|0|||
44559682|NCT02917629|79577698|FG001|Overall Study|Withdrawal by Subject|1|||
44559683|NCT02927847|79577707|FG000|Overall Study|Lost to Follow-up|1|||
44559684|NCT02927847|79577708|FG001|Overall Study|Lost to Follow-up|0|||
44559685|NCT02927847|79577707|FG000|Overall Study|Withdrawal by Subject|4|||
44559686|NCT02927847|79577708|FG001|Overall Study|Withdrawal by Subject|2|||
44559687|NCT02927847|79577707|FG000|Overall Study|PI withdrawn due to missed visits|1|||
44559688|NCT02927847|79577708|FG001|Overall Study|PI withdrawn due to missed visits|1|||
44559689|NCT02960438|79577718|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
44559690|NCT02960438|79577719|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
44559691|NCT02960438|79577720|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
44559692|NCT02960438|79577721|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
44559693|NCT02960438|79577718|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
44559694|NCT02960438|79577719|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
44559695|NCT02960438|79577720|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
44559696|NCT02960438|79577721|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
44559697|NCT02960438|79577718|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
44559698|NCT02960438|79577719|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
44559699|NCT02960438|79577720|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
44559700|NCT02960438|79577721|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
44559701|NCT02960438|79577718|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
44559702|NCT02960438|79577719|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
44559703|NCT02960438|79577720|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
44559704|NCT02960438|79577721|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
44559705|NCT02960438|79577718|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
44559706|NCT02960438|79577719|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
44559707|NCT02960438|79577720|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
44559708|NCT02960438|79577721|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
44559709|NCT02960438|79577718|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
44559710|NCT02960438|79577719|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
44559711|NCT02960438|79577720|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
44559712|NCT02960438|79577721|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
44559713|NCT02960438|79577718|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
44559714|NCT02960438|79577719|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
44559715|NCT02960438|79577720|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
44275253|NCT02239692|79221709|FG000|Overall Study|Physician Decision|0|||
44275254|NCT02239692|79221710|FG001|Overall Study|Physician Decision|1|||
44498887|NCT00112437|79503606|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498888|NCT00112437|79503607|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498889|NCT00112437|79503608|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498890|NCT00112437|79503609|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498891|NCT00112437|79503610|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498892|NCT00112437|79503611|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498893|NCT00112437|79503612|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498894|NCT00112437|79503613|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
44498895|NCT00112437|79503614|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498896|NCT00112437|79503615|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
44498897|NCT00112437|79503590|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498898|NCT00112437|79503591|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498899|NCT00112437|79503592|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498900|NCT00112437|79503593|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498901|NCT00112437|79503594|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498902|NCT00112437|79503595|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498903|NCT00112437|79503596|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498904|NCT00112437|79503597|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498905|NCT00112437|79503598|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498906|NCT00112437|79503599|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498907|NCT00112437|79503600|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498908|NCT00112437|79503601|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498909|NCT00112437|79503602|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498910|NCT00112437|79503603|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498911|NCT00112437|79503604|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498912|NCT00112437|79503605|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44559716|NCT02960438|79577721|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
44559717|NCT02960438|79577718|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
44559718|NCT02960438|79577719|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
44559719|NCT02960438|79577720|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
44559720|NCT02960438|79577721|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
44559721|NCT02960438|79577718|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
44559722|NCT02960438|79577719|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
44559723|NCT02960438|79577720|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
44559724|NCT02960438|79577721|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
44559725|NCT02960438|79577718|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
44232760|NCT01797965|79049964|FG001|Overall Study|Lost to Follow-up|8|||
44498913|NCT00112437|79503606|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498914|NCT00112437|79503607|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498915|NCT00112437|79503608|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498916|NCT00112437|79503609|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498917|NCT00112437|79503610|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498918|NCT00112437|79503611|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498919|NCT00112437|79503612|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
44498920|NCT00112437|79503613|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
44498921|NCT00112437|79503614|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
44498922|NCT00112437|79503615|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
44498923|NCT03653416|79503671|FG000|Overall Study|Protocol Violation|6|||
44498924|NCT03653416|79503672|FG001|Overall Study|Protocol Violation|1|||
44498925|NCT00112359|79503680|FG000|Overall Study|Unrelated adverse event|16|||
44498926|NCT00112359|79503681|FG001|Overall Study|Unrelated adverse event|8|||
44498927|NCT00112359|79503680|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
44498928|NCT00112359|79503681|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
44559726|NCT02960438|79577719|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
44559727|NCT02960438|79577720|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
44559728|NCT02960438|79577721|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
44559729|NCT02960438|79577718|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
44559730|NCT02960438|79577719|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
44559731|NCT02960438|79577720|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
44559732|NCT02960438|79577721|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
44559733|NCT02960438|79577718|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
44559734|NCT02960438|79577719|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
44559735|NCT02960438|79577720|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
44232761|NCT01797965|79049965|FG002|Overall Study|Lost to Follow-up|1|||
44376867|NCT00869440|79382110|FG003|Overall Study|Withdrawal by Subject|0|||
44376868|NCT00869440|79382107|FG000|Overall Study|Physician Decision|1|||
44376869|NCT00869440|79382108|FG001|Overall Study|Physician Decision|1|||
44376870|NCT00869440|79382109|FG002|Overall Study|Physician Decision|0|||
44376871|NCT00869440|79382110|FG003|Overall Study|Physician Decision|0|||
44376872|NCT00895947|79382122|FG000|Overall Study|Adverse Event|3|||
44376873|NCT00895947|79382123|FG001|Overall Study|Adverse Event|4|||
44376874|NCT00895947|79382122|FG000|Overall Study|Lost to Follow-up|3|||
44376875|NCT00895947|79382123|FG001|Overall Study|Lost to Follow-up|4|||
44376876|NCT00895947|79382122|FG000|Overall Study|Protocol Violation|4|||
44376877|NCT00895947|79382123|FG001|Overall Study|Protocol Violation|2|||
44376878|NCT00895947|79382122|FG000|Overall Study|Withdrawal by Subject|2|||
44498929|NCT00112359|79503680|FG000|Overall Study|Related adverse event|5|||
44498930|NCT00112359|79503681|FG001|Overall Study|Related adverse event|3|||
44559736|NCT02960438|79577721|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
44559737|NCT02957942|79577741|FG000|Overall Study|Withdrawal by Subject|0|||
44559738|NCT02957942|79577742|FG001|Overall Study|Withdrawal by Subject|1|||
44559739|NCT02957942|79577741|FG000|Overall Study|Practicing experiment protocol|0|||
44559740|NCT02957942|79577742|FG001|Overall Study|Practicing experiment protocol|6|||
44559741|NCT02959970|79577750|FG000|Overall Study|Adverse Event|1|||
44559742|NCT02959970|79577751|FG001|Overall Study|Adverse Event|0|||
44559743|NCT02959970|79577750|FG000|Overall Study|Withdrawal by Subject|0|||
44559744|NCT02959970|79577751|FG001|Overall Study|Withdrawal by Subject|2|||
44559745|NCT02959970|79577750|FG000|Overall Study|Lost to Follow-up|1|||
44559746|NCT02959970|79577751|FG001|Overall Study|Lost to Follow-up|5|||
44559747|NCT05300763|79577784|FG000|Overall Study|Adverse Event|0|||
44559748|NCT05300763|79577785|FG001|Overall Study|Adverse Event|1|||
44559749|NCT05300763|79577784|FG000|Overall Study|Major Protocol Deviation|1|||
44559750|NCT05300763|79577785|FG001|Overall Study|Major Protocol Deviation|0|||
44559751|NCT05300763|79577784|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
44559752|NCT05300763|79577785|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
44559753|NCT01383135|79577795|FG000|Overall Study|Not Scanned / Imaged|1|||
44559754|NCT01383135|79577796|FG001|Overall Study|Not Scanned / Imaged|0|||
44559755|NCT01383135|79577797|FG002|Overall Study|Not Scanned / Imaged|1|||
44559756|NCT01383135|79577798|FG003|Overall Study|Not Scanned / Imaged|0|||
44559757|NCT02925312|79577811|FG000|Overall Study|Lost to Follow-up|25|||
44559758|NCT02925312|79577812|FG001|Overall Study|Lost to Follow-up|0|||
44559759|NCT02925312|79577811|FG000|Overall Study|Adverse Event|2|||
44559760|NCT02925312|79577812|FG001|Overall Study|Adverse Event|0|||
44559761|NCT03196297|79577827|FG000|Main Period|Withdrawal by Subject|4|||
44559762|NCT03196297|79577827|FG000|Extension Period|Withdrawal by Subject|1|||
44559763|NCT03196297|79577827|FG000|Extension Period|Lack of Efficacy|2|||
44559764|NCT03192475|79577845|FG000|Overall Study|Death|0|||
44498931|NCT00112359|79503680|FG000|Overall Study|Lost to Follow-up|0|||
44498932|NCT00112359|79503681|FG001|Overall Study|Lost to Follow-up|1|||
44498933|NCT00112359|79503680|FG000|Overall Study|Personal/administrative|1|||
44498934|NCT00112359|79503681|FG001|Overall Study|Personal/administrative|1|||
44498935|NCT00112359|79503680|FG000|Overall Study|Other|3|||
44498936|NCT00112359|79503681|FG001|Overall Study|Other|0|||
44498937|NCT00119379|79503689|FG000|Overall Study|Adverse Event|4|||
44498938|NCT00119379|79503690|FG001|Overall Study|Adverse Event|1|||
44559765|NCT03192475|79577846|FG001|Overall Study|Death|1|||
44559766|NCT03192475|79577845|FG000|Overall Study|Lost to Follow-up|13|||
44559767|NCT03192475|79577846|FG001|Overall Study|Lost to Follow-up|8|||
44376879|NCT00895947|79382123|FG001|Overall Study|Withdrawal by Subject|0|||
44498939|NCT00118911|79503698|FG000|Overall Study|Withdrawal by Subject|2|||
44498940|NCT00118911|79503699|FG001|Overall Study|Withdrawal by Subject|5|||
44498941|NCT00131937|79503705|FG000|Overall Study|Adverse Event|3|||
44498942|NCT00131937|79503705|FG000|Overall Study|Withdrawal by Subject|2|||
44559768|NCT03189745|79577855|FG000|Overall Study|Conflict in work schedule of participant|1|||
44559769|NCT03189745|79577856|FG001|Overall Study|Conflict in work schedule of participant|1|||
44559770|NCT03188263|79577864|FG000|Overall Study|Withdrawal by Subject|3|||
44376880|NCT00869362|79382131|FG000|Overall Study|Death|0|||
44376881|NCT00869362|79382132|FG001|Overall Study|Death|2|||
44376882|NCT00869362|79382131|FG000|Overall Study|Lost to Follow-up|1|||
44376883|NCT00869362|79382132|FG001|Overall Study|Lost to Follow-up|3|||
44498943|NCT00131937|79503705|FG000|Overall Study|Physician Decision|1|||
44498944|NCT00131937|79503705|FG000|Overall Study|Disease Progression|7|||
44498945|NCT00131937|79503705|FG000|Overall Study|Alternative therapy|1|||
44498946|NCT00131469|79503711|FG000|Overall Study|Withdrawal by Subject|3|||
44498947|NCT00131469|79503712|FG001|Overall Study|Withdrawal by Subject|4|||
44498948|NCT00131469|79503711|FG000|Overall Study|Protocol Violation|3|||
44498949|NCT00131469|79503712|FG001|Overall Study|Protocol Violation|1|||
44498950|NCT00131469|79503711|FG000|Overall Study|Death|0|||
44498951|NCT00131469|79503712|FG001|Overall Study|Death|1|||
44498952|NCT00131469|79503711|FG000|Overall Study|Lost to Follow-up|0|||
44498953|NCT00131469|79503712|FG001|Overall Study|Lost to Follow-up|1|||
44498954|NCT00131469|79503711|FG000|Overall Study|scan not analyzable|3|||
44498955|NCT00131469|79503712|FG001|Overall Study|scan not analyzable|6|||
44498956|NCT00372593|79503721|FG000|Overall Study|Adverse Event|43|||
44498957|NCT00372593|79503722|FG001|Overall Study|Adverse Event|45|||
44498958|NCT00372593|79503723|FG002|Overall Study|Adverse Event|0|||
44498959|NCT00372593|79503721|FG000|Overall Study|Death|16|||
44498960|NCT00372593|79503722|FG001|Overall Study|Death|20|||
44498961|NCT00372593|79503723|FG002|Overall Study|Death|1|||
44498962|NCT00372593|79503721|FG000|Overall Study|Lack of Efficacy|82|||
44498963|NCT00372593|79503722|FG001|Overall Study|Lack of Efficacy|71|||
44498964|NCT00372593|79503723|FG002|Overall Study|Lack of Efficacy|2|||
44498965|NCT00372593|79503721|FG000|Overall Study|Lost to Follow-up|1|||
44498966|NCT00372593|79503722|FG001|Overall Study|Lost to Follow-up|0|||
44498967|NCT00372593|79503723|FG002|Overall Study|Lost to Follow-up|0|||
44498968|NCT00372593|79503721|FG000|Overall Study|Physician Decision|42|||
44498969|NCT00372593|79503722|FG001|Overall Study|Physician Decision|41|||
44498970|NCT00372593|79503723|FG002|Overall Study|Physician Decision|0|||
44498971|NCT00372593|79503721|FG000|Overall Study|Ineligible|20|||
44498972|NCT00372593|79503722|FG001|Overall Study|Ineligible|21|||
44498973|NCT00372593|79503723|FG002|Overall Study|Ineligible|1|||
44498974|NCT03666988|79503738|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
44498975|NCT03666988|79503739|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
44498976|NCT03666988|79503740|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
44498977|NCT03666988|79503741|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
44498978|NCT03666988|79503742|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
44498979|NCT03666988|79503743|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
44498980|NCT03666988|79503738|FG000|Part 1 (Up to 28 Months)|Other|0|||
44498981|NCT03666988|79503739|FG001|Part 1 (Up to 28 Months)|Other|1|||
44376884|NCT00588445|79382139|FG000|Overall Study|Protocol Violation|1|||
44498982|NCT03666988|79503740|FG002|Part 1 (Up to 28 Months)|Other|1|||
44498983|NCT03666988|79503741|FG003|Part 1 (Up to 28 Months)|Other|0|||
44498984|NCT03666988|79503742|FG004|Part 1 (Up to 28 Months)|Other|0|||
44498985|NCT03666988|79503743|FG005|Part 1 (Up to 28 Months)|Other|0|||
44498986|NCT03666988|79503738|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
44498987|NCT03666988|79503739|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
44498988|NCT03666988|79503740|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
44559771|NCT03188263|79577865|FG001|Overall Study|Withdrawal by Subject|0|||
44559772|NCT03188263|79577864|FG000|Overall Study|Physician Decision|1|||
44559773|NCT03188263|79577865|FG001|Overall Study|Physician Decision|0|||
44559774|NCT03188185|79577873|FG000|Stage 1|Adverse Event|4|||
44559775|NCT03188185|79577874|FG001|Stage 1|Adverse Event|12|||
44559776|NCT03188185|79577875|FG002|Stage 1|Adverse Event|0|||
44559777|NCT03188185|79577876|FG003|Stage 1|Adverse Event|0|||
44559778|NCT03188185|79577873|FG000|Stage 1|Lack of Efficacy|0|||
44559779|NCT03188185|79577874|FG001|Stage 1|Lack of Efficacy|2|||
44559780|NCT03188185|79577875|FG002|Stage 1|Lack of Efficacy|0|||
44559781|NCT03188185|79577876|FG003|Stage 1|Lack of Efficacy|0|||
44559782|NCT03188185|79577873|FG000|Stage 1|Lost to Follow-up|6|||
44559783|NCT03188185|79577874|FG001|Stage 1|Lost to Follow-up|1|||
44559784|NCT03188185|79577875|FG002|Stage 1|Lost to Follow-up|0|||
44559785|NCT03188185|79577876|FG003|Stage 1|Lost to Follow-up|0|||
44559786|NCT03188185|79577873|FG000|Stage 1|Withdrawal by Subject|9|||
44559787|NCT03188185|79577874|FG001|Stage 1|Withdrawal by Subject|0|||
44498989|NCT03666988|79503741|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
44498990|NCT03666988|79503742|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
44498991|NCT03666988|79503743|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
44498992|NCT03666988|79503738|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
44498993|NCT03666988|79503739|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
44498994|NCT03666988|79503740|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
44498995|NCT03666988|79503741|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
44498996|NCT03666988|79503742|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
44498997|NCT03666988|79503743|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
44498998|NCT03666988|79503738|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
44498999|NCT03666988|79503739|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
44499000|NCT03666988|79503740|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
44499001|NCT03666988|79503741|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
44559788|NCT03188185|79577875|FG002|Stage 1|Withdrawal by Subject|0|||
44559789|NCT03188185|79577876|FG003|Stage 1|Withdrawal by Subject|0|||
44559790|NCT03188185|79577873|FG000|Stage 1|Identified as a professional patient|0|||
44559791|NCT03188185|79577874|FG001|Stage 1|Identified as a professional patient|1|||
44559792|NCT03188185|79577875|FG002|Stage 1|Identified as a professional patient|0|||
44559793|NCT03188185|79577876|FG003|Stage 1|Identified as a professional patient|0|||
44559794|NCT03188185|79577873|FG000|Stage 2|Adverse Event|0|||
44559795|NCT03188185|79577874|FG001|Stage 2|Adverse Event|0|||
44559796|NCT03188185|79577875|FG002|Stage 2|Adverse Event|2|||
44232762|NCT01797965|79049966|FG003|Overall Study|Lost to Follow-up|2|||
44232763|NCT01797965|79049963|FG000|Overall Study|Consent withdrawn|130|||
44499002|NCT03666988|79503742|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
44499003|NCT03666988|79503743|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
44499004|NCT00382109|79503763|FG000|Overall Study|Adverse Event|3|||
44499005|NCT00382109|79503764|FG001|Overall Study|Adverse Event|0|||
44559797|NCT03188185|79577876|FG003|Stage 2|Adverse Event|4|||
44559798|NCT03188185|79577873|FG000|Stage 2|Lack of Efficacy|0|||
44559799|NCT03188185|79577874|FG001|Stage 2|Lack of Efficacy|0|||
44559800|NCT03188185|79577875|FG002|Stage 2|Lack of Efficacy|3|||
44559801|NCT03188185|79577876|FG003|Stage 2|Lack of Efficacy|0|||
44559802|NCT03188185|79577873|FG000|Stage 2|Lost to Follow-up|0|||
44559803|NCT03188185|79577874|FG001|Stage 2|Lost to Follow-up|0|||
44559804|NCT03188185|79577875|FG002|Stage 2|Lost to Follow-up|1|||
44559805|NCT03188185|79577876|FG003|Stage 2|Lost to Follow-up|0|||
44559806|NCT03188185|79577873|FG000|Stage 2|Physician Decision|0|||
44559807|NCT03188185|79577874|FG001|Stage 2|Physician Decision|0|||
44559808|NCT03188185|79577875|FG002|Stage 2|Physician Decision|0|||
44559809|NCT03188185|79577876|FG003|Stage 2|Physician Decision|1|||
44559810|NCT03188185|79577873|FG000|Stage 2|Withdrawal by Subject|0|||
44559811|NCT03188185|79577874|FG001|Stage 2|Withdrawal by Subject|0|||
44559812|NCT03188185|79577875|FG002|Stage 2|Withdrawal by Subject|3|||
44559813|NCT03188185|79577876|FG003|Stage 2|Withdrawal by Subject|1|||
44559814|NCT03186781|79577892|FG000|Overall Study|Lost to Follow-up|0|||
44232764|NCT01797965|79049964|FG001|Overall Study|Consent withdrawn|117|||
44232765|NCT01797965|79049965|FG002|Overall Study|Consent withdrawn|3|||
44232766|NCT01797965|79049966|FG003|Overall Study|Consent withdrawn|35|||
44232767|NCT01797965|79049963|FG000|Overall Study|Investigator decision|21|||
44559815|NCT03186781|79577893|FG001|Overall Study|Lost to Follow-up|0|||
44559816|NCT03186781|79577894|FG002|Overall Study|Lost to Follow-up|1|||
44559817|NCT03186781|79577895|FG003|Overall Study|Lost to Follow-up|0|||
44559818|NCT03186781|79577896|FG004|Overall Study|Lost to Follow-up|1|||
44559819|NCT03186781|79577897|FG005|Overall Study|Lost to Follow-up|0|||
44559820|NCT03186781|79577892|FG000|Overall Study|Moved from Area|0|||
44559821|NCT03186781|79577893|FG001|Overall Study|Moved from Area|0|||
44559822|NCT03186781|79577894|FG002|Overall Study|Moved from Area|0|||
44559823|NCT03186781|79577895|FG003|Overall Study|Moved from Area|0|||
44559824|NCT03186781|79577896|FG004|Overall Study|Moved from Area|1|||
44559825|NCT03186781|79577897|FG005|Overall Study|Moved from Area|0|||
44559826|NCT03186781|79577892|FG000|Overall Study|Withdrawal by Subject|0|||
44559827|NCT03186781|79577893|FG001|Overall Study|Withdrawal by Subject|0|||
44559828|NCT03186781|79577894|FG002|Overall Study|Withdrawal by Subject|0|||
44559829|NCT03186781|79577895|FG003|Overall Study|Withdrawal by Subject|0|||
44559830|NCT03186781|79577896|FG004|Overall Study|Withdrawal by Subject|1|||
44559831|NCT03186781|79577897|FG005|Overall Study|Withdrawal by Subject|0|||
44559832|NCT03184987|79577924|FG000|Overall Study|Withdrawal by Subject|0|||
44559833|NCT03184987|79577925|FG001|Overall Study|Withdrawal by Subject|1|||
44559834|NCT03184987|79577926|FG002|Overall Study|Withdrawal by Subject|2|||
44559835|NCT03184987|79577924|FG000|Overall Study|Physician Decision|0|||
44559836|NCT03184987|79577925|FG001|Overall Study|Physician Decision|0|||
44559837|NCT03184987|79577926|FG002|Overall Study|Physician Decision|1|||
44559838|NCT03184987|79577924|FG000|Overall Study|Adverse Event|1|||
44559839|NCT03184987|79577925|FG001|Overall Study|Adverse Event|0|||
44559840|NCT03184987|79577926|FG002|Overall Study|Adverse Event|1|||
44559841|NCT03184519|79577934|FG000|Overall Study|Lost to Follow-up|6|||
44559842|NCT03184519|79577934|FG000|Overall Study|Physician Decision|21|||
44232768|NCT01797965|79049964|FG001|Overall Study|Investigator decision|15|||
44232769|NCT01797965|79049965|FG002|Overall Study|Investigator decision|0|||
44232770|NCT01797965|79049966|FG003|Overall Study|Investigator decision|0|||
44232771|NCT01797965|79049963|FG000|Overall Study|Death|2|||
44232772|NCT01797965|79049964|FG001|Overall Study|Death|4|||
44559843|NCT03184441|79577938|FG000|Overall Study|Withdrawal by Subject|1|||
44559844|NCT03026166|79577947|FG000|Overall Study|Death|22|||
44232773|NCT01797965|79049965|FG002|Overall Study|Death|0|||
44232774|NCT01797965|79049966|FG003|Overall Study|Death|0|||
44232775|NCT01797965|79049963|FG000|Overall Study|Disease progression, defined by protocol|3|||
44232776|NCT01797965|79049964|FG001|Overall Study|Disease progression, defined by protocol|1|||
44232777|NCT01797965|79049965|FG002|Overall Study|Disease progression, defined by protocol|0|||
44232778|NCT01797965|79049966|FG003|Overall Study|Disease progression, defined by protocol|0|||
44232779|NCT01797965|79049963|FG000|Overall Study|Reason Not Specified|280|||
44232780|NCT01797965|79049964|FG001|Overall Study|Reason Not Specified|295|||
44275255|NCT02239692|79221709|FG000|Overall Study|Lost to Follow-up|1|||
44559845|NCT03026166|79577948|FG001|Overall Study|Death|7|||
44559846|NCT03026166|79577947|FG000|Overall Study|Physician Decision|2|||
44559847|NCT03026166|79577948|FG001|Overall Study|Physician Decision|0|||
44559848|NCT03026166|79577947|FG000|Overall Study|Withdrawal by Subject|1|||
44559849|NCT03026166|79577948|FG001|Overall Study|Withdrawal by Subject|2|||
44559850|NCT03026166|79577947|FG000|Overall Study|Lost to Follow-up|1|||
44232781|NCT01797965|79049965|FG002|Overall Study|Reason Not Specified|0|||
44275256|NCT02239692|79221710|FG001|Overall Study|Lost to Follow-up|4|||
44275257|NCT02239692|79221709|FG000|Overall Study|Withdrawal by Subject|3|||
44559851|NCT03026166|79577948|FG001|Overall Study|Lost to Follow-up|0|||
44559852|NCT03026166|79577947|FG000|Overall Study|Study Terminated by Sponsor|3|||
44559853|NCT03026166|79577948|FG001|Overall Study|Study Terminated by Sponsor|3|||
44559854|NCT03026166|79577947|FG000|Overall Study|Other|1|||
44275258|NCT02239692|79221710|FG001|Overall Study|Withdrawal by Subject|5|||
44232782|NCT01797965|79049966|FG003|Overall Study|Reason Not Specified|15|||
44232783|NCT01376388|79050011|FG000|Overall Study|Adverse Event|13|||
44232784|NCT01376388|79050011|FG000|Overall Study|Lack of Efficacy|2|||
44559855|NCT03026166|79577948|FG001|Overall Study|Other|0|||
44559856|NCT03026088|79577954|FG000|Overall Study|Study termination|20|||
44559857|NCT03024606|79577960|FG000|Overall Study|Withdrawal by Subject|9|||
44559858|NCT03024606|79577961|FG001|Overall Study|Withdrawal by Subject|10|||
44559859|NCT03180619|79577970|FG000|Overall Study|Withdrew Consent|5|||
44559860|NCT03180619|79577971|FG001|Overall Study|Withdrew Consent|0|||
44559861|NCT03180619|79577972|FG002|Overall Study|Withdrew Consent|2|||
44559862|NCT03180619|79577970|FG000|Overall Study|Death|2|||
44559863|NCT03180619|79577971|FG001|Overall Study|Death|1|||
44559864|NCT03180619|79577972|FG002|Overall Study|Death|2|||
44559865|NCT03180619|79577970|FG000|Overall Study|Adverse Event|2|||
44559866|NCT03180619|79577971|FG001|Overall Study|Adverse Event|0|||
44559867|NCT03180619|79577972|FG002|Overall Study|Adverse Event|1|||
44559868|NCT03180619|79577970|FG000|Overall Study|Investigator's discretion|2|||
44499006|NCT00382109|79503763|FG000|Overall Study|Physician Decision|6|||
44499007|NCT00382109|79503764|FG001|Overall Study|Physician Decision|1|||
44499008|NCT00382109|79503763|FG000|Overall Study|Withdrawal by Subject|1|||
44499009|NCT00382109|79503764|FG001|Overall Study|Withdrawal by Subject|0|||
44499010|NCT00382109|79503763|FG000|Overall Study|ineligible|2|||
44499011|NCT00382109|79503764|FG001|Overall Study|ineligible|0|||
44499012|NCT00382109|79503763|FG000|Overall Study|Other|0|||
44499013|NCT00382109|79503764|FG001|Overall Study|Other|2|||
44499014|NCT00382109|79503763|FG000|Overall Study|consent withdrawal|0|||
44499015|NCT00382109|79503764|FG001|Overall Study|consent withdrawal|1|||
44499016|NCT03651622|79503776|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
44499017|NCT03651622|79503777|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
44499018|NCT03651622|79503778|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
44499019|NCT03651622|79503776|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
44499020|NCT03651622|79503777|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
44499021|NCT03651622|79503778|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
44559869|NCT03180619|79577971|FG001|Overall Study|Investigator's discretion|0|||
44559870|NCT03180619|79577972|FG002|Overall Study|Investigator's discretion|1|||
44559871|NCT02915874|79577989|FG000|Overall Study|Lost to Follow-up|5|||
44559872|NCT02915874|79577990|FG001|Overall Study|Lost to Follow-up|4|||
44559873|NCT02915874|79577989|FG000|Overall Study|Withdrawal by Subject|1|||
44559874|NCT02915874|79577990|FG001|Overall Study|Withdrawal by Subject|1|||
44559875|NCT02915874|79577989|FG000|Overall Study|Started New Anxiety Medication|0|||
44559876|NCT02915874|79577990|FG001|Overall Study|Started New Anxiety Medication|1|||
44559877|NCT03022578|79577996|FG000|Overall Study|Adverse Event|1|||
44559878|NCT03022578|79577996|FG000|Overall Study|Lack of Efficacy|2|||
44559879|NCT03022578|79577996|FG000|Overall Study|Withdrawal by Subject|1|||
44559880|NCT03022422|79578006|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
44559881|NCT03022422|79578007|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
44559882|NCT03022422|79578008|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
44559883|NCT03022422|79578009|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
44559884|NCT03022422|79578010|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
44559885|NCT03022422|79578011|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
44559886|NCT03023826|79578027|FG000|Period 1|Withdrawal by Subject|0|||
44559887|NCT03023826|79578028|FG001|Period 1|Withdrawal by Subject|0|||
44559888|NCT03023826|79578029|FG002|Period 1|Withdrawal by Subject|0|||
44559889|NCT03023826|79578030|FG003|Period 1|Withdrawal by Subject|0|||
44559890|NCT03023826|79578031|FG004|Period 1|Withdrawal by Subject|1|||
44559891|NCT03023826|79578032|FG005|Period 1|Withdrawal by Subject|0|||
44559892|NCT03166735|79578045|FG000|Overall Study|Not Treated|1|||
44559893|NCT03166735|79578046|FG001|Overall Study|Not Treated|0|||
44559894|NCT03166735|79578047|FG002|Overall Study|Not Treated|0|||
44559895|NCT03166735|79578048|FG003|Overall Study|Not Treated|0|||
44559896|NCT03166735|79578049|FG004|Overall Study|Not Treated|0|||
44559897|NCT03166735|79578045|FG000|Overall Study|follow-up not completed as planned|0|||
44559898|NCT03166735|79578046|FG001|Overall Study|follow-up not completed as planned|1|||
44559899|NCT03166735|79578047|FG002|Overall Study|follow-up not completed as planned|1|||
44559900|NCT03166735|79578048|FG003|Overall Study|follow-up not completed as planned|0|||
44559901|NCT03166735|79578049|FG004|Overall Study|follow-up not completed as planned|1|||
44559902|NCT03166735|79578045|FG000|Overall Study|Withdrawal by Subject|0|||
44559903|NCT03166735|79578046|FG001|Overall Study|Withdrawal by Subject|0|||
44559904|NCT03166735|79578047|FG002|Overall Study|Withdrawal by Subject|1|||
44559905|NCT03166735|79578048|FG003|Overall Study|Withdrawal by Subject|1|||
44559906|NCT03166735|79578049|FG004|Overall Study|Withdrawal by Subject|2|||
44559907|NCT03166735|79578045|FG000|Overall Study|Lost to Follow-up|0|||
44559908|NCT03166735|79578046|FG001|Overall Study|Lost to Follow-up|2|||
44499022|NCT03651622|79503776|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
44499023|NCT03651622|79503777|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
44559909|NCT03166735|79578047|FG002|Overall Study|Lost to Follow-up|1|||
44559910|NCT03166735|79578048|FG003|Overall Study|Lost to Follow-up|0|||
44559911|NCT03166735|79578049|FG004|Overall Study|Lost to Follow-up|1|||
44499024|NCT03651622|79503778|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
44499025|NCT03651622|79503776|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
44499026|NCT03651622|79503777|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
44499027|NCT03651622|79503778|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
44559912|NCT03165955|79578062|FG000|Treatment|Withdrawal by Subject|3|||
44559913|NCT03165955|79578062|FG000|Treatment|Death|1|||
44559914|NCT03165955|79578062|FG000|Treatment|Adverse Event|1|||
44559915|NCT03165955|79578062|FG000|Treatment|Progressive disease|3|||
44559916|NCT03055494|79578068|FG000|Overall Study|Lost to Follow-up|6|||
44559917|NCT03055494|79578069|FG001|Overall Study|Lost to Follow-up|0|||
44559918|NCT03055494|79578068|FG000|Overall Study|Physician Decision|2|||
44559919|NCT03055494|79578069|FG001|Overall Study|Physician Decision|0|||
44559920|NCT03055494|79578068|FG000|Overall Study|Withdrawal by Subject|1|||
44559921|NCT03055494|79578069|FG001|Overall Study|Withdrawal by Subject|0|||
44559922|NCT03055494|79578068|FG000|Overall Study|Adverse Event|0|||
44559923|NCT03055494|79578069|FG001|Overall Study|Adverse Event|1|||
44559924|NCT03055494|79578068|FG000|Overall Study|Non-compliance with study treatment|1|||
44559925|NCT03055494|79578069|FG001|Overall Study|Non-compliance with study treatment|0|||
44559926|NCT02914548|79578079|FG000|Overall Study|Adverse Event|15|||
44559927|NCT02914548|79578080|FG001|Overall Study|Adverse Event|7|||
44559928|NCT02914548|79578081|FG002|Overall Study|Adverse Event|15|||
44559929|NCT02914548|79578079|FG000|Overall Study|Physician Decision|2|||
44559930|NCT02914548|79578080|FG001|Overall Study|Physician Decision|2|||
44559931|NCT02914548|79578081|FG002|Overall Study|Physician Decision|0|||
44559932|NCT02914548|79578079|FG000|Overall Study|Protocol Violation|1|||
44559933|NCT02914548|79578080|FG001|Overall Study|Protocol Violation|0|||
44559934|NCT02914548|79578081|FG002|Overall Study|Protocol Violation|0|||
44559935|NCT02914548|79578079|FG000|Overall Study|Withdrawal by Subject|3|||
44559936|NCT02914548|79578080|FG001|Overall Study|Withdrawal by Subject|4|||
44559937|NCT02914548|79578081|FG002|Overall Study|Withdrawal by Subject|4|||
44559938|NCT02914548|79578079|FG000|Overall Study|>40% of body surface area|0|||
44559939|NCT02914548|79578080|FG001|Overall Study|>40% of body surface area|1|||
44559940|NCT02914548|79578081|FG002|Overall Study|>40% of body surface area|1|||
44559941|NCT03165721|79578092|FG000|Overall Study|Refused further treatment|3|||
44559942|NCT03165721|79578093|FG001|Overall Study|Refused further treatment|0|||
44559943|NCT03165721|79578094|FG002|Overall Study|Refused further treatment|0|||
44559944|NCT03165721|79578092|FG000|Overall Study|Physician Decision|1|||
44559945|NCT03165721|79578093|FG001|Overall Study|Physician Decision|0|||
44559946|NCT03165721|79578094|FG002|Overall Study|Physician Decision|0|||
44559947|NCT02187198|79578110|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
44559948|NCT02187198|79578111|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
44559949|NCT02187198|79578110|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
44559950|NCT02187198|79578111|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
44559951|NCT02642029|79578117|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
44559952|NCT02642029|79578118|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
44559953|NCT02642029|79578119|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
44559954|NCT02642029|79578120|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
44559955|NCT02642029|79578121|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
44559956|NCT02642029|79578122|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
44559957|NCT02642029|79578117|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
44559958|NCT02642029|79578118|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
44559959|NCT02642029|79578119|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
44559960|NCT02642029|79578120|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
44559961|NCT02642029|79578121|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
44559962|NCT02642029|79578122|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
44559963|NCT02642029|79578117|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
44559964|NCT02642029|79578118|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
44559965|NCT02642029|79578119|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
44559966|NCT02642029|79578120|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
44559967|NCT02642029|79578121|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
44559968|NCT02642029|79578122|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
44275259|NCT02239692|79221709|FG000|Overall Study|Other reason|1|||
44275260|NCT02239692|79221710|FG001|Overall Study|Other reason|0|||
44275261|NCT02206152|79221738|FG000|Pre-Randomization|Withdrawal by Subject|2|||
44275262|NCT02239536|79221746|FG000|Overall Study|Non-neoplastic polyp|23|||
44559969|NCT02642029|79578117|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
44559970|NCT02642029|79578118|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
44275263|NCT02239536|79221747|FG001|Overall Study|Non-neoplastic polyp|17|||
44275264|NCT02239224|79221757|FG000|Overall Study|Administrative|0|||
44275265|NCT02239224|79221758|FG001|Overall Study|Administrative|0|||
44275266|NCT02239224|79221759|FG002|Overall Study|Administrative|3|||
44559971|NCT02642029|79578119|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
44559972|NCT02642029|79578120|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
44559973|NCT02642029|79578121|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
44559974|NCT02642029|79578122|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
44559975|NCT02642029|79578117|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
44275267|NCT02239224|79221760|FG003|Overall Study|Administrative|1|||
44559976|NCT02642029|79578118|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
44559977|NCT02642029|79578119|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
44559978|NCT02642029|79578120|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
44559979|NCT02642029|79578121|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
44559980|NCT02642029|79578122|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
44559981|NCT02642029|79578117|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
44559982|NCT02642029|79578118|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
44559983|NCT02642029|79578119|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
44559984|NCT02642029|79578120|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
44559985|NCT02642029|79578121|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
44559986|NCT02642029|79578122|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
44559987|NCT03178669|79578135|FG000|Overall Study|Adverse Event|4|||
44559988|NCT03178669|79578136|FG001|Overall Study|Adverse Event|1|||
44559989|NCT03178669|79578137|FG002|Overall Study|Adverse Event|4|||
44559990|NCT03178669|79578138|FG003|Overall Study|Adverse Event|2|||
44559991|NCT03178669|79578139|FG004|Overall Study|Adverse Event|2|||
44559992|NCT03178669|79578135|FG000|Overall Study|Lack of Efficacy|0|||
44559993|NCT03178669|79578136|FG001|Overall Study|Lack of Efficacy|0|||
44559994|NCT03178669|79578137|FG002|Overall Study|Lack of Efficacy|2|||
44559995|NCT03178669|79578138|FG003|Overall Study|Lack of Efficacy|0|||
44559996|NCT03178669|79578139|FG004|Overall Study|Lack of Efficacy|1|||
44559997|NCT03178669|79578135|FG000|Overall Study|Physician Decision|0|||
44559998|NCT03178669|79578136|FG001|Overall Study|Physician Decision|0|||
44559999|NCT03178669|79578137|FG002|Overall Study|Physician Decision|0|||
44560000|NCT03178669|79578138|FG003|Overall Study|Physician Decision|0|||
44560001|NCT03178669|79578139|FG004|Overall Study|Physician Decision|1|||
44560002|NCT03178669|79578135|FG000|Overall Study|Withdrawal by Subject|1|||
44560003|NCT03178669|79578136|FG001|Overall Study|Withdrawal by Subject|0|||
44560004|NCT03178669|79578137|FG002|Overall Study|Withdrawal by Subject|1|||
44560005|NCT03178669|79578138|FG003|Overall Study|Withdrawal by Subject|1|||
44560006|NCT03178669|79578139|FG004|Overall Study|Withdrawal by Subject|0|||
44560007|NCT03178669|79578135|FG000|Overall Study|Lost to Follow-up|0|||
44560008|NCT03178669|79578136|FG001|Overall Study|Lost to Follow-up|0|||
44560009|NCT03178669|79578137|FG002|Overall Study|Lost to Follow-up|0|||
44560010|NCT03178669|79578138|FG003|Overall Study|Lost to Follow-up|1|||
44560011|NCT03178669|79578139|FG004|Overall Study|Lost to Follow-up|0|||
44560012|NCT03178201|79578151|FG000|Overall Study|Off study|5|||
44560013|NCT03021642|79578155|FG000|Washout Period (21 Days)|Adverse Event|1|||
44560014|NCT03021642|79578156|FG001|Washout Period (21 Days)|Adverse Event|1|||
44560015|NCT03021564|79578164|FG000|Overall Study|Death|84|||
44560016|NCT03021564|79578165|FG001|Overall Study|Death|466|||
44560017|NCT03021564|79578164|FG000|Overall Study|Lost to Follow-up|0|||
44560018|NCT03021564|79578165|FG001|Overall Study|Lost to Follow-up|2|||
44560019|NCT03023046|79578175|FG000|Overall Study|Withdrawal by Subject|1|||
44560020|NCT03019458|79578183|FG000|Overall Study|Death|0|||
44560021|NCT03019458|79578184|FG001|Overall Study|Death|1|||
44560022|NCT02923830|79578194|FG000|Overall Study|Physician Decision|13|||
44560023|NCT02923830|79578195|FG001|Overall Study|Physician Decision|15|||
44560024|NCT03021018|79578204|FG000|Overall Study|Adverse Event|1|||
44560025|NCT03021018|79578205|FG001|Overall Study|Adverse Event|0|||
44560026|NCT03021018|79578206|FG002|Overall Study|Adverse Event|0|||
44560027|NCT03021018|79578204|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
44560028|NCT03021018|79578205|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
44232785|NCT01376388|79050011|FG000|Overall Study|Withdrawal by Subject|3|||
44232786|NCT01821677|79050028|FG000|Overall Study|Adverse Event|4|||
44560029|NCT03021018|79578206|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
44560030|NCT02509507|79578223|FG000|Overall Study|Death|21|||
44560031|NCT02509507|79578224|FG001|Overall Study|Death|3|||
44560032|NCT02509507|79578225|FG002|Overall Study|Death|22|||
44560033|NCT02509507|79578226|FG003|Overall Study|Death|13|||
44560034|NCT02509507|79578227|FG004|Overall Study|Death|6|||
44560035|NCT02509507|79578228|FG005|Overall Study|Death|9|||
44560036|NCT02509507|79578229|FG006|Overall Study|Death|4|||
44560037|NCT02509507|79578230|FG007|Overall Study|Death|3|||
44560038|NCT02509507|79578231|FG008|Overall Study|Death|7|||
44560039|NCT02509507|79578223|FG000|Overall Study|Lost to Follow-up|0|||
44232787|NCT01821677|79050029|FG001|Overall Study|Adverse Event|6|||
44232788|NCT01821677|79050030|FG002|Overall Study|Adverse Event|5|||
44232789|NCT01821677|79050028|FG000|Overall Study|Physician Decision|1|||
44232790|NCT01821677|79050029|FG001|Overall Study|Physician Decision|4|||
44232791|NCT01821677|79050030|FG002|Overall Study|Physician Decision|1|||
44560040|NCT02509507|79578224|FG001|Overall Study|Lost to Follow-up|1|||
44560041|NCT02509507|79578225|FG002|Overall Study|Lost to Follow-up|0|||
44560042|NCT02509507|79578226|FG003|Overall Study|Lost to Follow-up|0|||
44560043|NCT02509507|79578227|FG004|Overall Study|Lost to Follow-up|0|||
44560044|NCT02509507|79578228|FG005|Overall Study|Lost to Follow-up|1|||
44232792|NCT01821677|79050028|FG000|Overall Study|Non-compliance|0|||
44232793|NCT01821677|79050029|FG001|Overall Study|Non-compliance|1|||
44232794|NCT01821677|79050030|FG002|Overall Study|Non-compliance|2|||
44232795|NCT01821677|79050028|FG000|Overall Study|Lost to Follow-up|2|||
44232796|NCT01821677|79050029|FG001|Overall Study|Lost to Follow-up|1|||
44499028|NCT03651622|79503776|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
44499029|NCT03651622|79503777|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
44499030|NCT03651622|79503778|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
44499031|NCT00381797|79503791|FG000|Overall Study|Withdrawal by Subject|1|||
44499032|NCT00381797|79503792|FG001|Overall Study|Withdrawal by Subject|1|||
44499033|NCT00381797|79503793|FG002|Overall Study|Withdrawal by Subject|0|||
44499034|NCT00381797|79503794|FG003|Overall Study|Withdrawal by Subject|0|||
44499035|NCT00381797|79503795|FG004|Overall Study|Withdrawal by Subject|2|||
44560045|NCT02509507|79578229|FG006|Overall Study|Lost to Follow-up|0|||
44560046|NCT02509507|79578230|FG007|Overall Study|Lost to Follow-up|0|||
44560047|NCT02509507|79578231|FG008|Overall Study|Lost to Follow-up|0|||
44560048|NCT02509507|79578223|FG000|Overall Study|Withdrawal by Subject|2|||
44560049|NCT02509507|79578224|FG001|Overall Study|Withdrawal by Subject|0|||
44560050|NCT02509507|79578225|FG002|Overall Study|Withdrawal by Subject|1|||
44560051|NCT02509507|79578226|FG003|Overall Study|Withdrawal by Subject|4|||
44560052|NCT02509507|79578227|FG004|Overall Study|Withdrawal by Subject|0|||
44560053|NCT02509507|79578228|FG005|Overall Study|Withdrawal by Subject|3|||
44560054|NCT02509507|79578229|FG006|Overall Study|Withdrawal by Subject|3|||
44560055|NCT02509507|79578230|FG007|Overall Study|Withdrawal by Subject|0|||
44560056|NCT02509507|79578231|FG008|Overall Study|Withdrawal by Subject|0|||
44560057|NCT02509507|79578223|FG000|Overall Study|Continuing Study|0|||
44560058|NCT02509507|79578224|FG001|Overall Study|Continuing Study|1|||
44560059|NCT02509507|79578225|FG002|Overall Study|Continuing Study|1|||
44560060|NCT02509507|79578226|FG003|Overall Study|Continuing Study|5|||
44560061|NCT02509507|79578227|FG004|Overall Study|Continuing Study|4|||
44560062|NCT02509507|79578228|FG005|Overall Study|Continuing Study|5|||
44232797|NCT01821677|79050030|FG002|Overall Study|Lost to Follow-up|3|||
44232798|NCT01821677|79050028|FG000|Overall Study|Protocol Violation|0|||
44232799|NCT01821677|79050029|FG001|Overall Study|Protocol Violation|0|||
44232800|NCT01821677|79050030|FG002|Overall Study|Protocol Violation|2|||
44499036|NCT00381797|79503791|FG000|Overall Study|Ineligible|0|||
44499037|NCT00381797|79503792|FG001|Overall Study|Ineligible|0|||
44560063|NCT02509507|79578229|FG006|Overall Study|Continuing Study|3|||
44560064|NCT02509507|79578230|FG007|Overall Study|Continuing Study|2|||
44560065|NCT02509507|79578231|FG008|Overall Study|Continuing Study|3|||
44560066|NCT03176407|79578256|FG000|Overall Study|Protocol Violation|1|||
44560067|NCT03176407|79578256|FG000|Overall Study|human failure|1|||
44560068|NCT03176407|79578256|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
44560069|NCT03175549|79578264|FG000|Overall Study|Lost to Follow-up|2|||
44560070|NCT03175549|79578265|FG001|Overall Study|Lost to Follow-up|2|||
44232801|NCT01821677|79050028|FG000|Overall Study|Withdrawal by Subject|7|||
44232802|NCT01821677|79050029|FG001|Overall Study|Withdrawal by Subject|3|||
44232803|NCT01821677|79050030|FG002|Overall Study|Withdrawal by Subject|2|||
44232804|NCT01821677|79050028|FG000|Overall Study|Other|9|||
44560071|NCT03175549|79578264|FG000|Overall Study|Medication non-compliance|2|||
44560072|NCT03175549|79578265|FG001|Overall Study|Medication non-compliance|2|||
44560073|NCT03174925|79578273|FG000|Overall Study|Elastographic images not retrievable|2|||
44560074|NCT03174925|79578273|FG000|Overall Study|Elastography image not interpretable|1|||
44560075|NCT02924688|79578283|FG000|Overall Study|Adverse Event|9|||
44560076|NCT02924688|79578284|FG001|Overall Study|Adverse Event|3|||
44376885|NCT00588445|79382139|FG000|Overall Study|Withdrawal by Subject|3|||
44376886|NCT00588445|79382139|FG000|Overall Study|Disease Progression|1|||
44499038|NCT00381797|79503793|FG002|Overall Study|Ineligible|0|||
44499039|NCT00381797|79503794|FG003|Overall Study|Ineligible|1|||
44499040|NCT00381797|79503795|FG004|Overall Study|Ineligible|0|||
44499041|NCT03665038|79503831|FG000|Overall Study|Lost to Follow-up|0|||
44499042|NCT03665038|79503832|FG001|Overall Study|Lost to Follow-up|0|||
44499043|NCT03665038|79503833|FG002|Overall Study|Lost to Follow-up|1|||
44499044|NCT03664024|79503843|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
44499045|NCT03664024|79503843|FG000|Overall Study|Lost to Follow-up|2|||
44499046|NCT03664024|79503843|FG000|Overall Study|Withdrawal by Subject|2|||
44499047|NCT03664024|79503843|FG000|Overall Study|Death|80|||
44499048|NCT00381563|79503852|FG000|Overall Study|Withdrawal by Subject|5|||
44499049|NCT00381563|79503853|FG001|Overall Study|Withdrawal by Subject|5|||
44499050|NCT00381563|79503852|FG000|Overall Study|Lost to Follow-up|2|||
44499051|NCT00381563|79503853|FG001|Overall Study|Lost to Follow-up|0|||
44499052|NCT00381563|79503852|FG000|Overall Study|Protocol Violation|0|||
44499053|NCT00381563|79503853|FG001|Overall Study|Protocol Violation|1|||
44499054|NCT03624946|79503860|FG000|Overall Study|Lost to Follow-up|0|||
44499055|NCT03624946|79503861|FG001|Overall Study|Lost to Follow-up|1|||
44499056|NCT00381095|79503873|FG000|Overall Study|Death|3|||
44499057|NCT00381095|79503874|FG001|Overall Study|Death|4|||
44499058|NCT00381095|79503873|FG000|Overall Study|Lack of Efficacy|2|||
44499059|NCT00381095|79503874|FG001|Overall Study|Lack of Efficacy|4|||
44499060|NCT00381095|79503873|FG000|Overall Study|Other|2|||
44499061|NCT00381095|79503874|FG001|Overall Study|Other|2|||
44499062|NCT00381095|79503873|FG000|Overall Study|Protocol Violation|1|||
44499063|NCT00381095|79503874|FG001|Overall Study|Protocol Violation|1|||
44499064|NCT00381095|79503873|FG000|Overall Study|Withdrawal by Subject|3|||
44499065|NCT00381095|79503874|FG001|Overall Study|Withdrawal by Subject|3|||
44499066|NCT00381095|79503873|FG000|Overall Study|Adverse Event|2|||
44499067|NCT00381095|79503874|FG001|Overall Study|Adverse Event|7|||
44499068|NCT03619174|79503882|FG000|Overall Study|Lost to Follow-up|3|||
44499069|NCT03619174|79503883|FG001|Overall Study|Lost to Follow-up|0|||
44499070|NCT03619174|79503882|FG000|Overall Study|Withdrawal by Subject|4|||
44499071|NCT03619174|79503883|FG001|Overall Study|Withdrawal by Subject|3|||
44499072|NCT03619174|79503882|FG000|Overall Study|Pregnancy|1|||
44499073|NCT03619174|79503883|FG001|Overall Study|Pregnancy|1|||
44499074|NCT03619174|79503882|FG000|Overall Study|Discomfort during treatment|1|||
44499075|NCT03619174|79503883|FG001|Overall Study|Discomfort during treatment|0|||
44499076|NCT00112047|79503891|FG000|Randomized Phase|Lost to Follow-up|26|||
44499077|NCT00112047|79503892|FG001|Randomized Phase|Lost to Follow-up|33|||
44499078|NCT00112047|79503891|FG000|Randomized Phase|Adverse Event|10|||
44499079|NCT00112047|79503892|FG001|Randomized Phase|Adverse Event|10|||
44560077|NCT02924688|79578285|FG002|Overall Study|Adverse Event|2|||
44560078|NCT02924688|79578286|FG003|Overall Study|Adverse Event|2|||
44499080|NCT00112047|79503891|FG000|Randomized Phase|Withrawal of consent|10|||
44499081|NCT00112047|79503892|FG001|Randomized Phase|Withrawal of consent|18|||
44560079|NCT02924688|79578287|FG004|Overall Study|Adverse Event|3|||
44376887|NCT00588445|79382139|FG000|Overall Study|Not Treated|10|||
44499082|NCT00112047|79503891|FG000|Randomized Phase|Sub-optimal virological response|3|||
44499083|NCT00112047|79503892|FG001|Randomized Phase|Sub-optimal virological response|13|||
44499084|NCT00112047|79503891|FG000|Randomized Phase|Noncompliance|8|||
44499085|NCT00112047|79503892|FG001|Randomized Phase|Noncompliance|4|||
44499086|NCT00112047|79503891|FG000|Randomized Phase|Protocol Violation|2|||
44499087|NCT00112047|79503892|FG001|Randomized Phase|Protocol Violation|0|||
44560080|NCT02924688|79578288|FG005|Overall Study|Adverse Event|2|||
44560081|NCT02924688|79578283|FG000|Overall Study|Lack of Efficacy|2|||
44499088|NCT00112047|79503891|FG000|Randomized Phase|Pregnancy|3|||
44560082|NCT02924688|79578284|FG001|Overall Study|Lack of Efficacy|3|||
44499089|NCT00112047|79503892|FG001|Randomized Phase|Pregnancy|1|||
44499090|NCT00112047|79503891|FG000|Randomized Phase|Death|1|||
44499091|NCT00112047|79503892|FG001|Randomized Phase|Death|3|||
44499092|NCT00112047|79503891|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
44499093|NCT00112047|79503892|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
44499094|NCT00112047|79503891|FG000|Randomized Phase|Inability to swallow pills|0|||
44560083|NCT02924688|79578285|FG002|Overall Study|Lack of Efficacy|4|||
44560084|NCT02924688|79578286|FG003|Overall Study|Lack of Efficacy|2|||
44560085|NCT02924688|79578287|FG004|Overall Study|Lack of Efficacy|1|||
44560086|NCT02924688|79578288|FG005|Overall Study|Lack of Efficacy|1|||
44560087|NCT02924688|79578283|FG000|Overall Study|Protocol Violation|3|||
44560088|NCT02924688|79578284|FG001|Overall Study|Protocol Violation|7|||
44560089|NCT02924688|79578285|FG002|Overall Study|Protocol Violation|5|||
44560090|NCT02924688|79578286|FG003|Overall Study|Protocol Violation|6|||
44560091|NCT02924688|79578287|FG004|Overall Study|Protocol Violation|2|||
44560092|NCT02924688|79578288|FG005|Overall Study|Protocol Violation|2|||
44560093|NCT02924688|79578283|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
44560094|NCT02924688|79578284|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
44560095|NCT02924688|79578285|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
44560096|NCT02924688|79578286|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
44560097|NCT02924688|79578287|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
44560098|NCT02924688|79578288|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
44560099|NCT02924688|79578283|FG000|Overall Study|Lost to Follow-up|2|||
44560100|NCT02924688|79578284|FG001|Overall Study|Lost to Follow-up|4|||
44560101|NCT02924688|79578285|FG002|Overall Study|Lost to Follow-up|2|||
44560102|NCT02924688|79578286|FG003|Overall Study|Lost to Follow-up|4|||
44560103|NCT02924688|79578287|FG004|Overall Study|Lost to Follow-up|2|||
44560104|NCT02924688|79578288|FG005|Overall Study|Lost to Follow-up|4|||
44560105|NCT02924688|79578283|FG000|Overall Study|Physician Decision|2|||
44560106|NCT02924688|79578284|FG001|Overall Study|Physician Decision|1|||
44560107|NCT02924688|79578285|FG002|Overall Study|Physician Decision|0|||
44560108|NCT02924688|79578286|FG003|Overall Study|Physician Decision|1|||
44560109|NCT02924688|79578287|FG004|Overall Study|Physician Decision|1|||
44560110|NCT02924688|79578288|FG005|Overall Study|Physician Decision|1|||
44560111|NCT02924688|79578283|FG000|Overall Study|Withdrawal by Subject|14|||
44560112|NCT02924688|79578284|FG001|Overall Study|Withdrawal by Subject|13|||
44560113|NCT02924688|79578285|FG002|Overall Study|Withdrawal by Subject|9|||
44560114|NCT02924688|79578286|FG003|Overall Study|Withdrawal by Subject|12|||
44560115|NCT02924688|79578287|FG004|Overall Study|Withdrawal by Subject|13|||
44560116|NCT02924688|79578288|FG005|Overall Study|Withdrawal by Subject|14|||
44560117|NCT03011892|79578311|FG000|Double Blind (DB) Period|Adverse Event|0|||
44499095|NCT00112047|79503892|FG001|Randomized Phase|Inability to swallow pills|1|||
44560118|NCT03011892|79578312|FG001|Double Blind (DB) Period|Adverse Event|1|||
44560119|NCT03011892|79578313|FG002|Double Blind (DB) Period|Adverse Event|1|||
44499096|NCT00112047|79503891|FG000|Randomized Phase|Incarceration|3|||
44499097|NCT00112047|79503892|FG001|Randomized Phase|Incarceration|2|||
44499098|NCT00112047|79503891|FG000|Randomized Phase|Moved out of State|0|||
44499099|NCT00112047|79503892|FG001|Randomized Phase|Moved out of State|1|||
44499100|NCT00112047|79503891|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
44499101|NCT00112047|79503892|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
44499102|NCT00112047|79503891|FG000|Randomized Phase|High Hepatitis B DNA|0|||
44499103|NCT00112047|79503892|FG001|Randomized Phase|High Hepatitis B DNA|1|||
44499104|NCT00112047|79503891|FG000|Atripla Phase|Adverse Event|2|||
44499105|NCT00112047|79503892|FG001|Atripla Phase|Adverse Event|1|||
44499106|NCT00112047|79503891|FG000|Atripla Phase|Lost to Follow-up|5|||
44560120|NCT03011892|79578314|FG003|Double Blind (DB) Period|Adverse Event|0|||
44560121|NCT03011892|79578315|FG004|Double Blind (DB) Period|Adverse Event|0|||
44560122|NCT03011892|79578316|FG005|Double Blind (DB) Period|Adverse Event|0|||
44560123|NCT03011892|79578317|FG006|Double Blind (DB) Period|Adverse Event|0|||
44232805|NCT01821677|79050029|FG001|Overall Study|Other|0|||
44232806|NCT01821677|79050030|FG002|Overall Study|Other|0|||
44232807|NCT01797731|79050041|FG000|Overall Study|Didn't have proper radiographs required|3|||
44232808|NCT01797731|79050042|FG001|Overall Study|Didn't have proper radiographs required|3|||
44232809|NCT00709722|79050048|FG000|Overall Study|Adverse Event|1|||
44499107|NCT00112047|79503892|FG001|Atripla Phase|Lost to Follow-up|7|||
44499108|NCT00112047|79503891|FG000|Atripla Phase|Pregnancy|0|||
44560124|NCT03011892|79578318|FG007|Double Blind (DB) Period|Adverse Event|0|||
44560125|NCT03011892|79578319|FG008|Double Blind (DB) Period|Adverse Event|0|||
44560126|NCT03011892|79578320|FG009|Double Blind (DB) Period|Adverse Event|0|||
44560127|NCT03011892|79578321|FG010|Double Blind (DB) Period|Adverse Event|0|||
44560128|NCT03011892|79578322|FG011|Double Blind (DB) Period|Adverse Event|0|||
44560129|NCT03011892|79578311|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
44560130|NCT03011892|79578312|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
44232810|NCT01820585|79050069|FG000|Overall Study|Adverse Event|9|||
44499109|NCT00112047|79503892|FG001|Atripla Phase|Pregnancy|1|||
44560131|NCT03011892|79578313|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
44560132|NCT03011892|79578314|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
44560133|NCT03011892|79578315|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
44560134|NCT03011892|79578316|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
44560135|NCT03011892|79578317|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
44560136|NCT03011892|79578318|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
44376888|NCT00796315|79382145|FG000|Overall Study|Protocol Violation|0|||
44499110|NCT00112047|79503891|FG000|Atripla Phase|Death|0|||
44560137|NCT03011892|79578319|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
44560138|NCT03011892|79578320|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
44560139|NCT03011892|79578321|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
44560140|NCT03011892|79578322|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
44560141|NCT03011892|79578311|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
44560142|NCT03011892|79578312|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
44560143|NCT03011892|79578313|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
44560144|NCT03011892|79578314|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
44560145|NCT03011892|79578315|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
44560146|NCT03011892|79578316|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
44560147|NCT03011892|79578317|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
44560148|NCT03011892|79578318|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
44560149|NCT03011892|79578319|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
44560150|NCT03011892|79578320|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
44560151|NCT03011892|79578321|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
44560152|NCT03011892|79578322|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
44560153|NCT03011892|79578311|FG000|Double Blind (DB) Period|Other|1|||
44499111|NCT00112047|79503892|FG001|Atripla Phase|Death|2|||
44232811|NCT01820585|79050070|FG001|Overall Study|Adverse Event|13|||
44232812|NCT01820585|79050071|FG002|Overall Study|Adverse Event|23|||
44232813|NCT01820585|79050072|FG003|Overall Study|Adverse Event|34|||
44232814|NCT01820585|79050069|FG000|Overall Study|Lack of Efficacy|9|||
44232815|NCT01820585|79050070|FG001|Overall Study|Lack of Efficacy|7|||
44232816|NCT01820585|79050071|FG002|Overall Study|Lack of Efficacy|5|||
44499112|NCT00112047|79503891|FG000|Atripla Phase|Withdrew consent|7|||
44560154|NCT03011892|79578312|FG001|Double Blind (DB) Period|Other|1|||
44560155|NCT03011892|79578313|FG002|Double Blind (DB) Period|Other|1|||
44560156|NCT03011892|79578314|FG003|Double Blind (DB) Period|Other|0|||
44560157|NCT03011892|79578315|FG004|Double Blind (DB) Period|Other|1|||
44560158|NCT03011892|79578316|FG005|Double Blind (DB) Period|Other|0|||
44560159|NCT03011892|79578317|FG006|Double Blind (DB) Period|Other|0|||
44560160|NCT03011892|79578318|FG007|Double Blind (DB) Period|Other|0|||
44560161|NCT03011892|79578319|FG008|Double Blind (DB) Period|Other|0|||
44560162|NCT03011892|79578320|FG009|Double Blind (DB) Period|Other|0|||
44560163|NCT03011892|79578321|FG010|Double Blind (DB) Period|Other|0|||
44560164|NCT03011892|79578322|FG011|Double Blind (DB) Period|Other|0|||
44560165|NCT03011892|79578311|FG000|Double Blind (DB) Period|Physician Decision|1|||
44560166|NCT03011892|79578312|FG001|Double Blind (DB) Period|Physician Decision|0|||
44560167|NCT03011892|79578313|FG002|Double Blind (DB) Period|Physician Decision|1|||
44232817|NCT01820585|79050072|FG003|Overall Study|Lack of Efficacy|1|||
44499113|NCT00112047|79503892|FG001|Atripla Phase|Withdrew consent|7|||
44499114|NCT00112047|79503891|FG000|Atripla Phase|Sub-optimal virological response|0|||
44499115|NCT00112047|79503892|FG001|Atripla Phase|Sub-optimal virological response|1|||
44499116|NCT00112047|79503891|FG000|Atripla Phase|Non-compliance|1|||
44499117|NCT00112047|79503892|FG001|Atripla Phase|Non-compliance|0|||
44499118|NCT00112047|79503891|FG000|Atripla Phase|Other|3|||
44499119|NCT00112047|79503892|FG001|Atripla Phase|Other|1|||
44499120|NCT03658876|79503905|FG000|Overall Study|Protocol Violation|3|||
44499121|NCT03658876|79503906|FG001|Overall Study|Protocol Violation|2|||
44560168|NCT03011892|79578314|FG003|Double Blind (DB) Period|Physician Decision|0|||
44560169|NCT03011892|79578315|FG004|Double Blind (DB) Period|Physician Decision|0|||
44232818|NCT01820585|79050069|FG000|Overall Study|Withdrawal by Subject|3|||
44232819|NCT01820585|79050070|FG001|Overall Study|Withdrawal by Subject|7|||
44232820|NCT01820585|79050071|FG002|Overall Study|Withdrawal by Subject|3|||
44376889|NCT00796315|79382146|FG001|Overall Study|Protocol Violation|1|||
44499122|NCT03658876|79503905|FG000|Overall Study|Withdrawal by Subject|2|||
44499123|NCT03658876|79503906|FG001|Overall Study|Withdrawal by Subject|0|||
44560170|NCT03011892|79578316|FG005|Double Blind (DB) Period|Physician Decision|0|||
44560171|NCT03011892|79578317|FG006|Double Blind (DB) Period|Physician Decision|0|||
44560172|NCT03011892|79578318|FG007|Double Blind (DB) Period|Physician Decision|0|||
44499124|NCT03658876|79503905|FG000|Overall Study|Death|0|||
44232821|NCT01820585|79050072|FG003|Overall Study|Withdrawal by Subject|8|||
44232822|NCT01820585|79050069|FG000|Overall Study|Lost to Follow-up|3|||
44499125|NCT03658876|79503906|FG001|Overall Study|Death|1|||
44560173|NCT03011892|79578319|FG008|Double Blind (DB) Period|Physician Decision|0|||
44560174|NCT03011892|79578320|FG009|Double Blind (DB) Period|Physician Decision|0|||
44560175|NCT03011892|79578321|FG010|Double Blind (DB) Period|Physician Decision|0|||
44560176|NCT03011892|79578322|FG011|Double Blind (DB) Period|Physician Decision|0|||
44499126|NCT03658876|79503905|FG000|Overall Study|Intercurrent illness|6|||
44499127|NCT03658876|79503906|FG001|Overall Study|Intercurrent illness|4|||
44499128|NCT03658876|79503905|FG000|Overall Study|Transplantation/other operation|1|||
44499129|NCT03658876|79503906|FG001|Overall Study|Transplantation/other operation|5|||
44499130|NCT03618628|79503912|FG000|Overall Study|Death|1|||
44499131|NCT03618628|79503912|FG000|Overall Study|Lost to Follow-up|1|||
44499132|NCT03617770|79503918|FG000|Overall Study|Lost to Follow-up|1|||
44499133|NCT03617770|79503919|FG001|Overall Study|Lost to Follow-up|0|||
44499134|NCT03616600|79503927|FG000|Overall Study|Withdrawal by Subject|1|||
44499135|NCT03616600|79503928|FG001|Overall Study|Withdrawal by Subject|0|||
44499136|NCT00380393|79503937|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
44499137|NCT00380393|79503938|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
44499138|NCT00380393|79503937|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
44499139|NCT00380393|79503938|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
44499140|NCT00380393|79503937|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
44499141|NCT00380393|79503938|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
44499142|NCT00380393|79503937|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
44499143|NCT00380393|79503938|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
44499144|NCT00380393|79503937|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
44499145|NCT00380393|79503938|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
44499146|NCT00380393|79503937|FG000|Month 14|Withdrawal by Subject|9|||
44499147|NCT00380393|79503938|FG001|Month 14|Withdrawal by Subject|7|||
44499148|NCT00380393|79503937|FG000|Month 14|Death|1|||
44499149|NCT00380393|79503938|FG001|Month 14|Death|0|||
44499150|NCT00380393|79503937|FG000|Month 14|Lost to Follow-up|0|||
44499151|NCT00380393|79503938|FG001|Month 14|Lost to Follow-up|1|||
44499152|NCT00380393|79503937|FG000|Month 14|Migrated/moved from study area|39|||
44499153|NCT00380393|79503938|FG001|Month 14|Migrated/moved from study area|42|||
44499154|NCT00380393|79503937|FG000|Month 14|Protocol Violation|2|||
44499155|NCT00380393|79503938|FG001|Month 14|Protocol Violation|0|||
44499156|NCT00380393|79503937|FG000|Month 14|Others|6|||
44499157|NCT00380393|79503938|FG001|Month 14|Others|6|||
44499158|NCT00380081|79503950|FG000|Overall Study|Withdrawal by Subject|0|||
44499159|NCT00380081|79503951|FG001|Overall Study|Withdrawal by Subject|0|||
44499160|NCT00380081|79503952|FG002|Overall Study|Withdrawal by Subject|0|||
44499161|NCT00380081|79503953|FG003|Overall Study|Withdrawal by Subject|0|||
44499162|NCT00380081|79503954|FG004|Overall Study|Withdrawal by Subject|1|||
44499163|NCT00380081|79503955|FG005|Overall Study|Withdrawal by Subject|0|||
44499164|NCT00380081|79503950|FG000|Overall Study|Family Emergency|0|||
44499165|NCT00380081|79503951|FG001|Overall Study|Family Emergency|0|||
44499166|NCT00380081|79503952|FG002|Overall Study|Family Emergency|0|||
44499167|NCT00380081|79503953|FG003|Overall Study|Family Emergency|0|||
44499168|NCT00380081|79503954|FG004|Overall Study|Family Emergency|0|||
44499169|NCT00380081|79503955|FG005|Overall Study|Family Emergency|1|||
44499170|NCT03579940|79503974|FG000|Period 2|Withdrawal by Subject|0|||
44499171|NCT03579940|79503975|FG001|Period 2|Withdrawal by Subject|0|||
44499172|NCT03579940|79503976|FG002|Period 2|Withdrawal by Subject|1|||
44499173|NCT03579940|79503977|FG003|Period 2|Withdrawal by Subject|0|||
44499174|NCT03579940|79503978|FG004|Period 2|Withdrawal by Subject|0|||
44499175|NCT03579940|79503979|FG005|Period 2|Withdrawal by Subject|0|||
44560177|NCT03011892|79578311|FG000|Double Blind (DB) Period|Pregnancy|0|||
44499176|NCT03579940|79503980|FG006|Period 2|Withdrawal by Subject|0|||
44499177|NCT03579940|79503981|FG007|Period 2|Withdrawal by Subject|0|||
44499178|NCT03579940|79503982|FG008|Period 2|Withdrawal by Subject|0|||
44499179|NCT03579940|79503983|FG009|Period 2|Withdrawal by Subject|0|||
44232823|NCT01820585|79050070|FG001|Overall Study|Lost to Follow-up|3|||
44499180|NCT03579940|79503984|FG010|Period 2|Withdrawal by Subject|0|||
44499181|NCT00098306|79504019|FG000|Double Blind|Randomized, not treated|9|||
44499182|NCT00098306|79504020|FG001|Double Blind|Randomized, not treated|5|||
44499183|NCT00098306|79504021|FG002|Double Blind|Randomized, not treated|2|||
44499184|NCT00098306|79504022|FG003|Double Blind|Randomized, not treated|0|||
44499185|NCT00098306|79504023|FG004|Double Blind|Randomized, not treated|0|||
44499186|NCT00098306|79504024|FG005|Double Blind|Randomized, not treated|0|||
44499187|NCT00098306|79504025|FG006|Double Blind|Randomized, not treated|0|||
44499188|NCT00098306|79504019|FG000|Double Blind|Ongoing at cut-off date|151|||
44499189|NCT00098306|79504020|FG001|Double Blind|Ongoing at cut-off date|166|||
44499190|NCT00098306|79504021|FG002|Double Blind|Ongoing at cut-off date|72|||
44499191|NCT00098306|79504022|FG003|Double Blind|Ongoing at cut-off date|0|||
44499192|NCT00098306|79504023|FG004|Double Blind|Ongoing at cut-off date|0|||
44499193|NCT00098306|79504024|FG005|Double Blind|Ongoing at cut-off date|0|||
44499194|NCT00098306|79504025|FG006|Double Blind|Ongoing at cut-off date|0|||
44499195|NCT00098306|79504019|FG000|Double Blind|Adverse Event|11|||
44499196|NCT00098306|79504020|FG001|Double Blind|Adverse Event|10|||
44499197|NCT00098306|79504021|FG002|Double Blind|Adverse Event|6|||
44499198|NCT00098306|79504022|FG003|Double Blind|Adverse Event|0|||
44499199|NCT00098306|79504023|FG004|Double Blind|Adverse Event|0|||
44499200|NCT00098306|79504024|FG005|Double Blind|Adverse Event|0|||
44499201|NCT00098306|79504025|FG006|Double Blind|Adverse Event|0|||
44499202|NCT00098306|79504019|FG000|Double Blind|Lack of Efficacy|43|||
44499203|NCT00098306|79504020|FG001|Double Blind|Lack of Efficacy|34|||
44499204|NCT00098306|79504021|FG002|Double Blind|Lack of Efficacy|17|||
44499205|NCT00098306|79504022|FG003|Double Blind|Lack of Efficacy|0|||
44499206|NCT00098306|79504023|FG004|Double Blind|Lack of Efficacy|0|||
44499207|NCT00098306|79504024|FG005|Double Blind|Lack of Efficacy|0|||
44499208|NCT00098306|79504025|FG006|Double Blind|Lack of Efficacy|0|||
44499209|NCT00098306|79504019|FG000|Double Blind|Death|1|||
44499210|NCT00098306|79504020|FG001|Double Blind|Death|4|||
44499211|NCT00098306|79504021|FG002|Double Blind|Death|1|||
44499212|NCT00098306|79504022|FG003|Double Blind|Death|0|||
44499213|NCT00098306|79504023|FG004|Double Blind|Death|0|||
44499214|NCT00098306|79504024|FG005|Double Blind|Death|0|||
44499215|NCT00098306|79504025|FG006|Double Blind|Death|0|||
44499216|NCT00098306|79504019|FG000|Double Blind|Participant defaulted|19|||
44499217|NCT00098306|79504020|FG001|Double Blind|Participant defaulted|18|||
44499218|NCT00098306|79504021|FG002|Double Blind|Participant defaulted|11|||
44499219|NCT00098306|79504022|FG003|Double Blind|Participant defaulted|0|||
44499220|NCT00098306|79504023|FG004|Double Blind|Participant defaulted|0|||
44499221|NCT00098306|79504024|FG005|Double Blind|Participant defaulted|0|||
44499222|NCT00098306|79504025|FG006|Double Blind|Participant defaulted|0|||
44499223|NCT00098306|79504019|FG000|Double Blind|Un-specified|7|||
44499224|NCT00098306|79504020|FG001|Double Blind|Un-specified|3|||
44499225|NCT00098306|79504021|FG002|Double Blind|Un-specified|11|||
44499226|NCT00098306|79504022|FG003|Double Blind|Un-specified|0|||
44499227|NCT00098306|79504023|FG004|Double Blind|Un-specified|0|||
44499228|NCT00098306|79504024|FG005|Double Blind|Un-specified|0|||
44499229|NCT00098306|79504025|FG006|Double Blind|Un-specified|0|||
44499230|NCT00098306|79504019|FG000|Open Label|Lack of Efficacy|0|||
44499231|NCT00098306|79504020|FG001|Open Label|Lack of Efficacy|0|||
44499232|NCT00098306|79504021|FG002|Open Label|Lack of Efficacy|0|||
44232824|NCT01820585|79050071|FG002|Overall Study|Lost to Follow-up|0|||
44499233|NCT00098306|79504022|FG003|Open Label|Lack of Efficacy|13|||
44499234|NCT00098306|79504023|FG004|Open Label|Lack of Efficacy|0|||
44499235|NCT00098306|79504024|FG005|Open Label|Lack of Efficacy|0|||
44499236|NCT00098306|79504025|FG006|Open Label|Lack of Efficacy|0|||
44499237|NCT00098306|79504019|FG000|Open Label|Adverse Event|0|||
44499238|NCT00098306|79504020|FG001|Open Label|Adverse Event|0|||
44499239|NCT00098306|79504021|FG002|Open Label|Adverse Event|0|||
44499240|NCT00098306|79504022|FG003|Open Label|Adverse Event|2|||
44499241|NCT00098306|79504023|FG004|Open Label|Adverse Event|0|||
44499242|NCT00098306|79504024|FG005|Open Label|Adverse Event|0|||
44499243|NCT00098306|79504025|FG006|Open Label|Adverse Event|0|||
44499244|NCT00098306|79504019|FG000|Open Label|Death|0|||
44499245|NCT00098306|79504020|FG001|Open Label|Death|0|||
44499246|NCT00098306|79504021|FG002|Open Label|Death|0|||
44499247|NCT00098306|79504022|FG003|Open Label|Death|4|||
44499248|NCT00098306|79504023|FG004|Open Label|Death|0|||
44499249|NCT00098306|79504024|FG005|Open Label|Death|0|||
44499250|NCT00098306|79504025|FG006|Open Label|Death|0|||
44499251|NCT00098306|79504019|FG000|Open Label|Participant defaulted|0|||
44560178|NCT03011892|79578312|FG001|Double Blind (DB) Period|Pregnancy|0|||
44560179|NCT03011892|79578313|FG002|Double Blind (DB) Period|Pregnancy|0|||
44560180|NCT03011892|79578314|FG003|Double Blind (DB) Period|Pregnancy|0|||
44560181|NCT03011892|79578315|FG004|Double Blind (DB) Period|Pregnancy|1|||
44560182|NCT03011892|79578316|FG005|Double Blind (DB) Period|Pregnancy|0|||
44560183|NCT03011892|79578317|FG006|Double Blind (DB) Period|Pregnancy|0|||
44560184|NCT03011892|79578318|FG007|Double Blind (DB) Period|Pregnancy|0|||
44560185|NCT03011892|79578319|FG008|Double Blind (DB) Period|Pregnancy|0|||
44560186|NCT03011892|79578320|FG009|Double Blind (DB) Period|Pregnancy|0|||
44560187|NCT03011892|79578321|FG010|Double Blind (DB) Period|Pregnancy|0|||
44560188|NCT03011892|79578322|FG011|Double Blind (DB) Period|Pregnancy|0|||
44560189|NCT03011892|79578311|FG000|Double Blind (DB) Period|Protocol Violation|1|||
44560190|NCT03011892|79578312|FG001|Double Blind (DB) Period|Protocol Violation|0|||
44560191|NCT03011892|79578313|FG002|Double Blind (DB) Period|Protocol Violation|0|||
44560192|NCT03011892|79578314|FG003|Double Blind (DB) Period|Protocol Violation|0|||
44560193|NCT03011892|79578315|FG004|Double Blind (DB) Period|Protocol Violation|0|||
44560194|NCT03011892|79578316|FG005|Double Blind (DB) Period|Protocol Violation|0|||
44560195|NCT03011892|79578317|FG006|Double Blind (DB) Period|Protocol Violation|0|||
44560196|NCT03011892|79578318|FG007|Double Blind (DB) Period|Protocol Violation|0|||
44560197|NCT03011892|79578319|FG008|Double Blind (DB) Period|Protocol Violation|0|||
44560198|NCT03011892|79578320|FG009|Double Blind (DB) Period|Protocol Violation|0|||
44560199|NCT03011892|79578321|FG010|Double Blind (DB) Period|Protocol Violation|0|||
44560200|NCT03011892|79578322|FG011|Double Blind (DB) Period|Protocol Violation|0|||
44560201|NCT03011892|79578311|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
44560202|NCT03011892|79578312|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
44560203|NCT03011892|79578313|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
44560204|NCT03011892|79578314|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
44560205|NCT03011892|79578315|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
44560206|NCT03011892|79578316|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
44560207|NCT03011892|79578317|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
44560208|NCT03011892|79578318|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
44560209|NCT03011892|79578319|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
44560210|NCT03011892|79578320|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
44560211|NCT03011892|79578321|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
44499252|NCT00098306|79504020|FG001|Open Label|Participant defaulted|0|||
44499253|NCT00098306|79504021|FG002|Open Label|Participant defaulted|0|||
44499254|NCT00098306|79504022|FG003|Open Label|Participant defaulted|24|||
44560212|NCT03011892|79578322|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
44560213|NCT03011892|79578311|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
44560214|NCT03011892|79578312|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
44560215|NCT03011892|79578313|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
44560216|NCT03011892|79578314|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
44560217|NCT03011892|79578315|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
44560218|NCT03011892|79578316|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
44560219|NCT03011892|79578317|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
44560220|NCT03011892|79578318|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
44560221|NCT03011892|79578319|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
44560222|NCT03011892|79578320|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
44560223|NCT03011892|79578321|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
44232825|NCT01820585|79050072|FG003|Overall Study|Lost to Follow-up|3|||
44499255|NCT00098306|79504023|FG004|Open Label|Participant defaulted|0|||
44560224|NCT03011892|79578322|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
44560225|NCT03011892|79578311|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
44232826|NCT01820585|79050069|FG000|Overall Study|Protocol Violation|3|||
44232827|NCT01820585|79050070|FG001|Overall Study|Protocol Violation|1|||
44232828|NCT01820585|79050071|FG002|Overall Study|Protocol Violation|1|||
44232829|NCT01820585|79050072|FG003|Overall Study|Protocol Violation|1|||
44499256|NCT00098306|79504024|FG005|Open Label|Participant defaulted|0|||
44499257|NCT00098306|79504025|FG006|Open Label|Participant defaulted|0|||
44499258|NCT00098306|79504019|FG000|Open Label|Un-specified|0|||
44560226|NCT03011892|79578312|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
44560227|NCT03011892|79578313|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
44560228|NCT03011892|79578314|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
44560229|NCT03011892|79578315|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
44232830|NCT01820585|79050069|FG000|Overall Study|Subject non-compliance|0|||
44499259|NCT00098306|79504020|FG001|Open Label|Un-specified|0|||
44499260|NCT00098306|79504021|FG002|Open Label|Un-specified|0|||
44499261|NCT00098306|79504022|FG003|Open Label|Un-specified|15|||
44499262|NCT00098306|79504023|FG004|Open Label|Un-specified|0|||
44560230|NCT03011892|79578316|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
44560231|NCT03011892|79578317|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
44560232|NCT03011892|79578318|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
44560233|NCT03011892|79578319|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
44560234|NCT03011892|79578320|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
44560235|NCT03011892|79578321|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
44560236|NCT03011892|79578322|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
44560237|NCT03011892|79578311|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
44560238|NCT03011892|79578312|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
44560239|NCT03011892|79578313|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
44560240|NCT03011892|79578314|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
44560241|NCT03011892|79578315|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
44560242|NCT03011892|79578316|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
44232831|NCT01820585|79050070|FG001|Overall Study|Subject non-compliance|0|||
44232832|NCT01820585|79050071|FG002|Overall Study|Subject non-compliance|1|||
44376890|NCT00796315|79382147|FG002|Overall Study|Protocol Violation|0|||
44376891|NCT00855166|79382160|FG000|Overall Study|Adverse Event|0|||
44560243|NCT03011892|79578317|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
44560244|NCT03011892|79578318|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
44560245|NCT03011892|79578319|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
44560246|NCT03011892|79578320|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
44560247|NCT03011892|79578321|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
44560248|NCT03011892|79578322|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
44560249|NCT03011892|79578311|FG000|Open Label (OL) Period|Reason not specified|0|||
44560250|NCT03011892|79578312|FG001|Open Label (OL) Period|Reason not specified|0|||
44560251|NCT03011892|79578313|FG002|Open Label (OL) Period|Reason not specified|0|||
44560252|NCT03011892|79578314|FG003|Open Label (OL) Period|Reason not specified|0|||
44560253|NCT03011892|79578315|FG004|Open Label (OL) Period|Reason not specified|0|||
44560254|NCT03011892|79578316|FG005|Open Label (OL) Period|Reason not specified|0|||
44560255|NCT03011892|79578317|FG006|Open Label (OL) Period|Reason not specified|0|||
44560256|NCT03011892|79578318|FG007|Open Label (OL) Period|Reason not specified|1|||
44560257|NCT03011892|79578319|FG008|Open Label (OL) Period|Reason not specified|0|||
44560258|NCT03011892|79578320|FG009|Open Label (OL) Period|Reason not specified|0|||
44560259|NCT03011892|79578321|FG010|Open Label (OL) Period|Reason not specified|0|||
44560260|NCT03011892|79578322|FG011|Open Label (OL) Period|Reason not specified|0|||
44560261|NCT03017742|79578349|FG000|Overall Study|Protocol Violation|36|||
44560262|NCT03017742|79578349|FG000|Overall Study|Withdrawal by Subject|37|||
44560263|NCT03012828|79578359|FG000|Overall Study|Lost to Follow-up|1|||
44560264|NCT03012828|79578360|FG001|Overall Study|Lost to Follow-up|0|||
44560265|NCT03012828|79578361|FG002|Overall Study|Lost to Follow-up|1|||
44560266|NCT03012828|79578362|FG003|Overall Study|Lost to Follow-up|0|||
44376892|NCT00855166|79382161|FG001|Overall Study|Adverse Event|2|||
44376893|NCT00855166|79382160|FG000|Overall Study|Death|0|||
44376894|NCT00855166|79382161|FG001|Overall Study|Death|1|||
44376895|NCT00855166|79382160|FG000|Overall Study|Withdrawal by Subject|1|||
44376896|NCT00855166|79382161|FG001|Overall Study|Withdrawal by Subject|4|||
44376897|NCT00855166|79382160|FG000|Overall Study|Poor/non-compliance|2|||
44376898|NCT00855166|79382161|FG001|Overall Study|Poor/non-compliance|0|||
44376899|NCT00855166|79382160|FG000|Overall Study|Administrative reasons by sponsor|1|||
44560267|NCT03012828|79578363|FG004|Overall Study|Lost to Follow-up|1|||
44560268|NCT03012828|79578364|FG005|Overall Study|Lost to Follow-up|0|||
44560269|NCT03012828|79578359|FG000|Overall Study|Withdrawal by Subject|0|||
44560270|NCT03012828|79578360|FG001|Overall Study|Withdrawal by Subject|0|||
44560271|NCT03012828|79578361|FG002|Overall Study|Withdrawal by Subject|1|||
44560272|NCT03012828|79578362|FG003|Overall Study|Withdrawal by Subject|0|||
44560273|NCT03012828|79578363|FG004|Overall Study|Withdrawal by Subject|0|||
44376900|NCT00855166|79382161|FG001|Overall Study|Administrative reasons by sponsor|0|||
44560274|NCT03012828|79578364|FG005|Overall Study|Withdrawal by Subject|1|||
44376901|NCT00855166|79382160|FG000|Overall Study|Subject no longer meets study criteria|1|||
44376902|NCT00855166|79382161|FG001|Overall Study|Subject no longer meets study criteria|1|||
44560275|NCT03012828|79578359|FG000|Overall Study|Non-compliance with protocol|0|||
44232833|NCT01820585|79050072|FG003|Overall Study|Subject non-compliance|2|||
44232834|NCT01820585|79050069|FG000|Overall Study|at sponsor request|0|||
44232835|NCT01820585|79050070|FG001|Overall Study|at sponsor request|0|||
44232836|NCT01820585|79050071|FG002|Overall Study|at sponsor request|1|||
44232837|NCT01820585|79050072|FG003|Overall Study|at sponsor request|0|||
44232838|NCT01820585|79050069|FG000|Overall Study|Pregnancy|0|||
44232839|NCT01820585|79050070|FG001|Overall Study|Pregnancy|1|||
44232840|NCT01820585|79050071|FG002|Overall Study|Pregnancy|0|||
44232841|NCT01820585|79050072|FG003|Overall Study|Pregnancy|0|||
44232842|NCT01797263|79050084|FG000|Overall Study|Withdrawal by Subject|21|||
44232843|NCT01797263|79050085|FG001|Overall Study|Withdrawal by Subject|25|||
44232844|NCT01797263|79050084|FG000|Overall Study|Death|1|||
44232845|NCT01797263|79050085|FG001|Overall Study|Death|0|||
44232846|NCT01797263|79050084|FG000|Overall Study|Lost to Follow-up|15|||
44232847|NCT01797263|79050085|FG001|Overall Study|Lost to Follow-up|15|||
44232848|NCT01797185|79050140|FG000|Overall Study|Adverse Event|5|||
44232849|NCT01797185|79050141|FG001|Overall Study|Adverse Event|15|||
44232850|NCT01797185|79050142|FG002|Overall Study|Adverse Event|6|||
44232851|NCT01797185|79050140|FG000|Overall Study|Withdrawal by Subject|6|||
44232852|NCT01797185|79050141|FG001|Overall Study|Withdrawal by Subject|9|||
44232853|NCT01797185|79050142|FG002|Overall Study|Withdrawal by Subject|5|||
44232854|NCT01797185|79050140|FG000|Overall Study|Site terminated|8|||
44499263|NCT00098306|79504024|FG005|Open Label|Un-specified|0|||
44499264|NCT00098306|79504025|FG006|Open Label|Un-specified|0|||
44499265|NCT00098306|79504019|FG000|Open Label|Ongoing at cut-off date|0|||
44499266|NCT00098306|79504020|FG001|Open Label|Ongoing at cut-off date|0|||
44499267|NCT00098306|79504021|FG002|Open Label|Ongoing at cut-off date|0|||
44499268|NCT00098306|79504022|FG003|Open Label|Ongoing at cut-off date|269|||
44499269|NCT00098306|79504023|FG004|Open Label|Ongoing at cut-off date|62|||
44499270|NCT00098306|79504024|FG005|Open Label|Ongoing at cut-off date|0|||
44499271|NCT00098306|79504025|FG006|Open Label|Ongoing at cut-off date|0|||
44499272|NCT00098306|79504019|FG000|Observational Phase|Death|0|||
44499273|NCT00098306|79504020|FG001|Observational Phase|Death|0|||
44499274|NCT00098306|79504021|FG002|Observational Phase|Death|0|||
44499275|NCT00098306|79504022|FG003|Observational Phase|Death|0|||
44499276|NCT00098306|79504023|FG004|Observational Phase|Death|0|||
44232855|NCT01797185|79050141|FG001|Overall Study|Site terminated|4|||
44232856|NCT01797185|79050142|FG002|Overall Study|Site terminated|0|||
44232857|NCT01797185|79050140|FG000|Overall Study|Lost to Follow-up|2|||
44232858|NCT01797185|79050141|FG001|Overall Study|Lost to Follow-up|6|||
44232859|NCT01797185|79050142|FG002|Overall Study|Lost to Follow-up|1|||
44275268|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
44275269|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
44275270|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
44275271|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
44275272|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
44275273|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
44275274|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
44275275|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
44275276|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
44275277|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
44275278|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
44275279|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
44275280|NCT01600014|79221770|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
44275281|NCT01600014|79221771|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
44275282|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
44499277|NCT00098306|79504024|FG005|Observational Phase|Death|5|||
44499278|NCT00098306|79504025|FG006|Observational Phase|Death|4|||
44499279|NCT00098306|79504019|FG000|Observational Phase|Participant defaulted|0|||
44499280|NCT00098306|79504020|FG001|Observational Phase|Participant defaulted|0|||
44499281|NCT00098306|79504021|FG002|Observational Phase|Participant defaulted|0|||
44232860|NCT01797185|79050140|FG000|Overall Study|Withdrawn per sponsor|5|||
44232861|NCT01797185|79050141|FG001|Overall Study|Withdrawn per sponsor|0|||
44232862|NCT01797185|79050142|FG002|Overall Study|Withdrawn per sponsor|0|||
44232863|NCT01797185|79050140|FG000|Overall Study|Physician Decision|1|||
44232864|NCT01797185|79050141|FG001|Overall Study|Physician Decision|3|||
44232865|NCT01797185|79050142|FG002|Overall Study|Physician Decision|0|||
44232866|NCT01797185|79050140|FG000|Overall Study|Protocol Violation|1|||
44232867|NCT01797185|79050141|FG001|Overall Study|Protocol Violation|1|||
44232868|NCT01797185|79050142|FG002|Overall Study|Protocol Violation|0|||
44232869|NCT01819727|79050198|FG000|Overall Study|Adverse Event|8|||
44232870|NCT01819727|79050199|FG001|Overall Study|Adverse Event|9|||
44499282|NCT00098306|79504022|FG003|Observational Phase|Participant defaulted|0|||
44499283|NCT00098306|79504023|FG004|Observational Phase|Participant defaulted|0|||
44499284|NCT00098306|79504024|FG005|Observational Phase|Participant defaulted|34|||
44499285|NCT00098306|79504025|FG006|Observational Phase|Participant defaulted|18|||
44499286|NCT00098306|79504019|FG000|Observational Phase|Un-specified|0|||
44499287|NCT00098306|79504020|FG001|Observational Phase|Un-specified|0|||
44499288|NCT00098306|79504021|FG002|Observational Phase|Un-specified|0|||
44499289|NCT00098306|79504022|FG003|Observational Phase|Un-specified|0|||
44499290|NCT00098306|79504023|FG004|Observational Phase|Un-specified|0|||
44499291|NCT00098306|79504024|FG005|Observational Phase|Un-specified|7|||
44499292|NCT00098306|79504025|FG006|Observational Phase|Un-specified|4|||
44232871|NCT01819727|79050198|FG000|Overall Study|Death|1|||
44232872|NCT01819727|79050199|FG001|Overall Study|Death|0|||
44560276|NCT03012828|79578360|FG001|Overall Study|Non-compliance with protocol|0|||
44560277|NCT03012828|79578361|FG002|Overall Study|Non-compliance with protocol|0|||
44560278|NCT03012828|79578362|FG003|Overall Study|Non-compliance with protocol|0|||
44560279|NCT03012828|79578363|FG004|Overall Study|Non-compliance with protocol|1|||
44560280|NCT03012828|79578364|FG005|Overall Study|Non-compliance with protocol|0|||
44560281|NCT03012828|79578359|FG000|Overall Study|Delay to last visit would delay DBL|0|||
44560282|NCT03012828|79578360|FG001|Overall Study|Delay to last visit would delay DBL|0|||
44560283|NCT03012828|79578361|FG002|Overall Study|Delay to last visit would delay DBL|0|||
44560284|NCT03012828|79578362|FG003|Overall Study|Delay to last visit would delay DBL|0|||
44560285|NCT03012828|79578363|FG004|Overall Study|Delay to last visit would delay DBL|0|||
44560286|NCT03012828|79578364|FG005|Overall Study|Delay to last visit would delay DBL|1|||
44560287|NCT03010254|79578382|FG000|Overall Study|Adverse Event|0|||
44560288|NCT03010254|79578383|FG001|Overall Study|Adverse Event|1|||
44560289|NCT03010254|79578382|FG000|Overall Study|Lost to Follow-up|4|||
44560290|NCT03010254|79578383|FG001|Overall Study|Lost to Follow-up|0|||
44560291|NCT03010254|79578382|FG000|Overall Study|Withdrawal by Subject|1|||
44560292|NCT03010254|79578383|FG001|Overall Study|Withdrawal by Subject|1|||
44560293|NCT03010254|79578382|FG000|Overall Study|Other|2|||
44560294|NCT03010254|79578383|FG001|Overall Study|Other|3|||
44560295|NCT03008460|79578398|FG000|Overall Study|Protocol deviation|0|||
44560296|NCT03008460|79578399|FG001|Overall Study|Protocol deviation|2|||
44560297|NCT03008460|79578398|FG000|Overall Study|Study drug not dispensed|0|||
44560298|NCT03008460|79578399|FG001|Overall Study|Study drug not dispensed|1|||
44560299|NCT03008460|79578398|FG000|Overall Study|Adverse Event|0|||
44560300|NCT03008460|79578399|FG001|Overall Study|Adverse Event|1|||
44560301|NCT03008460|79578398|FG000|Overall Study|Withdrawal by Subject|5|||
44560302|NCT03008460|79578399|FG001|Overall Study|Withdrawal by Subject|6|||
44560303|NCT03008460|79578398|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
44560304|NCT03008460|79578399|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
44560305|NCT03008460|79578398|FG000|Overall Study|End of study visit outside permitted time window|0|||
44560306|NCT03008460|79578399|FG001|Overall Study|End of study visit outside permitted time window|1|||
44232873|NCT01819727|79050198|FG000|Overall Study|Lost to Follow-up|1|||
44232874|NCT01819727|79050199|FG001|Overall Study|Lost to Follow-up|1|||
44232875|NCT01819727|79050198|FG000|Overall Study|Physician Decision|3|||
44499293|NCT03615040|79504040|FG000|Overall Study|Withdrawal by Subject|2|||
44499294|NCT03615040|79504041|FG001|Overall Study|Withdrawal by Subject|1|||
44499295|NCT03615040|79504040|FG000|Overall Study|Physician Decision|2|||
44499296|NCT03615040|79504041|FG001|Overall Study|Physician Decision|2|||
44499297|NCT03615040|79504040|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
44499298|NCT03615040|79504041|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
44499299|NCT03615040|79504040|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
44499300|NCT03615040|79504041|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
44499301|NCT03615040|79504040|FG000|Overall Study|Death|0|||
44499302|NCT03615040|79504041|FG001|Overall Study|Death|2|||
44499303|NCT00068822|79504049|FG000|First Randomized Intervention|Lost to Follow-up|1|||
44499304|NCT00068822|79504050|FG001|First Randomized Intervention|Lost to Follow-up|2|||
44499305|NCT00068588|79504059|FG000|Overall Study|Adverse Event|0|||
44499306|NCT00068588|79504060|FG001|Overall Study|Adverse Event|0|||
44499307|NCT00068588|79504061|FG002|Overall Study|Adverse Event|2|||
44499308|NCT00068588|79504059|FG000|Overall Study|Withdrawal by Subject|0|||
44499309|NCT00068588|79504060|FG001|Overall Study|Withdrawal by Subject|0|||
44499310|NCT00068588|79504061|FG002|Overall Study|Withdrawal by Subject|1|||
44499311|NCT00068588|79504059|FG000|Overall Study|Poor KPS|0|||
44499312|NCT00068588|79504060|FG001|Overall Study|Poor KPS|0|||
44499313|NCT00068588|79504061|FG002|Overall Study|Poor KPS|1|||
44499314|NCT03650452|79504070|FG000|Overall Study|Physician Decision|1|||
44499315|NCT03650452|79504071|FG001|Overall Study|Physician Decision|0|||
44499316|NCT03650452|79504070|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
44232876|NCT01819727|79050199|FG001|Overall Study|Physician Decision|2|||
44232877|NCT01819727|79050198|FG000|Overall Study|Pregnancy|1|||
44232878|NCT01819727|79050199|FG001|Overall Study|Pregnancy|0|||
44232879|NCT01819727|79050198|FG000|Overall Study|Protocol Violation|0|||
44376903|NCT00587587|79382171|FG000|Overall Study|Lost to Follow-up|6|||
44560307|NCT03008460|79578398|FG000|Overall Study|Lost to Follow-up|1|||
44560308|NCT03008460|79578399|FG001|Overall Study|Lost to Follow-up|3|||
44275283|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
44376904|NCT00587587|79382172|FG001|Overall Study|Lost to Follow-up|1|||
44499317|NCT03650452|79504071|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44499318|NCT03650452|79504070|FG000|Overall Study|Adverse Event|3|||
44560309|NCT02914236|79578405|FG000|Overall Study|Lost to Follow-up|1|||
44560310|NCT03003390|79578411|FG000|Overall Study|Physician Decision|2|||
44560311|NCT03003390|79578412|FG001|Overall Study|Physician Decision|0|||
44499319|NCT03650452|79504071|FG001|Overall Study|Adverse Event|4|||
44499320|NCT03650452|79504070|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
44232880|NCT01819727|79050199|FG001|Overall Study|Protocol Violation|2|||
44560312|NCT03003390|79578411|FG000|Overall Study|Parent refused intervention|2|||
44560313|NCT03003390|79578412|FG001|Overall Study|Parent refused intervention|0|||
44560314|NCT03003000|79578426|FG000|Overall Study|Adverse Event|1|||
44560315|NCT03003000|79578427|FG001|Overall Study|Adverse Event|2|||
44560316|NCT03003000|79578428|FG002|Overall Study|Adverse Event|3|||
44560317|NCT03003000|79578426|FG000|Overall Study|Lack of Efficacy|1|||
44560318|NCT03003000|79578427|FG001|Overall Study|Lack of Efficacy|0|||
44560319|NCT03003000|79578428|FG002|Overall Study|Lack of Efficacy|0|||
44560320|NCT03003000|79578426|FG000|Overall Study|Non-compliant with protocol|0|||
44560321|NCT03003000|79578427|FG001|Overall Study|Non-compliant with protocol|1|||
44560322|NCT03003000|79578428|FG002|Overall Study|Non-compliant with protocol|1|||
44560323|NCT03003000|79578426|FG000|Overall Study|Refused to continue medication|2|||
44560324|NCT03003000|79578427|FG001|Overall Study|Refused to continue medication|0|||
44560325|NCT03003000|79578428|FG002|Overall Study|Refused to continue medication|0|||
44560326|NCT03003000|79578426|FG000|Overall Study|Other than listed|1|||
44560327|NCT03003000|79578427|FG001|Overall Study|Other than listed|1|||
44560328|NCT03003000|79578428|FG002|Overall Study|Other than listed|1|||
44560329|NCT03002610|79578439|FG000|Overall Study|Withdrawal by Subject|6|||
44560330|NCT03002610|79578440|FG001|Overall Study|Withdrawal by Subject|25|||
44560331|NCT03002610|79578441|FG002|Overall Study|Withdrawal by Subject|13|||
44560332|NCT03005106|79578449|FG000|Overall Study|Lost to Follow-up|16|||
44560333|NCT03005106|79578449|FG000|Overall Study|Adverse Event|1|||
44560334|NCT03005106|79578449|FG000|Overall Study|Physician Decision|1|||
44560335|NCT03005106|79578449|FG000|Overall Study|Death|2|||
44499321|NCT03650452|79504071|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
44499322|NCT03575806|79504079|FG000|Overall Study|Withdrawal by Subject|0|||
44499323|NCT03575806|79504080|FG001|Overall Study|Withdrawal by Subject|2|||
44560336|NCT01004861|79578466|FG000|Overall Study|Disease progression|3|||
44560337|NCT01004861|79578467|FG001|Overall Study|Disease progression|4|||
44560338|NCT01004861|79578468|FG002|Overall Study|Disease progression|5|||
44560339|NCT01004861|79578469|FG003|Overall Study|Disease progression|4|||
44560340|NCT01004861|79578470|FG004|Overall Study|Disease progression|4|||
44560341|NCT01004861|79578471|FG005|Overall Study|Disease progression|4|||
44560342|NCT01004861|79578472|FG006|Overall Study|Disease progression|5|||
44560343|NCT01004861|79578473|FG007|Overall Study|Disease progression|1|||
44560344|NCT01004861|79578474|FG008|Overall Study|Disease progression|4|||
44560345|NCT01004861|79578475|FG009|Overall Study|Disease progression|7|||
44560346|NCT01004861|79578476|FG010|Overall Study|Disease progression|6|||
44560347|NCT01004861|79578477|FG011|Overall Study|Disease progression|3|||
44560348|NCT01004861|79578478|FG012|Overall Study|Disease progression|8|||
44560349|NCT01004861|79578466|FG000|Overall Study|Physician Decision|0|||
44560350|NCT01004861|79578467|FG001|Overall Study|Physician Decision|2|||
44560351|NCT01004861|79578468|FG002|Overall Study|Physician Decision|1|||
44560352|NCT01004861|79578469|FG003|Overall Study|Physician Decision|1|||
44560353|NCT01004861|79578470|FG004|Overall Study|Physician Decision|1|||
44560354|NCT01004861|79578471|FG005|Overall Study|Physician Decision|0|||
44560355|NCT01004861|79578472|FG006|Overall Study|Physician Decision|0|||
44499324|NCT03575806|79504079|FG000|Overall Study|Protocol Violation|0|||
44499325|NCT03575806|79504080|FG001|Overall Study|Protocol Violation|2|||
44499326|NCT03610048|79504086|FG000|Overall Study|Study terminated by sponsor|84|||
44499327|NCT03610048|79504086|FG000|Overall Study|Adverse Event|32|||
44499328|NCT03610048|79504086|FG000|Overall Study|Withdrawal by Subject|31|||
44499329|NCT03610048|79504086|FG000|Overall Study|Lost to Follow-up|8|||
44499330|NCT03610048|79504086|FG000|Overall Study|Other|4|||
44499331|NCT03610048|79504086|FG000|Overall Study|Physician Decision|1|||
44499332|NCT03610048|79504086|FG000|Overall Study|Pregnancy|1|||
44499333|NCT03608254|79504090|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
44499334|NCT03608254|79504090|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
44499335|NCT03606460|79504096|FG000|Overall Study|Lost to Follow-up|1|||
44499336|NCT03606460|79504097|FG001|Overall Study|Lost to Follow-up|8|||
44499337|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
44560356|NCT01004861|79578473|FG007|Overall Study|Physician Decision|1|||
44560357|NCT01004861|79578474|FG008|Overall Study|Physician Decision|0|||
44560358|NCT01004861|79578475|FG009|Overall Study|Physician Decision|0|||
44560359|NCT01004861|79578476|FG010|Overall Study|Physician Decision|0|||
44560360|NCT01004861|79578477|FG011|Overall Study|Physician Decision|0|||
44232881|NCT01819727|79050198|FG000|Overall Study|Study Terminated by Sponsor|0|||
44499338|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
44499339|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
44499340|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
44560361|NCT01004861|79578478|FG012|Overall Study|Physician Decision|3|||
44560362|NCT01004861|79578466|FG000|Overall Study|Adverse Event|0|||
44560363|NCT01004861|79578467|FG001|Overall Study|Adverse Event|0|||
44560364|NCT01004861|79578468|FG002|Overall Study|Adverse Event|0|||
44232882|NCT01819727|79050199|FG001|Overall Study|Study Terminated by Sponsor|1|||
44560365|NCT01004861|79578469|FG003|Overall Study|Adverse Event|1|||
44560366|NCT01004861|79578470|FG004|Overall Study|Adverse Event|0|||
44560367|NCT01004861|79578471|FG005|Overall Study|Adverse Event|2|||
44560368|NCT01004861|79578472|FG006|Overall Study|Adverse Event|1|||
44560369|NCT01004861|79578473|FG007|Overall Study|Adverse Event|1|||
44560370|NCT01004861|79578474|FG008|Overall Study|Adverse Event|13|||
44560371|NCT01004861|79578475|FG009|Overall Study|Adverse Event|1|||
44560372|NCT01004861|79578476|FG010|Overall Study|Adverse Event|1|||
44560373|NCT01004861|79578477|FG011|Overall Study|Adverse Event|0|||
44560374|NCT01004861|79578478|FG012|Overall Study|Adverse Event|2|||
44560375|NCT01004861|79578466|FG000|Overall Study|Protocol Violation|0|||
44560376|NCT01004861|79578467|FG001|Overall Study|Protocol Violation|0|||
44560377|NCT01004861|79578468|FG002|Overall Study|Protocol Violation|0|||
44560378|NCT01004861|79578469|FG003|Overall Study|Protocol Violation|0|||
44560379|NCT01004861|79578470|FG004|Overall Study|Protocol Violation|1|||
44560380|NCT01004861|79578471|FG005|Overall Study|Protocol Violation|0|||
44560381|NCT01004861|79578472|FG006|Overall Study|Protocol Violation|0|||
44499341|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
44499342|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
44499343|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
44499344|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
44499345|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
44499346|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
44499347|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
44499348|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
44499349|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
44499350|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
44499351|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
44499352|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
44499353|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
44499354|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
44499355|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
44499356|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
44499357|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
44499358|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
44499359|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
44499360|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
44499361|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
44499362|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
44499363|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
44499364|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
44499365|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
44499366|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
44499367|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
44499368|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
44499369|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
44499370|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
44499371|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
44499372|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
44499373|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
44499374|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
44499375|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
44499376|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
44499377|NCT03605836|79504108|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
44499378|NCT03605836|79504109|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
44560382|NCT01004861|79578473|FG007|Overall Study|Protocol Violation|0|||
44560383|NCT01004861|79578474|FG008|Overall Study|Protocol Violation|0|||
44560384|NCT01004861|79578475|FG009|Overall Study|Protocol Violation|0|||
44560385|NCT01004861|79578476|FG010|Overall Study|Protocol Violation|0|||
44560386|NCT01004861|79578477|FG011|Overall Study|Protocol Violation|0|||
44232883|NCT01819727|79050198|FG000|Overall Study|Withdrawal by Subject|6|||
44560387|NCT01004861|79578478|FG012|Overall Study|Protocol Violation|0|||
44232884|NCT01819727|79050199|FG001|Overall Study|Withdrawal by Subject|11|||
44560388|NCT01004861|79578466|FG000|Overall Study|Lost to Follow-up|0|||
44560389|NCT01004861|79578467|FG001|Overall Study|Lost to Follow-up|0|||
44560390|NCT01004861|79578468|FG002|Overall Study|Lost to Follow-up|0|||
44560391|NCT01004861|79578469|FG003|Overall Study|Lost to Follow-up|0|||
44560392|NCT01004861|79578470|FG004|Overall Study|Lost to Follow-up|0|||
44560393|NCT01004861|79578471|FG005|Overall Study|Lost to Follow-up|0|||
44560394|NCT01004861|79578472|FG006|Overall Study|Lost to Follow-up|0|||
44560395|NCT01004861|79578473|FG007|Overall Study|Lost to Follow-up|1|||
44560396|NCT01004861|79578474|FG008|Overall Study|Lost to Follow-up|3|||
44560397|NCT01004861|79578475|FG009|Overall Study|Lost to Follow-up|0|||
44560398|NCT01004861|79578476|FG010|Overall Study|Lost to Follow-up|0|||
44560399|NCT01004861|79578477|FG011|Overall Study|Lost to Follow-up|1|||
44560400|NCT01004861|79578478|FG012|Overall Study|Lost to Follow-up|0|||
44275284|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
44560401|NCT01004861|79578466|FG000|Overall Study|Non-compliance|0|||
44275285|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
44275286|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
44275287|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
44275288|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
44275289|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
44275290|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
44275291|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
44376905|NCT00854620|79382180|FG000|Overall Study|Adverse Event|1|||
44275292|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
44275293|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
44275294|NCT01600014|79221770|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
44275295|NCT01600014|79221771|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
44376906|NCT00793585|79382186|FG000|Overall Study|Adverse Event|1|||
44376907|NCT00793585|79382187|FG001|Overall Study|Adverse Event|1|||
44499379|NCT03605836|79504110|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
44499380|NCT03605836|79504111|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
44499381|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
44499382|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
44499383|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
44499384|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
44499385|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
44499386|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
44499387|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
44499388|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
44499389|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
44499390|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
44499391|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
44499392|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
44499393|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
44499394|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
44499395|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
44499396|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
44560402|NCT01004861|79578467|FG001|Overall Study|Non-compliance|0|||
44560403|NCT01004861|79578468|FG002|Overall Study|Non-compliance|0|||
44275296|NCT01600014|79221770|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
44275297|NCT01600014|79221771|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
44275298|NCT01600014|79221770|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
44275299|NCT01600014|79221771|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
44275300|NCT01600014|79221770|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
44275301|NCT01600014|79221771|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
44275302|NCT02237196|79221793|FG000|Overall Study|Adverse Event|0|||
44275303|NCT02237196|79221794|FG001|Overall Study|Adverse Event|1|||
44275304|NCT02237196|79221795|FG002|Overall Study|Adverse Event|1|||
44275305|NCT02237196|79221796|FG003|Overall Study|Adverse Event|0|||
44275306|NCT02237196|79221793|FG000|Overall Study|Lost to Follow-up|4|||
44275307|NCT02237196|79221794|FG001|Overall Study|Lost to Follow-up|2|||
44275308|NCT02237196|79221795|FG002|Overall Study|Lost to Follow-up|4|||
44275309|NCT02237196|79221796|FG003|Overall Study|Lost to Follow-up|6|||
44275310|NCT02237196|79221793|FG000|Overall Study|Physician Decision|2|||
44560404|NCT01004861|79578469|FG003|Overall Study|Non-compliance|0|||
44560405|NCT01004861|79578470|FG004|Overall Study|Non-compliance|0|||
44560406|NCT01004861|79578471|FG005|Overall Study|Non-compliance|0|||
44376908|NCT00793585|79382186|FG000|Overall Study|Protocol Violation|1|||
44560407|NCT01004861|79578472|FG006|Overall Study|Non-compliance|0|||
44560408|NCT01004861|79578473|FG007|Overall Study|Non-compliance|0|||
44232885|NCT01819727|79050198|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
44560409|NCT01004861|79578474|FG008|Overall Study|Non-compliance|5|||
44560410|NCT01004861|79578475|FG009|Overall Study|Non-compliance|0|||
44560411|NCT01004861|79578476|FG010|Overall Study|Non-compliance|0|||
44560412|NCT01004861|79578477|FG011|Overall Study|Non-compliance|0|||
44560413|NCT01004861|79578478|FG012|Overall Study|Non-compliance|1|||
44560414|NCT01004861|79578466|FG000|Overall Study|Other|0|||
44560415|NCT01004861|79578467|FG001|Overall Study|Other|0|||
44560416|NCT01004861|79578468|FG002|Overall Study|Other|0|||
44560417|NCT01004861|79578469|FG003|Overall Study|Other|0|||
44560418|NCT01004861|79578470|FG004|Overall Study|Other|0|||
44560419|NCT01004861|79578471|FG005|Overall Study|Other|0|||
44560420|NCT01004861|79578472|FG006|Overall Study|Other|0|||
44560421|NCT01004861|79578473|FG007|Overall Study|Other|0|||
44560422|NCT01004861|79578474|FG008|Overall Study|Other|0|||
44560423|NCT01004861|79578475|FG009|Overall Study|Other|2|||
44560424|NCT01004861|79578476|FG010|Overall Study|Other|1|||
44560425|NCT01004861|79578477|FG011|Overall Study|Other|2|||
44560426|NCT01004861|79578478|FG012|Overall Study|Other|3|||
44560427|NCT01004861|79578466|FG000|Overall Study|Patient decision|0|||
44560428|NCT01004861|79578467|FG001|Overall Study|Patient decision|0|||
44560429|NCT01004861|79578468|FG002|Overall Study|Patient decision|0|||
44560430|NCT01004861|79578469|FG003|Overall Study|Patient decision|0|||
44560431|NCT01004861|79578470|FG004|Overall Study|Patient decision|1|||
44560432|NCT01004861|79578471|FG005|Overall Study|Patient decision|0|||
44560433|NCT01004861|79578472|FG006|Overall Study|Patient decision|1|||
44560434|NCT01004861|79578473|FG007|Overall Study|Patient decision|0|||
44560435|NCT01004861|79578474|FG008|Overall Study|Patient decision|7|||
44560436|NCT01004861|79578475|FG009|Overall Study|Patient decision|1|||
44560437|NCT01004861|79578476|FG010|Overall Study|Patient decision|1|||
44560438|NCT01004861|79578477|FG011|Overall Study|Patient decision|2|||
44560439|NCT01004861|79578478|FG012|Overall Study|Patient decision|3|||
44560440|NCT01004861|79578466|FG000|Overall Study|Transitioned to Phase 4 study|0|||
44560441|NCT01004861|79578467|FG001|Overall Study|Transitioned to Phase 4 study|0|||
44560442|NCT01004861|79578468|FG002|Overall Study|Transitioned to Phase 4 study|0|||
44560443|NCT01004861|79578469|FG003|Overall Study|Transitioned to Phase 4 study|0|||
44560444|NCT01004861|79578470|FG004|Overall Study|Transitioned to Phase 4 study|0|||
44560445|NCT01004861|79578471|FG005|Overall Study|Transitioned to Phase 4 study|0|||
44560446|NCT01004861|79578472|FG006|Overall Study|Transitioned to Phase 4 study|0|||
44232886|NCT01819727|79050199|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
44232887|NCT01819727|79050198|FG000|Overall Study|Quit due to lack of health benifits|0|||
44232888|NCT01819727|79050199|FG001|Overall Study|Quit due to lack of health benifits|1|||
44232889|NCT01795937|79050258|FG000|Overall Study|Withdrawal by Subject|1|||
44232890|NCT01795937|79050259|FG001|Overall Study|Withdrawal by Subject|0|||
44560447|NCT01004861|79578473|FG007|Overall Study|Transitioned to Phase 4 study|0|||
44560448|NCT01004861|79578474|FG008|Overall Study|Transitioned to Phase 4 study|2|||
44560449|NCT01004861|79578475|FG009|Overall Study|Transitioned to Phase 4 study|0|||
44232891|NCT01795937|79050260|FG002|Overall Study|Withdrawal by Subject|0|||
44232892|NCT01795937|79050258|FG000|Overall Study|Physician Decision|0|||
44232893|NCT01795937|79050259|FG001|Overall Study|Physician Decision|1|||
44232894|NCT01795937|79050260|FG002|Overall Study|Physician Decision|0|||
44232895|NCT01817777|79050302|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
44232896|NCT01817777|79050303|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
44560450|NCT01004861|79578476|FG010|Overall Study|Transitioned to Phase 4 study|0|||
44560451|NCT01004861|79578477|FG011|Overall Study|Transitioned to Phase 4 study|0|||
44560452|NCT01004861|79578478|FG012|Overall Study|Transitioned to Phase 4 study|0|||
44560453|NCT01004861|79578466|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560454|NCT01004861|79578467|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560455|NCT01004861|79578468|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560456|NCT01004861|79578469|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560457|NCT01004861|79578470|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560458|NCT01004861|79578471|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560459|NCT01004861|79578472|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560460|NCT01004861|79578473|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560461|NCT01004861|79578474|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
44560462|NCT01004861|79578475|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560463|NCT01004861|79578476|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560464|NCT01004861|79578477|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560465|NCT01004861|79578478|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
44560466|NCT01004861|79578466|FG000|Overall Study|Patient withdrew|0|||
44560467|NCT01004861|79578467|FG001|Overall Study|Patient withdrew|0|||
44560468|NCT01004861|79578468|FG002|Overall Study|Patient withdrew|0|||
44560469|NCT01004861|79578469|FG003|Overall Study|Patient withdrew|0|||
44560470|NCT01004861|79578470|FG004|Overall Study|Patient withdrew|0|||
44560471|NCT01004861|79578471|FG005|Overall Study|Patient withdrew|0|||
44560472|NCT01004861|79578472|FG006|Overall Study|Patient withdrew|0|||
44560473|NCT01004861|79578473|FG007|Overall Study|Patient withdrew|0|||
44560474|NCT01004861|79578474|FG008|Overall Study|Patient withdrew|1|||
44560475|NCT01004861|79578475|FG009|Overall Study|Patient withdrew|0|||
44560476|NCT01004861|79578476|FG010|Overall Study|Patient withdrew|0|||
44560477|NCT01004861|79578477|FG011|Overall Study|Patient withdrew|0|||
44560478|NCT01004861|79578478|FG012|Overall Study|Patient withdrew|0|||
44560479|NCT01004861|79578466|FG000|Overall Study|Surgical resection|0|||
44560480|NCT01004861|79578467|FG001|Overall Study|Surgical resection|0|||
44560481|NCT01004861|79578468|FG002|Overall Study|Surgical resection|0|||
44560482|NCT01004861|79578469|FG003|Overall Study|Surgical resection|0|||
44560483|NCT01004861|79578470|FG004|Overall Study|Surgical resection|0|||
44560484|NCT01004861|79578471|FG005|Overall Study|Surgical resection|0|||
44560485|NCT01004861|79578472|FG006|Overall Study|Surgical resection|0|||
44560486|NCT01004861|79578473|FG007|Overall Study|Surgical resection|0|||
44560487|NCT01004861|79578474|FG008|Overall Study|Surgical resection|1|||
44499397|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
44499398|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
44499399|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
44499400|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
44499401|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
44499402|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
44499403|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
44499404|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
44499405|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
44499406|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
44499407|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
44560488|NCT01004861|79578475|FG009|Overall Study|Surgical resection|0|||
44560489|NCT01004861|79578476|FG010|Overall Study|Surgical resection|0|||
44560490|NCT01004861|79578477|FG011|Overall Study|Surgical resection|0|||
44560491|NCT01004861|79578478|FG012|Overall Study|Surgical resection|0|||
44560492|NCT01004861|79578466|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44275311|NCT02237196|79221794|FG001|Overall Study|Physician Decision|0|||
44499408|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
44499409|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
44499410|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
44499411|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
44499412|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
44560493|NCT01004861|79578467|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560494|NCT01004861|79578468|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560495|NCT01004861|79578469|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560496|NCT01004861|79578470|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560497|NCT01004861|79578471|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560498|NCT01004861|79578472|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560499|NCT01004861|79578473|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560500|NCT01004861|79578474|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
44560501|NCT01004861|79578475|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560502|NCT01004861|79578476|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44499413|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
44499414|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
44499415|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
44560503|NCT01004861|79578477|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560504|NCT01004861|79578478|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
44560505|NCT01004861|79578466|FG000|Overall Study|Study termination by Sponsor|0|||
44560506|NCT01004861|79578467|FG001|Overall Study|Study termination by Sponsor|0|||
44560507|NCT01004861|79578468|FG002|Overall Study|Study termination by Sponsor|0|||
44560508|NCT01004861|79578469|FG003|Overall Study|Study termination by Sponsor|0|||
44560509|NCT01004861|79578470|FG004|Overall Study|Study termination by Sponsor|0|||
44560510|NCT01004861|79578471|FG005|Overall Study|Study termination by Sponsor|0|||
44560511|NCT01004861|79578472|FG006|Overall Study|Study termination by Sponsor|0|||
44560512|NCT01004861|79578473|FG007|Overall Study|Study termination by Sponsor|0|||
44560513|NCT01004861|79578474|FG008|Overall Study|Study termination by Sponsor|1|||
44560514|NCT01004861|79578475|FG009|Overall Study|Study termination by Sponsor|0|||
44560515|NCT01004861|79578476|FG010|Overall Study|Study termination by Sponsor|0|||
44560516|NCT01004861|79578477|FG011|Overall Study|Study termination by Sponsor|0|||
44560517|NCT01004861|79578478|FG012|Overall Study|Study termination by Sponsor|0|||
44560518|NCT03254459|79578525|FG000|Overall Study|Adverse Event|7|||
44499416|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
44499417|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
44499418|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
44499419|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
44499420|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
44499421|NCT03605836|79504108|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
44499422|NCT03605836|79504109|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
44499423|NCT03605836|79504110|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
44499424|NCT03605836|79504111|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
44499425|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
44499426|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
44275312|NCT02237196|79221795|FG002|Overall Study|Physician Decision|0|||
44275313|NCT02237196|79221796|FG003|Overall Study|Physician Decision|1|||
44275314|NCT02237196|79221793|FG000|Overall Study|Pregnancy|0|||
44560519|NCT03254459|79578526|FG001|Overall Study|Adverse Event|20|||
44560520|NCT03254459|79578525|FG000|Overall Study|Withdrawal by Subject Consent|3|||
44560521|NCT03254459|79578526|FG001|Overall Study|Withdrawal by Subject Consent|1|||
44560522|NCT03254459|79578525|FG000|Overall Study|Lost to Follow-up|0|||
44560523|NCT03254459|79578526|FG001|Overall Study|Lost to Follow-up|1|||
44560524|NCT03254459|79578525|FG000|Overall Study|Miscellaneous|0|||
44560525|NCT03254459|79578526|FG001|Overall Study|Miscellaneous|1|||
44560526|NCT02736617|79578532|FG000|Treatment|Adverse Event|1|||
44560527|NCT02736617|79578532|FG000|Treatment|Lack of Efficacy|1|||
44560528|NCT02736617|79578532|FG000|Treatment|Withdrawal by Subject|1|||
44499427|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
44499428|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
44499429|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
44499430|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
44499431|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
44499432|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
44499433|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
44499434|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
44499435|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
44499436|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
44499437|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
44499438|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
44499439|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
44499440|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
44499441|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
44499442|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
44499443|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
44499444|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
44499445|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
44499446|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
44499447|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
44499448|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
44499449|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
44560529|NCT02736617|79578532|FG000|Maintenance|Lack of Efficacy|4|||
44560530|NCT02736617|79578532|FG000|Maintenance|Physician Decision|1|||
44560531|NCT03251963|79578539|FG000|Overall Study|inappropriate Xa level timing|6|||
44560532|NCT03251963|79578540|FG001|Overall Study|inappropriate Xa level timing|3|||
44376909|NCT00793585|79382187|FG001|Overall Study|Protocol Violation|2|||
44499450|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
44499451|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
44499452|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
44499453|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
44499454|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
44499455|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
44499456|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
44499457|NCT03605680|79504124|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
44499458|NCT03605680|79504125|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
44499459|NCT03605680|79504126|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
44499460|NCT03605680|79504127|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
44499461|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
44514899|NCT03077698|79520766|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
44275315|NCT02237196|79221794|FG001|Overall Study|Pregnancy|0|||
44560533|NCT03251963|79578539|FG000|Overall Study|no peak Xa level drawn|2|||
44560534|NCT03251963|79578540|FG001|Overall Study|no peak Xa level drawn|0|||
44560535|NCT03251963|79578539|FG000|Overall Study|bled prior to Xa level|1|||
44560536|NCT03251963|79578540|FG001|Overall Study|bled prior to Xa level|2|||
44560537|NCT03287219|79578548|FG000|Overall Study|Protocol Violation|0|||
44560538|NCT03287219|79578549|FG001|Overall Study|Protocol Violation|2|||
44560539|NCT03286751|79578588|FG000|Washout Period 1|Withdrawal by Subject|0|||
44560540|NCT03286751|79578589|FG001|Washout Period 1|Withdrawal by Subject|0|||
44560541|NCT03286751|79578590|FG002|Washout Period 1|Withdrawal by Subject|0|||
44560542|NCT03286751|79578591|FG003|Washout Period 1|Withdrawal by Subject|0|||
44560543|NCT03286751|79578592|FG004|Washout Period 1|Withdrawal by Subject|1|||
44560544|NCT03286751|79578593|FG005|Washout Period 1|Withdrawal by Subject|0|||
44560545|NCT03286751|79578588|FG000|Washout Period 2|Personal Reasons|0|||
44560546|NCT03286751|79578589|FG001|Washout Period 2|Personal Reasons|1|||
44560547|NCT03286751|79578590|FG002|Washout Period 2|Personal Reasons|0|||
44560548|NCT03286751|79578591|FG003|Washout Period 2|Personal Reasons|0|||
44560549|NCT03286751|79578592|FG004|Washout Period 2|Personal Reasons|0|||
44560550|NCT03286751|79578593|FG005|Washout Period 2|Personal Reasons|0|||
44560551|NCT03286751|79578588|FG000|Washout Period 5|Adverse Event|0|||
44560552|NCT03286751|79578589|FG001|Washout Period 5|Adverse Event|0|||
44560553|NCT03286751|79578590|FG002|Washout Period 5|Adverse Event|0|||
44560554|NCT03286751|79578591|FG003|Washout Period 5|Adverse Event|0|||
44560555|NCT03286751|79578592|FG004|Washout Period 5|Adverse Event|1|||
44560556|NCT03286751|79578593|FG005|Washout Period 5|Adverse Event|0|||
44560557|NCT03249935|79578607|FG000|Overall Study|Discharged from facility early|36|||
44560558|NCT03249935|79578607|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
44560559|NCT03249935|79578607|FG000|Overall Study|Protocol Violation|5|||
44560560|NCT03285113|79578613|FG000|Overall Study|Unable to implant leads|2|||
44560561|NCT03000348|79578623|FG000|Overall Study|Adverse Event|1|||
44560562|NCT03000348|79578624|FG001|Overall Study|Adverse Event|1|||
44560563|NCT03000348|79578625|FG002|Overall Study|Adverse Event|1|||
44560564|NCT03000348|79578626|FG003|Overall Study|Adverse Event|1|||
44560565|NCT03000348|79578627|FG004|Overall Study|Adverse Event|1|||
44560566|NCT03000348|79578628|FG005|Overall Study|Adverse Event|1|||
44560567|NCT03000348|79578623|FG000|Overall Study|Lost to Follow-up|0|||
44560568|NCT03000348|79578624|FG001|Overall Study|Lost to Follow-up|0|||
44560569|NCT03000348|79578625|FG002|Overall Study|Lost to Follow-up|1|||
44499462|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
44499463|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
44499464|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
44499465|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
44499466|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
44499467|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
44499468|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
44499469|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44499470|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44499471|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44499472|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
44560570|NCT03000348|79578626|FG003|Overall Study|Lost to Follow-up|0|||
44560571|NCT03000348|79578627|FG004|Overall Study|Lost to Follow-up|0|||
44560572|NCT03000348|79578628|FG005|Overall Study|Lost to Follow-up|0|||
44232897|NCT01817777|79050304|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
44232898|NCT01817777|79050302|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
44232899|NCT01817777|79050303|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
44376910|NCT00898443|79382195|FG000|Overall Study|Withdrawal by Subject|1|||
44376911|NCT00898443|79382196|FG001|Overall Study|Withdrawal by Subject|0|||
44499473|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
44499474|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
44560573|NCT03000348|79578623|FG000|Overall Study|Withdrawal by Subject|0|||
44560574|NCT03000348|79578624|FG001|Overall Study|Withdrawal by Subject|1|||
44560575|NCT03000348|79578625|FG002|Overall Study|Withdrawal by Subject|0|||
44560576|NCT03000348|79578626|FG003|Overall Study|Withdrawal by Subject|0|||
44560577|NCT03000348|79578627|FG004|Overall Study|Withdrawal by Subject|0|||
44560578|NCT03000348|79578628|FG005|Overall Study|Withdrawal by Subject|0|||
44560579|NCT03000348|79578623|FG000|Overall Study|Consent|0|||
44560580|NCT03000348|79578624|FG001|Overall Study|Consent|0|||
44560581|NCT03000348|79578625|FG002|Overall Study|Consent|0|||
44560582|NCT03000348|79578626|FG003|Overall Study|Consent|0|||
44560583|NCT03000348|79578627|FG004|Overall Study|Consent|1|||
44560584|NCT03000348|79578628|FG005|Overall Study|Consent|0|||
44560585|NCT03000348|79578623|FG000|Overall Study|Failure to expectorate sputum|1|||
44560586|NCT03000348|79578624|FG001|Overall Study|Failure to expectorate sputum|0|||
44560587|NCT03000348|79578625|FG002|Overall Study|Failure to expectorate sputum|1|||
44560588|NCT03000348|79578626|FG003|Overall Study|Failure to expectorate sputum|0|||
44560589|NCT03000348|79578627|FG004|Overall Study|Failure to expectorate sputum|1|||
44560590|NCT03000348|79578628|FG005|Overall Study|Failure to expectorate sputum|0|||
44560591|NCT03000348|79578623|FG000|Overall Study|No gram negative|1|||
44560592|NCT03000348|79578624|FG001|Overall Study|No gram negative|2|||
44560593|NCT03000348|79578625|FG002|Overall Study|No gram negative|1|||
44560594|NCT03000348|79578626|FG003|Overall Study|No gram negative|1|||
44560595|NCT03000348|79578627|FG004|Overall Study|No gram negative|1|||
44560596|NCT03000348|79578628|FG005|Overall Study|No gram negative|1|||
44560597|NCT03000348|79578623|FG000|Overall Study|Patient had no transport|0|||
44560598|NCT03000348|79578624|FG001|Overall Study|Patient had no transport|0|||
44560599|NCT03000348|79578625|FG002|Overall Study|Patient had no transport|0|||
44560600|NCT03000348|79578626|FG003|Overall Study|Patient had no transport|1|||
44560601|NCT03000348|79578627|FG004|Overall Study|Patient had no transport|0|||
44560602|NCT03000348|79578628|FG005|Overall Study|Patient had no transport|0|||
44560603|NCT03000348|79578623|FG000|Overall Study|Dosing|0|||
44560604|NCT03000348|79578624|FG001|Overall Study|Dosing|0|||
44560605|NCT03000348|79578625|FG002|Overall Study|Dosing|0|||
44560606|NCT03000348|79578626|FG003|Overall Study|Dosing|0|||
44560607|NCT03000348|79578627|FG004|Overall Study|Dosing|1|||
44560608|NCT03000348|79578628|FG005|Overall Study|Dosing|0|||
44560609|NCT03283709|79578647|FG000|Overall Study|trial terminated|0|||
44560610|NCT03283709|79578648|FG001|Overall Study|trial terminated|1|||
44560611|NCT03247673|79578657|FG000|Overall Study|Withdrawal by Subject|1|||
44560612|NCT03247673|79578658|FG001|Overall Study|Withdrawal by Subject|0|||
44560613|NCT03247673|79578659|FG002|Overall Study|Withdrawal by Subject|3|||
44560614|NCT03247673|79578657|FG000|Overall Study|Lost to Follow-up|0|||
44560615|NCT03247673|79578658|FG001|Overall Study|Lost to Follow-up|0|||
44560616|NCT03247673|79578659|FG002|Overall Study|Lost to Follow-up|1|||
44499475|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
44499476|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
44499477|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
44499478|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
44499479|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
44499480|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
44499481|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
44560617|NCT03247517|79578670|FG000|Overall Study|Adverse Event|0|||
44560618|NCT03247517|79578671|FG001|Overall Study|Adverse Event|4|||
44560619|NCT03247517|79578672|FG002|Overall Study|Adverse Event|2|||
44376912|NCT00900159|79382204|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
44560620|NCT03247517|79578670|FG000|Overall Study|Lost to Follow-up|2|||
44560621|NCT03247517|79578671|FG001|Overall Study|Lost to Follow-up|6|||
44560622|NCT03247517|79578672|FG002|Overall Study|Lost to Follow-up|4|||
44560623|NCT03247517|79578670|FG000|Overall Study|Consent withdrawn by caregiver|1|||
44560624|NCT03247517|79578671|FG001|Overall Study|Consent withdrawn by caregiver|4|||
44560625|NCT03247517|79578672|FG002|Overall Study|Consent withdrawn by caregiver|7|||
44560626|NCT03247517|79578670|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
44232900|NCT01817777|79050304|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
44499482|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
44499483|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
44499484|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
44499485|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
44499486|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
44499487|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
44499488|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
44499489|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
44499490|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
44499491|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
44499492|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
44499493|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
44499494|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
44499495|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
44499496|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
44499497|NCT03605680|79504124|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
44499498|NCT03605680|79504125|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
44499499|NCT03605680|79504126|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
44499500|NCT03605680|79504127|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
44499501|NCT03572218|79504138|FG000|Overall Study|Lost to Follow-up|3|||
44499502|NCT03572218|79504139|FG001|Overall Study|Lost to Follow-up|2|||
44499503|NCT03572218|79504138|FG000|Overall Study|No longer available for study visits|2|||
44499504|NCT03572218|79504139|FG001|Overall Study|No longer available for study visits|1|||
44499505|NCT03572218|79504138|FG000|Overall Study|No longer interested|1|||
44499506|NCT03572218|79504139|FG001|Overall Study|No longer interested|2|||
44499507|NCT00111813|79504145|FG000|Overall Study|Adverse Event|1|||
44499508|NCT00111813|79504146|FG001|Overall Study|Adverse Event|2|||
44499509|NCT00111813|79504147|FG002|Overall Study|Adverse Event|4|||
44499510|NCT00111813|79504148|FG003|Overall Study|Adverse Event|2|||
44499511|NCT00111813|79504149|FG004|Overall Study|Adverse Event|2|||
44499512|NCT00111813|79504150|FG005|Overall Study|Adverse Event|2|||
44499513|NCT00111813|79504145|FG000|Overall Study|Progressive disease|2|||
44499514|NCT00111813|79504146|FG001|Overall Study|Progressive disease|1|||
44499515|NCT00111813|79504147|FG002|Overall Study|Progressive disease|5|||
44499516|NCT00111813|79504148|FG003|Overall Study|Progressive disease|3|||
44499517|NCT00111813|79504149|FG004|Overall Study|Progressive disease|4|||
44499518|NCT00111813|79504150|FG005|Overall Study|Progressive disease|3|||
44499519|NCT00111813|79504145|FG000|Overall Study|Lack of Efficacy|0|||
44499520|NCT00111813|79504146|FG001|Overall Study|Lack of Efficacy|0|||
44499521|NCT00111813|79504147|FG002|Overall Study|Lack of Efficacy|0|||
44499522|NCT00111813|79504148|FG003|Overall Study|Lack of Efficacy|0|||
44499523|NCT00111813|79504149|FG004|Overall Study|Lack of Efficacy|0|||
44499524|NCT00111813|79504150|FG005|Overall Study|Lack of Efficacy|1|||
44499525|NCT00111813|79504145|FG000|Overall Study|Other|0|||
44499526|NCT00111813|79504146|FG001|Overall Study|Other|0|||
44499527|NCT00111813|79504147|FG002|Overall Study|Other|1|||
44499528|NCT00111813|79504148|FG003|Overall Study|Other|0|||
44499529|NCT00111813|79504149|FG004|Overall Study|Other|0|||
44499530|NCT00111813|79504150|FG005|Overall Study|Other|0|||
44499531|NCT00118287|79504165|FG000|Overall Study|Intracranial haemorrhage|1|||
44499532|NCT00118287|79504165|FG000|Overall Study|Muscle pain|1|||
44499533|NCT00130689|79504169|FG000|Overall Study|Progressive Disease|29|||
44499534|NCT00130689|79504169|FG000|Overall Study|Death|1|||
44499535|NCT00130689|79504169|FG000|Overall Study|Clinical Deterioration|4|||
44499536|NCT00130689|79504169|FG000|Overall Study|Withdrawal by Subject|3|||
44499537|NCT00130689|79504169|FG000|Overall Study|Ineligible|6|||
44499538|NCT03605212|79504178|FG000|Treatment Period|Adverse Event|1|||
44499539|NCT03605212|79504179|FG001|Treatment Period|Adverse Event|0|||
44499540|NCT03605212|79504180|FG002|Treatment Period|Adverse Event|0|||
44499541|NCT03605212|79504181|FG003|Treatment Period|Adverse Event|0|||
44499542|NCT03605212|79504182|FG004|Treatment Period|Adverse Event|0|||
44499543|NCT03605212|79504178|FG000|Treatment Period|Physician Decision|0|||
44499544|NCT03605212|79504179|FG001|Treatment Period|Physician Decision|0|||
44499545|NCT03605212|79504180|FG002|Treatment Period|Physician Decision|0|||
44499546|NCT03605212|79504181|FG003|Treatment Period|Physician Decision|0|||
44499547|NCT03605212|79504182|FG004|Treatment Period|Physician Decision|1|||
44560627|NCT03247517|79578671|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
44560628|NCT03247517|79578672|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
44560629|NCT03247517|79578670|FG000|Overall Study|Protocol Violation|0|||
44560630|NCT03247517|79578671|FG001|Overall Study|Protocol Violation|2|||
44560631|NCT03247517|79578672|FG002|Overall Study|Protocol Violation|0|||
44560632|NCT03247517|79578670|FG000|Overall Study|Multiple reasons|3|||
44560633|NCT03247517|79578671|FG001|Overall Study|Multiple reasons|1|||
44560634|NCT03247517|79578672|FG002|Overall Study|Multiple reasons|0|||
44560635|NCT03283553|79578682|FG000|Patient Participant Flow|Death|5|||
44560636|NCT03283553|79578683|FG001|Patient Participant Flow|Death|10|||
44560637|NCT03283553|79578682|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
44560638|NCT03283553|79578683|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
44560639|NCT03283553|79578682|FG000|Patient Participant Flow|Lost to Follow-up|1|||
44560640|NCT03283553|79578683|FG001|Patient Participant Flow|Lost to Follow-up|1|||
44560641|NCT03283553|79578682|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
44560642|NCT03283553|79578683|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
44560643|NCT03283553|79578682|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
44560644|NCT03283553|79578683|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
44560645|NCT03283553|79578682|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
44560646|NCT03283553|79578683|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
44560647|NCT03283319|79578697|FG000|Overall Study|Lost to Follow-up|5|||
44560648|NCT03283319|79578698|FG001|Overall Study|Lost to Follow-up|4|||
44560649|NCT03283319|79578699|FG002|Overall Study|Lost to Follow-up|5|||
44560650|NCT03283319|79578700|FG003|Overall Study|Lost to Follow-up|5|||
44560651|NCT03283319|79578701|FG004|Overall Study|Lost to Follow-up|4|||
44560652|NCT03283319|79578702|FG005|Overall Study|Lost to Follow-up|3|||
44560653|NCT03283319|79578697|FG000|Overall Study|Withdrawal by Subject|2|||
44560654|NCT03283319|79578698|FG001|Overall Study|Withdrawal by Subject|2|||
44560655|NCT03283319|79578699|FG002|Overall Study|Withdrawal by Subject|2|||
44560656|NCT03283319|79578700|FG003|Overall Study|Withdrawal by Subject|1|||
44560657|NCT03283319|79578701|FG004|Overall Study|Withdrawal by Subject|0|||
44560658|NCT03283319|79578702|FG005|Overall Study|Withdrawal by Subject|1|||
44560659|NCT03283319|79578697|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
44560660|NCT03283319|79578698|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
44499548|NCT03603652|79504195|FG000|Overall Study|Death|2|||
44499549|NCT00117507|79504199|FG000|Overall Study|Adverse Event|4|||
44499550|NCT00117507|79504199|FG000|Overall Study|Abnormal laboratory values|3|||
44499551|NCT00117507|79504199|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44499552|NCT00117507|79504199|FG000|Overall Study|Patient withdrew consent|4|||
44499553|NCT00117507|79504199|FG000|Overall Study|Death|3|||
44499554|NCT03603496|79504206|FG000|Overall Study|Death|19|||
44499555|NCT03603496|79504207|FG001|Overall Study|Death|24|||
44499556|NCT03603496|79504206|FG000|Overall Study|Lost to Follow-up|141|||
44499557|NCT03603496|79504207|FG001|Overall Study|Lost to Follow-up|141|||
44499558|NCT03603496|79504206|FG000|Overall Study|Withdrawal by Subject|26|||
44499559|NCT03603496|79504207|FG001|Overall Study|Withdrawal by Subject|20|||
44499560|NCT03603028|79504213|FG000|Overall Study|Withdrawal by Subject|1|||
44499561|NCT03602482|79504219|FG000|Overall Study|Withdrawal by Subject|6|||
44499562|NCT03602482|79504220|FG001|Overall Study|Withdrawal by Subject|7|||
44499563|NCT03602482|79504221|FG002|Overall Study|Withdrawal by Subject|0|||
44499564|NCT03602482|79504222|FG003|Overall Study|Withdrawal by Subject|0|||
44499565|NCT00096135|79504237|FG000|Overall Study|Physician Decision|20|||
44499566|NCT00096135|79504238|FG001|Overall Study|Physician Decision|4|||
44499567|NCT00096135|79504237|FG000|Overall Study|Refusal of further protocol therapy|4|||
44499568|NCT00096135|79504238|FG001|Overall Study|Refusal of further protocol therapy|1|||
44499569|NCT00096135|79504237|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
44499570|NCT00096135|79504238|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
44499571|NCT00096135|79504237|FG000|Overall Study|Other, specify|15|||
44499572|NCT00096135|79504238|FG001|Overall Study|Other, specify|3|||
44499573|NCT00096135|79504237|FG000|Overall Study|Ineligible|2|||
44499574|NCT00096135|79504238|FG001|Overall Study|Ineligible|0|||
44499575|NCT00116805|79504246|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
44499576|NCT00116805|79504247|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
44560661|NCT03283319|79578699|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
44560662|NCT03283319|79578700|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
44499577|NCT00116805|79504246|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
44499578|NCT00116805|79504247|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
44499579|NCT00116805|79504246|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
44499580|NCT00116805|79504247|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
44560663|NCT03283319|79578701|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
44376913|NCT00900159|79382205|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
44376914|NCT00854308|79382224|FG000|Overall Study|Disease progression|42|||
44499581|NCT00116805|79504246|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
44560664|NCT03283319|79578702|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
44560665|NCT03282227|79578716|FG000|Overall Study|Exposure Goals Achieved|60|||
44560666|NCT03282227|79578716|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
44560667|NCT03282227|79578716|FG000|Overall Study|Adverse Event|15|||
44560668|NCT03282227|79578716|FG000|Overall Study|Lost to Follow-up|21|||
44560669|NCT03282227|79578716|FG000|Overall Study|Withdrawal by Subject|20|||
44560670|NCT03282227|79578716|FG000|Overall Study|Lack of Efficacy|12|||
44560671|NCT03282227|79578716|FG000|Overall Study|Sponsor decision|3|||
44499582|NCT00116805|79504247|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
44499583|NCT00116805|79504246|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
44560672|NCT03282227|79578716|FG000|Overall Study|Physician Decision|2|||
44560673|NCT03282227|79578716|FG000|Overall Study|Pregnancy|2|||
44560674|NCT03282227|79578716|FG000|Overall Study|Other|1|||
44560675|NCT03240575|79578724|FG000|Overall Study|Adverse Event|0|||
44560676|NCT03240575|79578725|FG001|Overall Study|Adverse Event|2|||
44560677|NCT03240575|79578726|FG002|Overall Study|Adverse Event|0|||
44560678|NCT03240575|79578727|FG003|Overall Study|Adverse Event|1|||
44560679|NCT03240575|79578724|FG000|Overall Study|Withdrawal by Subject|2|||
44560680|NCT03240575|79578725|FG001|Overall Study|Withdrawal by Subject|11|||
44560681|NCT03240575|79578726|FG002|Overall Study|Withdrawal by Subject|0|||
44560682|NCT03240575|79578727|FG003|Overall Study|Withdrawal by Subject|1|||
44560683|NCT03240575|79578724|FG000|Overall Study|Other|0|||
44560684|NCT03240575|79578725|FG001|Overall Study|Other|1|||
44560685|NCT03240575|79578726|FG002|Overall Study|Other|0|||
44560686|NCT03240575|79578727|FG003|Overall Study|Other|0|||
44560687|NCT03385265|79578739|FG000|Overall Study|Withdrawal by Subject|5|||
44560688|NCT03385265|79578740|FG001|Overall Study|Withdrawal by Subject|2|||
44499584|NCT00116805|79504247|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
44499585|NCT00116805|79504246|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
44499586|NCT00116805|79504247|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
44499587|NCT00116805|79504246|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
44499588|NCT00116805|79504247|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
44499589|NCT00116805|79504246|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
44499590|NCT00116805|79504247|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
44499591|NCT00116805|79504246|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
44499592|NCT00116805|79504247|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
44499593|NCT00116805|79504246|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
44499594|NCT00116805|79504247|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
44499595|NCT00116805|79504246|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
44499596|NCT00116805|79504247|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
44499597|NCT00116805|79504246|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
44499598|NCT00116805|79504247|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
44499599|NCT00116805|79504246|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
44499600|NCT00116805|79504247|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
44499601|NCT00116805|79504246|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
44499602|NCT00116805|79504247|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
44499603|NCT00116805|79504246|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
44560689|NCT03385265|79578741|FG002|Overall Study|Withdrawal by Subject|5|||
44560690|NCT03385265|79578742|FG003|Overall Study|Withdrawal by Subject|2|||
44560691|NCT03280121|79578754|FG000|Overall Study|Physician Decision|1|||
44560692|NCT03280121|79578754|FG000|Overall Study|Lost to Follow-up|1|||
44499604|NCT00116805|79504247|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
44560693|NCT03280121|79578754|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
44560694|NCT03233009|79578758|FG000|Overall Study|Lost to Follow-up|1|||
44376915|NCT00854308|79382225|FG001|Overall Study|Disease progression|50|||
44376916|NCT00854308|79382224|FG000|Overall Study|Adverse Event|8|||
44376917|NCT00854308|79382225|FG001|Overall Study|Adverse Event|3|||
44376918|NCT00854308|79382224|FG000|Overall Study|Death|2|||
44376919|NCT00854308|79382225|FG001|Overall Study|Death|5|||
44376920|NCT00854308|79382224|FG000|Overall Study|Physician Decision|6|||
44376921|NCT00854308|79382225|FG001|Overall Study|Physician Decision|6|||
44376922|NCT00854308|79382224|FG000|Overall Study|Withdrawal by Subject|4|||
44376923|NCT00854308|79382225|FG001|Overall Study|Withdrawal by Subject|2|||
44376924|NCT00854308|79382224|FG000|Overall Study|Sponsor's decision to terminate study|0|||
44376925|NCT00854308|79382225|FG001|Overall Study|Sponsor's decision to terminate study|1|||
44376926|NCT00592852|79382231|FG000|Overall Study|Non-compliance|1|||
44376927|NCT00592852|79382231|FG000|Overall Study|Adverse Event|3|||
44376928|NCT00592852|79382231|FG000|Overall Study|Found ineligible|1|||
44376929|NCT00592852|79382231|FG000|Overall Study|Withdrawal by Subject|1|||
44376930|NCT00895245|79382235|FG000|Overall Study|Lack of Efficacy|6|||
44499605|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
44499606|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
44499607|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
44499608|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
44499609|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
44499610|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
44560695|NCT04034225|79578773|FG000|Overall Study|Death|3|||
44560696|NCT04034225|79578773|FG000|Overall Study|Withdrawal by Subject|2|||
44560697|NCT04034225|79578773|FG000|Overall Study|Study termination by Sponsor|18|||
44560698|NCT04034225|79578773|FG000|Overall Study|Physician Decision|1|||
44560699|NCT04034225|79578773|FG000|Overall Study|Lack of Efficacy|1|||
44560700|NCT02999178|79578781|FG000|Overall Study|Adverse Event|85|||
44560701|NCT02999178|79578782|FG001|Overall Study|Adverse Event|62|||
44560702|NCT02999178|79578781|FG000|Overall Study|Protocol Violation|1|||
44499611|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
44499612|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
44499613|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
44499614|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
44499615|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
44499616|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
44499617|NCT00116805|79504246|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
44499618|NCT00116805|79504247|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
44499619|NCT00116805|79504246|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
44499620|NCT00116805|79504247|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
44499621|NCT00116805|79504246|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
44499622|NCT00116805|79504247|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
44499623|NCT00116805|79504246|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
44499624|NCT00116805|79504247|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
44499625|NCT00116805|79504246|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
44499626|NCT00116805|79504247|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
44499627|NCT00116805|79504246|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
44499628|NCT00116805|79504247|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
44499629|NCT00116805|79504246|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
44499630|NCT00116805|79504247|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
44499631|NCT00116805|79504246|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
44499632|NCT00116805|79504247|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
44499633|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
44499634|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
44499635|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
44560703|NCT02999178|79578782|FG001|Overall Study|Protocol Violation|2|||
44560704|NCT02999178|79578781|FG000|Overall Study|Lost to Follow-up|0|||
44560705|NCT02999178|79578782|FG001|Overall Study|Lost to Follow-up|2|||
44232901|NCT01817777|79050302|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
44376931|NCT00865306|79382241|FG000|Controlled Trial|Lost to Follow-up|1|||
44376932|NCT00865306|79382242|FG001|Controlled Trial|Lost to Follow-up|1|||
44499636|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
44499637|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
44560706|NCT02999178|79578781|FG000|Overall Study|Withdrawal by Subject|21|||
44560707|NCT02999178|79578782|FG001|Overall Study|Withdrawal by Subject|21|||
44376933|NCT00865306|79382241|FG000|Controlled Trial|Difficulty commuting|2|||
44560708|NCT02999178|79578781|FG000|Overall Study|Other reason not defined above|7|||
44560709|NCT02999178|79578782|FG001|Overall Study|Other reason not defined above|13|||
44560710|NCT02959190|79578794|FG000|Open Label|Adverse Event|5|||
44560711|NCT02959190|79578795|FG001|Open Label|Adverse Event|7|||
44560712|NCT02959190|79578796|FG002|Open Label|Adverse Event|3|||
44560713|NCT02959190|79578797|FG003|Open Label|Adverse Event|4|||
44560714|NCT02959190|79578794|FG000|Open Label|Pregnancy|0|||
44560715|NCT02959190|79578795|FG001|Open Label|Pregnancy|1|||
44560716|NCT02959190|79578796|FG002|Open Label|Pregnancy|0|||
44560717|NCT02959190|79578797|FG003|Open Label|Pregnancy|0|||
44560718|NCT02959190|79578794|FG000|Open Label|Withdrawal by Subject|2|||
44560719|NCT02959190|79578795|FG001|Open Label|Withdrawal by Subject|8|||
44560720|NCT02959190|79578796|FG002|Open Label|Withdrawal by Subject|0|||
44560721|NCT02959190|79578797|FG003|Open Label|Withdrawal by Subject|0|||
44560722|NCT02959190|79578794|FG000|Open Label|Physician Decision|0|||
44560723|NCT02959190|79578795|FG001|Open Label|Physician Decision|0|||
44560724|NCT02959190|79578796|FG002|Open Label|Physician Decision|1|||
44560725|NCT02959190|79578797|FG003|Open Label|Physician Decision|0|||
44560726|NCT02959190|79578794|FG000|Open Label|Protocol Violation|0|||
44560727|NCT02959190|79578795|FG001|Open Label|Protocol Violation|0|||
44560728|NCT02959190|79578796|FG002|Open Label|Protocol Violation|0|||
44560729|NCT02959190|79578797|FG003|Open Label|Protocol Violation|2|||
44560730|NCT02959190|79578794|FG000|Post Treatment Follow Up|Adverse Event|1|||
44560731|NCT02959190|79578795|FG001|Post Treatment Follow Up|Adverse Event|1|||
44560732|NCT02959190|79578796|FG002|Post Treatment Follow Up|Adverse Event|0|||
44560733|NCT02959190|79578797|FG003|Post Treatment Follow Up|Adverse Event|0|||
44560734|NCT02959190|79578794|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
44560735|NCT02959190|79578795|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
44560736|NCT02959190|79578796|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
44560737|NCT02959190|79578797|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
44560738|NCT01344356|79578818|FG000|Overall Study|Physician Decision|0|||
44560739|NCT01344356|79578819|FG001|Overall Study|Physician Decision|3|||
44560740|NCT01344356|79578818|FG000|Overall Study|Lost to Follow-up|0|||
44560741|NCT01344356|79578819|FG001|Overall Study|Lost to Follow-up|6|||
44560742|NCT02956460|79578845|FG000|Lens 1|Lost to Follow-up|1|||
44499638|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
44499639|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
44499640|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
44499641|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
44499642|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
44499643|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
44499644|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
44499645|NCT00116805|79504246|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
44499646|NCT00116805|79504247|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
44560743|NCT02956460|79578846|FG001|Lens 1|Lost to Follow-up|0|||
44560744|NCT02999100|79578858|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
44560745|NCT02999100|79578859|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
44275316|NCT02237196|79221795|FG002|Overall Study|Pregnancy|1|||
44499647|NCT00116805|79504246|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
44560746|NCT02999100|79578860|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
44560747|NCT02999100|79578861|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
44560748|NCT02999100|79578862|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
44499648|NCT00116805|79504247|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
44560749|NCT02999100|79578863|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
44560750|NCT02999100|79578858|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
44560751|NCT02999100|79578859|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
44560752|NCT02999100|79578860|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
44560753|NCT02999100|79578861|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
44560754|NCT02999100|79578862|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
44560755|NCT02999100|79578863|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
44560756|NCT02999100|79578858|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
44560757|NCT02999100|79578859|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
44560758|NCT02999100|79578860|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
44560759|NCT02999100|79578861|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
44560760|NCT02999100|79578862|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
44560761|NCT02999100|79578863|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
44560762|NCT02749370|79578885|FG000|Overall Study|Withdrawal by Subject|11|||
44560763|NCT02749370|79578885|FG000|Overall Study|Lost to Follow-up|3|||
44560764|NCT03607994|79578891|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
44560765|NCT03607994|79578892|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
44560766|NCT02996682|79578900|FG000|Overall Study|Death|0|||
44560767|NCT02996682|79578901|FG001|Overall Study|Death|3|||
44560768|NCT02873702|79578909|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
44560769|NCT02873702|79578910|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
44560770|NCT02873702|79578911|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
44560771|NCT02873702|79578912|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
44560772|NCT02873702|79578909|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
44560773|NCT02873702|79578910|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
44560774|NCT02873702|79578911|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
44560775|NCT02873702|79578912|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
44560776|NCT02873702|79578909|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
44232902|NCT01817777|79050303|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
44232903|NCT01817777|79050304|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
44232904|NCT01817777|79050302|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
44232905|NCT01817777|79050303|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
44232906|NCT01817777|79050304|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
44232907|NCT01817777|79050302|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
44560777|NCT02873702|79578910|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
44560778|NCT02873702|79578911|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
44560779|NCT02873702|79578912|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
44560780|NCT02873702|79578909|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
44560781|NCT02873702|79578910|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
44560782|NCT02873702|79578911|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
44560783|NCT02873702|79578912|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
44560784|NCT02873702|79578909|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
44560785|NCT02873702|79578910|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
44560786|NCT02873702|79578911|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
44560787|NCT02873702|79578912|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
44560788|NCT02911116|79578924|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44560789|NCT02911116|79578925|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44560790|NCT02911116|79578924|FG000|Overall Study|Lost to Follow-up|0|||
44560791|NCT02911116|79578925|FG001|Overall Study|Lost to Follow-up|1|||
44560792|NCT02998554|79578933|FG000|Overall Study|Adverse Event|8|||
44560793|NCT02998554|79578934|FG001|Overall Study|Adverse Event|3|||
44560794|NCT02998554|79578933|FG000|Overall Study|Protocol deviation|1|||
44560795|NCT02998554|79578934|FG001|Overall Study|Protocol deviation|0|||
44560796|NCT02998554|79578933|FG000|Overall Study|Withdrawal by Subject|2|||
44560797|NCT02998554|79578934|FG001|Overall Study|Withdrawal by Subject|6|||
44560798|NCT02998554|79578933|FG000|Overall Study|Lost to Follow-up|0|||
44560799|NCT02998554|79578934|FG001|Overall Study|Lost to Follow-up|1|||
44560800|NCT02998554|79578933|FG000|Overall Study|Lack of Efficacy|0|||
44560801|NCT02998554|79578934|FG001|Overall Study|Lack of Efficacy|1|||
44560802|NCT02996448|79578942|FG000|Overall Study|Study terminated due to adverse effects|3|||
44560803|NCT02995980|79578947|FG000|Overall Study|Lost to Follow-up|14|||
44560804|NCT02872142|79578952|FG000|Overall Study|Adverse Event|2|||
44560805|NCT02872142|79578952|FG000|Overall Study|Death|1|||
44560806|NCT02872142|79578952|FG000|Overall Study|Participant Decision|3|||
44560807|NCT02994654|79578956|FG000|Overall Study|Lost to Follow-up|1|||
44560808|NCT02870972|79578966|FG000|Overall Study|Adverse Event|1|||
44560809|NCT02870972|79578967|FG001|Overall Study|Adverse Event|0|||
44560810|NCT02870972|79578968|FG002|Overall Study|Adverse Event|0|||
44560811|NCT02870972|79578969|FG003|Overall Study|Adverse Event|0|||
44560812|NCT02870972|79578970|FG004|Overall Study|Adverse Event|0|||
44560813|NCT03214367|79578990|FG000|Lead-in Period|Withdrawal by Subject|50|||
44560814|NCT03214367|79578991|FG001|Lead-in Period|Withdrawal by Subject|0|||
44560815|NCT03214367|79578992|FG002|Lead-in Period|Withdrawal by Subject|0|||
44560816|NCT03214367|79578993|FG003|Lead-in Period|Withdrawal by Subject|0|||
44560817|NCT03214367|79578994|FG004|Lead-in Period|Withdrawal by Subject|2|||
44560818|NCT03214367|79578995|FG005|Lead-in Period|Withdrawal by Subject|0|||
44560819|NCT03214367|79578996|FG006|Lead-in Period|Withdrawal by Subject|0|||
44560820|NCT03214367|79578997|FG007|Lead-in Period|Withdrawal by Subject|0|||
44560821|NCT03214367|79578990|FG000|Lead-in Period|Adverse Event|3|||
44560822|NCT03214367|79578991|FG001|Lead-in Period|Adverse Event|0|||
44560823|NCT03214367|79578992|FG002|Lead-in Period|Adverse Event|0|||
44560824|NCT03214367|79578993|FG003|Lead-in Period|Adverse Event|0|||
44560825|NCT03214367|79578994|FG004|Lead-in Period|Adverse Event|0|||
44560826|NCT03214367|79578995|FG005|Lead-in Period|Adverse Event|0|||
44560827|NCT03214367|79578996|FG006|Lead-in Period|Adverse Event|0|||
44560828|NCT03214367|79578997|FG007|Lead-in Period|Adverse Event|0|||
44560829|NCT03214367|79578990|FG000|Lead-in Period|Lost to Follow-up|12|||
44560830|NCT03214367|79578991|FG001|Lead-in Period|Lost to Follow-up|0|||
44560831|NCT03214367|79578992|FG002|Lead-in Period|Lost to Follow-up|0|||
44560832|NCT03214367|79578993|FG003|Lead-in Period|Lost to Follow-up|0|||
44560833|NCT03214367|79578994|FG004|Lead-in Period|Lost to Follow-up|0|||
44560834|NCT03214367|79578995|FG005|Lead-in Period|Lost to Follow-up|0|||
44560835|NCT03214367|79578996|FG006|Lead-in Period|Lost to Follow-up|0|||
44560836|NCT03214367|79578997|FG007|Lead-in Period|Lost to Follow-up|0|||
44560837|NCT03214367|79578990|FG000|Lead-in Period|Sponsor Decision|11|||
44560838|NCT03214367|79578991|FG001|Lead-in Period|Sponsor Decision|0|||
44560839|NCT03214367|79578992|FG002|Lead-in Period|Sponsor Decision|0|||
44560840|NCT03214367|79578993|FG003|Lead-in Period|Sponsor Decision|0|||
44560841|NCT03214367|79578994|FG004|Lead-in Period|Sponsor Decision|0|||
44560842|NCT03214367|79578995|FG005|Lead-in Period|Sponsor Decision|0|||
44560843|NCT03214367|79578996|FG006|Lead-in Period|Sponsor Decision|0|||
44560844|NCT03214367|79578997|FG007|Lead-in Period|Sponsor Decision|0|||
44560845|NCT03214367|79578990|FG000|Lead-in Period|Physician Decision|12|||
44560846|NCT03214367|79578991|FG001|Lead-in Period|Physician Decision|0|||
44376934|NCT00865306|79382242|FG001|Controlled Trial|Difficulty commuting|0|||
44376935|NCT00865306|79382241|FG000|Controlled Trial|Improved btw baseline and first session|1|||
44560847|NCT03214367|79578992|FG002|Lead-in Period|Physician Decision|0|||
44560848|NCT03214367|79578993|FG003|Lead-in Period|Physician Decision|0|||
44560849|NCT03214367|79578994|FG004|Lead-in Period|Physician Decision|0|||
44560850|NCT03214367|79578995|FG005|Lead-in Period|Physician Decision|0|||
44560851|NCT03214367|79578996|FG006|Lead-in Period|Physician Decision|0|||
44560852|NCT03214367|79578997|FG007|Lead-in Period|Physician Decision|0|||
44560853|NCT03214367|79578990|FG000|Lead-in Period|Protocol Violation|5|||
44560854|NCT03214367|79578991|FG001|Lead-in Period|Protocol Violation|0|||
44560855|NCT03214367|79578992|FG002|Lead-in Period|Protocol Violation|0|||
44560856|NCT03214367|79578993|FG003|Lead-in Period|Protocol Violation|0|||
44560857|NCT03214367|79578994|FG004|Lead-in Period|Protocol Violation|0|||
44560858|NCT03214367|79578995|FG005|Lead-in Period|Protocol Violation|0|||
44560859|NCT03214367|79578996|FG006|Lead-in Period|Protocol Violation|0|||
44560860|NCT03214367|79578997|FG007|Lead-in Period|Protocol Violation|0|||
44560861|NCT03214367|79578990|FG000|Lead-in Period|Treatment Interruption|1|||
44560862|NCT03214367|79578991|FG001|Lead-in Period|Treatment Interruption|0|||
44560863|NCT03214367|79578992|FG002|Lead-in Period|Treatment Interruption|0|||
44560864|NCT03214367|79578993|FG003|Lead-in Period|Treatment Interruption|0|||
44560865|NCT03214367|79578994|FG004|Lead-in Period|Treatment Interruption|0|||
44560866|NCT03214367|79578995|FG005|Lead-in Period|Treatment Interruption|0|||
44560867|NCT03214367|79578996|FG006|Lead-in Period|Treatment Interruption|0|||
44560868|NCT03214367|79578997|FG007|Lead-in Period|Treatment Interruption|0|||
44560869|NCT03214367|79578990|FG000|Treatment Period|Adverse Event|0|||
44560870|NCT03214367|79578991|FG001|Treatment Period|Adverse Event|1|||
44560871|NCT03214367|79578992|FG002|Treatment Period|Adverse Event|4|||
44560872|NCT03214367|79578993|FG003|Treatment Period|Adverse Event|2|||
44560873|NCT03214367|79578994|FG004|Treatment Period|Adverse Event|0|||
44560874|NCT03214367|79578995|FG005|Treatment Period|Adverse Event|0|||
44560875|NCT03214367|79578996|FG006|Treatment Period|Adverse Event|0|||
44560876|NCT03214367|79578997|FG007|Treatment Period|Adverse Event|0|||
44560877|NCT03214367|79578990|FG000|Treatment Period|Death|0|||
44560878|NCT03214367|79578991|FG001|Treatment Period|Death|1|||
44560879|NCT03214367|79578992|FG002|Treatment Period|Death|1|||
44560880|NCT03214367|79578993|FG003|Treatment Period|Death|1|||
44560881|NCT03214367|79578994|FG004|Treatment Period|Death|0|||
44560882|NCT03214367|79578995|FG005|Treatment Period|Death|0|||
44560883|NCT03214367|79578996|FG006|Treatment Period|Death|0|||
44560884|NCT03214367|79578997|FG007|Treatment Period|Death|0|||
44560885|NCT03214367|79578990|FG000|Treatment Period|Lost to Follow-up|0|||
44232908|NCT01817777|79050303|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
44560886|NCT03214367|79578991|FG001|Treatment Period|Lost to Follow-up|5|||
44560887|NCT03214367|79578992|FG002|Treatment Period|Lost to Follow-up|3|||
44560888|NCT03214367|79578993|FG003|Treatment Period|Lost to Follow-up|2|||
44560889|NCT03214367|79578994|FG004|Treatment Period|Lost to Follow-up|0|||
44560890|NCT03214367|79578995|FG005|Treatment Period|Lost to Follow-up|2|||
44560891|NCT03214367|79578996|FG006|Treatment Period|Lost to Follow-up|1|||
44232909|NCT01817777|79050304|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
44232910|NCT01795547|79050330|FG000|Overall Study|Adverse Event|16|||
44232911|NCT01795547|79050331|FG001|Overall Study|Adverse Event|27|||
44560892|NCT03214367|79578997|FG007|Treatment Period|Lost to Follow-up|0|||
44560893|NCT03214367|79578990|FG000|Treatment Period|Sponsor Decision|0|||
44560894|NCT03214367|79578991|FG001|Treatment Period|Sponsor Decision|3|||
44560895|NCT03214367|79578992|FG002|Treatment Period|Sponsor Decision|0|||
44560896|NCT03214367|79578993|FG003|Treatment Period|Sponsor Decision|0|||
44560897|NCT03214367|79578994|FG004|Treatment Period|Sponsor Decision|0|||
44560898|NCT03214367|79578995|FG005|Treatment Period|Sponsor Decision|0|||
44560899|NCT03214367|79578996|FG006|Treatment Period|Sponsor Decision|0|||
44560900|NCT03214367|79578997|FG007|Treatment Period|Sponsor Decision|0|||
44560901|NCT03214367|79578990|FG000|Treatment Period|Physician Decision|0|||
44560902|NCT03214367|79578991|FG001|Treatment Period|Physician Decision|1|||
44560903|NCT03214367|79578992|FG002|Treatment Period|Physician Decision|2|||
44560904|NCT03214367|79578993|FG003|Treatment Period|Physician Decision|0|||
44560905|NCT03214367|79578994|FG004|Treatment Period|Physician Decision|0|||
44560906|NCT03214367|79578995|FG005|Treatment Period|Physician Decision|0|||
44560907|NCT03214367|79578996|FG006|Treatment Period|Physician Decision|0|||
44560908|NCT03214367|79578997|FG007|Treatment Period|Physician Decision|0|||
44560909|NCT03214367|79578990|FG000|Treatment Period|Protocol Violation|0|||
44560910|NCT03214367|79578991|FG001|Treatment Period|Protocol Violation|3|||
44560911|NCT03214367|79578992|FG002|Treatment Period|Protocol Violation|0|||
44560912|NCT03214367|79578993|FG003|Treatment Period|Protocol Violation|0|||
44560913|NCT03214367|79578994|FG004|Treatment Period|Protocol Violation|0|||
44560914|NCT03214367|79578995|FG005|Treatment Period|Protocol Violation|0|||
44560915|NCT03214367|79578996|FG006|Treatment Period|Protocol Violation|0|||
44560916|NCT03214367|79578997|FG007|Treatment Period|Protocol Violation|0|||
44560917|NCT03214367|79578990|FG000|Treatment Period|Withdrawal by Subject|0|||
44560918|NCT03214367|79578991|FG001|Treatment Period|Withdrawal by Subject|20|||
44560919|NCT03214367|79578992|FG002|Treatment Period|Withdrawal by Subject|23|||
44560920|NCT03214367|79578993|FG003|Treatment Period|Withdrawal by Subject|14|||
44560921|NCT03214367|79578994|FG004|Treatment Period|Withdrawal by Subject|0|||
44560922|NCT03214367|79578995|FG005|Treatment Period|Withdrawal by Subject|1|||
44560923|NCT03214367|79578996|FG006|Treatment Period|Withdrawal by Subject|1|||
44560924|NCT03214367|79578997|FG007|Treatment Period|Withdrawal by Subject|1|||
44560925|NCT02994108|79579013|FG000|Intervention Messages|Withdrawal by Subject|2|||
44560926|NCT02994108|79579014|FG001|Intervention Messages|Withdrawal by Subject|0|||
44560927|NCT02994108|79579013|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
44560928|NCT02994108|79579014|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
44560929|NCT02994108|79579013|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
44499649|NCT00116805|79504246|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
44499650|NCT00116805|79504247|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
44499651|NCT00116805|79504246|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
44499652|NCT00116805|79504247|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
44499653|NCT00116805|79504246|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
44499654|NCT00116805|79504247|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
44499655|NCT00116805|79504246|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
44499656|NCT00116805|79504247|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
44499657|NCT00116805|79504246|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
44499658|NCT00116805|79504247|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
44499659|NCT00116805|79504246|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
44499660|NCT00116805|79504247|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
44499661|NCT00116805|79504246|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
44499662|NCT00116805|79504247|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
44499663|NCT00116805|79504246|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
44499664|NCT00116805|79504247|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
44499665|NCT00116649|79504262|FG000|Overall Study|Adverse Event|20|||
44499666|NCT00116649|79504262|FG000|Overall Study|Lack of Efficacy|1|||
44499667|NCT00116649|79504262|FG000|Overall Study|Lost to Follow-up|32|||
44560930|NCT02994108|79579014|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
44560931|NCT02994108|79579013|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
44560932|NCT02994108|79579014|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
44560933|NCT03231371|79579021|FG000|Overall Study|Withdrawal by Subject|1|||
44560934|NCT03231371|79579021|FG000|Overall Study|chose or were ineligible to have MRI|12|||
44560935|NCT02870348|79579025|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
44560936|NCT03239873|79579031|FG000|Overall Study|Lost to Follow-up|15|||
44560937|NCT03239873|79579032|FG001|Overall Study|Lost to Follow-up|16|||
44560938|NCT03239873|79579031|FG000|Overall Study|Physician Decision|1|||
44560939|NCT03239873|79579032|FG001|Overall Study|Physician Decision|0|||
44560940|NCT03239873|79579031|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
44560941|NCT03239873|79579032|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
44560942|NCT03239873|79579031|FG000|Overall Study|Withdrawal by Subject|2|||
44560943|NCT03239873|79579032|FG001|Overall Study|Withdrawal by Subject|0|||
44560944|NCT03239873|79579031|FG000|Overall Study|Contraindication to study medication|1|||
44560945|NCT03239873|79579032|FG001|Overall Study|Contraindication to study medication|0|||
44560946|NCT03239873|79579031|FG000|Overall Study|Protocol Violation|1|||
44560947|NCT03239873|79579032|FG001|Overall Study|Protocol Violation|0|||
44560948|NCT03213509|79579040|FG000|Overall Study|Did not consent for verbal autopsy|4|||
44560949|NCT03213509|79579041|FG001|Overall Study|Did not consent for verbal autopsy|5|||
44560950|NCT03239483|79579050|FG000|Overall Study|Lost to Follow-up|1|||
44560951|NCT03239483|79579051|FG001|Overall Study|Lost to Follow-up|0|||
44560952|NCT03239483|79579050|FG000|Overall Study|Withdrawal by Subject|1|||
44560953|NCT03239483|79579051|FG001|Overall Study|Withdrawal by Subject|0|||
44560954|NCT02868554|79579060|FG000|Overall Study|Lost to Follow-up|3|||
44560955|NCT02868554|79579061|FG001|Overall Study|Lost to Follow-up|0|||
44560956|NCT02868554|79579062|FG002|Overall Study|Lost to Follow-up|1|||
44560957|NCT01068912|79579073|FG000|Overall Study|Adverse Event|2|||
44560958|NCT01068912|79579074|FG001|Overall Study|Adverse Event|3|||
44560959|NCT01068912|79579075|FG002|Overall Study|Adverse Event|2|||
44560960|NCT01068912|79579073|FG000|Overall Study|Withdrawal by Subject|5|||
44560961|NCT01068912|79579074|FG001|Overall Study|Withdrawal by Subject|6|||
44560962|NCT01068912|79579075|FG002|Overall Study|Withdrawal by Subject|6|||
44560963|NCT01068912|79579073|FG000|Overall Study|Lost to Follow-up|3|||
44560964|NCT01068912|79579074|FG001|Overall Study|Lost to Follow-up|7|||
44560965|NCT01068912|79579075|FG002|Overall Study|Lost to Follow-up|3|||
44560966|NCT01068912|79579073|FG000|Overall Study|Protocol Violation|0|||
44376936|NCT00865306|79382242|FG001|Controlled Trial|Improved btw baseline and first session|0|||
44560967|NCT01068912|79579074|FG001|Overall Study|Protocol Violation|2|||
44560968|NCT01068912|79579075|FG002|Overall Study|Protocol Violation|0|||
44560969|NCT01068912|79579073|FG000|Overall Study|aggravation influenza|1|||
44560970|NCT01068912|79579074|FG001|Overall Study|aggravation influenza|1|||
44560971|NCT01068912|79579075|FG002|Overall Study|aggravation influenza|1|||
44560972|NCT01068912|79579073|FG000|Overall Study|other underlying illness|0|||
44560973|NCT01068912|79579074|FG001|Overall Study|other underlying illness|3|||
44560974|NCT01068912|79579075|FG002|Overall Study|other underlying illness|3|||
44560975|NCT03229109|79579087|FG000|Overall Study|Withdrawal by Subject|0|||
44560976|NCT03229109|79579088|FG001|Overall Study|Withdrawal by Subject|0|||
44560977|NCT03229109|79579089|FG002|Overall Study|Withdrawal by Subject|0|||
44560978|NCT03229109|79579090|FG003|Overall Study|Withdrawal by Subject|1|||
44560979|NCT03212261|79579100|FG000|Overall Study|Became ineligible d/t tech|2|||
44560980|NCT03212261|79579100|FG000|Overall Study|Tech Trouble- No first study visit|1|||
44560981|NCT03212261|79579100|FG000|Overall Study|Lost to Follow-up|7|||
44560982|NCT03212261|79579100|FG000|Overall Study|Family Emergency|1|||
44560983|NCT03212261|79579100|FG000|Overall Study|Too busy/ No time|5|||
44560984|NCT02993250|79579107|FG000|Overall Study|Lost to Follow-up|0|||
44560985|NCT02993250|79579108|FG001|Overall Study|Lost to Follow-up|1|||
44560986|NCT02989194|79579117|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
44560987|NCT02989194|79579118|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
44560988|NCT02989194|79579119|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
44560989|NCT02989194|79579117|FG000|Overall Study|Lost to Follow-up|0|||
44560990|NCT02989194|79579118|FG001|Overall Study|Lost to Follow-up|1|||
44560991|NCT02989194|79579119|FG002|Overall Study|Lost to Follow-up|0|||
44560992|NCT02989194|79579117|FG000|Overall Study|Withdrawal by Subject|0|||
44560993|NCT02989194|79579118|FG001|Overall Study|Withdrawal by Subject|1|||
44560994|NCT02989194|79579119|FG002|Overall Study|Withdrawal by Subject|0|||
44560995|NCT02990910|79579140|FG000|Overall Study|Lack of Efficacy|6|||
44560996|NCT02990910|79579141|FG001|Overall Study|Lack of Efficacy|10|||
44560997|NCT03227861|79579147|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
44560998|NCT03227861|79579147|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
44560999|NCT03227861|79579147|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
44561000|NCT03227861|79579147|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
44561001|NCT03227861|79579147|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
44561002|NCT03227861|79579147|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
44561003|NCT03227861|79579147|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
44561004|NCT03227861|79579147|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
44561005|NCT03227861|79579147|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
44561006|NCT03227861|79579147|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
44561007|NCT01336712|79579153|FG000|Overall Study|Death|2|||
44561008|NCT01336712|79579153|FG000|Overall Study|Lack of Efficacy|1|||
44561009|NCT03208127|79579157|FG000|Overall Study|Death|1|||
44561010|NCT02865122|79579164|FG000|Overall Study|Adverse Event|1|||
44561011|NCT02865122|79579165|FG001|Overall Study|Adverse Event|0|||
44561012|NCT02865122|79579166|FG002|Overall Study|Adverse Event|0|||
44561013|NCT02864498|79579177|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
44499668|NCT00116649|79504262|FG000|Overall Study|Withdrawal by Subject|68|||
44499669|NCT00116649|79504262|FG000|Overall Study|Local Skin Reaction|9|||
44232912|NCT01795547|79050330|FG000|Overall Study|Lack of Efficacy|8|||
44499670|NCT00116649|79504262|FG000|Overall Study|Various Reasons|18|||
44499671|NCT00116649|79504262|FG000|Overall Study|Protocol Specified|7|||
44499672|NCT00083889|79504268|FG000|Overall Study|Adverse Event|76|||
44499673|NCT00083889|79504269|FG001|Overall Study|Adverse Event|86|||
44499674|NCT00083889|79504268|FG000|Overall Study|Protocol Violation|2|||
44499675|NCT00083889|79504269|FG001|Overall Study|Protocol Violation|2|||
44499676|NCT00083889|79504268|FG000|Overall Study|Withdrawal by Subject|22|||
44499677|NCT00083889|79504269|FG001|Overall Study|Withdrawal by Subject|24|||
44499678|NCT00083889|79504268|FG000|Overall Study|Lack of Efficacy|240|||
44499679|NCT00083889|79504269|FG001|Overall Study|Lack of Efficacy|219|||
44499680|NCT00083889|79504268|FG000|Overall Study|Decision of sponsor|32|||
44499681|NCT00083889|79504269|FG001|Overall Study|Decision of sponsor|4|||
44499682|NCT00083889|79504268|FG000|Overall Study|Randomized: did not take study drug|0|||
44499683|NCT00083889|79504269|FG001|Overall Study|Randomized: did not take study drug|15|||
44499684|NCT00083889|79504268|FG000|Overall Study|Completed on marketed sunitinub|3|||
44499685|NCT00083889|79504269|FG001|Overall Study|Completed on marketed sunitinub|0|||
44499686|NCT00083889|79504268|FG000|Overall Study|Crossover to SU011248|0|||
44499687|NCT00083889|79504269|FG001|Overall Study|Crossover to SU011248|25|||
44499688|NCT03572062|79504288|FG000|Overall Study|Adverse Event|0|||
44499689|NCT03572062|79504289|FG001|Overall Study|Adverse Event|0|||
44499690|NCT03572062|79504290|FG002|Overall Study|Adverse Event|0|||
44561014|NCT02864498|79579178|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
44561015|NCT02864498|79579179|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
44499691|NCT03572062|79504291|FG003|Overall Study|Adverse Event|0|||
44499692|NCT03572062|79504292|FG004|Overall Study|Adverse Event|0|||
44499693|NCT03572062|79504293|FG005|Overall Study|Adverse Event|0|||
44499694|NCT03572062|79504294|FG006|Overall Study|Adverse Event|0|||
44499695|NCT03572062|79504295|FG007|Overall Study|Adverse Event|0|||
44499696|NCT03572062|79504296|FG008|Overall Study|Adverse Event|1|||
44499697|NCT03572062|79504297|FG009|Overall Study|Adverse Event|3|||
44499698|NCT03572062|79504288|FG000|Overall Study|Death|0|||
44499699|NCT03572062|79504289|FG001|Overall Study|Death|0|||
44499700|NCT03572062|79504290|FG002|Overall Study|Death|0|||
44561016|NCT02864498|79579177|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
44561017|NCT02864498|79579178|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
44561018|NCT02864498|79579179|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
44561019|NCT02864498|79579177|FG000|Overall Study|Investigator Discretion|0|||
44561020|NCT02864498|79579178|FG001|Overall Study|Investigator Discretion|2|||
44561021|NCT02864498|79579179|FG002|Overall Study|Investigator Discretion|1|||
44561022|NCT02864498|79579177|FG000|Overall Study|Lost to Follow-up|8|||
44561023|NCT02864498|79579178|FG001|Overall Study|Lost to Follow-up|6|||
44561024|NCT02864498|79579179|FG002|Overall Study|Lost to Follow-up|3|||
44561025|NCT02864498|79579177|FG000|Overall Study|Lack of Efficacy|5|||
44561026|NCT02864498|79579178|FG001|Overall Study|Lack of Efficacy|3|||
44561027|NCT02864498|79579179|FG002|Overall Study|Lack of Efficacy|3|||
44561028|NCT02864498|79579177|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
44561029|NCT02864498|79579178|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
44561030|NCT02864498|79579179|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
44561031|NCT02864498|79579177|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
44561032|NCT02864498|79579178|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
44561033|NCT02864498|79579179|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
44561034|NCT02864498|79579177|FG000|Overall Study|Subject moved out of the country.|0|||
44561035|NCT02864498|79579178|FG001|Overall Study|Subject moved out of the country.|0|||
44561036|NCT02864498|79579179|FG002|Overall Study|Subject moved out of the country.|1|||
44561037|NCT03238781|79579190|FG000|Overall Study|Adverse Event|1|||
44561038|NCT03238781|79579191|FG001|Overall Study|Adverse Event|1|||
44561039|NCT03238781|79579192|FG002|Overall Study|Adverse Event|2|||
44561040|NCT03238781|79579190|FG000|Overall Study|Lost to Follow-up|2|||
44561041|NCT03238781|79579191|FG001|Overall Study|Lost to Follow-up|1|||
44561042|NCT03238781|79579192|FG002|Overall Study|Lost to Follow-up|2|||
44561043|NCT03238781|79579190|FG000|Overall Study|Withdrawal by Subject|23|||
44561044|NCT03238781|79579191|FG001|Overall Study|Withdrawal by Subject|14|||
44561045|NCT03238781|79579192|FG002|Overall Study|Withdrawal by Subject|16|||
44561046|NCT03238781|79579190|FG000|Overall Study|Decision by sponsor|0|||
44561047|NCT03238781|79579191|FG001|Overall Study|Decision by sponsor|1|||
44561048|NCT03238781|79579192|FG002|Overall Study|Decision by sponsor|0|||
44561049|NCT02097121|79579203|FG000|Overall Study|Other, not specified|4|||
44561050|NCT02097121|79579204|FG001|Overall Study|Other, not specified|2|||
44561051|NCT02097121|79579205|FG002|Overall Study|Other, not specified|3|||
44561052|NCT02097121|79579203|FG000|Overall Study|Lack of Efficacy|2|||
44561053|NCT02097121|79579204|FG001|Overall Study|Lack of Efficacy|1|||
44561054|NCT02097121|79579205|FG002|Overall Study|Lack of Efficacy|3|||
44561055|NCT02097121|79579203|FG000|Overall Study|Withdrawal by Subject|0|||
44561056|NCT02097121|79579204|FG001|Overall Study|Withdrawal by Subject|1|||
44561057|NCT02097121|79579205|FG002|Overall Study|Withdrawal by Subject|2|||
44561058|NCT02097121|79579203|FG000|Overall Study|Adverse Event|0|||
44561059|NCT02097121|79579204|FG001|Overall Study|Adverse Event|1|||
44561060|NCT02097121|79579205|FG002|Overall Study|Adverse Event|0|||
44561061|NCT02097121|79579203|FG000|Overall Study|Lost to Follow-up|1|||
44561062|NCT02097121|79579204|FG001|Overall Study|Lost to Follow-up|1|||
44561063|NCT02097121|79579205|FG002|Overall Study|Lost to Follow-up|2|||
44561064|NCT02747420|79579234|FG000|Overall Study|Lost to Follow-up|4|||
44561065|NCT02747420|79579235|FG001|Overall Study|Lost to Follow-up|2|||
44561066|NCT02747420|79579234|FG000|Overall Study|Withdrawal by Subject|3|||
44561067|NCT02747420|79579235|FG001|Overall Study|Withdrawal by Subject|2|||
44561068|NCT03238001|79579241|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
44561069|NCT03238001|79579241|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
44561070|NCT03238001|79579241|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
44561071|NCT03238001|79579241|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
44561072|NCT03238001|79579241|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
44561073|NCT03238001|79579241|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
44561074|NCT03238001|79579241|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
44561075|NCT03238001|79579241|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
44561076|NCT02747108|79579255|FG000|Overall Study|Death|2|||
44561077|NCT02747108|79579256|FG001|Overall Study|Death|2|||
44561078|NCT02747108|79579255|FG000|Overall Study|Withdrawal by Subject|1|||
44561079|NCT02747108|79579256|FG001|Overall Study|Withdrawal by Subject|0|||
44561080|NCT02747108|79579255|FG000|Overall Study|Protocol Violation|2|||
44561081|NCT02747108|79579256|FG001|Overall Study|Protocol Violation|0|||
44561082|NCT03226769|79579284|FG000|Overall Study|Withdrawal by Subject|0|||
44561083|NCT03226769|79579285|FG001|Overall Study|Withdrawal by Subject|1|||
44561084|NCT02864342|79579293|FG000|Overall Study|Eligibility Criteria Deviation|2|||
44561085|NCT02864342|79579294|FG001|Overall Study|Eligibility Criteria Deviation|3|||
44561086|NCT02864342|79579293|FG000|Overall Study|Withdrawal by Subject|4|||
44561087|NCT02864342|79579294|FG001|Overall Study|Withdrawal by Subject|2|||
44561088|NCT02864342|79579293|FG000|Overall Study|Device Technology Issue|6|||
44561089|NCT02864342|79579294|FG001|Overall Study|Device Technology Issue|7|||
44561090|NCT02864342|79579293|FG000|Overall Study|Death|0|||
44561091|NCT02864342|79579294|FG001|Overall Study|Death|1|||
44561092|NCT02864342|79579293|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
44561093|NCT02864342|79579294|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
44561094|NCT02864342|79579293|FG000|Overall Study|Lost to Follow-up|1|||
44561095|NCT02864342|79579294|FG001|Overall Study|Lost to Follow-up|5|||
44561096|NCT02864342|79579293|FG000|Overall Study|Lost Device|1|||
44561097|NCT02864342|79579294|FG001|Overall Study|Lost Device|0|||
44561098|NCT02864342|79579293|FG000|Overall Study|Adverse Event|1|||
44561099|NCT02864342|79579294|FG001|Overall Study|Adverse Event|0|||
44561100|NCT03237065|79579303|FG000|Overall Study|Adverse Event|0|||
44561101|NCT03237065|79579304|FG001|Overall Study|Adverse Event|2|||
44561102|NCT03237065|79579303|FG000|Overall Study|Protocol Violation|0|||
44561103|NCT03237065|79579304|FG001|Overall Study|Protocol Violation|1|||
44561104|NCT03237065|79579303|FG000|Overall Study|Withdrawal by Subject|3|||
44561105|NCT03237065|79579304|FG001|Overall Study|Withdrawal by Subject|0|||
44561106|NCT03237065|79579303|FG000|Overall Study|Lost to Follow-up|1|||
44561107|NCT03237065|79579304|FG001|Overall Study|Lost to Follow-up|0|||
44561108|NCT03237065|79579303|FG000|Overall Study|Unable to obtain venous access|0|||
44561109|NCT03237065|79579304|FG001|Overall Study|Unable to obtain venous access|1|||
44561110|NCT03171415|79579315|FG000|Overall Study|Lost to Follow-up|0|||
44561111|NCT03171415|79579316|FG001|Overall Study|Lost to Follow-up|0|||
44561112|NCT03171415|79579317|FG002|Overall Study|Lost to Follow-up|0|||
44561113|NCT03171415|79579318|FG003|Overall Study|Lost to Follow-up|0|||
44561114|NCT03171415|79579319|FG004|Overall Study|Lost to Follow-up|2|||
44561115|NCT03829241|79579344|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
44561116|NCT03829241|79579345|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
44561117|NCT03829241|79579344|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
44561118|NCT03829241|79579345|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
44499701|NCT03572062|79504291|FG003|Overall Study|Death|0|||
44499702|NCT03572062|79504292|FG004|Overall Study|Death|0|||
44499703|NCT03572062|79504293|FG005|Overall Study|Death|1|||
44499704|NCT03572062|79504294|FG006|Overall Study|Death|0|||
44499705|NCT03572062|79504295|FG007|Overall Study|Death|0|||
44499706|NCT03572062|79504296|FG008|Overall Study|Death|0|||
44499707|NCT03572062|79504297|FG009|Overall Study|Death|0|||
44499708|NCT03572062|79504288|FG000|Overall Study|Lost to Follow-up|0|||
44499709|NCT03572062|79504289|FG001|Overall Study|Lost to Follow-up|0|||
44499710|NCT03572062|79504290|FG002|Overall Study|Lost to Follow-up|0|||
44499711|NCT03572062|79504291|FG003|Overall Study|Lost to Follow-up|0|||
44561119|NCT03829241|79579344|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
44232913|NCT01795547|79050331|FG001|Overall Study|Lack of Efficacy|3|||
44561120|NCT03829241|79579345|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
44561121|NCT03829241|79579344|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
44561122|NCT03829241|79579345|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
44561123|NCT03829241|79579344|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
44232914|NCT01795547|79050330|FG000|Overall Study|Protocol Violation|6|||
44499712|NCT03572062|79504292|FG004|Overall Study|Lost to Follow-up|0|||
44499713|NCT03572062|79504293|FG005|Overall Study|Lost to Follow-up|1|||
44561124|NCT03829241|79579345|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
44499714|NCT03572062|79504294|FG006|Overall Study|Lost to Follow-up|1|||
44561125|NCT03829241|79579344|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
44561126|NCT03829241|79579345|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
44561127|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
44232915|NCT01795547|79050331|FG001|Overall Study|Protocol Violation|4|||
44232916|NCT01795547|79050330|FG000|Overall Study|Lost to Follow-up|2|||
44232917|NCT01795547|79050331|FG001|Overall Study|Lost to Follow-up|5|||
44232918|NCT01795547|79050330|FG000|Overall Study|Withdrawal of consent|7|||
44232919|NCT01795547|79050331|FG001|Overall Study|Withdrawal of consent|12|||
44232920|NCT01795547|79050330|FG000|Overall Study|Not Treated|4|||
44232921|NCT01795547|79050331|FG001|Overall Study|Not Treated|10|||
44232922|NCT01795547|79050330|FG000|Overall Study|Non-compliance with IMP|1|||
44232923|NCT01795547|79050331|FG001|Overall Study|Non-compliance with IMP|1|||
44232924|NCT01795547|79050330|FG000|Overall Study|Others|4|||
44232925|NCT01795547|79050331|FG001|Overall Study|Others|1|||
44232926|NCT01795547|79050330|FG000|Overall Study|Not stated|0|||
44232927|NCT01795547|79050331|FG001|Overall Study|Not stated|1|||
44232928|NCT01794923|79050357|FG000|Overall Study|Adverse Event|0|||
44232929|NCT01794923|79050358|FG001|Overall Study|Adverse Event|0|||
44232930|NCT01794923|79050359|FG002|Overall Study|Adverse Event|1|||
44232931|NCT01794845|79050367|FG000|Overall Study|Withdrawal by Subject|1|||
44232932|NCT01794689|79050375|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
44232933|NCT01794689|79050376|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
44232934|NCT01794689|79050377|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
44232935|NCT01794689|79050378|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
44232936|NCT01794689|79050375|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
44232937|NCT01794689|79050376|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
44499715|NCT03572062|79504295|FG007|Overall Study|Lost to Follow-up|0|||
44499716|NCT03572062|79504296|FG008|Overall Study|Lost to Follow-up|0|||
44499717|NCT03572062|79504297|FG009|Overall Study|Lost to Follow-up|0|||
44499718|NCT03572062|79504288|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499719|NCT03572062|79504289|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499720|NCT03572062|79504290|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499721|NCT03572062|79504291|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499722|NCT03572062|79504292|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499723|NCT03572062|79504293|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499724|NCT03572062|79504294|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499725|NCT03572062|79504295|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499726|NCT03572062|79504296|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
44499727|NCT03572062|79504297|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
44499728|NCT03572062|79504288|FG000|Overall Study|Study Terminated By Sponsor|0|||
44499729|NCT03572062|79504289|FG001|Overall Study|Study Terminated By Sponsor|0|||
44561128|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
44232938|NCT01794689|79050377|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
44232939|NCT01794689|79050378|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
44232940|NCT01794689|79050375|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
44232941|NCT01794689|79050376|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
44561129|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
44561130|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
44561131|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
44561132|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
44561133|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
44561134|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
44561135|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
44561136|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
44561137|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
44561138|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
44561139|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
44561140|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
44561141|NCT03829241|79579344|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
44561142|NCT03829241|79579345|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
44561143|NCT03164551|79579357|FG000|Overall Study|Imaging discontinued prior completion|8|||
44499730|NCT03572062|79504290|FG002|Overall Study|Study Terminated By Sponsor|0|||
44561144|NCT03164551|79579358|FG001|Overall Study|Imaging discontinued prior completion|0|||
44561145|NCT03164551|79579357|FG000|Overall Study|Participant was non-compliant|1|||
44561146|NCT03164551|79579358|FG001|Overall Study|Participant was non-compliant|0|||
44561147|NCT03164551|79579357|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
44561148|NCT03164551|79579358|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
44561149|NCT03164551|79579357|FG000|Overall Study|Other|8|||
44561150|NCT03164551|79579358|FG001|Overall Study|Other|2|||
44232942|NCT01794689|79050377|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
44499731|NCT03572062|79504291|FG003|Overall Study|Study Terminated By Sponsor|0|||
44499732|NCT03572062|79504292|FG004|Overall Study|Study Terminated By Sponsor|0|||
44561151|NCT02863328|79579366|FG000|Overall Study|Lost to Follow-up|4|||
44561152|NCT02863328|79579367|FG001|Overall Study|Lost to Follow-up|10|||
44232943|NCT01794689|79050378|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
44499733|NCT03572062|79504293|FG005|Overall Study|Study Terminated By Sponsor|0|||
44499734|NCT03572062|79504294|FG006|Overall Study|Study Terminated By Sponsor|0|||
44499735|NCT03572062|79504295|FG007|Overall Study|Study Terminated By Sponsor|0|||
44499736|NCT03572062|79504296|FG008|Overall Study|Study Terminated By Sponsor|29|||
44499737|NCT03572062|79504297|FG009|Overall Study|Study Terminated By Sponsor|27|||
44499738|NCT03572062|79504288|FG000|Overall Study|Physician Decision|0|||
44499739|NCT03572062|79504289|FG001|Overall Study|Physician Decision|0|||
44499740|NCT03572062|79504290|FG002|Overall Study|Physician Decision|0|||
44499741|NCT03572062|79504291|FG003|Overall Study|Physician Decision|0|||
44499742|NCT03572062|79504292|FG004|Overall Study|Physician Decision|0|||
44499743|NCT03572062|79504293|FG005|Overall Study|Physician Decision|0|||
44499744|NCT03572062|79504294|FG006|Overall Study|Physician Decision|0|||
44499745|NCT03572062|79504295|FG007|Overall Study|Physician Decision|0|||
44499746|NCT03572062|79504296|FG008|Overall Study|Physician Decision|1|||
44499747|NCT03572062|79504297|FG009|Overall Study|Physician Decision|0|||
44499748|NCT03572062|79504288|FG000|Overall Study|Withdrawal by Subject|0|||
44561153|NCT02863328|79579366|FG000|Overall Study|Withdrawal by Subject|7|||
44561154|NCT02863328|79579367|FG001|Overall Study|Withdrawal by Subject|12|||
44561155|NCT02863328|79579366|FG000|Overall Study|Died|0|||
44275317|NCT02237196|79221796|FG003|Overall Study|Pregnancy|1|||
44499749|NCT03572062|79504289|FG001|Overall Study|Withdrawal by Subject|0|||
44499750|NCT03572062|79504290|FG002|Overall Study|Withdrawal by Subject|0|||
44499751|NCT03572062|79504291|FG003|Overall Study|Withdrawal by Subject|0|||
44499752|NCT03572062|79504292|FG004|Overall Study|Withdrawal by Subject|0|||
44499753|NCT03572062|79504293|FG005|Overall Study|Withdrawal by Subject|0|||
44499754|NCT03572062|79504294|FG006|Overall Study|Withdrawal by Subject|0|||
44499755|NCT03572062|79504295|FG007|Overall Study|Withdrawal by Subject|0|||
44499756|NCT03572062|79504296|FG008|Overall Study|Withdrawal by Subject|0|||
44499757|NCT03572062|79504297|FG009|Overall Study|Withdrawal by Subject|1|||
44499758|NCT03572062|79504288|FG000|Overall Study|Randomized But Not Treated|0|||
44499759|NCT03572062|79504289|FG001|Overall Study|Randomized But Not Treated|0|||
44499760|NCT03572062|79504290|FG002|Overall Study|Randomized But Not Treated|0|||
44499761|NCT03572062|79504291|FG003|Overall Study|Randomized But Not Treated|0|||
44499762|NCT03572062|79504292|FG004|Overall Study|Randomized But Not Treated|1|||
44499763|NCT03572062|79504293|FG005|Overall Study|Randomized But Not Treated|2|||
44499764|NCT03572062|79504294|FG006|Overall Study|Randomized But Not Treated|0|||
44499765|NCT03572062|79504295|FG007|Overall Study|Randomized But Not Treated|1|||
44499766|NCT03572062|79504296|FG008|Overall Study|Randomized But Not Treated|0|||
44499767|NCT03572062|79504297|FG009|Overall Study|Randomized But Not Treated|0|||
44499768|NCT03571516|79504319|FG000|Overall Study|Severe diarrhea|1|||
44499769|NCT03571516|79504320|FG001|Overall Study|Severe diarrhea|0|||
44499770|NCT03571516|79504319|FG000|Overall Study|Withdrawal by Subject|0|||
44499771|NCT03571516|79504320|FG001|Overall Study|Withdrawal by Subject|1|||
44499772|NCT03600376|79504328|FG000|Overall Study|Adverse Event|1|||
44499773|NCT03600376|79504329|FG001|Overall Study|Adverse Event|1|||
44499774|NCT03600376|79504328|FG000|Overall Study|Transferred to other facility|1|||
44499775|NCT03600376|79504329|FG001|Overall Study|Transferred to other facility|0|||
44499776|NCT03600376|79504328|FG000|Overall Study|Investigator Decision|0|||
44499777|NCT03600376|79504329|FG001|Overall Study|Investigator Decision|4|||
44499778|NCT03600376|79504328|FG000|Overall Study|Determined to be ineligible for study|0|||
44499779|NCT03600376|79504329|FG001|Overall Study|Determined to be ineligible for study|1|||
44499780|NCT03599362|79504335|FG000|Overall Study|Screen Failure|3|||
44499781|NCT03598036|79504341|FG000|Overall Study|Withdrawal by Subject|1|||
44499782|NCT03598036|79504342|FG001|Overall Study|Withdrawal by Subject|0|||
44499783|NCT00082407|79504352|FG000|Overall Study|Adverse Event|20|||
44499784|NCT00082407|79504353|FG001|Overall Study|Adverse Event|0|||
44499785|NCT00082407|79504352|FG000|Overall Study|Protocol Violation|14|||
44499786|NCT00082407|79504353|FG001|Overall Study|Protocol Violation|12|||
44499787|NCT00082407|79504352|FG000|Overall Study|Patient Decision|13|||
44499788|NCT00082407|79504353|FG001|Overall Study|Patient Decision|6|||
44499789|NCT00082407|79504352|FG000|Overall Study|Physician Decision|5|||
44499790|NCT00082407|79504353|FG001|Overall Study|Physician Decision|3|||
44499791|NCT00082407|79504352|FG000|Overall Study|Loss of Glucose Control|2|||
44499792|NCT00082407|79504353|FG001|Overall Study|Loss of Glucose Control|2|||
44499793|NCT00082407|79504352|FG000|Overall Study|Death|2|||
44499794|NCT00082407|79504353|FG001|Overall Study|Death|1|||
44499795|NCT00082407|79504352|FG000|Overall Study|Lost to Follow-up|0|||
44499796|NCT00082407|79504353|FG001|Overall Study|Lost to Follow-up|3|||
44499797|NCT03643432|79504361|FG000|Overall Study|Lost to Follow-up|1|||
44499798|NCT03643432|79504362|FG001|Overall Study|Lost to Follow-up|0|||
44499799|NCT03810183|79504370|FG000|Overall Study|Study terminated by Sponsor|2|||
44499800|NCT03810183|79504371|FG001|Overall Study|Study terminated by Sponsor|1|||
44499801|NCT03597022|79504381|FG000|Overall Study|Premature termination of the study|7|||
44499802|NCT03597022|79504382|FG001|Overall Study|Premature termination of the study|7|||
44499803|NCT03597022|79504383|FG002|Overall Study|Premature termination of the study|8|||
44499804|NCT03597022|79504381|FG000|Overall Study|Serious adverse event|1|||
44499805|NCT03597022|79504382|FG001|Overall Study|Serious adverse event|1|||
44499806|NCT03597022|79504383|FG002|Overall Study|Serious adverse event|0|||
44499807|NCT03571204|79504394|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
44499808|NCT03571204|79504395|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
44499809|NCT03571204|79504396|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
44499810|NCT03571204|79504394|FG000|Overall Study|Physician Decision|0|||
44499811|NCT03571204|79504395|FG001|Overall Study|Physician Decision|1|||
44499812|NCT03571204|79504396|FG002|Overall Study|Physician Decision|0|||
44232944|NCT01794689|79050375|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
44499813|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
44499814|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
44499815|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
44499816|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
44499817|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
44499818|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
44499819|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
44499820|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
44499821|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
44561156|NCT02863328|79579367|FG001|Overall Study|Died|1|||
44499822|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
44499823|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
44232945|NCT01794689|79050376|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
44561157|NCT03040141|79579376|FG000|Overall Study|Death|1|||
44561158|NCT03040141|79579377|FG001|Overall Study|Death|2|||
44561159|NCT03040141|79579378|FG002|Overall Study|Death|3|||
44561160|NCT03040141|79579376|FG000|Overall Study|Withdrawal by Subject|3|||
44561161|NCT03040141|79579377|FG001|Overall Study|Withdrawal by Subject|1|||
44561162|NCT03040141|79579378|FG002|Overall Study|Withdrawal by Subject|1|||
44561163|NCT03040141|79579376|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
44561164|NCT03040141|79579377|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
44561165|NCT03040141|79579378|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
44561166|NCT03040141|79579376|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
44561167|NCT03040141|79579377|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
44561168|NCT03040141|79579378|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
44561169|NCT02937701|79579392|FG000|Day 1 to Week 22|Adverse Event|11|||
44561170|NCT02937701|79579393|FG001|Day 1 to Week 22|Adverse Event|14|||
44561171|NCT02937701|79579394|FG002|Day 1 to Week 22|Adverse Event|0|||
44561172|NCT02937701|79579395|FG003|Day 1 to Week 22|Adverse Event|0|||
44561173|NCT02937701|79579396|FG004|Day 1 to Week 22|Adverse Event|0|||
44561174|NCT02937701|79579392|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
44561175|NCT02937701|79579393|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
44561176|NCT02937701|79579394|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
44376937|NCT00865306|79382241|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
44376938|NCT00865306|79382242|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
44376939|NCT00865306|79382241|FG000|Controlled Trial|Withdrawal by Subject|0|||
44376940|NCT00865306|79382242|FG001|Controlled Trial|Withdrawal by Subject|1|||
44376941|NCT00896649|79382248|FG000|Overall Study|Physician Decision|1|||
44376942|NCT00896649|79382248|FG000|Overall Study|Pregnancy|1|||
44561177|NCT02937701|79579395|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
44561178|NCT02937701|79579396|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
44561179|NCT02937701|79579392|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
44561180|NCT02937701|79579393|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
44561181|NCT02937701|79579394|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
44561182|NCT02937701|79579395|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
44561183|NCT02937701|79579396|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
44561184|NCT02937701|79579392|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
44561185|NCT02937701|79579393|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
44561186|NCT02937701|79579394|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
44561187|NCT02937701|79579395|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
44561188|NCT02937701|79579396|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
44561189|NCT02937701|79579392|FG000|Day 1 to Week 22|Death|1|||
44561190|NCT02937701|79579393|FG001|Day 1 to Week 22|Death|1|||
44561191|NCT02937701|79579394|FG002|Day 1 to Week 22|Death|0|||
44561192|NCT02937701|79579395|FG003|Day 1 to Week 22|Death|0|||
44561193|NCT02937701|79579396|FG004|Day 1 to Week 22|Death|0|||
44561194|NCT02937701|79579392|FG000|Day 1 to Week 22|Protocol Violation|1|||
44561195|NCT02937701|79579393|FG001|Day 1 to Week 22|Protocol Violation|1|||
44561196|NCT02937701|79579394|FG002|Day 1 to Week 22|Protocol Violation|0|||
44561197|NCT02937701|79579395|FG003|Day 1 to Week 22|Protocol Violation|0|||
44561198|NCT02937701|79579396|FG004|Day 1 to Week 22|Protocol Violation|0|||
44561199|NCT02937701|79579392|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
44561200|NCT02937701|79579393|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
44561201|NCT02937701|79579394|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
44561202|NCT02937701|79579395|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
44561203|NCT02937701|79579396|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
44561204|NCT02937701|79579392|FG000|Day 1 to Week 22|Physician Decision|2|||
44561205|NCT02937701|79579393|FG001|Day 1 to Week 22|Physician Decision|0|||
44561206|NCT02937701|79579394|FG002|Day 1 to Week 22|Physician Decision|0|||
44561207|NCT02937701|79579395|FG003|Day 1 to Week 22|Physician Decision|0|||
44561208|NCT02937701|79579396|FG004|Day 1 to Week 22|Physician Decision|0|||
44561209|NCT02937701|79579392|FG000|Day 1 to Week 22|Other|1|||
44561210|NCT02937701|79579393|FG001|Day 1 to Week 22|Other|0|||
44561211|NCT02937701|79579394|FG002|Day 1 to Week 22|Other|0|||
44561212|NCT02937701|79579395|FG003|Day 1 to Week 22|Other|0|||
44561213|NCT02937701|79579396|FG004|Day 1 to Week 22|Other|0|||
44561214|NCT02937701|79579392|FG000|Week 22 to Week 50|Adverse Event|0|||
44561215|NCT02937701|79579393|FG001|Week 22 to Week 50|Adverse Event|0|||
44561216|NCT02937701|79579394|FG002|Week 22 to Week 50|Adverse Event|10|||
44561217|NCT02937701|79579395|FG003|Week 22 to Week 50|Adverse Event|3|||
44561218|NCT02937701|79579396|FG004|Week 22 to Week 50|Adverse Event|3|||
44561219|NCT02937701|79579392|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
44561220|NCT02937701|79579393|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
44561221|NCT02937701|79579394|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
44561222|NCT02937701|79579395|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
44561223|NCT02937701|79579396|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
44561224|NCT02937701|79579392|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
44561225|NCT02937701|79579393|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
44561226|NCT02937701|79579394|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
44561227|NCT02937701|79579395|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
44561228|NCT02937701|79579396|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
44561229|NCT02937701|79579392|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
44499824|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
44499825|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
44499826|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
44499827|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
44499828|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
44499829|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
44499830|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
44499831|NCT03569098|79504408|FG000|Double-Blind Treatment Cycle 1|Other|1|||
44499832|NCT03569098|79504409|FG001|Double-Blind Treatment Cycle 1|Other|0|||
44499833|NCT03569098|79504410|FG002|Double-Blind Treatment Cycle 1|Other|1|||
44499834|NCT03569098|79504408|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
44499835|NCT03569098|79504409|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
44499836|NCT03569098|79504410|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
44499837|NCT03569098|79504408|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
44499838|NCT03569098|79504409|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
44499839|NCT03569098|79504410|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
44499840|NCT03569098|79504408|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
44561230|NCT02937701|79579393|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
44561231|NCT02937701|79579394|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
44232946|NCT01794689|79050377|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
44232947|NCT01794689|79050378|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
44232948|NCT01794299|79050394|FG000|Overall Study|ATIR manufacturing not possible|1|||
44232949|NCT01794299|79050394|FG000|Overall Study|Death|14|||
44232950|NCT01794299|79050394|FG000|Overall Study|Graft failure|1|||
44232951|NCT01794299|79050394|FG000|Overall Study|ATIR batch rejected|2|||
44232952|NCT01794299|79050394|FG000|Overall Study|Relapse|2|||
44232953|NCT01794299|79050394|FG000|Overall Study|Discontinued from active follow-up|1|||
44232954|NCT01794299|79050394|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
44561232|NCT02937701|79579395|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
44561233|NCT02937701|79579396|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
44561234|NCT02937701|79579392|FG000|Week 22 to Week 50|Physician Decision|0|||
44561235|NCT02937701|79579393|FG001|Week 22 to Week 50|Physician Decision|0|||
44561236|NCT02937701|79579394|FG002|Week 22 to Week 50|Physician Decision|2|||
44561237|NCT02937701|79579395|FG003|Week 22 to Week 50|Physician Decision|0|||
44561238|NCT02937701|79579396|FG004|Week 22 to Week 50|Physician Decision|1|||
44561239|NCT02937701|79579392|FG000|Week 22 to Week 50|Other|0|||
44561240|NCT02937701|79579393|FG001|Week 22 to Week 50|Other|0|||
44561241|NCT02937701|79579394|FG002|Week 22 to Week 50|Other|0|||
44561242|NCT02937701|79579395|FG003|Week 22 to Week 50|Other|0|||
44561243|NCT02937701|79579396|FG004|Week 22 to Week 50|Other|1|||
44561244|NCT03169153|79579408|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
44561245|NCT03169153|79579409|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
44561246|NCT03169153|79579408|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
44561247|NCT03169153|79579409|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
44561248|NCT03169153|79579408|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
44376943|NCT00896649|79382248|FG000|Overall Study|missing documentation|1|||
44499841|NCT03569098|79504409|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
44499842|NCT03569098|79504410|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
44499843|NCT03569098|79504408|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
44499844|NCT03569098|79504409|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
44499845|NCT03569098|79504410|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
44499846|NCT03569098|79504408|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
44499847|NCT03569098|79504409|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
44499848|NCT03569098|79504410|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
44499849|NCT03569098|79504408|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
44499850|NCT03569098|79504409|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
44499851|NCT03569098|79504410|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
44499852|NCT03568942|79504421|FG000|Overall Study|Family emergency|1|||
44499853|NCT03568942|79504421|FG000|Overall Study|Lost to Follow-up|1|||
44499854|NCT00110019|79504427|FG000|Overall Study|Lack of Efficacy|253|||
44499855|NCT00110019|79504428|FG001|Overall Study|Lack of Efficacy|285|||
44232955|NCT01817075|79050400|FG000|Overall Study|Adverse Event|7|||
44232956|NCT01817075|79050401|FG001|Overall Study|Adverse Event|5|||
44232957|NCT01817075|79050400|FG000|Overall Study|Physician Decision|9|||
44232958|NCT01817075|79050401|FG001|Overall Study|Physician Decision|12|||
44499856|NCT00110019|79504427|FG000|Overall Study|Adverse Event|61|||
44499857|NCT00110019|79504428|FG001|Overall Study|Adverse Event|40|||
44499858|NCT00110019|79504427|FG000|Overall Study|Death|13|||
44499859|NCT00110019|79504428|FG001|Overall Study|Death|15|||
44499860|NCT00110019|79504427|FG000|Overall Study|Withdrawal by Subject|21|||
44499861|NCT00110019|79504428|FG001|Overall Study|Withdrawal by Subject|9|||
44499862|NCT00110019|79504427|FG000|Overall Study|alternative therapy|5|||
44499863|NCT00110019|79504428|FG001|Overall Study|alternative therapy|1|||
44499864|NCT00110019|79504427|FG000|Overall Study|complicating disease|1|||
44499865|NCT00110019|79504428|FG001|Overall Study|complicating disease|1|||
44499866|NCT00110019|79504427|FG000|Overall Study|symptom deterioration|13|||
44499867|NCT00110019|79504428|FG001|Overall Study|symptom deterioration|16|||
44499868|NCT00110019|79504427|FG000|Overall Study|Not start protocol therapy|17|||
44499869|NCT00110019|79504428|FG001|Overall Study|Not start protocol therapy|16|||
44499870|NCT00110019|79504427|FG000|Overall Study|other reasons|22|||
44499871|NCT00110019|79504428|FG001|Overall Study|other reasons|30|||
44499872|NCT03595618|79504438|FG000|Overall Study|Adverse Event|16|||
44499873|NCT03595618|79504439|FG001|Overall Study|Adverse Event|17|||
44499874|NCT03595618|79504440|FG002|Overall Study|Adverse Event|20|||
44499875|NCT03595618|79504441|FG003|Overall Study|Adverse Event|8|||
44499876|NCT03595618|79504438|FG000|Overall Study|Withdrawal by Subject|12|||
44232959|NCT01817075|79050400|FG000|Overall Study|Withdrawal by Subject|31|||
44232960|NCT01817075|79050401|FG001|Overall Study|Withdrawal by Subject|15|||
44232961|NCT01817075|79050400|FG000|Overall Study|Received Sorafenib after enrollment|0|||
44232962|NCT01817075|79050401|FG001|Overall Study|Received Sorafenib after enrollment|1|||
44232963|NCT01817075|79050400|FG000|Overall Study|Ineligible|0|||
44232964|NCT01817075|79050401|FG001|Overall Study|Ineligible|2|||
44232965|NCT01816763|79050410|FG000|Overall Study|The main reason for an incomplete survey|4|||
44232966|NCT01816763|79050411|FG001|Overall Study|The main reason for an incomplete survey|15|||
44232967|NCT01816763|79050412|FG002|Overall Study|The main reason for an incomplete survey|11|||
44499877|NCT03595618|79504439|FG001|Overall Study|Withdrawal by Subject|14|||
44499878|NCT03595618|79504440|FG002|Overall Study|Withdrawal by Subject|14|||
44499879|NCT03595618|79504441|FG003|Overall Study|Withdrawal by Subject|10|||
44499880|NCT03595618|79504438|FG000|Overall Study|Lost to Follow-up|6|||
44499881|NCT03595618|79504439|FG001|Overall Study|Lost to Follow-up|4|||
44499882|NCT03595618|79504440|FG002|Overall Study|Lost to Follow-up|5|||
44499883|NCT03595618|79504441|FG003|Overall Study|Lost to Follow-up|6|||
44232968|NCT01816685|79050425|FG000|Overall Study|Lost to Follow-up|7|||
44232969|NCT01816685|79050426|FG001|Overall Study|Lost to Follow-up|9|||
44499884|NCT03595618|79504438|FG000|Overall Study|Protocol Violation|2|||
44499885|NCT03595618|79504439|FG001|Overall Study|Protocol Violation|0|||
44499886|NCT03595618|79504440|FG002|Overall Study|Protocol Violation|6|||
44499887|NCT03595618|79504441|FG003|Overall Study|Protocol Violation|2|||
44499888|NCT03595618|79504438|FG000|Overall Study|Physician Decision|0|||
44499889|NCT03595618|79504439|FG001|Overall Study|Physician Decision|0|||
44275318|NCT02237196|79221793|FG000|Overall Study|Withdrawal by Subject|1|||
44499890|NCT03595618|79504440|FG002|Overall Study|Physician Decision|1|||
44499891|NCT03595618|79504441|FG003|Overall Study|Physician Decision|2|||
44499892|NCT03595618|79504438|FG000|Overall Study|Miscellaneous|7|||
44499893|NCT03595618|79504439|FG001|Overall Study|Miscellaneous|5|||
44499894|NCT03595618|79504440|FG002|Overall Study|Miscellaneous|10|||
44499895|NCT03595618|79504441|FG003|Overall Study|Miscellaneous|6|||
44499896|NCT02954848|79504453|FG000|Overall Study|Randomized but Not Treated|0|||
44499897|NCT02954848|79504454|FG001|Overall Study|Randomized but Not Treated|1|||
44499898|NCT02954848|79504453|FG000|Overall Study|Adverse Event|2|||
44499899|NCT02954848|79504454|FG001|Overall Study|Adverse Event|3|||
44499900|NCT02954848|79504453|FG000|Overall Study|Withdrawal by Participant|0|||
44499901|NCT02954848|79504454|FG001|Overall Study|Withdrawal by Participant|1|||
44499902|NCT03642262|79504460|FG000|Period 1|Withdrawal by Subject|1|||
44499903|NCT03642262|79504461|FG001|Period 1|Withdrawal by Subject|1|||
44499904|NCT03642262|79504460|FG000|Period 1|Adverse Event|0|||
44499905|NCT03642262|79504461|FG001|Period 1|Adverse Event|1|||
44499906|NCT00109707|79504471|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
44499907|NCT00109707|79504472|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
44499908|NCT00109707|79504473|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
44499909|NCT00109707|79504471|FG000|Overall Study|Abnormal laboratory values|1|||
44499910|NCT00109707|79504472|FG001|Overall Study|Abnormal laboratory values|0|||
44499911|NCT00109707|79504473|FG002|Overall Study|Abnormal laboratory values|0|||
44499912|NCT00109707|79504471|FG000|Overall Study|Administrative problems|2|||
44499913|NCT00109707|79504472|FG001|Overall Study|Administrative problems|0|||
44499914|NCT00109707|79504473|FG002|Overall Study|Administrative problems|1|||
44499915|NCT00109707|79504471|FG000|Overall Study|Adverse Event|10|||
44499916|NCT00109707|79504472|FG001|Overall Study|Adverse Event|2|||
44499917|NCT00109707|79504473|FG002|Overall Study|Adverse Event|3|||
44499918|NCT00109707|79504471|FG000|Overall Study|Death|4|||
44499919|NCT00109707|79504472|FG001|Overall Study|Death|0|||
44499920|NCT00109707|79504473|FG002|Overall Study|Death|0|||
44499921|NCT00109707|79504471|FG000|Overall Study|Disease progression|12|||
44499922|NCT00109707|79504472|FG001|Overall Study|Disease progression|4|||
44499923|NCT00109707|79504473|FG002|Overall Study|Disease progression|3|||
44499924|NCT00109707|79504471|FG000|Overall Study|Lost to Follow-up|3|||
44499925|NCT00109707|79504472|FG001|Overall Study|Lost to Follow-up|0|||
44499926|NCT00109707|79504473|FG002|Overall Study|Lost to Follow-up|0|||
44499927|NCT00109707|79504471|FG000|Overall Study|Protocol Violation|1|||
44499928|NCT00109707|79504472|FG001|Overall Study|Protocol Violation|0|||
44499929|NCT00109707|79504473|FG002|Overall Study|Protocol Violation|0|||
44499930|NCT00109707|79504471|FG000|Overall Study|Patient withdrew consent|6|||
44499931|NCT00109707|79504472|FG001|Overall Study|Patient withdrew consent|1|||
44499932|NCT00109707|79504473|FG002|Overall Study|Patient withdrew consent|0|||
44499933|NCT00095979|79504485|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
44499934|NCT00082173|79504496|FG000|Overall Study|Withdrawal by Subject|3|||
44499935|NCT00082173|79504497|FG001|Overall Study|Withdrawal by Subject|5|||
44499936|NCT00082173|79504496|FG000|Overall Study|Lost to Follow-up|1|||
44499937|NCT00082173|79504497|FG001|Overall Study|Lost to Follow-up|0|||
44499938|NCT00082173|79504496|FG000|Overall Study|Adverse Event|1|||
44232970|NCT01816685|79050425|FG000|Overall Study|Surgery Cancelled|3|||
44499939|NCT00082173|79504497|FG001|Overall Study|Adverse Event|0|||
44232971|NCT01816685|79050426|FG001|Overall Study|Surgery Cancelled|2|||
44499940|NCT00082173|79504496|FG000|Overall Study|Culture negative or resistant at baselin|5|||
44499941|NCT00082173|79504497|FG001|Overall Study|Culture negative or resistant at baselin|6|||
44499942|NCT00108069|79504505|FG000|Overall Study|Never rec'd study drug|0|||
44499943|NCT00108069|79504506|FG001|Overall Study|Never rec'd study drug|1|||
44232972|NCT00708552|79050457|FG000|Overall Study|Adverse Event|10|||
44232973|NCT00708552|79050458|FG001|Overall Study|Adverse Event|3|||
44499944|NCT00108069|79504505|FG000|Overall Study|Adverse Event|1|||
44499945|NCT00108069|79504506|FG001|Overall Study|Adverse Event|1|||
44499946|NCT00108069|79504505|FG000|Overall Study|Withdrawal by Subject|1|||
44499947|NCT00108069|79504506|FG001|Overall Study|Withdrawal by Subject|0|||
44499948|NCT00108069|79504505|FG000|Overall Study|Death|1|||
44499949|NCT00108069|79504506|FG001|Overall Study|Death|0|||
44499950|NCT00108069|79504505|FG000|Overall Study|Progessive disease|27|||
44232974|NCT00708552|79050459|FG002|Overall Study|Adverse Event|4|||
44499951|NCT00108069|79504506|FG001|Overall Study|Progessive disease|11|||
44499952|NCT00079274|79504525|FG000|Overall Study|Withdrawal by Subject|111|||
44499953|NCT00079274|79504526|FG001|Overall Study|Withdrawal by Subject|10|||
44499954|NCT00079274|79504527|FG002|Overall Study|Withdrawal by Subject|12|||
44499955|NCT00079274|79504528|FG003|Overall Study|Withdrawal by Subject|163|||
44499956|NCT00079274|79504529|FG004|Overall Study|Withdrawal by Subject|7|||
44499957|NCT00079274|79504530|FG005|Overall Study|Withdrawal by Subject|8|||
44499958|NCT00079274|79504531|FG006|Overall Study|Withdrawal by Subject|0|||
44499959|NCT00079274|79504525|FG000|Overall Study|Adverse Event|130|||
44499960|NCT00079274|79504526|FG001|Overall Study|Adverse Event|8|||
44499961|NCT00079274|79504527|FG002|Overall Study|Adverse Event|8|||
44499962|NCT00079274|79504528|FG003|Overall Study|Adverse Event|184|||
44499963|NCT00079274|79504529|FG004|Overall Study|Adverse Event|7|||
44499964|NCT00079274|79504530|FG005|Overall Study|Adverse Event|8|||
44499965|NCT00079274|79504531|FG006|Overall Study|Adverse Event|0|||
44499966|NCT00079274|79504525|FG000|Overall Study|Recurrence|21|||
44499967|NCT00079274|79504526|FG001|Overall Study|Recurrence|0|||
44499968|NCT00079274|79504527|FG002|Overall Study|Recurrence|1|||
44499969|NCT00079274|79504528|FG003|Overall Study|Recurrence|15|||
44499970|NCT00079274|79504529|FG004|Overall Study|Recurrence|0|||
44499971|NCT00079274|79504530|FG005|Overall Study|Recurrence|2|||
44499972|NCT00079274|79504531|FG006|Overall Study|Recurrence|0|||
44232975|NCT00708552|79050460|FG003|Overall Study|Adverse Event|6|||
44232976|NCT00708552|79050457|FG000|Overall Study|Lack of Efficacy|0|||
44499973|NCT00079274|79504525|FG000|Overall Study|Alternate Treatment|6|||
44499974|NCT00079274|79504526|FG001|Overall Study|Alternate Treatment|1|||
44499975|NCT00079274|79504527|FG002|Overall Study|Alternate Treatment|0|||
44499976|NCT00079274|79504528|FG003|Overall Study|Alternate Treatment|3|||
44499977|NCT00079274|79504529|FG004|Overall Study|Alternate Treatment|0|||
44499978|NCT00079274|79504530|FG005|Overall Study|Alternate Treatment|0|||
44499979|NCT00079274|79504531|FG006|Overall Study|Alternate Treatment|0|||
44499980|NCT00079274|79504525|FG000|Overall Study|Other Medical Problems|6|||
44499981|NCT00079274|79504526|FG001|Overall Study|Other Medical Problems|1|||
44499982|NCT00079274|79504527|FG002|Overall Study|Other Medical Problems|0|||
44499983|NCT00079274|79504528|FG003|Overall Study|Other Medical Problems|7|||
44499984|NCT00079274|79504529|FG004|Overall Study|Other Medical Problems|0|||
44499985|NCT00079274|79504530|FG005|Overall Study|Other Medical Problems|0|||
44499986|NCT00079274|79504531|FG006|Overall Study|Other Medical Problems|0|||
44499987|NCT00079274|79504525|FG000|Overall Study|Death|4|||
44499988|NCT00079274|79504526|FG001|Overall Study|Death|0|||
44499989|NCT00079274|79504527|FG002|Overall Study|Death|1|||
44499990|NCT00079274|79504528|FG003|Overall Study|Death|15|||
44499991|NCT00079274|79504529|FG004|Overall Study|Death|0|||
44499992|NCT00079274|79504530|FG005|Overall Study|Death|0|||
44499993|NCT00079274|79504531|FG006|Overall Study|Death|0|||
44499994|NCT00079274|79504525|FG000|Overall Study|Cytogenetic resistance|0|||
44232977|NCT00708552|79050458|FG001|Overall Study|Lack of Efficacy|4|||
44232978|NCT00708552|79050459|FG002|Overall Study|Lack of Efficacy|1|||
44499995|NCT00079274|79504526|FG001|Overall Study|Cytogenetic resistance|0|||
44499996|NCT00079274|79504527|FG002|Overall Study|Cytogenetic resistance|0|||
44499997|NCT00079274|79504528|FG003|Overall Study|Cytogenetic resistance|2|||
44499998|NCT00079274|79504529|FG004|Overall Study|Cytogenetic resistance|0|||
44499999|NCT00079274|79504530|FG005|Overall Study|Cytogenetic resistance|0|||
44500000|NCT00079274|79504531|FG006|Overall Study|Cytogenetic resistance|0|||
44500001|NCT00079274|79504525|FG000|Overall Study|Other|43|||
44500002|NCT00079274|79504526|FG001|Overall Study|Other|7|||
44500003|NCT00079274|79504527|FG002|Overall Study|Other|5|||
44500004|NCT00079274|79504528|FG003|Overall Study|Other|55|||
44500005|NCT00079274|79504529|FG004|Overall Study|Other|1|||
44500006|NCT00079274|79504530|FG005|Overall Study|Other|2|||
44500007|NCT00079274|79504531|FG006|Overall Study|Other|0|||
44500008|NCT00079040|79504544|FG000|Overall Study|Withdrew before treatment|1|||
44500009|NCT00079040|79504544|FG000|Overall Study|Ineligible|1|||
44500010|NCT00078806|79504548|FG000|Part 1A|Adverse Event|2|||
44500011|NCT00078806|79504549|FG001|Part 1A|Adverse Event|0|||
44500012|NCT00078806|79504550|FG002|Part 1A|Adverse Event|0|||
44500013|NCT00078806|79504551|FG003|Part 1A|Adverse Event|0|||
44500014|NCT00078806|79504548|FG000|Part 1A|Lack of Efficacy|7|||
44500015|NCT00078806|79504549|FG001|Part 1A|Lack of Efficacy|0|||
44500016|NCT00078806|79504550|FG002|Part 1A|Lack of Efficacy|0|||
44500017|NCT00078806|79504551|FG003|Part 1A|Lack of Efficacy|0|||
44500018|NCT00078806|79504548|FG000|Part 1A|Other|1|||
44500019|NCT00078806|79504549|FG001|Part 1A|Other|0|||
44500020|NCT00078806|79504550|FG002|Part 1A|Other|0|||
44500021|NCT00078806|79504551|FG003|Part 1A|Other|0|||
44500022|NCT00078806|79504548|FG000|Part 1B|Adverse Event|1|||
44500023|NCT00078806|79504549|FG001|Part 1B|Adverse Event|0|||
44500024|NCT00078806|79504550|FG002|Part 1B|Adverse Event|0|||
44500025|NCT00078806|79504551|FG003|Part 1B|Adverse Event|0|||
44232979|NCT00708552|79050460|FG003|Overall Study|Lack of Efficacy|0|||
44232980|NCT00708552|79050457|FG000|Overall Study|Protocol Violation|0|||
44500026|NCT00078806|79504548|FG000|Part 1B|Lack of Efficacy|7|||
44500027|NCT00078806|79504549|FG001|Part 1B|Lack of Efficacy|0|||
44500028|NCT00078806|79504550|FG002|Part 1B|Lack of Efficacy|0|||
44500029|NCT00078806|79504551|FG003|Part 1B|Lack of Efficacy|0|||
44500030|NCT00078806|79504548|FG000|Part 2|Adverse Event|0|||
44500031|NCT00078806|79504549|FG001|Part 2|Adverse Event|1|||
44500032|NCT00078806|79504550|FG002|Part 2|Adverse Event|0|||
44500033|NCT00078806|79504551|FG003|Part 2|Adverse Event|0|||
44500034|NCT00078338|79504568|FG000|Overall Study|Adverse Event|31|||
44500035|NCT00078338|79504569|FG001|Overall Study|Adverse Event|24|||
44232981|NCT00708552|79050458|FG001|Overall Study|Protocol Violation|0|||
44232982|NCT00708552|79050459|FG002|Overall Study|Protocol Violation|2|||
44232983|NCT00708552|79050460|FG003|Overall Study|Protocol Violation|4|||
44232984|NCT00708552|79050457|FG000|Overall Study|Lost to Follow-up|4|||
44232985|NCT00708552|79050458|FG001|Overall Study|Lost to Follow-up|2|||
44232986|NCT00708552|79050459|FG002|Overall Study|Lost to Follow-up|0|||
44232987|NCT00708552|79050460|FG003|Overall Study|Lost to Follow-up|1|||
44232988|NCT00708552|79050457|FG000|Overall Study|Physician Decision|1|||
44232989|NCT00708552|79050458|FG001|Overall Study|Physician Decision|2|||
44500036|NCT00078338|79504568|FG000|Overall Study|Lost to Follow-up|17|||
44500037|NCT00078338|79504569|FG001|Overall Study|Lost to Follow-up|2|||
44500038|NCT00078338|79504568|FG000|Overall Study|Protocol Violation|2|||
44500039|NCT00078338|79504569|FG001|Overall Study|Protocol Violation|2|||
44500040|NCT00078338|79504568|FG000|Overall Study|Disease Progression|4|||
44500041|NCT00078338|79504569|FG001|Overall Study|Disease Progression|7|||
44500042|NCT00078338|79504568|FG000|Overall Study|Other|28|||
44500043|NCT00078338|79504569|FG001|Overall Study|Other|16|||
44500044|NCT00078338|79504568|FG000|Overall Study|Subjects randomized, but not treated|3|||
44500045|NCT00078338|79504569|FG001|Overall Study|Subjects randomized, but not treated|3|||
44500046|NCT03808688|79504577|FG000|Overall Study|Adverse Event|13|||
44500047|NCT03808688|79504578|FG001|Overall Study|Adverse Event|17|||
44500048|NCT03808688|79504577|FG000|Overall Study|Lack of Efficacy|2|||
44500049|NCT03808688|79504578|FG001|Overall Study|Lack of Efficacy|0|||
44500050|NCT03808688|79504577|FG000|Overall Study|Lost to Follow-up|0|||
44500051|NCT03808688|79504578|FG001|Overall Study|Lost to Follow-up|2|||
44232990|NCT00708552|79050459|FG002|Overall Study|Physician Decision|0|||
44275319|NCT02237196|79221794|FG001|Overall Study|Withdrawal by Subject|1|||
44500052|NCT03808688|79504577|FG000|Overall Study|Withdrawal by Subject|1|||
44500053|NCT03808688|79504578|FG001|Overall Study|Withdrawal by Subject|0|||
44500054|NCT03808688|79504577|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
44500055|NCT03808688|79504578|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
44500056|NCT03808688|79504577|FG000|Overall Study|IOP Too High|1|||
44232991|NCT00708552|79050460|FG003|Overall Study|Physician Decision|0|||
44500057|NCT03808688|79504578|FG001|Overall Study|IOP Too High|1|||
44500058|NCT03808688|79504577|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
44500059|NCT03808688|79504578|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
44232992|NCT00708552|79050457|FG000|Overall Study|Withdrawal by Subject|12|||
44232993|NCT00708552|79050458|FG001|Overall Study|Withdrawal by Subject|7|||
44232994|NCT00708552|79050459|FG002|Overall Study|Withdrawal by Subject|8|||
44500060|NCT03808688|79504577|FG000|Overall Study|Visit Out of Window|0|||
44500061|NCT03808688|79504578|FG001|Overall Study|Visit Out of Window|1|||
44500062|NCT03808688|79504577|FG000|Overall Study|Medication Non-Compliance|0|||
44500063|NCT03808688|79504578|FG001|Overall Study|Medication Non-Compliance|1|||
44500064|NCT03808298|79504586|FG000|Overall Study|Adverse Event|3|||
44500065|NCT03808298|79504586|FG000|Overall Study|Physician Decision|1|||
44500066|NCT03808298|79504586|FG000|Overall Study|Withdrawal by Subject|1|||
44500067|NCT03808298|79504586|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
44500068|NCT00077636|79504617|FG000|Overall Study|Refused Treatment|9|||
44232995|NCT00708552|79050460|FG003|Overall Study|Withdrawal by Subject|10|||
44232996|NCT01816295|79050590|FG000|Double Blind Phase|Adverse Event|11|||
44232997|NCT01816295|79050591|FG001|Double Blind Phase|Adverse Event|8|||
44232998|NCT01816295|79050590|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
44500069|NCT00077636|79504618|FG001|Overall Study|Refused Treatment|31|||
44500070|NCT00077636|79504617|FG000|Overall Study|Admin|3|||
44500071|NCT00077636|79504618|FG001|Overall Study|Admin|3|||
44500072|NCT00077636|79504617|FG000|Overall Study|Withdrawal by Subject|2|||
44500073|NCT00077636|79504618|FG001|Overall Study|Withdrawal by Subject|2|||
44500074|NCT00077636|79504617|FG000|Overall Study|Adverse Event|17|||
44500075|NCT00077636|79504618|FG001|Overall Study|Adverse Event|34|||
44500076|NCT00077636|79504617|FG000|Overall Study|Protocol Violation|0|||
44143815|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
44143816|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
44500077|NCT00077636|79504618|FG001|Overall Study|Protocol Violation|2|||
44500078|NCT00077636|79504617|FG000|Overall Study|Lost to Follow-up|10|||
44143817|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
44143818|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
44143819|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
44143820|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
44143821|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
44143822|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
44232999|NCT01816295|79050591|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
44233000|NCT01816295|79050590|FG000|Double Blind Phase|Lost to Follow-up|3|||
44233001|NCT01816295|79050591|FG001|Double Blind Phase|Lost to Follow-up|5|||
44233002|NCT01816295|79050590|FG000|Double Blind Phase|Physician Decision|2|||
44233003|NCT01816295|79050591|FG001|Double Blind Phase|Physician Decision|2|||
44500079|NCT00077636|79504618|FG001|Overall Study|Lost to Follow-up|18|||
44500080|NCT00077636|79504617|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
44500081|NCT00077636|79504618|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
44500082|NCT00095199|79504629|FG000|Overall Study|Adverse Event|40|||
44500083|NCT00095199|79504630|FG001|Overall Study|Adverse Event|22|||
44500084|NCT00095199|79504631|FG002|Overall Study|Adverse Event|26|||
44500085|NCT00095199|79504632|FG003|Overall Study|Adverse Event|11|||
44500086|NCT00095199|79504629|FG000|Overall Study|Progressive disease|213|||
44500087|NCT00095199|79504630|FG001|Overall Study|Progressive disease|179|||
44500088|NCT00095199|79504631|FG002|Overall Study|Progressive disease|105|||
44500089|NCT00095199|79504632|FG003|Overall Study|Progressive disease|98|||
44500090|NCT00095199|79504629|FG000|Overall Study|Death|10|||
44500091|NCT00095199|79504630|FG001|Overall Study|Death|6|||
44500092|NCT00095199|79504631|FG002|Overall Study|Death|11|||
44500093|NCT00095199|79504632|FG003|Overall Study|Death|9|||
44500094|NCT00095199|79504629|FG000|Overall Study|Withdrawal by Subject|21|||
44500095|NCT00095199|79504630|FG001|Overall Study|Withdrawal by Subject|16|||
44500096|NCT00095199|79504631|FG002|Overall Study|Withdrawal by Subject|13|||
44500097|NCT00095199|79504632|FG003|Overall Study|Withdrawal by Subject|22|||
44500098|NCT00095199|79504629|FG000|Overall Study|Protocol Violation|4|||
44500099|NCT00095199|79504630|FG001|Overall Study|Protocol Violation|4|||
44500100|NCT00095199|79504631|FG002|Overall Study|Protocol Violation|2|||
44500101|NCT00095199|79504632|FG003|Overall Study|Protocol Violation|0|||
44500102|NCT00095199|79504629|FG000|Overall Study|Liver function test results elevated|0|||
44500103|NCT00095199|79504630|FG001|Overall Study|Liver function test results elevated|0|||
44500104|NCT00095199|79504631|FG002|Overall Study|Liver function test results elevated|1|||
44500105|NCT00095199|79504632|FG003|Overall Study|Liver function test results elevated|1|||
44233004|NCT01816295|79050590|FG000|Double Blind Phase|Protocol Violation|17|||
44233005|NCT01816295|79050591|FG001|Double Blind Phase|Protocol Violation|11|||
44233006|NCT01816295|79050590|FG000|Double Blind Phase|Sponsor Decision|8|||
44233007|NCT01816295|79050591|FG001|Double Blind Phase|Sponsor Decision|8|||
44233008|NCT01816295|79050590|FG000|Double Blind Phase|Withdrawal by Subject|22|||
44233009|NCT01816295|79050591|FG001|Double Blind Phase|Withdrawal by Subject|20|||
44233010|NCT01816295|79050590|FG000|OLE Phase|Adverse Event|17|||
44233011|NCT01816295|79050591|FG001|OLE Phase|Adverse Event|15|||
44233012|NCT01816295|79050590|FG000|OLE Phase|Death|1|||
44233013|NCT01816295|79050591|FG001|OLE Phase|Death|0|||
44233014|NCT01816295|79050590|FG000|OLE Phase|Entry Criteria Not Met|3|||
44233015|NCT01816295|79050591|FG001|OLE Phase|Entry Criteria Not Met|5|||
44233016|NCT01816295|79050590|FG000|OLE Phase|Lost to Follow-up|5|||
44233017|NCT01816295|79050591|FG001|OLE Phase|Lost to Follow-up|5|||
44233018|NCT01816295|79050590|FG000|OLE Phase|Physician Decision|3|||
44233019|NCT01816295|79050591|FG001|OLE Phase|Physician Decision|1|||
44233020|NCT01816295|79050590|FG000|OLE Phase|Protocol Violation|4|||
44233021|NCT01816295|79050591|FG001|OLE Phase|Protocol Violation|4|||
44233022|NCT01816295|79050590|FG000|OLE Phase|Sponsor Decision|7|||
44233023|NCT01816295|79050591|FG001|OLE Phase|Sponsor Decision|9|||
44233024|NCT01816295|79050590|FG000|OLE Phase|Withdrawal by Subject|10|||
44233025|NCT01816295|79050591|FG001|OLE Phase|Withdrawal by Subject|10|||
44233026|NCT01816295|79050590|FG000|OLE Phase|Lack of Efficacy|3|||
44233027|NCT01816295|79050591|FG001|OLE Phase|Lack of Efficacy|7|||
44233028|NCT01610297|79050616|FG000|Overall Study|Lost to Follow-up|1|||
44233029|NCT01793051|79050627|FG000|Overall Study|Withdrawal by Subject|6|||
44233030|NCT01793051|79050628|FG001|Overall Study|Withdrawal by Subject|4|||
44233031|NCT01793051|79050627|FG000|Overall Study|Adverse Event|0|||
44233032|NCT01793051|79050628|FG001|Overall Study|Adverse Event|2|||
44500106|NCT00095199|79504629|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
44500107|NCT00095199|79504630|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
44233033|NCT01793051|79050627|FG000|Overall Study|Too ill to continue|1|||
44233034|NCT01793051|79050628|FG001|Overall Study|Too ill to continue|0|||
44233035|NCT01793051|79050627|FG000|Overall Study|Switched chemo|1|||
44233036|NCT01793051|79050628|FG001|Overall Study|Switched chemo|1|||
44233037|NCT01793051|79050627|FG000|Overall Study|Lack of compliance|1|||
44233038|NCT01793051|79050628|FG001|Overall Study|Lack of compliance|0|||
44233039|NCT01793051|79050627|FG000|Overall Study|Requested to be removed from the study|1|||
44233040|NCT01793051|79050628|FG001|Overall Study|Requested to be removed from the study|1|||
44233041|NCT01816061|79050661|FG000|Overall Study|Lost to Follow-up|13|||
44500108|NCT00095199|79504631|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
44500109|NCT00095199|79504632|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
44500110|NCT00095199|79504629|FG000|Overall Study|Physician Decision|5|||
44500111|NCT00095199|79504630|FG001|Overall Study|Physician Decision|6|||
44500112|NCT00095199|79504631|FG002|Overall Study|Physician Decision|1|||
44500113|NCT00095199|79504632|FG003|Overall Study|Physician Decision|1|||
44500114|NCT00095199|79504629|FG000|Overall Study|Not eligible|1|||
44500115|NCT00095199|79504630|FG001|Overall Study|Not eligible|7|||
44500116|NCT00095199|79504631|FG002|Overall Study|Not eligible|0|||
44500117|NCT00095199|79504632|FG003|Overall Study|Not eligible|1|||
44376944|NCT00896649|79382248|FG000|Overall Study|technical difficulties|2|||
44376945|NCT00796003|79382255|FG000|Overall Study|Disease Progression|2|||
44376946|NCT00796003|79382256|FG001|Overall Study|Disease Progression|13|||
44376947|NCT00796003|79382255|FG000|Overall Study|Adverse Event|1|||
44376948|NCT00796003|79382256|FG001|Overall Study|Adverse Event|7|||
44376949|NCT00796003|79382255|FG000|Overall Study|Specified organ function not met|0|||
44376950|NCT00796003|79382256|FG001|Overall Study|Specified organ function not met|1|||
44376951|NCT00796003|79382255|FG000|Overall Study|Physician Decision|0|||
44376952|NCT00796003|79382256|FG001|Overall Study|Physician Decision|4|||
44376953|NCT00796003|79382255|FG000|Overall Study|Withdrawal by Subject|0|||
44376954|NCT00796003|79382256|FG001|Overall Study|Withdrawal by Subject|1|||
44376955|NCT00796003|79382255|FG000|Overall Study|Other|0|||
44376956|NCT00796003|79382256|FG001|Overall Study|Other|1|||
44376957|NCT00796003|79382255|FG000|Overall Study|Participants Not treated|0|||
44376958|NCT00796003|79382256|FG001|Overall Study|Participants Not treated|2|||
44376959|NCT00895011|79382268|FG000|Overall Study|Withdrawal by Subject|14|||
44376960|NCT00895011|79382269|FG001|Overall Study|Withdrawal by Subject|7|||
44376961|NCT00895011|79382270|FG002|Overall Study|Withdrawal by Subject|2|||
44376962|NCT00895011|79382268|FG000|Overall Study|Lost to Follow-up|5|||
44376963|NCT00895011|79382269|FG001|Overall Study|Lost to Follow-up|4|||
44376964|NCT00895011|79382270|FG002|Overall Study|Lost to Follow-up|1|||
44376965|NCT00895011|79382268|FG000|Overall Study|Protocol Violation|3|||
44376966|NCT00895011|79382269|FG001|Overall Study|Protocol Violation|1|||
44376967|NCT00895011|79382270|FG002|Overall Study|Protocol Violation|3|||
44376968|NCT00895011|79382268|FG000|Overall Study|Adverse Event|1|||
44561249|NCT03169153|79579409|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
44233042|NCT01816061|79050662|FG001|Overall Study|Lost to Follow-up|24|||
44376969|NCT00895011|79382269|FG001|Overall Study|Adverse Event|2|||
44376970|NCT00895011|79382270|FG002|Overall Study|Adverse Event|2|||
44376971|NCT00895011|79382268|FG000|Overall Study|schedule conflict|1|||
44376972|NCT00895011|79382269|FG001|Overall Study|schedule conflict|0|||
44500118|NCT00095199|79504629|FG000|Overall Study|Started Palliative Radiotherapy|1|||
44500119|NCT00095199|79504630|FG001|Overall Study|Started Palliative Radiotherapy|0|||
44233043|NCT01792115|79050688|FG000|Overall Study|Lost to Follow-up|0|||
44233044|NCT01792115|79050689|FG001|Overall Study|Lost to Follow-up|1|||
44233045|NCT01792115|79050690|FG002|Overall Study|Lost to Follow-up|0|||
44376973|NCT00895011|79382270|FG002|Overall Study|schedule conflict|0|||
44376974|NCT00899847|79382279|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
44376975|NCT00795535|79382285|FG000|Overall Study|incomplete data and technical problems|20|||
44376976|NCT00853762|79382293|FG000|Overall Study|Premature Termination|16|||
44376977|NCT00853762|79382294|FG001|Overall Study|Premature Termination|15|||
44376978|NCT00853762|79382295|FG002|Overall Study|Premature Termination|14|||
44376979|NCT00853762|79382296|FG003|Overall Study|Premature Termination|21|||
44376980|NCT00853762|79382293|FG000|Overall Study|Protocol Violation|0|||
44376981|NCT00853762|79382294|FG001|Overall Study|Protocol Violation|0|||
44376982|NCT00853762|79382295|FG002|Overall Study|Protocol Violation|0|||
44376983|NCT00853762|79382296|FG003|Overall Study|Protocol Violation|1|||
44376984|NCT00853762|79382293|FG000|Overall Study|Withdrawal by Subject|0|||
44376985|NCT00853762|79382294|FG001|Overall Study|Withdrawal by Subject|0|||
44376986|NCT00853762|79382295|FG002|Overall Study|Withdrawal by Subject|1|||
44376987|NCT00853762|79382296|FG003|Overall Study|Withdrawal by Subject|0|||
44376988|NCT00853762|79382293|FG000|Overall Study|Other|0|||
44376989|NCT00853762|79382294|FG001|Overall Study|Other|2|||
44376990|NCT00853762|79382295|FG002|Overall Study|Other|0|||
44376991|NCT00853762|79382296|FG003|Overall Study|Other|0|||
44376992|NCT00853762|79382293|FG000|Overall Study|Randomised but not Treated|0|||
44376993|NCT00853762|79382294|FG001|Overall Study|Randomised but not Treated|2|||
44376994|NCT00853762|79382295|FG002|Overall Study|Randomised but not Treated|2|||
44376995|NCT00853762|79382296|FG003|Overall Study|Randomised but not Treated|0|||
44376996|NCT00789529|79382308|FG000|Overall Study|Withdrawal by Subject|0|||
44376997|NCT00789529|79382309|FG001|Overall Study|Withdrawal by Subject|1|||
44376998|NCT00789529|79382308|FG000|Overall Study|Other Reason|1|||
44376999|NCT00789529|79382309|FG001|Overall Study|Other Reason|0|||
44377000|NCT00894933|79382315|FG000|Overall Study|Lost to Follow-up|2|||
44377001|NCT00894933|79382315|FG000|Overall Study|Cancelled Procedure|1|||
44377002|NCT00894933|79382315|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
44377003|NCT00792805|79382322|FG000|Overall Study|Adverse Event|12|||
44377004|NCT00792805|79382323|FG001|Overall Study|Adverse Event|10|||
44377005|NCT00792805|79382324|FG002|Overall Study|Adverse Event|10|||
44377006|NCT00792805|79382322|FG000|Overall Study|Subject withdrew consent|5|||
44377007|NCT00792805|79382323|FG001|Overall Study|Subject withdrew consent|6|||
44377008|NCT00792805|79382324|FG002|Overall Study|Subject withdrew consent|5|||
44377009|NCT00792805|79382322|FG000|Overall Study|Administrative problems|2|||
44377010|NCT00792805|79382323|FG001|Overall Study|Administrative problems|0|||
44233046|NCT01791803|79050702|FG000|Overall Study|Withdrawal by Subject|0|||
44233047|NCT01791803|79050703|FG001|Overall Study|Withdrawal by Subject|0|||
44233048|NCT01791803|79050704|FG002|Overall Study|Withdrawal by Subject|0|||
44377011|NCT00792805|79382324|FG002|Overall Study|Administrative problems|4|||
44377012|NCT00792805|79382322|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44377013|NCT00792805|79382323|FG001|Overall Study|Abnormal test procedure result(s)|2|||
44377014|NCT00792805|79382324|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44377015|NCT00792805|79382322|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44377016|NCT00792805|79382323|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
44377017|NCT00792805|79382324|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
44377018|NCT00792805|79382322|FG000|Overall Study|Lost to Follow-up|1|||
44377019|NCT00792805|79382323|FG001|Overall Study|Lost to Follow-up|1|||
44377020|NCT00792805|79382324|FG002|Overall Study|Lost to Follow-up|6|||
44377021|NCT00792805|79382322|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44377022|NCT00792805|79382323|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44377023|NCT00792805|79382324|FG002|Overall Study|Abnormal laboratory value(s)|1|||
44233049|NCT01791803|79050705|FG003|Overall Study|Withdrawal by Subject|2|||
44233050|NCT01791803|79050702|FG000|Overall Study|Physician Decision|0|||
44377024|NCT00792805|79382322|FG000|Overall Study|Protocol deviation|0|||
44377025|NCT00792805|79382323|FG001|Overall Study|Protocol deviation|1|||
44377026|NCT00792805|79382324|FG002|Overall Study|Protocol deviation|1|||
44377027|NCT00925002|79382335|FG000|Overall Study|Other|1|||
44377028|NCT00925002|79382336|FG001|Overall Study|Other|4|||
44377029|NCT00925002|79382337|FG002|Overall Study|Other|0|||
44377030|NCT00925002|79382335|FG000|Overall Study|Death|1|||
44377031|NCT00925002|79382336|FG001|Overall Study|Death|1|||
44377032|NCT00925002|79382337|FG002|Overall Study|Death|5|||
44233051|NCT01791803|79050703|FG001|Overall Study|Physician Decision|2|||
44233052|NCT01791803|79050704|FG002|Overall Study|Physician Decision|0|||
44275320|NCT02237196|79221795|FG002|Overall Study|Withdrawal by Subject|4|||
44377033|NCT00925002|79382335|FG000|Overall Study|Adverse Event|3|||
44377034|NCT00925002|79382336|FG001|Overall Study|Adverse Event|1|||
44377035|NCT00925002|79382337|FG002|Overall Study|Adverse Event|2|||
44233053|NCT01791803|79050705|FG003|Overall Study|Physician Decision|1|||
44377036|NCT00925002|79382335|FG000|Overall Study|Participant withdrew consent|1|||
44377037|NCT00925002|79382336|FG001|Overall Study|Participant withdrew consent|3|||
44377038|NCT00925002|79382337|FG002|Overall Study|Participant withdrew consent|3|||
44377039|NCT00928746|79382346|FG000|Overall Study|Adverse Event|2|||
44377040|NCT00928746|79382346|FG000|Overall Study|Protocol Violation|1|||
44377041|NCT00928746|79382346|FG000|Overall Study|Withdrawal by Subject|1|||
44377042|NCT00928746|79382346|FG000|Overall Study|Other|2|||
44377043|NCT00922428|79382352|FG000|Overall Study|retrospective/extremely implausible data|2|||
44377044|NCT00922428|79382352|FG000|Overall Study|no medication use or questionable use|13|||
44377045|NCT00894543|79382364|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
44377046|NCT00894543|79382365|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
44377047|NCT00894543|79382364|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
44377048|NCT00894543|79382365|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
44377049|NCT00922272|79382371|FG000|Open-label Phase|Adverse Event|5|||
44377050|NCT00922272|79382372|FG001|Open-label Phase|Adverse Event|0|||
44377051|NCT00922272|79382371|FG000|Open-label Phase|Protocol Violation|1|||
44377052|NCT00922272|79382372|FG001|Open-label Phase|Protocol Violation|0|||
44377053|NCT00922272|79382371|FG000|Open-label Phase|Withdrawal by Subject|11|||
44377054|NCT00922272|79382372|FG001|Open-label Phase|Withdrawal by Subject|0|||
44377055|NCT00922272|79382371|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
44377056|NCT00922272|79382372|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
44561250|NCT03169153|79579408|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
44233054|NCT01791803|79050702|FG000|Overall Study|Death|0|||
44233055|NCT01791803|79050703|FG001|Overall Study|Death|0|||
44233056|NCT01791803|79050704|FG002|Overall Study|Death|2|||
44233057|NCT01791803|79050705|FG003|Overall Study|Death|2|||
44561251|NCT03169153|79579409|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
44561252|NCT03168919|79579415|FG000|Overall Study|Withdrawal by Subject|2|||
44561253|NCT03205163|79579425|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
44561254|NCT03205163|79579426|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
44561255|NCT01759537|79579441|FG000|Overall Study|Death|1|||
44561256|NCT01759537|79579442|FG001|Overall Study|Death|1|||
44561257|NCT01759537|79579441|FG000|Overall Study|Pregnancy|1|||
44561258|NCT01759537|79579442|FG001|Overall Study|Pregnancy|1|||
44561259|NCT01759537|79579441|FG000|Overall Study|Lost to Follow-up|9|||
44561260|NCT01759537|79579442|FG001|Overall Study|Lost to Follow-up|9|||
44561261|NCT01759537|79579441|FG000|Overall Study|Accident involving jaw fracture|1|||
44561262|NCT01759537|79579442|FG001|Overall Study|Accident involving jaw fracture|1|||
44561263|NCT01759537|79579441|FG000|Overall Study|Subcrestal implant too coronal|1|||
44561264|NCT01759537|79579442|FG001|Overall Study|Subcrestal implant too coronal|1|||
44561265|NCT03204539|79579450|FG000|Overall Study|Loss of funding|0|||
44561266|NCT03204539|79579451|FG001|Overall Study|Loss of funding|1|||
44561267|NCT03502681|79579468|FG000|Overall Study|Adverse Event|1|||
44561268|NCT03502681|79579469|FG001|Overall Study|Adverse Event|1|||
44377057|NCT00922272|79382371|FG000|Open-label Phase|Withdrawal criteria met|5|||
44377058|NCT00922272|79382372|FG001|Open-label Phase|Withdrawal criteria met|0|||
44377059|NCT00922272|79382371|FG000|Double-blind Phase|Adverse Event|1|||
44377060|NCT00922272|79382372|FG001|Double-blind Phase|Adverse Event|1|||
44377061|NCT00922272|79382371|FG000|Double-blind Phase|Withdrawal by Subject|1|||
44377062|NCT00922272|79382372|FG001|Double-blind Phase|Withdrawal by Subject|1|||
44500120|NCT00095199|79504631|FG002|Overall Study|Started Palliative Radiotherapy|0|||
44500121|NCT00095199|79504632|FG003|Overall Study|Started Palliative Radiotherapy|0|||
44500122|NCT00095199|79504629|FG000|Overall Study|Started radiotherapy regimen|0|||
44500123|NCT00095199|79504630|FG001|Overall Study|Started radiotherapy regimen|1|||
44500124|NCT00095199|79504631|FG002|Overall Study|Started radiotherapy regimen|0|||
44500125|NCT00095199|79504632|FG003|Overall Study|Started radiotherapy regimen|0|||
44500126|NCT00095199|79504629|FG000|Overall Study|Primary tumor removed in other surgery|0|||
44500127|NCT00095199|79504630|FG001|Overall Study|Primary tumor removed in other surgery|1|||
44500128|NCT00095199|79504631|FG002|Overall Study|Primary tumor removed in other surgery|0|||
44500129|NCT00095199|79504632|FG003|Overall Study|Primary tumor removed in other surgery|0|||
44500130|NCT00095199|79504629|FG000|Overall Study|Data inadvertently lost by site|1|||
44500131|NCT00095199|79504630|FG001|Overall Study|Data inadvertently lost by site|0|||
44500132|NCT00095199|79504631|FG002|Overall Study|Data inadvertently lost by site|0|||
44500133|NCT00095199|79504632|FG003|Overall Study|Data inadvertently lost by site|0|||
44500134|NCT00075764|79504649|FG000|Overall Study|Adverse Event|5|||
44561269|NCT03502681|79579468|FG000|Overall Study|Disease Progression|2|||
44500135|NCT00075764|79504650|FG001|Overall Study|Adverse Event|12|||
44561270|NCT03502681|79579469|FG001|Overall Study|Disease Progression|1|||
44233058|NCT01791725|79050730|FG000|Overall Study|Withdrawal by Subject|0|||
44377063|NCT00922272|79382371|FG000|Double-blind Phase|Lost to Follow-up|2|||
44377064|NCT00922272|79382372|FG001|Double-blind Phase|Lost to Follow-up|1|||
44377065|NCT00922272|79382371|FG000|Double-blind Phase|Withdrawal criteria met|1|||
44377066|NCT00922272|79382372|FG001|Double-blind Phase|Withdrawal criteria met|1|||
44561271|NCT02860130|79579476|FG000|Overall Study|Adverse Event|2|||
44561272|NCT02860130|79579477|FG001|Overall Study|Adverse Event|3|||
44561273|NCT02860130|79579476|FG000|Overall Study|Protocol Violation|1|||
44561274|NCT02860130|79579477|FG001|Overall Study|Protocol Violation|1|||
44377067|NCT00922272|79382371|FG000|Double-blind Phase|Noncompliance|1|||
44377068|NCT00922272|79382372|FG001|Double-blind Phase|Noncompliance|1|||
44377069|NCT00922272|79382371|FG000|Double-blind Phase|Positive urine drug screen|1|||
44377070|NCT00922272|79382372|FG001|Double-blind Phase|Positive urine drug screen|1|||
44377071|NCT00853372|79382382|FG000|Overall Study|Death|30|||
44377072|NCT00853372|79382383|FG001|Overall Study|Death|26|||
44377073|NCT00853372|79382382|FG000|Overall Study|Lost to Follow-up|1|||
44377074|NCT00853372|79382383|FG001|Overall Study|Lost to Follow-up|2|||
44377075|NCT00853372|79382382|FG000|Overall Study|Full Consent Withdrawn|1|||
44561275|NCT02860130|79579476|FG000|Overall Study|Withdrawal by Subject|0|||
44561276|NCT02860130|79579477|FG001|Overall Study|Withdrawal by Subject|2|||
44377076|NCT00853372|79382383|FG001|Overall Study|Full Consent Withdrawn|1|||
44377077|NCT00848536|79382391|FG000|Overall Study|Adverse Event|2|||
44500136|NCT00075764|79504649|FG000|Overall Study|Death|4|||
44561277|NCT02860130|79579476|FG000|Overall Study|Physician Decision|2|||
44561278|NCT02860130|79579477|FG001|Overall Study|Physician Decision|2|||
44561279|NCT02860130|79579476|FG000|Overall Study|Other|2|||
44561280|NCT02860130|79579477|FG001|Overall Study|Other|1|||
44561281|NCT02986854|79579486|FG000|Overall Study|Withdrawal by Subject|0|||
44561282|NCT02986854|79579487|FG001|Overall Study|Withdrawal by Subject|1|||
44561283|NCT02986854|79579488|FG002|Overall Study|Withdrawal by Subject|1|||
44561284|NCT02986854|79579486|FG000|Overall Study|Lost to Follow-up|3|||
44561285|NCT02986854|79579487|FG001|Overall Study|Lost to Follow-up|11|||
44561286|NCT02986854|79579488|FG002|Overall Study|Lost to Follow-up|2|||
44561287|NCT02887183|79579498|FG000|Overall Study|Adverse Event|44|||
44561288|NCT02887183|79579498|FG000|Overall Study|Death|30|||
44561289|NCT02887183|79579498|FG000|Overall Study|Pregnancy|1|||
44561290|NCT02887183|79579498|FG000|Overall Study|Protocol Violation|6|||
44561291|NCT02887183|79579498|FG000|Overall Study|Technical Problems|2|||
44561292|NCT02887183|79579498|FG000|Overall Study|Lost to Follow-up|13|||
44561293|NCT02887183|79579498|FG000|Overall Study|Physician Decision|10|||
44561294|NCT02887183|79579498|FG000|Overall Study|Withdrawal by Subject|35|||
44561295|NCT03167359|79579502|FG000|Overall Study|Physician Decision|1|||
44561296|NCT03167359|79579502|FG000|Overall Study|Lost to Follow-up|1|||
44561297|NCT01068600|79579508|FG000|Overall Study|Withdrawal by Subject|5|||
44377078|NCT00848536|79382392|FG001|Overall Study|Adverse Event|2|||
44500137|NCT00075764|79504650|FG001|Overall Study|Death|8|||
44500138|NCT00075764|79504649|FG000|Overall Study|Withdrawal by Subject|28|||
44500139|NCT00075764|79504650|FG001|Overall Study|Withdrawal by Subject|18|||
44500140|NCT00075764|79504649|FG000|Overall Study|Progression|269|||
44500141|NCT00075764|79504650|FG001|Overall Study|Progression|274|||
44500142|NCT00075764|79504649|FG000|Overall Study|Still on treatment|8|||
44500143|NCT00075764|79504650|FG001|Overall Study|Still on treatment|15|||
44500144|NCT00075764|79504649|FG000|Overall Study|Delinquent|4|||
44500145|NCT00075764|79504650|FG001|Overall Study|Delinquent|2|||
44500146|NCT00075764|79504649|FG000|Overall Study|Not protocol specified|27|||
44500147|NCT00075764|79504650|FG001|Overall Study|Not protocol specified|19|||
44500148|NCT00075764|79504649|FG000|Overall Study|Under review|0|||
44500149|NCT00075764|79504650|FG001|Overall Study|Under review|1|||
44500150|NCT03568162|79504664|FG000|Overall Study|Adverse Event|0|||
44500151|NCT03568162|79504665|FG001|Overall Study|Adverse Event|1|||
44500152|NCT03568162|79504666|FG002|Overall Study|Adverse Event|2|||
44500153|NCT03568162|79504667|FG003|Overall Study|Adverse Event|0|||
44500154|NCT03568162|79504668|FG004|Overall Study|Adverse Event|0|||
44500155|NCT03568162|79504669|FG005|Overall Study|Adverse Event|1|||
44500156|NCT03568162|79504664|FG000|Overall Study|Death|0|||
44500157|NCT03568162|79504665|FG001|Overall Study|Death|0|||
44500158|NCT03568162|79504666|FG002|Overall Study|Death|0|||
44500159|NCT03568162|79504667|FG003|Overall Study|Death|0|||
44500160|NCT03568162|79504668|FG004|Overall Study|Death|1|||
44500161|NCT03568162|79504669|FG005|Overall Study|Death|0|||
44500162|NCT03568162|79504664|FG000|Overall Study|Lost to Follow-up|3|||
44500163|NCT03568162|79504665|FG001|Overall Study|Lost to Follow-up|2|||
44500164|NCT03568162|79504666|FG002|Overall Study|Lost to Follow-up|4|||
44500165|NCT03568162|79504667|FG003|Overall Study|Lost to Follow-up|2|||
44500166|NCT03568162|79504668|FG004|Overall Study|Lost to Follow-up|3|||
44500167|NCT03568162|79504669|FG005|Overall Study|Lost to Follow-up|2|||
44500168|NCT03568162|79504664|FG000|Overall Study|Physician Decision|0|||
44500169|NCT03568162|79504665|FG001|Overall Study|Physician Decision|1|||
44500170|NCT03568162|79504666|FG002|Overall Study|Physician Decision|1|||
44500171|NCT03568162|79504667|FG003|Overall Study|Physician Decision|0|||
44500172|NCT03568162|79504668|FG004|Overall Study|Physician Decision|1|||
44561298|NCT01068600|79579509|FG001|Overall Study|Withdrawal by Subject|6|||
44500173|NCT03568162|79504669|FG005|Overall Study|Physician Decision|0|||
44500174|NCT03568162|79504664|FG000|Overall Study|Pregnancy|0|||
44561299|NCT01068600|79579508|FG000|Overall Study|Adverse Event|3|||
44561300|NCT01068600|79579509|FG001|Overall Study|Adverse Event|3|||
44561301|NCT01068600|79579508|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44561302|NCT01068600|79579509|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44561303|NCT01068600|79579508|FG000|Overall Study|Lost to Follow-up|1|||
44561304|NCT01068600|79579509|FG001|Overall Study|Lost to Follow-up|2|||
44561305|NCT01068600|79579508|FG000|Overall Study|Protocol deviation|1|||
44561306|NCT01068600|79579509|FG001|Overall Study|Protocol deviation|1|||
44561307|NCT01068600|79579508|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44561308|NCT01068600|79579509|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
44561309|NCT01068600|79579508|FG000|Overall Study|Administrative problems|0|||
44561310|NCT01068600|79579509|FG001|Overall Study|Administrative problems|1|||
44561311|NCT01067976|79579515|FG000|Overall Study|Study drug never administered|20|||
44561312|NCT01067976|79579515|FG000|Overall Study|Study prematurely discontinued|2|||
44561313|NCT02858492|79579537|FG000|Overall Study|Withdrawal by Subject|0|||
44561314|NCT02858492|79579538|FG001|Overall Study|Withdrawal by Subject|1|||
44561315|NCT02858492|79579539|FG002|Overall Study|Withdrawal by Subject|0|||
44561316|NCT02858492|79579540|FG003|Overall Study|Withdrawal by Subject|1|||
44561317|NCT02858492|79579537|FG000|Overall Study|Adverse Event|0|||
44561318|NCT02858492|79579538|FG001|Overall Study|Adverse Event|0|||
44561319|NCT02858492|79579539|FG002|Overall Study|Adverse Event|0|||
44561320|NCT02858492|79579540|FG003|Overall Study|Adverse Event|3|||
44561321|NCT02858492|79579537|FG000|Overall Study|Lack of Efficacy|0|||
44561322|NCT02858492|79579538|FG001|Overall Study|Lack of Efficacy|0|||
44561323|NCT02858492|79579539|FG002|Overall Study|Lack of Efficacy|0|||
44561324|NCT02858492|79579540|FG003|Overall Study|Lack of Efficacy|1|||
44561325|NCT02858492|79579537|FG000|Overall Study|Protocol defined stopping criteria|0|||
44561326|NCT02858492|79579538|FG001|Overall Study|Protocol defined stopping criteria|0|||
44561327|NCT02858492|79579539|FG002|Overall Study|Protocol defined stopping criteria|0|||
44561328|NCT02858492|79579540|FG003|Overall Study|Protocol defined stopping criteria|1|||
44561329|NCT01067508|79579554|FG000|Overall Study|Physician Decision|0|||
44561330|NCT01067508|79579555|FG001|Overall Study|Physician Decision|1|||
44561331|NCT01067508|79579554|FG000|Overall Study|Withdrawal by Subject|0|||
44561332|NCT01067508|79579555|FG001|Overall Study|Withdrawal by Subject|1|||
44561333|NCT01067352|79579564|FG000|Overall Study|Withdrawal by Subject|1|||
44561334|NCT01067352|79579565|FG001|Overall Study|Withdrawal by Subject|2|||
44561335|NCT01067352|79579566|FG002|Overall Study|Withdrawal by Subject|1|||
44561336|NCT01067352|79579564|FG000|Overall Study|Physician Decision|0|||
44561337|NCT01067352|79579565|FG001|Overall Study|Physician Decision|1|||
44561338|NCT01067352|79579566|FG002|Overall Study|Physician Decision|0|||
44561339|NCT02986074|79579574|FG000|First Trial Period|Adverse Event|1|||
44561340|NCT02986074|79579575|FG001|First Trial Period|Adverse Event|0|||
44561341|NCT02986074|79579576|FG002|First Trial Period|Adverse Event|0|||
44561342|NCT02986074|79579577|FG003|First Trial Period|Adverse Event|0|||
44561343|NCT02986074|79579574|FG000|Follow up Period|system explant|0|||
44561344|NCT02986074|79579575|FG001|Follow up Period|system explant|0|||
44561345|NCT02986074|79579576|FG002|Follow up Period|system explant|1|||
44561346|NCT02986074|79579577|FG003|Follow up Period|system explant|2|||
44561347|NCT02986074|79579574|FG000|Follow up Period|Physician Decision|0|||
44561348|NCT02986074|79579575|FG001|Follow up Period|Physician Decision|0|||
44561349|NCT02986074|79579576|FG002|Follow up Period|Physician Decision|0|||
44561350|NCT02986074|79579577|FG003|Follow up Period|Physician Decision|1|||
44561351|NCT02920242|79579585|FG000|Overall Study|Withdrawal by Subject|1|||
44561352|NCT02920242|79579586|FG001|Overall Study|Withdrawal by Subject|0|||
44500175|NCT03568162|79504665|FG001|Overall Study|Pregnancy|0|||
44500176|NCT03568162|79504666|FG002|Overall Study|Pregnancy|0|||
44500177|NCT03568162|79504667|FG003|Overall Study|Pregnancy|1|||
44500178|NCT03568162|79504668|FG004|Overall Study|Pregnancy|0|||
44500179|NCT03568162|79504669|FG005|Overall Study|Pregnancy|0|||
44500180|NCT03568162|79504664|FG000|Overall Study|Protocol Violation|1|||
44500181|NCT03568162|79504665|FG001|Overall Study|Protocol Violation|0|||
44500182|NCT03568162|79504666|FG002|Overall Study|Protocol Violation|1|||
44561353|NCT02920242|79579587|FG002|Overall Study|Withdrawal by Subject|1|||
44561354|NCT02920242|79579585|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
44500183|NCT03568162|79504667|FG003|Overall Study|Protocol Violation|1|||
44500184|NCT03568162|79504668|FG004|Overall Study|Protocol Violation|1|||
44500185|NCT03568162|79504669|FG005|Overall Study|Protocol Violation|1|||
44561355|NCT02920242|79579586|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
44561356|NCT02920242|79579587|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
44561357|NCT02985996|79579600|FG000|Overall Study|Withdrawal by Subject|0|||
44561358|NCT02985996|79579601|FG001|Overall Study|Withdrawal by Subject|0|||
44561359|NCT02985996|79579602|FG002|Overall Study|Withdrawal by Subject|1|||
44561360|NCT02985996|79579603|FG003|Overall Study|Withdrawal by Subject|0|||
44561361|NCT02985996|79579604|FG004|Overall Study|Withdrawal by Subject|0|||
44561362|NCT02985996|79579600|FG000|Overall Study|Protocol Violation|0|||
44561363|NCT02985996|79579601|FG001|Overall Study|Protocol Violation|1|||
44561364|NCT02985996|79579602|FG002|Overall Study|Protocol Violation|0|||
44500186|NCT03568162|79504664|FG000|Overall Study|Withdrawal by Subject|15|||
44561365|NCT02985996|79579603|FG003|Overall Study|Protocol Violation|0|||
44561366|NCT02985996|79579604|FG004|Overall Study|Protocol Violation|0|||
44561367|NCT03225833|79579626|FG000|Overall Study|Adverse Event|0|||
44561368|NCT03225833|79579627|FG001|Overall Study|Adverse Event|1|||
44561369|NCT03225833|79579628|FG002|Overall Study|Adverse Event|2|||
44561370|NCT03225833|79579629|FG003|Overall Study|Adverse Event|0|||
44561371|NCT03225833|79579630|FG004|Overall Study|Adverse Event|0|||
44561372|NCT03225833|79579631|FG005|Overall Study|Adverse Event|2|||
44561373|NCT03225833|79579626|FG000|Overall Study|Withdrawal by Subject|1|||
44561374|NCT03225833|79579627|FG001|Overall Study|Withdrawal by Subject|0|||
44561375|NCT03225833|79579628|FG002|Overall Study|Withdrawal by Subject|0|||
44561376|NCT03225833|79579629|FG003|Overall Study|Withdrawal by Subject|0|||
44561377|NCT03225833|79579630|FG004|Overall Study|Withdrawal by Subject|1|||
44561378|NCT03225833|79579631|FG005|Overall Study|Withdrawal by Subject|0|||
44561379|NCT03225833|79579626|FG000|Overall Study|Termination of Study by Sponsor|4|||
44561380|NCT03225833|79579627|FG001|Overall Study|Termination of Study by Sponsor|0|||
44561381|NCT03225833|79579628|FG002|Overall Study|Termination of Study by Sponsor|0|||
44561382|NCT03225833|79579629|FG003|Overall Study|Termination of Study by Sponsor|0|||
44561383|NCT03225833|79579630|FG004|Overall Study|Termination of Study by Sponsor|0|||
44561384|NCT03225833|79579631|FG005|Overall Study|Termination of Study by Sponsor|7|||
44561385|NCT03225833|79579626|FG000|Overall Study|Sponsor Decision|0|||
44561386|NCT03225833|79579627|FG001|Overall Study|Sponsor Decision|0|||
44561387|NCT03225833|79579628|FG002|Overall Study|Sponsor Decision|0|||
44561388|NCT03225833|79579629|FG003|Overall Study|Sponsor Decision|0|||
44561389|NCT03225833|79579630|FG004|Overall Study|Sponsor Decision|0|||
44561390|NCT03225833|79579631|FG005|Overall Study|Sponsor Decision|1|||
44561391|NCT03203447|79579652|FG000|Overall Study|Withdrawal by Subject|2|||
44561392|NCT03203447|79579653|FG001|Overall Study|Withdrawal by Subject|1|||
44561393|NCT03203447|79579652|FG000|Overall Study|Lost to Follow-up|1|||
44561394|NCT03203447|79579653|FG001|Overall Study|Lost to Follow-up|10|||
44561395|NCT03203447|79579652|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
44561396|NCT03203447|79579653|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
44561397|NCT02858726|79579663|FG000|Overall Study|Adverse Event|4|||
44561398|NCT02858726|79579664|FG001|Overall Study|Adverse Event|4|||
44561399|NCT02858726|79579665|FG002|Overall Study|Adverse Event|9|||
44561400|NCT02858726|79579666|FG003|Overall Study|Adverse Event|1|||
44561401|NCT02858726|79579663|FG000|Overall Study|Physician Decision|0|||
44561402|NCT02858726|79579664|FG001|Overall Study|Physician Decision|0|||
44561403|NCT02858726|79579665|FG002|Overall Study|Physician Decision|1|||
44561404|NCT02858726|79579666|FG003|Overall Study|Physician Decision|0|||
44561405|NCT02858726|79579663|FG000|Overall Study|Protocol Violation|0|||
44561406|NCT02858726|79579664|FG001|Overall Study|Protocol Violation|0|||
44561407|NCT02858726|79579665|FG002|Overall Study|Protocol Violation|0|||
44561408|NCT02858726|79579666|FG003|Overall Study|Protocol Violation|1|||
44561409|NCT02858726|79579663|FG000|Overall Study|Study Terminated by Sponsor|0|||
44561410|NCT02858726|79579664|FG001|Overall Study|Study Terminated by Sponsor|0|||
44561411|NCT02858726|79579665|FG002|Overall Study|Study Terminated by Sponsor|0|||
44561412|NCT02858726|79579666|FG003|Overall Study|Study Terminated by Sponsor|1|||
44561413|NCT02858726|79579663|FG000|Overall Study|Withdrawal by Subject|1|||
44561414|NCT02858726|79579664|FG001|Overall Study|Withdrawal by Subject|2|||
44561415|NCT02858726|79579665|FG002|Overall Study|Withdrawal by Subject|1|||
44561416|NCT02858726|79579666|FG003|Overall Study|Withdrawal by Subject|0|||
44561417|NCT02858726|79579663|FG000|Overall Study|Noncompliance|0|||
44561418|NCT02858726|79579664|FG001|Overall Study|Noncompliance|1|||
44561419|NCT02858726|79579665|FG002|Overall Study|Noncompliance|0|||
44561420|NCT02858726|79579666|FG003|Overall Study|Noncompliance|0|||
44561421|NCT03203291|79579680|FG000|Overall Study|Withdrawal by Subject|1|||
44561422|NCT01068678|79579686|FG000|Overall Study|Lack of Efficacy|3|||
44561423|NCT01068678|79579687|FG001|Overall Study|Lack of Efficacy|2|||
44233059|NCT01791725|79050731|FG001|Overall Study|Withdrawal by Subject|1|||
44233060|NCT01791725|79050732|FG002|Overall Study|Withdrawal by Subject|0|||
44233061|NCT01791413|79050742|FG000|Overall Study|Lost to Follow-up|5|||
44233062|NCT01791413|79050743|FG001|Overall Study|Lost to Follow-up|1|||
44233063|NCT01610063|79050756|FG000|Overall Study|Lost to Follow-up|42|||
44561424|NCT01068678|79579686|FG000|Overall Study|Protocol Violation|5|||
44561425|NCT01068678|79579687|FG001|Overall Study|Protocol Violation|1|||
44561426|NCT01068678|79579686|FG000|Overall Study|Withdrawal criteria|12|||
44561427|NCT01068678|79579687|FG001|Overall Study|Withdrawal criteria|6|||
44561428|NCT01068678|79579686|FG000|Overall Study|Unclassified|18|||
44561429|NCT01068678|79579687|FG001|Overall Study|Unclassified|15|||
44561430|NCT03202511|79579693|FG000|Overall Study|Withdrawal by Subject|1|||
44561431|NCT03202511|79579694|FG001|Overall Study|Withdrawal by Subject|0|||
44561432|NCT02919696|79579715|FG000|Overall Study|Adverse Event|1|||
44561433|NCT02919696|79579716|FG001|Overall Study|Adverse Event|2|||
44561434|NCT02919696|79579715|FG000|Overall Study|Withdrawal by Subject|2|||
44233064|NCT01610063|79050757|FG001|Overall Study|Lost to Follow-up|20|||
44561435|NCT02919696|79579716|FG001|Overall Study|Withdrawal by Subject|1|||
44561436|NCT02919696|79579715|FG000|Overall Study|Sponsor Decision|1|||
44561437|NCT02919696|79579716|FG001|Overall Study|Sponsor Decision|1|||
44561438|NCT02919696|79579715|FG000|Overall Study|Never Treated|0|||
44561439|NCT02919696|79579716|FG001|Overall Study|Never Treated|1|||
44561440|NCT02935673|79579731|FG000|Overall Study|Adverse Event|0|||
44561441|NCT02935673|79579732|FG001|Overall Study|Adverse Event|1|||
44561442|NCT02935673|79579733|FG002|Overall Study|Adverse Event|0|||
44561443|NCT02935673|79579731|FG000|Overall Study|Withdrawal by Subject|1|||
44561444|NCT02935673|79579732|FG001|Overall Study|Withdrawal by Subject|2|||
44561445|NCT02935673|79579733|FG002|Overall Study|Withdrawal by Subject|0|||
44561446|NCT03201809|79579745|FG000|Overall Study|Lost to Follow-up|2|||
44561447|NCT03201809|79579746|FG001|Overall Study|Lost to Follow-up|0|||
44561448|NCT02985450|79579757|FG000|Overall Study|Lost to Follow-up|7|||
44561449|NCT02908464|79579766|FG000|Overall Study|Withdrawal by Subject|2|||
44561450|NCT02908464|79579767|FG001|Overall Study|Withdrawal by Subject|1|||
44561451|NCT02908464|79579766|FG000|Overall Study|Found ineligible after randomization|0|||
44561452|NCT02908464|79579767|FG001|Overall Study|Found ineligible after randomization|2|||
44561453|NCT02907216|79579776|FG000|Overall Study|No benefit to be obtained by continuing|0|||
44561454|NCT02907216|79579777|FG001|Overall Study|No benefit to be obtained by continuing|1|||
44561455|NCT02907216|79579776|FG000|Overall Study|Withdrawal by Subject|1|||
44561456|NCT02907216|79579777|FG001|Overall Study|Withdrawal by Subject|0|||
44561457|NCT02984982|79579785|FG000|Overall Study|Adverse Event|2|||
44377079|NCT00848536|79382391|FG000|Overall Study|Withdrawal by Subject|0|||
44377080|NCT00848536|79382392|FG001|Overall Study|Withdrawal by Subject|1|||
44561458|NCT02984982|79579786|FG001|Overall Study|Adverse Event|5|||
44561459|NCT02984982|79579785|FG000|Overall Study|Poor Compliance to Protocol|4|||
44561460|NCT02984982|79579786|FG001|Overall Study|Poor Compliance to Protocol|4|||
44561461|NCT02984982|79579785|FG000|Overall Study|Withdrawal by Subject|2|||
44561462|NCT02984982|79579786|FG001|Overall Study|Withdrawal by Subject|0|||
44561463|NCT02984982|79579785|FG000|Overall Study|Randomized but not treated|0|||
44561464|NCT02984982|79579786|FG001|Overall Study|Randomized but not treated|1|||
44561465|NCT02981472|79579795|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
44561466|NCT02981472|79579796|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
44561467|NCT02981472|79579795|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44561468|NCT02981472|79579796|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44561469|NCT02981472|79579795|FG000|Treatment Period|Adverse Event|6|||
44561470|NCT02981472|79579796|FG001|Treatment Period|Adverse Event|1|||
44561471|NCT02981472|79579795|FG000|Treatment Period|Participant withdrew consent|1|||
44561472|NCT02981472|79579796|FG001|Treatment Period|Participant withdrew consent|0|||
44561473|NCT02981472|79579795|FG000|Treatment Period|Lost to Follow-up|0|||
44561474|NCT02981472|79579796|FG001|Treatment Period|Lost to Follow-up|1|||
44561475|NCT02982720|79579808|FG000|Overall Study|Adverse Event|3|||
44561476|NCT02982720|79579808|FG000|Overall Study|Death|1|||
44561477|NCT00849667|79579815|FG000|Overall Study|Withdrawal by Subject|16|||
44561478|NCT00849667|79579816|FG001|Overall Study|Withdrawal by Subject|33|||
44561479|NCT00849667|79579817|FG002|Overall Study|Withdrawal by Subject|35|||
44561480|NCT00849667|79579815|FG000|Overall Study|Lost to Follow-up|8|||
44561481|NCT00849667|79579816|FG001|Overall Study|Lost to Follow-up|8|||
44561482|NCT00849667|79579817|FG002|Overall Study|Lost to Follow-up|8|||
44561483|NCT00849667|79579815|FG000|Overall Study|Adverse Event|1|||
44561484|NCT00849667|79579816|FG001|Overall Study|Adverse Event|2|||
44561485|NCT00849667|79579817|FG002|Overall Study|Adverse Event|0|||
44377081|NCT00848536|79382391|FG000|Overall Study|Protocol Violation|0|||
44377082|NCT00848536|79382392|FG001|Overall Study|Protocol Violation|1|||
44377083|NCT00848536|79382391|FG000|Overall Study|Noncompliance|1|||
44561486|NCT00849667|79579815|FG000|Overall Study|Other|18|||
44561487|NCT00849667|79579816|FG001|Overall Study|Other|19|||
44233065|NCT01813721|79050763|FG000|Overall Study|Ineligibility determined|63|||
44233066|NCT01813721|79050763|FG000|Overall Study|Withdrawal by Subject|1|||
44377084|NCT00848536|79382392|FG001|Overall Study|Noncompliance|0|||
44561488|NCT00849667|79579817|FG002|Overall Study|Other|18|||
44561489|NCT00849667|79579815|FG000|Overall Study|Progressive disease|119|||
44561490|NCT00849667|79579816|FG001|Overall Study|Progressive disease|100|||
44561491|NCT00849667|79579817|FG002|Overall Study|Progressive disease|112|||
44561492|NCT00849667|79579815|FG000|Overall Study|Sponsor decision|208|||
44561493|NCT00849667|79579816|FG001|Overall Study|Sponsor decision|204|||
44561494|NCT00849667|79579817|FG002|Overall Study|Sponsor decision|190|||
44561495|NCT00849667|79579815|FG000|Overall Study|Investigator discretion|0|||
44561496|NCT00849667|79579816|FG001|Overall Study|Investigator discretion|0|||
44561497|NCT00849667|79579817|FG002|Overall Study|Investigator discretion|1|||
44561498|NCT03201419|79579836|FG000|Overall Study|Adverse Event|3|||
44561499|NCT03201419|79579837|FG001|Overall Study|Adverse Event|1|||
44561500|NCT03201419|79579838|FG002|Overall Study|Adverse Event|0|||
44561501|NCT03201419|79579839|FG003|Overall Study|Adverse Event|0|||
44561502|NCT03201419|79579840|FG004|Overall Study|Adverse Event|1|||
44561503|NCT03201419|79579841|FG005|Overall Study|Adverse Event|1|||
44561504|NCT03201419|79579842|FG006|Overall Study|Adverse Event|5|||
44561505|NCT03201419|79579843|FG007|Overall Study|Adverse Event|0|||
44561506|NCT03201419|79579844|FG008|Overall Study|Adverse Event|0|||
44561507|NCT03201419|79579836|FG000|Overall Study|Lost to Follow-up|1|||
44561508|NCT03201419|79579837|FG001|Overall Study|Lost to Follow-up|0|||
44233067|NCT01790633|79050787|FG000|Overall Study|Protocol Violation|1|||
44233068|NCT01790633|79050788|FG001|Overall Study|Protocol Violation|2|||
44233069|NCT01790633|79050787|FG000|Overall Study|Did not have serology performed|47|||
44233070|NCT01790633|79050788|FG001|Overall Study|Did not have serology performed|0|||
44233071|NCT01790633|79050787|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
44233072|NCT01790633|79050788|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
44233073|NCT01788215|79050797|FG000|Overall Study|Withdrawal by Subject|0|||
44233074|NCT01788215|79050798|FG001|Overall Study|Withdrawal by Subject|1|||
44233075|NCT01788215|79050797|FG000|Overall Study|Lost to Follow-up|2|||
44233076|NCT01788215|79050798|FG001|Overall Study|Lost to Follow-up|0|||
44233077|NCT01787825|79050804|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
44233078|NCT01787825|79050805|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
44233079|NCT01787825|79050804|FG000|Overall Study|Data Not Analyzable|5|||
44377085|NCT00848536|79382391|FG000|Overall Study|Inadequate Control of IOP|1|||
44500187|NCT03568162|79504665|FG001|Overall Study|Withdrawal by Subject|15|||
44233080|NCT01787825|79050805|FG001|Overall Study|Data Not Analyzable|1|||
44233081|NCT01813019|79050814|FG000|Overall Study|Adverse Event|0|||
44233082|NCT01813019|79050815|FG001|Overall Study|Adverse Event|3|||
44233083|NCT01813019|79050814|FG000|Overall Study|Withdrawal by Subject|3|||
44233084|NCT01813019|79050815|FG001|Overall Study|Withdrawal by Subject|2|||
44233085|NCT01813019|79050814|FG000|Overall Study|administrative problems|2|||
44500188|NCT03568162|79504666|FG002|Overall Study|Withdrawal by Subject|26|||
44500189|NCT03568162|79504667|FG003|Overall Study|Withdrawal by Subject|22|||
44500190|NCT03568162|79504668|FG004|Overall Study|Withdrawal by Subject|6|||
44500191|NCT03568162|79504669|FG005|Overall Study|Withdrawal by Subject|9|||
44500192|NCT03568162|79504664|FG000|Overall Study|Others|3|||
44500193|NCT03568162|79504665|FG001|Overall Study|Others|4|||
44500194|NCT03568162|79504666|FG002|Overall Study|Others|1|||
44500195|NCT03568162|79504667|FG003|Overall Study|Others|4|||
44500196|NCT03568162|79504668|FG004|Overall Study|Others|2|||
44500197|NCT03568162|79504669|FG005|Overall Study|Others|1|||
44500198|NCT03567616|79504688|FG000|Overall Study|Disease progression|4|||
44500199|NCT03567616|79504688|FG000|Overall Study|Withdrawal by Subject|1|||
44500200|NCT03567616|79504688|FG000|Overall Study|Physician Decision|1|||
44500201|NCT03567616|79504688|FG000|Overall Study|Death|1|||
44500202|NCT03567616|79504688|FG000|Overall Study|Adverse Event|1|||
44500203|NCT03567382|79504697|FG000|Overall Study|Lost to Follow-up|1|||
44500204|NCT03567382|79504698|FG001|Overall Study|Lost to Follow-up|21|||
44500205|NCT03567382|79504699|FG002|Overall Study|Lost to Follow-up|1|||
44500206|NCT03567382|79504700|FG003|Overall Study|Lost to Follow-up|21|||
44500207|NCT03567382|79504697|FG000|Overall Study|Withdrawal by Subject|2|||
44500208|NCT03567382|79504698|FG001|Overall Study|Withdrawal by Subject|14|||
44500209|NCT03567382|79504699|FG002|Overall Study|Withdrawal by Subject|1|||
44500210|NCT03567382|79504700|FG003|Overall Study|Withdrawal by Subject|12|||
44500211|NCT03595384|79504711|FG000|Overall Study|Other time commitments|8|||
44500212|NCT03595384|79504711|FG000|Overall Study|Changes to session time|7|||
44500213|NCT03595384|79504711|FG000|Overall Study|Relocation out of country|1|||
44500214|NCT03591874|79504717|FG000|Overall Study|Adverse Event|4|||
44500215|NCT03591874|79504718|FG001|Overall Study|Adverse Event|0|||
44500216|NCT03591874|79504717|FG000|Overall Study|Withdrawal by Subject|2|||
44500217|NCT03591874|79504718|FG001|Overall Study|Withdrawal by Subject|1|||
44500218|NCT03591874|79504717|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
44500219|NCT03591874|79504718|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
44500220|NCT03591874|79504717|FG000|Overall Study|On Study at Time of Study Termination|12|||
44500221|NCT03591874|79504718|FG001|Overall Study|On Study at Time of Study Termination|6|||
44233086|NCT01813019|79050815|FG001|Overall Study|administrative problems|0|||
44233087|NCT01813019|79050814|FG000|Overall Study|Protocol Deviation|2|||
44233088|NCT01813019|79050815|FG001|Overall Study|Protocol Deviation|1|||
44500222|NCT03566680|79504724|FG000|Overall Study|Pregnancy|1|||
44500223|NCT03566680|79504724|FG000|Overall Study|Lost to Follow-up|13|||
44500224|NCT03566680|79504724|FG000|Overall Study|Withdrawal by Subject|3|||
44561509|NCT03201419|79579838|FG002|Overall Study|Lost to Follow-up|0|||
44561510|NCT03201419|79579839|FG003|Overall Study|Lost to Follow-up|0|||
44561511|NCT03201419|79579840|FG004|Overall Study|Lost to Follow-up|0|||
44561512|NCT03201419|79579841|FG005|Overall Study|Lost to Follow-up|0|||
44233089|NCT01787591|79050823|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
44500225|NCT00106353|79504730|FG000|Part 1|Disease progression|3|||
44500226|NCT00106353|79504731|FG001|Part 1|Disease progression|4|||
44561513|NCT03201419|79579842|FG006|Overall Study|Lost to Follow-up|0|||
44561514|NCT03201419|79579843|FG007|Overall Study|Lost to Follow-up|0|||
44561515|NCT03201419|79579844|FG008|Overall Study|Lost to Follow-up|0|||
44561516|NCT03201419|79579836|FG000|Overall Study|Protocol Deviation|0|||
44561517|NCT03201419|79579837|FG001|Overall Study|Protocol Deviation|0|||
44561518|NCT03201419|79579838|FG002|Overall Study|Protocol Deviation|0|||
44233090|NCT01787591|79050824|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
44233091|NCT01787591|79050825|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
44561519|NCT03201419|79579839|FG003|Overall Study|Protocol Deviation|0|||
44561520|NCT03201419|79579840|FG004|Overall Study|Protocol Deviation|0|||
44561521|NCT03201419|79579841|FG005|Overall Study|Protocol Deviation|0|||
44561522|NCT03201419|79579842|FG006|Overall Study|Protocol Deviation|1|||
44561523|NCT03201419|79579843|FG007|Overall Study|Protocol Deviation|0|||
44561524|NCT03201419|79579844|FG008|Overall Study|Protocol Deviation|0|||
44561525|NCT03201419|79579836|FG000|Overall Study|Withdrawal by Subject|4|||
44561526|NCT03201419|79579837|FG001|Overall Study|Withdrawal by Subject|2|||
44561527|NCT03201419|79579838|FG002|Overall Study|Withdrawal by Subject|1|||
44561528|NCT03201419|79579839|FG003|Overall Study|Withdrawal by Subject|0|||
44561529|NCT03201419|79579840|FG004|Overall Study|Withdrawal by Subject|0|||
44561530|NCT03201419|79579841|FG005|Overall Study|Withdrawal by Subject|0|||
44561531|NCT03201419|79579842|FG006|Overall Study|Withdrawal by Subject|0|||
44561532|NCT03201419|79579843|FG007|Overall Study|Withdrawal by Subject|1|||
44561533|NCT03201419|79579844|FG008|Overall Study|Withdrawal by Subject|2|||
44561534|NCT03201419|79579836|FG000|Overall Study|Other|0|||
44561535|NCT03201419|79579837|FG001|Overall Study|Other|0|||
44561536|NCT03201419|79579838|FG002|Overall Study|Other|1|||
44561537|NCT03201419|79579839|FG003|Overall Study|Other|0|||
44561538|NCT03201419|79579840|FG004|Overall Study|Other|0|||
44561539|NCT03201419|79579841|FG005|Overall Study|Other|0|||
44561540|NCT03201419|79579842|FG006|Overall Study|Other|0|||
44561541|NCT03201419|79579843|FG007|Overall Study|Other|0|||
44561542|NCT03201419|79579844|FG008|Overall Study|Other|0|||
44561543|NCT02924389|79579880|FG000|Overall Study|Lost to Follow-up|1|||
44561544|NCT02924389|79579881|FG001|Overall Study|Lost to Follow-up|0|||
44561545|NCT02924389|79579880|FG000|Overall Study|Physician Decision|2|||
44561546|NCT02924389|79579881|FG001|Overall Study|Physician Decision|0|||
44561547|NCT02924389|79579880|FG000|Overall Study|Withdrawal by Subject|3|||
44561548|NCT02924389|79579881|FG001|Overall Study|Withdrawal by Subject|0|||
44561549|NCT02924389|79579880|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
44561550|NCT02924389|79579881|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
44561551|NCT03235349|79579888|FG000|Overall Study|Adverse Event|1|||
44561552|NCT03235349|79579888|FG000|Overall Study|Other|1|||
44561553|NCT03235115|79579892|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
44561554|NCT03235115|79579893|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
44561555|NCT03235115|79579894|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
44561556|NCT03235115|79579895|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
44561557|NCT03235115|79579896|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
44561558|NCT03235115|79579897|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
44561559|NCT02923531|79579905|FG000|Overall Study|Adverse Event|4|||
44561560|NCT02923531|79579905|FG000|Overall Study|Clinical Deterioration|1|||
44561561|NCT02923531|79579905|FG000|Overall Study|Disease Progression|3|||
44561562|NCT02923531|79579905|FG000|Overall Study|Study Termination|1|||
44561563|NCT02934503|79579910|FG000|Overall Study|progression of disease|3|||
44561564|NCT02934503|79579910|FG000|Overall Study|Withdrawal by Subject|1|||
44561565|NCT02937545|79579916|FG000|Overall Study|Withdrawal by Subject|1|||
44561566|NCT02937545|79579917|FG001|Overall Study|Withdrawal by Subject|2|||
44561567|NCT02937545|79579918|FG002|Overall Study|Withdrawal by Subject|6|||
44561568|NCT02937545|79579919|FG003|Overall Study|Withdrawal by Subject|7|||
44561569|NCT02937545|79579916|FG000|Overall Study|Lost to Follow-up|1|||
44561570|NCT02937545|79579917|FG001|Overall Study|Lost to Follow-up|0|||
44561571|NCT02937545|79579918|FG002|Overall Study|Lost to Follow-up|0|||
44561572|NCT02937545|79579919|FG003|Overall Study|Lost to Follow-up|0|||
44561573|NCT03199391|79579930|FG000|Overall Study|Death|1|||
44561574|NCT03199391|79579930|FG000|Overall Study|Lost to Follow-up|3|||
44233092|NCT01787591|79050826|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
44561575|NCT03199391|79579930|FG000|Overall Study|Adverse Event|2|||
44561576|NCT03199391|79579930|FG000|Overall Study|Withdrawal by Subject|10|||
44561577|NCT03198767|79579941|FG000|Overall Study|Protocol Violation|0|||
44561578|NCT03198767|79579942|FG001|Overall Study|Protocol Violation|0|||
44561579|NCT03198767|79579943|FG002|Overall Study|Protocol Violation|0|||
44561580|NCT03198767|79579944|FG003|Overall Study|Protocol Violation|6|||
44561581|NCT03198767|79579945|FG004|Overall Study|Protocol Violation|0|||
44561582|NCT03198767|79579946|FG005|Overall Study|Protocol Violation|0|||
44561583|NCT03198767|79579947|FG006|Overall Study|Protocol Violation|0|||
44233093|NCT01812707|79050841|FG000|Overall Study|Adverse Event|0|||
44561584|NCT03162055|79579964|FG000|Overall Study|Adverse Event|6|||
44561585|NCT03162055|79579965|FG001|Overall Study|Adverse Event|5|||
44561586|NCT03162055|79579964|FG000|Overall Study|Death|3|||
44377086|NCT00848536|79382392|FG001|Overall Study|Inadequate Control of IOP|1|||
44377087|NCT00848536|79382391|FG000|Overall Study|Patient Moved|0|||
44500227|NCT00106353|79504732|FG002|Part 1|Disease progression|1|||
44500228|NCT00106353|79504733|FG003|Part 1|Disease progression|3|||
44500229|NCT00106353|79504734|FG004|Part 1|Disease progression|0|||
44500230|NCT00106353|79504735|FG005|Part 1|Disease progression|0|||
44275321|NCT02237196|79221796|FG003|Overall Study|Withdrawal by Subject|1|||
44233094|NCT01812707|79050842|FG001|Overall Study|Adverse Event|0|||
44233095|NCT01812707|79050843|FG002|Overall Study|Adverse Event|0|||
44233096|NCT01812707|79050844|FG003|Overall Study|Adverse Event|2|||
44233097|NCT01812707|79050841|FG000|Overall Study|Poor compliance to protocol|1|||
44500231|NCT00106353|79504736|FG006|Part 1|Disease progression|0|||
44500232|NCT00106353|79504730|FG000|Part 1|Withdrawal by Subject|0|||
44233098|NCT01812707|79050842|FG001|Overall Study|Poor compliance to protocol|0|||
44233099|NCT01812707|79050843|FG002|Overall Study|Poor compliance to protocol|0|||
44233100|NCT01812707|79050844|FG003|Overall Study|Poor compliance to protocol|0|||
44500233|NCT00106353|79504731|FG001|Part 1|Withdrawal by Subject|0|||
44500234|NCT00106353|79504732|FG002|Part 1|Withdrawal by Subject|1|||
44233101|NCT01812707|79050841|FG000|Overall Study|Consent withdrawn by participant|1|||
44233102|NCT01812707|79050842|FG001|Overall Study|Consent withdrawn by participant|0|||
44275322|NCT02237196|79221793|FG000|Overall Study|Site Error|1|||
44561587|NCT03162055|79579965|FG001|Overall Study|Death|3|||
44561588|NCT03162055|79579964|FG000|Overall Study|Lost to Follow-up|0|||
44561589|NCT03162055|79579965|FG001|Overall Study|Lost to Follow-up|1|||
44561590|NCT03162055|79579964|FG000|Overall Study|Study-specific withdrawal criteria|22|||
44561591|NCT03162055|79579965|FG001|Overall Study|Study-specific withdrawal criteria|14|||
44561592|NCT03162055|79579964|FG000|Overall Study|Withdrawal by Subject|17|||
44233103|NCT01812707|79050843|FG002|Overall Study|Consent withdrawn by participant|0|||
44233104|NCT01812707|79050844|FG003|Overall Study|Consent withdrawn by participant|0|||
44233105|NCT01787279|79050855|FG000|Overall Study|Lost to Follow-up|2|||
44233106|NCT01787279|79050855|FG000|Overall Study|Lack of Efficacy|1|||
44561593|NCT03162055|79579965|FG001|Overall Study|Withdrawal by Subject|2|||
44561594|NCT03162055|79579964|FG000|Overall Study|Did not receive treatment|2|||
44561595|NCT03162055|79579965|FG001|Overall Study|Did not receive treatment|0|||
44561596|NCT03162055|79579964|FG000|Overall Study|Incorrect randomization|4|||
44561597|NCT03162055|79579965|FG001|Overall Study|Incorrect randomization|3|||
44561598|NCT03162055|79579964|FG000|Overall Study|Other|8|||
44561599|NCT03162055|79579965|FG001|Overall Study|Other|15|||
44561600|NCT02927145|79579978|FG000|Initial Recruitment|Withdrawal by Subject|0|||
44561601|NCT02927145|79579979|FG001|Initial Recruitment|Withdrawal by Subject|1|||
44561602|NCT02927145|79579980|FG002|Initial Recruitment|Withdrawal by Subject|1|||
44561603|NCT02927145|79579981|FG003|Initial Recruitment|Withdrawal by Subject|4|||
44233107|NCT02728206|79050859|FG000|Overall Study|Death|1|||
44233108|NCT01811225|79050863|FG000|Treatment Period 1|Adverse Event|2|||
44233109|NCT01811225|79050864|FG001|Treatment Period 1|Adverse Event|3|||
44233110|NCT01811225|79050863|FG000|Treatment Period 1|Lost to Follow-up|12|||
44561604|NCT02927145|79579982|FG004|Initial Recruitment|Withdrawal by Subject|1|||
44561605|NCT02927145|79579983|FG005|Initial Recruitment|Withdrawal by Subject|1|||
44561606|NCT02927145|79579984|FG006|Initial Recruitment|Withdrawal by Subject|0|||
44275323|NCT02237196|79221794|FG001|Overall Study|Site Error|2|||
44275324|NCT02237196|79221795|FG002|Overall Study|Site Error|0|||
44275325|NCT02237196|79221796|FG003|Overall Study|Site Error|2|||
44275326|NCT02237118|79221812|FG000|Overall Study|Protocol Violation|0|||
44275327|NCT02237118|79221813|FG001|Overall Study|Protocol Violation|1|||
44275328|NCT02237118|79221812|FG000|Overall Study|consent withdrawn|1|||
44275329|NCT02237118|79221813|FG001|Overall Study|consent withdrawn|0|||
44275330|NCT02234622|79221829|FG000|Overall Study|Withdrawal by Subject|16|||
44275331|NCT02234622|79221830|FG001|Overall Study|Withdrawal by Subject|22|||
44275332|NCT02234622|79221829|FG000|Overall Study|Lost to Follow-up|27|||
44275333|NCT02234622|79221830|FG001|Overall Study|Lost to Follow-up|14|||
44275334|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
44275335|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
44275336|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
44275337|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
44275338|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
44275339|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
44500235|NCT00106353|79504733|FG003|Part 1|Withdrawal by Subject|2|||
44500236|NCT00106353|79504734|FG004|Part 1|Withdrawal by Subject|0|||
44500237|NCT00106353|79504735|FG005|Part 1|Withdrawal by Subject|0|||
44500238|NCT00106353|79504736|FG006|Part 1|Withdrawal by Subject|0|||
44275340|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
44275341|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
44275342|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
44275343|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
44275344|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
44275345|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
44275346|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
44275347|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
44275348|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
44275349|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
44275350|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
44275351|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
44275352|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
44275353|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
44275354|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
44275355|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
44275356|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
44275357|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
44275358|NCT02203032|79221838|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
44275359|NCT02203032|79221839|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
44275360|NCT02203032|79221840|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
44275361|NCT02203032|79221841|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
44275362|NCT02203032|79221838|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
44275363|NCT02203032|79221839|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
44275364|NCT02203032|79221840|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
44275365|NCT02203032|79221841|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
44275366|NCT02203032|79221838|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
44275367|NCT02203032|79221839|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
44275368|NCT02203032|79221840|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
44500239|NCT00106353|79504730|FG000|Part 1|Symptomatic deterioration|0|||
44500240|NCT00106353|79504731|FG001|Part 1|Symptomatic deterioration|0|||
44500241|NCT00106353|79504732|FG002|Part 1|Symptomatic deterioration|1|||
44500242|NCT00106353|79504733|FG003|Part 1|Symptomatic deterioration|0|||
44233111|NCT01811225|79050864|FG001|Treatment Period 1|Lost to Follow-up|8|||
44233112|NCT01811225|79050863|FG000|Treatment Period 1|transporation|1|||
44233113|NCT01811225|79050864|FG001|Treatment Period 1|transporation|0|||
44233114|NCT01811225|79050863|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
44233115|NCT01811225|79050864|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
44233116|NCT01811225|79050863|FG000|Treatment Period 2|Lost to Follow-up|1|||
44233117|NCT01811225|79050864|FG001|Treatment Period 2|Lost to Follow-up|2|||
44233118|NCT01811225|79050863|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
44233119|NCT01811225|79050864|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
44233120|NCT01809197|79050872|FG000|Overall Study|Lost to Follow-up|4|||
44233121|NCT01809197|79050873|FG001|Overall Study|Lost to Follow-up|2|||
44233122|NCT01809197|79050872|FG000|Overall Study|Adverse Event|2|||
44233123|NCT01809197|79050873|FG001|Overall Study|Adverse Event|3|||
44233124|NCT01809197|79050872|FG000|Overall Study|Failed slit lamp exam|1|||
44561607|NCT02927145|79579985|FG007|Initial Recruitment|Withdrawal by Subject|0|||
44561608|NCT02927145|79579986|FG008|Initial Recruitment|Withdrawal by Subject|2|||
44561609|NCT02927145|79579978|FG000|Initial Recruitment|Adverse Event|0|||
44561610|NCT02927145|79579979|FG001|Initial Recruitment|Adverse Event|0|||
44561611|NCT02927145|79579980|FG002|Initial Recruitment|Adverse Event|0|||
44561612|NCT02927145|79579981|FG003|Initial Recruitment|Adverse Event|0|||
44561613|NCT02927145|79579982|FG004|Initial Recruitment|Adverse Event|2|||
44561614|NCT02927145|79579983|FG005|Initial Recruitment|Adverse Event|0|||
44561615|NCT02927145|79579984|FG006|Initial Recruitment|Adverse Event|0|||
44561616|NCT02927145|79579985|FG007|Initial Recruitment|Adverse Event|0|||
44233125|NCT01809197|79050873|FG001|Overall Study|Failed slit lamp exam|0|||
44561617|NCT02927145|79579986|FG008|Initial Recruitment|Adverse Event|0|||
44561618|NCT02927145|79579978|FG000|Invitation for Additional Challenge|Pregnancy|0|||
44561619|NCT02927145|79579979|FG001|Invitation for Additional Challenge|Pregnancy|0|||
44561620|NCT02927145|79579980|FG002|Invitation for Additional Challenge|Pregnancy|0|||
44561621|NCT02927145|79579981|FG003|Invitation for Additional Challenge|Pregnancy|0|||
44561622|NCT02927145|79579982|FG004|Invitation for Additional Challenge|Pregnancy|0|||
44561623|NCT02927145|79579983|FG005|Invitation for Additional Challenge|Pregnancy|0|||
44561624|NCT02927145|79579984|FG006|Invitation for Additional Challenge|Pregnancy|1|||
44561625|NCT02927145|79579985|FG007|Invitation for Additional Challenge|Pregnancy|0|||
44561626|NCT02927145|79579986|FG008|Invitation for Additional Challenge|Pregnancy|0|||
44561627|NCT03688919|79580009|FG000|Overall Study|Lost to Follow-up|2|||
44561628|NCT03688919|79580010|FG001|Overall Study|Lost to Follow-up|1|||
44561629|NCT03688919|79580009|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
44561630|NCT03688919|79580010|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
44561631|NCT02888119|79580033|FG000|Overall Study|Lost to Follow-up|5|||
44561632|NCT02888119|79580034|FG001|Overall Study|Lost to Follow-up|4|||
44561633|NCT02888119|79580035|FG002|Overall Study|Lost to Follow-up|0|||
44561634|NCT03197129|79580044|FG000|Overall Study|did not answer the VPT: shyness|4|||
44561635|NCT03197129|79580045|FG001|Overall Study|did not answer the VPT: shyness|5|||
44561636|NCT03196973|79580054|FG000|Overall Study|Adverse Event|1|||
44561637|NCT03196973|79580055|FG001|Overall Study|Adverse Event|1|||
44561638|NCT03196973|79580056|FG002|Overall Study|Adverse Event|2|||
44561639|NCT03196973|79580054|FG000|Overall Study|Lack of Efficacy|2|||
44561640|NCT03196973|79580055|FG001|Overall Study|Lack of Efficacy|6|||
44561641|NCT03196973|79580056|FG002|Overall Study|Lack of Efficacy|1|||
44233126|NCT01809197|79050872|FG000|Overall Study|Non-Compliance|1|||
44233127|NCT01809197|79050873|FG001|Overall Study|Non-Compliance|1|||
44233128|NCT01809197|79050872|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
44233129|NCT01809197|79050873|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
44233130|NCT01809197|79050872|FG000|Overall Study|Withdrawal by Subject|1|||
44233131|NCT01809197|79050873|FG001|Overall Study|Withdrawal by Subject|1|||
44233132|NCT01809197|79050872|FG000|Overall Study|Product not available|0|||
44233133|NCT01809197|79050873|FG001|Overall Study|Product not available|1|||
44233134|NCT01786109|79050882|FG000|Overall Study|fail manometry barostat tube placement|1|||
44233135|NCT01786109|79050883|FG001|Overall Study|fail manometry barostat tube placement|0|||
44233136|NCT01786109|79050884|FG002|Overall Study|fail manometry barostat tube placement|0|||
44233137|NCT01786109|79050882|FG000|Overall Study|unrelated illness|0|||
44233138|NCT01786109|79050883|FG001|Overall Study|unrelated illness|0|||
44275369|NCT02203032|79221841|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
44561642|NCT03196973|79580054|FG000|Overall Study|Lost to Follow-up|4|||
44561643|NCT03196973|79580055|FG001|Overall Study|Lost to Follow-up|3|||
44561644|NCT03196973|79580056|FG002|Overall Study|Lost to Follow-up|2|||
44561645|NCT03196973|79580054|FG000|Overall Study|Consent withdrawn|2|||
44233139|NCT01786109|79050884|FG002|Overall Study|unrelated illness|1|||
44500243|NCT00106353|79504734|FG004|Part 1|Symptomatic deterioration|0|||
44500244|NCT00106353|79504735|FG005|Part 1|Symptomatic deterioration|0|||
44500245|NCT00106353|79504736|FG006|Part 1|Symptomatic deterioration|0|||
44500246|NCT00106353|79504730|FG000|Part 1|Entered follow-up phase|1|||
44500247|NCT00106353|79504731|FG001|Part 1|Entered follow-up phase|1|||
44500248|NCT00106353|79504732|FG002|Part 1|Entered follow-up phase|0|||
44500249|NCT00106353|79504733|FG003|Part 1|Entered follow-up phase|1|||
44500250|NCT00106353|79504734|FG004|Part 1|Entered follow-up phase|0|||
44500251|NCT00106353|79504735|FG005|Part 1|Entered follow-up phase|0|||
44561646|NCT03196973|79580055|FG001|Overall Study|Consent withdrawn|1|||
44561647|NCT03196973|79580056|FG002|Overall Study|Consent withdrawn|0|||
44561648|NCT03196973|79580054|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
44561649|NCT03196973|79580055|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
44561650|NCT03196973|79580056|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
44561651|NCT03196505|79580066|FG000|Overall Study|Physician Decision|26|||
44561652|NCT03196505|79580067|FG001|Overall Study|Physician Decision|26|||
44561653|NCT03196349|79580076|FG000|Overall Study|Did not receive study drug|0|||
44561654|NCT03196349|79580077|FG001|Overall Study|Did not receive study drug|1|||
44561655|NCT03196349|79580078|FG002|Overall Study|Did not receive study drug|2|||
44561656|NCT03196349|79580076|FG000|Overall Study|No data entered|2|||
44561657|NCT03196349|79580077|FG001|Overall Study|No data entered|4|||
44561658|NCT03196349|79580078|FG002|Overall Study|No data entered|0|||
44561659|NCT03196349|79580076|FG000|Overall Study|Study Terminated early|15|||
44561660|NCT03196349|79580077|FG001|Overall Study|Study Terminated early|9|||
44561661|NCT03196349|79580078|FG002|Overall Study|Study Terminated early|11|||
44561662|NCT02886715|79580089|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44561663|NCT02886715|79580090|FG001|Overall Study|Non-Compliance With Study Drug|2|||
44561664|NCT02886715|79580091|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44561665|NCT02886715|79580089|FG000|Overall Study|Adverse Event|4|||
44561666|NCT02886715|79580090|FG001|Overall Study|Adverse Event|2|||
44561667|NCT02886715|79580091|FG002|Overall Study|Adverse Event|0|||
44561668|NCT02886715|79580089|FG000|Overall Study|Lack of Efficacy|0|||
44561669|NCT02886715|79580090|FG001|Overall Study|Lack of Efficacy|2|||
44561670|NCT02886715|79580091|FG002|Overall Study|Lack of Efficacy|1|||
44561671|NCT02886715|79580089|FG000|Overall Study|Lost to Follow-up|29|||
44561672|NCT02886715|79580090|FG001|Overall Study|Lost to Follow-up|26|||
44561673|NCT02886715|79580091|FG002|Overall Study|Lost to Follow-up|10|||
44561674|NCT02886715|79580089|FG000|Overall Study|Pregnancy|1|||
44561675|NCT02886715|79580090|FG001|Overall Study|Pregnancy|1|||
44561676|NCT02886715|79580091|FG002|Overall Study|Pregnancy|1|||
44561677|NCT02886715|79580089|FG000|Overall Study|Protocol Violation|3|||
44561678|NCT02886715|79580090|FG001|Overall Study|Protocol Violation|2|||
44561679|NCT02886715|79580091|FG002|Overall Study|Protocol Violation|1|||
44561680|NCT02886715|79580089|FG000|Overall Study|Withdrawal by Subject|20|||
44561681|NCT02886715|79580090|FG001|Overall Study|Withdrawal by Subject|18|||
44561682|NCT02886715|79580091|FG002|Overall Study|Withdrawal by Subject|5|||
44561683|NCT02886715|79580089|FG000|Overall Study|missing|7|||
44561684|NCT02886715|79580090|FG001|Overall Study|missing|2|||
44561685|NCT02886715|79580091|FG002|Overall Study|missing|2|||
44561686|NCT03085797|79580101|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
44561687|NCT03085797|79580102|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
44561688|NCT03085797|79580101|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
44561689|NCT03085797|79580102|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
44561690|NCT03085797|79580101|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
44561691|NCT03085797|79580102|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
44561692|NCT03157531|79580110|FG000|Overall Study|Death|2|||
44561693|NCT03157531|79580110|FG000|Overall Study|Lost to Follow-up|4|||
44561694|NCT03159091|79580116|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
44561695|NCT03159091|79580117|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
44561696|NCT03159091|79580116|FG000|Overall Study|Patient has taken no dose of study drug|0|||
44561697|NCT03159091|79580117|FG001|Overall Study|Patient has taken no dose of study drug|1|||
44561698|NCT03196193|79580125|FG000|Overall Study|Adverse Event|1|||
44500252|NCT00106353|79504736|FG006|Part 1|Entered follow-up phase|0|||
44500253|NCT00106353|79504730|FG000|Part 1|Adverse Event|0|||
44500254|NCT00106353|79504731|FG001|Part 1|Adverse Event|0|||
44500255|NCT00106353|79504732|FG002|Part 1|Adverse Event|0|||
44500256|NCT00106353|79504733|FG003|Part 1|Adverse Event|1|||
44500257|NCT00106353|79504734|FG004|Part 1|Adverse Event|0|||
44500258|NCT00106353|79504735|FG005|Part 1|Adverse Event|0|||
44500259|NCT00106353|79504736|FG006|Part 1|Adverse Event|0|||
44500260|NCT00106353|79504730|FG000|Part 2|Disease progression|0|||
44500261|NCT00106353|79504731|FG001|Part 2|Disease progression|0|||
44500262|NCT00106353|79504732|FG002|Part 2|Disease progression|0|||
44500263|NCT00106353|79504733|FG003|Part 2|Disease progression|0|||
44500264|NCT00106353|79504734|FG004|Part 2|Disease progression|8|||
44500265|NCT00106353|79504735|FG005|Part 2|Disease progression|14|||
44561699|NCT03196193|79580126|FG001|Overall Study|Adverse Event|0|||
44561700|NCT03196193|79580125|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
44561701|NCT03196193|79580126|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
44561702|NCT03621761|79580135|FG000|Overall Study|Lost to Follow-up|1|||
44561703|NCT03621761|79580136|FG001|Overall Study|Lost to Follow-up|1|||
44500266|NCT00106353|79504736|FG006|Part 2|Disease progression|13|||
44500267|NCT00106353|79504730|FG000|Part 2|Death|0|||
44500268|NCT00106353|79504731|FG001|Part 2|Death|0|||
44500269|NCT00106353|79504732|FG002|Part 2|Death|0|||
44500270|NCT00106353|79504733|FG003|Part 2|Death|0|||
44500271|NCT00106353|79504734|FG004|Part 2|Death|3|||
44561704|NCT03621761|79580137|FG002|Overall Study|Lost to Follow-up|2|||
44561705|NCT03621761|79580135|FG000|Overall Study|Withdrawal by Subject|2|||
44561706|NCT03621761|79580136|FG001|Overall Study|Withdrawal by Subject|1|||
44500272|NCT00106353|79504735|FG005|Part 2|Death|0|||
44500273|NCT00106353|79504736|FG006|Part 2|Death|1|||
44500274|NCT00106353|79504730|FG000|Part 2|Symptomatic deterioration|0|||
44561707|NCT03621761|79580137|FG002|Overall Study|Withdrawal by Subject|1|||
44561708|NCT03621761|79580135|FG000|Overall Study|Became Ineligible|0|||
44561709|NCT03621761|79580136|FG001|Overall Study|Became Ineligible|2|||
44561710|NCT03621761|79580137|FG002|Overall Study|Became Ineligible|0|||
44561711|NCT03221387|79580145|FG000|Overall Study|Lost to Follow-up|1|||
44561712|NCT03221387|79580145|FG000|Overall Study|Lung transplant|1|||
44561713|NCT03318861|79580154|FG000|Overall Study|Death|2|||
44561714|NCT03318861|79580155|FG001|Overall Study|Death|3|||
44561715|NCT03318861|79580156|FG002|Overall Study|Death|3|||
44561716|NCT03318861|79580157|FG003|Overall Study|Death|2|||
44561717|NCT03318861|79580158|FG004|Overall Study|Death|2|||
44561718|NCT03318861|79580154|FG000|Overall Study|Enrolled But Never Treated|0|||
44561719|NCT03318861|79580155|FG001|Overall Study|Enrolled But Never Treated|1|||
44561720|NCT03318861|79580156|FG002|Overall Study|Enrolled But Never Treated|0|||
44561721|NCT03318861|79580157|FG003|Overall Study|Enrolled But Never Treated|1|||
44561722|NCT03318861|79580158|FG004|Overall Study|Enrolled But Never Treated|1|||
44561723|NCT03318861|79580154|FG000|Overall Study|Informed Consent Withdraw|0|||
44561724|NCT03318861|79580155|FG001|Overall Study|Informed Consent Withdraw|0|||
44561725|NCT03318861|79580156|FG002|Overall Study|Informed Consent Withdraw|0|||
44561726|NCT03318861|79580157|FG003|Overall Study|Informed Consent Withdraw|1|||
44561727|NCT03318861|79580158|FG004|Overall Study|Informed Consent Withdraw|0|||
44561728|NCT03318861|79580154|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
44561729|NCT03318861|79580155|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
44561730|NCT03318861|79580156|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
44561731|NCT03318861|79580157|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
44561732|NCT03318861|79580158|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
44561733|NCT03084315|79580173|FG000|Overall Study|Lost to Follow-up|8|||
44561734|NCT03084315|79580174|FG001|Overall Study|Lost to Follow-up|7|||
44561735|NCT03084315|79580173|FG000|Overall Study|Withdrawal by Subject|2|||
44561736|NCT03084315|79580174|FG001|Overall Study|Withdrawal by Subject|2|||
44561737|NCT03187301|79580180|FG000|Titration Period|Adverse Event|0|||
44561738|NCT03187301|79580181|FG001|Titration Period|Adverse Event|0|||
44561739|NCT03187301|79580182|FG002|Titration Period|Adverse Event|0|||
44561740|NCT03187301|79580183|FG003|Titration Period|Adverse Event|0|||
44561741|NCT03187301|79580184|FG004|Titration Period|Adverse Event|0|||
44561742|NCT03187301|79580185|FG005|Titration Period|Adverse Event|0|||
44561743|NCT03187301|79580186|FG006|Titration Period|Adverse Event|5|||
44561744|NCT03187301|79580180|FG000|Titration Period|Withdrawal by Subject|0|||
44561745|NCT03187301|79580181|FG001|Titration Period|Withdrawal by Subject|0|||
44561746|NCT03187301|79580182|FG002|Titration Period|Withdrawal by Subject|0|||
44561747|NCT03187301|79580183|FG003|Titration Period|Withdrawal by Subject|0|||
44561748|NCT03187301|79580184|FG004|Titration Period|Withdrawal by Subject|0|||
44561749|NCT03187301|79580185|FG005|Titration Period|Withdrawal by Subject|0|||
44561750|NCT03187301|79580186|FG006|Titration Period|Withdrawal by Subject|1|||
44561751|NCT03187301|79580180|FG000|Titration Period|Exclusion Criteria Met|0|||
44561752|NCT03187301|79580181|FG001|Titration Period|Exclusion Criteria Met|0|||
44561753|NCT03187301|79580182|FG002|Titration Period|Exclusion Criteria Met|0|||
44500275|NCT00106353|79504731|FG001|Part 2|Symptomatic deterioration|0|||
44500276|NCT00106353|79504732|FG002|Part 2|Symptomatic deterioration|0|||
44500277|NCT00106353|79504733|FG003|Part 2|Symptomatic deterioration|0|||
44500278|NCT00106353|79504734|FG004|Part 2|Symptomatic deterioration|3|||
44500279|NCT00106353|79504735|FG005|Part 2|Symptomatic deterioration|0|||
44500280|NCT00106353|79504736|FG006|Part 2|Symptomatic deterioration|0|||
44500281|NCT00106353|79504730|FG000|Part 2|Adverse Event|0|||
44500282|NCT00106353|79504731|FG001|Part 2|Adverse Event|0|||
44500283|NCT00106353|79504732|FG002|Part 2|Adverse Event|0|||
44500284|NCT00106353|79504733|FG003|Part 2|Adverse Event|0|||
44500285|NCT00106353|79504734|FG004|Part 2|Adverse Event|0|||
44561754|NCT03187301|79580183|FG003|Titration Period|Exclusion Criteria Met|0|||
44561755|NCT03187301|79580184|FG004|Titration Period|Exclusion Criteria Met|0|||
44561756|NCT03187301|79580185|FG005|Titration Period|Exclusion Criteria Met|0|||
44561757|NCT03187301|79580186|FG006|Titration Period|Exclusion Criteria Met|1|||
44500286|NCT00106353|79504735|FG005|Part 2|Adverse Event|2|||
44561758|NCT03187301|79580180|FG000|Pre-Intervention|Withdrawal by Subject|1|||
44561759|NCT03187301|79580181|FG001|Pre-Intervention|Withdrawal by Subject|0|||
44500287|NCT00106353|79504736|FG006|Part 2|Adverse Event|1|||
44500288|NCT00106353|79504730|FG000|Part 2|Other|0|||
44500289|NCT00106353|79504731|FG001|Part 2|Other|0|||
44500290|NCT00106353|79504732|FG002|Part 2|Other|0|||
44561760|NCT03187301|79580182|FG002|Pre-Intervention|Withdrawal by Subject|0|||
44561761|NCT03187301|79580183|FG003|Pre-Intervention|Withdrawal by Subject|0|||
44561762|NCT03187301|79580184|FG004|Pre-Intervention|Withdrawal by Subject|0|||
44561763|NCT03187301|79580185|FG005|Pre-Intervention|Withdrawal by Subject|0|||
44561764|NCT03187301|79580186|FG006|Pre-Intervention|Withdrawal by Subject|0|||
44561765|NCT02946047|79580211|FG000|Overall Study|Adverse Event|1|||
44561766|NCT02946047|79580212|FG001|Overall Study|Adverse Event|0|||
44561767|NCT02946047|79580213|FG002|Overall Study|Adverse Event|0|||
44561768|NCT02946047|79580214|FG003|Overall Study|Adverse Event|0|||
44561769|NCT03077919|79580226|FG000|Overall Study|Lost to Follow-up|4|||
44561770|NCT03077919|79580227|FG001|Overall Study|Lost to Follow-up|1|||
44561771|NCT03220217|79580236|FG000|Overall Study|Withdrawal by Subject|0|||
44561772|NCT03220217|79580237|FG001|Overall Study|Withdrawal by Subject|1|||
44561773|NCT03220217|79580238|FG002|Overall Study|Withdrawal by Subject|0|||
44561774|NCT03220217|79580236|FG000|Overall Study|Subject Missed Procedure|0|||
44561775|NCT03220217|79580237|FG001|Overall Study|Subject Missed Procedure|0|||
44500291|NCT00106353|79504733|FG003|Part 2|Other|0|||
44500292|NCT00106353|79504734|FG004|Part 2|Other|1|||
44500293|NCT00106353|79504735|FG005|Part 2|Other|1|||
44500294|NCT00106353|79504736|FG006|Part 2|Other|1|||
44500295|NCT00106353|79504730|FG000|Part 2|Withdrawal by Subject|0|||
44500296|NCT00106353|79504731|FG001|Part 2|Withdrawal by Subject|0|||
44500297|NCT00106353|79504732|FG002|Part 2|Withdrawal by Subject|0|||
44500298|NCT00106353|79504733|FG003|Part 2|Withdrawal by Subject|0|||
44500299|NCT00106353|79504734|FG004|Part 2|Withdrawal by Subject|1|||
44500300|NCT00106353|79504735|FG005|Part 2|Withdrawal by Subject|0|||
44500301|NCT00106353|79504736|FG006|Part 2|Withdrawal by Subject|0|||
44500302|NCT00106353|79504730|FG000|Part 2|Physician Decision|0|||
44500303|NCT00106353|79504731|FG001|Part 2|Physician Decision|0|||
44500304|NCT00106353|79504732|FG002|Part 2|Physician Decision|0|||
44500305|NCT00106353|79504733|FG003|Part 2|Physician Decision|0|||
44561776|NCT03220217|79580238|FG002|Overall Study|Subject Missed Procedure|1|||
44500306|NCT00106353|79504734|FG004|Part 2|Physician Decision|0|||
44500307|NCT00106353|79504735|FG005|Part 2|Physician Decision|1|||
44500308|NCT00106353|79504736|FG006|Part 2|Physician Decision|0|||
44500309|NCT00080301|79504759|FG000|Overall Study|Randomized but Never Treated|5|||
44561777|NCT03192137|79580269|FG000|Overall Study|Adverse Event|10|||
44561778|NCT03192137|79580270|FG001|Overall Study|Adverse Event|11|||
44561779|NCT03192137|79580269|FG000|Overall Study|Physician Decision|1|||
44233140|NCT01786109|79050882|FG000|Overall Study|adverse effects colon preparation|0|||
44233141|NCT01786109|79050883|FG001|Overall Study|adverse effects colon preparation|0|||
44233142|NCT01786109|79050884|FG002|Overall Study|adverse effects colon preparation|1|||
44233143|NCT02728596|79051018|FG000|Overall Study|Refusal unrelated to adverse event|3|||
44233144|NCT02728596|79051019|FG001|Overall Study|Refusal unrelated to adverse event|6|||
44233145|NCT02728596|79051020|FG002|Overall Study|Refusal unrelated to adverse event|7|||
44233146|NCT02728596|79051021|FG003|Overall Study|Refusal unrelated to adverse event|7|||
44233147|NCT02728596|79051018|FG000|Overall Study|Death|44|||
44233148|NCT02728596|79051019|FG001|Overall Study|Death|42|||
44233149|NCT02728596|79051020|FG002|Overall Study|Death|123|||
44233150|NCT02728596|79051021|FG003|Overall Study|Death|68|||
44233151|NCT00708162|79051395|FG000|Randomized Phase|Randomized but Not Treated|7|||
44233152|NCT00708162|79051396|FG001|Randomized Phase|Randomized but Not Treated|5|||
44233153|NCT00708162|79051395|FG000|Randomized Phase|Participant Noncompliance|40|||
44233154|NCT00708162|79051396|FG001|Randomized Phase|Participant Noncompliance|32|||
44233155|NCT00708162|79051395|FG000|Randomized Phase|Lost to Follow-up|34|||
44233156|NCT00708162|79051396|FG001|Randomized Phase|Lost to Follow-up|34|||
44233157|NCT00708162|79051395|FG000|Randomized Phase|Withdrew Consent|31|||
44233158|NCT00708162|79051396|FG001|Randomized Phase|Withdrew Consent|22|||
44233159|NCT00708162|79051395|FG000|Randomized Phase|Lack of Efficacy|14|||
44233160|NCT00708162|79051396|FG001|Randomized Phase|Lack of Efficacy|19|||
44500310|NCT00080301|79504760|FG001|Overall Study|Randomized but Never Treated|10|||
44500311|NCT00080301|79504759|FG000|Overall Study|Still on Treatment as of CSR date|0|||
44500312|NCT00080301|79504760|FG001|Overall Study|Still on Treatment as of CSR date|1|||
44500313|NCT00079677|79504769|FG000|Overall Study|Adverse Event|5|||
44500314|NCT00079677|79504770|FG001|Overall Study|Adverse Event|6|||
44500315|NCT00079677|79504769|FG000|Overall Study|Lack of Efficacy|1|||
44500316|NCT00079677|79504770|FG001|Overall Study|Lack of Efficacy|0|||
44500317|NCT00079677|79504769|FG000|Overall Study|Lost to Follow-up|2|||
44500318|NCT00079677|79504770|FG001|Overall Study|Lost to Follow-up|2|||
44500319|NCT00079677|79504769|FG000|Overall Study|Physician Decision|3|||
44233161|NCT00708162|79051395|FG000|Randomized Phase|Protocol Violation|10|||
44500320|NCT00079677|79504770|FG001|Overall Study|Physician Decision|0|||
44233162|NCT00708162|79051396|FG001|Randomized Phase|Protocol Violation|11|||
44233163|NCT00708162|79051395|FG000|Randomized Phase|Adverse Event|8|||
44233164|NCT00708162|79051396|FG001|Randomized Phase|Adverse Event|12|||
44500321|NCT00079677|79504769|FG000|Overall Study|Protocol Violation|2|||
44500322|NCT00079677|79504770|FG001|Overall Study|Protocol Violation|3|||
44500323|NCT00079677|79504769|FG000|Overall Study|Withdrawal by Subject|5|||
44233165|NCT00708162|79051395|FG000|Randomized Phase|Investigator's Discretion|7|||
44233166|NCT00708162|79051396|FG001|Randomized Phase|Investigator's Discretion|10|||
44233167|NCT00708162|79051395|FG000|Randomized Phase|Death|2|||
44233168|NCT00708162|79051396|FG001|Randomized Phase|Death|9|||
44233169|NCT00708162|79051395|FG000|Randomized Phase|Pregnancy|3|||
44233170|NCT00708162|79051396|FG001|Randomized Phase|Pregnancy|0|||
44233171|NCT00708162|79051395|FG000|Open-Label Phase|Lost to Follow-up|10|||
44233172|NCT00708162|79051396|FG001|Open-Label Phase|Lost to Follow-up|8|||
44233173|NCT00708162|79051395|FG000|Open-Label Phase|Withdrew Consent|12|||
44233174|NCT00708162|79051396|FG001|Open-Label Phase|Withdrew Consent|6|||
44233175|NCT00708162|79051395|FG000|Open-Label Phase|Participant Noncompliance|7|||
44233176|NCT00708162|79051396|FG001|Open-Label Phase|Participant Noncompliance|7|||
44233177|NCT00708162|79051395|FG000|Open-Label Phase|Lack of Efficacy|7|||
44561780|NCT03192137|79580270|FG001|Overall Study|Physician Decision|0|||
44561781|NCT03192137|79580269|FG000|Overall Study|Lack of Efficacy|20|||
44561782|NCT03192137|79580270|FG001|Overall Study|Lack of Efficacy|37|||
44561783|NCT03192137|79580269|FG000|Overall Study|Withdrawal by Subject|3|||
44561784|NCT03192137|79580270|FG001|Overall Study|Withdrawal by Subject|3|||
44561785|NCT03192137|79580269|FG000|Overall Study|Protocol Violation|4|||
44561786|NCT03192137|79580270|FG001|Overall Study|Protocol Violation|3|||
44561787|NCT03192137|79580269|FG000|Overall Study|Surgery Cancelled|4|||
44561788|NCT03192137|79580270|FG001|Overall Study|Surgery Cancelled|1|||
44561789|NCT03192137|79580269|FG000|Overall Study|Other - Various Administrative Reasons|8|||
44561790|NCT03192137|79580270|FG001|Overall Study|Other - Various Administrative Reasons|3|||
44561791|NCT03881059|79580290|FG000|Treatment Period - Part A|Adverse Event|1|||
44561792|NCT03881059|79580291|FG001|Treatment Period - Part A|Adverse Event|3|||
44561793|NCT03881059|79580292|FG002|Treatment Period - Part A|Adverse Event|4|||
44561794|NCT03881059|79580290|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
44561795|NCT03881059|79580291|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
44561796|NCT03881059|79580292|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
44561797|NCT03881059|79580290|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
44561798|NCT03881059|79580291|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
44561799|NCT03881059|79580292|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
44561800|NCT03881059|79580290|FG000|Treatment Period - Part A|Other reasons|2|||
44561801|NCT03881059|79580291|FG001|Treatment Period - Part A|Other reasons|1|||
44561802|NCT03881059|79580292|FG002|Treatment Period - Part A|Other reasons|0|||
44561803|NCT03881059|79580290|FG000|Treatment Period - Part B|Adverse Event|0|||
44561804|NCT03881059|79580291|FG001|Treatment Period - Part B|Adverse Event|0|||
44561805|NCT03881059|79580292|FG002|Treatment Period - Part B|Adverse Event|3|||
44561806|NCT03881059|79580290|FG000|Treatment Period - Part B|Death|0|||
44561807|NCT03881059|79580291|FG001|Treatment Period - Part B|Death|1|||
44561808|NCT03881059|79580292|FG002|Treatment Period - Part B|Death|1|||
44561809|NCT03881059|79580290|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
44561810|NCT03881059|79580291|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
44561811|NCT03881059|79580292|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
44561812|NCT03881059|79580290|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
44233178|NCT00708162|79051396|FG001|Open-Label Phase|Lack of Efficacy|4|||
44233179|NCT00708162|79051395|FG000|Open-Label Phase|Investigator's Discretion|3|||
44233180|NCT00708162|79051396|FG001|Open-Label Phase|Investigator's Discretion|2|||
44500324|NCT00079677|79504770|FG001|Overall Study|Withdrawal by Subject|3|||
44500325|NCT00079677|79504769|FG000|Overall Study|Miscellaneous|2|||
44500326|NCT00079677|79504770|FG001|Overall Study|Miscellaneous|0|||
44500327|NCT00095121|79504778|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
44500328|NCT00095121|79504779|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
44500329|NCT00095121|79504778|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
44500330|NCT00095121|79504779|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
44500331|NCT00094809|79504797|FG000|Overall Study|Protocol deviation|2|||
44500332|NCT00094809|79504798|FG001|Overall Study|Protocol deviation|2|||
44500333|NCT00094809|79504797|FG000|Overall Study|Noncompliance|1|||
44500334|NCT00094809|79504798|FG001|Overall Study|Noncompliance|0|||
44500335|NCT00094809|79504797|FG000|Overall Study|Adverse Event|3|||
44500336|NCT00094809|79504798|FG001|Overall Study|Adverse Event|1|||
44500337|NCT00094809|79504797|FG000|Overall Study|Withdrawal by Subject|8|||
44233181|NCT00708162|79051395|FG000|Open-Label Phase|Death|3|||
44233182|NCT00708162|79051396|FG001|Open-Label Phase|Death|1|||
44500338|NCT00094809|79504798|FG001|Overall Study|Withdrawal by Subject|9|||
44500339|NCT00094809|79504797|FG000|Overall Study|Disease progression|3|||
44561813|NCT03881059|79580291|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
44233183|NCT00708162|79051395|FG000|Open-Label Phase|Adverse Event|1|||
44233184|NCT00708162|79051396|FG001|Open-Label Phase|Adverse Event|2|||
44233185|NCT00708162|79051395|FG000|Open-Label Phase|Other|1|||
44233186|NCT00708162|79051396|FG001|Open-Label Phase|Other|0|||
44275370|NCT02203032|79221838|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
44500340|NCT00094809|79504798|FG001|Overall Study|Disease progression|3|||
44500341|NCT00094809|79504797|FG000|Overall Study|Physician Decision|3|||
44561814|NCT03881059|79580292|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
44561815|NCT03881059|79580290|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
44561816|NCT03881059|79580291|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
44561817|NCT03881059|79580292|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
44561818|NCT03881059|79580290|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
44561819|NCT03881059|79580291|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
44233187|NCT02245672|79051481|FG000|Overall Study|Adverse Event|4|||
44561820|NCT03881059|79580292|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
44561821|NCT03881059|79580290|FG000|Treatment Period - Part B|Other reasons|4|||
44561822|NCT03881059|79580291|FG001|Treatment Period - Part B|Other reasons|3|||
44561823|NCT03881059|79580292|FG002|Treatment Period - Part B|Other reasons|3|||
44561824|NCT02861534|79580307|FG000|Overall Study|Death|541|||
44561825|NCT02861534|79580308|FG001|Overall Study|Death|552|||
44561826|NCT02861534|79580307|FG000|Overall Study|Lost to Follow-up|14|||
44561827|NCT02861534|79580308|FG001|Overall Study|Lost to Follow-up|14|||
44561828|NCT02861534|79580307|FG000|Overall Study|Site Terminated by Sponsor|4|||
44561829|NCT02861534|79580308|FG001|Overall Study|Site Terminated by Sponsor|3|||
44561830|NCT02861534|79580307|FG000|Overall Study|Withdrawal by Subject|15|||
44561831|NCT02861534|79580308|FG001|Overall Study|Withdrawal by Subject|18|||
44561832|NCT03083847|79580349|FG000|Main|Physician Decision|0|||
44561833|NCT03083847|79580350|FG001|Main|Physician Decision|0|||
44561834|NCT03083847|79580351|FG002|Main|Physician Decision|0|||
44561835|NCT03083847|79580352|FG003|Main|Physician Decision|0|||
44561836|NCT03083847|79580353|FG004|Main|Physician Decision|0|||
44561837|NCT03083847|79580354|FG005|Main|Physician Decision|1|||
44561838|NCT03083847|79580355|FG006|Main|Physician Decision|0|||
44561839|NCT03083847|79580356|FG007|Main|Physician Decision|0|||
44561840|NCT03083847|79580357|FG008|Main|Physician Decision|0|||
44561841|NCT03083847|79580358|FG009|Main|Physician Decision|0|||
44561842|NCT03083847|79580349|FG000|Main|Pregnancy|0|||
44561843|NCT03083847|79580350|FG001|Main|Pregnancy|0|||
44561844|NCT03083847|79580351|FG002|Main|Pregnancy|0|||
44233188|NCT02245672|79051482|FG001|Overall Study|Adverse Event|4|||
44233189|NCT02245672|79051483|FG002|Overall Study|Adverse Event|4|||
44561845|NCT03083847|79580352|FG003|Main|Pregnancy|0|||
44561846|NCT03083847|79580353|FG004|Main|Pregnancy|0|||
44561847|NCT03083847|79580354|FG005|Main|Pregnancy|0|||
44561848|NCT03083847|79580355|FG006|Main|Pregnancy|0|||
44561849|NCT03083847|79580356|FG007|Main|Pregnancy|1|||
44233190|NCT02245672|79051481|FG000|Overall Study|Lost to Follow-up|3|||
44233191|NCT02245672|79051482|FG001|Overall Study|Lost to Follow-up|5|||
44233192|NCT02245672|79051483|FG002|Overall Study|Lost to Follow-up|1|||
44233193|NCT02245672|79051481|FG000|Overall Study|Withdrawal by Subject|6|||
44500342|NCT00094809|79504798|FG001|Overall Study|Physician Decision|5|||
44500343|NCT00094809|79504797|FG000|Overall Study|Lost to Follow-up|6|||
44561850|NCT03083847|79580357|FG008|Main|Pregnancy|0|||
44561851|NCT03083847|79580358|FG009|Main|Pregnancy|0|||
44561852|NCT03083847|79580349|FG000|Main|Adverse Event|0|||
44561853|NCT03083847|79580350|FG001|Main|Adverse Event|0|||
44561854|NCT03083847|79580351|FG002|Main|Adverse Event|0|||
44561855|NCT03083847|79580352|FG003|Main|Adverse Event|0|||
44233194|NCT02245672|79051482|FG001|Overall Study|Withdrawal by Subject|3|||
44233195|NCT02245672|79051483|FG002|Overall Study|Withdrawal by Subject|0|||
44500344|NCT00094809|79504798|FG001|Overall Study|Lost to Follow-up|6|||
44500345|NCT00094809|79504797|FG000|Overall Study|Death|19|||
44500346|NCT00094809|79504798|FG001|Overall Study|Death|25|||
44500347|NCT00094809|79504797|FG000|Overall Study|Protocol-specified criteria|1|||
44500348|NCT00094809|79504798|FG001|Overall Study|Protocol-specified criteria|1|||
44500349|NCT00094809|79504797|FG000|Overall Study|Other|2|||
44500350|NCT00094809|79504798|FG001|Overall Study|Other|4|||
44500351|NCT00094809|79504797|FG000|Overall Study|Informed consent signed after treatment|1|||
44500352|NCT00094809|79504798|FG001|Overall Study|Informed consent signed after treatment|0|||
44233196|NCT02245672|79051481|FG000|Overall Study|Randomized in error (not treated)|0|||
44233197|NCT02245672|79051482|FG001|Overall Study|Randomized in error (not treated)|1|||
44500353|NCT00094809|79504797|FG000|Overall Study|Study drug not received|2|||
44561856|NCT03083847|79580353|FG004|Main|Adverse Event|0|||
44561857|NCT03083847|79580354|FG005|Main|Adverse Event|0|||
44561858|NCT03083847|79580355|FG006|Main|Adverse Event|0|||
44561859|NCT03083847|79580356|FG007|Main|Adverse Event|2|||
44561860|NCT03083847|79580357|FG008|Main|Adverse Event|0|||
44561861|NCT03083847|79580358|FG009|Main|Adverse Event|0|||
44233198|NCT02245672|79051483|FG002|Overall Study|Randomized in error (not treated)|0|||
44233199|NCT00706992|79051628|FG000|Overall Study|Study termination|5|||
44500354|NCT00094809|79504798|FG001|Overall Study|Study drug not received|8|||
44500355|NCT00094809|79504797|FG000|Overall Study|Other|1|||
44561862|NCT03083847|79580349|FG000|Main|Withdrawal by Subject|0|||
44561863|NCT03083847|79580350|FG001|Main|Withdrawal by Subject|0|||
44561864|NCT03083847|79580351|FG002|Main|Withdrawal by Subject|0|||
44561865|NCT03083847|79580352|FG003|Main|Withdrawal by Subject|0|||
44233200|NCT00706992|79051629|FG001|Overall Study|Study termination|5|||
44233201|NCT00706992|79051630|FG002|Overall Study|Study termination|6|||
44233202|NCT00706992|79051631|FG003|Overall Study|Study termination|2|||
44233203|NCT00706992|79051632|FG004|Overall Study|Study termination|3|||
44233204|NCT00706992|79051633|FG005|Overall Study|Study termination|2|||
44233205|NCT00706992|79051634|FG006|Overall Study|Study termination|3|||
44233206|NCT00706992|79051628|FG000|Overall Study|Disease progression before treatment|0|||
44233207|NCT00706992|79051629|FG001|Overall Study|Disease progression before treatment|0|||
44233208|NCT00706992|79051630|FG002|Overall Study|Disease progression before treatment|0|||
44233209|NCT00706992|79051631|FG003|Overall Study|Disease progression before treatment|0|||
44233210|NCT00706992|79051632|FG004|Overall Study|Disease progression before treatment|1|||
44500356|NCT00094809|79504798|FG001|Overall Study|Other|1|||
44500357|NCT00075218|79504806|FG000|Double-Blind Treatment|Adverse Event|23|||
44500358|NCT00075218|79504807|FG001|Double-Blind Treatment|Adverse Event|4|||
44500359|NCT00075218|79504808|FG002|Double-Blind Treatment|Adverse Event|0|||
44500360|NCT00075218|79504806|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
44500361|NCT00075218|79504807|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
44500362|NCT00075218|79504808|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
44500363|NCT00075218|79504806|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
44500364|NCT00075218|79504807|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
44500365|NCT00075218|79504808|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
44500366|NCT00075218|79504806|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
44500367|NCT00075218|79504807|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
44500368|NCT00075218|79504808|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
44500369|NCT00075218|79504806|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
44500370|NCT00075218|79504807|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
44500371|NCT00075218|79504808|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
44500372|NCT00075218|79504806|FG000|Double-Blind Treatment|No study medication taken|2|||
44500373|NCT00075218|79504807|FG001|Double-Blind Treatment|No study medication taken|0|||
44500374|NCT00075218|79504808|FG002|Double-Blind Treatment|No study medication taken|0|||
44500375|NCT00075218|79504806|FG000|Open-Label Treatment|Lack of Efficacy|0|||
44500376|NCT00075218|79504807|FG001|Open-Label Treatment|Lack of Efficacy|0|||
44500377|NCT00075218|79504808|FG002|Open-Label Treatment|Lack of Efficacy|174|||
44500378|NCT00075218|79504806|FG000|Open-Label Treatment|Adverse Event|0|||
44500379|NCT00075218|79504807|FG001|Open-Label Treatment|Adverse Event|0|||
44500380|NCT00075218|79504808|FG002|Open-Label Treatment|Adverse Event|51|||
44500381|NCT00075218|79504806|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
44500382|NCT00075218|79504807|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
44500383|NCT00075218|79504808|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
44500384|NCT00075218|79504806|FG000|Open-Label Treatment|Decision of Sponsor|0|||
44500385|NCT00075218|79504807|FG001|Open-Label Treatment|Decision of Sponsor|0|||
44500386|NCT00075218|79504808|FG002|Open-Label Treatment|Decision of Sponsor|8|||
44500387|NCT00075218|79504806|FG000|Open-Label Treatment|Protocol Violation|0|||
44500388|NCT00075218|79504807|FG001|Open-Label Treatment|Protocol Violation|0|||
44500389|NCT00075218|79504808|FG002|Open-Label Treatment|Protocol Violation|1|||
44500390|NCT00075218|79504806|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
44500391|NCT00075218|79504807|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
44500392|NCT00075218|79504808|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
44500393|NCT00094653|79504818|FG000|Overall Study|Death|306|||
44500394|NCT00094653|79504819|FG001|Overall Study|Death|100|||
44500395|NCT00094653|79504820|FG002|Overall Study|Death|119|||
44500396|NCT00094653|79504818|FG000|Overall Study|Subject Withdrew Consent|10|||
44500397|NCT00094653|79504819|FG001|Overall Study|Subject Withdrew Consent|2|||
44500398|NCT00094653|79504820|FG002|Overall Study|Subject Withdrew Consent|3|||
44500399|NCT00094653|79504818|FG000|Overall Study|Other|2|||
44500400|NCT00094653|79504819|FG001|Overall Study|Other|2|||
44500401|NCT00094653|79504820|FG002|Overall Study|Other|2|||
44500402|NCT00094653|79504818|FG000|Overall Study|Lost to Follow-up|3|||
44233211|NCT00706992|79051633|FG005|Overall Study|Disease progression before treatment|0|||
44500403|NCT00094653|79504819|FG001|Overall Study|Lost to Follow-up|2|||
44500404|NCT00094653|79504820|FG002|Overall Study|Lost to Follow-up|1|||
44500405|NCT00094653|79504818|FG000|Overall Study|Protocol Violation|0|||
44500406|NCT00094653|79504819|FG001|Overall Study|Protocol Violation|0|||
44233212|NCT00706992|79051634|FG006|Overall Study|Disease progression before treatment|0|||
44500407|NCT00094653|79504820|FG002|Overall Study|Protocol Violation|1|||
44500408|NCT00104247|79504831|FG000|Overall Study|Withdrawal by Subject|1|||
44500409|NCT00104247|79504832|FG001|Overall Study|Withdrawal by Subject|0|||
44500410|NCT00104247|79504831|FG000|Overall Study|Noncompliant with dosing|0|||
44500411|NCT00104247|79504832|FG001|Overall Study|Noncompliant with dosing|1|||
44500412|NCT03591406|79504840|FG000|Overall Study|Adverse Event|5|||
44500413|NCT03591406|79504841|FG001|Overall Study|Adverse Event|3|||
44500414|NCT03591406|79504840|FG000|Overall Study|Protocol Violation|2|||
44500415|NCT03591406|79504841|FG001|Overall Study|Protocol Violation|1|||
44500416|NCT03591406|79504840|FG000|Overall Study|Withdrawal by Subject|0|||
44233213|NCT01785875|79051687|FG000|Overall Study|Withdrawal by Subject|41|||
44233214|NCT01785875|79051688|FG001|Overall Study|Withdrawal by Subject|34|||
44233215|NCT01785875|79051689|FG002|Overall Study|Withdrawal by Subject|36|||
44233216|NCT01785875|79051687|FG000|Overall Study|Lost to Follow-up|19|||
44233217|NCT01785875|79051688|FG001|Overall Study|Lost to Follow-up|22|||
44233218|NCT01785875|79051689|FG002|Overall Study|Lost to Follow-up|6|||
44561866|NCT03083847|79580353|FG004|Main|Withdrawal by Subject|0|||
44561867|NCT03083847|79580354|FG005|Main|Withdrawal by Subject|0|||
44561868|NCT03083847|79580355|FG006|Main|Withdrawal by Subject|1|||
44561869|NCT03083847|79580356|FG007|Main|Withdrawal by Subject|1|||
44561870|NCT03083847|79580357|FG008|Main|Withdrawal by Subject|0|||
44561871|NCT03083847|79580358|FG009|Main|Withdrawal by Subject|0|||
44561872|NCT03082677|79580386|FG000|Overall Study|Not Treated|2|||
44561873|NCT02858180|79580401|FG000|Overall Study|Lost to Follow-up|0|||
44561874|NCT02858180|79580402|FG001|Overall Study|Lost to Follow-up|2|||
44561875|NCT03082599|79580410|FG000|Overall Study|Lost to Follow-up|1|||
44561876|NCT03082599|79580411|FG001|Overall Study|Lost to Follow-up|0|||
44561877|NCT01346501|79580419|FG000|Overall Study|Initiated Other Biological Agents|3|||
44561878|NCT01346501|79580420|FG001|Overall Study|Initiated Other Biological Agents|1|||
44561879|NCT01346501|79580419|FG000|Overall Study|Other|8|||
44561880|NCT01346501|79580420|FG001|Overall Study|Other|12|||
44561881|NCT03160885|79580430|FG000|Initial Treatment Period|Not dosed|2|||
44561882|NCT03160885|79580431|FG001|Initial Treatment Period|Not dosed|0|||
44561883|NCT03160885|79580432|FG002|Initial Treatment Period|Not dosed|0|||
44561884|NCT03160885|79580433|FG003|Initial Treatment Period|Not dosed|0|||
44561885|NCT03160885|79580434|FG004|Initial Treatment Period|Not dosed|0|||
44561886|NCT03160885|79580435|FG005|Initial Treatment Period|Not dosed|0|||
44561887|NCT03160885|79580436|FG006|Initial Treatment Period|Not dosed|0|||
44561888|NCT03160885|79580430|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
44561889|NCT03160885|79580431|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
44561890|NCT03160885|79580432|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44561891|NCT03160885|79580433|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44561892|NCT03160885|79580434|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44561893|NCT03160885|79580435|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44561894|NCT03160885|79580436|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44561895|NCT03160885|79580430|FG000|Open-label Treatment|Not dosed|0|||
44561896|NCT03160885|79580431|FG001|Open-label Treatment|Not dosed|0|||
44561897|NCT03160885|79580432|FG002|Open-label Treatment|Not dosed|0|||
44561898|NCT03160885|79580433|FG003|Open-label Treatment|Not dosed|0|||
44561899|NCT03160885|79580434|FG004|Open-label Treatment|Not dosed|0|||
44561900|NCT03160885|79580435|FG005|Open-label Treatment|Not dosed|0|||
44233219|NCT01785875|79051687|FG000|Overall Study|Death|27|||
44561901|NCT03160885|79580436|FG006|Open-label Treatment|Not dosed|2|||
44561902|NCT03160885|79580430|FG000|Open-label Treatment|Discontinued IMP|0|||
44561903|NCT03160885|79580431|FG001|Open-label Treatment|Discontinued IMP|0|||
44233220|NCT01785875|79051688|FG001|Overall Study|Death|16|||
44561904|NCT03160885|79580432|FG002|Open-label Treatment|Discontinued IMP|0|||
44233221|NCT01785875|79051689|FG002|Overall Study|Death|7|||
44561905|NCT03160885|79580433|FG003|Open-label Treatment|Discontinued IMP|0|||
44561906|NCT03160885|79580434|FG004|Open-label Treatment|Discontinued IMP|0|||
44561907|NCT03160885|79580435|FG005|Open-label Treatment|Discontinued IMP|0|||
44233222|NCT01785875|79051687|FG000|Overall Study|Sponsor Decision|0|||
44561908|NCT03160885|79580436|FG006|Open-label Treatment|Discontinued IMP|131|||
44561909|NCT03160885|79580430|FG000|Open-label Treatment|Completed Week 50|0|||
44233223|NCT01785875|79051688|FG001|Overall Study|Sponsor Decision|2|||
44561910|NCT03160885|79580431|FG001|Open-label Treatment|Completed Week 50|0|||
44561911|NCT03160885|79580432|FG002|Open-label Treatment|Completed Week 50|0|||
44561912|NCT03160885|79580433|FG003|Open-label Treatment|Completed Week 50|0|||
44561913|NCT03160885|79580434|FG004|Open-label Treatment|Completed Week 50|0|||
44561914|NCT03160885|79580435|FG005|Open-label Treatment|Completed Week 50|0|||
44561915|NCT03160885|79580436|FG006|Open-label Treatment|Completed Week 50|4|||
44561916|NCT03160885|79580430|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
44561917|NCT03160885|79580431|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
44561918|NCT03160885|79580432|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
44561919|NCT03160885|79580433|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
44561920|NCT03160885|79580434|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
44561921|NCT03160885|79580435|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
44561922|NCT03160885|79580436|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
44561923|NCT03160885|79580430|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
44561924|NCT03160885|79580431|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
44561925|NCT03160885|79580432|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
44561926|NCT03160885|79580433|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
44561927|NCT03160885|79580434|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
44561928|NCT03160885|79580435|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
44561929|NCT03160885|79580436|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
44561930|NCT03160885|79580430|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44561931|NCT03160885|79580431|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44561932|NCT03160885|79580432|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
44561933|NCT03160885|79580433|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
44561934|NCT03160885|79580434|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
44500417|NCT03591406|79504841|FG001|Overall Study|Withdrawal by Subject|5|||
44500418|NCT03560986|79504849|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
44500419|NCT03560986|79504850|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
44500420|NCT03560986|79504849|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
44233224|NCT01785875|79051689|FG002|Overall Study|Sponsor Decision|0|||
44500421|NCT03560986|79504850|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
44500422|NCT03560986|79504849|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
44500423|NCT03560986|79504850|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
44500424|NCT03560986|79504849|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
44500425|NCT03560986|79504850|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
44500426|NCT03560986|79504849|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
44500427|NCT03560986|79504850|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
44233225|NCT01785875|79051687|FG000|Overall Study|Protocol Specified Criteria|207|||
44233226|NCT01785875|79051688|FG001|Overall Study|Protocol Specified Criteria|214|||
44500428|NCT03560986|79504849|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
44500429|NCT03560986|79504850|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
44500430|NCT03560986|79504849|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
44500431|NCT03560986|79504850|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
44500432|NCT03560518|79504865|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
44500433|NCT03560518|79504866|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
44500434|NCT03560518|79504867|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
44561935|NCT03160885|79580435|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
44561936|NCT03160885|79580436|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44561937|NCT03160885|79580430|FG000|Maintenance Treatment Period|Completed Week 50|0|||
44561938|NCT03160885|79580431|FG001|Maintenance Treatment Period|Completed Week 50|0|||
44561939|NCT03160885|79580432|FG002|Maintenance Treatment Period|Completed Week 50|1|||
44561940|NCT03160885|79580433|FG003|Maintenance Treatment Period|Completed Week 50|0|||
44561941|NCT03160885|79580434|FG004|Maintenance Treatment Period|Completed Week 50|0|||
44561942|NCT03160885|79580435|FG005|Maintenance Treatment Period|Completed Week 50|0|||
44561943|NCT03160885|79580436|FG006|Maintenance Treatment Period|Completed Week 50|0|||
44561944|NCT03181451|79580456|FG000|Overall Study|Adverse Event|0|||
44561945|NCT03181451|79580457|FG001|Overall Study|Adverse Event|1|||
44561946|NCT03181451|79580458|FG002|Overall Study|Adverse Event|0|||
44561947|NCT03181451|79580456|FG000|Overall Study|Withdrawal by Subject|0|||
44561948|NCT03181451|79580457|FG001|Overall Study|Withdrawal by Subject|1|||
44561949|NCT03181451|79580458|FG002|Overall Study|Withdrawal by Subject|0|||
44561950|NCT00406783|79580470|FG000|Overall Study|Adverse Event|4|||
44561951|NCT00406783|79580471|FG001|Overall Study|Adverse Event|4|||
44561952|NCT00406783|79580470|FG000|Overall Study|Treatment Failure|2|||
44561953|NCT00406783|79580471|FG001|Overall Study|Treatment Failure|3|||
44561954|NCT00406783|79580470|FG000|Overall Study|Lost to Follow-up|3|||
44561955|NCT00406783|79580471|FG001|Overall Study|Lost to Follow-up|0|||
44561956|NCT00406783|79580470|FG000|Overall Study|Withdrawal by Subject|1|||
44561957|NCT00406783|79580471|FG001|Overall Study|Withdrawal by Subject|4|||
44561958|NCT00406783|79580470|FG000|Overall Study|Protocol Violation|4|||
44561959|NCT00406783|79580471|FG001|Overall Study|Protocol Violation|4|||
44561960|NCT03179891|79580477|FG000|First Intervention|Withdrawal by Subject|1|||
44561961|NCT03179891|79580478|FG001|First Intervention|Withdrawal by Subject|1|||
44561962|NCT03179891|79580477|FG000|First Intervention|Unspecified reason|1|||
44561963|NCT03179891|79580478|FG001|First Intervention|Unspecified reason|0|||
44561964|NCT03179891|79580477|FG000|First Intervention|Protocol Violation|0|||
44561965|NCT03179891|79580478|FG001|First Intervention|Protocol Violation|1|||
44561966|NCT02973815|79580489|FG000|Post Intervention|Death|1|||
44561967|NCT02973815|79580490|FG001|Post Intervention|Death|0|||
44561968|NCT02973815|79580489|FG000|Post Intervention|Lost to Follow-up|7|||
44561969|NCT02973815|79580490|FG001|Post Intervention|Lost to Follow-up|24|||
44561970|NCT02973815|79580489|FG000|Follow-up|Lost to Follow-up|2|||
44561971|NCT02973815|79580490|FG001|Follow-up|Lost to Follow-up|0|||
44561972|NCT03160573|79580500|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
44561973|NCT03160573|79580501|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
44561974|NCT03160573|79580502|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
44561975|NCT03160573|79580503|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
44561976|NCT02736227|79580516|FG000|Overall Study|Withdrawal by Subject|0|||
44561977|NCT02736227|79580517|FG001|Overall Study|Withdrawal by Subject|0|||
44561978|NCT02736227|79580518|FG002|Overall Study|Withdrawal by Subject|1|||
44561979|NCT02736227|79580516|FG000|Overall Study|Physician Decision|0|||
44561980|NCT02736227|79580517|FG001|Overall Study|Physician Decision|0|||
44561981|NCT02736227|79580518|FG002|Overall Study|Physician Decision|5|||
44561982|NCT02736227|79580516|FG000|Overall Study|Non Compliant|0|||
44561983|NCT02736227|79580517|FG001|Overall Study|Non Compliant|0|||
44561984|NCT02736227|79580518|FG002|Overall Study|Non Compliant|2|||
44561985|NCT03176459|79580527|FG000|Overall Study|Lost to Follow-up|5|||
44561986|NCT03176459|79580528|FG001|Overall Study|Lost to Follow-up|7|||
44561987|NCT03155269|79580536|FG000|Overall Study|Withdrawal by Subject|4|||
44561988|NCT03155269|79580537|FG001|Overall Study|Withdrawal by Subject|5|||
44233227|NCT01785875|79051689|FG002|Overall Study|Protocol Specified Criteria|55|||
44233228|NCT01785875|79051687|FG000|Overall Study|Missing|0|||
44561989|NCT03155269|79580536|FG000|Overall Study|Lost to Follow-up|1|||
44561990|NCT03155269|79580537|FG001|Overall Study|Lost to Follow-up|2|||
44561991|NCT02906670|79580553|FG000|Cohort 1, QW|Radiological Progression|1|||
44561992|NCT02906670|79580554|FG001|Cohort 1, QW|Radiological Progression|0|||
44561993|NCT02906670|79580555|FG002|Cohort 1, QW|Radiological Progression|0|||
44561994|NCT02906670|79580556|FG003|Cohort 1, QW|Radiological Progression|0|||
44561995|NCT02906670|79580557|FG004|Cohort 1, QW|Radiological Progression|0|||
44561996|NCT02906670|79580558|FG005|Cohort 1, QW|Radiological Progression|0|||
44561997|NCT02906670|79580559|FG006|Cohort 1, QW|Radiological Progression|0|||
44561998|NCT02906670|79580560|FG007|Cohort 1, QW|Radiological Progression|0|||
44561999|NCT02906670|79580561|FG008|Cohort 1, QW|Radiological Progression|0|||
44562000|NCT02906670|79580562|FG009|Cohort 1, QW|Radiological Progression|0|||
44562001|NCT02906670|79580553|FG000|Cohort 2, QW|Radiological Progression|0|||
44562002|NCT02906670|79580554|FG001|Cohort 2, QW|Radiological Progression|1|||
44562003|NCT02906670|79580555|FG002|Cohort 2, QW|Radiological Progression|0|||
44562004|NCT02906670|79580556|FG003|Cohort 2, QW|Radiological Progression|0|||
44562005|NCT02906670|79580557|FG004|Cohort 2, QW|Radiological Progression|0|||
44562006|NCT02906670|79580558|FG005|Cohort 2, QW|Radiological Progression|0|||
44562007|NCT02906670|79580559|FG006|Cohort 2, QW|Radiological Progression|0|||
44562008|NCT02906670|79580560|FG007|Cohort 2, QW|Radiological Progression|0|||
44562009|NCT02906670|79580561|FG008|Cohort 2, QW|Radiological Progression|0|||
44562010|NCT02906670|79580562|FG009|Cohort 2, QW|Radiological Progression|0|||
44562011|NCT02906670|79580553|FG000|Cohort 3, QW|Radiological Progression|0|||
44562012|NCT02906670|79580554|FG001|Cohort 3, QW|Radiological Progression|0|||
44562013|NCT02906670|79580555|FG002|Cohort 3, QW|Radiological Progression|2|||
44562014|NCT02906670|79580556|FG003|Cohort 3, QW|Radiological Progression|0|||
44562015|NCT02906670|79580557|FG004|Cohort 3, QW|Radiological Progression|0|||
44562016|NCT02906670|79580558|FG005|Cohort 3, QW|Radiological Progression|0|||
44562017|NCT02906670|79580559|FG006|Cohort 3, QW|Radiological Progression|0|||
44562018|NCT02906670|79580560|FG007|Cohort 3, QW|Radiological Progression|0|||
44562019|NCT02906670|79580561|FG008|Cohort 3, QW|Radiological Progression|0|||
44562020|NCT02906670|79580562|FG009|Cohort 3, QW|Radiological Progression|0|||
44562021|NCT02906670|79580553|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562022|NCT02906670|79580554|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562023|NCT02906670|79580555|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
44562024|NCT02906670|79580556|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562025|NCT02906670|79580557|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562026|NCT02906670|79580558|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562027|NCT02906670|79580559|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562028|NCT02906670|79580560|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562029|NCT02906670|79580561|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562030|NCT02906670|79580562|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
44562031|NCT02906670|79580553|FG000|Cohort 4, Q2W|Radiological Progression|0|||
44562032|NCT02906670|79580554|FG001|Cohort 4, Q2W|Radiological Progression|0|||
44233229|NCT01785875|79051688|FG001|Overall Study|Missing|1|||
44500435|NCT03560518|79504865|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
44500436|NCT03560518|79504866|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
44500437|NCT03560518|79504867|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
44500438|NCT03560518|79504865|FG000|Double Blind Treatment Period|Protocol Violation|1|||
44500439|NCT03560518|79504866|FG001|Double Blind Treatment Period|Protocol Violation|2|||
44500440|NCT03560518|79504867|FG002|Double Blind Treatment Period|Protocol Violation|0|||
44500441|NCT03560518|79504865|FG000|Double Blind Treatment Period|Pregnancy|0|||
44500442|NCT03560518|79504866|FG001|Double Blind Treatment Period|Pregnancy|2|||
44233230|NCT01785875|79051689|FG002|Overall Study|Missing|3|||
44500443|NCT03560518|79504867|FG002|Double Blind Treatment Period|Pregnancy|0|||
44562033|NCT02906670|79580555|FG002|Cohort 4, Q2W|Radiological Progression|0|||
44562034|NCT02906670|79580556|FG003|Cohort 4, Q2W|Radiological Progression|0|||
44562035|NCT02906670|79580557|FG004|Cohort 4, Q2W|Radiological Progression|0|||
44562036|NCT02906670|79580558|FG005|Cohort 4, Q2W|Radiological Progression|1|||
44562037|NCT02906670|79580559|FG006|Cohort 4, Q2W|Radiological Progression|0|||
44562038|NCT02906670|79580560|FG007|Cohort 4, Q2W|Radiological Progression|0|||
44562039|NCT02906670|79580561|FG008|Cohort 4, Q2W|Radiological Progression|0|||
44562040|NCT02906670|79580562|FG009|Cohort 4, Q2W|Radiological Progression|0|||
44562041|NCT02906670|79580553|FG000|Cohort 4, Q2W|Clinical Progression|0|||
44562042|NCT02906670|79580554|FG001|Cohort 4, Q2W|Clinical Progression|0|||
44562043|NCT02906670|79580555|FG002|Cohort 4, Q2W|Clinical Progression|0|||
44562044|NCT02906670|79580556|FG003|Cohort 4, Q2W|Clinical Progression|0|||
44562045|NCT02906670|79580557|FG004|Cohort 4, Q2W|Clinical Progression|0|||
44562046|NCT02906670|79580558|FG005|Cohort 4, Q2W|Clinical Progression|2|||
44562047|NCT02906670|79580559|FG006|Cohort 4, Q2W|Clinical Progression|0|||
44562048|NCT02906670|79580560|FG007|Cohort 4, Q2W|Clinical Progression|0|||
44562049|NCT02906670|79580561|FG008|Cohort 4, Q2W|Clinical Progression|0|||
44562050|NCT02906670|79580562|FG009|Cohort 4, Q2W|Clinical Progression|0|||
44562051|NCT02906670|79580553|FG000|Cohort 5, Q2W|Radiological Progression|0|||
44562052|NCT02906670|79580554|FG001|Cohort 5, Q2W|Radiological Progression|0|||
44562053|NCT02906670|79580555|FG002|Cohort 5, Q2W|Radiological Progression|0|||
44562054|NCT02906670|79580556|FG003|Cohort 5, Q2W|Radiological Progression|0|||
44233231|NCT05567393|79051718|FG000|Overall Study|Voluntary Withdrawal|0|||
44233232|NCT05567393|79051719|FG001|Overall Study|Voluntary Withdrawal|0|||
44233233|NCT05567393|79051720|FG002|Overall Study|Voluntary Withdrawal|0|||
44233234|NCT05567393|79051721|FG003|Overall Study|Voluntary Withdrawal|0|||
44233235|NCT05567393|79051722|FG004|Overall Study|Voluntary Withdrawal|0|||
44233236|NCT05567393|79051723|FG005|Overall Study|Voluntary Withdrawal|0|||
44233237|NCT05567393|79051724|FG006|Overall Study|Voluntary Withdrawal|0|||
44233238|NCT05567393|79051725|FG007|Overall Study|Voluntary Withdrawal|0|||
44233239|NCT05567393|79051726|FG008|Overall Study|Voluntary Withdrawal|0|||
44233240|NCT05567393|79051727|FG009|Overall Study|Voluntary Withdrawal|0|||
44275371|NCT02203032|79221839|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
44275372|NCT02203032|79221840|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
44275373|NCT02203032|79221841|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
44500444|NCT03560518|79504865|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
44500445|NCT03560518|79504866|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
44500446|NCT03560518|79504867|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
44500447|NCT03560518|79504865|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
44500448|NCT03560518|79504866|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
44500449|NCT03560518|79504867|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
44500450|NCT03560518|79504865|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
44500451|NCT03560518|79504866|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
44500452|NCT03560518|79504867|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
44500453|NCT03560518|79504865|FG000|Double Blind Treatment Period|Adverse Event|0|||
44500454|NCT03560518|79504866|FG001|Double Blind Treatment Period|Adverse Event|3|||
44500455|NCT03560518|79504867|FG002|Double Blind Treatment Period|Adverse Event|1|||
44500456|NCT03560206|79504877|FG000|Overall Study|Lost to Follow-up|19|||
44500457|NCT03560206|79504878|FG001|Overall Study|Lost to Follow-up|11|||
44500458|NCT03560206|79504877|FG000|Overall Study|Withdrawal by Subject|2|||
44500459|NCT03560206|79504878|FG001|Overall Study|Withdrawal by Subject|4|||
44500460|NCT03560206|79504877|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
44500461|NCT03560206|79504878|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
44500462|NCT03560206|79504877|FG000|Overall Study|Busy schedule|14|||
44562055|NCT02906670|79580557|FG004|Cohort 5, Q2W|Radiological Progression|0|||
44233241|NCT05567393|79051728|FG010|Overall Study|Voluntary Withdrawal|0|||
44233242|NCT05567393|79051729|FG011|Overall Study|Voluntary Withdrawal|0|||
44233243|NCT05567393|79051730|FG012|Overall Study|Voluntary Withdrawal|0|||
44275374|NCT02203032|79221838|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
44275375|NCT02203032|79221839|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
44500463|NCT03560206|79504878|FG001|Overall Study|Busy schedule|2|||
44562056|NCT02906670|79580558|FG005|Cohort 5, Q2W|Radiological Progression|0|||
44562057|NCT02906670|79580559|FG006|Cohort 5, Q2W|Radiological Progression|4|||
44562058|NCT02906670|79580560|FG007|Cohort 5, Q2W|Radiological Progression|0|||
44562059|NCT02906670|79580561|FG008|Cohort 5, Q2W|Radiological Progression|0|||
44562060|NCT02906670|79580562|FG009|Cohort 5, Q2W|Radiological Progression|0|||
44562061|NCT02906670|79580553|FG000|Cohort 5, Q2W|Clinical Progression|0|||
44562062|NCT02906670|79580554|FG001|Cohort 5, Q2W|Clinical Progression|0|||
44562063|NCT02906670|79580555|FG002|Cohort 5, Q2W|Clinical Progression|0|||
44562064|NCT02906670|79580556|FG003|Cohort 5, Q2W|Clinical Progression|0|||
44562065|NCT02906670|79580557|FG004|Cohort 5, Q2W|Clinical Progression|0|||
44562066|NCT02906670|79580558|FG005|Cohort 5, Q2W|Clinical Progression|0|||
44562067|NCT02906670|79580559|FG006|Cohort 5, Q2W|Clinical Progression|1|||
44562068|NCT02906670|79580560|FG007|Cohort 5, Q2W|Clinical Progression|0|||
44562069|NCT02906670|79580561|FG008|Cohort 5, Q2W|Clinical Progression|0|||
44562070|NCT02906670|79580562|FG009|Cohort 5, Q2W|Clinical Progression|0|||
44562071|NCT02906670|79580553|FG000|Cohort 5, Q2W|Adverse Event|0|||
44377088|NCT00848536|79382392|FG001|Overall Study|Patient Moved|2|||
44500464|NCT03560206|79504877|FG000|Overall Study|patients' new health condition such as cancer|10|||
44500465|NCT03560206|79504878|FG001|Overall Study|patients' new health condition such as cancer|1|||
44500466|NCT02892760|79504884|FG000|Overall Study|Withdrawal by Subject|3|||
44562072|NCT02906670|79580554|FG001|Cohort 5, Q2W|Adverse Event|0|||
44562073|NCT02906670|79580555|FG002|Cohort 5, Q2W|Adverse Event|0|||
44562074|NCT02906670|79580556|FG003|Cohort 5, Q2W|Adverse Event|0|||
44562075|NCT02906670|79580557|FG004|Cohort 5, Q2W|Adverse Event|0|||
44562076|NCT02906670|79580558|FG005|Cohort 5, Q2W|Adverse Event|0|||
44562077|NCT02906670|79580559|FG006|Cohort 5, Q2W|Adverse Event|1|||
44562078|NCT02906670|79580560|FG007|Cohort 5, Q2W|Adverse Event|0|||
44562079|NCT02906670|79580561|FG008|Cohort 5, Q2W|Adverse Event|0|||
44562080|NCT02906670|79580562|FG009|Cohort 5, Q2W|Adverse Event|0|||
44500467|NCT03635086|79504893|FG000|Overall Study|Withdrawal of consent|0|||
44500468|NCT03635086|79504894|FG001|Overall Study|Withdrawal of consent|0|||
44500469|NCT03635086|79504895|FG002|Overall Study|Withdrawal of consent|1|||
44500470|NCT03635086|79504896|FG003|Overall Study|Withdrawal of consent|0|||
44500471|NCT03635086|79504897|FG004|Overall Study|Withdrawal of consent|0|||
44500472|NCT03635086|79504893|FG000|Overall Study|Adverse Event|0|||
44500473|NCT03635086|79504894|FG001|Overall Study|Adverse Event|1|||
44500474|NCT03635086|79504895|FG002|Overall Study|Adverse Event|0|||
44500475|NCT03635086|79504896|FG003|Overall Study|Adverse Event|0|||
44500476|NCT03635086|79504897|FG004|Overall Study|Adverse Event|0|||
44500477|NCT03635086|79504893|FG000|Overall Study|Lost to Follow-up|1|||
44500478|NCT03635086|79504894|FG001|Overall Study|Lost to Follow-up|0|||
44500479|NCT03635086|79504895|FG002|Overall Study|Lost to Follow-up|0|||
44500480|NCT03635086|79504896|FG003|Overall Study|Lost to Follow-up|0|||
44500481|NCT03635086|79504897|FG004|Overall Study|Lost to Follow-up|0|||
44500482|NCT03588910|79504912|FG000|Overall Study|Withdrawal by Subject|1|||
44500483|NCT03588910|79504913|FG001|Overall Study|Withdrawal by Subject|0|||
44500484|NCT03588910|79504912|FG000|Overall Study|Allergy|2|||
44500485|NCT03588910|79504913|FG001|Overall Study|Allergy|0|||
44562081|NCT02906670|79580553|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562082|NCT02906670|79580554|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562083|NCT02906670|79580555|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44500486|NCT03588910|79504912|FG000|Overall Study|Protocol Violation|0|||
44500487|NCT03588910|79504913|FG001|Overall Study|Protocol Violation|3|||
44500488|NCT03588910|79504912|FG000|Overall Study|Did not complete Day 1 Survey|5|||
44500489|NCT03588910|79504913|FG001|Overall Study|Did not complete Day 1 Survey|10|||
44500490|NCT03588910|79504912|FG000|Overall Study|Did not complete Day 7 Survey|5|||
44500491|NCT03588910|79504913|FG001|Overall Study|Did not complete Day 7 Survey|2|||
44500492|NCT03587974|79504921|FG000|Overall Study|caregiver demented, care recipient died|3|||
44562084|NCT02906670|79580556|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562085|NCT02906670|79580557|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562086|NCT02906670|79580558|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562087|NCT02906670|79580559|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
44562088|NCT02906670|79580560|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562089|NCT02906670|79580561|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562090|NCT02906670|79580562|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
44562091|NCT02906670|79580553|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
44562092|NCT02906670|79580554|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
44562093|NCT02906670|79580555|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
44562094|NCT02906670|79580556|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
44562095|NCT02906670|79580557|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
44562096|NCT02906670|79580558|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
44562097|NCT02906670|79580559|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
44562098|NCT02906670|79580560|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
44562099|NCT02906670|79580561|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
44562100|NCT02906670|79580562|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
44562101|NCT02906670|79580553|FG000|Cohort 5P, Q2W|Adverse Event|0|||
44562102|NCT02906670|79580554|FG001|Cohort 5P, Q2W|Adverse Event|0|||
44562103|NCT02906670|79580555|FG002|Cohort 5P, Q2W|Adverse Event|0|||
44562104|NCT02906670|79580556|FG003|Cohort 5P, Q2W|Adverse Event|0|||
44562105|NCT02906670|79580557|FG004|Cohort 5P, Q2W|Adverse Event|0|||
44562106|NCT02906670|79580558|FG005|Cohort 5P, Q2W|Adverse Event|0|||
44562107|NCT02906670|79580559|FG006|Cohort 5P, Q2W|Adverse Event|0|||
44562108|NCT02906670|79580560|FG007|Cohort 5P, Q2W|Adverse Event|1|||
44562109|NCT02906670|79580561|FG008|Cohort 5P, Q2W|Adverse Event|0|||
44562110|NCT02906670|79580562|FG009|Cohort 5P, Q2W|Adverse Event|0|||
44562111|NCT02906670|79580553|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
44562112|NCT02906670|79580554|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
44562113|NCT02906670|79580555|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
44562114|NCT02906670|79580556|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
44562115|NCT02906670|79580557|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
44562116|NCT02906670|79580558|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
44562117|NCT02906670|79580559|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
44562118|NCT02906670|79580560|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
44562119|NCT02906670|79580561|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
44562120|NCT02906670|79580562|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
44562121|NCT02906670|79580553|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
44562122|NCT02906670|79580554|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
44562123|NCT02906670|79580555|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
44562124|NCT02906670|79580556|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
44562125|NCT02906670|79580557|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
44233244|NCT05567393|79051731|FG013|Overall Study|Voluntary Withdrawal|1|||
44233245|NCT05567393|79051732|FG014|Overall Study|Voluntary Withdrawal|0|||
44233246|NCT05567393|79051733|FG015|Overall Study|Voluntary Withdrawal|0|||
44233247|NCT05567393|79051734|FG016|Overall Study|Voluntary Withdrawal|0|||
44562126|NCT02906670|79580558|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
44562127|NCT02906670|79580559|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
44562128|NCT02906670|79580560|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
44562129|NCT02906670|79580561|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
44562130|NCT02906670|79580562|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
44562131|NCT02906670|79580553|FG000|Cohort 4P, QW|Radiological Progression|0|||
44562132|NCT02906670|79580554|FG001|Cohort 4P, QW|Radiological Progression|0|||
44562133|NCT02906670|79580555|FG002|Cohort 4P, QW|Radiological Progression|0|||
44562134|NCT02906670|79580556|FG003|Cohort 4P, QW|Radiological Progression|3|||
44562135|NCT02906670|79580557|FG004|Cohort 4P, QW|Radiological Progression|0|||
44562136|NCT02906670|79580558|FG005|Cohort 4P, QW|Radiological Progression|0|||
44562137|NCT02906670|79580559|FG006|Cohort 4P, QW|Radiological Progression|0|||
44562138|NCT02906670|79580560|FG007|Cohort 4P, QW|Radiological Progression|0|||
44562139|NCT02906670|79580561|FG008|Cohort 4P, QW|Radiological Progression|0|||
44562140|NCT02906670|79580562|FG009|Cohort 4P, QW|Radiological Progression|0|||
44562141|NCT02906670|79580553|FG000|Cohort 7P, Q2W|Adverse Event|0|||
44562142|NCT02906670|79580554|FG001|Cohort 7P, Q2W|Adverse Event|0|||
44562143|NCT02906670|79580555|FG002|Cohort 7P, Q2W|Adverse Event|0|||
44562144|NCT02906670|79580556|FG003|Cohort 7P, Q2W|Adverse Event|0|||
44562145|NCT02906670|79580557|FG004|Cohort 7P, Q2W|Adverse Event|0|||
44562146|NCT02906670|79580558|FG005|Cohort 7P, Q2W|Adverse Event|0|||
44562147|NCT02906670|79580559|FG006|Cohort 7P, Q2W|Adverse Event|0|||
44562148|NCT02906670|79580560|FG007|Cohort 7P, Q2W|Adverse Event|0|||
44562149|NCT02906670|79580561|FG008|Cohort 7P, Q2W|Adverse Event|0|||
44562150|NCT02906670|79580562|FG009|Cohort 7P, Q2W|Adverse Event|1|||
44562151|NCT02906670|79580553|FG000|Cohort 7P, Q2W|Physician Decision|0|||
44562152|NCT02906670|79580554|FG001|Cohort 7P, Q2W|Physician Decision|0|||
44562153|NCT02906670|79580555|FG002|Cohort 7P, Q2W|Physician Decision|0|||
44562154|NCT02906670|79580556|FG003|Cohort 7P, Q2W|Physician Decision|0|||
44562155|NCT02906670|79580557|FG004|Cohort 7P, Q2W|Physician Decision|0|||
44562156|NCT02906670|79580558|FG005|Cohort 7P, Q2W|Physician Decision|0|||
44562157|NCT02906670|79580559|FG006|Cohort 7P, Q2W|Physician Decision|0|||
44562158|NCT02906670|79580560|FG007|Cohort 7P, Q2W|Physician Decision|0|||
44562159|NCT02906670|79580561|FG008|Cohort 7P, Q2W|Physician Decision|0|||
44562160|NCT02906670|79580562|FG009|Cohort 7P, Q2W|Physician Decision|1|||
44562161|NCT02906670|79580553|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562162|NCT02906670|79580554|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562163|NCT02906670|79580555|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562164|NCT02906670|79580556|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44233248|NCT05567393|79051735|FG017|Overall Study|Voluntary Withdrawal|0|||
44233249|NCT04973085|79051808|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
44233250|NCT04973085|79051809|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
44233251|NCT04542070|79051859|FG000|Overall Study|Adverse Event|10|||
44233252|NCT04542070|79051860|FG001|Overall Study|Adverse Event|3|||
44233253|NCT04542070|79051861|FG002|Overall Study|Adverse Event|1|||
44233254|NCT04542070|79051859|FG000|Overall Study|Lack of Efficacy|1|||
44233255|NCT04542070|79051860|FG001|Overall Study|Lack of Efficacy|2|||
44233256|NCT04542070|79051861|FG002|Overall Study|Lack of Efficacy|0|||
44500493|NCT03587974|79504922|FG001|Overall Study|caregiver demented, care recipient died|3|||
44500494|NCT03587974|79504921|FG000|Overall Study|Withdrawal by Subject|2|||
44500495|NCT03587974|79504922|FG001|Overall Study|Withdrawal by Subject|1|||
44500496|NCT00103857|79504935|FG000|54-Week Base Study|Adverse Event|12|||
44500497|NCT00103857|79504936|FG001|54-Week Base Study|Adverse Event|9|||
44500498|NCT00103857|79504937|FG002|54-Week Base Study|Adverse Event|11|||
44500499|NCT00103857|79504938|FG003|54-Week Base Study|Adverse Event|6|||
44500500|NCT00103857|79504939|FG004|54-Week Base Study|Adverse Event|5|||
44500501|NCT00103857|79504940|FG005|54-Week Base Study|Adverse Event|11|||
44500502|NCT00103857|79504941|FG006|54-Week Base Study|Adverse Event|3|||
44500503|NCT00103857|79504935|FG000|54-Week Base Study|Death|0|||
44500504|NCT00103857|79504936|FG001|54-Week Base Study|Death|0|||
44233257|NCT04542070|79051859|FG000|Overall Study|Lost to Follow-up|3|||
44233258|NCT04542070|79051860|FG001|Overall Study|Lost to Follow-up|4|||
44233259|NCT04542070|79051861|FG002|Overall Study|Lost to Follow-up|2|||
44233260|NCT04542070|79051859|FG000|Overall Study|Physician Decision|1|||
44233261|NCT04542070|79051860|FG001|Overall Study|Physician Decision|0|||
44500505|NCT00103857|79504937|FG002|54-Week Base Study|Death|0|||
44562165|NCT02906670|79580557|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562166|NCT02906670|79580558|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562167|NCT02906670|79580559|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562168|NCT02906670|79580560|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44500506|NCT00103857|79504938|FG003|54-Week Base Study|Death|0|||
44500507|NCT00103857|79504939|FG004|54-Week Base Study|Death|1|||
44500508|NCT00103857|79504940|FG005|54-Week Base Study|Death|1|||
44500509|NCT00103857|79504941|FG006|54-Week Base Study|Death|0|||
44562169|NCT02906670|79580561|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
44562170|NCT02906670|79580562|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
44562171|NCT02906670|79580553|FG000|Cohort 5P, QW|Radiological Progression|0|||
44562172|NCT02906670|79580554|FG001|Cohort 5P, QW|Radiological Progression|0|||
44562173|NCT02906670|79580555|FG002|Cohort 5P, QW|Radiological Progression|0|||
44562174|NCT02906670|79580556|FG003|Cohort 5P, QW|Radiological Progression|0|||
44562175|NCT02906670|79580557|FG004|Cohort 5P, QW|Radiological Progression|3|||
44562176|NCT02906670|79580558|FG005|Cohort 5P, QW|Radiological Progression|0|||
44562177|NCT02906670|79580559|FG006|Cohort 5P, QW|Radiological Progression|0|||
44562178|NCT02906670|79580560|FG007|Cohort 5P, QW|Radiological Progression|0|||
44562179|NCT02906670|79580561|FG008|Cohort 5P, QW|Radiological Progression|0|||
44562180|NCT02906670|79580562|FG009|Cohort 5P, QW|Radiological Progression|0|||
44562181|NCT02906358|79580614|FG000|Overall Study|Withdrawal by Subject|10|||
44562182|NCT02906358|79580615|FG001|Overall Study|Withdrawal by Subject|7|||
44562183|NCT02906358|79580614|FG000|Overall Study|Lost to Follow-up|12|||
44562184|NCT02906358|79580615|FG001|Overall Study|Lost to Follow-up|15|||
44562185|NCT02186834|79580621|FG000|Dose Escalation|Death|0|||
44562186|NCT02186834|79580622|FG001|Dose Escalation|Death|0|||
44562187|NCT02186834|79580623|FG002|Dose Escalation|Death|0|||
44562188|NCT02186834|79580624|FG003|Dose Escalation|Death|1|||
44562189|NCT02186834|79580625|FG004|Dose Escalation|Death|0|||
44562190|NCT02186834|79580626|FG005|Dose Escalation|Death|0|||
44562191|NCT02186834|79580621|FG000|Treatment at RP2D|Died prior to treatment|0|||
44562192|NCT02186834|79580622|FG001|Treatment at RP2D|Died prior to treatment|0|||
44562193|NCT02186834|79580623|FG002|Treatment at RP2D|Died prior to treatment|0|||
44562194|NCT02186834|79580624|FG003|Treatment at RP2D|Died prior to treatment|0|||
44562195|NCT02186834|79580625|FG004|Treatment at RP2D|Died prior to treatment|0|||
44500510|NCT00103857|79504935|FG000|54-Week Base Study|Lack of Efficacy|11|||
44500511|NCT00103857|79504936|FG001|54-Week Base Study|Lack of Efficacy|14|||
44500512|NCT00103857|79504937|FG002|54-Week Base Study|Lack of Efficacy|8|||
44500513|NCT00103857|79504938|FG003|54-Week Base Study|Lack of Efficacy|4|||
44500514|NCT00103857|79504939|FG004|54-Week Base Study|Lack of Efficacy|3|||
44500515|NCT00103857|79504940|FG005|54-Week Base Study|Lack of Efficacy|14|||
44500516|NCT00103857|79504941|FG006|54-Week Base Study|Lack of Efficacy|19|||
44500517|NCT00103857|79504935|FG000|54-Week Base Study|Lost to Follow-up|5|||
44500518|NCT00103857|79504936|FG001|54-Week Base Study|Lost to Follow-up|4|||
44500519|NCT00103857|79504937|FG002|54-Week Base Study|Lost to Follow-up|7|||
44500520|NCT00103857|79504938|FG003|54-Week Base Study|Lost to Follow-up|5|||
44500521|NCT00103857|79504939|FG004|54-Week Base Study|Lost to Follow-up|10|||
44500522|NCT00103857|79504940|FG005|54-Week Base Study|Lost to Follow-up|9|||
44500523|NCT00103857|79504941|FG006|54-Week Base Study|Lost to Follow-up|3|||
44500524|NCT00103857|79504935|FG000|54-Week Base Study|Physician Decision|1|||
44500525|NCT00103857|79504936|FG001|54-Week Base Study|Physician Decision|1|||
44500526|NCT00103857|79504937|FG002|54-Week Base Study|Physician Decision|0|||
44500527|NCT00103857|79504938|FG003|54-Week Base Study|Physician Decision|0|||
44500528|NCT00103857|79504939|FG004|54-Week Base Study|Physician Decision|1|||
44500529|NCT00103857|79504940|FG005|54-Week Base Study|Physician Decision|0|||
44500530|NCT00103857|79504941|FG006|54-Week Base Study|Physician Decision|0|||
44500531|NCT00103857|79504935|FG000|54-Week Base Study|Pregnancy|1|||
44500532|NCT00103857|79504936|FG001|54-Week Base Study|Pregnancy|0|||
44500533|NCT00103857|79504937|FG002|54-Week Base Study|Pregnancy|0|||
44500534|NCT00103857|79504938|FG003|54-Week Base Study|Pregnancy|0|||
44562196|NCT02186834|79580626|FG005|Treatment at RP2D|Died prior to treatment|1|||
44562197|NCT03144687|79580637|FG000|Overall Study|Death|0|||
44562198|NCT03144687|79580638|FG001|Overall Study|Death|2|||
44562199|NCT03144687|79580637|FG000|Overall Study|Lost to Follow-up|0|||
44233262|NCT04542070|79051861|FG002|Overall Study|Physician Decision|1|||
44233263|NCT04542070|79051859|FG000|Overall Study|Withdrawal by Subject|5|||
44500535|NCT00103857|79504939|FG004|54-Week Base Study|Pregnancy|1|||
44562200|NCT03144687|79580638|FG001|Overall Study|Lost to Follow-up|1|||
44562201|NCT03144687|79580637|FG000|Overall Study|Physician Decision|0|||
44562202|NCT03144687|79580638|FG001|Overall Study|Physician Decision|1|||
44500536|NCT00103857|79504940|FG005|54-Week Base Study|Pregnancy|0|||
44500537|NCT00103857|79504941|FG006|54-Week Base Study|Pregnancy|1|||
44562203|NCT03144687|79580637|FG000|Overall Study|Withdrawal by Subject|1|||
44500538|NCT00103857|79504935|FG000|54-Week Base Study|Protocol Violation|6|||
44500539|NCT00103857|79504936|FG001|54-Week Base Study|Protocol Violation|4|||
44500540|NCT00103857|79504937|FG002|54-Week Base Study|Protocol Violation|2|||
44500541|NCT00103857|79504938|FG003|54-Week Base Study|Protocol Violation|4|||
44562204|NCT03144687|79580638|FG001|Overall Study|Withdrawal by Subject|3|||
44562205|NCT03144687|79580637|FG000|Overall Study|Not Reported|2|||
44562206|NCT03144687|79580638|FG001|Overall Study|Not Reported|0|||
44562207|NCT03080961|79580648|FG000|Overall Study|Withdrawal by Subject|3|||
44562208|NCT02905266|79580672|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
44562209|NCT02905266|79580673|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
44562210|NCT02905266|79580672|FG000|Treatment Phase Part 1|Disease Progression|6|||
44562211|NCT02905266|79580673|FG001|Treatment Phase Part 1|Disease Progression|7|||
44562212|NCT02905266|79580672|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
44562213|NCT02905266|79580673|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
44562214|NCT02905266|79580672|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
44562215|NCT02905266|79580673|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
44562216|NCT02905266|79580672|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
44562217|NCT02905266|79580673|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
44562218|NCT02905266|79580672|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
44562219|NCT02905266|79580673|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
44562220|NCT02905266|79580672|FG000|Transition From Part 1 to Part 2|Death|0|||
44562221|NCT02905266|79580673|FG001|Transition From Part 1 to Part 2|Death|1|||
44562222|NCT02905266|79580672|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
44562223|NCT02905266|79580673|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
44562224|NCT02905266|79580672|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
44562225|NCT02905266|79580673|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
44562226|NCT02905266|79580672|FG000|Maintenance Phase Part 2|Disease Progression|9|||
44562227|NCT02905266|79580673|FG001|Maintenance Phase Part 2|Disease Progression|2|||
44562228|NCT02905266|79580672|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
44562229|NCT02905266|79580673|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
44562230|NCT02905266|79580672|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
44562231|NCT02905266|79580673|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
44562232|NCT02982018|79580681|FG000|Overall Study|Incorrect Lens Dispensed|1|||
44562233|NCT02982018|79580682|FG001|Overall Study|Incorrect Lens Dispensed|0|||
44562234|NCT02982018|79580681|FG000|Overall Study|Protocol Violation|1|||
44562235|NCT02982018|79580682|FG001|Overall Study|Protocol Violation|1|||
44562236|NCT02982018|79580681|FG000|Overall Study|Adverse Event|1|||
44562237|NCT02982018|79580682|FG001|Overall Study|Adverse Event|1|||
44562238|NCT02982018|79580681|FG000|Overall Study|Lens Discomfort|2|||
44562239|NCT02982018|79580682|FG001|Overall Study|Lens Discomfort|0|||
44562240|NCT02982018|79580681|FG000|Overall Study|Withdrawal by Subject|0|||
44500542|NCT00103857|79504939|FG004|54-Week Base Study|Protocol Violation|0|||
44500543|NCT00103857|79504940|FG005|54-Week Base Study|Protocol Violation|3|||
44233264|NCT04542070|79051860|FG001|Overall Study|Withdrawal by Subject|8|||
44233265|NCT04542070|79051861|FG002|Overall Study|Withdrawal by Subject|9|||
44500544|NCT00103857|79504941|FG006|54-Week Base Study|Protocol Violation|3|||
44500545|NCT00103857|79504935|FG000|54-Week Base Study|Withdrawal by Subject|17|||
44500546|NCT00103857|79504936|FG001|54-Week Base Study|Withdrawal by Subject|16|||
44500547|NCT00103857|79504937|FG002|54-Week Base Study|Withdrawal by Subject|16|||
44500548|NCT00103857|79504938|FG003|54-Week Base Study|Withdrawal by Subject|15|||
44500549|NCT00103857|79504939|FG004|54-Week Base Study|Withdrawal by Subject|10|||
44500550|NCT00103857|79504940|FG005|54-Week Base Study|Withdrawal by Subject|15|||
44500551|NCT00103857|79504941|FG006|54-Week Base Study|Withdrawal by Subject|4|||
44562241|NCT02982018|79580682|FG001|Overall Study|Withdrawal by Subject|1|||
44562242|NCT03080493|79580690|FG000|Overall Study|Did not provide NRS pain results|1|||
44562243|NCT03080493|79580691|FG001|Overall Study|Did not provide NRS pain results|0|||
44500552|NCT00103857|79504935|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
44500553|NCT00103857|79504936|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
44500554|NCT00103857|79504937|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
44562244|NCT03080493|79580690|FG000|Overall Study|Adverse Event|0|||
44562245|NCT03080493|79580691|FG001|Overall Study|Adverse Event|1|||
44562246|NCT03080493|79580690|FG000|Overall Study|Randomization error (parity group)|0|||
44562247|NCT03080493|79580691|FG001|Overall Study|Randomization error (parity group)|1|||
44562248|NCT01339910|79580699|FG000|Overall Study|Withdrawal by Subject|1|||
44562249|NCT01339910|79580700|FG001|Overall Study|Withdrawal by Subject|0|||
44562250|NCT01339910|79580699|FG000|Overall Study|Physician Decision|1|||
44233266|NCT04542070|79051859|FG000|Overall Study|Protocol Deviation|2|||
44233267|NCT04542070|79051860|FG001|Overall Study|Protocol Deviation|6|||
44233268|NCT04542070|79051861|FG002|Overall Study|Protocol Deviation|1|||
44233269|NCT04542070|79051859|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
44233270|NCT04542070|79051860|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
44233271|NCT04542070|79051861|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44233272|NCT04538950|79051870|FG000|Overall Study|Pulmonary Issues|2|||
44233273|NCT04538950|79051870|FG000|Overall Study|illness|2|||
44233274|NCT04445688|79051883|FG000|Washout (One Week)|Adverse Event|2|||
44233275|NCT04445688|79051883|FG000|Washout (One Week)|Withdrawal by Subject|1|||
44233276|NCT04382755|79051893|FG000|Overall Study|Withdrawal by Subject|1|||
44233277|NCT04382755|79051894|FG001|Overall Study|Withdrawal by Subject|0|||
44275376|NCT02203032|79221840|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
44275377|NCT02203032|79221841|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
44275378|NCT02203032|79221838|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
44562251|NCT01339910|79580700|FG001|Overall Study|Physician Decision|0|||
44562252|NCT01339910|79580699|FG000|Overall Study|Disease relapse|1|||
44562253|NCT01339910|79580700|FG001|Overall Study|Disease relapse|4|||
44562254|NCT02981082|79580708|FG000|Overall Study|Withdrawal by Subject|2|||
44562255|NCT02981082|79580709|FG001|Overall Study|Withdrawal by Subject|0|||
44562256|NCT02981082|79580708|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
44562257|NCT02981082|79580709|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
44562258|NCT02981082|79580708|FG000|Overall Study|Adverse Event|0|||
44562259|NCT02981082|79580709|FG001|Overall Study|Adverse Event|1|||
44562260|NCT01066104|79580717|FG000|Overall Study|Adverse Event|1|||
44562261|NCT01066104|79580718|FG001|Overall Study|Adverse Event|1|||
44562262|NCT01066104|79580717|FG000|Overall Study|Protocol Violation|1|||
44562263|NCT01066104|79580718|FG001|Overall Study|Protocol Violation|0|||
44562264|NCT02736968|79580729|FG000|Overall Study|Lost to Follow-up|0|||
44562265|NCT02736968|79580730|FG001|Overall Study|Lost to Follow-up|0|||
44562266|NCT02736968|79580731|FG002|Overall Study|Lost to Follow-up|0|||
44562267|NCT02736968|79580732|FG003|Overall Study|Lost to Follow-up|0|||
44562268|NCT02736968|79580733|FG004|Overall Study|Lost to Follow-up|0|||
44562269|NCT02736968|79580734|FG005|Overall Study|Lost to Follow-up|0|||
44562270|NCT02736968|79580735|FG006|Overall Study|Lost to Follow-up|5|||
44562271|NCT02736968|79580736|FG007|Overall Study|Lost to Follow-up|2|||
44562272|NCT02736968|79580729|FG000|Overall Study|COVID-19 Pandemic|0|||
44562273|NCT02736968|79580730|FG001|Overall Study|COVID-19 Pandemic|0|||
44562274|NCT02736968|79580731|FG002|Overall Study|COVID-19 Pandemic|0|||
44562275|NCT02736968|79580732|FG003|Overall Study|COVID-19 Pandemic|0|||
44562276|NCT02736968|79580733|FG004|Overall Study|COVID-19 Pandemic|0|||
44562277|NCT02736968|79580734|FG005|Overall Study|COVID-19 Pandemic|0|||
44562278|NCT02736968|79580735|FG006|Overall Study|COVID-19 Pandemic|2|||
44562279|NCT02736968|79580736|FG007|Overall Study|COVID-19 Pandemic|0|||
44562280|NCT02736968|79580729|FG000|Overall Study|Withdrawal by Subject|0|||
44562281|NCT02736968|79580730|FG001|Overall Study|Withdrawal by Subject|0|||
44562282|NCT02736968|79580731|FG002|Overall Study|Withdrawal by Subject|0|||
44562283|NCT02736968|79580732|FG003|Overall Study|Withdrawal by Subject|0|||
44562284|NCT02736968|79580733|FG004|Overall Study|Withdrawal by Subject|0|||
44562285|NCT02736968|79580734|FG005|Overall Study|Withdrawal by Subject|0|||
44562286|NCT02736968|79580735|FG006|Overall Study|Withdrawal by Subject|1|||
44562287|NCT02736968|79580736|FG007|Overall Study|Withdrawal by Subject|0|||
44562288|NCT02980224|79580749|FG000|Overall Study|Adverse Event|4|||
44562289|NCT02980224|79580750|FG001|Overall Study|Adverse Event|1|||
44562290|NCT02980224|79580749|FG000|Overall Study|Withdrawal by Subject|0|||
44562291|NCT02980224|79580750|FG001|Overall Study|Withdrawal by Subject|2|||
44562292|NCT02591615|79580760|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
44562293|NCT02591615|79580761|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
44562294|NCT02591615|79580762|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
44562295|NCT02591615|79580763|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
44562296|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
44562297|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
44562298|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
44562299|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
44562300|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
44562301|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
44233278|NCT04382755|79051893|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
44562302|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
44562303|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
44562304|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
44562305|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
44562306|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
44562307|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
44562308|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
44500555|NCT00103857|79504938|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
44562309|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
44562310|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
44233279|NCT04382755|79051894|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
44233280|NCT04382755|79051893|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
44233281|NCT04382755|79051894|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
44562311|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
44233282|NCT04322539|79051903|FG000|Overall Study|Withdrawal of consent|14|||
44233283|NCT04322539|79051904|FG001|Overall Study|Withdrawal of consent|8|||
44233284|NCT04322539|79051903|FG000|Overall Study|Death|317|||
44233285|NCT04322539|79051904|FG001|Overall Study|Death|173|||
44233286|NCT04322539|79051903|FG000|Overall Study|Adverse Event|1|||
44233287|NCT04322539|79051904|FG001|Overall Study|Adverse Event|0|||
44233288|NCT04322539|79051903|FG000|Overall Study|Lost to Follow-up|3|||
44233289|NCT04322539|79051904|FG001|Overall Study|Lost to Follow-up|0|||
44233290|NCT04322539|79051903|FG000|Overall Study|Other|2|||
44233291|NCT04322539|79051904|FG001|Overall Study|Other|3|||
44233292|NCT04322539|79051903|FG000|Overall Study|Ongoing|124|||
44233293|NCT04322539|79051904|FG001|Overall Study|Ongoing|46|||
44233294|NCT03928418|79051939|FG000|Overall Study|Lost to Follow-up|5|||
44233295|NCT03928418|79051940|FG001|Overall Study|Lost to Follow-up|3|||
44233296|NCT03928418|79051941|FG002|Overall Study|Lost to Follow-up|5|||
44233297|NCT03928418|79051939|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
44500556|NCT00103857|79504939|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
44500557|NCT00103857|79504940|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
44562312|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
44562313|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
44562314|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
44562315|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
44562316|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
44562317|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
44562318|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
44562319|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
44500558|NCT00103857|79504941|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
44500559|NCT00103857|79504935|FG000|54-Week Base Study|patient moved|0|||
44500560|NCT00103857|79504936|FG001|54-Week Base Study|patient moved|1|||
44500561|NCT00103857|79504937|FG002|54-Week Base Study|patient moved|1|||
44500562|NCT00103857|79504938|FG003|54-Week Base Study|patient moved|2|||
44500563|NCT00103857|79504939|FG004|54-Week Base Study|patient moved|3|||
44500564|NCT00103857|79504940|FG005|54-Week Base Study|patient moved|1|||
44500565|NCT00103857|79504941|FG006|54-Week Base Study|patient moved|0|||
44500566|NCT00103857|79504935|FG000|54-Week Base Study|non-compliance with study procedures|1|||
44500567|NCT00103857|79504936|FG001|54-Week Base Study|non-compliance with study procedures|2|||
44500568|NCT00103857|79504937|FG002|54-Week Base Study|non-compliance with study procedures|0|||
44500569|NCT00103857|79504938|FG003|54-Week Base Study|non-compliance with study procedures|0|||
44500570|NCT00103857|79504939|FG004|54-Week Base Study|non-compliance with study procedures|0|||
44500571|NCT00103857|79504940|FG005|54-Week Base Study|non-compliance with study procedures|2|||
44500572|NCT00103857|79504941|FG006|54-Week Base Study|non-compliance with study procedures|0|||
44562320|NCT02591615|79580760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
44562321|NCT02591615|79580761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
44233298|NCT03928418|79051940|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
44233299|NCT03928418|79051941|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
44500573|NCT00103857|79504935|FG000|54-Week Base Study|patient incarcerated|0|||
44500574|NCT00103857|79504936|FG001|54-Week Base Study|patient incarcerated|0|||
44500575|NCT00103857|79504937|FG002|54-Week Base Study|patient incarcerated|0|||
44233300|NCT03757130|79052000|FG000|Overall Study|Lost to Follow-up|0|||
44233301|NCT03757130|79052001|FG001|Overall Study|Lost to Follow-up|0|||
44233302|NCT03757130|79052002|FG002|Overall Study|Lost to Follow-up|0|||
44233303|NCT03757130|79052003|FG003|Overall Study|Lost to Follow-up|1|||
44562322|NCT02591615|79580762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
44562323|NCT02591615|79580763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
44562324|NCT02591615|79580760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
44562325|NCT02591615|79580761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
44562326|NCT02591615|79580762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
44562327|NCT02591615|79580763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
44562328|NCT02591615|79580760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
44562329|NCT02591615|79580761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
44562330|NCT02591615|79580762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
44562331|NCT02591615|79580763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
44562332|NCT02591615|79580760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
44562333|NCT02591615|79580761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
44562334|NCT02591615|79580762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
44562335|NCT02591615|79580763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
44562336|NCT02591615|79580760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
44562337|NCT02591615|79580761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
44562338|NCT02591615|79580762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
44562339|NCT02591615|79580763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
44562340|NCT02591615|79580760|FG000|Maintenance MK-3475|Adverse Event|0|||
44562341|NCT02591615|79580761|FG001|Maintenance MK-3475|Adverse Event|3|||
44562342|NCT02591615|79580762|FG002|Maintenance MK-3475|Adverse Event|1|||
44562343|NCT02591615|79580763|FG003|Maintenance MK-3475|Adverse Event|2|||
44562344|NCT02591615|79580760|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
44562345|NCT02591615|79580761|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
44562346|NCT02591615|79580762|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
44562347|NCT02591615|79580763|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
44562348|NCT02591615|79580760|FG000|Maintenance MK-3475|Death|0|||
44562349|NCT02591615|79580761|FG001|Maintenance MK-3475|Death|1|||
44562350|NCT02591615|79580762|FG002|Maintenance MK-3475|Death|1|||
44562351|NCT02591615|79580763|FG003|Maintenance MK-3475|Death|0|||
44233304|NCT03757130|79052004|FG004|Overall Study|Lost to Follow-up|0|||
44233305|NCT03757130|79052005|FG005|Overall Study|Lost to Follow-up|0|||
44233306|NCT03757130|79052006|FG006|Overall Study|Lost to Follow-up|0|||
44233307|NCT03757130|79052007|FG007|Overall Study|Lost to Follow-up|1|||
44233308|NCT03757130|79052000|FG000|Overall Study|Withdrawal by Subject|0|||
44233309|NCT03757130|79052001|FG001|Overall Study|Withdrawal by Subject|0|||
44500576|NCT00103857|79504938|FG003|54-Week Base Study|patient incarcerated|0|||
44562352|NCT02591615|79580760|FG000|Maintenance MK-3475|Physician discretion|0|||
44500577|NCT00103857|79504939|FG004|54-Week Base Study|patient incarcerated|1|||
44500578|NCT00103857|79504940|FG005|54-Week Base Study|patient incarcerated|1|||
44500579|NCT00103857|79504941|FG006|54-Week Base Study|patient incarcerated|0|||
44500580|NCT00103857|79504935|FG000|54-Week Base Study|laboratory reporting error|0|||
44500581|NCT00103857|79504936|FG001|54-Week Base Study|laboratory reporting error|0|||
44500582|NCT00103857|79504937|FG002|54-Week Base Study|laboratory reporting error|0|||
44500583|NCT00103857|79504938|FG003|54-Week Base Study|laboratory reporting error|0|||
44500584|NCT00103857|79504939|FG004|54-Week Base Study|laboratory reporting error|1|||
44500585|NCT00103857|79504940|FG005|54-Week Base Study|laboratory reporting error|0|||
44562353|NCT02591615|79580761|FG001|Maintenance MK-3475|Physician discretion|0|||
44562354|NCT02591615|79580762|FG002|Maintenance MK-3475|Physician discretion|1|||
44233310|NCT03757130|79052002|FG002|Overall Study|Withdrawal by Subject|0|||
44500586|NCT00103857|79504941|FG006|54-Week Base Study|laboratory reporting error|0|||
44562355|NCT02591615|79580763|FG003|Maintenance MK-3475|Physician discretion|0|||
44562356|NCT02591615|79580760|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
44562357|NCT02591615|79580761|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
44562358|NCT02591615|79580762|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
44500587|NCT00103857|79504935|FG000|54-Week Base Study|site error|0|||
44562359|NCT02591615|79580763|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
44500588|NCT00103857|79504936|FG001|54-Week Base Study|site error|0|||
44562360|NCT02591615|79580760|FG000|Maintenance MK-3475|In active treatment|2|||
44233311|NCT03757130|79052003|FG003|Overall Study|Withdrawal by Subject|0|||
44233312|NCT03757130|79052004|FG004|Overall Study|Withdrawal by Subject|0|||
44233313|NCT03757130|79052005|FG005|Overall Study|Withdrawal by Subject|0|||
44562361|NCT02591615|79580761|FG001|Maintenance MK-3475|In active treatment|0|||
44562362|NCT02591615|79580762|FG002|Maintenance MK-3475|In active treatment|0|||
44562363|NCT02591615|79580763|FG003|Maintenance MK-3475|In active treatment|1|||
44233314|NCT03757130|79052006|FG006|Overall Study|Withdrawal by Subject|1|||
44233315|NCT03757130|79052007|FG007|Overall Study|Withdrawal by Subject|0|||
44233316|NCT03555565|79052048|FG000|Overall Study|Case Report Forms Uncollected|2|||
44233317|NCT03555565|79052048|FG000|Overall Study|Protocol Deviation|13|||
44233318|NCT03519386|79052055|FG000|Overall Study|Withdrawal by Subject|4|||
44233319|NCT03519386|79052056|FG001|Overall Study|Withdrawal by Subject|1|||
44233320|NCT03519386|79052057|FG002|Overall Study|Withdrawal by Subject|2|||
44233321|NCT03519386|79052055|FG000|Overall Study|Physician Decision|1|||
44233322|NCT03519386|79052056|FG001|Overall Study|Physician Decision|1|||
44233323|NCT03519386|79052057|FG002|Overall Study|Physician Decision|1|||
44233324|NCT03519386|79052055|FG000|Overall Study|Lost to Follow-up|0|||
44233325|NCT03519386|79052056|FG001|Overall Study|Lost to Follow-up|1|||
44233326|NCT03519386|79052057|FG002|Overall Study|Lost to Follow-up|1|||
44233327|NCT03519386|79052055|FG000|Overall Study|Death|1|||
44233328|NCT03519386|79052056|FG001|Overall Study|Death|0|||
44233329|NCT03519386|79052057|FG002|Overall Study|Death|4|||
44233330|NCT03519386|79052055|FG000|Overall Study|Adverse Event|2|||
44233331|NCT03519386|79052056|FG001|Overall Study|Adverse Event|1|||
44233332|NCT03519386|79052057|FG002|Overall Study|Adverse Event|2|||
44233333|NCT03519386|79052055|FG000|Overall Study|Explanted|2|||
44233334|NCT03519386|79052056|FG001|Overall Study|Explanted|1|||
44233335|NCT03519386|79052057|FG002|Overall Study|Explanted|0|||
44233336|NCT03519386|79052055|FG000|Overall Study|Ongoing in study|190|||
44233337|NCT03519386|79052056|FG001|Overall Study|Ongoing in study|192|||
44233338|NCT03519386|79052057|FG002|Overall Study|Ongoing in study|183|||
44233339|NCT03369665|79052074|FG000|Overall Study|Adverse Event|3|||
44233340|NCT03369665|79052074|FG000|Overall Study|Lost to Follow-up|7|||
44233341|NCT03369665|79052074|FG000|Overall Study|Withdrawal by Subject|15|||
44233342|NCT03369665|79052074|FG000|Overall Study|Progression Disease|2|||
44233343|NCT03369665|79052074|FG000|Overall Study|Not classified|3|||
44233344|NCT03304249|79052091|FG000|Overall Study|Lost to Follow-up|8|||
44233345|NCT03304249|79052092|FG001|Overall Study|Lost to Follow-up|10|||
44233346|NCT03304249|79052091|FG000|Overall Study|Withdrawal by Subject|12|||
44233347|NCT03304249|79052092|FG001|Overall Study|Withdrawal by Subject|2|||
44233348|NCT03304249|79052091|FG000|Overall Study|Moved Out of District|4|||
44233349|NCT03304249|79052092|FG001|Overall Study|Moved Out of District|2|||
44233350|NCT03181893|79052148|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44233351|NCT03181893|79052149|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
44233352|NCT03181893|79052150|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44233353|NCT03181893|79052151|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44562364|NCT03077607|79580778|FG000|Period 1 (15 Days)|Adverse Event|1|||
44562365|NCT03077607|79580779|FG001|Period 1 (15 Days)|Adverse Event|0|||
44233354|NCT03181893|79052152|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44233355|NCT03181893|79052153|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44500589|NCT00103857|79504937|FG002|54-Week Base Study|site error|0|||
44500590|NCT00103857|79504938|FG003|54-Week Base Study|site error|0|||
44500591|NCT00103857|79504939|FG004|54-Week Base Study|site error|0|||
44500592|NCT00103857|79504940|FG005|54-Week Base Study|site error|1|||
44500593|NCT00103857|79504941|FG006|54-Week Base Study|site error|0|||
44500594|NCT00103857|79504935|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
44500595|NCT00103857|79504936|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
44500596|NCT00103857|79504937|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
44500597|NCT00103857|79504938|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
44500598|NCT00103857|79504939|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
44500599|NCT00103857|79504940|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
44562366|NCT03077607|79580778|FG000|Period 1 (15 Days)|Death|1|||
44233356|NCT03181893|79052154|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44233357|NCT03181893|79052155|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44233358|NCT03181893|79052156|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44500600|NCT00103857|79504941|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
44500601|NCT00103857|79504935|FG000|50-Week Extension Study|Adverse Event|2|||
44500602|NCT00103857|79504936|FG001|50-Week Extension Study|Adverse Event|3|||
44562367|NCT03077607|79580779|FG001|Period 1 (15 Days)|Death|0|||
44233359|NCT03181893|79052157|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44233360|NCT03181893|79052158|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
44275379|NCT02203032|79221839|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
44233361|NCT03181893|79052148|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
44233362|NCT03181893|79052149|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
44233363|NCT03181893|79052150|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233364|NCT03181893|79052151|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44562368|NCT03077607|79580778|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
44562369|NCT03077607|79580779|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
44562370|NCT03077607|79580778|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
44562371|NCT03077607|79580779|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
44562372|NCT02977572|79580798|FG000|Overall Study|Exclusion criterion|2|||
44562373|NCT02977572|79580799|FG001|Overall Study|Exclusion criterion|2|||
44562374|NCT02746874|79580811|FG000|Overall Study|Withdrawal by Subject|0|||
44562375|NCT02746874|79580812|FG001|Overall Study|Withdrawal by Subject|1|||
44562376|NCT02746874|79580811|FG000|Overall Study|Surgery Date Changed|0|||
44562377|NCT02746874|79580812|FG001|Overall Study|Surgery Date Changed|2|||
44562378|NCT03217175|79580818|FG000|Overall Study|Physician Decision|4|||
44562379|NCT03217175|79580819|FG001|Overall Study|Physician Decision|1|||
44562380|NCT01062126|79580825|FG000|Overall Study|Death|209|||
44562381|NCT01062126|79580825|FG000|Overall Study|All Withdrawals|324|||
44562382|NCT02522429|79580829|FG000|Overall Study|Lost to Follow-up|8|||
44562383|NCT02522429|79580829|FG000|Overall Study|Adverse Event|2|||
44562384|NCT02522429|79580829|FG000|Overall Study|Death|1|||
44562385|NCT02522429|79580829|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
44562386|NCT02974140|79580833|FG000|Overall Study|Adverse Event|2|||
44562387|NCT02974140|79580833|FG000|Overall Study|Lost to Follow-up|1|||
44562388|NCT02974140|79580833|FG000|Overall Study|Study Terminated by Sponsor|36|||
44562389|NCT02974842|79580840|FG000|Overall Study|Withdrawal by Subject|4|||
44562390|NCT02974842|79580840|FG000|Overall Study|Screen failures|4|||
44562391|NCT03172481|79580846|FG000|Double-blind|Withdrawal by Subject|1|||
44562392|NCT03172481|79580847|FG001|Double-blind|Withdrawal by Subject|0|||
44562393|NCT02855450|79580855|FG000|Overall Study|Adverse Event|1|||
44562394|NCT02855450|79580856|FG001|Overall Study|Adverse Event|0|||
44562395|NCT02855450|79580855|FG000|Overall Study|Lost to Follow-up|4|||
44562396|NCT02855450|79580856|FG001|Overall Study|Lost to Follow-up|0|||
44562397|NCT03172325|79580864|FG000|Overall Study|Adverse Event|2|||
44562398|NCT03172325|79580865|FG001|Overall Study|Adverse Event|3|||
44562399|NCT03172325|79580864|FG000|Overall Study|Positive PPD|1|||
44562400|NCT03172325|79580865|FG001|Overall Study|Positive PPD|0|||
44562401|NCT03172325|79580864|FG000|Overall Study|Poor Compliance|1|||
44562402|NCT03172325|79580865|FG001|Overall Study|Poor Compliance|1|||
44562403|NCT03085017|79580873|FG000|Overall Study|Death|0|||
44562404|NCT03085017|79580874|FG001|Overall Study|Death|3|||
44562405|NCT03215771|79580880|FG000|Overall Study|Withdrawal by Subject|2|||
44562406|NCT03215771|79580880|FG000|Overall Study|Physician Decision|1|||
44562407|NCT02745392|79580889|FG000|Overall Study|Lost to Follow-up|0|||
44562408|NCT02745392|79580890|FG001|Overall Study|Lost to Follow-up|1|||
44562409|NCT02745392|79580891|FG002|Overall Study|Lost to Follow-up|0|||
44562410|NCT02745392|79580892|FG003|Overall Study|Lost to Follow-up|0|||
44562411|NCT03076515|79580904|FG000|Overall Study|DMC decision based on interim analysis|25|||
44562412|NCT03076515|79580905|FG001|Overall Study|DMC decision based on interim analysis|29|||
44562413|NCT03170609|79580918|FG000|Overall Study|Death|0|||
44562414|NCT03170609|79580919|FG001|Overall Study|Death|0|||
44562415|NCT03170609|79580920|FG002|Overall Study|Death|1|||
44562416|NCT03170609|79580921|FG003|Overall Study|Death|0|||
44562417|NCT03170609|79580922|FG004|Overall Study|Death|0|||
44562418|NCT03170609|79580923|FG005|Overall Study|Death|0|||
44562419|NCT03170609|79580924|FG006|Overall Study|Death|0|||
44562420|NCT03170609|79580918|FG000|Overall Study|Withdrawal by Subject|1|||
44562421|NCT03170609|79580919|FG001|Overall Study|Withdrawal by Subject|2|||
44562422|NCT03170609|79580920|FG002|Overall Study|Withdrawal by Subject|0|||
44562423|NCT03170609|79580921|FG003|Overall Study|Withdrawal by Subject|0|||
44562424|NCT03170609|79580922|FG004|Overall Study|Withdrawal by Subject|0|||
44562425|NCT03170609|79580923|FG005|Overall Study|Withdrawal by Subject|0|||
44562426|NCT03170609|79580924|FG006|Overall Study|Withdrawal by Subject|1|||
44562427|NCT03170609|79580918|FG000|Overall Study|Lost to Follow-up|1|||
44562428|NCT03170609|79580919|FG001|Overall Study|Lost to Follow-up|0|||
44562429|NCT03170609|79580920|FG002|Overall Study|Lost to Follow-up|5|||
44562430|NCT03170609|79580921|FG003|Overall Study|Lost to Follow-up|2|||
44562431|NCT03170609|79580922|FG004|Overall Study|Lost to Follow-up|1|||
44562432|NCT03170609|79580923|FG005|Overall Study|Lost to Follow-up|1|||
44562433|NCT03170609|79580924|FG006|Overall Study|Lost to Follow-up|0|||
44562434|NCT03170609|79580918|FG000|Overall Study|Other|1|||
44562435|NCT03170609|79580919|FG001|Overall Study|Other|0|||
44562436|NCT03170609|79580920|FG002|Overall Study|Other|0|||
44562437|NCT03170609|79580921|FG003|Overall Study|Other|0|||
44562438|NCT03170609|79580922|FG004|Overall Study|Other|0|||
44562439|NCT03170609|79580923|FG005|Overall Study|Other|1|||
44562440|NCT03170609|79580924|FG006|Overall Study|Other|0|||
44562441|NCT01141712|79580940|FG000|Overall Study|Disease progression|3|||
44562442|NCT03219333|79580950|FG000|Overall Study|Withdrawal by Subject|8|||
44562443|NCT03219333|79580951|FG001|Overall Study|Withdrawal by Subject|3|||
44562444|NCT03219333|79580950|FG000|Overall Study|Lost to Follow-up|1|||
44562445|NCT03219333|79580951|FG001|Overall Study|Lost to Follow-up|0|||
44562446|NCT03219333|79580950|FG000|Overall Study|Death|94|||
44562447|NCT03219333|79580951|FG001|Overall Study|Death|44|||
44562448|NCT03219333|79580950|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
44562449|NCT03219333|79580951|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
44562450|NCT03168867|79580959|FG000|Overall Study|Withdrawal by Subject|1|||
44562451|NCT03168867|79580960|FG001|Overall Study|Withdrawal by Subject|5|||
44562452|NCT01064622|79580969|FG000|Randomized Phase II|Withdrawal by Subject|2|||
44562453|NCT01064622|79580970|FG001|Randomized Phase II|Withdrawal by Subject|2|||
44562454|NCT01064622|79580969|FG000|Randomized Phase II|Protocol Violation|0|||
44562455|NCT01064622|79580970|FG001|Randomized Phase II|Protocol Violation|1|||
44562456|NCT04163718|79580979|FG000|Overall Study|Study terminated|12|||
44562457|NCT01063764|79580983|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
44562458|NCT01063764|79580983|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
44562459|NCT01063764|79580983|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
44562460|NCT01063764|79580983|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
44562461|NCT01063764|79580983|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
44562462|NCT01063764|79580983|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
44562463|NCT01063764|79580983|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
44562464|NCT03075891|79580993|FG000|Overall Study|Withdrawal by Subject|3|||
44562465|NCT03075891|79580994|FG001|Overall Study|Withdrawal by Subject|6|||
44562466|NCT03075891|79580993|FG000|Overall Study|Lost to Follow-up|1|||
44562467|NCT03075891|79580994|FG001|Overall Study|Lost to Follow-up|0|||
44562468|NCT03075891|79580993|FG000|Overall Study|Pregnancy|3|||
44562469|NCT03075891|79580994|FG001|Overall Study|Pregnancy|1|||
44562470|NCT03075891|79580993|FG000|Overall Study|visits not performed (no time)|1|||
44562471|NCT03075891|79580994|FG001|Overall Study|visits not performed (no time)|0|||
44562472|NCT03075891|79580993|FG000|Overall Study|Drug abuse relapse issue|0|||
44500603|NCT00103857|79504937|FG002|50-Week Extension Study|Adverse Event|2|||
44500604|NCT00103857|79504938|FG003|50-Week Extension Study|Adverse Event|0|||
44500605|NCT00103857|79504939|FG004|50-Week Extension Study|Adverse Event|1|||
44500606|NCT00103857|79504940|FG005|50-Week Extension Study|Adverse Event|1|||
44500607|NCT00103857|79504941|FG006|50-Week Extension Study|Adverse Event|0|||
44500608|NCT00103857|79504935|FG000|50-Week Extension Study|Death|0|||
44500609|NCT00103857|79504936|FG001|50-Week Extension Study|Death|0|||
44500610|NCT00103857|79504937|FG002|50-Week Extension Study|Death|0|||
44500611|NCT00103857|79504938|FG003|50-Week Extension Study|Death|1|||
44500612|NCT00103857|79504939|FG004|50-Week Extension Study|Death|0|||
44500613|NCT00103857|79504940|FG005|50-Week Extension Study|Death|1|||
44500614|NCT00103857|79504941|FG006|50-Week Extension Study|Death|0|||
44500615|NCT00103857|79504935|FG000|50-Week Extension Study|Lack of Efficacy|26|||
44500616|NCT00103857|79504936|FG001|50-Week Extension Study|Lack of Efficacy|15|||
44500617|NCT00103857|79504937|FG002|50-Week Extension Study|Lack of Efficacy|13|||
44500618|NCT00103857|79504938|FG003|50-Week Extension Study|Lack of Efficacy|16|||
44500619|NCT00103857|79504939|FG004|50-Week Extension Study|Lack of Efficacy|8|||
44500620|NCT00103857|79504940|FG005|50-Week Extension Study|Lack of Efficacy|8|||
44500621|NCT00103857|79504941|FG006|50-Week Extension Study|Lack of Efficacy|0|||
44562473|NCT03075891|79580994|FG001|Overall Study|Drug abuse relapse issue|1|||
44562474|NCT03075891|79580993|FG000|Overall Study|Participant requiring study withdrawal|0|||
44562475|NCT03075891|79580994|FG001|Overall Study|Participant requiring study withdrawal|1|||
44562476|NCT03075891|79580993|FG000|Overall Study|Adverse event, non-fatal|1|||
44562477|NCT03075891|79580994|FG001|Overall Study|Adverse event, non-fatal|4|||
44562478|NCT02013167|79581004|FG000|Overall Study|Withdrawal by Subject|15|||
44562479|NCT02013167|79581005|FG001|Overall Study|Withdrawal by Subject|14|||
44562480|NCT02013167|79581004|FG000|Overall Study|Sponsor Decision|1|||
44562481|NCT02013167|79581005|FG001|Overall Study|Sponsor Decision|3|||
44562482|NCT02013167|79581004|FG000|Overall Study|Lost to Follow-up|0|||
44562483|NCT02013167|79581005|FG001|Overall Study|Lost to Follow-up|1|||
44562484|NCT02013167|79581004|FG000|Overall Study|Death|85|||
44562485|NCT02013167|79581005|FG001|Overall Study|Death|160|||
44562486|NCT01063062|79581014|FG000|Overall Study|Patient withdrew consent|0|||
44500622|NCT00103857|79504935|FG000|50-Week Extension Study|Lost to Follow-up|4|||
44500623|NCT00103857|79504936|FG001|50-Week Extension Study|Lost to Follow-up|0|||
44562487|NCT01063062|79581015|FG001|Overall Study|Patient withdrew consent|1|||
44562488|NCT01063062|79581014|FG000|Overall Study|Adverse Event|2|||
44562489|NCT01063062|79581015|FG001|Overall Study|Adverse Event|4|||
44562490|NCT01063062|79581014|FG000|Overall Study|Protocol Violation|5|||
44562491|NCT01063062|79581015|FG001|Overall Study|Protocol Violation|4|||
44562492|NCT01063062|79581014|FG000|Overall Study|Investigator's request|1|||
44562493|NCT01063062|79581015|FG001|Overall Study|Investigator's request|0|||
44562494|NCT01063062|79581014|FG000|Overall Study|Lost to Follow-up|0|||
44562495|NCT01063062|79581015|FG001|Overall Study|Lost to Follow-up|2|||
44562496|NCT01063062|79581014|FG000|Overall Study|Miscellaneous reason|0|||
44562497|NCT01063062|79581015|FG001|Overall Study|Miscellaneous reason|1|||
44562498|NCT02973048|79581024|FG000|Overall Study|Epidural catheter insertion failure|1|||
44562499|NCT02973048|79581025|FG001|Overall Study|Epidural catheter insertion failure|0|||
44562500|NCT02973048|79581024|FG000|Overall Study|Withdrawal by Subject|0|||
44562501|NCT02973048|79581025|FG001|Overall Study|Withdrawal by Subject|3|||
44562502|NCT02932943|79581033|FG000|Overall Study|Lost to Follow-up|0|||
44562503|NCT02932943|79581034|FG001|Overall Study|Lost to Follow-up|2|||
44562504|NCT02932943|79581033|FG000|Overall Study|Adverse Event|2|||
44562505|NCT02932943|79581034|FG001|Overall Study|Adverse Event|2|||
44562506|NCT02932943|79581033|FG000|Overall Study|Withdrawal by Subject|3|||
44562507|NCT02932943|79581034|FG001|Overall Study|Withdrawal by Subject|3|||
44562508|NCT02972658|79581059|FG000|Overall Study|Adverse Event|0|||
44562509|NCT02972658|79581060|FG001|Overall Study|Adverse Event|3|||
44562510|NCT02972658|79581061|FG002|Overall Study|Adverse Event|0|||
44562511|NCT02972658|79581062|FG003|Overall Study|Adverse Event|2|||
44562512|NCT02972658|79581059|FG000|Overall Study|Other-determined by Investigator|1|||
44562513|NCT02972658|79581060|FG001|Overall Study|Other-determined by Investigator|1|||
44562514|NCT02972658|79581061|FG002|Overall Study|Other-determined by Investigator|0|||
44562515|NCT02972658|79581062|FG003|Overall Study|Other-determined by Investigator|0|||
44562516|NCT02972658|79581059|FG000|Overall Study|Death|0|||
44562517|NCT02972658|79581060|FG001|Overall Study|Death|0|||
44562518|NCT02972658|79581061|FG002|Overall Study|Death|0|||
44562519|NCT02972658|79581062|FG003|Overall Study|Death|1|||
44562520|NCT02972658|79581059|FG000|Overall Study|Lost to Follow-up|0|||
44562521|NCT02972658|79581060|FG001|Overall Study|Lost to Follow-up|1|||
44562522|NCT02972658|79581061|FG002|Overall Study|Lost to Follow-up|1|||
44562523|NCT02972658|79581062|FG003|Overall Study|Lost to Follow-up|2|||
44562524|NCT02972658|79581059|FG000|Overall Study|Progressive Disease|0|||
44562525|NCT02972658|79581060|FG001|Overall Study|Progressive Disease|1|||
44562526|NCT02972658|79581061|FG002|Overall Study|Progressive Disease|0|||
44562527|NCT02972658|79581062|FG003|Overall Study|Progressive Disease|1|||
44562528|NCT02972658|79581059|FG000|Overall Study|Withdrawal by Subject|4|||
44562529|NCT02972658|79581060|FG001|Overall Study|Withdrawal by Subject|4|||
44562530|NCT02972658|79581061|FG002|Overall Study|Withdrawal by Subject|1|||
44562531|NCT02972658|79581062|FG003|Overall Study|Withdrawal by Subject|6|||
44562532|NCT02972658|79581059|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
44562533|NCT02972658|79581060|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
44562534|NCT02972658|79581061|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
44562535|NCT02972658|79581062|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
44562536|NCT02972658|79581059|FG000|Overall Study|Sponsor Decision|70|||
44562537|NCT02972658|79581060|FG001|Overall Study|Sponsor Decision|127|||
44562538|NCT02972658|79581061|FG002|Overall Study|Sponsor Decision|72|||
44500624|NCT00103857|79504937|FG002|50-Week Extension Study|Lost to Follow-up|1|||
44500625|NCT00103857|79504938|FG003|50-Week Extension Study|Lost to Follow-up|4|||
44500626|NCT00103857|79504939|FG004|50-Week Extension Study|Lost to Follow-up|3|||
44500627|NCT00103857|79504940|FG005|50-Week Extension Study|Lost to Follow-up|3|||
44500628|NCT00103857|79504941|FG006|50-Week Extension Study|Lost to Follow-up|0|||
44500629|NCT00103857|79504935|FG000|50-Week Extension Study|Physician Decision|0|||
44500630|NCT00103857|79504936|FG001|50-Week Extension Study|Physician Decision|1|||
44500631|NCT00103857|79504937|FG002|50-Week Extension Study|Physician Decision|1|||
44562539|NCT02972658|79581062|FG003|Overall Study|Sponsor Decision|119|||
44562540|NCT02853032|79581074|FG000|Overall Study|Adverse Event|4|||
44562541|NCT02853032|79581075|FG001|Overall Study|Adverse Event|0|||
44562542|NCT02853032|79581074|FG000|Overall Study|Withdrawal by Subject|3|||
44562543|NCT02853032|79581075|FG001|Overall Study|Withdrawal by Subject|1|||
44500632|NCT00103857|79504938|FG003|50-Week Extension Study|Physician Decision|0|||
44500633|NCT00103857|79504939|FG004|50-Week Extension Study|Physician Decision|0|||
44500634|NCT00103857|79504940|FG005|50-Week Extension Study|Physician Decision|0|||
44562544|NCT02853032|79581074|FG000|Overall Study|Requested to withdraw from all treatment|2|||
44562545|NCT02853032|79581075|FG001|Overall Study|Requested to withdraw from all treatment|2|||
44562546|NCT02232087|79581083|FG000|Overall Study|Withdrawal by Subject|2|||
44562547|NCT02232087|79581084|FG001|Overall Study|Withdrawal by Subject|0|||
44562548|NCT02232087|79581085|FG002|Overall Study|Withdrawal by Subject|0|||
44562549|NCT02232087|79581086|FG003|Overall Study|Withdrawal by Subject|0|||
44562550|NCT02232087|79581087|FG004|Overall Study|Withdrawal by Subject|0|||
44562551|NCT02232087|79581088|FG005|Overall Study|Withdrawal by Subject|1|||
44275380|NCT02203032|79221840|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
44275381|NCT02203032|79221841|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
44275382|NCT02169414|79221853|FG000|Overall Study|Withdrawal by Subject|1|||
44275383|NCT02169414|79221854|FG001|Overall Study|Withdrawal by Subject|0|||
44275384|NCT02169414|79221855|FG002|Overall Study|Withdrawal by Subject|0|||
44275385|NCT02169414|79221856|FG003|Overall Study|Withdrawal by Subject|0|||
44275386|NCT02169414|79221853|FG000|Overall Study|Adverse Event|0|||
44275387|NCT02169414|79221854|FG001|Overall Study|Adverse Event|1|||
44275388|NCT02169414|79221855|FG002|Overall Study|Adverse Event|0|||
44275389|NCT02169414|79221856|FG003|Overall Study|Adverse Event|0|||
44377089|NCT00922116|79382398|FG000|Overall Study|Adverse Event|4|||
44500635|NCT00103857|79504941|FG006|50-Week Extension Study|Physician Decision|0|||
44500636|NCT00103857|79504935|FG000|50-Week Extension Study|Pregnancy|0|||
44500637|NCT00103857|79504936|FG001|50-Week Extension Study|Pregnancy|0|||
44500638|NCT00103857|79504937|FG002|50-Week Extension Study|Pregnancy|1|||
44500639|NCT00103857|79504938|FG003|50-Week Extension Study|Pregnancy|0|||
44500640|NCT00103857|79504939|FG004|50-Week Extension Study|Pregnancy|1|||
44500641|NCT00103857|79504940|FG005|50-Week Extension Study|Pregnancy|0|||
44500642|NCT00103857|79504941|FG006|50-Week Extension Study|Pregnancy|0|||
44500643|NCT00103857|79504935|FG000|50-Week Extension Study|Protocol Violation|1|||
44500644|NCT00103857|79504936|FG001|50-Week Extension Study|Protocol Violation|1|||
44500645|NCT00103857|79504937|FG002|50-Week Extension Study|Protocol Violation|1|||
44500646|NCT00103857|79504938|FG003|50-Week Extension Study|Protocol Violation|2|||
44500647|NCT00103857|79504939|FG004|50-Week Extension Study|Protocol Violation|0|||
44500648|NCT00103857|79504940|FG005|50-Week Extension Study|Protocol Violation|1|||
44562552|NCT02232087|79581083|FG000|Overall Study|poor inhalation technique|0|||
44562553|NCT02232087|79581084|FG001|Overall Study|poor inhalation technique|1|||
44562554|NCT02232087|79581085|FG002|Overall Study|poor inhalation technique|0|||
44562555|NCT02232087|79581086|FG003|Overall Study|poor inhalation technique|0|||
44562556|NCT02232087|79581087|FG004|Overall Study|poor inhalation technique|0|||
44562557|NCT02232087|79581088|FG005|Overall Study|poor inhalation technique|2|||
44562558|NCT02232087|79581083|FG000|Overall Study|protocol stop criteria|0|||
44562559|NCT02232087|79581084|FG001|Overall Study|protocol stop criteria|1|||
44233365|NCT03181893|79052152|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233366|NCT03181893|79052153|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233367|NCT03181893|79052154|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233368|NCT03181893|79052155|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233369|NCT03181893|79052156|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233370|NCT03181893|79052157|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233371|NCT03181893|79052158|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
44233372|NCT03181893|79052148|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233373|NCT03181893|79052149|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233374|NCT03181893|79052150|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233375|NCT03181893|79052151|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233376|NCT03181893|79052152|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233377|NCT03181893|79052153|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233378|NCT03181893|79052154|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233379|NCT03181893|79052155|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
44377090|NCT00922116|79382398|FG000|Overall Study|Death|1|||
44275390|NCT02201940|79221872|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
44275391|NCT02201940|79221873|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
44377091|NCT00922116|79382398|FG000|Overall Study|Lost to Follow-up|1|||
44500649|NCT00103857|79504941|FG006|50-Week Extension Study|Protocol Violation|0|||
44500650|NCT00103857|79504935|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
44562560|NCT02232087|79581085|FG002|Overall Study|protocol stop criteria|0|||
44562561|NCT02232087|79581086|FG003|Overall Study|protocol stop criteria|1|||
44562562|NCT02232087|79581087|FG004|Overall Study|protocol stop criteria|0|||
44233380|NCT03181893|79052156|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
44377092|NCT00922116|79382398|FG000|Overall Study|Withdrawal by Subject|4|||
44377093|NCT00922116|79382398|FG000|Overall Study|Other|5|||
44377094|NCT00921024|79382404|FG000|Overall Study|Lost to Follow-up|2|||
44377095|NCT00921024|79382405|FG001|Overall Study|Lost to Follow-up|0|||
44377096|NCT00921024|79382404|FG000|Overall Study|Received concomittant therapy|2|||
44500651|NCT00103857|79504936|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
44500652|NCT00103857|79504937|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
44500653|NCT00103857|79504938|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
44500654|NCT00103857|79504939|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
44500655|NCT00103857|79504940|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
44500656|NCT00103857|79504941|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
44500657|NCT00103857|79504935|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
44500658|NCT00103857|79504936|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
44500659|NCT00103857|79504937|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
44500660|NCT00103857|79504938|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
44500661|NCT00103857|79504939|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
44500662|NCT00103857|79504940|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
44500663|NCT00103857|79504941|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
44500664|NCT00103857|79504935|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
44500665|NCT00103857|79504936|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
44500666|NCT00103857|79504937|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
44500667|NCT00103857|79504938|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
44500668|NCT00103857|79504939|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
44500669|NCT00103857|79504940|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
44500670|NCT00103857|79504941|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
44500671|NCT00103857|79504935|FG000|50-Week Extension Study|patient moved|0|||
44500672|NCT00103857|79504936|FG001|50-Week Extension Study|patient moved|0|||
44500673|NCT00103857|79504937|FG002|50-Week Extension Study|patient moved|1|||
44500674|NCT00103857|79504938|FG003|50-Week Extension Study|patient moved|2|||
44500675|NCT00103857|79504939|FG004|50-Week Extension Study|patient moved|0|||
44500676|NCT00103857|79504940|FG005|50-Week Extension Study|patient moved|0|||
44500677|NCT00103857|79504941|FG006|50-Week Extension Study|patient moved|0|||
44500678|NCT00103857|79504935|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
44500679|NCT00103857|79504936|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
44500680|NCT00103857|79504937|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
44500681|NCT00103857|79504938|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
44500682|NCT00103857|79504939|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
44500683|NCT00103857|79504940|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
44500684|NCT00103857|79504941|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
44500685|NCT00103857|79504935|FG000|50-Week Extension Study|reason unspecified|0|||
44500686|NCT00103857|79504936|FG001|50-Week Extension Study|reason unspecified|0|||
44500687|NCT00103857|79504937|FG002|50-Week Extension Study|reason unspecified|0|||
44500688|NCT00103857|79504938|FG003|50-Week Extension Study|reason unspecified|0|||
44500689|NCT00103857|79504939|FG004|50-Week Extension Study|reason unspecified|1|||
44500690|NCT00103857|79504940|FG005|50-Week Extension Study|reason unspecified|0|||
44500691|NCT00103857|79504941|FG006|50-Week Extension Study|reason unspecified|0|||
44500692|NCT03587584|79504958|FG000|Overall Study|SOC deviations|4|||
44500693|NCT03587584|79504959|FG001|Overall Study|SOC deviations|6|||
44500694|NCT03587584|79504958|FG000|Overall Study|Incomplete data|0|||
44500695|NCT03587584|79504959|FG001|Overall Study|Incomplete data|3|||
44500696|NCT03586726|79504965|FG000|Overall Study|Withdrawal by Subject|1|||
44500697|NCT03586648|79504969|FG000|Period 1|Withdrawal by Subject|0|||
44500698|NCT03586648|79504970|FG001|Period 1|Withdrawal by Subject|1|||
44500699|NCT03586648|79504969|FG000|Period 1|Lost to Follow-up|1|||
44500700|NCT03586648|79504970|FG001|Period 1|Lost to Follow-up|1|||
44500701|NCT03586648|79504969|FG000|Period 1|Adverse Event|1|||
44500702|NCT03586648|79504970|FG001|Period 1|Adverse Event|0|||
44500703|NCT03586648|79504969|FG000|Period 1|Study related symptoms or complaints|2|||
44500704|NCT03586648|79504970|FG001|Period 1|Study related symptoms or complaints|1|||
44500705|NCT03586648|79504969|FG000|Period 1|Physician Decision|0|||
44500706|NCT03586648|79504970|FG001|Period 1|Physician Decision|1|||
44500707|NCT03586648|79504969|FG000|Period 2|Adverse Event|1|||
44500708|NCT03586648|79504970|FG001|Period 2|Adverse Event|0|||
44275392|NCT02201940|79221872|FG000|Overall Study|Lack of Efficacy|2|||
44562563|NCT02232087|79581088|FG005|Overall Study|protocol stop criteria|0|||
44562564|NCT02232087|79581083|FG000|Overall Study|Adverse Event|0|||
44562565|NCT02232087|79581084|FG001|Overall Study|Adverse Event|0|||
44562566|NCT02232087|79581085|FG002|Overall Study|Adverse Event|0|||
44562567|NCT02232087|79581086|FG003|Overall Study|Adverse Event|0|||
44562568|NCT02232087|79581087|FG004|Overall Study|Adverse Event|1|||
44562569|NCT02232087|79581088|FG005|Overall Study|Adverse Event|0|||
44562570|NCT03168425|79581109|FG000|Overall Study|Lost to Follow-up|5|||
44562571|NCT03168425|79581110|FG001|Overall Study|Lost to Follow-up|8|||
44562572|NCT03168425|79581109|FG000|Overall Study|unable to confirm post op opioids|2|||
44562573|NCT03168425|79581110|FG001|Overall Study|unable to confirm post op opioids|3|||
44562574|NCT00004445|79581117|FG000|Overall Study|Physician Decision|2|||
44562575|NCT00004445|79581117|FG000|Overall Study|Withdrawal by Subject|1|||
44562576|NCT02972502|79581123|FG000|Overall Study|Lost to Follow-up|3|||
44562577|NCT02972502|79581124|FG001|Overall Study|Lost to Follow-up|1|||
44562578|NCT02972502|79581123|FG000|Overall Study|Withdrawal by Subject|1|||
44562579|NCT02972502|79581124|FG001|Overall Study|Withdrawal by Subject|1|||
44562580|NCT02971800|79581130|FG000|Overall Study|Protocol Violation|1|||
44562581|NCT02971800|79581130|FG000|Overall Study|Withdrawal by Subject|1|||
44562582|NCT02971800|79581130|FG000|Overall Study|Exclusion criteria prior intervention|1|||
44562583|NCT02971800|79581130|FG000|Overall Study|Number evaluable participant already reached|4|||
44562584|NCT03163667|79581136|FG000|Overall Study|Death|15|||
44562585|NCT03163667|79581137|FG001|Overall Study|Death|27|||
44562586|NCT03163667|79581136|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
44562587|NCT03163667|79581137|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
44562588|NCT03167411|79581145|FG000|Overall Study|Adverse Event|0|||
44562589|NCT03167411|79581146|FG001|Overall Study|Adverse Event|1|||
44562590|NCT01952847|79581156|FG000|Overall Study|Ineligible|1|||
44562591|NCT01952847|79581157|FG001|Overall Study|Ineligible|0|||
44562592|NCT01952847|79581158|FG002|Overall Study|Ineligible|0|||
44562593|NCT01952847|79581159|FG003|Overall Study|Ineligible|0|||
44562594|NCT01952847|79581156|FG000|Overall Study|Lack of Insurance Coverage|0|||
44562595|NCT01952847|79581157|FG001|Overall Study|Lack of Insurance Coverage|1|||
44562596|NCT01952847|79581158|FG002|Overall Study|Lack of Insurance Coverage|0|||
44562597|NCT01952847|79581159|FG003|Overall Study|Lack of Insurance Coverage|0|||
44562598|NCT01952847|79581156|FG000|Overall Study|Withdrawal by Subject|1|||
44562599|NCT01952847|79581157|FG001|Overall Study|Withdrawal by Subject|1|||
44562600|NCT01952847|79581158|FG002|Overall Study|Withdrawal by Subject|0|||
44562601|NCT01952847|79581159|FG003|Overall Study|Withdrawal by Subject|1|||
44562602|NCT01560585|79581171|FG000|Overall Study|Physician Decision|3|||
44562603|NCT03075501|79581178|FG000|Overall Study|Scheduling difficulties|15|||
44562604|NCT03075501|79581179|FG001|Overall Study|Scheduling difficulties|9|||
44562605|NCT02317991|79581186|FG000|Overall Study|Adverse Event|12|||
44562606|NCT02317991|79581186|FG000|Overall Study|Death|4|||
44562607|NCT02317991|79581186|FG000|Overall Study|Withdrawal by Subject|8|||
44562608|NCT02317991|79581186|FG000|Overall Study|Progressive Disease|41|||
44562609|NCT03075267|79581193|FG000|Overall Study|Protocol Violation|1|||
44562610|NCT03075267|79581194|FG001|Overall Study|Protocol Violation|0|||
44562611|NCT03075267|79581195|FG002|Overall Study|Protocol Violation|0|||
44562612|NCT03074331|79581203|FG000|Overall Study|Enrolled but Not Treated|1|||
44562613|NCT03074331|79581203|FG000|Overall Study|Lost to Follow-up|5|||
44562614|NCT03074331|79581203|FG000|Overall Study|Withdrew Consent|1|||
44562615|NCT02260193|79581210|FG000|Overall Study|Lack of Efficacy|0|||
44562616|NCT02260193|79581211|FG001|Overall Study|Lack of Efficacy|1|||
44562617|NCT02260193|79581212|FG002|Overall Study|Lack of Efficacy|6|||
44562618|NCT02260193|79581210|FG000|Overall Study|Adverse Event|3|||
44562619|NCT02260193|79581211|FG001|Overall Study|Adverse Event|4|||
44562620|NCT02260193|79581212|FG002|Overall Study|Adverse Event|1|||
44562621|NCT02260193|79581210|FG000|Overall Study|Protocol Violation|0|||
44562622|NCT02260193|79581211|FG001|Overall Study|Protocol Violation|4|||
44562623|NCT02260193|79581212|FG002|Overall Study|Protocol Violation|0|||
44562624|NCT02260193|79581210|FG000|Overall Study|Withdrawal by Subject|3|||
44562625|NCT02260193|79581211|FG001|Overall Study|Withdrawal by Subject|0|||
44562626|NCT02260193|79581212|FG002|Overall Study|Withdrawal by Subject|2|||
44562627|NCT02260193|79581210|FG000|Overall Study|Kidney Transplantation|0|||
44562628|NCT02260193|79581211|FG001|Overall Study|Kidney Transplantation|0|||
44562629|NCT02260193|79581212|FG002|Overall Study|Kidney Transplantation|1|||
44562630|NCT02849678|79581222|FG000|Overall Study|Protocol Violation|3|||
44562631|NCT02849678|79581223|FG001|Overall Study|Protocol Violation|6|||
44562632|NCT01596257|79581231|FG000|Overall Study|Inadequate Collection|23|||
44562633|NCT01596257|79581232|FG001|Overall Study|Inadequate Collection|19|||
44562634|NCT04577781|79581242|FG000|Overall Study|Adverse Event|2|||
44562635|NCT04577781|79581243|FG001|Overall Study|Adverse Event|2|||
44562636|NCT04577781|79581242|FG000|Overall Study|Physician Decision|1|||
44562637|NCT04577781|79581243|FG001|Overall Study|Physician Decision|0|||
44562638|NCT02737826|79581250|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
44562639|NCT02737826|79581251|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
44562640|NCT02737826|79581252|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
44562641|NCT03070431|79581279|FG000|Overall Study|Withdrawal by Subject|2|||
44562642|NCT03070431|79581279|FG000|Overall Study|Lost to Follow-up|2|||
44562643|NCT01071395|79581290|FG000|Overall Study|Withdrawal by Subject|2|||
44562644|NCT01071395|79581291|FG001|Overall Study|Withdrawal by Subject|1|||
44562645|NCT01071395|79581290|FG000|Overall Study|Adverse Event|3|||
44562646|NCT01071395|79581291|FG001|Overall Study|Adverse Event|1|||
44562647|NCT02970942|79581301|FG000|Overall Study|Death|0|||
44562648|NCT02970942|79581302|FG001|Overall Study|Death|1|||
44562649|NCT02970942|79581303|FG002|Overall Study|Death|0|||
44562650|NCT02970942|79581304|FG003|Overall Study|Death|0|||
44562651|NCT02970942|79581301|FG000|Overall Study|Lost to Follow-up|1|||
44562652|NCT02970942|79581302|FG001|Overall Study|Lost to Follow-up|0|||
44562653|NCT02970942|79581303|FG002|Overall Study|Lost to Follow-up|2|||
44562654|NCT02970942|79581304|FG003|Overall Study|Lost to Follow-up|1|||
44562655|NCT02970942|79581301|FG000|Overall Study|Withdrawal by Subject|3|||
44562656|NCT02970942|79581302|FG001|Overall Study|Withdrawal by Subject|5|||
44562657|NCT02970942|79581303|FG002|Overall Study|Withdrawal by Subject|3|||
44562658|NCT02970942|79581304|FG003|Overall Study|Withdrawal by Subject|2|||
44562659|NCT03073005|79581318|FG000|Overall Study|Death|6|||
44562660|NCT03073005|79581319|FG001|Overall Study|Death|0|||
44562661|NCT03073005|79581320|FG002|Overall Study|Death|7|||
44562662|NCT03073005|79581321|FG003|Overall Study|Death|0|||
44562663|NCT03073005|79581318|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
44562664|NCT03073005|79581319|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
44562665|NCT03073005|79581320|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
44562666|NCT03073005|79581321|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
44562667|NCT03073005|79581318|FG000|Overall Study|Lost to Follow-up|2|||
44562668|NCT03073005|79581319|FG001|Overall Study|Lost to Follow-up|2|||
44562669|NCT03073005|79581320|FG002|Overall Study|Lost to Follow-up|1|||
44562670|NCT03073005|79581321|FG003|Overall Study|Lost to Follow-up|2|||
44562671|NCT03073005|79581318|FG000|Overall Study|Withdrawal by Subject|0|||
44562672|NCT03073005|79581319|FG001|Overall Study|Withdrawal by Subject|4|||
44500709|NCT02892448|79504979|FG000|Overall Study|Screening failure|2|||
44500710|NCT02892448|79504980|FG001|Overall Study|Screening failure|2|||
44500711|NCT02892448|79504981|FG002|Overall Study|Screening failure|1|||
44500712|NCT03585712|79504989|FG000|Treatment Period 1|Protocol Violation|1|||
44500713|NCT03585712|79504990|FG001|Treatment Period 1|Protocol Violation|0|||
44500714|NCT03585712|79504991|FG002|Treatment Period 1|Protocol Violation|0|||
44500715|NCT03585712|79504989|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
44562673|NCT03073005|79581320|FG002|Overall Study|Withdrawal by Subject|4|||
44562674|NCT03073005|79581321|FG003|Overall Study|Withdrawal by Subject|4|||
44562675|NCT02849171|79581334|FG000|Overall Study|Withdrawal by Subject|1|||
44500716|NCT03585712|79504990|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
44500717|NCT03585712|79504991|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
44500718|NCT03585712|79504989|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
44500719|NCT03585712|79504990|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
44500720|NCT03585712|79504991|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
44500721|NCT03585712|79504989|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
44500722|NCT03585712|79504990|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
44562676|NCT02849171|79581334|FG000|Overall Study|Not treated|1|||
44562677|NCT02848664|79581347|FG000|Overall Study|Withdrawal by Subject|2|||
44562678|NCT02848664|79581347|FG000|Overall Study|Adverse Event|1|||
44562679|NCT02848664|79581347|FG000|Overall Study|no assistance for device training|1|||
44562680|NCT02969382|79581357|FG000|Overall Study|Adverse Event|8|||
44500723|NCT03585712|79504991|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
44500724|NCT03585244|79505008|FG000|Overall Study|Withdrawal by Subject|15|||
44562681|NCT02969382|79581358|FG001|Overall Study|Adverse Event|10|||
44562682|NCT02969382|79581357|FG000|Overall Study|Lack of Efficacy|4|||
44562683|NCT02969382|79581358|FG001|Overall Study|Lack of Efficacy|5|||
44562684|NCT02969382|79581357|FG000|Overall Study|Death|0|||
44562685|NCT02969382|79581358|FG001|Overall Study|Death|1|||
44562686|NCT02969382|79581357|FG000|Overall Study|PROTOCOL DEVIATION|0|||
44562687|NCT02969382|79581358|FG001|Overall Study|PROTOCOL DEVIATION|1|||
44562688|NCT02969382|79581357|FG000|Overall Study|Withdrawal by Subject|14|||
44562689|NCT02969382|79581358|FG001|Overall Study|Withdrawal by Subject|9|||
44562690|NCT01989104|79581369|FG000|Overall Study|Withdrawal by Subject|3|||
44562691|NCT01989104|79581370|FG001|Overall Study|Withdrawal by Subject|0|||
44562692|NCT01989104|79581371|FG002|Overall Study|Withdrawal by Subject|0|||
44562693|NCT01989104|79581372|FG003|Overall Study|Withdrawal by Subject|0|||
44562694|NCT01989104|79581373|FG004|Overall Study|Withdrawal by Subject|0|||
44562695|NCT02903238|79581385|FG000|Overall Study|Lost to Follow-up|4|||
44562696|NCT02847260|79581390|FG000|Overall Study|Adverse Event|3|||
44562697|NCT02847260|79581390|FG000|Overall Study|Withdrawal by Subject|2|||
44562698|NCT02847260|79581390|FG000|Overall Study|Clinical Deterioration|1|||
44562699|NCT02847260|79581390|FG000|Overall Study|Physician Decision|1|||
44562700|NCT02968563|79581396|FG000|Overall Study|Adverse Event|0|||
44562701|NCT02968563|79581397|FG001|Overall Study|Adverse Event|6|||
44562702|NCT02968563|79581396|FG000|Overall Study|Death|1|||
44562703|NCT02968563|79581397|FG001|Overall Study|Death|1|||
44562704|NCT02968563|79581396|FG000|Overall Study|Lost to Follow-up|0|||
44562705|NCT02968563|79581397|FG001|Overall Study|Lost to Follow-up|1|||
44562706|NCT02904096|79581405|FG000|Overall Study|Adverse Event|1|||
44562707|NCT02904096|79581406|FG001|Overall Study|Adverse Event|0|||
44562708|NCT02904096|79581405|FG000|Overall Study|Withdrawal by Subject|4|||
44562709|NCT02904096|79581406|FG001|Overall Study|Withdrawal by Subject|3|||
44562710|NCT02904096|79581405|FG000|Overall Study|Lost to Follow-up|10|||
44562711|NCT02904096|79581406|FG001|Overall Study|Lost to Follow-up|17|||
44562712|NCT02904096|79581405|FG000|Overall Study|Non-compliant|3|||
44562713|NCT02904096|79581406|FG001|Overall Study|Non-compliant|1|||
44562714|NCT02904096|79581405|FG000|Overall Study|Sponsor instructed|1|||
44562715|NCT02904096|79581406|FG001|Overall Study|Sponsor instructed|0|||
44562716|NCT03161405|79581416|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
44562717|NCT01813929|79581425|FG000|Overall Study|Withdrawal by Subject|0|||
44562718|NCT01813929|79581426|FG001|Overall Study|Withdrawal by Subject|1|||
44562719|NCT02901054|79581436|FG000|Overall Study|Physician Decision|1|||
44562720|NCT02901054|79581436|FG000|Overall Study|Withdrawal by Subject|3|||
44562721|NCT03068715|79581442|FG000|Overall Study|No longer met inclusion criteria|1|||
44562722|NCT03068715|79581443|FG001|Overall Study|No longer met inclusion criteria|0|||
44562723|NCT02966340|79581451|FG000|Overall Study|Adverse Event|0|||
44562724|NCT02966340|79581452|FG001|Overall Study|Adverse Event|1|||
44562725|NCT02966340|79581451|FG000|Overall Study|Lost to Follow-up|0|||
44562726|NCT02966340|79581452|FG001|Overall Study|Lost to Follow-up|1|||
44562727|NCT02966340|79581451|FG000|Overall Study|Withdrawal by Subject|1|||
44562728|NCT02966340|79581452|FG001|Overall Study|Withdrawal by Subject|0|||
44562729|NCT02966340|79581451|FG000|Overall Study|data acquisition error|1|||
44562730|NCT02966340|79581452|FG001|Overall Study|data acquisition error|0|||
44562731|NCT02966340|79581451|FG000|Overall Study|startle non-responder|1|||
44500725|NCT00074984|79505014|FG000|Overall Study|Death|1|||
44500726|NCT00074984|79505015|FG001|Overall Study|Death|2|||
44500727|NCT00074984|79505014|FG000|Overall Study|Withdrawal by Subject|2|||
44500728|NCT00074984|79505015|FG001|Overall Study|Withdrawal by Subject|3|||
44500729|NCT00074984|79505014|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
44500730|NCT00074984|79505015|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
44500731|NCT03583606|79505025|FG000|Overall Study|Lost to Follow-up|0|||
44500732|NCT03583606|79505026|FG001|Overall Study|Lost to Follow-up|1|||
44500733|NCT03583606|79505027|FG002|Overall Study|Lost to Follow-up|0|||
44500734|NCT03583606|79505025|FG000|Overall Study|Ineligible at baseline|1|||
44500735|NCT03583606|79505026|FG001|Overall Study|Ineligible at baseline|0|||
44500736|NCT03583606|79505027|FG002|Overall Study|Ineligible at baseline|0|||
44500737|NCT03583450|79505038|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
44562732|NCT02966340|79581452|FG001|Overall Study|startle non-responder|1|||
44562733|NCT03067311|79581460|FG000|Overall Study|Lost to Follow-up|1|||
44562734|NCT03067311|79581461|FG001|Overall Study|Lost to Follow-up|1|||
44562735|NCT03067311|79581460|FG000|Overall Study|Moved away|1|||
44562736|NCT03067311|79581461|FG001|Overall Study|Moved away|1|||
44562737|NCT04380519|79581470|FG000|Overall Study|Withdrawal by Subject|4|||
44562738|NCT04380519|79581471|FG001|Overall Study|Withdrawal by Subject|0|||
44562739|NCT04380519|79581472|FG002|Overall Study|Withdrawal by Subject|1|||
44562740|NCT04380519|79581470|FG000|Overall Study|Death|14|||
44562741|NCT04380519|79581471|FG001|Overall Study|Death|9|||
44562742|NCT04380519|79581472|FG002|Overall Study|Death|6|||
44562743|NCT04380519|79581470|FG000|Overall Study|Adverse Event|0|||
44562744|NCT04380519|79581471|FG001|Overall Study|Adverse Event|1|||
44562745|NCT04380519|79581472|FG002|Overall Study|Adverse Event|0|||
44562746|NCT04380519|79581470|FG000|Overall Study|relatives' decision|0|||
44562747|NCT04380519|79581471|FG001|Overall Study|relatives' decision|1|||
44562748|NCT04380519|79581472|FG002|Overall Study|relatives' decision|0|||
44562749|NCT02847182|79581482|FG000|Overall Study|Withdrawal by Subject|0|||
44562750|NCT02847182|79581483|FG001|Overall Study|Withdrawal by Subject|1|||
44562751|NCT02846558|79581499|FG000|Overall Study|Adverse Event|1|||
44562752|NCT02846558|79581500|FG001|Overall Study|Adverse Event|0|||
44562753|NCT02846558|79581501|FG002|Overall Study|Adverse Event|0|||
44562754|NCT02846558|79581502|FG003|Overall Study|Adverse Event|0|||
44562755|NCT02846558|79581499|FG000|Overall Study|Withdrawal by Subject|5|||
44562756|NCT02846558|79581500|FG001|Overall Study|Withdrawal by Subject|4|||
44562757|NCT02846558|79581501|FG002|Overall Study|Withdrawal by Subject|2|||
44500738|NCT03583450|79505039|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
44562758|NCT02846558|79581502|FG003|Overall Study|Withdrawal by Subject|2|||
44562759|NCT02846558|79581499|FG000|Overall Study|Lost to Follow-up|2|||
44562760|NCT02846558|79581500|FG001|Overall Study|Lost to Follow-up|0|||
44562761|NCT02846558|79581501|FG002|Overall Study|Lost to Follow-up|0|||
44562762|NCT02846558|79581502|FG003|Overall Study|Lost to Follow-up|0|||
44562763|NCT04362813|79581521|FG000|Overall Study|Death|12|||
44562764|NCT04362813|79581522|FG001|Overall Study|Death|16|||
44562765|NCT04362813|79581521|FG000|Overall Study|Withdrawal by Subject|3|||
44562766|NCT04362813|79581522|FG001|Overall Study|Withdrawal by Subject|1|||
44562767|NCT04362813|79581521|FG000|Overall Study|Protocol Violation|0|||
44562768|NCT04362813|79581522|FG001|Overall Study|Protocol Violation|3|||
44562769|NCT04362813|79581521|FG000|Overall Study|Lost to Follow-up|1|||
44562770|NCT04362813|79581522|FG001|Overall Study|Lost to Follow-up|1|||
44562771|NCT04362813|79581521|FG000|Overall Study|Enrolled but did not receive treatment|2|||
44562772|NCT04362813|79581522|FG001|Overall Study|Enrolled but did not receive treatment|4|||
44562773|NCT02966028|79581531|FG000|Overall Study|Adverse Event|7|||
44562774|NCT02966028|79581532|FG001|Overall Study|Adverse Event|13|||
44562775|NCT02966028|79581533|FG002|Overall Study|Adverse Event|10|||
44562776|NCT02966028|79581531|FG000|Overall Study|Physician Decision|1|||
44562777|NCT02966028|79581532|FG001|Overall Study|Physician Decision|0|||
44562778|NCT02966028|79581533|FG002|Overall Study|Physician Decision|2|||
44562779|NCT02966028|79581531|FG000|Overall Study|Withdrawal by Subject|7|||
44562780|NCT02966028|79581532|FG001|Overall Study|Withdrawal by Subject|5|||
44562781|NCT02966028|79581533|FG002|Overall Study|Withdrawal by Subject|5|||
44562782|NCT02966028|79581531|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
44500739|NCT03583372|79505051|FG000|Overall Study|Withdrawal by Subject|6|||
44500740|NCT03583372|79505052|FG001|Overall Study|Withdrawal by Subject|11|||
44500741|NCT03583372|79505053|FG002|Overall Study|Withdrawal by Subject|7|||
44500742|NCT03583372|79505054|FG003|Overall Study|Withdrawal by Subject|8|||
44500743|NCT03583372|79505051|FG000|Overall Study|Lost to Follow-up|4|||
44500744|NCT03583372|79505052|FG001|Overall Study|Lost to Follow-up|6|||
44500745|NCT03583372|79505053|FG002|Overall Study|Lost to Follow-up|3|||
44500746|NCT03583372|79505054|FG003|Overall Study|Lost to Follow-up|2|||
44500747|NCT03583372|79505051|FG000|Overall Study|Adverse Event|1|||
44500748|NCT03583372|79505052|FG001|Overall Study|Adverse Event|3|||
44500749|NCT03583372|79505053|FG002|Overall Study|Adverse Event|4|||
44500750|NCT03583372|79505054|FG003|Overall Study|Adverse Event|4|||
44500751|NCT03583372|79505051|FG000|Overall Study|Physician Decision|0|||
44500752|NCT03583372|79505052|FG001|Overall Study|Physician Decision|1|||
44500753|NCT03583372|79505053|FG002|Overall Study|Physician Decision|1|||
44500754|NCT03583372|79505054|FG003|Overall Study|Physician Decision|1|||
44562783|NCT02966028|79581532|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
44500755|NCT03583372|79505051|FG000|Overall Study|Lack of Efficacy|0|||
44562784|NCT02966028|79581533|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
44562785|NCT02925741|79581547|FG000|Overall Study|Withdrawal by Subject|11|||
44562786|NCT02925741|79581548|FG001|Overall Study|Withdrawal by Subject|0|||
44500756|NCT03583372|79505052|FG001|Overall Study|Lack of Efficacy|1|||
44500757|NCT03583372|79505053|FG002|Overall Study|Lack of Efficacy|0|||
44562787|NCT02964312|79581557|FG000|Overall Study|Lost to Follow-up|28|||
44562788|NCT02964312|79581557|FG000|Overall Study|Withdrawal by Subject|11|||
44562789|NCT02964312|79581557|FG000|Overall Study|Lack of Efficacy|10|||
44562790|NCT02964312|79581557|FG000|Overall Study|Did not consent to long-term FU|14|||
44562791|NCT02964312|79581557|FG000|Overall Study|Death|1|||
44562792|NCT02899962|79581581|FG000|Open-label Phase|Adverse Event|2|||
44562793|NCT02899962|79581582|FG001|Open-label Phase|Adverse Event|0|||
44562794|NCT02899962|79581583|FG002|Open-label Phase|Adverse Event|0|||
44562795|NCT02899962|79581581|FG000|Open-label Phase|Lost to Follow-up|9|||
44562796|NCT02899962|79581582|FG001|Open-label Phase|Lost to Follow-up|0|||
44562797|NCT02899962|79581583|FG002|Open-label Phase|Lost to Follow-up|0|||
44562798|NCT02899962|79581581|FG000|Open-label Phase|Other reasons|9|||
44562799|NCT02899962|79581582|FG001|Open-label Phase|Other reasons|0|||
44562800|NCT02899962|79581583|FG002|Open-label Phase|Other reasons|0|||
44562801|NCT02899962|79581581|FG000|Open-label Phase|Withdrawal by Subject|7|||
44562802|NCT02899962|79581582|FG001|Open-label Phase|Withdrawal by Subject|0|||
44562803|NCT02899962|79581583|FG002|Open-label Phase|Withdrawal by Subject|0|||
44562804|NCT02899962|79581581|FG000|Maintenance Phase|Adverse Event|0|||
44562805|NCT02899962|79581582|FG001|Maintenance Phase|Adverse Event|2|||
44562806|NCT02899962|79581583|FG002|Maintenance Phase|Adverse Event|1|||
44562807|NCT02899962|79581581|FG000|Maintenance Phase|Death|0|||
44562808|NCT02899962|79581582|FG001|Maintenance Phase|Death|0|||
44562809|NCT02899962|79581583|FG002|Maintenance Phase|Death|1|||
44562810|NCT02899962|79581581|FG000|Maintenance Phase|Lack of Efficacy|0|||
44562811|NCT02899962|79581582|FG001|Maintenance Phase|Lack of Efficacy|20|||
44562812|NCT02899962|79581583|FG002|Maintenance Phase|Lack of Efficacy|16|||
44562813|NCT02899962|79581581|FG000|Maintenance Phase|Lost to Follow-up|0|||
44562814|NCT02899962|79581582|FG001|Maintenance Phase|Lost to Follow-up|12|||
44562815|NCT02899962|79581583|FG002|Maintenance Phase|Lost to Follow-up|14|||
44562816|NCT02899962|79581581|FG000|Maintenance Phase|Other reasons|0|||
44562817|NCT02899962|79581582|FG001|Maintenance Phase|Other reasons|9|||
44562818|NCT02899962|79581583|FG002|Maintenance Phase|Other reasons|13|||
44562819|NCT02899962|79581581|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
44562820|NCT02899962|79581582|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
44562821|NCT02899962|79581583|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
44562822|NCT02899962|79581581|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
44562823|NCT02899962|79581582|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
44562824|NCT02899962|79581583|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
44562825|NCT02899962|79581581|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44562826|NCT02899962|79581582|FG001|Maintenance Phase|Withdrawal by Subject|30|||
44562827|NCT02899962|79581583|FG002|Maintenance Phase|Withdrawal by Subject|36|||
44562828|NCT02899338|79581592|FG000|Overall Study|Adverse Event|1|||
44562829|NCT02899338|79581593|FG001|Overall Study|Adverse Event|2|||
44562830|NCT02899338|79581592|FG000|Overall Study|Withdrawal by Subject|2|||
44562831|NCT02899338|79581593|FG001|Overall Study|Withdrawal by Subject|0|||
44562832|NCT03066609|79581602|FG000|INDUCTION|Pregnancy|0|||
44562833|NCT03066609|79581603|FG001|INDUCTION|Pregnancy|0|||
44562834|NCT03066609|79581604|FG002|INDUCTION|Pregnancy|1|||
44562835|NCT03066609|79581605|FG003|INDUCTION|Pregnancy|0|||
44562836|NCT03066609|79581602|FG000|INDUCTION|Lack of Efficacy|0|||
44562837|NCT03066609|79581603|FG001|INDUCTION|Lack of Efficacy|0|||
44562838|NCT03066609|79581604|FG002|INDUCTION|Lack of Efficacy|1|||
44562839|NCT03066609|79581605|FG003|INDUCTION|Lack of Efficacy|0|||
44562840|NCT03066609|79581602|FG000|INDUCTION|Adverse Event|2|||
44562841|NCT03066609|79581603|FG001|INDUCTION|Adverse Event|2|||
44562842|NCT03066609|79581604|FG002|INDUCTION|Adverse Event|0|||
44562843|NCT03066609|79581605|FG003|INDUCTION|Adverse Event|0|||
44562844|NCT03066609|79581602|FG000|MAINTENANCE|Adverse Event|0|||
44562845|NCT03066609|79581603|FG001|MAINTENANCE|Adverse Event|0|||
44562846|NCT03066609|79581604|FG002|MAINTENANCE|Adverse Event|0|||
44562847|NCT03066609|79581605|FG003|MAINTENANCE|Adverse Event|1|||
44562848|NCT03066609|79581602|FG000|MAINTENANCE|Withdrawal by Subject|4|||
44562849|NCT03066609|79581603|FG001|MAINTENANCE|Withdrawal by Subject|2|||
44562850|NCT03066609|79581604|FG002|MAINTENANCE|Withdrawal by Subject|1|||
44562851|NCT03066609|79581605|FG003|MAINTENANCE|Withdrawal by Subject|1|||
44562852|NCT03066609|79581602|FG000|MAINTENANCE|Lost to Follow-up|0|||
44562853|NCT03066609|79581603|FG001|MAINTENANCE|Lost to Follow-up|1|||
44562854|NCT03066609|79581604|FG002|MAINTENANCE|Lost to Follow-up|1|||
44562855|NCT03066609|79581605|FG003|MAINTENANCE|Lost to Follow-up|0|||
44562856|NCT03066609|79581602|FG000|MAINTENANCE|Pregnancy|1|||
44562857|NCT03066609|79581603|FG001|MAINTENANCE|Pregnancy|0|||
44562858|NCT03066609|79581604|FG002|MAINTENANCE|Pregnancy|0|||
44562859|NCT03066609|79581605|FG003|MAINTENANCE|Pregnancy|0|||
44562860|NCT03066609|79581602|FG000|MAINTENANCE|Lack of Efficacy|2|||
44562861|NCT03066609|79581603|FG001|MAINTENANCE|Lack of Efficacy|1|||
44562862|NCT03066609|79581604|FG002|MAINTENANCE|Lack of Efficacy|0|||
44562863|NCT03066609|79581605|FG003|MAINTENANCE|Lack of Efficacy|1|||
44562864|NCT03066609|79581602|FG000|OVERALL STUDY|Adverse Event|2|||
44562865|NCT03066609|79581603|FG001|OVERALL STUDY|Adverse Event|2|||
44562866|NCT03066609|79581604|FG002|OVERALL STUDY|Adverse Event|0|||
44562867|NCT03066609|79581605|FG003|OVERALL STUDY|Adverse Event|1|||
44562868|NCT03066609|79581602|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
44233381|NCT03181893|79052157|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44562869|NCT03066609|79581603|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
44562870|NCT03066609|79581604|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
44562871|NCT03066609|79581605|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
44562872|NCT03066609|79581602|FG000|OVERALL STUDY|Lost to Follow-up|1|||
44562873|NCT03066609|79581603|FG001|OVERALL STUDY|Lost to Follow-up|1|||
44233382|NCT03181893|79052158|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
44233383|NCT03181893|79052148|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233384|NCT03181893|79052149|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44562874|NCT03066609|79581604|FG002|OVERALL STUDY|Lost to Follow-up|1|||
44562875|NCT03066609|79581605|FG003|OVERALL STUDY|Lost to Follow-up|1|||
44562876|NCT03066609|79581602|FG000|OVERALL STUDY|Pregnancy|1|||
44562877|NCT03066609|79581603|FG001|OVERALL STUDY|Pregnancy|0|||
44562878|NCT03066609|79581604|FG002|OVERALL STUDY|Pregnancy|1|||
44562879|NCT03066609|79581605|FG003|OVERALL STUDY|Pregnancy|0|||
44562880|NCT03066609|79581602|FG000|OVERALL STUDY|Lack of Efficacy|2|||
44233385|NCT03181893|79052150|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233386|NCT03181893|79052151|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44500758|NCT03583372|79505054|FG003|Overall Study|Lack of Efficacy|1|||
44500759|NCT03583372|79505051|FG000|Overall Study|Death|1|||
44500760|NCT03583372|79505052|FG001|Overall Study|Death|0|||
44500761|NCT03583372|79505053|FG002|Overall Study|Death|0|||
44500762|NCT03583372|79505054|FG003|Overall Study|Death|0|||
44500763|NCT03583372|79505051|FG000|Overall Study|Protocol Violation|0|||
44500764|NCT03583372|79505052|FG001|Overall Study|Protocol Violation|1|||
44500765|NCT03583372|79505053|FG002|Overall Study|Protocol Violation|0|||
44500766|NCT03583372|79505054|FG003|Overall Study|Protocol Violation|0|||
44500767|NCT03583372|79505051|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
44233387|NCT03181893|79052152|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233388|NCT03181893|79052153|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233389|NCT03181893|79052154|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233390|NCT03181893|79052155|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44500768|NCT03583372|79505052|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
44500769|NCT03583372|79505053|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
44500770|NCT03583372|79505054|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
44500771|NCT03583372|79505051|FG000|Overall Study|Did Not Receive Study Drug|0|||
44500772|NCT03583372|79505052|FG001|Overall Study|Did Not Receive Study Drug|1|||
44500773|NCT03583372|79505053|FG002|Overall Study|Did Not Receive Study Drug|0|||
44500774|NCT03583372|79505054|FG003|Overall Study|Did Not Receive Study Drug|0|||
44500775|NCT03583372|79505051|FG000|Overall Study|Captured as Other in the Database|1|||
44500776|NCT03583372|79505052|FG001|Overall Study|Captured as Other in the Database|2|||
44500777|NCT03583372|79505053|FG002|Overall Study|Captured as Other in the Database|4|||
44500778|NCT03583372|79505054|FG003|Overall Study|Captured as Other in the Database|1|||
44500779|NCT03582826|79505066|FG000|Overall Study|Lost to Follow-up|39|||
44500780|NCT03582826|79505067|FG001|Overall Study|Lost to Follow-up|0|||
44500781|NCT03582826|79505066|FG000|Overall Study|Withdrawal by Subject|2|||
44500782|NCT03582826|79505067|FG001|Overall Study|Withdrawal by Subject|0|||
44500783|NCT03518008|79505082|FG000|Period 2, Second Week of Wear|Family emergency|0|||
44500784|NCT03518008|79505083|FG001|Period 2, Second Week of Wear|Family emergency|1|||
44500785|NCT03810014|79505093|FG000|Overall Study|Pregnancy|2|||
44500786|NCT03810014|79505094|FG001|Overall Study|Pregnancy|2|||
44500787|NCT03810014|79505095|FG002|Overall Study|Pregnancy|0|||
44500788|NCT03810014|79505096|FG003|Overall Study|Pregnancy|2|||
44233391|NCT03181893|79052156|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233392|NCT03181893|79052157|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
44233393|NCT03181893|79052158|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
44233394|NCT03181893|79052148|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233395|NCT03181893|79052149|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233396|NCT03181893|79052150|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44500789|NCT04978363|79505117|FG000|Overall Study|Other medical issues unrelated to the study|0|||
44500790|NCT04978363|79505118|FG001|Overall Study|Other medical issues unrelated to the study|0|||
44500791|NCT04978363|79505119|FG002|Overall Study|Other medical issues unrelated to the study|0|||
44562881|NCT03066609|79581603|FG001|OVERALL STUDY|Lack of Efficacy|1|||
44562882|NCT03066609|79581604|FG002|OVERALL STUDY|Lack of Efficacy|1|||
44562883|NCT03066609|79581605|FG003|OVERALL STUDY|Lack of Efficacy|1|||
44562884|NCT03066609|79581602|FG000|OVERALL STUDY|discontinued follow up|0|||
44562885|NCT03066609|79581603|FG001|OVERALL STUDY|discontinued follow up|2|||
44562886|NCT03066609|79581604|FG002|OVERALL STUDY|discontinued follow up|0|||
44233397|NCT03181893|79052151|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44275393|NCT02201940|79221873|FG001|Overall Study|Lack of Efficacy|113|||
44233398|NCT03181893|79052152|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233399|NCT03181893|79052153|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233400|NCT03181893|79052154|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233401|NCT03181893|79052155|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44275394|NCT02201940|79221872|FG000|Overall Study|Lost to Follow-up|5|||
44275395|NCT02201940|79221873|FG001|Overall Study|Lost to Follow-up|0|||
44275396|NCT02201940|79221872|FG000|Overall Study|Withdrew Consent|2|||
44275397|NCT02201940|79221873|FG001|Overall Study|Withdrew Consent|1|||
44275398|NCT02201940|79221872|FG000|Overall Study|Investigator's Discretion|1|||
44233402|NCT03181893|79052156|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233403|NCT03181893|79052157|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
44233404|NCT03181893|79052158|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
44233405|NCT03180840|79052183|FG000|Overall Study|Withdrawal by Subject|1|||
44233406|NCT03064035|79052194|FG000|Overall Study|Did not receive allocated intervention|4|||
44233407|NCT03064035|79052195|FG001|Overall Study|Did not receive allocated intervention|2|||
44233408|NCT03064035|79052194|FG000|Overall Study|Lost to Follow-up|1|||
44233409|NCT03064035|79052195|FG001|Overall Study|Lost to Follow-up|1|||
44275399|NCT02201940|79221873|FG001|Overall Study|Investigator's Discretion|1|||
44377097|NCT00921024|79382405|FG001|Overall Study|Received concomittant therapy|0|||
44233410|NCT03014206|79052208|FG000|Overall Study|Registration Violation|12|||
44275400|NCT02201940|79221872|FG000|Overall Study|Death|1|||
44275401|NCT02201940|79221873|FG001|Overall Study|Death|0|||
44275402|NCT02201940|79221872|FG000|Overall Study|Adverse Event|0|||
44275403|NCT02201940|79221873|FG001|Overall Study|Adverse Event|1|||
44275404|NCT02232984|79221879|FG000|Overall Study|Withdrawal by Subject|5|||
44275405|NCT02232984|79221879|FG000|Overall Study|Death|1|||
44275406|NCT02232984|79221879|FG000|Overall Study|Investigator withdrawal|10|||
44275407|NCT02232984|79221879|FG000|Overall Study|Device implant unsuccessful|53|||
44275408|NCT02232984|79221879|FG000|Overall Study|not disclosed by site|7|||
44275409|NCT02232984|79221879|FG000|Overall Study|Protocol Violation|1|||
44275410|NCT02169336|79221889|FG000|Overall Study|Lack of Efficacy|1|||
44275411|NCT02169336|79221890|FG001|Overall Study|Lack of Efficacy|1|||
44275412|NCT02169336|79221891|FG002|Overall Study|Lack of Efficacy|0|||
44275413|NCT02169336|79221889|FG000|Overall Study|Adverse Event|2|||
44275414|NCT02169336|79221890|FG001|Overall Study|Adverse Event|3|||
44275415|NCT02169336|79221891|FG002|Overall Study|Adverse Event|1|||
44275416|NCT02169336|79221889|FG000|Overall Study|Withdrawal by Subject|1|||
44275417|NCT02169336|79221890|FG001|Overall Study|Withdrawal by Subject|0|||
44275418|NCT02169336|79221891|FG002|Overall Study|Withdrawal by Subject|0|||
44275419|NCT02169336|79221889|FG000|Overall Study|Physician Decision|0|||
44275420|NCT02169336|79221890|FG001|Overall Study|Physician Decision|0|||
44275421|NCT02169336|79221891|FG002|Overall Study|Physician Decision|1|||
44275422|NCT02169336|79221889|FG000|Overall Study|Subject declined to continue dosing|0|||
44500792|NCT04978363|79505120|FG003|Overall Study|Other medical issues unrelated to the study|0|||
44500793|NCT04978363|79505121|FG004|Overall Study|Other medical issues unrelated to the study|1|||
44500794|NCT04978363|79505122|FG005|Overall Study|Other medical issues unrelated to the study|0|||
44500795|NCT04978363|79505123|FG006|Overall Study|Other medical issues unrelated to the study|0|||
44500796|NCT04978363|79505124|FG007|Overall Study|Other medical issues unrelated to the study|0|||
44500797|NCT04978363|79505125|FG008|Overall Study|Other medical issues unrelated to the study|0|||
44500798|NCT04978363|79505126|FG009|Overall Study|Other medical issues unrelated to the study|0|||
44562887|NCT03066609|79581605|FG003|OVERALL STUDY|discontinued follow up|0|||
44562888|NCT02964234|79581622|FG000|Overall Study|Lost to Follow-up|22|||
44562889|NCT02964234|79581623|FG001|Overall Study|Lost to Follow-up|13|||
44562890|NCT01345188|79581629|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
44562891|NCT01345188|79581629|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
44562892|NCT03852459|79581638|FG000|Overall Study|Adverse Event|2|||
44562893|NCT03852459|79581639|FG001|Overall Study|Adverse Event|2|||
44562894|NCT03852459|79581638|FG000|Overall Study|Withdrawal by Subject|1|||
44233411|NCT02822573|79052223|FG000|Overall Study|Lost to Follow-up|5|||
44233412|NCT02822573|79052224|FG001|Overall Study|Lost to Follow-up|3|||
44233413|NCT02822573|79052223|FG000|Overall Study|Physician Decision|1|||
44233414|NCT02822573|79052224|FG001|Overall Study|Physician Decision|1|||
44562895|NCT03852459|79581639|FG001|Overall Study|Withdrawal by Subject|1|||
44562896|NCT02896296|79581645|FG000|Overall Study|Adverse Event|1|||
44562897|NCT02896296|79581645|FG000|Overall Study|Lost to Follow-up|19|||
44562898|NCT02896296|79581645|FG000|Overall Study|Pregnancy|1|||
44562899|NCT02896296|79581645|FG000|Overall Study|Physician Decision|2|||
44562900|NCT02896296|79581645|FG000|Overall Study|Withdrawal by Subject|10|||
44233415|NCT02822573|79052223|FG000|Overall Study|Withdrawal by Subject|9|||
44233416|NCT02822573|79052224|FG001|Overall Study|Withdrawal by Subject|5|||
44233417|NCT02822573|79052223|FG000|Overall Study|Protocol Violation|6|||
44500799|NCT04978363|79505127|FG010|Overall Study|Other medical issues unrelated to the study|0|||
44500800|NCT04978363|79505117|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
44500801|NCT04978363|79505118|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
44500802|NCT04978363|79505119|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
44500803|NCT04978363|79505120|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
44500804|NCT04978363|79505121|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
44500805|NCT04978363|79505122|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
44500806|NCT04978363|79505123|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
44562901|NCT02896296|79581645|FG000|Overall Study|Site closing|7|||
44233418|NCT02822573|79052224|FG001|Overall Study|Protocol Violation|4|||
44275423|NCT02169336|79221890|FG001|Overall Study|Subject declined to continue dosing|0|||
44275424|NCT02169336|79221891|FG002|Overall Study|Subject declined to continue dosing|1|||
44233419|NCT02822573|79052223|FG000|Overall Study|Too sick or ill|2|||
44275425|NCT02609828|79221907|FG000|Overall Study|Adverse Event|8|||
44275426|NCT02609828|79221908|FG001|Overall Study|Adverse Event|1|||
44233420|NCT02822573|79052224|FG001|Overall Study|Too sick or ill|1|||
44233421|NCT02822573|79052223|FG000|Overall Study|Disease Progression|1|||
44275427|NCT02609828|79221909|FG002|Overall Study|Adverse Event|0|||
44562902|NCT02896296|79581645|FG000|Overall Study|Incarceration|1|||
44562903|NCT02896296|79581645|FG000|Overall Study|Relocation|1|||
44562904|NCT03740919|79581652|FG000|Lead-in Period|Lost to Follow-up|1|||
44562905|NCT03740919|79581653|FG001|Lead-in Period|Lost to Follow-up|0|||
44562906|NCT03740919|79581654|FG002|Lead-in Period|Lost to Follow-up|0|||
44562907|NCT03740919|79581655|FG003|Lead-in Period|Lost to Follow-up|0|||
44562908|NCT03740919|79581652|FG000|Lead-in Period|Physician Decision|2|||
44562909|NCT03740919|79581653|FG001|Lead-in Period|Physician Decision|0|||
44562910|NCT03740919|79581654|FG002|Lead-in Period|Physician Decision|0|||
44562911|NCT03740919|79581655|FG003|Lead-in Period|Physician Decision|0|||
44562912|NCT03740919|79581652|FG000|Lead-in Period|Protocol Violation|1|||
44562913|NCT03740919|79581653|FG001|Lead-in Period|Protocol Violation|0|||
44562914|NCT03740919|79581654|FG002|Lead-in Period|Protocol Violation|0|||
44562915|NCT03740919|79581655|FG003|Lead-in Period|Protocol Violation|0|||
44562916|NCT03740919|79581652|FG000|Lead-in Period|Withdrawal by Subject|10|||
44562917|NCT03740919|79581653|FG001|Lead-in Period|Withdrawal by Subject|0|||
44562918|NCT03740919|79581654|FG002|Lead-in Period|Withdrawal by Subject|0|||
44562919|NCT03740919|79581655|FG003|Lead-in Period|Withdrawal by Subject|0|||
44562920|NCT03740919|79581652|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
44562921|NCT03740919|79581653|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
44562922|NCT03740919|79581654|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
44562923|NCT03740919|79581655|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
44562924|NCT03740919|79581652|FG000|Lead-in Period|Study Task Too Burdensome|1|||
44562925|NCT03740919|79581653|FG001|Lead-in Period|Study Task Too Burdensome|0|||
44562926|NCT03740919|79581654|FG002|Lead-in Period|Study Task Too Burdensome|0|||
44562927|NCT03740919|79581655|FG003|Lead-in Period|Study Task Too Burdensome|0|||
44562928|NCT03740919|79581652|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
44562929|NCT03740919|79581653|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
44562930|NCT03740919|79581654|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
44562931|NCT03740919|79581655|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
44562932|NCT03740919|79581652|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
44562933|NCT03740919|79581653|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
44562934|NCT03740919|79581654|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
44562935|NCT03740919|79581655|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
44562936|NCT03740919|79581652|FG000|Treatment Period|Adverse Event|0|||
44562937|NCT03740919|79581653|FG001|Treatment Period|Adverse Event|0|||
44562938|NCT03740919|79581654|FG002|Treatment Period|Adverse Event|2|||
44562939|NCT03740919|79581655|FG003|Treatment Period|Adverse Event|0|||
44562940|NCT03740919|79581652|FG000|Treatment Period|Protocol Violation|0|||
44562941|NCT03740919|79581653|FG001|Treatment Period|Protocol Violation|1|||
44562942|NCT03740919|79581654|FG002|Treatment Period|Protocol Violation|0|||
44562943|NCT03740919|79581655|FG003|Treatment Period|Protocol Violation|0|||
44562944|NCT03740919|79581652|FG000|Treatment Period|Withdrawal by Subject|0|||
44562945|NCT03740919|79581653|FG001|Treatment Period|Withdrawal by Subject|7|||
44562946|NCT03740919|79581654|FG002|Treatment Period|Withdrawal by Subject|6|||
44562947|NCT03740919|79581655|FG003|Treatment Period|Withdrawal by Subject|2|||
44562948|NCT03740919|79581652|FG000|Treatment Period|Terminated by Sponsor|0|||
44562949|NCT03740919|79581653|FG001|Treatment Period|Terminated by Sponsor|1|||
44562950|NCT03740919|79581654|FG002|Treatment Period|Terminated by Sponsor|0|||
44562951|NCT03740919|79581655|FG003|Treatment Period|Terminated by Sponsor|0|||
44562952|NCT03740919|79581652|FG000|Treatment Period|Issue with Insulin Pump|0|||
44562953|NCT03740919|79581653|FG001|Treatment Period|Issue with Insulin Pump|1|||
44562954|NCT03740919|79581654|FG002|Treatment Period|Issue with Insulin Pump|0|||
44562955|NCT03740919|79581655|FG003|Treatment Period|Issue with Insulin Pump|0|||
44562956|NCT03740919|79581652|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
44562957|NCT03740919|79581653|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
44562958|NCT03740919|79581654|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
44562959|NCT03740919|79581655|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
44562960|NCT03740919|79581652|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
44562961|NCT03740919|79581653|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
44562962|NCT03740919|79581654|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
44562963|NCT03740919|79581655|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
44562964|NCT03740919|79581652|FG000|Treatment Period|Not Completing Diary|0|||
44562965|NCT03740919|79581653|FG001|Treatment Period|Not Completing Diary|0|||
44562966|NCT03740919|79581654|FG002|Treatment Period|Not Completing Diary|1|||
44562967|NCT03740919|79581655|FG003|Treatment Period|Not Completing Diary|0|||
44562968|NCT03740919|79581652|FG000|Treatment Period|Insulin Painful to Participant|0|||
44562969|NCT03740919|79581653|FG001|Treatment Period|Insulin Painful to Participant|0|||
44562970|NCT03740919|79581654|FG002|Treatment Period|Insulin Painful to Participant|1|||
44562971|NCT03740919|79581655|FG003|Treatment Period|Insulin Painful to Participant|0|||
44562972|NCT01335685|79581670|FG000|Overall Study|Study Terminated by Sponsor|2|||
44562973|NCT01335685|79581671|FG001|Overall Study|Study Terminated by Sponsor|1|||
44562974|NCT01335685|79581672|FG002|Overall Study|Study Terminated by Sponsor|1|||
44562975|NCT01335685|79581673|FG003|Overall Study|Study Terminated by Sponsor|10|||
44562976|NCT01335685|79581674|FG004|Overall Study|Study Terminated by Sponsor|0|||
44562977|NCT01335685|79581675|FG005|Overall Study|Study Terminated by Sponsor|4|||
44562978|NCT01335685|79581676|FG006|Overall Study|Study Terminated by Sponsor|2|||
44562979|NCT01335685|79581677|FG007|Overall Study|Study Terminated by Sponsor|3|||
44562980|NCT01335685|79581670|FG000|Overall Study|Withdrawal by Subject|1|||
44562981|NCT01335685|79581671|FG001|Overall Study|Withdrawal by Subject|0|||
44562982|NCT01335685|79581672|FG002|Overall Study|Withdrawal by Subject|0|||
44562983|NCT01335685|79581673|FG003|Overall Study|Withdrawal by Subject|1|||
44562984|NCT01335685|79581674|FG004|Overall Study|Withdrawal by Subject|0|||
44562985|NCT01335685|79581675|FG005|Overall Study|Withdrawal by Subject|0|||
44562986|NCT01335685|79581676|FG006|Overall Study|Withdrawal by Subject|0|||
44562987|NCT01335685|79581677|FG007|Overall Study|Withdrawal by Subject|0|||
44562988|NCT01335685|79581670|FG000|Overall Study|Reason not Specified|0|||
44562989|NCT01335685|79581671|FG001|Overall Study|Reason not Specified|0|||
44562990|NCT01335685|79581672|FG002|Overall Study|Reason not Specified|1|||
44562991|NCT01335685|79581673|FG003|Overall Study|Reason not Specified|0|||
44562992|NCT01335685|79581674|FG004|Overall Study|Reason not Specified|0|||
44562993|NCT01335685|79581675|FG005|Overall Study|Reason not Specified|1|||
44562994|NCT01335685|79581676|FG006|Overall Study|Reason not Specified|0|||
44562995|NCT01335685|79581677|FG007|Overall Study|Reason not Specified|0|||
44562996|NCT02926209|79581700|FG000|Study Cohort|Poor Bowel Preparation|1|||
44562997|NCT02926209|79581701|FG001|Study Cohort|Poor Bowel Preparation|0|||
44562998|NCT03066999|79581710|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
44562999|NCT03066999|79581711|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
44563000|NCT02963922|79581725|FG000|Overall Study|Adverse Event|15|||
44563001|NCT02963922|79581726|FG001|Overall Study|Adverse Event|6|||
44563002|NCT02963922|79581725|FG000|Overall Study|Protocol deviation|6|||
44563003|NCT02963922|79581726|FG001|Overall Study|Protocol deviation|6|||
44563004|NCT02963922|79581725|FG000|Overall Study|Lack of Efficacy|1|||
44563005|NCT02963922|79581726|FG001|Overall Study|Lack of Efficacy|1|||
44563006|NCT02963922|79581725|FG000|Overall Study|Lost to Follow-up|2|||
44563007|NCT02963922|79581726|FG001|Overall Study|Lost to Follow-up|3|||
44563008|NCT02963922|79581725|FG000|Overall Study|Other|8|||
44563009|NCT02963922|79581726|FG001|Overall Study|Other|14|||
44563010|NCT02881567|79581732|FG000|Overall Study|Adverse Event|1|||
44563011|NCT02881567|79581732|FG000|Overall Study|Lost to Follow-up|3|||
44563012|NCT02881567|79581732|FG000|Overall Study|Consent withdrawn|1|||
44563013|NCT02881567|79581732|FG000|Overall Study|Investigator decision|1|||
44563014|NCT02881567|79581732|FG000|Overall Study|Study terminated by sponsor|9|||
44563015|NCT02881567|79581732|FG000|Overall Study|Reason not Specified|3|||
44563016|NCT02962674|79581736|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
44563017|NCT02962908|79581746|FG000|Overall Study|Lost to Follow-up|0|||
44563018|NCT02962908|79581747|FG001|Overall Study|Lost to Follow-up|3|||
44563019|NCT02962908|79581748|FG002|Overall Study|Lost to Follow-up|0|||
44563020|NCT02962908|79581749|FG003|Overall Study|Lost to Follow-up|1|||
44563021|NCT02962908|79581746|FG000|Overall Study|Withdrawal by Subject|0|||
44563022|NCT02962908|79581747|FG001|Overall Study|Withdrawal by Subject|3|||
44563023|NCT02962908|79581748|FG002|Overall Study|Withdrawal by Subject|0|||
44563024|NCT02962908|79581749|FG003|Overall Study|Withdrawal by Subject|2|||
44563025|NCT02962908|79581746|FG000|Overall Study|Protocol Violation|0|||
44563026|NCT02962908|79581747|FG001|Overall Study|Protocol Violation|1|||
44563027|NCT02962908|79581748|FG002|Overall Study|Protocol Violation|0|||
44563028|NCT02962908|79581749|FG003|Overall Study|Protocol Violation|0|||
44563029|NCT02962908|79581746|FG000|Overall Study|Physician Decision|0|||
44233422|NCT02822573|79052224|FG001|Overall Study|Disease Progression|1|||
44233423|NCT02822573|79052223|FG000|Overall Study|No reason given|6|||
44233424|NCT02822573|79052224|FG001|Overall Study|No reason given|4|||
44233425|NCT02795676|79052232|FG000|Overall Study|Adverse Event|2|||
44233426|NCT02795676|79052233|FG001|Overall Study|Adverse Event|0|||
44377098|NCT00921024|79382404|FG000|Overall Study|Withdrawal by Subject|0|||
44500807|NCT04978363|79505124|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
44500808|NCT04978363|79505125|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
44500809|NCT04978363|79505126|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
44500810|NCT04978363|79505127|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
44500811|NCT04978363|79505117|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500812|NCT04978363|79505118|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
44500813|NCT04978363|79505119|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44563030|NCT02962908|79581747|FG001|Overall Study|Physician Decision|1|||
44563031|NCT02962908|79581748|FG002|Overall Study|Physician Decision|0|||
44563032|NCT02962908|79581749|FG003|Overall Study|Physician Decision|0|||
44563033|NCT02962284|79581767|FG000|Overall Study|Death|2|||
44563034|NCT02962284|79581768|FG001|Overall Study|Death|0|||
44233427|NCT02795676|79052232|FG000|Overall Study|Withdrawal by Subject|3|||
44233428|NCT02795676|79052233|FG001|Overall Study|Withdrawal by Subject|1|||
44563035|NCT02962284|79581767|FG000|Overall Study|Progressive disease|2|||
44563036|NCT02962284|79581768|FG001|Overall Study|Progressive disease|3|||
44563037|NCT02962284|79581767|FG000|Overall Study|Withdrawal by Subject|1|||
44563038|NCT02962284|79581768|FG001|Overall Study|Withdrawal by Subject|0|||
44563039|NCT01344876|79581776|FG000|Overall Study|Adverse Event|0|||
44563040|NCT01344876|79581777|FG001|Overall Study|Adverse Event|0|||
44563041|NCT01344876|79581778|FG002|Overall Study|Adverse Event|0|||
44563042|NCT01344876|79581779|FG003|Overall Study|Adverse Event|0|||
44563043|NCT01344876|79581780|FG004|Overall Study|Adverse Event|1|||
44563044|NCT01344876|79581776|FG000|Overall Study|Withdrawal by Subject|0|||
44563045|NCT01344876|79581777|FG001|Overall Study|Withdrawal by Subject|0|||
44563046|NCT01344876|79581778|FG002|Overall Study|Withdrawal by Subject|1|||
44563047|NCT01344876|79581779|FG003|Overall Study|Withdrawal by Subject|0|||
44563048|NCT01344876|79581780|FG004|Overall Study|Withdrawal by Subject|0|||
44563049|NCT01344876|79581776|FG000|Overall Study|Definite progression of primary disease|1|||
44563050|NCT01344876|79581777|FG001|Overall Study|Definite progression of primary disease|0|||
44563051|NCT01344876|79581778|FG002|Overall Study|Definite progression of primary disease|0|||
44563052|NCT01344876|79581779|FG003|Overall Study|Definite progression of primary disease|3|||
44563053|NCT01344876|79581780|FG004|Overall Study|Definite progression of primary disease|0|||
44233429|NCT02784535|79052239|FG000|Overall Study|Adverse Event|1|||
44233430|NCT02784535|79052240|FG001|Overall Study|Adverse Event|0|||
44233431|NCT02784535|79052239|FG000|Overall Study|Withdrawal by Subject|0|||
44233432|NCT02784535|79052240|FG001|Overall Study|Withdrawal by Subject|1|||
44233433|NCT02784535|79052239|FG000|Overall Study|Physician Decision|0|||
44233434|NCT02784535|79052240|FG001|Overall Study|Physician Decision|1|||
44233435|NCT02617511|79052251|FG000|Overall Study|Withdrawal by Subject|1|||
44233436|NCT02617511|79052252|FG001|Overall Study|Withdrawal by Subject|0|||
44233437|NCT02587234|79052260|FG000|Overall Study|Withdrawal by Subject|1|||
44233438|NCT02587234|79052261|FG001|Overall Study|Withdrawal by Subject|1|||
44233439|NCT02587234|79052260|FG000|Overall Study|Lost to Follow-up|0|||
44233440|NCT02587234|79052261|FG001|Overall Study|Lost to Follow-up|2|||
44233441|NCT02184195|79052269|FG000|Overall Study|Patient decision|5|||
44233442|NCT02184195|79052270|FG001|Overall Study|Patient decision|2|||
44233443|NCT02184195|79052269|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44233444|NCT02184195|79052270|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44233445|NCT02184195|79052269|FG000|Overall Study|Death|67|||
44233446|NCT02184195|79052270|FG001|Overall Study|Death|44|||
44233447|NCT02184195|79052269|FG000|Overall Study|Lost to Follow-up|1|||
44233448|NCT02184195|79052270|FG001|Overall Study|Lost to Follow-up|5|||
44233449|NCT02184195|79052269|FG000|Overall Study|Other|0|||
44233450|NCT02184195|79052270|FG001|Overall Study|Other|3|||
44233451|NCT02181413|79052278|FG000|Overall Study|Adverse Event|7|||
44233452|NCT02181413|79052279|FG001|Overall Study|Adverse Event|24|||
44233453|NCT02181413|79052278|FG000|Overall Study|Progressive Disease|121|||
44233454|NCT02181413|79052279|FG001|Overall Study|Progressive Disease|143|||
44233455|NCT02181413|79052278|FG000|Overall Study|Withdrawal by Subject|5|||
44233456|NCT02181413|79052279|FG001|Overall Study|Withdrawal by Subject|8|||
44233457|NCT02181413|79052278|FG000|Overall Study|Reason Not Specified|19|||
44233458|NCT02181413|79052279|FG001|Overall Study|Reason Not Specified|20|||
44275428|NCT02609828|79221910|FG003|Overall Study|Adverse Event|6|||
44500814|NCT04978363|79505120|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500815|NCT04978363|79505121|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500816|NCT04978363|79505122|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500817|NCT04978363|79505123|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44275429|NCT02609828|79221907|FG000|Overall Study|Death|15|||
44500818|NCT04978363|79505124|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500819|NCT04978363|79505125|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44563054|NCT02846324|79581797|FG000|Overall Study|Other|1|||
44563055|NCT02846324|79581798|FG001|Overall Study|Other|0|||
44275430|NCT02609828|79221908|FG001|Overall Study|Death|1|||
44275431|NCT02609828|79221909|FG002|Overall Study|Death|1|||
44563056|NCT02846324|79581799|FG002|Overall Study|Other|0|||
44563057|NCT02846324|79581800|FG003|Overall Study|Other|0|||
44563058|NCT02846324|79581797|FG000|Overall Study|Withdrawal by Subject|1|||
44233459|NCT02181413|79052278|FG000|Overall Study|Ongoing Study Treatment|0|||
44233460|NCT02181413|79052279|FG001|Overall Study|Ongoing Study Treatment|1|||
44233461|NCT02181413|79052278|FG000|Overall Study|Lost to Follow-up|0|||
44233462|NCT02181413|79052279|FG001|Overall Study|Lost to Follow-up|1|||
44233463|NCT02151981|79052287|FG000|Overall Study|Death|184|||
44233464|NCT02151981|79052288|FG001|Overall Study|Death|88|||
44275432|NCT02609828|79221910|FG003|Overall Study|Death|19|||
44233465|NCT02151981|79052287|FG000|Overall Study|Lost to Follow-up|7|||
44233466|NCT02151981|79052288|FG001|Overall Study|Lost to Follow-up|1|||
44233467|NCT02151981|79052287|FG000|Overall Study|Withdrawal by Subject|27|||
44563059|NCT02846324|79581798|FG001|Overall Study|Withdrawal by Subject|0|||
44563060|NCT02846324|79581799|FG002|Overall Study|Withdrawal by Subject|4|||
44563061|NCT02846324|79581800|FG003|Overall Study|Withdrawal by Subject|0|||
44563062|NCT03161093|79581825|FG000|Overall Study|Protocol Violation|11|||
44563063|NCT03161093|79581826|FG001|Overall Study|Protocol Violation|14|||
44563064|NCT03161093|79581827|FG002|Overall Study|Protocol Violation|6|||
44563065|NCT03161093|79581828|FG003|Overall Study|Protocol Violation|13|||
44563066|NCT03161093|79581829|FG004|Overall Study|Protocol Violation|1|||
44563067|NCT03161093|79581830|FG005|Overall Study|Protocol Violation|0|||
44563068|NCT03161093|79581825|FG000|Overall Study|Adverse Event|5|||
44563069|NCT03161093|79581826|FG001|Overall Study|Adverse Event|21|||
44563070|NCT03161093|79581827|FG002|Overall Study|Adverse Event|16|||
44563071|NCT03161093|79581828|FG003|Overall Study|Adverse Event|35|||
44563072|NCT03161093|79581829|FG004|Overall Study|Adverse Event|2|||
44563073|NCT03161093|79581830|FG005|Overall Study|Adverse Event|1|||
44563074|NCT03161093|79581825|FG000|Overall Study|Lack of Efficacy|9|||
44563075|NCT03161093|79581826|FG001|Overall Study|Lack of Efficacy|13|||
44563076|NCT03161093|79581827|FG002|Overall Study|Lack of Efficacy|9|||
44563077|NCT03161093|79581828|FG003|Overall Study|Lack of Efficacy|24|||
44563078|NCT03161093|79581829|FG004|Overall Study|Lack of Efficacy|4|||
44563079|NCT03161093|79581830|FG005|Overall Study|Lack of Efficacy|1|||
44563080|NCT03161093|79581825|FG000|Overall Study|Physician Decision|0|||
44563081|NCT03161093|79581826|FG001|Overall Study|Physician Decision|1|||
44563082|NCT03161093|79581827|FG002|Overall Study|Physician Decision|0|||
44563083|NCT03161093|79581828|FG003|Overall Study|Physician Decision|2|||
44563084|NCT03161093|79581829|FG004|Overall Study|Physician Decision|17|||
44563085|NCT03161093|79581830|FG005|Overall Study|Physician Decision|15|||
44563086|NCT03161093|79581825|FG000|Overall Study|Withdrawal by Subject|24|||
44233468|NCT02151981|79052288|FG001|Overall Study|Withdrawal by Subject|21|||
44233469|NCT02151981|79052287|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
44377099|NCT00921024|79382405|FG001|Overall Study|Withdrawal by Subject|3|||
44377100|NCT00928668|79382411|FG000|Overall Study|Adverse Event|1|||
44500820|NCT04978363|79505126|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500821|NCT04978363|79505127|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
44500822|NCT04101422|79505207|FG000|Overall Study|Ineligible|1|||
44500823|NCT04101422|79505208|FG001|Overall Study|Ineligible|0|||
44500824|NCT04101422|79505209|FG002|Overall Study|Ineligible|9|||
44500825|NCT04101422|79505210|FG003|Overall Study|Ineligible|0|||
44500826|NCT04101422|79505207|FG000|Overall Study|Withdrawal by Subject|0|||
44500827|NCT04101422|79505208|FG001|Overall Study|Withdrawal by Subject|0|||
44500828|NCT04101422|79505209|FG002|Overall Study|Withdrawal by Subject|1|||
44500829|NCT04101422|79505210|FG003|Overall Study|Withdrawal by Subject|0|||
44500830|NCT04101422|79505207|FG000|Overall Study|Not attending to the stimuli|0|||
44500831|NCT04101422|79505208|FG001|Overall Study|Not attending to the stimuli|0|||
44500832|NCT04101422|79505209|FG002|Overall Study|Not attending to the stimuli|4|||
44500833|NCT04101422|79505210|FG003|Overall Study|Not attending to the stimuli|0|||
44500834|NCT04101422|79505207|FG000|Overall Study|Did not download app|0|||
44500835|NCT04101422|79505208|FG001|Overall Study|Did not download app|0|||
44500836|NCT04101422|79505209|FG002|Overall Study|Did not download app|0|||
44500837|NCT04101422|79505210|FG003|Overall Study|Did not download app|17|||
44500838|NCT04101422|79505207|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
44500839|NCT04101422|79505208|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
44500840|NCT04101422|79505209|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
44500841|NCT04101422|79505210|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
44500842|NCT03841604|79505222|FG000|Overall Study|Withdrawal by Subject|3|||
44500843|NCT03841604|79505223|FG001|Overall Study|Withdrawal by Subject|1|||
44500844|NCT03841604|79505222|FG000|Overall Study|Adverse Event|4|||
44500845|NCT03841604|79505223|FG001|Overall Study|Adverse Event|2|||
44563087|NCT03161093|79581826|FG001|Overall Study|Withdrawal by Subject|73|||
44563088|NCT03161093|79581827|FG002|Overall Study|Withdrawal by Subject|44|||
44275433|NCT02609828|79221907|FG000|Overall Study|Insufficient clinical response|2|||
44500846|NCT03841604|79505222|FG000|Overall Study|Physician Decision|1|||
44563089|NCT03161093|79581828|FG003|Overall Study|Withdrawal by Subject|97|||
44563090|NCT03161093|79581829|FG004|Overall Study|Withdrawal by Subject|11|||
44563091|NCT03161093|79581830|FG005|Overall Study|Withdrawal by Subject|10|||
44563092|NCT03161093|79581825|FG000|Overall Study|Lost to Follow-up|3|||
44563093|NCT03161093|79581826|FG001|Overall Study|Lost to Follow-up|12|||
44563094|NCT03161093|79581827|FG002|Overall Study|Lost to Follow-up|4|||
44563095|NCT03161093|79581828|FG003|Overall Study|Lost to Follow-up|7|||
44563096|NCT03161093|79581829|FG004|Overall Study|Lost to Follow-up|8|||
44563097|NCT03161093|79581830|FG005|Overall Study|Lost to Follow-up|13|||
44563098|NCT03161093|79581825|FG000|Overall Study|Death|3|||
44563099|NCT03161093|79581826|FG001|Overall Study|Death|9|||
44563100|NCT03161093|79581827|FG002|Overall Study|Death|7|||
44563101|NCT03161093|79581828|FG003|Overall Study|Death|9|||
44563102|NCT03161093|79581829|FG004|Overall Study|Death|0|||
44563103|NCT03161093|79581830|FG005|Overall Study|Death|0|||
44563104|NCT03161093|79581825|FG000|Overall Study|Unknown - Not reported|0|||
44563105|NCT03161093|79581826|FG001|Overall Study|Unknown - Not reported|1|||
44563106|NCT03161093|79581827|FG002|Overall Study|Unknown - Not reported|0|||
44563107|NCT03161093|79581828|FG003|Overall Study|Unknown - Not reported|0|||
44563108|NCT03161093|79581829|FG004|Overall Study|Unknown - Not reported|0|||
44563109|NCT03161093|79581830|FG005|Overall Study|Unknown - Not reported|1|||
44563110|NCT02847650|79581851|FG000|Overall Study|Adverse Event|2|||
44563111|NCT02847650|79581852|FG001|Overall Study|Adverse Event|4|||
44563112|NCT02847650|79581851|FG000|Overall Study|Lost to Follow-up|1|||
44563113|NCT02847650|79581852|FG001|Overall Study|Lost to Follow-up|0|||
44563114|NCT02847650|79581851|FG000|Overall Study|Protocol Violation|0|||
44563115|NCT02847650|79581852|FG001|Overall Study|Protocol Violation|1|||
44563116|NCT02847650|79581851|FG000|Overall Study|Withdrawal by Subject|1|||
44563117|NCT02847650|79581852|FG001|Overall Study|Withdrawal by Subject|1|||
44563118|NCT02847494|79581860|FG000|Overall Study|Lost to Follow-up|8|||
44563119|NCT02847494|79581861|FG001|Overall Study|Lost to Follow-up|5|||
44563120|NCT02554253|79581869|FG000|Overall Study|ineligible after enrollment|1|||
44563121|NCT02554253|79581870|FG001|Overall Study|ineligible after enrollment|0|||
44563122|NCT02554253|79581869|FG000|Overall Study|converted to transcatheter procedure|0|||
44563123|NCT02554253|79581870|FG001|Overall Study|converted to transcatheter procedure|1|||
44563124|NCT02554253|79581869|FG000|Overall Study|received both drugs|0|||
44563125|NCT02554253|79581870|FG001|Overall Study|received both drugs|1|||
44563126|NCT03157583|79581877|FG000|Overall Study|Other (did not meet study criteria)|1|||
44563127|NCT02842736|79581895|FG000|Overall Study|Lost to Follow-up|13|||
44563128|NCT02842736|79581895|FG000|Overall Study|Intervention for menstrual bleeding|17|||
44563129|NCT02842736|79581895|FG000|Overall Study|Withdrawal by Subject|4|||
44563130|NCT02842736|79581895|FG000|Overall Study|Pregnancy|3|||
44563131|NCT02842736|79581895|FG000|Overall Study|Hysterectomy for fibroids|2|||
44563132|NCT02842736|79581895|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
44563133|NCT02842736|79581895|FG000|Overall Study|IUD: Mirena|1|||
44563134|NCT01307033|79581901|FG000|8-week Double-blind Period|Adverse Event|2|||
44563135|NCT01307033|79581902|FG001|8-week Double-blind Period|Adverse Event|0|||
44563136|NCT01307033|79581903|FG002|8-week Double-blind Period|Adverse Event|0|||
44563137|NCT01307033|79581904|FG003|8-week Double-blind Period|Adverse Event|0|||
44563138|NCT01307033|79581901|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
44563139|NCT01307033|79581902|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
44563140|NCT01307033|79581903|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
44563141|NCT01307033|79581904|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
44563142|NCT01307033|79581901|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
44563143|NCT01307033|79581902|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
44563144|NCT01307033|79581903|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
44563145|NCT01307033|79581904|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
44563146|NCT01307033|79581901|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
44563147|NCT01307033|79581902|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
44563148|NCT01307033|79581903|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
44563149|NCT01307033|79581904|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
44233470|NCT02151981|79052288|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
44233471|NCT02151981|79052287|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44563150|NCT01307033|79581901|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
44563151|NCT01307033|79581902|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
44563152|NCT01307033|79581903|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
44563153|NCT01307033|79581904|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
44563154|NCT01307033|79581901|FG000|44-week Open-label Extension|Adverse Event|0|||
44233472|NCT02151981|79052288|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44563155|NCT01307033|79581902|FG001|44-week Open-label Extension|Adverse Event|0|||
44563156|NCT01307033|79581903|FG002|44-week Open-label Extension|Adverse Event|2|||
44563157|NCT01307033|79581904|FG003|44-week Open-label Extension|Adverse Event|1|||
44563158|NCT01307033|79581901|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
44563159|NCT01307033|79581902|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
44563160|NCT01307033|79581903|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
44563161|NCT01307033|79581904|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
44233473|NCT02151981|79052287|FG000|Overall Study|Patient had no clinical benefit|1|||
44563162|NCT01307033|79581901|FG000|44-week Open-label Extension|Physician Decision|0|||
44563163|NCT01307033|79581902|FG001|44-week Open-label Extension|Physician Decision|0|||
44563164|NCT01307033|79581903|FG002|44-week Open-label Extension|Physician Decision|1|||
44563165|NCT01307033|79581904|FG003|44-week Open-label Extension|Physician Decision|0|||
44563166|NCT01307033|79581901|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
44563167|NCT01307033|79581902|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
44563168|NCT01307033|79581903|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
44563169|NCT01307033|79581904|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
44563170|NCT01307033|79581901|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
44563171|NCT01307033|79581902|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
44563172|NCT01307033|79581903|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
44563173|NCT01307033|79581904|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
44563174|NCT01307033|79581901|FG000|44-week Open-label Extension|Death|0|||
44563175|NCT01307033|79581902|FG001|44-week Open-label Extension|Death|0|||
44563176|NCT01307033|79581903|FG002|44-week Open-label Extension|Death|0|||
44563177|NCT01307033|79581904|FG003|44-week Open-label Extension|Death|1|||
44563178|NCT02844920|79581916|FG000|Overall Study|Lost to Follow-up|2|||
44563179|NCT03158311|79581923|FG000|Overall Study|Subject/Guardian Decision|10|||
44563180|NCT03158311|79581924|FG001|Overall Study|Subject/Guardian Decision|6|||
44563181|NCT03158311|79581925|FG002|Overall Study|Subject/Guardian Decision|11|||
44563182|NCT03158311|79581923|FG000|Overall Study|Adverse Event|5|||
44563183|NCT03158311|79581924|FG001|Overall Study|Adverse Event|3|||
44563184|NCT03158311|79581925|FG002|Overall Study|Adverse Event|3|||
44563185|NCT03158311|79581923|FG000|Overall Study|Techinical Problems|3|||
44563186|NCT03158311|79581924|FG001|Overall Study|Techinical Problems|1|||
44563187|NCT03158311|79581925|FG002|Overall Study|Techinical Problems|5|||
44563188|NCT03158311|79581923|FG000|Overall Study|Physician Decision|2|||
44563189|NCT03158311|79581924|FG001|Overall Study|Physician Decision|3|||
44563190|NCT03158311|79581925|FG002|Overall Study|Physician Decision|7|||
44563191|NCT03158311|79581923|FG000|Overall Study|Lost to Follow-up|1|||
44563192|NCT03158311|79581924|FG001|Overall Study|Lost to Follow-up|1|||
44563193|NCT03158311|79581925|FG002|Overall Study|Lost to Follow-up|1|||
44563194|NCT03158311|79581923|FG000|Overall Study|Sponsor decision|1|||
44563195|NCT03158311|79581924|FG001|Overall Study|Sponsor decision|0|||
44563196|NCT03158311|79581925|FG002|Overall Study|Sponsor decision|0|||
44563197|NCT03158311|79581923|FG000|Overall Study|Pregnancy|0|||
44563198|NCT03158311|79581924|FG001|Overall Study|Pregnancy|2|||
44563199|NCT03158311|79581925|FG002|Overall Study|Pregnancy|0|||
44563200|NCT03158311|79581923|FG000|Overall Study|Randomized in error|0|||
44563201|NCT03158311|79581924|FG001|Overall Study|Randomized in error|0|||
44563202|NCT03158311|79581925|FG002|Overall Study|Randomized in error|1|||
44563203|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
44563204|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
44563205|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
44563206|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
44563207|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
44563208|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
44563209|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
44563210|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
44563211|NCT01336621|79581937|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
44563212|NCT01336621|79581937|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
44563213|NCT01336621|79581937|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
44563214|NCT01336621|79581937|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
44563215|NCT01336621|79581937|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
44563216|NCT01336621|79581937|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
44563217|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
44563218|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
44563219|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
44563220|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
44563221|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
44563222|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
44563223|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
44563224|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
44563225|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
44563226|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
44563227|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
44563228|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
44563229|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
44563230|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
44563231|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
44233474|NCT02151981|79052288|FG001|Overall Study|Patient had no clinical benefit|0|||
44233475|NCT02151981|79052287|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
44233476|NCT02151981|79052288|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
44377101|NCT00928668|79382412|FG001|Overall Study|Adverse Event|0|||
44377102|NCT00928668|79382413|FG002|Overall Study|Adverse Event|0|||
44377103|NCT00928668|79382414|FG003|Overall Study|Adverse Event|0|||
44377104|NCT00928668|79382415|FG004|Overall Study|Adverse Event|0|||
44377105|NCT00928668|79382411|FG000|Overall Study|Protocol Violation|0|||
44500847|NCT03841604|79505223|FG001|Overall Study|Physician Decision|0|||
44500848|NCT03541187|79505240|FG000|Overall Study|Lost to Follow-up|2|||
44500849|NCT03541187|79505241|FG001|Overall Study|Lost to Follow-up|6|||
44500850|NCT03541187|79505240|FG000|Overall Study|Pregnancy|0|||
44377106|NCT00928668|79382412|FG001|Overall Study|Protocol Violation|0|||
44377107|NCT00928668|79382413|FG002|Overall Study|Protocol Violation|0|||
44500851|NCT03541187|79505241|FG001|Overall Study|Pregnancy|1|||
44500852|NCT03541187|79505240|FG000|Overall Study|Withdrawal by Subject|6|||
44500853|NCT03541187|79505241|FG001|Overall Study|Withdrawal by Subject|2|||
44500854|NCT03541187|79505240|FG000|Overall Study|Moved out of town|1|||
44500855|NCT03541187|79505241|FG001|Overall Study|Moved out of town|0|||
44500856|NCT03541187|79505240|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
44500857|NCT03541187|79505241|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
44500858|NCT03541187|79505240|FG000|Overall Study|Did not meet randomization criteria|1|||
44500859|NCT03541187|79505241|FG001|Overall Study|Did not meet randomization criteria|1|||
44500860|NCT03541187|79505240|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
44500861|NCT03541187|79505241|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
44500862|NCT03541187|79505240|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
44500863|NCT03541187|79505241|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
44500864|NCT03240081|79505258|FG000|Overall Study|Withdrawal by Subject|0|||
44233477|NCT02151981|79052287|FG000|Overall Study|Study terminated|0|||
44377108|NCT00928668|79382414|FG003|Overall Study|Protocol Violation|0|||
44377109|NCT00928668|79382415|FG004|Overall Study|Protocol Violation|1|||
44500865|NCT03240081|79505259|FG001|Overall Study|Withdrawal by Subject|2|||
44500866|NCT03240081|79505258|FG000|Overall Study|Lost to Follow-up|0|||
44500867|NCT03240081|79505259|FG001|Overall Study|Lost to Follow-up|1|||
44500868|NCT03003520|79505280|FG000|Overall Study|Adverse Event|9|||
44563232|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
44563233|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
44563234|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
44563235|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
44563236|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
44563237|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
44563238|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
44563239|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
44563240|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
44563241|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
44563242|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
44563243|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
44563244|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
44377110|NCT00928668|79382411|FG000|Overall Study|Withdrawal by Subject|0|||
44377111|NCT00928668|79382412|FG001|Overall Study|Withdrawal by Subject|1|||
44377112|NCT00928668|79382413|FG002|Overall Study|Withdrawal by Subject|1|||
44377113|NCT00928668|79382414|FG003|Overall Study|Withdrawal by Subject|0|||
44500869|NCT03003520|79505281|FG001|Overall Study|Adverse Event|0|||
44500870|NCT03003520|79505280|FG000|Overall Study|Death|1|||
44500871|NCT03003520|79505281|FG001|Overall Study|Death|0|||
44500872|NCT03003520|79505280|FG000|Overall Study|Other reasons|4|||
44500873|NCT03003520|79505281|FG001|Overall Study|Other reasons|0|||
44500874|NCT03003520|79505280|FG000|Overall Study|Withdrawal by Subject|6|||
44563245|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
44563246|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
44563247|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
44563248|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
44563249|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
44563250|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
44563251|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
44563252|NCT00383435|79581949|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
44563253|NCT00383435|79581950|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
44563254|NCT00383435|79581951|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
44563255|NCT00383435|79581952|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
44563256|NCT00383435|79581953|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
44563257|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
44563258|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
44563259|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
44563260|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
44563261|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
44563262|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
44563263|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
44563264|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
44563265|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
44563266|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
44563267|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
44563268|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
44563269|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
44563270|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
44563271|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
44563272|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
44563273|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
44563274|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
44563275|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
44563276|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
44563277|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
44233478|NCT02151981|79052288|FG001|Overall Study|Study terminated|1|||
44233479|NCT01981720|79052307|FG000|Overall Study|Adverse Event|1|||
44233480|NCT01981720|79052307|FG000|Overall Study|Withdrawal by Subject|3|||
44233481|NCT01981720|79052307|FG000|Overall Study|Pregnancy|1|||
44233482|NCT01974440|79052317|FG000|Overall Study|Lost to Follow-up|8|||
44233483|NCT01974440|79052318|FG001|Overall Study|Lost to Follow-up|7|||
44233484|NCT01974440|79052317|FG000|Overall Study|Withdrawal by Subject|20|||
44233485|NCT01974440|79052318|FG001|Overall Study|Withdrawal by Subject|19|||
44233486|NCT01974440|79052317|FG000|Overall Study|Ongoing|112|||
44233487|NCT01974440|79052318|FG001|Overall Study|Ongoing|116|||
44233488|NCT01802281|79052335|FG000|Overall Study|Death|1|||
44233489|NCT01802281|79052336|FG001|Overall Study|Death|2|||
44233490|NCT01802281|79052335|FG000|Overall Study|Withdrawal by Subject|2|||
44233491|NCT01802281|79052336|FG001|Overall Study|Withdrawal by Subject|1|||
44233492|NCT01802281|79052335|FG000|Overall Study|Ineligible|5|||
44233493|NCT01802281|79052336|FG001|Overall Study|Ineligible|3|||
44233494|NCT01678898|79052359|FG000|PB-102-F01|Adverse Event|0|||
44233495|NCT01678898|79052360|FG001|PB-102-F01|Adverse Event|1|||
44233496|NCT01678898|79052361|FG002|PB-102-F01|Adverse Event|0|||
44233497|NCT01678898|79052359|FG000|PB-102-F01|Physician Decision|0|||
44233498|NCT01678898|79052360|FG001|PB-102-F01|Physician Decision|1|||
44233499|NCT01678898|79052361|FG002|PB-102-F01|Physician Decision|0|||
44233500|NCT01485861|79052388|FG000|Phase Ib|Death|1|||
44233501|NCT01485861|79052389|FG001|Phase Ib|Death|0|||
44233502|NCT01485861|79052390|FG002|Phase Ib|Death|0|||
44233503|NCT01485861|79052391|FG003|Phase Ib|Death|0|||
44233504|NCT01485861|79052392|FG004|Phase Ib|Death|0|||
44233505|NCT01485861|79052393|FG005|Phase Ib|Death|0|||
44233506|NCT01485861|79052388|FG000|Phase Ib|Physician Decision|1|||
44233507|NCT01485861|79052389|FG001|Phase Ib|Physician Decision|1|||
44233508|NCT01485861|79052390|FG002|Phase Ib|Physician Decision|0|||
44233509|NCT01485861|79052391|FG003|Phase Ib|Physician Decision|0|||
44233510|NCT01485861|79052392|FG004|Phase Ib|Physician Decision|0|||
44233511|NCT01485861|79052393|FG005|Phase Ib|Physician Decision|0|||
44233512|NCT01485861|79052388|FG000|Phase Ib|Adverse Event|0|||
44233513|NCT01485861|79052389|FG001|Phase Ib|Adverse Event|4|||
44233514|NCT01485861|79052390|FG002|Phase Ib|Adverse Event|0|||
44233515|NCT01485861|79052391|FG003|Phase Ib|Adverse Event|0|||
44233516|NCT01485861|79052392|FG004|Phase Ib|Adverse Event|0|||
44233517|NCT01485861|79052393|FG005|Phase Ib|Adverse Event|0|||
44233518|NCT01485861|79052388|FG000|Phase Ib|Progression of disease|5|||
44233519|NCT01485861|79052389|FG001|Phase Ib|Progression of disease|0|||
44233520|NCT01485861|79052390|FG002|Phase Ib|Progression of disease|0|||
44233521|NCT01485861|79052391|FG003|Phase Ib|Progression of disease|0|||
44233522|NCT01485861|79052392|FG004|Phase Ib|Progression of disease|0|||
44233523|NCT01485861|79052393|FG005|Phase Ib|Progression of disease|0|||
44233524|NCT01485861|79052388|FG000|Phase Ib|Other|3|||
44233525|NCT01485861|79052389|FG001|Phase Ib|Other|0|||
44233526|NCT01485861|79052390|FG002|Phase Ib|Other|0|||
44233527|NCT01485861|79052391|FG003|Phase Ib|Other|0|||
44233528|NCT01485861|79052392|FG004|Phase Ib|Other|0|||
44233529|NCT01485861|79052393|FG005|Phase Ib|Other|0|||
44233530|NCT01485861|79052388|FG000|Phase Ib|Withdrawal by Subject|4|||
44233531|NCT01485861|79052389|FG001|Phase Ib|Withdrawal by Subject|1|||
44233532|NCT01485861|79052390|FG002|Phase Ib|Withdrawal by Subject|0|||
44233533|NCT01485861|79052391|FG003|Phase Ib|Withdrawal by Subject|0|||
44233534|NCT01485861|79052392|FG004|Phase Ib|Withdrawal by Subject|0|||
44233535|NCT01485861|79052393|FG005|Phase Ib|Withdrawal by Subject|0|||
44233536|NCT01485861|79052388|FG000|Phase II|Death|0|||
44233537|NCT01485861|79052389|FG001|Phase II|Death|0|||
44233538|NCT01485861|79052390|FG002|Phase II|Death|67|||
44233539|NCT01485861|79052391|FG003|Phase II|Death|71|||
44233540|NCT01485861|79052392|FG004|Phase II|Death|68|||
44233541|NCT01485861|79052393|FG005|Phase II|Death|0|||
44233542|NCT01485861|79052388|FG000|Phase II|Progression of Disease|0|||
44233543|NCT01485861|79052389|FG001|Phase II|Progression of Disease|0|||
44233544|NCT01485861|79052390|FG002|Phase II|Progression of Disease|1|||
44233545|NCT01485861|79052391|FG003|Phase II|Progression of Disease|0|||
44233546|NCT01485861|79052392|FG004|Phase II|Progression of Disease|0|||
44233547|NCT01485861|79052393|FG005|Phase II|Progression of Disease|0|||
44233548|NCT01485861|79052388|FG000|Phase II|Other|0|||
44233549|NCT01485861|79052389|FG001|Phase II|Other|0|||
44233550|NCT01485861|79052390|FG002|Phase II|Other|0|||
44233551|NCT01485861|79052391|FG003|Phase II|Other|1|||
44233552|NCT01485861|79052392|FG004|Phase II|Other|0|||
44233553|NCT01485861|79052393|FG005|Phase II|Other|0|||
44233554|NCT01485861|79052388|FG000|Phase II|Withdrawal by Subject|0|||
44233555|NCT01485861|79052389|FG001|Phase II|Withdrawal by Subject|0|||
44233556|NCT01485861|79052390|FG002|Phase II|Withdrawal by Subject|6|||
44233557|NCT01485861|79052391|FG003|Phase II|Withdrawal by Subject|3|||
44233558|NCT01485861|79052392|FG004|Phase II|Withdrawal by Subject|4|||
44233559|NCT01485861|79052393|FG005|Phase II|Withdrawal by Subject|0|||
44233560|NCT01485861|79052388|FG000|Phase II|Lost to Follow-up|0|||
44233561|NCT01485861|79052389|FG001|Phase II|Lost to Follow-up|0|||
44233562|NCT01485861|79052390|FG002|Phase II|Lost to Follow-up|2|||
44233563|NCT01485861|79052391|FG003|Phase II|Lost to Follow-up|3|||
44233564|NCT01485861|79052392|FG004|Phase II|Lost to Follow-up|5|||
44233565|NCT01485861|79052393|FG005|Phase II|Lost to Follow-up|0|||
44233566|NCT01485861|79052388|FG000|Phase II|Study Ended|0|||
44233567|NCT01485861|79052389|FG001|Phase II|Study Ended|0|||
44233568|NCT01485861|79052390|FG002|Phase II|Study Ended|7|||
44233569|NCT01485861|79052391|FG003|Phase II|Study Ended|8|||
44233570|NCT01485861|79052392|FG004|Phase II|Study Ended|6|||
44233571|NCT01485861|79052393|FG005|Phase II|Study Ended|0|||
44233572|NCT01485861|79052388|FG000|Safety Phase|Death|0|||
44233573|NCT01485861|79052389|FG001|Safety Phase|Death|0|||
44233574|NCT01485861|79052390|FG002|Safety Phase|Death|0|||
44233575|NCT01485861|79052391|FG003|Safety Phase|Death|0|||
44233576|NCT01485861|79052392|FG004|Safety Phase|Death|0|||
44233577|NCT01485861|79052393|FG005|Safety Phase|Death|2|||
44233578|NCT01485861|79052388|FG000|Safety Phase|Adverse Event|0|||
44233579|NCT01485861|79052389|FG001|Safety Phase|Adverse Event|0|||
44233580|NCT01485861|79052390|FG002|Safety Phase|Adverse Event|0|||
44233581|NCT01485861|79052391|FG003|Safety Phase|Adverse Event|0|||
44233582|NCT01485861|79052392|FG004|Safety Phase|Adverse Event|0|||
44233583|NCT01485861|79052393|FG005|Safety Phase|Adverse Event|1|||
44233584|NCT01485861|79052388|FG000|Safety Phase|Other|0|||
44233585|NCT01485861|79052389|FG001|Safety Phase|Other|0|||
44233586|NCT01485861|79052390|FG002|Safety Phase|Other|0|||
44233587|NCT01485861|79052391|FG003|Safety Phase|Other|0|||
44233588|NCT01485861|79052392|FG004|Safety Phase|Other|0|||
44233589|NCT01485861|79052393|FG005|Safety Phase|Other|5|||
44233590|NCT01485861|79052388|FG000|Safety Phase|Progression of Disease|0|||
44233591|NCT01485861|79052389|FG001|Safety Phase|Progression of Disease|0|||
44233592|NCT01485861|79052390|FG002|Safety Phase|Progression of Disease|0|||
44233593|NCT01485861|79052391|FG003|Safety Phase|Progression of Disease|0|||
44233594|NCT01485861|79052392|FG004|Safety Phase|Progression of Disease|0|||
44233595|NCT01485861|79052393|FG005|Safety Phase|Progression of Disease|9|||
44233596|NCT01485861|79052388|FG000|Safety Phase|Withdrawal by Subject|0|||
44233597|NCT01485861|79052389|FG001|Safety Phase|Withdrawal by Subject|0|||
44233598|NCT01485861|79052390|FG002|Safety Phase|Withdrawal by Subject|0|||
44233599|NCT01485861|79052391|FG003|Safety Phase|Withdrawal by Subject|0|||
44233600|NCT01485861|79052392|FG004|Safety Phase|Withdrawal by Subject|0|||
44233601|NCT01485861|79052393|FG005|Safety Phase|Withdrawal by Subject|6|||
44233602|NCT01485861|79052388|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
44233603|NCT01485861|79052389|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
44563278|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
44563279|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
44563280|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
44563281|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
44563282|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
44563283|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
44563284|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
44563285|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
44563286|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
44563287|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
44233604|NCT01485861|79052390|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
44233605|NCT01485861|79052391|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
44233606|NCT01485861|79052392|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
44563288|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
44563289|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
44563290|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
44563291|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
44563292|NCT00383435|79581949|FG000|26-Week Treatment Safety Extension|Administrative|1|||
44233607|NCT01485861|79052393|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
44233608|NCT01101438|79052427|FG000|Overall Study|Withdrawal by Subject|8|||
44233609|NCT01101438|79052428|FG001|Overall Study|Withdrawal by Subject|9|||
44233610|NCT00966979|79052438|FG000|Overall Study|Death|1|||
44233611|NCT00966979|79052438|FG000|Overall Study|Lost to Follow-up|6|||
44233612|NCT00966979|79052438|FG000|Overall Study|Withdrawal by Subject|14|||
44233613|NCT00966979|79052438|FG000|Overall Study|Adverse Event|5|||
44563293|NCT00383435|79581950|FG001|26-Week Treatment Safety Extension|Administrative|1|||
44563294|NCT00383435|79581951|FG002|26-Week Treatment Safety Extension|Administrative|0|||
44563295|NCT00383435|79581952|FG003|26-Week Treatment Safety Extension|Administrative|1|||
44563296|NCT00383435|79581953|FG004|26-Week Treatment Safety Extension|Administrative|0|||
44563297|NCT03157037|79581965|FG000|Overall Study|Death|1|||
44563298|NCT00381485|79581987|FG000|Open-Label Run-In Period|Adverse Event|9|||
44563299|NCT00381485|79581988|FG001|Open-Label Run-In Period|Adverse Event|0|||
44563300|NCT00381485|79581989|FG002|Open-Label Run-In Period|Adverse Event|0|||
44563301|NCT00381485|79581990|FG003|Open-Label Run-In Period|Adverse Event|0|||
44563302|NCT00381485|79581987|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
44563303|NCT00381485|79581988|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
44563304|NCT00381485|79581989|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
44563305|NCT00381485|79581990|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
44563306|NCT00381485|79581987|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
44563307|NCT00381485|79581988|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
44563308|NCT00381485|79581989|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
44563309|NCT00381485|79581990|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
44563310|NCT00381485|79581987|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
44563311|NCT00381485|79581988|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
44563312|NCT00381485|79581989|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
44563313|NCT00381485|79581990|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
44563314|NCT00381485|79581987|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
44563315|NCT00381485|79581988|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
44563316|NCT00381485|79581989|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
44563317|NCT00381485|79581990|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
44563318|NCT00381485|79581987|FG000|Open-Label Run-In Period|Treatment failure|1|||
44563319|NCT00381485|79581988|FG001|Open-Label Run-In Period|Treatment failure|0|||
44563320|NCT00381485|79581989|FG002|Open-Label Run-In Period|Treatment failure|0|||
44563321|NCT00381485|79581990|FG003|Open-Label Run-In Period|Treatment failure|0|||
44563322|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44563323|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Adverse Event|2|||
44563324|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Adverse Event|2|||
44563325|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Adverse Event|5|||
44563326|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
44563327|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
44563328|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
44563329|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
44563330|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44563331|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
44563332|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
44563333|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
44563334|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
44563335|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
44563336|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
44563337|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
44563338|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
44563339|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
44563340|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
44563341|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
44563342|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
44563343|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
44563344|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
44563345|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
44563346|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
44563347|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
44563348|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
44563349|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
44563350|NCT00381485|79581987|FG000|Double-Blind Treatment Period|Administrative|0|||
44563351|NCT00381485|79581988|FG001|Double-Blind Treatment Period|Administrative|1|||
44563352|NCT00381485|79581989|FG002|Double-Blind Treatment Period|Administrative|0|||
44563353|NCT00381485|79581990|FG003|Double-Blind Treatment Period|Administrative|1|||
44563354|NCT02840474|79582001|FG000|Overall Study|Lost to Follow-up|1|||
44563355|NCT02840474|79582002|FG001|Overall Study|Lost to Follow-up|0|||
44563356|NCT03155945|79582010|FG000|Overall Study|Lost to Follow-up|0|||
44563357|NCT03155945|79582011|FG001|Overall Study|Lost to Follow-up|1|||
44563358|NCT03155945|79582010|FG000|Overall Study|Withdrawal by Subject|0|||
44563359|NCT03155945|79582011|FG001|Overall Study|Withdrawal by Subject|1|||
44563360|NCT03155945|79582010|FG000|Overall Study|Other Reason|0|||
44563361|NCT03155945|79582011|FG001|Overall Study|Other Reason|1|||
44563362|NCT03160703|79582021|FG000|Overall Study|Withdrawal by Subject|0|||
44563363|NCT03160703|79582022|FG001|Overall Study|Withdrawal by Subject|0|||
44563364|NCT03160703|79582023|FG002|Overall Study|Withdrawal by Subject|0|||
44563365|NCT03160703|79582024|FG003|Overall Study|Withdrawal by Subject|1|||
44563366|NCT03159611|79582036|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
44563367|NCT03159611|79582037|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
44563368|NCT03159611|79582036|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
44563369|NCT03159611|79582037|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
44563370|NCT03159611|79582036|FG000|Overall Study|Protocol Violation|7|||
44563371|NCT03159611|79582037|FG001|Overall Study|Protocol Violation|4|||
44563372|NCT03159611|79582036|FG000|Overall Study|Adverse Event|1|||
44563373|NCT03159611|79582037|FG001|Overall Study|Adverse Event|0|||
44563374|NCT03159611|79582036|FG000|Overall Study|Withdrawal by Subject|1|||
44563375|NCT03159611|79582037|FG001|Overall Study|Withdrawal by Subject|1|||
44563376|NCT03159611|79582036|FG000|Overall Study|Non-compliance with protocol requirement|3|||
44563377|NCT03159611|79582037|FG001|Overall Study|Non-compliance with protocol requirement|2|||
44563378|NCT03159611|79582036|FG000|Overall Study|Inability to perform procedures|1|||
44563379|NCT03159611|79582037|FG001|Overall Study|Inability to perform procedures|0|||
44563380|NCT03159455|79582049|FG000|Overall Study|Adverse Event|0|||
44563381|NCT03159455|79582050|FG001|Overall Study|Adverse Event|0|||
44563382|NCT03159455|79582051|FG002|Overall Study|Adverse Event|0|||
44563383|NCT03159455|79582052|FG003|Overall Study|Adverse Event|0|||
44563384|NCT03159455|79582053|FG004|Overall Study|Adverse Event|0|||
44563385|NCT03159455|79582054|FG005|Overall Study|Adverse Event|1|||
44563386|NCT02838134|79582074|FG000|Overall Study|Lost to Follow-up|1|||
44563387|NCT02838134|79582075|FG001|Overall Study|Lost to Follow-up|2|||
44563388|NCT02838134|79582074|FG000|Overall Study|logistic problems|1|||
44563389|NCT02838134|79582075|FG001|Overall Study|logistic problems|1|||
44563390|NCT03150589|79582083|FG000|Overall Study|Withdrawal by Subject|16|||
44563391|NCT03150589|79582084|FG001|Overall Study|Withdrawal by Subject|9|||
44563392|NCT03150589|79582083|FG000|Overall Study|Adverse Event|7|||
44563393|NCT03150589|79582084|FG001|Overall Study|Adverse Event|6|||
44563394|NCT03150589|79582083|FG000|Overall Study|Protocol Violation|4|||
44563395|NCT03150589|79582084|FG001|Overall Study|Protocol Violation|3|||
44563396|NCT03150589|79582083|FG000|Overall Study|Lost to Follow-up|3|||
44563397|NCT03150589|79582084|FG001|Overall Study|Lost to Follow-up|3|||
44563398|NCT03150589|79582083|FG000|Overall Study|Death|2|||
44563399|NCT03150589|79582084|FG001|Overall Study|Death|3|||
44563400|NCT03150589|79582083|FG000|Overall Study|IP non-compliance and other reasons|12|||
44563401|NCT03150589|79582084|FG001|Overall Study|IP non-compliance and other reasons|3|||
44563402|NCT02835092|79582093|FG000|Overall Study|Withdrawal by Subject|3|||
44563403|NCT02835092|79582094|FG001|Overall Study|Withdrawal by Subject|6|||
44563404|NCT02835092|79582095|FG002|Overall Study|Withdrawal by Subject|3|||
44563405|NCT02835092|79582093|FG000|Overall Study|Lost to Follow-up|0|||
44563406|NCT02835092|79582094|FG001|Overall Study|Lost to Follow-up|2|||
44563407|NCT02835092|79582095|FG002|Overall Study|Lost to Follow-up|0|||
44563408|NCT03145207|79582103|FG000|Overall Study|volunteer started taking allergy shots|1|||
44563409|NCT03145207|79582103|FG000|Overall Study|baseline blood pressure high|1|||
44563410|NCT02836652|79582120|FG000|Overall Study|Death|3|||
44563411|NCT02836652|79582121|FG001|Overall Study|Death|3|||
44563412|NCT02836652|79582120|FG000|Overall Study|Transplant/Explant|3|||
44563413|NCT02836652|79582121|FG001|Overall Study|Transplant/Explant|4|||
44563414|NCT02836652|79582120|FG000|Overall Study|Withdrawn|9|||
44563415|NCT02836652|79582121|FG001|Overall Study|Withdrawn|9|||
44563416|NCT02836652|79582120|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
44563417|NCT02836652|79582121|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
44563418|NCT02836496|79582129|FG000|Overall Study|Adverse Event|2|||
44563419|NCT02836496|79582130|FG001|Overall Study|Adverse Event|1|||
44233614|NCT00966979|79052438|FG000|Overall Study|Sponsor terminated early|49|||
44233615|NCT00966979|79052438|FG000|Overall Study|Censored because surgery not done|2|||
44563420|NCT02836496|79582129|FG000|Overall Study|Withdrawal by Subject|0|||
44563421|NCT02836496|79582130|FG001|Overall Study|Withdrawal by Subject|1|||
44563422|NCT04213807|79582139|FG000|Overall Study|Physician Decision|0|||
44563423|NCT04213807|79582140|FG001|Overall Study|Physician Decision|0|||
44563424|NCT04213807|79582141|FG002|Overall Study|Physician Decision|1|||
44563425|NCT00577577|79582160|FG000|Overall Study|Adverse Event|3|||
44563426|NCT00577577|79582161|FG001|Overall Study|Adverse Event|2|||
44563427|NCT00577577|79582160|FG000|Overall Study|Lost to Follow-up|1|||
44563428|NCT00577577|79582161|FG001|Overall Study|Lost to Follow-up|0|||
44563429|NCT00577577|79582160|FG000|Overall Study|Protocol Violation|0|||
44563430|NCT00577577|79582161|FG001|Overall Study|Protocol Violation|3|||
44563431|NCT00577577|79582160|FG000|Overall Study|Transportation|1|||
44563432|NCT00577577|79582161|FG001|Overall Study|Transportation|0|||
44563433|NCT02833844|79582169|FG000|Double-Blind Period|Withdrawal by Subject|2|||
44563434|NCT02833844|79582170|FG001|Double-Blind Period|Withdrawal by Subject|3|||
44563435|NCT02833844|79582169|FG000|Double-Blind Period|Protocol Violation|0|||
44563436|NCT02833844|79582170|FG001|Double-Blind Period|Protocol Violation|4|||
44563437|NCT02833844|79582169|FG000|Open-Label Period|Death|0|||
44563438|NCT02833844|79582170|FG001|Open-Label Period|Death|2|||
44563439|NCT02833844|79582169|FG000|Open-Label Period|Lost to Follow-up|1|||
44563440|NCT02833844|79582170|FG001|Open-Label Period|Lost to Follow-up|0|||
44563441|NCT02833844|79582169|FG000|Open-Label Period|Withdrawal by Subject|1|||
44563442|NCT02833844|79582170|FG001|Open-Label Period|Withdrawal by Subject|0|||
44563443|NCT01341782|79582180|FG000|Overall Study|Adverse Event|1|||
44563444|NCT01341782|79582181|FG001|Overall Study|Adverse Event|1|||
44563445|NCT01341782|79582180|FG000|Overall Study|Withdrawal by Subject|6|||
44563446|NCT01341782|79582181|FG001|Overall Study|Withdrawal by Subject|5|||
44563447|NCT01341782|79582180|FG000|Overall Study|Missed 3 consecutive doses|0|||
44563448|NCT01341782|79582181|FG001|Overall Study|Missed 3 consecutive doses|4|||
44563449|NCT01341782|79582180|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
44563450|NCT01341782|79582181|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
44563451|NCT01341782|79582180|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
44563452|NCT01341782|79582181|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
44563453|NCT01341782|79582180|FG000|Overall Study|Other|5|||
44563454|NCT01341782|79582181|FG001|Overall Study|Other|0|||
44563455|NCT01341470|79582193|FG000|Overall Study|Sponsor decision|0|||
44563456|NCT01341470|79582194|FG001|Overall Study|Sponsor decision|0|||
44563457|NCT01341470|79582195|FG002|Overall Study|Sponsor decision|1|||
44563458|NCT01341470|79582196|FG003|Overall Study|Sponsor decision|1|||
44563459|NCT01341470|79582197|FG004|Overall Study|Sponsor decision|0|||
44563460|NCT01341470|79582198|FG005|Overall Study|Sponsor decision|1|||
44563461|NCT03143101|79582217|FG000|Overall Study|Withdrawal by Subject|0|||
44563462|NCT03143101|79582218|FG001|Overall Study|Withdrawal by Subject|1|||
44563463|NCT03143101|79582219|FG002|Overall Study|Withdrawal by Subject|0|||
44563464|NCT03143101|79582217|FG000|Overall Study|Lost to Follow-up|2|||
44563465|NCT03143101|79582218|FG001|Overall Study|Lost to Follow-up|2|||
44563466|NCT03143101|79582219|FG002|Overall Study|Lost to Follow-up|0|||
44563467|NCT00871351|79582230|FG000|Overall Study|Withdrawal by Subject|1|||
44563468|NCT00871351|79582231|FG001|Overall Study|Withdrawal by Subject|0|||
44275434|NCT02609828|79221908|FG001|Overall Study|Insufficient clinical response|1|||
44275435|NCT02609828|79221909|FG002|Overall Study|Insufficient clinical response|0|||
44275436|NCT02609828|79221910|FG003|Overall Study|Insufficient clinical response|0|||
44275437|NCT02609828|79221907|FG000|Overall Study|Lost to Follow-up|0|||
44275438|NCT02609828|79221908|FG001|Overall Study|Lost to Follow-up|0|||
44563469|NCT00871351|79582232|FG002|Overall Study|Withdrawal by Subject|0|||
44563470|NCT00871351|79582230|FG000|Overall Study|Adverse Event|3|||
44563471|NCT00871351|79582231|FG001|Overall Study|Adverse Event|1|||
44563472|NCT00871351|79582232|FG002|Overall Study|Adverse Event|0|||
44563473|NCT02745080|79582242|FG000|Overall Study|Adverse Event|13|||
44563474|NCT02745080|79582243|FG001|Overall Study|Adverse Event|21|||
44563475|NCT02745080|79582242|FG000|Overall Study|Lack of Efficacy|11|||
44563476|NCT02745080|79582243|FG001|Overall Study|Lack of Efficacy|23|||
44563477|NCT02745080|79582242|FG000|Overall Study|Lost to Follow-up|3|||
44563478|NCT02745080|79582243|FG001|Overall Study|Lost to Follow-up|3|||
44563479|NCT02745080|79582242|FG000|Overall Study|Physician Decision|3|||
44563480|NCT02745080|79582243|FG001|Overall Study|Physician Decision|0|||
44563481|NCT02745080|79582242|FG000|Overall Study|Protocol Violation|3|||
44563482|NCT02745080|79582243|FG001|Overall Study|Protocol Violation|1|||
44563483|NCT02745080|79582242|FG000|Overall Study|Withdrawal by Subject|22|||
44563484|NCT02745080|79582243|FG001|Overall Study|Withdrawal by Subject|41|||
44563485|NCT00521599|79582253|FG000|Overall Study|Adverse Event|5|||
44563486|NCT00521599|79582254|FG001|Overall Study|Adverse Event|7|||
44563487|NCT00521599|79582255|FG002|Overall Study|Adverse Event|6|||
44563488|NCT00521599|79582253|FG000|Overall Study|Treatment Failure|8|||
44563489|NCT00521599|79582254|FG001|Overall Study|Treatment Failure|9|||
44563490|NCT00521599|79582255|FG002|Overall Study|Treatment Failure|22|||
44563491|NCT00521599|79582253|FG000|Overall Study|Lost to Follow-up|2|||
44563492|NCT00521599|79582254|FG001|Overall Study|Lost to Follow-up|1|||
44563493|NCT00521599|79582255|FG002|Overall Study|Lost to Follow-up|2|||
44563494|NCT00521599|79582253|FG000|Overall Study|Withdrawal by Subject|3|||
44563495|NCT00521599|79582254|FG001|Overall Study|Withdrawal by Subject|5|||
44563496|NCT00521599|79582255|FG002|Overall Study|Withdrawal by Subject|1|||
44563497|NCT00521599|79582253|FG000|Overall Study|Withdrawal by subject treatment related|3|||
44563498|NCT00521599|79582254|FG001|Overall Study|Withdrawal by subject treatment related|1|||
44563499|NCT00521599|79582255|FG002|Overall Study|Withdrawal by subject treatment related|2|||
44563500|NCT00521599|79582253|FG000|Overall Study|Protocol Violation|2|||
44563501|NCT00521599|79582254|FG001|Overall Study|Protocol Violation|4|||
44563502|NCT00521599|79582255|FG002|Overall Study|Protocol Violation|2|||
44563503|NCT00521599|79582253|FG000|Overall Study|Did not meet protocol eligibility|2|||
44563504|NCT00521599|79582254|FG001|Overall Study|Did not meet protocol eligibility|2|||
44563505|NCT00521599|79582255|FG002|Overall Study|Did not meet protocol eligibility|1|||
44563506|NCT00442897|79582266|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
44563507|NCT00442897|79582267|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
44563508|NCT00442897|79582266|FG000|Base Study (12 Week Follow-up)|Death|0|||
44563509|NCT00442897|79582267|FG001|Base Study (12 Week Follow-up)|Death|1|||
44563510|NCT00442897|79582266|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
44563511|NCT00442897|79582267|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
44563512|NCT00442897|79582266|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
44563513|NCT00442897|79582267|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
44563514|NCT00442897|79582266|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
44563515|NCT00442897|79582267|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
44563516|NCT00442897|79582266|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
44563517|NCT00442897|79582267|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
44500875|NCT03003520|79505281|FG001|Overall Study|Withdrawal by Subject|0|||
44500876|NCT03003520|79505280|FG000|Overall Study|Progressive disease|9|||
44500877|NCT03003520|79505281|FG001|Overall Study|Progressive disease|1|||
44500878|NCT02958527|79505304|FG000|Overall Study|Not collected CRFs|12|||
44500879|NCT02586025|79505326|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
44500880|NCT02586025|79505327|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
44500881|NCT02586025|79505326|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
44500882|NCT02586025|79505327|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
44563518|NCT00442897|79582266|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
44563519|NCT00442897|79582267|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
44563520|NCT00442897|79582266|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
44563521|NCT00442897|79582267|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
44563522|NCT02834390|79582275|FG000|Induction Phase|Progressive disease|0|||
44563523|NCT02834390|79582276|FG001|Induction Phase|Progressive disease|1|||
44563524|NCT02834390|79582275|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
44563525|NCT02834390|79582276|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
44563526|NCT02834390|79582275|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
44563527|NCT02834390|79582276|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
44563528|NCT02834390|79582275|FG000|Consolidation Phase|Physician Decision|1|||
44563529|NCT02834390|79582276|FG001|Consolidation Phase|Physician Decision|1|||
44563530|NCT03141151|79582284|FG000|Overall Study|Lost to Follow-up|3|||
44563531|NCT03141151|79582285|FG001|Overall Study|Lost to Follow-up|2|||
44563532|NCT03141151|79582284|FG000|Overall Study|Withdrawal by Subject|3|||
44563533|NCT03141151|79582285|FG001|Overall Study|Withdrawal by Subject|2|||
44563534|NCT01358708|79582293|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
44563535|NCT01358708|79582294|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44563536|NCT01358708|79582293|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
44563537|NCT01358708|79582294|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
44563538|NCT01356602|79582307|FG000|Overall Study|Protocol Deviation|0|||
44563539|NCT01356602|79582308|FG001|Overall Study|Protocol Deviation|1|||
44563540|NCT01356602|79582309|FG002|Overall Study|Protocol Deviation|1|||
44563541|NCT01356602|79582307|FG000|Overall Study|Administrative Problems|1|||
44563542|NCT01356602|79582308|FG001|Overall Study|Administrative Problems|4|||
44563543|NCT01356602|79582309|FG002|Overall Study|Administrative Problems|5|||
44563544|NCT01356602|79582307|FG000|Overall Study|Lost to Follow-up|4|||
44563545|NCT01356602|79582308|FG001|Overall Study|Lost to Follow-up|5|||
44563546|NCT01356602|79582309|FG002|Overall Study|Lost to Follow-up|6|||
44563547|NCT01356602|79582307|FG000|Overall Study|Withdrawal by Subject|4|||
44563548|NCT01356602|79582308|FG001|Overall Study|Withdrawal by Subject|3|||
44563549|NCT01356602|79582309|FG002|Overall Study|Withdrawal by Subject|7|||
44563550|NCT01356602|79582307|FG000|Overall Study|Lack of Efficacy|0|||
44563551|NCT01356602|79582308|FG001|Overall Study|Lack of Efficacy|1|||
44563552|NCT01356602|79582309|FG002|Overall Study|Lack of Efficacy|4|||
44563553|NCT01356602|79582307|FG000|Overall Study|Adverse Event|0|||
44563554|NCT01356602|79582308|FG001|Overall Study|Adverse Event|1|||
44563555|NCT01356602|79582309|FG002|Overall Study|Adverse Event|1|||
44563556|NCT02830880|79582317|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
44563557|NCT02830880|79582317|FG000|Overall Study|Death|1|||
44563558|NCT02830880|79582317|FG000|Overall Study|Physician Decision|1|||
44233616|NCT00966979|79052438|FG000|Overall Study|Censored because study device was not implanted|14|||
44563559|NCT03141307|79582323|FG000|In-Hospital|Withdrawal by Subject|0|||
44563560|NCT03141307|79582324|FG001|In-Hospital|Withdrawal by Subject|2|||
44563561|NCT03141307|79582323|FG000|In-Hospital|Protocol Violation|4|||
44563562|NCT03141307|79582324|FG001|In-Hospital|Protocol Violation|0|||
44563563|NCT03141307|79582323|FG000|Follow-Up|Lost to Follow-up|97|||
44563564|NCT03141307|79582324|FG001|Follow-Up|Lost to Follow-up|54|||
44563565|NCT02825420|79582332|FG000|Overall Study|Death|30|||
44563566|NCT02825420|79582333|FG001|Overall Study|Death|12|||
44563567|NCT02825420|79582332|FG000|Overall Study|Progressive disease|6|||
44563568|NCT02825420|79582333|FG001|Overall Study|Progressive disease|1|||
44563569|NCT02825420|79582332|FG000|Overall Study|Lost to Follow-up|2|||
44563570|NCT02825420|79582333|FG001|Overall Study|Lost to Follow-up|2|||
44563571|NCT02825420|79582332|FG000|Overall Study|Withdrawal by Subject|1|||
44563572|NCT02825420|79582333|FG001|Overall Study|Withdrawal by Subject|1|||
44563573|NCT02825420|79582332|FG000|Overall Study|Protocol amendment not signed|1|||
44563574|NCT02825420|79582333|FG001|Overall Study|Protocol amendment not signed|1|||
44563575|NCT02825420|79582332|FG000|Overall Study|Physician Decision|1|||
44563576|NCT02825420|79582333|FG001|Overall Study|Physician Decision|0|||
44563577|NCT02825420|79582332|FG000|Overall Study|Did not receive PLD|2|||
44563578|NCT02825420|79582333|FG001|Overall Study|Did not receive PLD|0|||
44563579|NCT02829944|79582346|FG000|Overall Study|Physician Decision|0|||
44563580|NCT02829944|79582347|FG001|Overall Study|Physician Decision|1|||
44563581|NCT02829944|79582346|FG000|Overall Study|Screen Failure|2|||
44563582|NCT02829944|79582347|FG001|Overall Study|Screen Failure|2|||
44563583|NCT02829944|79582346|FG000|Overall Study|Inadequate Neuraxial Block|1|||
44563584|NCT02829944|79582347|FG001|Overall Study|Inadequate Neuraxial Block|1|||
44563585|NCT02829944|79582346|FG000|Overall Study|Withdrawal by Subject|2|||
44563586|NCT02829944|79582347|FG001|Overall Study|Withdrawal by Subject|1|||
44563587|NCT02829944|79582346|FG000|Overall Study|Catheter Displacement|1|||
44563588|NCT02829944|79582347|FG001|Overall Study|Catheter Displacement|0|||
44563589|NCT02829944|79582346|FG000|Overall Study|Catheter broke|0|||
44563590|NCT02829944|79582347|FG001|Overall Study|Catheter broke|1|||
44563591|NCT02829944|79582346|FG000|Overall Study|Staff unavailable|0|||
44563592|NCT02829944|79582347|FG001|Overall Study|Staff unavailable|1|||
44563593|NCT02824562|79582355|FG000|Overall Study|Lost to Follow-up|3|||
44563594|NCT02824562|79582356|FG001|Overall Study|Lost to Follow-up|4|||
44563595|NCT02824562|79582355|FG000|Overall Study|Death|0|||
44563596|NCT02824562|79582356|FG001|Overall Study|Death|1|||
44563597|NCT02744066|79582364|FG000|Overall Study|Withdrawal by parent|0|||
44563598|NCT02744066|79582365|FG001|Overall Study|Withdrawal by parent|1|||
44563599|NCT02744066|79582364|FG000|Overall Study|Discharged from NICU prior to completion|0|||
44563600|NCT02744066|79582365|FG001|Overall Study|Discharged from NICU prior to completion|4|||
44563601|NCT01338818|79582373|FG000|Overall Study|Adverse Event|8|||
44563602|NCT01338818|79582373|FG000|Overall Study|Lack of Efficacy|5|||
44563603|NCT01338818|79582373|FG000|Overall Study|no longer require study drug|1|||
44563604|NCT01338818|79582373|FG000|Overall Study|Withdrawal by Subject|11|||
44563605|NCT01338818|79582373|FG000|Overall Study|Lost to Follow-up|4|||
44563606|NCT01338818|79582373|FG000|Overall Study|Administrative problems|3|||
44563607|NCT01338818|79582373|FG000|Overall Study|Protocol Deviation|4|||
44563608|NCT02823470|79582379|FG000|Overall Study|Adverse Event|1|||
44563609|NCT02823470|79582380|FG001|Overall Study|Adverse Event|0|||
44563610|NCT02823470|79582379|FG000|Overall Study|Study terminated by sponsor|8|||
44563611|NCT02823470|79582380|FG001|Overall Study|Study terminated by sponsor|15|||
44563612|NCT01371656|79582391|FG000|Overall Study|Death|7|||
44563613|NCT01371656|79582392|FG001|Overall Study|Death|4|||
44563614|NCT01371656|79582391|FG000|Overall Study|Physician Decision|46|||
44563615|NCT01371656|79582392|FG001|Overall Study|Physician Decision|7|||
44563616|NCT01371656|79582391|FG000|Overall Study|Withdrawal by Subject|7|||
44563617|NCT01371656|79582392|FG001|Overall Study|Withdrawal by Subject|0|||
44563618|NCT01371656|79582391|FG000|Overall Study|Ineligible|4|||
44563619|NCT01371656|79582392|FG001|Overall Study|Ineligible|3|||
44563620|NCT01354106|79582398|FG000|Overall Study|Withdrawal by Subject|2|||
44563621|NCT01354028|79582404|FG000|Overall Study|Physician Decision|0|||
44563622|NCT01354028|79582405|FG001|Overall Study|Physician Decision|2|||
44563623|NCT01354028|79582404|FG000|Overall Study|Discharged before study start|2|||
44563624|NCT01354028|79582405|FG001|Overall Study|Discharged before study start|2|||
44563625|NCT01354028|79582404|FG000|Overall Study|No quiet alert state|0|||
44563626|NCT01354028|79582405|FG001|Overall Study|No quiet alert state|1|||
44563627|NCT01354964|79582419|FG000|Overall Study|Lost to Follow-up|2|||
44563628|NCT01354964|79582420|FG001|Overall Study|Lost to Follow-up|0|||
44563629|NCT01354964|79582419|FG000|Overall Study|IV access issues|1|||
44563630|NCT01354964|79582420|FG001|Overall Study|IV access issues|1|||
44563631|NCT01354964|79582419|FG000|Overall Study|Physician Decision|1|||
44563632|NCT01354964|79582420|FG001|Overall Study|Physician Decision|0|||
44563633|NCT01354496|79582430|FG000|Period 1|Adverse Event|0|||
44563634|NCT01354496|79582431|FG001|Period 1|Adverse Event|0|||
44563635|NCT01354496|79582432|FG002|Period 1|Adverse Event|1|||
44563636|NCT01354496|79582433|FG003|Period 1|Adverse Event|0|||
44563637|NCT01354496|79582434|FG004|Period 1|Adverse Event|0|||
44563638|NCT01354496|79582435|FG005|Period 1|Adverse Event|0|||
44563639|NCT01354496|79582430|FG000|Period 1|Physician Decision|0|||
44563640|NCT01354496|79582431|FG001|Period 1|Physician Decision|0|||
44563641|NCT01354496|79582432|FG002|Period 1|Physician Decision|1|||
44563642|NCT01354496|79582433|FG003|Period 1|Physician Decision|0|||
44275439|NCT02609828|79221909|FG002|Overall Study|Lost to Follow-up|0|||
44233617|NCT00966979|79052438|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
44233618|NCT00931606|79052456|FG000|Overall Study|Death|1|||
44233619|NCT00931606|79052457|FG001|Overall Study|Death|3|||
44233620|NCT00931606|79052458|FG002|Overall Study|Death|2|||
44233621|NCT00931606|79052459|FG003|Overall Study|Death|0|||
44233622|NCT00931606|79052456|FG000|Overall Study|Lost to Follow-up|0|||
44233623|NCT00931606|79052457|FG001|Overall Study|Lost to Follow-up|1|||
44563643|NCT01354496|79582434|FG004|Period 1|Physician Decision|0|||
44563644|NCT01354496|79582435|FG005|Period 1|Physician Decision|0|||
44563645|NCT01354496|79582430|FG000|Period 2|Adverse Event|0|||
44563646|NCT01354496|79582431|FG001|Period 2|Adverse Event|0|||
44563647|NCT01354496|79582432|FG002|Period 2|Adverse Event|0|||
44563648|NCT01354496|79582433|FG003|Period 2|Adverse Event|1|||
44563649|NCT01354496|79582434|FG004|Period 2|Adverse Event|0|||
44563650|NCT01354496|79582435|FG005|Period 2|Adverse Event|0|||
44563651|NCT01354496|79582430|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
44563652|NCT01354496|79582431|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
44563653|NCT01354496|79582432|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
44563654|NCT01354496|79582433|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
44563655|NCT01354496|79582434|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
44563656|NCT01354496|79582435|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
44563657|NCT02822222|79582458|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
44563658|NCT02822222|79582459|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
44563659|NCT02821910|79582471|FG000|Overall Study|Withdrawal by Subject|0|||
44563660|NCT02821910|79582472|FG001|Overall Study|Withdrawal by Subject|0|||
44563661|NCT02821910|79582473|FG002|Overall Study|Withdrawal by Subject|1|||
44563662|NCT02821910|79582474|FG003|Overall Study|Withdrawal by Subject|0|||
44563663|NCT02821910|79582475|FG004|Overall Study|Withdrawal by Subject|0|||
44563664|NCT02821910|79582476|FG005|Overall Study|Withdrawal by Subject|1|||
44563665|NCT02821910|79582471|FG000|Overall Study|Other than specified|1|||
44563666|NCT02821910|79582472|FG001|Overall Study|Other than specified|0|||
44563667|NCT02821910|79582473|FG002|Overall Study|Other than specified|1|||
44563668|NCT02821910|79582474|FG003|Overall Study|Other than specified|0|||
44563669|NCT02821910|79582475|FG004|Overall Study|Other than specified|0|||
44563670|NCT02821910|79582476|FG005|Overall Study|Other than specified|0|||
44563671|NCT02817776|79582490|FG000|Overall Study|Excluded|33|||
44563672|NCT02817776|79582490|FG000|Overall Study|Lost to Follow-up|20|||
44563673|NCT02817776|79582490|FG000|Overall Study|Withdrawal by Subject|33|||
44563674|NCT02817776|79582490|FG000|Overall Study|Death|2|||
44563675|NCT03138655|79582502|FG000|Overall Study|Adverse Event|2|||
44563676|NCT03138655|79582503|FG001|Overall Study|Adverse Event|1|||
44563677|NCT03138655|79582504|FG002|Overall Study|Adverse Event|2|||
44563678|NCT03138655|79582505|FG003|Overall Study|Adverse Event|1|||
44563679|NCT03138655|79582506|FG004|Overall Study|Adverse Event|1|||
44563680|NCT03138655|79582507|FG005|Overall Study|Adverse Event|4|||
44563681|NCT03138655|79582508|FG006|Overall Study|Adverse Event|2|||
44563682|NCT03138655|79582509|FG007|Overall Study|Adverse Event|2|||
44563683|NCT03138655|79582502|FG000|Overall Study|Withdrawal by Subject|0|||
44233624|NCT00931606|79052458|FG002|Overall Study|Lost to Follow-up|0|||
44500883|NCT02586025|79505326|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
44500884|NCT02586025|79505327|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
44500885|NCT02586025|79505326|FG000|Neoadjuvant Treatment|Death|1|||
44500886|NCT02586025|79505327|FG001|Neoadjuvant Treatment|Death|0|||
44500887|NCT02586025|79505326|FG000|Neoadjuvant Treatment|Adverse Event|1|||
44500888|NCT02586025|79505327|FG001|Neoadjuvant Treatment|Adverse Event|0|||
44500889|NCT02586025|79505326|FG000|Neoadjuvant Treatment|Physician Decision|2|||
44500890|NCT02586025|79505327|FG001|Neoadjuvant Treatment|Physician Decision|1|||
44500891|NCT02586025|79505326|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
44500892|NCT02586025|79505327|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
44500893|NCT02586025|79505326|FG000|Adjuvant Treatment|Recurrent Disease|4|||
44500894|NCT02586025|79505327|FG001|Adjuvant Treatment|Recurrent Disease|5|||
44500895|NCT02586025|79505326|FG000|Adjuvant Treatment|Physician Decision|0|||
44500896|NCT02586025|79505327|FG001|Adjuvant Treatment|Physician Decision|1|||
44500897|NCT02586025|79505326|FG000|Adjuvant Treatment|Pregnancy|1|||
44500898|NCT02586025|79505327|FG001|Adjuvant Treatment|Pregnancy|0|||
44500899|NCT02586025|79505326|FG000|Treatment-Free Follow-Up|Death|11|||
44500900|NCT02586025|79505327|FG001|Treatment-Free Follow-Up|Death|11|||
44500901|NCT02586025|79505326|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
44500902|NCT02586025|79505327|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
44500903|NCT02586025|79505326|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
44500904|NCT02586025|79505327|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
44500905|NCT02586025|79505326|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
44563684|NCT03138655|79582503|FG001|Overall Study|Withdrawal by Subject|1|||
44233625|NCT00931606|79052459|FG003|Overall Study|Lost to Follow-up|0|||
44233626|NCT00931606|79052456|FG000|Overall Study|Physician Decision|0|||
44233627|NCT00931606|79052457|FG001|Overall Study|Physician Decision|0|||
44500906|NCT02586025|79505327|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
44500907|NCT02586025|79505326|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
44500908|NCT02586025|79505327|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
44500909|NCT01721577|79505345|FG000|Overall Study|Lack of Efficacy|1|||
44500910|NCT01721577|79505346|FG001|Overall Study|Lack of Efficacy|0|||
44500911|NCT01721577|79505345|FG000|Overall Study|Death|1|||
44500912|NCT01721577|79505346|FG001|Overall Study|Death|0|||
44500913|NCT01721577|79505345|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
44500914|NCT01721577|79505346|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
44500915|NCT01721577|79505345|FG000|Overall Study|Adverse Event|0|||
44500916|NCT01721577|79505346|FG001|Overall Study|Adverse Event|2|||
44500917|NCT01411332|79505363|FG000|Enrollment|Protocol Violation|0|||
44500918|NCT01411332|79505364|FG001|Enrollment|Protocol Violation|1|||
44500919|NCT01411332|79505363|FG000|Enrollment|Withdrawal by Subject|0|||
44500920|NCT01411332|79505364|FG001|Enrollment|Withdrawal by Subject|1|||
44500921|NCT01411332|79505363|FG000|Treatment|Lost to Follow-up|1|||
44500922|NCT01411332|79505364|FG001|Treatment|Lost to Follow-up|0|||
44514900|NCT03077698|79520767|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
44514901|NCT03077698|79520766|FG000|Safety Follow Up|Withdrawal by Subject|2|||
44514902|NCT03077698|79520767|FG001|Safety Follow Up|Withdrawal by Subject|1|||
44514903|NCT03077698|79520766|FG000|Safety Follow Up|Transfer of care to hospice|1|||
44514904|NCT03077698|79520767|FG001|Safety Follow Up|Transfer of care to hospice|0|||
44514905|NCT03079102|79520785|FG000|Overall Study|Physician Decision|0|||
44514906|NCT03079102|79520786|FG001|Overall Study|Physician Decision|1|||
44514907|NCT02434354|79520792|FG000|Overall Study|screen fail|3|||
44514908|NCT03076996|79520796|FG000|Overall Study|Withdrawal by Subject|2|||
44514909|NCT03076996|79520796|FG000|Overall Study|Lost to Follow-up|3|||
44514910|NCT03076996|79520796|FG000|Overall Study|Literacy precluded participation|1|||
44514911|NCT03078868|79520800|FG000|Overall Study|Physician Decision|3|||
44514912|NCT04524598|79520808|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
44514913|NCT04524598|79520809|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
44514914|NCT04524598|79520810|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
44514915|NCT04524598|79520811|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
44514916|NCT04524598|79520812|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
44514917|NCT04524598|79520808|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
44514918|NCT04524598|79520809|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
44514919|NCT04524598|79520810|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514920|NCT04524598|79520811|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514921|NCT04524598|79520812|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514922|NCT04524598|79520808|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
44514923|NCT04524598|79520809|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
44514924|NCT04524598|79520810|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
44514925|NCT04524598|79520811|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
44514926|NCT04524598|79520812|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
44514927|NCT04524598|79520808|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
44514928|NCT04524598|79520809|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
44514929|NCT04524598|79520810|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
44514930|NCT04524598|79520811|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
44514931|NCT04524598|79520812|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
44514932|NCT04524598|79520808|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514933|NCT04524598|79520809|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514934|NCT04524598|79520810|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
44514935|NCT04524598|79520811|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
44514936|NCT04524598|79520812|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514937|NCT04524598|79520808|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
44514938|NCT04524598|79520809|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
44514939|NCT04524598|79520810|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
44514940|NCT04524598|79520811|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
44514941|NCT04524598|79520812|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
44514942|NCT04524598|79520808|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514943|NCT04524598|79520809|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514944|NCT04524598|79520810|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514945|NCT04524598|79520811|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
44514946|NCT04524598|79520812|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
44514947|NCT03075904|79520826|FG000|Overall Study|Physician Decision|3|||
44514948|NCT03075904|79520826|FG000|Overall Study|Need for Medication not Permitted|1|||
44514949|NCT03073798|79520830|FG000|Overall Study|Adverse Event|1|||
44563685|NCT03138655|79582504|FG002|Overall Study|Withdrawal by Subject|0|||
44563686|NCT03138655|79582505|FG003|Overall Study|Withdrawal by Subject|0|||
44563687|NCT03138655|79582506|FG004|Overall Study|Withdrawal by Subject|0|||
44563688|NCT03138655|79582507|FG005|Overall Study|Withdrawal by Subject|0|||
44563689|NCT03138655|79582508|FG006|Overall Study|Withdrawal by Subject|1|||
44563690|NCT03138655|79582509|FG007|Overall Study|Withdrawal by Subject|0|||
44563691|NCT03138655|79582502|FG000|Overall Study|Reason not Specified|1|||
44563692|NCT03138655|79582503|FG001|Overall Study|Reason not Specified|0|||
44563693|NCT03138655|79582504|FG002|Overall Study|Reason not Specified|0|||
44563694|NCT03138655|79582505|FG003|Overall Study|Reason not Specified|2|||
44563695|NCT03138655|79582506|FG004|Overall Study|Reason not Specified|1|||
44563696|NCT03138655|79582507|FG005|Overall Study|Reason not Specified|1|||
44563697|NCT03138655|79582508|FG006|Overall Study|Reason not Specified|0|||
44563698|NCT03138655|79582509|FG007|Overall Study|Reason not Specified|0|||
44563699|NCT02820038|79582535|FG000|Overall Study|Lost to Follow-up|7|||
44563700|NCT02820038|79582536|FG001|Overall Study|Lost to Follow-up|11|||
44563701|NCT02820038|79582537|FG002|Overall Study|Lost to Follow-up|2|||
44563702|NCT02820038|79582538|FG003|Overall Study|Lost to Follow-up|9|||
44563703|NCT02820038|79582535|FG000|Overall Study|Withdrawal by Subject|3|||
44563704|NCT02820038|79582536|FG001|Overall Study|Withdrawal by Subject|14|||
44563705|NCT02820038|79582537|FG002|Overall Study|Withdrawal by Subject|3|||
44563706|NCT02820038|79582538|FG003|Overall Study|Withdrawal by Subject|13|||
44563707|NCT02819804|79582549|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
44563708|NCT02819726|79582556|FG000|Part A (All Participants)|Lost to Follow-up|0|||
44563709|NCT02819726|79582557|FG001|Part A (All Participants)|Lost to Follow-up|1|||
44563710|NCT02819726|79582558|FG002|Part A (All Participants)|Lost to Follow-up|0|||
44563711|NCT02819726|79582559|FG003|Part A (All Participants)|Lost to Follow-up|0|||
44563712|NCT02819726|79582556|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
44563713|NCT02819726|79582557|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
44563714|NCT02819726|79582558|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
44563715|NCT02819726|79582559|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
44563716|NCT02819726|79582556|FG000|Part A (All Participants)|Protocol non-compliance|3|||
44563717|NCT02819726|79582557|FG001|Part A (All Participants)|Protocol non-compliance|4|||
44563718|NCT02819726|79582558|FG002|Part A (All Participants)|Protocol non-compliance|5|||
44563719|NCT02819726|79582559|FG003|Part A (All Participants)|Protocol non-compliance|0|||
44563720|NCT02819726|79582556|FG000|Part B (All Participants)|Lost to Follow-up|1|||
44563721|NCT02819726|79582557|FG001|Part B (All Participants)|Lost to Follow-up|1|||
44500923|NCT04881747|79505391|FG000|Period 2 Washout|Adverse Event|1|||
44500924|NCT04881747|79505392|FG001|Period 2 Washout|Adverse Event|0|||
44500925|NCT04881747|79505393|FG002|Period 2 Washout|Adverse Event|0|||
44500926|NCT04881747|79505394|FG003|Period 2 Washout|Adverse Event|0|||
44500927|NCT04881747|79505395|FG004|Period 2 Washout|Adverse Event|1|||
44500928|NCT04881747|79505396|FG005|Period 2 Washout|Adverse Event|0|||
44500929|NCT04881747|79505391|FG000|Period 2 Washout|Withdrawal by Subject|1|||
44500930|NCT04881747|79505392|FG001|Period 2 Washout|Withdrawal by Subject|0|||
44500931|NCT04881747|79505393|FG002|Period 2 Washout|Withdrawal by Subject|0|||
44500932|NCT04881747|79505394|FG003|Period 2 Washout|Withdrawal by Subject|1|||
44500933|NCT04881747|79505395|FG004|Period 2 Washout|Withdrawal by Subject|0|||
44500934|NCT04881747|79505396|FG005|Period 2 Washout|Withdrawal by Subject|0|||
44563722|NCT02819726|79582558|FG002|Part B (All Participants)|Lost to Follow-up|2|||
44233628|NCT00931606|79052458|FG002|Overall Study|Physician Decision|3|||
44563723|NCT02819726|79582559|FG003|Part B (All Participants)|Lost to Follow-up|2|||
44563724|NCT02819726|79582556|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
44563725|NCT02819726|79582557|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
44563726|NCT02819726|79582558|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
44563727|NCT02819726|79582559|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
44563728|NCT02819726|79582556|FG000|Part B (All Participants)|Protocol non-compliance|0|||
44563729|NCT02819726|79582557|FG001|Part B (All Participants)|Protocol non-compliance|0|||
44563730|NCT02819726|79582558|FG002|Part B (All Participants)|Protocol non-compliance|1|||
44563731|NCT02819726|79582559|FG003|Part B (All Participants)|Protocol non-compliance|0|||
44563732|NCT02816138|79582567|FG000|Overall Study|Adverse Event|1|||
44563733|NCT02815670|79582571|FG000|Overall Study|Prematurely discontinued of the trial|1|||
44563734|NCT02809976|79582575|FG000|Overall Study|Lost to Follow-up|1|||
44563735|NCT02809976|79582575|FG000|Overall Study|Withdrawal by Subject|1|||
44563736|NCT02880865|79582581|FG000|Overall Study|Adverse Event|1|||
44563737|NCT02880865|79582582|FG001|Overall Study|Adverse Event|0|||
44563738|NCT02880865|79582581|FG000|Overall Study|Withdrawal by Subject|0|||
44563739|NCT02880865|79582582|FG001|Overall Study|Withdrawal by Subject|2|||
44563740|NCT02880865|79582581|FG000|Overall Study|Physician Decision|0|||
44563741|NCT02880865|79582582|FG001|Overall Study|Physician Decision|1|||
44563742|NCT01854385|79582609|FG000|Pre-Treatment|Withdrawal by Subject|4|||
44563743|NCT01854385|79582609|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
44563744|NCT01854385|79582609|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
44563745|NCT01854385|79582609|FG000|Pre-Treatment|Unable to come for study visits|1|||
44563746|NCT01854385|79582609|FG000|Treatment|Lost to Follow-up|1|||
44500935|NCT04795622|79505406|FG000|Overall Study|Adverse Event|1|||
44500936|NCT04795622|79505407|FG001|Overall Study|Adverse Event|0|||
44500937|NCT04795622|79505406|FG000|Overall Study|Withdrawal by Subject|3|||
44500938|NCT04795622|79505407|FG001|Overall Study|Withdrawal by Subject|3|||
44500939|NCT04795622|79505406|FG000|Overall Study|Protocol Violation|0|||
44500940|NCT04795622|79505407|FG001|Overall Study|Protocol Violation|2|||
44500941|NCT04795622|79505406|FG000|Overall Study|Lost to Follow-up|2|||
44500942|NCT04795622|79505407|FG001|Overall Study|Lost to Follow-up|3|||
44500943|NCT04795622|79505406|FG000|Overall Study|Other|7|||
44500944|NCT04795622|79505407|FG001|Overall Study|Other|8|||
44500945|NCT04652245|79505428|FG000|Wash-Out Period|Adverse Event|0|||
44500946|NCT04652245|79505429|FG001|Wash-Out Period|Adverse Event|2|||
44500947|NCT04652245|79505428|FG000|Wash-Out Period|Withdrawal by Subject|0|||
44500948|NCT04652245|79505429|FG001|Wash-Out Period|Withdrawal by Subject|2|||
44500949|NCT04405739|79505446|FG000|Overall Study|Adverse Event|0|||
44500950|NCT04405739|79505447|FG001|Overall Study|Adverse Event|1|||
44563747|NCT02809118|79582616|FG000|Overall Study|Withdrawal by Subject|0|||
44563748|NCT02809118|79582617|FG001|Overall Study|Withdrawal by Subject|1|||
44563749|NCT02809118|79582618|FG002|Overall Study|Withdrawal by Subject|1|||
44563750|NCT03604159|79582628|FG000|Overall Study|Lost to Follow-up|6|||
44563751|NCT03604159|79582629|FG001|Overall Study|Lost to Follow-up|7|||
44563752|NCT02808338|79582635|FG000|Screening|Screen Failure|10|||
44563753|NCT02808338|79582635|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
44563754|NCT02808338|79582635|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
44563755|NCT02807948|79582646|FG000|Overall Study|Physician Decision|1|||
44563756|NCT02807948|79582647|FG001|Overall Study|Physician Decision|0|||
44563757|NCT02049710|79582654|FG000|Overall Study|Lost to Follow-up|319|||
44563758|NCT02049710|79582655|FG001|Overall Study|Lost to Follow-up|324|||
44563759|NCT05513625|79582674|FG000|Overall Study|Withdrawal by Subject|1|||
44563760|NCT04816708|79582695|FG000|Overall Study|Lost to Follow-up|10|||
44563761|NCT04816708|79582696|FG001|Overall Study|Lost to Follow-up|4|||
44563762|NCT04669600|79582713|FG000|Overall Study|Withdrawal by Subject|1|||
44377114|NCT00928668|79382415|FG004|Overall Study|Withdrawal by Subject|0|||
44377115|NCT00928668|79382411|FG000|Overall Study|Other reasons not listed above|0|||
44377116|NCT00928668|79382412|FG001|Overall Study|Other reasons not listed above|0|||
44377117|NCT00928668|79382413|FG002|Overall Study|Other reasons not listed above|0|||
44377118|NCT00928668|79382414|FG003|Overall Study|Other reasons not listed above|1|||
44377119|NCT00928668|79382415|FG004|Overall Study|Other reasons not listed above|0|||
44377120|NCT00592774|79382437|FG000|Overall Study|Adverse Event|5|||
44377121|NCT00592774|79382438|FG001|Overall Study|Adverse Event|19|||
44377122|NCT00592774|79382439|FG002|Overall Study|Adverse Event|2|||
44377123|NCT00592774|79382440|FG003|Overall Study|Adverse Event|14|||
44377124|NCT00592774|79382441|FG004|Overall Study|Adverse Event|8|||
44377125|NCT00592774|79382437|FG000|Overall Study|Protocol Violation|0|||
44377126|NCT00592774|79382438|FG001|Overall Study|Protocol Violation|1|||
44377127|NCT00592774|79382439|FG002|Overall Study|Protocol Violation|0|||
44377128|NCT00592774|79382440|FG003|Overall Study|Protocol Violation|0|||
44377129|NCT00592774|79382441|FG004|Overall Study|Protocol Violation|1|||
44377130|NCT00592774|79382437|FG000|Overall Study|Withdrawal by Subject|3|||
44377131|NCT00592774|79382438|FG001|Overall Study|Withdrawal by Subject|7|||
44377132|NCT00592774|79382439|FG002|Overall Study|Withdrawal by Subject|0|||
44377133|NCT00592774|79382440|FG003|Overall Study|Withdrawal by Subject|0|||
44377134|NCT00592774|79382441|FG004|Overall Study|Withdrawal by Subject|0|||
44377135|NCT00592774|79382437|FG000|Overall Study|Lack of Efficacy|3|||
44377136|NCT00592774|79382438|FG001|Overall Study|Lack of Efficacy|3|||
44377137|NCT00592774|79382439|FG002|Overall Study|Lack of Efficacy|0|||
44377138|NCT00592774|79382440|FG003|Overall Study|Lack of Efficacy|0|||
44377139|NCT00592774|79382441|FG004|Overall Study|Lack of Efficacy|2|||
44377140|NCT00592774|79382437|FG000|Overall Study|Physician Decision|0|||
44500951|NCT04405739|79505448|FG002|Overall Study|Adverse Event|0|||
44500952|NCT04405739|79505449|FG003|Overall Study|Adverse Event|0|||
44500953|NCT04405739|79505446|FG000|Overall Study|Lost to Follow-up|0|||
44500954|NCT04405739|79505447|FG001|Overall Study|Lost to Follow-up|2|||
44500955|NCT04405739|79505448|FG002|Overall Study|Lost to Follow-up|1|||
44500956|NCT04405739|79505449|FG003|Overall Study|Lost to Follow-up|3|||
44500957|NCT04405739|79505446|FG000|Overall Study|Withdrawal by Subject|0|||
44500958|NCT04405739|79505447|FG001|Overall Study|Withdrawal by Subject|2|||
44500959|NCT04405739|79505448|FG002|Overall Study|Withdrawal by Subject|1|||
44500960|NCT04405739|79505449|FG003|Overall Study|Withdrawal by Subject|1|||
44500961|NCT04405739|79505446|FG000|Overall Study|Death|0|||
44500962|NCT04405739|79505447|FG001|Overall Study|Death|0|||
44500963|NCT04405739|79505448|FG002|Overall Study|Death|1|||
44500964|NCT04405739|79505449|FG003|Overall Study|Death|0|||
44500965|NCT04405739|79505446|FG000|Overall Study|Transferred to rehab|0|||
44500966|NCT04405739|79505447|FG001|Overall Study|Transferred to rehab|0|||
44377141|NCT00592774|79382438|FG001|Overall Study|Physician Decision|1|||
44377142|NCT00592774|79382439|FG002|Overall Study|Physician Decision|1|||
44563763|NCT04669600|79582713|FG000|Overall Study|Other|6|||
44563764|NCT04120974|79582770|FG000|Overall Study|Death|1|||
44563765|NCT04120974|79582770|FG000|Overall Study|Physician Decision|1|||
44563766|NCT04120974|79582770|FG000|Overall Study|Lost to Follow-up|6|||
44377143|NCT00592774|79382440|FG003|Overall Study|Physician Decision|0|||
44377144|NCT00592774|79382441|FG004|Overall Study|Physician Decision|1|||
44377145|NCT00592774|79382437|FG000|Overall Study|Other|0|||
44377146|NCT00592774|79382438|FG001|Overall Study|Other|1|||
44377147|NCT00592774|79382439|FG002|Overall Study|Other|1|||
44377148|NCT00592774|79382440|FG003|Overall Study|Other|0|||
44377149|NCT00592774|79382441|FG004|Overall Study|Other|2|||
44377150|NCT00837694|79382459|FG000|Overall Study|Lost to Follow-up|2|||
44377151|NCT00837694|79382460|FG001|Overall Study|Lost to Follow-up|0|||
44377152|NCT00837694|79382461|FG002|Overall Study|Lost to Follow-up|2|||
44377153|NCT00837694|79382462|FG003|Overall Study|Lost to Follow-up|1|||
44377154|NCT00837694|79382463|FG004|Overall Study|Lost to Follow-up|1|||
44377155|NCT00837694|79382464|FG005|Overall Study|Lost to Follow-up|1|||
44377156|NCT00852202|79382481|FG000|Overall Study|Adverse Event|2|||
44377157|NCT00852202|79382482|FG001|Overall Study|Adverse Event|3|||
44377158|NCT00852202|79382483|FG002|Overall Study|Adverse Event|7|||
44377159|NCT00852202|79382481|FG000|Overall Study|Lack of Efficacy|4|||
44377160|NCT00852202|79382482|FG001|Overall Study|Lack of Efficacy|1|||
44377161|NCT00852202|79382483|FG002|Overall Study|Lack of Efficacy|2|||
44377162|NCT00852202|79382481|FG000|Overall Study|Protocol Violation|2|||
44377163|NCT00852202|79382482|FG001|Overall Study|Protocol Violation|2|||
44377164|NCT00852202|79382483|FG002|Overall Study|Protocol Violation|7|||
44500967|NCT04405739|79505448|FG002|Overall Study|Transferred to rehab|0|||
44500968|NCT04405739|79505449|FG003|Overall Study|Transferred to rehab|1|||
44500969|NCT04405739|79505446|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
44500970|NCT04405739|79505447|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
44233629|NCT00931606|79052459|FG003|Overall Study|Physician Decision|0|||
44233630|NCT00931606|79052456|FG000|Overall Study|Sponsor Decision|1|||
44233631|NCT00931606|79052457|FG001|Overall Study|Sponsor Decision|4|||
44233632|NCT00931606|79052458|FG002|Overall Study|Sponsor Decision|0|||
44233633|NCT00931606|79052459|FG003|Overall Study|Sponsor Decision|2|||
44233634|NCT00931606|79052456|FG000|Overall Study|Withdrawal by Subject|3|||
44233635|NCT00931606|79052457|FG001|Overall Study|Withdrawal by Subject|1|||
44233636|NCT00931606|79052458|FG002|Overall Study|Withdrawal by Subject|1|||
44233637|NCT00931606|79052459|FG003|Overall Study|Withdrawal by Subject|1|||
44233638|NCT00706914|79052530|FG000|Overall Study|Lack of Efficacy|0|||
44233639|NCT00706914|79052531|FG001|Overall Study|Lack of Efficacy|1|||
44233640|NCT00706914|79052532|FG002|Overall Study|Lack of Efficacy|0|||
44233641|NCT00706914|79052530|FG000|Overall Study|Lost to Follow-up|1|||
44233642|NCT00706914|79052531|FG001|Overall Study|Lost to Follow-up|0|||
44233643|NCT00706914|79052532|FG002|Overall Study|Lost to Follow-up|0|||
44233644|NCT00706914|79052530|FG000|Overall Study|Adverse Event|2|||
44233645|NCT00706914|79052531|FG001|Overall Study|Adverse Event|2|||
44233646|NCT00706914|79052532|FG002|Overall Study|Adverse Event|0|||
44233647|NCT00706914|79052530|FG000|Overall Study|Protocol Violation|3|||
44233648|NCT00706914|79052531|FG001|Overall Study|Protocol Violation|1|||
44233649|NCT00706914|79052532|FG002|Overall Study|Protocol Violation|1|||
44233650|NCT01808651|79052639|FG000|Study Period 1|Lost to Follow-up|1|||
44233651|NCT01808651|79052640|FG001|Study Period 1|Lost to Follow-up|3|||
44233652|NCT01808651|79052641|FG002|Study Period 1|Lost to Follow-up|0|||
44233653|NCT01808651|79052639|FG000|Study Period 1|Protocol Violation|1|||
44233654|NCT01808651|79052640|FG001|Study Period 1|Protocol Violation|0|||
44233655|NCT01808651|79052641|FG002|Study Period 1|Protocol Violation|1|||
44233656|NCT01808651|79052639|FG000|Study Period 1|Physician Decision|3|||
44233657|NCT01808651|79052640|FG001|Study Period 1|Physician Decision|2|||
44233658|NCT01808651|79052641|FG002|Study Period 1|Physician Decision|0|||
44233659|NCT01808651|79052639|FG000|Study Period 1|Lack of Efficacy|2|||
44233660|NCT01808651|79052640|FG001|Study Period 1|Lack of Efficacy|1|||
44233661|NCT01808651|79052641|FG002|Study Period 1|Lack of Efficacy|0|||
44377165|NCT00852202|79382481|FG000|Overall Study|Withdrawal by Subject|3|||
44377166|NCT00852202|79382482|FG001|Overall Study|Withdrawal by Subject|1|||
44500971|NCT04405739|79505448|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
44500972|NCT04405739|79505449|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
44500973|NCT04954326|79505482|FG000|Overall Study|Protocol Violation|0|||
44500974|NCT04954326|79505483|FG001|Overall Study|Protocol Violation|1|||
44563767|NCT04107805|79582783|FG000|Overall Study|Adverse Event|0|||
44233662|NCT01808651|79052639|FG000|Study Period 1|Adverse Event|10|||
44233663|NCT01808651|79052640|FG001|Study Period 1|Adverse Event|4|||
44233664|NCT01808651|79052641|FG002|Study Period 1|Adverse Event|1|||
44233665|NCT01808651|79052639|FG000|Study Period 1|Participant Decision|9|||
44233666|NCT01808651|79052640|FG001|Study Period 1|Participant Decision|7|||
44233667|NCT01808651|79052641|FG002|Study Period 1|Participant Decision|3|||
44233668|NCT00706134|79052706|FG000|Overall Study|Adverse Event|8|||
44233669|NCT00706134|79052707|FG001|Overall Study|Adverse Event|7|||
44233670|NCT00706134|79052708|FG002|Overall Study|Adverse Event|2|||
44377167|NCT00852202|79382483|FG002|Overall Study|Withdrawal by Subject|2|||
44377168|NCT00852202|79382481|FG000|Overall Study|Lost to Follow-up|5|||
44377169|NCT00852202|79382482|FG001|Overall Study|Lost to Follow-up|5|||
44377170|NCT00852202|79382483|FG002|Overall Study|Lost to Follow-up|6|||
44377171|NCT00852202|79382481|FG000|Overall Study|pregnancy,moving away and surgery|1|||
44233671|NCT00706134|79052709|FG003|Overall Study|Adverse Event|3|||
44233672|NCT00706134|79052706|FG000|Overall Study|Lost to Follow-up|0|||
44233673|NCT00706134|79052707|FG001|Overall Study|Lost to Follow-up|1|||
44233674|NCT00706134|79052708|FG002|Overall Study|Lost to Follow-up|0|||
44563768|NCT04107805|79582784|FG001|Overall Study|Adverse Event|0|||
44563769|NCT04107805|79582785|FG002|Overall Study|Adverse Event|0|||
44563770|NCT04107805|79582786|FG003|Overall Study|Adverse Event|1|||
44563771|NCT04107805|79582787|FG004|Overall Study|Adverse Event|0|||
44563772|NCT04107805|79582788|FG005|Overall Study|Adverse Event|1|||
44563773|NCT04107805|79582789|FG006|Overall Study|Adverse Event|0|||
44563774|NCT04107805|79582790|FG007|Overall Study|Adverse Event|0|||
44563775|NCT04107805|79582791|FG008|Overall Study|Adverse Event|1|||
44563776|NCT03997383|79582834|FG000|Double-blind Treatment Period|Adverse Event|4|||
44563777|NCT03997383|79582835|FG001|Double-blind Treatment Period|Adverse Event|3|||
44563778|NCT03997383|79582834|FG000|Double-blind Treatment Period|Death|4|||
44563779|NCT03997383|79582835|FG001|Double-blind Treatment Period|Death|4|||
44563780|NCT03997383|79582834|FG000|Double-blind Treatment Period|Physician Decision|2|||
44563781|NCT03997383|79582835|FG001|Double-blind Treatment Period|Physician Decision|0|||
44563782|NCT03997383|79582834|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
44233675|NCT00706134|79052709|FG003|Overall Study|Lost to Follow-up|0|||
44233676|NCT00706134|79052706|FG000|Overall Study|Protocol Violation|0|||
44233677|NCT00706134|79052707|FG001|Overall Study|Protocol Violation|6|||
44563783|NCT03997383|79582835|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
44563784|NCT03997383|79582834|FG000|Open-label Extension Period|Ongoing|148|||
44563785|NCT03997383|79582835|FG001|Open-label Extension Period|Ongoing|151|||
44563786|NCT03997383|79582834|FG000|Open-label Extension Period|Adverse Event|4|||
44563787|NCT03997383|79582835|FG001|Open-label Extension Period|Adverse Event|1|||
44563788|NCT03997383|79582834|FG000|Open-label Extension Period|Death|8|||
44563789|NCT03997383|79582835|FG001|Open-label Extension Period|Death|9|||
44563790|NCT03997383|79582834|FG000|Open-label Extension Period|Physician Decision|1|||
44563791|NCT03997383|79582835|FG001|Open-label Extension Period|Physician Decision|1|||
44563792|NCT03997383|79582834|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
44563793|NCT03997383|79582835|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
44563794|NCT03997383|79582834|FG000|Open-label Extension Period|Reason Not Specified|2|||
44563795|NCT03997383|79582835|FG001|Open-label Extension Period|Reason Not Specified|0|||
44563796|NCT03988751|79582849|FG000|Overall Study|Withdrawal by Subject|1|||
44563797|NCT03988751|79582850|FG001|Overall Study|Withdrawal by Subject|0|||
44563798|NCT03988751|79582849|FG000|Overall Study|Protocol Violation|0|||
44563799|NCT03988751|79582850|FG001|Overall Study|Protocol Violation|1|||
44563800|NCT03802331|79582868|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
44563801|NCT03802331|79582869|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
44563802|NCT03782376|79582877|FG000|Overall Study|Lost to Follow-up|2|||
44563803|NCT03782376|79582878|FG001|Overall Study|Lost to Follow-up|2|||
44563804|NCT03782376|79582877|FG000|Overall Study|Withdrawal by Subject|7|||
44563805|NCT03782376|79582878|FG001|Overall Study|Withdrawal by Subject|11|||
44563806|NCT03782376|79582877|FG000|Overall Study|Death|1|||
44563807|NCT03782376|79582878|FG001|Overall Study|Death|0|||
44563808|NCT03782376|79582877|FG000|Overall Study|Other|16|||
44563809|NCT03782376|79582878|FG001|Overall Study|Other|17|||
44233678|NCT00706134|79052708|FG002|Overall Study|Protocol Violation|0|||
44233679|NCT00706134|79052709|FG003|Overall Study|Protocol Violation|3|||
44233680|NCT00706134|79052706|FG000|Overall Study|Withdrawal by Subject|1|||
44233681|NCT00706134|79052707|FG001|Overall Study|Withdrawal by Subject|2|||
44233682|NCT00706134|79052708|FG002|Overall Study|Withdrawal by Subject|1|||
44233683|NCT00706134|79052709|FG003|Overall Study|Withdrawal by Subject|0|||
44233684|NCT00706134|79052706|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
44233685|NCT00706134|79052707|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44233686|NCT00706134|79052708|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
44233687|NCT00706134|79052709|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
44233688|NCT00706134|79052706|FG000|Overall Study|Did not meet study criteria|2|||
44233689|NCT00706134|79052707|FG001|Overall Study|Did not meet study criteria|0|||
44233690|NCT00706134|79052708|FG002|Overall Study|Did not meet study criteria|0|||
44233691|NCT00706134|79052709|FG003|Overall Study|Did not meet study criteria|0|||
44233692|NCT01808573|79052721|FG000|Overall Study|Death|212|||
44233693|NCT01808573|79052722|FG001|Overall Study|Death|240|||
44233694|NCT01808573|79052721|FG000|Overall Study|Withdrawal by Subject|12|||
44233695|NCT01808573|79052722|FG001|Overall Study|Withdrawal by Subject|10|||
44233696|NCT01808573|79052721|FG000|Overall Study|Lost to Follow-up|3|||
44233697|NCT01808573|79052722|FG001|Overall Study|Lost to Follow-up|0|||
44233698|NCT01808573|79052721|FG000|Overall Study|Discontinuation of study by sponsor|79|||
44233699|NCT01808573|79052722|FG001|Overall Study|Discontinuation of study by sponsor|64|||
44233700|NCT01808573|79052721|FG000|Overall Study|Randomized in Error|1|||
44233701|NCT01808573|79052722|FG001|Overall Study|Randomized in Error|0|||
44233702|NCT02246530|79052749|FG000|Overall Study|Lost to Follow-up|4|||
44233703|NCT02246530|79052750|FG001|Overall Study|Lost to Follow-up|0|||
44563810|NCT03573544|79582938|FG000|Overall Study|Adverse Event|0|||
44563811|NCT03573544|79582939|FG001|Overall Study|Adverse Event|0|||
44563812|NCT03573544|79582940|FG002|Overall Study|Adverse Event|0|||
44563813|NCT03573544|79582941|FG003|Overall Study|Adverse Event|3|||
44563814|NCT03573544|79582942|FG004|Overall Study|Adverse Event|1|||
44563815|NCT03573544|79582943|FG005|Overall Study|Adverse Event|0|||
44563816|NCT03573544|79582944|FG006|Overall Study|Adverse Event|2|||
44563817|NCT03573544|79582945|FG007|Overall Study|Adverse Event|0|||
44563818|NCT03573544|79582938|FG000|Overall Study|Physician Decision|0|||
44233704|NCT01808339|79052756|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233705|NCT01808339|79052757|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233706|NCT01808339|79052758|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233707|NCT01808339|79052759|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
44233708|NCT01808339|79052760|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
44233709|NCT01808339|79052761|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
44563819|NCT03573544|79582939|FG001|Overall Study|Physician Decision|0|||
44563820|NCT03573544|79582940|FG002|Overall Study|Physician Decision|0|||
44233710|NCT01808339|79052756|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44233711|NCT01808339|79052757|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44563821|NCT03573544|79582941|FG003|Overall Study|Physician Decision|0|||
44563822|NCT03573544|79582942|FG004|Overall Study|Physician Decision|0|||
44563823|NCT03573544|79582943|FG005|Overall Study|Physician Decision|0|||
44563824|NCT03573544|79582944|FG006|Overall Study|Physician Decision|1|||
44563825|NCT03573544|79582945|FG007|Overall Study|Physician Decision|0|||
44563826|NCT03573544|79582938|FG000|Overall Study|Withdrawal by Subject|2|||
44563827|NCT03573544|79582939|FG001|Overall Study|Withdrawal by Subject|0|||
44563828|NCT03573544|79582940|FG002|Overall Study|Withdrawal by Subject|0|||
44563829|NCT03573544|79582941|FG003|Overall Study|Withdrawal by Subject|1|||
44563830|NCT03573544|79582942|FG004|Overall Study|Withdrawal by Subject|1|||
44563831|NCT03573544|79582943|FG005|Overall Study|Withdrawal by Subject|1|||
44563832|NCT03573544|79582944|FG006|Overall Study|Withdrawal by Subject|0|||
44563833|NCT03573544|79582945|FG007|Overall Study|Withdrawal by Subject|1|||
44563834|NCT03573544|79582938|FG000|Overall Study|Disease progression|3|||
44563835|NCT03573544|79582939|FG001|Overall Study|Disease progression|3|||
44563836|NCT03573544|79582940|FG002|Overall Study|Disease progression|6|||
44563837|NCT03573544|79582941|FG003|Overall Study|Disease progression|4|||
44563838|NCT03573544|79582942|FG004|Overall Study|Disease progression|5|||
44563839|NCT03573544|79582943|FG005|Overall Study|Disease progression|7|||
44563840|NCT03573544|79582944|FG006|Overall Study|Disease progression|6|||
44563841|NCT03573544|79582945|FG007|Overall Study|Disease progression|7|||
44563842|NCT03412565|79582976|FG000|Overall Study|Lost to Follow-up|0|||
44563843|NCT03412565|79582977|FG001|Overall Study|Lost to Follow-up|0|||
44563844|NCT03412565|79582978|FG002|Overall Study|Lost to Follow-up|1|||
44563845|NCT03412565|79582979|FG003|Overall Study|Lost to Follow-up|0|||
44563846|NCT03412565|79582976|FG000|Overall Study|Physician Decision|0|||
44233712|NCT01808339|79052758|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44233713|NCT01808339|79052759|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44233714|NCT01808339|79052760|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44233715|NCT01808339|79052761|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44233716|NCT01808339|79052756|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233717|NCT01808339|79052757|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233718|NCT01808339|79052758|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
44233719|NCT01808339|79052759|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233720|NCT01808339|79052760|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233721|NCT01808339|79052761|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
44233722|NCT02727660|79052811|FG000|Overall Study|Lack of Efficacy|40|||
44233723|NCT02727660|79052812|FG001|Overall Study|Lack of Efficacy|40|||
44233724|NCT02727660|79052813|FG002|Overall Study|Lack of Efficacy|70|||
44233725|NCT02727660|79052811|FG000|Overall Study|Adverse Event|28|||
44563847|NCT03412565|79582977|FG001|Overall Study|Physician Decision|0|||
44563848|NCT03412565|79582978|FG002|Overall Study|Physician Decision|0|||
44563849|NCT03412565|79582979|FG003|Overall Study|Physician Decision|1|||
44563850|NCT03412565|79582976|FG000|Overall Study|Withdrawal by Subject|0|||
44563851|NCT03412565|79582977|FG001|Overall Study|Withdrawal by Subject|4|||
44233726|NCT02727660|79052812|FG001|Overall Study|Adverse Event|21|||
44233727|NCT02727660|79052813|FG002|Overall Study|Adverse Event|32|||
44233728|NCT02727660|79052811|FG000|Overall Study|Withdrawal by Subject|26|||
44563852|NCT03412565|79582978|FG002|Overall Study|Withdrawal by Subject|5|||
44563853|NCT03412565|79582979|FG003|Overall Study|Withdrawal by Subject|5|||
44563854|NCT03412565|79582976|FG000|Overall Study|Death|1|||
44563855|NCT03412565|79582977|FG001|Overall Study|Death|3|||
44563856|NCT03412565|79582978|FG002|Overall Study|Death|4|||
44563857|NCT03412565|79582979|FG003|Overall Study|Death|5|||
44563858|NCT03412565|79582976|FG000|Overall Study|Data collection ended|0|||
44563859|NCT03412565|79582977|FG001|Overall Study|Data collection ended|41|||
44563860|NCT03412565|79582978|FG002|Overall Study|Data collection ended|41|||
44233729|NCT02727660|79052812|FG001|Overall Study|Withdrawal by Subject|25|||
44233730|NCT02727660|79052813|FG002|Overall Study|Withdrawal by Subject|30|||
44233731|NCT02727660|79052811|FG000|Overall Study|Physician Decision|3|||
44233732|NCT02727660|79052812|FG001|Overall Study|Physician Decision|8|||
44233733|NCT02727660|79052813|FG002|Overall Study|Physician Decision|14|||
44233734|NCT02727660|79052811|FG000|Overall Study|Lost to Follow-up|5|||
44233735|NCT02727660|79052812|FG001|Overall Study|Lost to Follow-up|9|||
44233736|NCT02727660|79052813|FG002|Overall Study|Lost to Follow-up|8|||
44233737|NCT02727660|79052811|FG000|Overall Study|Protocol Violation|7|||
44233738|NCT02727660|79052812|FG001|Overall Study|Protocol Violation|5|||
44233739|NCT02727660|79052813|FG002|Overall Study|Protocol Violation|5|||
44563861|NCT03412565|79582979|FG003|Overall Study|Data collection ended|40|||
44563862|NCT03333915|79583001|FG000|Overall Study|Lost to Follow-up|0|||
44563863|NCT03333915|79583002|FG001|Overall Study|Lost to Follow-up|0|||
44233740|NCT02727660|79052811|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
44563864|NCT03333915|79583003|FG002|Overall Study|Lost to Follow-up|1|||
44563865|NCT03333915|79583004|FG003|Overall Study|Lost to Follow-up|0|||
44563866|NCT03333915|79583005|FG004|Overall Study|Lost to Follow-up|0|||
44563867|NCT03333915|79583001|FG000|Overall Study|Disease Progression|0|||
44563868|NCT03333915|79583002|FG001|Overall Study|Disease Progression|1|||
44563869|NCT03333915|79583003|FG002|Overall Study|Disease Progression|0|||
44233741|NCT02727660|79052812|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
44233742|NCT02727660|79052813|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
44233743|NCT02727660|79052811|FG000|Overall Study|Administrative Reasons|2|||
44233744|NCT02727660|79052812|FG001|Overall Study|Administrative Reasons|3|||
44233745|NCT02727660|79052813|FG002|Overall Study|Administrative Reasons|4|||
44233746|NCT01784861|79052827|FG000|Overall Study|Adverse Event|0|||
44233747|NCT01784861|79052828|FG001|Overall Study|Adverse Event|0|||
44233748|NCT01784861|79052829|FG002|Overall Study|Adverse Event|1|||
44233749|NCT01784861|79052830|FG003|Overall Study|Adverse Event|2|||
44233750|NCT01784861|79052831|FG004|Overall Study|Adverse Event|1|||
44233751|NCT01784861|79052832|FG005|Overall Study|Adverse Event|0|||
44233752|NCT01784861|79052827|FG000|Overall Study|Withdrawal by Subject|0|||
44233753|NCT01784861|79052828|FG001|Overall Study|Withdrawal by Subject|0|||
44233754|NCT01784861|79052829|FG002|Overall Study|Withdrawal by Subject|0|||
44233755|NCT01784861|79052830|FG003|Overall Study|Withdrawal by Subject|1|||
44233756|NCT01784861|79052831|FG004|Overall Study|Withdrawal by Subject|0|||
44233757|NCT01784861|79052832|FG005|Overall Study|Withdrawal by Subject|0|||
44233758|NCT01784861|79052827|FG000|Overall Study|Physician Decision|0|||
44233759|NCT01784861|79052828|FG001|Overall Study|Physician Decision|0|||
44233760|NCT01784861|79052829|FG002|Overall Study|Physician Decision|0|||
44233761|NCT01784861|79052830|FG003|Overall Study|Physician Decision|2|||
44233762|NCT01784861|79052831|FG004|Overall Study|Physician Decision|0|||
44233763|NCT01784861|79052832|FG005|Overall Study|Physician Decision|1|||
44233764|NCT02727192|79052906|FG000|Overall Study|Lost to Follow-up|1|||
44233765|NCT02727192|79052907|FG001|Overall Study|Lost to Follow-up|0|||
44233766|NCT02727192|79052908|FG002|Overall Study|Lost to Follow-up|0|||
44233767|NCT00705666|79052928|FG000|Overall Study|No post-treatment questionnaire|279|||
44233768|NCT00705666|79052928|FG000|Overall Study|Withdrawal by Subject|21|||
44233769|NCT00705666|79052928|FG000|Overall Study|Physician Decision|7|||
44233770|NCT00705666|79052928|FG000|Overall Study|Lost to Follow-up|5|||
44563870|NCT03333915|79583004|FG003|Overall Study|Disease Progression|0|||
44563871|NCT03333915|79583005|FG004|Overall Study|Disease Progression|0|||
44563872|NCT03333915|79583001|FG000|Overall Study|Death|0|||
44563873|NCT03333915|79583002|FG001|Overall Study|Death|0|||
44563874|NCT03333915|79583003|FG002|Overall Study|Death|0|||
44563875|NCT03333915|79583004|FG003|Overall Study|Death|37|||
44563876|NCT03333915|79583005|FG004|Overall Study|Death|18|||
44233771|NCT00705666|79052928|FG000|Overall Study|Death|1|||
44233772|NCT00705666|79052928|FG000|Overall Study|Adverse Event|4|||
44233773|NCT00705666|79052928|FG000|Overall Study|Other|12|||
44233774|NCT00705666|79052928|FG000|Overall Study|Other|2|||
44233775|NCT00705666|79052928|FG000|Overall Study|Lack of data|3|||
44233776|NCT00705666|79052928|FG000|Overall Study|Untreated|5|||
44233777|NCT02725866|79053087|FG000|Overall Study|Failure to return|6|||
44233778|NCT02725866|79053087|FG000|Overall Study|Withdrew consent|3|||
44233779|NCT02725866|79053087|FG000|Overall Study|Insufficient virological response|1|||
44563877|NCT03333915|79583001|FG000|Overall Study|Sponsor's Decision|0|||
44563878|NCT03333915|79583002|FG001|Overall Study|Sponsor's Decision|0|||
44563879|NCT03333915|79583003|FG002|Overall Study|Sponsor's Decision|0|||
44563880|NCT03333915|79583004|FG003|Overall Study|Sponsor's Decision|48|||
44563881|NCT03333915|79583005|FG004|Overall Study|Sponsor's Decision|4|||
44563882|NCT03333915|79583001|FG000|Overall Study|Withdrawal by Subject|0|||
44563883|NCT03333915|79583002|FG001|Overall Study|Withdrawal by Subject|0|||
44233780|NCT02725866|79053087|FG000|Overall Study|Other, not specified|4|||
44233781|NCT02726022|79053123|FG000|Overall Study|Adverse Event|14|||
44233782|NCT02726022|79053123|FG000|Overall Study|Treatment Failure|8|||
44233783|NCT02726022|79053123|FG000|Overall Study|Poor Compliance|13|||
44233784|NCT02726022|79053123|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
44563884|NCT03333915|79583003|FG002|Overall Study|Withdrawal by Subject|0|||
44233785|NCT02725788|79053138|FG000|Overall Study|Lost to Follow-up|1|||
44233786|NCT02725788|79053139|FG001|Overall Study|Lost to Follow-up|1|||
44500975|NCT04954326|79505482|FG000|Overall Study|Death|0|||
44500976|NCT04954326|79505483|FG001|Overall Study|Death|2|||
44500977|NCT04954326|79505482|FG000|Overall Study|Physician Decision|0|||
44500978|NCT04954326|79505483|FG001|Overall Study|Physician Decision|1|||
44500979|NCT04914819|79505491|FG000|Overall Study|Pregnancy|3|||
44500980|NCT04914819|79505492|FG001|Overall Study|Pregnancy|1|||
44500981|NCT04914819|79505491|FG000|Overall Study|Discontinued study|4|||
44500982|NCT04914819|79505492|FG001|Overall Study|Discontinued study|1|||
44500983|NCT04914819|79505491|FG000|Overall Study|Lost to Follow-up|7|||
44500984|NCT04914819|79505492|FG001|Overall Study|Lost to Follow-up|0|||
44500985|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
44500986|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
44500987|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
44500988|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
44500989|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
44500990|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
44500991|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
44500992|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
44500993|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
44500994|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
44500995|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
44500996|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
44500997|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
44500998|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
44500999|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
44501000|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
44501001|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
44501002|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
44501003|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
44501004|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
44501005|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
44501006|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
44501007|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
44501008|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
44501009|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
44501010|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
44501011|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
44501012|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
44501013|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
44501014|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
44501015|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
44501016|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
44501017|NCT04818346|79505507|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
44501018|NCT04818346|79505508|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
44501019|NCT04818346|79505509|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
44501020|NCT04818346|79505510|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
44501021|NCT04723394|79505522|FG000|Overall Study|Adverse Event|0|||
44501022|NCT04723394|79505523|FG001|Overall Study|Adverse Event|3|||
44501023|NCT04723394|79505522|FG000|Overall Study|Death|8|||
44233787|NCT02725788|79053138|FG000|Overall Study|Protocol Violation|0|||
44563885|NCT03333915|79583004|FG003|Overall Study|Withdrawal by Subject|5|||
44563886|NCT03333915|79583005|FG004|Overall Study|Withdrawal by Subject|1|||
44563887|NCT02993146|79583038|FG000|Overall Study|Withdrawal by Subject|0|||
44233788|NCT02725788|79053139|FG001|Overall Study|Protocol Violation|1|||
44233789|NCT02725710|79053278|FG000|Overall Study|Lost to Follow-up|1|||
44233790|NCT02725710|79053279|FG001|Overall Study|Lost to Follow-up|0|||
44233791|NCT02724462|79053310|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
44233792|NCT02724462|79053311|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
44233793|NCT02724462|79053310|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
44233794|NCT02724462|79053311|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
44501024|NCT04723394|79505523|FG001|Overall Study|Death|8|||
44501025|NCT04723394|79505522|FG000|Overall Study|Lost to Follow-up|20|||
44501026|NCT04723394|79505523|FG001|Overall Study|Lost to Follow-up|17|||
44501027|NCT04723394|79505522|FG000|Overall Study|Physician Decision|1|||
44501028|NCT04723394|79505523|FG001|Overall Study|Physician Decision|0|||
44501029|NCT04723394|79505522|FG000|Overall Study|Withdrawal by Subject|20|||
44501030|NCT04723394|79505523|FG001|Overall Study|Withdrawal by Subject|34|||
44501031|NCT04723394|79505522|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
44501032|NCT04723394|79505523|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
44501033|NCT04409002|79505533|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
44501034|NCT04289363|79505539|FG000|Overall Study|Lost to Follow-up|14|||
44501035|NCT04289363|79505540|FG001|Overall Study|Lost to Follow-up|0|||
44501036|NCT04235959|79505549|FG000|Overall Study|Protocol Violation|0|||
44501037|NCT04235959|79505550|FG001|Overall Study|Protocol Violation|1|||
44501038|NCT04235959|79505551|FG002|Overall Study|Protocol Violation|0|||
44501039|NCT04235959|79505549|FG000|Overall Study|Adverse Event|1|||
44501040|NCT04235959|79505550|FG001|Overall Study|Adverse Event|0|||
44501041|NCT04235959|79505551|FG002|Overall Study|Adverse Event|0|||
44501042|NCT03525613|79505586|FG000|Overall Study|Adverse Event|11|||
44501043|NCT03525613|79505587|FG001|Overall Study|Adverse Event|8|||
44501044|NCT03525613|79505588|FG002|Overall Study|Adverse Event|3|||
44501045|NCT03525613|79505589|FG003|Overall Study|Adverse Event|3|||
44501046|NCT03525613|79505586|FG000|Overall Study|Lost to Follow-up|4|||
44501047|NCT03525613|79505587|FG001|Overall Study|Lost to Follow-up|5|||
44501048|NCT03525613|79505588|FG002|Overall Study|Lost to Follow-up|3|||
44501049|NCT03525613|79505589|FG003|Overall Study|Lost to Follow-up|2|||
44501050|NCT03525613|79505586|FG000|Overall Study|Physician Decision|0|||
44501051|NCT03525613|79505587|FG001|Overall Study|Physician Decision|1|||
44501052|NCT03525613|79505588|FG002|Overall Study|Physician Decision|0|||
44501053|NCT03525613|79505589|FG003|Overall Study|Physician Decision|1|||
44501054|NCT03525613|79505586|FG000|Overall Study|Consent Withdrawal|25|||
44501055|NCT03525613|79505587|FG001|Overall Study|Consent Withdrawal|16|||
44501056|NCT03525613|79505588|FG002|Overall Study|Consent Withdrawal|12|||
44501057|NCT03525613|79505589|FG003|Overall Study|Consent Withdrawal|9|||
44563888|NCT02993146|79583039|FG001|Overall Study|Withdrawal by Subject|0|||
44563889|NCT02993146|79583040|FG002|Overall Study|Withdrawal by Subject|1|||
44563890|NCT02993146|79583041|FG003|Overall Study|Withdrawal by Subject|1|||
44563891|NCT02865928|79583057|FG000|Overall Study|Withdrawal by Subject|1|||
44563892|NCT02865928|79583058|FG001|Overall Study|Withdrawal by Subject|0|||
44563893|NCT02865928|79583057|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
44563894|NCT02865928|79583058|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
44563895|NCT02865928|79583057|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
44563896|NCT02865928|79583058|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
44563897|NCT02734290|79583066|FG000|Overall Study|Adverse Event|1|||
44563898|NCT02734290|79583067|FG001|Overall Study|Adverse Event|0|||
44563899|NCT02734290|79583066|FG000|Overall Study|Death|1|||
44563900|NCT02734290|79583067|FG001|Overall Study|Death|0|||
44563901|NCT02652260|79583075|FG000|Overall Study|Pregnancy|0|||
44563902|NCT02652260|79583076|FG001|Overall Study|Pregnancy|1|||
44563903|NCT02652260|79583075|FG000|Overall Study|Withdrawal by Subject|0|||
44563904|NCT02652260|79583076|FG001|Overall Study|Withdrawal by Subject|1|||
44563905|NCT02535741|79583100|FG000|Overall Study|Adverse Event|3|||
44563906|NCT02535741|79583100|FG000|Overall Study|Withdrawal by Subject|9|||
44563907|NCT02535741|79583100|FG000|Overall Study|Lost to Follow-up|10|||
44563908|NCT02535741|79583100|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
44563909|NCT02535741|79583100|FG000|Overall Study|Missing data|6|||
44563910|NCT02525627|79583107|FG000|Overall Study|Revision|1|||
44563911|NCT02525627|79583108|FG001|Overall Study|Revision|1|||
44563912|NCT02525627|79583107|FG000|Overall Study|Withdrawal by Subject|1|||
44563913|NCT02525627|79583108|FG001|Overall Study|Withdrawal by Subject|2|||
44563914|NCT02525627|79583107|FG000|Overall Study|Death|1|||
44563915|NCT02525627|79583108|FG001|Overall Study|Death|0|||
44563916|NCT02525627|79583107|FG000|Overall Study|Site terminated|11|||
44563917|NCT02525627|79583108|FG001|Overall Study|Site terminated|10|||
44563918|NCT02525588|79583116|FG000|Overall Study|Death|3|||
44563919|NCT02525588|79583117|FG001|Overall Study|Death|1|||
44563920|NCT02525588|79583116|FG000|Overall Study|Lost to Follow-up|2|||
44563921|NCT02525588|79583117|FG001|Overall Study|Lost to Follow-up|0|||
44563922|NCT02525588|79583116|FG000|Overall Study|Withdrawal by Subject|1|||
44563923|NCT02525588|79583117|FG001|Overall Study|Withdrawal by Subject|1|||
44563924|NCT02525588|79583116|FG000|Overall Study|Adverse Event|0|||
44563925|NCT02525588|79583117|FG001|Overall Study|Adverse Event|1|||
44563926|NCT02525562|79583123|FG000|Overall Study|Death|9|||
44563927|NCT02525562|79583124|FG001|Overall Study|Death|0|||
44563928|NCT02525562|79583125|FG002|Overall Study|Death|0|||
44563929|NCT02525562|79583123|FG000|Overall Study|Lost to Follow-up|19|||
44233795|NCT02724462|79053310|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
44501058|NCT03525613|79505586|FG000|Overall Study|Death|20|||
44501059|NCT03525613|79505587|FG001|Overall Study|Death|9|||
44563930|NCT02525562|79583124|FG001|Overall Study|Lost to Follow-up|0|||
44563931|NCT02525562|79583125|FG002|Overall Study|Lost to Follow-up|0|||
44563932|NCT02525562|79583123|FG000|Overall Study|Withdrawal by Subject|37|||
44563933|NCT02525562|79583124|FG001|Overall Study|Withdrawal by Subject|0|||
44563934|NCT02525562|79583125|FG002|Overall Study|Withdrawal by Subject|0|||
44563935|NCT02525562|79583123|FG000|Overall Study|Revision/Removal of Study Device|4|||
44563936|NCT02525562|79583124|FG001|Overall Study|Revision/Removal of Study Device|0|||
44233796|NCT02724462|79053311|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
44501060|NCT03525613|79505588|FG002|Overall Study|Death|7|||
44501061|NCT03525613|79505589|FG003|Overall Study|Death|1|||
44501062|NCT03525613|79505586|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
44501063|NCT03525613|79505587|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
44501064|NCT03525613|79505588|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
44501065|NCT03525613|79505589|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
44563937|NCT02525562|79583125|FG002|Overall Study|Revision/Removal of Study Device|0|||
44233797|NCT02724462|79053310|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
44501066|NCT03500692|79505603|FG000|Overall Study|Death|163|||
44501067|NCT03500692|79505603|FG000|Overall Study|Lost to Follow-up|76|||
44501068|NCT03500692|79505603|FG000|Overall Study|Termination Reasons|3|||
44563938|NCT02525562|79583123|FG000|Overall Study|Study Closed by Sponsor|154|||
44563939|NCT02525562|79583124|FG001|Overall Study|Study Closed by Sponsor|0|||
44563940|NCT02525562|79583125|FG002|Overall Study|Study Closed by Sponsor|0|||
44563941|NCT02524730|79583130|FG000|Overall Study|Lost to Follow-up|5|||
44563942|NCT02524730|79583130|FG000|Overall Study|Withdrawal by Subject|18|||
44563943|NCT02524730|79583130|FG000|Overall Study|Death|10|||
44563944|NCT02524730|79583130|FG000|Overall Study|Adverse Event|8|||
44501069|NCT03404960|79505618|FG000|Overall Study|Adverse Event|0|||
44501070|NCT03404960|79505619|FG001|Overall Study|Adverse Event|2|||
44501071|NCT03404960|79505618|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
44501072|NCT03404960|79505619|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
44501073|NCT03404960|79505618|FG000|Overall Study|Bowel obstruction|0|||
44501074|NCT03404960|79505619|FG001|Overall Study|Bowel obstruction|1|||
44501075|NCT03404960|79505618|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
44501076|NCT03404960|79505619|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
44501077|NCT03264404|79505625|FG000|Overall Study|Death|2|||
44501078|NCT03264404|79505625|FG000|Overall Study|Physician Decision|1|||
44501079|NCT03264404|79505625|FG000|Overall Study|Disease Progression|28|||
44501080|NCT03264404|79505625|FG000|Overall Study|Adverse Event|1|||
44501081|NCT03264404|79505625|FG000|Overall Study|Off study prior to treatment|2|||
44501082|NCT03118570|79505643|FG000|Overall Study|Adverse Event|2|||
44501083|NCT03118570|79505644|FG001|Overall Study|Adverse Event|0|||
44501084|NCT03118570|79505645|FG002|Overall Study|Adverse Event|0|||
44501085|NCT03118570|79505646|FG003|Overall Study|Adverse Event|0|||
44501086|NCT03118570|79505647|FG004|Overall Study|Adverse Event|3|||
44501087|NCT03118570|79505643|FG000|Overall Study|Withdrawal by Subject|0|||
44501088|NCT03118570|79505644|FG001|Overall Study|Withdrawal by Subject|1|||
44501089|NCT03118570|79505645|FG002|Overall Study|Withdrawal by Subject|4|||
44501090|NCT03118570|79505646|FG003|Overall Study|Withdrawal by Subject|0|||
44501091|NCT03118570|79505647|FG004|Overall Study|Withdrawal by Subject|1|||
44501092|NCT03118570|79505643|FG000|Overall Study|Lost to Follow-up|2|||
44501093|NCT03118570|79505644|FG001|Overall Study|Lost to Follow-up|3|||
44501094|NCT03118570|79505645|FG002|Overall Study|Lost to Follow-up|1|||
44501095|NCT03118570|79505646|FG003|Overall Study|Lost to Follow-up|0|||
44501096|NCT03118570|79505647|FG004|Overall Study|Lost to Follow-up|1|||
44501097|NCT03118570|79505643|FG000|Overall Study|Other, Not Specified|1|||
44501098|NCT03118570|79505644|FG001|Overall Study|Other, Not Specified|3|||
44501099|NCT03118570|79505645|FG002|Overall Study|Other, Not Specified|0|||
44501100|NCT03118570|79505646|FG003|Overall Study|Other, Not Specified|0|||
44501101|NCT03118570|79505647|FG004|Overall Study|Other, Not Specified|0|||
44501102|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
44501103|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
44501104|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
44501105|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
44501106|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
44501107|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
44501108|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
44501109|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
44501110|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
44501111|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
44501112|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
44501113|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
44501114|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
44501115|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
44501116|NCT02971683|79505662|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
44501117|NCT02971683|79505663|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
44501118|NCT02971683|79505662|FG000|Open-Label|Lost to Follow-up|1|||
44501119|NCT02971683|79505663|FG001|Open-Label|Lost to Follow-up|0|||
44501120|NCT02971683|79505662|FG000|Open-Label|Participants withdrew consent|0|||
44501121|NCT02971683|79505663|FG001|Open-Label|Participants withdrew consent|2|||
44501122|NCT02971683|79505662|FG000|Open-Label|Participant request to discontinue study treatment|1|||
44501123|NCT02971683|79505663|FG001|Open-Label|Participant request to discontinue study treatment|0|||
44501124|NCT02971683|79505662|FG000|Open-Label|Lack of Efficacy|2|||
44563945|NCT02524730|79583130|FG000|Overall Study|Protocol Violation|1|||
44501125|NCT02971683|79505663|FG001|Open-Label|Lack of Efficacy|0|||
44501126|NCT02971683|79505662|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
44501127|NCT02971683|79505663|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
44501128|NCT02971683|79505662|FG000|Long-Term Open Label|Participant withdrew consent|1|||
44501129|NCT02971683|79505663|FG001|Long-Term Open Label|Participant withdrew consent|0|||
44501130|NCT02971683|79505662|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
44501131|NCT02971683|79505663|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
44275440|NCT02609828|79221910|FG003|Overall Study|Lost to Follow-up|1|||
44563946|NCT02524730|79583130|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
44563947|NCT02522728|79583136|FG000|Overall Study|Withdrawal by Subject|6|||
44563948|NCT02522728|79583137|FG001|Overall Study|Withdrawal by Subject|6|||
44563949|NCT02522728|79583136|FG000|Overall Study|Death|4|||
44563950|NCT02522728|79583137|FG001|Overall Study|Death|3|||
44563951|NCT02522728|79583136|FG000|Overall Study|Adverse Event|2|||
44563952|NCT02522728|79583137|FG001|Overall Study|Adverse Event|1|||
44563953|NCT02522728|79583136|FG000|Overall Study|Did not receive randomized study device|0|||
44563954|NCT02522728|79583137|FG001|Overall Study|Did not receive randomized study device|1|||
44563955|NCT02520531|79583145|FG000|Overall Study|Revision of study device components|2|||
44563956|NCT02520531|79583146|FG001|Overall Study|Revision of study device components|2|||
44563957|NCT02520531|79583145|FG000|Overall Study|Death|1|||
44563958|NCT02520531|79583146|FG001|Overall Study|Death|2|||
44563959|NCT02520531|79583145|FG000|Overall Study|Lost to Follow-up|1|||
44563960|NCT02520531|79583146|FG001|Overall Study|Lost to Follow-up|1|||
44563961|NCT02520531|79583145|FG000|Overall Study|Meet exclusion criterion|0|||
44563962|NCT02520531|79583146|FG001|Overall Study|Meet exclusion criterion|1|||
44563963|NCT02520531|79583145|FG000|Overall Study|Withdrawal by Subject|1|||
44563964|NCT02520531|79583146|FG001|Overall Study|Withdrawal by Subject|0|||
44563965|NCT02520531|79583145|FG000|Overall Study|Not study device|1|||
44563966|NCT02520531|79583146|FG001|Overall Study|Not study device|0|||
44563967|NCT02446236|79583155|FG000|Overall Study|Screen Failure|1|||
44563968|NCT02446236|79583156|FG001|Overall Study|Screen Failure|0|||
44563969|NCT02446236|79583157|FG002|Overall Study|Screen Failure|1|||
44563970|NCT02446236|79583155|FG000|Overall Study|Actively Receiving Therapy|0|||
44563971|NCT02446236|79583156|FG001|Overall Study|Actively Receiving Therapy|0|||
44563972|NCT02446236|79583157|FG002|Overall Study|Actively Receiving Therapy|1|||
44563973|NCT02441803|79583166|FG000|Overall Study|Physician Decision|0|||
44563974|NCT02441803|79583167|FG001|Overall Study|Physician Decision|2|||
44563975|NCT02441803|79583168|FG002|Overall Study|Physician Decision|2|||
44563976|NCT02421939|79583178|FG000|Overall Study|Progressive disease|70|||
44563977|NCT02421939|79583179|FG001|Overall Study|Progressive disease|16|||
44563978|NCT02421939|79583178|FG000|Overall Study|Lack of Efficacy|21|||
44563979|NCT02421939|79583179|FG001|Overall Study|Lack of Efficacy|31|||
44563980|NCT02421939|79583178|FG000|Overall Study|Death|36|||
44563981|NCT02421939|79583179|FG001|Overall Study|Death|10|||
44563982|NCT02421939|79583178|FG000|Overall Study|Disease relapse|33|||
44563983|NCT02421939|79583179|FG001|Overall Study|Disease relapse|2|||
44563984|NCT02421939|79583178|FG000|Overall Study|Adverse Event|28|||
44563985|NCT02421939|79583179|FG001|Overall Study|Adverse Event|5|||
44563986|NCT02421939|79583178|FG000|Overall Study|Withdrawal by Subject|5|||
44563987|NCT02421939|79583179|FG001|Overall Study|Withdrawal by Subject|24|||
44563988|NCT02421939|79583178|FG000|Overall Study|Physician Decision|11|||
44563989|NCT02421939|79583179|FG001|Overall Study|Physician Decision|11|||
44563990|NCT02421939|79583178|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
44563991|NCT02421939|79583179|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
44563992|NCT02421939|79583178|FG000|Overall Study|Miscellaneous|4|||
44563993|NCT02421939|79583179|FG001|Overall Study|Miscellaneous|5|||
44563994|NCT02421939|79583178|FG000|Overall Study|Protocol deviation|1|||
44563995|NCT02421939|79583179|FG001|Overall Study|Protocol deviation|1|||
44563996|NCT02337829|79583189|FG000|Overall Study|Death|0|||
44563997|NCT02337829|79583190|FG001|Overall Study|Death|1|||
44563998|NCT02337829|79583191|FG002|Overall Study|Death|0|||
44563999|NCT02337829|79583192|FG003|Overall Study|Death|0|||
44564000|NCT02337829|79583189|FG000|Overall Study|Study terminated by sponsor|12|||
44564001|NCT02337829|79583190|FG001|Overall Study|Study terminated by sponsor|10|||
44564002|NCT02337829|79583191|FG002|Overall Study|Study terminated by sponsor|5|||
44564003|NCT02337829|79583192|FG003|Overall Study|Study terminated by sponsor|6|||
44564004|NCT02337829|79583189|FG000|Overall Study|discontinued for other reasons|6|||
44564005|NCT02337829|79583190|FG001|Overall Study|discontinued for other reasons|3|||
44564006|NCT02337829|79583191|FG002|Overall Study|discontinued for other reasons|1|||
44275441|NCT02609828|79221907|FG000|Overall Study|Protocol Violation|2|||
44275442|NCT02609828|79221908|FG001|Overall Study|Protocol Violation|0|||
44275443|NCT02609828|79221909|FG002|Overall Study|Protocol Violation|0|||
44275444|NCT02609828|79221910|FG003|Overall Study|Protocol Violation|1|||
44501132|NCT02971683|79505662|FG000|Long-Term Open Label|Adverse Event|1|||
44501133|NCT02971683|79505663|FG001|Long-Term Open Label|Adverse Event|2|||
44501134|NCT02971683|79505662|FG000|Long-Term Open Label|Lack of Efficacy|1|||
44501135|NCT02971683|79505663|FG001|Long-Term Open Label|Lack of Efficacy|1|||
44501136|NCT02899299|79505671|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
44501137|NCT02899299|79505672|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
44501138|NCT02899299|79505671|FG000|Pre-treatment|Participant withdrew consent|1|||
44501139|NCT02899299|79505672|FG001|Pre-treatment|Participant withdrew consent|11|||
44564007|NCT02337829|79583192|FG003|Overall Study|discontinued for other reasons|4|||
44564008|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
44564009|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
44564010|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
44564011|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
44564012|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
44564013|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
44564014|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
44564015|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
44564016|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
44564017|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
44564018|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
44564019|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
44564020|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
44564021|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
44564022|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
44564023|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
44564024|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
44564025|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
44564026|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
44564027|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
44564028|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
44564029|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
44564030|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
44564031|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
44564032|NCT02120352|79583204|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
44564033|NCT02120352|79583205|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
44564034|NCT02120352|79583206|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
44564035|NCT02120352|79583207|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
44564036|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
44564037|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
44564038|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
44275445|NCT02609828|79221907|FG000|Overall Study|Withdrawal by Subject|12|||
44275446|NCT02609828|79221908|FG001|Overall Study|Withdrawal by Subject|1|||
44275447|NCT02609828|79221909|FG002|Overall Study|Withdrawal by Subject|0|||
44275448|NCT02609828|79221910|FG003|Overall Study|Withdrawal by Subject|10|||
44275449|NCT02609828|79221907|FG000|Overall Study|Other|3|||
44275450|NCT02609828|79221908|FG001|Overall Study|Other|0|||
44275451|NCT02609828|79221909|FG002|Overall Study|Other|0|||
44275452|NCT02609828|79221910|FG003|Overall Study|Other|6|||
44275453|NCT02609828|79221907|FG000|Overall Study|Randomized but not treated|1|||
44275454|NCT02609828|79221908|FG001|Overall Study|Randomized but not treated|0|||
44275455|NCT02609828|79221909|FG002|Overall Study|Randomized but not treated|0|||
44275456|NCT02609828|79221910|FG003|Overall Study|Randomized but not treated|0|||
44275457|NCT01632306|79221926|FG000|Overall Study|Protocol Violation|1|||
44275458|NCT01632306|79221927|FG001|Overall Study|Protocol Violation|0|||
44275459|NCT01632306|79221928|FG002|Overall Study|Protocol Violation|0|||
44275460|NCT02201784|79221936|FG000|Overall Study|Failure to achieve adequate block|2|||
44275461|NCT02201784|79221937|FG001|Overall Study|Failure to achieve adequate block|0|||
44275462|NCT02201472|79221943|FG000|Overall Study|Lack of Efficacy|2|||
44275463|NCT02168946|79221988|FG000|Overall Study|Adverse Event|8|||
44275464|NCT02168946|79221989|FG001|Overall Study|Adverse Event|5|||
44275465|NCT02168946|79221988|FG000|Overall Study|Lost to Follow-up|3|||
44275466|NCT02168946|79221989|FG001|Overall Study|Lost to Follow-up|0|||
44275467|NCT02168946|79221988|FG000|Overall Study|Subject unable to come back for visits|1|||
44275468|NCT02168946|79221989|FG001|Overall Study|Subject unable to come back for visits|0|||
44501140|NCT02899299|79505671|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
44501141|NCT02899299|79505672|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
44501142|NCT02899299|79505671|FG000|Pre-treatment|Not reported|0|||
44501143|NCT02899299|79505672|FG001|Pre-treatment|Not reported|1|||
44501144|NCT02899299|79505671|FG000|Treatment|Disease Progression|182|||
44501145|NCT02899299|79505672|FG001|Treatment|Disease Progression|44|||
44501146|NCT02899299|79505671|FG000|Treatment|Study Drug Toxicity|59|||
44501147|NCT02899299|79505672|FG001|Treatment|Study Drug Toxicity|24|||
44501148|NCT02899299|79505671|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
44501149|NCT02899299|79505672|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
44501150|NCT02899299|79505671|FG000|Treatment|Participant request to discontinue Study treatment|4|||
44501151|NCT02899299|79505672|FG001|Treatment|Participant request to discontinue Study treatment|10|||
44501152|NCT02899299|79505671|FG000|Treatment|Participant withdrew consent|6|||
44501153|NCT02899299|79505672|FG001|Treatment|Participant withdrew consent|3|||
44501154|NCT02899299|79505671|FG000|Treatment|Lost to Follow-up|0|||
44501155|NCT02899299|79505672|FG001|Treatment|Lost to Follow-up|1|||
44501156|NCT02899299|79505671|FG000|Treatment|Maximum Clinical Benefit|10|||
44501157|NCT02899299|79505672|FG001|Treatment|Maximum Clinical Benefit|2|||
44564039|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
44564040|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
44564041|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
44564042|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
44564043|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
44564044|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
44564045|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
44564046|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
44564047|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
44564048|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
44564049|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
44564050|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
44564051|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
44564052|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
44564053|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
44564054|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
44564055|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
44564056|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
44564057|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
44564058|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
44564059|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
44564060|NCT02120352|79583204|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
44564061|NCT02120352|79583205|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
44564062|NCT02120352|79583206|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
44564063|NCT02120352|79583207|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
44564064|NCT02040857|79583221|FG000|Overall Study|Adverse Event|14|||
44564065|NCT02040857|79583221|FG000|Overall Study|Physician Decision|5|||
44564066|NCT02040857|79583221|FG000|Overall Study|Withdrawal by Subject|31|||
44564067|NCT02040857|79583221|FG000|Overall Study|patient non-compliance|3|||
44564068|NCT02040857|79583221|FG000|Overall Study|Lost to Follow-up|2|||
44564069|NCT02040857|79583221|FG000|Overall Study|recurrence|4|||
44564070|NCT02040857|79583221|FG000|Overall Study|ineligible|1|||
44564071|NCT00676715|79583258|FG000|Overall Study|Withdrawal by Subject|7|||
44564072|NCT00676715|79583259|FG001|Overall Study|Withdrawal by Subject|9|||
44564073|NCT00676715|79583260|FG002|Overall Study|Withdrawal by Subject|10|||
44564074|NCT00676715|79583261|FG003|Overall Study|Withdrawal by Subject|10|||
44564075|NCT00676715|79583258|FG000|Overall Study|Other|2|||
44564076|NCT00676715|79583259|FG001|Overall Study|Other|6|||
44564077|NCT00676715|79583260|FG002|Overall Study|Other|4|||
44564078|NCT00676715|79583261|FG003|Overall Study|Other|3|||
44564079|NCT00676715|79583258|FG000|Overall Study|Lost to Follow-up|1|||
44564080|NCT00676715|79583259|FG001|Overall Study|Lost to Follow-up|1|||
44564081|NCT00676715|79583260|FG002|Overall Study|Lost to Follow-up|7|||
44564082|NCT00676715|79583261|FG003|Overall Study|Lost to Follow-up|3|||
44564083|NCT00676715|79583258|FG000|Overall Study|Death|1|||
44564084|NCT00676715|79583259|FG001|Overall Study|Death|1|||
44564085|NCT00676715|79583260|FG002|Overall Study|Death|1|||
44564086|NCT00676715|79583261|FG003|Overall Study|Death|0|||
44564087|NCT00676715|79583258|FG000|Overall Study|Adverse Event|0|||
44564088|NCT00676715|79583259|FG001|Overall Study|Adverse Event|1|||
44564089|NCT00676715|79583260|FG002|Overall Study|Adverse Event|2|||
44564090|NCT00676715|79583261|FG003|Overall Study|Adverse Event|0|||
44564091|NCT00676715|79583258|FG000|Overall Study|Participants Ongoing|29|||
44564092|NCT00676715|79583259|FG001|Overall Study|Participants Ongoing|29|||
44564093|NCT00676715|79583260|FG002|Overall Study|Participants Ongoing|17|||
44564094|NCT00676715|79583261|FG003|Overall Study|Participants Ongoing|24|||
44564095|NCT00436982|79583273|FG000|Overall Study|Withdrawal by Subject|3|||
44564096|NCT00436982|79583274|FG001|Overall Study|Withdrawal by Subject|1|||
44564097|NCT00436982|79583273|FG000|Overall Study|Did not receive allocated intervention|0|||
44564098|NCT00436982|79583274|FG001|Overall Study|Did not receive allocated intervention|1|||
44564099|NCT00436982|79583273|FG000|Overall Study|no RSA data|1|||
44564100|NCT00436982|79583274|FG001|Overall Study|no RSA data|2|||
44564101|NCT00378105|79583286|FG000|Overall Study|Adverse Event|3|||
44564102|NCT00378105|79583287|FG001|Overall Study|Adverse Event|1|||
44564103|NCT00378105|79583286|FG000|Overall Study|Withdrawal by Subject|3|||
44564104|NCT00378105|79583287|FG001|Overall Study|Withdrawal by Subject|3|||
44564105|NCT00378105|79583286|FG000|Overall Study|Death|1|||
44564106|NCT00378105|79583287|FG001|Overall Study|Death|0|||
44564107|NCT00378105|79583286|FG000|Overall Study|Going to transplant|7|||
44564108|NCT00378105|79583287|FG001|Overall Study|Going to transplant|8|||
44564109|NCT00378105|79583286|FG000|Overall Study|Progressive disease|3|||
44564110|NCT00378105|79583287|FG001|Overall Study|Progressive disease|3|||
44564111|NCT00378105|79583286|FG000|Overall Study|remain on study|3|||
44564112|NCT00378105|79583287|FG001|Overall Study|remain on study|11|||
44564113|NCT00378105|79583286|FG000|Overall Study|Physician Decision|0|||
44501158|NCT02899299|79505671|FG000|Treatment|Poor/Non-compliance|1|||
44501159|NCT02899299|79505672|FG001|Treatment|Poor/Non-compliance|0|||
44501160|NCT02899299|79505671|FG000|Treatment|Participant no longer meets Study criteria|4|||
44501161|NCT02899299|79505672|FG001|Treatment|Participant no longer meets Study criteria|0|||
44501162|NCT02899299|79505671|FG000|Treatment|Administrative reason by Sponsor|2|||
44501163|NCT02899299|79505672|FG001|Treatment|Administrative reason by Sponsor|0|||
44501164|NCT02899299|79505671|FG000|Treatment|Other reasons|11|||
44501165|NCT02899299|79505672|FG001|Treatment|Other reasons|2|||
44501166|NCT02899299|79505671|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
44501167|NCT02899299|79505672|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
44501168|NCT02899195|79505678|FG000|Concurrent Durvalumab|Adverse Event|4|||
44501169|NCT02899195|79505678|FG000|Concurrent Durvalumab|Physician Decision|1|||
44501170|NCT02899195|79505678|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
44501171|NCT02899195|79505678|FG000|Concurrent Durvalumab|Progressive Disease|5|||
44501172|NCT02899195|79505678|FG000|Maintenance Durvalumab|Adverse Event|1|||
44501173|NCT02899195|79505678|FG000|Maintenance Durvalumab|Physician Decision|1|||
44501174|NCT02899195|79505678|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
44501175|NCT02899195|79505678|FG000|Maintenance Durvalumab|Progressive Disease|31|||
44501176|NCT02581943|79505747|FG000|Overall Study|Death|5|||
44501177|NCT02581943|79505748|FG001|Overall Study|Death|2|||
44501178|NCT02581943|79505747|FG000|Overall Study|Disease Progression|12|||
44501179|NCT02581943|79505748|FG001|Overall Study|Disease Progression|15|||
44501180|NCT02581943|79505747|FG000|Overall Study|Withdrawal by Subject|1|||
44501181|NCT02581943|79505748|FG001|Overall Study|Withdrawal by Subject|2|||
44501182|NCT02527200|79505763|FG000|Overall Study|Withdrawal by Subject|3|||
44501183|NCT02527200|79505764|FG001|Overall Study|Withdrawal by Subject|2|||
44501184|NCT02527200|79505765|FG002|Overall Study|Withdrawal by Subject|1|||
44501185|NCT02527200|79505766|FG003|Overall Study|Withdrawal by Subject|0|||
44501186|NCT02527200|79505763|FG000|Overall Study|Unclassified|0|||
44501187|NCT02527200|79505764|FG001|Overall Study|Unclassified|1|||
44501188|NCT02527200|79505765|FG002|Overall Study|Unclassified|0|||
44501189|NCT02527200|79505766|FG003|Overall Study|Unclassified|0|||
44501190|NCT02527200|79505763|FG000|Overall Study|Lost to Follow-up|0|||
44501191|NCT02527200|79505764|FG001|Overall Study|Lost to Follow-up|0|||
44501192|NCT02527200|79505765|FG002|Overall Study|Lost to Follow-up|1|||
44501193|NCT02527200|79505766|FG003|Overall Study|Lost to Follow-up|0|||
44501194|NCT02510040|79505783|FG000|Overall Study|Deemed no longer eligible|18|||
44501195|NCT02510040|79505784|FG001|Overall Study|Deemed no longer eligible|3|||
44501196|NCT02510040|79505785|FG002|Overall Study|Deemed no longer eligible|1|||
44501197|NCT01935089|79505811|FG000|Overall Study|Adverse Event|2|||
44501198|NCT01935089|79505811|FG000|Overall Study|Withdrawal by Subject|1|||
44501199|NCT00571727|79505847|FG000|Overall Study|Did not enter in this study|1|||
44501200|NCT00571727|79505847|FG000|Overall Study|Non-compliance|4|||
44501201|NCT00571727|79505847|FG000|Overall Study|Lost to Follow-up|30|||
44501202|NCT00571727|79505847|FG000|Overall Study|Poor growth|1|||
44501203|NCT00571727|79505847|FG000|Overall Study|Parent/patient decision|2|||
44501204|NCT00571727|79505847|FG000|Overall Study|Participant transferred to commercial drug|14|||
44501205|NCT00571727|79505847|FG000|Overall Study|Unable to provide study drug|6|||
44501206|NCT00571727|79505847|FG000|Overall Study|On-treatment at end of study|8|||
44501207|NCT00427349|79505851|FG000|Overall Study|Lack of Efficacy|23|||
44501208|NCT00427349|79505851|FG000|Overall Study|Adverse Event|14|||
44501209|NCT00427349|79505851|FG000|Overall Study|Death|1|||
44564114|NCT00378105|79583287|FG001|Overall Study|Physician Decision|2|||
44564115|NCT00378105|79583286|FG000|Overall Study|Going non-protocol therapy|0|||
44564116|NCT00378105|79583287|FG001|Overall Study|Going non-protocol therapy|1|||
44233798|NCT02724462|79053311|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
44233799|NCT02724462|79053310|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
44233800|NCT02724462|79053311|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
44233801|NCT02724462|79053310|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
44233802|NCT02724462|79053311|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
44233803|NCT02725476|79053368|FG000|Overall Study|Physician Decision|2|||
44233804|NCT02725476|79053369|FG001|Overall Study|Physician Decision|0|||
44233805|NCT02725476|79053368|FG000|Overall Study|Adverse Event|1|||
44377172|NCT00852202|79382482|FG001|Overall Study|pregnancy,moving away and surgery|0|||
44501210|NCT00427349|79505851|FG000|Overall Study|Withdrawal by Subject|3|||
44501211|NCT00427349|79505851|FG000|Overall Study|Alternative therapy|1|||
44501212|NCT00427349|79505851|FG000|Overall Study|Other|2|||
44501213|NCT00427349|79505851|FG000|Overall Study|Ineligible|1|||
44501214|NCT00427349|79505851|FG000|Overall Study|Never started therapy|1|||
44501215|NCT00309985|79505857|FG000|Overall Study|Disease progression|12|||
44501216|NCT00309985|79505858|FG001|Overall Study|Disease progression|0|||
44501217|NCT00309985|79505857|FG000|Overall Study|Adverse Event|30|||
44501218|NCT00309985|79505858|FG001|Overall Study|Adverse Event|0|||
44501219|NCT00309985|79505857|FG000|Overall Study|Death|2|||
44501220|NCT00309985|79505858|FG001|Overall Study|Death|0|||
44564117|NCT00378105|79583286|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
44564118|NCT00378105|79583287|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
44564119|NCT02806232|79583303|FG000|Overall Study|Lost to Follow-up|1|||
44564120|NCT02806232|79583304|FG001|Overall Study|Lost to Follow-up|2|||
44564121|NCT02806232|79583305|FG002|Overall Study|Lost to Follow-up|1|||
44564122|NCT02806232|79583306|FG003|Overall Study|Lost to Follow-up|0|||
44564123|NCT02806232|79583307|FG004|Overall Study|Lost to Follow-up|0|||
44564124|NCT02806232|79583308|FG005|Overall Study|Lost to Follow-up|1|||
44564125|NCT02806232|79583309|FG006|Overall Study|Lost to Follow-up|0|||
44564126|NCT02806232|79583310|FG007|Overall Study|Lost to Follow-up|0|||
44564127|NCT02806232|79583311|FG008|Overall Study|Lost to Follow-up|0|||
44564128|NCT02806232|79583303|FG000|Overall Study|Withdrawal by Subject|0|||
44564129|NCT02806232|79583304|FG001|Overall Study|Withdrawal by Subject|2|||
44564130|NCT02806232|79583305|FG002|Overall Study|Withdrawal by Subject|0|||
44564131|NCT02806232|79583306|FG003|Overall Study|Withdrawal by Subject|0|||
44564132|NCT02806232|79583307|FG004|Overall Study|Withdrawal by Subject|2|||
44564133|NCT02806232|79583308|FG005|Overall Study|Withdrawal by Subject|1|||
44564134|NCT02806232|79583309|FG006|Overall Study|Withdrawal by Subject|0|||
44564135|NCT02806232|79583310|FG007|Overall Study|Withdrawal by Subject|0|||
44564136|NCT02806232|79583311|FG008|Overall Study|Withdrawal by Subject|0|||
44233806|NCT02725476|79053369|FG001|Overall Study|Adverse Event|1|||
44233807|NCT02725008|79053470|FG000|Overall Study|Lost to Follow-up|7|||
44501221|NCT00309985|79505857|FG000|Overall Study|Withdrawal by Subject|5|||
44501222|NCT00309985|79505858|FG001|Overall Study|Withdrawal by Subject|1|||
44501223|NCT00309985|79505857|FG000|Overall Study|Physician Decision|3|||
44501224|NCT00309985|79505858|FG001|Overall Study|Physician Decision|0|||
44501225|NCT00309985|79505857|FG000|Overall Study|Never started treatment|7|||
44501226|NCT00309985|79505858|FG001|Overall Study|Never started treatment|0|||
44501227|NCT00309985|79505857|FG000|Overall Study|Complicating disease|1|||
44501228|NCT00309985|79505858|FG001|Overall Study|Complicating disease|0|||
44501229|NCT00309985|79505857|FG000|Overall Study|Non-compliance|1|||
44501230|NCT00309985|79505858|FG001|Overall Study|Non-compliance|0|||
44501231|NCT00309985|79505857|FG000|Overall Study|Chemotherapy discontinued only|1|||
44501232|NCT00309985|79505858|FG001|Overall Study|Chemotherapy discontinued only|0|||
44501233|NCT00098787|79505867|FG000|Overall Study|Never started treatment|3|||
44501234|NCT00098787|79505868|FG001|Overall Study|Never started treatment|2|||
44501235|NCT00098787|79505869|FG002|Overall Study|Never started treatment|1|||
44501236|NCT00098787|79505867|FG000|Overall Study|Ineligible|9|||
44501237|NCT00098787|79505868|FG001|Overall Study|Ineligible|7|||
44501238|NCT00098787|79505869|FG002|Overall Study|Ineligible|3|||
44501239|NCT00098787|79505867|FG000|Overall Study|Disease progression|28|||
44501240|NCT00098787|79505868|FG001|Overall Study|Disease progression|17|||
44377173|NCT00852202|79382483|FG002|Overall Study|pregnancy,moving away and surgery|2|||
44377174|NCT01074008|79382501|FG000|Overall Study|Adverse Event|0|||
44377175|NCT01074008|79382502|FG001|Overall Study|Adverse Event|1|||
44377176|NCT01074008|79382503|FG002|Overall Study|Adverse Event|0|||
44377177|NCT01074008|79382504|FG003|Overall Study|Adverse Event|0|||
44377178|NCT01074008|79382505|FG004|Overall Study|Adverse Event|0|||
44501241|NCT00098787|79505869|FG002|Overall Study|Disease progression|23|||
44564137|NCT02807402|79583331|FG000|Overall Study|Failure to Return|1|||
44564138|NCT02807402|79583331|FG000|Overall Study|Death|3|||
44564139|NCT02807402|79583331|FG000|Overall Study|Other|2|||
44564140|NCT02960490|79583345|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
44564141|NCT02960490|79583346|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
44564142|NCT02960490|79583347|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564143|NCT02960490|79583348|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564144|NCT02960490|79583349|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564145|NCT02960490|79583350|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564146|NCT02960490|79583351|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564147|NCT02960490|79583352|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564148|NCT02960490|79583353|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44501242|NCT00098787|79505867|FG000|Overall Study|Adverse Event|8|||
44501243|NCT00098787|79505868|FG001|Overall Study|Adverse Event|17|||
44564149|NCT02960490|79583354|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
44564150|NCT02960490|79583345|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564151|NCT02960490|79583346|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
44233808|NCT02725008|79053471|FG001|Overall Study|Lost to Follow-up|9|||
44233809|NCT02725008|79053470|FG000|Overall Study|Withdrawal by Subject|2|||
44501244|NCT00098787|79505869|FG002|Overall Study|Adverse Event|8|||
44501245|NCT00098787|79505867|FG000|Overall Study|Death|6|||
44564152|NCT02960490|79583347|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564153|NCT02960490|79583348|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44501246|NCT00098787|79505868|FG001|Overall Study|Death|1|||
44564154|NCT02960490|79583349|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44501247|NCT00098787|79505869|FG002|Overall Study|Death|0|||
44377179|NCT01074008|79382506|FG005|Overall Study|Adverse Event|0|||
44564155|NCT02960490|79583350|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564156|NCT02960490|79583351|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564157|NCT02960490|79583352|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564158|NCT02960490|79583353|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564159|NCT02960490|79583354|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
44564160|NCT02960490|79583345|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
44564161|NCT02960490|79583346|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
44564162|NCT02960490|79583347|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564163|NCT02960490|79583348|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564164|NCT02960490|79583349|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564165|NCT02960490|79583350|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564166|NCT02960490|79583351|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564167|NCT02960490|79583352|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564168|NCT02960490|79583353|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564169|NCT02960490|79583354|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
44564170|NCT02960490|79583345|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
44564171|NCT02960490|79583346|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
44564172|NCT02960490|79583347|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564173|NCT02960490|79583348|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564174|NCT02960490|79583349|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564175|NCT02960490|79583350|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564176|NCT02960490|79583351|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564177|NCT02960490|79583352|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564178|NCT02960490|79583353|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564179|NCT02960490|79583354|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
44564180|NCT02960490|79583345|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44564181|NCT02960490|79583346|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44564182|NCT02960490|79583347|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
44564183|NCT02960490|79583348|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
44564184|NCT02960490|79583349|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44564185|NCT02960490|79583350|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
44564186|NCT02960490|79583351|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44564187|NCT02960490|79583352|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44564188|NCT02960490|79583353|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44233810|NCT02725008|79053471|FG001|Overall Study|Withdrawal by Subject|2|||
44233811|NCT02725008|79053470|FG000|Overall Study|Admitted to hospital|0|||
44233812|NCT02725008|79053471|FG001|Overall Study|Admitted to hospital|1|||
44233813|NCT01807949|79053743|FG000|Overall Study|Adverse Event|1|||
44233814|NCT01807949|79053744|FG001|Overall Study|Adverse Event|2|||
44233815|NCT01807949|79053745|FG002|Overall Study|Adverse Event|2|||
44233816|NCT01807949|79053743|FG000|Overall Study|Withdrawal by Subject|1|||
44233817|NCT01807949|79053744|FG001|Overall Study|Withdrawal by Subject|2|||
44501248|NCT00098787|79505867|FG000|Overall Study|Withdrawal by Subject|4|||
44501249|NCT00098787|79505868|FG001|Overall Study|Withdrawal by Subject|12|||
44501250|NCT00098787|79505869|FG002|Overall Study|Withdrawal by Subject|6|||
44501251|NCT00098787|79505867|FG000|Overall Study|Alternative therapy|8|||
44501252|NCT00098787|79505868|FG001|Overall Study|Alternative therapy|13|||
44501253|NCT00098787|79505869|FG002|Overall Study|Alternative therapy|13|||
44501254|NCT00098787|79505867|FG000|Overall Study|Other|7|||
44501255|NCT00098787|79505868|FG001|Overall Study|Other|6|||
44501256|NCT00098787|79505869|FG002|Overall Study|Other|9|||
44501257|NCT00091169|79505879|FG000|Overall Study|Disease progression|3|||
44501258|NCT00091169|79505880|FG001|Overall Study|Disease progression|1|||
44501259|NCT00091169|79505879|FG000|Overall Study|Adverse Event|11|||
44501260|NCT00091169|79505880|FG001|Overall Study|Adverse Event|17|||
44501261|NCT00091169|79505879|FG000|Overall Study|Death|4|||
44501262|NCT00091169|79505880|FG001|Overall Study|Death|1|||
44501263|NCT00091169|79505879|FG000|Overall Study|Withdrawal by Subject|10|||
44501264|NCT00091169|79505880|FG001|Overall Study|Withdrawal by Subject|13|||
44501265|NCT00091169|79505879|FG000|Overall Study|Other|3|||
44501266|NCT00091169|79505880|FG001|Overall Study|Other|4|||
44501267|NCT00091169|79505879|FG000|Overall Study|Not start protocol therapy|26|||
44501268|NCT00091169|79505880|FG001|Overall Study|Not start protocol therapy|17|||
44501269|NCT00057876|79505894|FG000|Overall Study|Adverse Event|8|||
44501270|NCT00057876|79505895|FG001|Overall Study|Adverse Event|8|||
44233818|NCT01807949|79053745|FG002|Overall Study|Withdrawal by Subject|2|||
44501271|NCT00057876|79505894|FG000|Overall Study|Death|2|||
44501272|NCT00057876|79505895|FG001|Overall Study|Death|1|||
44501273|NCT00057876|79505894|FG000|Overall Study|Withdrawal by Subject|5|||
44501274|NCT00057876|79505895|FG001|Overall Study|Withdrawal by Subject|6|||
44501275|NCT00057876|79505894|FG000|Overall Study|Lack of Efficacy|10|||
44564189|NCT02960490|79583354|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
44564190|NCT02960490|79583345|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564191|NCT02960490|79583346|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564192|NCT02960490|79583347|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
44564193|NCT02960490|79583348|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564194|NCT02960490|79583349|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
44564195|NCT02960490|79583350|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564196|NCT02960490|79583351|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564197|NCT02960490|79583352|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564198|NCT02960490|79583353|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564199|NCT02960490|79583354|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
44564200|NCT02960490|79583345|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
44564201|NCT02960490|79583346|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
44564202|NCT02960490|79583347|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
44564203|NCT02960490|79583348|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
44564204|NCT02960490|79583349|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
44233819|NCT01807949|79053743|FG000|Overall Study|Non-Compliance|0|||
44233820|NCT01807949|79053744|FG001|Overall Study|Non-Compliance|0|||
44501276|NCT00057876|79505895|FG001|Overall Study|Lack of Efficacy|8|||
44501277|NCT00057876|79505894|FG000|Overall Study|Ineligible|1|||
44501278|NCT00057876|79505895|FG001|Overall Study|Ineligible|2|||
44501279|NCT00057876|79505894|FG000|Overall Study|other reason|2|||
44501280|NCT00057876|79505895|FG001|Overall Study|other reason|2|||
44501281|NCT00057876|79505894|FG000|Overall Study|other complicating disease|1|||
44501282|NCT00057876|79505895|FG001|Overall Study|other complicating disease|0|||
44501283|NCT00057837|79505903|FG000|Overall Study|Progression/relapse|12|||
44501284|NCT00057837|79505904|FG001|Overall Study|Progression/relapse|14|||
44501285|NCT00057837|79505903|FG000|Overall Study|Adverse Event|2|||
44501286|NCT00057837|79505904|FG001|Overall Study|Adverse Event|12|||
44501287|NCT00057837|79505903|FG000|Overall Study|Death|5|||
44501288|NCT00057837|79505904|FG001|Overall Study|Death|4|||
44501289|NCT00057837|79505903|FG000|Overall Study|Withdrawal by Subject|5|||
44501290|NCT00057837|79505904|FG001|Overall Study|Withdrawal by Subject|3|||
44501291|NCT00057837|79505903|FG000|Overall Study|Alternative therapy|0|||
44501292|NCT00057837|79505904|FG001|Overall Study|Alternative therapy|1|||
44501293|NCT00057837|79505903|FG000|Overall Study|Other complicating disease|2|||
44501294|NCT00057837|79505904|FG001|Overall Study|Other complicating disease|1|||
44501295|NCT00057837|79505903|FG000|Overall Study|Physician Decision|1|||
44501296|NCT00057837|79505904|FG001|Overall Study|Physician Decision|0|||
44501297|NCT00057837|79505903|FG000|Overall Study|Ineligible|3|||
44501298|NCT00057837|79505904|FG001|Overall Study|Ineligible|3|||
44501299|NCT00057837|79505903|FG000|Overall Study|Never started treatment|1|||
44501300|NCT00057837|79505904|FG001|Overall Study|Never started treatment|1|||
44501301|NCT00046930|79505912|FG000|Overall Study|Ineligible|12|||
44501302|NCT00046930|79505913|FG001|Overall Study|Ineligible|4|||
44501303|NCT00042939|79505924|FG000|Overall Study|Adverse Event|6|||
44501304|NCT00042939|79505925|FG001|Overall Study|Adverse Event|7|||
44501305|NCT00042939|79505924|FG000|Overall Study|Death|3|||
44501306|NCT00042939|79505925|FG001|Overall Study|Death|2|||
44501307|NCT00042939|79505924|FG000|Overall Study|Withdrawal by Subject|3|||
44501308|NCT00042939|79505925|FG001|Overall Study|Withdrawal by Subject|4|||
44501309|NCT00042939|79505924|FG000|Overall Study|Other disease|1|||
44501310|NCT00042939|79505925|FG001|Overall Study|Other disease|0|||
44501311|NCT00042939|79505924|FG000|Overall Study|Ineligible|2|||
44501312|NCT00042939|79505925|FG001|Overall Study|Ineligible|2|||
44501313|NCT00042939|79505924|FG000|Overall Study|Deterioration of health|3|||
44501314|NCT00042939|79505925|FG001|Overall Study|Deterioration of health|4|||
44501315|NCT00042939|79505924|FG000|Overall Study|QOL diminished|1|||
44501316|NCT00042939|79505925|FG001|Overall Study|QOL diminished|0|||
44501317|NCT00042939|79505924|FG000|Overall Study|Rising ca 19-9|1|||
44501318|NCT00042939|79505925|FG001|Overall Study|Rising ca 19-9|0|||
44501319|NCT00042939|79505924|FG000|Overall Study|Patient non-compliance|1|||
44501320|NCT00042939|79505925|FG001|Overall Study|Patient non-compliance|0|||
44501321|NCT00042939|79505924|FG000|Overall Study|Still on treatment|1|||
44501322|NCT00042939|79505925|FG001|Overall Study|Still on treatment|0|||
44501323|NCT00042939|79505924|FG000|Overall Study|Treatment break > 4 weeks|0|||
44501324|NCT00042939|79505925|FG001|Overall Study|Treatment break > 4 weeks|1|||
44501325|NCT00042939|79505924|FG000|Overall Study|Did not start treatment|2|||
44501326|NCT00042939|79505925|FG001|Overall Study|Did not start treatment|1|||
44501327|NCT00008385|79505933|FG000|Overall Study|Off treatment reasons not reported|79|||
44501328|NCT00008385|79505934|FG001|Overall Study|Off treatment reasons not reported|70|||
44501329|NCT00008385|79505933|FG000|Overall Study|Progressive disease|52|||
44501330|NCT00008385|79505934|FG001|Overall Study|Progressive disease|117|||
44564205|NCT02960490|79583350|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
44501331|NCT00008385|79505933|FG000|Overall Study|Adverse Event|8|||
44501332|NCT00008385|79505934|FG001|Overall Study|Adverse Event|20|||
44564206|NCT02960490|79583351|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
44564207|NCT02960490|79583352|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
44564208|NCT02960490|79583353|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
44564209|NCT02960490|79583354|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
44564210|NCT02960490|79583345|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44233821|NCT01807949|79053745|FG002|Overall Study|Non-Compliance|1|||
44501333|NCT00008385|79505933|FG000|Overall Study|Death|12|||
44501334|NCT00008385|79505934|FG001|Overall Study|Death|18|||
44501335|NCT00008385|79505933|FG000|Overall Study|Withdrawal by Subject|67|||
44501336|NCT00008385|79505934|FG001|Overall Study|Withdrawal by Subject|157|||
44501337|NCT00008385|79505933|FG000|Overall Study|Start non-protocol therapy|3|||
44501338|NCT00008385|79505934|FG001|Overall Study|Start non-protocol therapy|1|||
44501339|NCT00008385|79505933|FG000|Overall Study|Other complicating disease|17|||
44501340|NCT00008385|79505934|FG001|Overall Study|Other complicating disease|30|||
44501341|NCT00008385|79505933|FG000|Overall Study|Maximum dose reached|0|||
44501342|NCT00008385|79505934|FG001|Overall Study|Maximum dose reached|2|||
44501343|NCT00008385|79505933|FG000|Overall Study|Other|105|||
44501344|NCT00008385|79505934|FG001|Overall Study|Other|212|||
44564211|NCT02960490|79583346|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44501345|NCT00008385|79505933|FG000|Overall Study|Not start protocol therapy|44|||
44564212|NCT02960490|79583347|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44564213|NCT02960490|79583348|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44564214|NCT02960490|79583349|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44501346|NCT00008385|79505934|FG001|Overall Study|Not start protocol therapy|175|||
44501347|NCT00003907|79505949|FG000|Overall Study|Adverse Event|2|||
44501348|NCT00003907|79505950|FG001|Overall Study|Adverse Event|11|||
44501349|NCT00003907|79505949|FG000|Overall Study|Death|2|||
44564215|NCT02960490|79583350|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44564216|NCT02960490|79583351|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
44233822|NCT01807949|79053743|FG000|Overall Study|Undefined|0|||
44233823|NCT01807949|79053744|FG001|Overall Study|Undefined|1|||
44564217|NCT02960490|79583352|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
44564218|NCT02960490|79583353|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
44564219|NCT02960490|79583354|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
44564220|NCT02960490|79583345|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564221|NCT02960490|79583346|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564222|NCT02960490|79583347|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564223|NCT02960490|79583348|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564224|NCT02960490|79583349|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564225|NCT02960490|79583350|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564226|NCT02960490|79583351|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564227|NCT02960490|79583352|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
44233824|NCT01807949|79053745|FG002|Overall Study|Undefined|2|||
44501350|NCT00003907|79505950|FG001|Overall Study|Death|0|||
44564228|NCT02960490|79583353|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564229|NCT02960490|79583354|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
44564230|NCT02960490|79583345|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
44564231|NCT02960490|79583346|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
44564232|NCT02960490|79583347|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
44564233|NCT02960490|79583348|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
44564234|NCT02960490|79583349|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
44564235|NCT02960490|79583350|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
44564236|NCT02960490|79583351|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
44564237|NCT02960490|79583352|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
44564238|NCT02960490|79583353|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
44564239|NCT02960490|79583354|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
44564240|NCT02960490|79583345|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564241|NCT02960490|79583346|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564242|NCT02960490|79583347|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564243|NCT02960490|79583348|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564244|NCT02960490|79583349|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564245|NCT02960490|79583350|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564246|NCT02960490|79583351|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
44564247|NCT02960490|79583352|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564248|NCT02960490|79583353|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564249|NCT02960490|79583354|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
44564250|NCT02960490|79583345|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564251|NCT02960490|79583346|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564252|NCT02960490|79583347|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564253|NCT02960490|79583348|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564254|NCT02960490|79583349|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564255|NCT02960490|79583350|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564256|NCT02960490|79583351|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564257|NCT02960490|79583352|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
44564258|NCT02960490|79583353|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564259|NCT02960490|79583354|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
44564260|NCT02804750|79583378|FG000|Period 1|Adverse Event|0|||
44564261|NCT02804750|79583379|FG001|Period 1|Adverse Event|2|||
44564262|NCT02804750|79583378|FG000|Period 1|Withdrawal by Subject|0|||
44564263|NCT02804750|79583379|FG001|Period 1|Withdrawal by Subject|1|||
44564264|NCT02804750|79583378|FG000|Period 2|Adverse Event|1|||
44564265|NCT02804750|79583379|FG001|Period 2|Adverse Event|0|||
44501351|NCT00003907|79505949|FG000|Overall Study|Withdrawal by Subject|1|||
44501352|NCT00003907|79505950|FG001|Overall Study|Withdrawal by Subject|3|||
44501353|NCT00003907|79505949|FG000|Overall Study|Progressive disease|4|||
44501354|NCT00003907|79505950|FG001|Overall Study|Progressive disease|4|||
44501355|NCT00003907|79505949|FG000|Overall Study|Complicating disease|1|||
44501356|NCT00003907|79505950|FG001|Overall Study|Complicating disease|0|||
44501357|NCT00003907|79505949|FG000|Overall Study|Other|1|||
44501358|NCT00003907|79505950|FG001|Overall Study|Other|3|||
44501359|NCT00003907|79505949|FG000|Overall Study|ineligible or not treated|2|||
44501360|NCT00003907|79505950|FG001|Overall Study|ineligible or not treated|2|||
44501361|NCT04241315|79505958|FG000|Overall Study|Withdrawal by Subject|0|||
44501362|NCT04241315|79505959|FG001|Overall Study|Withdrawal by Subject|1|||
44501363|NCT04225026|79505965|FG000|Overall Study|Withdrawal by Subject|4|||
44501364|NCT04225026|79505965|FG000|Overall Study|Adverse Event|1|||
44501365|NCT04225026|79505965|FG000|Overall Study|Other|1|||
44501366|NCT04225026|79505965|FG000|Overall Study|Death|11|||
44501367|NCT04225026|79505965|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
44501368|NCT03493958|79506371|FG000|Overall Study|Withdrawal by Subject|6|||
44501369|NCT03493958|79506371|FG000|Overall Study|Lost to Follow-up|7|||
44501370|NCT03493958|79506371|FG000|Overall Study|Did not complete all required study procedures|2|||
44501371|NCT03486223|79506377|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
44564266|NCT02804750|79583378|FG000|Period 3|Adverse Event|0|||
44564267|NCT02804750|79583379|FG001|Period 3|Adverse Event|2|||
44564268|NCT02804750|79583378|FG000|Period 4|Adverse Event|0|||
44501372|NCT03486223|79506378|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
44564269|NCT02804750|79583379|FG001|Period 4|Adverse Event|5|||
44564270|NCT02959866|79583387|FG000|Overall Study|Withdrawal by Subject|1|||
44564271|NCT02748512|79583394|FG000|Overall Study|Lost to Follow-up|1|||
44564272|NCT02748512|79583395|FG001|Overall Study|Lost to Follow-up|1|||
44564273|NCT02748356|79583401|FG000|Overall Study|Withdrawal by Subject|1|||
44564274|NCT03439657|79583407|FG000|Overall Study|Adverse Event|2|||
44564275|NCT03439657|79583408|FG001|Overall Study|Adverse Event|3|||
44564276|NCT03439657|79583407|FG000|Overall Study|Lost to Follow-up|1|||
44564277|NCT03439657|79583408|FG001|Overall Study|Lost to Follow-up|0|||
44564278|NCT03439657|79583407|FG000|Overall Study|Protocol Violation|1|||
44564279|NCT03439657|79583408|FG001|Overall Study|Protocol Violation|1|||
44564280|NCT03439657|79583407|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
44564281|NCT03439657|79583408|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
44564282|NCT02803580|79583416|FG000|Overall Study|Death|13|||
44564283|NCT02803580|79583416|FG000|Overall Study|Lost to Follow-up|19|||
44564284|NCT02803580|79583416|FG000|Overall Study|Withdrawal by Subject|3|||
44564285|NCT02803580|79583416|FG000|Overall Study|Inclusion in clinical trial|1|||
44564286|NCT02878213|79583420|FG000|Overall Study|Withdrawal by Subject|2|||
44564287|NCT02878213|79583420|FG000|Overall Study|Adverse Event|1|||
44564288|NCT02802878|79583427|FG000|Overall Study|Withdrawal by Subject|3|||
44564289|NCT02802878|79583428|FG001|Overall Study|Withdrawal by Subject|3|||
44564290|NCT02802878|79583427|FG000|Overall Study|Protocol Violation|1|||
44564291|NCT02802878|79583428|FG001|Overall Study|Protocol Violation|0|||
44564292|NCT02801396|79583434|FG000|Period 1|Withdrawal by Subject|0|||
44564293|NCT02801396|79583435|FG001|Period 1|Withdrawal by Subject|0|||
44564294|NCT02801396|79583436|FG002|Period 1|Withdrawal by Subject|0|||
44564295|NCT02801396|79583437|FG003|Period 1|Withdrawal by Subject|0|||
44564296|NCT02801396|79583438|FG004|Period 1|Withdrawal by Subject|1|||
44564297|NCT02801396|79583439|FG005|Period 1|Withdrawal by Subject|0|||
44564298|NCT02800928|79583447|FG000|Overall Study|Withdrawal by Subject|1|||
44564299|NCT02800928|79583448|FG001|Overall Study|Withdrawal by Subject|1|||
44564300|NCT02800928|79583447|FG000|Overall Study|Protocol Violation|1|||
44564301|NCT02800928|79583448|FG001|Overall Study|Protocol Violation|1|||
44564302|NCT03148691|79583457|FG000|Overall Study|Protocol Violation|1|||
44564303|NCT03148691|79583458|FG001|Overall Study|Protocol Violation|2|||
44564304|NCT03148691|79583459|FG002|Overall Study|Protocol Violation|7|||
44564305|NCT03148691|79583457|FG000|Overall Study|Lost to Follow-up|0|||
44564306|NCT03148691|79583458|FG001|Overall Study|Lost to Follow-up|0|||
44564307|NCT03148691|79583459|FG002|Overall Study|Lost to Follow-up|1|||
44564308|NCT03148691|79583457|FG000|Overall Study|Other|1|||
44564309|NCT03148691|79583458|FG001|Overall Study|Other|0|||
44564310|NCT03148691|79583459|FG002|Overall Study|Other|0|||
44564311|NCT03148691|79583457|FG000|Overall Study|Withdrawal by Subject|1|||
44564312|NCT03148691|79583458|FG001|Overall Study|Withdrawal by Subject|0|||
44564313|NCT03148691|79583459|FG002|Overall Study|Withdrawal by Subject|0|||
44564314|NCT03148067|79583467|FG000|Overall Study|Lost to Follow-up|3|||
44564315|NCT03148067|79583467|FG000|Overall Study|Death|1|||
44564316|NCT03146741|79583481|FG000|Overall Study|Txp with non-HCV+ heart|4|||
44564317|NCT03146741|79583481|FG000|Overall Study|Listeted for MOT|2|||
44564318|NCT03146741|79583481|FG000|Overall Study|Physician Decision|2|||
44564319|NCT03146741|79583481|FG000|Overall Study|Awaiting txp|2|||
44501373|NCT03482024|79506389|FG000|Overall Study|Physician Decision|1|||
44501374|NCT03482024|79506390|FG001|Overall Study|Physician Decision|0|||
44501375|NCT03482024|79506391|FG002|Overall Study|Physician Decision|0|||
44501376|NCT03482024|79506392|FG003|Overall Study|Physician Decision|0|||
44501377|NCT03482024|79506393|FG004|Overall Study|Physician Decision|0|||
44501378|NCT03468309|79506405|FG000|Overall Study|Lost to Follow-up|4|||
44501379|NCT03468309|79506405|FG000|Overall Study|Withdrawal by Subject|2|||
44501380|NCT03423147|79506411|FG000|Overall Study|Lost to Follow-up|5|||
44501381|NCT03423147|79506412|FG001|Overall Study|Lost to Follow-up|8|||
44501382|NCT03423147|79506411|FG000|Overall Study|Withdrawal by Subject|1|||
44501383|NCT03423147|79506412|FG001|Overall Study|Withdrawal by Subject|0|||
44501384|NCT03423147|79506411|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
44501385|NCT03423147|79506412|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
44501386|NCT03423147|79506411|FG000|Overall Study|Age < 18|1|||
44564320|NCT03150719|79583487|FG000|Overall Study|Adverse Event|0|||
44564321|NCT03150719|79583488|FG001|Overall Study|Adverse Event|1|||
44564322|NCT03150719|79583487|FG000|Overall Study|Death|0|||
44564323|NCT03150719|79583488|FG001|Overall Study|Death|1|||
44564324|NCT03150719|79583487|FG000|Overall Study|Other|1|||
44564325|NCT03150719|79583488|FG001|Overall Study|Other|0|||
44564326|NCT04039217|79583494|FG000|Overall Study|Lost to Follow-up|1|||
44233825|NCT01807949|79053743|FG000|Overall Study|Randomized But Not Treated|0|||
44233826|NCT01807949|79053744|FG001|Overall Study|Randomized But Not Treated|2|||
44501387|NCT03423147|79506412|FG001|Overall Study|Age < 18|0|||
44501388|NCT03423147|79506411|FG000|Overall Study|No Trial of Labor|0|||
44501389|NCT03423147|79506412|FG001|Overall Study|No Trial of Labor|1|||
44564327|NCT00982111|79583504|FG000|Overall Study|Adverse Event|1|||
44564328|NCT00982111|79583505|FG001|Overall Study|Adverse Event|1|||
44564329|NCT00982111|79583504|FG000|Overall Study|Progressive Disease|46|||
44564330|NCT00982111|79583505|FG001|Overall Study|Progressive Disease|39|||
44564331|NCT00982111|79583504|FG000|Overall Study|Lost to Follow-up|9|||
44564332|NCT00982111|79583505|FG001|Overall Study|Lost to Follow-up|6|||
44564333|NCT00982111|79583504|FG000|Overall Study|New Anti-Cancer Therapy|5|||
44564334|NCT00982111|79583505|FG001|Overall Study|New Anti-Cancer Therapy|5|||
44564335|NCT00982111|79583504|FG000|Overall Study|Medical Decision|1|||
44564336|NCT00982111|79583505|FG001|Overall Study|Medical Decision|0|||
44564337|NCT00982111|79583504|FG000|Overall Study|Withdrawal by Subject|17|||
44564338|NCT00982111|79583505|FG001|Overall Study|Withdrawal by Subject|19|||
44564339|NCT00982111|79583504|FG000|Overall Study|Global Study End|0|||
44564340|NCT00982111|79583505|FG001|Overall Study|Global Study End|1|||
44564341|NCT00982111|79583504|FG000|Overall Study|Sponsor's Decision|0|||
44564342|NCT00982111|79583505|FG001|Overall Study|Sponsor's Decision|1|||
44564343|NCT02957682|79583514|FG000|Overall Study|Adverse Event|64|||
44564344|NCT02957682|79583515|FG001|Overall Study|Adverse Event|67|||
44564345|NCT02957682|79583514|FG000|Overall Study|Poor Compliance to Protocol|30|||
44564346|NCT02957682|79583515|FG001|Overall Study|Poor Compliance to Protocol|26|||
44564347|NCT02957682|79583514|FG000|Overall Study|Physician Decision|4|||
44564348|NCT02957682|79583515|FG001|Overall Study|Physician Decision|4|||
44564349|NCT02957682|79583514|FG000|Overall Study|Study Terminated by Sponsor|4|||
44564350|NCT02957682|79583515|FG001|Overall Study|Study Terminated by Sponsor|3|||
44564351|NCT02957682|79583514|FG000|Overall Study|Subject Moved|10|||
44564352|NCT02957682|79583515|FG001|Overall Study|Subject Moved|16|||
44564353|NCT02957682|79583514|FG000|Overall Study|Withdrawal by Subject|64|||
44564354|NCT02957682|79583515|FG001|Overall Study|Withdrawal by Subject|33|||
44564355|NCT02957682|79583514|FG000|Overall Study|Related to IMP Administration|3|||
44564356|NCT02957682|79583515|FG001|Overall Study|Related to IMP Administration|6|||
44564357|NCT02957682|79583514|FG000|Overall Study|Non-disclosed|16|||
44564358|NCT02957682|79583515|FG001|Overall Study|Non-disclosed|12|||
44564359|NCT02957682|79583514|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
44564360|NCT02957682|79583515|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
44564361|NCT03057951|79583523|FG000|Overall Study|Adverse Event|553|||
44564362|NCT03057951|79583524|FG001|Overall Study|Adverse Event|575|||
44564363|NCT03057951|79583523|FG000|Overall Study|Protocol Violation|30|||
44564364|NCT03057951|79583524|FG001|Overall Study|Protocol Violation|24|||
44564365|NCT03057951|79583523|FG000|Overall Study|Lost to Follow-up|6|||
44564366|NCT03057951|79583524|FG001|Overall Study|Lost to Follow-up|16|||
44564367|NCT03057951|79583523|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
44564368|NCT03057951|79583524|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
44564369|NCT03057951|79583523|FG000|Overall Study|Study drug stopped, reason missing|6|||
44564370|NCT03057951|79583524|FG001|Overall Study|Study drug stopped, reason missing|1|||
44564371|NCT03057951|79583523|FG000|Overall Study|Medical advice|6|||
44564372|NCT03057951|79583524|FG001|Overall Study|Medical advice|2|||
44564373|NCT03057951|79583523|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
44564374|NCT03057951|79583524|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
44233827|NCT01807949|79053745|FG002|Overall Study|Randomized But Not Treated|2|||
44233828|NCT01806779|79053757|FG000|Overall Study|Physician Decision|2|||
44564375|NCT03057951|79583523|FG000|Overall Study|Investigator decision|2|||
44564376|NCT03057951|79583524|FG001|Overall Study|Investigator decision|0|||
44564377|NCT03057951|79583523|FG000|Overall Study|Patient decision|5|||
44564378|NCT03057951|79583524|FG001|Overall Study|Patient decision|2|||
44564379|NCT03057951|79583523|FG000|Overall Study|Not attending study visits|3|||
44564380|NCT03057951|79583524|FG001|Overall Study|Not attending study visits|0|||
44564381|NCT03057951|79583523|FG000|Overall Study|Patient moved away|3|||
44564382|NCT03057951|79583524|FG001|Overall Study|Patient moved away|4|||
44564383|NCT03057951|79583523|FG000|Overall Study|Other reason than stated above|23|||
44564384|NCT03057951|79583524|FG001|Overall Study|Other reason than stated above|29|||
44233829|NCT01806779|79053758|FG001|Overall Study|Physician Decision|0|||
44233830|NCT01806779|79053759|FG002|Overall Study|Physician Decision|1|||
44564385|NCT03057951|79583523|FG000|Overall Study|Not treated|2|||
44564386|NCT03057951|79583524|FG001|Overall Study|Not treated|1|||
44564387|NCT03146663|79583532|FG000|Overall Study|Did not receive study treatment|1|||
44564388|NCT03146663|79583533|FG001|Overall Study|Did not receive study treatment|1|||
44564389|NCT02956278|79583543|FG000|Overall Study|Withdrawal by Subject|6|||
44564390|NCT02956278|79583544|FG001|Overall Study|Withdrawal by Subject|2|||
44564391|NCT02956278|79583545|FG002|Overall Study|Withdrawal by Subject|0|||
44564392|NCT02957136|79583555|FG000|Overall Study|Withdrawal by Subject|2|||
44564393|NCT02957136|79583556|FG001|Overall Study|Withdrawal by Subject|1|||
44564394|NCT03150485|79583562|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
44564395|NCT03150485|79583563|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
44564396|NCT03150485|79583564|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
44564397|NCT03150485|79583565|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
44564398|NCT03150485|79583566|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
44564399|NCT03150485|79583567|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
44564400|NCT03134911|79583574|FG000|Overall Study|Screen failure|31|||
44564401|NCT03134911|79583574|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
44564402|NCT03134599|79583593|FG000|Week 1|Lost to Follow-up|0|||
44564403|NCT03134599|79583594|FG001|Week 1|Lost to Follow-up|0|||
44564404|NCT03134599|79583595|FG002|Week 1|Lost to Follow-up|0|||
44564405|NCT03134599|79583596|FG003|Week 1|Lost to Follow-up|0|||
44564406|NCT03134599|79583597|FG004|Week 1|Lost to Follow-up|1|||
44564407|NCT03134599|79583598|FG005|Week 1|Lost to Follow-up|0|||
44564408|NCT03134599|79583593|FG000|Week 2|Lost to Follow-up|1|||
44564409|NCT03134599|79583594|FG001|Week 2|Lost to Follow-up|0|||
44564410|NCT03134599|79583595|FG002|Week 2|Lost to Follow-up|0|||
44564411|NCT03134599|79583596|FG003|Week 2|Lost to Follow-up|1|||
44564412|NCT03134599|79583597|FG004|Week 2|Lost to Follow-up|1|||
44564413|NCT03134599|79583598|FG005|Week 2|Lost to Follow-up|0|||
44564414|NCT03134599|79583593|FG000|Week 3|Lost to Follow-up|0|||
44564415|NCT03134599|79583594|FG001|Week 3|Lost to Follow-up|0|||
44377180|NCT01074008|79382507|FG006|Overall Study|Adverse Event|0|||
44501390|NCT03322631|79506422|FG000|Overall Study|Withdrawal by Subject|0|||
44501391|NCT03322631|79506423|FG001|Overall Study|Withdrawal by Subject|1|||
44501392|NCT03322631|79506424|FG002|Overall Study|Withdrawal by Subject|0|||
44501393|NCT03322631|79506425|FG003|Overall Study|Withdrawal by Subject|0|||
44501394|NCT03322631|79506422|FG000|Overall Study|Adverse Event|0|||
44501395|NCT03322631|79506423|FG001|Overall Study|Adverse Event|0|||
44501396|NCT03322631|79506424|FG002|Overall Study|Adverse Event|1|||
44501397|NCT03322631|79506425|FG003|Overall Study|Adverse Event|0|||
44501398|NCT03018704|79506444|FG000|Overall Study|Lost to Follow-up|1|||
44501399|NCT03018704|79506445|FG001|Overall Study|Lost to Follow-up|1|||
44501400|NCT02663349|79506451|FG000|Overall Study|Withdrawal by Subject|6|||
44501401|NCT02558491|79506455|FG000|First Invention|Withdrawal by Subject|3|||
44501402|NCT02558491|79506456|FG001|First Invention|Withdrawal by Subject|1|||
44501403|NCT02558491|79506455|FG000|First Invention|Data collection issues|1|||
44501404|NCT02558491|79506456|FG001|First Invention|Data collection issues|0|||
44501405|NCT02558491|79506455|FG000|First Invention|Stopping criteria|0|||
44501406|NCT02558491|79506456|FG001|First Invention|Stopping criteria|1|||
44501407|NCT02558491|79506455|FG000|First Invention|Changed parameters during trial|1|||
44501408|NCT02558491|79506456|FG001|First Invention|Changed parameters during trial|0|||
44501409|NCT02558491|79506455|FG000|Second Intervention|Withdrawal by Subject|1|||
44501410|NCT02558491|79506456|FG001|Second Intervention|Withdrawal by Subject|0|||
44501411|NCT02558491|79506455|FG000|Second Intervention|Stopping Criteria|1|||
44501412|NCT02558491|79506456|FG001|Second Intervention|Stopping Criteria|0|||
44501413|NCT02490878|79506465|FG000|Overall Study|deemed ineligible|0|||
44501414|NCT02490878|79506466|FG001|Overall Study|deemed ineligible|1|||
44501415|NCT02490878|79506465|FG000|Overall Study|progression prior to treatment|0|||
44501416|NCT02490878|79506466|FG001|Overall Study|progression prior to treatment|1|||
44501417|NCT02490878|79506465|FG000|Overall Study|only submitted baseline QOL|0|||
44501418|NCT02490878|79506466|FG001|Overall Study|only submitted baseline QOL|1|||
44501419|NCT02421601|79506472|FG000|Overall Study|Adverse Event|4|||
44501420|NCT02421601|79506472|FG000|Overall Study|Lack of Efficacy|5|||
44501421|NCT02421601|79506472|FG000|Overall Study|Physician Decision|1|||
44501422|NCT02421601|79506472|FG000|Overall Study|Withdrawal by Subject|31|||
44501423|NCT02421601|79506472|FG000|Overall Study|Others|41|||
44564416|NCT03134599|79583595|FG002|Week 3|Lost to Follow-up|0|||
44564417|NCT03134599|79583596|FG003|Week 3|Lost to Follow-up|1|||
44564418|NCT03134599|79583597|FG004|Week 3|Lost to Follow-up|0|||
44564419|NCT03134599|79583598|FG005|Week 3|Lost to Follow-up|1|||
44564420|NCT03153137|79583608|FG000|Overall Study|Lost to Follow-up|1|||
44564421|NCT03153137|79583609|FG001|Overall Study|Lost to Follow-up|0|||
44564422|NCT03153137|79583608|FG000|Overall Study|Withdrawal by Subject|2|||
44501424|NCT01934218|79506478|FG000|Double-blind Phase|Adverse Event|8|||
44501425|NCT01934218|79506479|FG001|Double-blind Phase|Adverse Event|8|||
44564423|NCT03153137|79583609|FG001|Overall Study|Withdrawal by Subject|1|||
44564424|NCT03153137|79583608|FG000|Overall Study|Physician Decision|0|||
44564425|NCT03153137|79583609|FG001|Overall Study|Physician Decision|3|||
44564426|NCT03136861|79583622|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
44564427|NCT03136861|79583623|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
44564428|NCT03136861|79583624|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
44564429|NCT03136861|79583625|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
44564430|NCT03136861|79583626|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
44564431|NCT03136861|79583627|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
44564432|NCT03136861|79583628|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
44564433|NCT03136861|79583622|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
44564434|NCT03136861|79583623|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
44564435|NCT03136861|79583624|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
44564436|NCT03136861|79583625|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
44564437|NCT03136861|79583626|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
44564438|NCT03136861|79583627|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
44564439|NCT03136861|79583628|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
44564440|NCT03136861|79583622|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
44564441|NCT03136861|79583623|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
44564442|NCT03136861|79583624|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
44564443|NCT03136861|79583625|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
44564444|NCT03136861|79583626|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
44564445|NCT03136861|79583627|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
44564446|NCT03136861|79583628|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
44564447|NCT03136861|79583622|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
44564448|NCT03136861|79583623|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
44564449|NCT03136861|79583624|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
44564450|NCT03136861|79583625|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
44564451|NCT03136861|79583626|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
44564452|NCT03136861|79583627|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
44564453|NCT03136861|79583628|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
44564454|NCT03136861|79583622|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
44564455|NCT03136861|79583623|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
44564456|NCT03136861|79583624|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
44564457|NCT03136861|79583625|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
44564458|NCT03136861|79583626|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
44564459|NCT03136861|79583627|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
44564460|NCT03136861|79583628|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
44564461|NCT03136861|79583622|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
44564462|NCT03136861|79583623|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
44564463|NCT03136861|79583624|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
44564464|NCT03136861|79583625|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
44564465|NCT03136861|79583626|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
44564466|NCT03136861|79583627|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
44564467|NCT03136861|79583628|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
44564468|NCT03136861|79583622|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
44564469|NCT03136861|79583623|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
44564470|NCT03136861|79583624|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
44564471|NCT03136861|79583625|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
44564472|NCT03136861|79583626|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
44564473|NCT03136861|79583627|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
44564474|NCT03136861|79583628|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
44564475|NCT03136861|79583622|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
44564476|NCT03136861|79583623|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
44564477|NCT03136861|79583624|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
44564478|NCT03136861|79583625|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
44564479|NCT03136861|79583626|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
44564480|NCT03136861|79583627|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
44564481|NCT03136861|79583628|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
44233831|NCT01806779|79053757|FG000|Overall Study|Lack of Efficacy|1|||
44233832|NCT01806779|79053758|FG001|Overall Study|Lack of Efficacy|1|||
44233833|NCT01806779|79053759|FG002|Overall Study|Lack of Efficacy|0|||
44233834|NCT01806779|79053757|FG000|Overall Study|Lost to Follow-up|19|||
44233835|NCT01806779|79053758|FG001|Overall Study|Lost to Follow-up|20|||
44233836|NCT01806779|79053759|FG002|Overall Study|Lost to Follow-up|0|||
44233837|NCT01806779|79053757|FG000|Overall Study|Withdrawal by Subject|20|||
44564482|NCT03316950|79583656|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
44564483|NCT03316950|79583657|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
44564484|NCT03316950|79583658|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
44564485|NCT03316950|79583659|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
44564486|NCT03316950|79583656|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
44564487|NCT03316950|79583657|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
44564488|NCT03316950|79583658|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
44564489|NCT03316950|79583659|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
44564490|NCT03316950|79583656|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
44564491|NCT03316950|79583657|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
44564492|NCT03316950|79583658|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
44564493|NCT03316950|79583659|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
44564494|NCT03139279|79583673|FG000|Overall Study|Physician Decision|2|||
44564495|NCT03139279|79583674|FG001|Overall Study|Physician Decision|0|||
44564496|NCT03139279|79583673|FG000|Overall Study|Protocol Violation|5|||
44564497|NCT03139279|79583674|FG001|Overall Study|Protocol Violation|4|||
44564498|NCT03139279|79583673|FG000|Overall Study|Withdrawal by Subject|0|||
44564499|NCT03139279|79583674|FG001|Overall Study|Withdrawal by Subject|2|||
44564500|NCT01370642|79583683|FG000|Overall Study|Adverse Event|2|||
44564501|NCT01370642|79583684|FG001|Overall Study|Adverse Event|1|||
44564502|NCT01370642|79583685|FG002|Overall Study|Adverse Event|1|||
44564503|NCT01370642|79583683|FG000|Overall Study|Detectable HCV RNA|0|||
44564504|NCT01370642|79583684|FG001|Overall Study|Detectable HCV RNA|0|||
44564505|NCT01370642|79583685|FG002|Overall Study|Detectable HCV RNA|22|||
44564506|NCT01370642|79583683|FG000|Overall Study|Lost to Follow-up|0|||
44564507|NCT01370642|79583684|FG001|Overall Study|Lost to Follow-up|0|||
44564508|NCT01370642|79583685|FG002|Overall Study|Lost to Follow-up|1|||
44564509|NCT01370642|79583683|FG000|Overall Study|Physician Decision|4|||
44564510|NCT01370642|79583684|FG001|Overall Study|Physician Decision|1|||
44564511|NCT01370642|79583685|FG002|Overall Study|Physician Decision|2|||
44564512|NCT01370642|79583683|FG000|Overall Study|Withdrawal by Subject|2|||
44564513|NCT01370642|79583684|FG001|Overall Study|Withdrawal by Subject|4|||
44564514|NCT01370642|79583685|FG002|Overall Study|Withdrawal by Subject|3|||
44564515|NCT02873208|79583693|FG000|Overall Study|Withdrawal by Subject|36|||
44564516|NCT02873208|79583693|FG000|Overall Study|Lost to Follow-up|22|||
44564517|NCT02873208|79583693|FG000|Overall Study|Adverse Event|15|||
44564518|NCT02873208|79583693|FG000|Overall Study|Non-compliance with study drug|12|||
44564519|NCT02873208|79583693|FG000|Overall Study|Protocol Violation|8|||
44564520|NCT02873208|79583693|FG000|Overall Study|Pregnancy|2|||
44564521|NCT02873208|79583693|FG000|Overall Study|Incarceration|1|||
44564522|NCT02873208|79583693|FG000|Overall Study|Lack of Efficacy|1|||
44564523|NCT02873208|79583693|FG000|Overall Study|Physician Decision|1|||
44564524|NCT03138967|79583699|FG000|Overall Study|Death|0|||
44564525|NCT03138967|79583700|FG001|Overall Study|Death|1|||
44564526|NCT03138967|79583699|FG000|Overall Study|Physician Decision|1|||
44564527|NCT03138967|79583700|FG001|Overall Study|Physician Decision|3|||
44564528|NCT01547117|79583710|FG000|Overall Study|Physician Decision|0|||
44564529|NCT01547117|79583711|FG001|Overall Study|Physician Decision|1|||
44564530|NCT01547117|79583712|FG002|Overall Study|Physician Decision|1|||
44564531|NCT01547117|79583713|FG003|Overall Study|Physician Decision|3|||
44564532|NCT01547117|79583710|FG000|Overall Study|Withdrawal by Subject|1|||
44564533|NCT01547117|79583711|FG001|Overall Study|Withdrawal by Subject|2|||
44564534|NCT01547117|79583712|FG002|Overall Study|Withdrawal by Subject|1|||
44564535|NCT01547117|79583713|FG003|Overall Study|Withdrawal by Subject|2|||
44564536|NCT03136159|79583741|FG000|Overall Study|chorioamnionitis|2|||
44564537|NCT03136159|79583742|FG001|Overall Study|chorioamnionitis|0|||
44564538|NCT03136159|79583741|FG000|Overall Study|vertical skin incision|1|||
44564539|NCT03136159|79583742|FG001|Overall Study|vertical skin incision|0|||
44564540|NCT03136159|79583741|FG000|Overall Study|additional dressing|1|||
44564541|NCT03136159|79583742|FG001|Overall Study|additional dressing|0|||
44564542|NCT03136159|79583741|FG000|Overall Study|never got dressing placed|1|||
44377181|NCT01074008|79382508|FG007|Overall Study|Adverse Event|0|||
44564543|NCT03136159|79583742|FG001|Overall Study|never got dressing placed|0|||
44564544|NCT01986933|79583753|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
44564545|NCT01986933|79583754|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
44564546|NCT01986933|79583755|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
44564547|NCT01986933|79583756|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
44564548|NCT01986933|79583757|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
44564549|NCT01986933|79583753|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
44564550|NCT01986933|79583754|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
44564551|NCT01986933|79583755|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
44564552|NCT01986933|79583756|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
44564553|NCT01986933|79583757|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
44564554|NCT01986933|79583753|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
44564555|NCT01986933|79583754|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
44564556|NCT01986933|79583755|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
44564557|NCT01986933|79583756|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
44564558|NCT01986933|79583757|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
44564559|NCT01986933|79583753|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
44564560|NCT01986933|79583754|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
44564561|NCT01986933|79583755|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
44564562|NCT01986933|79583756|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
44564563|NCT01986933|79583757|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
44564564|NCT01986933|79583753|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
44564565|NCT01986933|79583754|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
44564566|NCT01986933|79583755|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
44564567|NCT01986933|79583756|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
44564568|NCT01986933|79583757|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
44564569|NCT01986933|79583753|FG000|Active-to-active (Part B)|Adverse Event|0|||
44564570|NCT01986933|79583754|FG001|Active-to-active (Part B)|Adverse Event|2|||
44564571|NCT01986933|79583755|FG002|Active-to-active (Part B)|Adverse Event|0|||
44564572|NCT01986933|79583756|FG003|Active-to-active (Part B)|Adverse Event|1|||
44564573|NCT01986933|79583757|FG004|Active-to-active (Part B)|Adverse Event|3|||
44564574|NCT01986933|79583753|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
44564575|NCT01986933|79583754|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
44564576|NCT01986933|79583755|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
44564577|NCT01986933|79583756|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
44564578|NCT01986933|79583757|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
44564579|NCT01986933|79583753|FG000|Active-to-active (Part B)|Pregnancy|0|||
44564580|NCT01986933|79583754|FG001|Active-to-active (Part B)|Pregnancy|0|||
44564581|NCT01986933|79583755|FG002|Active-to-active (Part B)|Pregnancy|0|||
44564582|NCT01986933|79583756|FG003|Active-to-active (Part B)|Pregnancy|0|||
44564583|NCT01986933|79583757|FG004|Active-to-active (Part B)|Pregnancy|1|||
44564584|NCT01986933|79583753|FG000|Active-to-active (Part B)|Physician Decision|0|||
44564585|NCT01986933|79583754|FG001|Active-to-active (Part B)|Physician Decision|0|||
44564586|NCT01986933|79583755|FG002|Active-to-active (Part B)|Physician Decision|1|||
44564587|NCT01986933|79583756|FG003|Active-to-active (Part B)|Physician Decision|1|||
44564588|NCT01986933|79583757|FG004|Active-to-active (Part B)|Physician Decision|0|||
44564589|NCT01986933|79583753|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
44564590|NCT01986933|79583754|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
44564591|NCT01986933|79583755|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
44564592|NCT01986933|79583756|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
44564593|NCT01986933|79583757|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
44564594|NCT01986933|79583753|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
44564595|NCT01986933|79583754|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
44564596|NCT01986933|79583755|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
44564597|NCT01986933|79583756|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
44564598|NCT01986933|79583757|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
44564599|NCT01986933|79583753|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
44564600|NCT01986933|79583754|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
44564601|NCT01986933|79583755|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
44564602|NCT01986933|79583756|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
44564603|NCT01986933|79583757|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
44564604|NCT01986933|79583753|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
44564605|NCT01986933|79583754|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
44233838|NCT01806779|79053758|FG001|Overall Study|Withdrawal by Subject|23|||
44233839|NCT01806779|79053759|FG002|Overall Study|Withdrawal by Subject|22|||
44233840|NCT01607957|79053833|FG000|Overall Study|Not treated|1|||
44233841|NCT01607957|79053834|FG001|Overall Study|Not treated|1|||
44233842|NCT01607957|79053833|FG000|Overall Study|Death|367|||
44501426|NCT01934218|79506478|FG000|Double-blind Phase|Lack of Efficacy|6|||
44501427|NCT01934218|79506479|FG001|Double-blind Phase|Lack of Efficacy|7|||
44501428|NCT01934218|79506478|FG000|Double-blind Phase|Lost to Follow-up|7|||
44501429|NCT01934218|79506479|FG001|Double-blind Phase|Lost to Follow-up|14|||
44501430|NCT01934218|79506478|FG000|Double-blind Phase|Physician Decision|1|||
44501431|NCT01934218|79506479|FG001|Double-blind Phase|Physician Decision|2|||
44501432|NCT01934218|79506478|FG000|Double-blind Phase|Protocol Violation|4|||
44501433|NCT01934218|79506479|FG001|Double-blind Phase|Protocol Violation|0|||
44501434|NCT01934218|79506478|FG000|Double-blind Phase|Withdrawal by Subject|16|||
44501435|NCT01934218|79506479|FG001|Double-blind Phase|Withdrawal by Subject|13|||
44564606|NCT01986933|79583755|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
44233843|NCT01607957|79053834|FG001|Overall Study|Death|211|||
44233844|NCT01607957|79053833|FG000|Overall Study|Lost to Follow-up|3|||
44233845|NCT01607957|79053834|FG001|Overall Study|Lost to Follow-up|3|||
44233846|NCT01607957|79053833|FG000|Overall Study|Participant refusal|1|||
44233847|NCT01607957|79053834|FG001|Overall Study|Participant refusal|0|||
44233848|NCT01806623|79053854|FG000|Overall Study|Withdrawal by Subject|1|||
44233849|NCT01806623|79053854|FG000|Overall Study|Adverse Event|1|||
44233850|NCT01806623|79053854|FG000|Overall Study|Did not meet the inclusion criteria|56|||
44377182|NCT01074008|79382509|FG008|Overall Study|Adverse Event|0|||
44377183|NCT01074008|79382501|FG000|Overall Study|Withdrawal by Subject|1|||
44377184|NCT01074008|79382502|FG001|Overall Study|Withdrawal by Subject|1|||
44501436|NCT01934218|79506478|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
44501437|NCT01934218|79506479|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
44233851|NCT01806545|79053860|FG000|Overall Study|Adverse Event|2|||
44233852|NCT01806545|79053861|FG001|Overall Study|Adverse Event|3|||
44233853|NCT01806545|79053860|FG000|Overall Study|Lost to Follow-up|1|||
44233854|NCT01806545|79053861|FG001|Overall Study|Lost to Follow-up|0|||
44233855|NCT01806545|79053860|FG000|Overall Study|Withdrawal by Subject|3|||
44233856|NCT01806545|79053861|FG001|Overall Study|Withdrawal by Subject|2|||
44233857|NCT01806389|79053867|FG000|Overall Study|Withdrawal by Subject|4|||
44233858|NCT01781975|79054136|FG000|Overall Study|Death|1|||
44233859|NCT01781975|79054137|FG001|Overall Study|Death|0|||
44233860|NCT01781975|79054136|FG000|Overall Study|Withdrawal by Subject|1|||
44233861|NCT01781975|79054137|FG001|Overall Study|Withdrawal by Subject|1|||
44233862|NCT01804673|79054158|FG000|Overall Study|Adverse Event|4|||
44233863|NCT01804673|79054158|FG000|Overall Study|Withdrawal by Subject|1|||
44233864|NCT01804673|79054158|FG000|Overall Study|Lack of Efficacy|9|||
44233865|NCT01804673|79054158|FG000|Overall Study|Change to Oral Therapy|37|||
44233866|NCT01804673|79054158|FG000|Overall Study|No Further Therapy Required|84|||
44233867|NCT01804673|79054158|FG000|Overall Study|Use of Prohibited Medication|1|||
44233868|NCT01804673|79054158|FG000|Overall Study|Other|4|||
44233869|NCT01774097|79054168|FG000|Overall Study|Withdrawal by Subject|1|||
44233870|NCT01774097|79054169|FG001|Overall Study|Withdrawal by Subject|1|||
44233871|NCT01774097|79054168|FG000|Overall Study|Adverse Event|1|||
44233872|NCT01774097|79054169|FG001|Overall Study|Adverse Event|1|||
44233873|NCT02859558|79054243|FG000|Step 1|Not Eligible|0|||
44233874|NCT02859558|79054244|FG001|Step 1|Not Eligible|0|||
44233875|NCT02859558|79054245|FG002|Step 1|Not Eligible|0|||
44233876|NCT02859558|79054246|FG003|Step 1|Not Eligible|0|||
44233877|NCT02859558|79054247|FG004|Step 1|Not Eligible|3|||
44233878|NCT02859558|79054243|FG000|Step 1|Lost to Follow-up|1|||
44233879|NCT02859558|79054244|FG001|Step 1|Lost to Follow-up|3|||
44233880|NCT02859558|79054245|FG002|Step 1|Lost to Follow-up|3|||
44501438|NCT01934218|79506478|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
44501439|NCT01934218|79506479|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
44501440|NCT01934218|79506478|FG000|Open-Label Phase|Adverse Event|2|||
44501441|NCT01934218|79506479|FG001|Open-Label Phase|Adverse Event|4|||
44501442|NCT01934218|79506478|FG000|Open-Label Phase|Lack of Efficacy|1|||
44501443|NCT01934218|79506479|FG001|Open-Label Phase|Lack of Efficacy|4|||
44233881|NCT02859558|79054246|FG003|Step 1|Lost to Follow-up|0|||
44233882|NCT02859558|79054247|FG004|Step 1|Lost to Follow-up|0|||
44501444|NCT01934218|79506478|FG000|Open-Label Phase|Lost to Follow-up|4|||
44501445|NCT01934218|79506479|FG001|Open-Label Phase|Lost to Follow-up|2|||
44501446|NCT01934218|79506478|FG000|Open-Label Phase|Physician Decision|1|||
44501447|NCT01934218|79506479|FG001|Open-Label Phase|Physician Decision|0|||
44501448|NCT01934218|79506478|FG000|Open-Label Phase|Protocol Violation|1|||
44501449|NCT01934218|79506479|FG001|Open-Label Phase|Protocol Violation|0|||
44501450|NCT01934218|79506478|FG000|Open-Label Phase|Withdrawal by Subject|13|||
44501451|NCT01934218|79506479|FG001|Open-Label Phase|Withdrawal by Subject|11|||
44501452|NCT01934218|79506478|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
44501453|NCT01934218|79506479|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
44501454|NCT01934218|79506478|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
44501455|NCT01934218|79506479|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
44501456|NCT01702805|79506487|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
44564607|NCT01986933|79583756|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
44233883|NCT02859558|79054243|FG000|Step 1|Did Not Return to Clinic|2|||
44233884|NCT02859558|79054244|FG001|Step 1|Did Not Return to Clinic|3|||
44233885|NCT02859558|79054245|FG002|Step 1|Did Not Return to Clinic|4|||
44233886|NCT02859558|79054246|FG003|Step 1|Did Not Return to Clinic|0|||
44501457|NCT01702805|79506488|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
44501458|NCT01702805|79506487|FG000|Overall Study|Incomplete Follow-up|18|||
44501459|NCT01702805|79506488|FG001|Overall Study|Incomplete Follow-up|15|||
44564608|NCT01986933|79583757|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
44233887|NCT02859558|79054247|FG004|Step 1|Did Not Return to Clinic|0|||
44233888|NCT02859558|79054243|FG000|Step 1|Moved|0|||
44233889|NCT02859558|79054244|FG001|Step 1|Moved|1|||
44233890|NCT02859558|79054245|FG002|Step 1|Moved|1|||
44233891|NCT02859558|79054246|FG003|Step 1|Moved|0|||
44564609|NCT01986933|79583753|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
44564610|NCT01986933|79583754|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
44564611|NCT01986933|79583755|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
44564612|NCT01986933|79583756|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
44564613|NCT01986933|79583757|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
44564614|NCT01986933|79583753|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
44564615|NCT01986933|79583754|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
44564616|NCT01986933|79583755|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
44564617|NCT01986933|79583756|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
44564618|NCT01986933|79583757|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
44564619|NCT01986933|79583753|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
44564620|NCT01986933|79583754|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
44564621|NCT01986933|79583755|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
44564622|NCT01986933|79583756|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
44564623|NCT01986933|79583757|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
44564624|NCT01986933|79583753|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
44564625|NCT01986933|79583754|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
44564626|NCT01986933|79583755|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
44564627|NCT01986933|79583756|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
44564628|NCT01986933|79583757|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
44564629|NCT00394355|79583801|FG000|Overall Study|Adverse Event|10|||
44564630|NCT00394355|79583802|FG001|Overall Study|Adverse Event|6|||
44564631|NCT00394355|79583803|FG002|Overall Study|Adverse Event|7|||
44564632|NCT00394355|79583804|FG003|Overall Study|Adverse Event|8|||
44564633|NCT00394355|79583801|FG000|Overall Study|Did not meet protocol eligibility|1|||
44564634|NCT00394355|79583802|FG001|Overall Study|Did not meet protocol eligibility|5|||
44564635|NCT00394355|79583803|FG002|Overall Study|Did not meet protocol eligibility|4|||
44564636|NCT00394355|79583804|FG003|Overall Study|Did not meet protocol eligibility|2|||
44564637|NCT00394355|79583801|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
44564638|NCT00394355|79583802|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
44564639|NCT00394355|79583803|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
44564640|NCT00394355|79583804|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
44564641|NCT00394355|79583801|FG000|Overall Study|Subject withdrawal - related to drug|1|||
44564642|NCT00394355|79583802|FG001|Overall Study|Subject withdrawal - related to drug|0|||
44564643|NCT00394355|79583803|FG002|Overall Study|Subject withdrawal - related to drug|0|||
44564644|NCT00394355|79583804|FG003|Overall Study|Subject withdrawal - related to drug|0|||
44564645|NCT00394355|79583801|FG000|Overall Study|Lost to Follow-up|7|||
44564646|NCT00394355|79583802|FG001|Overall Study|Lost to Follow-up|5|||
44564647|NCT00394355|79583803|FG002|Overall Study|Lost to Follow-up|4|||
44564648|NCT00394355|79583804|FG003|Overall Study|Lost to Follow-up|3|||
44564649|NCT00394355|79583801|FG000|Overall Study|Noncompliance with protocol|4|||
44564650|NCT00394355|79583802|FG001|Overall Study|Noncompliance with protocol|3|||
44564651|NCT00394355|79583803|FG002|Overall Study|Noncompliance with protocol|10|||
44564652|NCT00394355|79583804|FG003|Overall Study|Noncompliance with protocol|8|||
44564653|NCT00394355|79583801|FG000|Overall Study|Administrative|0|||
44564654|NCT00394355|79583802|FG001|Overall Study|Administrative|1|||
44564655|NCT00394355|79583803|FG002|Overall Study|Administrative|1|||
44564656|NCT00394355|79583804|FG003|Overall Study|Administrative|1|||
44564657|NCT00394355|79583801|FG000|Overall Study|Lack of Efficacy|0|||
44501460|NCT01702805|79506487|FG000|Overall Study|Vital Status Assessment Only|40|||
44501461|NCT01702805|79506488|FG001|Overall Study|Vital Status Assessment Only|39|||
44564658|NCT00394355|79583802|FG001|Overall Study|Lack of Efficacy|0|||
44564659|NCT00394355|79583803|FG002|Overall Study|Lack of Efficacy|2|||
44564660|NCT00394355|79583804|FG003|Overall Study|Lack of Efficacy|3|||
44564661|NCT02797808|79583816|FG000|Overall Study|Withdrawal by Subject|1|||
44564662|NCT02797808|79583817|FG001|Overall Study|Withdrawal by Subject|1|||
44564663|NCT02797808|79583816|FG000|Overall Study|Physician Decision|6|||
44564664|NCT02797808|79583817|FG001|Overall Study|Physician Decision|2|||
44501462|NCT01702805|79506487|FG000|Overall Study|Lost to Follow-up|5|||
44501463|NCT01702805|79506488|FG001|Overall Study|Lost to Follow-up|5|||
44501464|NCT00097370|79506498|FG000|Stage 1|Adverse Event|3|||
44501465|NCT00097370|79506498|FG000|Stage 1|Withdrawal by Subject|1|||
44564665|NCT02796560|79583825|FG000|Overall Study|Adverse Event|2|||
44564666|NCT02796560|79583826|FG001|Overall Study|Adverse Event|0|||
44564667|NCT02796560|79583825|FG000|Overall Study|Withdrawal by Subject|2|||
44233892|NCT02859558|79054247|FG004|Step 1|Moved|0|||
44564668|NCT02796560|79583826|FG001|Overall Study|Withdrawal by Subject|2|||
44564669|NCT00344487|79583832|FG000|Overall Study|immunologic failure|1|||
44564670|NCT02871492|79583841|FG000|Overall Study|Lost to Follow-up|6|||
44564671|NCT02871492|79583842|FG001|Overall Study|Lost to Follow-up|3|||
44564672|NCT02871492|79583843|FG002|Overall Study|Lost to Follow-up|5|||
44564673|NCT02871492|79583841|FG000|Overall Study|Withdrawal by Subject|0|||
44501466|NCT00097370|79506498|FG000|Stage 1|Lack of Efficacy|2|||
44501467|NCT00097370|79506498|FG000|Stage 2|Adverse Event|5|||
44501468|NCT00097370|79506498|FG000|Stage 2|Withdrawal by Subject|1|||
44564674|NCT02871492|79583842|FG001|Overall Study|Withdrawal by Subject|0|||
44564675|NCT02871492|79583843|FG002|Overall Study|Withdrawal by Subject|1|||
44564676|NCT03143855|79583853|FG000|Overall Study|Withdrawal by Subject|4|||
44564677|NCT03143855|79583854|FG001|Overall Study|Withdrawal by Subject|3|||
44564678|NCT03143855|79583853|FG000|Overall Study|Protocol Violation|1|||
44564679|NCT03143855|79583854|FG001|Overall Study|Protocol Violation|0|||
44564680|NCT03143855|79583853|FG000|Overall Study|Participant experienced withdrawal|0|||
44564681|NCT03143855|79583854|FG001|Overall Study|Participant experienced withdrawal|1|||
44564682|NCT02878603|79583862|FG000|Overall Study|Lost to Follow-up|4|||
44564683|NCT02878603|79583863|FG001|Overall Study|Lost to Follow-up|1|||
44564684|NCT02878603|79583862|FG000|Overall Study|Withdrawal by Subject|1|||
44564685|NCT02878603|79583863|FG001|Overall Study|Withdrawal by Subject|1|||
44564686|NCT02878603|79583862|FG000|Overall Study|Death|1|||
44564687|NCT02878603|79583863|FG001|Overall Study|Death|0|||
44564688|NCT02878603|79583862|FG000|Overall Study|Physician Decision|0|||
44501469|NCT00097370|79506498|FG000|Stage 2|Lack of Efficacy|3|||
44564689|NCT02878603|79583863|FG001|Overall Study|Physician Decision|3|||
44564690|NCT01370408|79583869|FG000|Overall Study|treatment failure|9|||
44564691|NCT03294109|79583875|FG000|Overall Study|Withdrawal by Subject|6|||
44564692|NCT03294109|79583876|FG001|Overall Study|Withdrawal by Subject|5|||
44564693|NCT03132805|79583895|FG000|Overall Study|Lost to Follow-up|142|||
44564694|NCT03132805|79583896|FG001|Overall Study|Lost to Follow-up|141|||
44564695|NCT03132805|79583897|FG002|Overall Study|Lost to Follow-up|113|||
44564696|NCT02793128|79583905|FG000|Overall Study|Death|4|||
44564697|NCT02793128|79583905|FG000|Overall Study|Withdrawal by Subject|2|||
44564698|NCT02793128|79583905|FG000|Overall Study|Physician Decision|1|||
44564699|NCT02793128|79583905|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
44564700|NCT02793128|79583905|FG000|Overall Study|Patient elected nephroureterectomy|1|||
44564701|NCT03142451|79583919|FG000|Overall Study|Adverse Event|5|||
44564702|NCT03142451|79583920|FG001|Overall Study|Adverse Event|2|||
44564703|NCT03142451|79583919|FG000|Overall Study|Lost to Follow-up|25|||
44564704|NCT03142451|79583920|FG001|Overall Study|Lost to Follow-up|8|||
44564705|NCT03142451|79583919|FG000|Overall Study|Participant request|24|||
44564706|NCT03142451|79583920|FG001|Overall Study|Participant request|12|||
44501470|NCT00097370|79506498|FG000|Stage 2|Pregnancy|1|||
44501471|NCT00097370|79506498|FG000|Stage 2|Sponsor Terminated Study|2|||
44501472|NCT00097370|79506498|FG000|Stage 2|Lost to Follow-up|1|||
44501473|NCT00097370|79506498|FG000|Stage 3|Adverse Event|2|||
44501474|NCT00097370|79506498|FG000|Stage 3|Withdrawal by Subject|3|||
44501475|NCT00097370|79506498|FG000|Stage 3|Lack of Efficacy|1|||
44501476|NCT00097370|79506498|FG000|Stage 3|Sponsor Terminated Study|52|||
44501477|NCT00097370|79506498|FG000|Stage 3|Lost to Follow-up|1|||
44501478|NCT03515824|79506505|FG000|Overall Study|Death|3|||
44501479|NCT03515824|79506506|FG001|Overall Study|Death|2|||
44501480|NCT03515824|79506507|FG002|Overall Study|Death|6|||
44501481|NCT03515824|79506508|FG003|Overall Study|Death|0|||
44501482|NCT03515824|79506505|FG000|Overall Study|Lost to Follow-up|0|||
44501483|NCT03515824|79506506|FG001|Overall Study|Lost to Follow-up|1|||
44501484|NCT03515824|79506507|FG002|Overall Study|Lost to Follow-up|1|||
44501485|NCT03515824|79506508|FG003|Overall Study|Lost to Follow-up|0|||
44501486|NCT03515824|79506505|FG000|Overall Study|Study terminated by sponsor|0|||
44501487|NCT03515824|79506506|FG001|Overall Study|Study terminated by sponsor|1|||
44501488|NCT03515824|79506507|FG002|Overall Study|Study terminated by sponsor|6|||
44501489|NCT03515824|79506508|FG003|Overall Study|Study terminated by sponsor|0|||
44501490|NCT03515824|79506505|FG000|Overall Study|Status not recorded|0|||
44564707|NCT03142451|79583919|FG000|Overall Study|Protocol Violation|3|||
44564708|NCT03142451|79583920|FG001|Overall Study|Protocol Violation|1|||
44564709|NCT03142451|79583919|FG000|Overall Study|Other|1|||
44501491|NCT03515824|79506506|FG001|Overall Study|Status not recorded|0|||
44501492|NCT03515824|79506507|FG002|Overall Study|Status not recorded|2|||
44501493|NCT03515824|79506508|FG003|Overall Study|Status not recorded|0|||
44501494|NCT01089374|79506518|FG000|Overall Study|Lost to Follow-up|3|||
44564710|NCT03142451|79583920|FG001|Overall Study|Other|1|||
44564711|NCT03141905|79583928|FG000|Overall Study|Death|3|||
44564712|NCT03141905|79583929|FG001|Overall Study|Death|2|||
44501495|NCT01089374|79506519|FG001|Overall Study|Lost to Follow-up|0|||
44501496|NCT01089374|79506518|FG000|Overall Study|Withdrawal by Subject|1|||
44501497|NCT01089374|79506519|FG001|Overall Study|Withdrawal by Subject|0|||
44501498|NCT01089374|79506518|FG000|Overall Study|Study closed early - low accrual|6|||
44564713|NCT03141905|79583928|FG000|Overall Study|Withdrawal by Subject|1|||
44564714|NCT03141905|79583929|FG001|Overall Study|Withdrawal by Subject|0|||
44501499|NCT01089374|79506519|FG001|Overall Study|Study closed early - low accrual|0|||
44501500|NCT03511378|79506526|FG000|Overall Study|Withdrawal by Subject|2|||
44501501|NCT03511378|79506527|FG001|Overall Study|Withdrawal by Subject|2|||
44501502|NCT03511378|79506526|FG000|Overall Study|Patient not coming or schedule visit|1|||
44501503|NCT03511378|79506527|FG001|Overall Study|Patient not coming or schedule visit|0|||
44501504|NCT03511066|79506536|FG000|Overall Study|Withdrawal by Subject|1|||
44501505|NCT03511066|79506537|FG001|Overall Study|Withdrawal by Subject|2|||
44501506|NCT03511066|79506538|FG002|Overall Study|Withdrawal by Subject|3|||
44501507|NCT03511066|79506536|FG000|Overall Study|Lost to Follow-up|2|||
44501508|NCT03511066|79506537|FG001|Overall Study|Lost to Follow-up|3|||
44564715|NCT03141905|79583928|FG000|Overall Study|Lost to Follow-up|3|||
44501509|NCT03511066|79506538|FG002|Overall Study|Lost to Follow-up|0|||
44233893|NCT02859558|79054243|FG000|Step 1|Withdrawal By Participant|1|||
44233894|NCT02859558|79054244|FG001|Step 1|Withdrawal By Participant|2|||
44233895|NCT02859558|79054245|FG002|Step 1|Withdrawal By Participant|1|||
44233896|NCT02859558|79054246|FG003|Step 1|Withdrawal By Participant|0|||
44233897|NCT02859558|79054247|FG004|Step 1|Withdrawal By Participant|0|||
44233898|NCT02859558|79054243|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
44233899|NCT02859558|79054244|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
44233900|NCT02859558|79054245|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
44233901|NCT02859558|79054246|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
44233902|NCT02859558|79054247|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
44233903|NCT02859558|79054243|FG000|Step 1|Incarceration|0|||
44233904|NCT02859558|79054244|FG001|Step 1|Incarceration|1|||
44564716|NCT03141905|79583929|FG001|Overall Study|Lost to Follow-up|7|||
44564717|NCT03141905|79583928|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
44564718|NCT03141905|79583929|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
44564719|NCT01370018|79583936|FG000|Overall Study|Did not meet criteria for analysis|1|||
44564720|NCT04034355|79583942|FG000|Overall Study|Study terminated by Sponsor|10|||
44564721|NCT04034355|79583943|FG001|Overall Study|Study terminated by Sponsor|17|||
44564722|NCT04034355|79583942|FG000|Overall Study|Withdrawal by Subject|12|||
44564723|NCT04034355|79583943|FG001|Overall Study|Withdrawal by Subject|11|||
44564724|NCT04034355|79583942|FG000|Overall Study|Site terminated by Sponsor|4|||
44564725|NCT04034355|79583943|FG001|Overall Study|Site terminated by Sponsor|5|||
44564726|NCT04034355|79583942|FG000|Overall Study|Adverse Event|2|||
44564727|NCT04034355|79583943|FG001|Overall Study|Adverse Event|0|||
44564728|NCT04034355|79583942|FG000|Overall Study|Death|1|||
44564729|NCT04034355|79583943|FG001|Overall Study|Death|1|||
44564730|NCT04034355|79583942|FG000|Overall Study|Not reported|2|||
44564731|NCT04034355|79583943|FG001|Overall Study|Not reported|0|||
44564732|NCT04034355|79583942|FG000|Overall Study|Lost to Follow-up|1|||
44564733|NCT04034355|79583943|FG001|Overall Study|Lost to Follow-up|0|||
44564734|NCT04034355|79583942|FG000|Overall Study|Physician Decision|1|||
44564735|NCT04034355|79583943|FG001|Overall Study|Physician Decision|0|||
44564736|NCT04034355|79583942|FG000|Overall Study|Protocol Violation|0|||
44564737|NCT04034355|79583943|FG001|Overall Study|Protocol Violation|1|||
44564738|NCT04034355|79583942|FG000|Overall Study|Progressive disease|1|||
44564739|NCT04034355|79583943|FG001|Overall Study|Progressive disease|0|||
44564740|NCT01336764|79583960|FG000|Overall Study|Withdrawal by Subject|5|||
44564741|NCT01336764|79583961|FG001|Overall Study|Withdrawal by Subject|5|||
44564742|NCT01336608|79583970|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
44564743|NCT01336608|79583971|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44564744|NCT01336608|79583972|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44564745|NCT01336608|79583973|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44564746|NCT01336608|79583970|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
44564747|NCT01336608|79583971|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44233905|NCT02859558|79054245|FG002|Step 1|Incarceration|0|||
44233906|NCT02859558|79054246|FG003|Step 1|Incarceration|0|||
44564748|NCT01336608|79583972|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44564749|NCT01336608|79583973|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44233907|NCT02859558|79054247|FG004|Step 1|Incarceration|0|||
44233908|NCT02859558|79054243|FG000|Step 1|Non-Adherence to Study Drug|2|||
44233909|NCT02859558|79054244|FG001|Step 1|Non-Adherence to Study Drug|0|||
44233910|NCT02859558|79054245|FG002|Step 1|Non-Adherence to Study Drug|1|||
44564750|NCT01336608|79583970|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
44564751|NCT01336608|79583971|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
44564752|NCT01336608|79583972|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
44564753|NCT01336608|79583973|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
44564754|NCT01336608|79583970|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
44564755|NCT01336608|79583971|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
44564756|NCT01336608|79583972|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
44564757|NCT01336608|79583973|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
44233911|NCT02859558|79054246|FG003|Step 1|Non-Adherence to Study Drug|0|||
44233912|NCT02859558|79054247|FG004|Step 1|Non-Adherence to Study Drug|0|||
44233913|NCT02859558|79054243|FG000|Step 1|Non-Adherence to Study Requirements|3|||
44233914|NCT02859558|79054244|FG001|Step 1|Non-Adherence to Study Requirements|1|||
44233915|NCT02859558|79054245|FG002|Step 1|Non-Adherence to Study Requirements|0|||
44233916|NCT02859558|79054246|FG003|Step 1|Non-Adherence to Study Requirements|0|||
44233917|NCT02859558|79054247|FG004|Step 1|Non-Adherence to Study Requirements|0|||
44233918|NCT02859558|79054243|FG000|Step 1|Virologic Failure|2|||
44233919|NCT02859558|79054244|FG001|Step 1|Virologic Failure|1|||
44233920|NCT02859558|79054245|FG002|Step 1|Virologic Failure|1|||
44233921|NCT02859558|79054246|FG003|Step 1|Virologic Failure|0|||
44233922|NCT02859558|79054247|FG004|Step 1|Virologic Failure|0|||
44233923|NCT02859558|79054243|FG000|Step 2|Active On Study|23|||
44233924|NCT02859558|79054244|FG001|Step 2|Active On Study|38|||
44233925|NCT02859558|79054245|FG002|Step 2|Active On Study|20|||
44564758|NCT01336608|79583970|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
44564759|NCT01336608|79583971|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44564760|NCT01336608|79583972|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44377185|NCT01074008|79382503|FG002|Overall Study|Withdrawal by Subject|1|||
44233926|NCT02859558|79054246|FG003|Step 2|Active On Study|0|||
44233927|NCT02859558|79054247|FG004|Step 2|Active On Study|0|||
44233928|NCT02859558|79054243|FG000|Step 2|Did Not Return to Clinic|2|||
44233929|NCT02859558|79054244|FG001|Step 2|Did Not Return to Clinic|0|||
44233930|NCT02859558|79054245|FG002|Step 2|Did Not Return to Clinic|0|||
44233931|NCT02859558|79054246|FG003|Step 2|Did Not Return to Clinic|0|||
44233932|NCT02859558|79054247|FG004|Step 2|Did Not Return to Clinic|0|||
44233933|NCT02859558|79054243|FG000|Step 2|Unexpected Closure of Site|0|||
44233934|NCT02859558|79054244|FG001|Step 2|Unexpected Closure of Site|1|||
44233935|NCT02859558|79054245|FG002|Step 2|Unexpected Closure of Site|1|||
44233936|NCT02859558|79054246|FG003|Step 2|Unexpected Closure of Site|0|||
44233937|NCT02859558|79054247|FG004|Step 2|Unexpected Closure of Site|0|||
44233938|NCT00705432|79054298|FG000|Treatment Period|Adverse Event|45|||
44233939|NCT00705432|79054299|FG001|Treatment Period|Adverse Event|37|||
44233940|NCT00705432|79054300|FG002|Treatment Period|Adverse Event|51|||
44233941|NCT00705432|79054301|FG003|Treatment Period|Adverse Event|12|||
44233942|NCT00705432|79054302|FG004|Treatment Period|Adverse Event|8|||
44233943|NCT00705432|79054303|FG005|Treatment Period|Adverse Event|9|||
44233944|NCT00705432|79054298|FG000|Treatment Period|Treatment failure|92|||
44233945|NCT00705432|79054299|FG001|Treatment Period|Treatment failure|42|||
44233946|NCT00705432|79054300|FG002|Treatment Period|Treatment failure|33|||
44233947|NCT00705432|79054301|FG003|Treatment Period|Treatment failure|25|||
44233948|NCT00705432|79054302|FG004|Treatment Period|Treatment failure|13|||
44377186|NCT01074008|79382504|FG003|Overall Study|Withdrawal by Subject|0|||
44501510|NCT03510910|79506548|FG000|Overall Study|Incomplete Survey|2|||
44501511|NCT03510910|79506549|FG001|Overall Study|Incomplete Survey|3|||
44501512|NCT03509350|79506557|FG000|Overall Study|Withdrawal by Subject|0|||
44501513|NCT03509350|79506558|FG001|Overall Study|Withdrawal by Subject|2|||
44501514|NCT03478696|79506566|FG000|Overall Study|Adverse Event|1|||
44501515|NCT03478696|79506567|FG001|Overall Study|Adverse Event|5|||
44501516|NCT03478696|79506566|FG000|Overall Study|Lost to Follow-up|1|||
44501517|NCT03478696|79506567|FG001|Overall Study|Lost to Follow-up|0|||
44501518|NCT03478696|79506566|FG000|Overall Study|Physician Decision|6|||
44564761|NCT01336608|79583973|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44564762|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
44564763|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
44564764|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
44501519|NCT03478696|79506567|FG001|Overall Study|Physician Decision|3|||
44233949|NCT00705432|79054303|FG005|Treatment Period|Treatment failure|14|||
44233950|NCT00705432|79054298|FG000|Treatment Period|Non medical reason|26|||
44233951|NCT00705432|79054299|FG001|Treatment Period|Non medical reason|32|||
44233952|NCT00705432|79054300|FG002|Treatment Period|Non medical reason|37|||
44233953|NCT00705432|79054301|FG003|Treatment Period|Non medical reason|4|||
44233954|NCT00705432|79054302|FG004|Treatment Period|Non medical reason|7|||
44233955|NCT00705432|79054303|FG005|Treatment Period|Non medical reason|7|||
44233956|NCT00705432|79054298|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
44501520|NCT03478696|79506566|FG000|Overall Study|Withdrawal by Subject|9|||
44501521|NCT03478696|79506567|FG001|Overall Study|Withdrawal by Subject|4|||
44564765|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
44564766|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44564767|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
44564768|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44377187|NCT01074008|79382505|FG004|Overall Study|Withdrawal by Subject|1|||
44377188|NCT01074008|79382506|FG005|Overall Study|Withdrawal by Subject|0|||
44564769|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44564770|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
44564771|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
44564772|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
44564773|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
44564774|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
44564775|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
44564776|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
44564777|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
44564778|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
44564779|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
44564780|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
44564781|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
44564782|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44564783|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
44564784|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44564785|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44564786|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
44564787|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
44377189|NCT01074008|79382507|FG006|Overall Study|Withdrawal by Subject|0|||
44377190|NCT01074008|79382508|FG007|Overall Study|Withdrawal by Subject|0|||
44377191|NCT01074008|79382509|FG008|Overall Study|Withdrawal by Subject|0|||
44377192|NCT01074008|79382501|FG000|Overall Study|Lost to Follow-up|0|||
44377193|NCT01074008|79382502|FG001|Overall Study|Lost to Follow-up|1|||
44501522|NCT03477838|79506573|FG000|Overall Study|Lost to Follow-up|14|||
44501523|NCT00072176|79506579|FG000|Overall Study|Withdrawal by Subject|1|||
44501524|NCT00072176|79506580|FG001|Overall Study|Withdrawal by Subject|0|||
44501525|NCT00072176|79506579|FG000|Overall Study|Protocol Violation|0|||
44501526|NCT00072176|79506580|FG001|Overall Study|Protocol Violation|1|||
44501527|NCT00071396|79506586|FG000|Overall Study|Withdrawal by Subject|1|||
44501528|NCT00071396|79506586|FG000|Overall Study|Physician Decision|2|||
44501529|NCT03473236|79506600|FG000|Overall Study|Withdrawal by Subject|0|||
44501530|NCT03473236|79506601|FG001|Overall Study|Withdrawal by Subject|0|||
44501531|NCT03473236|79506602|FG002|Overall Study|Withdrawal by Subject|0|||
44501532|NCT03473236|79506603|FG003|Overall Study|Withdrawal by Subject|0|||
44501533|NCT03473236|79506604|FG004|Overall Study|Withdrawal by Subject|0|||
44501534|NCT03473236|79506605|FG005|Overall Study|Withdrawal by Subject|1|||
44501535|NCT03473236|79506606|FG006|Overall Study|Withdrawal by Subject|0|||
44501536|NCT03473236|79506607|FG007|Overall Study|Withdrawal by Subject|0|||
44501537|NCT03473236|79506608|FG008|Overall Study|Withdrawal by Subject|1|||
44501538|NCT03473236|79506609|FG009|Overall Study|Withdrawal by Subject|0|||
44501539|NCT03550378|79506641|FG000|Overall Study|Death|0|||
44501540|NCT03550378|79506642|FG001|Overall Study|Death|1|||
44501541|NCT03472534|79506649|FG000|Overall Study|Withdrawal by Subject|9|||
44501542|NCT03472534|79506649|FG000|Overall Study|Adverse Event|2|||
44501543|NCT03549130|79506655|FG000|Overall Study|Adverse Event|0|||
44501544|NCT03549130|79506656|FG001|Overall Study|Adverse Event|1|||
44501545|NCT03549130|79506655|FG000|Overall Study|Lost to Follow-up|0|||
44501546|NCT03549130|79506656|FG001|Overall Study|Lost to Follow-up|1|||
44501547|NCT03470194|79506666|FG000|Overall Study|Lost to Follow-up|11|||
44564788|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
44564789|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
44564790|NCT01336608|79583970|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44564791|NCT01336608|79583971|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
44564792|NCT01336608|79583972|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
44564793|NCT01336608|79583973|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
44564794|NCT01346371|79583992|FG000|Overall Study|Lost to Follow-up|2|||
44564795|NCT01346371|79583993|FG001|Overall Study|Lost to Follow-up|0|||
44564796|NCT03644849|79584011|FG000|Overall Study|Lost to Follow-up|1|||
44564797|NCT03644849|79584012|FG001|Overall Study|Lost to Follow-up|3|||
44564798|NCT03131479|79584023|FG000|Overall Study|Adverse Event|0|||
44564799|NCT03131479|79584024|FG001|Overall Study|Adverse Event|0|||
44377194|NCT01074008|79382503|FG002|Overall Study|Lost to Follow-up|1|||
44377195|NCT01074008|79382504|FG003|Overall Study|Lost to Follow-up|1|||
44564800|NCT03131479|79584025|FG002|Overall Study|Adverse Event|1|||
44564801|NCT03131479|79584026|FG003|Overall Study|Adverse Event|1|||
44233957|NCT00705432|79054299|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
44233958|NCT00705432|79054300|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
44233959|NCT00705432|79054301|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
44233960|NCT00705432|79054302|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
44233961|NCT00705432|79054303|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
44233962|NCT00705432|79054298|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
44233963|NCT00705432|79054299|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
44233964|NCT00705432|79054300|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
44377196|NCT01074008|79382505|FG004|Overall Study|Lost to Follow-up|1|||
44377197|NCT01074008|79382506|FG005|Overall Study|Lost to Follow-up|0|||
44377198|NCT01074008|79382507|FG006|Overall Study|Lost to Follow-up|1|||
44377199|NCT01074008|79382508|FG007|Overall Study|Lost to Follow-up|0|||
44377200|NCT01074008|79382509|FG008|Overall Study|Lost to Follow-up|4|||
44377201|NCT01073930|79382540|FG000|Overall Study|Withdrawal by Subject|3|||
44377202|NCT01073930|79382541|FG001|Overall Study|Withdrawal by Subject|2|||
44377203|NCT01073930|79382540|FG000|Overall Study|Lost to Follow-up|0|||
44377204|NCT01073930|79382541|FG001|Overall Study|Lost to Follow-up|1|||
44377205|NCT01073930|79382540|FG000|Overall Study|Adverse Event|0|||
44377206|NCT01073930|79382541|FG001|Overall Study|Adverse Event|1|||
44377207|NCT01073930|79382540|FG000|Overall Study|Noncompliance with study drug|0|||
44377208|NCT01073930|79382541|FG001|Overall Study|Noncompliance with study drug|1|||
44377209|NCT01073930|79382540|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
44377210|NCT01073930|79382541|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
44377211|NCT01073618|79382547|FG000|Overall Study|Death|208|||
44377212|NCT01073618|79382547|FG000|Overall Study|Adverse Event|19|||
44377213|NCT01073618|79382547|FG000|Overall Study|Other|80|||
44377214|NCT01073462|79382551|FG000|Overall Study|Death|14|||
44377215|NCT01073462|79382551|FG000|Overall Study|Kidney transplant|10|||
44377216|NCT01073462|79382551|FG000|Overall Study|Low parathyroid hormone levels|8|||
44377217|NCT01073462|79382551|FG000|Overall Study|Serious adverse event|2|||
44501548|NCT03470194|79506667|FG001|Overall Study|Lost to Follow-up|17|||
44501549|NCT03469336|79506673|FG000|Overall Study|Adverse Event|1|||
44501550|NCT03469258|79506683|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
44501551|NCT03503188|79506689|FG000|Overall Study|Non eligible in the sub study|0|||
44501552|NCT03503188|79506690|FG001|Overall Study|Non eligible in the sub study|1|||
44501553|NCT03502798|79506698|FG000|Overall Study|equipment failure|0|||
44501554|NCT03502798|79506699|FG001|Overall Study|equipment failure|7|||
44501555|NCT00066170|79506709|FG000|Overall Study|Adverse Event|2|||
44501556|NCT00066170|79506710|FG001|Overall Study|Adverse Event|4|||
44233965|NCT00705432|79054301|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
44233966|NCT00705432|79054302|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
44233967|NCT00705432|79054303|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
44233968|NCT00704964|79054314|FG000|Overall Study|Not completed on time|328|||
44377218|NCT01073462|79382551|FG000|Overall Study|Lost to Follow-up|7|||
44377219|NCT00789373|79382555|FG000|Induction|Adverse Event|64|||
44377220|NCT00789373|79382556|FG001|Induction|Adverse Event|0|||
44377221|NCT00789373|79382557|FG002|Induction|Adverse Event|0|||
44377222|NCT00789373|79382555|FG000|Induction|Death Due to study disease|24|||
44501557|NCT00066170|79506711|FG002|Overall Study|Adverse Event|1|||
44501558|NCT00066170|79506712|FG003|Overall Study|Adverse Event|7|||
44501559|NCT00066170|79506709|FG000|Overall Study|Serious Adverse Event|0|||
44501560|NCT00066170|79506710|FG001|Overall Study|Serious Adverse Event|0|||
44377223|NCT00789373|79382556|FG001|Induction|Death Due to study disease|0|||
44377224|NCT00789373|79382557|FG002|Induction|Death Due to study disease|0|||
44501561|NCT00066170|79506711|FG002|Overall Study|Serious Adverse Event|1|||
44501562|NCT00066170|79506712|FG003|Overall Study|Serious Adverse Event|1|||
44501563|NCT00066170|79506709|FG000|Overall Study|Lost to Follow-up|0|||
44501564|NCT00066170|79506710|FG001|Overall Study|Lost to Follow-up|1|||
44501565|NCT00066170|79506711|FG002|Overall Study|Lost to Follow-up|0|||
44501566|NCT00066170|79506712|FG003|Overall Study|Lost to Follow-up|0|||
44501567|NCT00066170|79506709|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
44501568|NCT00066170|79506710|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
44377225|NCT00789373|79382555|FG000|Induction|Death due to adverse event|19|||
44377226|NCT00789373|79382556|FG001|Induction|Death due to adverse event|0|||
44233969|NCT00704808|79054330|FG000|Overall Study|Discontinued prior to starting treatment|14|||
44233970|NCT00704808|79054330|FG000|Overall Study|Death|7|||
44233971|NCT00704808|79054330|FG000|Overall Study|Tumor progression|80|||
44233972|NCT00704808|79054330|FG000|Overall Study|Patient's decision|11|||
44233973|NCT00704808|79054330|FG000|Overall Study|Early therapy discontinuation|16|||
44233974|NCT00704808|79054330|FG000|Overall Study|Adverse Event|1|||
44377227|NCT00789373|79382557|FG002|Induction|Death due to adverse event|0|||
44564802|NCT03131479|79584027|FG004|Overall Study|Adverse Event|0|||
44564803|NCT03131479|79584023|FG000|Overall Study|Subject/Guardian Decision|0|||
44564804|NCT03131479|79584024|FG001|Overall Study|Subject/Guardian Decision|0|||
44501569|NCT00066170|79506711|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
44501570|NCT00066170|79506712|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
44501571|NCT00066170|79506709|FG000|Overall Study|Protocol Violation|3|||
44501572|NCT00066170|79506710|FG001|Overall Study|Protocol Violation|0|||
44501573|NCT00066170|79506711|FG002|Overall Study|Protocol Violation|0|||
44501574|NCT00066170|79506712|FG003|Overall Study|Protocol Violation|0|||
44501575|NCT00066170|79506709|FG000|Overall Study|Other|1|||
44501576|NCT00066170|79506710|FG001|Overall Study|Other|5|||
44564805|NCT03131479|79584025|FG002|Overall Study|Subject/Guardian Decision|0|||
44564806|NCT03131479|79584026|FG003|Overall Study|Subject/Guardian Decision|1|||
44564807|NCT03131479|79584027|FG004|Overall Study|Subject/Guardian Decision|0|||
44564808|NCT03602885|79584041|FG000|Overall Study|Lost to Follow-up|3|||
44564809|NCT03602885|79584042|FG001|Overall Study|Lost to Follow-up|0|||
44564810|NCT02880761|79584050|FG000|Overall Study|Death|6|||
44564811|NCT02880761|79584051|FG001|Overall Study|Death|8|||
44564812|NCT02880761|79584050|FG000|Overall Study|Withdrawal by Subject|3|||
44564813|NCT02880761|79584051|FG001|Overall Study|Withdrawal by Subject|6|||
44564814|NCT02880761|79584050|FG000|Overall Study|Protocol Violation|4|||
44377228|NCT00789373|79382555|FG000|Induction|Death due to toxicity|11|||
44564815|NCT02880761|79584051|FG001|Overall Study|Protocol Violation|3|||
44377229|NCT00789373|79382556|FG001|Induction|Death due to toxicity|0|||
44377230|NCT00789373|79382557|FG002|Induction|Death due to toxicity|0|||
44233975|NCT00704808|79054330|FG000|Overall Study|Lost to Follow-up|1|||
44233976|NCT00704808|79054330|FG000|Overall Study|Treatment change|1|||
44377231|NCT00789373|79382555|FG000|Induction|Death due to procedure|1|||
44564816|NCT02880761|79584050|FG000|Overall Study|Lost to Follow-up|3|||
44233977|NCT01375608|79054365|FG000|Overall Study|Withdrawal by Subject|2|||
44233978|NCT00704418|79054380|FG000|Overall Study|Withdrawal by Subject|2|||
44275469|NCT02168478|79222010|FG000|Overall Study|Withdrawal by Subject|1|||
44275470|NCT02168478|79222010|FG000|Overall Study|Did Not Consent to Participation|2|||
44275471|NCT02168478|79222010|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
44501577|NCT00066170|79506711|FG002|Overall Study|Other|2|||
44233979|NCT00704418|79054381|FG001|Overall Study|Withdrawal by Subject|0|||
44233980|NCT00704418|79054380|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
44233981|NCT00704418|79054381|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
44233982|NCT00704340|79054450|FG000|Overall Study|Lost to Follow-up|2|||
44233983|NCT00704340|79054451|FG001|Overall Study|Lost to Follow-up|1|||
44233984|NCT00704340|79054450|FG000|Overall Study|Death|0|||
44233985|NCT00704340|79054451|FG001|Overall Study|Death|1|||
44233986|NCT00552058|79054459|FG000|Overall Study|Adverse Event|8|||
44233987|NCT00552058|79054460|FG001|Overall Study|Adverse Event|7|||
44233988|NCT00552058|79054459|FG000|Overall Study|Lack of Efficacy|1|||
44233989|NCT00552058|79054460|FG001|Overall Study|Lack of Efficacy|5|||
44233990|NCT00552058|79054459|FG000|Overall Study|Lost to Follow-up|1|||
44233991|NCT00552058|79054460|FG001|Overall Study|Lost to Follow-up|0|||
44233992|NCT00552058|79054459|FG000|Overall Study|Withdrawal by Subject|4|||
44233993|NCT00552058|79054460|FG001|Overall Study|Withdrawal by Subject|4|||
44233994|NCT00552058|79054459|FG000|Overall Study|Other: Protocol Violation|0|||
44233995|NCT00552058|79054460|FG001|Overall Study|Other: Protocol Violation|1|||
44233996|NCT00552058|79054459|FG000|Overall Study|Other: Non Compliance|1|||
44233997|NCT00552058|79054460|FG001|Overall Study|Other: Non Compliance|2|||
44233998|NCT00552058|79054459|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
44233999|NCT00552058|79054460|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
44234000|NCT00552058|79054459|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
44234001|NCT00552058|79054460|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
44234002|NCT00552058|79054459|FG000|Overall Study|Other: Positive Stool Result|0|||
44234003|NCT00552058|79054460|FG001|Overall Study|Other: Positive Stool Result|1|||
44234004|NCT00552058|79054459|FG000|Overall Study|Other: Randomized in error|0|||
44234005|NCT00552058|79054460|FG001|Overall Study|Other: Randomized in error|1|||
44234006|NCT00552058|79054459|FG000|Overall Study|Other: Sponsors Decision|0|||
44234007|NCT00552058|79054460|FG001|Overall Study|Other: Sponsors Decision|1|||
44234008|NCT00552058|79054459|FG000|Overall Study|Other: Early Roll Over|1|||
44234009|NCT00552058|79054460|FG001|Overall Study|Other: Early Roll Over|0|||
44234010|NCT00550732|79054489|FG000|Overall Study|Death|4|||
44234011|NCT00550732|79054489|FG000|Overall Study|Withdrawal by Subject|2|||
44234012|NCT00550732|79054489|FG000|Overall Study|Physician Decision|2|||
44234013|NCT00550732|79054489|FG000|Overall Study|Lost to Follow-up|1|||
44234014|NCT00550732|79054489|FG000|Overall Study|Palliative care|1|||
44234015|NCT00550732|79054489|FG000|Overall Study|Adverse Event|1|||
44234016|NCT00550420|79054503|FG000|Overall Study|Adverse Event|28|||
44234017|NCT00550420|79054503|FG000|Overall Study|Lost to Follow-up|8|||
44234018|NCT00550420|79054503|FG000|Overall Study|Protocol Violation|11|||
44234019|NCT00550420|79054503|FG000|Overall Study|Withdrawal by Subject|30|||
44234020|NCT00550420|79054503|FG000|Overall Study|Still in study at termination|206|||
44234021|NCT00550420|79054503|FG000|Overall Study|Missing|2|||
44275472|NCT02200614|79223161|FG000|Double Blind Treatment|Adverse Event|86|||
44501578|NCT00066170|79506712|FG003|Overall Study|Other|0|||
44501579|NCT00065468|79506725|FG000|Overall Study|Death|172|||
44501580|NCT00065468|79506726|FG001|Overall Study|Death|169|||
44234022|NCT00550420|79054503|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
44234023|NCT00550420|79054503|FG000|Overall Study|Investigators opinion|1|||
44501581|NCT00065468|79506727|FG002|Overall Study|Death|171|||
44275473|NCT02200614|79223162|FG001|Double Blind Treatment|Adverse Event|48|||
44234024|NCT00550420|79054503|FG000|Overall Study|Lack of curative effect|1|||
44275474|NCT02200614|79223161|FG000|Double Blind Treatment|Confirmed metastasis|120|||
44275475|NCT02200614|79223162|FG001|Double Blind Treatment|Confirmed metastasis|140|||
44275476|NCT02200614|79223161|FG000|Double Blind Treatment|Judgment of the investigator|59|||
44275477|NCT02200614|79223162|FG001|Double Blind Treatment|Judgment of the investigator|99|||
44234025|NCT00550420|79054503|FG000|Overall Study|Unethical stop of enrollment|2|||
44234026|NCT00550420|79054503|FG000|Overall Study|Caregiver's decision to withdraw|1|||
44234027|NCT00550420|79054503|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
44234028|NCT00550420|79054503|FG000|Overall Study|Exclusion criteria|1|||
44275478|NCT02200614|79223161|FG000|Double Blind Treatment|Metastasis by local reading|1|||
44275479|NCT02200614|79223162|FG001|Double Blind Treatment|Metastasis by local reading|3|||
44275480|NCT02200614|79223161|FG000|Double Blind Treatment|Other reason|6|||
44275481|NCT02200614|79223162|FG001|Double Blind Treatment|Other reason|2|||
44275482|NCT02200614|79223161|FG000|Double Blind Treatment|Personal reason|77|||
44275483|NCT02200614|79223162|FG001|Double Blind Treatment|Personal reason|85|||
44275484|NCT02200614|79223161|FG000|Double Blind Treatment|Protocol deviation|14|||
44275485|NCT02200614|79223162|FG001|Double Blind Treatment|Protocol deviation|7|||
44275486|NCT02200614|79223161|FG000|Double Blind Treatment|Not treated|1|||
44275487|NCT02200614|79223162|FG001|Double Blind Treatment|Not treated|0|||
44275488|NCT02200614|79223161|FG000|Open Label|Adverse Event|41|||
44275489|NCT02200614|79223162|FG001|Open Label|Adverse Event|11|||
44275490|NCT02200614|79223161|FG000|Open Label|Confirmed metastasis|1|||
44275491|NCT02200614|79223162|FG001|Open Label|Confirmed metastasis|0|||
44275492|NCT02200614|79223161|FG000|Open Label|Judgment of the investigator|29|||
44275493|NCT02200614|79223162|FG001|Open Label|Judgment of the investigator|2|||
44275494|NCT02200614|79223161|FG000|Open Label|Metastasis by local reading|138|||
44275495|NCT02200614|79223162|FG001|Open Label|Metastasis by local reading|27|||
44275496|NCT02200614|79223161|FG000|Open Label|Other reason|22|||
44275497|NCT02200614|79223162|FG001|Open Label|Other reason|4|||
44275498|NCT02200614|79223161|FG000|Open Label|Personal reason|60|||
44275499|NCT02200614|79223162|FG001|Open Label|Personal reason|8|||
44275500|NCT02200614|79223161|FG000|Open Label|Protocol deviation|3|||
44275501|NCT02200614|79223162|FG001|Open Label|Protocol deviation|2|||
44275502|NCT02200614|79223161|FG000|Open Label|Missing|2|||
44275503|NCT02200614|79223162|FG001|Open Label|Missing|2|||
44275504|NCT02231892|79223173|FG000|Overall Study|Lost to Follow-up|1|||
44275505|NCT02231892|79223174|FG001|Overall Study|Lost to Follow-up|0|||
44275506|NCT02231892|79223175|FG002|Overall Study|Lost to Follow-up|3|||
44275507|NCT02231892|79223173|FG000|Overall Study|Withdrawal by Subject|4|||
44275508|NCT02231892|79223174|FG001|Overall Study|Withdrawal by Subject|3|||
44275509|NCT02231892|79223175|FG002|Overall Study|Withdrawal by Subject|15|||
44275510|NCT02231892|79223173|FG000|Overall Study|Physician Decision|0|||
44275511|NCT02231892|79223174|FG001|Overall Study|Physician Decision|2|||
44275512|NCT02231892|79223175|FG002|Overall Study|Physician Decision|4|||
44275513|NCT02231892|79223173|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
44275514|NCT02231892|79223174|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
44275515|NCT02231892|79223175|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
44275516|NCT02231892|79223173|FG000|Overall Study|Participant motor threshold was >83%|0|||
44275517|NCT02231892|79223174|FG001|Overall Study|Participant motor threshold was >83%|0|||
44275518|NCT02231892|79223175|FG002|Overall Study|Participant motor threshold was >83%|9|||
44275519|NCT02231892|79223173|FG000|Overall Study|Could not find motor threshold|2|||
44275520|NCT02231892|79223174|FG001|Overall Study|Could not find motor threshold|0|||
44275521|NCT02231892|79223175|FG002|Overall Study|Could not find motor threshold|1|||
44275522|NCT02231892|79223173|FG000|Overall Study|Could not find reliable motor hotspot|0|||
44275523|NCT02231892|79223174|FG001|Overall Study|Could not find reliable motor hotspot|0|||
44275524|NCT02231892|79223175|FG002|Overall Study|Could not find reliable motor hotspot|1|||
44275525|NCT02231580|79223191|FG000|Overall Study|Adverse Event|5|||
44275526|NCT02231580|79223192|FG001|Overall Study|Adverse Event|0|||
44501582|NCT00065468|79506725|FG000|Overall Study|Withdrawal by Subject|3|||
44234029|NCT00550420|79054503|FG000|Overall Study|Prohibited medicine|1|||
44234030|NCT00558064|79054515|FG000|Overall Study|Adverse Event|3|||
44234031|NCT00558064|79054516|FG001|Overall Study|Adverse Event|2|||
44234032|NCT00558064|79054515|FG000|Overall Study|Lack of Efficacy|0|||
44234033|NCT00558064|79054516|FG001|Overall Study|Lack of Efficacy|1|||
44234034|NCT00558064|79054515|FG000|Overall Study|Protocol Violation|1|||
44234035|NCT00558064|79054516|FG001|Overall Study|Protocol Violation|0|||
44234036|NCT00558064|79054515|FG000|Overall Study|Lost to Follow-up|0|||
44234037|NCT00558064|79054516|FG001|Overall Study|Lost to Follow-up|1|||
44275527|NCT02166606|79223200|FG000|Overall Study|Adverse Event|3|||
44275528|NCT02166606|79223200|FG000|Overall Study|Death|31|||
44275529|NCT02166606|79223200|FG000|Overall Study|Protocol Violation|7|||
44275530|NCT02166606|79223200|FG000|Overall Study|Lost to Follow-up|30|||
44275531|NCT02166606|79223200|FG000|Overall Study|Withdrawal by Subject|1|||
44275532|NCT02166606|79223200|FG000|Overall Study|Physician Decision|1|||
44275533|NCT02166606|79223200|FG000|Overall Study|Device upgrade|1|||
44377232|NCT00789373|79382556|FG001|Induction|Death due to procedure|0|||
44377233|NCT00789373|79382557|FG002|Induction|Death due to procedure|0|||
44234038|NCT00558064|79054515|FG000|Overall Study|Withdrawal by Subject|0|||
44234039|NCT00558064|79054516|FG001|Overall Study|Withdrawal by Subject|1|||
44234040|NCT00558064|79054515|FG000|Overall Study|No visit within allowance period|1|||
44234041|NCT00558064|79054516|FG001|Overall Study|No visit within allowance period|0|||
44234042|NCT00557830|79054525|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
44234043|NCT00557830|79054526|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
44234044|NCT00557830|79054527|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
44234045|NCT00557830|79054525|FG000|Screening Treatment Phase|Adverse Event|2|||
44234046|NCT00557830|79054526|FG001|Screening Treatment Phase|Adverse Event|0|||
44234047|NCT00557830|79054527|FG002|Screening Treatment Phase|Adverse Event|0|||
44234048|NCT00557830|79054525|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
44564817|NCT02880761|79584051|FG001|Overall Study|Lost to Follow-up|4|||
44564818|NCT02930941|79584059|FG000|Overall Study|Lost to Follow-up|1|||
44275534|NCT02166606|79223200|FG000|Overall Study|Enrolled after End of Enrollment|4|||
44234049|NCT00557830|79054526|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
44234050|NCT00557830|79054527|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
44234051|NCT00557440|79054538|FG000|Treatment Period 1|Adverse Event|0|||
44234052|NCT00557440|79054539|FG001|Treatment Period 1|Adverse Event|0|||
44234053|NCT00557440|79054540|FG002|Treatment Period 1|Adverse Event|1|||
44234054|NCT00556894|79054551|FG000|Overall Study|Adverse Event|2|||
44234055|NCT00556894|79054552|FG001|Overall Study|Adverse Event|3|||
44234056|NCT00556894|79054553|FG002|Overall Study|Adverse Event|3|||
44234057|NCT00556894|79054551|FG000|Overall Study|Death|1|||
44234058|NCT00556894|79054552|FG001|Overall Study|Death|0|||
44234059|NCT00556894|79054553|FG002|Overall Study|Death|0|||
44234060|NCT00556894|79054551|FG000|Overall Study|regulatory decision in Bulgaria|10|||
44234061|NCT00556894|79054552|FG001|Overall Study|regulatory decision in Bulgaria|14|||
44275535|NCT02230956|79223207|FG000|Overall Study|Adverse Event|1|||
44275536|NCT02230956|79223208|FG001|Overall Study|Adverse Event|1|||
44275537|NCT02230956|79223209|FG002|Overall Study|Adverse Event|0|||
44275538|NCT02230956|79223207|FG000|Overall Study|Lack of Efficacy|1|||
44275539|NCT02230956|79223208|FG001|Overall Study|Lack of Efficacy|1|||
44275540|NCT02230956|79223209|FG002|Overall Study|Lack of Efficacy|1|||
44275541|NCT02230956|79223207|FG000|Overall Study|Lost to Follow-up|1|||
44275542|NCT02230956|79223208|FG001|Overall Study|Lost to Follow-up|1|||
44275543|NCT02230956|79223209|FG002|Overall Study|Lost to Follow-up|2|||
44234062|NCT00556894|79054553|FG002|Overall Study|regulatory decision in Bulgaria|13|||
44275544|NCT02230956|79223207|FG000|Overall Study|Personal Reasons|2|||
44275545|NCT02230956|79223208|FG001|Overall Study|Personal Reasons|1|||
44377234|NCT00789373|79382555|FG000|Induction|Investigator decision|7|||
44234063|NCT00556894|79054551|FG000|Overall Study|Change in therapy|2|||
44234064|NCT00556894|79054552|FG001|Overall Study|Change in therapy|1|||
44234065|NCT00556894|79054553|FG002|Overall Study|Change in therapy|2|||
44234066|NCT00556894|79054551|FG000|Overall Study|Withdrawal by Subject|1|||
44234067|NCT00556894|79054552|FG001|Overall Study|Withdrawal by Subject|1|||
44234068|NCT00556894|79054553|FG002|Overall Study|Withdrawal by Subject|1|||
44234069|NCT02722044|79054561|FG000|Overall Study|Adverse Event|2|||
44377235|NCT00789373|79382556|FG001|Induction|Investigator decision|0|||
44377236|NCT00789373|79382557|FG002|Induction|Investigator decision|0|||
44377237|NCT00789373|79382555|FG000|Induction|Protocol entry criteria not met|9|||
44377238|NCT00789373|79382556|FG001|Induction|Protocol entry criteria not met|0|||
44275546|NCT02230956|79223209|FG002|Overall Study|Personal Reasons|1|||
44234070|NCT02722044|79054561|FG000|Overall Study|Physician Decision|1|||
44234071|NCT02722044|79054561|FG000|Overall Study|Withdrawal by Subject|1|||
44234072|NCT02722044|79054561|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
44275547|NCT02230956|79223207|FG000|Overall Study|Protocol Violation|0|||
44275548|NCT02230956|79223208|FG001|Overall Study|Protocol Violation|1|||
44275549|NCT02230956|79223209|FG002|Overall Study|Protocol Violation|1|||
44377239|NCT00789373|79382557|FG002|Induction|Protocol entry criteria not met|0|||
44564819|NCT02930941|79584060|FG001|Overall Study|Lost to Follow-up|2|||
44234073|NCT00556426|79054566|FG000|Overall Study|Withdrawal by Subject|3|||
44234074|NCT00556426|79054566|FG000|Overall Study|Death|6|||
44234075|NCT00555568|79054574|FG000|Overall Study|Lost to Follow-up|26|||
44234076|NCT00555568|79054575|FG001|Overall Study|Lost to Follow-up|16|||
44234077|NCT00555568|79054576|FG002|Overall Study|Lost to Follow-up|16|||
44234078|NCT00702702|79054587|FG000|Overall Study|Study prematurely terminated|56|||
44234079|NCT02721966|79054598|FG000|Overall Study|Protocol Violation|1|||
44234080|NCT02721966|79054599|FG001|Overall Study|Protocol Violation|0|||
44234081|NCT02721966|79054600|FG002|Overall Study|Protocol Violation|0|||
44234082|NCT02721966|79054601|FG003|Overall Study|Protocol Violation|0|||
44234083|NCT02721966|79054602|FG004|Overall Study|Protocol Violation|0|||
44234084|NCT02721966|79054598|FG000|Overall Study|Withdrawal by Subject|9|||
44234085|NCT02721966|79054599|FG001|Overall Study|Withdrawal by Subject|2|||
44234086|NCT02721966|79054600|FG002|Overall Study|Withdrawal by Subject|3|||
44234087|NCT02721966|79054601|FG003|Overall Study|Withdrawal by Subject|7|||
44234088|NCT02721966|79054602|FG004|Overall Study|Withdrawal by Subject|0|||
44234089|NCT02721966|79054598|FG000|Overall Study|Adverse Event|4|||
44234090|NCT02721966|79054599|FG001|Overall Study|Adverse Event|4|||
44234091|NCT02721966|79054600|FG002|Overall Study|Adverse Event|3|||
44234092|NCT02721966|79054601|FG003|Overall Study|Adverse Event|0|||
44234093|NCT02721966|79054602|FG004|Overall Study|Adverse Event|0|||
44234094|NCT02721966|79054598|FG000|Overall Study|Death|1|||
44234095|NCT02721966|79054599|FG001|Overall Study|Death|0|||
44234096|NCT02721966|79054600|FG002|Overall Study|Death|0|||
44234097|NCT02721966|79054601|FG003|Overall Study|Death|0|||
44234098|NCT02721966|79054602|FG004|Overall Study|Death|0|||
44234099|NCT02721966|79054598|FG000|Overall Study|Lack of Efficacy|7|||
44234100|NCT02721966|79054599|FG001|Overall Study|Lack of Efficacy|4|||
44234101|NCT02721966|79054600|FG002|Overall Study|Lack of Efficacy|0|||
44234102|NCT02721966|79054601|FG003|Overall Study|Lack of Efficacy|0|||
44234103|NCT02721966|79054602|FG004|Overall Study|Lack of Efficacy|0|||
44234104|NCT02721966|79054598|FG000|Overall Study|Lost to Follow-up|0|||
44234105|NCT02721966|79054599|FG001|Overall Study|Lost to Follow-up|0|||
44234106|NCT02721966|79054600|FG002|Overall Study|Lost to Follow-up|3|||
44234107|NCT02721966|79054601|FG003|Overall Study|Lost to Follow-up|0|||
44234108|NCT02721966|79054602|FG004|Overall Study|Lost to Follow-up|0|||
44234109|NCT02721966|79054598|FG000|Overall Study|Physician Decision|1|||
44234110|NCT02721966|79054599|FG001|Overall Study|Physician Decision|1|||
44234111|NCT02721966|79054600|FG002|Overall Study|Physician Decision|0|||
44234112|NCT02721966|79054601|FG003|Overall Study|Physician Decision|0|||
44234113|NCT02721966|79054602|FG004|Overall Study|Physician Decision|0|||
44234114|NCT02721966|79054598|FG000|Overall Study|Pregnancy|1|||
44234115|NCT02721966|79054599|FG001|Overall Study|Pregnancy|0|||
44234116|NCT02721966|79054600|FG002|Overall Study|Pregnancy|0|||
44234117|NCT02721966|79054601|FG003|Overall Study|Pregnancy|0|||
44234118|NCT02721966|79054602|FG004|Overall Study|Pregnancy|0|||
44234119|NCT02721966|79054598|FG000|Overall Study|Did not continue to period 2|5|||
44234120|NCT02721966|79054599|FG001|Overall Study|Did not continue to period 2|12|||
44234121|NCT02721966|79054600|FG002|Overall Study|Did not continue to period 2|0|||
44234122|NCT02721966|79054601|FG003|Overall Study|Did not continue to period 2|0|||
44234123|NCT02721966|79054602|FG004|Overall Study|Did not continue to period 2|5|||
44234124|NCT00553462|79054610|FG000|Overall Study|Adverse Event|4|||
44234125|NCT00553462|79054610|FG000|Overall Study|Progression|4|||
44234126|NCT00553462|79054610|FG000|Overall Study|Withdrawal by Subject|5|||
44234127|NCT00553462|79054610|FG000|Overall Study|Physician Decision|1|||
44234128|NCT00553150|79054616|FG000|Overall Study|Withdrawal by Subject|0|||
44234129|NCT00553150|79054617|FG001|Overall Study|Withdrawal by Subject|0|||
44234130|NCT00553150|79054618|FG002|Overall Study|Withdrawal by Subject|0|||
44234131|NCT00553150|79054619|FG003|Overall Study|Withdrawal by Subject|2|||
44234132|NCT00553150|79054616|FG000|Overall Study|Protocol Violation|0|||
44234133|NCT00553150|79054617|FG001|Overall Study|Protocol Violation|0|||
44275550|NCT02230956|79223207|FG000|Overall Study|Other Miscellaneous Reason|0|||
44234134|NCT00553150|79054618|FG002|Overall Study|Protocol Violation|0|||
44234135|NCT00553150|79054619|FG003|Overall Study|Protocol Violation|1|||
44234136|NCT00553150|79054616|FG000|Overall Study|Ineligible|0|||
44234137|NCT00553150|79054617|FG001|Overall Study|Ineligible|0|||
44234138|NCT00553150|79054618|FG002|Overall Study|Ineligible|0|||
44234139|NCT00553150|79054619|FG003|Overall Study|Ineligible|1|||
44234140|NCT03301350|79054627|FG000|Overall Study|Withdrawal by Subject|4|||
44234141|NCT03301350|79054627|FG000|Overall Study|Adverse Event|1|||
44234142|NCT03301350|79054627|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
44234143|NCT03301350|79054627|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
44234144|NCT03301350|79054627|FG000|Overall Study|no detail provided|1|||
44234145|NCT04735432|79054634|FG000|Overall Study|Other - due to personal reason|1|||
44234146|NCT04735432|79054635|FG001|Overall Study|Other - due to personal reason|0|||
44234147|NCT04735432|79054634|FG000|Overall Study|Adverse Event|2|||
44234148|NCT04735432|79054635|FG001|Overall Study|Adverse Event|0|||
44234149|NCT02722278|79054644|FG000|Overall Study|Withdrawal by Subject|5|||
44234150|NCT02722278|79054645|FG001|Overall Study|Withdrawal by Subject|3|||
44501583|NCT00065468|79506726|FG001|Overall Study|Withdrawal by Subject|4|||
44501584|NCT00065468|79506727|FG002|Overall Study|Withdrawal by Subject|5|||
44501585|NCT00065468|79506725|FG000|Overall Study|Lost to Follow-up|5|||
44501586|NCT00065468|79506726|FG001|Overall Study|Lost to Follow-up|3|||
44501587|NCT00065468|79506727|FG002|Overall Study|Lost to Follow-up|2|||
44501588|NCT00065468|79506725|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
44501589|NCT00065468|79506726|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
44234151|NCT02722278|79054644|FG000|Overall Study|Adverse Event|4|||
44234152|NCT02722278|79054645|FG001|Overall Study|Adverse Event|1|||
44234153|NCT02722278|79054644|FG000|Overall Study|Lost to Follow-up|2|||
44234154|NCT02722278|79054645|FG001|Overall Study|Lost to Follow-up|0|||
44234155|NCT02722278|79054644|FG000|Overall Study|Protocol Violation|1|||
44234156|NCT02722278|79054645|FG001|Overall Study|Protocol Violation|0|||
44234157|NCT02722278|79054644|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
44234158|NCT02722278|79054645|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
44234159|NCT02722278|79054644|FG000|Overall Study|Subject declined after tx assignment|0|||
44234160|NCT02722278|79054645|FG001|Overall Study|Subject declined after tx assignment|1|||
44234161|NCT02722278|79054644|FG000|Overall Study|Site closure not study related|0|||
44234162|NCT02722278|79054645|FG001|Overall Study|Site closure not study related|1|||
44234163|NCT00703092|79054653|FG000|Overall Study|Withdrawal by Subject|2|||
44234164|NCT02720484|79054657|FG000|Treatment on Study|Adverse Event|1|||
44234165|NCT02720484|79054657|FG000|Treatment on Study|Withdrawal by Subject|1|||
44501590|NCT00065468|79506727|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
44234166|NCT02720484|79054657|FG000|Treatment on Study|Progressive Disease|4|||
44234167|NCT02720484|79054657|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
44234168|NCT02720484|79054657|FG000|Follow Up for 2 Years|Death|3|||
44501591|NCT00065468|79506725|FG000|Overall Study|Disease progression|0|||
44501592|NCT00065468|79506726|FG001|Overall Study|Disease progression|0|||
44501593|NCT00065468|79506727|FG002|Overall Study|Disease progression|1|||
44501594|NCT00065468|79506725|FG000|Overall Study|Other|14|||
44501595|NCT00065468|79506726|FG001|Overall Study|Other|24|||
44501596|NCT00065468|79506727|FG002|Overall Study|Other|18|||
44501597|NCT00071006|79506735|FG000|Overall Study|Lack of Efficacy|7|||
44501598|NCT00071006|79506735|FG000|Overall Study|Adverse Event|1|||
44501599|NCT00071006|79506735|FG000|Overall Study|Withdrawal by Subject|1|||
44564820|NCT03137537|79584072|FG000|Overall Study|Adverse Event|0|||
44564821|NCT03137537|79584073|FG001|Overall Study|Adverse Event|1|||
44564822|NCT03137459|79584081|FG000|2-month Assessment|Withdrawal by Subject|13|||
44564823|NCT03137459|79584082|FG001|2-month Assessment|Withdrawal by Subject|3|||
44564824|NCT03137459|79584081|FG000|2-month Assessment|Unable to reach|42|||
44564825|NCT03137459|79584082|FG001|2-month Assessment|Unable to reach|32|||
44234169|NCT02720484|79054657|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
44234170|NCT02715804|79054663|FG000|Overall Study|Death|222|||
44234171|NCT02715804|79054664|FG001|Overall Study|Death|106|||
44234172|NCT02715804|79054663|FG000|Overall Study|Withdrawal by Subject|5|||
44234173|NCT02715804|79054664|FG001|Overall Study|Withdrawal by Subject|4|||
44234174|NCT02715804|79054663|FG000|Overall Study|Other than specified|2|||
44501600|NCT00071006|79506735|FG000|Overall Study|Other|3|||
44501601|NCT00094575|79506741|FG000|Overall Study|Death|146|||
44501602|NCT00094575|79506742|FG001|Overall Study|Death|146|||
44501603|NCT00057746|79506753|FG000|Overall Study|Withdrawal by Subject|0|||
44501604|NCT00057746|79506754|FG001|Overall Study|Withdrawal by Subject|0|||
44564826|NCT03137459|79584081|FG000|2-month Assessment|Refused assessment|7|||
44564827|NCT03137459|79584082|FG001|2-month Assessment|Refused assessment|5|||
44564828|NCT03137459|79584081|FG000|2-month Assessment|Acutely ill|6|||
44564829|NCT03137459|79584082|FG001|2-month Assessment|Acutely ill|2|||
44564830|NCT03137459|79584081|FG000|4-month Assessment|Death|4|||
44564831|NCT03137459|79584082|FG001|4-month Assessment|Death|2|||
44564832|NCT03137459|79584081|FG000|4-month Assessment|Withdrawal by Subject|4|||
44564833|NCT03137459|79584082|FG001|4-month Assessment|Withdrawal by Subject|2|||
44564834|NCT03137459|79584081|FG000|4-month Assessment|Unable to reach|44|||
44234175|NCT02715804|79054664|FG001|Overall Study|Other than specified|3|||
44234176|NCT02717832|79054670|FG000|Overall Study|Inability to place IV|3|||
44234177|NCT02717754|79054681|FG000|Overall Study|Incorrect Infusion Duration|0|||
44234178|NCT02717754|79054682|FG001|Overall Study|Incorrect Infusion Duration|0|||
44234179|NCT02717754|79054683|FG002|Overall Study|Incorrect Infusion Duration|0|||
44234180|NCT02717754|79054684|FG003|Overall Study|Incorrect Infusion Duration|10|||
44564835|NCT03137459|79584082|FG001|4-month Assessment|Unable to reach|29|||
44564836|NCT03137459|79584081|FG000|4-month Assessment|Refused assessment|24|||
44234181|NCT02717754|79054685|FG004|Overall Study|Incorrect Infusion Duration|20|||
44234182|NCT02717754|79054686|FG005|Overall Study|Incorrect Infusion Duration|20|||
44234183|NCT02717130|79054696|FG000|Overall Study|Withdrawal by Subject|1|||
44234184|NCT02717130|79054696|FG000|Overall Study|Adverse Event|1|||
44501605|NCT00057746|79506755|FG002|Overall Study|Withdrawal by Subject|1|||
44275551|NCT02230956|79223208|FG001|Overall Study|Other Miscellaneous Reason|1|||
44275552|NCT02230956|79223209|FG002|Overall Study|Other Miscellaneous Reason|2|||
44275553|NCT02230410|79223217|FG000|Overall Study|Screen Failure|3|||
44275554|NCT02230332|79223223|FG000|Overall Study|Adverse Event|2|||
44275555|NCT02230332|79223224|FG001|Overall Study|Adverse Event|1|||
44275556|NCT02230332|79223223|FG000|Overall Study|Lost to Follow-up|1|||
44275557|NCT02230332|79223224|FG001|Overall Study|Lost to Follow-up|0|||
44275558|NCT02230332|79223223|FG000|Overall Study|Protocol Violation|1|||
44234185|NCT02717130|79054696|FG000|Overall Study|Physician Decision|1|||
44234186|NCT02717130|79054696|FG000|Overall Study|Study Closure|4|||
44275559|NCT02230332|79223224|FG001|Overall Study|Protocol Violation|0|||
44275560|NCT02230254|79223230|FG000|Overall Study|Lost to Follow-up|3|||
44275561|NCT02198664|79223236|FG000|Overall Study|Adverse Event|2|||
44275562|NCT02198664|79223237|FG001|Overall Study|Adverse Event|0|||
44275563|NCT02198664|79223236|FG000|Overall Study|Withdrawal by Subject|11|||
44275564|NCT02198664|79223237|FG001|Overall Study|Withdrawal by Subject|8|||
44275565|NCT02198664|79223236|FG000|Overall Study|Failure to tolerate|2|||
44275566|NCT02198664|79223237|FG001|Overall Study|Failure to tolerate|0|||
44275567|NCT02198664|79223236|FG000|Overall Study|Not stated|1|||
44275568|NCT02198664|79223237|FG001|Overall Study|Not stated|0|||
44275569|NCT02165826|79223248|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
44275570|NCT02165826|79223249|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
44275571|NCT02165826|79223250|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
44275572|NCT02165826|79223248|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
44275573|NCT02165826|79223249|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
44275574|NCT02165826|79223250|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
44275575|NCT02165826|79223248|FG000|Main Treatment Period|Lost to Follow-up|4|||
44275576|NCT02165826|79223249|FG001|Main Treatment Period|Lost to Follow-up|2|||
44275577|NCT02165826|79223250|FG002|Main Treatment Period|Lost to Follow-up|1|||
44275578|NCT02165826|79223248|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
44275579|NCT02165826|79223249|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
44275580|NCT02165826|79223250|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
44275581|NCT02165826|79223248|FG000|Main Treatment Period|Lack of Efficacy|2|||
44275582|NCT02165826|79223249|FG001|Main Treatment Period|Lack of Efficacy|0|||
44275583|NCT02165826|79223250|FG002|Main Treatment Period|Lack of Efficacy|0|||
44275584|NCT02165826|79223248|FG000|Main Treatment Period|Reason Not Specified|8|||
44275585|NCT02165826|79223249|FG001|Main Treatment Period|Reason Not Specified|5|||
44275586|NCT02165826|79223250|FG002|Main Treatment Period|Reason Not Specified|16|||
44275587|NCT02165826|79223248|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
44275588|NCT02165826|79223249|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
44275589|NCT02165826|79223250|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
44275590|NCT02165826|79223248|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
44275591|NCT02165826|79223249|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
44275592|NCT02165826|79223250|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
44275593|NCT02165826|79223248|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
44275594|NCT02165826|79223249|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
44275595|NCT02165826|79223250|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
44275596|NCT02165826|79223248|FG000|Down-Titration Period|Reason Not Specified|1|||
44275597|NCT02165826|79223249|FG001|Down-Titration Period|Reason Not Specified|0|||
44234187|NCT02192502|79054716|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
44234188|NCT02192502|79054717|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
44234189|NCT02192502|79054716|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
44234190|NCT02192502|79054717|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
44234191|NCT02192502|79054716|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
44234192|NCT02192502|79054717|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
44234193|NCT01781429|79054738|FG000|Overall Study|Death|0|||
44234194|NCT01781429|79054739|FG001|Overall Study|Death|0|||
44275598|NCT02165826|79223250|FG002|Down-Titration Period|Reason Not Specified|2|||
44275599|NCT02198040|79223287|FG000|Overall Study|Work reasons|0|||
44275600|NCT02198040|79223288|FG001|Overall Study|Work reasons|1|||
44275601|NCT02198040|79223289|FG002|Overall Study|Work reasons|0|||
44275602|NCT02198040|79223287|FG000|Overall Study|Withdrawal by Subject|0|||
44275603|NCT02198040|79223288|FG001|Overall Study|Withdrawal by Subject|0|||
44275604|NCT02198040|79223289|FG002|Overall Study|Withdrawal by Subject|1|||
44275605|NCT02197806|79223303|FG000|Overall Study|Adverse Event|0|||
44275606|NCT02197806|79223304|FG001|Overall Study|Adverse Event|1|||
44275607|NCT02197806|79223305|FG002|Overall Study|Adverse Event|0|||
44275608|NCT02197806|79223306|FG003|Overall Study|Adverse Event|1|||
44275609|NCT02229864|79223353|FG000|Overall Study|Death|2|||
44275610|NCT02229864|79223353|FG000|Overall Study|Lost to Follow-up|1|||
44275611|NCT02229552|79223357|FG000|Baseline|Withdrawal by Subject|6|||
44275612|NCT02229552|79223357|FG000|1-year Follow up|Withdrawal by Subject|7|||
44275613|NCT02229552|79223357|FG000|1-year Follow up|Lost to Follow-up|18|||
44275614|NCT02229552|79223357|FG000|2-Year Follow up|Withdrawal by Subject|9|||
44275615|NCT02229552|79223357|FG000|2-Year Follow up|Lost to Follow-up|17|||
44275616|NCT02229396|79223364|FG000|Overall Study|Adverse Event|6|||
44275617|NCT02229396|79223365|FG001|Overall Study|Adverse Event|12|||
44275618|NCT02229396|79223366|FG002|Overall Study|Adverse Event|12|||
44275619|NCT02229396|79223364|FG000|Overall Study|Death|2|||
44501606|NCT00094107|79506763|FG000|Overall Study|Lack of Efficacy|23|||
44234195|NCT01781429|79054740|FG002|Overall Study|Death|0|||
44234196|NCT01781429|79054741|FG003|Overall Study|Death|0|||
44234197|NCT01781429|79054742|FG004|Overall Study|Death|0|||
44234198|NCT01781429|79054743|FG005|Overall Study|Death|0|||
44234199|NCT01781429|79054744|FG006|Overall Study|Death|0|||
44234200|NCT01781429|79054745|FG007|Overall Study|Death|0|||
44234201|NCT01781429|79054746|FG008|Overall Study|Death|0|||
44234202|NCT01781429|79054747|FG009|Overall Study|Death|1|||
44234203|NCT01781429|79054748|FG010|Overall Study|Death|0|||
44234204|NCT01781429|79054749|FG011|Overall Study|Death|0|||
44234205|NCT01781429|79054750|FG012|Overall Study|Death|1|||
44234206|NCT01781429|79054751|FG013|Overall Study|Death|0|||
44234207|NCT01781429|79054752|FG014|Overall Study|Death|1|||
44234208|NCT01781429|79054753|FG015|Overall Study|Death|0|||
44234209|NCT01781429|79054738|FG000|Overall Study|Withdrawal by Subject|0|||
44234210|NCT01781429|79054739|FG001|Overall Study|Withdrawal by Subject|0|||
44234211|NCT01781429|79054740|FG002|Overall Study|Withdrawal by Subject|0|||
44234212|NCT01781429|79054741|FG003|Overall Study|Withdrawal by Subject|0|||
44234213|NCT01781429|79054742|FG004|Overall Study|Withdrawal by Subject|0|||
44234214|NCT01781429|79054743|FG005|Overall Study|Withdrawal by Subject|0|||
44234215|NCT01781429|79054744|FG006|Overall Study|Withdrawal by Subject|0|||
44234216|NCT01781429|79054745|FG007|Overall Study|Withdrawal by Subject|0|||
44234217|NCT01781429|79054746|FG008|Overall Study|Withdrawal by Subject|1|||
44234218|NCT01781429|79054747|FG009|Overall Study|Withdrawal by Subject|3|||
44234219|NCT01781429|79054748|FG010|Overall Study|Withdrawal by Subject|1|||
44234220|NCT01781429|79054749|FG011|Overall Study|Withdrawal by Subject|1|||
44234221|NCT01781429|79054750|FG012|Overall Study|Withdrawal by Subject|5|||
44234222|NCT01781429|79054751|FG013|Overall Study|Withdrawal by Subject|2|||
44234223|NCT01781429|79054752|FG014|Overall Study|Withdrawal by Subject|3|||
44234224|NCT01781429|79054753|FG015|Overall Study|Withdrawal by Subject|0|||
44275620|NCT02229396|79223365|FG001|Overall Study|Death|3|||
44275621|NCT02229396|79223366|FG002|Overall Study|Death|1|||
44275622|NCT02229396|79223364|FG000|Overall Study|Lost to Follow-up|14|||
44234225|NCT01781429|79054738|FG000|Overall Study|Disease Progression|1|||
44234226|NCT01781429|79054739|FG001|Overall Study|Disease Progression|0|||
44234227|NCT01781429|79054740|FG002|Overall Study|Disease Progression|1|||
44275623|NCT02229396|79223365|FG001|Overall Study|Lost to Follow-up|14|||
44234228|NCT01781429|79054741|FG003|Overall Study|Disease Progression|1|||
44234229|NCT01781429|79054742|FG004|Overall Study|Disease Progression|1|||
44234230|NCT01781429|79054743|FG005|Overall Study|Disease Progression|4|||
44234231|NCT01781429|79054744|FG006|Overall Study|Disease Progression|7|||
44234232|NCT01781429|79054745|FG007|Overall Study|Disease Progression|4|||
44234233|NCT01781429|79054746|FG008|Overall Study|Disease Progression|6|||
44234234|NCT01781429|79054747|FG009|Overall Study|Disease Progression|15|||
44234235|NCT01781429|79054748|FG010|Overall Study|Disease Progression|15|||
44234236|NCT01781429|79054749|FG011|Overall Study|Disease Progression|15|||
44234237|NCT01781429|79054750|FG012|Overall Study|Disease Progression|15|||
44234238|NCT01781429|79054751|FG013|Overall Study|Disease Progression|4|||
44234239|NCT01781429|79054752|FG014|Overall Study|Disease Progression|11|||
44234240|NCT01781429|79054753|FG015|Overall Study|Disease Progression|0|||
44234241|NCT01781429|79054738|FG000|Overall Study|Unacceptable Toxicity|0|||
44275624|NCT02229396|79223366|FG002|Overall Study|Lost to Follow-up|21|||
44275625|NCT02229396|79223364|FG000|Overall Study|Protocol Violation|2|||
44275626|NCT02229396|79223365|FG001|Overall Study|Protocol Violation|1|||
44275627|NCT02229396|79223366|FG002|Overall Study|Protocol Violation|0|||
44275628|NCT02229396|79223364|FG000|Overall Study|Patient Incorrectly Randomized|0|||
44275629|NCT02229396|79223365|FG001|Overall Study|Patient Incorrectly Randomized|0|||
44275630|NCT02229396|79223366|FG002|Overall Study|Patient Incorrectly Randomized|1|||
44275631|NCT02229396|79223364|FG000|Overall Study|Other|10|||
44275632|NCT02229396|79223365|FG001|Overall Study|Other|18|||
44275633|NCT02229396|79223366|FG002|Overall Study|Other|15|||
44275634|NCT02229396|79223364|FG000|Overall Study|Withdrawal by Subject|42|||
44275635|NCT02229396|79223365|FG001|Overall Study|Withdrawal by Subject|28|||
44275636|NCT02229396|79223366|FG002|Overall Study|Withdrawal by Subject|41|||
44275637|NCT02229396|79223364|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
44275638|NCT02229396|79223365|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
44275639|NCT02229396|79223366|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
44275640|NCT02229396|79223364|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
44275641|NCT02229396|79223365|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
44275642|NCT02229396|79223366|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
44275643|NCT02197416|79223381|FG000|Overall Study|Other reasons|0|||
44275644|NCT02197416|79223382|FG001|Overall Study|Other reasons|2|||
44275645|NCT02197416|79223383|FG002|Overall Study|Other reasons|5|||
44275646|NCT02197416|79223381|FG000|Overall Study|Withdrawal by Subject|0|||
44275647|NCT02197416|79223382|FG001|Overall Study|Withdrawal by Subject|2|||
44275648|NCT02197416|79223383|FG002|Overall Study|Withdrawal by Subject|1|||
44275649|NCT02197416|79223381|FG000|Overall Study|Protocol Violation|1|||
44275650|NCT02197416|79223382|FG001|Overall Study|Protocol Violation|0|||
44275651|NCT02197416|79223383|FG002|Overall Study|Protocol Violation|1|||
44275652|NCT02197416|79223381|FG000|Overall Study|Adverse Event|0|||
44275653|NCT02197416|79223382|FG001|Overall Study|Adverse Event|0|||
44275654|NCT02197416|79223383|FG002|Overall Study|Adverse Event|1|||
44275655|NCT02165202|79223391|FG000|Oral Phase|Refused further participation|5|||
44275656|NCT02165202|79223392|FG001|Oral Phase|Refused further participation|1|||
44275657|NCT02165202|79223391|FG000|Oral Phase|Study product Related Toxicity|1|||
44275658|NCT02165202|79223392|FG001|Oral Phase|Study product Related Toxicity|0|||
44275659|NCT02165202|79223391|FG000|Oral Phase|Unable to contact Participant|1|||
44275660|NCT02165202|79223392|FG001|Oral Phase|Unable to contact Participant|1|||
44275661|NCT02165202|79223391|FG000|Oral Phase|Clinical reasons|1|||
44275662|NCT02165202|79223392|FG001|Oral Phase|Clinical reasons|0|||
44275663|NCT02165202|79223391|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
44275664|NCT02165202|79223392|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
44275665|NCT02165202|79223391|FG000|Oral Phase|CMC advised termination|1|||
44275666|NCT02165202|79223392|FG001|Oral Phase|CMC advised termination|0|||
44234242|NCT01781429|79054739|FG001|Overall Study|Unacceptable Toxicity|0|||
44234243|NCT01781429|79054740|FG002|Overall Study|Unacceptable Toxicity|0|||
44275667|NCT02165202|79223391|FG000|Oral Phase|Relocated, no follow-up planned|1|||
44275668|NCT02165202|79223392|FG001|Oral Phase|Relocated, no follow-up planned|0|||
44275669|NCT02165202|79223391|FG000|Oral Phase|Abnormal EKG|0|||
44275670|NCT02165202|79223392|FG001|Oral Phase|Abnormal EKG|1|||
44275671|NCT02165202|79223391|FG000|Injection Phase|Abnormal Lab Value|5|||
44234244|NCT01781429|79054741|FG003|Overall Study|Unacceptable Toxicity|0|||
44234245|NCT01781429|79054742|FG004|Overall Study|Unacceptable Toxicity|0|||
44275672|NCT02165202|79223392|FG001|Injection Phase|Abnormal Lab Value|1|||
44275673|NCT02165202|79223391|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
44275674|NCT02165202|79223392|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
44275675|NCT02165202|79223391|FG000|Injection Phase|Unable to attend within Visit Window|1|||
44275676|NCT02165202|79223392|FG001|Injection Phase|Unable to attend within Visit Window|0|||
44275677|NCT02165202|79223391|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
44275678|NCT02165202|79223392|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
44275679|NCT02165202|79223391|FG000|Injection Phase|End of Study|2|||
44275680|NCT02165202|79223392|FG001|Injection Phase|End of Study|1|||
44275681|NCT02165202|79223391|FG000|Injection Phase|Study Product related Toxicity|1|||
44275682|NCT02165202|79223392|FG001|Injection Phase|Study Product related Toxicity|0|||
44275683|NCT02165202|79223391|FG000|Injection Phase|No longer interested|0|||
44275684|NCT02165202|79223392|FG001|Injection Phase|No longer interested|1|||
44275685|NCT02165202|79223391|FG000|Injection Phase|Participant unwilling to comply|1|||
44275686|NCT02165202|79223392|FG001|Injection Phase|Participant unwilling to comply|0|||
44275687|NCT01628874|79223400|FG000|Overall Study|Physician Decision|1|||
44275688|NCT01628874|79223401|FG001|Overall Study|Physician Decision|1|||
44275689|NCT01628874|79223400|FG000|Overall Study|Age >4 months|4|||
44275690|NCT01628874|79223401|FG001|Overall Study|Age >4 months|2|||
44275691|NCT02196714|79223426|FG000|Overall Study|Protocol Violation|0|||
44275692|NCT02196714|79223427|FG001|Overall Study|Protocol Violation|0|||
44275693|NCT02196714|79223428|FG002|Overall Study|Protocol Violation|1|||
44275694|NCT02196714|79223429|FG003|Overall Study|Protocol Violation|0|||
44275695|NCT02196558|79223453|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
44501607|NCT00094107|79506763|FG000|Overall Study|Death|5|||
44234246|NCT01781429|79054743|FG005|Overall Study|Unacceptable Toxicity|0|||
44501608|NCT00094107|79506763|FG000|Overall Study|Adverse Event|3|||
44501609|NCT00094107|79506763|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
44501610|NCT00102063|79506770|FG000|Overall Study|Lack of Efficacy|5|||
44501611|NCT00102063|79506771|FG001|Overall Study|Lack of Efficacy|1|||
44501612|NCT00102063|79506772|FG002|Overall Study|Lack of Efficacy|1|||
44501613|NCT00102063|79506770|FG000|Overall Study|Adverse Event|7|||
44501614|NCT00102063|79506771|FG001|Overall Study|Adverse Event|4|||
44501615|NCT00102063|79506772|FG002|Overall Study|Adverse Event|2|||
44501616|NCT00102063|79506770|FG000|Overall Study|Withdrawal by Subject|4|||
44501617|NCT00102063|79506771|FG001|Overall Study|Withdrawal by Subject|12|||
44234247|NCT01781429|79054744|FG006|Overall Study|Unacceptable Toxicity|0|||
44234248|NCT01781429|79054745|FG007|Overall Study|Unacceptable Toxicity|0|||
44234249|NCT01781429|79054746|FG008|Overall Study|Unacceptable Toxicity|0|||
44234250|NCT01781429|79054747|FG009|Overall Study|Unacceptable Toxicity|0|||
44234251|NCT01781429|79054748|FG010|Overall Study|Unacceptable Toxicity|0|||
44234252|NCT01781429|79054749|FG011|Overall Study|Unacceptable Toxicity|2|||
44234253|NCT01781429|79054750|FG012|Overall Study|Unacceptable Toxicity|0|||
44234254|NCT01781429|79054751|FG013|Overall Study|Unacceptable Toxicity|0|||
44234255|NCT01781429|79054752|FG014|Overall Study|Unacceptable Toxicity|0|||
44234256|NCT01781429|79054753|FG015|Overall Study|Unacceptable Toxicity|0|||
44234257|NCT01781429|79054738|FG000|Overall Study|Patient Condition Changed|0|||
44234258|NCT01781429|79054739|FG001|Overall Study|Patient Condition Changed|0|||
44234259|NCT01781429|79054740|FG002|Overall Study|Patient Condition Changed|0|||
44234260|NCT01781429|79054741|FG003|Overall Study|Patient Condition Changed|0|||
44234261|NCT01781429|79054742|FG004|Overall Study|Patient Condition Changed|0|||
44234262|NCT01781429|79054743|FG005|Overall Study|Patient Condition Changed|0|||
44234263|NCT01781429|79054744|FG006|Overall Study|Patient Condition Changed|0|||
44234264|NCT01781429|79054745|FG007|Overall Study|Patient Condition Changed|0|||
44234265|NCT01781429|79054746|FG008|Overall Study|Patient Condition Changed|0|||
44234266|NCT01781429|79054747|FG009|Overall Study|Patient Condition Changed|4|||
44275696|NCT02196558|79223454|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
44275697|NCT02196558|79223455|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
44275698|NCT02196558|79223453|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
44275699|NCT02196558|79223454|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
44275700|NCT02196558|79223455|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
44275701|NCT02196558|79223453|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
44501618|NCT00102063|79506772|FG002|Overall Study|Withdrawal by Subject|5|||
44501619|NCT00102063|79506770|FG000|Overall Study|Lost to Follow-up|0|||
44564837|NCT03137459|79584082|FG001|4-month Assessment|Refused assessment|10|||
44564838|NCT03137459|79584081|FG000|4-month Assessment|Acutely ill|2|||
44564839|NCT03137459|79584082|FG001|4-month Assessment|Acutely ill|3|||
44564840|NCT03137459|79584081|FG000|6-months|Lost to Follow-up|14|||
44564841|NCT03137459|79584082|FG001|6-months|Lost to Follow-up|11|||
44564842|NCT03137459|79584081|FG000|6-months|Death|0|||
44564843|NCT03137459|79584082|FG001|6-months|Death|2|||
44564844|NCT03137459|79584081|FG000|6-months|Refused assessment|6|||
44564845|NCT03137459|79584082|FG001|6-months|Refused assessment|3|||
44564846|NCT03137459|79584081|FG000|6-months|Acutely ill|1|||
44564847|NCT03137459|79584082|FG001|6-months|Acutely ill|1|||
44564848|NCT03131713|79584091|FG000|Overall Study|Lost to Follow-up|5|||
44564849|NCT03131713|79584092|FG001|Overall Study|Lost to Follow-up|0|||
44564850|NCT02930005|79584100|FG000|Overall Study|Lost to Follow-up|1|||
44564851|NCT02930005|79584101|FG001|Overall Study|Lost to Follow-up|5|||
44564852|NCT03637491|79584111|FG000|Overall Study|Death|9|||
44564853|NCT03637491|79584112|FG001|Overall Study|Death|9|||
44564854|NCT03637491|79584113|FG002|Overall Study|Death|5|||
44564855|NCT03637491|79584114|FG003|Overall Study|Death|3|||
44564856|NCT03637491|79584111|FG000|Overall Study|Lost to Follow-up|0|||
44564857|NCT03637491|79584112|FG001|Overall Study|Lost to Follow-up|1|||
44564858|NCT03637491|79584113|FG002|Overall Study|Lost to Follow-up|0|||
44564859|NCT03637491|79584114|FG003|Overall Study|Lost to Follow-up|1|||
44564860|NCT03637491|79584111|FG000|Overall Study|Study Terminated By Sponsor|0|||
44564861|NCT03637491|79584112|FG001|Overall Study|Study Terminated By Sponsor|2|||
44564862|NCT03637491|79584113|FG002|Overall Study|Study Terminated By Sponsor|1|||
44564863|NCT03637491|79584114|FG003|Overall Study|Study Terminated By Sponsor|0|||
44564864|NCT03637491|79584111|FG000|Overall Study|Withdrawal by Subject|1|||
44564865|NCT03637491|79584112|FG001|Overall Study|Withdrawal by Subject|0|||
44564866|NCT03637491|79584113|FG002|Overall Study|Withdrawal by Subject|1|||
44564867|NCT03637491|79584114|FG003|Overall Study|Withdrawal by Subject|2|||
44564868|NCT03334539|79584148|FG000|Overall Study|Adverse Event|3|||
44564869|NCT03334539|79584149|FG001|Overall Study|Adverse Event|5|||
44564870|NCT03334539|79584150|FG002|Overall Study|Adverse Event|0|||
44564871|NCT03334539|79584148|FG000|Overall Study|Withdrawal by Subject|0|||
44564872|NCT03334539|79584149|FG001|Overall Study|Withdrawal by Subject|1|||
44564873|NCT03334539|79584150|FG002|Overall Study|Withdrawal by Subject|1|||
44564874|NCT03334539|79584148|FG000|Overall Study|Administrative Reasons|1|||
44564875|NCT03334539|79584149|FG001|Overall Study|Administrative Reasons|0|||
44564876|NCT03334539|79584150|FG002|Overall Study|Administrative Reasons|0|||
44564877|NCT03334539|79584148|FG000|Overall Study|Hypertension Not Controlled|0|||
44564878|NCT03334539|79584149|FG001|Overall Study|Hypertension Not Controlled|1|||
44564879|NCT03334539|79584150|FG002|Overall Study|Hypertension Not Controlled|0|||
44564880|NCT03296553|79584165|FG000|Overall Study|Withdrawal by Subject|1|||
44564881|NCT03296553|79584166|FG001|Overall Study|Withdrawal by Subject|1|||
44564882|NCT03296553|79584165|FG000|Overall Study|Death|1|||
44564883|NCT03296553|79584166|FG001|Overall Study|Death|0|||
44564884|NCT03131167|79584185|FG000|Overall Study|Other (Unspecified)|0|||
44564885|NCT03131167|79584186|FG001|Overall Study|Other (Unspecified)|0|||
44564886|NCT03131167|79584187|FG002|Overall Study|Other (Unspecified)|0|||
44564887|NCT03131167|79584188|FG003|Overall Study|Other (Unspecified)|0|||
44564888|NCT03131167|79584189|FG004|Overall Study|Other (Unspecified)|0|||
44564889|NCT03131167|79584190|FG005|Overall Study|Other (Unspecified)|1|||
44564890|NCT03131167|79584191|FG006|Overall Study|Other (Unspecified)|0|||
44564891|NCT03131167|79584192|FG007|Overall Study|Other (Unspecified)|0|||
44564892|NCT03131167|79584193|FG008|Overall Study|Other (Unspecified)|0|||
44564893|NCT03131167|79584194|FG009|Overall Study|Other (Unspecified)|0|||
44564894|NCT03131167|79584195|FG010|Overall Study|Other (Unspecified)|0|||
44564895|NCT03131167|79584196|FG011|Overall Study|Other (Unspecified)|0|||
44564896|NCT03131167|79584197|FG012|Overall Study|Other (Unspecified)|0|||
44564897|NCT03060447|79584228|FG000|Overall Study|Withdrawal by Subject|2|||
44564898|NCT03060447|79584229|FG001|Overall Study|Withdrawal by Subject|0|||
44564899|NCT01712789|79584241|FG000|Overall Study|Lack of Efficacy|2|||
44564900|NCT01712789|79584241|FG000|Overall Study|Lost to Follow-up|1|||
44564901|NCT01712789|79584241|FG000|Overall Study|Progressive Disease|504|||
44564902|NCT01712789|79584241|FG000|Overall Study|Death|57|||
44234267|NCT01781429|79054748|FG010|Overall Study|Patient Condition Changed|0|||
44275702|NCT02196558|79223454|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
44275703|NCT02196558|79223455|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
44275704|NCT02196558|79223453|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
44275705|NCT02196558|79223454|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
44501620|NCT00102063|79506771|FG001|Overall Study|Lost to Follow-up|0|||
44275706|NCT02196558|79223455|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
44275707|NCT02196558|79223453|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
44501621|NCT00102063|79506772|FG002|Overall Study|Lost to Follow-up|1|||
44501622|NCT00102063|79506770|FG000|Overall Study|Protocol Violation|0|||
44501623|NCT00102063|79506771|FG001|Overall Study|Protocol Violation|1|||
44501624|NCT00102063|79506772|FG002|Overall Study|Protocol Violation|1|||
44501625|NCT00065156|79506780|FG000|Overall Study|Adverse Event|37|||
44501626|NCT00065156|79506780|FG000|Overall Study|Lack of Efficacy|52|||
44275708|NCT02196558|79223454|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
44275709|NCT02196558|79223455|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
44275710|NCT02196324|79223476|FG000|Overall Study|Withdrawal by Subject|8|||
44275711|NCT02196324|79223477|FG001|Overall Study|Withdrawal by Subject|4|||
44275712|NCT02196324|79223476|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
44275713|NCT02196324|79223477|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
44501627|NCT00065156|79506780|FG000|Overall Study|Withdrawal by Subject|8|||
44501628|NCT00065156|79506780|FG000|Overall Study|Lost to Follow-up|1|||
44501629|NCT00065156|79506780|FG000|Overall Study|Death|11|||
44501630|NCT00065156|79506780|FG000|Overall Study|Study Closed by Sponsor|2|||
44501631|NCT00065156|79506780|FG000|Overall Study|Disease Progression|7|||
44501632|NCT00065156|79506780|FG000|Overall Study|Investigator Decision|2|||
44501633|NCT00065156|79506780|FG000|Overall Study|Non-Compliance|2|||
44501634|NCT00065156|79506780|FG000|Overall Study|Loss of Response|1|||
44501635|NCT00065156|79506780|FG000|Overall Study|Secondary Malign Disease|1|||
44501636|NCT00064298|79506786|FG000|Overall Study|Withdrawal by Subject|2|||
44501637|NCT00064298|79506787|FG001|Overall Study|Withdrawal by Subject|1|||
44501638|NCT00064298|79506786|FG000|Overall Study|Lost to Follow-up|2|||
44501639|NCT00064298|79506787|FG001|Overall Study|Lost to Follow-up|2|||
44501640|NCT00064298|79506786|FG000|Overall Study|Death|0|||
44501641|NCT00064298|79506787|FG001|Overall Study|Death|1|||
44501642|NCT00064298|79506786|FG000|Overall Study|Disease Progression|2|||
44501643|NCT00064298|79506787|FG001|Overall Study|Disease Progression|1|||
44501644|NCT00078819|79506795|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
44501645|NCT00078819|79506796|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
44501646|NCT00078819|79506797|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
44501647|NCT00078819|79506798|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
44501648|NCT00078819|79506795|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
44501649|NCT00078819|79506796|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
44501650|NCT00078819|79506797|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
44501651|NCT00078819|79506798|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
44501652|NCT00078819|79506795|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
44501653|NCT00078819|79506796|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
44501654|NCT00078819|79506797|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
44501655|NCT00078819|79506798|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
44501656|NCT00078819|79506795|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
44234268|NCT01781429|79054749|FG011|Overall Study|Patient Condition Changed|1|||
44234269|NCT01781429|79054750|FG012|Overall Study|Patient Condition Changed|0|||
44234270|NCT01781429|79054751|FG013|Overall Study|Patient Condition Changed|1|||
44234271|NCT01781429|79054752|FG014|Overall Study|Patient Condition Changed|0|||
44234272|NCT01781429|79054753|FG015|Overall Study|Patient Condition Changed|0|||
44234273|NCT01781429|79054738|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
44234274|NCT01781429|79054739|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
44234275|NCT01781429|79054740|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
44234276|NCT01781429|79054741|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
44234277|NCT01781429|79054742|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
44275714|NCT02196324|79223476|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
44377240|NCT00789373|79382555|FG000|Induction|Lost to Follow-up|6|||
44501657|NCT00078819|79506796|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
44564903|NCT01712789|79584241|FG000|Overall Study|Adverse Event|52|||
44234278|NCT01781429|79054743|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
44234279|NCT01781429|79054744|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
44234280|NCT01781429|79054745|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
44234281|NCT01781429|79054746|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
44234282|NCT01781429|79054747|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
44234283|NCT01781429|79054748|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
44234284|NCT01781429|79054749|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
44234285|NCT01781429|79054750|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
44234286|NCT01781429|79054751|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
44234287|NCT01781429|79054752|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
44234288|NCT01781429|79054753|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
44234289|NCT01781429|79054738|FG000|Overall Study|Enrolled, but not treated|0|||
44275715|NCT02196324|79223477|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
44501658|NCT00078819|79506797|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
44501659|NCT00078819|79506798|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
44501660|NCT00078819|79506795|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
44501661|NCT00078819|79506796|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
44501662|NCT00078819|79506797|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
44501663|NCT00078819|79506798|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
44501664|NCT00078819|79506795|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
44501665|NCT00078819|79506796|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
44501666|NCT00078819|79506797|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
44501667|NCT00078819|79506798|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
44501668|NCT00078819|79506795|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
44501669|NCT00078819|79506796|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
44501670|NCT00078819|79506797|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
44501671|NCT00078819|79506798|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
44501672|NCT00078819|79506795|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
44501673|NCT00078819|79506796|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
44501674|NCT00078819|79506797|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
44501675|NCT00078819|79506798|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
44501676|NCT00098865|79506815|FG000|Overall Study|Progressive Disease|6|||
44501677|NCT00098865|79506815|FG000|Overall Study|Adverse Event|2|||
44501678|NCT00098865|79506815|FG000|Overall Study|Alternative Therapy|1|||
44501679|NCT02954458|79506823|FG000|Overall Study|Adverse Event|0|||
44501680|NCT02954458|79506824|FG001|Overall Study|Adverse Event|0|||
44501681|NCT02954458|79506825|FG002|Overall Study|Adverse Event|0|||
44501682|NCT02954458|79506826|FG003|Overall Study|Adverse Event|1|||
44501683|NCT02954458|79506823|FG000|Overall Study|Withdrawal by Subject|0|||
44501684|NCT02954458|79506824|FG001|Overall Study|Withdrawal by Subject|0|||
44501685|NCT02954458|79506825|FG002|Overall Study|Withdrawal by Subject|0|||
44501686|NCT02954458|79506826|FG003|Overall Study|Withdrawal by Subject|1|||
44501687|NCT02954458|79506823|FG000|Overall Study|Physician Decision|0|||
44501688|NCT02954458|79506824|FG001|Overall Study|Physician Decision|0|||
44501689|NCT02954458|79506825|FG002|Overall Study|Physician Decision|1|||
44501690|NCT02954458|79506826|FG003|Overall Study|Physician Decision|1|||
44501691|NCT02954458|79506823|FG000|Overall Study|Lost to Follow-up|1|||
44501692|NCT02954458|79506824|FG001|Overall Study|Lost to Follow-up|0|||
44501693|NCT02954458|79506825|FG002|Overall Study|Lost to Follow-up|0|||
44501694|NCT02954458|79506826|FG003|Overall Study|Lost to Follow-up|1|||
44501695|NCT02954458|79506823|FG000|Overall Study|Death|0|||
44501696|NCT02954458|79506824|FG001|Overall Study|Death|0|||
44501697|NCT02954458|79506825|FG002|Overall Study|Death|0|||
44501698|NCT02954458|79506826|FG003|Overall Study|Death|1|||
44501699|NCT02954458|79506823|FG000|Overall Study|Other|0|||
44501700|NCT02954458|79506824|FG001|Overall Study|Other|0|||
44501701|NCT02954458|79506825|FG002|Overall Study|Other|0|||
44501702|NCT02954458|79506826|FG003|Overall Study|Other|7|||
44501703|NCT03500224|79506840|FG000|Overall Study|Withdrawal by Subject|2|||
44501704|NCT00077649|79506848|FG000|Overall Study|Adverse Event|5|||
44501705|NCT00077649|79506849|FG001|Overall Study|Adverse Event|1|||
44501706|NCT00077649|79506850|FG002|Overall Study|Adverse Event|7|||
44501707|NCT00077649|79506851|FG003|Overall Study|Adverse Event|9|||
44501708|NCT00077649|79506848|FG000|Overall Study|Lack of Efficacy|5|||
44501709|NCT00077649|79506849|FG001|Overall Study|Lack of Efficacy|3|||
44501710|NCT00077649|79506850|FG002|Overall Study|Lack of Efficacy|3|||
44501711|NCT00077649|79506851|FG003|Overall Study|Lack of Efficacy|2|||
44501712|NCT00077649|79506848|FG000|Overall Study|Withdrawal by Subject|0|||
44501713|NCT00077649|79506849|FG001|Overall Study|Withdrawal by Subject|1|||
44501714|NCT00077649|79506850|FG002|Overall Study|Withdrawal by Subject|1|||
44234290|NCT01781429|79054739|FG001|Overall Study|Enrolled, but not treated|0|||
44564904|NCT01712789|79584241|FG000|Overall Study|Miscellaneous|31|||
44564905|NCT01712789|79584241|FG000|Overall Study|Withdrawal by Subject|21|||
44564906|NCT01712789|79584241|FG000|Overall Study|Transition to Commercial Treatment|8|||
44564907|NCT01712789|79584241|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
44564908|NCT03074318|79584249|FG000|Overall Study|Adverse Event|0|||
44564909|NCT03074318|79584250|FG001|Overall Study|Adverse Event|1|||
44564910|NCT03074318|79584251|FG002|Overall Study|Adverse Event|1|||
44564911|NCT03074318|79584252|FG003|Overall Study|Adverse Event|1|||
44564912|NCT03074318|79584249|FG000|Overall Study|Death|1|||
44564913|NCT03074318|79584250|FG001|Overall Study|Death|0|||
44564914|NCT03074318|79584251|FG002|Overall Study|Death|0|||
44564915|NCT03074318|79584252|FG003|Overall Study|Death|0|||
44564916|NCT03074318|79584249|FG000|Overall Study|Withdrawal by Subject|1|||
44564917|NCT03074318|79584250|FG001|Overall Study|Withdrawal by Subject|2|||
44564918|NCT03074318|79584251|FG002|Overall Study|Withdrawal by Subject|2|||
44564919|NCT03074318|79584252|FG003|Overall Study|Withdrawal by Subject|4|||
44564920|NCT03074318|79584249|FG000|Overall Study|Trial Closure|2|||
44564921|NCT03074318|79584250|FG001|Overall Study|Trial Closure|2|||
44564922|NCT03074318|79584251|FG002|Overall Study|Trial Closure|3|||
44564923|NCT03074318|79584252|FG003|Overall Study|Trial Closure|11|||
44564924|NCT03135119|79584273|FG000|Overall Study|Lost to Follow-up|2|||
44564925|NCT03135119|79584274|FG001|Overall Study|Lost to Follow-up|0|||
44564926|NCT03135119|79584273|FG000|Overall Study|Physician Decision|1|||
44564927|NCT03135119|79584274|FG001|Overall Study|Physician Decision|1|||
44564928|NCT03135119|79584273|FG000|Overall Study|COVID-19 Shutdown|2|||
44564929|NCT03135119|79584274|FG001|Overall Study|COVID-19 Shutdown|2|||
44564930|NCT01369784|79584280|FG000|Overall Study|Protocol Violation|12|||
44564931|NCT03353675|79584284|FG000|Overall Study|Adverse Event|4|||
44564932|NCT03137069|79584294|FG000|Overall Study|Withdrawal by Subject|1|||
44564933|NCT03137069|79584295|FG001|Overall Study|Withdrawal by Subject|2|||
44564934|NCT03137069|79584296|FG002|Overall Study|Withdrawal by Subject|2|||
44564935|NCT03137069|79584297|FG003|Overall Study|Withdrawal by Subject|2|||
44564936|NCT03137069|79584298|FG004|Overall Study|Withdrawal by Subject|0|||
44564937|NCT03137069|79584299|FG005|Overall Study|Withdrawal by Subject|0|||
44564938|NCT03137069|79584294|FG000|Overall Study|Adverse Event|0|||
44564939|NCT03137069|79584295|FG001|Overall Study|Adverse Event|3|||
44564940|NCT03137069|79584296|FG002|Overall Study|Adverse Event|1|||
44564941|NCT03137069|79584297|FG003|Overall Study|Adverse Event|1|||
44564942|NCT03137069|79584298|FG004|Overall Study|Adverse Event|0|||
44564943|NCT03137069|79584299|FG005|Overall Study|Adverse Event|1|||
44564944|NCT03137069|79584294|FG000|Overall Study|Protocol Violation|0|||
44564945|NCT03137069|79584295|FG001|Overall Study|Protocol Violation|1|||
44564946|NCT03137069|79584296|FG002|Overall Study|Protocol Violation|0|||
44564947|NCT03137069|79584297|FG003|Overall Study|Protocol Violation|1|||
44564948|NCT03137069|79584298|FG004|Overall Study|Protocol Violation|1|||
44564949|NCT03137069|79584299|FG005|Overall Study|Protocol Violation|1|||
44564950|NCT03137069|79584294|FG000|Overall Study|Physician Decision|0|||
44564951|NCT03137069|79584295|FG001|Overall Study|Physician Decision|0|||
44564952|NCT03137069|79584296|FG002|Overall Study|Physician Decision|0|||
44564953|NCT03137069|79584297|FG003|Overall Study|Physician Decision|1|||
44564954|NCT03137069|79584298|FG004|Overall Study|Physician Decision|0|||
44564955|NCT03137069|79584299|FG005|Overall Study|Physician Decision|0|||
44564956|NCT03137069|79584294|FG000|Overall Study|Study Terminated by Sponsor|0|||
44564957|NCT03137069|79584295|FG001|Overall Study|Study Terminated by Sponsor|0|||
44564958|NCT03137069|79584296|FG002|Overall Study|Study Terminated by Sponsor|0|||
44564959|NCT03137069|79584297|FG003|Overall Study|Study Terminated by Sponsor|0|||
44564960|NCT03137069|79584298|FG004|Overall Study|Study Terminated by Sponsor|1|||
44564961|NCT03137069|79584299|FG005|Overall Study|Study Terminated by Sponsor|0|||
44564962|NCT03137069|79584294|FG000|Overall Study|Data Entry Error|0|||
44564963|NCT03137069|79584295|FG001|Overall Study|Data Entry Error|0|||
44564964|NCT03137069|79584296|FG002|Overall Study|Data Entry Error|0|||
44564965|NCT03137069|79584297|FG003|Overall Study|Data Entry Error|1|||
44564966|NCT03137069|79584298|FG004|Overall Study|Data Entry Error|0|||
44564967|NCT03137069|79584299|FG005|Overall Study|Data Entry Error|0|||
44564968|NCT02792504|79584317|FG000|Overall Study|Lost to Follow-up|24|||
44564969|NCT02792504|79584317|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
44501715|NCT00077649|79506851|FG003|Overall Study|Withdrawal by Subject|2|||
44564970|NCT03124459|79584327|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
44564971|NCT03124459|79584328|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
44564972|NCT03124459|79584329|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
44564973|NCT03124459|79584330|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
44564974|NCT03124459|79584331|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
44564975|NCT03124459|79584332|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
44564976|NCT03124459|79584327|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
44564977|NCT03124459|79584328|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
44564978|NCT03124459|79584329|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
44564979|NCT03124459|79584330|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
44564980|NCT03124459|79584331|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
44564981|NCT03124459|79584332|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
44564982|NCT03124459|79584327|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
44564983|NCT03124459|79584328|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
44234291|NCT01781429|79054740|FG002|Overall Study|Enrolled, but not treated|0|||
44377241|NCT00789373|79382556|FG001|Induction|Lost to Follow-up|0|||
44501716|NCT00077649|79506848|FG000|Overall Study|Lost to Follow-up|2|||
44501717|NCT00077649|79506849|FG001|Overall Study|Lost to Follow-up|2|||
44501718|NCT00077649|79506850|FG002|Overall Study|Lost to Follow-up|3|||
44501719|NCT00077649|79506851|FG003|Overall Study|Lost to Follow-up|2|||
44501720|NCT00077649|79506848|FG000|Overall Study|Abnormality of Laboratory Test|1|||
44501721|NCT00077649|79506849|FG001|Overall Study|Abnormality of Laboratory Test|2|||
44501722|NCT00077649|79506850|FG002|Overall Study|Abnormality of Laboratory Test|1|||
44501723|NCT00077649|79506851|FG003|Overall Study|Abnormality of Laboratory Test|2|||
44501724|NCT00077649|79506848|FG000|Overall Study|Randomized but never dosed|1|||
44501725|NCT00077649|79506849|FG001|Overall Study|Randomized but never dosed|0|||
44501726|NCT00077649|79506850|FG002|Overall Study|Randomized but never dosed|0|||
44501727|NCT00077649|79506851|FG003|Overall Study|Randomized but never dosed|0|||
44501728|NCT00038948|79506867|FG000|Overall Study|Adverse Event|131|||
44501729|NCT00038948|79506868|FG001|Overall Study|Adverse Event|43|||
44501730|NCT00038948|79506867|FG000|Overall Study|Lost to Follow-up|4|||
44501731|NCT00038948|79506868|FG001|Overall Study|Lost to Follow-up|4|||
44501732|NCT00038948|79506867|FG000|Overall Study|Nonmedical event|5|||
44501733|NCT00038948|79506868|FG001|Overall Study|Nonmedical event|7|||
44501734|NCT00038948|79506867|FG000|Overall Study|Withdrawal by Subject|23|||
44501735|NCT00038948|79506868|FG001|Overall Study|Withdrawal by Subject|10|||
44501736|NCT00038948|79506867|FG000|Overall Study|Protocol Violation|3|||
44501737|NCT00038948|79506868|FG001|Overall Study|Protocol Violation|7|||
44501738|NCT00038948|79506867|FG000|Overall Study|Lack of Efficacy|3|||
44501739|NCT00038948|79506868|FG001|Overall Study|Lack of Efficacy|6|||
44501740|NCT00054704|79506882|FG000|Overall Study|Lack of Efficacy|2|||
44501741|NCT00054704|79506883|FG001|Overall Study|Lack of Efficacy|3|||
44501742|NCT00054704|79506882|FG000|Overall Study|Adverse Event|3|||
44501743|NCT00054704|79506883|FG001|Overall Study|Adverse Event|1|||
44501744|NCT00054704|79506882|FG000|Overall Study|Lost to Follow-up|0|||
44501745|NCT00054704|79506883|FG001|Overall Study|Lost to Follow-up|1|||
44501746|NCT00031694|79506889|FG000|Overall Study|Adverse Event|12|||
44501747|NCT00031694|79506889|FG000|Overall Study|Death|2|||
44501748|NCT00031694|79506889|FG000|Overall Study|Withdrawal by Subject|5|||
44234292|NCT01781429|79054741|FG003|Overall Study|Enrolled, but not treated|0|||
44377242|NCT00789373|79382557|FG002|Induction|Lost to Follow-up|0|||
44377243|NCT00789373|79382555|FG000|Induction|Protocol Violation|1|||
44377244|NCT00789373|79382556|FG001|Induction|Protocol Violation|0|||
44377245|NCT00789373|79382557|FG002|Induction|Protocol Violation|0|||
44377246|NCT00789373|79382555|FG000|Induction|Progressive Disease|220|||
44501749|NCT00093795|79506897|FG000|Overall Study|No follow up data|20|||
44501750|NCT00093795|79506898|FG001|Overall Study|No follow up data|16|||
44501751|NCT00093795|79506899|FG002|Overall Study|No follow up data|17|||
44501752|NCT03467152|79506909|FG000|Overall Study|Adverse Event|4|||
44501753|NCT03467152|79506910|FG001|Overall Study|Adverse Event|5|||
44377247|NCT00789373|79382556|FG001|Induction|Progressive Disease|0|||
44501754|NCT03467152|79506911|FG002|Overall Study|Adverse Event|0|||
44501755|NCT03467152|79506909|FG000|Overall Study|Subject Choice|1|||
44501756|NCT03467152|79506910|FG001|Overall Study|Subject Choice|3|||
44501757|NCT03467152|79506911|FG002|Overall Study|Subject Choice|0|||
44564984|NCT03124459|79584329|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
44564985|NCT03124459|79584330|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
44564986|NCT03124459|79584331|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
44234293|NCT01781429|79054742|FG004|Overall Study|Enrolled, but not treated|0|||
44234294|NCT01781429|79054743|FG005|Overall Study|Enrolled, but not treated|0|||
44564987|NCT03124459|79584332|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
44564988|NCT03124459|79584327|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
44564989|NCT03124459|79584328|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
44564990|NCT03124459|79584329|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
44564991|NCT03124459|79584330|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
44564992|NCT03124459|79584331|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
44564993|NCT03124459|79584332|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
44564994|NCT03124459|79584327|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
44564995|NCT03124459|79584328|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
44564996|NCT03124459|79584329|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
44564997|NCT03124459|79584330|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
44564998|NCT03124459|79584331|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
44564999|NCT03124459|79584332|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
44565000|NCT03124459|79584327|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
44565001|NCT03124459|79584328|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
44501758|NCT03467152|79506909|FG000|Overall Study|Lost to Follow-up|1|||
44501759|NCT03467152|79506910|FG001|Overall Study|Lost to Follow-up|0|||
44501760|NCT03467152|79506911|FG002|Overall Study|Lost to Follow-up|0|||
44501761|NCT03467152|79506909|FG000|Overall Study|Withdrawal by Subject|4|||
44234295|NCT01781429|79054744|FG006|Overall Study|Enrolled, but not treated|0|||
44234296|NCT01781429|79054745|FG007|Overall Study|Enrolled, but not treated|0|||
44234297|NCT01781429|79054746|FG008|Overall Study|Enrolled, but not treated|0|||
44501762|NCT03467152|79506910|FG001|Overall Study|Withdrawal by Subject|2|||
44501763|NCT03467152|79506911|FG002|Overall Study|Withdrawal by Subject|0|||
44501764|NCT03467152|79506909|FG000|Overall Study|Others|3|||
44501765|NCT03467152|79506910|FG001|Overall Study|Others|0|||
44501766|NCT03467152|79506911|FG002|Overall Study|Others|0|||
44501767|NCT03467152|79506909|FG000|Overall Study|Not treated|3|||
44501768|NCT03467152|79506910|FG001|Overall Study|Not treated|1|||
44501769|NCT03467152|79506911|FG002|Overall Study|Not treated|6|||
44501770|NCT03466060|79506920|FG000|Period 1|Test Lens Damage|0|||
44501771|NCT03466060|79506921|FG001|Period 1|Test Lens Damage|2|||
44501772|NCT03466060|79506922|FG002|Period 1|Test Lens Damage|0|||
44501773|NCT03466060|79506923|FG003|Period 1|Test Lens Damage|0|||
44501774|NCT03466060|79506924|FG004|Period 1|Test Lens Damage|0|||
44501775|NCT03466060|79506925|FG005|Period 1|Test Lens Damage|0|||
44501776|NCT03466060|79506920|FG000|Period 1|Withdrawal by Subject|0|||
44501777|NCT03466060|79506921|FG001|Period 1|Withdrawal by Subject|0|||
44501778|NCT03466060|79506922|FG002|Period 1|Withdrawal by Subject|2|||
44501779|NCT03466060|79506923|FG003|Period 1|Withdrawal by Subject|0|||
44501780|NCT03466060|79506924|FG004|Period 1|Withdrawal by Subject|0|||
44501781|NCT03466060|79506925|FG005|Period 1|Withdrawal by Subject|0|||
44501782|NCT03466060|79506920|FG000|Period 1|Lost to Follow-up|0|||
44501783|NCT03466060|79506921|FG001|Period 1|Lost to Follow-up|0|||
44501784|NCT03466060|79506922|FG002|Period 1|Lost to Follow-up|0|||
44501785|NCT03466060|79506923|FG003|Period 1|Lost to Follow-up|1|||
44565002|NCT03124459|79584329|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
44565003|NCT03124459|79584330|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
44565004|NCT03124459|79584331|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
44565005|NCT03124459|79584332|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
44234298|NCT01781429|79054747|FG009|Overall Study|Enrolled, but not treated|0|||
44501786|NCT03466060|79506924|FG004|Period 1|Lost to Follow-up|0|||
44501787|NCT03466060|79506925|FG005|Period 1|Lost to Follow-up|0|||
44501788|NCT03466060|79506920|FG000|Period 1|Grade 2 Conjunctivitis|0|||
44501789|NCT03466060|79506921|FG001|Period 1|Grade 2 Conjunctivitis|0|||
44501790|NCT03466060|79506922|FG002|Period 1|Grade 2 Conjunctivitis|1|||
44501791|NCT03466060|79506923|FG003|Period 1|Grade 2 Conjunctivitis|0|||
44234299|NCT01781429|79054748|FG010|Overall Study|Enrolled, but not treated|1|||
44234300|NCT01781429|79054749|FG011|Overall Study|Enrolled, but not treated|0|||
44234301|NCT01781429|79054750|FG012|Overall Study|Enrolled, but not treated|0|||
44234302|NCT01781429|79054751|FG013|Overall Study|Enrolled, but not treated|0|||
44234303|NCT01781429|79054752|FG014|Overall Study|Enrolled, but not treated|0|||
44234304|NCT01781429|79054753|FG015|Overall Study|Enrolled, but not treated|0|||
44234305|NCT01773473|79054788|FG000|Overall Study|Adverse Event|3|||
44234306|NCT01773473|79054789|FG001|Overall Study|Adverse Event|2|||
44234307|NCT01773473|79054788|FG000|Overall Study|Protocol Violation|0|||
44234308|NCT01773473|79054789|FG001|Overall Study|Protocol Violation|4|||
44234309|NCT01773473|79054788|FG000|Overall Study|Physician Decision|3|||
44234310|NCT01773473|79054789|FG001|Overall Study|Physician Decision|5|||
44234311|NCT01773473|79054788|FG000|Overall Study|Sponsor Decision|2|||
44234312|NCT01773473|79054789|FG001|Overall Study|Sponsor Decision|0|||
44234313|NCT01773473|79054788|FG000|Overall Study|Lack of Efficacy|0|||
44234314|NCT01773473|79054789|FG001|Overall Study|Lack of Efficacy|1|||
44234315|NCT01773473|79054788|FG000|Overall Study|Non-Compliance with study drug|1|||
44234316|NCT01773473|79054789|FG001|Overall Study|Non-Compliance with study drug|4|||
44234317|NCT01773473|79054788|FG000|Overall Study|Withdrawal by Subject|5|||
44234318|NCT01773473|79054789|FG001|Overall Study|Withdrawal by Subject|3|||
44234319|NCT01773473|79054788|FG000|Overall Study|Lost to Follow-up|2|||
44234320|NCT01773473|79054789|FG001|Overall Study|Lost to Follow-up|0|||
44234321|NCT01772693|79054797|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
44234322|NCT01772693|79054798|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
44234323|NCT01772693|79054797|FG000|Overall Study|Withdrawal by Subject|2|||
44234324|NCT01772693|79054798|FG001|Overall Study|Withdrawal by Subject|0|||
44234325|NCT01772693|79054797|FG000|Overall Study|Alternative Treatment|2|||
44234326|NCT01772693|79054798|FG001|Overall Study|Alternative Treatment|0|||
44234327|NCT01779869|79054804|FG000|Overall Study|Physician Decision|2|||
44234328|NCT01772537|79054811|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
44234329|NCT01772537|79054812|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
44234330|NCT01772537|79054813|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
44234331|NCT01772147|79054826|FG000|Overall Study|Adverse Event|13|||
44377248|NCT00789373|79382557|FG002|Induction|Progressive Disease|0|||
44501792|NCT03466060|79506924|FG004|Period 1|Grade 2 Conjunctivitis|0|||
44501793|NCT03466060|79506925|FG005|Period 1|Grade 2 Conjunctivitis|0|||
44501794|NCT03466060|79506920|FG000|Period 2|Lens Handling Difficulties|0|||
44501795|NCT03466060|79506921|FG001|Period 2|Lens Handling Difficulties|0|||
44501796|NCT03466060|79506922|FG002|Period 2|Lens Handling Difficulties|1|||
44501797|NCT03466060|79506923|FG003|Period 2|Lens Handling Difficulties|0|||
44501798|NCT03466060|79506924|FG004|Period 2|Lens Handling Difficulties|0|||
44501799|NCT03466060|79506925|FG005|Period 2|Lens Handling Difficulties|0|||
44501800|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
44501801|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
44501802|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
44501803|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
44501804|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
44501805|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
44501806|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
44501807|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
44501808|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
44501809|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
44501810|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
44501811|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
44501812|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
44501813|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
44501814|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
44501815|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
44501816|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
44565006|NCT03134183|79584347|FG000|Overall Study|Withdrawal by Subject|1|||
44565007|NCT03134183|79584348|FG001|Overall Study|Withdrawal by Subject|1|||
44501817|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
44234332|NCT01772147|79054827|FG001|Overall Study|Adverse Event|10|||
44234333|NCT01772147|79054828|FG002|Overall Study|Adverse Event|6|||
44234334|NCT01772147|79054826|FG000|Overall Study|Withdrew Consent|7|||
44234335|NCT01772147|79054827|FG001|Overall Study|Withdrew Consent|8|||
44234336|NCT01772147|79054828|FG002|Overall Study|Withdrew Consent|4|||
44234337|NCT01772147|79054826|FG000|Overall Study|Lost to Follow-up|1|||
44377249|NCT00789373|79382555|FG000|Induction|Withdrawal by Subject|37|||
44501818|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
44501819|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
44234338|NCT01772147|79054827|FG001|Overall Study|Lost to Follow-up|0|||
44565008|NCT03136367|79584357|FG000|T1 Consultation|discontinued mistakenly included|2|||
44234339|NCT01772147|79054828|FG002|Overall Study|Lost to Follow-up|1|||
44234340|NCT01772147|79054826|FG000|Overall Study|Protocol Deviation|2|||
44234341|NCT01772147|79054827|FG001|Overall Study|Protocol Deviation|1|||
44234342|NCT01772147|79054828|FG002|Overall Study|Protocol Deviation|1|||
44565009|NCT03136367|79584358|FG001|T1 Consultation|discontinued mistakenly included|6|||
44565010|NCT03136367|79584359|FG002|T1 Consultation|discontinued mistakenly included|1|||
44565011|NCT03136367|79584357|FG000|T1 Consultation|Discontinued other|0|||
44565012|NCT03136367|79584358|FG001|T1 Consultation|Discontinued other|1|||
44565013|NCT03136367|79584359|FG002|T1 Consultation|Discontinued other|0|||
44565014|NCT03136367|79584357|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
44565015|NCT03136367|79584358|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
44565016|NCT03136367|79584359|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
44565017|NCT03136367|79584357|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
44565018|NCT03136367|79584358|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
44565019|NCT03136367|79584359|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
44565020|NCT03136367|79584357|FG000|T2 Post-consultation|Discontinued other|0|||
44565021|NCT03136367|79584358|FG001|T2 Post-consultation|Discontinued other|2|||
44565022|NCT03136367|79584359|FG002|T2 Post-consultation|Discontinued other|6|||
44377250|NCT00789373|79382556|FG001|Induction|Withdrawal by Subject|0|||
44377251|NCT00789373|79382557|FG002|Induction|Withdrawal by Subject|0|||
44377252|NCT00789373|79382555|FG000|Maintenance|Adverse Event|0|||
44377253|NCT00789373|79382556|FG001|Maintenance|Adverse Event|65|||
44377254|NCT00789373|79382557|FG002|Maintenance|Adverse Event|12|||
44377255|NCT00789373|79382555|FG000|Maintenance|Death due to study disease|0|||
44234343|NCT01772147|79054826|FG000|Overall Study|Lack of Efficacy|8|||
44234344|NCT01772147|79054827|FG001|Overall Study|Lack of Efficacy|6|||
44234345|NCT01772147|79054828|FG002|Overall Study|Lack of Efficacy|6|||
44234346|NCT01771913|79054838|FG000|Overall Study|Withdrawal by Subject|1|||
44234347|NCT01771913|79054839|FG001|Overall Study|Withdrawal by Subject|0|||
44234348|NCT01606787|79054847|FG000|Overall Study|Withdrawal by Subject|4|||
44234349|NCT01606787|79054848|FG001|Overall Study|Withdrawal by Subject|5|||
44234350|NCT01606787|79054847|FG000|Overall Study|Surgery canceled|0|||
44234351|NCT01606787|79054848|FG001|Overall Study|Surgery canceled|2|||
44234352|NCT01778855|79054856|FG000|Overall Study|Death|0|||
44234353|NCT01778855|79054857|FG001|Overall Study|Death|1|||
44234354|NCT01777997|79054863|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
44234355|NCT01777997|79054863|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
44234356|NCT01777997|79054863|FG000|Weeks 48 to 72/96 on ART|Death|1|||
44234357|NCT01777997|79054863|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
44275716|NCT02196324|79223476|FG000|Overall Study|Other|1|||
44275717|NCT02196324|79223477|FG001|Overall Study|Other|0|||
44275718|NCT02195700|79223485|FG000|Overall Study|Protocol Violation|0|||
44275719|NCT02195700|79223486|FG001|Overall Study|Protocol Violation|2|||
44275720|NCT02195700|79223485|FG000|Overall Study|Noncompliance|1|||
44275721|NCT02195700|79223486|FG001|Overall Study|Noncompliance|0|||
44377256|NCT00789373|79382556|FG001|Maintenance|Death due to study disease|3|||
44377257|NCT00789373|79382557|FG002|Maintenance|Death due to study disease|1|||
44377258|NCT00789373|79382555|FG000|Maintenance|Death due to adverse event|0|||
44377259|NCT00789373|79382556|FG001|Maintenance|Death due to adverse event|4|||
44565023|NCT03136367|79584357|FG000|T2 Post-consultation|Discontinued transferred care|0|||
44275722|NCT02195700|79223485|FG000|Overall Study|Adverse Event|1|||
44377260|NCT00789373|79382557|FG002|Maintenance|Death due to adverse event|1|||
44234358|NCT01770509|79054869|FG000|Overall Study|Injury|0|||
44275723|NCT02195700|79223486|FG001|Overall Study|Adverse Event|2|||
44377261|NCT00789373|79382555|FG000|Maintenance|Death due to toxicity|0|||
44565024|NCT03136367|79584358|FG001|T2 Post-consultation|Discontinued transferred care|0|||
44565025|NCT03136367|79584359|FG002|T2 Post-consultation|Discontinued transferred care|3|||
44565026|NCT03136367|79584357|FG000|T2 Post-consultation|Discontinued lost contact|0|||
44565027|NCT03136367|79584358|FG001|T2 Post-consultation|Discontinued lost contact|1|||
44565028|NCT03136367|79584359|FG002|T2 Post-consultation|Discontinued lost contact|0|||
44565029|NCT03136367|79584357|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
44234359|NCT01770509|79054870|FG001|Overall Study|Injury|1|||
44234360|NCT01770509|79054869|FG000|Overall Study|Lost to Follow-up|1|||
44275724|NCT02195700|79223485|FG000|Overall Study|Withdrawal by Subject|3|||
44377262|NCT00789373|79382556|FG001|Maintenance|Death due to toxicity|1|||
44377263|NCT00789373|79382557|FG002|Maintenance|Death due to toxicity|2|||
44377264|NCT00789373|79382555|FG000|Maintenance|Investigator Decision|0|||
44377265|NCT00789373|79382556|FG001|Maintenance|Investigator Decision|4|||
44377266|NCT00789373|79382557|FG002|Maintenance|Investigator Decision|2|||
44377267|NCT00789373|79382555|FG000|Maintenance|Protocol entry criteria not met|0|||
44377268|NCT00789373|79382556|FG001|Maintenance|Protocol entry criteria not met|2|||
44377269|NCT00789373|79382557|FG002|Maintenance|Protocol entry criteria not met|0|||
44377270|NCT00789373|79382555|FG000|Maintenance|Lost to Follow-up|0|||
44377271|NCT00789373|79382556|FG001|Maintenance|Lost to Follow-up|2|||
44565030|NCT03136367|79584358|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
44565031|NCT03136367|79584359|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
44565032|NCT03136367|79584357|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
44565033|NCT03136367|79584358|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
44565034|NCT03136367|79584359|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
44565035|NCT03136367|79584357|FG000|T3 1 Week After Surgery|other discontinued|2|||
44565036|NCT03136367|79584358|FG001|T3 1 Week After Surgery|other discontinued|4|||
44234361|NCT01770509|79054870|FG001|Overall Study|Lost to Follow-up|2|||
44565037|NCT03136367|79584359|FG002|T3 1 Week After Surgery|other discontinued|3|||
44565038|NCT03136367|79584357|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
44565039|NCT03136367|79584358|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
44565040|NCT03136367|79584359|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
44565041|NCT03136367|79584357|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
44565042|NCT03136367|79584358|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
44565043|NCT03136367|79584359|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
44565044|NCT03136367|79584357|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
44565045|NCT03136367|79584358|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
44565046|NCT03136367|79584359|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
44565047|NCT03136367|79584357|FG000|T4 12 Weeks After Surgery|Death|0|||
44565048|NCT03136367|79584358|FG001|T4 12 Weeks After Surgery|Death|1|||
44565049|NCT03136367|79584359|FG002|T4 12 Weeks After Surgery|Death|3|||
44565050|NCT03136367|79584357|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
44565051|NCT03136367|79584358|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
44565052|NCT03136367|79584359|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
44565053|NCT03136367|79584357|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
44565054|NCT03136367|79584358|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
44565055|NCT03136367|79584359|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
44565056|NCT03136367|79584357|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
44565057|NCT03136367|79584358|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
44565058|NCT03136367|79584359|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
44565059|NCT03136367|79584357|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
44565060|NCT03136367|79584358|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
44565061|NCT03136367|79584359|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
44565062|NCT03136367|79584357|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
44234362|NCT01770353|79054878|FG000|Overall Study|Progressive disease|2|||
44234363|NCT01770353|79054879|FG001|Overall Study|Progressive disease|1|||
44234364|NCT01770353|79054878|FG000|Overall Study|Adverse Event|0|||
44565063|NCT03136367|79584358|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
44565064|NCT03136367|79584359|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
44565065|NCT03136367|79584357|FG000|T5 1 Year After Surgery|Death|0|||
44565066|NCT03136367|79584358|FG001|T5 1 Year After Surgery|Death|0|||
44565067|NCT03136367|79584359|FG002|T5 1 Year After Surgery|Death|1|||
44565068|NCT03136367|79584357|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
44565069|NCT03136367|79584358|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
44565070|NCT03136367|79584359|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
44565071|NCT03136367|79584357|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
44565072|NCT03136367|79584358|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
44565073|NCT03136367|79584359|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
44234365|NCT01770353|79054879|FG001|Overall Study|Adverse Event|1|||
44377272|NCT00789373|79382557|FG002|Maintenance|Lost to Follow-up|0|||
44565074|NCT03136367|79584357|FG000|T5 1 Year After Surgery|study ended before due|31|||
44565075|NCT03136367|79584358|FG001|T5 1 Year After Surgery|study ended before due|103|||
44565076|NCT03136367|79584359|FG002|T5 1 Year After Surgery|study ended before due|110|||
44565077|NCT03136367|79584357|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
44234366|NCT01770353|79054878|FG000|Overall Study|Protocol Violation|1|||
44377273|NCT00789373|79382555|FG000|Maintenance|Progressive Disease|0|||
44377274|NCT00789373|79382556|FG001|Maintenance|Progressive Disease|253|||
44234367|NCT01770353|79054879|FG001|Overall Study|Protocol Violation|0|||
44234368|NCT01770353|79054878|FG000|Overall Study|Physician Decision|0|||
44234369|NCT01770353|79054879|FG001|Overall Study|Physician Decision|3|||
44234370|NCT01770353|79054878|FG000|Overall Study|Clinical deterioration|3|||
44565078|NCT03136367|79584358|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
44565079|NCT03136367|79584359|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
44565080|NCT03124381|79584372|FG000|Overall Study|Lost to Follow-up|1|||
44565081|NCT03124381|79584373|FG001|Overall Study|Lost to Follow-up|1|||
44565082|NCT03124381|79584372|FG000|Overall Study|Withdrawal by Subject|6|||
44565083|NCT03124381|79584373|FG001|Overall Study|Withdrawal by Subject|3|||
44565084|NCT03124381|79584372|FG000|Overall Study|Protocol Violation|0|||
44565085|NCT03124381|79584373|FG001|Overall Study|Protocol Violation|1|||
44565086|NCT03124381|79584372|FG000|Overall Study|Adverse Event|1|||
44565087|NCT03124381|79584373|FG001|Overall Study|Adverse Event|1|||
44565088|NCT03124381|79584372|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
44565089|NCT03124381|79584373|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
44565090|NCT03133793|79584383|FG000|Overall Study|Withdrawal by Subject|0|||
44565091|NCT03133793|79584384|FG001|Overall Study|Withdrawal by Subject|4|||
44565092|NCT03133793|79584385|FG002|Overall Study|Withdrawal by Subject|2|||
44565093|NCT03133793|79584386|FG003|Overall Study|Withdrawal by Subject|4|||
44565094|NCT03133793|79584383|FG000|Overall Study|Lost to Follow-up|1|||
44565095|NCT03133793|79584384|FG001|Overall Study|Lost to Follow-up|0|||
44565096|NCT03133793|79584385|FG002|Overall Study|Lost to Follow-up|2|||
44565097|NCT03133793|79584386|FG003|Overall Study|Lost to Follow-up|0|||
44565098|NCT03133793|79584383|FG000|Overall Study|Death|0|||
44565099|NCT03133793|79584384|FG001|Overall Study|Death|0|||
44565100|NCT03133793|79584385|FG002|Overall Study|Death|0|||
44565101|NCT03133793|79584386|FG003|Overall Study|Death|1|||
44234371|NCT01770353|79054879|FG001|Overall Study|Clinical deterioration|6|||
44234372|NCT01770353|79054878|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
44501820|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
44501821|NCT00092547|79506941|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
44501822|NCT00092547|79506942|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
44501823|NCT00092547|79506943|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
44501824|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
44501825|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
44501826|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
44501827|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
44501828|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
44501829|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
44501830|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
44501831|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
44501832|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
44501833|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
44501834|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
44501835|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
44565102|NCT02747238|79584402|FG000|Overall Study|Lack of Efficacy|0|||
44565103|NCT02747238|79584403|FG001|Overall Study|Lack of Efficacy|1|||
44565104|NCT02747238|79584402|FG000|Overall Study|Data lost|3|||
44234373|NCT01770353|79054879|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
44234374|NCT01777763|79054895|FG000|Overall Study|Adverse Event|2|||
44501836|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
44565105|NCT02747238|79584403|FG001|Overall Study|Data lost|5|||
44565106|NCT03133481|79584411|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
44565107|NCT03133481|79584412|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
44565108|NCT02864316|79584420|FG000|Overall Study|Progressive Disease|2|||
44565109|NCT02864316|79584421|FG001|Overall Study|Progressive Disease|1|||
44565110|NCT02864316|79584420|FG000|Overall Study|Adverse Event|0|||
44565111|NCT02864316|79584421|FG001|Overall Study|Adverse Event|1|||
44565112|NCT02862600|79584427|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
44565113|NCT02862600|79584427|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
44565114|NCT02862600|79584427|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
44565115|NCT02862600|79584427|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
44565116|NCT02864082|79584435|FG000|Overall Study|Adverse Event|1|||
44565117|NCT02864082|79584436|FG001|Overall Study|Adverse Event|1|||
44565118|NCT02864082|79584435|FG000|Overall Study|Lost to Follow-up|0|||
44565119|NCT02864082|79584436|FG001|Overall Study|Lost to Follow-up|1|||
44565120|NCT02864082|79584435|FG000|Overall Study|Withdrawal by Subject|2|||
44565121|NCT02864082|79584436|FG001|Overall Study|Withdrawal by Subject|2|||
44565122|NCT02792192|79584460|FG000|Overall Study|Death|1|||
44565123|NCT02792192|79584461|FG001|Overall Study|Death|0|||
44565124|NCT02792192|79584462|FG002|Overall Study|Death|0|||
44565125|NCT02792192|79584463|FG003|Overall Study|Death|0|||
44565126|NCT02792192|79584460|FG000|Overall Study|Informed Consent Withdrawn|4|||
44565127|NCT02792192|79584461|FG001|Overall Study|Informed Consent Withdrawn|0|||
44234375|NCT01777763|79054896|FG001|Overall Study|Adverse Event|32|||
44234376|NCT01777763|79054895|FG000|Overall Study|Protocol Violation|1|||
44234377|NCT01777763|79054896|FG001|Overall Study|Protocol Violation|7|||
44234378|NCT01777763|79054895|FG000|Overall Study|Withdrawal by Subject|0|||
44234379|NCT01777763|79054896|FG001|Overall Study|Withdrawal by Subject|2|||
44234380|NCT01777763|79054895|FG000|Overall Study|Treatment Failure|1|||
44234381|NCT01777763|79054896|FG001|Overall Study|Treatment Failure|6|||
44234382|NCT01769339|79054902|FG000|Overall Study|Lost to Follow-up|42|||
44234383|NCT01769339|79054902|FG000|Overall Study|Adverse Event|1|||
44234384|NCT01769105|79054908|FG000|First Intervention|Protocol Violation|2|||
44234385|NCT01769105|79054909|FG001|First Intervention|Protocol Violation|2|||
44234386|NCT01769105|79054908|FG000|Cross-over|Lost to Follow-up|5|||
44565128|NCT02792192|79584462|FG002|Overall Study|Informed Consent Withdrawn|0|||
44565129|NCT02792192|79584463|FG003|Overall Study|Informed Consent Withdrawn|0|||
44565130|NCT02792192|79584460|FG000|Overall Study|Physician Decision|1|||
44565131|NCT02792192|79584461|FG001|Overall Study|Physician Decision|0|||
44565132|NCT02792192|79584462|FG002|Overall Study|Physician Decision|0|||
44234387|NCT01769105|79054909|FG001|Cross-over|Lost to Follow-up|0|||
44234388|NCT01777139|79054917|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
44234389|NCT01777139|79054918|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
44565133|NCT02792192|79584463|FG003|Overall Study|Physician Decision|0|||
44565134|NCT02792192|79584460|FG000|Overall Study|Progressive Disease|0|||
44565135|NCT02792192|79584461|FG001|Overall Study|Progressive Disease|1|||
44565136|NCT02792192|79584462|FG002|Overall Study|Progressive Disease|0|||
44234390|NCT01777139|79054917|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
44234391|NCT01777139|79054918|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
44234392|NCT01777139|79054917|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
44234393|NCT01777139|79054918|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
44234394|NCT01777139|79054917|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
44234395|NCT01777139|79054918|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
44234396|NCT01777139|79054917|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
44234397|NCT01777139|79054918|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
44234398|NCT01777139|79054917|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
44565137|NCT02792192|79584463|FG003|Overall Study|Progressive Disease|0|||
44565138|NCT02792192|79584460|FG000|Overall Study|Study Terminated By Sponsor|6|||
44565139|NCT02792192|79584461|FG001|Overall Study|Study Terminated By Sponsor|10|||
44565140|NCT02792192|79584462|FG002|Overall Study|Study Terminated By Sponsor|0|||
44565141|NCT02792192|79584463|FG003|Overall Study|Study Terminated By Sponsor|0|||
44565142|NCT02964507|79584482|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
44234399|NCT01777139|79054918|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
44234400|NCT01777139|79054917|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
44234401|NCT01777139|79054918|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
44234402|NCT01777139|79054917|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
44234403|NCT01777139|79054918|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
44234404|NCT01768637|79054927|FG000|Overall Study|Lost to Follow-up|2|||
44234405|NCT01768637|79054928|FG001|Overall Study|Lost to Follow-up|7|||
44565143|NCT02964507|79584483|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
44565144|NCT02964507|79584484|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
44565145|NCT02964507|79584485|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
44565146|NCT02964507|79584486|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
44565147|NCT02964507|79584487|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
44565148|NCT02964507|79584488|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
44565149|NCT02964507|79584489|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
44234406|NCT01768637|79054927|FG000|Overall Study|Difficult blood draw|1|||
44234407|NCT01768637|79054928|FG001|Overall Study|Difficult blood draw|0|||
44234408|NCT01768559|79054937|FG000|Overall Study|Randomized but not treated|0|||
44234409|NCT01768559|79054938|FG001|Overall Study|Randomized but not treated|0|||
44234410|NCT01768559|79054939|FG002|Overall Study|Randomized but not treated|1|||
44234411|NCT01768559|79054937|FG000|Overall Study|Adverse Event|15|||
44234412|NCT01768559|79054938|FG001|Overall Study|Adverse Event|2|||
44234413|NCT01768559|79054939|FG002|Overall Study|Adverse Event|5|||
44234414|NCT01768559|79054937|FG000|Overall Study|Lack of Efficacy|6|||
44234415|NCT01768559|79054938|FG001|Overall Study|Lack of Efficacy|4|||
44234416|NCT01768559|79054939|FG002|Overall Study|Lack of Efficacy|0|||
44234417|NCT01768559|79054937|FG000|Overall Study|Poor compliance to protocol|0|||
44234418|NCT01768559|79054938|FG001|Overall Study|Poor compliance to protocol|3|||
44234419|NCT01768559|79054939|FG002|Overall Study|Poor compliance to protocol|2|||
44234420|NCT01768559|79054937|FG000|Overall Study|Other than specified|9|||
44234421|NCT01768559|79054938|FG001|Overall Study|Other than specified|8|||
44234422|NCT01768559|79054939|FG002|Overall Study|Other than specified|5|||
44234423|NCT00983619|79054963|FG000|Overall Study|Lost to Follow-up|0|||
44234424|NCT00983619|79054964|FG001|Overall Study|Lost to Follow-up|1|||
44275725|NCT02195700|79223486|FG001|Overall Study|Withdrawal by Subject|2|||
44275726|NCT02195700|79223485|FG000|Overall Study|Lost to Follow-up|1|||
44275727|NCT02195700|79223486|FG001|Overall Study|Lost to Follow-up|1|||
44565150|NCT02964507|79584482|FG000|Overall Study|Study terminated by Sponsor|9|||
44565151|NCT02964507|79584483|FG001|Overall Study|Study terminated by Sponsor|1|||
44565152|NCT02964507|79584484|FG002|Overall Study|Study terminated by Sponsor|9|||
44565153|NCT02964507|79584485|FG003|Overall Study|Study terminated by Sponsor|3|||
44565154|NCT02964507|79584486|FG004|Overall Study|Study terminated by Sponsor|3|||
44275728|NCT02228460|79223501|FG000|Overall Study|Adverse Event|1|||
44501837|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
44501838|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
44501839|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
44501840|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
44501841|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
44501842|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
44501843|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
44501844|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
44501845|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
44501846|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
44501847|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
44501848|NCT00092547|79506941|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
44501849|NCT00092547|79506942|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
44501850|NCT00092547|79506943|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
44501851|NCT00092547|79506941|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
44501852|NCT00092547|79506942|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
44501853|NCT00092547|79506943|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
44501854|NCT00092547|79506941|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
44501855|NCT00092547|79506942|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
44501856|NCT00092547|79506943|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
44501857|NCT00092547|79506941|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
44501858|NCT00092547|79506942|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
44501859|NCT00092547|79506943|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
44501860|NCT00092547|79506941|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
44501861|NCT00092547|79506942|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
44501862|NCT00092547|79506943|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
44501863|NCT03802994|79506959|FG000|Overall Study|Lost to Follow-up|0|||
44501864|NCT03802994|79506960|FG001|Overall Study|Lost to Follow-up|2|||
44501865|NCT03802994|79506961|FG002|Overall Study|Lost to Follow-up|3|||
44501866|NCT03802994|79506962|FG003|Overall Study|Lost to Follow-up|2|||
44501867|NCT03802994|79506963|FG004|Overall Study|Lost to Follow-up|2|||
44501868|NCT03465904|79506988|FG000|Overall Study|Withdrawal by Subject|9|||
44501869|NCT03465904|79506989|FG001|Overall Study|Withdrawal by Subject|5|||
44501870|NCT03465904|79506988|FG000|Overall Study|Lost to Follow-up|10|||
44501871|NCT03465904|79506989|FG001|Overall Study|Lost to Follow-up|9|||
44501872|NCT03465904|79506988|FG000|Overall Study|Protocol Violation|8|||
44501873|NCT03465904|79506989|FG001|Overall Study|Protocol Violation|5|||
44501874|NCT03465904|79506988|FG000|Overall Study|Ineligible for mITT analysis|62|||
44565155|NCT02964507|79584487|FG005|Overall Study|Study terminated by Sponsor|2|||
44565156|NCT02964507|79584488|FG006|Overall Study|Study terminated by Sponsor|0|||
44234425|NCT00983619|79054965|FG002|Overall Study|Lost to Follow-up|0|||
44234426|NCT00983619|79054966|FG003|Overall Study|Lost to Follow-up|0|||
44234427|NCT00983619|79054967|FG004|Overall Study|Lost to Follow-up|0|||
44234428|NCT00983619|79054968|FG005|Overall Study|Lost to Follow-up|2|||
44234429|NCT00983619|79054969|FG006|Overall Study|Lost to Follow-up|0|||
44234430|NCT00983619|79054970|FG007|Overall Study|Lost to Follow-up|0|||
44234431|NCT00983619|79054971|FG008|Overall Study|Lost to Follow-up|0|||
44234432|NCT00983619|79054972|FG009|Overall Study|Lost to Follow-up|0|||
44234433|NCT00983619|79054973|FG010|Overall Study|Lost to Follow-up|0|||
44234434|NCT00983619|79054974|FG011|Overall Study|Lost to Follow-up|2|||
44234435|NCT00983619|79054963|FG000|Overall Study|Withdrawal by Subject|2|||
44234436|NCT00983619|79054964|FG001|Overall Study|Withdrawal by Subject|1|||
44234437|NCT00983619|79054965|FG002|Overall Study|Withdrawal by Subject|1|||
44234438|NCT00983619|79054966|FG003|Overall Study|Withdrawal by Subject|3|||
44234439|NCT00983619|79054967|FG004|Overall Study|Withdrawal by Subject|1|||
44234440|NCT00983619|79054968|FG005|Overall Study|Withdrawal by Subject|23|||
44234441|NCT00983619|79054969|FG006|Overall Study|Withdrawal by Subject|0|||
44234442|NCT00983619|79054970|FG007|Overall Study|Withdrawal by Subject|0|||
44234443|NCT00983619|79054971|FG008|Overall Study|Withdrawal by Subject|0|||
44234444|NCT00983619|79054972|FG009|Overall Study|Withdrawal by Subject|0|||
44234445|NCT00983619|79054973|FG010|Overall Study|Withdrawal by Subject|1|||
44234446|NCT00983619|79054974|FG011|Overall Study|Withdrawal by Subject|1|||
44234447|NCT00983619|79054963|FG000|Overall Study|Death|0|||
44234448|NCT00983619|79054964|FG001|Overall Study|Death|2|||
44234449|NCT00983619|79054965|FG002|Overall Study|Death|2|||
44234450|NCT00983619|79054966|FG003|Overall Study|Death|1|||
44234451|NCT00983619|79054967|FG004|Overall Study|Death|2|||
44234452|NCT00983619|79054968|FG005|Overall Study|Death|30|||
44234453|NCT00983619|79054969|FG006|Overall Study|Death|1|||
44234454|NCT00983619|79054970|FG007|Overall Study|Death|0|||
44501875|NCT03465904|79506989|FG001|Overall Study|Ineligible for mITT analysis|47|||
44501876|NCT03802916|79506997|FG000|Overall Study|Adverse Event|0|||
44501877|NCT03802916|79506998|FG001|Overall Study|Adverse Event|1|||
44501878|NCT03802916|79506997|FG000|Overall Study|Withdrawal by Subject|0|||
44501879|NCT03802916|79506998|FG001|Overall Study|Withdrawal by Subject|1|||
44501880|NCT00076011|79507006|FG000|Overall Study|Death|1|||
44501881|NCT00076011|79507006|FG000|Overall Study|Adverse Event|10|||
44501882|NCT00076011|79507006|FG000|Overall Study|Lack of Efficacy|25|||
44501883|NCT00076011|79507006|FG000|Overall Study|Withdrawal by Subject|1|||
44501884|NCT00076011|79507006|FG000|Overall Study|Study terminated by sponsor|3|||
44501885|NCT00076011|79507006|FG000|Overall Study|Other|11|||
44501886|NCT00076011|79507006|FG000|Overall Study|Ongoing|1|||
44501887|NCT03465436|79507014|FG000|Period 1|Protocol Violation|0|||
44565157|NCT02964507|79584489|FG007|Overall Study|Study terminated by Sponsor|0|||
44565158|NCT02964507|79584482|FG000|Overall Study|Other|3|||
44565159|NCT02964507|79584483|FG001|Overall Study|Other|0|||
44565160|NCT02964507|79584484|FG002|Overall Study|Other|0|||
44565161|NCT02964507|79584485|FG003|Overall Study|Other|0|||
44565162|NCT02964507|79584486|FG004|Overall Study|Other|1|||
44565163|NCT02964507|79584487|FG005|Overall Study|Other|0|||
44565164|NCT02964507|79584488|FG006|Overall Study|Other|0|||
44565165|NCT02964507|79584489|FG007|Overall Study|Other|0|||
44234455|NCT00983619|79054971|FG008|Overall Study|Death|1|||
44501888|NCT03465436|79507015|FG001|Period 1|Protocol Violation|0|||
44501889|NCT03465436|79507016|FG002|Period 1|Protocol Violation|1|||
44501890|NCT03465436|79507017|FG003|Period 1|Protocol Violation|0|||
44501891|NCT03465436|79507014|FG000|Period 2|Protocol Violation|0|||
44234456|NCT00983619|79054972|FG009|Overall Study|Death|2|||
44234457|NCT00983619|79054973|FG010|Overall Study|Death|9|||
44234458|NCT00983619|79054974|FG011|Overall Study|Death|8|||
44234459|NCT00983619|79054963|FG000|Overall Study|Other|1|||
44234460|NCT00983619|79054964|FG001|Overall Study|Other|0|||
44234461|NCT00983619|79054965|FG002|Overall Study|Other|0|||
44234462|NCT00983619|79054966|FG003|Overall Study|Other|1|||
44234463|NCT00983619|79054967|FG004|Overall Study|Other|0|||
44234464|NCT00983619|79054968|FG005|Overall Study|Other|12|||
44234465|NCT00983619|79054969|FG006|Overall Study|Other|2|||
44234466|NCT00983619|79054970|FG007|Overall Study|Other|2|||
44234467|NCT00983619|79054971|FG008|Overall Study|Other|0|||
44234468|NCT00983619|79054972|FG009|Overall Study|Other|1|||
44501892|NCT03465436|79507015|FG001|Period 2|Protocol Violation|1|||
44565166|NCT02964507|79584482|FG000|Overall Study|Death|11|||
44234469|NCT00983619|79054973|FG010|Overall Study|Other|1|||
44275729|NCT02228460|79223501|FG000|Overall Study|Lost to Follow-up|1|||
44565167|NCT02964507|79584483|FG001|Overall Study|Death|9|||
44501893|NCT03465436|79507016|FG002|Period 2|Protocol Violation|0|||
44501894|NCT03465436|79507017|FG003|Period 2|Protocol Violation|0|||
44501895|NCT03465436|79507014|FG000|Period 3|Protocol Violation|1|||
44565168|NCT02964507|79584484|FG002|Overall Study|Death|12|||
44565169|NCT02964507|79584485|FG003|Overall Study|Death|2|||
44565170|NCT02964507|79584486|FG004|Overall Study|Death|10|||
44234470|NCT00983619|79054974|FG011|Overall Study|Other|0|||
44234471|NCT01767857|79055022|FG000|Overall Study|Adverse Event|27|||
44234472|NCT01767857|79055023|FG001|Overall Study|Adverse Event|7|||
44501896|NCT03465436|79507015|FG001|Period 3|Protocol Violation|1|||
44565171|NCT02964507|79584487|FG005|Overall Study|Death|5|||
44565172|NCT02964507|79584488|FG006|Overall Study|Death|0|||
44234473|NCT01767857|79055022|FG000|Overall Study|Death|28|||
44234474|NCT01767857|79055023|FG001|Overall Study|Death|13|||
44234475|NCT01767857|79055022|FG000|Overall Study|Lack of Efficacy|299|||
44234476|NCT01767857|79055023|FG001|Overall Study|Lack of Efficacy|151|||
44234477|NCT01767857|79055022|FG000|Overall Study|Lost to Follow-up|1|||
44234478|NCT01767857|79055023|FG001|Overall Study|Lost to Follow-up|1|||
44234479|NCT01767857|79055022|FG000|Overall Study|Withdrawal by Subject|38|||
44234480|NCT01767857|79055023|FG001|Overall Study|Withdrawal by Subject|18|||
44234481|NCT01767857|79055022|FG000|Overall Study|Physician Decision|17|||
44234482|NCT01767857|79055023|FG001|Overall Study|Physician Decision|10|||
44234483|NCT01767857|79055022|FG000|Overall Study|Protocol Terminated|1|||
44234484|NCT01767857|79055023|FG001|Overall Study|Protocol Terminated|0|||
44234485|NCT01767857|79055022|FG000|Overall Study|Randomized But Never Treated|19|||
44234486|NCT01767857|79055023|FG001|Overall Study|Randomized But Never Treated|13|||
44234487|NCT01775501|79055030|FG000|Overall Study|Discontinued prior to treatment|1|||
44234488|NCT01775189|79055059|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44234489|NCT01775189|79055060|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
44234490|NCT01775189|79055061|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44234491|NCT01775189|79055062|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44234492|NCT01775189|79055063|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44234493|NCT01775189|79055064|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44234494|NCT01775189|79055065|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
44234495|NCT01775189|79055059|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44234496|NCT01775189|79055060|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
44234497|NCT01775189|79055061|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44234498|NCT01775189|79055062|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44234499|NCT01775189|79055063|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44234500|NCT01775189|79055064|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44234501|NCT01775189|79055065|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
44234502|NCT01775189|79055059|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
44501897|NCT03465436|79507016|FG002|Period 3|Protocol Violation|0|||
44501898|NCT03465436|79507017|FG003|Period 3|Protocol Violation|0|||
44501899|NCT03465436|79507014|FG000|Period 4|Protocol Violation|0|||
44501900|NCT03465436|79507015|FG001|Period 4|Protocol Violation|0|||
44501901|NCT03465436|79507016|FG002|Period 4|Protocol Violation|1|||
44234503|NCT01775189|79055060|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
44501902|NCT03465436|79507017|FG003|Period 4|Protocol Violation|0|||
44501903|NCT00053846|79507031|FG000|Overall Study|Changed mind|8|||
44501904|NCT00053846|79507032|FG001|Overall Study|Changed mind|13|||
44501905|NCT00053846|79507031|FG000|Overall Study|Became too ill|8|||
44501906|NCT00053846|79507032|FG001|Overall Study|Became too ill|7|||
44501907|NCT00053846|79507031|FG000|Overall Study|Expired|5|||
44501908|NCT00053846|79507032|FG001|Overall Study|Expired|0|||
44501909|NCT00053846|79507031|FG000|Overall Study|Became ineligible|3|||
44501910|NCT00053846|79507032|FG001|Overall Study|Became ineligible|1|||
44501911|NCT00053846|79507031|FG000|Overall Study|Did not return data|1|||
44501912|NCT00053846|79507032|FG001|Overall Study|Did not return data|2|||
44501913|NCT00053846|79507031|FG000|Overall Study|Quit due to side effects|1|||
44501914|NCT00053846|79507032|FG001|Overall Study|Quit due to side effects|3|||
44501915|NCT00053846|79507031|FG000|Overall Study|Pills too large|0|||
44501916|NCT00053846|79507032|FG001|Overall Study|Pills too large|1|||
44501917|NCT00090987|79507038|FG000|Overall Study|Adverse Event|5|||
44501918|NCT00090987|79507038|FG000|Overall Study|Lack of Efficacy|7|||
44501919|NCT00090987|79507038|FG000|Overall Study|Withdrawal by Subject|3|||
44501920|NCT00090987|79507038|FG000|Overall Study|alternative therapy|1|||
44501921|NCT00090987|79507038|FG000|Overall Study|Non-compliance|4|||
44501922|NCT00090987|79507038|FG000|Overall Study|Incarcerated|1|||
44501923|NCT03464422|79507042|FG000|Overall Study|Lost to Follow-up|2|||
44501924|NCT03464422|79507042|FG000|Overall Study|Withdrawal by Subject|2|||
44501925|NCT03489304|79507048|FG000|Overall Study|Lost to Follow-up|4|||
44501926|NCT03543358|79507052|FG000|Overall Study|Death|1|||
44501927|NCT03543358|79507053|FG001|Overall Study|Death|0|||
44565173|NCT02964507|79584489|FG007|Overall Study|Death|0|||
44234504|NCT01775189|79055061|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
44234505|NCT01775189|79055062|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
44234506|NCT01775189|79055063|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
44377275|NCT00789373|79382557|FG002|Maintenance|Progressive Disease|152|||
44501928|NCT03543358|79507052|FG000|Overall Study|Disease Progression|1|||
44501929|NCT03543358|79507053|FG001|Overall Study|Disease Progression|0|||
44501930|NCT03543358|79507052|FG000|Overall Study|Parent Study Closure|1|||
44565174|NCT02964507|79584482|FG000|Overall Study|Withdrawal by Subject|1|||
44565175|NCT02964507|79584483|FG001|Overall Study|Withdrawal by Subject|0|||
44565176|NCT02964507|79584484|FG002|Overall Study|Withdrawal by Subject|1|||
44565177|NCT02964507|79584485|FG003|Overall Study|Withdrawal by Subject|1|||
44565178|NCT02964507|79584486|FG004|Overall Study|Withdrawal by Subject|0|||
44565179|NCT02964507|79584487|FG005|Overall Study|Withdrawal by Subject|1|||
44565180|NCT02964507|79584488|FG006|Overall Study|Withdrawal by Subject|0|||
44565181|NCT02964507|79584489|FG007|Overall Study|Withdrawal by Subject|0|||
44565182|NCT02964507|79584482|FG000|Overall Study|Physician Decision|2|||
44565183|NCT02964507|79584483|FG001|Overall Study|Physician Decision|0|||
44565184|NCT02964507|79584484|FG002|Overall Study|Physician Decision|3|||
44565185|NCT02964507|79584485|FG003|Overall Study|Physician Decision|0|||
44565186|NCT02964507|79584486|FG004|Overall Study|Physician Decision|1|||
44565187|NCT02964507|79584487|FG005|Overall Study|Physician Decision|0|||
44565188|NCT02964507|79584488|FG006|Overall Study|Physician Decision|0|||
44565189|NCT02964507|79584489|FG007|Overall Study|Physician Decision|0|||
44234507|NCT01775189|79055064|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
44234508|NCT01775189|79055065|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
44234509|NCT01775189|79055059|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
44234510|NCT01775189|79055060|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
44234511|NCT01775189|79055061|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
44234512|NCT01775189|79055062|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
44234513|NCT01775189|79055063|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
44234514|NCT01775189|79055064|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
44234515|NCT01775189|79055065|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
44234516|NCT01775189|79055059|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
44234517|NCT01775189|79055060|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
44234518|NCT01775189|79055061|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
44234519|NCT01775189|79055062|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
44234520|NCT01775189|79055063|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
44234521|NCT01775189|79055064|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
44234522|NCT01775189|79055065|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
44565190|NCT03170869|79584508|FG000|Overall Study|Protocol Violation|5|||
44234523|NCT01775189|79055059|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
44565191|NCT03170869|79584508|FG000|Overall Study|Early study termination|3|||
44565192|NCT02440464|79584515|FG000|Overall Study|Withdrawal by Subject|3|||
44565193|NCT02440464|79584516|FG001|Overall Study|Withdrawal by Subject|2|||
44565194|NCT03131453|79584526|FG000|Overall Study|Study terminated by Sponsor|424|||
44565195|NCT03131453|79584527|FG001|Overall Study|Study terminated by Sponsor|222|||
44565196|NCT03131453|79584528|FG002|Overall Study|Study terminated by Sponsor|438|||
44377276|NCT00789373|79382555|FG000|Maintenance|Withdrawal by Subject|0|||
44377277|NCT00789373|79382556|FG001|Maintenance|Withdrawal by Subject|21|||
44377278|NCT00789373|79382557|FG002|Maintenance|Withdrawal by Subject|8|||
44377279|NCT00789373|79382555|FG000|Maintenance|Sponsor Decision|0|||
44501931|NCT03543358|79507053|FG001|Overall Study|Parent Study Closure|0|||
44501932|NCT03485950|79507059|FG000|Overall Study|Adverse Event|1|||
44501933|NCT03485950|79507060|FG001|Overall Study|Adverse Event|0|||
44501934|NCT03485950|79507059|FG000|Overall Study|Death|3|||
44501935|NCT03485950|79507060|FG001|Overall Study|Death|2|||
44501936|NCT03485950|79507059|FG000|Overall Study|Withdrawal by Subject|3|||
44501937|NCT03485950|79507060|FG001|Overall Study|Withdrawal by Subject|0|||
44501938|NCT00060944|79507068|FG000|Overall Study|Adverse Event|12|||
44501939|NCT00060944|79507069|FG001|Overall Study|Adverse Event|10|||
44501940|NCT00060944|79507068|FG000|Overall Study|Death|2|||
44501941|NCT00060944|79507069|FG001|Overall Study|Death|3|||
44501942|NCT00060944|79507068|FG000|Overall Study|Withdrawal by Subject|18|||
44501943|NCT00060944|79507069|FG001|Overall Study|Withdrawal by Subject|5|||
44565197|NCT03131453|79584526|FG000|Overall Study|Withdrawal by Subject|18|||
44275730|NCT02227446|79223517|FG000|Overall Study|not eligible post randomization|18|||
44377280|NCT00789373|79382556|FG001|Maintenance|Sponsor Decision|0|||
44565198|NCT03131453|79584527|FG001|Overall Study|Withdrawal by Subject|7|||
44565199|NCT03131453|79584528|FG002|Overall Study|Withdrawal by Subject|13|||
44501944|NCT00060944|79507068|FG000|Overall Study|Disease Progression|93|||
44501945|NCT00060944|79507069|FG001|Overall Study|Disease Progression|94|||
44501946|NCT00060944|79507068|FG000|Overall Study|Lost to Follow-up|1|||
44565200|NCT03131453|79584526|FG000|Overall Study|Adverse Event|10|||
44565201|NCT03131453|79584527|FG001|Overall Study|Adverse Event|3|||
44565202|NCT03131453|79584528|FG002|Overall Study|Adverse Event|3|||
44565203|NCT03131453|79584526|FG000|Overall Study|Lost to Follow-up|1|||
44565204|NCT03131453|79584527|FG001|Overall Study|Lost to Follow-up|0|||
44565205|NCT03131453|79584528|FG002|Overall Study|Lost to Follow-up|1|||
44565206|NCT03131453|79584526|FG000|Overall Study|Physician Decision|1|||
44565207|NCT03131453|79584527|FG001|Overall Study|Physician Decision|0|||
44565208|NCT03131453|79584528|FG002|Overall Study|Physician Decision|1|||
44565209|NCT03131453|79584526|FG000|Overall Study|Non-compliance with study treatment|1|||
44565210|NCT03131453|79584527|FG001|Overall Study|Non-compliance with study treatment|0|||
44565211|NCT03131453|79584528|FG002|Overall Study|Non-compliance with study treatment|0|||
44565212|NCT03131453|79584526|FG000|Overall Study|Technical problems|1|||
44565213|NCT03131453|79584527|FG001|Overall Study|Technical problems|0|||
44565214|NCT03131453|79584528|FG002|Overall Study|Technical problems|0|||
44565215|NCT03131453|79584526|FG000|Overall Study|Protocol deviation|0|||
44565216|NCT03131453|79584527|FG001|Overall Study|Protocol deviation|1|||
44565217|NCT03131453|79584528|FG002|Overall Study|Protocol deviation|0|||
44565218|NCT02942277|79584556|FG000|Year 1|Withdrawal by Subject|0|||
44565219|NCT02942277|79584557|FG001|Year 1|Withdrawal by Subject|0|||
44565220|NCT02942277|79584558|FG002|Year 1|Withdrawal by Subject|0|||
44565221|NCT02942277|79584559|FG003|Year 1|Withdrawal by Subject|0|||
44565222|NCT02942277|79584560|FG004|Year 1|Withdrawal by Subject|1|||
44565223|NCT02942277|79584561|FG005|Year 1|Withdrawal by Subject|3|||
44565224|NCT02942277|79584562|FG006|Year 1|Withdrawal by Subject|0|||
44565225|NCT02942277|79584563|FG007|Year 1|Withdrawal by Subject|1|||
44565226|NCT02942277|79584564|FG008|Year 1|Withdrawal by Subject|0|||
44565227|NCT02942277|79584565|FG009|Year 1|Withdrawal by Subject|0|||
44565228|NCT02942277|79584566|FG010|Year 1|Withdrawal by Subject|3|||
44565229|NCT02942277|79584556|FG000|Year 1|Travel|0|||
44234524|NCT01775189|79055060|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
44234525|NCT01775189|79055061|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
44501947|NCT00060944|79507069|FG001|Overall Study|Lost to Follow-up|0|||
44501948|NCT00060944|79507068|FG000|Overall Study|Subject Ineligible To Continue|2|||
44501949|NCT00060944|79507069|FG001|Overall Study|Subject Ineligible To Continue|1|||
44501950|NCT00060944|79507068|FG000|Overall Study|Treatment Switch|0|||
44501951|NCT00060944|79507069|FG001|Overall Study|Treatment Switch|13|||
44501952|NCT00060944|79507068|FG000|Overall Study|Other|2|||
44501953|NCT00060944|79507069|FG001|Overall Study|Other|4|||
44501954|NCT00060944|79507068|FG000|Overall Study|randomized but not treated|6|||
44501955|NCT00060944|79507069|FG001|Overall Study|randomized but not treated|4|||
44501956|NCT03462082|79507075|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
44501957|NCT03462082|79507076|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
44501958|NCT03462082|79507077|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
44501959|NCT03462082|79507078|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
44501960|NCT03462082|79507079|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
44501961|NCT03462082|79507080|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
44501962|NCT03462082|79507081|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
44501963|NCT03462082|79507082|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
44501964|NCT03541252|79507092|FG000|Overall Study|Withdrawal by Subject|1|||
44501965|NCT00031460|79507098|FG000|Overall Study|Lost to Follow-up|0|||
44501966|NCT00031460|79507099|FG001|Overall Study|Lost to Follow-up|1|||
44501967|NCT00031460|79507098|FG000|Overall Study|Withdrawal by Subject|1|||
44501968|NCT00031460|79507099|FG001|Overall Study|Withdrawal by Subject|1|||
44501969|NCT00031460|79507098|FG000|Overall Study|Non-Compliant|1|||
44501970|NCT00031460|79507099|FG001|Overall Study|Non-Compliant|1|||
44501971|NCT00031460|79507098|FG000|Overall Study|Death|0|||
44501972|NCT00031460|79507099|FG001|Overall Study|Death|1|||
44565230|NCT02942277|79584557|FG001|Year 1|Travel|1|||
44234526|NCT01775189|79055062|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
44234527|NCT01775189|79055063|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
44234528|NCT01775189|79055064|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
44501973|NCT00031460|79507098|FG000|Overall Study|Reactivation of Disease|5|||
44501974|NCT00031460|79507099|FG001|Overall Study|Reactivation of Disease|9|||
44501975|NCT00031460|79507098|FG000|Overall Study|Disruption of blinded drug supply|2|||
44501976|NCT00031460|79507099|FG001|Overall Study|Disruption of blinded drug supply|0|||
44501977|NCT00031460|79507098|FG000|Overall Study|Confirmed unevaluable|0|||
44501978|NCT00031460|79507099|FG001|Overall Study|Confirmed unevaluable|1|||
44565231|NCT02942277|79584558|FG002|Year 1|Travel|0|||
44377281|NCT00789373|79382557|FG002|Maintenance|Sponsor Decision|2|||
44377282|NCT00789373|79382555|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
44377283|NCT00789373|79382556|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
44377284|NCT00789373|79382557|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
44377285|NCT00851890|79382572|FG000|Overall Study|Lost to Follow-up|0|||
44377286|NCT00851890|79382573|FG001|Overall Study|Lost to Follow-up|1|||
44377287|NCT00851890|79382574|FG002|Overall Study|Lost to Follow-up|0|||
44377288|NCT00851890|79382575|FG003|Overall Study|Lost to Follow-up|1|||
44377289|NCT00788827|79382585|FG000|Overall Study|Lack of Efficacy|2|||
44377290|NCT00592072|79382591|FG000|Wash Out Period|Lost to Follow-up|1|||
44377291|NCT00592072|79382592|FG001|Wash Out Period|Lost to Follow-up|1|||
44377292|NCT00792571|79382598|FG000|Overall Study|Death|1|||
44377293|NCT00792571|79382598|FG000|Overall Study|Adverse Event|4|||
44377294|NCT00792571|79382598|FG000|Overall Study|Withdrawal by Subject|1|||
44377295|NCT00792571|79382598|FG000|Overall Study|Other|4|||
44377296|NCT01069484|79382604|FG000|Overall Study|Death-in-near-family|1|||
44377297|NCT01069484|79382605|FG001|Overall Study|Death-in-near-family|0|||
44377298|NCT01069484|79382604|FG000|Overall Study|No specific reason|8|||
44377299|NCT01069484|79382605|FG001|Overall Study|No specific reason|2|||
44377300|NCT01069484|79382604|FG000|Overall Study|Illness mother or child|3|||
44377301|NCT01069484|79382605|FG001|Overall Study|Illness mother or child|1|||
44377302|NCT00794365|79382612|FG000|Overall Study|Lost to Follow-up|38|||
44377303|NCT00794365|79382612|FG000|Overall Study|Other|17|||
44377304|NCT00794365|79382612|FG000|Overall Study|Poor Compliance|11|||
44377305|NCT00794365|79382612|FG000|Overall Study|Adverse Event|10|||
44377306|NCT00794365|79382612|FG000|Overall Study|Lack of Efficacy|3|||
44377307|NCT01067144|79382618|FG000|Treatment|Did not receive allocated intervention|4|||
44565232|NCT02942277|79584559|FG003|Year 1|Travel|0|||
44565233|NCT02942277|79584560|FG004|Year 1|Travel|4|||
44565234|NCT02942277|79584561|FG005|Year 1|Travel|5|||
44565235|NCT02942277|79584562|FG006|Year 1|Travel|0|||
44565236|NCT02942277|79584563|FG007|Year 1|Travel|0|||
44565237|NCT02942277|79584564|FG008|Year 1|Travel|0|||
44565238|NCT02942277|79584565|FG009|Year 1|Travel|0|||
44565239|NCT02942277|79584566|FG010|Year 1|Travel|8|||
44565240|NCT02942277|79584556|FG000|Year 1|Joined Army|0|||
44565241|NCT02942277|79584557|FG001|Year 1|Joined Army|1|||
44565242|NCT02942277|79584558|FG002|Year 1|Joined Army|0|||
44565243|NCT02942277|79584559|FG003|Year 1|Joined Army|0|||
44565244|NCT02942277|79584560|FG004|Year 1|Joined Army|0|||
44565245|NCT02942277|79584561|FG005|Year 1|Joined Army|0|||
44565246|NCT02942277|79584562|FG006|Year 1|Joined Army|0|||
44565247|NCT02942277|79584563|FG007|Year 1|Joined Army|0|||
44565248|NCT02942277|79584564|FG008|Year 1|Joined Army|0|||
44565249|NCT02942277|79584565|FG009|Year 1|Joined Army|0|||
44565250|NCT02942277|79584566|FG010|Year 1|Joined Army|0|||
44565251|NCT02942277|79584556|FG000|Year 1|Subject met withdrawal criteria|0|||
44565252|NCT02942277|79584557|FG001|Year 1|Subject met withdrawal criteria|0|||
44565253|NCT02942277|79584558|FG002|Year 1|Subject met withdrawal criteria|0|||
44565254|NCT02942277|79584559|FG003|Year 1|Subject met withdrawal criteria|1|||
44565255|NCT02942277|79584560|FG004|Year 1|Subject met withdrawal criteria|0|||
44565256|NCT02942277|79584561|FG005|Year 1|Subject met withdrawal criteria|0|||
44565257|NCT02942277|79584562|FG006|Year 1|Subject met withdrawal criteria|0|||
44377308|NCT01067144|79382619|FG001|Treatment|Did not receive allocated intervention|7|||
44377309|NCT01067144|79382618|FG000|Follow-up|Lost to Follow-up|22|||
44377310|NCT01067144|79382619|FG001|Follow-up|Lost to Follow-up|12|||
44377311|NCT01067144|79382618|FG000|Follow-up|Censored owing to second surgery|19|||
44565258|NCT02942277|79584563|FG007|Year 1|Subject met withdrawal criteria|0|||
44565259|NCT02942277|79584564|FG008|Year 1|Subject met withdrawal criteria|0|||
44377312|NCT01067144|79382619|FG001|Follow-up|Censored owing to second surgery|28|||
44377313|NCT01067144|79382618|FG000|Follow-up|Withdrawal by Subject|18|||
44377314|NCT01067144|79382619|FG001|Follow-up|Withdrawal by Subject|14|||
44377315|NCT01067144|79382618|FG000|Follow-up|Surgery cancelled|0|||
44377316|NCT01067144|79382619|FG001|Follow-up|Surgery cancelled|1|||
44565260|NCT02942277|79584565|FG009|Year 1|Subject met withdrawal criteria|0|||
44565261|NCT02942277|79584566|FG010|Year 1|Subject met withdrawal criteria|0|||
44377317|NCT01067144|79382618|FG000|Follow-up|Death|0|||
44565262|NCT02942277|79584556|FG000|Year 1|Lost to Follow-up|0|||
44565263|NCT02942277|79584557|FG001|Year 1|Lost to Follow-up|0|||
44565264|NCT02942277|79584558|FG002|Year 1|Lost to Follow-up|0|||
44565265|NCT02942277|79584559|FG003|Year 1|Lost to Follow-up|0|||
44565266|NCT02942277|79584560|FG004|Year 1|Lost to Follow-up|1|||
44565267|NCT02942277|79584561|FG005|Year 1|Lost to Follow-up|0|||
44565268|NCT02942277|79584562|FG006|Year 1|Lost to Follow-up|0|||
44565269|NCT02942277|79584563|FG007|Year 1|Lost to Follow-up|0|||
44565270|NCT02942277|79584564|FG008|Year 1|Lost to Follow-up|0|||
44565271|NCT02942277|79584565|FG009|Year 1|Lost to Follow-up|0|||
44565272|NCT02942277|79584566|FG010|Year 1|Lost to Follow-up|2|||
44565273|NCT02942277|79584556|FG000|Year 1|Protocol Violation|0|||
44565274|NCT02942277|79584557|FG001|Year 1|Protocol Violation|0|||
44565275|NCT02942277|79584558|FG002|Year 1|Protocol Violation|0|||
44565276|NCT02942277|79584559|FG003|Year 1|Protocol Violation|0|||
44565277|NCT02942277|79584560|FG004|Year 1|Protocol Violation|1|||
44565278|NCT02942277|79584561|FG005|Year 1|Protocol Violation|1|||
44565279|NCT02942277|79584562|FG006|Year 1|Protocol Violation|0|||
44565280|NCT02942277|79584563|FG007|Year 1|Protocol Violation|0|||
44565281|NCT02942277|79584564|FG008|Year 1|Protocol Violation|0|||
44565282|NCT02942277|79584565|FG009|Year 1|Protocol Violation|0|||
44565283|NCT02942277|79584566|FG010|Year 1|Protocol Violation|2|||
44565284|NCT02942277|79584556|FG000|Year 1|Pregnancy|0|||
44565285|NCT02942277|79584557|FG001|Year 1|Pregnancy|0|||
44565286|NCT02942277|79584558|FG002|Year 1|Pregnancy|0|||
44565287|NCT02942277|79584559|FG003|Year 1|Pregnancy|0|||
44565288|NCT02942277|79584560|FG004|Year 1|Pregnancy|0|||
44234529|NCT01775189|79055065|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
44565289|NCT02942277|79584561|FG005|Year 1|Pregnancy|1|||
44565290|NCT02942277|79584562|FG006|Year 1|Pregnancy|0|||
44565291|NCT02942277|79584563|FG007|Year 1|Pregnancy|0|||
44565292|NCT02942277|79584564|FG008|Year 1|Pregnancy|0|||
44565293|NCT02942277|79584565|FG009|Year 1|Pregnancy|0|||
44565294|NCT02942277|79584566|FG010|Year 1|Pregnancy|0|||
44565295|NCT02942277|79584556|FG000|Year 2|Lost to Follow-up|0|||
44565296|NCT02942277|79584557|FG001|Year 2|Lost to Follow-up|0|||
44565297|NCT02942277|79584558|FG002|Year 2|Lost to Follow-up|0|||
44565298|NCT02942277|79584559|FG003|Year 2|Lost to Follow-up|0|||
44565299|NCT02942277|79584560|FG004|Year 2|Lost to Follow-up|2|||
44565300|NCT02942277|79584561|FG005|Year 2|Lost to Follow-up|1|||
44565301|NCT02942277|79584562|FG006|Year 2|Lost to Follow-up|0|||
44565302|NCT02942277|79584563|FG007|Year 2|Lost to Follow-up|0|||
44565303|NCT02942277|79584564|FG008|Year 2|Lost to Follow-up|0|||
44565304|NCT02942277|79584565|FG009|Year 2|Lost to Follow-up|0|||
44565305|NCT02942277|79584566|FG010|Year 2|Lost to Follow-up|0|||
44565306|NCT02942277|79584556|FG000|Year 2|Did not rescreen|0|||
44234530|NCT01770743|79055131|FG000|Overall Study|Adverse Event|1|||
44234531|NCT01770743|79055132|FG001|Overall Study|Adverse Event|0|||
44565307|NCT02942277|79584557|FG001|Year 2|Did not rescreen|0|||
44565308|NCT02942277|79584558|FG002|Year 2|Did not rescreen|1|||
44565309|NCT02942277|79584559|FG003|Year 2|Did not rescreen|1|||
44565310|NCT02942277|79584560|FG004|Year 2|Did not rescreen|9|||
44565311|NCT02942277|79584561|FG005|Year 2|Did not rescreen|6|||
44234532|NCT01770743|79055133|FG002|Overall Study|Adverse Event|0|||
44234533|NCT01770743|79055134|FG003|Overall Study|Adverse Event|0|||
44234534|NCT01770743|79055135|FG004|Overall Study|Adverse Event|0|||
44234535|NCT01770743|79055131|FG000|Overall Study|Withdrawal by Subject|0|||
44234536|NCT01770743|79055132|FG001|Overall Study|Withdrawal by Subject|0|||
44234537|NCT01770743|79055133|FG002|Overall Study|Withdrawal by Subject|1|||
44565312|NCT02942277|79584562|FG006|Year 2|Did not rescreen|0|||
44565313|NCT02942277|79584563|FG007|Year 2|Did not rescreen|1|||
44565314|NCT02942277|79584564|FG008|Year 2|Did not rescreen|0|||
44565315|NCT02942277|79584565|FG009|Year 2|Did not rescreen|0|||
44565316|NCT02942277|79584566|FG010|Year 2|Did not rescreen|21|||
44565317|NCT02942277|79584556|FG000|Year 2|Met withdrawal criteria|0|||
44565318|NCT02942277|79584557|FG001|Year 2|Met withdrawal criteria|0|||
44565319|NCT02942277|79584558|FG002|Year 2|Met withdrawal criteria|0|||
44565320|NCT02942277|79584559|FG003|Year 2|Met withdrawal criteria|0|||
44565321|NCT02942277|79584560|FG004|Year 2|Met withdrawal criteria|1|||
44565322|NCT02942277|79584561|FG005|Year 2|Met withdrawal criteria|2|||
44565323|NCT02942277|79584562|FG006|Year 2|Met withdrawal criteria|0|||
44565324|NCT02942277|79584563|FG007|Year 2|Met withdrawal criteria|0|||
44565325|NCT02942277|79584564|FG008|Year 2|Met withdrawal criteria|0|||
44565326|NCT02942277|79584565|FG009|Year 2|Met withdrawal criteria|0|||
44565327|NCT02942277|79584566|FG010|Year 2|Met withdrawal criteria|1|||
44565328|NCT02942277|79584556|FG000|Year 2|Travel|0|||
44565329|NCT02942277|79584557|FG001|Year 2|Travel|1|||
44565330|NCT02942277|79584558|FG002|Year 2|Travel|0|||
44565331|NCT02942277|79584559|FG003|Year 2|Travel|0|||
44565332|NCT02942277|79584560|FG004|Year 2|Travel|0|||
44565333|NCT02942277|79584561|FG005|Year 2|Travel|1|||
44565334|NCT02942277|79584562|FG006|Year 2|Travel|0|||
44565335|NCT02942277|79584563|FG007|Year 2|Travel|0|||
44565336|NCT02942277|79584564|FG008|Year 2|Travel|0|||
44565337|NCT02942277|79584565|FG009|Year 2|Travel|1|||
44565338|NCT02942277|79584566|FG010|Year 2|Travel|3|||
44565339|NCT02942277|79584556|FG000|Year 2|Non-compliant|0|||
44565340|NCT02942277|79584557|FG001|Year 2|Non-compliant|0|||
44565341|NCT02942277|79584558|FG002|Year 2|Non-compliant|0|||
44565342|NCT02942277|79584559|FG003|Year 2|Non-compliant|0|||
44565343|NCT02942277|79584560|FG004|Year 2|Non-compliant|1|||
44565344|NCT02942277|79584561|FG005|Year 2|Non-compliant|1|||
44565345|NCT02942277|79584562|FG006|Year 2|Non-compliant|0|||
44234538|NCT01770743|79055134|FG003|Overall Study|Withdrawal by Subject|1|||
44234539|NCT01770743|79055135|FG004|Overall Study|Withdrawal by Subject|1|||
44234540|NCT01770743|79055131|FG000|Overall Study|Lost to Follow-up|0|||
44234541|NCT01770743|79055132|FG001|Overall Study|Lost to Follow-up|2|||
44234542|NCT01770743|79055133|FG002|Overall Study|Lost to Follow-up|0|||
44234543|NCT01770743|79055134|FG003|Overall Study|Lost to Follow-up|0|||
44234544|NCT01770743|79055135|FG004|Overall Study|Lost to Follow-up|1|||
44234545|NCT01770743|79055131|FG000|Overall Study|Sponsor Terminated Subject|1|||
44501979|NCT03540160|79507105|FG000|Overall Study|Protocol Violation|1|||
44501980|NCT03540160|79507105|FG000|Overall Study|Physician Decision|8|||
44501981|NCT03540160|79507105|FG000|Overall Study|Lack of Efficacy|60|||
44501982|NCT03540160|79507105|FG000|Overall Study|Pregnancy|1|||
44501983|NCT03540160|79507105|FG000|Overall Study|Adverse Event|20|||
44501984|NCT03540160|79507105|FG000|Overall Study|Withdrawal by Subject|68|||
44501985|NCT03540160|79507105|FG000|Overall Study|COVID-19|2|||
44565346|NCT02942277|79584563|FG007|Year 2|Non-compliant|0|||
44565347|NCT02942277|79584564|FG008|Year 2|Non-compliant|0|||
44565348|NCT02942277|79584565|FG009|Year 2|Non-compliant|0|||
44565349|NCT02942277|79584566|FG010|Year 2|Non-compliant|0|||
44565350|NCT02942277|79584556|FG000|Year 2|Withdrawal by Subject|0|||
44565351|NCT02942277|79584557|FG001|Year 2|Withdrawal by Subject|0|||
44565352|NCT02942277|79584558|FG002|Year 2|Withdrawal by Subject|0|||
44565353|NCT02942277|79584559|FG003|Year 2|Withdrawal by Subject|0|||
44565354|NCT02942277|79584560|FG004|Year 2|Withdrawal by Subject|0|||
44565355|NCT02942277|79584561|FG005|Year 2|Withdrawal by Subject|0|||
44565356|NCT02942277|79584562|FG006|Year 2|Withdrawal by Subject|1|||
44565357|NCT02942277|79584563|FG007|Year 2|Withdrawal by Subject|0|||
44565358|NCT02942277|79584564|FG008|Year 2|Withdrawal by Subject|0|||
44565359|NCT02942277|79584565|FG009|Year 2|Withdrawal by Subject|0|||
44565360|NCT02942277|79584566|FG010|Year 2|Withdrawal by Subject|0|||
44565361|NCT02859324|79584617|FG000|Overall Study|Death|4|||
44234546|NCT01770743|79055132|FG001|Overall Study|Sponsor Terminated Subject|0|||
44234547|NCT01770743|79055133|FG002|Overall Study|Sponsor Terminated Subject|0|||
44234548|NCT01770743|79055134|FG003|Overall Study|Sponsor Terminated Subject|1|||
44501986|NCT03540160|79507105|FG000|Overall Study|Study Closure|10|||
44501987|NCT03540160|79507105|FG000|Overall Study|Lost to Follow-up|18|||
44501988|NCT03540160|79507105|FG000|Overall Study|Sponsor decision|191|||
44501989|NCT03459196|79507109|FG000|Overall Study|Subject didn't receive study catheter|2|||
44501990|NCT03459040|79507113|FG000|Overall Study|Death|8|||
44501991|NCT03459040|79507113|FG000|Overall Study|Withdrawal by Subject|1|||
44501992|NCT03457636|79507118|FG000|Overall Study|Lost to Follow-up|2|||
44501993|NCT03481816|79507124|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
44501994|NCT03481816|79507125|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
44234549|NCT01770743|79055135|FG004|Overall Study|Sponsor Terminated Subject|0|||
44234550|NCT01770743|79055131|FG000|Overall Study|Moving Out of State|0|||
44501995|NCT03481816|79507124|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
44501996|NCT03481816|79507125|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
44565362|NCT02859324|79584618|FG001|Overall Study|Death|6|||
44234551|NCT01770743|79055132|FG001|Overall Study|Moving Out of State|1|||
44501997|NCT03481816|79507124|FG000|Dose Expansion|Withdrawal by Subject|0|||
44501998|NCT03481816|79507125|FG001|Dose Expansion|Withdrawal by Subject|2|||
44234552|NCT01770743|79055133|FG002|Overall Study|Moving Out of State|0|||
44234553|NCT01770743|79055134|FG003|Overall Study|Moving Out of State|0|||
44501999|NCT03481816|79507124|FG000|Dose Expansion|Physician Decision|0|||
44565363|NCT02859324|79584619|FG002|Overall Study|Death|5|||
44565364|NCT02859324|79584617|FG000|Overall Study|Other reasons|3|||
44565365|NCT02859324|79584618|FG001|Overall Study|Other reasons|3|||
44565366|NCT02859324|79584619|FG002|Overall Study|Other reasons|0|||
44565367|NCT02143063|79584630|FG000|Overall Study|Lost to Follow-up|16|||
44565368|NCT02143063|79584631|FG001|Overall Study|Lost to Follow-up|28|||
44565369|NCT02143063|79584632|FG002|Overall Study|Lost to Follow-up|29|||
44565370|NCT02143063|79584630|FG000|Overall Study|Withdrawal by Subject|0|||
44565371|NCT02143063|79584631|FG001|Overall Study|Withdrawal by Subject|1|||
44565372|NCT02143063|79584632|FG002|Overall Study|Withdrawal by Subject|0|||
44565373|NCT02143063|79584630|FG000|Overall Study|Death|0|||
44565374|NCT02143063|79584631|FG001|Overall Study|Death|1|||
44565375|NCT02143063|79584632|FG002|Overall Study|Death|1|||
44565376|NCT02859246|79584640|FG000|Overall Study|Screen fails|3|||
44565377|NCT02859246|79584640|FG000|Overall Study|Adverse Event|1|||
44565378|NCT02859246|79584640|FG000|Overall Study|Withdrawal by Subject|1|||
44565379|NCT01083433|79584663|FG000|Overall Study|Lost to Follow-up|2|||
44565380|NCT01083433|79584664|FG001|Overall Study|Lost to Follow-up|1|||
44565381|NCT01083433|79584665|FG002|Overall Study|Lost to Follow-up|1|||
44565382|NCT01083433|79584663|FG000|Overall Study|Withdrawal by Subject|0|||
44565383|NCT01083433|79584664|FG001|Overall Study|Withdrawal by Subject|5|||
44565384|NCT01083433|79584665|FG002|Overall Study|Withdrawal by Subject|3|||
44565385|NCT01083433|79584663|FG000|Overall Study|Pregnancy|0|||
44565386|NCT01083433|79584664|FG001|Overall Study|Pregnancy|0|||
44565387|NCT01083433|79584665|FG002|Overall Study|Pregnancy|1|||
44565388|NCT02791490|79584679|FG000|Overall Study|Lost to Follow-up|1|||
44565389|NCT02791490|79584680|FG001|Overall Study|Lost to Follow-up|2|||
44565390|NCT02791490|79584679|FG000|Overall Study|Withdrawal by Subject|2|||
44565391|NCT02791490|79584680|FG001|Overall Study|Withdrawal by Subject|6|||
44565392|NCT02507973|79584695|FG000|Overall Study|Adverse Event|1|||
44565393|NCT02425644|79584703|FG000|Overall Study|Lost to Follow-up|2|||
44565394|NCT02425644|79584704|FG001|Overall Study|Lost to Follow-up|3|||
44565395|NCT02425644|79584703|FG000|Overall Study|Withdrawal by Subject|41|||
44565396|NCT02425644|79584704|FG001|Overall Study|Withdrawal by Subject|36|||
44565397|NCT02425644|79584703|FG000|Overall Study|Lack of Efficacy|3|||
44565398|NCT02425644|79584704|FG001|Overall Study|Lack of Efficacy|10|||
44565399|NCT02425644|79584703|FG000|Overall Study|Adverse Event|13|||
44565400|NCT02425644|79584704|FG001|Overall Study|Adverse Event|3|||
44565401|NCT02425644|79584703|FG000|Overall Study|Death|0|||
44565402|NCT02425644|79584704|FG001|Overall Study|Death|2|||
44565403|NCT02425644|79584703|FG000|Overall Study|Other|18|||
44565404|NCT02425644|79584704|FG001|Overall Study|Other|17|||
44565405|NCT02861664|79584716|FG000|Overall Study|Withdrawal of Consent|0|||
44565406|NCT02861664|79584717|FG001|Overall Study|Withdrawal of Consent|1|||
44565407|NCT01307787|79584725|FG000|Overall Study|Withdrawal by Subject|2|||
44565408|NCT01307787|79584726|FG001|Overall Study|Withdrawal by Subject|0|||
44565409|NCT03284853|79584739|FG000|Overall Study|Adverse Event|40|||
44565410|NCT03284853|79584740|FG001|Overall Study|Adverse Event|4|||
44565411|NCT03284853|79584739|FG000|Overall Study|Withdrawal by Subject|5|||
44565412|NCT03284853|79584740|FG001|Overall Study|Withdrawal by Subject|1|||
44565413|NCT03284853|79584739|FG000|Overall Study|Lost to Follow-up|1|||
44565414|NCT03284853|79584740|FG001|Overall Study|Lost to Follow-up|0|||
44502000|NCT03481816|79507125|FG001|Dose Expansion|Physician Decision|5|||
44502001|NCT03538054|79507133|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
44502002|NCT03538054|79507133|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
44502003|NCT03538054|79507133|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
44502004|NCT03480802|79507141|FG000|Overall Study|Lost to Follow-up|5|||
44502005|NCT03480802|79507142|FG001|Overall Study|Lost to Follow-up|1|||
44502006|NCT03480802|79507141|FG000|Overall Study|Withdrawal by Subject|2|||
44502007|NCT03480802|79507142|FG001|Overall Study|Withdrawal by Subject|1|||
44502008|NCT03480802|79507141|FG000|Overall Study|Relocated|0|||
44502009|NCT03480802|79507142|FG001|Overall Study|Relocated|1|||
44565415|NCT03284853|79584739|FG000|Overall Study|Lack of Efficacy|1|||
44565416|NCT03284853|79584740|FG001|Overall Study|Lack of Efficacy|0|||
44565417|NCT03284853|79584739|FG000|Overall Study|Disallowed Concurrent Medication|1|||
44565418|NCT03284853|79584740|FG001|Overall Study|Disallowed Concurrent Medication|1|||
44565419|NCT03284853|79584739|FG000|Overall Study|Protocol Violation|3|||
44565420|NCT03284853|79584740|FG001|Overall Study|Protocol Violation|3|||
44565421|NCT03284853|79584739|FG000|Overall Study|Death|0|||
44565422|NCT03284853|79584740|FG001|Overall Study|Death|1|||
44565423|NCT03284853|79584739|FG000|Overall Study|Other - Reason not reported in CSR|4|||
44565424|NCT03284853|79584740|FG001|Overall Study|Other - Reason not reported in CSR|3|||
44565425|NCT04497415|79584768|FG000|Overall Study|Lost to Follow-up|43|||
44565426|NCT04497415|79584769|FG001|Overall Study|Lost to Follow-up|27|||
44565427|NCT03125941|79584777|FG000|Overall Study|did not receive intervention|1|||
44565428|NCT03125941|79584778|FG001|Overall Study|did not receive intervention|2|||
44502010|NCT00050960|79507152|FG000|Overall Study|Progressive Disease|137|||
44502011|NCT00050960|79507153|FG001|Overall Study|Progressive Disease|93|||
44565429|NCT02774889|79584786|FG000|Overall Study|Lost to Follow-up|2|||
44565430|NCT02774889|79584787|FG001|Overall Study|Lost to Follow-up|1|||
44565431|NCT03125629|79584795|FG000|Overall Study|Withdrawal by Subject|2|||
44565432|NCT03125629|79584795|FG000|Overall Study|Equipment malfunction|1|||
44565433|NCT03125395|79584807|FG000|Overall Study|Adverse Event|2|||
44565434|NCT03125395|79584807|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
44565435|NCT03125395|79584807|FG000|Overall Study|Physician Decision|2|||
44565436|NCT03125395|79584807|FG000|Overall Study|Commercial drug is available|5|||
44565437|NCT00261807|79584821|FG000|Overall Study|Lost to Follow-up|2|||
44502012|NCT00050960|79507152|FG000|Overall Study|Stable Disease|19|||
44565438|NCT00261807|79584821|FG000|Overall Study|Adverse Event|2|||
44565439|NCT00261807|79584821|FG000|Overall Study|Death|1|||
44565440|NCT00261807|79584821|FG000|Overall Study|Protocol Violation|2|||
44565441|NCT02820753|79584828|FG000|2 Month|Withdrawal by Subject|3|||
44565442|NCT02820753|79584829|FG001|2 Month|Withdrawal by Subject|3|||
44565443|NCT02820753|79584828|FG000|2 Month|Lost to Follow-up|24|||
44565444|NCT02820753|79584829|FG001|2 Month|Lost to Follow-up|26|||
44565445|NCT02820753|79584828|FG000|2 Month|Stopped per NIH Hold|51|||
44565446|NCT02820753|79584829|FG001|2 Month|Stopped per NIH Hold|13|||
44565447|NCT02820753|79584828|FG000|6 Month|Withdrawal by Subject|2|||
44565448|NCT02820753|79584829|FG001|6 Month|Withdrawal by Subject|2|||
44565449|NCT02820753|79584828|FG000|6 Month|Lost to Follow-up|20|||
44565450|NCT02820753|79584829|FG001|6 Month|Lost to Follow-up|27|||
44565451|NCT02820753|79584828|FG000|6 Month|Stopped per NIH Hold|81|||
44234554|NCT01770743|79055135|FG004|Overall Study|Moving Out of State|0|||
44234555|NCT01767467|79055231|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
44234556|NCT01767467|79055232|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
44234557|NCT01767467|79055231|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
44234558|NCT01767467|79055232|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
44234559|NCT01767467|79055231|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
44234560|NCT01767467|79055232|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
44234561|NCT01767467|79055231|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
44234562|NCT01767467|79055232|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
44234563|NCT01767467|79055231|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
44234564|NCT01767467|79055232|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
44234565|NCT01767467|79055231|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
44234566|NCT01767467|79055232|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
44234567|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
44234568|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
44234569|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
44234570|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
44502013|NCT00050960|79507153|FG001|Overall Study|Stable Disease|48|||
44502014|NCT00050960|79507152|FG000|Overall Study|Partial Response|14|||
44502015|NCT00050960|79507153|FG001|Overall Study|Partial Response|19|||
44502016|NCT00050960|79507152|FG000|Overall Study|Complete Response|0|||
44502017|NCT00050960|79507153|FG001|Overall Study|Complete Response|2|||
44502018|NCT00050960|79507152|FG000|Overall Study|Adverse Event|62|||
44502019|NCT00050960|79507153|FG001|Overall Study|Adverse Event|61|||
44502020|NCT00050960|79507152|FG000|Overall Study|Lost to Follow-up|0|||
44502021|NCT00050960|79507153|FG001|Overall Study|Lost to Follow-up|1|||
44502022|NCT00050960|79507152|FG000|Overall Study|Withdrawal by Subject|23|||
44502023|NCT00050960|79507153|FG001|Overall Study|Withdrawal by Subject|18|||
44502024|NCT00050960|79507152|FG000|Overall Study|Administrative|31|||
44502025|NCT00050960|79507153|FG001|Overall Study|Administrative|46|||
44502026|NCT00050960|79507152|FG000|Overall Study|Non-compliance|3|||
44502027|NCT00050960|79507153|FG001|Overall Study|Non-compliance|1|||
44502028|NCT00050960|79507152|FG000|Overall Study|Death|13|||
44502029|NCT00050960|79507153|FG001|Overall Study|Death|15|||
44502030|NCT03456856|79507159|FG000|Overall Study|Lost to Follow-up|2|||
44565452|NCT02820753|79584829|FG001|6 Month|Stopped per NIH Hold|81|||
44565453|NCT02820753|79584828|FG000|6 Month|Death|0|||
44502031|NCT03456856|79507159|FG000|Overall Study|Withdrawal by Subject|1|||
44502032|NCT00058214|79507163|FG000|Overall Study|Adverse Event|1|||
44502033|NCT00097773|79507171|FG000|Overall Study|Lost to Follow-up|2|||
44502034|NCT00097773|79507172|FG001|Overall Study|Lost to Follow-up|2|||
44502035|NCT00097773|79507173|FG002|Overall Study|Lost to Follow-up|0|||
44565454|NCT02820753|79584829|FG001|6 Month|Death|1|||
44565455|NCT02861586|79584843|FG000|Overall Study|Withdrawal by Subject|1|||
44234571|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
44234572|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
44234573|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
44234574|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
44234575|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
44234576|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
44234577|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
44234578|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
44565456|NCT02861586|79584844|FG001|Overall Study|Withdrawal by Subject|2|||
44565457|NCT02861586|79584845|FG002|Overall Study|Withdrawal by Subject|0|||
44565458|NCT02861586|79584846|FG003|Overall Study|Withdrawal by Subject|0|||
44565459|NCT02861586|79584847|FG004|Overall Study|Withdrawal by Subject|0|||
44565460|NCT02861586|79584848|FG005|Overall Study|Withdrawal by Subject|1|||
44565461|NCT02861586|79584849|FG006|Overall Study|Withdrawal by Subject|1|||
44565462|NCT02861586|79584850|FG007|Overall Study|Withdrawal by Subject|0|||
44565463|NCT02861586|79584843|FG000|Overall Study|Lost to Follow-up|3|||
44565464|NCT02861586|79584844|FG001|Overall Study|Lost to Follow-up|1|||
44565465|NCT02861586|79584845|FG002|Overall Study|Lost to Follow-up|1|||
44565466|NCT02861586|79584846|FG003|Overall Study|Lost to Follow-up|0|||
44565467|NCT02861586|79584847|FG004|Overall Study|Lost to Follow-up|0|||
44565468|NCT02861586|79584848|FG005|Overall Study|Lost to Follow-up|3|||
44565469|NCT02861586|79584849|FG006|Overall Study|Lost to Follow-up|0|||
44565470|NCT02861586|79584850|FG007|Overall Study|Lost to Follow-up|0|||
44234579|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
44502036|NCT00097773|79507174|FG003|Overall Study|Lost to Follow-up|1|||
44502037|NCT00097773|79507171|FG000|Overall Study|Physician Decision|2|||
44502038|NCT00097773|79507172|FG001|Overall Study|Physician Decision|2|||
44502039|NCT00097773|79507173|FG002|Overall Study|Physician Decision|3|||
44502040|NCT00097773|79507174|FG003|Overall Study|Physician Decision|1|||
44502041|NCT00097773|79507171|FG000|Overall Study|Withdrawal by Subject|3|||
44502042|NCT00097773|79507172|FG001|Overall Study|Withdrawal by Subject|3|||
44502043|NCT00097773|79507173|FG002|Overall Study|Withdrawal by Subject|3|||
44502044|NCT00097773|79507174|FG003|Overall Study|Withdrawal by Subject|1|||
44502045|NCT00097773|79507171|FG000|Overall Study|Adverse Event|0|||
44502046|NCT00097773|79507172|FG001|Overall Study|Adverse Event|1|||
44502047|NCT00097773|79507173|FG002|Overall Study|Adverse Event|0|||
44565471|NCT02861586|79584843|FG000|Overall Study|Adverse Event|0|||
44565472|NCT02861586|79584844|FG001|Overall Study|Adverse Event|0|||
44565473|NCT02861586|79584845|FG002|Overall Study|Adverse Event|0|||
44565474|NCT02861586|79584846|FG003|Overall Study|Adverse Event|0|||
44565475|NCT02861586|79584847|FG004|Overall Study|Adverse Event|0|||
44565476|NCT02861586|79584848|FG005|Overall Study|Adverse Event|1|||
44565477|NCT02861586|79584849|FG006|Overall Study|Adverse Event|0|||
44565478|NCT02861586|79584850|FG007|Overall Study|Adverse Event|0|||
44565479|NCT03124537|79584893|FG000|Overall Study|Lost to Follow-up|3|||
44565480|NCT03124537|79584894|FG001|Overall Study|Lost to Follow-up|5|||
44565481|NCT03124537|79584893|FG000|Overall Study|App Crash, Incomplete Data|7|||
44565482|NCT03124537|79584894|FG001|Overall Study|App Crash, Incomplete Data|8|||
44565483|NCT03118297|79584902|FG000|Overall Study|Lost to Follow-up|0|||
44565484|NCT03118297|79584903|FG001|Overall Study|Lost to Follow-up|2|||
44565485|NCT03117361|79584909|FG000|Overall Study|Progressive disease|5|||
44565486|NCT03117361|79584909|FG000|Overall Study|Death|1|||
44565487|NCT03117361|79584909|FG000|Overall Study|Physician Decision|2|||
44565488|NCT03117361|79584909|FG000|Overall Study|On study treatment at the end of study|1|||
44565489|NCT03117361|79584909|FG000|Overall Study|Treatment-related adverse event|1|||
44565490|NCT01368614|79584913|FG000|Screening Period|Screen Failure|58|||
44565491|NCT01368614|79584914|FG001|Screening Period|Screen Failure|0|||
44565492|NCT01368614|79584915|FG002|Screening Period|Screen Failure|0|||
44565493|NCT01368614|79584916|FG003|Screening Period|Screen Failure|0|||
44565494|NCT01368614|79584913|FG000|Study Period|Withdrawal by Subject|0|||
44565495|NCT01368614|79584914|FG001|Study Period|Withdrawal by Subject|1|||
44565496|NCT01368614|79584915|FG002|Study Period|Withdrawal by Subject|1|||
44565497|NCT01368614|79584916|FG003|Study Period|Withdrawal by Subject|3|||
44565498|NCT01368614|79584913|FG000|Study Period|Lost to Follow-up|0|||
44565499|NCT01368614|79584914|FG001|Study Period|Lost to Follow-up|0|||
44565500|NCT01368614|79584915|FG002|Study Period|Lost to Follow-up|1|||
44565501|NCT01368614|79584916|FG003|Study Period|Lost to Follow-up|0|||
44234580|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
44234581|NCT01767467|79055231|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
44234582|NCT01767467|79055232|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
44234583|NCT04126083|79055305|FG000|Overall Study|Withdrawal by Subject|1|||
44234584|NCT01766921|79055345|FG000|Overall Study|Administrative Reason|5|||
44234585|NCT01766921|79055346|FG001|Overall Study|Administrative Reason|5|||
44234586|NCT01766921|79055345|FG000|Overall Study|Death|1|||
44234587|NCT01766921|79055346|FG001|Overall Study|Death|1|||
44234588|NCT01766921|79055345|FG000|Overall Study|Lost to Follow-up|1|||
44234589|NCT01766921|79055346|FG001|Overall Study|Lost to Follow-up|3|||
44234590|NCT01766921|79055345|FG000|Overall Study|Unclassified|2|||
44234591|NCT01766921|79055346|FG001|Overall Study|Unclassified|2|||
44234592|NCT01766921|79055345|FG000|Overall Study|Protocol Violation|1|||
44234593|NCT01766921|79055346|FG001|Overall Study|Protocol Violation|1|||
44234594|NCT01766921|79055345|FG000|Overall Study|Withdrawal by Subject|14|||
44234595|NCT01766921|79055346|FG001|Overall Study|Withdrawal by Subject|5|||
44234596|NCT01774799|79055364|FG000|Overall Study|Lost to Follow-up|1|||
44234597|NCT01774799|79055365|FG001|Overall Study|Lost to Follow-up|1|||
44234598|NCT01774799|79055366|FG002|Overall Study|Lost to Follow-up|0|||
44234599|NCT01774799|79055367|FG003|Overall Study|Lost to Follow-up|0|||
44234600|NCT01765751|79055409|FG000|Overall Study|Lost to Follow-up|0|||
44234601|NCT01765751|79055410|FG001|Overall Study|Lost to Follow-up|2|||
44234602|NCT01765751|79055411|FG002|Overall Study|Lost to Follow-up|1|||
44234603|NCT01736657|79055431|FG000|Overall Study|insufficient vascular access|1|||
44234604|NCT01736579|79055446|FG000|Overall Study|Termination of Study by Sponsor|2|||
44234605|NCT01736579|79055447|FG001|Overall Study|Termination of Study by Sponsor|2|||
44234606|NCT01765673|79055478|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
44234607|NCT01764659|79055485|FG000|Overall Study|Death|1|||
44234608|NCT01764659|79055485|FG000|Overall Study|Physician Decision|1|||
44502048|NCT00097773|79507174|FG003|Overall Study|Adverse Event|0|||
44502049|NCT00097773|79507171|FG000|Overall Study|Other|1|||
44502050|NCT00097773|79507172|FG001|Overall Study|Other|0|||
44565502|NCT03053427|79584926|FG000|Overall Study|Adverse Event|4|||
44565503|NCT03053427|79584927|FG001|Overall Study|Adverse Event|4|||
44565504|NCT03053427|79584926|FG000|Overall Study|Lack of Efficacy|1|||
44565505|NCT03053427|79584927|FG001|Overall Study|Lack of Efficacy|3|||
44565506|NCT03053427|79584926|FG000|Overall Study|Lost to Follow-up|2|||
44565507|NCT03053427|79584927|FG001|Overall Study|Lost to Follow-up|2|||
44565508|NCT03053427|79584926|FG000|Overall Study|Worsening of the target disease|0|||
44565509|NCT03053427|79584927|FG001|Overall Study|Worsening of the target disease|1|||
44502051|NCT00097773|79507173|FG002|Overall Study|Other|2|||
44502052|NCT00097773|79507174|FG003|Overall Study|Other|0|||
44502053|NCT03480022|79507191|FG000|Overall Study|Pregnancy|2|||
44502054|NCT03480022|79507192|FG001|Overall Study|Pregnancy|0|||
44502055|NCT03480022|79507191|FG000|Overall Study|Adverse Event|6|||
44502056|NCT03480022|79507192|FG001|Overall Study|Adverse Event|0|||
44502057|NCT03480022|79507191|FG000|Overall Study|Lack of Efficacy|0|||
44502058|NCT03480022|79507192|FG001|Overall Study|Lack of Efficacy|2|||
44502059|NCT03480022|79507191|FG000|Overall Study|Physician Decision|0|||
44502060|NCT03480022|79507192|FG001|Overall Study|Physician Decision|1|||
44502061|NCT03480022|79507191|FG000|Overall Study|Withdrawal by Subject|2|||
44502062|NCT03480022|79507192|FG001|Overall Study|Withdrawal by Subject|0|||
44502063|NCT03480022|79507191|FG000|Overall Study|Medication concerns|1|||
44502064|NCT03480022|79507192|FG001|Overall Study|Medication concerns|0|||
44502065|NCT03480022|79507191|FG000|Overall Study|Family member COVID exposure|0|||
44502066|NCT03480022|79507192|FG001|Overall Study|Family member COVID exposure|1|||
44502067|NCT03533608|79507198|FG000|Overall Study|Withdrawal by Subject|3|||
44502068|NCT03533608|79507198|FG000|Overall Study|Physician Decision|2|||
44502069|NCT00049322|79507205|FG000|Overall Study|disease burden|0|||
44502070|NCT00049322|79507206|FG001|Overall Study|disease burden|3|||
44565510|NCT03053427|79584926|FG000|Overall Study|Protocol Deviation|3|||
44565511|NCT03053427|79584927|FG001|Overall Study|Protocol Deviation|3|||
44234609|NCT01736189|79055491|FG000|Overall Study|Violation of registration criteria|41|||
44234610|NCT01736189|79055491|FG000|Overall Study|Protocol Violation|4|||
44234611|NCT01736189|79055491|FG000|Overall Study|Criteria and protocol violations|1|||
44275731|NCT02227446|79223518|FG001|Overall Study|not eligible post randomization|29|||
44565512|NCT03053427|79584926|FG000|Overall Study|Withdrawal by Subject|3|||
44565513|NCT03053427|79584927|FG001|Overall Study|Withdrawal by Subject|2|||
44565514|NCT03053427|79584926|FG000|Overall Study|Miscellaneous|0|||
44565515|NCT03053427|79584927|FG001|Overall Study|Miscellaneous|1|||
44234612|NCT01735175|79055523|FG000|Overall Study|Withdrawal by Subject|9|||
44234613|NCT01735175|79055524|FG001|Overall Study|Withdrawal by Subject|2|||
44234614|NCT01735175|79055523|FG000|Overall Study|Lost to Follow-up|4|||
44234615|NCT01735175|79055524|FG001|Overall Study|Lost to Follow-up|2|||
44234616|NCT01735175|79055523|FG000|Overall Study|Death|3|||
44234617|NCT01735175|79055524|FG001|Overall Study|Death|2|||
44502071|NCT00049322|79507205|FG000|Overall Study|Adverse Event|1|||
44502072|NCT00049322|79507206|FG001|Overall Study|Adverse Event|0|||
44502073|NCT00049322|79507205|FG000|Overall Study|refused angio|0|||
44234618|NCT01735175|79055523|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
44234619|NCT01735175|79055524|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
44234620|NCT01762943|79055536|FG000|Overall Study|Physician Decision|1|||
44234621|NCT01762943|79055537|FG001|Overall Study|Physician Decision|1|||
44234622|NCT01762943|79055536|FG000|Overall Study|Protocol Violation|1|||
44234623|NCT01762943|79055537|FG001|Overall Study|Protocol Violation|0|||
44234624|NCT01762943|79055536|FG000|Overall Study|Withdrawal by Subject|2|||
44234625|NCT01762943|79055537|FG001|Overall Study|Withdrawal by Subject|1|||
44234626|NCT01734785|79055600|FG000|Open-Label Period|Adverse Event|0|||
44234627|NCT01734785|79055601|FG001|Open-Label Period|Adverse Event|0|||
44234628|NCT01734785|79055602|FG002|Open-Label Period|Adverse Event|0|||
44234629|NCT01734785|79055603|FG003|Open-Label Period|Adverse Event|9|||
44234630|NCT01734785|79055600|FG000|Open-Label Period|Lack of Efficacy|0|||
44234631|NCT01734785|79055601|FG001|Open-Label Period|Lack of Efficacy|0|||
44234632|NCT01734785|79055602|FG002|Open-Label Period|Lack of Efficacy|0|||
44234633|NCT01734785|79055603|FG003|Open-Label Period|Lack of Efficacy|1|||
44275732|NCT02227446|79223517|FG000|Overall Study|Withdrawal by Subject|4|||
44275733|NCT02227446|79223518|FG001|Overall Study|Withdrawal by Subject|5|||
44377318|NCT01067144|79382619|FG001|Follow-up|Death|1|||
44377319|NCT01078298|79382627|FG000|Overall Study|Lost to Follow-up|12|||
44502074|NCT00049322|79507206|FG001|Overall Study|refused angio|3|||
44502075|NCT03437512|79507216|FG000|Randomized|Withdrawal by Subject|0|||
44502076|NCT03437512|79507217|FG001|Randomized|Withdrawal by Subject|2|||
44502077|NCT03437512|79507216|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
44502078|NCT03437512|79507217|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
44502079|NCT00058058|79507223|FG000|Overall Study|Withdrawal by Subject|4|||
44502080|NCT00058058|79507223|FG000|Overall Study|Ineligible|20|||
44502081|NCT00058058|79507223|FG000|Overall Study|Claustrophobic|5|||
44502082|NCT00058058|79507223|FG000|Overall Study|technical issues|6|||
44502083|NCT00058058|79507223|FG000|Overall Study|Poor positioning, illness,pain|3|||
44502084|NCT03532048|79507230|FG000|Overall Study|Lost to Follow-up|12|||
44502085|NCT03532048|79507231|FG001|Overall Study|Lost to Follow-up|17|||
44502086|NCT03532048|79507230|FG000|Overall Study|Withdrawal by Subject|7|||
44502087|NCT03532048|79507231|FG001|Overall Study|Withdrawal by Subject|0|||
44502088|NCT00008138|79507237|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
44502089|NCT00008138|79507237|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
44565516|NCT03052959|79584944|FG000|Overall Study|Lost to Follow-up|4|||
44565517|NCT03052959|79584945|FG001|Overall Study|Lost to Follow-up|5|||
44565518|NCT03120013|79584952|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44565519|NCT03120013|79584953|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
44565520|NCT01845649|79584961|FG000|Overall Study|Adverse Event|7|||
44565521|NCT01845649|79584962|FG001|Overall Study|Adverse Event|10|||
44565522|NCT01845649|79584961|FG000|Overall Study|Lack of Efficacy|1|||
44565523|NCT01845649|79584962|FG001|Overall Study|Lack of Efficacy|1|||
44565524|NCT01845649|79584961|FG000|Overall Study|Lost to Follow-up|2|||
44565525|NCT01845649|79584962|FG001|Overall Study|Lost to Follow-up|2|||
44565526|NCT01845649|79584961|FG000|Overall Study|Withdrew Consent|12|||
44565527|NCT01845649|79584962|FG001|Overall Study|Withdrew Consent|4|||
44565528|NCT01845649|79584961|FG000|Overall Study|Protocol Deviation|7|||
44565529|NCT01845649|79584962|FG001|Overall Study|Protocol Deviation|4|||
44565530|NCT01845649|79584961|FG000|Overall Study|Reason not Specified|2|||
44565531|NCT01845649|79584962|FG001|Overall Study|Reason not Specified|1|||
44565532|NCT01345929|79584970|FG000|Overall Study|Withdrawal by Subject|9|||
44565533|NCT01345929|79584971|FG001|Overall Study|Withdrawal by Subject|8|||
44565534|NCT01345929|79584970|FG000|Overall Study|Lost to Follow-up|9|||
44565535|NCT01345929|79584971|FG001|Overall Study|Lost to Follow-up|9|||
44565536|NCT01345929|79584970|FG000|Overall Study|Adverse Event|0|||
44565537|NCT01345929|79584971|FG001|Overall Study|Adverse Event|1|||
44565538|NCT01345929|79584970|FG000|Overall Study|Didn't meet eligibility criteria|2|||
44565539|NCT01345929|79584971|FG001|Overall Study|Didn't meet eligibility criteria|0|||
44565540|NCT01345929|79584970|FG000|Overall Study|40,000 CFU/ML|1|||
44565541|NCT01345929|79584971|FG001|Overall Study|40,000 CFU/ML|0|||
44502090|NCT00008138|79507237|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
44502091|NCT00008138|79507237|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
44502092|NCT00008138|79507237|FG000|Interval Debulking|Withdrawal by Subject|2|||
44565542|NCT01345929|79584970|FG000|Overall Study|Patient withdrawal|0|||
44565543|NCT01345929|79584971|FG001|Overall Study|Patient withdrawal|1|||
44565544|NCT01343901|79584977|FG000|Overall Study|Death|85|||
44565545|NCT01343901|79584977|FG000|Overall Study|Physician Decision|4|||
44565546|NCT01343901|79584977|FG000|Overall Study|Lost to Follow-up|12|||
44234634|NCT01734785|79055600|FG000|Open-Label Period|Protocol Violation|0|||
44234635|NCT01734785|79055601|FG001|Open-Label Period|Protocol Violation|0|||
44275734|NCT02227368|79223526|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
44275735|NCT02227368|79223527|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
44377320|NCT01078298|79382628|FG001|Overall Study|Lost to Follow-up|13|||
44565547|NCT01343901|79584977|FG000|Overall Study|Management by another medical team|11|||
44565548|NCT01343901|79584977|FG000|Overall Study|Participant decision|1|||
44565549|NCT03053271|79584981|FG000|Overall Study|Did not meet randomization criteria|3|||
44565550|NCT03053271|79584981|FG000|Overall Study|Withdrawal by Subject|1|||
44565551|NCT01343823|79584989|FG000|Overall Study|Study Terminated|1|||
44565552|NCT01343823|79584990|FG001|Overall Study|Study Terminated|0|||
44565553|NCT01343823|79584991|FG002|Overall Study|Study Terminated|0|||
44565554|NCT01343823|79584992|FG003|Overall Study|Study Terminated|1|||
44565555|NCT01343823|79584989|FG000|Overall Study|Withdrawal by Subject|1|||
44565556|NCT01343823|79584990|FG001|Overall Study|Withdrawal by Subject|0|||
44565557|NCT01343823|79584991|FG002|Overall Study|Withdrawal by Subject|0|||
44565558|NCT01343823|79584992|FG003|Overall Study|Withdrawal by Subject|0|||
44565559|NCT01318083|79585005|FG000|Overall Study|Adverse Event|4|||
44565560|NCT01318083|79585006|FG001|Overall Study|Adverse Event|1|||
44565561|NCT01318083|79585007|FG002|Overall Study|Adverse Event|2|||
44565562|NCT01318083|79585005|FG000|Overall Study|Withdrawal by Subject|1|||
44565563|NCT01318083|79585006|FG001|Overall Study|Withdrawal by Subject|0|||
44565564|NCT01318083|79585007|FG002|Overall Study|Withdrawal by Subject|2|||
44565565|NCT01318083|79585005|FG000|Overall Study|Lack of Efficacy|0|||
44565566|NCT01318083|79585006|FG001|Overall Study|Lack of Efficacy|0|||
44565567|NCT01318083|79585007|FG002|Overall Study|Lack of Efficacy|1|||
44565568|NCT01318083|79585005|FG000|Overall Study|Treatment Complications|1|||
44565569|NCT01318083|79585006|FG001|Overall Study|Treatment Complications|0|||
44565570|NCT01318083|79585007|FG002|Overall Study|Treatment Complications|0|||
44565571|NCT01318083|79585005|FG000|Overall Study|Lack of Study Medication Compliance|0|||
44565572|NCT01318083|79585006|FG001|Overall Study|Lack of Study Medication Compliance|1|||
44565573|NCT01318083|79585007|FG002|Overall Study|Lack of Study Medication Compliance|0|||
44565574|NCT01376323|79585020|FG000|Overall Study|Adverse Event|1|||
44565575|NCT01376323|79585021|FG001|Overall Study|Adverse Event|0|||
44565576|NCT01376323|79585022|FG002|Overall Study|Adverse Event|0|||
44565577|NCT01376323|79585023|FG003|Overall Study|Adverse Event|2|||
44565578|NCT01376323|79585024|FG004|Overall Study|Adverse Event|0|||
44565579|NCT01376323|79585020|FG000|Overall Study|Lost to Follow-up|0|||
44565580|NCT01376323|79585021|FG001|Overall Study|Lost to Follow-up|0|||
44565581|NCT01376323|79585022|FG002|Overall Study|Lost to Follow-up|0|||
44565582|NCT01376323|79585023|FG003|Overall Study|Lost to Follow-up|2|||
44565583|NCT01376323|79585024|FG004|Overall Study|Lost to Follow-up|0|||
44565584|NCT01376323|79585020|FG000|Overall Study|Physician Decision|1|||
44565585|NCT01376323|79585021|FG001|Overall Study|Physician Decision|0|||
44565586|NCT01376323|79585022|FG002|Overall Study|Physician Decision|2|||
44565587|NCT01376323|79585023|FG003|Overall Study|Physician Decision|1|||
44565588|NCT01376323|79585024|FG004|Overall Study|Physician Decision|1|||
44565589|NCT01376323|79585020|FG000|Overall Study|Withdrawal by Subject|0|||
44565590|NCT01376323|79585021|FG001|Overall Study|Withdrawal by Subject|1|||
44565591|NCT01376323|79585022|FG002|Overall Study|Withdrawal by Subject|1|||
44565592|NCT01376323|79585023|FG003|Overall Study|Withdrawal by Subject|0|||
44565593|NCT01376323|79585024|FG004|Overall Study|Withdrawal by Subject|0|||
44565594|NCT03725293|79585061|FG000|Overall Study|Physician Decision|9|||
44565595|NCT03725293|79585062|FG001|Overall Study|Physician Decision|6|||
44565596|NCT03725293|79585061|FG000|Overall Study|alternative vascular access needs|1|||
44565597|NCT03725293|79585062|FG001|Overall Study|alternative vascular access needs|2|||
44565598|NCT03725293|79585061|FG000|Overall Study|venous anatomy screen failures|2|||
44565599|NCT03725293|79585062|FG001|Overall Study|venous anatomy screen failures|1|||
44502093|NCT00008138|79507237|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
44502094|NCT00008138|79507237|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
44502095|NCT00008138|79507237|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
44502096|NCT03436732|79507244|FG000|Overall Study|Not treated-enrolled in different study|1|||
44502097|NCT03436732|79507245|FG001|Overall Study|Not treated-enrolled in different study|0|||
44502098|NCT03436732|79507244|FG000|Overall Study|Off study after cycle 1|1|||
44502099|NCT03436732|79507245|FG001|Overall Study|Off study after cycle 1|0|||
44502100|NCT03436732|79507244|FG000|Overall Study|Adverse Event|2|||
44502101|NCT03436732|79507245|FG001|Overall Study|Adverse Event|0|||
44502102|NCT03436732|79507244|FG000|Overall Study|Death|0|||
44502103|NCT03436732|79507245|FG001|Overall Study|Death|1|||
44502104|NCT03436420|79507252|FG000|Overall Study|Lack of Efficacy|3|||
44502105|NCT00027560|79507256|FG000|Overall Study|Withdrawal by Subject|1|||
44502106|NCT03451084|79507266|FG000|Overall Study|Withdrawal by Subject|2|||
44502107|NCT03451084|79507267|FG001|Overall Study|Withdrawal by Subject|1|||
44502108|NCT03451084|79507268|FG002|Overall Study|Withdrawal by Subject|2|||
44565600|NCT01368536|79585071|FG000|Overall Study|Adverse Event|5|||
44565601|NCT01368536|79585072|FG001|Overall Study|Adverse Event|6|||
44502109|NCT03451084|79507269|FG003|Overall Study|Withdrawal by Subject|1|||
44565602|NCT01368536|79585073|FG002|Overall Study|Adverse Event|8|||
44565603|NCT01368536|79585071|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44565604|NCT01368536|79585072|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44565605|NCT01368536|79585073|FG002|Overall Study|Abnormal laboratory value(s)|2|||
44565606|NCT01368536|79585071|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44565607|NCT01368536|79585072|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44565608|NCT01368536|79585073|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44565609|NCT01368536|79585071|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
44565610|NCT01368536|79585072|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44565611|NCT01368536|79585073|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44565612|NCT01368536|79585071|FG000|Overall Study|No longer required study medication|0|||
44565613|NCT01368536|79585072|FG001|Overall Study|No longer required study medication|0|||
44565614|NCT01368536|79585073|FG002|Overall Study|No longer required study medication|1|||
44565615|NCT01368536|79585071|FG000|Overall Study|Withdrawal by Subject|2|||
44565616|NCT01368536|79585072|FG001|Overall Study|Withdrawal by Subject|5|||
44565617|NCT01368536|79585073|FG002|Overall Study|Withdrawal by Subject|4|||
44565618|NCT01368536|79585071|FG000|Overall Study|Lost to Follow-up|3|||
44565619|NCT01368536|79585072|FG001|Overall Study|Lost to Follow-up|3|||
44565620|NCT01368536|79585073|FG002|Overall Study|Lost to Follow-up|5|||
44565621|NCT01368536|79585071|FG000|Overall Study|Administrative problems|34|||
44565622|NCT01368536|79585072|FG001|Overall Study|Administrative problems|39|||
44565623|NCT01368536|79585073|FG002|Overall Study|Administrative problems|35|||
44565624|NCT01368536|79585071|FG000|Overall Study|Protocol deviation|0|||
44565625|NCT01368536|79585072|FG001|Overall Study|Protocol deviation|3|||
44565626|NCT01368536|79585073|FG002|Overall Study|Protocol deviation|1|||
44565627|NCT03051165|79585082|FG000|Overall Study|Withdrawal by Subject|1|||
44565628|NCT03051165|79585082|FG000|Overall Study|Early termination of study|12|||
44565629|NCT01319929|79585088|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
44565630|NCT01319929|79585089|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
44565631|NCT01319929|79585088|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
44565632|NCT01319929|79585089|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
44565633|NCT01319929|79585088|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
44565634|NCT01319929|79585089|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
44565635|NCT01319929|79585088|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
44565636|NCT01319929|79585089|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
44565637|NCT01319929|79585088|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
44565638|NCT01319929|79585089|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
44565639|NCT03110185|79585098|FG000|Overall Study|Death|0|||
44565640|NCT03110185|79585099|FG001|Overall Study|Death|1|||
44565641|NCT03110185|79585098|FG000|Overall Study|Withdrawal by Subject|2|||
44565642|NCT03110185|79585099|FG001|Overall Study|Withdrawal by Subject|7|||
44565643|NCT03110185|79585098|FG000|Overall Study|Time Constraints|0|||
44565644|NCT03110185|79585099|FG001|Overall Study|Time Constraints|6|||
44565645|NCT03110185|79585098|FG000|Overall Study|Conflict with care|5|||
44565646|NCT03110185|79585099|FG001|Overall Study|Conflict with care|12|||
44565647|NCT03110185|79585098|FG000|Overall Study|Protocol Violation|1|||
44565648|NCT03110185|79585099|FG001|Overall Study|Protocol Violation|4|||
44565649|NCT03110185|79585098|FG000|Overall Study|MRI Incompatible|2|||
44565650|NCT03110185|79585099|FG001|Overall Study|MRI Incompatible|0|||
44502110|NCT03451084|79507266|FG000|Overall Study|Disease recurrence|0|||
44502111|NCT03451084|79507267|FG001|Overall Study|Disease recurrence|2|||
44502112|NCT03451084|79507268|FG002|Overall Study|Disease recurrence|0|||
44502113|NCT03451084|79507269|FG003|Overall Study|Disease recurrence|0|||
44502114|NCT03451084|79507266|FG000|Overall Study|Lack of Efficacy|0|||
44502115|NCT03451084|79507267|FG001|Overall Study|Lack of Efficacy|3|||
44502116|NCT03451084|79507268|FG002|Overall Study|Lack of Efficacy|0|||
44502117|NCT03451084|79507269|FG003|Overall Study|Lack of Efficacy|1|||
44502118|NCT03451084|79507266|FG000|Overall Study|Death|1|||
44502119|NCT03451084|79507267|FG001|Overall Study|Death|0|||
44502120|NCT03451084|79507268|FG002|Overall Study|Death|2|||
44502121|NCT03451084|79507269|FG003|Overall Study|Death|0|||
44502122|NCT03451084|79507266|FG000|Overall Study|Physician Decision|0|||
44502123|NCT03451084|79507267|FG001|Overall Study|Physician Decision|0|||
44502124|NCT03451084|79507268|FG002|Overall Study|Physician Decision|2|||
44565651|NCT03110185|79585098|FG000|Overall Study|Patient Refusal|0|||
44565652|NCT03110185|79585099|FG001|Overall Study|Patient Refusal|1|||
44565653|NCT02858076|79585110|FG000|Overall Study|Death|6|||
44565654|NCT02858076|79585111|FG001|Overall Study|Death|3|||
44565655|NCT02858076|79585110|FG000|Overall Study|Withdrawal by Subject|1|||
44502125|NCT03451084|79507269|FG003|Overall Study|Physician Decision|2|||
44502126|NCT03451084|79507266|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
44234636|NCT01734785|79055602|FG002|Open-Label Period|Protocol Violation|0|||
44234637|NCT01734785|79055603|FG003|Open-Label Period|Protocol Violation|13|||
44234638|NCT01734785|79055600|FG000|Open-Label Period|Lost to Follow-up|0|||
44234639|NCT01734785|79055601|FG001|Open-Label Period|Lost to Follow-up|0|||
44234640|NCT01734785|79055602|FG002|Open-Label Period|Lost to Follow-up|0|||
44234641|NCT01734785|79055603|FG003|Open-Label Period|Lost to Follow-up|14|||
44234642|NCT01734785|79055600|FG000|Open-Label Period|Withdrawal by Subject|0|||
44234643|NCT01734785|79055601|FG001|Open-Label Period|Withdrawal by Subject|0|||
44234644|NCT01734785|79055602|FG002|Open-Label Period|Withdrawal by Subject|0|||
44234645|NCT01734785|79055603|FG003|Open-Label Period|Withdrawal by Subject|12|||
44565656|NCT02858076|79585111|FG001|Overall Study|Withdrawal by Subject|5|||
44234646|NCT01734785|79055600|FG000|Open-Label Period|Other Reasons|0|||
44234647|NCT01734785|79055601|FG001|Open-Label Period|Other Reasons|0|||
44234648|NCT01734785|79055602|FG002|Open-Label Period|Other Reasons|0|||
44234649|NCT01734785|79055603|FG003|Open-Label Period|Other Reasons|224|||
44234650|NCT01734785|79055600|FG000|Double-Blind Period|Adverse Event|0|||
44502127|NCT03451084|79507267|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
44502128|NCT03451084|79507268|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
44502129|NCT03451084|79507269|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
44502130|NCT03451006|79507281|FG000|Overall Study|Withdrawal by Subject|2|||
44502131|NCT03451006|79507282|FG001|Overall Study|Withdrawal by Subject|2|||
44502132|NCT03450070|79507288|FG000|Overall Study|Withdrawal by Subject|8|||
44502133|NCT03449758|79507292|FG000|Overall Study|Major protocol deviation|1|||
44502134|NCT03449758|79507292|FG000|Overall Study|Treatment inefficacy|5|||
44565657|NCT02858076|79585110|FG000|Overall Study|Lost to Follow-up|2|||
44565658|NCT02858076|79585111|FG001|Overall Study|Lost to Follow-up|7|||
44275736|NCT02227368|79223526|FG000|Overall Study|Lost to Follow-up|1|||
44234651|NCT01734785|79055601|FG001|Double-Blind Period|Adverse Event|3|||
44234652|NCT01734785|79055602|FG002|Double-Blind Period|Adverse Event|2|||
44565659|NCT02858076|79585110|FG000|Overall Study|Completed Out of Window|1|||
44565660|NCT02858076|79585111|FG001|Overall Study|Completed Out of Window|3|||
44565661|NCT04594759|79585119|FG000|Overall Study|Lost to Follow-up|3|||
44565662|NCT02856282|79585123|FG000|Overall Study|Withdrawal by Subject|1|||
44565663|NCT03833817|79585129|FG000|Overall Study|Withdrawal by Subject|3|||
44565664|NCT03833817|79585130|FG001|Overall Study|Withdrawal by Subject|3|||
44565665|NCT03833817|79585129|FG000|Overall Study|Lost to Follow-up|3|||
44565666|NCT03833817|79585130|FG001|Overall Study|Lost to Follow-up|3|||
44565667|NCT03119701|79585138|FG000|6-day Dosing|Death|4|||
44565668|NCT03119701|79585139|FG001|6-day Dosing|Death|1|||
44565669|NCT03119701|79585138|FG000|6-day Dosing|Adverse Event|3|||
44565670|NCT03119701|79585139|FG001|6-day Dosing|Adverse Event|0|||
44565671|NCT03119701|79585138|FG000|6-day Dosing|Physician Decision|0|||
44565672|NCT03119701|79585139|FG001|6-day Dosing|Physician Decision|1|||
44565673|NCT03119701|79585138|FG000|6-day Dosing|Withdrawal by Subject|0|||
44565674|NCT03119701|79585139|FG001|6-day Dosing|Withdrawal by Subject|1|||
44565675|NCT03119701|79585138|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
44565676|NCT03119701|79585139|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
44565677|NCT02679781|79585153|FG000|Overall Study|Lost to Follow-up|1|||
44565678|NCT02679781|79585154|FG001|Overall Study|Lost to Follow-up|2|||
44565679|NCT02679781|79585153|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
44565680|NCT02679781|79585154|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
44565681|NCT03110029|79585171|FG000|Overall Study|Withdrawal by Subject|1|||
44565682|NCT03110029|79585172|FG001|Overall Study|Withdrawal by Subject|1|||
44565683|NCT04207749|79585180|FG000|Overall Study|Lost to Follow-up|0|||
44565684|NCT04207749|79585181|FG001|Overall Study|Lost to Follow-up|2|||
44565685|NCT04207749|79585180|FG000|Overall Study|Protocol Violation|0|||
44565686|NCT04207749|79585181|FG001|Overall Study|Protocol Violation|1|||
44565687|NCT04207749|79585180|FG000|Overall Study|Withdrawal by Subject|3|||
44565688|NCT04207749|79585181|FG001|Overall Study|Withdrawal by Subject|0|||
44565689|NCT04207749|79585180|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
44565690|NCT04207749|79585181|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
44565691|NCT03043365|79585192|FG000|Weeks 0 to Week 8|Adverse Event|1|||
44502135|NCT03449758|79507292|FG000|Overall Study|Adverse Event|9|||
44502136|NCT03449758|79507292|FG000|Overall Study|Consent withdrawal|1|||
44502137|NCT03449758|79507292|FG000|Overall Study|Other unspecified reason|3|||
44502138|NCT03449446|79507304|FG000|Overall Study|Randomized but Never Treated|0|||
44502139|NCT03449446|79507305|FG001|Overall Study|Randomized but Never Treated|0|||
44502140|NCT03449446|79507306|FG002|Overall Study|Randomized but Never Treated|1|||
44502141|NCT03449446|79507307|FG003|Overall Study|Randomized but Never Treated|1|||
44502142|NCT03449446|79507308|FG004|Overall Study|Randomized but Never Treated|1|||
44502143|NCT03449446|79507309|FG005|Overall Study|Randomized but Never Treated|0|||
44502144|NCT03449446|79507310|FG006|Overall Study|Randomized but Never Treated|0|||
44502145|NCT03449446|79507304|FG000|Overall Study|Unknown Reason|33|||
44502146|NCT03449446|79507305|FG001|Overall Study|Unknown Reason|1|||
44502147|NCT03449446|79507306|FG002|Overall Study|Unknown Reason|1|||
44502148|NCT03449446|79507307|FG003|Overall Study|Unknown Reason|1|||
44502149|NCT03449446|79507308|FG004|Overall Study|Unknown Reason|2|||
44502150|NCT03449446|79507309|FG005|Overall Study|Unknown Reason|2|||
44502151|NCT03449446|79507310|FG006|Overall Study|Unknown Reason|0|||
44502152|NCT03449446|79507304|FG000|Overall Study|Withdrew Consent|1|||
44502153|NCT03449446|79507305|FG001|Overall Study|Withdrew Consent|3|||
44502154|NCT03449446|79507306|FG002|Overall Study|Withdrew Consent|1|||
44502155|NCT03449446|79507307|FG003|Overall Study|Withdrew Consent|4|||
44502156|NCT03449446|79507308|FG004|Overall Study|Withdrew Consent|4|||
44502157|NCT03449446|79507309|FG005|Overall Study|Withdrew Consent|4|||
44502158|NCT03449446|79507310|FG006|Overall Study|Withdrew Consent|1|||
44502159|NCT03449446|79507304|FG000|Overall Study|Adverse Event|1|||
44502160|NCT03449446|79507305|FG001|Overall Study|Adverse Event|2|||
44502161|NCT03449446|79507306|FG002|Overall Study|Adverse Event|1|||
44502162|NCT03449446|79507307|FG003|Overall Study|Adverse Event|0|||
44502163|NCT03449446|79507308|FG004|Overall Study|Adverse Event|0|||
44502164|NCT03449446|79507309|FG005|Overall Study|Adverse Event|2|||
44502165|NCT03449446|79507310|FG006|Overall Study|Adverse Event|0|||
44502166|NCT03449446|79507304|FG000|Overall Study|Lost to Follow-up|0|||
44502167|NCT03449446|79507305|FG001|Overall Study|Lost to Follow-up|0|||
44502168|NCT03449446|79507306|FG002|Overall Study|Lost to Follow-up|2|||
44502169|NCT03449446|79507307|FG003|Overall Study|Lost to Follow-up|1|||
44502170|NCT03449446|79507308|FG004|Overall Study|Lost to Follow-up|3|||
44502171|NCT03449446|79507309|FG005|Overall Study|Lost to Follow-up|0|||
44502172|NCT03449446|79507310|FG006|Overall Study|Lost to Follow-up|0|||
44502173|NCT03449446|79507304|FG000|Overall Study|Investigator's Discretion|0|||
44502174|NCT03449446|79507305|FG001|Overall Study|Investigator's Discretion|1|||
44502175|NCT03449446|79507306|FG002|Overall Study|Investigator's Discretion|1|||
44502176|NCT03449446|79507307|FG003|Overall Study|Investigator's Discretion|2|||
44502177|NCT03449446|79507308|FG004|Overall Study|Investigator's Discretion|0|||
44502178|NCT03449446|79507309|FG005|Overall Study|Investigator's Discretion|0|||
44502179|NCT03449446|79507310|FG006|Overall Study|Investigator's Discretion|0|||
44502180|NCT03449446|79507304|FG000|Overall Study|Non Compliance with Study Drug|1|||
44502181|NCT03449446|79507305|FG001|Overall Study|Non Compliance with Study Drug|0|||
44565692|NCT03043365|79585193|FG001|Weeks 0 to Week 8|Adverse Event|3|||
44565693|NCT03043365|79585192|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
44502182|NCT03449446|79507306|FG002|Overall Study|Non Compliance with Study Drug|0|||
44502183|NCT03449446|79507307|FG003|Overall Study|Non Compliance with Study Drug|0|||
44502184|NCT03449446|79507308|FG004|Overall Study|Non Compliance with Study Drug|0|||
44502185|NCT03449446|79507309|FG005|Overall Study|Non Compliance with Study Drug|0|||
44502186|NCT03449446|79507310|FG006|Overall Study|Non Compliance with Study Drug|0|||
44502187|NCT03449446|79507304|FG000|Overall Study|Protocol Violation|0|||
44502188|NCT03449446|79507305|FG001|Overall Study|Protocol Violation|0|||
44502189|NCT03449446|79507306|FG002|Overall Study|Protocol Violation|0|||
44565694|NCT03043365|79585193|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
44565695|NCT03043365|79585192|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
44565696|NCT03043365|79585193|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
44565697|NCT03108157|79585203|FG000|Overall Study|Protocol Violation|15|||
44565698|NCT03108157|79585204|FG001|Overall Study|Protocol Violation|4|||
44502190|NCT03449446|79507307|FG003|Overall Study|Protocol Violation|0|||
44502191|NCT03449446|79507308|FG004|Overall Study|Protocol Violation|1|||
44502192|NCT03449446|79507309|FG005|Overall Study|Protocol Violation|1|||
44502193|NCT03449446|79507310|FG006|Overall Study|Protocol Violation|0|||
44502194|NCT03449446|79507304|FG000|Overall Study|Death|0|||
44502195|NCT03449446|79507305|FG001|Overall Study|Death|0|||
44565699|NCT04421131|79585211|FG000|Overall Study|Lost to Follow-up|1|||
44565700|NCT04421131|79585211|FG000|Overall Study|Protocol Violation|2|||
44565701|NCT04421131|79585211|FG000|Overall Study|App crashed|5|||
44565702|NCT04167345|79585220|FG000|Overall Study|Other|1|||
44565703|NCT04167345|79585221|FG001|Overall Study|Other|1|||
44565704|NCT04167345|79585222|FG002|Overall Study|Other|0|||
44565705|NCT04167345|79585223|FG003|Overall Study|Other|0|||
44565706|NCT04167345|79585224|FG004|Overall Study|Other|0|||
44234653|NCT01734785|79055603|FG003|Double-Blind Period|Adverse Event|0|||
44234654|NCT01734785|79055600|FG000|Double-Blind Period|Lack of Efficacy|0|||
44234655|NCT01734785|79055601|FG001|Double-Blind Period|Lack of Efficacy|1|||
44234656|NCT01734785|79055602|FG002|Double-Blind Period|Lack of Efficacy|0|||
44234657|NCT01734785|79055603|FG003|Double-Blind Period|Lack of Efficacy|0|||
44234658|NCT01734785|79055600|FG000|Double-Blind Period|Protocol Violation|0|||
44234659|NCT01734785|79055601|FG001|Double-Blind Period|Protocol Violation|1|||
44234660|NCT01734785|79055602|FG002|Double-Blind Period|Protocol Violation|1|||
44234661|NCT01734785|79055603|FG003|Double-Blind Period|Protocol Violation|0|||
44234662|NCT01734785|79055600|FG000|Double-Blind Period|Lost to Follow-up|2|||
44234663|NCT01734785|79055601|FG001|Double-Blind Period|Lost to Follow-up|4|||
44234664|NCT01734785|79055602|FG002|Double-Blind Period|Lost to Follow-up|2|||
44234665|NCT01734785|79055603|FG003|Double-Blind Period|Lost to Follow-up|0|||
44234666|NCT01734785|79055600|FG000|Double-Blind Period|Withdrawal by Subject|2|||
44234667|NCT01734785|79055601|FG001|Double-Blind Period|Withdrawal by Subject|0|||
44234668|NCT01734785|79055602|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44234669|NCT01734785|79055603|FG003|Double-Blind Period|Withdrawal by Subject|0|||
44234670|NCT01734785|79055600|FG000|Double-Blind Period|Not treated|1|||
44234671|NCT01734785|79055601|FG001|Double-Blind Period|Not treated|0|||
44234672|NCT01734785|79055602|FG002|Double-Blind Period|Not treated|0|||
44234673|NCT01734785|79055603|FG003|Double-Blind Period|Not treated|0|||
44234674|NCT01734395|79055612|FG000|Overall Study|Other|65|||
44234675|NCT01734395|79055612|FG000|Overall Study|Lost to Follow-up|287|||
44234676|NCT01734395|79055612|FG000|Overall Study|Lack of Efficacy|5|||
44234677|NCT01734395|79055612|FG000|Overall Study|Adverse Event|40|||
44234678|NCT01734395|79055612|FG000|Overall Study|Withdrawal by Subject|10|||
44234679|NCT01734395|79055612|FG000|Overall Study|Missing the reasons for not completed|3|||
44234680|NCT01597505|79055646|FG000|Overall Study|Physician Decision|5|||
44234681|NCT01597505|79055647|FG001|Overall Study|Physician Decision|0|||
44234682|NCT01597505|79055646|FG000|Overall Study|Adverse Event|19|||
44234683|NCT01597505|79055647|FG001|Overall Study|Adverse Event|7|||
44234684|NCT01597505|79055646|FG000|Overall Study|Lost to Follow-up|4|||
44234685|NCT01597505|79055647|FG001|Overall Study|Lost to Follow-up|2|||
44234686|NCT01597505|79055646|FG000|Overall Study|Withdrawal by Subject|10|||
44234687|NCT01597505|79055647|FG001|Overall Study|Withdrawal by Subject|18|||
44502196|NCT03449446|79507306|FG002|Overall Study|Death|0|||
44502197|NCT03449446|79507307|FG003|Overall Study|Death|0|||
44502198|NCT03449446|79507308|FG004|Overall Study|Death|1|||
44502199|NCT03449446|79507309|FG005|Overall Study|Death|0|||
44502200|NCT03449446|79507310|FG006|Overall Study|Death|0|||
44565707|NCT02854800|79585243|FG000|Overall Study|Protocol Violation|16|||
44565708|NCT02854800|79585244|FG001|Overall Study|Protocol Violation|11|||
44565709|NCT02854800|79585245|FG002|Overall Study|Protocol Violation|3|||
44565710|NCT02854800|79585243|FG000|Overall Study|Withdrawal by Subject|4|||
44234688|NCT01597505|79055646|FG000|Overall Study|Other|5|||
44234689|NCT01597505|79055647|FG001|Overall Study|Other|6|||
44565711|NCT02854800|79585244|FG001|Overall Study|Withdrawal by Subject|2|||
44565712|NCT02854800|79585245|FG002|Overall Study|Withdrawal by Subject|3|||
44234690|NCT01597505|79055646|FG000|Overall Study|Missing|1|||
44234691|NCT01597505|79055647|FG001|Overall Study|Missing|0|||
44234692|NCT01760447|79055686|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
44234693|NCT01760447|79055687|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
44234694|NCT01760447|79055688|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
44234695|NCT01760447|79055689|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
44502201|NCT03449134|79507329|FG000|52-Week Treatment Period|Death|2|||
44502202|NCT03449134|79507330|FG001|52-Week Treatment Period|Death|1|||
44234696|NCT01760447|79055686|FG000|Weeks 0-20|Withdrawal by Subject|2|||
44234697|NCT01760447|79055687|FG001|Weeks 0-20|Withdrawal by Subject|0|||
44234698|NCT01760447|79055688|FG002|Weeks 0-20|Withdrawal by Subject|1|||
44502203|NCT03449134|79507331|FG002|52-Week Treatment Period|Death|0|||
44502204|NCT03449134|79507329|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
44502205|NCT03449134|79507330|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
44565713|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
44565714|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
44565715|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
44565716|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Adverse Event|5|||
44565717|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Adverse Event|1|||
44565718|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Adverse Event|0|||
44565719|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
44565720|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
44565721|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
44565722|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Death|8|||
44565723|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Death|24|||
44565724|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Death|0|||
44565725|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
44565726|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
44565727|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
44565728|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
44565729|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
44565730|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
44565731|NCT02931539|79585258|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
44565732|NCT02931539|79585259|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
44565733|NCT02931539|79585260|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
44565734|NCT02931539|79585258|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
44565735|NCT02931539|79585259|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
44565736|NCT02931539|79585260|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
44565737|NCT04042077|79585277|FG000|Overall Study|Adverse Event|0|||
44502206|NCT03449134|79507331|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
44502207|NCT03449134|79507329|FG000|52-Week Treatment Period|Physician Decision|2|||
44502208|NCT03449134|79507330|FG001|52-Week Treatment Period|Physician Decision|3|||
44502209|NCT03449134|79507331|FG002|52-Week Treatment Period|Physician Decision|3|||
44502210|NCT03449134|79507329|FG000|52-Week Treatment Period|Screen Failure|1|||
44502211|NCT03449134|79507330|FG001|52-Week Treatment Period|Screen Failure|0|||
44502212|NCT03449134|79507331|FG002|52-Week Treatment Period|Screen Failure|1|||
44565738|NCT04042077|79585278|FG001|Overall Study|Adverse Event|1|||
44565739|NCT04042077|79585277|FG000|Overall Study|Death|2|||
44565740|NCT04042077|79585278|FG001|Overall Study|Death|1|||
44565741|NCT04042077|79585277|FG000|Overall Study|Physician Decision|2|||
44565742|NCT04042077|79585278|FG001|Overall Study|Physician Decision|0|||
44234699|NCT01760447|79055689|FG003|Weeks 0-20|Withdrawal by Subject|0|||
44234700|NCT01760447|79055686|FG000|Weeks 0-20|Lost to Follow-up|1|||
44502213|NCT03449134|79507329|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
44565743|NCT04042077|79585277|FG000|Overall Study|Withdrawal by Subject|3|||
44234701|NCT01760447|79055687|FG001|Weeks 0-20|Lost to Follow-up|0|||
44234702|NCT01760447|79055688|FG002|Weeks 0-20|Lost to Follow-up|1|||
44234703|NCT01760447|79055689|FG003|Weeks 0-20|Lost to Follow-up|1|||
44234704|NCT01760447|79055686|FG000|Weeks 0-20|Randomized but not treated|0|||
44234705|NCT01760447|79055687|FG001|Weeks 0-20|Randomized but not treated|0|||
44234706|NCT01760447|79055688|FG002|Weeks 0-20|Randomized but not treated|2|||
44234707|NCT01760447|79055689|FG003|Weeks 0-20|Randomized but not treated|0|||
44234708|NCT01760447|79055686|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
44234709|NCT01760447|79055687|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
44234710|NCT01760447|79055688|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
44234711|NCT01760447|79055689|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
44234712|NCT01760447|79055686|FG000|Weeks 20-54|Withdrawal by Subject|2|||
44234713|NCT01760447|79055687|FG001|Weeks 20-54|Withdrawal by Subject|1|||
44234714|NCT01760447|79055688|FG002|Weeks 20-54|Withdrawal by Subject|1|||
44234715|NCT01760447|79055689|FG003|Weeks 20-54|Withdrawal by Subject|2|||
44234716|NCT01760447|79055686|FG000|Weeks 20-54|Lost to Follow-up|0|||
44234717|NCT01760447|79055687|FG001|Weeks 20-54|Lost to Follow-up|0|||
44234718|NCT01760447|79055688|FG002|Weeks 20-54|Lost to Follow-up|1|||
44565744|NCT04042077|79585278|FG001|Overall Study|Withdrawal by Subject|2|||
44565745|NCT04042077|79585277|FG000|Overall Study|Lack of Efficacy|0|||
44565746|NCT04042077|79585278|FG001|Overall Study|Lack of Efficacy|1|||
44565747|NCT02853318|79585299|FG000|Overall Study|Withdrawal by Subject|1|||
44565748|NCT03113071|79585309|FG000|Overall Study|Withdrawal by Subject|1|||
44565749|NCT03113071|79585310|FG001|Overall Study|Withdrawal by Subject|0|||
44565750|NCT03050307|79585318|FG000|Overall Study|Adverse Event|4|||
44565751|NCT03050307|79585319|FG001|Overall Study|Adverse Event|2|||
44275737|NCT02227368|79223527|FG001|Overall Study|Lost to Follow-up|0|||
44275738|NCT02227368|79223526|FG000|Overall Study|Adverse Event|1|||
44502214|NCT03449134|79507330|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
44502215|NCT03449134|79507331|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
44502216|NCT03449134|79507329|FG000|52-Week Treatment Period|Site Closure|1|||
44502217|NCT03449134|79507330|FG001|52-Week Treatment Period|Site Closure|0|||
44502218|NCT03449134|79507331|FG002|52-Week Treatment Period|Site Closure|0|||
44502219|NCT03529162|79507344|FG000|Overall Study|Lost to Follow-up|2|||
44502220|NCT03529162|79507345|FG001|Overall Study|Lost to Follow-up|2|||
44502221|NCT03447730|79507356|FG000|Overall Study|Adverse Event|0|||
44502222|NCT03447730|79507357|FG001|Overall Study|Adverse Event|2|||
44502223|NCT03447730|79507358|FG002|Overall Study|Adverse Event|0|||
44502224|NCT03429556|79507370|FG000|Overall Study|Lost to Follow-up|0|||
44502225|NCT03429556|79507371|FG001|Overall Study|Lost to Follow-up|1|||
44502226|NCT03429556|79507372|FG002|Overall Study|Lost to Follow-up|0|||
44502227|NCT03429556|79507373|FG003|Overall Study|Lost to Follow-up|0|||
44502228|NCT03428152|79507385|FG000|Overall Study|Physician Decision|4|||
44502229|NCT03428152|79507386|FG001|Overall Study|Physician Decision|2|||
44502230|NCT03428152|79507385|FG000|Overall Study|Protocol Violation|3|||
44502231|NCT03428152|79507386|FG001|Overall Study|Protocol Violation|5|||
44502232|NCT03428152|79507385|FG000|Overall Study|Lack of Efficacy|0|||
44502233|NCT03428152|79507386|FG001|Overall Study|Lack of Efficacy|4|||
44502234|NCT03444766|79507392|FG000|Overall Study|Other Reasons|2|||
44502235|NCT03444766|79507392|FG000|Overall Study|Participant Withdrew Consent|5|||
44565752|NCT03050307|79585318|FG000|Overall Study|Significant Protocol Deviation|0|||
44565753|NCT03050307|79585319|FG001|Overall Study|Significant Protocol Deviation|1|||
44565754|NCT03050307|79585318|FG000|Overall Study|Lost to Follow-up|0|||
44565755|NCT03050307|79585319|FG001|Overall Study|Lost to Follow-up|1|||
44234719|NCT01760447|79055689|FG003|Weeks 20-54|Lost to Follow-up|2|||
44234720|NCT01732913|79055778|FG000|Overall Study|Study Terminated by Sponsor|105|||
44275739|NCT02227368|79223527|FG001|Overall Study|Adverse Event|0|||
44502236|NCT03444766|79507392|FG000|Overall Study|Lost to Follow-up|2|||
44502237|NCT03444766|79507392|FG000|Overall Study|Death|2|||
44234721|NCT01732913|79055779|FG001|Overall Study|Study Terminated by Sponsor|55|||
44234722|NCT01732913|79055778|FG000|Overall Study|Withdrawal by Subject|27|||
44502238|NCT03444766|79507392|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
44502239|NCT03444766|79507392|FG000|Overall Study|Disease Progression|49|||
44565756|NCT03050307|79585318|FG000|Overall Study|Voluntary Withdrawal|3|||
44565757|NCT03050307|79585319|FG001|Overall Study|Voluntary Withdrawal|4|||
44565758|NCT03050307|79585318|FG000|Overall Study|Reason not Specified|1|||
44234723|NCT01732913|79055779|FG001|Overall Study|Withdrawal by Subject|4|||
44234724|NCT01732913|79055778|FG000|Overall Study|Physician Decision|14|||
44234725|NCT01732913|79055779|FG001|Overall Study|Physician Decision|7|||
44234726|NCT01732913|79055778|FG000|Overall Study|Other|7|||
44234727|NCT01732913|79055779|FG001|Overall Study|Other|1|||
44234728|NCT01732913|79055778|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
44234729|NCT01732913|79055779|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
44234730|NCT01732835|79055810|FG000|6-month Primary Endpoint|Did not receive device|19|||
44234731|NCT01732835|79055810|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
44234732|NCT01732835|79055810|FG000|6-month Primary Endpoint|Adverse Event|3|||
44234733|NCT01732835|79055810|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
44234734|NCT01732835|79055810|FG000|2-year Extended Follow-up|Adverse Event|3|||
44234735|NCT01732835|79055810|FG000|2-year Extended Follow-up|Death|1|||
44234736|NCT01759511|79055864|FG000|Overall Study|Adverse Event|4|||
44234737|NCT01759511|79055864|FG000|Overall Study|Death|2|||
44234738|NCT01759511|79055864|FG000|Overall Study|Lack of Efficacy|2|||
44565759|NCT03050307|79585319|FG001|Overall Study|Reason not Specified|1|||
44565760|NCT03118765|79585345|FG000|Overall Study|Withdrawal by Subject|0|||
44565761|NCT03118765|79585346|FG001|Overall Study|Withdrawal by Subject|0|||
44565762|NCT03118765|79585347|FG002|Overall Study|Withdrawal by Subject|1|||
44565763|NCT03118765|79585348|FG003|Overall Study|Withdrawal by Subject|0|||
44565764|NCT03118765|79585349|FG004|Overall Study|Withdrawal by Subject|0|||
44565765|NCT03118765|79585345|FG000|Overall Study|Adverse Event|1|||
44565766|NCT03118765|79585346|FG001|Overall Study|Adverse Event|1|||
44565767|NCT03118765|79585347|FG002|Overall Study|Adverse Event|1|||
44565768|NCT03118765|79585348|FG003|Overall Study|Adverse Event|1|||
44565769|NCT03118765|79585349|FG004|Overall Study|Adverse Event|1|||
44565770|NCT03118765|79585345|FG000|Overall Study|Non compliance with Study Procedures|0|||
44565771|NCT03118765|79585346|FG001|Overall Study|Non compliance with Study Procedures|0|||
44565772|NCT03118765|79585347|FG002|Overall Study|Non compliance with Study Procedures|0|||
44565773|NCT03118765|79585348|FG003|Overall Study|Non compliance with Study Procedures|1|||
44565774|NCT03118765|79585349|FG004|Overall Study|Non compliance with Study Procedures|0|||
44565775|NCT03118765|79585345|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
44565776|NCT03118765|79585346|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
44565777|NCT03118765|79585347|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
44565778|NCT03118765|79585348|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
44565779|NCT03118765|79585349|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
44565780|NCT03118765|79585345|FG000|Overall Study|COPD Exacerbation|1|||
44565781|NCT03118765|79585346|FG001|Overall Study|COPD Exacerbation|0|||
44565782|NCT03118765|79585347|FG002|Overall Study|COPD Exacerbation|0|||
44565783|NCT03118765|79585348|FG003|Overall Study|COPD Exacerbation|1|||
44565784|NCT03118765|79585349|FG004|Overall Study|COPD Exacerbation|0|||
44565785|NCT03118765|79585345|FG000|Overall Study|Lost to Follow-up|1|||
44565786|NCT03118765|79585346|FG001|Overall Study|Lost to Follow-up|0|||
44234739|NCT01759511|79055864|FG000|Overall Study|Physician Decision|1|||
44234740|NCT01759511|79055864|FG000|Overall Study|Progressive Disease|5|||
44502240|NCT03426436|79507396|FG000|Overall Study|Incorrect lead placement|12|||
44502241|NCT03426436|79507396|FG000|Overall Study|Withdrawal by Subject|2|||
44502242|NCT03426436|79507396|FG000|Overall Study|Consent issue|1|||
44502243|NCT03426436|79507396|FG000|Overall Study|ECGs not saved|4|||
44502244|NCT03425188|79507400|FG000|Overall Study|Withdrawal by Subject|1|||
44502245|NCT03423238|79507407|FG000|Overall Study|Lost to Follow-up|1|||
44502246|NCT03423238|79507408|FG001|Overall Study|Lost to Follow-up|0|||
44502247|NCT03423238|79507407|FG000|Overall Study|Withdrawal by Subject|1|||
44565787|NCT03118765|79585347|FG002|Overall Study|Lost to Follow-up|1|||
44275740|NCT02162862|79223536|FG000|Overall Study|Lost to Follow-up|0|||
44275741|NCT02162862|79223537|FG001|Overall Study|Lost to Follow-up|11|||
44565788|NCT03118765|79585348|FG003|Overall Study|Lost to Follow-up|0|||
44565789|NCT03118765|79585349|FG004|Overall Study|Lost to Follow-up|0|||
44565790|NCT03118765|79585345|FG000|Overall Study|Sponsor Decision|1|||
44565791|NCT03118765|79585346|FG001|Overall Study|Sponsor Decision|0|||
44234741|NCT01759511|79055864|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
44234742|NCT01759511|79055864|FG000|Overall Study|Study Terminated by Sponsor|13|||
44234743|NCT01759511|79055864|FG000|Overall Study|Withdrawal by Subject|3|||
44275742|NCT02162862|79223538|FG002|Overall Study|Lost to Follow-up|0|||
44502248|NCT03423238|79507408|FG001|Overall Study|Withdrawal by Subject|0|||
44234744|NCT01732757|79055882|FG000|Overall Study|Lost to Follow-up|1|||
44234745|NCT01732757|79055883|FG001|Overall Study|Lost to Follow-up|0|||
44565792|NCT03118765|79585347|FG002|Overall Study|Sponsor Decision|1|||
44565793|NCT03118765|79585348|FG003|Overall Study|Sponsor Decision|0|||
44565794|NCT03118765|79585349|FG004|Overall Study|Sponsor Decision|1|||
44565795|NCT05222880|79585364|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
44565796|NCT05222880|79585364|FG000|Overall Study|Withdrew Consent during Study|1|||
44565797|NCT05222880|79585364|FG000|Overall Study|COVID-19 Related|1|||
44565798|NCT04810962|79585381|FG000|Overall Study|Adverse Event|0|||
44502249|NCT02953678|79507415|FG000|Overall Study|Adverse Event|20|||
44502250|NCT02953678|79507415|FG000|Overall Study|Death|7|||
44502251|NCT02953678|79507415|FG000|Overall Study|Physician Decision|23|||
44502252|NCT02953678|79507415|FG000|Overall Study|Progressive Disease of GVHD|7|||
44502253|NCT02953678|79507415|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
44502254|NCT02953678|79507415|FG000|Overall Study|Withdrawal by participant|3|||
44502255|NCT02953678|79507415|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
44502256|NCT02953678|79507415|FG000|Overall Study|Participants were transferred to commercial product.|3|||
44502257|NCT03412084|79507422|FG000|Overall Study|Withdrawal by Subject|2|||
44502258|NCT03412084|79507423|FG001|Overall Study|Withdrawal by Subject|0|||
44502259|NCT03412084|79507422|FG000|Overall Study|Participant moved|1|||
44502260|NCT03412084|79507423|FG001|Overall Study|Participant moved|0|||
44502261|NCT03412084|79507422|FG000|Overall Study|Lost to Follow-up|1|||
44502262|NCT03412084|79507423|FG001|Overall Study|Lost to Follow-up|1|||
44502263|NCT00090753|79507431|FG000|First Treatment Period|Adverse Event|20|||
44502264|NCT00090753|79507432|FG001|First Treatment Period|Adverse Event|8|||
44502265|NCT00090753|79507431|FG000|First Treatment Period|Death|88|||
44502266|NCT00090753|79507432|FG001|First Treatment Period|Death|62|||
44502267|NCT00090753|79507431|FG000|First Treatment Period|Lack of Efficacy|2|||
44502268|NCT00090753|79507432|FG001|First Treatment Period|Lack of Efficacy|1|||
44502269|NCT00090753|79507431|FG000|First Treatment Period|Refused Treatment|32|||
44502270|NCT00090753|79507432|FG001|First Treatment Period|Refused Treatment|25|||
44502271|NCT00090753|79507431|FG000|First Treatment Period|Lost to Follow-up|4|||
44502272|NCT00090753|79507432|FG001|First Treatment Period|Lost to Follow-up|4|||
44502273|NCT00090753|79507431|FG000|First Treatment Period|Renal Transplant|70|||
44502274|NCT00090753|79507432|FG001|First Treatment Period|Renal Transplant|50|||
44502275|NCT00090753|79507431|FG000|First Treatment Period|Mircera Commercialization|1|||
44502276|NCT00090753|79507432|FG001|First Treatment Period|Mircera Commercialization|0|||
44502277|NCT00090753|79507431|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
44502278|NCT00090753|79507432|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
44502279|NCT00090753|79507431|FG000|Extended Treatment Period|Adverse Event|11|||
44502280|NCT00090753|79507432|FG001|Extended Treatment Period|Adverse Event|0|||
44502281|NCT00090753|79507431|FG000|Extended Treatment Period|Death|58|||
44502282|NCT00090753|79507432|FG001|Extended Treatment Period|Death|30|||
44502283|NCT00090753|79507431|FG000|Extended Treatment Period|Lack of Efficacy|1|||
44502284|NCT00090753|79507432|FG001|Extended Treatment Period|Lack of Efficacy|0|||
44502285|NCT00090753|79507431|FG000|Extended Treatment Period|Refused Treatment|18|||
44502286|NCT00090753|79507432|FG001|Extended Treatment Period|Refused Treatment|12|||
44502287|NCT00090753|79507431|FG000|Extended Treatment Period|Lost to Follow-up|3|||
44502288|NCT00090753|79507432|FG001|Extended Treatment Period|Lost to Follow-up|1|||
44502289|NCT00090753|79507431|FG000|Extended Treatment Period|Renal Transplant|15|||
44502290|NCT00090753|79507432|FG001|Extended Treatment Period|Renal Transplant|12|||
44502291|NCT00090753|79507431|FG000|Extended Treatment Period|Mircera Commercialization|188|||
44502292|NCT00090753|79507432|FG001|Extended Treatment Period|Mircera Commercialization|93|||
44502293|NCT00090753|79507431|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
44502294|NCT00090753|79507432|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
44502295|NCT00048932|79507440|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
44502296|NCT00048932|79507441|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
44502297|NCT00048932|79507442|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
44502298|NCT00048932|79507440|FG000|Double Blind Period (DB)|Adverse Event|51|||
44565799|NCT04810962|79585382|FG001|Overall Study|Adverse Event|1|||
44565800|NCT04810962|79585381|FG000|Overall Study|Lost to Follow-up|2|||
44565801|NCT04810962|79585382|FG001|Overall Study|Lost to Follow-up|1|||
44565802|NCT04810962|79585381|FG000|Overall Study|Physician Decision|1|||
44565803|NCT04810962|79585382|FG001|Overall Study|Physician Decision|0|||
44565804|NCT04810962|79585381|FG000|Overall Study|Withdrawal by Subject|1|||
44565805|NCT04810962|79585382|FG001|Overall Study|Withdrawal by Subject|3|||
44565806|NCT04810962|79585381|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
44502299|NCT00048932|79507441|FG001|Double Blind Period (DB)|Adverse Event|19|||
44502300|NCT00048932|79507442|FG002|Double Blind Period (DB)|Adverse Event|0|||
44502301|NCT00048932|79507440|FG000|Double Blind Period (DB)|Death|5|||
44502302|NCT00048932|79507441|FG001|Double Blind Period (DB)|Death|3|||
44502303|NCT00048932|79507442|FG002|Double Blind Period (DB)|Death|0|||
44502304|NCT00048932|79507440|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
44502305|NCT00048932|79507441|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
44565807|NCT04810962|79585382|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
44565808|NCT04606134|79585415|FG000|Overall Study|Adverse Event|0|||
44565809|NCT04606134|79585416|FG001|Overall Study|Adverse Event|1|||
44565810|NCT04426825|79585422|FG000|Overall Study|Continuing on study|6|||
44565811|NCT04426825|79585422|FG000|Overall Study|Death|17|||
44565812|NCT04399538|79585431|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
44565813|NCT04399538|79585432|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
44565814|NCT04399538|79585433|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
44565815|NCT04399538|79585434|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
44565816|NCT04399538|79585435|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
44565817|NCT04399538|79585431|FG000|Double-Blind Treatment|Adverse Event|0|||
44234746|NCT01732757|79055884|FG002|Overall Study|Lost to Follow-up|0|||
44234747|NCT01758731|79055892|FG000|Overall Study|Physician Decision|1|||
44565818|NCT04399538|79585432|FG001|Double-Blind Treatment|Adverse Event|0|||
44565819|NCT04399538|79585433|FG002|Double-Blind Treatment|Adverse Event|0|||
44565820|NCT04399538|79585434|FG003|Double-Blind Treatment|Adverse Event|0|||
44565821|NCT04399538|79585435|FG004|Double-Blind Treatment|Adverse Event|1|||
44565822|NCT04399538|79585431|FG000|Follow-Up|Adverse Event|0|||
44565823|NCT04399538|79585432|FG001|Follow-Up|Adverse Event|0|||
44565824|NCT04399538|79585433|FG002|Follow-Up|Adverse Event|0|||
44565825|NCT04399538|79585434|FG003|Follow-Up|Adverse Event|0|||
44234748|NCT01606319|79055902|FG000|Overall Study|Lost to Follow-up|17|||
44234749|NCT01606319|79055903|FG001|Overall Study|Lost to Follow-up|14|||
44234750|NCT01606319|79055902|FG000|Overall Study|Withdrawal by Subject|9|||
44234751|NCT01606319|79055903|FG001|Overall Study|Withdrawal by Subject|12|||
44234752|NCT01606319|79055902|FG000|Overall Study|Physician Decision|1|||
44234753|NCT01606319|79055903|FG001|Overall Study|Physician Decision|2|||
44234754|NCT01606319|79055902|FG000|Overall Study|Lack of Efficacy|6|||
44234755|NCT01606319|79055903|FG001|Overall Study|Lack of Efficacy|8|||
44234756|NCT01606319|79055902|FG000|Overall Study|Adverse Event|1|||
44234757|NCT01606319|79055903|FG001|Overall Study|Adverse Event|4|||
44234758|NCT01757405|79055911|FG000|Overall Study|Lost to Follow-up|1|||
44234759|NCT01757405|79055912|FG001|Overall Study|Lost to Follow-up|1|||
44234760|NCT01757405|79055911|FG000|Overall Study|Withdrawal by Subject|0|||
44234761|NCT01757405|79055912|FG001|Overall Study|Withdrawal by Subject|1|||
44234762|NCT01455597|79055918|FG000|Overall Study|Adverse Event|7|||
44234763|NCT01455597|79055919|FG001|Overall Study|Adverse Event|0|||
44234764|NCT01455597|79055920|FG002|Overall Study|Adverse Event|5|||
44234765|NCT01455597|79055921|FG003|Overall Study|Adverse Event|1|||
44234766|NCT01455597|79055918|FG000|Overall Study|Lack of Efficacy|0|||
44234767|NCT01455597|79055919|FG001|Overall Study|Lack of Efficacy|1|||
44234768|NCT01455597|79055920|FG002|Overall Study|Lack of Efficacy|2|||
44234769|NCT01455597|79055921|FG003|Overall Study|Lack of Efficacy|0|||
44234770|NCT01455597|79055918|FG000|Overall Study|Lost to Follow-up|3|||
44234771|NCT01455597|79055919|FG001|Overall Study|Lost to Follow-up|0|||
44234772|NCT01455597|79055920|FG002|Overall Study|Lost to Follow-up|2|||
44234773|NCT01455597|79055921|FG003|Overall Study|Lost to Follow-up|1|||
44234774|NCT01455597|79055918|FG000|Overall Study|Withdrew Consent|6|||
44565826|NCT04399538|79585435|FG004|Follow-Up|Adverse Event|1|||
44565827|NCT04399538|79585431|FG000|Follow-Up|Withdrawal by Subject|0|||
44565828|NCT04399538|79585432|FG001|Follow-Up|Withdrawal by Subject|0|||
44234775|NCT01455597|79055919|FG001|Overall Study|Withdrew Consent|5|||
44234776|NCT01455597|79055920|FG002|Overall Study|Withdrew Consent|8|||
44234777|NCT01455597|79055921|FG003|Overall Study|Withdrew Consent|5|||
44234778|NCT01455597|79055918|FG000|Overall Study|Reason not Specified|1|||
44234779|NCT01455597|79055919|FG001|Overall Study|Reason not Specified|2|||
44234780|NCT01455597|79055920|FG002|Overall Study|Reason not Specified|3|||
44234781|NCT01455597|79055921|FG003|Overall Study|Reason not Specified|3|||
44234782|NCT01757171|79055944|FG000|Overall Study|Adverse Event|5|||
44234783|NCT01757171|79055945|FG001|Overall Study|Adverse Event|1|||
44234784|NCT01757171|79055944|FG000|Overall Study|Disease Progression|1|||
44234785|NCT01757171|79055945|FG001|Overall Study|Disease Progression|0|||
44234786|NCT01757171|79055944|FG000|Overall Study|Hospitalization|1|||
44565829|NCT04399538|79585433|FG002|Follow-Up|Withdrawal by Subject|0|||
44565830|NCT04399538|79585434|FG003|Follow-Up|Withdrawal by Subject|2|||
44565831|NCT04399538|79585435|FG004|Follow-Up|Withdrawal by Subject|0|||
44565832|NCT03094832|79585494|FG000|Overall Study|Lost to Follow-up|0|||
44565833|NCT03094832|79585495|FG001|Overall Study|Lost to Follow-up|0|||
44565834|NCT03094832|79585496|FG002|Overall Study|Lost to Follow-up|0|||
44502306|NCT00048932|79507442|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
44502307|NCT00048932|79507440|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
44502308|NCT00048932|79507441|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
44502309|NCT00048932|79507442|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
44502310|NCT00048932|79507440|FG000|Double Blind Period (DB)|Relocation|1|||
44502311|NCT00048932|79507441|FG001|Double Blind Period (DB)|Relocation|0|||
44502312|NCT00048932|79507442|FG002|Double Blind Period (DB)|Relocation|0|||
44502313|NCT00048932|79507440|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
44565835|NCT03094832|79585497|FG003|Overall Study|Lost to Follow-up|1|||
44565836|NCT03094832|79585498|FG004|Overall Study|Lost to Follow-up|1|||
44565837|NCT03094832|79585494|FG000|Overall Study|Death|1|||
44565838|NCT03094832|79585495|FG001|Overall Study|Death|0|||
44565839|NCT03094832|79585496|FG002|Overall Study|Death|0|||
44565840|NCT03094832|79585497|FG003|Overall Study|Death|0|||
44565841|NCT03094832|79585498|FG004|Overall Study|Death|0|||
44565842|NCT03094832|79585494|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44565843|NCT03094832|79585495|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44565844|NCT03094832|79585496|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44565845|NCT03094832|79585497|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
44565846|NCT03094832|79585498|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
44565847|NCT03094832|79585494|FG000|Overall Study|Other|13|||
44565848|NCT03094832|79585495|FG001|Overall Study|Other|20|||
44565849|NCT03094832|79585496|FG002|Overall Study|Other|1|||
44565850|NCT03094832|79585497|FG003|Overall Study|Other|7|||
44565851|NCT03094832|79585498|FG004|Overall Study|Other|1|||
44565852|NCT03036579|79585512|FG000|2 Years|Lost to Follow-up|1|||
44565853|NCT03036579|79585513|FG001|2 Years|Lost to Follow-up|0|||
44565854|NCT03036579|79585512|FG000|3 Years|Lost to Follow-up|0|||
44565855|NCT03036579|79585513|FG001|3 Years|Lost to Follow-up|1|||
44565856|NCT02867761|79585521|FG000|Overall Study|Participant withdrawn by investigator|0|||
44565857|NCT02867761|79585522|FG001|Overall Study|Participant withdrawn by investigator|1|||
44565858|NCT02867761|79585521|FG000|Overall Study|Lost to Follow-up|25|||
44565859|NCT02867761|79585522|FG001|Overall Study|Lost to Follow-up|18|||
44565860|NCT02867761|79585521|FG000|Overall Study|Unable to complete protocol|3|||
44565861|NCT02867761|79585522|FG001|Overall Study|Unable to complete protocol|7|||
44565862|NCT02719990|79585537|FG000|Overall Study|Physician Decision|2|||
44565863|NCT02719990|79585537|FG000|Overall Study|Withdrawal by Subject|2|||
44565864|NCT02719990|79585537|FG000|Overall Study|Study Terminated By Sponsor|32|||
44565865|NCT02494583|79585544|FG000|Overall Study|Death|224|||
44565866|NCT02494583|79585545|FG001|Overall Study|Death|214|||
44565867|NCT02494583|79585546|FG002|Overall Study|Death|225|||
44234787|NCT01757171|79055945|FG001|Overall Study|Hospitalization|0|||
44234788|NCT01757171|79055944|FG000|Overall Study|ECOG decline|1|||
44234789|NCT01757171|79055945|FG001|Overall Study|ECOG decline|0|||
44565868|NCT02494583|79585544|FG000|Overall Study|Lost to Follow-up|1|||
44565869|NCT02494583|79585545|FG001|Overall Study|Lost to Follow-up|0|||
44565870|NCT02494583|79585546|FG002|Overall Study|Lost to Follow-up|0|||
44565871|NCT02494583|79585544|FG000|Overall Study|Protocol Violation|1|||
44565872|NCT02494583|79585545|FG001|Overall Study|Protocol Violation|2|||
44565873|NCT02494583|79585546|FG002|Overall Study|Protocol Violation|0|||
44565874|NCT02494583|79585544|FG000|Overall Study|Screen Failure|0|||
44565875|NCT02494583|79585545|FG001|Overall Study|Screen Failure|1|||
44565876|NCT02494583|79585546|FG002|Overall Study|Screen Failure|0|||
44565877|NCT02494583|79585544|FG000|Overall Study|Transferred to Extension Study|15|||
44565878|NCT02494583|79585545|FG001|Overall Study|Transferred to Extension Study|15|||
44565879|NCT02494583|79585546|FG002|Overall Study|Transferred to Extension Study|6|||
44565880|NCT02494583|79585544|FG000|Overall Study|Did Not Continue on Extension Study|8|||
44565881|NCT02494583|79585545|FG001|Overall Study|Did Not Continue on Extension Study|10|||
44565882|NCT02494583|79585546|FG002|Overall Study|Did Not Continue on Extension Study|4|||
44565883|NCT02494583|79585544|FG000|Overall Study|Withdrawal by Subject|7|||
44565884|NCT02494583|79585545|FG001|Overall Study|Withdrawal by Subject|15|||
44565885|NCT02494583|79585546|FG002|Overall Study|Withdrawal by Subject|15|||
44565886|NCT02322814|79585561|FG000|Overall Study|Death|7|||
44565887|NCT02322814|79585562|FG001|Overall Study|Death|29|||
44565888|NCT02322814|79585563|FG002|Overall Study|Death|32|||
44565889|NCT02322814|79585564|FG003|Overall Study|Death|23|||
44565890|NCT02322814|79585565|FG004|Overall Study|Death|14|||
44565891|NCT02322814|79585561|FG000|Overall Study|Lost to Follow-up|1|||
44565892|NCT02322814|79585562|FG001|Overall Study|Lost to Follow-up|3|||
44565893|NCT02322814|79585563|FG002|Overall Study|Lost to Follow-up|3|||
44565894|NCT02322814|79585564|FG003|Overall Study|Lost to Follow-up|1|||
44565895|NCT02322814|79585565|FG004|Overall Study|Lost to Follow-up|0|||
44502314|NCT00048932|79507441|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
44565896|NCT02322814|79585561|FG000|Overall Study|Various Reasons|2|||
44565897|NCT02322814|79585562|FG001|Overall Study|Various Reasons|0|||
44565898|NCT02322814|79585563|FG002|Overall Study|Various Reasons|1|||
44234790|NCT01756235|79055951|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
44502315|NCT00048932|79507442|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
44502316|NCT00048932|79507440|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
44502317|NCT00048932|79507441|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
44502318|NCT00048932|79507442|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
44502319|NCT00048932|79507440|FG000|Double Blind Period (DB)|Pregnancy|1|||
44502320|NCT00048932|79507441|FG001|Double Blind Period (DB)|Pregnancy|0|||
44565899|NCT02322814|79585564|FG003|Overall Study|Various Reasons|1|||
44565900|NCT02322814|79585565|FG004|Overall Study|Various Reasons|0|||
44565901|NCT02322814|79585561|FG000|Overall Study|Progressive Disease|0|||
44565902|NCT02322814|79585562|FG001|Overall Study|Progressive Disease|0|||
44565903|NCT02322814|79585563|FG002|Overall Study|Progressive Disease|0|||
44565904|NCT02322814|79585564|FG003|Overall Study|Progressive Disease|1|||
44565905|NCT02322814|79585565|FG004|Overall Study|Progressive Disease|1|||
44565906|NCT02322814|79585561|FG000|Overall Study|Protocol Violation|1|||
44565907|NCT02322814|79585562|FG001|Overall Study|Protocol Violation|0|||
44565908|NCT02322814|79585563|FG002|Overall Study|Protocol Violation|0|||
44565909|NCT02322814|79585564|FG003|Overall Study|Protocol Violation|0|||
44565910|NCT02322814|79585565|FG004|Overall Study|Protocol Violation|0|||
44565911|NCT02322814|79585561|FG000|Overall Study|Study Terminated by Sponsor|0|||
44565912|NCT02322814|79585562|FG001|Overall Study|Study Terminated by Sponsor|7|||
44565913|NCT02322814|79585563|FG002|Overall Study|Study Terminated by Sponsor|9|||
44565914|NCT02322814|79585564|FG003|Overall Study|Study Terminated by Sponsor|5|||
44565915|NCT02322814|79585565|FG004|Overall Study|Study Terminated by Sponsor|13|||
44565916|NCT02322814|79585561|FG000|Overall Study|Withdrawal by Subject|5|||
44234791|NCT01730729|79055955|FG000|Overall Study|Adverse Event|1|||
44234792|NCT01730729|79055955|FG000|Overall Study|Death|1|||
44234793|NCT01730729|79055955|FG000|Overall Study|Progressive Disease|12|||
44234794|NCT01756157|79055959|FG000|First Intervention Period|Withdrawal by Subject|1|||
44234795|NCT01756157|79055960|FG001|First Intervention Period|Withdrawal by Subject|0|||
44234796|NCT01756157|79055959|FG000|First Intervention Period|Lost to Follow-up|0|||
44234797|NCT01756157|79055960|FG001|First Intervention Period|Lost to Follow-up|2|||
44234798|NCT01756079|79055966|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
44234799|NCT01756079|79055966|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
44234800|NCT01756079|79055966|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
44565917|NCT02322814|79585562|FG001|Overall Study|Withdrawal by Subject|4|||
44565918|NCT02322814|79585563|FG002|Overall Study|Withdrawal by Subject|2|||
44565919|NCT02322814|79585564|FG003|Overall Study|Withdrawal by Subject|1|||
44565920|NCT02322814|79585565|FG004|Overall Study|Withdrawal by Subject|3|||
44565921|NCT01333033|79585587|FG000|Overall Study|Ineligible|0|||
44565922|NCT01333033|79585588|FG001|Overall Study|Ineligible|0|||
44565923|NCT01333033|79585589|FG002|Overall Study|Ineligible|0|||
44565924|NCT01333033|79585590|FG003|Overall Study|Ineligible|0|||
44565925|NCT01333033|79585591|FG004|Overall Study|Ineligible|6|||
44234801|NCT01756079|79055966|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
44234802|NCT01756079|79055966|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
44234803|NCT04967885|79055973|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
44234804|NCT04967885|79055974|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
44234805|NCT04967885|79055973|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
44234806|NCT04967885|79055974|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
44502321|NCT00048932|79507442|FG002|Double Blind Period (DB)|Pregnancy|0|||
44502322|NCT00048932|79507440|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
44502323|NCT00048932|79507441|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
44502324|NCT00048932|79507442|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
44502325|NCT00048932|79507440|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
44502326|NCT00048932|79507441|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
44502327|NCT00048932|79507442|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
44502328|NCT00048932|79507440|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
44502329|NCT00048932|79507441|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
44565926|NCT01333033|79585592|FG005|Overall Study|Ineligible|8|||
44565927|NCT01333033|79585587|FG000|Overall Study|Withdrawal by Subject|0|||
44565928|NCT01333033|79585588|FG001|Overall Study|Withdrawal by Subject|0|||
44565929|NCT01333033|79585589|FG002|Overall Study|Withdrawal by Subject|0|||
44565930|NCT01333033|79585590|FG003|Overall Study|Withdrawal by Subject|0|||
44234807|NCT04967885|79055973|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
44275743|NCT02162862|79223536|FG000|Overall Study|Subject did not feel the med was needed|0|||
44502330|NCT00048932|79507442|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
44565931|NCT01333033|79585591|FG004|Overall Study|Withdrawal by Subject|4|||
44565932|NCT01333033|79585592|FG005|Overall Study|Withdrawal by Subject|2|||
44502331|NCT00048932|79507440|FG000|Open Label Period (OL)|Death|0|||
44565933|NCT01333033|79585587|FG000|Overall Study|PET inevaluable|0|||
44565934|NCT01333033|79585588|FG001|Overall Study|PET inevaluable|0|||
44565935|NCT01333033|79585589|FG002|Overall Study|PET inevaluable|0|||
44234808|NCT04967885|79055974|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
44234809|NCT04967885|79055973|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
44565936|NCT01333033|79585590|FG003|Overall Study|PET inevaluable|0|||
44565937|NCT01333033|79585591|FG004|Overall Study|PET inevaluable|2|||
44565938|NCT01333033|79585592|FG005|Overall Study|PET inevaluable|4|||
44565939|NCT01333033|79585587|FG000|Overall Study|Adverse Event|0|||
44234810|NCT04967885|79055974|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
44565940|NCT01333033|79585588|FG001|Overall Study|Adverse Event|0|||
44565941|NCT01333033|79585589|FG002|Overall Study|Adverse Event|0|||
44565942|NCT01333033|79585590|FG003|Overall Study|Adverse Event|0|||
44565943|NCT01333033|79585591|FG004|Overall Study|Adverse Event|2|||
44565944|NCT01333033|79585592|FG005|Overall Study|Adverse Event|1|||
44565945|NCT01333033|79585587|FG000|Overall Study|Progression|0|||
44234811|NCT04967885|79055973|FG000|EMI-II Intervention|Lost to Follow-up|14|||
44234812|NCT04967885|79055974|FG001|EMI-II Intervention|Lost to Follow-up|10|||
44234813|NCT04571060|79055991|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
44234814|NCT04571060|79055992|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
44234815|NCT04571060|79055991|FG000|Overall Study|Never treated migraine|47|||
44234816|NCT04571060|79055992|FG001|Overall Study|Never treated migraine|36|||
44275744|NCT02162862|79223537|FG001|Overall Study|Subject did not feel the med was needed|0|||
44377321|NCT01078298|79382627|FG000|Overall Study|Withdrawal by Subject|31|||
44377322|NCT01078298|79382628|FG001|Overall Study|Withdrawal by Subject|33|||
44377323|NCT01078298|79382627|FG000|Overall Study|Protocol Violation|6|||
44377324|NCT01078298|79382628|FG001|Overall Study|Protocol Violation|6|||
44502332|NCT00048932|79507441|FG001|Open Label Period (OL)|Death|0|||
44502333|NCT00048932|79507442|FG002|Open Label Period (OL)|Death|25|||
44502334|NCT00048932|79507440|FG000|Open Label Period (OL)|Adverse Event|0|||
44502335|NCT00048932|79507441|FG001|Open Label Period (OL)|Adverse Event|0|||
44502336|NCT00048932|79507442|FG002|Open Label Period (OL)|Adverse Event|103|||
44502337|NCT00048932|79507440|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
44502338|NCT00048932|79507441|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
44502339|NCT00048932|79507442|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
44502340|NCT00048932|79507440|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
44502341|NCT00048932|79507441|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
44502342|NCT00048932|79507442|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
44502343|NCT00048932|79507440|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
44502344|NCT00048932|79507441|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
44502345|NCT00048932|79507442|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
44502346|NCT00048932|79507440|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
44275745|NCT02162862|79223538|FG002|Overall Study|Subject did not feel the med was needed|4|||
44377325|NCT01078298|79382627|FG000|Overall Study|Adverse Event|6|||
44502347|NCT00048932|79507441|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
44502348|NCT00048932|79507442|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
44565946|NCT01333033|79585588|FG001|Overall Study|Progression|0|||
44234817|NCT04571060|79055991|FG000|Overall Study|Protocol Violation|4|||
44377326|NCT01078298|79382628|FG001|Overall Study|Adverse Event|5|||
44565947|NCT01333033|79585589|FG002|Overall Study|Progression|0|||
44377327|NCT01078298|79382627|FG000|Overall Study|Death|2|||
44377328|NCT01078298|79382628|FG001|Overall Study|Death|0|||
44377329|NCT01078298|79382627|FG000|Overall Study|Did not meet entrance criteria|0|||
44377330|NCT01078298|79382628|FG001|Overall Study|Did not meet entrance criteria|1|||
44377331|NCT01078298|79382627|FG000|Overall Study|Other|24|||
44377332|NCT01078298|79382628|FG001|Overall Study|Other|32|||
44377333|NCT00788593|79382634|FG000|Placebo Run-in Phase|Adverse Event|2|||
44377334|NCT00788593|79382635|FG001|Placebo Run-in Phase|Adverse Event|0|||
44377335|NCT00788593|79382636|FG002|Placebo Run-in Phase|Adverse Event|0|||
44377336|NCT00788593|79382634|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
44377337|NCT00788593|79382635|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
44377338|NCT00788593|79382636|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
44377339|NCT00788593|79382634|FG000|Placebo Run-in Phase|Protocol Violation|2|||
44377340|NCT00788593|79382635|FG001|Placebo Run-in Phase|Protocol Violation|0|||
44502349|NCT00048932|79507440|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
44502350|NCT00048932|79507441|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
44502351|NCT00048932|79507442|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
44502352|NCT00048932|79507440|FG000|Open Label Period (OL)|Pregnancy|0|||
44502353|NCT00048932|79507441|FG001|Open Label Period (OL)|Pregnancy|0|||
44502354|NCT00048932|79507442|FG002|Open Label Period (OL)|Pregnancy|6|||
44502355|NCT00048932|79507440|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
44502356|NCT00048932|79507441|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
44502357|NCT00048932|79507442|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
44502358|NCT00048932|79507440|FG000|Open Label Period (OL)|Investigator Retiring|0|||
44502359|NCT00048932|79507441|FG001|Open Label Period (OL)|Investigator Retiring|0|||
44502360|NCT00048932|79507442|FG002|Open Label Period (OL)|Investigator Retiring|2|||
44502361|NCT00048932|79507440|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
44502362|NCT00048932|79507441|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
44502363|NCT00048932|79507442|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
44502364|NCT00048932|79507440|FG000|Open Label Period (OL)|Participant Relocated|0|||
44502365|NCT00048932|79507441|FG001|Open Label Period (OL)|Participant Relocated|0|||
44502366|NCT00048932|79507442|FG002|Open Label Period (OL)|Participant Relocated|6|||
44502367|NCT00048932|79507440|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
44502368|NCT00048932|79507441|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
44502369|NCT00048932|79507442|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
44502370|NCT00048932|79507440|FG000|Open Label Period (OL)|Site Closure|0|||
44502371|NCT00048932|79507441|FG001|Open Label Period (OL)|Site Closure|0|||
44565948|NCT01333033|79585590|FG003|Overall Study|Progression|0|||
44234818|NCT04571060|79055992|FG001|Overall Study|Protocol Violation|2|||
44234819|NCT04571060|79055991|FG000|Overall Study|Withdrawal by Subject|6|||
44234820|NCT04571060|79055992|FG001|Overall Study|Withdrawal by Subject|2|||
44377341|NCT00788593|79382636|FG002|Placebo Run-in Phase|Protocol Violation|0|||
44377342|NCT00788593|79382634|FG000|First Intervention Period|Adverse Event|0|||
44377343|NCT00788593|79382635|FG001|First Intervention Period|Adverse Event|1|||
44377344|NCT00788593|79382636|FG002|First Intervention Period|Adverse Event|0|||
44377345|NCT00788593|79382634|FG000|Second Intervention Period|Lost to Follow-up|0|||
44377346|NCT00788593|79382635|FG001|Second Intervention Period|Lost to Follow-up|1|||
44377347|NCT00788593|79382636|FG002|Second Intervention Period|Lost to Follow-up|0|||
44502372|NCT00048932|79507442|FG002|Open Label Period (OL)|Site Closure|3|||
44502373|NCT00048932|79507440|FG000|Open Label Period (OL)|Trial Terminated|0|||
44275746|NCT02226198|79223576|FG000|Lead-in Phase|Protocol Violation|1|||
44234821|NCT04571060|79055991|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
44502374|NCT00048932|79507441|FG001|Open Label Period (OL)|Trial Terminated|0|||
44502375|NCT00048932|79507442|FG002|Open Label Period (OL)|Trial Terminated|1|||
44565949|NCT01333033|79585591|FG004|Overall Study|Progression|0|||
44565950|NCT01333033|79585592|FG005|Overall Study|Progression|1|||
44565951|NCT01333033|79585587|FG000|Overall Study|MD Decision|0|||
44565952|NCT01333033|79585588|FG001|Overall Study|MD Decision|0|||
44565953|NCT01333033|79585589|FG002|Overall Study|MD Decision|0|||
44565954|NCT01333033|79585590|FG003|Overall Study|MD Decision|0|||
44565955|NCT01333033|79585591|FG004|Overall Study|MD Decision|0|||
44565956|NCT01333033|79585592|FG005|Overall Study|MD Decision|2|||
44565957|NCT01192776|79585614|FG000|Overall Study|Death|8|||
44565958|NCT01192776|79585615|FG001|Overall Study|Death|15|||
44565959|NCT01192776|79585616|FG002|Overall Study|Death|18|||
44565960|NCT01192776|79585617|FG003|Overall Study|Death|15|||
44565961|NCT01192776|79585614|FG000|Overall Study|Lost to Follow-up|3|||
44565962|NCT01192776|79585615|FG001|Overall Study|Lost to Follow-up|6|||
44234822|NCT04571060|79055992|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
44234823|NCT04512066|79056002|FG000|Double-blind Treatment Period|Adverse Event|6|||
44234824|NCT04512066|79056003|FG001|Double-blind Treatment Period|Adverse Event|4|||
44502376|NCT00048932|79507440|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
44502377|NCT00048932|79507441|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
44502378|NCT00048932|79507442|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
44502379|NCT00048932|79507440|FG000|Open Label Period (OL)|Patient Decision|0|||
44502380|NCT00048932|79507441|FG001|Open Label Period (OL)|Patient Decision|0|||
44502381|NCT00048932|79507442|FG002|Open Label Period (OL)|Patient Decision|4|||
44502382|NCT00048932|79507440|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
44565963|NCT01192776|79585616|FG002|Overall Study|Lost to Follow-up|3|||
44565964|NCT01192776|79585617|FG003|Overall Study|Lost to Follow-up|5|||
44234825|NCT04512066|79056004|FG002|Double-blind Treatment Period|Adverse Event|5|||
44234826|NCT04512066|79056005|FG003|Double-blind Treatment Period|Adverse Event|1|||
44234827|NCT04512066|79056006|FG004|Double-blind Treatment Period|Adverse Event|0|||
44234828|NCT04512066|79056007|FG005|Double-blind Treatment Period|Adverse Event|0|||
44565965|NCT01367834|79585650|FG000|Overall Study|Withdrawal by Subject|2|||
44565966|NCT01367834|79585651|FG001|Overall Study|Withdrawal by Subject|2|||
44234829|NCT04512066|79056002|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
44275747|NCT02226198|79223577|FG001|Lead-in Phase|Protocol Violation|0|||
44502383|NCT00048932|79507441|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
44565967|NCT01367834|79585650|FG000|Overall Study|Study was ended.|0|||
44565968|NCT01367834|79585651|FG001|Overall Study|Study was ended.|1|||
44565969|NCT03106753|79585659|FG000|Overall Study|Withdrawal by Subject|0|||
44565970|NCT03106753|79585660|FG001|Overall Study|Withdrawal by Subject|1|||
44565971|NCT03045081|79585670|FG000|Overall Study|Withdrawal by Subject|6|||
44565972|NCT03045081|79585671|FG001|Overall Study|Withdrawal by Subject|11|||
44565973|NCT03107377|79585679|FG000|Overall Study|Adverse Event|3|||
44565974|NCT03107377|79585680|FG001|Overall Study|Adverse Event|3|||
44565975|NCT03107377|79585679|FG000|Overall Study|Protocol Violation|9|||
44565976|NCT03107377|79585680|FG001|Overall Study|Protocol Violation|12|||
44565977|NCT03107377|79585679|FG000|Overall Study|Physician Decision|3|||
44565978|NCT03107377|79585680|FG001|Overall Study|Physician Decision|6|||
44565979|NCT03107377|79585679|FG000|Overall Study|Pregnancy|7|||
44565980|NCT03107377|79585680|FG001|Overall Study|Pregnancy|7|||
44565981|NCT03107377|79585679|FG000|Overall Study|Withdrawal by Subject|16|||
44565982|NCT03107377|79585680|FG001|Overall Study|Withdrawal by Subject|22|||
44565983|NCT03107377|79585679|FG000|Overall Study|Lost to Follow-up|37|||
44565984|NCT03107377|79585680|FG001|Overall Study|Lost to Follow-up|34|||
44565985|NCT03107377|79585679|FG000|Overall Study|Other reason not specified|16|||
44565986|NCT03107377|79585680|FG001|Overall Study|Other reason not specified|15|||
44565987|NCT02545283|79585688|FG000|Overall Study|Lost to Follow-up|2|||
44565988|NCT02545283|79585689|FG001|Overall Study|Lost to Follow-up|4|||
44565989|NCT02545283|79585688|FG000|Overall Study|Withdrawal by Subject|5|||
44565990|NCT02545283|79585689|FG001|Overall Study|Withdrawal by Subject|9|||
44565991|NCT02545283|79585688|FG000|Overall Study|Death|109|||
44565992|NCT02545283|79585689|FG001|Overall Study|Death|211|||
44565993|NCT02545283|79585688|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
44565994|NCT02545283|79585689|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
44565995|NCT02545283|79585688|FG000|Overall Study|Study Terminated By Sponsor|33|||
44565996|NCT02545283|79585689|FG001|Overall Study|Study Terminated By Sponsor|71|||
44234830|NCT04512066|79056003|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
44234831|NCT04512066|79056004|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
44377348|NCT00788593|79382634|FG000|Second Intervention Period|Other|0|||
44377349|NCT00788593|79382635|FG001|Second Intervention Period|Other|0|||
44502384|NCT00048932|79507442|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
44502385|NCT00048932|79507440|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
44502386|NCT00048932|79507441|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
44502387|NCT00048932|79507442|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
44502388|NCT00048932|79507440|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
44502389|NCT00048932|79507441|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
44502390|NCT00048932|79507442|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
44502391|NCT00048932|79507440|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
44502392|NCT00048932|79507441|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
44502393|NCT00048932|79507442|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
44502394|NCT00048932|79507440|FG000|Open Label Period (OL)|Investigator Decision|0|||
44502395|NCT00048932|79507441|FG001|Open Label Period (OL)|Investigator Decision|0|||
44502396|NCT00048932|79507442|FG002|Open Label Period (OL)|Investigator Decision|4|||
44502397|NCT00048932|79507440|FG000|Open Label Period (OL)|Site Staff Issues|0|||
44502398|NCT00048932|79507441|FG001|Open Label Period (OL)|Site Staff Issues|0|||
44502399|NCT00048932|79507442|FG002|Open Label Period (OL)|Site Staff Issues|2|||
44502400|NCT00048932|79507440|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
44502401|NCT00048932|79507441|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
44502402|NCT00048932|79507442|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
44502403|NCT00048932|79507440|FG000|Open Label Period (OL)|Participant Surgery|0|||
44502404|NCT00048932|79507441|FG001|Open Label Period (OL)|Participant Surgery|0|||
44502405|NCT00048932|79507442|FG002|Open Label Period (OL)|Participant Surgery|1|||
44502406|NCT00073983|79507451|FG000|Overall Study|not evaluable|1|||
44502407|NCT03812679|79507457|FG000|Overall Study|Adverse Event|2|||
44502408|NCT03812679|79507457|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
44565997|NCT03282565|79585700|FG000|Overall Study|COVID-19 Research Shutdown|0|||
44565998|NCT03282565|79585701|FG001|Overall Study|COVID-19 Research Shutdown|2|||
44565999|NCT03282565|79585702|FG002|Overall Study|COVID-19 Research Shutdown|2|||
44502409|NCT03812679|79507457|FG000|Overall Study|Renal transplant|1|||
44502410|NCT03812679|79507457|FG000|Overall Study|Withdrawal by Subject|1|||
44502411|NCT03812679|79507457|FG000|Overall Study|Termination of study|2|||
44566000|NCT02875613|79585710|FG000|Overall Study|Withdrawal by Subject|1|||
44566001|NCT02815267|79585720|FG000|Double-Blind Phase|Adverse Event|0|||
44566002|NCT02815267|79585721|FG001|Double-Blind Phase|Adverse Event|3|||
44566003|NCT02815267|79585720|FG000|Double-Blind Phase|Lost to Follow-up|17|||
44502412|NCT03812679|79507457|FG000|Overall Study|Water device replacement|1|||
44502413|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
44275748|NCT02226198|79223578|FG002|Lead-in Phase|Protocol Violation|0|||
44377350|NCT00788593|79382636|FG002|Second Intervention Period|Other|1|||
44377351|NCT00793819|79382648|FG000|Overall Study|Adverse Event|8|||
44377352|NCT00793819|79382649|FG001|Overall Study|Adverse Event|4|||
44377353|NCT00793819|79382648|FG000|Overall Study|Lack of Efficacy|1|||
44377354|NCT00793819|79382649|FG001|Overall Study|Lack of Efficacy|1|||
44377355|NCT00793819|79382648|FG000|Overall Study|Withdrawal by Subject|4|||
44377356|NCT00793819|79382649|FG001|Overall Study|Withdrawal by Subject|3|||
44377357|NCT00793819|79382648|FG000|Overall Study|Lost to Follow-up|1|||
44377358|NCT00793819|79382649|FG001|Overall Study|Lost to Follow-up|1|||
44377359|NCT00792259|79382658|FG000|Overall Study|Poor Quality Scans|1|||
44377360|NCT00792259|79382659|FG001|Overall Study|Poor Quality Scans|0|||
44377361|NCT00792259|79382660|FG002|Overall Study|Poor Quality Scans|0|||
44377362|NCT00894387|79382670|FG000|Overall Study|Adverse Event|44|||
44377363|NCT00894387|79382671|FG001|Overall Study|Adverse Event|45|||
44377364|NCT00894387|79382670|FG000|Overall Study|Abnormal Laboratory values|2|||
44377365|NCT00894387|79382671|FG001|Overall Study|Abnormal Laboratory values|2|||
44377366|NCT00894387|79382670|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44377367|NCT00894387|79382671|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44377368|NCT00894387|79382670|FG000|Overall Study|Lost to Follow-up|3|||
44377369|NCT00894387|79382671|FG001|Overall Study|Lost to Follow-up|5|||
44275749|NCT02226198|79223576|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
44275750|NCT02226198|79223577|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
44275751|NCT02226198|79223578|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
44377370|NCT00894387|79382670|FG000|Overall Study|Administrative problems|2|||
44377371|NCT00894387|79382671|FG001|Overall Study|Administrative problems|2|||
44377372|NCT00894387|79382670|FG000|Overall Study|Death|77|||
44275752|NCT02226120|79223749|FG000|Overall Study|Adverse Event|60|||
44377373|NCT00894387|79382671|FG001|Overall Study|Death|76|||
44377374|NCT00894387|79382670|FG000|Overall Study|Protocol Deviation|4|||
44377375|NCT00894387|79382671|FG001|Overall Study|Protocol Deviation|0|||
44377376|NCT00894387|79382670|FG000|Overall Study|Patient's request|25|||
44377377|NCT00894387|79382671|FG001|Overall Study|Patient's request|30|||
44377378|NCT00894387|79382670|FG000|Overall Study|Other (Missing)|5|||
44377379|NCT00894387|79382671|FG001|Overall Study|Other (Missing)|3|||
44377380|NCT00894387|79382670|FG000|Overall Study|Mis-randomized|13|||
44377381|NCT00894387|79382671|FG001|Overall Study|Mis-randomized|9|||
44377382|NCT00894387|79382670|FG000|Overall Study|GCP non-compliance|0|||
44377383|NCT00894387|79382671|FG001|Overall Study|GCP non-compliance|2|||
44377384|NCT00928512|79382682|FG000|Overall Study|Adverse Event|4|||
44377385|NCT00928512|79382683|FG001|Overall Study|Adverse Event|3|||
44377386|NCT00928512|79382684|FG002|Overall Study|Adverse Event|2|||
44377387|NCT00928512|79382685|FG003|Overall Study|Adverse Event|8|||
44377388|NCT00928512|79382686|FG004|Overall Study|Adverse Event|6|||
44377389|NCT00928512|79382682|FG000|Overall Study|Lack of Efficacy|2|||
44377390|NCT00928512|79382683|FG001|Overall Study|Lack of Efficacy|0|||
44377391|NCT00928512|79382684|FG002|Overall Study|Lack of Efficacy|4|||
44377392|NCT00928512|79382685|FG003|Overall Study|Lack of Efficacy|7|||
44377393|NCT00928512|79382686|FG004|Overall Study|Lack of Efficacy|3|||
44377394|NCT00928512|79382682|FG000|Overall Study|Protocol Violation|0|||
44377395|NCT00928512|79382683|FG001|Overall Study|Protocol Violation|1|||
44377396|NCT00928512|79382684|FG002|Overall Study|Protocol Violation|0|||
44502414|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
44275753|NCT02226120|79223749|FG000|Overall Study|Death|172|||
44275754|NCT02226120|79223749|FG000|Overall Study|Study terminated by sponsor|1|||
44275755|NCT02226120|79223749|FG000|Overall Study|Technical problems|4|||
44275756|NCT02226120|79223749|FG000|Overall Study|Lost to Follow-up|13|||
44275757|NCT02226120|79223749|FG000|Overall Study|Physician Decision|21|||
44275758|NCT02226120|79223749|FG000|Overall Study|Withdrawal by parent/guardian|36|||
44377397|NCT00928512|79382685|FG003|Overall Study|Protocol Violation|1|||
44377398|NCT00928512|79382686|FG004|Overall Study|Protocol Violation|3|||
44377399|NCT00928512|79382682|FG000|Overall Study|Withdrawal by Subject|3|||
44377400|NCT00928512|79382683|FG001|Overall Study|Withdrawal by Subject|0|||
44502415|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
44502416|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
44275759|NCT02226120|79223749|FG000|Overall Study|Non-compliance with study drug|10|||
44377401|NCT00928512|79382684|FG002|Overall Study|Withdrawal by Subject|3|||
44377402|NCT00928512|79382685|FG003|Overall Study|Withdrawal by Subject|4|||
44275760|NCT02226120|79223749|FG000|Overall Study|Protocol deviation|1|||
44377403|NCT00928512|79382686|FG004|Overall Study|Withdrawal by Subject|0|||
44377404|NCT00928512|79382682|FG000|Overall Study|Lost to Follow-up|1|||
44377405|NCT00928512|79382683|FG001|Overall Study|Lost to Follow-up|1|||
44377406|NCT00928512|79382684|FG002|Overall Study|Lost to Follow-up|2|||
44377407|NCT00928512|79382685|FG003|Overall Study|Lost to Follow-up|1|||
44377408|NCT00928512|79382686|FG004|Overall Study|Lost to Follow-up|3|||
44377409|NCT00928512|79382682|FG000|Overall Study|Administrative Problems|0|||
44377410|NCT00928512|79382683|FG001|Overall Study|Administrative Problems|1|||
44566004|NCT02815267|79585721|FG001|Double-Blind Phase|Lost to Follow-up|9|||
44566005|NCT02815267|79585720|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
44566006|NCT02815267|79585721|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
44566007|NCT02815267|79585720|FG000|Double-Blind Phase|Protocol Violation|3|||
44566008|NCT02815267|79585721|FG001|Double-Blind Phase|Protocol Violation|2|||
44566009|NCT02815267|79585720|FG000|Double-Blind Phase|Site withdrawal|1|||
44566010|NCT02815267|79585721|FG001|Double-Blind Phase|Site withdrawal|6|||
44566011|NCT02815267|79585720|FG000|Double-Blind Phase|Received a disallowed medication|1|||
44566012|NCT02815267|79585721|FG001|Double-Blind Phase|Received a disallowed medication|1|||
44566013|NCT02815267|79585720|FG000|Open-Label Phase|Adverse Event|1|||
44566014|NCT02815267|79585721|FG001|Open-Label Phase|Adverse Event|1|||
44566015|NCT02815267|79585720|FG000|Open-Label Phase|Lost to Follow-up|23|||
44566016|NCT02815267|79585721|FG001|Open-Label Phase|Lost to Follow-up|9|||
44377411|NCT00928512|79382684|FG002|Overall Study|Administrative Problems|0|||
44377412|NCT00928512|79382685|FG003|Overall Study|Administrative Problems|0|||
44377413|NCT00928512|79382686|FG004|Overall Study|Administrative Problems|0|||
44377414|NCT00787891|79382704|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
44377415|NCT00787891|79382705|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
44377416|NCT00787891|79382704|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
44377417|NCT00787891|79382705|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
44377418|NCT00787891|79382704|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
44377419|NCT00787891|79382705|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
44502417|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
44502418|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
44502419|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
44502420|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
44502421|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
44566017|NCT02815267|79585720|FG000|Open-Label Phase|Withdrawal by Subject|24|||
44566018|NCT02815267|79585721|FG001|Open-Label Phase|Withdrawal by Subject|13|||
44502422|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
44502423|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
44502424|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
44502425|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
44502426|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
44502427|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
44502428|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
44502429|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
44502430|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
44502431|NCT02952820|79507464|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
44502432|NCT02952820|79507465|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
44502433|NCT02952820|79507466|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
44502434|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
44502435|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
44502436|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
44502437|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
44502438|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
44502439|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
44502440|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
44566019|NCT02815267|79585720|FG000|Open-Label Phase|Protocol Violation|0|||
44566020|NCT02815267|79585721|FG001|Open-Label Phase|Protocol Violation|1|||
44566021|NCT02815267|79585720|FG000|Open-Label Phase|Administrative|21|||
44566022|NCT02815267|79585721|FG001|Open-Label Phase|Administrative|12|||
44566023|NCT02815267|79585720|FG000|Open-Label Phase|Other|2|||
44566024|NCT02815267|79585721|FG001|Open-Label Phase|Other|5|||
44566025|NCT02930837|79585731|FG000|Overall Study|Adverse Event|6|||
44566026|NCT02930837|79585731|FG000|Overall Study|Lost to Follow-up|5|||
44566027|NCT02930837|79585731|FG000|Overall Study|Withdrawal by Subject|1|||
44566028|NCT01343277|79585737|FG000|Overall Study|Other|3|||
44566029|NCT01343277|79585738|FG001|Overall Study|Other|3|||
44566030|NCT01343277|79585737|FG000|Overall Study|Withdrawal by Subject|18|||
44566031|NCT01343277|79585738|FG001|Overall Study|Withdrawal by Subject|13|||
44566032|NCT01343277|79585737|FG000|Overall Study|Physician Decision|1|||
44566033|NCT01343277|79585738|FG001|Overall Study|Physician Decision|2|||
44566034|NCT01343277|79585737|FG000|Overall Study|Death|10|||
44566035|NCT01343277|79585738|FG001|Overall Study|Death|1|||
44566036|NCT01343277|79585737|FG000|Overall Study|Adverse Event|67|||
44566037|NCT01343277|79585738|FG001|Overall Study|Adverse Event|13|||
44566038|NCT01343277|79585737|FG000|Overall Study|Disease progression|270|||
44377420|NCT00787891|79382704|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
44377421|NCT00787891|79382705|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
44377422|NCT00787891|79382704|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
44377423|NCT00787891|79382705|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
44377424|NCT00787891|79382704|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
44377425|NCT00787891|79382705|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
44377426|NCT00787891|79382704|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
44377427|NCT00787891|79382705|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
44377428|NCT00787891|79382704|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
44566039|NCT01343277|79585738|FG001|Overall Study|Disease progression|138|||
44566040|NCT01343277|79585737|FG000|Overall Study|Randomized not treated|6|||
44377429|NCT00787891|79382705|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
44377430|NCT00787891|79382704|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
44502441|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
44502442|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
44502443|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
44502444|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
44502445|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
44502446|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
44502447|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
44502448|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
44502449|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
44502450|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
44502451|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
44502452|NCT02952820|79507464|FG000|Active Treatment Period (6 Months)|Not treated|0|||
44502453|NCT02952820|79507465|FG001|Active Treatment Period (6 Months)|Not treated|0|||
44502454|NCT02952820|79507466|FG002|Active Treatment Period (6 Months)|Not treated|1|||
44502455|NCT00006392|79507481|FG000|Overall Study|Ineligible|11|||
44502456|NCT00006392|79507482|FG001|Overall Study|Ineligible|3|||
44502457|NCT00006392|79507483|FG002|Overall Study|Ineligible|5|||
44566041|NCT01343277|79585738|FG001|Overall Study|Randomized not treated|21|||
44566042|NCT01343277|79585737|FG000|Overall Study|Treatment ongoing|8|||
44566043|NCT01343277|79585738|FG001|Overall Study|Treatment ongoing|2|||
44566044|NCT01343277|79585737|FG000|Overall Study|Subsequent anticancer therapy|1|||
44566045|NCT01343277|79585738|FG001|Overall Study|Subsequent anticancer therapy|0|||
44566046|NCT03135899|79585752|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
44566047|NCT03135899|79585753|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
44502458|NCT00006392|79507484|FG003|Overall Study|Ineligible|5|||
44566048|NCT03135899|79585754|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
44566049|NCT03135899|79585755|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
44566050|NCT03135899|79585756|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
44566051|NCT03135899|79585757|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
44566052|NCT03135899|79585758|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
44566053|NCT03135899|79585759|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
44566054|NCT03135899|79585752|FG000|Overall Study|Withdrawal by Subject|0|||
44566055|NCT03135899|79585753|FG001|Overall Study|Withdrawal by Subject|0|||
44566056|NCT03135899|79585754|FG002|Overall Study|Withdrawal by Subject|0|||
44566057|NCT03135899|79585755|FG003|Overall Study|Withdrawal by Subject|0|||
44566058|NCT03135899|79585756|FG004|Overall Study|Withdrawal by Subject|0|||
44566059|NCT03135899|79585757|FG005|Overall Study|Withdrawal by Subject|2|||
44566060|NCT03135899|79585758|FG006|Overall Study|Withdrawal by Subject|0|||
44566061|NCT03135899|79585759|FG007|Overall Study|Withdrawal by Subject|0|||
44566062|NCT02487979|79585773|FG000|Overall Study|Physician Decision|2|||
44566063|NCT02487979|79585773|FG000|Overall Study|Withdrawal by Subject|2|||
44566064|NCT02487979|79585773|FG000|Overall Study|Progressive Disease|17|||
44566065|NCT03103087|79585784|FG000|Overall Study|Did not receive any study drug|1|||
44566066|NCT03103087|79585785|FG001|Overall Study|Did not receive any study drug|0|||
44566067|NCT03103087|79585786|FG002|Overall Study|Did not receive any study drug|0|||
44566068|NCT03103087|79585784|FG000|Overall Study|Protocol Violation|1|||
44566069|NCT03103087|79585785|FG001|Overall Study|Protocol Violation|2|||
44566070|NCT03103087|79585786|FG002|Overall Study|Protocol Violation|1|||
44566071|NCT03103087|79585784|FG000|Overall Study|Lack of Efficacy|2|||
44566072|NCT03103087|79585785|FG001|Overall Study|Lack of Efficacy|1|||
44566073|NCT03103087|79585786|FG002|Overall Study|Lack of Efficacy|1|||
44566074|NCT03103087|79585784|FG000|Overall Study|Pregnancy|0|||
44566075|NCT03103087|79585785|FG001|Overall Study|Pregnancy|0|||
44566076|NCT03103087|79585786|FG002|Overall Study|Pregnancy|1|||
44566077|NCT03103087|79585784|FG000|Overall Study|Adverse Event|2|||
44566078|NCT03103087|79585785|FG001|Overall Study|Adverse Event|15|||
44566079|NCT03103087|79585786|FG002|Overall Study|Adverse Event|6|||
44566080|NCT03103087|79585784|FG000|Overall Study|Withdrawal by Subject|13|||
44566081|NCT03103087|79585785|FG001|Overall Study|Withdrawal by Subject|6|||
44566082|NCT03103087|79585786|FG002|Overall Study|Withdrawal by Subject|6|||
44566083|NCT03103087|79585784|FG000|Overall Study|Lost to Follow-up|4|||
44566084|NCT03103087|79585785|FG001|Overall Study|Lost to Follow-up|2|||
44566085|NCT03103087|79585786|FG002|Overall Study|Lost to Follow-up|7|||
44566086|NCT03103087|79585784|FG000|Overall Study|Other reason not reported|1|||
44234832|NCT04512066|79056005|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
44234833|NCT04512066|79056006|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
44234834|NCT04512066|79056007|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
44234835|NCT04512066|79056002|FG000|Double-blind Treatment Period|Physician Decision|1|||
44234836|NCT04512066|79056003|FG001|Double-blind Treatment Period|Physician Decision|0|||
44234837|NCT04512066|79056004|FG002|Double-blind Treatment Period|Physician Decision|1|||
44234838|NCT04512066|79056005|FG003|Double-blind Treatment Period|Physician Decision|0|||
44234839|NCT04512066|79056006|FG004|Double-blind Treatment Period|Physician Decision|0|||
44234840|NCT04512066|79056007|FG005|Double-blind Treatment Period|Physician Decision|0|||
44234841|NCT04512066|79056002|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
44234842|NCT04512066|79056003|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
44234843|NCT04512066|79056004|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
44234844|NCT04512066|79056005|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
44234845|NCT04512066|79056006|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
44234846|NCT04512066|79056007|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
44234847|NCT04512066|79056002|FG000|Extension Period|Adverse Event|0|||
44234848|NCT04512066|79056003|FG001|Extension Period|Adverse Event|1|||
44234849|NCT04512066|79056004|FG002|Extension Period|Adverse Event|4|||
44234850|NCT04512066|79056005|FG003|Extension Period|Adverse Event|3|||
44234851|NCT04512066|79056006|FG004|Extension Period|Adverse Event|1|||
44234852|NCT04512066|79056007|FG005|Extension Period|Adverse Event|3|||
44566087|NCT03103087|79585785|FG001|Overall Study|Other reason not reported|3|||
44566088|NCT03103087|79585786|FG002|Overall Study|Other reason not reported|5|||
44566089|NCT03131999|79585798|FG000|Overall Study|Withdrawal by Subject|0|||
44566090|NCT03131999|79585799|FG001|Overall Study|Withdrawal by Subject|1|||
44566091|NCT02263885|79585814|FG000|Overall Study|Withdrawal by Subject|7|||
44234853|NCT04512066|79056002|FG000|Extension Period|Death|0|||
44234854|NCT04512066|79056003|FG001|Extension Period|Death|0|||
44234855|NCT04512066|79056004|FG002|Extension Period|Death|0|||
44234856|NCT04512066|79056005|FG003|Extension Period|Death|0|||
44234857|NCT04512066|79056006|FG004|Extension Period|Death|0|||
44566092|NCT02263885|79585814|FG000|Overall Study|Alternative Treatment|3|||
44566093|NCT02000219|79585819|FG000|14-Week Study Period|Physician Decision|1|||
44566094|NCT02000219|79585819|FG000|14-Week Study Period|Adverse Event|1|||
44234858|NCT04512066|79056007|FG005|Extension Period|Death|1|||
44234859|NCT04512066|79056002|FG000|Extension Period|Lack of Efficacy|0|||
44566095|NCT02000219|79585819|FG000|14-Week Study Period|Underwent transplantation|1|||
44566096|NCT02000219|79585819|FG000|Continuation Period|Withdrawal by Subject|1|||
44234860|NCT04512066|79056003|FG001|Extension Period|Lack of Efficacy|4|||
44566097|NCT02000219|79585819|FG000|Continuation Period|Had liver transplant|2|||
44566098|NCT02000219|79585819|FG000|Continuation Period|Non-compliance with study drug|2|||
44566099|NCT03101371|79585825|FG000|Overall Study|Physician Decision|0|||
44566100|NCT03101371|79585826|FG001|Overall Study|Physician Decision|1|||
44566101|NCT03101371|79585825|FG000|Overall Study|Lost to Follow-up|1|||
44566102|NCT03101371|79585826|FG001|Overall Study|Lost to Follow-up|4|||
44566103|NCT03101371|79585825|FG000|Overall Study|Did not meet eligibility criteria|2|||
44566104|NCT03101371|79585826|FG001|Overall Study|Did not meet eligibility criteria|1|||
44566105|NCT02850276|79585832|FG000|Overall Study|screen failure|43|||
44566106|NCT02850276|79585832|FG000|Overall Study|Withdrawal by Subject|14|||
44566107|NCT02850276|79585832|FG000|Overall Study|Physician Decision|2|||
44566108|NCT02850276|79585832|FG000|Overall Study|Lost to Follow-up|2|||
44566109|NCT02783768|79585837|FG000|Overall Study|Lost to Follow-up|1|||
44566110|NCT02783768|79585838|FG001|Overall Study|Lost to Follow-up|0|||
44566111|NCT03131687|79585850|FG000|Overall Study|Adverse Event|0|||
44566112|NCT03131687|79585851|FG001|Overall Study|Adverse Event|1|||
44566113|NCT03131687|79585852|FG002|Overall Study|Adverse Event|0|||
44566114|NCT03131687|79585853|FG003|Overall Study|Adverse Event|1|||
44566115|NCT03131687|79585854|FG004|Overall Study|Adverse Event|2|||
44566116|NCT03131687|79585855|FG005|Overall Study|Adverse Event|2|||
44566117|NCT03131687|79585850|FG000|Overall Study|Death|1|||
44566118|NCT03131687|79585851|FG001|Overall Study|Death|0|||
44566119|NCT03131687|79585852|FG002|Overall Study|Death|0|||
44566120|NCT03131687|79585853|FG003|Overall Study|Death|0|||
44566121|NCT03131687|79585854|FG004|Overall Study|Death|0|||
44566122|NCT03131687|79585855|FG005|Overall Study|Death|0|||
44566123|NCT03131687|79585850|FG000|Overall Study|Withdrawal by Subject|3|||
44566124|NCT03131687|79585851|FG001|Overall Study|Withdrawal by Subject|3|||
44566125|NCT03131687|79585852|FG002|Overall Study|Withdrawal by Subject|3|||
44566126|NCT03131687|79585853|FG003|Overall Study|Withdrawal by Subject|1|||
44566127|NCT03131687|79585854|FG004|Overall Study|Withdrawal by Subject|2|||
44566128|NCT03131687|79585855|FG005|Overall Study|Withdrawal by Subject|1|||
44566129|NCT03131687|79585850|FG000|Overall Study|Lost to Follow-up|1|||
44566130|NCT03131687|79585851|FG001|Overall Study|Lost to Follow-up|4|||
44566131|NCT03131687|79585852|FG002|Overall Study|Lost to Follow-up|0|||
44566132|NCT03131687|79585853|FG003|Overall Study|Lost to Follow-up|1|||
44566133|NCT03131687|79585854|FG004|Overall Study|Lost to Follow-up|4|||
44566134|NCT03131687|79585855|FG005|Overall Study|Lost to Follow-up|2|||
44566135|NCT03131687|79585850|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
44566136|NCT03131687|79585851|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
44566137|NCT03131687|79585852|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
44566138|NCT03131687|79585853|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
44566139|NCT03131687|79585854|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
44566140|NCT03131687|79585855|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
44566141|NCT03131687|79585850|FG000|Overall Study|Principle Investigator Decision|0|||
44566142|NCT03131687|79585851|FG001|Overall Study|Principle Investigator Decision|1|||
44234861|NCT04512066|79056004|FG002|Extension Period|Lack of Efficacy|4|||
44234862|NCT04512066|79056005|FG003|Extension Period|Lack of Efficacy|1|||
44234863|NCT04512066|79056006|FG004|Extension Period|Lack of Efficacy|3|||
44234864|NCT04512066|79056007|FG005|Extension Period|Lack of Efficacy|3|||
44234865|NCT04512066|79056002|FG000|Extension Period|Lost to Follow-up|0|||
44234866|NCT04512066|79056003|FG001|Extension Period|Lost to Follow-up|1|||
44234867|NCT04512066|79056004|FG002|Extension Period|Lost to Follow-up|5|||
44234868|NCT04512066|79056005|FG003|Extension Period|Lost to Follow-up|2|||
44234869|NCT04512066|79056006|FG004|Extension Period|Lost to Follow-up|3|||
44234870|NCT04512066|79056007|FG005|Extension Period|Lost to Follow-up|2|||
44234871|NCT04512066|79056002|FG000|Extension Period|Non-compliance with study drug|0|||
44234872|NCT04512066|79056003|FG001|Extension Period|Non-compliance with study drug|1|||
44502459|NCT00006392|79507481|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
44566143|NCT03131687|79585852|FG002|Overall Study|Principle Investigator Decision|0|||
44566144|NCT03131687|79585853|FG003|Overall Study|Principle Investigator Decision|0|||
44234873|NCT04512066|79056004|FG002|Extension Period|Non-compliance with study drug|0|||
44502460|NCT00006392|79507482|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
44502461|NCT00006392|79507483|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
44502462|NCT00006392|79507484|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
44502463|NCT00379769|79507498|FG000|Main Study|Death|57|||
44502464|NCT00379769|79507499|FG001|Main Study|Death|67|||
44502465|NCT00379769|79507500|FG002|Main Study|Death|54|||
44502466|NCT00379769|79507501|FG003|Main Study|Death|72|||
44502467|NCT00379769|79507502|FG004|Main Study|Death|0|||
44502468|NCT00379769|79507503|FG005|Main Study|Death|0|||
44502469|NCT00379769|79507498|FG000|Main Study|Adverse Event|5|||
44502470|NCT00379769|79507499|FG001|Main Study|Adverse Event|8|||
44566145|NCT03131687|79585854|FG004|Overall Study|Principle Investigator Decision|0|||
44566146|NCT03131687|79585855|FG005|Overall Study|Principle Investigator Decision|0|||
44502471|NCT00379769|79507500|FG002|Main Study|Adverse Event|10|||
44502472|NCT00379769|79507501|FG003|Main Study|Adverse Event|11|||
44234874|NCT04512066|79056005|FG003|Extension Period|Non-compliance with study drug|0|||
44377431|NCT00787891|79382705|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
44377432|NCT00787891|79382704|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
44377433|NCT00787891|79382705|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
44377434|NCT00892437|79382715|FG000|Randomized Phase|Randomized but not treated|6|||
44377435|NCT00892437|79382716|FG001|Randomized Phase|Randomized but not treated|0|||
44377436|NCT00892437|79382715|FG000|Randomized Phase|Adverse Event|2|||
44377437|NCT00892437|79382716|FG001|Randomized Phase|Adverse Event|2|||
44502473|NCT00379769|79507502|FG004|Main Study|Adverse Event|0|||
44502474|NCT00379769|79507503|FG005|Main Study|Adverse Event|0|||
44502475|NCT00379769|79507498|FG000|Main Study|Lost to Follow-up|29|||
44502476|NCT00379769|79507499|FG001|Main Study|Lost to Follow-up|29|||
44502477|NCT00379769|79507500|FG002|Main Study|Lost to Follow-up|25|||
44502478|NCT00379769|79507501|FG003|Main Study|Lost to Follow-up|26|||
44502479|NCT00379769|79507502|FG004|Main Study|Lost to Follow-up|0|||
44502480|NCT00379769|79507503|FG005|Main Study|Lost to Follow-up|0|||
44502481|NCT00379769|79507498|FG000|Main Study|Withdrawal by Subject|46|||
44502482|NCT00379769|79507499|FG001|Main Study|Withdrawal by Subject|56|||
44502483|NCT00379769|79507500|FG002|Main Study|Withdrawal by Subject|72|||
44502484|NCT00379769|79507501|FG003|Main Study|Withdrawal by Subject|70|||
44502485|NCT00379769|79507502|FG004|Main Study|Withdrawal by Subject|0|||
44502486|NCT00379769|79507503|FG005|Main Study|Withdrawal by Subject|0|||
44502487|NCT00379769|79507498|FG000|Main Study|Moved to survival status follow-up only|27|||
44502488|NCT00379769|79507499|FG001|Main Study|Moved to survival status follow-up only|25|||
44502489|NCT00379769|79507500|FG002|Main Study|Moved to survival status follow-up only|32|||
44502490|NCT00379769|79507501|FG003|Main Study|Moved to survival status follow-up only|36|||
44502491|NCT00379769|79507502|FG004|Main Study|Moved to survival status follow-up only|0|||
44502492|NCT00379769|79507503|FG005|Main Study|Moved to survival status follow-up only|0|||
44502493|NCT00379769|79507498|FG000|Main Study|Participant moved|3|||
44502494|NCT00379769|79507499|FG001|Main Study|Participant moved|2|||
44502495|NCT00379769|79507500|FG002|Main Study|Participant moved|3|||
44502496|NCT00379769|79507501|FG003|Main Study|Participant moved|3|||
44502497|NCT00379769|79507502|FG004|Main Study|Participant moved|0|||
44502498|NCT00379769|79507503|FG005|Main Study|Participant moved|0|||
44502499|NCT00379769|79507498|FG000|Main Study|Poor compliance|3|||
44502500|NCT00379769|79507499|FG001|Main Study|Poor compliance|2|||
44502501|NCT00379769|79507500|FG002|Main Study|Poor compliance|2|||
44502502|NCT00379769|79507501|FG003|Main Study|Poor compliance|1|||
44502503|NCT00379769|79507502|FG004|Main Study|Poor compliance|0|||
44502504|NCT00379769|79507503|FG005|Main Study|Poor compliance|0|||
44502505|NCT00379769|79507498|FG000|Main Study|Prohibited glucose lowering medication|0|||
44502506|NCT00379769|79507499|FG001|Main Study|Prohibited glucose lowering medication|3|||
44502507|NCT00379769|79507500|FG002|Main Study|Prohibited glucose lowering medication|0|||
44502508|NCT00379769|79507501|FG003|Main Study|Prohibited glucose lowering medication|1|||
44377438|NCT00892437|79382715|FG000|Randomized Phase|Lost to Follow-up|1|||
44377439|NCT00892437|79382716|FG001|Randomized Phase|Lost to Follow-up|3|||
44502509|NCT00379769|79507502|FG004|Main Study|Prohibited glucose lowering medication|0|||
44502510|NCT00379769|79507503|FG005|Main Study|Prohibited glucose lowering medication|0|||
44502511|NCT00379769|79507498|FG000|Main Study|Site closed|4|||
44502512|NCT00379769|79507499|FG001|Main Study|Site closed|4|||
44502513|NCT00379769|79507500|FG002|Main Study|Site closed|4|||
44502514|NCT00379769|79507501|FG003|Main Study|Site closed|8|||
44502515|NCT00379769|79507502|FG004|Main Study|Site closed|0|||
44377440|NCT00892437|79382715|FG000|Randomized Phase|Investigator's Discretion|1|||
44377441|NCT00892437|79382716|FG001|Randomized Phase|Investigator's Discretion|0|||
44377442|NCT00892437|79382715|FG000|Randomized Phase|Withdrew Consent|1|||
44377443|NCT00892437|79382716|FG001|Randomized Phase|Withdrew Consent|0|||
44377444|NCT00892437|79382715|FG000|Open-Label Extension Phase|Adverse Event|4|||
44377445|NCT00892437|79382716|FG001|Open-Label Extension Phase|Adverse Event|2|||
44377446|NCT00892437|79382715|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
44377447|NCT00892437|79382716|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
44377448|NCT00892437|79382715|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
44377449|NCT00892437|79382716|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
44377450|NCT00892437|79382715|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
44377451|NCT00892437|79382716|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
44377452|NCT00892437|79382715|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
44377453|NCT00892437|79382716|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
44377454|NCT00792103|79382723|FG000|Overall Study|Enrolled, not treated|15|||
44502516|NCT00379769|79507503|FG005|Main Study|Site closed|0|||
44502517|NCT00379769|79507498|FG000|Main Study|Entry criteria violation|0|||
44502518|NCT00379769|79507499|FG001|Main Study|Entry criteria violation|0|||
44502519|NCT00379769|79507500|FG002|Main Study|Entry criteria violation|1|||
44502520|NCT00379769|79507501|FG003|Main Study|Entry criteria violation|1|||
44566147|NCT03131687|79585850|FG000|Overall Study|Inadvertent Enrollment|0|||
44566148|NCT03131687|79585851|FG001|Overall Study|Inadvertent Enrollment|0|||
44566149|NCT03131687|79585852|FG002|Overall Study|Inadvertent Enrollment|0|||
44566150|NCT03131687|79585853|FG003|Overall Study|Inadvertent Enrollment|1|||
44566151|NCT03131687|79585854|FG004|Overall Study|Inadvertent Enrollment|0|||
44566152|NCT03131687|79585855|FG005|Overall Study|Inadvertent Enrollment|0|||
44566153|NCT03101293|79585884|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
44566154|NCT03101293|79585885|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
44566155|NCT02850978|79585891|FG000|Overall Study|Uncollectable CRF|27|||
44566156|NCT02850978|79585891|FG000|Overall Study|No visit since the first visit|35|||
44566157|NCT02850978|79585891|FG000|Overall Study|Adverse Event|81|||
44566158|NCT02850978|79585891|FG000|Overall Study|Lack of Efficacy|40|||
44566159|NCT02850978|79585891|FG000|Overall Study|Improvement in condition|34|||
44275761|NCT02226120|79223749|FG000|Overall Study|missing treatment disposition pages|2|||
44377455|NCT00792103|79382723|FG000|Overall Study|Lost to Follow-up|17|||
44502521|NCT00379769|79507502|FG004|Main Study|Entry criteria violation|0|||
44502522|NCT00379769|79507503|FG005|Main Study|Entry criteria violation|0|||
44502523|NCT00379769|79507498|FG000|Main Study|Participant did not take study drug|0|||
44502524|NCT00379769|79507499|FG001|Main Study|Participant did not take study drug|0|||
44502525|NCT00379769|79507500|FG002|Main Study|Participant did not take study drug|1|||
44502526|NCT00379769|79507501|FG003|Main Study|Participant did not take study drug|0|||
44502527|NCT00379769|79507502|FG004|Main Study|Participant did not take study drug|0|||
44502528|NCT00379769|79507503|FG005|Main Study|Participant did not take study drug|0|||
44502529|NCT00379769|79507498|FG000|Main Study|Physician Decision|2|||
44502530|NCT00379769|79507499|FG001|Main Study|Physician Decision|2|||
44502531|NCT00379769|79507500|FG002|Main Study|Physician Decision|1|||
44502532|NCT00379769|79507501|FG003|Main Study|Physician Decision|1|||
44502533|NCT00379769|79507502|FG004|Main Study|Physician Decision|0|||
44502534|NCT00379769|79507503|FG005|Main Study|Physician Decision|0|||
44502535|NCT00379769|79507498|FG000|Main Study|Participant completed study at visit 27|1|||
44502536|NCT00379769|79507499|FG001|Main Study|Participant completed study at visit 27|0|||
44502537|NCT00379769|79507500|FG002|Main Study|Participant completed study at visit 27|0|||
44502538|NCT00379769|79507501|FG003|Main Study|Participant completed study at visit 27|0|||
44502539|NCT00379769|79507502|FG004|Main Study|Participant completed study at visit 27|0|||
44502540|NCT00379769|79507503|FG005|Main Study|Participant completed study at visit 27|0|||
44502541|NCT00379769|79507498|FG000|Main Study|Personal reasons|1|||
44502542|NCT00379769|79507499|FG001|Main Study|Personal reasons|0|||
44502543|NCT00379769|79507500|FG002|Main Study|Personal reasons|0|||
44502544|NCT00379769|79507501|FG003|Main Study|Personal reasons|0|||
44502545|NCT00379769|79507502|FG004|Main Study|Personal reasons|0|||
44502546|NCT00379769|79507503|FG005|Main Study|Personal reasons|0|||
44502547|NCT00379769|79507498|FG000|Main Study|Risk of heart failure|0|||
44502548|NCT00379769|79507499|FG001|Main Study|Risk of heart failure|1|||
44566160|NCT02850978|79585891|FG000|Overall Study|Lost to Follow-up|121|||
44502549|NCT00379769|79507500|FG002|Main Study|Risk of heart failure|0|||
44566161|NCT02850978|79585891|FG000|Overall Study|Reason not listed|88|||
44377456|NCT00792103|79382723|FG000|Overall Study|Adverse Event|25|||
44377457|NCT00792103|79382723|FG000|Overall Study|Withdrawal by Subject|52|||
44377458|NCT00792103|79382723|FG000|Overall Study|Protocol Violation|10|||
44502550|NCT00379769|79507501|FG003|Main Study|Risk of heart failure|0|||
44502551|NCT00379769|79507502|FG004|Main Study|Risk of heart failure|0|||
44502552|NCT00379769|79507503|FG005|Main Study|Risk of heart failure|0|||
44502553|NCT00379769|79507498|FG000|Main Study|Investigator refused to log temperature|0|||
44566162|NCT03135431|79585897|FG000|Overall Study|Study Surgeon not available|2|||
44566163|NCT03135431|79585898|FG001|Overall Study|Study Surgeon not available|0|||
44566164|NCT04534517|79585920|FG000|Overall Study|Adverse Event|1|||
44566165|NCT04534517|79585920|FG000|Overall Study|Withdrawal by Subject|1|||
44566166|NCT04534517|79585920|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
44566167|NCT04534517|79585920|FG000|Overall Study|COVID-19 Related|1|||
44566168|NCT02831257|79585924|FG000|Overall Study|Lack of Efficacy|3|||
44566169|NCT02831257|79585924|FG000|Overall Study|Adverse Event|2|||
44566170|NCT02831257|79585924|FG000|Overall Study|Physician Decision|1|||
44566171|NCT02831257|79585924|FG000|Overall Study|Withdrawal by Subject|6|||
44566172|NCT03100825|79585928|FG000|Overall Study|Participant/Guardian Decision|7|||
44566173|NCT03100825|79585928|FG000|Overall Study|Physician Decision|1|||
44566174|NCT02250534|79585935|FG000|Overall Study|Lost to Follow-up|18|||
44566175|NCT02250534|79585936|FG001|Overall Study|Lost to Follow-up|28|||
44566176|NCT02250534|79585937|FG002|Overall Study|Lost to Follow-up|33|||
44566177|NCT02250534|79585935|FG000|Overall Study|Personal reasons|7|||
44566178|NCT02250534|79585936|FG001|Overall Study|Personal reasons|8|||
44566179|NCT02250534|79585937|FG002|Overall Study|Personal reasons|14|||
44566180|NCT02250534|79585935|FG000|Overall Study|Adverse Event|6|||
44566181|NCT02250534|79585936|FG001|Overall Study|Adverse Event|3|||
44566182|NCT02250534|79585937|FG002|Overall Study|Adverse Event|8|||
44566183|NCT02250534|79585935|FG000|Overall Study|incarcerated|2|||
44566184|NCT02250534|79585936|FG001|Overall Study|incarcerated|1|||
44566185|NCT02250534|79585937|FG002|Overall Study|incarcerated|2|||
44566186|NCT02250534|79585935|FG000|Overall Study|Withdrawal by Subject|0|||
44566187|NCT02250534|79585936|FG001|Overall Study|Withdrawal by Subject|1|||
44566188|NCT02250534|79585937|FG002|Overall Study|Withdrawal by Subject|2|||
44566189|NCT02250534|79585935|FG000|Overall Study|Death|0|||
44566190|NCT02250534|79585936|FG001|Overall Study|Death|1|||
44566191|NCT02250534|79585937|FG002|Overall Study|Death|1|||
44566192|NCT02250534|79585935|FG000|Overall Study|Physician Decision|1|||
44566193|NCT02250534|79585936|FG001|Overall Study|Physician Decision|3|||
44566194|NCT02250534|79585937|FG002|Overall Study|Physician Decision|1|||
44566195|NCT02250534|79585935|FG000|Overall Study|Protocol Violation|1|||
44234875|NCT04512066|79056006|FG004|Extension Period|Non-compliance with study drug|0|||
44234876|NCT04512066|79056007|FG005|Extension Period|Non-compliance with study drug|1|||
44502554|NCT00379769|79507499|FG001|Main Study|Investigator refused to log temperature|0|||
44502555|NCT00379769|79507500|FG002|Main Study|Investigator refused to log temperature|1|||
44502556|NCT00379769|79507501|FG003|Main Study|Investigator refused to log temperature|0|||
44502557|NCT00379769|79507502|FG004|Main Study|Investigator refused to log temperature|0|||
44502558|NCT00379769|79507503|FG005|Main Study|Investigator refused to log temperature|0|||
44502559|NCT00379769|79507498|FG000|Main Study|Reason unspecified|0|||
44502560|NCT00379769|79507499|FG001|Main Study|Reason unspecified|0|||
44502561|NCT00379769|79507500|FG002|Main Study|Reason unspecified|1|||
44502562|NCT00379769|79507501|FG003|Main Study|Reason unspecified|0|||
44502563|NCT00379769|79507502|FG004|Main Study|Reason unspecified|0|||
44502564|NCT00379769|79507503|FG005|Main Study|Reason unspecified|0|||
44502565|NCT00379769|79507498|FG000|Observational Follow-up|Death|0|||
44566196|NCT02250534|79585936|FG001|Overall Study|Protocol Violation|0|||
44566197|NCT02250534|79585937|FG002|Overall Study|Protocol Violation|1|||
44566198|NCT02250534|79585935|FG000|Overall Study|Reason unknown|1|||
44377459|NCT00792103|79382723|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
44566199|NCT02250534|79585936|FG001|Overall Study|Reason unknown|0|||
44566200|NCT02250534|79585937|FG002|Overall Study|Reason unknown|0|||
44566201|NCT02848326|79585951|FG000|Treatment Period|Adverse Event|5|||
44566202|NCT02848326|79585952|FG001|Treatment Period|Adverse Event|4|||
44566203|NCT02848326|79585953|FG002|Treatment Period|Adverse Event|11|||
44566204|NCT02848326|79585954|FG003|Treatment Period|Adverse Event|6|||
44566205|NCT02848326|79585955|FG004|Treatment Period|Adverse Event|5|||
44566206|NCT02848326|79585956|FG005|Treatment Period|Adverse Event|7|||
44566207|NCT02848326|79585951|FG000|Treatment Period|Withdrawal of Consent|20|||
44566208|NCT02848326|79585952|FG001|Treatment Period|Withdrawal of Consent|6|||
44566209|NCT02848326|79585953|FG002|Treatment Period|Withdrawal of Consent|9|||
44566210|NCT02848326|79585954|FG003|Treatment Period|Withdrawal of Consent|6|||
44566211|NCT02848326|79585955|FG004|Treatment Period|Withdrawal of Consent|9|||
44566212|NCT02848326|79585956|FG005|Treatment Period|Withdrawal of Consent|6|||
44566213|NCT02848326|79585951|FG000|Treatment Period|Lost to Follow-up|5|||
44566214|NCT02848326|79585952|FG001|Treatment Period|Lost to Follow-up|1|||
44566215|NCT02848326|79585953|FG002|Treatment Period|Lost to Follow-up|11|||
44566216|NCT02848326|79585954|FG003|Treatment Period|Lost to Follow-up|7|||
44566217|NCT02848326|79585955|FG004|Treatment Period|Lost to Follow-up|2|||
44566218|NCT02848326|79585956|FG005|Treatment Period|Lost to Follow-up|3|||
44566219|NCT02848326|79585951|FG000|Treatment Period|Pregnancy|0|||
44377460|NCT00892281|79382729|FG000|Overall Study|Adverse Event|65|||
44377461|NCT00892281|79382730|FG001|Overall Study|Adverse Event|8|||
44377462|NCT00892281|79382729|FG000|Overall Study|Lost to Follow-up|81|||
44377463|NCT00892281|79382730|FG001|Overall Study|Lost to Follow-up|8|||
44377464|NCT00892281|79382729|FG000|Overall Study|Pregnancy|1|||
44377465|NCT00892281|79382730|FG001|Overall Study|Pregnancy|0|||
44377466|NCT00892281|79382729|FG000|Overall Study|Protocol Violation|7|||
44377467|NCT00892281|79382730|FG001|Overall Study|Protocol Violation|2|||
44377468|NCT00892281|79382729|FG000|Overall Study|Withdrawal by Subject|86|||
44377469|NCT00892281|79382730|FG001|Overall Study|Withdrawal by Subject|14|||
44377470|NCT00892281|79382729|FG000|Overall Study|Subject failed to return for final visit|2|||
44377471|NCT00892281|79382730|FG001|Overall Study|Subject failed to return for final visit|0|||
44377472|NCT00892281|79382729|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
44377473|NCT00892281|79382730|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
44377474|NCT00892281|79382729|FG000|Overall Study|Final visit completed 4 weeks late|0|||
44377475|NCT00892281|79382730|FG001|Overall Study|Final visit completed 4 weeks late|1|||
44377476|NCT00892281|79382729|FG000|Overall Study|Subject completed day after study closed|1|||
44377477|NCT00892281|79382730|FG001|Overall Study|Subject completed day after study closed|0|||
44377478|NCT00892281|79382729|FG000|Overall Study|Family emergency|1|||
44377479|NCT00892281|79382730|FG001|Overall Study|Family emergency|0|||
44377480|NCT00892281|79382729|FG000|Overall Study|Last visit not done - death in family|1|||
44377481|NCT00892281|79382730|FG001|Overall Study|Last visit not done - death in family|0|||
44566220|NCT02848326|79585952|FG001|Treatment Period|Pregnancy|0|||
44566221|NCT02848326|79585953|FG002|Treatment Period|Pregnancy|1|||
44566222|NCT02848326|79585954|FG003|Treatment Period|Pregnancy|1|||
44566223|NCT02848326|79585955|FG004|Treatment Period|Pregnancy|0|||
44377482|NCT00892281|79382729|FG000|Overall Study|Did not meet incl/excl criteria|1|||
44377483|NCT00892281|79382730|FG001|Overall Study|Did not meet incl/excl criteria|0|||
44377484|NCT00892281|79382729|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
44377485|NCT00892281|79382730|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
44377486|NCT00892281|79382729|FG000|Overall Study|Unable to redeem the drug voucher|1|||
44377487|NCT00892281|79382730|FG001|Overall Study|Unable to redeem the drug voucher|0|||
44377488|NCT00892281|79382729|FG000|Overall Study|Subject not good candidate for study|1|||
44377489|NCT00892281|79382730|FG001|Overall Study|Subject not good candidate for study|0|||
44502566|NCT00379769|79507499|FG001|Observational Follow-up|Death|0|||
44502567|NCT00379769|79507500|FG002|Observational Follow-up|Death|0|||
44502568|NCT00379769|79507501|FG003|Observational Follow-up|Death|0|||
44502569|NCT00379769|79507502|FG004|Observational Follow-up|Death|78|||
44502570|NCT00379769|79507503|FG005|Observational Follow-up|Death|70|||
44502571|NCT00379769|79507498|FG000|Observational Follow-up|Adverse Event|0|||
44502572|NCT00379769|79507499|FG001|Observational Follow-up|Adverse Event|0|||
44502573|NCT00379769|79507500|FG002|Observational Follow-up|Adverse Event|0|||
44502574|NCT00379769|79507501|FG003|Observational Follow-up|Adverse Event|0|||
44502575|NCT00379769|79507502|FG004|Observational Follow-up|Adverse Event|1|||
44502576|NCT00379769|79507503|FG005|Observational Follow-up|Adverse Event|0|||
44502577|NCT00379769|79507498|FG000|Observational Follow-up|Lost to Follow-up|0|||
44234877|NCT04512066|79056002|FG000|Extension Period|Other|0|||
44377490|NCT00892281|79382729|FG000|Overall Study|Subject did not return for any visits|1|||
44502578|NCT00379769|79507499|FG001|Observational Follow-up|Lost to Follow-up|0|||
44502579|NCT00379769|79507500|FG002|Observational Follow-up|Lost to Follow-up|0|||
44566224|NCT02848326|79585956|FG005|Treatment Period|Pregnancy|1|||
44377491|NCT00892281|79382730|FG001|Overall Study|Subject did not return for any visits|0|||
44234878|NCT04512066|79056003|FG001|Extension Period|Other|2|||
44377492|NCT00892281|79382729|FG000|Overall Study|Subject missed several visits/lost meds|1|||
44377493|NCT00892281|79382730|FG001|Overall Study|Subject missed several visits/lost meds|0|||
44377494|NCT00892281|79382729|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
44502580|NCT00379769|79507501|FG003|Observational Follow-up|Lost to Follow-up|0|||
44566225|NCT02848326|79585951|FG000|Treatment Period|Protocol Violation|4|||
44566226|NCT02848326|79585952|FG001|Treatment Period|Protocol Violation|3|||
44234879|NCT04512066|79056004|FG002|Extension Period|Other|0|||
44377495|NCT00892281|79382730|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
44377496|NCT00892281|79382729|FG000|Overall Study|Scheduled for knee replacement|0|||
44377497|NCT00892281|79382730|FG001|Overall Study|Scheduled for knee replacement|1|||
44566227|NCT02848326|79585953|FG002|Treatment Period|Protocol Violation|4|||
44566228|NCT02848326|79585954|FG003|Treatment Period|Protocol Violation|2|||
44566229|NCT02848326|79585955|FG004|Treatment Period|Protocol Violation|3|||
44566230|NCT02848326|79585956|FG005|Treatment Period|Protocol Violation|3|||
44566231|NCT02848326|79585951|FG000|Treatment Period|Non-compliance with Study Drug|4|||
44566232|NCT02848326|79585952|FG001|Treatment Period|Non-compliance with Study Drug|0|||
44566233|NCT02848326|79585953|FG002|Treatment Period|Non-compliance with Study Drug|0|||
44566234|NCT02848326|79585954|FG003|Treatment Period|Non-compliance with Study Drug|1|||
44566235|NCT02848326|79585955|FG004|Treatment Period|Non-compliance with Study Drug|0|||
44566236|NCT02848326|79585956|FG005|Treatment Period|Non-compliance with Study Drug|0|||
44566237|NCT02848326|79585951|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
44566238|NCT02848326|79585952|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
44566239|NCT02848326|79585953|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
44566240|NCT02848326|79585954|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
44377498|NCT00892281|79382729|FG000|Overall Study|PI complained of inadequate compensation|3|||
44502581|NCT00379769|79507502|FG004|Observational Follow-up|Lost to Follow-up|25|||
44566241|NCT02848326|79585955|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
44566242|NCT02848326|79585956|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
44566243|NCT02848326|79585951|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
44566244|NCT02848326|79585952|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
44566245|NCT02848326|79585953|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
44566246|NCT02848326|79585954|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
44566247|NCT02848326|79585955|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
44566248|NCT02848326|79585956|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
44566249|NCT03128723|79585970|FG000|Overall Study|Withdrawal by Subject|2|||
44566250|NCT03128411|79585974|FG000|Treatment Phase|Adverse Event|21|||
44566251|NCT03128411|79585974|FG000|Treatment Phase|Physician Decision|1|||
44566252|NCT03128411|79585974|FG000|Treatment Phase|Other|2|||
44566253|NCT03128411|79585974|FG000|Long Term Follow-up Phase|Death|2|||
44566254|NCT02847858|79585980|FG000|Overall Study|Lost to Follow-up|401|||
44502582|NCT00379769|79507503|FG005|Observational Follow-up|Lost to Follow-up|27|||
44502583|NCT00379769|79507498|FG000|Observational Follow-up|Withdrawal by Subject|0|||
44502584|NCT00379769|79507499|FG001|Observational Follow-up|Withdrawal by Subject|0|||
44502585|NCT00379769|79507500|FG002|Observational Follow-up|Withdrawal by Subject|0|||
44502586|NCT00379769|79507501|FG003|Observational Follow-up|Withdrawal by Subject|0|||
44502587|NCT00379769|79507502|FG004|Observational Follow-up|Withdrawal by Subject|12|||
44502588|NCT00379769|79507503|FG005|Observational Follow-up|Withdrawal by Subject|12|||
44502589|NCT00379769|79507498|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
44234880|NCT04512066|79056005|FG003|Extension Period|Other|0|||
44234881|NCT04512066|79056006|FG004|Extension Period|Other|0|||
44234882|NCT04512066|79056007|FG005|Extension Period|Other|0|||
44234883|NCT04512066|79056002|FG000|Extension Period|Physician Decision|0|||
44234884|NCT04512066|79056003|FG001|Extension Period|Physician Decision|2|||
44234885|NCT04512066|79056004|FG002|Extension Period|Physician Decision|0|||
44377499|NCT00892281|79382730|FG001|Overall Study|PI complained of inadequate compensation|0|||
44502590|NCT00379769|79507499|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
44502591|NCT00379769|79507500|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
44502592|NCT00379769|79507501|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
44502593|NCT00379769|79507502|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
44502594|NCT00379769|79507503|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
44502595|NCT00379769|79507498|FG000|Observational Follow-up|Physician Decision|0|||
44502596|NCT00379769|79507499|FG001|Observational Follow-up|Physician Decision|0|||
44502597|NCT00379769|79507500|FG002|Observational Follow-up|Physician Decision|0|||
44502598|NCT00379769|79507501|FG003|Observational Follow-up|Physician Decision|0|||
44502599|NCT00379769|79507502|FG004|Observational Follow-up|Physician Decision|8|||
44502600|NCT00379769|79507503|FG005|Observational Follow-up|Physician Decision|8|||
44566255|NCT02847858|79585981|FG001|Overall Study|Lost to Follow-up|269|||
44502601|NCT00379769|79507498|FG000|Observational Follow-up|Site Closed Early|0|||
44502602|NCT00379769|79507499|FG001|Observational Follow-up|Site Closed Early|0|||
44502603|NCT00379769|79507500|FG002|Observational Follow-up|Site Closed Early|0|||
44566256|NCT03124199|79585992|FG000|Overall Study|Lost to Follow-up|4|||
44566257|NCT04465916|79585998|FG000|Overall Study|Withdrawal by Subject|0|||
44566258|NCT04465916|79585999|FG001|Overall Study|Withdrawal by Subject|1|||
44566259|NCT05090852|79586005|FG000|Overall Study|Physician Decision|5|||
44566260|NCT00075816|79586020|FG000|Overall Study|Did not undergo transplantation|14|||
44566261|NCT00075816|79586021|FG001|Overall Study|Did not undergo transplantation|11|||
44234886|NCT04512066|79056005|FG003|Extension Period|Physician Decision|1|||
44234887|NCT04512066|79056006|FG004|Extension Period|Physician Decision|1|||
44234888|NCT04512066|79056007|FG005|Extension Period|Physician Decision|0|||
44566262|NCT00109772|79586035|FG000|Double-blind Treatment|Adverse Event|14|||
44566263|NCT00109772|79586036|FG001|Double-blind Treatment|Adverse Event|5|||
44566264|NCT00109772|79586035|FG000|Double-blind Treatment|Lack of Efficacy|1|||
44566265|NCT00109772|79586036|FG001|Double-blind Treatment|Lack of Efficacy|0|||
44566266|NCT00109772|79586035|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
44566267|NCT00109772|79586036|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
44566268|NCT00109772|79586035|FG000|Double-blind Treatment|Lost to Follow-up|2|||
44566269|NCT00109772|79586036|FG001|Double-blind Treatment|Lost to Follow-up|3|||
44566270|NCT00109772|79586035|FG000|Double-blind Treatment|Protocol Violation|0|||
44566271|NCT00109772|79586036|FG001|Double-blind Treatment|Protocol Violation|1|||
44566272|NCT00109772|79586035|FG000|Double-blind Treatment|Other|0|||
44566273|NCT00109772|79586036|FG001|Double-blind Treatment|Other|4|||
44566274|NCT00109772|79586035|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
44566275|NCT00109772|79586036|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
44566276|NCT00109772|79586035|FG000|Open-label Extension|Adverse Event|10|||
44566277|NCT00109772|79586036|FG001|Open-label Extension|Adverse Event|19|||
44566278|NCT00109772|79586035|FG000|Open-label Extension|Lack of Efficacy|19|||
44566279|NCT00109772|79586036|FG001|Open-label Extension|Lack of Efficacy|11|||
44566280|NCT00109772|79586035|FG000|Open-label Extension|Withdrawal by Subject|9|||
44566281|NCT00109772|79586036|FG001|Open-label Extension|Withdrawal by Subject|6|||
44566282|NCT00109772|79586035|FG000|Open-label Extension|Lost to Follow-up|1|||
44566283|NCT00109772|79586036|FG001|Open-label Extension|Lost to Follow-up|0|||
44566284|NCT00109772|79586035|FG000|Open-label Extension|Death|0|||
44566285|NCT00109772|79586036|FG001|Open-label Extension|Death|1|||
44566286|NCT00109772|79586035|FG000|Open-label Extension|Protocol Violation|2|||
44566287|NCT00109772|79586036|FG001|Open-label Extension|Protocol Violation|2|||
44566288|NCT00109772|79586035|FG000|Open-label Extension|Other|4|||
44566289|NCT00109772|79586036|FG001|Open-label Extension|Other|10|||
44566290|NCT02783066|79586042|FG000|Overall Study|Withdrawal by Subject|13|||
44566291|NCT01371305|79586053|FG000|Overall Study|Adverse Event|0|||
44566292|NCT01371305|79586054|FG001|Overall Study|Adverse Event|0|||
44566293|NCT01371305|79586055|FG002|Overall Study|Adverse Event|0|||
44566294|NCT01371305|79586056|FG003|Overall Study|Adverse Event|2|||
44566295|NCT01371305|79586057|FG004|Overall Study|Adverse Event|1|||
44566296|NCT01371305|79586058|FG005|Overall Study|Adverse Event|0|||
44566297|NCT01371305|79586053|FG000|Overall Study|Study terminated by sponsor|0|||
44566298|NCT01371305|79586054|FG001|Overall Study|Study terminated by sponsor|0|||
44566299|NCT01371305|79586055|FG002|Overall Study|Study terminated by sponsor|0|||
44566300|NCT01371305|79586056|FG003|Overall Study|Study terminated by sponsor|0|||
44566301|NCT01371305|79586057|FG004|Overall Study|Study terminated by sponsor|3|||
44566302|NCT01371305|79586058|FG005|Overall Study|Study terminated by sponsor|1|||
44566303|NCT01371305|79586053|FG000|Overall Study|Subject request|0|||
44234889|NCT04512066|79056002|FG000|Extension Period|Withdrawal by Subject|0|||
44502604|NCT00379769|79507501|FG003|Observational Follow-up|Site Closed Early|0|||
44502605|NCT00379769|79507502|FG004|Observational Follow-up|Site Closed Early|6|||
44502606|NCT00379769|79507503|FG005|Observational Follow-up|Site Closed Early|7|||
44502607|NCT00379769|79507498|FG000|Observational Follow-up|Participant Moved|0|||
44502608|NCT00379769|79507499|FG001|Observational Follow-up|Participant Moved|0|||
44502609|NCT00379769|79507500|FG002|Observational Follow-up|Participant Moved|0|||
44502610|NCT00379769|79507501|FG003|Observational Follow-up|Participant Moved|0|||
44502611|NCT00379769|79507502|FG004|Observational Follow-up|Participant Moved|0|||
44502612|NCT00379769|79507503|FG005|Observational Follow-up|Participant Moved|1|||
44502613|NCT00379769|79507498|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
44502614|NCT00379769|79507499|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
44502615|NCT00379769|79507500|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
44502616|NCT00379769|79507501|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
44502617|NCT00379769|79507502|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
44502618|NCT00379769|79507503|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
44502619|NCT00006164|79507532|FG000|Overall Study|Withdrew or lost to follow-up|70|||
44502620|NCT00006164|79507533|FG001|Overall Study|Withdrew or lost to follow-up|81|||
44502621|NCT00378599|79507539|FG000|Overall Study|Adverse Event|38|||
44502622|NCT00378599|79507539|FG000|Overall Study|Protocol Violation|2|||
44502623|NCT00378599|79507539|FG000|Overall Study|Treatment failure|7|||
44502624|NCT00378599|79507539|FG000|Overall Study|Withdrawal by Subject|5|||
44566304|NCT01371305|79586054|FG001|Overall Study|Subject request|0|||
44566305|NCT01371305|79586055|FG002|Overall Study|Subject request|0|||
44566306|NCT01371305|79586056|FG003|Overall Study|Subject request|0|||
44566307|NCT01371305|79586057|FG004|Overall Study|Subject request|0|||
44566308|NCT01371305|79586058|FG005|Overall Study|Subject request|1|||
44566309|NCT00109928|79586073|FG000|Overall Study|Adverse Event|2|||
44566310|NCT00109928|79586073|FG000|Overall Study|Progression|6|||
44566311|NCT00109928|79586073|FG000|Overall Study|Death|2|||
44566312|NCT00109928|79586073|FG000|Overall Study|not protocol specified|2|||
44566313|NCT00109928|79586073|FG000|Overall Study|not eligible|1|||
44566314|NCT00109850|79586078|FG000|Overall Study|Adverse Event|1|||
44566315|NCT00109850|79586078|FG000|Overall Study|Death|2|||
44566316|NCT00109850|79586078|FG000|Overall Study|Ineligible|1|||
44566317|NCT01342926|79586086|FG000|Overall Study|Adverse Event|5|||
44566318|NCT01342926|79586087|FG001|Overall Study|Adverse Event|8|||
44566319|NCT01342926|79586088|FG002|Overall Study|Adverse Event|10|||
44566320|NCT01342926|79586089|FG003|Overall Study|Adverse Event|7|||
44566321|NCT01342926|79586086|FG000|Overall Study|Lost to Follow-up|0|||
44566322|NCT01342926|79586087|FG001|Overall Study|Lost to Follow-up|1|||
44566323|NCT01342926|79586088|FG002|Overall Study|Lost to Follow-up|1|||
44566324|NCT01342926|79586089|FG003|Overall Study|Lost to Follow-up|0|||
44566325|NCT01342926|79586086|FG000|Overall Study|Investigator Discretion|2|||
44566326|NCT01342926|79586087|FG001|Overall Study|Investigator Discretion|2|||
44566327|NCT01342926|79586088|FG002|Overall Study|Investigator Discretion|0|||
44566328|NCT01342926|79586089|FG003|Overall Study|Investigator Discretion|0|||
44566329|NCT01342926|79586086|FG000|Overall Study|Withdrawal by Subject|2|||
44566330|NCT01342926|79586087|FG001|Overall Study|Withdrawal by Subject|4|||
44566331|NCT01342926|79586088|FG002|Overall Study|Withdrawal by Subject|3|||
44566332|NCT01342926|79586089|FG003|Overall Study|Withdrawal by Subject|5|||
44566333|NCT01810016|79586102|FG000|Overall Study|Progressive disease|1|||
44566334|NCT01810016|79586103|FG001|Overall Study|Progressive disease|1|||
44566335|NCT01810016|79586104|FG002|Overall Study|Progressive disease|0|||
44234890|NCT04512066|79056003|FG001|Extension Period|Withdrawal by Subject|3|||
44234891|NCT04512066|79056004|FG002|Extension Period|Withdrawal by Subject|7|||
44234892|NCT04512066|79056005|FG003|Extension Period|Withdrawal by Subject|11|||
44502625|NCT00378209|79507543|FG000|Overall Study|Progressive disease|11|||
44502626|NCT00378209|79507543|FG000|Overall Study|Adverse Event|3|||
44502627|NCT00378209|79507543|FG000|Overall Study|Initiation of non-protocol therapy|3|||
44502628|NCT00378209|79507543|FG000|Overall Study|Physician Decision|3|||
44502629|NCT00378209|79507543|FG000|Overall Study|Death|1|||
44502630|NCT00378209|79507543|FG000|Overall Study|Treatment delay|1|||
44502631|NCT00377819|79507550|FG000|Overall Study|Adverse Event|2|||
44502632|NCT00377819|79507551|FG001|Overall Study|Adverse Event|3|||
44502633|NCT00377819|79507550|FG000|Overall Study|Withdrawal by Subject|10|||
44502634|NCT00377819|79507551|FG001|Overall Study|Withdrawal by Subject|4|||
44502635|NCT00377819|79507550|FG000|Overall Study|Death|0|||
44502636|NCT00377819|79507551|FG001|Overall Study|Death|1|||
44502637|NCT00377819|79507550|FG000|Overall Study|Lost to Follow-up|0|||
44502638|NCT00377819|79507551|FG001|Overall Study|Lost to Follow-up|1|||
44502639|NCT00377819|79507550|FG000|Overall Study|Protocol Violation|1|||
44502640|NCT00377819|79507551|FG001|Overall Study|Protocol Violation|1|||
44502641|NCT03419962|79507557|FG000|Overall Study|Change to other medication|1|||
44234893|NCT04512066|79056006|FG004|Extension Period|Withdrawal by Subject|8|||
44502642|NCT03419962|79507557|FG000|Overall Study|Refusal of continuing with trial drug|1|||
44566336|NCT01810016|79586102|FG000|Overall Study|Death|0|||
44566337|NCT01810016|79586103|FG001|Overall Study|Death|0|||
44234894|NCT04512066|79056007|FG005|Extension Period|Withdrawal by Subject|4|||
44502643|NCT03419962|79507557|FG000|Overall Study|Lost to Follow-up|3|||
44502644|NCT03419962|79507557|FG000|Overall Study|Difficulty in inhaling the doses|1|||
44566338|NCT01810016|79586104|FG002|Overall Study|Death|1|||
44566339|NCT02843178|79586116|FG000|Overall Study|Lost to Follow-up|8|||
44566340|NCT02843178|79586117|FG001|Overall Study|Lost to Follow-up|8|||
44566341|NCT02843178|79586118|FG002|Overall Study|Lost to Follow-up|6|||
44566342|NCT02843178|79586119|FG003|Overall Study|Lost to Follow-up|3|||
44566343|NCT02843178|79586116|FG000|Overall Study|Withdrawal by Subject|0|||
44566344|NCT02843178|79586117|FG001|Overall Study|Withdrawal by Subject|0|||
44566345|NCT02843178|79586118|FG002|Overall Study|Withdrawal by Subject|1|||
44566346|NCT02843178|79586119|FG003|Overall Study|Withdrawal by Subject|1|||
44566347|NCT03123185|79586143|FG000|Overall Study|Withdrawal by Subject|0|||
44566348|NCT03123185|79586144|FG001|Overall Study|Withdrawal by Subject|0|||
44566349|NCT03123185|79586145|FG002|Overall Study|Withdrawal by Subject|0|||
44566350|NCT03123185|79586146|FG003|Overall Study|Withdrawal by Subject|0|||
44566351|NCT03123185|79586147|FG004|Overall Study|Withdrawal by Subject|0|||
44566352|NCT03123185|79586148|FG005|Overall Study|Withdrawal by Subject|0|||
44566353|NCT03123185|79586149|FG006|Overall Study|Withdrawal by Subject|0|||
44566354|NCT03123185|79586150|FG007|Overall Study|Withdrawal by Subject|0|||
44566355|NCT03123185|79586151|FG008|Overall Study|Withdrawal by Subject|0|||
44566356|NCT03123185|79586152|FG009|Overall Study|Withdrawal by Subject|0|||
44566357|NCT03123185|79586153|FG010|Overall Study|Withdrawal by Subject|0|||
44566358|NCT03123185|79586154|FG011|Overall Study|Withdrawal by Subject|0|||
44566359|NCT03123185|79586155|FG012|Overall Study|Withdrawal by Subject|1|||
44566360|NCT03123185|79586156|FG013|Overall Study|Withdrawal by Subject|0|||
44566361|NCT02842866|79586215|FG000|Overall Study|Serious Adverse Event|0|||
44566362|NCT02842866|79586216|FG001|Overall Study|Serious Adverse Event|1|||
44566363|NCT02842866|79586215|FG000|Overall Study|Protocol Violation|4|||
44566364|NCT02842866|79586216|FG001|Overall Study|Protocol Violation|2|||
44566365|NCT02842866|79586215|FG000|Overall Study|Lost to Follow-up|2|||
44566366|NCT02842866|79586216|FG001|Overall Study|Lost to Follow-up|0|||
44566367|NCT02842866|79586215|FG000|Overall Study|Withdrawal by Subject|1|||
44566368|NCT02842866|79586216|FG001|Overall Study|Withdrawal by Subject|0|||
44566369|NCT01316913|79586226|FG000|Overall Study|Adverse Event|17|||
44566370|NCT01316913|79586227|FG001|Overall Study|Adverse Event|20|||
44566371|NCT01316913|79586228|FG002|Overall Study|Adverse Event|15|||
44566372|NCT01316913|79586229|FG003|Overall Study|Adverse Event|11|||
44566373|NCT01316913|79586226|FG000|Overall Study|Lack of Efficacy|22|||
44566374|NCT01316913|79586227|FG001|Overall Study|Lack of Efficacy|12|||
44566375|NCT01316913|79586228|FG002|Overall Study|Lack of Efficacy|9|||
44566376|NCT01316913|79586229|FG003|Overall Study|Lack of Efficacy|13|||
44566377|NCT01316913|79586226|FG000|Overall Study|Protocol Violation|1|||
44566378|NCT01316913|79586227|FG001|Overall Study|Protocol Violation|4|||
44566379|NCT01316913|79586228|FG002|Overall Study|Protocol Violation|4|||
44566380|NCT01316913|79586229|FG003|Overall Study|Protocol Violation|1|||
44566381|NCT01316913|79586226|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
44566382|NCT01316913|79586227|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
44566383|NCT01316913|79586228|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
44566384|NCT01316913|79586229|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
44566385|NCT01316913|79586226|FG000|Overall Study|Lost to Follow-up|0|||
44566386|NCT01316913|79586227|FG001|Overall Study|Lost to Follow-up|1|||
44566387|NCT01316913|79586228|FG002|Overall Study|Lost to Follow-up|0|||
44566388|NCT01316913|79586229|FG003|Overall Study|Lost to Follow-up|2|||
44566389|NCT01316913|79586226|FG000|Overall Study|Withdrawal by Subject|10|||
44566390|NCT01316913|79586227|FG001|Overall Study|Withdrawal by Subject|9|||
44566391|NCT01316913|79586228|FG002|Overall Study|Withdrawal by Subject|10|||
44566392|NCT01316913|79586229|FG003|Overall Study|Withdrawal by Subject|6|||
44566393|NCT02875067|79586240|FG000|Overall Study|Withdrawal by Subject|1|||
44566394|NCT02875067|79586240|FG000|Overall Study|Withdrawal by Termination of Study|5|||
44566395|NCT02781506|79586244|FG000|Overall Study|Adverse Event|5|||
44566396|NCT03132753|79586250|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
44566397|NCT03132753|79586251|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
44566398|NCT03132753|79586250|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
44566399|NCT03132753|79586251|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
44566400|NCT01468454|79586257|FG000|Overall Study|Did not have surgery after PET|9|||
44566401|NCT03067077|79586262|FG000|Overall Study|Did not receive surgery|4|||
44566402|NCT03067077|79586263|FG001|Overall Study|Did not receive surgery|5|||
44566403|NCT03067077|79586262|FG000|Overall Study|Lost to Follow-up|3|||
44234895|NCT04426318|79056029|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
44377500|NCT00892281|79382729|FG000|Overall Study|Subject lost interest in program|0|||
44377501|NCT00892281|79382730|FG001|Overall Study|Subject lost interest in program|1|||
44377502|NCT00892281|79382729|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
44377503|NCT00892281|79382730|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
44566404|NCT03067077|79586263|FG001|Overall Study|Lost to Follow-up|2|||
44566405|NCT03096847|79586272|FG000|Overall Study|Other|2|||
44566406|NCT03096847|79586273|FG001|Overall Study|Other|1|||
44566407|NCT03096847|79586274|FG002|Overall Study|Other|2|||
44566408|NCT03096847|79586272|FG000|Overall Study|Lost to Follow-up|1|||
44566409|NCT03096847|79586273|FG001|Overall Study|Lost to Follow-up|0|||
44566410|NCT03096847|79586274|FG002|Overall Study|Lost to Follow-up|1|||
44566411|NCT03096847|79586272|FG000|Overall Study|Death|6|||
44566412|NCT03096847|79586273|FG001|Overall Study|Death|0|||
44566413|NCT03096847|79586274|FG002|Overall Study|Death|2|||
44566414|NCT03096847|79586272|FG000|Overall Study|Protocol Violation|3|||
44566415|NCT03096847|79586273|FG001|Overall Study|Protocol Violation|0|||
44566416|NCT03096847|79586274|FG002|Overall Study|Protocol Violation|6|||
44566417|NCT03096847|79586272|FG000|Overall Study|Physician Decision|12|||
44566418|NCT03096847|79586273|FG001|Overall Study|Physician Decision|2|||
44566419|NCT03096847|79586274|FG002|Overall Study|Physician Decision|8|||
44566420|NCT03096847|79586272|FG000|Overall Study|Withdrawal by Subject|24|||
44566421|NCT03096847|79586273|FG001|Overall Study|Withdrawal by Subject|1|||
44377504|NCT00892281|79382729|FG000|Overall Study|Death in family|1|||
44377505|NCT00892281|79382730|FG001|Overall Study|Death in family|0|||
44377506|NCT00892281|79382729|FG000|Overall Study|Lack of efficacy of study product|2|||
44377507|NCT00892281|79382730|FG001|Overall Study|Lack of efficacy of study product|0|||
44377508|NCT00892281|79382729|FG000|Overall Study|Subject not seen by PI at final visit|1|||
44377509|NCT00892281|79382730|FG001|Overall Study|Subject not seen by PI at final visit|0|||
44377510|NCT00892281|79382729|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
44502645|NCT03419962|79507557|FG000|Overall Study|Missing completion data|31|||
44566422|NCT03096847|79586274|FG002|Overall Study|Withdrawal by Subject|12|||
44566423|NCT03096847|79586272|FG000|Overall Study|Adverse Event|72|||
44566424|NCT03096847|79586273|FG001|Overall Study|Adverse Event|6|||
44566425|NCT03096847|79586274|FG002|Overall Study|Adverse Event|28|||
44566426|NCT03096847|79586272|FG000|Overall Study|Progressive disease|97|||
44566427|NCT03096847|79586273|FG001|Overall Study|Progressive disease|10|||
44566428|NCT03096847|79586274|FG002|Overall Study|Progressive disease|78|||
44566429|NCT03096847|79586272|FG000|Overall Study|Non-compliance with study medication|1|||
44566430|NCT03096847|79586273|FG001|Overall Study|Non-compliance with study medication|0|||
44566431|NCT03096847|79586274|FG002|Overall Study|Non-compliance with study medication|0|||
44566432|NCT03096847|79586272|FG000|Overall Study|New therapy for study indication|1|||
44566433|NCT03096847|79586273|FG001|Overall Study|New therapy for study indication|0|||
44566434|NCT03096847|79586274|FG002|Overall Study|New therapy for study indication|1|||
44566435|NCT01365182|79586293|FG000|Overall Study|Withdrawal by Subject|10|||
44566436|NCT01365182|79586294|FG001|Overall Study|Withdrawal by Subject|13|||
44566437|NCT01365182|79586295|FG002|Overall Study|Withdrawal by Subject|12|||
44566438|NCT03128099|79586313|FG000|Overall Study|High dose task was too long|0|||
44566439|NCT03128099|79586314|FG001|Overall Study|High dose task was too long|4|||
44566440|NCT03128099|79586315|FG002|Overall Study|High dose task was too long|0|||
44566441|NCT03128099|79586313|FG000|Overall Study|Participant got a full time job.|1|||
44566442|NCT03128099|79586314|FG001|Overall Study|Participant got a full time job.|0|||
44566443|NCT03128099|79586315|FG002|Overall Study|Participant got a full time job.|0|||
44566444|NCT03128099|79586313|FG000|Overall Study|Became homeless and lost contact|1|||
44566445|NCT03128099|79586314|FG001|Overall Study|Became homeless and lost contact|0|||
44566446|NCT03128099|79586315|FG002|Overall Study|Became homeless and lost contact|0|||
44566447|NCT03128099|79586313|FG000|Overall Study|Did not complete all the assessments|0|||
44566448|NCT03128099|79586314|FG001|Overall Study|Did not complete all the assessments|0|||
44566449|NCT03128099|79586315|FG002|Overall Study|Did not complete all the assessments|1|||
44566450|NCT02886494|79586323|FG000|Overall Study|Adverse Event|1|||
44275762|NCT02194998|79223914|FG000|On-HCV Treatment|Did not pick up study medication|0|||
44275763|NCT02194998|79223915|FG001|On-HCV Treatment|Did not pick up study medication|1|||
44275764|NCT02194998|79223916|FG002|On-HCV Treatment|Did not pick up study medication|0|||
44275765|NCT02194998|79223917|FG003|On-HCV Treatment|Did not pick up study medication|0|||
44275766|NCT02194998|79223914|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
44275767|NCT02194998|79223915|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
44275768|NCT02194998|79223916|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
44275769|NCT02194998|79223917|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
44275770|NCT02194062|79223930|FG000|Overall Study|Lost to Follow-up|2|||
44275771|NCT02194062|79223931|FG001|Overall Study|Lost to Follow-up|2|||
44275772|NCT02194062|79223932|FG002|Overall Study|Lost to Follow-up|5|||
44275773|NCT02193828|79223953|FG000|Overall Study|Withdrawal by Subject|0|||
44275774|NCT02193828|79223954|FG001|Overall Study|Withdrawal by Subject|0|||
44275775|NCT02193828|79223955|FG002|Overall Study|Withdrawal by Subject|1|||
44275776|NCT02193828|79223956|FG003|Overall Study|Withdrawal by Subject|1|||
44275777|NCT02192970|79223977|FG000|Overall Study|Lost to Follow-up|6|||
44275778|NCT02192970|79223978|FG001|Overall Study|Lost to Follow-up|0|||
44377511|NCT00892281|79382730|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
44502646|NCT00377429|79507561|FG000|Overall Study|Withdrawal by Subject|5|||
44502647|NCT00377429|79507561|FG000|Overall Study|Adverse Event|8|||
44502648|NCT00377429|79507561|FG000|Overall Study|Physician Decision|1|||
44502649|NCT00377429|79507561|FG000|Overall Study|Patient non-compliance|1|||
44502650|NCT00376961|79507565|FG000|Initial Registration|Adverse Event|1|||
44502651|NCT00376961|79507566|FG001|Initial Registration|Adverse Event|0|||
44502652|NCT00376961|79507565|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
44502653|NCT00376961|79507566|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
44502654|NCT00376961|79507565|FG000|Initial Registration|Progression/relapse|1|||
44502655|NCT00376961|79507566|FG001|Initial Registration|Progression/relapse|0|||
44502656|NCT00376961|79507565|FG000|Initial Registration|Ineligible|3|||
44502657|NCT00376961|79507566|FG001|Initial Registration|Ineligible|0|||
44502658|NCT00376961|79507565|FG000|Maintenance|Adverse Event|0|||
44502659|NCT00376961|79507566|FG001|Maintenance|Adverse Event|1|||
44502660|NCT00376961|79507565|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
44502661|NCT00376961|79507566|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
44566451|NCT02886494|79586324|FG001|Overall Study|Adverse Event|0|||
44566452|NCT02886494|79586323|FG000|Overall Study|Withdrawal by Subject|12|||
44234896|NCT04426318|79056030|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
44234897|NCT04356963|79056045|FG000|First Session|Withdrawal by Subject|1|||
44377512|NCT00892281|79382729|FG000|Overall Study|Missed multiple visits|1|||
44377513|NCT00892281|79382730|FG001|Overall Study|Missed multiple visits|0|||
44377514|NCT00892281|79382729|FG000|Overall Study|Missed visits rescheduled out of window|1|||
44377515|NCT00892281|79382730|FG001|Overall Study|Missed visits rescheduled out of window|0|||
44377516|NCT00892281|79382729|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
44377517|NCT00892281|79382730|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
44377518|NCT00892281|79382729|FG000|Overall Study|Subject had history of drug abuse|1|||
44377519|NCT00892281|79382730|FG001|Overall Study|Subject had history of drug abuse|0|||
44377520|NCT00892281|79382729|FG000|Overall Study|Rash on hand|1|||
44377521|NCT00892281|79382730|FG001|Overall Study|Rash on hand|0|||
44377522|NCT00892281|79382729|FG000|Overall Study|Visit 4 date out of window|1|||
44377523|NCT00892281|79382730|FG001|Overall Study|Visit 4 date out of window|0|||
44377524|NCT00784693|79382738|FG000|Overall Study|Lost to Follow-up|0|||
44377525|NCT00784693|79382739|FG001|Overall Study|Lost to Follow-up|1|||
44377526|NCT00784693|79382738|FG000|Overall Study|Lack of Efficacy|1|||
44377527|NCT00784693|79382739|FG001|Overall Study|Lack of Efficacy|1|||
44377528|NCT00784693|79382738|FG000|Overall Study|Withdrawal by Subject|0|||
44377529|NCT00784693|79382739|FG001|Overall Study|Withdrawal by Subject|4|||
44377530|NCT00784693|79382738|FG000|Overall Study|Randomized but not Treated|1|||
44502662|NCT00376961|79507565|FG000|Maintenance|Progression/relapse|0|||
44502663|NCT00376961|79507566|FG001|Maintenance|Progression/relapse|18|||
44502664|NCT00376961|79507565|FG000|Maintenance|Ineligible|0|||
44502665|NCT00376961|79507566|FG001|Maintenance|Ineligible|3|||
44502666|NCT03418324|79507576|FG000|Overall Study|Death|0|||
44502667|NCT03418324|79507577|FG001|Overall Study|Death|1|||
44502668|NCT03418324|79507576|FG000|Overall Study|Physician Decision|1|||
44502669|NCT03418324|79507577|FG001|Overall Study|Physician Decision|1|||
44502670|NCT00376259|79507585|FG000|Overall Study|Sponsor request - study termination|21|||
44502671|NCT00376259|79507586|FG001|Overall Study|Sponsor request - study termination|21|||
44502672|NCT00376259|79507585|FG000|Overall Study|Patient request|1|||
44502673|NCT00376259|79507586|FG001|Overall Study|Patient request|0|||
44502674|NCT03410056|79507596|FG000|Overall Study|Decision by Sponsor|0|||
44502675|NCT03410056|79507597|FG001|Overall Study|Decision by Sponsor|0|||
44502676|NCT03410056|79507598|FG002|Overall Study|Decision by Sponsor|3|||
44502677|NCT03410056|79507599|FG003|Overall Study|Decision by Sponsor|0|||
44502678|NCT03410056|79507600|FG004|Overall Study|Decision by Sponsor|0|||
44502679|NCT03410056|79507601|FG005|Overall Study|Decision by Sponsor|0|||
44502680|NCT03410056|79507602|FG006|Overall Study|Decision by Sponsor|0|||
44502681|NCT03410056|79507596|FG000|Overall Study|Withdrawal by Subject|0|||
44502682|NCT03410056|79507597|FG001|Overall Study|Withdrawal by Subject|2|||
44377531|NCT00784693|79382739|FG001|Overall Study|Randomized but not Treated|0|||
44377532|NCT00784693|79382738|FG000|Overall Study|Other|1|||
44502683|NCT03410056|79507598|FG002|Overall Study|Withdrawal by Subject|5|||
44377533|NCT00784693|79382739|FG001|Overall Study|Other|0|||
44377534|NCT00893763|79382747|FG000|Overall Study|extubated|110|||
44377535|NCT00893763|79382748|FG001|Overall Study|extubated|110|||
44502684|NCT03410056|79507599|FG003|Overall Study|Withdrawal by Subject|5|||
44502685|NCT03410056|79507600|FG004|Overall Study|Withdrawal by Subject|0|||
44502686|NCT03410056|79507601|FG005|Overall Study|Withdrawal by Subject|0|||
44502687|NCT03410056|79507602|FG006|Overall Study|Withdrawal by Subject|0|||
44502688|NCT03409666|79507620|FG000|Overall Study|Physician Decision|0|||
44502689|NCT03409666|79507621|FG001|Overall Study|Physician Decision|1|||
44502690|NCT03409666|79507620|FG000|Overall Study|Protocol Violation|0|||
44502691|NCT03409666|79507621|FG001|Overall Study|Protocol Violation|3|||
44377536|NCT00892047|79382758|FG000|Overall Study|Adverse Event|2|||
44377537|NCT00892047|79382759|FG001|Overall Study|Adverse Event|2|||
44377538|NCT00892047|79382758|FG000|Overall Study|subject burden|2|||
44377539|NCT00892047|79382759|FG001|Overall Study|subject burden|3|||
44377540|NCT00892047|79382758|FG000|Overall Study|Lack of Efficacy|0|||
44377541|NCT00892047|79382759|FG001|Overall Study|Lack of Efficacy|2|||
44377542|NCT00787267|79382767|FG000|Overall Study|Screen failure/Ineligible|10|||
44377543|NCT00787267|79382767|FG000|Overall Study|No Reason Provided|1|||
44502692|NCT03440944|79507629|FG000|Overall Study|Physician Decision|1|||
44502693|NCT03440944|79507630|FG001|Overall Study|Physician Decision|0|||
44502694|NCT03440944|79507629|FG000|Overall Study|No Acceptable Vasculature|0|||
44502695|NCT03440944|79507630|FG001|Overall Study|No Acceptable Vasculature|1|||
44502696|NCT00365105|79507639|FG000|Overall Study|Protocol Violation|5|||
44502697|NCT00365105|79507640|FG001|Overall Study|Protocol Violation|8|||
44566453|NCT02886494|79586324|FG001|Overall Study|Withdrawal by Subject|3|||
44566454|NCT02886494|79586323|FG000|Overall Study|Protocol Violation|4|||
44502698|NCT00399893|79507648|FG000|Overall Study|Withdrawal by Subject|1|||
44502699|NCT00399893|79507649|FG001|Overall Study|Withdrawal by Subject|0|||
44502700|NCT00048542|79507659|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
44502701|NCT00048542|79507660|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
44234898|NCT04356963|79056045|FG000|Second Session|Withdrawal by Subject|3|||
44502702|NCT00048542|79507661|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
44502703|NCT00048542|79507662|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44502704|NCT00048542|79507663|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
44502705|NCT00048542|79507664|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
44502706|NCT00048542|79507665|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
44502707|NCT00048542|79507666|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
44502708|NCT00048542|79507659|FG000|Double-Blind Phase|Protocol Violation|0|||
44502709|NCT00048542|79507660|FG001|Double-Blind Phase|Protocol Violation|0|||
44502710|NCT00048542|79507661|FG002|Double-Blind Phase|Protocol Violation|1|||
44502711|NCT00048542|79507662|FG003|Double-Blind Phase|Protocol Violation|0|||
44502712|NCT00048542|79507663|FG004|Double-Blind Phase|Protocol Violation|0|||
44502713|NCT00048542|79507664|FG005|Double-Blind Phase|Protocol Violation|0|||
44502714|NCT00048542|79507665|FG006|Double-Blind Phase|Protocol Violation|0|||
44502715|NCT00048542|79507666|FG007|Double-Blind Phase|Protocol Violation|0|||
44502716|NCT00048542|79507659|FG000|Double-Blind Phase|Sponsor request or decision|2|||
44502717|NCT00048542|79507660|FG001|Double-Blind Phase|Sponsor request or decision|0|||
44502718|NCT00048542|79507661|FG002|Double-Blind Phase|Sponsor request or decision|0|||
44502719|NCT00048542|79507662|FG003|Double-Blind Phase|Sponsor request or decision|0|||
44502720|NCT00048542|79507663|FG004|Double-Blind Phase|Sponsor request or decision|0|||
44502721|NCT00048542|79507664|FG005|Double-Blind Phase|Sponsor request or decision|0|||
44502722|NCT00048542|79507665|FG006|Double-Blind Phase|Sponsor request or decision|0|||
44502723|NCT00048542|79507666|FG007|Double-Blind Phase|Sponsor request or decision|0|||
44502724|NCT00048542|79507659|FG000|Double-Blind Phase|Randomized in error|1|||
44502725|NCT00048542|79507660|FG001|Double-Blind Phase|Randomized in error|0|||
44502726|NCT00048542|79507661|FG002|Double-Blind Phase|Randomized in error|0|||
44502727|NCT00048542|79507662|FG003|Double-Blind Phase|Randomized in error|0|||
44502728|NCT00048542|79507663|FG004|Double-Blind Phase|Randomized in error|0|||
44502729|NCT00048542|79507664|FG005|Double-Blind Phase|Randomized in error|0|||
44502730|NCT00048542|79507665|FG006|Double-Blind Phase|Randomized in error|0|||
44502731|NCT00048542|79507666|FG007|Double-Blind Phase|Randomized in error|0|||
44502732|NCT00048542|79507659|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
44502733|NCT00048542|79507660|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
44502734|NCT00048542|79507661|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
44502735|NCT00048542|79507662|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
44502736|NCT00048542|79507663|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
44502737|NCT00048542|79507664|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
44566455|NCT02886494|79586324|FG001|Overall Study|Protocol Violation|1|||
44502738|NCT00048542|79507665|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
44502739|NCT00048542|79507666|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
44502740|NCT00048542|79507659|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
44502741|NCT00048542|79507660|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
44566456|NCT00204477|79586335|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
44566457|NCT00204477|79586336|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
44377544|NCT00787267|79382767|FG000|Overall Study|Withdrawal by Subject|1|||
44377545|NCT00928434|79382774|FG000|Overall Study|Adverse Event|14|||
44377546|NCT00928434|79382775|FG001|Overall Study|Adverse Event|5|||
44566458|NCT00204477|79586335|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
44566459|NCT00204477|79586336|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
44566460|NCT02846532|79586345|FG000|Overall Study|Lost to Follow-up|0|||
44566461|NCT02846532|79586346|FG001|Overall Study|Lost to Follow-up|1|||
44566462|NCT02846532|79586347|FG002|Overall Study|Lost to Follow-up|1|||
44566463|NCT02846532|79586345|FG000|Overall Study|Withdrawal by Subject|1|||
44566464|NCT02846532|79586346|FG001|Overall Study|Withdrawal by Subject|2|||
44566465|NCT02846532|79586347|FG002|Overall Study|Withdrawal by Subject|0|||
44566466|NCT00842348|79586366|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
44566467|NCT00842348|79586367|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
44566468|NCT00842348|79586366|FG000|Study 729|Disease progression/death|19|||
44566469|NCT00842348|79586367|FG001|Study 729|Disease progression/death|30|||
44566470|NCT00842348|79586366|FG000|Study 729|Adverse Event|1|||
44566471|NCT00842348|79586367|FG001|Study 729|Adverse Event|1|||
44566472|NCT00842348|79586366|FG000|Study 729|Protocol Violation|1|||
44566473|NCT00842348|79586367|FG001|Study 729|Protocol Violation|1|||
44566474|NCT00842348|79586366|FG000|Study 729|Withdrawal by Subject|2|||
44566475|NCT00842348|79586367|FG001|Study 729|Withdrawal by Subject|4|||
44566476|NCT00842348|79586366|FG000|Study 729|Due to Sponsor stopping the study|1|||
44566477|NCT00842348|79586367|FG001|Study 729|Due to Sponsor stopping the study|1|||
44566478|NCT00842348|79586366|FG000|Study 729|Due to non-availability of IP|0|||
44566479|NCT00842348|79586367|FG001|Study 729|Due to non-availability of IP|1|||
44566480|NCT00842348|79586366|FG000|Study 729|Sponsor's decision|1|||
44566481|NCT00842348|79586367|FG001|Study 729|Sponsor's decision|0|||
44566482|NCT00842348|79586366|FG000|Study 729|Surgical resection|1|||
44566483|NCT00842348|79586367|FG001|Study 729|Surgical resection|0|||
44566484|NCT03095599|79586379|FG000|Overall Study|Withdrawal by Subject|1|||
44566485|NCT03095599|79586380|FG001|Overall Study|Withdrawal by Subject|0|||
44566486|NCT03095599|79586379|FG000|Overall Study|Lost to Follow-up|1|||
44566487|NCT03095599|79586380|FG001|Overall Study|Lost to Follow-up|0|||
44566488|NCT03095599|79586379|FG000|Overall Study|Withdrawal prior to vaccination|1|||
44566489|NCT03095599|79586380|FG001|Overall Study|Withdrawal prior to vaccination|0|||
44566490|NCT03095521|79586390|FG000|Overall Study|Withdrawal by Subject|0|||
44566491|NCT03095521|79586391|FG001|Overall Study|Withdrawal by Subject|1|||
44566492|NCT03095521|79586390|FG000|Overall Study|Lost to Follow-up|0|||
44566493|NCT03095521|79586391|FG001|Overall Study|Lost to Follow-up|1|||
44566494|NCT03033875|79586400|FG000|Overall Study|Withdrawal by Subject|5|||
44566495|NCT03033875|79586401|FG001|Overall Study|Withdrawal by Subject|9|||
44566496|NCT03033875|79586402|FG002|Overall Study|Withdrawal by Subject|4|||
44566497|NCT03033875|79586400|FG000|Overall Study|Other|14|||
44566498|NCT03033875|79586401|FG001|Overall Study|Other|15|||
44566499|NCT03033875|79586402|FG002|Overall Study|Other|8|||
44566500|NCT01968785|79586416|FG000|Overall Study|Withdrawal by Subject|1|||
44566501|NCT01968785|79586417|FG001|Overall Study|Withdrawal by Subject|0|||
44566502|NCT03095287|79586423|FG000|Overall Study|Treatment Failure|1|||
44566503|NCT03095287|79586423|FG000|Overall Study|Adverse Event|1|||
44566504|NCT02839746|79586441|FG000|Overall Study|Not met selection criteria|12|||
44566505|NCT00033293|79586447|FG000|Overall Study|Death|0|||
44566506|NCT00033293|79586448|FG001|Overall Study|Death|1|||
44502742|NCT00048542|79507661|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
44502743|NCT00048542|79507662|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
44566507|NCT00033293|79586447|FG000|Overall Study|Lack of Efficacy|5|||
44566508|NCT00033293|79586448|FG001|Overall Study|Lack of Efficacy|8|||
44566509|NCT00033293|79586447|FG000|Overall Study|Lost to Follow-up|0|||
44566510|NCT00033293|79586448|FG001|Overall Study|Lost to Follow-up|1|||
44566511|NCT00033293|79586447|FG000|Overall Study|Physician Decision|3|||
44566512|NCT00033293|79586448|FG001|Overall Study|Physician Decision|1|||
44566513|NCT00033293|79586447|FG000|Overall Study|Withdrawal by Subject|1|||
44566514|NCT00033293|79586448|FG001|Overall Study|Withdrawal by Subject|0|||
44566515|NCT00033293|79586447|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
44566516|NCT00033293|79586448|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
44502744|NCT00048542|79507663|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
44502745|NCT00048542|79507664|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
44502746|NCT00048542|79507665|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
44502747|NCT00048542|79507666|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
44502748|NCT00048542|79507659|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
44502749|NCT00048542|79507660|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
44502750|NCT00048542|79507661|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
44566517|NCT00033293|79586447|FG000|Overall Study|Treatment refused|0|||
44234899|NCT04356963|79056045|FG000|Second Session|Lost to Follow-up|1|||
44566518|NCT00033293|79586448|FG001|Overall Study|Treatment refused|6|||
44566519|NCT02039674|79586470|FG000|Overall Study|Adverse Event|0|||
44566520|NCT02039674|79586471|FG001|Overall Study|Adverse Event|0|||
44566521|NCT02039674|79586472|FG002|Overall Study|Adverse Event|0|||
44566522|NCT02039674|79586473|FG003|Overall Study|Adverse Event|1|||
44566523|NCT02039674|79586474|FG004|Overall Study|Adverse Event|0|||
44566524|NCT02039674|79586475|FG005|Overall Study|Adverse Event|0|||
44566525|NCT02039674|79586476|FG006|Overall Study|Adverse Event|0|||
44566526|NCT02039674|79586477|FG007|Overall Study|Adverse Event|0|||
44566527|NCT02039674|79586478|FG008|Overall Study|Adverse Event|2|||
44566528|NCT02039674|79586479|FG009|Overall Study|Adverse Event|1|||
44566529|NCT02039674|79586480|FG010|Overall Study|Adverse Event|0|||
44566530|NCT02039674|79586481|FG011|Overall Study|Adverse Event|2|||
44566531|NCT02039674|79586482|FG012|Overall Study|Adverse Event|3|||
44566532|NCT02039674|79586483|FG013|Overall Study|Adverse Event|1|||
44502751|NCT00048542|79507662|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
44502752|NCT00048542|79507663|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
44566533|NCT02039674|79586470|FG000|Overall Study|Death|2|||
44566534|NCT02039674|79586471|FG001|Overall Study|Death|0|||
44566535|NCT02039674|79586472|FG002|Overall Study|Death|2|||
44566536|NCT02039674|79586473|FG003|Overall Study|Death|3|||
44502753|NCT00048542|79507664|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
44502754|NCT00048542|79507665|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
44502755|NCT00048542|79507666|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
44502756|NCT00048542|79507659|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
44502757|NCT00048542|79507660|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
44502758|NCT00048542|79507661|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
44502759|NCT00048542|79507662|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
44502760|NCT00048542|79507663|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
44502761|NCT00048542|79507664|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
44502762|NCT00048542|79507665|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
44502763|NCT00048542|79507666|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
44502764|NCT00048542|79507659|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
44502765|NCT00048542|79507660|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
44502766|NCT00048542|79507661|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
44502767|NCT00048542|79507662|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
44502768|NCT00048542|79507663|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
44502769|NCT00048542|79507664|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
44502770|NCT00048542|79507665|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
44502771|NCT00048542|79507666|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
44502772|NCT00048542|79507659|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
44502773|NCT00048542|79507660|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
44502774|NCT00048542|79507661|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
44502775|NCT00048542|79507662|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
44502776|NCT00048542|79507663|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
44502777|NCT00048542|79507664|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
44502778|NCT00048542|79507665|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
44502779|NCT00048542|79507666|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
44502780|NCT00048542|79507659|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
44502781|NCT00048542|79507660|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
44502782|NCT00048542|79507661|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
44502783|NCT00048542|79507662|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
44502784|NCT00048542|79507663|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
44502785|NCT00048542|79507664|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
44502786|NCT00048542|79507665|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
44502787|NCT00048542|79507666|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
44502788|NCT00048542|79507659|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
44502789|NCT00048542|79507660|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
44502790|NCT00048542|79507661|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
44502791|NCT00048542|79507662|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
44502792|NCT00048542|79507663|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
44502793|NCT00048542|79507664|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
44502794|NCT00048542|79507665|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
44502795|NCT00048542|79507666|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
44566537|NCT02039674|79586474|FG004|Overall Study|Death|0|||
44566538|NCT02039674|79586475|FG005|Overall Study|Death|0|||
44566539|NCT02039674|79586476|FG006|Overall Study|Death|1|||
44566540|NCT02039674|79586477|FG007|Overall Study|Death|0|||
44566541|NCT02039674|79586478|FG008|Overall Study|Death|2|||
44566542|NCT02039674|79586479|FG009|Overall Study|Death|0|||
44566543|NCT02039674|79586480|FG010|Overall Study|Death|1|||
44566544|NCT02039674|79586481|FG011|Overall Study|Death|3|||
44566545|NCT02039674|79586482|FG012|Overall Study|Death|2|||
44566546|NCT02039674|79586483|FG013|Overall Study|Death|8|||
44566547|NCT02039674|79586470|FG000|Overall Study|Excluded Medication|1|||
44566548|NCT02039674|79586471|FG001|Overall Study|Excluded Medication|1|||
44566549|NCT02039674|79586472|FG002|Overall Study|Excluded Medication|0|||
44377547|NCT00928434|79382776|FG002|Overall Study|Adverse Event|18|||
44377548|NCT00928434|79382774|FG000|Overall Study|Protocol Violation|5|||
44377549|NCT00928434|79382775|FG001|Overall Study|Protocol Violation|0|||
44377550|NCT00928434|79382776|FG002|Overall Study|Protocol Violation|8|||
44377551|NCT00928434|79382774|FG000|Overall Study|Physician Decision|2|||
44377552|NCT00928434|79382775|FG001|Overall Study|Physician Decision|0|||
44377553|NCT00928434|79382776|FG002|Overall Study|Physician Decision|3|||
44377554|NCT00928434|79382774|FG000|Overall Study|Lost to Follow-up|1|||
44377555|NCT00928434|79382775|FG001|Overall Study|Lost to Follow-up|0|||
44377556|NCT00928434|79382776|FG002|Overall Study|Lost to Follow-up|3|||
44377557|NCT00928434|79382774|FG000|Overall Study|Withdrawal by Subject|5|||
44377558|NCT00928434|79382775|FG001|Overall Study|Withdrawal by Subject|3|||
44377559|NCT00928434|79382776|FG002|Overall Study|Withdrawal by Subject|2|||
44377560|NCT00928434|79382774|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
44377561|NCT00928434|79382775|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
44377562|NCT00928434|79382776|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
44377563|NCT00928434|79382774|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
44377564|NCT00928434|79382775|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
44377565|NCT00928434|79382776|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
44377566|NCT00928434|79382774|FG000|Overall Study|Other (not meeting above criteria)|5|||
44377567|NCT00928434|79382775|FG001|Overall Study|Other (not meeting above criteria)|1|||
44377568|NCT00928434|79382776|FG002|Overall Study|Other (not meeting above criteria)|2|||
44377569|NCT00787189|79382794|FG000|Overall Study|Lost to Follow-up|2|||
44377570|NCT00787189|79382795|FG001|Overall Study|Lost to Follow-up|2|||
44377571|NCT00784459|79382803|FG000|Overall Study|Adverse Event|0|||
44377572|NCT00784459|79382804|FG001|Overall Study|Adverse Event|2|||
44377573|NCT00786799|79382812|FG000|Overall Study|Lost to Follow-up|1|||
44377574|NCT00786799|79382813|FG001|Overall Study|Lost to Follow-up|1|||
44377575|NCT00786565|79382824|FG000|Enrollment Prior to Surgery|Site Closed|3|||
44377576|NCT00786565|79382824|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
44377577|NCT00786565|79382824|FG000|Post Surgery|Abnormal macular pucker|1|||
44377578|NCT00786565|79382824|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
44377579|NCT00784147|79382832|FG000|Overall Study|Lost to Follow-up|2|||
44377580|NCT00784147|79382833|FG001|Overall Study|Lost to Follow-up|4|||
44377581|NCT00784147|79382832|FG000|Overall Study|Withdrawal by Subject|1|||
44377582|NCT00784147|79382833|FG001|Overall Study|Withdrawal by Subject|3|||
44377583|NCT00784147|79382832|FG000|Overall Study|Physician Decision|2|||
44377584|NCT00784147|79382833|FG001|Overall Study|Physician Decision|1|||
44377585|NCT00784147|79382832|FG000|Overall Study|Protocol Violation|1|||
44377586|NCT00784147|79382833|FG001|Overall Study|Protocol Violation|1|||
44377587|NCT00784147|79382832|FG000|Overall Study|Death|2|||
44377588|NCT00784147|79382833|FG001|Overall Study|Death|0|||
44377589|NCT00891813|79382839|FG000|Overall Study|Adverse Event|3|||
44377590|NCT00891813|79382839|FG000|Overall Study|Withdrawal by Subject|1|||
44377591|NCT00891813|79382839|FG000|Overall Study|Patient Noncompliance|6|||
44377592|NCT00891813|79382839|FG000|Overall Study|Protocol Violation|2|||
44502796|NCT00048542|79507659|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
44502797|NCT00048542|79507660|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
44502798|NCT00048542|79507661|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
44502799|NCT00048542|79507662|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
44502800|NCT00048542|79507663|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
44377593|NCT00783835|79382856|FG000|Overall Study|Adverse Event|3|||
44377594|NCT00783835|79382856|FG000|Overall Study|Medical Criteria|1|||
44377595|NCT00783835|79382856|FG000|Overall Study|Withdrawal by Subject|2|||
44377596|NCT00783835|79382856|FG000|Overall Study|Lost to Follow-up|1|||
44377597|NCT00783835|79382856|FG000|Overall Study|Participant not Adherent|3|||
44377598|NCT00783289|79382864|FG000|Overall Study|Protocol Violation|0|||
44377599|NCT00783289|79382865|FG001|Overall Study|Protocol Violation|1|||
44377600|NCT00783289|79382866|FG002|Overall Study|Protocol Violation|0|||
44377601|NCT00783289|79382867|FG003|Overall Study|Protocol Violation|0|||
44377602|NCT00847912|79382882|FG000|Overall Study|Protocol Violation|6|||
44377603|NCT00847912|79382883|FG001|Overall Study|Protocol Violation|7|||
44377604|NCT00847912|79382882|FG000|Overall Study|Withdrawal by Subject|3|||
44377605|NCT00847912|79382883|FG001|Overall Study|Withdrawal by Subject|6|||
44234900|NCT04356963|79056045|FG000|Third Session|Lost to Follow-up|6|||
44377606|NCT00850564|79382890|FG000|Overall Study|Withdrawal by Subject|2|||
44377607|NCT00837148|79382894|FG000|Overall Study|Adverse Event|1|||
44377608|NCT00837148|79382894|FG000|Overall Study|Death|1|||
44566550|NCT02039674|79586473|FG003|Overall Study|Excluded Medication|1|||
44377609|NCT00849940|79382898|FG000|Overall Study|Physician Decision|4|||
44377610|NCT00849472|79382902|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
44377611|NCT00849472|79382902|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
44377612|NCT00849472|79382902|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
44377613|NCT00849472|79382902|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
44377614|NCT00849472|79382902|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
44377615|NCT00849472|79382902|FG000|Weekly Paclitaxel|Disease Progression|1|||
44377616|NCT00849472|79382902|FG000|Weekly Paclitaxel|Adverse Event|11|||
44377617|NCT00849472|79382902|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
44377618|NCT00849472|79382902|FG000|Weekly Paclitaxel|Physician Decision|3|||
44377619|NCT00849472|79382902|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
44377620|NCT00849472|79382902|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
44377621|NCT00849472|79382902|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
44377622|NCT00849472|79382902|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
44377623|NCT00849472|79382902|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
44377624|NCT00849472|79382902|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
44377625|NCT00849472|79382902|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
44502801|NCT00048542|79507664|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
44502802|NCT00048542|79507665|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
44502803|NCT00048542|79507666|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
44234901|NCT04356963|79056045|FG000|Third Session|Withdrawal by Subject|1|||
44234902|NCT03941483|79056058|FG000|Overall Study|Miscellaneous|2|||
44234903|NCT03941483|79056059|FG001|Overall Study|Miscellaneous|3|||
44234904|NCT03941483|79056060|FG002|Overall Study|Miscellaneous|0|||
44234905|NCT03941483|79056058|FG000|Overall Study|Study Terminated by Sponsor|1|||
44234906|NCT03941483|79056059|FG001|Overall Study|Study Terminated by Sponsor|0|||
44234907|NCT03941483|79056060|FG002|Overall Study|Study Terminated by Sponsor|0|||
44234908|NCT03941483|79056058|FG000|Overall Study|Withdrawal by Subject|1|||
44234909|NCT03941483|79056059|FG001|Overall Study|Withdrawal by Subject|4|||
44234910|NCT03941483|79056060|FG002|Overall Study|Withdrawal by Subject|1|||
44234911|NCT03941483|79056058|FG000|Overall Study|Lost to Follow-up|2|||
44566551|NCT02039674|79586474|FG004|Overall Study|Excluded Medication|0|||
44566552|NCT02039674|79586475|FG005|Overall Study|Excluded Medication|1|||
44566553|NCT02039674|79586476|FG006|Overall Study|Excluded Medication|0|||
44566554|NCT02039674|79586477|FG007|Overall Study|Excluded Medication|0|||
44566555|NCT02039674|79586478|FG008|Overall Study|Excluded Medication|2|||
44234912|NCT03941483|79056059|FG001|Overall Study|Lost to Follow-up|1|||
44566556|NCT02039674|79586479|FG009|Overall Study|Excluded Medication|3|||
44566557|NCT02039674|79586480|FG010|Overall Study|Excluded Medication|5|||
44566558|NCT02039674|79586481|FG011|Overall Study|Excluded Medication|6|||
44566559|NCT02039674|79586482|FG012|Overall Study|Excluded Medication|8|||
44566560|NCT02039674|79586483|FG013|Overall Study|Excluded Medication|3|||
44566561|NCT02039674|79586470|FG000|Overall Study|Lost to Follow-up|0|||
44566562|NCT02039674|79586471|FG001|Overall Study|Lost to Follow-up|0|||
44566563|NCT02039674|79586472|FG002|Overall Study|Lost to Follow-up|0|||
44234913|NCT03941483|79056060|FG002|Overall Study|Lost to Follow-up|8|||
44275779|NCT02192190|79224162|FG000|Overall Study|Adverse Event|1|||
44275780|NCT02192190|79224163|FG001|Overall Study|Adverse Event|1|||
44377626|NCT00849472|79382902|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
44502804|NCT00048542|79507659|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
44502805|NCT00048542|79507660|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
44502806|NCT00048542|79507661|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
44502807|NCT00048542|79507662|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
44502808|NCT00048542|79507663|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
44502809|NCT00048542|79507664|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
44502810|NCT00048542|79507665|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
44502811|NCT00048542|79507666|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
44502812|NCT00048542|79507659|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
44502813|NCT00048542|79507660|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
44502814|NCT00048542|79507661|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
44502815|NCT00048542|79507662|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
44502816|NCT00048542|79507663|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
44502817|NCT00048542|79507664|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
44502818|NCT00048542|79507665|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
44234914|NCT03941483|79056058|FG000|Overall Study|Death|3|||
44234915|NCT03941483|79056059|FG001|Overall Study|Death|2|||
44377627|NCT00782509|79382910|FG000|Overall Study|Adverse Event|20|||
44377628|NCT00782509|79382911|FG001|Overall Study|Adverse Event|10|||
44502819|NCT00048542|79507666|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
44566564|NCT02039674|79586473|FG003|Overall Study|Lost to Follow-up|0|||
44566565|NCT02039674|79586474|FG004|Overall Study|Lost to Follow-up|1|||
44566566|NCT02039674|79586475|FG005|Overall Study|Lost to Follow-up|1|||
44566567|NCT02039674|79586476|FG006|Overall Study|Lost to Follow-up|0|||
44234916|NCT03941483|79056060|FG002|Overall Study|Death|6|||
44234917|NCT03689855|79056096|FG000|Overall Study|Adverse Event|3|||
44234918|NCT03689855|79056096|FG000|Overall Study|Withdrawal by Subject|1|||
44566568|NCT02039674|79586477|FG007|Overall Study|Lost to Follow-up|0|||
44566569|NCT02039674|79586478|FG008|Overall Study|Lost to Follow-up|0|||
44566570|NCT02039674|79586479|FG009|Overall Study|Lost to Follow-up|0|||
44566571|NCT02039674|79586480|FG010|Overall Study|Lost to Follow-up|0|||
44566572|NCT02039674|79586481|FG011|Overall Study|Lost to Follow-up|2|||
44566573|NCT02039674|79586482|FG012|Overall Study|Lost to Follow-up|2|||
44566574|NCT02039674|79586483|FG013|Overall Study|Lost to Follow-up|1|||
44566575|NCT02039674|79586470|FG000|Overall Study|Physician Decision|0|||
44566576|NCT02039674|79586471|FG001|Overall Study|Physician Decision|0|||
44566577|NCT02039674|79586472|FG002|Overall Study|Physician Decision|0|||
44566578|NCT02039674|79586473|FG003|Overall Study|Physician Decision|0|||
44566579|NCT02039674|79586474|FG004|Overall Study|Physician Decision|0|||
44566580|NCT02039674|79586475|FG005|Overall Study|Physician Decision|0|||
44566581|NCT02039674|79586476|FG006|Overall Study|Physician Decision|0|||
44566582|NCT02039674|79586477|FG007|Overall Study|Physician Decision|0|||
44566583|NCT02039674|79586478|FG008|Overall Study|Physician Decision|0|||
44566584|NCT02039674|79586479|FG009|Overall Study|Physician Decision|0|||
44566585|NCT02039674|79586480|FG010|Overall Study|Physician Decision|0|||
44566586|NCT02039674|79586481|FG011|Overall Study|Physician Decision|1|||
44566587|NCT02039674|79586482|FG012|Overall Study|Physician Decision|1|||
44566588|NCT02039674|79586483|FG013|Overall Study|Physician Decision|0|||
44566589|NCT02039674|79586470|FG000|Overall Study|Progressive Disease|8|||
44566590|NCT02039674|79586471|FG001|Overall Study|Progressive Disease|8|||
44566591|NCT02039674|79586472|FG002|Overall Study|Progressive Disease|6|||
44566592|NCT02039674|79586473|FG003|Overall Study|Progressive Disease|7|||
44566593|NCT02039674|79586474|FG004|Overall Study|Progressive Disease|9|||
44566594|NCT02039674|79586475|FG005|Overall Study|Progressive Disease|10|||
44566595|NCT02039674|79586476|FG006|Overall Study|Progressive Disease|1|||
44566596|NCT02039674|79586477|FG007|Overall Study|Progressive Disease|3|||
44566597|NCT02039674|79586478|FG008|Overall Study|Progressive Disease|6|||
44566598|NCT02039674|79586479|FG009|Overall Study|Progressive Disease|4|||
44566599|NCT02039674|79586480|FG010|Overall Study|Progressive Disease|0|||
44566600|NCT02039674|79586481|FG011|Overall Study|Progressive Disease|34|||
44566601|NCT02039674|79586482|FG012|Overall Study|Progressive Disease|34|||
44566602|NCT02039674|79586483|FG013|Overall Study|Progressive Disease|18|||
44566603|NCT02039674|79586470|FG000|Overall Study|Withdrawal by Subject|1|||
44566604|NCT02039674|79586471|FG001|Overall Study|Withdrawal by Subject|2|||
44566605|NCT02039674|79586472|FG002|Overall Study|Withdrawal by Subject|3|||
44566606|NCT02039674|79586473|FG003|Overall Study|Withdrawal by Subject|0|||
44566607|NCT02039674|79586474|FG004|Overall Study|Withdrawal by Subject|1|||
44566608|NCT02039674|79586475|FG005|Overall Study|Withdrawal by Subject|0|||
44566609|NCT02039674|79586476|FG006|Overall Study|Withdrawal by Subject|0|||
44566610|NCT02039674|79586477|FG007|Overall Study|Withdrawal by Subject|0|||
44566611|NCT02039674|79586478|FG008|Overall Study|Withdrawal by Subject|0|||
44566612|NCT02039674|79586479|FG009|Overall Study|Withdrawal by Subject|1|||
44566613|NCT02039674|79586480|FG010|Overall Study|Withdrawal by Subject|1|||
44566614|NCT02039674|79586481|FG011|Overall Study|Withdrawal by Subject|4|||
44566615|NCT02039674|79586482|FG012|Overall Study|Withdrawal by Subject|6|||
44566616|NCT02039674|79586483|FG013|Overall Study|Withdrawal by Subject|2|||
44566617|NCT02039674|79586470|FG000|Overall Study|Clinical Progression|0|||
44566618|NCT02039674|79586471|FG001|Overall Study|Clinical Progression|0|||
44566619|NCT02039674|79586472|FG002|Overall Study|Clinical Progression|0|||
44566620|NCT02039674|79586473|FG003|Overall Study|Clinical Progression|0|||
44566621|NCT02039674|79586474|FG004|Overall Study|Clinical Progression|0|||
44234919|NCT03635996|79056100|FG000|Overall Study|Study terminated by Sponsor|94|||
44566622|NCT02039674|79586475|FG005|Overall Study|Clinical Progression|0|||
44566623|NCT02039674|79586476|FG006|Overall Study|Clinical Progression|1|||
44566624|NCT02039674|79586477|FG007|Overall Study|Clinical Progression|0|||
44566625|NCT02039674|79586478|FG008|Overall Study|Clinical Progression|0|||
44234920|NCT03635996|79056100|FG000|Overall Study|Withdrawal by Subject|20|||
44566626|NCT02039674|79586479|FG009|Overall Study|Clinical Progression|0|||
44566627|NCT02039674|79586480|FG010|Overall Study|Clinical Progression|0|||
44566628|NCT02039674|79586481|FG011|Overall Study|Clinical Progression|0|||
44234921|NCT03635996|79056100|FG000|Overall Study|Ablation|26|||
44566629|NCT02039674|79586482|FG012|Overall Study|Clinical Progression|1|||
44566630|NCT02039674|79586483|FG013|Overall Study|Clinical Progression|0|||
44566631|NCT02039674|79586470|FG000|Overall Study|Sponsor Decision|1|||
44566632|NCT02039674|79586471|FG001|Overall Study|Sponsor Decision|1|||
44566633|NCT02039674|79586472|FG002|Overall Study|Sponsor Decision|1|||
44566634|NCT02039674|79586473|FG003|Overall Study|Sponsor Decision|1|||
44566635|NCT02039674|79586474|FG004|Overall Study|Sponsor Decision|1|||
44566636|NCT02039674|79586475|FG005|Overall Study|Sponsor Decision|0|||
44566637|NCT02039674|79586476|FG006|Overall Study|Sponsor Decision|0|||
44566638|NCT02039674|79586477|FG007|Overall Study|Sponsor Decision|0|||
44566639|NCT02039674|79586478|FG008|Overall Study|Sponsor Decision|0|||
44566640|NCT02039674|79586479|FG009|Overall Study|Sponsor Decision|3|||
44566641|NCT02039674|79586480|FG010|Overall Study|Sponsor Decision|0|||
44566642|NCT02039674|79586481|FG011|Overall Study|Sponsor Decision|8|||
44566643|NCT02039674|79586482|FG012|Overall Study|Sponsor Decision|5|||
44566644|NCT02039674|79586483|FG013|Overall Study|Sponsor Decision|0|||
44566645|NCT02039674|79586470|FG000|Overall Study|Other|0|||
44566646|NCT02039674|79586471|FG001|Overall Study|Other|0|||
44566647|NCT02039674|79586472|FG002|Overall Study|Other|0|||
44566648|NCT02039674|79586473|FG003|Overall Study|Other|0|||
44566649|NCT02039674|79586474|FG004|Overall Study|Other|0|||
44566650|NCT02039674|79586475|FG005|Overall Study|Other|0|||
44566651|NCT02039674|79586476|FG006|Overall Study|Other|0|||
44566652|NCT02039674|79586477|FG007|Overall Study|Other|0|||
44566653|NCT02039674|79586478|FG008|Overall Study|Other|0|||
44566654|NCT02039674|79586479|FG009|Overall Study|Other|0|||
44566655|NCT02039674|79586480|FG010|Overall Study|Other|0|||
44566656|NCT02039674|79586481|FG011|Overall Study|Other|0|||
44566657|NCT02039674|79586482|FG012|Overall Study|Other|1|||
44566658|NCT02039674|79586483|FG013|Overall Study|Other|0|||
44566659|NCT03126227|79586523|FG000|Overall Study|Adverse Event|43|||
44566660|NCT03126227|79586524|FG001|Overall Study|Adverse Event|4|||
44566661|NCT03126227|79586523|FG000|Overall Study|Death|0|||
44566662|NCT03126227|79586524|FG001|Overall Study|Death|1|||
44566663|NCT03126227|79586523|FG000|Overall Study|Lost to Follow-up|0|||
44566664|NCT03126227|79586524|FG001|Overall Study|Lost to Follow-up|1|||
44566665|NCT03126227|79586523|FG000|Overall Study|Physician Decision|2|||
44566666|NCT03126227|79586524|FG001|Overall Study|Physician Decision|0|||
44566667|NCT03126227|79586523|FG000|Overall Study|Protocol Violation|1|||
44566668|NCT03126227|79586524|FG001|Overall Study|Protocol Violation|0|||
44566669|NCT03126227|79586523|FG000|Overall Study|Withdrawal by Subject|19|||
44566670|NCT03126227|79586524|FG001|Overall Study|Withdrawal by Subject|3|||
44566671|NCT03126227|79586523|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
44566672|NCT03126227|79586524|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
44566673|NCT03126227|79586523|FG000|Overall Study|Lack of dosing compliance|2|||
44566674|NCT03126227|79586524|FG001|Overall Study|Lack of dosing compliance|0|||
44566675|NCT03126227|79586523|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
44566676|NCT03126227|79586524|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
44566677|NCT03126227|79586523|FG000|Overall Study|Scheduling conflict|1|||
44566678|NCT03126227|79586524|FG001|Overall Study|Scheduling conflict|0|||
44566679|NCT03099187|79586532|FG000|Double-blind Treatment|Adverse Event|19|||
44234922|NCT03635996|79056100|FG000|Overall Study|Adverse Event|7|||
44234923|NCT03635996|79056100|FG000|Overall Study|Physician Decision|3|||
44234924|NCT03635996|79056100|FG000|Overall Study|Prohibited medication|5|||
44502820|NCT03814590|79507709|FG000|Overall Study|Adverse Event|0|||
44502821|NCT03814590|79507710|FG001|Overall Study|Adverse Event|0|||
44234925|NCT03635996|79056100|FG000|Overall Study|Did not meet eligibility criteria|5|||
44502822|NCT03814590|79507711|FG002|Overall Study|Adverse Event|0|||
44502823|NCT03814590|79507712|FG003|Overall Study|Adverse Event|0|||
44502824|NCT03814590|79507713|FG004|Overall Study|Adverse Event|0|||
44502825|NCT03814590|79507714|FG005|Overall Study|Adverse Event|1|||
44502826|NCT03814590|79507715|FG006|Overall Study|Adverse Event|1|||
44502827|NCT03814590|79507716|FG007|Overall Study|Adverse Event|1|||
44502828|NCT03814590|79507717|FG008|Overall Study|Adverse Event|0|||
44275781|NCT02192190|79224164|FG002|Overall Study|Adverse Event|0|||
44502829|NCT03814590|79507718|FG009|Overall Study|Adverse Event|0|||
44566680|NCT03099187|79586533|FG001|Double-blind Treatment|Adverse Event|1|||
44566681|NCT03099187|79586534|FG002|Double-blind Treatment|Adverse Event|0|||
44566682|NCT03099187|79586535|FG003|Double-blind Treatment|Adverse Event|0|||
44566683|NCT03099187|79586532|FG000|Double-blind Treatment|Death|1|||
44566684|NCT03099187|79586533|FG001|Double-blind Treatment|Death|3|||
44566685|NCT03099187|79586534|FG002|Double-blind Treatment|Death|0|||
44566686|NCT03099187|79586535|FG003|Double-blind Treatment|Death|0|||
44566687|NCT03099187|79586532|FG000|Double-blind Treatment|Lack of Efficacy|1|||
44566688|NCT03099187|79586533|FG001|Double-blind Treatment|Lack of Efficacy|0|||
44566689|NCT03099187|79586534|FG002|Double-blind Treatment|Lack of Efficacy|0|||
44566690|NCT03099187|79586535|FG003|Double-blind Treatment|Lack of Efficacy|0|||
44566691|NCT03099187|79586532|FG000|Double-blind Treatment|Physician Decision|2|||
44566692|NCT03099187|79586533|FG001|Double-blind Treatment|Physician Decision|1|||
44566693|NCT03099187|79586534|FG002|Double-blind Treatment|Physician Decision|0|||
44566694|NCT03099187|79586535|FG003|Double-blind Treatment|Physician Decision|0|||
44566695|NCT03099187|79586532|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
44566696|NCT03099187|79586533|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
44566697|NCT03099187|79586534|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
44566698|NCT03099187|79586535|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
44566699|NCT03099187|79586532|FG000|Double-blind Treatment|Lung transplantation|0|||
44566700|NCT03099187|79586533|FG001|Double-blind Treatment|Lung transplantation|1|||
44566701|NCT03099187|79586534|FG002|Double-blind Treatment|Lung transplantation|0|||
44566702|NCT03099187|79586535|FG003|Double-blind Treatment|Lung transplantation|0|||
44566703|NCT03099187|79586532|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
44566704|NCT03099187|79586533|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
44566705|NCT03099187|79586534|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
44566706|NCT03099187|79586535|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
44566707|NCT03099187|79586532|FG000|Double-blind Treatment|Disease progression|0|||
44566708|NCT03099187|79586533|FG001|Double-blind Treatment|Disease progression|1|||
44566709|NCT03099187|79586534|FG002|Double-blind Treatment|Disease progression|0|||
44566710|NCT03099187|79586535|FG003|Double-blind Treatment|Disease progression|0|||
44566711|NCT03099187|79586532|FG000|Double-blind Treatment|Randomization error|0|||
44566712|NCT03099187|79586533|FG001|Double-blind Treatment|Randomization error|2|||
44566713|NCT03099187|79586534|FG002|Double-blind Treatment|Randomization error|0|||
44566714|NCT03099187|79586535|FG003|Double-blind Treatment|Randomization error|0|||
44566715|NCT03099187|79586532|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
44566716|NCT03099187|79586533|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
44566717|NCT03099187|79586534|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
44566718|NCT03099187|79586535|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
44566719|NCT03099187|79586532|FG000|12-month Safety Follow-up|Adverse Event|0|||
44566720|NCT03099187|79586533|FG001|12-month Safety Follow-up|Adverse Event|0|||
44566721|NCT03099187|79586534|FG002|12-month Safety Follow-up|Adverse Event|5|||
44566722|NCT03099187|79586535|FG003|12-month Safety Follow-up|Adverse Event|12|||
44566723|NCT03099187|79586532|FG000|12-month Safety Follow-up|Death|0|||
44566724|NCT03099187|79586533|FG001|12-month Safety Follow-up|Death|0|||
44566725|NCT03099187|79586534|FG002|12-month Safety Follow-up|Death|7|||
44566726|NCT03099187|79586535|FG003|12-month Safety Follow-up|Death|9|||
44566727|NCT03099187|79586532|FG000|12-month Safety Follow-up|Lung transplantation|0|||
44566728|NCT03099187|79586533|FG001|12-month Safety Follow-up|Lung transplantation|0|||
44566729|NCT03099187|79586534|FG002|12-month Safety Follow-up|Lung transplantation|2|||
44566730|NCT03099187|79586535|FG003|12-month Safety Follow-up|Lung transplantation|1|||
44566731|NCT03099187|79586532|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
44566732|NCT03099187|79586533|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
44566733|NCT03099187|79586534|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
44566734|NCT03099187|79586535|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
44566735|NCT03099187|79586532|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
44566736|NCT03099187|79586533|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
44566737|NCT03099187|79586534|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
44566738|NCT03099187|79586535|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
44566739|NCT03099187|79586532|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
44566740|NCT03099187|79586533|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
44566741|NCT03099187|79586534|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
44566742|NCT03099187|79586535|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
44566743|NCT03099187|79586532|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
44566744|NCT03099187|79586533|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
44566745|NCT03099187|79586534|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
44566746|NCT03099187|79586535|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
44566747|NCT04535453|79586557|FG000|Overall Study|Death|0|||
44566748|NCT04535453|79586558|FG001|Overall Study|Death|1|||
44566749|NCT04535453|79586559|FG002|Overall Study|Death|0|||
44566750|NCT04535453|79586560|FG003|Overall Study|Death|0|||
44566751|NCT04535453|79586561|FG004|Overall Study|Death|0|||
44566752|NCT04535453|79586562|FG005|Overall Study|Death|0|||
44566753|NCT04535453|79586563|FG006|Overall Study|Death|0|||
44566754|NCT04535453|79586564|FG007|Overall Study|Death|0|||
44566755|NCT04535453|79586565|FG008|Overall Study|Death|0|||
44566756|NCT04535453|79586566|FG009|Overall Study|Death|0|||
44566757|NCT04535453|79586567|FG010|Overall Study|Death|0|||
44566758|NCT04535453|79586568|FG011|Overall Study|Death|0|||
44566759|NCT04535453|79586557|FG000|Overall Study|Lost to Follow-up|1|||
44566760|NCT04535453|79586558|FG001|Overall Study|Lost to Follow-up|1|||
44566761|NCT04535453|79586559|FG002|Overall Study|Lost to Follow-up|1|||
44566762|NCT04535453|79586560|FG003|Overall Study|Lost to Follow-up|0|||
44566763|NCT04535453|79586561|FG004|Overall Study|Lost to Follow-up|3|||
44566764|NCT04535453|79586562|FG005|Overall Study|Lost to Follow-up|1|||
44566765|NCT04535453|79586563|FG006|Overall Study|Lost to Follow-up|0|||
44566766|NCT04535453|79586564|FG007|Overall Study|Lost to Follow-up|0|||
44566767|NCT04535453|79586565|FG008|Overall Study|Lost to Follow-up|1|||
44566768|NCT04535453|79586566|FG009|Overall Study|Lost to Follow-up|1|||
44566769|NCT04535453|79586567|FG010|Overall Study|Lost to Follow-up|0|||
44566770|NCT04535453|79586568|FG011|Overall Study|Lost to Follow-up|0|||
44566771|NCT04535453|79586557|FG000|Overall Study|Physician Decision|0|||
44566772|NCT04535453|79586558|FG001|Overall Study|Physician Decision|0|||
44566773|NCT04535453|79586559|FG002|Overall Study|Physician Decision|0|||
44566774|NCT04535453|79586560|FG003|Overall Study|Physician Decision|1|||
44566775|NCT04535453|79586561|FG004|Overall Study|Physician Decision|0|||
44566776|NCT04535453|79586562|FG005|Overall Study|Physician Decision|0|||
44566777|NCT04535453|79586563|FG006|Overall Study|Physician Decision|0|||
44566778|NCT04535453|79586564|FG007|Overall Study|Physician Decision|0|||
44566779|NCT04535453|79586565|FG008|Overall Study|Physician Decision|0|||
44566780|NCT04535453|79586566|FG009|Overall Study|Physician Decision|0|||
44566781|NCT04535453|79586567|FG010|Overall Study|Physician Decision|0|||
44566782|NCT04535453|79586568|FG011|Overall Study|Physician Decision|0|||
44566783|NCT04535453|79586557|FG000|Overall Study|Withdrawal by Subject|3|||
44566784|NCT04535453|79586558|FG001|Overall Study|Withdrawal by Subject|6|||
44566785|NCT04535453|79586559|FG002|Overall Study|Withdrawal by Subject|3|||
44566786|NCT04535453|79586560|FG003|Overall Study|Withdrawal by Subject|3|||
44566787|NCT04535453|79586561|FG004|Overall Study|Withdrawal by Subject|2|||
44566788|NCT04535453|79586562|FG005|Overall Study|Withdrawal by Subject|1|||
44566789|NCT04535453|79586563|FG006|Overall Study|Withdrawal by Subject|1|||
44566790|NCT04535453|79586564|FG007|Overall Study|Withdrawal by Subject|1|||
44566791|NCT04535453|79586565|FG008|Overall Study|Withdrawal by Subject|1|||
44566792|NCT04535453|79586566|FG009|Overall Study|Withdrawal by Subject|1|||
44566793|NCT04535453|79586567|FG010|Overall Study|Withdrawal by Subject|0|||
44566794|NCT04535453|79586568|FG011|Overall Study|Withdrawal by Subject|1|||
44566795|NCT04535453|79586557|FG000|Overall Study|Other|0|||
44566796|NCT04535453|79586558|FG001|Overall Study|Other|0|||
44566797|NCT04535453|79586559|FG002|Overall Study|Other|1|||
44566798|NCT04535453|79586560|FG003|Overall Study|Other|0|||
44566799|NCT04535453|79586561|FG004|Overall Study|Other|1|||
44566800|NCT04535453|79586562|FG005|Overall Study|Other|0|||
44566801|NCT04535453|79586563|FG006|Overall Study|Other|1|||
44566802|NCT04535453|79586564|FG007|Overall Study|Other|1|||
44566803|NCT04535453|79586565|FG008|Overall Study|Other|1|||
44566804|NCT04535453|79586566|FG009|Overall Study|Other|0|||
44566805|NCT04535453|79586567|FG010|Overall Study|Other|0|||
44566806|NCT04535453|79586568|FG011|Overall Study|Other|0|||
44566807|NCT04463069|79586611|FG000|Overall Study|Withdrawal by Subject|2|||
44566808|NCT04463069|79586612|FG001|Overall Study|Withdrawal by Subject|10|||
44566809|NCT04463069|79586611|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
44566810|NCT04463069|79586612|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
44566811|NCT03521687|79586618|FG000|Overall Study|Adverse Event|4|||
44234926|NCT03635996|79056100|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
44234927|NCT03635996|79056100|FG000|Overall Study|Protocol Violation|1|||
44566812|NCT03521687|79586618|FG000|Overall Study|Physician Decision|1|||
44566813|NCT03125915|79586626|FG000|1 Month Follow up|Lost to Follow-up|3|||
44566814|NCT03125915|79586627|FG001|1 Month Follow up|Lost to Follow-up|3|||
44566815|NCT03125915|79586628|FG002|1 Month Follow up|Lost to Follow-up|2|||
44566816|NCT03125915|79586629|FG003|1 Month Follow up|Lost to Follow-up|3|||
44566817|NCT03125915|79586626|FG000|3 Month Follow-up|Lost to Follow-up|6|||
44566818|NCT03125915|79586627|FG001|3 Month Follow-up|Lost to Follow-up|4|||
44234928|NCT03635996|79056100|FG000|Overall Study|Lost to Follow-up|1|||
44566819|NCT03125915|79586628|FG002|3 Month Follow-up|Lost to Follow-up|4|||
44566820|NCT03125915|79586629|FG003|3 Month Follow-up|Lost to Follow-up|2|||
44566821|NCT03125915|79586626|FG000|6 Month Follow-up|Lost to Follow-up|7|||
44566822|NCT03125915|79586627|FG001|6 Month Follow-up|Lost to Follow-up|3|||
44566823|NCT03125915|79586628|FG002|6 Month Follow-up|Lost to Follow-up|6|||
44566824|NCT03125915|79586629|FG003|6 Month Follow-up|Lost to Follow-up|3|||
44566825|NCT03122171|79586639|FG000|Overall Study|Withdrawal by Subject|1|||
44566826|NCT01427725|79586643|FG000|Overall Study|Lost to Follow-up|17|||
44566827|NCT01427725|79586643|FG000|Overall Study|Protocol Violation|1|||
44566828|NCT01427725|79586643|FG000|Overall Study|Drug not administered|1|||
44566829|NCT01427725|79586643|FG000|Overall Study|Failure to visit|7|||
44566830|NCT01427725|79586643|FG000|Overall Study|Adverse Event|46|||
44234929|NCT03595878|79056107|FG000|Overall Study|Death|2|||
44234930|NCT03595878|79056108|FG001|Overall Study|Death|1|||
44234931|NCT03595878|79056109|FG002|Overall Study|Death|0|||
44566831|NCT01427725|79586643|FG000|Overall Study|Failure to visit after administration|40|||
44566832|NCT01427725|79586643|FG000|Overall Study|Patient's rejection|27|||
44566833|NCT01427725|79586643|FG000|Overall Study|Transfer to a different hospital|17|||
44566834|NCT01427725|79586643|FG000|Overall Study|Lack of Efficacy|8|||
44566835|NCT01427725|79586643|FG000|Overall Study|Death|7|||
44566836|NCT01427725|79586643|FG000|Overall Study|Symptom improvement|6|||
44566837|NCT01427725|79586643|FG000|Overall Study|AE and Patient's rejection|5|||
44234932|NCT03595878|79056107|FG000|Overall Study|Disease progression|2|||
44234933|NCT03595878|79056108|FG001|Overall Study|Disease progression|1|||
44566838|NCT01427725|79586643|FG000|Overall Study|Physician Decision|5|||
44566839|NCT01427725|79586643|FG000|Overall Study|Exacerbation of underlying disease|5|||
44566840|NCT01427725|79586643|FG000|Overall Study|Oral feeding difficulty|5|||
44566841|NCT01427725|79586643|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
44566842|NCT01427725|79586643|FG000|Overall Study|Forgetting prescription|1|||
44566843|NCT01427725|79586643|FG000|Overall Study|Other|2|||
44566844|NCT02839200|79586654|FG000|Overall Study|Withdrawal by Subject|2|||
44566845|NCT02839200|79586655|FG001|Overall Study|Withdrawal by Subject|0|||
44566846|NCT02839200|79586656|FG002|Overall Study|Withdrawal by Subject|1|||
44234934|NCT03595878|79056109|FG002|Overall Study|Disease progression|2|||
44234935|NCT03168464|79056155|FG000|Overall Study|Death|9|||
44234936|NCT03168464|79056155|FG000|Overall Study|Progression of disease|6|||
44234937|NCT02818920|79056159|FG000|Overall Study|Unresectable|4|||
44234938|NCT02818920|79056159|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
44234939|NCT02818920|79056159|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
44234940|NCT02818920|79056159|FG000|Overall Study|Adverse Event|3|||
44566847|NCT02839200|79586657|FG003|Overall Study|Withdrawal by Subject|0|||
44566848|NCT02839200|79586658|FG004|Overall Study|Withdrawal by Subject|0|||
44566849|NCT02839200|79586659|FG005|Overall Study|Withdrawal by Subject|1|||
44566850|NCT02839200|79586654|FG000|Overall Study|Lost to Follow-up|2|||
44566851|NCT02839200|79586655|FG001|Overall Study|Lost to Follow-up|0|||
44566852|NCT02839200|79586656|FG002|Overall Study|Lost to Follow-up|0|||
44566853|NCT02839200|79586657|FG003|Overall Study|Lost to Follow-up|0|||
44566854|NCT02839200|79586658|FG004|Overall Study|Lost to Follow-up|1|||
44566855|NCT02839200|79586659|FG005|Overall Study|Lost to Follow-up|0|||
44566856|NCT02839200|79586654|FG000|Overall Study|Adverse Event|0|||
44566857|NCT02839200|79586655|FG001|Overall Study|Adverse Event|0|||
44234941|NCT02818920|79056159|FG000|Overall Study|Developed Other Disease|1|||
44234942|NCT02818920|79056159|FG000|Overall Study|Refused Further Treatment|1|||
44234943|NCT01454401|79056185|FG000|Overall Study|Death|1|||
44275782|NCT02192190|79224165|FG003|Overall Study|Adverse Event|0|||
44275783|NCT02192190|79224166|FG004|Overall Study|Adverse Event|0|||
44275784|NCT02192190|79224167|FG005|Overall Study|Adverse Event|0|||
44275785|NCT02192190|79224162|FG000|Overall Study|Lost to Follow-up|3|||
44566858|NCT02839200|79586656|FG002|Overall Study|Adverse Event|0|||
44566859|NCT02839200|79586657|FG003|Overall Study|Adverse Event|0|||
44566860|NCT02839200|79586658|FG004|Overall Study|Adverse Event|1|||
44566861|NCT02839200|79586659|FG005|Overall Study|Adverse Event|0|||
44566862|NCT02839200|79586654|FG000|Overall Study|Randomized in error|0|||
44566863|NCT02839200|79586655|FG001|Overall Study|Randomized in error|1|||
44566864|NCT02839200|79586656|FG002|Overall Study|Randomized in error|0|||
44566865|NCT02839200|79586657|FG003|Overall Study|Randomized in error|0|||
44566866|NCT02839200|79586658|FG004|Overall Study|Randomized in error|0|||
44566867|NCT02839200|79586659|FG005|Overall Study|Randomized in error|0|||
44566868|NCT03118739|79586675|FG000|Overall Study|Physician Decision|0|||
44566869|NCT03118739|79586676|FG001|Overall Study|Physician Decision|1|||
44566870|NCT03118739|79586675|FG000|Overall Study|Withdrawal by Subject|5|||
44234944|NCT01454401|79056185|FG000|Overall Study|hospitalised|1|||
44234945|NCT01454401|79056185|FG000|Overall Study|osteomyelitis|2|||
44275786|NCT02192190|79224163|FG001|Overall Study|Lost to Follow-up|3|||
44275787|NCT02192190|79224164|FG002|Overall Study|Lost to Follow-up|2|||
44275788|NCT02192190|79224165|FG003|Overall Study|Lost to Follow-up|1|||
44566871|NCT03118739|79586676|FG001|Overall Study|Withdrawal by Subject|3|||
44566872|NCT03118739|79586675|FG000|Overall Study|Lost to Follow-up|2|||
44566873|NCT03118739|79586676|FG001|Overall Study|Lost to Follow-up|0|||
44566874|NCT03094195|79586685|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
44566875|NCT03094195|79586686|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
44234946|NCT01454401|79056185|FG000|Overall Study|non-adherence|1|||
44234947|NCT01344018|79056191|FG000|Overall Study|Death|22|||
44234948|NCT01344018|79056192|FG001|Overall Study|Death|25|||
44234949|NCT01344018|79056191|FG000|Overall Study|Lost to Follow-up|4|||
44234950|NCT01344018|79056192|FG001|Overall Study|Lost to Follow-up|7|||
44234951|NCT01755767|79056225|FG000|Overall Study|Progressive Disease|8|||
44234952|NCT01755767|79056226|FG001|Overall Study|Progressive Disease|7|||
44234953|NCT01755767|79056227|FG002|Overall Study|Progressive Disease|91|||
44234954|NCT01755767|79056228|FG003|Overall Study|Progressive Disease|43|||
44234955|NCT01755767|79056225|FG000|Overall Study|Clinical Disease Progression|4|||
44234956|NCT01755767|79056226|FG001|Overall Study|Clinical Disease Progression|2|||
44234957|NCT01755767|79056227|FG002|Overall Study|Clinical Disease Progression|29|||
44234958|NCT01755767|79056228|FG003|Overall Study|Clinical Disease Progression|20|||
44502830|NCT03814590|79507719|FG010|Overall Study|Adverse Event|1|||
44502831|NCT03814590|79507720|FG011|Overall Study|Adverse Event|0|||
44566876|NCT03094195|79586687|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
44566877|NCT03094195|79586688|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44566878|NCT03094195|79586689|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44566879|NCT03094195|79586690|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44566880|NCT03094195|79586691|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44566881|NCT03094195|79586692|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
44566882|NCT03094195|79586685|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
44566883|NCT03094195|79586686|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
44566884|NCT03094195|79586687|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
44566885|NCT03094195|79586688|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44566886|NCT03094195|79586689|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44566887|NCT03094195|79586690|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44566888|NCT03094195|79586691|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44566889|NCT03094195|79586692|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
44566890|NCT03094195|79586685|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566891|NCT03094195|79586686|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566892|NCT03094195|79586687|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
44566893|NCT03094195|79586688|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566894|NCT03094195|79586689|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566895|NCT03094195|79586690|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566896|NCT03094195|79586691|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566897|NCT03094195|79586692|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
44566898|NCT03094195|79586685|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44566899|NCT03094195|79586686|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
44566900|NCT03094195|79586687|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
44566901|NCT03094195|79586688|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44566902|NCT03094195|79586689|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44566903|NCT03094195|79586690|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44566904|NCT03094195|79586691|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44566905|NCT03094195|79586692|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
44566906|NCT02835690|79586713|FG000|Overall Study|Death|12|||
44566907|NCT02835690|79586714|FG001|Overall Study|Death|11|||
44566908|NCT02835690|79586715|FG002|Overall Study|Death|13|||
44502832|NCT03814590|79507721|FG012|Overall Study|Adverse Event|3|||
44234959|NCT01755767|79056225|FG000|Overall Study|Radiographic Disease Progression|9|||
44234960|NCT01755767|79056226|FG001|Overall Study|Radiographic Disease Progression|4|||
44234961|NCT01755767|79056227|FG002|Overall Study|Radiographic Disease Progression|44|||
44502833|NCT03814590|79507722|FG013|Overall Study|Adverse Event|0|||
44502834|NCT03814590|79507709|FG000|Overall Study|Lost to Follow-up|0|||
44502835|NCT03814590|79507710|FG001|Overall Study|Lost to Follow-up|2|||
44502836|NCT03814590|79507711|FG002|Overall Study|Lost to Follow-up|1|||
44502837|NCT03814590|79507712|FG003|Overall Study|Lost to Follow-up|0|||
44502838|NCT03814590|79507713|FG004|Overall Study|Lost to Follow-up|1|||
44502839|NCT03814590|79507714|FG005|Overall Study|Lost to Follow-up|1|||
44566909|NCT02835690|79586713|FG000|Overall Study|Transferred to Extension Study|2|||
44234962|NCT01755767|79056228|FG003|Overall Study|Radiographic Disease Progression|27|||
44234963|NCT01755767|79056225|FG000|Overall Study|Adverse Event|6|||
44502840|NCT03814590|79507715|FG006|Overall Study|Lost to Follow-up|1|||
44566910|NCT02835690|79586714|FG001|Overall Study|Transferred to Extension Study|2|||
44566911|NCT02835690|79586715|FG002|Overall Study|Transferred to Extension Study|1|||
44566912|NCT02835690|79586713|FG000|Overall Study|Did Not Continue on Extension Study|0|||
44566913|NCT02835690|79586714|FG001|Overall Study|Did Not Continue on Extension Study|0|||
44566914|NCT02835690|79586715|FG002|Overall Study|Did Not Continue on Extension Study|1|||
44566915|NCT02835690|79586713|FG000|Overall Study|Not Treated|0|||
44234964|NCT01755767|79056226|FG001|Overall Study|Adverse Event|0|||
44566916|NCT02835690|79586714|FG001|Overall Study|Not Treated|2|||
44566917|NCT02835690|79586715|FG002|Overall Study|Not Treated|0|||
44566918|NCT02837952|79586726|FG000|Overall Study|Adverse Event|0|||
44566919|NCT02837952|79586727|FG001|Overall Study|Adverse Event|1|||
44566920|NCT02837952|79586726|FG000|Overall Study|Withdrawal by Subject|4|||
44566921|NCT02837952|79586727|FG001|Overall Study|Withdrawal by Subject|5|||
44566922|NCT02837952|79586726|FG000|Overall Study|Medication Error|1|||
44566923|NCT02837952|79586727|FG001|Overall Study|Medication Error|0|||
44566924|NCT02832167|79586733|FG000|Treatment Period 1|Disease progression|90|||
44566925|NCT02832167|79586733|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
44234965|NCT01755767|79056227|FG002|Overall Study|Adverse Event|28|||
44566926|NCT02832167|79586733|FG000|Treatment Period 1|Death|2|||
44234966|NCT01755767|79056228|FG003|Overall Study|Adverse Event|11|||
44234967|NCT01755767|79056225|FG000|Overall Study|Death|1|||
44234968|NCT01755767|79056226|FG001|Overall Study|Death|2|||
44566927|NCT02832167|79586733|FG000|Treatment Period 1|Study Drug Toxicity|6|||
44566928|NCT02832167|79586733|FG000|Treatment Period 1|Participant request to discontinue|9|||
44566929|NCT02832167|79586733|FG000|Treatment Period 1|No longer meet study criteria|1|||
44566930|NCT02832167|79586733|FG000|Treatment Period 1|Participant withdrew consent|3|||
44566931|NCT02832167|79586733|FG000|Treatment Period 1|Other reasons|6|||
44566932|NCT02832167|79586733|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
44566933|NCT02832167|79586733|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
44566934|NCT02832167|79586733|FG000|Transition From Period 1 to Period 2|Death|2|||
44234969|NCT01755767|79056227|FG002|Overall Study|Death|15|||
44234970|NCT01755767|79056228|FG003|Overall Study|Death|4|||
44234971|NCT01755767|79056225|FG000|Overall Study|Subject Decision|0|||
44234972|NCT01755767|79056226|FG001|Overall Study|Subject Decision|0|||
44234973|NCT01755767|79056227|FG002|Overall Study|Subject Decision|10|||
44234974|NCT01755767|79056228|FG003|Overall Study|Subject Decision|3|||
44234975|NCT01755767|79056225|FG000|Overall Study|Withdrawal by Subject|0|||
44234976|NCT01755767|79056226|FG001|Overall Study|Withdrawal by Subject|0|||
44234977|NCT01755767|79056227|FG002|Overall Study|Withdrawal by Subject|2|||
44234978|NCT01755767|79056228|FG003|Overall Study|Withdrawal by Subject|1|||
44234979|NCT01755767|79056225|FG000|Overall Study|Other|0|||
44234980|NCT01755767|79056226|FG001|Overall Study|Other|0|||
44234981|NCT01755767|79056227|FG002|Overall Study|Other|2|||
44234982|NCT01755767|79056228|FG003|Overall Study|Other|3|||
44234983|NCT01755767|79056225|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
44234984|NCT01755767|79056226|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
44234985|NCT01755767|79056227|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
44234986|NCT01755767|79056228|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
44234987|NCT01730339|79056324|FG000|Overall Study|Withdrawal by Subject|3|||
44234988|NCT01730339|79056325|FG001|Overall Study|Withdrawal by Subject|2|||
44234989|NCT01730339|79056324|FG000|Overall Study|Lost to Follow-up|1|||
44234990|NCT01730339|79056325|FG001|Overall Study|Lost to Follow-up|1|||
44234991|NCT01730339|79056324|FG000|Overall Study|Un-specified|1|||
44234992|NCT01730339|79056325|FG001|Overall Study|Un-specified|0|||
44234993|NCT01754753|79056382|FG000|Overall Study|Study close|43|||
44234994|NCT01754753|79056383|FG001|Overall Study|Study close|44|||
44377629|NCT00782509|79382912|FG002|Overall Study|Adverse Event|20|||
44502841|NCT03814590|79507716|FG007|Overall Study|Lost to Follow-up|1|||
44502842|NCT03814590|79507717|FG008|Overall Study|Lost to Follow-up|0|||
44502843|NCT03814590|79507718|FG009|Overall Study|Lost to Follow-up|0|||
44502844|NCT03814590|79507719|FG010|Overall Study|Lost to Follow-up|1|||
44502845|NCT03814590|79507720|FG011|Overall Study|Lost to Follow-up|0|||
44502846|NCT03814590|79507721|FG012|Overall Study|Lost to Follow-up|0|||
44502847|NCT03814590|79507722|FG013|Overall Study|Lost to Follow-up|1|||
44502848|NCT03814590|79507709|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44566935|NCT02832167|79586733|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
44566936|NCT02832167|79586733|FG000|Treatment Period 2|Disease progression|69|||
44566937|NCT02832167|79586733|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
44566938|NCT02832167|79586733|FG000|Treatment Period 2|Maximum clinical benefit|1|||
44566939|NCT02832167|79586733|FG000|Treatment Period 2|Study Drug Toxicity|5|||
44234995|NCT01754753|79056382|FG000|Overall Study|Lost to Follow-up|9|||
44234996|NCT01754753|79056383|FG001|Overall Study|Lost to Follow-up|5|||
44234997|NCT01729871|79056391|FG000|Overall Study|Adverse Event|7|||
44234998|NCT01729871|79056392|FG001|Overall Study|Adverse Event|7|||
44234999|NCT01729871|79056391|FG000|Overall Study|Death|0|||
44235000|NCT01729871|79056392|FG001|Overall Study|Death|1|||
44235001|NCT01729871|79056391|FG000|Overall Study|Lack of Efficacy|0|||
44235002|NCT01729871|79056392|FG001|Overall Study|Lack of Efficacy|1|||
44235003|NCT01729871|79056391|FG000|Overall Study|Physician Decision|0|||
44235004|NCT01729871|79056392|FG001|Overall Study|Physician Decision|2|||
44235005|NCT01729871|79056391|FG000|Overall Study|Protocol Violation|1|||
44235006|NCT01729871|79056392|FG001|Overall Study|Protocol Violation|0|||
44502849|NCT03814590|79507710|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44566940|NCT02832167|79586733|FG000|Treatment Period 2|Participant request to discontinue|2|||
44566941|NCT02832167|79586733|FG000|Treatment Period 2|Participant withdrew consent|3|||
44566942|NCT02832167|79586733|FG000|Treatment Period 2|Other reasons|3|||
44566943|NCT02674529|79586739|FG000|Overall Study|Lost to Follow-up|1|||
44566944|NCT02674529|79586740|FG001|Overall Study|Lost to Follow-up|2|||
44502850|NCT03814590|79507711|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502851|NCT03814590|79507712|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44566945|NCT02674529|79586739|FG000|Overall Study|Withdrawal by Subject|2|||
44566946|NCT02674529|79586740|FG001|Overall Study|Withdrawal by Subject|1|||
44502852|NCT03814590|79507713|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502853|NCT03814590|79507714|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502854|NCT03814590|79507715|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502855|NCT03814590|79507716|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502856|NCT03814590|79507717|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44566947|NCT02674529|79586739|FG000|Overall Study|Physician Decision|0|||
44566948|NCT02674529|79586740|FG001|Overall Study|Physician Decision|1|||
44566949|NCT02674529|79586739|FG000|Overall Study|Protocol Violation|0|||
44566950|NCT02674529|79586740|FG001|Overall Study|Protocol Violation|1|||
44566951|NCT02626949|79586751|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
44566952|NCT02626949|79586752|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
44566953|NCT02626949|79586751|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
44566954|NCT02626949|79586752|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
44566955|NCT02626949|79586751|FG000|Enrolled|Lost to Follow-up|7|||
44566956|NCT02626949|79586752|FG001|Enrolled|Lost to Follow-up|6|||
44502857|NCT03814590|79507718|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
44502858|NCT03814590|79507719|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502859|NCT03814590|79507720|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502860|NCT03814590|79507721|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502861|NCT03814590|79507722|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
44502862|NCT03814590|79507709|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502863|NCT03814590|79507710|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502864|NCT03814590|79507711|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502865|NCT03814590|79507712|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502866|NCT03814590|79507713|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502867|NCT03814590|79507714|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
44502868|NCT03814590|79507715|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
44502869|NCT03814590|79507716|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
44502870|NCT03814590|79507717|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502871|NCT03814590|79507718|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
44502872|NCT03814590|79507719|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
44502873|NCT03814590|79507720|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
44502874|NCT03814590|79507721|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
44566957|NCT02626949|79586751|FG000|Enrolled|Withdrawal by Subject|3|||
44566958|NCT02626949|79586752|FG001|Enrolled|Withdrawal by Subject|2|||
44235007|NCT01729871|79056391|FG000|Overall Study|Withdrawal by Subject|0|||
44275789|NCT02192190|79224166|FG004|Overall Study|Lost to Follow-up|4|||
44566959|NCT03116399|79586760|FG000|Overall Study|Death|8|||
44566960|NCT03116399|79586761|FG001|Overall Study|Death|3|||
44566961|NCT03116399|79586760|FG000|Overall Study|Lost to Follow-up|7|||
44566962|NCT03116399|79586761|FG001|Overall Study|Lost to Follow-up|11|||
44566963|NCT03116399|79586760|FG000|Overall Study|Investigator Decision|1|||
44566964|NCT03116399|79586761|FG001|Overall Study|Investigator Decision|1|||
44566965|NCT03116399|79586760|FG000|Overall Study|Withdrawal by Subject|24|||
44566966|NCT03116399|79586761|FG001|Overall Study|Withdrawal by Subject|9|||
44566967|NCT03097861|79586770|FG000|Overall Study|Adverse Event|3|||
44566968|NCT03097861|79586771|FG001|Overall Study|Adverse Event|8|||
44566969|NCT03097861|79586772|FG002|Overall Study|Adverse Event|4|||
44566970|NCT03097861|79586770|FG000|Overall Study|Investigator Decision|0|||
44566971|NCT03097861|79586771|FG001|Overall Study|Investigator Decision|1|||
44566972|NCT03097861|79586772|FG002|Overall Study|Investigator Decision|0|||
44566973|NCT03097861|79586770|FG000|Overall Study|Lost to Follow-up|0|||
44566974|NCT03097861|79586771|FG001|Overall Study|Lost to Follow-up|7|||
44566975|NCT03097861|79586772|FG002|Overall Study|Lost to Follow-up|1|||
44566976|NCT03097861|79586770|FG000|Overall Study|Withdrawal by Subject|1|||
44566977|NCT03097861|79586771|FG001|Overall Study|Withdrawal by Subject|5|||
44566978|NCT03097861|79586772|FG002|Overall Study|Withdrawal by Subject|3|||
44566979|NCT03097861|79586770|FG000|Overall Study|Reason not provided|3|||
44566980|NCT03097861|79586771|FG001|Overall Study|Reason not provided|1|||
44377630|NCT00782509|79382910|FG000|Overall Study|Lost to Follow-up|1|||
44377631|NCT00782509|79382911|FG001|Overall Study|Lost to Follow-up|2|||
44502875|NCT03814590|79507722|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
44502876|NCT03814590|79507709|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44566981|NCT03097861|79586772|FG002|Overall Study|Reason not provided|1|||
44566982|NCT01816139|79586788|FG000|Overall Study|Adverse Event|6|||
44566983|NCT01816139|79586789|FG001|Overall Study|Adverse Event|8|||
44377632|NCT00782509|79382912|FG002|Overall Study|Lost to Follow-up|3|||
44377633|NCT00782509|79382910|FG000|Overall Study|Withdrawal by Subject|3|||
44377634|NCT00782509|79382911|FG001|Overall Study|Withdrawal by Subject|5|||
44502877|NCT03814590|79507710|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502878|NCT03814590|79507711|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502879|NCT03814590|79507712|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502880|NCT03814590|79507713|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502881|NCT03814590|79507714|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502882|NCT03814590|79507715|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502883|NCT03814590|79507716|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44502884|NCT03814590|79507717|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502885|NCT03814590|79507718|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44502886|NCT03814590|79507719|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502887|NCT03814590|79507720|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502888|NCT03814590|79507721|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502889|NCT03814590|79507722|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44502890|NCT03814590|79507709|FG000|Overall Study|UNKNOWN REASON|0|||
44502891|NCT03814590|79507710|FG001|Overall Study|UNKNOWN REASON|0|||
44502892|NCT03814590|79507711|FG002|Overall Study|UNKNOWN REASON|0|||
44502893|NCT03814590|79507712|FG003|Overall Study|UNKNOWN REASON|0|||
44502894|NCT03814590|79507713|FG004|Overall Study|UNKNOWN REASON|0|||
44502895|NCT03814590|79507714|FG005|Overall Study|UNKNOWN REASON|0|||
44502896|NCT03814590|79507715|FG006|Overall Study|UNKNOWN REASON|0|||
44502897|NCT03814590|79507716|FG007|Overall Study|UNKNOWN REASON|1|||
44502898|NCT03814590|79507717|FG008|Overall Study|UNKNOWN REASON|0|||
44502899|NCT03814590|79507718|FG009|Overall Study|UNKNOWN REASON|0|||
44502900|NCT03814590|79507719|FG010|Overall Study|UNKNOWN REASON|0|||
44502901|NCT03814590|79507720|FG011|Overall Study|UNKNOWN REASON|0|||
44502902|NCT03814590|79507721|FG012|Overall Study|UNKNOWN REASON|0|||
44502903|NCT03814590|79507722|FG013|Overall Study|UNKNOWN REASON|0|||
44502904|NCT00048074|79507765|FG000|Overall Study|Adverse Event|46|||
44377635|NCT00782509|79382912|FG002|Overall Study|Withdrawal by Subject|8|||
44502905|NCT00048074|79507766|FG001|Overall Study|Adverse Event|41|||
44566984|NCT01816139|79586788|FG000|Overall Study|Lack of Efficacy|1|||
44566985|NCT01816139|79586789|FG001|Overall Study|Lack of Efficacy|2|||
44566986|NCT01816139|79586788|FG000|Overall Study|Lost to Follow-up|5|||
44566987|NCT01816139|79586789|FG001|Overall Study|Lost to Follow-up|3|||
44566988|NCT01816139|79586788|FG000|Overall Study|Withdrew Consent|6|||
44566989|NCT01816139|79586789|FG001|Overall Study|Withdrew Consent|4|||
44566990|NCT01816139|79586788|FG000|Overall Study|Protocol Violation|6|||
44566991|NCT01816139|79586789|FG001|Overall Study|Protocol Violation|3|||
44566992|NCT01816139|79586788|FG000|Overall Study|Reason not Specified|4|||
44566993|NCT01816139|79586789|FG001|Overall Study|Reason not Specified|2|||
44566994|NCT02833350|79586832|FG000|Overall Study|Adverse Event|0|||
44566995|NCT02833350|79586833|FG001|Overall Study|Adverse Event|3|||
44566996|NCT02833350|79586834|FG002|Overall Study|Adverse Event|4|||
44235008|NCT01729871|79056392|FG001|Overall Study|Withdrawal by Subject|3|||
44235009|NCT01729871|79056391|FG000|Overall Study|Other|4|||
44235010|NCT01729871|79056392|FG001|Overall Study|Other|9|||
44235011|NCT02611323|79056409|FG000|Overall Study|Death|3|||
44235012|NCT02611323|79056410|FG001|Overall Study|Death|1|||
44377636|NCT00782509|79382910|FG000|Overall Study|Non compliance with protocol|2|||
44377637|NCT00782509|79382911|FG001|Overall Study|Non compliance with protocol|0|||
44377638|NCT00782509|79382912|FG002|Overall Study|Non compliance with protocol|0|||
44377639|NCT00782509|79382910|FG000|Overall Study|Other reasons not stated above|5|||
44566997|NCT02833350|79586835|FG003|Overall Study|Adverse Event|4|||
44566998|NCT02833350|79586836|FG004|Overall Study|Adverse Event|1|||
44566999|NCT02833350|79586837|FG005|Overall Study|Adverse Event|0|||
44567000|NCT02833350|79586838|FG006|Overall Study|Adverse Event|1|||
44567001|NCT02833350|79586832|FG000|Overall Study|Death|0|||
44377640|NCT00782509|79382911|FG001|Overall Study|Other reasons not stated above|2|||
44567002|NCT02833350|79586833|FG001|Overall Study|Death|0|||
44567003|NCT02833350|79586834|FG002|Overall Study|Death|1|||
44567004|NCT02833350|79586835|FG003|Overall Study|Death|0|||
44567005|NCT02833350|79586836|FG004|Overall Study|Death|0|||
44567006|NCT02833350|79586837|FG005|Overall Study|Death|0|||
44567007|NCT02833350|79586838|FG006|Overall Study|Death|0|||
44567008|NCT02833350|79586832|FG000|Overall Study|Lack of Efficacy|0|||
44235013|NCT02611323|79056411|FG002|Overall Study|Death|0|||
44567009|NCT02833350|79586833|FG001|Overall Study|Lack of Efficacy|2|||
44567010|NCT02833350|79586834|FG002|Overall Study|Lack of Efficacy|1|||
44567011|NCT02833350|79586835|FG003|Overall Study|Lack of Efficacy|4|||
44235014|NCT02611323|79056412|FG003|Overall Study|Death|0|||
44235015|NCT02611323|79056413|FG004|Overall Study|Death|1|||
44567012|NCT02833350|79586836|FG004|Overall Study|Lack of Efficacy|0|||
44502906|NCT00048074|79507767|FG002|Overall Study|Adverse Event|53|||
44235016|NCT02611323|79056414|FG005|Overall Study|Death|1|||
44502907|NCT00048074|79507765|FG000|Overall Study|Death|3|||
44235017|NCT02611323|79056415|FG006|Overall Study|Death|8|||
44235018|NCT02611323|79056416|FG007|Overall Study|Death|0|||
44235019|NCT02611323|79056417|FG008|Overall Study|Death|4|||
44235020|NCT02611323|79056418|FG009|Overall Study|Death|6|||
44235021|NCT02611323|79056419|FG010|Overall Study|Death|26|||
44235022|NCT02611323|79056409|FG000|Overall Study|Lost to Follow-up|1|||
44235023|NCT02611323|79056410|FG001|Overall Study|Lost to Follow-up|0|||
44235024|NCT02611323|79056411|FG002|Overall Study|Lost to Follow-up|0|||
44235025|NCT02611323|79056412|FG003|Overall Study|Lost to Follow-up|0|||
44235026|NCT02611323|79056413|FG004|Overall Study|Lost to Follow-up|0|||
44567013|NCT02833350|79586837|FG005|Overall Study|Lack of Efficacy|1|||
44567014|NCT02833350|79586838|FG006|Overall Study|Lack of Efficacy|1|||
44567015|NCT02833350|79586832|FG000|Overall Study|Lost to Follow-up|0|||
44567016|NCT02833350|79586833|FG001|Overall Study|Lost to Follow-up|1|||
44567017|NCT02833350|79586834|FG002|Overall Study|Lost to Follow-up|0|||
44567018|NCT02833350|79586835|FG003|Overall Study|Lost to Follow-up|0|||
44567019|NCT02833350|79586836|FG004|Overall Study|Lost to Follow-up|0|||
44567020|NCT02833350|79586837|FG005|Overall Study|Lost to Follow-up|0|||
44567021|NCT02833350|79586838|FG006|Overall Study|Lost to Follow-up|1|||
44567022|NCT02833350|79586832|FG000|Overall Study|Withdrawal by Subject|3|||
44567023|NCT02833350|79586833|FG001|Overall Study|Withdrawal by Subject|3|||
44567024|NCT02833350|79586834|FG002|Overall Study|Withdrawal by Subject|2|||
44567025|NCT02833350|79586835|FG003|Overall Study|Withdrawal by Subject|0|||
44567026|NCT02833350|79586836|FG004|Overall Study|Withdrawal by Subject|2|||
44235027|NCT02611323|79056414|FG005|Overall Study|Lost to Follow-up|0|||
44235028|NCT02611323|79056415|FG006|Overall Study|Lost to Follow-up|3|||
44235029|NCT02611323|79056416|FG007|Overall Study|Lost to Follow-up|0|||
44235030|NCT02611323|79056417|FG008|Overall Study|Lost to Follow-up|0|||
44235031|NCT02611323|79056418|FG009|Overall Study|Lost to Follow-up|0|||
44235032|NCT02611323|79056419|FG010|Overall Study|Lost to Follow-up|2|||
44502908|NCT00048074|79507766|FG001|Overall Study|Death|3|||
44502909|NCT00048074|79507767|FG002|Overall Study|Death|2|||
44502910|NCT00048074|79507765|FG000|Overall Study|Lost to Follow-up|2|||
44502911|NCT00048074|79507766|FG001|Overall Study|Lost to Follow-up|6|||
44502912|NCT00048074|79507767|FG002|Overall Study|Lost to Follow-up|6|||
44502913|NCT00048074|79507765|FG000|Overall Study|Withdrawal by Subject|28|||
44502914|NCT00048074|79507766|FG001|Overall Study|Withdrawal by Subject|30|||
44502915|NCT00048074|79507767|FG002|Overall Study|Withdrawal by Subject|35|||
44502916|NCT00048074|79507765|FG000|Overall Study|Protocol Violation|1|||
44502917|NCT00048074|79507766|FG001|Overall Study|Protocol Violation|3|||
44502918|NCT00048074|79507767|FG002|Overall Study|Protocol Violation|0|||
44502919|NCT00048074|79507765|FG000|Overall Study|Study participation was terminated|0|||
44502920|NCT00048074|79507766|FG001|Overall Study|Study participation was terminated|1|||
44502921|NCT00048074|79507767|FG002|Overall Study|Study participation was terminated|0|||
44502922|NCT00048074|79507765|FG000|Overall Study|Husband ill|0|||
44502923|NCT00048074|79507766|FG001|Overall Study|Husband ill|1|||
44502924|NCT00048074|79507767|FG002|Overall Study|Husband ill|0|||
44502925|NCT00048074|79507765|FG000|Overall Study|Poor compliance|0|||
44567027|NCT02833350|79586837|FG005|Overall Study|Withdrawal by Subject|0|||
44567028|NCT02833350|79586838|FG006|Overall Study|Withdrawal by Subject|2|||
44567029|NCT01343043|79586861|FG000|Overall Study|Disease progression before treatment|1|||
44567030|NCT01343043|79586862|FG001|Overall Study|Disease progression before treatment|0|||
44567031|NCT01343043|79586863|FG002|Overall Study|Disease progression before treatment|0|||
44567032|NCT01343043|79586864|FG003|Overall Study|Disease progression before treatment|0|||
44567033|NCT01343043|79586861|FG000|Overall Study|Withdrawal by Subject|1|||
44567034|NCT01343043|79586862|FG001|Overall Study|Withdrawal by Subject|0|||
44567035|NCT01343043|79586863|FG002|Overall Study|Withdrawal by Subject|0|||
44567036|NCT01343043|79586864|FG003|Overall Study|Withdrawal by Subject|0|||
44567037|NCT01343043|79586861|FG000|Overall Study|Death|1|||
44567038|NCT01343043|79586862|FG001|Overall Study|Death|1|||
44567039|NCT01343043|79586863|FG002|Overall Study|Death|0|||
44567040|NCT01343043|79586864|FG003|Overall Study|Death|1|||
44235033|NCT02611323|79056409|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235034|NCT02611323|79056410|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
44502926|NCT00048074|79507766|FG001|Overall Study|Poor compliance|1|||
44235035|NCT02611323|79056411|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235036|NCT02611323|79056412|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
44502927|NCT00048074|79507767|FG002|Overall Study|Poor compliance|0|||
44567041|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
44567042|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
44567043|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
44235037|NCT02611323|79056413|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
44502928|NCT00048074|79507765|FG000|Overall Study|Out of station|0|||
44502929|NCT00048074|79507766|FG001|Overall Study|Out of station|1|||
44502930|NCT00048074|79507767|FG002|Overall Study|Out of station|1|||
44235038|NCT02611323|79056414|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235039|NCT02611323|79056415|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235040|NCT02611323|79056416|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235041|NCT02611323|79056417|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235042|NCT02611323|79056418|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
44235043|NCT02611323|79056419|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
44235044|NCT02611323|79056409|FG000|Overall Study|Progressive Disease|0|||
44235045|NCT02611323|79056410|FG001|Overall Study|Progressive Disease|0|||
44235046|NCT02611323|79056411|FG002|Overall Study|Progressive Disease|0|||
44235047|NCT02611323|79056412|FG003|Overall Study|Progressive Disease|0|||
44235048|NCT02611323|79056413|FG004|Overall Study|Progressive Disease|0|||
44567044|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
44567045|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
44567046|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
44567047|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
44567048|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
44567049|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
44567050|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
44567051|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
44567052|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
44567053|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
44567054|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
44567055|NCT03548987|79586879|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
44567056|NCT03548987|79586880|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
44567057|NCT03548987|79586879|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
44567058|NCT03548987|79586880|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
44567059|NCT03548987|79586879|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
44567060|NCT03548987|79586880|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
44567061|NCT03548987|79586879|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
44567062|NCT03548987|79586880|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
44567063|NCT03548987|79586879|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
44567064|NCT03548987|79586880|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
44567065|NCT03548987|79586879|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
44235049|NCT02611323|79056414|FG005|Overall Study|Progressive Disease|0|||
44235050|NCT02611323|79056415|FG006|Overall Study|Progressive Disease|0|||
44235051|NCT02611323|79056416|FG007|Overall Study|Progressive Disease|0|||
44235052|NCT02611323|79056417|FG008|Overall Study|Progressive Disease|0|||
44235053|NCT02611323|79056418|FG009|Overall Study|Progressive Disease|0|||
44235054|NCT02611323|79056419|FG010|Overall Study|Progressive Disease|1|||
44235055|NCT02611323|79056409|FG000|Overall Study|Withdrawal by Subject|1|||
44235056|NCT02611323|79056410|FG001|Overall Study|Withdrawal by Subject|0|||
44235057|NCT02611323|79056411|FG002|Overall Study|Withdrawal by Subject|0|||
44235058|NCT02611323|79056412|FG003|Overall Study|Withdrawal by Subject|0|||
44235059|NCT02611323|79056413|FG004|Overall Study|Withdrawal by Subject|0|||
44235060|NCT02611323|79056414|FG005|Overall Study|Withdrawal by Subject|0|||
44235061|NCT02611323|79056415|FG006|Overall Study|Withdrawal by Subject|0|||
44235062|NCT02611323|79056416|FG007|Overall Study|Withdrawal by Subject|1|||
44235063|NCT02611323|79056417|FG008|Overall Study|Withdrawal by Subject|0|||
44235064|NCT02611323|79056418|FG009|Overall Study|Withdrawal by Subject|1|||
44235065|NCT02611323|79056419|FG010|Overall Study|Withdrawal by Subject|0|||
44235066|NCT01729559|79056458|FG000|Overall Study|Protocol Violation|31|||
44235067|NCT01729559|79056459|FG001|Overall Study|Protocol Violation|28|||
44377641|NCT00782509|79382912|FG002|Overall Study|Other reasons not stated above|3|||
44377642|NCT00782509|79382910|FG000|Overall Study|Lack of Efficacy|10|||
44377643|NCT00782509|79382911|FG001|Overall Study|Lack of Efficacy|5|||
44377644|NCT00782509|79382912|FG002|Overall Study|Lack of Efficacy|2|||
44377645|NCT00927810|79382931|FG000|Overall Study|Withdrawal by Subject|0|||
44502931|NCT00048074|79507765|FG000|Overall Study|Social reasons|1|||
44502932|NCT00048074|79507766|FG001|Overall Study|Social reasons|0|||
44502933|NCT00048074|79507767|FG002|Overall Study|Social reasons|0|||
44502934|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
44502935|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
44502936|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
44502937|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
44502938|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
44235068|NCT01728779|79056478|FG000|Overall Study|Withdrawal by Subject|1|||
44235069|NCT01728623|79056489|FG000|Overall Study|Disease progression|26|||
44235070|NCT01728623|79056489|FG000|Overall Study|Adverse Event|1|||
44235071|NCT01728623|79056489|FG000|Overall Study|Withdrawal by Subject|1|||
44235072|NCT01754129|79056496|FG000|Overall Study|Death|13|||
44377646|NCT00927810|79382932|FG001|Overall Study|Withdrawal by Subject|3|||
44235073|NCT01754129|79056496|FG000|Overall Study|Duodopa discontinuation|9|||
44235074|NCT01754129|79056496|FG000|Overall Study|Lost to Follow-up|7|||
44235075|NCT01754129|79056496|FG000|Overall Study|Withdrew consent|1|||
44235076|NCT01754129|79056496|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
44235077|NCT01728077|79056509|FG000|Overall Study|Lack of Efficacy|3|||
44235078|NCT01728077|79056510|FG001|Overall Study|Lack of Efficacy|1|||
44502939|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
44567066|NCT03548987|79586880|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
44567067|NCT03548987|79586879|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
44567068|NCT03548987|79586880|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
44567069|NCT01358760|79586890|FG000|Overall Study|Adverse Event|3|||
44567070|NCT01358760|79586891|FG001|Overall Study|Adverse Event|4|||
44567071|NCT01358760|79586892|FG002|Overall Study|Adverse Event|3|||
44567072|NCT01358760|79586890|FG000|Overall Study|Lost to Follow-up|1|||
44567073|NCT01358760|79586891|FG001|Overall Study|Lost to Follow-up|1|||
44567074|NCT01358760|79586892|FG002|Overall Study|Lost to Follow-up|3|||
44567075|NCT01358760|79586890|FG000|Overall Study|Withdrawal by Subject|5|||
44567076|NCT01358760|79586891|FG001|Overall Study|Withdrawal by Subject|3|||
44235079|NCT01728077|79056509|FG000|Overall Study|Lost to Follow-up|1|||
44502940|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
44567077|NCT01358760|79586892|FG002|Overall Study|Withdrawal by Subject|2|||
44567078|NCT01358760|79586890|FG000|Overall Study|Physician Decision|1|||
44567079|NCT01358760|79586891|FG001|Overall Study|Physician Decision|0|||
44567080|NCT01358760|79586892|FG002|Overall Study|Physician Decision|1|||
44567081|NCT01358760|79586890|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
44567082|NCT01358760|79586891|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
44567083|NCT01358760|79586892|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
44567084|NCT01341990|79586902|FG000|Overall Study|Adverse Event|0|||
44567085|NCT01341990|79586903|FG001|Overall Study|Adverse Event|1|||
44567086|NCT01341990|79586902|FG000|Overall Study|Torn Study Lens|1|||
44567087|NCT01341990|79586903|FG001|Overall Study|Torn Study Lens|0|||
44567088|NCT01341990|79586902|FG000|Overall Study|Withdrawal by Subject|2|||
44567089|NCT01341990|79586903|FG001|Overall Study|Withdrawal by Subject|0|||
44567090|NCT03048747|79586909|FG000|Overall Study|Adverse Event|2|||
44567091|NCT03048747|79586909|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
44567092|NCT03048747|79586909|FG000|Overall Study|Physician Decision|1|||
44567093|NCT01991067|79586971|FG000|Overall Study|Lost to Follow-up|6|||
44567094|NCT01991067|79586972|FG001|Overall Study|Lost to Follow-up|5|||
44567095|NCT01709331|79586978|FG000|Overall Study|Adverse Event|1|||
44567096|NCT03255083|79586986|FG000|Overall Study|Clinical progression|1|||
44567097|NCT03255083|79586987|FG001|Overall Study|Clinical progression|0|||
44567098|NCT03255083|79586988|FG002|Overall Study|Clinical progression|0|||
44567099|NCT03255083|79586989|FG003|Overall Study|Clinical progression|0|||
44567100|NCT03255083|79586986|FG000|Overall Study|Adverse Event|0|||
44502941|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
44502942|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
44502943|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
44502944|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
44502945|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
44502946|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
44502947|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
44502948|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
44502949|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
44502950|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
44502951|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502952|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502953|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44567101|NCT03255083|79586987|FG001|Overall Study|Adverse Event|1|||
44567102|NCT03255083|79586988|FG002|Overall Study|Adverse Event|0|||
44567103|NCT03255083|79586989|FG003|Overall Study|Adverse Event|0|||
44567104|NCT03255083|79586986|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
44567105|NCT03255083|79586987|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
44567106|NCT03255083|79586988|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
44235080|NCT01728077|79056510|FG001|Overall Study|Lost to Follow-up|0|||
44235081|NCT01728077|79056509|FG000|Overall Study|Subject choice|2|||
44502954|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502955|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502956|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502957|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44567107|NCT03255083|79586989|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
44567108|NCT03255083|79586986|FG000|Overall Study|Withdrawal by Subject|1|||
44567109|NCT03255083|79586987|FG001|Overall Study|Withdrawal by Subject|1|||
44567110|NCT03255083|79586988|FG002|Overall Study|Withdrawal by Subject|1|||
44567111|NCT03255083|79586989|FG003|Overall Study|Withdrawal by Subject|0|||
44567112|NCT04552587|79587005|FG000|Overall Study|Lost to Follow-up|4|||
44567113|NCT01316055|79587021|FG000|Overall Study|Lost to Follow-up|1|||
44567114|NCT01316055|79587022|FG001|Overall Study|Lost to Follow-up|0|||
44567115|NCT01316055|79587023|FG002|Overall Study|Lost to Follow-up|0|||
44567116|NCT01340976|79587040|FG000|Overall Study|Physician Decision|2|||
44567117|NCT01340976|79587041|FG001|Overall Study|Physician Decision|0|||
44567118|NCT01340976|79587042|FG002|Overall Study|Physician Decision|1|||
44377647|NCT00927810|79382933|FG002|Overall Study|Withdrawal by Subject|0|||
44377648|NCT00927810|79382934|FG003|Overall Study|Withdrawal by Subject|1|||
44377649|NCT00927810|79382931|FG000|Overall Study|Lost to Follow-up|0|||
44377650|NCT00927810|79382932|FG001|Overall Study|Lost to Follow-up|2|||
44502958|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502959|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44235082|NCT01728077|79056510|FG001|Overall Study|Subject choice|3|||
44235083|NCT01728077|79056509|FG000|Overall Study|Death|0|||
44235084|NCT01728077|79056510|FG001|Overall Study|Death|1|||
44235085|NCT01728077|79056509|FG000|Overall Study|Patient moving|1|||
44235086|NCT01728077|79056510|FG001|Overall Study|Patient moving|0|||
44567119|NCT01340976|79587043|FG003|Overall Study|Physician Decision|1|||
44567120|NCT01340976|79587044|FG004|Overall Study|Physician Decision|1|||
44235087|NCT01728077|79056509|FG000|Overall Study|Non compliance|1|||
44235088|NCT01728077|79056510|FG001|Overall Study|Non compliance|0|||
44567121|NCT01340976|79587045|FG005|Overall Study|Physician Decision|0|||
44235089|NCT01606007|79056529|FG000|Overall Study|Reason 'Other' in the protocol|0|||
44235090|NCT01606007|79056530|FG001|Overall Study|Reason 'Other' in the protocol|1|||
44235091|NCT01606007|79056531|FG002|Overall Study|Reason 'Other' in the protocol|1|||
44235092|NCT01606007|79056529|FG000|Overall Study|Pregnancy|0|||
44235093|NCT01606007|79056530|FG001|Overall Study|Pregnancy|1|||
44235094|NCT01606007|79056531|FG002|Overall Study|Pregnancy|1|||
44235095|NCT01606007|79056529|FG000|Overall Study|Withdrawal by Subject|8|||
44502960|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502961|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502962|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502963|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
44502964|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
44502965|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
44502966|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
44502967|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
44502968|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
44502969|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
44502970|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
44502971|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
44502972|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
44502973|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
44502974|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
44502975|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
44235096|NCT01606007|79056530|FG001|Overall Study|Withdrawal by Subject|6|||
44235097|NCT01606007|79056531|FG002|Overall Study|Withdrawal by Subject|1|||
44235098|NCT01606007|79056529|FG000|Overall Study|Adverse Event|0|||
44502976|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
44502977|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
44567122|NCT01340976|79587040|FG000|Overall Study|Death|0|||
44502978|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
44502979|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
44567123|NCT01340976|79587041|FG001|Overall Study|Death|1|||
44235099|NCT01606007|79056530|FG001|Overall Study|Adverse Event|1|||
44235100|NCT01606007|79056531|FG002|Overall Study|Adverse Event|1|||
44567124|NCT01340976|79587042|FG002|Overall Study|Death|0|||
44567125|NCT01340976|79587043|FG003|Overall Study|Death|0|||
44235101|NCT01606007|79056529|FG000|Overall Study|discontinue study treatment|0|||
44235102|NCT01606007|79056530|FG001|Overall Study|discontinue study treatment|2|||
44235103|NCT01606007|79056531|FG002|Overall Study|discontinue study treatment|1|||
44235104|NCT01606007|79056529|FG000|Overall Study|Lost to Follow-up|6|||
44235105|NCT01606007|79056530|FG001|Overall Study|Lost to Follow-up|8|||
44567126|NCT01340976|79587044|FG004|Overall Study|Death|0|||
44567127|NCT01340976|79587045|FG005|Overall Study|Death|0|||
44567128|NCT01340976|79587040|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
44567129|NCT01340976|79587041|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
44567130|NCT01340976|79587042|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
44567131|NCT01340976|79587043|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
44567132|NCT01340976|79587044|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
44567133|NCT01340976|79587045|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
44567134|NCT01340976|79587040|FG000|Overall Study|Withdrawal by Subject|0|||
44567135|NCT01340976|79587041|FG001|Overall Study|Withdrawal by Subject|0|||
44567136|NCT01340976|79587042|FG002|Overall Study|Withdrawal by Subject|0|||
44567137|NCT01340976|79587043|FG003|Overall Study|Withdrawal by Subject|1|||
44567138|NCT01340976|79587044|FG004|Overall Study|Withdrawal by Subject|1|||
44567139|NCT01340976|79587045|FG005|Overall Study|Withdrawal by Subject|0|||
44235106|NCT01606007|79056531|FG002|Overall Study|Lost to Follow-up|5|||
44235107|NCT01606007|79056529|FG000|Overall Study|Poor/Non-compliance|1|||
44502980|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
44502981|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
44502982|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
44502983|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
44502984|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
44502985|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
44502986|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
44502987|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
44502988|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
44502989|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
44502990|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
44502991|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
44502992|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
44502993|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
44502994|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
44502995|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
44502996|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
44502997|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
44502998|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44502999|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503000|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503001|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503002|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503003|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503004|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503005|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503006|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503007|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503008|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44503009|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
44503010|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
44503011|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
44503012|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
44503013|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503014|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44567140|NCT01340976|79587040|FG000|Overall Study|Other anemia treatment|1|||
44567141|NCT01340976|79587041|FG001|Overall Study|Other anemia treatment|0|||
44503015|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503016|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44567142|NCT01340976|79587042|FG002|Overall Study|Other anemia treatment|2|||
44567143|NCT01340976|79587043|FG003|Overall Study|Other anemia treatment|1|||
44567144|NCT01340976|79587044|FG004|Overall Study|Other anemia treatment|0|||
44235108|NCT01606007|79056530|FG001|Overall Study|Poor/Non-compliance|0|||
44567145|NCT01340976|79587045|FG005|Overall Study|Other anemia treatment|1|||
44567146|NCT01340976|79587040|FG000|Overall Study|Adverse Event|0|||
44567147|NCT01340976|79587041|FG001|Overall Study|Adverse Event|1|||
44567148|NCT01340976|79587042|FG002|Overall Study|Adverse Event|0|||
44567149|NCT01340976|79587043|FG003|Overall Study|Adverse Event|0|||
44567150|NCT01340976|79587044|FG004|Overall Study|Adverse Event|0|||
44567151|NCT01340976|79587045|FG005|Overall Study|Adverse Event|0|||
44235109|NCT01606007|79056531|FG002|Overall Study|Poor/Non-compliance|0|||
44235110|NCT01753193|79056610|FG000|Overall Study|Withdrawal by Subject|23|||
44235111|NCT01753193|79056610|FG000|Overall Study|Lost to Follow-up|6|||
44235112|NCT01753193|79056610|FG000|Overall Study|Death|1|||
44235113|NCT01753193|79056610|FG000|Overall Study|Other|16|||
44235114|NCT01727297|79056657|FG000|Overall Study|Death|13|||
44235115|NCT01727297|79056658|FG001|Overall Study|Death|0|||
44235116|NCT01727297|79056657|FG000|Overall Study|Protocol Violation|1|||
44235117|NCT01727297|79056658|FG001|Overall Study|Protocol Violation|10|||
44567152|NCT01680016|79587067|FG000|Overall Study|Adverse Event|0|||
44567153|NCT01680016|79587068|FG001|Overall Study|Adverse Event|0|||
44503017|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503018|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503019|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503020|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503021|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503022|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503023|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
44503024|NCT03831191|79507779|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503025|NCT03831191|79507780|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503026|NCT03831191|79507781|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503027|NCT03831191|79507782|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
44503028|NCT03831191|79507783|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503029|NCT03831191|79507784|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503030|NCT03831191|79507785|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503031|NCT03831191|79507786|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503032|NCT03831191|79507787|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503033|NCT03831191|79507788|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503034|NCT03831191|79507789|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503035|NCT03831191|79507790|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503036|NCT03831191|79507791|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503037|NCT03831191|79507792|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503038|NCT03831191|79507793|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
44503039|NCT03831191|79507779|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
44503040|NCT03831191|79507780|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
44503041|NCT03831191|79507781|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
44503042|NCT03831191|79507782|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
44503043|NCT03831191|79507783|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
44503044|NCT03831191|79507784|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
44567154|NCT01680016|79587069|FG002|Overall Study|Adverse Event|1|||
44235118|NCT01727297|79056657|FG000|Overall Study|Adverse Event|3|||
44235119|NCT01727297|79056658|FG001|Overall Study|Adverse Event|1|||
44503045|NCT03831191|79507785|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
44503046|NCT03831191|79507786|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
44503047|NCT03831191|79507787|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
44567155|NCT01680016|79587070|FG003|Overall Study|Adverse Event|4|||
44235120|NCT01727297|79056657|FG000|Overall Study|Lost to Follow-up|11|||
44235121|NCT01727297|79056658|FG001|Overall Study|Lost to Follow-up|0|||
44235122|NCT01727297|79056657|FG000|Overall Study|Withdrawal by Subject|26|||
44235123|NCT01727297|79056658|FG001|Overall Study|Withdrawal by Subject|27|||
44235124|NCT01727297|79056657|FG000|Overall Study|Physician Decision|19|||
44235125|NCT01727297|79056658|FG001|Overall Study|Physician Decision|5|||
44235126|NCT01727297|79056657|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
44567156|NCT01680016|79587067|FG000|Overall Study|The Subject went out of The Trial|1|||
44567157|NCT01680016|79587068|FG001|Overall Study|The Subject went out of The Trial|0|||
44567158|NCT01680016|79587069|FG002|Overall Study|The Subject went out of The Trial|3|||
44567159|NCT01680016|79587070|FG003|Overall Study|The Subject went out of The Trial|0|||
44567160|NCT01680016|79587067|FG000|Overall Study|Protocol Violation|0|||
44567161|NCT01680016|79587068|FG001|Overall Study|Protocol Violation|1|||
44567162|NCT01680016|79587069|FG002|Overall Study|Protocol Violation|0|||
44567163|NCT01680016|79587070|FG003|Overall Study|Protocol Violation|0|||
44567164|NCT01680016|79587067|FG000|Overall Study|Withdrawal by Subject|5|||
44567165|NCT01680016|79587068|FG001|Overall Study|Withdrawal by Subject|7|||
44567166|NCT01680016|79587069|FG002|Overall Study|Withdrawal by Subject|1|||
44567167|NCT01680016|79587070|FG003|Overall Study|Withdrawal by Subject|1|||
44567168|NCT01340898|79587095|FG000|Primary Phase|Serious Adverse Events|0|||
44567169|NCT01340898|79587096|FG001|Primary Phase|Serious Adverse Events|0|||
44567170|NCT01340898|79587097|FG002|Primary Phase|Serious Adverse Events|1|||
44567171|NCT01340898|79587095|FG000|Primary Phase|Withdrawal by Subject|8|||
44567172|NCT01340898|79587096|FG001|Primary Phase|Withdrawal by Subject|7|||
44567173|NCT01340898|79587097|FG002|Primary Phase|Withdrawal by Subject|5|||
44567174|NCT01340898|79587095|FG000|Primary Phase|Migrated/moved from study area|4|||
44567175|NCT01340898|79587096|FG001|Primary Phase|Migrated/moved from study area|1|||
44567176|NCT01340898|79587097|FG002|Primary Phase|Migrated/moved from study area|0|||
44567177|NCT01340898|79587095|FG000|Primary Phase|Lost to Follow-up|4|||
44567178|NCT01340898|79587096|FG001|Primary Phase|Lost to Follow-up|1|||
44567179|NCT01340898|79587097|FG002|Primary Phase|Lost to Follow-up|0|||
44567180|NCT01340898|79587095|FG000|Booster Phase|Withdrawal by Subject|3|||
44567181|NCT01340898|79587096|FG001|Booster Phase|Withdrawal by Subject|0|||
44567182|NCT01340898|79587097|FG002|Booster Phase|Withdrawal by Subject|4|||
44235127|NCT01727297|79056658|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
44235128|NCT01753115|79056674|FG000|Overall Study|Lost to Follow-up|3|||
44235129|NCT01753115|79056675|FG001|Overall Study|Lost to Follow-up|6|||
44235130|NCT01753115|79056676|FG002|Overall Study|Lost to Follow-up|8|||
44235131|NCT01753115|79056674|FG000|Overall Study|Withdrawal by Subject|6|||
44235132|NCT01753115|79056675|FG001|Overall Study|Withdrawal by Subject|5|||
44235133|NCT01753115|79056676|FG002|Overall Study|Withdrawal by Subject|6|||
44235134|NCT01753115|79056674|FG000|Overall Study|Subject non-compliant|3|||
44235135|NCT01753115|79056675|FG001|Overall Study|Subject non-compliant|3|||
44235136|NCT01753115|79056676|FG002|Overall Study|Subject non-compliant|0|||
44235137|NCT01753115|79056674|FG000|Overall Study|Used excluded drug|0|||
44235138|NCT01753115|79056675|FG001|Overall Study|Used excluded drug|1|||
44235139|NCT01753115|79056676|FG002|Overall Study|Used excluded drug|0|||
44235140|NCT01727141|79056697|FG000|Overall Study|Physician Decision|0|||
44235141|NCT01727141|79056698|FG001|Overall Study|Physician Decision|1|||
44235142|NCT01727141|79056699|FG002|Overall Study|Physician Decision|0|||
44235143|NCT01727141|79056700|FG003|Overall Study|Physician Decision|2|||
44235144|NCT01727141|79056697|FG000|Overall Study|Lost to Follow-up|0|||
44235145|NCT01727141|79056698|FG001|Overall Study|Lost to Follow-up|2|||
44235146|NCT01727141|79056699|FG002|Overall Study|Lost to Follow-up|0|||
44503048|NCT03831191|79507788|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
44503049|NCT03831191|79507789|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
44503050|NCT03831191|79507790|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
44503051|NCT03831191|79507791|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
44503052|NCT03831191|79507792|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
44503053|NCT03831191|79507793|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
44503054|NCT03831191|79507779|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503055|NCT03831191|79507780|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503056|NCT03831191|79507781|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503057|NCT03831191|79507782|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503058|NCT03831191|79507783|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503059|NCT03831191|79507784|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503060|NCT03831191|79507785|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44567183|NCT01340898|79587095|FG000|Booster Phase|Migrated/moved from study area|3|||
44567184|NCT01340898|79587096|FG001|Booster Phase|Migrated/moved from study area|0|||
44567185|NCT01340898|79587097|FG002|Booster Phase|Migrated/moved from study area|0|||
44567186|NCT01340898|79587095|FG000|Booster Phase|Lost to Follow-up|4|||
44235147|NCT01727141|79056700|FG003|Overall Study|Lost to Follow-up|0|||
44235148|NCT01727141|79056697|FG000|Overall Study|Death|0|||
44235149|NCT01727141|79056698|FG001|Overall Study|Death|1|||
44235150|NCT01727141|79056699|FG002|Overall Study|Death|1|||
44235151|NCT01727141|79056700|FG003|Overall Study|Death|1|||
44235152|NCT01727141|79056697|FG000|Overall Study|Protocol deviation|1|||
44235153|NCT01727141|79056698|FG001|Overall Study|Protocol deviation|1|||
44235154|NCT01727141|79056699|FG002|Overall Study|Protocol deviation|0|||
44235155|NCT01727141|79056700|FG003|Overall Study|Protocol deviation|1|||
44235156|NCT01727141|79056697|FG000|Overall Study|Withdrawal by Subject|4|||
44235157|NCT01727141|79056698|FG001|Overall Study|Withdrawal by Subject|4|||
44503061|NCT03831191|79507786|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503062|NCT03831191|79507787|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503063|NCT03831191|79507788|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503064|NCT03831191|79507789|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503065|NCT03831191|79507790|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503066|NCT03831191|79507791|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503067|NCT03831191|79507792|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
44503068|NCT03831191|79507793|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
44503069|NCT03831191|79507779|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503070|NCT03831191|79507780|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44235158|NCT01727141|79056699|FG002|Overall Study|Withdrawal by Subject|2|||
44235159|NCT01727141|79056700|FG003|Overall Study|Withdrawal by Subject|11|||
44377651|NCT00927810|79382933|FG002|Overall Study|Lost to Follow-up|1|||
44503071|NCT03831191|79507781|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503072|NCT03831191|79507782|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503073|NCT03831191|79507783|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44235160|NCT01726517|79056724|FG000|Overall Study|Withdrawal by Subject|0|||
44567187|NCT01340898|79587096|FG001|Booster Phase|Lost to Follow-up|2|||
44567188|NCT01340898|79587097|FG002|Booster Phase|Lost to Follow-up|3|||
44567189|NCT03097315|79587118|FG000|Overall Study|Withdrawal by Subject|1|||
44567190|NCT03039699|79587124|FG000|Overall Study|Incorrect inclusion|5|||
44567191|NCT03039699|79587125|FG001|Overall Study|Incorrect inclusion|4|||
44567192|NCT03039699|79587124|FG000|Overall Study|Lack of data to assess study endpoint|5|||
44235161|NCT01726517|79056725|FG001|Overall Study|Withdrawal by Subject|0|||
44235162|NCT01726517|79056726|FG002|Overall Study|Withdrawal by Subject|1|||
44235163|NCT01726517|79056727|FG003|Overall Study|Withdrawal by Subject|0|||
44235164|NCT01726517|79056728|FG004|Overall Study|Withdrawal by Subject|0|||
44235165|NCT01752023|79056742|FG000|Overall Study|Physician Decision|2|||
44235166|NCT01752023|79056743|FG001|Overall Study|Physician Decision|1|||
44235167|NCT01726049|79056755|FG000|Overall Study|Death|1|||
44235168|NCT01726049|79056756|FG001|Overall Study|Death|1|||
44235169|NCT01726049|79056755|FG000|Overall Study|Adverse Event|4|||
44235170|NCT01726049|79056756|FG001|Overall Study|Adverse Event|1|||
44235171|NCT01726049|79056755|FG000|Overall Study|refused second HC|0|||
44235172|NCT01726049|79056756|FG001|Overall Study|refused second HC|2|||
44235173|NCT01605617|79056777|FG000|First Intervention|Adverse Event|0|||
44235174|NCT01605617|79056778|FG001|First Intervention|Adverse Event|1|||
44235175|NCT01605617|79056777|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
44377652|NCT00927810|79382934|FG003|Overall Study|Lost to Follow-up|1|||
44377653|NCT00927810|79382931|FG000|Overall Study|Death|0|||
44377654|NCT00927810|79382932|FG001|Overall Study|Death|2|||
44377655|NCT00927810|79382933|FG002|Overall Study|Death|0|||
44377656|NCT00927810|79382934|FG003|Overall Study|Death|0|||
44377657|NCT00927810|79382931|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44377658|NCT00927810|79382932|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44377659|NCT00927810|79382933|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44235176|NCT01605617|79056778|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
44377660|NCT00927810|79382934|FG003|Overall Study|Abnormal laboratory value(s)|0|||
44567193|NCT03039699|79587125|FG001|Overall Study|Lack of data to assess study endpoint|3|||
44235177|NCT01751867|79056795|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
44235178|NCT01751867|79056796|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
44567194|NCT03039699|79587124|FG000|Overall Study|Bacterial infection|12|||
44567195|NCT03039699|79587125|FG001|Overall Study|Bacterial infection|28|||
44567196|NCT02833974|79587133|FG000|Overall Study|Lost to Follow-up|1|||
44567197|NCT02833974|79587134|FG001|Overall Study|Lost to Follow-up|0|||
44567198|NCT02833974|79587133|FG000|Overall Study|Adverse Event|0|||
44567199|NCT02833974|79587134|FG001|Overall Study|Adverse Event|3|||
44567200|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
44567201|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
44567202|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
44567203|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
44567204|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
44567205|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
44567206|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
44567207|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
44567208|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
44567209|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
44567210|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
44567211|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
44567212|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
44567213|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
44567214|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
44567215|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
44567216|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
44567217|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
44567218|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
44567219|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
44567220|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
44567221|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
44567222|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
44567223|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
44567224|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
44567225|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
44567226|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
44567227|NCT03093415|79587143|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
44567228|NCT03093415|79587144|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
44235179|NCT01751867|79056795|FG000|Overall Study|Diease Progression|4|||
44503074|NCT03831191|79507784|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503075|NCT03831191|79507785|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503076|NCT03831191|79507786|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503077|NCT03831191|79507787|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503078|NCT03831191|79507788|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503079|NCT03831191|79507789|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503080|NCT03831191|79507790|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503081|NCT03831191|79507791|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503082|NCT03831191|79507792|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
44503083|NCT03831191|79507793|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
44503084|NCT00005906|79507826|FG000|Overall Study|Lack of Efficacy|3|||
44503085|NCT03409276|79507835|FG000|Overall Study|Withdrawal by Subject|0|||
44503086|NCT03409276|79507836|FG001|Overall Study|Withdrawal by Subject|0|||
44503087|NCT03409276|79507837|FG002|Overall Study|Withdrawal by Subject|0|||
44503088|NCT03409276|79507838|FG003|Overall Study|Withdrawal by Subject|0|||
44503089|NCT03409276|79507839|FG004|Overall Study|Withdrawal by Subject|1|||
44503090|NCT03409276|79507835|FG000|Overall Study|Lost to Follow-up|0|||
44503091|NCT03409276|79507836|FG001|Overall Study|Lost to Follow-up|0|||
44503092|NCT03409276|79507837|FG002|Overall Study|Lost to Follow-up|0|||
44503093|NCT03409276|79507838|FG003|Overall Study|Lost to Follow-up|2|||
44503094|NCT03409276|79507839|FG004|Overall Study|Lost to Follow-up|2|||
44377661|NCT00848926|79382952|FG000|Treatment Period|Progressive disease|45|||
44377662|NCT00848926|79382952|FG000|Treatment Period|Adverse Event|20|||
44377663|NCT00848926|79382952|FG000|Treatment Period|Physician Decision|12|||
44377664|NCT00848926|79382952|FG000|Treatment Period|Withdrawal by Subject|7|||
44377665|NCT00848926|79382952|FG000|Follow-up Period|Lost to Follow-up|7|||
44377666|NCT00848926|79382952|FG000|Follow-up Period|Withdrawal by Subject|3|||
44377667|NCT00848926|79382952|FG000|Follow-up Period|Other|2|||
44377668|NCT00847132|79382958|FG000|Overall Study|Death|1|||
44377669|NCT00847132|79382959|FG001|Overall Study|Death|1|||
44377670|NCT00918138|79382967|FG000|Overall Study|Subject withdrew consent|1|||
44503095|NCT00004562|79507857|FG000|Overall Study|Lost to Follow-up|102|||
44503096|NCT00004562|79507858|FG001|Overall Study|Lost to Follow-up|91|||
44503097|NCT00004412|79507867|FG000|Randomized Period|Moved to Crossover Period|3|||
44503098|NCT00004412|79507868|FG001|Randomized Period|Moved to Crossover Period|0|||
44503099|NCT00004412|79507869|FG002|Randomized Period|Moved to Crossover Period|0|||
44503100|NCT03440320|79507879|FG000|Overall Study|Withdrawal by Subject|0|||
44235180|NCT01751867|79056796|FG001|Overall Study|Diease Progression|18|||
44235181|NCT01751867|79056795|FG000|Overall Study|Adverse Event|8|||
44235182|NCT01751867|79056796|FG001|Overall Study|Adverse Event|15|||
44235183|NCT01751867|79056795|FG000|Overall Study|Poor Compliance|0|||
44235184|NCT01751867|79056796|FG001|Overall Study|Poor Compliance|5|||
44235185|NCT01751867|79056795|FG000|Overall Study|Withdrawal by Subject|3|||
44235186|NCT01751867|79056796|FG001|Overall Study|Withdrawal by Subject|1|||
44235187|NCT01751867|79056795|FG000|Overall Study|Physician Decision|4|||
44235188|NCT01751867|79056796|FG001|Overall Study|Physician Decision|7|||
44235189|NCT01751867|79056795|FG000|Overall Study|Protocol Violation|0|||
44235190|NCT01751867|79056796|FG001|Overall Study|Protocol Violation|2|||
44235191|NCT01751867|79056795|FG000|Overall Study|Death|0|||
44235192|NCT01751867|79056796|FG001|Overall Study|Death|5|||
44503101|NCT03440320|79507880|FG001|Overall Study|Withdrawal by Subject|1|||
44235193|NCT01751867|79056795|FG000|Overall Study|Other|11|||
44235194|NCT01751867|79056796|FG001|Overall Study|Other|37|||
44377671|NCT00918138|79382968|FG001|Overall Study|Subject withdrew consent|1|||
44377672|NCT00918138|79382967|FG000|Overall Study|Death|1|||
44377673|NCT00918138|79382968|FG001|Overall Study|Death|0|||
44377674|NCT00782275|79382974|FG000|Overall Study|Adverse Event|11|||
44377675|NCT00782275|79382974|FG000|Overall Study|Withdrawal by Subject|1|||
44377676|NCT00782275|79382974|FG000|Overall Study|Progressive Disease|21|||
44567229|NCT03093415|79587145|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
44567230|NCT03093415|79587143|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
44567231|NCT03093415|79587144|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
44567232|NCT03093415|79587145|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
44567233|NCT01358526|79587155|FG000|Open-label Titration Period|Adverse Event|95|||
44567234|NCT01358526|79587156|FG001|Open-label Titration Period|Adverse Event|0|||
44567235|NCT01358526|79587157|FG002|Open-label Titration Period|Adverse Event|0|||
44235195|NCT01751867|79056795|FG000|Overall Study|Randomized but not treated.|2|||
44235196|NCT01751867|79056796|FG001|Overall Study|Randomized but not treated.|1|||
44235197|NCT01751165|79056822|FG000|Overall Study|Adverse event, serious fatal|1|||
44235198|NCT01751165|79056823|FG001|Overall Study|Adverse event, serious fatal|0|||
44235199|NCT01751165|79056824|FG002|Overall Study|Adverse event, serious fatal|1|||
44235200|NCT01751165|79056822|FG000|Overall Study|Withdrawal by Subject|0|||
44235201|NCT01751165|79056823|FG001|Overall Study|Withdrawal by Subject|0|||
44235202|NCT01751165|79056824|FG002|Overall Study|Withdrawal by Subject|1|||
44235203|NCT01751165|79056822|FG000|Overall Study|Serious adverse event|0|||
44235204|NCT01751165|79056823|FG001|Overall Study|Serious adverse event|2|||
44235205|NCT01751165|79056824|FG002|Overall Study|Serious adverse event|0|||
44235206|NCT01751165|79056822|FG000|Overall Study|Lost to Follow-up|1|||
44235207|NCT01751165|79056823|FG001|Overall Study|Lost to Follow-up|1|||
44235208|NCT01751165|79056824|FG002|Overall Study|Lost to Follow-up|1|||
44235209|NCT01751087|79056849|FG000|Overall Study|Withdrawal by Subject|1|||
44235210|NCT01751087|79056850|FG001|Overall Study|Withdrawal by Subject|0|||
44235211|NCT01751087|79056851|FG002|Overall Study|Withdrawal by Subject|0|||
44235212|NCT01751087|79056849|FG000|Overall Study|Physician Decision|0|||
44235213|NCT01751087|79056850|FG001|Overall Study|Physician Decision|0|||
44235214|NCT01751087|79056851|FG002|Overall Study|Physician Decision|1|||
44235215|NCT01750697|79056859|FG000|Overall Study|Transferred Back to Local Hospital|1|||
44235216|NCT01750697|79056859|FG000|Overall Study|Physician and Family Decision|1|||
44235217|NCT01750697|79056859|FG000|Overall Study|Transferred to Adult Services|5|||
44235218|NCT01750697|79056859|FG000|Overall Study|Physician Decision|1|||
44503102|NCT00004088|79507888|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
44503103|NCT00004088|79507888|FG000|Overall Study|Withdrawal by Subject|1|||
44503104|NCT00004088|79507888|FG000|Overall Study|Protocol Violation|3|||
44503105|NCT00004088|79507888|FG000|Overall Study|Physician Decision|1|||
44503106|NCT03439072|79507892|FG000|Overall Study|Withdrawal by Subject|2|||
44503107|NCT03439072|79507893|FG001|Overall Study|Withdrawal by Subject|3|||
44235219|NCT01750697|79056859|FG000|Overall Study|Withdrawal by Subject|1|||
44567236|NCT01358526|79587155|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
44235220|NCT01750229|79056870|FG000|Randomized Crossover Phase|Adverse Event|1|||
44235221|NCT01750229|79056870|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
44235222|NCT01750229|79056870|FG000|Long-term Follow-up Phase|Adverse Event|2|||
44503108|NCT03439072|79507892|FG000|Overall Study|Physician Decision|0|||
44503109|NCT03439072|79507893|FG001|Overall Study|Physician Decision|1|||
44567237|NCT01358526|79587156|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
44567238|NCT01358526|79587157|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
44567239|NCT01358526|79587155|FG000|Open-label Titration Period|Lost to Follow-up|25|||
44567240|NCT01358526|79587156|FG001|Open-label Titration Period|Lost to Follow-up|0|||
44567241|NCT01358526|79587157|FG002|Open-label Titration Period|Lost to Follow-up|0|||
44567242|NCT01358526|79587155|FG000|Open-label Titration Period|Lack of Efficacy|107|||
44567243|NCT01358526|79587156|FG001|Open-label Titration Period|Lack of Efficacy|0|||
44567244|NCT01358526|79587157|FG002|Open-label Titration Period|Lack of Efficacy|0|||
44567245|NCT01358526|79587155|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
44567246|NCT01358526|79587156|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
44567247|NCT01358526|79587157|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
44567248|NCT01358526|79587155|FG000|Open-label Titration Period|Administrative|8|||
44567249|NCT01358526|79587156|FG001|Open-label Titration Period|Administrative|0|||
44567250|NCT01358526|79587157|FG002|Open-label Titration Period|Administrative|0|||
44567251|NCT01358526|79587155|FG000|Open-label Titration Period|Did not qualify|178|||
44567252|NCT01358526|79587156|FG001|Open-label Titration Period|Did not qualify|0|||
44567253|NCT01358526|79587157|FG002|Open-label Titration Period|Did not qualify|0|||
44567254|NCT01358526|79587155|FG000|Double-blind Phase|Adverse Event|0|||
44567255|NCT01358526|79587156|FG001|Double-blind Phase|Adverse Event|24|||
44567256|NCT01358526|79587157|FG002|Double-blind Phase|Adverse Event|23|||
44567257|NCT01358526|79587155|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44567258|NCT01358526|79587156|FG001|Double-blind Phase|Withdrawal by Subject|10|||
44567259|NCT01358526|79587157|FG002|Double-blind Phase|Withdrawal by Subject|8|||
44567260|NCT01358526|79587155|FG000|Double-blind Phase|Lost to Follow-up|0|||
44567261|NCT01358526|79587156|FG001|Double-blind Phase|Lost to Follow-up|4|||
44567262|NCT01358526|79587157|FG002|Double-blind Phase|Lost to Follow-up|1|||
44567263|NCT01358526|79587155|FG000|Double-blind Phase|Lack of Efficacy|0|||
44567264|NCT01358526|79587156|FG001|Double-blind Phase|Lack of Efficacy|31|||
44567265|NCT01358526|79587157|FG002|Double-blind Phase|Lack of Efficacy|73|||
44567266|NCT01358526|79587155|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
44567267|NCT01358526|79587156|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
44567268|NCT01358526|79587157|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
44567269|NCT01358526|79587155|FG000|Double-blind Phase|Administrative|0|||
44235223|NCT01750229|79056870|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
44235224|NCT01724489|79056882|FG000|Overall Study|Adverse Event|8|||
44235225|NCT01724489|79056883|FG001|Overall Study|Adverse Event|3|||
44235226|NCT01724489|79056882|FG000|Overall Study|Surgery, medication|1|||
44235227|NCT01724489|79056883|FG001|Overall Study|Surgery, medication|1|||
44235228|NCT01724489|79056882|FG000|Overall Study|Lost to Follow-up|1|||
44235229|NCT01724489|79056883|FG001|Overall Study|Lost to Follow-up|2|||
44235230|NCT01724489|79056882|FG000|Overall Study|Withdrawal by Subject|6|||
44235231|NCT01724489|79056883|FG001|Overall Study|Withdrawal by Subject|6|||
44235232|NCT01724177|79056898|FG000|Overall Study|Adverse Event|8|||
44235233|NCT01724177|79056898|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
44235234|NCT01724177|79056898|FG000|Overall Study|Nervous participant|1|||
44235235|NCT01724177|79056898|FG000|Overall Study|Serious Adverse Event Related|1|||
44235236|NCT01724021|79056915|FG000|Overall Study|Adverse Event|11|||
44235237|NCT01724021|79056916|FG001|Overall Study|Adverse Event|6|||
44235238|NCT01724021|79056915|FG000|Overall Study|Death|46|||
44235239|NCT01724021|79056916|FG001|Overall Study|Death|58|||
44235240|NCT01724021|79056915|FG000|Overall Study|Participant request/ Withdrew consent|18|||
44235241|NCT01724021|79056916|FG001|Overall Study|Participant request/ Withdrew consent|14|||
44235242|NCT01724021|79056915|FG000|Overall Study|Lost to Follow-up|15|||
44235243|NCT01724021|79056916|FG001|Overall Study|Lost to Follow-up|15|||
44235244|NCT01724021|79056915|FG000|Overall Study|Reason Not Specified|36|||
44235245|NCT01724021|79056916|FG001|Overall Study|Reason Not Specified|39|||
44235246|NCT01724021|79056915|FG000|Overall Study|Missing|1|||
44235247|NCT01724021|79056916|FG001|Overall Study|Missing|1|||
44235248|NCT01723397|79056930|FG000|Study Period 1|Protocol Violation|0|||
44503110|NCT00078312|79507899|FG000|Overall Study|Adverse Event|43|||
44503111|NCT00078312|79507899|FG000|Overall Study|Lack of Efficacy|15|||
44503112|NCT00078312|79507899|FG000|Overall Study|Lost to Follow-up|41|||
44503113|NCT00078312|79507899|FG000|Overall Study|Physician Decision|9|||
44503114|NCT00078312|79507899|FG000|Overall Study|Protocol Violation|3|||
44503115|NCT00078312|79507899|FG000|Overall Study|Withdrawal by Subject|33|||
44503116|NCT00078312|79507899|FG000|Overall Study|Miscellaneous|33|||
44503117|NCT00003896|79507903|FG000|Overall Study|Adverse Event|16|||
44503118|NCT00003896|79507903|FG000|Overall Study|Withdrawal by Subject|1|||
44503119|NCT00003896|79507903|FG000|Overall Study|Lack of Efficacy|1|||
44503120|NCT00003896|79507903|FG000|Overall Study|Death|3|||
44503121|NCT00003896|79507903|FG000|Overall Study|not protocol specified|3|||
44235249|NCT01723397|79056931|FG001|Study Period 1|Protocol Violation|1|||
44235250|NCT01723397|79056930|FG000|Study Period 2|Protocol Violation|0|||
44235251|NCT01723397|79056931|FG001|Study Period 2|Protocol Violation|1|||
44235252|NCT01723163|79056939|FG000|Treatment Phase|Withdrawal by Subject|14|||
44567270|NCT01358526|79587156|FG001|Double-blind Phase|Administrative|6|||
44567271|NCT01358526|79587157|FG002|Double-blind Phase|Administrative|10|||
44567272|NCT02830776|79587164|FG000|Overall Study|Lost to Follow-up|1|||
44567273|NCT03039621|79587171|FG000|Overall Study|Violation of inclusion criteria|3|||
44567274|NCT03039621|79587172|FG001|Overall Study|Violation of inclusion criteria|2|||
44567275|NCT03039621|79587171|FG000|Overall Study|Non-compliance with protocol requirement|4|||
44567276|NCT03039621|79587172|FG001|Overall Study|Non-compliance with protocol requirement|5|||
44567277|NCT03039621|79587171|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
44567278|NCT03039621|79587172|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
44567279|NCT03039621|79587171|FG000|Overall Study|Violation of non-inclusion criteria|1|||
44567280|NCT03039621|79587172|FG001|Overall Study|Violation of non-inclusion criteria|2|||
44567281|NCT03041181|79587180|FG000|Overall Study|Disease Progression|1|||
44567282|NCT03041181|79587181|FG001|Overall Study|Disease Progression|2|||
44567283|NCT02828436|79587187|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
44567284|NCT02828436|79587188|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
44567285|NCT02828436|79587187|FG000|Period 1|Lost to Follow-up|0|||
44567286|NCT02828436|79587188|FG001|Period 1|Lost to Follow-up|1|||
44567287|NCT02828436|79587187|FG000|Period 2|Withdrawal by Subject|4|||
44567288|NCT02828436|79587188|FG001|Period 2|Withdrawal by Subject|0|||
44567289|NCT02828436|79587187|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
44567290|NCT02828436|79587188|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
44567291|NCT02828436|79587187|FG000|Period 2|Lost to Follow-up|1|||
44567292|NCT02828436|79587188|FG001|Period 2|Lost to Follow-up|0|||
44567293|NCT02828124|79587202|FG000|Overall Study|Disease Progression|1|||
44503122|NCT00003896|79507903|FG000|Overall Study|ineligible|5|||
44503123|NCT00003830|79507910|FG000|Overall Study|No follow up data|3|||
44503124|NCT00003830|79507911|FG001|Overall Study|No follow up data|0|||
44503125|NCT00003830|79507910|FG000|Overall Study|Sentinel node positive patients|829|||
44503126|NCT00003830|79507911|FG001|Overall Study|Sentinel node positive patients|793|||
44503127|NCT03407482|79507919|FG000|Overall Study|Adverse Event|12|||
44503128|NCT03407482|79507919|FG000|Overall Study|Disease Relapse|1|||
44503129|NCT03407482|79507919|FG000|Overall Study|Lost to Follow-up|1|||
44503130|NCT03407482|79507919|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44503131|NCT03407482|79507919|FG000|Overall Study|Pregnancy|2|||
44503132|NCT03407482|79507919|FG000|Overall Study|Protocol Violation|1|||
44503133|NCT03407482|79507919|FG000|Overall Study|Study Terminated By Sponsor|106|||
44503134|NCT03407482|79507919|FG000|Overall Study|Withdrawal by Subject|6|||
44503135|NCT03407482|79507919|FG000|Overall Study|Data Entry Error|1|||
44503136|NCT00003782|79507926|FG000|Overall Study|No follow up data|30|||
44503137|NCT00003782|79507927|FG001|Overall Study|No follow up data|31|||
44503138|NCT00003782|79507928|FG002|Overall Study|No follow up data|26|||
44503139|NCT03389308|79507936|FG000|Overall Study|Withdrawal by Subject|5|||
44503140|NCT03389308|79507936|FG000|Overall Study|Lost to Follow-up|3|||
44503141|NCT03389308|79507936|FG000|Overall Study|Adverse Event|2|||
44503142|NCT03389308|79507936|FG000|Overall Study|Sponsor Request|2|||
44503143|NCT03407170|79507940|FG000|Overall Study|Adverse Event|1|||
44503144|NCT03406858|79507944|FG000|Overall Study|Failure to receive treatment drug.|1|||
44503145|NCT03406858|79507944|FG000|Overall Study|ineligible|1|||
44503146|NCT03406702|79507948|FG000|Overall Study|Missed Day 27 Dosing|1|||
44503147|NCT00003656|79507966|FG000|Overall Study|Adverse Event|0|||
44503148|NCT00003656|79507967|FG001|Overall Study|Adverse Event|1|||
44503149|NCT00003590|79507974|FG000|Overall Study|Ineligible Patient|1|||
44503150|NCT00003590|79507974|FG000|Overall Study|Adverse Event|7|||
44503151|NCT00003590|79507974|FG000|Overall Study|Withdrawal by Subject|1|||
44235253|NCT01723163|79056940|FG001|Treatment Phase|Withdrawal by Subject|6|||
44235254|NCT01723163|79056939|FG000|Treatment Phase|Withdrawal by PI|5|||
44377677|NCT00782275|79382974|FG000|Overall Study|Physician Decision|4|||
44503152|NCT00003590|79507974|FG000|Overall Study|Lack of Efficacy|11|||
44503153|NCT00003590|79507974|FG000|Overall Study|Death|1|||
44503154|NCT00003590|79507974|FG000|Overall Study|Physician Decision|1|||
44503155|NCT03416374|79507980|FG000|Between Treatment Period I and II|Other|0|||
44503156|NCT03416374|79507981|FG001|Between Treatment Period I and II|Other|9|||
44503157|NCT03416374|79507980|FG000|Treatment Period II|Lack of Efficacy|3|||
44503158|NCT03416374|79507981|FG001|Treatment Period II|Lack of Efficacy|11|||
44503159|NCT03416374|79507980|FG000|Treatment Period II|Adverse Event|1|||
44503160|NCT03416374|79507981|FG001|Treatment Period II|Adverse Event|4|||
44503161|NCT03416374|79507980|FG000|Treatment Period II|Death|0|||
44567294|NCT02828124|79587203|FG001|Overall Study|Disease Progression|2|||
44567295|NCT02828124|79587204|FG002|Overall Study|Disease Progression|1|||
44567296|NCT02828124|79587205|FG003|Overall Study|Disease Progression|4|||
44567297|NCT02828124|79587202|FG000|Overall Study|AE Unrelated to Study Drug|0|||
44567298|NCT02828124|79587203|FG001|Overall Study|AE Unrelated to Study Drug|0|||
44567299|NCT02828124|79587204|FG002|Overall Study|AE Unrelated to Study Drug|0|||
44567300|NCT02828124|79587205|FG003|Overall Study|AE Unrelated to Study Drug|1|||
44567301|NCT02828124|79587202|FG000|Overall Study|Subject Withdrew Consent|0|||
44567302|NCT02828124|79587203|FG001|Overall Study|Subject Withdrew Consent|0|||
44567303|NCT02828124|79587204|FG002|Overall Study|Subject Withdrew Consent|0|||
44567304|NCT02828124|79587205|FG003|Overall Study|Subject Withdrew Consent|1|||
44567305|NCT02829996|79587220|FG000|Overall Study|Withdrawal by Subject|1|||
44567306|NCT02829996|79587221|FG001|Overall Study|Withdrawal by Subject|0|||
44567307|NCT02829996|79587222|FG002|Overall Study|Withdrawal by Subject|0|||
44567308|NCT02829996|79587223|FG003|Overall Study|Withdrawal by Subject|0|||
44567309|NCT02829996|79587224|FG004|Overall Study|Withdrawal by Subject|0|||
44567310|NCT02827500|79587238|FG000|Overall Study|Death|7|||
44567311|NCT02827500|79587239|FG001|Overall Study|Death|3|||
44567312|NCT02827500|79587238|FG000|Overall Study|Lost to Follow-up|1|||
44567313|NCT02827500|79587239|FG001|Overall Study|Lost to Follow-up|1|||
44567314|NCT02827500|79587238|FG000|Overall Study|Withdrawal by Subject|3|||
44567315|NCT02827500|79587239|FG001|Overall Study|Withdrawal by Subject|1|||
44567316|NCT02827500|79587238|FG000|Overall Study|Missing primary endpoint data|3|||
44567317|NCT02827500|79587239|FG001|Overall Study|Missing primary endpoint data|1|||
44567318|NCT02827500|79587238|FG000|Overall Study|Other|5|||
44567319|NCT02827500|79587239|FG001|Overall Study|Other|1|||
44567320|NCT02826798|79587250|FG000|Overall Study|Withdrawal by Subject|0|||
44567321|NCT02826798|79587251|FG001|Overall Study|Withdrawal by Subject|1|||
44567322|NCT02826798|79587252|FG002|Overall Study|Withdrawal by Subject|0|||
44567323|NCT02826798|79587253|FG003|Overall Study|Withdrawal by Subject|1|||
44567324|NCT02826798|79587254|FG004|Overall Study|Withdrawal by Subject|0|||
44567325|NCT02829138|79587268|FG000|Overall Study|Withdrawal by Subject|1|||
44567326|NCT02829138|79587269|FG001|Overall Study|Withdrawal by Subject|0|||
44567327|NCT02825550|79587275|FG000|Overall Study|Physician Decision|1|||
44567328|NCT02744040|79587284|FG000|Overall Study|Withdrawal by Subject|3|||
44567329|NCT02744040|79587285|FG001|Overall Study|Withdrawal by Subject|2|||
44567330|NCT02744040|79587286|FG002|Overall Study|Withdrawal by Subject|2|||
44567331|NCT02744040|79587284|FG000|Overall Study|Physician Decision|0|||
44567332|NCT02744040|79587285|FG001|Overall Study|Physician Decision|8|||
44567333|NCT02744040|79587286|FG002|Overall Study|Physician Decision|13|||
44567334|NCT02744040|79587284|FG000|Overall Study|Lost to Follow-up|3|||
44567335|NCT02744040|79587285|FG001|Overall Study|Lost to Follow-up|1|||
44567336|NCT02744040|79587286|FG002|Overall Study|Lost to Follow-up|7|||
44567337|NCT02743962|79587296|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
44567338|NCT02743962|79587297|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
44235255|NCT01723163|79056940|FG001|Treatment Phase|Withdrawal by PI|1|||
44235256|NCT01723163|79056939|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
44235257|NCT01723163|79056940|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
44567339|NCT03094416|79587306|FG000|Run-in|Screening failure|8|||
44567340|NCT03094416|79587306|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
44567341|NCT03094416|79587306|FG000|Run-in|Withdrawal by Subject|3|||
44567342|NCT03094416|79587306|FG000|Treatment Period|Withdrawal by Subject|2|||
44235258|NCT01723163|79056939|FG000|3-Month Follow-up|Unable to Contact|12|||
44567343|NCT03041025|79587314|FG000|Overall Study|Adverse Event|0|||
44567344|NCT03041025|79587315|FG001|Overall Study|Adverse Event|0|||
44567345|NCT03041025|79587316|FG002|Overall Study|Adverse Event|1|||
44567346|NCT03041025|79587314|FG000|Overall Study|Lost to Follow-up|1|||
44567347|NCT03041025|79587315|FG001|Overall Study|Lost to Follow-up|0|||
44567348|NCT03041025|79587316|FG002|Overall Study|Lost to Follow-up|0|||
44567349|NCT03041025|79587314|FG000|Overall Study|Withdrawal by Subject|0|||
44567350|NCT03041025|79587315|FG001|Overall Study|Withdrawal by Subject|0|||
44567351|NCT03041025|79587316|FG002|Overall Study|Withdrawal by Subject|1|||
44567352|NCT01338870|79587333|FG000|Overall Study|Lost to Follow-up|0|||
44567353|NCT01338870|79587334|FG001|Overall Study|Lost to Follow-up|0|||
44567354|NCT01338870|79587335|FG002|Overall Study|Lost to Follow-up|1|||
44567355|NCT01338870|79587336|FG003|Overall Study|Lost to Follow-up|0|||
44567356|NCT01338870|79587337|FG004|Overall Study|Lost to Follow-up|1|||
44567357|NCT01338870|79587338|FG005|Overall Study|Lost to Follow-up|0|||
44567358|NCT01338870|79587333|FG000|Overall Study|Withdrawal by Subject|2|||
44567359|NCT01338870|79587334|FG001|Overall Study|Withdrawal by Subject|3|||
44567360|NCT01338870|79587335|FG002|Overall Study|Withdrawal by Subject|4|||
44567361|NCT01338870|79587336|FG003|Overall Study|Withdrawal by Subject|0|||
44567362|NCT01338870|79587337|FG004|Overall Study|Withdrawal by Subject|0|||
44567363|NCT01338870|79587338|FG005|Overall Study|Withdrawal by Subject|2|||
44567364|NCT01338870|79587333|FG000|Overall Study|Other|3|||
44567365|NCT01338870|79587334|FG001|Overall Study|Other|3|||
44567366|NCT01338870|79587335|FG002|Overall Study|Other|3|||
44567367|NCT01338870|79587336|FG003|Overall Study|Other|2|||
44567368|NCT01338870|79587337|FG004|Overall Study|Other|0|||
44567369|NCT01338870|79587338|FG005|Overall Study|Other|2|||
44235259|NCT01723163|79056940|FG001|3-Month Follow-up|Unable to Contact|19|||
44235260|NCT01723163|79056939|FG000|6-Month Follow-up|Death|1|||
44235261|NCT01723163|79056940|FG001|6-Month Follow-up|Death|0|||
44235262|NCT01723163|79056939|FG000|6-Month Follow-up|Unable to Contact|17|||
44235263|NCT01723163|79056940|FG001|6-Month Follow-up|Unable to Contact|15|||
44235264|NCT01723163|79056939|FG000|12-Month Follow-up|Death|1|||
44235265|NCT01723163|79056940|FG001|12-Month Follow-up|Death|0|||
44503162|NCT03416374|79507981|FG001|Treatment Period II|Death|1|||
44503163|NCT03416374|79507980|FG000|Treatment Period II|Other|0|||
44503164|NCT03416374|79507981|FG001|Treatment Period II|Other|2|||
44503165|NCT03799952|79507992|FG000|Overall Study|Program was too easy, discontinued|1|||
44503166|NCT03799952|79507993|FG001|Overall Study|Program was too easy, discontinued|0|||
44503167|NCT03799952|79507992|FG000|Overall Study|Lost to Follow-up|0|||
44503168|NCT03799952|79507993|FG001|Overall Study|Lost to Follow-up|2|||
44503169|NCT00077766|79508001|FG000|Overall Study|Adverse Event|1|||
44503170|NCT00077766|79508002|FG001|Overall Study|Adverse Event|1|||
44503171|NCT00077766|79508001|FG000|Overall Study|Withdrawal by Subject|4|||
44503172|NCT00077766|79508002|FG001|Overall Study|Withdrawal by Subject|3|||
44503173|NCT00077766|79508001|FG000|Overall Study|Death|12|||
44503174|NCT00077766|79508002|FG001|Overall Study|Death|10|||
44503175|NCT00077766|79508001|FG000|Overall Study|Lost to Follow-up|2|||
44503176|NCT00077766|79508002|FG001|Overall Study|Lost to Follow-up|0|||
44503177|NCT00077766|79508001|FG000|Overall Study|Protocol Violation|1|||
44567370|NCT01338870|79587333|FG000|Overall Study|Protocol Violation|0|||
44503178|NCT00077766|79508002|FG001|Overall Study|Protocol Violation|0|||
44503179|NCT00077766|79508001|FG000|Overall Study|Kidney Transplantation|9|||
44503180|NCT00077766|79508002|FG001|Overall Study|Kidney Transplantation|5|||
44567371|NCT01338870|79587334|FG001|Overall Study|Protocol Violation|2|||
44567372|NCT01338870|79587335|FG002|Overall Study|Protocol Violation|2|||
44567373|NCT01338870|79587336|FG003|Overall Study|Protocol Violation|2|||
44567374|NCT01338870|79587337|FG004|Overall Study|Protocol Violation|1|||
44567375|NCT01338870|79587338|FG005|Overall Study|Protocol Violation|1|||
44567376|NCT01338870|79587333|FG000|Overall Study|Adverse Event|4|||
44567377|NCT01338870|79587334|FG001|Overall Study|Adverse Event|4|||
44567378|NCT01338870|79587335|FG002|Overall Study|Adverse Event|1|||
44567379|NCT01338870|79587336|FG003|Overall Study|Adverse Event|5|||
44567380|NCT01338870|79587337|FG004|Overall Study|Adverse Event|4|||
44567381|NCT01338870|79587338|FG005|Overall Study|Adverse Event|1|||
44567382|NCT02824224|79587354|FG000|Overall Study|Discontinued, IUS expulsion|0|||
44567383|NCT02824224|79587355|FG001|Overall Study|Discontinued, IUS expulsion|1|||
44567384|NCT02824224|79587354|FG000|Overall Study|Did not show up for allocation visit|2|||
44567385|NCT02824224|79587355|FG001|Overall Study|Did not show up for allocation visit|0|||
44567386|NCT01338792|79587361|FG000|Overall Study|Adverse Event|2|||
44567387|NCT01338792|79587361|FG000|Overall Study|Death|1|||
44567388|NCT01338792|79587361|FG000|Overall Study|Withdrawal by Subject|1|||
44567389|NCT01314105|79587367|FG000|Overall Study|Progressive Disease|6|||
44567390|NCT01314105|79587368|FG001|Overall Study|Progressive Disease|10|||
44567391|NCT01314105|79587367|FG000|Overall Study|Refused to continue taking medication|0|||
44567392|NCT01314105|79587368|FG001|Overall Study|Refused to continue taking medication|1|||
44567393|NCT01314105|79587367|FG000|Overall Study|Other Adverse Event|1|||
44503181|NCT00077766|79508001|FG000|Overall Study|Transplantation|5|||
44503182|NCT00077766|79508002|FG001|Overall Study|Transplantation|1|||
44567394|NCT01314105|79587368|FG001|Overall Study|Other Adverse Event|1|||
44567395|NCT03040713|79587376|FG000|Overall Study|Positive amyloid scan|3|||
44567396|NCT01966471|79587382|FG000|Overall Study|Death|44|||
44567397|NCT01966471|79587383|FG001|Overall Study|Death|56|||
44567398|NCT01966471|79587382|FG000|Overall Study|Lost to Follow-up|46|||
44567399|NCT01966471|79587383|FG001|Overall Study|Lost to Follow-up|39|||
44567400|NCT01966471|79587382|FG000|Overall Study|Various reasons|4|||
44567401|NCT01966471|79587383|FG001|Overall Study|Various reasons|4|||
44567402|NCT01966471|79587382|FG000|Overall Study|Physician Decision|7|||
44567403|NCT01966471|79587383|FG001|Overall Study|Physician Decision|5|||
44567404|NCT01966471|79587382|FG000|Overall Study|Study Terminated By Sponsor|758|||
44567405|NCT01966471|79587383|FG001|Overall Study|Study Terminated By Sponsor|773|||
44567406|NCT01966471|79587382|FG000|Overall Study|Withdrawal by Subject|59|||
44567407|NCT01966471|79587383|FG001|Overall Study|Withdrawal by Subject|51|||
44567408|NCT03227471|79587412|FG000|Overall Study|Withdrawal by Subject|0|||
44567409|NCT03227471|79587413|FG001|Overall Study|Withdrawal by Subject|0|||
44567410|NCT03227471|79587414|FG002|Overall Study|Withdrawal by Subject|0|||
44567411|NCT03227471|79587415|FG003|Overall Study|Withdrawal by Subject|0|||
44567412|NCT03227471|79587416|FG004|Overall Study|Withdrawal by Subject|1|||
44567413|NCT03227471|79587417|FG005|Overall Study|Withdrawal by Subject|0|||
44567414|NCT03227471|79587418|FG006|Overall Study|Withdrawal by Subject|0|||
44503183|NCT00077766|79508001|FG000|Overall Study|Investigators Discretion|1|||
44503184|NCT00077766|79508002|FG001|Overall Study|Investigators Discretion|0|||
44503185|NCT00077766|79508001|FG000|Overall Study|Participant's decision|1|||
44503186|NCT00077766|79508002|FG001|Overall Study|Participant's decision|0|||
44503187|NCT00077766|79508001|FG000|Overall Study|Dialysis Discontinued|1|||
44567415|NCT03227471|79587419|FG007|Overall Study|Withdrawal by Subject|0|||
44235266|NCT01723163|79056939|FG000|12-Month Follow-up|Unable to Contact|23|||
44503188|NCT00077766|79508002|FG001|Overall Study|Dialysis Discontinued|0|||
44503189|NCT00077766|79508001|FG000|Overall Study|Dialysis|0|||
44567416|NCT03227471|79587420|FG008|Overall Study|Withdrawal by Subject|0|||
44567417|NCT03227471|79587421|FG009|Overall Study|Withdrawal by Subject|0|||
44567418|NCT03227471|79587422|FG010|Overall Study|Withdrawal by Subject|0|||
44567419|NCT03227471|79587423|FG011|Overall Study|Withdrawal by Subject|0|||
44567420|NCT03227471|79587424|FG012|Overall Study|Withdrawal by Subject|1|||
44567421|NCT03227471|79587425|FG013|Overall Study|Withdrawal by Subject|0|||
44567422|NCT03227471|79587426|FG014|Overall Study|Withdrawal by Subject|0|||
44567423|NCT03227471|79587412|FG000|Overall Study|Randomized, Never Dosed|0|||
44567424|NCT03227471|79587413|FG001|Overall Study|Randomized, Never Dosed|0|||
44567425|NCT03227471|79587414|FG002|Overall Study|Randomized, Never Dosed|0|||
44567426|NCT03227471|79587415|FG003|Overall Study|Randomized, Never Dosed|0|||
44567427|NCT03227471|79587416|FG004|Overall Study|Randomized, Never Dosed|0|||
44567428|NCT03227471|79587417|FG005|Overall Study|Randomized, Never Dosed|0|||
44567429|NCT03227471|79587418|FG006|Overall Study|Randomized, Never Dosed|0|||
44567430|NCT03227471|79587419|FG007|Overall Study|Randomized, Never Dosed|0|||
44567431|NCT03227471|79587420|FG008|Overall Study|Randomized, Never Dosed|0|||
44567432|NCT03227471|79587421|FG009|Overall Study|Randomized, Never Dosed|0|||
44567433|NCT03227471|79587422|FG010|Overall Study|Randomized, Never Dosed|0|||
44567434|NCT03227471|79587423|FG011|Overall Study|Randomized, Never Dosed|0|||
44567435|NCT03227471|79587424|FG012|Overall Study|Randomized, Never Dosed|0|||
44567436|NCT03227471|79587425|FG013|Overall Study|Randomized, Never Dosed|0|||
44567437|NCT03227471|79587426|FG014|Overall Study|Randomized, Never Dosed|1|||
44235267|NCT01723163|79056940|FG001|12-Month Follow-up|Unable to Contact|28|||
44235268|NCT01722071|79056950|FG000|Overall Study|Protocol Violation|1|||
44235269|NCT01722071|79056951|FG001|Overall Study|Protocol Violation|0|||
44235270|NCT01721759|79056957|FG000|Treatment Period|Disease Progression|85|||
44567438|NCT01354314|79587491|FG000|Overall Study|Lost to Follow-up|1|||
44567439|NCT01354314|79587492|FG001|Overall Study|Lost to Follow-up|0|||
44567440|NCT01354314|79587493|FG002|Overall Study|Lost to Follow-up|1|||
44567441|NCT01354314|79587494|FG003|Overall Study|Lost to Follow-up|1|||
44567442|NCT01354314|79587491|FG000|Overall Study|Withdrawal by Subject|0|||
44567443|NCT01354314|79587492|FG001|Overall Study|Withdrawal by Subject|0|||
44567444|NCT01354314|79587493|FG002|Overall Study|Withdrawal by Subject|1|||
44567445|NCT01354314|79587494|FG003|Overall Study|Withdrawal by Subject|0|||
44567446|NCT01354314|79587491|FG000|Overall Study|Adverse Event|0|||
44567447|NCT01354314|79587492|FG001|Overall Study|Adverse Event|0|||
44567448|NCT01354314|79587493|FG002|Overall Study|Adverse Event|0|||
44567449|NCT01354314|79587494|FG003|Overall Study|Adverse Event|1|||
44567450|NCT01354314|79587491|FG000|Overall Study|Protocol Violation|1|||
44567451|NCT01354314|79587492|FG001|Overall Study|Protocol Violation|1|||
44567452|NCT01354314|79587493|FG002|Overall Study|Protocol Violation|0|||
44567453|NCT01354314|79587494|FG003|Overall Study|Protocol Violation|0|||
44567454|NCT01354314|79587491|FG000|Overall Study|Less than 90% Adherence|4|||
44567455|NCT01354314|79587492|FG001|Overall Study|Less than 90% Adherence|2|||
44567456|NCT01354314|79587493|FG002|Overall Study|Less than 90% Adherence|6|||
44567457|NCT01354314|79587494|FG003|Overall Study|Less than 90% Adherence|4|||
44567458|NCT03194321|79587506|FG000|Overall Study|Withdrawal by Subject|1|||
44567459|NCT03194321|79587506|FG000|Overall Study|Lost to Follow-up|1|||
44567460|NCT03194321|79587506|FG000|Overall Study|Travel for Follow-up|1|||
44567461|NCT01354938|79587510|FG000|Overall Study|Lost to Follow-up|1|||
44567462|NCT03092791|79587533|FG000|Overall Study|Lost to Follow-up|0|||
44567463|NCT03092791|79587534|FG001|Overall Study|Lost to Follow-up|0|||
44567464|NCT03092791|79587535|FG002|Overall Study|Lost to Follow-up|0|||
44567465|NCT03092791|79587536|FG003|Overall Study|Lost to Follow-up|0|||
44567466|NCT03092791|79587537|FG004|Overall Study|Lost to Follow-up|0|||
44567467|NCT03092791|79587538|FG005|Overall Study|Lost to Follow-up|0|||
44567468|NCT03092791|79587539|FG006|Overall Study|Lost to Follow-up|1|||
44567469|NCT03092791|79587540|FG007|Overall Study|Lost to Follow-up|0|||
44567470|NCT03092791|79587533|FG000|Overall Study|Withdrawal of Consent|0|||
44567471|NCT03092791|79587534|FG001|Overall Study|Withdrawal of Consent|0|||
44567472|NCT03092791|79587535|FG002|Overall Study|Withdrawal of Consent|0|||
44567473|NCT03092791|79587536|FG003|Overall Study|Withdrawal of Consent|0|||
44567474|NCT03092791|79587537|FG004|Overall Study|Withdrawal of Consent|4|||
44235271|NCT01721759|79056957|FG000|Treatment Period|Study drug toxicity|14|||
44235272|NCT01721759|79056957|FG000|Treatment Period|Death|1|||
44235273|NCT01721759|79056957|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
44235274|NCT01721759|79056957|FG000|Treatment Period|Participant request to withdraw|3|||
44377678|NCT00782275|79382974|FG000|Overall Study|Not started treatment|1|||
44503190|NCT00077766|79508002|FG001|Overall Study|Dialysis|1|||
44503191|NCT00077766|79508001|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
44503192|NCT00077766|79508002|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
44503193|NCT00077766|79508001|FG000|Overall Study|Started Nocturnal Dialysis|0|||
44503194|NCT00077766|79508002|FG001|Overall Study|Started Nocturnal Dialysis|1|||
44503195|NCT00077766|79508001|FG000|Overall Study|Stop Dialysis|0|||
44503196|NCT00077766|79508002|FG001|Overall Study|Stop Dialysis|1|||
44503197|NCT00077766|79508001|FG000|Overall Study|Participants Vacation|2|||
44503198|NCT00077766|79508002|FG001|Overall Study|Participants Vacation|1|||
44567475|NCT03092791|79587538|FG005|Overall Study|Withdrawal of Consent|12|||
44567476|NCT03092791|79587539|FG006|Overall Study|Withdrawal of Consent|6|||
44567477|NCT03092791|79587540|FG007|Overall Study|Withdrawal of Consent|4|||
44567478|NCT03092791|79587533|FG000|Overall Study|Study Termination|0|||
44567479|NCT03092791|79587534|FG001|Overall Study|Study Termination|0|||
44235275|NCT01721759|79056957|FG000|Treatment Period|Other Reasons|3|||
44567480|NCT03092791|79587535|FG002|Overall Study|Study Termination|0|||
44567481|NCT03092791|79587536|FG003|Overall Study|Study Termination|0|||
44567482|NCT03092791|79587537|FG004|Overall Study|Study Termination|55|||
44567483|NCT03092791|79587538|FG005|Overall Study|Study Termination|46|||
44567484|NCT03092791|79587539|FG006|Overall Study|Study Termination|53|||
44567485|NCT03092791|79587540|FG007|Overall Study|Study Termination|55|||
44567486|NCT03092791|79587533|FG000|Overall Study|Death|0|||
44567487|NCT03092791|79587534|FG001|Overall Study|Death|0|||
44567488|NCT03092791|79587535|FG002|Overall Study|Death|0|||
44567489|NCT03092791|79587536|FG003|Overall Study|Death|0|||
44567490|NCT03092791|79587537|FG004|Overall Study|Death|0|||
44567491|NCT03092791|79587538|FG005|Overall Study|Death|1|||
44567492|NCT03092791|79587539|FG006|Overall Study|Death|0|||
44567493|NCT03092791|79587540|FG007|Overall Study|Death|1|||
44567494|NCT03092791|79587533|FG000|Overall Study|Reason Not Specified|0|||
44567495|NCT03092791|79587534|FG001|Overall Study|Reason Not Specified|0|||
44567496|NCT03092791|79587535|FG002|Overall Study|Reason Not Specified|0|||
44567497|NCT03092791|79587536|FG003|Overall Study|Reason Not Specified|0|||
44567498|NCT03092791|79587537|FG004|Overall Study|Reason Not Specified|1|||
44567499|NCT03092791|79587538|FG005|Overall Study|Reason Not Specified|1|||
44567500|NCT03092791|79587539|FG006|Overall Study|Reason Not Specified|0|||
44567501|NCT03092791|79587540|FG007|Overall Study|Reason Not Specified|0|||
44567502|NCT02505425|79587567|FG000|Overall Study|Lost to Follow-up|41|||
44567503|NCT02505425|79587568|FG001|Overall Study|Lost to Follow-up|61|||
44567504|NCT02505425|79587569|FG002|Overall Study|Lost to Follow-up|31|||
44567505|NCT02505425|79587570|FG003|Overall Study|Lost to Follow-up|19|||
44567506|NCT02505425|79587567|FG000|Overall Study|Withdrawal by Subject|39|||
44567507|NCT02505425|79587568|FG001|Overall Study|Withdrawal by Subject|9|||
44567508|NCT02505425|79587569|FG002|Overall Study|Withdrawal by Subject|19|||
44567509|NCT02505425|79587570|FG003|Overall Study|Withdrawal by Subject|7|||
44567510|NCT02505425|79587567|FG000|Overall Study|Death|8|||
44567511|NCT02505425|79587568|FG001|Overall Study|Death|12|||
44567512|NCT02505425|79587569|FG002|Overall Study|Death|0|||
44567513|NCT02505425|79587570|FG003|Overall Study|Death|0|||
44567514|NCT03089047|79587582|FG000|Overall Study|Lost to Follow-up|1|||
44567515|NCT03089047|79587583|FG001|Overall Study|Lost to Follow-up|0|||
44567516|NCT01371006|79587591|FG000|Overall Study|Adverse Event|1|||
44235276|NCT01721759|79056957|FG000|End of Study Period|Participant Withdrew Consent|5|||
44235277|NCT01721759|79056957|FG000|End of Study Period|Death|101|||
44235278|NCT01721759|79056957|FG000|End of Study Period|Lost to Follow-up|1|||
44235279|NCT01721759|79056957|FG000|End of Study Period|Other Reasons|10|||
44235280|NCT01721369|79056966|FG000|Overall Study|Not initial etiological diagnosis|12|||
44235281|NCT01721057|79057028|FG000|Treatment Period|Withdrawal by Subject|11|||
44503199|NCT03388138|79508011|FG000|Overall Study|Protocol Violation|1|||
44503200|NCT03388138|79508012|FG001|Overall Study|Protocol Violation|0|||
44503201|NCT02952898|79508021|FG000|Overall Study|Withdrawal by Subject|10|||
44503202|NCT02952898|79508022|FG001|Overall Study|Withdrawal by Subject|8|||
44503203|NCT02952898|79508023|FG002|Overall Study|Withdrawal by Subject|8|||
44503204|NCT02952898|79508021|FG000|Overall Study|Adverse Event|8|||
44503205|NCT02952898|79508022|FG001|Overall Study|Adverse Event|8|||
44503206|NCT02952898|79508023|FG002|Overall Study|Adverse Event|3|||
44503207|NCT02952898|79508021|FG000|Overall Study|Lost to Follow-up|3|||
44503208|NCT02952898|79508022|FG001|Overall Study|Lost to Follow-up|2|||
44503209|NCT02952898|79508023|FG002|Overall Study|Lost to Follow-up|2|||
44503210|NCT02952898|79508021|FG000|Overall Study|Non-compliance with study drug|1|||
44503211|NCT02952898|79508022|FG001|Overall Study|Non-compliance with study drug|1|||
44503212|NCT02952898|79508023|FG002|Overall Study|Non-compliance with study drug|2|||
44503213|NCT00045734|79508031|FG000|Overall Study|Protocol Violation|1|||
44503214|NCT03387046|79508037|FG000|Overall Study|Adverse Event|1|||
44503215|NCT03387046|79508038|FG001|Overall Study|Adverse Event|1|||
44503216|NCT00045110|79508047|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
44503217|NCT00045110|79508048|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
44503218|NCT00045110|79508049|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
44503219|NCT00045110|79508047|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
44503220|NCT00045110|79508048|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
44503221|NCT00045110|79508049|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
44503222|NCT00045110|79508047|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
44503223|NCT00045110|79508048|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
44567517|NCT01371006|79587592|FG001|Overall Study|Adverse Event|0|||
44567518|NCT01371552|79587627|FG000|Part 1, First 3 Days|Inconvenience|0|||
44567519|NCT01371552|79587628|FG001|Part 1, First 3 Days|Inconvenience|0|||
44567520|NCT01371552|79587629|FG002|Part 1, First 3 Days|Inconvenience|1|||
44567521|NCT01371552|79587630|FG003|Part 1, First 3 Days|Inconvenience|0|||
44567522|NCT01371552|79587631|FG004|Part 1, First 3 Days|Inconvenience|0|||
44567523|NCT01371552|79587632|FG005|Part 1, First 3 Days|Inconvenience|0|||
44567524|NCT02819310|79587641|FG000|Overall Study|Withdrawal by Subject|37|||
44235282|NCT01721057|79057029|FG001|Treatment Period|Withdrawal by Subject|5|||
44567525|NCT02819310|79587641|FG000|Overall Study|Lost to Follow-up|16|||
44567526|NCT02819310|79587641|FG000|Overall Study|Adverse Event|13|||
44567527|NCT02819310|79587641|FG000|Overall Study|Lack of Efficacy|5|||
44567528|NCT02819310|79587641|FG000|Overall Study|Physician Decision|8|||
44567529|NCT02819310|79587641|FG000|Overall Study|Protocol Violation|30|||
44567530|NCT03087643|79587647|FG000|Overall Study|Withdrawal by Subject|2|||
44567531|NCT03087643|79587648|FG001|Overall Study|Withdrawal by Subject|4|||
44567532|NCT03087643|79587647|FG000|Overall Study|Death|2|||
44567533|NCT03087643|79587648|FG001|Overall Study|Death|2|||
44567534|NCT02821962|79587656|FG000|Overall Study|Lost to Follow-up|2|||
44567535|NCT02821962|79587657|FG001|Overall Study|Lost to Follow-up|0|||
44567536|NCT03092479|79587665|FG000|Overall Study|Lost to Follow-up|3|||
44567537|NCT03092479|79587666|FG001|Overall Study|Lost to Follow-up|2|||
44567538|NCT03092479|79587665|FG000|Overall Study|Withdrawal by Subject|4|||
44567539|NCT03092479|79587666|FG001|Overall Study|Withdrawal by Subject|0|||
44567540|NCT03086551|79587674|FG000|First Intervention|Failure to meet inclusion criterion|1|||
44567541|NCT03086551|79587675|FG001|First Intervention|Failure to meet inclusion criterion|0|||
44567542|NCT03086551|79587674|FG000|First Intervention|Lost to Follow-up|0|||
44567543|NCT03086551|79587675|FG001|First Intervention|Lost to Follow-up|1|||
44567544|NCT03086551|79587674|FG000|Washout|Lost to Follow-up|1|||
44567545|NCT03086551|79587675|FG001|Washout|Lost to Follow-up|2|||
44567546|NCT03086551|79587674|FG000|Washout|Withdrawal by Subject|2|||
44567547|NCT03086551|79587675|FG001|Washout|Withdrawal by Subject|1|||
44567548|NCT03265249|79587683|FG000|Overall Study|Withdrawal by Subject|0|||
44567549|NCT03265249|79587684|FG001|Overall Study|Withdrawal by Subject|1|||
44567550|NCT02951767|79587690|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
44567551|NCT02951767|79587690|FG000|Overall Study|Withdrawal by Subject|5|||
44567552|NCT02951767|79587690|FG000|Overall Study|Death|59|||
44567553|NCT02951767|79587690|FG000|Overall Study|Lost to Follow-up|1|||
44567554|NCT03093181|79587697|FG000|Overall Study|Withdrawal by Subject|2|||
44567555|NCT03093181|79587698|FG001|Overall Study|Withdrawal by Subject|1|||
44567556|NCT03093181|79587699|FG002|Overall Study|Withdrawal by Subject|2|||
44567557|NCT03093181|79587697|FG000|Overall Study|Other (Not specified)|1|||
44567558|NCT03093181|79587698|FG001|Overall Study|Other (Not specified)|0|||
44567559|NCT03093181|79587699|FG002|Overall Study|Other (Not specified)|0|||
44567560|NCT03093181|79587697|FG000|Overall Study|Adverse Event|0|||
44567561|NCT03093181|79587698|FG001|Overall Study|Adverse Event|1|||
44567562|NCT03093181|79587699|FG002|Overall Study|Adverse Event|0|||
44567563|NCT03093181|79587697|FG000|Overall Study|Other (Protocol violation)|0|||
44567564|NCT03093181|79587698|FG001|Overall Study|Other (Protocol violation)|0|||
44567565|NCT03093181|79587699|FG002|Overall Study|Other (Protocol violation)|1|||
44567566|NCT03091777|79587710|FG000|Overall Study|Pregnancy|2|||
44567567|NCT03091777|79587711|FG001|Overall Study|Pregnancy|1|||
44567568|NCT03091777|79587712|FG002|Overall Study|Pregnancy|0|||
44567569|NCT03091777|79587710|FG000|Overall Study|Adverse Event|2|||
44567570|NCT03091777|79587711|FG001|Overall Study|Adverse Event|1|||
44567571|NCT03091777|79587712|FG002|Overall Study|Adverse Event|4|||
44567572|NCT03091777|79587710|FG000|Overall Study|Withdrawal by Subject|4|||
44567573|NCT03091777|79587711|FG001|Overall Study|Withdrawal by Subject|2|||
44567574|NCT03091777|79587712|FG002|Overall Study|Withdrawal by Subject|6|||
44567575|NCT03091777|79587710|FG000|Overall Study|Protocol Violation|2|||
44235283|NCT01721057|79057030|FG002|Treatment Period|Withdrawal by Subject|8|||
44235284|NCT01721057|79057031|FG003|Treatment Period|Withdrawal by Subject|0|||
44235285|NCT01721057|79057032|FG004|Treatment Period|Withdrawal by Subject|0|||
44567576|NCT03091777|79587711|FG001|Overall Study|Protocol Violation|1|||
44567577|NCT03091777|79587712|FG002|Overall Study|Protocol Violation|1|||
44567578|NCT03091777|79587710|FG000|Overall Study|Lost to Follow-up|12|||
44235286|NCT01721057|79057033|FG005|Treatment Period|Withdrawal by Subject|0|||
44567579|NCT03091777|79587711|FG001|Overall Study|Lost to Follow-up|14|||
44567580|NCT03091777|79587712|FG002|Overall Study|Lost to Follow-up|7|||
44567581|NCT03091777|79587710|FG000|Overall Study|Lack of Efficacy|0|||
44567582|NCT03091777|79587711|FG001|Overall Study|Lack of Efficacy|0|||
44567583|NCT03091777|79587712|FG002|Overall Study|Lack of Efficacy|5|||
44567584|NCT03091777|79587710|FG000|Overall Study|Noncompliance with study drug|2|||
44567585|NCT03091777|79587711|FG001|Overall Study|Noncompliance with study drug|3|||
44567586|NCT03091777|79587712|FG002|Overall Study|Noncompliance with study drug|1|||
44235287|NCT01721057|79057034|FG006|Treatment Period|Withdrawal by Subject|0|||
44567587|NCT03091777|79587710|FG000|Overall Study|Physician Decision|1|||
44567588|NCT03091777|79587711|FG001|Overall Study|Physician Decision|0|||
44567589|NCT03091777|79587712|FG002|Overall Study|Physician Decision|1|||
44567590|NCT03091777|79587710|FG000|Overall Study|Abnormal Laboratory Value|7|||
44567591|NCT03091777|79587711|FG001|Overall Study|Abnormal Laboratory Value|11|||
44567592|NCT03091777|79587712|FG002|Overall Study|Abnormal Laboratory Value|12|||
44567593|NCT02818998|79587723|FG000|Overall Study|Adverse Event|3|||
44567594|NCT02818998|79587724|FG001|Overall Study|Adverse Event|2|||
44567595|NCT02818998|79587725|FG002|Overall Study|Adverse Event|1|||
44567596|NCT02818998|79587723|FG000|Overall Study|Lost to Follow-up|4|||
44567597|NCT02818998|79587724|FG001|Overall Study|Lost to Follow-up|1|||
44567598|NCT02818998|79587725|FG002|Overall Study|Lost to Follow-up|2|||
44567599|NCT02818998|79587723|FG000|Overall Study|Withdrawal by sponsor|0|||
44567600|NCT02818998|79587724|FG001|Overall Study|Withdrawal by sponsor|1|||
44567601|NCT02818998|79587725|FG002|Overall Study|Withdrawal by sponsor|1|||
44567602|NCT02818998|79587723|FG000|Overall Study|Death|3|||
44567603|NCT02818998|79587724|FG001|Overall Study|Death|6|||
44567604|NCT02818998|79587725|FG002|Overall Study|Death|8|||
44567605|NCT02818998|79587723|FG000|Overall Study|Withdrawal by Subject|7|||
44567606|NCT02818998|79587724|FG001|Overall Study|Withdrawal by Subject|6|||
44567607|NCT02818998|79587725|FG002|Overall Study|Withdrawal by Subject|6|||
44235288|NCT01721057|79057028|FG000|Treatment Period|Adverse Event|7|||
44235289|NCT01721057|79057029|FG001|Treatment Period|Adverse Event|10|||
44235290|NCT01721057|79057030|FG002|Treatment Period|Adverse Event|12|||
44235291|NCT01721057|79057031|FG003|Treatment Period|Adverse Event|0|||
44235292|NCT01721057|79057032|FG004|Treatment Period|Adverse Event|0|||
44235293|NCT01721057|79057033|FG005|Treatment Period|Adverse Event|0|||
44235294|NCT01721057|79057034|FG006|Treatment Period|Adverse Event|0|||
44567608|NCT02818998|79587723|FG000|Overall Study|Physician Decision|1|||
44235295|NCT01721057|79057028|FG000|Treatment Period|Lack of Efficacy|7|||
44235296|NCT01721057|79057029|FG001|Treatment Period|Lack of Efficacy|3|||
44235297|NCT01721057|79057030|FG002|Treatment Period|Lack of Efficacy|0|||
44235298|NCT01721057|79057031|FG003|Treatment Period|Lack of Efficacy|0|||
44235299|NCT01721057|79057032|FG004|Treatment Period|Lack of Efficacy|0|||
44235300|NCT01721057|79057033|FG005|Treatment Period|Lack of Efficacy|0|||
44235301|NCT01721057|79057034|FG006|Treatment Period|Lack of Efficacy|0|||
44235302|NCT01721057|79057028|FG000|Treatment Period|Lost to Follow-up|1|||
44235303|NCT01721057|79057029|FG001|Treatment Period|Lost to Follow-up|0|||
44235304|NCT01721057|79057030|FG002|Treatment Period|Lost to Follow-up|0|||
44235305|NCT01721057|79057031|FG003|Treatment Period|Lost to Follow-up|0|||
44235306|NCT01721057|79057032|FG004|Treatment Period|Lost to Follow-up|0|||
44235307|NCT01721057|79057033|FG005|Treatment Period|Lost to Follow-up|0|||
44235308|NCT01721057|79057034|FG006|Treatment Period|Lost to Follow-up|0|||
44235309|NCT01721057|79057028|FG000|Treatment Period|Physician Decision|0|||
44235310|NCT01721057|79057029|FG001|Treatment Period|Physician Decision|1|||
44235311|NCT01721057|79057030|FG002|Treatment Period|Physician Decision|3|||
44235312|NCT01721057|79057031|FG003|Treatment Period|Physician Decision|0|||
44235313|NCT01721057|79057032|FG004|Treatment Period|Physician Decision|0|||
44235314|NCT01721057|79057033|FG005|Treatment Period|Physician Decision|0|||
44235315|NCT01721057|79057034|FG006|Treatment Period|Physician Decision|0|||
44235316|NCT01721057|79057028|FG000|Treatment Period|Death|2|||
44235317|NCT01721057|79057029|FG001|Treatment Period|Death|0|||
44235318|NCT01721057|79057030|FG002|Treatment Period|Death|0|||
44235319|NCT01721057|79057031|FG003|Treatment Period|Death|0|||
44235320|NCT01721057|79057032|FG004|Treatment Period|Death|0|||
44235321|NCT01721057|79057033|FG005|Treatment Period|Death|0|||
44235322|NCT01721057|79057034|FG006|Treatment Period|Death|0|||
44235323|NCT01721057|79057028|FG000|Rescue Period|Adverse Event|0|||
44567609|NCT02818998|79587724|FG001|Overall Study|Physician Decision|0|||
44567610|NCT02818998|79587725|FG002|Overall Study|Physician Decision|0|||
44567611|NCT02821416|79587735|FG000|Overall Study|Adverse Event|0|||
44567612|NCT02821416|79587736|FG001|Overall Study|Adverse Event|1|||
44567613|NCT02821416|79587735|FG000|Overall Study|Withdrawal by Subject|2|||
44235324|NCT01721057|79057029|FG001|Rescue Period|Adverse Event|0|||
44235325|NCT01721057|79057030|FG002|Rescue Period|Adverse Event|0|||
44567614|NCT02821416|79587736|FG001|Overall Study|Withdrawal by Subject|0|||
44235326|NCT01721057|79057031|FG003|Rescue Period|Adverse Event|1|||
44235327|NCT01721057|79057032|FG004|Rescue Period|Adverse Event|0|||
44235328|NCT01721057|79057033|FG005|Rescue Period|Adverse Event|0|||
44235329|NCT01721057|79057034|FG006|Rescue Period|Adverse Event|0|||
44567615|NCT02821416|79587735|FG000|Overall Study|Lost to Follow-up|1|||
44567616|NCT02821416|79587736|FG001|Overall Study|Lost to Follow-up|0|||
44567617|NCT03108521|79587745|FG000|Overall Study|Lost to Follow-up|3|||
44567618|NCT03108521|79587746|FG001|Overall Study|Lost to Follow-up|0|||
44235330|NCT01721057|79057028|FG000|Rescue Period|Lack of Efficacy|0|||
44235331|NCT01721057|79057029|FG001|Rescue Period|Lack of Efficacy|0|||
44235332|NCT01721057|79057030|FG002|Rescue Period|Lack of Efficacy|0|||
44235333|NCT01721057|79057031|FG003|Rescue Period|Lack of Efficacy|2|||
44235334|NCT01721057|79057032|FG004|Rescue Period|Lack of Efficacy|0|||
44235335|NCT01721057|79057033|FG005|Rescue Period|Lack of Efficacy|0|||
44567619|NCT03108521|79587745|FG000|Overall Study|Lack of Efficacy|2|||
44567620|NCT03108521|79587746|FG001|Overall Study|Lack of Efficacy|0|||
44567621|NCT03108521|79587745|FG000|Overall Study|Physician Decision|4|||
44567622|NCT03108521|79587746|FG001|Overall Study|Physician Decision|0|||
44567623|NCT03108521|79587745|FG000|Overall Study|Adverse Event|3|||
44235336|NCT01721057|79057034|FG006|Rescue Period|Lack of Efficacy|0|||
44235337|NCT04570384|79057063|FG000|Overall Study|Adverse Event|2|||
44235338|NCT04570384|79057064|FG001|Overall Study|Adverse Event|1|||
44235339|NCT04570384|79057063|FG000|Overall Study|Death|2|||
44235340|NCT04570384|79057064|FG001|Overall Study|Death|5|||
44235341|NCT04570384|79057063|FG000|Overall Study|Lost to Follow-up|1|||
44235342|NCT04570384|79057064|FG001|Overall Study|Lost to Follow-up|0|||
44235343|NCT04570384|79057063|FG000|Overall Study|Other|1|||
44235344|NCT04570384|79057064|FG001|Overall Study|Other|0|||
44503224|NCT00045110|79508049|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
44503225|NCT03353740|79508066|FG000|Overall Study|Images for these participants not viable|52|||
44503226|NCT00003476|79508070|FG000|Overall Study|Not evaluable|1|||
44503227|NCT00003470|79508074|FG000|Overall Study|Not evaluable|6|||
44503228|NCT03386344|79508081|FG000|Overall Study|Adverse Event|6|||
44503229|NCT03386344|79508082|FG001|Overall Study|Adverse Event|3|||
44503230|NCT03386344|79508083|FG002|Overall Study|Adverse Event|1|||
44503231|NCT03386344|79508081|FG000|Overall Study|Poor Compliance to Protocol|0|||
44503232|NCT03386344|79508082|FG001|Overall Study|Poor Compliance to Protocol|1|||
44503233|NCT03386344|79508083|FG002|Overall Study|Poor Compliance to Protocol|0|||
44503234|NCT03386344|79508081|FG000|Overall Study|Study Terminated by Sponsor|101|||
44235345|NCT04570384|79057063|FG000|Overall Study|Protocol Violation|0|||
44235346|NCT04570384|79057064|FG001|Overall Study|Protocol Violation|1|||
44503235|NCT03386344|79508082|FG001|Overall Study|Study Terminated by Sponsor|102|||
44235347|NCT04570384|79057063|FG000|Overall Study|Sponsor Decision|1|||
44235348|NCT04570384|79057064|FG001|Overall Study|Sponsor Decision|0|||
44503236|NCT03386344|79508083|FG002|Overall Study|Study Terminated by Sponsor|106|||
44503237|NCT03386344|79508081|FG000|Overall Study|Lost to Follow-up|3|||
44567624|NCT03108521|79587746|FG001|Overall Study|Adverse Event|0|||
44567625|NCT02817828|79587769|FG000|Overall Study|Lost to Follow-up|41|||
44567626|NCT02817828|79587769|FG000|Overall Study|Adverse event not related to bleeding|104|||
44567627|NCT02817828|79587769|FG000|Overall Study|Adverse event related to bleeding|53|||
44567628|NCT02817828|79587769|FG000|Overall Study|Protocol Violation|11|||
44567629|NCT02817828|79587769|FG000|Overall Study|Pregnancy|7|||
44567630|NCT02817828|79587769|FG000|Overall Study|Pregnancy wish|15|||
44567631|NCT02817828|79587769|FG000|Overall Study|Withdrawal by Subject|78|||
44567632|NCT02817828|79587769|FG000|Overall Study|Other|26|||
44567633|NCT02817906|79587780|FG000|Overall Study|Adverse Event|3|||
44567634|NCT02817906|79587781|FG001|Overall Study|Adverse Event|0|||
44567635|NCT02817906|79587780|FG000|Overall Study|Lack of Efficacy|1|||
44567636|NCT02817906|79587781|FG001|Overall Study|Lack of Efficacy|0|||
44567637|NCT02817906|79587780|FG000|Overall Study|Protocol Violation|1|||
44567638|NCT02817906|79587781|FG001|Overall Study|Protocol Violation|1|||
44567639|NCT02817906|79587780|FG000|Overall Study|Study Terminated by Sponsor|2|||
44567640|NCT02817906|79587781|FG001|Overall Study|Study Terminated by Sponsor|2|||
44567641|NCT02817906|79587780|FG000|Overall Study|Withdrawal by Subject|7|||
44567642|NCT02817906|79587781|FG001|Overall Study|Withdrawal by Subject|0|||
44567643|NCT02817906|79587780|FG000|Overall Study|Other|2|||
44567644|NCT02817906|79587781|FG001|Overall Study|Other|2|||
44503238|NCT03386344|79508082|FG001|Overall Study|Lost to Follow-up|2|||
44503239|NCT03386344|79508083|FG002|Overall Study|Lost to Follow-up|1|||
44503240|NCT03386344|79508081|FG000|Overall Study|At the Participant's own Request|7|||
44503241|NCT03386344|79508082|FG001|Overall Study|At the Participant's own Request|7|||
44503242|NCT03386344|79508083|FG002|Overall Study|At the Participant's own Request|8|||
44503243|NCT03386344|79508081|FG000|Overall Study|Reason not Specified|0|||
44503244|NCT03386344|79508082|FG001|Overall Study|Reason not Specified|1|||
44503245|NCT03386344|79508083|FG002|Overall Study|Reason not Specified|0|||
44235349|NCT04570384|79057063|FG000|Overall Study|Withdrawal by Subject|4|||
44235350|NCT04570384|79057064|FG001|Overall Study|Withdrawal by Subject|2|||
44567645|NCT02817594|79587792|FG000|Overall Study|Withdrawal by Subject|1|||
44567646|NCT02817594|79587792|FG000|Overall Study|Other|1|||
44567647|NCT02817594|79587792|FG000|Overall Study|Did Not Receive Treatment|1|||
44567648|NCT02813694|79587802|FG000|Overall Study|Physician Decision|0|||
44567649|NCT02813694|79587803|FG001|Overall Study|Physician Decision|1|||
44567650|NCT02813694|79587802|FG000|Overall Study|Withdrawal by Subject|10|||
44567651|NCT02813694|79587803|FG001|Overall Study|Withdrawal by Subject|9|||
44567652|NCT02813694|79587802|FG000|Overall Study|Lost to Follow-up|1|||
44567653|NCT02813694|79587803|FG001|Overall Study|Lost to Follow-up|1|||
44567654|NCT02813694|79587802|FG000|Overall Study|Death|3|||
44567655|NCT02813694|79587803|FG001|Overall Study|Death|3|||
44567656|NCT02813694|79587802|FG000|Overall Study|Randomized- did not receive study drug|2|||
44567657|NCT02813694|79587803|FG001|Overall Study|Randomized- did not receive study drug|0|||
44567658|NCT02813694|79587802|FG000|Overall Study|Patient hospitalized|1|||
44567659|NCT02813694|79587803|FG001|Overall Study|Patient hospitalized|0|||
44567660|NCT03103919|79587811|FG000|Overall Study|Adverse Event|2|||
44567661|NCT03103919|79587812|FG001|Overall Study|Adverse Event|2|||
44567662|NCT02810964|79587822|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
44567663|NCT02810964|79587823|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
44235351|NCT02563522|79057117|FG000|Overall Study|Adverse Event|2|||
44503246|NCT00399035|79508094|FG000|Overall Study|Death|289|||
44503247|NCT00399035|79508095|FG001|Overall Study|Death|141|||
44503248|NCT00399035|79508096|FG002|Overall Study|Death|234|||
44503249|NCT00399035|79508094|FG000|Overall Study|Lost to Follow-up|2|||
44503250|NCT00399035|79508095|FG001|Overall Study|Lost to Follow-up|1|||
44503251|NCT00399035|79508096|FG002|Overall Study|Lost to Follow-up|5|||
44567664|NCT02810964|79587822|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
44567665|NCT02810964|79587823|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
44567666|NCT02810964|79587822|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
44567667|NCT02810964|79587823|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
44567668|NCT02810964|79587822|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
44567669|NCT02810964|79587823|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
44567670|NCT03103763|79587832|FG000|Overall Study|Death|15|||
44567671|NCT03103763|79587833|FG001|Overall Study|Death|5|||
44567672|NCT03103763|79587834|FG002|Overall Study|Death|5|||
44567673|NCT03103763|79587832|FG000|Overall Study|Withdrawal by Subject|0|||
44567674|NCT03103763|79587833|FG001|Overall Study|Withdrawal by Subject|3|||
44567675|NCT03103763|79587834|FG002|Overall Study|Withdrawal by Subject|2|||
44567676|NCT03101267|79587858|FG000|Primary Study Period|Withdrawal by Subject|1|||
44567677|NCT03101267|79587859|FG001|Primary Study Period|Withdrawal by Subject|2|||
44567678|NCT03101267|79587860|FG002|Primary Study Period|Withdrawal by Subject|3|||
44567679|NCT03101267|79587858|FG000|Primary Study Period|Miscellaneous|2|||
44567680|NCT03101267|79587859|FG001|Primary Study Period|Miscellaneous|0|||
44567681|NCT03101267|79587860|FG002|Primary Study Period|Miscellaneous|0|||
44567682|NCT02810418|79587875|FG000|Arm A Dose Escalation|Adverse Event|2|||
44567683|NCT02810418|79587876|FG001|Arm A Dose Escalation|Adverse Event|1|||
44567684|NCT02810418|79587877|FG002|Arm A Dose Escalation|Adverse Event|0|||
44567685|NCT02810418|79587878|FG003|Arm A Dose Escalation|Adverse Event|0|||
44567686|NCT02810418|79587879|FG004|Arm A Dose Escalation|Adverse Event|0|||
44567687|NCT02810418|79587880|FG005|Arm A Dose Escalation|Adverse Event|0|||
44567688|NCT02810418|79587881|FG006|Arm A Dose Escalation|Adverse Event|0|||
44567689|NCT02810418|79587875|FG000|Dose Expansion|Adverse Event|0|||
44567690|NCT02810418|79587876|FG001|Dose Expansion|Adverse Event|1|||
44567691|NCT02810418|79587877|FG002|Dose Expansion|Adverse Event|1|||
44567692|NCT02810418|79587878|FG003|Dose Expansion|Adverse Event|0|||
44567693|NCT02810418|79587879|FG004|Dose Expansion|Adverse Event|0|||
44567694|NCT02810418|79587880|FG005|Dose Expansion|Adverse Event|0|||
44567695|NCT02810418|79587881|FG006|Dose Expansion|Adverse Event|0|||
44567696|NCT02810418|79587875|FG000|Dose Expansion|Physician Decision|0|||
44567697|NCT02810418|79587876|FG001|Dose Expansion|Physician Decision|0|||
44567698|NCT02810418|79587877|FG002|Dose Expansion|Physician Decision|2|||
44567699|NCT02810418|79587878|FG003|Dose Expansion|Physician Decision|0|||
44567700|NCT02810418|79587879|FG004|Dose Expansion|Physician Decision|0|||
44567701|NCT02810418|79587880|FG005|Dose Expansion|Physician Decision|0|||
44567702|NCT02810418|79587881|FG006|Dose Expansion|Physician Decision|0|||
44567703|NCT02810418|79587875|FG000|Arm B Dose Escalation|Adverse Event|0|||
44567704|NCT02810418|79587876|FG001|Arm B Dose Escalation|Adverse Event|0|||
44567705|NCT02810418|79587877|FG002|Arm B Dose Escalation|Adverse Event|0|||
44567706|NCT02810418|79587878|FG003|Arm B Dose Escalation|Adverse Event|0|||
44567707|NCT02810418|79587879|FG004|Arm B Dose Escalation|Adverse Event|1|||
44567708|NCT02810418|79587880|FG005|Arm B Dose Escalation|Adverse Event|2|||
44567709|NCT02810418|79587881|FG006|Arm B Dose Escalation|Adverse Event|0|||
44567710|NCT02810340|79587947|FG000|Overall Study|Withdrawal by Subject|1|||
44567711|NCT02810340|79587948|FG001|Overall Study|Withdrawal by Subject|0|||
44567712|NCT02810340|79587949|FG002|Overall Study|Withdrawal by Subject|0|||
44567713|NCT02810340|79587947|FG000|Overall Study|Incarceration|0|||
44567714|NCT02810340|79587948|FG001|Overall Study|Incarceration|1|||
44567715|NCT02810340|79587949|FG002|Overall Study|Incarceration|0|||
44567716|NCT02810340|79587947|FG000|Overall Study|Lost to Follow-up|0|||
44567717|NCT02810340|79587948|FG001|Overall Study|Lost to Follow-up|0|||
44567718|NCT02810340|79587949|FG002|Overall Study|Lost to Follow-up|1|||
44567719|NCT02817516|79587961|FG000|Overall Study|Other|0|||
44567720|NCT02817516|79587962|FG001|Overall Study|Other|0|||
44567721|NCT02817516|79587963|FG002|Overall Study|Other|1|||
44567722|NCT02817516|79587964|FG003|Overall Study|Other|0|||
44377679|NCT00782275|79382974|FG000|Overall Study|Other|3|||
44567723|NCT02928029|79587979|FG000|Overall Study|Withdrawal by Subject|0|||
44567724|NCT02928029|79587980|FG001|Overall Study|Withdrawal by Subject|1|||
44567725|NCT02928029|79587979|FG000|Overall Study|Radiological progression|1|||
44567726|NCT02928029|79587980|FG001|Overall Study|Radiological progression|0|||
44567727|NCT02928029|79587979|FG000|Overall Study|Clinical progression|1|||
44567728|NCT02928029|79587980|FG001|Overall Study|Clinical progression|2|||
44567729|NCT02928029|79587979|FG000|Overall Study|AE not related to clinical progression|1|||
44567730|NCT02928029|79587980|FG001|Overall Study|AE not related to clinical progression|1|||
44567731|NCT02806986|79587986|FG000|Treatment Stage 1|Adverse Event|1|||
44567732|NCT02806986|79587986|FG000|Treatment Stage 2|Adverse Event|3|||
44567733|NCT02806986|79587986|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
44567734|NCT03095651|79588002|FG000|Overall Study|Lost to Follow-up|1|||
44567735|NCT03095651|79588003|FG001|Overall Study|Lost to Follow-up|1|||
44567736|NCT03095651|79588004|FG002|Overall Study|Lost to Follow-up|0|||
44567737|NCT03095651|79588005|FG003|Overall Study|Lost to Follow-up|1|||
44567738|NCT03095651|79588006|FG004|Overall Study|Lost to Follow-up|0|||
44567739|NCT03095651|79588007|FG005|Overall Study|Lost to Follow-up|0|||
44567740|NCT03095651|79588008|FG006|Overall Study|Lost to Follow-up|0|||
44567741|NCT03095651|79588009|FG007|Overall Study|Lost to Follow-up|0|||
44567742|NCT03095651|79588002|FG000|Overall Study|Withdrawal by Subject|0|||
44567743|NCT03095651|79588003|FG001|Overall Study|Withdrawal by Subject|0|||
44567744|NCT03095651|79588004|FG002|Overall Study|Withdrawal by Subject|0|||
44567745|NCT03095651|79588005|FG003|Overall Study|Withdrawal by Subject|0|||
44567746|NCT03095651|79588006|FG004|Overall Study|Withdrawal by Subject|0|||
44567747|NCT03095651|79588007|FG005|Overall Study|Withdrawal by Subject|1|||
44567748|NCT03095651|79588008|FG006|Overall Study|Withdrawal by Subject|0|||
44567749|NCT03095651|79588009|FG007|Overall Study|Withdrawal by Subject|0|||
44567750|NCT02808312|79588032|FG000|Overall Study|Enrolled but Never Treated|0|||
44567751|NCT02808312|79588033|FG001|Overall Study|Enrolled but Never Treated|0|||
44567752|NCT02808312|79588034|FG002|Overall Study|Enrolled but Never Treated|1|||
44567753|NCT02808312|79588035|FG003|Overall Study|Enrolled but Never Treated|0|||
44567754|NCT02808312|79588036|FG004|Overall Study|Enrolled but Never Treated|0|||
44567755|NCT03099161|79588056|FG000|Overall Study|Adverse Event|0|||
44567756|NCT03099161|79588057|FG001|Overall Study|Adverse Event|0|||
44567757|NCT03099161|79588058|FG002|Overall Study|Adverse Event|2|||
44567758|NCT03099161|79588056|FG000|Overall Study|Physician Decision|2|||
44567759|NCT03099161|79588057|FG001|Overall Study|Physician Decision|0|||
44567760|NCT03099161|79588058|FG002|Overall Study|Physician Decision|0|||
44567761|NCT03099161|79588056|FG000|Overall Study|Progressive Disease|1|||
44567762|NCT03099161|79588057|FG001|Overall Study|Progressive Disease|4|||
44567763|NCT03099161|79588058|FG002|Overall Study|Progressive Disease|1|||
44567764|NCT03095027|79588066|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
44567765|NCT03095027|79588067|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
44567766|NCT04227197|79588075|FG000|Randomization|Protocol Violation|1|||
44567767|NCT04227197|79588076|FG001|Randomization|Protocol Violation|0|||
44567768|NCT04227197|79588075|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
44567769|NCT04227197|79588076|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
44567770|NCT04227197|79588075|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
44567771|NCT04227197|79588076|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
44567772|NCT04227197|79588075|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
44567773|NCT04227197|79588076|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
44567774|NCT04227197|79588075|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
44567775|NCT04227197|79588076|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
44567776|NCT04227197|79588075|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
44567777|NCT04227197|79588076|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
44567778|NCT04227197|79588075|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
44567779|NCT04227197|79588076|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
44567780|NCT03080935|79588087|FG000|Overall Study|Death|34|||
44567781|NCT03080935|79588088|FG001|Overall Study|Death|50|||
44567782|NCT03080935|79588087|FG000|Overall Study|Lost to Follow-up|5|||
44567783|NCT03080935|79588088|FG001|Overall Study|Lost to Follow-up|4|||
44567784|NCT03080935|79588087|FG000|Overall Study|Withdrawal by Subject|11|||
44235352|NCT02563522|79057118|FG001|Overall Study|Adverse Event|3|||
44235353|NCT02563522|79057117|FG000|Overall Study|Lost to Follow-up|1|||
44235354|NCT02563522|79057118|FG001|Overall Study|Lost to Follow-up|0|||
44235355|NCT02563522|79057117|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
44235356|NCT02563522|79057118|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
44235357|NCT03578146|79057130|FG000|Overall Study|Did Not Receive Treatment|1|||
44235358|NCT03578146|79057131|FG001|Overall Study|Did Not Receive Treatment|0|||
44235359|NCT03578146|79057132|FG002|Overall Study|Did Not Receive Treatment|0|||
44235360|NCT03578146|79057133|FG003|Overall Study|Did Not Receive Treatment|0|||
44503252|NCT00399035|79508094|FG000|Overall Study|Withdrawal by Subject|19|||
44503253|NCT00399035|79508095|FG001|Overall Study|Withdrawal by Subject|15|||
44503254|NCT00399035|79508096|FG002|Overall Study|Withdrawal by Subject|12|||
44503255|NCT00399035|79508094|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
44503256|NCT00399035|79508095|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
44503257|NCT00399035|79508096|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
44503258|NCT00399035|79508094|FG000|Overall Study|Severe non-compliance with protocol|2|||
44503259|NCT00399035|79508095|FG001|Overall Study|Severe non-compliance with protocol|1|||
44503260|NCT00399035|79508096|FG002|Overall Study|Severe non-compliance with protocol|0|||
44503261|NCT00073749|79508110|FG000|Overall Study|Disease Progression|2|||
44503262|NCT00073749|79508111|FG001|Overall Study|Disease Progression|0|||
44503263|NCT00073749|79508112|FG002|Overall Study|Disease Progression|3|||
44567785|NCT03080935|79588088|FG001|Overall Study|Withdrawal by Subject|15|||
44567786|NCT02921789|79588100|FG000|Overall Study|Adverse Event|0|||
44567787|NCT02921789|79588101|FG001|Overall Study|Adverse Event|1|||
44567788|NCT02921789|79588100|FG000|Overall Study|Lost to Follow-up|1|||
44567789|NCT02921789|79588101|FG001|Overall Study|Lost to Follow-up|0|||
44235361|NCT03578146|79057134|FG004|Overall Study|Did Not Receive Treatment|0|||
44235362|NCT03578146|79057135|FG005|Overall Study|Did Not Receive Treatment|2|||
44235363|NCT03578146|79057130|FG000|Overall Study|Lost to Follow-up|0|||
44235364|NCT03578146|79057131|FG001|Overall Study|Lost to Follow-up|1|||
44235365|NCT03578146|79057132|FG002|Overall Study|Lost to Follow-up|1|||
44235366|NCT03578146|79057133|FG003|Overall Study|Lost to Follow-up|0|||
44235367|NCT03578146|79057134|FG004|Overall Study|Lost to Follow-up|0|||
44377680|NCT00791557|79382978|FG000|Overall Study|Adverse Event|1|||
44377681|NCT00920790|79382982|FG000|Overall Study|aggravation of general condition|14|||
44377682|NCT00781963|79382988|FG000|Overall Study|Death|3|||
44377683|NCT00781963|79382989|FG001|Overall Study|Death|0|||
44377684|NCT00781963|79382988|FG000|Overall Study|Lost to Follow-up|2|||
44377685|NCT00781963|79382989|FG001|Overall Study|Lost to Follow-up|1|||
44377686|NCT00781963|79382988|FG000|Overall Study|Withdrawal by Subject|3|||
44377687|NCT00781963|79382989|FG001|Overall Study|Withdrawal by Subject|1|||
44503264|NCT00073749|79508113|FG003|Overall Study|Disease Progression|2|||
44503265|NCT00073749|79508114|FG004|Overall Study|Disease Progression|3|||
44503266|NCT00073749|79508115|FG005|Overall Study|Disease Progression|1|||
44503267|NCT00073749|79508116|FG006|Overall Study|Disease Progression|3|||
44503268|NCT00073749|79508110|FG000|Overall Study|Death|0|||
44503269|NCT00073749|79508111|FG001|Overall Study|Death|1|||
44503270|NCT00073749|79508112|FG002|Overall Study|Death|1|||
44503271|NCT00073749|79508113|FG003|Overall Study|Death|0|||
44503272|NCT00073749|79508114|FG004|Overall Study|Death|0|||
44503273|NCT00073749|79508115|FG005|Overall Study|Death|0|||
44503274|NCT00073749|79508116|FG006|Overall Study|Death|29|||
44503275|NCT00073749|79508110|FG000|Overall Study|Adverse Event|0|||
44503276|NCT00073749|79508111|FG001|Overall Study|Adverse Event|3|||
44503277|NCT00073749|79508112|FG002|Overall Study|Adverse Event|6|||
44503278|NCT00073749|79508113|FG003|Overall Study|Adverse Event|4|||
44503279|NCT00073749|79508114|FG004|Overall Study|Adverse Event|2|||
44503280|NCT00073749|79508115|FG005|Overall Study|Adverse Event|1|||
44503281|NCT00073749|79508116|FG006|Overall Study|Adverse Event|0|||
44503282|NCT00073749|79508110|FG000|Overall Study|Physician Decision|0|||
44503283|NCT00073749|79508111|FG001|Overall Study|Physician Decision|0|||
44503284|NCT00073749|79508112|FG002|Overall Study|Physician Decision|1|||
44503285|NCT00073749|79508113|FG003|Overall Study|Physician Decision|0|||
44503286|NCT00073749|79508114|FG004|Overall Study|Physician Decision|0|||
44503287|NCT00073749|79508115|FG005|Overall Study|Physician Decision|2|||
44503288|NCT00073749|79508116|FG006|Overall Study|Physician Decision|0|||
44503289|NCT00073749|79508110|FG000|Overall Study|Withdrawal by Subject|0|||
44503290|NCT00073749|79508111|FG001|Overall Study|Withdrawal by Subject|1|||
44503291|NCT00073749|79508112|FG002|Overall Study|Withdrawal by Subject|0|||
44503292|NCT00073749|79508113|FG003|Overall Study|Withdrawal by Subject|0|||
44503293|NCT00073749|79508114|FG004|Overall Study|Withdrawal by Subject|1|||
44503294|NCT00073749|79508115|FG005|Overall Study|Withdrawal by Subject|0|||
44503295|NCT00073749|79508116|FG006|Overall Study|Withdrawal by Subject|2|||
44503296|NCT00073749|79508110|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
44503297|NCT00073749|79508111|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
44503298|NCT00073749|79508112|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
44503299|NCT00073749|79508113|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
44503300|NCT00073749|79508114|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
44503301|NCT00073749|79508115|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
44503302|NCT00073749|79508116|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
44503303|NCT00073749|79508110|FG000|Overall Study|Lost to Follow-up|0|||
44503304|NCT00073749|79508111|FG001|Overall Study|Lost to Follow-up|0|||
44503305|NCT00073749|79508112|FG002|Overall Study|Lost to Follow-up|0|||
44503306|NCT00073749|79508113|FG003|Overall Study|Lost to Follow-up|0|||
44503307|NCT00073749|79508114|FG004|Overall Study|Lost to Follow-up|0|||
44567790|NCT02921789|79588100|FG000|Overall Study|Protocol Deviation|2|||
44567791|NCT02921789|79588101|FG001|Overall Study|Protocol Deviation|0|||
44503308|NCT00073749|79508115|FG005|Overall Study|Lost to Follow-up|0|||
44503309|NCT00073749|79508116|FG006|Overall Study|Lost to Follow-up|2|||
44377688|NCT00781963|79382988|FG000|Overall Study|Refused follow-up|9|||
44377689|NCT00781963|79382989|FG001|Overall Study|Refused follow-up|0|||
44567792|NCT02921789|79588100|FG000|Overall Study|Withdrawal by Subject|2|||
44567793|NCT02921789|79588101|FG001|Overall Study|Withdrawal by Subject|1|||
44235368|NCT03578146|79057135|FG005|Overall Study|Lost to Follow-up|1|||
44503310|NCT00073749|79508110|FG000|Overall Study|Other|0|||
44503311|NCT00073749|79508111|FG001|Overall Study|Other|0|||
44503312|NCT00073749|79508112|FG002|Overall Study|Other|0|||
44503313|NCT00073749|79508113|FG003|Overall Study|Other|0|||
44503314|NCT00073749|79508114|FG004|Overall Study|Other|0|||
44503315|NCT00073749|79508115|FG005|Overall Study|Other|2|||
44567794|NCT02921789|79588100|FG000|Overall Study|Miscellaneous|3|||
44567795|NCT02921789|79588101|FG001|Overall Study|Miscellaneous|2|||
44567796|NCT03097289|79588116|FG000|Overall Study|Adverse Event|1|||
44567797|NCT03097289|79588116|FG000|Overall Study|Equipment failure|2|||
44567798|NCT03097289|79588116|FG000|Overall Study|Collected platelet product unusable|3|||
44567799|NCT02419742|79588123|FG000|Overall Study|Adverse Event|2|||
44567800|NCT02419742|79588124|FG001|Overall Study|Adverse Event|0|||
44567801|NCT02419742|79588123|FG000|Overall Study|Disease Progression|0|||
44567802|NCT02419742|79588124|FG001|Overall Study|Disease Progression|1|||
44567803|NCT02419742|79588123|FG000|Overall Study|Withdrew Consent|2|||
44567804|NCT02419742|79588124|FG001|Overall Study|Withdrew Consent|1|||
44567805|NCT02419742|79588123|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
44567806|NCT02419742|79588124|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
44567807|NCT02409290|79588134|FG000|Overall Study|Protocol Violation|3|||
44567808|NCT02409290|79588135|FG001|Overall Study|Protocol Violation|6|||
44567809|NCT02409290|79588136|FG002|Overall Study|Protocol Violation|9|||
44567810|NCT02409290|79588137|FG003|Overall Study|Protocol Violation|4|||
44567811|NCT02409290|79588134|FG000|Overall Study|No positive culture/no baseline sample|3|||
44567812|NCT02409290|79588135|FG001|Overall Study|No positive culture/no baseline sample|9|||
44567813|NCT02409290|79588136|FG002|Overall Study|No positive culture/no baseline sample|6|||
44567814|NCT02409290|79588137|FG003|Overall Study|No positive culture/no baseline sample|5|||
44567815|NCT02409290|79588134|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
44567816|NCT02409290|79588135|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
44567817|NCT02409290|79588136|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
44567818|NCT02409290|79588137|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
44567819|NCT02898077|79588149|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
44567820|NCT02898077|79588150|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
44567821|NCT02898077|79588149|FG000|Overall Study|Lost to Follow-up|4|||
44567822|NCT02898077|79588150|FG001|Overall Study|Lost to Follow-up|3|||
44567823|NCT02898077|79588149|FG000|Overall Study|Physician Decision|0|||
44567824|NCT02898077|79588150|FG001|Overall Study|Physician Decision|2|||
44567825|NCT02898077|79588149|FG000|Overall Study|Sponsor Decision|32|||
44567826|NCT02898077|79588150|FG001|Overall Study|Sponsor Decision|13|||
44567827|NCT02898077|79588149|FG000|Overall Study|Withdrawal by Subject|6|||
44567828|NCT02898077|79588150|FG001|Overall Study|Withdrawal by Subject|3|||
44567829|NCT02898077|79588149|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
44567830|NCT02898077|79588150|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
44567831|NCT02898077|79588149|FG000|Overall Study|Ended extension period|3|||
44567832|NCT02898077|79588150|FG001|Overall Study|Ended extension period|0|||
44567833|NCT03097133|79588158|FG000|Overall Study|Lost to Follow-up|3|||
44567834|NCT03097133|79588159|FG001|Overall Study|Lost to Follow-up|2|||
44567835|NCT03097133|79588158|FG000|Overall Study|Withdrawal by Subject|2|||
44567836|NCT03097133|79588159|FG001|Overall Study|Withdrawal by Subject|5|||
44567837|NCT03097133|79588158|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
44567838|NCT03097133|79588159|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
44567839|NCT03097133|79588158|FG000|Overall Study|Other|3|||
44235369|NCT02716896|79057151|FG000|Overall Study|Physician Decision|0|||
44567840|NCT03097133|79588159|FG001|Overall Study|Other|2|||
44567841|NCT03097133|79588158|FG000|Overall Study|Adverse Event|1|||
44567842|NCT03097133|79588159|FG001|Overall Study|Adverse Event|0|||
44567843|NCT03889639|79588173|FG000|Overall Study|Withdrawal by Subject|0|||
44567844|NCT03889639|79588174|FG001|Overall Study|Withdrawal by Subject|0|||
44567845|NCT03889639|79588175|FG002|Overall Study|Withdrawal by Subject|0|||
44567846|NCT03889639|79588176|FG003|Overall Study|Withdrawal by Subject|0|||
44567847|NCT03889639|79588177|FG004|Overall Study|Withdrawal by Subject|0|||
44567848|NCT03889639|79588178|FG005|Overall Study|Withdrawal by Subject|0|||
44567849|NCT03889639|79588179|FG006|Overall Study|Withdrawal by Subject|0|||
44567850|NCT03889639|79588180|FG007|Overall Study|Withdrawal by Subject|1|||
44567851|NCT03265145|79588203|FG000|Overall Study|Protocol Violation|2|||
44567852|NCT03265145|79588204|FG001|Overall Study|Protocol Violation|0|||
44567853|NCT03265145|79588203|FG000|Overall Study|Adverse Event|1|||
44567854|NCT03265145|79588204|FG001|Overall Study|Adverse Event|0|||
44567855|NCT03265145|79588203|FG000|Overall Study|Withdrawal by Subject|23|||
44567856|NCT03265145|79588204|FG001|Overall Study|Withdrawal by Subject|19|||
44567857|NCT03265145|79588203|FG000|Overall Study|Death|12|||
44567858|NCT03265145|79588204|FG001|Overall Study|Death|12|||
44567859|NCT03265145|79588203|FG000|Overall Study|Lost to Follow-up|13|||
44567860|NCT03265145|79588204|FG001|Overall Study|Lost to Follow-up|9|||
44567861|NCT03265145|79588203|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
44567862|NCT03265145|79588204|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
44567863|NCT03265145|79588203|FG000|Overall Study|Switched back to previous medication|1|||
44567864|NCT03265145|79588204|FG001|Overall Study|Switched back to previous medication|0|||
44567865|NCT03265145|79588203|FG000|Overall Study|Did not want to take medication|1|||
44567866|NCT03265145|79588204|FG001|Overall Study|Did not want to take medication|0|||
44567867|NCT03265145|79588203|FG000|Overall Study|Subject could not afford medication|0|||
44567868|NCT03265145|79588204|FG001|Overall Study|Subject could not afford medication|1|||
44567869|NCT03265145|79588203|FG000|Overall Study|Site closed|2|||
44567870|NCT03265145|79588204|FG001|Overall Study|Site closed|3|||
44567871|NCT03265145|79588203|FG000|Overall Study|Incorrectly randomized|16|||
44567872|NCT03265145|79588204|FG001|Overall Study|Incorrectly randomized|6|||
44567873|NCT03265145|79588203|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
44567874|NCT03265145|79588204|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
44567875|NCT03265145|79588203|FG000|Overall Study|Physician Decision|0|||
44567876|NCT03265145|79588204|FG001|Overall Study|Physician Decision|3|||
44567877|NCT03265145|79588203|FG000|Overall Study|Subject transferred to another facility|0|||
44567878|NCT03265145|79588204|FG001|Overall Study|Subject transferred to another facility|1|||
44567879|NCT05674344|79588215|FG000|Overall Study|Screen Fail|21|||
44567880|NCT05674344|79588215|FG000|Overall Study|Incomplete study procedures|3|||
44567881|NCT04424641|79588281|FG000|Overall Study|Death|1|||
44567882|NCT04424641|79588282|FG001|Overall Study|Death|2|||
44567883|NCT04424641|79588283|FG002|Overall Study|Death|3|||
44567884|NCT04424641|79588284|FG003|Overall Study|Death|0|||
44567885|NCT04424641|79588285|FG004|Overall Study|Death|3|||
44567886|NCT04424641|79588286|FG005|Overall Study|Death|0|||
44567887|NCT04424641|79588287|FG006|Overall Study|Death|1|||
44567888|NCT04424641|79588288|FG007|Overall Study|Death|2|||
44567889|NCT04424641|79588281|FG000|Overall Study|Sponsor decision|0|||
44567890|NCT04424641|79588282|FG001|Overall Study|Sponsor decision|2|||
44567891|NCT04424641|79588283|FG002|Overall Study|Sponsor decision|3|||
44567892|NCT04424641|79588284|FG003|Overall Study|Sponsor decision|7|||
44235370|NCT02716896|79057152|FG001|Overall Study|Physician Decision|1|||
44235371|NCT02715726|79057207|FG000|Overall Study|Adverse Event|2|||
44235372|NCT02715726|79057208|FG001|Overall Study|Adverse Event|6|||
44503316|NCT00073749|79508116|FG006|Overall Study|Other|0|||
44503317|NCT00398567|79508138|FG000|Overall Study|Disease Progression|3|||
44503318|NCT00398567|79508139|FG001|Overall Study|Disease Progression|4|||
44503319|NCT00398567|79508140|FG002|Overall Study|Disease Progression|27|||
44503320|NCT00398567|79508138|FG000|Overall Study|Withdrawal by Subject|1|||
44503321|NCT00398567|79508139|FG001|Overall Study|Withdrawal by Subject|0|||
44503322|NCT00398567|79508140|FG002|Overall Study|Withdrawal by Subject|4|||
44503323|NCT00398567|79508138|FG000|Overall Study|Adverse Event|0|||
44503324|NCT00398567|79508139|FG001|Overall Study|Adverse Event|0|||
44503325|NCT00398567|79508140|FG002|Overall Study|Adverse Event|2|||
44503326|NCT00398567|79508138|FG000|Overall Study|Protocol Violation|0|||
44503327|NCT00398567|79508139|FG001|Overall Study|Protocol Violation|0|||
44503328|NCT00398567|79508140|FG002|Overall Study|Protocol Violation|1|||
44503329|NCT05249569|79508146|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
44503330|NCT04779879|79508169|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
44503331|NCT04779879|79508170|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
44503332|NCT04779879|79508171|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
44503333|NCT04779879|79508172|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
44503334|NCT04779879|79508173|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
44503335|NCT04779879|79508174|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
44503336|NCT04779879|79508169|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
44503337|NCT04779879|79508170|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
44503338|NCT04779879|79508171|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
44567893|NCT04424641|79588285|FG004|Overall Study|Sponsor decision|2|||
44567894|NCT04424641|79588286|FG005|Overall Study|Sponsor decision|2|||
44567895|NCT04424641|79588287|FG006|Overall Study|Sponsor decision|3|||
44567896|NCT04424641|79588288|FG007|Overall Study|Sponsor decision|4|||
44567897|NCT04424641|79588281|FG000|Overall Study|Withdrawal by Subject|0|||
44567898|NCT04424641|79588282|FG001|Overall Study|Withdrawal by Subject|0|||
44567899|NCT04424641|79588283|FG002|Overall Study|Withdrawal by Subject|0|||
44567900|NCT04424641|79588284|FG003|Overall Study|Withdrawal by Subject|0|||
44567901|NCT04424641|79588285|FG004|Overall Study|Withdrawal by Subject|1|||
44567902|NCT04424641|79588286|FG005|Overall Study|Withdrawal by Subject|0|||
44567903|NCT04424641|79588287|FG006|Overall Study|Withdrawal by Subject|0|||
44567904|NCT04424641|79588288|FG007|Overall Study|Withdrawal by Subject|0|||
44567905|NCT04424641|79588281|FG000|Overall Study|Other|0|||
44567906|NCT04424641|79588282|FG001|Overall Study|Other|0|||
44567907|NCT04424641|79588283|FG002|Overall Study|Other|1|||
44567908|NCT04424641|79588284|FG003|Overall Study|Other|0|||
44567909|NCT04424641|79588285|FG004|Overall Study|Other|0|||
44567910|NCT04424641|79588286|FG005|Overall Study|Other|0|||
44567911|NCT04424641|79588287|FG006|Overall Study|Other|0|||
44567912|NCT04424641|79588288|FG007|Overall Study|Other|0|||
44567913|NCT04276090|79588317|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
44567914|NCT04276090|79588318|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
44567915|NCT04105842|79588328|FG000|Overall Study|Withdrawal by Subject|2|||
44567916|NCT04088734|79588335|FG000|Overall Study|Other, Not Specified|5|||
44567917|NCT03868787|79588358|FG000|Overall Study|Withdrawal by Subject|2|||
44567918|NCT03868787|79588359|FG001|Overall Study|Withdrawal by Subject|1|||
44567919|NCT03457701|79588390|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
44567920|NCT03457701|79588391|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
44567921|NCT03457701|79588390|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
44567922|NCT03457701|79588391|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
44567923|NCT02694978|79588484|FG000|Overall Study|Adverse Event|10|||
44567924|NCT02694978|79588485|FG001|Overall Study|Adverse Event|9|||
44567925|NCT02694978|79588484|FG000|Overall Study|Withdrawal by Subject|22|||
44567926|NCT02694978|79588485|FG001|Overall Study|Withdrawal by Subject|19|||
44567927|NCT02694978|79588484|FG000|Overall Study|Lost to Follow-up|14|||
44567928|NCT02694978|79588485|FG001|Overall Study|Lost to Follow-up|17|||
44567929|NCT02694978|79588484|FG000|Overall Study|Death|4|||
44567930|NCT02694978|79588485|FG001|Overall Study|Death|1|||
44567931|NCT02694978|79588484|FG000|Overall Study|Other-Decision of Participant|6|||
44567932|NCT02694978|79588485|FG001|Overall Study|Other-Decision of Participant|1|||
44567933|NCT02694978|79588484|FG000|Overall Study|Other-Investigator's decision|1|||
44567934|NCT02694978|79588485|FG001|Overall Study|Other-Investigator's decision|0|||
44567935|NCT02694978|79588484|FG000|Overall Study|Other-Unable to be reached|0|||
44567936|NCT02694978|79588485|FG001|Overall Study|Other-Unable to be reached|1|||
44567937|NCT02694978|79588484|FG000|Overall Study|Other-Protocol noncompliant|2|||
44567938|NCT02694978|79588485|FG001|Overall Study|Other-Protocol noncompliant|1|||
44567939|NCT02694978|79588484|FG000|Overall Study|Other-Personal reasons|3|||
44567940|NCT02694978|79588485|FG001|Overall Study|Other-Personal reasons|3|||
44567941|NCT02694978|79588484|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
44567942|NCT02694978|79588485|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
44567943|NCT02563002|79588493|FG000|Overall Study|Death|62|||
44567944|NCT02563002|79588494|FG001|Overall Study|Death|75|||
44235373|NCT02715726|79057207|FG000|Overall Study|Protocol Violation|1|||
44503339|NCT04779879|79508172|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
44503340|NCT04779879|79508173|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
44503341|NCT04779879|79508174|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
44503342|NCT04779879|79508169|FG000|Part C: Up to Week 36|Death|0|||
44503343|NCT04779879|79508170|FG001|Part C: Up to Week 36|Death|0|||
44503344|NCT04779879|79508171|FG002|Part C: Up to Week 36|Death|0|||
44503345|NCT04779879|79508172|FG003|Part C: Up to Week 36|Death|0|||
44503346|NCT04779879|79508173|FG004|Part C: Up to Week 36|Death|0|||
44567945|NCT02563002|79588493|FG000|Overall Study|Lost to Follow-up|1|||
44567946|NCT02563002|79588494|FG001|Overall Study|Lost to Follow-up|0|||
44567947|NCT02563002|79588493|FG000|Overall Study|Withdrawal by Subject|0|||
44567948|NCT02563002|79588494|FG001|Overall Study|Withdrawal by Subject|9|||
44503347|NCT04779879|79508174|FG005|Part C: Up to Week 36|Death|1|||
44567949|NCT02563002|79588493|FG000|Overall Study|Ongoing|90|||
44567950|NCT02563002|79588494|FG001|Overall Study|Ongoing|70|||
44567951|NCT02454933|79588505|FG000|Overall Study|Progressive disease|7|||
44503348|NCT04779879|79508169|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
44567952|NCT02454933|79588506|FG001|Overall Study|Progressive disease|5|||
44567953|NCT02454933|79588505|FG000|Overall Study|Adverse Event|1|||
44567954|NCT02454933|79588506|FG001|Overall Study|Adverse Event|1|||
44567955|NCT02454933|79588505|FG000|Overall Study|Withdrawal by Subject|0|||
44567956|NCT02454933|79588506|FG001|Overall Study|Withdrawal by Subject|2|||
44567957|NCT02430480|79588511|FG000|Overall Study|Death|1|||
44567958|NCT02430480|79588511|FG000|Overall Study|Anesthesia concerns|1|||
44567959|NCT02430480|79588511|FG000|Overall Study|Progressed on treatment|1|||
44567960|NCT01205048|79588525|FG000|Overall Study|Withdrawal by Subject|14|||
44567961|NCT01205048|79588525|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
44567962|NCT01205048|79588525|FG000|Overall Study|Lost to Follow-up|4|||
44567963|NCT01205048|79588525|FG000|Overall Study|Other|2|||
44567964|NCT01052779|79588533|FG000|Overall Study|Adverse Event|1|||
44567965|NCT01052779|79588534|FG001|Overall Study|Adverse Event|4|||
44567966|NCT01052779|79588533|FG000|Overall Study|Withdrawal by Subject|1|||
44567967|NCT01052779|79588534|FG001|Overall Study|Withdrawal by Subject|2|||
44567968|NCT01052779|79588533|FG000|Overall Study|Other-Protocol Violation|1|||
44567969|NCT01052779|79588534|FG001|Overall Study|Other-Protocol Violation|1|||
44567970|NCT01052779|79588533|FG000|Overall Study|Other-Surgery|0|||
44567971|NCT01052779|79588534|FG001|Overall Study|Other-Surgery|2|||
44567972|NCT01052779|79588533|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
44567973|NCT01052779|79588534|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
44567974|NCT00591370|79588544|FG000|Overall Study|Not Treated|2|||
44567975|NCT03064763|79588548|FG000|Overall Study|Lost to Follow-up|1|||
44567976|NCT03064763|79588548|FG000|Overall Study|Death|8|||
44567977|NCT02782676|79588552|FG000|Overall Study|Lost to Follow-up|0|||
44567978|NCT02782676|79588553|FG001|Overall Study|Lost to Follow-up|1|||
44567979|NCT02471339|79588561|FG000|Overall Study|Did not provide follow-up data|2|||
44567980|NCT02471339|79588562|FG001|Overall Study|Did not provide follow-up data|0|||
44567981|NCT00107978|79588570|FG000|Overall Study|Adverse Event|1|||
44567982|NCT00107978|79588571|FG001|Overall Study|Adverse Event|5|||
44567983|NCT00107978|79588570|FG000|Overall Study|Death|3|||
44567984|NCT00107978|79588571|FG001|Overall Study|Death|3|||
44567985|NCT00107978|79588570|FG000|Overall Study|Lost to Follow-up|20|||
44567986|NCT00107978|79588571|FG001|Overall Study|Lost to Follow-up|28|||
44567987|NCT00107978|79588570|FG000|Overall Study|Withdrawal by Subject|4|||
44567988|NCT00107978|79588571|FG001|Overall Study|Withdrawal by Subject|9|||
44567989|NCT00107978|79588570|FG000|Overall Study|Protocol Violation|0|||
44567990|NCT00107978|79588571|FG001|Overall Study|Protocol Violation|1|||
44567991|NCT00107978|79588570|FG000|Overall Study|Other|5|||
44567992|NCT00107978|79588571|FG001|Overall Study|Other|4|||
44567993|NCT02781818|79588580|FG000|Overall Study|Lost to Follow-up|4|||
44567994|NCT02781818|79588581|FG001|Overall Study|Lost to Follow-up|2|||
44567995|NCT02781818|79588582|FG002|Overall Study|Lost to Follow-up|1|||
44567996|NCT02927873|79588596|FG000|Overall Study|Lost to Follow-up|0|||
44567997|NCT02927873|79588597|FG001|Overall Study|Lost to Follow-up|1|||
44567998|NCT02927873|79588598|FG002|Overall Study|Lost to Follow-up|0|||
44567999|NCT02927873|79588599|FG003|Overall Study|Lost to Follow-up|0|||
44568000|NCT02927873|79588600|FG004|Overall Study|Lost to Follow-up|0|||
44568001|NCT02927873|79588601|FG005|Overall Study|Lost to Follow-up|0|||
44568002|NCT02927873|79588596|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44568003|NCT02927873|79588597|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
44568004|NCT02927873|79588598|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44568005|NCT02927873|79588599|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44568006|NCT02927873|79588600|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44568007|NCT02927873|79588601|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
44568008|NCT02927873|79588596|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44568009|NCT02927873|79588597|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44568010|NCT02927873|79588598|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44568011|NCT02927873|79588599|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44235374|NCT02715726|79057208|FG001|Overall Study|Protocol Violation|0|||
44568012|NCT02927873|79588600|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44568013|NCT02927873|79588601|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44568014|NCT02927873|79588596|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
44235375|NCT02715726|79057207|FG000|Overall Study|Death|2|||
44235376|NCT02715726|79057208|FG001|Overall Study|Death|1|||
44568015|NCT02927873|79588597|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
44568016|NCT02927873|79588598|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
44568017|NCT02927873|79588599|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
44568018|NCT02927873|79588600|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
44568019|NCT02927873|79588601|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
44568020|NCT02927873|79588596|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
44568021|NCT02927873|79588597|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
44568022|NCT02927873|79588598|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
44568023|NCT02927873|79588599|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
44568024|NCT02927873|79588600|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
44568025|NCT02927873|79588601|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
44568026|NCT02927873|79588596|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
44568027|NCT02927873|79588597|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
44568028|NCT02927873|79588598|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
44568029|NCT02927873|79588599|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
44568030|NCT02927873|79588600|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
44568031|NCT02927873|79588601|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
44568032|NCT01220999|79588620|FG000|Overall Study|Progressive disease|0|||
44568033|NCT01220999|79588621|FG001|Overall Study|Progressive disease|0|||
44568034|NCT01220999|79588622|FG002|Overall Study|Progressive disease|1|||
44568035|NCT01220999|79588623|FG003|Overall Study|Progressive disease|0|||
44568036|NCT01220999|79588624|FG004|Overall Study|Progressive disease|0|||
44568037|NCT00142415|79588642|FG000|Overall Study|Physician Decision|0|||
44568038|NCT00142415|79588643|FG001|Overall Study|Physician Decision|0|||
44568039|NCT00142415|79588644|FG002|Overall Study|Physician Decision|0|||
44568040|NCT00142415|79588645|FG003|Overall Study|Physician Decision|0|||
44568041|NCT00142415|79588646|FG004|Overall Study|Physician Decision|1|||
44568042|NCT00142415|79588647|FG005|Overall Study|Physician Decision|2|||
44568043|NCT02781584|79588689|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
44568044|NCT02781584|79588690|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
44568045|NCT02781584|79588691|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
44568046|NCT02781584|79588692|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
44568047|NCT02781584|79588693|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
44568048|NCT02781584|79588694|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
44568049|NCT02781584|79588695|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
44568050|NCT02781584|79588696|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
44568051|NCT02781584|79588697|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
44568052|NCT02781584|79588698|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
44568053|NCT02781584|79588699|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
44568054|NCT02781584|79588700|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
44568055|NCT02781584|79588701|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
44568056|NCT02781584|79588689|FG000|Pre-treatment Phase|Adverse Event|0|||
44568057|NCT02781584|79588690|FG001|Pre-treatment Phase|Adverse Event|0|||
44568058|NCT02781584|79588691|FG002|Pre-treatment Phase|Adverse Event|0|||
44568059|NCT02781584|79588692|FG003|Pre-treatment Phase|Adverse Event|0|||
44568060|NCT02781584|79588693|FG004|Pre-treatment Phase|Adverse Event|0|||
44568061|NCT02781584|79588694|FG005|Pre-treatment Phase|Adverse Event|0|||
44568062|NCT02781584|79588695|FG006|Pre-treatment Phase|Adverse Event|0|||
44568063|NCT02781584|79588696|FG007|Pre-treatment Phase|Adverse Event|0|||
44568064|NCT02781584|79588697|FG008|Pre-treatment Phase|Adverse Event|0|||
44568065|NCT02781584|79588698|FG009|Pre-treatment Phase|Adverse Event|0|||
44568066|NCT02781584|79588699|FG010|Pre-treatment Phase|Adverse Event|0|||
44568067|NCT02781584|79588700|FG011|Pre-treatment Phase|Adverse Event|1|||
44568068|NCT02781584|79588701|FG012|Pre-treatment Phase|Adverse Event|0|||
44568069|NCT02781584|79588689|FG000|Treatment Phase|Withdrew Consent|0|||
44568070|NCT02781584|79588690|FG001|Treatment Phase|Withdrew Consent|0|||
44568071|NCT02781584|79588691|FG002|Treatment Phase|Withdrew Consent|0|||
44568072|NCT02781584|79588692|FG003|Treatment Phase|Withdrew Consent|0|||
44568073|NCT02781584|79588693|FG004|Treatment Phase|Withdrew Consent|0|||
44235377|NCT02715726|79057207|FG000|Overall Study|Participant moved|1|||
44568074|NCT02781584|79588694|FG005|Treatment Phase|Withdrew Consent|1|||
44568075|NCT02781584|79588695|FG006|Treatment Phase|Withdrew Consent|0|||
44568076|NCT02781584|79588696|FG007|Treatment Phase|Withdrew Consent|0|||
44568077|NCT02781584|79588697|FG008|Treatment Phase|Withdrew Consent|0|||
44568078|NCT02781584|79588698|FG009|Treatment Phase|Withdrew Consent|0|||
44568079|NCT02781584|79588699|FG010|Treatment Phase|Withdrew Consent|1|||
44568080|NCT02781584|79588700|FG011|Treatment Phase|Withdrew Consent|2|||
44568081|NCT02781584|79588701|FG012|Treatment Phase|Withdrew Consent|0|||
44568082|NCT02781584|79588689|FG000|Treatment Phase|Adverse Event|0|||
44568083|NCT02781584|79588690|FG001|Treatment Phase|Adverse Event|0|||
44568084|NCT02781584|79588691|FG002|Treatment Phase|Adverse Event|0|||
44568085|NCT02781584|79588692|FG003|Treatment Phase|Adverse Event|0|||
44568086|NCT02781584|79588693|FG004|Treatment Phase|Adverse Event|0|||
44568087|NCT02781584|79588694|FG005|Treatment Phase|Adverse Event|0|||
44568088|NCT02781584|79588695|FG006|Treatment Phase|Adverse Event|0|||
44568089|NCT02781584|79588696|FG007|Treatment Phase|Adverse Event|1|||
44568090|NCT02781584|79588697|FG008|Treatment Phase|Adverse Event|0|||
44568091|NCT02781584|79588698|FG009|Treatment Phase|Adverse Event|0|||
44568092|NCT02781584|79588699|FG010|Treatment Phase|Adverse Event|0|||
44568093|NCT02781584|79588700|FG011|Treatment Phase|Adverse Event|0|||
44568094|NCT02781584|79588701|FG012|Treatment Phase|Adverse Event|0|||
44568095|NCT02776670|79588731|FG000|Overall Study|Adverse Event|0|||
44568096|NCT02776670|79588732|FG001|Overall Study|Adverse Event|2|||
44568097|NCT02776670|79588731|FG000|Overall Study|Protocol Violation|0|||
44568098|NCT02776670|79588732|FG001|Overall Study|Protocol Violation|2|||
44568099|NCT02776670|79588731|FG000|Overall Study|Withdrawal by Subject|0|||
44568100|NCT02776670|79588732|FG001|Overall Study|Withdrawal by Subject|1|||
44568101|NCT02776670|79588731|FG000|Overall Study|Other - Reason not given|0|||
44568102|NCT02776670|79588732|FG001|Overall Study|Other - Reason not given|1|||
44568103|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
44568104|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
44568105|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
44568106|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44568107|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44568108|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44568109|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44568110|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44568111|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44568112|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
44568113|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
44568114|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
44568115|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44568116|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44568117|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44568118|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44568119|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44568120|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44568121|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
44568122|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
44568123|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
44568124|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44568125|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44568126|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44568127|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44568128|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44377690|NCT00920556|79382995|FG000|Overall Study|Adverse Event|16|||
44568129|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44568130|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568131|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568132|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
44568133|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568134|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568135|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568136|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568137|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568138|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44568139|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
44568140|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
44568141|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
44235378|NCT02715726|79057208|FG001|Overall Study|Participant moved|3|||
44568142|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44568143|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44568144|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44568145|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44568146|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44235379|NCT02715726|79057207|FG000|Overall Study|Other than specified above|11|||
44568147|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44568148|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
44568149|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568150|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568151|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568152|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568153|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568154|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568155|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568156|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44568157|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
44568158|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
44568159|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568160|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568161|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568162|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568163|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568164|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568165|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44568166|NCT01307423|79588741|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568167|NCT01307423|79588742|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
44568168|NCT01307423|79588743|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
44568169|NCT01307423|79588744|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568170|NCT01307423|79588745|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568171|NCT01307423|79588746|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568172|NCT01307423|79588747|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568173|NCT01307423|79588748|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568174|NCT01307423|79588749|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
44568175|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
44568176|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
44568177|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
44568178|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
44568179|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
44568180|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
44568181|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
44568182|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
44568183|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
44568184|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
44568185|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
44568186|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
44568187|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
44568188|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
44568189|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
44568190|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
44568191|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
44568192|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
44568193|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568194|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568195|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44235380|NCT02715726|79057208|FG001|Overall Study|Other than specified above|15|||
44235381|NCT02715726|79057207|FG000|Overall Study|Randomized but not treated|1|||
44235382|NCT02715726|79057208|FG001|Overall Study|Randomized but not treated|2|||
44568196|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568197|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568198|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
44568199|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568200|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568201|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
44568202|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
44568203|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
44568204|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
44568205|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
44568206|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
44568207|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
44568208|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
44568209|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
44568210|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
44568211|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568212|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568213|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568214|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
44568215|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568216|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568217|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568218|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568219|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
44568220|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
44568221|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
44568222|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
44568223|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
44568224|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
44568225|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
44568226|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
44503349|NCT04779879|79508170|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
44503350|NCT04779879|79508171|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
44503351|NCT04779879|79508172|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
44568227|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
44568228|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
44568229|NCT01307423|79588741|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568230|NCT01307423|79588742|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568231|NCT01307423|79588743|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568232|NCT01307423|79588744|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568233|NCT01307423|79588745|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568234|NCT01307423|79588746|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
44568235|NCT01307423|79588747|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568236|NCT01307423|79588748|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568237|NCT01307423|79588749|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
44568238|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44235383|NCT04248816|79057221|FG000|Overall Study|Ineligible post-randomization|7|||
44235384|NCT04248816|79057222|FG001|Overall Study|Ineligible post-randomization|21|||
44235385|NCT04248816|79057223|FG002|Overall Study|Ineligible post-randomization|25|||
44235386|NCT02314156|79057260|FG000|Overall Study|Adverse Event|1|||
44235387|NCT02314156|79057261|FG001|Overall Study|Adverse Event|0|||
44235388|NCT02314156|79057260|FG000|Overall Study|Withdrawal by Subject|1|||
44235389|NCT02314156|79057261|FG001|Overall Study|Withdrawal by Subject|0|||
44235390|NCT02716584|79057476|FG000|Overall Study|Lost to Follow-up|8|||
44235391|NCT02716584|79057477|FG001|Overall Study|Lost to Follow-up|5|||
44235392|NCT02716194|79057558|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
44235393|NCT02716194|79057559|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
44503352|NCT04779879|79508173|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
44503353|NCT04779879|79508174|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
44503354|NCT04535167|79508215|FG000|Treatment|Adverse Event|0|||
44503355|NCT04535167|79508216|FG001|Treatment|Adverse Event|0|||
44503356|NCT04535167|79508217|FG002|Treatment|Adverse Event|0|||
44503357|NCT04535167|79508218|FG003|Treatment|Adverse Event|0|||
44503358|NCT04535167|79508219|FG004|Treatment|Adverse Event|0|||
44235394|NCT02716194|79057560|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
44235395|NCT03773484|79057630|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
44503359|NCT04535167|79508220|FG005|Treatment|Adverse Event|0|||
44503360|NCT04535167|79508221|FG006|Treatment|Adverse Event|1|||
44503361|NCT04535167|79508215|FG000|Follow-Up|Death|0|||
44503362|NCT04535167|79508216|FG001|Follow-Up|Death|0|||
44235396|NCT02715258|79057813|FG000|Overall Study|Withdrawal by Subject|6|||
44235397|NCT02715258|79057814|FG001|Overall Study|Withdrawal by Subject|1|||
44235398|NCT02715258|79057813|FG000|Overall Study|Lost to Follow-up|7|||
44235399|NCT02715258|79057814|FG001|Overall Study|Lost to Follow-up|1|||
44568239|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
44568240|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
44568241|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44568242|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44568243|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44568244|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
44568245|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
44568246|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
44568247|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44568248|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
44568249|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
44568250|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44568251|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44568252|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44568253|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
44568254|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
44568255|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
44568256|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568257|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568258|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
44568259|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568260|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568261|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568262|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568263|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568264|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
44568265|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44568266|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
44568267|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
44568268|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44568269|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44568270|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44568271|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44568272|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
44568273|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
44568274|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44568275|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
44568276|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44568277|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44568278|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44568279|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44568280|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
44568281|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
44568282|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
44568283|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44568284|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
44568285|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
44568286|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44568287|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44568288|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44568289|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
44568290|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
44568291|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
44568292|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44568293|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
44568294|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
44235400|NCT02715258|79057813|FG000|Overall Study|Terminated by Sponsor|0|||
44235401|NCT02715258|79057814|FG001|Overall Study|Terminated by Sponsor|1|||
44235402|NCT02715258|79057813|FG000|Overall Study|Death|0|||
44235403|NCT02715258|79057814|FG001|Overall Study|Death|1|||
44235404|NCT02715258|79057813|FG000|Overall Study|Subject non-compliant|1|||
44235405|NCT02715258|79057814|FG001|Overall Study|Subject non-compliant|1|||
44235406|NCT02715258|79057813|FG000|Overall Study|GCP violation|2|||
44235407|NCT02715258|79057814|FG001|Overall Study|GCP violation|1|||
44235408|NCT02714868|79057839|FG000|Overall Study|Withdrawal by Subject|3|||
44568295|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44568296|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44568297|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44568298|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
44568299|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
44568300|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
44568301|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568302|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
44568303|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
44568304|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568305|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568306|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568307|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568308|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568309|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
44568310|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44568311|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
44568312|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
44568313|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44568314|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44568315|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44568316|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44568317|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
44568318|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
44568319|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44568320|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
44568321|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
44568322|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44568323|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44568324|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44568325|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
44568326|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
44568327|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
44568328|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568329|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
44568330|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568331|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568332|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568333|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568334|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568335|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
44568336|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
44568337|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568338|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
44568339|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568340|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568341|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568342|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568343|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568344|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568345|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
44568346|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44568347|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
44568348|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44568349|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44235409|NCT02714868|79057840|FG001|Overall Study|Withdrawal by Subject|0|||
44235410|NCT02714868|79057839|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
44235411|NCT02714868|79057840|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
44568350|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44568351|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44568352|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44568353|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
44235412|NCT02714868|79057839|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
44568354|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
44568355|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44568356|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
44568357|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
44568358|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44568359|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44568360|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44568361|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44568362|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
44568363|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
44568364|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568365|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568366|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
44568367|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568368|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568369|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568370|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568371|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568372|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
44568373|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568374|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568375|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568376|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568377|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568378|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568379|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568380|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
44568381|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
44568382|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44568383|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
44568384|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
44568385|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44568386|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44568387|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44568388|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44568389|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
44568390|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
44568391|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568392|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
44568393|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
44568394|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568395|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568396|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568397|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568398|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568399|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
44568400|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44568401|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
44568402|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
44568403|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44568404|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44568405|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44568406|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44568407|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44568408|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
44568409|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44235413|NCT02714868|79057840|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
44235414|NCT02713542|79058155|FG000|Overall Study|Use of prohibited medication|14|||
44235415|NCT02713542|79058156|FG001|Overall Study|Use of prohibited medication|5|||
44568410|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
44568411|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44568412|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44235416|NCT02713542|79058155|FG000|Overall Study|Withdrawal by Subject|4|||
44568413|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44568414|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44568415|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44568416|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44568417|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
44568418|NCT01307423|79588741|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44235417|NCT02713542|79058156|FG001|Overall Study|Withdrawal by Subject|1|||
44568419|NCT01307423|79588742|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44568420|NCT01307423|79588743|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
44568421|NCT01307423|79588744|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44568422|NCT01307423|79588745|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44568423|NCT01307423|79588746|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44568424|NCT01307423|79588747|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
44568425|NCT01307423|79588748|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
44568426|NCT01307423|79588749|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
44568427|NCT02778074|79588783|FG000|Overall Study|Lost to Follow-up|7|||
44568428|NCT02778074|79588784|FG001|Overall Study|Lost to Follow-up|10|||
44568429|NCT02775344|79588801|FG000|Overall Study|No ovarian cyst identified|3|||
44568430|NCT02775344|79588802|FG001|Overall Study|No ovarian cyst identified|2|||
44568431|NCT02777918|79588810|FG000|Overall Study|Medical reasons|1|||
44568432|NCT02777918|79588811|FG001|Overall Study|Medical reasons|2|||
44568433|NCT02777918|79588810|FG000|Overall Study|Too busy / stressed|1|||
44568434|NCT02777918|79588811|FG001|Overall Study|Too busy / stressed|1|||
44568435|NCT02777918|79588810|FG000|Overall Study|Withdrawal by Subject|1|||
44568436|NCT02777918|79588811|FG001|Overall Study|Withdrawal by Subject|1|||
44568437|NCT02927795|79588817|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
44568438|NCT02927795|79588817|FG000|Overall Study|Not Treated|4|||
44568439|NCT02767856|79588823|FG000|Overall Study|Lost to Follow-up|9|||
44568440|NCT02767856|79588824|FG001|Overall Study|Lost to Follow-up|1|||
44568441|NCT02767856|79588823|FG000|Overall Study|Withdrawal by Subject|2|||
44568442|NCT02767856|79588824|FG001|Overall Study|Withdrawal by Subject|1|||
44568443|NCT03087851|79588833|FG000|Overall Study|Withdraw on medical grounds|0|||
44568444|NCT03087851|79588834|FG001|Overall Study|Withdraw on medical grounds|1|||
44568445|NCT03087851|79588835|FG002|Overall Study|Withdraw on medical grounds|2|||
44568446|NCT03092375|79588847|FG000|Overall Study|Lack of Efficacy|0|||
44568447|NCT03092375|79588848|FG001|Overall Study|Lack of Efficacy|1|||
44568448|NCT03092375|79588849|FG002|Overall Study|Lack of Efficacy|1|||
44568449|NCT03092375|79588850|FG003|Overall Study|Lack of Efficacy|0|||
44568450|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Other|34|||
44568451|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Other|0|||
44568452|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Other|0|||
44568453|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Other|0|||
44568454|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Death|14|||
44568455|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Death|0|||
44568456|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Death|0|||
44568457|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Death|0|||
44568458|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
44568459|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
44568460|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
44568461|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
44568462|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
44568463|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
44568464|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
44568465|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
44568466|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
44568467|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
44568468|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
44568469|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
44568470|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
44568471|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
44568472|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
44568473|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
44568474|NCT01995513|79588867|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
44568475|NCT01995513|79588868|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
44568476|NCT01995513|79588869|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
44568477|NCT01995513|79588870|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
44568478|NCT01995513|79588867|FG000|Period 1: Second Open Label Treatment|Other|0|||
44568479|NCT01995513|79588868|FG001|Period 1: Second Open Label Treatment|Other|2|||
44568480|NCT01995513|79588869|FG002|Period 1: Second Open Label Treatment|Other|0|||
44568481|NCT01995513|79588870|FG003|Period 1: Second Open Label Treatment|Other|0|||
44568482|NCT01995513|79588867|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
44568483|NCT01995513|79588868|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
44235418|NCT03548220|79058240|FG000|Overall Study|Lost to Follow-up|1|||
44235419|NCT03548220|79058241|FG001|Overall Study|Lost to Follow-up|0|||
44235420|NCT03548220|79058242|FG002|Overall Study|Lost to Follow-up|0|||
44235421|NCT03548220|79058243|FG003|Overall Study|Lost to Follow-up|0|||
44235422|NCT02712996|79058278|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
44235423|NCT02712996|79058279|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
44235424|NCT00701064|79058395|FG000|Overall Study|Protocol Violation|1|||
44235425|NCT00701064|79058396|FG001|Overall Study|Protocol Violation|1|||
44235426|NCT00701064|79058395|FG000|Overall Study|Withdrawal by Subject|1|||
44235427|NCT00701064|79058396|FG001|Overall Study|Withdrawal by Subject|1|||
44235428|NCT00701064|79058395|FG000|Overall Study|initiated other PTSD treatment|2|||
44235429|NCT00701064|79058396|FG001|Overall Study|initiated other PTSD treatment|2|||
44235430|NCT05779072|79058404|FG000|Overall Study|Lost to Follow-up|0|||
44235431|NCT05779072|79058405|FG001|Overall Study|Lost to Follow-up|1|||
44235432|NCT05779072|79058404|FG000|Overall Study|Withdrawal by Subject|1|||
44235433|NCT05779072|79058405|FG001|Overall Study|Withdrawal by Subject|5|||
44235434|NCT05089682|79058420|FG000|Overall Study|Withdrawal by Subject|2|||
44235435|NCT05055128|79058429|FG000|Overall Study|Adverse Event|0|||
44235436|NCT05055128|79058430|FG001|Overall Study|Adverse Event|0|||
44235437|NCT05055128|79058431|FG002|Overall Study|Adverse Event|0|||
44235438|NCT05055128|79058432|FG003|Overall Study|Adverse Event|1|||
44235439|NCT05055128|79058433|FG004|Overall Study|Adverse Event|1|||
44235440|NCT05055128|79058429|FG000|Overall Study|Protocol Violation|0|||
44235441|NCT05055128|79058430|FG001|Overall Study|Protocol Violation|0|||
44235442|NCT05055128|79058431|FG002|Overall Study|Protocol Violation|0|||
44235443|NCT05055128|79058432|FG003|Overall Study|Protocol Violation|1|||
44235444|NCT05055128|79058433|FG004|Overall Study|Protocol Violation|0|||
44235445|NCT05055128|79058429|FG000|Overall Study|Withdrawal by Subject|5|||
44235446|NCT05055128|79058430|FG001|Overall Study|Withdrawal by Subject|2|||
44235447|NCT05055128|79058431|FG002|Overall Study|Withdrawal by Subject|2|||
44235448|NCT05055128|79058432|FG003|Overall Study|Withdrawal by Subject|4|||
44235449|NCT05055128|79058433|FG004|Overall Study|Withdrawal by Subject|2|||
44235450|NCT05055128|79058429|FG000|Overall Study|Randomized By Mistake|0|||
44235451|NCT05055128|79058430|FG001|Overall Study|Randomized By Mistake|1|||
44235452|NCT05055128|79058431|FG002|Overall Study|Randomized By Mistake|0|||
44235453|NCT05055128|79058432|FG003|Overall Study|Randomized By Mistake|0|||
44235454|NCT05055128|79058433|FG004|Overall Study|Randomized By Mistake|0|||
44235455|NCT05055128|79058429|FG000|Overall Study|Other|1|||
44235456|NCT05055128|79058430|FG001|Overall Study|Other|0|||
44235457|NCT05055128|79058431|FG002|Overall Study|Other|0|||
44235458|NCT05055128|79058432|FG003|Overall Study|Other|0|||
44235459|NCT05055128|79058433|FG004|Overall Study|Other|0|||
44235460|NCT05038020|79058449|FG000|Overall Study|Early Termination|3|||
44235461|NCT05038020|79058450|FG001|Overall Study|Early Termination|0|||
44235462|NCT04796610|79058465|FG000|Overall Study|Withdrawal by Subject|1|||
44235463|NCT04796610|79058466|FG001|Overall Study|Withdrawal by Subject|0|||
44235464|NCT04796610|79058467|FG002|Overall Study|Withdrawal by Subject|0|||
44235465|NCT04796610|79058468|FG003|Overall Study|Withdrawal by Subject|0|||
44235466|NCT04796610|79058465|FG000|Overall Study|Lost to Follow-up|2|||
44235467|NCT04796610|79058466|FG001|Overall Study|Lost to Follow-up|0|||
44235468|NCT04796610|79058467|FG002|Overall Study|Lost to Follow-up|1|||
44235469|NCT04796610|79058468|FG003|Overall Study|Lost to Follow-up|1|||
44235470|NCT04702997|79058478|FG000|Overall Study|Withdrawal by Subject|1|||
44235471|NCT04702997|79058479|FG001|Overall Study|Withdrawal by Subject|1|||
44235472|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
44235473|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
44235474|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
44235475|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
44235476|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
44235477|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
44235478|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
44235479|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
44235480|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
44235481|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
44235482|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
44235483|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
44235484|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
44235485|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
44235486|NCT04173494|79058500|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
44235487|NCT04173494|79058501|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
44235488|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
44235489|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
44235490|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
44235491|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
44235492|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
44235493|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
44235494|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
44235495|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
44235496|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
44235497|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
44235498|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
44235499|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
44235500|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
44235501|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
44235502|NCT04173494|79058500|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
44235503|NCT04173494|79058501|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
44275790|NCT02192190|79224167|FG005|Overall Study|Lost to Follow-up|3|||
44275791|NCT02192190|79224162|FG000|Overall Study|Physician Decision|2|||
44275792|NCT02192190|79224163|FG001|Overall Study|Physician Decision|0|||
44275793|NCT02192190|79224164|FG002|Overall Study|Physician Decision|0|||
44275794|NCT02192190|79224165|FG003|Overall Study|Physician Decision|0|||
44503363|NCT04535167|79508217|FG002|Follow-Up|Death|0|||
44503364|NCT04535167|79508218|FG003|Follow-Up|Death|0|||
44503365|NCT04535167|79508219|FG004|Follow-Up|Death|0|||
44503366|NCT04535167|79508220|FG005|Follow-Up|Death|0|||
44503367|NCT04535167|79508221|FG006|Follow-Up|Death|1|||
44503368|NCT04535167|79508215|FG000|Follow-Up|Lost to Follow-up|0|||
44503369|NCT04535167|79508216|FG001|Follow-Up|Lost to Follow-up|0|||
44503370|NCT04535167|79508217|FG002|Follow-Up|Lost to Follow-up|0|||
44503371|NCT04535167|79508218|FG003|Follow-Up|Lost to Follow-up|1|||
44503372|NCT04535167|79508219|FG004|Follow-Up|Lost to Follow-up|0|||
44503373|NCT04535167|79508220|FG005|Follow-Up|Lost to Follow-up|0|||
44503374|NCT04535167|79508221|FG006|Follow-Up|Lost to Follow-up|0|||
44503375|NCT04223791|79508239|FG000|Overall Study|Lost to Follow-up|0|||
44503376|NCT04223791|79508240|FG001|Overall Study|Lost to Follow-up|4|||
44503377|NCT04223791|79508239|FG000|Overall Study|Physician Decision|5|||
44503378|NCT04223791|79508240|FG001|Overall Study|Physician Decision|1|||
44503379|NCT04223791|79508239|FG000|Overall Study|Protocol Violation|1|||
44503380|NCT04223791|79508240|FG001|Overall Study|Protocol Violation|1|||
44503381|NCT04223791|79508239|FG000|Overall Study|Withdrawal by Subject|10|||
44503382|NCT04223791|79508240|FG001|Overall Study|Withdrawal by Subject|12|||
44503383|NCT04223791|79508239|FG000|Overall Study|Pregnancy|1|||
44568484|NCT01995513|79588869|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
44568485|NCT01995513|79588870|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
44568486|NCT01995513|79588867|FG000|Period 2: Double Blind Treatment|Death|0|||
44568487|NCT01995513|79588868|FG001|Period 2: Double Blind Treatment|Death|0|||
44568488|NCT01995513|79588869|FG002|Period 2: Double Blind Treatment|Death|0|||
44568489|NCT01995513|79588870|FG003|Period 2: Double Blind Treatment|Death|1|||
44568490|NCT01995513|79588867|FG000|Period 2: Double Blind Treatment|Other|0|||
44568491|NCT01995513|79588868|FG001|Period 2: Double Blind Treatment|Other|0|||
44568492|NCT01995513|79588869|FG002|Period 2: Double Blind Treatment|Other|3|||
44568493|NCT01995513|79588870|FG003|Period 2: Double Blind Treatment|Other|3|||
44568494|NCT01995513|79588867|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
44568495|NCT01995513|79588868|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
44568496|NCT01995513|79588869|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
44568497|NCT01995513|79588870|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
44568498|NCT01995513|79588867|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
44568499|NCT01995513|79588868|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
44568500|NCT01995513|79588869|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
44568501|NCT01995513|79588870|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
44568502|NCT01995513|79588867|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
44568503|NCT01995513|79588868|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
44568504|NCT01995513|79588869|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
44568505|NCT01995513|79588870|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
44568506|NCT01995513|79588867|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
44568507|NCT01995513|79588868|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
44568508|NCT01995513|79588869|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
44568509|NCT01995513|79588870|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
44568510|NCT02927171|79588886|FG000|Overall Study|Lost to Follow-up|0|||
44568511|NCT02927171|79588887|FG001|Overall Study|Lost to Follow-up|1|||
44568512|NCT03087617|79588897|FG000|Overall Study|Lost to Follow-up|32|||
44568513|NCT03087617|79588898|FG001|Overall Study|Lost to Follow-up|30|||
44235504|NCT03920215|79058526|FG000|Overall Study|Lost to Follow-up|1|||
44235505|NCT03920215|79058527|FG001|Overall Study|Lost to Follow-up|2|||
44568514|NCT03087617|79588899|FG002|Overall Study|Lost to Follow-up|30|||
44568515|NCT03087617|79588900|FG003|Overall Study|Lost to Follow-up|39|||
44568516|NCT00103610|79588912|FG000|Overall Study|Entered Rescue Procedure|10|||
44568517|NCT00103610|79588913|FG001|Overall Study|Entered Rescue Procedure|52|||
44568518|NCT00103610|79588912|FG000|Overall Study|Death|16|||
44568519|NCT00103610|79588913|FG001|Overall Study|Death|12|||
44568520|NCT00103610|79588912|FG000|Overall Study|Elective Withdrawal|4|||
44568521|NCT00103610|79588913|FG001|Overall Study|Elective Withdrawal|0|||
44568522|NCT00103610|79588912|FG000|Overall Study|Lost to Follow-up|3|||
44568523|NCT00103610|79588913|FG001|Overall Study|Lost to Follow-up|1|||
44235506|NCT03920215|79058528|FG002|Overall Study|Lost to Follow-up|0|||
44235507|NCT03920215|79058529|FG003|Overall Study|Lost to Follow-up|0|||
44235508|NCT03920215|79058526|FG000|Overall Study|Death|0|||
44235509|NCT03920215|79058527|FG001|Overall Study|Death|0|||
44235510|NCT03920215|79058528|FG002|Overall Study|Death|0|||
44235511|NCT03920215|79058529|FG003|Overall Study|Death|1|||
44235512|NCT03878134|79058539|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
44235513|NCT03874429|79058545|FG000|Overall Study|Adverse Event|2|||
44235514|NCT03874429|79058546|FG001|Overall Study|Adverse Event|2|||
44235515|NCT03874429|79058545|FG000|Overall Study|Lack of Efficacy|0|||
44235516|NCT03874429|79058546|FG001|Overall Study|Lack of Efficacy|1|||
44503384|NCT04223791|79508240|FG001|Overall Study|Pregnancy|1|||
44503385|NCT04223791|79508239|FG000|Overall Study|Ongoing in Study|305|||
44503386|NCT04223791|79508240|FG001|Overall Study|Ongoing in Study|302|||
44503387|NCT04115293|79508248|FG000|Overall Study|Adverse Event|0|||
44503388|NCT04115293|79508249|FG001|Overall Study|Adverse Event|2|||
44503389|NCT04115293|79508248|FG000|Overall Study|Withdrawal by Subject|2|||
44503390|NCT04115293|79508249|FG001|Overall Study|Withdrawal by Subject|1|||
44503391|NCT04115293|79508248|FG000|Overall Study|Physician Decision|1|||
44503392|NCT04115293|79508249|FG001|Overall Study|Physician Decision|0|||
44503393|NCT04115293|79508248|FG000|Overall Study|Death|1|||
44568524|NCT00103610|79588912|FG000|Overall Study|Adverse Event|2|||
44568525|NCT00103610|79588913|FG001|Overall Study|Adverse Event|2|||
44568526|NCT00103610|79588912|FG000|Overall Study|Other|2|||
44568527|NCT00103610|79588913|FG001|Overall Study|Other|7|||
44568528|NCT00103610|79588912|FG000|Overall Study|Failed mobilization|1|||
44568529|NCT00103610|79588913|FG001|Overall Study|Failed mobilization|5|||
44568530|NCT00103610|79588912|FG000|Overall Study|Noncompliance|0|||
44568531|NCT00103610|79588913|FG001|Overall Study|Noncompliance|1|||
44568532|NCT03091439|79588922|FG000|Overall Study|Study Terminated by the Sponsor|1|||
44568533|NCT03091439|79588923|FG001|Overall Study|Study Terminated by the Sponsor|0|||
44503394|NCT04115293|79508249|FG001|Overall Study|Death|1|||
44235517|NCT03874429|79058545|FG000|Overall Study|Covid-19 pandemic|4|||
44235518|NCT03874429|79058546|FG001|Overall Study|Covid-19 pandemic|2|||
44503395|NCT04035499|79508255|FG000|Overall Study|Death|2|||
44235519|NCT03733730|79058576|FG000|Overall Study|Lost to Follow-up|1|||
44235520|NCT03733730|79058577|FG001|Overall Study|Lost to Follow-up|32|||
44235521|NCT03733730|79058576|FG000|Overall Study|Other|1|||
44235522|NCT03733730|79058577|FG001|Overall Study|Other|0|||
44275795|NCT02192190|79224166|FG004|Overall Study|Physician Decision|0|||
44275796|NCT02192190|79224167|FG005|Overall Study|Physician Decision|0|||
44275797|NCT02192190|79224162|FG000|Overall Study|Terminated by Sponsor|43|||
44568534|NCT03086447|79588931|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44275798|NCT02192190|79224163|FG001|Overall Study|Terminated by Sponsor|23|||
44568535|NCT03086447|79588932|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
44568536|NCT03086447|79588931|FG000|Overall Study|Lost Lens|2|||
44568537|NCT03086447|79588932|FG001|Overall Study|Lost Lens|5|||
44568538|NCT03086447|79588931|FG000|Overall Study|Product quality complaint|0|||
44568539|NCT03086447|79588932|FG001|Overall Study|Product quality complaint|1|||
44568540|NCT03086447|79588931|FG000|Overall Study|Lens Damage|1|||
44568541|NCT03086447|79588932|FG001|Overall Study|Lens Damage|6|||
44568542|NCT03086447|79588931|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
44568543|NCT03086447|79588932|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
44568544|NCT03086447|79588931|FG000|Overall Study|Test Article No Longer Available|1|||
44568545|NCT03086447|79588932|FG001|Overall Study|Test Article No Longer Available|0|||
44568546|NCT03086447|79588931|FG000|Overall Study|Protocol Violation|2|||
44568547|NCT03086447|79588932|FG001|Overall Study|Protocol Violation|4|||
44568548|NCT03086447|79588931|FG000|Overall Study|Lost to Follow-up|0|||
44568549|NCT03086447|79588932|FG001|Overall Study|Lost to Follow-up|1|||
44235523|NCT03733730|79058576|FG000|Overall Study|Adverse Event|0|||
44568550|NCT03086447|79588931|FG000|Overall Study|Adverse Event|3|||
44568551|NCT03086447|79588932|FG001|Overall Study|Adverse Event|0|||
44568552|NCT03086447|79588931|FG000|Overall Study|Lens Discomfort|2|||
44568553|NCT03086447|79588932|FG001|Overall Study|Lens Discomfort|1|||
44568554|NCT03083639|79588963|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
44568555|NCT03083639|79588964|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
44568556|NCT03083639|79588963|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
44568557|NCT03083639|79588964|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
44568558|NCT02927431|79588973|FG000|Overall Study|Withdrawal by Subject|0|||
44568559|NCT02927431|79588974|FG001|Overall Study|Withdrawal by Subject|0|||
44568560|NCT02927431|79588975|FG002|Overall Study|Withdrawal by Subject|1|||
44568561|NCT03083483|79588988|FG000|Overall Study|Adverse Event|1|||
44568562|NCT03083483|79588989|FG001|Overall Study|Adverse Event|1|||
44568563|NCT03083483|79588990|FG002|Overall Study|Adverse Event|1|||
44568564|NCT03083483|79588988|FG000|Overall Study|Lost to Follow-up|2|||
44568565|NCT03083483|79588989|FG001|Overall Study|Lost to Follow-up|1|||
44568566|NCT03083483|79588990|FG002|Overall Study|Lost to Follow-up|1|||
44568567|NCT03083483|79588988|FG000|Overall Study|technological issues|1|||
44568568|NCT03083483|79588989|FG001|Overall Study|technological issues|0|||
44568569|NCT03083483|79588990|FG002|Overall Study|technological issues|1|||
44568570|NCT03085927|79589002|FG000|Overall Study|Withdrawal by Subject|1|||
44568571|NCT03085927|79589003|FG001|Overall Study|Withdrawal by Subject|4|||
44568572|NCT03085927|79589002|FG000|Overall Study|Lost to Follow-up|3|||
44568573|NCT03085927|79589003|FG001|Overall Study|Lost to Follow-up|1|||
44568574|NCT03085927|79589002|FG000|Overall Study|Death|1|||
44568575|NCT03085927|79589003|FG001|Overall Study|Death|0|||
44235524|NCT03733730|79058577|FG001|Overall Study|Adverse Event|4|||
44235525|NCT03733730|79058576|FG000|Overall Study|Death|0|||
44568576|NCT03085927|79589002|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
44235526|NCT03733730|79058577|FG001|Overall Study|Death|5|||
44235527|NCT03733730|79058576|FG000|Overall Study|Withdrawal by Subject|0|||
44235528|NCT03733730|79058577|FG001|Overall Study|Withdrawal by Subject|8|||
44235529|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
44235530|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
44235531|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
44235532|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
44235533|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
44235534|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
44275799|NCT02192190|79224164|FG002|Overall Study|Terminated by Sponsor|20|||
44235535|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
44568577|NCT03085927|79589003|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
44568578|NCT03085927|79589002|FG000|Overall Study|Dyad Became Ineligible|0|||
44568579|NCT03085927|79589003|FG001|Overall Study|Dyad Became Ineligible|1|||
44568580|NCT04392583|79589011|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
44568581|NCT04497987|79589017|FG000|Overall Study|Adverse Event|1|||
44568582|NCT04497987|79589018|FG001|Overall Study|Adverse Event|0|||
44568583|NCT04497987|79589017|FG000|Overall Study|Death|21|||
44568584|NCT04497987|79589018|FG001|Overall Study|Death|13|||
44568585|NCT04497987|79589017|FG000|Overall Study|Lost to Follow-up|19|||
44568586|NCT04497987|79589018|FG001|Overall Study|Lost to Follow-up|17|||
44235536|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
44235537|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
44235538|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
44235539|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
44235540|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
44235541|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
44235542|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
44235543|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
44235544|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
44235545|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
44235546|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
44235547|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
44235548|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
44235549|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
44235550|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
44235551|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
44235552|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
44235553|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
44235554|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
44235555|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
44235556|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
44235557|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
44235558|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
44235559|NCT03713632|79058594|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
44235560|NCT03713632|79058595|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
44235561|NCT03713632|79058596|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
44235562|NCT03713632|79058597|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
44235563|NCT03713632|79058598|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
44235564|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
44235565|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
44235566|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
44235567|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
44235568|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
44235569|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
44235570|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
44235571|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
44235572|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
44235573|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
44235574|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
44235575|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
44235576|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
44568587|NCT04497987|79589017|FG000|Overall Study|Other - as reported by the investigator|22|||
44568588|NCT04497987|79589018|FG001|Overall Study|Other - as reported by the investigator|16|||
44568589|NCT04497987|79589017|FG000|Overall Study|Physician Decision|1|||
44568590|NCT04497987|79589018|FG001|Overall Study|Physician Decision|0|||
44235577|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
44235578|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
44235579|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
44235580|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
44235581|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
44235582|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
44235583|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
44235584|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
44235585|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
44235586|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
44235587|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
44235588|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
44235589|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
44235590|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
44275800|NCT02192190|79224165|FG003|Overall Study|Terminated by Sponsor|23|||
44568591|NCT04497987|79589017|FG000|Overall Study|Withdrawal by Subject|35|||
44568592|NCT04497987|79589018|FG001|Overall Study|Withdrawal by Subject|21|||
44235591|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
44235592|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
44275801|NCT02192190|79224166|FG004|Overall Study|Terminated by Sponsor|21|||
44235593|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
44503396|NCT04035499|79508255|FG000|Overall Study|Withdrawal by Subject|1|||
44503397|NCT03915067|79508262|FG000|Overall Study|Adverse Event|0|||
44503398|NCT03915067|79508263|FG001|Overall Study|Adverse Event|0|||
44568593|NCT00974571|79589028|FG000|Overall Study|Adverse Event|31|||
44568594|NCT00974571|79589029|FG001|Overall Study|Adverse Event|4|||
44568595|NCT00974571|79589030|FG002|Overall Study|Adverse Event|27|||
44568596|NCT00974571|79589028|FG000|Overall Study|Lack of Efficacy|3|||
44568597|NCT00974571|79589029|FG001|Overall Study|Lack of Efficacy|2|||
44568598|NCT00974571|79589030|FG002|Overall Study|Lack of Efficacy|9|||
44503399|NCT03915067|79508264|FG002|Overall Study|Adverse Event|1|||
44503400|NCT03915067|79508262|FG000|Overall Study|Withdrawal by Subject|4|||
44503401|NCT03915067|79508263|FG001|Overall Study|Withdrawal by Subject|3|||
44503402|NCT03915067|79508264|FG002|Overall Study|Withdrawal by Subject|0|||
44503403|NCT03915067|79508262|FG000|Overall Study|Lost to Follow-up|3|||
44503404|NCT03915067|79508263|FG001|Overall Study|Lost to Follow-up|2|||
44503405|NCT03915067|79508264|FG002|Overall Study|Lost to Follow-up|0|||
44503406|NCT03915067|79508262|FG000|Overall Study|Protocol Deviation|0|||
44503407|NCT03915067|79508263|FG001|Overall Study|Protocol Deviation|0|||
44503408|NCT03915067|79508264|FG002|Overall Study|Protocol Deviation|1|||
44503409|NCT03915067|79508262|FG000|Overall Study|Covid-19 Related Issues|2|||
44503410|NCT03915067|79508263|FG001|Overall Study|Covid-19 Related Issues|4|||
44503411|NCT03915067|79508264|FG002|Overall Study|Covid-19 Related Issues|4|||
44503412|NCT03915067|79508262|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
44568599|NCT00974571|79589028|FG000|Overall Study|Lost to Follow-up|2|||
44568600|NCT00974571|79589029|FG001|Overall Study|Lost to Follow-up|1|||
44568601|NCT00974571|79589030|FG002|Overall Study|Lost to Follow-up|2|||
44568602|NCT00974571|79589028|FG000|Overall Study|Protocol Violation|13|||
44568603|NCT00974571|79589029|FG001|Overall Study|Protocol Violation|4|||
44568604|NCT00974571|79589030|FG002|Overall Study|Protocol Violation|18|||
44568605|NCT00974571|79589028|FG000|Overall Study|Withdrawal by Subject|14|||
44568606|NCT00974571|79589029|FG001|Overall Study|Withdrawal by Subject|5|||
44568607|NCT00974571|79589030|FG002|Overall Study|Withdrawal by Subject|16|||
44568608|NCT00974571|79589028|FG000|Overall Study|Patient Moved|1|||
44568609|NCT00974571|79589029|FG001|Overall Study|Patient Moved|0|||
44568610|NCT00974571|79589030|FG002|Overall Study|Patient Moved|1|||
44568611|NCT00974571|79589028|FG000|Overall Study|Other|4|||
44568612|NCT00974571|79589029|FG001|Overall Study|Other|0|||
44568613|NCT00974571|79589030|FG002|Overall Study|Other|10|||
44568614|NCT02766608|79589043|FG000|Overall Study|Adverse Event|27|||
44568615|NCT02766608|79589044|FG001|Overall Study|Adverse Event|22|||
44568616|NCT02766608|79589045|FG002|Overall Study|Adverse Event|17|||
44568617|NCT02766608|79589046|FG003|Overall Study|Adverse Event|13|||
44568618|NCT02766608|79589047|FG004|Overall Study|Adverse Event|12|||
44235594|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Death|0|||
44235595|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Death|1|||
44503413|NCT03915067|79508263|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
44568619|NCT02766608|79589043|FG000|Overall Study|Withdrawal by Subject|21|||
44568620|NCT02766608|79589044|FG001|Overall Study|Withdrawal by Subject|20|||
44568621|NCT02766608|79589045|FG002|Overall Study|Withdrawal by Subject|24|||
44568622|NCT02766608|79589046|FG003|Overall Study|Withdrawal by Subject|13|||
44568623|NCT02766608|79589047|FG004|Overall Study|Withdrawal by Subject|10|||
44503414|NCT03915067|79508264|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
44503415|NCT03654404|79508272|FG000|Overall Study|Death|1|||
44568624|NCT02766608|79589043|FG000|Overall Study|Lack of Efficacy|16|||
44503416|NCT03654404|79508272|FG000|Overall Study|Lost to Follow-up|2|||
44568625|NCT02766608|79589044|FG001|Overall Study|Lack of Efficacy|15|||
44235596|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Death|0|||
44235597|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Death|0|||
44235598|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Death|0|||
44235599|NCT03713632|79058594|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
44235600|NCT03713632|79058595|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
44235601|NCT03713632|79058596|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
44235602|NCT03713632|79058597|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
44568626|NCT02766608|79589045|FG002|Overall Study|Lack of Efficacy|32|||
44568627|NCT02766608|79589046|FG003|Overall Study|Lack of Efficacy|8|||
44568628|NCT02766608|79589047|FG004|Overall Study|Lack of Efficacy|2|||
44568629|NCT02766608|79589043|FG000|Overall Study|Lost to Follow-up|6|||
44568630|NCT02766608|79589044|FG001|Overall Study|Lost to Follow-up|3|||
44568631|NCT02766608|79589045|FG002|Overall Study|Lost to Follow-up|5|||
44568632|NCT02766608|79589046|FG003|Overall Study|Lost to Follow-up|2|||
44568633|NCT02766608|79589047|FG004|Overall Study|Lost to Follow-up|2|||
44568634|NCT02766608|79589043|FG000|Overall Study|Physician Decision|3|||
44568635|NCT02766608|79589044|FG001|Overall Study|Physician Decision|2|||
44568636|NCT02766608|79589045|FG002|Overall Study|Physician Decision|3|||
44568637|NCT02766608|79589046|FG003|Overall Study|Physician Decision|1|||
44568638|NCT02766608|79589047|FG004|Overall Study|Physician Decision|2|||
44568639|NCT02766608|79589043|FG000|Overall Study|Protocol disc criteria|3|||
44568640|NCT02766608|79589044|FG001|Overall Study|Protocol disc criteria|3|||
44568641|NCT02766608|79589045|FG002|Overall Study|Protocol disc criteria|4|||
44568642|NCT02766608|79589046|FG003|Overall Study|Protocol disc criteria|0|||
44568643|NCT02766608|79589047|FG004|Overall Study|Protocol disc criteria|0|||
44568644|NCT02766608|79589043|FG000|Overall Study|Protocol Violation|0|||
44568645|NCT02766608|79589044|FG001|Overall Study|Protocol Violation|4|||
44568646|NCT02766608|79589045|FG002|Overall Study|Protocol Violation|4|||
44568647|NCT02766608|79589046|FG003|Overall Study|Protocol Violation|0|||
44568648|NCT02766608|79589047|FG004|Overall Study|Protocol Violation|1|||
44568649|NCT02766608|79589043|FG000|Overall Study|Administrative Reasons|3|||
44568650|NCT02766608|79589044|FG001|Overall Study|Administrative Reasons|1|||
44568651|NCT02766608|79589045|FG002|Overall Study|Administrative Reasons|1|||
44568652|NCT02766608|79589046|FG003|Overall Study|Administrative Reasons|0|||
44568653|NCT02766608|79589047|FG004|Overall Study|Administrative Reasons|0|||
44568654|NCT00960141|79589065|FG000|Overall Study|Adverse Event|4|||
44235603|NCT03713632|79058598|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
44235604|NCT03517436|79058620|FG000|Overall Study|Death|3|||
44503417|NCT03654404|79508272|FG000|Overall Study|Withdrawal by Subject|5|||
44503418|NCT03447314|79508337|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
44503419|NCT03447314|79508338|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
44503420|NCT03447314|79508339|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
44503421|NCT03447314|79508340|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
44503422|NCT03447314|79508341|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
44503423|NCT03447314|79508342|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
44503424|NCT03447314|79508343|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
44503425|NCT03447314|79508344|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503426|NCT03447314|79508345|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503427|NCT03447314|79508346|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503428|NCT03447314|79508347|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
44503429|NCT03447314|79508348|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
44503430|NCT03447314|79508349|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503431|NCT03447314|79508350|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503432|NCT03447314|79508351|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503433|NCT03447314|79508352|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44568655|NCT00960141|79589066|FG001|Overall Study|Adverse Event|8|||
44568656|NCT00960141|79589067|FG002|Overall Study|Adverse Event|2|||
44568657|NCT00960141|79589065|FG000|Overall Study|Lack of Efficacy|3|||
44235605|NCT03517436|79058620|FG000|Overall Study|Withdrawal by Subject|4|||
44235606|NCT03517436|79058620|FG000|Overall Study|Did not receive study valve.|1|||
44235607|NCT03237286|79058627|FG000|Overall Study|Withdrawal by Subject|1|||
44235608|NCT03237286|79058628|FG001|Overall Study|Withdrawal by Subject|0|||
44503434|NCT03447314|79508353|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44568658|NCT00960141|79589066|FG001|Overall Study|Lack of Efficacy|4|||
44568659|NCT00960141|79589067|FG002|Overall Study|Lack of Efficacy|2|||
44568660|NCT00960141|79589065|FG000|Overall Study|Lost to Follow-up|1|||
44503435|NCT03447314|79508354|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
44503436|NCT03447314|79508337|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
44568661|NCT00960141|79589066|FG001|Overall Study|Lost to Follow-up|0|||
44568662|NCT00960141|79589067|FG002|Overall Study|Lost to Follow-up|0|||
44568663|NCT00960141|79589065|FG000|Overall Study|Protocol Violation|1|||
44568664|NCT00960141|79589066|FG001|Overall Study|Protocol Violation|3|||
44568665|NCT00960141|79589067|FG002|Overall Study|Protocol Violation|2|||
44568666|NCT00960141|79589065|FG000|Overall Study|Withdrawal by Subject|1|||
44568667|NCT00960141|79589066|FG001|Overall Study|Withdrawal by Subject|2|||
44235609|NCT03237286|79058629|FG002|Overall Study|Withdrawal by Subject|2|||
44235610|NCT03237286|79058627|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
44235611|NCT03237286|79058628|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
44235612|NCT03237286|79058629|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
44235613|NCT03170349|79058636|FG000|At 30 Days Follow-up|Death|1|||
44235614|NCT03170349|79058636|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
44235615|NCT03170349|79058636|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
44235616|NCT03170349|79058636|FG000|At 6 Months Follow-up|Death|3|||
44235617|NCT03170349|79058636|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
44235618|NCT03170349|79058636|FG000|At 1 Year Follow-up|Death|6|||
44235619|NCT03170349|79058636|FG000|At 2 Year Follow-up|Missed Visit|4|||
44235620|NCT03170349|79058636|FG000|At 2 Year Follow-up|Death|13|||
44235621|NCT03170349|79058636|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
44235622|NCT02836236|79058656|FG000|Overall Study|Randomized but Never Treated|1|||
44235623|NCT02836236|79058657|FG001|Overall Study|Randomized but Never Treated|0|||
44235624|NCT02836236|79058656|FG000|Overall Study|Withdrew Consent|2|||
44235625|NCT02836236|79058657|FG001|Overall Study|Withdrew Consent|0|||
44235626|NCT02836236|79058656|FG000|Overall Study|Adverse Event|0|||
44235627|NCT02836236|79058657|FG001|Overall Study|Adverse Event|1|||
44235628|NCT02836236|79058656|FG000|Overall Study|Investigator's Discretion|1|||
44235629|NCT02836236|79058657|FG001|Overall Study|Investigator's Discretion|0|||
44235630|NCT02836236|79058656|FG000|Overall Study|Still on Study|101|||
44235631|NCT02836236|79058657|FG001|Overall Study|Still on Study|49|||
44503437|NCT03447314|79508338|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503438|NCT03447314|79508339|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
44503439|NCT03447314|79508340|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503440|NCT03447314|79508341|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44275802|NCT02192190|79224167|FG005|Overall Study|Terminated by Sponsor|23|||
44275803|NCT02192190|79224162|FG000|Overall Study|Withdrawal by Subject|4|||
44275804|NCT02192190|79224163|FG001|Overall Study|Withdrawal by Subject|1|||
44275805|NCT02192190|79224164|FG002|Overall Study|Withdrawal by Subject|2|||
44275806|NCT02192190|79224165|FG003|Overall Study|Withdrawal by Subject|1|||
44275807|NCT02192190|79224166|FG004|Overall Study|Withdrawal by Subject|5|||
44503441|NCT03447314|79508342|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
44503442|NCT03447314|79508343|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
44503443|NCT03447314|79508344|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44568668|NCT00960141|79589067|FG002|Overall Study|Withdrawal by Subject|1|||
44568669|NCT02771522|79589075|FG000|Overall Study|Lost to Follow-up|3|||
44568670|NCT02771522|79589075|FG000|Overall Study|Withdrawal by Subject|2|||
44568671|NCT02771522|79589075|FG000|Overall Study|No white spot lesions|3|||
44568672|NCT00759655|79589084|FG000|Overall Study|Termination of the study by sponsor|1|||
44568673|NCT02771366|79589090|FG000|Period 1|Withdrawal by Subject|0|||
44568674|NCT02771366|79589091|FG001|Period 1|Withdrawal by Subject|2|||
44568675|NCT02771366|79589090|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
44568676|NCT02771366|79589091|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
44568677|NCT03396471|79589098|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
44568678|NCT03396471|79589098|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
44568679|NCT03396471|79589098|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
44568680|NCT03396471|79589098|FG000|Study Treatment - Up to 22 Months|Death|2|||
44568681|NCT03396471|79589098|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
44568682|NCT03396471|79589098|FG000|Follow up - Up to 2 Years|Death|9|||
44568683|NCT03396471|79589098|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
44568684|NCT03396471|79589098|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
44568685|NCT03396471|79589098|FG000|Follow up - Up to 2 Years|study terminated|1|||
44568686|NCT03396471|79589098|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
44568687|NCT03396471|79589098|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
44568688|NCT00103142|79589104|FG000|Overall Study|Adverse Event|1|||
44568689|NCT00103142|79589105|FG001|Overall Study|Adverse Event|0|||
44568690|NCT00103142|79589104|FG000|Overall Study|Progression of disease|2|||
44503444|NCT03447314|79508345|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503445|NCT03447314|79508346|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503446|NCT03447314|79508347|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44568691|NCT00103142|79589105|FG001|Overall Study|Progression of disease|1|||
44568692|NCT00943683|79589115|FG000|Overall Study|Adverse Event|3|||
44235632|NCT02670525|79058665|FG000|Overall Study|Death|94|||
44235633|NCT02670525|79058666|FG001|Overall Study|Death|14|||
44235634|NCT02670525|79058665|FG000|Overall Study|Lost to Follow-up|4|||
44235635|NCT02670525|79058666|FG001|Overall Study|Lost to Follow-up|1|||
44275808|NCT02192190|79224167|FG005|Overall Study|Withdrawal by Subject|3|||
44275809|NCT02192190|79224162|FG000|Overall Study|Could not Keep Visit Schedule|1|||
44235636|NCT02670525|79058665|FG000|Overall Study|Subject withdrew consent|1|||
44235637|NCT02670525|79058666|FG001|Overall Study|Subject withdrew consent|0|||
44235638|NCT02670525|79058665|FG000|Overall Study|Unknown, data entry delayed|123|||
44235639|NCT02670525|79058666|FG001|Overall Study|Unknown, data entry delayed|78|||
44235640|NCT02394795|79058674|FG000|Overall Study|Adverse Event|92|||
44235641|NCT02394795|79058675|FG001|Overall Study|Adverse Event|70|||
44235642|NCT02394795|79058674|FG000|Overall Study|Lost to Follow-up|0|||
44235643|NCT02394795|79058675|FG001|Overall Study|Lost to Follow-up|1|||
44275810|NCT02192190|79224163|FG001|Overall Study|Could not Keep Visit Schedule|0|||
44275811|NCT02192190|79224164|FG002|Overall Study|Could not Keep Visit Schedule|0|||
44275812|NCT02192190|79224165|FG003|Overall Study|Could not Keep Visit Schedule|0|||
44275813|NCT02192190|79224166|FG004|Overall Study|Could not Keep Visit Schedule|0|||
44275814|NCT02192190|79224167|FG005|Overall Study|Could not Keep Visit Schedule|0|||
44275815|NCT02192190|79224162|FG000|Overall Study|Positive Drug Screen|0|||
44503447|NCT03447314|79508348|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503448|NCT03447314|79508349|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503449|NCT03447314|79508350|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503450|NCT03447314|79508351|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503451|NCT03447314|79508352|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503452|NCT03447314|79508353|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44503453|NCT03447314|79508354|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
44235644|NCT02394795|79058674|FG000|Overall Study|Withdrawal by Subject|17|||
44235645|NCT02394795|79058675|FG001|Overall Study|Withdrawal by Subject|26|||
44235646|NCT02394795|79058674|FG000|Overall Study|Lack of Efficacy|181|||
44235647|NCT02394795|79058675|FG001|Overall Study|Lack of Efficacy|211|||
44235648|NCT02394795|79058674|FG000|Overall Study|Death|4|||
44235649|NCT02394795|79058675|FG001|Overall Study|Death|5|||
44235650|NCT02394795|79058674|FG000|Overall Study|Physician Decision|109|||
44235651|NCT02394795|79058675|FG001|Overall Study|Physician Decision|93|||
44235652|NCT02255422|79058688|FG000|Overall Study|Withdrawal by Subject|0|||
44235653|NCT02255422|79058689|FG001|Overall Study|Withdrawal by Subject|0|||
44235654|NCT02255422|79058690|FG002|Overall Study|Withdrawal by Subject|0|||
44235655|NCT02255422|79058691|FG003|Overall Study|Withdrawal by Subject|0|||
44235656|NCT02255422|79058692|FG004|Overall Study|Withdrawal by Subject|0|||
44235657|NCT02255422|79058693|FG005|Overall Study|Withdrawal by Subject|0|||
44235658|NCT02255422|79058694|FG006|Overall Study|Withdrawal by Subject|2|||
44235659|NCT02255422|79058688|FG000|Overall Study|Lost to Follow-up|0|||
44235660|NCT02255422|79058689|FG001|Overall Study|Lost to Follow-up|0|||
44568693|NCT00943683|79589116|FG001|Overall Study|Adverse Event|3|||
44568694|NCT00943683|79589115|FG000|Overall Study|Lost to Follow-up|1|||
44568695|NCT00943683|79589116|FG001|Overall Study|Lost to Follow-up|1|||
44275816|NCT02192190|79224163|FG001|Overall Study|Positive Drug Screen|0|||
44275817|NCT02192190|79224164|FG002|Overall Study|Positive Drug Screen|0|||
44275818|NCT02192190|79224165|FG003|Overall Study|Positive Drug Screen|1|||
44275819|NCT02192190|79224166|FG004|Overall Study|Positive Drug Screen|0|||
44275820|NCT02192190|79224167|FG005|Overall Study|Positive Drug Screen|0|||
44275821|NCT02192190|79224162|FG000|Overall Study|Inadequate Pain Relief|0|||
44275822|NCT02192190|79224163|FG001|Overall Study|Inadequate Pain Relief|1|||
44235661|NCT02255422|79058690|FG002|Overall Study|Lost to Follow-up|1|||
44235662|NCT02255422|79058691|FG003|Overall Study|Lost to Follow-up|0|||
44235663|NCT02255422|79058692|FG004|Overall Study|Lost to Follow-up|0|||
44235664|NCT02255422|79058693|FG005|Overall Study|Lost to Follow-up|0|||
44235665|NCT02255422|79058694|FG006|Overall Study|Lost to Follow-up|0|||
44235666|NCT02142959|79058713|FG000|Overall Study|Adverse Event|1|||
44235667|NCT02142959|79058714|FG001|Overall Study|Adverse Event|0|||
44235668|NCT02142959|79058715|FG002|Overall Study|Adverse Event|0|||
44235669|NCT02142959|79058713|FG000|Overall Study|Death|0|||
44235670|NCT02142959|79058714|FG001|Overall Study|Death|1|||
44235671|NCT02142959|79058715|FG002|Overall Study|Death|0|||
44235672|NCT02142959|79058713|FG000|Overall Study|Withdrawal by Subject|3|||
44235673|NCT02142959|79058714|FG001|Overall Study|Withdrawal by Subject|1|||
44235674|NCT02142959|79058715|FG002|Overall Study|Withdrawal by Subject|3|||
44235675|NCT02142959|79058713|FG000|Overall Study|Administrative Reasons|1|||
44235676|NCT02142959|79058714|FG001|Overall Study|Administrative Reasons|0|||
44235677|NCT02142959|79058715|FG002|Overall Study|Administrative Reasons|1|||
44235678|NCT02142959|79058713|FG000|Overall Study|Missing|0|||
44235679|NCT02142959|79058714|FG001|Overall Study|Missing|1|||
44235680|NCT02142959|79058715|FG002|Overall Study|Missing|0|||
44235681|NCT02142959|79058713|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
44235682|NCT02142959|79058714|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
44235683|NCT02142959|79058715|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
44275823|NCT02192190|79224164|FG002|Overall Study|Inadequate Pain Relief|1|||
44275824|NCT02192190|79224165|FG003|Overall Study|Inadequate Pain Relief|0|||
44275825|NCT02192190|79224166|FG004|Overall Study|Inadequate Pain Relief|0|||
44275826|NCT02192190|79224167|FG005|Overall Study|Inadequate Pain Relief|0|||
44568696|NCT00943683|79589115|FG000|Overall Study|Protocol Violation|1|||
44235684|NCT02142959|79058713|FG000|Overall Study|Patient didn't complete end of study visit|0|||
44235685|NCT02142959|79058714|FG001|Overall Study|Patient didn't complete end of study visit|0|||
44235686|NCT02142959|79058715|FG002|Overall Study|Patient didn't complete end of study visit|1|||
44235687|NCT02128113|79058726|FG000|Overall Study|Withdrawal by Subject|3|||
44235688|NCT02128113|79058727|FG001|Overall Study|Withdrawal by Subject|1|||
44235689|NCT02128113|79058728|FG002|Overall Study|Withdrawal by Subject|0|||
44235690|NCT02128113|79058726|FG000|Overall Study|Protocol Violation|0|||
44235691|NCT02128113|79058727|FG001|Overall Study|Protocol Violation|1|||
44235692|NCT02128113|79058728|FG002|Overall Study|Protocol Violation|0|||
44235693|NCT02128113|79058726|FG000|Overall Study|Surgery cancelled|0|||
44235694|NCT02128113|79058727|FG001|Overall Study|Surgery cancelled|1|||
44235695|NCT02128113|79058728|FG002|Overall Study|Surgery cancelled|0|||
44235696|NCT02128113|79058726|FG000|Overall Study|Adverse Event|0|||
44235697|NCT02128113|79058727|FG001|Overall Study|Adverse Event|0|||
44235698|NCT02128113|79058728|FG002|Overall Study|Adverse Event|1|||
44235699|NCT02036970|79058765|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
44235700|NCT02036970|79058766|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
44235701|NCT02036970|79058767|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
44235702|NCT02036970|79058768|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
44235703|NCT02036970|79058769|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
44235704|NCT02036970|79058770|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
44568697|NCT00943683|79589116|FG001|Overall Study|Protocol Violation|2|||
44568698|NCT00943683|79589115|FG000|Overall Study|Withdrawal by Subject|1|||
44568699|NCT00943683|79589116|FG001|Overall Study|Withdrawal by Subject|0|||
44568700|NCT00943683|79589115|FG000|Overall Study|Patient Moved|1|||
44568701|NCT00943683|79589116|FG001|Overall Study|Patient Moved|0|||
44568702|NCT00911547|79589126|FG000|Overall Study|Adverse Event|8|||
44568703|NCT00911547|79589127|FG001|Overall Study|Adverse Event|27|||
44568704|NCT00911547|79589128|FG002|Overall Study|Adverse Event|11|||
44568705|NCT00911547|79589129|FG003|Overall Study|Adverse Event|6|||
44235705|NCT02036970|79058771|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
44235706|NCT02036970|79058772|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
44235707|NCT02036970|79058773|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
44235708|NCT02036970|79058774|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
44235709|NCT02036970|79058765|FG000|Part 1: Day 1 Through Week 16|Death|0|||
44235710|NCT02036970|79058766|FG001|Part 1: Day 1 Through Week 16|Death|0|||
44235711|NCT02036970|79058767|FG002|Part 1: Day 1 Through Week 16|Death|0|||
44235712|NCT02036970|79058768|FG003|Part 1: Day 1 Through Week 16|Death|0|||
44235713|NCT02036970|79058769|FG004|Part 1: Day 1 Through Week 16|Death|0|||
44235714|NCT02036970|79058770|FG005|Part 1: Day 1 Through Week 16|Death|0|||
44235715|NCT02036970|79058771|FG006|Part 1: Day 1 Through Week 16|Death|0|||
44235716|NCT02036970|79058772|FG007|Part 1: Day 1 Through Week 16|Death|0|||
44235717|NCT02036970|79058773|FG008|Part 1: Day 1 Through Week 16|Death|1|||
44235718|NCT02036970|79058774|FG009|Part 1: Day 1 Through Week 16|Death|0|||
44235719|NCT02036970|79058765|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
44235720|NCT02036970|79058766|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235721|NCT02036970|79058767|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
44235722|NCT02036970|79058768|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235723|NCT02036970|79058769|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235724|NCT02036970|79058770|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235725|NCT02036970|79058771|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235726|NCT02036970|79058772|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235727|NCT02036970|79058773|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
44235728|NCT02036970|79058774|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
44235729|NCT02036970|79058765|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44235730|NCT02036970|79058766|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44235731|NCT02036970|79058767|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44235732|NCT02036970|79058768|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44235733|NCT02036970|79058769|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
44568706|NCT00911547|79589126|FG000|Overall Study|Lost to Follow-up|0|||
44568707|NCT00911547|79589127|FG001|Overall Study|Lost to Follow-up|0|||
44568708|NCT00911547|79589128|FG002|Overall Study|Lost to Follow-up|2|||
44568709|NCT00911547|79589129|FG003|Overall Study|Lost to Follow-up|1|||
44568710|NCT00911547|79589126|FG000|Overall Study|Protocol Violation|0|||
44235734|NCT02036970|79058770|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44235735|NCT02036970|79058771|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44235736|NCT02036970|79058772|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
44568711|NCT00911547|79589127|FG001|Overall Study|Protocol Violation|5|||
44568712|NCT00911547|79589128|FG002|Overall Study|Protocol Violation|5|||
44568713|NCT00911547|79589129|FG003|Overall Study|Protocol Violation|1|||
44568714|NCT00911547|79589126|FG000|Overall Study|Withdrawal by Subject|3|||
44568715|NCT00911547|79589127|FG001|Overall Study|Withdrawal by Subject|10|||
44568716|NCT00911547|79589128|FG002|Overall Study|Withdrawal by Subject|4|||
44235737|NCT02036970|79058773|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
44235738|NCT02036970|79058774|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
44235739|NCT02036970|79058765|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235740|NCT02036970|79058766|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235741|NCT02036970|79058767|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235742|NCT02036970|79058768|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
44235743|NCT02036970|79058769|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235744|NCT02036970|79058770|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44568717|NCT00911547|79589129|FG003|Overall Study|Withdrawal by Subject|8|||
44568718|NCT00899379|79589144|FG000|Overall Study|Adverse Event|2|||
44568719|NCT00899379|79589145|FG001|Overall Study|Adverse Event|2|||
44568720|NCT00899379|79589146|FG002|Overall Study|Adverse Event|1|||
44568721|NCT00899379|79589147|FG003|Overall Study|Adverse Event|1|||
44568722|NCT00899379|79589148|FG004|Overall Study|Adverse Event|2|||
44568723|NCT00899379|79589144|FG000|Overall Study|Lack of Efficacy|0|||
44568724|NCT00899379|79589145|FG001|Overall Study|Lack of Efficacy|4|||
44568725|NCT00899379|79589146|FG002|Overall Study|Lack of Efficacy|3|||
44235745|NCT02036970|79058771|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235746|NCT02036970|79058772|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235747|NCT02036970|79058773|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235748|NCT02036970|79058774|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
44235749|NCT02036970|79058765|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
44235750|NCT02036970|79058766|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
44235751|NCT02036970|79058767|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
44235752|NCT02036970|79058768|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
44235753|NCT02036970|79058769|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
44235754|NCT02036970|79058770|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
44235755|NCT02036970|79058771|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
44568726|NCT00899379|79589147|FG003|Overall Study|Lack of Efficacy|0|||
44568727|NCT00899379|79589148|FG004|Overall Study|Lack of Efficacy|1|||
44568728|NCT00899379|79589144|FG000|Overall Study|Lost to Follow-up|9|||
44568729|NCT00899379|79589145|FG001|Overall Study|Lost to Follow-up|3|||
44568730|NCT00899379|79589146|FG002|Overall Study|Lost to Follow-up|0|||
44568731|NCT00899379|79589147|FG003|Overall Study|Lost to Follow-up|6|||
44568732|NCT00899379|79589148|FG004|Overall Study|Lost to Follow-up|2|||
44568733|NCT00899379|79589144|FG000|Overall Study|Protocol Violation|0|||
44568734|NCT00899379|79589145|FG001|Overall Study|Protocol Violation|0|||
44568735|NCT00899379|79589146|FG002|Overall Study|Protocol Violation|1|||
44568736|NCT00899379|79589147|FG003|Overall Study|Protocol Violation|1|||
44568737|NCT00899379|79589148|FG004|Overall Study|Protocol Violation|0|||
44568738|NCT00899379|79589144|FG000|Overall Study|Withdrawal by Subject|2|||
44568739|NCT00899379|79589145|FG001|Overall Study|Withdrawal by Subject|4|||
44568740|NCT00899379|79589146|FG002|Overall Study|Withdrawal by Subject|2|||
44568741|NCT00899379|79589147|FG003|Overall Study|Withdrawal by Subject|3|||
44568742|NCT00899379|79589148|FG004|Overall Study|Withdrawal by Subject|6|||
44568743|NCT00899379|79589144|FG000|Overall Study|Pregnancy|0|||
44568744|NCT00899379|79589145|FG001|Overall Study|Pregnancy|0|||
44568745|NCT00899379|79589146|FG002|Overall Study|Pregnancy|1|||
44568746|NCT00899379|79589147|FG003|Overall Study|Pregnancy|0|||
44568747|NCT00899379|79589148|FG004|Overall Study|Pregnancy|1|||
44235756|NCT02036970|79058772|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
44235757|NCT02036970|79058773|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
44235758|NCT02036970|79058774|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
44568748|NCT00899379|79589144|FG000|Overall Study|Patient Uncooperative|0|||
44568749|NCT00899379|79589145|FG001|Overall Study|Patient Uncooperative|1|||
44568750|NCT00899379|79589146|FG002|Overall Study|Patient Uncooperative|0|||
44235759|NCT02036970|79058765|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235760|NCT02036970|79058766|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235761|NCT02036970|79058767|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235762|NCT02036970|79058768|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235763|NCT02036970|79058769|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235764|NCT02036970|79058770|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235765|NCT02036970|79058771|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
44568751|NCT00899379|79589147|FG003|Overall Study|Patient Uncooperative|1|||
44235766|NCT02036970|79058772|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
44235767|NCT02036970|79058773|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
44275827|NCT02224638|79224195|FG000|Overall Study|Adverse Event|1|||
44568752|NCT00899379|79589148|FG004|Overall Study|Patient Uncooperative|2|||
44568753|NCT00899379|79589144|FG000|Overall Study|Abnormal Baseline ECG|0|||
44568754|NCT00899379|79589145|FG001|Overall Study|Abnormal Baseline ECG|0|||
44568755|NCT00899379|79589146|FG002|Overall Study|Abnormal Baseline ECG|0|||
44568756|NCT00899379|79589147|FG003|Overall Study|Abnormal Baseline ECG|1|||
44568757|NCT00899379|79589148|FG004|Overall Study|Abnormal Baseline ECG|0|||
44568758|NCT00899379|79589144|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
44568759|NCT00899379|79589145|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
44568760|NCT00899379|79589146|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
44568761|NCT00899379|79589147|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44568762|NCT00899379|79589148|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44235768|NCT02036970|79058774|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
44235769|NCT02036970|79058765|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235770|NCT02036970|79058766|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
44235771|NCT02036970|79058767|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
44235772|NCT02036970|79058768|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235773|NCT02036970|79058769|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235774|NCT02036970|79058770|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235775|NCT02036970|79058771|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235776|NCT02036970|79058772|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235777|NCT02036970|79058773|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
44235778|NCT02036970|79058774|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
44235779|NCT02036970|79058765|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
44235780|NCT02036970|79058766|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
44235781|NCT02036970|79058767|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
44568763|NCT00899379|79589144|FG000|Overall Study|Not Completed/Entered Extn|5|||
44568764|NCT00899379|79589145|FG001|Overall Study|Not Completed/Entered Extn|1|||
44568765|NCT00899379|79589146|FG002|Overall Study|Not Completed/Entered Extn|6|||
44568766|NCT00899379|79589147|FG003|Overall Study|Not Completed/Entered Extn|4|||
44568767|NCT00899379|79589148|FG004|Overall Study|Not Completed/Entered Extn|3|||
44568768|NCT00899379|79589144|FG000|Overall Study|Study Terminated|3|||
44568769|NCT00899379|79589145|FG001|Overall Study|Study Terminated|0|||
44568770|NCT00899379|79589146|FG002|Overall Study|Study Terminated|3|||
44568771|NCT00899379|79589147|FG003|Overall Study|Study Terminated|3|||
44568772|NCT00899379|79589148|FG004|Overall Study|Study Terminated|1|||
44568773|NCT00899379|79589144|FG000|Overall Study|Lost to Follow-up|3|||
44568774|NCT00899379|79589145|FG001|Overall Study|Lost to Follow-up|1|||
44568775|NCT00899379|79589146|FG002|Overall Study|Lost to Follow-up|0|||
44568776|NCT00899379|79589147|FG003|Overall Study|Lost to Follow-up|2|||
44568777|NCT00899379|79589148|FG004|Overall Study|Lost to Follow-up|5|||
44568778|NCT00899379|79589144|FG000|Overall Study|Withdrawal by Subject|4|||
44568779|NCT00899379|79589145|FG001|Overall Study|Withdrawal by Subject|7|||
44568780|NCT00899379|79589146|FG002|Overall Study|Withdrawal by Subject|4|||
44568781|NCT00899379|79589147|FG003|Overall Study|Withdrawal by Subject|7|||
44568782|NCT00899379|79589148|FG004|Overall Study|Withdrawal by Subject|2|||
44568783|NCT00899379|79589144|FG000|Overall Study|Pregnancy|1|||
44568784|NCT00899379|79589145|FG001|Overall Study|Pregnancy|0|||
44568785|NCT00899379|79589146|FG002|Overall Study|Pregnancy|0|||
44568786|NCT00899379|79589147|FG003|Overall Study|Pregnancy|0|||
44568787|NCT00899379|79589148|FG004|Overall Study|Pregnancy|0|||
44568788|NCT00899379|79589144|FG000|Overall Study|Patient Uncooperative|0|||
44568789|NCT00899379|79589145|FG001|Overall Study|Patient Uncooperative|0|||
44568790|NCT00899379|79589146|FG002|Overall Study|Patient Uncooperative|0|||
44568791|NCT00899379|79589147|FG003|Overall Study|Patient Uncooperative|1|||
44568792|NCT00899379|79589148|FG004|Overall Study|Patient Uncooperative|0|||
44235782|NCT02036970|79058768|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
44235783|NCT02036970|79058769|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
44235784|NCT02036970|79058770|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
44568793|NCT00899379|79589144|FG000|Overall Study|Abnormal Prestudy Labs|0|||
44568794|NCT00899379|79589145|FG001|Overall Study|Abnormal Prestudy Labs|0|||
44568795|NCT00899379|79589146|FG002|Overall Study|Abnormal Prestudy Labs|0|||
44568796|NCT00899379|79589147|FG003|Overall Study|Abnormal Prestudy Labs|0|||
44568797|NCT00899379|79589148|FG004|Overall Study|Abnormal Prestudy Labs|2|||
44568798|NCT00899379|79589144|FG000|Overall Study|Abnormal Baseline ECG|0|||
44235785|NCT02036970|79058771|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
44235786|NCT02036970|79058772|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
44235787|NCT02036970|79058773|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
44235788|NCT02036970|79058774|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
44235789|NCT01748825|79058964|FG000|Dose Escalation|Refused further treatment|2|||
44235790|NCT01748825|79058965|FG001|Dose Escalation|Refused further treatment|2|||
44235791|NCT01748825|79058966|FG002|Dose Escalation|Refused further treatment|0|||
44235792|NCT01748825|79058967|FG003|Dose Escalation|Refused further treatment|0|||
44235793|NCT01748825|79058968|FG004|Dose Escalation|Refused further treatment|1|||
44235794|NCT01748825|79058969|FG005|Dose Escalation|Refused further treatment|2|||
44568799|NCT00899379|79589145|FG001|Overall Study|Abnormal Baseline ECG|0|||
44568800|NCT00899379|79589146|FG002|Overall Study|Abnormal Baseline ECG|1|||
44568801|NCT00899379|79589147|FG003|Overall Study|Abnormal Baseline ECG|1|||
44568802|NCT00899379|79589148|FG004|Overall Study|Abnormal Baseline ECG|0|||
44568803|NCT00899379|79589144|FG000|Overall Study|No Attack Pretreatment|3|||
44568804|NCT00899379|79589145|FG001|Overall Study|No Attack Pretreatment|5|||
44235795|NCT01748825|79058970|FG006|Dose Escalation|Refused further treatment|0|||
44235796|NCT01748825|79058971|FG007|Dose Escalation|Refused further treatment|0|||
44235797|NCT01748825|79058972|FG008|Dose Escalation|Refused further treatment|0|||
44235798|NCT01748825|79058973|FG009|Dose Escalation|Refused further treatment|0|||
44235799|NCT01748825|79058964|FG000|Dose Escalation|Switched to alternative treatment|0|||
44235800|NCT01748825|79058965|FG001|Dose Escalation|Switched to alternative treatment|0|||
44503454|NCT03447314|79508337|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503455|NCT03447314|79508338|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503456|NCT03447314|79508339|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
44503457|NCT03447314|79508340|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44568805|NCT00899379|79589146|FG002|Overall Study|No Attack Pretreatment|5|||
44503458|NCT03447314|79508341|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503459|NCT03447314|79508342|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503460|NCT03447314|79508343|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503461|NCT03447314|79508344|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503462|NCT03447314|79508345|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503463|NCT03447314|79508346|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503464|NCT03447314|79508347|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503465|NCT03447314|79508348|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503466|NCT03447314|79508349|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503467|NCT03447314|79508350|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503468|NCT03447314|79508351|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503469|NCT03447314|79508352|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503470|NCT03447314|79508353|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503471|NCT03447314|79508354|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
44503472|NCT03447314|79508337|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503473|NCT03447314|79508338|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503474|NCT03447314|79508339|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
44503475|NCT03447314|79508340|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503476|NCT03447314|79508341|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503477|NCT03447314|79508342|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503478|NCT03447314|79508343|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503479|NCT03447314|79508344|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503480|NCT03447314|79508345|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503481|NCT03447314|79508346|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503482|NCT03447314|79508347|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503483|NCT03447314|79508348|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503484|NCT03447314|79508349|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503485|NCT03447314|79508350|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503486|NCT03447314|79508351|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503487|NCT03447314|79508352|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503488|NCT03447314|79508353|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503489|NCT03447314|79508354|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
44503490|NCT03447314|79508337|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503491|NCT03447314|79508338|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503492|NCT03447314|79508339|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503493|NCT03447314|79508340|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503494|NCT03447314|79508341|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503495|NCT03447314|79508342|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503496|NCT03447314|79508343|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503497|NCT03447314|79508344|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503498|NCT03447314|79508345|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503499|NCT03447314|79508346|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503500|NCT03447314|79508347|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
44503501|NCT03447314|79508348|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503502|NCT03447314|79508349|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44568806|NCT00899379|79589147|FG003|Overall Study|No Attack Pretreatment|6|||
44568807|NCT00899379|79589148|FG004|Overall Study|No Attack Pretreatment|4|||
44568808|NCT00899379|79589144|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
44568809|NCT00899379|79589145|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44568810|NCT00899379|79589146|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44568811|NCT00899379|79589147|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44235801|NCT01748825|79058966|FG002|Dose Escalation|Switched to alternative treatment|0|||
44235802|NCT01748825|79058967|FG003|Dose Escalation|Switched to alternative treatment|1|||
44235803|NCT01748825|79058968|FG004|Dose Escalation|Switched to alternative treatment|0|||
44235804|NCT01748825|79058969|FG005|Dose Escalation|Switched to alternative treatment|0|||
44235805|NCT01748825|79058970|FG006|Dose Escalation|Switched to alternative treatment|0|||
44235806|NCT01748825|79058971|FG007|Dose Escalation|Switched to alternative treatment|0|||
44235807|NCT01748825|79058972|FG008|Dose Escalation|Switched to alternative treatment|0|||
44235808|NCT01748825|79058973|FG009|Dose Escalation|Switched to alternative treatment|0|||
44235809|NCT01748825|79058964|FG000|Dose Escalation|Adverse Event|0|||
44235810|NCT01748825|79058965|FG001|Dose Escalation|Adverse Event|0|||
44235811|NCT01748825|79058966|FG002|Dose Escalation|Adverse Event|0|||
44235812|NCT01748825|79058967|FG003|Dose Escalation|Adverse Event|0|||
44235813|NCT01748825|79058968|FG004|Dose Escalation|Adverse Event|0|||
44235814|NCT01748825|79058969|FG005|Dose Escalation|Adverse Event|0|||
44235815|NCT01748825|79058970|FG006|Dose Escalation|Adverse Event|1|||
44235816|NCT01748825|79058971|FG007|Dose Escalation|Adverse Event|0|||
44235817|NCT01748825|79058972|FG008|Dose Escalation|Adverse Event|0|||
44235818|NCT01748825|79058973|FG009|Dose Escalation|Adverse Event|0|||
44235819|NCT01748825|79058964|FG000|Dose Expansion|Refused further treatment|0|||
44235820|NCT01748825|79058965|FG001|Dose Expansion|Refused further treatment|0|||
44235821|NCT01748825|79058966|FG002|Dose Expansion|Refused further treatment|0|||
44235822|NCT01748825|79058967|FG003|Dose Expansion|Refused further treatment|0|||
44235823|NCT01748825|79058968|FG004|Dose Expansion|Refused further treatment|0|||
44235824|NCT01748825|79058969|FG005|Dose Expansion|Refused further treatment|0|||
44235825|NCT01748825|79058970|FG006|Dose Expansion|Refused further treatment|0|||
44235826|NCT01748825|79058971|FG007|Dose Expansion|Refused further treatment|0|||
44235827|NCT01748825|79058972|FG008|Dose Expansion|Refused further treatment|1|||
44235828|NCT01748825|79058973|FG009|Dose Expansion|Refused further treatment|1|||
44235829|NCT01748825|79058964|FG000|Dose Expansion|Switched to alternative treatment|0|||
44235830|NCT01748825|79058965|FG001|Dose Expansion|Switched to alternative treatment|0|||
44235831|NCT01748825|79058966|FG002|Dose Expansion|Switched to alternative treatment|0|||
44235832|NCT01748825|79058967|FG003|Dose Expansion|Switched to alternative treatment|0|||
44235833|NCT01748825|79058968|FG004|Dose Expansion|Switched to alternative treatment|0|||
44235834|NCT01748825|79058969|FG005|Dose Expansion|Switched to alternative treatment|0|||
44235835|NCT01748825|79058970|FG006|Dose Expansion|Switched to alternative treatment|0|||
44235836|NCT01748825|79058971|FG007|Dose Expansion|Switched to alternative treatment|0|||
44235837|NCT01748825|79058972|FG008|Dose Expansion|Switched to alternative treatment|0|||
44235838|NCT01748825|79058973|FG009|Dose Expansion|Switched to alternative treatment|1|||
44235839|NCT01748825|79058964|FG000|Dose Expansion|Adverse Event|0|||
44235840|NCT01748825|79058965|FG001|Dose Expansion|Adverse Event|0|||
44235841|NCT01748825|79058966|FG002|Dose Expansion|Adverse Event|0|||
44235842|NCT01748825|79058967|FG003|Dose Expansion|Adverse Event|0|||
44235843|NCT01748825|79058968|FG004|Dose Expansion|Adverse Event|0|||
44235844|NCT01748825|79058969|FG005|Dose Expansion|Adverse Event|0|||
44235845|NCT01748825|79058970|FG006|Dose Expansion|Adverse Event|0|||
44235846|NCT01748825|79058971|FG007|Dose Expansion|Adverse Event|0|||
44235847|NCT01748825|79058972|FG008|Dose Expansion|Adverse Event|0|||
44235848|NCT01748825|79058973|FG009|Dose Expansion|Adverse Event|3|||
44235849|NCT01748825|79058964|FG000|Dose Expansion|Physician Decision|0|||
44235850|NCT01748825|79058965|FG001|Dose Expansion|Physician Decision|0|||
44235851|NCT01748825|79058966|FG002|Dose Expansion|Physician Decision|0|||
44235852|NCT01748825|79058967|FG003|Dose Expansion|Physician Decision|0|||
44235853|NCT01748825|79058968|FG004|Dose Expansion|Physician Decision|0|||
44235854|NCT01748825|79058969|FG005|Dose Expansion|Physician Decision|0|||
44235855|NCT01748825|79058970|FG006|Dose Expansion|Physician Decision|0|||
44235856|NCT01748825|79058971|FG007|Dose Expansion|Physician Decision|0|||
44235857|NCT01748825|79058972|FG008|Dose Expansion|Physician Decision|1|||
44235858|NCT01748825|79058973|FG009|Dose Expansion|Physician Decision|0|||
44503503|NCT03447314|79508350|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503504|NCT03447314|79508351|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503505|NCT03447314|79508352|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44235859|NCT01720667|79059035|FG000|Overall Study|Adverse Event|1|||
44235860|NCT01720667|79059036|FG001|Overall Study|Adverse Event|1|||
44235861|NCT01720667|79059035|FG000|Overall Study|Withdrawal by Subject|3|||
44235862|NCT01720667|79059036|FG001|Overall Study|Withdrawal by Subject|0|||
44235863|NCT01720043|79059044|FG000|Overall Study|Withdrawal by Subject|1|||
44514950|NCT03073798|79520830|FG000|Overall Study|Withdrawal by Subject|1|||
44235864|NCT00700752|79059048|FG000|First Intervention|Withdrawal by Subject|0|||
44235865|NCT00700752|79059049|FG001|First Intervention|Withdrawal by Subject|2|||
44235866|NCT01747811|79059066|FG000|Overall Study|Lack of Efficacy|2|||
44235867|NCT01747811|79059067|FG001|Overall Study|Lack of Efficacy|4|||
44235868|NCT01747655|79059075|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
44235869|NCT01747655|79059076|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
44235870|NCT01747655|79059075|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
44235871|NCT01747655|79059076|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
44235872|NCT01747655|79059075|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
44235873|NCT01747655|79059076|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
44235874|NCT01718483|79059084|FG000|Overall Study|Withdrawal by Subject|14|||
44235875|NCT01718483|79059085|FG001|Overall Study|Withdrawal by Subject|12|||
44235876|NCT01718483|79059084|FG000|Overall Study|Adverse Event|5|||
44235877|NCT01718483|79059085|FG001|Overall Study|Adverse Event|12|||
44235878|NCT01718483|79059084|FG000|Overall Study|Lost to Follow-up|8|||
44235879|NCT01718483|79059085|FG001|Overall Study|Lost to Follow-up|3|||
44235880|NCT01718483|79059084|FG000|Overall Study|Protocol Violation|4|||
44235881|NCT01718483|79059085|FG001|Overall Study|Protocol Violation|2|||
44235882|NCT01718483|79059084|FG000|Overall Study|Other|1|||
44235883|NCT01718483|79059085|FG001|Overall Study|Other|4|||
44568812|NCT00899379|79589148|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
44568813|NCT00899379|79589144|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
44568814|NCT00899379|79589145|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
44568815|NCT00899379|79589146|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
44568816|NCT00899379|79589147|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
44568817|NCT00899379|79589148|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
44568818|NCT04326439|79589156|FG000|Overall Study|Withdrawal by Subject|1|||
44568819|NCT04326439|79589157|FG001|Overall Study|Withdrawal by Subject|0|||
44568820|NCT04326439|79589156|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
44568821|NCT04326439|79589157|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
44568822|NCT04326439|79589156|FG000|Overall Study|Relapse after Induction 2|0|||
44568823|NCT04326439|79589157|FG001|Overall Study|Relapse after Induction 2|1|||
44568824|NCT04326439|79589156|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
44568825|NCT04326439|79589157|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
44568826|NCT00145795|79589171|FG000|Overall Study|Adverse Event|1|||
44568827|NCT00145795|79589172|FG001|Overall Study|Adverse Event|0|||
44568828|NCT02771210|79589180|FG000|Period 1|Adverse Event|5|||
44568829|NCT02771210|79589181|FG001|Period 1|Adverse Event|3|||
44568830|NCT02771210|79589180|FG000|Period 1|Lack of Efficacy|3|||
44568831|NCT02771210|79589181|FG001|Period 1|Lack of Efficacy|6|||
44568832|NCT02771210|79589180|FG000|Period 1|Lost to Follow-up|2|||
44568833|NCT02771210|79589181|FG001|Period 1|Lost to Follow-up|0|||
44568834|NCT02771210|79589180|FG000|Period 1|Physician Decision|0|||
44568835|NCT02771210|79589181|FG001|Period 1|Physician Decision|1|||
44568836|NCT02771210|79589180|FG000|Period 1|Withdrawal by Subject|0|||
44568837|NCT02771210|79589181|FG001|Period 1|Withdrawal by Subject|3|||
44568838|NCT02771210|79589180|FG000|Period 1|Withdrawal of informed consent|1|||
44568839|NCT02771210|79589181|FG001|Period 1|Withdrawal of informed consent|5|||
44568840|NCT02771210|79589180|FG000|Period 2|Adverse Event|1|||
44568841|NCT02771210|79589181|FG001|Period 2|Adverse Event|0|||
44568842|NCT02771210|79589180|FG000|Period 2|Lack of Efficacy|0|||
44568843|NCT02771210|79589181|FG001|Period 2|Lack of Efficacy|1|||
44568844|NCT02771210|79589180|FG000|Period 2|Withdrawal by Subject|1|||
44568845|NCT02771210|79589181|FG001|Period 2|Withdrawal by Subject|0|||
44568846|NCT02771210|79589180|FG000|Period 2|Withdrawal of informed consent|0|||
44235884|NCT01718483|79059084|FG000|Overall Study|Pregnancy|1|||
44235885|NCT01718483|79059085|FG001|Overall Study|Pregnancy|1|||
44235886|NCT01718483|79059084|FG000|Overall Study|Lack of Efficacy|1|||
44235887|NCT01718483|79059085|FG001|Overall Study|Lack of Efficacy|0|||
44235888|NCT01717859|79059091|FG000|Overall Study|Adverse Event|5|||
44235889|NCT01717859|79059091|FG000|Overall Study|Moved out of state|1|||
44235890|NCT01717859|79059091|FG000|Overall Study|Patient concerned about mental health|1|||
44235891|NCT01717859|79059091|FG000|Overall Study|Lost to Follow-up|1|||
44235892|NCT01717859|79059091|FG000|Overall Study|Withdrawal by Subject|2|||
44235893|NCT01747499|79059375|FG000|Overall Study|Steroid refractory aGvHD|1|||
44235894|NCT01747499|79059376|FG001|Overall Study|Steroid refractory aGvHD|0|||
44235895|NCT01747499|79059377|FG002|Overall Study|Steroid refractory aGvHD|0|||
44503506|NCT03447314|79508353|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503507|NCT03447314|79508354|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
44503508|NCT03447314|79508337|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503509|NCT03447314|79508338|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503510|NCT03447314|79508339|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503511|NCT03447314|79508340|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
44503512|NCT03447314|79508341|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503513|NCT03447314|79508342|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
44503514|NCT03447314|79508343|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503515|NCT03447314|79508344|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44568847|NCT02771210|79589181|FG001|Period 2|Withdrawal of informed consent|2|||
44568848|NCT00898677|79589191|FG000|Overall Study|Adverse Event|0|||
44235896|NCT01747499|79059378|FG003|Overall Study|Steroid refractory aGvHD|1|||
44235897|NCT01747499|79059379|FG004|Overall Study|Steroid refractory aGvHD|4|||
44235898|NCT01747499|79059375|FG000|Overall Study|Physician Decision|0|||
44235899|NCT01747499|79059376|FG001|Overall Study|Physician Decision|1|||
44235900|NCT01747499|79059377|FG002|Overall Study|Physician Decision|0|||
44235901|NCT01747499|79059378|FG003|Overall Study|Physician Decision|0|||
44235902|NCT01747499|79059379|FG004|Overall Study|Physician Decision|2|||
44568849|NCT00898677|79589192|FG001|Overall Study|Adverse Event|0|||
44568850|NCT00898677|79589193|FG002|Overall Study|Adverse Event|1|||
44568851|NCT00898677|79589194|FG003|Overall Study|Adverse Event|0|||
44568852|NCT00898677|79589191|FG000|Overall Study|Lost to Follow-up|0|||
44568853|NCT00898677|79589192|FG001|Overall Study|Lost to Follow-up|0|||
44568854|NCT00898677|79589193|FG002|Overall Study|Lost to Follow-up|2|||
44568855|NCT00898677|79589194|FG003|Overall Study|Lost to Follow-up|0|||
44568856|NCT00898677|79589191|FG000|Overall Study|Protocol Violation|1|||
44568857|NCT00898677|79589192|FG001|Overall Study|Protocol Violation|1|||
44568858|NCT00898677|79589193|FG002|Overall Study|Protocol Violation|2|||
44568859|NCT00898677|79589194|FG003|Overall Study|Protocol Violation|0|||
44568860|NCT00898677|79589191|FG000|Overall Study|Withdrawal by Subject|0|||
44568861|NCT00898677|79589192|FG001|Overall Study|Withdrawal by Subject|0|||
44568862|NCT00898677|79589193|FG002|Overall Study|Withdrawal by Subject|0|||
44568863|NCT00898677|79589194|FG003|Overall Study|Withdrawal by Subject|1|||
44568864|NCT00898677|79589191|FG000|Overall Study|Not Treated: Adverse Event|0|||
44568865|NCT00898677|79589192|FG001|Overall Study|Not Treated: Adverse Event|2|||
44275828|NCT02224638|79224196|FG001|Overall Study|Adverse Event|1|||
44275829|NCT02224560|79224211|FG000|Overall Study|Protocol Deviation|1|||
44275830|NCT02224560|79224212|FG001|Overall Study|Protocol Deviation|0|||
44275831|NCT02224560|79224213|FG002|Overall Study|Protocol Deviation|0|||
44568866|NCT00898677|79589193|FG002|Overall Study|Not Treated: Adverse Event|1|||
44568867|NCT00898677|79589194|FG003|Overall Study|Not Treated: Adverse Event|0|||
44568868|NCT00898677|79589191|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
44568869|NCT00898677|79589192|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
44568870|NCT00898677|79589193|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
44568871|NCT00898677|79589194|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
44503516|NCT03447314|79508345|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503517|NCT03447314|79508346|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503518|NCT03447314|79508347|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503519|NCT03447314|79508348|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503520|NCT03447314|79508349|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503521|NCT03447314|79508350|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503522|NCT03447314|79508351|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503523|NCT03447314|79508352|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503524|NCT03447314|79508353|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503525|NCT03447314|79508354|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
44503526|NCT03423121|79508397|FG000|Overall Study|Lost to Follow-up|2|||
44503527|NCT03423121|79508398|FG001|Overall Study|Lost to Follow-up|6|||
44568872|NCT00898677|79589191|FG000|Overall Study|Not Treated: Pregnancy|0|||
44568873|NCT00898677|79589192|FG001|Overall Study|Not Treated: Pregnancy|0|||
44235903|NCT01747499|79059375|FG000|Overall Study|Death|0|||
44275832|NCT02224560|79224211|FG000|Overall Study|Withdrawal by Subject|2|||
44275833|NCT02224560|79224212|FG001|Overall Study|Withdrawal by Subject|0|||
44275834|NCT02224560|79224213|FG002|Overall Study|Withdrawal by Subject|1|||
44275835|NCT02224560|79224211|FG000|Overall Study|Met Withdrawal Criteria|1|||
44275836|NCT02224560|79224212|FG001|Overall Study|Met Withdrawal Criteria|0|||
44275837|NCT02224560|79224213|FG002|Overall Study|Met Withdrawal Criteria|0|||
44275838|NCT02224560|79224211|FG000|Overall Study|Adverse Event|4|||
44275839|NCT02224560|79224212|FG001|Overall Study|Adverse Event|1|||
44275840|NCT02224560|79224213|FG002|Overall Study|Adverse Event|1|||
44275841|NCT02224560|79224211|FG000|Overall Study|Withdrawn by Investigator|1|||
44503528|NCT03423121|79508397|FG000|Overall Study|Adverse Event|1|||
44503529|NCT03423121|79508398|FG001|Overall Study|Adverse Event|0|||
44568874|NCT00898677|79589193|FG002|Overall Study|Not Treated: Pregnancy|1|||
44568875|NCT00898677|79589194|FG003|Overall Study|Not Treated: Pregnancy|0|||
44568876|NCT00898677|79589191|FG000|Overall Study|Not Treated: Protocol Violation|2|||
44568877|NCT00898677|79589192|FG001|Overall Study|Not Treated: Protocol Violation|0|||
44568878|NCT00898677|79589193|FG002|Overall Study|Not Treated: Protocol Violation|2|||
44568879|NCT00898677|79589194|FG003|Overall Study|Not Treated: Protocol Violation|0|||
44235904|NCT01747499|79059376|FG001|Overall Study|Death|0|||
44235905|NCT01747499|79059377|FG002|Overall Study|Death|0|||
44235906|NCT01747499|79059378|FG003|Overall Study|Death|1|||
44235907|NCT01747499|79059379|FG004|Overall Study|Death|1|||
44275842|NCT02224560|79224212|FG001|Overall Study|Withdrawn by Investigator|1|||
44275843|NCT02224560|79224213|FG002|Overall Study|Withdrawn by Investigator|0|||
44275844|NCT02161458|79224225|FG000|Overall Study|Withdrawal by Subject|0|||
44568880|NCT00898677|79589191|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
44235908|NCT01747499|79059375|FG000|Overall Study|Withdrawal by Subject|0|||
44503530|NCT03335475|79508406|FG000|Overall Study|Did not wear accelerometer|4|||
44235909|NCT01747499|79059376|FG001|Overall Study|Withdrawal by Subject|0|||
44235910|NCT01747499|79059377|FG002|Overall Study|Withdrawal by Subject|0|||
44235911|NCT01747499|79059378|FG003|Overall Study|Withdrawal by Subject|0|||
44235912|NCT01747499|79059379|FG004|Overall Study|Withdrawal by Subject|6|||
44235913|NCT01747499|79059375|FG000|Overall Study|Developed AML and death|0|||
44235914|NCT01747499|79059376|FG001|Overall Study|Developed AML and death|0|||
44235915|NCT01747499|79059377|FG002|Overall Study|Developed AML and death|0|||
44275845|NCT02161458|79224226|FG001|Overall Study|Withdrawal by Subject|4|||
44275846|NCT02161458|79224227|FG002|Overall Study|Withdrawal by Subject|4|||
44503531|NCT03335475|79508407|FG001|Overall Study|Did not wear accelerometer|0|||
44503532|NCT03335475|79508406|FG000|Overall Study|Withdrawal by Subject|0|||
44503533|NCT03335475|79508407|FG001|Overall Study|Withdrawal by Subject|1|||
44503534|NCT03252756|79508415|FG000|Overall Study|Protocol Violation|2|||
44503535|NCT03252756|79508416|FG001|Overall Study|Protocol Violation|4|||
44503536|NCT03252756|79508415|FG000|Overall Study|COVID-19 Pandemic|1|||
44503537|NCT03252756|79508416|FG001|Overall Study|COVID-19 Pandemic|1|||
44503538|NCT03252756|79508415|FG000|Overall Study|Study Drug Expiration|0|||
44503539|NCT03252756|79508416|FG001|Overall Study|Study Drug Expiration|1|||
44503540|NCT03164356|79508428|FG000|Overall Study|Lost to Follow-up|1|||
44503541|NCT03164356|79508429|FG001|Overall Study|Lost to Follow-up|1|||
44503542|NCT03164356|79508430|FG002|Overall Study|Lost to Follow-up|2|||
44503543|NCT03164356|79508431|FG003|Overall Study|Lost to Follow-up|1|||
44503544|NCT03164356|79508428|FG000|Overall Study|Physician Decision|0|||
44503545|NCT03164356|79508429|FG001|Overall Study|Physician Decision|0|||
44503546|NCT03164356|79508430|FG002|Overall Study|Physician Decision|3|||
44503547|NCT03164356|79508431|FG003|Overall Study|Physician Decision|0|||
44503548|NCT03164356|79508428|FG000|Overall Study|Protocol Violation|2|||
44503549|NCT03164356|79508429|FG001|Overall Study|Protocol Violation|1|||
44503550|NCT03164356|79508430|FG002|Overall Study|Protocol Violation|0|||
44503551|NCT03164356|79508431|FG003|Overall Study|Protocol Violation|0|||
44503552|NCT03164356|79508428|FG000|Overall Study|Withdrawal by Subject|1|||
44503553|NCT03164356|79508429|FG001|Overall Study|Withdrawal by Subject|0|||
44503554|NCT03164356|79508430|FG002|Overall Study|Withdrawal by Subject|0|||
44503555|NCT03164356|79508431|FG003|Overall Study|Withdrawal by Subject|0|||
44503556|NCT03164356|79508428|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
44503557|NCT03164356|79508429|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
44503558|NCT03164356|79508430|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
44503559|NCT03164356|79508431|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
44503560|NCT03164356|79508428|FG000|Overall Study|Subject Incarcerated|0|||
44503561|NCT03164356|79508429|FG001|Overall Study|Subject Incarcerated|1|||
44235916|NCT01747499|79059378|FG003|Overall Study|Developed AML and death|0|||
44235917|NCT01747499|79059379|FG004|Overall Study|Developed AML and death|1|||
44503562|NCT03164356|79508430|FG002|Overall Study|Subject Incarcerated|0|||
44503563|NCT03164356|79508431|FG003|Overall Study|Subject Incarcerated|0|||
44503564|NCT03164356|79508428|FG000|Overall Study|Prosthetist unable to participate|0|||
44568881|NCT00898677|79589192|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
44568882|NCT00898677|79589193|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
44568883|NCT00898677|79589194|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
44568884|NCT00898677|79589191|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
44568885|NCT00898677|79589192|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
44568886|NCT00898677|79589193|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
44568887|NCT00898677|79589194|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
44568888|NCT00898677|79589191|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
44568889|NCT00898677|79589192|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
44568890|NCT00898677|79589193|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
44568891|NCT00898677|79589194|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
44568892|NCT00898677|79589191|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
44568893|NCT00898677|79589192|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
44568894|NCT00898677|79589193|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
44235918|NCT01747499|79059375|FG000|Overall Study|Determined not to be eligible|0|||
44235919|NCT01747499|79059376|FG001|Overall Study|Determined not to be eligible|0|||
44235920|NCT01747499|79059377|FG002|Overall Study|Determined not to be eligible|0|||
44235921|NCT01747499|79059378|FG003|Overall Study|Determined not to be eligible|0|||
44235922|NCT01747499|79059379|FG004|Overall Study|Determined not to be eligible|1|||
44568895|NCT00898677|79589194|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
44568896|NCT00898677|79589191|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
44568897|NCT00898677|79589192|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
44568898|NCT00898677|79589193|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
44568899|NCT00898677|79589194|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
44568900|NCT00898677|79589191|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
44568901|NCT00898677|79589192|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
44235923|NCT01717391|79059411|FG000|Overall Study|Withdrawal by Subject|5|||
44235924|NCT01717391|79059411|FG000|Overall Study|Physician Decision|1|||
44235925|NCT01717391|79059411|FG000|Overall Study|FLT technical failure|3|||
44235926|NCT01746017|79059554|FG000|Period 1|Withdrawal by Subject|0|||
44235927|NCT01746017|79059555|FG001|Period 1|Withdrawal by Subject|0|||
44235928|NCT01746017|79059556|FG002|Period 1|Withdrawal by Subject|0|||
44235929|NCT01746017|79059557|FG003|Period 1|Withdrawal by Subject|0|||
44235930|NCT01746017|79059558|FG004|Period 1|Withdrawal by Subject|0|||
44235931|NCT01746017|79059559|FG005|Period 1|Withdrawal by Subject|0|||
44235932|NCT01746017|79059560|FG006|Period 1|Withdrawal by Subject|1|||
44235933|NCT01746017|79059561|FG007|Period 1|Withdrawal by Subject|0|||
44235934|NCT01746017|79059562|FG008|Period 1|Withdrawal by Subject|0|||
44235935|NCT01746017|79059563|FG009|Period 1|Withdrawal by Subject|0|||
44235936|NCT01746017|79059564|FG010|Period 1|Withdrawal by Subject|0|||
44235937|NCT01746017|79059554|FG000|Period 3|Withdrawal by Subject|0|||
44503565|NCT03164356|79508429|FG001|Overall Study|Prosthetist unable to participate|2|||
44503566|NCT03164356|79508430|FG002|Overall Study|Prosthetist unable to participate|1|||
44503567|NCT03164356|79508431|FG003|Overall Study|Prosthetist unable to participate|0|||
44503568|NCT01925131|79508466|FG000|Overall Study|Death|0|||
44503569|NCT01925131|79508467|FG001|Overall Study|Death|0|||
44503570|NCT01925131|79508468|FG002|Overall Study|Death|1|||
44503571|NCT01925131|79508469|FG003|Overall Study|Death|0|||
44503572|NCT01925131|79508470|FG004|Overall Study|Death|0|||
44503573|NCT01925131|79508471|FG005|Overall Study|Death|0|||
44235938|NCT01746017|79059555|FG001|Period 3|Withdrawal by Subject|0|||
44235939|NCT01746017|79059556|FG002|Period 3|Withdrawal by Subject|0|||
44235940|NCT01746017|79059557|FG003|Period 3|Withdrawal by Subject|0|||
44503574|NCT01925131|79508466|FG000|Overall Study|Progression/Relapse|1|||
44503575|NCT01925131|79508467|FG001|Overall Study|Progression/Relapse|1|||
44235941|NCT01746017|79059558|FG004|Period 3|Withdrawal by Subject|0|||
44235942|NCT01746017|79059559|FG005|Period 3|Withdrawal by Subject|1|||
44235943|NCT01746017|79059560|FG006|Period 3|Withdrawal by Subject|0|||
44235944|NCT01746017|79059561|FG007|Period 3|Withdrawal by Subject|0|||
44235945|NCT01746017|79059562|FG008|Period 3|Withdrawal by Subject|0|||
44235946|NCT01746017|79059563|FG009|Period 3|Withdrawal by Subject|0|||
44235947|NCT01746017|79059564|FG010|Period 3|Withdrawal by Subject|0|||
44235948|NCT01717313|79059626|FG000|Phase A (Weeks 0 to 24)|Death|0|||
44235949|NCT01717313|79059627|FG001|Phase A (Weeks 0 to 24)|Death|1|||
44568902|NCT00898677|79589193|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
44568903|NCT00898677|79589194|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
44568904|NCT00898677|79589191|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
44568905|NCT00898677|79589192|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
44568906|NCT00898677|79589193|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
44568907|NCT00898677|79589194|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
44568908|NCT02770820|79589204|FG000|Overall Study|Death|1|||
44568909|NCT02770820|79589204|FG000|Overall Study|Physician Decision|2|||
44235950|NCT01717313|79059626|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
44235951|NCT01717313|79059627|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
44235952|NCT01717313|79059626|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
44235953|NCT01717313|79059627|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
44235954|NCT01717313|79059626|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
44235955|NCT01717313|79059627|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
44235956|NCT01717313|79059626|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
44235957|NCT01717313|79059627|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
44235958|NCT01717313|79059626|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
44235959|NCT01717313|79059627|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
44235960|NCT01717313|79059626|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
44235961|NCT01717313|79059627|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
44235962|NCT01717313|79059626|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
44235963|NCT01717313|79059627|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
44275847|NCT02161458|79224228|FG003|Overall Study|Withdrawal by Subject|0|||
44275848|NCT02161458|79224225|FG000|Overall Study|Lost to Follow-up|0|||
44275849|NCT02161458|79224226|FG001|Overall Study|Lost to Follow-up|2|||
44503576|NCT01925131|79508468|FG002|Overall Study|Progression/Relapse|4|||
44503577|NCT01925131|79508469|FG003|Overall Study|Progression/Relapse|0|||
44503578|NCT01925131|79508470|FG004|Overall Study|Progression/Relapse|0|||
44503579|NCT01925131|79508471|FG005|Overall Study|Progression/Relapse|1|||
44503580|NCT01925131|79508466|FG000|Overall Study|Patient Refusal|1|||
44503581|NCT01925131|79508467|FG001|Overall Study|Patient Refusal|0|||
44503582|NCT01925131|79508468|FG002|Overall Study|Patient Refusal|0|||
44503583|NCT01925131|79508469|FG003|Overall Study|Patient Refusal|0|||
44503584|NCT01925131|79508470|FG004|Overall Study|Patient Refusal|0|||
44503585|NCT01925131|79508471|FG005|Overall Study|Patient Refusal|0|||
44503586|NCT01925131|79508466|FG000|Overall Study|Adverse Event|0|||
44503587|NCT01925131|79508467|FG001|Overall Study|Adverse Event|0|||
44503588|NCT01925131|79508468|FG002|Overall Study|Adverse Event|2|||
44503589|NCT01925131|79508469|FG003|Overall Study|Adverse Event|0|||
44503590|NCT01925131|79508470|FG004|Overall Study|Adverse Event|1|||
44503591|NCT01925131|79508471|FG005|Overall Study|Adverse Event|3|||
44503592|NCT01925131|79508466|FG000|Overall Study|Other - Not Protocol Specified|3|||
44503593|NCT01925131|79508467|FG001|Overall Study|Other - Not Protocol Specified|1|||
44503594|NCT01925131|79508468|FG002|Overall Study|Other - Not Protocol Specified|2|||
44503595|NCT01925131|79508469|FG003|Overall Study|Other - Not Protocol Specified|5|||
44503596|NCT01925131|79508470|FG004|Overall Study|Other - Not Protocol Specified|10|||
44235964|NCT01717313|79059626|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
44568910|NCT03082729|79589208|FG000|Overall Study|Lost to Follow-up|7|||
44235965|NCT01717313|79059627|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
44235966|NCT01745393|79059639|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
44235967|NCT01745393|79059640|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
44235968|NCT01745393|79059639|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
44503597|NCT01925131|79508471|FG005|Overall Study|Other - Not Protocol Specified|6|||
44503598|NCT01698918|79508487|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
44503599|NCT01698918|79508487|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
44503600|NCT01698918|79508487|FG000|First Line Treatment (Core+Extension)|Death|2|||
44235969|NCT01745393|79059640|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
44568911|NCT03082729|79589208|FG000|Overall Study|Physician Decision|2|||
44568912|NCT03082729|79589208|FG000|Overall Study|Withdrawal by Subject|1|||
44568913|NCT03082729|79589208|FG000|Overall Study|Lack of Efficacy|9|||
44568914|NCT03082729|79589208|FG000|Overall Study|Adverse Event|4|||
44568915|NCT03082729|79589208|FG000|Overall Study|Protocol Violation|6|||
44568916|NCT03082729|79589208|FG000|Overall Study|Fear of study procedure|1|||
44568917|NCT03082729|79589208|FG000|Overall Study|Scheduling conflict|1|||
44568918|NCT02764190|79589220|FG000|Overall Study|Lost to Follow-up|17|||
44568919|NCT02764190|79589221|FG001|Overall Study|Lost to Follow-up|13|||
44568920|NCT03077659|79589230|FG000|Overall Study|Withdrawal by Subject|0|||
44568921|NCT03077659|79589231|FG001|Overall Study|Withdrawal by Subject|0|||
44568922|NCT03077659|79589232|FG002|Overall Study|Withdrawal by Subject|1|||
44568923|NCT02807883|79589243|FG000|Overall Study|Withdrawal by Subject|2|||
44568924|NCT03082261|79589247|FG000|Overall Study|Death|4|||
44235970|NCT01745393|79059639|FG000|12-month Follow-up|Lost to Follow-up|6|||
44235971|NCT01745393|79059640|FG001|12-month Follow-up|Lost to Follow-up|5|||
44235972|NCT01744691|79059671|FG000|Overall Study|Progressive Disease|18|||
44235973|NCT01744691|79059671|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
44235974|NCT01744691|79059671|FG000|Overall Study|Withdrawal of consent for treatment|3|||
44235975|NCT01744691|79059671|FG000|Overall Study|Physician Decision|4|||
44235976|NCT01716533|79059706|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
44235977|NCT01716533|79059707|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
44235978|NCT01716533|79059708|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
44235979|NCT01716533|79059709|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
44235980|NCT01716533|79059706|FG000|Overall Study|Withdrawal by Subject|0|||
44235981|NCT01716533|79059707|FG001|Overall Study|Withdrawal by Subject|0|||
44235982|NCT01716533|79059708|FG002|Overall Study|Withdrawal by Subject|0|||
44235983|NCT01716533|79059709|FG003|Overall Study|Withdrawal by Subject|5|||
44235984|NCT01716533|79059706|FG000|Overall Study|Death|0|||
44235985|NCT01716533|79059707|FG001|Overall Study|Death|0|||
44235986|NCT01716533|79059708|FG002|Overall Study|Death|0|||
44235987|NCT01716533|79059709|FG003|Overall Study|Death|2|||
44235988|NCT01716533|79059706|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
44235989|NCT01716533|79059707|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
44235990|NCT01716533|79059708|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
44235991|NCT01716533|79059709|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
44235992|NCT01375374|79059723|FG000|Overall Study|Adverse Event|1|||
44235993|NCT01743989|79060321|FG000|Treatment Phase|Unstable MR4.0|0|||
44235994|NCT01743989|79060322|FG001|Treatment Phase|Unstable MR4.0|6|||
44235995|NCT01743989|79060323|FG002|Treatment Phase|Unstable MR4.0|263|||
44235996|NCT01743989|79060321|FG000|Treatment Phase|Adverse Event|0|||
44235997|NCT01743989|79060322|FG001|Treatment Phase|Adverse Event|4|||
44235998|NCT01743989|79060323|FG002|Treatment Phase|Adverse Event|67|||
44235999|NCT01743989|79060321|FG000|Treatment Phase|Withdrawal by Subject|1|||
44236000|NCT01743989|79060322|FG001|Treatment Phase|Withdrawal by Subject|3|||
44568925|NCT03082261|79589247|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
44568926|NCT03082261|79589247|FG000|Overall Study|Insurance denial|1|||
44568927|NCT03082261|79589247|FG000|Overall Study|Peripheral lead added|1|||
44568928|NCT03082261|79589247|FG000|Overall Study|Withdrawal by Subject|40|||
44568929|NCT03082261|79589247|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
44568930|NCT03082261|79589247|FG000|Overall Study|Subject implanted with device other than study device|1|||
44568931|NCT03082261|79589247|FG000|Overall Study|Lost to Follow-up|14|||
44568932|NCT03082261|79589247|FG000|Overall Study|Subject moved to a different state|1|||
44568933|NCT03082261|79589247|FG000|Overall Study|Subject non-compliance|2|||
44568934|NCT03082261|79589247|FG000|Overall Study|Subject participation terminated by investigator|9|||
44568935|NCT03082261|79589247|FG000|Overall Study|Subject participation terminated by sponsor|4|||
44568936|NCT03082261|79589247|FG000|Overall Study|System explant|19|||
44568937|NCT03082261|79589247|FG000|Overall Study|Unable to place lead(s)|2|||
44568938|NCT03082261|79589247|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
44568939|NCT00102440|79589254|FG000|Overall Study|Lost to Follow-up|25|||
44236001|NCT01743989|79060323|FG002|Treatment Phase|Withdrawal by Subject|28|||
44236002|NCT01743989|79060321|FG000|Treatment Phase|Death|0|||
44236003|NCT01743989|79060322|FG001|Treatment Phase|Death|1|||
44236004|NCT01743989|79060323|FG002|Treatment Phase|Death|3|||
44568940|NCT00102440|79589255|FG001|Overall Study|Lost to Follow-up|18|||
44568941|NCT00102440|79589256|FG002|Overall Study|Lost to Follow-up|21|||
44568942|NCT00102440|79589254|FG000|Overall Study|Adverse Event|16|||
44568943|NCT00102440|79589255|FG001|Overall Study|Adverse Event|23|||
44568944|NCT00102440|79589256|FG002|Overall Study|Adverse Event|8|||
44568945|NCT00102440|79589254|FG000|Overall Study|Gout Flare|10|||
44568946|NCT00102440|79589255|FG001|Overall Study|Gout Flare|28|||
44568947|NCT00102440|79589256|FG002|Overall Study|Gout Flare|9|||
44568948|NCT00102440|79589254|FG000|Overall Study|Personal Reason(s)|19|||
44568949|NCT00102440|79589255|FG001|Overall Study|Personal Reason(s)|13|||
44568950|NCT00102440|79589256|FG002|Overall Study|Personal Reason(s)|13|||
44568951|NCT00102440|79589254|FG000|Overall Study|Other|11|||
44568952|NCT00102440|79589255|FG001|Overall Study|Other|14|||
44568953|NCT00102440|79589256|FG002|Overall Study|Other|14|||
44568954|NCT00102440|79589254|FG000|Overall Study|Protocol Violation|7|||
44568955|NCT00102440|79589255|FG001|Overall Study|Protocol Violation|2|||
44568956|NCT00102440|79589256|FG002|Overall Study|Protocol Violation|1|||
44568957|NCT02762084|79589280|FG000|Overall Study|Withdrawal by Subject|1|||
44568958|NCT02762084|79589281|FG001|Overall Study|Withdrawal by Subject|0|||
44568959|NCT02762084|79589282|FG002|Overall Study|Withdrawal by Subject|0|||
44236005|NCT01743989|79060321|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
44236006|NCT01743989|79060322|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
44236007|NCT01743989|79060323|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
44236008|NCT01743989|79060321|FG000|Treatment Phase|Protocol deviation|0|||
44236009|NCT01743989|79060322|FG001|Treatment Phase|Protocol deviation|0|||
44236010|NCT01743989|79060323|FG002|Treatment Phase|Protocol deviation|3|||
44236011|NCT01743989|79060321|FG000|Treatment Phase|Pregnancy|0|||
44236012|NCT01743989|79060322|FG001|Treatment Phase|Pregnancy|0|||
44236013|NCT01743989|79060323|FG002|Treatment Phase|Pregnancy|2|||
44236014|NCT01743989|79060321|FG000|Treatment Phase|Lost to Follow-up|0|||
44236015|NCT01743989|79060322|FG001|Treatment Phase|Lost to Follow-up|0|||
44236016|NCT01743989|79060323|FG002|Treatment Phase|Lost to Follow-up|2|||
44236017|NCT01743989|79060321|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
44236018|NCT01743989|79060322|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
44503601|NCT01698918|79508487|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
44503602|NCT01698918|79508487|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
44503603|NCT01698918|79508487|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
44503604|NCT01698918|79508487|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
44503605|NCT01698918|79508487|FG000|Second Line Treatment (Core+Extension)|Death|1|||
44503606|NCT01698918|79508487|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
44503607|NCT01698918|79508487|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
44503608|NCT01208974|79508500|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
44503609|NCT01208974|79508501|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
44503610|NCT01208974|79508502|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
44503611|NCT01208974|79508503|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
44503612|NCT01208974|79508500|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
44568960|NCT02762084|79589280|FG000|Overall Study|Adverse Event|0|||
44568961|NCT02762084|79589281|FG001|Overall Study|Adverse Event|0|||
44568962|NCT02762084|79589282|FG002|Overall Study|Adverse Event|1|||
44568963|NCT02763644|79589294|FG000|Overall Study|Patient/guardian decision|1|||
44568964|NCT02763644|79589295|FG001|Overall Study|Patient/guardian decision|0|||
44236019|NCT01743989|79060323|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
44236020|NCT01743989|79060321|FG000|Treatment Phase|Administrative problems|0|||
44568965|NCT02763644|79589294|FG000|Overall Study|Death|1|||
44568966|NCT02763644|79589295|FG001|Overall Study|Death|1|||
44236021|NCT01743989|79060322|FG001|Treatment Phase|Administrative problems|0|||
44236022|NCT01743989|79060323|FG002|Treatment Phase|Administrative problems|1|||
44236023|NCT01743989|79060321|FG000|Treatment Phase|New cancer (CML) therapy|0|||
44236024|NCT01743989|79060322|FG001|Treatment Phase|New cancer (CML) therapy|1|||
44568967|NCT02763644|79589294|FG000|Overall Study|Adverse Event|1|||
44568968|NCT02763644|79589295|FG001|Overall Study|Adverse Event|1|||
44236025|NCT01743989|79060323|FG002|Treatment Phase|New cancer (CML) therapy|0|||
44236026|NCT01743989|79060321|FG000|Treatment Phase|Physician Decision|0|||
44236027|NCT01743989|79060322|FG001|Treatment Phase|Physician Decision|0|||
44236028|NCT01743989|79060323|FG002|Treatment Phase|Physician Decision|3|||
44236029|NCT01743989|79060321|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
44236030|NCT01743989|79060322|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
44236031|NCT01743989|79060323|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
44236032|NCT01743989|79060321|FG000|Treatment Phase|Not randomized by mistake|0|||
44236033|NCT01743989|79060322|FG001|Treatment Phase|Not randomized by mistake|0|||
44236034|NCT01743989|79060323|FG002|Treatment Phase|Not randomized by mistake|1|||
44236035|NCT01743989|79060321|FG000|Treatment Phase|Included by mistake|0|||
44236036|NCT01743989|79060322|FG001|Treatment Phase|Included by mistake|0|||
44236037|NCT01743989|79060323|FG002|Treatment Phase|Included by mistake|1|||
44236038|NCT01743989|79060321|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
44236039|NCT01743989|79060322|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
44236040|NCT01743989|79060323|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
44236041|NCT01743989|79060321|FG000|TFR Phase|Adverse Event|0|||
44236042|NCT01743989|79060322|FG001|TFR Phase|Adverse Event|1|||
44236043|NCT01743989|79060323|FG002|TFR Phase|Adverse Event|0|||
44236044|NCT01743989|79060321|FG000|TFR Phase|Lost to Follow-up|0|||
44236045|NCT01743989|79060322|FG001|TFR Phase|Lost to Follow-up|2|||
44236046|NCT01743989|79060323|FG002|TFR Phase|Lost to Follow-up|0|||
44236047|NCT01743989|79060321|FG000|TFR Phase|Physician Decision|0|||
44236048|NCT01743989|79060322|FG001|TFR Phase|Physician Decision|1|||
44275850|NCT02161458|79224227|FG002|Overall Study|Lost to Follow-up|1|||
44275851|NCT02161458|79224228|FG003|Overall Study|Lost to Follow-up|0|||
44275852|NCT02223858|79224240|FG000|Overall Study|Death|1|||
44275853|NCT02223858|79224241|FG001|Overall Study|Death|1|||
44503613|NCT01208974|79508501|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
44503614|NCT01208974|79508502|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
44503615|NCT01208974|79508503|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
44503616|NCT01208974|79508500|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
44503617|NCT01208974|79508501|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
44503618|NCT01208974|79508502|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
44503619|NCT01208974|79508503|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
44503620|NCT00840177|79508513|FG000|Overall Study|Adverse Event|5|||
44503621|NCT00840177|79508514|FG001|Overall Study|Adverse Event|1|||
44275854|NCT02223858|79224240|FG000|Overall Study|Lost to Follow-up|6|||
44275855|NCT02223858|79224241|FG001|Overall Study|Lost to Follow-up|11|||
44275856|NCT02223858|79224240|FG000|Overall Study|Withdrawal by Subject|8|||
44275857|NCT02223858|79224241|FG001|Overall Study|Withdrawal by Subject|5|||
44275858|NCT02223858|79224240|FG000|Overall Study|Refused|9|||
44275859|NCT02223858|79224241|FG001|Overall Study|Refused|9|||
44275860|NCT02223390|79224249|FG000|Overall Study|Lost to Follow-up|9|||
44275861|NCT02223390|79224250|FG001|Overall Study|Lost to Follow-up|4|||
44275862|NCT04914000|79226117|FG000|Overall Study|Lost to Follow-up|8|||
44275863|NCT04914000|79226117|FG000|Overall Study|Withdrawal by Subject|1|||
44275864|NCT04530825|79226134|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
44275865|NCT04530825|79226135|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
44275866|NCT04530825|79226136|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
44275867|NCT04530825|79226137|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
44275868|NCT04530825|79226134|FG000|Overall Study|Did not complete follow-up|3|||
44275869|NCT04530825|79226135|FG001|Overall Study|Did not complete follow-up|0|||
44275870|NCT04530825|79226136|FG002|Overall Study|Did not complete follow-up|0|||
44275871|NCT04530825|79226137|FG003|Overall Study|Did not complete follow-up|0|||
44275872|NCT04169373|79226151|FG000|Week 1 to Week 14|Adverse Event|1|||
44275873|NCT04169373|79226152|FG001|Week 1 to Week 14|Adverse Event|0|||
44275874|NCT04169373|79226153|FG002|Week 1 to Week 14|Adverse Event|1|||
44275875|NCT04169373|79226154|FG003|Week 1 to Week 14|Adverse Event|2|||
44275876|NCT04169373|79226151|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
44275877|NCT04169373|79226152|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
44275878|NCT04169373|79226153|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
44275879|NCT04169373|79226154|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
44503622|NCT00840177|79508515|FG002|Overall Study|Adverse Event|1|||
44568969|NCT02807844|79589313|FG000|Overall Study|Physician Decision|0|||
44236049|NCT01743989|79060323|FG002|TFR Phase|Physician Decision|0|||
44236050|NCT01743989|79060321|FG000|TFR Phase|Logistical problems|0|||
44236051|NCT01743989|79060322|FG001|TFR Phase|Logistical problems|2|||
44236052|NCT01743989|79060323|FG002|TFR Phase|Logistical problems|0|||
44236053|NCT01743989|79060321|FG000|TFR Phase|Protocol deviation|0|||
44236054|NCT01743989|79060322|FG001|TFR Phase|Protocol deviation|1|||
44236055|NCT01743989|79060323|FG002|TFR Phase|Protocol deviation|0|||
44236056|NCT01743989|79060321|FG000|TFR Phase|Withdrawal by Subject|0|||
44236057|NCT01743989|79060322|FG001|TFR Phase|Withdrawal by Subject|2|||
44236058|NCT01743989|79060323|FG002|TFR Phase|Withdrawal by Subject|0|||
44236059|NCT01743989|79060321|FG000|Re-treatment Phase|Adverse Event|8|||
44236060|NCT01743989|79060322|FG001|Re-treatment Phase|Adverse Event|4|||
44236061|NCT01743989|79060323|FG002|Re-treatment Phase|Adverse Event|0|||
44236062|NCT01743989|79060321|FG000|Re-treatment Phase|Death|1|||
44236063|NCT01743989|79060322|FG001|Re-treatment Phase|Death|1|||
44236064|NCT01743989|79060323|FG002|Re-treatment Phase|Death|0|||
44236065|NCT01743989|79060321|FG000|Re-treatment Phase|Administrative problems|1|||
44236066|NCT01743989|79060322|FG001|Re-treatment Phase|Administrative problems|1|||
44236067|NCT01743989|79060323|FG002|Re-treatment Phase|Administrative problems|0|||
44236068|NCT01743989|79060321|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
44236069|NCT01743989|79060322|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
44236070|NCT01743989|79060323|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
44236071|NCT01743989|79060321|FG000|Re-treatment Phase|Unstable MR|1|||
44236072|NCT01743989|79060322|FG001|Re-treatment Phase|Unstable MR|0|||
44236073|NCT01743989|79060323|FG002|Re-treatment Phase|Unstable MR|0|||
44236074|NCT01743989|79060321|FG000|Re-treatment Phase|Physician Decision|0|||
44236075|NCT01743989|79060322|FG001|Re-treatment Phase|Physician Decision|1|||
44236076|NCT01743989|79060323|FG002|Re-treatment Phase|Physician Decision|0|||
44236077|NCT01743989|79060321|FG000|Re-treatment Phase|Lost to Follow-up|0|||
44236078|NCT01743989|79060322|FG001|Re-treatment Phase|Lost to Follow-up|1|||
44236079|NCT01743989|79060323|FG002|Re-treatment Phase|Lost to Follow-up|0|||
44236080|NCT01605461|79060356|FG000|Overall Study|Lost to Follow-up|3|||
44236081|NCT01605461|79060356|FG000|Overall Study|Withdrawal by Subject|1|||
44236082|NCT01742897|79060360|FG000|Overall Study|Adverse Event|3|||
44236083|NCT01742897|79060360|FG000|Overall Study|Withdrawal by Subject|1|||
44236084|NCT01742897|79060360|FG000|Overall Study|Other|1|||
44236085|NCT01715831|79060364|FG000|Overall Study|Adverse Event|1|||
44236086|NCT01741259|79060370|FG000|Overall Study|Protocol Violation|6|||
44236087|NCT01741259|79060371|FG001|Overall Study|Protocol Violation|4|||
44236088|NCT01741259|79060370|FG000|Overall Study|Withdrawal by Subject|0|||
44236089|NCT01741259|79060371|FG001|Overall Study|Withdrawal by Subject|2|||
44236090|NCT01715129|79060377|FG000|Overall Study|Adverse Event, fatal|1|||
44236091|NCT01715129|79060377|FG000|Overall Study|Lack of Efficacy|3|||
44236092|NCT01715129|79060377|FG000|Overall Study|Protocol Violation|1|||
44236093|NCT01715129|79060377|FG000|Overall Study|Consent Withdrawn|2|||
44236094|NCT01715129|79060377|FG000|Overall Study|Lost to Follow-up|1|||
44236095|NCT01715129|79060377|FG000|Overall Study|Other|1|||
44236096|NCT01740791|79060470|FG000|Overall Study|Randomized but never treated|5|||
44236097|NCT01740791|79060471|FG001|Overall Study|Randomized but never treated|3|||
44236098|NCT01740791|79060472|FG002|Overall Study|Randomized but never treated|2|||
44236099|NCT01740791|79060473|FG003|Overall Study|Randomized but never treated|2|||
44236100|NCT01740791|79060474|FG004|Overall Study|Randomized but never treated|1|||
44236101|NCT01740791|79060475|FG005|Overall Study|Randomized but never treated|3|||
44275880|NCT04169373|79226151|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
44275881|NCT04169373|79226152|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
44503623|NCT00840177|79508513|FG000|Overall Study|Refusal unrelated to adverse events|1|||
44503624|NCT00840177|79508514|FG001|Overall Study|Refusal unrelated to adverse events|0|||
44503625|NCT00840177|79508515|FG002|Overall Study|Refusal unrelated to adverse events|1|||
44503626|NCT00840177|79508513|FG000|Overall Study|Progression/relapse|2|||
44503627|NCT00840177|79508514|FG001|Overall Study|Progression/relapse|0|||
44503628|NCT00840177|79508515|FG002|Overall Study|Progression/relapse|0|||
44568970|NCT02807844|79589314|FG001|Overall Study|Physician Decision|0|||
44568971|NCT02807844|79589315|FG002|Overall Study|Physician Decision|0|||
44568972|NCT02807844|79589316|FG003|Overall Study|Physician Decision|0|||
44236102|NCT01740791|79060470|FG000|Overall Study|Lost to Follow-up|2|||
44236103|NCT01740791|79060471|FG001|Overall Study|Lost to Follow-up|0|||
44236104|NCT01740791|79060472|FG002|Overall Study|Lost to Follow-up|2|||
44236105|NCT01740791|79060473|FG003|Overall Study|Lost to Follow-up|3|||
44236106|NCT01740791|79060474|FG004|Overall Study|Lost to Follow-up|2|||
44236107|NCT01740791|79060475|FG005|Overall Study|Lost to Follow-up|3|||
44236108|NCT01740791|79060470|FG000|Overall Study|Withdrew Consent|4|||
44503629|NCT00840177|79508513|FG000|Overall Study|Death|4|||
44503630|NCT00840177|79508514|FG001|Overall Study|Death|5|||
44503631|NCT00840177|79508515|FG002|Overall Study|Death|5|||
44236109|NCT01740791|79060471|FG001|Overall Study|Withdrew Consent|0|||
44236110|NCT01740791|79060472|FG002|Overall Study|Withdrew Consent|1|||
44236111|NCT01740791|79060473|FG003|Overall Study|Withdrew Consent|2|||
44236112|NCT01740791|79060474|FG004|Overall Study|Withdrew Consent|0|||
44236113|NCT01740791|79060475|FG005|Overall Study|Withdrew Consent|3|||
44236114|NCT01740791|79060470|FG000|Overall Study|Investigator's discretion|1|||
44236115|NCT01740791|79060471|FG001|Overall Study|Investigator's discretion|0|||
44236116|NCT01740791|79060472|FG002|Overall Study|Investigator's discretion|1|||
44236117|NCT01740791|79060473|FG003|Overall Study|Investigator's discretion|0|||
44236118|NCT01740791|79060474|FG004|Overall Study|Investigator's discretion|0|||
44236119|NCT01740791|79060475|FG005|Overall Study|Investigator's discretion|1|||
44236120|NCT01740791|79060470|FG000|Overall Study|Adverse Event|0|||
44236121|NCT01740791|79060471|FG001|Overall Study|Adverse Event|0|||
44236122|NCT01740791|79060472|FG002|Overall Study|Adverse Event|0|||
44236123|NCT01740791|79060473|FG003|Overall Study|Adverse Event|0|||
44236124|NCT01740791|79060474|FG004|Overall Study|Adverse Event|0|||
44236125|NCT01740791|79060475|FG005|Overall Study|Adverse Event|1|||
44236126|NCT01740323|79060532|FG000|Overall Study|Adverse Event|1|||
44236127|NCT01740323|79060533|FG001|Overall Study|Adverse Event|0|||
44236128|NCT01740323|79060532|FG000|Overall Study|Randomized but did not take study drug|1|||
44236129|NCT01740323|79060533|FG001|Overall Study|Randomized but did not take study drug|0|||
44236130|NCT01740089|79060551|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
44236131|NCT01740089|79060552|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
44236132|NCT01740089|79060553|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
44236133|NCT01740089|79060551|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
44236134|NCT01740089|79060552|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
44236135|NCT01740089|79060553|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
44236136|NCT01740089|79060551|FG000|After 12 Weeks|Lack of Efficacy|3|||
44236137|NCT01740089|79060552|FG001|After 12 Weeks|Lack of Efficacy|1|||
44236138|NCT01740089|79060553|FG002|After 12 Weeks|Lack of Efficacy|4|||
44236139|NCT01740089|79060551|FG000|After 12 Weeks|Adverse Event|2|||
44236140|NCT01740089|79060552|FG001|After 12 Weeks|Adverse Event|0|||
44236141|NCT01740089|79060553|FG002|After 12 Weeks|Adverse Event|5|||
44236142|NCT01740089|79060551|FG000|After 12 Weeks|Protocol Violation|1|||
44236143|NCT01740089|79060552|FG001|After 12 Weeks|Protocol Violation|1|||
44236144|NCT01740089|79060553|FG002|After 12 Weeks|Protocol Violation|1|||
44236145|NCT01740089|79060551|FG000|After 12 Weeks|Withdrawal by Subject|1|||
44236146|NCT01740089|79060552|FG001|After 12 Weeks|Withdrawal by Subject|1|||
44236147|NCT01740089|79060553|FG002|After 12 Weeks|Withdrawal by Subject|1|||
44236148|NCT01739933|79060564|FG000|Overall Study|Death|89|||
44236149|NCT01739933|79060565|FG001|Overall Study|Death|86|||
44236150|NCT01739933|79060564|FG000|Overall Study|Withdrawal by Subject|10|||
44236151|NCT01739933|79060565|FG001|Overall Study|Withdrawal by Subject|8|||
44236152|NCT01739933|79060564|FG000|Overall Study|Lost to Follow-up|3|||
44236153|NCT01739933|79060565|FG001|Overall Study|Lost to Follow-up|10|||
44236154|NCT01739933|79060564|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
44236155|NCT01739933|79060565|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
44236156|NCT01738919|79060582|FG000|Overall Study|Lost to Follow-up|1|||
44236157|NCT01738919|79060583|FG001|Overall Study|Lost to Follow-up|0|||
44236158|NCT01738919|79060582|FG000|Overall Study|Immigrated|0|||
44236159|NCT01738919|79060583|FG001|Overall Study|Immigrated|1|||
44236160|NCT01738919|79060582|FG000|Overall Study|Withdrawal by Subject|0|||
44236161|NCT01738919|79060583|FG001|Overall Study|Withdrawal by Subject|1|||
44236162|NCT01738919|79060582|FG000|Overall Study|Not treated in accordance to guidelines|0|||
44236163|NCT01738919|79060583|FG001|Overall Study|Not treated in accordance to guidelines|1|||
44236164|NCT01712399|79060604|FG000|Overall Study|Lost to Follow-up|1|||
44236165|NCT01712399|79060604|FG000|Overall Study|Withdrawal by Subject|39|||
44236166|NCT01712399|79060604|FG000|Overall Study|Death|1|||
44236167|NCT01712399|79060604|FG000|Overall Study|Adverse Event|11|||
44236168|NCT01712399|79060604|FG000|Overall Study|Study closure|345|||
44236169|NCT03225846|79060711|FG000|Overall Study|Adverse Event|0|||
44236170|NCT03225846|79060712|FG001|Overall Study|Adverse Event|0|||
44236171|NCT03225846|79060713|FG002|Overall Study|Adverse Event|0|||
44236172|NCT03225846|79060714|FG003|Overall Study|Adverse Event|0|||
44236173|NCT03225846|79060715|FG004|Overall Study|Adverse Event|0|||
44236174|NCT03225846|79060716|FG005|Overall Study|Adverse Event|0|||
44236175|NCT03225846|79060717|FG006|Overall Study|Adverse Event|6|||
44236176|NCT03225846|79060711|FG000|Overall Study|Withdrawal by Subject|0|||
44236177|NCT03225846|79060712|FG001|Overall Study|Withdrawal by Subject|1|||
44236178|NCT03225846|79060713|FG002|Overall Study|Withdrawal by Subject|0|||
44236179|NCT03225846|79060714|FG003|Overall Study|Withdrawal by Subject|0|||
44236180|NCT03225846|79060715|FG004|Overall Study|Withdrawal by Subject|0|||
44236181|NCT03225846|79060716|FG005|Overall Study|Withdrawal by Subject|0|||
44377691|NCT00920556|79382995|FG000|Overall Study|Physician Decision|7|||
44236182|NCT03225846|79060717|FG006|Overall Study|Withdrawal by Subject|0|||
44236183|NCT03225846|79060711|FG000|Overall Study|Death|0|||
44236184|NCT03225846|79060712|FG001|Overall Study|Death|1|||
44236185|NCT03225846|79060713|FG002|Overall Study|Death|0|||
44236186|NCT03225846|79060714|FG003|Overall Study|Death|0|||
44236187|NCT03225846|79060715|FG004|Overall Study|Death|0|||
44236188|NCT03225846|79060716|FG005|Overall Study|Death|0|||
44236189|NCT03225846|79060717|FG006|Overall Study|Death|0|||
44236190|NCT03225846|79060711|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
44236191|NCT03225846|79060712|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
44236192|NCT03225846|79060713|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
44236193|NCT03225846|79060714|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
44236194|NCT03225846|79060715|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
44236195|NCT03225846|79060716|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
44377692|NCT00920556|79382995|FG000|Overall Study|Withdrawal by Subject|1|||
44377693|NCT00781885|79383003|FG000|Overall Study|Physician Decision|1|||
44377694|NCT00918684|79383007|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
44377695|NCT00918684|79383007|FG000|Treatment Phase|Lack of Efficacy|6|||
44503632|NCT00840177|79508513|FG000|Overall Study|not protocol specified|6|||
44503633|NCT00840177|79508514|FG001|Overall Study|not protocol specified|3|||
44236196|NCT03225846|79060717|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
44236197|NCT03225846|79060711|FG000|Overall Study|Patient decision|0|||
44503634|NCT00840177|79508515|FG002|Overall Study|not protocol specified|0|||
44503635|NCT00840177|79508513|FG000|Overall Study|Ineligible|0|||
44503636|NCT00840177|79508514|FG001|Overall Study|Ineligible|0|||
44503637|NCT00840177|79508515|FG002|Overall Study|Ineligible|3|||
44503638|NCT00840177|79508513|FG000|Overall Study|Did not start treatment|0|||
44503639|NCT00840177|79508514|FG001|Overall Study|Did not start treatment|0|||
44503640|NCT00840177|79508515|FG002|Overall Study|Did not start treatment|1|||
44503641|NCT01347580|79508525|FG000|Overall Study|Withdrawal by Subject|13|||
44503642|NCT01347580|79508526|FG001|Overall Study|Withdrawal by Subject|23|||
44503643|NCT01347580|79508525|FG000|Overall Study|Death|30|||
44568973|NCT02807844|79589317|FG004|Overall Study|Physician Decision|0|||
44568974|NCT02807844|79589318|FG005|Overall Study|Physician Decision|0|||
44568975|NCT02807844|79589319|FG006|Overall Study|Physician Decision|3|||
44568976|NCT02807844|79589320|FG007|Overall Study|Physician Decision|0|||
44568977|NCT02807844|79589321|FG008|Overall Study|Physician Decision|1|||
44568978|NCT02807844|79589322|FG009|Overall Study|Physician Decision|2|||
44568979|NCT02807844|79589313|FG000|Overall Study|Death|0|||
44236198|NCT03225846|79060712|FG001|Overall Study|Patient decision|0|||
44236199|NCT03225846|79060713|FG002|Overall Study|Patient decision|0|||
44236200|NCT03225846|79060714|FG003|Overall Study|Patient decision|0|||
44236201|NCT03225846|79060715|FG004|Overall Study|Patient decision|0|||
44503644|NCT01347580|79508526|FG001|Overall Study|Death|19|||
44503645|NCT01347580|79508525|FG000|Overall Study|Protocol Violation|10|||
44503646|NCT01347580|79508526|FG001|Overall Study|Protocol Violation|7|||
44503647|NCT01347580|79508525|FG000|Overall Study|Lost to Follow-up|3|||
44503648|NCT01347580|79508526|FG001|Overall Study|Lost to Follow-up|1|||
44568980|NCT02807844|79589314|FG001|Overall Study|Death|0|||
44568981|NCT02807844|79589315|FG002|Overall Study|Death|2|||
44568982|NCT02807844|79589316|FG003|Overall Study|Death|4|||
44568983|NCT02807844|79589317|FG004|Overall Study|Death|1|||
44568984|NCT02807844|79589318|FG005|Overall Study|Death|2|||
44568985|NCT02807844|79589319|FG006|Overall Study|Death|1|||
44568986|NCT02807844|79589320|FG007|Overall Study|Death|2|||
44568987|NCT02807844|79589321|FG008|Overall Study|Death|0|||
44568988|NCT02807844|79589322|FG009|Overall Study|Death|1|||
44568989|NCT02807844|79589313|FG000|Overall Study|Withdrawal by Subject|0|||
44568990|NCT02807844|79589314|FG001|Overall Study|Withdrawal by Subject|0|||
44568991|NCT02807844|79589315|FG002|Overall Study|Withdrawal by Subject|2|||
44568992|NCT02807844|79589316|FG003|Overall Study|Withdrawal by Subject|1|||
44568993|NCT02807844|79589317|FG004|Overall Study|Withdrawal by Subject|1|||
44236202|NCT03225846|79060716|FG005|Overall Study|Patient decision|0|||
44236203|NCT03225846|79060717|FG006|Overall Study|Patient decision|1|||
44236204|NCT01712009|79060782|FG000|Overall Study|Withdrawal by Subject|24|||
44236205|NCT01712009|79060783|FG001|Overall Study|Withdrawal by Subject|15|||
44236206|NCT01712009|79060784|FG002|Overall Study|Withdrawal by Subject|8|||
44236207|NCT01712009|79060782|FG000|Overall Study|Lost to Follow-up|2|||
44377696|NCT00918684|79383007|FG000|Treatment Phase|Lost to Follow-up|2|||
44236208|NCT01712009|79060783|FG001|Overall Study|Lost to Follow-up|0|||
44377697|NCT00918684|79383007|FG000|Treatment Phase|Physician Decision|8|||
44503649|NCT01347580|79508525|FG000|Overall Study|Had other reason|9|||
44503650|NCT01347580|79508526|FG001|Overall Study|Had other reason|6|||
44503651|NCT00398411|79508534|FG000|Overall Study|Death|0|||
44503652|NCT00398411|79508535|FG001|Overall Study|Death|1|||
44568994|NCT02807844|79589318|FG005|Overall Study|Withdrawal by Subject|0|||
44236209|NCT01712009|79060784|FG002|Overall Study|Lost to Follow-up|1|||
44236210|NCT01712009|79060782|FG000|Overall Study|Decision by Sponsor|12|||
44236211|NCT01712009|79060783|FG001|Overall Study|Decision by Sponsor|14|||
44236212|NCT01712009|79060784|FG002|Overall Study|Decision by Sponsor|12|||
44236213|NCT01711853|79060813|FG000|Overall Study|Not treated|3|||
44236214|NCT01708187|79060819|FG000|Overall Study|Lost to Follow-up|0|||
44236215|NCT01708187|79060820|FG001|Overall Study|Lost to Follow-up|1|||
44236216|NCT01740401|79060896|FG000|Overall Study|Progression of disease|6|||
44236217|NCT01740401|79060896|FG000|Overall Study|Adverse Event|2|||
44236218|NCT01740401|79060896|FG000|Overall Study|Did not reach primary endpoint|2|||
44236219|NCT01711619|79060917|FG000|Overall Study|Early study termination|10|||
44236220|NCT01711619|79060918|FG001|Overall Study|Early study termination|14|||
44236221|NCT01711619|79060917|FG000|Overall Study|Withdrawal by Subject|3|||
44236222|NCT01711619|79060918|FG001|Overall Study|Withdrawal by Subject|7|||
44236223|NCT01711619|79060917|FG000|Overall Study|Protocol Violation|2|||
44236224|NCT01711619|79060918|FG001|Overall Study|Protocol Violation|3|||
44236225|NCT01711619|79060917|FG000|Overall Study|Adverse Event|2|||
44236226|NCT01711619|79060918|FG001|Overall Study|Adverse Event|0|||
44236227|NCT01711619|79060917|FG000|Overall Study|Lost to Follow-up|1|||
44236228|NCT01711619|79060918|FG001|Overall Study|Lost to Follow-up|0|||
44236229|NCT01710527|79060933|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
44236230|NCT01710527|79060934|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
44236231|NCT01706939|79060942|FG000|Pre Randomization|Screen Failure|1|||
44236232|NCT01706939|79060943|FG001|Pre Randomization|Screen Failure|0|||
44236233|NCT01706939|79060944|FG002|Pre Randomization|Screen Failure|0|||
44236234|NCT01706939|79060942|FG000|Pre Randomization|Ineligible for Randomization|1|||
44236235|NCT01706939|79060943|FG001|Pre Randomization|Ineligible for Randomization|0|||
44236236|NCT01706939|79060944|FG002|Pre Randomization|Ineligible for Randomization|0|||
44236237|NCT01706939|79060942|FG000|Pre Randomization|Withdrawal by Subject|1|||
44236238|NCT01706939|79060943|FG001|Pre Randomization|Withdrawal by Subject|0|||
44236239|NCT01706939|79060944|FG002|Pre Randomization|Withdrawal by Subject|0|||
44236240|NCT01706939|79060942|FG000|Randomization|Insufficient QoL survey compliance|0|||
44236241|NCT01706939|79060943|FG001|Randomization|Insufficient QoL survey compliance|1|||
44236242|NCT01706939|79060944|FG002|Randomization|Insufficient QoL survey compliance|1|||
44236243|NCT01706939|79060942|FG000|Randomization|Progression of disease|0|||
44236244|NCT01706939|79060943|FG001|Randomization|Progression of disease|2|||
44236245|NCT01706939|79060944|FG002|Randomization|Progression of disease|1|||
44236246|NCT01709903|79060953|FG000|Overall Study|administrative problems|2|||
44236247|NCT01709903|79060954|FG001|Overall Study|administrative problems|6|||
44236248|NCT01709903|79060953|FG000|Overall Study|Abnormal test procedure results|1|||
44236249|NCT01709903|79060954|FG001|Overall Study|Abnormal test procedure results|0|||
44236250|NCT01709903|79060953|FG000|Overall Study|In ability to use device|1|||
44236251|NCT01709903|79060954|FG001|Overall Study|In ability to use device|1|||
44236252|NCT01709903|79060953|FG000|Overall Study|no longer needed study drug|0|||
44236253|NCT01709903|79060954|FG001|Overall Study|no longer needed study drug|1|||
44236254|NCT01709903|79060953|FG000|Overall Study|Lost to Follow-up|0|||
44236255|NCT01709903|79060954|FG001|Overall Study|Lost to Follow-up|2|||
44236256|NCT01709903|79060953|FG000|Overall Study|Death|2|||
44236257|NCT01709903|79060954|FG001|Overall Study|Death|0|||
44503653|NCT03352414|79508543|FG000|Overall Study|Ineligible by operative criteria|12|||
44568995|NCT02807844|79589319|FG006|Overall Study|Withdrawal by Subject|1|||
44568996|NCT02807844|79589320|FG007|Overall Study|Withdrawal by Subject|0|||
44503654|NCT03352414|79508544|FG001|Overall Study|Ineligible by operative criteria|10|||
44503655|NCT00364793|79508556|FG000|Overall Study|Adverse Event|2|||
44503656|NCT00364793|79508557|FG001|Overall Study|Adverse Event|0|||
44503657|NCT00364793|79508558|FG002|Overall Study|Adverse Event|0|||
44503658|NCT00364793|79508559|FG003|Overall Study|Adverse Event|0|||
44503659|NCT00364793|79508556|FG000|Overall Study|Death|1|||
44568997|NCT02807844|79589321|FG008|Overall Study|Withdrawal by Subject|0|||
44568998|NCT02807844|79589322|FG009|Overall Study|Withdrawal by Subject|0|||
44236258|NCT01709903|79060953|FG000|Overall Study|Protocol Violation|3|||
44503660|NCT00364793|79508557|FG001|Overall Study|Death|0|||
44503661|NCT00364793|79508558|FG002|Overall Study|Death|1|||
44503662|NCT00364793|79508559|FG003|Overall Study|Death|0|||
44236259|NCT01709903|79060954|FG001|Overall Study|Protocol Violation|2|||
44236260|NCT01709903|79060953|FG000|Overall Study|Lack of Efficacy|3|||
44236261|NCT01709903|79060954|FG001|Overall Study|Lack of Efficacy|3|||
44236262|NCT01709903|79060953|FG000|Overall Study|Withdrawal by Subject|6|||
44236263|NCT01709903|79060954|FG001|Overall Study|Withdrawal by Subject|6|||
44236264|NCT01709903|79060953|FG000|Overall Study|Adverse Event|11|||
44236265|NCT01709903|79060954|FG001|Overall Study|Adverse Event|18|||
44236266|NCT04492618|79060960|FG000|Overall Study|Withdrawal by Subject|1|||
44503663|NCT00364793|79508556|FG000|Overall Study|Lack of Efficacy|3|||
44568999|NCT02807844|79589313|FG000|Overall Study|Progressive disease|5|||
44236267|NCT04978090|79060964|FG000|Overall Study|unable to adequately fit device|2|||
44236268|NCT04677504|79060970|FG000|Overall Study|Death|31|||
44236269|NCT04677504|79060971|FG001|Overall Study|Death|24|||
44503664|NCT00364793|79508557|FG001|Overall Study|Lack of Efficacy|3|||
44236270|NCT04677504|79060970|FG000|Overall Study|Progressive Disease|1|||
44236271|NCT04677504|79060971|FG001|Overall Study|Progressive Disease|0|||
44236272|NCT04677504|79060970|FG000|Overall Study|Symptomatic Deterioration|1|||
44236273|NCT04677504|79060971|FG001|Overall Study|Symptomatic Deterioration|0|||
44236274|NCT04677504|79060970|FG000|Overall Study|Withdrawal by Subject|2|||
44236275|NCT04677504|79060971|FG001|Overall Study|Withdrawal by Subject|5|||
44236276|NCT04677504|79060970|FG000|Overall Study|Ongoing in study|48|||
44236277|NCT04677504|79060971|FG001|Overall Study|Ongoing in study|50|||
44236278|NCT04635631|79060979|FG000|Overall Study|Adverse Event|1|||
44236279|NCT04635631|79060979|FG000|Overall Study|Progressive disease|13|||
44236280|NCT04635631|79060979|FG000|Overall Study|Withdrawal by Subject|1|||
44236281|NCT04269395|79060996|FG000|Overall Study|Lost to Follow-up|1|||
44236282|NCT04269395|79060997|FG001|Overall Study|Lost to Follow-up|0|||
44236283|NCT04269395|79060996|FG000|Overall Study|Study terminated by Sponsor|13|||
44236284|NCT04269395|79060997|FG001|Overall Study|Study terminated by Sponsor|10|||
44236285|NCT04143594|79061007|FG000|Overall Study|Still on study|48|||
44236286|NCT04143594|79061008|FG001|Overall Study|Still on study|42|||
44236287|NCT04143594|79061009|FG002|Overall Study|Still on study|48|||
44236288|NCT04143594|79061010|FG003|Overall Study|Still on study|18|||
44236289|NCT04143594|79061007|FG000|Overall Study|Withdrew consent|0|||
44236290|NCT04143594|79061008|FG001|Overall Study|Withdrew consent|6|||
44236291|NCT04143594|79061009|FG002|Overall Study|Withdrew consent|1|||
44236292|NCT04143594|79061010|FG003|Overall Study|Withdrew consent|1|||
44236293|NCT04143594|79061007|FG000|Overall Study|Lost to Follow-up|2|||
44236294|NCT04143594|79061008|FG001|Overall Study|Lost to Follow-up|2|||
44236295|NCT04143594|79061009|FG002|Overall Study|Lost to Follow-up|3|||
44236296|NCT04143594|79061010|FG003|Overall Study|Lost to Follow-up|0|||
44236297|NCT04143594|79061007|FG000|Overall Study|Investigator's discretion|1|||
44236298|NCT04143594|79061008|FG001|Overall Study|Investigator's discretion|2|||
44236299|NCT04143594|79061009|FG002|Overall Study|Investigator's discretion|0|||
44236300|NCT04143594|79061010|FG003|Overall Study|Investigator's discretion|0|||
44236301|NCT04143594|79061007|FG000|Overall Study|Lack of Efficacy|0|||
44236302|NCT04143594|79061008|FG001|Overall Study|Lack of Efficacy|1|||
44236303|NCT04143594|79061009|FG002|Overall Study|Lack of Efficacy|0|||
44236304|NCT04143594|79061010|FG003|Overall Study|Lack of Efficacy|0|||
44236305|NCT04143594|79061007|FG000|Overall Study|Protocol Violation|0|||
44236306|NCT04143594|79061008|FG001|Overall Study|Protocol Violation|0|||
44236307|NCT04143594|79061009|FG002|Overall Study|Protocol Violation|0|||
44236308|NCT04143594|79061010|FG003|Overall Study|Protocol Violation|1|||
44236309|NCT04046549|79061027|FG000|Overall Study|Adverse Event|1|||
44236310|NCT04046549|79061027|FG000|Overall Study|Physician Decision|1|||
44236311|NCT04046549|79061027|FG000|Overall Study|Withdrawal by Subject|3|||
44236312|NCT04046549|79061027|FG000|Overall Study|Other, Not Specified|5|||
44236313|NCT03403205|79061036|FG000|Overall Study|Randomized but not treated|1|||
44236314|NCT03403205|79061037|FG001|Overall Study|Randomized but not treated|0|||
44236315|NCT03403205|79061038|FG002|Overall Study|Randomized but not treated|4|||
44236316|NCT03403205|79061039|FG003|Overall Study|Randomized but not treated|2|||
44236317|NCT03403205|79061036|FG000|Overall Study|Withdrawal by Subject|4|||
44236318|NCT03403205|79061037|FG001|Overall Study|Withdrawal by Subject|2|||
44236319|NCT03403205|79061038|FG002|Overall Study|Withdrawal by Subject|2|||
44236320|NCT03403205|79061039|FG003|Overall Study|Withdrawal by Subject|1|||
44236321|NCT03403205|79061036|FG000|Overall Study|Adverse Event|4|||
44236322|NCT03403205|79061037|FG001|Overall Study|Adverse Event|0|||
44236323|NCT03403205|79061038|FG002|Overall Study|Adverse Event|1|||
44236324|NCT03403205|79061039|FG003|Overall Study|Adverse Event|0|||
44236325|NCT03403205|79061036|FG000|Overall Study|Death|1|||
44236326|NCT03403205|79061037|FG001|Overall Study|Death|0|||
44236327|NCT03403205|79061038|FG002|Overall Study|Death|1|||
44236328|NCT03403205|79061039|FG003|Overall Study|Death|0|||
44236329|NCT03403205|79061036|FG000|Overall Study|Lost to Follow-up|1|||
44236330|NCT03403205|79061037|FG001|Overall Study|Lost to Follow-up|1|||
44236331|NCT03403205|79061038|FG002|Overall Study|Lost to Follow-up|0|||
44236332|NCT03403205|79061039|FG003|Overall Study|Lost to Follow-up|0|||
44236333|NCT03403205|79061036|FG000|Overall Study|Pregnancy|1|||
44236334|NCT03403205|79061037|FG001|Overall Study|Pregnancy|0|||
44236335|NCT03403205|79061038|FG002|Overall Study|Pregnancy|0|||
44236336|NCT03403205|79061039|FG003|Overall Study|Pregnancy|0|||
44236337|NCT03403205|79061036|FG000|Overall Study|Protocol Deviation|0|||
44236338|NCT03403205|79061037|FG001|Overall Study|Protocol Deviation|1|||
44236339|NCT03403205|79061038|FG002|Overall Study|Protocol Deviation|0|||
44236340|NCT03403205|79061039|FG003|Overall Study|Protocol Deviation|0|||
44236341|NCT03375112|79061051|FG000|Overall Study|Withdrawal by Subject|3|||
44236342|NCT03375112|79061052|FG001|Overall Study|Withdrawal by Subject|0|||
44236343|NCT03122106|79061058|FG000|Overall Study|Not enough tissue|1|||
44236344|NCT03122106|79061058|FG000|Overall Study|Disease progression during screening|2|||
44236345|NCT03122106|79061058|FG000|Overall Study|Poor RNA quality for vaccine|1|||
44569000|NCT02807844|79589314|FG001|Overall Study|Progressive disease|12|||
44569001|NCT02807844|79589315|FG002|Overall Study|Progressive disease|8|||
44569002|NCT02807844|79589316|FG003|Overall Study|Progressive disease|8|||
44569003|NCT02807844|79589317|FG004|Overall Study|Progressive disease|3|||
44569004|NCT02807844|79589318|FG005|Overall Study|Progressive disease|8|||
44569005|NCT02807844|79589319|FG006|Overall Study|Progressive disease|14|||
44569006|NCT02807844|79589320|FG007|Overall Study|Progressive disease|17|||
44569007|NCT02807844|79589321|FG008|Overall Study|Progressive disease|19|||
44569008|NCT02807844|79589322|FG009|Overall Study|Progressive disease|15|||
44569009|NCT02807844|79589313|FG000|Overall Study|Adverse Event|1|||
44569010|NCT02807844|79589314|FG001|Overall Study|Adverse Event|0|||
44569011|NCT02807844|79589315|FG002|Overall Study|Adverse Event|0|||
44569012|NCT02807844|79589316|FG003|Overall Study|Adverse Event|0|||
44569013|NCT02807844|79589317|FG004|Overall Study|Adverse Event|1|||
44569014|NCT02807844|79589318|FG005|Overall Study|Adverse Event|1|||
44569015|NCT02807844|79589319|FG006|Overall Study|Adverse Event|1|||
44569016|NCT02807844|79589320|FG007|Overall Study|Adverse Event|1|||
44569017|NCT02807844|79589321|FG008|Overall Study|Adverse Event|1|||
44569018|NCT02807844|79589322|FG009|Overall Study|Adverse Event|2|||
44569019|NCT02763254|79589348|FG000|Overall Study|Adverse Event|1|||
44569020|NCT02805972|79589354|FG000|Washout Period|Lost to Follow-up|3|||
44569021|NCT02805972|79589355|FG001|Washout Period|Lost to Follow-up|0|||
44569022|NCT03032523|79589373|FG000|Overall Study|Withdrawal by Subject|2|||
44569023|NCT03032523|79589374|FG001|Overall Study|Withdrawal by Subject|2|||
44569024|NCT03032523|79589373|FG000|Overall Study|Physician Decision|1|||
44569025|NCT03032523|79589374|FG001|Overall Study|Physician Decision|0|||
44569026|NCT03031899|79589381|FG000|Overall Study|Protocol Violation|1|||
44236346|NCT02923739|79061066|FG000|Overall Study|Withdrawal by Subject|2|||
44236347|NCT02923739|79061067|FG001|Overall Study|Withdrawal by Subject|0|||
44236348|NCT02923739|79061068|FG002|Overall Study|Withdrawal by Subject|0|||
44236349|NCT02923739|79061069|FG003|Overall Study|Withdrawal by Subject|0|||
44236350|NCT02923739|79061066|FG000|Overall Study|Failed Screening|3|||
44236351|NCT02923739|79061067|FG001|Overall Study|Failed Screening|0|||
44236352|NCT02923739|79061068|FG002|Overall Study|Failed Screening|0|||
44236353|NCT02923739|79061069|FG003|Overall Study|Failed Screening|0|||
44236354|NCT02920892|79061081|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
44236355|NCT02920892|79061082|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
44236356|NCT02920892|79061083|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
44236357|NCT02920892|79061081|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
44377698|NCT00918684|79383007|FG000|Treatment Phase|Protocol Violation|1|||
44377699|NCT00918684|79383007|FG000|Treatment Phase|Withdrawal by Subject|8|||
44377700|NCT00786409|79383011|FG000|Overall Study|Withdrawal by Subject|2|||
44503665|NCT00364793|79508558|FG002|Overall Study|Lack of Efficacy|1|||
44503666|NCT00364793|79508559|FG003|Overall Study|Lack of Efficacy|1|||
44503667|NCT00364793|79508556|FG000|Overall Study|Lost to Follow-up|1|||
44503668|NCT00364793|79508557|FG001|Overall Study|Lost to Follow-up|0|||
44503669|NCT00364793|79508558|FG002|Overall Study|Lost to Follow-up|2|||
44503670|NCT00364793|79508559|FG003|Overall Study|Lost to Follow-up|0|||
44503671|NCT00364793|79508556|FG000|Overall Study|Poor or non-compliance|1|||
44503672|NCT00364793|79508557|FG001|Overall Study|Poor or non-compliance|1|||
44503673|NCT00364793|79508558|FG002|Overall Study|Poor or non-compliance|0|||
44503674|NCT00364793|79508559|FG003|Overall Study|Poor or non-compliance|1|||
44503675|NCT00364793|79508556|FG000|Overall Study|No longer meets criteria|0|||
44503676|NCT00364793|79508557|FG001|Overall Study|No longer meets criteria|0|||
44569027|NCT03031899|79589381|FG000|Overall Study|lesion disappeared after stopping habit|1|||
44569028|NCT03086369|79589394|FG000|Overall Study|Lost to Follow-up|1|||
44569029|NCT03086369|79589395|FG001|Overall Study|Lost to Follow-up|0|||
44569030|NCT03086369|79589396|FG002|Overall Study|Lost to Follow-up|0|||
44236358|NCT02920892|79061082|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
44236359|NCT02920892|79061083|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
44236360|NCT02920892|79061081|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
44236361|NCT02920892|79061082|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
44503677|NCT00364793|79508558|FG002|Overall Study|No longer meets criteria|0|||
44503678|NCT00364793|79508559|FG003|Overall Study|No longer meets criteria|1|||
44236362|NCT02920892|79061083|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
44236363|NCT02920892|79061081|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
44236364|NCT02920892|79061082|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
44236365|NCT02920892|79061083|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
44236366|NCT02920892|79061081|FG000|Placebo-Controlled Period|Physician Decision|0|||
44236367|NCT02920892|79061082|FG001|Placebo-Controlled Period|Physician Decision|0|||
44236368|NCT02920892|79061083|FG002|Placebo-Controlled Period|Physician Decision|1|||
44236369|NCT02920892|79061081|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
44236370|NCT02920892|79061082|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
44503679|NCT00364793|79508556|FG000|Overall Study|Withdrawal by Subject|0|||
44503680|NCT00364793|79508557|FG001|Overall Study|Withdrawal by Subject|1|||
44503681|NCT00364793|79508558|FG002|Overall Study|Withdrawal by Subject|0|||
44503682|NCT00364793|79508559|FG003|Overall Study|Withdrawal by Subject|0|||
44503683|NCT03351478|79508575|FG000|Overall Study|At the subject's own request|11|||
44503684|NCT03351478|79508576|FG001|Overall Study|At the subject's own request|12|||
44569031|NCT03086369|79589397|FG003|Overall Study|Lost to Follow-up|2|||
44569032|NCT03086369|79589398|FG004|Overall Study|Lost to Follow-up|1|||
44569033|NCT03086369|79589394|FG000|Overall Study|Physician Decision|0|||
44569034|NCT03086369|79589395|FG001|Overall Study|Physician Decision|0|||
44569035|NCT03086369|79589396|FG002|Overall Study|Physician Decision|0|||
44569036|NCT03086369|79589397|FG003|Overall Study|Physician Decision|1|||
44569037|NCT03086369|79589398|FG004|Overall Study|Physician Decision|2|||
44569038|NCT03086369|79589394|FG000|Overall Study|Withdrawal by Subject|0|||
44569039|NCT03086369|79589395|FG001|Overall Study|Withdrawal by Subject|0|||
44569040|NCT03086369|79589396|FG002|Overall Study|Withdrawal by Subject|0|||
44569041|NCT03086369|79589397|FG003|Overall Study|Withdrawal by Subject|5|||
44569042|NCT03086369|79589398|FG004|Overall Study|Withdrawal by Subject|3|||
44569043|NCT03086369|79589394|FG000|Overall Study|Progressive Disease|0|||
44569044|NCT03086369|79589395|FG001|Overall Study|Progressive Disease|0|||
44569045|NCT03086369|79589396|FG002|Overall Study|Progressive Disease|0|||
44569046|NCT03086369|79589397|FG003|Overall Study|Progressive Disease|1|||
44569047|NCT03086369|79589398|FG004|Overall Study|Progressive Disease|1|||
44569048|NCT00101582|79589414|FG000|Overall Study|Ineligibility determined|0|||
44569049|NCT00101582|79589415|FG001|Overall Study|Ineligibility determined|1|||
44569050|NCT00101582|79589414|FG000|Overall Study|Adverse Event|1|||
44569051|NCT00101582|79589415|FG001|Overall Study|Adverse Event|4|||
44569052|NCT00101582|79589414|FG000|Overall Study|Withdrawal by Subject|6|||
44569053|NCT00101582|79589415|FG001|Overall Study|Withdrawal by Subject|4|||
44569054|NCT00101582|79589414|FG000|Overall Study|Physician Decision|1|||
44569055|NCT00101582|79589415|FG001|Overall Study|Physician Decision|0|||
44569056|NCT00101582|79589414|FG000|Overall Study|Death|3|||
44569057|NCT00101582|79589415|FG001|Overall Study|Death|5|||
44569058|NCT00101582|79589414|FG000|Overall Study|Other|0|||
44569059|NCT00101582|79589415|FG001|Overall Study|Other|1|||
44569060|NCT03086135|79589446|FG000|Overall Study|Adverse Event|1|||
44377701|NCT00786409|79383011|FG000|Overall Study|Adverse Event|2|||
44503685|NCT03351478|79508577|FG002|Overall Study|At the subject's own request|5|||
44569061|NCT03086135|79589446|FG000|Overall Study|Lost to Follow-up|2|||
44569062|NCT02762708|79589463|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
44569063|NCT02762708|79589464|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
44569064|NCT02762708|79589465|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
44569065|NCT02762708|79589466|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
44569066|NCT02760602|79589478|FG000|Overall Study|Withdrawal by Subject|1|||
44569067|NCT02760602|79589479|FG001|Overall Study|Withdrawal by Subject|0|||
44569068|NCT02760602|79589478|FG000|Overall Study|Terminated by sponsor|12|||
44569069|NCT02760602|79589479|FG001|Overall Study|Terminated by sponsor|13|||
44569070|NCT00210249|79589485|FG000|Overall Study|Lost to Follow-up|5|||
44569071|NCT00210249|79589485|FG000|Overall Study|Protocol Violation|11|||
44503686|NCT03351478|79508575|FG000|Overall Study|Adverse Event|1|||
44569072|NCT03086057|79589493|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
44569073|NCT03086057|79589494|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
44569074|NCT03086057|79589495|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
44569075|NCT03086057|79589496|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
44569076|NCT03086057|79589493|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
44503687|NCT03351478|79508576|FG001|Overall Study|Adverse Event|2|||
44569077|NCT03086057|79589494|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
44569078|NCT03086057|79589495|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
44569079|NCT03086057|79589496|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
44569080|NCT03086057|79589493|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
44569081|NCT03086057|79589494|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
44569082|NCT03086057|79589495|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
44569083|NCT03086057|79589496|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
44569084|NCT03086057|79589493|FG000|Stage 1: PrEP Uptake|Death|1|||
44569085|NCT03086057|79589494|FG001|Stage 1: PrEP Uptake|Death|0|||
44569086|NCT03086057|79589495|FG002|Stage 1: PrEP Uptake|Death|0|||
44236371|NCT02920892|79061083|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
44236372|NCT02920892|79061081|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
44236373|NCT02920892|79061082|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
44236374|NCT02920892|79061083|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
44236375|NCT02920892|79061081|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
44236376|NCT02920892|79061082|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
44236377|NCT02920892|79061083|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
44236378|NCT02509052|79061094|FG000|Overall Study|Non compliance|0|||
44236379|NCT02509052|79061095|FG001|Overall Study|Non compliance|0|||
44236380|NCT02509052|79061096|FG002|Overall Study|Non compliance|1|||
44236381|NCT02365597|79061109|FG000|Overall Study|Lost to Follow-up|0|||
44236382|NCT02365597|79061110|FG001|Overall Study|Lost to Follow-up|1|||
44236383|NCT02365597|79061111|FG002|Overall Study|Lost to Follow-up|0|||
44236384|NCT02365597|79061112|FG003|Overall Study|Lost to Follow-up|1|||
44236385|NCT02365597|79061109|FG000|Overall Study|Withdrawal by Subject|1|||
44236386|NCT02365597|79061110|FG001|Overall Study|Withdrawal by Subject|8|||
44569087|NCT03086057|79589496|FG003|Stage 1: PrEP Uptake|Death|0|||
44569088|NCT03086057|79589493|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
44569089|NCT03086057|79589494|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
44569090|NCT03086057|79589495|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
44569091|NCT03086057|79589496|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
44569092|NCT03086057|79589493|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
44569093|NCT03086057|79589494|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
44569094|NCT03086057|79589495|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
44569095|NCT03086057|79589496|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
44569096|NCT03086057|79589493|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
44569097|NCT03086057|79589494|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
44569098|NCT03086057|79589495|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
44236387|NCT02365597|79061111|FG002|Overall Study|Withdrawal by Subject|5|||
44236388|NCT02365597|79061112|FG003|Overall Study|Withdrawal by Subject|1|||
44236389|NCT02365597|79061109|FG000|Overall Study|Sponsor's decision|1|||
44236390|NCT02365597|79061110|FG001|Overall Study|Sponsor's decision|3|||
44503688|NCT03351478|79508577|FG002|Overall Study|Adverse Event|1|||
44503689|NCT03351478|79508575|FG000|Overall Study|Poor compliance to protocol|1|||
44503690|NCT03351478|79508576|FG001|Overall Study|Poor compliance to protocol|0|||
44503691|NCT03351478|79508577|FG002|Overall Study|Poor compliance to protocol|0|||
44503692|NCT03351478|79508575|FG000|Overall Study|Reason not Specified|1|||
44503693|NCT03351478|79508576|FG001|Overall Study|Reason not Specified|3|||
44503694|NCT03351478|79508577|FG002|Overall Study|Reason not Specified|0|||
44503695|NCT03351478|79508575|FG000|Overall Study|Lost to Follow-up|0|||
44503696|NCT03351478|79508576|FG001|Overall Study|Lost to Follow-up|0|||
44503697|NCT03351478|79508577|FG002|Overall Study|Lost to Follow-up|1|||
44503698|NCT00363545|79508587|FG000|Overall Study|Serious Adverse Event|0|||
44569099|NCT03086057|79589496|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
44236391|NCT02365597|79061111|FG002|Overall Study|Sponsor's decision|13|||
44236392|NCT02365597|79061112|FG003|Overall Study|Sponsor's decision|0|||
44236393|NCT02365597|79061109|FG000|Overall Study|Other|0|||
44236394|NCT02365597|79061110|FG001|Overall Study|Other|4|||
44236395|NCT02365597|79061111|FG002|Overall Study|Other|0|||
44569100|NCT02759120|79589508|FG000|Overall Study|Death|34|||
44569101|NCT02759120|79589509|FG001|Overall Study|Death|36|||
44236396|NCT02365597|79061112|FG003|Overall Study|Other|0|||
44236397|NCT02365597|79061109|FG000|Overall Study|Enrolled but not treated|0|||
44236398|NCT02365597|79061110|FG001|Overall Study|Enrolled but not treated|1|||
44236399|NCT02365597|79061111|FG002|Overall Study|Enrolled but not treated|1|||
44569102|NCT02759120|79589508|FG000|Overall Study|Lost to Follow-up|4|||
44569103|NCT02759120|79589509|FG001|Overall Study|Lost to Follow-up|7|||
44569104|NCT02759120|79589508|FG000|Overall Study|Physician Decision|3|||
44569105|NCT02759120|79589509|FG001|Overall Study|Physician Decision|0|||
44569106|NCT02759120|79589508|FG000|Overall Study|Withdrawal by Subject|28|||
44236400|NCT02365597|79061112|FG003|Overall Study|Enrolled but not treated|0|||
44236401|NCT02365597|79061109|FG000|Overall Study|Ongoing|0|||
44236402|NCT02365597|79061110|FG001|Overall Study|Ongoing|0|||
44236403|NCT02365597|79061111|FG002|Overall Study|Ongoing|0|||
44569107|NCT02759120|79589509|FG001|Overall Study|Withdrawal by Subject|15|||
44569108|NCT02759120|79589508|FG000|Overall Study|Moved out of area|3|||
44569109|NCT02759120|79589509|FG001|Overall Study|Moved out of area|4|||
44569110|NCT02759120|79589508|FG000|Overall Study|Lung transplant|3|||
44569111|NCT02759120|79589509|FG001|Overall Study|Lung transplant|5|||
44569112|NCT02759120|79589508|FG000|Overall Study|Other reason not completed|10|||
44569113|NCT02759120|79589509|FG001|Overall Study|Other reason not completed|12|||
44569114|NCT00101192|79589528|FG000|Overall Study|Ineligible|6|||
44569115|NCT00101192|79589528|FG000|Overall Study|Inevaluable|1|||
44569116|NCT03031431|79589532|FG000|Overall Study|Infant removed by maternal request|1|||
44569117|NCT03029247|79589538|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
44569118|NCT03029247|79589539|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
44569119|NCT03029247|79589538|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
44569120|NCT03029247|79589539|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
44569121|NCT03029247|79589538|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
44569122|NCT03029247|79589539|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
44503699|NCT00363545|79508588|FG001|Overall Study|Serious Adverse Event|1|||
44503700|NCT00363545|79508587|FG000|Overall Study|Withdrawal by Subject|12|||
44503701|NCT00363545|79508588|FG001|Overall Study|Withdrawal by Subject|15|||
44569123|NCT03029247|79589538|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
44569124|NCT03029247|79589539|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
44569125|NCT04313283|79589545|FG000|Overall Study|did not complete intervention|4|||
44569126|NCT02754440|79589553|FG000|Overall Study|Protocol Violation|3|||
44569127|NCT02754440|79589554|FG001|Overall Study|Protocol Violation|2|||
44569128|NCT02754440|79589555|FG002|Overall Study|Protocol Violation|2|||
44569129|NCT02754440|79589556|FG003|Overall Study|Protocol Violation|6|||
44569130|NCT02754440|79589553|FG000|Overall Study|Adverse Event|3|||
44569131|NCT02754440|79589554|FG001|Overall Study|Adverse Event|1|||
44569132|NCT02754440|79589555|FG002|Overall Study|Adverse Event|0|||
44503702|NCT00363545|79508587|FG000|Overall Study|Migrated/moved from study area|3|||
44503703|NCT00363545|79508588|FG001|Overall Study|Migrated/moved from study area|6|||
44236404|NCT02365597|79061112|FG003|Overall Study|Ongoing|17|||
44377702|NCT00786409|79383011|FG000|Overall Study|Pregnancy|2|||
44503704|NCT00363545|79508587|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
44503705|NCT00363545|79508588|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
44503706|NCT00363545|79508587|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
44503707|NCT00363545|79508588|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
44503708|NCT00363545|79508587|FG000|Overall Study|Others|1|||
44503709|NCT00363545|79508588|FG001|Overall Study|Others|0|||
44503710|NCT03351244|79508597|FG000|Overall Study|Adverse Event|7|||
44503711|NCT03351244|79508598|FG001|Overall Study|Adverse Event|11|||
44503712|NCT03351244|79508599|FG002|Overall Study|Adverse Event|12|||
44503713|NCT03351244|79508597|FG000|Overall Study|Investigator's decision|0|||
44503714|NCT03351244|79508598|FG001|Overall Study|Investigator's decision|0|||
44503715|NCT03351244|79508599|FG002|Overall Study|Investigator's decision|2|||
44569133|NCT02754440|79589556|FG003|Overall Study|Adverse Event|9|||
44569134|NCT02754440|79589553|FG000|Overall Study|Withdrawal by Subject|0|||
44569135|NCT02754440|79589554|FG001|Overall Study|Withdrawal by Subject|0|||
44569136|NCT02754440|79589555|FG002|Overall Study|Withdrawal by Subject|0|||
44569137|NCT02754440|79589556|FG003|Overall Study|Withdrawal by Subject|1|||
44569138|NCT02754440|79589553|FG000|Overall Study|Equipment failure|0|||
44569139|NCT02754440|79589554|FG001|Overall Study|Equipment failure|5|||
44569140|NCT02754440|79589555|FG002|Overall Study|Equipment failure|5|||
44236405|NCT02220894|79061129|FG000|Overall Study|Adverse Event|127|||
44377703|NCT00786409|79383011|FG000|Overall Study|Lost to Follow-up|1|||
44503716|NCT03351244|79508597|FG000|Overall Study|System error|0|||
44503717|NCT03351244|79508598|FG001|Overall Study|System error|0|||
44503718|NCT03351244|79508599|FG002|Overall Study|System error|2|||
44503719|NCT03351244|79508597|FG000|Overall Study|COVID-19 restrictions|3|||
44503720|NCT03351244|79508598|FG001|Overall Study|COVID-19 restrictions|0|||
44503721|NCT03351244|79508599|FG002|Overall Study|COVID-19 restrictions|1|||
44569141|NCT02754440|79589556|FG003|Overall Study|Equipment failure|7|||
44569142|NCT02754440|79589553|FG000|Overall Study|Subject issues not resulting in AE|0|||
44503722|NCT03351244|79508597|FG000|Overall Study|Non-compliance|2|||
44503723|NCT03351244|79508598|FG001|Overall Study|Non-compliance|5|||
44503724|NCT03351244|79508599|FG002|Overall Study|Non-compliance|0|||
44503725|NCT03351244|79508597|FG000|Overall Study|Withdrawal by Subject|11|||
44503726|NCT03351244|79508598|FG001|Overall Study|Withdrawal by Subject|16|||
44503727|NCT03351244|79508599|FG002|Overall Study|Withdrawal by Subject|13|||
44503728|NCT03351244|79508597|FG000|Overall Study|Lost to Follow-up|2|||
44569143|NCT02754440|79589554|FG001|Overall Study|Subject issues not resulting in AE|0|||
44569144|NCT02754440|79589555|FG002|Overall Study|Subject issues not resulting in AE|0|||
44569145|NCT02754440|79589556|FG003|Overall Study|Subject issues not resulting in AE|12|||
44569146|NCT02753816|79589568|FG000|Overall Study|Protocol Violation|0|||
44569147|NCT02753816|79589569|FG001|Overall Study|Protocol Violation|1|||
44569148|NCT02753816|79589570|FG002|Overall Study|Protocol Violation|0|||
44569149|NCT02752802|79589578|FG000|Overall Study|Contrast Volume Not Collected|1|||
44569150|NCT02752802|79589579|FG001|Overall Study|Contrast Volume Not Collected|0|||
44569151|NCT02756078|79589596|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
44569152|NCT02756078|79589597|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
44569153|NCT02756078|79589596|FG000|Period 1|Lost to Follow-up|0|||
44569154|NCT02756078|79589597|FG001|Period 1|Lost to Follow-up|2|||
44569155|NCT02756078|79589596|FG000|Period 1|Protocol Violation|0|||
44569156|NCT02756078|79589597|FG001|Period 1|Protocol Violation|1|||
44569157|NCT02756078|79589596|FG000|Period 1|Adverse Event|1|||
44569158|NCT02756078|79589597|FG001|Period 1|Adverse Event|10|||
44569159|NCT02756078|79589596|FG000|Period 1|Withdrawal by Subject|6|||
44569160|NCT02756078|79589597|FG001|Period 1|Withdrawal by Subject|6|||
44569161|NCT02756078|79589596|FG000|Period 1|Lens Discomfort|2|||
44569162|NCT02756078|79589597|FG001|Period 1|Lens Discomfort|2|||
44569163|NCT02756078|79589596|FG000|Period 2|Adverse Event|3|||
44569164|NCT02756078|79589597|FG001|Period 2|Adverse Event|5|||
44569165|NCT02756078|79589596|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
44569166|NCT02756078|79589597|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
44569167|NCT02756078|79589596|FG000|Period 2|Withdrawal by Subject|3|||
44569168|NCT02756078|79589597|FG001|Period 2|Withdrawal by Subject|1|||
44569169|NCT02752958|79589603|FG000|Overall Study|Adverse Event|3|||
44569170|NCT02752958|79589603|FG000|Overall Study|Lost to Follow-up|1|||
44569171|NCT02752958|79589603|FG000|Overall Study|Protocol Violation|1|||
44569172|NCT02752958|79589603|FG000|Overall Study|Withdrawal by Subject|2|||
44569173|NCT02752958|79589603|FG000|Overall Study|Other (Reason not specified)|2|||
44569174|NCT02805660|79589616|FG000|Overall Study|Death|5|||
44569175|NCT02805660|79589617|FG001|Overall Study|Death|2|||
44569176|NCT02805660|79589618|FG002|Overall Study|Death|9|||
44236406|NCT02220894|79061130|FG001|Overall Study|Adverse Event|74|||
44503729|NCT03351244|79508598|FG001|Overall Study|Lost to Follow-up|6|||
44503730|NCT03351244|79508599|FG002|Overall Study|Lost to Follow-up|4|||
44503731|NCT03351244|79508597|FG000|Overall Study|Protocol Violation|2|||
44503732|NCT03351244|79508598|FG001|Overall Study|Protocol Violation|2|||
44503733|NCT03351244|79508599|FG002|Overall Study|Protocol Violation|0|||
44569177|NCT02805660|79589619|FG003|Overall Study|Death|5|||
44569178|NCT02805660|79589620|FG004|Overall Study|Death|0|||
44569179|NCT02805660|79589621|FG005|Overall Study|Death|14|||
44569180|NCT02805660|79589622|FG006|Overall Study|Death|12|||
44569181|NCT02805660|79589616|FG000|Overall Study|Lost to Follow-up|0|||
44569182|NCT02805660|79589617|FG001|Overall Study|Lost to Follow-up|1|||
44569183|NCT02805660|79589618|FG002|Overall Study|Lost to Follow-up|1|||
44569184|NCT02805660|79589619|FG003|Overall Study|Lost to Follow-up|2|||
44569185|NCT02805660|79589620|FG004|Overall Study|Lost to Follow-up|0|||
44569186|NCT02805660|79589621|FG005|Overall Study|Lost to Follow-up|0|||
44569187|NCT02805660|79589622|FG006|Overall Study|Lost to Follow-up|0|||
44569188|NCT02805660|79589616|FG000|Overall Study|Withdrawal by Subject|0|||
44569189|NCT02805660|79589617|FG001|Overall Study|Withdrawal by Subject|0|||
44569190|NCT02805660|79589618|FG002|Overall Study|Withdrawal by Subject|0|||
44569191|NCT02805660|79589619|FG003|Overall Study|Withdrawal by Subject|3|||
44569192|NCT02805660|79589620|FG004|Overall Study|Withdrawal by Subject|1|||
44569193|NCT02805660|79589621|FG005|Overall Study|Withdrawal by Subject|0|||
44569194|NCT02805660|79589622|FG006|Overall Study|Withdrawal by Subject|2|||
44569195|NCT02805660|79589616|FG000|Overall Study|Study terminated by Sponsor|0|||
44569196|NCT02805660|79589617|FG001|Overall Study|Study terminated by Sponsor|0|||
44569197|NCT02805660|79589618|FG002|Overall Study|Study terminated by Sponsor|1|||
44569198|NCT02805660|79589619|FG003|Overall Study|Study terminated by Sponsor|4|||
44569199|NCT02805660|79589620|FG004|Overall Study|Study terminated by Sponsor|2|||
44569200|NCT02805660|79589621|FG005|Overall Study|Study terminated by Sponsor|3|||
44569201|NCT02805660|79589622|FG006|Overall Study|Study terminated by Sponsor|1|||
44569202|NCT02805660|79589616|FG000|Overall Study|Miscellaneous|0|||
44569203|NCT02805660|79589617|FG001|Overall Study|Miscellaneous|1|||
44569204|NCT02805660|79589618|FG002|Overall Study|Miscellaneous|0|||
44569205|NCT02805660|79589619|FG003|Overall Study|Miscellaneous|4|||
44569206|NCT02805660|79589620|FG004|Overall Study|Miscellaneous|0|||
44569207|NCT02805660|79589621|FG005|Overall Study|Miscellaneous|6|||
44569208|NCT02805660|79589622|FG006|Overall Study|Miscellaneous|4|||
44569209|NCT02807376|79589653|FG000|Overall Study|Intra-operative exclusion criteria|3|||
44569210|NCT02807376|79589654|FG001|Overall Study|Intra-operative exclusion criteria|0|||
44569211|NCT02807376|79589653|FG000|Overall Study|Lost to Follow-up|0|||
44569212|NCT02807376|79589654|FG001|Overall Study|Lost to Follow-up|1|||
44569213|NCT02804178|79589660|FG000|Overall Study|Adverse Event|1|||
44569214|NCT02917941|79589664|FG000|Treatment Period|Adverse Event|11|||
44569215|NCT02917941|79589664|FG000|Treatment Period|Progressive Disease|11|||
44569216|NCT02917941|79589664|FG000|Treatment Period|Reason not Specified|2|||
44569217|NCT02917941|79589664|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
44569218|NCT02917941|79589664|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
44569219|NCT01333956|79589672|FG000|Overall Study|Lost to Follow-up|1|||
44569220|NCT01333956|79589673|FG001|Overall Study|Lost to Follow-up|2|||
44569221|NCT01333956|79589674|FG002|Overall Study|Lost to Follow-up|0|||
44569222|NCT01333956|79589675|FG003|Overall Study|Lost to Follow-up|1|||
44569223|NCT01333956|79589672|FG000|Overall Study|Unable to complete study procedure|1|||
44569224|NCT01333956|79589673|FG001|Overall Study|Unable to complete study procedure|0|||
44569225|NCT01333956|79589674|FG002|Overall Study|Unable to complete study procedure|0|||
44569226|NCT01333956|79589675|FG003|Overall Study|Unable to complete study procedure|1|||
44569227|NCT01333956|79589672|FG000|Overall Study|Withdrawal by Subject|0|||
44236407|NCT02220894|79061129|FG000|Overall Study|Death|418|||
44236408|NCT02220894|79061130|FG001|Overall Study|Death|508|||
44236409|NCT02220894|79061129|FG000|Overall Study|Lost to Follow-up|0|||
44236410|NCT02220894|79061130|FG001|Overall Study|Lost to Follow-up|4|||
44236411|NCT02220894|79061129|FG000|Overall Study|Site Terminated by Sponsor|2|||
44236412|NCT02220894|79061130|FG001|Overall Study|Site Terminated by Sponsor|0|||
44236413|NCT02220894|79061129|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
44236414|NCT02220894|79061130|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
44236415|NCT02220894|79061129|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44236416|NCT02220894|79061130|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44236417|NCT02220894|79061129|FG000|Overall Study|Withdrawal by Subject|10|||
44236418|NCT02220894|79061130|FG001|Overall Study|Withdrawal by Subject|9|||
44569228|NCT01333956|79589673|FG001|Overall Study|Withdrawal by Subject|2|||
44569229|NCT01333956|79589674|FG002|Overall Study|Withdrawal by Subject|1|||
44569230|NCT01333956|79589675|FG003|Overall Study|Withdrawal by Subject|0|||
44569231|NCT01333722|79589688|FG000|Overall Study|Lack of Efficacy|0|||
44569232|NCT01333722|79589689|FG001|Overall Study|Lack of Efficacy|2|||
44569233|NCT01333722|79589688|FG000|Overall Study|Withdrawal by Subject|0|||
44236419|NCT02068092|79061137|FG000|Overall Study|Physician Decision|2|||
44569234|NCT01333722|79589689|FG001|Overall Study|Withdrawal by Subject|1|||
44236420|NCT02068092|79061137|FG000|Overall Study|Adverse Event|2|||
44236421|NCT02068092|79061137|FG000|Overall Study|Lost to Follow-up|4|||
44569235|NCT01370694|79589697|FG000|Overall Study|Switched to rituximab|4|||
44569236|NCT01370694|79589697|FG000|Overall Study|Progressive disease|2|||
44569237|NCT03315143|79589703|FG000|Overall Study|Death|240|||
44569238|NCT03315143|79589704|FG001|Overall Study|Death|246|||
44569239|NCT03315143|79589703|FG000|Overall Study|Withdrawal by Subject|57|||
44569240|NCT03315143|79589704|FG001|Overall Study|Withdrawal by Subject|68|||
44569241|NCT03315143|79589703|FG000|Overall Study|Site Terminated by Sponsor|256|||
44569242|NCT03315143|79589704|FG001|Overall Study|Site Terminated by Sponsor|282|||
44569243|NCT03315143|79589703|FG000|Overall Study|Study Terminated by Sponsor|4723|||
44569244|NCT03315143|79589704|FG001|Overall Study|Study Terminated by Sponsor|4664|||
44569245|NCT03315143|79589703|FG000|Overall Study|Reason not Specified|16|||
44569246|NCT03315143|79589704|FG001|Overall Study|Reason not Specified|32|||
44569247|NCT02797080|79589710|FG000|Overall Study|Lost to Follow-up|1|||
44569248|NCT02797080|79589710|FG000|Overall Study|Withdrawal by Subject|1|||
44569249|NCT02915835|79589716|FG000|Overall Study|Physician Decision|1|||
44569250|NCT02915835|79589717|FG001|Overall Study|Physician Decision|0|||
44569251|NCT02915835|79589716|FG000|Overall Study|Withdrawal by Subject|0|||
44569252|NCT02915835|79589717|FG001|Overall Study|Withdrawal by Subject|1|||
44569253|NCT01370616|79589725|FG000|Overall Study|Adverse Event|11|||
44569254|NCT01370616|79589726|FG001|Overall Study|Adverse Event|16|||
44569255|NCT01370616|79589725|FG000|Overall Study|Death|1|||
44236422|NCT02068092|79061137|FG000|Overall Study|Withdrawal by Subject|2|||
44569256|NCT01370616|79589726|FG001|Overall Study|Death|0|||
44569257|NCT01370616|79589725|FG000|Overall Study|Lack of Efficacy|6|||
44569258|NCT01370616|79589726|FG001|Overall Study|Lack of Efficacy|2|||
44569259|NCT01370616|79589725|FG000|Overall Study|Lost to Follow-up|0|||
44569260|NCT01370616|79589726|FG001|Overall Study|Lost to Follow-up|3|||
44569261|NCT01370616|79589725|FG000|Overall Study|Physician Decision|6|||
44569262|NCT01370616|79589726|FG001|Overall Study|Physician Decision|6|||
44569263|NCT01370616|79589725|FG000|Overall Study|Progressive Disease|0|||
44569264|NCT01370616|79589726|FG001|Overall Study|Progressive Disease|1|||
44569265|NCT01370616|79589725|FG000|Overall Study|Recovery|1|||
44569266|NCT01370616|79589726|FG001|Overall Study|Recovery|0|||
44569267|NCT01370616|79589725|FG000|Overall Study|Technical Problems|3|||
44569268|NCT01370616|79589726|FG001|Overall Study|Technical Problems|5|||
44569269|NCT01370616|79589725|FG000|Overall Study|Withdrawal by Subject|34|||
44569270|NCT01370616|79589726|FG001|Overall Study|Withdrawal by Subject|34|||
44569271|NCT02916927|79589739|FG000|Overall Study|Discharged prior to study drug receipt|0|||
44569272|NCT02916927|79589740|FG001|Overall Study|Discharged prior to study drug receipt|2|||
44569273|NCT02916927|79589739|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
44569274|NCT02916927|79589740|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
44569275|NCT02916927|79589739|FG000|Overall Study|Withdrawal before first time point|1|||
44569276|NCT02916927|79589740|FG001|Overall Study|Withdrawal before first time point|0|||
44569277|NCT02916693|79589746|FG000|Overall Study|Lost to Follow-up|7|||
44569278|NCT02574455|79589756|FG000|Overall Study|Death|197|||
44569279|NCT02574455|79589757|FG001|Overall Study|Death|210|||
44569280|NCT02574455|79589756|FG000|Overall Study|Withdrawal of Consent|11|||
44569281|NCT02574455|79589757|FG001|Overall Study|Withdrawal of Consent|28|||
44569282|NCT02574455|79589756|FG000|Overall Study|Lost to Follow-up|4|||
44569283|NCT02574455|79589757|FG001|Overall Study|Lost to Follow-up|4|||
44569284|NCT02574455|79589756|FG000|Overall Study|Sponsor's Decision|55|||
44569285|NCT02574455|79589757|FG001|Overall Study|Sponsor's Decision|20|||
44569286|NCT02795832|79589769|FG000|Overall Study|Adverse Event|0|||
44569287|NCT02795832|79589770|FG001|Overall Study|Adverse Event|0|||
44569288|NCT02795832|79589771|FG002|Overall Study|Adverse Event|0|||
44569289|NCT02795832|79589772|FG003|Overall Study|Adverse Event|0|||
44569290|NCT02795832|79589773|FG004|Overall Study|Adverse Event|0|||
44236423|NCT01959672|79061141|FG000|Overall Study|Death|1|||
44569291|NCT02795832|79589774|FG005|Overall Study|Adverse Event|3|||
44569292|NCT02794974|79589798|FG000|Overall Study|Physician Decision|0|||
44569293|NCT02794974|79589799|FG001|Overall Study|Physician Decision|1|||
44569294|NCT02419417|79589816|FG000|Overall Study|Disease progression|5|||
44569295|NCT02419417|79589817|FG001|Overall Study|Disease progression|4|||
44569296|NCT02419417|79589818|FG002|Overall Study|Disease progression|13|||
44569297|NCT02419417|79589819|FG003|Overall Study|Disease progression|10|||
44569298|NCT02419417|79589820|FG004|Overall Study|Disease progression|10|||
44569299|NCT02419417|79589821|FG005|Overall Study|Disease progression|3|||
44569300|NCT02419417|79589822|FG006|Overall Study|Disease progression|4|||
44569301|NCT02419417|79589823|FG007|Overall Study|Disease progression|5|||
44569302|NCT02419417|79589824|FG008|Overall Study|Disease progression|13|||
44569303|NCT02419417|79589825|FG009|Overall Study|Disease progression|9|||
44569304|NCT02419417|79589826|FG010|Overall Study|Disease progression|0|||
44569305|NCT02419417|79589816|FG000|Overall Study|Study drug toxicity|0|||
44569306|NCT02419417|79589817|FG001|Overall Study|Study drug toxicity|0|||
44569307|NCT02419417|79589818|FG002|Overall Study|Study drug toxicity|0|||
44569308|NCT02419417|79589819|FG003|Overall Study|Study drug toxicity|0|||
44569309|NCT02419417|79589820|FG004|Overall Study|Study drug toxicity|1|||
44569310|NCT02419417|79589821|FG005|Overall Study|Study drug toxicity|0|||
44569311|NCT02419417|79589822|FG006|Overall Study|Study drug toxicity|0|||
44569312|NCT02419417|79589823|FG007|Overall Study|Study drug toxicity|0|||
44569313|NCT02419417|79589824|FG008|Overall Study|Study drug toxicity|0|||
44569314|NCT02419417|79589825|FG009|Overall Study|Study drug toxicity|0|||
44569315|NCT02419417|79589826|FG010|Overall Study|Study drug toxicity|0|||
44569316|NCT02419417|79589816|FG000|Overall Study|Adverse event unrelated to study drug|0|||
44569317|NCT02419417|79589817|FG001|Overall Study|Adverse event unrelated to study drug|0|||
44569318|NCT02419417|79589818|FG002|Overall Study|Adverse event unrelated to study drug|0|||
44569319|NCT02419417|79589819|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44569320|NCT02419417|79589820|FG004|Overall Study|Adverse event unrelated to study drug|2|||
44569321|NCT02419417|79589821|FG005|Overall Study|Adverse event unrelated to study drug|1|||
44569322|NCT02419417|79589822|FG006|Overall Study|Adverse event unrelated to study drug|0|||
44569323|NCT02419417|79589823|FG007|Overall Study|Adverse event unrelated to study drug|1|||
44569324|NCT02419417|79589824|FG008|Overall Study|Adverse event unrelated to study drug|0|||
44569325|NCT02419417|79589825|FG009|Overall Study|Adverse event unrelated to study drug|0|||
44569326|NCT02419417|79589826|FG010|Overall Study|Adverse event unrelated to study drug|0|||
44569327|NCT02419417|79589816|FG000|Overall Study|Participant request to discontinue|0|||
44569328|NCT02419417|79589817|FG001|Overall Study|Participant request to discontinue|0|||
44569329|NCT02419417|79589818|FG002|Overall Study|Participant request to discontinue|0|||
44569330|NCT02419417|79589819|FG003|Overall Study|Participant request to discontinue|0|||
44569331|NCT02419417|79589820|FG004|Overall Study|Participant request to discontinue|0|||
44569332|NCT02419417|79589821|FG005|Overall Study|Participant request to discontinue|0|||
44569333|NCT02419417|79589822|FG006|Overall Study|Participant request to discontinue|0|||
44569334|NCT02419417|79589823|FG007|Overall Study|Participant request to discontinue|0|||
44569335|NCT02419417|79589824|FG008|Overall Study|Participant request to discontinue|0|||
44236424|NCT00071760|79061169|FG000|Overall Study|Adverse Event|2|||
44569336|NCT02419417|79589825|FG009|Overall Study|Participant request to discontinue|1|||
44569337|NCT02419417|79589826|FG010|Overall Study|Participant request to discontinue|0|||
44569338|NCT02419417|79589816|FG000|Overall Study|Withdrawal by Subject|0|||
44569339|NCT02419417|79589817|FG001|Overall Study|Withdrawal by Subject|0|||
44569340|NCT02419417|79589818|FG002|Overall Study|Withdrawal by Subject|0|||
44569341|NCT02419417|79589819|FG003|Overall Study|Withdrawal by Subject|0|||
44569342|NCT02419417|79589820|FG004|Overall Study|Withdrawal by Subject|0|||
44569343|NCT02419417|79589821|FG005|Overall Study|Withdrawal by Subject|0|||
44569344|NCT02419417|79589822|FG006|Overall Study|Withdrawal by Subject|0|||
44236425|NCT00071760|79061170|FG001|Overall Study|Adverse Event|1|||
44236426|NCT00071760|79061169|FG000|Overall Study|Lost to Follow-up|0|||
44236427|NCT00071760|79061170|FG001|Overall Study|Lost to Follow-up|3|||
44236428|NCT00071760|79061169|FG000|Overall Study|Protocol Violation|1|||
44503734|NCT03386032|79508612|FG000|Overall Study|Lack of Efficacy|6|||
44503735|NCT03386032|79508613|FG001|Overall Study|Lack of Efficacy|2|||
44503736|NCT03386032|79508614|FG002|Overall Study|Lack of Efficacy|0|||
44503737|NCT03386032|79508612|FG000|Overall Study|Adverse Event|2|||
44503738|NCT03386032|79508613|FG001|Overall Study|Adverse Event|2|||
44503739|NCT03386032|79508614|FG002|Overall Study|Adverse Event|0|||
44503740|NCT03386032|79508612|FG000|Overall Study|Withdrawal by Subject|1|||
44503741|NCT03386032|79508613|FG001|Overall Study|Withdrawal by Subject|0|||
44503742|NCT03386032|79508614|FG002|Overall Study|Withdrawal by Subject|0|||
44503743|NCT03386032|79508612|FG000|Overall Study|Lost to Follow-up|9|||
44503744|NCT03386032|79508613|FG001|Overall Study|Lost to Follow-up|3|||
44503745|NCT03386032|79508614|FG002|Overall Study|Lost to Follow-up|0|||
44503746|NCT00077610|79508625|FG000|Overall Study|Adverse Event|9|||
44503747|NCT00077610|79508626|FG001|Overall Study|Adverse Event|7|||
44503748|NCT00077610|79508627|FG002|Overall Study|Adverse Event|1|||
44569345|NCT02419417|79589823|FG007|Overall Study|Withdrawal by Subject|0|||
44503749|NCT00077610|79508625|FG000|Overall Study|Lost to Follow-up|0|||
44503750|NCT00077610|79508626|FG001|Overall Study|Lost to Follow-up|1|||
44569346|NCT02419417|79589824|FG008|Overall Study|Withdrawal by Subject|0|||
44569347|NCT02419417|79589825|FG009|Overall Study|Withdrawal by Subject|0|||
44569348|NCT02419417|79589826|FG010|Overall Study|Withdrawal by Subject|1|||
44503751|NCT00077610|79508627|FG002|Overall Study|Lost to Follow-up|2|||
44569349|NCT00777491|79589867|FG000|Overall Study|Protocol Violation|0|||
44569350|NCT00777491|79589868|FG001|Overall Study|Protocol Violation|2|||
44569351|NCT00777491|79589867|FG000|Overall Study|Did not receive any protocol treatment|2|||
44569352|NCT00777491|79589868|FG001|Overall Study|Did not receive any protocol treatment|0|||
44569353|NCT02066532|79589878|FG000|Phase II|Withdrawal by Subject|1|||
44569354|NCT02066532|79589879|FG001|Phase II|Withdrawal by Subject|0|||
44569355|NCT02066532|79589880|FG002|Phase II|Withdrawal by Subject|0|||
44569356|NCT02066532|79589881|FG003|Phase II|Withdrawal by Subject|0|||
44569357|NCT03077711|79589888|FG000|Overall Study|Lost to Follow-up|2|||
44236429|NCT00071760|79061170|FG001|Overall Study|Protocol Violation|0|||
44236430|NCT00071760|79061169|FG000|Overall Study|Withdrawal by Subject|0|||
44236431|NCT00071760|79061170|FG001|Overall Study|Withdrawal by Subject|1|||
44236432|NCT00071760|79061169|FG000|Overall Study|Insufficient Viral Load Response|1|||
44236433|NCT00071760|79061170|FG001|Overall Study|Insufficient Viral Load Response|1|||
44236434|NCT00071760|79061169|FG000|Overall Study|Lack of availability of RTV|1|||
44569358|NCT03077711|79589889|FG001|Overall Study|Lost to Follow-up|2|||
44569359|NCT03077711|79589888|FG000|Overall Study|noncompliant taking medication|2|||
44569360|NCT03077711|79589889|FG001|Overall Study|noncompliant taking medication|0|||
44569361|NCT04311463|79589916|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
44569362|NCT04311463|79589917|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
44569363|NCT04311463|79589916|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
44569364|NCT04311463|79589917|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
44569365|NCT04311463|79589916|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
44569366|NCT04311463|79589917|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
44569367|NCT01370538|79589930|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
44569368|NCT01370538|79589931|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
44569369|NCT01370538|79589930|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44569370|NCT01370538|79589931|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44569371|NCT01370538|79589930|FG000|Overall Study|Adverse Event|1|||
44569372|NCT01370538|79589931|FG001|Overall Study|Adverse Event|0|||
44569373|NCT01370538|79589930|FG000|Overall Study|Protocol Violation|8|||
44569374|NCT01370538|79589931|FG001|Overall Study|Protocol Violation|5|||
44569375|NCT01370538|79589930|FG000|Overall Study|Development of study specific withdrawal|1|||
44569376|NCT01370538|79589931|FG001|Overall Study|Development of study specific withdrawal|1|||
44569377|NCT01370538|79589930|FG000|Overall Study|Lost to follow up|6|||
44569378|NCT01370538|79589931|FG001|Overall Study|Lost to follow up|10|||
44569379|NCT03402841|79589950|FG000|Overall Study|Withdrawal by Subject|3|||
44569380|NCT03402841|79589950|FG000|Overall Study|Lost to Follow-up|2|||
44503752|NCT00077610|79508625|FG000|Overall Study|Withdrawal by Subject|4|||
44503753|NCT00077610|79508626|FG001|Overall Study|Withdrawal by Subject|10|||
44503754|NCT00077610|79508627|FG002|Overall Study|Withdrawal by Subject|6|||
44503755|NCT00077610|79508625|FG000|Overall Study|Death|17|||
44503756|NCT00077610|79508626|FG001|Overall Study|Death|13|||
44503757|NCT00077610|79508627|FG002|Overall Study|Death|13|||
44503758|NCT00077610|79508625|FG000|Overall Study|Renal transplant|12|||
44503759|NCT00077610|79508626|FG001|Overall Study|Renal transplant|15|||
44503760|NCT00077610|79508627|FG002|Overall Study|Renal transplant|11|||
44503761|NCT00077610|79508625|FG000|Overall Study|Withdrew from dialysis care|5|||
44503762|NCT00077610|79508626|FG001|Overall Study|Withdrew from dialysis care|0|||
44503763|NCT00077610|79508627|FG002|Overall Study|Withdrew from dialysis care|3|||
44503764|NCT00077610|79508625|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44503765|NCT00077610|79508626|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44503766|NCT00077610|79508627|FG002|Overall Study|Insufficient Therapeutic Response|0|||
44503767|NCT00077610|79508625|FG000|Overall Study|Multiple blood transfusions|0|||
44503768|NCT00077610|79508626|FG001|Overall Study|Multiple blood transfusions|0|||
44503769|NCT00077610|79508627|FG002|Overall Study|Multiple blood transfusions|1|||
44503770|NCT00077610|79508625|FG000|Overall Study|Principal Investigator's decision|1|||
44503771|NCT00077610|79508626|FG001|Overall Study|Principal Investigator's decision|0|||
44503772|NCT00077610|79508627|FG002|Overall Study|Principal Investigator's decision|1|||
44503773|NCT00077610|79508625|FG000|Overall Study|Worsening of health condition|1|||
44503774|NCT00077610|79508626|FG001|Overall Study|Worsening of health condition|1|||
44503775|NCT00077610|79508627|FG002|Overall Study|Worsening of health condition|0|||
44503776|NCT00077610|79508625|FG000|Overall Study|Given Epogen in hospital|1|||
44503777|NCT00077610|79508626|FG001|Overall Study|Given Epogen in hospital|0|||
44503778|NCT00077610|79508627|FG002|Overall Study|Given Epogen in hospital|0|||
44503779|NCT00077610|79508625|FG000|Overall Study|Transferred to other unit|0|||
44503780|NCT00077610|79508626|FG001|Overall Study|Transferred to other unit|0|||
44503781|NCT00077610|79508627|FG002|Overall Study|Transferred to other unit|1|||
44503782|NCT00077610|79508625|FG000|Overall Study|Transferred to nursing home|0|||
44503783|NCT00077610|79508626|FG001|Overall Study|Transferred to nursing home|0|||
44569381|NCT03402841|79589950|FG000|Overall Study|Death|146|||
44569382|NCT02881957|79589965|FG000|Overall Study|Comfort care|0|||
44569383|NCT02881957|79589966|FG001|Overall Study|Comfort care|1|||
44569384|NCT02881957|79589965|FG000|Overall Study|Concurrent trial enrollment|0|||
44569385|NCT02881957|79589966|FG001|Overall Study|Concurrent trial enrollment|1|||
44569386|NCT02881957|79589965|FG000|Overall Study|Discharged within 48 hours|0|||
44569387|NCT02881957|79589966|FG001|Overall Study|Discharged within 48 hours|1|||
44569388|NCT02881957|79589965|FG000|Overall Study|Withdrawal by Subject|2|||
44569389|NCT02881957|79589966|FG001|Overall Study|Withdrawal by Subject|1|||
44569390|NCT02881957|79589965|FG000|Overall Study|Protocol Violation|1|||
44569391|NCT02881957|79589966|FG001|Overall Study|Protocol Violation|0|||
44569392|NCT03022461|79589972|FG000|Overall Study|Death|3|||
44569393|NCT02750930|79589977|FG000|Overall Study|Study closed/terminated|8|||
44569394|NCT03078907|79589983|FG000|Overall Study|Adverse Event|2|||
44569395|NCT03078907|79589984|FG001|Overall Study|Adverse Event|0|||
44569396|NCT03078907|79589983|FG000|Overall Study|Other|1|||
44569397|NCT03078907|79589984|FG001|Overall Study|Other|0|||
44569398|NCT03078907|79589983|FG000|Overall Study|Protocol Violation|0|||
44569399|NCT03078907|79589984|FG001|Overall Study|Protocol Violation|1|||
44569400|NCT03249714|79589992|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
44377704|NCT00919854|79383015|FG000|Overall Study|Adverse Event|1|||
44377705|NCT00891735|79383023|FG000|Overall Study|Adverse Event|2|||
44503784|NCT00077610|79508627|FG002|Overall Study|Transferred to nursing home|1|||
44569401|NCT03249714|79589993|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
44569402|NCT03249714|79589992|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
44569403|NCT03249714|79589993|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
44569404|NCT03249714|79589992|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
44569405|NCT03249714|79589993|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
44569406|NCT03249714|79589992|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
44569407|NCT03249714|79589993|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
44569408|NCT02925117|79590019|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
44569409|NCT02925117|79590020|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
44569410|NCT02925117|79590021|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
44569411|NCT02925117|79590022|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
44569412|NCT02925117|79590023|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44569413|NCT02925117|79590024|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44569414|NCT02925117|79590025|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44236435|NCT00071760|79061170|FG001|Overall Study|Lack of availability of RTV|0|||
44236436|NCT00071760|79061169|FG000|Overall Study|Physician Decision|2|||
44236437|NCT00071760|79061170|FG001|Overall Study|Physician Decision|1|||
44236438|NCT00071760|79061169|FG000|Overall Study|Relocation|0|||
44236439|NCT00071760|79061170|FG001|Overall Study|Relocation|1|||
44236440|NCT05327816|79061215|FG000|Overall Study|Lost to Follow-up|1|||
44236441|NCT05327816|79061216|FG001|Overall Study|Lost to Follow-up|0|||
44236442|NCT05327816|79061217|FG002|Overall Study|Lost to Follow-up|0|||
44236443|NCT05327816|79061218|FG003|Overall Study|Lost to Follow-up|0|||
44236444|NCT05327816|79061219|FG004|Overall Study|Lost to Follow-up|0|||
44503785|NCT00077610|79508625|FG000|Overall Study|Transfer to satellite unit|1|||
44503786|NCT00077610|79508626|FG001|Overall Study|Transfer to satellite unit|0|||
44503787|NCT00077610|79508627|FG002|Overall Study|Transfer to satellite unit|0|||
44503788|NCT00077610|79508625|FG000|Overall Study|Transfer to other center for surgery|1|||
44503789|NCT00077610|79508626|FG001|Overall Study|Transfer to other center for surgery|0|||
44503790|NCT00077610|79508627|FG002|Overall Study|Transfer to other center for surgery|0|||
44503791|NCT00077610|79508625|FG000|Overall Study|Change in dialysis modality|1|||
44503792|NCT00077610|79508626|FG001|Overall Study|Change in dialysis modality|0|||
44569415|NCT02925117|79590026|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44236445|NCT05327816|79061220|FG005|Overall Study|Lost to Follow-up|0|||
44236446|NCT05327816|79061221|FG006|Overall Study|Lost to Follow-up|0|||
44569416|NCT02925117|79590027|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44569417|NCT02925117|79590028|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44569418|NCT02925117|79590029|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44569419|NCT02925117|79590030|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
44569420|NCT02925117|79590019|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
44569421|NCT02925117|79590020|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
44569422|NCT02925117|79590021|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
44569423|NCT02925117|79590022|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569424|NCT02925117|79590023|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569425|NCT02925117|79590024|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569426|NCT02925117|79590025|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569427|NCT02925117|79590026|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569428|NCT02925117|79590027|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569429|NCT02925117|79590028|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569430|NCT02925117|79590029|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569431|NCT02925117|79590030|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
44569432|NCT02925117|79590019|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
44569433|NCT02925117|79590020|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
44569434|NCT02925117|79590021|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569435|NCT02925117|79590022|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569436|NCT02925117|79590023|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569437|NCT02925117|79590024|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569438|NCT02925117|79590025|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569439|NCT02925117|79590026|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569440|NCT02925117|79590027|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569441|NCT02925117|79590028|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569442|NCT02925117|79590029|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569443|NCT02925117|79590030|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
44569444|NCT02925117|79590019|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
44569445|NCT02925117|79590020|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
44569446|NCT02925117|79590021|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
44569447|NCT02925117|79590022|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
44569448|NCT02925117|79590023|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
44377706|NCT00891735|79383024|FG001|Overall Study|Adverse Event|0|||
44377707|NCT00891735|79383025|FG002|Overall Study|Adverse Event|2|||
44236447|NCT05327816|79061222|FG007|Overall Study|Lost to Follow-up|0|||
44236448|NCT05327816|79061223|FG008|Overall Study|Lost to Follow-up|0|||
44236449|NCT05327816|79061224|FG009|Overall Study|Lost to Follow-up|1|||
44236450|NCT05327816|79061225|FG010|Overall Study|Lost to Follow-up|0|||
44377708|NCT00891735|79383026|FG003|Overall Study|Adverse Event|0|||
44569449|NCT02925117|79590024|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
44569450|NCT02925117|79590025|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
44569451|NCT02925117|79590026|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
44569452|NCT02925117|79590027|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
44569453|NCT02925117|79590028|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
44569454|NCT02925117|79590029|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
44236451|NCT05327816|79061215|FG000|Overall Study|Withdrawal by Subject|0|||
44569455|NCT02925117|79590030|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
44569456|NCT02925117|79590019|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569457|NCT02925117|79590020|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569458|NCT02925117|79590021|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569459|NCT02925117|79590022|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569460|NCT02925117|79590023|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569461|NCT02925117|79590024|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
44569462|NCT02925117|79590025|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569463|NCT02925117|79590026|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569464|NCT02925117|79590027|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569465|NCT02925117|79590028|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
44569466|NCT02925117|79590029|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
44569467|NCT02925117|79590030|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
44569468|NCT02925117|79590019|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
44569469|NCT02925117|79590020|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
44236452|NCT05327816|79061216|FG001|Overall Study|Withdrawal by Subject|0|||
44569470|NCT02925117|79590021|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
44569471|NCT02925117|79590022|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
44377709|NCT00891735|79383023|FG000|Overall Study|Death|8|||
44569472|NCT02925117|79590023|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
44569473|NCT02925117|79590024|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
44377710|NCT00891735|79383024|FG001|Overall Study|Death|5|||
44377711|NCT00891735|79383025|FG002|Overall Study|Death|4|||
44236453|NCT05327816|79061217|FG002|Overall Study|Withdrawal by Subject|0|||
44236454|NCT05327816|79061218|FG003|Overall Study|Withdrawal by Subject|0|||
44377712|NCT00891735|79383026|FG003|Overall Study|Death|5|||
44377713|NCT00891735|79383023|FG000|Overall Study|Lost to Follow-up|2|||
44377714|NCT00891735|79383024|FG001|Overall Study|Lost to Follow-up|2|||
44569474|NCT02925117|79590025|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
44569475|NCT02925117|79590026|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
44569476|NCT02925117|79590027|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
44569477|NCT02925117|79590028|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
44569478|NCT02925117|79590029|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
44569479|NCT02925117|79590030|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
44569480|NCT02925117|79590019|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
44569481|NCT02925117|79590020|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
44569482|NCT02925117|79590021|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
44569483|NCT02925117|79590022|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
44569484|NCT02925117|79590023|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
44569485|NCT02925117|79590024|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
44569486|NCT02925117|79590025|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
44569487|NCT02925117|79590026|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
44569488|NCT02925117|79590027|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
44569489|NCT02925117|79590028|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
44569490|NCT02925117|79590029|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
44569491|NCT02925117|79590030|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
44569492|NCT02925117|79590019|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
44569493|NCT02925117|79590020|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
44569494|NCT02925117|79590021|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
44569495|NCT02925117|79590022|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
44569496|NCT02925117|79590023|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
44569497|NCT02925117|79590024|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
44569498|NCT02925117|79590025|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
44569499|NCT02925117|79590026|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
44569500|NCT02925117|79590027|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
44569501|NCT02925117|79590028|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
44569502|NCT02925117|79590029|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
44569503|NCT02925117|79590030|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
44503793|NCT00077610|79508627|FG002|Overall Study|Change in dialysis modality|0|||
44503794|NCT00077610|79508625|FG000|Overall Study|Relocation|0|||
44503795|NCT00077610|79508626|FG001|Overall Study|Relocation|8|||
44503796|NCT00077610|79508627|FG002|Overall Study|Relocation|5|||
44503797|NCT00077610|79508625|FG000|Overall Study|Financial issues|0|||
44503798|NCT00077610|79508626|FG001|Overall Study|Financial issues|1|||
44503799|NCT00077610|79508627|FG002|Overall Study|Financial issues|0|||
44503800|NCT00077610|79508625|FG000|Overall Study|Sponsors decision to withdraw|0|||
44503801|NCT00077610|79508626|FG001|Overall Study|Sponsors decision to withdraw|0|||
44503802|NCT00077610|79508627|FG002|Overall Study|Sponsors decision to withdraw|1|||
44503803|NCT03385564|79508644|FG000|Overall Study|Adverse Event|0|||
44503804|NCT03385564|79508645|FG001|Overall Study|Adverse Event|0|||
44503805|NCT03385564|79508646|FG002|Overall Study|Adverse Event|3|||
44503806|NCT03385564|79508647|FG003|Overall Study|Adverse Event|3|||
44503807|NCT03385564|79508644|FG000|Overall Study|Other than listed|0|||
44503808|NCT03385564|79508645|FG001|Overall Study|Other than listed|0|||
44503809|NCT03385564|79508646|FG002|Overall Study|Other than listed|0|||
44503810|NCT03385564|79508647|FG003|Overall Study|Other than listed|5|||
44503811|NCT03385564|79508644|FG000|Overall Study|Withdrawal by Subject|0|||
44503812|NCT03385564|79508645|FG001|Overall Study|Withdrawal by Subject|1|||
44503813|NCT03385564|79508646|FG002|Overall Study|Withdrawal by Subject|1|||
44503814|NCT03385564|79508647|FG003|Overall Study|Withdrawal by Subject|0|||
44503815|NCT03385564|79508644|FG000|Overall Study|Lack of Efficacy|0|||
44503816|NCT03385564|79508645|FG001|Overall Study|Lack of Efficacy|0|||
44503817|NCT03385564|79508646|FG002|Overall Study|Lack of Efficacy|0|||
44569504|NCT03075163|79590054|FG000|Overall Study|not eligible for treatment limb|138|||
44569505|NCT03075163|79590055|FG001|Overall Study|not eligible for treatment limb|138|||
44503818|NCT03385564|79508647|FG003|Overall Study|Lack of Efficacy|1|||
44503819|NCT03385564|79508644|FG000|Overall Study|Death|0|||
44569506|NCT03078751|79590063|FG000|Overall Study|Adverse Event|4|||
44377715|NCT00891735|79383025|FG002|Overall Study|Lost to Follow-up|2|||
44503820|NCT03385564|79508645|FG001|Overall Study|Death|0|||
44503821|NCT03385564|79508646|FG002|Overall Study|Death|1|||
44503822|NCT03385564|79508647|FG003|Overall Study|Death|0|||
44503823|NCT00066222|79508657|FG000|Overall Study|No protocol treatment received|1|||
44503824|NCT00397943|79508666|FG000|Overall Study|Unspecified reasons|12|||
44503825|NCT00397943|79508667|FG001|Overall Study|Unspecified reasons|9|||
44503826|NCT00397943|79508668|FG002|Overall Study|Unspecified reasons|0|||
44236455|NCT05327816|79061219|FG004|Overall Study|Withdrawal by Subject|1|||
44236456|NCT05327816|79061220|FG005|Overall Study|Withdrawal by Subject|1|||
44236457|NCT05327816|79061221|FG006|Overall Study|Withdrawal by Subject|0|||
44236458|NCT05327816|79061222|FG007|Overall Study|Withdrawal by Subject|0|||
44236459|NCT05327816|79061223|FG008|Overall Study|Withdrawal by Subject|0|||
44236460|NCT05327816|79061224|FG009|Overall Study|Withdrawal by Subject|0|||
44236461|NCT05327816|79061225|FG010|Overall Study|Withdrawal by Subject|0|||
44236462|NCT05327816|79061215|FG000|Overall Study|Study Terminated by Sponsor|11|||
44236463|NCT05327816|79061216|FG001|Overall Study|Study Terminated by Sponsor|12|||
44236464|NCT05327816|79061217|FG002|Overall Study|Study Terminated by Sponsor|12|||
44236465|NCT05327816|79061218|FG003|Overall Study|Study Terminated by Sponsor|12|||
44236466|NCT05327816|79061219|FG004|Overall Study|Study Terminated by Sponsor|11|||
44236467|NCT05327816|79061220|FG005|Overall Study|Study Terminated by Sponsor|11|||
44236468|NCT05327816|79061221|FG006|Overall Study|Study Terminated by Sponsor|11|||
44236469|NCT05327816|79061222|FG007|Overall Study|Study Terminated by Sponsor|11|||
44236470|NCT05327816|79061223|FG008|Overall Study|Study Terminated by Sponsor|11|||
44236471|NCT05327816|79061224|FG009|Overall Study|Study Terminated by Sponsor|11|||
44236472|NCT05327816|79061225|FG010|Overall Study|Study Terminated by Sponsor|12|||
44236473|NCT05327816|79061215|FG000|Overall Study|Randomized but not treated|0|||
44236474|NCT05327816|79061216|FG001|Overall Study|Randomized but not treated|0|||
44236475|NCT05327816|79061217|FG002|Overall Study|Randomized but not treated|0|||
44236476|NCT05327816|79061218|FG003|Overall Study|Randomized but not treated|0|||
44236477|NCT05327816|79061219|FG004|Overall Study|Randomized but not treated|0|||
44236478|NCT05327816|79061220|FG005|Overall Study|Randomized but not treated|0|||
44569507|NCT03078751|79590064|FG001|Overall Study|Adverse Event|0|||
44569508|NCT03078751|79590063|FG000|Overall Study|Physician Decision|1|||
44569509|NCT03078751|79590064|FG001|Overall Study|Physician Decision|0|||
44569510|NCT03078751|79590063|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
44569511|NCT03078751|79590064|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
44569512|NCT03078751|79590063|FG000|Overall Study|Subject/guardian decision|8|||
44569513|NCT03078751|79590064|FG001|Overall Study|Subject/guardian decision|1|||
44569514|NCT03078751|79590063|FG000|Overall Study|Untreated|0|||
44569515|NCT03078751|79590064|FG001|Overall Study|Untreated|4|||
44569516|NCT02924883|79590089|FG000|Overall Study|Death|39|||
44569517|NCT02924883|79590090|FG001|Overall Study|Death|20|||
44569518|NCT02924883|79590089|FG000|Overall Study|Lost to Follow-up|1|||
44569519|NCT02924883|79590090|FG001|Overall Study|Lost to Follow-up|0|||
44569520|NCT02924883|79590089|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
44569521|NCT02924883|79590090|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
44569522|NCT02924883|79590089|FG000|Overall Study|Protocol Violation|1|||
44569523|NCT02924883|79590090|FG001|Overall Study|Protocol Violation|0|||
44569524|NCT02924883|79590089|FG000|Overall Study|Withdrawal by Subject|22|||
44569525|NCT02924883|79590090|FG001|Overall Study|Withdrawal by Subject|16|||
44569526|NCT02924883|79590089|FG000|Overall Study|Progressive Disease|1|||
44569527|NCT02924883|79590090|FG001|Overall Study|Progressive Disease|0|||
44569528|NCT02924883|79590089|FG000|Overall Study|Study Terminated by Sponsor|69|||
44569529|NCT02924883|79590090|FG001|Overall Study|Study Terminated by Sponsor|32|||
44569530|NCT01369680|79590113|FG000|Overall Study|Lost to Follow-up|0|||
44569531|NCT01369680|79590114|FG001|Overall Study|Lost to Follow-up|0|||
44569532|NCT01369680|79590115|FG002|Overall Study|Lost to Follow-up|1|||
44569533|NCT01369680|79590116|FG003|Overall Study|Lost to Follow-up|2|||
44569534|NCT03074149|79590148|FG000|Overall Study|Reason unknown|22|||
44569535|NCT03074149|79590149|FG001|Overall Study|Reason unknown|35|||
44569536|NCT03074149|79590148|FG000|Overall Study|Death|10|||
44569537|NCT03074149|79590149|FG001|Overall Study|Death|45|||
44236479|NCT05327816|79061221|FG006|Overall Study|Randomized but not treated|1|||
44503827|NCT00397943|79508669|FG003|Overall Study|Unspecified reasons|0|||
44503828|NCT00397943|79508670|FG004|Overall Study|Unspecified reasons|0|||
44503829|NCT00066066|79508685|FG000|Overall Study|Lost to Follow-up|6|||
44503830|NCT00066066|79508686|FG001|Overall Study|Lost to Follow-up|4|||
44503831|NCT00066066|79508687|FG002|Overall Study|Lost to Follow-up|7|||
44503832|NCT00066066|79508688|FG003|Overall Study|Lost to Follow-up|4|||
44503833|NCT00066066|79508689|FG004|Overall Study|Lost to Follow-up|3|||
44503834|NCT00066066|79508690|FG005|Overall Study|Lost to Follow-up|5|||
44503835|NCT00363467|79508704|FG000|Overall Study|Physician Decision|1|||
44503836|NCT00397631|79508710|FG000|Overall Study|Adverse Event|5|||
44503837|NCT00397631|79508711|FG001|Overall Study|Adverse Event|6|||
44503838|NCT00397631|79508710|FG000|Overall Study|Lack of Efficacy|7|||
44503839|NCT00397631|79508711|FG001|Overall Study|Lack of Efficacy|10|||
44503840|NCT00397631|79508710|FG000|Overall Study|Lost to Follow-up|8|||
44503841|NCT00397631|79508711|FG001|Overall Study|Lost to Follow-up|9|||
44569538|NCT02751320|79590157|FG000|Overall Study|Adverse Event|2|||
44569539|NCT02751320|79590157|FG000|Overall Study|Withdrawal by Subject|1|||
44569540|NCT02206035|79590185|FG000|Overall Study|Physician Decision|10|||
44236480|NCT05327816|79061222|FG007|Overall Study|Randomized but not treated|1|||
44236481|NCT05327816|79061223|FG008|Overall Study|Randomized but not treated|1|||
44236482|NCT05327816|79061224|FG009|Overall Study|Randomized but not treated|0|||
44569541|NCT02206035|79590186|FG001|Overall Study|Physician Decision|0|||
44503842|NCT00397631|79508710|FG000|Overall Study|Physician Decision|2|||
44503843|NCT00397631|79508711|FG001|Overall Study|Physician Decision|0|||
44503844|NCT00397631|79508710|FG000|Overall Study|Protocol Violation|0|||
44503845|NCT00397631|79508711|FG001|Overall Study|Protocol Violation|1|||
44569542|NCT02206035|79590187|FG002|Overall Study|Physician Decision|175|||
44569543|NCT02746471|79590194|FG000|Overall Study|Death|43|||
44569544|NCT02746471|79590194|FG000|Overall Study|Exited before 36 months|1119|||
44569545|NCT02591953|79590201|FG000|Overall Study|Lost to Follow-up|6|||
44569546|NCT02591953|79590202|FG001|Overall Study|Lost to Follow-up|6|||
44569547|NCT03073213|79590210|FG000|Multiple Dose Period|Protocol Violation|0|||
44569548|NCT03073213|79590211|FG001|Multiple Dose Period|Protocol Violation|0|||
44569549|NCT03073213|79590212|FG002|Multiple Dose Period|Protocol Violation|1|||
44569550|NCT03070483|79590221|FG000|Overall Study|Lost to Follow-up|2|||
44569551|NCT02231762|79590226|FG000|Combination Phase|Adverse Event|10|||
44569552|NCT02231762|79590227|FG001|Combination Phase|Adverse Event|0|||
44569553|NCT02231762|79590228|FG002|Combination Phase|Adverse Event|0|||
44569554|NCT02231762|79590229|FG003|Combination Phase|Adverse Event|0|||
44569555|NCT02231762|79590226|FG000|Combination Phase|Withdrawal by Subject|2|||
44569556|NCT02231762|79590227|FG001|Combination Phase|Withdrawal by Subject|0|||
44569557|NCT02231762|79590228|FG002|Combination Phase|Withdrawal by Subject|0|||
44569558|NCT02231762|79590229|FG003|Combination Phase|Withdrawal by Subject|0|||
44236483|NCT05327816|79061225|FG010|Overall Study|Randomized but not treated|0|||
44236484|NCT05265247|79061265|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
44377716|NCT00891735|79383026|FG003|Overall Study|Lost to Follow-up|2|||
44503846|NCT00397631|79508710|FG000|Overall Study|Withdrawal by Subject|7|||
44503847|NCT00397631|79508711|FG001|Overall Study|Withdrawal by Subject|14|||
44503848|NCT00397631|79508710|FG000|Overall Study|protocol discontinuation criteria|1|||
44503849|NCT00397631|79508711|FG001|Overall Study|protocol discontinuation criteria|4|||
44503850|NCT00077376|79508717|FG000|Overall Study|Adverse Event|8|||
44503851|NCT00077376|79508717|FG000|Overall Study|Withdrawal by Subject|2|||
44503852|NCT00077376|79508717|FG000|Overall Study|Death|1|||
44503853|NCT00077376|79508717|FG000|Overall Study|Physician Decision|1|||
44503854|NCT00077376|79508717|FG000|Overall Study|Alternative therapy|5|||
44503855|NCT00077376|79508717|FG000|Overall Study|Complicating disease|1|||
44503856|NCT00077376|79508717|FG000|Overall Study|Still on treatment|1|||
44503857|NCT00077376|79508717|FG000|Overall Study|Symptomatic deterioration|1|||
44503858|NCT00077376|79508717|FG000|Overall Study|Surgery|1|||
44503859|NCT00077376|79508717|FG000|Overall Study|Insurance ran out|1|||
44503860|NCT00363311|79508723|FG000|Overall Study|Adverse Event|6|||
44503861|NCT00363311|79508724|FG001|Overall Study|Adverse Event|4|||
44503862|NCT00363311|79508723|FG000|Overall Study|Lost to Follow-up|3|||
44503863|NCT00363311|79508724|FG001|Overall Study|Lost to Follow-up|0|||
44503864|NCT00363311|79508723|FG000|Overall Study|Protocol Violation|1|||
44503865|NCT00363311|79508724|FG001|Overall Study|Protocol Violation|2|||
44503866|NCT00363311|79508723|FG000|Overall Study|Withdrawal by Subject|12|||
44503867|NCT00363311|79508724|FG001|Overall Study|Withdrawal by Subject|6|||
44503868|NCT00363311|79508723|FG000|Overall Study|Physician Decision|1|||
44503869|NCT00363311|79508724|FG001|Overall Study|Physician Decision|1|||
44503870|NCT00363311|79508723|FG000|Overall Study|Sponsor Terminated Study|2|||
44503871|NCT00363311|79508724|FG001|Overall Study|Sponsor Terminated Study|2|||
44503872|NCT00363311|79508723|FG000|Overall Study|Disease Progression|46|||
44503873|NCT00363311|79508724|FG001|Overall Study|Disease Progression|26|||
44503874|NCT00363311|79508723|FG000|Overall Study|Non-Compliance|1|||
44503875|NCT00363311|79508724|FG001|Overall Study|Non-Compliance|1|||
44503876|NCT00363311|79508723|FG000|Overall Study|Participant Refused Biopsy|1|||
44503877|NCT00363311|79508724|FG001|Overall Study|Participant Refused Biopsy|0|||
44503878|NCT00363311|79508723|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
44503879|NCT00363311|79508724|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
44503880|NCT00363311|79508723|FG000|Overall Study|Participant Opted for Treatment|1|||
44503881|NCT00363311|79508724|FG001|Overall Study|Participant Opted for Treatment|0|||
44503882|NCT00363311|79508723|FG000|Overall Study|Participant Moved to Another Country|1|||
44503883|NCT00363311|79508724|FG001|Overall Study|Participant Moved to Another Country|0|||
44503884|NCT00363311|79508723|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
44503885|NCT00363311|79508724|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
44503886|NCT00363311|79508723|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
44503887|NCT00363311|79508724|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
44503888|NCT00363311|79508723|FG000|Overall Study|Participant Moved to Louisiana|0|||
44503889|NCT00363311|79508724|FG001|Overall Study|Participant Moved to Louisiana|1|||
44503890|NCT00362609|79508732|FG000|Overall Study|Withdrawal by Subject|0|||
44503891|NCT00362609|79508733|FG001|Overall Study|Withdrawal by Subject|1|||
44569559|NCT02231762|79590226|FG000|Combination Phase|Disease Progression|6|||
44569560|NCT02231762|79590227|FG001|Combination Phase|Disease Progression|0|||
44503892|NCT00362609|79508732|FG000|Overall Study|Protocol Violation|0|||
44503893|NCT00362609|79508733|FG001|Overall Study|Protocol Violation|1|||
44503894|NCT00362375|79508741|FG000|Overall Study|Lost to Follow-up|40|||
44503895|NCT00362375|79508742|FG001|Overall Study|Lost to Follow-up|35|||
44569561|NCT02231762|79590228|FG002|Combination Phase|Disease Progression|0|||
44569562|NCT02231762|79590229|FG003|Combination Phase|Disease Progression|0|||
44236485|NCT05265247|79061266|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
44236486|NCT05265247|79061265|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
44236487|NCT05265247|79061266|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
44236488|NCT05265247|79061265|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
44236489|NCT05265247|79061266|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
44236490|NCT05033743|79061276|FG000|Overall Study|Lost to Follow-up|1|||
44236491|NCT05033743|79061276|FG000|Overall Study|Protocol Violation|2|||
44236492|NCT05033743|79061276|FG000|Overall Study|Withdrawal by Subject|1|||
44236493|NCT04984278|79061282|FG000|Period 1|Withdrawal by Subject|1|||
44236494|NCT04984278|79061283|FG001|Period 1|Withdrawal by Subject|0|||
44236495|NCT04984278|79061282|FG000|Period 1|Other|0|||
44236496|NCT04984278|79061283|FG001|Period 1|Other|1|||
44236497|NCT04984278|79061282|FG000|Period 2|Adverse Event|1|||
44236498|NCT04984278|79061283|FG001|Period 2|Adverse Event|0|||
44569563|NCT02231762|79590226|FG000|Combination Phase|Did not meet inclusion criteria|1|||
44569564|NCT02231762|79590227|FG001|Combination Phase|Did not meet inclusion criteria|0|||
44569565|NCT02231762|79590228|FG002|Combination Phase|Did not meet inclusion criteria|0|||
44569566|NCT02231762|79590229|FG003|Combination Phase|Did not meet inclusion criteria|0|||
44569567|NCT02231762|79590226|FG000|Combination Phase|Protocol Violation|1|||
44569568|NCT02231762|79590227|FG001|Combination Phase|Protocol Violation|0|||
44569569|NCT02231762|79590228|FG002|Combination Phase|Protocol Violation|0|||
44569570|NCT02231762|79590229|FG003|Combination Phase|Protocol Violation|0|||
44569571|NCT02231762|79590226|FG000|Maintenance Phase|Disease progression|0|||
44569572|NCT02231762|79590227|FG001|Maintenance Phase|Disease progression|3|||
44569573|NCT02231762|79590228|FG002|Maintenance Phase|Disease progression|4|||
44569574|NCT02231762|79590229|FG003|Maintenance Phase|Disease progression|3|||
44569575|NCT02231762|79590226|FG000|Maintenance Phase|Adverse Event|0|||
44569576|NCT02231762|79590227|FG001|Maintenance Phase|Adverse Event|0|||
44569577|NCT02231762|79590228|FG002|Maintenance Phase|Adverse Event|1|||
44569578|NCT02231762|79590229|FG003|Maintenance Phase|Adverse Event|2|||
44569579|NCT03023397|79590246|FG000|Run-In|Failed screening allergen challenge|1|||
44569580|NCT03023397|79590247|FG001|Run-In|Failed screening allergen challenge|0|||
44569581|NCT03023397|79590248|FG002|Run-In|Failed screening allergen challenge|0|||
44569582|NCT03023397|79590246|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
44569583|NCT03023397|79590247|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
44569584|NCT03023397|79590248|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
44569585|NCT04325906|79590259|FG000|Overall Study|Withdrawal by Subject|2|||
44569586|NCT04325906|79590260|FG001|Overall Study|Withdrawal by Subject|0|||
44569587|NCT03068455|79590268|FG000|Pre-treatment Period|Disease progression|0|||
44569588|NCT03068455|79590269|FG001|Pre-treatment Period|Disease progression|1|||
44569589|NCT03068455|79590268|FG000|Pre-treatment Period|Participant withdrew consent|1|||
44569590|NCT03068455|79590269|FG001|Pre-treatment Period|Participant withdrew consent|1|||
44569591|NCT03068455|79590268|FG000|Pre-treatment Period|Poor/non-compliance|0|||
44569592|NCT03068455|79590269|FG001|Pre-treatment Period|Poor/non-compliance|1|||
44569593|NCT03068455|79590268|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
44236499|NCT04984278|79061282|FG000|Period 2|Other|0|||
44236500|NCT04984278|79061283|FG001|Period 2|Other|1|||
44236501|NCT04596995|79061289|FG000|Overall Study|Lack of Efficacy|8|||
44236502|NCT04596995|79061289|FG000|Overall Study|Lost to Follow-up|3|||
44236503|NCT04596995|79061289|FG000|Overall Study|Withdrawal by Subject|12|||
44236504|NCT04596995|79061289|FG000|Overall Study|Sponsor decision|3|||
44569594|NCT03068455|79590269|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
44569595|NCT03068455|79590268|FG000|Pre-treatment Period|Not reported|2|||
44569596|NCT03068455|79590269|FG001|Pre-treatment Period|Not reported|1|||
44569597|NCT03068455|79590268|FG000|Treatment Period|Disease progression|166|||
44569598|NCT03068455|79590269|FG001|Treatment Period|Disease progression|208|||
44569599|NCT03068455|79590268|FG000|Treatment Period|Study drug toxicity|317|||
44569600|NCT03068455|79590269|FG001|Treatment Period|Study drug toxicity|104|||
44569601|NCT03068455|79590268|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
44569602|NCT03068455|79590269|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
44569603|NCT03068455|79590268|FG000|Treatment Period|Participant request to stop therapy|33|||
44236505|NCT04596995|79061289|FG000|Overall Study|Enrolled in managed access program|3|||
44569604|NCT03068455|79590269|FG001|Treatment Period|Participant request to stop therapy|20|||
44569605|NCT03068455|79590268|FG000|Treatment Period|Participant withdrew consent|5|||
44236506|NCT04559529|79061297|FG000|First Intervention (1 Day)|Adverse Event|0|||
44236507|NCT04559529|79061298|FG001|First Intervention (1 Day)|Adverse Event|0|||
44236508|NCT04559529|79061299|FG002|First Intervention (1 Day)|Adverse Event|0|||
44236509|NCT04559529|79061300|FG003|First Intervention (1 Day)|Adverse Event|1|||
44569606|NCT03068455|79590269|FG001|Treatment Period|Participant withdrew consent|10|||
44236510|NCT04559529|79061297|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
44569607|NCT03068455|79590268|FG000|Treatment Period|Poor/non-compliance|3|||
44569608|NCT03068455|79590269|FG001|Treatment Period|Poor/non-compliance|0|||
44569609|NCT03068455|79590268|FG000|Treatment Period|Participant no longer meets study criteria|1|||
44569610|NCT03068455|79590269|FG001|Treatment Period|Participant no longer meets study criteria|3|||
44569611|NCT03068455|79590268|FG000|Treatment Period|Other reasons|12|||
44569612|NCT03068455|79590269|FG001|Treatment Period|Other reasons|4|||
44569613|NCT03067987|79590277|FG000|Overall Study|Lost to Follow-up|7|||
44569614|NCT03067987|79590278|FG001|Overall Study|Lost to Follow-up|10|||
44236511|NCT04559529|79061298|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
44236512|NCT04559529|79061299|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
44236513|NCT04559529|79061300|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
44236514|NCT04559529|79061297|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
44236515|NCT04559529|79061298|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
44236516|NCT04559529|79061299|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
44236517|NCT04559529|79061300|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
44236518|NCT04516746|79061312|FG000|Overall Study|Randomized but not Treated|51|||
44236519|NCT04516746|79061313|FG001|Overall Study|Randomized but not Treated|19|||
44236520|NCT04516746|79061312|FG000|Overall Study|Adverse Event|0|||
44569615|NCT03067987|79590277|FG000|Overall Study|Protocol Violation|1|||
44569616|NCT03067987|79590278|FG001|Overall Study|Protocol Violation|2|||
44236521|NCT04516746|79061313|FG001|Overall Study|Adverse Event|1|||
44236522|NCT04516746|79061312|FG000|Overall Study|Death|62|||
44236523|NCT04516746|79061313|FG001|Overall Study|Death|32|||
44236524|NCT04516746|79061312|FG000|Overall Study|Lost to Follow-up|3431|||
44503896|NCT00362297|79508750|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
44503897|NCT00362297|79508751|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
44503898|NCT00065442|79508759|FG000|Overall Study|Lost to Follow-up|1|||
44503899|NCT00065442|79508760|FG001|Overall Study|Lost to Follow-up|1|||
44503900|NCT00065442|79508759|FG000|Overall Study|Death|121|||
44503901|NCT00065442|79508760|FG001|Overall Study|Death|210|||
44503902|NCT00065442|79508759|FG000|Overall Study|Withdrawal by Subject|3|||
44503903|NCT00065442|79508760|FG001|Overall Study|Withdrawal by Subject|9|||
44236525|NCT04516746|79061313|FG001|Overall Study|Lost to Follow-up|1831|||
44236526|NCT04516746|79061312|FG000|Overall Study|Withdrawal by Subject|1946|||
44236527|NCT04516746|79061313|FG001|Overall Study|Withdrawal by Subject|1696|||
44236528|NCT04516746|79061312|FG000|Overall Study|Physician Decision|10|||
44503904|NCT00090402|79508769|FG000|Overall Study|Death|1|||
44503905|NCT00090402|79508770|FG001|Overall Study|Death|1|||
44569617|NCT03067987|79590277|FG000|Overall Study|Withdrawal by Subject|2|||
44503906|NCT00090402|79508771|FG002|Overall Study|Death|0|||
44569618|NCT03067987|79590278|FG001|Overall Study|Withdrawal by Subject|1|||
44569619|NCT04035200|79590287|FG000|Overall Study|Lost to Follow-up|0|||
44569620|NCT04035200|79590288|FG001|Overall Study|Lost to Follow-up|1|||
44569621|NCT04035200|79590289|FG002|Overall Study|Lost to Follow-up|0|||
44569622|NCT04035200|79590287|FG000|Overall Study|Withdrawal by Subject|1|||
44569623|NCT04035200|79590288|FG001|Overall Study|Withdrawal by Subject|4|||
44569624|NCT04035200|79590289|FG002|Overall Study|Withdrawal by Subject|4|||
44569625|NCT04035200|79590287|FG000|Overall Study|COVID-19|1|||
44569626|NCT04035200|79590288|FG001|Overall Study|COVID-19|0|||
44569627|NCT04035200|79590289|FG002|Overall Study|COVID-19|0|||
44569628|NCT04035200|79590287|FG000|Overall Study|Early Termination|0|||
44569629|NCT04035200|79590288|FG001|Overall Study|Early Termination|1|||
44569630|NCT04035200|79590289|FG002|Overall Study|Early Termination|0|||
44569631|NCT04035200|79590287|FG000|Overall Study|Non-compliance|0|||
44569632|NCT04035200|79590288|FG001|Overall Study|Non-compliance|1|||
44569633|NCT04035200|79590289|FG002|Overall Study|Non-compliance|0|||
44569634|NCT03197870|79590300|FG000|Overall Study|Adverse Event|9|||
44503907|NCT00090402|79508769|FG000|Overall Study|subject moved|0|||
44503908|NCT00090402|79508770|FG001|Overall Study|subject moved|1|||
44503909|NCT00090402|79508771|FG002|Overall Study|subject moved|0|||
44503910|NCT00090402|79508769|FG000|Overall Study|stopped taking study medication|1|||
44503911|NCT00090402|79508770|FG001|Overall Study|stopped taking study medication|0|||
44503912|NCT00090402|79508771|FG002|Overall Study|stopped taking study medication|1|||
44503913|NCT00361283|79508782|FG000|Overall Study|Lost to Follow-up|27|||
44503914|NCT00077064|79508788|FG000|Overall Study|Adverse Event|0|||
44503915|NCT00077064|79508789|FG001|Overall Study|Adverse Event|4|||
44503916|NCT00077064|79508788|FG000|Overall Study|Patient refusal|0|||
44503917|NCT00077064|79508789|FG001|Overall Study|Patient refusal|2|||
44503918|NCT00396383|79508796|FG000|Overall Study|Death|2|||
44503919|NCT00396383|79508796|FG000|Overall Study|Lost to Follow-up|1|||
44569635|NCT03197870|79590301|FG001|Overall Study|Adverse Event|4|||
44569636|NCT03197870|79590302|FG002|Overall Study|Adverse Event|6|||
44569637|NCT03197870|79590300|FG000|Overall Study|Withdrawal by Subject|2|||
44569638|NCT03197870|79590301|FG001|Overall Study|Withdrawal by Subject|3|||
44569639|NCT03197870|79590302|FG002|Overall Study|Withdrawal by Subject|0|||
44503920|NCT00395447|79508802|FG000|Overall Study|Death|37|||
44569640|NCT03197870|79590300|FG000|Overall Study|Lost to Follow-up|2|||
44569641|NCT03197870|79590301|FG001|Overall Study|Lost to Follow-up|2|||
44569642|NCT03197870|79590302|FG002|Overall Study|Lost to Follow-up|0|||
44569643|NCT03197870|79590300|FG000|Overall Study|data not available|1|||
44569644|NCT03197870|79590301|FG001|Overall Study|data not available|1|||
44569645|NCT03197870|79590302|FG002|Overall Study|data not available|0|||
44569646|NCT04889222|79590313|FG000|Overall Study|Did not meet eligibility criteria|8|||
44569647|NCT04889222|79590313|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
44569648|NCT04889222|79590313|FG000|Overall Study|Did not proceed due to time constraints|5|||
44569649|NCT03067441|79590345|FG000|Overall Study|Withdrawal by Subject|16|||
44569650|NCT03067441|79590346|FG001|Overall Study|Withdrawal by Subject|34|||
44569651|NCT03067441|79590345|FG000|Overall Study|Lost to Follow-up|7|||
44569652|NCT03067441|79590346|FG001|Overall Study|Lost to Follow-up|5|||
44569653|NCT03067441|79590345|FG000|Overall Study|Adverse Event|7|||
44569654|NCT03067441|79590346|FG001|Overall Study|Adverse Event|14|||
44569655|NCT03067441|79590345|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
44569656|NCT03067441|79590346|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
44569657|NCT03067441|79590345|FG000|Overall Study|Physician Decision|1|||
44569658|NCT03067441|79590346|FG001|Overall Study|Physician Decision|3|||
44569659|NCT03067441|79590345|FG000|Overall Study|Other|1|||
44569660|NCT03067441|79590346|FG001|Overall Study|Other|1|||
44569661|NCT02600923|79590355|FG000|Overall Study|Death|10|||
44569662|NCT02600923|79590355|FG000|Overall Study|Adverse Event|3|||
44569663|NCT02600923|79590355|FG000|Overall Study|Global deterioration of health status|2|||
44569664|NCT02600923|79590355|FG000|Overall Study|Insufficient clinical response|6|||
44569665|NCT02600923|79590355|FG000|Overall Study|Lost to Follow-up|1|||
44236529|NCT04516746|79061313|FG001|Overall Study|Physician Decision|8|||
44236530|NCT04516746|79061312|FG000|Overall Study|Other|35|||
44236531|NCT04516746|79061313|FG001|Overall Study|Other|16|||
44236532|NCT04423718|79061337|FG000|Overall Study|Adverse Event|6|||
44236533|NCT04423718|79061338|FG001|Overall Study|Adverse Event|2|||
44569666|NCT02600923|79590355|FG000|Overall Study|Withdrawal by Subject|5|||
44569667|NCT02600923|79590355|FG000|Overall Study|Objective progression or relapse|50|||
44236534|NCT04423718|79061339|FG002|Overall Study|Adverse Event|5|||
44236535|NCT04423718|79061337|FG000|Overall Study|Physician Decision|1|||
44236536|NCT04423718|79061338|FG001|Overall Study|Physician Decision|4|||
44236537|NCT04423718|79061339|FG002|Overall Study|Physician Decision|1|||
44236538|NCT04423718|79061337|FG000|Overall Study|Protocol Violation|0|||
44236539|NCT04423718|79061338|FG001|Overall Study|Protocol Violation|1|||
44236540|NCT04423718|79061339|FG002|Overall Study|Protocol Violation|1|||
44236541|NCT04423718|79061337|FG000|Overall Study|Lost to Follow-up|1|||
44236542|NCT04423718|79061338|FG001|Overall Study|Lost to Follow-up|1|||
44236543|NCT04423718|79061339|FG002|Overall Study|Lost to Follow-up|2|||
44236544|NCT04423718|79061337|FG000|Overall Study|Lack of Efficacy|2|||
44236545|NCT04423718|79061338|FG001|Overall Study|Lack of Efficacy|0|||
44236546|NCT04423718|79061339|FG002|Overall Study|Lack of Efficacy|0|||
44236547|NCT04423718|79061337|FG000|Overall Study|Withdrawal by Subject|6|||
44236548|NCT04423718|79061338|FG001|Overall Study|Withdrawal by Subject|8|||
44236549|NCT04423718|79061339|FG002|Overall Study|Withdrawal by Subject|14|||
44236550|NCT04423718|79061337|FG000|Overall Study|Death|5|||
44236551|NCT04423718|79061338|FG001|Overall Study|Death|3|||
44236552|NCT04423718|79061339|FG002|Overall Study|Death|2|||
44236553|NCT04423718|79061337|FG000|Overall Study|COVID-19 pandemic|2|||
44503921|NCT00395447|79508803|FG001|Overall Study|Death|32|||
44503922|NCT00395447|79508802|FG000|Overall Study|Lost to Follow-up|52|||
44503923|NCT00395447|79508803|FG001|Overall Study|Lost to Follow-up|43|||
44503924|NCT00395447|79508802|FG000|Overall Study|Withdrawal by Subject|24|||
44503925|NCT00395447|79508803|FG001|Overall Study|Withdrawal by Subject|19|||
44503926|NCT00395447|79508802|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
44503927|NCT00395447|79508803|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
44503928|NCT03404674|79508815|FG000|Overall Study|Inability to Attend Future Visits|0|||
44503929|NCT03404674|79508816|FG001|Overall Study|Inability to Attend Future Visits|1|||
44503930|NCT03404674|79508817|FG002|Overall Study|Inability to Attend Future Visits|1|||
44503931|NCT03404674|79508818|FG003|Overall Study|Inability to Attend Future Visits|0|||
44503932|NCT03404674|79508819|FG004|Overall Study|Inability to Attend Future Visits|0|||
44236554|NCT04423718|79061338|FG001|Overall Study|COVID-19 pandemic|2|||
44236555|NCT04423718|79061339|FG002|Overall Study|COVID-19 pandemic|2|||
44236556|NCT04423718|79061337|FG000|Overall Study|Other|6|||
44236557|NCT04423718|79061338|FG001|Overall Study|Other|2|||
44236558|NCT04423718|79061339|FG002|Overall Study|Other|2|||
44236559|NCT04423718|79061337|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
44236560|NCT04423718|79061338|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
44503933|NCT03404674|79508820|FG005|Overall Study|Inability to Attend Future Visits|0|||
44503934|NCT03404674|79508815|FG000|Overall Study|Behavioral Problems|0|||
44569668|NCT02600923|79590355|FG000|Overall Study|Study terminated by Sponsor|53|||
44569669|NCT02600923|79590355|FG000|Overall Study|Not treated|1|||
44569670|NCT03070171|79590361|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
44569671|NCT03070171|79590362|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
44569672|NCT03070171|79590361|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
44236561|NCT04423718|79061339|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
44236562|NCT04305587|79061360|FG000|Overall Study|Withdrawal by Subject|0|||
44236563|NCT04305587|79061361|FG001|Overall Study|Withdrawal by Subject|0|||
44236564|NCT04305587|79061362|FG002|Overall Study|Withdrawal by Subject|0|||
44236565|NCT04305587|79061363|FG003|Overall Study|Withdrawal by Subject|1|||
44236566|NCT04305587|79061364|FG004|Overall Study|Withdrawal by Subject|0|||
44236567|NCT04305587|79061365|FG005|Overall Study|Withdrawal by Subject|0|||
44236568|NCT04305587|79061366|FG006|Overall Study|Withdrawal by Subject|0|||
44236569|NCT04305587|79061367|FG007|Overall Study|Withdrawal by Subject|0|||
44236570|NCT04305587|79061368|FG008|Overall Study|Withdrawal by Subject|0|||
44236571|NCT04137224|79061397|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
44236572|NCT04137224|79061398|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
44236573|NCT04137224|79061397|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
44236574|NCT04137224|79061398|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
44236575|NCT04137224|79061397|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
44236576|NCT04137224|79061398|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
44236577|NCT03872128|79061425|FG000|Overall Study|Dropped out before treatment|1|||
44236578|NCT03872128|79061426|FG001|Overall Study|Dropped out before treatment|0|||
44236579|NCT03872128|79061427|FG002|Overall Study|Dropped out before treatment|4|||
44236580|NCT03872128|79061425|FG000|Overall Study|Lost to Follow-up|2|||
44236581|NCT03872128|79061426|FG001|Overall Study|Lost to Follow-up|5|||
44236582|NCT03872128|79061427|FG002|Overall Study|Lost to Follow-up|8|||
44236583|NCT03740698|79061449|FG000|Overall Study|Physician Decision|0|||
44569673|NCT03070171|79590362|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
44569674|NCT03644017|79590368|FG000|Overall Study|Access Abandonment|5|||
44569675|NCT03644017|79590368|FG000|Overall Study|Kidney Transplant|2|||
44569676|NCT00158054|79590374|FG000|Overall Study|Refused to continue|3|||
44569677|NCT00158054|79590375|FG001|Overall Study|Refused to continue|0|||
44569678|NCT00158054|79590374|FG000|Overall Study|Unavailable for follow up|7|||
44236584|NCT03740698|79061450|FG001|Overall Study|Physician Decision|1|||
44236585|NCT03740698|79061451|FG002|Overall Study|Physician Decision|1|||
44236586|NCT03718533|79061459|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
44236587|NCT03718533|79061459|FG000|Overall Study|Protocol deviation|1|||
44569679|NCT00158054|79590375|FG001|Overall Study|Unavailable for follow up|3|||
44569680|NCT01337960|79590384|FG000|Overall Study|Lost to Follow-up|1|||
44569681|NCT01337960|79590385|FG001|Overall Study|Lost to Follow-up|0|||
44569682|NCT01337960|79590386|FG002|Overall Study|Lost to Follow-up|0|||
44569683|NCT01337960|79590384|FG000|Overall Study|Withdrawal by Subject|1|||
44569684|NCT01337960|79590385|FG001|Overall Study|Withdrawal by Subject|0|||
44569685|NCT01337960|79590386|FG002|Overall Study|Withdrawal by Subject|0|||
44569686|NCT02750306|79590405|FG000|Overall Study|Withdrawal by Subject|5|||
44569687|NCT02750306|79590406|FG001|Overall Study|Withdrawal by Subject|2|||
44569688|NCT02750306|79590405|FG000|Overall Study|Protocol Violation|1|||
44569689|NCT02750306|79590406|FG001|Overall Study|Protocol Violation|0|||
44569690|NCT01816165|79590414|FG000|Overall Study|Adverse Event|1|||
44569691|NCT01816165|79590415|FG001|Overall Study|Adverse Event|0|||
44569692|NCT01816165|79590416|FG002|Overall Study|Adverse Event|0|||
44569693|NCT01816165|79590417|FG003|Overall Study|Adverse Event|0|||
44236588|NCT03718533|79061459|FG000|Overall Study|Disease progression|1|||
44236589|NCT03718533|79061459|FG000|Overall Study|Relapse|1|||
44236590|NCT03718533|79061459|FG000|Overall Study|Physician Decision|2|||
44236591|NCT03718533|79061459|FG000|Overall Study|Physician Decision and Adverse Event|1|||
44236592|NCT03541642|79061466|FG000|Overall Study|Withdrawal by Subject|1|||
44236593|NCT03541642|79061467|FG001|Overall Study|Withdrawal by Subject|2|||
44236594|NCT03541642|79061466|FG000|Overall Study|Lost to Follow-up|16|||
44236595|NCT03541642|79061467|FG001|Overall Study|Lost to Follow-up|12|||
44569694|NCT01677988|79590446|FG000|Overall Study|Lack of Efficacy|2|||
44569695|NCT02926573|79590453|FG000|Overall Study|Nausea|1|||
44569696|NCT02926573|79590454|FG001|Overall Study|Nausea|0|||
44236596|NCT03541642|79061466|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
44249733|NCT01504412|79083927|FG004|Overall Study|Withdrawal by Subject|1|||
44236597|NCT03541642|79061467|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
44236598|NCT03534284|79061476|FG000|Overall Study|Death|2|||
44236599|NCT03534284|79061477|FG001|Overall Study|Death|3|||
44236600|NCT03534284|79061478|FG002|Overall Study|Death|3|||
44236601|NCT03534284|79061476|FG000|Overall Study|Withdrawal by Subject|5|||
44236602|NCT03534284|79061477|FG001|Overall Study|Withdrawal by Subject|0|||
44236603|NCT03534284|79061478|FG002|Overall Study|Withdrawal by Subject|0|||
44236606|NCT03375463|79061521|FG000|Period 1|Lost to Follow-up|0|||
44236607|NCT03375463|79061522|FG001|Period 1|Lost to Follow-up|0|||
44236608|NCT03375463|79061523|FG002|Period 1|Lost to Follow-up|1|||
44236609|NCT03375463|79061524|FG003|Period 1|Lost to Follow-up|0|||
44236610|NCT03375463|79061525|FG004|Period 1|Lost to Follow-up|0|||
44236611|NCT03375463|79061526|FG005|Period 1|Lost to Follow-up|0|||
44236612|NCT03375463|79061521|FG000|Period 1|Adverse Event|0|||
44236613|NCT03375463|79061522|FG001|Period 1|Adverse Event|0|||
44236614|NCT03375463|79061523|FG002|Period 1|Adverse Event|0|||
44236615|NCT03375463|79061524|FG003|Period 1|Adverse Event|0|||
44236616|NCT03375463|79061525|FG004|Period 1|Adverse Event|1|||
44503935|NCT03404674|79508816|FG001|Overall Study|Behavioral Problems|0|||
44236617|NCT03375463|79061526|FG005|Period 1|Adverse Event|0|||
44236618|NCT03375463|79061521|FG000|Period 2|Lost to Follow-up|1|||
44236619|NCT03375463|79061522|FG001|Period 2|Lost to Follow-up|1|||
44236620|NCT03375463|79061523|FG002|Period 2|Lost to Follow-up|0|||
44236621|NCT03375463|79061524|FG003|Period 2|Lost to Follow-up|0|||
44236622|NCT03375463|79061525|FG004|Period 2|Lost to Follow-up|0|||
44236623|NCT03375463|79061526|FG005|Period 2|Lost to Follow-up|0|||
44503936|NCT03404674|79508817|FG002|Overall Study|Behavioral Problems|1|||
44569697|NCT02926573|79590453|FG000|Overall Study|Remain intubated|2|||
44569698|NCT02926573|79590454|FG001|Overall Study|Remain intubated|2|||
44569699|NCT02926573|79590453|FG000|Overall Study|Change in surgery plan|3|||
44569700|NCT02926573|79590454|FG001|Overall Study|Change in surgery plan|1|||
44569701|NCT02926573|79590453|FG000|Overall Study|Change to outpatient status|5|||
44569702|NCT02926573|79590454|FG001|Overall Study|Change to outpatient status|1|||
44569703|NCT02926573|79590453|FG000|Overall Study|Withdrawal by Subject|0|||
44569704|NCT02926573|79590454|FG001|Overall Study|Withdrawal by Subject|2|||
44569705|NCT02926573|79590453|FG000|Overall Study|Return to operating room|0|||
44569706|NCT02926573|79590454|FG001|Overall Study|Return to operating room|2|||
44569707|NCT02926573|79590453|FG000|Overall Study|Delirium|0|||
44569708|NCT02926573|79590454|FG001|Overall Study|Delirium|1|||
44569709|NCT00158860|79590462|FG000|Overall Study|Adverse Event|3|||
44569710|NCT00158860|79590463|FG001|Overall Study|Adverse Event|6|||
44569711|NCT00158860|79590462|FG000|Overall Study|Lost to Follow-up|11|||
44569712|NCT00158860|79590463|FG001|Overall Study|Lost to Follow-up|17|||
44569713|NCT00158860|79590462|FG000|Overall Study|Protocol Violation|8|||
44569714|NCT00158860|79590463|FG001|Overall Study|Protocol Violation|23|||
44569715|NCT00158860|79590462|FG000|Overall Study|Withdrawal by Subject|7|||
44569716|NCT00158860|79590463|FG001|Overall Study|Withdrawal by Subject|17|||
44569717|NCT00158860|79590462|FG000|Overall Study|MOVING OUT OF STATE|1|||
44569718|NCT00158860|79590463|FG001|Overall Study|MOVING OUT OF STATE|0|||
44569719|NCT00158860|79590462|FG000|Overall Study|Pregnancy|3|||
44569720|NCT00158860|79590463|FG001|Overall Study|Pregnancy|3|||
44569721|NCT00158860|79590462|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
44569722|NCT00158860|79590463|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
44569723|NCT00158860|79590462|FG000|Overall Study|SPONSOR REQUEST|0|||
44569724|NCT00158860|79590463|FG001|Overall Study|SPONSOR REQUEST|1|||
44569725|NCT00158860|79590462|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
44569726|NCT00158860|79590463|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
44569727|NCT00158860|79590462|FG000|Overall Study|Closed per sponsor|0|||
44377717|NCT00891735|79383023|FG000|Overall Study|Physician's decision to withdraw patient|1|||
44569728|NCT00158860|79590463|FG001|Overall Study|Closed per sponsor|1|||
44569729|NCT03067129|79590474|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
44569730|NCT03067129|79590475|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
44569731|NCT03067129|79590476|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
44569732|NCT03067129|79590477|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
44569733|NCT03067129|79590474|FG000|Overall Study|Withdrawal by Subject|0|||
44569734|NCT03067129|79590475|FG001|Overall Study|Withdrawal by Subject|0|||
44569735|NCT03067129|79590476|FG002|Overall Study|Withdrawal by Subject|1|||
44569736|NCT03067129|79590477|FG003|Overall Study|Withdrawal by Subject|2|||
44569737|NCT03067129|79590474|FG000|Overall Study|Lost to Follow-up|5|||
44236624|NCT03366337|79061549|FG000|Overall Study|Lost to Follow-up|1|||
44236625|NCT03366337|79061550|FG001|Overall Study|Lost to Follow-up|0|||
44236626|NCT03366337|79061551|FG002|Overall Study|Lost to Follow-up|1|||
44236627|NCT03366337|79061552|FG003|Overall Study|Lost to Follow-up|0|||
44236628|NCT03366337|79061549|FG000|Overall Study|Withdrawal by Subject|2|||
44236629|NCT03366337|79061550|FG001|Overall Study|Withdrawal by Subject|0|||
44236630|NCT03366337|79061551|FG002|Overall Study|Withdrawal by Subject|1|||
44236631|NCT03366337|79061552|FG003|Overall Study|Withdrawal by Subject|1|||
44569738|NCT03067129|79590475|FG001|Overall Study|Lost to Follow-up|5|||
44569739|NCT03067129|79590476|FG002|Overall Study|Lost to Follow-up|4|||
44569740|NCT03067129|79590477|FG003|Overall Study|Lost to Follow-up|3|||
44569741|NCT01679236|79590499|FG000|Overall Study|Lost to Follow-up|15|||
44569742|NCT01679236|79590500|FG001|Overall Study|Lost to Follow-up|15|||
44236632|NCT03144674|79061566|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
44275882|NCT04169373|79226153|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
44569743|NCT01679002|79590509|FG000|Overall Study|Adverse Event|1|||
44569744|NCT01679002|79590510|FG001|Overall Study|Adverse Event|1|||
44569745|NCT01679002|79590511|FG002|Overall Study|Adverse Event|0|||
44569746|NCT04409509|79590521|FG000|Overall Study|Failure to meet randomization requirement|1|||
44569747|NCT04409509|79590522|FG001|Overall Study|Failure to meet randomization requirement|0|||
44569748|NCT04409509|79590521|FG000|Overall Study|Adverse Event|0|||
44569749|NCT04409509|79590522|FG001|Overall Study|Adverse Event|1|||
44569750|NCT04409509|79590521|FG000|Overall Study|Death|11|||
44569751|NCT04409509|79590522|FG001|Overall Study|Death|10|||
44236633|NCT03144674|79061567|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
44236634|NCT03144674|79061568|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
44236635|NCT03144674|79061569|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
44275883|NCT04169373|79226154|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
44275884|NCT04169373|79226151|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
44503937|NCT03404674|79508818|FG003|Overall Study|Behavioral Problems|0|||
44503938|NCT03404674|79508819|FG004|Overall Study|Behavioral Problems|0|||
44503939|NCT03404674|79508820|FG005|Overall Study|Behavioral Problems|0|||
44503940|NCT03404674|79508815|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
44503941|NCT03404674|79508816|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
44503942|NCT03404674|79508817|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
44503943|NCT03404674|79508818|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
44503944|NCT03404674|79508819|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
44503945|NCT03404674|79508820|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
44503946|NCT00064662|79508837|FG000|Overall Study|Death|1|||
44503947|NCT00064662|79508838|FG001|Overall Study|Death|1|||
44503948|NCT00064662|79508837|FG000|Overall Study|Lost to Follow-up|57|||
44569752|NCT04409509|79590521|FG000|Overall Study|Non-compliance with study drug|0|||
44569753|NCT04409509|79590522|FG001|Overall Study|Non-compliance with study drug|1|||
44569754|NCT04409509|79590521|FG000|Overall Study|Lost to Follow-up|0|||
44569755|NCT04409509|79590522|FG001|Overall Study|Lost to Follow-up|3|||
44569756|NCT04409509|79590521|FG000|Overall Study|Withdrawal by Subject|0|||
44569757|NCT04409509|79590522|FG001|Overall Study|Withdrawal by Subject|3|||
44569758|NCT04409509|79590521|FG000|Overall Study|Randomized by mistake|0|||
44236636|NCT03144674|79061566|FG000|Overall Study|Death|3|||
44236637|NCT03144674|79061567|FG001|Overall Study|Death|1|||
44236638|NCT03144674|79061568|FG002|Overall Study|Death|1|||
44503949|NCT00064662|79508838|FG001|Overall Study|Lost to Follow-up|44|||
44569759|NCT04409509|79590522|FG001|Overall Study|Randomized by mistake|1|||
44569760|NCT04409509|79590521|FG000|Overall Study|Other|1|||
44569761|NCT04409509|79590522|FG001|Overall Study|Other|1|||
44569762|NCT01678924|79590533|FG000|Overall Study|Adverse Event|1|||
44503950|NCT00064662|79508837|FG000|Overall Study|Withdrawal by Subject|14|||
44569763|NCT01678924|79590534|FG001|Overall Study|Adverse Event|1|||
44236639|NCT03144674|79061569|FG003|Overall Study|Death|10|||
44236640|NCT03144674|79061566|FG000|Overall Study|Lost to Follow-up|0|||
44236641|NCT03144674|79061567|FG001|Overall Study|Lost to Follow-up|1|||
44569764|NCT01678924|79590535|FG002|Overall Study|Adverse Event|0|||
44236642|NCT03144674|79061568|FG002|Overall Study|Lost to Follow-up|1|||
44236643|NCT03144674|79061569|FG003|Overall Study|Lost to Follow-up|1|||
44236644|NCT03144674|79061566|FG000|Overall Study|Withdrawal by Participant|0|||
44236645|NCT03144674|79061567|FG001|Overall Study|Withdrawal by Participant|0|||
44236646|NCT03144674|79061568|FG002|Overall Study|Withdrawal by Participant|0|||
44236647|NCT03144674|79061569|FG003|Overall Study|Withdrawal by Participant|3|||
44236648|NCT03144674|79061566|FG000|Overall Study|Reason not Specified|0|||
44236649|NCT03144674|79061567|FG001|Overall Study|Reason not Specified|0|||
44236650|NCT03144674|79061568|FG002|Overall Study|Reason not Specified|2|||
44236651|NCT03144674|79061569|FG003|Overall Study|Reason not Specified|4|||
44236652|NCT02887859|79061584|FG000|Overall Study|Ongoing|6|||
44236653|NCT02887859|79061584|FG000|Overall Study|Adverse Event|7|||
44236654|NCT02887859|79061584|FG000|Overall Study|Death|1|||
44236655|NCT02887859|79061584|FG000|Overall Study|Physician Decision|1|||
44236656|NCT02789345|79061591|FG000|Overall Study|Adverse Event|0|||
44236657|NCT02789345|79061592|FG001|Overall Study|Adverse Event|0|||
44236658|NCT02789345|79061593|FG002|Overall Study|Adverse Event|1|||
44236659|NCT02789345|79061591|FG000|Overall Study|Death|0|||
44236660|NCT02789345|79061592|FG001|Overall Study|Death|0|||
44236661|NCT02789345|79061593|FG002|Overall Study|Death|1|||
44236662|NCT02789345|79061591|FG000|Overall Study|Physician Decision|2|||
44236663|NCT02789345|79061592|FG001|Overall Study|Physician Decision|0|||
44236664|NCT02789345|79061593|FG002|Overall Study|Physician Decision|1|||
44236665|NCT02789345|79061591|FG000|Overall Study|Progressive Disease|1|||
44236666|NCT02789345|79061592|FG001|Overall Study|Progressive Disease|3|||
44236667|NCT02789345|79061593|FG002|Overall Study|Progressive Disease|14|||
44236668|NCT02747927|79061604|FG000|Overall Study|Adverse Event|5|||
44236669|NCT02747927|79061605|FG001|Overall Study|Adverse Event|14|||
44236670|NCT02747927|79061604|FG000|Overall Study|Lost to Follow-up|22|||
44236671|NCT02747927|79061605|FG001|Overall Study|Lost to Follow-up|43|||
44236672|NCT02747927|79061604|FG000|Overall Study|Pregnancy|34|||
44236673|NCT02747927|79061605|FG001|Overall Study|Pregnancy|66|||
44236674|NCT02747927|79061604|FG000|Overall Study|Protocol Violation|2|||
44236675|NCT02747927|79061605|FG001|Overall Study|Protocol Violation|4|||
44236676|NCT02747927|79061604|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
44236677|NCT02747927|79061605|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
44236678|NCT02747927|79061604|FG000|Overall Study|Reason not Specified|11|||
44236679|NCT02747927|79061605|FG001|Overall Study|Reason not Specified|27|||
44236680|NCT02557295|79061616|FG000|Overall Study|Withdrawal by Subject|9|||
44236681|NCT02557295|79061617|FG001|Overall Study|Withdrawal by Subject|2|||
44236682|NCT02557295|79061618|FG002|Overall Study|Withdrawal by Subject|4|||
44236683|NCT02557295|79061619|FG003|Overall Study|Withdrawal by Subject|0|||
44236684|NCT02557295|79061620|FG004|Overall Study|Withdrawal by Subject|0|||
44236685|NCT02557295|79061621|FG005|Overall Study|Withdrawal by Subject|0|||
44236686|NCT02557295|79061622|FG006|Overall Study|Withdrawal by Subject|15|||
44236687|NCT02557295|79061623|FG007|Overall Study|Withdrawal by Subject|1|||
44236688|NCT02557295|79061624|FG008|Overall Study|Withdrawal by Subject|3|||
44236689|NCT02557295|79061616|FG000|Overall Study|Disease Progression|0|||
44275885|NCT04169373|79226152|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
44275886|NCT04169373|79226153|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
44275887|NCT04169373|79226154|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
44275888|NCT04169373|79226151|FG000|Week 1 to Week 14|Other|1|||
44569765|NCT01678924|79590536|FG003|Overall Study|Adverse Event|1|||
44569766|NCT01678924|79590533|FG000|Overall Study|Lack of Efficacy|7|||
44569767|NCT01678924|79590534|FG001|Overall Study|Lack of Efficacy|2|||
44569768|NCT01678924|79590535|FG002|Overall Study|Lack of Efficacy|0|||
44569769|NCT01678924|79590536|FG003|Overall Study|Lack of Efficacy|5|||
44569770|NCT01678924|79590533|FG000|Overall Study|Lost to Follow-up|0|||
44236690|NCT02557295|79061617|FG001|Overall Study|Disease Progression|0|||
44236691|NCT02557295|79061618|FG002|Overall Study|Disease Progression|0|||
44236692|NCT02557295|79061619|FG003|Overall Study|Disease Progression|0|||
44236693|NCT02557295|79061620|FG004|Overall Study|Disease Progression|0|||
44236694|NCT02557295|79061621|FG005|Overall Study|Disease Progression|0|||
44236695|NCT02557295|79061622|FG006|Overall Study|Disease Progression|1|||
44236696|NCT02557295|79061623|FG007|Overall Study|Disease Progression|0|||
44236697|NCT02557295|79061624|FG008|Overall Study|Disease Progression|0|||
44236698|NCT02557295|79061616|FG000|Overall Study|Lack of Efficacy|24|||
44236699|NCT02557295|79061617|FG001|Overall Study|Lack of Efficacy|1|||
44236700|NCT02557295|79061618|FG002|Overall Study|Lack of Efficacy|3|||
44236701|NCT02557295|79061619|FG003|Overall Study|Lack of Efficacy|0|||
44569771|NCT01678924|79590534|FG001|Overall Study|Lost to Follow-up|4|||
44569772|NCT01678924|79590535|FG002|Overall Study|Lost to Follow-up|0|||
44569773|NCT01678924|79590536|FG003|Overall Study|Lost to Follow-up|2|||
44569774|NCT01678924|79590533|FG000|Overall Study|Personal Reasons|2|||
44569775|NCT01678924|79590534|FG001|Overall Study|Personal Reasons|2|||
44569776|NCT01678924|79590535|FG002|Overall Study|Personal Reasons|2|||
44569777|NCT01678924|79590536|FG003|Overall Study|Personal Reasons|7|||
44569778|NCT01678924|79590533|FG000|Overall Study|Withdrawal by Subject|0|||
44569779|NCT01678924|79590534|FG001|Overall Study|Withdrawal by Subject|3|||
44569780|NCT01678924|79590535|FG002|Overall Study|Withdrawal by Subject|0|||
44236702|NCT02557295|79061620|FG004|Overall Study|Lack of Efficacy|0|||
44569781|NCT01678924|79590536|FG003|Overall Study|Withdrawal by Subject|2|||
44569782|NCT01678924|79590533|FG000|Overall Study|Unable to attend scheduled visits|0|||
44569783|NCT01678924|79590534|FG001|Overall Study|Unable to attend scheduled visits|0|||
44569784|NCT01678924|79590535|FG002|Overall Study|Unable to attend scheduled visits|0|||
44569785|NCT01678924|79590536|FG003|Overall Study|Unable to attend scheduled visits|1|||
44569786|NCT02925793|79590550|FG000|Overall Study|Adverse Event|3|||
44569787|NCT02925793|79590551|FG001|Overall Study|Adverse Event|3|||
44569788|NCT02925793|79590552|FG002|Overall Study|Adverse Event|6|||
44569789|NCT02925793|79590550|FG000|Overall Study|Withdrawal by Subject|16|||
44569790|NCT02925793|79590551|FG001|Overall Study|Withdrawal by Subject|15|||
44569791|NCT02925793|79590552|FG002|Overall Study|Withdrawal by Subject|13|||
44236703|NCT02557295|79061621|FG005|Overall Study|Lack of Efficacy|0|||
44236704|NCT02557295|79061622|FG006|Overall Study|Lack of Efficacy|12|||
44236705|NCT02557295|79061623|FG007|Overall Study|Lack of Efficacy|1|||
44236706|NCT02557295|79061624|FG008|Overall Study|Lack of Efficacy|0|||
44236707|NCT02557295|79061616|FG000|Overall Study|Adverse Event|16|||
44236708|NCT02557295|79061617|FG001|Overall Study|Adverse Event|2|||
44236709|NCT02557295|79061618|FG002|Overall Study|Adverse Event|3|||
44236710|NCT02557295|79061619|FG003|Overall Study|Adverse Event|0|||
44236711|NCT02557295|79061620|FG004|Overall Study|Adverse Event|0|||
44236712|NCT02557295|79061621|FG005|Overall Study|Adverse Event|0|||
44236713|NCT02557295|79061622|FG006|Overall Study|Adverse Event|2|||
44236714|NCT02557295|79061623|FG007|Overall Study|Adverse Event|1|||
44236715|NCT02557295|79061624|FG008|Overall Study|Adverse Event|1|||
44236716|NCT02557295|79061616|FG000|Overall Study|Lost to Follow-up|4|||
44236717|NCT02557295|79061617|FG001|Overall Study|Lost to Follow-up|0|||
44236718|NCT02557295|79061618|FG002|Overall Study|Lost to Follow-up|0|||
44236719|NCT02557295|79061619|FG003|Overall Study|Lost to Follow-up|0|||
44236720|NCT02557295|79061620|FG004|Overall Study|Lost to Follow-up|0|||
44236721|NCT02557295|79061621|FG005|Overall Study|Lost to Follow-up|0|||
44236722|NCT02557295|79061622|FG006|Overall Study|Lost to Follow-up|9|||
44236723|NCT02557295|79061623|FG007|Overall Study|Lost to Follow-up|0|||
44236724|NCT02557295|79061624|FG008|Overall Study|Lost to Follow-up|0|||
44236725|NCT02557295|79061616|FG000|Overall Study|Study Close|54|||
44236726|NCT02557295|79061617|FG001|Overall Study|Study Close|3|||
44236727|NCT02557295|79061618|FG002|Overall Study|Study Close|5|||
44236728|NCT02557295|79061619|FG003|Overall Study|Study Close|3|||
44236729|NCT02557295|79061620|FG004|Overall Study|Study Close|0|||
44236730|NCT02557295|79061621|FG005|Overall Study|Study Close|0|||
44236731|NCT02557295|79061622|FG006|Overall Study|Study Close|37|||
44236732|NCT02557295|79061623|FG007|Overall Study|Study Close|3|||
44236733|NCT02557295|79061624|FG008|Overall Study|Study Close|19|||
44236734|NCT02557295|79061616|FG000|Overall Study|except for study close|4|||
44236735|NCT02557295|79061617|FG001|Overall Study|except for study close|0|||
44236736|NCT02557295|79061618|FG002|Overall Study|except for study close|0|||
44503951|NCT00064662|79508838|FG001|Overall Study|Withdrawal by Subject|14|||
44503952|NCT00064662|79508837|FG000|Overall Study|Administratively withdrawn|2|||
44503953|NCT00064662|79508838|FG001|Overall Study|Administratively withdrawn|2|||
44503954|NCT03404518|79508846|FG000|Overall Study|Lost to Follow-up|28|||
44503955|NCT03404518|79508847|FG001|Overall Study|Lost to Follow-up|30|||
44503956|NCT03404518|79508846|FG000|Overall Study|Protocol Violation|13|||
44569792|NCT02925793|79590550|FG000|Overall Study|Investigator Discretion|0|||
44503957|NCT03404518|79508847|FG001|Overall Study|Protocol Violation|6|||
44569793|NCT02925793|79590551|FG001|Overall Study|Investigator Discretion|1|||
44569794|NCT02925793|79590552|FG002|Overall Study|Investigator Discretion|1|||
44569795|NCT02925793|79590550|FG000|Overall Study|Lost to Follow-up|2|||
44236737|NCT02557295|79061619|FG003|Overall Study|except for study close|0|||
44236738|NCT02557295|79061620|FG004|Overall Study|except for study close|0|||
44236739|NCT02557295|79061621|FG005|Overall Study|except for study close|0|||
44236740|NCT02557295|79061622|FG006|Overall Study|except for study close|5|||
44236741|NCT02557295|79061623|FG007|Overall Study|except for study close|1|||
44236742|NCT02557295|79061624|FG008|Overall Study|except for study close|0|||
44236743|NCT02425046|79061638|FG000|Overall Study|Lost to Follow-up|52|||
44503958|NCT03404206|79508856|FG000|Overall Study|Withdrawal by Subject|1|||
44236744|NCT02425046|79061639|FG001|Overall Study|Lost to Follow-up|50|||
44236745|NCT02425046|79061640|FG002|Overall Study|Lost to Follow-up|56|||
44236746|NCT02425046|79061638|FG000|Overall Study|Withdrawal by Subject|16|||
44569796|NCT02925793|79590551|FG001|Overall Study|Lost to Follow-up|3|||
44569797|NCT02925793|79590552|FG002|Overall Study|Lost to Follow-up|1|||
44569798|NCT02925793|79590550|FG000|Overall Study|Lack of Efficacy|2|||
44569799|NCT02925793|79590551|FG001|Overall Study|Lack of Efficacy|6|||
44569800|NCT02925793|79590552|FG002|Overall Study|Lack of Efficacy|4|||
44569801|NCT02925793|79590550|FG000|Overall Study|Other:|2|||
44569802|NCT02925793|79590551|FG001|Overall Study|Other:|1|||
44569803|NCT02925793|79590552|FG002|Overall Study|Other:|3|||
44236747|NCT02425046|79061639|FG001|Overall Study|Withdrawal by Subject|12|||
44569804|NCT03071263|79590562|FG000|Overall Study|Adverse Event|1|||
44569805|NCT03071263|79590563|FG001|Overall Study|Adverse Event|3|||
44569806|NCT03071263|79590562|FG000|Overall Study|Withdrawal by Subject|1|||
44569807|NCT03071263|79590563|FG001|Overall Study|Withdrawal by Subject|3|||
44569808|NCT03071263|79590562|FG000|Overall Study|Physician Decision|1|||
44569809|NCT03071263|79590563|FG001|Overall Study|Physician Decision|0|||
44569810|NCT03071263|79590562|FG000|Overall Study|Participant moved to another city|0|||
44569811|NCT03071263|79590563|FG001|Overall Study|Participant moved to another city|1|||
44569812|NCT00157196|79590575|FG000|Overall Study|Ongoing at data cut-off|9|||
44569813|NCT03066193|79590579|FG000|Overall Study|Withdrawal by Subject|1|||
44569814|NCT03922321|79590583|FG000|Overall Study|Participant Moved|1|||
44569815|NCT03922321|79590583|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
44569816|NCT01677910|79590590|FG000|Double-Blind Treatment Period|Adverse Event|6|||
44569817|NCT01677910|79590591|FG001|Double-Blind Treatment Period|Adverse Event|2|||
44569818|NCT01677910|79590592|FG002|Double-Blind Treatment Period|Adverse Event|3|||
44569819|NCT01677910|79590593|FG003|Double-Blind Treatment Period|Adverse Event|0|||
44569820|NCT01677910|79590590|FG000|Double-Blind Treatment Period|Physician Decision|0|||
44569821|NCT01677910|79590591|FG001|Double-Blind Treatment Period|Physician Decision|0|||
44569822|NCT01677910|79590592|FG002|Double-Blind Treatment Period|Physician Decision|1|||
44569823|NCT01677910|79590593|FG003|Double-Blind Treatment Period|Physician Decision|0|||
44569824|NCT01677910|79590590|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
44236748|NCT02425046|79061640|FG002|Overall Study|Withdrawal by Subject|0|||
44236749|NCT02255435|79061674|FG000|Overall Study|Patient's Limited Time Availability|0|||
44236750|NCT02255435|79061675|FG001|Overall Study|Patient's Limited Time Availability|0|||
44569825|NCT01677910|79590591|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
44569826|NCT01677910|79590592|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
44569827|NCT01677910|79590593|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
44569828|NCT01677910|79590590|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
44569829|NCT01677910|79590591|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
44569830|NCT01677910|79590592|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
44236751|NCT02255435|79061676|FG002|Overall Study|Patient's Limited Time Availability|0|||
44236752|NCT02255435|79061677|FG003|Overall Study|Patient's Limited Time Availability|0|||
44236753|NCT02255435|79061678|FG004|Overall Study|Patient's Limited Time Availability|0|||
44236754|NCT02255435|79061679|FG005|Overall Study|Patient's Limited Time Availability|0|||
44569831|NCT01677910|79590593|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
44569832|NCT01677910|79590590|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
44569833|NCT01677910|79590591|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
44249734|NCT01504412|79083923|FG000|Overall Study|Other|2|||
44569834|NCT01677910|79590592|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
44569835|NCT01677910|79590593|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
44569836|NCT01677910|79590590|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
44569837|NCT01677910|79590591|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
44569838|NCT01677910|79590592|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
44569839|NCT01677910|79590593|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
44569840|NCT01677910|79590590|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
44569841|NCT01677910|79590591|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
44569842|NCT01677910|79590592|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
44569843|NCT01677910|79590593|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
44569844|NCT01677910|79590590|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
44569845|NCT01677910|79590591|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
44569846|NCT01677910|79590592|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
44569847|NCT01677910|79590593|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
44569848|NCT01677910|79590590|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
44569849|NCT01677910|79590591|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
44569850|NCT01677910|79590592|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
44569851|NCT01677910|79590593|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
44569852|NCT01677910|79590590|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
44569853|NCT01677910|79590591|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
44569854|NCT01677910|79590592|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
44569855|NCT01677910|79590593|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
44569856|NCT03911713|79590608|FG000|Overall Study|Lost to Follow-up|0|||
44569857|NCT03911713|79590609|FG001|Overall Study|Lost to Follow-up|2|||
44569858|NCT03911713|79590610|FG002|Overall Study|Lost to Follow-up|0|||
44569859|NCT03911713|79590611|FG003|Overall Study|Lost to Follow-up|0|||
44569860|NCT03911713|79590612|FG004|Overall Study|Lost to Follow-up|0|||
44569861|NCT03911713|79590608|FG000|Overall Study|Other|0|||
44236755|NCT02255435|79061680|FG006|Overall Study|Patient's Limited Time Availability|0|||
44236756|NCT02255435|79061681|FG007|Overall Study|Patient's Limited Time Availability|1|||
44503959|NCT03404206|79508857|FG001|Overall Study|Withdrawal by Subject|1|||
44503960|NCT03404206|79508858|FG002|Overall Study|Withdrawal by Subject|0|||
44503961|NCT03404206|79508856|FG000|Overall Study|Lost to Follow-up|3|||
44503962|NCT03404206|79508857|FG001|Overall Study|Lost to Follow-up|1|||
44503963|NCT03404206|79508858|FG002|Overall Study|Lost to Follow-up|0|||
44503964|NCT03403426|79508866|FG000|Overall Study|Death|1|||
44503965|NCT03403426|79508866|FG000|Overall Study|Lost to Follow-up|2|||
44503966|NCT00394901|79508874|FG000|Baseline Phase|Protocol Violation|0|||
44503967|NCT00394901|79508875|FG001|Baseline Phase|Protocol Violation|0|||
44503968|NCT00394901|79508876|FG002|Baseline Phase|Protocol Violation|1|||
44503969|NCT00394901|79508877|FG003|Baseline Phase|Protocol Violation|0|||
44503970|NCT00394901|79508874|FG000|Double-blind Phase|Adverse Event|5|||
44503971|NCT00394901|79508875|FG001|Double-blind Phase|Adverse Event|7|||
44503972|NCT00394901|79508876|FG002|Double-blind Phase|Adverse Event|16|||
44503973|NCT00394901|79508877|FG003|Double-blind Phase|Adverse Event|20|||
44503974|NCT00394901|79508874|FG000|Double-blind Phase|Lack of Efficacy|6|||
44503975|NCT00394901|79508875|FG001|Double-blind Phase|Lack of Efficacy|4|||
44503976|NCT00394901|79508876|FG002|Double-blind Phase|Lack of Efficacy|1|||
44503977|NCT00394901|79508877|FG003|Double-blind Phase|Lack of Efficacy|3|||
44503978|NCT00394901|79508874|FG000|Double-blind Phase|Withdrawal by Subject|2|||
44503979|NCT00394901|79508875|FG001|Double-blind Phase|Withdrawal by Subject|0|||
44503980|NCT00394901|79508876|FG002|Double-blind Phase|Withdrawal by Subject|0|||
44503981|NCT00394901|79508877|FG003|Double-blind Phase|Withdrawal by Subject|0|||
44503982|NCT00394901|79508874|FG000|Double-blind Phase|Lost to Follow-up|0|||
44503983|NCT00394901|79508875|FG001|Double-blind Phase|Lost to Follow-up|0|||
44503984|NCT00394901|79508876|FG002|Double-blind Phase|Lost to Follow-up|0|||
44503985|NCT00394901|79508877|FG003|Double-blind Phase|Lost to Follow-up|1|||
44503986|NCT00394901|79508874|FG000|Double-blind Phase|Protocol Violation|0|||
44503987|NCT00394901|79508875|FG001|Double-blind Phase|Protocol Violation|0|||
44503988|NCT00394901|79508876|FG002|Double-blind Phase|Protocol Violation|0|||
44503989|NCT00394901|79508877|FG003|Double-blind Phase|Protocol Violation|1|||
44503990|NCT00394901|79508874|FG000|Double-blind Phase|Death|1|||
44503991|NCT00394901|79508875|FG001|Double-blind Phase|Death|0|||
44503992|NCT00394901|79508876|FG002|Double-blind Phase|Death|0|||
44503993|NCT00394901|79508877|FG003|Double-blind Phase|Death|0|||
44503994|NCT00394901|79508874|FG000|Double-blind Phase|Subject's Personal Reason|1|||
44503995|NCT00394901|79508875|FG001|Double-blind Phase|Subject's Personal Reason|0|||
44503996|NCT00394901|79508876|FG002|Double-blind Phase|Subject's Personal Reason|0|||
44503997|NCT00394901|79508877|FG003|Double-blind Phase|Subject's Personal Reason|1|||
44503998|NCT00394901|79508874|FG000|Double-blind Phase|Lack of Compliance|0|||
44503999|NCT00394901|79508875|FG001|Double-blind Phase|Lack of Compliance|3|||
44569862|NCT03911713|79590609|FG001|Overall Study|Other|0|||
44569863|NCT03911713|79590610|FG002|Overall Study|Other|0|||
44504000|NCT00394901|79508876|FG002|Double-blind Phase|Lack of Compliance|0|||
44504001|NCT00394901|79508877|FG003|Double-blind Phase|Lack of Compliance|0|||
44504002|NCT00394901|79508874|FG000|Double-blind Phase|Entry into another study was found|0|||
44504003|NCT00394901|79508875|FG001|Double-blind Phase|Entry into another study was found|0|||
44569864|NCT03911713|79590611|FG003|Overall Study|Other|1|||
44569865|NCT03911713|79590612|FG004|Overall Study|Other|0|||
44569866|NCT03911713|79590608|FG000|Overall Study|Randomized, Never Dosed|1|||
44569867|NCT03911713|79590609|FG001|Overall Study|Randomized, Never Dosed|0|||
44569868|NCT03911713|79590610|FG002|Overall Study|Randomized, Never Dosed|0|||
44569869|NCT03911713|79590611|FG003|Overall Study|Randomized, Never Dosed|1|||
44569870|NCT03911713|79590612|FG004|Overall Study|Randomized, Never Dosed|0|||
44569871|NCT03065023|79590630|FG000|Overall Study|Progressive Disease|0|||
44569872|NCT03065023|79590631|FG001|Overall Study|Progressive Disease|1|||
44569873|NCT03065023|79590632|FG002|Overall Study|Progressive Disease|0|||
44569874|NCT03065023|79590633|FG003|Overall Study|Progressive Disease|0|||
44569875|NCT03065023|79590634|FG004|Overall Study|Progressive Disease|0|||
44569876|NCT03065023|79590630|FG000|Overall Study|Death|2|||
44569877|NCT03065023|79590631|FG001|Overall Study|Death|0|||
44569878|NCT03065023|79590632|FG002|Overall Study|Death|1|||
44569879|NCT03065023|79590633|FG003|Overall Study|Death|1|||
44569880|NCT03065023|79590634|FG004|Overall Study|Death|0|||
44569881|NCT03065023|79590630|FG000|Overall Study|Lost to Follow-up|0|||
44569882|NCT03065023|79590631|FG001|Overall Study|Lost to Follow-up|1|||
44569883|NCT03065023|79590632|FG002|Overall Study|Lost to Follow-up|0|||
44569884|NCT03065023|79590633|FG003|Overall Study|Lost to Follow-up|0|||
44569885|NCT03065023|79590634|FG004|Overall Study|Lost to Follow-up|0|||
44569886|NCT03065023|79590630|FG000|Overall Study|Participant Decision|0|||
44569887|NCT03065023|79590631|FG001|Overall Study|Participant Decision|0|||
44569888|NCT03065023|79590632|FG002|Overall Study|Participant Decision|0|||
44569889|NCT03065023|79590633|FG003|Overall Study|Participant Decision|1|||
44569890|NCT03065023|79590634|FG004|Overall Study|Participant Decision|0|||
44569891|NCT03065023|79590630|FG000|Overall Study|Withdrawal by Subject|0|||
44569892|NCT03065023|79590631|FG001|Overall Study|Withdrawal by Subject|0|||
44569893|NCT03065023|79590632|FG002|Overall Study|Withdrawal by Subject|0|||
44569894|NCT03065023|79590633|FG003|Overall Study|Withdrawal by Subject|1|||
44569895|NCT03065023|79590634|FG004|Overall Study|Withdrawal by Subject|0|||
44569896|NCT03614923|79590647|FG000|Overall Study|Withdrawal by Subject|2|||
44569897|NCT03614923|79590648|FG001|Overall Study|Withdrawal by Subject|1|||
44569898|NCT03614923|79590649|FG002|Overall Study|Withdrawal by Subject|1|||
44569899|NCT03614923|79590647|FG000|Overall Study|Adverse Event|0|||
44569900|NCT03614923|79590648|FG001|Overall Study|Adverse Event|2|||
44569901|NCT03614923|79590649|FG002|Overall Study|Adverse Event|1|||
44569902|NCT03614923|79590647|FG000|Overall Study|Lost to Follow-up|1|||
44569903|NCT03614923|79590648|FG001|Overall Study|Lost to Follow-up|0|||
44569904|NCT03614923|79590649|FG002|Overall Study|Lost to Follow-up|1|||
44569905|NCT03614923|79590647|FG000|Overall Study|Lack of Efficacy|2|||
44569906|NCT03614923|79590648|FG001|Overall Study|Lack of Efficacy|0|||
44569907|NCT03614923|79590649|FG002|Overall Study|Lack of Efficacy|1|||
44569908|NCT03614923|79590647|FG000|Overall Study|Non-compliance|0|||
44569909|NCT03614923|79590648|FG001|Overall Study|Non-compliance|1|||
44569910|NCT03614923|79590649|FG002|Overall Study|Non-compliance|0|||
44569911|NCT03614923|79590647|FG000|Overall Study|Other|0|||
44569912|NCT03614923|79590648|FG001|Overall Study|Other|1|||
44569913|NCT03614923|79590649|FG002|Overall Study|Other|1|||
44569914|NCT05098509|79590671|FG000|Overall Study|Withdrawal by Subject|0|||
44569915|NCT05098509|79590672|FG001|Overall Study|Withdrawal by Subject|0|||
44569916|NCT05098509|79590673|FG002|Overall Study|Withdrawal by Subject|1|||
44569917|NCT05098509|79590674|FG003|Overall Study|Withdrawal by Subject|0|||
44569918|NCT05098509|79590671|FG000|Overall Study|Early study termination|1|||
44569919|NCT05098509|79590672|FG001|Overall Study|Early study termination|1|||
44569920|NCT05098509|79590673|FG002|Overall Study|Early study termination|1|||
44569921|NCT05098509|79590674|FG003|Overall Study|Early study termination|0|||
44569922|NCT04962698|79590684|FG000|Motor Imagery|Technical difficulty|1|||
44569923|NCT04962698|79590685|FG001|Motor Imagery|Technical difficulty|0|||
44569924|NCT04962698|79590684|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
44569925|NCT04962698|79590685|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
44569926|NCT04962698|79590684|FG000|Kinesthetic MI|Technical difficulty|1|||
44569927|NCT04962698|79590685|FG001|Kinesthetic MI|Technical difficulty|0|||
44569928|NCT04962698|79590684|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
44569929|NCT04962698|79590685|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
44569930|NCT04962698|79590684|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
44569931|NCT04962698|79590685|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
44569932|NCT04962698|79590684|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
44569933|NCT04962698|79590685|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
44569934|NCT04962698|79590684|FG000|Virtual-hand Interaction|Technical difficulty|1|||
44569935|NCT04962698|79590685|FG001|Virtual-hand Interaction|Technical difficulty|0|||
44569936|NCT04962698|79590684|FG000|Robotic Action Observation|Technical difficulty|1|||
44569937|NCT04962698|79590685|FG001|Robotic Action Observation|Technical difficulty|0|||
44569938|NCT04962698|79590684|FG000|Rest|Technical difficulty|1|||
44249735|NCT01504412|79083924|FG001|Overall Study|Other|1|||
44569939|NCT04962698|79590685|FG001|Rest|Technical difficulty|0|||
44569940|NCT04962698|79590684|FG000|Rest|Exclusion criteria met after enrollment|0|||
44569941|NCT04962698|79590685|FG001|Rest|Exclusion criteria met after enrollment|2|||
44569942|NCT04609514|79590694|FG000|Overall Study|Lost to Follow-up|5|||
44569943|NCT04609514|79590695|FG001|Overall Study|Lost to Follow-up|4|||
44569944|NCT04609514|79590694|FG000|Overall Study|Withdrawal by PI|0|||
44569945|NCT04609514|79590695|FG001|Overall Study|Withdrawal by PI|2|||
44569946|NCT04489771|79590704|FG000|Overall Study|Death|27|||
44569947|NCT04489771|79590705|FG001|Overall Study|Death|25|||
44569948|NCT04489771|79590704|FG000|Overall Study|Withdrawal by Subject|1|||
44569949|NCT04489771|79590705|FG001|Overall Study|Withdrawal by Subject|0|||
44569950|NCT04489771|79590704|FG000|Overall Study|Participants Ongoing in Study|50|||
44569951|NCT04489771|79590705|FG001|Overall Study|Participants Ongoing in Study|51|||
44569952|NCT04467840|79590713|FG000|Overall Study|Death|35|||
44569953|NCT04467840|79590714|FG001|Overall Study|Death|39|||
44569954|NCT04467840|79590713|FG000|Overall Study|Withdrawal by Subject|8|||
44569955|NCT04467840|79590714|FG001|Overall Study|Withdrawal by Subject|4|||
44569956|NCT04467840|79590713|FG000|Overall Study|Adverse Event|2|||
44569957|NCT04467840|79590714|FG001|Overall Study|Adverse Event|0|||
44569958|NCT04467840|79590713|FG000|Overall Study|Lost to Follow-up|1|||
44569959|NCT04467840|79590714|FG001|Overall Study|Lost to Follow-up|3|||
44569960|NCT04467840|79590713|FG000|Overall Study|Physician Decision|1|||
44569961|NCT04467840|79590714|FG001|Overall Study|Physician Decision|0|||
44569962|NCT04467840|79590713|FG000|Overall Study|Other|1|||
44569963|NCT04467840|79590714|FG001|Overall Study|Other|5|||
44504004|NCT00394901|79508876|FG002|Double-blind Phase|Entry into another study was found|1|||
44569964|NCT04467840|79590713|FG000|Overall Study|Missing study completion status|3|||
44569965|NCT04467840|79590714|FG001|Overall Study|Missing study completion status|1|||
44569966|NCT04295499|79590724|FG000|Overall Study|moving out of state|1|||
44569967|NCT04295499|79590725|FG001|Overall Study|moving out of state|0|||
44569968|NCT04295499|79590724|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
44569969|NCT04295499|79590725|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
44569970|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
44569971|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
44569972|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
44569973|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
44569974|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
44569975|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
44569976|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
44569977|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
44236757|NCT02255435|79061682|FG008|Overall Study|Patient's Limited Time Availability|0|||
44236758|NCT02255435|79061683|FG009|Overall Study|Patient's Limited Time Availability|0|||
44236759|NCT02255435|79061674|FG000|Overall Study|Withdrawal by Subject|0|||
44236760|NCT02255435|79061675|FG001|Overall Study|Withdrawal by Subject|0|||
44236761|NCT02255435|79061676|FG002|Overall Study|Withdrawal by Subject|0|||
44236762|NCT02255435|79061677|FG003|Overall Study|Withdrawal by Subject|0|||
44236763|NCT02255435|79061678|FG004|Overall Study|Withdrawal by Subject|0|||
44236764|NCT02255435|79061679|FG005|Overall Study|Withdrawal by Subject|0|||
44236765|NCT02255435|79061680|FG006|Overall Study|Withdrawal by Subject|0|||
44236766|NCT02255435|79061681|FG007|Overall Study|Withdrawal by Subject|0|||
44504005|NCT00394901|79508877|FG003|Double-blind Phase|Entry into another study was found|0|||
44504006|NCT00394901|79508874|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
44504007|NCT00394901|79508875|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
44504008|NCT00394901|79508876|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
44504009|NCT00394901|79508877|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
44504010|NCT03349060|79508893|FG000|Overall Study|Adverse Event|9|||
44504011|NCT03349060|79508894|FG001|Overall Study|Adverse Event|9|||
44504012|NCT03349060|79508895|FG002|Overall Study|Adverse Event|7|||
44236767|NCT02255435|79061682|FG008|Overall Study|Withdrawal by Subject|1|||
44377718|NCT00891735|79383024|FG001|Overall Study|Physician's decision to withdraw patient|0|||
44504013|NCT03349060|79508893|FG000|Overall Study|Lack of Efficacy|1|||
44569978|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
44569979|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
44569980|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
44569981|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
44569982|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
44569983|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
44236768|NCT02255435|79061683|FG009|Overall Study|Withdrawal by Subject|4|||
44236769|NCT02255435|79061674|FG000|Overall Study|Administrative reasons|0|||
44236770|NCT02255435|79061675|FG001|Overall Study|Administrative reasons|0|||
44236771|NCT02255435|79061676|FG002|Overall Study|Administrative reasons|0|||
44236772|NCT02255435|79061677|FG003|Overall Study|Administrative reasons|0|||
44236773|NCT02255435|79061678|FG004|Overall Study|Administrative reasons|0|||
44236774|NCT02255435|79061679|FG005|Overall Study|Administrative reasons|0|||
44236775|NCT02255435|79061680|FG006|Overall Study|Administrative reasons|0|||
44236776|NCT02255435|79061681|FG007|Overall Study|Administrative reasons|0|||
44236777|NCT02255435|79061682|FG008|Overall Study|Administrative reasons|0|||
44236778|NCT02255435|79061683|FG009|Overall Study|Administrative reasons|2|||
44236779|NCT01721798|79061709|FG000|Overall Study|Death|0|||
44236780|NCT01721798|79061710|FG001|Overall Study|Death|0|||
44236781|NCT01721798|79061711|FG002|Overall Study|Death|1|||
44236782|NCT01721798|79061712|FG003|Overall Study|Death|1|||
44236783|NCT01721798|79061709|FG000|Overall Study|Lost to Follow-up|2|||
44236784|NCT01721798|79061710|FG001|Overall Study|Lost to Follow-up|2|||
44236785|NCT01721798|79061711|FG002|Overall Study|Lost to Follow-up|9|||
44377719|NCT00891735|79383025|FG002|Overall Study|Physician's decision to withdraw patient|0|||
44236786|NCT01721798|79061712|FG003|Overall Study|Lost to Follow-up|9|||
44236787|NCT01721798|79061709|FG000|Overall Study|Pregnancy|0|||
44236788|NCT01721798|79061710|FG001|Overall Study|Pregnancy|0|||
44236789|NCT01721798|79061711|FG002|Overall Study|Pregnancy|1|||
44236790|NCT01721798|79061712|FG003|Overall Study|Pregnancy|1|||
44236791|NCT01721798|79061709|FG000|Overall Study|Withdrawal by Subject|1|||
44236792|NCT01721798|79061710|FG001|Overall Study|Withdrawal by Subject|0|||
44236793|NCT01721798|79061711|FG002|Overall Study|Withdrawal by Subject|2|||
44236794|NCT01721798|79061712|FG003|Overall Study|Withdrawal by Subject|1|||
44236795|NCT01721798|79061709|FG000|Overall Study|Not eligible for 24 month visit|1|||
44236796|NCT01721798|79061710|FG001|Overall Study|Not eligible for 24 month visit|0|||
44377720|NCT00891735|79383026|FG003|Overall Study|Physician's decision to withdraw patient|0|||
44377721|NCT00891735|79383023|FG000|Overall Study|Patient's decision to withdraw|4|||
44377722|NCT00891735|79383024|FG001|Overall Study|Patient's decision to withdraw|9|||
44377723|NCT00891735|79383025|FG002|Overall Study|Patient's decision to withdraw|4|||
44377724|NCT00891735|79383026|FG003|Overall Study|Patient's decision to withdraw|8|||
44377725|NCT00891657|79383038|FG000|Overall Study|Withdrawal by Subject|1|||
44377726|NCT00891657|79383039|FG001|Overall Study|Withdrawal by Subject|1|||
44377727|NCT00917124|79383047|FG000|Overall Study|Protocol Violation|4|||
44377728|NCT00917124|79383048|FG001|Overall Study|Protocol Violation|6|||
44377729|NCT00889863|79383054|FG000|Part I: Open Label|Death|1|||
44377730|NCT00889863|79383055|FG001|Part I: Open Label|Death|0|||
44377731|NCT00889863|79383054|FG000|Part I: Open Label|Adverse Event|4|||
44377732|NCT00889863|79383055|FG001|Part I: Open Label|Adverse Event|0|||
44377733|NCT00889863|79383054|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
44377734|NCT00889863|79383055|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
44377735|NCT00889863|79383054|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
44377736|NCT00889863|79383055|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
44377737|NCT00889863|79383054|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
44377738|NCT00889863|79383055|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
44377739|NCT00889863|79383054|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
44377740|NCT00889863|79383055|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
44377741|NCT00889863|79383054|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
44377742|NCT00889863|79383055|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
44504014|NCT03349060|79508894|FG001|Overall Study|Lack of Efficacy|0|||
44504015|NCT03349060|79508895|FG002|Overall Study|Lack of Efficacy|2|||
44236797|NCT01721798|79061711|FG002|Overall Study|Not eligible for 24 month visit|8|||
44236798|NCT01721798|79061712|FG003|Overall Study|Not eligible for 24 month visit|7|||
44236799|NCT01038778|79061736|FG000|Overall Study|Withdrawal by Subject|0|||
44504016|NCT03349060|79508893|FG000|Overall Study|Lost to Follow-up|2|||
44504017|NCT03349060|79508894|FG001|Overall Study|Lost to Follow-up|1|||
44504018|NCT03349060|79508895|FG002|Overall Study|Lost to Follow-up|1|||
44504019|NCT03349060|79508893|FG000|Overall Study|Protocol Violation|2|||
44504020|NCT03349060|79508894|FG001|Overall Study|Protocol Violation|2|||
44504021|NCT03349060|79508895|FG002|Overall Study|Protocol Violation|1|||
44504022|NCT03349060|79508893|FG000|Overall Study|Withdrawal by Subject|5|||
44504023|NCT03349060|79508894|FG001|Overall Study|Withdrawal by Subject|3|||
44236800|NCT01038778|79061737|FG001|Overall Study|Withdrawal by Subject|2|||
44504024|NCT03349060|79508895|FG002|Overall Study|Withdrawal by Subject|4|||
44236801|NCT01038778|79061738|FG002|Overall Study|Withdrawal by Subject|3|||
44236802|NCT00704288|79061747|FG000|Overall Treatment Period|Adverse Event|11|||
44236803|NCT00704288|79061748|FG001|Overall Treatment Period|Adverse Event|8|||
44236804|NCT00704288|79061749|FG002|Overall Treatment Period|Adverse Event|22|||
44236805|NCT00704288|79061747|FG000|Overall Treatment Period|Death|0|||
44236806|NCT00704288|79061748|FG001|Overall Treatment Period|Death|0|||
44236807|NCT00704288|79061749|FG002|Overall Treatment Period|Death|1|||
44377743|NCT00915018|79383065|FG000|Overall Study|Death|75|||
44377744|NCT00915018|79383066|FG001|Overall Study|Death|70|||
44377745|NCT00915018|79383065|FG000|Overall Study|Lost to Follow-up|10|||
44377746|NCT00915018|79383066|FG001|Overall Study|Lost to Follow-up|5|||
44377747|NCT00915018|79383065|FG000|Overall Study|Withdrawal by Subject|38|||
44377748|NCT00915018|79383066|FG001|Overall Study|Withdrawal by Subject|27|||
44377749|NCT00915018|79383065|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
44236808|NCT00704288|79061747|FG000|Overall Treatment Period|Physician Decision|0|||
44236809|NCT00704288|79061748|FG001|Overall Treatment Period|Physician Decision|2|||
44236810|NCT00704288|79061749|FG002|Overall Treatment Period|Physician Decision|0|||
44236811|NCT00704288|79061747|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
44236812|NCT00704288|79061748|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
44236813|NCT00704288|79061749|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
44236814|NCT00704288|79061747|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
44236815|NCT00704288|79061748|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
44236816|NCT00704288|79061749|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
44236817|NCT00704288|79061747|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
44236818|NCT00704288|79061748|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
44236819|NCT00704288|79061749|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
44236820|NCT00704288|79061747|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
44504025|NCT03349060|79508893|FG000|Overall Study|Medication error,no linked adverse event|0|||
44569984|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
44569985|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
44569986|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
44569987|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
44236821|NCT00704288|79061748|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
44236822|NCT00704288|79061749|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
44236823|NCT00704288|79061747|FG000|Overall Treatment Period|Roll-over to another study|1|||
44377750|NCT00915018|79383066|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
44504026|NCT03349060|79508894|FG001|Overall Study|Medication error,no linked adverse event|0|||
44504027|NCT03349060|79508895|FG002|Overall Study|Medication error,no linked adverse event|1|||
44569988|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
44504028|NCT03349060|79508893|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
44504029|NCT03349060|79508894|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
44504030|NCT03349060|79508895|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
44504031|NCT03349060|79508893|FG000|Overall Study|Other|2|||
44504032|NCT03349060|79508894|FG001|Overall Study|Other|1|||
44504033|NCT03349060|79508895|FG002|Overall Study|Other|0|||
44504034|NCT03348904|79508906|FG000|Overall Study|Administrative reason by the sponsor|0|||
44504035|NCT03348904|79508907|FG001|Overall Study|Administrative reason by the sponsor|1|||
44504036|NCT03348904|79508908|FG002|Overall Study|Administrative reason by the sponsor|0|||
44504037|NCT00359021|79508918|FG000|Overall Study|Adverse Event|26|||
44504038|NCT00359021|79508919|FG001|Overall Study|Adverse Event|8|||
44504039|NCT00359021|79508918|FG000|Overall Study|Subject Non-Compliant|1|||
44504040|NCT00359021|79508919|FG001|Overall Study|Subject Non-Compliant|2|||
44504041|NCT00359021|79508918|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
44569989|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
44569990|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
44569991|NCT04021290|79590733|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
44569992|NCT04021290|79590734|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
44569993|NCT04021290|79590735|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
44569994|NCT04021290|79590733|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
44569995|NCT04021290|79590734|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
44569996|NCT04021290|79590735|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
44569997|NCT04021290|79590733|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
44569998|NCT04021290|79590734|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
44569999|NCT04021290|79590735|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
44570000|NCT04021290|79590733|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
44570001|NCT04021290|79590734|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
44570002|NCT04021290|79590735|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
44570003|NCT04021290|79590733|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
44570004|NCT04021290|79590734|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
44570005|NCT04021290|79590735|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
44570006|NCT03630705|79590747|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
44570007|NCT03630705|79590748|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
44570008|NCT03630705|79590749|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
44570009|NCT03630705|79590750|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
44570010|NCT03630705|79590747|FG000|Overall Study|Lost to Follow-up|1|||
44570011|NCT03630705|79590748|FG001|Overall Study|Lost to Follow-up|2|||
44570012|NCT03630705|79590749|FG002|Overall Study|Lost to Follow-up|0|||
44570013|NCT03630705|79590750|FG003|Overall Study|Lost to Follow-up|0|||
44570014|NCT03539458|79590767|FG000|Overall Study|Death|1|||
44570015|NCT03534180|79590771|FG000|Overall Study|Withdrawal by Subject|1|||
44570016|NCT03494166|79590781|FG000|Overall Study|Death|0|||
44570017|NCT03494166|79590782|FG001|Overall Study|Death|0|||
44570018|NCT03494166|79590783|FG002|Overall Study|Death|0|||
44570019|NCT03494166|79590784|FG003|Overall Study|Death|1|||
44570020|NCT03494166|79590785|FG004|Overall Study|Death|3|||
44570021|NCT03494166|79590786|FG005|Overall Study|Death|0|||
44570022|NCT03494166|79590781|FG000|Overall Study|Lost to Follow-up|2|||
44570023|NCT03494166|79590782|FG001|Overall Study|Lost to Follow-up|2|||
44570024|NCT03494166|79590783|FG002|Overall Study|Lost to Follow-up|2|||
44570025|NCT03494166|79590784|FG003|Overall Study|Lost to Follow-up|2|||
44570026|NCT03494166|79590785|FG004|Overall Study|Lost to Follow-up|14|||
44570027|NCT03494166|79590786|FG005|Overall Study|Lost to Follow-up|0|||
44570028|NCT03494166|79590781|FG000|Overall Study|Withdrawal by Subject|10|||
44570029|NCT03494166|79590782|FG001|Overall Study|Withdrawal by Subject|7|||
44570030|NCT03494166|79590783|FG002|Overall Study|Withdrawal by Subject|0|||
44570031|NCT03494166|79590784|FG003|Overall Study|Withdrawal by Subject|5|||
44570032|NCT03494166|79590785|FG004|Overall Study|Withdrawal by Subject|3|||
44570033|NCT03494166|79590786|FG005|Overall Study|Withdrawal by Subject|17|||
44570034|NCT03494166|79590781|FG000|Overall Study|Screen failure|1|||
44570035|NCT03494166|79590782|FG001|Overall Study|Screen failure|0|||
44570036|NCT03494166|79590783|FG002|Overall Study|Screen failure|0|||
44570037|NCT03494166|79590784|FG003|Overall Study|Screen failure|0|||
44570038|NCT03494166|79590785|FG004|Overall Study|Screen failure|1|||
44504042|NCT00359021|79508919|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
44504043|NCT00359021|79508918|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
44504044|NCT00359021|79508919|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
44504045|NCT00359021|79508918|FG000|Overall Study|Withdrawal by Subject|2|||
44504046|NCT00359021|79508919|FG001|Overall Study|Withdrawal by Subject|9|||
44504047|NCT00359021|79508918|FG000|Overall Study|Lost to Follow-up|1|||
44504048|NCT00359021|79508919|FG001|Overall Study|Lost to Follow-up|0|||
44504049|NCT00359021|79508918|FG000|Overall Study|Other|4|||
44504050|NCT00359021|79508919|FG001|Overall Study|Other|1|||
44504051|NCT00359021|79508918|FG000|Overall Study|Pregnancy|1|||
44504052|NCT00359021|79508919|FG001|Overall Study|Pregnancy|0|||
44504053|NCT00360269|79508929|FG000|Overall Study|Lost to Follow-up|7|||
44570039|NCT03494166|79590786|FG005|Overall Study|Screen failure|0|||
44570040|NCT03367156|79590808|FG000|Overall Study|Lack of interest|3|||
44570041|NCT03367156|79590809|FG001|Overall Study|Lack of interest|1|||
44570042|NCT03367156|79590808|FG000|Overall Study|Death|2|||
44570043|NCT03367156|79590809|FG001|Overall Study|Death|0|||
44570044|NCT03367156|79590808|FG000|Overall Study|Lost to Follow-up|2|||
44236824|NCT00704288|79061748|FG001|Overall Treatment Period|Roll-over to another study|0|||
44504054|NCT00360269|79508930|FG001|Overall Study|Lost to Follow-up|9|||
44504055|NCT00360269|79508929|FG000|Overall Study|Physician Decision|1|||
44504056|NCT00360269|79508930|FG001|Overall Study|Physician Decision|2|||
44504057|NCT00360269|79508929|FG000|Overall Study|Adverse Event|1|||
44570045|NCT03367156|79590809|FG001|Overall Study|Lost to Follow-up|1|||
44570046|NCT03367156|79590808|FG000|Overall Study|Became ineligible|1|||
44570047|NCT03367156|79590809|FG001|Overall Study|Became ineligible|2|||
44570048|NCT03367156|79590808|FG000|Overall Study|Hospitalization|1|||
44570049|NCT03367156|79590809|FG001|Overall Study|Hospitalization|0|||
44570050|NCT03367156|79590808|FG000|Overall Study|Concerned about Treatment|11|||
44570051|NCT03367156|79590809|FG001|Overall Study|Concerned about Treatment|3|||
44570052|NCT03367156|79590808|FG000|Overall Study|Started new treatment|4|||
44570053|NCT03367156|79590809|FG001|Overall Study|Started new treatment|1|||
44570054|NCT03302299|79590817|FG000|Overall Study|Protocol Violation|1|||
44570055|NCT03262935|79590824|FG000|Overall Study|Withdrawal by Subject|6|||
44570056|NCT03262935|79590825|FG001|Overall Study|Withdrawal by Subject|7|||
44236825|NCT00704288|79061749|FG002|Overall Treatment Period|Roll-over to another study|4|||
44236826|NCT00704288|79061747|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
44236827|NCT00704288|79061748|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
44236828|NCT00704288|79061749|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
44236829|NCT00704288|79061747|FG000|Extended Post Treatment Follow Up Period|Death|41|||
44236830|NCT00704288|79061748|FG001|Extended Post Treatment Follow Up Period|Death|50|||
44236831|NCT00704288|79061749|FG002|Extended Post Treatment Follow Up Period|Death|93|||
44570057|NCT03262935|79590824|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
44570058|NCT03262935|79590825|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
44570059|NCT03262935|79590824|FG000|Overall Study|Death|181|||
44236832|NCT00704288|79061747|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
44236833|NCT00704288|79061748|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
44236834|NCT00704288|79061749|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
44236835|NCT00704288|79061747|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
44236836|NCT00704288|79061748|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
44570060|NCT03262935|79590825|FG001|Overall Study|Death|94|||
44570061|NCT03262935|79590824|FG000|Overall Study|Lost to Follow-up|9|||
44570062|NCT03262935|79590825|FG001|Overall Study|Lost to Follow-up|4|||
44570063|NCT03262935|79590824|FG000|Overall Study|Other reason|5|||
44570064|NCT03262935|79590825|FG001|Overall Study|Other reason|0|||
44570065|NCT02603562|79590854|FG000|Overall Study|Lost to Follow-up|1|||
44570066|NCT02586727|79590860|FG000|Overall Study|Lost to Follow-up|1|||
44570067|NCT02586727|79590861|FG001|Overall Study|Lost to Follow-up|0|||
44236837|NCT00704288|79061749|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
44236838|NCT00704288|79061747|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
44236839|NCT00704288|79061748|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
44504058|NCT00360269|79508930|FG001|Overall Study|Adverse Event|0|||
44504059|NCT00360269|79508929|FG000|Overall Study|Withdrawal by Subject|1|||
44504060|NCT00360269|79508930|FG001|Overall Study|Withdrawal by Subject|1|||
44504061|NCT00076752|79508936|FG000|Overall Study|Death|2|||
44504062|NCT00076752|79508936|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
44504063|NCT03384940|79508944|FG000|Overall Study|Progressive disease|36|||
44504064|NCT03384940|79508945|FG001|Overall Study|Progressive disease|11|||
44504065|NCT03384940|79508946|FG002|Overall Study|Progressive disease|13|||
44504066|NCT03384940|79508944|FG000|Overall Study|Clinical progression|4|||
44504067|NCT03384940|79508945|FG001|Overall Study|Clinical progression|0|||
44504068|NCT03384940|79508946|FG002|Overall Study|Clinical progression|3|||
44504069|NCT03384940|79508944|FG000|Overall Study|Adverse Event|7|||
44504070|NCT03384940|79508945|FG001|Overall Study|Adverse Event|1|||
44504071|NCT03384940|79508946|FG002|Overall Study|Adverse Event|1|||
44504072|NCT03384940|79508944|FG000|Overall Study|Withdrawal by Subject|3|||
44504073|NCT03384940|79508945|FG001|Overall Study|Withdrawal by Subject|1|||
44504074|NCT03384940|79508946|FG002|Overall Study|Withdrawal by Subject|0|||
44504075|NCT03384940|79508944|FG000|Overall Study|Physician Decision|1|||
44504076|NCT03384940|79508945|FG001|Overall Study|Physician Decision|1|||
44570068|NCT02339909|79590888|FG000|Overall Study|Became ineligible after randomisation|89|||
44570069|NCT02339909|79590889|FG001|Overall Study|Became ineligible after randomisation|63|||
44570070|NCT02339909|79590890|FG002|Overall Study|Became ineligible after randomisation|71|||
44236840|NCT00704288|79061749|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
44504077|NCT03384940|79508946|FG002|Overall Study|Physician Decision|0|||
44570071|NCT02076113|79590900|FG000|Overall Study|Lost to Follow-up|4|||
44570072|NCT02076113|79590901|FG001|Overall Study|Lost to Follow-up|1|||
44570073|NCT02076113|79590900|FG000|Overall Study|Withdrawal by Subject|2|||
44570074|NCT02076113|79590901|FG001|Overall Study|Withdrawal by Subject|3|||
44570075|NCT02076113|79590900|FG000|Overall Study|Death|1|||
44570076|NCT02076113|79590901|FG001|Overall Study|Death|3|||
44570077|NCT01586910|79590912|FG000|Overall Study|Death|4|||
44570078|NCT01586910|79590913|FG001|Overall Study|Death|4|||
44570079|NCT01586910|79590912|FG000|Overall Study|Withdrawal by Subject|6|||
44570080|NCT01586910|79590913|FG001|Overall Study|Withdrawal by Subject|43|||
44570081|NCT01586910|79590912|FG000|Overall Study|Physician withdrew Subject|5|||
44570082|NCT01586910|79590913|FG001|Overall Study|Physician withdrew Subject|24|||
44570083|NCT01496976|79590921|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
44570084|NCT02915016|79590944|FG000|Overall Study|Lost to Follow-up|4|||
44570085|NCT02915016|79590945|FG001|Overall Study|Lost to Follow-up|2|||
44570086|NCT02915016|79590946|FG002|Overall Study|Lost to Follow-up|5|||
44570087|NCT02915016|79590947|FG003|Overall Study|Lost to Follow-up|3|||
44570088|NCT02915016|79590948|FG004|Overall Study|Lost to Follow-up|5|||
44570089|NCT02915016|79590949|FG005|Overall Study|Lost to Follow-up|2|||
44570090|NCT02915016|79590950|FG006|Overall Study|Lost to Follow-up|8|||
44504078|NCT03384940|79508944|FG000|Overall Study|Death|2|||
44504079|NCT03384940|79508945|FG001|Overall Study|Death|1|||
44570091|NCT02915016|79590951|FG007|Overall Study|Lost to Follow-up|2|||
44570092|NCT02915016|79590944|FG000|Overall Study|Physician Decision|0|||
44570093|NCT02915016|79590945|FG001|Overall Study|Physician Decision|0|||
44570094|NCT02915016|79590946|FG002|Overall Study|Physician Decision|1|||
44570095|NCT02915016|79590947|FG003|Overall Study|Physician Decision|0|||
44570096|NCT02915016|79590948|FG004|Overall Study|Physician Decision|0|||
44570097|NCT02915016|79590949|FG005|Overall Study|Physician Decision|1|||
44570098|NCT02915016|79590950|FG006|Overall Study|Physician Decision|2|||
44570099|NCT02915016|79590951|FG007|Overall Study|Physician Decision|0|||
44570100|NCT02915016|79590944|FG000|Overall Study|Withdrawal by Subject|2|||
44570101|NCT02915016|79590945|FG001|Overall Study|Withdrawal by Subject|0|||
44570102|NCT02915016|79590946|FG002|Overall Study|Withdrawal by Subject|1|||
44570103|NCT02915016|79590947|FG003|Overall Study|Withdrawal by Subject|0|||
44570104|NCT02915016|79590948|FG004|Overall Study|Withdrawal by Subject|1|||
44570105|NCT02915016|79590949|FG005|Overall Study|Withdrawal by Subject|3|||
44570106|NCT02915016|79590950|FG006|Overall Study|Withdrawal by Subject|1|||
44570107|NCT02915016|79590951|FG007|Overall Study|Withdrawal by Subject|1|||
44570108|NCT02915016|79590944|FG000|Overall Study|Elected not to continue|0|||
44570109|NCT02915016|79590945|FG001|Overall Study|Elected not to continue|0|||
44570110|NCT02915016|79590946|FG002|Overall Study|Elected not to continue|0|||
44504080|NCT03384940|79508946|FG002|Overall Study|Death|0|||
44504081|NCT03384940|79508944|FG000|Overall Study|Other|0|||
44504082|NCT03384940|79508945|FG001|Overall Study|Other|0|||
44504083|NCT03384940|79508946|FG002|Overall Study|Other|1|||
44570111|NCT02915016|79590947|FG003|Overall Study|Elected not to continue|1|||
44570112|NCT02915016|79590948|FG004|Overall Study|Elected not to continue|0|||
44570113|NCT02915016|79590949|FG005|Overall Study|Elected not to continue|0|||
44570114|NCT02915016|79590950|FG006|Overall Study|Elected not to continue|1|||
44570115|NCT02915016|79590951|FG007|Overall Study|Elected not to continue|0|||
44570116|NCT02915016|79590944|FG000|Overall Study|HIV infection|1|||
44570117|NCT02915016|79590945|FG001|Overall Study|HIV infection|1|||
44570118|NCT02915016|79590946|FG002|Overall Study|HIV infection|1|||
44570119|NCT02915016|79590947|FG003|Overall Study|HIV infection|0|||
44570120|NCT02915016|79590948|FG004|Overall Study|HIV infection|1|||
44570121|NCT02915016|79590949|FG005|Overall Study|HIV infection|0|||
44570122|NCT02915016|79590950|FG006|Overall Study|HIV infection|0|||
44570123|NCT02915016|79590951|FG007|Overall Study|HIV infection|0|||
44570124|NCT02915016|79590944|FG000|Overall Study|Participant unable to adhere|0|||
44570125|NCT02915016|79590945|FG001|Overall Study|Participant unable to adhere|0|||
44504084|NCT00075582|79508956|FG000|Overall Study|Adverse Event|3|||
44504085|NCT00075582|79508957|FG001|Overall Study|Adverse Event|1|||
44504086|NCT00075582|79508956|FG000|Overall Study|Lack of Efficacy|4|||
44504087|NCT00075582|79508957|FG001|Overall Study|Lack of Efficacy|8|||
44504088|NCT00075582|79508956|FG000|Overall Study|Physician Decision|5|||
44504089|NCT00075582|79508957|FG001|Overall Study|Physician Decision|8|||
44570126|NCT02915016|79590946|FG002|Overall Study|Participant unable to adhere|0|||
44570127|NCT02915016|79590947|FG003|Overall Study|Participant unable to adhere|0|||
44570128|NCT02915016|79590948|FG004|Overall Study|Participant unable to adhere|0|||
44570129|NCT02915016|79590949|FG005|Overall Study|Participant unable to adhere|0|||
44570130|NCT02915016|79590950|FG006|Overall Study|Participant unable to adhere|0|||
44570131|NCT02915016|79590951|FG007|Overall Study|Participant unable to adhere|1|||
44504090|NCT00075582|79508956|FG000|Overall Study|Withdrawal by Subject|2|||
44504091|NCT00075582|79508957|FG001|Overall Study|Withdrawal by Subject|2|||
44504092|NCT00075582|79508956|FG000|Overall Study|Ineligible for study|36|||
44570132|NCT03323749|79590971|FG000|Double-blind Period|Lost to Follow-up|4|||
44570133|NCT03323749|79590972|FG001|Double-blind Period|Lost to Follow-up|5|||
44570134|NCT03323749|79590971|FG000|Double-blind Period|Adverse Event|3|||
44570135|NCT03323749|79590972|FG001|Double-blind Period|Adverse Event|1|||
44570136|NCT03323749|79590971|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
44570137|NCT03323749|79590972|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
44570138|NCT03323749|79590971|FG000|Open-Label Period|Adverse Event|3|||
44570139|NCT03323749|79590972|FG001|Open-Label Period|Adverse Event|10|||
44504093|NCT00075582|79508957|FG001|Overall Study|Ineligible for study|16|||
44570140|NCT03323749|79590971|FG000|Open-Label Period|Withdrawal by Subject|7|||
44570141|NCT03323749|79590972|FG001|Open-Label Period|Withdrawal by Subject|5|||
44570142|NCT02208024|79590991|FG000|Overall Study|Withdrawal by Subject|1|||
44570143|NCT02660086|79590997|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
44570144|NCT02660086|79590998|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
44570145|NCT02660086|79590997|FG000|Overall Study- 12-month|Left full-time employment|12|||
44570146|NCT02660086|79590998|FG001|Overall Study- 12-month|Left full-time employment|20|||
44570147|NCT02660086|79590997|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
44570148|NCT02660086|79590998|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
44570149|NCT02660086|79590997|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
44570150|NCT02660086|79590998|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
44570151|NCT02660086|79590997|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
44570152|NCT02660086|79590998|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
44570153|NCT02660086|79590997|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
44570154|NCT02660086|79590998|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
44570155|NCT01678144|79591004|FG000|Stage 1: MAR Classic|Adverse Event|1|||
44570156|NCT00153920|79591008|FG000|Overall Study|Adverse Event|9|||
44570157|NCT00153920|79591008|FG000|Overall Study|Progressive Disease|9|||
44570158|NCT00153920|79591008|FG000|Overall Study|Physician Decision|3|||
44570159|NCT00153920|79591008|FG000|Overall Study|Lack of Response|3|||
44570160|NCT00153920|79591008|FG000|Overall Study|Death|2|||
44570161|NCT00153920|79591008|FG000|Overall Study|Withdrawal by Subject|1|||
44570162|NCT00153920|79591008|FG000|Overall Study|Non-Protocol Therapy|1|||
44570163|NCT00153920|79591008|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
44570164|NCT00153920|79591008|FG000|Overall Study|Progressive Disease before Trt|1|||
44570165|NCT02660242|79591012|FG000|Glucose Tabs|Lost to Follow-up|1|||
44570166|NCT02660242|79591012|FG000|Glucagon Injection|Lost to Follow-up|1|||
44570167|NCT03072043|79591028|FG000|Overall Study|Death|0|||
44570168|NCT03072043|79591029|FG001|Overall Study|Death|0|||
44570169|NCT03072043|79591030|FG002|Overall Study|Death|3|||
44570170|NCT03072043|79591028|FG000|Overall Study|Adverse Event|0|||
44570171|NCT03072043|79591029|FG001|Overall Study|Adverse Event|0|||
44570172|NCT03072043|79591030|FG002|Overall Study|Adverse Event|2|||
44504094|NCT00063258|79508969|FG000|Overall Study|Physician Decision|2|||
44504095|NCT00063258|79508970|FG001|Overall Study|Physician Decision|0|||
44504096|NCT00063258|79508969|FG000|Overall Study|Lack of Efficacy|2|||
44504097|NCT00063258|79508970|FG001|Overall Study|Lack of Efficacy|0|||
44504098|NCT00088530|79508978|FG000|Overall Study|Progressive/Relapsed Disease|28|||
44504099|NCT00088530|79508979|FG001|Overall Study|Progressive/Relapsed Disease|39|||
44504100|NCT00088530|79508978|FG000|Overall Study|Adverse Event|15|||
44504101|NCT00088530|79508979|FG001|Overall Study|Adverse Event|9|||
44504102|NCT00088530|79508978|FG000|Overall Study|Withdrawal by Subject|2|||
44504103|NCT00088530|79508979|FG001|Overall Study|Withdrawal by Subject|5|||
44570173|NCT03072043|79591028|FG000|Overall Study|Withdrawal by Subject|0|||
44504104|NCT00088530|79508978|FG000|Overall Study|Lost to Follow-up|2|||
44504105|NCT00088530|79508979|FG001|Overall Study|Lost to Follow-up|0|||
44570174|NCT03072043|79591029|FG001|Overall Study|Withdrawal by Subject|0|||
44570175|NCT03072043|79591030|FG002|Overall Study|Withdrawal by Subject|4|||
44570176|NCT03069313|79591042|FG000|Overall Study|Adverse Event|5|||
44570177|NCT03068767|79591048|FG000|Overall Study|Lost to Follow-up|7|||
44570178|NCT03068767|79591049|FG001|Overall Study|Lost to Follow-up|3|||
44570179|NCT03068767|79591048|FG000|Overall Study|Protocol Violation|3|||
44504106|NCT00088530|79508978|FG000|Overall Study|Physician Decision|2|||
44504107|NCT00088530|79508979|FG001|Overall Study|Physician Decision|0|||
44570180|NCT03068767|79591049|FG001|Overall Study|Protocol Violation|0|||
44570181|NCT03020745|79591063|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570182|NCT03020745|79591064|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570183|NCT03020745|79591065|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570184|NCT03020745|79591066|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570185|NCT03020745|79591067|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570186|NCT03020745|79591068|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570187|NCT03020745|79591069|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570188|NCT03020745|79591070|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570189|NCT03020745|79591071|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
44570190|NCT03020745|79591072|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
44570191|NCT03020745|79591063|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570192|NCT03020745|79591064|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44236841|NCT00322712|79061766|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
44236842|NCT01605227|79061772|FG000|Overall Study|Did not receive study treatment|2|||
44236843|NCT01605227|79061773|FG001|Overall Study|Did not receive study treatment|3|||
44236844|NCT01605227|79061772|FG000|Overall Study|Adverse Event|228|||
44236845|NCT01605227|79061773|FG001|Overall Study|Adverse Event|42|||
44236846|NCT01605227|79061772|FG000|Overall Study|Progressive Disease|132|||
44236847|NCT01605227|79061773|FG001|Overall Study|Progressive Disease|128|||
44236848|NCT01605227|79061772|FG000|Overall Study|Clinical Deterioration|227|||
44236849|NCT01605227|79061773|FG001|Overall Study|Clinical Deterioration|133|||
44236850|NCT01605227|79061772|FG000|Overall Study|Lost to Follow-up|1|||
44236851|NCT01605227|79061773|FG001|Overall Study|Lost to Follow-up|0|||
44236852|NCT01605227|79061772|FG000|Overall Study|Protocol Violation|1|||
44236853|NCT01605227|79061773|FG001|Overall Study|Protocol Violation|0|||
44236854|NCT01605227|79061772|FG000|Overall Study|Physician Decision|9|||
44236855|NCT01605227|79061773|FG001|Overall Study|Physician Decision|7|||
44236856|NCT01605227|79061772|FG000|Overall Study|Withdrawal by Subject|18|||
44236857|NCT01605227|79061773|FG001|Overall Study|Withdrawal by Subject|14|||
44236858|NCT01605227|79061772|FG000|Overall Study|Sponsor Decision|2|||
44236859|NCT01605227|79061773|FG001|Overall Study|Sponsor Decision|0|||
44236860|NCT01605227|79061772|FG000|Overall Study|Started New Therapy|1|||
44236861|NCT01605227|79061773|FG001|Overall Study|Started New Therapy|0|||
44275889|NCT04169373|79226152|FG001|Week 1 to Week 14|Other|3|||
44570193|NCT03020745|79591065|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570194|NCT03020745|79591066|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570195|NCT03020745|79591067|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570196|NCT03020745|79591068|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44275890|NCT04169373|79226153|FG002|Week 1 to Week 14|Other|3|||
44275891|NCT04169373|79226154|FG003|Week 1 to Week 14|Other|5|||
44570197|NCT03020745|79591069|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570198|NCT03020745|79591070|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
44570199|NCT03020745|79591071|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570200|NCT03020745|79591072|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
44570201|NCT03020745|79591063|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44570202|NCT03020745|79591064|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44570203|NCT03020745|79591065|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44570204|NCT03020745|79591066|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44570205|NCT03020745|79591067|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44570206|NCT03020745|79591068|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
44570207|NCT03020745|79591069|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44570208|NCT03020745|79591070|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44236862|NCT01605227|79061772|FG000|Overall Study|Subject Decision|0|||
44504108|NCT00088530|79508978|FG000|Overall Study|Sponsor decision|0|||
44504109|NCT00088530|79508979|FG001|Overall Study|Sponsor decision|1|||
44504110|NCT00088530|79508978|FG000|Overall Study|Patient never treated|1|||
44504111|NCT00088530|79508979|FG001|Overall Study|Patient never treated|0|||
44504112|NCT00359801|79508987|FG000|Overall Study|Lost to Follow-up|72|||
44504113|NCT00359801|79508988|FG001|Overall Study|Lost to Follow-up|58|||
44504114|NCT00359801|79508987|FG000|Overall Study|Withdrawal by Subject|143|||
44504115|NCT00359801|79508988|FG001|Overall Study|Withdrawal by Subject|96|||
44504116|NCT00359801|79508987|FG000|Overall Study|Other|66|||
44504117|NCT00359801|79508988|FG001|Overall Study|Other|46|||
44504118|NCT00359801|79508987|FG000|Overall Study|Final Status Unknown: missing data|7|||
44504119|NCT00359801|79508988|FG001|Overall Study|Final Status Unknown: missing data|4|||
44570209|NCT03020745|79591071|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
44570210|NCT03020745|79591072|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
44236863|NCT01605227|79061773|FG001|Overall Study|Subject Decision|1|||
44236864|NCT01605227|79061772|FG000|Overall Study|Dose Held >6 weeks|0|||
44275892|NCT04169373|79226151|FG000|Week 14 to Week 52|Adverse Event|1|||
44570211|NCT03020745|79591063|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44275893|NCT04169373|79226152|FG001|Week 14 to Week 52|Adverse Event|0|||
44504120|NCT00359801|79508987|FG000|Overall Study|Sponsor Decision|17|||
44504121|NCT00359801|79508988|FG001|Overall Study|Sponsor Decision|16|||
44570212|NCT03020745|79591064|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44570213|NCT03020745|79591065|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44570214|NCT03020745|79591066|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44570215|NCT03020745|79591067|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44570216|NCT03020745|79591068|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44236865|NCT01605227|79061773|FG001|Overall Study|Dose Held >6 weeks|1|||
44236866|NCT01709513|79061782|FG000|Overall Study|Randomized but not treated|0|||
44236867|NCT01709513|79061783|FG001|Overall Study|Randomized but not treated|1|||
44236868|NCT01709513|79061784|FG002|Overall Study|Randomized but not treated|0|||
44236869|NCT01709513|79061782|FG000|Overall Study|Adverse Event|16|||
44236870|NCT01709513|79061783|FG001|Overall Study|Adverse Event|31|||
44236871|NCT01709513|79061784|FG002|Overall Study|Adverse Event|23|||
44236872|NCT01709513|79061782|FG000|Overall Study|Poor compliance to protocol|2|||
44236873|NCT01709513|79061783|FG001|Overall Study|Poor compliance to protocol|0|||
44236874|NCT01709513|79061784|FG002|Overall Study|Poor compliance to protocol|0|||
44236875|NCT01709513|79061782|FG000|Overall Study|Other|3|||
44236876|NCT01709513|79061783|FG001|Overall Study|Other|11|||
44236877|NCT01709513|79061784|FG002|Overall Study|Other|7|||
44377751|NCT00916578|79383072|FG000|Overall Study|Physician Decision|2|||
44504122|NCT00045032|79508997|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
44504123|NCT00045032|79508998|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
44504124|NCT00045032|79508999|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
44504125|NCT00045032|79508997|FG000|Overall Study|Death|22|||
44504126|NCT00045032|79508998|FG001|Overall Study|Death|24|||
44504127|NCT00045032|79508999|FG002|Overall Study|Death|17|||
44504128|NCT00045032|79508997|FG000|Overall Study|Insufficient Therapeutic Response|542|||
44504129|NCT00045032|79508998|FG001|Overall Study|Insufficient Therapeutic Response|437|||
44504130|NCT00045032|79508999|FG002|Overall Study|Insufficient Therapeutic Response|445|||
44504131|NCT00045032|79508997|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
44504132|NCT00045032|79508998|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
44504133|NCT00045032|79508999|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
44504134|NCT00045032|79508997|FG000|Overall Study|Other Protocol Violation|2|||
44504135|NCT00045032|79508998|FG001|Overall Study|Other Protocol Violation|0|||
44504136|NCT00045032|79508999|FG002|Overall Study|Other Protocol Violation|1|||
44504137|NCT00045032|79508997|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
44504138|NCT00045032|79508998|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
44504139|NCT00045032|79508999|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
44570217|NCT03020745|79591069|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44236878|NCT01605071|79061797|FG000|Overall Study|Withdrawal by Subject|3|||
44236879|NCT01605071|79061798|FG001|Overall Study|Withdrawal by Subject|2|||
44504140|NCT00045032|79508997|FG000|Overall Study|Failure to Return|57|||
44570218|NCT03020745|79591070|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44570219|NCT03020745|79591071|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
44570220|NCT03020745|79591072|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
44570221|NCT03019965|79591107|FG000|Overall Study|Withdrawal by Subject|1|||
44570222|NCT03019965|79591108|FG001|Overall Study|Withdrawal by Subject|0|||
44570223|NCT03019965|79591107|FG000|Overall Study|Protocol Violation|1|||
44570224|NCT03019965|79591108|FG001|Overall Study|Protocol Violation|3|||
44570225|NCT03019965|79591107|FG000|Overall Study|viral or fungal infection|3|||
44570226|NCT03019965|79591108|FG001|Overall Study|viral or fungal infection|4|||
44570227|NCT03019965|79591107|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
44570228|NCT03019965|79591108|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
44570229|NCT03019965|79591107|FG000|Overall Study|Physician Decision|1|||
44570230|NCT03019965|79591108|FG001|Overall Study|Physician Decision|1|||
44570231|NCT01675882|79591127|FG000|Overall Study|Adverse Event|0|||
44570232|NCT01675882|79591128|FG001|Overall Study|Adverse Event|2|||
44570233|NCT01675882|79591129|FG002|Overall Study|Adverse Event|1|||
44570234|NCT01675882|79591130|FG003|Overall Study|Adverse Event|0|||
44570235|NCT01675882|79591127|FG000|Overall Study|Participant unwilling to continue|2|||
44570236|NCT01675882|79591128|FG001|Overall Study|Participant unwilling to continue|4|||
44236880|NCT02710422|79061808|FG000|Overall Study|Termination of study|9|||
44236881|NCT02710422|79061809|FG001|Overall Study|Termination of study|9|||
44236882|NCT01706159|79061819|FG000|Overall Study|Withdrawal Criteria|2|||
44236883|NCT01706159|79061820|FG001|Overall Study|Withdrawal Criteria|1|||
44236884|NCT01706159|79061819|FG000|Overall Study|Unclassified|6|||
44236885|NCT01706159|79061820|FG001|Overall Study|Unclassified|1|||
44236886|NCT01706003|79061828|FG000|Overall Study|Withdrawal by Subject|2|||
44236887|NCT01706003|79061829|FG001|Overall Study|Withdrawal by Subject|0|||
44236888|NCT01706003|79061828|FG000|Overall Study|Not scheduled|3|||
44236889|NCT01706003|79061829|FG001|Overall Study|Not scheduled|0|||
44236890|NCT01706003|79061828|FG000|Overall Study|Lost to Follow-up|6|||
44236891|NCT01706003|79061829|FG001|Overall Study|Lost to Follow-up|4|||
44236892|NCT01705691|79061837|FG000|Overall Study|Death|1|||
44236893|NCT01705691|79061838|FG001|Overall Study|Death|2|||
44236894|NCT01705691|79061837|FG000|Overall Study|Withdrawal by Subject|1|||
44236895|NCT01705691|79061838|FG001|Overall Study|Withdrawal by Subject|2|||
44236896|NCT01705691|79061837|FG000|Overall Study|Lost to Follow-up|1|||
44504141|NCT00045032|79508998|FG001|Overall Study|Failure to Return|62|||
44504142|NCT00045032|79508999|FG002|Overall Study|Failure to Return|61|||
44236897|NCT01705691|79061838|FG001|Overall Study|Lost to Follow-up|1|||
44236898|NCT01705691|79061837|FG000|Overall Study|Other|0|||
44236899|NCT01705691|79061838|FG001|Overall Study|Other|1|||
44275894|NCT04169373|79226153|FG002|Week 14 to Week 52|Adverse Event|0|||
44275895|NCT04169373|79226154|FG003|Week 14 to Week 52|Adverse Event|1|||
44275896|NCT04169373|79226151|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
44504143|NCT00045032|79508997|FG000|Overall Study|Other|93|||
44504144|NCT00045032|79508998|FG001|Overall Study|Other|84|||
44504145|NCT00045032|79508999|FG002|Overall Study|Other|105|||
44504146|NCT00356915|79509012|FG000|Overall Study|Non compliance|1|||
44504147|NCT00356915|79509013|FG001|Overall Study|Non compliance|2|||
44504148|NCT00356915|79509014|FG002|Overall Study|Non compliance|1|||
44504149|NCT00356915|79509012|FG000|Overall Study|Protocol Violation|2|||
44504150|NCT00356915|79509013|FG001|Overall Study|Protocol Violation|3|||
44504151|NCT00356915|79509014|FG002|Overall Study|Protocol Violation|2|||
44504152|NCT00356915|79509012|FG000|Overall Study|Withdrawal by Subject|14|||
44504153|NCT00356915|79509013|FG001|Overall Study|Withdrawal by Subject|14|||
44504154|NCT00356915|79509014|FG002|Overall Study|Withdrawal by Subject|10|||
44504155|NCT00356915|79509012|FG000|Overall Study|Lack of Efficacy|0|||
44570237|NCT01675882|79591129|FG002|Overall Study|Participant unwilling to continue|2|||
44570238|NCT01675882|79591130|FG003|Overall Study|Participant unwilling to continue|1|||
44570239|NCT01675882|79591127|FG000|Overall Study|Lost to Follow-up|0|||
44570240|NCT01675882|79591128|FG001|Overall Study|Lost to Follow-up|1|||
44236900|NCT03766906|79061844|FG000|Overall Study|Withdrawal by Subject|6|||
44236901|NCT01705145|79061848|FG000|Part B|Adverse Event|1|||
44236902|NCT01704755|79061866|FG000|Overall Study|Adverse Event|4|||
44504156|NCT00356915|79509013|FG001|Overall Study|Lack of Efficacy|0|||
44504157|NCT00356915|79509014|FG002|Overall Study|Lack of Efficacy|3|||
44570241|NCT01675882|79591129|FG002|Overall Study|Lost to Follow-up|0|||
44570242|NCT01675882|79591130|FG003|Overall Study|Lost to Follow-up|0|||
44570243|NCT01675882|79591127|FG000|Overall Study|Non-compliance|0|||
44570244|NCT01675882|79591128|FG001|Overall Study|Non-compliance|0|||
44236903|NCT01704755|79061867|FG001|Overall Study|Adverse Event|1|||
44236904|NCT01704755|79061866|FG000|Overall Study|Lost to Follow-up|3|||
44236905|NCT01704755|79061867|FG001|Overall Study|Lost to Follow-up|4|||
44236906|NCT01704755|79061866|FG000|Overall Study|Withdrew consent|1|||
44236907|NCT01704755|79061867|FG001|Overall Study|Withdrew consent|1|||
44236908|NCT01704755|79061866|FG000|Overall Study|Other (not specified)|3|||
44236909|NCT01704755|79061867|FG001|Overall Study|Other (not specified)|1|||
44236910|NCT01704755|79061866|FG000|Overall Study|Withdrew consent and personal issues|1|||
44236911|NCT01704755|79061867|FG001|Overall Study|Withdrew consent and personal issues|0|||
44236912|NCT01704599|79061873|FG000|Overall Study|Adverse Event|1|||
44236913|NCT03599518|79061905|FG000|Overall Study|Clinical progression|0|||
44570245|NCT01675882|79591129|FG002|Overall Study|Non-compliance|0|||
44570246|NCT01675882|79591130|FG003|Overall Study|Non-compliance|1|||
44570247|NCT03018249|79591142|FG000|Overall Study|Withdrawal by Subject|2|||
44570248|NCT03018249|79591143|FG001|Overall Study|Withdrawal by Subject|2|||
44570249|NCT02923245|79591161|FG000|Overall Study|ultrasound order was cancelled|2|||
44570250|NCT02923245|79591162|FG001|Overall Study|ultrasound order was cancelled|1|||
44570251|NCT00905606|79591178|FG000|Period 1|Adverse Event|0|||
44236914|NCT03599518|79061906|FG001|Overall Study|Clinical progression|0|||
44236915|NCT03599518|79061907|FG002|Overall Study|Clinical progression|0|||
44504158|NCT00356915|79509012|FG000|Overall Study|Lost to Follow-up|27|||
44504159|NCT00356915|79509013|FG001|Overall Study|Lost to Follow-up|34|||
44570252|NCT00905606|79591179|FG001|Period 1|Adverse Event|1|||
44504160|NCT00356915|79509014|FG002|Overall Study|Lost to Follow-up|14|||
44504161|NCT00356915|79509012|FG000|Overall Study|Administrative Decision|0|||
44504162|NCT00356915|79509013|FG001|Overall Study|Administrative Decision|0|||
44504163|NCT00356915|79509014|FG002|Overall Study|Administrative Decision|1|||
44504164|NCT00356915|79509012|FG000|Overall Study|Physician Decision|0|||
44504165|NCT00356915|79509013|FG001|Overall Study|Physician Decision|2|||
44570253|NCT00905606|79591178|FG000|Washout|Withdrawal by Subject|1|||
44504166|NCT00356915|79509014|FG002|Overall Study|Physician Decision|0|||
44504167|NCT00356915|79509012|FG000|Overall Study|Adverse Event|21|||
44504168|NCT00356915|79509013|FG001|Overall Study|Adverse Event|31|||
44504169|NCT00356915|79509014|FG002|Overall Study|Adverse Event|8|||
44504170|NCT00356915|79509012|FG000|Overall Study|Miscellaneous reasons|11|||
44570254|NCT00905606|79591179|FG001|Washout|Withdrawal by Subject|0|||
44570255|NCT01676896|79591186|FG000|Overall Study|Withdrawal by Subject|12|||
44570256|NCT01676896|79591187|FG001|Overall Study|Withdrawal by Subject|7|||
44570257|NCT01676896|79591188|FG002|Overall Study|Withdrawal by Subject|19|||
44570258|NCT03017235|79591198|FG000|Overall Study|Withdrawal by Subject|4|||
44570259|NCT03017235|79591199|FG001|Overall Study|Withdrawal by Subject|3|||
44570260|NCT03017235|79591198|FG000|Overall Study|Lost to Follow-up|2|||
44570261|NCT03017235|79591199|FG001|Overall Study|Lost to Follow-up|7|||
44570262|NCT03017235|79591198|FG000|Overall Study|Adverse Event|0|||
44570263|NCT03017235|79591199|FG001|Overall Study|Adverse Event|1|||
44570264|NCT03017235|79591198|FG000|Overall Study|Protocol Violation|2|||
44570265|NCT03017235|79591199|FG001|Overall Study|Protocol Violation|1|||
44570266|NCT03017235|79591198|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
44570267|NCT03017235|79591199|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
44570268|NCT03017079|79591207|FG000|Overall Study|Physician Decision|1|||
44570269|NCT03017079|79591208|FG001|Overall Study|Physician Decision|1|||
44570270|NCT03017079|79591207|FG000|Overall Study|Death|3|||
44570271|NCT03017079|79591208|FG001|Overall Study|Death|2|||
44570272|NCT03017079|79591207|FG000|Overall Study|Lack of Efficacy|2|||
44570273|NCT03017079|79591208|FG001|Overall Study|Lack of Efficacy|2|||
44570274|NCT03017079|79591207|FG000|Overall Study|Protocol Violation|0|||
44570275|NCT03017079|79591208|FG001|Overall Study|Protocol Violation|1|||
44570276|NCT03015363|79591221|FG000|Overall Study|Physician Decision|14|||
44236916|NCT03599518|79061908|FG003|Overall Study|Clinical progression|0|||
44236917|NCT03599518|79061909|FG004|Overall Study|Clinical progression|1|||
44236918|NCT03599518|79061905|FG000|Overall Study|Adverse Event|0|||
44570277|NCT03015363|79591221|FG000|Overall Study|Withdrawal by Subject|3|||
44570278|NCT02880371|79591233|FG000|Phase 1b|Lost to Follow-up|1|||
44236919|NCT03599518|79061906|FG001|Overall Study|Adverse Event|0|||
44504171|NCT00356915|79509013|FG001|Overall Study|Miscellaneous reasons|8|||
44504172|NCT00356915|79509014|FG002|Overall Study|Miscellaneous reasons|3|||
44504173|NCT00356759|79509030|FG000|Overall Study|Death|5|||
44504174|NCT00356759|79509031|FG001|Overall Study|Death|2|||
44504175|NCT00356759|79509030|FG000|Overall Study|Withdrawal by Subject|2|||
44570279|NCT02880371|79591234|FG001|Phase 1b|Lost to Follow-up|0|||
44570280|NCT02880371|79591235|FG002|Phase 1b|Lost to Follow-up|0|||
44570281|NCT02880371|79591236|FG003|Phase 1b|Lost to Follow-up|0|||
44570282|NCT02880371|79591237|FG004|Phase 1b|Lost to Follow-up|0|||
44236920|NCT03599518|79061907|FG002|Overall Study|Adverse Event|0|||
44236921|NCT03599518|79061908|FG003|Overall Study|Adverse Event|0|||
44570283|NCT02880371|79591238|FG005|Phase 1b|Lost to Follow-up|0|||
44504176|NCT00356759|79509031|FG001|Overall Study|Withdrawal by Subject|2|||
44504177|NCT00356759|79509030|FG000|Overall Study|Adverse Event|1|||
44236922|NCT03599518|79061909|FG004|Overall Study|Adverse Event|1|||
44236923|NCT03599518|79061905|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
44504178|NCT00356759|79509031|FG001|Overall Study|Adverse Event|3|||
44504179|NCT00356759|79509030|FG000|Overall Study|Lost to Follow-up|1|||
44504180|NCT00356759|79509031|FG001|Overall Study|Lost to Follow-up|1|||
44504181|NCT00356759|79509030|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
44504182|NCT00356759|79509031|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
44504183|NCT03804710|79509039|FG000|Overall Study|Adverse Event|0|||
44504184|NCT03804710|79509040|FG001|Overall Study|Adverse Event|3|||
44504185|NCT03804710|79509039|FG000|Overall Study|Withdrawal by Subject|2|||
44504186|NCT03804710|79509040|FG001|Overall Study|Withdrawal by Subject|1|||
44504187|NCT03804710|79509039|FG000|Overall Study|Other|0|||
44504188|NCT03804710|79509040|FG001|Overall Study|Other|1|||
44570284|NCT02880371|79591239|FG006|Phase 1b|Lost to Follow-up|0|||
44570285|NCT02880371|79591240|FG007|Phase 1b|Lost to Follow-up|0|||
44570286|NCT02880371|79591233|FG000|Phase 1b|Participants terminated by Sponsor|1|||
44570287|NCT02880371|79591234|FG001|Phase 1b|Participants terminated by Sponsor|0|||
44570288|NCT02880371|79591235|FG002|Phase 1b|Participants terminated by Sponsor|0|||
44570289|NCT02880371|79591236|FG003|Phase 1b|Participants terminated by Sponsor|0|||
44570290|NCT02880371|79591237|FG004|Phase 1b|Participants terminated by Sponsor|0|||
44570291|NCT02880371|79591238|FG005|Phase 1b|Participants terminated by Sponsor|0|||
44570292|NCT02880371|79591239|FG006|Phase 1b|Participants terminated by Sponsor|0|||
44570293|NCT02880371|79591240|FG007|Phase 1b|Participants terminated by Sponsor|0|||
44570294|NCT02880371|79591233|FG000|Phase 1b|Withdrawal by Subject|0|||
44570295|NCT02880371|79591234|FG001|Phase 1b|Withdrawal by Subject|0|||
44504189|NCT00356603|79509052|FG000|Overall Study|Other|6|||
44504190|NCT00356603|79509053|FG001|Overall Study|Other|3|||
44504191|NCT00002558|79509063|FG000|Overall Study|Withdrawal by Subject|0|||
44504192|NCT00002558|79509064|FG001|Overall Study|Withdrawal by Subject|1|||
44504193|NCT00001880|79509070|FG000|Overall Study|Death|14|||
44504194|NCT00043550|79509077|FG000|Overall Study|Withdrawal by Subject|22|||
44504195|NCT00043550|79509078|FG001|Overall Study|Withdrawal by Subject|12|||
44504196|NCT00043550|79509079|FG002|Overall Study|Withdrawal by Subject|20|||
44504197|NCT00041756|79509092|FG000|Overall Study|Adverse Event|4|||
44504198|NCT00041756|79509093|FG001|Overall Study|Adverse Event|10|||
44504199|NCT00041756|79509094|FG002|Overall Study|Adverse Event|6|||
44570296|NCT02880371|79591235|FG002|Phase 1b|Withdrawal by Subject|1|||
44570297|NCT02880371|79591236|FG003|Phase 1b|Withdrawal by Subject|0|||
44570298|NCT02880371|79591237|FG004|Phase 1b|Withdrawal by Subject|0|||
44570299|NCT02880371|79591238|FG005|Phase 1b|Withdrawal by Subject|0|||
44570300|NCT02880371|79591239|FG006|Phase 1b|Withdrawal by Subject|0|||
44570301|NCT02880371|79591240|FG007|Phase 1b|Withdrawal by Subject|0|||
44570302|NCT02880371|79591233|FG000|Phase 1b|Death|4|||
44570303|NCT02880371|79591234|FG001|Phase 1b|Death|6|||
44570304|NCT02880371|79591235|FG002|Phase 1b|Death|5|||
44570305|NCT02880371|79591236|FG003|Phase 1b|Death|1|||
44570306|NCT02880371|79591237|FG004|Phase 1b|Death|0|||
44570307|NCT02880371|79591238|FG005|Phase 1b|Death|0|||
44570308|NCT02880371|79591239|FG006|Phase 1b|Death|0|||
44143823|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
44504200|NCT00041756|79509095|FG003|Overall Study|Adverse Event|11|||
44504201|NCT00041756|79509096|FG004|Overall Study|Adverse Event|34|||
44504202|NCT00041756|79509092|FG000|Overall Study|Protocol Violation|1|||
44570309|NCT02880371|79591240|FG007|Phase 1b|Death|0|||
44570310|NCT02880371|79591233|FG000|Phase 1b|Enrolled but not Treated|0|||
44570311|NCT02880371|79591234|FG001|Phase 1b|Enrolled but not Treated|1|||
44570312|NCT02880371|79591235|FG002|Phase 1b|Enrolled but not Treated|0|||
44570313|NCT02880371|79591236|FG003|Phase 1b|Enrolled but not Treated|0|||
44570314|NCT02880371|79591237|FG004|Phase 1b|Enrolled but not Treated|0|||
44570315|NCT02880371|79591238|FG005|Phase 1b|Enrolled but not Treated|0|||
44570316|NCT02880371|79591239|FG006|Phase 1b|Enrolled but not Treated|0|||
44570317|NCT02880371|79591240|FG007|Phase 1b|Enrolled but not Treated|0|||
44570318|NCT02880371|79591233|FG000|Phase 2|Enrolled but not Treated|0|||
44570319|NCT02880371|79591234|FG001|Phase 2|Enrolled but not Treated|0|||
44570320|NCT02880371|79591235|FG002|Phase 2|Enrolled but not Treated|0|||
44570321|NCT02880371|79591236|FG003|Phase 2|Enrolled but not Treated|0|||
44570322|NCT02880371|79591237|FG004|Phase 2|Enrolled but not Treated|0|||
44570323|NCT02880371|79591238|FG005|Phase 2|Enrolled but not Treated|1|||
44570324|NCT02880371|79591239|FG006|Phase 2|Enrolled but not Treated|1|||
44570325|NCT02880371|79591240|FG007|Phase 2|Enrolled but not Treated|0|||
44570326|NCT02880371|79591233|FG000|Phase 2|Other|0|||
44570327|NCT02880371|79591234|FG001|Phase 2|Other|0|||
44570328|NCT02880371|79591235|FG002|Phase 2|Other|0|||
44570329|NCT02880371|79591236|FG003|Phase 2|Other|0|||
44570330|NCT02880371|79591237|FG004|Phase 2|Other|0|||
44570331|NCT02880371|79591238|FG005|Phase 2|Other|1|||
44570332|NCT02880371|79591239|FG006|Phase 2|Other|2|||
44236924|NCT03599518|79061906|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
44236925|NCT03599518|79061907|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
44236926|NCT03599518|79061908|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
44236927|NCT03599518|79061909|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
44236928|NCT03599518|79061905|FG000|Overall Study|Participant withdrawal from study treatment|0|||
44236929|NCT03599518|79061906|FG001|Overall Study|Participant withdrawal from study treatment|0|||
44236930|NCT03599518|79061907|FG002|Overall Study|Participant withdrawal from study treatment|1|||
44236931|NCT03599518|79061908|FG003|Overall Study|Participant withdrawal from study treatment|0|||
44236932|NCT03599518|79061909|FG004|Overall Study|Participant withdrawal from study treatment|0|||
44275897|NCT04169373|79226152|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
44275898|NCT04169373|79226153|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
44504203|NCT00041756|79509093|FG001|Overall Study|Protocol Violation|1|||
44504204|NCT00041756|79509094|FG002|Overall Study|Protocol Violation|2|||
44504205|NCT00041756|79509095|FG003|Overall Study|Protocol Violation|2|||
44504206|NCT00041756|79509096|FG004|Overall Study|Protocol Violation|1|||
44504207|NCT00041756|79509092|FG000|Overall Study|Withdrawal by Subject|3|||
44504208|NCT00041756|79509093|FG001|Overall Study|Withdrawal by Subject|3|||
44504209|NCT00041756|79509094|FG002|Overall Study|Withdrawal by Subject|4|||
44570333|NCT02880371|79591240|FG007|Phase 2|Other|1|||
44504210|NCT00041756|79509095|FG003|Overall Study|Withdrawal by Subject|2|||
44504211|NCT00041756|79509096|FG004|Overall Study|Withdrawal by Subject|3|||
44504212|NCT00041756|79509092|FG000|Overall Study|Lost to Follow-up|0|||
44504213|NCT00041756|79509093|FG001|Overall Study|Lost to Follow-up|1|||
44504214|NCT00041756|79509094|FG002|Overall Study|Lost to Follow-up|0|||
44504215|NCT00041756|79509095|FG003|Overall Study|Lost to Follow-up|1|||
44504216|NCT00041756|79509096|FG004|Overall Study|Lost to Follow-up|0|||
44504217|NCT00041756|79509092|FG000|Overall Study|Unable to meet protocol criteria|0|||
44570334|NCT02880371|79591233|FG000|Phase 2|Participants terminated by Sponsor|0|||
44570335|NCT02880371|79591234|FG001|Phase 2|Participants terminated by Sponsor|0|||
44570336|NCT02880371|79591235|FG002|Phase 2|Participants terminated by Sponsor|0|||
44570337|NCT02880371|79591236|FG003|Phase 2|Participants terminated by Sponsor|0|||
44570338|NCT02880371|79591237|FG004|Phase 2|Participants terminated by Sponsor|1|||
44570339|NCT02880371|79591238|FG005|Phase 2|Participants terminated by Sponsor|6|||
44570340|NCT02880371|79591239|FG006|Phase 2|Participants terminated by Sponsor|1|||
44236933|NCT02709486|79061986|FG000|Overall Study|Adverse Event|2|||
44236934|NCT02709486|79061987|FG001|Overall Study|Adverse Event|5|||
44236935|NCT02709486|79061988|FG002|Overall Study|Adverse Event|3|||
44275899|NCT04169373|79226154|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
44570341|NCT02880371|79591240|FG007|Phase 2|Participants terminated by Sponsor|5|||
44275900|NCT04169373|79226151|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
44275901|NCT04169373|79226152|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
44504218|NCT00041756|79509093|FG001|Overall Study|Unable to meet protocol criteria|0|||
44504219|NCT00041756|79509094|FG002|Overall Study|Unable to meet protocol criteria|1|||
44570342|NCT02880371|79591233|FG000|Phase 2|Death|0|||
44570343|NCT02880371|79591234|FG001|Phase 2|Death|0|||
44570344|NCT02880371|79591235|FG002|Phase 2|Death|0|||
44570345|NCT02880371|79591236|FG003|Phase 2|Death|0|||
44570346|NCT02880371|79591237|FG004|Phase 2|Death|1|||
44570347|NCT02880371|79591238|FG005|Phase 2|Death|10|||
44570348|NCT02880371|79591239|FG006|Phase 2|Death|20|||
44570349|NCT02880371|79591240|FG007|Phase 2|Death|5|||
44570350|NCT02880371|79591233|FG000|Phase 2|Lost to Follow-up|0|||
44570351|NCT02880371|79591234|FG001|Phase 2|Lost to Follow-up|0|||
44570352|NCT02880371|79591235|FG002|Phase 2|Lost to Follow-up|0|||
44570353|NCT02880371|79591236|FG003|Phase 2|Lost to Follow-up|0|||
44570354|NCT02880371|79591237|FG004|Phase 2|Lost to Follow-up|0|||
44570355|NCT02880371|79591238|FG005|Phase 2|Lost to Follow-up|0|||
44570356|NCT02880371|79591239|FG006|Phase 2|Lost to Follow-up|3|||
44570357|NCT02880371|79591240|FG007|Phase 2|Lost to Follow-up|0|||
44570358|NCT02880371|79591233|FG000|Phase 2|Withdrawal by Subject|0|||
44570359|NCT02880371|79591234|FG001|Phase 2|Withdrawal by Subject|0|||
44570360|NCT02880371|79591235|FG002|Phase 2|Withdrawal by Subject|0|||
44570361|NCT02880371|79591236|FG003|Phase 2|Withdrawal by Subject|0|||
44570362|NCT02880371|79591237|FG004|Phase 2|Withdrawal by Subject|0|||
44570363|NCT02880371|79591238|FG005|Phase 2|Withdrawal by Subject|1|||
44570364|NCT02880371|79591239|FG006|Phase 2|Withdrawal by Subject|1|||
44570365|NCT02880371|79591240|FG007|Phase 2|Withdrawal by Subject|0|||
44275902|NCT04169373|79226153|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
44570366|NCT02880371|79591233|FG000|Phase 2|End of Study page not completed by error|0|||
44570367|NCT02880371|79591234|FG001|Phase 2|End of Study page not completed by error|0|||
44570368|NCT02880371|79591235|FG002|Phase 2|End of Study page not completed by error|0|||
44570369|NCT02880371|79591236|FG003|Phase 2|End of Study page not completed by error|0|||
44275903|NCT04169373|79226154|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
44275904|NCT04169373|79226151|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
44275905|NCT04169373|79226152|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
44570370|NCT02880371|79591237|FG004|Phase 2|End of Study page not completed by error|0|||
44570371|NCT02880371|79591238|FG005|Phase 2|End of Study page not completed by error|1|||
44570372|NCT02880371|79591239|FG006|Phase 2|End of Study page not completed by error|0|||
44570373|NCT02880371|79591240|FG007|Phase 2|End of Study page not completed by error|0|||
44570374|NCT02837029|79591263|FG000|Screening|Failed to meet screening requirements.|7|||
44570375|NCT02837029|79591264|FG001|Screening|Failed to meet screening requirements.|3|||
44570376|NCT02837029|79591265|FG002|Screening|Failed to meet screening requirements.|0|||
44275906|NCT04169373|79226153|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
44275907|NCT04169373|79226154|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
44275908|NCT04169373|79226151|FG000|Week 14 to Week 52|Other|4|||
44236936|NCT02709486|79061986|FG000|Overall Study|Death|0|||
44236937|NCT02709486|79061987|FG001|Overall Study|Death|0|||
44236938|NCT02709486|79061988|FG002|Overall Study|Death|2|||
44236939|NCT02709486|79061986|FG000|Overall Study|Insufficient clinical response|7|||
44236940|NCT02709486|79061987|FG001|Overall Study|Insufficient clinical response|3|||
44236941|NCT02709486|79061988|FG002|Overall Study|Insufficient clinical response|3|||
44236942|NCT02709486|79061986|FG000|Overall Study|Lost to Follow-up|3|||
44236943|NCT02709486|79061987|FG001|Overall Study|Lost to Follow-up|2|||
44236944|NCT02709486|79061988|FG002|Overall Study|Lost to Follow-up|2|||
44275909|NCT04169373|79226152|FG001|Week 14 to Week 52|Other|5|||
44504220|NCT00041756|79509095|FG003|Overall Study|Unable to meet protocol criteria|0|||
44504221|NCT00041756|79509096|FG004|Overall Study|Unable to meet protocol criteria|1|||
44504222|NCT00041756|79509092|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
44504223|NCT00041756|79509093|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
44504224|NCT00041756|79509094|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
44504225|NCT00041756|79509095|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
44504226|NCT00041756|79509096|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
44504227|NCT00041132|79509108|FG000|Overall Study|Adverse Event|19|||
44504228|NCT00041132|79509108|FG000|Overall Study|Death|1|||
44504229|NCT00041132|79509108|FG000|Overall Study|Not Eligible|7|||
44504230|NCT00041132|79509108|FG000|Overall Study|Withdrawal by Subject|1|||
44504231|NCT00041132|79509108|FG000|Overall Study|Physician Decision|2|||
44504232|NCT00040742|79509116|FG000|Overall Study|Death|0|||
44504233|NCT00040742|79509117|FG001|Overall Study|Death|0|||
44236945|NCT02709486|79061986|FG000|Overall Study|Other|0|||
44570377|NCT02837029|79591263|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
44236946|NCT02709486|79061987|FG001|Overall Study|Other|2|||
44236947|NCT02709486|79061988|FG002|Overall Study|Other|3|||
44570378|NCT02837029|79591264|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
44570379|NCT02837029|79591265|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
44570380|NCT02837029|79591263|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
44570381|NCT02837029|79591264|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
44570382|NCT02837029|79591265|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
44570383|NCT02837029|79591263|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
44570384|NCT02837029|79591264|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
44570385|NCT02837029|79591265|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
44570386|NCT02837029|79591263|FG000|Cycle 2 and Beyond|Adverse Event|1|||
44570387|NCT02837029|79591264|FG001|Cycle 2 and Beyond|Adverse Event|0|||
44570388|NCT02837029|79591265|FG002|Cycle 2 and Beyond|Adverse Event|0|||
44236948|NCT02709486|79061986|FG000|Overall Study|Withdrawal by Subject|32|||
44236949|NCT02709486|79061987|FG001|Overall Study|Withdrawal by Subject|22|||
44236950|NCT02709486|79061988|FG002|Overall Study|Withdrawal by Subject|32|||
44504234|NCT00040742|79509118|FG002|Overall Study|Death|1|||
44504235|NCT00040742|79509119|FG003|Overall Study|Death|0|||
44570389|NCT02837029|79591263|FG000|2 Year Follow-up|Death|6|||
44570390|NCT02837029|79591264|FG001|2 Year Follow-up|Death|7|||
44504236|NCT00040742|79509116|FG000|Overall Study|Adverse Event|15|||
44570391|NCT02837029|79591265|FG002|2 Year Follow-up|Death|0|||
44570392|NCT03010527|79591277|FG000|Overall Study|Death|0|||
44570393|NCT03010527|79591278|FG001|Overall Study|Death|0|||
44570394|NCT03010527|79591279|FG002|Overall Study|Death|1|||
44570395|NCT03010527|79591277|FG000|Overall Study|Adverse Event|0|||
44570396|NCT03010527|79591278|FG001|Overall Study|Adverse Event|4|||
44570397|NCT03010527|79591279|FG002|Overall Study|Adverse Event|2|||
44570398|NCT03010527|79591277|FG000|Overall Study|Protocol Violation|0|||
44570399|NCT03010527|79591278|FG001|Overall Study|Protocol Violation|1|||
44570400|NCT03010527|79591279|FG002|Overall Study|Protocol Violation|0|||
44570401|NCT03010527|79591277|FG000|Overall Study|Lost to Follow-up|0|||
44570402|NCT03010527|79591278|FG001|Overall Study|Lost to Follow-up|2|||
44570403|NCT03010527|79591279|FG002|Overall Study|Lost to Follow-up|1|||
44570404|NCT03010527|79591277|FG000|Overall Study|Withdrawal by Subject|0|||
44570405|NCT03010527|79591278|FG001|Overall Study|Withdrawal by Subject|3|||
44570406|NCT03010527|79591279|FG002|Overall Study|Withdrawal by Subject|4|||
44570407|NCT03010527|79591277|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
44504237|NCT00040742|79509117|FG001|Overall Study|Adverse Event|16|||
44504238|NCT00040742|79509118|FG002|Overall Study|Adverse Event|21|||
44504239|NCT00040742|79509119|FG003|Overall Study|Adverse Event|9|||
44504240|NCT00040742|79509116|FG000|Overall Study|Withdrawal by Subject|7|||
44504241|NCT00040742|79509117|FG001|Overall Study|Withdrawal by Subject|15|||
44504242|NCT00040742|79509118|FG002|Overall Study|Withdrawal by Subject|10|||
44504243|NCT00040742|79509119|FG003|Overall Study|Withdrawal by Subject|13|||
44504244|NCT00040742|79509116|FG000|Overall Study|Chemotoxicity|4|||
44504245|NCT00040742|79509117|FG001|Overall Study|Chemotoxicity|3|||
44504246|NCT00040742|79509118|FG002|Overall Study|Chemotoxicity|5|||
44504247|NCT00040742|79509119|FG003|Overall Study|Chemotoxicity|2|||
44504248|NCT00040742|79509116|FG000|Overall Study|Incomplete Forms|6|||
44504249|NCT00040742|79509117|FG001|Overall Study|Incomplete Forms|10|||
44504250|NCT00040742|79509118|FG002|Overall Study|Incomplete Forms|4|||
44504251|NCT00040742|79509119|FG003|Overall Study|Incomplete Forms|5|||
44504252|NCT00040742|79509116|FG000|Overall Study|Other medical|7|||
44504253|NCT00040742|79509117|FG001|Overall Study|Other medical|5|||
44504254|NCT00040742|79509118|FG002|Overall Study|Other medical|5|||
44504255|NCT00040742|79509119|FG003|Overall Study|Other medical|5|||
44504256|NCT00040664|79509129|FG000|Overall Study|Adverse Event|12|||
44504257|NCT00040664|79509130|FG001|Overall Study|Adverse Event|3|||
44504258|NCT00040664|79509131|FG002|Overall Study|Adverse Event|2|||
44504259|NCT00040664|79509132|FG003|Overall Study|Adverse Event|7|||
44504260|NCT00040664|79509129|FG000|Overall Study|Lack of Efficacy|9|||
44504261|NCT00040664|79509130|FG001|Overall Study|Lack of Efficacy|2|||
44504262|NCT00040664|79509131|FG002|Overall Study|Lack of Efficacy|3|||
44236951|NCT00703326|79062192|FG000|Overall Study|Lost to Follow-up|47|||
44236952|NCT00703326|79062193|FG001|Overall Study|Lost to Follow-up|18|||
44504263|NCT00040664|79509132|FG003|Overall Study|Lack of Efficacy|4|||
44504264|NCT00040664|79509129|FG000|Overall Study|Insufficient CD4 response|1|||
44504265|NCT00040664|79509130|FG001|Overall Study|Insufficient CD4 response|0|||
44504266|NCT00040664|79509131|FG002|Overall Study|Insufficient CD4 response|1|||
44504267|NCT00040664|79509132|FG003|Overall Study|Insufficient CD4 response|0|||
44570408|NCT03010527|79591278|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
44504268|NCT00040664|79509129|FG000|Overall Study|Lost to Follow-up|4|||
44570409|NCT03010527|79591279|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
44570410|NCT03010527|79591277|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
44570411|NCT03010527|79591278|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
44570412|NCT03010527|79591279|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
44570413|NCT03010527|79591277|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
44570414|NCT03010527|79591278|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
44570415|NCT03010527|79591279|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
44570416|NCT00794924|79591312|FG000|Overall Study|Lost to Follow-up|6|||
44570417|NCT00794924|79591313|FG001|Overall Study|Lost to Follow-up|8|||
44570418|NCT00794924|79591312|FG000|Overall Study|Withdrawal by Subject|48|||
44570419|NCT00794924|79591313|FG001|Overall Study|Withdrawal by Subject|60|||
44570420|NCT00794924|79591312|FG000|Overall Study|Adverse Event|6|||
44570421|NCT00794924|79591313|FG001|Overall Study|Adverse Event|2|||
44570422|NCT02914275|79591319|FG000|Overall Study|Lost to Follow-up|84|||
44236953|NCT00703326|79062192|FG000|Overall Study|Withdrawal by Subject|54|||
44504269|NCT00040664|79509130|FG001|Overall Study|Lost to Follow-up|2|||
44570423|NCT02914275|79591320|FG001|Overall Study|Lost to Follow-up|29|||
44570424|NCT02914275|79591319|FG000|Overall Study|Withdrawal by Subject|26|||
44570425|NCT02914275|79591320|FG001|Overall Study|Withdrawal by Subject|10|||
44570426|NCT02914275|79591319|FG000|Overall Study|Protocol Violation|1|||
44570427|NCT02914275|79591320|FG001|Overall Study|Protocol Violation|1|||
44570428|NCT02914275|79591319|FG000|Overall Study|Physician Decision|3|||
44570429|NCT02914275|79591320|FG001|Overall Study|Physician Decision|1|||
44570430|NCT02914275|79591319|FG000|Overall Study|Other|4|||
44570431|NCT02914275|79591320|FG001|Overall Study|Other|1|||
44570432|NCT02914275|79591319|FG000|Overall Study|Excluded due to invalid informed consent|3|||
44570433|NCT02914275|79591320|FG001|Overall Study|Excluded due to invalid informed consent|0|||
44570434|NCT00792116|79591332|FG000|Overall Study|Lost to Follow-up|0|||
44570435|NCT00792116|79591333|FG001|Overall Study|Lost to Follow-up|1|||
44570436|NCT00792116|79591332|FG000|Overall Study|Discontnued intervention|1|||
44570437|NCT00792116|79591333|FG001|Overall Study|Discontnued intervention|0|||
44570438|NCT00489827|79591348|FG000|Overall Study|Intraoperative exclusion criteria|1|||
44570439|NCT00489827|79591349|FG001|Overall Study|Intraoperative exclusion criteria|1|||
44570440|NCT00489827|79591348|FG000|Overall Study|Intraoperative exclusion criteria|1|||
44570441|NCT00489827|79591349|FG001|Overall Study|Intraoperative exclusion criteria|1|||
44570442|NCT02604433|79591357|FG000|Overall Study|Withdrawal by Subject|37|||
44570443|NCT02604433|79591358|FG001|Overall Study|Withdrawal by Subject|16|||
44570444|NCT02604433|79591357|FG000|Overall Study|Adverse Event|4|||
44570445|NCT02604433|79591358|FG001|Overall Study|Adverse Event|0|||
44570446|NCT02604433|79591357|FG000|Overall Study|Other reasons|3|||
44570447|NCT02604433|79591358|FG001|Overall Study|Other reasons|5|||
44570448|NCT02604433|79591357|FG000|Overall Study|Death|4|||
44570449|NCT02604433|79591358|FG001|Overall Study|Death|1|||
44570450|NCT02604433|79591357|FG000|Overall Study|Transition to Rollover Protocol|169|||
44570451|NCT02604433|79591358|FG001|Overall Study|Transition to Rollover Protocol|82|||
44570452|NCT02604433|79591357|FG000|Overall Study|Physician Decision|1|||
44570453|NCT02604433|79591358|FG001|Overall Study|Physician Decision|1|||
44570454|NCT02604433|79591357|FG000|Overall Study|Lack of Efficacy|0|||
44570455|NCT02604433|79591358|FG001|Overall Study|Lack of Efficacy|1|||
44570456|NCT02659150|79591364|FG000|Subject Enrollment|Physician Decision|3|||
44570457|NCT02659150|79591364|FG000|Subject Enrollment|Withdrawal by Subject|2|||
44570458|NCT02659150|79591364|FG000|Baseline Imaging|Withdrawal by Subject|1|||
44570459|NCT02659150|79591364|FG000|Baseline Imaging|Physician Decision|1|||
44570460|NCT02659150|79591364|FG000|Study Drug Dosing|Adverse Event|1|||
44570461|NCT03006393|79591371|FG000|Overall Study|Withdrawal by Subject|1|||
44504270|NCT00040664|79509131|FG002|Overall Study|Lost to Follow-up|0|||
44504271|NCT00040664|79509132|FG003|Overall Study|Lost to Follow-up|2|||
44504272|NCT00040664|79509129|FG000|Overall Study|Protocol Violation|2|||
44504273|NCT00040664|79509130|FG001|Overall Study|Protocol Violation|1|||
44504274|NCT00040664|79509131|FG002|Overall Study|Protocol Violation|0|||
44504275|NCT00040664|79509132|FG003|Overall Study|Protocol Violation|1|||
44504276|NCT00040664|79509129|FG000|Overall Study|Withdrawal by Subject|7|||
44504277|NCT00040664|79509130|FG001|Overall Study|Withdrawal by Subject|0|||
44504278|NCT00040664|79509131|FG002|Overall Study|Withdrawal by Subject|3|||
44504279|NCT00040664|79509132|FG003|Overall Study|Withdrawal by Subject|4|||
44504280|NCT00040664|79509129|FG000|Overall Study|Pregnancy|3|||
44504281|NCT00040664|79509130|FG001|Overall Study|Pregnancy|0|||
44504282|NCT00040664|79509131|FG002|Overall Study|Pregnancy|0|||
44504283|NCT00040664|79509132|FG003|Overall Study|Pregnancy|3|||
44236954|NCT00703326|79062193|FG001|Overall Study|Withdrawal by Subject|20|||
44504284|NCT00040664|79509129|FG000|Overall Study|Medication adherence/compliance problems|8|||
44570462|NCT03006393|79591372|FG001|Overall Study|Withdrawal by Subject|1|||
44570463|NCT03006393|79591371|FG000|Overall Study|Pregnancy|0|||
44570464|NCT03006393|79591372|FG001|Overall Study|Pregnancy|1|||
44570465|NCT03006393|79591371|FG000|Overall Study|Lost to Follow-up|0|||
44236955|NCT00703326|79062192|FG000|Overall Study|Adverse Event|1|||
44570466|NCT03006393|79591372|FG001|Overall Study|Lost to Follow-up|1|||
44570467|NCT00882440|79591389|FG000|Overall Study|Adverse Event|2|||
44570468|NCT00882440|79591390|FG001|Overall Study|Adverse Event|2|||
44570469|NCT00882440|79591391|FG002|Overall Study|Adverse Event|2|||
44570470|NCT00882440|79591392|FG003|Overall Study|Adverse Event|1|||
44570471|NCT00882440|79591393|FG004|Overall Study|Adverse Event|1|||
44570472|NCT00882440|79591394|FG005|Overall Study|Adverse Event|4|||
44570473|NCT00882440|79591395|FG006|Overall Study|Adverse Event|2|||
44236956|NCT00703326|79062193|FG001|Overall Study|Adverse Event|0|||
44236957|NCT04868500|79062246|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
44236958|NCT04868500|79062247|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
44236959|NCT04868500|79062246|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
44236960|NCT04868500|79062247|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
44236961|NCT04372186|79062255|FG000|Overall Study|Death|24|||
44236962|NCT04372186|79062256|FG001|Overall Study|Death|11|||
44249736|NCT01504412|79083925|FG002|Overall Study|Other|1|||
44275910|NCT04169373|79226153|FG002|Week 14 to Week 52|Other|4|||
44570474|NCT00882440|79591389|FG000|Overall Study|Lack of Efficacy|3|||
44570475|NCT00882440|79591390|FG001|Overall Study|Lack of Efficacy|5|||
44570476|NCT00882440|79591391|FG002|Overall Study|Lack of Efficacy|2|||
44570477|NCT00882440|79591392|FG003|Overall Study|Lack of Efficacy|0|||
44570478|NCT00882440|79591393|FG004|Overall Study|Lack of Efficacy|0|||
44570479|NCT00882440|79591394|FG005|Overall Study|Lack of Efficacy|3|||
44570480|NCT00882440|79591395|FG006|Overall Study|Lack of Efficacy|0|||
44570481|NCT00882440|79591389|FG000|Overall Study|Lost to Follow-up|2|||
44275911|NCT04169373|79226154|FG003|Week 14 to Week 52|Other|5|||
44275912|NCT04169373|79226151|FG000|Week 14 to Week 52|Ongoing|0|||
44275913|NCT04169373|79226152|FG001|Week 14 to Week 52|Ongoing|1|||
44275914|NCT04169373|79226153|FG002|Week 14 to Week 52|Ongoing|0|||
44275915|NCT04169373|79226154|FG003|Week 14 to Week 52|Ongoing|0|||
44275916|NCT04154930|79226169|FG000|Overall Study|Withdrawal by Subject|15|||
44504285|NCT00040664|79509130|FG001|Overall Study|Medication adherence/compliance problems|2|||
44504286|NCT00040664|79509131|FG002|Overall Study|Medication adherence/compliance problems|1|||
44504287|NCT00040664|79509132|FG003|Overall Study|Medication adherence/compliance problems|5|||
44504288|NCT00040664|79509129|FG000|Overall Study|Poor taste|2|||
44504289|NCT00040664|79509130|FG001|Overall Study|Poor taste|0|||
44504290|NCT00040664|79509131|FG002|Overall Study|Poor taste|2|||
44504291|NCT00040664|79509132|FG003|Overall Study|Poor taste|0|||
44504292|NCT00040664|79509129|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
44504293|NCT00040664|79509130|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
44504294|NCT00040664|79509131|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
44504295|NCT00040664|79509132|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
44504296|NCT00040664|79509129|FG000|Overall Study|Change of formulation|2|||
44504297|NCT00040664|79509130|FG001|Overall Study|Change of formulation|2|||
44504298|NCT00040664|79509131|FG002|Overall Study|Change of formulation|0|||
44504299|NCT00040664|79509132|FG003|Overall Study|Change of formulation|0|||
44504300|NCT00040664|79509129|FG000|Overall Study|Non-viability of oral suspension|1|||
44504301|NCT00040664|79509130|FG001|Overall Study|Non-viability of oral suspension|0|||
44504302|NCT00040664|79509131|FG002|Overall Study|Non-viability of oral suspension|1|||
44504303|NCT00040664|79509132|FG003|Overall Study|Non-viability of oral suspension|0|||
44504304|NCT02952586|79509152|FG000|Lead-In Phase (7 Days)|Death|0|||
44504305|NCT02952586|79509153|FG001|Lead-In Phase (7 Days)|Death|1|||
44504306|NCT02952586|79509152|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
44504307|NCT02952586|79509153|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
44504308|NCT02952586|79509152|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
44504309|NCT02952586|79509153|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
44504310|NCT02952586|79509152|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
44504311|NCT02952586|79509153|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
44504312|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
44504313|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
44275917|NCT04154930|79226170|FG001|Overall Study|Withdrawal by Subject|6|||
44275918|NCT04154930|79226169|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
44275919|NCT04154930|79226170|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
44275920|NCT04154930|79226169|FG000|Overall Study|Lost to Follow-up|14|||
44275921|NCT04154930|79226170|FG001|Overall Study|Lost to Follow-up|6|||
44504314|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
44570482|NCT00882440|79591390|FG001|Overall Study|Lost to Follow-up|0|||
44570483|NCT00882440|79591391|FG002|Overall Study|Lost to Follow-up|1|||
44570484|NCT00882440|79591392|FG003|Overall Study|Lost to Follow-up|1|||
44275922|NCT04154930|79226169|FG000|Overall Study|Other|6|||
44275923|NCT04154930|79226170|FG001|Overall Study|Other|0|||
44504315|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
44504316|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
44504317|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
44275924|NCT04124471|79226176|FG000|Overall Study|screen failure|1|||
44514951|NCT03075826|79520835|FG000|Overall Study|Withdrawal by Subject|1|||
44570485|NCT00882440|79591393|FG004|Overall Study|Lost to Follow-up|1|||
44570486|NCT00882440|79591394|FG005|Overall Study|Lost to Follow-up|0|||
44570487|NCT00882440|79591395|FG006|Overall Study|Lost to Follow-up|1|||
44570488|NCT00882440|79591389|FG000|Overall Study|Protocol Violation|0|||
44570489|NCT00882440|79591390|FG001|Overall Study|Protocol Violation|0|||
44570490|NCT00882440|79591391|FG002|Overall Study|Protocol Violation|1|||
44570491|NCT00882440|79591392|FG003|Overall Study|Protocol Violation|1|||
44570492|NCT00882440|79591393|FG004|Overall Study|Protocol Violation|1|||
44570493|NCT00882440|79591394|FG005|Overall Study|Protocol Violation|0|||
44570494|NCT00882440|79591395|FG006|Overall Study|Protocol Violation|0|||
44570495|NCT00882440|79591389|FG000|Overall Study|Withdrawal by Subject|2|||
44570496|NCT00882440|79591390|FG001|Overall Study|Withdrawal by Subject|1|||
44570497|NCT00882440|79591391|FG002|Overall Study|Withdrawal by Subject|1|||
44570498|NCT00882440|79591392|FG003|Overall Study|Withdrawal by Subject|0|||
44570499|NCT00882440|79591393|FG004|Overall Study|Withdrawal by Subject|6|||
44570500|NCT00882440|79591394|FG005|Overall Study|Withdrawal by Subject|0|||
44570501|NCT00882440|79591395|FG006|Overall Study|Withdrawal by Subject|1|||
44570502|NCT00882440|79591389|FG000|Overall Study|Patient Uncooperative|2|||
44570503|NCT00882440|79591390|FG001|Overall Study|Patient Uncooperative|0|||
44570504|NCT00882440|79591391|FG002|Overall Study|Patient Uncooperative|0|||
44570505|NCT00882440|79591392|FG003|Overall Study|Patient Uncooperative|0|||
44570506|NCT00882440|79591393|FG004|Overall Study|Patient Uncooperative|1|||
44570507|NCT00882440|79591394|FG005|Overall Study|Patient Uncooperative|0|||
44570508|NCT00882440|79591395|FG006|Overall Study|Patient Uncooperative|0|||
44504318|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
44504319|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
44504320|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
44504321|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
44504322|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
44504323|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
44504324|NCT02952586|79509152|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
44504325|NCT02952586|79509153|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
44504326|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Death|3|||
44504327|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Death|8|||
44504328|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
44504329|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
44504330|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
44504331|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
44570509|NCT03005067|79591406|FG000|Overall Study|Withdrawal by Subject|3|||
44570510|NCT03005067|79591407|FG001|Overall Study|Withdrawal by Subject|2|||
44570511|NCT03005067|79591406|FG000|Overall Study|Adverse Event|4|||
44504332|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
44504333|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
44504334|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
44570512|NCT03005067|79591407|FG001|Overall Study|Adverse Event|3|||
44570513|NCT03005067|79591406|FG000|Overall Study|Other (reason not specified)|3|||
44570514|NCT03005067|79591407|FG001|Overall Study|Other (reason not specified)|1|||
44570515|NCT03005067|79591406|FG000|Overall Study|Protocol Violation|0|||
44570516|NCT03005067|79591407|FG001|Overall Study|Protocol Violation|1|||
44570517|NCT02658448|79591413|FG000|Overall Study|Lost to Follow-up|1|||
44570518|NCT00870818|79591422|FG000|Overall Study|Lost to Follow-up|3|||
44570519|NCT00870818|79591423|FG001|Overall Study|Lost to Follow-up|2|||
44570520|NCT00870818|79591424|FG002|Overall Study|Lost to Follow-up|1|||
44570521|NCT00870818|79591425|FG003|Overall Study|Lost to Follow-up|0|||
44570522|NCT00870818|79591426|FG004|Overall Study|Lost to Follow-up|0|||
44570523|NCT00870818|79591422|FG000|Overall Study|Withdrawal by Subject|0|||
44570524|NCT00870818|79591423|FG001|Overall Study|Withdrawal by Subject|0|||
44570525|NCT00870818|79591424|FG002|Overall Study|Withdrawal by Subject|1|||
44570526|NCT00870818|79591425|FG003|Overall Study|Withdrawal by Subject|2|||
44570527|NCT00870818|79591426|FG004|Overall Study|Withdrawal by Subject|0|||
44570528|NCT00870818|79591422|FG000|Overall Study|Terminated by sponsor|29|||
44570529|NCT00870818|79591423|FG001|Overall Study|Terminated by sponsor|70|||
44570530|NCT00870818|79591424|FG002|Overall Study|Terminated by sponsor|36|||
44570531|NCT00870818|79591425|FG003|Overall Study|Terminated by sponsor|36|||
44570532|NCT00870818|79591426|FG004|Overall Study|Terminated by sponsor|38|||
44570533|NCT00870818|79591422|FG000|Overall Study|Other|0|||
44570534|NCT00870818|79591423|FG001|Overall Study|Other|1|||
44570535|NCT00870818|79591424|FG002|Overall Study|Other|0|||
44570536|NCT00870818|79591425|FG003|Overall Study|Other|0|||
44570537|NCT00870818|79591426|FG004|Overall Study|Other|0|||
44570538|NCT03075761|79591440|FG000|Overall Study|Lost to Follow-up|1|||
44570539|NCT03075761|79591441|FG001|Overall Study|Lost to Follow-up|6|||
44570540|NCT03000075|79591455|FG000|Part A|Adverse Event|4|||
44570541|NCT03000075|79591456|FG001|Part A|Adverse Event|0|||
44570542|NCT03000075|79591457|FG002|Part A|Adverse Event|0|||
44570543|NCT03000075|79591458|FG003|Part A|Adverse Event|0|||
44570544|NCT03000075|79591459|FG004|Part A|Adverse Event|0|||
44570545|NCT03000075|79591460|FG005|Part A|Adverse Event|0|||
44570546|NCT03000075|79591461|FG006|Part A|Adverse Event|0|||
44570547|NCT03000075|79591455|FG000|Part B|Not dosed due to AE|0|||
44570548|NCT03000075|79591456|FG001|Part B|Not dosed due to AE|0|||
44570549|NCT03000075|79591457|FG002|Part B|Not dosed due to AE|0|||
44570550|NCT03000075|79591458|FG003|Part B|Not dosed due to AE|0|||
44570551|NCT03000075|79591459|FG004|Part B|Not dosed due to AE|0|||
44570552|NCT03000075|79591460|FG005|Part B|Not dosed due to AE|2|||
44570553|NCT03000075|79591461|FG006|Part B|Not dosed due to AE|1|||
44570554|NCT03000075|79591455|FG000|Part B|Adverse Event|0|||
44570555|NCT03000075|79591456|FG001|Part B|Adverse Event|0|||
44570556|NCT03000075|79591457|FG002|Part B|Adverse Event|0|||
44570557|NCT03000075|79591458|FG003|Part B|Adverse Event|0|||
44570558|NCT03000075|79591459|FG004|Part B|Adverse Event|1|||
44570559|NCT03000075|79591460|FG005|Part B|Adverse Event|0|||
44570560|NCT03000075|79591461|FG006|Part B|Adverse Event|0|||
44570561|NCT03073109|79591479|FG000|Overall Study|Adverse Event|0|||
44570562|NCT03073109|79591480|FG001|Overall Study|Adverse Event|1|||
44570563|NCT03073109|79591479|FG000|Overall Study|Other|2|||
44570564|NCT03073109|79591480|FG001|Overall Study|Other|0|||
44570565|NCT03073109|79591479|FG000|Overall Study|Lost to Follow-up|8|||
44570566|NCT03073109|79591480|FG001|Overall Study|Lost to Follow-up|1|||
44570567|NCT02371889|79591502|FG000|Overall Study|Adverse medication effect|11|||
44570568|NCT02371889|79591503|FG001|Overall Study|Adverse medication effect|2|||
44570569|NCT02371889|79591502|FG000|Overall Study|Lost to Follow-up|6|||
44570570|NCT02371889|79591503|FG001|Overall Study|Lost to Follow-up|5|||
44570571|NCT02371889|79591502|FG000|Overall Study|Personal time constraints|2|||
44570572|NCT02371889|79591503|FG001|Overall Study|Personal time constraints|4|||
44570573|NCT02371889|79591502|FG000|Overall Study|Lack of Efficacy|0|||
44570574|NCT02371889|79591503|FG001|Overall Study|Lack of Efficacy|2|||
44570575|NCT02371889|79591502|FG000|Overall Study|Relapse|0|||
44570576|NCT02371889|79591503|FG001|Overall Study|Relapse|1|||
44570577|NCT03072875|79591513|FG000|Overall Study|Lost to Follow-up|1|||
44570578|NCT04250077|79591521|FG000|Overall Study|Withdrawal by Subject|0|||
44570579|NCT04250077|79591522|FG001|Overall Study|Withdrawal by Subject|1|||
44570580|NCT04250077|79591523|FG002|Overall Study|Withdrawal by Subject|0|||
44570581|NCT04250077|79591521|FG000|Overall Study|Lost to Follow-up|2|||
44570582|NCT04250077|79591522|FG001|Overall Study|Lost to Follow-up|3|||
44570583|NCT04250077|79591523|FG002|Overall Study|Lost to Follow-up|0|||
44570584|NCT00859430|79591535|FG000|First Intervention|Withdrawal by Subject|0|||
44570585|NCT00859430|79591536|FG001|First Intervention|Withdrawal by Subject|1|||
44570586|NCT02913105|79591553|FG000|Overall Study|Adverse Event|11|||
44570587|NCT02913105|79591554|FG001|Overall Study|Adverse Event|0|||
44570588|NCT02913105|79591555|FG002|Overall Study|Adverse Event|4|||
44570589|NCT02913105|79591553|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44570590|NCT02913105|79591554|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44570591|NCT02913105|79591555|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44570592|NCT02913105|79591553|FG000|Overall Study|Reason Not Specified|3|||
44570593|NCT02913105|79591554|FG001|Overall Study|Reason Not Specified|1|||
44570594|NCT02913105|79591555|FG002|Overall Study|Reason Not Specified|1|||
44570595|NCT02913105|79591553|FG000|Overall Study|Physician Decision|1|||
44570596|NCT02913105|79591554|FG001|Overall Study|Physician Decision|1|||
44570597|NCT02913105|79591555|FG002|Overall Study|Physician Decision|0|||
44570598|NCT02913105|79591553|FG000|Overall Study|Withdrawal by Subject|0|||
44570599|NCT02913105|79591554|FG001|Overall Study|Withdrawal by Subject|3|||
44570600|NCT02913105|79591555|FG002|Overall Study|Withdrawal by Subject|1|||
44570601|NCT00840632|79591573|FG000|First Intervention|Withdrawal by Subject|0|||
44570602|NCT00840632|79591574|FG001|First Intervention|Withdrawal by Subject|1|||
44570603|NCT00840632|79591573|FG000|Washout|Withdrawal by Subject|1|||
44570604|NCT00840632|79591574|FG001|Washout|Withdrawal by Subject|1|||
44570605|NCT01602562|79591591|FG000|Overall Study|Adverse Event|3|||
44570606|NCT01602562|79591592|FG001|Overall Study|Adverse Event|1|||
44570607|NCT01602562|79591591|FG000|Overall Study|Physician Decision|1|||
44570608|NCT01602562|79591592|FG001|Overall Study|Physician Decision|1|||
44570609|NCT01602562|79591591|FG000|Overall Study|Withdrawal by Subject|1|||
44570610|NCT01602562|79591592|FG001|Overall Study|Withdrawal by Subject|1|||
44570611|NCT01945775|79591601|FG000|Overall Study|Death|214|||
44570612|NCT01945775|79591602|FG001|Overall Study|Death|98|||
44570613|NCT01945775|79591601|FG000|Overall Study|Lost to Follow-up|12|||
44570614|NCT01945775|79591602|FG001|Overall Study|Lost to Follow-up|7|||
44570615|NCT01945775|79591601|FG000|Overall Study|Withdrawal by Subject|11|||
44570616|NCT01945775|79591602|FG001|Overall Study|Withdrawal by Subject|21|||
44236963|NCT04372186|79062255|FG000|Overall Study|Transferred to a different facility for care|0|||
44236964|NCT04372186|79062256|FG001|Overall Study|Transferred to a different facility for care|2|||
44236965|NCT04317040|79062286|FG000|Overall Study|Lost to Follow-up|2|||
44570617|NCT01945775|79591601|FG000|Overall Study|Other|50|||
44570618|NCT01945775|79591602|FG001|Overall Study|Other|18|||
44570619|NCT03072719|79591630|FG000|Overall Study|Adverse Event|1|||
44236966|NCT04317040|79062287|FG001|Overall Study|Lost to Follow-up|0|||
44236967|NCT04317040|79062286|FG000|Overall Study|Death|16|||
44236968|NCT04317040|79062287|FG001|Overall Study|Death|18|||
44236969|NCT04317040|79062286|FG000|Overall Study|Withdrawal by Subject|0|||
44236970|NCT04317040|79062287|FG001|Overall Study|Withdrawal by Subject|1|||
44236971|NCT04317040|79062286|FG000|Overall Study|Incomplete assessments|0|||
44236972|NCT04317040|79062287|FG001|Overall Study|Incomplete assessments|1|||
44236973|NCT00703014|79062367|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
44236974|NCT00703014|79062368|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
44236975|NCT00703014|79062369|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
44236976|NCT00703014|79062370|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
44236977|NCT00703014|79062367|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
44236978|NCT00703014|79062368|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
44236979|NCT00703014|79062369|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
44504335|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
44504336|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
44504337|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
44504338|NCT02952586|79509152|FG000|CRT for Cisplatin (63 Days)|Other|1|||
44504339|NCT02952586|79509153|FG001|CRT for Cisplatin (63 Days)|Other|1|||
44504340|NCT02952586|79509152|FG000|CRT for IMRT (63 Days)|Death|5|||
44504341|NCT02952586|79509153|FG001|CRT for IMRT (63 Days)|Death|8|||
44504342|NCT02952586|79509152|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
44504343|NCT02952586|79509153|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
44504344|NCT02952586|79509152|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
44504345|NCT02952586|79509153|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
44504346|NCT02952586|79509152|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
44504347|NCT02952586|79509153|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
44504348|NCT02952586|79509152|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
44504349|NCT02952586|79509153|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
44236980|NCT00703014|79062370|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
44236981|NCT03915496|79062418|FG000|Overall Study|Adverse Event|2|||
44504350|NCT02952586|79509152|FG000|CRT for IMRT (63 Days)|Other|1|||
44504351|NCT02952586|79509153|FG001|CRT for IMRT (63 Days)|Other|0|||
44504352|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Death|17|||
44504353|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Death|11|||
44504354|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
44570620|NCT03072719|79591631|FG001|Overall Study|Adverse Event|1|||
44570621|NCT00835796|79591639|FG000|First Intervention|Withdrawal by Subject|0|||
44570622|NCT00835796|79591640|FG001|First Intervention|Withdrawal by Subject|1|||
44570623|NCT00835640|79591646|FG000|Second Intervention|Protocol Violation|1|||
44570624|NCT00835640|79591647|FG001|Second Intervention|Protocol Violation|0|||
44570625|NCT02942017|79591653|FG000|Overall Study|Adverse Event|0|||
44570626|NCT02942017|79591654|FG001|Overall Study|Adverse Event|1|||
44570627|NCT02942017|79591653|FG000|Overall Study|Withdrawal by Subject|0|||
44570628|NCT02942017|79591654|FG001|Overall Study|Withdrawal by Subject|1|||
44570629|NCT02942017|79591653|FG000|Overall Study|Lost to Follow-up|1|||
44570630|NCT02942017|79591654|FG001|Overall Study|Lost to Follow-up|1|||
44570631|NCT02942017|79591653|FG000|Overall Study|Randomized but not dosed|1|||
44570632|NCT02942017|79591654|FG001|Overall Study|Randomized but not dosed|3|||
44570633|NCT00835406|79591669|FG000|Period: First Intervention|Adverse Event|0|||
44570634|NCT00835406|79591670|FG001|Period: First Intervention|Adverse Event|1|||
44236982|NCT03915496|79062419|FG001|Overall Study|Adverse Event|1|||
44236983|NCT03915496|79062420|FG002|Overall Study|Adverse Event|2|||
44236984|NCT02709330|79062437|FG000|Overall Study|Death|5|||
44236985|NCT02709330|79062438|FG001|Overall Study|Death|0|||
44504355|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
44570635|NCT00835406|79591669|FG000|Period: First Intervention|Withdrawal by Subject|2|||
44570636|NCT00835406|79591670|FG001|Period: First Intervention|Withdrawal by Subject|0|||
44570637|NCT00835406|79591669|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
44570638|NCT00835406|79591670|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
44570639|NCT00835172|79591676|FG000|Washout|Protocol Violation|0|||
44570640|NCT00835172|79591677|FG001|Washout|Protocol Violation|1|||
44570641|NCT01676116|79591683|FG000|Overall Study|Withdrawal criteria|2|||
44570642|NCT01676116|79591684|FG001|Overall Study|Withdrawal criteria|14|||
44570643|NCT01676116|79591683|FG000|Overall Study|Adverse Event|1|||
44570644|NCT01676116|79591684|FG001|Overall Study|Adverse Event|2|||
44570645|NCT01676116|79591683|FG000|Overall Study|Unclassified|4|||
44570646|NCT01676116|79591684|FG001|Overall Study|Unclassified|10|||
44570647|NCT01676116|79591683|FG000|Overall Study|Protocol Violation|9|||
44570648|NCT01676116|79591684|FG001|Overall Study|Protocol Violation|3|||
44570649|NCT00740480|79591690|FG000|Overall Study|Adverse Event|1|||
44570650|NCT00740480|79591690|FG000|Overall Study|Physician Decision|1|||
44504356|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
44570651|NCT02743520|79591693|FG000|Overall Study|Withdrawal by Subject|1|||
44570652|NCT03001557|79591712|FG000|Core Phase|Randomized but not treated|0|||
44570653|NCT03001557|79591713|FG001|Core Phase|Randomized but not treated|0|||
44570654|NCT03001557|79591714|FG002|Core Phase|Randomized but not treated|1|||
44570655|NCT03001557|79591715|FG003|Core Phase|Randomized but not treated|0|||
44570656|NCT03001557|79591716|FG004|Core Phase|Randomized but not treated|0|||
44570657|NCT03001557|79591717|FG005|Core Phase|Randomized but not treated|0|||
44570658|NCT03001557|79591718|FG006|Core Phase|Randomized but not treated|0|||
44570659|NCT03001557|79591719|FG007|Core Phase|Randomized but not treated|0|||
44570660|NCT03001557|79591712|FG000|Extension Phase|Adverse Event|0|||
44570661|NCT03001557|79591713|FG001|Extension Phase|Adverse Event|0|||
44570662|NCT03001557|79591714|FG002|Extension Phase|Adverse Event|0|||
44570663|NCT03001557|79591715|FG003|Extension Phase|Adverse Event|0|||
44570664|NCT03001557|79591716|FG004|Extension Phase|Adverse Event|0|||
44570665|NCT03001557|79591717|FG005|Extension Phase|Adverse Event|2|||
44570666|NCT03001557|79591718|FG006|Extension Phase|Adverse Event|0|||
44570667|NCT03001557|79591719|FG007|Extension Phase|Adverse Event|0|||
44570668|NCT03001557|79591712|FG000|Extension Phase|Withdrawal by Subject|0|||
44570669|NCT03001557|79591713|FG001|Extension Phase|Withdrawal by Subject|0|||
44570670|NCT03001557|79591714|FG002|Extension Phase|Withdrawal by Subject|0|||
44570671|NCT03001557|79591715|FG003|Extension Phase|Withdrawal by Subject|0|||
44504357|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
44504358|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
44504359|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
44504360|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
44504361|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
44504362|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
44504363|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
44504364|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
44504365|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
44504366|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
44504367|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
44504368|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Other|2|||
44504369|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Other|1|||
44236986|NCT02709330|79062437|FG000|Overall Study|Lost to Follow-up|2|||
44504370|NCT02952586|79509152|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
44570672|NCT03001557|79591716|FG004|Extension Phase|Withdrawal by Subject|0|||
44570673|NCT03001557|79591717|FG005|Extension Phase|Withdrawal by Subject|1|||
44570674|NCT03001557|79591718|FG006|Extension Phase|Withdrawal by Subject|5|||
44570675|NCT03001557|79591719|FG007|Extension Phase|Withdrawal by Subject|2|||
44570676|NCT03001557|79591712|FG000|Extension Phase|Lost to Follow-up|0|||
44570677|NCT03001557|79591713|FG001|Extension Phase|Lost to Follow-up|0|||
44570678|NCT03001557|79591714|FG002|Extension Phase|Lost to Follow-up|0|||
44570679|NCT03001557|79591715|FG003|Extension Phase|Lost to Follow-up|0|||
44570680|NCT03001557|79591716|FG004|Extension Phase|Lost to Follow-up|0|||
44570681|NCT03001557|79591717|FG005|Extension Phase|Lost to Follow-up|0|||
44570682|NCT03001557|79591718|FG006|Extension Phase|Lost to Follow-up|2|||
44570683|NCT03001557|79591719|FG007|Extension Phase|Lost to Follow-up|1|||
44570684|NCT03001557|79591712|FG000|Extension Phase|Administrative Reason|0|||
44570685|NCT03001557|79591713|FG001|Extension Phase|Administrative Reason|0|||
44570686|NCT03001557|79591714|FG002|Extension Phase|Administrative Reason|0|||
44570687|NCT03001557|79591715|FG003|Extension Phase|Administrative Reason|0|||
44570688|NCT03001557|79591716|FG004|Extension Phase|Administrative Reason|0|||
44570689|NCT03001557|79591717|FG005|Extension Phase|Administrative Reason|1|||
44570690|NCT03001557|79591718|FG006|Extension Phase|Administrative Reason|3|||
44570691|NCT03001557|79591719|FG007|Extension Phase|Administrative Reason|3|||
44570692|NCT03001557|79591712|FG000|Extension Phase|Loss of caregiver|0|||
44570693|NCT03001557|79591713|FG001|Extension Phase|Loss of caregiver|0|||
44570694|NCT03001557|79591714|FG002|Extension Phase|Loss of caregiver|0|||
44570695|NCT03001557|79591715|FG003|Extension Phase|Loss of caregiver|0|||
44570696|NCT03001557|79591716|FG004|Extension Phase|Loss of caregiver|0|||
44570697|NCT03001557|79591717|FG005|Extension Phase|Loss of caregiver|0|||
44570698|NCT03001557|79591718|FG006|Extension Phase|Loss of caregiver|1|||
44570699|NCT03001557|79591719|FG007|Extension Phase|Loss of caregiver|0|||
44570700|NCT03001557|79591712|FG000|Extension Phase|Others|0|||
44570701|NCT03001557|79591713|FG001|Extension Phase|Others|0|||
44570702|NCT03001557|79591714|FG002|Extension Phase|Others|0|||
44570703|NCT03001557|79591715|FG003|Extension Phase|Others|0|||
44570704|NCT03001557|79591716|FG004|Extension Phase|Others|0|||
44570705|NCT03001557|79591717|FG005|Extension Phase|Others|1|||
44570706|NCT03001557|79591718|FG006|Extension Phase|Others|3|||
44570707|NCT03001557|79591719|FG007|Extension Phase|Others|0|||
44236987|NCT02709330|79062438|FG001|Overall Study|Lost to Follow-up|0|||
44236988|NCT02709330|79062437|FG000|Overall Study|Physician Decision|2|||
44236989|NCT02709330|79062438|FG001|Overall Study|Physician Decision|0|||
44236990|NCT02709330|79062437|FG000|Overall Study|Withdrawal by Subject|4|||
44236991|NCT02709330|79062438|FG001|Overall Study|Withdrawal by Subject|0|||
44236992|NCT02709096|79062446|FG000|Overall Study|non-compliance|1|||
44570708|NCT00830336|79591756|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
44570709|NCT00830336|79591757|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
44570710|NCT00830258|79591763|FG000|First Intervention|Adverse Event|1|||
44570711|NCT00830258|79591764|FG001|First Intervention|Adverse Event|0|||
44570712|NCT00830258|79591763|FG000|Washout: 7 Days|Protocol Violation|1|||
44236993|NCT02709096|79062447|FG001|Overall Study|non-compliance|1|||
44570713|NCT00830258|79591764|FG001|Washout: 7 Days|Protocol Violation|0|||
44570714|NCT03349775|79591770|FG000|Overall Study|Side Effects|1|||
44570715|NCT03349775|79591771|FG001|Overall Study|Side Effects|2|||
44570716|NCT03349775|79591770|FG000|Overall Study|Withdrawal by Subject|1|||
44570717|NCT03349775|79591771|FG001|Overall Study|Withdrawal by Subject|1|||
44570718|NCT03349775|79591770|FG000|Overall Study|No primary outcome measurements|0|||
44570719|NCT03349775|79591771|FG001|Overall Study|No primary outcome measurements|1|||
44570720|NCT00830024|79591779|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
44236994|NCT01372410|79062453|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
44236995|NCT01372410|79062454|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
44570721|NCT00830024|79591780|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
44570722|NCT00829868|79591786|FG000|Washout|Physician Decision|1|||
44236996|NCT01372410|79062455|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
44236997|NCT01372410|79062456|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
44236998|NCT01372410|79062457|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
44236999|NCT01372410|79062458|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
44237000|NCT01372410|79062459|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
44237001|NCT01372410|79062460|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
44237002|NCT01372410|79062453|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
44237003|NCT01372410|79062454|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
44237004|NCT01372410|79062455|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
44237005|NCT01372410|79062456|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
44237006|NCT01372410|79062457|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
44237007|NCT01372410|79062458|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
44237008|NCT01372410|79062459|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
44237009|NCT01372410|79062460|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
44237010|NCT01372410|79062453|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237011|NCT01372410|79062454|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237012|NCT01372410|79062455|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237013|NCT01372410|79062456|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237014|NCT01372410|79062457|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
44237015|NCT01372410|79062458|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237016|NCT01372410|79062459|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237017|NCT01372410|79062460|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
44237018|NCT01372410|79062453|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237019|NCT01372410|79062454|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237020|NCT01372410|79062455|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237021|NCT01372410|79062456|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237022|NCT01372410|79062457|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237023|NCT01372410|79062458|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237024|NCT01372410|79062459|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
44237025|NCT01372410|79062460|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
44237026|NCT01372410|79062453|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
44237027|NCT01372410|79062454|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
44237028|NCT01372410|79062455|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
44237029|NCT01372410|79062456|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
44504371|NCT02952586|79509153|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
44504372|NCT02952586|79509152|FG000|Follow-Up Phase (90 Days)|Death|12|||
44504373|NCT02952586|79509153|FG001|Follow-Up Phase (90 Days)|Death|10|||
44504374|NCT02952586|79509152|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
44504375|NCT02952586|79509153|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
44504376|NCT02952586|79509152|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
44504377|NCT02952586|79509153|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
44504378|NCT02952586|79509152|FG000|Follow-Up Phase (90 Days)|Other|7|||
44570723|NCT00829868|79591787|FG001|Washout|Physician Decision|0|||
44570724|NCT00829790|79591793|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
44237030|NCT01372410|79062457|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
44237031|NCT01372410|79062458|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
44237032|NCT01372410|79062459|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
44237033|NCT01372410|79062460|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
44237034|NCT01372410|79062453|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44504379|NCT02952586|79509153|FG001|Follow-Up Phase (90 Days)|Other|5|||
44504380|NCT02952586|79509152|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
44570725|NCT00829790|79591794|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
44570726|NCT03207815|79591800|FG000|Overall Study|Protocol Violation|3|||
44237035|NCT01372410|79062454|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44237036|NCT01372410|79062455|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44237037|NCT01372410|79062456|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44237038|NCT01372410|79062457|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
44237039|NCT01372410|79062458|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44237040|NCT01372410|79062459|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44237041|NCT01372410|79062460|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
44237042|NCT01372410|79062453|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
44237043|NCT01372410|79062454|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
44237044|NCT01372410|79062455|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
44237045|NCT01372410|79062456|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
44237046|NCT01372410|79062457|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
44237047|NCT01372410|79062458|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
44570727|NCT03207815|79591801|FG001|Overall Study|Protocol Violation|1|||
44570728|NCT03207815|79591800|FG000|Overall Study|Adverse Event|1|||
44570729|NCT03207815|79591801|FG001|Overall Study|Adverse Event|2|||
44570730|NCT03207815|79591800|FG000|Overall Study|Lost to Follow-up|1|||
44570731|NCT03207815|79591801|FG001|Overall Study|Lost to Follow-up|2|||
44570732|NCT03207815|79591800|FG000|Overall Study|Investigator's Discretion|1|||
44570733|NCT03207815|79591801|FG001|Overall Study|Investigator's Discretion|1|||
44570734|NCT03207815|79591800|FG000|Overall Study|Lack of Efficacy|0|||
44570735|NCT03207815|79591801|FG001|Overall Study|Lack of Efficacy|1|||
44570736|NCT03207815|79591800|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
44570737|NCT03207815|79591801|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
44570738|NCT03207815|79591800|FG000|Overall Study|Withdrew Consent|1|||
44570739|NCT03207815|79591801|FG001|Overall Study|Withdrew Consent|0|||
44570740|NCT02911935|79591809|FG000|Overall Study|Lost to Follow-up|5|||
44570741|NCT02911935|79591810|FG001|Overall Study|Lost to Follow-up|7|||
44570742|NCT00829712|79591818|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
44570743|NCT00829712|79591819|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
44570744|NCT03069989|79591834|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
44570745|NCT03069989|79591835|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
44570746|NCT02698163|79591862|FG000|Overall Study|Lost to Follow-up|0|||
44570747|NCT02698163|79591863|FG001|Overall Study|Lost to Follow-up|1|||
44570748|NCT03817190|79591871|FG000|Overall Study|Early Termination|13|||
44570749|NCT03817190|79591872|FG001|Overall Study|Early Termination|20|||
44570750|NCT03817190|79591871|FG000|Overall Study|Adverse Event|10|||
44570751|NCT03817190|79591872|FG001|Overall Study|Adverse Event|17|||
44570752|NCT03817190|79591871|FG000|Overall Study|Withdrawal by Subject|12|||
44570753|NCT03817190|79591872|FG001|Overall Study|Withdrawal by Subject|8|||
44570754|NCT03817190|79591871|FG000|Overall Study|Lost to Follow-up|11|||
44237048|NCT01372410|79062459|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
44237049|NCT01372410|79062460|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
44237050|NCT01372410|79062453|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44377752|NCT00916578|79383072|FG000|Overall Study|Withdrawal by Subject|3|||
44377753|NCT00916578|79383072|FG000|Overall Study|Insurance Denial|2|||
44377754|NCT00889707|79383078|FG000|Overall Study|Adverse Event|1|||
44377755|NCT00889707|79383079|FG001|Overall Study|Adverse Event|0|||
44377756|NCT00889707|79383078|FG000|Overall Study|Withdrawal by Subject|4|||
44377757|NCT00889707|79383079|FG001|Overall Study|Withdrawal by Subject|3|||
44377758|NCT00889707|79383078|FG000|Overall Study|Lost to Follow-up|0|||
44377759|NCT00889707|79383079|FG001|Overall Study|Lost to Follow-up|2|||
44377760|NCT00889707|79383078|FG000|Overall Study|Lack of Efficacy|2|||
44377761|NCT00889707|79383079|FG001|Overall Study|Lack of Efficacy|5|||
44377762|NCT00914940|79383085|FG000|D0 to D100 Post-transplant|Death|2|||
44377763|NCT00914940|79383085|FG000|D101 to 2 Years Post-transplant|Death|8|||
44377764|NCT00914940|79383085|FG000|2 Years to 5 Years Post-transplant|Death|3|||
44377765|NCT00835978|79383093|FG000|Overall Study|Death|33|||
44377766|NCT00835978|79383094|FG001|Overall Study|Death|40|||
44377767|NCT00835978|79383095|FG002|Overall Study|Death|49|||
44377768|NCT00835978|79383096|FG003|Overall Study|Death|4|||
44377769|NCT00835978|79383093|FG000|Overall Study|Lost to Follow-up|3|||
44377770|NCT00835978|79383094|FG001|Overall Study|Lost to Follow-up|4|||
44377771|NCT00835978|79383095|FG002|Overall Study|Lost to Follow-up|2|||
44377772|NCT00835978|79383096|FG003|Overall Study|Lost to Follow-up|1|||
44377773|NCT00835978|79383093|FG000|Overall Study|Other|5|||
44570755|NCT03817190|79591872|FG001|Overall Study|Lost to Follow-up|7|||
44570756|NCT03817190|79591871|FG000|Overall Study|Lack of Efficacy|7|||
44570757|NCT03817190|79591872|FG001|Overall Study|Lack of Efficacy|5|||
44570758|NCT03817190|79591871|FG000|Overall Study|Investigator Decision|5|||
44570759|NCT03817190|79591872|FG001|Overall Study|Investigator Decision|1|||
44377774|NCT00835978|79383094|FG001|Overall Study|Other|1|||
44570760|NCT03817190|79591871|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
44570761|NCT03817190|79591872|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
44570762|NCT03817190|79591871|FG000|Overall Study|Lack of Contact|1|||
44570763|NCT03817190|79591872|FG001|Overall Study|Lack of Contact|0|||
44570764|NCT03817190|79591871|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
44570765|NCT03817190|79591872|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
44570766|NCT03797222|79591891|FG000|Overall Study|Withdrawal by Subject|1|||
44237051|NCT01372410|79062454|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44237052|NCT01372410|79062455|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44237053|NCT01372410|79062456|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44237054|NCT01372410|79062457|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44237055|NCT01372410|79062458|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44237056|NCT01372410|79062459|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
44377775|NCT00835978|79383095|FG002|Overall Study|Other|8|||
44504381|NCT02952586|79509153|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
44570767|NCT02742818|79591901|FG000|Overall Study|Adverse Event|0|||
44570768|NCT02742818|79591902|FG001|Overall Study|Adverse Event|1|||
44570769|NCT02742818|79591901|FG000|Overall Study|Protocol Violation|0|||
44570770|NCT02742818|79591902|FG001|Overall Study|Protocol Violation|1|||
44570771|NCT03069365|79591910|FG000|Overall Study|Adverse Event|1|||
44570772|NCT03065933|79591914|FG000|Overall Study|study terminated|5|||
44570773|NCT04256629|79591924|FG000|Overall Study|Adverse Event|0|||
44570774|NCT04256629|79591925|FG001|Overall Study|Adverse Event|0|||
44570775|NCT04256629|79591926|FG002|Overall Study|Adverse Event|0|||
44570776|NCT04256629|79591927|FG003|Overall Study|Adverse Event|0|||
44570777|NCT04256629|79591928|FG004|Overall Study|Adverse Event|0|||
44570778|NCT04256629|79591929|FG005|Overall Study|Adverse Event|1|||
44570779|NCT04256629|79591924|FG000|Overall Study|Protocol Violation|0|||
44570780|NCT04256629|79591925|FG001|Overall Study|Protocol Violation|1|||
44570781|NCT04256629|79591926|FG002|Overall Study|Protocol Violation|0|||
44570782|NCT04256629|79591927|FG003|Overall Study|Protocol Violation|0|||
44570783|NCT04256629|79591928|FG004|Overall Study|Protocol Violation|0|||
44570784|NCT04256629|79591929|FG005|Overall Study|Protocol Violation|0|||
44570785|NCT01346293|79591939|FG000|Overall Study|Protocol Violation|30|||
44570786|NCT01346293|79591940|FG001|Overall Study|Protocol Violation|9|||
44570787|NCT01346293|79591939|FG000|Overall Study|Lost to Follow-up|21|||
44570788|NCT01346293|79591940|FG001|Overall Study|Lost to Follow-up|8|||
44570789|NCT01346293|79591939|FG000|Overall Study|Withdrawal by Subject|15|||
44570790|NCT01346293|79591940|FG001|Overall Study|Withdrawal by Subject|4|||
44570791|NCT01346293|79591939|FG000|Overall Study|Other|1|||
44570792|NCT01346293|79591940|FG001|Overall Study|Other|0|||
44570793|NCT03502187|79591960|FG000|Overall Study|Withdrawal by Subject|4|||
44237057|NCT01372410|79062460|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
44504382|NCT02952586|79509152|FG000|LT Follow-up (up to 45 Months)|Death|51|||
44504383|NCT02952586|79509153|FG001|LT Follow-up (up to 45 Months)|Death|31|||
44504384|NCT02952586|79509152|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
44504385|NCT02952586|79509153|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
44504386|NCT02952586|79509152|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
44504387|NCT02952586|79509153|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
44504388|NCT02952586|79509152|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
44504389|NCT02952586|79509153|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
44504390|NCT03384316|79509162|FG000|Overall Study|Screen failure|0|||
44504391|NCT03384316|79509163|FG001|Overall Study|Screen failure|1|||
44504392|NCT03403192|79509175|FG000|Overall Study|Lost to Follow-up|1|||
44504393|NCT03403192|79509176|FG001|Overall Study|Lost to Follow-up|2|||
44504394|NCT03403192|79509177|FG002|Overall Study|Lost to Follow-up|0|||
44504395|NCT03403192|79509178|FG003|Overall Study|Lost to Follow-up|0|||
44570794|NCT03502187|79591961|FG001|Overall Study|Withdrawal by Subject|3|||
44504396|NCT03403192|79509175|FG000|Overall Study|Unable to respond|0|||
44570795|NCT03502187|79591962|FG002|Overall Study|Withdrawal by Subject|3|||
44377776|NCT00835978|79383096|FG003|Overall Study|Other|0|||
44570796|NCT03502187|79591960|FG000|Overall Study|Lost to Follow-up|5|||
44504397|NCT03403192|79509176|FG001|Overall Study|Unable to respond|1|||
44504398|NCT03403192|79509177|FG002|Overall Study|Unable to respond|0|||
44570797|NCT03502187|79591961|FG001|Overall Study|Lost to Follow-up|4|||
44570798|NCT03502187|79591962|FG002|Overall Study|Lost to Follow-up|5|||
44570799|NCT03058705|79591970|FG000|Overall Study|Withdrawal by Subject|2|||
44570800|NCT03058705|79591970|FG000|Overall Study|Physician Decision|2|||
44570801|NCT02998671|79591979|FG000|Period 1|Study Terminated By Sponsor|2|||
44570802|NCT02998671|79591980|FG001|Period 1|Study Terminated By Sponsor|1|||
44570803|NCT02998671|79591981|FG002|Period 1|Study Terminated By Sponsor|0|||
44570804|NCT02998671|79591982|FG003|Period 1|Study Terminated By Sponsor|0|||
44570805|NCT02998671|79591983|FG004|Period 1|Study Terminated By Sponsor|1|||
44570806|NCT02998671|79591979|FG000|Period 1|Withdrawal by Subject|1|||
44570807|NCT02998671|79591980|FG001|Period 1|Withdrawal by Subject|2|||
44570808|NCT02998671|79591981|FG002|Period 1|Withdrawal by Subject|0|||
44570809|NCT02998671|79591982|FG003|Period 1|Withdrawal by Subject|0|||
44570810|NCT02998671|79591983|FG004|Period 1|Withdrawal by Subject|2|||
44570811|NCT02998671|79591979|FG000|Period 1|Pregnancy|1|||
44237058|NCT01372410|79062453|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
44237059|NCT01372410|79062454|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
44237060|NCT01372410|79062455|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
44237061|NCT01372410|79062456|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
44237062|NCT01372410|79062457|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
44237063|NCT01372410|79062458|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
44570812|NCT02998671|79591980|FG001|Period 1|Pregnancy|0|||
44570813|NCT02998671|79591981|FG002|Period 1|Pregnancy|0|||
44570814|NCT02998671|79591982|FG003|Period 1|Pregnancy|0|||
44570815|NCT02998671|79591983|FG004|Period 1|Pregnancy|0|||
44570816|NCT02998671|79591979|FG000|Period 1|Adverse Event|0|||
44570817|NCT02998671|79591980|FG001|Period 1|Adverse Event|0|||
44570818|NCT02998671|79591981|FG002|Period 1|Adverse Event|0|||
44570819|NCT02998671|79591982|FG003|Period 1|Adverse Event|0|||
44570820|NCT02998671|79591983|FG004|Period 1|Adverse Event|1|||
44570821|NCT02998671|79591979|FG000|Period 2|Adverse Event|0|||
44237064|NCT01372410|79062459|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
44237065|NCT01372410|79062460|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
44237066|NCT01372410|79062453|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44570822|NCT02998671|79591980|FG001|Period 2|Adverse Event|1|||
44570823|NCT02998671|79591981|FG002|Period 2|Adverse Event|0|||
44570824|NCT02998671|79591982|FG003|Period 2|Adverse Event|0|||
44570825|NCT02998671|79591983|FG004|Period 2|Adverse Event|0|||
44570826|NCT02998671|79591979|FG000|Period 2|Study Terminated By Sponsor|3|||
44570827|NCT02998671|79591980|FG001|Period 2|Study Terminated By Sponsor|5|||
44570828|NCT02998671|79591981|FG002|Period 2|Study Terminated By Sponsor|1|||
44570829|NCT02998671|79591982|FG003|Period 2|Study Terminated By Sponsor|3|||
44570830|NCT02998671|79591983|FG004|Period 2|Study Terminated By Sponsor|0|||
44570831|NCT02998671|79591979|FG000|Period 2|Withdrawal by Subject|0|||
44570832|NCT02998671|79591980|FG001|Period 2|Withdrawal by Subject|1|||
44570833|NCT02998671|79591981|FG002|Period 2|Withdrawal by Subject|0|||
44570834|NCT02998671|79591982|FG003|Period 2|Withdrawal by Subject|0|||
44570835|NCT02998671|79591983|FG004|Period 2|Withdrawal by Subject|0|||
44570836|NCT02998671|79591979|FG000|Period 2|Lost to Follow-up|0|||
44570837|NCT02998671|79591980|FG001|Period 2|Lost to Follow-up|0|||
44570838|NCT02998671|79591981|FG002|Period 2|Lost to Follow-up|0|||
44570839|NCT02998671|79591982|FG003|Period 2|Lost to Follow-up|1|||
44570840|NCT02998671|79591983|FG004|Period 2|Lost to Follow-up|0|||
44570841|NCT02660827|79592003|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
44570842|NCT02660827|79592003|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
44570843|NCT02660827|79592003|FG000|From Study to End of Continued Access|Adverse Event|3|||
44570844|NCT02660827|79592003|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
44570845|NCT02660827|79592003|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
44570846|NCT02660827|79592003|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
44570847|NCT02660827|79592003|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
44570848|NCT02660827|79592003|FG000|Period 2: Continued Access Period|Adverse Event|3|||
44570849|NCT01069419|79592024|FG000|Overall Study|Adverse Event|233|||
44570850|NCT01069419|79592024|FG000|Overall Study|Lack of Efficacy|332|||
44570851|NCT01069419|79592024|FG000|Overall Study|Lost to Follow-up|49|||
44570852|NCT01069419|79592024|FG000|Overall Study|Remission of disease|11|||
44570853|NCT01069419|79592024|FG000|Overall Study|Withdrawal by Subject|34|||
44570854|NCT01069419|79592024|FG000|Overall Study|Other Reason|43|||
44237067|NCT01372410|79062454|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44237068|NCT01372410|79062455|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44237069|NCT01372410|79062456|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44237070|NCT01372410|79062457|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44237071|NCT01372410|79062458|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
44249737|NCT01504412|79083926|FG003|Overall Study|Other|6|||
44570855|NCT01069419|79592024|FG000|Overall Study|Missing termination information|13|||
44570856|NCT01069341|79592028|FG000|Overall Study|Lost to Follow-up|1|||
44570857|NCT02996097|79592032|FG000|Overall Study|Lost to Follow-up|11|||
44570858|NCT02996097|79592033|FG001|Overall Study|Lost to Follow-up|11|||
44570859|NCT02992899|79592049|FG000|Overall Study|Withdrawal by Subject|1|||
44570860|NCT02992899|79592050|FG001|Overall Study|Withdrawal by Subject|0|||
44570861|NCT02992899|79592049|FG000|Overall Study|Lost to Follow-up|1|||
44570862|NCT02992899|79592050|FG001|Overall Study|Lost to Follow-up|3|||
44570863|NCT01602484|79592058|FG000|Overall Study|Airway issues unrelated to study|0|||
44570864|NCT01602484|79592059|FG001|Overall Study|Airway issues unrelated to study|1|||
44570865|NCT02989389|79592079|FG000|Period 1|Lost to Follow-up|0|||
44237072|NCT01372410|79062459|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44570866|NCT02989389|79592080|FG001|Period 1|Lost to Follow-up|1|||
44570867|NCT02989389|79592081|FG002|Period 1|Lost to Follow-up|0|||
44570868|NCT02989389|79592082|FG003|Period 1|Lost to Follow-up|0|||
44570869|NCT02989389|79592083|FG004|Period 1|Lost to Follow-up|0|||
44570870|NCT02989389|79592084|FG005|Period 1|Lost to Follow-up|0|||
44570871|NCT02989389|79592085|FG006|Period 1|Lost to Follow-up|0|||
44570872|NCT02989389|79592086|FG007|Period 1|Lost to Follow-up|0|||
44570873|NCT02989389|79592087|FG008|Period 1|Lost to Follow-up|0|||
44570874|NCT02989389|79592088|FG009|Period 1|Lost to Follow-up|0|||
44237073|NCT01372410|79062460|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
44237074|NCT01704287|79062498|FG000|Initial Treatment Period|Death|139|||
44237075|NCT01704287|79062499|FG001|Initial Treatment Period|Death|129|||
44570875|NCT02989389|79592079|FG000|Period 1|Physician Decision|0|||
44570876|NCT02989389|79592080|FG001|Period 1|Physician Decision|0|||
44570877|NCT02989389|79592081|FG002|Period 1|Physician Decision|0|||
44570878|NCT02989389|79592082|FG003|Period 1|Physician Decision|0|||
44570879|NCT02989389|79592083|FG004|Period 1|Physician Decision|0|||
44570880|NCT02989389|79592084|FG005|Period 1|Physician Decision|0|||
44570881|NCT02989389|79592085|FG006|Period 1|Physician Decision|0|||
44570882|NCT02989389|79592086|FG007|Period 1|Physician Decision|0|||
44570883|NCT02989389|79592087|FG008|Period 1|Physician Decision|1|||
44570884|NCT02989389|79592088|FG009|Period 1|Physician Decision|0|||
44237076|NCT01704287|79062500|FG002|Initial Treatment Period|Death|71|||
44570885|NCT02653300|79592128|FG000|Overall Study|Withdrawal by Subject|2|||
44570886|NCT00430508|79592136|FG000|Overall Study|Adverse Event|2|||
44570887|NCT00430508|79592137|FG001|Overall Study|Adverse Event|3|||
44570888|NCT00430508|79592138|FG002|Overall Study|Adverse Event|5|||
44570889|NCT00430508|79592139|FG003|Overall Study|Adverse Event|3|||
44570890|NCT00430508|79592136|FG000|Overall Study|Withdrawal by Subject|0|||
44570891|NCT00430508|79592137|FG001|Overall Study|Withdrawal by Subject|1|||
44570892|NCT00430508|79592138|FG002|Overall Study|Withdrawal by Subject|1|||
44570893|NCT00430508|79592139|FG003|Overall Study|Withdrawal by Subject|1|||
44570894|NCT00430508|79592136|FG000|Overall Study|responder at visit 4|0|||
44570895|NCT00430508|79592137|FG001|Overall Study|responder at visit 4|0|||
44570896|NCT00430508|79592138|FG002|Overall Study|responder at visit 4|2|||
44570897|NCT00430508|79592139|FG003|Overall Study|responder at visit 4|0|||
44570898|NCT00430508|79592136|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
44570899|NCT00430508|79592137|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
44237077|NCT01704287|79062501|FG003|Initial Treatment Period|Death|0|||
44237078|NCT01704287|79062502|FG004|Initial Treatment Period|Death|0|||
44237079|NCT01704287|79062498|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
44237080|NCT01704287|79062499|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
44570900|NCT00430508|79592138|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
44237081|NCT01704287|79062500|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
44237082|NCT01704287|79062501|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
44570901|NCT00430508|79592139|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
44570902|NCT00430508|79592136|FG000|Overall Study|Other|1|||
44570903|NCT00430508|79592137|FG001|Overall Study|Other|1|||
44570904|NCT00430508|79592138|FG002|Overall Study|Other|3|||
44570905|NCT00430508|79592139|FG003|Overall Study|Other|0|||
44570906|NCT02988219|79592147|FG000|Overall Study|Lack of Efficacy|1|||
44570907|NCT02988219|79592148|FG001|Overall Study|Lack of Efficacy|1|||
44570908|NCT02988219|79592147|FG000|Overall Study|Withdrawal by Subject|0|||
44237083|NCT01704287|79062502|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
44237084|NCT01704287|79062498|FG000|Initial Treatment Period|Lost to Follow-up|5|||
44237085|NCT01704287|79062499|FG001|Initial Treatment Period|Lost to Follow-up|3|||
44237086|NCT01704287|79062500|FG002|Initial Treatment Period|Lost to Follow-up|0|||
44237087|NCT01704287|79062501|FG003|Initial Treatment Period|Lost to Follow-up|0|||
44237088|NCT01704287|79062502|FG004|Initial Treatment Period|Lost to Follow-up|0|||
44237089|NCT01704287|79062498|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
44237090|NCT01704287|79062499|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
44504399|NCT03403192|79509178|FG003|Overall Study|Unable to respond|0|||
44504400|NCT03403192|79509175|FG000|Overall Study|Incomplete|3|||
44504401|NCT03403192|79509176|FG001|Overall Study|Incomplete|1|||
44504402|NCT03403192|79509177|FG002|Overall Study|Incomplete|3|||
44237091|NCT01704287|79062500|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
44237092|NCT01704287|79062501|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
44237093|NCT01704287|79062502|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
44237094|NCT01704287|79062498|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
44237095|NCT01704287|79062499|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
44237096|NCT01704287|79062500|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
44504403|NCT03403192|79509178|FG003|Overall Study|Incomplete|6|||
44504404|NCT00356525|79509192|FG000|Overall Study|Progressive Disease|8|||
44504405|NCT00356525|79509193|FG001|Overall Study|Progressive Disease|5|||
44504406|NCT00356525|79509194|FG002|Overall Study|Progressive Disease|4|||
44504407|NCT00356525|79509195|FG003|Overall Study|Progressive Disease|2|||
44570909|NCT02988219|79592148|FG001|Overall Study|Withdrawal by Subject|2|||
44570910|NCT01346059|79592156|FG000|Overall Study|Withdrawal by Subject|1|||
44570911|NCT01346059|79592157|FG001|Overall Study|Withdrawal by Subject|0|||
44570912|NCT01318915|79592163|FG000|Overall Study|Lost to Follow-up|1|||
44570913|NCT02987205|79592169|FG000|Overall Study|Adverse Event|1|||
44570914|NCT02987205|79592169|FG000|Overall Study|Withdrawal by Subject|3|||
44504408|NCT00356525|79509192|FG000|Overall Study|Adverse Event|1|||
44504409|NCT00356525|79509193|FG001|Overall Study|Adverse Event|3|||
44504410|NCT00356525|79509194|FG002|Overall Study|Adverse Event|1|||
44504411|NCT00356525|79509195|FG003|Overall Study|Adverse Event|1|||
44504412|NCT00356525|79509192|FG000|Overall Study|Lost to Follow-up|1|||
44504413|NCT00356525|79509193|FG001|Overall Study|Lost to Follow-up|0|||
44504414|NCT00356525|79509194|FG002|Overall Study|Lost to Follow-up|0|||
44504415|NCT00356525|79509195|FG003|Overall Study|Lost to Follow-up|0|||
44504416|NCT00356525|79509192|FG000|Overall Study|Physician Decision|2|||
44504417|NCT00356525|79509193|FG001|Overall Study|Physician Decision|2|||
44504418|NCT00356525|79509194|FG002|Overall Study|Physician Decision|2|||
44504419|NCT00356525|79509195|FG003|Overall Study|Physician Decision|1|||
44504420|NCT00356525|79509192|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
44570915|NCT02926937|79592191|FG000|Overall Study|Adverse Event|0|||
44570916|NCT02926937|79592192|FG001|Overall Study|Adverse Event|1|||
44237097|NCT01704287|79062501|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
44275925|NCT04093024|79226182|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
44275926|NCT04093024|79226183|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
44504421|NCT00356525|79509193|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
44504422|NCT00356525|79509194|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
44504423|NCT00356525|79509195|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
44504424|NCT00356525|79509192|FG000|Overall Study|Withdrawal by Subject|1|||
44504425|NCT00356525|79509193|FG001|Overall Study|Withdrawal by Subject|1|||
44504426|NCT00356525|79509194|FG002|Overall Study|Withdrawal by Subject|0|||
44504427|NCT00356525|79509195|FG003|Overall Study|Withdrawal by Subject|3|||
44570917|NCT02926937|79592193|FG002|Overall Study|Adverse Event|1|||
44504428|NCT00356525|79509192|FG000|Overall Study|Death|0|||
44504429|NCT00356525|79509193|FG001|Overall Study|Death|0|||
44504430|NCT00356525|79509194|FG002|Overall Study|Death|0|||
44570918|NCT02926937|79592191|FG000|Overall Study|Poor Compliance to Protocol|1|||
44237098|NCT01704287|79062502|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
44237099|NCT01704287|79062498|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
44237100|NCT01704287|79062499|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
44237101|NCT01704287|79062500|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
44237102|NCT01704287|79062501|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
44504431|NCT00356525|79509195|FG003|Overall Study|Death|1|||
44237103|NCT01704287|79062502|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
44504432|NCT00356525|79509192|FG000|Overall Study|Sponsor Decision|0|||
44504433|NCT00356525|79509193|FG001|Overall Study|Sponsor Decision|0|||
44504434|NCT00356525|79509194|FG002|Overall Study|Sponsor Decision|0|||
44504435|NCT00356525|79509195|FG003|Overall Study|Sponsor Decision|1|||
44504436|NCT00356369|79509207|FG000|Active Phase|Withdrawal by Subject|2|||
44504437|NCT00356369|79509208|FG001|Active Phase|Withdrawal by Subject|1|||
44504438|NCT03383614|79509218|FG000|Overall Study|Withdrawal by Subject|0|||
44504439|NCT03383614|79509219|FG001|Overall Study|Withdrawal by Subject|1|||
44504440|NCT03383614|79509220|FG002|Overall Study|Withdrawal by Subject|0|||
44504441|NCT03383614|79509221|FG003|Overall Study|Withdrawal by Subject|0|||
44504442|NCT03403036|79509236|FG000|Overall Study|Lack of Efficacy|5|||
44504443|NCT00356135|79509243|FG000|Overall Study|Protocol Violation|1|||
44504444|NCT00356135|79509244|FG001|Overall Study|Protocol Violation|0|||
44504445|NCT00356135|79509245|FG002|Overall Study|Protocol Violation|0|||
44504446|NCT00356135|79509243|FG000|Overall Study|Adverse Event|1|||
44504447|NCT00356135|79509244|FG001|Overall Study|Adverse Event|0|||
44504448|NCT00356135|79509245|FG002|Overall Study|Adverse Event|0|||
44504449|NCT00356135|79509243|FG000|Overall Study|Lost to Follow-up|0|||
44504450|NCT00356135|79509244|FG001|Overall Study|Lost to Follow-up|0|||
44504451|NCT00356135|79509245|FG002|Overall Study|Lost to Follow-up|1|||
44504452|NCT00356135|79509243|FG000|Overall Study|Physician Decision|1|||
44504453|NCT00356135|79509244|FG001|Overall Study|Physician Decision|1|||
44504454|NCT00356135|79509245|FG002|Overall Study|Physician Decision|1|||
44504455|NCT00356135|79509243|FG000|Overall Study|Subject non-compliance|1|||
44504456|NCT00356135|79509244|FG001|Overall Study|Subject non-compliance|1|||
44504457|NCT00356135|79509245|FG002|Overall Study|Subject non-compliance|3|||
44504458|NCT03383146|79509257|FG000|Overall Study|Screen Failure|1|||
44504459|NCT03383146|79509258|FG001|Overall Study|Screen Failure|0|||
44237104|NCT01704287|79062498|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
44237105|NCT01704287|79062499|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
44504460|NCT03383146|79509257|FG000|Overall Study|Adverse Event|6|||
44504461|NCT03383146|79509258|FG001|Overall Study|Adverse Event|18|||
44504462|NCT03383146|79509257|FG000|Overall Study|Lack of Efficacy|0|||
44570919|NCT02926937|79592192|FG001|Overall Study|Poor Compliance to Protocol|0|||
44570920|NCT02926937|79592193|FG002|Overall Study|Poor Compliance to Protocol|0|||
44570921|NCT02926937|79592191|FG000|Overall Study|Lost to Follow-up|4|||
44570922|NCT02926937|79592192|FG001|Overall Study|Lost to Follow-up|5|||
44570923|NCT02926937|79592193|FG002|Overall Study|Lost to Follow-up|0|||
44570924|NCT02926937|79592191|FG000|Overall Study|At the Participant's own Request|11|||
44570925|NCT02926937|79592192|FG001|Overall Study|At the Participant's own Request|5|||
44570926|NCT02926937|79592193|FG002|Overall Study|At the Participant's own Request|8|||
44570927|NCT02926937|79592191|FG000|Overall Study|Reason not Specified|3|||
44570928|NCT02926937|79592192|FG001|Overall Study|Reason not Specified|4|||
44570929|NCT02926937|79592193|FG002|Overall Study|Reason not Specified|2|||
44570930|NCT00151892|79592204|FG000|Overall Study|Lack of Efficacy|50|||
44570931|NCT00151892|79592205|FG001|Overall Study|Lack of Efficacy|57|||
44570932|NCT00151892|79592204|FG000|Overall Study|Patient request|10|||
44570933|NCT00151892|79592205|FG001|Overall Study|Patient request|7|||
44570934|NCT00151892|79592204|FG000|Overall Study|Lost to Follow-up|5|||
44570935|NCT00151892|79592205|FG001|Overall Study|Lost to Follow-up|10|||
44570936|NCT00151892|79592204|FG000|Overall Study|Adverse Event|6|||
44570937|NCT00151892|79592205|FG001|Overall Study|Adverse Event|3|||
44570938|NCT00151892|79592204|FG000|Overall Study|Protocol Violation|3|||
44570939|NCT00151892|79592205|FG001|Overall Study|Protocol Violation|3|||
44570940|NCT00151892|79592204|FG000|Overall Study|Non-compliance|0|||
44570941|NCT00151892|79592205|FG001|Overall Study|Non-compliance|1|||
44570942|NCT00151892|79592204|FG000|Overall Study|Pregnancy|0|||
44570943|NCT00151892|79592205|FG001|Overall Study|Pregnancy|1|||
44570944|NCT00151892|79592204|FG000|Overall Study|Did not return for a visit|1|||
44570945|NCT00151892|79592205|FG001|Overall Study|Did not return for a visit|0|||
44570946|NCT00151892|79592204|FG000|Overall Study|Used prohibited corticosteroids|1|||
44570947|NCT00151892|79592205|FG001|Overall Study|Used prohibited corticosteroids|0|||
44570948|NCT00151892|79592204|FG000|Overall Study|Lack of study medication at center|0|||
44570949|NCT00151892|79592205|FG001|Overall Study|Lack of study medication at center|1|||
44570950|NCT03055195|79592229|FG000|Overall Study|Lack of Efficacy|1|||
44570951|NCT03055195|79592230|FG001|Overall Study|Lack of Efficacy|0|||
44570952|NCT03055195|79592229|FG000|Overall Study|Withdrawal by Subject|6|||
44570953|NCT03055195|79592230|FG001|Overall Study|Withdrawal by Subject|7|||
44570954|NCT03055195|79592229|FG000|Overall Study|Study Terminated by Sponsor|2|||
44570955|NCT03055195|79592230|FG001|Overall Study|Study Terminated by Sponsor|6|||
44570956|NCT03055195|79592229|FG000|Overall Study|Protocol Violation|2|||
44570957|NCT03055195|79592230|FG001|Overall Study|Protocol Violation|1|||
44570958|NCT03055195|79592229|FG000|Overall Study|Physician Decision|1|||
44570959|NCT03055195|79592230|FG001|Overall Study|Physician Decision|0|||
44570960|NCT02921919|79592238|FG000|Overall Study|Other|5|||
44570961|NCT02921919|79592239|FG001|Overall Study|Other|6|||
44570962|NCT02921919|79592238|FG000|Overall Study|Lost to Follow-up|0|||
44570963|NCT02921919|79592239|FG001|Overall Study|Lost to Follow-up|1|||
44570964|NCT02921919|79592238|FG000|Overall Study|Withdrawal by Subject|5|||
44570965|NCT02921919|79592239|FG001|Overall Study|Withdrawal by Subject|1|||
44570966|NCT02921919|79592238|FG000|Overall Study|Disease Progression|47|||
44570967|NCT02921919|79592239|FG001|Overall Study|Disease Progression|38|||
44570968|NCT02921919|79592238|FG000|Overall Study|Physician Decision|3|||
44570969|NCT02921919|79592239|FG001|Overall Study|Physician Decision|2|||
44570970|NCT02921919|79592238|FG000|Overall Study|Adverse Event|6|||
44570971|NCT02921919|79592239|FG001|Overall Study|Adverse Event|4|||
44570972|NCT02910219|79592261|FG000|Overall Study|Withdrawal by Subject|1|||
44570973|NCT02910219|79592262|FG001|Overall Study|Withdrawal by Subject|1|||
44570974|NCT01068717|79592268|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
44570975|NCT01068717|79592269|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
44570976|NCT01068717|79592270|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
44237106|NCT01704287|79062500|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
44237107|NCT01704287|79062501|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
44570977|NCT01068717|79592271|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
44570978|NCT02921763|79592285|FG000|Overall Study|Adverse Event|4|||
44570979|NCT02921763|79592285|FG000|Overall Study|Lost to Follow-up|4|||
44570980|NCT02921763|79592285|FG000|Overall Study|Lack of Efficacy|3|||
44570981|NCT02921763|79592285|FG000|Overall Study|Protocol Violation|2|||
44570982|NCT02921763|79592285|FG000|Overall Study|Withdrawal by Subject|2|||
44570983|NCT02921763|79592285|FG000|Overall Study|Physician Decision|1|||
44570984|NCT02921763|79592285|FG000|Overall Study|No data obtained|2|||
44570985|NCT01318135|79592307|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
44570986|NCT01318135|79592308|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44570987|NCT01318135|79592309|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44570988|NCT01318135|79592310|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44570989|NCT01318135|79592311|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44237108|NCT01704287|79062502|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
44570990|NCT01318135|79592312|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44570991|NCT01318135|79592313|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44570992|NCT01318135|79592314|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44570993|NCT01318135|79592307|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
44570994|NCT01318135|79592308|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44570995|NCT01318135|79592309|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44570996|NCT01318135|79592310|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44570997|NCT01318135|79592311|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44570998|NCT01318135|79592312|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44570999|NCT01318135|79592313|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44571000|NCT01318135|79592314|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
44571001|NCT01318135|79592307|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
44571002|NCT01318135|79592308|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
44571003|NCT01318135|79592309|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
44571004|NCT01318135|79592310|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
44571005|NCT01318135|79592311|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
44571006|NCT01318135|79592312|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
44571007|NCT01318135|79592313|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
44571008|NCT01318135|79592314|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
44571009|NCT01318135|79592307|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
44571010|NCT01318135|79592308|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
44571011|NCT01318135|79592309|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
44571012|NCT01318135|79592310|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
44571013|NCT01318135|79592311|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
44571014|NCT01318135|79592312|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
44571015|NCT01318135|79592313|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
44571016|NCT01318135|79592314|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
44571017|NCT01318135|79592307|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44571018|NCT01318135|79592308|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44571019|NCT01318135|79592309|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44571020|NCT01318135|79592310|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44571021|NCT01318135|79592311|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44571022|NCT01318135|79592312|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44571023|NCT01318135|79592313|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44571024|NCT01318135|79592314|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44571025|NCT01318135|79592307|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
44571026|NCT01318135|79592308|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
44571027|NCT01318135|79592309|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
44571028|NCT01318135|79592310|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
44571029|NCT01318135|79592311|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
44571030|NCT01318135|79592312|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
44571031|NCT01318135|79592313|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
44571032|NCT01318135|79592314|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
44571033|NCT01318135|79592307|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571034|NCT01318135|79592308|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571035|NCT01318135|79592309|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571036|NCT01318135|79592310|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571037|NCT01318135|79592311|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571038|NCT01318135|79592312|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571039|NCT01318135|79592313|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
44571040|NCT01318135|79592314|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
44571041|NCT02922153|79592326|FG000|Overall Study|Death|8|||
44571042|NCT02922153|79592327|FG001|Overall Study|Death|1|||
44571043|NCT02922153|79592326|FG000|Overall Study|Lost to Follow-up|1|||
44571044|NCT02922153|79592327|FG001|Overall Study|Lost to Follow-up|0|||
44571045|NCT02922153|79592326|FG000|Overall Study|Physician Decision|1|||
44571046|NCT02922153|79592327|FG001|Overall Study|Physician Decision|1|||
44571047|NCT02920983|79592333|FG000|Dispense 1|Unacceptable Lens Fit|0|||
44571048|NCT02920983|79592334|FG001|Dispense 1|Unacceptable Lens Fit|0|||
44571049|NCT02920983|79592335|FG002|Dispense 1|Unacceptable Lens Fit|0|||
44571050|NCT02920983|79592336|FG003|Dispense 1|Unacceptable Lens Fit|0|||
44571051|NCT02920983|79592337|FG004|Dispense 1|Unacceptable Lens Fit|1|||
44571052|NCT02920983|79592338|FG005|Dispense 1|Unacceptable Lens Fit|0|||
44571053|NCT02920983|79592333|FG000|Dispense 2|Unscceptable lens fit|1|||
44571054|NCT02920983|79592334|FG001|Dispense 2|Unscceptable lens fit|0|||
44571055|NCT02920983|79592335|FG002|Dispense 2|Unscceptable lens fit|0|||
44571056|NCT02920983|79592336|FG003|Dispense 2|Unscceptable lens fit|0|||
44571057|NCT02920983|79592337|FG004|Dispense 2|Unscceptable lens fit|1|||
44571058|NCT02920983|79592338|FG005|Dispense 2|Unscceptable lens fit|0|||
44571059|NCT02920983|79592333|FG000|Dispense 3|Unacceptable Lens Fit|1|||
44571060|NCT02920983|79592334|FG001|Dispense 3|Unacceptable Lens Fit|1|||
44571061|NCT02920983|79592335|FG002|Dispense 3|Unacceptable Lens Fit|0|||
44571062|NCT02920983|79592336|FG003|Dispense 3|Unacceptable Lens Fit|0|||
44571063|NCT02920983|79592337|FG004|Dispense 3|Unacceptable Lens Fit|1|||
44571064|NCT02920983|79592338|FG005|Dispense 3|Unacceptable Lens Fit|0|||
44571065|NCT02654002|79592355|FG000|Overall Study|Adverse Event|0|||
44571066|NCT02654002|79592356|FG001|Overall Study|Adverse Event|0|||
44571067|NCT02654002|79592357|FG002|Overall Study|Adverse Event|0|||
44571068|NCT02654002|79592358|FG003|Overall Study|Adverse Event|0|||
44571069|NCT02654002|79592359|FG004|Overall Study|Adverse Event|0|||
44571070|NCT02654002|79592360|FG005|Overall Study|Adverse Event|0|||
44571071|NCT02654002|79592361|FG006|Overall Study|Adverse Event|1|||
44571072|NCT02654002|79592362|FG007|Overall Study|Adverse Event|0|||
44571073|NCT02654002|79592363|FG008|Overall Study|Adverse Event|0|||
44571074|NCT02654002|79592355|FG000|Overall Study|Withdrew Consent|0|||
44571075|NCT02654002|79592356|FG001|Overall Study|Withdrew Consent|0|||
44571076|NCT02654002|79592357|FG002|Overall Study|Withdrew Consent|0|||
44571077|NCT02654002|79592358|FG003|Overall Study|Withdrew Consent|0|||
44571078|NCT02654002|79592359|FG004|Overall Study|Withdrew Consent|0|||
44571079|NCT02654002|79592360|FG005|Overall Study|Withdrew Consent|1|||
44571080|NCT02654002|79592361|FG006|Overall Study|Withdrew Consent|0|||
44571081|NCT02654002|79592362|FG007|Overall Study|Withdrew Consent|1|||
44571082|NCT02654002|79592363|FG008|Overall Study|Withdrew Consent|0|||
44571083|NCT01675492|79592398|FG000|Overall Study|study completed early - product approval|42|||
44571084|NCT03924622|79592409|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
44571085|NCT03924622|79592410|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
44571086|NCT03924622|79592411|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
44571087|NCT03924622|79592412|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
44571088|NCT03924622|79592413|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
44504463|NCT03383146|79509258|FG001|Overall Study|Lack of Efficacy|3|||
44504464|NCT03383146|79509257|FG000|Overall Study|Withdrawal by Subject|20|||
44504465|NCT03383146|79509258|FG001|Overall Study|Withdrawal by Subject|36|||
44504466|NCT03383146|79509257|FG000|Overall Study|Lost to Follow-up|5|||
44504467|NCT03383146|79509258|FG001|Overall Study|Lost to Follow-up|15|||
44504468|NCT03383146|79509257|FG000|Overall Study|Death|0|||
44504469|NCT03383146|79509258|FG001|Overall Study|Death|2|||
44504470|NCT03383146|79509257|FG000|Overall Study|Physician Decision|0|||
44504471|NCT03383146|79509258|FG001|Overall Study|Physician Decision|1|||
44504472|NCT03383146|79509257|FG000|Overall Study|Protocol Deviation|1|||
44571089|NCT03924622|79592414|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
44571090|NCT04044664|79592431|FG000|Stage 1|Adverse Event|3|||
44571091|NCT04044664|79592432|FG001|Stage 1|Adverse Event|3|||
44571092|NCT04044664|79592433|FG002|Stage 1|Adverse Event|1|||
44571093|NCT04044664|79592431|FG000|Stage 1|Lost to Follow-up|3|||
44571094|NCT04044664|79592432|FG001|Stage 1|Lost to Follow-up|2|||
44571095|NCT04044664|79592433|FG002|Stage 1|Lost to Follow-up|2|||
44571096|NCT04044664|79592431|FG000|Stage 1|Withdrawal by Subject|9|||
44504473|NCT03383146|79509258|FG001|Overall Study|Protocol Deviation|8|||
44504474|NCT03383146|79509257|FG000|Overall Study|Study Terminated by the Sponsor|48|||
44377777|NCT00835978|79383093|FG000|Overall Study|Objective progression or relapse|2|||
44377778|NCT00835978|79383094|FG001|Overall Study|Objective progression or relapse|0|||
44504475|NCT03383146|79509258|FG001|Overall Study|Study Terminated by the Sponsor|95|||
44504476|NCT03383146|79509257|FG000|Overall Study|Reason not Specified|4|||
44504477|NCT03383146|79509258|FG001|Overall Study|Reason not Specified|6|||
44504478|NCT03616964|79509268|FG000|Overall Study|Adverse Event|15|||
44504479|NCT03616964|79509269|FG001|Overall Study|Adverse Event|10|||
44504480|NCT03616964|79509270|FG002|Overall Study|Adverse Event|16|||
44504481|NCT03616964|79509268|FG000|Overall Study|Death|3|||
44504482|NCT03616964|79509269|FG001|Overall Study|Death|0|||
44504483|NCT03616964|79509270|FG002|Overall Study|Death|4|||
44504484|NCT03616964|79509268|FG000|Overall Study|Lack of Efficacy|4|||
44504485|NCT03616964|79509269|FG001|Overall Study|Lack of Efficacy|8|||
44504486|NCT03616964|79509270|FG002|Overall Study|Lack of Efficacy|8|||
44504487|NCT03616964|79509268|FG000|Overall Study|Lost to Follow-up|2|||
44504488|NCT03616964|79509269|FG001|Overall Study|Lost to Follow-up|1|||
44504489|NCT03616964|79509270|FG002|Overall Study|Lost to Follow-up|3|||
44504490|NCT03616964|79509268|FG000|Overall Study|Withdrawal by Subject|18|||
44504491|NCT03616964|79509269|FG001|Overall Study|Withdrawal by Subject|14|||
44504492|NCT03616964|79509270|FG002|Overall Study|Withdrawal by Subject|21|||
44504493|NCT03616964|79509268|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
44504494|NCT03616964|79509269|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
44504495|NCT03616964|79509270|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
44504496|NCT03616964|79509268|FG000|Overall Study|Sponsor's Decision|1|||
44504497|NCT03616964|79509269|FG001|Overall Study|Sponsor's Decision|0|||
44504498|NCT03616964|79509270|FG002|Overall Study|Sponsor's Decision|0|||
44504499|NCT03616964|79509268|FG000|Overall Study|Physician Decision|0|||
44504500|NCT03616964|79509269|FG001|Overall Study|Physician Decision|2|||
44504501|NCT03616964|79509270|FG002|Overall Study|Physician Decision|0|||
44504502|NCT03616964|79509268|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
44504503|NCT03616964|79509269|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
44504504|NCT03616964|79509270|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
44504505|NCT03616964|79509268|FG000|Overall Study|Protocol Violation|0|||
44504506|NCT03616964|79509269|FG001|Overall Study|Protocol Violation|1|||
44504507|NCT03616964|79509270|FG002|Overall Study|Protocol Violation|0|||
44504508|NCT03616964|79509268|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
44504509|NCT03616964|79509269|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
44504510|NCT03616964|79509270|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
44504511|NCT03616964|79509268|FG000|Overall Study|Randomized but Never Treated|1|||
44504512|NCT03616964|79509269|FG001|Overall Study|Randomized but Never Treated|1|||
44504513|NCT03616964|79509270|FG002|Overall Study|Randomized but Never Treated|1|||
44504514|NCT00350519|79509282|FG000|Overall Study|Death|0|||
44504515|NCT00350519|79509283|FG001|Overall Study|Death|1|||
44504516|NCT00350519|79509282|FG000|Overall Study|Physician Decision|0|||
44504517|NCT00350519|79509283|FG001|Overall Study|Physician Decision|1|||
44504518|NCT00350519|79509282|FG000|Overall Study|Protocol Violation|1|||
44504519|NCT00350519|79509283|FG001|Overall Study|Protocol Violation|2|||
44504520|NCT00350519|79509282|FG000|Overall Study|Withdrawal by Subject|3|||
44504521|NCT00350519|79509283|FG001|Overall Study|Withdrawal by Subject|2|||
44504522|NCT03382912|79509291|FG000|Overall Study|Physician Decision|0|||
44504523|NCT03382912|79509292|FG001|Overall Study|Physician Decision|1|||
44504524|NCT03382912|79509291|FG000|Overall Study|Sponsor Decision|6|||
44504525|NCT03382912|79509292|FG001|Overall Study|Sponsor Decision|6|||
44504526|NCT03382912|79509291|FG000|Overall Study|Withdrawal by Subject|0|||
44504527|NCT03382912|79509292|FG001|Overall Study|Withdrawal by Subject|5|||
44504528|NCT00350207|79509301|FG000|Overall Study|Adverse Event|5|||
44504529|NCT00350207|79509302|FG001|Overall Study|Adverse Event|2|||
44504530|NCT00350207|79509303|FG002|Overall Study|Adverse Event|2|||
44504531|NCT00350207|79509301|FG000|Overall Study|Lack of Efficacy|1|||
44504532|NCT00350207|79509302|FG001|Overall Study|Lack of Efficacy|0|||
44504533|NCT00350207|79509303|FG002|Overall Study|Lack of Efficacy|2|||
44504534|NCT00350207|79509301|FG000|Overall Study|Lost to Follow-up|1|||
44504535|NCT00350207|79509302|FG001|Overall Study|Lost to Follow-up|0|||
44504536|NCT00350207|79509303|FG002|Overall Study|Lost to Follow-up|1|||
44504537|NCT00350207|79509301|FG000|Overall Study|Withdrawal by Subject|0|||
44504538|NCT00350207|79509302|FG001|Overall Study|Withdrawal by Subject|1|||
44504539|NCT00350207|79509303|FG002|Overall Study|Withdrawal by Subject|1|||
44504540|NCT00350207|79509301|FG000|Overall Study|Other|1|||
44504541|NCT00350207|79509302|FG001|Overall Study|Other|3|||
44504542|NCT00350207|79509303|FG002|Overall Study|Other|1|||
44504543|NCT00349973|79509313|FG000|Overall Study|Adverse Event|3|||
44504544|NCT00349973|79509314|FG001|Overall Study|Adverse Event|3|||
44504545|NCT00349973|79509313|FG000|Overall Study|Withdrawal by Subject|1|||
44504546|NCT00349973|79509314|FG001|Overall Study|Withdrawal by Subject|0|||
44504547|NCT03187262|79509320|FG000|Induction|Lack of Efficacy|2|||
44504548|NCT03187262|79509320|FG000|Induction|Progressive Disease|4|||
44504549|NCT03187262|79509320|FG000|Consolidation|Progressive Disease|5|||
44571097|NCT04044664|79592432|FG001|Stage 1|Withdrawal by Subject|1|||
44571098|NCT04044664|79592433|FG002|Stage 1|Withdrawal by Subject|0|||
44571099|NCT04044664|79592431|FG000|Stage 1|noncompliance, personal reason|2|||
44571100|NCT04044664|79592432|FG001|Stage 1|noncompliance, personal reason|0|||
44571101|NCT04044664|79592433|FG002|Stage 1|noncompliance, personal reason|0|||
44571102|NCT04044664|79592431|FG000|Stage 1|randomization error|0|||
44571103|NCT04044664|79592432|FG001|Stage 1|randomization error|1|||
44571104|NCT04044664|79592433|FG002|Stage 1|randomization error|0|||
44571105|NCT04044664|79592431|FG000|Stage 2|Adverse Event|2|||
44571106|NCT04044664|79592432|FG001|Stage 2|Adverse Event|0|||
44571107|NCT04044664|79592433|FG002|Stage 2|Adverse Event|0|||
44571108|NCT04044664|79592431|FG000|Stage 2|Lost to Follow-up|3|||
44571109|NCT04044664|79592432|FG001|Stage 2|Lost to Follow-up|2|||
44571110|NCT04044664|79592433|FG002|Stage 2|Lost to Follow-up|1|||
44571111|NCT04044664|79592431|FG000|Stage 2|Withdrawal by Subject|3|||
44571112|NCT04044664|79592432|FG001|Stage 2|Withdrawal by Subject|0|||
44571113|NCT04044664|79592433|FG002|Stage 2|Withdrawal by Subject|0|||
44571114|NCT04044664|79592431|FG000|Stage 2|protocol deviation|1|||
44571115|NCT04044664|79592432|FG001|Stage 2|protocol deviation|0|||
44571116|NCT04044664|79592433|FG002|Stage 2|protocol deviation|0|||
44571117|NCT00150176|79592443|FG000|Overall Study|Adverse Event|16|||
44571118|NCT00150176|79592444|FG001|Overall Study|Adverse Event|53|||
44571119|NCT00150176|79592443|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
44571120|NCT00150176|79592444|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
44571121|NCT00150176|79592443|FG000|Overall Study|Withdrawal by Subject|19|||
44571122|NCT00150176|79592444|FG001|Overall Study|Withdrawal by Subject|12|||
44571123|NCT00150176|79592443|FG000|Overall Study|Lost to Follow-up|3|||
44571124|NCT00150176|79592444|FG001|Overall Study|Lost to Follow-up|3|||
44571125|NCT00150176|79592443|FG000|Overall Study|OTHER|11|||
44571126|NCT00150176|79592444|FG001|Overall Study|OTHER|13|||
44571127|NCT02985879|79592454|FG000|Overall Study|Adverse Event|7|||
44571128|NCT02985879|79592455|FG001|Overall Study|Adverse Event|9|||
44571129|NCT02985879|79592456|FG002|Overall Study|Adverse Event|7|||
44571130|NCT02985879|79592454|FG000|Overall Study|Withdrew consent|6|||
44571131|NCT02985879|79592455|FG001|Overall Study|Withdrew consent|8|||
44571132|NCT02985879|79592456|FG002|Overall Study|Withdrew consent|10|||
44571133|NCT02985879|79592454|FG000|Overall Study|Lost to Follow-up|1|||
44571134|NCT02985879|79592455|FG001|Overall Study|Lost to Follow-up|0|||
44571135|NCT02985879|79592456|FG002|Overall Study|Lost to Follow-up|2|||
44571136|NCT02985879|79592454|FG000|Overall Study|Other, not specified|62|||
44571137|NCT02985879|79592455|FG001|Overall Study|Other, not specified|58|||
44377779|NCT00835978|79383095|FG002|Overall Study|Objective progression or relapse|1|||
44377780|NCT00835978|79383096|FG003|Overall Study|Objective progression or relapse|0|||
44377781|NCT00835978|79383093|FG000|Overall Study|Adverse Event|1|||
44377782|NCT00835978|79383094|FG001|Overall Study|Adverse Event|0|||
44377783|NCT00835978|79383095|FG002|Overall Study|Adverse Event|1|||
44377784|NCT00835978|79383096|FG003|Overall Study|Adverse Event|0|||
44377785|NCT00835978|79383093|FG000|Overall Study|Withdrawal by Subject|0|||
44377786|NCT00835978|79383094|FG001|Overall Study|Withdrawal by Subject|3|||
44377787|NCT00835978|79383095|FG002|Overall Study|Withdrawal by Subject|0|||
44377788|NCT00835978|79383096|FG003|Overall Study|Withdrawal by Subject|5|||
44377789|NCT00835978|79383093|FG000|Overall Study|Study terminated by sponsor|12|||
44377790|NCT00835978|79383094|FG001|Overall Study|Study terminated by sponsor|8|||
44377791|NCT00835978|79383095|FG002|Overall Study|Study terminated by sponsor|30|||
44377792|NCT00835978|79383096|FG003|Overall Study|Study terminated by sponsor|0|||
44377793|NCT00914628|79383113|FG000|Overall Study|Death|35|||
44504550|NCT03381196|79509326|FG000|Overall Study|Withdrawal by Subject|7|||
44504551|NCT03381196|79509327|FG001|Overall Study|Withdrawal by Subject|7|||
44504552|NCT03381196|79509326|FG000|Overall Study|Other|0|||
44504553|NCT03381196|79509327|FG001|Overall Study|Other|1|||
44504554|NCT03381196|79509326|FG000|Overall Study|Lost to Follow-up|5|||
44504555|NCT03381196|79509327|FG001|Overall Study|Lost to Follow-up|4|||
44504556|NCT03381196|79509326|FG000|Overall Study|Death|0|||
44504557|NCT03381196|79509327|FG001|Overall Study|Death|1|||
44571138|NCT02985879|79592456|FG002|Overall Study|Other, not specified|58|||
44377794|NCT00914628|79383114|FG001|Overall Study|Death|17|||
44504558|NCT03381196|79509326|FG000|Overall Study|Adverse Event|1|||
44571139|NCT01067469|79592472|FG000|Overall Study|Withdrawal by Subject|0|||
44571140|NCT01067469|79592473|FG001|Overall Study|Withdrawal by Subject|1|||
44571141|NCT01067469|79592472|FG000|Overall Study|Disease Progression|0|||
44504559|NCT03381196|79509327|FG001|Overall Study|Adverse Event|0|||
44504560|NCT03381196|79509326|FG000|Overall Study|Randomized, not treated|3|||
44571142|NCT01067469|79592473|FG001|Overall Study|Disease Progression|1|||
44571143|NCT02985021|79592479|FG000|Overall Study|Inability to comply with study procedures|1|||
44571144|NCT01066923|79592487|FG000|Overall Study|Withdrawal by Subject|3|||
44571145|NCT01066923|79592488|FG001|Overall Study|Withdrawal by Subject|3|||
44571146|NCT01066923|79592489|FG002|Overall Study|Withdrawal by Subject|8|||
44571147|NCT01066923|79592490|FG003|Overall Study|Withdrawal by Subject|8|||
44571148|NCT02919267|79592515|FG000|Overall Study|Protocol Violation|0|||
44571149|NCT02919267|79592516|FG001|Overall Study|Protocol Violation|3|||
44571150|NCT02919267|79592517|FG002|Overall Study|Protocol Violation|3|||
44571151|NCT02919267|79592518|FG003|Overall Study|Protocol Violation|4|||
44571152|NCT01368900|79592528|FG000|Overall Study|Lost to Follow-up|7|||
44571153|NCT02910063|79592534|FG000|Phase 2|Withdrawal by Subject|3|||
44571154|NCT02910063|79592535|FG001|Phase 2|Withdrawal by Subject|0|||
44571155|NCT02910063|79592536|FG002|Phase 2|Withdrawal by Subject|0|||
44571156|NCT02910063|79592534|FG000|Phase 2|Lost to Follow-up|1|||
44571157|NCT02910063|79592535|FG001|Phase 2|Lost to Follow-up|0|||
44571158|NCT02910063|79592536|FG002|Phase 2|Lost to Follow-up|0|||
44571159|NCT02910063|79592534|FG000|Phase 2|Death|24|||
44571160|NCT02910063|79592535|FG001|Phase 2|Death|0|||
44571161|NCT02910063|79592536|FG002|Phase 2|Death|0|||
44571162|NCT02909907|79592547|FG000|Overall Study|Withdrawal by Subject|0|||
44571163|NCT02909907|79592548|FG001|Overall Study|Withdrawal by Subject|1|||
44571164|NCT02651194|79592554|FG000|Overall Study|Lost to Follow-up|3|||
44571165|NCT02651194|79592554|FG000|Overall Study|Other|2|||
44571166|NCT02907177|79592560|FG000|Overall Study|Death|0|||
44571167|NCT02907177|79592561|FG001|Overall Study|Death|1|||
44571168|NCT02907177|79592560|FG000|Overall Study|Physician Decision|3|||
44571169|NCT02907177|79592561|FG001|Overall Study|Physician Decision|3|||
44571170|NCT02907177|79592560|FG000|Overall Study|Withdrawal by Subject|15|||
44571171|NCT02907177|79592561|FG001|Overall Study|Withdrawal by Subject|7|||
44571172|NCT02907177|79592560|FG000|Overall Study|Sponsor's Decision|50|||
44571173|NCT02907177|79592561|FG001|Overall Study|Sponsor's Decision|57|||
44571174|NCT02652442|79592567|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
44571175|NCT02906709|79592581|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
44571176|NCT02906709|79592582|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
44571177|NCT02906709|79592581|FG000|Phase A (Week 0 to Week 16)|Death|0|||
44571178|NCT02906709|79592582|FG001|Phase A (Week 0 to Week 16)|Death|1|||
44571179|NCT02906709|79592581|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
44571180|NCT02906709|79592582|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
44571181|NCT02906709|79592581|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
44571182|NCT02906709|79592582|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
44571183|NCT00318656|79592596|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
44571184|NCT00318656|79592597|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
44571185|NCT00318656|79592596|FG000|Overall Study|Did not receive any treatment|0|||
44571186|NCT00318656|79592597|FG001|Overall Study|Did not receive any treatment|1|||
44571187|NCT02908347|79592603|FG000|Overall Study|Adverse Event|0|||
44571188|NCT02908347|79592604|FG001|Overall Study|Adverse Event|1|||
44571189|NCT02908347|79592603|FG000|Overall Study|Lost to Follow-up|1|||
44571190|NCT02908347|79592604|FG001|Overall Study|Lost to Follow-up|0|||
44571191|NCT02983305|79592626|FG000|Overall Study|incomplete data|2|||
44571192|NCT02983305|79592627|FG001|Overall Study|incomplete data|0|||
44571193|NCT03663166|79592633|FG000|Overall Study|Withdrawal by Subject|1|||
44571194|NCT02983227|79592640|FG000|Overall Study|Adverse Event|21|||
44571195|NCT02983227|79592641|FG001|Overall Study|Adverse Event|3|||
44377795|NCT00914628|79383113|FG000|Overall Study|Medical decision|4|||
44377796|NCT00914628|79383114|FG001|Overall Study|Medical decision|0|||
44504561|NCT03381196|79509327|FG001|Overall Study|Randomized, not treated|6|||
44504562|NCT02950558|79509335|FG000|Overall Study|Lost to Follow-up|2|||
44504563|NCT02950558|79509336|FG001|Overall Study|Lost to Follow-up|0|||
44504564|NCT03345472|79509343|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
44504565|NCT03345472|79509343|FG000|Implant to 3 Months|Physician Decision|1|||
44504566|NCT03345472|79509343|FG000|Implant to 3 Months|Adverse Event|1|||
44504567|NCT03345472|79509343|FG000|3 Months to 12 Months|Physician Decision|3|||
44571196|NCT02983227|79592640|FG000|Overall Study|Death|3|||
44571197|NCT02983227|79592641|FG001|Overall Study|Death|0|||
44571198|NCT02983227|79592640|FG000|Overall Study|Lack of Efficacy|8|||
44571199|NCT02983227|79592641|FG001|Overall Study|Lack of Efficacy|1|||
44571200|NCT02983227|79592640|FG000|Overall Study|Lost to Follow-up|3|||
44571201|NCT02983227|79592641|FG001|Overall Study|Lost to Follow-up|0|||
44504568|NCT03345472|79509343|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
44571202|NCT02983227|79592640|FG000|Overall Study|Multiple Reasons|2|||
44504569|NCT03345472|79509343|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
44571203|NCT02983227|79592641|FG001|Overall Study|Multiple Reasons|1|||
44571204|NCT02983227|79592640|FG000|Overall Study|Physician Decision|3|||
44571205|NCT02983227|79592641|FG001|Overall Study|Physician Decision|1|||
44571206|NCT02983227|79592640|FG000|Overall Study|Withdrawal by Subject|19|||
44571207|NCT02983227|79592641|FG001|Overall Study|Withdrawal by Subject|8|||
44571208|NCT00301262|79592649|FG000|Double Blind Phase (DB)|Adverse Event|1|||
44571209|NCT00301262|79592650|FG001|Double Blind Phase (DB)|Adverse Event|0|||
44571210|NCT00301262|79592649|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
44571211|NCT00301262|79592650|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
44571212|NCT00301262|79592649|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
44571213|NCT00301262|79592650|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
44571214|NCT00301262|79592649|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
44571215|NCT00301262|79592650|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
44571216|NCT00301262|79592649|FG000|Double Blind Phase (DB)|Other|1|||
44571217|NCT00301262|79592650|FG001|Double Blind Phase (DB)|Other|4|||
44571218|NCT00301262|79592649|FG000|Open Label Phase (OL)|Adverse Event|1|||
44571219|NCT00301262|79592650|FG001|Open Label Phase (OL)|Adverse Event|0|||
44571220|NCT00301262|79592649|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
44571221|NCT00301262|79592650|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
44571222|NCT00301262|79592649|FG000|Open Label Phase (OL)|Other|2|||
44571223|NCT00301262|79592650|FG001|Open Label Phase (OL)|Other|0|||
44571224|NCT02905149|79592677|FG000|Overall Study|Lost to Follow-up|2|||
44571225|NCT02905149|79592678|FG001|Overall Study|Lost to Follow-up|0|||
44571226|NCT02790606|79592684|FG000|Overall Study|Death|27|||
44571227|NCT02790606|79592684|FG000|Overall Study|Lost to Follow-up|4|||
44571228|NCT02790606|79592684|FG000|Overall Study|Physician Decision|3|||
44571229|NCT02790606|79592684|FG000|Overall Study|Withdrawal by Subject|1|||
44571230|NCT03077620|79592692|FG000|Overall Study|Unable to place lumbar catheter|1|||
44571231|NCT03077620|79592693|FG001|Overall Study|Unable to place lumbar catheter|0|||
44571232|NCT03077620|79592694|FG002|Overall Study|Unable to place lumbar catheter|1|||
44571233|NCT03077620|79592695|FG003|Overall Study|Unable to place lumbar catheter|0|||
44571234|NCT03077620|79592692|FG000|Overall Study|Withdrawal by Subject|0|||
44571235|NCT03077620|79592693|FG001|Overall Study|Withdrawal by Subject|1|||
44571236|NCT03077620|79592694|FG002|Overall Study|Withdrawal by Subject|0|||
44571237|NCT03077620|79592695|FG003|Overall Study|Withdrawal by Subject|0|||
44571238|NCT03077620|79592692|FG000|Overall Study|Physician Decision|0|||
44571239|NCT03077620|79592693|FG001|Overall Study|Physician Decision|0|||
44571240|NCT03077620|79592694|FG002|Overall Study|Physician Decision|1|||
44571241|NCT03077620|79592695|FG003|Overall Study|Physician Decision|0|||
44571242|NCT02982213|79592716|FG000|Overall Study|Did not complete follow up questionnaire|5|||
44571243|NCT02982213|79592717|FG001|Overall Study|Did not complete follow up questionnaire|1|||
44571244|NCT02649634|79592725|FG000|Overall Study|Withdrawal by Subject|3|||
44571245|NCT02649634|79592726|FG001|Overall Study|Withdrawal by Subject|5|||
44571246|NCT02649634|79592725|FG000|Overall Study|Lost to Follow-up|0|||
44377797|NCT00914628|79383113|FG000|Overall Study|Protocol Violation|1|||
44377798|NCT00914628|79383114|FG001|Overall Study|Protocol Violation|0|||
44377799|NCT00914628|79383113|FG000|Overall Study|Lack of Efficacy|1|||
44377800|NCT00914628|79383114|FG001|Overall Study|Lack of Efficacy|0|||
44377801|NCT00914628|79383113|FG000|Overall Study|non-randomized|1|||
44377802|NCT00914628|79383114|FG001|Overall Study|non-randomized|0|||
44377803|NCT00914628|79383113|FG000|Overall Study|Relapse|1|||
44377804|NCT00914628|79383114|FG001|Overall Study|Relapse|2|||
44504570|NCT03345472|79509343|FG000|3 Months to 12 Months|Adverse Event|1|||
44504571|NCT03345472|79509343|FG000|3 Months to 12 Months|Death|1|||
44504572|NCT00349349|79509350|FG000|Overall Study|Adverse Event|5|||
44504573|NCT00349349|79509351|FG001|Overall Study|Adverse Event|6|||
44504574|NCT00349349|79509352|FG002|Overall Study|Adverse Event|2|||
44504575|NCT00349349|79509350|FG000|Overall Study|Withdrawal by Subject|5|||
44504576|NCT00349349|79509351|FG001|Overall Study|Withdrawal by Subject|2|||
44504577|NCT00349349|79509352|FG002|Overall Study|Withdrawal by Subject|1|||
44377805|NCT00914628|79383113|FG000|Overall Study|Study terminated by Sponsor|14|||
44377806|NCT00914628|79383114|FG001|Overall Study|Study terminated by Sponsor|8|||
44377807|NCT00914628|79383113|FG000|Overall Study|Patients who did not receive a single dose|7|||
44377808|NCT00914628|79383114|FG001|Overall Study|Patients who did not receive a single dose|1|||
44377809|NCT01077518|79383126|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
44377810|NCT01077518|79383127|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
44504578|NCT00349349|79509350|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
44504579|NCT00349349|79509351|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
44571247|NCT02649634|79592726|FG001|Overall Study|Lost to Follow-up|1|||
44571248|NCT01066143|79592732|FG000|Overall Study|ineligible for the study|8|||
44571249|NCT02980107|79592738|FG000|Overall Study|Withdrawal by Subject|51|||
44571250|NCT02980107|79592739|FG001|Overall Study|Withdrawal by Subject|62|||
44377811|NCT01077518|79383128|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
44504580|NCT00349349|79509352|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
44571251|NCT02652130|79592745|FG000|Overall Study|Death|1|||
44571252|NCT02979639|79592749|FG000|Overall Study|Withdrawal based on medical judgement|1|||
44571253|NCT02979639|79592749|FG000|Overall Study|Lost to Follow-up|8|||
44504581|NCT00349349|79509350|FG000|Overall Study|Death|13|||
44504582|NCT00349349|79509351|FG001|Overall Study|Death|10|||
44504583|NCT00349349|79509352|FG002|Overall Study|Death|1|||
44504584|NCT00349349|79509350|FG000|Overall Study|Other Treatment Selected|2|||
44504585|NCT00349349|79509351|FG001|Overall Study|Other Treatment Selected|0|||
44504586|NCT00349349|79509352|FG002|Overall Study|Other Treatment Selected|0|||
44571254|NCT02979639|79592749|FG000|Overall Study|Withdrawal by Subject|3|||
44571255|NCT02979639|79592749|FG000|Overall Study|Adverse Event|2|||
44571256|NCT01674634|79592753|FG000|Overall Study|Withdrawal by Subject|3|||
44571257|NCT01674634|79592753|FG000|Overall Study|Lost to Follow-up|3|||
44571258|NCT02979249|79592761|FG000|Overall Study|Lost to Follow-up|2|||
44571259|NCT02979249|79592761|FG000|Overall Study|Withdrawal by Subject|4|||
44571260|NCT02112552|79592765|FG000|Overall Study|Withdrawal by Subject|1|||
44571261|NCT02112552|79592765|FG000|Overall Study|Adverse Event|1|||
44571262|NCT02976519|79592776|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
44571263|NCT02976519|79592777|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
44571264|NCT02976519|79592778|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
44571265|NCT02976519|79592779|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
44571266|NCT02976519|79592780|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
44571267|NCT02976519|79592781|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
44571268|NCT02976519|79592782|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
44571269|NCT02976519|79592776|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
44571270|NCT02976519|79592777|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
44504587|NCT00349349|79509350|FG000|Overall Study|Participant Reduced General Condition|0|||
44504588|NCT00349349|79509351|FG001|Overall Study|Participant Reduced General Condition|1|||
44504589|NCT00349349|79509352|FG002|Overall Study|Participant Reduced General Condition|0|||
44504590|NCT00349349|79509350|FG000|Overall Study|Physician Decision|1|||
44504591|NCT00349349|79509351|FG001|Overall Study|Physician Decision|2|||
44504592|NCT00349349|79509352|FG002|Overall Study|Physician Decision|1|||
44504593|NCT00349349|79509350|FG000|Overall Study|No Response|0|||
44504594|NCT00349349|79509351|FG001|Overall Study|No Response|3|||
44504595|NCT00349349|79509352|FG002|Overall Study|No Response|0|||
44504596|NCT00349349|79509350|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
44571271|NCT02976519|79592778|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
44571272|NCT02976519|79592779|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
44571273|NCT02976519|79592780|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
44571274|NCT02976519|79592781|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
44571275|NCT02976519|79592782|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
44571276|NCT02976519|79592776|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
44571277|NCT02976519|79592777|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
44571278|NCT02976519|79592778|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
44571279|NCT02976519|79592779|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
44571280|NCT02976519|79592780|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
44571281|NCT02976519|79592781|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
44571282|NCT02976519|79592782|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
44571283|NCT02976519|79592776|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
44571284|NCT02976519|79592777|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
44571285|NCT02976519|79592778|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
44571286|NCT02976519|79592779|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
44571287|NCT02976519|79592780|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
44571288|NCT02976519|79592781|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
44571289|NCT02976519|79592782|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
44571290|NCT02976519|79592776|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
44571291|NCT02976519|79592777|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
44571292|NCT02976519|79592778|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
44571293|NCT02976519|79592779|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
44571294|NCT02976519|79592780|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
44571295|NCT02976519|79592781|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
44571296|NCT02976519|79592782|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
44571297|NCT02975973|79592887|FG000|Overall Study|Adverse Event|1|||
44504597|NCT00349349|79509351|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
44504598|NCT00349349|79509352|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
44504599|NCT02950480|79509364|FG000|Overall Study|Withdrawal by Subject|1|||
44504600|NCT02950480|79509365|FG001|Overall Study|Withdrawal by Subject|0|||
44504601|NCT00348881|79509373|FG000|Overall Study|Lost to Follow-up|12|||
44504602|NCT00348881|79509374|FG001|Overall Study|Lost to Follow-up|6|||
44504603|NCT00348881|79509373|FG000|Overall Study|Withdrawal by Subject|3|||
44504604|NCT00348881|79509374|FG001|Overall Study|Withdrawal by Subject|4|||
44504605|NCT00348881|79509373|FG000|Overall Study|Adverse Event|2|||
44504606|NCT00348881|79509374|FG001|Overall Study|Adverse Event|0|||
44504607|NCT00348881|79509373|FG000|Overall Study|Serious Adverse Event|0|||
44504608|NCT00348881|79509374|FG001|Overall Study|Serious Adverse Event|2|||
44504609|NCT03376516|79509384|FG000|Overall Study|Not treated|1|||
44504610|NCT03376516|79509384|FG000|Overall Study|Consent withdrawn|1|||
44504611|NCT03797144|79509410|FG000|Enrollment|Protocol Violation|4|||
44504612|NCT03797144|79509411|FG001|Enrollment|Protocol Violation|1|||
44504613|NCT03797144|79509410|FG000|Surgery|Protocol Violation|1|||
44504614|NCT03797144|79509411|FG001|Surgery|Protocol Violation|0|||
44504615|NCT03797144|79509410|FG000|3 Month|Early termination cut-off date|2|||
44571298|NCT02975973|79592888|FG001|Overall Study|Adverse Event|1|||
44571299|NCT02975973|79592889|FG002|Overall Study|Adverse Event|1|||
44571300|NCT02975973|79592890|FG003|Overall Study|Adverse Event|0|||
44504616|NCT03797144|79509411|FG001|3 Month|Early termination cut-off date|0|||
44504617|NCT03797144|79509410|FG000|12 Month|Early termination cut-off date|8|||
44571301|NCT01362322|79592902|FG000|Overall Study|Withdrawal by Subject|3|||
44504618|NCT03797144|79509411|FG001|12 Month|Early termination cut-off date|9|||
44504619|NCT03797144|79509410|FG000|24 Month|Early termination cut-off date|1|||
44504620|NCT03797144|79509411|FG001|24 Month|Early termination cut-off date|1|||
44504621|NCT00347009|79509418|FG000|Overall Study|Death|1|||
44504622|NCT00347009|79509418|FG000|Overall Study|Adverse Event|6|||
44504623|NCT00347009|79509418|FG000|Overall Study|Withdrawal by Subject|3|||
44504624|NCT00347009|79509418|FG000|Overall Study|Physician Decision|5|||
44237109|NCT01682837|79062530|FG000|Baseline|Withdrawal by Subject|5|||
44504625|NCT00347009|79509418|FG000|Overall Study|Lost to Follow-up|4|||
44504626|NCT00347009|79509418|FG000|Overall Study|Protocol Violation|2|||
44504627|NCT00347009|79509418|FG000|Overall Study|Adverse Laboratory Experience|1|||
44504628|NCT00347009|79509418|FG000|Overall Study|Insufficient Viral Suppression|3|||
44571302|NCT01362322|79592903|FG001|Overall Study|Withdrawal by Subject|1|||
44571303|NCT01362322|79592902|FG000|Overall Study|Lost to Follow-up|2|||
44571304|NCT01362322|79592903|FG001|Overall Study|Lost to Follow-up|6|||
44571305|NCT02918877|79592911|FG000|Overall Study|Withdrawal by Subject|2|||
44571306|NCT02918877|79592912|FG001|Overall Study|Withdrawal by Subject|2|||
44571307|NCT02918877|79592911|FG000|Overall Study|Surgery cancelled|1|||
44571308|NCT02918877|79592912|FG001|Overall Study|Surgery cancelled|0|||
44571309|NCT02918877|79592911|FG000|Overall Study|Physician Decision|1|||
44571310|NCT02918877|79592912|FG001|Overall Study|Physician Decision|0|||
44571311|NCT02918877|79592911|FG000|Overall Study|Received intraoperative steroids|1|||
44571312|NCT02918877|79592912|FG001|Overall Study|Received intraoperative steroids|0|||
44571313|NCT02918877|79592911|FG000|Overall Study|Unable to obtain lab samples|1|||
44571314|NCT02918877|79592912|FG001|Overall Study|Unable to obtain lab samples|0|||
44571315|NCT02918877|79592911|FG000|Overall Study|Unsafe to perform BAL|0|||
44571316|NCT02918877|79592912|FG001|Overall Study|Unsafe to perform BAL|1|||
44571317|NCT01674712|79592923|FG000|Overall Study|Adverse Event|5|||
44571318|NCT01674712|79592924|FG001|Overall Study|Adverse Event|6|||
44571319|NCT01674712|79592925|FG002|Overall Study|Adverse Event|3|||
44571320|NCT01674712|79592926|FG003|Overall Study|Adverse Event|4|||
44571321|NCT01674712|79592927|FG004|Overall Study|Adverse Event|6|||
44571322|NCT01674712|79592923|FG000|Overall Study|Lost to Follow-up|1|||
44571323|NCT01674712|79592924|FG001|Overall Study|Lost to Follow-up|0|||
44571324|NCT01674712|79592925|FG002|Overall Study|Lost to Follow-up|0|||
44571325|NCT01674712|79592926|FG003|Overall Study|Lost to Follow-up|0|||
44571326|NCT01674712|79592927|FG004|Overall Study|Lost to Follow-up|0|||
44571327|NCT01674712|79592923|FG000|Overall Study|Protocol Violation|2|||
44571328|NCT01674712|79592924|FG001|Overall Study|Protocol Violation|0|||
44571329|NCT01674712|79592925|FG002|Overall Study|Protocol Violation|0|||
44571330|NCT01674712|79592926|FG003|Overall Study|Protocol Violation|0|||
44571331|NCT01674712|79592927|FG004|Overall Study|Protocol Violation|0|||
44571332|NCT01674712|79592923|FG000|Overall Study|Withdrawal by Subject|2|||
44571333|NCT01674712|79592924|FG001|Overall Study|Withdrawal by Subject|2|||
44571334|NCT01674712|79592925|FG002|Overall Study|Withdrawal by Subject|5|||
44571335|NCT01674712|79592926|FG003|Overall Study|Withdrawal by Subject|4|||
44571336|NCT01674712|79592927|FG004|Overall Study|Withdrawal by Subject|3|||
44571337|NCT01674712|79592923|FG000|Overall Study|Administrative|0|||
44571338|NCT01674712|79592924|FG001|Overall Study|Administrative|1|||
44571339|NCT01674712|79592925|FG002|Overall Study|Administrative|0|||
44571340|NCT01674712|79592926|FG003|Overall Study|Administrative|0|||
44571341|NCT01674712|79592927|FG004|Overall Study|Administrative|1|||
44571342|NCT01674712|79592923|FG000|Overall Study|Lack of Efficacy|0|||
44571343|NCT01674712|79592924|FG001|Overall Study|Lack of Efficacy|0|||
44571344|NCT01674712|79592925|FG002|Overall Study|Lack of Efficacy|1|||
44571345|NCT01674712|79592926|FG003|Overall Study|Lack of Efficacy|0|||
44571346|NCT01674712|79592927|FG004|Overall Study|Lack of Efficacy|1|||
44571347|NCT01368432|79592941|FG000|Overall Study|Lost to Follow-up|0|||
44571348|NCT01368432|79592942|FG001|Overall Study|Lost to Follow-up|1|||
44571349|NCT01063881|79592965|FG000|Overall Study|Adverse Event|12|||
44571350|NCT01063881|79592966|FG001|Overall Study|Adverse Event|2|||
44571351|NCT01063881|79592967|FG002|Overall Study|Adverse Event|0|||
44571352|NCT01063881|79592965|FG000|Overall Study|Lost to Follow-up|13|||
44571353|NCT01063881|79592966|FG001|Overall Study|Lost to Follow-up|7|||
44571354|NCT01063881|79592967|FG002|Overall Study|Lost to Follow-up|1|||
44571355|NCT01063881|79592965|FG000|Overall Study|Withdrawal by Subject|25|||
44571356|NCT01063881|79592966|FG001|Overall Study|Withdrawal by Subject|1|||
44571357|NCT01063881|79592967|FG002|Overall Study|Withdrawal by Subject|0|||
44571358|NCT01063881|79592965|FG000|Overall Study|Reason for not completed not specified|5|||
44571359|NCT01063881|79592966|FG001|Overall Study|Reason for not completed not specified|1|||
44571360|NCT01063881|79592967|FG002|Overall Study|Reason for not completed not specified|0|||
44571361|NCT01062555|79592984|FG000|Phase 1|Death|10|||
44571362|NCT01062555|79592985|FG001|Phase 1|Death|17|||
44571363|NCT01062555|79592986|FG002|Phase 1|Death|0|||
44571364|NCT01062555|79592987|FG003|Phase 1|Death|0|||
44571365|NCT01062555|79592984|FG000|Phase 1|Graft Failure|12|||
44571366|NCT01062555|79592985|FG001|Phase 1|Graft Failure|8|||
44571367|NCT01062555|79592986|FG002|Phase 1|Graft Failure|0|||
44571368|NCT01062555|79592987|FG003|Phase 1|Graft Failure|0|||
44571369|NCT01062555|79592984|FG000|Phase 1|Withdrawal by Subject|1|||
44571370|NCT01062555|79592985|FG001|Phase 1|Withdrawal by Subject|1|||
44571371|NCT01062555|79592986|FG002|Phase 1|Withdrawal by Subject|0|||
44571372|NCT01062555|79592987|FG003|Phase 1|Withdrawal by Subject|0|||
44571373|NCT01062555|79592984|FG000|Phase 2|Death|0|||
44571374|NCT01062555|79592985|FG001|Phase 2|Death|0|||
44571375|NCT01062555|79592986|FG002|Phase 2|Death|8|||
44571376|NCT01062555|79592987|FG003|Phase 2|Death|3|||
44571377|NCT01062555|79592984|FG000|Phase 2|Graft failure|0|||
44571378|NCT01062555|79592985|FG001|Phase 2|Graft failure|0|||
44571379|NCT01062555|79592986|FG002|Phase 2|Graft failure|7|||
44571380|NCT01062555|79592987|FG003|Phase 2|Graft failure|4|||
44571381|NCT01062555|79592984|FG000|Phase 2|Withdrawal by Subject|0|||
44571382|NCT01062555|79592985|FG001|Phase 2|Withdrawal by Subject|0|||
44571383|NCT01062555|79592986|FG002|Phase 2|Withdrawal by Subject|0|||
44571384|NCT01062555|79592987|FG003|Phase 2|Withdrawal by Subject|7|||
44571385|NCT01062555|79592984|FG000|Phase 2|Protocol Violation|0|||
44571386|NCT01062555|79592985|FG001|Phase 2|Protocol Violation|0|||
44571387|NCT01062555|79592986|FG002|Phase 2|Protocol Violation|0|||
44571388|NCT01062555|79592987|FG003|Phase 2|Protocol Violation|3|||
44571389|NCT01062555|79592984|FG000|Phase 2|Physician Decision|0|||
44571390|NCT01062555|79592985|FG001|Phase 2|Physician Decision|0|||
44571391|NCT01062555|79592986|FG002|Phase 2|Physician Decision|0|||
44571392|NCT01062555|79592987|FG003|Phase 2|Physician Decision|17|||
44571393|NCT01064817|79592999|FG000|Study Completion|Physician Decision|1|||
44571394|NCT01064817|79593000|FG001|Study Completion|Physician Decision|0|||
44571395|NCT01064817|79592999|FG000|Study Completion|Withdrawal by Subject|1|||
44571396|NCT01064817|79593000|FG001|Study Completion|Withdrawal by Subject|0|||
44571397|NCT01368276|79593008|FG000|Overall Study|Death|1|||
44571398|NCT01368276|79593009|FG001|Overall Study|Death|10|||
44571399|NCT01064739|79593015|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
44571400|NCT01061775|79593025|FG000|Overall Study|Physician Decision|2|||
44571401|NCT01061775|79593025|FG000|Overall Study|Lost to Follow-up|1|||
44571402|NCT02651116|79593032|FG000|Overall Study|Adverse Event|0|||
44571403|NCT02651116|79593033|FG001|Overall Study|Adverse Event|1|||
44571404|NCT02651116|79593032|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
44571405|NCT02651116|79593033|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
44377812|NCT01077518|79383126|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
44377813|NCT01077518|79383127|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
44504629|NCT00347009|79509418|FG000|Overall Study|Increased ALT/HBV DNA|1|||
44504630|NCT00347009|79509418|FG000|Overall Study|Serious Adverse Event|1|||
44504631|NCT00346775|79509426|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
44504632|NCT00346775|79509427|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
44504633|NCT00346775|79509426|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
44504634|NCT00346775|79509427|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
44504635|NCT00346775|79509426|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
44504636|NCT00346775|79509427|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
44504637|NCT00346697|79509439|FG000|Overall Study|Lost to Follow-up|0|||
44504638|NCT00346697|79509440|FG001|Overall Study|Lost to Follow-up|1|||
44504639|NCT03400852|79509450|FG000|Blinded Treatment Period|Physician Decision|0|||
44504640|NCT03400852|79509451|FG001|Blinded Treatment Period|Physician Decision|1|||
44504641|NCT03400852|79509452|FG002|Blinded Treatment Period|Physician Decision|0|||
44504642|NCT03400852|79509450|FG000|Blinded Treatment Period|Adverse Event|1|||
44504643|NCT03400852|79509451|FG001|Blinded Treatment Period|Adverse Event|1|||
44504644|NCT03400852|79509452|FG002|Blinded Treatment Period|Adverse Event|0|||
44504645|NCT03400852|79509450|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
44504646|NCT03400852|79509451|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
44504647|NCT03400852|79509452|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
44504648|NCT03400852|79509450|FG000|Open Label Period|Physician Decision|0|||
44504649|NCT03400852|79509451|FG001|Open Label Period|Physician Decision|0|||
44504650|NCT03400852|79509452|FG002|Open Label Period|Physician Decision|1|||
44504651|NCT03400852|79509450|FG000|Open Label Period|Study terminated by sponsor|0|||
44504652|NCT03400852|79509451|FG001|Open Label Period|Study terminated by sponsor|0|||
44504653|NCT03400852|79509452|FG002|Open Label Period|Study terminated by sponsor|21|||
44504654|NCT03398356|79509463|FG000|Before Treatment|Lost to Follow-up|1|||
44504655|NCT03398356|79509464|FG001|Before Treatment|Lost to Follow-up|2|||
44504656|NCT03398356|79509465|FG002|Before Treatment|Lost to Follow-up|0|||
44504657|NCT03398356|79509463|FG000|Before Treatment|drug intolerance|2|||
44504658|NCT03398356|79509464|FG001|Before Treatment|drug intolerance|1|||
44504659|NCT03398356|79509465|FG002|Before Treatment|drug intolerance|0|||
44504660|NCT03398356|79509463|FG000|Before Treatment|Withdrawal by Subject|0|||
44571406|NCT01061385|79593041|FG000|Overall Study|Lost to Follow-up|1|||
44571407|NCT01061385|79593042|FG001|Overall Study|Lost to Follow-up|0|||
44571408|NCT01061385|79593041|FG000|Overall Study|subject decision not related to AE|0|||
44571409|NCT01061385|79593042|FG001|Overall Study|subject decision not related to AE|1|||
44571410|NCT02973477|79593051|FG000|First Intervention|Lost to Follow-up|0|||
44571411|NCT02973477|79593052|FG001|First Intervention|Lost to Follow-up|2|||
44571412|NCT02973477|79593051|FG000|Washout|Withdrawal by Subject|1|||
44571413|NCT02973477|79593052|FG001|Washout|Withdrawal by Subject|0|||
44571414|NCT02973477|79593051|FG000|Second Intervention|Lost to Follow-up|1|||
44571415|NCT02973477|79593052|FG001|Second Intervention|Lost to Follow-up|0|||
44571416|NCT02788656|79593066|FG000|Overall Study|Withdrawal by Subject|1|||
44571417|NCT02788656|79593067|FG001|Overall Study|Withdrawal by Subject|0|||
44571418|NCT00283868|79593075|FG000|Overall Study|Lost to Follow-up|7|||
44571419|NCT00283868|79593076|FG001|Overall Study|Lost to Follow-up|8|||
44571420|NCT02973087|79593082|FG000|Overall Study|Withdrawal by Subject|2|||
44571421|NCT02973087|79593083|FG001|Overall Study|Withdrawal by Subject|1|||
44571422|NCT02973087|79593082|FG000|Overall Study|Adverse Event|1|||
44237110|NCT01703819|79062567|FG000|Overall Study|Adverse Event|0|||
44237111|NCT01703819|79062568|FG001|Overall Study|Adverse Event|1|||
44237112|NCT01703819|79062567|FG000|Overall Study|Withdrawal by Subject|0|||
44237113|NCT01703819|79062568|FG001|Overall Study|Withdrawal by Subject|1|||
44237114|NCT01682759|79062580|FG000|Overall Study|Death|2|||
44237115|NCT01682759|79062581|FG001|Overall Study|Death|1|||
44237116|NCT01682759|79062580|FG000|Overall Study|Lost to Follow-up|10|||
44237117|NCT01682759|79062581|FG001|Overall Study|Lost to Follow-up|13|||
44237118|NCT01682759|79062580|FG000|Overall Study|Physician Decision|1|||
44237119|NCT01682759|79062581|FG001|Overall Study|Physician Decision|1|||
44237120|NCT01682759|79062580|FG000|Overall Study|Withdrawal by Subject|56|||
44237121|NCT01682759|79062581|FG001|Overall Study|Withdrawal by Subject|55|||
44237122|NCT01682681|79062591|FG000|Overall Study|Lack of Efficacy|62|||
44237123|NCT01682681|79062591|FG000|Overall Study|Withdrawal by Subject|1|||
44237124|NCT01682681|79062591|FG000|Overall Study|Moved to other hospital|10|||
44237125|NCT01682681|79062591|FG000|Overall Study|Lost to Follow-up|174|||
44237126|NCT01682681|79062591|FG000|Overall Study|Adverse Event|46|||
44237127|NCT01682681|79062591|FG000|Overall Study|tapering of topiramate|5|||
44237128|NCT01682681|79062591|FG000|Overall Study|Other|21|||
44237129|NCT01682681|79062591|FG000|Overall Study|Low compliance|13|||
44237130|NCT01682603|79062595|FG000|Overall Study|Lost to Follow-up|3|||
44237131|NCT01682213|79062611|FG000|Overall Study|Withdrawal by Subject|2|||
44237132|NCT01703741|79062620|FG000|Overall Study|Withdrawal by Subject|6|||
44237133|NCT01703741|79062620|FG000|Overall Study|Adverse Event|2|||
44504661|NCT03398356|79509464|FG001|Before Treatment|Withdrawal by Subject|5|||
44504662|NCT03398356|79509465|FG002|Before Treatment|Withdrawal by Subject|0|||
44504663|NCT03398356|79509463|FG000|Before Treatment|Physician Decision|0|||
44504664|NCT03398356|79509464|FG001|Before Treatment|Physician Decision|0|||
44504665|NCT03398356|79509465|FG002|Before Treatment|Physician Decision|11|||
44504666|NCT03398356|79509463|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
44504667|NCT03398356|79509464|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
44504668|NCT03398356|79509465|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
44504669|NCT00346151|79509473|FG000|Overall Study|Withdrawal by Subject|3|||
44504670|NCT00130286|79509481|FG000|Overall Study|Withdrawal by Subject|0|||
44504671|NCT00130286|79509482|FG001|Overall Study|Withdrawal by Subject|1|||
44571423|NCT02973087|79593083|FG001|Overall Study|Adverse Event|0|||
44571424|NCT02973087|79593082|FG000|Overall Study|other|1|||
44571425|NCT02973087|79593083|FG001|Overall Study|other|1|||
44571426|NCT00271544|79593103|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
44237134|NCT01703741|79062620|FG000|Overall Study|Physician Decision|2|||
44237135|NCT01703741|79062620|FG000|Overall Study|Protocol Violation|1|||
44237136|NCT01703741|79062620|FG000|Overall Study|Lost to Follow-up|3|||
44237137|NCT01703741|79062620|FG000|Overall Study|Subject did not want to continue|2|||
44237138|NCT01703741|79062620|FG000|Overall Study|Subject cannot comply with study visits|1|||
44237139|NCT01703741|79062620|FG000|Overall Study|Subject started testosterone injections|1|||
44237140|NCT01681511|79062626|FG000|Overall Study|No Treatment Received|1|||
44237141|NCT01681511|79062627|FG001|Overall Study|No Treatment Received|3|||
44571427|NCT00271544|79593103|FG000|Overall Study|Model 4196 lead not attempted|9|||
44237142|NCT01681511|79062626|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
44237143|NCT01681511|79062627|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
44237144|NCT01681511|79062626|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
44237145|NCT01681511|79062627|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
44237146|NCT01681511|79062626|FG000|Overall Study|No Daily Urine Sample Collected|0|||
44237147|NCT01681511|79062627|FG001|Overall Study|No Daily Urine Sample Collected|1|||
44237148|NCT01681511|79062626|FG000|Overall Study|No post-catheter sample collected|11|||
44237149|NCT01681511|79062627|FG001|Overall Study|No post-catheter sample collected|4|||
44237150|NCT01681433|79062635|FG000|Overall Study|Lack of Efficacy|23|||
44237151|NCT01681433|79062636|FG001|Overall Study|Lack of Efficacy|23|||
44237152|NCT01681433|79062635|FG000|Overall Study|Withdrawal by Subject|5|||
44237153|NCT01681433|79062636|FG001|Overall Study|Withdrawal by Subject|5|||
44237154|NCT01681433|79062635|FG000|Overall Study|Protocol Violation|2|||
44237155|NCT01681433|79062636|FG001|Overall Study|Protocol Violation|0|||
44237156|NCT01681433|79062635|FG000|Overall Study|Adverse Event|2|||
44237157|NCT01681433|79062636|FG001|Overall Study|Adverse Event|4|||
44237158|NCT01681433|79062635|FG000|Overall Study|Lost to Follow-up|0|||
44237159|NCT01681433|79062636|FG001|Overall Study|Lost to Follow-up|1|||
44237160|NCT01681277|79062647|FG000|Overall Study|Adverse Event|1|||
44237161|NCT01681277|79062648|FG001|Overall Study|Adverse Event|0|||
44237162|NCT01681277|79062649|FG002|Overall Study|Adverse Event|0|||
44237163|NCT01681277|79062650|FG003|Overall Study|Adverse Event|0|||
44237164|NCT01681277|79062651|FG004|Overall Study|Adverse Event|0|||
44237165|NCT01703117|79062669|FG000|Overall Study|Adverse Event|4|||
44237166|NCT01703117|79062670|FG001|Overall Study|Adverse Event|3|||
44237167|NCT01703117|79062669|FG000|Overall Study|Withdrawal by Subject|0|||
44237168|NCT01703117|79062670|FG001|Overall Study|Withdrawal by Subject|1|||
44571428|NCT00271544|79593103|FG000|Overall Study|Implant not attempted|4|||
44571429|NCT05342532|79593121|FG000|Overall Study|Adverse Event|5|||
44571430|NCT05342532|79593122|FG001|Overall Study|Adverse Event|20|||
44571431|NCT05342532|79593121|FG000|Overall Study|Lost to Follow-up|10|||
44571432|NCT05342532|79593122|FG001|Overall Study|Lost to Follow-up|15|||
44571433|NCT02984943|79593128|FG000|Overall Study|Withdrawal by Subject|3|||
44571434|NCT02984943|79593128|FG000|Overall Study|Physician Decision|1|||
44571435|NCT02787408|79593132|FG000|Overall Study|Death|16|||
44571436|NCT02787408|79593132|FG000|Overall Study|Withdrawal by Subject|1|||
44571437|NCT02787408|79593132|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
44571438|NCT02971605|79593136|FG000|Overall Study|Withdrawal by Subject|1|||
44571439|NCT03054337|79593148|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
44571440|NCT03054337|79593149|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
44571441|NCT03054337|79593150|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
44571442|NCT03054337|79593151|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
44571443|NCT03054337|79593152|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
44571444|NCT03054337|79593153|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
44571445|NCT01060059|79593186|FG000|Overall Study|Adverse Event|1|||
44571446|NCT01060059|79593187|FG001|Overall Study|Adverse Event|1|||
44571447|NCT01060059|79593186|FG000|Overall Study|Death|2|||
44571448|NCT01060059|79593187|FG001|Overall Study|Death|3|||
44571449|NCT01060059|79593186|FG000|Overall Study|Lost to Follow-up|18|||
44571450|NCT01060059|79593187|FG001|Overall Study|Lost to Follow-up|34|||
44571451|NCT01060059|79593186|FG000|Overall Study|entry criteria not met|4|||
44571452|NCT01060059|79593187|FG001|Overall Study|entry criteria not met|3|||
44571453|NCT01060059|79593186|FG000|Overall Study|Withdrawal by Subject|35|||
44504672|NCT00130286|79509483|FG002|Overall Study|Withdrawal by Subject|2|||
44504673|NCT00130286|79509484|FG003|Overall Study|Withdrawal by Subject|2|||
44504674|NCT00130286|79509481|FG000|Overall Study|Adverse Event|0|||
44504675|NCT00130286|79509482|FG001|Overall Study|Adverse Event|0|||
44504676|NCT00130286|79509483|FG002|Overall Study|Adverse Event|2|||
44504677|NCT00130286|79509484|FG003|Overall Study|Adverse Event|0|||
44504678|NCT00130286|79509481|FG000|Overall Study|Missing lab specimens|0|||
44504679|NCT00130286|79509482|FG001|Overall Study|Missing lab specimens|2|||
44504680|NCT00130286|79509483|FG002|Overall Study|Missing lab specimens|0|||
44504681|NCT00130286|79509484|FG003|Overall Study|Missing lab specimens|0|||
44571454|NCT01060059|79593187|FG001|Overall Study|Withdrawal by Subject|23|||
44571455|NCT01060059|79593186|FG000|Overall Study|lack of glycemic control|2|||
44571456|NCT01060059|79593187|FG001|Overall Study|lack of glycemic control|1|||
44571457|NCT01060059|79593186|FG000|Overall Study|lack of compliance|5|||
44571458|NCT01060059|79593187|FG001|Overall Study|lack of compliance|2|||
44571459|NCT02648932|79593201|FG000|Overall Study|No transplant|3|||
44237169|NCT01702961|79062678|FG000|Overall Study|Additional treatment|3|||
44237170|NCT01702961|79062678|FG000|Overall Study|Progressive disease|5|||
44504682|NCT00346073|79509496|FG000|Overall Study|Serious Adverse Event|2|||
44237171|NCT01702961|79062678|FG000|Overall Study|Relapse|20|||
44237172|NCT01702961|79062678|FG000|Overall Study|Death|6|||
44237173|NCT01702961|79062678|FG000|Overall Study|Lost to Follow-up|2|||
44237174|NCT01702961|79062678|FG000|Overall Study|Ongoing|11|||
44571460|NCT02648932|79593202|FG001|Overall Study|No transplant|1|||
44571461|NCT02122458|79593215|FG000|Overall Study|Withdrawal by Subject|0|||
44571462|NCT02122458|79593216|FG001|Overall Study|Withdrawal by Subject|0|||
44571463|NCT02122458|79593217|FG002|Overall Study|Withdrawal by Subject|0|||
44571464|NCT02122458|79593218|FG003|Overall Study|Withdrawal by Subject|4|||
44571465|NCT02122458|79593219|FG004|Overall Study|Withdrawal by Subject|4|||
44571466|NCT02122458|79593220|FG005|Overall Study|Withdrawal by Subject|4|||
44571467|NCT02122458|79593221|FG006|Overall Study|Withdrawal by Subject|0|||
44571468|NCT02122458|79593215|FG000|Overall Study|Lost to Follow-up|1|||
44571469|NCT02122458|79593216|FG001|Overall Study|Lost to Follow-up|3|||
44571470|NCT02122458|79593217|FG002|Overall Study|Lost to Follow-up|0|||
44571471|NCT02122458|79593218|FG003|Overall Study|Lost to Follow-up|7|||
44571472|NCT02122458|79593219|FG004|Overall Study|Lost to Follow-up|5|||
44571473|NCT02122458|79593220|FG005|Overall Study|Lost to Follow-up|15|||
44571474|NCT02122458|79593221|FG006|Overall Study|Lost to Follow-up|1|||
44571475|NCT02122458|79593215|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
44571476|NCT02122458|79593216|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
44571477|NCT02122458|79593217|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
44571478|NCT02122458|79593218|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
44571479|NCT02122458|79593219|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
44571480|NCT02122458|79593220|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
44571481|NCT02122458|79593221|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
44571482|NCT02122458|79593215|FG000|Overall Study|Adverse Event|1|||
44571483|NCT02122458|79593216|FG001|Overall Study|Adverse Event|0|||
44571484|NCT02122458|79593217|FG002|Overall Study|Adverse Event|0|||
44571485|NCT02122458|79593218|FG003|Overall Study|Adverse Event|0|||
44571486|NCT02122458|79593219|FG004|Overall Study|Adverse Event|0|||
44571487|NCT02122458|79593220|FG005|Overall Study|Adverse Event|0|||
44571488|NCT02122458|79593221|FG006|Overall Study|Adverse Event|0|||
44571489|NCT02122458|79593215|FG000|Overall Study|Experimental Error|0|||
44571490|NCT02122458|79593216|FG001|Overall Study|Experimental Error|0|||
44571491|NCT02122458|79593217|FG002|Overall Study|Experimental Error|0|||
44571492|NCT02122458|79593218|FG003|Overall Study|Experimental Error|0|||
44571493|NCT02122458|79593219|FG004|Overall Study|Experimental Error|3|||
44571494|NCT02122458|79593220|FG005|Overall Study|Experimental Error|0|||
44571495|NCT02122458|79593221|FG006|Overall Study|Experimental Error|0|||
44571496|NCT02122458|79593215|FG000|Overall Study|Deployed or Moved|0|||
44571497|NCT02122458|79593216|FG001|Overall Study|Deployed or Moved|0|||
44571498|NCT02122458|79593217|FG002|Overall Study|Deployed or Moved|0|||
44571499|NCT02122458|79593218|FG003|Overall Study|Deployed or Moved|0|||
44571500|NCT02122458|79593219|FG004|Overall Study|Deployed or Moved|1|||
44571501|NCT02122458|79593220|FG005|Overall Study|Deployed or Moved|0|||
44571502|NCT02122458|79593221|FG006|Overall Study|Deployed or Moved|0|||
44571503|NCT02122458|79593215|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
44571504|NCT02122458|79593216|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
44571505|NCT02122458|79593217|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
44571506|NCT02122458|79593218|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
44571507|NCT02122458|79593219|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
44571508|NCT02122458|79593220|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
44571509|NCT02122458|79593221|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
44571510|NCT02122458|79593215|FG000|Overall Study|Noncompliance|0|||
44571511|NCT02122458|79593216|FG001|Overall Study|Noncompliance|1|||
44571512|NCT02122458|79593217|FG002|Overall Study|Noncompliance|0|||
44571513|NCT02122458|79593218|FG003|Overall Study|Noncompliance|0|||
44571514|NCT02122458|79593219|FG004|Overall Study|Noncompliance|0|||
44571515|NCT02122458|79593220|FG005|Overall Study|Noncompliance|0|||
44571516|NCT02122458|79593221|FG006|Overall Study|Noncompliance|0|||
44571517|NCT02903511|79593237|FG000|Overall Study|Withdrawal by Subject|1|||
44237175|NCT01593917|79062682|FG000|Overall Study|Death|67|||
44237176|NCT01593917|79062682|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
44237177|NCT01593917|79062682|FG000|Overall Study|Withdrawal by Subject|23|||
44237178|NCT01593917|79062682|FG000|Overall Study|Lost to Follow-up|12|||
44571518|NCT02903511|79593238|FG001|Overall Study|Withdrawal by Subject|0|||
44571519|NCT02903511|79593237|FG000|Overall Study|Lost to Follow-up|3|||
44571520|NCT02903511|79593238|FG001|Overall Study|Lost to Follow-up|2|||
44571521|NCT01368042|79593255|FG000|Overall Study|Death|14|||
44571522|NCT01368042|79593255|FG000|Overall Study|Protocol Violation|11|||
44571523|NCT01368042|79593255|FG000|Overall Study|Lost to Follow-up|4|||
44571524|NCT01368042|79593255|FG000|Overall Study|Transplanted|1|||
44571525|NCT00126776|79593261|FG000|Overall Study|follow up complete on all patients|0|||
44571526|NCT00126776|79593262|FG001|Overall Study|follow up complete on all patients|0|||
44237179|NCT01593917|79062682|FG000|Overall Study|Protocol Violation|5|||
44571527|NCT01674010|79593266|FG000|Open Treatment Phase 1|Adverse Event|10|||
44571528|NCT01674010|79593267|FG001|Open Treatment Phase 1|Adverse Event|0|||
44571529|NCT01674010|79593268|FG002|Open Treatment Phase 1|Adverse Event|0|||
44571530|NCT01674010|79593266|FG000|Open Treatment Phase 1|Death|1|||
44571531|NCT01674010|79593267|FG001|Open Treatment Phase 1|Death|0|||
44571532|NCT01674010|79593268|FG002|Open Treatment Phase 1|Death|0|||
44571533|NCT01674010|79593266|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
44571534|NCT01674010|79593267|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
44571535|NCT01674010|79593268|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
44571536|NCT01674010|79593266|FG000|Open Treatment Phase 1|Physician Decision|9|||
44571537|NCT01674010|79593267|FG001|Open Treatment Phase 1|Physician Decision|0|||
44571538|NCT01674010|79593268|FG002|Open Treatment Phase 1|Physician Decision|0|||
44237180|NCT01593917|79062682|FG000|Overall Study|Physician Decision|3|||
44237181|NCT01593761|79062686|FG000|Overall Study|Lost to Follow-up|1|||
44237182|NCT01593761|79062686|FG000|Overall Study|culture negative for MRSA at baseline|5|||
44571539|NCT01674010|79593266|FG000|Open Treatment Phase 1|Protocol Violation|7|||
44571540|NCT01674010|79593267|FG001|Open Treatment Phase 1|Protocol Violation|0|||
44571541|NCT01674010|79593268|FG002|Open Treatment Phase 1|Protocol Violation|0|||
44571542|NCT01674010|79593266|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
44571543|NCT01674010|79593267|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
44571544|NCT01674010|79593268|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
44571545|NCT01674010|79593266|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
44571546|NCT01674010|79593267|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
44571547|NCT01674010|79593268|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
44571548|NCT01674010|79593266|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
44571549|NCT01674010|79593267|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
44571550|NCT01674010|79593268|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
44571551|NCT01674010|79593266|FG000|Randomization Phase 2|Adverse Event|0|||
44571552|NCT01674010|79593267|FG001|Randomization Phase 2|Adverse Event|1|||
44571553|NCT01674010|79593268|FG002|Randomization Phase 2|Adverse Event|1|||
44571554|NCT01674010|79593266|FG000|Randomization Phase 2|Lost to Follow-up|0|||
44237183|NCT01593761|79062686|FG000|Overall Study|positive for hepatitis C virus|1|||
44237184|NCT01593761|79062686|FG000|Overall Study|secondary cellulitis|1|||
44237185|NCT02706834|79062707|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44237186|NCT02706834|79062708|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
44237187|NCT02706834|79062709|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44237188|NCT02706834|79062710|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
44237189|NCT02706834|79062711|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
44237190|NCT02706834|79062712|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
44237191|NCT02706834|79062713|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
44237192|NCT02706834|79062714|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
44237193|NCT02706834|79062715|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
44237194|NCT02706834|79062716|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
44237195|NCT02706834|79062717|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
44237196|NCT02706834|79062707|FG000|Overall Study|Lost to Follow-up|0|||
44275927|NCT04093024|79226182|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
44275928|NCT04093024|79226183|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
44504683|NCT00346073|79509497|FG001|Overall Study|Serious Adverse Event|0|||
44504684|NCT00346073|79509496|FG000|Overall Study|Lost to Follow-up|39|||
44504685|NCT00346073|79509497|FG001|Overall Study|Lost to Follow-up|24|||
44504686|NCT03374488|79509505|FG000|Overall Study|Death|13|||
44504687|NCT03374488|79509506|FG001|Overall Study|Death|13|||
44504688|NCT03374488|79509505|FG000|Overall Study|Withdrawal by Subject|3|||
44504689|NCT03374488|79509506|FG001|Overall Study|Withdrawal by Subject|1|||
44504690|NCT03374488|79509505|FG000|Overall Study|Physician Decision|3|||
44504691|NCT03374488|79509506|FG001|Overall Study|Physician Decision|0|||
44504692|NCT00345683|79509515|FG000|Overall Study|Lost to Follow-up|19|||
44504693|NCT00345683|79509516|FG001|Overall Study|Lost to Follow-up|7|||
44504694|NCT00345683|79509515|FG000|Overall Study|Other|6|||
44504695|NCT00345683|79509516|FG001|Overall Study|Other|2|||
44504696|NCT03828383|79509524|FG000|Overall Study|Lost to Follow-up|3|||
44504697|NCT03828383|79509525|FG001|Overall Study|Lost to Follow-up|2|||
44504698|NCT03828383|79509524|FG000|Overall Study|Withdrawal by Subject|4|||
44504699|NCT03828383|79509525|FG001|Overall Study|Withdrawal by Subject|5|||
44571555|NCT01674010|79593267|FG001|Randomization Phase 2|Lost to Follow-up|1|||
44571556|NCT01674010|79593268|FG002|Randomization Phase 2|Lost to Follow-up|2|||
44571557|NCT01674010|79593266|FG000|Randomization Phase 2|Mood episode recurrence|0|||
44571558|NCT01674010|79593267|FG001|Randomization Phase 2|Mood episode recurrence|8|||
44571559|NCT01674010|79593268|FG002|Randomization Phase 2|Mood episode recurrence|2|||
44571560|NCT01674010|79593266|FG000|Randomization Phase 2|Physician Decision|0|||
44571561|NCT01674010|79593267|FG001|Randomization Phase 2|Physician Decision|0|||
44571562|NCT01674010|79593268|FG002|Randomization Phase 2|Physician Decision|2|||
44237197|NCT02706834|79062708|FG001|Overall Study|Lost to Follow-up|0|||
44237198|NCT02706834|79062709|FG002|Overall Study|Lost to Follow-up|1|||
44237199|NCT02706834|79062710|FG003|Overall Study|Lost to Follow-up|0|||
44504700|NCT00345605|79509531|FG000|Arm 1|Adverse Event|0|||
44504701|NCT00345605|79509532|FG001|Arm 1|Adverse Event|1|||
44504702|NCT00345605|79509531|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
44237200|NCT02706834|79062711|FG004|Overall Study|Lost to Follow-up|0|||
44237201|NCT02706834|79062712|FG005|Overall Study|Lost to Follow-up|0|||
44237202|NCT02706834|79062713|FG006|Overall Study|Lost to Follow-up|0|||
44237203|NCT02706834|79062714|FG007|Overall Study|Lost to Follow-up|0|||
44237204|NCT02706834|79062715|FG008|Overall Study|Lost to Follow-up|0|||
44237205|NCT02706834|79062716|FG009|Overall Study|Lost to Follow-up|0|||
44237206|NCT02706834|79062717|FG010|Overall Study|Lost to Follow-up|0|||
44237207|NCT02706834|79062707|FG000|Overall Study|Voluntary Withdrawal|1|||
44237208|NCT02706834|79062708|FG001|Overall Study|Voluntary Withdrawal|0|||
44237209|NCT02706834|79062709|FG002|Overall Study|Voluntary Withdrawal|0|||
44237210|NCT02706834|79062710|FG003|Overall Study|Voluntary Withdrawal|0|||
44237211|NCT02706834|79062711|FG004|Overall Study|Voluntary Withdrawal|0|||
44237212|NCT02706834|79062712|FG005|Overall Study|Voluntary Withdrawal|0|||
44237213|NCT02706834|79062713|FG006|Overall Study|Voluntary Withdrawal|0|||
44237214|NCT02706834|79062714|FG007|Overall Study|Voluntary Withdrawal|0|||
44237215|NCT02706834|79062715|FG008|Overall Study|Voluntary Withdrawal|0|||
44571563|NCT01674010|79593266|FG000|Randomization Phase 2|Pregnancy|0|||
44571564|NCT01674010|79593267|FG001|Randomization Phase 2|Pregnancy|1|||
44571565|NCT01674010|79593268|FG002|Randomization Phase 2|Pregnancy|1|||
44571566|NCT01674010|79593266|FG000|Randomization Phase 2|Protocol Violation|0|||
44571567|NCT01674010|79593267|FG001|Randomization Phase 2|Protocol Violation|1|||
44571568|NCT01674010|79593268|FG002|Randomization Phase 2|Protocol Violation|1|||
44571569|NCT01674010|79593266|FG000|Randomization Phase 2|Sponsor Decision|0|||
44571570|NCT01674010|79593267|FG001|Randomization Phase 2|Sponsor Decision|42|||
44571571|NCT01674010|79593268|FG002|Randomization Phase 2|Sponsor Decision|45|||
44571572|NCT01674010|79593266|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
44571573|NCT01674010|79593267|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
44571574|NCT01674010|79593268|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
44571575|NCT01345669|79593278|FG000|Overall Study|Primary tumour recurrence|53|||
44571576|NCT01345669|79593279|FG001|Overall Study|Primary tumour recurrence|32|||
44571577|NCT01345669|79593278|FG000|Overall Study|Second primary tumour|4|||
44571578|NCT01345669|79593279|FG001|Overall Study|Second primary tumour|3|||
44237216|NCT02706834|79062716|FG009|Overall Study|Voluntary Withdrawal|1|||
44237217|NCT02706834|79062717|FG010|Overall Study|Voluntary Withdrawal|0|||
44237218|NCT02706834|79062707|FG000|Overall Study|Other Reason Not Specified|1|||
44237219|NCT02706834|79062708|FG001|Overall Study|Other Reason Not Specified|0|||
44237220|NCT02706834|79062709|FG002|Overall Study|Other Reason Not Specified|0|||
44571579|NCT01345669|79593278|FG000|Overall Study|Adverse Event|63|||
44571580|NCT01345669|79593279|FG001|Overall Study|Adverse Event|9|||
44571581|NCT01345669|79593278|FG000|Overall Study|Protocol Violation|3|||
44504703|NCT00345605|79509532|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
44504704|NCT03394924|79509543|FG000|Overall Study|Adverse Event|0|||
44504705|NCT03394924|79509544|FG001|Overall Study|Adverse Event|5|||
44504706|NCT03394924|79509545|FG002|Overall Study|Adverse Event|0|||
44504707|NCT03394924|79509543|FG000|Overall Study|Withdrawal by Subject|2|||
44504708|NCT03394924|79509544|FG001|Overall Study|Withdrawal by Subject|0|||
44504709|NCT03394924|79509545|FG002|Overall Study|Withdrawal by Subject|0|||
44504710|NCT03394924|79509543|FG000|Overall Study|Lost to Follow-up|0|||
44504711|NCT03394924|79509544|FG001|Overall Study|Lost to Follow-up|1|||
44504712|NCT03394924|79509545|FG002|Overall Study|Lost to Follow-up|0|||
44504713|NCT03394924|79509543|FG000|Overall Study|Did not meet all inclusion criteria|1|||
44504714|NCT03394924|79509544|FG001|Overall Study|Did not meet all inclusion criteria|0|||
44504715|NCT03394924|79509545|FG002|Overall Study|Did not meet all inclusion criteria|0|||
44504716|NCT00345293|79509555|FG000|Overall Study|Unable to access line for sample|1|||
44504717|NCT00345293|79509556|FG001|Overall Study|Unable to access line for sample|0|||
44504718|NCT00345293|79509555|FG000|Overall Study|Withdrawal by Subject|1|||
44504719|NCT00345293|79509556|FG001|Overall Study|Withdrawal by Subject|0|||
44504720|NCT00355121|79509565|FG000|Overall Study|Did not receive study vaccine|1|||
44504721|NCT00355121|79509566|FG001|Overall Study|Did not receive study vaccine|0|||
44571582|NCT01345669|79593279|FG001|Overall Study|Protocol Violation|1|||
44571583|NCT01345669|79593278|FG000|Overall Study|Lost to Follow-up|1|||
44571584|NCT01345669|79593279|FG001|Overall Study|Lost to Follow-up|1|||
44504722|NCT00355121|79509567|FG002|Overall Study|Did not receive study vaccine|1|||
44571585|NCT01345669|79593278|FG000|Overall Study|Withdrawal by Subject|52|||
44571586|NCT01345669|79593279|FG001|Overall Study|Withdrawal by Subject|13|||
44571587|NCT01345669|79593278|FG000|Overall Study|Other Reasons|111|||
44571588|NCT01345669|79593279|FG001|Overall Study|Other Reasons|60|||
44237221|NCT02706834|79062710|FG003|Overall Study|Other Reason Not Specified|0|||
44237222|NCT02706834|79062711|FG004|Overall Study|Other Reason Not Specified|1|||
44237223|NCT02706834|79062712|FG005|Overall Study|Other Reason Not Specified|0|||
44237224|NCT02706834|79062713|FG006|Overall Study|Other Reason Not Specified|0|||
44237225|NCT02706834|79062714|FG007|Overall Study|Other Reason Not Specified|0|||
44504723|NCT00355121|79509565|FG000|Overall Study|Adverse Event|0|||
44504724|NCT00355121|79509566|FG001|Overall Study|Adverse Event|1|||
44504725|NCT00355121|79509567|FG002|Overall Study|Adverse Event|0|||
44571589|NCT05334212|79593285|FG000|Overall Study|Study terminated prematurely|7|||
44571590|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
44571591|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
44571592|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
44571593|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
44571594|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
44571595|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
44237226|NCT02706834|79062715|FG008|Overall Study|Other Reason Not Specified|0|||
44237227|NCT02706834|79062716|FG009|Overall Study|Other Reason Not Specified|0|||
44237228|NCT02706834|79062717|FG010|Overall Study|Other Reason Not Specified|0|||
44237229|NCT01702025|79062766|FG000|Overall Study|Equipment failure|1|||
44237230|NCT01702025|79062767|FG001|Overall Study|Equipment failure|0|||
44237231|NCT01702025|79062768|FG002|Overall Study|Equipment failure|0|||
44237232|NCT01702025|79062769|FG003|Overall Study|Equipment failure|0|||
44237233|NCT01702025|79062766|FG000|Overall Study|Adverse Event|1|||
44571596|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
44571597|NCT01673854|79593289|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
44237234|NCT01702025|79062767|FG001|Overall Study|Adverse Event|1|||
44237235|NCT01702025|79062768|FG002|Overall Study|Adverse Event|1|||
44237236|NCT01702025|79062769|FG003|Overall Study|Adverse Event|0|||
44237237|NCT01592747|79062786|FG000|Overall Study|Loss of Therapeutic Response|107|||
44237238|NCT01592747|79062787|FG001|Overall Study|Loss of Therapeutic Response|108|||
44237239|NCT01592747|79062788|FG002|Overall Study|Loss of Therapeutic Response|100|||
44237240|NCT01592747|79062786|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
44237241|NCT01592747|79062787|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
44237242|NCT01592747|79062788|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
44237243|NCT01592747|79062786|FG000|Overall Study|Adverse Event|1|||
44237244|NCT01592747|79062787|FG001|Overall Study|Adverse Event|0|||
44237245|NCT01592747|79062788|FG002|Overall Study|Adverse Event|0|||
44237246|NCT01592747|79062786|FG000|Overall Study|Protocol Violation|4|||
44237247|NCT01592747|79062787|FG001|Overall Study|Protocol Violation|0|||
44237248|NCT01592747|79062788|FG002|Overall Study|Protocol Violation|4|||
44237249|NCT01592747|79062786|FG000|Overall Study|Lack of Efficacy|0|||
44237250|NCT01592747|79062787|FG001|Overall Study|Lack of Efficacy|1|||
44237251|NCT01592747|79062788|FG002|Overall Study|Lack of Efficacy|0|||
44237252|NCT01592747|79062786|FG000|Overall Study|Withdrawal by Subject|2|||
44237253|NCT01592747|79062787|FG001|Overall Study|Withdrawal by Subject|0|||
44504726|NCT00355121|79509565|FG000|Overall Study|Protocol Violation|7|||
44504727|NCT00355121|79509566|FG001|Overall Study|Protocol Violation|9|||
44504728|NCT00355121|79509567|FG002|Overall Study|Protocol Violation|1|||
44504729|NCT00355121|79509565|FG000|Overall Study|Lost to Follow-up|4|||
44504730|NCT00355121|79509566|FG001|Overall Study|Lost to Follow-up|7|||
44504731|NCT00355121|79509567|FG002|Overall Study|Lost to Follow-up|1|||
44504732|NCT00355121|79509565|FG000|Overall Study|Withdrawal by Subject|9|||
44504733|NCT00355121|79509566|FG001|Overall Study|Withdrawal by Subject|10|||
44504734|NCT00355121|79509567|FG002|Overall Study|Withdrawal by Subject|2|||
44504735|NCT00355121|79509565|FG000|Overall Study|Serious adverse events|0|||
44504736|NCT00355121|79509566|FG001|Overall Study|Serious adverse events|2|||
44504737|NCT00355121|79509567|FG002|Overall Study|Serious adverse events|0|||
44504738|NCT00343889|79509580|FG000|Overall Study|Lost to Follow-up|2|||
44504739|NCT00343889|79509581|FG001|Overall Study|Lost to Follow-up|0|||
44504740|NCT00343889|79509580|FG000|Overall Study|Withdrawal by Subject|0|||
44504741|NCT00343889|79509581|FG001|Overall Study|Withdrawal by Subject|1|||
44504742|NCT00343889|79509580|FG000|Overall Study|Protocol Violation|1|||
44504743|NCT00343889|79509581|FG001|Overall Study|Protocol Violation|0|||
44504744|NCT00354341|79509589|FG000|Overall Study|Adverse Event|1|||
44504745|NCT00354341|79509590|FG001|Overall Study|Adverse Event|0|||
44504746|NCT00354341|79509589|FG000|Overall Study|Death|0|||
44504747|NCT00354341|79509590|FG001|Overall Study|Death|2|||
44504748|NCT00354341|79509589|FG000|Overall Study|Refused treatment|1|||
44504749|NCT00354341|79509590|FG001|Overall Study|Refused treatment|2|||
44504750|NCT00354341|79509589|FG000|Overall Study|Failure to return|0|||
44504751|NCT00354341|79509590|FG001|Overall Study|Failure to return|1|||
44504752|NCT00354341|79509589|FG000|Overall Study|Other|1|||
44504753|NCT00354341|79509590|FG001|Overall Study|Other|2|||
44571598|NCT01673854|79593289|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
44504754|NCT00354107|79509596|FG000|Overall Study|Adverse Event|2|||
44504755|NCT00354107|79509596|FG000|Overall Study|Physician Decision|2|||
44571599|NCT01673854|79593289|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
44237254|NCT01592747|79062788|FG002|Overall Study|Withdrawal by Subject|2|||
44237255|NCT01592747|79062786|FG000|Overall Study|Lost to Follow-up|1|||
44237256|NCT01592747|79062787|FG001|Overall Study|Lost to Follow-up|0|||
44237257|NCT01592747|79062788|FG002|Overall Study|Lost to Follow-up|1|||
44237258|NCT01592747|79062786|FG000|Overall Study|Other Reasons|1|||
44504756|NCT00354107|79509596|FG000|Overall Study|Withdrawal by Subject|1|||
44504757|NCT00354029|79509602|FG000|Overall Study|Protocol Violation|4|||
44504758|NCT00354029|79509603|FG001|Overall Study|Protocol Violation|2|||
44237259|NCT01592747|79062787|FG001|Overall Study|Other Reasons|1|||
44237260|NCT01592747|79062788|FG002|Overall Study|Other Reasons|0|||
44237261|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Death|3|||
44237262|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Death|3|||
44237263|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Death|0|||
44237264|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Death|0|||
44237265|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
44237266|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
44237267|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
44237268|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
44237269|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
44237270|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
44237271|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
44237272|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
44237273|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
44237274|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
44237275|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
44237276|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
44237277|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
44237278|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
44237279|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
44237280|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
44237281|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
44237282|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
44237283|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
44237284|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
44237285|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
44237286|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
44237287|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
44237288|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
44237289|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Other|6|||
44237290|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Other|3|||
44237291|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Other|0|||
44237292|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Other|0|||
44237293|NCT02051608|79062801|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
44237294|NCT02051608|79062802|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
44237295|NCT02051608|79062803|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
44237296|NCT02051608|79062804|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
44237297|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Adverse Event|0|||
44237298|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Adverse Event|0|||
44237299|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Adverse Event|6|||
44237300|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Adverse Event|8|||
44237301|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Death|0|||
44237302|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Death|0|||
44237303|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Death|7|||
44237304|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Death|4|||
44237305|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
44237306|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
44237307|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
44237308|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
44237309|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
44237310|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
44237311|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
44237312|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
44237313|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
44237314|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
44237315|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
44237316|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
44237317|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
44237318|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
44237319|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
44237320|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
44237321|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Physician Decision|0|||
44237322|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Physician Decision|0|||
44571600|NCT01673854|79593289|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
44571601|NCT01673854|79593289|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
44571602|NCT01343407|79593293|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
44237323|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Physician Decision|8|||
44237324|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Physician Decision|5|||
44571603|NCT01343407|79593294|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
44571604|NCT01343407|79593295|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
44571605|NCT01343407|79593296|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
44571606|NCT01343407|79593297|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
44571607|NCT01343407|79593298|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
44571608|NCT01343407|79593293|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
44571609|NCT01343407|79593294|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
44571610|NCT01343407|79593295|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
44571611|NCT01343407|79593296|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
44571612|NCT01343407|79593297|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
44571613|NCT01343407|79593298|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
44571614|NCT01367886|79593306|FG000|Overall Study|Lost to Follow-up|4|||
44571615|NCT01367886|79593306|FG000|Overall Study|Lack of Efficacy|2|||
44571616|NCT01367886|79593306|FG000|Overall Study|Death|1|||
44571617|NCT01673698|79593313|FG000|Overall Study|Lost to Follow-up|51|||
44571618|NCT01673698|79593314|FG001|Overall Study|Lost to Follow-up|13|||
44571619|NCT02786004|79593323|FG000|Overall Study|Withdrawal by Subject|0|||
44571620|NCT02786004|79593324|FG001|Overall Study|Withdrawal by Subject|1|||
44571621|NCT03051607|79593332|FG000|Overall Study|Adverse Event|66|||
44571622|NCT01062399|79593341|FG000|Overall Study|Protocol Violation|0|||
44571623|NCT01062399|79593342|FG001|Overall Study|Protocol Violation|1|||
44571624|NCT01062399|79593343|FG002|Overall Study|Protocol Violation|0|||
44571625|NCT01062399|79593344|FG003|Overall Study|Protocol Violation|6|||
44571626|NCT01062399|79593345|FG004|Overall Study|Protocol Violation|4|||
44571627|NCT01317277|79593359|FG000|Overall Study|Lost to Follow-up|3|||
44571628|NCT01317277|79593360|FG001|Overall Study|Lost to Follow-up|1|||
44571629|NCT01317277|79593359|FG000|Overall Study|Lost MEMS|1|||
44571630|NCT01317277|79593360|FG001|Overall Study|Lost MEMS|1|||
44571631|NCT01317277|79593359|FG000|Overall Study|Unable to comply with intervention|1|||
44571632|NCT01317277|79593360|FG001|Overall Study|Unable to comply with intervention|0|||
44571633|NCT01317277|79593359|FG000|Overall Study|Withdrawal by Subject|1|||
44571634|NCT01317277|79593360|FG001|Overall Study|Withdrawal by Subject|0|||
44571635|NCT01317277|79593359|FG000|Overall Study|Adverse Event|1|||
44571636|NCT01317277|79593360|FG001|Overall Study|Adverse Event|0|||
44571637|NCT04820686|79593369|FG000|Overall Study|Withdrawal by Subject|5|||
44571638|NCT04820686|79593370|FG001|Overall Study|Withdrawal by Subject|2|||
44571639|NCT04820686|79593371|FG002|Overall Study|Withdrawal by Subject|3|||
44571640|NCT04820686|79593369|FG000|Overall Study|Study Termination|25|||
44571641|NCT04820686|79593370|FG001|Overall Study|Study Termination|13|||
44571642|NCT04820686|79593371|FG002|Overall Study|Study Termination|14|||
44571643|NCT04820686|79593369|FG000|Overall Study|Adverse Event|0|||
44571644|NCT04820686|79593370|FG001|Overall Study|Adverse Event|1|||
44571645|NCT04820686|79593371|FG002|Overall Study|Adverse Event|0|||
44571646|NCT02740478|79593386|FG000|Overall Study|Withdrawal by Subject|1|||
44504759|NCT00353873|79509611|FG000|Overall Study|Protocol Violation|1|||
44504760|NCT00353873|79509612|FG001|Overall Study|Protocol Violation|2|||
44504761|NCT00353873|79509611|FG000|Overall Study|Exacerbation|1|||
44504762|NCT00353873|79509612|FG001|Overall Study|Exacerbation|0|||
44504763|NCT00353873|79509611|FG000|Overall Study|Adverse Event|1|||
44504764|NCT00353873|79509612|FG001|Overall Study|Adverse Event|0|||
44504765|NCT00353873|79509611|FG000|Overall Study|Physician Decision|2|||
44504766|NCT00353873|79509612|FG001|Overall Study|Physician Decision|0|||
44504767|NCT00353873|79509611|FG000|Overall Study|Withdrawal by Subject|1|||
44571647|NCT02969655|79593392|FG000|Overall Study|Withdrawal by Subject|3|||
44571648|NCT02969655|79593393|FG001|Overall Study|Withdrawal by Subject|2|||
44571649|NCT02969655|79593392|FG000|Overall Study|Physician Decision|4|||
44571650|NCT02969655|79593393|FG001|Overall Study|Physician Decision|3|||
44571651|NCT02969655|79593392|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
44237325|NCT02051608|79062801|FG000|Part 2: Open-label Extension|Other|0|||
44237326|NCT02051608|79062802|FG001|Part 2: Open-label Extension|Other|0|||
44237327|NCT02051608|79062803|FG002|Part 2: Open-label Extension|Other|9|||
44504768|NCT00353873|79509612|FG001|Overall Study|Withdrawal by Subject|1|||
44504769|NCT03796676|79509621|FG000|Overall Study|Adverse Event|2|||
44504770|NCT03796676|79509622|FG001|Overall Study|Adverse Event|1|||
44571652|NCT02969655|79593393|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
44571653|NCT02969655|79593392|FG000|Overall Study|Adverse Event|10|||
44571654|NCT02969655|79593393|FG001|Overall Study|Adverse Event|8|||
44237328|NCT02051608|79062804|FG003|Part 2: Open-label Extension|Other|9|||
44571655|NCT01317199|79593404|FG000|Dose-escalation Phase 1|Physician Decision|5|||
44571656|NCT01317199|79593405|FG001|Dose-escalation Phase 1|Physician Decision|0|||
44571657|NCT01317199|79593406|FG002|Dose-escalation Phase 1|Physician Decision|0|||
44571658|NCT01317199|79593407|FG003|Dose-escalation Phase 1|Physician Decision|0|||
44571659|NCT01317199|79593404|FG000|Dose-escalation Phase 1|Disease progression|1|||
44571660|NCT01317199|79593405|FG001|Dose-escalation Phase 1|Disease progression|0|||
44504771|NCT03796676|79509623|FG002|Overall Study|Adverse Event|2|||
44237329|NCT02705586|79062817|FG000|Overall Study|Health Issues|2|||
44237330|NCT02705586|79062817|FG000|Overall Study|Transportation Difficulties|5|||
44237331|NCT02705586|79062817|FG000|Overall Study|Vacation/Planned Absence|1|||
44237332|NCT01592045|79062823|FG000|Overall Study|Disease Progression|1|||
44237333|NCT01592045|79062824|FG001|Overall Study|Disease Progression|1|||
44237334|NCT01592045|79062823|FG000|Overall Study|Adverse Event|1|||
44237335|NCT01592045|79062824|FG001|Overall Study|Adverse Event|1|||
44237336|NCT01592045|79062823|FG000|Overall Study|Withdrawal by Subject|1|||
44237337|NCT01592045|79062824|FG001|Overall Study|Withdrawal by Subject|0|||
44237338|NCT01592045|79062823|FG000|Overall Study|Moved out of country|2|||
44237339|NCT01592045|79062824|FG001|Overall Study|Moved out of country|0|||
44237340|NCT01591499|79062832|FG000|Baseline Visit|Withdrawal by Subject|0|||
44237341|NCT01591499|79062833|FG001|Baseline Visit|Withdrawal by Subject|2|||
44237342|NCT01591499|79062834|FG002|Baseline Visit|Withdrawal by Subject|0|||
44237343|NCT01591499|79062835|FG003|Baseline Visit|Withdrawal by Subject|2|||
44237344|NCT01591499|79062832|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
44237345|NCT01591499|79062833|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
44237346|NCT01591499|79062834|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
44237347|NCT01591499|79062835|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
44237348|NCT01591499|79062832|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
44237349|NCT01591499|79062833|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
44237350|NCT01591499|79062834|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
44237351|NCT01591499|79062835|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
44237352|NCT01590797|79062861|FG000|Overall Study|Adverse Event|4|||
44237353|NCT01590797|79062862|FG001|Overall Study|Adverse Event|3|||
44237354|NCT01590797|79062861|FG000|Overall Study|Lack of Efficacy|0|||
44237355|NCT01590797|79062862|FG001|Overall Study|Lack of Efficacy|2|||
44237356|NCT01590797|79062861|FG000|Overall Study|Lost to Follow-up|0|||
44237357|NCT01590797|79062862|FG001|Overall Study|Lost to Follow-up|1|||
44237358|NCT01590797|79062861|FG000|Overall Study|Protocol Violation|4|||
44237359|NCT01590797|79062862|FG001|Overall Study|Protocol Violation|1|||
44237360|NCT01590797|79062861|FG000|Overall Study|Withdrawal by Subject|7|||
44237361|NCT01590797|79062862|FG001|Overall Study|Withdrawal by Subject|5|||
44237362|NCT01590797|79062861|FG000|Overall Study|Other Protocol Specified Criteria|2|||
44237363|NCT01590797|79062862|FG001|Overall Study|Other Protocol Specified Criteria|4|||
44237364|NCT01590563|79062868|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
44237365|NCT01701401|79062877|FG000|Overall Study|Randomized But Not Treated|3|||
44237366|NCT01701401|79062878|FG001|Overall Study|Randomized But Not Treated|1|||
44237367|NCT01701401|79062879|FG002|Overall Study|Randomized But Not Treated|0|||
44237368|NCT01701401|79062880|FG003|Overall Study|Randomized But Not Treated|1|||
44275929|NCT04093024|79226182|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
44504772|NCT03796676|79509621|FG000|Overall Study|Lost to Follow-up|2|||
44504773|NCT03796676|79509622|FG001|Overall Study|Lost to Follow-up|1|||
44504774|NCT03796676|79509623|FG002|Overall Study|Lost to Follow-up|0|||
44504775|NCT03796676|79509621|FG000|Overall Study|Protocol Violation|0|||
44504776|NCT03796676|79509622|FG001|Overall Study|Protocol Violation|0|||
44504777|NCT03796676|79509623|FG002|Overall Study|Protocol Violation|1|||
44504778|NCT03796676|79509621|FG000|Overall Study|Withdrawal by Subject|1|||
44504779|NCT03796676|79509622|FG001|Overall Study|Withdrawal by Subject|1|||
44504780|NCT03796676|79509623|FG002|Overall Study|Withdrawal by Subject|0|||
44504781|NCT03796676|79509621|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
44504782|NCT03796676|79509622|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
44504783|NCT03796676|79509623|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
44504784|NCT03342898|79509637|FG000|Overall Study|Adverse Event|3|||
44504785|NCT03342898|79509638|FG001|Overall Study|Adverse Event|1|||
44504786|NCT03342898|79509639|FG002|Overall Study|Adverse Event|0|||
44504787|NCT03342898|79509637|FG000|Overall Study|Lost to Follow-up|44|||
44504788|NCT03342898|79509638|FG001|Overall Study|Lost to Follow-up|40|||
44504789|NCT03342898|79509639|FG002|Overall Study|Lost to Follow-up|42|||
44504790|NCT03342898|79509637|FG000|Overall Study|Withdrawal of Consent|5|||
44504791|NCT03342898|79509638|FG001|Overall Study|Withdrawal of Consent|9|||
44504792|NCT03342898|79509639|FG002|Overall Study|Withdrawal of Consent|11|||
44504793|NCT03342898|79509637|FG000|Overall Study|Death|0|||
44504794|NCT03342898|79509638|FG001|Overall Study|Death|1|||
44504795|NCT03342898|79509639|FG002|Overall Study|Death|1|||
44504796|NCT03342898|79509637|FG000|Overall Study|Reason not Specified|2|||
44504797|NCT03342898|79509638|FG001|Overall Study|Reason not Specified|2|||
44504798|NCT03342898|79509639|FG002|Overall Study|Reason not Specified|0|||
44504799|NCT00339833|79509649|FG000|Overall Study|Withdrawal by Subject|1|||
44504800|NCT00339833|79509650|FG001|Overall Study|Withdrawal by Subject|2|||
44237369|NCT01701401|79062877|FG000|Overall Study|Lost to Follow-up|5|||
44237370|NCT01701401|79062878|FG001|Overall Study|Lost to Follow-up|5|||
44237371|NCT01701401|79062879|FG002|Overall Study|Lost to Follow-up|1|||
44237372|NCT01701401|79062880|FG003|Overall Study|Lost to Follow-up|3|||
44237373|NCT01701401|79062877|FG000|Overall Study|Withdrew Consent|0|||
44237374|NCT01701401|79062878|FG001|Overall Study|Withdrew Consent|3|||
44237375|NCT01701401|79062879|FG002|Overall Study|Withdrew Consent|1|||
44237376|NCT01701401|79062880|FG003|Overall Study|Withdrew Consent|2|||
44237377|NCT01701401|79062877|FG000|Overall Study|Lack of Efficacy|1|||
44237378|NCT01701401|79062878|FG001|Overall Study|Lack of Efficacy|0|||
44237379|NCT01701401|79062879|FG002|Overall Study|Lack of Efficacy|2|||
44237380|NCT01701401|79062880|FG003|Overall Study|Lack of Efficacy|0|||
44237381|NCT01701401|79062877|FG000|Overall Study|Adverse Event|1|||
44237382|NCT01701401|79062878|FG001|Overall Study|Adverse Event|0|||
44237383|NCT01701401|79062879|FG002|Overall Study|Adverse Event|0|||
44237384|NCT01701401|79062880|FG003|Overall Study|Adverse Event|0|||
44571661|NCT01317199|79593406|FG002|Dose-escalation Phase 1|Disease progression|0|||
44571662|NCT01317199|79593407|FG003|Dose-escalation Phase 1|Disease progression|0|||
44571663|NCT01317199|79593404|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
44571664|NCT01317199|79593405|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
44571665|NCT01317199|79593406|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
44571666|NCT01317199|79593407|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
44571667|NCT01317199|79593404|FG000|Randomized Phase 2|Disease progression|0|||
44571668|NCT01317199|79593405|FG001|Randomized Phase 2|Disease progression|3|||
44571669|NCT01317199|79593406|FG002|Randomized Phase 2|Disease progression|7|||
44571670|NCT01317199|79593407|FG003|Randomized Phase 2|Disease progression|5|||
44571671|NCT01317199|79593404|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
44571672|NCT01317199|79593405|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
44571673|NCT01317199|79593406|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
44571674|NCT01317199|79593407|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
44571675|NCT01317199|79593404|FG000|Randomized Phase 2|Adverse Event|0|||
44571676|NCT01317199|79593405|FG001|Randomized Phase 2|Adverse Event|0|||
44571677|NCT01317199|79593406|FG002|Randomized Phase 2|Adverse Event|0|||
44571678|NCT01317199|79593407|FG003|Randomized Phase 2|Adverse Event|1|||
44571679|NCT01317199|79593404|FG000|Randomized Phase 2|Comorbidities|0|||
44571680|NCT01317199|79593405|FG001|Randomized Phase 2|Comorbidities|2|||
44571681|NCT01317199|79593406|FG002|Randomized Phase 2|Comorbidities|2|||
44571682|NCT01317199|79593407|FG003|Randomized Phase 2|Comorbidities|2|||
44571683|NCT01317199|79593404|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
44571684|NCT01317199|79593405|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
44571685|NCT01317199|79593406|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
44571686|NCT01317199|79593407|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
44571687|NCT01317199|79593404|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
44571688|NCT01317199|79593405|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
44571689|NCT01317199|79593406|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
44571690|NCT01317199|79593407|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
44571691|NCT01317199|79593404|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
44571692|NCT01317199|79593405|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
44571693|NCT01317199|79593406|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
44571694|NCT01317199|79593407|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
44571695|NCT01317199|79593404|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
44571696|NCT01317199|79593405|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
44571697|NCT01317199|79593406|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
44571698|NCT01317199|79593407|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
44571699|NCT02648698|79593426|FG000|Overall Study|Protocol Violation|1|||
44571700|NCT02648698|79593427|FG001|Overall Study|Protocol Violation|5|||
44571701|NCT02970669|79593435|FG000|Double-blind Period|Adverse Event|4|||
44571702|NCT02970669|79593436|FG001|Double-blind Period|Adverse Event|0|||
44571703|NCT02970669|79593435|FG000|Double-blind Period|Death|1|||
44571704|NCT02970669|79593436|FG001|Double-blind Period|Death|0|||
44571705|NCT02970669|79593435|FG000|Double-blind Period|Study terminated by sponsor|1|||
44571706|NCT02970669|79593436|FG001|Double-blind Period|Study terminated by sponsor|2|||
44571707|NCT02970669|79593435|FG000|Double-blind Period|Physician Decision|0|||
44571708|NCT02970669|79593436|FG001|Double-blind Period|Physician Decision|2|||
44571709|NCT02970669|79593435|FG000|Double-blind Period|Withdrawal by Subject|2|||
44571710|NCT02970669|79593436|FG001|Double-blind Period|Withdrawal by Subject|2|||
44571711|NCT02970669|79593435|FG000|Open-label Period|Withdrawal by Subject|2|||
44571712|NCT02970669|79593436|FG001|Open-label Period|Withdrawal by Subject|2|||
44571713|NCT02970669|79593435|FG000|Open-label Period|Adverse Event|1|||
44571714|NCT02970669|79593436|FG001|Open-label Period|Adverse Event|0|||
44571715|NCT02970669|79593435|FG000|Open-label Period|Physician Decision|1|||
44571716|NCT02970669|79593436|FG001|Open-label Period|Physician Decision|0|||
44571717|NCT02902965|79593444|FG000|Overall Study|Withdrawal by Subject|10|||
44237385|NCT01701401|79062877|FG000|Overall Study|Protocol Violation|0|||
44237386|NCT01701401|79062878|FG001|Overall Study|Protocol Violation|0|||
44237387|NCT01701401|79062879|FG002|Overall Study|Protocol Violation|1|||
44237388|NCT01701401|79062880|FG003|Overall Study|Protocol Violation|0|||
44237389|NCT01701245|79062892|FG000|Overall Study|Protocol Violation|1|||
44237390|NCT01701245|79062893|FG001|Overall Study|Protocol Violation|3|||
44237391|NCT01701245|79062892|FG000|Overall Study|Did not complete the open label period|11|||
44571718|NCT02902809|79593449|FG000|Overall Study|Discontinuation of asthma program|28|||
44571719|NCT01362244|79593455|FG000|Overall Study|Adverse Event|3|||
44571720|NCT01362244|79593456|FG001|Overall Study|Adverse Event|5|||
44571721|NCT01362244|79593455|FG000|Overall Study|Lack of Efficacy|5|||
44571722|NCT01362244|79593456|FG001|Overall Study|Lack of Efficacy|11|||
44571723|NCT01362244|79593455|FG000|Overall Study|Lost to Follow-up|0|||
44571724|NCT01362244|79593456|FG001|Overall Study|Lost to Follow-up|2|||
44571725|NCT01362244|79593455|FG000|Overall Study|Protocol Violation|5|||
44571726|NCT01362244|79593456|FG001|Overall Study|Protocol Violation|1|||
44571727|NCT01362244|79593455|FG000|Overall Study|Withdrawal by Subject|2|||
44571728|NCT01362244|79593456|FG001|Overall Study|Withdrawal by Subject|1|||
44571729|NCT01362244|79593455|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
44571730|NCT01362244|79593456|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
44571731|NCT01362244|79593455|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
44571732|NCT01362244|79593456|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
44571733|NCT02969187|79593464|FG000|Overall Study|Physician Decision|12|||
44571734|NCT02969187|79593465|FG001|Overall Study|Physician Decision|13|||
44571735|NCT03050359|79593475|FG000|Overall Study|Randomized But Not Treated|2|||
44571736|NCT03050359|79593476|FG001|Overall Study|Randomized But Not Treated|0|||
44571737|NCT03050359|79593475|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
44571738|NCT03050359|79593476|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
44571739|NCT03050359|79593475|FG000|Overall Study|Significant Protocol Deviation|2|||
44571740|NCT03050359|79593476|FG001|Overall Study|Significant Protocol Deviation|3|||
44571741|NCT03050359|79593475|FG000|Overall Study|Lost to Follow-up|2|||
44571742|NCT03050359|79593476|FG001|Overall Study|Lost to Follow-up|1|||
44571743|NCT03050359|79593475|FG000|Overall Study|Voluntary Withdrawal|4|||
44571744|NCT03050359|79593476|FG001|Overall Study|Voluntary Withdrawal|6|||
44571745|NCT03050359|79593475|FG000|Overall Study|Pregnancy|1|||
44571746|NCT03050359|79593476|FG001|Overall Study|Pregnancy|0|||
44571747|NCT03050359|79593475|FG000|Overall Study|Reason Not Specified|1|||
44571748|NCT03050359|79593476|FG001|Overall Study|Reason Not Specified|0|||
44571749|NCT02785770|79593484|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
44571750|NCT02785770|79593485|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
44571751|NCT02785770|79593486|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
44571752|NCT02785770|79593487|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
44571753|NCT02785770|79593484|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
44571754|NCT02785770|79593485|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
44571755|NCT02785770|79593486|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
44571756|NCT02785770|79593487|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
44571757|NCT02785770|79593484|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
44571758|NCT02785770|79593485|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
44571759|NCT02785770|79593486|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
44571760|NCT02785770|79593487|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
44571761|NCT02965833|79593500|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
44571762|NCT02965833|79593501|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
44571763|NCT02965833|79593500|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
44571764|NCT02965833|79593501|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
44571765|NCT02965833|79593500|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
44571766|NCT02965833|79593501|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
44571767|NCT02965833|79593500|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
44571768|NCT02965833|79593501|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
44571769|NCT02965833|79593500|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
44571770|NCT02965833|79593501|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
44571771|NCT02968173|79593507|FG000|Overall Study|Withdrawal by Subject|1|||
44571772|NCT02785458|79593514|FG000|1 Month|Withdrawal by Subject|2|||
44571773|NCT02785458|79593515|FG001|1 Month|Withdrawal by Subject|1|||
44571774|NCT02785458|79593514|FG000|1 Month|Lost to Follow-up|38|||
44571775|NCT02785458|79593515|FG001|1 Month|Lost to Follow-up|31|||
44571776|NCT02785458|79593514|FG000|1 Month|Deemed Ineligible|1|||
44571777|NCT02785458|79593515|FG001|1 Month|Deemed Ineligible|0|||
44571778|NCT02785458|79593514|FG000|1 Month|Completed Evaluation by Baseline|42|||
44571779|NCT02785458|79593515|FG001|1 Month|Completed Evaluation by Baseline|39|||
44571780|NCT02785458|79593514|FG000|1 Month|Partial Interview|0|||
44571781|NCT02785458|79593515|FG001|1 Month|Partial Interview|4|||
44571782|NCT02785458|79593514|FG000|3 Months|Withdrawal by Subject|3|||
44237392|NCT01701245|79062893|FG001|Overall Study|Did not complete the open label period|12|||
44571783|NCT02785458|79593515|FG001|3 Months|Withdrawal by Subject|1|||
44571784|NCT02785458|79593514|FG000|3 Months|Lost to Follow-up|25|||
44571785|NCT02785458|79593515|FG001|3 Months|Lost to Follow-up|21|||
44571786|NCT02785458|79593514|FG000|3 Months|Completed Evaluation at 1 Month|100|||
44571787|NCT02785458|79593515|FG001|3 Months|Completed Evaluation at 1 Month|89|||
44571788|NCT02784834|79593521|FG000|Overall Study|Lack of Efficacy|1|||
44571789|NCT02966223|79593525|FG000|Overall Study|Physician Decision|3|||
44237393|NCT01590017|79062899|FG000|Overall Study|Adverse Event|1|||
44571790|NCT02966223|79593525|FG000|Overall Study|Withdrawal by Subject|11|||
44571791|NCT02966223|79593525|FG000|Overall Study|Lost to Follow-up|1|||
44571792|NCT03049735|79593532|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
44571793|NCT03049735|79593533|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
44571794|NCT03049735|79593534|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
44571795|NCT03049735|79593532|FG000|Overall Study|Other|5|||
44571796|NCT03049735|79593533|FG001|Overall Study|Other|3|||
44571797|NCT03049735|79593534|FG002|Overall Study|Other|1|||
44571798|NCT03049735|79593532|FG000|Overall Study|Lack of Efficacy|4|||
44571799|NCT03049735|79593533|FG001|Overall Study|Lack of Efficacy|0|||
44571800|NCT03049735|79593534|FG002|Overall Study|Lack of Efficacy|3|||
44571801|NCT03049735|79593532|FG000|Overall Study|Protocol deviation|1|||
44571802|NCT03049735|79593533|FG001|Overall Study|Protocol deviation|0|||
44571803|NCT03049735|79593534|FG002|Overall Study|Protocol deviation|0|||
44571804|NCT03049735|79593532|FG000|Overall Study|Pregnancy|0|||
44571805|NCT03049735|79593533|FG001|Overall Study|Pregnancy|0|||
44571806|NCT03049735|79593534|FG002|Overall Study|Pregnancy|1|||
44571807|NCT03049735|79593532|FG000|Overall Study|Adverse Event|7|||
44571808|NCT03049735|79593533|FG001|Overall Study|Adverse Event|18|||
44571809|NCT03049735|79593534|FG002|Overall Study|Adverse Event|5|||
44571810|NCT03049735|79593532|FG000|Overall Study|Withdrawal by Subject|10|||
44571811|NCT03049735|79593533|FG001|Overall Study|Withdrawal by Subject|3|||
44571812|NCT03049735|79593534|FG002|Overall Study|Withdrawal by Subject|7|||
44571813|NCT03049735|79593532|FG000|Overall Study|Lost to Follow-up|1|||
44571814|NCT03049735|79593533|FG001|Overall Study|Lost to Follow-up|5|||
44571815|NCT03049735|79593534|FG002|Overall Study|Lost to Follow-up|5|||
44571816|NCT01295944|79593542|FG000|Overall Study|Switched to alternative treatment|1|||
44571817|NCT01295944|79593542|FG000|Overall Study|Ineligible|9|||
44571818|NCT01295944|79593542|FG000|Overall Study|Withdrawal by Subject|4|||
44571819|NCT01295944|79593542|FG000|Overall Study|Participant chose to be treated in Peru|1|||
44237394|NCT01590017|79062899|FG000|Overall Study|Withdrawal by Subject|1|||
44237395|NCT01590017|79062899|FG000|Overall Study|Lack of Efficacy|1|||
44237396|NCT01590017|79062899|FG000|Overall Study|Physician Decision|1|||
44237397|NCT01700621|79062905|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
44237398|NCT01700621|79062906|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
44237399|NCT01700621|79062905|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
44237400|NCT01700621|79062906|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
44237401|NCT01700621|79062905|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
44237402|NCT01700621|79062906|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
44237403|NCT01589237|79062917|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
44237404|NCT01589237|79062918|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
44237405|NCT01589237|79062919|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
44237406|NCT01589237|79062920|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
44237407|NCT01589237|79062917|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
44237408|NCT01589237|79062918|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
44237409|NCT01589237|79062919|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
44237410|NCT01589237|79062920|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
44237411|NCT01589237|79062917|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
44237412|NCT01589237|79062918|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
44237413|NCT01589237|79062919|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
44237414|NCT01589237|79062920|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
44237415|NCT01589237|79062917|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
44237416|NCT01589237|79062918|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
44504801|NCT00339833|79509649|FG000|Overall Study|toothache|0|||
44504802|NCT00339833|79509650|FG001|Overall Study|toothache|1|||
44504803|NCT00339833|79509649|FG000|Overall Study|indigestion|0|||
44504804|NCT00339833|79509650|FG001|Overall Study|indigestion|1|||
44504805|NCT00339833|79509649|FG000|Overall Study|Chest pain|0|||
44504806|NCT00339833|79509650|FG001|Overall Study|Chest pain|1|||
44504807|NCT00339833|79509649|FG000|Overall Study|minor infection|0|||
44504808|NCT00339833|79509650|FG001|Overall Study|minor infection|1|||
44504809|NCT00339833|79509649|FG000|Overall Study|Poor venous access|2|||
44504810|NCT00339833|79509650|FG001|Overall Study|Poor venous access|2|||
44504811|NCT00339833|79509649|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
44504812|NCT00339833|79509650|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
44571820|NCT01295944|79593542|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
44571821|NCT01295944|79593542|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
44571822|NCT01295944|79593542|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
44571823|NCT02965599|79593548|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
44571824|NCT02965599|79593549|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
44571825|NCT02898597|79593558|FG000|Overall Study|Protocol Violation|4|||
44571826|NCT02898597|79593559|FG001|Overall Study|Protocol Violation|2|||
44571827|NCT02898597|79593558|FG000|Overall Study|Lost to Follow-up|0|||
44504813|NCT00339833|79509649|FG000|Overall Study|Error in data records|1|||
44571828|NCT02898597|79593559|FG001|Overall Study|Lost to Follow-up|9|||
44571829|NCT02898597|79593558|FG000|Overall Study|Death|0|||
44571830|NCT02898597|79593559|FG001|Overall Study|Death|1|||
44571831|NCT02899377|79593567|FG000|Overall Study|Adverse Event|1|||
44571832|NCT02899377|79593568|FG001|Overall Study|Adverse Event|0|||
44571833|NCT01316887|79593579|FG000|Overall Study|Adverse Event|13|||
44571834|NCT01316887|79593580|FG001|Overall Study|Adverse Event|21|||
44571835|NCT01316887|79593581|FG002|Overall Study|Adverse Event|17|||
44571836|NCT01316887|79593579|FG000|Overall Study|Lack of Efficacy|9|||
44571837|NCT01316887|79593580|FG001|Overall Study|Lack of Efficacy|3|||
44571838|NCT01316887|79593581|FG002|Overall Study|Lack of Efficacy|1|||
44571839|NCT01316887|79593579|FG000|Overall Study|Protocol Violation|2|||
44571840|NCT01316887|79593580|FG001|Overall Study|Protocol Violation|6|||
44571841|NCT01316887|79593581|FG002|Overall Study|Protocol Violation|6|||
44571842|NCT01316887|79593579|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
44571843|NCT01316887|79593580|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
44571844|NCT01316887|79593581|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
44571845|NCT01316887|79593579|FG000|Overall Study|Study Closed/Terminated|2|||
44571846|NCT01316887|79593580|FG001|Overall Study|Study Closed/Terminated|4|||
44571847|NCT01316887|79593581|FG002|Overall Study|Study Closed/Terminated|3|||
44571848|NCT01316887|79593579|FG000|Overall Study|Lost to Follow-up|1|||
44571849|NCT01316887|79593580|FG001|Overall Study|Lost to Follow-up|7|||
44571850|NCT01316887|79593581|FG002|Overall Study|Lost to Follow-up|5|||
44571851|NCT01316887|79593579|FG000|Overall Study|Withdrawal by Subject|8|||
44571852|NCT01316887|79593580|FG001|Overall Study|Withdrawal by Subject|16|||
44571853|NCT01316887|79593581|FG002|Overall Study|Withdrawal by Subject|15|||
44571854|NCT02897349|79593592|FG000|Overall Study|Lost to Follow-up|2|||
44571855|NCT02897349|79593593|FG001|Overall Study|Lost to Follow-up|2|||
44571856|NCT02897349|79593592|FG000|Overall Study|Adverse Event|3|||
44571857|NCT02897349|79593593|FG001|Overall Study|Adverse Event|3|||
44571858|NCT02897349|79593592|FG000|Overall Study|Other than listed above|0|||
44571859|NCT02897349|79593593|FG001|Overall Study|Other than listed above|1|||
44571860|NCT03047551|79593610|FG000|Overall Study|Did not receive TAS|1|||
44571861|NCT03047551|79593611|FG001|Overall Study|Did not receive TAS|0|||
44571862|NCT03047551|79593610|FG000|Overall Study|Physician Decision|1|||
44571863|NCT03047551|79593611|FG001|Overall Study|Physician Decision|0|||
44571864|NCT03047551|79593610|FG000|Overall Study|Withdrawal by Subject|0|||
44571865|NCT03047551|79593611|FG001|Overall Study|Withdrawal by Subject|1|||
44571866|NCT03047551|79593610|FG000|Overall Study|Probe malfunction|0|||
44571867|NCT03047551|79593611|FG001|Overall Study|Probe malfunction|1|||
44571868|NCT03047551|79593610|FG000|Overall Study|Ineligible|0|||
44571869|NCT03047551|79593611|FG001|Overall Study|Ineligible|1|||
44571870|NCT02964741|79593620|FG000|Overall Study|Protocol Violation|1|||
44571871|NCT02964741|79593621|FG001|Overall Study|Protocol Violation|0|||
44571872|NCT02964741|79593622|FG002|Overall Study|Protocol Violation|0|||
44571873|NCT02964741|79593620|FG000|Overall Study|Withdrawal by Subject|0|||
44571874|NCT02964741|79593621|FG001|Overall Study|Withdrawal by Subject|1|||
44571875|NCT02964741|79593622|FG002|Overall Study|Withdrawal by Subject|0|||
44571876|NCT02964741|79593620|FG000|Overall Study|claustrophobia|1|||
44571877|NCT02964741|79593621|FG001|Overall Study|claustrophobia|0|||
44571878|NCT02964741|79593622|FG002|Overall Study|claustrophobia|0|||
44571879|NCT01316419|79593628|FG000|Overall Study|Not treated|103|||
44571880|NCT01316419|79593628|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
44571881|NCT01316419|79593628|FG000|Overall Study|Lost to Follow-up|19|||
44571882|NCT02964039|79593635|FG000|Overall Study|Medical reason unrelated to study participation|1|||
44571883|NCT02964039|79593636|FG001|Overall Study|Medical reason unrelated to study participation|0|||
44571884|NCT02964039|79593637|FG002|Overall Study|Medical reason unrelated to study participation|3|||
44571885|NCT02964039|79593635|FG000|Overall Study|Research shutdown due to pandemic|2|||
44504814|NCT00339833|79509650|FG001|Overall Study|Error in data records|0|||
44504815|NCT03793556|79509658|FG000|Overall Study|Withdrawal by Subject|12|||
44571886|NCT02964039|79593636|FG001|Overall Study|Research shutdown due to pandemic|0|||
44571887|NCT02964039|79593637|FG002|Overall Study|Research shutdown due to pandemic|1|||
44237417|NCT01589237|79062919|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
44237418|NCT01589237|79062920|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
44237419|NCT01700387|79062936|FG000|Overall Study|Withdrawal by Subject|1|||
44504816|NCT03793556|79509659|FG001|Overall Study|Withdrawal by Subject|1|||
44504817|NCT03793556|79509658|FG000|Overall Study|Lost to Follow-up|1|||
44504818|NCT03793556|79509659|FG001|Overall Study|Lost to Follow-up|1|||
44504819|NCT03392194|79509670|FG000|Overall Study|Withdrawal by Subject|1|||
44504820|NCT03392194|79509671|FG001|Overall Study|Withdrawal by Subject|2|||
44504821|NCT03392194|79509670|FG000|Overall Study|Conflicts with personal schedule|1|||
44504822|NCT03392194|79509671|FG001|Overall Study|Conflicts with personal schedule|0|||
44504823|NCT03828617|79509681|FG000|Overall Study|Lost to Follow-up|22|||
44571888|NCT02964039|79593635|FG000|Overall Study|Withdrawal by Subject|0|||
44571889|NCT02964039|79593636|FG001|Overall Study|Withdrawal by Subject|1|||
44571890|NCT02964039|79593637|FG002|Overall Study|Withdrawal by Subject|0|||
44571891|NCT02964039|79593635|FG000|Overall Study|Lost to Follow-up|1|||
44377814|NCT01077518|79383128|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
44377815|NCT01077518|79383126|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
44377816|NCT01077518|79383127|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
44377817|NCT01077518|79383128|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
44504824|NCT03828617|79509682|FG001|Overall Study|Lost to Follow-up|12|||
44504825|NCT03828617|79509683|FG002|Overall Study|Lost to Follow-up|23|||
44504826|NCT03828617|79509684|FG003|Overall Study|Lost to Follow-up|7|||
44504827|NCT03828617|79509681|FG000|Overall Study|No longer met eligibility criteria|0|||
44504828|NCT03828617|79509682|FG001|Overall Study|No longer met eligibility criteria|1|||
44504829|NCT03828617|79509683|FG002|Overall Study|No longer met eligibility criteria|1|||
44504830|NCT03828617|79509684|FG003|Overall Study|No longer met eligibility criteria|3|||
44504831|NCT03828617|79509681|FG000|Overall Study|Protocol Violation|0|||
44504832|NCT03828617|79509682|FG001|Overall Study|Protocol Violation|2|||
44504833|NCT03828617|79509683|FG002|Overall Study|Protocol Violation|0|||
44504834|NCT03828617|79509684|FG003|Overall Study|Protocol Violation|0|||
44504835|NCT03828617|79509681|FG000|Overall Study|Withdrawal by Subject|2|||
44504836|NCT03828617|79509682|FG001|Overall Study|Withdrawal by Subject|0|||
44504837|NCT03828617|79509683|FG002|Overall Study|Withdrawal by Subject|2|||
44504838|NCT03828617|79509684|FG003|Overall Study|Withdrawal by Subject|0|||
44504839|NCT03391960|79509693|FG000|Overall Study|Protocol Violation|0|||
44504840|NCT03391960|79509694|FG001|Overall Study|Protocol Violation||||
44504841|NCT03390166|79509720|FG000|Overall Study|Death|0|||
44504842|NCT03390166|79509721|FG001|Overall Study|Death|1|||
44504843|NCT03390166|79509720|FG000|Overall Study|Lost to Follow-up|6|||
44504844|NCT03390166|79509721|FG001|Overall Study|Lost to Follow-up|4|||
44504845|NCT03390166|79509720|FG000|Overall Study|Physician Decision|2|||
44504846|NCT03390166|79509721|FG001|Overall Study|Physician Decision|1|||
44504847|NCT03390166|79509720|FG000|Overall Study|Move from study area|3|||
44504848|NCT03390166|79509721|FG001|Overall Study|Move from study area|2|||
44504849|NCT03390166|79509720|FG000|Overall Study|To militarycamp for conscript|1|||
44504850|NCT03390166|79509721|FG001|Overall Study|To militarycamp for conscript|0|||
44504851|NCT03390166|79509720|FG000|Overall Study|To drug therapy course|0|||
44504852|NCT03390166|79509721|FG001|Overall Study|To drug therapy course|1|||
44504853|NCT03390166|79509720|FG000|Overall Study|Move to work oversea|0|||
44504854|NCT03390166|79509721|FG001|Overall Study|Move to work oversea|1|||
44504855|NCT03828539|79509729|FG000|Overall Study|Adverse Event|3|||
44504856|NCT03828539|79509730|FG001|Overall Study|Adverse Event|12|||
44504857|NCT03828539|79509729|FG000|Overall Study|Patient's/guardian's decision|3|||
44504858|NCT03828539|79509730|FG001|Overall Study|Patient's/guardian's decision|5|||
44504859|NCT03828539|79509729|FG000|Overall Study|Lost to Follow-up|4|||
44504860|NCT03828539|79509730|FG001|Overall Study|Lost to Follow-up|2|||
44504861|NCT03828539|79509729|FG000|Overall Study|Protocol Violation|3|||
44504862|NCT03828539|79509730|FG001|Overall Study|Protocol Violation|2|||
44504863|NCT03828539|79509729|FG000|Overall Study|Withdrawal of informed consent|2|||
44504864|NCT03828539|79509730|FG001|Overall Study|Withdrawal of informed consent|1|||
44504865|NCT03828539|79509729|FG000|Overall Study|New therapy for study indication|1|||
44504866|NCT03828539|79509730|FG001|Overall Study|New therapy for study indication|0|||
44504867|NCT03336502|79509738|FG000|Overall Study|Physician Decision|0|||
44504868|NCT03336502|79509739|FG001|Overall Study|Physician Decision|1|||
44504869|NCT03336502|79509738|FG000|Overall Study|Prohibited Drugs|1|||
44504870|NCT03336502|79509739|FG001|Overall Study|Prohibited Drugs|1|||
44504871|NCT03336502|79509738|FG000|Overall Study|Death|1|||
44504872|NCT03336502|79509739|FG001|Overall Study|Death|2|||
44504873|NCT03336502|79509738|FG000|Overall Study|Adverse Event|2|||
44504874|NCT03336502|79509739|FG001|Overall Study|Adverse Event|5|||
44504875|NCT00338741|79509747|FG000|Overall Study|Lost to Follow-up|2|||
44504876|NCT00338741|79509748|FG001|Overall Study|Lost to Follow-up|0|||
44504877|NCT03370510|79509756|FG000|Overall Study|COVID-19|2|||
44504878|NCT03370510|79509757|FG001|Overall Study|COVID-19|0|||
44504879|NCT00351611|79509765|FG000|Overall Study|Adverse Event|11|||
44504880|NCT00351611|79509766|FG001|Overall Study|Adverse Event|3|||
44504881|NCT00351611|79509765|FG000|Overall Study|Death|1|||
44504882|NCT00351611|79509766|FG001|Overall Study|Death|0|||
44504883|NCT00351611|79509765|FG000|Overall Study|Lost to Follow-up|1|||
44504884|NCT00351611|79509766|FG001|Overall Study|Lost to Follow-up|0|||
44504885|NCT00351611|79509765|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
44504886|NCT00351611|79509766|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
44504887|NCT00351611|79509765|FG000|Overall Study|Other|1|||
44504888|NCT00351611|79509766|FG001|Overall Study|Other|0|||
44504889|NCT00351611|79509765|FG000|Overall Study|Protocol Violation|0|||
44504890|NCT00351611|79509766|FG001|Overall Study|Protocol Violation|2|||
44504891|NCT00351533|79509774|FG000|Overall Study|Extubated before first BAL|1|||
44504892|NCT00351533|79509775|FG001|Overall Study|Extubated before first BAL|0|||
44504893|NCT00351533|79509774|FG000|Overall Study|Lost to Follow-up|1|||
44571892|NCT02964039|79593636|FG001|Overall Study|Lost to Follow-up|0|||
44571893|NCT02964039|79593637|FG002|Overall Study|Lost to Follow-up|1|||
44571894|NCT02897115|79593647|FG000|Overall Study|Early termination of study by sponsor|11|||
44571895|NCT02897115|79593648|FG001|Overall Study|Early termination of study by sponsor|8|||
44571896|NCT02896569|79593656|FG000|Overall Study|Lost to Follow-up|2|||
44571897|NCT02896569|79593657|FG001|Overall Study|Lost to Follow-up|1|||
44571898|NCT02896569|79593656|FG000|Overall Study|Physician Decision|1|||
44571899|NCT02896569|79593657|FG001|Overall Study|Physician Decision|3|||
44237420|NCT01700387|79062937|FG001|Overall Study|Withdrawal by Subject|2|||
44237421|NCT01700387|79062936|FG000|Overall Study|Adverse Event|1|||
44237422|NCT01700387|79062937|FG001|Overall Study|Adverse Event|1|||
44237423|NCT01700387|79062936|FG000|Overall Study|Lost to Follow-up|2|||
44237424|NCT01700387|79062937|FG001|Overall Study|Lost to Follow-up|1|||
44237425|NCT01699685|79062949|FG000|Period 1|Adverse Event|1|||
44237426|NCT01699685|79062950|FG001|Period 1|Adverse Event|1|||
44237427|NCT01699685|79062949|FG000|Period 1|Medical or ethical, noncompliance|2|||
44237428|NCT01699685|79062950|FG001|Period 1|Medical or ethical, noncompliance|0|||
44237429|NCT01699685|79062949|FG000|Period 1|Other|0|||
44237430|NCT01699685|79062950|FG001|Period 1|Other|1|||
44237431|NCT01699685|79062949|FG000|Period 1|Patient request|0|||
44237432|NCT01699685|79062950|FG001|Period 1|Patient request|1|||
44237433|NCT01699685|79062949|FG000|Period 2|Lost to Follow-up|1|||
44237434|NCT01699685|79062950|FG001|Period 2|Lost to Follow-up|0|||
44237435|NCT01587989|79062958|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
44237436|NCT01587989|79062959|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
44237437|NCT01587989|79062960|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
44237438|NCT01587989|79062958|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
44237439|NCT01587989|79062959|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
44237440|NCT01587989|79062960|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
44237441|NCT01587989|79062958|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
44237442|NCT01587989|79062959|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
44237443|NCT01587989|79062960|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
44237444|NCT01587989|79062958|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
44237445|NCT01587989|79062959|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
44237446|NCT01587989|79062960|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
44237447|NCT01587989|79062958|FG000|Randomized Study Treatment|Screening failure|0|||
44237448|NCT01587989|79062959|FG001|Randomized Study Treatment|Screening failure|1|||
44237449|NCT01587989|79062960|FG002|Randomized Study Treatment|Screening failure|0|||
44237450|NCT01587989|79062958|FG000|Randomized Study Treatment|Physician Decision|0|||
44571900|NCT02896569|79593656|FG000|Overall Study|Adverse Event|0|||
44571901|NCT02896569|79593657|FG001|Overall Study|Adverse Event|1|||
44571902|NCT02896569|79593656|FG000|Overall Study|Withdrawal by Subject|1|||
44571903|NCT02896569|79593657|FG001|Overall Study|Withdrawal by Subject|0|||
44571904|NCT04030195|79593666|FG000|Overall Study|Withdrawal by Subject|2|||
44571905|NCT04030195|79593667|FG001|Overall Study|Withdrawal by Subject|0|||
44571906|NCT04030195|79593668|FG002|Overall Study|Withdrawal by Subject|0|||
44571907|NCT01673620|79593679|FG000|Overall Study|Adverse Event|1|||
44571908|NCT01673620|79593680|FG001|Overall Study|Adverse Event|0|||
44571909|NCT03044197|79593694|FG000|Overall Study|Withdrawal by Subject|3|||
44571910|NCT03044197|79593695|FG001|Overall Study|Withdrawal by Subject|1|||
44571911|NCT03043651|79593723|FG000|Overall Study|Death|1|||
44571912|NCT03043651|79593723|FG000|Overall Study|Progressive Disease|2|||
44571913|NCT03043651|79593723|FG000|Overall Study|Adverse Event|2|||
44237451|NCT01587989|79062959|FG001|Randomized Study Treatment|Physician Decision|0|||
44237452|NCT01587989|79062960|FG002|Randomized Study Treatment|Physician Decision|1|||
44237453|NCT01697969|79062966|FG000|Overall Study|Did not meet inc/exc criteria|3|||
44377818|NCT01077518|79383126|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
44377819|NCT01077518|79383127|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
44571914|NCT03043651|79593723|FG000|Overall Study|Withdrawal by Subject|4|||
44571915|NCT03043651|79593723|FG000|Overall Study|Study Terminated by Sponsor|39|||
44237454|NCT01586819|79062973|FG000|Overall Study|Withdrawal by Subject|1|||
44237455|NCT01586819|79062974|FG001|Overall Study|Withdrawal by Subject|0|||
44237456|NCT01697579|79062985|FG000|Base Study-Cycle 1|Adverse Event|1|||
44237457|NCT01697579|79062986|FG001|Base Study-Cycle 1|Adverse Event|0|||
44237458|NCT01697579|79062987|FG002|Base Study-Cycle 1|Adverse Event|0|||
44237459|NCT01697579|79062988|FG003|Base Study-Cycle 1|Adverse Event|0|||
44237460|NCT01697579|79062989|FG004|Base Study-Cycle 1|Adverse Event|0|||
44237461|NCT01697579|79062990|FG005|Base Study-Cycle 1|Adverse Event|0|||
44237462|NCT01697579|79062991|FG006|Base Study-Cycle 1|Adverse Event|0|||
44237463|NCT01697579|79062985|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
44237464|NCT01697579|79062986|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
44571916|NCT03536143|79593727|FG000|Overall Study|Early termination, Sponsor decision|1|||
44571917|NCT01344759|79593737|FG000|Overall Study|Patients failed to reach sedation level|0|||
44571918|NCT01344759|79593738|FG001|Overall Study|Patients failed to reach sedation level|2|||
44571919|NCT05027451|79593761|FG000|Overall Study|Lost to Follow-up|1|||
44571920|NCT05027451|79593762|FG001|Overall Study|Lost to Follow-up|1|||
44571921|NCT04549454|79593796|FG000|T1 to T2|Lost to Follow-up|22|||
44571922|NCT04549454|79593797|FG001|T1 to T2|Lost to Follow-up|26|||
44571923|NCT04549454|79593796|FG000|T1 to T3|Lost to Follow-up|31|||
44571924|NCT04549454|79593797|FG001|T1 to T3|Lost to Follow-up|36|||
44571925|NCT03519256|79593844|FG000|Overall Study|Disease recurrence|4|||
44571926|NCT03519256|79593845|FG001|Overall Study|Disease recurrence|4|||
44571927|NCT03519256|79593846|FG002|Overall Study|Disease recurrence|5|||
44571928|NCT03519256|79593847|FG003|Overall Study|Disease recurrence|2|||
44571929|NCT03519256|79593844|FG000|Overall Study|Study drug toxicity|0|||
44571930|NCT03519256|79593845|FG001|Overall Study|Study drug toxicity|2|||
44571931|NCT03519256|79593846|FG002|Overall Study|Study drug toxicity|5|||
44571932|NCT03519256|79593847|FG003|Overall Study|Study drug toxicity|2|||
44571933|NCT03519256|79593844|FG000|Overall Study|Adverse event unrelated to study drug|0|||
44237465|NCT01697579|79062987|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
44237466|NCT01697579|79062988|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
44237467|NCT01697579|79062989|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
44237468|NCT01697579|79062990|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
44237469|NCT01697579|79062991|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
44237470|NCT01697579|79062985|FG000|Base Study-Cycle 1|Protocol Violation|0|||
44237471|NCT01697579|79062986|FG001|Base Study-Cycle 1|Protocol Violation|0|||
44237472|NCT01697579|79062987|FG002|Base Study-Cycle 1|Protocol Violation|0|||
44237473|NCT01697579|79062988|FG003|Base Study-Cycle 1|Protocol Violation|0|||
44237474|NCT01697579|79062989|FG004|Base Study-Cycle 1|Protocol Violation|3|||
44237475|NCT01697579|79062990|FG005|Base Study-Cycle 1|Protocol Violation|0|||
44237476|NCT01697579|79062991|FG006|Base Study-Cycle 1|Protocol Violation|0|||
44237477|NCT01697579|79062985|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
44237478|NCT01697579|79062986|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
44237479|NCT01697579|79062987|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
44237480|NCT01697579|79062988|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
44237481|NCT01697579|79062989|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
44237482|NCT01697579|79062990|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
44237483|NCT01697579|79062991|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
44237484|NCT01697579|79062985|FG000|Base Study-Cycle 1|Technical Problems|0|||
44237485|NCT01697579|79062986|FG001|Base Study-Cycle 1|Technical Problems|0|||
44237486|NCT01697579|79062987|FG002|Base Study-Cycle 1|Technical Problems|1|||
44571934|NCT03519256|79593845|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44571935|NCT03519256|79593846|FG002|Overall Study|Adverse event unrelated to study drug|1|||
44571936|NCT03519256|79593847|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44571937|NCT03519256|79593844|FG000|Overall Study|Participant request to discontinue study treatment|0|||
44571938|NCT03519256|79593845|FG001|Overall Study|Participant request to discontinue study treatment|0|||
44571939|NCT03519256|79593846|FG002|Overall Study|Participant request to discontinue study treatment|0|||
44571940|NCT03519256|79593847|FG003|Overall Study|Participant request to discontinue study treatment|2|||
44571941|NCT03519256|79593844|FG000|Overall Study|Other reasons|0|||
44571942|NCT03519256|79593845|FG001|Overall Study|Other reasons|0|||
44237487|NCT01697579|79062988|FG003|Base Study-Cycle 1|Technical Problems|1|||
44237488|NCT01697579|79062989|FG004|Base Study-Cycle 1|Technical Problems|0|||
44237489|NCT01697579|79062990|FG005|Base Study-Cycle 1|Technical Problems|0|||
44237490|NCT01697579|79062991|FG006|Base Study-Cycle 1|Technical Problems|0|||
44237491|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Death|0|||
44237492|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Death|0|||
44237493|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Death|0|||
44237494|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Death|0|||
44237495|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Death|0|||
44237496|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Death|0|||
44237497|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Death|2|||
44504894|NCT00351533|79509775|FG001|Overall Study|Lost to Follow-up|3|||
44504895|NCT00351533|79509774|FG000|Overall Study|Physician Decision|0|||
44504896|NCT00351533|79509775|FG001|Overall Study|Physician Decision|1|||
44504897|NCT00351533|79509774|FG000|Overall Study|Withdrawal by Subject|0|||
44504898|NCT00351533|79509775|FG001|Overall Study|Withdrawal by Subject|1|||
44504899|NCT00351377|79509781|FG000|Overall Study|Adverse Event|5|||
44504900|NCT00351377|79509781|FG000|Overall Study|Death|1|||
44504901|NCT00351377|79509781|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44504902|NCT00337727|79509787|FG000|Overall Study|Adverse Event|5|||
44504903|NCT00337727|79509788|FG001|Overall Study|Adverse Event|3|||
44504904|NCT00337727|79509787|FG000|Overall Study|Lost to Follow-up|5|||
44237498|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44237499|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44237500|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44571943|NCT03519256|79593846|FG002|Overall Study|Other reasons|2|||
44571944|NCT03519256|79593847|FG003|Overall Study|Other reasons|0|||
44571945|NCT03519256|79593844|FG000|Overall Study|Disease progression|6|||
44237501|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44237502|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44237503|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
44237504|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
44237505|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
44237506|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
44237507|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
44237508|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
44571946|NCT03519256|79593845|FG001|Overall Study|Disease progression|3|||
44571947|NCT03519256|79593846|FG002|Overall Study|Disease progression|2|||
44571948|NCT03519256|79593847|FG003|Overall Study|Disease progression|1|||
44571949|NCT03519256|79593844|FG000|Overall Study|Lost to Follow-up|0|||
44237509|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
44237510|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
44237511|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
44237512|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
44237513|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
44237514|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
44237515|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
44237516|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
44237517|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
44237518|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
44237519|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
44237520|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
44237521|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
44237522|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
44237523|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
44237524|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
44237525|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
44237526|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
44237527|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
44237528|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
44237529|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
44571950|NCT03519256|79593845|FG001|Overall Study|Lost to Follow-up|1|||
44571951|NCT03519256|79593846|FG002|Overall Study|Lost to Follow-up|0|||
44571952|NCT03519256|79593847|FG003|Overall Study|Lost to Follow-up|0|||
44571953|NCT02799602|79593883|FG000|Overall Study|Protocol Violation|1|||
44571954|NCT02799602|79593884|FG001|Overall Study|Protocol Violation|0|||
44571955|NCT02799602|79593883|FG000|Overall Study|Physician Decision|3|||
44571956|NCT02799602|79593884|FG001|Overall Study|Physician Decision|7|||
44571957|NCT02799602|79593883|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
44571958|NCT02799602|79593884|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
44571959|NCT02799602|79593883|FG000|Overall Study|Lost to Follow-up|4|||
44571960|NCT02799602|79593884|FG001|Overall Study|Lost to Follow-up|1|||
44571961|NCT02799602|79593883|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
44571962|NCT02799602|79593884|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
44571963|NCT02799602|79593883|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
44571964|NCT02799602|79593884|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
44571965|NCT02799602|79593883|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
44237530|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
44237531|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
44237532|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
44237533|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
44237534|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
44237535|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
44237536|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
44237537|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
44237538|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
44237539|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
44237540|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
44237541|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
44237542|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
44237543|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
44571966|NCT02799602|79593884|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
44571967|NCT02799602|79593883|FG000|Overall Study|Withdrawal by Subject|25|||
44571968|NCT02799602|79593884|FG001|Overall Study|Withdrawal by Subject|37|||
44571969|NCT02799602|79593883|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
44237544|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
44237545|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
44237546|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
44237547|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
44237548|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
44237549|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
44237550|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
44237551|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
44571970|NCT02799602|79593884|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
44237552|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
44237553|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
44237554|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
44571971|NCT02799602|79593883|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
44571972|NCT02799602|79593884|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
44571973|NCT02799602|79593883|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
44571974|NCT02799602|79593884|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
44571975|NCT02799602|79593883|FG000|Overall Study|Death|8|||
44571976|NCT02799602|79593884|FG001|Overall Study|Death|5|||
44571977|NCT02799602|79593883|FG000|Overall Study|Other|3|||
44571978|NCT02799602|79593884|FG001|Overall Study|Other|3|||
44571979|NCT02799602|79593883|FG000|Overall Study|GCP violation|1|||
44571980|NCT02799602|79593884|FG001|Overall Study|GCP violation|0|||
44571981|NCT02243709|79593901|FG000|Phase 1|Lost to Follow-up|0|||
44571982|NCT02243709|79593902|FG001|Phase 1|Lost to Follow-up|1|||
44571983|NCT02243709|79593901|FG000|Phase 1|Withdrawal by Subject|1|||
44571984|NCT02243709|79593902|FG001|Phase 1|Withdrawal by Subject|0|||
44571985|NCT02243709|79593901|FG000|Phase 1|Protocol Violation|0|||
44571986|NCT02243709|79593902|FG001|Phase 1|Protocol Violation|1|||
44571987|NCT02243709|79593901|FG000|Phase 1|Adverse Event|0|||
44571988|NCT02243709|79593902|FG001|Phase 1|Adverse Event|1|||
44571989|NCT01891396|79593914|FG000|Overall Study|Withdrawal by Subject|4|||
44571990|NCT01891396|79593915|FG001|Overall Study|Withdrawal by Subject|4|||
44571991|NCT01891396|79593916|FG002|Overall Study|Withdrawal by Subject|3|||
44571992|NCT01891396|79593914|FG000|Overall Study|Lost to Follow-up|0|||
44571993|NCT01891396|79593915|FG001|Overall Study|Lost to Follow-up|1|||
44571994|NCT01891396|79593916|FG002|Overall Study|Lost to Follow-up|0|||
44571995|NCT01746225|79593931|FG000|Overall Study|Death|1|||
44571996|NCT01746225|79593932|FG001|Overall Study|Death|0|||
44571997|NCT01746225|79593933|FG002|Overall Study|Death|1|||
44571998|NCT01746225|79593931|FG000|Overall Study|Withdrawal by Subject|5|||
44571999|NCT01746225|79593932|FG001|Overall Study|Withdrawal by Subject|15|||
44572000|NCT01746225|79593933|FG002|Overall Study|Withdrawal by Subject|19|||
44572001|NCT01746225|79593931|FG000|Overall Study|Physician Decision|14|||
44572002|NCT01746225|79593932|FG001|Overall Study|Physician Decision|11|||
44572003|NCT01746225|79593933|FG002|Overall Study|Physician Decision|3|||
44572004|NCT01746225|79593931|FG000|Overall Study|Adverse Event|15|||
44572005|NCT01746225|79593932|FG001|Overall Study|Adverse Event|12|||
44572006|NCT01746225|79593933|FG002|Overall Study|Adverse Event|17|||
44572007|NCT01746225|79593931|FG000|Overall Study|Continuing Treatment|5|||
44572008|NCT01746225|79593932|FG001|Overall Study|Continuing Treatment|8|||
44572009|NCT01746225|79593933|FG002|Overall Study|Continuing Treatment|3|||
44237555|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
44237556|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
44237557|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
44237558|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
44237559|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
44237560|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
44237561|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
44237562|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
44237563|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
44237564|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
44237565|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
44237566|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
44237567|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
44237568|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
44572010|NCT01471522|79593954|FG000|Overall Study|Withdrawal by Subject|28|||
44572011|NCT01471522|79593955|FG001|Overall Study|Withdrawal by Subject|22|||
44572012|NCT01471522|79593954|FG000|Overall Study|Lost to Follow-up|36|||
44572013|NCT01471522|79593955|FG001|Overall Study|Lost to Follow-up|26|||
44572014|NCT01191008|79593962|FG000|Overall Study|Protocol Violation|7|||
44572015|NCT01191008|79593962|FG000|Overall Study|Lost to Follow-up|8|||
44572016|NCT00821587|79593968|FG000|Overall Study|Physician Decision|0|||
44572017|NCT00821587|79593969|FG001|Overall Study|Physician Decision|1|||
44572018|NCT00645801|79593977|FG000|Overall Study|unclear if patient took all the medication.|1|||
44572019|NCT00645801|79593978|FG001|Overall Study|unclear if patient took all the medication.|0|||
44572020|NCT00645801|79593977|FG000|Overall Study|Lost to Follow-up|19|||
44572021|NCT00645801|79593978|FG001|Overall Study|Lost to Follow-up|15|||
44572022|NCT00424099|79593992|FG000|Overall Study|Adverse Event|0|||
44572023|NCT00424099|79593993|FG001|Overall Study|Adverse Event|1|||
44572024|NCT00424099|79593994|FG002|Overall Study|Adverse Event|1|||
44572025|NCT00424099|79593995|FG003|Overall Study|Adverse Event|0|||
44572026|NCT00424099|79593992|FG000|Overall Study|Death|0|||
44572027|NCT00424099|79593993|FG001|Overall Study|Death|1|||
44572028|NCT00424099|79593994|FG002|Overall Study|Death|0|||
44572029|NCT00424099|79593995|FG003|Overall Study|Death|0|||
44572030|NCT00424099|79593992|FG000|Overall Study|Illness|2|||
44572031|NCT00424099|79593993|FG001|Overall Study|Illness|0|||
44572032|NCT00424099|79593994|FG002|Overall Study|Illness|1|||
44572033|NCT00424099|79593995|FG003|Overall Study|Illness|4|||
44572034|NCT00424099|79593992|FG000|Overall Study|Lost to Follow-up|0|||
44572035|NCT00424099|79593993|FG001|Overall Study|Lost to Follow-up|0|||
44572036|NCT00424099|79593994|FG002|Overall Study|Lost to Follow-up|3|||
44572037|NCT00424099|79593995|FG003|Overall Study|Lost to Follow-up|0|||
44572038|NCT00424099|79593992|FG000|Overall Study|Hospitalized|1|||
44572039|NCT00424099|79593993|FG001|Overall Study|Hospitalized|2|||
44572040|NCT00424099|79593994|FG002|Overall Study|Hospitalized|1|||
44572041|NCT00424099|79593995|FG003|Overall Study|Hospitalized|3|||
44572042|NCT00424099|79593992|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
44572043|NCT00424099|79593993|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
44572044|NCT00424099|79593994|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
44572045|NCT00424099|79593995|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
44572046|NCT00424099|79593992|FG000|Overall Study|Withdrawal by Subject|1|||
44572047|NCT00424099|79593993|FG001|Overall Study|Withdrawal by Subject|9|||
44572048|NCT00424099|79593994|FG002|Overall Study|Withdrawal by Subject|4|||
44572049|NCT00424099|79593995|FG003|Overall Study|Withdrawal by Subject|6|||
44572050|NCT00424099|79593992|FG000|Overall Study|Physician Decision|0|||
44572051|NCT00424099|79593993|FG001|Overall Study|Physician Decision|0|||
44572052|NCT00424099|79593994|FG002|Overall Study|Physician Decision|1|||
44572053|NCT00424099|79593995|FG003|Overall Study|Physician Decision|0|||
44572054|NCT00424099|79593992|FG000|Overall Study|Missing|0|||
44572055|NCT00424099|79593993|FG001|Overall Study|Missing|0|||
44572056|NCT00424099|79593994|FG002|Overall Study|Missing|1|||
44572057|NCT00424099|79593995|FG003|Overall Study|Missing|0|||
44572058|NCT02988661|79594018|FG000|Overall Study|Death|2|||
44572059|NCT02988661|79594019|FG001|Overall Study|Death|18|||
44572060|NCT02988661|79594018|FG000|Overall Study|Lost to Follow-up|0|||
44572061|NCT02988661|79594019|FG001|Overall Study|Lost to Follow-up|33|||
44572062|NCT02988661|79594018|FG000|Overall Study|Withdrawal by Subject|0|||
44572063|NCT02988661|79594019|FG001|Overall Study|Withdrawal by Subject|6|||
44572064|NCT02988661|79594018|FG000|Overall Study|Unable to complete the 18-month survey|1|||
44572065|NCT02988661|79594019|FG001|Overall Study|Unable to complete the 18-month survey|27|||
44572066|NCT03738397|79594027|FG000|Overall Study|Adverse Event|3|||
44572067|NCT03738397|79594028|FG001|Overall Study|Adverse Event|7|||
44572068|NCT03738397|79594027|FG000|Overall Study|Withdrawal by Subject|8|||
44572069|NCT03738397|79594028|FG001|Overall Study|Withdrawal by Subject|11|||
44572070|NCT03738397|79594027|FG000|Overall Study|Lost to Follow-up|8|||
44572071|NCT03738397|79594028|FG001|Overall Study|Lost to Follow-up|5|||
44572072|NCT03738397|79594027|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
44572073|NCT03738397|79594028|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
44572074|NCT03738397|79594027|FG000|Overall Study|Other|4|||
44237569|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
44237570|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
44237571|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
44249738|NCT01504412|79083927|FG004|Overall Study|Other|1|||
44572075|NCT03738397|79594028|FG001|Overall Study|Other|6|||
44572076|NCT02960217|79594036|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
44572077|NCT02960217|79594037|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
44572078|NCT02960217|79594036|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
44572079|NCT02960217|79594037|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
44572080|NCT02960217|79594036|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
44572081|NCT02960217|79594037|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
44572082|NCT02960217|79594036|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
44572083|NCT02960217|79594037|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
44572084|NCT02960217|79594036|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
44572085|NCT02960217|79594037|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
44572086|NCT02960217|79594036|FG000|Open-Label Extension Phase|Adverse Event|1|||
44572087|NCT02960217|79594037|FG001|Open-Label Extension Phase|Adverse Event|0|||
44572088|NCT02960217|79594036|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
44572089|NCT02960217|79594037|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
44572090|NCT02960217|79594036|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
44572091|NCT02960217|79594037|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
44572092|NCT02960217|79594036|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
44572093|NCT02960217|79594037|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
44572094|NCT02959983|79594049|FG000|Overall Study|Protocol Violation|0|||
44572095|NCT02959983|79594050|FG001|Overall Study|Protocol Violation|1|||
44572096|NCT02959983|79594049|FG000|Overall Study|Lack of Efficacy|0|||
44572097|NCT02959983|79594050|FG001|Overall Study|Lack of Efficacy|1|||
44572098|NCT02959983|79594049|FG000|Overall Study|Lost to Follow-up|12|||
44572099|NCT02959983|79594050|FG001|Overall Study|Lost to Follow-up|9|||
44572100|NCT02959983|79594049|FG000|Overall Study|Other|1|||
44572101|NCT02959983|79594050|FG001|Overall Study|Other|1|||
44572102|NCT02959983|79594049|FG000|Overall Study|Physician Decision|1|||
44572103|NCT02959983|79594050|FG001|Overall Study|Physician Decision|0|||
44572104|NCT02959983|79594049|FG000|Overall Study|Adverse Event|5|||
44572105|NCT02959983|79594050|FG001|Overall Study|Adverse Event|1|||
44572106|NCT02959983|79594049|FG000|Overall Study|Withdrawal by Subject|7|||
44572107|NCT02959983|79594050|FG001|Overall Study|Withdrawal by Subject|12|||
44572108|NCT01344447|79594056|FG000|Overall Study|Adverse Event|1|||
44572109|NCT01344447|79594056|FG000|Overall Study|Protocol Violation|1|||
44572110|NCT01344447|79594056|FG000|Overall Study|Withdrawal by Subject|1|||
44572111|NCT01344447|79594056|FG000|Overall Study|The contrast was not seen|1|||
44572112|NCT01344447|79594056|FG000|Overall Study|Physician Decision|1|||
44572113|NCT01344447|79594056|FG000|Overall Study|MRA unsuccessful|1|||
44572114|NCT01344447|79594056|FG000|Overall Study|Bolus tracking failed|1|||
44572115|NCT01344447|79594056|FG000|Overall Study|Error of power injector|1|||
44572116|NCT03513068|79594066|FG000|Overall Study|Death|1|||
44572117|NCT03513068|79594067|FG001|Overall Study|Death|0|||
44572118|NCT03513068|79594066|FG000|Overall Study|Withdrawal by Subject|4|||
44572119|NCT03513068|79594067|FG001|Overall Study|Withdrawal by Subject|6|||
44572120|NCT01348425|79594075|FG000|Overall Study|Imaging was not taken.|1|||
44572121|NCT01348425|79594076|FG001|Overall Study|Imaging was not taken.|1|||
44572122|NCT03041701|79594084|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
44572123|NCT03041701|79594085|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
44572124|NCT03041701|79594086|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
44572125|NCT03041701|79594084|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
44572126|NCT03041701|79594085|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
44572127|NCT03041701|79594086|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
44572128|NCT02956629|79594103|FG000|Overall Study|Adverse Event|0|||
44572129|NCT02956629|79594104|FG001|Overall Study|Adverse Event|0|||
44572130|NCT02956629|79594105|FG002|Overall Study|Adverse Event|1|||
44572131|NCT02956629|79594106|FG003|Overall Study|Adverse Event|0|||
44572132|NCT02956629|79594107|FG004|Overall Study|Adverse Event|0|||
44572133|NCT02956629|79594108|FG005|Overall Study|Adverse Event|0|||
44572134|NCT02956629|79594103|FG000|Overall Study|Lost to Follow-up|2|||
44572135|NCT02956629|79594104|FG001|Overall Study|Lost to Follow-up|5|||
44572136|NCT02956629|79594105|FG002|Overall Study|Lost to Follow-up|3|||
44572137|NCT02956629|79594106|FG003|Overall Study|Lost to Follow-up|1|||
44572138|NCT02956629|79594107|FG004|Overall Study|Lost to Follow-up|0|||
44572139|NCT02956629|79594108|FG005|Overall Study|Lost to Follow-up|1|||
44237572|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
44237573|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
44237574|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
44237575|NCT01697579|79062985|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
44237576|NCT01697579|79062986|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
44237577|NCT01697579|79062987|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
44237578|NCT01697579|79062988|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
44237579|NCT01697579|79062989|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
44237580|NCT01697579|79062990|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
44237581|NCT01697579|79062991|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
44237582|NCT01586195|79063019|FG000|Overall Study|Death|11|||
44237583|NCT01586195|79063019|FG000|Overall Study|Withdrawal of Consent|5|||
44237584|NCT01586195|79063019|FG000|Overall Study|Started new anti-melanoma therapy|1|||
44275930|NCT04093024|79226183|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
44572140|NCT02956629|79594103|FG000|Overall Study|Withdrawal by Subject|3|||
44572141|NCT02956629|79594104|FG001|Overall Study|Withdrawal by Subject|1|||
44572142|NCT02956629|79594105|FG002|Overall Study|Withdrawal by Subject|0|||
44572143|NCT02956629|79594106|FG003|Overall Study|Withdrawal by Subject|0|||
44572144|NCT02956629|79594107|FG004|Overall Study|Withdrawal by Subject|0|||
44572145|NCT02956629|79594108|FG005|Overall Study|Withdrawal by Subject|0|||
44572146|NCT01348347|79594125|FG000|Overall Study|Withdrawal by Subject|1|||
44572147|NCT01348347|79594126|FG001|Overall Study|Withdrawal by Subject|1|||
44572148|NCT01348347|79594127|FG002|Overall Study|Withdrawal by Subject|1|||
44572149|NCT01348347|79594125|FG000|Overall Study|Progressive disease|2|||
44572150|NCT01348347|79594126|FG001|Overall Study|Progressive disease|5|||
44572151|NCT01348347|79594127|FG002|Overall Study|Progressive disease|5|||
44572152|NCT02959671|79594136|FG000|Overall Study|Adverse Event|2|||
44572153|NCT02959671|79594136|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
44572154|NCT01597258|79594140|FG000|Overall Study|No Drug Administration|1|||
44572155|NCT02958267|79594146|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
44572156|NCT02958267|79594147|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
44572157|NCT02958267|79594146|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
44572158|NCT02958267|79594147|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
44572159|NCT02958267|79594146|FG000|Follow-up Visits|Additional treatment pursued|2|||
44572160|NCT02958267|79594147|FG001|Follow-up Visits|Additional treatment pursued|1|||
44572161|NCT01952574|79594157|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
44572162|NCT01952574|79594158|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
44572163|NCT01952574|79594159|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
44572164|NCT01952574|79594160|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
44572165|NCT01952574|79594161|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44572166|NCT01952574|79594162|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44572167|NCT01952574|79594163|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44572168|NCT01952574|79594157|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
44572169|NCT01952574|79594158|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
44572170|NCT01952574|79594159|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
44572171|NCT01952574|79594160|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
44572172|NCT01952574|79594161|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
44572173|NCT01952574|79594162|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
44572174|NCT01952574|79594163|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
44572175|NCT01952574|79594157|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
44572176|NCT01952574|79594158|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
44572177|NCT01952574|79594159|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
44572178|NCT01952574|79594160|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
44572179|NCT01952574|79594161|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
44572180|NCT01952574|79594162|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
44572181|NCT01952574|79594163|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
44572182|NCT01952574|79594157|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
44572183|NCT01952574|79594158|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
44572184|NCT01952574|79594159|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
44572185|NCT01952574|79594160|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
44572186|NCT01952574|79594161|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
44572187|NCT01952574|79594162|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
44572188|NCT01952574|79594163|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
44572189|NCT01952574|79594157|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
44572190|NCT01952574|79594158|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
44572191|NCT01952574|79594159|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
44572192|NCT01952574|79594160|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
44237585|NCT01586195|79063019|FG000|Overall Study|Reason not specified|9|||
44237586|NCT01585961|79063023|FG000|Overall Study|Death|6|||
44572193|NCT01952574|79594161|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
44572194|NCT01952574|79594162|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
44572195|NCT01952574|79594163|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
44572196|NCT01952574|79594157|FG000|Open-label Treatment Phase|Missing|0|||
44237587|NCT01585961|79063023|FG000|Overall Study|Physician Decision|1|||
44237588|NCT01585961|79063023|FG000|Overall Study|Decision to use non-study catheter|1|||
44237589|NCT01585961|79063023|FG000|Overall Study|Withdrawal by Subject|1|||
44237590|NCT01585961|79063023|FG000|Overall Study|Lost to Follow-up|23|||
44237591|NCT01585961|79063023|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
44237592|NCT01697501|79063027|FG000|Overall Study|Protocol Violation|2|||
44237593|NCT01697345|79063040|FG000|Overall Study|Withdrawal by Subject|1|||
44237594|NCT01697267|79063109|FG000|Overall Study|Death|3|||
44237595|NCT01697267|79063110|FG001|Overall Study|Death|1|||
44237596|NCT01697267|79063109|FG000|Overall Study|Withdrawal by Subject|5|||
44237597|NCT01697267|79063110|FG001|Overall Study|Withdrawal by Subject|5|||
44237598|NCT01697267|79063109|FG000|Overall Study|Adverse Event|2|||
44237599|NCT01697267|79063110|FG001|Overall Study|Adverse Event|1|||
44237600|NCT01697267|79063109|FG000|Overall Study|Lost to Follow-up|2|||
44572197|NCT01952574|79594158|FG001|Open-label Treatment Phase|Missing|0|||
44237601|NCT01697267|79063110|FG001|Overall Study|Lost to Follow-up|4|||
44237602|NCT01697267|79063109|FG000|Overall Study|Physician Decision|2|||
44237603|NCT01697267|79063110|FG001|Overall Study|Physician Decision|4|||
44237604|NCT01696955|79063172|FG000|Main Study|Protocol Violation|1|||
44237605|NCT01696955|79063173|FG001|Main Study|Protocol Violation|0|||
44237606|NCT01696955|79063172|FG000|Main Study|Withdrawal by Subject|1|||
44237607|NCT01696955|79063173|FG001|Main Study|Withdrawal by Subject|1|||
44237608|NCT02702388|79063197|FG000|Overall Study|Disease Progression|18|||
44237609|NCT02702388|79063198|FG001|Overall Study|Disease Progression|25|||
44237610|NCT02702388|79063197|FG000|Overall Study|Withdrawal by Subject|9|||
44237611|NCT02702388|79063198|FG001|Overall Study|Withdrawal by Subject|7|||
44237612|NCT02702388|79063197|FG000|Overall Study|Adverse Event|11|||
44237613|NCT02702388|79063198|FG001|Overall Study|Adverse Event|15|||
44237614|NCT02702388|79063197|FG000|Overall Study|Other|2|||
44237615|NCT02702388|79063198|FG001|Overall Study|Other|4|||
44237616|NCT01696877|79063224|FG000|Overall Study|Adverse Event|0|||
44237617|NCT01696877|79063225|FG001|Overall Study|Adverse Event|1|||
44237618|NCT02703636|79063412|FG000|Overall Study|Adverse Event|14|||
44237619|NCT02703636|79063412|FG000|Overall Study|Study stopped by sponsor|1|||
44572198|NCT01952574|79594159|FG002|Open-label Treatment Phase|Missing|0|||
44572199|NCT01952574|79594160|FG003|Open-label Treatment Phase|Missing|0|||
44572200|NCT01952574|79594161|FG004|Open-label Treatment Phase|Missing|4|||
44572201|NCT01952574|79594162|FG005|Open-label Treatment Phase|Missing|0|||
44572202|NCT01952574|79594163|FG006|Open-label Treatment Phase|Missing|0|||
44572203|NCT01952574|79594157|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
44572204|NCT01952574|79594158|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
44572205|NCT01952574|79594159|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
44572206|NCT01952574|79594160|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
44572207|NCT01952574|79594161|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
44572208|NCT01952574|79594162|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
44572209|NCT01952574|79594163|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
44572210|NCT01952574|79594157|FG000|Open-label Treatment Phase|Death|0|||
44572211|NCT01952574|79594158|FG001|Open-label Treatment Phase|Death|0|||
44572212|NCT01952574|79594159|FG002|Open-label Treatment Phase|Death|0|||
44572213|NCT01952574|79594160|FG003|Open-label Treatment Phase|Death|0|||
44572214|NCT01952574|79594161|FG004|Open-label Treatment Phase|Death|1|||
44572215|NCT01952574|79594162|FG005|Open-label Treatment Phase|Death|0|||
44572216|NCT01952574|79594163|FG006|Open-label Treatment Phase|Death|0|||
44572217|NCT01952574|79594157|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
44572218|NCT01952574|79594158|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
44572219|NCT01952574|79594159|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
44572220|NCT01952574|79594160|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
44572221|NCT01952574|79594161|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
44572222|NCT01952574|79594162|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
44572223|NCT01952574|79594163|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
44572224|NCT01952574|79594157|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
44572225|NCT01952574|79594158|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
44237620|NCT02703636|79063412|FG000|Overall Study|Withdrawal by Subject|1|||
44237621|NCT02703324|79063640|FG000|Period Two|Withdrawal by Subject|0|||
44237622|NCT02703324|79063641|FG001|Period Two|Withdrawal by Subject|0|||
44237623|NCT02703324|79063642|FG002|Period Two|Withdrawal by Subject|1|||
44504905|NCT00337727|79509788|FG001|Overall Study|Lost to Follow-up|4|||
44237624|NCT02703324|79063643|FG003|Period Two|Withdrawal by Subject|0|||
44237625|NCT02703324|79063644|FG004|Period Two|Withdrawal by Subject|0|||
44237626|NCT02703324|79063645|FG005|Period Two|Withdrawal by Subject|0|||
44504906|NCT00337727|79509787|FG000|Overall Study|Physician Decision|1|||
44572226|NCT01952574|79594159|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
44572227|NCT01952574|79594160|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
44572228|NCT01952574|79594161|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
44572229|NCT01952574|79594162|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
44572230|NCT01952574|79594163|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
44572231|NCT02959437|79594192|FG000|Overall Study|Death|33|||
44572232|NCT02959437|79594193|FG001|Overall Study|Death|3|||
44572233|NCT02959437|79594194|FG002|Overall Study|Death|0|||
44572234|NCT02959437|79594195|FG003|Overall Study|Death|0|||
44572235|NCT02959437|79594192|FG000|Overall Study|Lost to Follow-up|3|||
44572236|NCT02959437|79594193|FG001|Overall Study|Lost to Follow-up|1|||
44572237|NCT02959437|79594194|FG002|Overall Study|Lost to Follow-up|0|||
44572238|NCT02959437|79594195|FG003|Overall Study|Lost to Follow-up|0|||
44572239|NCT02959437|79594192|FG000|Overall Study|Withdrawal by Subject|11|||
44572240|NCT02959437|79594193|FG001|Overall Study|Withdrawal by Subject|3|||
44572241|NCT02959437|79594194|FG002|Overall Study|Withdrawal by Subject|0|||
44572242|NCT02959437|79594195|FG003|Overall Study|Withdrawal by Subject|0|||
44572243|NCT02959437|79594192|FG000|Overall Study|Progressive Disease|9|||
44572244|NCT02959437|79594193|FG001|Overall Study|Progressive Disease|1|||
44572245|NCT02959437|79594194|FG002|Overall Study|Progressive Disease|0|||
44572246|NCT02959437|79594195|FG003|Overall Study|Progressive Disease|0|||
44572247|NCT02959437|79594192|FG000|Overall Study|Study Terminated by Sponsor|4|||
44572248|NCT02959437|79594193|FG001|Overall Study|Study Terminated by Sponsor|0|||
44572249|NCT02959437|79594194|FG002|Overall Study|Study Terminated by Sponsor|0|||
44572250|NCT02959437|79594195|FG003|Overall Study|Study Terminated by Sponsor|0|||
44572251|NCT02959437|79594192|FG000|Overall Study|Other Unspecified|2|||
44572252|NCT02959437|79594193|FG001|Overall Study|Other Unspecified|0|||
44572253|NCT02959437|79594194|FG002|Overall Study|Other Unspecified|0|||
44572254|NCT02959437|79594195|FG003|Overall Study|Other Unspecified|0|||
44572255|NCT02957331|79594208|FG000|Overall Study|Protocol Violation|1|||
44237627|NCT02701764|79063656|FG000|Overall Study|Lost to Follow-up|0|||
44237628|NCT02701764|79063657|FG001|Overall Study|Lost to Follow-up|1|||
44572256|NCT02957331|79594209|FG001|Overall Study|Protocol Violation|0|||
44237629|NCT01696643|79063838|FG000|Overall Study|Adverse Event|15|||
44237630|NCT01696643|79063839|FG001|Overall Study|Adverse Event|7|||
44237631|NCT01696643|79063838|FG000|Overall Study|Death|1|||
44572257|NCT05212883|79594215|FG000|Overall Study|Invalid test result|125|||
44572258|NCT04995055|79594223|FG000|Period 1|COVID-19 Related|1|||
44572259|NCT04995055|79594224|FG001|Period 1|COVID-19 Related|0|||
44572260|NCT04995055|79594223|FG000|Period 1|Withdrawal by Subject|0|||
44572261|NCT04995055|79594224|FG001|Period 1|Withdrawal by Subject|1|||
44237632|NCT01696643|79063839|FG001|Overall Study|Death|2|||
44237633|NCT01696643|79063838|FG000|Overall Study|Lack of Efficacy|3|||
44572262|NCT04995055|79594223|FG000|Period 1|Subject discontinued due to timing|4|||
44237634|NCT01696643|79063839|FG001|Overall Study|Lack of Efficacy|0|||
44237635|NCT01696643|79063838|FG000|Overall Study|Lost to Follow-up|67|||
44237636|NCT01696643|79063839|FG001|Overall Study|Lost to Follow-up|67|||
44237637|NCT01696643|79063838|FG000|Overall Study|Physician Decision|3|||
44237638|NCT01696643|79063839|FG001|Overall Study|Physician Decision|2|||
44237639|NCT01696643|79063838|FG000|Overall Study|Pregnancy|0|||
44237640|NCT01696643|79063839|FG001|Overall Study|Pregnancy|1|||
44237641|NCT01696643|79063838|FG000|Overall Study|Protocol Violation|7|||
44237642|NCT01696643|79063839|FG001|Overall Study|Protocol Violation|7|||
44237643|NCT01696643|79063838|FG000|Overall Study|Study Terminated by Sponsor|286|||
44237644|NCT01696643|79063839|FG001|Overall Study|Study Terminated by Sponsor|294|||
44237645|NCT01696643|79063838|FG000|Overall Study|Withdrawal by Subject|142|||
44237646|NCT01696643|79063839|FG001|Overall Study|Withdrawal by Subject|149|||
44237647|NCT01696643|79063838|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
44237648|NCT01696643|79063839|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
44504907|NCT00337727|79509788|FG001|Overall Study|Physician Decision|0|||
44504908|NCT00337727|79509787|FG000|Overall Study|Protocol Violation|4|||
44504909|NCT00337727|79509788|FG001|Overall Study|Protocol Violation|0|||
44504910|NCT00337727|79509787|FG000|Overall Study|Withdrawal by Subject|3|||
44504911|NCT00337727|79509788|FG001|Overall Study|Withdrawal by Subject|5|||
44504912|NCT00324233|79509796|FG000|First Period|unable to insert catheter|1|||
44504913|NCT00324233|79509797|FG001|First Period|unable to insert catheter|0|||
44504914|NCT00324233|79509796|FG000|Second Period|unable to insert catheter|1|||
44504915|NCT00324233|79509797|FG001|Second Period|unable to insert catheter|1|||
44504916|NCT00324233|79509796|FG000|Second Period|Protocol Violation|4|||
44504917|NCT00324233|79509797|FG001|Second Period|Protocol Violation|6|||
44504918|NCT03335566|79509805|FG000|Overall Study|Adverse Event|0|||
44504919|NCT03335566|79509806|FG001|Overall Study|Adverse Event|1|||
44504920|NCT03335566|79509805|FG000|Overall Study|Lost to Follow-up|1|||
44504921|NCT03335566|79509806|FG001|Overall Study|Lost to Follow-up|0|||
44504922|NCT03335566|79509805|FG000|Overall Study|Technical Problems|1|||
44504923|NCT03335566|79509806|FG001|Overall Study|Technical Problems|0|||
44504924|NCT03335566|79509805|FG000|Overall Study|Protocol Violation|1|||
44504925|NCT03335566|79509806|FG001|Overall Study|Protocol Violation|0|||
44504926|NCT03335566|79509805|FG000|Overall Study|Other than specified above|1|||
44504927|NCT03335566|79509806|FG001|Overall Study|Other than specified above|2|||
44504928|NCT03369418|79509814|FG000|Overall Study|Withdrawal by Subject|3|||
44504929|NCT03369418|79509815|FG001|Overall Study|Withdrawal by Subject|3|||
44504930|NCT03334630|79509823|FG000|Overall Study|Withdrawal by Subject|7|||
44504931|NCT03334630|79509824|FG001|Overall Study|Withdrawal by Subject|7|||
44504932|NCT03334630|79509823|FG000|Overall Study|Lost to Follow-up|3|||
44504933|NCT03334630|79509824|FG001|Overall Study|Lost to Follow-up|1|||
44504934|NCT03334630|79509823|FG000|Overall Study|Adverse Event|0|||
44504935|NCT03334630|79509824|FG001|Overall Study|Adverse Event|1|||
44504936|NCT03334630|79509823|FG000|Overall Study|Physician Decision|1|||
44504937|NCT03334630|79509824|FG001|Overall Study|Physician Decision|1|||
44504938|NCT03334630|79509823|FG000|Overall Study|Enrollment closed|2|||
44504939|NCT03334630|79509824|FG001|Overall Study|Enrollment closed|1|||
44504940|NCT03334630|79509823|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
44504941|NCT03334630|79509824|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
44504942|NCT03334630|79509823|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
44504943|NCT03334630|79509824|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
44504944|NCT03368170|79509832|FG000|Overall Study|Adverse Event|2|||
44504945|NCT03368170|79509833|FG001|Overall Study|Adverse Event|1|||
44504946|NCT00324155|79509841|FG000|Enrolled and Randomized|No longer met study criteria|3|||
44504947|NCT00324155|79509842|FG001|Enrolled and Randomized|No longer met study criteria|0|||
44504948|NCT00324155|79509841|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
44504949|NCT00324155|79509842|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
44504950|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
44572263|NCT04995055|79594224|FG001|Period 1|Subject discontinued due to timing|4|||
44572264|NCT04785144|79594240|FG000|Overall Study|Withdrawal by Subject|4|||
44572265|NCT04785144|79594241|FG001|Overall Study|Withdrawal by Subject|1|||
44237649|NCT01696643|79063838|FG000|Overall Study|Site Error|2|||
44237650|NCT01696643|79063839|FG001|Overall Study|Site Error|1|||
44504951|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
44504952|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
44504953|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
44504954|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Death|8|||
44504955|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Death|15|||
44504956|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
44504957|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
44237651|NCT01696643|79063838|FG000|Overall Study|Participant Incarcerated|0|||
44237652|NCT01696643|79063839|FG001|Overall Study|Participant Incarcerated|1|||
44237653|NCT01696643|79063838|FG000|Overall Study|Medical Monitor Decision|0|||
44237654|NCT01696643|79063839|FG001|Overall Study|Medical Monitor Decision|2|||
44572266|NCT04785144|79594242|FG002|Overall Study|Withdrawal by Subject|0|||
44377820|NCT01077518|79383128|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
44377821|NCT01077518|79383126|FG000|Optional Ofa Phase|Physician Decision|0|||
44377822|NCT01077518|79383127|FG001|Optional Ofa Phase|Physician Decision|0|||
44377823|NCT01077518|79383128|FG002|Optional Ofa Phase|Physician Decision|1|||
44504958|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
44504959|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
44504960|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
44504961|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
44504962|NCT00324155|79509841|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
44504963|NCT00324155|79509842|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
44504964|NCT00324155|79509841|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
44572267|NCT04785144|79594243|FG003|Overall Study|Withdrawal by Subject|0|||
44572268|NCT04785144|79594244|FG004|Overall Study|Withdrawal by Subject|0|||
44572269|NCT04785144|79594245|FG005|Overall Study|Withdrawal by Subject|2|||
44572270|NCT04785144|79594246|FG006|Overall Study|Withdrawal by Subject|2|||
44572271|NCT04785144|79594247|FG007|Overall Study|Withdrawal by Subject|0|||
44572272|NCT04785144|79594248|FG008|Overall Study|Withdrawal by Subject|1|||
44572273|NCT04785144|79594249|FG009|Overall Study|Withdrawal by Subject|0|||
44572274|NCT04785144|79594240|FG000|Overall Study|Lost to Follow-up|1|||
44572275|NCT04785144|79594241|FG001|Overall Study|Lost to Follow-up|0|||
44572276|NCT04785144|79594242|FG002|Overall Study|Lost to Follow-up|0|||
44572277|NCT04785144|79594243|FG003|Overall Study|Lost to Follow-up|0|||
44572278|NCT04785144|79594244|FG004|Overall Study|Lost to Follow-up|1|||
44572279|NCT04785144|79594245|FG005|Overall Study|Lost to Follow-up|2|||
44572280|NCT04785144|79594246|FG006|Overall Study|Lost to Follow-up|1|||
44572281|NCT04785144|79594247|FG007|Overall Study|Lost to Follow-up|2|||
44572282|NCT04785144|79594248|FG008|Overall Study|Lost to Follow-up|4|||
44572283|NCT04785144|79594249|FG009|Overall Study|Lost to Follow-up|1|||
44572284|NCT04785144|79594240|FG000|Overall Study|Protocol Violation|0|||
44572285|NCT04785144|79594241|FG001|Overall Study|Protocol Violation|0|||
44572286|NCT04785144|79594242|FG002|Overall Study|Protocol Violation|0|||
44572287|NCT04785144|79594243|FG003|Overall Study|Protocol Violation|0|||
44572288|NCT04785144|79594244|FG004|Overall Study|Protocol Violation|0|||
44572289|NCT04785144|79594245|FG005|Overall Study|Protocol Violation|0|||
44572290|NCT04785144|79594246|FG006|Overall Study|Protocol Violation|1|||
44572291|NCT04785144|79594247|FG007|Overall Study|Protocol Violation|0|||
44572292|NCT04785144|79594248|FG008|Overall Study|Protocol Violation|0|||
44572293|NCT04785144|79594249|FG009|Overall Study|Protocol Violation|0|||
44572294|NCT04785144|79594240|FG000|Overall Study|Physician Decision|0|||
44572295|NCT04785144|79594241|FG001|Overall Study|Physician Decision|0|||
44572296|NCT04785144|79594242|FG002|Overall Study|Physician Decision|0|||
44572297|NCT04785144|79594243|FG003|Overall Study|Physician Decision|0|||
44572298|NCT04785144|79594244|FG004|Overall Study|Physician Decision|0|||
44572299|NCT04785144|79594245|FG005|Overall Study|Physician Decision|0|||
44572300|NCT04785144|79594246|FG006|Overall Study|Physician Decision|0|||
44572301|NCT04785144|79594247|FG007|Overall Study|Physician Decision|0|||
44237655|NCT01696643|79063838|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
44237656|NCT01696643|79063839|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
44237657|NCT01695317|79063851|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
44237658|NCT01695317|79063852|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
44572302|NCT04785144|79594248|FG008|Overall Study|Physician Decision|0|||
44237659|NCT01695317|79063851|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
44237660|NCT01695317|79063852|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
44237661|NCT02701296|79063908|FG000|Overall Study|Incomplete Data|0|||
44237662|NCT02701296|79063909|FG001|Overall Study|Incomplete Data|2|||
44237663|NCT01582451|79063926|FG000|Overall Study|Adverse Event|1|||
44504965|NCT00324155|79509842|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
44504966|NCT00324155|79509841|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
44572303|NCT04785144|79594249|FG009|Overall Study|Physician Decision|1|||
44572304|NCT04785144|79594240|FG000|Overall Study|Unable to continue due to work schedule|0|||
44572305|NCT04785144|79594241|FG001|Overall Study|Unable to continue due to work schedule|0|||
44237664|NCT01582451|79063927|FG001|Overall Study|Adverse Event|3|||
44237665|NCT01582451|79063926|FG000|Overall Study|Death|3|||
44572306|NCT04785144|79594242|FG002|Overall Study|Unable to continue due to work schedule|0|||
44572307|NCT04785144|79594243|FG003|Overall Study|Unable to continue due to work schedule|0|||
44572308|NCT04785144|79594244|FG004|Overall Study|Unable to continue due to work schedule|0|||
44237666|NCT01582451|79063927|FG001|Overall Study|Death|3|||
44377824|NCT01077518|79383126|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
44572309|NCT04785144|79594245|FG005|Overall Study|Unable to continue due to work schedule|0|||
44572310|NCT04785144|79594246|FG006|Overall Study|Unable to continue due to work schedule|0|||
44572311|NCT04785144|79594247|FG007|Overall Study|Unable to continue due to work schedule|0|||
44572312|NCT04785144|79594248|FG008|Overall Study|Unable to continue due to work schedule|0|||
44572313|NCT04785144|79594249|FG009|Overall Study|Unable to continue due to work schedule|1|||
44377825|NCT01077518|79383127|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
44504967|NCT00324155|79509842|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
44504968|NCT00324155|79509841|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
44504969|NCT00324155|79509842|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
44504970|NCT00324155|79509841|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
44504971|NCT00324155|79509842|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
44504972|NCT00324155|79509841|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
44504973|NCT00324155|79509842|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
44504974|NCT00324155|79509841|FG000|Follow-up Phase|On-going participants still on drug|11|||
44572314|NCT04743635|79594292|FG000|Overall Study|Lost to Follow-up|2|||
44572315|NCT04743635|79594293|FG001|Overall Study|Lost to Follow-up|0|||
44572316|NCT04712110|79594300|FG000|Overall Study|Lost to Follow-up|0|||
44572317|NCT04712110|79594301|FG001|Overall Study|Lost to Follow-up|1|||
44572318|NCT04712110|79594300|FG000|Overall Study|Withdrawal by Subject|0|||
44572319|NCT04712110|79594301|FG001|Overall Study|Withdrawal by Subject|4|||
44572320|NCT04712110|79594300|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
44572321|NCT04712110|79594301|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
44572322|NCT03877510|79594311|FG000|Overall Study|Death|6|||
44572323|NCT03877510|79594311|FG000|Overall Study|Lost to Follow-up|2|||
44572324|NCT03877510|79594311|FG000|Overall Study|Non-compliance with study drug|2|||
44572325|NCT03877510|79594311|FG000|Overall Study|Lack of Efficacy|14|||
44572326|NCT03877510|79594311|FG000|Overall Study|Adverse Event|20|||
44572327|NCT03877510|79594311|FG000|Overall Study|Withdrawal by Subject|22|||
44572328|NCT03877510|79594311|FG000|Overall Study|Miscellaneous|1|||
44572329|NCT03846427|79594315|FG000|Overall Study|Death|13|||
44572330|NCT03846427|79594315|FG000|Overall Study|Withdrawal by Subject|3|||
44572331|NCT03846427|79594315|FG000|Overall Study|Physician Decision|1|||
44572332|NCT03706079|79594344|FG000|Predecessor Study|Death|0|||
44572333|NCT03706079|79594345|FG001|Predecessor Study|Death|2|||
44572334|NCT03706079|79594346|FG002|Predecessor Study|Death|0|||
44572335|NCT03706079|79594347|FG003|Predecessor Study|Death|1|||
44572336|NCT03706079|79594348|FG004|Predecessor Study|Death|0|||
44572337|NCT03706079|79594349|FG005|Predecessor Study|Death|0|||
44572338|NCT03706079|79594344|FG000|Predecessor Study|Lost to Follow-up|5|||
44572339|NCT03706079|79594345|FG001|Predecessor Study|Lost to Follow-up|2|||
44572340|NCT03706079|79594346|FG002|Predecessor Study|Lost to Follow-up|0|||
44572341|NCT03706079|79594347|FG003|Predecessor Study|Lost to Follow-up|0|||
44572342|NCT03706079|79594348|FG004|Predecessor Study|Lost to Follow-up|1|||
44572343|NCT03706079|79594349|FG005|Predecessor Study|Lost to Follow-up|0|||
44572344|NCT03706079|79594344|FG000|Predecessor Study|Withdrawal by Subject|8|||
44572345|NCT03706079|79594345|FG001|Predecessor Study|Withdrawal by Subject|15|||
44572346|NCT03706079|79594346|FG002|Predecessor Study|Withdrawal by Subject|0|||
44572347|NCT03706079|79594347|FG003|Predecessor Study|Withdrawal by Subject|5|||
44572348|NCT03706079|79594348|FG004|Predecessor Study|Withdrawal by Subject|2|||
44572349|NCT03706079|79594349|FG005|Predecessor Study|Withdrawal by Subject|0|||
44572350|NCT03706079|79594344|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
44572351|NCT03706079|79594345|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
44572352|NCT03706079|79594346|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
44572353|NCT03706079|79594347|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
44572354|NCT03706079|79594348|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
44572355|NCT03706079|79594349|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
44572356|NCT03706079|79594344|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
44572357|NCT03706079|79594345|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
44237667|NCT01582451|79063926|FG000|Overall Study|Lost to Follow-up|0|||
44237668|NCT01582451|79063927|FG001|Overall Study|Lost to Follow-up|2|||
44237669|NCT01582451|79063926|FG000|Overall Study|Protocol Violation|11|||
44237670|NCT01582451|79063927|FG001|Overall Study|Protocol Violation|3|||
44237671|NCT01582451|79063926|FG000|Overall Study|Withdrawal by Subject|13|||
44237672|NCT01582451|79063927|FG001|Overall Study|Withdrawal by Subject|9|||
44237673|NCT01582451|79063926|FG000|Overall Study|Physician Decision|3|||
44237674|NCT01582451|79063927|FG001|Overall Study|Physician Decision|0|||
44237675|NCT01582451|79063926|FG000|Overall Study|Sponsor Decision|1|||
44572358|NCT03706079|79594346|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
44237676|NCT01582451|79063927|FG001|Overall Study|Sponsor Decision|0|||
44237677|NCT02700984|79064011|FG000|Overall Study|Death|2|||
44237678|NCT02700984|79064012|FG001|Overall Study|Death|1|||
44572359|NCT03706079|79594347|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
44572360|NCT03706079|79594348|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
44572361|NCT03706079|79594349|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
44572362|NCT03706079|79594344|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
44572363|NCT03706079|79594345|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
44572364|NCT03706079|79594346|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
44572365|NCT03706079|79594347|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
44572366|NCT03706079|79594348|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
44572367|NCT03706079|79594349|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
44572368|NCT03706079|79594344|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
44572369|NCT03706079|79594345|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
44572370|NCT03706079|79594346|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
44572371|NCT03706079|79594347|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
44572372|NCT03706079|79594348|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
44572373|NCT03706079|79594349|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
44572374|NCT03706079|79594344|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
44572375|NCT03706079|79594345|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
44572376|NCT03706079|79594346|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
44572377|NCT03706079|79594347|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
44572378|NCT03706079|79594348|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
44572379|NCT03706079|79594349|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
44572380|NCT03706079|79594344|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
44572381|NCT03706079|79594345|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
44572382|NCT03706079|79594346|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
44572383|NCT03706079|79594347|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
44572384|NCT03706079|79594348|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
44572385|NCT03706079|79594349|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
44572386|NCT03706079|79594344|FG000|Long Term Extension (DESTINATION)|Death|8|||
44572387|NCT03706079|79594345|FG001|Long Term Extension (DESTINATION)|Death|2|||
44572388|NCT03706079|79594346|FG002|Long Term Extension (DESTINATION)|Death|2|||
44572389|NCT03706079|79594347|FG003|Long Term Extension (DESTINATION)|Death|1|||
44572390|NCT03706079|79594348|FG004|Long Term Extension (DESTINATION)|Death|0|||
44572391|NCT03706079|79594349|FG005|Long Term Extension (DESTINATION)|Death|0|||
44572392|NCT03657160|79594363|FG000|Overall Study|Adverse Event|5|||
44572393|NCT03657160|79594364|FG001|Overall Study|Adverse Event|6|||
44572394|NCT03657160|79594363|FG000|Overall Study|Protocol Deviation|3|||
44572395|NCT03657160|79594364|FG001|Overall Study|Protocol Deviation|0|||
44572396|NCT03657160|79594363|FG000|Overall Study|Withdrawal by Subject|18|||
44572397|NCT03657160|79594364|FG001|Overall Study|Withdrawal by Subject|16|||
44572398|NCT03657160|79594363|FG000|Overall Study|Site Termination|1|||
44572399|NCT03657160|79594364|FG001|Overall Study|Site Termination|0|||
44572400|NCT03657160|79594363|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
44572401|NCT03657160|79594364|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
44572402|NCT03657160|79594363|FG000|Overall Study|Death|33|||
44572403|NCT03657160|79594364|FG001|Overall Study|Death|26|||
44572404|NCT03657160|79594363|FG000|Overall Study|Death (COVID-19-Related)|1|||
44572405|NCT03657160|79594364|FG001|Overall Study|Death (COVID-19-Related)|0|||
44504975|NCT00324155|79509842|FG001|Follow-up Phase|On-going participants still on drug|6|||
44504976|NCT03334396|79509869|FG000|Overall Study|Adverse Event|1|||
44504977|NCT03334396|79509870|FG001|Overall Study|Adverse Event|0|||
44504978|NCT03334396|79509871|FG002|Overall Study|Adverse Event|1|||
44504979|NCT03334396|79509872|FG003|Overall Study|Adverse Event|0|||
44504980|NCT03334396|79509873|FG004|Overall Study|Adverse Event|0|||
44504981|NCT03334396|79509874|FG005|Overall Study|Adverse Event|0|||
44504982|NCT03334396|79509875|FG006|Overall Study|Adverse Event|0|||
44504983|NCT03334396|79509876|FG007|Overall Study|Adverse Event|0|||
44504984|NCT03334396|79509869|FG000|Overall Study|Lack of Efficacy|10|||
44504985|NCT03334396|79509870|FG001|Overall Study|Lack of Efficacy|4|||
44504986|NCT03334396|79509871|FG002|Overall Study|Lack of Efficacy|1|||
44504987|NCT03334396|79509872|FG003|Overall Study|Lack of Efficacy|3|||
44504988|NCT03334396|79509873|FG004|Overall Study|Lack of Efficacy|1|||
44572406|NCT03657160|79594363|FG000|Overall Study|Reason Not Specified|5|||
44572407|NCT03657160|79594364|FG001|Overall Study|Reason Not Specified|5|||
44572408|NCT03657160|79594363|FG000|Overall Study|Other (COVID-19-Related)|0|||
44572409|NCT03657160|79594364|FG001|Overall Study|Other (COVID-19-Related)|1|||
44572410|NCT03635320|79594374|FG000|Overall Study|not implanted the device|1|||
44572411|NCT03635320|79594375|FG001|Overall Study|not implanted the device|2|||
44572412|NCT03635320|79594374|FG000|Overall Study|Withdrawal by Subject|11|||
44504989|NCT03334396|79509874|FG005|Overall Study|Lack of Efficacy|0|||
44572413|NCT03635320|79594375|FG001|Overall Study|Withdrawal by Subject|6|||
44572414|NCT03508726|79594392|FG000|Overall Study|Withdrawal by Subject|0|||
44572415|NCT03508726|79594393|FG001|Overall Study|Withdrawal by Subject|1|||
44572416|NCT03499964|79594402|FG000|Overall Study|Lack of Efficacy|6|||
44572417|NCT03499964|79594403|FG001|Overall Study|Lack of Efficacy|26|||
44572418|NCT03499964|79594402|FG000|Overall Study|Adverse Event|1|||
44572419|NCT03499964|79594403|FG001|Overall Study|Adverse Event|0|||
44572420|NCT03499964|79594402|FG000|Overall Study|Death|1|||
44572421|NCT03499964|79594403|FG001|Overall Study|Death|0|||
44572422|NCT03499964|79594402|FG000|Overall Study|Withdrawal by Subject|2|||
44572423|NCT03499964|79594403|FG001|Overall Study|Withdrawal by Subject|1|||
44572424|NCT03499964|79594402|FG000|Overall Study|Lost to Follow-up|1|||
44572425|NCT03499964|79594403|FG001|Overall Study|Lost to Follow-up|0|||
44572426|NCT03279692|79594409|FG000|Overall Study|Withdrawal by Subject|1|||
44572427|NCT03001882|79594426|FG000|Overall Study|Death|1|||
44572428|NCT03001882|79594427|FG001|Overall Study|Death|0|||
44572429|NCT03001882|79594428|FG002|Overall Study|Death|0|||
44237679|NCT02700984|79064011|FG000|Overall Study|Lost to Follow-up|2|||
44237680|NCT02700984|79064012|FG001|Overall Study|Lost to Follow-up|1|||
44237681|NCT02700984|79064011|FG000|Overall Study|Physician Decision|0|||
44237682|NCT02700984|79064012|FG001|Overall Study|Physician Decision|1|||
44237683|NCT02700984|79064011|FG000|Overall Study|Withdrawal by Subject|8|||
44237684|NCT02700984|79064012|FG001|Overall Study|Withdrawal by Subject|9|||
44237685|NCT02700984|79064011|FG000|Overall Study|Reason not specified|3|||
44237686|NCT02700984|79064012|FG001|Overall Study|Reason not specified|2|||
44237687|NCT02696850|79064086|FG000|Overall Study|Withdrawal by Subject|3|||
44237688|NCT02696850|79064087|FG001|Overall Study|Withdrawal by Subject|3|||
44237689|NCT02696850|79064086|FG000|Overall Study|Lost to Follow-up|8|||
44237690|NCT02696850|79064087|FG001|Overall Study|Lost to Follow-up|5|||
44237691|NCT02698410|79064241|FG000|Overall Study|Adverse Event|2|||
44237692|NCT02698410|79064241|FG000|Overall Study|Withdrawal by Subject|1|||
44237693|NCT02698410|79064241|FG000|Overall Study|Other|1|||
44237694|NCT02699892|79064245|FG000|Overall Study|Other|36|||
44237695|NCT02698176|79064252|FG000|Overall Study|Progressive disease|4|||
44237696|NCT02698176|79064253|FG001|Overall Study|Progressive disease|3|||
44237697|NCT02698176|79064254|FG002|Overall Study|Progressive disease|1|||
44237698|NCT02698176|79064255|FG003|Overall Study|Progressive disease|0|||
44237699|NCT02698176|79064252|FG000|Overall Study|Adverse Event|2|||
44237700|NCT02698176|79064253|FG001|Overall Study|Adverse Event|0|||
44237701|NCT02698176|79064254|FG002|Overall Study|Adverse Event|0|||
44237702|NCT02698176|79064255|FG003|Overall Study|Adverse Event|0|||
44237703|NCT02698176|79064252|FG000|Overall Study|Clinical progression|3|||
44237704|NCT02698176|79064253|FG001|Overall Study|Clinical progression|0|||
44237705|NCT02698176|79064254|FG002|Overall Study|Clinical progression|0|||
44237706|NCT02698176|79064255|FG003|Overall Study|Clinical progression|0|||
44237707|NCT02693418|79064271|FG000|Overall Study|Lost to Follow-up|1|||
44237708|NCT02693418|79064272|FG001|Overall Study|Lost to Follow-up|2|||
44237709|NCT02693418|79064273|FG002|Overall Study|Lost to Follow-up|0|||
44237710|NCT02693418|79064274|FG003|Overall Study|Lost to Follow-up|0|||
44237711|NCT02693418|79064275|FG004|Overall Study|Lost to Follow-up|0|||
44237712|NCT02693418|79064271|FG000|Overall Study|Menses during study period|0|||
44237713|NCT02693418|79064272|FG001|Overall Study|Menses during study period|0|||
44237714|NCT02693418|79064273|FG002|Overall Study|Menses during study period|2|||
44237715|NCT02693418|79064274|FG003|Overall Study|Menses during study period|0|||
44377826|NCT01077518|79383128|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
44377827|NCT01077518|79383126|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
44377828|NCT01077518|79383127|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
44377829|NCT01077518|79383128|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
44377830|NCT00835120|79383137|FG000|Overall Study|Lack of Efficacy|1|||
44377831|NCT00835120|79383137|FG000|Overall Study|Lost to Follow-up|3|||
44237716|NCT02693418|79064275|FG004|Overall Study|Menses during study period|0|||
44237717|NCT02693106|79064308|FG000|Overall Study|No time|3|||
44237718|NCT02546986|79064320|FG000|Treatment Period|Progressive Disease|20|||
44237719|NCT02546986|79064321|FG001|Treatment Period|Progressive Disease|22|||
44237720|NCT02546986|79064320|FG000|Treatment Period|Adverse Event|14|||
44504990|NCT03334396|79509875|FG006|Overall Study|Lack of Efficacy|0|||
44504991|NCT03334396|79509876|FG007|Overall Study|Lack of Efficacy|1|||
44504992|NCT03334396|79509869|FG000|Overall Study|Lost to Follow-up|0|||
44504993|NCT03334396|79509870|FG001|Overall Study|Lost to Follow-up|0|||
44504994|NCT03334396|79509871|FG002|Overall Study|Lost to Follow-up|1|||
44504995|NCT03334396|79509872|FG003|Overall Study|Lost to Follow-up|0|||
44504996|NCT03334396|79509873|FG004|Overall Study|Lost to Follow-up|0|||
44504997|NCT03334396|79509874|FG005|Overall Study|Lost to Follow-up|0|||
44504998|NCT03334396|79509875|FG006|Overall Study|Lost to Follow-up|1|||
44504999|NCT03334396|79509876|FG007|Overall Study|Lost to Follow-up|0|||
44505000|NCT03334396|79509869|FG000|Overall Study|Physician Decision|1|||
44505001|NCT03334396|79509870|FG001|Overall Study|Physician Decision|0|||
44505002|NCT03334396|79509871|FG002|Overall Study|Physician Decision|0|||
44505003|NCT03334396|79509872|FG003|Overall Study|Physician Decision|0|||
44505004|NCT03334396|79509873|FG004|Overall Study|Physician Decision|0|||
44572430|NCT03001882|79594429|FG003|Overall Study|Death|3|||
44377832|NCT00835120|79383137|FG000|Overall Study|Adverse Event|2|||
44572431|NCT03001882|79594426|FG000|Overall Study|Participant withdrew consent|0|||
44572432|NCT03001882|79594427|FG001|Overall Study|Participant withdrew consent|1|||
44143824|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
44237721|NCT02546986|79064321|FG001|Treatment Period|Adverse Event|6|||
44237722|NCT02546986|79064320|FG000|Treatment Period|Symptomatic Deterioration|4|||
44377833|NCT00835120|79383137|FG000|Overall Study|Withdrawal by Subject|2|||
44377834|NCT00914316|79383145|FG000|Phase 1|Physician Decision|4|||
44377835|NCT00914316|79383146|FG001|Phase 1|Physician Decision|0|||
44377836|NCT00914316|79383147|FG002|Phase 1|Physician Decision|1|||
44377837|NCT00914316|79383148|FG003|Phase 1|Physician Decision|2|||
44377838|NCT00914316|79383145|FG000|Phase 1|Withdrawal by Subject|0|||
44377839|NCT00914316|79383146|FG001|Phase 1|Withdrawal by Subject|2|||
44377840|NCT00914316|79383147|FG002|Phase 1|Withdrawal by Subject|4|||
44377841|NCT00914316|79383148|FG003|Phase 1|Withdrawal by Subject|0|||
44377842|NCT00914316|79383145|FG000|Phase 1|Adverse Event|1|||
44377843|NCT00914316|79383146|FG001|Phase 1|Adverse Event|0|||
44505005|NCT03334396|79509874|FG005|Overall Study|Physician Decision|0|||
44505006|NCT03334396|79509875|FG006|Overall Study|Physician Decision|0|||
44505007|NCT03334396|79509876|FG007|Overall Study|Physician Decision|0|||
44505008|NCT03334396|79509869|FG000|Overall Study|Withdrawal by Subject|10|||
44505009|NCT03334396|79509870|FG001|Overall Study|Withdrawal by Subject|5|||
44505010|NCT03334396|79509871|FG002|Overall Study|Withdrawal by Subject|7|||
44505011|NCT03334396|79509872|FG003|Overall Study|Withdrawal by Subject|2|||
44572433|NCT03001882|79594428|FG002|Overall Study|Participant withdrew consent|0|||
44572434|NCT03001882|79594429|FG003|Overall Study|Participant withdrew consent|5|||
44505012|NCT03334396|79509873|FG004|Overall Study|Withdrawal by Subject|2|||
44505013|NCT03334396|79509874|FG005|Overall Study|Withdrawal by Subject|1|||
44505014|NCT03334396|79509875|FG006|Overall Study|Withdrawal by Subject|2|||
44505015|NCT03334396|79509876|FG007|Overall Study|Withdrawal by Subject|0|||
44505016|NCT03334396|79509869|FG000|Overall Study|Pregnancy|0|||
44505017|NCT03334396|79509870|FG001|Overall Study|Pregnancy|1|||
44505018|NCT03334396|79509871|FG002|Overall Study|Pregnancy|0|||
44505019|NCT03334396|79509872|FG003|Overall Study|Pregnancy|0|||
44572435|NCT03001882|79594426|FG000|Overall Study|Other reasons|1|||
44572436|NCT03001882|79594427|FG001|Overall Study|Other reasons|2|||
44572437|NCT03001882|79594428|FG002|Overall Study|Other reasons|0|||
44572438|NCT03001882|79594429|FG003|Overall Study|Other reasons|5|||
44572439|NCT03001882|79594426|FG000|Overall Study|Administrative reason by sponsor|0|||
44572440|NCT03001882|79594427|FG001|Overall Study|Administrative reason by sponsor|0|||
44572441|NCT03001882|79594428|FG002|Overall Study|Administrative reason by sponsor|0|||
44572442|NCT03001882|79594429|FG003|Overall Study|Administrative reason by sponsor|1|||
44572443|NCT03001882|79594426|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
44572444|NCT03001882|79594427|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
44572445|NCT03001882|79594428|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
44572446|NCT03001882|79594429|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
44572447|NCT03001882|79594426|FG000|Overall Study|Not reported|0|||
44572448|NCT03001882|79594427|FG001|Overall Study|Not reported|0|||
44572449|NCT03001882|79594428|FG002|Overall Study|Not reported|0|||
44572450|NCT03001882|79594429|FG003|Overall Study|Not reported|6|||
44572451|NCT03001882|79594426|FG000|Overall Study|Maximum clinical benefit|1|||
44572452|NCT03001882|79594427|FG001|Overall Study|Maximum clinical benefit|2|||
44572453|NCT03001882|79594428|FG002|Overall Study|Maximum clinical benefit|0|||
44572454|NCT03001882|79594429|FG003|Overall Study|Maximum clinical benefit|10|||
44572455|NCT03001882|79594426|FG000|Overall Study|AE unrelated to study drug|3|||
44572456|NCT03001882|79594427|FG001|Overall Study|AE unrelated to study drug|3|||
44572457|NCT03001882|79594428|FG002|Overall Study|AE unrelated to study drug|0|||
44572458|NCT03001882|79594429|FG003|Overall Study|AE unrelated to study drug|11|||
44237723|NCT02546986|79064321|FG001|Treatment Period|Symptomatic Deterioration|3|||
44377844|NCT00914316|79383147|FG002|Phase 1|Adverse Event|0|||
44377845|NCT00914316|79383148|FG003|Phase 1|Adverse Event|0|||
44377846|NCT00914316|79383145|FG000|Phase 2|Withdrawal by Subject|1|||
44572459|NCT03001882|79594426|FG000|Overall Study|Study Drug Toxicity|8|||
44572460|NCT03001882|79594427|FG001|Overall Study|Study Drug Toxicity|5|||
44377847|NCT00914316|79383146|FG001|Phase 2|Withdrawal by Subject|0|||
44377848|NCT00914316|79383147|FG002|Phase 2|Withdrawal by Subject|1|||
44377849|NCT00914316|79383148|FG003|Phase 2|Withdrawal by Subject|0|||
44377850|NCT00827632|79383160|FG000|Overall Study|Lost to Follow-up|8|||
44572461|NCT03001882|79594428|FG002|Overall Study|Study Drug Toxicity|0|||
44572462|NCT03001882|79594429|FG003|Overall Study|Study Drug Toxicity|37|||
44572463|NCT03001882|79594426|FG000|Overall Study|Disease progression|15|||
44572464|NCT03001882|79594427|FG001|Overall Study|Disease progression|14|||
44572465|NCT03001882|79594428|FG002|Overall Study|Disease progression|2|||
44572466|NCT03001882|79594429|FG003|Overall Study|Disease progression|90|||
44572467|NCT02985151|79594446|FG000|Original Randomization|Withdrawal by Subject|0|||
44572468|NCT02985151|79594447|FG001|Original Randomization|Withdrawal by Subject|1|||
44572469|NCT02603432|79594519|FG000|Overall Study|Ongoing|184|||
44572470|NCT02603432|79594520|FG001|Overall Study|Ongoing|144|||
44572471|NCT02603432|79594519|FG000|Overall Study|Adverse Event|1|||
44572472|NCT02603432|79594520|FG001|Overall Study|Adverse Event|0|||
44572473|NCT02603432|79594519|FG000|Overall Study|Death|144|||
44505020|NCT03334396|79509873|FG004|Overall Study|Pregnancy|0|||
44505021|NCT03334396|79509874|FG005|Overall Study|Pregnancy|0|||
44505022|NCT03334396|79509875|FG006|Overall Study|Pregnancy|0|||
44505023|NCT03334396|79509876|FG007|Overall Study|Pregnancy|0|||
44505024|NCT03334396|79509869|FG000|Overall Study|Ineligible|0|||
44505025|NCT03334396|79509870|FG001|Overall Study|Ineligible|1|||
44505026|NCT03334396|79509871|FG002|Overall Study|Ineligible|0|||
44505027|NCT03334396|79509872|FG003|Overall Study|Ineligible|0|||
44505028|NCT03334396|79509873|FG004|Overall Study|Ineligible|0|||
44505029|NCT03334396|79509874|FG005|Overall Study|Ineligible|0|||
44505030|NCT03334396|79509875|FG006|Overall Study|Ineligible|0|||
44505031|NCT03334396|79509876|FG007|Overall Study|Ineligible|0|||
44505032|NCT03334396|79509869|FG000|Overall Study|Started New Job|1|||
44505033|NCT03334396|79509870|FG001|Overall Study|Started New Job|0|||
44505034|NCT03334396|79509871|FG002|Overall Study|Started New Job|0|||
44505035|NCT03334396|79509872|FG003|Overall Study|Started New Job|0|||
44505036|NCT03334396|79509873|FG004|Overall Study|Started New Job|0|||
44505037|NCT03334396|79509874|FG005|Overall Study|Started New Job|0|||
44505038|NCT03334396|79509875|FG006|Overall Study|Started New Job|0|||
44237724|NCT02546986|79064320|FG000|Treatment Period|Death|3|||
44505039|NCT03334396|79509876|FG007|Overall Study|Started New Job|0|||
44505040|NCT03338998|79509895|FG000|Treatment Period|Withdrawal by Subject|1|||
44505041|NCT03338998|79509896|FG001|Treatment Period|Withdrawal by Subject|1|||
44572474|NCT02603432|79594520|FG001|Overall Study|Death|177|||
44572475|NCT02603432|79594519|FG000|Overall Study|Lost to Follow-up|4|||
44572476|NCT02603432|79594520|FG001|Overall Study|Lost to Follow-up|6|||
44572477|NCT02603432|79594519|FG000|Overall Study|Progressive Disease|5|||
44572478|NCT02603432|79594520|FG001|Overall Study|Progressive Disease|5|||
44572479|NCT02603432|79594519|FG000|Overall Study|Withdrawal by Subject|9|||
44572480|NCT02603432|79594520|FG001|Overall Study|Withdrawal by Subject|17|||
44572481|NCT02603432|79594519|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
44572482|NCT02603432|79594520|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44572483|NCT02603432|79594519|FG000|Overall Study|Other|0|||
44572484|NCT02603432|79594520|FG001|Overall Study|Other|1|||
44572485|NCT02582866|79594526|FG000|Overall Study|Death|1|||
44572486|NCT02582866|79594526|FG000|Overall Study|Lack of Efficacy|2|||
44572487|NCT02582866|79594526|FG000|Overall Study|Lost to Follow-up|2|||
44572488|NCT02582866|79594526|FG000|Overall Study|Withdrawal by Subject|7|||
44572489|NCT02582866|79594526|FG000|Overall Study|Investigator decision|5|||
44572490|NCT02582866|79594526|FG000|Overall Study|Participant wants to get pregnant|1|||
44572491|NCT02582866|79594526|FG000|Overall Study|Pregnancy|2|||
44572492|NCT02582866|79594526|FG000|Overall Study|Sponsor decision|1|||
44572493|NCT02582866|79594526|FG000|Overall Study|Withdrawal due to personal reasons|1|||
44572494|NCT01734928|79594536|FG000|Randomization|Physician Decision|0|||
44572495|NCT01734928|79594537|FG001|Randomization|Physician Decision|1|||
44237725|NCT02546986|79064321|FG001|Treatment Period|Death|4|||
44237726|NCT02546986|79064320|FG000|Treatment Period|Physician Decision|1|||
44237727|NCT02546986|79064321|FG001|Treatment Period|Physician Decision|2|||
44237728|NCT02546986|79064320|FG000|Treatment Period|Protocol Violation|1|||
44505042|NCT03338998|79509895|FG000|Treatment Period|Adverse Event|0|||
44572496|NCT01734928|79594536|FG000|Randomization|clinical progression|0|||
44572497|NCT01734928|79594537|FG001|Randomization|clinical progression|1|||
44572498|NCT01734928|79594536|FG000|Randomization|progressive disease|0|||
44572499|NCT01734928|79594537|FG001|Randomization|progressive disease|2|||
44572500|NCT01734928|79594536|FG000|Randomization|Withdrew informed consent|0|||
44505043|NCT03338998|79509896|FG001|Treatment Period|Adverse Event|2|||
44505044|NCT03338998|79509895|FG000|Treatment Period|Protocol deviation|1|||
44505045|NCT03338998|79509896|FG001|Treatment Period|Protocol deviation|0|||
44505046|NCT03338998|79509895|FG000|Treatment Period|Physician Decision|2|||
44505047|NCT03338998|79509896|FG001|Treatment Period|Physician Decision|0|||
44505048|NCT03338998|79509895|FG000|Treatment Period|Subject failed swallow test|4|||
44505049|NCT03338998|79509896|FG001|Treatment Period|Subject failed swallow test|0|||
44505050|NCT03338998|79509895|FG000|Safety Follow-Up Period|Adverse Event|0|||
44505051|NCT03338998|79509896|FG001|Safety Follow-Up Period|Adverse Event|1|||
44505052|NCT03338998|79509895|FG000|Safety Follow-Up Period|Protocol deviation|1|||
44505053|NCT03338998|79509896|FG001|Safety Follow-Up Period|Protocol deviation|0|||
44505054|NCT03338998|79509895|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
44505055|NCT03338998|79509896|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
44572501|NCT01734928|79594537|FG001|Randomization|Withdrew informed consent|4|||
44572502|NCT01734928|79594536|FG000|Randomization|Death|1|||
44572503|NCT01734928|79594537|FG001|Randomization|Death|0|||
44572504|NCT01734928|79594536|FG000|Randomization|Randomization error|1|||
44505056|NCT03338296|79509905|FG000|Overall Study|Adverse Event|0|||
44505057|NCT03338296|79509906|FG001|Overall Study|Adverse Event|1|||
44572505|NCT01734928|79594537|FG001|Randomization|Randomization error|0|||
44572506|NCT01734928|79594536|FG000|Randomization|Lost to Follow-up|1|||
44572507|NCT01734928|79594537|FG001|Randomization|Lost to Follow-up|0|||
44572508|NCT01734928|79594536|FG000|Treatment Period|Lost to Follow-up|0|||
44237729|NCT02546986|79064321|FG001|Treatment Period|Protocol Violation|0|||
44572509|NCT01734928|79594537|FG001|Treatment Period|Lost to Follow-up|2|||
44572510|NCT01734928|79594536|FG000|Treatment Period|Progressive Disease|167|||
44572511|NCT01734928|79594537|FG001|Treatment Period|Progressive Disease|165|||
44572512|NCT01734928|79594536|FG000|Treatment Period|Adverse Event|39|||
44572513|NCT01734928|79594537|FG001|Treatment Period|Adverse Event|52|||
44505058|NCT03338296|79509905|FG000|Overall Study|Withdrawal by Subject|14|||
44505059|NCT03338296|79509906|FG001|Overall Study|Withdrawal by Subject|13|||
44505060|NCT03338296|79509905|FG000|Overall Study|Lost to Follow-up|10|||
44505061|NCT03338296|79509906|FG001|Overall Study|Lost to Follow-up|10|||
44505062|NCT03338296|79509905|FG000|Overall Study|Study Terminated by Sponsor|77|||
44505063|NCT03338296|79509906|FG001|Overall Study|Study Terminated by Sponsor|76|||
44505064|NCT03338296|79509905|FG000|Overall Study|Other|2|||
44572514|NCT01734928|79594536|FG000|Treatment Period|Withdrawal of Consent|25|||
44572515|NCT01734928|79594537|FG001|Treatment Period|Withdrawal of Consent|22|||
44572516|NCT01734928|79594536|FG000|Treatment Period|Death|20|||
44572517|NCT01734928|79594537|FG001|Treatment Period|Death|9|||
44572518|NCT01734928|79594536|FG000|Treatment Period|Other Reasons|27|||
44572519|NCT01734928|79594537|FG001|Treatment Period|Other Reasons|19|||
44572520|NCT01734928|79594536|FG000|Treatment Period|Pregnancy|0|||
44572521|NCT01734928|79594537|FG001|Treatment Period|Pregnancy|1|||
44572522|NCT00667459|79594545|FG000|Overall Study|Death|0|||
44572523|NCT00667459|79594546|FG001|Overall Study|Death|2|||
44572524|NCT00667459|79594545|FG000|Overall Study|Lost to Follow-up|8|||
44572525|NCT00667459|79594546|FG001|Overall Study|Lost to Follow-up|43|||
44572526|NCT00453544|79594560|FG000|Overall Study|Withdrawal by Subject|1|||
44572527|NCT00453544|79594561|FG001|Overall Study|Withdrawal by Subject|0|||
44572528|NCT00453544|79594562|FG002|Overall Study|Withdrawal by Subject|0|||
44572529|NCT00453544|79594563|FG003|Overall Study|Withdrawal by Subject|0|||
44572530|NCT00453544|79594560|FG000|Overall Study|Primary outcome measure not completed|1|||
44572531|NCT00453544|79594561|FG001|Overall Study|Primary outcome measure not completed|1|||
44572532|NCT00453544|79594562|FG002|Overall Study|Primary outcome measure not completed|0|||
44572533|NCT00453544|79594563|FG003|Overall Study|Primary outcome measure not completed|1|||
44572534|NCT02646124|79594587|FG000|Overall Study|Lost to Follow-up|0|||
44572535|NCT02646124|79594588|FG001|Overall Study|Lost to Follow-up|2|||
44572536|NCT01597492|79594596|FG000|Overall Study|Withdrawal by Subject|1|||
44572537|NCT01597492|79594597|FG001|Overall Study|Withdrawal by Subject|2|||
44572538|NCT01597492|79594596|FG000|Overall Study|Adverse Event|3|||
44572539|NCT01597492|79594597|FG001|Overall Study|Adverse Event|0|||
44572540|NCT01597492|79594596|FG000|Overall Study|Lost to Follow-up|0|||
44572541|NCT01597492|79594597|FG001|Overall Study|Lost to Follow-up|2|||
44572542|NCT01597492|79594596|FG000|Overall Study|Other Reason|2|||
44572543|NCT01597492|79594597|FG001|Overall Study|Other Reason|0|||
44572544|NCT03423602|79594603|FG000|Overall Study|Death|1|||
44572545|NCT03423602|79594603|FG000|Overall Study|Lost to Follow-up|6|||
44572546|NCT03423602|79594603|FG000|Overall Study|Protocol Violation|1|||
44572547|NCT03423602|79594603|FG000|Overall Study|Withdrawal by Subject|4|||
44572548|NCT00109590|79594610|FG000|Overall Study|Lost to Follow-up|1|||
44572549|NCT00109590|79594611|FG001|Overall Study|Lost to Follow-up|0|||
44572550|NCT00109590|79594612|FG002|Overall Study|Lost to Follow-up|1|||
44572551|NCT00109590|79594610|FG000|Overall Study|Never Started Treatment|1|||
44572552|NCT00109590|79594611|FG001|Overall Study|Never Started Treatment|2|||
44237730|NCT02546986|79064320|FG000|Treatment Period|Withdrawal by Subject|1|||
44237731|NCT02546986|79064321|FG001|Treatment Period|Withdrawal by Subject|1|||
44237732|NCT02546986|79064320|FG000|Treatment Period|Non-compliance with Study Drug|0|||
44237733|NCT02546986|79064321|FG001|Treatment Period|Non-compliance with Study Drug|1|||
44237734|NCT02546986|79064320|FG000|Treatment Period|Study Terminated by Sponsor|0|||
44505065|NCT03338296|79509906|FG001|Overall Study|Other|7|||
44505066|NCT03338296|79509905|FG000|Overall Study|Missing|0|||
44505067|NCT03338296|79509906|FG001|Overall Study|Missing|1|||
44505068|NCT03338062|79509914|FG000|Overall Study|Alternative Therapy|1|||
44505069|NCT03338062|79509915|FG001|Overall Study|Alternative Therapy|0|||
44505070|NCT03364192|79509922|FG000|Overall Study|Ineligible|10|||
44572553|NCT00109590|79594612|FG002|Overall Study|Never Started Treatment|3|||
44572554|NCT02781558|79594636|FG000|Overall Study|Lost to Follow-up|2|||
44572555|NCT02781558|79594637|FG001|Overall Study|Lost to Follow-up|2|||
44572556|NCT02781558|79594636|FG000|Overall Study|Adverse Event|1|||
44275931|NCT04093024|79226182|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
44275932|NCT04093024|79226183|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
44275933|NCT03633929|79226217|FG000|Overall Study|Lost to Follow-up|1|||
44275934|NCT03633929|79226217|FG000|Overall Study|Did not login to software. Did not participate|3|||
44275935|NCT03625687|79226221|FG000|Overall Study|Death|1|||
44275936|NCT02785952|79226244|FG000|Overall Study|Adverse Event|31|||
44275937|NCT02785952|79226245|FG001|Overall Study|Adverse Event|19|||
44377851|NCT00827632|79383161|FG001|Overall Study|Lost to Follow-up|12|||
44572557|NCT02781558|79594637|FG001|Overall Study|Adverse Event|0|||
44572558|NCT03041311|79594646|FG000|Overall Study|Death|39|||
44572559|NCT03041311|79594647|FG001|Overall Study|Death|42|||
44572560|NCT03041311|79594646|FG000|Overall Study|Lost to Follow-up|0|||
44237735|NCT02546986|79064321|FG001|Treatment Period|Study Terminated by Sponsor|1|||
44237736|NCT02546986|79064320|FG000|Treatment Period|Miscellaneous|7|||
44237737|NCT02546986|79064321|FG001|Treatment Period|Miscellaneous|9|||
44237738|NCT02546986|79064320|FG000|Survival Follow-Up Phase|Missing Status|3|||
44237739|NCT02546986|79064321|FG001|Survival Follow-Up Phase|Missing Status|5|||
44237740|NCT02546986|79064320|FG000|Survival Follow-Up Phase|Death|18|||
44237741|NCT02546986|79064321|FG001|Survival Follow-Up Phase|Death|12|||
44237742|NCT02546986|79064320|FG000|Survival Follow-Up Phase|Alive|13|||
44237743|NCT02546986|79064321|FG001|Survival Follow-Up Phase|Alive|16|||
44237744|NCT02546986|79064320|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
44237745|NCT02546986|79064321|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
44237746|NCT02689206|79064332|FG000|Overall Study|Adverse Event|0|||
44237747|NCT02689206|79064333|FG001|Overall Study|Adverse Event|0|||
44237748|NCT02689206|79064334|FG002|Overall Study|Adverse Event|1|||
44237749|NCT02689206|79064335|FG003|Overall Study|Adverse Event|0|||
44237750|NCT02689206|79064336|FG004|Overall Study|Adverse Event|2|||
44237751|NCT02689206|79064332|FG000|Overall Study|Protocol Violation|1|||
44237752|NCT02689206|79064333|FG001|Overall Study|Protocol Violation|0|||
44237753|NCT02689206|79064334|FG002|Overall Study|Protocol Violation|0|||
44237754|NCT02689206|79064335|FG003|Overall Study|Protocol Violation|1|||
44237755|NCT02689206|79064336|FG004|Overall Study|Protocol Violation|2|||
44237756|NCT02689206|79064332|FG000|Overall Study|Other: Reached stopping criteria|0|||
44237757|NCT02689206|79064333|FG001|Overall Study|Other: Reached stopping criteria|1|||
44237758|NCT02689206|79064334|FG002|Overall Study|Other: Reached stopping criteria|2|||
44237759|NCT02689206|79064335|FG003|Overall Study|Other: Reached stopping criteria|3|||
44237760|NCT02689206|79064336|FG004|Overall Study|Other: Reached stopping criteria|4|||
44237761|NCT02689206|79064332|FG000|Overall Study|Physician Decision|1|||
44505071|NCT03364192|79509922|FG000|Overall Study|Withdrawal by Subject|5|||
44505072|NCT03364192|79509922|FG000|Overall Study|Lost to Follow-up|1|||
44505073|NCT03783962|79509929|FG000|Overall Study|Lost to Follow-up|3|||
44505074|NCT03783962|79509930|FG001|Overall Study|Lost to Follow-up|6|||
44505075|NCT03783962|79509929|FG000|Overall Study|Protocol Violation|0|||
44505076|NCT03783962|79509930|FG001|Overall Study|Protocol Violation|1|||
44505077|NCT03361228|79509938|FG000|Overall Study|Other|1|||
44505078|NCT03361228|79509939|FG001|Overall Study|Other|1|||
44505079|NCT03361228|79509938|FG000|Overall Study|Death|3|||
44505080|NCT03361228|79509939|FG001|Overall Study|Death|0|||
44505081|NCT03359590|79509945|FG000|First Intervention|Withdrawal by Subject|1|||
44505082|NCT03359590|79509946|FG001|First Intervention|Withdrawal by Subject|1|||
44505083|NCT03359590|79509945|FG000|First Intervention|Protocol Violation|0|||
44505084|NCT03359590|79509946|FG001|First Intervention|Protocol Violation|1|||
44505085|NCT05085964|79509954|FG000|Overall Study|Premature termination of study|21|||
44505086|NCT05085964|79509955|FG001|Overall Study|Premature termination of study|0|||
44505087|NCT02891200|79509964|FG000|Overall Study|Lost to Follow-up|31|||
44505088|NCT02891200|79509965|FG001|Overall Study|Lost to Follow-up|36|||
44505089|NCT02891200|79509964|FG000|Overall Study|Death|10|||
44505090|NCT02891200|79509965|FG001|Overall Study|Death|9|||
44505091|NCT02891200|79509964|FG000|Overall Study|Withdrawal by Subject|1|||
44505092|NCT02891200|79509965|FG001|Overall Study|Withdrawal by Subject|4|||
44505093|NCT02946580|79509973|FG000|Overall Study|Withdrawal by Subject|1|||
44505094|NCT02946580|79509974|FG001|Overall Study|Withdrawal by Subject|2|||
44505095|NCT02946580|79509973|FG000|Overall Study|Adverse Event|0|||
44505096|NCT02946580|79509974|FG001|Overall Study|Adverse Event|2|||
44505097|NCT02946580|79509973|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
44505098|NCT02946580|79509974|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
44505099|NCT00323609|79509982|FG000|Overall Study|Death|16|||
44237762|NCT02689206|79064333|FG001|Overall Study|Physician Decision|0|||
44237763|NCT02689206|79064334|FG002|Overall Study|Physician Decision|0|||
44237764|NCT02689206|79064335|FG003|Overall Study|Physician Decision|0|||
44505100|NCT00323609|79509983|FG001|Overall Study|Death|21|||
44237765|NCT02689206|79064336|FG004|Overall Study|Physician Decision|0|||
44237766|NCT02689206|79064332|FG000|Overall Study|Withdrawal by Subject|1|||
44237767|NCT02689206|79064333|FG001|Overall Study|Withdrawal by Subject|0|||
44572561|NCT03041311|79594647|FG001|Overall Study|Lost to Follow-up|1|||
44237768|NCT02689206|79064334|FG002|Overall Study|Withdrawal by Subject|1|||
44572562|NCT03041311|79594646|FG000|Overall Study|Withdrawal by Subject|8|||
44572563|NCT03041311|79594647|FG001|Overall Study|Withdrawal by Subject|5|||
44572564|NCT03041311|79594646|FG000|Overall Study|Sponsor Terminated Study|2|||
44572565|NCT03041311|79594647|FG001|Overall Study|Sponsor Terminated Study|4|||
44572566|NCT03041311|79594646|FG000|Overall Study|Disease Progression|3|||
44572567|NCT03041311|79594647|FG001|Overall Study|Disease Progression|1|||
44572568|NCT03041311|79594646|FG000|Overall Study|Randomized in error, did not receive drug|2|||
44572569|NCT03041311|79594647|FG001|Overall Study|Randomized in error, did not receive drug|0|||
44572570|NCT02644096|79594663|FG000|Overall Study|Withdrawal by Subject|28|||
44572571|NCT02644096|79594664|FG001|Overall Study|Withdrawal by Subject|25|||
44572572|NCT02643628|79594672|FG000|Overall Study|Lost to Follow-up|1|||
44572573|NCT02643628|79594673|FG001|Overall Study|Lost to Follow-up|4|||
44572574|NCT02643628|79594672|FG000|Overall Study|Withdrawal by Subject|0|||
44572575|NCT02643628|79594673|FG001|Overall Study|Withdrawal by Subject|1|||
44572576|NCT02643628|79594672|FG000|Overall Study|Relocated out of state|0|||
44572577|NCT02643628|79594673|FG001|Overall Study|Relocated out of state|1|||
44572578|NCT02643472|79594683|FG000|Overall Study|Death|2|||
44572579|NCT02643472|79594684|FG001|Overall Study|Death|5|||
44572580|NCT02643472|79594683|FG000|Overall Study|Withdrawal by Subject|3|||
44572581|NCT02643472|79594684|FG001|Overall Study|Withdrawal by Subject|2|||
44572582|NCT02643472|79594683|FG000|Overall Study|Protocol Violation|0|||
44572583|NCT02643472|79594684|FG001|Overall Study|Protocol Violation|1|||
44572584|NCT02643472|79594683|FG000|Overall Study|Lost to Follow-up|22|||
44572585|NCT02643472|79594684|FG001|Overall Study|Lost to Follow-up|26|||
44572586|NCT02738840|79594692|FG000|Overall Study|MRI Scan not Performed|5|||
44572587|NCT02738840|79594692|FG000|Overall Study|Lost to Follow-up|1|||
44572588|NCT02738840|79594692|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
44572589|NCT02738840|79594692|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
44572590|NCT02643394|79594698|FG000|Overall Study|Protocol Violation|4|||
44572591|NCT02643394|79594699|FG001|Overall Study|Protocol Violation|5|||
44572592|NCT03538158|79594707|FG000|Overall Study|Lost to Follow-up|13|||
44572593|NCT03538158|79594708|FG001|Overall Study|Lost to Follow-up|7|||
44572594|NCT03538158|79594707|FG000|Overall Study|Withdrawal by Subject|2|||
44572595|NCT03538158|79594708|FG001|Overall Study|Withdrawal by Subject|1|||
44572596|NCT02643082|79594714|FG000|Period 1|Adverse Event|1|||
44572597|NCT02643082|79594715|FG001|Period 1|Adverse Event|0|||
44572598|NCT00353496|79594724|FG000|Overall Study|Adverse Event|1|||
44572599|NCT00353496|79594725|FG001|Overall Study|Adverse Event|0|||
44572600|NCT00353496|79594724|FG000|Overall Study|Protocol Violation|2|||
44572601|NCT00353496|79594725|FG001|Overall Study|Protocol Violation|2|||
44572602|NCT00353496|79594724|FG000|Overall Study|Withdrawal by Subject|3|||
44572603|NCT00353496|79594725|FG001|Overall Study|Withdrawal by Subject|4|||
44572604|NCT00353496|79594724|FG000|Overall Study|Physician Decision|6|||
44572605|NCT00353496|79594725|FG001|Overall Study|Physician Decision|9|||
44572606|NCT00353496|79594724|FG000|Overall Study|Not otherwise specified|4|||
44572607|NCT00353496|79594725|FG001|Overall Study|Not otherwise specified|2|||
44572608|NCT01361464|79594741|FG000|Overall Study|Death|1|||
44572609|NCT01361464|79594741|FG000|Overall Study|Withdrawal by Subject|2|||
44237769|NCT02689206|79064335|FG003|Overall Study|Withdrawal by Subject|0|||
44377852|NCT00827632|79383160|FG000|Overall Study|Early withdrawal|14|||
44505101|NCT00323609|79509984|FG002|Overall Study|Death|0|||
44505102|NCT00323609|79509985|FG003|Overall Study|Death|0|||
44505103|NCT00323609|79509982|FG000|Overall Study|Lost to Follow-up|9|||
44505104|NCT00323609|79509983|FG001|Overall Study|Lost to Follow-up|10|||
44505105|NCT00323609|79509984|FG002|Overall Study|Lost to Follow-up|0|||
44505106|NCT00323609|79509985|FG003|Overall Study|Lost to Follow-up|0|||
44505107|NCT00323609|79509982|FG000|Overall Study|Physician Decision|2|||
44505108|NCT00323609|79509983|FG001|Overall Study|Physician Decision|0|||
44505109|NCT00323609|79509984|FG002|Overall Study|Physician Decision|0|||
44505110|NCT00323609|79509985|FG003|Overall Study|Physician Decision|1|||
44572610|NCT03486912|79594749|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
44572611|NCT03486912|79594750|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
44572612|NCT03486912|79594751|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
44572613|NCT03486912|79594752|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
44572614|NCT03486912|79594749|FG000|Treatment Period|Withdrawal by Subject|3|||
44377853|NCT00827632|79383161|FG001|Overall Study|Early withdrawal|11|||
44572615|NCT03486912|79594750|FG001|Treatment Period|Withdrawal by Subject|3|||
44572616|NCT03486912|79594751|FG002|Treatment Period|Withdrawal by Subject|3|||
44572617|NCT03486912|79594752|FG003|Treatment Period|Withdrawal by Subject|2|||
44572618|NCT03486912|79594749|FG000|Treatment Period|Other Reasons|0|||
44505111|NCT00323609|79509982|FG000|Overall Study|Withdrawal by Subject|11|||
44572619|NCT03486912|79594750|FG001|Treatment Period|Other Reasons|2|||
44572620|NCT03486912|79594751|FG002|Treatment Period|Other Reasons|1|||
44572621|NCT03486912|79594752|FG003|Treatment Period|Other Reasons|1|||
44572622|NCT03486912|79594749|FG000|Treatment Period|Adverse Event|0|||
44572623|NCT03486912|79594750|FG001|Treatment Period|Adverse Event|1|||
44572624|NCT03486912|79594751|FG002|Treatment Period|Adverse Event|1|||
44572625|NCT03486912|79594752|FG003|Treatment Period|Adverse Event|0|||
44572626|NCT03486912|79594749|FG000|Treatment Period|Lost to Follow-up|1|||
44572627|NCT03486912|79594750|FG001|Treatment Period|Lost to Follow-up|0|||
44377854|NCT00827242|79383169|FG000|Overall Study|Withdrawal by Subject|2|||
44377855|NCT00827242|79383170|FG001|Overall Study|Withdrawal by Subject|4|||
44377856|NCT00827242|79383169|FG000|Overall Study|Protocol Violation|1|||
44505112|NCT00323609|79509983|FG001|Overall Study|Withdrawal by Subject|23|||
44505113|NCT00323609|79509984|FG002|Overall Study|Withdrawal by Subject|4|||
44572628|NCT03486912|79594751|FG002|Treatment Period|Lost to Follow-up|0|||
44505114|NCT00323609|79509985|FG003|Overall Study|Withdrawal by Subject|4|||
44505115|NCT00323609|79509982|FG000|Overall Study|Other non-VCF-related medical condition|3|||
44505116|NCT00323609|79509983|FG001|Overall Study|Other non-VCF-related medical condition|2|||
44505117|NCT00323609|79509984|FG002|Overall Study|Other non-VCF-related medical condition|0|||
44505118|NCT00323609|79509985|FG003|Overall Study|Other non-VCF-related medical condition|0|||
44505119|NCT00323609|79509982|FG000|Overall Study|Sponsor discontinued trial|29|||
44505120|NCT00323609|79509983|FG001|Overall Study|Sponsor discontinued trial|29|||
44505121|NCT00323609|79509984|FG002|Overall Study|Sponsor discontinued trial|0|||
44505122|NCT00323609|79509985|FG003|Overall Study|Sponsor discontinued trial|0|||
44505123|NCT00323609|79509982|FG000|Overall Study|Unrelenting or severe back pain|1|||
44505124|NCT00323609|79509983|FG001|Overall Study|Unrelenting or severe back pain|1|||
44505125|NCT00323609|79509984|FG002|Overall Study|Unrelenting or severe back pain|0|||
44505126|NCT00323609|79509985|FG003|Overall Study|Unrelenting or severe back pain|0|||
44505127|NCT00323609|79509982|FG000|Overall Study|Logistical withdrawal|9|||
44505128|NCT00323609|79509983|FG001|Overall Study|Logistical withdrawal|5|||
44572629|NCT03486912|79594752|FG003|Treatment Period|Lost to Follow-up|2|||
44572630|NCT02642614|79594766|FG000|Overall Study|Adverse Event|1|||
44572631|NCT02642614|79594767|FG001|Overall Study|Adverse Event|1|||
44572632|NCT02642614|79594768|FG002|Overall Study|Adverse Event|2|||
44572633|NCT02642614|79594769|FG003|Overall Study|Adverse Event|2|||
44572634|NCT02642614|79594766|FG000|Overall Study|Lost to Follow-up|1|||
44572635|NCT02642614|79594767|FG001|Overall Study|Lost to Follow-up|0|||
44572636|NCT02642614|79594768|FG002|Overall Study|Lost to Follow-up|0|||
44572637|NCT02642614|79594769|FG003|Overall Study|Lost to Follow-up|0|||
44572638|NCT02642614|79594766|FG000|Overall Study|Withdrawal by Subject|1|||
44572639|NCT02642614|79594767|FG001|Overall Study|Withdrawal by Subject|1|||
44572640|NCT02642614|79594768|FG002|Overall Study|Withdrawal by Subject|0|||
44572641|NCT02642614|79594769|FG003|Overall Study|Withdrawal by Subject|0|||
44572642|NCT02781324|79594784|FG000|Overall Study|Withdrawal by Subject|1|||
44572643|NCT02781324|79594785|FG001|Overall Study|Withdrawal by Subject|0|||
44572644|NCT02781324|79594784|FG000|Overall Study|Physician Decision|1|||
44572645|NCT02781324|79594785|FG001|Overall Study|Physician Decision|2|||
44572646|NCT03292146|79594795|FG000|Baseline to 12 Months|Relocation|1|||
44572647|NCT03292146|79594796|FG001|Baseline to 12 Months|Relocation|0|||
44572648|NCT03292146|79594795|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
44572649|NCT03292146|79594796|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
44572650|NCT03292146|79594795|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
44572651|NCT03292146|79594796|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
44572652|NCT03292146|79594795|FG000|12 Months to 24 Months|Planning pregnancy|2|||
44572653|NCT03292146|79594796|FG001|12 Months to 24 Months|Planning pregnancy|2|||
44237770|NCT02689206|79064336|FG004|Overall Study|Withdrawal by Subject|0|||
44237771|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
44237772|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
44237773|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
44377857|NCT00827242|79383170|FG001|Overall Study|Protocol Violation|3|||
44572654|NCT03292146|79594795|FG000|12 Months to 24 Months|Personal reasons|1|||
44237774|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
44237775|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44572655|NCT03292146|79594796|FG001|12 Months to 24 Months|Personal reasons|0|||
44572656|NCT03292146|79594795|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
44505129|NCT00323609|79509984|FG002|Overall Study|Logistical withdrawal|0|||
44505130|NCT00323609|79509985|FG003|Overall Study|Logistical withdrawal|1|||
44505131|NCT00323609|79509982|FG000|Overall Study|Other reason|11|||
44505132|NCT00323609|79509983|FG001|Overall Study|Other reason|8|||
44505133|NCT00323609|79509984|FG002|Overall Study|Other reason|4|||
44505134|NCT00323609|79509985|FG003|Overall Study|Other reason|9|||
44505135|NCT04598152|79509991|FG000|Overall Study|Lost to Follow-up|0|||
44505136|NCT04598152|79509992|FG001|Overall Study|Lost to Follow-up|1|||
44505137|NCT00323297|79510000|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
44505138|NCT00323297|79510001|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
44505139|NCT00323297|79510000|FG000|Part A (Double Blind Randomized)|Death|0|||
44505140|NCT00323297|79510001|FG001|Part A (Double Blind Randomized)|Death|1|||
44505141|NCT00323297|79510000|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
44505142|NCT00323297|79510001|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
44505143|NCT00323297|79510000|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
44505144|NCT00323297|79510001|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
44505145|NCT00323297|79510000|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
44505146|NCT00323297|79510001|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
44505147|NCT00323297|79510000|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
44505148|NCT00323297|79510001|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
44505149|NCT00323297|79510000|FG000|Part B (Open-label)|Death|0|||
44505150|NCT00323297|79510001|FG001|Part B (Open-label)|Death|1|||
44505151|NCT00323297|79510000|FG000|Part B (Open-label)|Reason unspecified|0|||
44505152|NCT00323297|79510001|FG001|Part B (Open-label)|Reason unspecified|1|||
44505153|NCT00323297|79510000|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
44505154|NCT00323297|79510001|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
44505155|NCT00323297|79510000|FG000|Part B (Open-label)|Lack of Efficacy|3|||
44505156|NCT00323297|79510001|FG001|Part B (Open-label)|Lack of Efficacy|1|||
44505157|NCT00323297|79510000|FG000|Part B (Open-label)|Adverse Event|5|||
44505158|NCT00323297|79510001|FG001|Part B (Open-label)|Adverse Event|5|||
44505159|NCT00323297|79510000|FG000|Part B (Open-label)|Protocol Violation|0|||
44505160|NCT00323297|79510001|FG001|Part B (Open-label)|Protocol Violation|1|||
44505161|NCT00323063|79510009|FG000|Overall Study|Adverse Event|1|||
44505162|NCT00323063|79510010|FG001|Overall Study|Adverse Event|0|||
44505163|NCT00323063|79510009|FG000|Overall Study|brain mets discovered prior to treatment|1|||
44505164|NCT00323063|79510010|FG001|Overall Study|brain mets discovered prior to treatment|0|||
44505165|NCT00322049|79510020|FG000|Overall Study|Moved out of area|0|||
44505166|NCT00322049|79510021|FG001|Overall Study|Moved out of area|0|||
44505167|NCT00322049|79510022|FG002|Overall Study|Moved out of area|0|||
44505168|NCT00322049|79510023|FG003|Overall Study|Moved out of area|1|||
44505169|NCT00322049|79510020|FG000|Overall Study|Infected with Dengue during study|0|||
44505170|NCT00322049|79510021|FG001|Overall Study|Infected with Dengue during study|1|||
44505171|NCT00322049|79510022|FG002|Overall Study|Infected with Dengue during study|0|||
44505172|NCT00322049|79510023|FG003|Overall Study|Infected with Dengue during study|0|||
44505173|NCT00321893|79510044|FG000|Overall Study|Non-Compliance/Refusal|16|||
44505174|NCT00321893|79510045|FG001|Overall Study|Non-Compliance/Refusal|10|||
44505175|NCT00321893|79510044|FG000|Overall Study|Lost to Follow-up|2|||
44505176|NCT00321893|79510045|FG001|Overall Study|Lost to Follow-up|1|||
44505177|NCT00321893|79510044|FG000|Overall Study|Adverse Event|6|||
44505178|NCT00321893|79510045|FG001|Overall Study|Adverse Event|3|||
44505179|NCT00371345|79510053|FG000|Overall Study|Disease Progression|21|||
44505180|NCT00371345|79510054|FG001|Overall Study|Disease Progression|35|||
44505181|NCT00371345|79510053|FG000|Overall Study|Study Drug Toxicity|1|||
44505182|NCT00371345|79510054|FG001|Overall Study|Study Drug Toxicity|7|||
44505183|NCT00371345|79510053|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
44505184|NCT00371345|79510054|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
44505185|NCT00371345|79510053|FG000|Overall Study|Participant Request|1|||
44505186|NCT00371345|79510054|FG001|Overall Study|Participant Request|1|||
44505187|NCT00371345|79510053|FG000|Overall Study|Participant Withdrew Consent|0|||
44505188|NCT00371345|79510054|FG001|Overall Study|Participant Withdrew Consent|1|||
44505189|NCT00321737|79510077|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
44505190|NCT00321737|79510078|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
44505191|NCT00321737|79510079|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
44505192|NCT00321737|79510077|FG000|Overall Study|Adverse Event|11|||
44505193|NCT00321737|79510078|FG001|Overall Study|Adverse Event|3|||
44505194|NCT00321737|79510079|FG002|Overall Study|Adverse Event|6|||
44505195|NCT00321737|79510077|FG000|Overall Study|Lost to Follow-up|5|||
44505196|NCT00321737|79510078|FG001|Overall Study|Lost to Follow-up|5|||
44505197|NCT00321737|79510079|FG002|Overall Study|Lost to Follow-up|6|||
44505198|NCT00321737|79510077|FG000|Overall Study|Withdrawal by Subject|19|||
44505199|NCT00321737|79510078|FG001|Overall Study|Withdrawal by Subject|12|||
44505200|NCT00321737|79510079|FG002|Overall Study|Withdrawal by Subject|17|||
44505201|NCT00321737|79510077|FG000|Overall Study|Protocol Violation|0|||
44505202|NCT00321737|79510078|FG001|Overall Study|Protocol Violation|0|||
44505203|NCT00321737|79510079|FG002|Overall Study|Protocol Violation|1|||
44505204|NCT00321737|79510077|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
44505205|NCT00321737|79510078|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
44505206|NCT00321737|79510079|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
44505207|NCT00321737|79510077|FG000|Overall Study|Possible Barrett's Esophagus|2|||
44505208|NCT00321737|79510078|FG001|Overall Study|Possible Barrett's Esophagus|1|||
44505209|NCT00321737|79510079|FG002|Overall Study|Possible Barrett's Esophagus|1|||
44505210|NCT00321737|79510077|FG000|Overall Study|Therapeutic Failure|6|||
44505211|NCT00321737|79510078|FG001|Overall Study|Therapeutic Failure|0|||
44572657|NCT03292146|79594796|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
44572658|NCT01360996|79594805|FG000|Overall Study|Withdrawal by Subject|4|||
44572659|NCT01360996|79594806|FG001|Overall Study|Withdrawal by Subject|3|||
44572660|NCT01360996|79594807|FG002|Overall Study|Withdrawal by Subject|2|||
44572661|NCT01360996|79594805|FG000|Overall Study|Noncompliant|2|||
44572662|NCT01360996|79594806|FG001|Overall Study|Noncompliant|0|||
44505212|NCT00321737|79510079|FG002|Overall Study|Therapeutic Failure|2|||
44572663|NCT01360996|79594807|FG002|Overall Study|Noncompliant|0|||
44377858|NCT00827242|79383169|FG000|Overall Study|Lost to Follow-up|0|||
44505213|NCT00321737|79510077|FG000|Overall Study|Pregnancy|0|||
44505214|NCT00321737|79510078|FG001|Overall Study|Pregnancy|2|||
44505215|NCT00321737|79510079|FG002|Overall Study|Pregnancy|0|||
44505216|NCT00321737|79510077|FG000|Overall Study|Noncompliance|2|||
44505217|NCT00321737|79510078|FG001|Overall Study|Noncompliance|0|||
44505218|NCT00321737|79510079|FG002|Overall Study|Noncompliance|0|||
44505219|NCT00321737|79510077|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
44505220|NCT00321737|79510078|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
44505221|NCT00321737|79510079|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
44572664|NCT02639338|79594816|FG000|Overall Study|Lost to Follow-up|2|||
44505222|NCT00320801|79510089|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
44505223|NCT00320801|79510090|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
44505224|NCT00320801|79510091|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
44505225|NCT00320801|79510092|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
44505226|NCT00320801|79510089|FG000|Open-label Run-in Period|Adverse Event|33|||
44505227|NCT00320801|79510090|FG001|Open-label Run-in Period|Adverse Event|0|||
44505228|NCT00320801|79510091|FG002|Open-label Run-in Period|Adverse Event|0|||
44505229|NCT00320801|79510092|FG003|Open-label Run-in Period|Adverse Event|0|||
44505230|NCT00320801|79510089|FG000|Open-label Run-in Period|Administrative|10|||
44505231|NCT00320801|79510090|FG001|Open-label Run-in Period|Administrative|0|||
44505232|NCT00320801|79510091|FG002|Open-label Run-in Period|Administrative|0|||
44505233|NCT00320801|79510092|FG003|Open-label Run-in Period|Administrative|0|||
44505234|NCT00320801|79510089|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
44505235|NCT00320801|79510090|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
44505236|NCT00320801|79510091|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
44505237|NCT00320801|79510092|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
44505238|NCT00320801|79510089|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
44505239|NCT00320801|79510090|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
44505240|NCT00320801|79510091|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
44505241|NCT00320801|79510092|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
44505242|NCT00320801|79510089|FG000|Open-label Run-in Period|Did not qualify|1|||
44505243|NCT00320801|79510090|FG001|Open-label Run-in Period|Did not qualify|0|||
44505244|NCT00320801|79510091|FG002|Open-label Run-in Period|Did not qualify|0|||
44249739|NCT01504412|79083923|FG000|Overall Study|Lost to Follow-up|0|||
44377859|NCT00827242|79383170|FG001|Overall Study|Lost to Follow-up|3|||
44377860|NCT00827242|79383169|FG000|Overall Study|Adverse Event Excluding Death|2|||
44377861|NCT00827242|79383170|FG001|Overall Study|Adverse Event Excluding Death|1|||
44377862|NCT00827242|79383169|FG000|Overall Study|Entry Criteria Not Met|4|||
44377863|NCT00827242|79383170|FG001|Overall Study|Entry Criteria Not Met|1|||
44377864|NCT00827242|79383169|FG000|Overall Study|Physician Decision|2|||
44377865|NCT00827242|79383170|FG001|Overall Study|Physician Decision|0|||
44377866|NCT00827242|79383169|FG000|Overall Study|Death|1|||
44377867|NCT00827242|79383170|FG001|Overall Study|Death|0|||
44377868|NCT00827242|79383169|FG000|Overall Study|Lack of Efficacy|1|||
44377869|NCT00827242|79383170|FG001|Overall Study|Lack of Efficacy|0|||
44377870|NCT01077362|79383179|FG000|Overall Study|Lack of Efficacy|13|||
44377871|NCT01077362|79383180|FG001|Overall Study|Lack of Efficacy|8|||
44377872|NCT01077362|79383181|FG002|Overall Study|Lack of Efficacy|10|||
44377873|NCT01077362|79383179|FG000|Overall Study|Lost to Follow-up|1|||
44377874|NCT01077362|79383180|FG001|Overall Study|Lost to Follow-up|0|||
44377875|NCT01077362|79383181|FG002|Overall Study|Lost to Follow-up|3|||
44377876|NCT01077362|79383179|FG000|Overall Study|Adverse Event|12|||
44505245|NCT00320801|79510092|FG003|Open-label Run-in Period|Did not qualify|0|||
44505246|NCT00320801|79510089|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44505247|NCT00320801|79510090|FG001|Double-blind Phase|Withdrawal by Subject|0|||
44505248|NCT00320801|79510091|FG002|Double-blind Phase|Withdrawal by Subject|1|||
44505249|NCT00320801|79510092|FG003|Double-blind Phase|Withdrawal by Subject|0|||
44505250|NCT00320801|79510089|FG000|Double-blind Phase|Adverse Event|0|||
44505251|NCT00320801|79510090|FG001|Double-blind Phase|Adverse Event|2|||
44505252|NCT00320801|79510091|FG002|Double-blind Phase|Adverse Event|8|||
44505253|NCT00320801|79510092|FG003|Double-blind Phase|Adverse Event|0|||
44505254|NCT00320801|79510089|FG000|Double-blind Phase|Administrative|0|||
44505255|NCT00320801|79510090|FG001|Double-blind Phase|Administrative|0|||
44505256|NCT00320801|79510091|FG002|Double-blind Phase|Administrative|4|||
44505257|NCT00320801|79510092|FG003|Double-blind Phase|Administrative|0|||
44505258|NCT00320801|79510089|FG000|Double-blind Phase|Lack of Efficacy|0|||
44505259|NCT00320801|79510090|FG001|Double-blind Phase|Lack of Efficacy|9|||
44377877|NCT01077362|79383180|FG001|Overall Study|Adverse Event|7|||
44377878|NCT01077362|79383181|FG002|Overall Study|Adverse Event|4|||
44377879|NCT01077362|79383179|FG000|Overall Study|Withdrawal by Subject|5|||
44377880|NCT01077362|79383180|FG001|Overall Study|Withdrawal by Subject|3|||
44505260|NCT00320801|79510091|FG002|Double-blind Phase|Lack of Efficacy|1|||
44505261|NCT00320801|79510092|FG003|Double-blind Phase|Lack of Efficacy|0|||
44505262|NCT00320801|79510089|FG000|Extension Phase|Withdrawal by Subject|0|||
44505263|NCT00320801|79510090|FG001|Extension Phase|Withdrawal by Subject|0|||
44572665|NCT02639338|79594817|FG001|Overall Study|Lost to Follow-up|2|||
44377881|NCT01077362|79383181|FG002|Overall Study|Withdrawal by Subject|5|||
44377882|NCT01077362|79383179|FG000|Overall Study|Other|0|||
44572666|NCT02639338|79594816|FG000|Overall Study|Withdrew Consent|1|||
44572667|NCT02639338|79594817|FG001|Overall Study|Withdrew Consent|2|||
44572668|NCT02639338|79594816|FG000|Overall Study|Death|1|||
44572669|NCT02639338|79594817|FG001|Overall Study|Death|0|||
44572670|NCT02639338|79594816|FG000|Overall Study|Randomized but Not Treated|0|||
44572671|NCT02639338|79594817|FG001|Overall Study|Randomized but Not Treated|1|||
44377883|NCT01077362|79383180|FG001|Overall Study|Other|1|||
44377884|NCT01077362|79383181|FG002|Overall Study|Other|2|||
44377885|NCT00846586|79383196|FG000|Overall Study|Adverse Event|20|||
44377886|NCT00846586|79383197|FG001|Overall Study|Adverse Event|10|||
44377887|NCT00846586|79383196|FG000|Overall Study|Subject withdrew consent|8|||
44377888|NCT00846586|79383197|FG001|Overall Study|Subject withdrew consent|10|||
44377889|NCT00846586|79383196|FG000|Overall Study|Administrative problems|5|||
44377890|NCT00846586|79383197|FG001|Overall Study|Administrative problems|4|||
44377891|NCT00846586|79383196|FG000|Overall Study|Death|2|||
44377892|NCT00846586|79383197|FG001|Overall Study|Death|0|||
44377893|NCT00846586|79383196|FG000|Overall Study|Protocol deviation|2|||
44377894|NCT00846586|79383197|FG001|Overall Study|Protocol deviation|6|||
44377895|NCT00846586|79383196|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44572672|NCT01754857|79594823|FG000|Overall Study|Adverse Event|7|||
44572673|NCT01754857|79594823|FG000|Overall Study|Disease progression|3|||
44505264|NCT00320801|79510091|FG002|Extension Phase|Withdrawal by Subject|0|||
44572674|NCT01754857|79594823|FG000|Overall Study|Physician Decision|2|||
44505265|NCT00320801|79510092|FG003|Extension Phase|Withdrawal by Subject|6|||
44505266|NCT00320801|79510089|FG000|Extension Phase|Adverse Event|0|||
44505267|NCT00320801|79510090|FG001|Extension Phase|Adverse Event|0|||
44237776|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237777|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237778|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44377896|NCT00846586|79383197|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44377897|NCT00846586|79383196|FG000|Overall Study|Lost to Follow-up|1|||
44505268|NCT00320801|79510091|FG002|Extension Phase|Adverse Event|0|||
44505269|NCT00320801|79510092|FG003|Extension Phase|Adverse Event|8|||
44505270|NCT00320801|79510089|FG000|Extension Phase|Administrative|0|||
44572675|NCT01754857|79594823|FG000|Overall Study|Withdrawal by Subject|3|||
44377898|NCT00846586|79383197|FG001|Overall Study|Lost to Follow-up|4|||
44377899|NCT00846586|79383196|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44505271|NCT00320801|79510090|FG001|Extension Phase|Administrative|0|||
44377900|NCT00846586|79383197|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44377901|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
44572676|NCT01754857|79594823|FG000|Overall Study|other complicating disease|1|||
44572677|NCT01754857|79594823|FG000|Overall Study|ineligible to continue onto maintenance|1|||
44377902|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
44505272|NCT00320801|79510091|FG002|Extension Phase|Administrative|0|||
44505273|NCT00320801|79510092|FG003|Extension Phase|Administrative|29|||
44237779|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237780|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237781|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44572678|NCT01754857|79594823|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
44572679|NCT01754857|79594823|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
44572680|NCT02900352|79594829|FG000|Overall Study|Lost to Follow-up|28|||
44572681|NCT02900352|79594830|FG001|Overall Study|Lost to Follow-up|17|||
44572682|NCT03040687|79594839|FG000|Overall Study|Withdrawal by Subject|1|||
44572683|NCT03040687|79594840|FG001|Overall Study|Withdrawal by Subject|0|||
44572684|NCT03040687|79594841|FG002|Overall Study|Withdrawal by Subject|0|||
44572685|NCT03042559|79594851|FG000|Overall Study|drop out|1|||
44572686|NCT03042559|79594852|FG001|Overall Study|drop out|1|||
44572687|NCT02780856|79594858|FG000|Overall Study|Lost to Follow-up|1|||
44572688|NCT02321540|79594871|FG000|Overall Study|Death|0|||
44572689|NCT02321540|79594872|FG001|Overall Study|Death|1|||
44572690|NCT02321540|79594871|FG000|Overall Study|Progression|3|||
44572691|NCT02321540|79594872|FG001|Overall Study|Progression|9|||
44572692|NCT00108732|79594902|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
44572693|NCT00108732|79594902|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
44572694|NCT00108732|79594902|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
44572695|NCT00108732|79594902|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
44572696|NCT00108732|79594902|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
44572697|NCT00108732|79594902|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
44572698|NCT00108732|79594902|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
44572699|NCT00107952|79594908|FG000|Overall Study|Death|75|||
44572700|NCT00107952|79594909|FG001|Overall Study|Death|61|||
44572701|NCT00107952|79594908|FG000|Overall Study|Lost to Follow-up|0|||
44572702|NCT00107952|79594909|FG001|Overall Study|Lost to Follow-up|3|||
44572703|NCT00107952|79594908|FG000|Overall Study|Withdrawal by Subject|9|||
44572704|NCT00107952|79594909|FG001|Overall Study|Withdrawal by Subject|6|||
44572705|NCT00107952|79594908|FG000|Overall Study|Other|2|||
44572706|NCT00107952|79594909|FG001|Overall Study|Other|5|||
44572707|NCT00107952|79594908|FG000|Overall Study|Never received study treatment|9|||
44572708|NCT00107952|79594909|FG001|Overall Study|Never received study treatment|6|||
44572709|NCT01366638|79594927|FG000|Overall Study|Withdrawal by Subject|0|||
44572710|NCT01366638|79594928|FG001|Overall Study|Withdrawal by Subject|0|||
44377903|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Adverse Event|31|||
44377904|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Adverse Event|21|||
44572711|NCT01366638|79594929|FG002|Overall Study|Withdrawal by Subject|6|||
44572712|NCT01366638|79594927|FG000|Overall Study|Other|1|||
44572713|NCT01366638|79594928|FG001|Overall Study|Other|0|||
44572714|NCT01366638|79594929|FG002|Overall Study|Other|0|||
44572715|NCT02780700|79594937|FG000|Overall Study|Progressive disease|1|||
44572716|NCT04230122|79594975|FG000|Overall Study|Lost to Follow-up|1|||
44572717|NCT04230122|79594976|FG001|Overall Study|Lost to Follow-up|0|||
44572718|NCT02780388|79594987|FG000|Overall Study|Lost to Follow-up|0|||
44572719|NCT02780388|79594988|FG001|Overall Study|Lost to Follow-up|1|||
44572720|NCT02780388|79594989|FG002|Overall Study|Lost to Follow-up|0|||
44572721|NCT02780388|79594990|FG003|Overall Study|Lost to Follow-up|0|||
44572722|NCT02780388|79594991|FG004|Overall Study|Lost to Follow-up|0|||
44572723|NCT02780388|79594987|FG000|Overall Study|Withdrawal by Subject|1|||
44572724|NCT02780388|79594988|FG001|Overall Study|Withdrawal by Subject|1|||
44572725|NCT02780388|79594989|FG002|Overall Study|Withdrawal by Subject|0|||
44572726|NCT02780388|79594990|FG003|Overall Study|Withdrawal by Subject|0|||
44572727|NCT02780388|79594991|FG004|Overall Study|Withdrawal by Subject|0|||
44572728|NCT03491462|79595009|FG000|Overall Study|Lost to Follow-up|2|||
44572729|NCT03491462|79595010|FG001|Overall Study|Lost to Follow-up|0|||
44572730|NCT03491462|79595009|FG000|Overall Study|Adverse Event|11|||
44572731|NCT03491462|79595010|FG001|Overall Study|Adverse Event|1|||
44572732|NCT03491462|79595009|FG000|Overall Study|Physician Decision|3|||
44572733|NCT03491462|79595010|FG001|Overall Study|Physician Decision|0|||
44572734|NCT03491462|79595009|FG000|Overall Study|Withdrawal by Subject|22|||
44572735|NCT03491462|79595010|FG001|Overall Study|Withdrawal by Subject|15|||
44572736|NCT02224573|79595018|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
44572737|NCT02224573|79595019|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
44572738|NCT02224573|79595018|FG000|Treatment Phase|Started on Other IMP|1|||
44572739|NCT02224573|79595019|FG001|Treatment Phase|Started on Other IMP|0|||
44572740|NCT02224573|79595018|FG000|Treatment Phase|Participant Discontinued IMP|0|||
44572741|NCT02224573|79595019|FG001|Treatment Phase|Participant Discontinued IMP|1|||
44572742|NCT02224573|79595018|FG000|Treatment Phase|Lack of Efficacy|15|||
44572743|NCT02224573|79595019|FG001|Treatment Phase|Lack of Efficacy|8|||
44572744|NCT02224573|79595018|FG000|Treatment Phase|Began Commercial Product|1|||
44572745|NCT02224573|79595019|FG001|Treatment Phase|Began Commercial Product|0|||
44572746|NCT02224573|79595018|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
44572747|NCT02224573|79595019|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
44572748|NCT02224573|79595018|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
44572749|NCT02224573|79595019|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
44572750|NCT02224573|79595018|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
44572751|NCT02224573|79595019|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
44572752|NCT02224573|79595018|FG000|Treatment Phase|Continued Compassionate Use|1|||
44572753|NCT02224573|79595019|FG001|Treatment Phase|Continued Compassionate Use|0|||
44572754|NCT02224573|79595018|FG000|Treatment Phase|Lack of Efficiency|2|||
44572755|NCT02224573|79595019|FG001|Treatment Phase|Lack of Efficiency|1|||
44572756|NCT02224573|79595018|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
44572757|NCT02224573|79595019|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
44572758|NCT02224573|79595018|FG000|Treatment Phase|Participant Moved|2|||
44572759|NCT02224573|79595019|FG001|Treatment Phase|Participant Moved|0|||
44377905|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
44572760|NCT02224573|79595018|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
44572761|NCT02224573|79595019|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
44572762|NCT02224573|79595018|FG000|Treatment Phase|Refused Medication|1|||
44572763|NCT02224573|79595019|FG001|Treatment Phase|Refused Medication|1|||
44572764|NCT02224573|79595018|FG000|Treatment Phase|Adverse Event|26|||
44377906|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
44572765|NCT02224573|79595019|FG001|Treatment Phase|Adverse Event|38|||
44237782|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237783|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237784|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
44237785|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
44237786|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
44237787|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
44237788|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
44237789|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44505274|NCT00320801|79510089|FG000|Extension Phase|Lack of Efficacy|0|||
44505275|NCT00320801|79510090|FG001|Extension Phase|Lack of Efficacy|0|||
44505276|NCT00320801|79510091|FG002|Extension Phase|Lack of Efficacy|0|||
44505277|NCT00320801|79510092|FG003|Extension Phase|Lack of Efficacy|2|||
44505278|NCT00320801|79510089|FG000|Extension Phase|Lost to Follow-up|0|||
44505279|NCT00320801|79510090|FG001|Extension Phase|Lost to Follow-up|0|||
44505280|NCT00320801|79510091|FG002|Extension Phase|Lost to Follow-up|0|||
44505281|NCT00320801|79510092|FG003|Extension Phase|Lost to Follow-up|3|||
44505282|NCT00320489|79510104|FG000|Overall Study|Adverse Event|26|||
44505283|NCT00320489|79510105|FG001|Overall Study|Adverse Event|25|||
44505284|NCT00320489|79510104|FG000|Overall Study|Clinical Relapse|26|||
44505285|NCT00320489|79510105|FG001|Overall Study|Clinical Relapse|20|||
44505286|NCT00320489|79510104|FG000|Overall Study|Death|0|||
44505287|NCT00320489|79510105|FG001|Overall Study|Death|2|||
44505288|NCT00320489|79510104|FG000|Overall Study|Entry Criteria Exclusion|2|||
44505289|NCT00320489|79510105|FG001|Overall Study|Entry Criteria Exclusion|4|||
44237790|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44572766|NCT02224573|79595018|FG000|Treatment Phase|Placed in Group Home|0|||
44572767|NCT02224573|79595019|FG001|Treatment Phase|Placed in Group Home|1|||
44572768|NCT02224573|79595018|FG000|Treatment Phase|Pursued Other Trials|1|||
44572769|NCT02224573|79595019|FG001|Treatment Phase|Pursued Other Trials|0|||
44572770|NCT02224573|79595018|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
44572771|NCT02224573|79595019|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
44572772|NCT02224573|79595018|FG000|Treatment Phase|Lost to Follow-up|2|||
44572773|NCT02224573|79595019|FG001|Treatment Phase|Lost to Follow-up|1|||
44572774|NCT02224573|79595018|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
44572775|NCT02224573|79595019|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
44572776|NCT02224573|79595018|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
44572777|NCT02224573|79595019|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
44572778|NCT02224573|79595018|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
44572779|NCT02224573|79595019|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
44572780|NCT02224573|79595018|FG000|Taper Phase|Adverse Event|1|||
44237791|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44572781|NCT02224573|79595019|FG001|Taper Phase|Adverse Event|1|||
44572782|NCT01360840|79595029|FG000|Overall Study|Ongoing at data cut-off|10|||
44572783|NCT01360840|79595030|FG001|Overall Study|Ongoing at data cut-off|10|||
44237792|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44572784|NCT01360840|79595031|FG002|Overall Study|Ongoing at data cut-off|9|||
44572785|NCT03350984|79595043|FG000|Overall Study|Death|1|||
44572786|NCT03350984|79595044|FG001|Overall Study|Death|0|||
44572787|NCT03350984|79595043|FG000|Overall Study|Lost to Follow-up|5|||
44572788|NCT03350984|79595044|FG001|Overall Study|Lost to Follow-up|6|||
44572789|NCT03350984|79595043|FG000|Overall Study|Protocol Violation|1|||
44112519|NCT00150462|78895079|FG000|Overall Study|Disease Progression or Relapse|3|||
44112520|NCT00150462|78895080|FG001|Overall Study|Disease Progression or Relapse|1|||
44112521|NCT00150462|78895081|FG002|Overall Study|Disease Progression or Relapse|2|||
44112522|NCT00150462|78895082|FG003|Overall Study|Disease Progression or Relapse|1|||
44112523|NCT00150462|78895083|FG004|Overall Study|Disease Progression or Relapse|2|||
44112524|NCT00150462|78895084|FG005|Overall Study|Disease Progression or Relapse|2|||
44112525|NCT00150462|78895085|FG006|Overall Study|Disease Progression or Relapse|3|||
44112526|NCT00150462|78895086|FG007|Overall Study|Disease Progression or Relapse|5|||
44112527|NCT00150462|78895087|FG008|Overall Study|Disease Progression or Relapse|5|||
44112528|NCT00150462|78895088|FG009|Overall Study|Disease Progression or Relapse|3|||
44112529|NCT00150462|78895089|FG010|Overall Study|Disease Progression or Relapse|2|||
44112530|NCT00150462|78895079|FG000|Overall Study|Withdrawal by Subject|0|||
44112531|NCT00150462|78895080|FG001|Overall Study|Withdrawal by Subject|1|||
44112532|NCT00150462|78895081|FG002|Overall Study|Withdrawal by Subject|1|||
44112533|NCT00150462|78895082|FG003|Overall Study|Withdrawal by Subject|0|||
44112534|NCT00150462|78895083|FG004|Overall Study|Withdrawal by Subject|1|||
44112535|NCT00150462|78895084|FG005|Overall Study|Withdrawal by Subject|2|||
44112536|NCT00150462|78895085|FG006|Overall Study|Withdrawal by Subject|0|||
44112537|NCT00150462|78895086|FG007|Overall Study|Withdrawal by Subject|1|||
44112538|NCT00150462|78895087|FG008|Overall Study|Withdrawal by Subject|0|||
44112539|NCT00150462|78895088|FG009|Overall Study|Withdrawal by Subject|1|||
44112540|NCT00150462|78895089|FG010|Overall Study|Withdrawal by Subject|0|||
44112541|NCT00150462|78895079|FG000|Overall Study|Death|0|||
44112542|NCT00150462|78895080|FG001|Overall Study|Death|1|||
44112543|NCT00150462|78895081|FG002|Overall Study|Death|0|||
44112544|NCT00150462|78895082|FG003|Overall Study|Death|0|||
44112545|NCT00150462|78895083|FG004|Overall Study|Death|0|||
44112546|NCT00150462|78895084|FG005|Overall Study|Death|0|||
44112547|NCT00150462|78895085|FG006|Overall Study|Death|0|||
44112548|NCT00150462|78895086|FG007|Overall Study|Death|0|||
44112549|NCT00150462|78895087|FG008|Overall Study|Death|1|||
44112550|NCT00150462|78895088|FG009|Overall Study|Death|0|||
44112551|NCT00150462|78895089|FG010|Overall Study|Death|0|||
44112552|NCT00150462|78895079|FG000|Overall Study|Adverse Event|0|||
44112553|NCT00150462|78895080|FG001|Overall Study|Adverse Event|0|||
44112554|NCT00150462|78895081|FG002|Overall Study|Adverse Event|0|||
44112555|NCT00150462|78895082|FG003|Overall Study|Adverse Event|1|||
44112556|NCT00150462|78895083|FG004|Overall Study|Adverse Event|0|||
44112557|NCT00150462|78895084|FG005|Overall Study|Adverse Event|0|||
44112558|NCT00150462|78895085|FG006|Overall Study|Adverse Event|0|||
44237793|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44237794|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44237795|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44237796|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44505290|NCT00320489|79510104|FG000|Overall Study|Lack of Efficacy|16|||
44505291|NCT00320489|79510105|FG001|Overall Study|Lack of Efficacy|7|||
44505292|NCT00320489|79510104|FG000|Overall Study|Lost to Follow-up|21|||
44505293|NCT00320489|79510105|FG001|Overall Study|Lost to Follow-up|22|||
44505294|NCT00320489|79510104|FG000|Overall Study|Physician Decision|8|||
44505295|NCT00320489|79510105|FG001|Overall Study|Physician Decision|8|||
44505296|NCT00320489|79510104|FG000|Overall Study|Protocol Violation|4|||
44505297|NCT00320489|79510105|FG001|Overall Study|Protocol Violation|4|||
44505298|NCT00320489|79510104|FG000|Overall Study|Sponsor Decision|3|||
44505299|NCT00320489|79510105|FG001|Overall Study|Sponsor Decision|3|||
44505300|NCT00320489|79510104|FG000|Overall Study|Withdrawal by Subject|39|||
44505301|NCT00320489|79510105|FG001|Overall Study|Withdrawal by Subject|41|||
44112559|NCT00150462|78895086|FG007|Overall Study|Adverse Event|2|||
44112560|NCT00150462|78895087|FG008|Overall Study|Adverse Event|0|||
44112561|NCT00150462|78895088|FG009|Overall Study|Adverse Event|1|||
44112562|NCT00150462|78895089|FG010|Overall Study|Adverse Event|0|||
44112563|NCT00150462|78895079|FG000|Overall Study|Physician Decision|0|||
44112564|NCT00150462|78895080|FG001|Overall Study|Physician Decision|0|||
44505302|NCT03928028|79510114|FG000|Overall Study|Physician Decision|9|||
44505303|NCT03928028|79510115|FG001|Overall Study|Physician Decision|6|||
44112565|NCT00150462|78895081|FG002|Overall Study|Physician Decision|1|||
44112566|NCT00150462|78895082|FG003|Overall Study|Physician Decision|1|||
44112567|NCT00150462|78895083|FG004|Overall Study|Physician Decision|0|||
44237797|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44112568|NCT00150462|78895084|FG005|Overall Study|Physician Decision|0|||
44112569|NCT00150462|78895085|FG006|Overall Study|Physician Decision|0|||
44112570|NCT00150462|78895086|FG007|Overall Study|Physician Decision|0|||
44112571|NCT00150462|78895087|FG008|Overall Study|Physician Decision|0|||
44112572|NCT00150462|78895088|FG009|Overall Study|Physician Decision|0|||
44112573|NCT00150462|78895089|FG010|Overall Study|Physician Decision|0|||
44112574|NCT00150462|78895079|FG000|Overall Study|Other|0|||
44112575|NCT00150462|78895080|FG001|Overall Study|Other|0|||
44112576|NCT00150462|78895081|FG002|Overall Study|Other|0|||
44112577|NCT00150462|78895082|FG003|Overall Study|Other|0|||
44112578|NCT00150462|78895083|FG004|Overall Study|Other|0|||
44112579|NCT00150462|78895084|FG005|Overall Study|Other|0|||
44112580|NCT00150462|78895085|FG006|Overall Study|Other|0|||
44112581|NCT00150462|78895086|FG007|Overall Study|Other|0|||
44112582|NCT00150462|78895087|FG008|Overall Study|Other|0|||
44112583|NCT00150462|78895088|FG009|Overall Study|Other|1|||
44112584|NCT00150462|78895089|FG010|Overall Study|Other|1|||
44112585|NCT01368081|78895129|FG000|Overall Study|Adverse Event|4|||
44112586|NCT01368081|78895130|FG001|Overall Study|Adverse Event|4|||
44112587|NCT01368081|78895131|FG002|Overall Study|Adverse Event|3|||
44112588|NCT01368081|78895132|FG003|Overall Study|Adverse Event|2|||
44112589|NCT01368081|78895133|FG004|Overall Study|Adverse Event|2|||
44112590|NCT01368081|78895134|FG005|Overall Study|Adverse Event|5|||
44112591|NCT01368081|78895135|FG006|Overall Study|Adverse Event|6|||
44112592|NCT01368081|78895136|FG007|Overall Study|Adverse Event|2|||
44112593|NCT01368081|78895137|FG008|Overall Study|Adverse Event|3|||
44112594|NCT01368081|78895138|FG009|Overall Study|Adverse Event|5|||
44112595|NCT01368081|78895139|FG010|Overall Study|Adverse Event|6|||
44112596|NCT01368081|78895140|FG011|Overall Study|Adverse Event|1|||
44112597|NCT01368081|78895141|FG012|Overall Study|Adverse Event|3|||
44112598|NCT01368081|78895129|FG000|Overall Study|Lack of Efficacy|0|||
44112599|NCT01368081|78895130|FG001|Overall Study|Lack of Efficacy|1|||
44112600|NCT01368081|78895131|FG002|Overall Study|Lack of Efficacy|0|||
44112601|NCT01368081|78895132|FG003|Overall Study|Lack of Efficacy|1|||
44112602|NCT01368081|78895133|FG004|Overall Study|Lack of Efficacy|0|||
44112603|NCT01368081|78895134|FG005|Overall Study|Lack of Efficacy|0|||
44112604|NCT01368081|78895135|FG006|Overall Study|Lack of Efficacy|0|||
44112605|NCT01368081|78895136|FG007|Overall Study|Lack of Efficacy|2|||
44112606|NCT01368081|78895137|FG008|Overall Study|Lack of Efficacy|0|||
44112607|NCT01368081|78895138|FG009|Overall Study|Lack of Efficacy|0|||
44112608|NCT01368081|78895139|FG010|Overall Study|Lack of Efficacy|0|||
44112609|NCT01368081|78895140|FG011|Overall Study|Lack of Efficacy|0|||
44112610|NCT01368081|78895141|FG012|Overall Study|Lack of Efficacy|0|||
44112611|NCT01368081|78895129|FG000|Overall Study|Protocol Violation|0|||
44112612|NCT01368081|78895130|FG001|Overall Study|Protocol Violation|0|||
44112613|NCT01368081|78895131|FG002|Overall Study|Protocol Violation|0|||
44112614|NCT01368081|78895132|FG003|Overall Study|Protocol Violation|0|||
44112615|NCT01368081|78895133|FG004|Overall Study|Protocol Violation|0|||
44112616|NCT01368081|78895134|FG005|Overall Study|Protocol Violation|1|||
44112617|NCT01368081|78895135|FG006|Overall Study|Protocol Violation|0|||
44112618|NCT01368081|78895136|FG007|Overall Study|Protocol Violation|1|||
44112619|NCT01368081|78895137|FG008|Overall Study|Protocol Violation|0|||
44112620|NCT01368081|78895138|FG009|Overall Study|Protocol Violation|0|||
44112621|NCT01368081|78895139|FG010|Overall Study|Protocol Violation|0|||
44112622|NCT01368081|78895140|FG011|Overall Study|Protocol Violation|0|||
44112623|NCT01368081|78895141|FG012|Overall Study|Protocol Violation|0|||
44112624|NCT01368081|78895129|FG000|Overall Study|Lost to Follow-up|0|||
44112625|NCT01368081|78895130|FG001|Overall Study|Lost to Follow-up|0|||
44237798|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44112626|NCT01368081|78895131|FG002|Overall Study|Lost to Follow-up|0|||
44112627|NCT01368081|78895132|FG003|Overall Study|Lost to Follow-up|0|||
44237799|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
44377907|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
44377908|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
44112628|NCT01368081|78895133|FG004|Overall Study|Lost to Follow-up|0|||
44112629|NCT01368081|78895134|FG005|Overall Study|Lost to Follow-up|0|||
44112630|NCT01368081|78895135|FG006|Overall Study|Lost to Follow-up|0|||
44112631|NCT01368081|78895136|FG007|Overall Study|Lost to Follow-up|0|||
44112632|NCT01368081|78895137|FG008|Overall Study|Lost to Follow-up|0|||
44112633|NCT01368081|78895138|FG009|Overall Study|Lost to Follow-up|0|||
44112634|NCT01368081|78895139|FG010|Overall Study|Lost to Follow-up|0|||
44112635|NCT01368081|78895140|FG011|Overall Study|Lost to Follow-up|0|||
44112636|NCT01368081|78895141|FG012|Overall Study|Lost to Follow-up|1|||
44112637|NCT01368081|78895129|FG000|Overall Study|Withdrawal by Subject|4|||
44377909|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
44505304|NCT03928028|79510116|FG002|Overall Study|Physician Decision|3|||
44112638|NCT01368081|78895130|FG001|Overall Study|Withdrawal by Subject|4|||
44112639|NCT01368081|78895131|FG002|Overall Study|Withdrawal by Subject|1|||
44112640|NCT01368081|78895132|FG003|Overall Study|Withdrawal by Subject|1|||
44112641|NCT01368081|78895133|FG004|Overall Study|Withdrawal by Subject|0|||
44112642|NCT01368081|78895134|FG005|Overall Study|Withdrawal by Subject|3|||
44112643|NCT01368081|78895135|FG006|Overall Study|Withdrawal by Subject|4|||
44112644|NCT01368081|78895136|FG007|Overall Study|Withdrawal by Subject|2|||
44112645|NCT01368081|78895137|FG008|Overall Study|Withdrawal by Subject|5|||
44112646|NCT01368081|78895138|FG009|Overall Study|Withdrawal by Subject|4|||
44112647|NCT01368081|78895139|FG010|Overall Study|Withdrawal by Subject|3|||
44112648|NCT01368081|78895140|FG011|Overall Study|Withdrawal by Subject|2|||
44112649|NCT01368081|78895141|FG012|Overall Study|Withdrawal by Subject|0|||
44112650|NCT01368081|78895129|FG000|Overall Study|Other reason not defined above|2|||
44112651|NCT01368081|78895130|FG001|Overall Study|Other reason not defined above|0|||
44112652|NCT01368081|78895131|FG002|Overall Study|Other reason not defined above|0|||
44112653|NCT01368081|78895132|FG003|Overall Study|Other reason not defined above|1|||
44112654|NCT01368081|78895133|FG004|Overall Study|Other reason not defined above|0|||
44112655|NCT01368081|78895134|FG005|Overall Study|Other reason not defined above|1|||
44112656|NCT01368081|78895135|FG006|Overall Study|Other reason not defined above|2|||
44112657|NCT01368081|78895136|FG007|Overall Study|Other reason not defined above|0|||
44112658|NCT01368081|78895137|FG008|Overall Study|Other reason not defined above|0|||
44112659|NCT01368081|78895138|FG009|Overall Study|Other reason not defined above|1|||
44112660|NCT01368081|78895139|FG010|Overall Study|Other reason not defined above|0|||
44112661|NCT01368081|78895140|FG011|Overall Study|Other reason not defined above|0|||
44572790|NCT03350984|79595044|FG001|Overall Study|Protocol Violation|2|||
44572791|NCT03350984|79595043|FG000|Overall Study|Physician Decision|1|||
44572792|NCT03350984|79595044|FG001|Overall Study|Physician Decision|0|||
44572793|NCT05176717|79595062|FG000|Overall Study|Sponsor Decision|1|||
44572794|NCT05176717|79595063|FG001|Overall Study|Sponsor Decision|2|||
44572795|NCT05176717|79595064|FG002|Overall Study|Sponsor Decision|2|||
44572796|NCT02770248|79595074|FG000|Overall Study|Adverse Event|0|||
44572797|NCT02770248|79595075|FG001|Overall Study|Adverse Event|1|||
44572798|NCT02770248|79595074|FG000|Overall Study|Randomized in error, prior to treatment|0|||
44572799|NCT02770248|79595075|FG001|Overall Study|Randomized in error, prior to treatment|1|||
44572800|NCT01344369|79595083|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
44572801|NCT01344369|79595084|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
44572802|NCT01344369|79595083|FG000|Washout of 28 Days|Physician Decision|0|||
44572803|NCT01344369|79595084|FG001|Washout of 28 Days|Physician Decision|1|||
44572804|NCT01344369|79595083|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
44572805|NCT01344369|79595084|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
44572806|NCT03179462|79595093|FG000|Overall Study|screening failure|1|||
44572807|NCT03179462|79595094|FG001|Overall Study|screening failure|2|||
44572808|NCT03179462|79595095|FG002|Overall Study|screening failure|0|||
44572809|NCT01314703|79595103|FG000|Overall Study|screen failure and closed enrollment|8|||
44572810|NCT01360762|79595108|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
44572811|NCT01360762|79595108|FG000|Main Study Period (12-month Treatment)|Death|5|||
44572812|NCT01360762|79595108|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
44572813|NCT01360762|79595108|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
44572814|NCT01360762|79595108|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
44572815|NCT01360762|79595108|FG000|Whole Study Period|Lost to Follow-up|10|||
44572816|NCT01360762|79595108|FG000|Whole Study Period|Death|7|||
44572817|NCT01360762|79595108|FG000|Whole Study Period|Patient relapsed|18|||
44572818|NCT01360762|79595108|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
44572819|NCT04382924|79595115|FG000|Overall Study|Death|2|||
44572820|NCT04382924|79595116|FG001|Overall Study|Death|5|||
44572821|NCT04382924|79595117|FG002|Overall Study|Death|4|||
44572822|NCT04382924|79595115|FG000|Overall Study|Protocol Violation|0|||
44572823|NCT04382924|79595116|FG001|Overall Study|Protocol Violation|1|||
44572824|NCT04382924|79595117|FG002|Overall Study|Protocol Violation|1|||
44572825|NCT04382924|79595115|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
44572826|NCT04382924|79595116|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
44572827|NCT04382924|79595117|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
44572828|NCT04382924|79595115|FG000|Overall Study|Withdrawal by Subject|6|||
44572829|NCT04382924|79595116|FG001|Overall Study|Withdrawal by Subject|3|||
44572830|NCT04382924|79595117|FG002|Overall Study|Withdrawal by Subject|6|||
44572831|NCT03044431|79595131|FG000|Overall Study|Lost to Follow-up|59|||
44572832|NCT02770170|79595139|FG000|Overall Study|Withdrawal by Subject|0|||
44572833|NCT02770170|79595140|FG001|Overall Study|Withdrawal by Subject|0|||
44572834|NCT02770170|79595141|FG002|Overall Study|Withdrawal by Subject|0|||
44572835|NCT02770170|79595142|FG003|Overall Study|Withdrawal by Subject|2|||
44112662|NCT01368081|78895141|FG012|Overall Study|Other reason not defined above|3|||
44112663|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
44112664|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
44112665|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
44112666|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
44572836|NCT02770170|79595139|FG000|Overall Study|due to pregnancy|1|||
44572837|NCT02770170|79595140|FG001|Overall Study|due to pregnancy|0|||
44112667|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
44572838|NCT02770170|79595141|FG002|Overall Study|due to pregnancy|0|||
44572839|NCT02770170|79595142|FG003|Overall Study|due to pregnancy|0|||
44572840|NCT02770170|79595139|FG000|Overall Study|Lack of Efficacy|2|||
44112668|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
44112669|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
44112670|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
44112671|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Other|4|||
44112672|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Other|1|||
44112673|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
44112674|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
44112675|NCT00303498|78895171|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
44112676|NCT00303498|78895172|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
44112677|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
44112678|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
44112679|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Death|1|||
44112680|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Death|0|||
44112681|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
44112682|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
44112683|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
44112684|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
44112685|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
44112686|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
44112687|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
44112688|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
44112689|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Other|1|||
44112690|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Other|0|||
44112691|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
44112692|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
44112693|NCT00303498|78895171|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
44112694|NCT00303498|78895172|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
44112695|NCT02588092|78895188|FG000|Overall Study|Death|4|||
44112696|NCT02588092|78895189|FG001|Overall Study|Death|3|||
44112697|NCT02588092|78895190|FG002|Overall Study|Death|3|||
44112698|NCT02588092|78895191|FG003|Overall Study|Death|3|||
44112699|NCT02588092|78895192|FG004|Overall Study|Death|2|||
44112700|NCT02588092|78895193|FG005|Overall Study|Death|2|||
44112701|NCT02588092|78895194|FG006|Overall Study|Death|2|||
44112702|NCT02588092|78895195|FG007|Overall Study|Death|1|||
44112703|NCT02588092|78895196|FG008|Overall Study|Death|5|||
44112704|NCT02588092|78895197|FG009|Overall Study|Death|2|||
44112705|NCT02588092|78895188|FG000|Overall Study|Withdrawal by Subject|0|||
44112706|NCT02588092|78895189|FG001|Overall Study|Withdrawal by Subject|0|||
44112707|NCT02588092|78895190|FG002|Overall Study|Withdrawal by Subject|0|||
44112708|NCT02588092|78895191|FG003|Overall Study|Withdrawal by Subject|0|||
44112709|NCT02588092|78895192|FG004|Overall Study|Withdrawal by Subject|0|||
44112710|NCT02588092|78895193|FG005|Overall Study|Withdrawal by Subject|1|||
44112711|NCT02588092|78895194|FG006|Overall Study|Withdrawal by Subject|1|||
44505305|NCT03928028|79510114|FG000|Overall Study|Withdrawal by Subject|12|||
44112712|NCT02588092|78895195|FG007|Overall Study|Withdrawal by Subject|2|||
44112713|NCT02588092|78895196|FG008|Overall Study|Withdrawal by Subject|0|||
44505306|NCT03928028|79510115|FG001|Overall Study|Withdrawal by Subject|3|||
44505307|NCT03928028|79510116|FG002|Overall Study|Withdrawal by Subject|3|||
44505308|NCT00320411|79510124|FG000|Overall Study|No investigational product admin.|4|||
44505309|NCT00320255|79510134|FG000|Overall Study|Lack of Efficacy|1|||
44505310|NCT00320255|79510135|FG001|Overall Study|Lack of Efficacy|0|||
44505311|NCT00320255|79510136|FG002|Overall Study|Lack of Efficacy|0|||
44505312|NCT00320255|79510137|FG003|Overall Study|Lack of Efficacy|0|||
44505313|NCT00320255|79510138|FG004|Overall Study|Lack of Efficacy|0|||
44505314|NCT00320255|79510139|FG005|Overall Study|Lack of Efficacy|0|||
44505315|NCT00320255|79510134|FG000|Overall Study|Adverse Event|5|||
44505316|NCT00320255|79510135|FG001|Overall Study|Adverse Event|2|||
44505317|NCT00320255|79510136|FG002|Overall Study|Adverse Event|3|||
44505318|NCT00320255|79510137|FG003|Overall Study|Adverse Event|2|||
44505319|NCT00320255|79510138|FG004|Overall Study|Adverse Event|0|||
44505320|NCT00320255|79510139|FG005|Overall Study|Adverse Event|0|||
44505321|NCT00320255|79510134|FG000|Overall Study|Withdrawal by Subject|1|||
44505322|NCT00320255|79510135|FG001|Overall Study|Withdrawal by Subject|2|||
44505323|NCT00320255|79510136|FG002|Overall Study|Withdrawal by Subject|2|||
44505324|NCT00320255|79510137|FG003|Overall Study|Withdrawal by Subject|4|||
44505325|NCT00320255|79510138|FG004|Overall Study|Withdrawal by Subject|0|||
44505326|NCT00320255|79510139|FG005|Overall Study|Withdrawal by Subject|0|||
44505327|NCT00320255|79510134|FG000|Overall Study|Poor compliance/noncompliance|1|||
44505328|NCT00320255|79510135|FG001|Overall Study|Poor compliance/noncompliance|1|||
44505329|NCT00320255|79510136|FG002|Overall Study|Poor compliance/noncompliance|0|||
44237800|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237801|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
44237802|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237803|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237804|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237805|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237806|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237807|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237808|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237809|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237810|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237811|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237812|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44237813|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
44237814|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
44237815|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
44237816|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237817|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237818|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237819|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237820|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237821|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237822|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237823|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237824|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237825|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237826|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44237827|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
44237828|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237829|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
44237830|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237831|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237832|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237833|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237834|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237835|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237836|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237837|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237838|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237839|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237840|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
44237841|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
44237842|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44505330|NCT00320255|79510137|FG003|Overall Study|Poor compliance/noncompliance|1|||
44505331|NCT00320255|79510138|FG004|Overall Study|Poor compliance/noncompliance|0|||
44505332|NCT00320255|79510139|FG005|Overall Study|Poor compliance/noncompliance|0|||
44505333|NCT00320255|79510134|FG000|Overall Study|No longer meets study criteria|0|||
44505334|NCT00320255|79510135|FG001|Overall Study|No longer meets study criteria|0|||
44505335|NCT00320255|79510136|FG002|Overall Study|No longer meets study criteria|0|||
44505336|NCT00320255|79510137|FG003|Overall Study|No longer meets study criteria|1|||
44505337|NCT00320255|79510138|FG004|Overall Study|No longer meets study criteria|0|||
44572841|NCT02770170|79595140|FG001|Overall Study|Lack of Efficacy|0|||
44572842|NCT02770170|79595141|FG002|Overall Study|Lack of Efficacy|0|||
44572843|NCT02770170|79595142|FG003|Overall Study|Lack of Efficacy|1|||
44572844|NCT02770170|79595139|FG000|Overall Study|Adverse Event|4|||
44572845|NCT02770170|79595140|FG001|Overall Study|Adverse Event|3|||
44572846|NCT02770170|79595141|FG002|Overall Study|Adverse Event|5|||
44572847|NCT02770170|79595142|FG003|Overall Study|Adverse Event|3|||
44572848|NCT02770170|79595139|FG000|Overall Study|due to disease worsening|0|||
44572849|NCT02770170|79595140|FG001|Overall Study|due to disease worsening|0|||
44572850|NCT02770170|79595141|FG002|Overall Study|due to disease worsening|0|||
44237843|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
44237844|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237845|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237846|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44505338|NCT00320255|79510139|FG005|Overall Study|No longer meets study criteria|0|||
44572851|NCT02770170|79595142|FG003|Overall Study|due to disease worsening|1|||
44572852|NCT02769858|79595152|FG000|Overall Study|Withdrawal by Subject|2|||
44505339|NCT00320255|79510134|FG000|Overall Study|Other|3|||
44505340|NCT00320255|79510135|FG001|Overall Study|Other|2|||
44505341|NCT00320255|79510136|FG002|Overall Study|Other|1|||
44505342|NCT00320255|79510137|FG003|Overall Study|Other|0|||
44112714|NCT02588092|78895197|FG009|Overall Study|Withdrawal by Subject|0|||
44112715|NCT02588092|78895188|FG000|Overall Study|Started Another Treatment|0|||
44112716|NCT02588092|78895189|FG001|Overall Study|Started Another Treatment|0|||
44112717|NCT02588092|78895190|FG002|Overall Study|Started Another Treatment|0|||
44112718|NCT02588092|78895191|FG003|Overall Study|Started Another Treatment|0|||
44112719|NCT02588092|78895192|FG004|Overall Study|Started Another Treatment|1|||
44112720|NCT02588092|78895193|FG005|Overall Study|Started Another Treatment|0|||
44112721|NCT02588092|78895194|FG006|Overall Study|Started Another Treatment|0|||
44112722|NCT02588092|78895195|FG007|Overall Study|Started Another Treatment|1|||
44112723|NCT02588092|78895196|FG008|Overall Study|Started Another Treatment|0|||
44112724|NCT02588092|78895197|FG009|Overall Study|Started Another Treatment|0|||
44112725|NCT02588092|78895188|FG000|Overall Study|Sponsor Decision|0|||
44112726|NCT02588092|78895189|FG001|Overall Study|Sponsor Decision|0|||
44112727|NCT02588092|78895190|FG002|Overall Study|Sponsor Decision|0|||
44112728|NCT02588092|78895191|FG003|Overall Study|Sponsor Decision|0|||
44112729|NCT02588092|78895192|FG004|Overall Study|Sponsor Decision|0|||
44112730|NCT02588092|78895193|FG005|Overall Study|Sponsor Decision|0|||
44112731|NCT02588092|78895194|FG006|Overall Study|Sponsor Decision|0|||
44112732|NCT02588092|78895195|FG007|Overall Study|Sponsor Decision|0|||
44112733|NCT02588092|78895196|FG008|Overall Study|Sponsor Decision|1|||
44112734|NCT02588092|78895197|FG009|Overall Study|Sponsor Decision|1|||
44112735|NCT01367847|78895225|FG000|Overall Study|Withdrawal by Subject|2|||
44112736|NCT01367847|78895226|FG001|Overall Study|Withdrawal by Subject|2|||
44112737|NCT00150618|78895238|FG000|Overall Study|Adverse Event|2|||
44112738|NCT00150618|78895239|FG001|Overall Study|Adverse Event|2|||
44112739|NCT00150618|78895240|FG002|Overall Study|Adverse Event|6|||
44112740|NCT00150618|78895241|FG003|Overall Study|Adverse Event|9|||
44112741|NCT00150618|78895242|FG004|Overall Study|Adverse Event|5|||
44112742|NCT00150618|78895238|FG000|Overall Study|Withdrawal by Subject|6|||
44112743|NCT00150618|78895239|FG001|Overall Study|Withdrawal by Subject|8|||
44505343|NCT00320255|79510138|FG004|Overall Study|Other|0|||
44505344|NCT00320255|79510139|FG005|Overall Study|Other|0|||
44505345|NCT00370331|79510156|FG000|Overall Study|Adverse Event|4|||
44572853|NCT02769624|79595156|FG000|Overall Study|Lost to Follow-up|0|||
44572854|NCT02769624|79595157|FG001|Overall Study|Lost to Follow-up|1|||
44572855|NCT03446768|79595165|FG000|Overall Study|Withdrawal by Subject|0|||
44572856|NCT03446768|79595166|FG001|Overall Study|Withdrawal by Subject|1|||
44572857|NCT02676284|79595172|FG000|Overall Study|Withdrawal by Subject|1|||
44572858|NCT02769312|79595178|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
44572859|NCT02769312|79595179|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
44572860|NCT02769312|79595178|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
44572861|NCT02769312|79595179|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
44572862|NCT02769312|79595178|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
44572863|NCT02769312|79595179|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
44572864|NCT02769312|79595178|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
44572865|NCT02769312|79595179|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
44572866|NCT02769312|79595178|FG000|Follow-up|Lost to Follow-up|1|||
44572867|NCT02769312|79595179|FG001|Follow-up|Lost to Follow-up|1|||
44572868|NCT01673386|79595186|FG000|Overall Study|Study terminated by sponsor|16|||
44572869|NCT01673386|79595187|FG001|Overall Study|Study terminated by sponsor|22|||
44572870|NCT01673386|79595186|FG000|Overall Study|Adverse Event|5|||
44572871|NCT01673386|79595187|FG001|Overall Study|Adverse Event|2|||
44572872|NCT01673386|79595186|FG000|Overall Study|Progressive disease|4|||
44572873|NCT01673386|79595187|FG001|Overall Study|Progressive disease|1|||
44572874|NCT01673386|79595186|FG000|Overall Study|Withdrawal by Subject|0|||
44572875|NCT01673386|79595187|FG001|Overall Study|Withdrawal by Subject|2|||
44572876|NCT00103740|79595195|FG000|Period 1 - Core|Adverse Event|1|||
44572877|NCT00103740|79595196|FG001|Period 1 - Core|Adverse Event|0|||
44112744|NCT00150618|78895240|FG002|Overall Study|Withdrawal by Subject|8|||
44112745|NCT00150618|78895241|FG003|Overall Study|Withdrawal by Subject|4|||
44112746|NCT00150618|78895242|FG004|Overall Study|Withdrawal by Subject|5|||
44112747|NCT00150618|78895238|FG000|Overall Study|Lost to Follow-up|4|||
44505346|NCT00370331|79510157|FG001|Overall Study|Adverse Event|13|||
44572878|NCT00103740|79595195|FG000|Period 1 - Core|Protocol Violation|3|||
44572879|NCT00103740|79595196|FG001|Period 1 - Core|Protocol Violation|2|||
44572880|NCT00103740|79595195|FG000|Period 1 - Core|Patient withdrew consent|3|||
44572881|NCT00103740|79595196|FG001|Period 1 - Core|Patient withdrew consent|2|||
44572882|NCT00103740|79595195|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
44572883|NCT00103740|79595196|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
44572884|NCT00103740|79595195|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
44572885|NCT00103740|79595196|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
44112748|NCT00150618|78895239|FG001|Overall Study|Lost to Follow-up|1|||
44505347|NCT00370331|79510156|FG000|Overall Study|Withdrawal by Subject|2|||
44112749|NCT00150618|78895240|FG002|Overall Study|Lost to Follow-up|5|||
44112750|NCT00150618|78895241|FG003|Overall Study|Lost to Follow-up|8|||
44112751|NCT00150618|78895242|FG004|Overall Study|Lost to Follow-up|4|||
44112752|NCT00150618|78895238|FG000|Overall Study|Protocol Violation|1|||
44572886|NCT00103740|79595195|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
44572887|NCT00103740|79595196|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
44572888|NCT00103740|79595195|FG000|Period 2 - Extended Observation Period|Death|6|||
44572889|NCT00103740|79595196|FG001|Period 2 - Extended Observation Period|Death|2|||
44572890|NCT00103740|79595195|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
44572891|NCT00103740|79595196|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
44572892|NCT01281644|79595202|FG000|Overall Study|Lost to Follow-up|3|||
44572893|NCT01281644|79595202|FG000|Overall Study|Withdrawal by Subject|2|||
44572894|NCT02869893|79595208|FG000|Overall Study|participant aversion to IV|5|||
44572895|NCT02869893|79595208|FG000|Overall Study|participant fear of MRI scanner|2|||
44572896|NCT02872311|79595232|FG000|Overall Study|Death|2|||
44572897|NCT02872311|79595233|FG001|Overall Study|Death|0|||
44572898|NCT02872311|79595234|FG002|Overall Study|Death|0|||
44572899|NCT02872311|79595235|FG003|Overall Study|Death|0|||
44572900|NCT02872311|79595236|FG004|Overall Study|Death|0|||
44572901|NCT02872311|79595232|FG000|Overall Study|Lost to Follow-up|2|||
44572902|NCT02872311|79595233|FG001|Overall Study|Lost to Follow-up|0|||
44572903|NCT02872311|79595234|FG002|Overall Study|Lost to Follow-up|0|||
44572904|NCT02872311|79595235|FG003|Overall Study|Lost to Follow-up|0|||
44572905|NCT02872311|79595236|FG004|Overall Study|Lost to Follow-up|0|||
44572906|NCT02872311|79595232|FG000|Overall Study|Protocol Violation|0|||
44112753|NCT00150618|78895239|FG001|Overall Study|Protocol Violation|0|||
44112754|NCT00150618|78895240|FG002|Overall Study|Protocol Violation|0|||
44112755|NCT00150618|78895241|FG003|Overall Study|Protocol Violation|0|||
44112756|NCT00150618|78895242|FG004|Overall Study|Protocol Violation|1|||
44112757|NCT00150618|78895238|FG000|Overall Study|Lack of Efficacy|1|||
44112758|NCT00150618|78895239|FG001|Overall Study|Lack of Efficacy|4|||
44237847|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237848|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237849|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237850|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237851|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237852|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237853|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237854|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44237855|NCT01695239|79064356|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
44237856|NCT01695239|79064357|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237857|NCT01695239|79064358|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44505348|NCT00370331|79510157|FG001|Overall Study|Withdrawal by Subject|4|||
44505349|NCT00370331|79510156|FG000|Overall Study|Lost to Follow-up|0|||
44505350|NCT00370331|79510157|FG001|Overall Study|Lost to Follow-up|3|||
44505351|NCT00370331|79510156|FG000|Overall Study|Lack of Efficacy|0|||
44505352|NCT00370331|79510157|FG001|Overall Study|Lack of Efficacy|1|||
44505353|NCT00370331|79510156|FG000|Overall Study|Non-compliance|0|||
44505354|NCT00370331|79510157|FG001|Overall Study|Non-compliance|1|||
44505355|NCT00370331|79510156|FG000|Overall Study|Protocol Violation|1|||
44505356|NCT00370331|79510157|FG001|Overall Study|Protocol Violation|1|||
44505357|NCT02962960|79510166|FG000|Overall Study|Withdrawal by Subject|1|||
44237858|NCT01695239|79064359|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237859|NCT01695239|79064360|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237860|NCT01695239|79064361|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237861|NCT01695239|79064362|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237862|NCT01695239|79064363|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237863|NCT01695239|79064364|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44505358|NCT02962960|79510167|FG001|Overall Study|Withdrawal by Subject|1|||
44505359|NCT02962960|79510168|FG002|Overall Study|Withdrawal by Subject|0|||
44505360|NCT02962960|79510166|FG000|Overall Study|Adverse Event|1|||
44572907|NCT02872311|79595233|FG001|Overall Study|Protocol Violation|2|||
44572908|NCT02872311|79595234|FG002|Overall Study|Protocol Violation|1|||
44572909|NCT02872311|79595235|FG003|Overall Study|Protocol Violation|0|||
44572910|NCT02872311|79595236|FG004|Overall Study|Protocol Violation|0|||
44572911|NCT02871375|79595264|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
44112759|NCT00150618|78895240|FG002|Overall Study|Lack of Efficacy|7|||
44112760|NCT00150618|78895241|FG003|Overall Study|Lack of Efficacy|4|||
44505361|NCT02962960|79510167|FG001|Overall Study|Adverse Event|1|||
44505362|NCT02962960|79510168|FG002|Overall Study|Adverse Event|0|||
44505363|NCT02962960|79510166|FG000|Overall Study|Protocol Violation|1|||
44505364|NCT02962960|79510167|FG001|Overall Study|Protocol Violation|0|||
44112761|NCT00150618|78895242|FG004|Overall Study|Lack of Efficacy|6|||
44112762|NCT00150618|78895238|FG000|Overall Study|No study meds|0|||
44572912|NCT02871375|79595265|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
44572913|NCT02867709|79595276|FG000|Treatment Period|Adverse Event|1|||
44572914|NCT02867709|79595277|FG001|Treatment Period|Adverse Event|1|||
44572915|NCT02867709|79595278|FG002|Treatment Period|Adverse Event|2|||
44572916|NCT02867709|79595276|FG000|Treatment Period|Withdrawal of Consent|7|||
44572917|NCT02867709|79595277|FG001|Treatment Period|Withdrawal of Consent|9|||
44572918|NCT02867709|79595278|FG002|Treatment Period|Withdrawal of Consent|8|||
44572919|NCT02867709|79595276|FG000|Treatment Period|Lost to Follow-up|17|||
44112763|NCT00150618|78895239|FG001|Overall Study|No study meds|0|||
44112764|NCT00150618|78895240|FG002|Overall Study|No study meds|0|||
44112765|NCT00150618|78895241|FG003|Overall Study|No study meds|0|||
44572920|NCT02867709|79595277|FG001|Treatment Period|Lost to Follow-up|20|||
44572921|NCT02867709|79595278|FG002|Treatment Period|Lost to Follow-up|20|||
44112766|NCT00150618|78895242|FG004|Overall Study|No study meds|2|||
44237864|NCT01695239|79064365|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237865|NCT01695239|79064366|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237866|NCT01695239|79064367|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44377910|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
44572922|NCT02867709|79595276|FG000|Treatment Period|Lack of Qualifying Event|42|||
44572923|NCT02867709|79595277|FG001|Treatment Period|Lack of Qualifying Event|55|||
44572924|NCT02867709|79595278|FG002|Treatment Period|Lack of Qualifying Event|42|||
44572925|NCT02867709|79595276|FG000|Treatment Period|Protocol Violation|3|||
44572926|NCT02867709|79595277|FG001|Treatment Period|Protocol Violation|2|||
44572927|NCT02867709|79595278|FG002|Treatment Period|Protocol Violation|3|||
44572928|NCT02867709|79595276|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
44572929|NCT02867709|79595277|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
44572930|NCT02867709|79595278|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
44572931|NCT02867709|79595276|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
44572932|NCT02867709|79595277|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
44572933|NCT02867709|79595278|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
44572934|NCT02867709|79595276|FG000|Safety Follow-up Period|Pregnancy|0|||
44572935|NCT02867709|79595277|FG001|Safety Follow-up Period|Pregnancy|1|||
44572936|NCT02867709|79595278|FG002|Safety Follow-up Period|Pregnancy|0|||
44572937|NCT02867709|79595276|FG000|Safety Follow-up Period|Protocol Violation|0|||
44572938|NCT02867709|79595277|FG001|Safety Follow-up Period|Protocol Violation|1|||
44572939|NCT02867709|79595278|FG002|Safety Follow-up Period|Protocol Violation|1|||
44572940|NCT03044353|79595289|FG000|Overall Study|Adverse Event|0|||
44572941|NCT03044353|79595290|FG001|Overall Study|Adverse Event|1|||
44572942|NCT03044353|79595291|FG002|Overall Study|Adverse Event|0|||
44572943|NCT01361308|79595300|FG000|Overall Study|Withdrawal by Subject|9|||
44572944|NCT01361308|79595301|FG001|Overall Study|Withdrawal by Subject|13|||
44572945|NCT01361308|79595300|FG000|Overall Study|Physician Decision|3|||
44572946|NCT01361308|79595301|FG001|Overall Study|Physician Decision|3|||
44572947|NCT01361308|79595300|FG000|Overall Study|Lack of Efficacy|2|||
44572948|NCT01361308|79595301|FG001|Overall Study|Lack of Efficacy|0|||
44572949|NCT01361308|79595300|FG000|Overall Study|Protocol Violation|1|||
44572950|NCT01361308|79595301|FG001|Overall Study|Protocol Violation|0|||
44572951|NCT01361308|79595300|FG000|Overall Study|Lost to Follow-up|5|||
44572952|NCT01361308|79595301|FG001|Overall Study|Lost to Follow-up|4|||
44572953|NCT01361308|79595300|FG000|Overall Study|Adverse Event|8|||
44572954|NCT01361308|79595301|FG001|Overall Study|Adverse Event|4|||
44572955|NCT01361308|79595300|FG000|Overall Study|Eligibility Criteria Not Met|2|||
44572956|NCT01361308|79595301|FG001|Overall Study|Eligibility Criteria Not Met|3|||
44572957|NCT01361308|79595300|FG000|Overall Study|Failed C-SSRS|5|||
44572958|NCT01361308|79595301|FG001|Overall Study|Failed C-SSRS|2|||
44572959|NCT01361308|79595300|FG000|Overall Study|Other|0|||
44572960|NCT01361308|79595301|FG001|Overall Study|Other|1|||
44572961|NCT02872935|79595313|FG000|Overall Study|Other|0|||
44572962|NCT02872935|79595314|FG001|Overall Study|Other|1|||
44572963|NCT00103662|79595322|FG000|Overall Study|Entered Rescue Procedure|0|||
44572964|NCT00103662|79595323|FG001|Overall Study|Entered Rescue Procedure|7|||
44572965|NCT00103662|79595322|FG000|Overall Study|Death|7|||
44377911|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
44572966|NCT00103662|79595323|FG001|Overall Study|Death|7|||
44572967|NCT00103662|79595322|FG000|Overall Study|Elective Withdrawal|5|||
44572968|NCT00103662|79595323|FG001|Overall Study|Elective Withdrawal|5|||
44572969|NCT00103662|79595322|FG000|Overall Study|Lost to Follow-up|0|||
44572970|NCT00103662|79595323|FG001|Overall Study|Lost to Follow-up|1|||
44572971|NCT00103662|79595322|FG000|Overall Study|Other|6|||
44572972|NCT00103662|79595323|FG001|Overall Study|Other|9|||
44572973|NCT00103662|79595322|FG000|Overall Study|Failed mobilization|0|||
44572974|NCT00103662|79595323|FG001|Overall Study|Failed mobilization|4|||
44572975|NCT00103662|79595322|FG000|Overall Study|Intercurrent illness|1|||
44112767|NCT00150618|78895238|FG000|Overall Study|Physician Decision|0|||
44572976|NCT00103662|79595323|FG001|Overall Study|Intercurrent illness|0|||
44572977|NCT02865915|79595331|FG000|Overall Study|Pregnancy|1|||
44572978|NCT02865915|79595332|FG001|Overall Study|Pregnancy|0|||
44572979|NCT02865915|79595331|FG000|Overall Study|Withdrawal by Subject|1|||
44572980|NCT02865915|79595332|FG001|Overall Study|Withdrawal by Subject|1|||
44572981|NCT02865915|79595331|FG000|Overall Study|Adverse Event|0|||
44572982|NCT02865915|79595332|FG001|Overall Study|Adverse Event|4|||
44572983|NCT02865915|79595331|FG000|Overall Study|Lost to Follow-up|0|||
44572984|NCT02865915|79595332|FG001|Overall Study|Lost to Follow-up|1|||
44572985|NCT02865915|79595331|FG000|Overall Study|Protocol Violation|0|||
44572986|NCT02865915|79595332|FG001|Overall Study|Protocol Violation|1|||
44572987|NCT02865915|79595331|FG000|Overall Study|Study terminated by sponsor|23|||
44572988|NCT02865915|79595332|FG001|Overall Study|Study terminated by sponsor|18|||
44572989|NCT02865915|79595331|FG000|Overall Study|Dosing group discontinued|0|||
44572990|NCT02865915|79595332|FG001|Overall Study|Dosing group discontinued|5|||
44572991|NCT00354835|79595340|FG000|Overall Study|Death|1|||
44572992|NCT00354835|79595341|FG001|Overall Study|Death|1|||
44572993|NCT00354835|79595340|FG000|Overall Study|Physician Decision|8|||
44572994|NCT00354835|79595341|FG001|Overall Study|Physician Decision|13|||
44572995|NCT00354835|79595340|FG000|Overall Study|Withdrawal by Subject|2|||
44572996|NCT00354835|79595341|FG001|Overall Study|Withdrawal by Subject|1|||
44572997|NCT00354835|79595340|FG000|Overall Study|Ineligible|17|||
44572998|NCT00354835|79595341|FG001|Overall Study|Ineligible|16|||
44572999|NCT00354835|79595340|FG000|Overall Study|Disease progression or relapse|15|||
44112768|NCT00150618|78895239|FG001|Overall Study|Physician Decision|2|||
44112769|NCT00150618|78895240|FG002|Overall Study|Physician Decision|0|||
44112770|NCT00150618|78895241|FG003|Overall Study|Physician Decision|0|||
44112771|NCT00150618|78895242|FG004|Overall Study|Physician Decision|1|||
44112772|NCT00150618|78895238|FG000|Overall Study|Lack of compliance|2|||
44112773|NCT00150618|78895239|FG001|Overall Study|Lack of compliance|1|||
44112774|NCT00150618|78895240|FG002|Overall Study|Lack of compliance|1|||
44112775|NCT00150618|78895241|FG003|Overall Study|Lack of compliance|0|||
44112776|NCT00150618|78895242|FG004|Overall Study|Lack of compliance|1|||
44112777|NCT00150618|78895238|FG000|Overall Study|Abnormal ECG|1|||
44112778|NCT00150618|78895239|FG001|Overall Study|Abnormal ECG|0|||
44237867|NCT01695239|79064368|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237868|NCT01695239|79064369|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44237869|NCT01695239|79064356|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237870|NCT01695239|79064357|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237871|NCT01695239|79064358|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237872|NCT01695239|79064359|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237873|NCT01695239|79064360|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237874|NCT01695239|79064361|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237875|NCT01695239|79064362|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237876|NCT01695239|79064363|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
44275938|NCT02785952|79226244|FG000|Overall Study|Refusal unrelated to adverse events|10|||
44505365|NCT02962960|79510168|FG002|Overall Study|Protocol Violation|0|||
44505366|NCT00369941|79510180|FG000|Overall Study|Never Treated|1|||
44505367|NCT00369941|79510181|FG001|Overall Study|Never Treated|2|||
44505368|NCT00369941|79510180|FG000|Overall Study|Adverse Event|14|||
44505369|NCT00369941|79510181|FG001|Overall Study|Adverse Event|28|||
44505370|NCT00369941|79510180|FG000|Overall Study|Lack of Efficacy|6|||
44505371|NCT00369941|79510181|FG001|Overall Study|Lack of Efficacy|10|||
44505372|NCT00369941|79510180|FG000|Overall Study|Lost to Follow-up|12|||
44505373|NCT00369941|79510181|FG001|Overall Study|Lost to Follow-up|22|||
44505374|NCT00369941|79510180|FG000|Overall Study|Protocol Violation|5|||
44505375|NCT00369941|79510181|FG001|Overall Study|Protocol Violation|3|||
44505376|NCT00369941|79510180|FG000|Overall Study|Withdrawal by Subject|5|||
44573000|NCT00354835|79595341|FG001|Overall Study|Disease progression or relapse|22|||
44573001|NCT00354835|79595340|FG000|Overall Study|Adverse Event|6|||
44573002|NCT00354835|79595341|FG001|Overall Study|Adverse Event|0|||
44573003|NCT00354835|79595340|FG000|Overall Study|Refusal of further therapy|3|||
44573004|NCT00354835|79595341|FG001|Overall Study|Refusal of further therapy|8|||
44573005|NCT02768298|79595364|FG000|Overall Study|Adverse Event|1|||
44573006|NCT02768298|79595365|FG001|Overall Study|Adverse Event|4|||
44573007|NCT02768298|79595364|FG000|Overall Study|Death|2|||
44573008|NCT02768298|79595365|FG001|Overall Study|Death|1|||
44573009|NCT02768298|79595364|FG000|Overall Study|Non-compliance with study treatment|0|||
44573010|NCT02768298|79595365|FG001|Overall Study|Non-compliance with study treatment|1|||
44573011|NCT02768298|79595364|FG000|Overall Study|Subject/guardian decision|1|||
44573012|NCT02768298|79595365|FG001|Overall Study|Subject/guardian decision|0|||
44573013|NCT02768298|79595364|FG000|Overall Study|Withdrawal of informed consent|0|||
44573014|NCT02768298|79595365|FG001|Overall Study|Withdrawal of informed consent|1|||
44573015|NCT02775864|79595375|FG000|Overall Study|Data ended end of 2010|1764|||
44573016|NCT02775864|79595376|FG001|Overall Study|Data ended end of 2010|2880|||
44573017|NCT02775864|79595377|FG002|Overall Study|Data ended end of 2010|1140|||
44573018|NCT02775864|79595378|FG003|Overall Study|Data ended end of 2010|1194|||
44573019|NCT02775864|79595375|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
44573020|NCT02775864|79595376|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
44573021|NCT02775864|79595377|FG002|Overall Study|Medicaid eligibility discontinued|720|||
44377912|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
44377913|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Administrative problems|3|||
44377914|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Administrative problems|3|||
44112779|NCT00150618|78895240|FG002|Overall Study|Abnormal ECG|0|||
44112780|NCT00150618|78895241|FG003|Overall Study|Abnormal ECG|0|||
44112781|NCT00150618|78895242|FG004|Overall Study|Abnormal ECG|0|||
44112782|NCT00150618|78895238|FG000|Overall Study|Sponsor's decision|0|||
44112783|NCT00150618|78895239|FG001|Overall Study|Sponsor's decision|0|||
44112784|NCT00150618|78895240|FG002|Overall Study|Sponsor's decision|0|||
44112785|NCT00150618|78895241|FG003|Overall Study|Sponsor's decision|1|||
44112786|NCT00150618|78895242|FG004|Overall Study|Sponsor's decision|0|||
44112787|NCT01359046|78895256|FG000|Overall Study|Did not receive allocated intervention|6|||
44112788|NCT01359046|78895257|FG001|Overall Study|Did not receive allocated intervention|6|||
44112789|NCT01359046|78895256|FG000|Overall Study|Physician Decision|1|||
44112790|NCT01359046|78895257|FG001|Overall Study|Physician Decision|11|||
44112791|NCT02741310|78895265|FG000|Overall Study|Sponsor Decision|2|||
44112792|NCT02741310|78895266|FG001|Overall Study|Sponsor Decision|2|||
44112793|NCT01367457|78895283|FG000|Overall Study|Death|2|||
44112794|NCT01367457|78895284|FG001|Overall Study|Death|0|||
44112795|NCT01367457|78895285|FG002|Overall Study|Death|0|||
44112796|NCT01367457|78895283|FG000|Overall Study|Investigator's decision|2|||
44112797|NCT01367457|78895284|FG001|Overall Study|Investigator's decision|0|||
44112798|NCT01367457|78895285|FG002|Overall Study|Investigator's decision|0|||
44112799|NCT01367457|78895283|FG000|Overall Study|Clinical decline (CD)|2|||
44112800|NCT01367457|78895284|FG001|Overall Study|Clinical decline (CD)|0|||
44112801|NCT01367457|78895285|FG002|Overall Study|Clinical decline (CD)|0|||
44112802|NCT01367457|78895283|FG000|Overall Study|Progression and death|8|||
44112803|NCT01367457|78895284|FG001|Overall Study|Progression and death|0|||
44112804|NCT01367457|78895285|FG002|Overall Study|Progression and death|0|||
44112805|NCT01367457|78895283|FG000|Overall Study|Toxicity|16|||
44112806|NCT01367457|78895284|FG001|Overall Study|Toxicity|0|||
44112807|NCT01367457|78895285|FG002|Overall Study|Toxicity|0|||
44112808|NCT01367457|78895283|FG000|Overall Study|Progression|137|||
44112809|NCT01367457|78895284|FG001|Overall Study|Progression|0|||
44112810|NCT01367457|78895285|FG002|Overall Study|Progression|0|||
44112811|NCT01367457|78895283|FG000|Overall Study|Patient asks for rest + slow progression|1|||
44249740|NCT01504412|79083924|FG001|Overall Study|Lost to Follow-up|2|||
44377915|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Death|5|||
44505377|NCT00369941|79510181|FG001|Overall Study|Withdrawal by Subject|18|||
44505378|NCT00369941|79510180|FG000|Overall Study|Pregnancy|4|||
44505379|NCT00369941|79510181|FG001|Overall Study|Pregnancy|2|||
44505380|NCT00369941|79510180|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
44505381|NCT00369941|79510181|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
44505382|NCT00369941|79510180|FG000|Overall Study|Moved|11|||
44505383|NCT00369941|79510181|FG001|Overall Study|Moved|5|||
44505384|NCT00369941|79510180|FG000|Overall Study|Treatment with Prohibited Medication|3|||
44505385|NCT00369941|79510181|FG001|Overall Study|Treatment with Prohibited Medication|1|||
44573022|NCT02775864|79595378|FG003|Overall Study|Medicaid eligibility discontinued|890|||
44573023|NCT02964273|79595391|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
44573024|NCT02964273|79595392|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
44573025|NCT02964273|79595393|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
44573026|NCT02964273|79595394|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
44573027|NCT02964273|79595391|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
44573028|NCT02964273|79595392|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
44573029|NCT02964273|79595393|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
44573030|NCT02964273|79595394|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
44573031|NCT02964273|79595391|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
44573032|NCT02964273|79595392|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
44573033|NCT02964273|79595393|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
44573034|NCT02964273|79595394|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
44573035|NCT02964273|79595391|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
44573036|NCT02964273|79595392|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
44377916|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Death|8|||
44505386|NCT00369941|79510180|FG000|Overall Study|Employment Interfered with Study Visits|1|||
44505387|NCT00369941|79510181|FG001|Overall Study|Employment Interfered with Study Visits|0|||
44573037|NCT02964273|79595393|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
44573038|NCT02964273|79595394|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
44573039|NCT02964273|79595391|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
44112812|NCT01367457|78895284|FG001|Overall Study|Patient asks for rest + slow progression|0|||
44112813|NCT01367457|78895285|FG002|Overall Study|Patient asks for rest + slow progression|0|||
44505388|NCT00369941|79510180|FG000|Overall Study|Study Site Terminated|2|||
44112814|NCT01367457|78895283|FG000|Overall Study|Investigator's opinion, stable disease|1|||
44573040|NCT02964273|79595392|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
44112815|NCT01367457|78895284|FG001|Overall Study|Investigator's opinion, stable disease|0|||
44112816|NCT01367457|78895285|FG002|Overall Study|Investigator's opinion, stable disease|0|||
44112817|NCT01367457|78895283|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
44112818|NCT01367457|78895284|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
44112819|NCT01367457|78895285|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
44112820|NCT01367457|78895283|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
44112821|NCT01367457|78895284|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
44112822|NCT01367457|78895285|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
44112823|NCT01367457|78895283|FG000|Overall Study|low grade toxicities + stable disease|1|||
44112824|NCT01367457|78895284|FG001|Overall Study|low grade toxicities + stable disease|0|||
44112825|NCT01367457|78895285|FG002|Overall Study|low grade toxicities + stable disease|0|||
44112826|NCT01367457|78895283|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
44112827|NCT01367457|78895284|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
44112828|NCT01367457|78895285|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
44112829|NCT01367457|78895283|FG000|Overall Study|Withdrawal by Subject|1|||
44112830|NCT01367457|78895284|FG001|Overall Study|Withdrawal by Subject|0|||
44112831|NCT01367457|78895285|FG002|Overall Study|Withdrawal by Subject|0|||
44112832|NCT01367457|78895283|FG000|Overall Study|CD, associated leukaemia|1|||
44112833|NCT01367457|78895284|FG001|Overall Study|CD, associated leukaemia|0|||
44112834|NCT01367457|78895285|FG002|Overall Study|CD, associated leukaemia|0|||
44112835|NCT01367457|78895283|FG000|Overall Study|Uncontrolled pain|1|||
44112836|NCT01367457|78895284|FG001|Overall Study|Uncontrolled pain|0|||
44112837|NCT01367457|78895285|FG002|Overall Study|Uncontrolled pain|0|||
44112838|NCT01367457|78895283|FG000|Overall Study|Overall status worsens to grade 4|1|||
44112839|NCT01367457|78895284|FG001|Overall Study|Overall status worsens to grade 4|0|||
44112840|NCT01367457|78895285|FG002|Overall Study|Overall status worsens to grade 4|0|||
44112841|NCT01367457|78895283|FG000|Overall Study|Stabilisation + frequent infections|1|||
44112842|NCT01367457|78895284|FG001|Overall Study|Stabilisation + frequent infections|0|||
44112843|NCT01367457|78895285|FG002|Overall Study|Stabilisation + frequent infections|0|||
44112844|NCT01367457|78895283|FG000|Overall Study|No clinical benefit|1|||
44112845|NCT01367457|78895284|FG001|Overall Study|No clinical benefit|0|||
44112846|NCT01367457|78895285|FG002|Overall Study|No clinical benefit|0|||
44112847|NCT01367457|78895283|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
44112848|NCT01367457|78895284|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
44112849|NCT01367457|78895285|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
44112850|NCT01367457|78895283|FG000|Overall Study|Overall decline|1|||
44112851|NCT01367457|78895284|FG001|Overall Study|Overall decline|0|||
44112852|NCT01367457|78895285|FG002|Overall Study|Overall decline|0|||
44112853|NCT01367457|78895283|FG000|Overall Study|Rejection of treatment|1|||
44112854|NCT01367457|78895284|FG001|Overall Study|Rejection of treatment|0|||
44112855|NCT01367457|78895285|FG002|Overall Study|Rejection of treatment|0|||
44112856|NCT01367457|78895283|FG000|Overall Study|Lost to Follow-up|1|||
44112857|NCT01367457|78895284|FG001|Overall Study|Lost to Follow-up|0|||
44112858|NCT01367457|78895285|FG002|Overall Study|Lost to Follow-up|0|||
44275939|NCT02785952|79226245|FG001|Overall Study|Refusal unrelated to adverse events|5|||
44275940|NCT02785952|79226244|FG000|Overall Study|Disease progression/relapse|61|||
44505389|NCT00369941|79510181|FG001|Overall Study|Study Site Terminated|0|||
44505390|NCT00369941|79510180|FG000|Overall Study|Miscellaneous|3|||
44573041|NCT02964273|79595393|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
44573042|NCT02964273|79595394|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
44505391|NCT00369941|79510181|FG001|Overall Study|Miscellaneous|3|||
44505392|NCT00319553|79510190|FG000|Overall Study|Protocol Violation|1|||
44505393|NCT00319553|79510191|FG001|Overall Study|Protocol Violation|2|||
44505394|NCT00319553|79510190|FG000|Overall Study|Lost to Follow-up|2|||
44505395|NCT00319553|79510191|FG001|Overall Study|Lost to Follow-up|1|||
44505396|NCT00319553|79510190|FG000|Overall Study|Withdrawal by Subject|1|||
44505397|NCT00319553|79510191|FG001|Overall Study|Withdrawal by Subject|1|||
44505398|NCT00369785|79510199|FG000|Overall Study|Physician Decision|3|||
44505399|NCT00369785|79510200|FG001|Overall Study|Physician Decision|2|||
44505400|NCT00369785|79510199|FG000|Overall Study|Death|1|||
44505401|NCT00369785|79510200|FG001|Overall Study|Death|2|||
44505402|NCT00369785|79510199|FG000|Overall Study|Withdrawal by Subject|7|||
44505403|NCT00369785|79510200|FG001|Overall Study|Withdrawal by Subject|6|||
44112859|NCT01367457|78895283|FG000|Overall Study|Death from septic shock|1|||
44112860|NCT01367457|78895284|FG001|Overall Study|Death from septic shock|0|||
44112861|NCT01367457|78895285|FG002|Overall Study|Death from septic shock|0|||
44112862|NCT01367457|78895283|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
44112863|NCT01367457|78895284|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
44112864|NCT01367457|78895285|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
44112865|NCT01367457|78895283|FG000|Overall Study|Patient's Wish|1|||
44112866|NCT01367457|78895284|FG001|Overall Study|Patient's Wish|0|||
44505404|NCT00369785|79510199|FG000|Overall Study|Toxicity|6|||
44573043|NCT02964273|79595391|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
44573044|NCT02964273|79595392|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
44573045|NCT02964273|79595393|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
44573046|NCT02964273|79595394|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
44573047|NCT02773446|79595413|FG000|First Admission|Withdrawal by Subject|0|||
44573048|NCT02773446|79595414|FG001|First Admission|Withdrawal by Subject|0|||
44112867|NCT01367457|78895285|FG002|Overall Study|Patient's Wish|0|||
44112868|NCT01367457|78895283|FG000|Overall Study|Palliative. Overall decline|1|||
44505405|NCT00369785|79510200|FG001|Overall Study|Toxicity|4|||
44573049|NCT02773446|79595415|FG002|First Admission|Withdrawal by Subject|0|||
44112869|NCT01367457|78895284|FG001|Overall Study|Palliative. Overall decline|0|||
44112870|NCT01367457|78895285|FG002|Overall Study|Palliative. Overall decline|0|||
44112871|NCT01367457|78895283|FG000|Overall Study|Suspected DP/suspected active infection|1|||
44112872|NCT01367457|78895284|FG001|Overall Study|Suspected DP/suspected active infection|0|||
44112873|NCT01367457|78895285|FG002|Overall Study|Suspected DP/suspected active infection|0|||
44112874|NCT00235326|78895295|FG000|Overall Study|Lost to Follow-up|746|||
44112875|NCT00235326|78895296|FG001|Overall Study|Lost to Follow-up|1400|||
44112876|NCT00162942|78895306|FG000|Overall Study|Adverse Event|10|||
44112877|NCT00162942|78895307|FG001|Overall Study|Adverse Event|6|||
44112878|NCT00162942|78895306|FG000|Overall Study|Death|1|||
44112879|NCT00162942|78895307|FG001|Overall Study|Death|0|||
44112880|NCT00162942|78895306|FG000|Overall Study|Withdrawal by Subject|3|||
44112881|NCT00162942|78895307|FG001|Overall Study|Withdrawal by Subject|6|||
44112882|NCT00162942|78895306|FG000|Overall Study|Physician Decision|1|||
44112883|NCT00162942|78895307|FG001|Overall Study|Physician Decision|0|||
44112884|NCT00162942|78895306|FG000|Overall Study|Enter Open-Label Study|76|||
44112885|NCT00162942|78895307|FG001|Overall Study|Enter Open-Label Study|35|||
44112886|NCT00162942|78895306|FG000|Overall Study|Alternate Therapy|6|||
44112887|NCT00162942|78895307|FG001|Overall Study|Alternate Therapy|2|||
44112888|NCT00162942|78895306|FG000|Overall Study|Lack of Efficacy|1|||
44112889|NCT00162942|78895307|FG001|Overall Study|Lack of Efficacy|0|||
44112890|NCT00162942|78895306|FG000|Overall Study|Flare During Active Treatment|7|||
44112891|NCT00162942|78895307|FG001|Overall Study|Flare During Active Treatment|3|||
44112892|NCT00162942|78895306|FG000|Overall Study|2 or more consecutive treatments missed|1|||
44112893|NCT00162942|78895307|FG001|Overall Study|2 or more consecutive treatments missed|0|||
44112894|NCT02786901|78895337|FG000|Overall Study|Adverse Event|1|||
44112895|NCT02786901|78895338|FG001|Overall Study|Adverse Event|1|||
44112896|NCT02786901|78895339|FG002|Overall Study|Adverse Event|2|||
44112897|NCT02786901|78895337|FG000|Overall Study|Physician Decision|1|||
44112898|NCT02786901|78895338|FG001|Overall Study|Physician Decision|0|||
44112899|NCT02786901|78895339|FG002|Overall Study|Physician Decision|0|||
44112900|NCT02786901|78895337|FG000|Overall Study|Rescue Therapy Use|71|||
44112901|NCT02786901|78895338|FG001|Overall Study|Rescue Therapy Use|49|||
44237877|NCT01695239|79064364|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237878|NCT01695239|79064365|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237879|NCT01695239|79064366|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237880|NCT01695239|79064367|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237881|NCT01695239|79064368|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44573050|NCT02773446|79595416|FG003|First Admission|Withdrawal by Subject|1|||
44573051|NCT02773446|79595417|FG004|First Admission|Withdrawal by Subject|0|||
44573052|NCT02773446|79595418|FG005|First Admission|Withdrawal by Subject|0|||
44573053|NCT02773446|79595413|FG000|First Admission|Lost to Follow-up|1|||
44112902|NCT02786901|78895339|FG002|Overall Study|Rescue Therapy Use|33|||
44112903|NCT02786901|78895337|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
44237882|NCT01695239|79064369|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
44237883|NCT01695239|79064356|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44505406|NCT00369785|79510199|FG000|Overall Study|Never started|0|||
44505407|NCT00369785|79510200|FG001|Overall Study|Never started|2|||
44505408|NCT00369785|79510199|FG000|Overall Study|Progression|4|||
44505409|NCT00369785|79510200|FG001|Overall Study|Progression|4|||
44505410|NCT00369785|79510199|FG000|Overall Study|Multiple reasons|6|||
44505411|NCT00369785|79510200|FG001|Overall Study|Multiple reasons|5|||
44505412|NCT00369707|79510206|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
44505413|NCT00369707|79510206|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
44505414|NCT00369707|79510206|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
44505415|NCT00369707|79510206|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
44505416|NCT00369707|79510206|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
44112904|NCT02786901|78895338|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
44112905|NCT02786901|78895339|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
44112906|NCT02786901|78895337|FG000|Overall Study|Disallowed medication|1|||
44112907|NCT02786901|78895338|FG001|Overall Study|Disallowed medication|1|||
44112908|NCT02786901|78895339|FG002|Overall Study|Disallowed medication|0|||
44112909|NCT02786901|78895337|FG000|Overall Study|Randomized in error|2|||
44112910|NCT02786901|78895338|FG001|Overall Study|Randomized in error|0|||
44112911|NCT02786901|78895339|FG002|Overall Study|Randomized in error|1|||
44112912|NCT02137239|78895349|FG000|Overall Study|Discontinued Study Treatment|0|||
44112913|NCT02137239|78895350|FG001|Overall Study|Discontinued Study Treatment|3|||
44112914|NCT02137239|78895349|FG000|Overall Study|Withdrew Consent|1|||
44573054|NCT02773446|79595414|FG001|First Admission|Lost to Follow-up|0|||
44573055|NCT02773446|79595415|FG002|First Admission|Lost to Follow-up|0|||
44573056|NCT02773446|79595416|FG003|First Admission|Lost to Follow-up|0|||
44573057|NCT02773446|79595417|FG004|First Admission|Lost to Follow-up|0|||
44573058|NCT02773446|79595418|FG005|First Admission|Lost to Follow-up|0|||
44573059|NCT02773368|79595437|FG000|Overall Study|Lost to Follow-up|4|||
44573060|NCT02773368|79595438|FG001|Overall Study|Lost to Follow-up|1|||
44573061|NCT02773368|79595437|FG000|Overall Study|Withdrawal by Subject|5|||
44573062|NCT02773368|79595438|FG001|Overall Study|Withdrawal by Subject|1|||
44573063|NCT02773368|79595437|FG000|Overall Study|Unclassified|1|||
44573064|NCT02773368|79595438|FG001|Overall Study|Unclassified|1|||
44573065|NCT02773368|79595437|FG000|Overall Study|Missing|0|||
44573066|NCT02773368|79595438|FG001|Overall Study|Missing|1|||
44573067|NCT01336647|79595447|FG000|Overall Study|Lost to Follow-up|4|||
44573068|NCT01336647|79595448|FG001|Overall Study|Lost to Follow-up|1|||
44573069|NCT01336647|79595449|FG002|Overall Study|Lost to Follow-up|3|||
44573070|NCT01336569|79595459|FG000|Overall Study|Lost to Follow-up|4|||
44573071|NCT02772978|79595463|FG000|Overall Study|Withdrawal by Subject|1|||
44573072|NCT02772978|79595464|FG001|Overall Study|Withdrawal by Subject|1|||
44573073|NCT00104052|79595469|FG000|Overall Study|Adverse Event|1|||
44573074|NCT00104052|79595469|FG000|Overall Study|Lack of Efficacy|26|||
44573075|NCT00104052|79595469|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
44573076|NCT02777970|79595476|FG000|Overall Study|Lost to Follow-up|0|||
44573077|NCT02777970|79595477|FG001|Overall Study|Lost to Follow-up|1|||
44573078|NCT02777970|79595478|FG002|Overall Study|Lost to Follow-up|0|||
44573079|NCT02777970|79595476|FG000|Overall Study|Protocol Violation|1|||
44573080|NCT02777970|79595477|FG001|Overall Study|Protocol Violation|0|||
44573081|NCT02777970|79595478|FG002|Overall Study|Protocol Violation|0|||
44573082|NCT03037489|79595490|FG000|Overall Study|Adverse Event|4|||
44573083|NCT03037489|79595491|FG001|Overall Study|Adverse Event|0|||
44573084|NCT03037489|79595490|FG000|Overall Study|Withdrawal by Subject|3|||
44573085|NCT03037489|79595491|FG001|Overall Study|Withdrawal by Subject|0|||
44573086|NCT01336023|79595500|FG000|Week 0 to Week 26|Adverse Event|8|||
44573087|NCT01336023|79595501|FG001|Week 0 to Week 26|Adverse Event|10|||
44573088|NCT01336023|79595502|FG002|Week 0 to Week 26|Adverse Event|24|||
44573089|NCT01336023|79595500|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
44573090|NCT01336023|79595501|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
44573091|NCT01336023|79595502|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
44573092|NCT01336023|79595500|FG000|Week 0 to Week 26|Protocol Violation|1|||
44573093|NCT01336023|79595501|FG001|Week 0 to Week 26|Protocol Violation|2|||
44573094|NCT01336023|79595502|FG002|Week 0 to Week 26|Protocol Violation|0|||
44573095|NCT01336023|79595500|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
44573096|NCT01336023|79595501|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
44573097|NCT01336023|79595502|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
44573098|NCT01336023|79595500|FG000|Week 0 to Week 26|Unclassified|5|||
44573099|NCT01336023|79595501|FG001|Week 0 to Week 26|Unclassified|16|||
44573100|NCT01336023|79595502|FG002|Week 0 to Week 26|Unclassified|9|||
44573101|NCT01336023|79595500|FG000|Week 27 to 52|Adverse Event|1|||
44573102|NCT01336023|79595501|FG001|Week 27 to 52|Adverse Event|5|||
44573103|NCT01336023|79595502|FG002|Week 27 to 52|Adverse Event|2|||
44573104|NCT01336023|79595500|FG000|Week 27 to 52|Protocol Violation|0|||
44573105|NCT01336023|79595501|FG001|Week 27 to 52|Protocol Violation|2|||
44573106|NCT01336023|79595502|FG002|Week 27 to 52|Protocol Violation|1|||
44573107|NCT01336023|79595500|FG000|Week 27 to 52|Withdrawal Criteria|14|||
44573108|NCT01336023|79595501|FG001|Week 27 to 52|Withdrawal Criteria|19|||
44573109|NCT01336023|79595502|FG002|Week 27 to 52|Withdrawal Criteria|16|||
44573110|NCT01336023|79595500|FG000|Week 27 to 52|Unclassified|13|||
44573111|NCT01336023|79595501|FG001|Week 27 to 52|Unclassified|18|||
44573112|NCT01336023|79595502|FG002|Week 27 to 52|Unclassified|9|||
44573113|NCT03039283|79595510|FG000|Overall Study|Protocol Violation|2|||
44573114|NCT02863575|79595532|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
44112915|NCT02137239|78895350|FG001|Overall Study|Withdrew Consent|1|||
44237884|NCT01695239|79064357|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44249741|NCT01504412|79083925|FG002|Overall Study|Lost to Follow-up|0|||
44573115|NCT02863575|79595533|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
44573116|NCT02863575|79595534|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
44573117|NCT02863575|79595532|FG000|Overall Study|Withdrawal by Subject|0|||
44573118|NCT02863575|79595533|FG001|Overall Study|Withdrawal by Subject|1|||
44573119|NCT02863575|79595534|FG002|Overall Study|Withdrawal by Subject|1|||
44573120|NCT02863575|79595532|FG000|Overall Study|Adverse Event|0|||
44573121|NCT02863575|79595533|FG001|Overall Study|Adverse Event|1|||
44573122|NCT02863575|79595534|FG002|Overall Study|Adverse Event|0|||
44573123|NCT01227187|79595546|FG000|Overall Study|Physician Decision|0|||
44573124|NCT01227187|79595547|FG001|Overall Study|Physician Decision|0|||
44112916|NCT02137239|78895349|FG000|Overall Study|Adverse Event|2|||
44112917|NCT02137239|78895350|FG001|Overall Study|Adverse Event|2|||
44112918|NCT02741076|78895369|FG000|Overall Study|Adverse Event|0|||
44112919|NCT02741076|78895370|FG001|Overall Study|Adverse Event|1|||
44112920|NCT02741076|78895371|FG002|Overall Study|Adverse Event|1|||
44112921|NCT02741076|78895372|FG003|Overall Study|Adverse Event|0|||
44112922|NCT02741076|78895369|FG000|Overall Study|Lack of Efficacy|1|||
44112923|NCT02741076|78895370|FG001|Overall Study|Lack of Efficacy|0|||
44112924|NCT02741076|78895371|FG002|Overall Study|Lack of Efficacy|0|||
44112925|NCT02741076|78895372|FG003|Overall Study|Lack of Efficacy|0|||
44112926|NCT02741076|78895369|FG000|Overall Study|Withdrawal by Subject|0|||
44112927|NCT02741076|78895370|FG001|Overall Study|Withdrawal by Subject|1|||
44112928|NCT02741076|78895371|FG002|Overall Study|Withdrawal by Subject|0|||
44112929|NCT02741076|78895372|FG003|Overall Study|Withdrawal by Subject|0|||
44112930|NCT02741076|78895369|FG000|Overall Study|Sponsor Request|2|||
44237885|NCT01695239|79064358|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237886|NCT01695239|79064359|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44573125|NCT01227187|79595548|FG002|Overall Study|Physician Decision|0|||
44573126|NCT01227187|79595549|FG003|Overall Study|Physician Decision|1|||
44573127|NCT02638012|79595570|FG000|Overall Study|Lost to Follow-up|1|||
44573128|NCT00103506|79595576|FG000|Overall Study|Study closed by sponsor|34|||
44573129|NCT00103506|79595577|FG001|Overall Study|Study closed by sponsor|37|||
44573130|NCT00103506|79595576|FG000|Overall Study|Death|257|||
44573131|NCT00103506|79595577|FG001|Overall Study|Death|253|||
44573132|NCT00103506|79595576|FG000|Overall Study|Lost to Follow-up|13|||
44573133|NCT00103506|79595577|FG001|Overall Study|Lost to Follow-up|13|||
44573134|NCT00103506|79595576|FG000|Overall Study|Withdrawal by Subject|18|||
44573135|NCT00103506|79595577|FG001|Overall Study|Withdrawal by Subject|21|||
44573136|NCT02765490|79595585|FG000|Overall Study|Lost to Follow-up|1|||
44573137|NCT02765490|79595586|FG001|Overall Study|Lost to Follow-up|1|||
44573138|NCT02765490|79595585|FG000|Overall Study|Other|0|||
44573139|NCT02765490|79595586|FG001|Overall Study|Other|1|||
44573140|NCT02765490|79595585|FG000|Overall Study|Death|0|||
44573141|NCT02765490|79595586|FG001|Overall Study|Death|1|||
44573142|NCT02639182|79595594|FG000|Overall Study|Disease Progression|50|||
44573143|NCT02639182|79595595|FG001|Overall Study|Disease Progression|49|||
44573144|NCT02639182|79595594|FG000|Overall Study|Adverse Event|7|||
44573145|NCT02639182|79595595|FG001|Overall Study|Adverse Event|5|||
44573146|NCT02639182|79595594|FG000|Overall Study|Physician Decision|3|||
44573147|NCT02639182|79595595|FG001|Overall Study|Physician Decision|3|||
44573148|NCT02639182|79595594|FG000|Overall Study|Withdrew Consent|5|||
44573149|NCT02639182|79595595|FG001|Overall Study|Withdrew Consent|4|||
44573150|NCT02639182|79595594|FG000|Overall Study|Lost to Follow-up|0|||
44573151|NCT02639182|79595595|FG001|Overall Study|Lost to Follow-up|1|||
44573152|NCT02639182|79595594|FG000|Overall Study|Study Closure|1|||
44573153|NCT02639182|79595595|FG001|Overall Study|Study Closure|2|||
44573154|NCT02639182|79595594|FG000|Overall Study|Sponsor Ended Study|0|||
44573155|NCT02639182|79595595|FG001|Overall Study|Sponsor Ended Study|1|||
44573156|NCT02639182|79595594|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
44573157|NCT02639182|79595595|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
44573158|NCT02863419|79595604|FG000|Overall Study|Lost to Follow-up|0|||
44573159|NCT02863419|79595605|FG001|Overall Study|Lost to Follow-up|1|||
44573160|NCT02863419|79595606|FG002|Overall Study|Lost to Follow-up|4|||
44573161|NCT02863419|79595604|FG000|Overall Study|Withdrawal by Subject|5|||
44573162|NCT02863419|79595605|FG001|Overall Study|Withdrawal by Subject|5|||
44573163|NCT02863419|79595606|FG002|Overall Study|Withdrawal by Subject|3|||
44112931|NCT02741076|78895370|FG001|Overall Study|Sponsor Request|3|||
44237887|NCT01695239|79064360|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237888|NCT01695239|79064361|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237889|NCT01695239|79064362|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44377917|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Disease progression|139|||
44377918|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Disease progression|119|||
44377919|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
44573164|NCT02863419|79595604|FG000|Overall Study|Died|3|||
44573165|NCT02863419|79595605|FG001|Overall Study|Died|4|||
44573166|NCT02863419|79595606|FG002|Overall Study|Died|1|||
44573167|NCT02765100|79595616|FG000|Overall Study|subject found ineligible after baseline|1|||
44573168|NCT02765100|79595617|FG001|Overall Study|subject found ineligible after baseline|1|||
44573169|NCT02765100|79595616|FG000|Overall Study|Lost to Follow-up|0|||
44573170|NCT02765100|79595617|FG001|Overall Study|Lost to Follow-up|1|||
44573171|NCT02761980|79595627|FG000|Overall Study|Adverse Event|4|||
44573172|NCT02761980|79595628|FG001|Overall Study|Adverse Event|6|||
44112932|NCT02741076|78895371|FG002|Overall Study|Sponsor Request|0|||
44112933|NCT02741076|78895372|FG003|Overall Study|Sponsor Request|1|||
44112934|NCT02741076|78895369|FG000|Overall Study|No additional information available|0|||
44112935|NCT02741076|78895370|FG001|Overall Study|No additional information available|0|||
44112936|NCT02741076|78895371|FG002|Overall Study|No additional information available|1|||
44573173|NCT02761980|79595629|FG002|Overall Study|Adverse Event|5|||
44112937|NCT02741076|78895372|FG003|Overall Study|No additional information available|1|||
44112938|NCT01666444|78895385|FG000|Overall Study|Did not initiate treatment|2|||
44112939|NCT01666444|78895386|FG001|Overall Study|Did not initiate treatment|1|||
44112940|NCT05159622|78895394|FG000|Overall Study|Lost to Follow-up|4|||
44112941|NCT05159622|78895395|FG001|Overall Study|Lost to Follow-up|5|||
44112942|NCT01665430|78895407|FG000|Overall Study|Adverse Event|1|||
44112943|NCT01665430|78895407|FG000|Overall Study|Withdrawal by Subject|6|||
44112944|NCT01665430|78895407|FG000|Overall Study|Other Unspecified|2|||
44112945|NCT02739594|78895413|FG000|Overall Study|Undesired Event|3|||
44112946|NCT02739594|78895414|FG001|Overall Study|Undesired Event|4|||
44112947|NCT02739594|78895413|FG000|Overall Study|Violation of Eligibility Criteria|1|||
44112948|NCT02739594|78895414|FG001|Overall Study|Violation of Eligibility Criteria|2|||
44112949|NCT02739594|78895413|FG000|Overall Study|Protocol Violation|5|||
44112950|NCT02739594|78895414|FG001|Overall Study|Protocol Violation|6|||
44112951|NCT02739594|78895413|FG000|Overall Study|Death|4|||
44112952|NCT02739594|78895414|FG001|Overall Study|Death|2|||
44112953|NCT02739594|78895413|FG000|Overall Study|Renal Insufficiency|4|||
44112954|NCT02739594|78895414|FG001|Overall Study|Renal Insufficiency|6|||
44112955|NCT02739594|78895413|FG000|Overall Study|Administrative Reasons|1|||
44112956|NCT02739594|78895414|FG001|Overall Study|Administrative Reasons|3|||
44112957|NCT02739594|78895413|FG000|Overall Study|Withdrawal by Subject|1|||
44112958|NCT02739594|78895414|FG001|Overall Study|Withdrawal by Subject|1|||
44112959|NCT02739594|78895413|FG000|Overall Study|Lost to Follow-up|0|||
44112960|NCT02739594|78895414|FG001|Overall Study|Lost to Follow-up|1|||
44112961|NCT02739594|78895413|FG000|Overall Study|Elevated Serum Creatinine|0|||
44112962|NCT02739594|78895414|FG001|Overall Study|Elevated Serum Creatinine|1|||
44237890|NCT01695239|79064363|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
44237891|NCT01695239|79064364|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237892|NCT01695239|79064365|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237893|NCT01695239|79064366|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237894|NCT01695239|79064367|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237895|NCT01695239|79064368|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237896|NCT01695239|79064369|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
44237897|NCT01695239|79064356|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237898|NCT01695239|79064357|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237899|NCT01695239|79064358|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237900|NCT01695239|79064359|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237901|NCT01695239|79064360|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44249742|NCT01504412|79083926|FG003|Overall Study|Lost to Follow-up|0|||
44573174|NCT02761980|79595630|FG003|Overall Study|Adverse Event|6|||
44573175|NCT02761980|79595627|FG000|Overall Study|Withdrawal by Subject|0|||
44573176|NCT02761980|79595628|FG001|Overall Study|Withdrawal by Subject|1|||
44573177|NCT02761980|79595629|FG002|Overall Study|Withdrawal by Subject|0|||
44573178|NCT02761980|79595630|FG003|Overall Study|Withdrawal by Subject|0|||
44573179|NCT02761980|79595627|FG000|Overall Study|Other|0|||
44573180|NCT02761980|79595628|FG001|Overall Study|Other|0|||
44573181|NCT02761980|79595629|FG002|Overall Study|Other|1|||
44573182|NCT02761980|79595630|FG003|Overall Study|Other|0|||
44573183|NCT02862171|79595649|FG000|Overall Study|Death|1|||
44573184|NCT02862171|79595649|FG000|Overall Study|Lost to Follow-up|13|||
44573185|NCT02862171|79595649|FG000|Overall Study|Withdrawal by Subject|57|||
44573186|NCT02862171|79595649|FG000|Overall Study|Non-compliance|4|||
44573187|NCT02862171|79595649|FG000|Overall Study|HIV-1 seroconversion|18|||
44573188|NCT02638948|79595657|FG000|Overall Study|Withdrawal by Subject|4|||
44573189|NCT02638948|79595658|FG001|Overall Study|Withdrawal by Subject|5|||
44573190|NCT02638948|79595659|FG002|Overall Study|Withdrawal by Subject|3|||
44573191|NCT02638948|79595660|FG003|Overall Study|Withdrawal by Subject|1|||
44573192|NCT02638948|79595657|FG000|Overall Study|Administrative Reason by Sponsor|0|||
44573193|NCT02638948|79595658|FG001|Overall Study|Administrative Reason by Sponsor|1|||
44573194|NCT02638948|79595659|FG002|Overall Study|Administrative Reason by Sponsor|0|||
44573195|NCT02638948|79595660|FG003|Overall Study|Administrative Reason by Sponsor|4|||
44573196|NCT02638948|79595657|FG000|Overall Study|Adverse Event|0|||
44573197|NCT02638948|79595658|FG001|Overall Study|Adverse Event|0|||
44573198|NCT02638948|79595659|FG002|Overall Study|Adverse Event|1|||
44573199|NCT02638948|79595660|FG003|Overall Study|Adverse Event|1|||
44573200|NCT02638948|79595657|FG000|Overall Study|Lack of Efficacy|1|||
44573201|NCT02638948|79595658|FG001|Overall Study|Lack of Efficacy|1|||
44573202|NCT02638948|79595659|FG002|Overall Study|Lack of Efficacy|0|||
44112963|NCT02739594|78895413|FG000|Overall Study|Other|6|||
44112964|NCT02739594|78895414|FG001|Overall Study|Other|2|||
44112965|NCT03989232|78895423|FG000|Overall Study|Lost to Follow-up|3|||
44112966|NCT03989232|78895424|FG001|Overall Study|Lost to Follow-up|10|||
44112967|NCT03989232|78895423|FG000|Overall Study|Withdrawal by Subject|6|||
44573203|NCT02638948|79595660|FG003|Overall Study|Lack of Efficacy|0|||
44573204|NCT02638948|79595657|FG000|Overall Study|Lost to Follow-up|0|||
44573205|NCT02638948|79595658|FG001|Overall Study|Lost to Follow-up|0|||
44112968|NCT03989232|78895424|FG001|Overall Study|Withdrawal by Subject|6|||
44112969|NCT03989232|78895423|FG000|Overall Study|Death|1|||
44112970|NCT03989232|78895424|FG001|Overall Study|Death|2|||
44112971|NCT02585830|78895430|FG000|Overall Study|Withdrawal by Subject|3|||
44112972|NCT02584504|78895437|FG000|Double-blind Treatment|Participant withdrew consent|0|||
44112973|NCT02584504|78895438|FG001|Double-blind Treatment|Participant withdrew consent|0|||
44112974|NCT02584504|78895439|FG002|Double-blind Treatment|Participant withdrew consent|1|||
44112975|NCT02584504|78895437|FG000|Double-blind Treatment|Adverse Event|0|||
44112976|NCT02584504|78895438|FG001|Double-blind Treatment|Adverse Event|1|||
44112977|NCT02584504|78895439|FG002|Double-blind Treatment|Adverse Event|0|||
44112978|NCT02584504|78895437|FG000|Double-blind Treatment|Family Matter|0|||
44112979|NCT02584504|78895438|FG001|Double-blind Treatment|Family Matter|1|||
44112980|NCT02584504|78895439|FG002|Double-blind Treatment|Family Matter|0|||
44112981|NCT02584504|78895437|FG000|Open-label Treatment|Participant withdrew consent|0|||
44112982|NCT02584504|78895438|FG001|Open-label Treatment|Participant withdrew consent|0|||
44112983|NCT02584504|78895439|FG002|Open-label Treatment|Participant withdrew consent|4|||
44112984|NCT02584504|78895437|FG000|Open-label Treatment|Adverse Event|2|||
44112985|NCT02584504|78895438|FG001|Open-label Treatment|Adverse Event|2|||
44112986|NCT02584504|78895439|FG002|Open-label Treatment|Adverse Event|3|||
44112987|NCT02584504|78895437|FG000|Open-label Treatment|Physician Decision|0|||
44112988|NCT02584504|78895438|FG001|Open-label Treatment|Physician Decision|1|||
44112989|NCT02584504|78895439|FG002|Open-label Treatment|Physician Decision|0|||
44112990|NCT02584504|78895437|FG000|Open-label Treatment|Entered but not treated|0|||
44112991|NCT02584504|78895438|FG001|Open-label Treatment|Entered but not treated|1|||
44112992|NCT02584504|78895439|FG002|Open-label Treatment|Entered but not treated|1|||
44112993|NCT04354155|78895464|FG000|Overall Study|Withdrawal by Subject|1|||
44112994|NCT04354155|78895464|FG000|Overall Study|Did not meet criteria for study intervention|1|||
44112995|NCT02586064|78895470|FG000|Overall Study|Other Obligations|6|||
44112996|NCT02586064|78895471|FG001|Overall Study|Other Obligations|6|||
44112997|NCT02586064|78895470|FG000|Overall Study|Other|3|||
44112998|NCT02586064|78895471|FG001|Overall Study|Other|7|||
44112999|NCT02586064|78895470|FG000|Overall Study|Never Started|3|||
44113000|NCT02586064|78895471|FG001|Overall Study|Never Started|3|||
44113001|NCT02586064|78895470|FG000|Overall Study|Lost Interest|1|||
44113002|NCT02586064|78895471|FG001|Overall Study|Lost Interest|4|||
44113003|NCT02586064|78895470|FG000|Overall Study|Miscellaneous Life Issues|0|||
44113004|NCT02586064|78895471|FG001|Overall Study|Miscellaneous Life Issues|5|||
44113005|NCT02586064|78895470|FG000|Overall Study|Infrequent Attendance|2|||
44113006|NCT02586064|78895471|FG001|Overall Study|Infrequent Attendance|1|||
44113007|NCT02586064|78895470|FG000|Overall Study|Timed Out|2|||
44113008|NCT02586064|78895471|FG001|Overall Study|Timed Out|0|||
44113009|NCT02586064|78895470|FG000|Overall Study|AUD relapse|0|||
44113010|NCT02586064|78895471|FG001|Overall Study|AUD relapse|2|||
44113011|NCT02586064|78895470|FG000|Overall Study|Legal Issue|1|||
44113012|NCT02586064|78895471|FG001|Overall Study|Legal Issue|0|||
44113013|NCT03810495|78895480|FG000|Overall Study|Lost to Follow-up|2|||
44113014|NCT03810495|78895480|FG000|Overall Study|Withdrawal by Subject|1|||
44113015|NCT02782923|78895484|FG000|Overall Study|Lost to Follow-up|15|||
44113016|NCT03760458|78895493|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
44113017|NCT03760458|78895494|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
44113018|NCT03760458|78895495|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
44113019|NCT03760458|78895496|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
44113020|NCT03760458|78895497|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
44113021|NCT02066415|78895512|FG000|Overall Study|Decision by Sponsor|5|||
44113022|NCT02066415|78895513|FG001|Overall Study|Decision by Sponsor|4|||
44113023|NCT02066415|78895514|FG002|Overall Study|Decision by Sponsor|2|||
44113024|NCT02066415|78895512|FG000|Overall Study|Withdrawal by Subject|9|||
44113025|NCT02066415|78895513|FG001|Overall Study|Withdrawal by Subject|1|||
44113026|NCT02066415|78895514|FG002|Overall Study|Withdrawal by Subject|4|||
44113027|NCT02066415|78895512|FG000|Overall Study|Lost to Follow-up|7|||
44113028|NCT02066415|78895513|FG001|Overall Study|Lost to Follow-up|2|||
44113029|NCT02066415|78895514|FG002|Overall Study|Lost to Follow-up|2|||
44113030|NCT02583256|78895526|FG000|Overall Study|Withdrawal by Subject|0|||
44113031|NCT02583256|78895527|FG001|Overall Study|Withdrawal by Subject|1|||
44113032|NCT02583256|78895528|FG002|Overall Study|Withdrawal by Subject|1|||
44113033|NCT02583256|78895529|FG003|Overall Study|Withdrawal by Subject|0|||
44237902|NCT01695239|79064361|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44113034|NCT02583256|78895526|FG000|Overall Study|Lost to Follow-up|1|||
44113035|NCT02583256|78895527|FG001|Overall Study|Lost to Follow-up|1|||
44113036|NCT02583256|78895528|FG002|Overall Study|Lost to Follow-up|0|||
44113037|NCT02583256|78895529|FG003|Overall Study|Lost to Follow-up|1|||
44113038|NCT02583256|78895526|FG000|Overall Study|Administrative/Other|2|||
44113039|NCT02583256|78895527|FG001|Overall Study|Administrative/Other|0|||
44113040|NCT02583256|78895528|FG002|Overall Study|Administrative/Other|1|||
44113041|NCT02583256|78895529|FG003|Overall Study|Administrative/Other|2|||
44113042|NCT02584660|78895552|FG000|Overall Study|Adverse Event|4|||
44113043|NCT02584660|78895553|FG001|Overall Study|Adverse Event|0|||
44113044|NCT02584660|78895552|FG000|Overall Study|Lost to Follow-up|3|||
44113045|NCT02584660|78895553|FG001|Overall Study|Lost to Follow-up|4|||
44113046|NCT02584660|78895552|FG000|Overall Study|Protocol Violation|0|||
44113047|NCT02584660|78895553|FG001|Overall Study|Protocol Violation|1|||
44113048|NCT02584660|78895552|FG000|Overall Study|Withdrawal by Subject|0|||
44113049|NCT02584660|78895553|FG001|Overall Study|Withdrawal by Subject|2|||
44113050|NCT02584660|78895552|FG000|Overall Study|Other|0|||
44113051|NCT02584660|78895553|FG001|Overall Study|Other|1|||
44113052|NCT02582632|78895575|FG000|Overall Study|Other|1|||
44113053|NCT02178722|78895584|FG000|Overall Study|Withdrawal by Subject|0|||
44113054|NCT02178722|78895585|FG001|Overall Study|Withdrawal by Subject|0|||
44113055|NCT02178722|78895586|FG002|Overall Study|Withdrawal by Subject|0|||
44113056|NCT02178722|78895587|FG003|Overall Study|Withdrawal by Subject|2|||
44113057|NCT02178722|78895588|FG004|Overall Study|Withdrawal by Subject|33|||
44113058|NCT02178722|78895584|FG000|Overall Study|Death|2|||
44113059|NCT02178722|78895585|FG001|Overall Study|Death|13|||
44113060|NCT02178722|78895586|FG002|Overall Study|Death|12|||
44113061|NCT02178722|78895587|FG003|Overall Study|Death|12|||
44113062|NCT02178722|78895588|FG004|Overall Study|Death|205|||
44113063|NCT02178722|78895584|FG000|Overall Study|Lost to Follow-up|0|||
44113064|NCT02178722|78895585|FG001|Overall Study|Lost to Follow-up|0|||
44113065|NCT02178722|78895586|FG002|Overall Study|Lost to Follow-up|0|||
44113066|NCT02178722|78895587|FG003|Overall Study|Lost to Follow-up|2|||
44113067|NCT02178722|78895588|FG004|Overall Study|Lost to Follow-up|11|||
44113068|NCT02178722|78895584|FG000|Overall Study|Study terminated by Sponsor|2|||
44113069|NCT02178722|78895585|FG001|Overall Study|Study terminated by Sponsor|7|||
44113070|NCT02178722|78895586|FG002|Overall Study|Study terminated by Sponsor|6|||
44113071|NCT02178722|78895587|FG003|Overall Study|Study terminated by Sponsor|4|||
44113072|NCT02178722|78895588|FG004|Overall Study|Study terminated by Sponsor|128|||
44113073|NCT02178722|78895584|FG000|Overall Study|Physician Decision|0|||
44113074|NCT02178722|78895585|FG001|Overall Study|Physician Decision|0|||
44113075|NCT02178722|78895586|FG002|Overall Study|Physician Decision|0|||
44113076|NCT02178722|78895587|FG003|Overall Study|Physician Decision|0|||
44113077|NCT02178722|78895588|FG004|Overall Study|Physician Decision|3|||
44113078|NCT02178722|78895584|FG000|Overall Study|Other|0|||
44113079|NCT02178722|78895585|FG001|Overall Study|Other|0|||
44113080|NCT02178722|78895586|FG002|Overall Study|Other|0|||
44113081|NCT02178722|78895587|FG003|Overall Study|Other|0|||
44113082|NCT02178722|78895588|FG004|Overall Study|Other|2|||
44113083|NCT00972309|78895605|FG000|Overall Study|Switched to alternative treatment|0|||
44113084|NCT00972309|78895606|FG001|Overall Study|Switched to alternative treatment|2|||
44113085|NCT00972309|78895605|FG000|Overall Study|Refused further treatment|0|||
44113086|NCT00972309|78895606|FG001|Overall Study|Refused further treatment|1|||
44113087|NCT00972309|78895605|FG000|Overall Study|Late determination of ineligibility|0|||
44113088|NCT00972309|78895606|FG001|Overall Study|Late determination of ineligibility|1|||
44113089|NCT00972309|78895605|FG000|Overall Study|Second malignancy|1|||
44113090|NCT00972309|78895606|FG001|Overall Study|Second malignancy|1|||
44573206|NCT02638948|79595659|FG002|Overall Study|Lost to Follow-up|1|||
44573207|NCT02638948|79595660|FG003|Overall Study|Lost to Follow-up|1|||
44573208|NCT02638948|79595657|FG000|Overall Study|Poor/Non-Compliance|0|||
44573209|NCT02638948|79595658|FG001|Overall Study|Poor/Non-Compliance|2|||
44573210|NCT02638948|79595659|FG002|Overall Study|Poor/Non-Compliance|1|||
44573211|NCT02638948|79595660|FG003|Overall Study|Poor/Non-Compliance|0|||
44573212|NCT02638948|79595657|FG000|Overall Study|Participant no longer met study criteria|0|||
44573213|NCT02638948|79595658|FG001|Overall Study|Participant no longer met study criteria|1|||
44573214|NCT02638948|79595659|FG002|Overall Study|Participant no longer met study criteria|0|||
44573215|NCT02638948|79595660|FG003|Overall Study|Participant no longer met study criteria|0|||
44573216|NCT02638948|79595657|FG000|Overall Study|Other than specified above|4|||
44573217|NCT02638948|79595658|FG001|Overall Study|Other than specified above|1|||
44573218|NCT02638948|79595659|FG002|Overall Study|Other than specified above|1|||
44573219|NCT02638948|79595660|FG003|Overall Study|Other than specified above|1|||
44573220|NCT00102960|79595676|FG000|Overall Study|Death|23|||
44573221|NCT00102960|79595677|FG001|Overall Study|Death|11|||
44573222|NCT00102960|79595678|FG002|Overall Study|Death|11|||
44113091|NCT00972309|78895605|FG000|Overall Study|Visa issues|0|||
44113092|NCT00972309|78895606|FG001|Overall Study|Visa issues|1|||
44573223|NCT00102960|79595676|FG000|Overall Study|Lost to Follow-up|6|||
44113093|NCT00972309|78895605|FG000|Overall Study|Secondary cancer (SCC)|0|||
44113094|NCT00972309|78895606|FG001|Overall Study|Secondary cancer (SCC)|1|||
44113095|NCT00972309|78895605|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
44113096|NCT00972309|78895606|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
44113097|NCT00972309|78895605|FG000|Overall Study|Lost to Follow-up|1|||
44113098|NCT00972309|78895606|FG001|Overall Study|Lost to Follow-up|1|||
44113099|NCT00972309|78895605|FG000|Overall Study|Disease progression on study|10|||
44113100|NCT00972309|78895606|FG001|Overall Study|Disease progression on study|4|||
44113101|NCT02582242|78895625|FG000|Overall Study|Adverse Event|4|||
44113102|NCT02582242|78895626|FG001|Overall Study|Adverse Event|3|||
44113103|NCT02582242|78895625|FG000|Overall Study|Protocol Violation|3|||
44113104|NCT02582242|78895626|FG001|Overall Study|Protocol Violation|1|||
44573224|NCT00102960|79595677|FG001|Overall Study|Lost to Follow-up|12|||
44573225|NCT00102960|79595678|FG002|Overall Study|Lost to Follow-up|16|||
44573226|NCT00102960|79595676|FG000|Overall Study|Withdrawal by Subject|1|||
44573227|NCT00102960|79595677|FG001|Overall Study|Withdrawal by Subject|0|||
44573228|NCT00102960|79595678|FG002|Overall Study|Withdrawal by Subject|1|||
44113105|NCT02582242|78895625|FG000|Overall Study|Lost to Follow-up|0|||
44113106|NCT02582242|78895626|FG001|Overall Study|Lost to Follow-up|1|||
44113107|NCT02582242|78895625|FG000|Overall Study|Withdrawal by Subject|11|||
44237903|NCT01695239|79064362|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237904|NCT01695239|79064363|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
44237905|NCT01695239|79064364|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237906|NCT01695239|79064365|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44113108|NCT02582242|78895626|FG001|Overall Study|Withdrawal by Subject|11|||
44113109|NCT02582242|78895625|FG000|Overall Study|Unclassified|2|||
44113110|NCT02582242|78895626|FG001|Overall Study|Unclassified|1|||
44113111|NCT00663351|78895634|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
44113112|NCT00663351|78895635|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
44113113|NCT00663351|78895634|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
44113114|NCT00663351|78895635|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
44237907|NCT01695239|79064366|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237908|NCT01695239|79064367|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44237909|NCT01695239|79064368|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44249743|NCT01504412|79083927|FG004|Overall Study|Lost to Follow-up|0|||
44573229|NCT02858895|79595690|FG000|Overall Study|Disease progression|31|||
44113115|NCT00663351|78895634|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
44113116|NCT00663351|78895635|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
44113117|NCT00663351|78895634|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
44113118|NCT00663351|78895635|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
44113119|NCT00663351|78895634|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
44113120|NCT00663351|78895635|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
44113121|NCT00663351|78895634|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
44113122|NCT00663351|78895635|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
44573230|NCT02858895|79595690|FG000|Overall Study|Death|2|||
44573231|NCT02858895|79595690|FG000|Overall Study|Adverse Event|1|||
44573232|NCT02858895|79595690|FG000|Overall Study|Withdrawal by Subject|3|||
44573233|NCT02858895|79595690|FG000|Overall Study|hospice,|1|||
44573234|NCT02858895|79595690|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
44573235|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
44573236|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
44573237|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
44573238|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
44573239|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
44573240|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
44573241|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
44573242|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
44573243|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
44573244|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
44573245|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
44573246|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
44573247|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
44573248|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
44573249|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
44573250|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
44573251|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
44573252|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
44573253|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
44573254|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
44573255|NCT02637856|79595701|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
44573256|NCT02637856|79595702|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
44573257|NCT02637856|79595701|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
44573258|NCT02637856|79595702|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
44573259|NCT02637856|79595701|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
44113123|NCT00616941|78895644|FG000|Overall Study|Progressive Disease|1|||
44113124|NCT00616941|78895645|FG001|Overall Study|Progressive Disease|2|||
44113125|NCT00616941|78895646|FG002|Overall Study|Progressive Disease|1|||
44113126|NCT00616941|78895644|FG000|Overall Study|Adverse Event|0|||
44377920|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
44113127|NCT00616941|78895645|FG001|Overall Study|Adverse Event|1|||
44113128|NCT00616941|78895646|FG002|Overall Study|Adverse Event|1|||
44113129|NCT00616941|78895644|FG000|Overall Study|Subject Non-compliance|0|||
44113130|NCT00616941|78895645|FG001|Overall Study|Subject Non-compliance|0|||
44113131|NCT00616941|78895646|FG002|Overall Study|Subject Non-compliance|1|||
44113132|NCT00616941|78895644|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
44113133|NCT00616941|78895645|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
44113134|NCT00616941|78895646|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
44113135|NCT00616941|78895644|FG000|Overall Study|Vaccination Suspended|0|||
44113136|NCT00616941|78895645|FG001|Overall Study|Vaccination Suspended|0|||
44113137|NCT00616941|78895646|FG002|Overall Study|Vaccination Suspended|3|||
44113138|NCT00105560|78895654|FG000|Overall Study|Lost to Follow-up|1|||
44143825|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
44143826|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
44143827|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
44143828|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
44143829|NCT03420781|78933121|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
44143830|NCT03420781|78933122|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
44143831|NCT03420781|78933123|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
44143832|NCT03420781|78933124|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
44143833|NCT03420781|78933125|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
44143834|NCT03420781|78933121|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
44143835|NCT03420781|78933122|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
44143836|NCT03420781|78933123|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
44143837|NCT03420781|78933124|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
44143838|NCT03420781|78933125|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
44143839|NCT03420781|78933121|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
44143840|NCT03420781|78933122|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
44143841|NCT03420781|78933123|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
44143842|NCT03420781|78933124|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
44143843|NCT03420781|78933125|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
44143844|NCT03420781|78933121|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
44143845|NCT03420781|78933122|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
44143846|NCT03420781|78933123|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
44143847|NCT03420781|78933124|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
44143848|NCT03420781|78933125|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
44143849|NCT03269695|78933143|FG000|Overall Study|Adverse Event|2|||
44143850|NCT03269695|78933144|FG001|Overall Study|Adverse Event|1|||
44143851|NCT03269695|78933143|FG000|Overall Study|Lack of Efficacy|0|||
44143852|NCT03269695|78933144|FG001|Overall Study|Lack of Efficacy|1|||
44143853|NCT03269695|78933143|FG000|Overall Study|Withdrawal by Subject|0|||
44573260|NCT02637856|79595702|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
44573261|NCT02858037|79595708|FG000|Overall Study|Death|1|||
44573262|NCT02858037|79595708|FG000|Overall Study|Withdrawal by Subject|18|||
44573263|NCT02858037|79595708|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
44573264|NCT02858037|79595708|FG000|Overall Study|Lost to Follow-up|3|||
44573265|NCT02858037|79595708|FG000|Overall Study|Other|4|||
44573266|NCT02856555|79595715|FG000|Overall Study|Adverse Event|1|||
44573267|NCT02856555|79595716|FG001|Overall Study|Adverse Event|0|||
44573268|NCT02856555|79595717|FG002|Overall Study|Adverse Event|0|||
44573269|NCT02856555|79595715|FG000|Overall Study|Lost to Follow-up|1|||
44573270|NCT02856555|79595716|FG001|Overall Study|Lost to Follow-up|3|||
44573271|NCT02856555|79595717|FG002|Overall Study|Lost to Follow-up|0|||
44573272|NCT02856555|79595715|FG000|Overall Study|Withdrawal by Subject|3|||
44573273|NCT02856555|79595716|FG001|Overall Study|Withdrawal by Subject|0|||
44573274|NCT02856555|79595717|FG002|Overall Study|Withdrawal by Subject|0|||
44573275|NCT02856555|79595715|FG000|Overall Study|Randomized but Never Treated|0|||
44573276|NCT02856555|79595716|FG001|Overall Study|Randomized but Never Treated|1|||
44573277|NCT02856555|79595717|FG002|Overall Study|Randomized but Never Treated|0|||
44573278|NCT02637232|79595755|FG000|Overall Study|Lost to Follow-up|42|||
44573279|NCT02637232|79595755|FG000|Overall Study|Adverse Event|11|||
44573280|NCT02637232|79595755|FG000|Overall Study|patient 's decision|2|||
44573281|NCT02855541|79595759|FG000|Overall Study|Change in health status|2|||
44573282|NCT02855541|79595759|FG000|Overall Study|Withdrawal by Subject|2|||
44573283|NCT02635984|79595765|FG000|Overall Study|Lost to Follow-up|2|||
44573284|NCT02635984|79595766|FG001|Overall Study|Lost to Follow-up|4|||
44143854|NCT03269695|78933144|FG001|Overall Study|Withdrawal by Subject|1|||
44573285|NCT02635984|79595765|FG000|Overall Study|Study Arm Closed|1|||
44573286|NCT02635984|79595766|FG001|Overall Study|Study Arm Closed|0|||
44573287|NCT01147653|79595774|FG000|Year 2|Withdrawal by Subject|2|||
44573288|NCT01147653|79595775|FG001|Year 2|Withdrawal by Subject|3|||
44573289|NCT02747043|79595796|FG000|Overall Study|Other|1|||
44113139|NCT02577718|78895667|FG000|Overall Study|Death|6|||
44113140|NCT02577718|78895667|FG000|Overall Study|Withdrawal by Subject|2|||
44113141|NCT00520533|78895673|FG000|Overall Study|Death|1|||
44113142|NCT00520533|78895673|FG000|Overall Study|Suspension of the study for safety reasons|1|||
44113143|NCT00520533|78895673|FG000|Overall Study|Withdrawal by Subject|1|||
44113144|NCT00520533|78895673|FG000|Overall Study|Physician Decision|1|||
44113145|NCT01664104|78895682|FG000|Overall Study|Adverse Event|6|||
44113146|NCT01664104|78895682|FG000|Overall Study|Lack of Efficacy|2|||
44573290|NCT02747043|79595797|FG001|Overall Study|Other|1|||
44573291|NCT02747043|79595796|FG000|Overall Study|Adverse Event|3|||
44573292|NCT02747043|79595797|FG001|Overall Study|Adverse Event|1|||
44113147|NCT01664104|78895682|FG000|Overall Study|Withdrawal by Subject|1|||
44113148|NCT01664104|78895682|FG000|Overall Study|Lost to Follow-up|4|||
44113149|NCT01664104|78895682|FG000|Overall Study|Other|1|||
44113150|NCT01664104|78895682|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
44113151|NCT02739984|78895690|FG000|Overall Study|Sponsor Decision|1|||
44113152|NCT02739984|78895691|FG001|Overall Study|Sponsor Decision|0|||
44113153|NCT02739984|78895690|FG000|Overall Study|Withdrawal by Subject|1|||
44113154|NCT02739984|78895691|FG001|Overall Study|Withdrawal by Subject|1|||
44113155|NCT02739984|78895690|FG000|Overall Study|Death|0|||
44113156|NCT02739984|78895691|FG001|Overall Study|Death|1|||
44113157|NCT02739984|78895690|FG000|Overall Study|Lost to Follow-up|3|||
44113158|NCT02739984|78895691|FG001|Overall Study|Lost to Follow-up|0|||
44113159|NCT00496730|78895699|FG000|Overall Study|Lost to Follow-up|4|||
44113160|NCT00496730|78895700|FG001|Overall Study|Lost to Follow-up|3|||
44113161|NCT00496730|78895699|FG000|Overall Study|Withdrawal by Subject|2|||
44113162|NCT00496730|78895700|FG001|Overall Study|Withdrawal by Subject|2|||
44113163|NCT02739828|78895706|FG000|Overall Study|Adverse Event|1|||
44113164|NCT02739828|78895706|FG000|Overall Study|Lost to Follow-up|4|||
44113165|NCT04435808|78895721|FG000|Overall Study|Study stopped by DSMB|0|||
44113166|NCT04435808|78895722|FG001|Overall Study|Study stopped by DSMB|1|||
44113167|NCT01664494|78895745|FG000|Overall Study|Withdrawal by Subject|27|||
44113168|NCT01664494|78895745|FG000|Overall Study|Death|18|||
44113169|NCT01664494|78895745|FG000|Overall Study|Other|49|||
44113170|NCT01664494|78895745|FG000|Overall Study|Lost to Follow-up|99|||
44113171|NCT02577016|78895751|FG000|Overall Study|Adverse Event|2|||
44113172|NCT02577016|78895752|FG001|Overall Study|Adverse Event|1|||
44113173|NCT02577016|78895751|FG000|Overall Study|Physician Decision|0|||
44113174|NCT02577016|78895752|FG001|Overall Study|Physician Decision|1|||
44113175|NCT05101252|78895760|FG000|Overall Study|Unsatisfactory Test Article|1|||
44113176|NCT05101252|78895761|FG001|Overall Study|Unsatisfactory Test Article|0|||
44573293|NCT02747043|79595796|FG000|Overall Study|Withdrawal by Subject|1|||
44573294|NCT02747043|79595797|FG001|Overall Study|Withdrawal by Subject|1|||
44113177|NCT05101252|78895760|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
44113178|NCT05101252|78895761|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
44113179|NCT05101252|78895760|FG000|Overall Study|Withdrew Consent during study|0|||
44113180|NCT05101252|78895761|FG001|Overall Study|Withdrew Consent during study|1|||
44113181|NCT05101252|78895760|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
44113182|NCT05101252|78895761|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
44113183|NCT03316586|78895767|FG000|Overall Study|Adverse Event|2|||
44113184|NCT03316586|78895767|FG000|Overall Study|Physician Decision|3|||
44113185|NCT03316586|78895767|FG000|Overall Study|Lack of Efficacy|10|||
44113186|NCT03316586|78895767|FG000|Overall Study|still on treatment|1|||
44573295|NCT02747043|79595796|FG000|Overall Study|Physician Decision|1|||
44573296|NCT02747043|79595797|FG001|Overall Study|Physician Decision|1|||
44573297|NCT02747043|79595796|FG000|Overall Study|Protocol Violation|0|||
44573298|NCT02747043|79595797|FG001|Overall Study|Protocol Violation|1|||
44573299|NCT02747043|79595796|FG000|Overall Study|Disease progression|4|||
44573300|NCT02747043|79595797|FG001|Overall Study|Disease progression|0|||
44573301|NCT02637076|79595805|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
44113187|NCT03316586|78895767|FG000|Overall Study|Patient needed radiation therapy|1|||
44113188|NCT03316586|78895767|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
44113189|NCT00107991|78895771|FG000|Eligibility Assessment|Disease not severe enough|7|||
44113190|NCT00107991|78895771|FG000|Eligibility Assessment|Unwilling to participate|7|||
44113191|NCT00107991|78895771|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
44113192|NCT00107991|78895771|FG000|Eligibility Assessment|Abnormal labs|2|||
44113193|NCT00107991|78895771|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
44113194|NCT00107991|78895771|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
44573302|NCT02637076|79595806|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
44573303|NCT02637076|79595805|FG000|Overall Study|Withdrawal by Subject|0|||
44113195|NCT00107991|78895771|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
44113196|NCT00107991|78895771|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
44113197|NCT00107991|78895771|FG000|12 Week Treatment Period|Adverse Event|1|||
44113198|NCT00107991|78895771|FG000|12 Week Treatment Period|Protocol Violation|1|||
44573304|NCT02637076|79595806|FG001|Overall Study|Withdrawal by Subject|4|||
44573305|NCT02854605|79595815|FG000|Overall Study|Adverse Event|1|||
44573306|NCT02854605|79595816|FG001|Overall Study|Adverse Event|5|||
44573307|NCT02854605|79595817|FG002|Overall Study|Adverse Event|2|||
44573308|NCT02854605|79595815|FG000|Overall Study|Lost to Follow-up|0|||
44573309|NCT02854605|79595816|FG001|Overall Study|Lost to Follow-up|2|||
44573310|NCT02854605|79595817|FG002|Overall Study|Lost to Follow-up|0|||
44573311|NCT02854605|79595815|FG000|Overall Study|Withdrew Consent|1|||
44113199|NCT00107991|78895771|FG000|12 Week Treatment Period|Incarcerated|1|||
44113200|NCT00107991|78895771|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
44113201|NCT00492856|78895775|FG000|Induction|Adverse Event|2|||
44113202|NCT00492856|78895776|FG001|Induction|Adverse Event|0|||
44573312|NCT02854605|79595816|FG001|Overall Study|Withdrew Consent|0|||
44113203|NCT00492856|78895777|FG002|Induction|Adverse Event|0|||
44113204|NCT00492856|78895778|FG003|Induction|Adverse Event|0|||
44113205|NCT00492856|78895775|FG000|Induction|Withdrawal by Subject|1|||
44113206|NCT00492856|78895776|FG001|Induction|Withdrawal by Subject|0|||
44113207|NCT00492856|78895777|FG002|Induction|Withdrawal by Subject|0|||
44113208|NCT00492856|78895778|FG003|Induction|Withdrawal by Subject|0|||
44113209|NCT00492856|78895775|FG000|Induction|Death|3|||
44113210|NCT00492856|78895776|FG001|Induction|Death|0|||
44113211|NCT00492856|78895777|FG002|Induction|Death|0|||
44113212|NCT00492856|78895778|FG003|Induction|Death|0|||
44113213|NCT00492856|78895775|FG000|Consolidation|Adverse Event|6|||
44113214|NCT00492856|78895776|FG001|Consolidation|Adverse Event|0|||
44113215|NCT00492856|78895777|FG002|Consolidation|Adverse Event|0|||
44113216|NCT00492856|78895778|FG003|Consolidation|Adverse Event|0|||
44113217|NCT00492856|78895775|FG000|Consolidation|Not protocol specified|2|||
44113218|NCT00492856|78895776|FG001|Consolidation|Not protocol specified|0|||
44113219|NCT00492856|78895777|FG002|Consolidation|Not protocol specified|0|||
44113220|NCT00492856|78895778|FG003|Consolidation|Not protocol specified|0|||
44113221|NCT00492856|78895775|FG000|Consolidation|Lost to Follow-up|1|||
44113222|NCT00492856|78895776|FG001|Consolidation|Lost to Follow-up|0|||
44113223|NCT00492856|78895777|FG002|Consolidation|Lost to Follow-up|0|||
44113224|NCT00492856|78895778|FG003|Consolidation|Lost to Follow-up|0|||
44113225|NCT00492856|78895775|FG000|Post-consolidation|Adverse Event|0|||
44113226|NCT00492856|78895776|FG001|Post-consolidation|Adverse Event|4|||
44113227|NCT00492856|78895777|FG002|Post-consolidation|Adverse Event|0|||
44113228|NCT00492856|78895778|FG003|Post-consolidation|Adverse Event|1|||
44113229|NCT00492856|78895775|FG000|Post-consolidation|Withdrawal by Subject|0|||
44113230|NCT00492856|78895776|FG001|Post-consolidation|Withdrawal by Subject|4|||
44113231|NCT00492856|78895777|FG002|Post-consolidation|Withdrawal by Subject|0|||
44113232|NCT00492856|78895778|FG003|Post-consolidation|Withdrawal by Subject|0|||
44113233|NCT00492856|78895775|FG000|Post-consolidation|Death|0|||
44573313|NCT02854605|79595817|FG002|Overall Study|Withdrew Consent|1|||
44573314|NCT02854605|79595815|FG000|Overall Study|Investigator's Discretion|1|||
44573315|NCT02854605|79595816|FG001|Overall Study|Investigator's Discretion|0|||
44573316|NCT02854605|79595817|FG002|Overall Study|Investigator's Discretion|0|||
44573317|NCT02854605|79595815|FG000|Overall Study|Protocol Violation|0|||
44573318|NCT02854605|79595816|FG001|Overall Study|Protocol Violation|0|||
44573319|NCT02854605|79595817|FG002|Overall Study|Protocol Violation|1|||
44573320|NCT05059977|79595835|FG000|Overall Study|Withdrawal by Subject|0|||
44573321|NCT05059977|79595836|FG001|Overall Study|Withdrawal by Subject|0|||
44573322|NCT05059977|79595837|FG002|Overall Study|Withdrawal by Subject|1|||
44573323|NCT04803305|79595851|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
44573324|NCT04803305|79595852|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
44573325|NCT04803305|79595851|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
44573326|NCT04803305|79595852|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
44573327|NCT04803305|79595851|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
44113234|NCT00492856|78895776|FG001|Post-consolidation|Death|1|||
44113235|NCT00492856|78895777|FG002|Post-consolidation|Death|0|||
44113236|NCT00492856|78895778|FG003|Post-consolidation|Death|0|||
44113237|NCT00492856|78895775|FG000|Post-consolidation|Not protocol specified|0|||
44113238|NCT00492856|78895776|FG001|Post-consolidation|Not protocol specified|1|||
44113239|NCT00492856|78895777|FG002|Post-consolidation|Not protocol specified|0|||
44113240|NCT00492856|78895778|FG003|Post-consolidation|Not protocol specified|0|||
44113241|NCT00492856|78895775|FG000|Post-consolidation|Lost to Follow-up|0|||
44113242|NCT00492856|78895776|FG001|Post-consolidation|Lost to Follow-up|2|||
44113243|NCT00492856|78895777|FG002|Post-consolidation|Lost to Follow-up|0|||
44113244|NCT00492856|78895778|FG003|Post-consolidation|Lost to Follow-up|0|||
44113245|NCT00492856|78895775|FG000|Post-consolidation|Observation Arm|0|||
44113246|NCT00492856|78895776|FG001|Post-consolidation|Observation Arm|0|||
44573328|NCT04803305|79595852|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
44573329|NCT04803305|79595851|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
44573330|NCT04803305|79595852|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
44573331|NCT04803305|79595851|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
44113247|NCT00492856|78895777|FG002|Post-consolidation|Observation Arm|27|||
44249744|NCT01504412|79083923|FG000|Overall Study|Lack of Efficacy|0|||
44573332|NCT04803305|79595852|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
44573333|NCT04803305|79595851|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
44573334|NCT04803305|79595852|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
44573335|NCT04803305|79595851|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
44573336|NCT04803305|79595852|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
44113248|NCT00492856|78895778|FG003|Post-consolidation|Observation Arm|0|||
44113249|NCT02782377|78895790|FG000|Overall Study|Physician Decision|5|||
44113250|NCT02410629|78895797|FG000|Overall Study|Family cannot commit to the study|2|||
44113251|NCT02410629|78895798|FG001|Overall Study|Family cannot commit to the study|1|||
44113252|NCT02410629|78895797|FG000|Overall Study|Subject returned to work|1|||
44113253|NCT02410629|78895798|FG001|Overall Study|Subject returned to work|0|||
44113254|NCT02410629|78895797|FG000|Overall Study|Subject moved back to home country|0|||
44113255|NCT02410629|78895798|FG001|Overall Study|Subject moved back to home country|1|||
44113256|NCT02410629|78895797|FG000|Overall Study|Subject underwent heart surgery|0|||
44113257|NCT02410629|78895798|FG001|Overall Study|Subject underwent heart surgery|1|||
44113258|NCT02252211|78895806|FG000|Overall Study|Adverse Event|0|||
44113259|NCT02252211|78895807|FG001|Overall Study|Adverse Event|1|||
44113260|NCT02252211|78895808|FG002|Overall Study|Adverse Event|0|||
44113261|NCT02252211|78895806|FG000|Overall Study|Progressive disease|3|||
44113262|NCT02252211|78895807|FG001|Overall Study|Progressive disease|2|||
44113263|NCT02252211|78895808|FG002|Overall Study|Progressive disease|0|||
44113264|NCT02252211|78895806|FG000|Overall Study|Withdrawal by Subject|1|||
44113265|NCT02252211|78895807|FG001|Overall Study|Withdrawal by Subject|0|||
44113266|NCT02252211|78895808|FG002|Overall Study|Withdrawal by Subject|0|||
44113267|NCT02252211|78895806|FG000|Overall Study|Serious Adverse Event During Screening|1|||
44113268|NCT02252211|78895807|FG001|Overall Study|Serious Adverse Event During Screening|0|||
44113269|NCT02252211|78895808|FG002|Overall Study|Serious Adverse Event During Screening|1|||
44113270|NCT02776683|78895815|FG000|Pre-switch Period|Protocol Violation|1|||
44113271|NCT02776683|78895816|FG001|Pre-switch Period|Protocol Violation|0|||
44113272|NCT02776683|78895815|FG000|Pre-switch Period|Adverse Event|21|||
44113273|NCT02776683|78895816|FG001|Pre-switch Period|Adverse Event|0|||
44113274|NCT02776683|78895815|FG000|Pre-switch Period|Withdrawal by Subject|9|||
44113275|NCT02776683|78895816|FG001|Pre-switch Period|Withdrawal by Subject|0|||
44113276|NCT02776683|78895815|FG000|Pre-switch Period|Physician Decision|7|||
44113277|NCT02776683|78895816|FG001|Pre-switch Period|Physician Decision|0|||
44113278|NCT02776683|78895815|FG000|Pre-switch Period|Progressive disease|39|||
44113279|NCT02776683|78895816|FG001|Pre-switch Period|Progressive disease|0|||
44113280|NCT02776683|78895815|FG000|Pre-switch Period|Other than listed|3|||
44113281|NCT02776683|78895816|FG001|Pre-switch Period|Other than listed|0|||
44113282|NCT02776683|78895815|FG000|Post-switch Period|Adverse Event|0|||
44113283|NCT02776683|78895816|FG001|Post-switch Period|Adverse Event|3|||
44113284|NCT02776683|78895815|FG000|Post-switch Period|Withdrawal by Subject|0|||
44113285|NCT02776683|78895816|FG001|Post-switch Period|Withdrawal by Subject|2|||
44113286|NCT02776683|78895815|FG000|Post-switch Period|Physician Decision|0|||
44113287|NCT02776683|78895816|FG001|Post-switch Period|Physician Decision|3|||
44113288|NCT02776683|78895815|FG000|Post-switch Period|Progressive disease|0|||
44113289|NCT02776683|78895816|FG001|Post-switch Period|Progressive disease|20|||
44237910|NCT01695239|79064369|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
44573337|NCT04803305|79595851|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
44573338|NCT04803305|79595852|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
44573339|NCT04607135|79595870|FG000|Overall Study|Physician Decision|1|||
44573340|NCT04607135|79595870|FG000|Overall Study|Withdrawal by Subject|1|||
44573341|NCT04607135|79595870|FG000|Overall Study|Equipment not working|3|||
44573342|NCT04525885|79595885|FG000|Overall Study|Screen Failure|1|||
44573343|NCT04525885|79595886|FG001|Overall Study|Screen Failure|0|||
44573344|NCT04525885|79595887|FG002|Overall Study|Screen Failure|0|||
44573345|NCT04525885|79595885|FG000|Overall Study|Withdrawal by Subject|14|||
44573346|NCT04525885|79595886|FG001|Overall Study|Withdrawal by Subject|6|||
44573347|NCT04525885|79595887|FG002|Overall Study|Withdrawal by Subject|20|||
44573348|NCT04525885|79595885|FG000|Overall Study|Physician Decision|1|||
44573349|NCT04525885|79595886|FG001|Overall Study|Physician Decision|0|||
44573350|NCT04525885|79595887|FG002|Overall Study|Physician Decision|1|||
44573351|NCT04426006|79595900|FG000|Inclusion|Protocol Violation|1|||
44573352|NCT04426006|79595900|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
44113290|NCT02776683|78895815|FG000|Post-switch Period|Other than listed|0|||
44113291|NCT02776683|78895816|FG001|Post-switch Period|Other than listed|15|||
44113292|NCT02731742|78895824|FG000|Overall Study|Death|1|||
44113293|NCT02731742|78895825|FG001|Overall Study|Death|2|||
44113294|NCT02731742|78895826|FG002|Overall Study|Death|5|||
44113295|NCT02731742|78895827|FG003|Overall Study|Death|0|||
44113296|NCT02731742|78895824|FG000|Overall Study|Physician Decision|0|||
44113297|NCT02731742|78895825|FG001|Overall Study|Physician Decision|0|||
44113298|NCT02731742|78895826|FG002|Overall Study|Physician Decision|0|||
44113299|NCT02731742|78895827|FG003|Overall Study|Physician Decision|1|||
44573353|NCT04426006|79595900|FG000|Inclusion|Blood sample at inclusion not done|1|||
44113300|NCT02731742|78895824|FG000|Overall Study|Study Terminated by Sponsor|2|||
44113301|NCT02731742|78895825|FG001|Overall Study|Study Terminated by Sponsor|1|||
44113302|NCT02731742|78895826|FG002|Overall Study|Study Terminated by Sponsor|1|||
44113303|NCT02731742|78895827|FG003|Overall Study|Study Terminated by Sponsor|1|||
44113304|NCT00104871|78895850|FG000|Overall Study|Not evaluable|1|||
44113305|NCT03487796|78895858|FG000|Overall Study|Lost to Follow-up|18|||
44113306|NCT03487796|78895859|FG001|Overall Study|Lost to Follow-up|6|||
44113307|NCT02148705|78895874|FG000|Overall Study|Death|2|||
44113308|NCT02148705|78895875|FG001|Overall Study|Death|0|||
44113309|NCT02148705|78895876|FG002|Overall Study|Death|0|||
44113310|NCT02148705|78895874|FG000|Overall Study|Lost to Follow-up|13|||
44113311|NCT02148705|78895875|FG001|Overall Study|Lost to Follow-up|4|||
44113312|NCT02148705|78895876|FG002|Overall Study|Lost to Follow-up|10|||
44113313|NCT02148705|78895874|FG000|Overall Study|Withdrawal by Subject|3|||
44113314|NCT02148705|78895875|FG001|Overall Study|Withdrawal by Subject|0|||
44113315|NCT02148705|78895876|FG002|Overall Study|Withdrawal by Subject|2|||
44113316|NCT02148705|78895874|FG000|Overall Study|Not Treated|0|||
44113317|NCT02148705|78895875|FG001|Overall Study|Not Treated|1|||
44113318|NCT02148705|78895876|FG002|Overall Study|Not Treated|5|||
44113319|NCT03446612|78895886|FG000|Overall Study|Protocol defined stopping criteria|0|||
44113320|NCT03446612|78895887|FG001|Overall Study|Protocol defined stopping criteria|1|||
44113321|NCT02730728|78895898|FG000|Overall Study|Withdrawal by Subject|0|||
44113322|NCT02730728|78895899|FG001|Overall Study|Withdrawal by Subject|1|||
44113323|NCT02730728|78895900|FG002|Overall Study|Withdrawal by Subject|0|||
44113324|NCT02730728|78895898|FG000|Overall Study|Lack of Efficacy|0|||
44113325|NCT02730728|78895899|FG001|Overall Study|Lack of Efficacy|1|||
44113326|NCT02730728|78895900|FG002|Overall Study|Lack of Efficacy|1|||
44113327|NCT00104637|78895908|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
44113328|NCT00104637|78895909|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
44113329|NCT02768103|78895918|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
44113330|NCT02767323|78895927|FG000|Overall Study|Withdrawal by Subject|17|||
44113331|NCT02767323|78895928|FG001|Overall Study|Withdrawal by Subject|5|||
44113332|NCT02767323|78895929|FG002|Overall Study|Withdrawal by Subject|13|||
44113333|NCT02767323|78895930|FG003|Overall Study|Withdrawal by Subject|0|||
44113334|NCT02767323|78895927|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
44113335|NCT02767323|78895928|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
44113336|NCT02767323|78895929|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
44113337|NCT02767323|78895930|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
44113338|NCT04304950|78895945|FG000|Overall Study|Lost to Follow-up|1|||
44113339|NCT04304950|78895946|FG001|Overall Study|Lost to Follow-up|1|||
44113340|NCT02780115|78895960|FG000|Overall Study|Withdrawal by Subject|0|||
44237911|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237912|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237913|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237914|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237915|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44573354|NCT04426006|79595900|FG000|3 Months|Lost to Follow-up|17|||
44573355|NCT04426006|79595900|FG000|12 Months|Lost to Follow-up|38|||
44573356|NCT03959241|79595907|FG000|Overall Study|Withdrawal by Subject|7|||
44573357|NCT03959241|79595908|FG001|Overall Study|Withdrawal by Subject|8|||
44573358|NCT03959241|79595907|FG000|Overall Study|Lost to Follow-up|1|||
44573359|NCT03959241|79595908|FG001|Overall Study|Lost to Follow-up|0|||
44573360|NCT03959241|79595907|FG000|Overall Study|Move to Hospice Care|1|||
44573361|NCT03959241|79595908|FG001|Overall Study|Move to Hospice Care|0|||
44573362|NCT03959241|79595907|FG000|Overall Study|Screen Failure|1|||
44573363|NCT03959241|79595908|FG001|Overall Study|Screen Failure|0|||
44573364|NCT03959241|79595907|FG000|Overall Study|Disease Relapse|0|||
44573365|NCT03959241|79595908|FG001|Overall Study|Disease Relapse|1|||
44573366|NCT03959241|79595907|FG000|Overall Study|Off Study|1|||
44573367|NCT03959241|79595908|FG001|Overall Study|Off Study|0|||
44573368|NCT03705169|79595928|FG000|Overall Study|Lost to Follow-up|0|||
44573369|NCT03705169|79595929|FG001|Overall Study|Lost to Follow-up|0|||
44237916|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44573370|NCT03705169|79595930|FG002|Overall Study|Lost to Follow-up|0|||
44113341|NCT02780115|78895961|FG001|Overall Study|Withdrawal by Subject|1|||
44113342|NCT02780115|78895962|FG002|Overall Study|Withdrawal by Subject|1|||
44113343|NCT02780115|78895963|FG003|Overall Study|Withdrawal by Subject|0|||
44573371|NCT03705169|79595931|FG003|Overall Study|Lost to Follow-up|2|||
44573372|NCT03705169|79595932|FG004|Overall Study|Lost to Follow-up|0|||
44573373|NCT03705169|79595933|FG005|Overall Study|Lost to Follow-up|2|||
44113344|NCT02780115|78895964|FG004|Overall Study|Withdrawal by Subject|0|||
44113345|NCT02780115|78895960|FG000|Overall Study|Adverse Event|0|||
44113346|NCT02780115|78895961|FG001|Overall Study|Adverse Event|0|||
44113347|NCT02780115|78895962|FG002|Overall Study|Adverse Event|0|||
44573374|NCT03705169|79595934|FG006|Overall Study|Lost to Follow-up|1|||
44573375|NCT03705169|79595935|FG007|Overall Study|Lost to Follow-up|0|||
44573376|NCT03705169|79595936|FG008|Overall Study|Lost to Follow-up|0|||
44573377|NCT03705169|79595937|FG009|Overall Study|Lost to Follow-up|1|||
44573378|NCT03705169|79595928|FG000|Overall Study|Adverse Event|0|||
44573379|NCT03705169|79595929|FG001|Overall Study|Adverse Event|0|||
44573380|NCT03705169|79595930|FG002|Overall Study|Adverse Event|0|||
44237917|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237918|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237919|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
44237920|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
44237921|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237922|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237923|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44237924|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
44573381|NCT03705169|79595931|FG003|Overall Study|Adverse Event|1|||
44573382|NCT03705169|79595932|FG004|Overall Study|Adverse Event|0|||
44573383|NCT03705169|79595933|FG005|Overall Study|Adverse Event|0|||
44573384|NCT03705169|79595934|FG006|Overall Study|Adverse Event|0|||
44573385|NCT03705169|79595935|FG007|Overall Study|Adverse Event|0|||
44573386|NCT03705169|79595936|FG008|Overall Study|Adverse Event|0|||
44573387|NCT03705169|79595937|FG009|Overall Study|Adverse Event|0|||
44573388|NCT03705169|79595928|FG000|Overall Study|Site Closure|0|||
44573389|NCT03705169|79595929|FG001|Overall Study|Site Closure|0|||
44573390|NCT03705169|79595930|FG002|Overall Study|Site Closure|0|||
44573391|NCT03705169|79595931|FG003|Overall Study|Site Closure|1|||
44573392|NCT03705169|79595932|FG004|Overall Study|Site Closure|0|||
44573393|NCT03705169|79595933|FG005|Overall Study|Site Closure|0|||
44573394|NCT03705169|79595934|FG006|Overall Study|Site Closure|0|||
44573395|NCT03705169|79595935|FG007|Overall Study|Site Closure|0|||
44573396|NCT03705169|79595936|FG008|Overall Study|Site Closure|0|||
44573397|NCT03705169|79595937|FG009|Overall Study|Site Closure|0|||
44573398|NCT03705169|79595928|FG000|Overall Study|Did not receive study treatment|0|||
44573399|NCT03705169|79595929|FG001|Overall Study|Did not receive study treatment|0|||
44573400|NCT03705169|79595930|FG002|Overall Study|Did not receive study treatment|0|||
44573401|NCT03705169|79595931|FG003|Overall Study|Did not receive study treatment|1|||
44573402|NCT03705169|79595932|FG004|Overall Study|Did not receive study treatment|0|||
44573403|NCT03705169|79595933|FG005|Overall Study|Did not receive study treatment|0|||
44573404|NCT03705169|79595934|FG006|Overall Study|Did not receive study treatment|0|||
44573405|NCT03705169|79595935|FG007|Overall Study|Did not receive study treatment|0|||
44573406|NCT03705169|79595936|FG008|Overall Study|Did not receive study treatment|0|||
44573407|NCT03705169|79595937|FG009|Overall Study|Did not receive study treatment|0|||
44573408|NCT03705169|79595928|FG000|Overall Study|Concerns about study visit compliance|0|||
44573409|NCT03705169|79595929|FG001|Overall Study|Concerns about study visit compliance|0|||
44573410|NCT03705169|79595930|FG002|Overall Study|Concerns about study visit compliance|0|||
44573411|NCT03705169|79595931|FG003|Overall Study|Concerns about study visit compliance|1|||
44573412|NCT03705169|79595932|FG004|Overall Study|Concerns about study visit compliance|0|||
44573413|NCT03705169|79595933|FG005|Overall Study|Concerns about study visit compliance|0|||
44573414|NCT03705169|79595934|FG006|Overall Study|Concerns about study visit compliance|0|||
44573415|NCT03705169|79595935|FG007|Overall Study|Concerns about study visit compliance|0|||
44573416|NCT03705169|79595936|FG008|Overall Study|Concerns about study visit compliance|0|||
44573417|NCT03705169|79595937|FG009|Overall Study|Concerns about study visit compliance|0|||
44573418|NCT03414684|79595974|FG000|First-course Treatment|Complete response|0|||
44573419|NCT03414684|79595975|FG001|First-course Treatment|Complete response|1|||
44573420|NCT03414684|79595974|FG000|First-course Treatment|Intercurrent illness|1|||
44573421|NCT03414684|79595975|FG001|First-course Treatment|Intercurrent illness|0|||
44573422|NCT03414684|79595974|FG000|First-course Treatment|Progressive Disease|31|||
44573423|NCT03414684|79595975|FG001|First-course Treatment|Progressive Disease|32|||
44573424|NCT03414684|79595974|FG000|First-course Treatment|Adverse Event|1|||
44573425|NCT03414684|79595975|FG001|First-course Treatment|Adverse Event|2|||
44573426|NCT03414684|79595974|FG000|First-course Treatment|Physician Decision|0|||
44573427|NCT03414684|79595975|FG001|First-course Treatment|Physician Decision|1|||
44113348|NCT02780115|78895963|FG003|Overall Study|Adverse Event|1|||
44113349|NCT02780115|78895964|FG004|Overall Study|Adverse Event|1|||
44237925|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
44377921|NCT00785785|79383205|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
44377922|NCT00785785|79383206|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
44377923|NCT00785785|79383205|FG000|Optional Extension Phase|Adverse Event|4|||
44113350|NCT02766777|78895976|FG000|Overall Study|Adverse Event|12|||
44573428|NCT03414684|79595974|FG000|First-course Treatment|Withdrawal by Subject|0|||
44573429|NCT03414684|79595975|FG001|First-course Treatment|Withdrawal by Subject|1|||
44573430|NCT03414684|79595974|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
44573431|NCT03414684|79595975|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
44113351|NCT02766777|78895976|FG000|Overall Study|Lost to Follow-up|16|||
44113352|NCT02766777|78895976|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44113353|NCT02766777|78895976|FG000|Overall Study|Protocol Violation|1|||
44113354|NCT02766777|78895976|FG000|Overall Study|Withdrawal by Subject|4|||
44113355|NCT00157014|78895984|FG000|Overall Study|Death|4|||
44113356|NCT00157014|78895985|FG001|Overall Study|Death|2|||
44113357|NCT00157014|78895986|FG002|Overall Study|Death|1|||
44113358|NCT00157014|78895987|FG003|Overall Study|Death|1|||
44113359|NCT00157014|78895984|FG000|Overall Study|Physician Decision|0|||
44113360|NCT00157014|78895985|FG001|Overall Study|Physician Decision|1|||
44113361|NCT00157014|78895986|FG002|Overall Study|Physician Decision|0|||
44113362|NCT00157014|78895987|FG003|Overall Study|Physician Decision|0|||
44113363|NCT00157014|78895984|FG000|Overall Study|Medications withdrawn on family request|0|||
44113364|NCT00157014|78895985|FG001|Overall Study|Medications withdrawn on family request|1|||
44113365|NCT00157014|78895986|FG002|Overall Study|Medications withdrawn on family request|0|||
44113366|NCT00157014|78895987|FG003|Overall Study|Medications withdrawn on family request|0|||
44113367|NCT00157014|78895984|FG000|Overall Study|Patient withdrawn by investigator|1|||
44505417|NCT00369707|79510206|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
44505418|NCT00369707|79510206|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
44505419|NCT00369707|79510206|FG000|Follow up for 2 Years After Treatment|Death|1|||
44573432|NCT03414684|79595974|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
44573433|NCT03414684|79595975|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
44573434|NCT03414684|79595974|FG000|First-course Treatment|Still on treatment|3|||
44573435|NCT03414684|79595975|FG001|First-course Treatment|Still on treatment|0|||
44573436|NCT03414684|79595974|FG000|First-course Treatment|Never started protocol therapy|2|||
44573437|NCT03414684|79595975|FG001|First-course Treatment|Never started protocol therapy|1|||
44573438|NCT03414684|79595974|FG000|Crossover Treatment|Progressive disease|0|||
44573439|NCT03414684|79595975|FG001|Crossover Treatment|Progressive disease|12|||
44573440|NCT03414684|79595974|FG000|Crossover Treatment|Adverse Event|0|||
44573441|NCT03414684|79595975|FG001|Crossover Treatment|Adverse Event|3|||
44573442|NCT03414684|79595974|FG000|Crossover Treatment|Physician Decision|0|||
44573443|NCT03414684|79595975|FG001|Crossover Treatment|Physician Decision|1|||
44573444|NCT03414684|79595974|FG000|Crossover Treatment|Still on treatment|0|||
44573445|NCT03414684|79595975|FG001|Crossover Treatment|Still on treatment|2|||
44573446|NCT03298451|79595996|FG000|Overall Study|Death|275|||
44573447|NCT03298451|79595997|FG001|Overall Study|Death|260|||
44573448|NCT03298451|79595998|FG002|Overall Study|Death|122|||
44573449|NCT03298451|79595999|FG003|Overall Study|Death|280|||
44573450|NCT03298451|79595996|FG000|Overall Study|Lost to Follow-up|1|||
44573451|NCT03298451|79595997|FG001|Overall Study|Lost to Follow-up|1|||
44573452|NCT03298451|79595998|FG002|Overall Study|Lost to Follow-up|0|||
44573453|NCT03298451|79595999|FG003|Overall Study|Lost to Follow-up|7|||
44573454|NCT03298451|79595996|FG000|Overall Study|Withdrawal by Subject|9|||
44573455|NCT03298451|79595997|FG001|Overall Study|Withdrawal by Subject|7|||
44573456|NCT03298451|79595998|FG002|Overall Study|Withdrawal by Subject|1|||
44573457|NCT03298451|79595999|FG003|Overall Study|Withdrawal by Subject|20|||
44573458|NCT02244463|79596042|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
44573459|NCT02244463|79596043|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
44573460|NCT02244463|79596044|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
44573461|NCT02244463|79596045|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
44573462|NCT02244463|79596046|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
44573463|NCT02244463|79596047|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
44573464|NCT02244463|79596042|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
44573465|NCT02244463|79596043|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
44573466|NCT02244463|79596044|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
44573467|NCT02244463|79596045|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
44113368|NCT00157014|78895985|FG001|Overall Study|Patient withdrawn by investigator|0|||
44505420|NCT00369707|79510206|FG000|Follow up for 2 Years After Treatment|Other|2|||
44505421|NCT02943460|79510213|FG000|Blinded Study Phase|Adverse Event|3|||
44505422|NCT02943460|79510214|FG001|Blinded Study Phase|Adverse Event|0|||
44505423|NCT02943460|79510215|FG002|Blinded Study Phase|Adverse Event|0|||
44505424|NCT02943460|79510213|FG000|Blinded Study Phase|Withdrew Consent|0|||
44505425|NCT02943460|79510214|FG001|Blinded Study Phase|Withdrew Consent|1|||
44237926|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
44377924|NCT00785785|79383206|FG001|Optional Extension Phase|Adverse Event|5|||
44505426|NCT02943460|79510215|FG002|Blinded Study Phase|Withdrew Consent|0|||
44505427|NCT02943460|79510213|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
44573468|NCT02244463|79596046|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
44573469|NCT02244463|79596047|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
44573470|NCT02244463|79596042|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
44573471|NCT02244463|79596043|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
44573472|NCT02244463|79596044|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
44573473|NCT02244463|79596045|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
44113369|NCT00157014|78895986|FG002|Overall Study|Patient withdrawn by investigator|0|||
44113370|NCT00157014|78895987|FG003|Overall Study|Patient withdrawn by investigator|0|||
44113371|NCT00157014|78895984|FG000|Overall Study|Patient unable to return in nursing home|1|||
44113372|NCT00157014|78895985|FG001|Overall Study|Patient unable to return in nursing home|0|||
44113373|NCT00157014|78895986|FG002|Overall Study|Patient unable to return in nursing home|0|||
44113374|NCT00157014|78895987|FG003|Overall Study|Patient unable to return in nursing home|0|||
44113375|NCT00157014|78895984|FG000|Overall Study|Patient would not receive transplant|0|||
44113376|NCT00157014|78895985|FG001|Overall Study|Patient would not receive transplant|1|||
44113377|NCT00157014|78895986|FG002|Overall Study|Patient would not receive transplant|0|||
44113378|NCT00157014|78895987|FG003|Overall Study|Patient would not receive transplant|0|||
44113379|NCT00157014|78895984|FG000|Overall Study|Withdrawal by Subject|1|||
44113380|NCT00157014|78895985|FG001|Overall Study|Withdrawal by Subject|0|||
44113381|NCT00157014|78895986|FG002|Overall Study|Withdrawal by Subject|0|||
44113382|NCT00157014|78895987|FG003|Overall Study|Withdrawal by Subject|0|||
44113383|NCT02778867|78895999|FG000|Phase 1|Withdrawal by Subject|2|||
44113384|NCT02778867|78896000|FG001|Phase 1|Withdrawal by Subject|3|||
44113385|NCT02778867|78896001|FG002|Phase 1|Withdrawal by Subject|0|||
44113386|NCT02778867|78896002|FG003|Phase 1|Withdrawal by Subject|0|||
44113387|NCT02778867|78895999|FG000|Phase 2|Withdrawal by Subject|0|||
44113388|NCT02778867|78896000|FG001|Phase 2|Withdrawal by Subject|0|||
44113389|NCT02778867|78896001|FG002|Phase 2|Withdrawal by Subject|1|||
44113390|NCT02778867|78896002|FG003|Phase 2|Withdrawal by Subject|0|||
44113391|NCT02778867|78895999|FG000|Phase 2|Physician Decision|0|||
44113392|NCT02778867|78896000|FG001|Phase 2|Physician Decision|0|||
44113393|NCT02778867|78896001|FG002|Phase 2|Physician Decision|0|||
44113394|NCT02778867|78896002|FG003|Phase 2|Physician Decision|1|||
44113395|NCT02778867|78895999|FG000|Phase 2|Adverse Event|0|||
44113396|NCT02778867|78896000|FG001|Phase 2|Adverse Event|0|||
44113397|NCT02778867|78896001|FG002|Phase 2|Adverse Event|0|||
44113398|NCT02778867|78896002|FG003|Phase 2|Adverse Event|1|||
44113399|NCT02778555|78896015|FG000|Overall Study|Withdrawal by Subject|55|||
44113400|NCT02778555|78896016|FG001|Overall Study|Withdrawal by Subject|32|||
44113401|NCT02778555|78896017|FG002|Overall Study|Withdrawal by Subject|107|||
44113402|NCT02778399|78896031|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
44113403|NCT02778399|78896032|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
44113404|NCT02778399|78896033|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
44113405|NCT02778399|78896034|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
44113406|NCT02778399|78896035|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
44113407|NCT02778399|78896036|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
44113408|NCT02778399|78896031|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
44113409|NCT02778399|78896032|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
44113410|NCT02778399|78896033|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
44113411|NCT02778399|78896034|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
44113412|NCT02778399|78896035|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
44113413|NCT02778399|78896036|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
44113414|NCT02778399|78896031|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
44113415|NCT02778399|78896032|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
44573474|NCT02244463|79596046|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
44573475|NCT02244463|79596047|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
44573476|NCT02244463|79596042|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
44573477|NCT02244463|79596043|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
44573478|NCT02244463|79596044|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
44573479|NCT02244463|79596045|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
44573480|NCT02244463|79596046|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
44573481|NCT02244463|79596047|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
44573482|NCT02244463|79596042|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
44573483|NCT02244463|79596043|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
44573484|NCT02244463|79596044|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
44573485|NCT02244463|79596045|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
44573486|NCT02244463|79596046|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
44573487|NCT02244463|79596047|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
44113416|NCT02778399|78896033|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
44113417|NCT02778399|78896034|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
44113418|NCT02778399|78896035|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
44113419|NCT02778399|78896036|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
44113420|NCT02778399|78896031|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
44113421|NCT02778399|78896032|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
44113422|NCT02778399|78896033|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
44113423|NCT02778399|78896034|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
44573488|NCT02244463|79596042|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
44113424|NCT02778399|78896035|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
44573489|NCT02244463|79596043|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
44113425|NCT02778399|78896036|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
44113426|NCT02778399|78896031|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
44113427|NCT02778399|78896032|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
44113428|NCT02778399|78896033|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
44113429|NCT02778399|78896034|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
44113430|NCT02778399|78896035|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
44113431|NCT02778399|78896036|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
44113432|NCT02778399|78896031|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
44113433|NCT02778399|78896032|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
44113434|NCT02778399|78896033|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
44113435|NCT02778399|78896034|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
44113436|NCT02778399|78896035|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
44113437|NCT02778399|78896036|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
44113438|NCT02778399|78896031|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
44113439|NCT02778399|78896032|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
44113440|NCT02778399|78896033|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
44113441|NCT02778399|78896034|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
44113442|NCT02778399|78896035|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
44113443|NCT02778399|78896036|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
44113444|NCT02778399|78896031|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
44113445|NCT02778399|78896032|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
44113446|NCT02778399|78896033|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
44113447|NCT02778399|78896034|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
44113448|NCT02778399|78896035|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
44113449|NCT02778399|78896036|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
44113450|NCT02778399|78896031|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
44113451|NCT02778399|78896032|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
44237927|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
44237928|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
44237929|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
44573490|NCT02244463|79596044|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
44573491|NCT02244463|79596045|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
44573492|NCT02244463|79596046|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
44573493|NCT02244463|79596047|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
44573494|NCT02244463|79596042|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
44573495|NCT02244463|79596043|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
44573496|NCT02244463|79596044|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
44573497|NCT02244463|79596045|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
44573498|NCT02244463|79596046|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
44573499|NCT02244463|79596047|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
44573500|NCT02244463|79596042|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
44573501|NCT02244463|79596043|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
44573502|NCT02244463|79596044|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
44573503|NCT02244463|79596045|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
44573504|NCT02244463|79596046|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
44573505|NCT02244463|79596047|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
44573506|NCT02244463|79596042|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
44573507|NCT02244463|79596043|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
44573508|NCT02244463|79596044|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
44573509|NCT02244463|79596045|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
44573510|NCT02244463|79596046|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
44573511|NCT02244463|79596047|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
44573512|NCT02244463|79596042|FG000|Period 5: Phase II|Disease Progression|0|||
44573513|NCT02244463|79596043|FG001|Period 5: Phase II|Disease Progression|0|||
44573514|NCT02244463|79596044|FG002|Period 5: Phase II|Disease Progression|0|||
44573515|NCT02244463|79596045|FG003|Period 5: Phase II|Disease Progression|0|||
44573516|NCT02244463|79596046|FG004|Period 5: Phase II|Disease Progression|10|||
44573517|NCT02244463|79596047|FG005|Period 5: Phase II|Disease Progression|11|||
44573518|NCT02244463|79596042|FG000|Period 5: Phase II|Physician Decision|0|||
44573519|NCT02244463|79596043|FG001|Period 5: Phase II|Physician Decision|0|||
44573520|NCT02244463|79596044|FG002|Period 5: Phase II|Physician Decision|0|||
44573521|NCT02244463|79596045|FG003|Period 5: Phase II|Physician Decision|0|||
44573522|NCT02244463|79596046|FG004|Period 5: Phase II|Physician Decision|3|||
44573523|NCT02244463|79596047|FG005|Period 5: Phase II|Physician Decision|2|||
44573524|NCT02244463|79596042|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
44573525|NCT02244463|79596043|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
44573526|NCT02244463|79596044|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
44573527|NCT02244463|79596045|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
44113452|NCT02778399|78896033|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
44113453|NCT02778399|78896034|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
44113454|NCT02778399|78896035|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
44113455|NCT02778399|78896036|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
44113456|NCT02778399|78896031|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
44113457|NCT02778399|78896032|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
44113458|NCT02778399|78896033|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
44113459|NCT02778399|78896034|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
44113460|NCT02778399|78896035|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
44113461|NCT02778399|78896036|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
44113462|NCT02778399|78896031|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
44113463|NCT02778399|78896032|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
44113464|NCT02778399|78896033|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
44113465|NCT02778399|78896034|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
44113466|NCT02778399|78896035|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
44113467|NCT02778399|78896036|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
44113468|NCT03656744|78896085|FG000|Overall Study|Adverse Event|1|||
44113469|NCT03656744|78896086|FG001|Overall Study|Adverse Event|4|||
44113470|NCT03656744|78896087|FG002|Overall Study|Adverse Event|1|||
44113471|NCT03656744|78896085|FG000|Overall Study|Protocol Violation|1|||
44113472|NCT03656744|78896086|FG001|Overall Study|Protocol Violation|0|||
44113473|NCT03656744|78896087|FG002|Overall Study|Protocol Violation|0|||
44113474|NCT03656744|78896085|FG000|Overall Study|Lost to Follow-up|2|||
44113475|NCT03656744|78896086|FG001|Overall Study|Lost to Follow-up|2|||
44113476|NCT03656744|78896087|FG002|Overall Study|Lost to Follow-up|0|||
44113477|NCT03656744|78896085|FG000|Overall Study|Withdrawal by Subject|0|||
44113478|NCT03656744|78896086|FG001|Overall Study|Withdrawal by Subject|1|||
44113479|NCT03656744|78896087|FG002|Overall Study|Withdrawal by Subject|0|||
44113480|NCT03656744|78896085|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
44113481|NCT03656744|78896086|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
44113482|NCT03656744|78896087|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
44113483|NCT02739360|78896095|FG000|Overall Study|Adverse Event|1|||
44113484|NCT02739360|78896095|FG000|Overall Study|Study terminated by Sponsor|2|||
44113485|NCT01822522|78896105|FG000|Overall Study|Adverse Event|1|||
44113486|NCT01822522|78896106|FG001|Overall Study|Adverse Event|1|||
44113487|NCT01822522|78896107|FG002|Overall Study|Adverse Event|1|||
44113488|NCT01822522|78896108|FG003|Overall Study|Adverse Event|0|||
44113489|NCT01822522|78896109|FG004|Overall Study|Adverse Event|0|||
44113490|NCT01822522|78896110|FG005|Overall Study|Adverse Event|1|||
44113491|NCT01822522|78896105|FG000|Overall Study|Death|3|||
44113492|NCT01822522|78896106|FG001|Overall Study|Death|0|||
44113493|NCT01822522|78896107|FG002|Overall Study|Death|2|||
44113494|NCT01822522|78896108|FG003|Overall Study|Death|0|||
44113495|NCT01822522|78896109|FG004|Overall Study|Death|0|||
44113496|NCT01822522|78896110|FG005|Overall Study|Death|0|||
44113497|NCT01822522|78896105|FG000|Overall Study|Lost to Follow-up|0|||
44113498|NCT01822522|78896106|FG001|Overall Study|Lost to Follow-up|0|||
44113499|NCT01822522|78896107|FG002|Overall Study|Lost to Follow-up|1|||
44113500|NCT01822522|78896108|FG003|Overall Study|Lost to Follow-up|1|||
44113501|NCT01822522|78896109|FG004|Overall Study|Lost to Follow-up|0|||
44113502|NCT01822522|78896110|FG005|Overall Study|Lost to Follow-up|1|||
44113503|NCT01822522|78896105|FG000|Overall Study|Withdrawal by Subject|0|||
44377925|NCT00785785|79383205|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
44505428|NCT02943460|79510214|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
44113504|NCT01822522|78896106|FG001|Overall Study|Withdrawal by Subject|0|||
44113505|NCT01822522|78896107|FG002|Overall Study|Withdrawal by Subject|0|||
44113506|NCT01822522|78896108|FG003|Overall Study|Withdrawal by Subject|1|||
44113507|NCT01822522|78896109|FG004|Overall Study|Withdrawal by Subject|0|||
44113508|NCT01822522|78896110|FG005|Overall Study|Withdrawal by Subject|0|||
44113509|NCT01822522|78896105|FG000|Overall Study|Lack of Efficacy|0|||
44113510|NCT01822522|78896106|FG001|Overall Study|Lack of Efficacy|0|||
44113511|NCT01822522|78896107|FG002|Overall Study|Lack of Efficacy|0|||
44113512|NCT01822522|78896108|FG003|Overall Study|Lack of Efficacy|0|||
44113513|NCT01822522|78896109|FG004|Overall Study|Lack of Efficacy|0|||
44113514|NCT01822522|78896110|FG005|Overall Study|Lack of Efficacy|2|||
44113515|NCT00102687|78896154|FG000|Initial Period|Withdrawal by Subject|6|||
44113516|NCT00102687|78896155|FG001|Initial Period|Withdrawal by Subject|3|||
44113517|NCT00102687|78896156|FG002|Initial Period|Withdrawal by Subject|5|||
44113518|NCT00102687|78896157|FG003|Initial Period|Withdrawal by Subject|0|||
44113519|NCT00102687|78896158|FG004|Initial Period|Withdrawal by Subject|0|||
44113520|NCT00102687|78896154|FG000|Initial Period|Adverse Event|4|||
44113521|NCT00102687|78896155|FG001|Initial Period|Adverse Event|7|||
44113522|NCT00102687|78896156|FG002|Initial Period|Adverse Event|9|||
44113523|NCT00102687|78896157|FG003|Initial Period|Adverse Event|0|||
44113524|NCT00102687|78896158|FG004|Initial Period|Adverse Event|0|||
44113525|NCT00102687|78896154|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
44113526|NCT00102687|78896155|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
44113527|NCT00102687|78896156|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
44113528|NCT00102687|78896157|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
44113529|NCT00102687|78896158|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
44113530|NCT00102687|78896154|FG000|Initial Period|Protocol Violation|0|||
44113531|NCT00102687|78896155|FG001|Initial Period|Protocol Violation|0|||
44113532|NCT00102687|78896156|FG002|Initial Period|Protocol Violation|2|||
44113533|NCT00102687|78896157|FG003|Initial Period|Protocol Violation|0|||
44113534|NCT00102687|78896158|FG004|Initial Period|Protocol Violation|0|||
44113535|NCT00102687|78896154|FG000|Initial Period|Physician Decision|2|||
44113536|NCT00102687|78896155|FG001|Initial Period|Physician Decision|9|||
44113537|NCT00102687|78896156|FG002|Initial Period|Physician Decision|6|||
44573528|NCT02244463|79596046|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
44573529|NCT02244463|79596047|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
44573530|NCT02244463|79596042|FG000|Period 5: Phase II|Intercurrent Illness|0|||
44113538|NCT00102687|78896157|FG003|Initial Period|Physician Decision|0|||
44113539|NCT00102687|78896158|FG004|Initial Period|Physician Decision|0|||
44113540|NCT00102687|78896154|FG000|Initial Period|Sponsor's decision|0|||
44113541|NCT00102687|78896155|FG001|Initial Period|Sponsor's decision|1|||
44113542|NCT00102687|78896156|FG002|Initial Period|Sponsor's decision|1|||
44113543|NCT00102687|78896157|FG003|Initial Period|Sponsor's decision|0|||
44113544|NCT00102687|78896158|FG004|Initial Period|Sponsor's decision|0|||
44113545|NCT00102687|78896154|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
44113546|NCT00102687|78896155|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
44113547|NCT00102687|78896156|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
44113548|NCT00102687|78896157|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
44113549|NCT00102687|78896158|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
44505429|NCT02943460|79510215|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
44505430|NCT02943460|79510213|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
44505431|NCT02943460|79510214|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
44505432|NCT02943460|79510215|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
44505433|NCT02943460|79510213|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
44505434|NCT02943460|79510214|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
44505435|NCT02943460|79510215|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
44505436|NCT03768206|79510226|FG000|Overall Study|Lost to Follow-up|2|||
44505437|NCT03768206|79510227|FG001|Overall Study|Lost to Follow-up|1|||
44573531|NCT02244463|79596043|FG001|Period 5: Phase II|Intercurrent Illness|0|||
44573532|NCT02244463|79596044|FG002|Period 5: Phase II|Intercurrent Illness|0|||
44573533|NCT02244463|79596045|FG003|Period 5: Phase II|Intercurrent Illness|0|||
44573534|NCT02244463|79596046|FG004|Period 5: Phase II|Intercurrent Illness|2|||
44573535|NCT02244463|79596047|FG005|Period 5: Phase II|Intercurrent Illness|0|||
44573536|NCT02244463|79596042|FG000|Period 5: Phase II|Adverse Event|0|||
44573537|NCT02244463|79596043|FG001|Period 5: Phase II|Adverse Event|0|||
44573538|NCT02244463|79596044|FG002|Period 5: Phase II|Adverse Event|0|||
44573539|NCT02244463|79596045|FG003|Period 5: Phase II|Adverse Event|0|||
44573540|NCT02244463|79596046|FG004|Period 5: Phase II|Adverse Event|0|||
44573541|NCT02244463|79596047|FG005|Period 5: Phase II|Adverse Event|2|||
44573542|NCT02244463|79596042|FG000|Period 5: Phase II|Still On treatment|0|||
44573543|NCT02244463|79596043|FG001|Period 5: Phase II|Still On treatment|0|||
44573544|NCT02244463|79596044|FG002|Period 5: Phase II|Still On treatment|0|||
44573545|NCT02244463|79596045|FG003|Period 5: Phase II|Still On treatment|0|||
44573546|NCT02244463|79596046|FG004|Period 5: Phase II|Still On treatment|0|||
44573547|NCT02244463|79596047|FG005|Period 5: Phase II|Still On treatment|3|||
44573548|NCT02038777|79596084|FG000|Overall Study|Death|0|||
44573549|NCT02038777|79596085|FG001|Overall Study|Death|2|||
44573550|NCT02038777|79596086|FG002|Overall Study|Death|0|||
44573551|NCT02038777|79596087|FG003|Overall Study|Death|1|||
44573552|NCT02038777|79596088|FG004|Overall Study|Death|2|||
44573553|NCT02038777|79596089|FG005|Overall Study|Death|4|||
44573554|NCT02038777|79596090|FG006|Overall Study|Death|0|||
44113550|NCT00102687|78896154|FG000|Initial Period|Death|1|||
44505438|NCT03768206|79510226|FG000|Overall Study|Withdrawal by Subject|0|||
44505439|NCT03768206|79510227|FG001|Overall Study|Withdrawal by Subject|1|||
44505440|NCT03767894|79510234|FG000|Overall Study|Withdrawal by Subject|1|||
44505441|NCT03766646|79510240|FG000|Overall Study|Withdrawal by Subject|1|||
44505442|NCT03766646|79510241|FG001|Overall Study|Withdrawal by Subject|0|||
44573555|NCT02038777|79596091|FG007|Overall Study|Death|10|||
44573556|NCT02038777|79596084|FG000|Overall Study|Lost to Follow-up|0|||
44573557|NCT02038777|79596085|FG001|Overall Study|Lost to Follow-up|0|||
44573558|NCT02038777|79596086|FG002|Overall Study|Lost to Follow-up|0|||
44573559|NCT02038777|79596087|FG003|Overall Study|Lost to Follow-up|1|||
44573560|NCT02038777|79596088|FG004|Overall Study|Lost to Follow-up|0|||
44113551|NCT00102687|78896155|FG001|Initial Period|Death|1|||
44113552|NCT00102687|78896156|FG002|Initial Period|Death|1|||
44113553|NCT00102687|78896157|FG003|Initial Period|Death|0|||
44113554|NCT00102687|78896158|FG004|Initial Period|Death|0|||
44113555|NCT00102687|78896154|FG000|Maintenance Period|Withdrawal by Subject|4|||
44113556|NCT00102687|78896155|FG001|Maintenance Period|Withdrawal by Subject|0|||
44113557|NCT00102687|78896156|FG002|Maintenance Period|Withdrawal by Subject|2|||
44113558|NCT00102687|78896157|FG003|Maintenance Period|Withdrawal by Subject|3|||
44113559|NCT00102687|78896158|FG004|Maintenance Period|Withdrawal by Subject|1|||
44113560|NCT00102687|78896154|FG000|Maintenance Period|Adverse Event|1|||
44113561|NCT00102687|78896155|FG001|Maintenance Period|Adverse Event|0|||
44113562|NCT00102687|78896156|FG002|Maintenance Period|Adverse Event|0|||
44113563|NCT00102687|78896157|FG003|Maintenance Period|Adverse Event|1|||
44113564|NCT00102687|78896158|FG004|Maintenance Period|Adverse Event|3|||
44113565|NCT00102687|78896154|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
44113566|NCT00102687|78896155|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
44113567|NCT00102687|78896156|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
44113568|NCT00102687|78896157|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
44113569|NCT00102687|78896158|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
44113570|NCT00102687|78896154|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
44113571|NCT00102687|78896155|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
44113572|NCT00102687|78896156|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
44113573|NCT00102687|78896157|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
44113574|NCT00102687|78896158|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
44573561|NCT02038777|79596089|FG005|Overall Study|Lost to Follow-up|0|||
44573562|NCT02038777|79596090|FG006|Overall Study|Lost to Follow-up|0|||
44113575|NCT00102687|78896154|FG000|Maintenance Period|Death|0|||
44113576|NCT00102687|78896155|FG001|Maintenance Period|Death|0|||
44113577|NCT00102687|78896156|FG002|Maintenance Period|Death|0|||
44113578|NCT00102687|78896157|FG003|Maintenance Period|Death|1|||
44113579|NCT00102687|78896158|FG004|Maintenance Period|Death|1|||
44113580|NCT00102687|78896154|FG000|Maintenance Period|Physician Decision|1|||
44113581|NCT00102687|78896155|FG001|Maintenance Period|Physician Decision|2|||
44573563|NCT02038777|79596091|FG007|Overall Study|Lost to Follow-up|0|||
44573564|NCT02038777|79596084|FG000|Overall Study|Other|0|||
44573565|NCT02038777|79596085|FG001|Overall Study|Other|1|||
44573566|NCT02038777|79596086|FG002|Overall Study|Other|0|||
44113582|NCT00102687|78896156|FG002|Maintenance Period|Physician Decision|3|||
44113583|NCT00102687|78896157|FG003|Maintenance Period|Physician Decision|0|||
44113584|NCT00102687|78896158|FG004|Maintenance Period|Physician Decision|4|||
44113585|NCT00102531|78896176|FG000|Overall Study|Adverse Event|0|||
44113586|NCT00102531|78896177|FG001|Overall Study|Adverse Event|1|||
44113587|NCT00102531|78896176|FG000|Overall Study|Disease Progression|5|||
44113588|NCT00102531|78896177|FG001|Overall Study|Disease Progression|9|||
44505443|NCT03766646|79510240|FG000|Overall Study|Protocol Violation|0|||
44505444|NCT03766646|79510241|FG001|Overall Study|Protocol Violation|3|||
44505445|NCT03765164|79510249|FG000|Pre-intervention|Withdrawal by Subject|5|||
44505446|NCT03765164|79510250|FG001|Pre-intervention|Withdrawal by Subject|6|||
44505447|NCT00369629|79510256|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
44505448|NCT00369629|79510257|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
44113589|NCT00102531|78896176|FG000|Overall Study|Physician Decision|0|||
44113590|NCT00102531|78896177|FG001|Overall Study|Physician Decision|1|||
44113591|NCT02771145|78896183|FG000|Overall Study|Adverse Event|3|||
44113592|NCT02771145|78896183|FG000|Overall Study|Lost to Follow-up|1|||
44573567|NCT02038777|79596087|FG003|Overall Study|Other|2|||
44573568|NCT02038777|79596088|FG004|Overall Study|Other|1|||
44573569|NCT02038777|79596089|FG005|Overall Study|Other|0|||
44573570|NCT02038777|79596090|FG006|Overall Study|Other|0|||
44573571|NCT02038777|79596091|FG007|Overall Study|Other|0|||
44573572|NCT02038777|79596084|FG000|Overall Study|Randomized but not treated|0|||
44573573|NCT02038777|79596085|FG001|Overall Study|Randomized but not treated|1|||
44113593|NCT02578186|78896203|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
44113594|NCT02578186|78896204|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
44113595|NCT02578186|78896203|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
44113596|NCT02578186|78896204|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
44113597|NCT00103311|78896212|FG000|Overall Study|Lost to Follow-up|1|||
44113598|NCT00103311|78896213|FG001|Overall Study|Lost to Follow-up|0|||
44113599|NCT00103311|78896212|FG000|Overall Study|Withdrawal by Subject|2|||
44505449|NCT00369629|79510258|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
44113600|NCT00103311|78896213|FG001|Overall Study|Withdrawal by Subject|1|||
44505450|NCT00369629|79510259|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
44505451|NCT00369629|79510256|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
44505452|NCT00369629|79510257|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
44573574|NCT02038777|79596086|FG002|Overall Study|Randomized but not treated|0|||
44573575|NCT02038777|79596087|FG003|Overall Study|Randomized but not treated|0|||
44573576|NCT02038777|79596088|FG004|Overall Study|Randomized but not treated|0|||
44113601|NCT00103311|78896212|FG000|Overall Study|Adverse Event|1|||
44113602|NCT00103311|78896213|FG001|Overall Study|Adverse Event|0|||
44113603|NCT02576938|78896226|FG000|Overall Study|Adverse Event|5|||
44113604|NCT02576938|78896227|FG001|Overall Study|Adverse Event|3|||
44113605|NCT02576938|78896228|FG002|Overall Study|Adverse Event|6|||
44113606|NCT02576938|78896226|FG000|Overall Study|Protocol Violation|1|||
44113607|NCT02576938|78896227|FG001|Overall Study|Protocol Violation|1|||
44113608|NCT02576938|78896228|FG002|Overall Study|Protocol Violation|1|||
44113609|NCT02576938|78896226|FG000|Overall Study|Withdrawal by Subject|3|||
44113610|NCT02576938|78896227|FG001|Overall Study|Withdrawal by Subject|2|||
44113611|NCT02576938|78896228|FG002|Overall Study|Withdrawal by Subject|4|||
44113612|NCT02576938|78896226|FG000|Overall Study|Lack of Efficacy|9|||
44113613|NCT02576938|78896227|FG001|Overall Study|Lack of Efficacy|4|||
44113614|NCT02576938|78896228|FG002|Overall Study|Lack of Efficacy|0|||
44113615|NCT02576938|78896226|FG000|Overall Study|Lost to Follow-up|2|||
44113616|NCT02576938|78896227|FG001|Overall Study|Lost to Follow-up|0|||
44113617|NCT02576938|78896228|FG002|Overall Study|Lost to Follow-up|1|||
44113618|NCT02576938|78896226|FG000|Overall Study|Physician Decision|0|||
44113619|NCT02576938|78896227|FG001|Overall Study|Physician Decision|1|||
44113620|NCT02576938|78896228|FG002|Overall Study|Physician Decision|0|||
44113621|NCT02576938|78896226|FG000|Overall Study|Met Exclusion Criteria|0|||
44113622|NCT02576938|78896227|FG001|Overall Study|Met Exclusion Criteria|1|||
44113623|NCT02576938|78896228|FG002|Overall Study|Met Exclusion Criteria|0|||
44113624|NCT02576860|78896240|FG000|Overall Study|Adverse Event|6|||
44113625|NCT02576860|78896241|FG001|Overall Study|Adverse Event|6|||
44113626|NCT02576860|78896240|FG000|Overall Study|Lost to Follow-up|5|||
44113627|NCT02576860|78896241|FG001|Overall Study|Lost to Follow-up|7|||
44113628|NCT02576860|78896240|FG000|Overall Study|Physician Decision|0|||
44113629|NCT02576860|78896241|FG001|Overall Study|Physician Decision|1|||
44113630|NCT02576860|78896240|FG000|Overall Study|Protocol Violation|0|||
44113631|NCT02576860|78896241|FG001|Overall Study|Protocol Violation|2|||
44113632|NCT02576860|78896240|FG000|Overall Study|Withdrawal by Subject|13|||
44113633|NCT02576860|78896241|FG001|Overall Study|Withdrawal by Subject|8|||
44113634|NCT02576860|78896240|FG000|Overall Study|Disallowed medication|1|||
44113635|NCT02576860|78896241|FG001|Overall Study|Disallowed medication|0|||
44113636|NCT02572570|78896248|FG000|Overall Study|Study Terminated|27|||
44113637|NCT00709202|78896257|FG000|Overall Study|Withdrawal by Subject|6|||
44113638|NCT00709202|78896258|FG001|Overall Study|Withdrawal by Subject|6|||
44113639|NCT00709124|78896267|FG000|Overall Study|Death|3|||
44113640|NCT00709124|78896268|FG001|Overall Study|Death|1|||
44113641|NCT00709124|78896267|FG000|Overall Study|encephalopathy; can't do assessment|1|||
44113642|NCT00709124|78896268|FG001|Overall Study|encephalopathy; can't do assessment|0|||
44113643|NCT02738580|78896280|FG000|Overall Study|Adverse Event|1|||
44113644|NCT02738580|78896281|FG001|Overall Study|Adverse Event|0|||
44113645|NCT02738580|78896280|FG000|Overall Study|Lack of Efficacy|3|||
44113646|NCT02738580|78896281|FG001|Overall Study|Lack of Efficacy|2|||
44113647|NCT02738580|78896280|FG000|Overall Study|Withdrawal by Subject|0|||
44113648|NCT02738580|78896281|FG001|Overall Study|Withdrawal by Subject|1|||
44113649|NCT02738580|78896280|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
44113650|NCT02738580|78896281|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
44113651|NCT02571244|78896289|FG000|Overall Study|Lost to Follow-up|0|||
44113652|NCT02571244|78896290|FG001|Overall Study|Lost to Follow-up|1|||
44113653|NCT02571244|78896289|FG000|Overall Study|Unable to reach out post discharge|3|||
44113654|NCT02571244|78896290|FG001|Overall Study|Unable to reach out post discharge|0|||
44113655|NCT02573350|78896301|FG000|Overall Study|Lost to Follow-up|2|||
44113656|NCT02573350|78896302|FG001|Overall Study|Lost to Follow-up|1|||
44237930|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
44237931|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
44113657|NCT02573350|78896301|FG000|Overall Study|Adverse Event|3|||
44113658|NCT02573350|78896302|FG001|Overall Study|Adverse Event|4|||
44113659|NCT02573350|78896301|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
44113660|NCT02573350|78896302|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
44113661|NCT02573350|78896301|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
44113662|NCT02573350|78896302|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
44377926|NCT00785785|79383206|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
44505453|NCT00369629|79510258|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
44505454|NCT00369629|79510259|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
44505455|NCT00369629|79510256|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
44505456|NCT00369629|79510257|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
44505457|NCT00369629|79510258|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
44113663|NCT02573350|78896301|FG000|Overall Study|Subject withdrew consent to participate|6|||
44505458|NCT00369629|79510259|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
44113664|NCT02573350|78896302|FG001|Overall Study|Subject withdrew consent to participate|1|||
44113665|NCT02573350|78896301|FG000|Overall Study|Protocol Deviation|1|||
44237932|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
44113666|NCT02573350|78896302|FG001|Overall Study|Protocol Deviation|1|||
44113667|NCT01376804|78896311|FG000|Treatment Period|Withdrawal by Subject|1|||
44113668|NCT01376804|78896311|FG000|Treatment Period|Adverse Event|6|||
44113669|NCT01376804|78896311|FG000|Treatment Period|Patient did not receive study drug|1|||
44113670|NCT02574520|78896319|FG000|Overall Study|Not dosed|2|||
44113671|NCT02574520|78896320|FG001|Overall Study|Not dosed|0|||
44113672|NCT02574520|78896321|FG002|Overall Study|Not dosed|5|||
44113673|NCT02574520|78896322|FG003|Overall Study|Not dosed|4|||
44113674|NCT02574520|78896319|FG000|Overall Study|Adverse Event|0|||
44113675|NCT02574520|78896320|FG001|Overall Study|Adverse Event|0|||
44113676|NCT02574520|78896321|FG002|Overall Study|Adverse Event|0|||
44113677|NCT02574520|78896322|FG003|Overall Study|Adverse Event|1|||
44113678|NCT02574520|78896319|FG000|Overall Study|Withdrawal by Subject|0|||
44113679|NCT02574520|78896320|FG001|Overall Study|Withdrawal by Subject|0|||
44113680|NCT02574520|78896321|FG002|Overall Study|Withdrawal by Subject|0|||
44113681|NCT02574520|78896322|FG003|Overall Study|Withdrawal by Subject|1|||
44113682|NCT02574520|78896319|FG000|Overall Study|Other|0|||
44113683|NCT02574520|78896320|FG001|Overall Study|Other|0|||
44113684|NCT02574520|78896321|FG002|Overall Study|Other|0|||
44113685|NCT02574520|78896322|FG003|Overall Study|Other|2|||
44113686|NCT00709592|78896334|FG000|Overall Study|Unable to proceed to transplant|0|||
44113687|NCT00709592|78896335|FG001|Overall Study|Unable to proceed to transplant|1|||
44113688|NCT02570152|78896341|FG000|Overall Study|Protocol Violation|2|||
44113689|NCT02570152|78896341|FG000|Overall Study|Migrated/moved from study area|13|||
44113690|NCT02570074|78896347|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
44113691|NCT02570074|78896348|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
44113692|NCT02569996|78896366|FG000|Overall Study|Adverse Event|6|||
44113693|NCT02569996|78896366|FG000|Overall Study|Physician Decision|3|||
44113694|NCT02569996|78896366|FG000|Overall Study|Progression of the disease|18|||
44113695|NCT02569996|78896366|FG000|Overall Study|New anti-lymphoma treatment|1|||
44113696|NCT02569996|78896366|FG000|Overall Study|Non-compliance|9|||
44113697|NCT02569996|78896366|FG000|Overall Study|Withdrawal by Subject|5|||
44113698|NCT02569996|78896366|FG000|Overall Study|Lost to Follow-up|5|||
44113699|NCT02569996|78896366|FG000|Overall Study|Complete remission|7|||
44113700|NCT02569996|78896366|FG000|Overall Study|Unknown reason|1|||
44113701|NCT02572882|78896370|FG000|Overall Study|Withdrawal by Subject|1|||
44113702|NCT02572882|78896370|FG000|Overall Study|Participant received kidney transplant|1|||
44573577|NCT02038777|79596089|FG005|Overall Study|Randomized but not treated|0|||
44573578|NCT02038777|79596090|FG006|Overall Study|Randomized but not treated|0|||
44573579|NCT02038777|79596091|FG007|Overall Study|Randomized but not treated|0|||
44573580|NCT02038777|79596084|FG000|Overall Study|Started Chemotherapy|1|||
44573581|NCT02038777|79596085|FG001|Overall Study|Started Chemotherapy|0|||
44573582|NCT02038777|79596086|FG002|Overall Study|Started Chemotherapy|3|||
44573583|NCT02038777|79596087|FG003|Overall Study|Started Chemotherapy|0|||
44573584|NCT02038777|79596088|FG004|Overall Study|Started Chemotherapy|0|||
44573585|NCT02038777|79596089|FG005|Overall Study|Started Chemotherapy|0|||
44573586|NCT02038777|79596090|FG006|Overall Study|Started Chemotherapy|0|||
44573587|NCT02038777|79596091|FG007|Overall Study|Started Chemotherapy|0|||
44573588|NCT02853435|79596128|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
44237933|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
44237934|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
44237935|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
44237936|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
44237937|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
44237938|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
44237939|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237940|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237941|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237942|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237943|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237944|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44113703|NCT00708500|78896400|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
44113704|NCT00708500|78896401|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
44113705|NCT00708500|78896402|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
44113706|NCT00708500|78896400|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
44113707|NCT00708500|78896401|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
44113708|NCT00708500|78896402|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
44113709|NCT00708500|78896400|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
44573589|NCT02853435|79596129|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
44113710|NCT00708500|78896401|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
44573590|NCT02853435|79596130|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
44573591|NCT02853435|79596131|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
44573592|NCT02853435|79596132|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
44573593|NCT02853435|79596133|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
44573594|NCT02635204|79596165|FG000|Overall Study|Adverse Event|1|||
44573595|NCT02635204|79596166|FG001|Overall Study|Adverse Event|0|||
44573596|NCT02635204|79596165|FG000|Overall Study|Lost to Follow-up|1|||
44573597|NCT02635204|79596166|FG001|Overall Study|Lost to Follow-up|1|||
44573598|NCT00102804|79596174|FG000|Overall Study|Progressive Disease (PD)|307|||
44573599|NCT00102804|79596175|FG001|Overall Study|Progressive Disease (PD)|196|||
44573600|NCT00102804|79596174|FG000|Overall Study|Withdrawal by Subject|46|||
44573601|NCT00102804|79596175|FG001|Overall Study|Withdrawal by Subject|7|||
44573602|NCT00102804|79596174|FG000|Overall Study|Adverse Event|37|||
44573603|NCT00102804|79596175|FG001|Overall Study|Adverse Event|3|||
44573604|NCT00102804|79596174|FG000|Overall Study|Physician Decision|24|||
44573605|NCT00102804|79596175|FG001|Overall Study|Physician Decision|6|||
44573606|NCT00102804|79596174|FG000|Overall Study|Death|5|||
44573607|NCT00102804|79596175|FG001|Overall Study|Death|6|||
44573608|NCT00102804|79596174|FG000|Overall Study|Enrollment Criteria Not Met|6|||
44573609|NCT00102804|79596175|FG001|Overall Study|Enrollment Criteria Not Met|0|||
44573610|NCT00102804|79596174|FG000|Overall Study|Lost to Follow-up|4|||
44573611|NCT00102804|79596175|FG001|Overall Study|Lost to Follow-up|1|||
44573612|NCT00102804|79596174|FG000|Overall Study|Protocol Violation|2|||
44573613|NCT00102804|79596175|FG001|Overall Study|Protocol Violation|1|||
44573614|NCT00102804|79596174|FG000|Overall Study|Satisfactory Response|2|||
44573615|NCT00102804|79596175|FG001|Overall Study|Satisfactory Response|0|||
44573616|NCT00102804|79596174|FG000|Overall Study|Sponsor Decision|1|||
44573617|NCT00102804|79596175|FG001|Overall Study|Sponsor Decision|0|||
44573618|NCT00102804|79596174|FG000|Overall Study|Alive, Receiving Treatment|7|||
44573619|NCT00102804|79596175|FG001|Overall Study|Alive, Receiving Treatment|2|||
44573620|NCT01814072|79596213|FG000|Overall Study|Lost to Follow-up|2|||
44573621|NCT01814072|79596214|FG001|Overall Study|Lost to Follow-up|2|||
44573622|NCT01814072|79596215|FG002|Overall Study|Lost to Follow-up|2|||
44573623|NCT01814072|79596216|FG003|Overall Study|Lost to Follow-up|0|||
44573624|NCT01814072|79596217|FG004|Overall Study|Lost to Follow-up|2|||
44573625|NCT01814072|79596218|FG005|Overall Study|Lost to Follow-up|3|||
44573626|NCT01814072|79596219|FG006|Overall Study|Lost to Follow-up|3|||
44573627|NCT01814072|79596220|FG007|Overall Study|Lost to Follow-up|1|||
44573628|NCT01814072|79596221|FG008|Overall Study|Lost to Follow-up|2|||
44573629|NCT01814072|79596222|FG009|Overall Study|Lost to Follow-up|3|||
44573630|NCT01814072|79596223|FG010|Overall Study|Lost to Follow-up|1|||
44573631|NCT01814072|79596224|FG011|Overall Study|Lost to Follow-up|2|||
44573632|NCT01814072|79596225|FG012|Overall Study|Lost to Follow-up|2|||
44573633|NCT01814072|79596226|FG013|Overall Study|Lost to Follow-up|1|||
44573634|NCT01814072|79596227|FG014|Overall Study|Lost to Follow-up|2|||
44573635|NCT01814072|79596228|FG015|Overall Study|Lost to Follow-up|1|||
44573636|NCT01814072|79596229|FG016|Overall Study|Lost to Follow-up|3|||
44573637|NCT01814072|79596230|FG017|Overall Study|Lost to Follow-up|1|||
44573638|NCT01814072|79596231|FG018|Overall Study|Lost to Follow-up|3|||
44573639|NCT01814072|79596232|FG019|Overall Study|Lost to Follow-up|3|||
44249745|NCT01504412|79083924|FG001|Overall Study|Lack of Efficacy|0|||
44505459|NCT00369629|79510256|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
44505460|NCT00369629|79510257|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
44505461|NCT00369629|79510258|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
44505462|NCT00369629|79510259|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
44505463|NCT00369629|79510256|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
44505464|NCT00369629|79510257|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
44505465|NCT00369629|79510258|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
44505466|NCT00369629|79510259|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
44505467|NCT00369629|79510256|FG000|Completed 4 More Cycles|Progressive disease|2|||
44505468|NCT00369629|79510257|FG001|Completed 4 More Cycles|Progressive disease|1|||
44505469|NCT00369629|79510258|FG002|Completed 4 More Cycles|Progressive disease|2|||
44573640|NCT01814072|79596233|FG020|Overall Study|Lost to Follow-up|2|||
44573641|NCT01814072|79596234|FG021|Overall Study|Lost to Follow-up|1|||
44573642|NCT01814072|79596235|FG022|Overall Study|Lost to Follow-up|3|||
44505470|NCT00369629|79510259|FG003|Completed 4 More Cycles|Progressive disease|0|||
44505471|NCT00369629|79510256|FG000|Follow up for 1 Year|Death|2|||
44505472|NCT00369629|79510257|FG001|Follow up for 1 Year|Death|1|||
44505473|NCT00369629|79510258|FG002|Follow up for 1 Year|Death|1|||
44573643|NCT01814072|79596236|FG023|Overall Study|Lost to Follow-up|1|||
44573644|NCT01814072|79596237|FG024|Overall Study|Lost to Follow-up|4|||
44573645|NCT01814072|79596238|FG025|Overall Study|Lost to Follow-up|1|||
44573646|NCT01814072|79596239|FG026|Overall Study|Lost to Follow-up|1|||
44573647|NCT01814072|79596240|FG027|Overall Study|Lost to Follow-up|2|||
44573648|NCT01814072|79596241|FG028|Overall Study|Lost to Follow-up|3|||
44573649|NCT01814072|79596242|FG029|Overall Study|Lost to Follow-up|3|||
44573650|NCT01814072|79596243|FG030|Overall Study|Lost to Follow-up|2|||
44573651|NCT01814072|79596244|FG031|Overall Study|Lost to Follow-up|0|||
44573652|NCT01814072|79596213|FG000|Overall Study|Withdrawal by Subject|2|||
44573653|NCT01814072|79596214|FG001|Overall Study|Withdrawal by Subject|0|||
44573654|NCT01814072|79596215|FG002|Overall Study|Withdrawal by Subject|1|||
44573655|NCT01814072|79596216|FG003|Overall Study|Withdrawal by Subject|0|||
44573656|NCT01814072|79596217|FG004|Overall Study|Withdrawal by Subject|2|||
44573657|NCT01814072|79596218|FG005|Overall Study|Withdrawal by Subject|3|||
44113711|NCT00708500|78896402|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
44113712|NCT00708500|78896400|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
44113713|NCT00708500|78896401|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
44113714|NCT00708500|78896402|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
44113715|NCT00708500|78896400|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
44113716|NCT00708500|78896401|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
44113717|NCT00708500|78896402|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
44113718|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
44113719|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
44113720|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
44113721|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
44113722|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
44113723|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
44113724|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
44113725|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
44113726|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
44113727|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
44573658|NCT01814072|79596219|FG006|Overall Study|Withdrawal by Subject|1|||
44573659|NCT01814072|79596220|FG007|Overall Study|Withdrawal by Subject|0|||
44573660|NCT01814072|79596221|FG008|Overall Study|Withdrawal by Subject|1|||
44573661|NCT01814072|79596222|FG009|Overall Study|Withdrawal by Subject|2|||
44573662|NCT01814072|79596223|FG010|Overall Study|Withdrawal by Subject|0|||
44573663|NCT01814072|79596224|FG011|Overall Study|Withdrawal by Subject|0|||
44573664|NCT01814072|79596225|FG012|Overall Study|Withdrawal by Subject|1|||
44573665|NCT01814072|79596226|FG013|Overall Study|Withdrawal by Subject|1|||
44573666|NCT01814072|79596227|FG014|Overall Study|Withdrawal by Subject|1|||
44573667|NCT01814072|79596228|FG015|Overall Study|Withdrawal by Subject|1|||
44573668|NCT01814072|79596229|FG016|Overall Study|Withdrawal by Subject|0|||
44573669|NCT01814072|79596230|FG017|Overall Study|Withdrawal by Subject|0|||
44573670|NCT01814072|79596231|FG018|Overall Study|Withdrawal by Subject|0|||
44573671|NCT01814072|79596232|FG019|Overall Study|Withdrawal by Subject|2|||
44573672|NCT01814072|79596233|FG020|Overall Study|Withdrawal by Subject|0|||
44573673|NCT01814072|79596234|FG021|Overall Study|Withdrawal by Subject|0|||
44573674|NCT01814072|79596235|FG022|Overall Study|Withdrawal by Subject|1|||
44573675|NCT01814072|79596236|FG023|Overall Study|Withdrawal by Subject|0|||
44573676|NCT01814072|79596237|FG024|Overall Study|Withdrawal by Subject|2|||
44573677|NCT01814072|79596238|FG025|Overall Study|Withdrawal by Subject|1|||
44573678|NCT01814072|79596239|FG026|Overall Study|Withdrawal by Subject|1|||
44573679|NCT01814072|79596240|FG027|Overall Study|Withdrawal by Subject|2|||
44573680|NCT01814072|79596241|FG028|Overall Study|Withdrawal by Subject|1|||
44573681|NCT01814072|79596242|FG029|Overall Study|Withdrawal by Subject|0|||
44573682|NCT01814072|79596243|FG030|Overall Study|Withdrawal by Subject|0|||
44573683|NCT01814072|79596244|FG031|Overall Study|Withdrawal by Subject|0|||
44573684|NCT03038113|79596299|FG000|Overall Study|Withdrawal by Subject|0|||
44573685|NCT03038113|79596300|FG001|Overall Study|Withdrawal by Subject|0|||
44573686|NCT03038113|79596301|FG002|Overall Study|Withdrawal by Subject|1|||
44573687|NCT03038113|79596302|FG003|Overall Study|Withdrawal by Subject|0|||
44573688|NCT03038113|79596303|FG004|Overall Study|Withdrawal by Subject|0|||
44573689|NCT03038113|79596304|FG005|Overall Study|Withdrawal by Subject|0|||
44573690|NCT03038113|79596305|FG006|Overall Study|Withdrawal by Subject|0|||
44573691|NCT03038113|79596306|FG007|Overall Study|Withdrawal by Subject|0|||
44573692|NCT03038113|79596307|FG008|Overall Study|Withdrawal by Subject|0|||
44573693|NCT03038113|79596308|FG009|Overall Study|Withdrawal by Subject|0|||
44573694|NCT03038113|79596309|FG010|Overall Study|Withdrawal by Subject|0|||
44573695|NCT03038113|79596310|FG011|Overall Study|Withdrawal by Subject|0|||
44573696|NCT03038113|79596311|FG012|Overall Study|Withdrawal by Subject|0|||
44573697|NCT03038113|79596312|FG013|Overall Study|Withdrawal by Subject|1|||
44113728|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
44113729|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
44113730|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
44573698|NCT03038113|79596299|FG000|Overall Study|Lost to Follow-up|0|||
44573699|NCT03038113|79596300|FG001|Overall Study|Lost to Follow-up|0|||
44573700|NCT03038113|79596301|FG002|Overall Study|Lost to Follow-up|0|||
44573701|NCT03038113|79596302|FG003|Overall Study|Lost to Follow-up|0|||
44573702|NCT03038113|79596303|FG004|Overall Study|Lost to Follow-up|0|||
44573703|NCT03038113|79596304|FG005|Overall Study|Lost to Follow-up|0|||
44573704|NCT03038113|79596305|FG006|Overall Study|Lost to Follow-up|1|||
44573705|NCT03038113|79596306|FG007|Overall Study|Lost to Follow-up|0|||
44573706|NCT03038113|79596307|FG008|Overall Study|Lost to Follow-up|0|||
44573707|NCT03038113|79596308|FG009|Overall Study|Lost to Follow-up|0|||
44573708|NCT03038113|79596309|FG010|Overall Study|Lost to Follow-up|0|||
44573709|NCT03038113|79596310|FG011|Overall Study|Lost to Follow-up|0|||
44113731|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
44113732|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
44113733|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
44113734|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
44113735|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
44113736|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
44113737|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
44113738|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
44113739|NCT00708500|78896400|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
44113740|NCT00708500|78896401|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
44573710|NCT03038113|79596311|FG012|Overall Study|Lost to Follow-up|0|||
44573711|NCT03038113|79596312|FG013|Overall Study|Lost to Follow-up|0|||
44573712|NCT00968149|79596361|FG000|Overall Study|Adverse Event|5|||
44573713|NCT00968149|79596362|FG001|Overall Study|Adverse Event|1|||
44573714|NCT00968149|79596361|FG000|Overall Study|Lack of Efficacy|0|||
44573715|NCT00968149|79596362|FG001|Overall Study|Lack of Efficacy|4|||
44573716|NCT00968149|79596361|FG000|Overall Study|Lost to Follow-up|0|||
44573717|NCT00968149|79596362|FG001|Overall Study|Lost to Follow-up|1|||
44573718|NCT00968149|79596361|FG000|Overall Study|Protocol Violation|4|||
44573719|NCT00968149|79596362|FG001|Overall Study|Protocol Violation|0|||
44573720|NCT00968149|79596361|FG000|Overall Study|Withdrawal by Subject|2|||
44573721|NCT00968149|79596362|FG001|Overall Study|Withdrawal by Subject|0|||
44573722|NCT00963469|79596371|FG000|Overall Study|Adverse Event|15|||
44573723|NCT00963469|79596372|FG001|Overall Study|Adverse Event|11|||
44573724|NCT00963469|79596373|FG002|Overall Study|Adverse Event|1|||
44573725|NCT00963469|79596371|FG000|Overall Study|Lack of Efficacy|10|||
44573726|NCT00963469|79596372|FG001|Overall Study|Lack of Efficacy|7|||
44573727|NCT00963469|79596373|FG002|Overall Study|Lack of Efficacy|2|||
44573728|NCT00963469|79596371|FG000|Overall Study|Lost to Follow-up|1|||
44573729|NCT00963469|79596372|FG001|Overall Study|Lost to Follow-up|1|||
44573730|NCT00963469|79596373|FG002|Overall Study|Lost to Follow-up|0|||
44573731|NCT00963469|79596371|FG000|Overall Study|Protocol Violation|5|||
44573732|NCT00963469|79596372|FG001|Overall Study|Protocol Violation|5|||
44573733|NCT00963469|79596373|FG002|Overall Study|Protocol Violation|3|||
44573734|NCT00963469|79596371|FG000|Overall Study|Withdrawal by Subject|4|||
44573735|NCT00963469|79596372|FG001|Overall Study|Withdrawal by Subject|1|||
44113741|NCT00708500|78896402|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
44113742|NCT00708500|78896400|FG000|FOLLOWUP|Adverse Event|0|||
44113743|NCT00708500|78896401|FG001|FOLLOWUP|Adverse Event|1|||
44113744|NCT00708500|78896402|FG002|FOLLOWUP|Adverse Event|0|||
44113745|NCT00708500|78896400|FG000|FOLLOWUP|Lost to Follow-up|1|||
44113746|NCT00708500|78896401|FG001|FOLLOWUP|Lost to Follow-up|6|||
44113747|NCT00708500|78896402|FG002|FOLLOWUP|Lost to Follow-up|4|||
44113748|NCT00708500|78896400|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
44113749|NCT00708500|78896401|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
44113750|NCT00708500|78896402|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
44113751|NCT00708500|78896400|FG000|FOLLOWUP|Subject withdrew consent|31|||
44113752|NCT00708500|78896401|FG001|FOLLOWUP|Subject withdrew consent|4|||
44505474|NCT00369629|79510259|FG003|Follow up for 1 Year|Death|0|||
44505475|NCT00369629|79510256|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
44505476|NCT00369629|79510257|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
44505477|NCT00369629|79510258|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
44505478|NCT00369629|79510259|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
44505479|NCT00369629|79510256|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
44505480|NCT00369629|79510257|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
44505481|NCT00369629|79510258|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
44573736|NCT00963469|79596373|FG002|Overall Study|Withdrawal by Subject|1|||
44573737|NCT00963469|79596371|FG000|Overall Study|Pre-randomization Adverse Event|1|||
44573738|NCT00963469|79596372|FG001|Overall Study|Pre-randomization Adverse Event|2|||
44573739|NCT00963469|79596373|FG002|Overall Study|Pre-randomization Adverse Event|0|||
44573740|NCT00963469|79596371|FG000|Overall Study|Moved|1|||
44113753|NCT00708500|78896402|FG002|FOLLOWUP|Subject withdrew consent|5|||
44113754|NCT00708500|78896400|FG000|FOLLOWUP|Non-compliance with protocol|5|||
44113755|NCT00708500|78896401|FG001|FOLLOWUP|Non-compliance with protocol|0|||
44113756|NCT00708500|78896402|FG002|FOLLOWUP|Non-compliance with protocol|1|||
44113757|NCT00708734|78896419|FG000|Overall Study|scheduling conflict|2|||
44573741|NCT00963469|79596372|FG001|Overall Study|Moved|0|||
44573742|NCT00963469|79596373|FG002|Overall Study|Moved|0|||
44573743|NCT00963469|79596371|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
44573744|NCT00963469|79596372|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
44573745|NCT00963469|79596373|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
44573746|NCT00897949|79596384|FG000|Overall Study|Adverse Event|1|||
44113758|NCT00708734|78896419|FG000|Overall Study|moved|1|||
44113759|NCT00708734|78896419|FG000|Overall Study|leg injury|1|||
44113760|NCT00708734|78896419|FG000|Overall Study|knee replacement|1|||
44113761|NCT00708734|78896419|FG000|Overall Study|vertigo|1|||
44113762|NCT00708734|78896419|FG000|Overall Study|leg fracture|1|||
44113763|NCT04834362|78896425|FG000|Overall Study|Death|1|||
44113764|NCT04834362|78896426|FG001|Overall Study|Death|2|||
44113765|NCT00101907|78896438|FG000|Overall Study|Adverse Event|1|||
44113766|NCT00101907|78896439|FG001|Overall Study|Adverse Event|0|||
44113767|NCT00101907|78896440|FG002|Overall Study|Adverse Event|0|||
44113768|NCT00101907|78896441|FG003|Overall Study|Adverse Event|0|||
44113769|NCT00101907|78896442|FG004|Overall Study|Adverse Event|0|||
44113770|NCT00101907|78896443|FG005|Overall Study|Adverse Event|0|||
44113771|NCT00101907|78896438|FG000|Overall Study|Death|0|||
44113772|NCT00101907|78896439|FG001|Overall Study|Death|1|||
44113773|NCT00101907|78896440|FG002|Overall Study|Death|0|||
44113774|NCT00101907|78896441|FG003|Overall Study|Death|0|||
44113775|NCT00101907|78896442|FG004|Overall Study|Death|3|||
44113776|NCT00101907|78896443|FG005|Overall Study|Death|0|||
44113777|NCT00101907|78896438|FG000|Overall Study|Physician Decision|0|||
44113778|NCT00101907|78896439|FG001|Overall Study|Physician Decision|0|||
44113779|NCT00101907|78896440|FG002|Overall Study|Physician Decision|0|||
44113780|NCT00101907|78896441|FG003|Overall Study|Physician Decision|1|||
44113781|NCT00101907|78896442|FG004|Overall Study|Physician Decision|1|||
44113782|NCT00101907|78896443|FG005|Overall Study|Physician Decision|0|||
44113783|NCT00101907|78896438|FG000|Overall Study|Withdrawal by Subject|1|||
44113784|NCT00101907|78896439|FG001|Overall Study|Withdrawal by Subject|0|||
44113785|NCT00101907|78896440|FG002|Overall Study|Withdrawal by Subject|1|||
44113786|NCT00101907|78896441|FG003|Overall Study|Withdrawal by Subject|0|||
44113787|NCT00101907|78896442|FG004|Overall Study|Withdrawal by Subject|1|||
44113788|NCT00101907|78896443|FG005|Overall Study|Withdrawal by Subject|0|||
44113789|NCT02565784|78896464|FG000|First Treatment|Adverse Event|1|||
44113790|NCT02565784|78896464|FG000|First Treatment|Withdrawal by Subject|1|||
44113791|NCT02565784|78896464|FG000|Second Treatment|Withdrawal by Subject|2|||
44113792|NCT04650204|78896511|FG000|Overall Study|Study was Terminated|2|||
44113793|NCT04650204|78896512|FG001|Overall Study|Study was Terminated|1|||
44113794|NCT02761629|78896520|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
44113795|NCT02761629|78896521|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
44113796|NCT02761629|78896520|FG000|Overall Study|Insufficient Therapeutic Response|2|||
44113797|NCT02761629|78896521|FG001|Overall Study|Insufficient Therapeutic Response|7|||
44113798|NCT02761629|78896520|FG000|Overall Study|Failure to Return|2|||
44113799|NCT02761629|78896521|FG001|Overall Study|Failure to Return|4|||
44113800|NCT02761629|78896520|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
44113801|NCT02761629|78896521|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
44113802|NCT02761629|78896520|FG000|Overall Study|Protocol Violation|2|||
44113803|NCT02761629|78896521|FG001|Overall Study|Protocol Violation|2|||
44113804|NCT02761629|78896520|FG000|Overall Study|Withdrawal by Subject|0|||
44113805|NCT02761629|78896521|FG001|Overall Study|Withdrawal by Subject|3|||
44113806|NCT02761629|78896520|FG000|Overall Study|Other|0|||
44113807|NCT02761629|78896521|FG001|Overall Study|Other|2|||
44113808|NCT02761629|78896520|FG000|Overall Study|Lost to Follow-up|4|||
44113809|NCT02761629|78896521|FG001|Overall Study|Lost to Follow-up|1|||
44113810|NCT02761629|78896520|FG000|Overall Study|Randomized But Not Treated|8|||
44113811|NCT02761629|78896521|FG001|Overall Study|Randomized But Not Treated|4|||
44505482|NCT00369629|79510259|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
44505483|NCT02469064|79510271|FG000|Overall Study|Request not to receive intervention.|1|||
44505484|NCT02469064|79510272|FG001|Overall Study|Request not to receive intervention.|3|||
44505485|NCT02446912|79510281|FG000|Overall Study|Adverse Event|3|||
44505486|NCT02446912|79510282|FG001|Overall Study|Adverse Event|13|||
44113812|NCT02760927|78896527|FG000|Overall Study|Tube Slippage from Device|1|||
44113813|NCT00101439|78896533|FG000|Period 2|Withdrawal by Subject|0|||
44113814|NCT00101439|78896534|FG001|Period 2|Withdrawal by Subject|2|||
44113815|NCT04033068|78896544|FG000|Overall Study|Withdrawal by Subject|0|||
44113816|NCT04033068|78896545|FG001|Overall Study|Withdrawal by Subject|0|||
44113817|NCT04033068|78896546|FG002|Overall Study|Withdrawal by Subject|1|||
44505487|NCT02446912|79510283|FG002|Overall Study|Adverse Event|5|||
44113818|NCT04033068|78896547|FG003|Overall Study|Withdrawal by Subject|0|||
44113819|NCT04033068|78896544|FG000|Overall Study|Lost to Follow-up|0|||
44113820|NCT04033068|78896545|FG001|Overall Study|Lost to Follow-up|1|||
44113821|NCT04033068|78896546|FG002|Overall Study|Lost to Follow-up|0|||
44113822|NCT04033068|78896547|FG003|Overall Study|Lost to Follow-up|0|||
44113823|NCT04033068|78896544|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
44505488|NCT02446912|79510281|FG000|Overall Study|Condition under investigation worsened|0|||
44505489|NCT02446912|79510282|FG001|Overall Study|Condition under investigation worsened|1|||
44113824|NCT04033068|78896545|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
44113825|NCT04033068|78896546|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
44113826|NCT04033068|78896547|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
44113827|NCT02762565|78896557|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
44113828|NCT02757963|78896570|FG000|Overall Study|Adverse Event|3|||
44113829|NCT02757963|78896570|FG000|Overall Study|Reached Stopping Criteria|1054|||
44113830|NCT02757963|78896570|FG000|Overall Study|Lost to Follow-up|5|||
44113831|NCT02757963|78896570|FG000|Overall Study|Physician Decision|1|||
44113832|NCT02757963|78896570|FG000|Overall Study|Withdrawal by Subject|34|||
44113833|NCT03111732|78896585|FG000|Overall Study|Enrolled in different study|1|||
44113834|NCT03111732|78896585|FG000|Overall Study|Progressive disease|3|||
44113835|NCT03111732|78896585|FG000|Overall Study|Withdrawal by Subject|1|||
44113836|NCT01663714|78896594|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
44113837|NCT01663714|78896594|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
44113838|NCT01663714|78896594|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
44113839|NCT01663714|78896594|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
44113840|NCT01663714|78896594|FG000|Long-Term Follow-Up|Death|4|||
44113841|NCT01663714|78896594|FG000|Long-Term Follow-Up|Non-compliance|1|||
44113842|NCT01663636|78896616|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
44113843|NCT01663636|78896617|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
44113844|NCT03065244|78896625|FG000|Overall Study|Lost to Follow-up|1|||
44113845|NCT03065244|78896626|FG001|Overall Study|Lost to Follow-up|1|||
44113846|NCT03065244|78896625|FG000|Overall Study|Diagnosed with a different disease|1|||
44113847|NCT03065244|78896626|FG001|Overall Study|Diagnosed with a different disease|1|||
44113848|NCT03065244|78896625|FG000|Overall Study|Protocol Violation|0|||
44113849|NCT03065244|78896626|FG001|Overall Study|Protocol Violation|1|||
44113850|NCT03065244|78896625|FG000|Overall Study|Withdrawal by Subject|1|||
44113851|NCT03065244|78896626|FG001|Overall Study|Withdrawal by Subject|1|||
44113852|NCT00100815|78896632|FG000|Overall Study|Progression|24|||
44113853|NCT00100815|78896632|FG000|Overall Study|Adverse Event|18|||
44113854|NCT00100815|78896632|FG000|Overall Study|Death|4|||
44113855|NCT00100815|78896632|FG000|Overall Study|Other|3|||
44113856|NCT00708422|78896638|FG000|Overall Study|Adverse Event|3|||
44113857|NCT00708422|78896639|FG001|Overall Study|Adverse Event|1|||
44113858|NCT00708422|78896638|FG000|Overall Study|Withdrawal by Subject|1|||
44113859|NCT00708422|78896639|FG001|Overall Study|Withdrawal by Subject|0|||
44113860|NCT02760069|78896648|FG000|Overall Study|Withdrawal by Subject|0|||
44113861|NCT02760069|78896649|FG001|Overall Study|Withdrawal by Subject|1|||
44113862|NCT02760069|78896650|FG002|Overall Study|Withdrawal by Subject|1|||
44113863|NCT00707486|78896658|FG000|Overall Study|Withdrawal by Subject|1|||
44113864|NCT02759055|78896666|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
44113865|NCT02759055|78896667|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
44113866|NCT00708032|78896675|FG000|Overall Study|Adverse Event|0|||
44113867|NCT00708032|78896676|FG001|Overall Study|Adverse Event|2|||
44113868|NCT00708032|78896675|FG000|Overall Study|Lost to Follow-up|1|||
44113869|NCT00708032|78896676|FG001|Overall Study|Lost to Follow-up|2|||
44113870|NCT00708032|78896675|FG000|Overall Study|Pregnancy|0|||
44113871|NCT00708032|78896676|FG001|Overall Study|Pregnancy|1|||
44113872|NCT00708032|78896675|FG000|Overall Study|Poor vision|0|||
44113873|NCT00708032|78896676|FG001|Overall Study|Poor vision|6|||
44113874|NCT00708032|78896675|FG000|Overall Study|Visit out of range at month 12|4|||
44113875|NCT00708032|78896676|FG001|Overall Study|Visit out of range at month 12|1|||
44113876|NCT00708032|78896675|FG000|Overall Study|Did not meet protocol criteria|1|||
44113877|NCT00708032|78896676|FG001|Overall Study|Did not meet protocol criteria|2|||
44113878|NCT00708032|78896675|FG000|Overall Study|Protocol Violation|4|||
44113879|NCT00708032|78896676|FG001|Overall Study|Protocol Violation|1|||
44113880|NCT00708032|78896675|FG000|Overall Study|Withdrawal by Subject|0|||
44113881|NCT00708032|78896676|FG001|Overall Study|Withdrawal by Subject|1|||
44113882|NCT00707174|78896684|FG000|Overall Study|Adverse Event|1|||
44237945|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237946|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44113883|NCT00707174|78896685|FG001|Overall Study|Adverse Event|6|||
44113884|NCT00707174|78896684|FG000|Overall Study|Withdrawal by Subject|4|||
44113885|NCT00707174|78896685|FG001|Overall Study|Withdrawal by Subject|1|||
44237947|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
44237948|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
44377927|NCT00785785|79383205|FG000|Optional Extension Phase|Lost to Follow-up|1|||
44377928|NCT00785785|79383206|FG001|Optional Extension Phase|Lost to Follow-up|0|||
44377929|NCT00785785|79383205|FG000|Optional Extension Phase|Administrative problems|2|||
44113886|NCT02756403|78896695|FG000|Overall Study|Unable to swallow medication|0|||
44113887|NCT02756403|78896696|FG001|Overall Study|Unable to swallow medication|1|||
44113888|NCT02756403|78896697|FG002|Overall Study|Unable to swallow medication|1|||
44505490|NCT02446912|79510283|FG002|Overall Study|Condition under investigation worsened|1|||
44113889|NCT02756403|78896698|FG003|Overall Study|Unable to swallow medication|1|||
44113890|NCT02756403|78896695|FG000|Overall Study|Did not complete Procedure|0|||
44113891|NCT02756403|78896696|FG001|Overall Study|Did not complete Procedure|1|||
44113892|NCT02756403|78896697|FG002|Overall Study|Did not complete Procedure|0|||
44113893|NCT02756403|78896698|FG003|Overall Study|Did not complete Procedure|0|||
44113894|NCT02756403|78896695|FG000|Overall Study|Changed Mind About Procedure|0|||
44113895|NCT02756403|78896696|FG001|Overall Study|Changed Mind About Procedure|0|||
44113896|NCT02756403|78896697|FG002|Overall Study|Changed Mind About Procedure|1|||
44113897|NCT02756403|78896698|FG003|Overall Study|Changed Mind About Procedure|0|||
44113898|NCT02756403|78896695|FG000|Overall Study|Protocol Violation|0|||
44113899|NCT02756403|78896696|FG001|Overall Study|Protocol Violation|1|||
44113900|NCT02756403|78896697|FG002|Overall Study|Protocol Violation|0|||
44113901|NCT02756403|78896698|FG003|Overall Study|Protocol Violation|1|||
44113902|NCT02753595|78896710|FG000|Overall Study|Sponsor termination|2|||
44113903|NCT02753595|78896711|FG001|Overall Study|Sponsor termination|2|||
44113904|NCT00707954|78896721|FG000|Overall Study|Physician Decision|0|||
44113905|NCT00707954|78896722|FG001|Overall Study|Physician Decision|0|||
44113906|NCT00707954|78896723|FG002|Overall Study|Physician Decision|0|||
44113907|NCT00707954|78896724|FG003|Overall Study|Physician Decision|0|||
44113908|NCT00707954|78896725|FG004|Overall Study|Physician Decision|1|||
44113909|NCT02565706|78896741|FG000|Overall Study|Withdrawal by Subject|5|||
44113910|NCT02565706|78896742|FG001|Overall Study|Withdrawal by Subject|7|||
44113911|NCT02565706|78896743|FG002|Overall Study|Withdrawal by Subject|7|||
44113912|NCT02565706|78896744|FG003|Overall Study|Withdrawal by Subject|11|||
44113913|NCT02565706|78896741|FG000|Overall Study|Lost to Follow-up|72|||
44113914|NCT02565706|78896742|FG001|Overall Study|Lost to Follow-up|75|||
44113915|NCT02565706|78896743|FG002|Overall Study|Lost to Follow-up|82|||
44113916|NCT02565706|78896744|FG003|Overall Study|Lost to Follow-up|74|||
44113917|NCT00706628|78896763|FG000|Overall Study|Other Adverse Event|16|||
44113918|NCT00706628|78896764|FG001|Overall Study|Other Adverse Event|5|||
44113919|NCT00706628|78896765|FG002|Overall Study|Other Adverse Event|5|||
44113920|NCT00706628|78896766|FG003|Overall Study|Other Adverse Event|2|||
44113921|NCT00706628|78896763|FG000|Overall Study|Non compliant with protocol|0|||
44113922|NCT00706628|78896764|FG001|Overall Study|Non compliant with protocol|1|||
44113923|NCT00706628|78896765|FG002|Overall Study|Non compliant with protocol|0|||
44113924|NCT00706628|78896766|FG003|Overall Study|Non compliant with protocol|0|||
44113925|NCT00706628|78896763|FG000|Overall Study|Consent withdrawn|6|||
44113926|NCT00706628|78896764|FG001|Overall Study|Consent withdrawn|1|||
44113927|NCT00706628|78896765|FG002|Overall Study|Consent withdrawn|3|||
44113928|NCT00706628|78896766|FG003|Overall Study|Consent withdrawn|0|||
44113929|NCT00706628|78896763|FG000|Overall Study|Progressive disease|20|||
44113930|NCT00706628|78896764|FG001|Overall Study|Progressive disease|13|||
44113931|NCT00706628|78896765|FG002|Overall Study|Progressive disease|8|||
44113932|NCT00706628|78896766|FG003|Overall Study|Progressive disease|1|||
44237949|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237950|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44237951|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44505491|NCT02446912|79510281|FG000|Overall Study|Study-specific withdrawal criteria|1|||
44573747|NCT00897949|79596385|FG001|Overall Study|Adverse Event|1|||
44573748|NCT00897949|79596386|FG002|Overall Study|Adverse Event|0|||
44573749|NCT00897949|79596384|FG000|Overall Study|Lost to Follow-up|0|||
44573750|NCT00897949|79596385|FG001|Overall Study|Lost to Follow-up|2|||
44573751|NCT00897949|79596386|FG002|Overall Study|Lost to Follow-up|1|||
44573752|NCT00897949|79596384|FG000|Overall Study|Protocol Violation|6|||
44113933|NCT00706628|78896763|FG000|Overall Study|Other than those stated above|4|||
44237952|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
44249746|NCT01504412|79083925|FG002|Overall Study|Lack of Efficacy|1|||
44505492|NCT02446912|79510282|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44505493|NCT02446912|79510283|FG002|Overall Study|Study-specific withdrawal criteria|0|||
44505494|NCT02446912|79510281|FG000|Overall Study|Lack of Efficacy|1|||
44505495|NCT02446912|79510282|FG001|Overall Study|Lack of Efficacy|4|||
44505496|NCT02446912|79510283|FG002|Overall Study|Lack of Efficacy|7|||
44505497|NCT02446912|79510281|FG000|Overall Study|Lost to Follow-up|0|||
44505498|NCT02446912|79510282|FG001|Overall Study|Lost to Follow-up|0|||
44505499|NCT02446912|79510283|FG002|Overall Study|Lost to Follow-up|2|||
44505500|NCT02446912|79510281|FG000|Overall Study|Severe non-compliance to protocol|1|||
44505501|NCT02446912|79510282|FG001|Overall Study|Severe non-compliance to protocol|0|||
44505502|NCT02446912|79510283|FG002|Overall Study|Severe non-compliance to protocol|1|||
44505503|NCT02446912|79510281|FG000|Overall Study|Withdrawal by Subject|10|||
44113934|NCT00706628|78896764|FG001|Overall Study|Other than those stated above|0|||
44573753|NCT00897949|79596385|FG001|Overall Study|Protocol Violation|3|||
44113935|NCT00706628|78896765|FG002|Overall Study|Other than those stated above|0|||
44505504|NCT02446912|79510282|FG001|Overall Study|Withdrawal by Subject|15|||
44505505|NCT02446912|79510283|FG002|Overall Study|Withdrawal by Subject|15|||
44505506|NCT02446912|79510281|FG000|Overall Study|Miscellaneous|2|||
44573754|NCT00897949|79596386|FG002|Overall Study|Protocol Violation|1|||
44113936|NCT00706628|78896766|FG003|Overall Study|Other than those stated above|0|||
44113937|NCT00706628|78896763|FG000|Overall Study|Not treated|1|||
44113938|NCT00706628|78896764|FG001|Overall Study|Not treated|1|||
44113939|NCT00706628|78896765|FG002|Overall Study|Not treated|0|||
44113940|NCT00706628|78896766|FG003|Overall Study|Not treated|0|||
44113941|NCT02561806|78896781|FG000|Induction Period|Adverse Event|0|||
44113942|NCT02561806|78896782|FG001|Induction Period|Adverse Event|2|||
44113943|NCT02561806|78896781|FG000|Induction Period|Lack of Efficacy|1|||
44113944|NCT02561806|78896782|FG001|Induction Period|Lack of Efficacy|0|||
44113945|NCT02561806|78896781|FG000|Induction Period|Withdrawal by Subject|0|||
44113946|NCT02561806|78896782|FG001|Induction Period|Withdrawal by Subject|2|||
44113947|NCT02561806|78896781|FG000|Induction Period|Site staff became unblinded|1|||
44113948|NCT02561806|78896782|FG001|Induction Period|Site staff became unblinded|0|||
44113949|NCT02561806|78896781|FG000|Induction Period|Randomized but not treated|0|||
44113950|NCT02561806|78896782|FG001|Induction Period|Randomized but not treated|1|||
44113951|NCT02561806|78896781|FG000|Maintenance Period|Adverse Event|2|||
44113952|NCT02561806|78896782|FG001|Maintenance Period|Adverse Event|1|||
44113953|NCT02561806|78896781|FG000|Maintenance Period|Lack of Efficacy|3|||
44113954|NCT02561806|78896782|FG001|Maintenance Period|Lack of Efficacy|1|||
44113955|NCT02561806|78896781|FG000|Maintenance Period|Lost to Follow-up|2|||
44113956|NCT02561806|78896782|FG001|Maintenance Period|Lost to Follow-up|2|||
44113957|NCT02561806|78896781|FG000|Maintenance Period|Protocol Violation|1|||
44113958|NCT02561806|78896782|FG001|Maintenance Period|Protocol Violation|0|||
44113959|NCT02561806|78896781|FG000|Maintenance Period|Withdrawal by Subject|5|||
44113960|NCT02561806|78896782|FG001|Maintenance Period|Withdrawal by Subject|3|||
44113961|NCT02561806|78896781|FG000|Maintenance Period|Site staff became unblinded|0|||
44113962|NCT02561806|78896782|FG001|Maintenance Period|Site staff became unblinded|1|||
44113963|NCT02561806|78896781|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
44113964|NCT02561806|78896782|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
44113965|NCT02561806|78896781|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
44113966|NCT02561806|78896782|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
44113967|NCT02561572|78896805|FG000|Overall Study|Inadequate time before surgery|2|||
44113968|NCT02561572|78896806|FG001|Overall Study|Inadequate time before surgery|1|||
44113969|NCT02561572|78896805|FG000|Overall Study|Protocol Violation|0|||
44113970|NCT02561572|78896806|FG001|Overall Study|Protocol Violation|1|||
44113971|NCT02180217|78896815|FG000|Overall Study|Adverse Event|3|||
44113972|NCT02180217|78896816|FG001|Overall Study|Adverse Event|2|||
44505507|NCT02446912|79510282|FG001|Overall Study|Miscellaneous|2|||
44505508|NCT02446912|79510283|FG002|Overall Study|Miscellaneous|4|||
44505509|NCT00736840|79510291|FG000|Overall Study|Lost to Follow-up|13|||
44505510|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Adverse Event|11|||
44505511|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Adverse Event|23|||
44505512|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Adverse Event|29|||
44505513|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Adverse Event|2|||
44505514|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Adverse Event|8|||
44505515|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
44505516|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
44505517|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
44505518|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
44505519|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
44505520|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
44505521|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
44505522|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
44505523|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
44505524|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
44505525|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
44505526|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
44505527|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
44505528|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
44505529|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
44505530|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
44505531|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
44573755|NCT00897949|79596384|FG000|Overall Study|Withdrawal by Subject|1|||
44573756|NCT00897949|79596385|FG001|Overall Study|Withdrawal by Subject|2|||
44573757|NCT00897949|79596386|FG002|Overall Study|Withdrawal by Subject|0|||
44573758|NCT00897949|79596384|FG000|Overall Study|Patient Uncoorperative|0|||
44573759|NCT00897949|79596385|FG001|Overall Study|Patient Uncoorperative|2|||
44573760|NCT00897949|79596386|FG002|Overall Study|Patient Uncoorperative|1|||
44573761|NCT00897949|79596384|FG000|Overall Study|Lost to Follow-up|30|||
44573762|NCT00897949|79596385|FG001|Overall Study|Lost to Follow-up|23|||
44113973|NCT02180217|78896817|FG002|Overall Study|Adverse Event|22|||
44113974|NCT02180217|78896815|FG000|Overall Study|Death|1|||
44113975|NCT02180217|78896816|FG001|Overall Study|Death|1|||
44113976|NCT02180217|78896817|FG002|Overall Study|Death|0|||
44113977|NCT02180217|78896815|FG000|Overall Study|Withdrawal by Subject|1|||
44113978|NCT02180217|78896816|FG001|Overall Study|Withdrawal by Subject|1|||
44113979|NCT02180217|78896817|FG002|Overall Study|Withdrawal by Subject|4|||
44113980|NCT02180217|78896815|FG000|Overall Study|Subject/Guardian decision|5|||
44113981|NCT02180217|78896816|FG001|Overall Study|Subject/Guardian decision|3|||
44113982|NCT02180217|78896817|FG002|Overall Study|Subject/Guardian decision|6|||
44113983|NCT02180217|78896815|FG000|Overall Study|Physician Decision|1|||
44113984|NCT02180217|78896816|FG001|Overall Study|Physician Decision|1|||
44113985|NCT02180217|78896817|FG002|Overall Study|Physician Decision|6|||
44113986|NCT02180217|78896815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44113987|NCT02180217|78896816|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44113988|NCT02180217|78896817|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44113989|NCT02560558|78896834|FG000|Overall Study|Adverse Event|1|||
44113990|NCT02560558|78896835|FG001|Overall Study|Adverse Event|0|||
44113991|NCT02560558|78896834|FG000|Overall Study|Death|0|||
44113992|NCT02560558|78896835|FG001|Overall Study|Death|2|||
44113993|NCT02560558|78896834|FG000|Overall Study|Lost to Follow-up|0|||
44573763|NCT00897949|79596386|FG002|Overall Study|Lost to Follow-up|17|||
44113994|NCT02560558|78896835|FG001|Overall Study|Lost to Follow-up|4|||
44113995|NCT02560558|78896834|FG000|Overall Study|Protocol Violation|3|||
44113996|NCT02560558|78896835|FG001|Overall Study|Protocol Violation|0|||
44113997|NCT02560558|78896834|FG000|Overall Study|Withdrawal by Subject|3|||
44113998|NCT02560558|78896835|FG001|Overall Study|Withdrawal by Subject|0|||
44113999|NCT02568046|78896843|FG000|Overall Study|Adverse Event|0|||
44114000|NCT02568046|78896844|FG001|Overall Study|Adverse Event|1|||
44114001|NCT02568046|78896843|FG000|Overall Study|Death|2|||
44114002|NCT02568046|78896844|FG001|Overall Study|Death|0|||
44114003|NCT02568046|78896843|FG000|Overall Study|Progressive Disease|1|||
44114004|NCT02568046|78896844|FG001|Overall Study|Progressive Disease|0|||
44114005|NCT02568046|78896843|FG000|Overall Study|Withdrawal by Subject|2|||
44114006|NCT02568046|78896844|FG001|Overall Study|Withdrawal by Subject|1|||
44114007|NCT02568046|78896843|FG000|Overall Study|Other Events|0|||
44114008|NCT02568046|78896844|FG001|Overall Study|Other Events|1|||
44114009|NCT02567656|78896856|FG000|Overall Study|Premature discontinuation due to PD|1|||
44114010|NCT02567656|78896857|FG001|Overall Study|Premature discontinuation due to PD|1|||
44114011|NCT02567656|78896858|FG002|Overall Study|Premature discontinuation due to PD|2|||
44114012|NCT02567656|78896859|FG003|Overall Study|Premature discontinuation due to PD|0|||
44114013|NCT02567656|78896860|FG004|Overall Study|Premature discontinuation due to PD|0|||
44114014|NCT02567656|78896861|FG005|Overall Study|Premature discontinuation due to PD|0|||
44114015|NCT02560012|78896875|FG000|Overall Study|Study Terminated|2|||
44114016|NCT02567266|78896882|FG000|Overall Study|Withdrawal by Subject|10|||
44114017|NCT02567266|78896883|FG001|Overall Study|Withdrawal by Subject|7|||
44114018|NCT02567266|78896884|FG002|Overall Study|Withdrawal by Subject|6|||
44114019|NCT02567266|78896882|FG000|Overall Study|Lost to Follow-up|13|||
44114020|NCT02567266|78896883|FG001|Overall Study|Lost to Follow-up|8|||
44114021|NCT02567266|78896884|FG002|Overall Study|Lost to Follow-up|10|||
44114022|NCT02567188|78896892|FG000|Overall Study|Death|10|||
44114023|NCT02567188|78896892|FG000|Overall Study|Terminated Mircera Treatment|9|||
44114024|NCT02567188|78896892|FG000|Overall Study|Lost to Follow-up|5|||
44114025|NCT02567188|78896892|FG000|Overall Study|Adverse Event|1|||
44114026|NCT02567188|78896892|FG000|Overall Study|Withdrawal by Subject|1|||
44114027|NCT02567188|78896892|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
44114028|NCT02567188|78896892|FG000|Overall Study|Moved and Changed Clinic|1|||
44114029|NCT02567188|78896892|FG000|Overall Study|Started Hemodialysis|2|||
44114030|NCT02567188|78896892|FG000|Overall Study|Protocol Violation|5|||
44237953|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
44237954|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
44237955|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
44505532|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
44505533|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
44505534|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
44505535|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
44505536|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
44505537|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
44505538|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
44505539|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
44505540|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
44505541|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
44505542|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
44505543|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
44505544|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
44505545|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Move|0|||
44573764|NCT00897949|79596384|FG000|Overall Study|Withdrawal by Subject|24|||
44114031|NCT00706238|78896897|FG000|Overall Study|Disease progression|4|||
44114032|NCT00706238|78896897|FG000|Overall Study|Other|1|||
44114033|NCT03321968|78896904|FG000|Overall Study|Withdrawal by Subject|1|||
44114034|NCT03321968|78896905|FG001|Overall Study|Withdrawal by Subject|2|||
44114035|NCT03321968|78896906|FG002|Overall Study|Withdrawal by Subject|1|||
44114036|NCT03321968|78896904|FG000|Overall Study|Lost to Follow-up|2|||
44114037|NCT03321968|78896905|FG001|Overall Study|Lost to Follow-up|0|||
44114038|NCT03321968|78896906|FG002|Overall Study|Lost to Follow-up|1|||
44573765|NCT00897949|79596385|FG001|Overall Study|Withdrawal by Subject|31|||
44573766|NCT00897949|79596386|FG002|Overall Study|Withdrawal by Subject|17|||
44573767|NCT00897949|79596384|FG000|Overall Study|Abnormal Prestudy Labs|2|||
44573768|NCT00897949|79596385|FG001|Overall Study|Abnormal Prestudy Labs|3|||
44573769|NCT00897949|79596386|FG002|Overall Study|Abnormal Prestudy Labs|4|||
44573770|NCT00897949|79596384|FG000|Overall Study|Abnormal Baseline ECG|2|||
44573771|NCT00897949|79596385|FG001|Overall Study|Abnormal Baseline ECG|2|||
44573772|NCT00897949|79596386|FG002|Overall Study|Abnormal Baseline ECG|4|||
44573773|NCT00897949|79596384|FG000|Overall Study|Need for Concom. Med.|0|||
44573774|NCT00897949|79596385|FG001|Overall Study|Need for Concom. Med.|1|||
44573775|NCT00897949|79596386|FG002|Overall Study|Need for Concom. Med.|1|||
44114039|NCT03321968|78896904|FG000|Overall Study|Other than specified|0|||
44114040|NCT03321968|78896905|FG001|Overall Study|Other than specified|0|||
44114041|NCT03321968|78896906|FG002|Overall Study|Other than specified|1|||
44114042|NCT05338333|78896920|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
44114043|NCT05338333|78896921|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
44114044|NCT05051579|78896937|FG000|Overall Study|Withdrawal by Subject|3|||
44114045|NCT05051579|78896938|FG001|Overall Study|Withdrawal by Subject|5|||
44114046|NCT05051579|78896939|FG002|Overall Study|Withdrawal by Subject|2|||
44114047|NCT05051579|78896940|FG003|Overall Study|Withdrawal by Subject|1|||
44114048|NCT05051579|78896941|FG004|Overall Study|Withdrawal by Subject|4|||
44114049|NCT05051579|78896942|FG005|Overall Study|Withdrawal by Subject|0|||
44114050|NCT05051579|78896943|FG006|Overall Study|Withdrawal by Subject|4|||
44114051|NCT05051579|78896937|FG000|Overall Study|Lost to Follow-up|1|||
44114052|NCT05051579|78896938|FG001|Overall Study|Lost to Follow-up|0|||
44114053|NCT05051579|78896939|FG002|Overall Study|Lost to Follow-up|0|||
44114054|NCT05051579|78896940|FG003|Overall Study|Lost to Follow-up|0|||
44114055|NCT05051579|78896941|FG004|Overall Study|Lost to Follow-up|1|||
44114056|NCT05051579|78896942|FG005|Overall Study|Lost to Follow-up|0|||
44114057|NCT05051579|78896943|FG006|Overall Study|Lost to Follow-up|1|||
44114058|NCT05051579|78896937|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
44114059|NCT05051579|78896938|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
44114060|NCT05051579|78896939|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
44237956|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
44237957|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
44237958|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
44237959|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
44237960|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
44505546|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Move|1|||
44114061|NCT05051579|78896940|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
44114062|NCT05051579|78896941|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
44114063|NCT05051579|78896942|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
44114064|NCT05051579|78896943|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
44114065|NCT05051579|78896937|FG000|Overall Study|Adverse Event|2|||
44505547|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Move|0|||
44505548|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Move|0|||
44505549|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Move|0|||
44505550|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
44505551|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
44505552|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
44505553|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
44505554|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
44505555|NCT00318461|79510300|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
44505556|NCT00318461|79510301|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
44505557|NCT00318461|79510302|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
44505558|NCT00318461|79510303|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
44505559|NCT00318461|79510304|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
44505560|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Work commitment|0|||
44505561|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Work commitment|0|||
44505562|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Work commitment|0|||
44505563|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Work commitment|0|||
44505564|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Work commitment|1|||
44505565|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Investigator decision|0|||
44505566|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Investigator decision|0|||
44505567|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Investigator decision|0|||
44573776|NCT00897949|79596384|FG000|Overall Study|Lack of Migraine Attack|29|||
44114066|NCT05051579|78896938|FG001|Overall Study|Adverse Event|1|||
44114067|NCT05051579|78896939|FG002|Overall Study|Adverse Event|0|||
44505568|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Investigator decision|0|||
44573777|NCT00897949|79596385|FG001|Overall Study|Lack of Migraine Attack|30|||
44114068|NCT05051579|78896940|FG003|Overall Study|Adverse Event|4|||
44114069|NCT05051579|78896941|FG004|Overall Study|Adverse Event|1|||
44114070|NCT05051579|78896942|FG005|Overall Study|Adverse Event|2|||
44114071|NCT05051579|78896943|FG006|Overall Study|Adverse Event|0|||
44114072|NCT05051579|78896937|FG000|Overall Study|Inadvertent Enrollment|0|||
44114073|NCT05051579|78896938|FG001|Overall Study|Inadvertent Enrollment|0|||
44114074|NCT05051579|78896939|FG002|Overall Study|Inadvertent Enrollment|0|||
44114075|NCT05051579|78896940|FG003|Overall Study|Inadvertent Enrollment|0|||
44114076|NCT05051579|78896941|FG004|Overall Study|Inadvertent Enrollment|0|||
44114077|NCT05051579|78896942|FG005|Overall Study|Inadvertent Enrollment|0|||
44114078|NCT05051579|78896943|FG006|Overall Study|Inadvertent Enrollment|1|||
44114079|NCT05051579|78896937|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
44114080|NCT05051579|78896938|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
44114081|NCT05051579|78896939|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
44114082|NCT05051579|78896940|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
44114083|NCT05051579|78896941|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
44114084|NCT05051579|78896942|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
44114085|NCT05051579|78896943|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
44114086|NCT05051579|78896937|FG000|Overall Study|Sponsor Decision|0|||
44114087|NCT05051579|78896938|FG001|Overall Study|Sponsor Decision|0|||
44114088|NCT05051579|78896939|FG002|Overall Study|Sponsor Decision|0|||
44114089|NCT05051579|78896940|FG003|Overall Study|Sponsor Decision|0|||
44114090|NCT05051579|78896941|FG004|Overall Study|Sponsor Decision|1|||
44114091|NCT05051579|78896942|FG005|Overall Study|Sponsor Decision|0|||
44114092|NCT05051579|78896943|FG006|Overall Study|Sponsor Decision|0|||
44114093|NCT05051579|78896937|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
44114094|NCT05051579|78896938|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
44114095|NCT05051579|78896939|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
44114096|NCT05051579|78896940|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
44114097|NCT05051579|78896941|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
44114098|NCT05051579|78896942|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
44114099|NCT05051579|78896943|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
44237961|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
44237962|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
44237963|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
44237964|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
44237965|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
44237966|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
44237967|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237968|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237969|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237970|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237971|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44505569|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Investigator decision|1|||
44505570|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Lack of time|1|||
44505571|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Lack of time|0|||
44505572|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Lack of time|0|||
44505573|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Lack of time|0|||
44505574|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Lack of time|0|||
44505575|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
44505576|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
44505577|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
44505578|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
44505579|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
44505580|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
44505581|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
44505582|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
44505583|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
44505584|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
44505585|NCT00318461|79510300|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
44505586|NCT00318461|79510301|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
44505587|NCT00318461|79510302|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
44505588|NCT00318461|79510303|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
44505589|NCT00318461|79510304|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
44505590|NCT00318461|79510300|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
44505591|NCT00318461|79510301|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
44505592|NCT00318461|79510302|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
44114100|NCT04964128|78896967|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
44114101|NCT04964128|78896967|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
44114102|NCT04881760|78896982|FG000|Overall Study|Adverse Event|0|||
44114103|NCT04881760|78896983|FG001|Overall Study|Adverse Event|1|||
44114104|NCT04881760|78896984|FG002|Overall Study|Adverse Event|1|||
44114105|NCT04881760|78896985|FG003|Overall Study|Adverse Event|0|||
44114106|NCT04881760|78896986|FG004|Overall Study|Adverse Event|1|||
44114107|NCT04881760|78896987|FG005|Overall Study|Adverse Event|1|||
44114108|NCT04881760|78896988|FG006|Overall Study|Adverse Event|2|||
44114109|NCT04881760|78896982|FG000|Overall Study|Death|0|||
44114110|NCT04881760|78896983|FG001|Overall Study|Death|0|||
44114111|NCT04881760|78896984|FG002|Overall Study|Death|0|||
44114112|NCT04881760|78896985|FG003|Overall Study|Death|1|||
44237972|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237973|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237974|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237975|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
44237976|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
44237977|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237978|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237979|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237980|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
44237981|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237982|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237983|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237984|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237985|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237986|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237987|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237988|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237989|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
44237990|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
44237991|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237992|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237993|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237994|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
44237995|NCT01695239|79064356|FG000|Extension Long-Term Extension Periods|Death|0|||
44237996|NCT01695239|79064357|FG001|Extension Long-Term Extension Periods|Death|0|||
44237997|NCT01695239|79064358|FG002|Extension Long-Term Extension Periods|Death|0|||
44237998|NCT01695239|79064359|FG003|Extension Long-Term Extension Periods|Death|0|||
44237999|NCT01695239|79064360|FG004|Extension Long-Term Extension Periods|Death|0|||
44238000|NCT01695239|79064361|FG005|Extension Long-Term Extension Periods|Death|0|||
44238001|NCT01695239|79064362|FG006|Extension Long-Term Extension Periods|Death|0|||
44238002|NCT01695239|79064363|FG007|Extension Long-Term Extension Periods|Death|0|||
44238003|NCT01695239|79064364|FG008|Extension Long-Term Extension Periods|Death|1|||
44238004|NCT01695239|79064365|FG009|Extension Long-Term Extension Periods|Death|0|||
44238005|NCT01695239|79064366|FG010|Extension Long-Term Extension Periods|Death|0|||
44238006|NCT01695239|79064367|FG011|Extension Long-Term Extension Periods|Death|0|||
44238007|NCT01695239|79064368|FG012|Extension Long-Term Extension Periods|Death|0|||
44238008|NCT01695239|79064369|FG013|Extension Long-Term Extension Periods|Death|0|||
44238009|NCT01695239|79064356|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238010|NCT01695239|79064357|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238011|NCT01695239|79064358|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238012|NCT01695239|79064359|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238013|NCT01695239|79064360|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238014|NCT01695239|79064361|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238015|NCT01695239|79064362|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238016|NCT01695239|79064363|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238017|NCT01695239|79064364|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238018|NCT01695239|79064365|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44114113|NCT04881760|78896986|FG004|Overall Study|Death|0|||
44114114|NCT04881760|78896987|FG005|Overall Study|Death|0|||
44114115|NCT04881760|78896988|FG006|Overall Study|Death|0|||
44238019|NCT01695239|79064366|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
44238020|NCT01695239|79064367|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
44114116|NCT04881760|78896982|FG000|Overall Study|Lost to Follow-up|5|||
44114117|NCT04881760|78896983|FG001|Overall Study|Lost to Follow-up|7|||
44114118|NCT04881760|78896984|FG002|Overall Study|Lost to Follow-up|5|||
44114119|NCT04881760|78896985|FG003|Overall Study|Lost to Follow-up|1|||
44114120|NCT04881760|78896986|FG004|Overall Study|Lost to Follow-up|2|||
44114121|NCT04881760|78896987|FG005|Overall Study|Lost to Follow-up|4|||
44114122|NCT04881760|78896988|FG006|Overall Study|Lost to Follow-up|4|||
44114123|NCT04881760|78896982|FG000|Overall Study|Withdrawal by Subject|13|||
44114124|NCT04881760|78896983|FG001|Overall Study|Withdrawal by Subject|1|||
44114125|NCT04881760|78896984|FG002|Overall Study|Withdrawal by Subject|1|||
44114126|NCT04881760|78896985|FG003|Overall Study|Withdrawal by Subject|4|||
44114127|NCT04881760|78896986|FG004|Overall Study|Withdrawal by Subject|2|||
44114128|NCT04881760|78896987|FG005|Overall Study|Withdrawal by Subject|1|||
44114129|NCT04881760|78896988|FG006|Overall Study|Withdrawal by Subject|2|||
44114130|NCT04881760|78896982|FG000|Overall Study|Randomized but Never Treated|0|||
44114131|NCT04881760|78896983|FG001|Overall Study|Randomized but Never Treated|0|||
44114132|NCT04881760|78896984|FG002|Overall Study|Randomized but Never Treated|0|||
44114133|NCT04881760|78896985|FG003|Overall Study|Randomized but Never Treated|1|||
44114134|NCT04881760|78896986|FG004|Overall Study|Randomized but Never Treated|0|||
44114135|NCT04881760|78896987|FG005|Overall Study|Randomized but Never Treated|0|||
44114136|NCT04881760|78896988|FG006|Overall Study|Randomized but Never Treated|0|||
44114137|NCT04881760|78896982|FG000|Overall Study|Inadvertent Enrollment|2|||
44114138|NCT04881760|78896983|FG001|Overall Study|Inadvertent Enrollment|0|||
44114139|NCT04881760|78896984|FG002|Overall Study|Inadvertent Enrollment|0|||
44114140|NCT04881760|78896985|FG003|Overall Study|Inadvertent Enrollment|0|||
44114141|NCT04881760|78896986|FG004|Overall Study|Inadvertent Enrollment|0|||
44114142|NCT04881760|78896987|FG005|Overall Study|Inadvertent Enrollment|0|||
44114143|NCT04881760|78896988|FG006|Overall Study|Inadvertent Enrollment|0|||
44114144|NCT04881760|78896982|FG000|Overall Study|Site Closure|0|||
44114145|NCT04881760|78896983|FG001|Overall Study|Site Closure|0|||
44114146|NCT04881760|78896984|FG002|Overall Study|Site Closure|0|||
44114147|NCT04881760|78896985|FG003|Overall Study|Site Closure|1|||
44114148|NCT04881760|78896986|FG004|Overall Study|Site Closure|0|||
44114149|NCT04881760|78896987|FG005|Overall Study|Site Closure|0|||
44114150|NCT04881760|78896988|FG006|Overall Study|Site Closure|0|||
44114151|NCT04749797|78897007|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
44114152|NCT04749797|78897008|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
44114153|NCT04749797|78897009|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
44114154|NCT04747275|78897019|FG000|Overall Study|Study terminated|0|||
44114155|NCT04747275|78897020|FG001|Overall Study|Study terminated|1|||
44114156|NCT04556552|78897028|FG000|Overall Study|Lost to Follow-up|1|||
44114157|NCT04556552|78897029|FG001|Overall Study|Lost to Follow-up|0|||
44114158|NCT04556552|78897028|FG000|Overall Study|Claustrophobia|0|||
44114159|NCT04556552|78897029|FG001|Overall Study|Claustrophobia|1|||
44114160|NCT04556552|78897028|FG000|Overall Study|Inability to continue|0|||
44114161|NCT04556552|78897029|FG001|Overall Study|Inability to continue|1|||
44114162|NCT04496167|78897037|FG000|Overall Study|Adverse Event|6|||
44114163|NCT04496167|78897038|FG001|Overall Study|Adverse Event|2|||
44114164|NCT04496167|78897037|FG000|Overall Study|Withdrawal by Subject|7|||
44114165|NCT04496167|78897038|FG001|Overall Study|Withdrawal by Subject|6|||
44114166|NCT04496167|78897037|FG000|Overall Study|Lost to Follow-up|3|||
44114167|NCT04496167|78897038|FG001|Overall Study|Lost to Follow-up|5|||
44114168|NCT04496167|78897037|FG000|Overall Study|Not Treated|1|||
44114169|NCT04496167|78897038|FG001|Overall Study|Not Treated|2|||
44114170|NCT04496167|78897037|FG000|Overall Study|Other Than Specified|1|||
44114171|NCT04496167|78897038|FG001|Overall Study|Other Than Specified|1|||
44114172|NCT04238481|78897081|FG000|Overall Study|Miscellaneous|0|||
44114173|NCT04238481|78897082|FG001|Overall Study|Miscellaneous|1|||
44114174|NCT04238481|78897083|FG002|Overall Study|Miscellaneous|0|||
44114175|NCT04238481|78897084|FG003|Overall Study|Miscellaneous|0|||
44114176|NCT04145700|78897096|FG000|Overall Study|Withdrawal by Subject|8|||
44114177|NCT04145700|78897097|FG001|Overall Study|Withdrawal by Subject|3|||
44114178|NCT04079738|78897103|FG000|Study Treatment|Death|1|||
44238021|NCT01695239|79064368|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
44238022|NCT01695239|79064369|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
44238023|NCT01695239|79064356|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238024|NCT01695239|79064357|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238025|NCT01695239|79064358|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44114179|NCT04079738|78897104|FG001|Study Treatment|Death|0|||
44114180|NCT04079738|78897105|FG002|Study Treatment|Death|0|||
44505593|NCT00318461|79510303|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
44114181|NCT04079738|78897106|FG003|Study Treatment|Death|0|||
44114182|NCT04079738|78897103|FG000|Study Treatment|Adverse Event|2|||
44114183|NCT04079738|78897104|FG001|Study Treatment|Adverse Event|0|||
44114184|NCT04079738|78897105|FG002|Study Treatment|Adverse Event|0|||
44114185|NCT04079738|78897106|FG003|Study Treatment|Adverse Event|0|||
44114186|NCT04079738|78897103|FG000|Study Treatment|withdrawal before treatment|1|||
44114187|NCT04079738|78897104|FG001|Study Treatment|withdrawal before treatment|0|||
44114188|NCT04079738|78897105|FG002|Study Treatment|withdrawal before treatment|0|||
44114189|NCT04079738|78897106|FG003|Study Treatment|withdrawal before treatment|0|||
44114190|NCT04079738|78897103|FG000|Study Treatment|symptomatic deterioration|2|||
44114191|NCT04079738|78897104|FG001|Study Treatment|symptomatic deterioration|0|||
44114192|NCT04079738|78897105|FG002|Study Treatment|symptomatic deterioration|0|||
44114193|NCT04079738|78897106|FG003|Study Treatment|symptomatic deterioration|0|||
44114194|NCT04079738|78897103|FG000|Study Treatment|Disease Progression|1|||
44114195|NCT04079738|78897104|FG001|Study Treatment|Disease Progression|0|||
44114196|NCT04079738|78897105|FG002|Study Treatment|Disease Progression|0|||
44114197|NCT04079738|78897106|FG003|Study Treatment|Disease Progression|0|||
44114198|NCT04079738|78897103|FG000|Study Treatment|withdrawal after treatment|1|||
44114199|NCT04079738|78897104|FG001|Study Treatment|withdrawal after treatment|0|||
44114200|NCT04079738|78897105|FG002|Study Treatment|withdrawal after treatment|0|||
44114201|NCT04079738|78897106|FG003|Study Treatment|withdrawal after treatment|0|||
44114202|NCT04079738|78897103|FG000|Follow up|Withdrawal by Subject|3|||
44114203|NCT04079738|78897104|FG001|Follow up|Withdrawal by Subject|0|||
44114204|NCT04079738|78897105|FG002|Follow up|Withdrawal by Subject|0|||
44114205|NCT04079738|78897106|FG003|Follow up|Withdrawal by Subject|0|||
44114206|NCT04079738|78897103|FG000|Follow up|Death|5|||
44114207|NCT04079738|78897104|FG001|Follow up|Death|0|||
44114208|NCT04079738|78897105|FG002|Follow up|Death|0|||
44114209|NCT04079738|78897106|FG003|Follow up|Death|0|||
44114210|NCT04054635|78897115|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
44114211|NCT04054635|78897116|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
44114212|NCT04054635|78897117|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
44114213|NCT04054635|78897115|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
44114214|NCT04054635|78897116|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
44114215|NCT04054635|78897117|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
44114216|NCT03820726|78897125|FG000|Overall Study|Other than listed|23|||
44114217|NCT03820726|78897125|FG000|Overall Study|Withdrawal by Subject|37|||
44114218|NCT03820726|78897125|FG000|Overall Study|Lost to Follow-up|3|||
44114219|NCT03820726|78897125|FG000|Overall Study|Protocol deviation|1|||
44114220|NCT03820726|78897125|FG000|Overall Study|Adverse Event|146|||
44114221|NCT03820726|78897125|FG000|Overall Study|Not treated|1|||
44114222|NCT03744312|78897131|FG000|Overall Study|Withdrawal by Subject|0|||
44114223|NCT03744312|78897132|FG001|Overall Study|Withdrawal by Subject|1|||
44114224|NCT03744312|78897131|FG000|Overall Study|Screen fail|0|||
44114225|NCT03744312|78897132|FG001|Overall Study|Screen fail|1|||
44114226|NCT03737123|78897140|FG000|Study Treatment|Adverse Event|2|||
44114227|NCT03737123|78897141|FG001|Study Treatment|Adverse Event|0|||
44114228|NCT03737123|78897140|FG000|Study Treatment|Disease Progression|2|||
44114229|NCT03737123|78897141|FG001|Study Treatment|Disease Progression|0|||
44114230|NCT03737123|78897140|FG000|Study Treatment|Withdrawal by Subject|2|||
44114231|NCT03737123|78897141|FG001|Study Treatment|Withdrawal by Subject|0|||
44114232|NCT03737123|78897140|FG000|Follow up|Death|1|||
44114233|NCT03737123|78897141|FG001|Follow up|Death|0|||
44114234|NCT03737123|78897140|FG000|Follow up|Withdrawal by Subject|1|||
44114235|NCT03737123|78897141|FG001|Follow up|Withdrawal by Subject|0|||
44114236|NCT03737123|78897140|FG000|Follow up|Termination of study|4|||
44114237|NCT03737123|78897141|FG001|Follow up|Termination of study|0|||
44114238|NCT03502707|78897164|FG000|Overall Study|Adverse Event|0|||
44114239|NCT03502707|78897165|FG001|Overall Study|Adverse Event|0|||
44114240|NCT03502707|78897166|FG002|Overall Study|Adverse Event|0|||
44114241|NCT03502707|78897167|FG003|Overall Study|Adverse Event|0|||
44114242|NCT03502707|78897168|FG004|Overall Study|Adverse Event|0|||
44114243|NCT03502707|78897169|FG005|Overall Study|Adverse Event|0|||
44114244|NCT03502707|78897170|FG006|Overall Study|Adverse Event|0|||
44114245|NCT03502707|78897171|FG007|Overall Study|Adverse Event|0|||
44114246|NCT03502707|78897172|FG008|Overall Study|Adverse Event|0|||
44505594|NCT00318461|79510304|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
44505595|NCT00318461|79510300|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
44505596|NCT00318461|79510301|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
44505597|NCT00318461|79510302|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
44505598|NCT00318461|79510303|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
44505599|NCT00318461|79510304|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
44505600|NCT00318461|79510300|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
44505601|NCT00318461|79510301|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
44505602|NCT00318461|79510302|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
44505603|NCT00318461|79510303|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
44505604|NCT00318461|79510304|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
44505605|NCT00318461|79510300|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
44505606|NCT00318461|79510301|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
44505607|NCT00318461|79510302|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
44114247|NCT03502707|78897173|FG009|Overall Study|Adverse Event|0|||
44114248|NCT03502707|78897174|FG010|Overall Study|Adverse Event|0|||
44114249|NCT03502707|78897175|FG011|Overall Study|Adverse Event|0|||
44114250|NCT03502707|78897176|FG012|Overall Study|Adverse Event|0|||
44114251|NCT03502707|78897177|FG013|Overall Study|Adverse Event|0|||
44114252|NCT03502707|78897178|FG014|Overall Study|Adverse Event|0|||
44114253|NCT03502707|78897179|FG015|Overall Study|Adverse Event|1|||
44114254|NCT03502707|78897180|FG016|Overall Study|Adverse Event|5|||
44114255|NCT03502707|78897181|FG017|Overall Study|Adverse Event|0|||
44114256|NCT03502707|78897164|FG000|Overall Study|Death|0|||
44114257|NCT03502707|78897165|FG001|Overall Study|Death|0|||
44114258|NCT03502707|78897166|FG002|Overall Study|Death|0|||
44114259|NCT03502707|78897167|FG003|Overall Study|Death|1|||
44114260|NCT03502707|78897168|FG004|Overall Study|Death|0|||
44114261|NCT03502707|78897169|FG005|Overall Study|Death|0|||
44114262|NCT03502707|78897170|FG006|Overall Study|Death|0|||
44114263|NCT03502707|78897171|FG007|Overall Study|Death|0|||
44114264|NCT03502707|78897172|FG008|Overall Study|Death|1|||
44114265|NCT03502707|78897173|FG009|Overall Study|Death|1|||
44114266|NCT03502707|78897174|FG010|Overall Study|Death|0|||
44114267|NCT03502707|78897175|FG011|Overall Study|Death|0|||
44114268|NCT03502707|78897176|FG012|Overall Study|Death|1|||
44114269|NCT03502707|78897177|FG013|Overall Study|Death|0|||
44114270|NCT03502707|78897178|FG014|Overall Study|Death|0|||
44114271|NCT03502707|78897179|FG015|Overall Study|Death|1|||
44114272|NCT03502707|78897180|FG016|Overall Study|Death|0|||
44114273|NCT03502707|78897181|FG017|Overall Study|Death|0|||
44114274|NCT03502707|78897164|FG000|Overall Study|Lost to Follow-up|0|||
44114275|NCT03502707|78897165|FG001|Overall Study|Lost to Follow-up|0|||
44114276|NCT03502707|78897166|FG002|Overall Study|Lost to Follow-up|0|||
44114277|NCT03502707|78897167|FG003|Overall Study|Lost to Follow-up|0|||
44114278|NCT03502707|78897168|FG004|Overall Study|Lost to Follow-up|0|||
44114279|NCT03502707|78897169|FG005|Overall Study|Lost to Follow-up|0|||
44114280|NCT03502707|78897170|FG006|Overall Study|Lost to Follow-up|0|||
44114281|NCT03502707|78897171|FG007|Overall Study|Lost to Follow-up|5|||
44114282|NCT03502707|78897172|FG008|Overall Study|Lost to Follow-up|0|||
44114283|NCT03502707|78897173|FG009|Overall Study|Lost to Follow-up|2|||
44114284|NCT03502707|78897174|FG010|Overall Study|Lost to Follow-up|1|||
44114285|NCT03502707|78897175|FG011|Overall Study|Lost to Follow-up|2|||
44114286|NCT03502707|78897176|FG012|Overall Study|Lost to Follow-up|1|||
44114287|NCT03502707|78897177|FG013|Overall Study|Lost to Follow-up|1|||
44114288|NCT03502707|78897178|FG014|Overall Study|Lost to Follow-up|0|||
44114289|NCT03502707|78897179|FG015|Overall Study|Lost to Follow-up|4|||
44114290|NCT03502707|78897180|FG016|Overall Study|Lost to Follow-up|9|||
44114291|NCT03502707|78897181|FG017|Overall Study|Lost to Follow-up|2|||
44114292|NCT03502707|78897164|FG000|Overall Study|Physician Decision|0|||
44114293|NCT03502707|78897165|FG001|Overall Study|Physician Decision|0|||
44114294|NCT03502707|78897166|FG002|Overall Study|Physician Decision|0|||
44114295|NCT03502707|78897167|FG003|Overall Study|Physician Decision|0|||
44114296|NCT03502707|78897168|FG004|Overall Study|Physician Decision|0|||
44114297|NCT03502707|78897169|FG005|Overall Study|Physician Decision|0|||
44114298|NCT03502707|78897170|FG006|Overall Study|Physician Decision|0|||
44114299|NCT03502707|78897171|FG007|Overall Study|Physician Decision|0|||
44114300|NCT03502707|78897172|FG008|Overall Study|Physician Decision|2|||
44114301|NCT03502707|78897173|FG009|Overall Study|Physician Decision|1|||
44114302|NCT03502707|78897174|FG010|Overall Study|Physician Decision|0|||
44114303|NCT03502707|78897175|FG011|Overall Study|Physician Decision|0|||
44114304|NCT03502707|78897176|FG012|Overall Study|Physician Decision|0|||
44114305|NCT03502707|78897177|FG013|Overall Study|Physician Decision|0|||
44114306|NCT03502707|78897178|FG014|Overall Study|Physician Decision|1|||
44114307|NCT03502707|78897179|FG015|Overall Study|Physician Decision|3|||
44114308|NCT03502707|78897180|FG016|Overall Study|Physician Decision|0|||
44114309|NCT03502707|78897181|FG017|Overall Study|Physician Decision|0|||
44114310|NCT03502707|78897164|FG000|Overall Study|Protocol Violation|0|||
44238026|NCT01695239|79064359|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238027|NCT01695239|79064360|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238028|NCT01695239|79064361|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238029|NCT01695239|79064362|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238030|NCT01695239|79064363|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44114311|NCT03502707|78897165|FG001|Overall Study|Protocol Violation|0|||
44114312|NCT03502707|78897166|FG002|Overall Study|Protocol Violation|0|||
44114313|NCT03502707|78897167|FG003|Overall Study|Protocol Violation|0|||
44114314|NCT03502707|78897168|FG004|Overall Study|Protocol Violation|0|||
44114315|NCT03502707|78897169|FG005|Overall Study|Protocol Violation|0|||
44114316|NCT03502707|78897170|FG006|Overall Study|Protocol Violation|0|||
44114317|NCT03502707|78897171|FG007|Overall Study|Protocol Violation|0|||
44114318|NCT03502707|78897172|FG008|Overall Study|Protocol Violation|0|||
44114319|NCT03502707|78897173|FG009|Overall Study|Protocol Violation|0|||
44114320|NCT03502707|78897174|FG010|Overall Study|Protocol Violation|0|||
44114321|NCT03502707|78897175|FG011|Overall Study|Protocol Violation|0|||
44114322|NCT03502707|78897176|FG012|Overall Study|Protocol Violation|0|||
44114323|NCT03502707|78897177|FG013|Overall Study|Protocol Violation|0|||
44114324|NCT03502707|78897178|FG014|Overall Study|Protocol Violation|0|||
44114325|NCT03502707|78897179|FG015|Overall Study|Protocol Violation|1|||
44114326|NCT03502707|78897180|FG016|Overall Study|Protocol Violation|0|||
44114327|NCT03502707|78897181|FG017|Overall Study|Protocol Violation|0|||
44114328|NCT03502707|78897164|FG000|Overall Study|Withdrawal by Subject|1|||
44114329|NCT03502707|78897165|FG001|Overall Study|Withdrawal by Subject|1|||
44114330|NCT03502707|78897166|FG002|Overall Study|Withdrawal by Subject|0|||
44114331|NCT03502707|78897167|FG003|Overall Study|Withdrawal by Subject|0|||
44114332|NCT03502707|78897168|FG004|Overall Study|Withdrawal by Subject|0|||
44114333|NCT03502707|78897169|FG005|Overall Study|Withdrawal by Subject|2|||
44114334|NCT03502707|78897170|FG006|Overall Study|Withdrawal by Subject|0|||
44114335|NCT03502707|78897171|FG007|Overall Study|Withdrawal by Subject|3|||
44114336|NCT03502707|78897172|FG008|Overall Study|Withdrawal by Subject|1|||
44114337|NCT03502707|78897173|FG009|Overall Study|Withdrawal by Subject|2|||
44114338|NCT03502707|78897174|FG010|Overall Study|Withdrawal by Subject|12|||
44114339|NCT03502707|78897175|FG011|Overall Study|Withdrawal by Subject|23|||
44114340|NCT03502707|78897176|FG012|Overall Study|Withdrawal by Subject|5|||
44114341|NCT03502707|78897177|FG013|Overall Study|Withdrawal by Subject|3|||
44114342|NCT03502707|78897178|FG014|Overall Study|Withdrawal by Subject|3|||
44114343|NCT03502707|78897179|FG015|Overall Study|Withdrawal by Subject|43|||
44114344|NCT03502707|78897180|FG016|Overall Study|Withdrawal by Subject|44|||
44114345|NCT03502707|78897181|FG017|Overall Study|Withdrawal by Subject|18|||
44114346|NCT03502707|78897164|FG000|Overall Study|Sponsor's Decision|1|||
44114347|NCT03502707|78897165|FG001|Overall Study|Sponsor's Decision|0|||
44114348|NCT03502707|78897166|FG002|Overall Study|Sponsor's Decision|0|||
44114349|NCT03502707|78897167|FG003|Overall Study|Sponsor's Decision|0|||
44573778|NCT00897949|79596386|FG002|Overall Study|Lack of Migraine Attack|19|||
44573779|NCT00897949|79596384|FG000|Overall Study|Did not take study drug|9|||
44573780|NCT00897949|79596385|FG001|Overall Study|Did not take study drug|3|||
44573781|NCT00897949|79596386|FG002|Overall Study|Did not take study drug|4|||
44573782|NCT02760810|79596400|FG000|Overall Study|Protocol Violation|1|||
44573783|NCT02760654|79596406|FG000|Overall Study|Lost to Follow-up|3|||
44573784|NCT02760654|79596407|FG001|Overall Study|Lost to Follow-up|3|||
44573785|NCT02760654|79596406|FG000|Overall Study|Withdrawal by Subject|4|||
44573786|NCT02760654|79596407|FG001|Overall Study|Withdrawal by Subject|3|||
44573787|NCT00725491|79596415|FG000|Overall Study|Adverse Event|3|||
44573788|NCT00725491|79596416|FG001|Overall Study|Adverse Event|2|||
44573789|NCT00725491|79596415|FG000|Overall Study|Pregnancy|0|||
44573790|NCT00725491|79596416|FG001|Overall Study|Pregnancy|3|||
44573791|NCT00725491|79596415|FG000|Overall Study|Risk for hyperstimulation|2|||
44573792|NCT00725491|79596416|FG001|Overall Study|Risk for hyperstimulation|9|||
44573793|NCT00725491|79596415|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
44573794|NCT00725491|79596416|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
44114350|NCT03502707|78897168|FG004|Overall Study|Sponsor's Decision|0|||
44114351|NCT03502707|78897169|FG005|Overall Study|Sponsor's Decision|0|||
44114352|NCT03502707|78897170|FG006|Overall Study|Sponsor's Decision|0|||
44114353|NCT03502707|78897171|FG007|Overall Study|Sponsor's Decision|0|||
44114354|NCT03502707|78897172|FG008|Overall Study|Sponsor's Decision|0|||
44114355|NCT03502707|78897173|FG009|Overall Study|Sponsor's Decision|1|||
44114356|NCT03502707|78897174|FG010|Overall Study|Sponsor's Decision|0|||
44114357|NCT03502707|78897175|FG011|Overall Study|Sponsor's Decision|0|||
44114358|NCT03502707|78897176|FG012|Overall Study|Sponsor's Decision|0|||
44114359|NCT03502707|78897177|FG013|Overall Study|Sponsor's Decision|0|||
44114360|NCT03502707|78897178|FG014|Overall Study|Sponsor's Decision|0|||
44114361|NCT03502707|78897179|FG015|Overall Study|Sponsor's Decision|2|||
44114362|NCT03502707|78897180|FG016|Overall Study|Sponsor's Decision|1|||
44114363|NCT03502707|78897181|FG017|Overall Study|Sponsor's Decision|0|||
44114364|NCT03502707|78897164|FG000|Overall Study|Initiated Prohibited Medication|0|||
44114365|NCT03502707|78897165|FG001|Overall Study|Initiated Prohibited Medication|0|||
44114366|NCT03502707|78897166|FG002|Overall Study|Initiated Prohibited Medication|0|||
44114367|NCT03502707|78897167|FG003|Overall Study|Initiated Prohibited Medication|0|||
44238031|NCT01695239|79064364|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238032|NCT01695239|79064365|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238033|NCT01695239|79064366|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238034|NCT01695239|79064367|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44238035|NCT01695239|79064368|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
44238036|NCT01695239|79064369|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
44238037|NCT01695239|79064356|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
44573795|NCT00725491|79596415|FG000|Overall Study|Fertilization failure|0|||
44114368|NCT03502707|78897168|FG004|Overall Study|Initiated Prohibited Medication|0|||
44114369|NCT03502707|78897169|FG005|Overall Study|Initiated Prohibited Medication|0|||
44114370|NCT03502707|78897170|FG006|Overall Study|Initiated Prohibited Medication|0|||
44114371|NCT03502707|78897171|FG007|Overall Study|Initiated Prohibited Medication|0|||
44114372|NCT03502707|78897172|FG008|Overall Study|Initiated Prohibited Medication|0|||
44114373|NCT03502707|78897173|FG009|Overall Study|Initiated Prohibited Medication|0|||
44114374|NCT03502707|78897174|FG010|Overall Study|Initiated Prohibited Medication|0|||
44114375|NCT03502707|78897175|FG011|Overall Study|Initiated Prohibited Medication|0|||
44114376|NCT03502707|78897176|FG012|Overall Study|Initiated Prohibited Medication|0|||
44114377|NCT03502707|78897177|FG013|Overall Study|Initiated Prohibited Medication|0|||
44573796|NCT00725491|79596416|FG001|Overall Study|Fertilization failure|1|||
44114378|NCT03502707|78897178|FG014|Overall Study|Initiated Prohibited Medication|0|||
44114379|NCT03502707|78897179|FG015|Overall Study|Initiated Prohibited Medication|0|||
44114380|NCT03502707|78897180|FG016|Overall Study|Initiated Prohibited Medication|1|||
44114381|NCT03502707|78897181|FG017|Overall Study|Initiated Prohibited Medication|0|||
44114382|NCT03502707|78897164|FG000|Overall Study|Other|0|||
44114383|NCT03502707|78897165|FG001|Overall Study|Other|0|||
44114384|NCT03502707|78897166|FG002|Overall Study|Other|0|||
44114385|NCT03502707|78897167|FG003|Overall Study|Other|0|||
44114386|NCT03502707|78897168|FG004|Overall Study|Other|0|||
44114387|NCT03502707|78897169|FG005|Overall Study|Other|0|||
44114388|NCT03502707|78897170|FG006|Overall Study|Other|0|||
44114389|NCT03502707|78897171|FG007|Overall Study|Other|0|||
44114390|NCT03502707|78897172|FG008|Overall Study|Other|1|||
44114391|NCT03502707|78897173|FG009|Overall Study|Other|1|||
44114392|NCT03502707|78897174|FG010|Overall Study|Other|2|||
44114393|NCT03502707|78897175|FG011|Overall Study|Other|0|||
44114394|NCT03502707|78897176|FG012|Overall Study|Other|0|||
44114395|NCT03502707|78897177|FG013|Overall Study|Other|0|||
44114396|NCT03502707|78897178|FG014|Overall Study|Other|0|||
44114397|NCT03502707|78897179|FG015|Overall Study|Other|4|||
44114398|NCT03502707|78897180|FG016|Overall Study|Other|1|||
44114399|NCT03502707|78897181|FG017|Overall Study|Other|0|||
44114400|NCT03502707|78897164|FG000|Overall Study|Randomized but not vaccinated|0|||
44114401|NCT03502707|78897165|FG001|Overall Study|Randomized but not vaccinated|0|||
44114402|NCT03502707|78897166|FG002|Overall Study|Randomized but not vaccinated|0|||
44114403|NCT03502707|78897167|FG003|Overall Study|Randomized but not vaccinated|0|||
44114404|NCT03502707|78897168|FG004|Overall Study|Randomized but not vaccinated|0|||
44114405|NCT03502707|78897169|FG005|Overall Study|Randomized but not vaccinated|0|||
44114406|NCT03502707|78897170|FG006|Overall Study|Randomized but not vaccinated|0|||
44114407|NCT03502707|78897171|FG007|Overall Study|Randomized but not vaccinated|0|||
44114408|NCT03502707|78897172|FG008|Overall Study|Randomized but not vaccinated|0|||
44114409|NCT03502707|78897173|FG009|Overall Study|Randomized but not vaccinated|0|||
44114410|NCT03502707|78897174|FG010|Overall Study|Randomized but not vaccinated|0|||
44114411|NCT03502707|78897175|FG011|Overall Study|Randomized but not vaccinated|1|||
44114412|NCT03502707|78897176|FG012|Overall Study|Randomized but not vaccinated|0|||
44114413|NCT03502707|78897177|FG013|Overall Study|Randomized but not vaccinated|0|||
44114414|NCT03502707|78897178|FG014|Overall Study|Randomized but not vaccinated|0|||
44114415|NCT03502707|78897179|FG015|Overall Study|Randomized but not vaccinated|0|||
44114416|NCT03502707|78897180|FG016|Overall Study|Randomized but not vaccinated|0|||
44114417|NCT03502707|78897181|FG017|Overall Study|Randomized but not vaccinated|1|||
44114418|NCT03425006|78897231|FG000|Overall Study|Withdrawal by Subject|1|||
44114419|NCT03425006|78897231|FG000|Overall Study|Physician Decision|1|||
44114420|NCT03425006|78897231|FG000|Overall Study|Death|1|||
44114421|NCT03401073|78897237|FG000|Overall Study|Lost to Follow-up|1|||
44114422|NCT03401073|78897238|FG001|Overall Study|Lost to Follow-up|2|||
44114423|NCT02915263|78897263|FG000|Overall Study|Covid|3|||
44114424|NCT02915263|78897264|FG001|Overall Study|Covid|2|||
44114425|NCT02343952|78897270|FG000|Study Treatment|Disease Progression|23|||
44114426|NCT02343952|78897270|FG000|Study Treatment|Death|3|||
44114427|NCT02343952|78897270|FG000|Study Treatment|Adverse Event|19|||
44114428|NCT02343952|78897270|FG000|Study Treatment|Withdrawal by Subject|7|||
44114429|NCT02343952|78897270|FG000|Study Treatment|other complicating Diseases|1|||
44114430|NCT02343952|78897270|FG000|Follow up|Withdrawal by Subject|3|||
44114431|NCT02343952|78897270|FG000|Follow up|Death|33|||
44114432|NCT02343952|78897270|FG000|Follow up|Patient does not meet eligibility for study.|1|||
44114433|NCT02343952|78897270|FG000|Follow up|Research department closed by the practice.|5|||
44114434|NCT02343952|78897270|FG000|Follow up|Patient went home to Russia|1|||
44114435|NCT02343952|78897270|FG000|Follow up|Disease Progression|1|||
44114436|NCT02343952|78897270|FG000|Follow up|study terminated|1|||
44114437|NCT01592370|78897281|FG000|Overall Study|Disease Progression|62|||
44114438|NCT01592370|78897282|FG001|Overall Study|Disease Progression|16|||
44114439|NCT01592370|78897283|FG002|Overall Study|Disease Progression|52|||
44114440|NCT01592370|78897284|FG003|Overall Study|Disease Progression|3|||
44114441|NCT01592370|78897285|FG004|Overall Study|Disease Progression|3|||
44114442|NCT01592370|78897286|FG005|Overall Study|Disease Progression|31|||
44114443|NCT01592370|78897287|FG006|Overall Study|Disease Progression|14|||
44238038|NCT01695239|79064357|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
44377930|NCT00785785|79383206|FG001|Optional Extension Phase|Administrative problems|0|||
44114444|NCT01592370|78897281|FG000|Overall Study|Study Drug Toxicity|14|||
44114445|NCT01592370|78897282|FG001|Overall Study|Study Drug Toxicity|3|||
44114446|NCT01592370|78897283|FG002|Overall Study|Study Drug Toxicity|0|||
44114447|NCT01592370|78897284|FG003|Overall Study|Study Drug Toxicity|0|||
44114448|NCT01592370|78897285|FG004|Overall Study|Study Drug Toxicity|0|||
44114449|NCT01592370|78897286|FG005|Overall Study|Study Drug Toxicity|0|||
44114450|NCT01592370|78897287|FG006|Overall Study|Study Drug Toxicity|1|||
44114451|NCT01592370|78897281|FG000|Overall Study|AE unrelated to study drug|4|||
44114452|NCT01592370|78897282|FG001|Overall Study|AE unrelated to study drug|3|||
44114453|NCT01592370|78897283|FG002|Overall Study|AE unrelated to study drug|0|||
44114454|NCT01592370|78897284|FG003|Overall Study|AE unrelated to study drug|0|||
44114455|NCT01592370|78897285|FG004|Overall Study|AE unrelated to study drug|0|||
44114456|NCT01592370|78897286|FG005|Overall Study|AE unrelated to study drug|0|||
44114457|NCT01592370|78897287|FG006|Overall Study|AE unrelated to study drug|1|||
44114458|NCT01592370|78897281|FG000|Overall Study|Request to discontinue study treatment|5|||
44114459|NCT01592370|78897282|FG001|Overall Study|Request to discontinue study treatment|0|||
44114460|NCT01592370|78897283|FG002|Overall Study|Request to discontinue study treatment|2|||
44114461|NCT01592370|78897284|FG003|Overall Study|Request to discontinue study treatment|0|||
44114462|NCT01592370|78897285|FG004|Overall Study|Request to discontinue study treatment|1|||
44114463|NCT01592370|78897286|FG005|Overall Study|Request to discontinue study treatment|2|||
44114464|NCT01592370|78897287|FG006|Overall Study|Request to discontinue study treatment|0|||
44114465|NCT01592370|78897281|FG000|Overall Study|Withdrew consent|1|||
44114466|NCT01592370|78897282|FG001|Overall Study|Withdrew consent|2|||
44114467|NCT01592370|78897283|FG002|Overall Study|Withdrew consent|1|||
44114468|NCT01592370|78897284|FG003|Overall Study|Withdrew consent|1|||
44114469|NCT01592370|78897285|FG004|Overall Study|Withdrew consent|0|||
44114470|NCT01592370|78897286|FG005|Overall Study|Withdrew consent|0|||
44114471|NCT01592370|78897287|FG006|Overall Study|Withdrew consent|0|||
44114472|NCT01592370|78897281|FG000|Overall Study|Maximum clinical benefit|11|||
44114473|NCT01592370|78897282|FG001|Overall Study|Maximum clinical benefit|1|||
44114474|NCT01592370|78897283|FG002|Overall Study|Maximum clinical benefit|7|||
44114475|NCT01592370|78897284|FG003|Overall Study|Maximum clinical benefit|1|||
44114476|NCT01592370|78897285|FG004|Overall Study|Maximum clinical benefit|0|||
44114477|NCT01592370|78897286|FG005|Overall Study|Maximum clinical benefit|0|||
44114478|NCT01592370|78897287|FG006|Overall Study|Maximum clinical benefit|0|||
44114479|NCT01592370|78897281|FG000|Overall Study|No longer meets study criteria|1|||
44114480|NCT01592370|78897282|FG001|Overall Study|No longer meets study criteria|0|||
44114481|NCT01592370|78897283|FG002|Overall Study|No longer meets study criteria|0|||
44114482|NCT01592370|78897284|FG003|Overall Study|No longer meets study criteria|0|||
44114483|NCT01592370|78897285|FG004|Overall Study|No longer meets study criteria|0|||
44114484|NCT01592370|78897286|FG005|Overall Study|No longer meets study criteria|0|||
44114485|NCT01592370|78897287|FG006|Overall Study|No longer meets study criteria|0|||
44114486|NCT01592370|78897281|FG000|Overall Study|Other Reasons|6|||
44114487|NCT01592370|78897282|FG001|Overall Study|Other Reasons|0|||
44114488|NCT01592370|78897283|FG002|Overall Study|Other Reasons|10|||
44114489|NCT01592370|78897284|FG003|Overall Study|Other Reasons|0|||
44114490|NCT01592370|78897285|FG004|Overall Study|Other Reasons|0|||
44114491|NCT01592370|78897286|FG005|Overall Study|Other Reasons|1|||
44114492|NCT01592370|78897287|FG006|Overall Study|Other Reasons|0|||
44114493|NCT00777036|78897315|FG000|On Treatment|Reason Not Specified|4|||
44114494|NCT00777036|78897316|FG001|On Treatment|Reason Not Specified|7|||
44114495|NCT00777036|78897317|FG002|On Treatment|Reason Not Specified|12|||
44114496|NCT00777036|78897315|FG000|On Treatment|Failure to Meet Study Criteria|0|||
44114497|NCT00777036|78897316|FG001|On Treatment|Failure to Meet Study Criteria|1|||
44114498|NCT00777036|78897317|FG002|On Treatment|Failure to Meet Study Criteria|0|||
44114499|NCT00777036|78897315|FG000|On Treatment|Non-compliance with Study Drug|1|||
44114500|NCT00777036|78897316|FG001|On Treatment|Non-compliance with Study Drug|0|||
44114501|NCT00777036|78897317|FG002|On Treatment|Non-compliance with Study Drug|0|||
44377931|NCT00785785|79383205|FG000|Optional Extension Phase|Death|1|||
44505608|NCT00318461|79510303|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
44505609|NCT00318461|79510304|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
44505610|NCT00318461|79510300|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
44505611|NCT00318461|79510301|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
44505612|NCT00318461|79510302|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
44505613|NCT00318461|79510303|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
44505614|NCT00318461|79510304|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
44505615|NCT03764072|79510331|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
44505616|NCT03764072|79510332|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
44505617|NCT03764072|79510333|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
44505618|NCT03764072|79510334|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
44505619|NCT03764072|79510335|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
44505620|NCT03764072|79510336|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
44505621|NCT03764072|79510331|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
44505622|NCT03764072|79510332|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
44573797|NCT00725491|79596415|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
44573798|NCT00725491|79596416|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
44238039|NCT01695239|79064358|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
44377932|NCT00785785|79383206|FG001|Optional Extension Phase|Death|5|||
44377933|NCT00785785|79383205|FG000|Optional Extension Phase|Disease progression|22|||
44114502|NCT00777036|78897315|FG000|On Treatment|Maximum Clinical Benefit|2|||
44114503|NCT00777036|78897316|FG001|On Treatment|Maximum Clinical Benefit|0|||
44114504|NCT00777036|78897317|FG002|On Treatment|Maximum Clinical Benefit|1|||
44114505|NCT00777036|78897315|FG000|On Treatment|Withdrawal by Subject|3|||
44114506|NCT00777036|78897316|FG001|On Treatment|Withdrawal by Subject|2|||
44114507|NCT00777036|78897317|FG002|On Treatment|Withdrawal by Subject|3|||
44114508|NCT00777036|78897315|FG000|On Treatment|Death|0|||
44114509|NCT00777036|78897316|FG001|On Treatment|Death|2|||
44114510|NCT00777036|78897317|FG002|On Treatment|Death|0|||
44114511|NCT00777036|78897315|FG000|On Treatment|Study Drug Toxicity|0|||
44114512|NCT00777036|78897316|FG001|On Treatment|Study Drug Toxicity|0|||
44114513|NCT00777036|78897317|FG002|On Treatment|Study Drug Toxicity|1|||
44114514|NCT00777036|78897315|FG000|On Treatment|Progressive Disease|5|||
44114515|NCT00777036|78897316|FG001|On Treatment|Progressive Disease|4|||
44114516|NCT00777036|78897317|FG002|On Treatment|Progressive Disease|6|||
44114517|NCT00777036|78897315|FG000|Follow-Up|Lost to Follow-up|1|||
44114518|NCT00777036|78897316|FG001|Follow-Up|Lost to Follow-up|0|||
44114519|NCT00777036|78897317|FG002|Follow-Up|Lost to Follow-up|0|||
44114520|NCT00777036|78897315|FG000|Follow-Up|Reason Not Specified|2|||
44114521|NCT00777036|78897316|FG001|Follow-Up|Reason Not Specified|0|||
44114522|NCT00777036|78897317|FG002|Follow-Up|Reason Not Specified|0|||
44114523|NCT00777036|78897315|FG000|Follow-Up|Withdrawal by Subject|1|||
44114524|NCT00777036|78897316|FG001|Follow-Up|Withdrawal by Subject|0|||
44114525|NCT00777036|78897317|FG002|Follow-Up|Withdrawal by Subject|4|||
44114526|NCT00777036|78897315|FG000|Follow-Up|Death|1|||
44114527|NCT00777036|78897316|FG001|Follow-Up|Death|8|||
44114528|NCT00777036|78897317|FG002|Follow-Up|Death|0|||
44114529|NCT00176644|78897332|FG000|Overall Study|Withdrawal by Subject|1|||
44114530|NCT04649164|78897350|FG000|Overall Study|Withdrawal by Subject|1|||
44114531|NCT04649164|78897351|FG001|Overall Study|Withdrawal by Subject|1|||
44114532|NCT04649164|78897352|FG002|Overall Study|Withdrawal by Subject|2|||
44114533|NCT04649164|78897350|FG000|Overall Study|Participant's care recipient expired|0|||
44114534|NCT04649164|78897351|FG001|Overall Study|Participant's care recipient expired|0|||
44114535|NCT04649164|78897352|FG002|Overall Study|Participant's care recipient expired|2|||
44114536|NCT00706004|78897393|FG000|Overall Study|Did not meet eligibility criteria|2|||
44114537|NCT02724644|78897400|FG000|Overall Study|Adverse Event|7|||
44114538|NCT02724644|78897401|FG001|Overall Study|Adverse Event|1|||
44114539|NCT02724644|78897400|FG000|Overall Study|Lost to Follow-up|6|||
44114540|NCT02724644|78897401|FG001|Overall Study|Lost to Follow-up|2|||
44114541|NCT02724644|78897400|FG000|Overall Study|Withdrawal by Subject|7|||
44114542|NCT02724644|78897401|FG001|Overall Study|Withdrawal by Subject|1|||
44114543|NCT02724644|78897400|FG000|Overall Study|Administrative|1|||
44114544|NCT02724644|78897401|FG001|Overall Study|Administrative|0|||
44238040|NCT01695239|79064359|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
44238041|NCT01695239|79064360|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
44238042|NCT01695239|79064361|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
44238043|NCT01695239|79064362|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
44238044|NCT01695239|79064363|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
44573799|NCT02634580|79596426|FG000|Double-blind Treatment Period|Subject Request|1|||
44573800|NCT02634580|79596427|FG001|Double-blind Treatment Period|Subject Request|0|||
44573801|NCT02634580|79596428|FG002|Double-blind Treatment Period|Subject Request|1|||
44573802|NCT02634580|79596429|FG003|Double-blind Treatment Period|Subject Request|1|||
44573803|NCT02634580|79596426|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
44573804|NCT02634580|79596427|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
44573805|NCT02634580|79596428|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
44573806|NCT02634580|79596429|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
44573807|NCT02225366|79596440|FG000|Overall Study|Lack of Efficacy|1|||
44573808|NCT02225366|79596441|FG001|Overall Study|Lack of Efficacy|0|||
44573809|NCT00697255|79596449|FG000|Stage 1a|Insufficient ovarian response|1|||
44573810|NCT00697255|79596450|FG001|Stage 1a|Insufficient ovarian response|0|||
44573811|NCT00697255|79596449|FG000|Stage 1a|Multifollicular growth|1|||
44573812|NCT00697255|79596450|FG001|Stage 1a|Multifollicular growth|0|||
44573813|NCT00697255|79596449|FG000|Stage 1a|Not growing of dominant follicle|1|||
44573814|NCT00697255|79596450|FG001|Stage 1a|Not growing of dominant follicle|0|||
44573815|NCT00697255|79596449|FG000|Stage 1b|Not growing of dominant follicle|0|||
44114545|NCT02725268|78897411|FG000|Overall Study|Death|58|||
44114546|NCT02725268|78897412|FG001|Overall Study|Death|59|||
44114547|NCT02725268|78897413|FG002|Overall Study|Death|30|||
44114548|NCT02725268|78897414|FG003|Overall Study|Death|16|||
44573816|NCT00697255|79596450|FG001|Stage 1b|Not growing of dominant follicle|1|||
44114549|NCT02725268|78897411|FG000|Overall Study|Lost to Follow-up|4|||
44114550|NCT02725268|78897412|FG001|Overall Study|Lost to Follow-up|3|||
44114551|NCT02725268|78897413|FG002|Overall Study|Lost to Follow-up|0|||
44114552|NCT02725268|78897414|FG003|Overall Study|Lost to Follow-up|1|||
44114553|NCT02725268|78897411|FG000|Overall Study|Site Terminated by Sponsor|0|||
44114554|NCT02725268|78897412|FG001|Overall Study|Site Terminated by Sponsor|1|||
44114555|NCT02725268|78897413|FG002|Overall Study|Site Terminated by Sponsor|0|||
44114556|NCT02725268|78897414|FG003|Overall Study|Site Terminated by Sponsor|0|||
44114557|NCT02725268|78897411|FG000|Overall Study|Withdrawal by Subject|8|||
44573817|NCT00697255|79596449|FG000|Stage 1b|Insufficient ovarian response|0|||
44573818|NCT00697255|79596450|FG001|Stage 1b|Insufficient ovarian response|1|||
44573819|NCT05350423|79596458|FG000|Overall Study|Lost to Follow-up|3|||
44573820|NCT05350423|79596459|FG001|Overall Study|Lost to Follow-up|3|||
44573821|NCT05350423|79596458|FG000|Overall Study|screen failure|5|||
44114558|NCT02725268|78897412|FG001|Overall Study|Withdrawal by Subject|6|||
44114559|NCT02725268|78897413|FG002|Overall Study|Withdrawal by Subject|8|||
44114560|NCT02725268|78897414|FG003|Overall Study|Withdrawal by Subject|1|||
44114561|NCT02725268|78897411|FG000|Overall Study|Reason not Specified|2|||
44114562|NCT02725268|78897412|FG001|Overall Study|Reason not Specified|1|||
44114563|NCT02725268|78897413|FG002|Overall Study|Reason not Specified|0|||
44114564|NCT02725268|78897414|FG003|Overall Study|Reason not Specified|0|||
44573822|NCT05350423|79596459|FG001|Overall Study|screen failure|6|||
44573823|NCT04896385|79596467|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
44573824|NCT04896385|79596468|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
44573825|NCT04896385|79596469|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
44114565|NCT02724956|78897426|FG000|Overall Study|Physician Decision|1|||
44114566|NCT02724956|78897427|FG001|Overall Study|Physician Decision|0|||
44114567|NCT02724956|78897426|FG000|Overall Study|Lack of Efficacy|0|||
44114568|NCT02724956|78897427|FG001|Overall Study|Lack of Efficacy|1|||
44114569|NCT02724956|78897426|FG000|Overall Study|Withdrawal by Subject|0|||
44114570|NCT02724956|78897427|FG001|Overall Study|Withdrawal by Subject|1|||
44114571|NCT00705536|78897435|FG000|Start Period 1|Withdrawal by Subject|0|||
44114572|NCT00705536|78897436|FG001|Start Period 1|Withdrawal by Subject|0|||
44114573|NCT00705536|78897437|FG002|Start Period 1|Withdrawal by Subject|0|||
44114574|NCT00705536|78897438|FG003|Start Period 1|Withdrawal by Subject|1|||
44114575|NCT02724020|78897460|FG000|Overall Study|Death|16|||
44114576|NCT02724020|78897461|FG001|Overall Study|Death|18|||
44114577|NCT02724020|78897462|FG002|Overall Study|Death|19|||
44114578|NCT02724020|78897460|FG000|Overall Study|Lost to Follow-up|0|||
44114579|NCT02724020|78897461|FG001|Overall Study|Lost to Follow-up|3|||
44114580|NCT02724020|78897462|FG002|Overall Study|Lost to Follow-up|0|||
44114581|NCT02724020|78897460|FG000|Overall Study|Site Terminated by Sponsor|15|||
44114582|NCT02724020|78897461|FG001|Overall Study|Site Terminated by Sponsor|8|||
44573826|NCT04896385|79596470|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
44573827|NCT04896385|79596467|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
44114583|NCT02724020|78897462|FG002|Overall Study|Site Terminated by Sponsor|8|||
44114584|NCT02724020|78897460|FG000|Overall Study|Withdrawal by Subject|1|||
44114585|NCT02724020|78897461|FG001|Overall Study|Withdrawal by Subject|3|||
44114586|NCT02724020|78897462|FG002|Overall Study|Withdrawal by Subject|5|||
44114587|NCT02660034|78897484|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
44114588|NCT02660034|78897485|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
44114589|NCT02660034|78897486|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
44114590|NCT02660034|78897487|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
44114591|NCT02660034|78897488|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
44114592|NCT02660034|78897489|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
44114593|NCT02660034|78897490|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
44114594|NCT02660034|78897491|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
44114595|NCT02660034|78897492|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
44114596|NCT02660034|78897493|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
44114597|NCT02660034|78897494|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
44114598|NCT02660034|78897495|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
44114599|NCT02660034|78897496|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
44114600|NCT02660034|78897497|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
44114601|NCT02660034|78897484|FG000|Overall Study|Progressive Disease (Clinical)|7|||
44114602|NCT02660034|78897485|FG001|Overall Study|Progressive Disease (Clinical)|8|||
44573828|NCT04896385|79596468|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
44573829|NCT04896385|79596469|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
44573830|NCT04896385|79596470|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
44114603|NCT02660034|78897486|FG002|Overall Study|Progressive Disease (Clinical)|3|||
44114604|NCT02660034|78897487|FG003|Overall Study|Progressive Disease (Clinical)|9|||
44114605|NCT02660034|78897488|FG004|Overall Study|Progressive Disease (Clinical)|3|||
44114606|NCT02660034|78897489|FG005|Overall Study|Progressive Disease (Clinical)|0|||
44114607|NCT02660034|78897490|FG006|Overall Study|Progressive Disease (Clinical)|0|||
44114608|NCT02660034|78897491|FG007|Overall Study|Progressive Disease (Clinical)|0|||
44114609|NCT02660034|78897492|FG008|Overall Study|Progressive Disease (Clinical)|0|||
44114610|NCT02660034|78897493|FG009|Overall Study|Progressive Disease (Clinical)|0|||
44114611|NCT02660034|78897494|FG010|Overall Study|Progressive Disease (Clinical)|0|||
44114612|NCT02660034|78897495|FG011|Overall Study|Progressive Disease (Clinical)|0|||
44114613|NCT02660034|78897496|FG012|Overall Study|Progressive Disease (Clinical)|0|||
44114614|NCT02660034|78897497|FG013|Overall Study|Progressive Disease (Clinical)|0|||
44114615|NCT02660034|78897484|FG000|Overall Study|Lost to Follow-up|0|||
44114616|NCT02660034|78897485|FG001|Overall Study|Lost to Follow-up|0|||
44377934|NCT00785785|79383206|FG001|Optional Extension Phase|Disease progression|70|||
44114617|NCT02660034|78897486|FG002|Overall Study|Lost to Follow-up|1|||
44114618|NCT02660034|78897487|FG003|Overall Study|Lost to Follow-up|1|||
44114619|NCT02660034|78897488|FG004|Overall Study|Lost to Follow-up|0|||
44114620|NCT02660034|78897489|FG005|Overall Study|Lost to Follow-up|0|||
44114621|NCT02660034|78897490|FG006|Overall Study|Lost to Follow-up|0|||
44114622|NCT02660034|78897491|FG007|Overall Study|Lost to Follow-up|0|||
44114623|NCT02660034|78897492|FG008|Overall Study|Lost to Follow-up|0|||
44114624|NCT02660034|78897493|FG009|Overall Study|Lost to Follow-up|1|||
44114625|NCT02660034|78897494|FG010|Overall Study|Lost to Follow-up|1|||
44114626|NCT02660034|78897495|FG011|Overall Study|Lost to Follow-up|1|||
44114627|NCT02660034|78897496|FG012|Overall Study|Lost to Follow-up|0|||
44114628|NCT02660034|78897497|FG013|Overall Study|Lost to Follow-up|0|||
44114629|NCT02660034|78897484|FG000|Overall Study|Participant moved into special access scheme|1|||
44114630|NCT02660034|78897485|FG001|Overall Study|Participant moved into special access scheme|2|||
44114631|NCT02660034|78897486|FG002|Overall Study|Participant moved into special access scheme|0|||
44114632|NCT02660034|78897487|FG003|Overall Study|Participant moved into special access scheme|0|||
44114633|NCT02660034|78897488|FG004|Overall Study|Participant moved into special access scheme|0|||
44114634|NCT02660034|78897489|FG005|Overall Study|Participant moved into special access scheme|0|||
44114635|NCT02660034|78897490|FG006|Overall Study|Participant moved into special access scheme|0|||
44114636|NCT02660034|78897491|FG007|Overall Study|Participant moved into special access scheme|0|||
44114637|NCT02660034|78897492|FG008|Overall Study|Participant moved into special access scheme|0|||
44114638|NCT02660034|78897493|FG009|Overall Study|Participant moved into special access scheme|0|||
44114639|NCT02660034|78897494|FG010|Overall Study|Participant moved into special access scheme|0|||
44114640|NCT02660034|78897495|FG011|Overall Study|Participant moved into special access scheme|0|||
44114641|NCT02660034|78897496|FG012|Overall Study|Participant moved into special access scheme|0|||
44114642|NCT02660034|78897497|FG013|Overall Study|Participant moved into special access scheme|0|||
44114643|NCT02660034|78897484|FG000|Overall Study|Adverse Event|1|||
44573831|NCT04896385|79596467|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
44573832|NCT04896385|79596468|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
44573833|NCT04896385|79596469|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
44573834|NCT04896385|79596470|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
44573835|NCT04896385|79596467|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
44573836|NCT04896385|79596468|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
44573837|NCT04896385|79596469|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
44114644|NCT02660034|78897485|FG001|Overall Study|Adverse Event|0|||
44114645|NCT02660034|78897486|FG002|Overall Study|Adverse Event|0|||
44114646|NCT02660034|78897487|FG003|Overall Study|Adverse Event|0|||
44114647|NCT02660034|78897488|FG004|Overall Study|Adverse Event|0|||
44114648|NCT02660034|78897489|FG005|Overall Study|Adverse Event|0|||
44114649|NCT02660034|78897490|FG006|Overall Study|Adverse Event|0|||
44114650|NCT02660034|78897491|FG007|Overall Study|Adverse Event|0|||
44114651|NCT02660034|78897492|FG008|Overall Study|Adverse Event|0|||
44114652|NCT02660034|78897493|FG009|Overall Study|Adverse Event|0|||
44114653|NCT02660034|78897494|FG010|Overall Study|Adverse Event|0|||
44114654|NCT02660034|78897495|FG011|Overall Study|Adverse Event|0|||
44114655|NCT02660034|78897496|FG012|Overall Study|Adverse Event|0|||
44114656|NCT02660034|78897497|FG013|Overall Study|Adverse Event|0|||
44114657|NCT02660034|78897484|FG000|Overall Study|Sponsor Decision|0|||
44114658|NCT02660034|78897485|FG001|Overall Study|Sponsor Decision|1|||
44114659|NCT02660034|78897486|FG002|Overall Study|Sponsor Decision|2|||
44114660|NCT02660034|78897487|FG003|Overall Study|Sponsor Decision|2|||
44114661|NCT02660034|78897488|FG004|Overall Study|Sponsor Decision|3|||
44114662|NCT02660034|78897489|FG005|Overall Study|Sponsor Decision|0|||
44114663|NCT02660034|78897490|FG006|Overall Study|Sponsor Decision|0|||
44114664|NCT02660034|78897491|FG007|Overall Study|Sponsor Decision|0|||
44114665|NCT02660034|78897492|FG008|Overall Study|Sponsor Decision|0|||
44114666|NCT02660034|78897493|FG009|Overall Study|Sponsor Decision|0|||
44505623|NCT03764072|79510333|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
44505624|NCT03764072|79510334|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
44505625|NCT03764072|79510335|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
44505626|NCT03764072|79510336|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
44505627|NCT03764072|79510331|FG000|Overall Study|Lost to Follow-up|0|||
44505628|NCT03764072|79510332|FG001|Overall Study|Lost to Follow-up|0|||
44505629|NCT03764072|79510333|FG002|Overall Study|Lost to Follow-up|0|||
44505630|NCT03764072|79510334|FG003|Overall Study|Lost to Follow-up|0|||
44505631|NCT03764072|79510335|FG004|Overall Study|Lost to Follow-up|1|||
44505632|NCT03764072|79510336|FG005|Overall Study|Lost to Follow-up|0|||
44505633|NCT03333928|79510358|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
44505634|NCT03333928|79510359|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
44505635|NCT03333928|79510360|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
44114667|NCT02660034|78897494|FG010|Overall Study|Sponsor Decision|0|||
44114668|NCT02660034|78897495|FG011|Overall Study|Sponsor Decision|0|||
44114669|NCT02660034|78897496|FG012|Overall Study|Sponsor Decision|0|||
44114670|NCT02660034|78897497|FG013|Overall Study|Sponsor Decision|1|||
44114671|NCT02660034|78897484|FG000|Overall Study|Withdrawal by Subject|0|||
44114672|NCT02660034|78897485|FG001|Overall Study|Withdrawal by Subject|0|||
44114673|NCT02660034|78897486|FG002|Overall Study|Withdrawal by Subject|0|||
44114674|NCT02660034|78897487|FG003|Overall Study|Withdrawal by Subject|0|||
44114675|NCT02660034|78897488|FG004|Overall Study|Withdrawal by Subject|0|||
44114676|NCT02660034|78897489|FG005|Overall Study|Withdrawal by Subject|0|||
44573838|NCT04896385|79596470|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
44573839|NCT04896385|79596467|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
44573840|NCT04896385|79596468|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
44114677|NCT02660034|78897490|FG006|Overall Study|Withdrawal by Subject|1|||
44114678|NCT02660034|78897491|FG007|Overall Study|Withdrawal by Subject|1|||
44114679|NCT02660034|78897492|FG008|Overall Study|Withdrawal by Subject|1|||
44114680|NCT02660034|78897493|FG009|Overall Study|Withdrawal by Subject|0|||
44114681|NCT02660034|78897494|FG010|Overall Study|Withdrawal by Subject|0|||
44114682|NCT02660034|78897495|FG011|Overall Study|Withdrawal by Subject|1|||
44114683|NCT02660034|78897496|FG012|Overall Study|Withdrawal by Subject|2|||
44114684|NCT02660034|78897497|FG013|Overall Study|Withdrawal by Subject|0|||
44114685|NCT02660034|78897484|FG000|Overall Study|Death|0|||
44114686|NCT02660034|78897485|FG001|Overall Study|Death|0|||
44114687|NCT02660034|78897486|FG002|Overall Study|Death|0|||
44114688|NCT02660034|78897487|FG003|Overall Study|Death|0|||
44114689|NCT02660034|78897488|FG004|Overall Study|Death|0|||
44114690|NCT02660034|78897489|FG005|Overall Study|Death|13|||
44114691|NCT02660034|78897490|FG006|Overall Study|Death|14|||
44114692|NCT02660034|78897491|FG007|Overall Study|Death|10|||
44114693|NCT02660034|78897492|FG008|Overall Study|Death|9|||
44114694|NCT02660034|78897493|FG009|Overall Study|Death|21|||
44114695|NCT02660034|78897494|FG010|Overall Study|Death|17|||
44114696|NCT02660034|78897495|FG011|Overall Study|Death|15|||
44114697|NCT02660034|78897496|FG012|Overall Study|Death|18|||
44114698|NCT02660034|78897497|FG013|Overall Study|Death|7|||
44114699|NCT02660034|78897484|FG000|Overall Study|Physician Decision|0|||
44114700|NCT02660034|78897485|FG001|Overall Study|Physician Decision|0|||
44114701|NCT02660034|78897486|FG002|Overall Study|Physician Decision|0|||
44114702|NCT02660034|78897487|FG003|Overall Study|Physician Decision|0|||
44114703|NCT02660034|78897488|FG004|Overall Study|Physician Decision|0|||
44238045|NCT01695239|79064364|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
44238046|NCT01695239|79064365|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
44505636|NCT03333928|79510358|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
44505637|NCT03333928|79510359|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
44505638|NCT03333928|79510360|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
44505639|NCT03333928|79510358|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
44505640|NCT03333928|79510359|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
44505641|NCT03333928|79510360|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
44505642|NCT03333928|79510358|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
44505643|NCT03333928|79510359|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
44573841|NCT04896385|79596469|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
44573842|NCT04896385|79596470|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
44573843|NCT04896385|79596467|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
44573844|NCT04896385|79596468|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
44573845|NCT04896385|79596469|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
44573846|NCT04896385|79596470|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
44573847|NCT04359823|79596491|FG000|Overall Study|Lost to Follow-up|0|||
44573848|NCT04359823|79596492|FG001|Overall Study|Lost to Follow-up|1|||
44573849|NCT04359823|79596491|FG000|Overall Study|Withdrawal by Subject|0|||
44573850|NCT04359823|79596492|FG001|Overall Study|Withdrawal by Subject|1|||
44573851|NCT04229446|79596511|FG000|Overall Study|Death|12|||
44573852|NCT04229446|79596512|FG001|Overall Study|Death|10|||
44573853|NCT04229446|79596511|FG000|Overall Study|Lost to Follow-up|5|||
44573854|NCT04229446|79596512|FG001|Overall Study|Lost to Follow-up|8|||
44573855|NCT03701763|79596547|FG000|Placebo-controlled Phase|Adverse Event|1|||
44505644|NCT03333928|79510360|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
44114704|NCT02660034|78897489|FG005|Overall Study|Physician Decision|0|||
44114705|NCT02660034|78897490|FG006|Overall Study|Physician Decision|0|||
44238047|NCT01695239|79064366|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
44238048|NCT01695239|79064367|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
44114706|NCT02660034|78897491|FG007|Overall Study|Physician Decision|0|||
44238049|NCT01695239|79064368|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
44114707|NCT02660034|78897492|FG008|Overall Study|Physician Decision|0|||
44114708|NCT02660034|78897493|FG009|Overall Study|Physician Decision|0|||
44114709|NCT02660034|78897494|FG010|Overall Study|Physician Decision|0|||
44114710|NCT02660034|78897495|FG011|Overall Study|Physician Decision|0|||
44114711|NCT02660034|78897496|FG012|Overall Study|Physician Decision|0|||
44114712|NCT02660034|78897497|FG013|Overall Study|Physician Decision|1|||
44114713|NCT02660034|78897484|FG000|Overall Study|Participants transferred to LTE|0|||
44114714|NCT02660034|78897485|FG001|Overall Study|Participants transferred to LTE|0|||
44114715|NCT02660034|78897486|FG002|Overall Study|Participants transferred to LTE|0|||
44114716|NCT02660034|78897487|FG003|Overall Study|Participants transferred to LTE|0|||
44114717|NCT02660034|78897488|FG004|Overall Study|Participants transferred to LTE|0|||
44114718|NCT02660034|78897489|FG005|Overall Study|Participants transferred to LTE|10|||
44114719|NCT02660034|78897490|FG006|Overall Study|Participants transferred to LTE|8|||
44114720|NCT02660034|78897491|FG007|Overall Study|Participants transferred to LTE|8|||
44114721|NCT02660034|78897492|FG008|Overall Study|Participants transferred to LTE|10|||
44114722|NCT02660034|78897493|FG009|Overall Study|Participants transferred to LTE|1|||
44114723|NCT02660034|78897494|FG010|Overall Study|Participants transferred to LTE|2|||
44114724|NCT02660034|78897495|FG011|Overall Study|Participants transferred to LTE|4|||
44114725|NCT02660034|78897496|FG012|Overall Study|Participants transferred to LTE|1|||
44114726|NCT02660034|78897497|FG013|Overall Study|Participants transferred to LTE|1|||
44114727|NCT02193867|78897540|FG000|Overall Study|Death|2|||
44114728|NCT02193867|78897540|FG000|Overall Study|Sponsor Study Termination|2|||
44114729|NCT02200770|78897568|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
44114730|NCT02200770|78897569|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
44114731|NCT02200770|78897568|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
44114732|NCT02200770|78897569|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
44114733|NCT02200770|78897568|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
44114734|NCT02200770|78897569|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
44114735|NCT02200770|78897568|FG000|Randomized-controlled Period (RCP)|Other|1|||
44573856|NCT03701763|79596548|FG001|Placebo-controlled Phase|Adverse Event|5|||
44573857|NCT03701763|79596549|FG002|Placebo-controlled Phase|Adverse Event|0|||
44573858|NCT03701763|79596550|FG003|Placebo-controlled Phase|Adverse Event|0|||
44573859|NCT03701763|79596547|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
44573860|NCT03701763|79596548|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
44573861|NCT03701763|79596549|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
44573862|NCT03701763|79596550|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
44573863|NCT03701763|79596547|FG000|Placebo-controlled Phase|Miscellaneous|2|||
44573864|NCT03701763|79596548|FG001|Placebo-controlled Phase|Miscellaneous|0|||
44573865|NCT03701763|79596549|FG002|Placebo-controlled Phase|Miscellaneous|0|||
44573866|NCT03701763|79596550|FG003|Placebo-controlled Phase|Miscellaneous|0|||
44573867|NCT03701763|79596547|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
44573868|NCT03701763|79596548|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
44573869|NCT03701763|79596549|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
44573870|NCT03701763|79596550|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
44573871|NCT03701763|79596547|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
44573872|NCT03701763|79596548|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
44573873|NCT03701763|79596549|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
44573874|NCT03701763|79596550|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
44573875|NCT03701763|79596547|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
44573876|NCT03701763|79596548|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
44573877|NCT03701763|79596549|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
44573878|NCT03701763|79596550|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
44573879|NCT03701763|79596547|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
44573880|NCT03701763|79596548|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
44573881|NCT03701763|79596549|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
44573882|NCT03701763|79596550|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
44573883|NCT03701763|79596547|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
44573884|NCT03701763|79596548|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
44573885|NCT03701763|79596549|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
44573886|NCT03701763|79596550|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
44573887|NCT03701763|79596547|FG000|Apremilast Extension Phase|Adverse Event|0|||
44573888|NCT03701763|79596548|FG001|Apremilast Extension Phase|Adverse Event|0|||
44573889|NCT03701763|79596549|FG002|Apremilast Extension Phase|Adverse Event|3|||
44573890|NCT03701763|79596550|FG003|Apremilast Extension Phase|Adverse Event|1|||
44573891|NCT03701763|79596547|FG000|Apremilast Extension Phase|Miscellaneous|0|||
44573892|NCT03701763|79596548|FG001|Apremilast Extension Phase|Miscellaneous|0|||
44573893|NCT03701763|79596549|FG002|Apremilast Extension Phase|Miscellaneous|2|||
44573894|NCT03701763|79596550|FG003|Apremilast Extension Phase|Miscellaneous|1|||
44573895|NCT03701763|79596547|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
44114736|NCT02200770|78897569|FG001|Randomized-controlled Period (RCP)|Other|2|||
44114737|NCT02200770|78897568|FG000|Open-label Period (OLP)|Adverse Event|1|||
44114738|NCT02200770|78897569|FG001|Open-label Period (OLP)|Adverse Event|2|||
44114739|NCT02200770|78897568|FG000|Open-label Period (OLP)|Death|1|||
44114740|NCT02200770|78897569|FG001|Open-label Period (OLP)|Death|2|||
44114741|NCT02200770|78897568|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
44114742|NCT02200770|78897569|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
44114743|NCT02200770|78897568|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
44114744|NCT02200770|78897569|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
44114745|NCT02200770|78897568|FG000|Open-label Period (OLP)|Other|6|||
44114746|NCT02200770|78897569|FG001|Open-label Period (OLP)|Other|15|||
44114747|NCT01186848|78897591|FG000|Overall Study|Lost to Follow-up|4|||
44114748|NCT01186848|78897591|FG000|Overall Study|Withdrawal by Subject|2|||
44114749|NCT01186848|78897591|FG000|Overall Study|Adverse Event|2|||
44114750|NCT01024608|78897599|FG000|Overall Study|Adverse Event|1|||
44114751|NCT01024608|78897600|FG001|Overall Study|Adverse Event|0|||
44114752|NCT01024608|78897599|FG000|Overall Study|Withdrawal by Subject|1|||
44114753|NCT01024608|78897600|FG001|Overall Study|Withdrawal by Subject|0|||
44114754|NCT01024608|78897599|FG000|Overall Study|Lost to Follow-up|0|||
44114755|NCT01024608|78897600|FG001|Overall Study|Lost to Follow-up|1|||
44114756|NCT01024608|78897599|FG000|Overall Study|Protocol Violation|0|||
44114757|NCT01024608|78897600|FG001|Overall Study|Protocol Violation|3|||
44114758|NCT01024608|78897599|FG000|Overall Study|Never received study treatment|2|||
44114759|NCT01024608|78897600|FG001|Overall Study|Never received study treatment|0|||
44114760|NCT00910650|78897606|FG000|Overall Study|Death|2|||
44114761|NCT03996876|78897641|FG000|Overall Study|Incomplete Data|2|||
44114762|NCT03996876|78897642|FG001|Overall Study|Incomplete Data|4|||
44114763|NCT01460160|78897649|FG000|Treatment Phase|Lack of Efficacy|3|||
44114764|NCT01460160|78897649|FG000|Treatment Phase|Study Drug Toxicity|2|||
44114765|NCT01460160|78897649|FG000|Treatment Phase|Adverse Event|8|||
44114766|NCT01460160|78897649|FG000|Treatment Phase|Withdrawal by Subject|4|||
44114767|NCT01460160|78897649|FG000|Treatment Phase|Death|2|||
44114768|NCT01460160|78897649|FG000|Treatment Phase|Other reasons|9|||
44114769|NCT01460160|78897649|FG000|Follow-up Phase|Withdrawal by Subject|4|||
44114770|NCT01460160|78897649|FG000|Follow-up Phase|Death|14|||
44114771|NCT01460160|78897649|FG000|Follow-up Phase|Lost to Follow-up|7|||
44114772|NCT01460160|78897649|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
44114773|NCT01460160|78897649|FG000|Follow-up Phase|Other and not reported reasons|5|||
44114774|NCT01170702|78897657|FG000|Overall Study|Exclusion criteria met after consent|1|||
44114775|NCT01170702|78897658|FG001|Overall Study|Exclusion criteria met after consent|2|||
44114776|NCT01170702|78897659|FG002|Overall Study|Exclusion criteria met after consent|0|||
44114777|NCT01170702|78897660|FG003|Overall Study|Exclusion criteria met after consent|2|||
44114778|NCT02723864|78897699|FG000|Overall Study|Refused further treatment|1|||
44114779|NCT02723864|78897700|FG001|Overall Study|Refused further treatment|0|||
44114780|NCT02723864|78897701|FG002|Overall Study|Refused further treatment|0|||
44114781|NCT02723864|78897702|FG003|Overall Study|Refused further treatment|0|||
44114782|NCT02723864|78897703|FG004|Overall Study|Refused further treatment|1|||
44114783|NCT02723864|78897704|FG005|Overall Study|Refused further treatment|2|||
44114784|NCT02723864|78897705|FG006|Overall Study|Refused further treatment|0|||
44238050|NCT01695239|79064369|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
44505645|NCT03333928|79510358|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
44505646|NCT03333928|79510359|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
44505647|NCT03333928|79510360|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
44505648|NCT03333928|79510358|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
44505649|NCT03333928|79510359|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
44505650|NCT03333928|79510360|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
44573896|NCT03701763|79596548|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
44573897|NCT03701763|79596549|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
44573898|NCT03701763|79596550|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
44573899|NCT03701763|79596547|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
44573900|NCT03701763|79596548|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
44573901|NCT03701763|79596549|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
44573902|NCT03701763|79596550|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
44114785|NCT02723864|78897699|FG000|Overall Study|Exceed treatment hold time|0|||
44505651|NCT03333928|79510358|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
44573903|NCT03701763|79596547|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
44114786|NCT02723864|78897700|FG001|Overall Study|Exceed treatment hold time|1|||
44114787|NCT02723864|78897701|FG002|Overall Study|Exceed treatment hold time|0|||
44238051|NCT01695239|79064356|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44573904|NCT03701763|79596548|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
44114788|NCT02723864|78897702|FG003|Overall Study|Exceed treatment hold time|0|||
44114789|NCT02723864|78897703|FG004|Overall Study|Exceed treatment hold time|0|||
44114790|NCT02723864|78897704|FG005|Overall Study|Exceed treatment hold time|0|||
44114791|NCT02723864|78897705|FG006|Overall Study|Exceed treatment hold time|0|||
44114792|NCT02723864|78897699|FG000|Overall Study|Clinical progression|0|||
44249747|NCT01504412|79083926|FG003|Overall Study|Lack of Efficacy|0|||
44114793|NCT02723864|78897700|FG001|Overall Study|Clinical progression|0|||
44114794|NCT02723864|78897701|FG002|Overall Study|Clinical progression|1|||
44114795|NCT02723864|78897702|FG003|Overall Study|Clinical progression|0|||
44114796|NCT02723864|78897703|FG004|Overall Study|Clinical progression|0|||
44573905|NCT03701763|79596549|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
44573906|NCT03701763|79596550|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
44573907|NCT03701763|79596547|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
44573908|NCT03701763|79596548|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
44573909|NCT03701763|79596549|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
44573910|NCT03701763|79596550|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
44573911|NCT03701763|79596547|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
44573912|NCT03701763|79596548|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
44573913|NCT03701763|79596549|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
44573914|NCT03701763|79596550|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
44573915|NCT03701763|79596547|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
44573916|NCT03701763|79596548|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
44573917|NCT03701763|79596549|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
44573918|NCT03701763|79596550|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
44573919|NCT03701763|79596547|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
44573920|NCT03701763|79596548|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
44573921|NCT03701763|79596549|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
44573922|NCT03701763|79596550|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
44573923|NCT03701763|79596547|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
44573924|NCT03701763|79596548|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
44573925|NCT03701763|79596549|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
44573926|NCT03701763|79596550|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
44573927|NCT03575897|79596589|FG000|Overall Study|Lost to Follow-up|12|||
44573928|NCT03575897|79596590|FG001|Overall Study|Lost to Follow-up|13|||
44573929|NCT03439748|79596598|FG000|Overall Study|Withdrawal by Subject|11|||
44573930|NCT03439748|79596599|FG001|Overall Study|Withdrawal by Subject|17|||
44573931|NCT03433001|79596605|FG000|Overall Study|Lack of Efficacy|109|||
44573932|NCT03433001|79596605|FG000|Overall Study|Adverse Event|69|||
44573933|NCT03433001|79596605|FG000|Overall Study|Withdrawal by Subject|10|||
44573934|NCT03433001|79596605|FG000|Overall Study|Death|12|||
44573935|NCT03433001|79596605|FG000|Overall Study|Lost to Follow-up|4|||
44573936|NCT03433001|79596605|FG000|Overall Study|Other|25|||
44573937|NCT03330847|79596612|FG000|Overall Study|Patients ongoing study|62|||
44573938|NCT03330847|79596613|FG001|Overall Study|Patients ongoing study|65|||
44114797|NCT02723864|78897704|FG005|Overall Study|Clinical progression|3|||
44114798|NCT02723864|78897705|FG006|Overall Study|Clinical progression|1|||
44114799|NCT02723864|78897699|FG000|Overall Study|Physician Decision|0|||
44114800|NCT02723864|78897700|FG001|Overall Study|Physician Decision|0|||
44114801|NCT02723864|78897701|FG002|Overall Study|Physician Decision|0|||
44114802|NCT02723864|78897702|FG003|Overall Study|Physician Decision|0|||
44114803|NCT02723864|78897703|FG004|Overall Study|Physician Decision|0|||
44114804|NCT02723864|78897704|FG005|Overall Study|Physician Decision|0|||
44114805|NCT02723864|78897705|FG006|Overall Study|Physician Decision|1|||
44114806|NCT02723864|78897699|FG000|Overall Study|Changes in patient condition|0|||
44114807|NCT02723864|78897700|FG001|Overall Study|Changes in patient condition|0|||
44114808|NCT02723864|78897701|FG002|Overall Study|Changes in patient condition|0|||
44114809|NCT02723864|78897702|FG003|Overall Study|Changes in patient condition|0|||
44114810|NCT02723864|78897703|FG004|Overall Study|Changes in patient condition|0|||
44114811|NCT02723864|78897704|FG005|Overall Study|Changes in patient condition|1|||
44114812|NCT02723864|78897705|FG006|Overall Study|Changes in patient condition|0|||
44505652|NCT03333928|79510359|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
44505653|NCT03333928|79510360|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
44505654|NCT03333928|79510358|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
44505655|NCT03333928|79510359|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
44505656|NCT03333928|79510360|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
44505657|NCT02945410|79510382|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
44505658|NCT02945410|79510383|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
44505659|NCT02945410|79510384|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
44573939|NCT03330847|79596614|FG002|Overall Study|Patients ongoing study|15|||
44573940|NCT03314935|79596639|FG000|Phase 1|Death|4|||
44573941|NCT03314935|79596640|FG001|Phase 1|Death|2|||
44505660|NCT02945410|79510385|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
44505661|NCT02945410|79510386|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
44505662|NCT02945410|79510387|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
44505663|NCT02945410|79510382|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
44573942|NCT03314935|79596641|FG002|Phase 1|Death|5|||
44573943|NCT03314935|79596642|FG003|Phase 1|Death|4|||
44573944|NCT03314935|79596643|FG004|Phase 1|Death|3|||
44573945|NCT03314935|79596644|FG005|Phase 1|Death|4|||
44114813|NCT02723864|78897699|FG000|Overall Study|Patient choice|0|||
44114814|NCT02723864|78897700|FG001|Overall Study|Patient choice|0|||
44114815|NCT02723864|78897701|FG002|Overall Study|Patient choice|0|||
44114816|NCT02723864|78897702|FG003|Overall Study|Patient choice|0|||
44114817|NCT02723864|78897703|FG004|Overall Study|Patient choice|0|||
44114818|NCT02723864|78897704|FG005|Overall Study|Patient choice|1|||
44114819|NCT02723864|78897705|FG006|Overall Study|Patient choice|0|||
44114820|NCT02723864|78897699|FG000|Overall Study|Adverse Event|0|||
44114821|NCT02723864|78897700|FG001|Overall Study|Adverse Event|0|||
44238052|NCT01695239|79064357|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44505664|NCT02945410|79510383|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
44505665|NCT02945410|79510384|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
44505666|NCT02945410|79510385|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
44505667|NCT02945410|79510386|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
44505668|NCT02945410|79510387|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
44505669|NCT02945410|79510382|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
44573946|NCT03314935|79596645|FG006|Phase 1|Death|5|||
44573947|NCT03314935|79596646|FG007|Phase 1|Death|4|||
44573948|NCT03314935|79596647|FG008|Phase 1|Death|3|||
44573949|NCT03314935|79596648|FG009|Phase 1|Death|0|||
44573950|NCT03314935|79596649|FG010|Phase 1|Death|0|||
44573951|NCT03314935|79596650|FG011|Phase 1|Death|0|||
44573952|NCT03314935|79596651|FG012|Phase 1|Death|0|||
44573953|NCT03314935|79596652|FG013|Phase 1|Death|0|||
44573954|NCT03314935|79596653|FG014|Phase 1|Death|0|||
44573955|NCT03314935|79596639|FG000|Phase 1|Withdrawal by Subject|2|||
44573956|NCT03314935|79596640|FG001|Phase 1|Withdrawal by Subject|1|||
44573957|NCT03314935|79596641|FG002|Phase 1|Withdrawal by Subject|1|||
44573958|NCT03314935|79596642|FG003|Phase 1|Withdrawal by Subject|2|||
44573959|NCT03314935|79596643|FG004|Phase 1|Withdrawal by Subject|1|||
44573960|NCT03314935|79596644|FG005|Phase 1|Withdrawal by Subject|0|||
44573961|NCT03314935|79596645|FG006|Phase 1|Withdrawal by Subject|1|||
44573962|NCT03314935|79596646|FG007|Phase 1|Withdrawal by Subject|0|||
44573963|NCT03314935|79596647|FG008|Phase 1|Withdrawal by Subject|1|||
44573964|NCT03314935|79596648|FG009|Phase 1|Withdrawal by Subject|0|||
44573965|NCT03314935|79596649|FG010|Phase 1|Withdrawal by Subject|0|||
44573966|NCT03314935|79596650|FG011|Phase 1|Withdrawal by Subject|0|||
44573967|NCT03314935|79596651|FG012|Phase 1|Withdrawal by Subject|0|||
44573968|NCT03314935|79596652|FG013|Phase 1|Withdrawal by Subject|0|||
44573969|NCT03314935|79596653|FG014|Phase 1|Withdrawal by Subject|0|||
44573970|NCT03314935|79596639|FG000|Phase 1|Progressive Disease|2|||
44573971|NCT03314935|79596640|FG001|Phase 1|Progressive Disease|0|||
44573972|NCT03314935|79596641|FG002|Phase 1|Progressive Disease|0|||
44573973|NCT03314935|79596642|FG003|Phase 1|Progressive Disease|1|||
44573974|NCT03314935|79596643|FG004|Phase 1|Progressive Disease|0|||
44573975|NCT03314935|79596644|FG005|Phase 1|Progressive Disease|0|||
44573976|NCT03314935|79596645|FG006|Phase 1|Progressive Disease|0|||
44573977|NCT03314935|79596646|FG007|Phase 1|Progressive Disease|0|||
44573978|NCT03314935|79596647|FG008|Phase 1|Progressive Disease|0|||
44573979|NCT03314935|79596648|FG009|Phase 1|Progressive Disease|0|||
44573980|NCT03314935|79596649|FG010|Phase 1|Progressive Disease|0|||
44573981|NCT03314935|79596650|FG011|Phase 1|Progressive Disease|0|||
44573982|NCT03314935|79596651|FG012|Phase 1|Progressive Disease|0|||
44573983|NCT03314935|79596652|FG013|Phase 1|Progressive Disease|0|||
44573984|NCT03314935|79596653|FG014|Phase 1|Progressive Disease|0|||
44573985|NCT03314935|79596639|FG000|Phase 1|Study Terminated by Sponsor|0|||
44573986|NCT03314935|79596640|FG001|Phase 1|Study Terminated by Sponsor|1|||
44573987|NCT03314935|79596641|FG002|Phase 1|Study Terminated by Sponsor|0|||
44573988|NCT03314935|79596642|FG003|Phase 1|Study Terminated by Sponsor|0|||
44573989|NCT03314935|79596643|FG004|Phase 1|Study Terminated by Sponsor|0|||
44573990|NCT03314935|79596644|FG005|Phase 1|Study Terminated by Sponsor|0|||
44573991|NCT03314935|79596645|FG006|Phase 1|Study Terminated by Sponsor|0|||
44573992|NCT03314935|79596646|FG007|Phase 1|Study Terminated by Sponsor|0|||
44114822|NCT02723864|78897701|FG002|Overall Study|Adverse Event|0|||
44238053|NCT01695239|79064358|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44505670|NCT02945410|79510383|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
44505671|NCT02945410|79510384|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
44505672|NCT02945410|79510385|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
44573993|NCT03314935|79596647|FG008|Phase 1|Study Terminated by Sponsor|1|||
44573994|NCT03314935|79596648|FG009|Phase 1|Study Terminated by Sponsor|0|||
44573995|NCT03314935|79596649|FG010|Phase 1|Study Terminated by Sponsor|0|||
44249748|NCT01504412|79083927|FG004|Overall Study|Lack of Efficacy|1|||
44573996|NCT03314935|79596650|FG011|Phase 1|Study Terminated by Sponsor|0|||
44573997|NCT03314935|79596651|FG012|Phase 1|Study Terminated by Sponsor|0|||
44114823|NCT02723864|78897702|FG003|Overall Study|Adverse Event|0|||
44114824|NCT02723864|78897703|FG004|Overall Study|Adverse Event|0|||
44573998|NCT03314935|79596652|FG013|Phase 1|Study Terminated by Sponsor|0|||
44573999|NCT03314935|79596653|FG014|Phase 1|Study Terminated by Sponsor|0|||
44574000|NCT03314935|79596639|FG000|Phase 1|"Captured as Other in Database"|0|||
44574001|NCT03314935|79596640|FG001|Phase 1|"Captured as Other in Database"|2|||
44574002|NCT03314935|79596641|FG002|Phase 1|"Captured as Other in Database"|0|||
44574003|NCT03314935|79596642|FG003|Phase 1|"Captured as Other in Database"|0|||
44574004|NCT03314935|79596643|FG004|Phase 1|"Captured as Other in Database"|0|||
44114825|NCT02723864|78897704|FG005|Overall Study|Adverse Event|1|||
44114826|NCT02723864|78897705|FG006|Overall Study|Adverse Event|0|||
44114827|NCT02723864|78897699|FG000|Overall Study|Started new treatment|0|||
44114828|NCT02723864|78897700|FG001|Overall Study|Started new treatment|0|||
44114829|NCT02723864|78897701|FG002|Overall Study|Started new treatment|0|||
44114830|NCT02723864|78897702|FG003|Overall Study|Started new treatment|0|||
44114831|NCT02723864|78897703|FG004|Overall Study|Started new treatment|0|||
44114832|NCT02723864|78897704|FG005|Overall Study|Started new treatment|1|||
44114833|NCT02723864|78897705|FG006|Overall Study|Started new treatment|0|||
44114834|NCT02723864|78897699|FG000|Overall Study|Switched to alternative treatment|0|||
44114835|NCT02723864|78897700|FG001|Overall Study|Switched to alternative treatment|0|||
44114836|NCT02723864|78897701|FG002|Overall Study|Switched to alternative treatment|0|||
44114837|NCT02723864|78897702|FG003|Overall Study|Switched to alternative treatment|0|||
44114838|NCT02723864|78897703|FG004|Overall Study|Switched to alternative treatment|0|||
44114839|NCT02723864|78897704|FG005|Overall Study|Switched to alternative treatment|1|||
44114840|NCT02723864|78897705|FG006|Overall Study|Switched to alternative treatment|0|||
44114841|NCT02723864|78897699|FG000|Overall Study|Late determination of ineligibility|0|||
44114842|NCT02723864|78897700|FG001|Overall Study|Late determination of ineligibility|0|||
44114843|NCT02723864|78897701|FG002|Overall Study|Late determination of ineligibility|0|||
44114844|NCT02723864|78897702|FG003|Overall Study|Late determination of ineligibility|0|||
44114845|NCT02723864|78897703|FG004|Overall Study|Late determination of ineligibility|0|||
44114846|NCT02723864|78897704|FG005|Overall Study|Late determination of ineligibility|1|||
44114847|NCT02723864|78897705|FG006|Overall Study|Late determination of ineligibility|0|||
44114848|NCT00705146|78897744|FG000|Overall Study|Lost to Follow-up|1|||
44114849|NCT00705146|78897745|FG001|Overall Study|Lost to Follow-up|1|||
44114850|NCT03203642|78897753|FG000|Overall Study|Adverse Event|3|||
44114851|NCT03203642|78897754|FG001|Overall Study|Adverse Event|1|||
44114852|NCT03203642|78897753|FG000|Overall Study|Withdrawal by Subject|6|||
44114853|NCT03203642|78897754|FG001|Overall Study|Withdrawal by Subject|6|||
44114854|NCT03203642|78897753|FG000|Overall Study|Lost to Follow-up|2|||
44114855|NCT03203642|78897754|FG001|Overall Study|Lost to Follow-up|1|||
44114856|NCT03203642|78897753|FG000|Overall Study|Termination of the study by sponsor|1|||
44114857|NCT03203642|78897754|FG001|Overall Study|Termination of the study by sponsor|1|||
44114858|NCT03203642|78897753|FG000|Overall Study|Participant moved|0|||
44114859|NCT03203642|78897754|FG001|Overall Study|Participant moved|1|||
44114860|NCT03203642|78897753|FG000|Overall Study|Investigator's decision|3|||
44114861|NCT03203642|78897754|FG001|Overall Study|Investigator's decision|0|||
44114862|NCT03203642|78897753|FG000|Overall Study|Other than above specified|0|||
44114863|NCT03203642|78897754|FG001|Overall Study|Other than above specified|1|||
44114864|NCT02737722|78897764|FG000|Overall Study|Physician Decision|0|||
44114865|NCT02737722|78897765|FG001|Overall Study|Physician Decision|0|||
44114866|NCT02737722|78897766|FG002|Overall Study|Physician Decision|1|||
44114867|NCT02737722|78897767|FG003|Overall Study|Physician Decision|0|||
44114868|NCT03792750|78897777|FG000|Overall Study|Death|3|||
44114869|NCT02750709|78897782|FG000|Treatment Period 1|Adverse Event|0|||
44114870|NCT02750709|78897783|FG001|Treatment Period 1|Adverse Event|0|||
44114871|NCT02750709|78897784|FG002|Treatment Period 1|Adverse Event|0|||
44114872|NCT02750709|78897785|FG003|Treatment Period 1|Adverse Event|0|||
44114873|NCT02750709|78897786|FG004|Treatment Period 1|Adverse Event|0|||
44114874|NCT02750709|78897787|FG005|Treatment Period 1|Adverse Event|1|||
44114875|NCT02723786|78897795|FG000|Overall Study|Lost to Follow-up|1|||
44114876|NCT02723084|78897814|FG000|Overall Study|Withdrawal by Subject|1|||
44114877|NCT02723084|78897815|FG001|Overall Study|Withdrawal by Subject|1|||
44114878|NCT02723084|78897814|FG000|Overall Study|Lost to Follow-up|3|||
44114879|NCT02723084|78897815|FG001|Overall Study|Lost to Follow-up|0|||
44114880|NCT02750943|78897823|FG000|Overall Study|Lost to Follow-up|1|||
44238054|NCT01695239|79064359|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238055|NCT01695239|79064360|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238056|NCT01695239|79064361|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238057|NCT01695239|79064362|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238058|NCT01695239|79064363|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238059|NCT01695239|79064364|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238060|NCT01695239|79064365|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238061|NCT01695239|79064366|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44238062|NCT01695239|79064367|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44249749|NCT01504412|79083923|FG000|Overall Study|Death|0|||
44114881|NCT02750943|78897824|FG001|Overall Study|Lost to Follow-up|2|||
44114882|NCT02750943|78897823|FG000|Overall Study|Withdrawal by Subject|5|||
44114883|NCT02750943|78897824|FG001|Overall Study|Withdrawal by Subject|7|||
44114884|NCT05177094|78897849|FG000|Overall Study|Adverse Event|5|||
44114885|NCT05177094|78897850|FG001|Overall Study|Adverse Event|5|||
44114886|NCT05177094|78897849|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
44114887|NCT05177094|78897850|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
44114888|NCT05177094|78897849|FG000|Overall Study|Protocol Deviation|3|||
44114889|NCT05177094|78897850|FG001|Overall Study|Protocol Deviation|0|||
44238063|NCT01695239|79064368|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
44574005|NCT03314935|79596644|FG005|Phase 1|"Captured as Other in Database"|0|||
44574006|NCT03314935|79596645|FG006|Phase 1|"Captured as Other in Database"|1|||
44574007|NCT03314935|79596646|FG007|Phase 1|"Captured as Other in Database"|1|||
44574008|NCT03314935|79596647|FG008|Phase 1|"Captured as Other in Database"|1|||
44574009|NCT03314935|79596648|FG009|Phase 1|"Captured as Other in Database"|0|||
44574010|NCT03314935|79596649|FG010|Phase 1|"Captured as Other in Database"|0|||
44574011|NCT03314935|79596650|FG011|Phase 1|"Captured as Other in Database"|0|||
44574012|NCT03314935|79596651|FG012|Phase 1|"Captured as Other in Database"|0|||
44574013|NCT03314935|79596652|FG013|Phase 1|"Captured as Other in Database"|0|||
44574014|NCT03314935|79596653|FG014|Phase 1|"Captured as Other in Database"|0|||
44574015|NCT03314935|79596639|FG000|Phase 1|Lost to Follow-up|0|||
44574016|NCT03314935|79596640|FG001|Phase 1|Lost to Follow-up|0|||
44574017|NCT03314935|79596641|FG002|Phase 1|Lost to Follow-up|0|||
44574018|NCT03314935|79596642|FG003|Phase 1|Lost to Follow-up|0|||
44574019|NCT03314935|79596643|FG004|Phase 1|Lost to Follow-up|0|||
44574020|NCT03314935|79596644|FG005|Phase 1|Lost to Follow-up|0|||
44574021|NCT03314935|79596645|FG006|Phase 1|Lost to Follow-up|0|||
44238064|NCT01695239|79064369|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
44238065|NCT01694849|79064419|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
44377935|NCT00785785|79383205|FG000|Optional Extension Phase|Protocol deviation|0|||
44114890|NCT05177094|78897849|FG000|Overall Study|Withdrawal by Subject|6|||
44114891|NCT05177094|78897850|FG001|Overall Study|Withdrawal by Subject|3|||
44114892|NCT05177094|78897849|FG000|Overall Study|Participant could not tolerate long study visits|1|||
44114893|NCT05177094|78897850|FG001|Overall Study|Participant could not tolerate long study visits|0|||
44114894|NCT05104749|78897860|FG000|Overall Study|Lost to Follow-up|2|||
44114895|NCT05104749|78897861|FG001|Overall Study|Lost to Follow-up|3|||
44114896|NCT05098041|78897867|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
44114897|NCT04648241|78897888|FG000|Overall Study|Lost to Follow-up|1|||
44114898|NCT04648241|78897889|FG001|Overall Study|Lost to Follow-up|0|||
44114899|NCT04124952|78897924|FG000|Overall Study|Lost to Follow-up|1|||
44114900|NCT03677596|78897965|FG000|Overall Study|Adverse Event|0|||
44114901|NCT03677596|78897966|FG001|Overall Study|Adverse Event|1|||
44114902|NCT03677596|78897965|FG000|Overall Study|Death|10|||
44114903|NCT03677596|78897966|FG001|Overall Study|Death|6|||
44114904|NCT03677596|78897965|FG000|Overall Study|Lost to Follow-up|0|||
44114905|NCT03677596|78897966|FG001|Overall Study|Lost to Follow-up|1|||
44114906|NCT03677596|78897965|FG000|Overall Study|Progressive Disease|8|||
44377936|NCT00785785|79383206|FG001|Optional Extension Phase|Protocol deviation|2|||
44377937|NCT00785785|79383205|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
44377938|NCT00785785|79383206|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
44377939|NCT01077284|79383217|FG000|Overall Study|Adverse Event|2|||
44114907|NCT03677596|78897966|FG001|Overall Study|Progressive Disease|8|||
44114908|NCT03677596|78897965|FG000|Overall Study|Withdrawal by Subject|3|||
44114909|NCT03677596|78897966|FG001|Overall Study|Withdrawal by Subject|0|||
44114910|NCT03677596|78897965|FG000|Overall Study|Disease Relapse|2|||
44114911|NCT03677596|78897966|FG001|Overall Study|Disease Relapse|2|||
44114912|NCT03677596|78897965|FG000|Overall Study|Other|0|||
44114913|NCT03677596|78897966|FG001|Overall Study|Other|1|||
44114914|NCT03422627|78897986|FG000|Overall Study|Protocol-specified Criteria|1|||
44114915|NCT03422627|78897987|FG001|Overall Study|Protocol-specified Criteria|1|||
44377940|NCT01077284|79383218|FG001|Overall Study|Adverse Event|0|||
44505673|NCT02945410|79510386|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
44505674|NCT02945410|79510387|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
44505675|NCT02945254|79510397|FG000|Overall Study|Lost to Follow-up|1|||
44505676|NCT02945254|79510398|FG001|Overall Study|Lost to Follow-up|0|||
44505677|NCT02945254|79510397|FG000|Overall Study|Withdrawal by Subject|1|||
44505678|NCT02945254|79510398|FG001|Overall Study|Withdrawal by Subject|0|||
44505679|NCT02943070|79510416|FG000|Overall Study|Physician Decision|1|||
44505680|NCT02943070|79510416|FG000|Overall Study|Adverse Event|2|||
44505681|NCT02943070|79510416|FG000|Overall Study|Death|2|||
44574022|NCT03314935|79596646|FG007|Phase 1|Lost to Follow-up|0|||
44574023|NCT03314935|79596647|FG008|Phase 1|Lost to Follow-up|1|||
44114916|NCT03422627|78897988|FG002|Overall Study|Protocol-specified Criteria|0|||
44114917|NCT03422627|78897989|FG003|Overall Study|Protocol-specified Criteria|0|||
44574024|NCT03314935|79596648|FG009|Phase 1|Lost to Follow-up|0|||
44574025|NCT03314935|79596649|FG010|Phase 1|Lost to Follow-up|0|||
44574026|NCT03314935|79596650|FG011|Phase 1|Lost to Follow-up|0|||
44114918|NCT03422627|78897990|FG004|Overall Study|Protocol-specified Criteria|2|||
44114919|NCT03422627|78897986|FG000|Overall Study|Requirement for Alternative Therapy|1|||
44114920|NCT03422627|78897987|FG001|Overall Study|Requirement for Alternative Therapy|1|||
44114921|NCT03422627|78897988|FG002|Overall Study|Requirement for Alternative Therapy|2|||
44114922|NCT03422627|78897989|FG003|Overall Study|Requirement for Alternative Therapy|0|||
44249750|NCT01504412|79083924|FG001|Overall Study|Death|0|||
44505682|NCT02943070|79510416|FG000|Overall Study|Withdrawal by Subject|3|||
44505683|NCT02943070|79510416|FG000|Overall Study|Lost to Follow-up|4|||
44574027|NCT03314935|79596651|FG012|Phase 1|Lost to Follow-up|0|||
44574028|NCT03314935|79596652|FG013|Phase 1|Lost to Follow-up|0|||
44574029|NCT03314935|79596653|FG014|Phase 1|Lost to Follow-up|0|||
44574030|NCT03314935|79596639|FG000|Phase 2|Death|0|||
44574031|NCT03314935|79596640|FG001|Phase 2|Death|0|||
44574032|NCT03314935|79596641|FG002|Phase 2|Death|0|||
44574033|NCT03314935|79596642|FG003|Phase 2|Death|0|||
44574034|NCT03314935|79596643|FG004|Phase 2|Death|0|||
44574035|NCT03314935|79596644|FG005|Phase 2|Death|0|||
44574036|NCT03314935|79596645|FG006|Phase 2|Death|0|||
44574037|NCT03314935|79596646|FG007|Phase 2|Death|0|||
44574038|NCT03314935|79596647|FG008|Phase 2|Death|0|||
44574039|NCT03314935|79596648|FG009|Phase 2|Death|5|||
44574040|NCT03314935|79596649|FG010|Phase 2|Death|20|||
44574041|NCT03314935|79596650|FG011|Phase 2|Death|6|||
44574042|NCT03314935|79596651|FG012|Phase 2|Death|7|||
44574043|NCT03314935|79596652|FG013|Phase 2|Death|6|||
44574044|NCT03314935|79596653|FG014|Phase 2|Death|17|||
44574045|NCT03314935|79596639|FG000|Phase 2|Withdrawal by Subject|0|||
44574046|NCT03314935|79596640|FG001|Phase 2|Withdrawal by Subject|0|||
44574047|NCT03314935|79596641|FG002|Phase 2|Withdrawal by Subject|0|||
44574048|NCT03314935|79596642|FG003|Phase 2|Withdrawal by Subject|0|||
44574049|NCT03314935|79596643|FG004|Phase 2|Withdrawal by Subject|0|||
44574050|NCT03314935|79596644|FG005|Phase 2|Withdrawal by Subject|0|||
44574051|NCT03314935|79596645|FG006|Phase 2|Withdrawal by Subject|0|||
44238066|NCT01694849|79064420|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
44238067|NCT01694849|79064421|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
44238068|NCT01694849|79064419|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
44238069|NCT01694849|79064420|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
44238070|NCT01694849|79064421|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
44377941|NCT01077284|79383219|FG002|Overall Study|Adverse Event|1|||
44377942|NCT01077284|79383217|FG000|Overall Study|Lost to Follow-up|1|||
44505684|NCT02943070|79510416|FG000|Overall Study|Retreatment or TURP|13|||
44574052|NCT03314935|79596646|FG007|Phase 2|Withdrawal by Subject|0|||
44574053|NCT03314935|79596647|FG008|Phase 2|Withdrawal by Subject|0|||
44574054|NCT03314935|79596648|FG009|Phase 2|Withdrawal by Subject|1|||
44574055|NCT03314935|79596649|FG010|Phase 2|Withdrawal by Subject|4|||
44574056|NCT03314935|79596650|FG011|Phase 2|Withdrawal by Subject|0|||
44574057|NCT03314935|79596651|FG012|Phase 2|Withdrawal by Subject|1|||
44574058|NCT03314935|79596652|FG013|Phase 2|Withdrawal by Subject|0|||
44574059|NCT03314935|79596653|FG014|Phase 2|Withdrawal by Subject|1|||
44377943|NCT01077284|79383218|FG001|Overall Study|Lost to Follow-up|2|||
44377944|NCT01077284|79383219|FG002|Overall Study|Lost to Follow-up|0|||
44505685|NCT02943070|79510416|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
44505686|NCT03332212|79510440|FG000|Overall Study|Not treated|0|||
44505687|NCT03332212|79510441|FG001|Overall Study|Not treated|1|||
44505688|NCT03332212|79510442|FG002|Overall Study|Not treated|0|||
44505689|NCT03332212|79510443|FG003|Overall Study|Not treated|0|||
44505690|NCT03332212|79510440|FG000|Overall Study|Adverse Event|0|||
44505691|NCT03332212|79510441|FG001|Overall Study|Adverse Event|0|||
44505692|NCT03332212|79510442|FG002|Overall Study|Adverse Event|0|||
44505693|NCT03332212|79510443|FG003|Overall Study|Adverse Event|1|||
44505694|NCT03332212|79510440|FG000|Overall Study|worsening of disease under study|1|||
44505695|NCT03332212|79510441|FG001|Overall Study|worsening of disease under study|1|||
44505696|NCT03332212|79510442|FG002|Overall Study|worsening of disease under study|0|||
44505697|NCT03332212|79510443|FG003|Overall Study|worsening of disease under study|0|||
44505698|NCT03331666|79510453|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
44505699|NCT03331666|79510454|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
44377945|NCT01077284|79383217|FG000|Overall Study|Withdrawal by Subject|2|||
44377946|NCT01077284|79383218|FG001|Overall Study|Withdrawal by Subject|3|||
44377947|NCT01077284|79383219|FG002|Overall Study|Withdrawal by Subject|1|||
44505700|NCT03331042|79510464|FG000|Overall Study|Protocol Violation|1|||
44505701|NCT03331042|79510465|FG001|Overall Study|Protocol Violation|0|||
44505702|NCT03331042|79510466|FG002|Overall Study|Protocol Violation|0|||
44505703|NCT03331042|79510467|FG003|Overall Study|Protocol Violation|0|||
44505704|NCT03331042|79510464|FG000|Overall Study|Physician Decision|0|||
44505705|NCT03331042|79510465|FG001|Overall Study|Physician Decision|0|||
44505706|NCT03331042|79510466|FG002|Overall Study|Physician Decision|1|||
44505707|NCT03331042|79510467|FG003|Overall Study|Physician Decision|0|||
44505708|NCT03331042|79510464|FG000|Overall Study|Lost to Follow-up|0|||
44574060|NCT03314935|79596639|FG000|Phase 2|Progressive Disease|0|||
44574061|NCT03314935|79596640|FG001|Phase 2|Progressive Disease|0|||
44574062|NCT03314935|79596641|FG002|Phase 2|Progressive Disease|0|||
44574063|NCT03314935|79596642|FG003|Phase 2|Progressive Disease|0|||
44574064|NCT03314935|79596643|FG004|Phase 2|Progressive Disease|0|||
44574065|NCT03314935|79596644|FG005|Phase 2|Progressive Disease|0|||
44574066|NCT03314935|79596645|FG006|Phase 2|Progressive Disease|0|||
44574067|NCT03314935|79596646|FG007|Phase 2|Progressive Disease|0|||
44574068|NCT03314935|79596647|FG008|Phase 2|Progressive Disease|0|||
44574069|NCT03314935|79596648|FG009|Phase 2|Progressive Disease|1|||
44574070|NCT03314935|79596649|FG010|Phase 2|Progressive Disease|1|||
44574071|NCT03314935|79596650|FG011|Phase 2|Progressive Disease|1|||
44574072|NCT03314935|79596651|FG012|Phase 2|Progressive Disease|2|||
44574073|NCT03314935|79596652|FG013|Phase 2|Progressive Disease|0|||
44574074|NCT03314935|79596653|FG014|Phase 2|Progressive Disease|1|||
44574075|NCT03314935|79596639|FG000|Phase 2|Study Terminated by Sponsor|0|||
44574076|NCT03314935|79596640|FG001|Phase 2|Study Terminated by Sponsor|0|||
44574077|NCT03314935|79596641|FG002|Phase 2|Study Terminated by Sponsor|0|||
44574078|NCT03314935|79596642|FG003|Phase 2|Study Terminated by Sponsor|0|||
44574079|NCT03314935|79596643|FG004|Phase 2|Study Terminated by Sponsor|0|||
44574080|NCT03314935|79596644|FG005|Phase 2|Study Terminated by Sponsor|0|||
44574081|NCT03314935|79596645|FG006|Phase 2|Study Terminated by Sponsor|0|||
44574082|NCT03314935|79596646|FG007|Phase 2|Study Terminated by Sponsor|0|||
44574083|NCT03314935|79596647|FG008|Phase 2|Study Terminated by Sponsor|0|||
44574084|NCT03314935|79596648|FG009|Phase 2|Study Terminated by Sponsor|0|||
44574085|NCT03314935|79596649|FG010|Phase 2|Study Terminated by Sponsor|7|||
44574086|NCT03314935|79596650|FG011|Phase 2|Study Terminated by Sponsor|2|||
44574087|NCT03314935|79596651|FG012|Phase 2|Study Terminated by Sponsor|1|||
44114923|NCT03422627|78897990|FG004|Overall Study|Requirement for Alternative Therapy|0|||
44114924|NCT03422627|78897986|FG000|Overall Study|Disease Progression|1|||
44114925|NCT03422627|78897987|FG001|Overall Study|Disease Progression|0|||
44114926|NCT03422627|78897988|FG002|Overall Study|Disease Progression|1|||
44114927|NCT03422627|78897989|FG003|Overall Study|Disease Progression|2|||
44114928|NCT03422627|78897990|FG004|Overall Study|Disease Progression|0|||
44114929|NCT03422627|78897986|FG000|Overall Study|Adverse Event|2|||
44114930|NCT03422627|78897987|FG001|Overall Study|Adverse Event|1|||
44114931|NCT03422627|78897988|FG002|Overall Study|Adverse Event|0|||
44114932|NCT03422627|78897989|FG003|Overall Study|Adverse Event|0|||
44114933|NCT03422627|78897990|FG004|Overall Study|Adverse Event|2|||
44114934|NCT03422627|78897986|FG000|Overall Study|Ineligibility Determined|0|||
44114935|NCT03422627|78897987|FG001|Overall Study|Ineligibility Determined|1|||
44114936|NCT03422627|78897988|FG002|Overall Study|Ineligibility Determined|0|||
44114937|NCT03422627|78897989|FG003|Overall Study|Ineligibility Determined|0|||
44114938|NCT03422627|78897990|FG004|Overall Study|Ineligibility Determined|0|||
44114939|NCT03422627|78897986|FG000|Overall Study|Death|0|||
44114940|NCT03422627|78897987|FG001|Overall Study|Death|1|||
44114941|NCT03422627|78897988|FG002|Overall Study|Death|1|||
44114942|NCT03422627|78897989|FG003|Overall Study|Death|0|||
44114943|NCT03422627|78897990|FG004|Overall Study|Death|0|||
44114944|NCT03422627|78897986|FG000|Overall Study|Withdrawal by Subject|0|||
44114945|NCT03422627|78897987|FG001|Overall Study|Withdrawal by Subject|0|||
44114946|NCT03422627|78897988|FG002|Overall Study|Withdrawal by Subject|0|||
44114947|NCT03422627|78897989|FG003|Overall Study|Withdrawal by Subject|1|||
44114948|NCT03422627|78897990|FG004|Overall Study|Withdrawal by Subject|0|||
44114949|NCT03403621|78898002|FG000|Overall Study|Withdrawal by Subject|2|||
44114950|NCT03403621|78898003|FG001|Overall Study|Withdrawal by Subject|2|||
44114951|NCT03225105|78898013|FG000|Overall Study|Withdrawal by Subject|1|||
44114952|NCT03225105|78898014|FG001|Overall Study|Withdrawal by Subject|0|||
44114953|NCT03225105|78898015|FG002|Overall Study|Withdrawal by Subject|0|||
44114954|NCT03225105|78898016|FG003|Overall Study|Withdrawal by Subject|0|||
44114955|NCT03225105|78898013|FG000|Overall Study|Death|0|||
44114956|NCT03225105|78898014|FG001|Overall Study|Death|4|||
44114957|NCT03225105|78898015|FG002|Overall Study|Death|2|||
44114958|NCT03225105|78898016|FG003|Overall Study|Death|0|||
44114959|NCT03225105|78898013|FG000|Overall Study|Study termination per Sponsor Decision|2|||
44114960|NCT03225105|78898014|FG001|Overall Study|Study termination per Sponsor Decision|0|||
44114961|NCT03225105|78898015|FG002|Overall Study|Study termination per Sponsor Decision|3|||
44505709|NCT03331042|79510465|FG001|Overall Study|Lost to Follow-up|0|||
44505710|NCT03331042|79510466|FG002|Overall Study|Lost to Follow-up|0|||
44505711|NCT03331042|79510467|FG003|Overall Study|Lost to Follow-up|1|||
44505712|NCT03762668|79510485|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
44505713|NCT03762668|79510486|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
44505714|NCT03762200|79510492|FG000|Overall Study|Death|2|||
44505715|NCT03711370|79510498|FG000|Overall Study|Lost to Follow-up|16|||
44505716|NCT03711370|79510499|FG001|Overall Study|Lost to Follow-up|10|||
44505717|NCT03711370|79510498|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
44574088|NCT03314935|79596652|FG013|Phase 2|Study Terminated by Sponsor|4|||
44574089|NCT03314935|79596653|FG014|Phase 2|Study Terminated by Sponsor|4|||
44574090|NCT03314935|79596639|FG000|Phase 2|Lost to Follow-up|0|||
44574091|NCT03314935|79596640|FG001|Phase 2|Lost to Follow-up|0|||
44574092|NCT03314935|79596641|FG002|Phase 2|Lost to Follow-up|0|||
44114962|NCT03225105|78898016|FG003|Overall Study|Study termination per Sponsor Decision|3|||
44114963|NCT02900976|78898047|FG000|Overall Study|Adverse Event|0|||
44114964|NCT02900976|78898048|FG001|Overall Study|Adverse Event|1|||
44114965|NCT02900976|78898047|FG000|Overall Study|Physician Decision|0|||
44114966|NCT02900976|78898048|FG001|Overall Study|Physician Decision|2|||
44114967|NCT02900976|78898047|FG000|Overall Study|Progressive disease|0|||
44114968|NCT02900976|78898048|FG001|Overall Study|Progressive disease|6|||
44114969|NCT02654015|78898055|FG000|Overall Study|Death|12|||
44574093|NCT03314935|79596642|FG003|Phase 2|Lost to Follow-up|0|||
44238071|NCT01694849|79064419|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
44238072|NCT01694849|79064420|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
44238073|NCT01694849|79064421|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
44238074|NCT01694849|79064419|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
44238075|NCT01694849|79064420|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
44238076|NCT01694849|79064421|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
44238077|NCT01694849|79064419|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
44238078|NCT01694849|79064420|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
44238079|NCT01694849|79064421|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
44238080|NCT01694849|79064419|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
44238081|NCT01694849|79064420|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
44238082|NCT01694849|79064421|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
44238083|NCT01694849|79064419|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
44238084|NCT01694849|79064420|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
44238085|NCT01694849|79064421|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
44238086|NCT01694849|79064419|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
44238087|NCT01694849|79064420|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
44238088|NCT01694849|79064421|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
44238089|NCT01694771|79064470|FG000|Overall Study|Adverse Event|18|||
44238090|NCT01694771|79064471|FG001|Overall Study|Adverse Event|16|||
44238091|NCT01694771|79064470|FG000|Overall Study|Lack of Efficacy|1|||
44238092|NCT01694771|79064471|FG001|Overall Study|Lack of Efficacy|0|||
44238093|NCT01694771|79064470|FG000|Overall Study|Non compliance protocol|7|||
44238094|NCT01694771|79064471|FG001|Overall Study|Non compliance protocol|6|||
44238095|NCT01694771|79064470|FG000|Overall Study|Lost to Follow-up|2|||
44238096|NCT01694771|79064471|FG001|Overall Study|Lost to Follow-up|3|||
44238097|NCT01694771|79064470|FG000|Overall Study|Consent withdrawn|7|||
44238098|NCT01694771|79064471|FG001|Overall Study|Consent withdrawn|9|||
44238099|NCT01694771|79064470|FG000|Overall Study|Other reasons|5|||
44238100|NCT01694771|79064471|FG001|Overall Study|Other reasons|6|||
44238101|NCT01582061|79064500|FG000|Overall Study|Lack of Efficacy|3|||
44238102|NCT01582061|79064501|FG001|Overall Study|Lack of Efficacy|23|||
44238103|NCT01582061|79064500|FG000|Overall Study|Adverse Event|12|||
44238104|NCT01582061|79064501|FG001|Overall Study|Adverse Event|8|||
44238105|NCT01582061|79064500|FG000|Overall Study|Withdrawal by Subject|10|||
44238106|NCT01582061|79064501|FG001|Overall Study|Withdrawal by Subject|4|||
44238107|NCT01582061|79064500|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44238108|NCT01582061|79064501|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44238109|NCT01582061|79064500|FG000|Overall Study|Death|0|||
44238110|NCT01582061|79064501|FG001|Overall Study|Death|1|||
44238111|NCT01582061|79064500|FG000|Overall Study|condition no longer requires study drug|1|||
44238112|NCT01582061|79064501|FG001|Overall Study|condition no longer requires study drug|0|||
44238113|NCT01582061|79064500|FG000|Overall Study|Lost to Follow-up|1|||
44238114|NCT01582061|79064501|FG001|Overall Study|Lost to Follow-up|0|||
44238115|NCT01693523|79064520|FG000|Overall Study|Adverse Event|2|||
44238116|NCT01693523|79064521|FG001|Overall Study|Adverse Event|1|||
44238117|NCT01693523|79064522|FG002|Overall Study|Adverse Event|0|||
44238118|NCT01693523|79064520|FG000|Overall Study|Death|0|||
44238119|NCT01693523|79064521|FG001|Overall Study|Death|1|||
44238120|NCT01693523|79064522|FG002|Overall Study|Death|1|||
44238121|NCT01693523|79064520|FG000|Overall Study|Lost to Follow-up|0|||
44238122|NCT01693523|79064521|FG001|Overall Study|Lost to Follow-up|0|||
44238123|NCT01693523|79064522|FG002|Overall Study|Lost to Follow-up|4|||
44238124|NCT01693523|79064520|FG000|Overall Study|Physician Decision|0|||
44238125|NCT01693523|79064521|FG001|Overall Study|Physician Decision|0|||
44238126|NCT01693523|79064522|FG002|Overall Study|Physician Decision|1|||
44238127|NCT01693523|79064520|FG000|Overall Study|Withdrawal by Subject|1|||
44238128|NCT01693523|79064521|FG001|Overall Study|Withdrawal by Subject|2|||
44238129|NCT01693523|79064522|FG002|Overall Study|Withdrawal by Subject|2|||
44238130|NCT01693523|79064520|FG000|Overall Study|Lack of compliance study medication|1|||
44275941|NCT02785952|79226245|FG001|Overall Study|Disease progression/relapse|89|||
44275942|NCT02785952|79226244|FG000|Overall Study|Death|11|||
44275943|NCT02785952|79226245|FG001|Overall Study|Death|7|||
44377948|NCT01077284|79383217|FG000|Overall Study|Other|0|||
44574094|NCT03314935|79596643|FG004|Phase 2|Lost to Follow-up|0|||
44238131|NCT01693523|79064521|FG001|Overall Study|Lack of compliance study medication|2|||
44114970|NCT02654015|78898055|FG000|Overall Study|Lost to Follow-up|3|||
44114971|NCT02542696|78898059|FG000|Overall Study|Adverse Event|167|||
44238132|NCT01693523|79064522|FG002|Overall Study|Lack of compliance study medication|0|||
44238133|NCT01693523|79064520|FG000|Overall Study|Chemotherapy was held|1|||
44238134|NCT01693523|79064521|FG001|Overall Study|Chemotherapy was held|2|||
44238135|NCT01693523|79064522|FG002|Overall Study|Chemotherapy was held|0|||
44238136|NCT01581593|79064538|FG000|Overall Study|Withdrawal by Subject|1|||
44238137|NCT01581281|79064549|FG000|Overall Study|Early Study Closure|15|||
44275944|NCT02785952|79226244|FG000|Overall Study|Other- not protocol specified|6|||
44574095|NCT03314935|79596644|FG005|Phase 2|Lost to Follow-up|0|||
44574096|NCT03314935|79596645|FG006|Phase 2|Lost to Follow-up|0|||
44574097|NCT03314935|79596646|FG007|Phase 2|Lost to Follow-up|0|||
44574098|NCT03314935|79596647|FG008|Phase 2|Lost to Follow-up|0|||
44574099|NCT03314935|79596648|FG009|Phase 2|Lost to Follow-up|1|||
44574100|NCT03314935|79596649|FG010|Phase 2|Lost to Follow-up|0|||
44574101|NCT03314935|79596650|FG011|Phase 2|Lost to Follow-up|0|||
44574102|NCT03314935|79596651|FG012|Phase 2|Lost to Follow-up|0|||
44114972|NCT02542696|78898059|FG000|Overall Study|Lack of Efficacy|26|||
44114973|NCT02542696|78898059|FG000|Overall Study|Lost to Follow-up|6|||
44114974|NCT02542696|78898059|FG000|Overall Study|Withdrawal by Subject|104|||
44574103|NCT03314935|79596652|FG013|Phase 2|Lost to Follow-up|0|||
44574104|NCT03314935|79596653|FG014|Phase 2|Lost to Follow-up|1|||
44574105|NCT03314935|79596639|FG000|Phase 2|Physician Decision|0|||
44574106|NCT03314935|79596640|FG001|Phase 2|Physician Decision|0|||
44574107|NCT03314935|79596641|FG002|Phase 2|Physician Decision|0|||
44574108|NCT03314935|79596642|FG003|Phase 2|Physician Decision|0|||
44574109|NCT03314935|79596643|FG004|Phase 2|Physician Decision|0|||
44574110|NCT03314935|79596644|FG005|Phase 2|Physician Decision|0|||
44574111|NCT03314935|79596645|FG006|Phase 2|Physician Decision|0|||
44574112|NCT03314935|79596646|FG007|Phase 2|Physician Decision|0|||
44574113|NCT03314935|79596647|FG008|Phase 2|Physician Decision|0|||
44574114|NCT03314935|79596648|FG009|Phase 2|Physician Decision|0|||
44574115|NCT03314935|79596649|FG010|Phase 2|Physician Decision|1|||
44574116|NCT03314935|79596650|FG011|Phase 2|Physician Decision|0|||
44574117|NCT03314935|79596651|FG012|Phase 2|Physician Decision|0|||
44574118|NCT03314935|79596652|FG013|Phase 2|Physician Decision|0|||
44574119|NCT03314935|79596653|FG014|Phase 2|Physician Decision|0|||
44574120|NCT03169361|79596696|FG000|Overall Study|Protocol Violation|32|||
44574121|NCT03031847|79596713|FG000|Overall Study|Death|1|||
44574122|NCT03031847|79596714|FG001|Overall Study|Death|1|||
44574123|NCT03031847|79596715|FG002|Overall Study|Death|2|||
44574124|NCT03031847|79596716|FG003|Overall Study|Death|3|||
44574125|NCT03031847|79596713|FG000|Overall Study|Lost to Follow-up|1|||
44574126|NCT03031847|79596714|FG001|Overall Study|Lost to Follow-up|1|||
44574127|NCT03031847|79596715|FG002|Overall Study|Lost to Follow-up|2|||
44574128|NCT03031847|79596716|FG003|Overall Study|Lost to Follow-up|3|||
44574129|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
44574130|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
44574131|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
44574132|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
44574133|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
44574134|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
44574135|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
44574136|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
44574137|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
44574138|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
44574139|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
44574140|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
44574141|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
44574142|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
44574143|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
44574144|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
44574145|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
44114975|NCT02542696|78898059|FG000|Overall Study|Protocol Violation|5|||
44505718|NCT03711370|79510499|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
44505719|NCT03478930|79510515|FG000|Overall Study|Adverse Event|0|||
44505720|NCT03478930|79510516|FG001|Overall Study|Adverse Event|1|||
44505721|NCT03478930|79510515|FG000|Overall Study|Lack of Efficacy|3|||
44505722|NCT03478930|79510516|FG001|Overall Study|Lack of Efficacy|3|||
44505723|NCT03478930|79510515|FG000|Overall Study|Withdrawal by Subject|6|||
44505724|NCT03478930|79510516|FG001|Overall Study|Withdrawal by Subject|5|||
44505725|NCT03038438|79510522|FG000|Overall Study|Death|3|||
44505726|NCT03038438|79510522|FG000|Overall Study|Lost to Follow-up|8|||
44505727|NCT03038438|79510522|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
44505728|NCT03038438|79510522|FG000|Overall Study|Withdrawal by Subject|5|||
44505729|NCT03038438|79510522|FG000|Overall Study|No 36-Month Follow-Up|18|||
44505730|NCT03523000|79510526|FG000|Overall Study|Withdrawal by Subject|3|||
44505731|NCT03523000|79510527|FG001|Overall Study|Withdrawal by Subject|0|||
44505732|NCT03523000|79510526|FG000|Overall Study|Unsuccessful trial|2|||
44505733|NCT03523000|79510527|FG001|Overall Study|Unsuccessful trial|0|||
44574146|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
44114976|NCT02542696|78898059|FG000|Overall Study|Death|8|||
44505734|NCT03327220|79510538|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
44505735|NCT03327220|79510539|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
44114977|NCT02542696|78898059|FG000|Overall Study|DECREASED OFF TIME|1|||
44114978|NCT02542696|78898059|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
44114979|NCT02542696|78898059|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
44114980|NCT02542696|78898059|FG000|Overall Study|MEDICAL HISTORY|1|||
44114981|NCT02542696|78898059|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
44114982|NCT02542696|78898059|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
44114983|NCT02542696|78898059|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
44114984|NCT02542696|78898059|FG000|Overall Study|SPONSOR DECISION|3|||
44114985|NCT02542696|78898059|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
44114986|NCT02542696|78898059|FG000|Overall Study|SUBJECT DECISION|2|||
44114987|NCT02339740|78898066|FG000|Overall Study|Death|1|||
44114988|NCT02339740|78898067|FG001|Overall Study|Death|0|||
44114989|NCT02339740|78898066|FG000|Overall Study|Physician Decision|0|||
44114990|NCT02339740|78898067|FG001|Overall Study|Physician Decision|2|||
44114991|NCT02339740|78898066|FG000|Overall Study|Withdrawal by Subject|5|||
44114992|NCT02339740|78898067|FG001|Overall Study|Withdrawal by Subject|1|||
44114993|NCT02339740|78898066|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
44114994|NCT02339740|78898067|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
44114995|NCT02163395|78898073|FG000|Overall Study|Withdrawal by Subject|1|||
44114996|NCT02163395|78898073|FG000|Overall Study|Lost to Follow-up|3|||
44114997|NCT02163395|78898073|FG000|Overall Study|Adverse Event|1|||
44114998|NCT01397552|78898083|FG000|Overall Study|Adverse Event|1|||
44114999|NCT01397552|78898084|FG001|Overall Study|Adverse Event|0|||
44574147|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
44574148|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
44574149|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
44574150|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
44574151|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
44574152|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
44574153|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
44574154|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
44574155|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
44574156|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
44574157|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
44574158|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
44574159|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
44574160|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
44574161|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
44574162|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
44574163|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
44574164|NCT02831764|79596728|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
44574165|NCT02831764|79596729|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
44574166|NCT02831764|79596730|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
44574167|NCT02831764|79596731|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
44574168|NCT02831764|79596732|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
44574169|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
44574170|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
44574171|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
44574172|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
44574173|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
44574174|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44574175|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44574176|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
44115000|NCT01397552|78898083|FG000|Overall Study|Withdrawal by Subject|2|||
44115001|NCT01397552|78898084|FG001|Overall Study|Withdrawal by Subject|1|||
44115002|NCT01256710|78898090|FG000|Overall Study|Death|449|||
44115003|NCT01256710|78898090|FG000|Overall Study|System Explant|67|||
44115004|NCT01256710|78898090|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
44115005|NCT01256710|78898090|FG000|Overall Study|Lost to Follow-up|67|||
44115006|NCT01256710|78898090|FG000|Overall Study|Withdrawal by Subject|29|||
44238138|NCT01581281|79064550|FG001|Overall Study|Early Study Closure|6|||
44574177|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44115007|NCT01256710|78898090|FG000|Overall Study|Physician Decision|9|||
44115008|NCT01256710|78898090|FG000|Overall Study|Subject Noncompliance|2|||
44115009|NCT01256710|78898090|FG000|Overall Study|Study Terminated by Sponsor|273|||
44115010|NCT01096368|78898101|FG000|Overall Study|Death|0|||
44115011|NCT01096368|78898102|FG001|Overall Study|Death|1|||
44115012|NCT01096368|78898103|FG002|Overall Study|Death|0|||
44115013|NCT01096368|78898104|FG003|Overall Study|Death|0|||
44115014|NCT01096368|78898105|FG004|Overall Study|Death|0|||
44115015|NCT01096368|78898101|FG000|Overall Study|Physician Decision|0|||
44115016|NCT01096368|78898102|FG001|Overall Study|Physician Decision|13|||
44115017|NCT01096368|78898103|FG002|Overall Study|Physician Decision|2|||
44115018|NCT01096368|78898104|FG003|Overall Study|Physician Decision|4|||
44115019|NCT01096368|78898105|FG004|Overall Study|Physician Decision|6|||
44115020|NCT01096368|78898101|FG000|Overall Study|Withdrawal by Subject|0|||
44115021|NCT01096368|78898102|FG001|Overall Study|Withdrawal by Subject|52|||
44115022|NCT01096368|78898103|FG002|Overall Study|Withdrawal by Subject|0|||
44115023|NCT01096368|78898104|FG003|Overall Study|Withdrawal by Subject|10|||
44115024|NCT01096368|78898105|FG004|Overall Study|Withdrawal by Subject|14|||
44115025|NCT01096368|78898101|FG000|Overall Study|Ineligible|0|||
44115026|NCT01096368|78898102|FG001|Overall Study|Ineligible|3|||
44115027|NCT01096368|78898103|FG002|Overall Study|Ineligible|2|||
44115028|NCT01096368|78898104|FG003|Overall Study|Ineligible|0|||
44115029|NCT01096368|78898105|FG004|Overall Study|Ineligible|25|||
44115030|NCT01096368|78898101|FG000|Overall Study|Did not start treatment|0|||
44115031|NCT01096368|78898102|FG001|Overall Study|Did not start treatment|4|||
44115032|NCT01096368|78898103|FG002|Overall Study|Did not start treatment|4|||
44574178|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44574179|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44574180|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44574181|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
44574182|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
44574183|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44574184|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
44574185|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
44115033|NCT01096368|78898104|FG003|Overall Study|Did not start treatment|0|||
44115034|NCT01096368|78898105|FG004|Overall Study|Did not start treatment|0|||
44115035|NCT01096368|78898101|FG000|Overall Study|Progressive disease|0|||
44238139|NCT01581281|79064551|FG002|Overall Study|Early Study Closure|12|||
44238140|NCT02692716|79064562|FG000|Overall Study|Lost to Follow-up|2|||
44238141|NCT02692716|79064563|FG001|Overall Study|Lost to Follow-up|5|||
44238142|NCT02692716|79064562|FG000|Overall Study|Withdrawal by Subject|3|||
44238143|NCT02692716|79064563|FG001|Overall Study|Withdrawal by Subject|1|||
44238144|NCT01580969|79064572|FG000|Overall Study|Physician Decision|3|||
44115036|NCT01096368|78898102|FG001|Overall Study|Progressive disease|6|||
44115037|NCT01096368|78898103|FG002|Overall Study|Progressive disease|0|||
44115038|NCT01096368|78898104|FG003|Overall Study|Progressive disease|10|||
44115039|NCT01096368|78898105|FG004|Overall Study|Progressive disease|3|||
44115040|NCT01096368|78898101|FG000|Overall Study|Other|0|||
44238145|NCT01580969|79064573|FG001|Overall Study|Physician Decision|0|||
44238146|NCT01580969|79064574|FG002|Overall Study|Physician Decision|0|||
44115041|NCT01096368|78898102|FG001|Overall Study|Other|0|||
44115042|NCT01096368|78898103|FG002|Overall Study|Other|1|||
44115043|NCT01096368|78898104|FG003|Overall Study|Other|0|||
44115044|NCT01096368|78898105|FG004|Overall Study|Other|0|||
44115045|NCT01096368|78898101|FG000|Overall Study|Treated with institutional review|0|||
44115046|NCT01096368|78898102|FG001|Overall Study|Treated with institutional review|0|||
44115047|NCT01096368|78898103|FG002|Overall Study|Treated with institutional review|0|||
44115048|NCT01096368|78898104|FG003|Overall Study|Treated with institutional review|0|||
44115049|NCT01096368|78898105|FG004|Overall Study|Treated with institutional review|1|||
44115050|NCT00938587|78898133|FG000|Overall Study|Adverse Event|2|||
44115051|NCT00938587|78898134|FG001|Overall Study|Adverse Event|0|||
44115052|NCT00938587|78898135|FG002|Overall Study|Adverse Event|0|||
44115053|NCT00938587|78898136|FG003|Overall Study|Adverse Event|2|||
44115054|NCT00938587|78898133|FG000|Overall Study|Did not meet entrance criteria|0|||
44115055|NCT00938587|78898134|FG001|Overall Study|Did not meet entrance criteria|0|||
44115056|NCT00938587|78898135|FG002|Overall Study|Did not meet entrance criteria|1|||
44238147|NCT01693367|79064584|FG000|Overall Study|Withdrawal by Subject|1|||
44238148|NCT01693367|79064585|FG001|Overall Study|Withdrawal by Subject|1|||
44505736|NCT03327220|79510538|FG000|Overall Study|Investigator Decision|2|||
44505737|NCT03327220|79510539|FG001|Overall Study|Investigator Decision|0|||
44505738|NCT03327220|79510538|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
44505739|NCT03327220|79510539|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
44505740|NCT03327220|79510538|FG000|Overall Study|Fungal infection|1|||
44505741|NCT03327220|79510539|FG001|Overall Study|Fungal infection|0|||
44505742|NCT03327220|79510538|FG000|Overall Study|Discharged to Rehabilitation|0|||
44505743|NCT03327220|79510539|FG001|Overall Study|Discharged to Rehabilitation|1|||
44115057|NCT00938587|78898136|FG003|Overall Study|Did not meet entrance criteria|0|||
44115058|NCT00938587|78898133|FG000|Overall Study|Withdrawal by Subject|1|||
44115059|NCT00938587|78898134|FG001|Overall Study|Withdrawal by Subject|1|||
44115060|NCT00938587|78898135|FG002|Overall Study|Withdrawal by Subject|0|||
44505744|NCT03327220|79510538|FG000|Overall Study|Missing|1|||
44505745|NCT03327220|79510539|FG001|Overall Study|Missing|0|||
44238149|NCT01693367|79064584|FG000|Overall Study|Physician Decision|0|||
44238150|NCT01693367|79064585|FG001|Overall Study|Physician Decision|1|||
44115061|NCT00938587|78898136|FG003|Overall Study|Withdrawal by Subject|0|||
44115062|NCT00937937|78898146|FG000|Overall Study|Adverse Event|6|||
44115063|NCT00937937|78898146|FG000|Overall Study|Withdrawal by Subject|2|||
44115064|NCT00937937|78898146|FG000|Overall Study|Progression/relapse|61|||
44115065|NCT00937937|78898146|FG000|Overall Study|Death|1|||
44115066|NCT00937937|78898146|FG000|Overall Study|Other|2|||
44115067|NCT00810693|78898154|FG000|Treatment Period|Adverse Event|8|||
44115068|NCT00810693|78898155|FG001|Treatment Period|Adverse Event|1|||
44115069|NCT00810693|78898156|FG002|Treatment Period|Adverse Event|7|||
44115070|NCT00810693|78898154|FG000|Treatment Period|Death|0|||
44115071|NCT00810693|78898155|FG001|Treatment Period|Death|1|||
44115072|NCT00810693|78898156|FG002|Treatment Period|Death|2|||
44115073|NCT00810693|78898154|FG000|Treatment Period|Lack of Efficacy|0|||
44115074|NCT00810693|78898155|FG001|Treatment Period|Lack of Efficacy|0|||
44115075|NCT00810693|78898156|FG002|Treatment Period|Lack of Efficacy|1|||
44115076|NCT00810693|78898154|FG000|Treatment Period|Lost to Follow-up|1|||
44115077|NCT00810693|78898155|FG001|Treatment Period|Lost to Follow-up|0|||
44115078|NCT00810693|78898156|FG002|Treatment Period|Lost to Follow-up|0|||
44115079|NCT00810693|78898154|FG000|Treatment Period|Non-compliance|1|||
44115080|NCT00810693|78898155|FG001|Treatment Period|Non-compliance|0|||
44115081|NCT00810693|78898156|FG002|Treatment Period|Non-compliance|0|||
44115082|NCT00810693|78898154|FG000|Treatment Period|Protocol Violation|1|||
44115083|NCT00810693|78898155|FG001|Treatment Period|Protocol Violation|2|||
44115084|NCT00810693|78898156|FG002|Treatment Period|Protocol Violation|2|||
44115085|NCT00810693|78898154|FG000|Treatment Period|Withdrawal by Subject|6|||
44115086|NCT00810693|78898155|FG001|Treatment Period|Withdrawal by Subject|2|||
44115087|NCT00810693|78898156|FG002|Treatment Period|Withdrawal by Subject|3|||
44115088|NCT00810693|78898154|FG000|Treatment Period|Not treated|0|||
44115089|NCT00810693|78898155|FG001|Treatment Period|Not treated|1|||
44115090|NCT00810693|78898156|FG002|Treatment Period|Not treated|1|||
44115091|NCT00810693|78898154|FG000|Follow-up Period (FUP)|Adverse Event|3|||
44115092|NCT00810693|78898155|FG001|Follow-up Period (FUP)|Adverse Event|1|||
44115093|NCT00810693|78898156|FG002|Follow-up Period (FUP)|Adverse Event|1|||
44115094|NCT00810693|78898154|FG000|Follow-up Period (FUP)|Death|2|||
44115095|NCT00810693|78898155|FG001|Follow-up Period (FUP)|Death|0|||
44115096|NCT00810693|78898156|FG002|Follow-up Period (FUP)|Death|1|||
44115097|NCT00810693|78898154|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
44115098|NCT00810693|78898155|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
44115099|NCT00810693|78898156|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
44115100|NCT00810693|78898154|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
44115101|NCT00810693|78898155|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
44115102|NCT00810693|78898156|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
44115103|NCT00810693|78898154|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
44115104|NCT00810693|78898155|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
44115105|NCT00810693|78898156|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
44115106|NCT00381641|78898166|FG000|Overall Study|Withdrawal by Subject|0|||
44115107|NCT00381641|78898167|FG001|Overall Study|Withdrawal by Subject|2|||
44115108|NCT00334815|78898175|FG000|Overall Study|Adverse Event|3|||
44115109|NCT00334815|78898176|FG001|Overall Study|Adverse Event|2|||
44115110|NCT00334815|78898175|FG000|Overall Study|Death|0|||
44115111|NCT00334815|78898176|FG001|Overall Study|Death|2|||
44115112|NCT00334815|78898175|FG000|Overall Study|Progression|1|||
44574186|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
44574187|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
44574188|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
44574189|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
44574190|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
44574191|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
44574192|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
44574193|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
44574194|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
44574195|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
44574196|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
44574197|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
44115113|NCT00334815|78898176|FG001|Overall Study|Progression|0|||
44115114|NCT00334815|78898175|FG000|Overall Study|ineligible|1|||
44115115|NCT00334815|78898176|FG001|Overall Study|ineligible|1|||
44115116|NCT00334815|78898175|FG000|Overall Study|patient refused treatment|0|||
44115117|NCT00334815|78898176|FG001|Overall Study|patient refused treatment|1|||
44115118|NCT00334815|78898175|FG000|Overall Study|Physician Decision|2|||
44115119|NCT00334815|78898176|FG001|Overall Study|Physician Decision|4|||
44115120|NCT04730349|78898195|FG000|Overall Study|Participant withdrew consent|1|||
44115121|NCT04730349|78898196|FG001|Overall Study|Participant withdrew consent|0|||
44115122|NCT04730349|78898195|FG000|Overall Study|Disease progression|6|||
44115123|NCT04730349|78898196|FG001|Overall Study|Disease progression|4|||
44115124|NCT04730349|78898195|FG000|Overall Study|Study drug toxicity|0|||
44115125|NCT04730349|78898196|FG001|Overall Study|Study drug toxicity|1|||
44115126|NCT04307394|78898215|FG000|Overall Study|Lost to Follow-up|3|||
44115127|NCT04307394|78898215|FG000|Overall Study|Withdrawal by Subject|2|||
44115128|NCT03940742|78898241|FG000|Overall Study|Lost to Follow-up|0|||
44115129|NCT03940742|78898242|FG001|Overall Study|Lost to Follow-up|0|||
44115130|NCT03940742|78898243|FG002|Overall Study|Lost to Follow-up|0|||
44115131|NCT03940742|78898244|FG003|Overall Study|Lost to Follow-up|1|||
44115132|NCT03917654|78898266|FG000|Year 1|Withdrawal by Subject|1|||
44115133|NCT03917654|78898267|FG001|Year 1|Withdrawal by Subject|0|||
44115134|NCT03917654|78898268|FG002|Year 1|Withdrawal by Subject|0|||
44115135|NCT03917654|78898269|FG003|Year 1|Withdrawal by Subject|0|||
44115136|NCT03917654|78898270|FG004|Year 1|Withdrawal by Subject|0|||
44115137|NCT03917654|78898271|FG005|Year 1|Withdrawal by Subject|1|||
44115138|NCT03917654|78898272|FG006|Year 1|Withdrawal by Subject|6|||
44115139|NCT03917654|78898273|FG007|Year 1|Withdrawal by Subject|2|||
44115140|NCT03917654|78898274|FG008|Year 1|Withdrawal by Subject|5|||
44115141|NCT03917654|78898275|FG009|Year 1|Withdrawal by Subject|3|||
44115142|NCT03917654|78898276|FG010|Year 1|Withdrawal by Subject|1|||
44115143|NCT03917654|78898277|FG011|Year 1|Withdrawal by Subject|0|||
44115144|NCT03917654|78898266|FG000|Year 1|Travel|0|||
44115145|NCT03917654|78898267|FG001|Year 1|Travel|1|||
44115146|NCT03917654|78898268|FG002|Year 1|Travel|1|||
44115147|NCT03917654|78898269|FG003|Year 1|Travel|0|||
44115148|NCT03917654|78898270|FG004|Year 1|Travel|4|||
44115149|NCT03917654|78898271|FG005|Year 1|Travel|4|||
44115150|NCT03917654|78898272|FG006|Year 1|Travel|10|||
44115151|NCT03917654|78898273|FG007|Year 1|Travel|8|||
44115152|NCT03917654|78898274|FG008|Year 1|Travel|2|||
44115153|NCT03917654|78898275|FG009|Year 1|Travel|5|||
44115154|NCT03917654|78898276|FG010|Year 1|Travel|3|||
44115155|NCT03917654|78898277|FG011|Year 1|Travel|3|||
44115156|NCT03917654|78898266|FG000|Year 1|Subject moved away from site|0|||
44115157|NCT03917654|78898267|FG001|Year 1|Subject moved away from site|1|||
44115158|NCT03917654|78898268|FG002|Year 1|Subject moved away from site|0|||
44115159|NCT03917654|78898269|FG003|Year 1|Subject moved away from site|0|||
44115160|NCT03917654|78898270|FG004|Year 1|Subject moved away from site|0|||
44115161|NCT03917654|78898271|FG005|Year 1|Subject moved away from site|0|||
44115162|NCT03917654|78898272|FG006|Year 1|Subject moved away from site|1|||
44115163|NCT03917654|78898273|FG007|Year 1|Subject moved away from site|2|||
44115164|NCT03917654|78898274|FG008|Year 1|Subject moved away from site|1|||
44115165|NCT03917654|78898275|FG009|Year 1|Subject moved away from site|0|||
44115166|NCT03917654|78898276|FG010|Year 1|Subject moved away from site|0|||
44115167|NCT03917654|78898277|FG011|Year 1|Subject moved away from site|3|||
44115168|NCT03917654|78898266|FG000|Year 1|Spouse/Family member request|0|||
44115169|NCT03917654|78898267|FG001|Year 1|Spouse/Family member request|0|||
44115170|NCT03917654|78898268|FG002|Year 1|Spouse/Family member request|1|||
44115171|NCT03917654|78898269|FG003|Year 1|Spouse/Family member request|0|||
44115172|NCT03917654|78898270|FG004|Year 1|Spouse/Family member request|1|||
44115173|NCT03917654|78898271|FG005|Year 1|Spouse/Family member request|0|||
44115174|NCT03917654|78898272|FG006|Year 1|Spouse/Family member request|0|||
44115175|NCT03917654|78898273|FG007|Year 1|Spouse/Family member request|2|||
44115176|NCT03917654|78898274|FG008|Year 1|Spouse/Family member request|0|||
44115177|NCT03917654|78898275|FG009|Year 1|Spouse/Family member request|0|||
44115178|NCT03917654|78898276|FG010|Year 1|Spouse/Family member request|0|||
44115179|NCT03917654|78898277|FG011|Year 1|Spouse/Family member request|1|||
44115180|NCT03917654|78898266|FG000|Year 1|Death|0|||
44115181|NCT03917654|78898267|FG001|Year 1|Death|0|||
44115182|NCT03917654|78898268|FG002|Year 1|Death|0|||
44115183|NCT03917654|78898269|FG003|Year 1|Death|0|||
44115184|NCT03917654|78898270|FG004|Year 1|Death|0|||
44115185|NCT03917654|78898271|FG005|Year 1|Death|0|||
44115186|NCT03917654|78898272|FG006|Year 1|Death|0|||
44377949|NCT01077284|79383218|FG001|Overall Study|Other|0|||
44115187|NCT03917654|78898273|FG007|Year 1|Death|0|||
44115188|NCT03917654|78898274|FG008|Year 1|Death|1|||
44115189|NCT03917654|78898275|FG009|Year 1|Death|1|||
44115190|NCT03917654|78898276|FG010|Year 1|Death|0|||
44115191|NCT03917654|78898277|FG011|Year 1|Death|0|||
44115192|NCT03917654|78898266|FG000|Year 1|Lost to Follow-up|0|||
44115193|NCT03917654|78898267|FG001|Year 1|Lost to Follow-up|0|||
44115194|NCT03917654|78898268|FG002|Year 1|Lost to Follow-up|0|||
44115195|NCT03917654|78898269|FG003|Year 1|Lost to Follow-up|0|||
44115196|NCT03917654|78898270|FG004|Year 1|Lost to Follow-up|0|||
44115197|NCT03917654|78898271|FG005|Year 1|Lost to Follow-up|0|||
44115198|NCT03917654|78898272|FG006|Year 1|Lost to Follow-up|2|||
44115199|NCT03917654|78898273|FG007|Year 1|Lost to Follow-up|0|||
44115200|NCT03917654|78898274|FG008|Year 1|Lost to Follow-up|0|||
44115201|NCT03917654|78898275|FG009|Year 1|Lost to Follow-up|0|||
44115202|NCT03917654|78898276|FG010|Year 1|Lost to Follow-up|0|||
44115203|NCT03917654|78898277|FG011|Year 1|Lost to Follow-up|0|||
44115204|NCT03917654|78898266|FG000|Year 1|Missed visits|0|||
44115205|NCT03917654|78898267|FG001|Year 1|Missed visits|0|||
44115206|NCT03917654|78898268|FG002|Year 1|Missed visits|0|||
44115207|NCT03917654|78898269|FG003|Year 1|Missed visits|0|||
44115208|NCT03917654|78898270|FG004|Year 1|Missed visits|0|||
44115209|NCT03917654|78898271|FG005|Year 1|Missed visits|0|||
44115210|NCT03917654|78898272|FG006|Year 1|Missed visits|0|||
44115211|NCT03917654|78898273|FG007|Year 1|Missed visits|0|||
44115212|NCT03917654|78898274|FG008|Year 1|Missed visits|0|||
44115213|NCT03917654|78898275|FG009|Year 1|Missed visits|0|||
44115214|NCT03917654|78898276|FG010|Year 1|Missed visits|1|||
44115215|NCT03917654|78898277|FG011|Year 1|Missed visits|1|||
44115216|NCT03917654|78898266|FG000|Year 1|Pregnancy|0|||
44115217|NCT03917654|78898267|FG001|Year 1|Pregnancy|0|||
44115218|NCT03917654|78898268|FG002|Year 1|Pregnancy|0|||
44115219|NCT03917654|78898269|FG003|Year 1|Pregnancy|0|||
44115220|NCT03917654|78898270|FG004|Year 1|Pregnancy|0|||
44115221|NCT03917654|78898271|FG005|Year 1|Pregnancy|0|||
44115222|NCT03917654|78898272|FG006|Year 1|Pregnancy|0|||
44115223|NCT03917654|78898273|FG007|Year 1|Pregnancy|1|||
44115224|NCT03917654|78898274|FG008|Year 1|Pregnancy|0|||
44115225|NCT03917654|78898275|FG009|Year 1|Pregnancy|1|||
44115226|NCT03917654|78898276|FG010|Year 1|Pregnancy|0|||
44115227|NCT03917654|78898277|FG011|Year 1|Pregnancy|0|||
44115228|NCT03917654|78898266|FG000|Year 2|Travel|1|||
44115229|NCT03917654|78898267|FG001|Year 2|Travel|0|||
44115230|NCT03917654|78898268|FG002|Year 2|Travel|0|||
44115231|NCT03917654|78898269|FG003|Year 2|Travel|0|||
44115232|NCT03917654|78898270|FG004|Year 2|Travel|1|||
44115233|NCT03917654|78898271|FG005|Year 2|Travel|1|||
44115234|NCT03917654|78898272|FG006|Year 2|Travel|2|||
44115235|NCT03917654|78898273|FG007|Year 2|Travel|1|||
44115236|NCT03917654|78898274|FG008|Year 2|Travel|0|||
44115237|NCT03917654|78898275|FG009|Year 2|Travel|1|||
44574198|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
44574199|NCT02831764|79596728|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
44574200|NCT02831764|79596729|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
44574201|NCT02831764|79596730|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
44574202|NCT02831764|79596731|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
44574203|NCT02831764|79596732|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
44574204|NCT02831764|79596728|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44574205|NCT02831764|79596729|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44574206|NCT02831764|79596730|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44574207|NCT02831764|79596731|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44574208|NCT02831764|79596732|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
44574209|NCT02831764|79596728|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44574210|NCT02831764|79596729|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44574211|NCT02831764|79596730|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44574212|NCT02831764|79596731|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44574213|NCT02831764|79596732|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
44574214|NCT02831764|79596728|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44505746|NCT00318149|79510551|FG000|Overall Study|Adverse Event|0|||
44505747|NCT00318149|79510552|FG001|Overall Study|Adverse Event|0|||
44505748|NCT00318149|79510553|FG002|Overall Study|Adverse Event|0|||
44505749|NCT00318149|79510554|FG003|Overall Study|Adverse Event|0|||
44505750|NCT00318149|79510555|FG004|Overall Study|Adverse Event|0|||
44505751|NCT00318149|79510556|FG005|Overall Study|Adverse Event|2|||
44505752|NCT00317603|79510572|FG000|Overall Study|Progressive Disease|3|||
44505753|NCT03326518|79510579|FG000|Overall Study|Protocol Violation|1|||
44505754|NCT03326518|79510580|FG001|Overall Study|Protocol Violation|0|||
44505755|NCT03326518|79510581|FG002|Overall Study|Protocol Violation|0|||
44505756|NCT03326518|79510579|FG000|Overall Study|Withdrawal by Subject|1|||
44505757|NCT03326518|79510580|FG001|Overall Study|Withdrawal by Subject|0|||
44505758|NCT03326518|79510581|FG002|Overall Study|Withdrawal by Subject|0|||
44505759|NCT03326518|79510579|FG000|Overall Study|Lost to Follow-up|1|||
44505760|NCT03326518|79510580|FG001|Overall Study|Lost to Follow-up|0|||
44505761|NCT03326518|79510581|FG002|Overall Study|Lost to Follow-up|1|||
44505762|NCT00317369|79510592|FG000|Overall Study|Adverse Event|2|||
44505763|NCT00317369|79510593|FG001|Overall Study|Adverse Event|1|||
44505764|NCT00317369|79510594|FG002|Overall Study|Adverse Event|0|||
44505765|NCT00317369|79510592|FG000|Overall Study|Lack of Efficacy|0|||
44505766|NCT00317369|79510593|FG001|Overall Study|Lack of Efficacy|1|||
44115238|NCT03917654|78898276|FG010|Year 2|Travel|0|||
44115239|NCT03917654|78898277|FG011|Year 2|Travel|1|||
44115240|NCT03917654|78898266|FG000|Year 2|Married|1|||
44115241|NCT03917654|78898267|FG001|Year 2|Married|0|||
44115242|NCT03917654|78898268|FG002|Year 2|Married|0|||
44505767|NCT00317369|79510594|FG002|Overall Study|Lack of Efficacy|1|||
44115243|NCT03917654|78898269|FG003|Year 2|Married|0|||
44115244|NCT03917654|78898270|FG004|Year 2|Married|0|||
44115245|NCT03917654|78898271|FG005|Year 2|Married|0|||
44115246|NCT03917654|78898272|FG006|Year 2|Married|1|||
44115247|NCT03917654|78898273|FG007|Year 2|Married|1|||
44115248|NCT03917654|78898274|FG008|Year 2|Married|0|||
44115249|NCT03917654|78898275|FG009|Year 2|Married|0|||
44115250|NCT03917654|78898276|FG010|Year 2|Married|0|||
44115251|NCT03917654|78898277|FG011|Year 2|Married|0|||
44115252|NCT03917654|78898266|FG000|Year 2|Subject moved away from site|1|||
44115253|NCT03917654|78898267|FG001|Year 2|Subject moved away from site|0|||
44115254|NCT03917654|78898268|FG002|Year 2|Subject moved away from site|0|||
44115255|NCT03917654|78898269|FG003|Year 2|Subject moved away from site|0|||
44115256|NCT03917654|78898270|FG004|Year 2|Subject moved away from site|1|||
44115257|NCT03917654|78898271|FG005|Year 2|Subject moved away from site|0|||
44115258|NCT03917654|78898272|FG006|Year 2|Subject moved away from site|2|||
44115259|NCT03917654|78898273|FG007|Year 2|Subject moved away from site|3|||
44115260|NCT03917654|78898274|FG008|Year 2|Subject moved away from site|0|||
44115261|NCT03917654|78898275|FG009|Year 2|Subject moved away from site|2|||
44115262|NCT03917654|78898276|FG010|Year 2|Subject moved away from site|0|||
44115263|NCT03917654|78898277|FG011|Year 2|Subject moved away from site|1|||
44115264|NCT03917654|78898266|FG000|Year 2|Year 2 Screening failure|0|||
44115265|NCT03917654|78898267|FG001|Year 2|Year 2 Screening failure|1|||
44115266|NCT03917654|78898268|FG002|Year 2|Year 2 Screening failure|0|||
44115267|NCT03917654|78898269|FG003|Year 2|Year 2 Screening failure|0|||
44115268|NCT03917654|78898270|FG004|Year 2|Year 2 Screening failure|2|||
44115269|NCT03917654|78898271|FG005|Year 2|Year 2 Screening failure|0|||
44115270|NCT03917654|78898272|FG006|Year 2|Year 2 Screening failure|4|||
44115271|NCT03917654|78898273|FG007|Year 2|Year 2 Screening failure|3|||
44115272|NCT03917654|78898274|FG008|Year 2|Year 2 Screening failure|10|||
44115273|NCT03917654|78898275|FG009|Year 2|Year 2 Screening failure|2|||
44115274|NCT03917654|78898276|FG010|Year 2|Year 2 Screening failure|1|||
44115275|NCT03917654|78898277|FG011|Year 2|Year 2 Screening failure|1|||
44115276|NCT03917654|78898266|FG000|Year 2|Death|0|||
44377950|NCT01077284|79383219|FG002|Overall Study|Other|1|||
44574215|NCT02831764|79596729|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44574216|NCT02831764|79596730|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44574217|NCT02831764|79596731|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44574218|NCT02831764|79596732|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
44574219|NCT02831764|79596728|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44574220|NCT02831764|79596729|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44574221|NCT02831764|79596730|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44115277|NCT03917654|78898267|FG001|Year 2|Death|0|||
44115278|NCT03917654|78898268|FG002|Year 2|Death|0|||
44115279|NCT03917654|78898269|FG003|Year 2|Death|0|||
44377951|NCT00826618|79383227|FG000|Overall Study|Withdrawal by Subject|1|||
44377952|NCT01077128|79383231|FG000|Overall Study|Adverse Event|8|||
44377953|NCT01077128|79383231|FG000|Overall Study|Lack of Efficacy|1|||
44505768|NCT00317369|79510592|FG000|Overall Study|Withdrawal by Subject|0|||
44505769|NCT00317369|79510593|FG001|Overall Study|Withdrawal by Subject|0|||
44505770|NCT00317369|79510594|FG002|Overall Study|Withdrawal by Subject|1|||
44505771|NCT03325894|79510604|FG000|Overall Study|Adverse Event|2|||
44505772|NCT03325894|79510605|FG001|Overall Study|Adverse Event|3|||
44505773|NCT03325894|79510604|FG000|Overall Study|Protocol Violation|1|||
44505774|NCT03325894|79510605|FG001|Overall Study|Protocol Violation|2|||
44505775|NCT03325894|79510604|FG000|Overall Study|Withdrawal by Subject|10|||
44505776|NCT03325894|79510605|FG001|Overall Study|Withdrawal by Subject|6|||
44505777|NCT03325894|79510604|FG000|Overall Study|Lost to Follow-up|4|||
44505778|NCT03325894|79510605|FG001|Overall Study|Lost to Follow-up|9|||
44505779|NCT03325894|79510604|FG000|Overall Study|Lack of Efficacy|8|||
44505780|NCT03325894|79510605|FG001|Overall Study|Lack of Efficacy|14|||
44505781|NCT03325894|79510604|FG000|Overall Study|Study Terminated by Sponsor|38|||
44505782|NCT03325894|79510605|FG001|Overall Study|Study Terminated by Sponsor|43|||
44505783|NCT03325894|79510604|FG000|Overall Study|Other (Not received Treatment)|1|||
44505784|NCT03325894|79510605|FG001|Overall Study|Other (Not received Treatment)|0|||
44505785|NCT01239368|79510624|FG000|Overall Study|Principal investigator discretion|1|||
44505786|NCT01239368|79510625|FG001|Overall Study|Principal investigator discretion|0|||
44505787|NCT01239368|79510626|FG002|Overall Study|Principal investigator discretion|0|||
44505788|NCT01239368|79510627|FG003|Overall Study|Principal investigator discretion|0|||
44505789|NCT01239368|79510628|FG004|Overall Study|Principal investigator discretion|1|||
44505790|NCT01239368|79510629|FG005|Overall Study|Principal investigator discretion|2|||
44505791|NCT01239368|79510630|FG006|Overall Study|Principal investigator discretion|0|||
44115280|NCT03917654|78898270|FG004|Year 2|Death|0|||
44238151|NCT02696226|79064595|FG000|Overall Study|Study terminated - lack of enrollment|1|||
44377954|NCT01077128|79383231|FG000|Overall Study|Disease exacerbation|1|||
44505792|NCT01239368|79510631|FG007|Overall Study|Principal investigator discretion|0|||
44505793|NCT01239368|79510632|FG008|Overall Study|Principal investigator discretion|0|||
44505794|NCT01239368|79510633|FG009|Overall Study|Principal investigator discretion|1|||
44115281|NCT03917654|78898271|FG005|Year 2|Death|1|||
44115282|NCT03917654|78898272|FG006|Year 2|Death|0|||
44115283|NCT03917654|78898273|FG007|Year 2|Death|0|||
44377955|NCT01077128|79383231|FG000|Overall Study|Adverse event and consent withdrawal|1|||
44115284|NCT03917654|78898274|FG008|Year 2|Death|1|||
44115285|NCT03917654|78898275|FG009|Year 2|Death|1|||
44115286|NCT03917654|78898276|FG010|Year 2|Death|0|||
44115287|NCT03917654|78898277|FG011|Year 2|Death|0|||
44115288|NCT03917654|78898266|FG000|Year 2|Withdrawal by Subject|0|||
44115289|NCT03917654|78898267|FG001|Year 2|Withdrawal by Subject|0|||
44115290|NCT03917654|78898268|FG002|Year 2|Withdrawal by Subject|0|||
44115291|NCT03917654|78898269|FG003|Year 2|Withdrawal by Subject|0|||
44115292|NCT03917654|78898270|FG004|Year 2|Withdrawal by Subject|0|||
44115293|NCT03917654|78898271|FG005|Year 2|Withdrawal by Subject|0|||
44115294|NCT03917654|78898272|FG006|Year 2|Withdrawal by Subject|3|||
44115295|NCT03917654|78898273|FG007|Year 2|Withdrawal by Subject|0|||
44115296|NCT03917654|78898274|FG008|Year 2|Withdrawal by Subject|2|||
44115297|NCT03917654|78898275|FG009|Year 2|Withdrawal by Subject|5|||
44115298|NCT03917654|78898276|FG010|Year 2|Withdrawal by Subject|0|||
44115299|NCT03917654|78898277|FG011|Year 2|Withdrawal by Subject|0|||
44115300|NCT03917654|78898266|FG000|Year 2|Spouse/family member request|0|||
44115301|NCT03917654|78898267|FG001|Year 2|Spouse/family member request|0|||
44115302|NCT03917654|78898268|FG002|Year 2|Spouse/family member request|0|||
44115303|NCT03917654|78898269|FG003|Year 2|Spouse/family member request|0|||
44115304|NCT03917654|78898270|FG004|Year 2|Spouse/family member request|0|||
44115305|NCT03917654|78898271|FG005|Year 2|Spouse/family member request|0|||
44115306|NCT03917654|78898272|FG006|Year 2|Spouse/family member request|1|||
44115307|NCT03917654|78898273|FG007|Year 2|Spouse/family member request|0|||
44115308|NCT03917654|78898274|FG008|Year 2|Spouse/family member request|0|||
44115309|NCT03917654|78898275|FG009|Year 2|Spouse/family member request|0|||
44115310|NCT03917654|78898276|FG010|Year 2|Spouse/family member request|0|||
44115311|NCT03917654|78898277|FG011|Year 2|Spouse/family member request|0|||
44115312|NCT03917654|78898266|FG000|Year 2|Lost to Follow-up|0|||
44115313|NCT03917654|78898267|FG001|Year 2|Lost to Follow-up|0|||
44115314|NCT03917654|78898268|FG002|Year 2|Lost to Follow-up|0|||
44115315|NCT03917654|78898269|FG003|Year 2|Lost to Follow-up|0|||
44115316|NCT03917654|78898270|FG004|Year 2|Lost to Follow-up|0|||
44115317|NCT03917654|78898271|FG005|Year 2|Lost to Follow-up|0|||
44115318|NCT03917654|78898272|FG006|Year 2|Lost to Follow-up|1|||
44115319|NCT03917654|78898273|FG007|Year 2|Lost to Follow-up|0|||
44115320|NCT03917654|78898274|FG008|Year 2|Lost to Follow-up|1|||
44115321|NCT03917654|78898275|FG009|Year 2|Lost to Follow-up|0|||
44115322|NCT03917654|78898276|FG010|Year 2|Lost to Follow-up|0|||
44115323|NCT03917654|78898277|FG011|Year 2|Lost to Follow-up|1|||
44115324|NCT03917654|78898266|FG000|Year 2|Adverse Event|0|||
44115325|NCT03917654|78898267|FG001|Year 2|Adverse Event|0|||
44115326|NCT03917654|78898268|FG002|Year 2|Adverse Event|0|||
44115327|NCT03917654|78898269|FG003|Year 2|Adverse Event|0|||
44115328|NCT03917654|78898270|FG004|Year 2|Adverse Event|0|||
44115329|NCT03917654|78898271|FG005|Year 2|Adverse Event|0|||
44115330|NCT03917654|78898272|FG006|Year 2|Adverse Event|0|||
44115331|NCT03917654|78898273|FG007|Year 2|Adverse Event|0|||
44115332|NCT03917654|78898274|FG008|Year 2|Adverse Event|0|||
44115333|NCT03917654|78898275|FG009|Year 2|Adverse Event|1|||
44115334|NCT03917654|78898276|FG010|Year 2|Adverse Event|0|||
44115335|NCT03917654|78898277|FG011|Year 2|Adverse Event|0|||
44115336|NCT03060577|78898314|FG000|Overall Study|Withdrawal by Subject|25|||
44115337|NCT03060577|78898315|FG001|Overall Study|Withdrawal by Subject|5|||
44574222|NCT02831764|79596731|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44115338|NCT03060577|78898314|FG000|Overall Study|Physician Decision|4|||
44115339|NCT03060577|78898315|FG001|Overall Study|Physician Decision|3|||
44115340|NCT03060577|78898314|FG000|Overall Study|Lost to Follow-up|3|||
44115341|NCT03060577|78898315|FG001|Overall Study|Lost to Follow-up|0|||
44115342|NCT03060577|78898314|FG000|Overall Study|Death|7|||
44115343|NCT03060577|78898315|FG001|Overall Study|Death|1|||
44505795|NCT01239368|79510624|FG000|Overall Study|Disease progression on study|1|||
44505796|NCT01239368|79510625|FG001|Overall Study|Disease progression on study|1|||
44505797|NCT01239368|79510626|FG002|Overall Study|Disease progression on study|1|||
44505798|NCT01239368|79510627|FG003|Overall Study|Disease progression on study|1|||
44505799|NCT01239368|79510628|FG004|Overall Study|Disease progression on study|4|||
44505800|NCT01239368|79510629|FG005|Overall Study|Disease progression on study|2|||
44505801|NCT01239368|79510630|FG006|Overall Study|Disease progression on study|5|||
44574223|NCT02831764|79596732|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
44574224|NCT02396199|79596741|FG000|Overall Study|Lost to Follow-up|1|||
44574225|NCT02396199|79596741|FG000|Overall Study|Death|4|||
44115344|NCT03060577|78898314|FG000|Overall Study|Adverse Event|9|||
44115345|NCT03060577|78898315|FG001|Overall Study|Adverse Event|1|||
44115346|NCT03060577|78898314|FG000|Overall Study|Inclusion/Exclusion|1|||
44115347|NCT03060577|78898315|FG001|Overall Study|Inclusion/Exclusion|0|||
44115348|NCT03060577|78898314|FG000|Overall Study|Other|8|||
44115349|NCT03060577|78898315|FG001|Overall Study|Other|2|||
44115350|NCT02872714|78898326|FG000|Overall Study|Progressive Disease|1|||
44115351|NCT02872714|78898327|FG001|Overall Study|Progressive Disease|2|||
44115352|NCT02872714|78898328|FG002|Overall Study|Progressive Disease|0|||
44505802|NCT01239368|79510631|FG007|Overall Study|Disease progression on study|0|||
44115353|NCT02872714|78898329|FG003|Overall Study|Progressive Disease|0|||
44115354|NCT02872714|78898330|FG004|Overall Study|Progressive Disease|0|||
44115355|NCT02872714|78898326|FG000|Overall Study|Death|87|||
44115356|NCT02872714|78898327|FG001|Overall Study|Death|36|||
44115357|NCT02872714|78898328|FG002|Overall Study|Death|8|||
44115358|NCT02872714|78898329|FG003|Overall Study|Death|81|||
44115359|NCT02872714|78898330|FG004|Overall Study|Death|2|||
44115360|NCT02872714|78898326|FG000|Overall Study|Lost to Follow-up|2|||
44115361|NCT02872714|78898327|FG001|Overall Study|Lost to Follow-up|1|||
44115362|NCT02872714|78898328|FG002|Overall Study|Lost to Follow-up|0|||
44115363|NCT02872714|78898329|FG003|Overall Study|Lost to Follow-up|3|||
44115364|NCT02872714|78898330|FG004|Overall Study|Lost to Follow-up|0|||
44115365|NCT02872714|78898326|FG000|Overall Study|Physician Decision|0|||
44115366|NCT02872714|78898327|FG001|Overall Study|Physician Decision|0|||
44115367|NCT02872714|78898328|FG002|Overall Study|Physician Decision|0|||
44115368|NCT02872714|78898329|FG003|Overall Study|Physician Decision|1|||
44115369|NCT02872714|78898330|FG004|Overall Study|Physician Decision|0|||
44115370|NCT02872714|78898326|FG000|Overall Study|Withdrawal by Subject|1|||
44115371|NCT02872714|78898327|FG001|Overall Study|Withdrawal by Subject|3|||
44115372|NCT02872714|78898328|FG002|Overall Study|Withdrawal by Subject|0|||
44115373|NCT02872714|78898329|FG003|Overall Study|Withdrawal by Subject|2|||
44115374|NCT02872714|78898330|FG004|Overall Study|Withdrawal by Subject|0|||
44115375|NCT02872714|78898326|FG000|Overall Study|Captured as Other|2|||
44115376|NCT02872714|78898327|FG001|Overall Study|Captured as Other|0|||
44115377|NCT02872714|78898328|FG002|Overall Study|Captured as Other|0|||
44115378|NCT02872714|78898329|FG003|Overall Study|Captured as Other|1|||
44115379|NCT02872714|78898330|FG004|Overall Study|Captured as Other|0|||
44115380|NCT02787005|78898350|FG000|Overall Study|Adverse Event|24|||
44115381|NCT02787005|78898351|FG001|Overall Study|Adverse Event|9|||
44115382|NCT02787005|78898352|FG002|Overall Study|Adverse Event|9|||
44115383|NCT02787005|78898353|FG003|Overall Study|Adverse Event|7|||
44115384|NCT02787005|78898354|FG004|Overall Study|Adverse Event|2|||
44115385|NCT02787005|78898350|FG000|Overall Study|Death|100|||
44115386|NCT02787005|78898351|FG001|Overall Study|Death|53|||
44115387|NCT02787005|78898352|FG002|Overall Study|Death|48|||
44115388|NCT02787005|78898353|FG003|Overall Study|Death|69|||
44115389|NCT02787005|78898354|FG004|Overall Study|Death|38|||
44115390|NCT02787005|78898350|FG000|Overall Study|Sponsor Decision|7|||
44115391|NCT02787005|78898351|FG001|Overall Study|Sponsor Decision|4|||
44115392|NCT02787005|78898352|FG002|Overall Study|Sponsor Decision|0|||
44115393|NCT02787005|78898353|FG003|Overall Study|Sponsor Decision|4|||
44115394|NCT02787005|78898354|FG004|Overall Study|Sponsor Decision|5|||
44115395|NCT02787005|78898350|FG000|Overall Study|Withdrawal by Subject|2|||
44115396|NCT02787005|78898351|FG001|Overall Study|Withdrawal by Subject|1|||
44115397|NCT02787005|78898352|FG002|Overall Study|Withdrawal by Subject|1|||
44115398|NCT02787005|78898353|FG003|Overall Study|Withdrawal by Subject|0|||
44115399|NCT02787005|78898354|FG004|Overall Study|Withdrawal by Subject|1|||
44505803|NCT01239368|79510632|FG008|Overall Study|Disease progression on study|0|||
44115400|NCT02787005|78898350|FG000|Overall Study|Screen Failure|0|||
44115401|NCT02787005|78898351|FG001|Overall Study|Screen Failure|2|||
44115402|NCT02787005|78898352|FG002|Overall Study|Screen Failure|0|||
44115403|NCT02787005|78898353|FG003|Overall Study|Screen Failure|0|||
44115404|NCT02787005|78898354|FG004|Overall Study|Screen Failure|1|||
44115405|NCT02787005|78898350|FG000|Overall Study|Lost to Follow-up|0|||
44115406|NCT02787005|78898351|FG001|Overall Study|Lost to Follow-up|0|||
44115407|NCT02787005|78898352|FG002|Overall Study|Lost to Follow-up|0|||
44115408|NCT02787005|78898353|FG003|Overall Study|Lost to Follow-up|1|||
44115409|NCT02787005|78898354|FG004|Overall Study|Lost to Follow-up|0|||
44505804|NCT01239368|79510633|FG009|Overall Study|Disease progression on study|2|||
44505805|NCT01239368|79510624|FG000|Overall Study|Refused further treatment|0|||
44505806|NCT01239368|79510625|FG001|Overall Study|Refused further treatment|0|||
44505807|NCT01239368|79510626|FG002|Overall Study|Refused further treatment|0|||
44505808|NCT01239368|79510627|FG003|Overall Study|Refused further treatment|0|||
44505809|NCT01239368|79510628|FG004|Overall Study|Refused further treatment|0|||
44505810|NCT01239368|79510629|FG005|Overall Study|Refused further treatment|0|||
44505811|NCT01239368|79510630|FG006|Overall Study|Refused further treatment|0|||
44505812|NCT01239368|79510631|FG007|Overall Study|Refused further treatment|0|||
44505813|NCT01239368|79510632|FG008|Overall Study|Refused further treatment|0|||
44505814|NCT01239368|79510633|FG009|Overall Study|Refused further treatment|1|||
44505815|NCT01239368|79510624|FG000|Overall Study|Death|0|||
44505816|NCT01239368|79510625|FG001|Overall Study|Death|0|||
44505817|NCT01239368|79510626|FG002|Overall Study|Death|0|||
44505818|NCT01239368|79510627|FG003|Overall Study|Death|0|||
44115410|NCT02514083|78898385|FG000|Overall Study|Adverse Event|1|||
44115411|NCT02395848|78898389|FG000|Overall Study|Lost to Follow-up|2|||
44115412|NCT02061761|78898406|FG000|Overall Study|Disease progression|2|||
44505819|NCT01239368|79510628|FG004|Overall Study|Death|0|||
44115413|NCT02061761|78898407|FG001|Overall Study|Disease progression|8|||
44115414|NCT02061761|78898408|FG002|Overall Study|Disease progression|4|||
44505820|NCT01239368|79510629|FG005|Overall Study|Death|0|||
44505821|NCT01239368|79510630|FG006|Overall Study|Death|1|||
44574226|NCT01661881|79596754|FG000|Overall Study|Disease Progression|1|||
44574227|NCT01353313|79596760|FG000|Overall Study|Lost to Follow-up|22|||
44115415|NCT02061761|78898409|FG003|Overall Study|Disease progression|5|||
44115416|NCT02061761|78898410|FG004|Overall Study|Disease progression|9|||
44115417|NCT02061761|78898411|FG005|Overall Study|Disease progression|3|||
44115418|NCT02061761|78898412|FG006|Overall Study|Disease progression|1|||
44115419|NCT02061761|78898413|FG007|Overall Study|Disease progression|2|||
44115420|NCT02061761|78898414|FG008|Overall Study|Disease progression|28|||
44115421|NCT02061761|78898406|FG000|Overall Study|Study Drug toxicity|0|||
44115422|NCT02061761|78898407|FG001|Overall Study|Study Drug toxicity|0|||
44115423|NCT02061761|78898408|FG002|Overall Study|Study Drug toxicity|0|||
44115424|NCT02061761|78898409|FG003|Overall Study|Study Drug toxicity|0|||
44115425|NCT02061761|78898410|FG004|Overall Study|Study Drug toxicity|0|||
44115426|NCT02061761|78898411|FG005|Overall Study|Study Drug toxicity|1|||
44115427|NCT02061761|78898412|FG006|Overall Study|Study Drug toxicity|0|||
44115428|NCT02061761|78898413|FG007|Overall Study|Study Drug toxicity|2|||
44115429|NCT02061761|78898414|FG008|Overall Study|Study Drug toxicity|6|||
44115430|NCT02061761|78898406|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
44115431|NCT02061761|78898407|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
44115432|NCT02061761|78898408|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
44115433|NCT02061761|78898409|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
44115434|NCT02061761|78898410|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
44115435|NCT02061761|78898411|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
44115436|NCT02061761|78898412|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
44115437|NCT02061761|78898413|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
44115438|NCT02061761|78898414|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
44115439|NCT02061761|78898406|FG000|Overall Study|Participant request to discontinue study treatment|0|||
44115440|NCT02061761|78898407|FG001|Overall Study|Participant request to discontinue study treatment|0|||
44115441|NCT02061761|78898408|FG002|Overall Study|Participant request to discontinue study treatment|2|||
44115442|NCT02061761|78898409|FG003|Overall Study|Participant request to discontinue study treatment|2|||
44115443|NCT02061761|78898410|FG004|Overall Study|Participant request to discontinue study treatment|0|||
44115444|NCT02061761|78898411|FG005|Overall Study|Participant request to discontinue study treatment|1|||
44115445|NCT02061761|78898412|FG006|Overall Study|Participant request to discontinue study treatment|0|||
44115446|NCT02061761|78898413|FG007|Overall Study|Participant request to discontinue study treatment|0|||
44115447|NCT02061761|78898414|FG008|Overall Study|Participant request to discontinue study treatment|2|||
44115448|NCT02061761|78898406|FG000|Overall Study|Withdrawal by Subject|0|||
44115449|NCT02061761|78898407|FG001|Overall Study|Withdrawal by Subject|0|||
44115450|NCT02061761|78898408|FG002|Overall Study|Withdrawal by Subject|0|||
44115451|NCT02061761|78898409|FG003|Overall Study|Withdrawal by Subject|0|||
44115452|NCT02061761|78898410|FG004|Overall Study|Withdrawal by Subject|0|||
44115453|NCT02061761|78898411|FG005|Overall Study|Withdrawal by Subject|0|||
44115454|NCT02061761|78898412|FG006|Overall Study|Withdrawal by Subject|0|||
44115455|NCT02061761|78898413|FG007|Overall Study|Withdrawal by Subject|0|||
44115456|NCT02061761|78898414|FG008|Overall Study|Withdrawal by Subject|2|||
44115457|NCT02061761|78898406|FG000|Overall Study|Maximum clinical benefit|0|||
44115458|NCT02061761|78898407|FG001|Overall Study|Maximum clinical benefit|0|||
44115459|NCT02061761|78898408|FG002|Overall Study|Maximum clinical benefit|0|||
44115460|NCT02061761|78898409|FG003|Overall Study|Maximum clinical benefit|1|||
44115461|NCT02061761|78898410|FG004|Overall Study|Maximum clinical benefit|0|||
44115462|NCT02061761|78898411|FG005|Overall Study|Maximum clinical benefit|0|||
44115463|NCT02061761|78898412|FG006|Overall Study|Maximum clinical benefit|0|||
44115464|NCT02061761|78898413|FG007|Overall Study|Maximum clinical benefit|0|||
44115465|NCT02061761|78898414|FG008|Overall Study|Maximum clinical benefit|6|||
44115466|NCT02061761|78898406|FG000|Overall Study|Participant no longer meets study criteria|0|||
44115467|NCT02061761|78898407|FG001|Overall Study|Participant no longer meets study criteria|0|||
44115468|NCT02061761|78898408|FG002|Overall Study|Participant no longer meets study criteria|0|||
44115469|NCT02061761|78898409|FG003|Overall Study|Participant no longer meets study criteria|0|||
44115470|NCT02061761|78898410|FG004|Overall Study|Participant no longer meets study criteria|0|||
44115471|NCT02061761|78898411|FG005|Overall Study|Participant no longer meets study criteria|0|||
44115472|NCT02061761|78898412|FG006|Overall Study|Participant no longer meets study criteria|0|||
44115473|NCT02061761|78898413|FG007|Overall Study|Participant no longer meets study criteria|0|||
44115474|NCT02061761|78898414|FG008|Overall Study|Participant no longer meets study criteria|1|||
44115475|NCT02061761|78898406|FG000|Overall Study|Other reasons|0|||
44115476|NCT02061761|78898407|FG001|Overall Study|Other reasons|0|||
44115477|NCT02061761|78898408|FG002|Overall Study|Other reasons|0|||
44115478|NCT02061761|78898409|FG003|Overall Study|Other reasons|0|||
44115479|NCT02061761|78898410|FG004|Overall Study|Other reasons|2|||
44115480|NCT02061761|78898411|FG005|Overall Study|Other reasons|0|||
44115481|NCT02061761|78898412|FG006|Overall Study|Other reasons|0|||
44574228|NCT01353313|79596761|FG001|Overall Study|Lost to Follow-up|23|||
44574229|NCT01353313|79596760|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
44574230|NCT01353313|79596761|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
44115482|NCT02061761|78898413|FG007|Overall Study|Other reasons|0|||
44238152|NCT02696226|79064596|FG001|Overall Study|Study terminated - lack of enrollment|0|||
44238153|NCT02696226|79064597|FG002|Overall Study|Study terminated - lack of enrollment|2|||
44238154|NCT02696226|79064598|FG003|Overall Study|Study terminated - lack of enrollment|0|||
44238155|NCT01692275|79064614|FG000|Overall Study|Lost to Follow-up|57|||
44115483|NCT02061761|78898414|FG008|Overall Study|Other reasons|6|||
44115484|NCT01927068|78898442|FG000|Overall Study|Death|37|||
44115485|NCT01927068|78898443|FG001|Overall Study|Death|3|||
44115486|NCT01927068|78898442|FG000|Overall Study|Withdrawal by Subject|50|||
44115487|NCT01927068|78898443|FG001|Overall Study|Withdrawal by Subject|3|||
44115488|NCT01927068|78898442|FG000|Overall Study|Lost to Follow-up|10|||
44115489|NCT01927068|78898443|FG001|Overall Study|Lost to Follow-up|2|||
44115490|NCT01927068|78898442|FG000|Overall Study|Physician Decision|9|||
44115491|NCT01927068|78898443|FG001|Overall Study|Physician Decision|0|||
44115492|NCT01927068|78898442|FG000|Overall Study|Missed last follow-up visit|2|||
44115493|NCT01927068|78898443|FG001|Overall Study|Missed last follow-up visit|0|||
44115494|NCT01309230|78898452|FG000|Overall Study|Withdrawal by Subject|0|||
44115495|NCT01309230|78898453|FG001|Overall Study|Withdrawal by Subject|2|||
44115496|NCT01309230|78898452|FG000|Overall Study|Observation arm closed|0|||
44238156|NCT01692275|79064615|FG001|Overall Study|Lost to Follow-up|48|||
44238157|NCT01692275|79064614|FG000|Overall Study|Withdrawal by Subject|9|||
44238158|NCT01692275|79064615|FG001|Overall Study|Withdrawal by Subject|11|||
44238159|NCT02692560|79064635|FG000|Overall Study|Withdrawal by Subject|0|||
44238160|NCT02692560|79064636|FG001|Overall Study|Withdrawal by Subject|6|||
44377956|NCT01077128|79383231|FG000|Overall Study|Adverse event and disease exacerbation|1|||
44377957|NCT01077128|79383231|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
44377958|NCT01077128|79383231|FG000|Overall Study|Other|54|||
44377959|NCT00826540|79383285|FG000|Overall Study|ineligible|3|||
44377960|NCT00826540|79383285|FG000|Overall Study|Withdrawal by Subject|1|||
44377961|NCT01077050|79383289|FG000|Overall Study|Subjects signed ICF could not be located|1|||
44377962|NCT01077050|79383289|FG000|Overall Study|Screen failure|8|||
44377963|NCT00592384|79383295|FG000|Overall Study|Withdrawal by Subject|5|||
44377964|NCT00592384|79383296|FG001|Overall Study|Withdrawal by Subject|6|||
44377965|NCT00846040|79383305|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
44377966|NCT00846040|79383306|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
44377967|NCT00846040|79383307|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
44377968|NCT00846040|79383305|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
44377969|NCT00846040|79383306|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
44377970|NCT00846040|79383307|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
44377971|NCT00826228|79383316|FG000|Overall Study|Withdrawal by Subject|1|||
44377972|NCT00825994|79383321|FG000|Overall Study|Withdrawal by Subject|2|||
44377973|NCT00825994|79383321|FG000|Overall Study|Lost to Follow-up|1|||
44377974|NCT00825994|79383321|FG000|Overall Study|Protocol Violation|1|||
44377975|NCT00825994|79383321|FG000|Overall Study|Placebo Responder at V2|1|||
44377976|NCT00825916|79383328|FG000|Overall Study|Lost to Follow-up|4|||
44377977|NCT00825916|79383329|FG001|Overall Study|Lost to Follow-up|2|||
44377978|NCT00825916|79383330|FG002|Overall Study|Lost to Follow-up|1|||
44377979|NCT00791479|79383377|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
44377980|NCT00791479|79383378|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
44377981|NCT00791479|79383379|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
44377982|NCT00791479|79383380|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
44505822|NCT01239368|79510631|FG007|Overall Study|Death|0|||
44115497|NCT01309230|78898453|FG001|Overall Study|Observation arm closed|2|||
44115498|NCT00819832|78898465|FG000|Overall Study|Sponsor Termination of Study|3|||
44238161|NCT02688192|79064644|FG000|Overall Study|Lost to Follow-up|11|||
44238162|NCT02688192|79064645|FG001|Overall Study|Lost to Follow-up|5|||
44377983|NCT00791479|79383381|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
44377984|NCT00791479|79383382|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
44377985|NCT00791479|79383377|FG000|Overall Study|Adverse Event|0|||
44377986|NCT00791479|79383378|FG001|Overall Study|Adverse Event|1|||
44377987|NCT00791479|79383379|FG002|Overall Study|Adverse Event|0|||
44377988|NCT00791479|79383380|FG003|Overall Study|Adverse Event|2|||
44505823|NCT01239368|79510632|FG008|Overall Study|Death|0|||
44505824|NCT01239368|79510633|FG009|Overall Study|Death|0|||
44505825|NCT00369161|79510681|FG000|Overall Study|Adverse Event|15|||
44505826|NCT00369161|79510682|FG001|Overall Study|Adverse Event|13|||
44505827|NCT00369161|79510681|FG000|Overall Study|Abnormal laboratory value|0|||
44505828|NCT00369161|79510682|FG001|Overall Study|Abnormal laboratory value|1|||
44505829|NCT00369161|79510681|FG000|Overall Study|Lack of Efficacy|3|||
44505830|NCT00369161|79510682|FG001|Overall Study|Lack of Efficacy|1|||
44505831|NCT00369161|79510681|FG000|Overall Study|Protocol Violation|0|||
44505832|NCT00369161|79510682|FG001|Overall Study|Protocol Violation|2|||
44505833|NCT00369161|79510681|FG000|Overall Study|Withdrawal by Subject|2|||
44505834|NCT00369161|79510682|FG001|Overall Study|Withdrawal by Subject|3|||
44505835|NCT00369161|79510681|FG000|Overall Study|Death|1|||
44505836|NCT00369161|79510682|FG001|Overall Study|Death|2|||
44115499|NCT00819832|78898466|FG001|Overall Study|Sponsor Termination of Study|0|||
44115500|NCT00819832|78898467|FG002|Overall Study|Sponsor Termination of Study|0|||
44115501|NCT00819832|78898468|FG003|Overall Study|Sponsor Termination of Study|0|||
44115502|NCT00819832|78898469|FG004|Overall Study|Sponsor Termination of Study|0|||
44377989|NCT00791479|79383381|FG004|Overall Study|Adverse Event|0|||
44377990|NCT00791479|79383382|FG005|Overall Study|Adverse Event|1|||
44377991|NCT00791479|79383377|FG000|Overall Study|Lost to Follow-up|0|||
44377992|NCT00791479|79383378|FG001|Overall Study|Lost to Follow-up|1|||
44377993|NCT00791479|79383379|FG002|Overall Study|Lost to Follow-up|0|||
44377994|NCT00791479|79383380|FG003|Overall Study|Lost to Follow-up|0|||
44377995|NCT00791479|79383381|FG004|Overall Study|Lost to Follow-up|0|||
44377996|NCT00791479|79383382|FG005|Overall Study|Lost to Follow-up|1|||
44377997|NCT00791479|79383377|FG000|Overall Study|Protocol Violation|2|||
44377998|NCT00791479|79383378|FG001|Overall Study|Protocol Violation|1|||
44377999|NCT00791479|79383379|FG002|Overall Study|Protocol Violation|0|||
44378000|NCT00791479|79383380|FG003|Overall Study|Protocol Violation|1|||
44115503|NCT00819832|78898470|FG005|Overall Study|Sponsor Termination of Study|0|||
44115504|NCT00704522|78898486|FG000|Overall Study|Lack of Efficacy|65|||
44115505|NCT00704522|78898487|FG001|Overall Study|Lack of Efficacy|17|||
44115506|NCT00704522|78898486|FG000|Overall Study|Failure to appear again at hospital|56|||
44115507|NCT00704522|78898487|FG001|Overall Study|Failure to appear again at hospital|10|||
44115508|NCT00704522|78898486|FG000|Overall Study|Withdrawal by Subject|17|||
44115509|NCT00704522|78898487|FG001|Overall Study|Withdrawal by Subject|8|||
44115510|NCT00704522|78898486|FG000|Overall Study|Adverse Event|9|||
44115511|NCT00704522|78898487|FG001|Overall Study|Adverse Event|1|||
44115512|NCT00704522|78898486|FG000|Overall Study|Undefined causes|9|||
44115513|NCT00704522|78898487|FG001|Overall Study|Undefined causes|7|||
44378001|NCT00791479|79383381|FG004|Overall Study|Protocol Violation|0|||
44378002|NCT00791479|79383382|FG005|Overall Study|Protocol Violation|0|||
44115514|NCT00704522|78898486|FG000|Overall Study|No information on therapy end|27|||
44115515|NCT00704522|78898487|FG001|Overall Study|No information on therapy end|2|||
44115516|NCT02723630|78898502|FG000|Intervention Period 1|Adverse Event|1|||
44115517|NCT02723630|78898503|FG001|Intervention Period 1|Adverse Event|0|||
44115518|NCT02723630|78898504|FG002|Intervention Period 1|Adverse Event|0|||
44115519|NCT02723630|78898505|FG003|Intervention Period 1|Adverse Event|0|||
44115520|NCT02723630|78898506|FG004|Intervention Period 1|Adverse Event|0|||
44115521|NCT02723630|78898507|FG005|Intervention Period 1|Adverse Event|0|||
44115522|NCT02723630|78898502|FG000|Intervention Period 3|consumption of restricted item|0|||
44115523|NCT02723630|78898503|FG001|Intervention Period 3|consumption of restricted item|1|||
44115524|NCT02723630|78898504|FG002|Intervention Period 3|consumption of restricted item|0|||
44115525|NCT02723630|78898505|FG003|Intervention Period 3|consumption of restricted item|0|||
44115526|NCT02723630|78898506|FG004|Intervention Period 3|consumption of restricted item|0|||
44115527|NCT02723630|78898507|FG005|Intervention Period 3|consumption of restricted item|0|||
44115528|NCT04089735|78898550|FG000|Overall Study|Adverse Event|1|||
44115529|NCT04089735|78898551|FG001|Overall Study|Adverse Event|0|||
44115530|NCT04089735|78898552|FG002|Overall Study|Adverse Event|1|||
44378003|NCT00791479|79383377|FG000|Overall Study|Withdrawal by Subject|0|||
44378004|NCT00791479|79383378|FG001|Overall Study|Withdrawal by Subject|0|||
44505837|NCT00369161|79510681|FG000|Overall Study|Graft loss|4|||
44505838|NCT00369161|79510682|FG001|Overall Study|Graft loss|0|||
44505839|NCT00369161|79510681|FG000|Overall Study|Administrative Problem|2|||
44505840|NCT00369161|79510682|FG001|Overall Study|Administrative Problem|2|||
44505841|NCT00337571|79510692|FG000|Overall Study|Lack of Efficacy|3|||
44505842|NCT00337571|79510693|FG001|Overall Study|Lack of Efficacy|0|||
44505843|NCT00337571|79510694|FG002|Overall Study|Lack of Efficacy|0|||
44505844|NCT00337571|79510695|FG003|Overall Study|Lack of Efficacy|0|||
44505845|NCT00337571|79510692|FG000|Overall Study|Adverse Event|4|||
44505846|NCT00337571|79510693|FG001|Overall Study|Adverse Event|5|||
44505847|NCT00337571|79510694|FG002|Overall Study|Adverse Event|8|||
44505848|NCT00337571|79510695|FG003|Overall Study|Adverse Event|4|||
44505849|NCT00337571|79510692|FG000|Overall Study|Withdrawal by Subject|2|||
44505850|NCT00337571|79510693|FG001|Overall Study|Withdrawal by Subject|2|||
44378005|NCT00791479|79383379|FG002|Overall Study|Withdrawal by Subject|0|||
44505851|NCT00337571|79510694|FG002|Overall Study|Withdrawal by Subject|1|||
44505852|NCT00337571|79510695|FG003|Overall Study|Withdrawal by Subject|0|||
44505853|NCT00337571|79510692|FG000|Overall Study|Lost to Follow-up|3|||
44115531|NCT04089735|78898553|FG003|Overall Study|Adverse Event|1|||
44115532|NCT04089735|78898554|FG004|Overall Study|Adverse Event|0|||
44115533|NCT04089735|78898555|FG005|Overall Study|Adverse Event|0|||
44115534|NCT04089735|78898550|FG000|Overall Study|Physician Decision|0|||
44115535|NCT04089735|78898551|FG001|Overall Study|Physician Decision|3|||
44115536|NCT04089735|78898552|FG002|Overall Study|Physician Decision|0|||
44378006|NCT00791479|79383380|FG003|Overall Study|Withdrawal by Subject|1|||
44378007|NCT00791479|79383381|FG004|Overall Study|Withdrawal by Subject|0|||
44378008|NCT00791479|79383382|FG005|Overall Study|Withdrawal by Subject|1|||
44378009|NCT00890097|79383406|FG000|Overall Study|Adverse Event|21|||
44505854|NCT00337571|79510693|FG001|Overall Study|Lost to Follow-up|1|||
44115537|NCT04089735|78898553|FG003|Overall Study|Physician Decision|0|||
44115538|NCT04089735|78898554|FG004|Overall Study|Physician Decision|0|||
44115539|NCT04089735|78898555|FG005|Overall Study|Physician Decision|0|||
44115540|NCT04089735|78898550|FG000|Overall Study|Withdrawal by Subject|0|||
44115541|NCT04089735|78898551|FG001|Overall Study|Withdrawal by Subject|0|||
44115542|NCT04089735|78898552|FG002|Overall Study|Withdrawal by Subject|1|||
44115543|NCT04089735|78898553|FG003|Overall Study|Withdrawal by Subject|0|||
44115544|NCT04089735|78898554|FG004|Overall Study|Withdrawal by Subject|0|||
44115545|NCT04089735|78898555|FG005|Overall Study|Withdrawal by Subject|0|||
44115546|NCT04089735|78898550|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
44115547|NCT04089735|78898551|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
44115548|NCT04089735|78898552|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
44115549|NCT04089735|78898553|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
44115550|NCT04089735|78898554|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
44115551|NCT04089735|78898555|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
44115552|NCT01876784|78898571|FG000|Overall Study|Withdrawal by Subject|17|||
44115553|NCT01876784|78898572|FG001|Overall Study|Withdrawal by Subject|2|||
44115554|NCT01876784|78898571|FG000|Overall Study|Adverse Event|15|||
44115555|NCT01876784|78898572|FG001|Overall Study|Adverse Event|2|||
44115556|NCT01876784|78898571|FG000|Overall Study|Protocol Violation|1|||
44115557|NCT01876784|78898572|FG001|Overall Study|Protocol Violation|0|||
44115558|NCT01876784|78898571|FG000|Overall Study|Disease progression|37|||
44115559|NCT01876784|78898572|FG001|Overall Study|Disease progression|67|||
44115560|NCT01876784|78898571|FG000|Overall Study|Lost to Follow-up|0|||
44115561|NCT01876784|78898572|FG001|Overall Study|Lost to Follow-up|1|||
44115562|NCT01876784|78898571|FG000|Overall Study|Death|1|||
44115563|NCT01876784|78898572|FG001|Overall Study|Death|0|||
44115564|NCT01876784|78898571|FG000|Overall Study|Randomized but not treated|2|||
44115565|NCT01876784|78898572|FG001|Overall Study|Randomized but not treated|1|||
44115566|NCT01876784|78898571|FG000|Overall Study|Other than specified above|5|||
44115567|NCT01876784|78898572|FG001|Overall Study|Other than specified above|6|||
44115568|NCT01876784|78898571|FG000|Overall Study|Ongoing|41|||
44115569|NCT01876784|78898572|FG001|Overall Study|Ongoing|40|||
44115570|NCT04205162|78898580|FG000|Overall Study|Lost to Follow-up|1|||
44115571|NCT04205162|78898581|FG001|Overall Study|Lost to Follow-up|0|||
44115572|NCT04205162|78898580|FG000|Overall Study|Withdrawal by Subject|2|||
44115573|NCT04205162|78898581|FG001|Overall Study|Withdrawal by Subject|0|||
44238163|NCT02688192|79064644|FG000|Overall Study|Physician Decision|1|||
44574231|NCT02764320|79596769|FG000|Overall Study|Withdrawal by Subject|35|||
44574232|NCT02764320|79596770|FG001|Overall Study|Withdrawal by Subject|38|||
44574233|NCT02764320|79596769|FG000|Overall Study|Protocol Violation|11|||
44574234|NCT02764320|79596770|FG001|Overall Study|Protocol Violation|6|||
44115574|NCT04205162|78898580|FG000|Overall Study|University closure due to COVID-19|1|||
44115575|NCT04205162|78898581|FG001|Overall Study|University closure due to COVID-19|0|||
44115576|NCT01329939|78898606|FG000|Overall Study|Lost to Follow-up|3|||
44115577|NCT01329939|78898607|FG001|Overall Study|Lost to Follow-up|0|||
44115578|NCT01329939|78898608|FG002|Overall Study|Lost to Follow-up|1|||
44115579|NCT01329939|78898609|FG003|Overall Study|Lost to Follow-up|2|||
44115580|NCT01329939|78898606|FG000|Overall Study|Withdrawal by Subject|0|||
44115581|NCT01329939|78898607|FG001|Overall Study|Withdrawal by Subject|1|||
44115582|NCT01329939|78898608|FG002|Overall Study|Withdrawal by Subject|0|||
44115583|NCT01329939|78898609|FG003|Overall Study|Withdrawal by Subject|0|||
44115584|NCT01329939|78898606|FG000|Overall Study|Adverse Event|0|||
44238164|NCT02688192|79064645|FG001|Overall Study|Physician Decision|0|||
44574235|NCT02764320|79596769|FG000|Overall Study|Adverse Event|2|||
44574236|NCT02764320|79596770|FG001|Overall Study|Adverse Event|0|||
44574237|NCT02764320|79596769|FG000|Overall Study|Health Issues unable to continue|2|||
44574238|NCT02764320|79596770|FG001|Overall Study|Health Issues unable to continue|0|||
44574239|NCT02764320|79596769|FG000|Overall Study|Did not meet inclusion criteria|1|||
44238165|NCT01579565|79064654|FG000|Randomized|Adverse Event|1|||
44238166|NCT01579565|79064655|FG001|Randomized|Adverse Event|3|||
44574240|NCT02764320|79596770|FG001|Overall Study|Did not meet inclusion criteria|0|||
44574241|NCT02764320|79596769|FG000|Overall Study|Subject moved|0|||
44574242|NCT02764320|79596770|FG001|Overall Study|Subject moved|2|||
44574243|NCT02764320|79596769|FG000|Overall Study|Overused medication unavailable|0|||
44115585|NCT01329939|78898607|FG001|Overall Study|Adverse Event|0|||
44115586|NCT01329939|78898608|FG002|Overall Study|Adverse Event|0|||
44115587|NCT01329939|78898609|FG003|Overall Study|Adverse Event|3|||
44115588|NCT02499900|78898621|FG000|Core Study Period|Other|1|||
44115589|NCT02499900|78898622|FG001|Core Study Period|Other|4|||
44115590|NCT02499900|78898621|FG000|Core Study Period|Lost to Follow-up|1|||
44115591|NCT02499900|78898622|FG001|Core Study Period|Lost to Follow-up|2|||
44115592|NCT02499900|78898621|FG000|Core Study Period|Per sponsor request|0|||
44238167|NCT01579565|79064654|FG000|Randomized|Withdrawal by Subject|3|||
44115593|NCT02499900|78898622|FG001|Core Study Period|Per sponsor request|1|||
44115594|NCT02499900|78898621|FG000|Core Study Period|Pregnancy|1|||
44115595|NCT02499900|78898622|FG001|Core Study Period|Pregnancy|0|||
44115596|NCT02499900|78898621|FG000|Core Study Period|Protocol Violation|3|||
44115597|NCT02499900|78898622|FG001|Core Study Period|Protocol Violation|0|||
44115598|NCT02499900|78898621|FG000|Core Study Period|Withdrawal by Subject|11|||
44115599|NCT02499900|78898622|FG001|Core Study Period|Withdrawal by Subject|10|||
44115600|NCT02499900|78898621|FG000|Core Study Period|Adverse Event|18|||
44115601|NCT02499900|78898622|FG001|Core Study Period|Adverse Event|14|||
44115602|NCT02499900|78898621|FG000|Core Study Period|Death|0|||
44574244|NCT02764320|79596770|FG001|Overall Study|Overused medication unavailable|1|||
44574245|NCT02764320|79596769|FG000|Overall Study|Seeking care outside site|0|||
44574246|NCT02764320|79596770|FG001|Overall Study|Seeking care outside site|1|||
44574247|NCT02764320|79596769|FG000|Overall Study|Technology barriers|0|||
44574248|NCT02764320|79596770|FG001|Overall Study|Technology barriers|1|||
44574249|NCT02851407|79596778|FG000|Overall Study|Withdrawal by parent/guardian|2|||
44574250|NCT02851407|79596779|FG001|Overall Study|Withdrawal by parent/guardian|7|||
44574251|NCT02851407|79596778|FG000|Overall Study|Protocol deviation|0|||
44115603|NCT02499900|78898622|FG001|Core Study Period|Death|1|||
44115604|NCT02499900|78898621|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
44115605|NCT02499900|78898622|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
44115606|NCT02499900|78898621|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
44115607|NCT02499900|78898622|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
44115608|NCT02499900|78898621|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
44115609|NCT02499900|78898622|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
44115610|NCT02499900|78898621|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
44115611|NCT02499900|78898622|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
44115612|NCT02499900|78898621|FG000|Extension Study Period|Adverse Event|2|||
44115613|NCT02499900|78898622|FG001|Extension Study Period|Adverse Event|4|||
44115614|NCT02499900|78898621|FG000|Extension Study Period|Withdrawal by Subject|5|||
44115615|NCT02499900|78898622|FG001|Extension Study Period|Withdrawal by Subject|2|||
44115616|NCT02499900|78898621|FG000|Extension Study Period|Physician Decision|2|||
44115617|NCT02499900|78898622|FG001|Extension Study Period|Physician Decision|5|||
44115618|NCT02499900|78898621|FG000|Extension Study Period|Pregnancy|1|||
44115619|NCT02499900|78898622|FG001|Extension Study Period|Pregnancy|2|||
44115620|NCT02499900|78898621|FG000|Extension Study Period|Lost to Follow-up|2|||
44115621|NCT02499900|78898622|FG001|Extension Study Period|Lost to Follow-up|5|||
44115622|NCT02499900|78898621|FG000|Extension Study Period|Other|0|||
44115623|NCT02499900|78898622|FG001|Extension Study Period|Other|2|||
44115624|NCT03505749|78898636|FG000|Overall Study|Lost to Follow-up|7|||
44115625|NCT03505749|78898637|FG001|Overall Study|Lost to Follow-up|11|||
44115626|NCT03505749|78898636|FG000|Overall Study|Withdrawal by Subject|6|||
44115627|NCT03505749|78898637|FG001|Overall Study|Withdrawal by Subject|0|||
44115628|NCT03505749|78898636|FG000|Overall Study|Discharged from treatment|3|||
44115629|NCT03505749|78898637|FG001|Overall Study|Discharged from treatment|6|||
44115630|NCT03436797|78898659|FG000|Overall Study|Withdrawal by Subject|2|||
44115631|NCT03436797|78898659|FG000|Overall Study|Adverse Event|4|||
44115632|NCT03436797|78898659|FG000|Overall Study|Lost to Follow-up|1|||
44115633|NCT03436797|78898659|FG000|Overall Study|Death|1|||
44115634|NCT03436797|78898659|FG000|Overall Study|Non-Specific|2|||
44115635|NCT03710642|78898668|FG000|Overall Study|Adverse Event|5|||
44115636|NCT03710642|78898669|FG001|Overall Study|Adverse Event|1|||
44115637|NCT03710642|78898668|FG000|Overall Study|non-site physician recommendation|1|||
44115638|NCT03710642|78898669|FG001|Overall Study|non-site physician recommendation|0|||
44115639|NCT03710642|78898668|FG000|Overall Study|Participant unwilling or unable to participate|1|||
44115640|NCT03710642|78898669|FG001|Overall Study|Participant unwilling or unable to participate|1|||
44115641|NCT03710642|78898668|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
44115642|NCT03710642|78898669|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
44115643|NCT03710642|78898668|FG000|Overall Study|NA-no code provided|1|||
44378010|NCT00890097|79383407|FG001|Overall Study|Adverse Event|32|||
44574252|NCT02851407|79596779|FG001|Overall Study|Protocol deviation|1|||
44574253|NCT02851407|79596778|FG000|Overall Study|Transferred to another hospital to continue|1|||
44574254|NCT02851407|79596779|FG001|Overall Study|Transferred to another hospital to continue|0|||
44574255|NCT02851407|79596778|FG000|Overall Study|Other Death|30|||
44115644|NCT03710642|78898669|FG001|Overall Study|NA-no code provided|0|||
44115645|NCT03710642|78898668|FG000|Overall Study|Withdrawal by Subject|1|||
44574256|NCT02851407|79596779|FG001|Overall Study|Other Death|20|||
44115646|NCT03710642|78898669|FG001|Overall Study|Withdrawal by Subject|0|||
44115647|NCT00705224|78898675|FG000|Overall Study|Adverse Event|1|||
44115648|NCT00705224|78898675|FG000|Overall Study|Lack of Efficacy|2|||
44115649|NCT00705224|78898675|FG000|Overall Study|Withdrawal by Subject|3|||
44115650|NCT00705224|78898675|FG000|Overall Study|Lost to Follow-up|5|||
44115651|NCT02722148|78898682|FG000|Overall Study|Lost to Follow-up|2|||
44115652|NCT02722148|78898682|FG000|Overall Study|Non compliant with treatment regimen|3|||
44115653|NCT00704132|78898688|FG000|Overall Study|Clinical Adverse Experience|1|||
44115654|NCT00704132|78898689|FG001|Overall Study|Clinical Adverse Experience|0|||
44115655|NCT00704132|78898688|FG000|Overall Study|Lack of Efficacy|0|||
44115656|NCT00704132|78898689|FG001|Overall Study|Lack of Efficacy|1|||
44115657|NCT00704132|78898688|FG000|Overall Study|Withdrawal by Subject|0|||
44115658|NCT00704132|78898689|FG001|Overall Study|Withdrawal by Subject|1|||
44115659|NCT01329549|78898704|FG000|Overall Study|Withdrawal by Subject|1|||
44115660|NCT01329549|78898704|FG000|Overall Study|Adverse Event|1|||
44115661|NCT02736474|78898710|FG000|Overall Study|Lost to Follow-up|0|||
44115662|NCT02736474|78898711|FG001|Overall Study|Lost to Follow-up|1|||
44115663|NCT00702650|78898733|FG000|Overall Study|Withdrawal by Subject|9|||
44115664|NCT00702650|78898733|FG000|Overall Study|Non-Compliance of Study Drug|3|||
44115665|NCT00702650|78898733|FG000|Overall Study|Lost to Follow-up|2|||
44115666|NCT00702650|78898733|FG000|Overall Study|Non-Compliance with Site Directives|1|||
44115667|NCT00702650|78898733|FG000|Overall Study|Sponsor Request|1|||
44115668|NCT00702650|78898733|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
44115669|NCT00702650|78898733|FG000|Overall Study|Adverse Event|3|||
44115670|NCT01337115|78898739|FG000|Overall Study|Protocol Violation|2|||
44574257|NCT02851407|79596778|FG000|Overall Study|Adverse event, serious fatal|6|||
44574258|NCT02851407|79596779|FG001|Overall Study|Adverse event, serious fatal|8|||
44574259|NCT02851407|79596778|FG000|Overall Study|Consent withdrawn by participant|5|||
44574260|NCT02851407|79596779|FG001|Overall Study|Consent withdrawn by participant|3|||
44574261|NCT02851407|79596778|FG000|Overall Study|Screen failure|2|||
44574262|NCT02851407|79596779|FG001|Overall Study|Screen failure|1|||
44574263|NCT02851407|79596778|FG000|Overall Study|Disease relapse|9|||
44574264|NCT02851407|79596779|FG001|Overall Study|Disease relapse|6|||
44574265|NCT02851407|79596778|FG000|Overall Study|Physician Decision|7|||
44574266|NCT02851407|79596779|FG001|Overall Study|Physician Decision|6|||
44574267|NCT02851407|79596778|FG000|Overall Study|Transferred to hospital closer to home|0|||
44574268|NCT02851407|79596779|FG001|Overall Study|Transferred to hospital closer to home|1|||
44574269|NCT02851407|79596778|FG000|Overall Study|Enrolled in an investigational study|0|||
44574270|NCT02851407|79596779|FG001|Overall Study|Enrolled in an investigational study|1|||
44574271|NCT02851407|79596778|FG000|Overall Study|Early recovery|1|||
44574272|NCT02851407|79596779|FG001|Overall Study|Early recovery|0|||
44574273|NCT02851407|79596778|FG000|Overall Study|Adverse event, non-fatal|7|||
44574274|NCT02851407|79596779|FG001|Overall Study|Adverse event, non-fatal|5|||
44115671|NCT01337115|78898740|FG001|Overall Study|Protocol Violation|0|||
44115672|NCT03761784|78898750|FG000|Overall Study|Adverse Event|4|||
44115673|NCT03761784|78898751|FG001|Overall Study|Adverse Event|0|||
44115674|NCT03761784|78898750|FG000|Overall Study|Lost to Follow-up|10|||
44115675|NCT03761784|78898751|FG001|Overall Study|Lost to Follow-up|7|||
44115676|NCT03761784|78898750|FG000|Overall Study|Pregnancy|1|||
44115677|NCT03761784|78898751|FG001|Overall Study|Pregnancy|0|||
44574275|NCT02851407|79596778|FG000|Overall Study|Lost to Follow-up|0|||
44574276|NCT02851407|79596779|FG001|Overall Study|Lost to Follow-up|2|||
44574277|NCT02636608|79596785|FG000|Overall Study|Failure to Return|4|||
44574278|NCT02636608|79596785|FG000|Overall Study|Insufficient Virological Response|1|||
44574279|NCT02636608|79596785|FG000|Overall Study|Death|3|||
44574280|NCT02636608|79596785|FG000|Overall Study|Other|2|||
44574281|NCT02636608|79596785|FG000|Overall Study|Did Not Receive Treatment|1|||
44574282|NCT02759562|79596794|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
44574283|NCT02759562|79596795|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
44574284|NCT02759562|79596794|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
44574285|NCT02759562|79596795|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
44574286|NCT02746575|79596802|FG000|Overall Study|Surgery cancelled or time chaned|13|||
44574287|NCT02746575|79596802|FG000|Overall Study|Received epidural|10|||
44574288|NCT02746575|79596802|FG000|Overall Study|Withdrawal by Subject|3|||
44574289|NCT02746575|79596802|FG000|Overall Study|Bradycardia/hypotension|9|||
44574290|NCT02746575|79596802|FG000|Overall Study|Study paused|8|||
44574291|NCT02746575|79596802|FG000|Overall Study|put on beta-blocker|3|||
44574292|NCT02746575|79596802|FG000|Overall Study|type of surgery|1|||
44115678|NCT03761784|78898750|FG000|Overall Study|Protocol Violation|2|||
44115679|NCT03761784|78898751|FG001|Overall Study|Protocol Violation|0|||
44115680|NCT03761784|78898750|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
44238168|NCT01579565|79064655|FG001|Randomized|Withdrawal by Subject|0|||
44574293|NCT02746575|79596802|FG000|Overall Study|typ of surgery|1|||
44574294|NCT02746575|79596802|FG000|Overall Study|PI unavailable|1|||
44574295|NCT02746575|79596802|FG000|Overall Study|Unknown history of CVA|1|||
44574296|NCT03625466|79596808|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
44115681|NCT03761784|78898751|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
44115682|NCT03761784|78898750|FG000|Overall Study|Withdrawal by Subject|9|||
44115683|NCT03761784|78898751|FG001|Overall Study|Withdrawal by Subject|4|||
44115684|NCT03761784|78898750|FG000|Overall Study|Physician Decision|1|||
44115685|NCT03761784|78898751|FG001|Overall Study|Physician Decision|0|||
44115686|NCT03761784|78898750|FG000|Overall Study|Other Than Specified|1|||
44115687|NCT03761784|78898751|FG001|Overall Study|Other Than Specified|0|||
44574297|NCT03625466|79596809|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
44574298|NCT03625466|79596810|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
44574299|NCT03625466|79596808|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
44574300|NCT03625466|79596809|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
44574301|NCT03625466|79596810|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
44574302|NCT03625466|79596808|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
44574303|NCT03625466|79596809|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
44115688|NCT03195894|78898759|FG000|Overall Study|"An example is Started other treatment."|4|||
44115689|NCT03195894|78898760|FG001|Overall Study|"An example is Started other treatment."|5|||
44115690|NCT03195894|78898759|FG000|Overall Study|Withdrawal by Subject|15|||
44115691|NCT03195894|78898760|FG001|Overall Study|Withdrawal by Subject|4|||
44115692|NCT03195894|78898759|FG000|Overall Study|Lost to Follow-up|14|||
44115693|NCT03195894|78898760|FG001|Overall Study|Lost to Follow-up|19|||
44115694|NCT01337973|78898772|FG000|Overall Study|Lost to Follow-up|2|||
44115695|NCT01337973|78898773|FG001|Overall Study|Lost to Follow-up|4|||
44115696|NCT01337973|78898774|FG002|Overall Study|Lost to Follow-up|3|||
44115697|NCT01337973|78898772|FG000|Overall Study|Death|1|||
44115698|NCT01337973|78898773|FG001|Overall Study|Death|2|||
44115699|NCT01337973|78898774|FG002|Overall Study|Death|1|||
44115700|NCT01337973|78898772|FG000|Overall Study|Withdrawal by Subject|10|||
44115701|NCT01337973|78898773|FG001|Overall Study|Withdrawal by Subject|8|||
44115702|NCT01337973|78898774|FG002|Overall Study|Withdrawal by Subject|4|||
44115703|NCT01337973|78898772|FG000|Overall Study|missing data on primary outcome|3|||
44115704|NCT01337973|78898773|FG001|Overall Study|missing data on primary outcome|1|||
44115705|NCT01337973|78898774|FG002|Overall Study|missing data on primary outcome|3|||
44115706|NCT02929056|78898784|FG000|Overall Study|Lost to Follow-up|0|||
44115707|NCT02929056|78898785|FG001|Overall Study|Lost to Follow-up|1|||
44115708|NCT00157755|78898804|FG000|Overall Study|Death|2|||
44115709|NCT00157755|78898805|FG001|Overall Study|Death|3|||
44115710|NCT00157755|78898806|FG002|Overall Study|Death|3|||
44115711|NCT00157755|78898807|FG003|Overall Study|Death|2|||
44115712|NCT00157755|78898808|FG004|Overall Study|Death|0|||
44115713|NCT00157755|78898809|FG005|Overall Study|Death|0|||
44115714|NCT00157755|78898804|FG000|Overall Study|Lost to Follow-up|0|||
44115715|NCT00157755|78898805|FG001|Overall Study|Lost to Follow-up|0|||
44115716|NCT00157755|78898806|FG002|Overall Study|Lost to Follow-up|1|||
44115717|NCT00157755|78898807|FG003|Overall Study|Lost to Follow-up|0|||
44505855|NCT00337571|79510694|FG002|Overall Study|Lost to Follow-up|0|||
44505856|NCT00337571|79510695|FG003|Overall Study|Lost to Follow-up|1|||
44574304|NCT03625466|79596810|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
44574305|NCT02853123|79596817|FG000|Treatment Period 1|Adverse Event|0|||
44574306|NCT02853123|79596818|FG001|Treatment Period 1|Adverse Event|3|||
44574307|NCT02853123|79596817|FG000|Washout Period|Worsening of COPD|0|||
44574308|NCT02853123|79596818|FG001|Washout Period|Worsening of COPD|3|||
44574309|NCT02853123|79596817|FG000|Washout Period|Adverse Event|1|||
44574310|NCT02853123|79596818|FG001|Washout Period|Adverse Event|0|||
44574311|NCT02634346|79596828|FG000|Overall Study|Withdrawal by Subject|8|||
44574312|NCT02634346|79596829|FG001|Overall Study|Withdrawal by Subject|9|||
44574313|NCT02634346|79596830|FG002|Overall Study|Withdrawal by Subject|8|||
44574314|NCT02634346|79596828|FG000|Overall Study|Adverse Event|2|||
44574315|NCT02634346|79596829|FG001|Overall Study|Adverse Event|2|||
44574316|NCT02634346|79596830|FG002|Overall Study|Adverse Event|7|||
44574317|NCT02634346|79596828|FG000|Overall Study|Lack of Efficacy|1|||
44275945|NCT02785952|79226245|FG001|Overall Study|Other- not protocol specified|4|||
44505857|NCT00337571|79510692|FG000|Overall Study|Poor/noncompliance|1|||
44505858|NCT00337571|79510693|FG001|Overall Study|Poor/noncompliance|1|||
44505859|NCT00337571|79510694|FG002|Overall Study|Poor/noncompliance|1|||
44505860|NCT00337571|79510695|FG003|Overall Study|Poor/noncompliance|1|||
44505861|NCT00337571|79510692|FG000|Overall Study|No longer met study criteria|1|||
44505862|NCT00337571|79510693|FG001|Overall Study|No longer met study criteria|0|||
44505863|NCT00337571|79510694|FG002|Overall Study|No longer met study criteria|0|||
44505864|NCT00337571|79510695|FG003|Overall Study|No longer met study criteria|0|||
44574318|NCT02634346|79596829|FG001|Overall Study|Lack of Efficacy|2|||
44574319|NCT02634346|79596830|FG002|Overall Study|Lack of Efficacy|8|||
44574320|NCT02634346|79596828|FG000|Overall Study|Lost to Follow-up|1|||
44115718|NCT00157755|78898808|FG004|Overall Study|Lost to Follow-up|0|||
44115719|NCT00157755|78898809|FG005|Overall Study|Lost to Follow-up|0|||
44115720|NCT00157755|78898804|FG000|Overall Study|Withdrawal by Subject|0|||
44115721|NCT00157755|78898805|FG001|Overall Study|Withdrawal by Subject|0|||
44115722|NCT00157755|78898806|FG002|Overall Study|Withdrawal by Subject|1|||
44115723|NCT00157755|78898807|FG003|Overall Study|Withdrawal by Subject|1|||
44115724|NCT00157755|78898808|FG004|Overall Study|Withdrawal by Subject|1|||
44505865|NCT00337571|79510692|FG000|Overall Study|High Potassium level|0|||
44574321|NCT02634346|79596829|FG001|Overall Study|Lost to Follow-up|0|||
44574322|NCT02634346|79596830|FG002|Overall Study|Lost to Follow-up|0|||
44574323|NCT02634346|79596828|FG000|Overall Study|Protocol Violation|0|||
44115725|NCT00157755|78898809|FG005|Overall Study|Withdrawal by Subject|2|||
44115726|NCT00157755|78898804|FG000|Overall Study|Explant due to infection|0|||
44115727|NCT00157755|78898805|FG001|Overall Study|Explant due to infection|0|||
44115728|NCT00157755|78898806|FG002|Overall Study|Explant due to infection|1|||
44115729|NCT00157755|78898807|FG003|Overall Study|Explant due to infection|0|||
44115730|NCT00157755|78898808|FG004|Overall Study|Explant due to infection|0|||
44115731|NCT00157755|78898809|FG005|Overall Study|Explant due to infection|0|||
44115732|NCT00157755|78898804|FG000|Overall Study|Medical reason|0|||
44115733|NCT00157755|78898805|FG001|Overall Study|Medical reason|0|||
44115734|NCT00157755|78898806|FG002|Overall Study|Medical reason|1|||
44115735|NCT00157755|78898807|FG003|Overall Study|Medical reason|1|||
44115736|NCT00157755|78898808|FG004|Overall Study|Medical reason|0|||
44115737|NCT00157755|78898809|FG005|Overall Study|Medical reason|0|||
44115738|NCT00157755|78898804|FG000|Overall Study|Study site closure|0|||
44115739|NCT00157755|78898805|FG001|Overall Study|Study site closure|1|||
44115740|NCT00157755|78898806|FG002|Overall Study|Study site closure|0|||
44115741|NCT00157755|78898807|FG003|Overall Study|Study site closure|0|||
44115742|NCT00157755|78898808|FG004|Overall Study|Study site closure|0|||
44115743|NCT00157755|78898809|FG005|Overall Study|Study site closure|0|||
44115744|NCT00157755|78898804|FG000|Overall Study|Subject non-compliance|0|||
44115745|NCT00157755|78898805|FG001|Overall Study|Subject non-compliance|0|||
44115746|NCT00157755|78898806|FG002|Overall Study|Subject non-compliance|0|||
44115747|NCT00157755|78898807|FG003|Overall Study|Subject non-compliance|0|||
44115748|NCT00157755|78898808|FG004|Overall Study|Subject non-compliance|0|||
44115749|NCT00157755|78898809|FG005|Overall Study|Subject non-compliance|1|||
44115750|NCT00157755|78898804|FG000|Overall Study|Study completion|0|||
44574324|NCT02634346|79596829|FG001|Overall Study|Protocol Violation|1|||
44574325|NCT02634346|79596830|FG002|Overall Study|Protocol Violation|0|||
44574326|NCT00849147|79596838|FG000|Overall Study|Withdrawal by Subject|1|||
44115751|NCT00157755|78898805|FG001|Overall Study|Study completion|0|||
44115752|NCT00157755|78898806|FG002|Overall Study|Study completion|0|||
44115753|NCT00157755|78898807|FG003|Overall Study|Study completion|0|||
44115754|NCT00157755|78898808|FG004|Overall Study|Study completion|1|||
44115755|NCT00157755|78898809|FG005|Overall Study|Study completion|2|||
44115756|NCT02723006|78898818|FG000|Overall Study|Withdrawal by Subject|0|||
44115757|NCT02723006|78898819|FG001|Overall Study|Withdrawal by Subject|1|||
44115758|NCT02723006|78898820|FG002|Overall Study|Withdrawal by Subject|1|||
44115759|NCT02723006|78898818|FG000|Overall Study|Study Terminated by Sponsor|1|||
44115760|NCT02723006|78898819|FG001|Overall Study|Study Terminated by Sponsor|6|||
44115761|NCT02723006|78898820|FG002|Overall Study|Study Terminated by Sponsor|6|||
44115762|NCT00702962|78898830|FG000|Overall Study|Progressive disease|0|||
44115763|NCT00702962|78898831|FG001|Overall Study|Progressive disease|1|||
44115764|NCT00702962|78898830|FG000|Overall Study|Hospitalized for other health disorder|1|||
44115765|NCT00702962|78898831|FG001|Overall Study|Hospitalized for other health disorder|0|||
44115766|NCT01379508|78898843|FG000|Treatment to Week 104|Adverse Event|2|||
44115767|NCT01379508|78898844|FG001|Treatment to Week 104|Adverse Event|0|||
44115768|NCT01379508|78898845|FG002|Treatment to Week 104|Adverse Event|5|||
44115769|NCT01379508|78898846|FG003|Treatment to Week 104|Adverse Event|0|||
44115770|NCT01379508|78898843|FG000|Treatment to Week 104|Abnormal lab value|1|||
44115771|NCT01379508|78898844|FG001|Treatment to Week 104|Abnormal lab value|0|||
44115772|NCT01379508|78898845|FG002|Treatment to Week 104|Abnormal lab value|0|||
44115773|NCT01379508|78898846|FG003|Treatment to Week 104|Abnormal lab value|0|||
44115774|NCT01379508|78898843|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
44115775|NCT01379508|78898844|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
44115776|NCT01379508|78898845|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
44115777|NCT01379508|78898846|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
44115778|NCT01379508|78898843|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
44115779|NCT01379508|78898844|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
44115780|NCT01379508|78898845|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
44115781|NCT01379508|78898846|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
44115782|NCT01379508|78898843|FG000|Treatment to Week 104|Lost to Follow-up|5|||
44115783|NCT01379508|78898844|FG001|Treatment to Week 104|Lost to Follow-up|0|||
44115784|NCT01379508|78898845|FG002|Treatment to Week 104|Lost to Follow-up|3|||
44275946|NCT02785952|79226244|FG000|Overall Study|On protocol treatment|6|||
44275947|NCT02785952|79226245|FG001|Overall Study|On protocol treatment|3|||
44115785|NCT01379508|78898846|FG003|Treatment to Week 104|Lost to Follow-up|0|||
44115786|NCT01379508|78898843|FG000|Treatment to Week 104|Administrative problems|3|||
44115787|NCT01379508|78898844|FG001|Treatment to Week 104|Administrative problems|1|||
44115788|NCT01379508|78898845|FG002|Treatment to Week 104|Administrative problems|0|||
44115789|NCT01379508|78898846|FG003|Treatment to Week 104|Administrative problems|0|||
44115790|NCT01379508|78898843|FG000|Treatment to Week 104|Protocol Violation|1|||
44115791|NCT01379508|78898844|FG001|Treatment to Week 104|Protocol Violation|1|||
44115792|NCT01379508|78898845|FG002|Treatment to Week 104|Protocol Violation|1|||
44115793|NCT01379508|78898846|FG003|Treatment to Week 104|Protocol Violation|0|||
44378011|NCT00890097|79383408|FG002|Overall Study|Adverse Event|28|||
44115794|NCT01379508|78898843|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
44115795|NCT01379508|78898844|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
44115796|NCT01379508|78898845|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
44115797|NCT01379508|78898846|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
44115798|NCT01379508|78898843|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
44115799|NCT01379508|78898844|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
44115800|NCT01379508|78898845|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
44115801|NCT01379508|78898846|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
44115802|NCT01379508|78898843|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
44115803|NCT01379508|78898844|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
44115804|NCT01379508|78898845|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
44115805|NCT01379508|78898846|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
44115806|NCT01379508|78898843|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
44115807|NCT01379508|78898844|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
44115808|NCT01379508|78898845|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
44115809|NCT01379508|78898846|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
44115810|NCT02722928|78898862|FG000|Overall Study|Standard CT was not as required per prot|5|||
44115811|NCT02722928|78898863|FG001|Overall Study|Standard CT was not as required per prot|13|||
44115812|NCT02722928|78898862|FG000|Overall Study|Required Intraoperative MRI|5|||
44115813|NCT02722928|78898863|FG001|Overall Study|Required Intraoperative MRI|7|||
44115814|NCT02722304|78898894|FG000|Overall Study|Study Terminated by Sponsor|1|||
44115815|NCT02722304|78898895|FG001|Overall Study|Study Terminated by Sponsor|0|||
44115816|NCT02722304|78898896|FG002|Overall Study|Study Terminated by Sponsor|2|||
44115817|NCT02722304|78898897|FG003|Overall Study|Study Terminated by Sponsor|1|||
44115818|NCT02722304|78898898|FG004|Overall Study|Study Terminated by Sponsor|1|||
44115819|NCT02722304|78898894|FG000|Overall Study|Other|0|||
44115820|NCT02722304|78898895|FG001|Overall Study|Other|0|||
44115821|NCT02722304|78898896|FG002|Overall Study|Other|0|||
44115822|NCT02722304|78898897|FG003|Overall Study|Other|1|||
44115823|NCT02722304|78898898|FG004|Overall Study|Other|1|||
44115824|NCT00709956|78898914|FG000|Overall Study|Withdrawal by Subject|1|||
44115825|NCT00709956|78898915|FG001|Overall Study|Withdrawal by Subject|1|||
44115826|NCT00709956|78898914|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
44115827|NCT00709956|78898915|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
44115828|NCT02719028|78898945|FG000|Overall Study|Adverse Event|2|||
44115829|NCT02719028|78898946|FG001|Overall Study|Adverse Event|1|||
44115830|NCT02719028|78898947|FG002|Overall Study|Adverse Event|4|||
44115831|NCT02719028|78898948|FG003|Overall Study|Adverse Event|8|||
44115832|NCT02719028|78898945|FG000|Overall Study|Physician Decision|0|||
44115833|NCT02719028|78898946|FG001|Overall Study|Physician Decision|1|||
44115834|NCT02719028|78898947|FG002|Overall Study|Physician Decision|1|||
44115835|NCT02719028|78898948|FG003|Overall Study|Physician Decision|1|||
44115836|NCT02719028|78898945|FG000|Overall Study|Use of prohibited medication|0|||
44115837|NCT02719028|78898946|FG001|Overall Study|Use of prohibited medication|0|||
44115838|NCT02719028|78898947|FG002|Overall Study|Use of prohibited medication|1|||
44115839|NCT02719028|78898948|FG003|Overall Study|Use of prohibited medication|0|||
44115840|NCT02719028|78898945|FG000|Overall Study|Protocol Violation|0|||
44115841|NCT02719028|78898946|FG001|Overall Study|Protocol Violation|0|||
44115842|NCT02719028|78898947|FG002|Overall Study|Protocol Violation|0|||
44115843|NCT02719028|78898948|FG003|Overall Study|Protocol Violation|1|||
44115844|NCT02720510|78898960|FG000|Overall Study|Study Terminated by the sponsor|2|||
44115845|NCT02720510|78898961|FG001|Overall Study|Study Terminated by the sponsor|0|||
44115846|NCT02720510|78898960|FG000|Overall Study|Adverse Event|0|||
44115847|NCT02720510|78898961|FG001|Overall Study|Adverse Event|1|||
44115848|NCT02720510|78898960|FG000|Overall Study|Physician Decision|1|||
44115849|NCT02720510|78898961|FG001|Overall Study|Physician Decision|2|||
44115850|NCT02720198|78898969|FG000|Overall Study|Withdrawal by Subject|0|||
44115851|NCT02720198|78898970|FG001|Overall Study|Withdrawal by Subject|1|||
44115852|NCT00703118|78898992|FG000|Overall Study|Adverse Event|1|||
44115853|NCT00703118|78898993|FG001|Overall Study|Adverse Event|2|||
44115854|NCT00703118|78898994|FG002|Overall Study|Adverse Event|2|||
44505866|NCT00337571|79510693|FG001|Overall Study|High Potassium level|0|||
44505867|NCT00337571|79510694|FG002|Overall Study|High Potassium level|0|||
44505868|NCT00337571|79510695|FG003|Overall Study|High Potassium level|1|||
44505869|NCT00368927|79510707|FG000|Overall Study|Lost to Follow-up|2|||
44505870|NCT00368927|79510708|FG001|Overall Study|Lost to Follow-up|0|||
44115855|NCT00703118|78898992|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
44115856|NCT00703118|78898993|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
44115857|NCT00703118|78898994|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
44115858|NCT00703118|78898992|FG000|Overall Study|Lost to Follow-up|6|||
44115859|NCT00703118|78898993|FG001|Overall Study|Lost to Follow-up|4|||
44115860|NCT00703118|78898994|FG002|Overall Study|Lost to Follow-up|4|||
44115861|NCT00703118|78898992|FG000|Overall Study|Withdrawal by Subject|8|||
44115862|NCT00703118|78898993|FG001|Overall Study|Withdrawal by Subject|7|||
44249751|NCT01504412|79083925|FG002|Overall Study|Death|0|||
44115863|NCT00703118|78898994|FG002|Overall Study|Withdrawal by Subject|13|||
44115864|NCT00703118|78898992|FG000|Overall Study|Other|0|||
44115865|NCT00703118|78898993|FG001|Overall Study|Other|0|||
44115866|NCT00703118|78898994|FG002|Overall Study|Other|1|||
44115867|NCT00909753|78899016|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
44115868|NCT00909753|78899017|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
44115869|NCT00909753|78899016|FG000|Period: Second Intervention|Protocol Violation|1|||
44115870|NCT00909753|78899017|FG001|Period: Second Intervention|Protocol Violation|0|||
44115871|NCT03715764|78899023|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
44115872|NCT03715764|78899024|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
44115873|NCT03715764|78899023|FG000|3 Month Follow-up|Lost to Follow-up|2|||
44115874|NCT03715764|78899024|FG001|3 Month Follow-up|Lost to Follow-up|2|||
44115875|NCT03715764|78899023|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
44115876|NCT03715764|78899024|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
44115877|NCT03715764|78899023|FG000|6 Month Follow-up|Lost to Follow-up|3|||
44115878|NCT03715764|78899024|FG001|6 Month Follow-up|Lost to Follow-up|0|||
44115879|NCT03715764|78899023|FG000|12 Month Follow-up|Lost to Follow-up|2|||
44115880|NCT03715764|78899024|FG001|12 Month Follow-up|Lost to Follow-up|3|||
44115881|NCT03715764|78899023|FG000|12 Month Follow-up|Pregnancy|0|||
44115882|NCT03715764|78899024|FG001|12 Month Follow-up|Pregnancy|1|||
44115883|NCT03715764|78899023|FG000|12 Month Follow-up|Surgery|2|||
44238169|NCT01579565|79064654|FG000|Randomized|inadequate preoperative pupil dilation|0|||
44275948|NCT02674685|79226253|FG000|Overall Study|Withdrawal by Subject|4|||
44275949|NCT02654236|79226260|FG000|Overall Study|Withdrawal by Subject|0|||
44275950|NCT02654236|79226261|FG001|Overall Study|Withdrawal by Subject|0|||
44275951|NCT02654236|79226262|FG002|Overall Study|Withdrawal by Subject|2|||
44275952|NCT02372136|79226272|FG000|Overall Study|Death|3|||
44275953|NCT02372136|79226273|FG001|Overall Study|Death|1|||
44505871|NCT00368927|79510707|FG000|Overall Study|Adverse Event|1|||
44505872|NCT00368927|79510708|FG001|Overall Study|Adverse Event|1|||
44505873|NCT00368927|79510707|FG000|Overall Study|Withdrawal by Subject|1|||
44505874|NCT00368927|79510708|FG001|Overall Study|Withdrawal by Subject|2|||
44505875|NCT00368927|79510707|FG000|Overall Study|Physician Decision|1|||
44505876|NCT00368927|79510708|FG001|Overall Study|Physician Decision|0|||
44505877|NCT00316589|79510731|FG000|Overall Study|Withdrawal by Subject|0|||
44505878|NCT00316589|79510732|FG001|Overall Study|Withdrawal by Subject|5|||
44505879|NCT00316589|79510733|FG002|Overall Study|Withdrawal by Subject|0|||
44505880|NCT00316589|79510734|FG003|Overall Study|Withdrawal by Subject|1|||
44574327|NCT00849147|79596838|FG000|Overall Study|Protocol Violation|2|||
44574328|NCT00849147|79596838|FG000|Overall Study|Disease Relapse/Progression|2|||
44574329|NCT00101166|79596842|FG000|Overall Study|progressive disease|10|||
44574330|NCT02759016|79596848|FG000|Overall Study|Not treated with BI 836826|1|||
44574331|NCT02759016|79596849|FG001|Overall Study|Not treated with BI 836826|0|||
44574332|NCT02759016|79596848|FG000|Overall Study|Progressive disease|1|||
44574333|NCT02759016|79596849|FG001|Overall Study|Progressive disease|0|||
44574334|NCT02759016|79596848|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
44574335|NCT02759016|79596849|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
44574336|NCT02759016|79596848|FG000|Overall Study|Other not defined above|2|||
44574337|NCT02759016|79596849|FG001|Overall Study|Other not defined above|1|||
44574338|NCT02852967|79596861|FG000|Overall Study|Adverse Event|3|||
44574339|NCT02852967|79596862|FG001|Overall Study|Adverse Event|1|||
44574340|NCT02852967|79596863|FG002|Overall Study|Adverse Event|0|||
44574341|NCT02852967|79596864|FG003|Overall Study|Adverse Event|1|||
44238170|NCT01579565|79064655|FG001|Randomized|inadequate preoperative pupil dilation|1|||
44238171|NCT01579565|79064654|FG000|Randomized|prohibited preoperative eating|1|||
44238172|NCT01579565|79064655|FG001|Randomized|prohibited preoperative eating|0|||
44238173|NCT01579565|79064654|FG000|Randomized|prohibited preoperative medication|0|||
44238174|NCT01579565|79064655|FG001|Randomized|prohibited preoperative medication|1|||
44238175|NCT01579565|79064654|FG000|Treated|Physician Decision|0|||
44238176|NCT01579565|79064655|FG001|Treated|Physician Decision|1|||
44238177|NCT01579565|79064654|FG000|Treated|Lost to Follow-up|2|||
44238178|NCT01579565|79064655|FG001|Treated|Lost to Follow-up|1|||
44238179|NCT01579565|79064654|FG000|Treated|declined to return for final visit|0|||
44505881|NCT00316589|79510731|FG000|Overall Study|Subject unwilling/unable to comply|0|||
44505882|NCT00316589|79510732|FG001|Overall Study|Subject unwilling/unable to comply|6|||
44505883|NCT00316589|79510733|FG002|Overall Study|Subject unwilling/unable to comply|0|||
44505884|NCT00316589|79510734|FG003|Overall Study|Subject unwilling/unable to comply|2|||
44505885|NCT00316589|79510731|FG000|Overall Study|Adverse Event|1|||
44574342|NCT02852967|79596865|FG004|Overall Study|Adverse Event|0|||
44574343|NCT02852967|79596861|FG000|Overall Study|Death|1|||
44574344|NCT02852967|79596862|FG001|Overall Study|Death|0|||
44115884|NCT03715764|78899024|FG001|12 Month Follow-up|Surgery|0|||
44115885|NCT03715764|78899023|FG000|12 Month Follow-up|Wrong address|1|||
44115886|NCT03715764|78899024|FG001|12 Month Follow-up|Wrong address|0|||
44115887|NCT03715764|78899023|FG000|12 Month Follow-up|No symptoms|1|||
44238180|NCT01579565|79064655|FG001|Treated|declined to return for final visit|1|||
44275954|NCT02194829|79226283|FG000|Overall Study|Adverse Event|2|||
44115888|NCT03715764|78899024|FG001|12 Month Follow-up|No symptoms|0|||
44115889|NCT03715764|78899023|FG000|12 Month Follow-up|Changed primary care centre|0|||
44115890|NCT03715764|78899024|FG001|12 Month Follow-up|Changed primary care centre|1|||
44115891|NCT02718326|78899033|FG000|Overall Study|Adverse Event|4|||
44115892|NCT02718326|78899034|FG001|Overall Study|Adverse Event|9|||
44115893|NCT02718326|78899035|FG002|Overall Study|Adverse Event|0|||
44115894|NCT02718326|78899033|FG000|Overall Study|Death|8|||
44574345|NCT02852967|79596863|FG002|Overall Study|Death|0|||
44115895|NCT02718326|78899034|FG001|Overall Study|Death|1|||
44115896|NCT02718326|78899035|FG002|Overall Study|Death|2|||
44115897|NCT02718326|78899033|FG000|Overall Study|Withdrawal by Subject|4|||
44115898|NCT02718326|78899034|FG001|Overall Study|Withdrawal by Subject|9|||
44115899|NCT02718326|78899035|FG002|Overall Study|Withdrawal by Subject|6|||
44115900|NCT02718326|78899033|FG000|Overall Study|Lost to Follow-up|18|||
44115901|NCT02718326|78899034|FG001|Overall Study|Lost to Follow-up|5|||
44115902|NCT02718326|78899035|FG002|Overall Study|Lost to Follow-up|14|||
44115903|NCT02718326|78899033|FG000|Overall Study|Protocol Deviation|1|||
44115904|NCT02718326|78899034|FG001|Overall Study|Protocol Deviation|0|||
44115905|NCT02718326|78899035|FG002|Overall Study|Protocol Deviation|0|||
44238181|NCT01578785|79064665|FG000|Overall Study|Withdrawal by Subject|0|||
44238182|NCT01578785|79064666|FG001|Overall Study|Withdrawal by Subject|1|||
44238183|NCT01578785|79064665|FG000|Overall Study|Study terminated by sponsor|59|||
44238184|NCT01578785|79064666|FG001|Overall Study|Study terminated by sponsor|118|||
44574346|NCT02852967|79596864|FG003|Overall Study|Death|0|||
44574347|NCT02852967|79596865|FG004|Overall Study|Death|0|||
44574348|NCT02852967|79596861|FG000|Overall Study|Lost to Follow-up|1|||
44574349|NCT02852967|79596862|FG001|Overall Study|Lost to Follow-up|2|||
44574350|NCT02852967|79596863|FG002|Overall Study|Lost to Follow-up|3|||
44574351|NCT02852967|79596864|FG003|Overall Study|Lost to Follow-up|4|||
44574352|NCT02852967|79596865|FG004|Overall Study|Lost to Follow-up|4|||
44574353|NCT02852967|79596861|FG000|Overall Study|Withdrawal by Subject|6|||
44574354|NCT02852967|79596862|FG001|Overall Study|Withdrawal by Subject|12|||
44574355|NCT02852967|79596863|FG002|Overall Study|Withdrawal by Subject|7|||
44574356|NCT02852967|79596864|FG003|Overall Study|Withdrawal by Subject|10|||
44574357|NCT02852967|79596865|FG004|Overall Study|Withdrawal by Subject|10|||
44115906|NCT02718326|78899033|FG000|Overall Study|Pregnancy|1|||
44238185|NCT02692482|79064674|FG000|Overall Study|Death|2|||
44238186|NCT02692482|79064675|FG001|Overall Study|Death|2|||
44238187|NCT02692482|79064674|FG000|Overall Study|Withdrawal by Subject|1|||
44238188|NCT02692482|79064675|FG001|Overall Study|Withdrawal by Subject|2|||
44238189|NCT01578551|79064684|FG000|Overall Study|Adverse Event|1|||
44238190|NCT01578551|79064685|FG001|Overall Study|Adverse Event|0|||
44238191|NCT01692197|79064692|FG000|Overall Study|Failed Screening|3|||
44238192|NCT01692119|79064699|FG000|Overall Study|Protocol Violation|3|||
44238193|NCT01692119|79064700|FG001|Overall Study|Protocol Violation|1|||
44238194|NCT01692119|79064699|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
44238195|NCT01692119|79064700|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
44238196|NCT01691885|79064706|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
44238197|NCT01691885|79064707|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
44238198|NCT01691885|79064706|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
44238199|NCT01691885|79064707|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
44238200|NCT01587703|79064740|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
44238201|NCT01587703|79064741|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238202|NCT01587703|79064742|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44505886|NCT00316589|79510732|FG001|Overall Study|Adverse Event|0|||
44505887|NCT00316589|79510733|FG002|Overall Study|Adverse Event|0|||
44505888|NCT00316589|79510734|FG003|Overall Study|Adverse Event|1|||
44505889|NCT00316589|79510731|FG000|Overall Study|Physician Decision|0|||
44505890|NCT00316589|79510732|FG001|Overall Study|Physician Decision|1|||
44505891|NCT00316589|79510733|FG002|Overall Study|Physician Decision|0|||
44505892|NCT00316589|79510734|FG003|Overall Study|Physician Decision|0|||
44505893|NCT00316589|79510731|FG000|Overall Study|Other reason|0|||
44505894|NCT00316589|79510732|FG001|Overall Study|Other reason|12|||
44505895|NCT00316589|79510733|FG002|Overall Study|Other reason|1|||
44505896|NCT00316589|79510734|FG003|Overall Study|Other reason|1|||
44505897|NCT00316277|79510748|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
44505898|NCT00316277|79510749|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
44505899|NCT00316277|79510748|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
44505900|NCT00316277|79510749|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
44574358|NCT02852967|79596861|FG000|Overall Study|SAE|0|||
44574359|NCT02852967|79596862|FG001|Overall Study|SAE|0|||
44574360|NCT02852967|79596863|FG002|Overall Study|SAE|0|||
44115907|NCT02718326|78899034|FG001|Overall Study|Pregnancy|0|||
44115908|NCT02718326|78899035|FG002|Overall Study|Pregnancy|0|||
44115909|NCT03600714|78899045|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
44115910|NCT02720042|78899084|FG000|Overall Study|Death|3|||
44115911|NCT02720042|78899084|FG000|Overall Study|Lost to Follow-up|4|||
44574361|NCT02852967|79596864|FG003|Overall Study|SAE|3|||
44574362|NCT02852967|79596865|FG004|Overall Study|SAE|0|||
44574363|NCT02852967|79596861|FG000|Overall Study|Elevated Liver Enzymes|2|||
44238203|NCT01587703|79064743|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238204|NCT01587703|79064744|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238205|NCT01587703|79064745|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238206|NCT01587703|79064746|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238207|NCT01587703|79064747|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238208|NCT01587703|79064748|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238209|NCT01587703|79064749|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238210|NCT01587703|79064750|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238211|NCT01587703|79064751|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238212|NCT01587703|79064752|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238213|NCT01587703|79064753|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238214|NCT01587703|79064754|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238215|NCT01587703|79064755|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238216|NCT01587703|79064756|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238217|NCT01587703|79064757|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238218|NCT01587703|79064758|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
44238219|NCT01587703|79064740|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238220|NCT01587703|79064741|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238221|NCT01587703|79064742|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238222|NCT01587703|79064743|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238223|NCT01587703|79064744|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238224|NCT01587703|79064745|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
44238225|NCT01587703|79064746|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238226|NCT01587703|79064747|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
44238227|NCT01587703|79064748|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238228|NCT01587703|79064749|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238229|NCT01587703|79064750|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238230|NCT01587703|79064751|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238231|NCT01587703|79064752|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238232|NCT01587703|79064753|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238233|NCT01587703|79064754|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238234|NCT01587703|79064755|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238235|NCT01587703|79064756|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238236|NCT01587703|79064757|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238237|NCT01587703|79064758|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
44238238|NCT01587703|79064740|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238239|NCT01587703|79064741|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238240|NCT01587703|79064742|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238241|NCT01587703|79064743|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238242|NCT01587703|79064744|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238243|NCT01587703|79064745|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238244|NCT01587703|79064746|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
44238245|NCT01587703|79064747|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238246|NCT01587703|79064748|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238247|NCT01587703|79064749|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238248|NCT01587703|79064750|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238249|NCT01587703|79064751|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238250|NCT01587703|79064752|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238251|NCT01587703|79064753|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44505901|NCT00316277|79510748|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
44238252|NCT01587703|79064754|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44505902|NCT00316277|79510749|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
44505903|NCT00316277|79510748|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
44505904|NCT00316277|79510749|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
44505905|NCT00316277|79510748|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
44505906|NCT00316277|79510749|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
44505907|NCT00368849|79510763|FG000|Overall Study|Withdrawal by Subject|0|||
44505908|NCT00368849|79510764|FG001|Overall Study|Withdrawal by Subject|1|||
44505909|NCT00368849|79510763|FG000|Overall Study|Physician Decision|0|||
44505910|NCT00368849|79510764|FG001|Overall Study|Physician Decision|1|||
44505911|NCT00316199|79510771|FG000|Overall Study|Adverse Event|2|||
44505912|NCT00316199|79510771|FG000|Overall Study|Death|8|||
44505913|NCT00316199|79510771|FG000|Overall Study|Lost to Follow-up|2|||
44574364|NCT02852967|79596862|FG001|Overall Study|Elevated Liver Enzymes|0|||
44574365|NCT02852967|79596863|FG002|Overall Study|Elevated Liver Enzymes|0|||
44115912|NCT02720042|78899084|FG000|Overall Study|Withdrawal by Subject|1|||
44115913|NCT02720042|78899084|FG000|Overall Study|Physician Decision|3|||
44115914|NCT02720042|78899084|FG000|Overall Study|Phasix Mesh explanted|1|||
44115915|NCT02720042|78899084|FG000|Overall Study|unable due to non-study-related illness|3|||
44115916|NCT01352793|78899090|FG000|Overall Study|Lost to Follow-up|289|||
44115917|NCT01352793|78899091|FG001|Overall Study|Lost to Follow-up|125|||
44115918|NCT01352793|78899090|FG000|Overall Study|Withdrawal by Subject|120|||
44115919|NCT01352793|78899091|FG001|Overall Study|Withdrawal by Subject|55|||
44115920|NCT01352793|78899090|FG000|Overall Study|Protocol Violation|44|||
44115921|NCT01352793|78899091|FG001|Overall Study|Protocol Violation|23|||
44115922|NCT01352793|78899090|FG000|Overall Study|Adverse Event|44|||
44115923|NCT01352793|78899091|FG001|Overall Study|Adverse Event|10|||
44115924|NCT01352793|78899090|FG000|Overall Study|Physician Decision|1|||
44115925|NCT01352793|78899091|FG001|Overall Study|Physician Decision|0|||
44115926|NCT01352793|78899090|FG000|Overall Study|Pregnancy|26|||
44115927|NCT01352793|78899091|FG001|Overall Study|Pregnancy|8|||
44115928|NCT01352793|78899090|FG000|Overall Study|Other|25|||
44115929|NCT01352793|78899091|FG001|Overall Study|Other|7|||
44115930|NCT01352793|78899090|FG000|Overall Study|Medication error|2|||
44115931|NCT01352793|78899091|FG001|Overall Study|Medication error|2|||
44115932|NCT01352793|78899090|FG000|Overall Study|Death|1|||
44115933|NCT01352793|78899091|FG001|Overall Study|Death|0|||
44115934|NCT01352793|78899090|FG000|Overall Study|Randomized but not vaccinated|8|||
44115935|NCT01352793|78899091|FG001|Overall Study|Randomized but not vaccinated|0|||
44115936|NCT01352793|78899090|FG000|Overall Study|No longer meets eligibility criteria|25|||
44115937|NCT01352793|78899091|FG001|Overall Study|No longer meets eligibility criteria|15|||
44115938|NCT02717546|78899097|FG000|Overall Study|Lost to Follow-up|12|||
44115939|NCT01378962|78899101|FG000|Overall Study|Death|14|||
44115940|NCT01378962|78899101|FG000|Overall Study|Lost to Follow-up|1|||
44115941|NCT01378962|78899101|FG000|Overall Study|Other|2|||
44115942|NCT00890409|78899107|FG000|Overall Study|Lost to Follow-up|20|||
44115943|NCT00890409|78899108|FG001|Overall Study|Lost to Follow-up|21|||
44115944|NCT04495478|78899119|FG000|Overall Study|Withdrawal by Subject|0|||
44115945|NCT04495478|78899120|FG001|Overall Study|Withdrawal by Subject|0|||
44115946|NCT04495478|78899121|FG002|Overall Study|Withdrawal by Subject|0|||
44115947|NCT04495478|78899122|FG003|Overall Study|Withdrawal by Subject|1|||
44115948|NCT04495478|78899123|FG004|Overall Study|Withdrawal by Subject|0|||
44115949|NCT04495478|78899124|FG005|Overall Study|Withdrawal by Subject|0|||
44115950|NCT04495478|78899125|FG006|Overall Study|Withdrawal by Subject|0|||
44115951|NCT04495478|78899119|FG000|Overall Study|Physician Decision|0|||
44574366|NCT02852967|79596864|FG003|Overall Study|Elevated Liver Enzymes|2|||
44574367|NCT02852967|79596865|FG004|Overall Study|Elevated Liver Enzymes|2|||
44574368|NCT02852967|79596861|FG000|Overall Study|Physician Decision|0|||
44574369|NCT02852967|79596862|FG001|Overall Study|Physician Decision|0|||
44574370|NCT02852967|79596863|FG002|Overall Study|Physician Decision|0|||
44574371|NCT02852967|79596864|FG003|Overall Study|Physician Decision|1|||
44574372|NCT02852967|79596865|FG004|Overall Study|Physician Decision|0|||
44574373|NCT02852967|79596861|FG000|Overall Study|Lack of Efficacy|0|||
44574374|NCT02852967|79596862|FG001|Overall Study|Lack of Efficacy|1|||
44574375|NCT02852967|79596863|FG002|Overall Study|Lack of Efficacy|0|||
44574376|NCT02852967|79596864|FG003|Overall Study|Lack of Efficacy|0|||
44574377|NCT02852967|79596865|FG004|Overall Study|Lack of Efficacy|0|||
44574378|NCT02852967|79596861|FG000|Overall Study|Non-compliance|0|||
44574379|NCT02852967|79596862|FG001|Overall Study|Non-compliance|0|||
44574380|NCT02852967|79596863|FG002|Overall Study|Non-compliance|1|||
44574381|NCT02852967|79596864|FG003|Overall Study|Non-compliance|1|||
44574382|NCT02852967|79596865|FG004|Overall Study|Non-compliance|0|||
44574383|NCT02852967|79596861|FG000|Overall Study|Dispensing Drug Violation|0|||
44574384|NCT02852967|79596862|FG001|Overall Study|Dispensing Drug Violation|0|||
44574385|NCT02852967|79596863|FG002|Overall Study|Dispensing Drug Violation|1|||
44574386|NCT02852967|79596864|FG003|Overall Study|Dispensing Drug Violation|0|||
44574387|NCT02852967|79596865|FG004|Overall Study|Dispensing Drug Violation|0|||
44574388|NCT02852967|79596861|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
44574389|NCT02852967|79596862|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
44574390|NCT02852967|79596863|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
44574391|NCT02852967|79596864|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
44574392|NCT02852967|79596865|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
44574393|NCT02762994|79596893|FG000|Overall Study|Withdrawal by Subject|0|||
44574394|NCT02762994|79596894|FG001|Overall Study|Withdrawal by Subject|1|||
44574395|NCT02762994|79596895|FG002|Overall Study|Withdrawal by Subject|2|||
44115952|NCT04495478|78899120|FG001|Overall Study|Physician Decision|1|||
44115953|NCT04495478|78899121|FG002|Overall Study|Physician Decision|0|||
44115954|NCT04495478|78899122|FG003|Overall Study|Physician Decision|0|||
44115955|NCT04495478|78899123|FG004|Overall Study|Physician Decision|1|||
44115956|NCT04495478|78899124|FG005|Overall Study|Physician Decision|0|||
44115957|NCT04495478|78899125|FG006|Overall Study|Physician Decision|0|||
44115958|NCT00152763|78899151|FG000|Overall Study|Death|4|||
44115959|NCT00152763|78899152|FG001|Overall Study|Death|1|||
44115960|NCT00152763|78899153|FG002|Overall Study|Death|2|||
44115961|NCT00152763|78899154|FG003|Overall Study|Death|1|||
44115962|NCT00152763|78899151|FG000|Overall Study|Lost to Follow-up|6|||
44115963|NCT00152763|78899152|FG001|Overall Study|Lost to Follow-up|4|||
44115964|NCT00152763|78899153|FG002|Overall Study|Lost to Follow-up|2|||
44115965|NCT00152763|78899154|FG003|Overall Study|Lost to Follow-up|13|||
44115966|NCT03181542|78899168|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
44115967|NCT03181542|78899169|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
44115968|NCT00806403|78899177|FG000|Overall Study|Death|4|||
44115969|NCT00806403|78899178|FG001|Overall Study|Death|3|||
44115970|NCT00701558|78899195|FG000|Overall Study|Death|7|||
44115971|NCT00701558|78899195|FG000|Overall Study|Lost to Follow-up|8|||
44115972|NCT01663402|78899218|FG000|Overall Study|Randomized but not treated|19|||
44115973|NCT01663402|78899219|FG001|Overall Study|Randomized but not treated|11|||
44115974|NCT01663402|78899218|FG000|Overall Study|Adverse Event|347|||
44115975|NCT01663402|78899219|FG001|Overall Study|Adverse Event|362|||
44115976|NCT01663402|78899218|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
44115977|NCT01663402|78899219|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
44115978|NCT01663402|78899218|FG000|Overall Study|Poor compliance to protocol|529|||
44115979|NCT01663402|78899219|FG001|Overall Study|Poor compliance to protocol|454|||
44115980|NCT01663402|78899218|FG000|Overall Study|Physician Decision|77|||
44115981|NCT01663402|78899219|FG001|Overall Study|Physician Decision|62|||
44115982|NCT01663402|78899218|FG000|Overall Study|Site terminated by sponsor|1|||
44115983|NCT01663402|78899219|FG001|Overall Study|Site terminated by sponsor|3|||
44115984|NCT01663402|78899218|FG000|Overall Study|Participant moved|139|||
44115985|NCT01663402|78899219|FG001|Overall Study|Participant moved|104|||
44115986|NCT01663402|78899218|FG000|Overall Study|Withdrawal by Subject|118|||
44115987|NCT01663402|78899219|FG001|Overall Study|Withdrawal by Subject|91|||
44115988|NCT01663402|78899218|FG000|Overall Study|Related to study drug administration|96|||
44115989|NCT01663402|78899219|FG001|Overall Study|Related to study drug administration|105|||
44115990|NCT01663402|78899218|FG000|Overall Study|Lost to Follow-up|17|||
44115991|NCT01663402|78899219|FG001|Overall Study|Lost to Follow-up|15|||
44115992|NCT01663402|78899218|FG000|Overall Study|Other than specified above|172|||
44115993|NCT01663402|78899219|FG001|Overall Study|Other than specified above|147|||
44115994|NCT00859521|78899236|FG000|Washout|Withdrawal by Subject|0|||
44115995|NCT00859521|78899237|FG001|Washout|Withdrawal by Subject|1|||
44115996|NCT00841815|78899252|FG000|Washout|Withdrawal by Subject|0|||
44115997|NCT00841815|78899253|FG001|Washout|Withdrawal by Subject|1|||
44115998|NCT00841659|78899260|FG000|Washout: 2 Weeks|Protocol Violation|1|||
44115999|NCT00841659|78899261|FG001|Washout: 2 Weeks|Protocol Violation|0|||
44116000|NCT02716298|78899265|FG000|First Intervention (1 Month)|Lens discomfort|1|||
44116001|NCT02716298|78899266|FG001|First Intervention (1 Month)|Lens discomfort|1|||
44116002|NCT00840879|78899279|FG000|Second Intervention|Withdrawal by Subject|1|||
44116003|NCT00840879|78899280|FG001|Second Intervention|Withdrawal by Subject|0|||
44116004|NCT00840411|78899295|FG000|First Intervention|Adverse Event|1|||
44116005|NCT00840411|78899296|FG001|First Intervention|Adverse Event|0|||
44116006|NCT00840411|78899295|FG000|Washout|Withdrawal by Subject|1|||
44116007|NCT00840411|78899296|FG001|Washout|Withdrawal by Subject|0|||
44116008|NCT00836901|78899309|FG000|First Intervention|Withdrawal by Subject|1|||
44116009|NCT00836901|78899310|FG001|First Intervention|Withdrawal by Subject|0|||
44116010|NCT04466384|78899314|FG000|First Phase|Protocol Violation|1|||
44116011|NCT04466384|78899315|FG001|First Phase|Protocol Violation|0|||
44116012|NCT04466384|78899314|FG000|First Phase|Missing data|1|||
44116013|NCT04466384|78899315|FG001|First Phase|Missing data|0|||
44116014|NCT04466384|78899314|FG000|Cross Over Phase|Physician Decision|1|||
44116015|NCT04466384|78899315|FG001|Cross Over Phase|Physician Decision|0|||
44116016|NCT04466384|78899314|FG000|Cross Over Phase|Withdrawal by Subject|0|||
44116017|NCT04466384|78899315|FG001|Cross Over Phase|Withdrawal by Subject|1|||
44116018|NCT03050814|78899326|FG000|Overall Study|Screen failures|0|||
44116019|NCT03050814|78899327|FG001|Overall Study|Screen failures|0|||
44116020|NCT03050814|78899328|FG002|Overall Study|Screen failures|4|||
44116021|NCT00835575|78899336|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
44116022|NCT00835575|78899337|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
44116023|NCT04601194|78899341|FG000|Overall Study|Lost to Follow-up|7|||
44116024|NCT00835263|78899354|FG000|Second Intervention|Adverse Event|1|||
44116025|NCT00835263|78899355|FG001|Second Intervention|Adverse Event|0|||
44238253|NCT01587703|79064755|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44116026|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
44116027|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
44116028|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
44116029|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
44116030|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
44116031|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
44116032|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
44116033|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
44116034|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
44116035|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
44116036|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
44116037|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
44116038|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
44116039|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
44116040|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
44116041|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
44116042|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
44116043|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
44116044|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
44116045|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
44116046|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
44116047|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
44116048|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
44116049|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
44116050|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
44116051|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
44116052|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
44378012|NCT00890097|79383406|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
44378013|NCT00890097|79383407|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
44378014|NCT00890097|79383408|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
44378015|NCT00890097|79383406|FG000|Overall Study|Withdrew Consent|9|||
44378016|NCT00890097|79383407|FG001|Overall Study|Withdrew Consent|6|||
44378017|NCT00890097|79383408|FG002|Overall Study|Withdrew Consent|9|||
44116053|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
44116054|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
44116055|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
44116056|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
44116057|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
44116058|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
44116059|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
44116060|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
44116061|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
44116062|NCT01963208|78899393|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
44116063|NCT01963208|78899394|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
44116064|NCT01963208|78899395|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
44116065|NCT01963208|78899396|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
44116066|NCT01963208|78899397|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
44116067|NCT01963208|78899398|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
44116068|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
44116069|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
44116070|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
44116071|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
44116072|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
44116073|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
44116074|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
44116075|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
44116076|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
44116077|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
44116078|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
44116079|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
44116080|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
44116081|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
44116082|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
44116083|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
44116084|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
44116085|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
44116086|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
44116087|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
44116088|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
44116089|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
44116090|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
44116091|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
44116092|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
44378018|NCT00890097|79383406|FG000|Overall Study|Lost to Follow-up|5|||
44574396|NCT02762994|79596896|FG003|Overall Study|Withdrawal by Subject|0|||
44116093|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
44378019|NCT00890097|79383407|FG001|Overall Study|Lost to Follow-up|5|||
44116094|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
44116095|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
44116096|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
44116097|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
44116098|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
44116099|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
44116100|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
44116101|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
44116102|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
44116103|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
44116104|NCT01963208|78899393|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
44116105|NCT01963208|78899394|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
44116106|NCT01963208|78899395|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
44116107|NCT01963208|78899396|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
44116108|NCT01963208|78899397|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
44116109|NCT01963208|78899398|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
44116110|NCT00834873|78899410|FG000|First Intervention|Adverse Event|0|||
44116111|NCT00834873|78899411|FG001|First Intervention|Adverse Event|1|||
44116112|NCT01377480|78899419|FG000|Overall Study|Protocol Violation|0|||
44116113|NCT01377480|78899420|FG001|Overall Study|Protocol Violation|0|||
44116114|NCT01377480|78899421|FG002|Overall Study|Protocol Violation|0|||
44116115|NCT01377480|78899422|FG003|Overall Study|Protocol Violation|4|||
44116116|NCT01377480|78899419|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
44116117|NCT01377480|78899420|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
44116118|NCT01377480|78899421|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
44116119|NCT01377480|78899422|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
44116120|NCT01377480|78899419|FG000|Overall Study|Withdrawal by Subject|0|||
44116121|NCT01377480|78899420|FG001|Overall Study|Withdrawal by Subject|0|||
44116122|NCT01377480|78899421|FG002|Overall Study|Withdrawal by Subject|1|||
44116123|NCT01377480|78899422|FG003|Overall Study|Withdrawal by Subject|0|||
44116124|NCT01377480|78899419|FG000|Overall Study|Serious adverse event|0|||
44116125|NCT01377480|78899420|FG001|Overall Study|Serious adverse event|0|||
44116126|NCT01377480|78899421|FG002|Overall Study|Serious adverse event|1|||
44116127|NCT01377480|78899422|FG003|Overall Study|Serious adverse event|1|||
44116128|NCT01377480|78899419|FG000|Overall Study|Other|0|||
44116129|NCT01377480|78899420|FG001|Overall Study|Other|0|||
44116130|NCT01377480|78899421|FG002|Overall Study|Other|7|||
44116131|NCT01377480|78899422|FG003|Overall Study|Other|6|||
44116132|NCT00834795|78899434|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
44116133|NCT00834795|78899435|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
44116134|NCT00834795|78899434|FG000|Second Intervention|Adverse Event|1|||
44116135|NCT00834795|78899435|FG001|Second Intervention|Adverse Event|0|||
44116136|NCT00834717|78899441|FG000|First Intervention|Adverse Event|1|||
44116137|NCT00834717|78899442|FG001|First Intervention|Adverse Event|0|||
44116138|NCT00834717|78899441|FG000|First Intervention|Withdrawal by Subject|0|||
44116139|NCT00834717|78899442|FG001|First Intervention|Withdrawal by Subject|1|||
44505914|NCT00316121|79510777|FG000|Overall Study|Death|1|||
44505915|NCT00316121|79510778|FG001|Overall Study|Death|0|||
44505916|NCT00316121|79510777|FG000|Overall Study|Lost to Follow-up|14|||
44505917|NCT00316121|79510778|FG001|Overall Study|Lost to Follow-up|8|||
44505918|NCT00316121|79510777|FG000|Overall Study|Withdrawal by Subject|2|||
44505919|NCT00316121|79510778|FG001|Overall Study|Withdrawal by Subject|0|||
44505920|NCT00316121|79510777|FG000|Overall Study|Reason is missing|1|||
44505921|NCT00316121|79510778|FG001|Overall Study|Reason is missing|0|||
44505922|NCT00316121|79510777|FG000|Overall Study|Subject relocated|1|||
44505923|NCT00316121|79510778|FG001|Overall Study|Subject relocated|1|||
44505924|NCT00316121|79510777|FG000|Overall Study|Subject refused to return|1|||
44505925|NCT00316121|79510778|FG001|Overall Study|Subject refused to return|0|||
44505926|NCT00316121|79510777|FG000|Overall Study|Subject no show for visit x 3|1|||
44505927|NCT00316121|79510778|FG001|Overall Study|Subject no show for visit x 3|0|||
44505928|NCT00316121|79510777|FG000|Overall Study|Subject did not have 24 month visit|1|||
44505929|NCT00316121|79510778|FG001|Overall Study|Subject did not have 24 month visit|0|||
44505930|NCT00337103|79510797|FG000|Overall Study|Progressive Disease|414|||
44116140|NCT00834639|78899448|FG000|Second Intervention|Physician Decision|0|||
44116141|NCT00834639|78899449|FG001|Second Intervention|Physician Decision|2|||
44116142|NCT00834249|78899469|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
44116143|NCT00834249|78899470|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
44116144|NCT00834249|78899469|FG000|Second Intervention|Adverse Event|1|||
44116145|NCT00834249|78899470|FG001|Second Intervention|Adverse Event|0|||
44116146|NCT00833937|78899476|FG000|Washout|Withdrawal by Subject|1|||
44116147|NCT00833937|78899477|FG001|Washout|Withdrawal by Subject|0|||
44116148|NCT00924170|78899483|FG000|Overall Study|Refused further treatment|0|||
44505931|NCT00337103|79510798|FG001|Overall Study|Progressive Disease|410|||
44505932|NCT00337103|79510797|FG000|Overall Study|Adverse Event|45|||
44505933|NCT00337103|79510798|FG001|Overall Study|Adverse Event|59|||
44505934|NCT00337103|79510797|FG000|Overall Study|Subject Choice|34|||
44116149|NCT00924170|78899484|FG001|Overall Study|Refused further treatment|1|||
44116150|NCT00924170|78899483|FG000|Overall Study|Physician Decision|0|||
44116151|NCT00924170|78899484|FG001|Overall Study|Physician Decision|1|||
44116152|NCT00924170|78899483|FG000|Overall Study|Progressive disease|3|||
44116153|NCT00924170|78899484|FG001|Overall Study|Progressive disease|6|||
44116154|NCT00924170|78899483|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
44116155|NCT00924170|78899484|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
44116156|NCT00924170|78899483|FG000|Overall Study|Death|1|||
44116157|NCT00924170|78899484|FG001|Overall Study|Death|0|||
44116158|NCT00828321|78899498|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
44116159|NCT00828321|78899499|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
44116160|NCT00828321|78899498|FG000|Second Intervention|Protocol Violation|0|||
44116161|NCT00828321|78899499|FG001|Second Intervention|Protocol Violation|1|||
44116162|NCT01352715|78899505|FG000|Overall Study|Death|3|||
44116163|NCT01352715|78899506|FG001|Overall Study|Death|3|||
44116164|NCT01352715|78899505|FG000|Overall Study|Lost to Follow-up|5|||
44116165|NCT01352715|78899506|FG001|Overall Study|Lost to Follow-up|7|||
44116166|NCT01352715|78899505|FG000|Overall Study|Withdrawal by Subject|4|||
44116167|NCT01352715|78899506|FG001|Overall Study|Withdrawal by Subject|8|||
44116168|NCT01352715|78899505|FG000|Overall Study|site closure|16|||
44116169|NCT01352715|78899506|FG001|Overall Study|site closure|15|||
44116170|NCT01352715|78899505|FG000|Overall Study|no final visit in closeout period|15|||
44116171|NCT01352715|78899506|FG001|Overall Study|no final visit in closeout period|12|||
44116172|NCT01352715|78899505|FG000|Overall Study|major ineligibility|2|||
44116173|NCT01352715|78899506|FG001|Overall Study|major ineligibility|1|||
44116174|NCT00919893|78899517|FG000|Overall Study|Protocol Violation|19|||
44116175|NCT00919893|78899518|FG001|Overall Study|Protocol Violation|9|||
44116176|NCT02559622|78899526|FG000|Overall Study|Progressive disease|0|||
44116177|NCT02559622|78899527|FG001|Overall Study|Progressive disease|1|||
44116178|NCT02559622|78899528|FG002|Overall Study|Progressive disease|0|||
44116179|NCT02559622|78899529|FG003|Overall Study|Progressive disease|0|||
44116180|NCT02559622|78899526|FG000|Overall Study|Adverse Event|0|||
44116181|NCT02559622|78899527|FG001|Overall Study|Adverse Event|2|||
44116182|NCT02559622|78899528|FG002|Overall Study|Adverse Event|2|||
44116183|NCT02559622|78899529|FG003|Overall Study|Adverse Event|2|||
44116184|NCT02559622|78899526|FG000|Overall Study|Patient/guardian decision|1|||
44116185|NCT02559622|78899527|FG001|Overall Study|Patient/guardian decision|2|||
44116186|NCT02559622|78899528|FG002|Overall Study|Patient/guardian decision|0|||
44116187|NCT02559622|78899529|FG003|Overall Study|Patient/guardian decision|1|||
44116188|NCT02559310|78899545|FG000|Overall Study|Death|4|||
44116189|NCT02559310|78899546|FG001|Overall Study|Death|3|||
44116190|NCT02559310|78899545|FG000|Overall Study|Lost to Follow-up|5|||
44116191|NCT02559310|78899546|FG001|Overall Study|Lost to Follow-up|3|||
44116192|NCT02559310|78899545|FG000|Overall Study|Physician Decision|2|||
44116193|NCT02559310|78899546|FG001|Overall Study|Physician Decision|1|||
44116194|NCT02559310|78899545|FG000|Overall Study|Withdrawal by Subject|13|||
44116195|NCT02559310|78899546|FG001|Overall Study|Withdrawal by Subject|9|||
44116196|NCT02559310|78899545|FG000|Overall Study|Sponsor Decision|0|||
44116197|NCT02559310|78899546|FG001|Overall Study|Sponsor Decision|1|||
44116198|NCT02559310|78899545|FG000|Overall Study|Randomized but not treated|3|||
44116199|NCT02559310|78899546|FG001|Overall Study|Randomized but not treated|2|||
44116200|NCT02555878|78899554|FG000|Overall Study|Lost to Follow-up|2|||
44116201|NCT02555878|78899555|FG001|Overall Study|Lost to Follow-up|3|||
44116202|NCT02555878|78899554|FG000|Overall Study|Withdrawal by Subject|48|||
44238254|NCT01587703|79064756|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238255|NCT01587703|79064757|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238256|NCT01587703|79064758|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
44238257|NCT01587703|79064740|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
44238258|NCT01587703|79064741|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
44505935|NCT00337103|79510798|FG001|Overall Study|Subject Choice|27|||
44505936|NCT00337103|79510797|FG000|Overall Study|Clinical Progression|27|||
44505937|NCT00337103|79510798|FG001|Overall Study|Clinical Progression|24|||
44505938|NCT00337103|79510797|FG000|Overall Study|Physician Decision|15|||
44505939|NCT00337103|79510798|FG001|Overall Study|Physician Decision|14|||
44505940|NCT00337103|79510797|FG000|Overall Study|Withdrawal by Subject|8|||
44116203|NCT02555878|78899555|FG001|Overall Study|Withdrawal by Subject|48|||
44116204|NCT02555878|78899554|FG000|Overall Study|Adverse Event|12|||
44116205|NCT02555878|78899555|FG001|Overall Study|Adverse Event|8|||
44116206|NCT02555878|78899554|FG000|Overall Study|Death|74|||
44116207|NCT02555878|78899555|FG001|Overall Study|Death|59|||
44116208|NCT02555878|78899554|FG000|Overall Study|Protocol Violation|1|||
44249752|NCT01504412|79083926|FG003|Overall Study|Death|1|||
44505941|NCT00337103|79510798|FG001|Overall Study|Withdrawal by Subject|5|||
44505942|NCT00337103|79510797|FG000|Overall Study|Other|5|||
44116209|NCT02555878|78899555|FG001|Overall Study|Protocol Violation|2|||
44116210|NCT02555878|78899554|FG000|Overall Study|Physician Decision|12|||
44116211|NCT02555878|78899555|FG001|Overall Study|Physician Decision|13|||
44116212|NCT02555878|78899554|FG000|Overall Study|Other|17|||
44116213|NCT02555878|78899555|FG001|Overall Study|Other|17|||
44116214|NCT02555722|78899563|FG000|Week 2|Adverse Event|0|||
44116215|NCT02555722|78899564|FG001|Week 2|Adverse Event|1|||
44116216|NCT02555722|78899563|FG000|Week 2|Withdrawal by Subject|1|||
44116217|NCT02555722|78899564|FG001|Week 2|Withdrawal by Subject|0|||
44116218|NCT02555722|78899563|FG000|Month 1|Lens Discomfort|1|||
44116219|NCT02555722|78899564|FG001|Month 1|Lens Discomfort|0|||
44116220|NCT02555722|78899563|FG000|Month 2|Withdrawal by Subject|3|||
44116221|NCT02555722|78899564|FG001|Month 2|Withdrawal by Subject|0|||
44116222|NCT02555722|78899563|FG000|Month 2|Lost to Follow-up|1|||
44116223|NCT02555722|78899564|FG001|Month 2|Lost to Follow-up|0|||
44116224|NCT03287960|78899616|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
44116225|NCT03287960|78899616|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
44116226|NCT02558296|78899623|FG000|Completed the Study Through Week 24|Adverse Event|9|||
44116227|NCT02558296|78899624|FG001|Completed the Study Through Week 24|Adverse Event|3|||
44116228|NCT02558296|78899623|FG000|Completed the Study Through Week 24|Death|7|||
44116229|NCT02558296|78899624|FG001|Completed the Study Through Week 24|Death|7|||
44116230|NCT02558296|78899623|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
44116231|NCT02558296|78899624|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
44116232|NCT02558296|78899623|FG000|Completed the Study Through Week 24|Physician Decision|1|||
44116233|NCT02558296|78899624|FG001|Completed the Study Through Week 24|Physician Decision|0|||
44116234|NCT02558296|78899623|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
44116235|NCT02558296|78899624|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
44116236|NCT02558296|78899623|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
44116237|NCT02558296|78899624|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
44116238|NCT02558296|78899623|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
44116239|NCT02558296|78899624|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
44116240|NCT02558296|78899623|FG000|Completed the Study|Adverse Event|14|||
44116241|NCT02558296|78899624|FG001|Completed the Study|Adverse Event|5|||
44116242|NCT02558296|78899623|FG000|Completed the Study|Death|39|||
44116243|NCT02558296|78899624|FG001|Completed the Study|Death|25|||
44116244|NCT02558296|78899623|FG000|Completed the Study|Lost to Follow-up|31|||
44116245|NCT02558296|78899624|FG001|Completed the Study|Lost to Follow-up|23|||
44116246|NCT02558296|78899623|FG000|Completed the Study|Physician Decision|6|||
44116247|NCT02558296|78899624|FG001|Completed the Study|Physician Decision|0|||
44116248|NCT02558296|78899623|FG000|Completed the Study|Protocol Violation|2|||
44116249|NCT02558296|78899624|FG001|Completed the Study|Protocol Violation|1|||
44116250|NCT02558296|78899623|FG000|Completed the Study|Withdrawal by Subject|53|||
44116251|NCT02558296|78899624|FG001|Completed the Study|Withdrawal by Subject|31|||
44116252|NCT02558296|78899623|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
44238259|NCT01587703|79064742|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
44574397|NCT02762994|79596893|FG000|Overall Study|Protocol Violation|1|||
44574398|NCT02762994|79596894|FG001|Overall Study|Protocol Violation|0|||
44574399|NCT02762994|79596895|FG002|Overall Study|Protocol Violation|0|||
44574400|NCT02762994|79596896|FG003|Overall Study|Protocol Violation|2|||
44574401|NCT02852265|79596912|FG000|3-month Follow-up|Lost to Follow-up|1|||
44574402|NCT02852265|79596913|FG001|3-month Follow-up|Lost to Follow-up|1|||
44574403|NCT02633800|79596925|FG000|Overall Study|Death|3|||
44574404|NCT02633800|79596926|FG001|Overall Study|Death|3|||
44574405|NCT02633800|79596925|FG000|Overall Study|Reason not provided|1|||
44574406|NCT02633800|79596926|FG001|Overall Study|Reason not provided|0|||
44574407|NCT02633800|79596925|FG000|Overall Study|Radiologic(al) progression|23|||
44574408|NCT02633800|79596926|FG001|Overall Study|Radiologic(al) progression|23|||
44574409|NCT02633800|79596925|FG000|Overall Study|Clinical progression|3|||
44574410|NCT02633800|79596926|FG001|Overall Study|Clinical progression|6|||
44574411|NCT02633800|79596925|FG000|Overall Study|Study terminated by sponsor|6|||
44574412|NCT02633800|79596926|FG001|Overall Study|Study terminated by sponsor|5|||
44574413|NCT02633800|79596925|FG000|Overall Study|Adverse event, non-fatal|7|||
44574414|NCT02633800|79596926|FG001|Overall Study|Adverse event, non-fatal|2|||
44574415|NCT02633800|79596925|FG000|Overall Study|Withdrawal by Subject|0|||
44574416|NCT02633800|79596926|FG001|Overall Study|Withdrawal by Subject|3|||
44574417|NCT02633800|79596925|FG000|Overall Study|Patient Request|1|||
44574418|NCT02633800|79596926|FG001|Overall Study|Patient Request|1|||
44574419|NCT03829657|79596935|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
44238260|NCT01587703|79064743|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
44238261|NCT01587703|79064744|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
44116253|NCT02558296|78899624|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
44116254|NCT02737475|78899661|FG000|Overall Study|Other reasons|0|||
44116255|NCT02737475|78899662|FG001|Overall Study|Other reasons|0|||
44238262|NCT01587703|79064745|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
44238263|NCT01587703|79064746|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
44238264|NCT01587703|79064747|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
44574420|NCT03829657|79596936|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
44574421|NCT03829657|79596937|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
44116256|NCT02737475|78899663|FG002|Overall Study|Other reasons|0|||
44116257|NCT02737475|78899664|FG003|Overall Study|Other reasons|0|||
44116258|NCT02737475|78899665|FG004|Overall Study|Other reasons|1|||
44116259|NCT02737475|78899666|FG005|Overall Study|Other reasons|1|||
44116260|NCT02737475|78899667|FG006|Overall Study|Other reasons|0|||
44116261|NCT02737475|78899668|FG007|Overall Study|Other reasons|0|||
44116262|NCT02737475|78899669|FG008|Overall Study|Other reasons|1|||
44116263|NCT02737475|78899670|FG009|Overall Study|Other reasons|0|||
44116264|NCT02737475|78899671|FG010|Overall Study|Other reasons|1|||
44116265|NCT02737475|78899672|FG011|Overall Study|Other reasons|0|||
44116266|NCT02737475|78899673|FG012|Overall Study|Other reasons|0|||
44116267|NCT02737475|78899674|FG013|Overall Study|Other reasons|0|||
44116268|NCT02737475|78899675|FG014|Overall Study|Other reasons|0|||
44116269|NCT02737475|78899676|FG015|Overall Study|Other reasons|0|||
44116270|NCT02737475|78899677|FG016|Overall Study|Other reasons|0|||
44116271|NCT02737475|78899678|FG017|Overall Study|Other reasons|0|||
44116272|NCT02737475|78899679|FG018|Overall Study|Other reasons|0|||
44116273|NCT02737475|78899680|FG019|Overall Study|Other reasons|0|||
44116274|NCT02737475|78899681|FG020|Overall Study|Other reasons|0|||
44116275|NCT02737475|78899682|FG021|Overall Study|Other reasons|1|||
44116276|NCT02737475|78899683|FG022|Overall Study|Other reasons|0|||
44116277|NCT02737475|78899684|FG023|Overall Study|Other reasons|1|||
44116278|NCT02737475|78899685|FG024|Overall Study|Other reasons|1|||
44116279|NCT02737475|78899686|FG025|Overall Study|Other reasons|1|||
44116280|NCT02737475|78899687|FG026|Overall Study|Other reasons|0|||
44116281|NCT02737475|78899661|FG000|Overall Study|Death|1|||
44116282|NCT02737475|78899662|FG001|Overall Study|Death|0|||
44116283|NCT02737475|78899663|FG002|Overall Study|Death|0|||
44116284|NCT02737475|78899664|FG003|Overall Study|Death|1|||
44116285|NCT02737475|78899665|FG004|Overall Study|Death|0|||
44116286|NCT02737475|78899666|FG005|Overall Study|Death|0|||
44116287|NCT02737475|78899667|FG006|Overall Study|Death|0|||
44116288|NCT02737475|78899668|FG007|Overall Study|Death|2|||
44116289|NCT02737475|78899669|FG008|Overall Study|Death|0|||
44116290|NCT02737475|78899670|FG009|Overall Study|Death|0|||
44116291|NCT02737475|78899671|FG010|Overall Study|Death|0|||
44116292|NCT02737475|78899672|FG011|Overall Study|Death|4|||
44116293|NCT02737475|78899673|FG012|Overall Study|Death|2|||
44116294|NCT02737475|78899674|FG013|Overall Study|Death|2|||
44116295|NCT02737475|78899675|FG014|Overall Study|Death|0|||
44116296|NCT02737475|78899676|FG015|Overall Study|Death|2|||
44116297|NCT02737475|78899677|FG016|Overall Study|Death|2|||
44116298|NCT02737475|78899678|FG017|Overall Study|Death|2|||
44116299|NCT02737475|78899679|FG018|Overall Study|Death|1|||
44116300|NCT02737475|78899680|FG019|Overall Study|Death|0|||
44116301|NCT02737475|78899681|FG020|Overall Study|Death|0|||
44116302|NCT02737475|78899682|FG021|Overall Study|Death|0|||
44116303|NCT02737475|78899683|FG022|Overall Study|Death|0|||
44116304|NCT02737475|78899684|FG023|Overall Study|Death|0|||
44116305|NCT02737475|78899685|FG024|Overall Study|Death|0|||
44505943|NCT00337103|79510798|FG001|Overall Study|Other|6|||
44505944|NCT00337103|79510797|FG000|Overall Study|Entry Criteria Not Met|4|||
44505945|NCT00337103|79510798|FG001|Overall Study|Entry Criteria Not Met|1|||
44505946|NCT00337103|79510797|FG000|Overall Study|Lost to Follow-up|1|||
44505947|NCT00337103|79510798|FG001|Overall Study|Lost to Follow-up|2|||
44505948|NCT00337103|79510797|FG000|Overall Study|Death|1|||
44505949|NCT00337103|79510798|FG001|Overall Study|Death|0|||
44505950|NCT00415532|79510807|FG000|Treatment Period|Adverse Event|2|||
44505951|NCT00415532|79510808|FG001|Treatment Period|Adverse Event|3|||
44505952|NCT00415532|79510807|FG000|Treatment Period|Death|2|||
44505953|NCT00415532|79510808|FG001|Treatment Period|Death|1|||
44505954|NCT00415532|79510807|FG000|Treatment Period|Lost to Follow-up|1|||
44505955|NCT00415532|79510808|FG001|Treatment Period|Lost to Follow-up|1|||
44505956|NCT00415532|79510807|FG000|Treatment Period|Protocol Violation|1|||
44505957|NCT00415532|79510808|FG001|Treatment Period|Protocol Violation|0|||
44505958|NCT00415532|79510807|FG000|Treatment Period|Withdrawal by Subject|6|||
44505959|NCT00415532|79510808|FG001|Treatment Period|Withdrawal by Subject|6|||
44116306|NCT02737475|78899686|FG025|Overall Study|Death|0|||
44116307|NCT02737475|78899687|FG026|Overall Study|Death|0|||
44116308|NCT02737475|78899661|FG000|Overall Study|Participant withdrew consent|0|||
44116309|NCT02737475|78899662|FG001|Overall Study|Participant withdrew consent|0|||
44505960|NCT00415532|79510807|FG000|Treatment Period|Other|2|||
44505961|NCT00415532|79510808|FG001|Treatment Period|Other|2|||
44505962|NCT00415532|79510807|FG000|Treatment Period|Ineligibility determined|1|||
44505963|NCT00415532|79510808|FG001|Treatment Period|Ineligibility determined|1|||
44116310|NCT02737475|78899663|FG002|Overall Study|Participant withdrew consent|0|||
44116311|NCT02737475|78899664|FG003|Overall Study|Participant withdrew consent|0|||
44116312|NCT02737475|78899665|FG004|Overall Study|Participant withdrew consent|0|||
44116313|NCT02737475|78899666|FG005|Overall Study|Participant withdrew consent|2|||
44116314|NCT02737475|78899667|FG006|Overall Study|Participant withdrew consent|0|||
44116315|NCT02737475|78899668|FG007|Overall Study|Participant withdrew consent|0|||
44116316|NCT02737475|78899669|FG008|Overall Study|Participant withdrew consent|0|||
44116317|NCT02737475|78899670|FG009|Overall Study|Participant withdrew consent|0|||
44116318|NCT02737475|78899671|FG010|Overall Study|Participant withdrew consent|0|||
44116319|NCT02737475|78899672|FG011|Overall Study|Participant withdrew consent|0|||
44116320|NCT02737475|78899673|FG012|Overall Study|Participant withdrew consent|0|||
44116321|NCT02737475|78899674|FG013|Overall Study|Participant withdrew consent|0|||
44116322|NCT02737475|78899675|FG014|Overall Study|Participant withdrew consent|1|||
44116323|NCT02737475|78899676|FG015|Overall Study|Participant withdrew consent|0|||
44116324|NCT02737475|78899677|FG016|Overall Study|Participant withdrew consent|0|||
44116325|NCT02737475|78899678|FG017|Overall Study|Participant withdrew consent|2|||
44116326|NCT02737475|78899679|FG018|Overall Study|Participant withdrew consent|1|||
44116327|NCT02737475|78899680|FG019|Overall Study|Participant withdrew consent|0|||
44116328|NCT02737475|78899681|FG020|Overall Study|Participant withdrew consent|2|||
44116329|NCT02737475|78899682|FG021|Overall Study|Participant withdrew consent|0|||
44116330|NCT02737475|78899683|FG022|Overall Study|Participant withdrew consent|0|||
44116331|NCT02737475|78899684|FG023|Overall Study|Participant withdrew consent|0|||
44116332|NCT02737475|78899685|FG024|Overall Study|Participant withdrew consent|0|||
44116333|NCT02737475|78899686|FG025|Overall Study|Participant withdrew consent|0|||
44116334|NCT02737475|78899687|FG026|Overall Study|Participant withdrew consent|0|||
44116335|NCT02737475|78899661|FG000|Overall Study|Lost to Follow-up|0|||
44116336|NCT02737475|78899662|FG001|Overall Study|Lost to Follow-up|0|||
44116337|NCT02737475|78899663|FG002|Overall Study|Lost to Follow-up|0|||
44116338|NCT02737475|78899664|FG003|Overall Study|Lost to Follow-up|0|||
44116339|NCT02737475|78899665|FG004|Overall Study|Lost to Follow-up|0|||
44116340|NCT02737475|78899666|FG005|Overall Study|Lost to Follow-up|0|||
44116341|NCT02737475|78899667|FG006|Overall Study|Lost to Follow-up|0|||
44116342|NCT02737475|78899668|FG007|Overall Study|Lost to Follow-up|0|||
44116343|NCT02737475|78899669|FG008|Overall Study|Lost to Follow-up|0|||
44116344|NCT02737475|78899670|FG009|Overall Study|Lost to Follow-up|0|||
44116345|NCT02737475|78899671|FG010|Overall Study|Lost to Follow-up|0|||
44116346|NCT02737475|78899672|FG011|Overall Study|Lost to Follow-up|0|||
44116347|NCT02737475|78899673|FG012|Overall Study|Lost to Follow-up|0|||
44116348|NCT02737475|78899674|FG013|Overall Study|Lost to Follow-up|0|||
44116349|NCT02737475|78899675|FG014|Overall Study|Lost to Follow-up|0|||
44116350|NCT02737475|78899676|FG015|Overall Study|Lost to Follow-up|1|||
44116351|NCT02737475|78899677|FG016|Overall Study|Lost to Follow-up|0|||
44116352|NCT02737475|78899678|FG017|Overall Study|Lost to Follow-up|0|||
44116353|NCT02737475|78899679|FG018|Overall Study|Lost to Follow-up|0|||
44116354|NCT02737475|78899680|FG019|Overall Study|Lost to Follow-up|0|||
44116355|NCT02737475|78899681|FG020|Overall Study|Lost to Follow-up|0|||
44116356|NCT02737475|78899682|FG021|Overall Study|Lost to Follow-up|0|||
44574422|NCT03829657|79596938|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
44574423|NCT03829657|79596939|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
44574424|NCT03829657|79596935|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
44574425|NCT03829657|79596936|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
44574426|NCT03829657|79596937|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
44574427|NCT03829657|79596938|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
44574428|NCT03829657|79596939|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
44574429|NCT03829657|79596935|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
44574430|NCT03829657|79596936|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
44574431|NCT03829657|79596937|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
44574432|NCT03829657|79596938|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
44574433|NCT03829657|79596939|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
44574434|NCT03829657|79596935|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
44116357|NCT02737475|78899683|FG022|Overall Study|Lost to Follow-up|0|||
44116358|NCT02737475|78899684|FG023|Overall Study|Lost to Follow-up|0|||
44116359|NCT02737475|78899685|FG024|Overall Study|Lost to Follow-up|0|||
44116360|NCT02737475|78899686|FG025|Overall Study|Lost to Follow-up|0|||
44116361|NCT02737475|78899687|FG026|Overall Study|Lost to Follow-up|0|||
44116362|NCT02737475|78899661|FG000|Overall Study|Disease Progression|0|||
44116363|NCT02737475|78899662|FG001|Overall Study|Disease Progression|0|||
44116364|NCT02737475|78899663|FG002|Overall Study|Disease Progression|0|||
44116365|NCT02737475|78899664|FG003|Overall Study|Disease Progression|0|||
44116366|NCT02737475|78899665|FG004|Overall Study|Disease Progression|0|||
44116367|NCT02737475|78899666|FG005|Overall Study|Disease Progression|0|||
44116368|NCT02737475|78899667|FG006|Overall Study|Disease Progression|0|||
44116369|NCT02737475|78899668|FG007|Overall Study|Disease Progression|0|||
44116370|NCT02737475|78899669|FG008|Overall Study|Disease Progression|0|||
44116371|NCT02737475|78899670|FG009|Overall Study|Disease Progression|0|||
44116372|NCT02737475|78899671|FG010|Overall Study|Disease Progression|0|||
44116373|NCT02737475|78899672|FG011|Overall Study|Disease Progression|0|||
44116374|NCT02737475|78899673|FG012|Overall Study|Disease Progression|0|||
44116375|NCT02737475|78899674|FG013|Overall Study|Disease Progression|0|||
44116376|NCT02737475|78899675|FG014|Overall Study|Disease Progression|0|||
44116377|NCT02737475|78899676|FG015|Overall Study|Disease Progression|0|||
44116378|NCT02737475|78899677|FG016|Overall Study|Disease Progression|0|||
44116379|NCT02737475|78899678|FG017|Overall Study|Disease Progression|0|||
44116380|NCT02737475|78899679|FG018|Overall Study|Disease Progression|0|||
44116381|NCT02737475|78899680|FG019|Overall Study|Disease Progression|0|||
44116382|NCT02737475|78899681|FG020|Overall Study|Disease Progression|0|||
44116383|NCT02737475|78899682|FG021|Overall Study|Disease Progression|0|||
44116384|NCT02737475|78899683|FG022|Overall Study|Disease Progression|0|||
44116385|NCT02737475|78899684|FG023|Overall Study|Disease Progression|0|||
44116386|NCT02737475|78899685|FG024|Overall Study|Disease Progression|0|||
44116387|NCT02737475|78899686|FG025|Overall Study|Disease Progression|0|||
44116388|NCT02737475|78899687|FG026|Overall Study|Disease Progression|1|||
44505964|NCT00415532|79510807|FG000|Treatment Period|Noncompliance|1|||
44505965|NCT00415532|79510808|FG001|Treatment Period|Noncompliance|1|||
44505966|NCT00415532|79510807|FG000|Treatment Period|Requirement for alternative therapy|1|||
44505967|NCT00415532|79510808|FG001|Treatment Period|Requirement for alternative therapy|0|||
44505968|NCT00415532|79510807|FG000|Safety Follow Up Period|Adverse Event|1|||
44505969|NCT00415532|79510808|FG001|Safety Follow Up Period|Adverse Event|3|||
44505970|NCT00415532|79510807|FG000|Safety Follow Up Period|Death|3|||
44505971|NCT00415532|79510808|FG001|Safety Follow Up Period|Death|0|||
44505972|NCT00415532|79510807|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
44505973|NCT00415532|79510808|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
44505974|NCT00415532|79510807|FG000|Safety Follow Up Period|Other|1|||
44505975|NCT00415532|79510808|FG001|Safety Follow Up Period|Other|4|||
44505976|NCT00415532|79510807|FG000|Safety Follow Up Period|Ineligibility determined|1|||
44574435|NCT03829657|79596936|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
44574436|NCT03829657|79596937|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
44574437|NCT03829657|79596938|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
44574438|NCT03829657|79596939|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
44574439|NCT03829657|79596935|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
44574440|NCT03829657|79596936|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
44574441|NCT03829657|79596937|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
44574442|NCT03829657|79596938|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
44574443|NCT03829657|79596939|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
44574444|NCT03829657|79596935|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
44574445|NCT03829657|79596936|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
44574446|NCT03829657|79596937|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
44574447|NCT03829657|79596938|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
44574448|NCT03829657|79596939|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
44574449|NCT03829657|79596935|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
44574450|NCT03829657|79596936|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
44574451|NCT03829657|79596937|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
44574452|NCT03829657|79596938|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
44574453|NCT03829657|79596939|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
44574454|NCT03829657|79596935|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
44574455|NCT03829657|79596936|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
44574456|NCT03829657|79596937|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
44574457|NCT03829657|79596938|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
44574458|NCT03829657|79596939|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
44574459|NCT03829657|79596935|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
44574460|NCT03829657|79596936|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
44574461|NCT03829657|79596937|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
44574462|NCT03829657|79596938|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
44574463|NCT03829657|79596939|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
44574464|NCT03829657|79596935|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
44574465|NCT03829657|79596936|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
44574466|NCT03829657|79596937|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
44574467|NCT03829657|79596938|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
44574468|NCT03829657|79596939|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
44116389|NCT02557672|78899777|FG000|Overall Study|Withdrawal by Subject|4|||
44116390|NCT02557672|78899778|FG001|Overall Study|Withdrawal by Subject|2|||
44378020|NCT00890097|79383408|FG002|Overall Study|Lost to Follow-up|5|||
44505977|NCT00415532|79510808|FG001|Safety Follow Up Period|Ineligibility determined|1|||
44116391|NCT02714426|78899790|FG000|Overall Study|Withdrawal by Subject|2|||
44505978|NCT00415532|79510807|FG000|Safety Follow Up Period|Noncompliance|1|||
44505979|NCT00415532|79510808|FG001|Safety Follow Up Period|Noncompliance|0|||
44505980|NCT00415532|79510807|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
44116392|NCT02714426|78899791|FG001|Overall Study|Withdrawal by Subject|2|||
44116393|NCT02925923|78899804|FG000|Overall Study|blood samples hemolyzed|0|||
44116394|NCT02925923|78899805|FG001|Overall Study|blood samples hemolyzed|2|||
44116395|NCT02410343|78899813|FG000|Core Period (24 Weeks)|Adverse Event|1|||
44116396|NCT02410343|78899814|FG001|Core Period (24 Weeks)|Adverse Event|0|||
44116397|NCT02410343|78899813|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
44116398|NCT02410343|78899814|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
44116399|NCT02410343|78899813|FG000|Extension Period (12 Months)|Adverse Event|1|||
44116400|NCT02410343|78899814|FG001|Extension Period (12 Months)|Adverse Event|0|||
44116401|NCT02410343|78899813|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
44116402|NCT02410343|78899814|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
44116403|NCT03064841|78899821|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
44116404|NCT03064841|78899821|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
44116405|NCT03064841|78899821|FG000|Overall Study|Screen failure|2|||
44116406|NCT02045303|78899827|FG000|Overall Study|Protocol Violation|2|||
44116407|NCT02045303|78899828|FG001|Overall Study|Protocol Violation|1|||
44116408|NCT02045303|78899829|FG002|Overall Study|Protocol Violation|0|||
44116409|NCT02045303|78899827|FG000|Overall Study|Withdrawal by Subject|0|||
44116410|NCT02045303|78899828|FG001|Overall Study|Withdrawal by Subject|2|||
44116411|NCT02045303|78899829|FG002|Overall Study|Withdrawal by Subject|0|||
44116412|NCT03064451|78899842|FG000|Overall Study|Lost to Follow-up|1|||
44116413|NCT03064451|78899842|FG000|Overall Study|Mapping Failure|4|||
44116414|NCT03064451|78899842|FG000|Overall Study|Exited prior to procedure|8|||
44116415|NCT03064451|78899842|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
44116416|NCT03058679|78899848|FG000|Baseline to Week 6|Lost to Follow-up|3|||
44116417|NCT03058679|78899849|FG001|Baseline to Week 6|Lost to Follow-up|2|||
44116418|NCT03058679|78899848|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
44116419|NCT03058679|78899849|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
44116420|NCT03058679|78899848|FG000|Baseline to Week 6|Adverse Event|6|||
44116421|NCT03058679|78899849|FG001|Baseline to Week 6|Adverse Event|6|||
44116422|NCT03058679|78899848|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
44116423|NCT03058679|78899849|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
44116424|NCT03058679|78899848|FG000|Baseline to Week 6|Difficulty following the diet|0|||
44116425|NCT03058679|78899849|FG001|Baseline to Week 6|Difficulty following the diet|2|||
44116426|NCT03058679|78899848|FG000|Baseline to Week 6|Physician Decision|1|||
44116427|NCT03058679|78899849|FG001|Baseline to Week 6|Physician Decision|0|||
44116428|NCT03058679|78899848|FG000|Week 6 to Week 12|Change in medication|5|||
44116429|NCT03058679|78899849|FG001|Week 6 to Week 12|Change in medication|7|||
44116430|NCT03058679|78899848|FG000|Week 6 to Week 12|Adverse Event|4|||
44116431|NCT03058679|78899849|FG001|Week 6 to Week 12|Adverse Event|3|||
44116432|NCT03058679|78899848|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
44116433|NCT03058679|78899849|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
44116434|NCT03058679|78899848|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
44116435|NCT03058679|78899849|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
44116436|NCT03382821|78899857|FG000|Overall Study|Did not receive allocated intervention.|0|||
44116437|NCT03382821|78899858|FG001|Overall Study|Did not receive allocated intervention.|3|||
44116438|NCT02557516|78899869|FG000|Overall Study|Adverse Event|1|||
44116439|NCT02557516|78899870|FG001|Overall Study|Adverse Event|0|||
44116440|NCT02557516|78899871|FG002|Overall Study|Adverse Event|2|||
44116441|NCT02557516|78899872|FG003|Overall Study|Adverse Event|1|||
44116442|NCT02557516|78899869|FG000|Overall Study|Disease progression|0|||
44116443|NCT02557516|78899870|FG001|Overall Study|Disease progression|2|||
44116444|NCT02557516|78899871|FG002|Overall Study|Disease progression|0|||
44505981|NCT00415532|79510808|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
44505982|NCT00315731|79510814|FG000|Overall Study|Lost to Follow-up|1|||
44505983|NCT00315731|79510814|FG000|Overall Study|Death|5|||
44505984|NCT00062868|79510841|FG000|Dose Level 1|Death|2|||
44505985|NCT00062868|79510842|FG001|Dose Level 1|Death|0|||
44505986|NCT00062868|79510843|FG002|Dose Level 1|Death|0|||
44505987|NCT00062868|79510844|FG003|Dose Level 1|Death|2|||
44505988|NCT00062868|79510845|FG004|Dose Level 1|Death|0|||
44505989|NCT00062868|79510846|FG005|Dose Level 1|Death|0|||
44505990|NCT00062868|79510847|FG006|Dose Level 1|Death|3|||
44505991|NCT00062868|79510848|FG007|Dose Level 1|Death|0|||
44505992|NCT00062868|79510849|FG008|Dose Level 1|Death|0|||
44505993|NCT00062868|79510850|FG009|Dose Level 1|Death|0|||
44116445|NCT02557516|78899872|FG003|Overall Study|Disease progression|0|||
44116446|NCT02557516|78899869|FG000|Overall Study|Physician Decision|0|||
44116447|NCT02557516|78899870|FG001|Overall Study|Physician Decision|2|||
44116448|NCT02557516|78899871|FG002|Overall Study|Physician Decision|0|||
44116449|NCT02557516|78899872|FG003|Overall Study|Physician Decision|0|||
44116450|NCT02557516|78899869|FG000|Overall Study|Sponsor decision|0|||
44116451|NCT02557516|78899870|FG001|Overall Study|Sponsor decision|1|||
44505994|NCT00062868|79510851|FG010|Dose Level 1|Death|0|||
44505995|NCT00062868|79510852|FG011|Dose Level 1|Death|0|||
44505996|NCT00062868|79510853|FG012|Dose Level 1|Death|0|||
44505997|NCT00062868|79510854|FG013|Dose Level 1|Death|0|||
44505998|NCT00062868|79510855|FG014|Dose Level 1|Death|0|||
44238265|NCT01587703|79064748|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44505999|NCT00062868|79510856|FG015|Dose Level 1|Death|0|||
44506000|NCT00062868|79510857|FG016|Dose Level 1|Death|0|||
44506001|NCT00062868|79510858|FG017|Dose Level 1|Death|0|||
44506002|NCT00062868|79510859|FG018|Dose Level 1|Death|7|||
44506003|NCT00062868|79510860|FG019|Dose Level 1|Death|0|||
44506004|NCT00062868|79510861|FG020|Dose Level 1|Death|1|||
44506005|NCT00062868|79510841|FG000|Dose Level 1|Lost to Follow-up|0|||
44506006|NCT00062868|79510842|FG001|Dose Level 1|Lost to Follow-up|0|||
44506007|NCT00062868|79510843|FG002|Dose Level 1|Lost to Follow-up|0|||
44506008|NCT00062868|79510844|FG003|Dose Level 1|Lost to Follow-up|0|||
44506009|NCT00062868|79510845|FG004|Dose Level 1|Lost to Follow-up|0|||
44506010|NCT00062868|79510846|FG005|Dose Level 1|Lost to Follow-up|0|||
44506011|NCT00062868|79510847|FG006|Dose Level 1|Lost to Follow-up|0|||
44506012|NCT00062868|79510848|FG007|Dose Level 1|Lost to Follow-up|0|||
44506013|NCT00062868|79510849|FG008|Dose Level 1|Lost to Follow-up|0|||
44506014|NCT00062868|79510850|FG009|Dose Level 1|Lost to Follow-up|0|||
44506015|NCT00062868|79510851|FG010|Dose Level 1|Lost to Follow-up|0|||
44506016|NCT00062868|79510852|FG011|Dose Level 1|Lost to Follow-up|0|||
44506017|NCT00062868|79510853|FG012|Dose Level 1|Lost to Follow-up|1|||
44506018|NCT00062868|79510854|FG013|Dose Level 1|Lost to Follow-up|0|||
44506019|NCT00062868|79510855|FG014|Dose Level 1|Lost to Follow-up|0|||
44506020|NCT00062868|79510856|FG015|Dose Level 1|Lost to Follow-up|0|||
44574469|NCT03035227|79596950|FG000|Overall Study|study stopped due to PI leaving institut|1|||
44574470|NCT03035227|79596951|FG001|Overall Study|study stopped due to PI leaving institut|1|||
44574471|NCT00100932|79596961|FG000|Overall Study|Adverse Event|11|||
44574472|NCT00100932|79596962|FG001|Overall Study|Adverse Event|2|||
44574473|NCT00100932|79596961|FG000|Overall Study|Withdrawal by Subject|6|||
44574474|NCT00100932|79596962|FG001|Overall Study|Withdrawal by Subject|0|||
44574475|NCT00100932|79596961|FG000|Overall Study|Progressive Disease|44|||
44574476|NCT00100932|79596962|FG001|Overall Study|Progressive Disease|18|||
44574477|NCT00100932|79596961|FG000|Overall Study|Physician Decision|7|||
44574478|NCT00100932|79596962|FG001|Overall Study|Physician Decision|5|||
44574479|NCT00100932|79596961|FG000|Overall Study|Other|5|||
44574480|NCT00100932|79596962|FG001|Overall Study|Other|2|||
44574481|NCT03180307|79596970|FG000|Overall Study|Lost to Follow-up|2|||
44574482|NCT03180307|79596971|FG001|Overall Study|Lost to Follow-up|0|||
44574483|NCT03180307|79596970|FG000|Overall Study|Death|1|||
44574484|NCT03180307|79596971|FG001|Overall Study|Death|0|||
44574485|NCT03180307|79596970|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
44574486|NCT03180307|79596971|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
44574487|NCT02848833|79596975|FG000|Overall Study|subject who are duplicated|1|||
44574488|NCT02848833|79596975|FG000|Overall Study|have not taken the study drug|11|||
44574489|NCT02848833|79596975|FG000|Overall Study|follow-up failure|6|||
44574490|NCT02848833|79596975|FG000|Overall Study|Protocol Violation|119|||
44574491|NCT03361189|79596981|FG000|Overall Study|Received heart transplant|1|||
44574492|NCT03361189|79596982|FG001|Overall Study|Received heart transplant|0|||
44574493|NCT03361189|79596981|FG000|Overall Study|Pacemake replacement|0|||
44574494|NCT03361189|79596982|FG001|Overall Study|Pacemake replacement|1|||
44574495|NCT00092131|79596990|FG000|Treatment Period I|Adverse Event|1|||
44574496|NCT00092131|79596991|FG001|Treatment Period I|Adverse Event|0|||
44574497|NCT00092131|79596990|FG000|Treatment Period II|Adverse Event|0|||
44574498|NCT00092131|79596991|FG001|Treatment Period II|Adverse Event|1|||
44574499|NCT02668783|79596999|FG000|Overall Study|Pregnancy|0|||
44574500|NCT02668783|79597000|FG001|Overall Study|Pregnancy|1|||
44574501|NCT02668783|79596999|FG000|Overall Study|Protocol Violation|2|||
44574502|NCT02668783|79597000|FG001|Overall Study|Protocol Violation|1|||
44574503|NCT02668783|79596999|FG000|Overall Study|Study terminated by sponsor|9|||
44574504|NCT02668783|79597000|FG001|Overall Study|Study terminated by sponsor|10|||
44574505|NCT02668783|79596999|FG000|Overall Study|Subject moved|1|||
44574506|NCT02668783|79597000|FG001|Overall Study|Subject moved|0|||
44238266|NCT01587703|79064749|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44506021|NCT00062868|79510857|FG016|Dose Level 1|Lost to Follow-up|0|||
44506022|NCT00062868|79510858|FG017|Dose Level 1|Lost to Follow-up|0|||
44506023|NCT00062868|79510859|FG018|Dose Level 1|Lost to Follow-up|2|||
44506024|NCT00062868|79510860|FG019|Dose Level 1|Lost to Follow-up|0|||
44506025|NCT00062868|79510861|FG020|Dose Level 1|Lost to Follow-up|1|||
44506026|NCT00062868|79510841|FG000|Dose Level 2|Death|0|||
44574507|NCT02668783|79596999|FG000|Overall Study|Withdrawal by Subject|1|||
44574508|NCT02668783|79597000|FG001|Overall Study|Withdrawal by Subject|0|||
44574509|NCT00101010|79597006|FG000|Overall Study|Physician Decision|1|||
44506027|NCT00062868|79510842|FG001|Dose Level 2|Death|3|||
44506028|NCT00062868|79510843|FG002|Dose Level 2|Death|0|||
44506029|NCT00062868|79510844|FG003|Dose Level 2|Death|0|||
44506030|NCT00062868|79510845|FG004|Dose Level 2|Death|2|||
44506031|NCT00062868|79510846|FG005|Dose Level 2|Death|0|||
44506032|NCT00062868|79510847|FG006|Dose Level 2|Death|0|||
44506033|NCT00062868|79510848|FG007|Dose Level 2|Death|0|||
44506034|NCT00062868|79510849|FG008|Dose Level 2|Death|0|||
44506035|NCT00062868|79510850|FG009|Dose Level 2|Death|0|||
44116452|NCT02557516|78899871|FG002|Overall Study|Sponsor decision|2|||
44116453|NCT02557516|78899872|FG003|Overall Study|Sponsor decision|8|||
44116454|NCT00711555|78899891|FG000|Overall Study|Adverse Event|3|||
44116455|NCT02713490|78899896|FG000|Overall Study|Withdrawal by Subject|2|||
44116456|NCT02713490|78899897|FG001|Overall Study|Withdrawal by Subject|1|||
44116457|NCT02713490|78899896|FG000|Overall Study|Did not receive study drug|1|||
44116458|NCT02713490|78899897|FG001|Overall Study|Did not receive study drug|0|||
44116459|NCT02713490|78899896|FG000|Overall Study|Met exclusion criteria|0|||
44116460|NCT02713490|78899897|FG001|Overall Study|Met exclusion criteria|1|||
44116461|NCT03772574|78899906|FG000|Overall Study|Protocol Violation|2|||
44116462|NCT03772574|78899907|FG001|Overall Study|Protocol Violation|0|||
44116463|NCT03772574|78899908|FG002|Overall Study|Protocol Violation|0|||
44116464|NCT03772574|78899906|FG000|Overall Study|Discomfort|0|||
44116465|NCT03772574|78899907|FG001|Overall Study|Discomfort|5|||
44116466|NCT03772574|78899908|FG002|Overall Study|Discomfort|4|||
44116467|NCT02743221|78899918|FG000|Overall Study|Progressive disease|29|||
44116468|NCT02743221|78899919|FG001|Overall Study|Progressive disease|38|||
44116469|NCT02743221|78899918|FG000|Overall Study|Adverse Event|17|||
44116470|NCT02743221|78899919|FG001|Overall Study|Adverse Event|14|||
44116471|NCT02743221|78899918|FG000|Overall Study|non medical reason|8|||
44116472|NCT02743221|78899919|FG001|Overall Study|non medical reason|2|||
44116473|NCT02743221|78899918|FG000|Overall Study|Physician Decision|2|||
44116474|NCT02743221|78899919|FG001|Overall Study|Physician Decision|5|||
44116475|NCT02743221|78899918|FG000|Overall Study|Patient not eligible, not treated|0|||
44116476|NCT02743221|78899919|FG001|Overall Study|Patient not eligible, not treated|1|||
44116477|NCT03836625|78899927|FG000|Overall Study|Lost to Follow-up|9|||
44116478|NCT03836625|78899928|FG001|Overall Study|Lost to Follow-up|9|||
44116479|NCT03836625|78899927|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
44116480|NCT03836625|78899928|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
44116481|NCT03836625|78899927|FG000|Overall Study|Death|0|||
44116482|NCT03836625|78899928|FG001|Overall Study|Death|1|||
44116483|NCT03836625|78899927|FG000|Overall Study|Refused follow-up|0|||
44116484|NCT03836625|78899928|FG001|Overall Study|Refused follow-up|1|||
44116485|NCT01358968|78899934|FG000|Period 2|Adverse Event|0|||
44116486|NCT01358968|78899935|FG001|Period 2|Adverse Event|1|||
44116487|NCT01358968|78899936|FG002|Period 2|Adverse Event|0|||
44116488|NCT01358968|78899937|FG003|Period 2|Adverse Event|0|||
44116489|NCT01358968|78899934|FG000|Continued Access Phase|Progression of Disease|0|||
44116490|NCT01358968|78899935|FG001|Continued Access Phase|Progression of Disease|0|||
44116491|NCT01358968|78899936|FG002|Continued Access Phase|Progression of Disease|8|||
44116492|NCT01358968|78899937|FG003|Continued Access Phase|Progression of Disease|4|||
44116493|NCT01358968|78899934|FG000|Continued Access Phase|Protocol Violation|0|||
44116494|NCT01358968|78899935|FG001|Continued Access Phase|Protocol Violation|0|||
44116495|NCT01358968|78899936|FG002|Continued Access Phase|Protocol Violation|0|||
44116496|NCT01358968|78899937|FG003|Continued Access Phase|Protocol Violation|2|||
44116497|NCT01358968|78899934|FG000|Continued Access Phase|Withdrawal by Subject|0|||
44116498|NCT01358968|78899935|FG001|Continued Access Phase|Withdrawal by Subject|0|||
44378021|NCT00890097|79383406|FG000|Overall Study|Noncompliance|0|||
44378022|NCT00890097|79383407|FG001|Overall Study|Noncompliance|4|||
44378023|NCT00890097|79383408|FG002|Overall Study|Noncompliance|4|||
44378024|NCT00890097|79383406|FG000|Overall Study|Sponsor Decision|7|||
44378025|NCT00890097|79383407|FG001|Overall Study|Sponsor Decision|11|||
44378026|NCT00890097|79383408|FG002|Overall Study|Sponsor Decision|7|||
44378027|NCT00890097|79383406|FG000|Overall Study|Did not attend final visit|2|||
44506036|NCT00062868|79510851|FG010|Dose Level 2|Death|1|||
44506037|NCT00062868|79510852|FG011|Dose Level 2|Death|0|||
44506038|NCT00062868|79510853|FG012|Dose Level 2|Death|0|||
44506039|NCT00062868|79510854|FG013|Dose Level 2|Death|0|||
44506040|NCT00062868|79510855|FG014|Dose Level 2|Death|0|||
44506041|NCT00062868|79510856|FG015|Dose Level 2|Death|0|||
44506042|NCT00062868|79510857|FG016|Dose Level 2|Death|2|||
44506043|NCT00062868|79510858|FG017|Dose Level 2|Death|0|||
44506044|NCT00062868|79510859|FG018|Dose Level 2|Death|0|||
44506045|NCT00062868|79510860|FG019|Dose Level 2|Death|0|||
44378028|NCT00890097|79383407|FG001|Overall Study|Did not attend final visit|3|||
44378029|NCT00890097|79383408|FG002|Overall Study|Did not attend final visit|0|||
44506046|NCT00062868|79510861|FG020|Dose Level 2|Death|0|||
44116499|NCT01358968|78899936|FG002|Continued Access Phase|Withdrawal by Subject|3|||
44116500|NCT01358968|78899937|FG003|Continued Access Phase|Withdrawal by Subject|0|||
44116501|NCT01358968|78899934|FG000|Continued Access Phase|Death|0|||
44116502|NCT01358968|78899935|FG001|Continued Access Phase|Death|0|||
44506047|NCT00062868|79510841|FG000|Dose Level 2|Lost to Follow-up|0|||
44116503|NCT01358968|78899936|FG002|Continued Access Phase|Death|1|||
44116504|NCT01358968|78899937|FG003|Continued Access Phase|Death|1|||
44116505|NCT00701090|78899949|FG000|Overall Study|Adverse Event|11|||
44116506|NCT00701090|78899950|FG001|Overall Study|Adverse Event|2|||
44378030|NCT00890097|79383406|FG000|Overall Study|Subject Decision|3|||
44506048|NCT00062868|79510842|FG001|Dose Level 2|Lost to Follow-up|0|||
44506049|NCT00062868|79510843|FG002|Dose Level 2|Lost to Follow-up|0|||
44506050|NCT00062868|79510844|FG003|Dose Level 2|Lost to Follow-up|0|||
44116507|NCT00701090|78899949|FG000|Overall Study|Death|0|||
44116508|NCT00701090|78899950|FG001|Overall Study|Death|1|||
44116509|NCT00701090|78899949|FG000|Overall Study|Lack of Efficacy|5|||
44116510|NCT00701090|78899950|FG001|Overall Study|Lack of Efficacy|4|||
44116511|NCT00701090|78899949|FG000|Overall Study|Lost to Follow-up|9|||
44116512|NCT00701090|78899950|FG001|Overall Study|Lost to Follow-up|9|||
44116513|NCT00701090|78899949|FG000|Overall Study|Physician Decision|3|||
44116514|NCT00701090|78899950|FG001|Overall Study|Physician Decision|4|||
44116515|NCT00701090|78899949|FG000|Overall Study|Protocol Violation|2|||
44116516|NCT00701090|78899950|FG001|Overall Study|Protocol Violation|3|||
44116517|NCT00701090|78899949|FG000|Overall Study|Withdrawal by Subject|11|||
44116518|NCT00701090|78899950|FG001|Overall Study|Withdrawal by Subject|16|||
44116519|NCT00701090|78899949|FG000|Overall Study|Other|7|||
44116520|NCT00701090|78899950|FG001|Overall Study|Other|12|||
44116521|NCT03057977|78899958|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
44116522|NCT03057977|78899959|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
44116523|NCT03057977|78899958|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
44116524|NCT03057977|78899959|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
44116525|NCT03057977|78899958|FG000|Discontinuation From Treatment|Protocol Violation|6|||
44116526|NCT03057977|78899959|FG001|Discontinuation From Treatment|Protocol Violation|5|||
44116527|NCT03057977|78899958|FG000|Discontinuation From Treatment|Not treated|4|||
44116528|NCT03057977|78899959|FG001|Discontinuation From Treatment|Not treated|0|||
44116529|NCT03057977|78899958|FG000|Discontinuation From Treatment|Adverse Event|343|||
44116530|NCT03057977|78899959|FG001|Discontinuation From Treatment|Adverse Event|337|||
44116531|NCT03057977|78899958|FG000|Discontinuation From Treatment|Reason Unknown|0|||
44116532|NCT03057977|78899959|FG001|Discontinuation From Treatment|Reason Unknown|1|||
44116533|NCT03057977|78899958|FG000|Discontinuation From Treatment|Personal Reasons|1|||
44116534|NCT03057977|78899959|FG001|Discontinuation From Treatment|Personal Reasons|1|||
44574510|NCT02848599|79597012|FG000|Overall Study|Protocol Violation|7|||
44574511|NCT02848599|79597013|FG001|Overall Study|Protocol Violation|9|||
44574512|NCT00778999|79597044|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
44574513|NCT00778999|79597045|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
44574514|NCT00778999|79597044|FG000|Overall Study|Did not receive recFSH|14|||
44574515|NCT00778999|79597045|FG001|Overall Study|Did not receive recFSH|20|||
44574516|NCT02631850|79597055|FG000|Treatment Period|Lost to Follow-up|0|||
44574517|NCT02631850|79597056|FG001|Treatment Period|Lost to Follow-up|1|||
44574518|NCT02631850|79597057|FG002|Treatment Period|Lost to Follow-up|0|||
44574519|NCT02631850|79597058|FG003|Treatment Period|Lost to Follow-up|0|||
44574520|NCT02631850|79597055|FG000|Treatment Period|Protocol Violation|1|||
44574521|NCT02631850|79597056|FG001|Treatment Period|Protocol Violation|0|||
44574522|NCT02631850|79597057|FG002|Treatment Period|Protocol Violation|0|||
44574523|NCT02631850|79597058|FG003|Treatment Period|Protocol Violation|0|||
44574524|NCT02631850|79597055|FG000|Treatment Period|Withdrawal by Subject|0|||
44574525|NCT02631850|79597056|FG001|Treatment Period|Withdrawal by Subject|5|||
44574526|NCT02631850|79597057|FG002|Treatment Period|Withdrawal by Subject|2|||
44116535|NCT03057977|78899958|FG000|Discontinuation From Treatment|Unblinded medication|1|||
44116536|NCT03057977|78899959|FG001|Discontinuation From Treatment|Unblinded medication|0|||
44116537|NCT03057977|78899958|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
44116538|NCT03057977|78899959|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
44116539|NCT03057977|78899958|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
44116540|NCT03057977|78899959|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
44116541|NCT03057977|78899958|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
44506051|NCT00062868|79510845|FG004|Dose Level 2|Lost to Follow-up|0|||
44506052|NCT00062868|79510846|FG005|Dose Level 2|Lost to Follow-up|0|||
44506053|NCT00062868|79510847|FG006|Dose Level 2|Lost to Follow-up|0|||
44506054|NCT00062868|79510848|FG007|Dose Level 2|Lost to Follow-up|0|||
44506055|NCT00062868|79510849|FG008|Dose Level 2|Lost to Follow-up|0|||
44506056|NCT00062868|79510850|FG009|Dose Level 2|Lost to Follow-up|0|||
44506057|NCT00062868|79510851|FG010|Dose Level 2|Lost to Follow-up|0|||
44506058|NCT00062868|79510852|FG011|Dose Level 2|Lost to Follow-up|0|||
44506059|NCT00062868|79510853|FG012|Dose Level 2|Lost to Follow-up|0|||
44506060|NCT00062868|79510854|FG013|Dose Level 2|Lost to Follow-up|1|||
44506061|NCT00062868|79510855|FG014|Dose Level 2|Lost to Follow-up|0|||
44506062|NCT00062868|79510856|FG015|Dose Level 2|Lost to Follow-up|0|||
44506063|NCT00062868|79510857|FG016|Dose Level 2|Lost to Follow-up|1|||
44506064|NCT00062868|79510858|FG017|Dose Level 2|Lost to Follow-up|0|||
44506065|NCT00062868|79510859|FG018|Dose Level 2|Lost to Follow-up|0|||
44506066|NCT00062868|79510860|FG019|Dose Level 2|Lost to Follow-up|0|||
44506067|NCT00062868|79510861|FG020|Dose Level 2|Lost to Follow-up|0|||
44506068|NCT00062868|79510841|FG000|Dose Level 3|Death|0|||
44506069|NCT00062868|79510842|FG001|Dose Level 3|Death|0|||
44506070|NCT00062868|79510843|FG002|Dose Level 3|Death|0|||
44506071|NCT00062868|79510844|FG003|Dose Level 3|Death|0|||
44506072|NCT00062868|79510845|FG004|Dose Level 3|Death|0|||
44506073|NCT00062868|79510846|FG005|Dose Level 3|Death|0|||
44116542|NCT03057977|78899959|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
44116543|NCT03057977|78899958|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
44116544|NCT03057977|78899959|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
44116545|NCT03057977|78899958|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
44116546|NCT03057977|78899959|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
44116547|NCT03057977|78899958|FG000|Discontinuation From Treatment|Not attending study visit|3|||
44116548|NCT03057977|78899959|FG001|Discontinuation From Treatment|Not attending study visit|10|||
44116549|NCT03057977|78899958|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
44116550|NCT03057977|78899959|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
44116551|NCT03057977|78899958|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
44116552|NCT03057977|78899959|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
44116553|NCT03057977|78899958|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
44116554|NCT03057977|78899959|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
44116555|NCT03057977|78899958|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
44116556|NCT03057977|78899959|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
44116557|NCT03057977|78899958|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
44116558|NCT03057977|78899959|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
44116559|NCT03062891|78899971|FG000|Overall Study|Withdrawal by Subject|2|||
44116560|NCT03062891|78899972|FG001|Overall Study|Withdrawal by Subject|0|||
44116561|NCT03062891|78899971|FG000|Overall Study|Lost to Follow-up|50|||
44116562|NCT03062891|78899972|FG001|Overall Study|Lost to Follow-up|38|||
44116563|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
44116564|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
44116565|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
44116566|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
44116567|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
44116568|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
44116569|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
44116570|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
44116571|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
44116572|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
44116573|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
44116574|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
44116575|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
44116576|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
44116577|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
44116578|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
44116579|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
44116580|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
44116581|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
44116582|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
44116583|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
44116584|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
44116585|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
44116586|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
44116587|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
44116588|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
44116589|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
44116590|NCT02552212|78899981|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
44116591|NCT02552212|78899982|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
44116592|NCT02552212|78899983|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
44116593|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
44116594|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
44116595|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
44116596|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
44116597|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
44116598|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
44116599|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
44238267|NCT01587703|79064750|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238268|NCT01587703|79064751|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238269|NCT01587703|79064752|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238270|NCT01587703|79064753|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238271|NCT01587703|79064754|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238272|NCT01587703|79064755|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238273|NCT01587703|79064756|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238274|NCT01587703|79064757|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44378031|NCT00890097|79383407|FG001|Overall Study|Subject Decision|2|||
44116600|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
44116601|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
44116602|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
44116603|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
44116604|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
44116605|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
44116606|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
44116607|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
44116608|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
44116609|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
44116610|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
44116611|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
44116612|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
44116613|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
44116614|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
44116615|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
44116616|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
44116617|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
44116618|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
44116619|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
44116620|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
44116621|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
44116622|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
44116623|NCT02552212|78899981|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
44116624|NCT02552212|78899982|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
44116625|NCT02552212|78899983|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
44116626|NCT00685919|78900003|FG000|Overall Study|Withdrawal by Subject|0|||
44116627|NCT00685919|78900004|FG001|Overall Study|Withdrawal by Subject|0|||
44116628|NCT00685919|78900005|FG002|Overall Study|Withdrawal by Subject|1|||
44116629|NCT00685919|78900006|FG003|Overall Study|Withdrawal by Subject|0|||
44116630|NCT00685919|78900003|FG000|Overall Study|Physician Decision|1|||
44116631|NCT00685919|78900004|FG001|Overall Study|Physician Decision|0|||
44116632|NCT00685919|78900005|FG002|Overall Study|Physician Decision|0|||
44116633|NCT00685919|78900006|FG003|Overall Study|Physician Decision|0|||
44116634|NCT03061331|78900018|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
44116635|NCT03061331|78900019|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
44116636|NCT00700778|78900025|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
44116637|NCT02551666|78900031|FG000|Overall Study|Withdrawal by Subject|1|||
44116638|NCT02551666|78900032|FG001|Overall Study|Withdrawal by Subject|3|||
44116639|NCT03061175|78900044|FG000|Baseline|Participant was deemed ineligible|1|||
44116640|NCT03061175|78900045|FG001|Baseline|Participant was deemed ineligible|0|||
44116641|NCT03061175|78900044|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
44116642|NCT03061175|78900045|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
44116643|NCT03061175|78900044|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
44116644|NCT03061175|78900045|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
44116645|NCT03061175|78900044|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
44116646|NCT03061175|78900045|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
44116647|NCT03061097|78900062|FG000|Overall Study|Withdrawal by Subject|0|||
44116648|NCT03061097|78900063|FG001|Overall Study|Withdrawal by Subject|3|||
44116649|NCT02554318|78900071|FG000|Overall Study|Withdrawal by Subject|10|||
44116650|NCT02554318|78900072|FG001|Overall Study|Withdrawal by Subject|8|||
44116651|NCT02550106|78900078|FG000|Overall Study|Adverse Event|1|||
44116652|NCT02550106|78900078|FG000|Overall Study|Lack of Efficacy|3|||
44116653|NCT02550106|78900078|FG000|Overall Study|Protocol Violation|6|||
44116654|NCT02550106|78900078|FG000|Overall Study|Withdrawal by Subject|2|||
44116655|NCT03060551|78900084|FG000|Overall Study|Withdrawal by Subject|1|||
44116656|NCT03060551|78900084|FG000|Overall Study|Adverse Event|1|||
44116657|NCT01662310|78900088|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
44116658|NCT01662310|78900089|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
44116659|NCT01662310|78900090|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
44116660|NCT01662310|78900091|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
44116661|NCT01662310|78900092|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
44116662|NCT01662310|78900088|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
44116663|NCT01662310|78900089|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
44116664|NCT01662310|78900090|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
44116665|NCT01662310|78900091|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
44116666|NCT01662310|78900092|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
44116667|NCT01662310|78900088|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
44116668|NCT01662310|78900089|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
44116669|NCT01662310|78900090|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
44116670|NCT01662310|78900091|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
44116671|NCT01662310|78900092|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
44116672|NCT01662310|78900088|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
44116673|NCT01662310|78900089|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
44116674|NCT01662310|78900090|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
44116675|NCT01662310|78900091|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
44116676|NCT01662310|78900092|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
44116677|NCT01662310|78900088|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
44116678|NCT01662310|78900089|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
44116679|NCT01662310|78900090|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
44116680|NCT01662310|78900091|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
44116681|NCT01662310|78900092|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
44116682|NCT01662310|78900088|FG000|Run-In or Stabilization Phase|Other|1|||
44116683|NCT01662310|78900089|FG001|Run-In or Stabilization Phase|Other|0|||
44116684|NCT01662310|78900090|FG002|Run-In or Stabilization Phase|Other|0|||
44116685|NCT01662310|78900091|FG003|Run-In or Stabilization Phase|Other|0|||
44116686|NCT01662310|78900092|FG004|Run-In or Stabilization Phase|Other|0|||
44116687|NCT01662310|78900088|FG000|Double-Blind Phase|Adverse Event|0|||
44116688|NCT01662310|78900089|FG001|Double-Blind Phase|Adverse Event|0|||
44116689|NCT01662310|78900090|FG002|Double-Blind Phase|Adverse Event|1|||
44116690|NCT01662310|78900091|FG003|Double-Blind Phase|Adverse Event|0|||
44116691|NCT01662310|78900092|FG004|Double-Blind Phase|Adverse Event|0|||
44116692|NCT01662310|78900088|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44116693|NCT01662310|78900089|FG001|Double-Blind Phase|Lost to Follow-up|3|||
44116694|NCT01662310|78900090|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44116695|NCT01662310|78900091|FG003|Double-Blind Phase|Lost to Follow-up|0|||
44116696|NCT01662310|78900092|FG004|Double-Blind Phase|Lost to Follow-up|0|||
44116697|NCT01662310|78900088|FG000|Double-Blind Phase|Pregnancy|0|||
44116698|NCT01662310|78900089|FG001|Double-Blind Phase|Pregnancy|2|||
44116699|NCT01662310|78900090|FG002|Double-Blind Phase|Pregnancy|0|||
44116700|NCT01662310|78900091|FG003|Double-Blind Phase|Pregnancy|0|||
44116701|NCT01662310|78900092|FG004|Double-Blind Phase|Pregnancy|0|||
44116702|NCT01662310|78900088|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
44116703|NCT01662310|78900089|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
44116704|NCT01662310|78900090|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
44116705|NCT01662310|78900091|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44116706|NCT01662310|78900092|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
44116707|NCT01662310|78900088|FG000|Double-Blind Phase|Other|0|||
44116708|NCT01662310|78900089|FG001|Double-Blind Phase|Other|0|||
44116709|NCT01662310|78900090|FG002|Double-Blind Phase|Other|1|||
44116710|NCT01662310|78900091|FG003|Double-Blind Phase|Other|0|||
44116711|NCT01662310|78900092|FG004|Double-Blind Phase|Other|0|||
44116712|NCT01662310|78900088|FG000|Double-Blind Phase|Randomized but not treated|0|||
44116713|NCT01662310|78900089|FG001|Double-Blind Phase|Randomized but not treated|1|||
44116714|NCT01662310|78900090|FG002|Double-Blind Phase|Randomized but not treated|0|||
44116715|NCT01662310|78900091|FG003|Double-Blind Phase|Randomized but not treated|0|||
44116716|NCT01662310|78900092|FG004|Double-Blind Phase|Randomized but not treated|0|||
44116717|NCT01662310|78900088|FG000|Open-Label Extension Phase|Adverse Event|0|||
44116718|NCT01662310|78900089|FG001|Open-Label Extension Phase|Adverse Event|0|||
44238275|NCT01587703|79064758|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
44238276|NCT01587703|79064740|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238277|NCT01587703|79064741|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238278|NCT01587703|79064742|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238279|NCT01587703|79064743|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238280|NCT01587703|79064744|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238281|NCT01587703|79064745|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238282|NCT01587703|79064746|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238283|NCT01587703|79064747|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238284|NCT01587703|79064748|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
44238285|NCT01587703|79064749|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
44238286|NCT01587703|79064750|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
44238287|NCT01587703|79064751|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238288|NCT01587703|79064752|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238289|NCT01587703|79064753|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238290|NCT01587703|79064754|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44378032|NCT00890097|79383408|FG002|Overall Study|Subject Decision|6|||
44378033|NCT00890097|79383406|FG000|Overall Study|Randomization Error|2|||
44116719|NCT01662310|78900090|FG002|Open-Label Extension Phase|Adverse Event|0|||
44116720|NCT01662310|78900091|FG003|Open-Label Extension Phase|Adverse Event|3|||
44116721|NCT01662310|78900092|FG004|Open-Label Extension Phase|Adverse Event|0|||
44116722|NCT01662310|78900088|FG000|Open-Label Extension Phase|Death|0|||
44116723|NCT01662310|78900089|FG001|Open-Label Extension Phase|Death|0|||
44116724|NCT01662310|78900090|FG002|Open-Label Extension Phase|Death|0|||
44116725|NCT01662310|78900091|FG003|Open-Label Extension Phase|Death|1|||
44116726|NCT01662310|78900092|FG004|Open-Label Extension Phase|Death|0|||
44116727|NCT01662310|78900088|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
44116728|NCT01662310|78900089|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
44116729|NCT01662310|78900090|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
44116730|NCT01662310|78900091|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
44116731|NCT01662310|78900092|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
44116732|NCT01662310|78900088|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
44116733|NCT01662310|78900089|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
44116734|NCT01662310|78900090|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
44116735|NCT01662310|78900091|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
44116736|NCT01662310|78900092|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
44116737|NCT01662310|78900088|FG000|Open-Label Extension Phase|Pregnancy|0|||
44116738|NCT01662310|78900089|FG001|Open-Label Extension Phase|Pregnancy|0|||
44116739|NCT01662310|78900090|FG002|Open-Label Extension Phase|Pregnancy|0|||
44116740|NCT01662310|78900091|FG003|Open-Label Extension Phase|Pregnancy|1|||
44116741|NCT01662310|78900092|FG004|Open-Label Extension Phase|Pregnancy|0|||
44116742|NCT01662310|78900088|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
44116743|NCT01662310|78900089|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
44116744|NCT01662310|78900090|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
44116745|NCT01662310|78900091|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
44116746|NCT01662310|78900092|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
44116747|NCT00700622|78900106|FG000|Overall Study|Adverse Event|4|||
44116748|NCT00700622|78900107|FG001|Overall Study|Adverse Event|0|||
44116749|NCT00700622|78900106|FG000|Overall Study|Lost to Follow-up|0|||
44116750|NCT00700622|78900107|FG001|Overall Study|Lost to Follow-up|1|||
44116751|NCT00700622|78900106|FG000|Overall Study|Physician Decision|2|||
44116752|NCT00700622|78900107|FG001|Overall Study|Physician Decision|1|||
44116753|NCT00700622|78900106|FG000|Overall Study|Protocol Violation|0|||
44116754|NCT00700622|78900107|FG001|Overall Study|Protocol Violation|1|||
44116755|NCT00700622|78900106|FG000|Overall Study|Withdrawal by Subject|4|||
44116756|NCT00700622|78900107|FG001|Overall Study|Withdrawal by Subject|1|||
44116757|NCT00700622|78900106|FG000|Overall Study|Other|3|||
44116758|NCT00700622|78900107|FG001|Overall Study|Other|1|||
44116759|NCT02553928|78900115|FG000|Overall Study|Adverse Event|2|||
44116760|NCT02553928|78900116|FG001|Overall Study|Adverse Event|1|||
44116761|NCT02553928|78900115|FG000|Overall Study|Lost to Follow-up|0|||
44116762|NCT02553928|78900116|FG001|Overall Study|Lost to Follow-up|1|||
44116763|NCT02553928|78900115|FG000|Overall Study|Administrative reason(s)|0|||
44116764|NCT02553928|78900116|FG001|Overall Study|Administrative reason(s)|1|||
44116765|NCT03076775|78900125|FG000|Overall Study|Lost to Follow-up|1|||
44116766|NCT03076775|78900126|FG001|Overall Study|Lost to Follow-up|0|||
44116767|NCT03058991|78900143|FG000|Overall Study|Lost to Follow-up|17|||
44116768|NCT03058991|78900144|FG001|Overall Study|Lost to Follow-up|12|||
44116769|NCT03058991|78900145|FG002|Overall Study|Lost to Follow-up|12|||
44116770|NCT03058991|78900143|FG000|Overall Study|Withdrawal by Subject|1|||
44116771|NCT03058991|78900144|FG001|Overall Study|Withdrawal by Subject|0|||
44116772|NCT03058991|78900145|FG002|Overall Study|Withdrawal by Subject|0|||
44116773|NCT00700310|78900157|FG000|Overall Study|Adverse Event|6|||
44116774|NCT00700310|78900158|FG001|Overall Study|Adverse Event|10|||
44116775|NCT00700310|78900159|FG002|Overall Study|Adverse Event|5|||
44116776|NCT00700310|78900160|FG003|Overall Study|Adverse Event|11|||
44116777|NCT00700310|78900157|FG000|Overall Study|Lost to Follow-up|4|||
44116778|NCT00700310|78900158|FG001|Overall Study|Lost to Follow-up|1|||
44116779|NCT00700310|78900159|FG002|Overall Study|Lost to Follow-up|0|||
44116780|NCT00700310|78900160|FG003|Overall Study|Lost to Follow-up|1|||
44116781|NCT00700310|78900157|FG000|Overall Study|Withdrawal by Subject|8|||
44116782|NCT00700310|78900158|FG001|Overall Study|Withdrawal by Subject|9|||
44116783|NCT00700310|78900159|FG002|Overall Study|Withdrawal by Subject|8|||
44116784|NCT00700310|78900160|FG003|Overall Study|Withdrawal by Subject|8|||
44116785|NCT00700310|78900157|FG000|Overall Study|Lack of Efficacy|0|||
44116786|NCT00700310|78900158|FG001|Overall Study|Lack of Efficacy|3|||
44116787|NCT00700310|78900159|FG002|Overall Study|Lack of Efficacy|0|||
44116788|NCT00700310|78900160|FG003|Overall Study|Lack of Efficacy|1|||
44116789|NCT00700310|78900157|FG000|Overall Study|Administrative/Other|1|||
44116790|NCT00700310|78900158|FG001|Overall Study|Administrative/Other|3|||
44116791|NCT00700310|78900159|FG002|Overall Study|Administrative/Other|1|||
44116792|NCT00700310|78900160|FG003|Overall Study|Administrative/Other|3|||
44116793|NCT00700310|78900157|FG000|Overall Study|Randomized, Not Treated|2|||
44116794|NCT00700310|78900158|FG001|Overall Study|Randomized, Not Treated|0|||
44116795|NCT00700310|78900159|FG002|Overall Study|Randomized, Not Treated|2|||
44116796|NCT00700310|78900160|FG003|Overall Study|Randomized, Not Treated|2|||
44116797|NCT01575548|78900181|FG000|Overall Study|Adverse Event|15|||
44116798|NCT01575548|78900182|FG001|Overall Study|Adverse Event|2|||
44116799|NCT01575548|78900181|FG000|Overall Study|Disease progression|12|||
44116800|NCT01575548|78900182|FG001|Overall Study|Disease progression|25|||
44116801|NCT01575548|78900181|FG000|Overall Study|Death|1|||
44116802|NCT01575548|78900182|FG001|Overall Study|Death|0|||
44116803|NCT01575548|78900181|FG000|Overall Study|Other complicating disease|1|||
44574527|NCT02631850|79597058|FG003|Treatment Period|Withdrawal by Subject|2|||
44574528|NCT02631850|79597055|FG000|Treatment Period|Adverse Event|1|||
44574529|NCT02631850|79597056|FG001|Treatment Period|Adverse Event|0|||
44574530|NCT02631850|79597057|FG002|Treatment Period|Adverse Event|2|||
44574531|NCT02631850|79597058|FG003|Treatment Period|Adverse Event|3|||
44574532|NCT02631850|79597055|FG000|Treatment Period|Family medical issue|1|||
44116804|NCT01575548|78900182|FG001|Overall Study|Other complicating disease|0|||
44116805|NCT01575548|78900181|FG000|Overall Study|Withdrawal by Subject|7|||
44116806|NCT01575548|78900182|FG001|Overall Study|Withdrawal by Subject|3|||
44116807|NCT01575548|78900181|FG000|Overall Study|Noncompliance|1|||
44116808|NCT01575548|78900182|FG001|Overall Study|Noncompliance|0|||
44116809|NCT01575548|78900181|FG000|Overall Study|Anticipated surgery|0|||
44116810|NCT01575548|78900182|FG001|Overall Study|Anticipated surgery|1|||
44116811|NCT01575548|78900181|FG000|Overall Study|Never started protocol therapy|3|||
44116812|NCT01575548|78900182|FG001|Overall Study|Never started protocol therapy|2|||
44116813|NCT02554786|78900210|FG000|Overall Study|Subject/guardian decision|29|||
44116814|NCT02554786|78900211|FG001|Overall Study|Subject/guardian decision|17|||
44116815|NCT02554786|78900212|FG002|Overall Study|Subject/guardian decision|18|||
44116816|NCT02554786|78900213|FG003|Overall Study|Subject/guardian decision|30|||
44116817|NCT02554786|78900214|FG004|Overall Study|Subject/guardian decision|20|||
44116818|NCT02554786|78900210|FG000|Overall Study|Lost to Follow-up|4|||
44116819|NCT02554786|78900211|FG001|Overall Study|Lost to Follow-up|3|||
44116820|NCT02554786|78900212|FG002|Overall Study|Lost to Follow-up|4|||
44116821|NCT02554786|78900213|FG003|Overall Study|Lost to Follow-up|2|||
44116822|NCT02554786|78900214|FG004|Overall Study|Lost to Follow-up|2|||
44116823|NCT02554786|78900210|FG000|Overall Study|Protocol deviation|1|||
44116824|NCT02554786|78900211|FG001|Overall Study|Protocol deviation|3|||
44116825|NCT02554786|78900212|FG002|Overall Study|Protocol deviation|3|||
44116826|NCT02554786|78900213|FG003|Overall Study|Protocol deviation|4|||
44116827|NCT02554786|78900214|FG004|Overall Study|Protocol deviation|2|||
44116828|NCT02554786|78900210|FG000|Overall Study|Technical problems|1|||
44116829|NCT02554786|78900211|FG001|Overall Study|Technical problems|1|||
44116830|NCT02554786|78900212|FG002|Overall Study|Technical problems|0|||
44116831|NCT02554786|78900213|FG003|Overall Study|Technical problems|2|||
44116832|NCT02554786|78900214|FG004|Overall Study|Technical problems|1|||
44116833|NCT02554786|78900210|FG000|Overall Study|Adverse Event|0|||
44116834|NCT02554786|78900211|FG001|Overall Study|Adverse Event|0|||
44116835|NCT02554786|78900212|FG002|Overall Study|Adverse Event|0|||
44116836|NCT02554786|78900213|FG003|Overall Study|Adverse Event|0|||
44116837|NCT02554786|78900214|FG004|Overall Study|Adverse Event|2|||
44116838|NCT02554786|78900210|FG000|Overall Study|Death|0|||
44116839|NCT02554786|78900211|FG001|Overall Study|Death|0|||
44116840|NCT02554786|78900212|FG002|Overall Study|Death|0|||
44116841|NCT02554786|78900213|FG003|Overall Study|Death|1|||
44116842|NCT02554786|78900214|FG004|Overall Study|Death|0|||
44116843|NCT02554786|78900210|FG000|Overall Study|Non-compliance with study treatment|0|||
44574533|NCT02631850|79597056|FG001|Treatment Period|Family medical issue|0|||
44116844|NCT02554786|78900211|FG001|Overall Study|Non-compliance with study treatment|1|||
44116845|NCT02554786|78900212|FG002|Overall Study|Non-compliance with study treatment|1|||
44116846|NCT02554786|78900213|FG003|Overall Study|Non-compliance with study treatment|0|||
44238291|NCT01587703|79064755|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238292|NCT01587703|79064756|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44238293|NCT01587703|79064757|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44506074|NCT00062868|79510847|FG006|Dose Level 3|Death|0|||
44506075|NCT00062868|79510848|FG007|Dose Level 3|Death|0|||
44506076|NCT00062868|79510849|FG008|Dose Level 3|Death|0|||
44506077|NCT00062868|79510850|FG009|Dose Level 3|Death|0|||
44506078|NCT00062868|79510851|FG010|Dose Level 3|Death|0|||
44506079|NCT00062868|79510852|FG011|Dose Level 3|Death|1|||
44506080|NCT00062868|79510853|FG012|Dose Level 3|Death|0|||
44506081|NCT00062868|79510854|FG013|Dose Level 3|Death|0|||
44574534|NCT02631850|79597057|FG002|Treatment Period|Family medical issue|0|||
44574535|NCT02631850|79597058|FG003|Treatment Period|Family medical issue|0|||
44574536|NCT02631850|79597055|FG000|6 Month Follow up|Lost to Follow-up|5|||
44238294|NCT01587703|79064758|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
44574537|NCT02631850|79597056|FG001|6 Month Follow up|Lost to Follow-up|8|||
44238295|NCT01587703|79064740|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44116847|NCT02554786|78900214|FG004|Overall Study|Non-compliance with study treatment|1|||
44116848|NCT02554786|78900210|FG000|Overall Study|Physician Decision|0|||
44116849|NCT02554786|78900211|FG001|Overall Study|Physician Decision|1|||
44116850|NCT02554786|78900212|FG002|Overall Study|Physician Decision|4|||
44116851|NCT02554786|78900213|FG003|Overall Study|Physician Decision|1|||
44116852|NCT02554786|78900214|FG004|Overall Study|Physician Decision|1|||
44116853|NCT02554786|78900210|FG000|Overall Study|Pregnancy|0|||
44506082|NCT00062868|79510855|FG014|Dose Level 3|Death|0|||
44506083|NCT00062868|79510856|FG015|Dose Level 3|Death|0|||
44506084|NCT00062868|79510857|FG016|Dose Level 3|Death|0|||
44116854|NCT02554786|78900211|FG001|Overall Study|Pregnancy|0|||
44116855|NCT02554786|78900212|FG002|Overall Study|Pregnancy|0|||
44116856|NCT02554786|78900213|FG003|Overall Study|Pregnancy|1|||
44116857|NCT02554786|78900214|FG004|Overall Study|Pregnancy|1|||
44116858|NCT01347645|78900235|FG000|Overall Study|Death|1|||
44116859|NCT01347645|78900236|FG001|Overall Study|Death|5|||
44116860|NCT01347645|78900237|FG002|Overall Study|Death|2|||
44116861|NCT01347645|78900238|FG003|Overall Study|Death|7|||
44116862|NCT01347645|78900239|FG004|Overall Study|Death|7|||
44116863|NCT01347645|78900235|FG000|Overall Study|Lost to Follow-up|1|||
44116864|NCT01347645|78900236|FG001|Overall Study|Lost to Follow-up|1|||
44116865|NCT01347645|78900237|FG002|Overall Study|Lost to Follow-up|0|||
44116866|NCT01347645|78900238|FG003|Overall Study|Lost to Follow-up|1|||
44116867|NCT01347645|78900239|FG004|Overall Study|Lost to Follow-up|1|||
44116868|NCT01347645|78900235|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
44116869|NCT01347645|78900236|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
44116870|NCT01347645|78900237|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
44116871|NCT01347645|78900238|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
44116872|NCT01347645|78900239|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
44116873|NCT01347645|78900235|FG000|Overall Study|Other|1|||
44116874|NCT01347645|78900236|FG001|Overall Study|Other|0|||
44116875|NCT01347645|78900237|FG002|Overall Study|Other|0|||
44116876|NCT01347645|78900238|FG003|Overall Study|Other|0|||
44116877|NCT01347645|78900239|FG004|Overall Study|Other|1|||
44116878|NCT01347645|78900235|FG000|Overall Study|Withdrawal by Subject|0|||
44116879|NCT01347645|78900236|FG001|Overall Study|Withdrawal by Subject|0|||
44116880|NCT01347645|78900237|FG002|Overall Study|Withdrawal by Subject|0|||
44116881|NCT01347645|78900238|FG003|Overall Study|Withdrawal by Subject|3|||
44116882|NCT01347645|78900239|FG004|Overall Study|Withdrawal by Subject|3|||
44116883|NCT01347645|78900235|FG000|Overall Study|Physician Decision|0|||
44116884|NCT01347645|78900236|FG001|Overall Study|Physician Decision|0|||
44116885|NCT01347645|78900237|FG002|Overall Study|Physician Decision|0|||
44116886|NCT01347645|78900238|FG003|Overall Study|Physician Decision|0|||
44116887|NCT01347645|78900239|FG004|Overall Study|Physician Decision|1|||
44116888|NCT01347645|78900235|FG000|Overall Study|Adverse Event|0|||
44116889|NCT01347645|78900236|FG001|Overall Study|Adverse Event|0|||
44116890|NCT01347645|78900237|FG002|Overall Study|Adverse Event|0|||
44116891|NCT01347645|78900238|FG003|Overall Study|Adverse Event|1|||
44116892|NCT01347645|78900239|FG004|Overall Study|Adverse Event|1|||
44116893|NCT00484419|78900277|FG000|Overall Study|Adverse Event|3|||
44116894|NCT00484419|78900278|FG001|Overall Study|Adverse Event|0|||
44116895|NCT00484419|78900279|FG002|Overall Study|Adverse Event|0|||
44116896|NCT00484419|78900277|FG000|Overall Study|Lost to Follow-up|1|||
44116897|NCT00484419|78900278|FG001|Overall Study|Lost to Follow-up|0|||
44116898|NCT00484419|78900279|FG002|Overall Study|Lost to Follow-up|2|||
44116899|NCT00484419|78900277|FG000|Overall Study|Withdrawal by Subject|3|||
44116900|NCT00484419|78900278|FG001|Overall Study|Withdrawal by Subject|1|||
44116901|NCT00484419|78900279|FG002|Overall Study|Withdrawal by Subject|1|||
44116902|NCT00484419|78900277|FG000|Overall Study|subject met discontinuation criteria|2|||
44116903|NCT00484419|78900278|FG001|Overall Study|subject met discontinuation criteria|2|||
44116904|NCT00484419|78900279|FG002|Overall Study|subject met discontinuation criteria|4|||
44116905|NCT00484419|78900277|FG000|Overall Study|required restricted medication|1|||
44116906|NCT00484419|78900278|FG001|Overall Study|required restricted medication|0|||
44116907|NCT00484419|78900279|FG002|Overall Study|required restricted medication|1|||
44116908|NCT00484419|78900277|FG000|Overall Study|Physician Decision|1|||
44116909|NCT00484419|78900278|FG001|Overall Study|Physician Decision|1|||
44238296|NCT01587703|79064741|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238297|NCT01587703|79064742|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238298|NCT01587703|79064743|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238299|NCT01587703|79064744|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238300|NCT01587703|79064745|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238301|NCT01587703|79064746|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238302|NCT01587703|79064747|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238303|NCT01587703|79064748|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
44238304|NCT01587703|79064749|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44249753|NCT01504412|79083927|FG004|Overall Study|Death|0|||
44378034|NCT00890097|79383407|FG001|Overall Study|Randomization Error|0|||
44116910|NCT00484419|78900279|FG002|Overall Study|Physician Decision|1|||
44116911|NCT00484419|78900277|FG000|Overall Study|subject unable to receive medication|1|||
44116912|NCT00484419|78900278|FG001|Overall Study|subject unable to receive medication|0|||
44116913|NCT00484419|78900279|FG002|Overall Study|subject unable to receive medication|0|||
44116914|NCT00484419|78900277|FG000|Overall Study|subject relocated|0|||
44116915|NCT00484419|78900278|FG001|Overall Study|subject relocated|1|||
44506085|NCT00062868|79510858|FG017|Dose Level 3|Death|1|||
44506086|NCT00062868|79510859|FG018|Dose Level 3|Death|0|||
44506087|NCT00062868|79510860|FG019|Dose Level 3|Death|0|||
44506088|NCT00062868|79510861|FG020|Dose Level 3|Death|0|||
44506089|NCT00062868|79510841|FG000|Dose Level 3|Lost to Follow-up|0|||
44506090|NCT00062868|79510842|FG001|Dose Level 3|Lost to Follow-up|0|||
44506091|NCT00062868|79510843|FG002|Dose Level 3|Lost to Follow-up|0|||
44574538|NCT02631850|79597057|FG002|6 Month Follow up|Lost to Follow-up|3|||
44574539|NCT02631850|79597058|FG003|6 Month Follow up|Lost to Follow-up|5|||
44574540|NCT02631850|79597055|FG000|6 Month Follow up|Withdrawal by Subject|1|||
44574541|NCT02631850|79597056|FG001|6 Month Follow up|Withdrawal by Subject|0|||
44574542|NCT02631850|79597057|FG002|6 Month Follow up|Withdrawal by Subject|0|||
44574543|NCT02631850|79597058|FG003|6 Month Follow up|Withdrawal by Subject|2|||
44574544|NCT02631850|79597055|FG000|6 Month Follow up|Adverse Event|1|||
44574545|NCT02631850|79597056|FG001|6 Month Follow up|Adverse Event|4|||
44574546|NCT02631850|79597057|FG002|6 Month Follow up|Adverse Event|1|||
44116916|NCT00484419|78900279|FG002|Overall Study|subject relocated|0|||
44116917|NCT00484419|78900277|FG000|Overall Study|sponsor decision, randomized in error|0|||
44116918|NCT00484419|78900278|FG001|Overall Study|sponsor decision, randomized in error|0|||
44116919|NCT00484419|78900279|FG002|Overall Study|sponsor decision, randomized in error|2|||
44116920|NCT03220724|78900288|FG000|Overall Study|Lost to Follow-up|2|||
44116921|NCT03220724|78900289|FG001|Overall Study|Lost to Follow-up|1|||
44116922|NCT03220724|78900290|FG002|Overall Study|Lost to Follow-up|0|||
44116923|NCT03220724|78900291|FG003|Overall Study|Lost to Follow-up|3|||
44116924|NCT03220724|78900288|FG000|Overall Study|Withdrawal by Subject|1|||
44116925|NCT03220724|78900289|FG001|Overall Study|Withdrawal by Subject|1|||
44116926|NCT03220724|78900290|FG002|Overall Study|Withdrawal by Subject|1|||
44116927|NCT03220724|78900291|FG003|Overall Study|Withdrawal by Subject|0|||
44116928|NCT03056573|78900303|FG000|Overall Study|Death|2|||
44116929|NCT03056573|78900304|FG001|Overall Study|Death|4|||
44238305|NCT01587703|79064750|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
44238306|NCT01587703|79064751|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238307|NCT01587703|79064752|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238308|NCT01587703|79064753|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238309|NCT01587703|79064754|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238310|NCT01587703|79064755|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238311|NCT01587703|79064756|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238312|NCT01587703|79064757|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238313|NCT01587703|79064758|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
44238314|NCT01587703|79064740|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238315|NCT01587703|79064741|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238316|NCT01587703|79064742|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238317|NCT01587703|79064743|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238318|NCT01587703|79064744|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238319|NCT01587703|79064745|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238320|NCT01587703|79064746|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44506092|NCT00062868|79510844|FG003|Dose Level 3|Lost to Follow-up|0|||
44116930|NCT03056573|78900303|FG000|Overall Study|Withdrawal by Subject|2|||
44116931|NCT03056573|78900304|FG001|Overall Study|Withdrawal by Subject|0|||
44116932|NCT03056573|78900303|FG000|Overall Study|Lost to Follow-up|1|||
44116933|NCT03056573|78900304|FG001|Overall Study|Lost to Follow-up|1|||
44116934|NCT02553772|78900312|FG000|Overall Study|Adverse Event|2|||
44116935|NCT02553772|78900313|FG001|Overall Study|Adverse Event|3|||
44116936|NCT02553772|78900312|FG000|Overall Study|Lost to Follow-up|2|||
44116937|NCT02553772|78900313|FG001|Overall Study|Lost to Follow-up|1|||
44116938|NCT02553772|78900312|FG000|Overall Study|Withdrawal of Consent|1|||
44116939|NCT02553772|78900313|FG001|Overall Study|Withdrawal of Consent|1|||
44116940|NCT02553772|78900312|FG000|Overall Study|Lack of Efficacy|1|||
44116941|NCT02553772|78900313|FG001|Overall Study|Lack of Efficacy|0|||
44116942|NCT02553772|78900312|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44116943|NCT02553772|78900313|FG001|Overall Study|Other Miscellaneous Reasons|1|||
44116944|NCT02553538|78900321|FG000|Overall Study|Could Not Reach by Telephone|133|||
44116945|NCT02553538|78900322|FG001|Overall Study|Could Not Reach by Telephone|0|||
44116946|NCT02553538|78900321|FG000|Overall Study|Died or Left Network|54|||
44506093|NCT00062868|79510845|FG004|Dose Level 3|Lost to Follow-up|0|||
44574547|NCT02631850|79597058|FG003|6 Month Follow up|Adverse Event|3|||
44574548|NCT02631850|79597055|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
44116947|NCT02553538|78900322|FG001|Overall Study|Died or Left Network|56|||
44116948|NCT02548156|78900328|FG000|Washout Period 1|Lost to Follow-up|0|||
44116949|NCT02548156|78900329|FG001|Washout Period 1|Lost to Follow-up|0|||
44116950|NCT02548156|78900330|FG002|Washout Period 1|Lost to Follow-up|0|||
44116951|NCT02548156|78900331|FG003|Washout Period 1|Lost to Follow-up|0|||
44116952|NCT02548156|78900332|FG004|Washout Period 1|Lost to Follow-up|1|||
44116953|NCT02548156|78900333|FG005|Washout Period 1|Lost to Follow-up|0|||
44116954|NCT01503515|78900343|FG000|Overall Study|Adverse Event|4|||
44116955|NCT01503515|78900344|FG001|Overall Study|Adverse Event|5|||
44116956|NCT01503515|78900343|FG000|Overall Study|Death|0|||
44116957|NCT01503515|78900344|FG001|Overall Study|Death|1|||
44116958|NCT01503515|78900343|FG000|Overall Study|Physician Decision|14|||
44116959|NCT01503515|78900344|FG001|Overall Study|Physician Decision|23|||
44116960|NCT01503515|78900343|FG000|Overall Study|Withdrawal by Subject|0|||
44116961|NCT01503515|78900344|FG001|Overall Study|Withdrawal by Subject|1|||
44116962|NCT01503515|78900343|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
44116963|NCT01503515|78900344|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
44116964|NCT01503515|78900343|FG000|Overall Study|Ineligible|1|||
44116965|NCT01503515|78900344|FG001|Overall Study|Ineligible|1|||
44116966|NCT02742519|78900352|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
44116967|NCT02742519|78900353|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
44116968|NCT02742519|78900354|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
44116969|NCT02742519|78900352|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
44116970|NCT02742519|78900353|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
44116971|NCT02742519|78900354|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
44116972|NCT02742519|78900352|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
44116973|NCT02742519|78900353|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
44116974|NCT02742519|78900354|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
44116975|NCT01375010|78900364|FG000|Overall Study|Lost to Follow-up|8|||
44116976|NCT01375010|78900365|FG001|Overall Study|Lost to Follow-up|2|||
44116977|NCT01375010|78900364|FG000|Overall Study|Withdrawal by Subject|4|||
44116978|NCT01375010|78900365|FG001|Overall Study|Withdrawal by Subject|2|||
44116979|NCT00659061|78900389|FG000|Overall Study|Migration due to political unrest|21|||
44116980|NCT00659061|78900390|FG001|Overall Study|Migration due to political unrest|15|||
44116981|NCT02548078|78900407|FG000|Overall Study|Serious adverse event/Adverse event|1|||
44116982|NCT02548078|78900408|FG001|Overall Study|Serious adverse event/Adverse event|0|||
44116983|NCT02548078|78900407|FG000|Overall Study|Moved from study area|3|||
44116984|NCT02548078|78900408|FG001|Overall Study|Moved from study area|3|||
44116985|NCT02548078|78900407|FG000|Overall Study|Lost to Follow-up|1|||
44116986|NCT02548078|78900408|FG001|Overall Study|Lost to Follow-up|3|||
44116987|NCT02916433|78900423|FG000|Overall Study|Withdrawal by Subject|1|||
44116988|NCT02916433|78900424|FG001|Overall Study|Withdrawal by Subject|0|||
44116989|NCT02916433|78900423|FG000|Overall Study|Physician Decision|1|||
44116990|NCT02916433|78900424|FG001|Overall Study|Physician Decision|0|||
44116991|NCT00526227|78900433|FG000|Overall Study|Device not implanted|1|||
44116992|NCT00526227|78900433|FG000|Overall Study|Death|1|||
44116993|NCT02547922|78900441|FG000|Overall Study|Withdrawal by Subject|9|||
44116994|NCT02547922|78900442|FG001|Overall Study|Withdrawal by Subject|6|||
44116995|NCT02547922|78900443|FG002|Overall Study|Withdrawal by Subject|10|||
44116996|NCT02547922|78900441|FG000|Overall Study|Adverse Event|3|||
44116997|NCT02547922|78900442|FG001|Overall Study|Adverse Event|1|||
44116998|NCT02547922|78900443|FG002|Overall Study|Adverse Event|2|||
44116999|NCT02547922|78900441|FG000|Overall Study|Lost to Follow-up|1|||
44117000|NCT02547922|78900442|FG001|Overall Study|Lost to Follow-up|0|||
44117001|NCT02547922|78900443|FG002|Overall Study|Lost to Follow-up|0|||
44117002|NCT02547922|78900441|FG000|Overall Study|Lack of Efficacy|5|||
44117003|NCT02547922|78900442|FG001|Overall Study|Lack of Efficacy|7|||
44117004|NCT02547922|78900443|FG002|Overall Study|Lack of Efficacy|4|||
44117005|NCT02547922|78900441|FG000|Overall Study|Death|1|||
44117006|NCT02547922|78900442|FG001|Overall Study|Death|0|||
44117007|NCT02547922|78900443|FG002|Overall Study|Death|0|||
44117008|NCT02547922|78900441|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
44117009|NCT02547922|78900442|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
44117010|NCT02547922|78900443|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
44117011|NCT02547922|78900441|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
44117012|NCT02547922|78900442|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
44117013|NCT02547922|78900443|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
44117014|NCT02547922|78900441|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
44117015|NCT02547922|78900442|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
44117016|NCT02547922|78900443|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
44117017|NCT02547922|78900441|FG000|Overall Study|Physician Decision|2|||
44275955|NCT02194829|79226284|FG001|Overall Study|Adverse Event|2|||
44117018|NCT02547922|78900442|FG001|Overall Study|Physician Decision|1|||
44275956|NCT02194829|79226283|FG000|Overall Study|Death|0|||
44117019|NCT02547922|78900443|FG002|Overall Study|Physician Decision|2|||
44117020|NCT02547922|78900441|FG000|Overall Study|Patients did not receive IP|1|||
44117021|NCT02547922|78900442|FG001|Overall Study|Patients did not receive IP|1|||
44117022|NCT02547922|78900443|FG002|Overall Study|Patients did not receive IP|0|||
44117023|NCT02547766|78900457|FG000|Overall Study|Withdrawal by Subject|1|||
44117024|NCT02742441|78900470|FG000|Overall Study|Lost to Follow-up|4|||
44117025|NCT02742441|78900471|FG001|Overall Study|Lost to Follow-up|4|||
44117026|NCT02742441|78900470|FG000|Overall Study|Withdrawal by Subject|2|||
44117027|NCT02742441|78900471|FG001|Overall Study|Withdrawal by Subject|2|||
44117028|NCT02742441|78900470|FG000|Overall Study|Adverse Event|0|||
44117029|NCT02742441|78900471|FG001|Overall Study|Adverse Event|2|||
44117030|NCT02547220|78900479|FG000|Overall Study|Withdrawal by Subject|1|||
44117031|NCT02547220|78900480|FG001|Overall Study|Withdrawal by Subject|0|||
44117032|NCT02547220|78900479|FG000|Overall Study|Study terminated by sponsor|18|||
44117033|NCT02547220|78900480|FG001|Overall Study|Study terminated by sponsor|20|||
44117034|NCT02542072|78900488|FG000|First Intervention (1 Month)|Adverse Event|1|||
44117035|NCT02542072|78900489|FG001|First Intervention (1 Month)|Adverse Event|1|||
44117036|NCT02542072|78900488|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
44117037|NCT02542072|78900489|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
44117038|NCT02542072|78900488|FG000|First Intervention (1 Month)|Lens discomfort|1|||
44117039|NCT02542072|78900489|FG001|First Intervention (1 Month)|Lens discomfort|2|||
44117040|NCT02542072|78900488|FG000|First Intervention (1 Month)|Protocol Violation|1|||
44117041|NCT02542072|78900489|FG001|First Intervention (1 Month)|Protocol Violation|0|||
44117042|NCT02542072|78900488|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
44117043|NCT02542072|78900489|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
44117044|NCT02542072|78900488|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
44117045|NCT02542072|78900489|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
44117046|NCT02547454|78900515|FG000|Overall Study|Due to hemodialysis|53|||
44117047|NCT02547454|78900515|FG000|Overall Study|Due to transplantation|1|||
44117048|NCT02547454|78900515|FG000|Overall Study|Due to no further need to treat|4|||
44117049|NCT02547454|78900515|FG000|Overall Study|Death|38|||
44117050|NCT02547454|78900515|FG000|Overall Study|Lost to Follow-up|26|||
44117051|NCT02547454|78900515|FG000|Overall Study|Other|39|||
44117052|NCT02547454|78900515|FG000|Overall Study|No data|11|||
44117053|NCT00415623|78900521|FG000|Overall Study|Adverse Event|3|||
44117054|NCT00415623|78900522|FG001|Overall Study|Adverse Event|4|||
44117055|NCT00415623|78900521|FG000|Overall Study|Death|1|||
44117056|NCT00415623|78900522|FG001|Overall Study|Death|0|||
44117057|NCT00415623|78900521|FG000|Overall Study|Withdrawal by Subject|1|||
44117058|NCT00415623|78900522|FG001|Overall Study|Withdrawal by Subject|1|||
44117059|NCT01969409|78900531|FG000|Overall Study|Death|2|||
44117060|NCT01969409|78900532|FG001|Overall Study|Death|2|||
44117061|NCT01969409|78900531|FG000|Overall Study|Transplant|1|||
44117062|NCT01969409|78900532|FG001|Overall Study|Transplant|1|||
44117063|NCT01969409|78900531|FG000|Overall Study|Withdrawal by Subject|0|||
44117064|NCT01969409|78900532|FG001|Overall Study|Withdrawal by Subject|1|||
44117065|NCT00150813|78900538|FG000|Overall Study|Adverse Event|1|||
44117066|NCT00150813|78900538|FG000|Overall Study|Lack of Efficacy|1|||
44117067|NCT00150813|78900538|FG000|Overall Study|Lost to Follow-up|5|||
44117068|NCT00150813|78900538|FG000|Overall Study|Withdrawal by Subject|5|||
44117069|NCT00150813|78900538|FG000|Overall Study|Remission|3|||
44117070|NCT00150813|78900538|FG000|Overall Study|Planned pregancy|1|||
44117071|NCT00150813|78900538|FG000|Overall Study|Switch to commercially available LEV|2|||
44117072|NCT02712788|78900544|FG000|Overall Study|Physician Decision|1|||
44117073|NCT02712788|78900545|FG001|Overall Study|Physician Decision|0|||
44117074|NCT02712788|78900544|FG000|Overall Study|Protocol Violation|1|||
44117075|NCT02712788|78900545|FG001|Overall Study|Protocol Violation|0|||
44117076|NCT02308111|78900553|FG000|Overall Study|Adverse Event|31|||
44117077|NCT02308111|78900554|FG001|Overall Study|Adverse Event|19|||
44117078|NCT02308111|78900553|FG000|Overall Study|Death|9|||
44117079|NCT02308111|78900554|FG001|Overall Study|Death|6|||
44117080|NCT02308111|78900553|FG000|Overall Study|Lost to Follow-up|2|||
44117081|NCT02308111|78900554|FG001|Overall Study|Lost to Follow-up|7|||
44117082|NCT02308111|78900553|FG000|Overall Study|Physician Decision|6|||
44117083|NCT02308111|78900554|FG001|Overall Study|Physician Decision|17|||
44117084|NCT02308111|78900553|FG000|Overall Study|Protocol Violation|0|||
44275957|NCT02194829|79226284|FG001|Overall Study|Death|1|||
44117085|NCT02308111|78900554|FG001|Overall Study|Protocol Violation|1|||
44117086|NCT02308111|78900553|FG000|Overall Study|Withdrawal by Subject|28|||
44117087|NCT02308111|78900554|FG001|Overall Study|Withdrawal by Subject|38|||
44117088|NCT02308111|78900553|FG000|Overall Study|Study Terminated by Sponsor|72|||
44117089|NCT02308111|78900554|FG001|Overall Study|Study Terminated by Sponsor|61|||
44117090|NCT02308111|78900553|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
44117091|NCT02308111|78900554|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
44117092|NCT02308111|78900553|FG000|Overall Study|Site Closure|3|||
44117093|NCT02308111|78900554|FG001|Overall Study|Site Closure|3|||
44117094|NCT02308111|78900553|FG000|Overall Study|Non-compliance with Study Drug|3|||
44117095|NCT02308111|78900554|FG001|Overall Study|Non-compliance with Study Drug|1|||
44117096|NCT02308111|78900553|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
44117097|NCT02308111|78900554|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
44117098|NCT02308111|78900553|FG000|Overall Study|Liver Transplant|3|||
44117099|NCT02308111|78900554|FG001|Overall Study|Liver Transplant|3|||
44378035|NCT00890097|79383408|FG002|Overall Study|Randomization Error|0|||
44275958|NCT02194829|79226283|FG000|Overall Study|Disease progression|0|||
44117100|NCT02308111|78900553|FG000|Overall Study|Liver Transplant Waitlist|2|||
44117101|NCT02308111|78900554|FG001|Overall Study|Liver Transplant Waitlist|2|||
44117102|NCT02308111|78900553|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
44117103|NCT02308111|78900554|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
44117104|NCT01346189|78900565|FG000|Overall Study|Withdrawal by Subject|7|||
44117105|NCT01346189|78900566|FG001|Overall Study|Withdrawal by Subject|5|||
44117106|NCT01346189|78900567|FG002|Overall Study|Withdrawal by Subject|3|||
44117107|NCT01346189|78900568|FG003|Overall Study|Withdrawal by Subject|5|||
44117108|NCT01346189|78900565|FG000|Overall Study|Physician Decision|4|||
44117109|NCT01346189|78900566|FG001|Overall Study|Physician Decision|0|||
44117110|NCT01346189|78900567|FG002|Overall Study|Physician Decision|0|||
44117111|NCT01346189|78900568|FG003|Overall Study|Physician Decision|0|||
44117112|NCT01346189|78900565|FG000|Overall Study|Moved|3|||
44117113|NCT01346189|78900566|FG001|Overall Study|Moved|0|||
44117114|NCT01346189|78900567|FG002|Overall Study|Moved|4|||
44117115|NCT01346189|78900568|FG003|Overall Study|Moved|0|||
44117116|NCT01346189|78900565|FG000|Overall Study|Other|2|||
44117117|NCT01346189|78900566|FG001|Overall Study|Other|4|||
44117118|NCT01346189|78900567|FG002|Overall Study|Other|7|||
44117119|NCT01346189|78900568|FG003|Overall Study|Other|3|||
44117120|NCT01346189|78900565|FG000|Overall Study|Death|0|||
44117121|NCT01346189|78900566|FG001|Overall Study|Death|3|||
44117122|NCT01346189|78900567|FG002|Overall Study|Death|0|||
44117123|NCT01346189|78900568|FG003|Overall Study|Death|0|||
44117124|NCT01346189|78900565|FG000|Overall Study|Non-health system primary care physician|0|||
44117125|NCT01346189|78900566|FG001|Overall Study|Non-health system primary care physician|5|||
44117126|NCT01346189|78900567|FG002|Overall Study|Non-health system primary care physician|0|||
44117127|NCT01346189|78900568|FG003|Overall Study|Non-health system primary care physician|0|||
44117128|NCT01346189|78900565|FG000|Overall Study|Travel|0|||
44117129|NCT01346189|78900566|FG001|Overall Study|Travel|0|||
44117130|NCT01346189|78900567|FG002|Overall Study|Travel|0|||
44117131|NCT01346189|78900568|FG003|Overall Study|Travel|3|||
44117132|NCT00369317|78900578|FG000|Overall Study|Adverse Event|3|||
44117133|NCT00369317|78900578|FG000|Overall Study|Death|1|||
44117134|NCT00369317|78900578|FG000|Overall Study|Lack of Efficacy|5|||
44117135|NCT00369317|78900578|FG000|Overall Study|Physician Decision|2|||
44117136|NCT00369317|78900578|FG000|Overall Study|Withdrawal by Subject|8|||
44117137|NCT00369317|78900578|FG000|Overall Study|Ineligible|1|||
44117138|NCT03193021|78900585|FG000|Overall Study|Lost to Follow-up|1|||
44117139|NCT03193021|78900586|FG001|Overall Study|Lost to Follow-up|1|||
44117140|NCT03913091|78900594|FG000|Overall Study|Lost to Follow-up|18|||
44117141|NCT03913091|78900595|FG001|Overall Study|Lost to Follow-up|11|||
44117142|NCT03913091|78900594|FG000|Overall Study|Required additional meds/surgery|1|||
44117143|NCT03913091|78900595|FG001|Overall Study|Required additional meds/surgery|2|||
44117144|NCT03913091|78900594|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
44117145|NCT03913091|78900595|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
44117146|NCT01318499|78900619|FG000|Overall Study|Adverse Event|16|||
44117147|NCT01318499|78900620|FG001|Overall Study|Adverse Event|11|||
44117148|NCT01318499|78900621|FG002|Overall Study|Adverse Event|6|||
44117149|NCT01318499|78900619|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
44117150|NCT01318499|78900620|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
44117151|NCT01318499|78900621|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
44117152|NCT01318499|78900619|FG000|Overall Study|Noncompliance|2|||
44117153|NCT01318499|78900620|FG001|Overall Study|Noncompliance|3|||
44117154|NCT01318499|78900621|FG002|Overall Study|Noncompliance|0|||
44117155|NCT01318499|78900619|FG000|Overall Study|Treatment Failure|19|||
44117156|NCT01318499|78900620|FG001|Overall Study|Treatment Failure|19|||
44117157|NCT01318499|78900621|FG002|Overall Study|Treatment Failure|101|||
44117158|NCT01318499|78900619|FG000|Overall Study|Protocol Violation|2|||
44506094|NCT00062868|79510846|FG005|Dose Level 3|Lost to Follow-up|0|||
44506095|NCT00062868|79510847|FG006|Dose Level 3|Lost to Follow-up|0|||
44117159|NCT01318499|78900620|FG001|Overall Study|Protocol Violation|4|||
44117160|NCT01318499|78900621|FG002|Overall Study|Protocol Violation|2|||
44506096|NCT00062868|79510848|FG007|Dose Level 3|Lost to Follow-up|0|||
44117161|NCT01318499|78900619|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
44117162|NCT01318499|78900620|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
44117163|NCT01318499|78900621|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
44117164|NCT01318499|78900619|FG000|Overall Study|Other|7|||
44117165|NCT01318499|78900620|FG001|Overall Study|Other|10|||
44117166|NCT01318499|78900621|FG002|Overall Study|Other|22|||
44506097|NCT00062868|79510849|FG008|Dose Level 3|Lost to Follow-up|0|||
44117167|NCT02285595|78900655|FG000|Overall Study|Lost to Follow-up|14|||
44117168|NCT02285595|78900655|FG000|Overall Study|Withdrawal by Subject|1|||
44117169|NCT02712398|78900678|FG000|Overall Study|Withdrawal by Subject|6|||
44117170|NCT02712398|78900678|FG000|Overall Study|Lost to Follow-up|6|||
44506098|NCT00062868|79510850|FG009|Dose Level 3|Lost to Follow-up|0|||
44117171|NCT02712398|78900678|FG000|Overall Study|Sponsor Decision|1|||
44506099|NCT00062868|79510851|FG010|Dose Level 3|Lost to Follow-up|0|||
44117172|NCT02712398|78900678|FG000|Overall Study|Physician Decision|1|||
44117173|NCT02712398|78900678|FG000|Overall Study|Death|2|||
44117174|NCT02712398|78900678|FG000|Overall Study|Re-operation|21|||
44117175|NCT00282867|78900685|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
44117176|NCT00282867|78900686|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
44117177|NCT00282867|78900687|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
44117178|NCT00151281|78900697|FG000|Overall Study|Not evaluable|3|||
44117179|NCT01318109|78900712|FG000|Overall Study|Adverse Event|0|||
44117180|NCT01318109|78900713|FG001|Overall Study|Adverse Event|2|||
44117181|NCT01318109|78900714|FG002|Overall Study|Adverse Event|0|||
44117182|NCT01318109|78900712|FG000|Overall Study|Withdrawal by Subject|1|||
44117183|NCT01318109|78900713|FG001|Overall Study|Withdrawal by Subject|0|||
44117184|NCT01318109|78900714|FG002|Overall Study|Withdrawal by Subject|0|||
44117185|NCT01318109|78900712|FG000|Overall Study|Schedule Conflict|0|||
44117186|NCT01318109|78900713|FG001|Overall Study|Schedule Conflict|1|||
44117187|NCT01318109|78900714|FG002|Overall Study|Schedule Conflict|0|||
44117188|NCT02712554|78900724|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
44117189|NCT02712554|78900725|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
44117190|NCT02712554|78900724|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
44117191|NCT02712554|78900725|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
44117192|NCT02712554|78900724|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
44117193|NCT02712554|78900725|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
44117194|NCT02712554|78900724|FG000|Part B: Qualification Phase|Adverse Event|0|||
44117195|NCT02712554|78900725|FG001|Part B: Qualification Phase|Adverse Event|1|||
44117196|NCT02712554|78900724|FG000|Part B: Treatment Phase|Adverse Event|0|||
44117197|NCT02712554|78900725|FG001|Part B: Treatment Phase|Adverse Event|1|||
44117198|NCT02712554|78900724|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
44117199|NCT02712554|78900725|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
44574549|NCT02631850|79597056|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
44574550|NCT02631850|79597057|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
44574551|NCT02631850|79597058|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
44574552|NCT00103038|79597069|FG000|Overall Study|Withdrawal by Subject|8|||
44574553|NCT00103038|79597069|FG000|Overall Study|Screen failure|3|||
44574554|NCT00103038|79597069|FG000|Overall Study|Death|1|||
44574555|NCT00103038|79597069|FG000|Overall Study|Physician Decision|1|||
44574556|NCT00620035|79597076|FG000|Overall Study|Adverse Event|106|||
44574557|NCT00620035|79597076|FG000|Overall Study|Withdrawal of Informed Consent|1|||
44574558|NCT00620035|79597076|FG000|Overall Study|Other Reason|38|||
44574559|NCT03034057|79597080|FG000|Overall Study|Withdrawal by Subject|10|||
44117200|NCT02712554|78900724|FG000|Part B: Treatment Phase|Other|0|||
44117201|NCT02712554|78900725|FG001|Part B: Treatment Phase|Other|1|||
44117202|NCT02712320|78900748|FG000|Overall Study|Lost to Follow-up|1|||
44117203|NCT02712320|78900748|FG000|Overall Study|Withdrawal by Subject|1|||
44117204|NCT02712320|78900748|FG000|Overall Study|Transferred to another facility|1|||
44117205|NCT02712320|78900748|FG000|Overall Study|Treating with the prohibited medications|2|||
44117206|NCT03052751|78900754|FG000|Dosing Period 1|Adverse Event|0|||
44117207|NCT03052751|78900755|FG001|Dosing Period 1|Adverse Event|1|||
44117208|NCT03052751|78900756|FG002|Dosing Period 1|Adverse Event|0|||
44117209|NCT03052751|78900757|FG003|Dosing Period 1|Adverse Event|0|||
44506100|NCT00062868|79510852|FG011|Dose Level 3|Lost to Follow-up|0|||
44117210|NCT03052751|78900758|FG004|Dosing Period 1|Adverse Event|0|||
44506101|NCT00062868|79510853|FG012|Dose Level 3|Lost to Follow-up|0|||
44506102|NCT00062868|79510854|FG013|Dose Level 3|Lost to Follow-up|0|||
44506103|NCT00062868|79510855|FG014|Dose Level 3|Lost to Follow-up|1|||
44506104|NCT00062868|79510856|FG015|Dose Level 3|Lost to Follow-up|0|||
44506105|NCT00062868|79510857|FG016|Dose Level 3|Lost to Follow-up|0|||
44506106|NCT00062868|79510858|FG017|Dose Level 3|Lost to Follow-up|0|||
44506107|NCT00062868|79510859|FG018|Dose Level 3|Lost to Follow-up|0|||
44506108|NCT00062868|79510860|FG019|Dose Level 3|Lost to Follow-up|0|||
44506109|NCT00062868|79510861|FG020|Dose Level 3|Lost to Follow-up|0|||
44506110|NCT00062868|79510841|FG000|Dose Level 3|Withdrew|0|||
44506111|NCT00062868|79510842|FG001|Dose Level 3|Withdrew|0|||
44506112|NCT00062868|79510843|FG002|Dose Level 3|Withdrew|2|||
44506113|NCT00062868|79510844|FG003|Dose Level 3|Withdrew|0|||
44506114|NCT00062868|79510845|FG004|Dose Level 3|Withdrew|0|||
44506115|NCT00062868|79510846|FG005|Dose Level 3|Withdrew|0|||
44506116|NCT00062868|79510847|FG006|Dose Level 3|Withdrew|0|||
44506117|NCT00062868|79510848|FG007|Dose Level 3|Withdrew|0|||
44506118|NCT00062868|79510849|FG008|Dose Level 3|Withdrew|0|||
44506119|NCT00062868|79510850|FG009|Dose Level 3|Withdrew|0|||
44506120|NCT00062868|79510851|FG010|Dose Level 3|Withdrew|0|||
44506121|NCT00062868|79510852|FG011|Dose Level 3|Withdrew|0|||
44506122|NCT00062868|79510853|FG012|Dose Level 3|Withdrew|0|||
44506123|NCT00062868|79510854|FG013|Dose Level 3|Withdrew|0|||
44506124|NCT00062868|79510855|FG014|Dose Level 3|Withdrew|0|||
44506125|NCT00062868|79510856|FG015|Dose Level 3|Withdrew|0|||
44506126|NCT00062868|79510857|FG016|Dose Level 3|Withdrew|0|||
44117211|NCT03052751|78900759|FG005|Dosing Period 1|Adverse Event|0|||
44117212|NCT03052751|78900754|FG000|Dosing Period 2|Adverse Event|0|||
44117213|NCT03052751|78900755|FG001|Dosing Period 2|Adverse Event|0|||
44117214|NCT03052751|78900756|FG002|Dosing Period 2|Adverse Event|3|||
44117215|NCT03052751|78900757|FG003|Dosing Period 2|Adverse Event|0|||
44117216|NCT03052751|78900758|FG004|Dosing Period 2|Adverse Event|0|||
44117217|NCT03052751|78900759|FG005|Dosing Period 2|Adverse Event|0|||
44117218|NCT03052751|78900754|FG000|Observation Period|Adverse Event|0|||
44117219|NCT03052751|78900755|FG001|Observation Period|Adverse Event|0|||
44117220|NCT03052751|78900756|FG002|Observation Period|Adverse Event|0|||
44117221|NCT03052751|78900757|FG003|Observation Period|Adverse Event|0|||
44117222|NCT03052751|78900758|FG004|Observation Period|Adverse Event|1|||
44117223|NCT03052751|78900759|FG005|Observation Period|Adverse Event|0|||
44117224|NCT01317797|78900772|FG000|Overall Study|Other|0|||
44117225|NCT01317797|78900773|FG001|Overall Study|Other|1|||
44117226|NCT01317797|78900774|FG002|Overall Study|Other|0|||
44117227|NCT01317797|78900772|FG000|Overall Study|Withdrawal of Patient|0|||
44117228|NCT01317797|78900773|FG001|Overall Study|Withdrawal of Patient|0|||
44117229|NCT01317797|78900774|FG002|Overall Study|Withdrawal of Patient|1|||
44117230|NCT01343693|78900782|FG000|Overall Study|Lost to Follow-up|9|||
44117231|NCT02712008|78900789|FG000|Baseline (Day 1) up to Week 12|Death|3|||
44117232|NCT02712008|78900790|FG001|Baseline (Day 1) up to Week 12|Death|0|||
44117233|NCT02712008|78900791|FG002|Baseline (Day 1) up to Week 12|Death|0|||
44117234|NCT02712008|78900792|FG003|Baseline (Day 1) up to Week 12|Death|0|||
44117235|NCT02712008|78900793|FG004|Baseline (Day 1) up to Week 12|Death|0|||
44117236|NCT02712008|78900794|FG005|Baseline (Day 1) up to Week 12|Death|0|||
44117237|NCT02712008|78900795|FG006|Baseline (Day 1) up to Week 12|Death|0|||
44117238|NCT02712008|78900796|FG007|Baseline (Day 1) up to Week 12|Death|0|||
44117239|NCT02712008|78900789|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44117240|NCT02712008|78900790|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
44117241|NCT02712008|78900791|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
44117242|NCT02712008|78900792|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44117243|NCT02712008|78900793|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44117244|NCT02712008|78900794|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44117245|NCT02712008|78900795|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44117246|NCT02712008|78900796|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
44117247|NCT02712008|78900789|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
44117248|NCT02712008|78900790|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44117249|NCT02712008|78900791|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
44117250|NCT02712008|78900792|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44117251|NCT02712008|78900793|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44117252|NCT02712008|78900794|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44117253|NCT02712008|78900795|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44117254|NCT02712008|78900796|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
44117255|NCT02712008|78900789|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117256|NCT02712008|78900790|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117257|NCT02712008|78900791|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
44117258|NCT02712008|78900792|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117259|NCT02712008|78900793|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117260|NCT02712008|78900794|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117261|NCT02712008|78900795|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117262|NCT02712008|78900796|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
44117263|NCT02712008|78900789|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117264|NCT02712008|78900790|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
44117265|NCT02712008|78900791|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117266|NCT02712008|78900792|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117267|NCT02712008|78900793|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117268|NCT02712008|78900794|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117269|NCT02712008|78900795|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117270|NCT02712008|78900796|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
44117271|NCT02712008|78900789|FG000|From Week 12 up to Week 36|Adverse Event|0|||
44117272|NCT02712008|78900790|FG001|From Week 12 up to Week 36|Adverse Event|0|||
44117273|NCT02712008|78900791|FG002|From Week 12 up to Week 36|Adverse Event|0|||
44117274|NCT02712008|78900792|FG003|From Week 12 up to Week 36|Adverse Event|0|||
44117275|NCT02712008|78900793|FG004|From Week 12 up to Week 36|Adverse Event|1|||
44117276|NCT02712008|78900794|FG005|From Week 12 up to Week 36|Adverse Event|0|||
44117277|NCT02712008|78900795|FG006|From Week 12 up to Week 36|Adverse Event|0|||
44117278|NCT02712008|78900796|FG007|From Week 12 up to Week 36|Adverse Event|2|||
44117279|NCT02712008|78900789|FG000|From Week 12 up to Week 36|Death|1|||
44378036|NCT00890097|79383406|FG000|Overall Study|Failed inclusion criteria|3|||
44378037|NCT00890097|79383407|FG001|Overall Study|Failed inclusion criteria|4|||
44117280|NCT02712008|78900790|FG001|From Week 12 up to Week 36|Death|0|||
44117281|NCT02712008|78900791|FG002|From Week 12 up to Week 36|Death|0|||
44117282|NCT02712008|78900792|FG003|From Week 12 up to Week 36|Death|0|||
44117283|NCT02712008|78900793|FG004|From Week 12 up to Week 36|Death|0|||
44117284|NCT02712008|78900794|FG005|From Week 12 up to Week 36|Death|0|||
44117285|NCT02712008|78900795|FG006|From Week 12 up to Week 36|Death|1|||
44117286|NCT02712008|78900796|FG007|From Week 12 up to Week 36|Death|0|||
44117287|NCT02712008|78900789|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
44117288|NCT02712008|78900790|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
44117289|NCT02712008|78900791|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
44117290|NCT02712008|78900792|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
44117291|NCT02712008|78900793|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
44117292|NCT02712008|78900794|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
44117293|NCT02712008|78900795|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
44117294|NCT02712008|78900796|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
44117295|NCT02712008|78900789|FG000|From Week 12 up to Week 36|Physician Decision|0|||
44117296|NCT02712008|78900790|FG001|From Week 12 up to Week 36|Physician Decision|0|||
44117297|NCT02712008|78900791|FG002|From Week 12 up to Week 36|Physician Decision|0|||
44117298|NCT02712008|78900792|FG003|From Week 12 up to Week 36|Physician Decision|1|||
44117299|NCT02712008|78900793|FG004|From Week 12 up to Week 36|Physician Decision|1|||
44117300|NCT02712008|78900794|FG005|From Week 12 up to Week 36|Physician Decision|0|||
44117301|NCT02712008|78900795|FG006|From Week 12 up to Week 36|Physician Decision|0|||
44117302|NCT02712008|78900796|FG007|From Week 12 up to Week 36|Physician Decision|0|||
44117303|NCT02712008|78900789|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
44117304|NCT02712008|78900790|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
44117305|NCT02712008|78900791|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
44117306|NCT02712008|78900792|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
44117307|NCT02712008|78900793|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
44117308|NCT02712008|78900794|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
44117309|NCT02712008|78900795|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
44117310|NCT02712008|78900796|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
44117311|NCT02711306|78900816|FG000|Overall Study|Withdrawal by Subject|2|||
44117312|NCT02711306|78900817|FG001|Overall Study|Withdrawal by Subject|2|||
44117313|NCT02710292|78900823|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
44117314|NCT02710292|78900824|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
44117315|NCT02710292|78900823|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
44117316|NCT02710292|78900824|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
44117317|NCT02710214|78900833|FG000|Overall Study|Lost to Follow-up|1|||
44117318|NCT02710214|78900834|FG001|Overall Study|Lost to Follow-up|0|||
44117319|NCT02710214|78900833|FG000|Overall Study|Lack of Efficacy|0|||
44117320|NCT02710214|78900834|FG001|Overall Study|Lack of Efficacy|1|||
44117321|NCT02710214|78900833|FG000|Overall Study|Death|0|||
44117322|NCT02710214|78900834|FG001|Overall Study|Death|1|||
44117323|NCT03052517|78900843|FG000|Overall Study|Study Terminated By Sponsor|928|||
44117324|NCT03052517|78900844|FG001|Overall Study|Study Terminated By Sponsor|938|||
44117325|NCT03052517|78900845|FG002|Overall Study|Study Terminated By Sponsor|296|||
44117326|NCT03052517|78900843|FG000|Overall Study|Subject/Guardian Decision|50|||
44117327|NCT03052517|78900844|FG001|Overall Study|Subject/Guardian Decision|45|||
44117328|NCT03052517|78900845|FG002|Overall Study|Subject/Guardian Decision|22|||
44117329|NCT03052517|78900843|FG000|Overall Study|Lack of Efficacy|23|||
44117330|NCT03052517|78900844|FG001|Overall Study|Lack of Efficacy|14|||
44117331|NCT03052517|78900845|FG002|Overall Study|Lack of Efficacy|7|||
44117332|NCT03052517|78900843|FG000|Overall Study|Adverse Event|6|||
44117333|NCT03052517|78900844|FG001|Overall Study|Adverse Event|5|||
44117334|NCT03052517|78900845|FG002|Overall Study|Adverse Event|0|||
44117335|NCT03052517|78900843|FG000|Overall Study|Physician Decision|4|||
44117336|NCT03052517|78900844|FG001|Overall Study|Physician Decision|5|||
44117337|NCT03052517|78900845|FG002|Overall Study|Physician Decision|1|||
44117338|NCT03052517|78900843|FG000|Overall Study|Death|3|||
44117339|NCT03052517|78900844|FG001|Overall Study|Death|0|||
44117340|NCT03052517|78900845|FG002|Overall Study|Death|1|||
44117341|NCT03052517|78900843|FG000|Overall Study|Lost to Follow-up|2|||
44117342|NCT03052517|78900844|FG001|Overall Study|Lost to Follow-up|4|||
44117343|NCT03052517|78900845|FG002|Overall Study|Lost to Follow-up|0|||
44117344|NCT03052517|78900843|FG000|Overall Study|Pregnancy|1|||
44117345|NCT03052517|78900844|FG001|Overall Study|Pregnancy|0|||
44117346|NCT03052517|78900845|FG002|Overall Study|Pregnancy|1|||
44117347|NCT03052517|78900843|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
44117348|NCT03052517|78900844|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
44117349|NCT03052517|78900845|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
44117350|NCT03052517|78900843|FG000|Overall Study|Technical Problems|0|||
44238321|NCT01587703|79064747|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238322|NCT01587703|79064748|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238323|NCT01587703|79064749|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
44378038|NCT00890097|79383408|FG002|Overall Study|Failed inclusion criteria|0|||
44117351|NCT03052517|78900844|FG001|Overall Study|Technical Problems|1|||
44117352|NCT03052517|78900845|FG002|Overall Study|Technical Problems|0|||
44117353|NCT02708498|78900861|FG000|Overall Study|Death|20|||
44117354|NCT02708498|78900862|FG001|Overall Study|Death|19|||
44117355|NCT02708498|78900863|FG002|Overall Study|Death|0|||
44117356|NCT02708498|78900864|FG003|Overall Study|Death|0|||
44117357|NCT02708498|78900865|FG004|Overall Study|Death|1|||
44117358|NCT02708498|78900866|FG005|Overall Study|Death|0|||
44117359|NCT02708498|78900867|FG006|Overall Study|Death|0|||
44117360|NCT02708498|78900868|FG007|Overall Study|Death|0|||
44117361|NCT02708498|78900861|FG000|Overall Study|Unknown reason, missing data|0|||
44117362|NCT02708498|78900862|FG001|Overall Study|Unknown reason, missing data|0|||
44117363|NCT02708498|78900863|FG002|Overall Study|Unknown reason, missing data|62|||
44117364|NCT02708498|78900864|FG003|Overall Study|Unknown reason, missing data|51|||
44117365|NCT02708498|78900865|FG004|Overall Study|Unknown reason, missing data|195|||
44117366|NCT02708498|78900866|FG005|Overall Study|Unknown reason, missing data|132|||
44117367|NCT02708498|78900867|FG006|Overall Study|Unknown reason, missing data|0|||
44117368|NCT02708498|78900868|FG007|Overall Study|Unknown reason, missing data|0|||
44117369|NCT02710136|78900886|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
44117370|NCT02710136|78900887|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
44117371|NCT03702231|78900897|FG000|Overall Study|Withdrawal by Subject|1|||
44117372|NCT03702231|78900898|FG001|Overall Study|Withdrawal by Subject|0|||
44117373|NCT03702231|78900899|FG002|Overall Study|Withdrawal by Subject|0|||
44117374|NCT03702231|78900897|FG000|Overall Study|Protocol Violation|0|||
44117375|NCT03702231|78900898|FG001|Overall Study|Protocol Violation|0|||
44117376|NCT03702231|78900899|FG002|Overall Study|Protocol Violation|1|||
44117377|NCT03702231|78900897|FG000|Overall Study|Change in CLL Treatment|0|||
44117378|NCT03702231|78900898|FG001|Overall Study|Change in CLL Treatment|0|||
44117379|NCT03702231|78900899|FG002|Overall Study|Change in CLL Treatment|1|||
44117380|NCT03702231|78900897|FG000|Overall Study|COVID Pandemic|1|||
44117381|NCT03702231|78900898|FG001|Overall Study|COVID Pandemic|4|||
44117382|NCT03702231|78900899|FG002|Overall Study|COVID Pandemic|1|||
44117383|NCT03702231|78900897|FG000|Overall Study|Non-compliance|0|||
44117384|NCT03702231|78900898|FG001|Overall Study|Non-compliance|0|||
44117385|NCT03702231|78900899|FG002|Overall Study|Non-compliance|1|||
44117386|NCT02741271|78900909|FG000|Overall Study|Lost to Follow-up|2|||
44117387|NCT02741271|78900910|FG001|Overall Study|Lost to Follow-up|0|||
44117388|NCT02741271|78900909|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44117389|NCT02741271|78900910|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
44117390|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
44117391|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
44117392|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
44117393|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
44117394|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
44117395|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
44117396|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
44117397|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
44117398|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
44117399|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
44117400|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
44117401|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
44117402|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
44117403|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
44117404|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
44117405|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
44117406|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
44117407|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
44117408|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
44117409|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
44117410|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
44117411|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
44117412|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
44117413|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
44117414|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
44117415|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
44117416|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
44506127|NCT00062868|79510858|FG017|Dose Level 3|Withdrew|0|||
44506128|NCT00062868|79510859|FG018|Dose Level 3|Withdrew|0|||
44506129|NCT00062868|79510860|FG019|Dose Level 3|Withdrew|0|||
44506130|NCT00062868|79510861|FG020|Dose Level 3|Withdrew|0|||
44506131|NCT00075504|79510907|FG000|Overall Study|Withdrawal by Subject|9|||
44506132|NCT00075504|79510908|FG001|Overall Study|Withdrawal by Subject|7|||
44117417|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
44506133|NCT00062166|79510914|FG000|Overall Study|Withdrawal by Subject|6|||
44117418|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
44117419|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
44117420|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
44117421|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
44117422|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
44117423|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
44117424|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
44117425|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
44117426|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
44117427|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
44117428|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
44117429|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
44117430|NCT02709746|78900923|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
44117431|NCT02709746|78900924|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
44117432|NCT02709746|78900925|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
44117433|NCT02709746|78900926|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
44117434|NCT02709746|78900927|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
44117435|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
44117436|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
44117437|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
44117438|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
44117439|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
44117440|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
44117441|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
44117442|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
44117443|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
44117444|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
44117445|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
44117446|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
44117447|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
44117448|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
44117449|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
44117450|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
44117451|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
44117452|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
44117453|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
44117454|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
44117455|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
44117456|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
44117457|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
44117458|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
44117459|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
44117460|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
44117461|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
44117462|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
44117463|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
44117464|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
44117465|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
44117466|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
44238324|NCT01587703|79064750|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
44238325|NCT01587703|79064751|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238326|NCT01587703|79064752|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238327|NCT01587703|79064753|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44117467|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
44117468|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
44238328|NCT01587703|79064754|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44378039|NCT00890097|79383406|FG000|Overall Study|Transportation|0|||
44378040|NCT00890097|79383407|FG001|Overall Study|Transportation|2|||
44378041|NCT00890097|79383408|FG002|Overall Study|Transportation|0|||
44378042|NCT00890097|79383406|FG000|Overall Study|Subject Moved|0|||
44378043|NCT00890097|79383407|FG001|Overall Study|Subject Moved|4|||
44238329|NCT01587703|79064755|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44378044|NCT00890097|79383408|FG002|Overall Study|Subject Moved|0|||
44574560|NCT03034057|79597080|FG000|Overall Study|Protocol Violation|1|||
44117469|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
44117470|NCT02709746|78900923|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
44117471|NCT02709746|78900924|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
44117472|NCT02709746|78900925|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
44117473|NCT02709746|78900926|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
44117474|NCT02709746|78900927|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
44117475|NCT01317641|78900948|FG000|Overall Study|Not treated|0|||
44117476|NCT01317641|78900949|FG001|Overall Study|Not treated|0|||
44117477|NCT01317641|78900950|FG002|Overall Study|Not treated|0|||
44117478|NCT01317641|78900951|FG003|Overall Study|Not treated|0|||
44117479|NCT01317641|78900952|FG004|Overall Study|Not treated|0|||
44117480|NCT01317641|78900953|FG005|Overall Study|Not treated|0|||
44117481|NCT01317641|78900954|FG006|Overall Study|Not treated|0|||
44117482|NCT01317641|78900955|FG007|Overall Study|Not treated|1|||
44117483|NCT01317641|78900956|FG008|Overall Study|Not treated|1|||
44117484|NCT01317641|78900948|FG000|Overall Study|Adverse Event|0|||
44117485|NCT01317641|78900949|FG001|Overall Study|Adverse Event|1|||
44117486|NCT01317641|78900950|FG002|Overall Study|Adverse Event|0|||
44117487|NCT01317641|78900951|FG003|Overall Study|Adverse Event|1|||
44117488|NCT01317641|78900952|FG004|Overall Study|Adverse Event|0|||
44117489|NCT01317641|78900953|FG005|Overall Study|Adverse Event|0|||
44117490|NCT01317641|78900954|FG006|Overall Study|Adverse Event|2|||
44117491|NCT01317641|78900955|FG007|Overall Study|Adverse Event|1|||
44117492|NCT01317641|78900956|FG008|Overall Study|Adverse Event|0|||
44117493|NCT01317641|78900948|FG000|Overall Study|Protocol Violation|1|||
44117494|NCT01317641|78900949|FG001|Overall Study|Protocol Violation|0|||
44117495|NCT01317641|78900950|FG002|Overall Study|Protocol Violation|0|||
44117496|NCT01317641|78900951|FG003|Overall Study|Protocol Violation|0|||
44117497|NCT01317641|78900952|FG004|Overall Study|Protocol Violation|0|||
44117498|NCT01317641|78900953|FG005|Overall Study|Protocol Violation|0|||
44117499|NCT01317641|78900954|FG006|Overall Study|Protocol Violation|0|||
44117500|NCT01317641|78900955|FG007|Overall Study|Protocol Violation|0|||
44117501|NCT01317641|78900956|FG008|Overall Study|Protocol Violation|0|||
44117502|NCT01317641|78900948|FG000|Overall Study|Disease progression|0|||
44117503|NCT01317641|78900949|FG001|Overall Study|Disease progression|0|||
44117504|NCT01317641|78900950|FG002|Overall Study|Disease progression|0|||
44117505|NCT01317641|78900951|FG003|Overall Study|Disease progression|0|||
44117506|NCT01317641|78900952|FG004|Overall Study|Disease progression|0|||
44117507|NCT01317641|78900953|FG005|Overall Study|Disease progression|0|||
44117508|NCT01317641|78900954|FG006|Overall Study|Disease progression|0|||
44117509|NCT01317641|78900955|FG007|Overall Study|Disease progression|3|||
44117510|NCT01317641|78900956|FG008|Overall Study|Disease progression|4|||
44117511|NCT01317641|78900948|FG000|Overall Study|Withdrawal by Subject|0|||
44117512|NCT01317641|78900949|FG001|Overall Study|Withdrawal by Subject|0|||
44117513|NCT01317641|78900950|FG002|Overall Study|Withdrawal by Subject|0|||
44117514|NCT01317641|78900951|FG003|Overall Study|Withdrawal by Subject|0|||
44117515|NCT01317641|78900952|FG004|Overall Study|Withdrawal by Subject|0|||
44117516|NCT01317641|78900953|FG005|Overall Study|Withdrawal by Subject|0|||
44117517|NCT01317641|78900954|FG006|Overall Study|Withdrawal by Subject|1|||
44117518|NCT01317641|78900955|FG007|Overall Study|Withdrawal by Subject|0|||
44117519|NCT01317641|78900956|FG008|Overall Study|Withdrawal by Subject|0|||
44117520|NCT03186794|78900992|FG000|Overall Study|Physician Decision|2|||
44117521|NCT03186794|78900992|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
44117522|NCT02290431|78900997|FG000|Overall Study|Adverse Event|20|||
44117523|NCT02290431|78900997|FG000|Overall Study|Progressive disease|4|||
44117524|NCT02290431|78900997|FG000|Overall Study|Study terminated by Sponsor|1|||
44117525|NCT02290431|78900997|FG000|Overall Study|Physician Decision|2|||
44117526|NCT02707952|78901005|FG000|Overall Study|Adverse Event|1|||
44117527|NCT02707952|78901006|FG001|Overall Study|Adverse Event|0|||
44117528|NCT02707952|78901007|FG002|Overall Study|Adverse Event|0|||
44117529|NCT02707952|78901008|FG003|Overall Study|Adverse Event|0|||
44117530|NCT02707952|78901005|FG000|Overall Study|Lost to Follow-up|1|||
44117531|NCT02707952|78901006|FG001|Overall Study|Lost to Follow-up|0|||
44378045|NCT00890097|79383406|FG000|Overall Study|Protocol Deviation|1|||
44574561|NCT03034057|79597080|FG000|Overall Study|Not defined|2|||
44574562|NCT03034057|79597080|FG000|Overall Study|Lost to Follow-up|19|||
44574563|NCT03034057|79597080|FG000|Overall Study|Adverse Event|22|||
44117532|NCT02707952|78901007|FG002|Overall Study|Lost to Follow-up|0|||
44117533|NCT02707952|78901008|FG003|Overall Study|Lost to Follow-up|0|||
44117534|NCT02707952|78901005|FG000|Overall Study|Withdrawal by Subject|0|||
44117535|NCT02707952|78901006|FG001|Overall Study|Withdrawal by Subject|1|||
44117536|NCT02707952|78901007|FG002|Overall Study|Withdrawal by Subject|2|||
44117537|NCT02707952|78901008|FG003|Overall Study|Withdrawal by Subject|0|||
44574564|NCT03034057|79597080|FG000|Overall Study|Medication error without associated AE|1|||
44117538|NCT03050801|78901026|FG000|Experiment 1|Lost to Follow-up|0|||
44117539|NCT03050801|78901027|FG001|Experiment 1|Lost to Follow-up|1|||
44117540|NCT03050801|78901028|FG002|Experiment 1|Lost to Follow-up|0|||
44117541|NCT03050801|78901029|FG003|Experiment 1|Lost to Follow-up|0|||
44117542|NCT03050801|78901030|FG004|Experiment 1|Lost to Follow-up|0|||
44117543|NCT03050801|78901031|FG005|Experiment 1|Lost to Follow-up|0|||
44117544|NCT03050801|78901026|FG000|Experiment 1|Physician Decision|0|||
44117545|NCT03050801|78901027|FG001|Experiment 1|Physician Decision|3|||
44117546|NCT03050801|78901028|FG002|Experiment 1|Physician Decision|0|||
44117547|NCT03050801|78901029|FG003|Experiment 1|Physician Decision|0|||
44117548|NCT03050801|78901030|FG004|Experiment 1|Physician Decision|0|||
44117549|NCT03050801|78901031|FG005|Experiment 1|Physician Decision|0|||
44117550|NCT03050801|78901026|FG000|Experiment 1|Change of experimental design|0|||
44117551|NCT03050801|78901027|FG001|Experiment 1|Change of experimental design|3|||
44117552|NCT03050801|78901028|FG002|Experiment 1|Change of experimental design|0|||
44117553|NCT03050801|78901029|FG003|Experiment 1|Change of experimental design|0|||
44117554|NCT03050801|78901030|FG004|Experiment 1|Change of experimental design|0|||
44117555|NCT03050801|78901031|FG005|Experiment 1|Change of experimental design|0|||
44117556|NCT03050801|78901026|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
44117557|NCT03050801|78901027|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
44117558|NCT03050801|78901028|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
44117559|NCT03050801|78901029|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
44117560|NCT03050801|78901030|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
44117561|NCT03050801|78901031|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
44117562|NCT03050801|78901026|FG000|Experiment 2|Lost to Follow-up|0|||
44117563|NCT03050801|78901027|FG001|Experiment 2|Lost to Follow-up|0|||
44117564|NCT03050801|78901028|FG002|Experiment 2|Lost to Follow-up|0|||
44117565|NCT03050801|78901029|FG003|Experiment 2|Lost to Follow-up|1|||
44117566|NCT03050801|78901030|FG004|Experiment 2|Lost to Follow-up|1|||
44117567|NCT03050801|78901031|FG005|Experiment 2|Lost to Follow-up|0|||
44117568|NCT03050801|78901026|FG000|Experiment 2|Physician Decision|0|||
44117569|NCT03050801|78901027|FG001|Experiment 2|Physician Decision|0|||
44117570|NCT03050801|78901028|FG002|Experiment 2|Physician Decision|0|||
44117571|NCT03050801|78901029|FG003|Experiment 2|Physician Decision|0|||
44117572|NCT03050801|78901030|FG004|Experiment 2|Physician Decision|1|||
44117573|NCT03050801|78901031|FG005|Experiment 2|Physician Decision|0|||
44117574|NCT03050801|78901026|FG000|Experiment 2|Pregnancy|0|||
44117575|NCT03050801|78901027|FG001|Experiment 2|Pregnancy|0|||
44117576|NCT03050801|78901028|FG002|Experiment 2|Pregnancy|0|||
44117577|NCT03050801|78901029|FG003|Experiment 2|Pregnancy|0|||
44117578|NCT03050801|78901030|FG004|Experiment 2|Pregnancy|1|||
44117579|NCT03050801|78901031|FG005|Experiment 2|Pregnancy|0|||
44117580|NCT03050801|78901026|FG000|Experiment 2|Withdrawal by Subject|0|||
44117581|NCT03050801|78901027|FG001|Experiment 2|Withdrawal by Subject|0|||
44117582|NCT03050801|78901028|FG002|Experiment 2|Withdrawal by Subject|0|||
44117583|NCT03050801|78901029|FG003|Experiment 2|Withdrawal by Subject|1|||
44117584|NCT03050801|78901030|FG004|Experiment 2|Withdrawal by Subject|0|||
44117585|NCT03050801|78901031|FG005|Experiment 2|Withdrawal by Subject|0|||
44117586|NCT03050801|78901026|FG000|Experiment 2|Poor data quality|0|||
44117587|NCT03050801|78901027|FG001|Experiment 2|Poor data quality|0|||
44117588|NCT03050801|78901028|FG002|Experiment 2|Poor data quality|0|||
44117589|NCT03050801|78901029|FG003|Experiment 2|Poor data quality|4|||
44117590|NCT03050801|78901030|FG004|Experiment 2|Poor data quality|1|||
44117591|NCT03050801|78901031|FG005|Experiment 2|Poor data quality|0|||
44117592|NCT03050801|78901026|FG000|Experiment 2|Discomfort during stimulation|0|||
44117593|NCT03050801|78901027|FG001|Experiment 2|Discomfort during stimulation|0|||
44117594|NCT03050801|78901028|FG002|Experiment 2|Discomfort during stimulation|0|||
44117595|NCT03050801|78901029|FG003|Experiment 2|Discomfort during stimulation|0|||
44117596|NCT03050801|78901030|FG004|Experiment 2|Discomfort during stimulation|0|||
44117597|NCT03050801|78901031|FG005|Experiment 2|Discomfort during stimulation|2|||
44117598|NCT02707640|78901050|FG000|Overall Study|Adverse Event|4|||
44574565|NCT02757768|79597086|FG000|Overall Study|Randomized Never Received Study Drug|3|||
44574566|NCT02757768|79597087|FG001|Overall Study|Randomized Never Received Study Drug|4|||
44574567|NCT02757768|79597086|FG000|Overall Study|Adverse Event|5|||
44574568|NCT02757768|79597087|FG001|Overall Study|Adverse Event|3|||
44574569|NCT02757768|79597086|FG000|Overall Study|Lack of Efficacy|2|||
44574570|NCT02757768|79597087|FG001|Overall Study|Lack of Efficacy|1|||
44574571|NCT02757768|79597086|FG000|Overall Study|Lost to Follow-up|1|||
44574572|NCT02757768|79597087|FG001|Overall Study|Lost to Follow-up|0|||
44574573|NCT02757768|79597086|FG000|Overall Study|Protocol Deviation|2|||
44117599|NCT02707640|78901051|FG001|Overall Study|Adverse Event|2|||
44238330|NCT01587703|79064756|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44574574|NCT02757768|79597087|FG001|Overall Study|Protocol Deviation|9|||
44574575|NCT02757768|79597086|FG000|Overall Study|Withdrawal by Subject|16|||
44574576|NCT02757768|79597087|FG001|Overall Study|Withdrawal by Subject|9|||
44574577|NCT02757768|79597086|FG000|Overall Study|Miscellaneous|4|||
44574578|NCT02757768|79597087|FG001|Overall Study|Miscellaneous|2|||
44117600|NCT02707640|78901050|FG000|Overall Study|Death|1|||
44117601|NCT02707640|78901051|FG001|Overall Study|Death|2|||
44117602|NCT02707640|78901050|FG000|Overall Study|Physician Decision|2|||
44117603|NCT02707640|78901051|FG001|Overall Study|Physician Decision|0|||
44117604|NCT02707640|78901050|FG000|Overall Study|Withdrawal by Subject|0|||
44117605|NCT02707640|78901051|FG001|Overall Study|Withdrawal by Subject|1|||
44117606|NCT02707640|78901050|FG000|Overall Study|Participant's Personal Decision|1|||
44117607|NCT02707640|78901051|FG001|Overall Study|Participant's Personal Decision|2|||
44117608|NCT02707640|78901050|FG000|Overall Study|Sponsor Discretion|1|||
44117609|NCT02707640|78901051|FG001|Overall Study|Sponsor Discretion|0|||
44117610|NCT02708966|78901059|FG000|Overall Study|Lost to Follow-up|2|||
44117611|NCT02708966|78901060|FG001|Overall Study|Lost to Follow-up|2|||
44117612|NCT02706938|78901068|FG000|First Period, 6 Weeks|Adverse Event|8|||
44117613|NCT02706938|78901069|FG001|First Period, 6 Weeks|Adverse Event|0|||
44117614|NCT02706938|78901068|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
44117615|NCT02706938|78901069|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
44117616|NCT02706938|78901068|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
44117617|NCT02706938|78901069|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
44117618|NCT02706938|78901068|FG000|Second Period, 6 Weeks|Adverse Event|0|||
44117619|NCT02706938|78901069|FG001|Second Period, 6 Weeks|Adverse Event|7|||
44117620|NCT02706938|78901068|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
44117621|NCT02706938|78901069|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
44117622|NCT03053063|78901079|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
44117623|NCT03053063|78901080|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
44117624|NCT03053063|78901081|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
44117625|NCT03053063|78901082|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
44117626|NCT03053063|78901079|FG000|Randomized Phase|Withdrew consent|8|||
44117627|NCT03053063|78901080|FG001|Randomized Phase|Withdrew consent|11|||
44117628|NCT03053063|78901081|FG002|Randomized Phase|Withdrew consent|5|||
44117629|NCT03053063|78901082|FG003|Randomized Phase|Withdrew consent|0|||
44117630|NCT03053063|78901079|FG000|Randomized Phase|Investigator's Discretion|8|||
44117631|NCT03053063|78901080|FG001|Randomized Phase|Investigator's Discretion|6|||
44117632|NCT03053063|78901081|FG002|Randomized Phase|Investigator's Discretion|2|||
44117633|NCT03053063|78901082|FG003|Randomized Phase|Investigator's Discretion|0|||
44117634|NCT03053063|78901079|FG000|Randomized Phase|Lost to Follow-up|3|||
44117635|NCT03053063|78901080|FG001|Randomized Phase|Lost to Follow-up|5|||
44117636|NCT03053063|78901081|FG002|Randomized Phase|Lost to Follow-up|1|||
44117637|NCT03053063|78901082|FG003|Randomized Phase|Lost to Follow-up|0|||
44117638|NCT03053063|78901079|FG000|Randomized Phase|Adverse Event|0|||
44117639|NCT03053063|78901080|FG001|Randomized Phase|Adverse Event|1|||
44117640|NCT03053063|78901081|FG002|Randomized Phase|Adverse Event|0|||
44117641|NCT03053063|78901082|FG003|Randomized Phase|Adverse Event|0|||
44117642|NCT03053063|78901079|FG000|Randomized Phase|Randomized but Never Treated|1|||
44117643|NCT03053063|78901080|FG001|Randomized Phase|Randomized but Never Treated|3|||
44117644|NCT03053063|78901081|FG002|Randomized Phase|Randomized but Never Treated|2|||
44117645|NCT03053063|78901082|FG003|Randomized Phase|Randomized but Never Treated|0|||
44574579|NCT05225389|79597095|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
44574580|NCT02753946|79597101|FG000|Overall Study|Adverse Event|7|||
44574581|NCT02753946|79597102|FG001|Overall Study|Adverse Event|6|||
44574582|NCT02753946|79597101|FG000|Overall Study|Withdrawal by Subject|6|||
44574583|NCT02753946|79597102|FG001|Overall Study|Withdrawal by Subject|1|||
44574584|NCT02753946|79597101|FG000|Overall Study|Lack of Efficacy|1|||
44574585|NCT02753946|79597102|FG001|Overall Study|Lack of Efficacy|0|||
44574586|NCT02753946|79597101|FG000|Overall Study|Physician Decision|0|||
44574587|NCT02753946|79597102|FG001|Overall Study|Physician Decision|2|||
44574588|NCT02756832|79597108|FG000|Overall Study|Lost for Observation after Baseline|6|||
44574589|NCT02756832|79597108|FG000|Overall Study|Lost for Observation|13|||
44574590|NCT02756832|79597108|FG000|Overall Study|Patient's Unwillingness|12|||
44574591|NCT02756832|79597108|FG000|Overall Study|Insufficient Efficacy|2|||
44574592|NCT02756832|79597108|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
44574593|NCT02756832|79597108|FG000|Overall Study|Reason not Specified|9|||
44574594|NCT02756832|79597108|FG000|Overall Study|Protocol Deviation|10|||
44574595|NCT00106080|79597114|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
44574596|NCT00106080|79597115|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
44574597|NCT02633020|79597123|FG000|Overall Study|Adverse Event|1|||
44117646|NCT03053063|78901079|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
44117647|NCT03053063|78901080|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
44117648|NCT03053063|78901081|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
44117649|NCT03053063|78901082|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
44117650|NCT03053063|78901079|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
44117651|NCT03053063|78901080|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
44117652|NCT03053063|78901081|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
44117653|NCT03053063|78901082|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
44117654|NCT03053063|78901079|FG000|Open-Label Phase|Death|0|||
44574598|NCT02633020|79597124|FG001|Overall Study|Adverse Event|0|||
44574599|NCT00106626|79597134|FG000|Overall Study|Adverse Event|5|||
44117655|NCT03053063|78901080|FG001|Open-Label Phase|Death|0|||
44574600|NCT00106626|79597135|FG001|Overall Study|Adverse Event|4|||
44117656|NCT03053063|78901081|FG002|Open-Label Phase|Death|0|||
44117657|NCT03053063|78901082|FG003|Open-Label Phase|Death|2|||
44117658|NCT03053063|78901079|FG000|Open-Label Phase|Investigator's discretion|0|||
44117659|NCT03053063|78901080|FG001|Open-Label Phase|Investigator's discretion|0|||
44117660|NCT03053063|78901081|FG002|Open-Label Phase|Investigator's discretion|0|||
44117661|NCT03053063|78901082|FG003|Open-Label Phase|Investigator's discretion|2|||
44117662|NCT01316939|78901104|FG000|Overall Study|Study closed/terminated|26|||
44117663|NCT01316939|78901105|FG001|Overall Study|Study closed/terminated|25|||
44117664|NCT01316939|78901106|FG002|Overall Study|Study closed/terminated|23|||
44117665|NCT01316939|78901104|FG000|Overall Study|Lack of Efficacy|24|||
44117666|NCT01316939|78901105|FG001|Overall Study|Lack of Efficacy|25|||
44117667|NCT01316939|78901106|FG002|Overall Study|Lack of Efficacy|25|||
44117668|NCT01316939|78901104|FG000|Overall Study|Adverse Event|9|||
44117669|NCT01316939|78901105|FG001|Overall Study|Adverse Event|12|||
44117670|NCT01316939|78901106|FG002|Overall Study|Adverse Event|11|||
44117671|NCT01316939|78901104|FG000|Overall Study|Withdrawal by Subject|1|||
44117672|NCT01316939|78901105|FG001|Overall Study|Withdrawal by Subject|3|||
44117673|NCT01316939|78901106|FG002|Overall Study|Withdrawal by Subject|6|||
44117674|NCT01316939|78901104|FG000|Overall Study|Physician Decision|2|||
44117675|NCT01316939|78901105|FG001|Overall Study|Physician Decision|2|||
44117676|NCT01316939|78901106|FG002|Overall Study|Physician Decision|1|||
44117677|NCT01316939|78901104|FG000|Overall Study|Lost to Follow-up|0|||
44117678|NCT01316939|78901105|FG001|Overall Study|Lost to Follow-up|0|||
44117679|NCT01316939|78901106|FG002|Overall Study|Lost to Follow-up|2|||
44117680|NCT01316939|78901104|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
44117681|NCT01316939|78901105|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
44117682|NCT01316939|78901106|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
44117683|NCT01316939|78901104|FG000|Overall Study|Protocol Violation|0|||
44117684|NCT01316939|78901105|FG001|Overall Study|Protocol Violation|1|||
44117685|NCT01316939|78901106|FG002|Overall Study|Protocol Violation|0|||
44117686|NCT03044249|78901116|FG000|Overall Study|Adverse Event|4|||
44117687|NCT03044249|78901117|FG001|Overall Study|Adverse Event|9|||
44117688|NCT03044249|78901116|FG000|Overall Study|Lost to Follow-up|1|||
44117689|NCT03044249|78901117|FG001|Overall Study|Lost to Follow-up|0|||
44117690|NCT03044249|78901116|FG000|Overall Study|Non-compliance with Study Drug|1|||
44117691|NCT03044249|78901117|FG001|Overall Study|Non-compliance with Study Drug|0|||
44117692|NCT03044249|78901116|FG000|Overall Study|Study Terminated by Sponsor|2|||
44117693|NCT03044249|78901117|FG001|Overall Study|Study Terminated by Sponsor|0|||
44117694|NCT03044249|78901116|FG000|Overall Study|Withdrawal by Subject|2|||
44117695|NCT03044249|78901117|FG001|Overall Study|Withdrawal by Subject|5|||
44117696|NCT02704130|78901130|FG000|Overall Study|Physician Decision|5|||
44117697|NCT02704130|78901131|FG001|Overall Study|Physician Decision|3|||
44117698|NCT03740009|78901137|FG000|Overall Study|Physician Decision|9|||
44117699|NCT03740009|78901137|FG000|Overall Study|Lost to Follow-up|1|||
44117700|NCT03649217|78901141|FG000|Overall Study|subject had severe ataxia not initially found|1|||
44117701|NCT03649217|78901141|FG000|Overall Study|subject had cognitive issues not initially found|1|||
44117702|NCT03138889|78901170|FG000|Overall Study|Withdrawal by Subject|5|||
44117703|NCT03138889|78901171|FG001|Overall Study|Withdrawal by Subject|5|||
44117704|NCT03138889|78901172|FG002|Overall Study|Withdrawal by Subject|0|||
44117705|NCT03138889|78901173|FG003|Overall Study|Withdrawal by Subject|2|||
44574601|NCT00106626|79597136|FG002|Overall Study|Adverse Event|3|||
44574602|NCT00106626|79597137|FG003|Overall Study|Adverse Event|3|||
44574603|NCT00106626|79597134|FG000|Overall Study|Progressive Disease|4|||
44574604|NCT00106626|79597135|FG001|Overall Study|Progressive Disease|1|||
44574605|NCT00106626|79597136|FG002|Overall Study|Progressive Disease|9|||
44117706|NCT03138889|78901174|FG004|Overall Study|Withdrawal by Subject|1|||
44117707|NCT03138889|78901175|FG005|Overall Study|Withdrawal by Subject|3|||
44117708|NCT03138889|78901176|FG006|Overall Study|Withdrawal by Subject|0|||
44238331|NCT01587703|79064757|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44238332|NCT01587703|79064758|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
44117709|NCT03138889|78901177|FG007|Overall Study|Withdrawal by Subject|1|||
44117710|NCT02706392|78901229|FG000|Overall Study|Death|1|||
44117711|NCT02706392|78901230|FG001|Overall Study|Death|0|||
44117712|NCT02706392|78901231|FG002|Overall Study|Death|2|||
44117713|NCT02706392|78901232|FG003|Overall Study|Death|2|||
44117714|NCT02706392|78901233|FG004|Overall Study|Death|5|||
44117715|NCT02706392|78901234|FG005|Overall Study|Death|2|||
44117716|NCT03042767|78901250|FG000|Overall Study|Lost to Follow-up|1|||
44117717|NCT03042767|78901251|FG001|Overall Study|Lost to Follow-up|2|||
44117718|NCT00703820|78901259|FG000|Overall Study|Adverse Event|12|||
44117719|NCT00703820|78901260|FG001|Overall Study|Adverse Event|17|||
44117720|NCT00703820|78901259|FG000|Overall Study|Death|5|||
44574606|NCT00106626|79597137|FG003|Overall Study|Progressive Disease|10|||
44117721|NCT00703820|78901260|FG001|Overall Study|Death|0|||
44117722|NCT00703820|78901259|FG000|Overall Study|Lack of Efficacy|11|||
44117723|NCT00703820|78901260|FG001|Overall Study|Lack of Efficacy|11|||
44117724|NCT00703820|78901259|FG000|Overall Study|Received non-protocol therapy|1|||
44574607|NCT00106626|79597134|FG000|Overall Study|Received radiation on new therapy|1|||
44574608|NCT00106626|79597135|FG001|Overall Study|Received radiation on new therapy|0|||
44574609|NCT00106626|79597136|FG002|Overall Study|Received radiation on new therapy|0|||
44574610|NCT00106626|79597137|FG003|Overall Study|Received radiation on new therapy|0|||
44574611|NCT00106626|79597134|FG000|Overall Study|> 14 day delay in therapy start|0|||
44574612|NCT00106626|79597135|FG001|Overall Study|> 14 day delay in therapy start|1|||
44574613|NCT00106626|79597136|FG002|Overall Study|> 14 day delay in therapy start|0|||
44574614|NCT00106626|79597137|FG003|Overall Study|> 14 day delay in therapy start|0|||
44574615|NCT02632786|79597154|FG000|Overall Study|Adverse Event|2|||
44574616|NCT02632786|79597155|FG001|Overall Study|Adverse Event|1|||
44574617|NCT02632786|79597154|FG000|Overall Study|Death|3|||
44117725|NCT00703820|78901260|FG001|Overall Study|Received non-protocol therapy|0|||
44117726|NCT00703820|78901259|FG000|Overall Study|Physician Decision|4|||
44117727|NCT00703820|78901260|FG001|Overall Study|Physician Decision|5|||
44117728|NCT00703820|78901259|FG000|Overall Study|Withdrawal by Subject|2|||
44117729|NCT00703820|78901260|FG001|Overall Study|Withdrawal by Subject|1|||
44117730|NCT03045887|78901278|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
44117731|NCT03045887|78901279|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117732|NCT03045887|78901280|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117733|NCT03045887|78901281|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117734|NCT03045887|78901282|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117735|NCT03045887|78901283|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117736|NCT03045887|78901284|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117737|NCT03045887|78901285|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117738|NCT03045887|78901286|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117739|NCT03045887|78901287|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
44117740|NCT03045887|78901278|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117741|NCT03045887|78901279|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117742|NCT03045887|78901280|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117743|NCT03045887|78901281|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
44117744|NCT03045887|78901282|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117745|NCT03045887|78901283|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117746|NCT03045887|78901284|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117747|NCT03045887|78901285|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117748|NCT03045887|78901286|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117749|NCT03045887|78901287|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
44117750|NCT03045887|78901278|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
44117751|NCT03045887|78901279|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117752|NCT03045887|78901280|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117753|NCT03045887|78901281|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117754|NCT03045887|78901282|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117755|NCT03045887|78901283|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
44574618|NCT02632786|79597155|FG001|Overall Study|Death|2|||
44574619|NCT02632786|79597154|FG000|Overall Study|Physician Decision|5|||
44574620|NCT02632786|79597155|FG001|Overall Study|Physician Decision|4|||
44574621|NCT02632786|79597154|FG000|Overall Study|Withdrawal by Subject|1|||
44574622|NCT02632786|79597155|FG001|Overall Study|Withdrawal by Subject|0|||
44574623|NCT02755818|79597166|FG000|Overall Study|Withdrawal by Subject|0|||
44574624|NCT02755818|79597167|FG001|Overall Study|Withdrawal by Subject|0|||
44574625|NCT02755818|79597168|FG002|Overall Study|Withdrawal by Subject|0|||
44574626|NCT02755818|79597169|FG003|Overall Study|Withdrawal by Subject|2|||
44574627|NCT02755818|79597166|FG000|Overall Study|withdrawal by PI|0|||
44574628|NCT02755818|79597167|FG001|Overall Study|withdrawal by PI|0|||
44574629|NCT02755818|79597168|FG002|Overall Study|withdrawal by PI|1|||
44574630|NCT02755818|79597169|FG003|Overall Study|withdrawal by PI|1|||
44574631|NCT03033745|79597184|FG000|Overall Study|Protocol Violation|0|||
44574632|NCT03033745|79597185|FG001|Overall Study|Protocol Violation|0|||
44574633|NCT03033745|79597186|FG002|Overall Study|Protocol Violation|1|||
44574634|NCT03033745|79597184|FG000|Overall Study|Adverse Event|1|||
44574635|NCT03033745|79597185|FG001|Overall Study|Adverse Event|0|||
44574636|NCT03033745|79597186|FG002|Overall Study|Adverse Event|1|||
44117756|NCT03045887|78901284|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117757|NCT03045887|78901285|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117758|NCT03045887|78901286|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
44275959|NCT02194829|79226284|FG001|Overall Study|Disease progression|1|||
44574637|NCT03033745|79597184|FG000|Overall Study|Withdrawal by Subject|0|||
44275960|NCT02194829|79226283|FG000|Overall Study|Withdrawal by Subject|0|||
44574638|NCT03033745|79597185|FG001|Overall Study|Withdrawal by Subject|1|||
44574639|NCT03033745|79597186|FG002|Overall Study|Withdrawal by Subject|0|||
44574640|NCT01672294|79597205|FG000|Overall Study|Withdrawal by Subject|4|||
44574641|NCT01672294|79597206|FG001|Overall Study|Withdrawal by Subject|4|||
44574642|NCT01672294|79597207|FG002|Overall Study|Withdrawal by Subject|4|||
44574643|NCT01672294|79597208|FG003|Overall Study|Withdrawal by Subject|4|||
44378046|NCT00890097|79383407|FG001|Overall Study|Protocol Deviation|1|||
44378047|NCT00890097|79383408|FG002|Overall Study|Protocol Deviation|1|||
44378048|NCT00913458|79383416|FG000|Phase 1|Non-Responder|54|||
44378049|NCT00913458|79383417|FG001|Phase 1|Non-Responder|0|||
44378050|NCT00913458|79383418|FG002|Phase 1|Non-Responder|0|||
44378051|NCT00913458|79383419|FG003|Phase 1|Non-Responder|0|||
44574644|NCT01672294|79597205|FG000|Overall Study|Excluded by study|1|||
44574645|NCT01672294|79597206|FG001|Overall Study|Excluded by study|1|||
44574646|NCT01672294|79597207|FG002|Overall Study|Excluded by study|0|||
44574647|NCT01672294|79597208|FG003|Overall Study|Excluded by study|0|||
44378052|NCT00913458|79383420|FG004|Phase 1|Non-Responder|0|||
44378053|NCT00913458|79383421|FG005|Phase 1|Non-Responder|0|||
44378054|NCT00913458|79383422|FG006|Phase 1|Non-Responder|0|||
44378055|NCT00913458|79383416|FG000|Phase 1|Subject Request|17|||
44378056|NCT00913458|79383417|FG001|Phase 1|Subject Request|0|||
44378057|NCT00913458|79383418|FG002|Phase 1|Subject Request|0|||
44378058|NCT00913458|79383419|FG003|Phase 1|Subject Request|0|||
44378059|NCT00913458|79383420|FG004|Phase 1|Subject Request|0|||
44378060|NCT00913458|79383421|FG005|Phase 1|Subject Request|0|||
44378061|NCT00913458|79383422|FG006|Phase 1|Subject Request|0|||
44574648|NCT01672294|79597205|FG000|Overall Study|Lost to Follow-up|1|||
44574649|NCT01672294|79597206|FG001|Overall Study|Lost to Follow-up|16|||
44574650|NCT01672294|79597207|FG002|Overall Study|Lost to Follow-up|7|||
44574651|NCT01672294|79597208|FG003|Overall Study|Lost to Follow-up|9|||
44574652|NCT02755116|79597220|FG000|Overall Study|surgery converted to open, pt admitted|3|||
44574653|NCT02755116|79597221|FG001|Overall Study|surgery converted to open, pt admitted|1|||
44574654|NCT02754492|79597231|FG000|Overall Study|Protocol Violation|2|||
44574655|NCT02754492|79597232|FG001|Overall Study|Protocol Violation|2|||
44574656|NCT02754492|79597233|FG002|Overall Study|Protocol Violation|0|||
44574657|NCT02754492|79597234|FG003|Overall Study|Protocol Violation|1|||
44574658|NCT02754492|79597231|FG000|Overall Study|Withdrawal by Subject|2|||
44574659|NCT02754492|79597232|FG001|Overall Study|Withdrawal by Subject|0|||
44574660|NCT02754492|79597233|FG002|Overall Study|Withdrawal by Subject|0|||
44574661|NCT02754492|79597234|FG003|Overall Study|Withdrawal by Subject|0|||
44378062|NCT00913458|79383416|FG000|Phase 1|Adverse Event|20|||
44378063|NCT00913458|79383417|FG001|Phase 1|Adverse Event|0|||
44378064|NCT00913458|79383418|FG002|Phase 1|Adverse Event|0|||
44378065|NCT00913458|79383419|FG003|Phase 1|Adverse Event|0|||
44378066|NCT00913458|79383420|FG004|Phase 1|Adverse Event|0|||
44378067|NCT00913458|79383421|FG005|Phase 1|Adverse Event|0|||
44378068|NCT00913458|79383422|FG006|Phase 1|Adverse Event|0|||
44378069|NCT00913458|79383416|FG000|Phase 1|Lost to Follow-up|2|||
44378070|NCT00913458|79383417|FG001|Phase 1|Lost to Follow-up|0|||
44378071|NCT00913458|79383418|FG002|Phase 1|Lost to Follow-up|0|||
44378072|NCT00913458|79383419|FG003|Phase 1|Lost to Follow-up|0|||
44378073|NCT00913458|79383420|FG004|Phase 1|Lost to Follow-up|0|||
44378074|NCT00913458|79383421|FG005|Phase 1|Lost to Follow-up|0|||
44378075|NCT00913458|79383422|FG006|Phase 1|Lost to Follow-up|0|||
44574662|NCT02754492|79597231|FG000|Overall Study|Equipment malfuntion|0|||
44574663|NCT02754492|79597232|FG001|Overall Study|Equipment malfuntion|0|||
44574664|NCT02754492|79597233|FG002|Overall Study|Equipment malfuntion|2|||
44574665|NCT02754492|79597234|FG003|Overall Study|Equipment malfuntion|5|||
44574666|NCT02754492|79597231|FG000|Overall Study|Adverse Event|0|||
44574667|NCT02754492|79597232|FG001|Overall Study|Adverse Event|0|||
44574668|NCT02754492|79597233|FG002|Overall Study|Adverse Event|0|||
44574669|NCT02754492|79597234|FG003|Overall Study|Adverse Event|13|||
44574670|NCT02754492|79597231|FG000|Overall Study|Venous access issues not resulting in AE|0|||
44574671|NCT02754492|79597232|FG001|Overall Study|Venous access issues not resulting in AE|0|||
44574672|NCT02754492|79597233|FG002|Overall Study|Venous access issues not resulting in AE|0|||
44574673|NCT02754492|79597234|FG003|Overall Study|Venous access issues not resulting in AE|4|||
44574674|NCT04068688|79597253|FG000|Overall Study|Lost to Follow-up|1|||
44378076|NCT00913458|79383416|FG000|Phase 1|Protocol Violation|10|||
44574675|NCT04068688|79597254|FG001|Overall Study|Lost to Follow-up|1|||
44574676|NCT04068688|79597255|FG002|Overall Study|Lost to Follow-up|0|||
44574677|NCT04068688|79597256|FG003|Overall Study|Lost to Follow-up|0|||
44574678|NCT04068688|79597257|FG004|Overall Study|Lost to Follow-up|5|||
44574679|NCT04068688|79597258|FG005|Overall Study|Lost to Follow-up|5|||
44574680|NCT04068688|79597259|FG006|Overall Study|Lost to Follow-up|0|||
44378077|NCT00913458|79383417|FG001|Phase 1|Protocol Violation|0|||
44378078|NCT00913458|79383418|FG002|Phase 1|Protocol Violation|0|||
44378079|NCT00913458|79383419|FG003|Phase 1|Protocol Violation|0|||
44378080|NCT00913458|79383420|FG004|Phase 1|Protocol Violation|0|||
44378081|NCT00913458|79383421|FG005|Phase 1|Protocol Violation|0|||
44378082|NCT00913458|79383422|FG006|Phase 1|Protocol Violation|0|||
44574681|NCT04068688|79597260|FG007|Overall Study|Lost to Follow-up|0|||
44574682|NCT04068688|79597261|FG008|Overall Study|Lost to Follow-up|1|||
44574683|NCT04068688|79597262|FG009|Overall Study|Lost to Follow-up|0|||
44378083|NCT00913458|79383416|FG000|Phase 1|Sponsor|2|||
44378084|NCT00913458|79383417|FG001|Phase 1|Sponsor|0|||
44378085|NCT00913458|79383418|FG002|Phase 1|Sponsor|0|||
44378086|NCT00913458|79383419|FG003|Phase 1|Sponsor|0|||
44378087|NCT00913458|79383420|FG004|Phase 1|Sponsor|0|||
44378088|NCT00913458|79383421|FG005|Phase 1|Sponsor|0|||
44378089|NCT00913458|79383422|FG006|Phase 1|Sponsor|0|||
44378090|NCT00913458|79383416|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
44378091|NCT00913458|79383417|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
44378092|NCT00913458|79383418|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
44378093|NCT00913458|79383419|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
44378094|NCT00913458|79383420|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
44378095|NCT00913458|79383421|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
44378096|NCT00913458|79383422|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
44378097|NCT00913458|79383416|FG000|Phase 2|Non-Responder|0|||
44378098|NCT00913458|79383417|FG001|Phase 2|Non-Responder|5|||
44378099|NCT00913458|79383418|FG002|Phase 2|Non-Responder|7|||
44378100|NCT00913458|79383419|FG003|Phase 2|Non-Responder|12|||
44378101|NCT00913458|79383420|FG004|Phase 2|Non-Responder|0|||
44378102|NCT00913458|79383421|FG005|Phase 2|Non-Responder|0|||
44378103|NCT00913458|79383422|FG006|Phase 2|Non-Responder|0|||
44378104|NCT00913458|79383416|FG000|Phase 2|Subject Request|0|||
44378105|NCT00913458|79383417|FG001|Phase 2|Subject Request|0|||
44378106|NCT00913458|79383418|FG002|Phase 2|Subject Request|1|||
44378107|NCT00913458|79383419|FG003|Phase 2|Subject Request|2|||
44378108|NCT00913458|79383420|FG004|Phase 2|Subject Request|0|||
44378109|NCT00913458|79383421|FG005|Phase 2|Subject Request|0|||
44378110|NCT00913458|79383422|FG006|Phase 2|Subject Request|0|||
44378111|NCT00913458|79383416|FG000|Phase 2|Adverse Event|0|||
44378112|NCT00913458|79383417|FG001|Phase 2|Adverse Event|3|||
44378113|NCT00913458|79383418|FG002|Phase 2|Adverse Event|0|||
44378114|NCT00913458|79383419|FG003|Phase 2|Adverse Event|1|||
44378115|NCT00913458|79383420|FG004|Phase 2|Adverse Event|0|||
44378116|NCT00913458|79383421|FG005|Phase 2|Adverse Event|0|||
44378117|NCT00913458|79383422|FG006|Phase 2|Adverse Event|0|||
44378118|NCT00913458|79383416|FG000|Phase 2|Lost to Follow-up|0|||
44378119|NCT00913458|79383417|FG001|Phase 2|Lost to Follow-up|0|||
44378120|NCT00913458|79383418|FG002|Phase 2|Lost to Follow-up|0|||
44378121|NCT00913458|79383419|FG003|Phase 2|Lost to Follow-up|1|||
44378122|NCT00913458|79383420|FG004|Phase 2|Lost to Follow-up|0|||
44378123|NCT00913458|79383421|FG005|Phase 2|Lost to Follow-up|0|||
44378124|NCT00913458|79383422|FG006|Phase 2|Lost to Follow-up|0|||
44378125|NCT00913458|79383416|FG000|Phase 2|Protocol Violation|0|||
44378126|NCT00913458|79383417|FG001|Phase 2|Protocol Violation|2|||
44378127|NCT00913458|79383418|FG002|Phase 2|Protocol Violation|0|||
44378128|NCT00913458|79383419|FG003|Phase 2|Protocol Violation|0|||
44378129|NCT00913458|79383420|FG004|Phase 2|Protocol Violation|0|||
44378130|NCT00913458|79383421|FG005|Phase 2|Protocol Violation|0|||
44378131|NCT00913458|79383422|FG006|Phase 2|Protocol Violation|0|||
44378132|NCT00913458|79383416|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
44378133|NCT00913458|79383417|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
44378134|NCT00913458|79383418|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
44378135|NCT00913458|79383419|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
44378136|NCT00913458|79383420|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
44378137|NCT00913458|79383421|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
44378138|NCT00913458|79383422|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
44378139|NCT00913458|79383416|FG000|Phase 3|Adverse Event|0|||
44378140|NCT00913458|79383417|FG001|Phase 3|Adverse Event|0|||
44378141|NCT00913458|79383418|FG002|Phase 3|Adverse Event|0|||
44378142|NCT00913458|79383419|FG003|Phase 3|Adverse Event|0|||
44378143|NCT00913458|79383420|FG004|Phase 3|Adverse Event|5|||
44378144|NCT00913458|79383421|FG005|Phase 3|Adverse Event|4|||
44378145|NCT00913458|79383422|FG006|Phase 3|Adverse Event|1|||
44378146|NCT00913458|79383416|FG000|Phase 3|Lost to Follow-up|0|||
44378147|NCT00913458|79383417|FG001|Phase 3|Lost to Follow-up|0|||
44378148|NCT00913458|79383418|FG002|Phase 3|Lost to Follow-up|0|||
44238333|NCT01587703|79064740|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238334|NCT01587703|79064741|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238335|NCT01587703|79064742|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44378149|NCT00913458|79383419|FG003|Phase 3|Lost to Follow-up|0|||
44378150|NCT00913458|79383420|FG004|Phase 3|Lost to Follow-up|2|||
44378151|NCT00913458|79383421|FG005|Phase 3|Lost to Follow-up|0|||
44378152|NCT00913458|79383422|FG006|Phase 3|Lost to Follow-up|0|||
44378153|NCT00913458|79383416|FG000|Phase 3|Non-Responder|0|||
44378154|NCT00913458|79383417|FG001|Phase 3|Non-Responder|0|||
44378155|NCT00913458|79383418|FG002|Phase 3|Non-Responder|0|||
44378156|NCT00913458|79383419|FG003|Phase 3|Non-Responder|0|||
44378157|NCT00913458|79383420|FG004|Phase 3|Non-Responder|0|||
44378158|NCT00913458|79383421|FG005|Phase 3|Non-Responder|1|||
44378159|NCT00913458|79383422|FG006|Phase 3|Non-Responder|3|||
44378160|NCT00913458|79383416|FG000|Phase 3|Withdrawal by Subject|0|||
44378161|NCT00913458|79383417|FG001|Phase 3|Withdrawal by Subject|0|||
44378162|NCT00913458|79383418|FG002|Phase 3|Withdrawal by Subject|0|||
44378163|NCT00913458|79383419|FG003|Phase 3|Withdrawal by Subject|0|||
44378164|NCT00913458|79383420|FG004|Phase 3|Withdrawal by Subject|1|||
44378165|NCT00913458|79383421|FG005|Phase 3|Withdrawal by Subject|2|||
44378166|NCT00913458|79383422|FG006|Phase 3|Withdrawal by Subject|0|||
44117759|NCT03045887|78901287|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
44117760|NCT03045887|78901278|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117761|NCT03045887|78901279|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117762|NCT03045887|78901280|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
44117763|NCT03045887|78901281|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
44117764|NCT03045887|78901282|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117765|NCT03045887|78901283|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117766|NCT03045887|78901284|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117767|NCT03045887|78901285|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117768|NCT03045887|78901286|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117769|NCT03045887|78901287|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
44117770|NCT03045887|78901278|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117771|NCT03045887|78901279|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117772|NCT03045887|78901280|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117773|NCT03045887|78901281|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
44117774|NCT03045887|78901282|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117775|NCT03045887|78901283|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117776|NCT03045887|78901284|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117777|NCT03045887|78901285|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117778|NCT03045887|78901286|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44506134|NCT00087438|79510919|FG000|Overall Study|Ineligible / No protocol treatment|4|||
44506135|NCT00321464|79510927|FG000|Overall Study|Death|169|||
44117779|NCT03045887|78901287|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44117780|NCT01564537|78901316|FG000|Overall Study|Site Terminated by Sponsor|1|||
44117781|NCT01564537|78901317|FG001|Overall Study|Site Terminated by Sponsor|0|||
44117782|NCT01564537|78901316|FG000|Overall Study|Withdrawal by Subject|12|||
44117783|NCT01564537|78901317|FG001|Overall Study|Withdrawal by Subject|14|||
44117784|NCT01564537|78901316|FG000|Overall Study|Lost to Follow-up|7|||
44117785|NCT01564537|78901317|FG001|Overall Study|Lost to Follow-up|3|||
44117786|NCT01564537|78901316|FG000|Overall Study|Reason not specified|81|||
44117787|NCT01564537|78901317|FG001|Overall Study|Reason not specified|82|||
44117788|NCT03042611|78901328|FG000|Core Phase|Withdrawal by Subject|13|||
44117789|NCT03042611|78901329|FG001|Core Phase|Withdrawal by Subject|4|||
44117790|NCT03042611|78901330|FG002|Core Phase|Withdrawal by Subject|0|||
44117791|NCT03042611|78901331|FG003|Core Phase|Withdrawal by Subject|0|||
44506136|NCT00321464|79510928|FG001|Overall Study|Death|174|||
44506137|NCT00321464|79510927|FG000|Overall Study|Disease progression|124|||
44506138|NCT00321464|79510928|FG001|Overall Study|Disease progression|124|||
44506139|NCT00321464|79510927|FG000|Overall Study|Withdrawal by Subject|117|||
44506140|NCT00321464|79510928|FG001|Overall Study|Withdrawal by Subject|118|||
44506141|NCT00321464|79510927|FG000|Overall Study|Participant request|57|||
44506142|NCT00321464|79510928|FG001|Overall Study|Participant request|61|||
44506143|NCT00321464|79510927|FG000|Overall Study|Adverse Event|43|||
44506144|NCT00321464|79510928|FG001|Overall Study|Adverse Event|28|||
44506145|NCT00321464|79510927|FG000|Overall Study|Physician Decision|15|||
44506146|NCT00321464|79510928|FG001|Overall Study|Physician Decision|14|||
44506147|NCT00321464|79510927|FG000|Overall Study|Noncompliance|4|||
44506148|NCT00321464|79510928|FG001|Overall Study|Noncompliance|10|||
44506149|NCT00321464|79510927|FG000|Overall Study|Lost to Follow-up|7|||
44506150|NCT00321464|79510928|FG001|Overall Study|Lost to Follow-up|8|||
44506151|NCT00321464|79510927|FG000|Overall Study|Protocol deviation|0|||
44506152|NCT00321464|79510928|FG001|Overall Study|Protocol deviation|2|||
44506153|NCT00321464|79510927|FG000|Overall Study|Ineligibility determined|2|||
44506154|NCT00321464|79510928|FG001|Overall Study|Ineligibility determined|1|||
44506155|NCT00321464|79510927|FG000|Overall Study|Other|21|||
44506156|NCT00321464|79510928|FG001|Overall Study|Other|18|||
44506157|NCT02889796|79510938|FG000|Overall Study|Withdrew Consent|18|||
44506158|NCT02889796|79510939|FG001|Overall Study|Withdrew Consent|29|||
44506159|NCT02889796|79510940|FG002|Overall Study|Withdrew Consent|20|||
44506160|NCT02889796|79510941|FG003|Overall Study|Withdrew Consent|1|||
44506161|NCT02889796|79510942|FG004|Overall Study|Withdrew Consent|2|||
44506162|NCT02889796|79510943|FG005|Overall Study|Withdrew Consent|35|||
44117792|NCT03042611|78901328|FG000|Core Phase|Death|232|||
44117793|NCT03042611|78901329|FG001|Core Phase|Death|110|||
44117794|NCT03042611|78901330|FG002|Core Phase|Death|0|||
44117795|NCT03042611|78901331|FG003|Core Phase|Death|0|||
44117796|NCT03042611|78901328|FG000|Core Phase|Lost to Follow-up|4|||
44117797|NCT03042611|78901329|FG001|Core Phase|Lost to Follow-up|7|||
44506163|NCT02889796|79510938|FG000|Overall Study|Investigator's Discretion|10|||
44506164|NCT02889796|79510939|FG001|Overall Study|Investigator's Discretion|9|||
44506165|NCT02889796|79510940|FG002|Overall Study|Investigator's Discretion|10|||
44506166|NCT02889796|79510941|FG003|Overall Study|Investigator's Discretion|3|||
44506167|NCT02889796|79510942|FG004|Overall Study|Investigator's Discretion|0|||
44506168|NCT02889796|79510943|FG005|Overall Study|Investigator's Discretion|15|||
44506169|NCT02889796|79510938|FG000|Overall Study|Adverse Event|17|||
44506170|NCT02889796|79510939|FG001|Overall Study|Adverse Event|8|||
44117798|NCT03042611|78901330|FG002|Core Phase|Lost to Follow-up|0|||
44117799|NCT03042611|78901331|FG003|Core Phase|Lost to Follow-up|0|||
44117800|NCT03042611|78901328|FG000|Core Phase|Physician Decision|7|||
44117801|NCT03042611|78901329|FG001|Core Phase|Physician Decision|2|||
44117802|NCT03042611|78901330|FG002|Core Phase|Physician Decision|0|||
44117803|NCT03042611|78901331|FG003|Core Phase|Physician Decision|0|||
44117804|NCT03042611|78901328|FG000|Core Phase|Study Closed|0|||
44117805|NCT03042611|78901329|FG001|Core Phase|Study Closed|1|||
44117806|NCT03042611|78901330|FG002|Core Phase|Study Closed|0|||
44117807|NCT03042611|78901331|FG003|Core Phase|Study Closed|0|||
44117808|NCT03042611|78901328|FG000|Extension Phase|Death|0|||
44117809|NCT03042611|78901329|FG001|Extension Phase|Death|0|||
44117810|NCT03042611|78901330|FG002|Extension Phase|Death|34|||
44117811|NCT03042611|78901331|FG003|Extension Phase|Death|16|||
44117812|NCT03042611|78901328|FG000|Extension Phase|Lost to Follow-up|0|||
44117813|NCT03042611|78901329|FG001|Extension Phase|Lost to Follow-up|0|||
44117814|NCT03042611|78901330|FG002|Extension Phase|Lost to Follow-up|1|||
44117815|NCT03042611|78901331|FG003|Extension Phase|Lost to Follow-up|1|||
44117816|NCT03042611|78901328|FG000|Extension Phase|Study Closed|0|||
44117817|NCT03042611|78901329|FG001|Extension Phase|Study Closed|0|||
44117818|NCT03042611|78901330|FG002|Extension Phase|Study Closed|17|||
44117819|NCT03042611|78901331|FG003|Extension Phase|Study Closed|11|||
44117820|NCT02701634|78901339|FG000|Overall Study|Adverse Event|2|||
44117821|NCT02701634|78901340|FG001|Overall Study|Adverse Event|3|||
44117822|NCT02701634|78901339|FG000|Overall Study|Death|1|||
44117823|NCT02701634|78901340|FG001|Overall Study|Death|0|||
44117824|NCT02701634|78901339|FG000|Overall Study|Investigator's Discretion|7|||
44117825|NCT02701634|78901340|FG001|Overall Study|Investigator's Discretion|4|||
44117826|NCT02701634|78901339|FG000|Overall Study|Study terminated by Sponsor|15|||
44117827|NCT02701634|78901340|FG001|Overall Study|Study terminated by Sponsor|17|||
44117828|NCT02701634|78901339|FG000|Overall Study|Withdrew Consent|6|||
44506171|NCT02889796|79510940|FG002|Overall Study|Adverse Event|8|||
44506172|NCT02889796|79510941|FG003|Overall Study|Adverse Event|4|||
44506173|NCT02889796|79510942|FG004|Overall Study|Adverse Event|1|||
44506174|NCT02889796|79510943|FG005|Overall Study|Adverse Event|7|||
44506175|NCT02889796|79510938|FG000|Overall Study|Lost to Follow-up|5|||
44506176|NCT02889796|79510939|FG001|Overall Study|Lost to Follow-up|7|||
44574684|NCT04068688|79597253|FG000|Overall Study|Withdrawal by Subject|1|||
44574685|NCT04068688|79597254|FG001|Overall Study|Withdrawal by Subject|1|||
44506177|NCT02889796|79510940|FG002|Overall Study|Lost to Follow-up|2|||
44506178|NCT02889796|79510941|FG003|Overall Study|Lost to Follow-up|0|||
44506179|NCT02889796|79510942|FG004|Overall Study|Lost to Follow-up|2|||
44506180|NCT02889796|79510943|FG005|Overall Study|Lost to Follow-up|6|||
44506181|NCT02889796|79510938|FG000|Overall Study|Protocol Violation|0|||
44506182|NCT02889796|79510939|FG001|Overall Study|Protocol Violation|1|||
44506183|NCT02889796|79510940|FG002|Overall Study|Protocol Violation|3|||
44506184|NCT02889796|79510941|FG003|Overall Study|Protocol Violation|0|||
44506185|NCT02889796|79510942|FG004|Overall Study|Protocol Violation|0|||
44506186|NCT02889796|79510943|FG005|Overall Study|Protocol Violation|4|||
44574686|NCT04068688|79597255|FG002|Overall Study|Withdrawal by Subject|0|||
44574687|NCT04068688|79597256|FG003|Overall Study|Withdrawal by Subject|0|||
44574688|NCT04068688|79597257|FG004|Overall Study|Withdrawal by Subject|0|||
44574689|NCT04068688|79597258|FG005|Overall Study|Withdrawal by Subject|0|||
44574690|NCT04068688|79597259|FG006|Overall Study|Withdrawal by Subject|0|||
44574691|NCT04068688|79597260|FG007|Overall Study|Withdrawal by Subject|0|||
44574692|NCT04068688|79597261|FG008|Overall Study|Withdrawal by Subject|0|||
44574693|NCT04068688|79597262|FG009|Overall Study|Withdrawal by Subject|0|||
44574694|NCT04068688|79597253|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
44574695|NCT04068688|79597254|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
44574696|NCT04068688|79597255|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574697|NCT04068688|79597256|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574698|NCT04068688|79597257|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574699|NCT04068688|79597258|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574700|NCT04068688|79597259|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574701|NCT04068688|79597260|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574702|NCT04068688|79597261|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44117829|NCT02701634|78901340|FG001|Overall Study|Withdrew Consent|7|||
44117830|NCT02701634|78901339|FG000|Overall Study|Randomized but not treated|1|||
44117831|NCT02701634|78901340|FG001|Overall Study|Randomized but not treated|0|||
44117832|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
44117833|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
44117834|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
44117835|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
44117836|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
44117837|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
44117838|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
44117839|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
44117840|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Death|0|||
44117841|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Death|0|||
44117842|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Death|0|||
44117843|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Death|1|||
44117844|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Death|1|||
44117845|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Death|0|||
44117846|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Death|2|||
44117847|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Death|0|||
44117848|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44117849|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44117850|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44117851|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
44117852|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44574703|NCT04068688|79597262|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
44574704|NCT01671748|79597290|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
44574705|NCT01671748|79597291|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
44574706|NCT01671748|79597290|FG000|4 Week run-in Phase|Adverse Event|1|||
44117853|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44117854|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44117855|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
44117856|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117857|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117858|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117859|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
44117860|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117861|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117862|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117863|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
44117864|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
44117865|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
44117866|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
44117867|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
44117868|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
44117869|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
44117870|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
44117871|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
44117872|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
44117873|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
44574707|NCT01671748|79597291|FG001|4 Week run-in Phase|Adverse Event|0|||
44574708|NCT01671748|79597290|FG000|4 Week run-in Phase|Not eligible|9|||
44574709|NCT01671748|79597291|FG001|4 Week run-in Phase|Not eligible|0|||
44574710|NCT02657889|79597301|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
44574711|NCT02657889|79597302|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
44574712|NCT02657889|79597303|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
44574713|NCT02657889|79597304|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
44117874|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
44117875|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
44378167|NCT00913458|79383416|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
44378168|NCT00913458|79383417|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
44378169|NCT00913458|79383418|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
44378170|NCT00913458|79383419|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
44378171|NCT00913458|79383420|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
44506187|NCT02889796|79510938|FG000|Overall Study|Non-compliance With Study Drug|0|||
44506188|NCT02889796|79510939|FG001|Overall Study|Non-compliance With Study Drug|2|||
44506189|NCT02889796|79510940|FG002|Overall Study|Non-compliance With Study Drug|0|||
44506190|NCT02889796|79510941|FG003|Overall Study|Non-compliance With Study Drug|0|||
44506191|NCT02889796|79510942|FG004|Overall Study|Non-compliance With Study Drug|1|||
44506192|NCT02889796|79510943|FG005|Overall Study|Non-compliance With Study Drug|2|||
44506193|NCT02889796|79510938|FG000|Overall Study|Death|1|||
44506194|NCT02889796|79510939|FG001|Overall Study|Death|1|||
44506195|NCT02889796|79510940|FG002|Overall Study|Death|0|||
44506196|NCT02889796|79510941|FG003|Overall Study|Death|1|||
44506197|NCT02889796|79510942|FG004|Overall Study|Death|0|||
44574714|NCT02657889|79597301|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
44574715|NCT02657889|79597302|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
44117876|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
44117877|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
44506198|NCT02889796|79510943|FG005|Overall Study|Death|1|||
44506199|NCT02889796|79510938|FG000|Overall Study|Pregnancy|0|||
44506200|NCT02889796|79510939|FG001|Overall Study|Pregnancy|1|||
44117878|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
44117879|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
44117880|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
44117881|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
44117882|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
44117883|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
44117884|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
44117885|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
44117886|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
44117887|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
44117888|NCT02442765|78901350|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
44238336|NCT01587703|79064743|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238337|NCT01587703|79064744|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238338|NCT01587703|79064745|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238339|NCT01587703|79064746|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238340|NCT01587703|79064747|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238341|NCT01587703|79064748|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
44238342|NCT01587703|79064749|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238343|NCT01587703|79064750|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238344|NCT01587703|79064751|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238345|NCT01587703|79064752|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238346|NCT01587703|79064753|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238347|NCT01587703|79064754|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238348|NCT01587703|79064755|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44378172|NCT00913458|79383421|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
44378173|NCT00913458|79383422|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
44378174|NCT00785707|79383439|FG000|Overall Study|Lost to Follow-up|7|||
44506201|NCT02889796|79510940|FG002|Overall Study|Pregnancy|1|||
44506202|NCT02889796|79510941|FG003|Overall Study|Pregnancy|0|||
44506203|NCT02889796|79510942|FG004|Overall Study|Pregnancy|0|||
44238349|NCT01587703|79064756|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238350|NCT01587703|79064757|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238351|NCT01587703|79064758|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
44238352|NCT01587703|79064740|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238353|NCT01587703|79064741|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238354|NCT01587703|79064742|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238355|NCT01587703|79064743|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238356|NCT01587703|79064744|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238357|NCT01587703|79064745|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44506204|NCT02889796|79510943|FG005|Overall Study|Pregnancy|0|||
44506205|NCT02889796|79510938|FG000|Overall Study|Randomized but not Dosed|2|||
44506206|NCT02889796|79510939|FG001|Overall Study|Randomized but not Dosed|0|||
44506207|NCT02889796|79510940|FG002|Overall Study|Randomized but not Dosed|0|||
44506208|NCT02889796|79510941|FG003|Overall Study|Randomized but not Dosed|0|||
44574716|NCT02657889|79597303|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
44574717|NCT02657889|79597304|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
44574718|NCT02657889|79597301|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
44574719|NCT02657889|79597302|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
44574720|NCT02657889|79597303|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
44574721|NCT02657889|79597304|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
44574722|NCT02657889|79597301|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
44574723|NCT02657889|79597302|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
44574724|NCT02657889|79597303|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
44574725|NCT02657889|79597304|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
44574726|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
44574727|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
44574728|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
44574729|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
44506209|NCT02889796|79510942|FG004|Overall Study|Randomized but not Dosed|0|||
44506210|NCT02889796|79510943|FG005|Overall Study|Randomized but not Dosed|2|||
44574730|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
44117889|NCT02442765|78901351|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
44117890|NCT02442765|78901352|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
44117891|NCT02442765|78901353|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
44117892|NCT02442765|78901354|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
44506211|NCT02889562|79510968|FG000|Overall Study|Physician Decision|0|||
44506212|NCT02889562|79510969|FG001|Overall Study|Physician Decision|1|||
44117893|NCT02442765|78901355|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
44117894|NCT02442765|78901356|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
44117895|NCT02442765|78901357|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
44117896|NCT02699684|78901388|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
44117897|NCT02699684|78901389|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
44117898|NCT02700698|78901398|FG000|Overall Study|Withdrawal by Subject|1|||
44117899|NCT02700698|78901399|FG001|Overall Study|Withdrawal by Subject|0|||
44117900|NCT01774721|78901407|FG000|Overall Study|Death|133|||
44117901|NCT01774721|78901408|FG001|Overall Study|Death|152|||
44117902|NCT01774721|78901407|FG000|Overall Study|Withdrawal by Subject|20|||
44117903|NCT01774721|78901408|FG001|Overall Study|Withdrawal by Subject|14|||
44117904|NCT01774721|78901407|FG000|Overall Study|Lost to Follow-up|6|||
44117905|NCT01774721|78901408|FG001|Overall Study|Lost to Follow-up|7|||
44117906|NCT01774721|78901407|FG000|Overall Study|Did not meet eligibility criteria|0|||
44117907|NCT01774721|78901408|FG001|Overall Study|Did not meet eligibility criteria|3|||
44117908|NCT01774721|78901407|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
44117909|NCT01774721|78901408|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
44117910|NCT01774721|78901407|FG000|Overall Study|Study terminated by sponsor|5|||
44117911|NCT01774721|78901408|FG001|Overall Study|Study terminated by sponsor|0|||
44117912|NCT01774721|78901407|FG000|Overall Study|Disease progression|5|||
44117913|NCT01774721|78901408|FG001|Overall Study|Disease progression|0|||
44117914|NCT02699450|78901420|FG000|Overall Study|Death|2|||
44117915|NCT02699450|78901421|FG001|Overall Study|Death|1|||
44117916|NCT02699450|78901422|FG002|Overall Study|Death|2|||
44117917|NCT02699450|78901420|FG000|Overall Study|Met Criteria for Study Exit|0|||
44117918|NCT02699450|78901421|FG001|Overall Study|Met Criteria for Study Exit|0|||
44117919|NCT02699450|78901422|FG002|Overall Study|Met Criteria for Study Exit|1|||
44117920|NCT02699450|78901420|FG000|Overall Study|Protocol Violation|4|||
44117921|NCT02699450|78901421|FG001|Overall Study|Protocol Violation|3|||
44117922|NCT02699450|78901422|FG002|Overall Study|Protocol Violation|5|||
44117923|NCT02699450|78901420|FG000|Overall Study|Lost to Follow-up|3|||
44117924|NCT02699450|78901421|FG001|Overall Study|Lost to Follow-up|0|||
44117925|NCT02699450|78901422|FG002|Overall Study|Lost to Follow-up|5|||
44117926|NCT02699450|78901420|FG000|Overall Study|Physician Decision|2|||
44117927|NCT02699450|78901421|FG001|Overall Study|Physician Decision|0|||
44117928|NCT02699450|78901422|FG002|Overall Study|Physician Decision|0|||
44117929|NCT02699450|78901420|FG000|Overall Study|Withdrawal by Subject|3|||
44117930|NCT02699450|78901421|FG001|Overall Study|Withdrawal by Subject|1|||
44117931|NCT02699450|78901422|FG002|Overall Study|Withdrawal by Subject|2|||
44117932|NCT02699450|78901420|FG000|Overall Study|Adverse Event|1|||
44117933|NCT02699450|78901421|FG001|Overall Study|Adverse Event|0|||
44117934|NCT02699450|78901422|FG002|Overall Study|Adverse Event|0|||
44117935|NCT02699996|78901433|FG000|Overall Study|Withdrawal by Subject|5|||
44117936|NCT02699996|78901434|FG001|Overall Study|Withdrawal by Subject|2|||
44117937|NCT02739321|78901443|FG000|Overall Study|Lack of Efficacy|1|||
44117938|NCT02739321|78901444|FG001|Overall Study|Lack of Efficacy|1|||
44117939|NCT02739321|78901443|FG000|Overall Study|Lost to Follow-up|1|||
44238358|NCT01587703|79064746|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238359|NCT01587703|79064747|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238360|NCT01587703|79064748|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44117940|NCT02739321|78901444|FG001|Overall Study|Lost to Follow-up|1|||
44117941|NCT02739321|78901443|FG000|Overall Study|Withdrawal by Subject|1|||
44117942|NCT02739321|78901444|FG001|Overall Study|Withdrawal by Subject|2|||
44117943|NCT02696798|78901462|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
44117944|NCT02696798|78901463|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
44117945|NCT02696798|78901464|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
44117946|NCT02696798|78901462|FG000|Blinded Treatment Dosing Period|Death|0|||
44238361|NCT01587703|79064749|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238362|NCT01587703|79064750|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44117947|NCT02696798|78901463|FG001|Blinded Treatment Dosing Period|Death|0|||
44117948|NCT02696798|78901464|FG002|Blinded Treatment Dosing Period|Death|1|||
44117949|NCT02696798|78901462|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
44238363|NCT01587703|79064751|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238364|NCT01587703|79064752|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44117950|NCT02696798|78901463|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
44506213|NCT02889562|79510968|FG000|Overall Study|Withdrawal by Subject|0|||
44506214|NCT02889562|79510969|FG001|Overall Study|Withdrawal by Subject|1|||
44117951|NCT02696798|78901464|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
44117952|NCT02696798|78901462|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
44506215|NCT03323164|79510977|FG000|Overall Study|Poor quality imaging/scans|2|||
44506216|NCT03323164|79510978|FG001|Overall Study|Poor quality imaging/scans|2|||
44506217|NCT03323086|79510990|FG000|Overall Study|Lost to Follow-up|3|||
44506218|NCT03323086|79510991|FG001|Overall Study|Lost to Follow-up|2|||
44506219|NCT02888080|79510999|FG000|Overall Study|Subject / Guardian decision|1|||
44117953|NCT02696798|78901463|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
44117954|NCT02696798|78901464|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
44378175|NCT00913380|79383445|FG000|Clinical Outcomes|Lost to Follow-up|6|||
44378176|NCT00913380|79383446|FG001|Clinical Outcomes|Lost to Follow-up|6|||
44378177|NCT00785629|79383456|FG000|Overall Study|Adverse Event|2|||
44378178|NCT00785629|79383457|FG001|Overall Study|Adverse Event|1|||
44238365|NCT01587703|79064753|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238366|NCT01587703|79064754|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238367|NCT01587703|79064755|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238368|NCT01587703|79064756|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238369|NCT01587703|79064757|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
44238370|NCT01587703|79064758|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
44275961|NCT02194829|79226284|FG001|Overall Study|Withdrawal by Subject|1|||
44506220|NCT02888080|79511000|FG001|Overall Study|Subject / Guardian decision|3|||
44506221|NCT02888080|79510999|FG000|Overall Study|New Therapy for study indication|1|||
44506222|NCT02888080|79511000|FG001|Overall Study|New Therapy for study indication|0|||
44506223|NCT02888080|79510999|FG000|Overall Study|Lack of Efficacy|0|||
44506224|NCT02888080|79511000|FG001|Overall Study|Lack of Efficacy|1|||
44506225|NCT02888080|79510999|FG000|Overall Study|Adverse Event|0|||
44506226|NCT02888080|79511000|FG001|Overall Study|Adverse Event|1|||
44506227|NCT03322462|79511006|FG000|Overall Study|Technical difficulties|2|||
44506228|NCT03322462|79511006|FG000|Overall Study|Other|1|||
44506229|NCT00086580|79511014|FG000|Treatment Period|Disease progression|9|||
44574731|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
44574732|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
44574733|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
44574734|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
44574735|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
44574736|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
44574737|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
44574738|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
44117955|NCT02696798|78901462|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
44506230|NCT00086580|79511015|FG001|Treatment Period|Disease progression|8|||
44506231|NCT00086580|79511014|FG000|Treatment Period|Unable to comply with protocol|3|||
44506232|NCT00086580|79511015|FG001|Treatment Period|Unable to comply with protocol|1|||
44506233|NCT00086580|79511014|FG000|Treatment Period|Withdrawal by Subject|7|||
44117956|NCT02696798|78901463|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
44117957|NCT02696798|78901464|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
44117958|NCT02696798|78901462|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
44117959|NCT02696798|78901463|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
44117960|NCT02696798|78901464|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
44117961|NCT02696798|78901462|FG000|Extended Treatment Period|Adverse Event|1|||
44117962|NCT02696798|78901463|FG001|Extended Treatment Period|Adverse Event|4|||
44117963|NCT02696798|78901464|FG002|Extended Treatment Period|Adverse Event|5|||
44117964|NCT02696798|78901462|FG000|Extended Treatment Period|Lack of Efficacy|7|||
44117965|NCT02696798|78901463|FG001|Extended Treatment Period|Lack of Efficacy|2|||
44117966|NCT02696798|78901464|FG002|Extended Treatment Period|Lack of Efficacy|2|||
44117967|NCT02696798|78901462|FG000|Extended Treatment Period|Lost to Follow-up|1|||
44117968|NCT02696798|78901463|FG001|Extended Treatment Period|Lost to Follow-up|0|||
44117969|NCT02696798|78901464|FG002|Extended Treatment Period|Lost to Follow-up|0|||
44275962|NCT02194829|79226283|FG000|Overall Study|Never started protocol therapy|0|||
44275963|NCT02194829|79226284|FG001|Overall Study|Never started protocol therapy|1|||
44378179|NCT00785629|79383458|FG002|Overall Study|Adverse Event|1|||
44378180|NCT00785629|79383459|FG003|Overall Study|Adverse Event|5|||
44117970|NCT02696798|78901462|FG000|Extended Treatment Period|Physician Decision|0|||
44117971|NCT02696798|78901463|FG001|Extended Treatment Period|Physician Decision|1|||
44506234|NCT00086580|79511015|FG001|Treatment Period|Withdrawal by Subject|8|||
44506235|NCT00086580|79511014|FG000|Treatment Period|Physician Decision|13|||
44378181|NCT00785629|79383456|FG000|Overall Study|Protocol Violation|1|||
44378182|NCT00785629|79383457|FG001|Overall Study|Protocol Violation|2|||
44506236|NCT00086580|79511015|FG001|Treatment Period|Physician Decision|7|||
44506237|NCT00086580|79511014|FG000|Treatment Period|AE - not treatment related|7|||
44506238|NCT00086580|79511015|FG001|Treatment Period|AE - not treatment related|7|||
44506239|NCT00086580|79511014|FG000|Treatment Period|Toxicity - treatment related|15|||
44506240|NCT00086580|79511015|FG001|Treatment Period|Toxicity - treatment related|15|||
44506241|NCT00086580|79511014|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
44378183|NCT00785629|79383458|FG002|Overall Study|Protocol Violation|4|||
44378184|NCT00785629|79383459|FG003|Overall Study|Protocol Violation|5|||
44506242|NCT00086580|79511015|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
44117972|NCT02696798|78901464|FG002|Extended Treatment Period|Physician Decision|0|||
44506243|NCT00086580|79511014|FG000|Treatment Period|Death|5|||
44238371|NCT01587703|79064740|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238372|NCT01587703|79064741|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238373|NCT01587703|79064742|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238374|NCT01587703|79064743|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238375|NCT01587703|79064744|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238376|NCT01587703|79064745|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44117973|NCT02696798|78901462|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
44117974|NCT02696798|78901463|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
44117975|NCT02696798|78901464|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
44117976|NCT02696798|78901462|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
44117977|NCT02696798|78901463|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
44117978|NCT02696798|78901464|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
44117979|NCT02696798|78901462|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
44238377|NCT01587703|79064746|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238378|NCT01587703|79064747|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238379|NCT01587703|79064748|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44117980|NCT02696798|78901463|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
44117981|NCT02696798|78901464|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
44117982|NCT02696798|78901462|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
44117983|NCT02696798|78901463|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
44117984|NCT02696798|78901464|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
44117985|NCT02696798|78901462|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
44117986|NCT02696798|78901463|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
44117987|NCT02696798|78901464|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
44117988|NCT02696798|78901462|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
44117989|NCT02696798|78901463|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
44117990|NCT02696798|78901464|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
44117991|NCT02696798|78901462|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
44117992|NCT02696798|78901463|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
44117993|NCT02696798|78901464|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
44117994|NCT02698826|78901486|FG000|Overall Study|Death|13|||
44117995|NCT02698826|78901486|FG000|Overall Study|Adverse Event|1|||
44117996|NCT02541604|78901504|FG000|Overall Study|Death|6|||
44117997|NCT02541604|78901505|FG001|Overall Study|Death|5|||
44117998|NCT02541604|78901506|FG002|Overall Study|Death|7|||
44117999|NCT02541604|78901507|FG003|Overall Study|Death|2|||
44118000|NCT02541604|78901508|FG004|Overall Study|Death|9|||
44118001|NCT02541604|78901509|FG005|Overall Study|Death|8|||
44118002|NCT02541604|78901510|FG006|Overall Study|Death|9|||
44118003|NCT02541604|78901511|FG007|Overall Study|Death|9|||
44118004|NCT02541604|78901512|FG008|Overall Study|Death|3|||
44118005|NCT02541604|78901513|FG009|Overall Study|Death|4|||
44118006|NCT02541604|78901514|FG010|Overall Study|Death|2|||
44118007|NCT02541604|78901515|FG011|Overall Study|Death|3|||
44118008|NCT02541604|78901504|FG000|Overall Study|Lost to Follow-up|2|||
44118009|NCT02541604|78901505|FG001|Overall Study|Lost to Follow-up|0|||
44118010|NCT02541604|78901506|FG002|Overall Study|Lost to Follow-up|1|||
44118011|NCT02541604|78901507|FG003|Overall Study|Lost to Follow-up|0|||
44118012|NCT02541604|78901508|FG004|Overall Study|Lost to Follow-up|0|||
44118013|NCT02541604|78901509|FG005|Overall Study|Lost to Follow-up|1|||
44118014|NCT02541604|78901510|FG006|Overall Study|Lost to Follow-up|1|||
44118015|NCT02541604|78901511|FG007|Overall Study|Lost to Follow-up|0|||
44118016|NCT02541604|78901512|FG008|Overall Study|Lost to Follow-up|0|||
44238380|NCT01587703|79064749|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238381|NCT01587703|79064750|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238382|NCT01587703|79064751|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238383|NCT01587703|79064752|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44506244|NCT00086580|79511015|FG001|Treatment Period|Death|7|||
44506245|NCT00086580|79511014|FG000|Treatment Period|Other|5|||
44506246|NCT00086580|79511015|FG001|Treatment Period|Other|3|||
44506247|NCT00086580|79511014|FG000|Follow-up Period|Disease progression|72|||
44506248|NCT00086580|79511015|FG001|Follow-up Period|Disease progression|99|||
44506249|NCT00086580|79511014|FG000|Follow-up Period|Unable to comply with protocol|5|||
44118017|NCT02541604|78901513|FG009|Overall Study|Lost to Follow-up|0|||
44506250|NCT00086580|79511015|FG001|Follow-up Period|Unable to comply with protocol|0|||
44118018|NCT02541604|78901514|FG010|Overall Study|Lost to Follow-up|0|||
44118019|NCT02541604|78901515|FG011|Overall Study|Lost to Follow-up|0|||
44118020|NCT02541604|78901504|FG000|Overall Study|Withdrawal by Subject|2|||
44118021|NCT02541604|78901505|FG001|Overall Study|Withdrawal by Subject|0|||
44118022|NCT02541604|78901506|FG002|Overall Study|Withdrawal by Subject|1|||
44118023|NCT02541604|78901507|FG003|Overall Study|Withdrawal by Subject|0|||
44118024|NCT02541604|78901508|FG004|Overall Study|Withdrawal by Subject|1|||
44118025|NCT02541604|78901509|FG005|Overall Study|Withdrawal by Subject|1|||
44118026|NCT02541604|78901510|FG006|Overall Study|Withdrawal by Subject|0|||
44238384|NCT01587703|79064753|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238385|NCT01587703|79064754|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238386|NCT01587703|79064755|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238387|NCT01587703|79064756|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
44238388|NCT01587703|79064757|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
44238389|NCT01587703|79064758|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
44238390|NCT01587703|79064740|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238391|NCT01587703|79064741|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238392|NCT01587703|79064742|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238393|NCT01587703|79064743|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238394|NCT01587703|79064744|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238395|NCT01587703|79064745|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238396|NCT01587703|79064746|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238397|NCT01587703|79064747|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238398|NCT01587703|79064748|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238399|NCT01587703|79064749|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238400|NCT01587703|79064750|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238401|NCT01587703|79064751|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238402|NCT01587703|79064752|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238403|NCT01587703|79064753|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238404|NCT01587703|79064754|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238405|NCT01587703|79064755|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
44238406|NCT01587703|79064756|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238407|NCT01587703|79064757|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238408|NCT01587703|79064758|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
44238409|NCT01587703|79064740|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238410|NCT01587703|79064741|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238411|NCT01587703|79064742|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238412|NCT01587703|79064743|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238413|NCT01587703|79064744|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238414|NCT01587703|79064745|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238415|NCT01587703|79064746|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238416|NCT01587703|79064747|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238417|NCT01587703|79064748|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238418|NCT01587703|79064749|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238419|NCT01587703|79064750|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238420|NCT01587703|79064751|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
44238421|NCT01587703|79064752|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238422|NCT01587703|79064753|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238423|NCT01587703|79064754|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
44238424|NCT01587703|79064755|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238425|NCT01587703|79064756|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238426|NCT01587703|79064757|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238427|NCT01587703|79064758|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
44238428|NCT01587703|79064740|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238429|NCT01587703|79064741|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238430|NCT01587703|79064742|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238431|NCT01587703|79064743|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238432|NCT01587703|79064744|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238433|NCT01587703|79064745|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238434|NCT01587703|79064746|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238435|NCT01587703|79064747|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238436|NCT01587703|79064748|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238437|NCT01587703|79064749|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238438|NCT01587703|79064750|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238439|NCT01587703|79064751|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
44238440|NCT01587703|79064752|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
44238441|NCT01587703|79064753|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
44238442|NCT01587703|79064754|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
44238443|NCT01587703|79064755|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
44238444|NCT01587703|79064756|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
44238445|NCT01587703|79064757|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238446|NCT01587703|79064758|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
44238447|NCT01587703|79064740|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
44506251|NCT00086580|79511014|FG000|Follow-up Period|Withdrawal by Subject|6|||
44506252|NCT00086580|79511015|FG001|Follow-up Period|Withdrawal by Subject|6|||
44506253|NCT00086580|79511014|FG000|Follow-up Period|Physician Decision|0|||
44238448|NCT01587703|79064741|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238449|NCT01587703|79064742|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238450|NCT01587703|79064743|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238451|NCT01587703|79064744|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238452|NCT01587703|79064745|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238453|NCT01587703|79064746|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238454|NCT01587703|79064747|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238455|NCT01587703|79064748|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238456|NCT01587703|79064749|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238457|NCT01587703|79064750|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238458|NCT01587703|79064751|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
44238459|NCT01587703|79064752|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
44238460|NCT01587703|79064753|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
44238461|NCT01587703|79064754|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
44238462|NCT01587703|79064755|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
44238463|NCT01587703|79064756|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
44238464|NCT01587703|79064757|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238465|NCT01587703|79064758|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
44238466|NCT01587703|79064740|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238467|NCT01587703|79064741|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238468|NCT01587703|79064742|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238469|NCT01587703|79064743|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238470|NCT01587703|79064744|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238471|NCT01587703|79064745|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238472|NCT01587703|79064746|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238473|NCT01587703|79064747|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238474|NCT01587703|79064748|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238475|NCT01587703|79064749|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238476|NCT01587703|79064750|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238477|NCT01587703|79064751|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
44238478|NCT01587703|79064752|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238479|NCT01587703|79064753|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238480|NCT01587703|79064754|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44574739|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
44574740|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
44574741|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
44574742|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
44574743|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
44574744|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
44574745|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
44574746|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
44574747|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
44574748|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
44574749|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
44574750|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
44574751|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
44574752|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
44574753|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
44574754|NCT02657889|79597301|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
44574755|NCT02657889|79597302|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
44574756|NCT02657889|79597303|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
44574757|NCT02657889|79597304|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
44574758|NCT03034915|79597319|FG000|Overall Study|Adverse Event|29|||
44574759|NCT03034915|79597320|FG001|Overall Study|Adverse Event|32|||
44574760|NCT03034915|79597321|FG002|Overall Study|Adverse Event|22|||
44574761|NCT03034915|79597319|FG000|Overall Study|Lost to Follow-up|5|||
44574762|NCT03034915|79597320|FG001|Overall Study|Lost to Follow-up|13|||
44574763|NCT03034915|79597321|FG002|Overall Study|Lost to Follow-up|3|||
44574764|NCT03034915|79597319|FG000|Overall Study|Withdrawal by Subject|29|||
44574765|NCT03034915|79597320|FG001|Overall Study|Withdrawal by Subject|46|||
44574766|NCT03034915|79597321|FG002|Overall Study|Withdrawal by Subject|41|||
44574767|NCT03034915|79597319|FG000|Overall Study|Protocol Deviation|2|||
44574768|NCT03034915|79597320|FG001|Overall Study|Protocol Deviation|14|||
44574769|NCT03034915|79597321|FG002|Overall Study|Protocol Deviation|7|||
44574770|NCT03034915|79597319|FG000|Overall Study|Lack of Efficacy|8|||
44574771|NCT03034915|79597320|FG001|Overall Study|Lack of Efficacy|16|||
44118027|NCT02541604|78901511|FG007|Overall Study|Withdrawal by Subject|0|||
44238481|NCT01587703|79064755|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238482|NCT01587703|79064756|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238483|NCT01587703|79064757|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238484|NCT01587703|79064758|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
44238485|NCT01577381|79064821|FG000|Overall Study|Discontinued|2|||
44238486|NCT01577381|79064822|FG001|Overall Study|Discontinued|1|||
44238487|NCT01577381|79064823|FG002|Overall Study|Discontinued|2|||
44238488|NCT01577381|79064824|FG003|Overall Study|Discontinued|2|||
44238489|NCT01577381|79064821|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
44238490|NCT01577381|79064822|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
44238491|NCT01577381|79064823|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
44238492|NCT01577381|79064824|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
44238493|NCT02686164|79064834|FG000|Overall Study|Adverse Event|1|||
44238494|NCT02686164|79064834|FG000|Overall Study|Withdrawal of consent|1|||
44238495|NCT02686164|79064834|FG000|Overall Study|Clinical progression|1|||
44238496|NCT01691105|79064855|FG000|1 Month Follow-up|Lost to Follow-up|41|||
44238497|NCT01691105|79064856|FG001|1 Month Follow-up|Lost to Follow-up|38|||
44238498|NCT01691105|79064855|FG000|1 Month Follow-up|Death|2|||
44238499|NCT01691105|79064856|FG001|1 Month Follow-up|Death|3|||
44238500|NCT01691105|79064855|FG000|6 Month Follow-up|Lost to Follow-up|39|||
44238501|NCT01691105|79064856|FG001|6 Month Follow-up|Lost to Follow-up|58|||
44238502|NCT01691105|79064855|FG000|6 Month Follow-up|Death|13|||
44238503|NCT01691105|79064856|FG001|6 Month Follow-up|Death|13|||
44238504|NCT01691105|79064855|FG000|12 Month Follow-up|Lost to Follow-up|50|||
44238505|NCT01691105|79064856|FG001|12 Month Follow-up|Lost to Follow-up|71|||
44238506|NCT01691105|79064855|FG000|12 Month Follow-up|Death|22|||
44238507|NCT01691105|79064856|FG001|12 Month Follow-up|Death|30|||
44238508|NCT01691105|79064855|FG000|12 Month Biochemical Verification|Death|22|||
44238509|NCT01691105|79064856|FG001|12 Month Biochemical Verification|Death|30|||
44238510|NCT01691105|79064855|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
44238511|NCT01691105|79064856|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
44238512|NCT01691105|79064855|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
44238513|NCT01691105|79064856|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
44238514|NCT02685072|79064864|FG000|Treatment Period|Lost to Follow-up|12|||
44238515|NCT02685072|79064865|FG001|Treatment Period|Lost to Follow-up|6|||
44238516|NCT02685072|79064864|FG000|Treatment Period|Withdrawal by Subject|1|||
44238517|NCT02685072|79064865|FG001|Treatment Period|Withdrawal by Subject|3|||
44238518|NCT02685072|79064864|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
44238519|NCT02685072|79064865|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
44238520|NCT02695524|79064935|FG000|Overall Study|Lost to Follow-up|3|||
44238521|NCT02695524|79064936|FG001|Overall Study|Lost to Follow-up|2|||
44238522|NCT02695524|79064935|FG000|Overall Study|Death|0|||
44238523|NCT02695524|79064936|FG001|Overall Study|Death|1|||
44238524|NCT01576367|79064942|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44238525|NCT01576367|79064942|FG000|Overall Study|Moved to commercial use after 6 months|1|||
44238526|NCT01689857|79064953|FG000|Overall Study|Lost to Follow-up|5|||
44238527|NCT01689857|79064954|FG001|Overall Study|Lost to Follow-up|2|||
44238528|NCT01587079|79064960|FG000|Overall Study|Protocol-specified criteria|9|||
44238529|NCT01587079|79064960|FG000|Overall Study|Protocol Violation|5|||
44238530|NCT01587079|79064960|FG000|Overall Study|Lost to Follow-up|2|||
44238531|NCT01587079|79064960|FG000|Overall Study|Physician Decision|2|||
44238532|NCT01587079|79064960|FG000|Overall Study|Withdrawal by Subject|7|||
44238533|NCT01587079|79064960|FG000|Overall Study|Adverse Event|14|||
44238534|NCT01587001|79065013|FG000|Overall Study|Lost to Follow-up|2|||
44238535|NCT01587001|79065014|FG001|Overall Study|Lost to Follow-up|0|||
44238536|NCT01587001|79065013|FG000|Overall Study|Insufficient samples to complete testing|4|||
44238537|NCT01587001|79065014|FG001|Overall Study|Insufficient samples to complete testing|1|||
44238538|NCT01568047|79065044|FG000|Overall Study|Ineligibility|1|||
44238539|NCT01568047|79065045|FG001|Overall Study|Ineligibility|0|||
44238540|NCT01568047|79065046|FG002|Overall Study|Ineligibility|0|||
44238541|NCT01568047|79065047|FG003|Overall Study|Ineligibility|0|||
44238542|NCT01568047|79065044|FG000|Overall Study|Withdrawal by Subject|0|||
44238543|NCT01568047|79065045|FG001|Overall Study|Withdrawal by Subject|1|||
44238544|NCT01568047|79065046|FG002|Overall Study|Withdrawal by Subject|0|||
44238545|NCT01568047|79065047|FG003|Overall Study|Withdrawal by Subject|0|||
44238546|NCT01568047|79065044|FG000|Overall Study|Adverse Event|0|||
44238547|NCT01568047|79065045|FG001|Overall Study|Adverse Event|0|||
44238548|NCT01568047|79065046|FG002|Overall Study|Adverse Event|1|||
44238549|NCT01568047|79065047|FG003|Overall Study|Adverse Event|1|||
44238550|NCT01688999|79065060|FG000|Overall Study|Withdrawal by Subject|5|||
44378185|NCT00785629|79383456|FG000|Overall Study|administrative decision|5|||
44378186|NCT00785629|79383457|FG001|Overall Study|administrative decision|1|||
44378187|NCT00785629|79383458|FG002|Overall Study|administrative decision|3|||
44378188|NCT00785629|79383459|FG003|Overall Study|administrative decision|4|||
44238551|NCT01688999|79065061|FG001|Overall Study|Withdrawal by Subject|1|||
44238552|NCT01688999|79065062|FG002|Overall Study|Withdrawal by Subject|1|||
44238553|NCT01688999|79065060|FG000|Overall Study|Adverse Event|2|||
44238554|NCT01688999|79065061|FG001|Overall Study|Adverse Event|0|||
44238555|NCT01688999|79065062|FG002|Overall Study|Adverse Event|2|||
44238556|NCT01688999|79065060|FG000|Overall Study|Ineligible/Not treated|1|||
44238557|NCT01688999|79065061|FG001|Overall Study|Ineligible/Not treated|0|||
44238558|NCT01688999|79065062|FG002|Overall Study|Ineligible/Not treated|0|||
44238559|NCT01541917|79065086|FG000|Overall Study|Lost to Follow-up|2|||
44238560|NCT01541917|79065087|FG001|Overall Study|Lost to Follow-up|2|||
44238561|NCT01541917|79065086|FG000|Overall Study|Withdrawal by Subject|13|||
44238562|NCT01541917|79065087|FG001|Overall Study|Withdrawal by Subject|7|||
44238563|NCT01688921|79065107|FG000|Overall Study|Lost to Follow-up|7|||
44238564|NCT01688921|79065108|FG001|Overall Study|Lost to Follow-up|13|||
44238565|NCT01688921|79065107|FG000|Overall Study|Physician Decision|6|||
44238566|NCT01688921|79065108|FG001|Overall Study|Physician Decision|1|||
44238567|NCT01688921|79065107|FG000|Overall Study|Protocol Violation|0|||
44238568|NCT01688921|79065108|FG001|Overall Study|Protocol Violation|1|||
44238569|NCT01688921|79065107|FG000|Overall Study|informed consent|3|||
44238570|NCT01688921|79065108|FG001|Overall Study|informed consent|0|||
44238571|NCT01541371|79065130|FG000|Overall Study|Withdrawal by Subject|14|||
44574772|NCT03034915|79597321|FG002|Overall Study|Lack of Efficacy|18|||
44574773|NCT03034915|79597319|FG000|Overall Study|Site closed|2|||
44574774|NCT03034915|79597320|FG001|Overall Study|Site closed|2|||
44574775|NCT03034915|79597321|FG002|Overall Study|Site closed|4|||
44574776|NCT03034915|79597319|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
44574777|NCT03034915|79597320|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
44574778|NCT03034915|79597321|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
44574779|NCT03034915|79597319|FG000|Overall Study|Physician Decision|1|||
44574780|NCT03034915|79597320|FG001|Overall Study|Physician Decision|5|||
44574781|NCT03034915|79597321|FG002|Overall Study|Physician Decision|2|||
44574782|NCT02631538|79597333|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
44574783|NCT02631538|79597334|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
44574784|NCT02631538|79597335|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
44238572|NCT01541371|79065130|FG000|Overall Study|Lost to Follow-up|21|||
44238573|NCT01541371|79065130|FG000|Overall Study|Adverse Event|15|||
44238574|NCT01541371|79065130|FG000|Overall Study|Lack of Efficacy|12|||
44238575|NCT01541371|79065130|FG000|Overall Study|Protocol Violation|6|||
44238576|NCT01541371|79065130|FG000|Overall Study|Study medication non-compliance|3|||
44238577|NCT01541371|79065130|FG000|Overall Study|Other|6|||
44238578|NCT01687673|79065163|FG000|Overall Study|Physician Decision|1|||
44506254|NCT00086580|79511015|FG001|Follow-up Period|Physician Decision|1|||
44506255|NCT00086580|79511014|FG000|Follow-up Period|AE - not related|1|||
44506256|NCT00086580|79511015|FG001|Follow-up Period|AE - not related|0|||
44506257|NCT00086580|79511014|FG000|Follow-up Period|Death|13|||
44506258|NCT00086580|79511015|FG001|Follow-up Period|Death|7|||
44506259|NCT00086580|79511014|FG000|Follow-up Period|Other|7|||
44506260|NCT00086580|79511015|FG001|Follow-up Period|Other|6|||
44506261|NCT00086580|79511014|FG000|Observation Period|Unable to comply with protocol|1|||
44506262|NCT00086580|79511015|FG001|Observation Period|Unable to comply with protocol|1|||
44506263|NCT00086580|79511014|FG000|Observation Period|Withdrawal by Subject|4|||
44506264|NCT00086580|79511015|FG001|Observation Period|Withdrawal by Subject|2|||
44506265|NCT00086580|79511014|FG000|Observation Period|Death|33|||
44506266|NCT00086580|79511015|FG001|Observation Period|Death|55|||
44506267|NCT00086580|79511014|FG000|Observation Period|Other|8|||
44506268|NCT00086580|79511015|FG001|Observation Period|Other|7|||
44506269|NCT00086502|79511023|FG000|Overall Study|Adverse Event|11|||
44506270|NCT00086502|79511024|FG001|Overall Study|Adverse Event|2|||
44506271|NCT00086502|79511023|FG000|Overall Study|Lack of Efficacy|0|||
44506272|NCT00086502|79511024|FG001|Overall Study|Lack of Efficacy|2|||
44506273|NCT00086502|79511023|FG000|Overall Study|Lost to Follow-up|3|||
44506274|NCT00086502|79511024|FG001|Overall Study|Lost to Follow-up|1|||
44506275|NCT00086502|79511023|FG000|Overall Study|Physician Decision|1|||
44506276|NCT00086502|79511024|FG001|Overall Study|Physician Decision|1|||
44506277|NCT00086502|79511023|FG000|Overall Study|Pregnancy|0|||
44506278|NCT00086502|79511024|FG001|Overall Study|Pregnancy|1|||
44506279|NCT00086502|79511023|FG000|Overall Study|Protocol Violation|3|||
44506280|NCT00086502|79511024|FG001|Overall Study|Protocol Violation|3|||
44574785|NCT02631538|79597336|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
44238579|NCT01687595|79065243|FG000|Overall Study|Withdrawal by Subject|8|||
44506281|NCT00086502|79511023|FG000|Overall Study|Withdrawal by Subject|5|||
44506282|NCT00086502|79511024|FG001|Overall Study|Withdrawal by Subject|6|||
44238580|NCT01687595|79065244|FG001|Overall Study|Withdrawal by Subject|0|||
44238581|NCT01687595|79065243|FG000|Overall Study|Lost to Follow-up|3|||
44506283|NCT00086502|79511023|FG000|Overall Study|Patient Moved|1|||
44506284|NCT00086502|79511024|FG001|Overall Study|Patient Moved|1|||
44506285|NCT00086502|79511023|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
44506286|NCT00086502|79511024|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
44506287|NCT00086502|79511023|FG000|Overall Study|Patient Accidentally Unblinded|1|||
44506288|NCT00086502|79511024|FG001|Overall Study|Patient Accidentally Unblinded|0|||
44574786|NCT02631538|79597333|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
44574787|NCT02631538|79597334|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
44574788|NCT02631538|79597335|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
44238582|NCT01687595|79065244|FG001|Overall Study|Lost to Follow-up|1|||
44238583|NCT01687595|79065243|FG000|Overall Study|Investigator's decision|1|||
44238584|NCT01687595|79065244|FG001|Overall Study|Investigator's decision|0|||
44238585|NCT01687595|79065243|FG000|Overall Study|Sponsor's decision|1|||
44238586|NCT01687595|79065244|FG001|Overall Study|Sponsor's decision|0|||
44238587|NCT01687595|79065243|FG000|Overall Study|Noncompliance|1|||
44238588|NCT01687595|79065244|FG001|Overall Study|Noncompliance|2|||
44238589|NCT01687595|79065243|FG000|Overall Study|Other than specified|56|||
44238590|NCT01687595|79065244|FG001|Overall Study|Other than specified|7|||
44275964|NCT02087046|79226291|FG000|Overall Study|Adverse Event|4|||
44275965|NCT02087046|79226291|FG000|Overall Study|Death|1|||
44275966|NCT02087046|79226291|FG000|Overall Study|Lost to Follow-up|3|||
44238591|NCT01687283|79065252|FG000|Overall Study|Adverse Event|11|||
44238592|NCT01687283|79065253|FG001|Overall Study|Adverse Event|4|||
44238593|NCT01687283|79065252|FG000|Overall Study|Lack of Efficacy|3|||
44275967|NCT02087046|79226291|FG000|Overall Study|Withdrawal by Subject|2|||
44275968|NCT02087046|79226291|FG000|Overall Study|Physician Decision|1|||
44275969|NCT01390038|79226300|FG000|Overall Study|Death|1|||
44275970|NCT01390038|79226300|FG000|Overall Study|Lost to Follow-up|1|||
44506289|NCT03826667|79511030|FG000|Overall Study|Protocol deviation|21|||
44506290|NCT03636542|79511042|FG000|Overall Study|Lost to Follow-up|1|||
44238594|NCT01687283|79065253|FG001|Overall Study|Lack of Efficacy|1|||
44238595|NCT01687283|79065252|FG000|Overall Study|Protocol Violation|1|||
44238596|NCT01687283|79065253|FG001|Overall Study|Protocol Violation|3|||
44506291|NCT03636542|79511043|FG001|Overall Study|Lost to Follow-up|1|||
44506292|NCT03636542|79511042|FG000|Overall Study|Physician Decision|0|||
44506293|NCT03636542|79511043|FG001|Overall Study|Physician Decision|1|||
44506294|NCT03636542|79511042|FG000|Overall Study|Withdrawal by Subject|1|||
44574789|NCT02631538|79597336|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
44574790|NCT02631538|79597333|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
44574791|NCT02631538|79597334|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
44574792|NCT02631538|79597335|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
44574793|NCT02631538|79597336|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
44574794|NCT02631538|79597333|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
44574795|NCT02631538|79597334|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
44574796|NCT02631538|79597335|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
44574797|NCT02631538|79597336|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
44574798|NCT02631538|79597333|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
44574799|NCT02631538|79597334|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
44574800|NCT02631538|79597335|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
44574801|NCT02631538|79597336|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
44574802|NCT02631538|79597333|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
44574803|NCT02631538|79597334|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
44574804|NCT02631538|79597335|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
44574805|NCT02631538|79597336|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
44574806|NCT04587271|79597361|FG000|Overall Study|Lost to Follow-up|2|||
44574807|NCT04587271|79597362|FG001|Overall Study|Lost to Follow-up|2|||
44238597|NCT01687283|79065252|FG000|Overall Study|protocol defined stopping criteria|8|||
44275971|NCT01390038|79226300|FG000|Overall Study|Withdrawal by Subject|4|||
44378189|NCT00785629|79383456|FG000|Overall Study|Withdrawal by Subject|0|||
44506295|NCT03636542|79511043|FG001|Overall Study|Withdrawal by Subject|0|||
44506296|NCT03305770|79511051|FG000|Overall Study|Physician Decision - prior to dispense|0|||
44506297|NCT03305770|79511052|FG001|Overall Study|Physician Decision - prior to dispense|1|||
44506298|NCT03305770|79511051|FG000|Overall Study|Subject moved|1|||
44506299|NCT03305770|79511052|FG001|Overall Study|Subject moved|0|||
44506300|NCT00086190|79511063|FG000|Overall Study|Adverse Event|6|||
44506301|NCT00086190|79511064|FG001|Overall Study|Adverse Event|2|||
44506302|NCT00086190|79511065|FG002|Overall Study|Adverse Event|2|||
44506303|NCT00086190|79511063|FG000|Overall Study|Withdrawal by Subject|0|||
44574808|NCT04587271|79597363|FG002|Overall Study|Lost to Follow-up|0|||
44574809|NCT04587271|79597364|FG003|Overall Study|Lost to Follow-up|2|||
44118028|NCT02541604|78901512|FG008|Overall Study|Withdrawal by Subject|1|||
44238598|NCT01687283|79065253|FG001|Overall Study|protocol defined stopping criteria|10|||
44238599|NCT01687283|79065252|FG000|Overall Study|Lost to Follow-up|1|||
44275972|NCT01390038|79226300|FG000|Overall Study|Simpliciti System Removal|2|||
44506304|NCT00086190|79511064|FG001|Overall Study|Withdrawal by Subject|2|||
44506305|NCT00086190|79511065|FG002|Overall Study|Withdrawal by Subject|2|||
44506306|NCT00086190|79511063|FG000|Overall Study|Protocol Violation|1|||
44275973|NCT00621192|79226318|FG000|Overall Study|Withdrawal by Subject|0|||
44506307|NCT00086190|79511064|FG001|Overall Study|Protocol Violation|0|||
44506308|NCT00086190|79511065|FG002|Overall Study|Protocol Violation|0|||
44506309|NCT00086190|79511063|FG000|Overall Study|Moved|1|||
44574810|NCT04587271|79597365|FG004|Overall Study|Lost to Follow-up|2|||
44506310|NCT00086190|79511064|FG001|Overall Study|Moved|0|||
44506311|NCT00086190|79511065|FG002|Overall Study|Moved|0|||
44506312|NCT00086190|79511063|FG000|Overall Study|Worsening depression|0|||
44506313|NCT00086190|79511064|FG001|Overall Study|Worsening depression|0|||
44506314|NCT00086190|79511065|FG002|Overall Study|Worsening depression|2|||
44238600|NCT01687283|79065253|FG001|Overall Study|Lost to Follow-up|1|||
44238601|NCT01687283|79065252|FG000|Overall Study|Investigator discretion|2|||
44238602|NCT01687283|79065253|FG001|Overall Study|Investigator discretion|0|||
44238603|NCT01687283|79065252|FG000|Overall Study|Withdrawal by Subject|9|||
44238604|NCT01687283|79065253|FG001|Overall Study|Withdrawal by Subject|8|||
44238605|NCT02684370|79065262|FG000|Part A|Adverse Event|2|||
44238606|NCT02684370|79065263|FG001|Part A|Adverse Event|0|||
44238607|NCT02684370|79065264|FG002|Part A|Adverse Event|1|||
44238608|NCT02684370|79065265|FG003|Part A|Adverse Event|0|||
44238609|NCT02684370|79065266|FG004|Part A|Adverse Event|0|||
44238610|NCT02684370|79065267|FG005|Part A|Adverse Event|0|||
44238611|NCT02684370|79065262|FG000|Part A|Lost to Follow-up|1|||
44238612|NCT02684370|79065263|FG001|Part A|Lost to Follow-up|1|||
44238613|NCT02684370|79065264|FG002|Part A|Lost to Follow-up|0|||
44238614|NCT02684370|79065265|FG003|Part A|Lost to Follow-up|0|||
44238615|NCT02684370|79065266|FG004|Part A|Lost to Follow-up|0|||
44238616|NCT02684370|79065267|FG005|Part A|Lost to Follow-up|0|||
44238617|NCT02684370|79065262|FG000|Part A|Subject Withdrawal|1|||
44238618|NCT02684370|79065263|FG001|Part A|Subject Withdrawal|0|||
44238619|NCT02684370|79065264|FG002|Part A|Subject Withdrawal|3|||
44238620|NCT02684370|79065265|FG003|Part A|Subject Withdrawal|0|||
44238621|NCT02684370|79065266|FG004|Part A|Subject Withdrawal|0|||
44238622|NCT02684370|79065267|FG005|Part A|Subject Withdrawal|0|||
44238623|NCT02684370|79065262|FG000|Part A|Other|0|||
44238624|NCT02684370|79065263|FG001|Part A|Other|0|||
44238625|NCT02684370|79065264|FG002|Part A|Other|1|||
44238626|NCT02684370|79065265|FG003|Part A|Other|0|||
44238627|NCT02684370|79065266|FG004|Part A|Other|0|||
44238628|NCT02684370|79065267|FG005|Part A|Other|0|||
44238629|NCT02684370|79065262|FG000|Part B|Adverse Event|0|||
44238630|NCT02684370|79065263|FG001|Part B|Adverse Event|0|||
44238631|NCT02684370|79065264|FG002|Part B|Adverse Event|0|||
44238632|NCT02684370|79065265|FG003|Part B|Adverse Event|0|||
44238633|NCT02684370|79065266|FG004|Part B|Adverse Event|2|||
44238634|NCT02684370|79065267|FG005|Part B|Adverse Event|1|||
44238635|NCT02684370|79065262|FG000|Part B|Lost to Follow-up|0|||
44238636|NCT02684370|79065263|FG001|Part B|Lost to Follow-up|0|||
44238637|NCT02684370|79065264|FG002|Part B|Lost to Follow-up|0|||
44238638|NCT02684370|79065265|FG003|Part B|Lost to Follow-up|1|||
44238639|NCT02684370|79065266|FG004|Part B|Lost to Follow-up|2|||
44238640|NCT02684370|79065267|FG005|Part B|Lost to Follow-up|5|||
44238641|NCT02684370|79065262|FG000|Part B|Subject Withdrawal|0|||
44238642|NCT02684370|79065263|FG001|Part B|Subject Withdrawal|0|||
44238643|NCT02684370|79065264|FG002|Part B|Subject Withdrawal|0|||
44238644|NCT02684370|79065265|FG003|Part B|Subject Withdrawal|1|||
44238645|NCT02684370|79065266|FG004|Part B|Subject Withdrawal|1|||
44238646|NCT02684370|79065267|FG005|Part B|Subject Withdrawal|2|||
44238647|NCT01686581|79065294|FG000|Overall Study|Side-effects or Health Problems|15|||
44238648|NCT01686581|79065294|FG000|Overall Study|Lack of Efficacy|90|||
44238649|NCT01686581|79065294|FG000|Overall Study|Participant Concerned about Risks|6|||
44506315|NCT03320824|79511075|FG000|Overall Study|Withdrawal by Subject|8|||
44506316|NCT03320824|79511076|FG001|Overall Study|Withdrawal by Subject|1|||
44506317|NCT03320824|79511075|FG000|Overall Study|Lost to Follow-up|10|||
44506318|NCT03320824|79511076|FG001|Overall Study|Lost to Follow-up|1|||
44506319|NCT03320824|79511075|FG000|Overall Study|moved out of state|0|||
44506320|NCT03320824|79511076|FG001|Overall Study|moved out of state|1|||
44506321|NCT03320824|79511075|FG000|Overall Study|could not complete final visit|0|||
44506322|NCT03320824|79511076|FG001|Overall Study|could not complete final visit|1|||
44506323|NCT03275350|79511088|FG000|Overall Study|Lost to Follow-up|4|||
44238650|NCT01686581|79065294|FG000|Overall Study|Thinks Injections Too Painful|8|||
44238651|NCT01686581|79065294|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
44238652|NCT01686581|79065294|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
44238653|NCT01686581|79065294|FG000|Overall Study|Thinks it is Inconvenient|17|||
44238654|NCT01686581|79065294|FG000|Overall Study|Other Miscellaneous Reasons|36|||
44238655|NCT01686581|79065294|FG000|Overall Study|Reason Missing|1|||
44238656|NCT02691936|79065312|FG000|Overall Study|Withdrawal by Subject|2|||
44238657|NCT02691936|79065313|FG001|Overall Study|Withdrawal by Subject|5|||
44238658|NCT01685801|79065360|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
44238659|NCT01685801|79065361|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
44275974|NCT00621192|79226319|FG001|Overall Study|Withdrawal by Subject|0|||
44506324|NCT03275350|79511089|FG001|Overall Study|Lost to Follow-up|6|||
44506325|NCT03275350|79511088|FG000|Overall Study|Death|2|||
44506326|NCT03275350|79511089|FG001|Overall Study|Death|1|||
44238660|NCT01685801|79065362|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
44238661|NCT01685801|79065363|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
44238662|NCT01685801|79065360|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
44238663|NCT01685801|79065361|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
44238664|NCT01685801|79065362|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
44238665|NCT01685801|79065363|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
44238666|NCT01353222|79065382|FG000|Overall Study|Death|30|||
44238667|NCT01353222|79065383|FG001|Overall Study|Death|30|||
44238668|NCT01353222|79065382|FG000|Overall Study|Withdrawal by Subject|8|||
44238669|NCT01353222|79065383|FG001|Overall Study|Withdrawal by Subject|5|||
44238670|NCT01353222|79065382|FG000|Overall Study|Study Terminated|31|||
44238671|NCT01353222|79065383|FG001|Overall Study|Study Terminated|37|||
44238672|NCT01353222|79065382|FG000|Overall Study|Site closed research department|1|||
44238673|NCT01353222|79065383|FG001|Overall Study|Site closed research department|0|||
44238674|NCT01684943|79065413|FG000|Overall Study|Inadequate Venous Access|3|||
44238675|NCT01684943|79065414|FG001|Overall Study|Inadequate Venous Access|0|||
44506327|NCT03275350|79511088|FG000|Overall Study|Physician Decision|1|||
44506328|NCT03275350|79511089|FG001|Overall Study|Physician Decision|0|||
44238676|NCT01684943|79065415|FG002|Overall Study|Inadequate Venous Access|0|||
44238677|NCT01684943|79065413|FG000|Overall Study|Principal Investigator Determination|1|||
44238678|NCT01684943|79065414|FG001|Overall Study|Principal Investigator Determination|0|||
44238679|NCT01684943|79065415|FG002|Overall Study|Principal Investigator Determination|0|||
44238680|NCT01684943|79065413|FG000|Overall Study|Excluded from Analysis|1|||
44238681|NCT01684943|79065414|FG001|Overall Study|Excluded from Analysis|1|||
44238682|NCT01684943|79065415|FG002|Overall Study|Excluded from Analysis|1|||
44238683|NCT01684943|79065413|FG000|Overall Study|Lost to Follow-up|3|||
44238684|NCT01684943|79065414|FG001|Overall Study|Lost to Follow-up|0|||
44238685|NCT01684943|79065415|FG002|Overall Study|Lost to Follow-up|0|||
44238686|NCT01684943|79065413|FG000|Overall Study|Planning Pregnancy|1|||
44238687|NCT01684943|79065414|FG001|Overall Study|Planning Pregnancy|0|||
44506329|NCT03275350|79511088|FG000|Overall Study|Incarcerated|1|||
44506330|NCT03275350|79511089|FG001|Overall Study|Incarcerated|1|||
44506331|NCT03319732|79511096|FG000|Overall Study|Adverse Event|40|||
44506332|NCT03319732|79511096|FG000|Overall Study|Withdrawal by Subject|50|||
44506333|NCT03319732|79511096|FG000|Overall Study|MS relapse|10|||
44506334|NCT03319732|79511096|FG000|Overall Study|reason not specified|5|||
44506335|NCT03304522|79511103|FG000|Overall Study|Adverse Event|0|||
44506336|NCT03304522|79511104|FG001|Overall Study|Adverse Event|4|||
44506337|NCT03304522|79511103|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
44506338|NCT03304522|79511104|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
44506339|NCT03304522|79511103|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
44506340|NCT03304522|79511104|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
44506341|NCT03304522|79511103|FG000|Overall Study|Other|0|||
44506342|NCT03304522|79511104|FG001|Overall Study|Other|1|||
44506343|NCT03315286|79511112|FG000|Overall Study|Lost to Follow-up|0|||
44506344|NCT03315286|79511113|FG001|Overall Study|Lost to Follow-up|3|||
44506345|NCT03315286|79511112|FG000|Overall Study|Withdrawal by Subject|1|||
44506346|NCT03315286|79511113|FG001|Overall Study|Withdrawal by Subject|0|||
44506347|NCT03315286|79511112|FG000|Overall Study|Protocol Violation|0|||
44506348|NCT03315286|79511113|FG001|Overall Study|Protocol Violation|1|||
44506349|NCT03273946|79511119|FG000|Overall Study|Withdrawal by Subject|5|||
44506350|NCT03273946|79511119|FG000|Overall Study|Unwillingness of the guardian|1|||
44574811|NCT04587271|79597366|FG005|Overall Study|Lost to Follow-up|0|||
44574812|NCT04587271|79597361|FG000|Overall Study|Caregiver brought child to visits|0|||
44574813|NCT04587271|79597362|FG001|Overall Study|Caregiver brought child to visits|0|||
44574814|NCT04587271|79597363|FG002|Overall Study|Caregiver brought child to visits|0|||
44574815|NCT04587271|79597364|FG003|Overall Study|Caregiver brought child to visits|1|||
44574816|NCT04587271|79597365|FG004|Overall Study|Caregiver brought child to visits|0|||
44574817|NCT04587271|79597366|FG005|Overall Study|Caregiver brought child to visits|0|||
44574818|NCT02631148|79597381|FG000|Overall Study|8 were ineligible|8|||
44574819|NCT02631148|79597382|FG001|Overall Study|8 were ineligible|0|||
44574820|NCT02631148|79597381|FG000|Overall Study|Withdrawal by Subject|1|||
44574821|NCT02631148|79597382|FG001|Overall Study|Withdrawal by Subject|0|||
44574822|NCT02631148|79597381|FG000|Overall Study|PAH not available to study participant|1|||
44574823|NCT02631148|79597382|FG001|Overall Study|PAH not available to study participant|0|||
44574824|NCT02753400|79597390|FG000|Overall Study|Adverse Event|3|||
44238688|NCT01684943|79065415|FG002|Overall Study|Planning Pregnancy|0|||
44238689|NCT01683383|79065430|FG000|Overall Study|Infant was not transported|1|||
44238690|NCT01683383|79065431|FG001|Overall Study|Infant was not transported|0|||
44238691|NCT02694744|79065439|FG000|Overall Study|Adverse Event|2|||
44238692|NCT02694744|79065440|FG001|Overall Study|Adverse Event|1|||
44238693|NCT02694744|79065439|FG000|Overall Study|Withdrawal by Subject|2|||
44238694|NCT02694744|79065440|FG001|Overall Study|Withdrawal by Subject|1|||
44238695|NCT02694744|79065439|FG000|Overall Study|Physician Decision|1|||
44506351|NCT03273946|79511119|FG000|Overall Study|Participant refused to use the drug|2|||
44506352|NCT03273946|79511119|FG000|Overall Study|Participant relative refused to use drug|1|||
44574825|NCT02753400|79597391|FG001|Overall Study|Adverse Event|0|||
44238696|NCT02694744|79065440|FG001|Overall Study|Physician Decision|2|||
44238697|NCT02694744|79065439|FG000|Overall Study|Lost to Follow-up|1|||
44238698|NCT02694744|79065440|FG001|Overall Study|Lost to Follow-up|0|||
44238699|NCT02694744|79065439|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
44238700|NCT02694744|79065440|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
44238701|NCT01683071|79065454|FG000|Part 1|Lack of Efficacy|1|||
44238702|NCT01683071|79065455|FG001|Part 1|Lack of Efficacy|0|||
44238703|NCT01683071|79065456|FG002|Part 1|Lack of Efficacy|0|||
44238704|NCT01683071|79065457|FG003|Part 1|Lack of Efficacy|3|||
44238705|NCT01683071|79065458|FG004|Part 1|Lack of Efficacy|0|||
44238706|NCT01683071|79065459|FG005|Part 1|Lack of Efficacy|0|||
44238707|NCT01683071|79065454|FG000|Part 1|Withdrawal by Subject|1|||
44238708|NCT01683071|79065455|FG001|Part 1|Withdrawal by Subject|2|||
44238709|NCT01683071|79065456|FG002|Part 1|Withdrawal by Subject|2|||
44238710|NCT01683071|79065457|FG003|Part 1|Withdrawal by Subject|1|||
44238711|NCT01683071|79065458|FG004|Part 1|Withdrawal by Subject|0|||
44238712|NCT01683071|79065459|FG005|Part 1|Withdrawal by Subject|0|||
44238713|NCT01683071|79065454|FG000|Part 1|Surgery Cancelled|1|||
44238714|NCT01683071|79065455|FG001|Part 1|Surgery Cancelled|0|||
44238715|NCT01683071|79065456|FG002|Part 1|Surgery Cancelled|0|||
44238716|NCT01683071|79065457|FG003|Part 1|Surgery Cancelled|0|||
44238717|NCT01683071|79065458|FG004|Part 1|Surgery Cancelled|0|||
44238718|NCT01683071|79065459|FG005|Part 1|Surgery Cancelled|0|||
44238719|NCT01683071|79065454|FG000|Part 1|Did not receive study drug|1|||
44238720|NCT01683071|79065455|FG001|Part 1|Did not receive study drug|0|||
44238721|NCT01683071|79065456|FG002|Part 1|Did not receive study drug|0|||
44238722|NCT01683071|79065457|FG003|Part 1|Did not receive study drug|1|||
44238723|NCT01683071|79065458|FG004|Part 1|Did not receive study drug|0|||
44238724|NCT01683071|79065459|FG005|Part 1|Did not receive study drug|0|||
44238725|NCT01683071|79065454|FG000|Part 1|Early termination; met exclusion criteria|0|||
44238726|NCT01683071|79065455|FG001|Part 1|Early termination; met exclusion criteria|2|||
44238727|NCT01683071|79065456|FG002|Part 1|Early termination; met exclusion criteria|1|||
44238728|NCT01683071|79065457|FG003|Part 1|Early termination; met exclusion criteria|0|||
44238729|NCT01683071|79065458|FG004|Part 1|Early termination; met exclusion criteria|0|||
44238730|NCT01683071|79065459|FG005|Part 1|Early termination; met exclusion criteria|0|||
44238731|NCT01683071|79065454|FG000|Part 2|Lack of Efficacy|0|||
44238732|NCT01683071|79065455|FG001|Part 2|Lack of Efficacy|0|||
44238733|NCT01683071|79065456|FG002|Part 2|Lack of Efficacy|0|||
44238734|NCT01683071|79065457|FG003|Part 2|Lack of Efficacy|0|||
44238735|NCT01683071|79065458|FG004|Part 2|Lack of Efficacy|3|||
44238736|NCT01683071|79065459|FG005|Part 2|Lack of Efficacy|4|||
44238737|NCT01683071|79065454|FG000|Part 2|Lost to Follow-up|0|||
44238738|NCT01683071|79065455|FG001|Part 2|Lost to Follow-up|0|||
44238739|NCT01683071|79065456|FG002|Part 2|Lost to Follow-up|0|||
44238740|NCT01683071|79065457|FG003|Part 2|Lost to Follow-up|0|||
44238741|NCT01683071|79065458|FG004|Part 2|Lost to Follow-up|2|||
44238742|NCT01683071|79065459|FG005|Part 2|Lost to Follow-up|0|||
44238743|NCT01683071|79065454|FG000|Part 2|Withdrawal by Subject|0|||
44238744|NCT01683071|79065455|FG001|Part 2|Withdrawal by Subject|0|||
44238745|NCT01683071|79065456|FG002|Part 2|Withdrawal by Subject|0|||
44238746|NCT01683071|79065457|FG003|Part 2|Withdrawal by Subject|0|||
44238747|NCT01683071|79065458|FG004|Part 2|Withdrawal by Subject|3|||
44238748|NCT01683071|79065459|FG005|Part 2|Withdrawal by Subject|3|||
44238749|NCT01683071|79065454|FG000|Part 2|Surgery cancelled|0|||
44238750|NCT01683071|79065455|FG001|Part 2|Surgery cancelled|0|||
44238751|NCT01683071|79065456|FG002|Part 2|Surgery cancelled|0|||
44238752|NCT01683071|79065457|FG003|Part 2|Surgery cancelled|0|||
44238753|NCT01683071|79065458|FG004|Part 2|Surgery cancelled|4|||
44238754|NCT01683071|79065459|FG005|Part 2|Surgery cancelled|2|||
44238755|NCT01683071|79065454|FG000|Part 2|Did not receive study drug|0|||
44238756|NCT01683071|79065455|FG001|Part 2|Did not receive study drug|0|||
44238757|NCT01683071|79065456|FG002|Part 2|Did not receive study drug|0|||
44238758|NCT01683071|79065457|FG003|Part 2|Did not receive study drug|0|||
44238759|NCT01683071|79065458|FG004|Part 2|Did not receive study drug|2|||
44238760|NCT01683071|79065459|FG005|Part 2|Did not receive study drug|1|||
44238761|NCT01683071|79065454|FG000|Part 2|Met exclusion criterion|0|||
44238762|NCT01683071|79065455|FG001|Part 2|Met exclusion criterion|0|||
44238763|NCT01683071|79065456|FG002|Part 2|Met exclusion criterion|0|||
44238764|NCT01683071|79065457|FG003|Part 2|Met exclusion criterion|0|||
44238765|NCT01683071|79065458|FG004|Part 2|Met exclusion criterion|1|||
44275975|NCT00621192|79226320|FG002|Overall Study|Withdrawal by Subject|2|||
44238766|NCT01683071|79065459|FG005|Part 2|Met exclusion criterion|1|||
44238767|NCT01683071|79065454|FG000|Part 2|Protocol deviation|0|||
44238768|NCT01683071|79065455|FG001|Part 2|Protocol deviation|0|||
44238769|NCT01683071|79065456|FG002|Part 2|Protocol deviation|0|||
44238770|NCT01683071|79065457|FG003|Part 2|Protocol deviation|0|||
44238771|NCT01683071|79065458|FG004|Part 2|Protocol deviation|1|||
44238772|NCT01683071|79065459|FG005|Part 2|Protocol deviation|2|||
44238773|NCT01683071|79065454|FG000|Part 2|Withdrawal by investigator decision|0|||
44238774|NCT01683071|79065455|FG001|Part 2|Withdrawal by investigator decision|0|||
44238775|NCT01683071|79065456|FG002|Part 2|Withdrawal by investigator decision|0|||
44238776|NCT01683071|79065457|FG003|Part 2|Withdrawal by investigator decision|0|||
44238777|NCT01683071|79065458|FG004|Part 2|Withdrawal by investigator decision|1|||
44275976|NCT00621192|79226321|FG003|Overall Study|Withdrawal by Subject|0|||
44238778|NCT01683071|79065459|FG005|Part 2|Withdrawal by investigator decision|2|||
44238779|NCT01567865|79065483|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
44238780|NCT01567865|79065484|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
44238781|NCT01567865|79065485|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
44238782|NCT01567865|79065486|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
44238783|NCT01567865|79065483|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
44238784|NCT01567865|79065484|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
44238785|NCT01567865|79065485|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
44238786|NCT01567865|79065486|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
44118029|NCT02541604|78901513|FG009|Overall Study|Withdrawal by Subject|0|||
44118030|NCT02541604|78901514|FG010|Overall Study|Withdrawal by Subject|0|||
44118031|NCT02541604|78901515|FG011|Overall Study|Withdrawal by Subject|0|||
44118032|NCT02541604|78901504|FG000|Overall Study|Study Terminated by Sponsor|1|||
44118033|NCT02541604|78901505|FG001|Overall Study|Study Terminated by Sponsor|4|||
44118034|NCT02541604|78901506|FG002|Overall Study|Study Terminated by Sponsor|2|||
44118035|NCT02541604|78901507|FG003|Overall Study|Study Terminated by Sponsor|1|||
44118036|NCT02541604|78901508|FG004|Overall Study|Study Terminated by Sponsor|0|||
44118037|NCT02541604|78901509|FG005|Overall Study|Study Terminated by Sponsor|0|||
44118038|NCT02541604|78901510|FG006|Overall Study|Study Terminated by Sponsor|0|||
44118039|NCT02541604|78901511|FG007|Overall Study|Study Terminated by Sponsor|0|||
44238787|NCT01567163|79065497|FG000|Overall Study|Progressive Disease|2|||
44238788|NCT01567163|79065497|FG000|Overall Study|Lost to Follow-up|2|||
44238789|NCT01567085|79065506|FG000|Overall Study|Death|6|||
44238790|NCT01567085|79065506|FG000|Overall Study|Adverse Event|6|||
44238791|NCT01567085|79065506|FG000|Overall Study|Lost to Follow-up|3|||
44238792|NCT01567085|79065506|FG000|Overall Study|Graft loss|2|||
44238793|NCT01567085|79065506|FG000|Overall Study|Renal transplantectomy|1|||
44574826|NCT02753400|79597390|FG000|Overall Study|Withdrawal by Subject|2|||
44574827|NCT02753400|79597391|FG001|Overall Study|Withdrawal by Subject|1|||
44574828|NCT03943147|79597408|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
44574829|NCT03943147|79597409|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
44574830|NCT03943147|79597408|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
44574831|NCT03943147|79597409|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
44574832|NCT03943147|79597408|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
44574833|NCT03943147|79597409|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
44574834|NCT03943147|79597408|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
44574835|NCT03943147|79597409|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
44574836|NCT03943147|79597408|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
44574837|NCT03943147|79597409|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
44574838|NCT03943147|79597408|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
44574839|NCT03943147|79597409|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
44574840|NCT03730987|79597427|FG000|Overall Study|Lost to Follow-up|2|||
44574841|NCT03730987|79597428|FG001|Overall Study|Lost to Follow-up|0|||
44574842|NCT03730987|79597429|FG002|Overall Study|Lost to Follow-up|2|||
44574843|NCT03730987|79597430|FG003|Overall Study|Lost to Follow-up|0|||
44574844|NCT02844543|79597441|FG000|Overall Study|Withdrawal by Subject|4|||
44574845|NCT02844543|79597441|FG000|Overall Study|Did not meet eligibility criteria|1|||
44574846|NCT03034135|79597445|FG000|Overall Study|Withdrawal by Subject|2|||
44574847|NCT01671280|79597449|FG000|Overall Study|Withdrawal by Subject|2|||
44574848|NCT01405963|79597455|FG000|Overall Study|Moved Away|2|||
44574849|NCT01405963|79597456|FG001|Overall Study|Moved Away|0|||
44574850|NCT01405963|79597455|FG000|Overall Study|Adverse Event|0|||
44574851|NCT01405963|79597456|FG001|Overall Study|Adverse Event|1|||
44238794|NCT01567085|79065506|FG000|Overall Study|Returned to chronic dialysis|1|||
44506353|NCT00314951|79511125|FG000|Treatment|Didn't meet criteria for mITT population|16|||
44506354|NCT00314951|79511126|FG001|Treatment|Didn't meet criteria for mITT population|11|||
44506355|NCT00314951|79511125|FG000|Follow-up|mITT failure|44|||
44506356|NCT00314951|79511126|FG001|Follow-up|mITT failure|34|||
44506357|NCT00085644|79511134|FG000|Double-Blind Period|Adverse Event|5|||
44506358|NCT00085644|79511135|FG001|Double-Blind Period|Adverse Event|2|||
44506359|NCT00085644|79511136|FG002|Double-Blind Period|Adverse Event|0|||
44506360|NCT00085644|79511134|FG000|Double-Blind Period|Withdrawal by Subject|3|||
44506361|NCT00085644|79511135|FG001|Double-Blind Period|Withdrawal by Subject|0|||
44506362|NCT00085644|79511136|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44506363|NCT00085644|79511134|FG000|Double-Blind Period|Lost to Follow-up|2|||
44506364|NCT00085644|79511135|FG001|Double-Blind Period|Lost to Follow-up|1|||
44118040|NCT02541604|78901512|FG008|Overall Study|Study Terminated by Sponsor|0|||
44118041|NCT02541604|78901513|FG009|Overall Study|Study Terminated by Sponsor|0|||
44118042|NCT02541604|78901514|FG010|Overall Study|Study Terminated by Sponsor|0|||
44506365|NCT00085644|79511136|FG002|Double-Blind Period|Lost to Follow-up|0|||
44506366|NCT00085644|79511134|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
44238795|NCT01567085|79065506|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
44506367|NCT00085644|79511135|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
44238796|NCT01566773|79065510|FG000|Overall Study|Protocol specified criteria|4|||
44238797|NCT01566773|79065510|FG000|Overall Study|Protocol Violation|4|||
44238798|NCT01566773|79065510|FG000|Overall Study|Withdrawal by Subject|9|||
44238799|NCT01566773|79065510|FG000|Overall Study|Administrative reason|1|||
44238800|NCT01566773|79065510|FG000|Overall Study|Adverse Event|10|||
44238801|NCT01566773|79065510|FG000|Overall Study|Physician Decision|2|||
44238802|NCT01566149|79065532|FG000|Overall Study|Adverse Event|0|||
44238803|NCT01566149|79065533|FG001|Overall Study|Adverse Event|1|||
44238804|NCT01566149|79065532|FG000|Overall Study|Non-compliance with study medication|2|||
44238805|NCT01566149|79065533|FG001|Overall Study|Non-compliance with study medication|0|||
44238806|NCT01566149|79065532|FG000|Overall Study|Protocol Violation|0|||
44238807|NCT01566149|79065533|FG001|Overall Study|Protocol Violation|1|||
44238808|NCT01566149|79065532|FG000|Overall Study|Withdrawal by Subject|1|||
44238809|NCT01566149|79065533|FG001|Overall Study|Withdrawal by Subject|0|||
44238810|NCT01565993|79065541|FG000|Overall Study|Physician Decision|0|||
44238811|NCT01565993|79065542|FG001|Overall Study|Physician Decision|3|||
44238812|NCT01565291|79065550|FG000|Overall Study|Withdrawal by Subject|1|||
44238813|NCT01565291|79065551|FG001|Overall Study|Withdrawal by Subject|0|||
44238814|NCT02691702|79065568|FG000|Overall Study|Adverse Event|1|||
44238815|NCT02691702|79065569|FG001|Overall Study|Adverse Event|0|||
44238816|NCT02691702|79065570|FG002|Overall Study|Adverse Event|0|||
44238817|NCT02691702|79065571|FG003|Overall Study|Adverse Event|0|||
44238818|NCT02691702|79065572|FG004|Overall Study|Adverse Event|0|||
44238819|NCT02691702|79065573|FG005|Overall Study|Adverse Event|0|||
44238820|NCT02691702|79065574|FG006|Overall Study|Adverse Event|0|||
44238821|NCT02691702|79065575|FG007|Overall Study|Adverse Event|0|||
44238822|NCT02691702|79065576|FG008|Overall Study|Adverse Event|1|||
44238823|NCT02691702|79065577|FG009|Overall Study|Adverse Event|0|||
44238824|NCT02691702|79065578|FG010|Overall Study|Adverse Event|1|||
44238825|NCT02691702|79065568|FG000|Overall Study|Lost to Follow-up|0|||
44238826|NCT02691702|79065569|FG001|Overall Study|Lost to Follow-up|0|||
44238827|NCT02691702|79065570|FG002|Overall Study|Lost to Follow-up|1|||
44238828|NCT02691702|79065571|FG003|Overall Study|Lost to Follow-up|0|||
44238829|NCT02691702|79065572|FG004|Overall Study|Lost to Follow-up|0|||
44238830|NCT02691702|79065573|FG005|Overall Study|Lost to Follow-up|2|||
44238831|NCT02691702|79065574|FG006|Overall Study|Lost to Follow-up|0|||
44238832|NCT02691702|79065575|FG007|Overall Study|Lost to Follow-up|0|||
44238833|NCT02691702|79065576|FG008|Overall Study|Lost to Follow-up|0|||
44238834|NCT02691702|79065577|FG009|Overall Study|Lost to Follow-up|0|||
44238835|NCT02691702|79065578|FG010|Overall Study|Lost to Follow-up|1|||
44238836|NCT02691702|79065568|FG000|Overall Study|Withdrawal by Subject|1|||
44238837|NCT02691702|79065569|FG001|Overall Study|Withdrawal by Subject|1|||
44238838|NCT02691702|79065570|FG002|Overall Study|Withdrawal by Subject|0|||
44238839|NCT02691702|79065571|FG003|Overall Study|Withdrawal by Subject|0|||
44506368|NCT00085644|79511136|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
44506369|NCT00085644|79511134|FG000|Double-Blind Period|Contemplating pregnancy|1|||
44506370|NCT00085644|79511135|FG001|Double-Blind Period|Contemplating pregnancy|0|||
44506371|NCT00085644|79511136|FG002|Double-Blind Period|Contemplating pregnancy|0|||
44506372|NCT00085644|79511134|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
44506373|NCT00085644|79511135|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
44506374|NCT00085644|79511136|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
44506375|NCT00085644|79511134|FG000|Open-Label Period|Adverse Event|0|||
44506376|NCT00085644|79511135|FG001|Open-Label Period|Adverse Event|0|||
44506377|NCT00085644|79511136|FG002|Open-Label Period|Adverse Event|38|||
44506378|NCT00085644|79511134|FG000|Open-Label Period|Withdrawal by Subject|0|||
44506379|NCT00085644|79511135|FG001|Open-Label Period|Withdrawal by Subject|0|||
44506380|NCT00085644|79511136|FG002|Open-Label Period|Withdrawal by Subject|29|||
44506381|NCT00085644|79511134|FG000|Open-Label Period|Lost to Follow-up|0|||
44506382|NCT00085644|79511135|FG001|Open-Label Period|Lost to Follow-up|0|||
44506383|NCT00085644|79511136|FG002|Open-Label Period|Lost to Follow-up|13|||
44506384|NCT00085644|79511134|FG000|Open-Label Period|Lack of Efficacy|0|||
44238840|NCT02691702|79065572|FG004|Overall Study|Withdrawal by Subject|0|||
44238841|NCT02691702|79065573|FG005|Overall Study|Withdrawal by Subject|1|||
44238842|NCT02691702|79065574|FG006|Overall Study|Withdrawal by Subject|2|||
44238843|NCT02691702|79065575|FG007|Overall Study|Withdrawal by Subject|0|||
44506385|NCT00085644|79511135|FG001|Open-Label Period|Lack of Efficacy|0|||
44506386|NCT00085644|79511136|FG002|Open-Label Period|Lack of Efficacy|15|||
44506387|NCT00085644|79511134|FG000|Open-Label Period|Pregnancy|0|||
44238844|NCT02691702|79065576|FG008|Overall Study|Withdrawal by Subject|0|||
44238845|NCT02691702|79065577|FG009|Overall Study|Withdrawal by Subject|0|||
44238846|NCT02691702|79065578|FG010|Overall Study|Withdrawal by Subject|0|||
44238847|NCT02691702|79065568|FG000|Overall Study|Other|0|||
44506388|NCT00085644|79511135|FG001|Open-Label Period|Pregnancy|0|||
44506389|NCT00085644|79511136|FG002|Open-Label Period|Pregnancy|3|||
44238848|NCT02691702|79065569|FG001|Overall Study|Other|0|||
44238849|NCT02691702|79065570|FG002|Overall Study|Other|0|||
44238850|NCT02691702|79065571|FG003|Overall Study|Other|0|||
44238851|NCT02691702|79065572|FG004|Overall Study|Other|0|||
44238852|NCT02691702|79065573|FG005|Overall Study|Other|0|||
44238853|NCT02691702|79065574|FG006|Overall Study|Other|1|||
44238854|NCT02691702|79065575|FG007|Overall Study|Other|0|||
44238855|NCT02691702|79065576|FG008|Overall Study|Other|1|||
44238856|NCT02691702|79065577|FG009|Overall Study|Other|0|||
44238857|NCT02691702|79065578|FG010|Overall Study|Other|0|||
44238858|NCT02691702|79065568|FG000|Overall Study|Protocol Violation|0|||
44238859|NCT02691702|79065569|FG001|Overall Study|Protocol Violation|0|||
44574852|NCT01405963|79597455|FG000|Overall Study|Lost to Follow-up|0|||
44574853|NCT01405963|79597456|FG001|Overall Study|Lost to Follow-up|1|||
44574854|NCT02628418|79597476|FG000|Overall Study|Lost to Follow-up|1|||
44574855|NCT02628418|79597477|FG001|Overall Study|Lost to Follow-up|2|||
44574856|NCT02752776|79597505|FG000|Overall Study|Adverse Event|15|||
44574857|NCT02752776|79597506|FG001|Overall Study|Adverse Event|23|||
44574858|NCT02752776|79597507|FG002|Overall Study|Adverse Event|11|||
44574859|NCT02752776|79597505|FG000|Overall Study|Lack of Efficacy|2|||
44574860|NCT02752776|79597506|FG001|Overall Study|Lack of Efficacy|6|||
44574861|NCT02752776|79597507|FG002|Overall Study|Lack of Efficacy|14|||
44574862|NCT02752776|79597505|FG000|Overall Study|Lost to Follow-up|11|||
44574863|NCT02752776|79597506|FG001|Overall Study|Lost to Follow-up|12|||
44574864|NCT02752776|79597507|FG002|Overall Study|Lost to Follow-up|4|||
44574865|NCT02752776|79597505|FG000|Overall Study|Non-compliance with study treatment|0|||
44574866|NCT02752776|79597506|FG001|Overall Study|Non-compliance with study treatment|0|||
44574867|NCT02752776|79597507|FG002|Overall Study|Non-compliance with study treatment|1|||
44574868|NCT02752776|79597505|FG000|Overall Study|Physician Decision|2|||
44574869|NCT02752776|79597506|FG001|Overall Study|Physician Decision|6|||
44574870|NCT02752776|79597507|FG002|Overall Study|Physician Decision|2|||
44574871|NCT02752776|79597505|FG000|Overall Study|Pregnancy|1|||
44574872|NCT02752776|79597506|FG001|Overall Study|Pregnancy|6|||
44574873|NCT02752776|79597507|FG002|Overall Study|Pregnancy|3|||
44574874|NCT02752776|79597505|FG000|Overall Study|Protocol Violation|10|||
44574875|NCT02752776|79597506|FG001|Overall Study|Protocol Violation|13|||
44574876|NCT02752776|79597507|FG002|Overall Study|Protocol Violation|6|||
44574877|NCT02752776|79597505|FG000|Overall Study|Subject/guardian decision|8|||
44574878|NCT02752776|79597506|FG001|Overall Study|Subject/guardian decision|6|||
44574879|NCT02752776|79597507|FG002|Overall Study|Subject/guardian decision|4|||
44574880|NCT02752776|79597505|FG000|Overall Study|Death|0|||
44574881|NCT02752776|79597506|FG001|Overall Study|Death|0|||
44574882|NCT02752776|79597507|FG002|Overall Study|Death|1|||
44574883|NCT02752776|79597505|FG000|Overall Study|Withdrawal by Subject|3|||
44238860|NCT02691702|79065570|FG002|Overall Study|Protocol Violation|0|||
44238861|NCT02691702|79065571|FG003|Overall Study|Protocol Violation|0|||
44238862|NCT02691702|79065572|FG004|Overall Study|Protocol Violation|0|||
44238863|NCT02691702|79065573|FG005|Overall Study|Protocol Violation|0|||
44238864|NCT02691702|79065574|FG006|Overall Study|Protocol Violation|0|||
44238865|NCT02691702|79065575|FG007|Overall Study|Protocol Violation|0|||
44238866|NCT02691702|79065576|FG008|Overall Study|Protocol Violation|0|||
44378190|NCT00785629|79383457|FG001|Overall Study|Withdrawal by Subject|1|||
44574884|NCT02752776|79597506|FG001|Overall Study|Withdrawal by Subject|4|||
44574885|NCT02752776|79597507|FG002|Overall Study|Withdrawal by Subject|2|||
44574886|NCT01342965|79597519|FG000|Overall Study|Death|58|||
44574887|NCT01342965|79597520|FG001|Overall Study|Death|57|||
44574888|NCT01342965|79597519|FG000|Overall Study|Lost to Follow-up|5|||
44574889|NCT01342965|79597520|FG001|Overall Study|Lost to Follow-up|3|||
44118043|NCT02541604|78901515|FG011|Overall Study|Study Terminated by Sponsor|0|||
44118044|NCT02541604|78901504|FG000|Overall Study|Medical condition may jeopardize safety|0|||
44238867|NCT02691702|79065577|FG009|Overall Study|Protocol Violation|2|||
44378191|NCT00785629|79383458|FG002|Overall Study|Withdrawal by Subject|2|||
44506390|NCT00085644|79511134|FG000|Open-Label Period|Contemplating pregnancy|0|||
44506391|NCT00085644|79511135|FG001|Open-Label Period|Contemplating pregnancy|0|||
44506392|NCT00085644|79511136|FG002|Open-Label Period|Contemplating pregnancy|3|||
44506393|NCT00085644|79511134|FG000|Open-Label Period|Protocol Violation|0|||
44506394|NCT00085644|79511135|FG001|Open-Label Period|Protocol Violation|0|||
44506395|NCT00085644|79511136|FG002|Open-Label Period|Protocol Violation|4|||
44506396|NCT00085644|79511134|FG000|Open-Label Period|Personal reason|0|||
44506397|NCT00085644|79511135|FG001|Open-Label Period|Personal reason|0|||
44506398|NCT00085644|79511136|FG002|Open-Label Period|Personal reason|4|||
44506399|NCT03315208|79511145|FG000|Overall Study|Lost to Follow-up|11|||
44506400|NCT03315208|79511146|FG001|Overall Study|Lost to Follow-up|6|||
44506401|NCT03315208|79511145|FG000|Overall Study|Withdrawal by Subject|2|||
44506402|NCT03315208|79511146|FG001|Overall Study|Withdrawal by Subject|0|||
44506403|NCT00314795|79511153|FG000|Overall Study|Adverse Event|8|||
44574890|NCT01342965|79597519|FG000|Overall Study|Other Reasons- Unspecified|44|||
44574891|NCT01342965|79597520|FG001|Overall Study|Other Reasons- Unspecified|38|||
44238868|NCT02691702|79065578|FG010|Overall Study|Protocol Violation|0|||
44238869|NCT01564277|79065612|FG000|Overall Study|Protocol Violation|0|||
44238870|NCT01564277|79065613|FG001|Overall Study|Protocol Violation|1|||
44238871|NCT01564277|79065612|FG000|Overall Study|Physician Decision|1|||
44574892|NCT01342965|79597519|FG000|Overall Study|Withdrawal by Subject|2|||
44238872|NCT01564277|79065613|FG001|Overall Study|Physician Decision|0|||
44238873|NCT02679222|79065619|FG000|Overall Study|No time for project|1|||
44238874|NCT01563185|79065631|FG000|Overall Study|Withdrawal by Subject|1|||
44506404|NCT00314795|79511153|FG000|Overall Study|Death|4|||
44506405|NCT00314795|79511153|FG000|Overall Study|Reason not Specified|3|||
44506406|NCT00314795|79511153|FG000|Overall Study|Renal Transplant|3|||
44506407|NCT00314795|79511153|FG000|Overall Study|Participants Withdrew Consent|2|||
44506408|NCT00314327|79511157|FG000|Overall Study|Withdrawal by Subject|1|||
44506409|NCT00336479|79511165|FG000|Overall Study|Adverse Event|8|||
44506410|NCT00336479|79511166|FG001|Overall Study|Adverse Event|11|||
44506411|NCT00336479|79511167|FG002|Overall Study|Adverse Event|18|||
44506412|NCT00336479|79511168|FG003|Overall Study|Adverse Event|4|||
44506413|NCT00336479|79511165|FG000|Overall Study|Noncompliant|1|||
44506414|NCT00336479|79511166|FG001|Overall Study|Noncompliant|7|||
44506415|NCT00336479|79511167|FG002|Overall Study|Noncompliant|3|||
44506416|NCT00336479|79511168|FG003|Overall Study|Noncompliant|0|||
44506417|NCT00336479|79511165|FG000|Overall Study|Physician Decision|2|||
44506418|NCT00336479|79511166|FG001|Overall Study|Physician Decision|3|||
44506419|NCT00336479|79511167|FG002|Overall Study|Physician Decision|1|||
44506420|NCT00336479|79511168|FG003|Overall Study|Physician Decision|0|||
44506421|NCT00336479|79511165|FG000|Overall Study|Lost to Follow-up|3|||
44506422|NCT00336479|79511166|FG001|Overall Study|Lost to Follow-up|2|||
44506423|NCT00336479|79511167|FG002|Overall Study|Lost to Follow-up|0|||
44506424|NCT00336479|79511168|FG003|Overall Study|Lost to Follow-up|0|||
44506425|NCT00336479|79511165|FG000|Overall Study|Withdrawal by Subject|3|||
44506426|NCT00336479|79511166|FG001|Overall Study|Withdrawal by Subject|2|||
44506427|NCT00336479|79511167|FG002|Overall Study|Withdrawal by Subject|3|||
44506428|NCT00336479|79511168|FG003|Overall Study|Withdrawal by Subject|0|||
44506429|NCT00336479|79511165|FG000|Overall Study|Other|0|||
44506430|NCT00336479|79511166|FG001|Overall Study|Other|0|||
44506431|NCT00336479|79511167|FG002|Overall Study|Other|1|||
44506432|NCT00336479|79511168|FG003|Overall Study|Other|0|||
44506433|NCT00336479|79511165|FG000|Overall Study|Virologic Stopping Rule|20|||
44506434|NCT00336479|79511166|FG001|Overall Study|Virologic Stopping Rule|0|||
44506435|NCT00336479|79511167|FG002|Overall Study|Virologic Stopping Rule|0|||
44506436|NCT00336479|79511168|FG003|Overall Study|Virologic Stopping Rule|0|||
44506437|NCT00314249|79511181|FG000|Overall Study|Adverse Event|73|||
44506438|NCT00314249|79511182|FG001|Overall Study|Adverse Event|94|||
44506439|NCT00314249|79511181|FG000|Overall Study|Lack of Efficacy|33|||
44506440|NCT00314249|79511182|FG001|Overall Study|Lack of Efficacy|24|||
44506441|NCT00314249|79511181|FG000|Overall Study|Withdrawal by Subject|21|||
44506442|NCT00314249|79511182|FG001|Overall Study|Withdrawal by Subject|28|||
44506443|NCT00314249|79511181|FG000|Overall Study|Lost to Follow-up|15|||
44506444|NCT00314249|79511182|FG001|Overall Study|Lost to Follow-up|9|||
44506445|NCT00314249|79511181|FG000|Overall Study|Physician Decision|1|||
44506446|NCT00314249|79511182|FG001|Overall Study|Physician Decision|1|||
44506447|NCT00314249|79511181|FG000|Overall Study|Withdrawn for other reasons|4|||
44506448|NCT00314249|79511182|FG001|Overall Study|Withdrawn for other reasons|1|||
44506449|NCT00314249|79511181|FG000|Overall Study|Non-Compliant|5|||
44506450|NCT00314249|79511182|FG001|Overall Study|Non-Compliant|6|||
44506451|NCT03315130|79511191|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
44506452|NCT03315130|79511192|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
44506453|NCT03315130|79511193|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
44506454|NCT03315130|79511194|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
44506455|NCT03315130|79511191|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
44506456|NCT03315130|79511192|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
44506457|NCT03315130|79511193|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
44506458|NCT03315130|79511194|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
44506459|NCT03315130|79511191|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
44506460|NCT03315130|79511192|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
44506461|NCT03315130|79511193|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
44506462|NCT03315130|79511194|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
44506463|NCT03315130|79511191|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
44506464|NCT03315130|79511192|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
44506465|NCT03315130|79511193|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
44506466|NCT03315130|79511194|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
44506467|NCT03315130|79511191|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
44238875|NCT01563185|79065631|FG000|Overall Study|Non-Compliance with study drug|1|||
44249754|NCT01503164|79083957|FG000|Overall Study|Withdrawal by Subject|2|||
44506468|NCT03315130|79511192|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
44506469|NCT03315130|79511193|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
44506470|NCT03315130|79511194|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
44506471|NCT03315130|79511191|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
44506472|NCT03315130|79511192|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
44506473|NCT03315130|79511193|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
44506474|NCT03315130|79511194|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
44506475|NCT03273166|79511214|FG000|Overall Study|Withdrawn prior to Completion|31|||
44506476|NCT03314662|79511222|FG000|Overall Study|Withdrawal by Subject|1|||
44506477|NCT03314662|79511223|FG001|Overall Study|Withdrawal by Subject|1|||
44506478|NCT03314662|79511224|FG002|Overall Study|Withdrawal by Subject|1|||
44506479|NCT03314662|79511222|FG000|Overall Study|Lost to Follow-up|5|||
44506480|NCT03314662|79511223|FG001|Overall Study|Lost to Follow-up|4|||
44506481|NCT03314662|79511224|FG002|Overall Study|Lost to Follow-up|4|||
44506482|NCT03314662|79511222|FG000|Overall Study|Death|2|||
44574893|NCT01342965|79597520|FG001|Overall Study|Withdrawal by Subject|9|||
44574894|NCT02629822|79597526|FG000|Base Study|Lost to Follow-up|2|||
44574895|NCT02629822|79597526|FG000|Base Study|Non-Compliance With Study Drug|1|||
44574896|NCT02629822|79597526|FG000|Extension Study|Adverse Event|1|||
44574897|NCT02629822|79597526|FG000|Extension Study|Lost to Follow-up|1|||
44574898|NCT03462706|79597535|FG000|Overall Study|Polyp was pedunculated|1|||
44574899|NCT03462706|79597536|FG001|Overall Study|Polyp was pedunculated|0|||
44574900|NCT03462706|79597537|FG002|Overall Study|Polyp was pedunculated|1|||
44574901|NCT03462706|79597538|FG003|Overall Study|Polyp was pedunculated|0|||
44574902|NCT03462706|79597535|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
44574903|NCT03462706|79597536|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
44574904|NCT03462706|79597537|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
44574905|NCT03462706|79597538|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
44574906|NCT02840253|79597548|FG000|Overall Study|Unsuccessful block|4|||
44574907|NCT02752074|79597554|FG000|Overall Study|Lost to Follow-up|1|||
44574908|NCT02752074|79597555|FG001|Overall Study|Lost to Follow-up|4|||
44574909|NCT02752074|79597554|FG000|Overall Study|Death|146|||
44574910|NCT02752074|79597555|FG001|Overall Study|Death|129|||
44574911|NCT02752074|79597554|FG000|Overall Study|Withdrawal by Subject|9|||
44574912|NCT02752074|79597555|FG001|Overall Study|Withdrawal by Subject|10|||
44574913|NCT02835495|79597563|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
44574914|NCT02835495|79597564|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
44574915|NCT02835495|79597563|FG000|Overall Study|Declined in-person follow-up visit|4|||
44574916|NCT02835495|79597564|FG001|Overall Study|Declined in-person follow-up visit|2|||
44574917|NCT02835339|79597574|FG000|Overall Study|Did not receive allocated intervention|13|||
44574918|NCT02835339|79597575|FG001|Overall Study|Did not receive allocated intervention|16|||
44574919|NCT02832063|79597583|FG000|Overall Study|Adverse Event|2|||
44574920|NCT02832063|79597584|FG001|Overall Study|Adverse Event|1|||
44574921|NCT02832063|79597583|FG000|Overall Study|Physician Decision|5|||
44574922|NCT02832063|79597584|FG001|Overall Study|Physician Decision|7|||
44574923|NCT02832063|79597583|FG000|Overall Study|Lost to Follow-up|15|||
44574924|NCT02832063|79597584|FG001|Overall Study|Lost to Follow-up|8|||
44238876|NCT03305848|79065635|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
44238877|NCT03305848|79065635|FG000|Overall Study|Physician Decision|2|||
44238878|NCT01563029|79065644|FG000|Overall Study|Adverse Event|1|||
44238879|NCT01563029|79065645|FG001|Overall Study|Adverse Event|0|||
44238880|NCT01563029|79065646|FG002|Overall Study|Adverse Event|1|||
44238881|NCT01563029|79065647|FG003|Overall Study|Adverse Event|2|||
44238882|NCT01563029|79065648|FG004|Overall Study|Adverse Event|1|||
44238883|NCT01563029|79065644|FG000|Overall Study|Lack of Efficacy|42|||
44238884|NCT01563029|79065645|FG001|Overall Study|Lack of Efficacy|16|||
44238885|NCT01563029|79065646|FG002|Overall Study|Lack of Efficacy|23|||
44238886|NCT01563029|79065647|FG003|Overall Study|Lack of Efficacy|21|||
44238887|NCT01563029|79065648|FG004|Overall Study|Lack of Efficacy|19|||
44238888|NCT01563029|79065644|FG000|Overall Study|Protocol Violation|1|||
44238889|NCT01563029|79065645|FG001|Overall Study|Protocol Violation|2|||
44238890|NCT01563029|79065646|FG002|Overall Study|Protocol Violation|3|||
44238891|NCT01563029|79065647|FG003|Overall Study|Protocol Violation|1|||
44238892|NCT01563029|79065648|FG004|Overall Study|Protocol Violation|3|||
44238893|NCT01563029|79065644|FG000|Overall Study|Protocol defined stopping criteria|1|||
44378192|NCT00785629|79383459|FG003|Overall Study|Withdrawal by Subject|2|||
44506483|NCT03314662|79511223|FG001|Overall Study|Death|0|||
44506484|NCT03314662|79511224|FG002|Overall Study|Death|0|||
44574925|NCT02832063|79597583|FG000|Overall Study|Withdrawal by Subject|10|||
44574926|NCT02832063|79597584|FG001|Overall Study|Withdrawal by Subject|21|||
44574927|NCT02832063|79597583|FG000|Overall Study|Other|2|||
44574928|NCT02832063|79597584|FG001|Overall Study|Other|1|||
44574929|NCT04412707|79597603|FG000|Cycle 1|Death|0|||
44574930|NCT04412707|79597604|FG001|Cycle 1|Death|3|||
44574931|NCT04412707|79597603|FG000|Cycle 1|Disease progression|1|||
44238894|NCT01563029|79065645|FG001|Overall Study|Protocol defined stopping criteria|0|||
44378193|NCT00916344|79383467|FG000|Overall Study|Death|2|||
44506485|NCT03271528|79511242|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
44506486|NCT03271528|79511243|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
44574932|NCT04412707|79597604|FG001|Cycle 1|Disease progression|2|||
44238895|NCT01563029|79065646|FG002|Overall Study|Protocol defined stopping criteria|0|||
44238896|NCT01563029|79065647|FG003|Overall Study|Protocol defined stopping criteria|0|||
44238897|NCT01563029|79065648|FG004|Overall Study|Protocol defined stopping criteria|0|||
44238898|NCT01563029|79065644|FG000|Overall Study|Lost to Follow-up|1|||
44574933|NCT04412707|79597603|FG000|Cycle 2|Death|0|||
44574934|NCT04412707|79597604|FG001|Cycle 2|Death|1|||
44574935|NCT04412707|79597603|FG000|Cycle 2|Disease progression|3|||
44574936|NCT04412707|79597604|FG001|Cycle 2|Disease progression|0|||
44574937|NCT04412707|79597603|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
44574938|NCT04412707|79597604|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
44574939|NCT04412707|79597603|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
44574940|NCT04412707|79597604|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
44574941|NCT04412707|79597603|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
44574942|NCT04412707|79597604|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
44574943|NCT04412707|79597603|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
44574944|NCT04412707|79597604|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
44574945|NCT01358721|79597623|FG000|Overall Study|Withdrawal by Subject|0|||
44574946|NCT01358721|79597624|FG001|Overall Study|Withdrawal by Subject|0|||
44574947|NCT01358721|79597625|FG002|Overall Study|Withdrawal by Subject|0|||
44574948|NCT01358721|79597626|FG003|Overall Study|Withdrawal by Subject|1|||
44574949|NCT01358721|79597623|FG000|Overall Study|Death|0|||
44506487|NCT03271528|79511242|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
44574950|NCT01358721|79597624|FG001|Overall Study|Death|2|||
44574951|NCT01358721|79597625|FG002|Overall Study|Death|0|||
44574952|NCT01358721|79597626|FG003|Overall Study|Death|0|||
44238899|NCT01563029|79065645|FG001|Overall Study|Lost to Follow-up|0|||
44238900|NCT01563029|79065646|FG002|Overall Study|Lost to Follow-up|1|||
44238901|NCT01563029|79065647|FG003|Overall Study|Lost to Follow-up|1|||
44506488|NCT03271528|79511243|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
44238902|NCT01563029|79065648|FG004|Overall Study|Lost to Follow-up|1|||
44238903|NCT01563029|79065644|FG000|Overall Study|Physician Decision|3|||
44238904|NCT01563029|79065645|FG001|Overall Study|Physician Decision|5|||
44238905|NCT01563029|79065646|FG002|Overall Study|Physician Decision|2|||
44238906|NCT01563029|79065647|FG003|Overall Study|Physician Decision|4|||
44506489|NCT03271528|79511242|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
44506490|NCT03271528|79511243|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
44506491|NCT03271528|79511242|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
44506492|NCT03271528|79511243|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
44506493|NCT03271528|79511242|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
44506494|NCT03271528|79511243|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
44506495|NCT03271528|79511242|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
44506496|NCT03271528|79511243|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
44506497|NCT03271528|79511242|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
44506498|NCT03271528|79511243|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
44506499|NCT03301714|79511252|FG000|Overall Study|Lost to Follow-up|10|||
44506500|NCT03301714|79511253|FG001|Overall Study|Lost to Follow-up|4|||
44506501|NCT03301714|79511254|FG002|Overall Study|Lost to Follow-up|4|||
44506502|NCT03301714|79511252|FG000|Overall Study|Did not receive allocated intervention|0|||
44506503|NCT03301714|79511253|FG001|Overall Study|Did not receive allocated intervention|2|||
44506504|NCT03301714|79511254|FG002|Overall Study|Did not receive allocated intervention|3|||
44506505|NCT03299686|79511267|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
44506506|NCT03299686|79511268|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
44506507|NCT03299686|79511267|FG000|Treatment Epoch|Physician Decision|1|||
44506508|NCT03299686|79511268|FG001|Treatment Epoch|Physician Decision|0|||
44506509|NCT03299686|79511267|FG000|Treatment Epoch|Adverse Event|8|||
44506510|NCT03299686|79511268|FG001|Treatment Epoch|Adverse Event|4|||
44506511|NCT03299686|79511267|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
44506512|NCT03299686|79511268|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
44506513|NCT03462758|79511276|FG000|Overall Study|Chose no or other method of contraception|20|||
44506514|NCT03462758|79511277|FG001|Overall Study|Chose no or other method of contraception|23|||
44506515|NCT03462758|79511276|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
44506516|NCT03462758|79511277|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
44506517|NCT03462758|79511276|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
44506518|NCT03462758|79511277|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
44506519|NCT03462758|79511276|FG000|Overall Study|Medical contraindication|2|||
44506520|NCT03462758|79511277|FG001|Overall Study|Medical contraindication|2|||
44574953|NCT01358721|79597623|FG000|Overall Study|Study Drug Toxicity|1|||
44574954|NCT01358721|79597624|FG001|Overall Study|Study Drug Toxicity|3|||
44574955|NCT01358721|79597625|FG002|Overall Study|Study Drug Toxicity|4|||
44574956|NCT01358721|79597626|FG003|Overall Study|Study Drug Toxicity|5|||
44506521|NCT03462758|79511276|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
44506522|NCT03462758|79511277|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
44506523|NCT00075270|79511285|FG000|Overall Study|Withdrawal by Subject|28|||
44506524|NCT00075270|79511286|FG001|Overall Study|Withdrawal by Subject|21|||
44506525|NCT00075270|79511285|FG000|Overall Study|Lost to Follow-up|25|||
44238907|NCT01563029|79065648|FG004|Overall Study|Physician Decision|2|||
44506526|NCT00075270|79511286|FG001|Overall Study|Lost to Follow-up|28|||
44506527|NCT00075270|79511285|FG000|Overall Study|Protocol Violation|0|||
44506528|NCT00075270|79511286|FG001|Overall Study|Protocol Violation|2|||
44378194|NCT00916344|79383467|FG000|Overall Study|ICD upgrade|1|||
44378195|NCT00916344|79383467|FG000|Overall Study|Drop-out|5|||
44378196|NCT00913770|79383474|FG000|Overall Study|Unable to contact|24|||
44378197|NCT00913770|79383475|FG001|Overall Study|Unable to contact|19|||
44238908|NCT01563029|79065644|FG000|Overall Study|Withdrawal by Subject|4|||
44238909|NCT01563029|79065645|FG001|Overall Study|Withdrawal by Subject|1|||
44238910|NCT01563029|79065646|FG002|Overall Study|Withdrawal by Subject|3|||
44238911|NCT01563029|79065647|FG003|Overall Study|Withdrawal by Subject|4|||
44238912|NCT01563029|79065648|FG004|Overall Study|Withdrawal by Subject|3|||
44238913|NCT01562873|79065661|FG000|Overall Study|Disease Progression per RECIST|10|||
44238914|NCT01562873|79065662|FG001|Overall Study|Disease Progression per RECIST|0|||
44238915|NCT01562873|79065661|FG000|Overall Study|Adverse Event|1|||
44238916|NCT01562873|79065662|FG001|Overall Study|Adverse Event|0|||
44275977|NCT00621192|79226318|FG000|Overall Study|Physician Decision|1|||
44378198|NCT00913770|79383476|FG002|Overall Study|Unable to contact|13|||
44506529|NCT00075270|79511285|FG000|Overall Study|Death|198|||
44506530|NCT00075270|79511286|FG001|Overall Study|Death|215|||
44506531|NCT00075270|79511285|FG000|Overall Study|Other/Unknown|9|||
44506532|NCT00075270|79511286|FG001|Overall Study|Other/Unknown|5|||
44506533|NCT00075270|79511285|FG000|Overall Study|Missing|26|||
44506534|NCT00075270|79511286|FG001|Overall Study|Missing|13|||
44506535|NCT00074958|79511293|FG000|Overall Study|Adverse Event|1|||
44506536|NCT02940574|79511299|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
44506537|NCT02940574|79511300|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
44506538|NCT02940574|79511299|FG000|1-year Follow-up|Lost to Follow-up|3|||
44506539|NCT02940574|79511300|FG001|1-year Follow-up|Lost to Follow-up|4|||
44506540|NCT03760250|79511319|FG000|Overall Study|Withdrawal by Subject|1|||
44506541|NCT03760250|79511319|FG000|Overall Study|Physician Decision|1|||
44506542|NCT03757988|79511323|FG000|Overall Study|Withdrawal by Subject|1|||
44275978|NCT00621192|79226319|FG001|Overall Study|Physician Decision|3|||
44574957|NCT01358721|79597623|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
44574958|NCT01358721|79597624|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
44574959|NCT01358721|79597625|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
44574960|NCT01358721|79597626|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
44574961|NCT01358721|79597623|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
44574962|NCT01358721|79597624|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
44574963|NCT01358721|79597625|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
44574964|NCT01358721|79597626|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
44574965|NCT01358721|79597623|FG000|Overall Study|Adverse Event related to study drug|1|||
44574966|NCT01358721|79597624|FG001|Overall Study|Adverse Event related to study drug|0|||
44275979|NCT00621192|79226320|FG002|Overall Study|Physician Decision|0|||
44275980|NCT00621192|79226321|FG003|Overall Study|Physician Decision|0|||
44275981|NCT00621192|79226318|FG000|Overall Study|Protocol Violation|1|||
44378199|NCT00913770|79383474|FG000|Overall Study|Refused|11|||
44378200|NCT00913770|79383475|FG001|Overall Study|Refused|10|||
44506543|NCT00313781|79511330|FG000|Before Crossover|Death|22|||
44506544|NCT00313781|79511331|FG001|Before Crossover|Death|8|||
44574967|NCT01358721|79597625|FG002|Overall Study|Adverse Event related to study drug|0|||
44574968|NCT01358721|79597626|FG003|Overall Study|Adverse Event related to study drug|1|||
44574969|NCT01358721|79597623|FG000|Overall Study|Disease Progression|19|||
44574970|NCT01358721|79597624|FG001|Overall Study|Disease Progression|15|||
44574971|NCT01358721|79597625|FG002|Overall Study|Disease Progression|17|||
44574972|NCT01358721|79597626|FG003|Overall Study|Disease Progression|15|||
44574973|NCT01358721|79597623|FG000|Overall Study|Out of State/Unmet Criteria|0|||
44574974|NCT01358721|79597624|FG001|Overall Study|Out of State/Unmet Criteria|0|||
44574975|NCT01358721|79597625|FG002|Overall Study|Out of State/Unmet Criteria|1|||
44574976|NCT01358721|79597626|FG003|Overall Study|Out of State/Unmet Criteria|0|||
44574977|NCT01341639|79597638|FG000|Infant Series|Protocol Violation|1|||
44378201|NCT00913770|79383476|FG002|Overall Study|Refused|8|||
44378202|NCT00780559|79383486|FG000|Overall Study|Lost to Follow-up|2|||
44574978|NCT01341639|79597639|FG001|Infant Series|Protocol Violation|0|||
44574979|NCT01341639|79597638|FG000|Infant Series|Not Vaccinated|0|||
44574980|NCT01341639|79597639|FG001|Infant Series|Not Vaccinated|1|||
44574981|NCT01341639|79597638|FG000|Infant Series|Adverse Event|0|||
44574982|NCT01341639|79597639|FG001|Infant Series|Adverse Event|5|||
44378203|NCT00780559|79383487|FG001|Overall Study|Lost to Follow-up|7|||
44506545|NCT00313781|79511332|FG002|Before Crossover|Death|0|||
44506546|NCT00313781|79511330|FG000|Before Crossover|Lost to Follow-up|0|||
44506547|NCT00313781|79511331|FG001|Before Crossover|Lost to Follow-up|3|||
44506548|NCT00313781|79511332|FG002|Before Crossover|Lost to Follow-up|0|||
44238917|NCT01562873|79065661|FG000|Overall Study|Clinical Disease Progression|9|||
44238918|NCT01562873|79065662|FG001|Overall Study|Clinical Disease Progression|0|||
44275982|NCT00621192|79226319|FG001|Overall Study|Protocol Violation|0|||
44378204|NCT00780559|79383486|FG000|Overall Study|Death|1|||
44574983|NCT01341639|79597638|FG000|Infant Series|Withdrawal by Subject|11|||
44574984|NCT01341639|79597639|FG001|Infant Series|Withdrawal by Subject|8|||
44574985|NCT01341639|79597638|FG000|Infant Series|Lost to Follow-up|0|||
44574986|NCT01341639|79597639|FG001|Infant Series|Lost to Follow-up|2|||
44574987|NCT01341639|79597638|FG000|Infant Series|Site 0048 Participants|17|||
44574988|NCT01341639|79597639|FG001|Infant Series|Site 0048 Participants|16|||
44574989|NCT01341639|79597638|FG000|Interim Period|Withdrawal by Subject|6|||
44574990|NCT01341639|79597639|FG001|Interim Period|Withdrawal by Subject|7|||
44574991|NCT01341639|79597638|FG000|Interim Period|Lost to Follow-up|2|||
44574992|NCT01341639|79597639|FG001|Interim Period|Lost to Follow-up|0|||
44574993|NCT01341639|79597638|FG000|Interim Period|Physician Decision|0|||
44574994|NCT01341639|79597639|FG001|Interim Period|Physician Decision|1|||
44574995|NCT01341639|79597638|FG000|Interim Period|Protocol Violation|0|||
44574996|NCT01341639|79597639|FG001|Interim Period|Protocol Violation|1|||
44574997|NCT01341639|79597638|FG000|Post-Treatment|Withdrawal by Subject|0|||
44574998|NCT01341639|79597639|FG001|Post-Treatment|Withdrawal by Subject|1|||
44574999|NCT01341639|79597638|FG000|Post-Treatment|Adverse Event|0|||
44575000|NCT01341639|79597639|FG001|Post-Treatment|Adverse Event|2|||
44575001|NCT02628028|79597653|FG000|Dosing Period|Withdrawal by Subject|0|||
44575002|NCT02628028|79597654|FG001|Dosing Period|Withdrawal by Subject|0|||
44575003|NCT02628028|79597655|FG002|Dosing Period|Withdrawal by Subject|1|||
44575004|NCT02628028|79597656|FG003|Dosing Period|Withdrawal by Subject|0|||
44575005|NCT02628028|79597657|FG004|Dosing Period|Withdrawal by Subject|2|||
44575006|NCT02628028|79597658|FG005|Dosing Period|Withdrawal by Subject|4|||
44575007|NCT02628028|79597659|FG006|Dosing Period|Withdrawal by Subject|1|||
44575008|NCT02628028|79597660|FG007|Dosing Period|Withdrawal by Subject|1|||
44575009|NCT02628028|79597653|FG000|Dosing Period|Adverse Event|0|||
44575010|NCT02628028|79597654|FG001|Dosing Period|Adverse Event|0|||
44575011|NCT02628028|79597655|FG002|Dosing Period|Adverse Event|0|||
44575012|NCT02628028|79597656|FG003|Dosing Period|Adverse Event|0|||
44575013|NCT02628028|79597657|FG004|Dosing Period|Adverse Event|2|||
44575014|NCT02628028|79597658|FG005|Dosing Period|Adverse Event|1|||
44575015|NCT02628028|79597659|FG006|Dosing Period|Adverse Event|3|||
44575016|NCT02628028|79597660|FG007|Dosing Period|Adverse Event|2|||
44575017|NCT02628028|79597653|FG000|Dosing Period|Death|0|||
44575018|NCT02628028|79597654|FG001|Dosing Period|Death|0|||
44575019|NCT02628028|79597655|FG002|Dosing Period|Death|0|||
44575020|NCT02628028|79597656|FG003|Dosing Period|Death|0|||
44575021|NCT02628028|79597657|FG004|Dosing Period|Death|0|||
44575022|NCT02628028|79597658|FG005|Dosing Period|Death|0|||
44575023|NCT02628028|79597659|FG006|Dosing Period|Death|0|||
44575024|NCT02628028|79597660|FG007|Dosing Period|Death|1|||
44575025|NCT02628028|79597653|FG000|Dosing Period|Lack of Efficacy|0|||
44575026|NCT02628028|79597654|FG001|Dosing Period|Lack of Efficacy|0|||
44575027|NCT02628028|79597655|FG002|Dosing Period|Lack of Efficacy|0|||
44575028|NCT02628028|79597656|FG003|Dosing Period|Lack of Efficacy|0|||
44575029|NCT02628028|79597657|FG004|Dosing Period|Lack of Efficacy|3|||
44575030|NCT02628028|79597658|FG005|Dosing Period|Lack of Efficacy|0|||
44575031|NCT02628028|79597659|FG006|Dosing Period|Lack of Efficacy|1|||
44575032|NCT02628028|79597660|FG007|Dosing Period|Lack of Efficacy|0|||
44575033|NCT02628028|79597653|FG000|Dosing Period|Study Terminated by Sponsor|0|||
44575034|NCT02628028|79597654|FG001|Dosing Period|Study Terminated by Sponsor|0|||
44575035|NCT02628028|79597655|FG002|Dosing Period|Study Terminated by Sponsor|0|||
44575036|NCT02628028|79597656|FG003|Dosing Period|Study Terminated by Sponsor|0|||
44575037|NCT02628028|79597657|FG004|Dosing Period|Study Terminated by Sponsor|7|||
44575038|NCT02628028|79597658|FG005|Dosing Period|Study Terminated by Sponsor|6|||
44575039|NCT02628028|79597659|FG006|Dosing Period|Study Terminated by Sponsor|7|||
44575040|NCT02628028|79597660|FG007|Dosing Period|Study Terminated by Sponsor|7|||
44575041|NCT02628028|79597653|FG000|Dosing Period|Physician Decision|0|||
44575042|NCT02628028|79597654|FG001|Dosing Period|Physician Decision|0|||
44575043|NCT02628028|79597655|FG002|Dosing Period|Physician Decision|0|||
44575044|NCT02628028|79597656|FG003|Dosing Period|Physician Decision|0|||
44238919|NCT01562873|79065661|FG000|Overall Study|Clinical PD and adverse event|1|||
44238920|NCT01562873|79065662|FG001|Overall Study|Clinical PD and adverse event|0|||
44575045|NCT02628028|79597657|FG004|Dosing Period|Physician Decision|0|||
44575046|NCT02628028|79597658|FG005|Dosing Period|Physician Decision|1|||
44575047|NCT02628028|79597659|FG006|Dosing Period|Physician Decision|0|||
44575048|NCT02628028|79597660|FG007|Dosing Period|Physician Decision|0|||
44575049|NCT02628028|79597653|FG000|Dosing Period|Site Terminated by Sponsor|0|||
44575050|NCT02628028|79597654|FG001|Dosing Period|Site Terminated by Sponsor|0|||
44575051|NCT02628028|79597655|FG002|Dosing Period|Site Terminated by Sponsor|0|||
44575052|NCT02628028|79597656|FG003|Dosing Period|Site Terminated by Sponsor|0|||
44575053|NCT02628028|79597657|FG004|Dosing Period|Site Terminated by Sponsor|0|||
44575054|NCT02628028|79597658|FG005|Dosing Period|Site Terminated by Sponsor|1|||
44575055|NCT02628028|79597659|FG006|Dosing Period|Site Terminated by Sponsor|1|||
44575056|NCT02628028|79597660|FG007|Dosing Period|Site Terminated by Sponsor|0|||
44575057|NCT02628028|79597653|FG000|Dosing Period|Lost to Follow-up|0|||
44575058|NCT02628028|79597654|FG001|Dosing Period|Lost to Follow-up|0|||
44575059|NCT02628028|79597655|FG002|Dosing Period|Lost to Follow-up|0|||
44575060|NCT02628028|79597656|FG003|Dosing Period|Lost to Follow-up|0|||
44506549|NCT00313781|79511330|FG000|Before Crossover|Withdrawal by Subject|3|||
44506550|NCT00313781|79511331|FG001|Before Crossover|Withdrawal by Subject|1|||
44506551|NCT00313781|79511332|FG002|Before Crossover|Withdrawal by Subject|0|||
44575061|NCT02628028|79597657|FG004|Dosing Period|Lost to Follow-up|0|||
44575062|NCT02628028|79597658|FG005|Dosing Period|Lost to Follow-up|0|||
44575063|NCT02628028|79597659|FG006|Dosing Period|Lost to Follow-up|1|||
44575064|NCT02628028|79597660|FG007|Dosing Period|Lost to Follow-up|0|||
44575065|NCT02628028|79597653|FG000|Dosing Period|Other|0|||
44575066|NCT02628028|79597654|FG001|Dosing Period|Other|0|||
44575067|NCT02628028|79597655|FG002|Dosing Period|Other|0|||
44575068|NCT02628028|79597656|FG003|Dosing Period|Other|0|||
44575069|NCT02628028|79597657|FG004|Dosing Period|Other|2|||
44238921|NCT03273712|79065666|FG000|Overall Study|Death|5|||
44238922|NCT03273712|79065666|FG000|Overall Study|Adverse Event|1|||
44238923|NCT03273712|79065666|FG000|Overall Study|Disease Progression|1|||
44238924|NCT01562327|79065671|FG000|Overall Study|Adverse Event|2|||
44238925|NCT01562327|79065671|FG000|Overall Study|Lack of Efficacy|1|||
44238926|NCT01562327|79065671|FG000|Overall Study|Participant drop-out|1|||
44378205|NCT00780559|79383487|FG001|Overall Study|Death|0|||
44506552|NCT00313781|79511330|FG000|Before Crossover|Other|45|||
44118045|NCT02541604|78901505|FG001|Overall Study|Medical condition may jeopardize safety|0|||
44118046|NCT02541604|78901506|FG002|Overall Study|Medical condition may jeopardize safety|0|||
44118047|NCT02541604|78901507|FG003|Overall Study|Medical condition may jeopardize safety|0|||
44118048|NCT02541604|78901508|FG004|Overall Study|Medical condition may jeopardize safety|0|||
44118049|NCT02541604|78901509|FG005|Overall Study|Medical condition may jeopardize safety|0|||
44118050|NCT02541604|78901510|FG006|Overall Study|Medical condition may jeopardize safety|0|||
44118051|NCT02541604|78901511|FG007|Overall Study|Medical condition may jeopardize safety|1|||
44118052|NCT02541604|78901512|FG008|Overall Study|Medical condition may jeopardize safety|0|||
44118053|NCT02541604|78901513|FG009|Overall Study|Medical condition may jeopardize safety|0|||
44118054|NCT02541604|78901514|FG010|Overall Study|Medical condition may jeopardize safety|0|||
44118055|NCT02541604|78901515|FG011|Overall Study|Medical condition may jeopardize safety|0|||
44506553|NCT00313781|79511331|FG001|Before Crossover|Other|30|||
44506554|NCT00313781|79511332|FG002|Before Crossover|Other|0|||
44506555|NCT00313781|79511330|FG000|Before Crossover|Crossover|0|||
44506556|NCT00313781|79511331|FG001|Before Crossover|Crossover|37|||
44506557|NCT00313781|79511332|FG002|Before Crossover|Crossover|0|||
44506558|NCT00313781|79511330|FG000|Before Crossover|Randomized, not treated|5|||
44506559|NCT00313781|79511331|FG001|Before Crossover|Randomized, not treated|0|||
44506560|NCT00313781|79511332|FG002|Before Crossover|Randomized, not treated|0|||
44506561|NCT00313781|79511330|FG000|After Crossover|Death|0|||
44506562|NCT00313781|79511331|FG001|After Crossover|Death|0|||
44506563|NCT00313781|79511332|FG002|After Crossover|Death|6|||
44506564|NCT00313781|79511330|FG000|After Crossover|Withdrawal by Subject|0|||
44506565|NCT00313781|79511331|FG001|After Crossover|Withdrawal by Subject|0|||
44575070|NCT02628028|79597658|FG005|Dosing Period|Other|1|||
44575071|NCT02628028|79597659|FG006|Dosing Period|Other|2|||
44506566|NCT00313781|79511332|FG002|After Crossover|Withdrawal by Subject|3|||
44506567|NCT00313781|79511330|FG000|After Crossover|Other|0|||
44506568|NCT00313781|79511331|FG001|After Crossover|Other|0|||
44506569|NCT00313781|79511332|FG002|After Crossover|Other|18|||
44575072|NCT02628028|79597660|FG007|Dosing Period|Other|4|||
44575073|NCT02628028|79597653|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
44575074|NCT02628028|79597654|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
44575075|NCT02628028|79597655|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
44575076|NCT02628028|79597656|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
44575077|NCT02628028|79597657|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
44575078|NCT02628028|79597658|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
44575079|NCT02628028|79597659|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
44118056|NCT02546674|78901564|FG000|Overall Study|Adverse Event|19|||
44118057|NCT02546674|78901564|FG000|Overall Study|Death|1|||
44118058|NCT02546674|78901564|FG000|Overall Study|Lost to Follow-up|1|||
44378206|NCT00912912|79383495|FG000|Overall Study|Withdrawal by Subject|1|||
44575080|NCT02628028|79597660|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
44575081|NCT02628028|79597653|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
44118059|NCT02546674|78901564|FG000|Overall Study|Physician Decision|13|||
44118060|NCT02546674|78901564|FG000|Overall Study|Pregnancy|1|||
44238927|NCT01562327|79065671|FG000|Overall Study|Infusion not received at 6 month window|4|||
44506570|NCT00368537|79511343|FG000|Randomization|No study drug dosed|13|||
44575082|NCT02628028|79597654|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
44238928|NCT01561313|79065678|FG000|Overall Study|Withdrawal by Subject|1|||
44378207|NCT00912912|79383495|FG000|Overall Study|Disease Progression|3|||
44506571|NCT00368537|79511344|FG001|Randomization|No study drug dosed|6|||
44506572|NCT00368537|79511343|FG000|Baseline Participants|Lost to Follow-up|16|||
44506573|NCT00368537|79511344|FG001|Baseline Participants|Lost to Follow-up|17|||
44575083|NCT02628028|79597655|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
44575084|NCT02628028|79597656|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
44575085|NCT02628028|79597657|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
44575086|NCT02628028|79597658|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
44575087|NCT02628028|79597659|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
44575088|NCT02628028|79597660|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
44575089|NCT02628028|79597653|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
44575090|NCT02628028|79597654|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
44575091|NCT02628028|79597655|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
44575092|NCT02628028|79597656|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
44575093|NCT02628028|79597657|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
44575094|NCT02628028|79597658|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
44575095|NCT02628028|79597659|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
44575096|NCT02628028|79597660|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
44575097|NCT02628028|79597653|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
44575098|NCT02628028|79597654|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
44575099|NCT02628028|79597655|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
44575100|NCT02628028|79597656|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
44575101|NCT02628028|79597657|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
44118061|NCT02546674|78901564|FG000|Overall Study|Progressive Disease|2|||
44118062|NCT02546674|78901564|FG000|Overall Study|Protocol Deviation|2|||
44238929|NCT01561313|79065679|FG001|Overall Study|Withdrawal by Subject|0|||
44238930|NCT01561313|79065678|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
44118063|NCT02546674|78901564|FG000|Overall Study|Subject/Guardian Decision|6|||
44118064|NCT02546674|78901564|FG000|Overall Study|Withdrawal of Informed Consent|3|||
44238931|NCT01561313|79065679|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
44238932|NCT01561079|79065685|FG000|Overall Study|Physician Decision|17|||
44238933|NCT01561079|79065685|FG000|Overall Study|Withdrawal by Subject|59|||
44506574|NCT00368537|79511343|FG000|Baseline Participants|Withdrawal by Subject|6|||
44238934|NCT01561079|79065685|FG000|Overall Study|Protocol Violation|2|||
44238935|NCT01559675|79065730|FG000|Overall Study|Protocol Violation|1|||
44238936|NCT01559675|79065731|FG001|Overall Study|Protocol Violation|2|||
44238937|NCT01559675|79065730|FG000|Overall Study|2nd operation on same patient excluded|14|||
44238938|NCT01559675|79065731|FG001|Overall Study|2nd operation on same patient excluded|12|||
44238939|NCT01374906|79065739|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44238940|NCT01374906|79065740|FG001|Overall Study|Abnormal laboratory value(s)|3|||
44275983|NCT00621192|79226320|FG002|Overall Study|Protocol Violation|0|||
44275984|NCT00621192|79226321|FG003|Overall Study|Protocol Violation|1|||
44275985|NCT00621192|79226318|FG000|Overall Study|Adverse Event|0|||
44275986|NCT00621192|79226319|FG001|Overall Study|Adverse Event|1|||
44275987|NCT00621192|79226320|FG002|Overall Study|Adverse Event|0|||
44275988|NCT00621192|79226321|FG003|Overall Study|Adverse Event|1|||
44275989|NCT00621192|79226318|FG000|Overall Study|Death|2|||
44506575|NCT00368537|79511344|FG001|Baseline Participants|Withdrawal by Subject|4|||
44506576|NCT00368537|79511343|FG000|Baseline Participants|Death|1|||
44275990|NCT00621192|79226319|FG001|Overall Study|Death|5|||
44275991|NCT00621192|79226320|FG002|Overall Study|Death|0|||
44275992|NCT00621192|79226321|FG003|Overall Study|Death|0|||
44275993|NCT00621192|79226318|FG000|Overall Study|Final Assessments not Completed|0|||
44275994|NCT00621192|79226319|FG001|Overall Study|Final Assessments not Completed|0|||
44275995|NCT00621192|79226320|FG002|Overall Study|Final Assessments not Completed|3|||
44275996|NCT00621192|79226321|FG003|Overall Study|Final Assessments not Completed|1|||
44506577|NCT00368537|79511344|FG001|Baseline Participants|Death|2|||
44275997|NCT00278200|79226333|FG000|Overall Study|Death|1|||
44275998|NCT00278200|79226334|FG001|Overall Study|Death|3|||
44275999|NCT00278200|79226333|FG000|Overall Study|Physician Decision|0|||
44506578|NCT00368537|79511343|FG000|Baseline Participants|No susceptibility|1|||
44506579|NCT00368537|79511344|FG001|Baseline Participants|No susceptibility|0|||
44506580|NCT00368537|79511343|FG000|Baseline Participants|Patient uncompliant|0|||
44276000|NCT00278200|79226334|FG001|Overall Study|Physician Decision|1|||
44276001|NCT00255346|79226345|FG000|Overall Study|Adverse Event|1|||
44276002|NCT00255346|79226346|FG001|Overall Study|Adverse Event|0|||
44506581|NCT00368537|79511344|FG001|Baseline Participants|Patient uncompliant|1|||
44506582|NCT00313703|79511354|FG000|Overall Study|Lost to Follow-up|11|||
44506583|NCT00313703|79511355|FG001|Overall Study|Lost to Follow-up|2|||
44506584|NCT00313703|79511356|FG002|Overall Study|Lost to Follow-up|5|||
44506585|NCT00313703|79511357|FG003|Overall Study|Lost to Follow-up|12|||
44506586|NCT00313313|79511370|FG000|Overall Study|Lack of Efficacy|14|||
44506587|NCT00313313|79511371|FG001|Overall Study|Lack of Efficacy|9|||
44506588|NCT00313313|79511372|FG002|Overall Study|Lack of Efficacy|20|||
44506589|NCT00313313|79511370|FG000|Overall Study|Withdrawal of consent by subject|18|||
44506590|NCT00313313|79511371|FG001|Overall Study|Withdrawal of consent by subject|17|||
44276003|NCT00255346|79226347|FG002|Overall Study|Adverse Event|0|||
44276004|NCT00255346|79226348|FG003|Overall Study|Adverse Event|0|||
44506591|NCT00313313|79511372|FG002|Overall Study|Withdrawal of consent by subject|31|||
44378208|NCT00889005|79383501|FG000|Overall Study|Lost to Follow-up|4|||
44506592|NCT00313313|79511370|FG000|Overall Study|Lost to Follow-up|10|||
44506593|NCT00313313|79511371|FG001|Overall Study|Lost to Follow-up|7|||
44506594|NCT00313313|79511372|FG002|Overall Study|Lost to Follow-up|9|||
44506595|NCT00313313|79511370|FG000|Overall Study|Adverse Event|15|||
44506596|NCT00313313|79511371|FG001|Overall Study|Adverse Event|16|||
44506597|NCT00313313|79511372|FG002|Overall Study|Adverse Event|12|||
44506598|NCT00313313|79511370|FG000|Overall Study|Physician Decision|2|||
44506599|NCT00313313|79511371|FG001|Overall Study|Physician Decision|6|||
44506600|NCT00313313|79511372|FG002|Overall Study|Physician Decision|4|||
44506601|NCT00313313|79511370|FG000|Overall Study|Poor/Noncompliance|3|||
44506602|NCT00313313|79511371|FG001|Overall Study|Poor/Noncompliance|6|||
44506603|NCT00313313|79511372|FG002|Overall Study|Poor/Noncompliance|2|||
44575102|NCT02628028|79597658|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
44575103|NCT02628028|79597659|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
44575104|NCT02628028|79597660|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
44575105|NCT02628028|79597653|FG000|Long-term Extension (LTE) Period|Other|0|||
44575106|NCT02628028|79597654|FG001|Long-term Extension (LTE) Period|Other|0|||
44575107|NCT02628028|79597655|FG002|Long-term Extension (LTE) Period|Other|0|||
44575108|NCT02628028|79597656|FG003|Long-term Extension (LTE) Period|Other|0|||
44118065|NCT02546362|78901569|FG000|4-week Treatment Period|Lost to Follow-up|1|||
44118066|NCT02546362|78901569|FG000|4-week Treatment Period|Change in medication|2|||
44118067|NCT02546362|78901569|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
44118068|NCT02546362|78901569|FG000|12-week Treatment Period|Lost to Follow-up|2|||
44118069|NCT02546362|78901569|FG000|12-week Treatment Period|Change in medication|1|||
44118070|NCT02698436|78901575|FG000|Overall Study|Adverse Event|1|||
44118071|NCT02698436|78901576|FG001|Overall Study|Adverse Event|0|||
44118072|NCT02698436|78901575|FG000|Overall Study|Withdrawal by Subject|3|||
44118073|NCT02698436|78901576|FG001|Overall Study|Withdrawal by Subject|3|||
44506604|NCT00313313|79511370|FG000|Overall Study|Pregnancy|1|||
44506605|NCT00313313|79511371|FG001|Overall Study|Pregnancy|2|||
44506606|NCT00313313|79511372|FG002|Overall Study|Pregnancy|0|||
44506607|NCT00313313|79511370|FG000|Overall Study|Death|0|||
44506608|NCT00313313|79511371|FG001|Overall Study|Death|0|||
44506609|NCT00313313|79511372|FG002|Overall Study|Death|2|||
44506610|NCT00313313|79511370|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
44506611|NCT00313313|79511371|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
44506612|NCT00313313|79511372|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
44506613|NCT00312845|79511382|FG000|Overall Study|Adverse Event|19|||
44506614|NCT00312845|79511383|FG001|Overall Study|Adverse Event|5|||
44506615|NCT00312845|79511382|FG000|Overall Study|Death|2|||
44506616|NCT00312845|79511383|FG001|Overall Study|Death|2|||
44506617|NCT00312845|79511382|FG000|Overall Study|Withdrawal by Subject|14|||
44506618|NCT00312845|79511383|FG001|Overall Study|Withdrawal by Subject|6|||
44506619|NCT00312845|79511382|FG000|Overall Study|Disease Progression|56|||
44506620|NCT00312845|79511383|FG001|Overall Study|Disease Progression|77|||
44506621|NCT00312845|79511382|FG000|Overall Study|Lost to Follow-up|2|||
44575109|NCT02628028|79597657|FG004|Long-term Extension (LTE) Period|Other|0|||
44118074|NCT02698436|78901575|FG000|Overall Study|Lost to Follow-up|2|||
44118075|NCT02698436|78901576|FG001|Overall Study|Lost to Follow-up|4|||
44118076|NCT02698436|78901575|FG000|Overall Study|Non-compliance with study regimen|1|||
44118077|NCT02698436|78901576|FG001|Overall Study|Non-compliance with study regimen|0|||
44238941|NCT01374906|79065739|FG000|Overall Study|Administrative problems|2|||
44238942|NCT01374906|79065740|FG001|Overall Study|Administrative problems|2|||
44238943|NCT01374906|79065739|FG000|Overall Study|Adverse Event|10|||
44238944|NCT01374906|79065740|FG001|Overall Study|Adverse Event|11|||
44238945|NCT01374906|79065739|FG000|Overall Study|Death|0|||
44238946|NCT01374906|79065740|FG001|Overall Study|Death|2|||
44238947|NCT01374906|79065739|FG000|Overall Study|Protocol Violation|2|||
44238948|NCT01374906|79065740|FG001|Overall Study|Protocol Violation|2|||
44238949|NCT01374906|79065739|FG000|Overall Study|Withdrawal by Subject|15|||
44238950|NCT01374906|79065740|FG001|Overall Study|Withdrawal by Subject|9|||
44238951|NCT01374906|79065739|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
44238952|NCT01374906|79065740|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
44238953|NCT02683746|79065770|FG000|Overall Study|Adverse Event|3|||
44238954|NCT02683746|79065771|FG001|Overall Study|Adverse Event|2|||
44238955|NCT02683746|79065770|FG000|Overall Study|Lost to Follow-up|5|||
44238956|NCT02683746|79065771|FG001|Overall Study|Lost to Follow-up|6|||
44238957|NCT02683746|79065770|FG000|Overall Study|Withdrawal by Subject|6|||
44238958|NCT02683746|79065771|FG001|Overall Study|Withdrawal by Subject|5|||
44118078|NCT02694536|78901582|FG000|Overall Study|Progressive Disease|40|||
44238959|NCT02683746|79065770|FG000|Overall Study|Physician Decision|2|||
44506622|NCT00312845|79511383|FG001|Overall Study|Lost to Follow-up|0|||
44118079|NCT02694536|78901582|FG000|Overall Study|Lost to Follow-up|1|||
44238960|NCT02683746|79065771|FG001|Overall Study|Physician Decision|1|||
44506623|NCT00312845|79511382|FG000|Overall Study|Other|6|||
44506624|NCT00312845|79511383|FG001|Overall Study|Other|5|||
44506625|NCT00368069|79511391|FG000|Overall Study|Adverse Event|5|||
44378209|NCT00889005|79383502|FG001|Overall Study|Lost to Follow-up|2|||
44378210|NCT00889005|79383501|FG000|Overall Study|Withdrawal by Subject|4|||
44378211|NCT00889005|79383502|FG001|Overall Study|Withdrawal by Subject|0|||
44378212|NCT00779857|79383508|FG000|Overall Study|Death|1|||
44378213|NCT00779857|79383508|FG000|Overall Study|Withdrawal by Subject|3|||
44378214|NCT00779857|79383508|FG000|Overall Study|Missed Visit|2|||
44378215|NCT00913692|79383512|FG000|Screening (4 Months)|Physician Decision|3|||
44378216|NCT00913692|79383512|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
44378217|NCT00913692|79383512|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
44378218|NCT00784927|79383519|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
44276005|NCT00255346|79226349|FG004|Overall Study|Adverse Event|0|||
44276006|NCT02222922|79228490|FG000|Overall Study|Death|0|||
44276007|NCT02222922|79228491|FG001|Overall Study|Death|0|||
44276008|NCT02222922|79228492|FG002|Overall Study|Death|0|||
44276009|NCT02222922|79228493|FG003|Overall Study|Death|0|||
44276010|NCT02222922|79228494|FG004|Overall Study|Death|13|||
44276011|NCT02222922|79228495|FG005|Overall Study|Death|0|||
44276012|NCT02222922|79228496|FG006|Overall Study|Death|0|||
44276013|NCT02222922|79228497|FG007|Overall Study|Death|0|||
44276014|NCT02222922|79228498|FG008|Overall Study|Death|2|||
44276015|NCT02222922|79228490|FG000|Overall Study|Lost to Follow-up|0|||
44276016|NCT02222922|79228491|FG001|Overall Study|Lost to Follow-up|0|||
44276017|NCT02222922|79228492|FG002|Overall Study|Lost to Follow-up|1|||
44276018|NCT02222922|79228493|FG003|Overall Study|Lost to Follow-up|0|||
44276019|NCT02222922|79228494|FG004|Overall Study|Lost to Follow-up|9|||
44276020|NCT02222922|79228495|FG005|Overall Study|Lost to Follow-up|1|||
44276021|NCT02222922|79228496|FG006|Overall Study|Lost to Follow-up|0|||
44276022|NCT02222922|79228497|FG007|Overall Study|Lost to Follow-up|0|||
44276023|NCT02222922|79228498|FG008|Overall Study|Lost to Follow-up|0|||
44276024|NCT02222922|79228490|FG000|Overall Study|Other|0|||
44378219|NCT00784927|79383519|FG000|Overall Study|Protocol Violation|1|||
44378220|NCT00784927|79383519|FG000|Overall Study|Ineligible|1|||
44378221|NCT00779779|79383524|FG000|Overall Study|Adverse Event|1|||
44378222|NCT00779779|79383524|FG000|Overall Study|Protocol Violation|14|||
44378223|NCT00779779|79383524|FG000|Overall Study|Withdrawal by Subject|4|||
44378224|NCT00779779|79383524|FG000|Overall Study|Lost to Follow-up|5|||
44378225|NCT00845728|79383530|FG000|Overall Study|Abnormal laboratory value (s)|2|||
44378226|NCT00845728|79383531|FG001|Overall Study|Abnormal laboratory value (s)|2|||
44506626|NCT00368069|79511392|FG001|Overall Study|Adverse Event|2|||
44506627|NCT00368069|79511391|FG000|Overall Study|Lack of Efficacy|0|||
44506628|NCT00368069|79511392|FG001|Overall Study|Lack of Efficacy|1|||
44506629|NCT00368069|79511391|FG000|Overall Study|Lost to Follow-up|1|||
44506630|NCT00368069|79511392|FG001|Overall Study|Lost to Follow-up|0|||
44506631|NCT00368069|79511391|FG000|Overall Study|Protocol Violation|0|||
44506632|NCT00368069|79511392|FG001|Overall Study|Protocol Violation|2|||
44506633|NCT00368069|79511391|FG000|Overall Study|Withdrawal of Consent|2|||
44506634|NCT00368069|79511392|FG001|Overall Study|Withdrawal of Consent|1|||
44506635|NCT00368069|79511391|FG000|Overall Study|no blood sampling possible|0|||
44506636|NCT00368069|79511392|FG001|Overall Study|no blood sampling possible|1|||
44506637|NCT00367991|79511400|FG000|Overall Study|Withdrawal by Subject|1|||
44506638|NCT00367991|79511401|FG001|Overall Study|Withdrawal by Subject|1|||
44506639|NCT00367991|79511400|FG000|Overall Study|Adverse Event|1|||
44506640|NCT00367991|79511401|FG001|Overall Study|Adverse Event|1|||
44506641|NCT00367835|79511409|FG000|Overall Study|Adverse Event|14|||
44506642|NCT00367835|79511410|FG001|Overall Study|Adverse Event|1|||
44506643|NCT00367835|79511409|FG000|Overall Study|Protocol Violation|1|||
44506644|NCT00367835|79511410|FG001|Overall Study|Protocol Violation|7|||
44276025|NCT02222922|79228491|FG001|Overall Study|Other|0|||
44276026|NCT02222922|79228492|FG002|Overall Study|Other|0|||
44506645|NCT00367835|79511409|FG000|Overall Study|Withdrawal by Subject|7|||
44506646|NCT00367835|79511410|FG001|Overall Study|Withdrawal by Subject|6|||
44506647|NCT00367835|79511409|FG000|Overall Study|Lost to Follow-up|1|||
44506648|NCT00367835|79511410|FG001|Overall Study|Lost to Follow-up|4|||
44506649|NCT00367835|79511409|FG000|Overall Study|Lack of Efficacy|3|||
44276027|NCT02222922|79228493|FG003|Overall Study|Other|2|||
44276028|NCT02222922|79228494|FG004|Overall Study|Other|10|||
44276029|NCT02222922|79228495|FG005|Overall Study|Other|2|||
44378227|NCT00845728|79383530|FG000|Overall Study|Patient's inability to use the device|4|||
44378228|NCT00845728|79383531|FG001|Overall Study|Patient's inability to use the device|6|||
44378229|NCT00845728|79383530|FG000|Overall Study|Abnormal test procedure result (s)|7|||
44506650|NCT00367835|79511410|FG001|Overall Study|Lack of Efficacy|12|||
44506651|NCT00367835|79511409|FG000|Overall Study|Subject in juvenile detention center|1|||
44506652|NCT00367835|79511410|FG001|Overall Study|Subject in juvenile detention center|0|||
44575110|NCT02628028|79597658|FG005|Long-term Extension (LTE) Period|Other|3|||
44575111|NCT02628028|79597659|FG006|Long-term Extension (LTE) Period|Other|4|||
44506653|NCT00367835|79511409|FG000|Overall Study|refused blood collection|1|||
44276030|NCT02222922|79228496|FG006|Overall Study|Other|2|||
44276031|NCT02222922|79228497|FG007|Overall Study|Other|4|||
44276032|NCT02222922|79228498|FG008|Overall Study|Other|1|||
44575112|NCT02628028|79597660|FG007|Long-term Extension (LTE) Period|Other|3|||
44575113|NCT03977701|79597692|FG000|Overall Study|COVID-19 pandemic|0|||
44575114|NCT03977701|79597693|FG001|Overall Study|COVID-19 pandemic|0|||
44575115|NCT03977701|79597694|FG002|Overall Study|COVID-19 pandemic|0|||
44575116|NCT03977701|79597695|FG003|Overall Study|COVID-19 pandemic|0|||
44575117|NCT03977701|79597696|FG004|Overall Study|COVID-19 pandemic|0|||
44575118|NCT03977701|79597697|FG005|Overall Study|COVID-19 pandemic|1|||
44575119|NCT03977701|79597698|FG006|Overall Study|COVID-19 pandemic|0|||
44575120|NCT03977701|79597699|FG007|Overall Study|COVID-19 pandemic|1|||
44575121|NCT03977701|79597700|FG008|Overall Study|COVID-19 pandemic|0|||
44575122|NCT03977701|79597701|FG009|Overall Study|COVID-19 pandemic|0|||
44575123|NCT02814526|79597740|FG000|Overall Study|Adverse Event|4|||
44575124|NCT02814526|79597741|FG001|Overall Study|Adverse Event|3|||
44575125|NCT02814526|79597740|FG000|Overall Study|Death|1|||
44575126|NCT02814526|79597741|FG001|Overall Study|Death|1|||
44575127|NCT02814526|79597740|FG000|Overall Study|Lost to Follow-up|3|||
44575128|NCT02814526|79597741|FG001|Overall Study|Lost to Follow-up|4|||
44575129|NCT02814526|79597740|FG000|Overall Study|non site physician decision|1|||
44575130|NCT02814526|79597741|FG001|Overall Study|non site physician decision|0|||
44575131|NCT02814526|79597740|FG000|Overall Study|participant noncompliance|1|||
44575132|NCT02814526|79597741|FG001|Overall Study|participant noncompliance|1|||
44575133|NCT02814526|79597740|FG000|Overall Study|Withdrawal by Subject|20|||
44575134|NCT02814526|79597741|FG001|Overall Study|Withdrawal by Subject|14|||
44575135|NCT02814526|79597740|FG000|Overall Study|safety risk|2|||
44575136|NCT02814526|79597741|FG001|Overall Study|safety risk|1|||
44575137|NCT02814526|79597740|FG000|Overall Study|early termination-study terminated|1|||
44575138|NCT02814526|79597741|FG001|Overall Study|early termination-study terminated|2|||
44575139|NCT02814526|79597740|FG000|Overall Study|Other|0|||
44575140|NCT02814526|79597741|FG001|Overall Study|Other|4|||
44575141|NCT02329834|79597749|FG000|Overall Study|Physician Decision|1|||
44575142|NCT02329834|79597750|FG001|Overall Study|Physician Decision|0|||
44575143|NCT01340937|79597761|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
44575144|NCT01340937|79597762|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
44276033|NCT02222922|79228490|FG000|Overall Study|Participant refused further follow-up|1|||
44378230|NCT00845728|79383531|FG001|Overall Study|Abnormal test procedure result (s)|2|||
44506654|NCT00367835|79511410|FG001|Overall Study|refused blood collection|0|||
44506655|NCT00367835|79511409|FG000|Overall Study|Did not respond to calls|1|||
44506656|NCT00367835|79511410|FG001|Overall Study|Did not respond to calls|0|||
44506657|NCT00367835|79511409|FG000|Overall Study|History of lead poisoning|0|||
44506658|NCT00367835|79511410|FG001|Overall Study|History of lead poisoning|1|||
44506659|NCT03267940|79511422|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
44506660|NCT03267940|79511423|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
44506661|NCT03267940|79511424|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
44506662|NCT03267940|79511425|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
44506663|NCT03267940|79511426|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
44506664|NCT03267940|79511427|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
44506665|NCT03267940|79511422|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
44506666|NCT03267940|79511423|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
44506667|NCT03267940|79511424|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
44506668|NCT03267940|79511425|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
44506669|NCT03267940|79511426|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
44506670|NCT03267940|79511427|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
44506671|NCT03267940|79511422|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
44506672|NCT03267940|79511423|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
44506673|NCT03267940|79511424|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
44506674|NCT03267940|79511425|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
44506675|NCT03267940|79511426|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
44506676|NCT03267940|79511427|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
44506677|NCT03267940|79511422|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
44506678|NCT03267940|79511423|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
44506679|NCT03267940|79511424|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
44506680|NCT03267940|79511425|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
44575145|NCT01340937|79597763|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
44575146|NCT01340937|79597764|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
44575147|NCT01340937|79597761|FG000|Period 1: Infant Series|Adverse Event|0|||
44575148|NCT01340937|79597762|FG001|Period 1: Infant Series|Adverse Event|1|||
44575149|NCT01340937|79597763|FG002|Period 1: Infant Series|Adverse Event|4|||
44575150|NCT01340937|79597764|FG003|Period 1: Infant Series|Adverse Event|0|||
44575151|NCT01340937|79597761|FG000|Period 1: Infant Series|Death|2|||
44575152|NCT01340937|79597762|FG001|Period 1: Infant Series|Death|0|||
44575153|NCT01340937|79597763|FG002|Period 1: Infant Series|Death|2|||
44575154|NCT01340937|79597764|FG003|Period 1: Infant Series|Death|0|||
44506681|NCT03267940|79511426|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
44506682|NCT03267940|79511427|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
44506683|NCT03267940|79511422|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
44506684|NCT03267940|79511423|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
44506685|NCT03267940|79511424|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
44506686|NCT03267940|79511425|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
44506687|NCT03267940|79511426|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
44506688|NCT03267940|79511427|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
44506689|NCT03267940|79511422|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
44506690|NCT03267940|79511423|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
44506691|NCT03267940|79511424|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
44506692|NCT03267940|79511425|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
44506693|NCT03267940|79511426|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
44506694|NCT03267940|79511427|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
44575155|NCT01340937|79597761|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
44575156|NCT01340937|79597762|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
44575157|NCT01340937|79597763|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
44575158|NCT01340937|79597764|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
44506695|NCT03267940|79511422|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
44506696|NCT03267940|79511423|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
44506697|NCT03267940|79511424|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
44506698|NCT03267940|79511425|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
44506699|NCT03267940|79511426|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
44506700|NCT03267940|79511427|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
44506701|NCT03267940|79511422|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
44506702|NCT03267940|79511423|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
44506703|NCT03267940|79511424|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
44506704|NCT03267940|79511425|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
44506705|NCT03267940|79511426|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
44506706|NCT03267940|79511427|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
44575159|NCT01340937|79597761|FG000|Period 1: Infant Series|Physician Decision|2|||
44575160|NCT01340937|79597762|FG001|Period 1: Infant Series|Physician Decision|3|||
44118080|NCT02694536|78901582|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
44118081|NCT02694536|78901582|FG000|Overall Study|Withdrawal by Subject|8|||
44118082|NCT02694536|78901582|FG000|Overall Study|Death|8|||
44118083|NCT02694536|78901582|FG000|Overall Study|Other|22|||
44118084|NCT01661686|78901588|FG000|Overall Study|Lost to Follow-up|2|||
44118085|NCT01661686|78901589|FG001|Overall Study|Lost to Follow-up|1|||
44118086|NCT01661686|78901588|FG000|Overall Study|did not receive allocated intervention|0|||
44118087|NCT01661686|78901589|FG001|Overall Study|did not receive allocated intervention|1|||
44118088|NCT02696096|78901595|FG000|Overall Study|ruled out at screening|1|||
44118089|NCT02696096|78901595|FG000|Overall Study|did not attend second fMRI|1|||
44118090|NCT02693834|78901603|FG000|Baseline Measurement|Withdrawal by Subject|1|||
44118091|NCT02693834|78901604|FG001|Baseline Measurement|Withdrawal by Subject|0|||
44118092|NCT02693834|78901603|FG000|Baseline Measurement|Adverse Event|1|||
44118093|NCT02693834|78901604|FG001|Baseline Measurement|Adverse Event|0|||
44575161|NCT01340937|79597763|FG002|Period 1: Infant Series|Physician Decision|1|||
44575162|NCT01340937|79597764|FG003|Period 1: Infant Series|Physician Decision|0|||
44575163|NCT01340937|79597761|FG000|Period 1: Infant Series|Protocol Violation|1|||
44575164|NCT01340937|79597762|FG001|Period 1: Infant Series|Protocol Violation|4|||
44575165|NCT01340937|79597763|FG002|Period 1: Infant Series|Protocol Violation|4|||
44575166|NCT01340937|79597764|FG003|Period 1: Infant Series|Protocol Violation|3|||
44575167|NCT01340937|79597761|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
44575168|NCT01340937|79597762|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
44575169|NCT01340937|79597763|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
44575170|NCT01340937|79597764|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
44575171|NCT01340937|79597761|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
44575172|NCT01340937|79597762|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
44575173|NCT01340937|79597763|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
44575174|NCT01340937|79597764|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
44378231|NCT00845728|79383530|FG000|Overall Study|Lost to Follow-up|22|||
44506707|NCT03267940|79511422|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
44506708|NCT03267940|79511423|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
44575175|NCT01340937|79597761|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
44118094|NCT02693834|78901603|FG000|Week 2 Practice|Adverse Event|0|||
44118095|NCT02693834|78901604|FG001|Week 2 Practice|Adverse Event|1|||
44118096|NCT02545504|78901612|FG000|Overall Study|Death|174|||
44378232|NCT00845728|79383531|FG001|Overall Study|Lost to Follow-up|13|||
44575176|NCT01340937|79597762|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
44575177|NCT01340937|79597763|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
44575178|NCT01340937|79597764|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
44575179|NCT01340937|79597761|FG000|Period 2: Interim Period|Adverse Event|1|||
44575180|NCT01340937|79597762|FG001|Period 2: Interim Period|Adverse Event|0|||
44575181|NCT01340937|79597763|FG002|Period 2: Interim Period|Adverse Event|1|||
44378233|NCT00845728|79383530|FG000|Overall Study|Death|24|||
44378234|NCT00845728|79383531|FG001|Overall Study|Death|26|||
44378235|NCT00845728|79383530|FG000|Overall Study|Administrative Problems|34|||
44378236|NCT00845728|79383531|FG001|Overall Study|Administrative Problems|26|||
44378237|NCT00845728|79383530|FG000|Overall Study|Protocol Violation|36|||
44378238|NCT00845728|79383531|FG001|Overall Study|Protocol Violation|24|||
44238961|NCT02691468|79065779|FG000|Overall Study|Bronchial blocker use|2|||
44575182|NCT01340937|79597764|FG003|Period 2: Interim Period|Adverse Event|0|||
44575183|NCT01340937|79597761|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
44575184|NCT01340937|79597762|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
44575185|NCT01340937|79597763|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
44575186|NCT01340937|79597764|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
44575187|NCT01340937|79597761|FG000|Period 2: Interim Period|Physician Decision|0|||
44575188|NCT01340937|79597762|FG001|Period 2: Interim Period|Physician Decision|1|||
44575189|NCT01340937|79597763|FG002|Period 2: Interim Period|Physician Decision|1|||
44575190|NCT01340937|79597764|FG003|Period 2: Interim Period|Physician Decision|0|||
44575191|NCT01340937|79597761|FG000|Period 2: Interim Period|Protocol Violation|5|||
44575192|NCT01340937|79597762|FG001|Period 2: Interim Period|Protocol Violation|3|||
44575193|NCT01340937|79597763|FG002|Period 2: Interim Period|Protocol Violation|6|||
44575194|NCT01340937|79597764|FG003|Period 2: Interim Period|Protocol Violation|3|||
44575195|NCT01340937|79597761|FG000|Period 2: Interim Period|Technical problems|4|||
44575196|NCT01340937|79597762|FG001|Period 2: Interim Period|Technical problems|4|||
44575197|NCT01340937|79597763|FG002|Period 2: Interim Period|Technical problems|6|||
44575198|NCT01340937|79597764|FG003|Period 2: Interim Period|Technical problems|3|||
44575199|NCT01340937|79597761|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
44575200|NCT01340937|79597762|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
44575201|NCT01340937|79597763|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
44575202|NCT01340937|79597764|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
44575203|NCT01340937|79597761|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
44575204|NCT01340937|79597762|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
44575205|NCT01340937|79597763|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
44575206|NCT01340937|79597764|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
44575207|NCT01340937|79597761|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
44575208|NCT01340937|79597762|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
44575209|NCT01340937|79597763|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
44575210|NCT01340937|79597764|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
44575211|NCT01340937|79597761|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
44575212|NCT01340937|79597762|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
44575213|NCT01340937|79597763|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
44575214|NCT01340937|79597764|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
44575215|NCT03028129|79597782|FG000|Overall Study|Adverse Event|13|||
44575216|NCT03028129|79597783|FG001|Overall Study|Adverse Event|2|||
44575217|NCT03028129|79597782|FG000|Overall Study|Lost to Follow-up|50|||
44575218|NCT03028129|79597783|FG001|Overall Study|Lost to Follow-up|38|||
44575219|NCT03028129|79597782|FG000|Overall Study|Physician Decision|0|||
44575220|NCT03028129|79597783|FG001|Overall Study|Physician Decision|1|||
44575221|NCT03028129|79597782|FG000|Overall Study|Protocol Violation|1|||
44575222|NCT03028129|79597783|FG001|Overall Study|Protocol Violation|1|||
44575223|NCT03028129|79597782|FG000|Overall Study|Withdrawal by Subject|62|||
44575224|NCT03028129|79597783|FG001|Overall Study|Withdrawal by Subject|45|||
44575225|NCT03026257|79597795|FG000|Overall Study|Adverse Event|3|||
44575226|NCT03026257|79597796|FG001|Overall Study|Adverse Event|0|||
44575227|NCT03026257|79597797|FG002|Overall Study|Adverse Event|0|||
44575228|NCT03026257|79597798|FG003|Overall Study|Adverse Event|0|||
44575229|NCT03026257|79597799|FG004|Overall Study|Adverse Event|0|||
44575230|NCT03026257|79597800|FG005|Overall Study|Adverse Event|0|||
44575231|NCT03026257|79597795|FG000|Overall Study|Lost to Follow-up|1|||
44378239|NCT00845728|79383530|FG000|Overall Study|Lack of Efficacy|51|||
44378240|NCT00845728|79383531|FG001|Overall Study|Lack of Efficacy|39|||
44575232|NCT03026257|79597796|FG001|Overall Study|Lost to Follow-up|0|||
44575233|NCT03026257|79597797|FG002|Overall Study|Lost to Follow-up|0|||
44575234|NCT03026257|79597798|FG003|Overall Study|Lost to Follow-up|0|||
44575235|NCT03026257|79597799|FG004|Overall Study|Lost to Follow-up|0|||
44575236|NCT03026257|79597800|FG005|Overall Study|Lost to Follow-up|0|||
44575237|NCT03026257|79597795|FG000|Overall Study|Protocol Violation|1|||
44575238|NCT03026257|79597796|FG001|Overall Study|Protocol Violation|0|||
44575239|NCT03026257|79597797|FG002|Overall Study|Protocol Violation|0|||
44575240|NCT03026257|79597798|FG003|Overall Study|Protocol Violation|1|||
44575241|NCT03026257|79597799|FG004|Overall Study|Protocol Violation|1|||
44575242|NCT03026257|79597800|FG005|Overall Study|Protocol Violation|0|||
44575243|NCT03026257|79597795|FG000|Overall Study|Withdrawal by Subject|1|||
44575244|NCT03026257|79597796|FG001|Overall Study|Withdrawal by Subject|1|||
44575245|NCT03026257|79597797|FG002|Overall Study|Withdrawal by Subject|0|||
44575246|NCT03026257|79597798|FG003|Overall Study|Withdrawal by Subject|0|||
44575247|NCT03026257|79597799|FG004|Overall Study|Withdrawal by Subject|0|||
44378241|NCT00845728|79383530|FG000|Overall Study|Adverse Event|101|||
44378242|NCT00845728|79383531|FG001|Overall Study|Adverse Event|96|||
44378243|NCT00845728|79383530|FG000|Overall Study|Withdrawal by Subject|105|||
44378244|NCT00845728|79383531|FG001|Overall Study|Withdrawal by Subject|108|||
44506709|NCT03267940|79511424|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
44506710|NCT03267940|79511425|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
44118097|NCT02545504|78901613|FG001|Overall Study|Death|168|||
44118098|NCT02545504|78901612|FG000|Overall Study|Unknown reason|30|||
44118099|NCT02545504|78901613|FG001|Overall Study|Unknown reason|32|||
44118100|NCT02545504|78901612|FG000|Overall Study|Withdrew consent|9|||
44118101|NCT02545504|78901613|FG001|Overall Study|Withdrew consent|11|||
44118102|NCT02545504|78901612|FG000|Overall Study|Investigator's discretion|3|||
44118103|NCT02545504|78901613|FG001|Overall Study|Investigator's discretion|1|||
44118104|NCT02545504|78901612|FG000|Overall Study|Lost to Follow-up|2|||
44118105|NCT02545504|78901613|FG001|Overall Study|Lost to Follow-up|2|||
44118106|NCT02545270|78901626|FG000|Overall Study|technical difficulties|0|||
44118107|NCT02545270|78901627|FG001|Overall Study|technical difficulties|1|||
44118108|NCT02545270|78901628|FG002|Overall Study|technical difficulties|0|||
44118109|NCT02545270|78901626|FG000|Overall Study|Videos being too similar to other|0|||
44118110|NCT02545270|78901627|FG001|Overall Study|Videos being too similar to other|0|||
44118111|NCT02545270|78901628|FG002|Overall Study|Videos being too similar to other|2|||
44118112|NCT02540668|78901637|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
44118113|NCT02540668|78901638|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
44118114|NCT02535364|78901662|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
44118115|NCT02535364|78901662|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
44118116|NCT02535364|78901662|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
44118117|NCT02535364|78901662|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
44118118|NCT02535364|78901662|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
44118119|NCT02535364|78901662|FG000|Part B Screening|Death|2|||
44118120|NCT02535364|78901662|FG000|Part B Screening|Physician Decision|1|||
44118121|NCT02535364|78901662|FG000|Part B Screening|Withdrawal by Subject|1|||
44118122|NCT02535364|78901662|FG000|Part B Screening|Adverse Event|1|||
44118123|NCT02535364|78901662|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
44118124|NCT02535364|78901662|FG000|Study Treatment|Death|1|||
44118125|NCT02535364|78901662|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
44118126|NCT02535364|78901662|FG000|12-Month Follow-up Period|Disease progression|22|||
44118127|NCT02535364|78901662|FG000|12-Month Follow-up Period|Death|5|||
44118128|NCT02535364|78901662|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
44118129|NCT02535364|78901662|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
44118130|NCT02535364|78901662|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
44506711|NCT03267940|79511426|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
44506712|NCT03267940|79511427|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
44506713|NCT03296566|79511447|FG000|Overall Study|Lost to Follow-up|19|||
44506714|NCT03296566|79511448|FG001|Overall Study|Lost to Follow-up|46|||
44506715|NCT03296566|79511447|FG000|Overall Study|Withdrawal by Subject|0|||
44506716|NCT03296566|79511448|FG001|Overall Study|Withdrawal by Subject|3|||
44506717|NCT03755882|79511458|FG000|Period 1|Protocol Violation|1|||
44506718|NCT03755882|79511459|FG001|Period 1|Protocol Violation|0|||
44506719|NCT03755882|79511458|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
44506720|NCT03755882|79511459|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
44506721|NCT00312377|79511467|FG000|Overall Study|Death|403|||
44506722|NCT00312377|79511468|FG001|Overall Study|Death|418|||
44506723|NCT00312377|79511467|FG000|Overall Study|Withdrawal by Subject|23|||
44575248|NCT03026257|79597800|FG005|Overall Study|Withdrawal by Subject|0|||
44575249|NCT01670188|79597816|FG000|Overall Study|Death|0|||
44575250|NCT01670188|79597817|FG001|Overall Study|Death|1|||
44575251|NCT01933048|79597825|FG000|Overall Study|Lost to Follow-up|15|||
44575252|NCT01933048|79597826|FG001|Overall Study|Lost to Follow-up|18|||
44575253|NCT01933048|79597825|FG000|Overall Study|personal reasons|1|||
44118131|NCT02540356|78901668|FG000|Overall Study|Terminated due to disease progression|1|||
44118132|NCT02540356|78901669|FG001|Overall Study|Terminated due to disease progression|0|||
44378245|NCT00779467|79383541|FG000|Overall Study|Lack of Efficacy|11|||
44378246|NCT00779467|79383542|FG001|Overall Study|Lack of Efficacy|2|||
44118133|NCT02534896|78901677|FG000|Overall Study|Adverse Event|2|||
44378247|NCT00779467|79383543|FG002|Overall Study|Lack of Efficacy|6|||
44378248|NCT00779467|79383544|FG003|Overall Study|Lack of Efficacy|11|||
44506724|NCT00312377|79511468|FG001|Overall Study|Withdrawal by Subject|30|||
44575254|NCT01933048|79597826|FG001|Overall Study|personal reasons|1|||
44575255|NCT01933048|79597825|FG000|Overall Study|Protocol Violation|7|||
44575256|NCT01933048|79597826|FG001|Overall Study|Protocol Violation|8|||
44575257|NCT01933048|79597825|FG000|Overall Study|Physician Decision|1|||
44575258|NCT01933048|79597826|FG001|Overall Study|Physician Decision|0|||
44575259|NCT01933048|79597825|FG000|Overall Study|unknown reasons|1|||
44118134|NCT02534896|78901678|FG001|Overall Study|Adverse Event|1|||
44118135|NCT02534896|78901679|FG002|Overall Study|Adverse Event|1|||
44118136|NCT02534896|78901677|FG000|Overall Study|Insufficient therapeutic response|2|||
44118137|NCT02534896|78901678|FG001|Overall Study|Insufficient therapeutic response|0|||
44575260|NCT01933048|79597826|FG001|Overall Study|unknown reasons|1|||
44575261|NCT02751450|79597837|FG000|Overall Study|Adverse Event|1|||
44575262|NCT02751450|79597838|FG001|Overall Study|Adverse Event|0|||
44506725|NCT00312377|79511467|FG000|Overall Study|Lost to Follow-up|9|||
44506726|NCT00312377|79511468|FG001|Overall Study|Lost to Follow-up|12|||
44506727|NCT00312377|79511467|FG000|Overall Study|Non-compliance|0|||
44506728|NCT00312377|79511468|FG001|Overall Study|Non-compliance|2|||
44506729|NCT00312377|79511467|FG000|Overall Study|Randomised but never received treatment|6|||
44506730|NCT00312377|79511468|FG001|Overall Study|Randomised but never received treatment|6|||
44506731|NCT00312377|79511467|FG000|Overall Study|Discontinue treatment survival follow up|202|||
44506732|NCT00312377|79511468|FG001|Overall Study|Discontinue treatment survival follow up|200|||
44506733|NCT00312377|79511467|FG000|Overall Study|Site ended participation in study|1|||
44506734|NCT00312377|79511468|FG001|Overall Study|Site ended participation in study|0|||
44506735|NCT03295318|79511477|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
44506736|NCT03295318|79511478|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
44506737|NCT03295318|79511479|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
44506738|NCT03295318|79511477|FG000|Overall Study|Death|1|||
44506739|NCT03295318|79511478|FG001|Overall Study|Death|1|||
44575263|NCT01358175|79597849|FG000|Overall Study|Death|1|||
44575264|NCT01358175|79597850|FG001|Overall Study|Death|0|||
44575265|NCT01358175|79597851|FG002|Overall Study|Death|1|||
44575266|NCT01358175|79597849|FG000|Overall Study|Withdrawal by Subject|9|||
44575267|NCT01358175|79597850|FG001|Overall Study|Withdrawal by Subject|5|||
44575268|NCT01358175|79597851|FG002|Overall Study|Withdrawal by Subject|10|||
44575269|NCT01358175|79597849|FG000|Overall Study|Technical issues|0|||
44575270|NCT01358175|79597850|FG001|Overall Study|Technical issues|1|||
44575271|NCT01358175|79597851|FG002|Overall Study|Technical issues|0|||
44575272|NCT01358175|79597849|FG000|Overall Study|Pregnancy|0|||
44575273|NCT01358175|79597850|FG001|Overall Study|Pregnancy|1|||
44575274|NCT01358175|79597851|FG002|Overall Study|Pregnancy|0|||
44575275|NCT01358175|79597849|FG000|Overall Study|Physician Decision|1|||
44575276|NCT01358175|79597850|FG001|Overall Study|Physician Decision|0|||
44575277|NCT01358175|79597851|FG002|Overall Study|Physician Decision|0|||
44575278|NCT01358175|79597849|FG000|Overall Study|Non Compliance with Study Treatment|0|||
44575279|NCT01358175|79597850|FG001|Overall Study|Non Compliance with Study Treatment|1|||
44575280|NCT01358175|79597851|FG002|Overall Study|Non Compliance with Study Treatment|1|||
44575281|NCT01358175|79597849|FG000|Overall Study|Lost to Follow-up|1|||
44575282|NCT01358175|79597850|FG001|Overall Study|Lost to Follow-up|1|||
44575283|NCT01358175|79597851|FG002|Overall Study|Lost to Follow-up|3|||
44575284|NCT01358175|79597849|FG000|Overall Study|Lack of Efficacy|3|||
44575285|NCT01358175|79597850|FG001|Overall Study|Lack of Efficacy|8|||
44575286|NCT01358175|79597851|FG002|Overall Study|Lack of Efficacy|6|||
44575287|NCT01358175|79597849|FG000|Overall Study|Adverse Event|6|||
44575288|NCT01358175|79597850|FG001|Overall Study|Adverse Event|11|||
44575289|NCT01358175|79597851|FG002|Overall Study|Adverse Event|11|||
44575290|NCT04116229|79597865|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
44575291|NCT04116229|79597866|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
44575292|NCT04116229|79597865|FG000|Overall Study|Scheduling not possible.|0|||
44575293|NCT04116229|79597866|FG001|Overall Study|Scheduling not possible.|1|||
44575294|NCT02210832|79597875|FG000|Overall Study|Pregnancy termination .|3|||
44575295|NCT02210832|79597876|FG001|Overall Study|Pregnancy termination .|4|||
44575296|NCT02210832|79597877|FG002|Overall Study|Pregnancy termination .|1|||
44575297|NCT02210832|79597875|FG000|Overall Study|Lost to Follow-up|26|||
44575298|NCT02210832|79597876|FG001|Overall Study|Lost to Follow-up|32|||
44575299|NCT02210832|79597877|FG002|Overall Study|Lost to Follow-up|17|||
44575300|NCT02833077|79597890|FG000|Overall Study|Adverse Event|1|||
44575301|NCT02833077|79597891|FG001|Overall Study|Adverse Event|2|||
44118138|NCT02534896|78901679|FG002|Overall Study|Insufficient therapeutic response|0|||
44276034|NCT02222922|79228491|FG001|Overall Study|Participant refused further follow-up|0|||
44276035|NCT02222922|79228492|FG002|Overall Study|Participant refused further follow-up|0|||
44506740|NCT03295318|79511479|FG002|Overall Study|Death|1|||
44506741|NCT03295318|79511477|FG000|Overall Study|Protocol Violation|4|||
44506742|NCT03295318|79511478|FG001|Overall Study|Protocol Violation|3|||
44506743|NCT03295318|79511479|FG002|Overall Study|Protocol Violation|3|||
44575302|NCT02833077|79597890|FG000|Overall Study|Lost to Follow-up|10|||
44575303|NCT02833077|79597891|FG001|Overall Study|Lost to Follow-up|1|||
44575304|NCT02833077|79597890|FG000|Overall Study|Personal Reasons|6|||
44575305|NCT02833077|79597891|FG001|Overall Study|Personal Reasons|4|||
44575306|NCT02833077|79597890|FG000|Overall Study|Protocol Deviation|0|||
44575307|NCT02833077|79597891|FG001|Overall Study|Protocol Deviation|1|||
44575308|NCT01355679|79597898|FG000|Overall Study|benign tumor types found at biopsy|2|||
44575309|NCT02832375|79597905|FG000|Overall Study|Lost to Follow-up|1|||
44575310|NCT02832375|79597906|FG001|Overall Study|Lost to Follow-up|0|||
44575311|NCT02832375|79597905|FG000|Overall Study|Withdrawal of Consent|1|||
44575312|NCT02832375|79597906|FG001|Overall Study|Withdrawal of Consent|0|||
44575313|NCT02925403|79597915|FG000|Overall Study|Lost to Follow-up|0|||
44575314|NCT02925403|79597916|FG001|Overall Study|Lost to Follow-up|1|||
44575315|NCT02626780|79597922|FG000|Overall Study|Withdrawal by Subject|3|||
44575316|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
44575317|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
44575318|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
44575319|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
44575320|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
44575321|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
44575322|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
44575323|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
44575324|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
44575325|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
44575326|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
44575327|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
44575328|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
44575329|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
44575330|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
44575331|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
44575332|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
44575333|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
44575334|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
44575335|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
44575336|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
44575337|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
44575338|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
44575339|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
44575340|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
44575341|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
44575342|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
44575343|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
44575344|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
44575345|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
44575346|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
44575347|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
44575348|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
44575349|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
44575350|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
44575351|NCT02831673|79597937|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
44575352|NCT02831673|79597938|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
44575353|NCT02831673|79597939|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
44575354|NCT02831673|79597940|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
44575355|NCT02831673|79597941|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
44575356|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
44118139|NCT02697734|78901689|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
44118140|NCT02697734|78901690|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
44118141|NCT02697734|78901689|FG000|Core Phase - up to Week 48|Adverse Event|1|||
44118142|NCT02697734|78901690|FG001|Core Phase - up to Week 48|Adverse Event|2|||
44118143|NCT02697734|78901689|FG000|Core Phase - up to Week 48|Physician Decision|1|||
44118144|NCT02697734|78901690|FG001|Core Phase - up to Week 48|Physician Decision|0|||
44118145|NCT02697734|78901689|FG000|Optional Extension Phase|Adverse Event|5|||
44506744|NCT03295318|79511477|FG000|Overall Study|Withdrawal by Subject|0|||
44506745|NCT03295318|79511478|FG001|Overall Study|Withdrawal by Subject|0|||
44506746|NCT03295318|79511479|FG002|Overall Study|Withdrawal by Subject|1|||
44506747|NCT03295318|79511477|FG000|Overall Study|Subject discontinued due to travel|0|||
44506748|NCT03295318|79511478|FG001|Overall Study|Subject discontinued due to travel|1|||
44506749|NCT03295318|79511479|FG002|Overall Study|Subject discontinued due to travel|0|||
44506750|NCT03311230|79511509|FG000|Overall Study|Withdrawal by Subject|1|||
44506751|NCT03311230|79511510|FG001|Overall Study|Withdrawal by Subject|4|||
44506752|NCT03311230|79511511|FG002|Overall Study|Withdrawal by Subject|2|||
44575357|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
44118146|NCT02697734|78901690|FG001|Optional Extension Phase|Adverse Event|1|||
44506753|NCT03311230|79511512|FG003|Overall Study|Withdrawal by Subject|7|||
44575358|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
44575359|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
44575360|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
44575361|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44506754|NCT03311230|79511509|FG000|Overall Study|Unrelated injury|0|||
44506755|NCT03311230|79511510|FG001|Overall Study|Unrelated injury|1|||
44575362|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44575363|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
44575364|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
44575365|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
44575366|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44575367|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44575368|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44575369|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
44575370|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
44575371|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
44575372|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
44575373|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
44575374|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
44575375|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
44575376|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
44575377|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
44575378|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
44575379|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
44575380|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
44118147|NCT02697734|78901689|FG000|Optional Extension Phase|Physician Decision|0|||
44118148|NCT02697734|78901690|FG001|Optional Extension Phase|Physician Decision|1|||
44118149|NCT02692586|78901704|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
44238962|NCT02691468|79065780|FG001|Overall Study|Bronchial blocker use|1|||
44238963|NCT02691468|79065779|FG000|Overall Study|Lost to Follow-up|2|||
44238964|NCT02691468|79065780|FG001|Overall Study|Lost to Follow-up|1|||
44238965|NCT02691468|79065779|FG000|Overall Study|Failure to advance FOB|2|||
44238966|NCT02691468|79065780|FG001|Overall Study|Failure to advance FOB|0|||
44238967|NCT02678676|79065788|FG000|Overall Study|Death|619|||
44238968|NCT02678676|79065789|FG001|Overall Study|Death|649|||
44238969|NCT02678676|79065788|FG000|Overall Study|Withdrawal by Subject|13|||
44238970|NCT02678676|79065789|FG001|Overall Study|Withdrawal by Subject|5|||
44238971|NCT02678676|79065788|FG000|Overall Study|Lost to Follow-up|171|||
44238972|NCT02678676|79065789|FG001|Overall Study|Lost to Follow-up|151|||
44506756|NCT03311230|79511511|FG002|Overall Study|Unrelated injury|0|||
44238973|NCT02678676|79065788|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
44238974|NCT02678676|79065789|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
44238975|NCT01558739|79065795|FG000|Overall Study|Adverse Event|7|||
44238976|NCT01558739|79065795|FG000|Overall Study|Withdrawal by Subject|2|||
44238977|NCT01558739|79065795|FG000|Overall Study|Death|3|||
44238978|NCT01558739|79065795|FG000|Overall Study|Disease Progression|4|||
44238979|NCT01558739|79065795|FG000|Overall Study|Protocol Violation|1|||
44238980|NCT02683668|79065799|FG000|Period 2|Withdrawal by Subject|0|||
44238981|NCT02683668|79065800|FG001|Period 2|Withdrawal by Subject|1|||
44276036|NCT02222922|79228493|FG003|Overall Study|Participant refused further follow-up|1|||
44506757|NCT03311230|79511512|FG003|Overall Study|Unrelated injury|0|||
44506758|NCT00312221|79511525|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
44506759|NCT00312221|79511526|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
44506760|NCT00312221|79511527|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
44506761|NCT00312221|79511528|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
44506762|NCT00312221|79511525|FG000|Open-label Run-in Period|Adverse Event|74|||
44506763|NCT00312221|79511526|FG001|Open-label Run-in Period|Adverse Event|0|||
44506764|NCT00312221|79511527|FG002|Open-label Run-in Period|Adverse Event|0|||
44506765|NCT00312221|79511528|FG003|Open-label Run-in Period|Adverse Event|0|||
44506766|NCT00312221|79511525|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
44506767|NCT00312221|79511526|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
44506768|NCT00312221|79511527|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
44506769|NCT00312221|79511528|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
44506770|NCT00312221|79511525|FG000|Open-label Run-in Period|Administrative|42|||
44575381|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
44118150|NCT02692586|78901704|FG000|Overall Study|Received adjunctive thrombolytics|2|||
44238982|NCT02683668|79065801|FG002|Period 2|Withdrawal by Subject|0|||
44238983|NCT02678286|79065809|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
44118151|NCT02534350|78901710|FG000|Overall Study|Randomized But Not Treated|1|||
44506771|NCT00312221|79511526|FG001|Open-label Run-in Period|Administrative|0|||
44506772|NCT00312221|79511527|FG002|Open-label Run-in Period|Administrative|0|||
44506773|NCT00312221|79511528|FG003|Open-label Run-in Period|Administrative|0|||
44506774|NCT00312221|79511525|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
44506775|NCT00312221|79511526|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
44506776|NCT00312221|79511527|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
44506777|NCT00312221|79511528|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
44118152|NCT02534350|78901711|FG001|Overall Study|Randomized But Not Treated|0|||
44118153|NCT02534350|78901710|FG000|Overall Study|Protocol Violation|1|||
44378249|NCT00779467|79383541|FG000|Overall Study|failed inclusion criteria|3|||
44506778|NCT00312221|79511525|FG000|Open-label Run-in Period|Did not qualify|5|||
44506779|NCT00312221|79511526|FG001|Open-label Run-in Period|Did not qualify|0|||
44506780|NCT00312221|79511527|FG002|Open-label Run-in Period|Did not qualify|0|||
44506781|NCT00312221|79511528|FG003|Open-label Run-in Period|Did not qualify|0|||
44506782|NCT00312221|79511525|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44506783|NCT00312221|79511526|FG001|Double-blind Phase|Withdrawal by Subject|6|||
44506784|NCT00312221|79511527|FG002|Double-blind Phase|Withdrawal by Subject|8|||
44506785|NCT00312221|79511528|FG003|Double-blind Phase|Withdrawal by Subject|7|||
44506786|NCT00312221|79511525|FG000|Double-blind Phase|Adverse Event|0|||
44506787|NCT00312221|79511526|FG001|Double-blind Phase|Adverse Event|10|||
44506788|NCT00312221|79511527|FG002|Double-blind Phase|Adverse Event|19|||
44506789|NCT00312221|79511528|FG003|Double-blind Phase|Adverse Event|18|||
44506790|NCT00312221|79511525|FG000|Double-blind Phase|Lost to Follow-up|0|||
44506791|NCT00312221|79511526|FG001|Double-blind Phase|Lost to Follow-up|0|||
44506792|NCT00312221|79511527|FG002|Double-blind Phase|Lost to Follow-up|2|||
44506793|NCT00312221|79511528|FG003|Double-blind Phase|Lost to Follow-up|2|||
44506794|NCT00312221|79511525|FG000|Double-blind Phase|Administrative|0|||
44506795|NCT00312221|79511526|FG001|Double-blind Phase|Administrative|26|||
44506796|NCT00312221|79511527|FG002|Double-blind Phase|Administrative|37|||
44506797|NCT00312221|79511528|FG003|Double-blind Phase|Administrative|33|||
44506798|NCT00312221|79511525|FG000|Double-blind Phase|Lack of Efficacy|0|||
44506799|NCT00312221|79511526|FG001|Double-blind Phase|Lack of Efficacy|17|||
44506800|NCT00312221|79511527|FG002|Double-blind Phase|Lack of Efficacy|6|||
44506801|NCT00312221|79511528|FG003|Double-blind Phase|Lack of Efficacy|10|||
44506802|NCT03294538|79511552|FG000|Overall Study|Adverse Event|0|||
44506803|NCT03294538|79511553|FG001|Overall Study|Adverse Event|1|||
44506804|NCT03294538|79511554|FG002|Overall Study|Adverse Event|1|||
44506805|NCT03294538|79511552|FG000|Overall Study|Lost to Follow-up|1|||
44506806|NCT03294538|79511553|FG001|Overall Study|Lost to Follow-up|0|||
44506807|NCT03294538|79511554|FG002|Overall Study|Lost to Follow-up|0|||
44506808|NCT03294538|79511552|FG000|Overall Study|Outside of Visit Window|4|||
44506809|NCT03294538|79511553|FG001|Overall Study|Outside of Visit Window|4|||
44506810|NCT03294538|79511554|FG002|Overall Study|Outside of Visit Window|1|||
44506811|NCT03265600|79511564|FG000|Overall Study|Lost to Follow-up|17|||
44506812|NCT03265600|79511565|FG001|Overall Study|Lost to Follow-up|5|||
44506813|NCT03265600|79511564|FG000|Overall Study|Withdrawal by Subject|4|||
44506814|NCT03265600|79511565|FG001|Overall Study|Withdrawal by Subject|2|||
44506815|NCT03265600|79511564|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
44506816|NCT03265600|79511565|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
44506817|NCT00335153|79511571|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
44506818|NCT00335153|79511571|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
44506819|NCT00335153|79511571|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
44506820|NCT00335153|79511571|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
44506821|NCT00335153|79511571|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
44506822|NCT00335153|79511571|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
44506823|NCT00335153|79511571|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
44506824|NCT00335153|79511571|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
44506825|NCT00335153|79511571|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
44506826|NCT00335153|79511571|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
44506827|NCT03265132|79511577|FG000|Overall Study|Adverse Event|0|||
44506828|NCT03265132|79511578|FG001|Overall Study|Adverse Event|1|||
44506829|NCT03265132|79511577|FG000|Overall Study|Lack of Efficacy|0|||
44506830|NCT03265132|79511578|FG001|Overall Study|Lack of Efficacy|2|||
44506831|NCT03265132|79511577|FG000|Overall Study|Progressive disease|0|||
44506832|NCT03265132|79511578|FG001|Overall Study|Progressive disease|2|||
44506833|NCT03265132|79511577|FG000|Overall Study|Withdrawal by Subject|0|||
44506834|NCT03265132|79511578|FG001|Overall Study|Withdrawal by Subject|1|||
44506835|NCT02939950|79511588|FG000|Overall Study|Lost to Follow-up|13|||
44506836|NCT02939950|79511589|FG001|Overall Study|Lost to Follow-up|16|||
44506837|NCT02939950|79511588|FG000|Overall Study|Positive slit lamp findings|0|||
44506838|NCT02939950|79511589|FG001|Overall Study|Positive slit lamp findings|1|||
44506839|NCT02939950|79511588|FG000|Overall Study|Chalazion upper lid|0|||
44506840|NCT02939950|79511589|FG001|Overall Study|Chalazion upper lid|1|||
44506841|NCT02939950|79511588|FG000|Overall Study|Lack of motivation|0|||
44506842|NCT02939950|79511589|FG001|Overall Study|Lack of motivation|2|||
44506843|NCT02939950|79511588|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
44575382|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
44575383|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
44575384|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
44575385|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
44575386|NCT02831673|79597937|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
44575387|NCT02831673|79597938|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
44575388|NCT02831673|79597939|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
44575389|NCT02831673|79597940|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
44575390|NCT02831673|79597941|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
44575391|NCT02831673|79597937|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
44575392|NCT02831673|79597938|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
44575393|NCT02831673|79597939|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
44575394|NCT02831673|79597940|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
44575395|NCT02831673|79597941|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
44575396|NCT02831673|79597937|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44575397|NCT02831673|79597938|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44575398|NCT02831673|79597939|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44575399|NCT02831673|79597940|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
44575400|NCT02831673|79597941|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
44575401|NCT02831673|79597937|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44575402|NCT02831673|79597938|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44575403|NCT02831673|79597939|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44575404|NCT02831673|79597940|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
44575405|NCT02831673|79597941|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
44575406|NCT02831673|79597937|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44575407|NCT02831673|79597938|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44575408|NCT02831673|79597939|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44575409|NCT02831673|79597940|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
44575410|NCT02831673|79597941|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
44575411|NCT02831673|79597937|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44575412|NCT02831673|79597938|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44575413|NCT02831673|79597939|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44575414|NCT02831673|79597940|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
44575415|NCT02831673|79597941|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
44575416|NCT02830893|79597959|FG000|Overall Study|Relocation to out of the country|1|||
44575417|NCT02830893|79597960|FG001|Overall Study|Relocation to out of the country|0|||
44575418|NCT02830893|79597959|FG000|Overall Study|Lost to Follow-up|0|||
44575419|NCT02830893|79597960|FG001|Overall Study|Lost to Follow-up|2|||
44575420|NCT02830893|79597959|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
44575421|NCT02830893|79597960|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
44575422|NCT02625922|79597968|FG000|Overall Study|Non-availability of IMP|1|||
44575423|NCT02625922|79597969|FG001|Overall Study|Non-availability of IMP|1|||
44575424|NCT02625922|79597968|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
44575425|NCT02625922|79597969|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
44506844|NCT02939950|79511589|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
44506845|NCT02939950|79511588|FG000|Overall Study|Military orders|1|||
44506846|NCT02939950|79511589|FG001|Overall Study|Military orders|0|||
44506847|NCT02939950|79511588|FG000|Overall Study|Participant Relocated|5|||
44506848|NCT02939950|79511589|FG001|Overall Study|Participant Relocated|3|||
44506849|NCT02939950|79511588|FG000|Overall Study|Study related symptoms|8|||
44506850|NCT02939950|79511589|FG001|Overall Study|Study related symptoms|8|||
44506851|NCT02939950|79511588|FG000|Overall Study|Unacceptable lens movement|2|||
44506852|NCT02939950|79511589|FG001|Overall Study|Unacceptable lens movement|0|||
44506853|NCT02939950|79511588|FG000|Overall Study|Protocol Violation|6|||
44506854|NCT02939950|79511589|FG001|Overall Study|Protocol Violation|3|||
44506855|NCT02939950|79511588|FG000|Overall Study|Physician Decision|2|||
44506856|NCT02939950|79511589|FG001|Overall Study|Physician Decision|0|||
44506857|NCT02939950|79511588|FG000|Overall Study|Pregnancy|6|||
44575426|NCT03350035|79597981|FG000|Overall Study|Lack of Efficacy|2|||
44575427|NCT03350035|79597982|FG001|Overall Study|Lack of Efficacy|0|||
44575428|NCT03350035|79597983|FG002|Overall Study|Lack of Efficacy|0|||
44118154|NCT02534350|78901711|FG001|Overall Study|Protocol Violation|0|||
44506858|NCT02939950|79511589|FG001|Overall Study|Pregnancy|7|||
44506859|NCT02939950|79511588|FG000|Overall Study|Withdrawal by Subject|12|||
44506860|NCT02939950|79511589|FG001|Overall Study|Withdrawal by Subject|28|||
44506861|NCT02939950|79511588|FG000|Overall Study|Adverse Event|7|||
44506862|NCT02939950|79511589|FG001|Overall Study|Adverse Event|3|||
44506863|NCT02939950|79511588|FG000|Overall Study|Randomized, not dispensed|1|||
44506864|NCT02939950|79511589|FG001|Overall Study|Randomized, not dispensed|0|||
44506865|NCT02939950|79511588|FG000|Overall Study|Ineligible at Baseline|2|||
44506866|NCT02939950|79511589|FG001|Overall Study|Ineligible at Baseline|8|||
44506867|NCT03753542|79511597|FG000|Overall Study|Lost to Follow-up|9|||
44506868|NCT03753542|79511598|FG001|Overall Study|Lost to Follow-up|14|||
44506869|NCT03292588|79511606|FG000|Overall Study|Death|1|||
44506870|NCT03292588|79511607|FG001|Overall Study|Death|0|||
44506871|NCT03292588|79511606|FG000|Overall Study|Lost to Follow-up|12|||
44506872|NCT03292588|79511607|FG001|Overall Study|Lost to Follow-up|16|||
44506873|NCT03292588|79511606|FG000|Overall Study|Physician Decision|0|||
44575429|NCT03350035|79597981|FG000|Overall Study|Subject discharged to hospice|0|||
44575430|NCT03350035|79597982|FG001|Overall Study|Subject discharged to hospice|0|||
44575431|NCT03350035|79597983|FG002|Overall Study|Subject discharged to hospice|1|||
44575432|NCT01358331|79598017|FG000|Overall Study|Lost to Follow-up|0|||
44575433|NCT01358331|79598018|FG001|Overall Study|Lost to Follow-up|0|||
44575434|NCT01358331|79598019|FG002|Overall Study|Lost to Follow-up|0|||
44575435|NCT01358331|79598020|FG003|Overall Study|Lost to Follow-up|1|||
44575436|NCT01358331|79598021|FG004|Overall Study|Lost to Follow-up|0|||
44575437|NCT01358331|79598022|FG005|Overall Study|Lost to Follow-up|0|||
44575438|NCT01358331|79598017|FG000|Overall Study|Withdrawal by Subject|0|||
44575439|NCT01358331|79598018|FG001|Overall Study|Withdrawal by Subject|0|||
44575440|NCT01358331|79598019|FG002|Overall Study|Withdrawal by Subject|0|||
44575441|NCT01358331|79598020|FG003|Overall Study|Withdrawal by Subject|1|||
44575442|NCT01358331|79598021|FG004|Overall Study|Withdrawal by Subject|1|||
44575443|NCT01358331|79598022|FG005|Overall Study|Withdrawal by Subject|1|||
44575444|NCT01358331|79598017|FG000|Overall Study|Adverse Events|1|||
44575445|NCT01358331|79598018|FG001|Overall Study|Adverse Events|1|||
44575446|NCT01358331|79598019|FG002|Overall Study|Adverse Events|1|||
44575447|NCT01358331|79598020|FG003|Overall Study|Adverse Events|0|||
44575448|NCT01358331|79598021|FG004|Overall Study|Adverse Events|1|||
44575449|NCT01358331|79598022|FG005|Overall Study|Adverse Events|5|||
44575450|NCT01358331|79598017|FG000|Overall Study|Symptomatic Deterioration|0|||
44575451|NCT01358331|79598018|FG001|Overall Study|Symptomatic Deterioration|0|||
44575452|NCT01358331|79598019|FG002|Overall Study|Symptomatic Deterioration|0|||
44575453|NCT01358331|79598020|FG003|Overall Study|Symptomatic Deterioration|0|||
44575454|NCT01358331|79598021|FG004|Overall Study|Symptomatic Deterioration|1|||
44238984|NCT02678286|79065810|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
44238985|NCT02678286|79065809|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
44238986|NCT02678286|79065810|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
44506874|NCT03292588|79511607|FG001|Overall Study|Physician Decision|1|||
44506875|NCT03292588|79511606|FG000|Overall Study|Withdrawal by Subject|4|||
44506876|NCT03292588|79511607|FG001|Overall Study|Withdrawal by Subject|4|||
44575455|NCT01358331|79598022|FG005|Overall Study|Symptomatic Deterioration|0|||
44575456|NCT01358331|79598017|FG000|Overall Study|Participants did not wish to continue|0|||
44575457|NCT01358331|79598018|FG001|Overall Study|Participants did not wish to continue|0|||
44575458|NCT01358331|79598019|FG002|Overall Study|Participants did not wish to continue|0|||
44238987|NCT02678286|79065809|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
44506877|NCT03292588|79511606|FG000|Overall Study|Move out of town|1|||
44575459|NCT01358331|79598020|FG003|Overall Study|Participants did not wish to continue|0|||
44575460|NCT01358331|79598021|FG004|Overall Study|Participants did not wish to continue|1|||
44575461|NCT01358331|79598022|FG005|Overall Study|Participants did not wish to continue|0|||
44575462|NCT01358331|79598017|FG000|Overall Study|Progress of disease under investigation|1|||
44575463|NCT01358331|79598018|FG001|Overall Study|Progress of disease under investigation|2|||
44575464|NCT01358331|79598019|FG002|Overall Study|Progress of disease under investigation|3|||
44575465|NCT01358331|79598020|FG003|Overall Study|Progress of disease under investigation|1|||
44575466|NCT01358331|79598021|FG004|Overall Study|Progress of disease under investigation|3|||
44575467|NCT01358331|79598022|FG005|Overall Study|Progress of disease under investigation|0|||
44575468|NCT02828241|79598038|FG000|Overall Study|Adverse Event|7|||
44575469|NCT02828241|79598039|FG001|Overall Study|Adverse Event|2|||
44575470|NCT02828241|79598038|FG000|Overall Study|Protocol Violation|1|||
44575471|NCT02828241|79598039|FG001|Overall Study|Protocol Violation|0|||
44575472|NCT01355523|79598048|FG000|Overall Study|Withdrawal by Subject|1|||
44575473|NCT01355523|79598049|FG001|Overall Study|Withdrawal by Subject|4|||
44575474|NCT01355523|79598048|FG000|Overall Study|Lost to Follow-up|0|||
44575475|NCT01355523|79598049|FG001|Overall Study|Lost to Follow-up|2|||
44118155|NCT02534350|78901710|FG000|Overall Study|Withdrew Consent|2|||
44118156|NCT02534350|78901711|FG001|Overall Study|Withdrew Consent|0|||
44506878|NCT03292588|79511607|FG001|Overall Study|Move out of town|0|||
44575476|NCT01355523|79598048|FG000|Overall Study|Protocol Violation|0|||
44575477|NCT01355523|79598049|FG001|Overall Study|Protocol Violation|2|||
44575478|NCT01355523|79598048|FG000|Overall Study|Adverse Event|0|||
44575479|NCT01355523|79598049|FG001|Overall Study|Adverse Event|2|||
44575480|NCT02625220|79598055|FG000|Overall Study|Adverse Event|2|||
44575481|NCT02625220|79598055|FG000|Overall Study|Lost to Follow-up|2|||
44575482|NCT02625220|79598055|FG000|Overall Study|Protocol Violation|1|||
44514952|NCT03075826|79520835|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
44506879|NCT03292588|79511606|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
44238988|NCT02678286|79065810|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
44238989|NCT02678286|79065809|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
44238990|NCT02678286|79065810|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
44238991|NCT02678286|79065809|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
44238992|NCT02678286|79065810|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
44238993|NCT02682264|79065818|FG000|Overall Study|Withdrawal by Subject|56|||
44238994|NCT02682264|79065819|FG001|Overall Study|Withdrawal by Subject|45|||
44238995|NCT02682264|79065818|FG000|Overall Study|Lost to Follow-up|49|||
44238996|NCT02682264|79065819|FG001|Overall Study|Lost to Follow-up|41|||
44506880|NCT03292588|79511607|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
44506881|NCT03752528|79511615|FG000|Part A|Lost to Follow-up|1|||
44506882|NCT03752528|79511615|FG000|Part A|Protocol Violation|1|||
44506883|NCT03752528|79511615|FG000|Part B|Protocol Violation|1|||
44506884|NCT03752528|79511615|FG000|Part B|Study terminated by sponsor|3|||
44506885|NCT00334295|79511622|FG000|Overall Study|Patients received fewer than 3 injection|5|||
44506886|NCT03292432|79511628|FG000|Overall Study|Lost to Follow-up|11|||
44506887|NCT03292432|79511629|FG001|Overall Study|Lost to Follow-up|8|||
44506888|NCT03292432|79511628|FG000|Overall Study|Death|2|||
44506889|NCT03292432|79511629|FG001|Overall Study|Death|1|||
44506890|NCT03292432|79511628|FG000|Overall Study|Withdrawal by Subject|1|||
44506891|NCT03292432|79511629|FG001|Overall Study|Withdrawal by Subject|2|||
44575483|NCT02625220|79598055|FG000|Overall Study|Study discontinued at site|2|||
44575484|NCT02826603|79598061|FG000|Overall Study|Adverse Event|17|||
44575485|NCT02826603|79598062|FG001|Overall Study|Adverse Event|9|||
44575486|NCT02826603|79598061|FG000|Overall Study|Lack of Efficacy|4|||
44575487|NCT02826603|79598062|FG001|Overall Study|Lack of Efficacy|9|||
44575488|NCT02826603|79598061|FG000|Overall Study|Lost to Follow-up|13|||
44575489|NCT02826603|79598062|FG001|Overall Study|Lost to Follow-up|12|||
44575490|NCT02826603|79598061|FG000|Overall Study|Noncompliance with treatment|0|||
44575491|NCT02826603|79598062|FG001|Overall Study|Noncompliance with treatment|2|||
44575492|NCT02826603|79598061|FG000|Overall Study|Physician Decision|1|||
44575493|NCT02826603|79598062|FG001|Overall Study|Physician Decision|7|||
44575494|NCT02826603|79598061|FG000|Overall Study|Pregnancy|1|||
44575495|NCT02826603|79598062|FG001|Overall Study|Pregnancy|2|||
44575496|NCT02826603|79598061|FG000|Overall Study|Protocol Violation|3|||
44575497|NCT02826603|79598062|FG001|Overall Study|Protocol Violation|3|||
44575498|NCT02826603|79598061|FG000|Overall Study|Withdrawal by Subject|20|||
44575499|NCT02826603|79598062|FG001|Overall Study|Withdrawal by Subject|19|||
44575500|NCT02826603|79598061|FG000|Overall Study|Death|2|||
44575501|NCT02826603|79598062|FG001|Overall Study|Death|0|||
44575502|NCT02826603|79598061|FG000|Overall Study|New therapy for study indication|0|||
44575503|NCT02826603|79598062|FG001|Overall Study|New therapy for study indication|1|||
44575504|NCT05270460|79598078|FG000|Overall Study|Adverse Event|0|||
44575505|NCT05270460|79598079|FG001|Overall Study|Adverse Event|1|||
44575506|NCT05270460|79598080|FG002|Overall Study|Adverse Event|0|||
44575507|NCT05270460|79598078|FG000|Overall Study|Early Termination|0|||
44575508|NCT05270460|79598079|FG001|Overall Study|Early Termination|1|||
44575509|NCT05270460|79598080|FG002|Overall Study|Early Termination|0|||
44575510|NCT04622592|79598105|FG000|Overall Study|Death|0|||
44575511|NCT04622592|79598106|FG001|Overall Study|Death|0|||
44575512|NCT04622592|79598107|FG002|Overall Study|Death|1|||
44378250|NCT00779467|79383542|FG001|Overall Study|failed inclusion criteria|3|||
44575513|NCT04622592|79598108|FG003|Overall Study|Death|0|||
44118157|NCT02688764|78901719|FG000|Overall Study|Adverse Event|3|||
44118158|NCT02688764|78901720|FG001|Overall Study|Adverse Event|3|||
44118159|NCT02688764|78901719|FG000|Overall Study|AE/Kidney transplant|1|||
44118160|NCT02688764|78901720|FG001|Overall Study|AE/Kidney transplant|0|||
44118161|NCT02688764|78901719|FG000|Overall Study|AE/Lack of efficacy|1|||
44118162|NCT02688764|78901720|FG001|Overall Study|AE/Lack of efficacy|0|||
44118163|NCT02688764|78901719|FG000|Overall Study|AE/Non-compl.|1|||
44506892|NCT03292432|79511628|FG000|Overall Study|Site closed before any data collected|1|||
44118164|NCT02688764|78901720|FG001|Overall Study|AE/Non-compl.|0|||
44238997|NCT02682264|79065818|FG000|Overall Study|Lack of Efficacy|14|||
44238998|NCT02682264|79065819|FG001|Overall Study|Lack of Efficacy|16|||
44506893|NCT03292432|79511629|FG001|Overall Study|Site closed before any data collected|0|||
44506894|NCT03291808|79511635|FG000|Overall Study|Lost to Follow-up|6|||
44575514|NCT04622592|79598109|FG004|Overall Study|Death|0|||
44575515|NCT04622592|79598110|FG005|Overall Study|Death|0|||
44575516|NCT04622592|79598111|FG006|Overall Study|Death|0|||
44575517|NCT04622592|79598112|FG007|Overall Study|Death|1|||
44575518|NCT04622592|79598105|FG000|Overall Study|Lost to Follow-up|0|||
44575519|NCT04622592|79598106|FG001|Overall Study|Lost to Follow-up|0|||
44575520|NCT04622592|79598107|FG002|Overall Study|Lost to Follow-up|0|||
44118165|NCT02688764|78901719|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
44575521|NCT04622592|79598108|FG003|Overall Study|Lost to Follow-up|3|||
44575522|NCT04622592|79598109|FG004|Overall Study|Lost to Follow-up|1|||
44575523|NCT04622592|79598110|FG005|Overall Study|Lost to Follow-up|0|||
44575524|NCT04622592|79598111|FG006|Overall Study|Lost to Follow-up|2|||
44575525|NCT04622592|79598112|FG007|Overall Study|Lost to Follow-up|2|||
44575526|NCT04622592|79598105|FG000|Overall Study|Physician Decision|0|||
44575527|NCT04622592|79598106|FG001|Overall Study|Physician Decision|0|||
44575528|NCT04622592|79598107|FG002|Overall Study|Physician Decision|0|||
44575529|NCT04622592|79598108|FG003|Overall Study|Physician Decision|0|||
44575530|NCT04622592|79598109|FG004|Overall Study|Physician Decision|1|||
44575531|NCT04622592|79598110|FG005|Overall Study|Physician Decision|0|||
44575532|NCT04622592|79598111|FG006|Overall Study|Physician Decision|0|||
44575533|NCT04622592|79598112|FG007|Overall Study|Physician Decision|0|||
44575534|NCT04622592|79598105|FG000|Overall Study|Withdrawal by Subject|1|||
44575535|NCT04622592|79598106|FG001|Overall Study|Withdrawal by Subject|0|||
44575536|NCT04622592|79598107|FG002|Overall Study|Withdrawal by Subject|2|||
44575537|NCT04622592|79598108|FG003|Overall Study|Withdrawal by Subject|0|||
44575538|NCT04622592|79598109|FG004|Overall Study|Withdrawal by Subject|0|||
44575539|NCT04622592|79598110|FG005|Overall Study|Withdrawal by Subject|0|||
44575540|NCT04622592|79598111|FG006|Overall Study|Withdrawal by Subject|1|||
44575541|NCT04622592|79598112|FG007|Overall Study|Withdrawal by Subject|4|||
44575542|NCT04622592|79598105|FG000|Overall Study|Other than specified above|0|||
44575543|NCT04622592|79598106|FG001|Overall Study|Other than specified above|0|||
44575544|NCT04622592|79598107|FG002|Overall Study|Other than specified above|1|||
44575545|NCT04622592|79598108|FG003|Overall Study|Other than specified above|0|||
44575546|NCT04622592|79598109|FG004|Overall Study|Other than specified above|0|||
44575547|NCT04622592|79598110|FG005|Overall Study|Other than specified above|0|||
44575548|NCT04622592|79598111|FG006|Overall Study|Other than specified above|0|||
44575549|NCT04622592|79598112|FG007|Overall Study|Other than specified above|0|||
44575550|NCT04523220|79598133|FG000|Main Treatment Period|Physician Decision|1|||
44575551|NCT04523220|79598134|FG001|Main Treatment Period|Physician Decision|1|||
44575552|NCT04523220|79598135|FG002|Main Treatment Period|Physician Decision|0|||
44575553|NCT04523220|79598133|FG000|Main Treatment Period|Other|5|||
44575554|NCT04523220|79598134|FG001|Main Treatment Period|Other|2|||
44575555|NCT04523220|79598135|FG002|Main Treatment Period|Other|4|||
44575556|NCT04523220|79598133|FG000|Main Treatment Period|Subject Decision|5|||
44575557|NCT04523220|79598134|FG001|Main Treatment Period|Subject Decision|7|||
44575558|NCT04523220|79598135|FG002|Main Treatment Period|Subject Decision|3|||
44575559|NCT04523220|79598133|FG000|Main Treatment Period|Death|5|||
44575560|NCT04523220|79598134|FG001|Main Treatment Period|Death|11|||
44575561|NCT04523220|79598135|FG002|Main Treatment Period|Death|4|||
44575562|NCT04523220|79598133|FG000|Main Treatment Period|Adverse Event|11|||
44575563|NCT04523220|79598134|FG001|Main Treatment Period|Adverse Event|9|||
44575564|NCT04523220|79598135|FG002|Main Treatment Period|Adverse Event|9|||
44575565|NCT04523220|79598133|FG000|Main Treatment Period|Withdrawal by Subject|3|||
44575566|NCT04523220|79598134|FG001|Main Treatment Period|Withdrawal by Subject|3|||
44575567|NCT04523220|79598135|FG002|Main Treatment Period|Withdrawal by Subject|4|||
44575568|NCT04523220|79598133|FG000|Main Treatment Period|Study drug never adminstered|10|||
44575569|NCT04523220|79598134|FG001|Main Treatment Period|Study drug never adminstered|3|||
44575570|NCT04523220|79598135|FG002|Main Treatment Period|Study drug never adminstered|5|||
44575571|NCT04523220|79598133|FG000|Extension Treatment Period|Physician Decision|1|||
44575572|NCT04523220|79598134|FG001|Extension Treatment Period|Physician Decision|0|||
44575573|NCT04523220|79598135|FG002|Extension Treatment Period|Physician Decision|3|||
44575574|NCT04523220|79598133|FG000|Extension Treatment Period|Other|2|||
44575575|NCT04523220|79598134|FG001|Extension Treatment Period|Other|6|||
44575576|NCT04523220|79598135|FG002|Extension Treatment Period|Other|6|||
44575577|NCT04523220|79598133|FG000|Extension Treatment Period|Subject Decision|5|||
44118166|NCT02688764|78901720|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
44118167|NCT02688764|78901719|FG000|Overall Study|AE/Other|0|||
44118168|NCT02688764|78901720|FG001|Overall Study|AE/Other|1|||
44118169|NCT02688764|78901719|FG000|Overall Study|AE/Physician decision|1|||
44575578|NCT04523220|79598134|FG001|Extension Treatment Period|Subject Decision|2|||
44118170|NCT02688764|78901720|FG001|Overall Study|AE/Physician decision|0|||
44118171|NCT02688764|78901719|FG000|Overall Study|AE/Withd. parent|3|||
44118172|NCT02688764|78901720|FG001|Overall Study|AE/Withd. parent|0|||
44118173|NCT02688764|78901719|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
44118174|NCT02688764|78901720|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
44575579|NCT04523220|79598135|FG002|Extension Treatment Period|Subject Decision|4|||
44118175|NCT02688764|78901719|FG000|Overall Study|AE/Withd. subject|1|||
44575580|NCT04523220|79598133|FG000|Extension Treatment Period|Death|6|||
44575581|NCT04523220|79598134|FG001|Extension Treatment Period|Death|4|||
44575582|NCT04523220|79598135|FG002|Extension Treatment Period|Death|7|||
44575583|NCT04523220|79598133|FG000|Extension Treatment Period|Adverse Event|6|||
44575584|NCT04523220|79598134|FG001|Extension Treatment Period|Adverse Event|7|||
44118176|NCT02688764|78901720|FG001|Overall Study|AE/Withd. subject|0|||
44575585|NCT04523220|79598135|FG002|Extension Treatment Period|Adverse Event|9|||
44575586|NCT04523220|79598133|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
44575587|NCT04523220|79598134|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
44575588|NCT04523220|79598135|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
44575589|NCT04523220|79598133|FG000|Extension Treatment Period|Study drug never administered|0|||
44575590|NCT04523220|79598134|FG001|Extension Treatment Period|Study drug never administered|1|||
44575591|NCT04523220|79598135|FG002|Extension Treatment Period|Study drug never administered|0|||
44575592|NCT04222088|79598166|FG000|Overall Study|Lost to Follow-up|5|||
44575593|NCT04222088|79598167|FG001|Overall Study|Lost to Follow-up|1|||
44575594|NCT04222088|79598166|FG000|Overall Study|Withdrawal by Subject|4|||
44575595|NCT04222088|79598167|FG001|Overall Study|Withdrawal by Subject|0|||
44575596|NCT03978520|79598178|FG000|Overall Study|Adverse Event|2|||
44575597|NCT03978520|79598179|FG001|Overall Study|Adverse Event|5|||
44575598|NCT03978520|79598180|FG002|Overall Study|Adverse Event|3|||
44575599|NCT03978520|79598181|FG003|Overall Study|Adverse Event|5|||
44575600|NCT03978520|79598182|FG004|Overall Study|Adverse Event|6|||
44575601|NCT03978520|79598178|FG000|Overall Study|Withdrawal by Subject|10|||
44575602|NCT03978520|79598179|FG001|Overall Study|Withdrawal by Subject|4|||
44575603|NCT03978520|79598180|FG002|Overall Study|Withdrawal by Subject|5|||
44575604|NCT03978520|79598181|FG003|Overall Study|Withdrawal by Subject|6|||
44575605|NCT03978520|79598182|FG004|Overall Study|Withdrawal by Subject|5|||
44575606|NCT03978520|79598178|FG000|Overall Study|Lost to Follow-up|2|||
44575607|NCT03978520|79598179|FG001|Overall Study|Lost to Follow-up|2|||
44575608|NCT03978520|79598180|FG002|Overall Study|Lost to Follow-up|2|||
44575609|NCT03978520|79598181|FG003|Overall Study|Lost to Follow-up|0|||
44575610|NCT03978520|79598182|FG004|Overall Study|Lost to Follow-up|1|||
44575611|NCT03978520|79598178|FG000|Overall Study|COVID-19 infection|0|||
44575612|NCT03978520|79598179|FG001|Overall Study|COVID-19 infection|1|||
44575613|NCT03978520|79598180|FG002|Overall Study|COVID-19 infection|0|||
44575614|NCT03978520|79598181|FG003|Overall Study|COVID-19 infection|0|||
44575615|NCT03978520|79598182|FG004|Overall Study|COVID-19 infection|0|||
44575616|NCT03978520|79598178|FG000|Overall Study|Other, not specified|9|||
44575617|NCT03978520|79598179|FG001|Overall Study|Other, not specified|4|||
44575618|NCT03978520|79598180|FG002|Overall Study|Other, not specified|1|||
44575619|NCT03978520|79598181|FG003|Overall Study|Other, not specified|1|||
44575620|NCT03978520|79598182|FG004|Overall Study|Other, not specified|2|||
44506895|NCT03291808|79511635|FG000|Overall Study|Research burden|4|||
44506896|NCT03263806|79511641|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
44506897|NCT03263806|79511642|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
44506898|NCT03263806|79511641|FG000|Overall Study|Withdrawal by Subject|0|||
44575621|NCT03978520|79598178|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
44575622|NCT03978520|79598179|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
44575623|NCT03978520|79598180|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
44575624|NCT03978520|79598181|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
44575625|NCT03978520|79598182|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
44575626|NCT03929393|79598194|FG000|Overall Study|Death|1|||
44575627|NCT03929393|79598195|FG001|Overall Study|Death|0|||
44575628|NCT03929393|79598194|FG000|Overall Study|Time Commitment|2|||
44575629|NCT03929393|79598195|FG001|Overall Study|Time Commitment|5|||
44575630|NCT03929393|79598194|FG000|Overall Study|Motor Vehicle Accident|0|||
44575631|NCT03929393|79598195|FG001|Overall Study|Motor Vehicle Accident|1|||
44575632|NCT03929393|79598194|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
44575633|NCT03929393|79598195|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
44575634|NCT03929393|79598194|FG000|Overall Study|Other|1|||
44575635|NCT03929393|79598195|FG001|Overall Study|Other|3|||
44378251|NCT00779467|79383543|FG002|Overall Study|failed inclusion criteria|1|||
44506899|NCT03263806|79511642|FG001|Overall Study|Withdrawal by Subject|1|||
44506900|NCT03263806|79511641|FG000|Overall Study|Study Termination|5|||
44506901|NCT03263806|79511642|FG001|Overall Study|Study Termination|6|||
44506902|NCT03751280|79511650|FG000|Overall Study|Adverse Event|0|||
44506903|NCT03751280|79511651|FG001|Overall Study|Adverse Event|1|||
44506904|NCT03751280|79511650|FG000|Overall Study|Lost to Follow-up|3|||
44575636|NCT03874715|79598203|FG000|Overall Study|Adverse Event|2|||
44575637|NCT03874715|79598204|FG001|Overall Study|Adverse Event|0|||
44575638|NCT03874715|79598203|FG000|Overall Study|Poor compliance to protocol|5|||
44575639|NCT03874715|79598204|FG001|Overall Study|Poor compliance to protocol|1|||
44506905|NCT03751280|79511651|FG001|Overall Study|Lost to Follow-up|5|||
44506906|NCT03751280|79511650|FG000|Overall Study|Physician Decision|0|||
44506907|NCT03751280|79511651|FG001|Overall Study|Physician Decision|2|||
44506908|NCT03751280|79511650|FG000|Overall Study|Protocol Violation|0|||
44506909|NCT03751280|79511651|FG001|Overall Study|Protocol Violation|2|||
44575640|NCT03874715|79598203|FG000|Overall Study|Withdrawal by Subject|1|||
44575641|NCT03874715|79598204|FG001|Overall Study|Withdrawal by Subject|0|||
44575642|NCT03874715|79598203|FG000|Overall Study|Other-unspecified|1|||
44506910|NCT03751280|79511650|FG000|Overall Study|Withdrawal by Subject|5|||
44575643|NCT03874715|79598204|FG001|Overall Study|Other-unspecified|0|||
44575644|NCT03502200|79598216|FG000|Overall Study|Adverse Event|1|||
44575645|NCT03502200|79598217|FG001|Overall Study|Adverse Event|0|||
44506911|NCT03751280|79511651|FG001|Overall Study|Withdrawal by Subject|2|||
44506912|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
44575646|NCT03502200|79598216|FG000|Overall Study|Lost to Follow-up|36|||
44575647|NCT03502200|79598217|FG001|Overall Study|Lost to Follow-up|38|||
44575648|NCT03502200|79598216|FG000|Overall Study|Study Team Decision|1|||
44575649|NCT03502200|79598217|FG001|Overall Study|Study Team Decision|1|||
44575650|NCT03502200|79598216|FG000|Overall Study|Withdrawal by Subject|5|||
44575651|NCT03502200|79598217|FG001|Overall Study|Withdrawal by Subject|7|||
44575652|NCT03502200|79598216|FG000|Overall Study|Death|0|||
44575653|NCT03502200|79598217|FG001|Overall Study|Death|2|||
44506913|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
44506914|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
44118177|NCT02688764|78901719|FG000|Overall Study|Kidney transplant|10|||
44118178|NCT02688764|78901720|FG001|Overall Study|Kidney transplant|4|||
44118179|NCT02688764|78901719|FG000|Overall Study|Lack of Efficacy|3|||
44118180|NCT02688764|78901720|FG001|Overall Study|Lack of Efficacy|2|||
44118181|NCT02688764|78901719|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
44118182|NCT02688764|78901720|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
44118183|NCT02688764|78901719|FG000|Overall Study|Non-compliance with study drug|4|||
44118184|NCT02688764|78901720|FG001|Overall Study|Non-compliance with study drug|0|||
44118185|NCT02688764|78901719|FG000|Overall Study|Non-compl./Physician decision|2|||
44118186|NCT02688764|78901720|FG001|Overall Study|Non-compl./Physician decision|0|||
44118187|NCT02688764|78901719|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
44118188|NCT02688764|78901720|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
44118189|NCT02688764|78901719|FG000|Overall Study|Non-compl./Withd. subject|0|||
44118190|NCT02688764|78901720|FG001|Overall Study|Non-compl./Withd. subject|2|||
44118191|NCT02688764|78901719|FG000|Overall Study|Phosphorus level outside safe range|0|||
44118192|NCT02688764|78901720|FG001|Overall Study|Phosphorus level outside safe range|1|||
44118193|NCT02688764|78901719|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
44118194|NCT02688764|78901720|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
44506915|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
44506916|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
44506917|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
44506918|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
44506919|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
44506920|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
44575654|NCT03336242|79598225|FG000|Overall Study|Adverse Event|0|||
44575655|NCT03336242|79598226|FG001|Overall Study|Adverse Event|1|||
44575656|NCT03334435|79598237|FG000|Overall Study|Ongoing as of Week 52|70|||
44575657|NCT03334435|79598238|FG001|Overall Study|Ongoing as of Week 52|32|||
44575658|NCT03334435|79598239|FG002|Overall Study|Ongoing as of Week 52|379|||
44506921|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
44506922|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
44118195|NCT02688764|78901719|FG000|Overall Study|Study drug taste/Withd. parent|1|||
44506923|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
44575659|NCT03334435|79598240|FG003|Overall Study|Ongoing as of Week 52|519|||
44575660|NCT03334435|79598241|FG004|Overall Study|Ongoing as of Week 52|146|||
44118196|NCT02688764|78901720|FG001|Overall Study|Study drug taste/Withd. parent|0|||
44118197|NCT02688764|78901719|FG000|Overall Study|Subject moving out|2|||
44118198|NCT02688764|78901720|FG001|Overall Study|Subject moving out|0|||
44118199|NCT02688764|78901719|FG000|Overall Study|Subject taken off dialysis|1|||
44118200|NCT02688764|78901720|FG001|Overall Study|Subject taken off dialysis|0|||
44118201|NCT02688764|78901719|FG000|Overall Study|Withdrawal by parent|3|||
44118202|NCT02688764|78901720|FG001|Overall Study|Withdrawal by parent|0|||
44118203|NCT02688608|78901729|FG000|Overall Study|Lost to Follow-up|1|||
44118204|NCT02688530|78901737|FG000|Overall Study|Withdrawal by Subject|0|||
44238999|NCT02682264|79065818|FG000|Overall Study|Withdrawal by Parent|6|||
44239000|NCT02682264|79065819|FG001|Overall Study|Withdrawal by Parent|7|||
44239001|NCT02682264|79065818|FG000|Overall Study|Adverse Event|9|||
44239002|NCT02682264|79065819|FG001|Overall Study|Adverse Event|0|||
44239003|NCT02682264|79065818|FG000|Overall Study|Noncompliance with study drug|1|||
44239004|NCT02682264|79065819|FG001|Overall Study|Noncompliance with study drug|4|||
44239005|NCT02682264|79065818|FG000|Overall Study|Pregnancy|1|||
44239006|NCT02682264|79065819|FG001|Overall Study|Pregnancy|2|||
44239007|NCT02682264|79065818|FG000|Overall Study|Recovery|1|||
44575661|NCT03334435|79598237|FG000|Overall Study|Lack of Efficacy|3|||
44575662|NCT03334435|79598238|FG001|Overall Study|Lack of Efficacy|5|||
44575663|NCT03334435|79598239|FG002|Overall Study|Lack of Efficacy|76|||
44575664|NCT03334435|79598240|FG003|Overall Study|Lack of Efficacy|140|||
44118205|NCT02688530|78901738|FG001|Overall Study|Withdrawal by Subject|1|||
44118206|NCT02688530|78901739|FG002|Overall Study|Withdrawal by Subject|0|||
44118207|NCT02688530|78901740|FG003|Overall Study|Withdrawal by Subject|0|||
44118208|NCT02688530|78901737|FG000|Overall Study|Lost to Follow-up|0|||
44118209|NCT02688530|78901738|FG001|Overall Study|Lost to Follow-up|0|||
44239008|NCT02682264|79065819|FG001|Overall Study|Recovery|2|||
44239009|NCT02682264|79065818|FG000|Overall Study|Progressive Disease|1|||
44118210|NCT02688530|78901739|FG002|Overall Study|Lost to Follow-up|2|||
44118211|NCT02688530|78901740|FG003|Overall Study|Lost to Follow-up|0|||
44118212|NCT05083559|78901756|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
44118213|NCT05083559|78901757|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
44118214|NCT05083559|78901756|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
44575665|NCT03334435|79598241|FG004|Overall Study|Lack of Efficacy|61|||
44575666|NCT03334435|79598237|FG000|Overall Study|Adverse Event|2|||
44575667|NCT03334435|79598238|FG001|Overall Study|Adverse Event|1|||
44575668|NCT03334435|79598239|FG002|Overall Study|Adverse Event|9|||
44575669|NCT03334435|79598240|FG003|Overall Study|Adverse Event|23|||
44575670|NCT03334435|79598241|FG004|Overall Study|Adverse Event|13|||
44575671|NCT03334435|79598237|FG000|Overall Study|Withdrawal by Subject|11|||
44575672|NCT03334435|79598238|FG001|Overall Study|Withdrawal by Subject|4|||
44575673|NCT03334435|79598239|FG002|Overall Study|Withdrawal by Subject|38|||
44575674|NCT03334435|79598240|FG003|Overall Study|Withdrawal by Subject|42|||
44575675|NCT03334435|79598241|FG004|Overall Study|Withdrawal by Subject|20|||
44575676|NCT03334435|79598237|FG000|Overall Study|Lost to Follow-up|3|||
44575677|NCT03334435|79598238|FG001|Overall Study|Lost to Follow-up|0|||
44575678|NCT03334435|79598239|FG002|Overall Study|Lost to Follow-up|2|||
44575679|NCT03334435|79598240|FG003|Overall Study|Lost to Follow-up|1|||
44575680|NCT03334435|79598241|FG004|Overall Study|Lost to Follow-up|1|||
44575681|NCT03334435|79598237|FG000|Overall Study|Death|0|||
44575682|NCT03334435|79598238|FG001|Overall Study|Death|0|||
44575683|NCT03334435|79598239|FG002|Overall Study|Death|0|||
44575684|NCT03334435|79598240|FG003|Overall Study|Death|1|||
44575685|NCT03334435|79598241|FG004|Overall Study|Death|0|||
44575686|NCT03334435|79598237|FG000|Overall Study|Other|0|||
44575687|NCT03334435|79598238|FG001|Overall Study|Other|1|||
44575688|NCT03334435|79598239|FG002|Overall Study|Other|3|||
44575689|NCT03334435|79598240|FG003|Overall Study|Other|2|||
44575690|NCT03334435|79598241|FG004|Overall Study|Other|1|||
44575691|NCT02919449|79598314|FG000|Overall Study|Withdrawal by Subject|1|||
44575692|NCT02919449|79598314|FG000|Overall Study|Investigator decision|1|||
44575693|NCT02769832|79598318|FG000|Overall Study|Death|30|||
44575694|NCT02530970|79598323|FG000|Overall Study|Adverse Event|8|||
44575695|NCT02530970|79598323|FG000|Overall Study|Lost to Follow-up|88|||
44575696|NCT02530970|79598323|FG000|Overall Study|Physician Decision|5|||
44575697|NCT02530970|79598323|FG000|Overall Study|Withdrawal by Subject|14|||
44575698|NCT02530970|79598323|FG000|Overall Study|Death|6|||
44575699|NCT02530970|79598323|FG000|Overall Study|Hospitalization|1|||
44575700|NCT02530970|79598323|FG000|Overall Study|Insurance|2|||
44575701|NCT02530970|79598323|FG000|Overall Study|Explant|2|||
44575702|NCT02530970|79598323|FG000|Overall Study|Change in Provider|5|||
44575703|NCT02530970|79598323|FG000|Overall Study|Relocation|3|||
44575704|NCT02418156|79598327|FG000|Overall Study|Lost to Follow-up|12|||
44575705|NCT02418156|79598327|FG000|Overall Study|Death|2|||
44575706|NCT02418156|79598327|FG000|Overall Study|Physician Decision|1|||
44575707|NCT02418156|79598327|FG000|Overall Study|Withdrawal by Subject|1|||
44575708|NCT02418156|79598327|FG000|Overall Study|Subject refused to return|1|||
44575709|NCT01850524|79598367|FG000|Overall Study|Lost to Follow-up|5|||
44118215|NCT05083559|78901757|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
44239010|NCT02682264|79065819|FG001|Overall Study|Progressive Disease|0|||
44506924|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
44506925|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
44506926|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
44506927|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
44506928|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
44506929|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
44506930|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
44514953|NCT02865850|79520850|FG000|Overall Study|Death|15|||
44575710|NCT01850524|79598368|FG001|Overall Study|Lost to Follow-up|10|||
44239011|NCT02682264|79065818|FG000|Overall Study|Technical Problems|0|||
44378252|NCT00779467|79383544|FG003|Overall Study|failed inclusion criteria|2|||
44378253|NCT00779467|79383541|FG000|Overall Study|missing data|1|||
44575711|NCT01850524|79598367|FG000|Overall Study|Withdrawal by Subject|24|||
44575712|NCT01850524|79598368|FG001|Overall Study|Withdrawal by Subject|22|||
44239012|NCT02682264|79065819|FG001|Overall Study|Technical Problems|1|||
44378254|NCT00779467|79383542|FG001|Overall Study|missing data|0|||
44575713|NCT01850524|79598367|FG000|Overall Study|Reason not Specified|142|||
44575714|NCT01850524|79598368|FG001|Overall Study|Reason not Specified|141|||
44575715|NCT01609842|79598385|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
44575716|NCT01609842|79598386|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
44575717|NCT01569594|79598396|FG000|Overall Study|Physician Decision|4|||
44575718|NCT01569594|79598396|FG000|Overall Study|Death|13|||
44575719|NCT01569594|79598396|FG000|Overall Study|Lost to Follow-up|22|||
44575720|NCT01569594|79598396|FG000|Overall Study|Adverse Event|2|||
44575721|NCT01569594|79598396|FG000|Overall Study|Withdrawal by Subject|13|||
44575722|NCT01569594|79598396|FG000|Overall Study|Other|4|||
44575723|NCT01569594|79598396|FG000|Overall Study|No ECM used|9|||
44575724|NCT00593840|79598400|FG000|Overall Study|Withdrawal by Subject|1|||
44575725|NCT01329900|79598433|FG000|Overall Study|Elevated creatinine/renal function|1|||
44575726|NCT02825043|79598437|FG000|Overall Study|Lost to Follow-up|4|||
44575727|NCT02750592|79598452|FG000|Overall Study|Adverse Event|3|||
44575728|NCT02750592|79598452|FG000|Overall Study|Lack of Efficacy|2|||
44575729|NCT02624986|79598464|FG000|Overall Study|Death|0|||
44118216|NCT05083559|78901756|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
44118217|NCT05083559|78901757|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
44118218|NCT03037307|78901763|FG000|Period 1|Did Not Meet Study Criteria|0|||
44118219|NCT03037307|78901764|FG001|Period 1|Did Not Meet Study Criteria|0|||
44118220|NCT03037307|78901765|FG002|Period 1|Did Not Meet Study Criteria|0|||
44118221|NCT03037307|78901766|FG003|Period 1|Did Not Meet Study Criteria|1|||
44575730|NCT02624986|79598465|FG001|Overall Study|Death|1|||
44575731|NCT02624986|79598466|FG002|Overall Study|Death|2|||
44575732|NCT02624986|79598467|FG003|Overall Study|Death|2|||
44575733|NCT02624986|79598468|FG004|Overall Study|Death|2|||
44575734|NCT02624986|79598469|FG005|Overall Study|Death|0|||
44575735|NCT02624986|79598470|FG006|Overall Study|Death|0|||
44575736|NCT02624986|79598471|FG007|Overall Study|Death|1|||
44575737|NCT02624986|79598464|FG000|Overall Study|Study Terminated by Sponsor|1|||
44575738|NCT02624986|79598465|FG001|Overall Study|Study Terminated by Sponsor|1|||
44575739|NCT02624986|79598466|FG002|Overall Study|Study Terminated by Sponsor|0|||
44575740|NCT02624986|79598467|FG003|Overall Study|Study Terminated by Sponsor|1|||
44575741|NCT02624986|79598468|FG004|Overall Study|Study Terminated by Sponsor|2|||
44575742|NCT02624986|79598469|FG005|Overall Study|Study Terminated by Sponsor|2|||
44575743|NCT02624986|79598470|FG006|Overall Study|Study Terminated by Sponsor|4|||
44575744|NCT02624986|79598471|FG007|Overall Study|Study Terminated by Sponsor|3|||
44575745|NCT02624986|79598464|FG000|Overall Study|Progressive Disease|0|||
44118222|NCT03037307|78901767|FG004|Period 1|Did Not Meet Study Criteria|0|||
44575746|NCT02624986|79598465|FG001|Overall Study|Progressive Disease|1|||
44575747|NCT02624986|79598466|FG002|Overall Study|Progressive Disease|0|||
44575748|NCT02624986|79598467|FG003|Overall Study|Progressive Disease|0|||
44575749|NCT02624986|79598468|FG004|Overall Study|Progressive Disease|0|||
44575750|NCT02624986|79598469|FG005|Overall Study|Progressive Disease|0|||
44575751|NCT02624986|79598470|FG006|Overall Study|Progressive Disease|0|||
44575752|NCT02624986|79598471|FG007|Overall Study|Progressive Disease|0|||
44575753|NCT02624986|79598464|FG000|Overall Study|Protocol Violation|1|||
44118223|NCT03037307|78901768|FG005|Period 1|Did Not Meet Study Criteria|0|||
44118224|NCT02538094|78901777|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
44118225|NCT02538094|78901778|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
44118226|NCT02538094|78901777|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
44118227|NCT02538094|78901778|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
44118228|NCT02686034|78901786|FG000|Run-In Period 1|Eligibility|12|||
44118229|NCT02686034|78901787|FG001|Run-In Period 1|Eligibility|10|||
44506931|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
44506932|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
44506933|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
44506934|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
44506935|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
44575754|NCT02624986|79598465|FG001|Overall Study|Protocol Violation|0|||
44575755|NCT02624986|79598466|FG002|Overall Study|Protocol Violation|0|||
44575756|NCT02624986|79598467|FG003|Overall Study|Protocol Violation|0|||
44575757|NCT02624986|79598468|FG004|Overall Study|Protocol Violation|0|||
44575758|NCT02624986|79598469|FG005|Overall Study|Protocol Violation|0|||
44575759|NCT02624986|79598470|FG006|Overall Study|Protocol Violation|0|||
44506936|NCT00311363|79511661|FG000|24-Week Single-Blind Treatment Period|Death|1|||
44506937|NCT00311363|79511662|FG001|24-Week Single-Blind Treatment Period|Death|0|||
44506938|NCT00311363|79511663|FG002|24-Week Single-Blind Treatment Period|Death|0|||
44575760|NCT02624986|79598471|FG007|Overall Study|Protocol Violation|0|||
44575761|NCT02624986|79598464|FG000|Overall Study|Withdrawal by Subject|0|||
44575762|NCT02624986|79598465|FG001|Overall Study|Withdrawal by Subject|0|||
44118230|NCT02686034|78901786|FG000|Run-In Period 1|Withdrawal by Subject|4|||
44506939|NCT00311363|79511661|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
44575763|NCT02624986|79598466|FG002|Overall Study|Withdrawal by Subject|0|||
44575764|NCT02624986|79598467|FG003|Overall Study|Withdrawal by Subject|0|||
44118231|NCT02686034|78901787|FG001|Run-In Period 1|Withdrawal by Subject|3|||
44118232|NCT02686034|78901786|FG000|Run-In Period 1|Lost to Follow-up|4|||
44506940|NCT00311363|79511662|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
44575765|NCT02624986|79598468|FG004|Overall Study|Withdrawal by Subject|0|||
44575766|NCT02624986|79598469|FG005|Overall Study|Withdrawal by Subject|0|||
44575767|NCT02624986|79598470|FG006|Overall Study|Withdrawal by Subject|0|||
44575768|NCT02624986|79598471|FG007|Overall Study|Withdrawal by Subject|1|||
44575769|NCT02587598|79598504|FG000|Overall Study|Death|4|||
44575770|NCT02587598|79598505|FG001|Overall Study|Death|8|||
44575771|NCT02587598|79598506|FG002|Overall Study|Death|4|||
44575772|NCT02587598|79598507|FG003|Overall Study|Death|16|||
44575773|NCT02587598|79598508|FG004|Overall Study|Death|9|||
44575774|NCT02587598|79598509|FG005|Overall Study|Death|4|||
44575775|NCT02587598|79598510|FG006|Overall Study|Death|6|||
44575776|NCT02587598|79598511|FG007|Overall Study|Death|7|||
44575777|NCT02587598|79598512|FG008|Overall Study|Death|9|||
44575778|NCT02587598|79598513|FG009|Overall Study|Death|1|||
44575779|NCT02587598|79598514|FG010|Overall Study|Death|3|||
44575780|NCT02587598|79598504|FG000|Overall Study|Study Terminated by the Sponsor|0|||
44575781|NCT02587598|79598505|FG001|Overall Study|Study Terminated by the Sponsor|1|||
44575782|NCT02587598|79598506|FG002|Overall Study|Study Terminated by the Sponsor|0|||
44575783|NCT02587598|79598507|FG003|Overall Study|Study Terminated by the Sponsor|3|||
44575784|NCT02587598|79598508|FG004|Overall Study|Study Terminated by the Sponsor|0|||
44575785|NCT02587598|79598509|FG005|Overall Study|Study Terminated by the Sponsor|1|||
44575786|NCT02587598|79598510|FG006|Overall Study|Study Terminated by the Sponsor|0|||
44575787|NCT02587598|79598511|FG007|Overall Study|Study Terminated by the Sponsor|0|||
44575788|NCT02587598|79598512|FG008|Overall Study|Study Terminated by the Sponsor|0|||
44118233|NCT02686034|78901787|FG001|Run-In Period 1|Lost to Follow-up|4|||
44118234|NCT02686034|78901786|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
44118235|NCT02686034|78901787|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
44506941|NCT00311363|79511663|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
44506942|NCT00311363|79511661|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
44506943|NCT00311363|79511662|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
44506944|NCT00311363|79511663|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
44506945|NCT00311363|79511661|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
44506946|NCT00311363|79511662|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
44506947|NCT00311363|79511663|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
44506948|NCT00311363|79511661|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
44506949|NCT00311363|79511662|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
44506950|NCT00311363|79511663|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
44506951|NCT00311363|79511661|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
44506952|NCT00311363|79511662|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
44506953|NCT00311363|79511663|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
44506954|NCT00311363|79511661|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
44506955|NCT00311363|79511662|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
44506956|NCT00311363|79511663|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
44506957|NCT00333983|79511676|FG000|Overall Study|Lost to Follow-up|2|||
44506958|NCT00333983|79511677|FG001|Overall Study|Lost to Follow-up|1|||
44506959|NCT00333983|79511678|FG002|Overall Study|Lost to Follow-up|0|||
44506960|NCT00333983|79511676|FG000|Overall Study|Adverse Event|1|||
44575789|NCT02587598|79598513|FG009|Overall Study|Study Terminated by the Sponsor|1|||
44575790|NCT02587598|79598514|FG010|Overall Study|Study Terminated by the Sponsor|6|||
44575791|NCT02587598|79598504|FG000|Overall Study|Reason for study withdrawal not specified|0|||
44575792|NCT02587598|79598505|FG001|Overall Study|Reason for study withdrawal not specified|1|||
44575793|NCT02587598|79598506|FG002|Overall Study|Reason for study withdrawal not specified|0|||
44575794|NCT02587598|79598507|FG003|Overall Study|Reason for study withdrawal not specified|0|||
44575795|NCT02587598|79598508|FG004|Overall Study|Reason for study withdrawal not specified|0|||
44575796|NCT02587598|79598509|FG005|Overall Study|Reason for study withdrawal not specified|0|||
44575797|NCT02587598|79598510|FG006|Overall Study|Reason for study withdrawal not specified|0|||
44575798|NCT02587598|79598511|FG007|Overall Study|Reason for study withdrawal not specified|0|||
44575799|NCT02587598|79598512|FG008|Overall Study|Reason for study withdrawal not specified|0|||
44575800|NCT02587598|79598513|FG009|Overall Study|Reason for study withdrawal not specified|0|||
44575801|NCT02587598|79598514|FG010|Overall Study|Reason for study withdrawal not specified|0|||
44575802|NCT02587598|79598504|FG000|Overall Study|Withdrawal by Subject|0|||
44575803|NCT02587598|79598505|FG001|Overall Study|Withdrawal by Subject|1|||
44575804|NCT02587598|79598506|FG002|Overall Study|Withdrawal by Subject|0|||
44118236|NCT02686034|78901786|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
44118237|NCT02686034|78901787|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
44118238|NCT02686034|78901786|FG000|Randomized Controlled Period 2|Adverse Event|0|||
44378255|NCT00779467|79383543|FG002|Overall Study|missing data|1|||
44506961|NCT00333983|79511677|FG001|Overall Study|Adverse Event|1|||
44506962|NCT00333983|79511678|FG002|Overall Study|Adverse Event|1|||
44506963|NCT00333983|79511676|FG000|Overall Study|Withdrawal by Subject|0|||
44575805|NCT02587598|79598507|FG003|Overall Study|Withdrawal by Subject|2|||
44575806|NCT02587598|79598508|FG004|Overall Study|Withdrawal by Subject|3|||
44575807|NCT02587598|79598509|FG005|Overall Study|Withdrawal by Subject|1|||
44575808|NCT02587598|79598510|FG006|Overall Study|Withdrawal by Subject|0|||
44575809|NCT02587598|79598511|FG007|Overall Study|Withdrawal by Subject|0|||
44575810|NCT02587598|79598512|FG008|Overall Study|Withdrawal by Subject|0|||
44575811|NCT02587598|79598513|FG009|Overall Study|Withdrawal by Subject|1|||
44575812|NCT02587598|79598514|FG010|Overall Study|Withdrawal by Subject|2|||
44118239|NCT02686034|78901787|FG001|Randomized Controlled Period 2|Adverse Event|2|||
44118240|NCT02686034|78901786|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
44118241|NCT02686034|78901787|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
44118242|NCT02686034|78901786|FG000|Open Label Period 3|Lost to Follow-up|0|||
44118243|NCT02686034|78901787|FG001|Open Label Period 3|Lost to Follow-up|1|||
44118244|NCT02685488|78901795|FG000|Overall Study|Withdrawal by Subject|0|||
44118245|NCT02685488|78901796|FG001|Overall Study|Withdrawal by Subject|1|||
44118246|NCT02533570|78901805|FG000|Overall Study|Adverse Event|0|||
44118247|NCT02533570|78901806|FG001|Overall Study|Adverse Event|1|||
44118248|NCT02533570|78901807|FG002|Overall Study|Adverse Event|1|||
44118249|NCT03036839|78901818|FG000|Overall Study|Adverse Event|0|||
44118250|NCT03036839|78901819|FG001|Overall Study|Adverse Event|0|||
44118251|NCT03036839|78901820|FG002|Overall Study|Adverse Event|1|||
44118252|NCT03036839|78901818|FG000|Overall Study|Death|3|||
44118253|NCT03036839|78901819|FG001|Overall Study|Death|0|||
44118254|NCT03036839|78901820|FG002|Overall Study|Death|3|||
44118255|NCT03036839|78901818|FG000|Overall Study|Withdrew Consent|0|||
44118256|NCT03036839|78901819|FG001|Overall Study|Withdrew Consent|0|||
44118257|NCT03036839|78901820|FG002|Overall Study|Withdrew Consent|1|||
44118258|NCT01286207|78901831|FG000|Overall Study|Adverse Event|27|||
44118259|NCT01286207|78901832|FG001|Overall Study|Adverse Event|41|||
44118260|NCT01286207|78901833|FG002|Overall Study|Adverse Event|8|||
44118261|NCT01286207|78901831|FG000|Overall Study|Lost to Follow-up|49|||
44118262|NCT01286207|78901832|FG001|Overall Study|Lost to Follow-up|43|||
44118263|NCT01286207|78901833|FG002|Overall Study|Lost to Follow-up|20|||
44118264|NCT01286207|78901831|FG000|Overall Study|Withdrawal by Subject|93|||
44118265|NCT01286207|78901832|FG001|Overall Study|Withdrawal by Subject|79|||
44118266|NCT01286207|78901833|FG002|Overall Study|Withdrawal by Subject|41|||
44118267|NCT01286207|78901831|FG000|Overall Study|Lack of Response|92|||
44118268|NCT01286207|78901832|FG001|Overall Study|Lack of Response|38|||
44118269|NCT01286207|78901833|FG002|Overall Study|Lack of Response|8|||
44118270|NCT01286207|78901831|FG000|Overall Study|Other|37|||
44118271|NCT01286207|78901832|FG001|Overall Study|Other|47|||
44118272|NCT01286207|78901833|FG002|Overall Study|Other|13|||
44118273|NCT00968201|78901870|FG000|Base Study - (Period II)|Adverse Event|8|||
44118274|NCT00968201|78901871|FG001|Base Study - (Period II)|Adverse Event|0|||
44118275|NCT00968201|78901872|FG002|Base Study - (Period II)|Adverse Event|16|||
44118276|NCT00968201|78901870|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
44118277|NCT00968201|78901871|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
44118278|NCT00968201|78901872|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
44118279|NCT00968201|78901870|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
44118280|NCT00968201|78901871|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
44118281|NCT00968201|78901872|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
44118282|NCT00968201|78901870|FG000|Base Study - (Period II)|Protocol Violation|12|||
44118283|NCT00968201|78901871|FG001|Base Study - (Period II)|Protocol Violation|0|||
44118284|NCT00968201|78901872|FG002|Base Study - (Period II)|Protocol Violation|12|||
44118285|NCT00968201|78901870|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
44118286|NCT00968201|78901871|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
44118287|NCT00968201|78901872|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
44118288|NCT00968201|78901870|FG000|Base Study - (Period II)|Site Error|0|||
44506964|NCT00333983|79511677|FG001|Overall Study|Withdrawal by Subject|3|||
44506965|NCT00333983|79511678|FG002|Overall Study|Withdrawal by Subject|1|||
44506966|NCT03262012|79511690|FG000|Overall Study|Withdrawal by Subject|15|||
44506967|NCT03262012|79511691|FG001|Overall Study|Withdrawal by Subject|13|||
44506968|NCT03262012|79511692|FG002|Overall Study|Withdrawal by Subject|8|||
44506969|NCT03262012|79511693|FG003|Overall Study|Withdrawal by Subject|7|||
44506970|NCT03262012|79511690|FG000|Overall Study|Adverse Event|10|||
44506971|NCT03262012|79511691|FG001|Overall Study|Adverse Event|12|||
44506972|NCT03262012|79511692|FG002|Overall Study|Adverse Event|4|||
44506973|NCT03262012|79511693|FG003|Overall Study|Adverse Event|6|||
44506974|NCT03262012|79511690|FG000|Overall Study|Physician Decision|2|||
44506975|NCT03262012|79511691|FG001|Overall Study|Physician Decision|5|||
44506976|NCT03262012|79511692|FG002|Overall Study|Physician Decision|1|||
44575813|NCT02587598|79598504|FG000|Overall Study|Physician Decision|0|||
44118289|NCT00968201|78901871|FG001|Base Study - (Period II)|Site Error|0|||
44118290|NCT00968201|78901872|FG002|Base Study - (Period II)|Site Error|1|||
44118291|NCT00968201|78901870|FG000|Extension Study - (Period III)|Adverse Event|0|||
44118292|NCT00968201|78901871|FG001|Extension Study - (Period III)|Adverse Event|5|||
44118293|NCT00968201|78901872|FG002|Extension Study - (Period III)|Adverse Event|22|||
44506977|NCT03262012|79511693|FG003|Overall Study|Physician Decision|0|||
44118294|NCT00968201|78901870|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
44118295|NCT00968201|78901871|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
44118296|NCT00968201|78901872|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
44506978|NCT03262012|79511690|FG000|Overall Study|Lack of Efficacy|0|||
44506979|NCT03262012|79511691|FG001|Overall Study|Lack of Efficacy|5|||
44506980|NCT03262012|79511692|FG002|Overall Study|Lack of Efficacy|1|||
44575814|NCT02587598|79598505|FG001|Overall Study|Physician Decision|0|||
44575815|NCT02587598|79598506|FG002|Overall Study|Physician Decision|0|||
44575816|NCT02587598|79598507|FG003|Overall Study|Physician Decision|0|||
44575817|NCT02587598|79598508|FG004|Overall Study|Physician Decision|0|||
44575818|NCT02587598|79598509|FG005|Overall Study|Physician Decision|0|||
44575819|NCT02587598|79598510|FG006|Overall Study|Physician Decision|0|||
44575820|NCT02587598|79598511|FG007|Overall Study|Physician Decision|0|||
44575821|NCT02587598|79598512|FG008|Overall Study|Physician Decision|0|||
44575822|NCT02587598|79598513|FG009|Overall Study|Physician Decision|0|||
44575823|NCT02587598|79598514|FG010|Overall Study|Physician Decision|3|||
44575824|NCT02485574|79598550|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
44575825|NCT02624284|79598562|FG000|Overall Study|Withdrawal by Subject|3|||
44575826|NCT02624284|79598563|FG001|Overall Study|Withdrawal by Subject|6|||
44118297|NCT00968201|78901870|FG000|Extension Study - (Period III)|Protocol Violation|0|||
44118298|NCT00968201|78901871|FG001|Extension Study - (Period III)|Protocol Violation|17|||
44506981|NCT03262012|79511693|FG003|Overall Study|Lack of Efficacy|2|||
44506982|NCT03262012|79511690|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
44506983|NCT03262012|79511691|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
44506984|NCT03262012|79511692|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
44506985|NCT03262012|79511693|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
44506986|NCT03288142|79511705|FG000|Overall Study|Lost to Follow-up|22|||
44506987|NCT03288142|79511706|FG001|Overall Study|Lost to Follow-up|15|||
44506988|NCT00310817|79511718|FG000|Overall Study|AE or Death|3|||
44506989|NCT00310817|79511719|FG001|Overall Study|AE or Death|1|||
44506990|NCT00310817|79511720|FG002|Overall Study|AE or Death|0|||
44506991|NCT00310817|79511721|FG003|Overall Study|AE or Death|0|||
44506992|NCT00310817|79511718|FG000|Overall Study|Withdrawal by Subject|1|||
44506993|NCT00310817|79511719|FG001|Overall Study|Withdrawal by Subject|4|||
44506994|NCT00310817|79511720|FG002|Overall Study|Withdrawal by Subject|6|||
44506995|NCT00310817|79511721|FG003|Overall Study|Withdrawal by Subject|7|||
44506996|NCT00310817|79511718|FG000|Overall Study|Lost to Follow-up|2|||
44506997|NCT00310817|79511719|FG001|Overall Study|Lost to Follow-up|1|||
44506998|NCT00310817|79511720|FG002|Overall Study|Lost to Follow-up|0|||
44506999|NCT00310817|79511721|FG003|Overall Study|Lost to Follow-up|0|||
44507000|NCT00310817|79511718|FG000|Overall Study|Inappropriate Enrollment|1|||
44507001|NCT00310817|79511719|FG001|Overall Study|Inappropriate Enrollment|0|||
44507002|NCT00310817|79511720|FG002|Overall Study|Inappropriate Enrollment|1|||
44507003|NCT00310817|79511721|FG003|Overall Study|Inappropriate Enrollment|0|||
44507004|NCT00310817|79511718|FG000|Overall Study|Protocol Violation|1|||
44507005|NCT00310817|79511719|FG001|Overall Study|Protocol Violation|1|||
44507006|NCT00310817|79511720|FG002|Overall Study|Protocol Violation|1|||
44507007|NCT00310817|79511721|FG003|Overall Study|Protocol Violation|1|||
44507008|NCT00310817|79511718|FG000|Overall Study|Unable to classify|3|||
44507009|NCT00310817|79511719|FG001|Overall Study|Unable to classify|1|||
44507010|NCT00310817|79511720|FG002|Overall Study|Unable to classify|0|||
44507011|NCT00310817|79511721|FG003|Overall Study|Unable to classify|0|||
44507012|NCT02940886|79511766|FG000|Overall Study|Adverse Event|7|||
44507013|NCT02940886|79511767|FG001|Overall Study|Adverse Event|3|||
44507014|NCT02940886|79511766|FG000|Overall Study|Protocol Violation|0|||
44507015|NCT02940886|79511767|FG001|Overall Study|Protocol Violation|2|||
44507016|NCT02940886|79511766|FG000|Overall Study|Withdrawal by Subject|28|||
44507017|NCT02940886|79511767|FG001|Overall Study|Withdrawal by Subject|20|||
44507018|NCT02940886|79511766|FG000|Overall Study|Death|1|||
44507019|NCT02940886|79511767|FG001|Overall Study|Death|0|||
44507020|NCT02940886|79511766|FG000|Overall Study|Lack of Efficacy|1|||
44507021|NCT02940886|79511767|FG001|Overall Study|Lack of Efficacy|0|||
44507022|NCT02940886|79511766|FG000|Overall Study|Lost to Follow-up|49|||
44507023|NCT02940886|79511767|FG001|Overall Study|Lost to Follow-up|21|||
44507024|NCT02940886|79511766|FG000|Overall Study|Physician Decision|9|||
44507025|NCT02940886|79511767|FG001|Overall Study|Physician Decision|4|||
44118299|NCT00968201|78901872|FG002|Extension Study - (Period III)|Protocol Violation|14|||
44507026|NCT02940886|79511766|FG000|Overall Study|Sponsor decision|0|||
44507027|NCT02940886|79511767|FG001|Overall Study|Sponsor decision|1|||
44507028|NCT02940886|79511766|FG000|Overall Study|No treatment|7|||
44507029|NCT02940886|79511767|FG001|Overall Study|No treatment|2|||
44507030|NCT02940886|79511766|FG000|Overall Study|Enrolment error|0|||
44239013|NCT02682264|79065818|FG000|Overall Study|Moved abroad and unable to continue|0|||
44507031|NCT02940886|79511767|FG001|Overall Study|Enrolment error|1|||
44507032|NCT03285958|79511777|FG000|Overall Study|Lost to Follow-up|1|||
44507033|NCT03285958|79511778|FG001|Overall Study|Lost to Follow-up|1|||
44507034|NCT03285958|79511777|FG000|Overall Study|Withdrawal by Subject|1|||
44507035|NCT03285958|79511778|FG001|Overall Study|Withdrawal by Subject|0|||
44575827|NCT02624284|79598564|FG002|Overall Study|Withdrawal by Subject|3|||
44507036|NCT03285958|79511777|FG000|Overall Study|Not able to attend required orientation|3|||
44507037|NCT03285958|79511778|FG001|Overall Study|Not able to attend required orientation|0|||
44507038|NCT03285646|79511787|FG000|Overall Study|Adverse Event|1|||
44575828|NCT02624284|79598562|FG000|Overall Study|Protocol Violation|9|||
44575829|NCT02624284|79598563|FG001|Overall Study|Protocol Violation|10|||
44575830|NCT02624284|79598564|FG002|Overall Study|Protocol Violation|7|||
44507039|NCT03285646|79511788|FG001|Overall Study|Adverse Event|0|||
44507040|NCT03285646|79511787|FG000|Overall Study|Withdrawal by Subject|10|||
44507041|NCT03285646|79511788|FG001|Overall Study|Withdrawal by Subject|2|||
44507042|NCT03285646|79511787|FG000|Overall Study|Lost to Follow-up|2|||
44507043|NCT03285646|79511788|FG001|Overall Study|Lost to Follow-up|1|||
44507044|NCT03285646|79511787|FG000|Overall Study|Investigator/Sponsor Decision|0|||
44507045|NCT03285646|79511788|FG001|Overall Study|Investigator/Sponsor Decision|1|||
44507046|NCT03309202|79511799|FG000|Overall Study|Lost to Follow-up|1|||
44507047|NCT03309202|79511800|FG001|Overall Study|Lost to Follow-up|0|||
44507048|NCT03309202|79511801|FG002|Overall Study|Lost to Follow-up|0|||
44507049|NCT03309202|79511802|FG003|Overall Study|Lost to Follow-up|0|||
44507050|NCT00074490|79511817|FG000|Overall Study|Progressive malignancy|0|||
44507051|NCT00074490|79511818|FG001|Overall Study|Progressive malignancy|7|||
44507052|NCT00074490|79511819|FG002|Overall Study|Progressive malignancy|0|||
44507053|NCT00074490|79511820|FG003|Overall Study|Progressive malignancy|0|||
44507054|NCT00074490|79511821|FG004|Overall Study|Progressive malignancy|3|||
44507055|NCT00074490|79511822|FG005|Overall Study|Progressive malignancy|0|||
44507056|NCT03285490|79511837|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
44507057|NCT03285490|79511838|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
44507058|NCT03285490|79511837|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
44507059|NCT03285490|79511838|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
44507060|NCT02939716|79511845|FG000|Overall Study|scanner failure|0|||
44575831|NCT02624284|79598562|FG000|Overall Study|Revealed exclusionary condition|2|||
44118300|NCT00968201|78901870|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
44118301|NCT00968201|78901871|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
44118302|NCT00968201|78901872|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
44118303|NCT00968201|78901870|FG000|Extension Study - (Period III)|Patient Relocated|0|||
44239014|NCT02682264|79065819|FG001|Overall Study|Moved abroad and unable to continue|3|||
44507061|NCT02939716|79511846|FG001|Overall Study|scanner failure|0|||
44118304|NCT00968201|78901871|FG001|Extension Study - (Period III)|Patient Relocated|1|||
44118305|NCT00968201|78901872|FG002|Extension Study - (Period III)|Patient Relocated|1|||
44118306|NCT00968201|78901870|FG000|Extension Study - (Period III)|Noncompliance|0|||
44118307|NCT00968201|78901871|FG001|Extension Study - (Period III)|Noncompliance|0|||
44118308|NCT00968201|78901872|FG002|Extension Study - (Period III)|Noncompliance|3|||
44575832|NCT02624284|79598563|FG001|Overall Study|Revealed exclusionary condition|2|||
44575833|NCT02624284|79598564|FG002|Overall Study|Revealed exclusionary condition|0|||
44575834|NCT02624284|79598562|FG000|Overall Study|Adverse Event|0|||
44118309|NCT00968201|78901870|FG000|Extension Study - (Period III)|Other|0|||
44118310|NCT00968201|78901871|FG001|Extension Study - (Period III)|Other|0|||
44575835|NCT02624284|79598563|FG001|Overall Study|Adverse Event|0|||
44575836|NCT02624284|79598564|FG002|Overall Study|Adverse Event|1|||
44575837|NCT02738450|79598576|FG000|Overall Study|Withdrawal by Subject|0|||
44575838|NCT02738450|79598577|FG001|Overall Study|Withdrawal by Subject|2|||
44575839|NCT02738450|79598578|FG002|Overall Study|Withdrawal by Subject|0|||
44575840|NCT02624050|79598589|FG000|Overall Study|Physician Decision|4|||
44575841|NCT02624050|79598590|FG001|Overall Study|Physician Decision|0|||
44575842|NCT02624050|79598589|FG000|Overall Study|Protocol Violation|2|||
44575843|NCT02624050|79598590|FG001|Overall Study|Protocol Violation|0|||
44575844|NCT01338987|79598606|FG000|Overall Study|enrolled on new protocol|0|||
44575845|NCT01338987|79598607|FG001|Overall Study|enrolled on new protocol|0|||
44575846|NCT01338987|79598608|FG002|Overall Study|enrolled on new protocol|1|||
44575847|NCT01338987|79598609|FG003|Overall Study|enrolled on new protocol|0|||
44575848|NCT01338987|79598610|FG004|Overall Study|enrolled on new protocol|0|||
44575849|NCT01338987|79598606|FG000|Overall Study|Disease progression on study|2|||
44575850|NCT01338987|79598607|FG001|Overall Study|Disease progression on study|1|||
44575851|NCT01338987|79598608|FG002|Overall Study|Disease progression on study|1|||
44575852|NCT01338987|79598609|FG003|Overall Study|Disease progression on study|0|||
44575853|NCT01338987|79598610|FG004|Overall Study|Disease progression on study|0|||
44575854|NCT03706430|79598624|FG000|Overall Study|No A-Line placed|5|||
44118311|NCT00968201|78901872|FG002|Extension Study - (Period III)|Other|2|||
44507062|NCT02939716|79511847|FG002|Overall Study|scanner failure|0|||
44507063|NCT02939716|79511848|FG003|Overall Study|scanner failure|1|||
44507064|NCT02939716|79511849|FG004|Overall Study|scanner failure|1|||
44507065|NCT02939716|79511850|FG005|Overall Study|scanner failure|1|||
44507066|NCT00367133|79511879|FG000|2 Years|Death|20|||
44575855|NCT03706430|79598624|FG000|Overall Study|Subject had gel nail polish|1|||
44575856|NCT03706430|79598624|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
44575857|NCT03706430|79598624|FG000|Overall Study|Cancelled Case|6|||
44575858|NCT03706430|79598624|FG000|Overall Study|Physician Decision|2|||
44575859|NCT02738138|79598646|FG000|Overall Study|Adverse Event|0|||
44575860|NCT02738138|79598647|FG001|Overall Study|Adverse Event|1|||
44575861|NCT02738138|79598646|FG000|Overall Study|Lost to Follow-up|2|||
44575862|NCT02738138|79598647|FG001|Overall Study|Lost to Follow-up|0|||
44575863|NCT02738138|79598646|FG000|Overall Study|Other - not further specified|1|||
44118312|NCT00968201|78901870|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
44575864|NCT02738138|79598647|FG001|Overall Study|Other - not further specified|0|||
44575865|NCT01355289|79598656|FG000|Core Study|Adverse Event, Non-Fatal|1|||
44575866|NCT01355289|79598657|FG001|Core Study|Adverse Event, Non-Fatal|0|||
44575867|NCT01355289|79598658|FG002|Core Study|Adverse Event, Non-Fatal|0|||
44575868|NCT01355289|79598659|FG003|Core Study|Adverse Event, Non-Fatal|0|||
44575869|NCT01355289|79598660|FG004|Core Study|Adverse Event, Non-Fatal|0|||
44575870|NCT01355289|79598656|FG000|Core Study|Inadequate Therapeutic Effect|0|||
44118313|NCT00968201|78901871|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
44378256|NCT00779467|79383544|FG003|Overall Study|missing data|4|||
44378257|NCT00779467|79383541|FG000|Overall Study|technical issue|0|||
44378258|NCT00779467|79383542|FG001|Overall Study|technical issue|0|||
44378259|NCT00779467|79383543|FG002|Overall Study|technical issue|2|||
44118314|NCT00968201|78901872|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
44118315|NCT00943397|78901883|FG000|Overall Study|Adverse Event|0|||
44118316|NCT00943397|78901884|FG001|Overall Study|Adverse Event|6|||
44118317|NCT00943397|78901883|FG000|Overall Study|Lost to Follow-up|0|||
44118318|NCT00943397|78901884|FG001|Overall Study|Lost to Follow-up|4|||
44118319|NCT00943397|78901883|FG000|Overall Study|Protocol Violation|2|||
44118320|NCT00943397|78901884|FG001|Overall Study|Protocol Violation|5|||
44118321|NCT00943397|78901883|FG000|Overall Study|Withdrawal by Subject|1|||
44118322|NCT00943397|78901884|FG001|Overall Study|Withdrawal by Subject|1|||
44118323|NCT00943397|78901883|FG000|Overall Study|Site terminated and other|12|||
44118324|NCT00943397|78901884|FG001|Overall Study|Site terminated and other|56|||
44118325|NCT00702845|78901892|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
44118326|NCT00702845|78901893|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
44118327|NCT00702845|78901892|FG000|Overall Study|Too high ovarian response|5|||
44118328|NCT00702845|78901893|FG001|Overall Study|Too high ovarian response|1|||
44118329|NCT00702845|78901892|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
44378260|NCT00779467|79383544|FG003|Overall Study|technical issue|1|||
44507067|NCT00367133|79511880|FG001|2 Years|Death|12|||
44507068|NCT00367133|79511881|FG002|2 Years|Death|12|||
44507069|NCT00367133|79511879|FG000|2 Years|Dropped|34|||
44507070|NCT00367133|79511880|FG001|2 Years|Dropped|19|||
44507071|NCT00367133|79511881|FG002|2 Years|Dropped|33|||
44507072|NCT00367133|79511879|FG000|2 Years|Missed visit|4|||
44507073|NCT00367133|79511880|FG001|2 Years|Missed visit|5|||
44507074|NCT00367133|79511881|FG002|2 Years|Missed visit|4|||
44507075|NCT00367055|79511891|FG000|Overall Study|Adverse Event|6|||
44507076|NCT00367055|79511892|FG001|Overall Study|Adverse Event|3|||
44507077|NCT00367055|79511891|FG000|Overall Study|Patient's Willing|3|||
44507078|NCT00367055|79511892|FG001|Overall Study|Patient's Willing|2|||
44507079|NCT00367055|79511891|FG000|Overall Study|Lack of Efficacy|1|||
44507080|NCT00367055|79511892|FG001|Overall Study|Lack of Efficacy|2|||
44507081|NCT00367055|79511891|FG000|Overall Study|Lost to Follow-up|1|||
44507082|NCT00367055|79511892|FG001|Overall Study|Lost to Follow-up|1|||
44507083|NCT00367055|79511891|FG000|Overall Study|Protocol Violation|0|||
44507084|NCT00367055|79511892|FG001|Overall Study|Protocol Violation|1|||
44507085|NCT00367055|79511891|FG000|Overall Study|Stopping Criterion Met|0|||
44507086|NCT00367055|79511892|FG001|Overall Study|Stopping Criterion Met|1|||
44507087|NCT00367055|79511891|FG000|Overall Study|Participant Living too Far from Hospital|0|||
44507088|NCT00367055|79511892|FG001|Overall Study|Participant Living too Far from Hospital|1|||
44507089|NCT00057330|79511900|FG000|Overall Study|Adverse Event|9|||
44118330|NCT00702845|78901893|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
44118331|NCT00702845|78901892|FG000|Overall Study|Insufficient ovarian response|1|||
44378261|NCT00779467|79383541|FG000|Overall Study|unavailable research staff|0|||
44378262|NCT00779467|79383542|FG001|Overall Study|unavailable research staff|0|||
44378263|NCT00779467|79383543|FG002|Overall Study|unavailable research staff|0|||
44378264|NCT00779467|79383544|FG003|Overall Study|unavailable research staff|1|||
44378265|NCT00778921|79383557|FG000|Overall Study|Adverse Event|9|||
44507090|NCT00057330|79511901|FG001|Overall Study|Adverse Event|12|||
44507091|NCT00057330|79511900|FG000|Overall Study|Death|1|||
44507092|NCT00057330|79511901|FG001|Overall Study|Death|0|||
44507093|NCT00057330|79511900|FG000|Overall Study|Protocol Violation|1|||
44575871|NCT01355289|79598657|FG001|Core Study|Inadequate Therapeutic Effect|0|||
44575872|NCT01355289|79598658|FG002|Core Study|Inadequate Therapeutic Effect|0|||
44575873|NCT01355289|79598659|FG003|Core Study|Inadequate Therapeutic Effect|1|||
44378266|NCT00778921|79383558|FG001|Overall Study|Adverse Event|10|||
44378267|NCT00778921|79383559|FG002|Overall Study|Adverse Event|14|||
44507094|NCT00057330|79511901|FG001|Overall Study|Protocol Violation|1|||
44507095|NCT00057330|79511900|FG000|Overall Study|Withdrawal by Subject|115|||
44507096|NCT00057330|79511901|FG001|Overall Study|Withdrawal by Subject|84|||
44507097|NCT00057330|79511900|FG000|Overall Study|Lost to Follow-up|745|||
44507098|NCT00057330|79511901|FG001|Overall Study|Lost to Follow-up|617|||
44118332|NCT00702845|78901893|FG001|Overall Study|Insufficient ovarian response|0|||
44507099|NCT00057330|79511900|FG000|Overall Study|Physician Decision|1|||
44507100|NCT00057330|79511901|FG001|Overall Study|Physician Decision|0|||
44378268|NCT00778921|79383557|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
44378269|NCT00778921|79383558|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
44378270|NCT00778921|79383559|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
44378271|NCT00778921|79383557|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
44378272|NCT00778921|79383558|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
44378273|NCT00778921|79383559|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
44378274|NCT00778921|79383557|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
44378275|NCT00778921|79383558|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
44378276|NCT00778921|79383559|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
44378277|NCT00778921|79383557|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
44378278|NCT00778921|79383558|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
44378279|NCT00778921|79383559|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
44378280|NCT00778921|79383557|FG000|Overall Study|Patient withdrew request|3|||
44575874|NCT01355289|79598660|FG004|Core Study|Inadequate Therapeutic Effect|0|||
44575875|NCT01355289|79598656|FG000|Core Study|Other|0|||
44239015|NCT02682264|79065818|FG000|Overall Study|Stopped test article application|0|||
44239016|NCT02682264|79065819|FG001|Overall Study|Stopped test article application|1|||
44575876|NCT01355289|79598657|FG001|Core Study|Other|0|||
44575877|NCT01355289|79598658|FG002|Core Study|Other|0|||
44575878|NCT01355289|79598659|FG003|Core Study|Other|1|||
44575879|NCT01355289|79598660|FG004|Core Study|Other|0|||
44575880|NCT01355289|79598656|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
44575881|NCT01355289|79598657|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
44575882|NCT01355289|79598658|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
44575883|NCT01355289|79598659|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
44378281|NCT00778921|79383558|FG001|Overall Study|Patient withdrew request|1|||
44378282|NCT00778921|79383559|FG002|Overall Study|Patient withdrew request|6|||
44118333|NCT00702845|78901892|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
44118334|NCT00702845|78901893|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
44118335|NCT00702845|78901892|FG000|Overall Study|No or abnormal fertilization|4|||
44118336|NCT00702845|78901893|FG001|Overall Study|No or abnormal fertilization|2|||
44118337|NCT00702845|78901892|FG000|Overall Study|Patient's decision|2|||
44118338|NCT00702845|78901893|FG001|Overall Study|Patient's decision|1|||
44118339|NCT00702845|78901892|FG000|Overall Study|Not randomized|0|||
44118340|NCT00702845|78901893|FG001|Overall Study|Not randomized|1|||
44118341|NCT01302847|78901907|FG000|Overall Study|Ongoing|0|||
44118342|NCT01302847|78901908|FG001|Overall Study|Ongoing|0|||
44118343|NCT01302847|78901909|FG002|Overall Study|Ongoing|0|||
44118344|NCT01302847|78901910|FG003|Overall Study|Ongoing|0|||
44118345|NCT01302847|78901911|FG004|Overall Study|Ongoing|0|||
44118346|NCT01302847|78901912|FG005|Overall Study|Ongoing|27|||
44118347|NCT01302847|78901913|FG006|Overall Study|Ongoing|22|||
44239017|NCT01566721|79065827|FG000|Treatment Period|Withdrawal by Subject|35|||
44239018|NCT01566721|79065828|FG001|Treatment Period|Withdrawal by Subject|9|||
44239019|NCT01566721|79065827|FG000|Treatment Period|Disease Progression/Recurrence|37|||
44239020|NCT01566721|79065828|FG001|Treatment Period|Disease Progression/Recurrence|13|||
44239021|NCT01566721|79065827|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
44239022|NCT01566721|79065828|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
44239023|NCT01566721|79065827|FG000|Treatment Period|Other|13|||
44378283|NCT00778921|79383557|FG000|Overall Study|Lost to Follow-up|0|||
44378284|NCT00778921|79383558|FG001|Overall Study|Lost to Follow-up|2|||
44378285|NCT00778921|79383559|FG002|Overall Study|Lost to Follow-up|1|||
44378286|NCT00778921|79383557|FG000|Overall Study|Administrative Problems|1|||
44378287|NCT00778921|79383558|FG001|Overall Study|Administrative Problems|2|||
44378288|NCT00778921|79383559|FG002|Overall Study|Administrative Problems|0|||
44378289|NCT00778921|79383557|FG000|Overall Study|Protocol Violation|3|||
44378290|NCT00778921|79383558|FG001|Overall Study|Protocol Violation|0|||
44378291|NCT00778921|79383559|FG002|Overall Study|Protocol Violation|2|||
44378292|NCT00778921|79383557|FG000|Overall Study|Not treated|0|||
44378293|NCT00778921|79383558|FG001|Overall Study|Not treated|2|||
44507101|NCT00057330|79511900|FG000|Overall Study|Other|260|||
44507102|NCT00057330|79511901|FG001|Overall Study|Other|206|||
44507103|NCT03283696|79511909|FG000|Overall Study|Physician Decision|5|||
44507104|NCT03283696|79511910|FG001|Overall Study|Physician Decision|6|||
44507105|NCT03283696|79511909|FG000|Overall Study|Withdrawal by Subject|2|||
44507106|NCT03283696|79511910|FG001|Overall Study|Withdrawal by Subject|0|||
44507107|NCT02939560|79511916|FG000|Overall Study|Withdrawal by Subject|2|||
44507108|NCT02939560|79511916|FG000|Overall Study|Protocol Violation|1|||
44507109|NCT03748706|79511920|FG000|Overall Study|Lost to Follow-up|1|||
44507110|NCT03747302|79511926|FG000|Overall Study|Withdrawal by Subject|1|||
44507111|NCT03747302|79511927|FG001|Overall Study|Withdrawal by Subject|2|||
44507112|NCT00056862|79511937|FG000|Overall Study|Protocol Violation|1|||
44118348|NCT01302847|78901914|FG007|Overall Study|Ongoing|17|||
44118349|NCT01302847|78901907|FG000|Overall Study|Death|0|||
44118350|NCT01302847|78901908|FG001|Overall Study|Death|1|||
44118351|NCT01302847|78901909|FG002|Overall Study|Death|0|||
44239024|NCT01566721|79065828|FG001|Treatment Period|Other|2|||
44239025|NCT01566721|79065827|FG000|Treatment Period|Lack of Compliance|5|||
44276037|NCT02222922|79228494|FG004|Overall Study|Participant refused further follow-up|6|||
44276038|NCT02222922|79228495|FG005|Overall Study|Participant refused further follow-up|0|||
44276039|NCT02222922|79228496|FG006|Overall Study|Participant refused further follow-up|0|||
44276040|NCT02222922|79228497|FG007|Overall Study|Participant refused further follow-up|0|||
44276041|NCT02222922|79228498|FG008|Overall Study|Participant refused further follow-up|3|||
44276042|NCT02161146|79228550|FG000|Overall Study|Adverse Event|1|||
44276043|NCT02161146|79228551|FG001|Overall Study|Adverse Event|1|||
44276044|NCT02161146|79228552|FG002|Overall Study|Adverse Event|0|||
44276045|NCT02161146|79228553|FG003|Overall Study|Adverse Event|1|||
44276046|NCT02161146|79228554|FG004|Overall Study|Adverse Event|0|||
44276047|NCT02161146|79228550|FG000|Overall Study|Lost to Follow-up|0|||
44276048|NCT02161146|79228551|FG001|Overall Study|Lost to Follow-up|1|||
44276049|NCT02161146|79228552|FG002|Overall Study|Lost to Follow-up|0|||
44276050|NCT02161146|79228553|FG003|Overall Study|Lost to Follow-up|0|||
44276051|NCT02161146|79228554|FG004|Overall Study|Lost to Follow-up|0|||
44276052|NCT02161146|79228550|FG000|Overall Study|Personal Reasons|0|||
44239026|NCT01566721|79065828|FG001|Treatment Period|Lack of Compliance|1|||
44239027|NCT01566721|79065827|FG000|Treatment Period|Adverse Event|100|||
44276053|NCT02161146|79228551|FG001|Overall Study|Personal Reasons|1|||
44276054|NCT02161146|79228552|FG002|Overall Study|Personal Reasons|0|||
44276055|NCT02161146|79228553|FG003|Overall Study|Personal Reasons|2|||
44276056|NCT02161146|79228554|FG004|Overall Study|Personal Reasons|1|||
44276057|NCT02161146|79228550|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44507113|NCT00056862|79511938|FG001|Overall Study|Protocol Violation|0|||
44507114|NCT00056316|79511946|FG000|Overall Study|Withdrawal by Subject|2|||
44239028|NCT01566721|79065828|FG001|Treatment Period|Adverse Event|30|||
44239029|NCT01566721|79065827|FG000|Treatment Period|Pregnancy|1|||
44239030|NCT01566721|79065828|FG001|Treatment Period|Pregnancy|0|||
44239031|NCT01566721|79065827|FG000|Safety Follow-up|Physician Decision|6|||
44239032|NCT01566721|79065828|FG001|Safety Follow-up|Physician Decision|4|||
44239033|NCT01566721|79065827|FG000|Safety Follow-up|Lost to Follow-up|101|||
44239034|NCT01566721|79065828|FG001|Safety Follow-up|Lost to Follow-up|48|||
44239035|NCT01566721|79065827|FG000|Safety Follow-up|Withdrawal by Subject|155|||
44239036|NCT01566721|79065828|FG001|Safety Follow-up|Withdrawal by Subject|49|||
44239037|NCT01566721|79065827|FG000|Safety Follow-up|Death|28|||
44239038|NCT01566721|79065828|FG001|Safety Follow-up|Death|4|||
44239039|NCT01566721|79065827|FG000|Safety Follow-up|Non-compliance|7|||
44239040|NCT01566721|79065828|FG001|Safety Follow-up|Non-compliance|3|||
44239041|NCT01566721|79065827|FG000|Safety Follow-up|Protocol Violation|7|||
44239042|NCT01566721|79065828|FG001|Safety Follow-up|Protocol Violation|0|||
44239043|NCT01566721|79065827|FG000|Safety Follow-up|Site closure|2|||
44507115|NCT00056316|79511947|FG001|Overall Study|Withdrawal by Subject|2|||
44507116|NCT00056316|79511946|FG000|Overall Study|Death/NH placement of pt|1|||
44507117|NCT00056316|79511947|FG001|Overall Study|Death/NH placement of pt|1|||
44507118|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
44507119|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
44507120|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
44507121|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
44507122|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
44507123|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
44507124|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
44507125|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
44507126|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
44507127|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
44507128|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
44507129|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
44239044|NCT01566721|79065828|FG001|Safety Follow-up|Site closure|3|||
44276058|NCT02161146|79228551|FG001|Overall Study|Other Miscellaneous Reasons|1|||
44276059|NCT02161146|79228552|FG002|Overall Study|Other Miscellaneous Reasons|0|||
44276060|NCT02161146|79228553|FG003|Overall Study|Other Miscellaneous Reasons|0|||
44276061|NCT02161146|79228554|FG004|Overall Study|Other Miscellaneous Reasons|0|||
44507130|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
44507131|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
44507132|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
44514954|NCT02865850|79520851|FG001|Overall Study|Death|19|||
44276062|NCT02222688|79228789|FG000|Overall Study|Withdrawal by Subject|0|||
44276063|NCT02222688|79228790|FG001|Overall Study|Withdrawal by Subject|0|||
44276064|NCT02222688|79228791|FG002|Overall Study|Withdrawal by Subject|0|||
44276065|NCT02222688|79228792|FG003|Overall Study|Withdrawal by Subject|2|||
44276066|NCT02222688|79228793|FG004|Overall Study|Withdrawal by Subject|1|||
44239045|NCT01566721|79065827|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
44239046|NCT01566721|79065828|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
44239047|NCT01566721|79065827|FG000|Safety Follow-up|Missing|7|||
44239048|NCT01566721|79065828|FG001|Safety Follow-up|Missing|2|||
44575884|NCT01355289|79598660|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
44575885|NCT01355289|79598656|FG000|Open Label Extension|Lost to Follow-up|0|||
44575886|NCT01355289|79598657|FG001|Open Label Extension|Lost to Follow-up|0|||
44575887|NCT01355289|79598658|FG002|Open Label Extension|Lost to Follow-up|0|||
44575888|NCT01355289|79598659|FG003|Open Label Extension|Lost to Follow-up|0|||
44575889|NCT01355289|79598660|FG004|Open Label Extension|Lost to Follow-up|1|||
44575890|NCT01355289|79598656|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
44575891|NCT01355289|79598657|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
44575892|NCT01355289|79598658|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
44575893|NCT01355289|79598659|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
44575894|NCT01355289|79598660|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
44575895|NCT01355289|79598656|FG000|Open Label Extension|Other|0|||
44575896|NCT01355289|79598657|FG001|Open Label Extension|Other|0|||
44575897|NCT01355289|79598658|FG002|Open Label Extension|Other|0|||
44575898|NCT01355289|79598659|FG003|Open Label Extension|Other|0|||
44575899|NCT01355289|79598660|FG004|Open Label Extension|Other|3|||
44575900|NCT02737592|79598673|FG000|Overall Study|Withdrawal by Subject|1|||
44575901|NCT02737358|79598700|FG000|Overall Study|Withdrawal by Subject|7|||
44575902|NCT02737358|79598701|FG001|Overall Study|Withdrawal by Subject|12|||
44575903|NCT02737358|79598700|FG000|Overall Study|Lost to Follow-up|2|||
44575904|NCT02737358|79598701|FG001|Overall Study|Lost to Follow-up|3|||
44575905|NCT01354431|79598710|FG000|Pre-Treatment Period|Not reported|1|||
44575906|NCT01354431|79598711|FG001|Pre-Treatment Period|Not reported|0|||
44575907|NCT01354431|79598712|FG002|Pre-Treatment Period|Not reported|0|||
44575908|NCT01354431|79598710|FG000|Treatment Period|Disease Progression|50|||
44575909|NCT01354431|79598711|FG001|Treatment Period|Disease Progression|40|||
44575910|NCT01354431|79598712|FG002|Treatment Period|Disease Progression|44|||
44507133|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
44507134|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
44507135|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
44507136|NCT03308968|79511956|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
44507137|NCT03308968|79511957|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
44507138|NCT03308968|79511958|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
44507139|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
44507140|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
44507141|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
44507142|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
44507143|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
44507144|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
44507145|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
44507146|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
44507147|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
44507148|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
44507149|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
44507150|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
44507151|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
44507152|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
44507153|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
44507154|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
44507155|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
44507156|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
44507157|NCT03308968|79511956|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
44507158|NCT03308968|79511957|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
44507159|NCT03308968|79511958|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
44507160|NCT02940730|79511971|FG000|Intervention 2|Physician Decision|7|||
44507161|NCT02940730|79511972|FG001|Intervention 2|Physician Decision|0|||
44507162|NCT03741062|79511980|FG000|Overall Study|Protocol Violation|1|||
44507163|NCT03741062|79511981|FG001|Overall Study|Protocol Violation|0|||
44507164|NCT03281668|79511987|FG000|Overall Study|Physician Decision|1|||
44507165|NCT03281668|79511987|FG000|Overall Study|scheduling conflict, family circumstance|2|||
44507166|NCT03281668|79511987|FG000|Overall Study|Withdrawal by Subject|4|||
44575911|NCT01354431|79598710|FG000|Treatment Period|Study Drug Toxicity|5|||
44575912|NCT01354431|79598711|FG001|Treatment Period|Study Drug Toxicity|8|||
44575913|NCT01354431|79598712|FG002|Treatment Period|Study Drug Toxicity|4|||
44575914|NCT01354431|79598710|FG000|Treatment Period|Death|0|||
44575915|NCT01354431|79598711|FG001|Treatment Period|Death|1|||
44507167|NCT03281668|79511987|FG000|Overall Study|Lost to Follow-up|1|||
44507168|NCT03307174|79511993|FG000|Overall Study|Unplanned ICU Administrion|5|||
44507169|NCT03307174|79511994|FG001|Overall Study|Unplanned ICU Administrion|3|||
44575916|NCT01354431|79598712|FG002|Treatment Period|Death|0|||
44575917|NCT01354431|79598710|FG000|Treatment Period|AE unrelated to study drug|1|||
44575918|NCT01354431|79598711|FG001|Treatment Period|AE unrelated to study drug|2|||
44575919|NCT01354431|79598712|FG002|Treatment Period|AE unrelated to study drug|5|||
44575920|NCT01354431|79598710|FG000|Treatment Period|Participant request to discontinue|2|||
44575921|NCT01354431|79598711|FG001|Treatment Period|Participant request to discontinue|2|||
44575922|NCT01354431|79598712|FG002|Treatment Period|Participant request to discontinue|1|||
44239049|NCT01566721|79065827|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
44239050|NCT01566721|79065828|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
44239051|NCT01566721|79065827|FG000|Safety Follow-up|Sponsor decision|1|||
44239052|NCT01566721|79065828|FG001|Safety Follow-up|Sponsor decision|0|||
44239053|NCT01566721|79065827|FG000|Safety Follow-up|Adverse Event|8|||
44239054|NCT01566721|79065828|FG001|Safety Follow-up|Adverse Event|4|||
44239055|NCT01541215|79065843|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
44239056|NCT01541215|79065844|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
44239057|NCT01541215|79065843|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
44239058|NCT01541215|79065844|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
44239059|NCT01541215|79065843|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
44239060|NCT01541215|79065844|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
44239061|NCT01541215|79065843|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
44239062|NCT01541215|79065844|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
44239063|NCT01541215|79065843|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
44239064|NCT01541215|79065844|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
44239065|NCT01541215|79065843|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
44239066|NCT01541215|79065844|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
44239067|NCT01540981|79065856|FG000|Overall Study|Withdrawal by Subject|1|||
44239068|NCT01540981|79065857|FG001|Overall Study|Withdrawal by Subject|0|||
44239069|NCT01585987|79065865|FG000|Randomized|Withdrawal by Subject|0|||
44239070|NCT01585987|79065866|FG001|Randomized|Withdrawal by Subject|4|||
44239071|NCT01585987|79065865|FG000|Randomized|No longer met criteria|0|||
44239072|NCT01585987|79065866|FG001|Randomized|No longer met criteria|2|||
44239073|NCT01585987|79065865|FG000|Treated|Disease Progression|39|||
44239074|NCT01585987|79065866|FG001|Treated|Disease Progression|36|||
44239075|NCT01585987|79065865|FG000|Treated|Study Drug Toxicity|9|||
44239076|NCT01585987|79065866|FG001|Treated|Study Drug Toxicity|5|||
44239077|NCT01585987|79065865|FG000|Treated|Adverse Event|3|||
44239078|NCT01585987|79065866|FG001|Treated|Adverse Event|0|||
44239079|NCT01585987|79065865|FG000|Treated|Withdrawal by Subject|1|||
44239080|NCT01585987|79065866|FG001|Treated|Withdrawal by Subject|2|||
44276067|NCT02222688|79228794|FG005|Overall Study|Withdrawal by Subject|0|||
44276068|NCT02222688|79228795|FG006|Overall Study|Withdrawal by Subject|1|||
44276069|NCT02222688|79228789|FG000|Overall Study|Disease progression|1|||
44276070|NCT02222688|79228790|FG001|Overall Study|Disease progression|0|||
44276071|NCT02222688|79228791|FG002|Overall Study|Disease progression|0|||
44507170|NCT03307174|79511993|FG000|Overall Study|Aborted Surgery|1|||
44507171|NCT03307174|79511994|FG001|Overall Study|Aborted Surgery|2|||
44507172|NCT03307174|79511993|FG000|Overall Study|Hypotension|6|||
44575923|NCT01354431|79598710|FG000|Treatment Period|Participant withdrew consent|0|||
44575924|NCT01354431|79598711|FG001|Treatment Period|Participant withdrew consent|1|||
44575925|NCT01354431|79598712|FG002|Treatment Period|Participant withdrew consent|0|||
44575926|NCT01354431|79598710|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
44575927|NCT01354431|79598711|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
44575928|NCT01354431|79598712|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
44575929|NCT02736578|79598722|FG000|Overall Study|Adverse Event|1|||
44575930|NCT02736578|79598723|FG001|Overall Study|Adverse Event|0|||
44575931|NCT02622724|79598735|FG000|Overall Study|Death|51|||
44575932|NCT02622724|79598736|FG001|Overall Study|Death|53|||
44575933|NCT02622724|79598735|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
44575934|NCT02622724|79598736|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
44575935|NCT02622724|79598735|FG000|Overall Study|Early termination of study|38|||
44507173|NCT03307174|79511994|FG001|Overall Study|Hypotension|0|||
44507174|NCT03307174|79511993|FG000|Overall Study|Nonfunctional epidural|1|||
44507175|NCT03307174|79511994|FG001|Overall Study|Nonfunctional epidural|1|||
44507176|NCT03307174|79511993|FG000|Overall Study|Planned epidural removal|1|||
44507177|NCT03307174|79511994|FG001|Overall Study|Planned epidural removal|0|||
44507178|NCT03307174|79511993|FG000|Overall Study|Intrathecal catheter placement|0|||
44507179|NCT03307174|79511994|FG001|Overall Study|Intrathecal catheter placement|1|||
44575936|NCT02622724|79598736|FG001|Overall Study|Early termination of study|43|||
44575937|NCT01354353|79598754|FG000|Overall Study|Adverse Event|1|||
44239081|NCT01585987|79065865|FG000|Treated|Death|1|||
44239082|NCT01585987|79065866|FG001|Treated|Death|0|||
44276072|NCT02222688|79228792|FG003|Overall Study|Disease progression|0|||
44276073|NCT02222688|79228793|FG004|Overall Study|Disease progression|0|||
44507180|NCT03258814|79512002|FG000|Overall Study|Early Termination|4|||
44239083|NCT01585987|79065865|FG000|Treated|Lost to Follow-up|0|||
44239084|NCT01585987|79065866|FG001|Treated|Lost to Follow-up|1|||
44239085|NCT01585987|79065865|FG000|Treated|Maximum Clinical Benefit|0|||
44239086|NCT01585987|79065866|FG001|Treated|Maximum Clinical Benefit|1|||
44239087|NCT01585987|79065865|FG000|Treated|Non-Specified|1|||
44239088|NCT01585987|79065866|FG001|Treated|Non-Specified|2|||
44575938|NCT01354353|79598755|FG001|Overall Study|Adverse Event|0|||
44575939|NCT01354353|79598756|FG002|Overall Study|Adverse Event|0|||
44575940|NCT01354353|79598757|FG003|Overall Study|Adverse Event|4|||
44575941|NCT01354353|79598758|FG004|Overall Study|Adverse Event|0|||
44575942|NCT01354353|79598759|FG005|Overall Study|Adverse Event|5|||
44575943|NCT01354353|79598754|FG000|Overall Study|Entry Criteria Not Met|0|||
44575944|NCT01354353|79598755|FG001|Overall Study|Entry Criteria Not Met|0|||
44575945|NCT01354353|79598756|FG002|Overall Study|Entry Criteria Not Met|0|||
44575946|NCT01354353|79598757|FG003|Overall Study|Entry Criteria Not Met|1|||
44575947|NCT01354353|79598758|FG004|Overall Study|Entry Criteria Not Met|1|||
44575948|NCT01354353|79598759|FG005|Overall Study|Entry Criteria Not Met|0|||
44575949|NCT01354353|79598754|FG000|Overall Study|Physician Decision|0|||
44575950|NCT01354353|79598755|FG001|Overall Study|Physician Decision|1|||
44575951|NCT01354353|79598756|FG002|Overall Study|Physician Decision|1|||
44575952|NCT01354353|79598757|FG003|Overall Study|Physician Decision|0|||
44575953|NCT01354353|79598758|FG004|Overall Study|Physician Decision|0|||
44575954|NCT01354353|79598759|FG005|Overall Study|Physician Decision|0|||
44575955|NCT01354353|79598754|FG000|Overall Study|Withdrawal by Subject|2|||
44575956|NCT01354353|79598755|FG001|Overall Study|Withdrawal by Subject|0|||
44575957|NCT01354353|79598756|FG002|Overall Study|Withdrawal by Subject|1|||
44575958|NCT01354353|79598757|FG003|Overall Study|Withdrawal by Subject|0|||
44575959|NCT01354353|79598758|FG004|Overall Study|Withdrawal by Subject|0|||
44575960|NCT01354353|79598759|FG005|Overall Study|Withdrawal by Subject|1|||
44575961|NCT02622568|79598782|FG000|Overall Study|Lost to Follow-up|5|||
44575962|NCT02622568|79598783|FG001|Overall Study|Lost to Follow-up|5|||
44575963|NCT01354899|79598789|FG000|Overall Study|discharge from the hospital|2|||
44575964|NCT01354899|79598789|FG000|Overall Study|Protocol Violation|1|||
44575965|NCT01353963|79598793|FG000|Overall Study|Adverse Event|2|||
44575966|NCT02820597|79598802|FG000|Overall Study|Lost to Follow-up|12|||
44575967|NCT02822235|79598808|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
44575968|NCT02822235|79598809|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
44575969|NCT02822235|79598808|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
44575970|NCT02822235|79598809|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
44575971|NCT02822235|79598808|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
44575972|NCT02822235|79598809|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
44575973|NCT02822235|79598808|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
44575974|NCT02822235|79598809|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
44575975|NCT02822235|79598808|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
44575976|NCT02822235|79598809|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
44575977|NCT02822235|79598808|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
44575978|NCT02822235|79598809|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
44575979|NCT02817555|79598824|FG000|Overall Study|Death|1|||
44575980|NCT02817555|79598825|FG001|Overall Study|Death|3|||
44575981|NCT02817555|79598824|FG000|Overall Study|moved away|1|||
44575982|NCT02817555|79598825|FG001|Overall Study|moved away|0|||
44575983|NCT02817555|79598824|FG000|Overall Study|transplant|1|||
44575984|NCT02817555|79598825|FG001|Overall Study|transplant|1|||
44575985|NCT02817555|79598824|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
44575986|NCT02817555|79598825|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
44575987|NCT02817087|79598833|FG000|Overall Study|Withdrawal by Subject|2|||
44575988|NCT02817087|79598834|FG001|Overall Study|Withdrawal by Subject|0|||
44575989|NCT02813577|79598840|FG000|Overall Study|Study terminated|4|||
44575990|NCT02815293|79598847|FG000|Overall Study|Study termination by sponsor|10|||
44575991|NCT02815293|79598848|FG001|Overall Study|Study termination by sponsor|7|||
44575992|NCT02815293|79598849|FG002|Overall Study|Study termination by sponsor|0|||
44575993|NCT02815293|79598847|FG000|Overall Study|Participants not randomized|0|||
44239089|NCT01585987|79065865|FG000|Treated|Subject Request|0|||
44239090|NCT01585987|79065866|FG001|Treated|Subject Request|1|||
44239091|NCT01585987|79065865|FG000|Treated|Poor/Non-Compliance|0|||
44575994|NCT02815293|79598848|FG001|Overall Study|Participants not randomized|0|||
44575995|NCT02815293|79598849|FG002|Overall Study|Participants not randomized|18|||
44575996|NCT02815293|79598847|FG000|Overall Study|Adverse Event|0|||
44239092|NCT01585987|79065866|FG001|Treated|Poor/Non-Compliance|1|||
44239093|NCT01585831|79065875|FG000|Overall Study|Physician Decision|0|||
44239094|NCT01585831|79065876|FG001|Overall Study|Physician Decision|1|||
44575997|NCT02815293|79598848|FG001|Overall Study|Adverse Event|1|||
44239095|NCT01585831|79065875|FG000|Overall Study|Withdrawal by Subject|2|||
44575998|NCT02815293|79598849|FG002|Overall Study|Adverse Event|0|||
44575999|NCT02813421|79598857|FG000|Overall Study|Withdrawal by Subject|1|||
44576000|NCT02813421|79598858|FG001|Overall Study|Withdrawal by Subject|2|||
44576001|NCT02813421|79598857|FG000|Overall Study|Lost to Follow-up|1|||
44576002|NCT02813421|79598858|FG001|Overall Study|Lost to Follow-up|1|||
44576003|NCT03672188|79598879|FG000|Overall Study|Withdrawal by Subject|0|||
44576004|NCT03672188|79598880|FG001|Overall Study|Withdrawal by Subject|0|||
44239096|NCT01585831|79065876|FG001|Overall Study|Withdrawal by Subject|1|||
44576005|NCT03672188|79598881|FG002|Overall Study|Withdrawal by Subject|0|||
44576006|NCT03672188|79598882|FG003|Overall Study|Withdrawal by Subject|3|||
44576007|NCT03672188|79598883|FG004|Overall Study|Withdrawal by Subject|0|||
44576008|NCT03672188|79598884|FG005|Overall Study|Withdrawal by Subject|0|||
44576009|NCT03672188|79598885|FG006|Overall Study|Withdrawal by Subject|0|||
44576010|NCT03672188|79598886|FG007|Overall Study|Withdrawal by Subject|0|||
44576011|NCT03672188|79598887|FG008|Overall Study|Withdrawal by Subject|0|||
44576012|NCT03672188|79598888|FG009|Overall Study|Withdrawal by Subject|0|||
44576013|NCT03672188|79598889|FG010|Overall Study|Withdrawal by Subject|0|||
44576014|NCT03672188|79598890|FG011|Overall Study|Withdrawal by Subject|0|||
44576015|NCT03672188|79598891|FG012|Overall Study|Withdrawal by Subject|0|||
44378294|NCT00778921|79383559|FG002|Overall Study|Not treated|2|||
44378295|NCT00915876|79383569|FG000|Overall Study|Adverse Event|0|||
44378296|NCT00915876|79383570|FG001|Overall Study|Adverse Event|1|||
44378297|NCT00776659|79383576|FG000|Overall Study|Lost to Follow-up|15|||
44378298|NCT00776659|79383576|FG000|Overall Study|Withdrawal by Subject|10|||
44378299|NCT00776659|79383576|FG000|Overall Study|Study Terminated by Sponsor|1|||
44378300|NCT00825682|79383582|FG000|Overall Study|personal reasons/ inconvenience|13|||
44378301|NCT00825682|79383583|FG001|Overall Study|personal reasons/ inconvenience|5|||
44507181|NCT03258814|79512003|FG001|Overall Study|Early Termination|3|||
44118352|NCT01302847|78901910|FG003|Overall Study|Death|0|||
44118353|NCT01302847|78901911|FG004|Overall Study|Death|0|||
44118354|NCT01302847|78901912|FG005|Overall Study|Death|1|||
44118355|NCT01302847|78901913|FG006|Overall Study|Death|1|||
44276074|NCT02222688|79228794|FG005|Overall Study|Disease progression|0|||
44276075|NCT02222688|79228795|FG006|Overall Study|Disease progression|0|||
44507182|NCT03258814|79512004|FG002|Overall Study|Early Termination|10|||
44507183|NCT03257410|79512013|FG000|Overall Study|Adverse Event|2|||
44507184|NCT03257410|79512014|FG001|Overall Study|Adverse Event|3|||
44507185|NCT03257410|79512013|FG000|Overall Study|Protocol Violation|1|||
44507186|NCT03257410|79512014|FG001|Overall Study|Protocol Violation|2|||
44507187|NCT03257410|79512013|FG000|Overall Study|Lost to Follow-up|1|||
44576016|NCT03672188|79598892|FG013|Overall Study|Withdrawal by Subject|0|||
44576017|NCT03672188|79598893|FG014|Overall Study|Withdrawal by Subject|0|||
44576018|NCT03672188|79598879|FG000|Overall Study|Death|0|||
44576019|NCT03672188|79598880|FG001|Overall Study|Death|0|||
44576020|NCT03672188|79598881|FG002|Overall Study|Death|0|||
44576021|NCT03672188|79598882|FG003|Overall Study|Death|0|||
44576022|NCT03672188|79598883|FG004|Overall Study|Death|0|||
44576023|NCT03672188|79598884|FG005|Overall Study|Death|0|||
44576024|NCT03672188|79598885|FG006|Overall Study|Death|0|||
44576025|NCT03672188|79598886|FG007|Overall Study|Death|0|||
44576026|NCT03672188|79598887|FG008|Overall Study|Death|0|||
44576027|NCT03672188|79598888|FG009|Overall Study|Death|0|||
44576028|NCT03672188|79598889|FG010|Overall Study|Death|0|||
44576029|NCT03672188|79598890|FG011|Overall Study|Death|0|||
44576030|NCT03672188|79598891|FG012|Overall Study|Death|1|||
44576031|NCT03672188|79598892|FG013|Overall Study|Death|0|||
44576032|NCT03672188|79598893|FG014|Overall Study|Death|0|||
44576033|NCT03672188|79598879|FG000|Overall Study|Lost to Follow-up|0|||
44576034|NCT03672188|79598880|FG001|Overall Study|Lost to Follow-up|0|||
44576035|NCT03672188|79598881|FG002|Overall Study|Lost to Follow-up|1|||
44576036|NCT03672188|79598882|FG003|Overall Study|Lost to Follow-up|0|||
44576037|NCT03672188|79598883|FG004|Overall Study|Lost to Follow-up|0|||
44576038|NCT03672188|79598884|FG005|Overall Study|Lost to Follow-up|0|||
44576039|NCT03672188|79598885|FG006|Overall Study|Lost to Follow-up|0|||
44576040|NCT03672188|79598886|FG007|Overall Study|Lost to Follow-up|0|||
44576041|NCT03672188|79598887|FG008|Overall Study|Lost to Follow-up|0|||
44576042|NCT03672188|79598888|FG009|Overall Study|Lost to Follow-up|0|||
44576043|NCT03672188|79598889|FG010|Overall Study|Lost to Follow-up|0|||
44576044|NCT03672188|79598890|FG011|Overall Study|Lost to Follow-up|0|||
44576045|NCT03672188|79598891|FG012|Overall Study|Lost to Follow-up|0|||
44576046|NCT03672188|79598892|FG013|Overall Study|Lost to Follow-up|0|||
44576047|NCT03672188|79598893|FG014|Overall Study|Lost to Follow-up|0|||
44118356|NCT01302847|78901914|FG007|Overall Study|Death|0|||
44118357|NCT01302847|78901907|FG000|Overall Study|Pregnancy|2|||
44276076|NCT02159352|79228847|FG000|Overall Study|Adverse Event|3|||
44276077|NCT02159352|79228848|FG001|Overall Study|Adverse Event|1|||
44378302|NCT00833794|79383592|FG000|Open-label Phase|Adverse Event|225|||
44378303|NCT00833794|79383593|FG001|Open-label Phase|Adverse Event|0|||
44507188|NCT03257410|79512014|FG001|Overall Study|Lost to Follow-up|0|||
44507189|NCT03257410|79512013|FG000|Overall Study|Withdrawal by Subject|1|||
44576048|NCT02620384|79598961|FG000|Overall Study|Adverse Event|2|||
44576049|NCT02620384|79598962|FG001|Overall Study|Adverse Event|1|||
44576050|NCT02620384|79598961|FG000|Overall Study|Discharged prior to 2nd dose|2|||
44576051|NCT02620384|79598962|FG001|Overall Study|Discharged prior to 2nd dose|5|||
44576052|NCT02620384|79598961|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
44576053|NCT02620384|79598962|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
44576054|NCT03915860|79598968|FG000|Overall Study|Adverse Event|3|||
44118358|NCT01302847|78901908|FG001|Overall Study|Pregnancy|0|||
44118359|NCT01302847|78901909|FG002|Overall Study|Pregnancy|0|||
44576055|NCT03915860|79598968|FG000|Overall Study|Withdrawal by Subject|6|||
44576056|NCT03915860|79598968|FG000|Overall Study|Lost to Follow-up|2|||
44576057|NCT03915860|79598968|FG000|Overall Study|Other than specified|3|||
44576058|NCT05047211|79598983|FG000|Overall Study|Lost to Follow-up|8|||
44576059|NCT05047211|79598984|FG001|Overall Study|Lost to Follow-up|5|||
44576060|NCT04958642|79598993|FG000|Overall Study|Transferred to OLEX program|3|||
44118360|NCT01302847|78901910|FG003|Overall Study|Pregnancy|0|||
44118361|NCT01302847|78901911|FG004|Overall Study|Pregnancy|0|||
44118362|NCT01302847|78901912|FG005|Overall Study|Pregnancy|0|||
44118363|NCT01302847|78901913|FG006|Overall Study|Pregnancy|0|||
44576061|NCT04958642|79598994|FG001|Overall Study|Transferred to OLEX program|0|||
44576062|NCT04958642|79598995|FG002|Overall Study|Transferred to OLEX program|5|||
44576063|NCT04958642|79598993|FG000|Overall Study|Death|0|||
44576064|NCT04958642|79598994|FG001|Overall Study|Death|0|||
44576065|NCT04958642|79598995|FG002|Overall Study|Death|1|||
44576066|NCT04958642|79598993|FG000|Overall Study|Withdrawal by Subject|4|||
44576067|NCT04958642|79598994|FG001|Overall Study|Withdrawal by Subject|9|||
44576068|NCT04958642|79598995|FG002|Overall Study|Withdrawal by Subject|13|||
44576069|NCT04958642|79598993|FG000|Overall Study|Investigator's Decision|0|||
44576070|NCT04958642|79598994|FG001|Overall Study|Investigator's Decision|0|||
44576071|NCT04958642|79598995|FG002|Overall Study|Investigator's Decision|1|||
44576072|NCT04958642|79598993|FG000|Overall Study|Adverse Event|1|||
44576073|NCT04958642|79598994|FG001|Overall Study|Adverse Event|0|||
44576074|NCT04958642|79598995|FG002|Overall Study|Adverse Event|1|||
44576075|NCT04958642|79598993|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
44576076|NCT04958642|79598994|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
44576077|NCT04958642|79598995|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
44576078|NCT04958642|79598993|FG000|Overall Study|Lost to Follow-up|1|||
44576079|NCT04958642|79598994|FG001|Overall Study|Lost to Follow-up|0|||
44576080|NCT04958642|79598995|FG002|Overall Study|Lost to Follow-up|0|||
44576081|NCT04958642|79598993|FG000|Overall Study|Transferred to EAP following study termination|0|||
44576082|NCT04958642|79598994|FG001|Overall Study|Transferred to EAP following study termination|0|||
44576083|NCT04958642|79598995|FG002|Overall Study|Transferred to EAP following study termination|1|||
44576084|NCT04958642|79598993|FG000|Overall Study|Transferred to Expanded Access Program|1|||
44576085|NCT04958642|79598994|FG001|Overall Study|Transferred to Expanded Access Program|0|||
44576086|NCT04958642|79598995|FG002|Overall Study|Transferred to Expanded Access Program|0|||
44118364|NCT01302847|78901914|FG007|Overall Study|Pregnancy|0|||
44118365|NCT01302847|78901907|FG000|Overall Study|Virologic failure|0|||
44118366|NCT01302847|78901908|FG001|Overall Study|Virologic failure|2|||
44118367|NCT01302847|78901909|FG002|Overall Study|Virologic failure|2|||
44118368|NCT01302847|78901910|FG003|Overall Study|Virologic failure|0|||
44507190|NCT03257410|79512014|FG001|Overall Study|Withdrawal by Subject|2|||
44507191|NCT03257410|79512013|FG000|Overall Study|Physician Decision|1|||
44507192|NCT03257410|79512014|FG001|Overall Study|Physician Decision|1|||
44507193|NCT03257410|79512013|FG000|Overall Study|Renal transplantation|2|||
44507194|NCT03257410|79512014|FG001|Overall Study|Renal transplantation|0|||
44507195|NCT03257410|79512013|FG000|Overall Study|Switch to peritoneal dialysis|1|||
44507196|NCT03257410|79512014|FG001|Overall Study|Switch to peritoneal dialysis|0|||
44507197|NCT03257410|79512013|FG000|Overall Study|Death|3|||
44507198|NCT03257410|79512014|FG001|Overall Study|Death|2|||
44507199|NCT03257410|79512013|FG000|Overall Study|Change to another dialysis center|2|||
44507200|NCT03257410|79512014|FG001|Overall Study|Change to another dialysis center|2|||
44507201|NCT03257410|79512013|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
44507202|NCT03257410|79512014|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
44507203|NCT03257410|79512013|FG000|Overall Study|Miscellaneous|2|||
44507204|NCT03257410|79512014|FG001|Overall Study|Miscellaneous|2|||
44507205|NCT03257410|79512013|FG000|Overall Study|Other|0|||
44507206|NCT03257410|79512014|FG001|Overall Study|Other|1|||
44576087|NCT04321343|79599007|FG000|Overall Study|Adverse Event|0|||
44576088|NCT04321343|79599008|FG001|Overall Study|Adverse Event|0|||
44576089|NCT04321343|79599009|FG002|Overall Study|Adverse Event|1|||
44576090|NCT04321343|79599010|FG003|Overall Study|Adverse Event|0|||
44576091|NCT04321343|79599007|FG000|Overall Study|Death|0|||
44576092|NCT04321343|79599008|FG001|Overall Study|Death|0|||
44576093|NCT04321343|79599009|FG002|Overall Study|Death|0|||
44576094|NCT04321343|79599010|FG003|Overall Study|Death|1|||
44118369|NCT01302847|78901911|FG004|Overall Study|Virologic failure|1|||
44118370|NCT01302847|78901912|FG005|Overall Study|Virologic failure|1|||
44118371|NCT01302847|78901913|FG006|Overall Study|Virologic failure|0|||
44507207|NCT00056160|79512022|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
44576095|NCT04321343|79599007|FG000|Overall Study|Pregnancy|1|||
44507208|NCT00056160|79512023|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
44576096|NCT04321343|79599008|FG001|Overall Study|Pregnancy|0|||
44576097|NCT04321343|79599009|FG002|Overall Study|Pregnancy|0|||
44118372|NCT01302847|78901914|FG007|Overall Study|Virologic failure|2|||
44118373|NCT01302847|78901907|FG000|Overall Study|Severe debilitation, unable to continue|0|||
44118374|NCT01302847|78901908|FG001|Overall Study|Severe debilitation, unable to continue|0|||
44507209|NCT00056160|79512022|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
44507210|NCT00056160|79512023|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
44507211|NCT00056160|79512022|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
44507212|NCT00056160|79512023|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
44507213|NCT00056160|79512022|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
44507214|NCT00056160|79512023|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
44507215|NCT00056160|79512022|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
44507216|NCT00056160|79512023|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
44507217|NCT00056160|79512022|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
44507218|NCT00056160|79512023|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
44507219|NCT00056160|79512022|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
44576098|NCT04321343|79599010|FG003|Overall Study|Pregnancy|0|||
44576099|NCT04321343|79599007|FG000|Overall Study|Protocol Violation|1|||
44576100|NCT04321343|79599008|FG001|Overall Study|Protocol Violation|1|||
44576101|NCT04321343|79599009|FG002|Overall Study|Protocol Violation|1|||
44118375|NCT01302847|78901909|FG002|Overall Study|Severe debilitation, unable to continue|0|||
44118376|NCT01302847|78901910|FG003|Overall Study|Severe debilitation, unable to continue|0|||
44576102|NCT04321343|79599010|FG003|Overall Study|Protocol Violation|1|||
44576103|NCT04321343|79599007|FG000|Overall Study|Withdrawal by Subject|0|||
44576104|NCT04321343|79599008|FG001|Overall Study|Withdrawal by Subject|6|||
44576105|NCT04321343|79599009|FG002|Overall Study|Withdrawal by Subject|0|||
44576106|NCT04321343|79599010|FG003|Overall Study|Withdrawal by Subject|2|||
44576107|NCT04321343|79599007|FG000|Overall Study|Lost to Follow-up|2|||
44576108|NCT04321343|79599008|FG001|Overall Study|Lost to Follow-up|2|||
44576109|NCT04321343|79599009|FG002|Overall Study|Lost to Follow-up|1|||
44576110|NCT04321343|79599010|FG003|Overall Study|Lost to Follow-up|3|||
44576111|NCT04238754|79599024|FG000|Washout - 1 Week|Lost to Follow-up|1|||
44576112|NCT04238754|79599025|FG001|Washout - 1 Week|Lost to Follow-up|0|||
44576113|NCT04150068|79599047|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
44576114|NCT04150068|79599048|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
44576115|NCT04150068|79599049|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
44576116|NCT04150068|79599047|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
44576117|NCT04150068|79599048|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
44576118|NCT04150068|79599049|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
44576119|NCT03920293|79599058|FG000|Overall Study|Withdrawal by Subject|2|||
44576120|NCT03920293|79599059|FG001|Overall Study|Withdrawal by Subject|1|||
44576121|NCT03920293|79599058|FG000|Overall Study|Physician Decision|1|||
44576122|NCT03920293|79599059|FG001|Overall Study|Physician Decision|2|||
44576123|NCT03920293|79599058|FG000|Overall Study|Adverse Event|0|||
44576124|NCT03920293|79599059|FG001|Overall Study|Adverse Event|2|||
44576125|NCT03920293|79599058|FG000|Overall Study|Sponsor Decision|0|||
44576126|NCT03920293|79599059|FG001|Overall Study|Sponsor Decision|1|||
44576127|NCT03920293|79599058|FG000|Overall Study|Death|2|||
44576128|NCT03920293|79599059|FG001|Overall Study|Death|0|||
44576129|NCT03920293|79599058|FG000|Overall Study|Protocol Violation|1|||
44118377|NCT01302847|78901911|FG004|Overall Study|Severe debilitation, unable to continue|0|||
44118378|NCT01302847|78901912|FG005|Overall Study|Severe debilitation, unable to continue|1|||
44118379|NCT01302847|78901913|FG006|Overall Study|Severe debilitation, unable to continue|1|||
44118380|NCT01302847|78901914|FG007|Overall Study|Severe debilitation, unable to continue|0|||
44118381|NCT01302847|78901907|FG000|Overall Study|Not able to get to clinic|1|||
44118382|NCT01302847|78901908|FG001|Overall Study|Not able to get to clinic|1|||
44118383|NCT01302847|78901909|FG002|Overall Study|Not able to get to clinic|0|||
44118384|NCT01302847|78901910|FG003|Overall Study|Not able to get to clinic|0|||
44118385|NCT01302847|78901911|FG004|Overall Study|Not able to get to clinic|0|||
44118386|NCT01302847|78901912|FG005|Overall Study|Not able to get to clinic|0|||
44118387|NCT01302847|78901913|FG006|Overall Study|Not able to get to clinic|0|||
44118388|NCT01302847|78901914|FG007|Overall Study|Not able to get to clinic|0|||
44118389|NCT01302847|78901907|FG000|Overall Study|Site closing|2|||
44239097|NCT01565941|79065884|FG000|Overall Study|Withdrawn by parent/guardian|3|||
44239098|NCT01565941|79065885|FG001|Overall Study|Withdrawn by parent/guardian|2|||
44239099|NCT01565941|79065884|FG000|Overall Study|Randomized; did not receive intevention|8|||
44239100|NCT01565941|79065885|FG001|Overall Study|Randomized; did not receive intevention|2|||
44576130|NCT03920293|79599059|FG001|Overall Study|Protocol Violation|0|||
44507220|NCT00056160|79512023|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
44507221|NCT00056160|79512022|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
44576131|NCT03920293|79599058|FG000|Overall Study|Noncompliance|1|||
44576132|NCT03920293|79599059|FG001|Overall Study|Noncompliance|0|||
44576133|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
44576134|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
44576135|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
44576136|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
44576137|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
44576138|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
44576139|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
44118390|NCT01302847|78901908|FG001|Overall Study|Site closing|2|||
44118391|NCT01302847|78901909|FG002|Overall Study|Site closing|0|||
44118392|NCT01302847|78901910|FG003|Overall Study|Site closing|0|||
44118393|NCT01302847|78901911|FG004|Overall Study|Site closing|0|||
44118394|NCT01302847|78901912|FG005|Overall Study|Site closing|0|||
44118395|NCT01302847|78901913|FG006|Overall Study|Site closing|0|||
44118396|NCT01302847|78901914|FG007|Overall Study|Site closing|0|||
44118397|NCT01302847|78901907|FG000|Overall Study|Withdrawal by Subject|1|||
44118398|NCT01302847|78901908|FG001|Overall Study|Withdrawal by Subject|0|||
44239101|NCT01558271|79065896|FG000|Overall Study|Adverse Event|6|||
44239102|NCT01558271|79065897|FG001|Overall Study|Adverse Event|3|||
44239103|NCT01558271|79065898|FG002|Overall Study|Adverse Event|4|||
44239104|NCT01558271|79065896|FG000|Overall Study|Lost to Follow-up|1|||
44576140|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
44576141|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
44576142|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
44576143|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Death|0|||
44576144|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Death|0|||
44576145|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Death|1|||
44576146|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Death|0|||
44576147|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Death|0|||
44576148|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
44576149|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
44576150|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
44576151|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
44576152|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
44576153|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Other|2|||
44576154|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Other|1|||
44576155|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Other|0|||
44576156|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Other|0|||
44576157|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Other|0|||
44576158|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
44576159|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
44276078|NCT02159352|79228847|FG000|Overall Study|Withdrawal by Subject|0|||
44276079|NCT02159352|79228848|FG001|Overall Study|Withdrawal by Subject|1|||
44576160|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
44576161|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
44576162|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
44576163|NCT03317496|79599082|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
44576164|NCT03317496|79599083|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
44576165|NCT03317496|79599084|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
44576166|NCT03317496|79599085|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
44576167|NCT03317496|79599086|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
44576168|NCT03317496|79599082|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
44576169|NCT03317496|79599083|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
44576170|NCT03317496|79599084|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
44576171|NCT03317496|79599085|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
44576172|NCT03317496|79599086|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
44576173|NCT03317496|79599082|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
44576174|NCT03317496|79599083|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
44576175|NCT03317496|79599084|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
44576176|NCT03317496|79599085|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
44576177|NCT03317496|79599086|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
44576178|NCT03317496|79599082|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
44576179|NCT03317496|79599083|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
44118399|NCT01302847|78901909|FG002|Overall Study|Withdrawal by Subject|0|||
44118400|NCT01302847|78901910|FG003|Overall Study|Withdrawal by Subject|0|||
44239105|NCT01558271|79065897|FG001|Overall Study|Lost to Follow-up|0|||
44239106|NCT01558271|79065898|FG002|Overall Study|Lost to Follow-up|0|||
44239107|NCT01558271|79065896|FG000|Overall Study|Protocol Violation|1|||
44507222|NCT00056160|79512023|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
44507223|NCT00056160|79512022|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
44507224|NCT00056160|79512023|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
44507225|NCT00056160|79512022|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
44507226|NCT00056160|79512023|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
44507227|NCT00056160|79512022|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
44507228|NCT00056160|79512023|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
44507229|NCT00056160|79512022|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
44507230|NCT00056160|79512023|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
44576180|NCT03317496|79599084|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
44576181|NCT03317496|79599085|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
44239108|NCT01558271|79065897|FG001|Overall Study|Protocol Violation|0|||
44239109|NCT01558271|79065898|FG002|Overall Study|Protocol Violation|0|||
44576182|NCT03317496|79599086|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
44576183|NCT03317496|79599082|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
44576184|NCT03317496|79599083|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
44576185|NCT03317496|79599084|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
44576186|NCT03317496|79599085|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
44576187|NCT03317496|79599086|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
44576188|NCT03317496|79599082|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
44576189|NCT03317496|79599083|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
44576190|NCT03317496|79599084|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
44576191|NCT03317496|79599085|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
44576192|NCT03317496|79599086|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
44576193|NCT03317496|79599082|FG000|Phase 2: Treatment|Adverse Event|0|||
44576194|NCT03317496|79599083|FG001|Phase 2: Treatment|Adverse Event|0|||
44576195|NCT03317496|79599084|FG002|Phase 2: Treatment|Adverse Event|0|||
44576196|NCT03317496|79599085|FG003|Phase 2: Treatment|Adverse Event|0|||
44576197|NCT03317496|79599086|FG004|Phase 2: Treatment|Adverse Event|6|||
44576198|NCT03317496|79599082|FG000|Phase 2: Treatment|Progressive disease|0|||
44576199|NCT03317496|79599083|FG001|Phase 2: Treatment|Progressive disease|0|||
44576200|NCT03317496|79599084|FG002|Phase 2: Treatment|Progressive disease|0|||
44378304|NCT00833794|79383592|FG000|Open-label Phase|Lack of Efficacy|28|||
44378305|NCT00833794|79383593|FG001|Open-label Phase|Lack of Efficacy|0|||
44378306|NCT00833794|79383592|FG000|Open-label Phase|Withdrawal by Subject|48|||
44507231|NCT00056160|79512022|FG000|Final Follow-up|Transferred into expanded access study.|3|||
44378307|NCT00833794|79383593|FG001|Open-label Phase|Withdrawal by Subject|0|||
44378308|NCT00833794|79383592|FG000|Open-label Phase|Physician Decision|20|||
44378309|NCT00833794|79383593|FG001|Open-label Phase|Physician Decision|0|||
44378310|NCT00833794|79383592|FG000|Open-label Phase|Administrative reason|1|||
44378311|NCT00833794|79383593|FG001|Open-label Phase|Administrative reason|0|||
44378312|NCT00833794|79383592|FG000|Open-label Phase|Protocol Violation|47|||
44378313|NCT00833794|79383593|FG001|Open-label Phase|Protocol Violation|0|||
44507232|NCT00056160|79512023|FG001|Final Follow-up|Transferred into expanded access study.|0|||
44507233|NCT00056160|79512022|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
44507234|NCT00056160|79512023|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
44507235|NCT00056160|79512022|FG000|Final Follow-up|Adverse Event|1|||
44576201|NCT03317496|79599085|FG003|Phase 2: Treatment|Progressive disease|0|||
44576202|NCT03317496|79599086|FG004|Phase 2: Treatment|Progressive disease|22|||
44576203|NCT03317496|79599082|FG000|Phase 2: Treatment|Other|0|||
44576204|NCT03317496|79599083|FG001|Phase 2: Treatment|Other|0|||
44576205|NCT03317496|79599084|FG002|Phase 2: Treatment|Other|0|||
44576206|NCT03317496|79599085|FG003|Phase 2: Treatment|Other|0|||
44576207|NCT03317496|79599086|FG004|Phase 2: Treatment|Other|4|||
44576208|NCT03317496|79599082|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
44576209|NCT03317496|79599083|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
44576210|NCT03317496|79599084|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
44576211|NCT03317496|79599085|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
44576212|NCT03317496|79599086|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
44576213|NCT03317496|79599082|FG000|Phase 2: Treatment|Physician Decision|0|||
44576214|NCT03317496|79599083|FG001|Phase 2: Treatment|Physician Decision|0|||
44576215|NCT03317496|79599084|FG002|Phase 2: Treatment|Physician Decision|0|||
44576216|NCT03317496|79599085|FG003|Phase 2: Treatment|Physician Decision|0|||
44576217|NCT03317496|79599086|FG004|Phase 2: Treatment|Physician Decision|1|||
44576218|NCT03317496|79599082|FG000|Phase 2: Treatment|Death|0|||
44576219|NCT03317496|79599083|FG001|Phase 2: Treatment|Death|0|||
44576220|NCT03317496|79599084|FG002|Phase 2: Treatment|Death|0|||
44576221|NCT03317496|79599085|FG003|Phase 2: Treatment|Death|0|||
44507236|NCT00056160|79512023|FG001|Final Follow-up|Adverse Event|0|||
44507237|NCT00061932|79512031|FG000|Overall Study|Withdrawal by Subject|13|||
44507238|NCT00061932|79512032|FG001|Overall Study|Withdrawal by Subject|4|||
44507239|NCT04984889|79512074|FG000|Extension Part|Ongoing|5|||
44507240|NCT04769739|79512100|FG000|Overall Study|Colorectal cancer obstruction|2|||
44507241|NCT04769739|79512101|FG001|Overall Study|Colorectal cancer obstruction|0|||
44576222|NCT03317496|79599086|FG004|Phase 2: Treatment|Death|1|||
44576223|NCT03317496|79599082|FG000|Phase 2: Follow-up|Death|0|||
44239110|NCT01558271|79065896|FG000|Overall Study|Withdrawal by Subject|10|||
44378314|NCT00833794|79383592|FG000|Open-label Phase|Did not complete wash-out period|12|||
44378315|NCT00833794|79383593|FG001|Open-label Phase|Did not complete wash-out period|0|||
44378316|NCT00833794|79383592|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
44378317|NCT00833794|79383593|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
44576224|NCT03317496|79599083|FG001|Phase 2: Follow-up|Death|0|||
44576225|NCT03317496|79599084|FG002|Phase 2: Follow-up|Death|0|||
44576226|NCT03317496|79599085|FG003|Phase 2: Follow-up|Death|0|||
44576227|NCT03317496|79599086|FG004|Phase 2: Follow-up|Death|24|||
44576228|NCT03317496|79599082|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
44576229|NCT03317496|79599083|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
44576230|NCT03317496|79599084|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
44576231|NCT03317496|79599085|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
44378318|NCT00833794|79383592|FG000|Double-blind Phase|Adverse Event|44|||
44576232|NCT03317496|79599086|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
44576233|NCT03317496|79599082|FG000|Phase 2: Follow-up|Other|0|||
44576234|NCT03317496|79599083|FG001|Phase 2: Follow-up|Other|0|||
44576235|NCT03317496|79599084|FG002|Phase 2: Follow-up|Other|0|||
44576236|NCT03317496|79599085|FG003|Phase 2: Follow-up|Other|0|||
44576237|NCT03317496|79599086|FG004|Phase 2: Follow-up|Other|1|||
44576238|NCT03317496|79599082|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
44576239|NCT03317496|79599083|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
44576240|NCT03317496|79599084|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
44576241|NCT03317496|79599085|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
44576242|NCT03317496|79599086|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
44576243|NCT02836249|79599108|FG000|Overall Study|Randomized but Never Treated|0|||
44576244|NCT02836249|79599109|FG001|Overall Study|Randomized but Never Treated|1|||
44576245|NCT02836249|79599108|FG000|Overall Study|Pregnancy|2|||
44576246|NCT02836249|79599109|FG001|Overall Study|Pregnancy|0|||
44576247|NCT02836249|79599108|FG000|Overall Study|Withdrew Consent|0|||
44576248|NCT02836249|79599109|FG001|Overall Study|Withdrew Consent|1|||
44576249|NCT02836249|79599108|FG000|Overall Study|Lost to Follow-up|0|||
44576250|NCT02836249|79599109|FG001|Overall Study|Lost to Follow-up|1|||
44576251|NCT02836249|79599108|FG000|Overall Study|Still on Study|121|||
44576252|NCT02836249|79599109|FG001|Overall Study|Still on Study|55|||
44576253|NCT01849562|79599122|FG000|Overall Study|Lost to Follow-up|1|||
44576254|NCT01849562|79599123|FG001|Overall Study|Lost to Follow-up|0|||
44576255|NCT01849562|79599124|FG002|Overall Study|Lost to Follow-up|0|||
44576256|NCT01849562|79599122|FG000|Overall Study|Non-compliance with Study Drug|1|||
44576257|NCT01849562|79599123|FG001|Overall Study|Non-compliance with Study Drug|0|||
44576258|NCT01849562|79599124|FG002|Overall Study|Non-compliance with Study Drug|0|||
44576259|NCT01700179|79599133|FG000|Overall Study|Physician Decision|2|||
44576260|NCT00665223|79599149|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
44576261|NCT00665223|79599150|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
44576262|NCT00665223|79599151|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
44576263|NCT00665223|79599149|FG000|Randomized Phase (26 Weeks)|Death|0|||
44576264|NCT00665223|79599150|FG001|Randomized Phase (26 Weeks)|Death|0|||
44576265|NCT00665223|79599151|FG002|Randomized Phase (26 Weeks)|Death|1|||
44576266|NCT00665223|79599149|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
44576267|NCT00665223|79599150|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
44576268|NCT00665223|79599151|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
44576269|NCT00665223|79599149|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
44576270|NCT00665223|79599150|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
44576271|NCT00665223|79599151|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
44576272|NCT00665223|79599149|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
44576273|NCT00665223|79599150|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
44576274|NCT00665223|79599151|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
44576275|NCT00665223|79599149|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
44576276|NCT00665223|79599150|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
44118401|NCT01302847|78901911|FG004|Overall Study|Withdrawal by Subject|1|||
44118402|NCT01302847|78901912|FG005|Overall Study|Withdrawal by Subject|0|||
44118403|NCT01302847|78901913|FG006|Overall Study|Withdrawal by Subject|0|||
44118404|NCT01302847|78901914|FG007|Overall Study|Withdrawal by Subject|1|||
44118405|NCT01302847|78901907|FG000|Overall Study|Not willing to adhere to requirements|5|||
44118406|NCT01302847|78901908|FG001|Overall Study|Not willing to adhere to requirements|0|||
44118407|NCT01302847|78901909|FG002|Overall Study|Not willing to adhere to requirements|0|||
44118408|NCT01302847|78901910|FG003|Overall Study|Not willing to adhere to requirements|1|||
44118409|NCT01302847|78901911|FG004|Overall Study|Not willing to adhere to requirements|0|||
44239111|NCT01558271|79065897|FG001|Overall Study|Withdrawal by Subject|6|||
44239112|NCT01558271|79065898|FG002|Overall Study|Withdrawal by Subject|12|||
44239113|NCT01558271|79065896|FG000|Overall Study|Physician Decision|0|||
44576277|NCT00665223|79599151|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
44576278|NCT00665223|79599149|FG000|Open-Label Period (26 Weeks)|Death|0|||
44576279|NCT00665223|79599150|FG001|Open-Label Period (26 Weeks)|Death|1|||
44239114|NCT01558271|79065897|FG001|Overall Study|Physician Decision|2|||
44576280|NCT00665223|79599151|FG002|Open-Label Period (26 Weeks)|Death|0|||
44576281|NCT00665223|79599149|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
44118410|NCT01302847|78901912|FG005|Overall Study|Not willing to adhere to requirements|0|||
44118411|NCT01302847|78901913|FG006|Overall Study|Not willing to adhere to requirements|0|||
44576282|NCT00665223|79599150|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
44576283|NCT00665223|79599151|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
44576284|NCT00665223|79599149|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
44576285|NCT00665223|79599150|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
44576286|NCT00665223|79599151|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
44239115|NCT01558271|79065898|FG002|Overall Study|Physician Decision|1|||
44576287|NCT00665223|79599149|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
44576288|NCT00665223|79599150|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
44576289|NCT00665223|79599151|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
44118412|NCT01302847|78901914|FG007|Overall Study|Not willing to adhere to requirements|2|||
44118413|NCT01302847|78901907|FG000|Overall Study|Site unable to contact participant|2|||
44118414|NCT01302847|78901908|FG001|Overall Study|Site unable to contact participant|1|||
44118415|NCT01302847|78901909|FG002|Overall Study|Site unable to contact participant|0|||
44118416|NCT01302847|78901910|FG003|Overall Study|Site unable to contact participant|0|||
44118417|NCT01302847|78901911|FG004|Overall Study|Site unable to contact participant|0|||
44118418|NCT01302847|78901912|FG005|Overall Study|Site unable to contact participant|0|||
44118419|NCT01302847|78901913|FG006|Overall Study|Site unable to contact participant|2|||
44118420|NCT01302847|78901914|FG007|Overall Study|Site unable to contact participant|0|||
44118421|NCT03039569|78901943|FG000|Overall Study|Lost to Follow-up|5|||
44118422|NCT03039569|78901944|FG001|Overall Study|Lost to Follow-up|4|||
44118423|NCT02738775|78901957|FG000|Overall Study|Withdrawal by Subject|0|||
44118424|NCT02738775|78901958|FG001|Overall Study|Withdrawal by Subject|1|||
44118425|NCT02738775|78901959|FG002|Overall Study|Withdrawal by Subject|0|||
44118426|NCT02738775|78901960|FG003|Overall Study|Withdrawal by Subject|0|||
44118427|NCT02738775|78901961|FG004|Overall Study|Withdrawal by Subject|0|||
44118428|NCT02738775|78901962|FG005|Overall Study|Withdrawal by Subject|0|||
44118429|NCT02738775|78901957|FG000|Overall Study|Adverse Event|0|||
44118430|NCT02738775|78901958|FG001|Overall Study|Adverse Event|0|||
44118431|NCT02738775|78901959|FG002|Overall Study|Adverse Event|0|||
44276080|NCT02187744|79228885|FG000|Study|Participant refused further follow-up|1|||
44507242|NCT04769739|79512102|FG002|Overall Study|Colorectal cancer obstruction|0|||
44507243|NCT04769739|79512103|FG003|Overall Study|Colorectal cancer obstruction|0|||
44507244|NCT04769739|79512100|FG000|Overall Study|Failed cecal intubation|1|||
44507245|NCT04769739|79512101|FG001|Overall Study|Failed cecal intubation|0|||
44507246|NCT04769739|79512102|FG002|Overall Study|Failed cecal intubation|0|||
44507247|NCT04769739|79512103|FG003|Overall Study|Failed cecal intubation|1|||
44507248|NCT04769739|79512100|FG000|Overall Study|Poor bowel preparation|0|||
44507249|NCT04769739|79512101|FG001|Overall Study|Poor bowel preparation|0|||
44507250|NCT04769739|79512102|FG002|Overall Study|Poor bowel preparation|0|||
44507251|NCT04769739|79512103|FG003|Overall Study|Poor bowel preparation|1|||
44507252|NCT04750278|79512116|FG000|Overall Study|Death|9|||
44507253|NCT04750278|79512117|FG001|Overall Study|Death|10|||
44507254|NCT04750278|79512118|FG002|Overall Study|Death|10|||
44507255|NCT04750278|79512116|FG000|Overall Study|Withdrawal by Subject|4|||
44507256|NCT04750278|79512117|FG001|Overall Study|Withdrawal by Subject|1|||
44507257|NCT04750278|79512118|FG002|Overall Study|Withdrawal by Subject|2|||
44507258|NCT04750278|79512116|FG000|Overall Study|Lost to Follow-up|1|||
44507259|NCT04750278|79512117|FG001|Overall Study|Lost to Follow-up|1|||
44507260|NCT04750278|79512118|FG002|Overall Study|Lost to Follow-up|1|||
44507261|NCT04750278|79512116|FG000|Overall Study|Pregnancy|1|||
44507262|NCT04750278|79512117|FG001|Overall Study|Pregnancy|0|||
44507263|NCT04750278|79512118|FG002|Overall Study|Pregnancy|0|||
44507264|NCT04750278|79512116|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
44507265|NCT04750278|79512117|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
44507266|NCT04750278|79512118|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
44507267|NCT04750278|79512116|FG000|Overall Study|Non-compliance|0|||
44507268|NCT04750278|79512117|FG001|Overall Study|Non-compliance|0|||
44507269|NCT04750278|79512118|FG002|Overall Study|Non-compliance|1|||
44507270|NCT04750278|79512116|FG000|Overall Study|Transfer to Outside Facility|0|||
44507271|NCT04750278|79512117|FG001|Overall Study|Transfer to Outside Facility|2|||
44507272|NCT04750278|79512118|FG002|Overall Study|Transfer to Outside Facility|1|||
44507273|NCT04750278|79512116|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
44507274|NCT04750278|79512117|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
44507275|NCT04750278|79512118|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
44507276|NCT04750278|79512116|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
44507277|NCT04750278|79512117|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
44507278|NCT04750278|79512118|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
44507279|NCT04317274|79512175|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
44507280|NCT04317274|79512176|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
44507281|NCT04317274|79512177|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
44507282|NCT04317274|79512178|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
44507283|NCT03875911|79512191|FG000|Overall Study|Lost to Follow-up|3|||
44507284|NCT03875911|79512192|FG001|Overall Study|Lost to Follow-up|6|||
44507285|NCT03875911|79512193|FG002|Overall Study|Lost to Follow-up|2|||
44507286|NCT03875911|79512191|FG000|Overall Study|Surgery cancelled|1|||
44507287|NCT03875911|79512192|FG001|Overall Study|Surgery cancelled|0|||
44507288|NCT03875911|79512193|FG002|Overall Study|Surgery cancelled|1|||
44507289|NCT03875911|79512191|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
44507290|NCT03875911|79512192|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
44576290|NCT00665223|79599149|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
44576291|NCT00665223|79599150|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
44576292|NCT00665223|79599151|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
44576293|NCT03786380|79599172|FG000|Overall Study|Adverse Event|1|||
44576294|NCT03786380|79599173|FG001|Overall Study|Adverse Event|0|||
44576295|NCT03786380|79599174|FG002|Overall Study|Adverse Event|0|||
44576296|NCT03786380|79599175|FG003|Overall Study|Adverse Event|3|||
44576297|NCT03786380|79599176|FG004|Overall Study|Adverse Event|1|||
44576298|NCT03786380|79599172|FG000|Overall Study|Lack of Efficacy|0|||
44576299|NCT03786380|79599173|FG001|Overall Study|Lack of Efficacy|0|||
44576300|NCT03786380|79599174|FG002|Overall Study|Lack of Efficacy|0|||
44576301|NCT03786380|79599175|FG003|Overall Study|Lack of Efficacy|0|||
44576302|NCT03786380|79599176|FG004|Overall Study|Lack of Efficacy|1|||
44576303|NCT03786380|79599172|FG000|Overall Study|Withdrawal by Subject|1|||
44576304|NCT03786380|79599173|FG001|Overall Study|Withdrawal by Subject|2|||
44576305|NCT03786380|79599174|FG002|Overall Study|Withdrawal by Subject|2|||
44576306|NCT03786380|79599175|FG003|Overall Study|Withdrawal by Subject|1|||
44576307|NCT03786380|79599176|FG004|Overall Study|Withdrawal by Subject|2|||
44576308|NCT03786380|79599172|FG000|Overall Study|Lost to Follow-up|3|||
44576309|NCT03786380|79599173|FG001|Overall Study|Lost to Follow-up|0|||
44576310|NCT03786380|79599174|FG002|Overall Study|Lost to Follow-up|1|||
44576311|NCT03786380|79599175|FG003|Overall Study|Lost to Follow-up|2|||
44576312|NCT03786380|79599176|FG004|Overall Study|Lost to Follow-up|0|||
44576313|NCT03786380|79599172|FG000|Overall Study|Physician Decision|0|||
44576314|NCT03786380|79599173|FG001|Overall Study|Physician Decision|0|||
44576315|NCT03786380|79599174|FG002|Overall Study|Physician Decision|1|||
44576316|NCT03786380|79599175|FG003|Overall Study|Physician Decision|0|||
44576317|NCT03786380|79599176|FG004|Overall Study|Physician Decision|0|||
44576318|NCT03786380|79599172|FG000|Overall Study|Study Terminated by the Sponsor|30|||
44576319|NCT03786380|79599173|FG001|Overall Study|Study Terminated by the Sponsor|20|||
44576320|NCT03786380|79599174|FG002|Overall Study|Study Terminated by the Sponsor|50|||
44576321|NCT03786380|79599175|FG003|Overall Study|Study Terminated by the Sponsor|57|||
44576322|NCT03786380|79599176|FG004|Overall Study|Study Terminated by the Sponsor|23|||
44118432|NCT02738775|78901960|FG003|Overall Study|Adverse Event|1|||
44118433|NCT02738775|78901961|FG004|Overall Study|Adverse Event|0|||
44576323|NCT03786380|79599172|FG000|Overall Study|Reason Not Specified|0|||
44576324|NCT03786380|79599173|FG001|Overall Study|Reason Not Specified|0|||
44576325|NCT03786380|79599174|FG002|Overall Study|Reason Not Specified|0|||
44576326|NCT03786380|79599175|FG003|Overall Study|Reason Not Specified|0|||
44576327|NCT03786380|79599176|FG004|Overall Study|Reason Not Specified|1|||
44576328|NCT02626000|79599188|FG000|Overall Study|Decision by Sponsor|1|||
44576329|NCT02626000|79599188|FG000|Overall Study|Death|29|||
44576330|NCT02736890|79599204|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
44576331|NCT02736890|79599205|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
44576332|NCT02736890|79599204|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
44576333|NCT02736890|79599205|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
44576334|NCT02779556|79599213|FG000|Baseline|Partial baseline interview completed|1|||
44576335|NCT02779556|79599214|FG001|Baseline|Partial baseline interview completed|0|||
44576336|NCT02779556|79599213|FG000|3 Months|Lost to Follow-up|40|||
44576337|NCT02779556|79599214|FG001|3 Months|Lost to Follow-up|29|||
44576338|NCT02779556|79599213|FG000|3 Months|Missed 3 month clinic visit|27|||
44576339|NCT02779556|79599214|FG001|3 Months|Missed 3 month clinic visit|19|||
44576340|NCT02779556|79599213|FG000|6 Month|Lost to Follow-up|33|||
44576341|NCT02779556|79599214|FG001|6 Month|Lost to Follow-up|39|||
44576342|NCT02779556|79599213|FG000|6 Month HbA1c|No value collected during window|69|||
44576343|NCT02779556|79599214|FG001|6 Month HbA1c|No value collected during window|50|||
44576344|NCT02779556|79599213|FG000|12 Month HbA1c|No value collected during window|138|||
44576345|NCT02779556|79599214|FG001|12 Month HbA1c|No value collected during window|102|||
44576346|NCT01669798|79599220|FG000|Overall Study|Physician Decision|5|||
44118434|NCT02738775|78901962|FG005|Overall Study|Adverse Event|0|||
44118435|NCT02738775|78901957|FG000|Overall Study|Pregnancy|0|||
44118436|NCT02738775|78901958|FG001|Overall Study|Pregnancy|1|||
44239116|NCT01565707|79065914|FG000|Overall Study|Adverse Event|1|||
44576347|NCT02334722|79599226|FG000|Overall Study|Lost to Follow-up|4|||
44239117|NCT01565707|79065915|FG001|Overall Study|Adverse Event|6|||
44576348|NCT02334722|79599227|FG001|Overall Study|Lost to Follow-up|0|||
44118437|NCT02738775|78901959|FG002|Overall Study|Pregnancy|0|||
44118438|NCT02738775|78901960|FG003|Overall Study|Pregnancy|0|||
44576349|NCT02334722|79599226|FG000|Overall Study|6 week questionnaire not completed|2|||
44576350|NCT02334722|79599227|FG001|Overall Study|6 week questionnaire not completed|0|||
44118439|NCT02738775|78901961|FG004|Overall Study|Pregnancy|0|||
44576351|NCT02334722|79599226|FG000|Overall Study|Unable to obtain medication|1|||
44576352|NCT02334722|79599227|FG001|Overall Study|Unable to obtain medication|1|||
44576353|NCT02334722|79599226|FG000|Overall Study|Withdrawal by Subject|0|||
44576354|NCT02334722|79599227|FG001|Overall Study|Withdrawal by Subject|3|||
44576355|NCT02334722|79599226|FG000|Overall Study|Adverse Event|0|||
44118440|NCT02738775|78901962|FG005|Overall Study|Pregnancy|0|||
44576356|NCT02334722|79599227|FG001|Overall Study|Adverse Event|2|||
44576357|NCT02334722|79599226|FG000|Overall Study|Physician Decision|0|||
44576358|NCT02334722|79599227|FG001|Overall Study|Physician Decision|1|||
44576359|NCT00812708|79599242|FG000|Overall Study|Device could not be implanted|2|||
44576360|NCT00812708|79599242|FG000|Overall Study|Lack of medical insurance|1|||
44576361|NCT00812708|79599242|FG000|Overall Study|Switched to another study|1|||
44576362|NCT00812708|79599242|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
44576363|NCT00812708|79599242|FG000|Overall Study|Signed consent but later withdrew|3|||
44576364|NCT03761810|79599258|FG000|Overall Study|Adverse Event|12|||
44576365|NCT03761810|79599259|FG001|Overall Study|Adverse Event|0|||
44576366|NCT03761810|79599258|FG000|Overall Study|Lost to Follow-up|15|||
44576367|NCT03761810|79599259|FG001|Overall Study|Lost to Follow-up|7|||
44576368|NCT03761810|79599258|FG000|Overall Study|Pregnancy|1|||
44576369|NCT03761810|79599259|FG001|Overall Study|Pregnancy|0|||
44576370|NCT03761810|79599258|FG000|Overall Study|Withdrawal by Subject|14|||
44576371|NCT03761810|79599259|FG001|Overall Study|Withdrawal by Subject|5|||
44239118|NCT01565707|79065916|FG002|Overall Study|Adverse Event|2|||
44378319|NCT00833794|79383593|FG001|Double-blind Phase|Adverse Event|11|||
44576372|NCT03761810|79599258|FG000|Overall Study|Physician Decision|1|||
44576373|NCT03761810|79599259|FG001|Overall Study|Physician Decision|0|||
44576374|NCT03761810|79599258|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
44576375|NCT03761810|79599259|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44576376|NCT03761810|79599258|FG000|Overall Study|Other Than Specified|1|||
44576377|NCT03761810|79599259|FG001|Overall Study|Other Than Specified|0|||
44576378|NCT02811159|79599270|FG000|Treatment Course 1|Lost to Follow-up|1|||
44576379|NCT01889186|79599276|FG000|Overall Study|Adverse event- not related to progression|18|||
44576380|NCT01889186|79599277|FG001|Overall Study|Adverse event- not related to progression|5|||
44576381|NCT01889186|79599276|FG000|Overall Study|Adverse event- related to progression|7|||
44576382|NCT01889186|79599277|FG001|Overall Study|Adverse event- related to progression|2|||
44576383|NCT01889186|79599276|FG000|Overall Study|COVID-19 logistical restrictions|1|||
44576384|NCT01889186|79599277|FG001|Overall Study|COVID-19 logistical restrictions|0|||
44576385|NCT01889186|79599276|FG000|Overall Study|Investigator request|1|||
44576386|NCT01889186|79599277|FG001|Overall Study|Investigator request|1|||
44576387|NCT01889186|79599276|FG000|Overall Study|Progressive disease- Richter's|12|||
44576388|NCT01889186|79599277|FG001|Overall Study|Progressive disease- Richter's|7|||
44576389|NCT01889186|79599276|FG000|Overall Study|Progressive disease per protocol|46|||
44576390|NCT01889186|79599277|FG001|Overall Study|Progressive disease per protocol|17|||
44576391|NCT01889186|79599276|FG000|Overall Study|Stem cell transplant|2|||
44576392|NCT01889186|79599277|FG001|Overall Study|Stem cell transplant|1|||
44576393|NCT01889186|79599276|FG000|Overall Study|Withdrew consent|2|||
44576394|NCT01889186|79599277|FG001|Overall Study|Withdrew consent|3|||
44576395|NCT01889186|79599276|FG000|Overall Study|Other, not specified|18|||
44576396|NCT01889186|79599277|FG001|Overall Study|Other, not specified|15|||
44576397|NCT01510184|79599287|FG000|Overall Study|Sponsor discretion|28|||
44576398|NCT01510184|79599288|FG001|Overall Study|Sponsor discretion|28|||
44576399|NCT01510184|79599287|FG000|Overall Study|Death|1|||
44576400|NCT01510184|79599288|FG001|Overall Study|Death|2|||
44576401|NCT01510184|79599287|FG000|Overall Study|Withdrawal by Subject|1|||
44576402|NCT01510184|79599288|FG001|Overall Study|Withdrawal by Subject|4|||
44576403|NCT01510184|79599287|FG000|Overall Study|Other|0|||
44576404|NCT01510184|79599288|FG001|Overall Study|Other|1|||
44507291|NCT03875911|79512193|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
44507292|NCT03836053|79512215|FG000|Overall Study|Protocol-specified criteria|0|||
44507293|NCT03836053|79512216|FG001|Overall Study|Protocol-specified criteria|2|||
44507294|NCT03836053|79512217|FG002|Overall Study|Protocol-specified criteria|1|||
44507295|NCT03836053|79512215|FG000|Overall Study|Death|1|||
44507296|NCT03836053|79512216|FG001|Overall Study|Death|6|||
44507297|NCT03836053|79512217|FG002|Overall Study|Death|4|||
44507298|NCT03836053|79512215|FG000|Overall Study|Withdrawal of consent from study|0|||
44507299|NCT03836053|79512216|FG001|Overall Study|Withdrawal of consent from study|0|||
44239119|NCT01565707|79065917|FG003|Overall Study|Adverse Event|1|||
44239120|NCT01565707|79065914|FG000|Overall Study|Lost to Follow-up|1|||
44239121|NCT01565707|79065915|FG001|Overall Study|Lost to Follow-up|0|||
44576405|NCT02809833|79599313|FG000|Overall Study|Death|3|||
44576406|NCT02809833|79599313|FG000|Overall Study|Intolerance|54|||
44507300|NCT03836053|79512217|FG002|Overall Study|Withdrawal of consent from study|1|||
44576407|NCT02809833|79599313|FG000|Overall Study|Lack of Efficacy|89|||
44576408|NCT02809833|79599313|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
44576409|NCT02809833|79599313|FG000|Overall Study|Noncompliance|1|||
44576410|NCT02809833|79599313|FG000|Overall Study|Withdrawal by Subject|34|||
44576411|NCT02809833|79599313|FG000|Overall Study|Lost to Follow-up|35|||
44576412|NCT02809833|79599313|FG000|Overall Study|Adverse Event (AE)|24|||
44576413|NCT02809833|79599313|FG000|Overall Study|Other|5|||
44576414|NCT02809833|79599313|FG000|Overall Study|Missing Information|52|||
44576415|NCT02797262|79599319|FG000|Overall Study|Withdrawal by Subject|5|||
44576416|NCT02797262|79599320|FG001|Overall Study|Withdrawal by Subject|1|||
44239122|NCT01565707|79065916|FG002|Overall Study|Lost to Follow-up|0|||
44576417|NCT02797262|79599319|FG000|Overall Study|Lost to Follow-up|10|||
44576418|NCT02797262|79599320|FG001|Overall Study|Lost to Follow-up|7|||
44576419|NCT02797262|79599319|FG000|Overall Study|Death|1|||
44576420|NCT02797262|79599320|FG001|Overall Study|Death|2|||
44576421|NCT02797262|79599319|FG000|Overall Study|Adverse Event|1|||
44507301|NCT03836053|79512215|FG000|Overall Study|Decision by sponsor|0|||
44507302|NCT03836053|79512216|FG001|Overall Study|Decision by sponsor|2|||
44507303|NCT03836053|79512217|FG002|Overall Study|Decision by sponsor|4|||
44507304|NCT03647137|79512246|FG000|Overall Study|Scan Limitation|2|||
44507305|NCT03647137|79512247|FG001|Overall Study|Scan Limitation|1|||
44507306|NCT03647137|79512248|FG002|Overall Study|Scan Limitation|1|||
44507307|NCT03647137|79512249|FG003|Overall Study|Scan Limitation|2|||
44118441|NCT02738775|78901957|FG000|Overall Study|Missing|0|||
44507308|NCT03481660|79512262|FG000|Overall Study|Adverse Event|5|||
44507309|NCT03481660|79512263|FG001|Overall Study|Adverse Event|4|||
44507310|NCT03481660|79512262|FG000|Overall Study|Death|13|||
44507311|NCT03481660|79512263|FG001|Overall Study|Death|9|||
44507312|NCT03481660|79512262|FG000|Overall Study|Lost to Follow-up|2|||
44507313|NCT03481660|79512263|FG001|Overall Study|Lost to Follow-up|2|||
44507314|NCT03481660|79512262|FG000|Overall Study|Physician Decision|2|||
44507315|NCT03481660|79512263|FG001|Overall Study|Physician Decision|3|||
44507316|NCT03481660|79512262|FG000|Overall Study|Withdrawal by Subject|14|||
44507317|NCT03481660|79512263|FG001|Overall Study|Withdrawal by Subject|7|||
44507318|NCT03454893|79512270|FG000|Overall Study|Study Terminated by the Sponsor|5|||
44507319|NCT03454893|79512270|FG000|Overall Study|Did not pass screening|4|||
44507320|NCT03379792|79512280|FG000|Overall Study|Physician Decision|0|||
44507321|NCT03379792|79512281|FG001|Overall Study|Physician Decision|0|||
44507322|NCT03379792|79512282|FG002|Overall Study|Physician Decision|0|||
44507323|NCT03379792|79512283|FG003|Overall Study|Physician Decision|1|||
44507324|NCT03379792|79512284|FG004|Overall Study|Physician Decision|0|||
44118442|NCT02738775|78901958|FG001|Overall Study|Missing|0|||
44118443|NCT02738775|78901959|FG002|Overall Study|Missing|0|||
44118444|NCT02738775|78901960|FG003|Overall Study|Missing|0|||
44118445|NCT02738775|78901961|FG004|Overall Study|Missing|0|||
44118446|NCT02738775|78901962|FG005|Overall Study|Missing|1|||
44118447|NCT02314923|78901999|FG000|Overall Study|Death|0|||
44239123|NCT01565707|79065917|FG003|Overall Study|Lost to Follow-up|0|||
44507325|NCT03379792|79512285|FG005|Overall Study|Physician Decision|0|||
44507326|NCT03379792|79512280|FG000|Overall Study|Withdrawal by Subject|0|||
44507327|NCT03379792|79512281|FG001|Overall Study|Withdrawal by Subject|0|||
44507328|NCT03379792|79512282|FG002|Overall Study|Withdrawal by Subject|0|||
44507329|NCT03379792|79512283|FG003|Overall Study|Withdrawal by Subject|0|||
44507330|NCT03379792|79512284|FG004|Overall Study|Withdrawal by Subject|1|||
44507331|NCT03379792|79512285|FG005|Overall Study|Withdrawal by Subject|1|||
44507332|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
44507333|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
44507334|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
44507335|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
44507336|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
44576422|NCT02797262|79599320|FG001|Overall Study|Adverse Event|0|||
44576423|NCT02797262|79599319|FG000|Overall Study|COVID-19|2|||
44576424|NCT02797262|79599320|FG001|Overall Study|COVID-19|1|||
44576425|NCT02797262|79599319|FG000|Overall Study|Out-of-country|1|||
44576426|NCT02797262|79599320|FG001|Overall Study|Out-of-country|0|||
44576427|NCT02809053|79599328|FG000|Overall Study|Death|0|||
44576428|NCT02809053|79599329|FG001|Overall Study|Death|1|||
44576429|NCT02809053|79599328|FG000|Overall Study|Lost to Follow-up|3|||
44576430|NCT02809053|79599329|FG001|Overall Study|Lost to Follow-up|1|||
44576431|NCT02809053|79599328|FG000|Overall Study|Withdrawal by Subject|2|||
44576432|NCT02809053|79599329|FG001|Overall Study|Withdrawal by Subject|3|||
44576433|NCT02809053|79599328|FG000|Overall Study|Disease Progression|2|||
44576434|NCT02809053|79599329|FG001|Overall Study|Disease Progression|1|||
44576435|NCT02808975|79599337|FG000|Overall Study|Adverse Event|3|||
44239124|NCT01565707|79065914|FG000|Overall Study|Protocol Violation|1|||
44239125|NCT01565707|79065915|FG001|Overall Study|Protocol Violation|0|||
44239126|NCT01565707|79065916|FG002|Overall Study|Protocol Violation|0|||
44507337|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
44507338|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Death|1|||
44507339|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Death|1|||
44576436|NCT02808975|79599338|FG001|Overall Study|Adverse Event|4|||
44576437|NCT02808975|79599337|FG000|Overall Study|Withdrew consent|9|||
44576438|NCT02808975|79599338|FG001|Overall Study|Withdrew consent|8|||
44576439|NCT02808975|79599337|FG000|Overall Study|Lost to Follow-up|4|||
44118448|NCT02314923|78902000|FG001|Overall Study|Death|0|||
44118449|NCT02314923|78902001|FG002|Overall Study|Death|0|||
44118450|NCT02314923|78902002|FG003|Overall Study|Death|1|||
44239127|NCT01565707|79065917|FG003|Overall Study|Protocol Violation|1|||
44507340|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Death|1|||
44576440|NCT02808975|79599338|FG001|Overall Study|Lost to Follow-up|6|||
44576441|NCT02808975|79599337|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
44118451|NCT02314923|78902003|FG004|Overall Study|Death|0|||
44118452|NCT02314923|78902004|FG005|Overall Study|Death|0|||
44118453|NCT02314923|78902005|FG006|Overall Study|Death|0|||
44118454|NCT02314923|78902006|FG007|Overall Study|Death|0|||
44507341|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Death|0|||
44507342|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Death|0|||
44507343|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Death|0|||
44507344|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
44507345|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
44507346|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
44507347|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
44507348|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
44507349|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
44507350|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
44507351|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
44507352|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
44507353|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
44507354|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
44507355|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
44576442|NCT02808975|79599338|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
44576443|NCT02808975|79599337|FG000|Overall Study|Other, not specified|5|||
44576444|NCT02808975|79599338|FG001|Overall Study|Other, not specified|1|||
44576445|NCT02976038|79599344|FG000|Overall Study|Physician Decision|22|||
44118455|NCT02314923|78902007|FG008|Overall Study|Death|0|||
44118456|NCT02314923|78902008|FG009|Overall Study|Death|0|||
44118457|NCT02314923|78901999|FG000|Overall Study|Lost to Follow-up|2|||
44118458|NCT02314923|78902000|FG001|Overall Study|Lost to Follow-up|3|||
44576446|NCT02976038|79599344|FG000|Overall Study|Withdrawal by Subject|3|||
44576447|NCT02976038|79599344|FG000|Overall Study|Lost to Follow-up|2|||
44576448|NCT02976038|79599344|FG000|Overall Study|Adverse Event|1|||
44576449|NCT02808819|79599369|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
44576450|NCT02808819|79599370|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
44576451|NCT02808819|79599369|FG000|Overall Study|Withdrawal by Subject|10|||
44576452|NCT02808819|79599370|FG001|Overall Study|Withdrawal by Subject|13|||
44576453|NCT02808819|79599369|FG000|Overall Study|Site terminated by sponsor|2|||
44576454|NCT02808819|79599370|FG001|Overall Study|Site terminated by sponsor|0|||
44576455|NCT02808819|79599369|FG000|Overall Study|Pregnancy|1|||
44576456|NCT02808819|79599370|FG001|Overall Study|Pregnancy|0|||
44576457|NCT02808819|79599369|FG000|Overall Study|Lost to Follow-up|1|||
44576458|NCT02808819|79599370|FG001|Overall Study|Lost to Follow-up|6|||
44576459|NCT02808819|79599369|FG000|Overall Study|Protocol Violation|0|||
44576460|NCT02808819|79599370|FG001|Overall Study|Protocol Violation|1|||
44576461|NCT02808819|79599369|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
44576462|NCT02808819|79599370|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
44576463|NCT02808819|79599369|FG000|Overall Study|Death|1|||
44576464|NCT02808819|79599370|FG001|Overall Study|Death|0|||
44576465|NCT02808819|79599369|FG000|Overall Study|Adverse Event|3|||
44576466|NCT02808819|79599370|FG001|Overall Study|Adverse Event|4|||
44576467|NCT02808429|79599380|FG000|Overall Study|Lost to Follow-up|1|||
44576468|NCT02808429|79599381|FG001|Overall Study|Lost to Follow-up|0|||
44576469|NCT02808429|79599382|FG002|Overall Study|Lost to Follow-up|0|||
44576470|NCT02808429|79599380|FG000|Overall Study|Protocol Violation|0|||
44576471|NCT02808429|79599381|FG001|Overall Study|Protocol Violation|1|||
44576472|NCT02808429|79599382|FG002|Overall Study|Protocol Violation|0|||
44576473|NCT02808429|79599380|FG000|Overall Study|Premature study termination by sponsor|2|||
44576474|NCT02808429|79599381|FG001|Overall Study|Premature study termination by sponsor|0|||
44576475|NCT02808429|79599382|FG002|Overall Study|Premature study termination by sponsor|1|||
44576476|NCT02808429|79599380|FG000|Overall Study|Relocation|0|||
44576477|NCT02808429|79599381|FG001|Overall Study|Relocation|0|||
44576478|NCT02808429|79599382|FG002|Overall Study|Relocation|1|||
44576479|NCT01594762|79599392|FG000|Overall Study|Withdrawal by Subject|1|||
44576480|NCT01594762|79599393|FG001|Overall Study|Withdrawal by Subject|0|||
44118459|NCT02314923|78902001|FG002|Overall Study|Lost to Follow-up|1|||
44118460|NCT02314923|78902002|FG003|Overall Study|Lost to Follow-up|0|||
44118461|NCT02314923|78902003|FG004|Overall Study|Lost to Follow-up|0|||
44576481|NCT01594762|79599392|FG000|Overall Study|Lost to Follow-up|10|||
44576482|NCT01594762|79599393|FG001|Overall Study|Lost to Follow-up|10|||
44576483|NCT02615470|79599401|FG000|Overall Study|Lost to Follow-up|21|||
44576484|NCT02615470|79599402|FG001|Overall Study|Lost to Follow-up|32|||
44576485|NCT02806947|79599410|FG000|Overall Study|Withdrawal by Subject|5|||
44576486|NCT02806947|79599411|FG001|Overall Study|Withdrawal by Subject|1|||
44576487|NCT02806713|79599419|FG000|Overall Study|Urethral injury during procedure|1|||
44118462|NCT02314923|78902004|FG005|Overall Study|Lost to Follow-up|0|||
44118463|NCT02314923|78902005|FG006|Overall Study|Lost to Follow-up|3|||
44576488|NCT02806713|79599420|FG001|Overall Study|Urethral injury during procedure|0|||
44576489|NCT02806713|79599419|FG000|Overall Study|cancelled surgery|1|||
44576490|NCT02806713|79599420|FG001|Overall Study|cancelled surgery|2|||
44576491|NCT02807493|79599428|FG000|Overall Study|Adverse Event|5|||
44576492|NCT02807493|79599429|FG001|Overall Study|Adverse Event|2|||
44576493|NCT02807493|79599428|FG000|Overall Study|Lost to Follow-up|6|||
44576494|NCT02807493|79599429|FG001|Overall Study|Lost to Follow-up|0|||
44576495|NCT02807493|79599428|FG000|Overall Study|Physician Decision|4|||
44576496|NCT02807493|79599429|FG001|Overall Study|Physician Decision|1|||
44576497|NCT02807493|79599428|FG000|Overall Study|Protocol Violation|7|||
44576498|NCT02807493|79599429|FG001|Overall Study|Protocol Violation|0|||
44576499|NCT02807493|79599428|FG000|Overall Study|Withdrawal by Subject|17|||
44576500|NCT02807493|79599429|FG001|Overall Study|Withdrawal by Subject|10|||
44576501|NCT02807493|79599428|FG000|Overall Study|Other withdrawal|17|||
44576502|NCT02807493|79599429|FG001|Overall Study|Other withdrawal|0|||
44576503|NCT02807493|79599428|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
44576504|NCT02807493|79599429|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
44576505|NCT02807259|79599437|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
44576506|NCT02807259|79599438|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
44576507|NCT02807259|79599437|FG000|Midline (3 Months)|migration, refusal, not available|30|||
44576508|NCT02807259|79599438|FG001|Midline (3 Months)|migration, refusal, not available|34|||
44576509|NCT02807259|79599437|FG000|Endline (3 Months)|migration, refusal, not available|35|||
44576510|NCT02807259|79599438|FG001|Endline (3 Months)|migration, refusal, not available|87|||
44576511|NCT02802345|79599448|FG000|Overall Study|Not Treated|0|||
44576512|NCT02802345|79599449|FG001|Overall Study|Not Treated|1|||
44576513|NCT02802345|79599448|FG000|Overall Study|Adverse Event|28|||
44576514|NCT02802345|79599449|FG001|Overall Study|Adverse Event|20|||
44576515|NCT02802345|79599448|FG000|Overall Study|Withdrawal by Subject|3|||
44576516|NCT02802345|79599449|FG001|Overall Study|Withdrawal by Subject|3|||
44576517|NCT02802345|79599448|FG000|Overall Study|Protocol Violation|0|||
44576518|NCT02802345|79599449|FG001|Overall Study|Protocol Violation|1|||
44576519|NCT02802345|79599448|FG000|Overall Study|Other than listed|1|||
44576520|NCT02802345|79599449|FG001|Overall Study|Other than listed|5|||
44576521|NCT02801877|79599459|FG000|Overall Study|Lost to Follow-up|1|||
44576522|NCT02801877|79599460|FG001|Overall Study|Lost to Follow-up|1|||
44576523|NCT02801877|79599461|FG002|Overall Study|Lost to Follow-up|2|||
44576524|NCT02801877|79599462|FG003|Overall Study|Lost to Follow-up|0|||
44576525|NCT02801877|79599459|FG000|Overall Study|Never Started Treatment|2|||
44576526|NCT02801877|79599460|FG001|Overall Study|Never Started Treatment|0|||
44576527|NCT02801877|79599461|FG002|Overall Study|Never Started Treatment|4|||
44576528|NCT02801877|79599462|FG003|Overall Study|Never Started Treatment|0|||
44576529|NCT02805309|79599475|FG000|Overall Study|Lost to Follow-up|2|||
44576530|NCT02805309|79599476|FG001|Overall Study|Lost to Follow-up|2|||
44576531|NCT02805309|79599477|FG002|Overall Study|Lost to Follow-up|2|||
44576532|NCT02805309|79599475|FG000|Overall Study|Post-Randomization Exclusion|0|||
44576533|NCT02805309|79599476|FG001|Overall Study|Post-Randomization Exclusion|2|||
44576534|NCT02805309|79599477|FG002|Overall Study|Post-Randomization Exclusion|1|||
44576535|NCT02804763|79599489|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
44576536|NCT02804763|79599490|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
44576537|NCT02804763|79599491|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
44576538|NCT02804763|79599492|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
44576539|NCT02804763|79599489|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
44576540|NCT02804763|79599490|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
44576541|NCT02804763|79599491|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
44576542|NCT02804763|79599492|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
44576543|NCT02804763|79599489|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
44576544|NCT02804763|79599490|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
44576545|NCT02804763|79599491|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
44576546|NCT02804763|79599492|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
44576547|NCT02804763|79599489|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
44576548|NCT02804763|79599490|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
44118464|NCT02314923|78902006|FG007|Overall Study|Lost to Follow-up|4|||
44239128|NCT01565707|79065914|FG000|Overall Study|Withdrawal by Subject|3|||
44239129|NCT01565707|79065915|FG001|Overall Study|Withdrawal by Subject|1|||
44378320|NCT00833794|79383592|FG000|Double-blind Phase|Lack of Efficacy|34|||
44576549|NCT02804763|79599491|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
44576550|NCT02804763|79599492|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
44576551|NCT02804763|79599489|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
44576552|NCT02804763|79599490|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
44576553|NCT02804763|79599491|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
44576554|NCT02804763|79599492|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
44576555|NCT02804763|79599489|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
44118465|NCT02314923|78902007|FG008|Overall Study|Lost to Follow-up|2|||
44576556|NCT02804763|79599490|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
44576557|NCT02804763|79599491|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
44576558|NCT02804763|79599492|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
44576559|NCT02748057|79599508|FG000|Overall Study|Adverse Event|1|||
44576560|NCT02748057|79599509|FG001|Overall Study|Adverse Event|0|||
44576561|NCT02748057|79599508|FG000|Overall Study|Physician Decision|0|||
44576562|NCT02748057|79599509|FG001|Overall Study|Physician Decision|1|||
44576563|NCT02748057|79599508|FG000|Overall Study|Protocol Violation|2|||
44576564|NCT02748057|79599509|FG001|Overall Study|Protocol Violation|1|||
44576565|NCT02748057|79599508|FG000|Overall Study|Participant Moved|1|||
44576566|NCT02748057|79599509|FG001|Overall Study|Participant Moved|0|||
44576567|NCT02748057|79599508|FG000|Overall Study|Withdrawal by Subject|1|||
44576568|NCT02748057|79599509|FG001|Overall Study|Withdrawal by Subject|0|||
44576569|NCT02748213|79599517|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
44576570|NCT02748213|79599518|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
44576571|NCT02748213|79599517|FG000|Overall Study|Abnormal Laboratory Test|1|||
44576572|NCT02748213|79599518|FG001|Overall Study|Abnormal Laboratory Test|0|||
44576573|NCT02748213|79599517|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
44576574|NCT02748213|79599518|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
44576575|NCT02748213|79599517|FG000|Overall Study|Death|5|||
44576576|NCT02748213|79599518|FG001|Overall Study|Death|3|||
44576577|NCT02748213|79599517|FG000|Overall Study|Insufficient Therapeutic Response|56|||
44576578|NCT02748213|79599518|FG001|Overall Study|Insufficient Therapeutic Response|57|||
44576579|NCT02748213|79599517|FG000|Overall Study|Violation of Selection Criteria|2|||
44576580|NCT02748213|79599518|FG001|Overall Study|Violation of Selection Criteria|0|||
44576581|NCT02748213|79599517|FG000|Overall Study|Protocol Violation|6|||
44576582|NCT02748213|79599518|FG001|Overall Study|Protocol Violation|4|||
44576583|NCT02748213|79599517|FG000|Overall Study|Refused Treatment*|6|||
44576584|NCT02748213|79599518|FG001|Overall Study|Refused Treatment*|6|||
44576585|NCT02748213|79599517|FG000|Overall Study|Failure to Return|1|||
44576586|NCT02748213|79599518|FG001|Overall Study|Failure to Return|0|||
44576587|NCT02748213|79599517|FG000|Overall Study|Other|30|||
44576588|NCT02748213|79599518|FG001|Overall Study|Other|29|||
44576589|NCT02613910|79599524|FG000|Overall Study|Termination of study|1|||
44576590|NCT02802735|79599531|FG000|Overall Study|Withdrawal by Subject|0|||
44576591|NCT02802735|79599532|FG001|Overall Study|Withdrawal by Subject|1|||
44576592|NCT02802735|79599533|FG002|Overall Study|Withdrawal by Subject|0|||
44576593|NCT02802735|79599534|FG003|Overall Study|Withdrawal by Subject|0|||
44576594|NCT02802735|79599535|FG004|Overall Study|Withdrawal by Subject|0|||
44576595|NCT02799381|79599565|FG000|Overall Study|Withdrew consent|3|||
44576596|NCT02799381|79599566|FG001|Overall Study|Withdrew consent|2|||
44576597|NCT02799381|79599565|FG000|Overall Study|Adverse Event|0|||
44576598|NCT02799381|79599566|FG001|Overall Study|Adverse Event|1|||
44576599|NCT02799381|79599565|FG000|Overall Study|Participant did not take any study drug|1|||
44576600|NCT02799381|79599566|FG001|Overall Study|Participant did not take any study drug|0|||
44576601|NCT01333059|79599574|FG000|Overall Study|Physician Decision|3|||
44576602|NCT01333059|79599575|FG001|Overall Study|Physician Decision|3|||
44576603|NCT01333059|79599574|FG000|Overall Study|Protocol Violation|3|||
44576604|NCT01333059|79599575|FG001|Overall Study|Protocol Violation|0|||
44576605|NCT01370733|79599585|FG000|Overall Study|Withdrawal by Subject|8|||
44576606|NCT01370733|79599586|FG001|Overall Study|Withdrawal by Subject|8|||
44576607|NCT01370733|79599585|FG000|Overall Study|Lost to Follow-up|3|||
44576608|NCT01370733|79599586|FG001|Overall Study|Lost to Follow-up|0|||
44576609|NCT01370733|79599585|FG000|Overall Study|Adverse Event|2|||
44576610|NCT01370733|79599586|FG001|Overall Study|Adverse Event|4|||
44576611|NCT01370733|79599585|FG000|Overall Study|Lack of Efficacy|3|||
44576612|NCT01370733|79599586|FG001|Overall Study|Lack of Efficacy|5|||
44576613|NCT01370733|79599585|FG000|Overall Study|Physician Decision|0|||
44576614|NCT01370733|79599586|FG001|Overall Study|Physician Decision|2|||
44576615|NCT01370733|79599585|FG000|Overall Study|Protocol Violation|1|||
44576616|NCT01370733|79599586|FG001|Overall Study|Protocol Violation|3|||
44576617|NCT02613364|79599595|FG000|Overall Study|Other|19|||
44576618|NCT02613364|79599596|FG001|Overall Study|Other|29|||
44576619|NCT02613364|79599597|FG002|Overall Study|Other|17|||
44576620|NCT02613364|79599595|FG000|Overall Study|Too time consuming|21|||
44576621|NCT02613364|79599596|FG001|Overall Study|Too time consuming|26|||
44576622|NCT02613364|79599597|FG002|Overall Study|Too time consuming|26|||
44576623|NCT02613364|79599595|FG000|Overall Study|Withdrawal by Subject|13|||
44576624|NCT02613364|79599596|FG001|Overall Study|Withdrawal by Subject|18|||
44576625|NCT02613364|79599597|FG002|Overall Study|Withdrawal by Subject|17|||
44576626|NCT02613364|79599595|FG000|Overall Study|Medical|12|||
44576627|NCT02613364|79599596|FG001|Overall Study|Medical|13|||
44576628|NCT02613364|79599597|FG002|Overall Study|Medical|9|||
44576629|NCT02613364|79599595|FG000|Overall Study|Disliked Study Procedure|1|||
44576630|NCT02613364|79599596|FG001|Overall Study|Disliked Study Procedure|1|||
44576631|NCT02613364|79599597|FG002|Overall Study|Disliked Study Procedure|4|||
44576632|NCT02613364|79599595|FG000|Overall Study|Disliked Intervention|0|||
44576633|NCT02613364|79599596|FG001|Overall Study|Disliked Intervention|3|||
44576634|NCT02613364|79599597|FG002|Overall Study|Disliked Intervention|3|||
44576635|NCT01370655|79599617|FG000|Period 1|Adverse Event|2|||
44576636|NCT01370655|79599618|FG001|Period 1|Adverse Event|0|||
44576637|NCT01370655|79599619|FG002|Period 1|Adverse Event|0|||
44576638|NCT01370655|79599620|FG003|Period 1|Adverse Event|0|||
44576639|NCT01370655|79599621|FG004|Period 1|Adverse Event|0|||
44576640|NCT01370655|79599622|FG005|Period 1|Adverse Event|0|||
44576641|NCT01370655|79599623|FG006|Period 1|Adverse Event|1|||
44576642|NCT01370655|79599624|FG007|Period 1|Adverse Event|0|||
44576643|NCT01370655|79599625|FG008|Period 1|Adverse Event|0|||
44118466|NCT02314923|78902008|FG009|Overall Study|Lost to Follow-up|0|||
44118467|NCT02314923|78901999|FG000|Overall Study|Withdrawal by Subject|0|||
44118468|NCT02314923|78902000|FG001|Overall Study|Withdrawal by Subject|0|||
44118469|NCT02314923|78902001|FG002|Overall Study|Withdrawal by Subject|1|||
44118470|NCT02314923|78902002|FG003|Overall Study|Withdrawal by Subject|0|||
44118471|NCT02314923|78902003|FG004|Overall Study|Withdrawal by Subject|1|||
44118472|NCT02314923|78902004|FG005|Overall Study|Withdrawal by Subject|0|||
44118473|NCT02314923|78902005|FG006|Overall Study|Withdrawal by Subject|1|||
44118474|NCT02314923|78902006|FG007|Overall Study|Withdrawal by Subject|0|||
44118475|NCT02314923|78902007|FG008|Overall Study|Withdrawal by Subject|0|||
44118476|NCT02314923|78902008|FG009|Overall Study|Withdrawal by Subject|0|||
44118477|NCT02314923|78901999|FG000|Overall Study|Physician Decision|0|||
44118478|NCT02314923|78902000|FG001|Overall Study|Physician Decision|1|||
44118479|NCT02314923|78902001|FG002|Overall Study|Physician Decision|0|||
44118480|NCT02314923|78902002|FG003|Overall Study|Physician Decision|0|||
44118481|NCT02314923|78902003|FG004|Overall Study|Physician Decision|0|||
44118482|NCT02314923|78902004|FG005|Overall Study|Physician Decision|0|||
44118483|NCT02314923|78902005|FG006|Overall Study|Physician Decision|0|||
44118484|NCT02314923|78902006|FG007|Overall Study|Physician Decision|0|||
44118485|NCT02314923|78902007|FG008|Overall Study|Physician Decision|0|||
44118486|NCT02314923|78902008|FG009|Overall Study|Physician Decision|0|||
44118487|NCT02314923|78901999|FG000|Overall Study|Participant unavailable|0|||
44118488|NCT02314923|78902000|FG001|Overall Study|Participant unavailable|0|||
44118489|NCT02314923|78902001|FG002|Overall Study|Participant unavailable|0|||
44118490|NCT02314923|78902002|FG003|Overall Study|Participant unavailable|0|||
44118491|NCT02314923|78902003|FG004|Overall Study|Participant unavailable|0|||
44118492|NCT02314923|78902004|FG005|Overall Study|Participant unavailable|1|||
44118493|NCT02314923|78902005|FG006|Overall Study|Participant unavailable|0|||
44118494|NCT02314923|78902006|FG007|Overall Study|Participant unavailable|0|||
44118495|NCT02314923|78902007|FG008|Overall Study|Participant unavailable|0|||
44118496|NCT02314923|78902008|FG009|Overall Study|Participant unavailable|0|||
44118497|NCT02314923|78901999|FG000|Overall Study|Screen failure|0|||
44118498|NCT02314923|78902000|FG001|Overall Study|Screen failure|0|||
44118499|NCT02314923|78902001|FG002|Overall Study|Screen failure|0|||
44118500|NCT02314923|78902002|FG003|Overall Study|Screen failure|0|||
44118501|NCT02314923|78902003|FG004|Overall Study|Screen failure|0|||
44118502|NCT02314923|78902004|FG005|Overall Study|Screen failure|0|||
44118503|NCT02314923|78902005|FG006|Overall Study|Screen failure|1|||
44118504|NCT02314923|78902006|FG007|Overall Study|Screen failure|0|||
44118505|NCT02314923|78902007|FG008|Overall Study|Screen failure|0|||
44507356|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
44507357|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
44507358|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
44507359|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
44507360|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
44507361|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
44507362|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
44507363|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
44507364|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
44507365|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
44507366|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
44576644|NCT01370655|79599626|FG009|Period 1|Adverse Event|0|||
44576645|NCT01370655|79599627|FG010|Period 1|Adverse Event|0|||
44576646|NCT01370655|79599628|FG011|Period 1|Adverse Event|0|||
44118506|NCT02314923|78902008|FG009|Overall Study|Screen failure|0|||
44507367|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
44576647|NCT01370655|79599617|FG000|Period 2|Adverse Event|0|||
44576648|NCT01370655|79599618|FG001|Period 2|Adverse Event|0|||
44118507|NCT02314923|78901999|FG000|Overall Study|Participant relocation|1|||
44118508|NCT02314923|78902000|FG001|Overall Study|Participant relocation|0|||
44576649|NCT01370655|79599619|FG002|Period 2|Adverse Event|1|||
44118509|NCT02314923|78902001|FG002|Overall Study|Participant relocation|0|||
44118510|NCT02314923|78902002|FG003|Overall Study|Participant relocation|0|||
44118511|NCT02314923|78902003|FG004|Overall Study|Participant relocation|0|||
44118512|NCT02314923|78902004|FG005|Overall Study|Participant relocation|0|||
44118513|NCT02314923|78902005|FG006|Overall Study|Participant relocation|0|||
44118514|NCT02314923|78902006|FG007|Overall Study|Participant relocation|1|||
44118515|NCT02314923|78902007|FG008|Overall Study|Participant relocation|0|||
44118516|NCT02314923|78902008|FG009|Overall Study|Participant relocation|0|||
44118517|NCT03023137|78902033|FG000|Overall Study|Multiple pregnancy|2|||
44118518|NCT03023137|78902034|FG001|Overall Study|Multiple pregnancy|4|||
44118519|NCT03023137|78902033|FG000|Overall Study|Lost to Follow-up|1|||
44118520|NCT03023137|78902034|FG001|Overall Study|Lost to Follow-up|1|||
44118521|NCT03023137|78902033|FG000|Overall Study|Protocol Violation|0|||
44118522|NCT03023137|78902034|FG001|Overall Study|Protocol Violation|4|||
44118523|NCT03023137|78902033|FG000|Overall Study|Lost the baby in a car accident|1|||
44118524|NCT03023137|78902034|FG001|Overall Study|Lost the baby in a car accident|0|||
44118525|NCT03049813|78902045|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
44118526|NCT03049813|78902046|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
44118527|NCT03049813|78902047|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
44118528|NCT03049813|78902048|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
44118529|NCT03049813|78902045|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
44118530|NCT03049813|78902046|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
44118531|NCT03049813|78902047|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
44576650|NCT01370655|79599620|FG003|Period 2|Adverse Event|0|||
44576651|NCT01370655|79599621|FG004|Period 2|Adverse Event|1|||
44576652|NCT01370655|79599622|FG005|Period 2|Adverse Event|0|||
44576653|NCT01370655|79599623|FG006|Period 2|Adverse Event|0|||
44576654|NCT01370655|79599624|FG007|Period 2|Adverse Event|1|||
44576655|NCT01370655|79599625|FG008|Period 2|Adverse Event|0|||
44576656|NCT01370655|79599626|FG009|Period 2|Adverse Event|0|||
44576657|NCT01370655|79599627|FG010|Period 2|Adverse Event|0|||
44576658|NCT01370655|79599628|FG011|Period 2|Adverse Event|0|||
44576659|NCT01370655|79599617|FG000|Period 2|met protocol specified stopping criteria|0|||
44576660|NCT01370655|79599618|FG001|Period 2|met protocol specified stopping criteria|0|||
44576661|NCT01370655|79599619|FG002|Period 2|met protocol specified stopping criteria|1|||
44576662|NCT01370655|79599620|FG003|Period 2|met protocol specified stopping criteria|0|||
44576663|NCT01370655|79599621|FG004|Period 2|met protocol specified stopping criteria|0|||
44576664|NCT01370655|79599622|FG005|Period 2|met protocol specified stopping criteria|0|||
44576665|NCT01370655|79599623|FG006|Period 2|met protocol specified stopping criteria|1|||
44576666|NCT01370655|79599624|FG007|Period 2|met protocol specified stopping criteria|0|||
44576667|NCT01370655|79599625|FG008|Period 2|met protocol specified stopping criteria|1|||
44576668|NCT01370655|79599626|FG009|Period 2|met protocol specified stopping criteria|0|||
44576669|NCT01370655|79599627|FG010|Period 2|met protocol specified stopping criteria|1|||
44576670|NCT01370655|79599628|FG011|Period 2|met protocol specified stopping criteria|0|||
44576671|NCT01370655|79599617|FG000|Period 2|Withdrawal by Subject|0|||
44576672|NCT01370655|79599618|FG001|Period 2|Withdrawal by Subject|0|||
44576673|NCT01370655|79599619|FG002|Period 2|Withdrawal by Subject|0|||
44576674|NCT01370655|79599620|FG003|Period 2|Withdrawal by Subject|0|||
44576675|NCT01370655|79599621|FG004|Period 2|Withdrawal by Subject|0|||
44576676|NCT01370655|79599622|FG005|Period 2|Withdrawal by Subject|0|||
44576677|NCT01370655|79599623|FG006|Period 2|Withdrawal by Subject|0|||
44576678|NCT01370655|79599624|FG007|Period 2|Withdrawal by Subject|0|||
44118532|NCT03049813|78902048|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
44118533|NCT03049813|78902045|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
44118534|NCT03049813|78902046|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
44118535|NCT03049813|78902047|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
44507368|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
44507369|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
44507370|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
44507371|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
44507372|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
44507373|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
44507374|NCT03370133|79512302|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
44507375|NCT03370133|79512303|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
44507376|NCT03370133|79512304|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
44507377|NCT03370133|79512305|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
44507378|NCT03370133|79512306|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
44576679|NCT01370655|79599625|FG008|Period 2|Withdrawal by Subject|1|||
44118536|NCT03049813|78902048|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
44118537|NCT03049813|78902045|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
44118538|NCT03049813|78902046|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
44118539|NCT03049813|78902047|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
44507379|NCT03370133|79512307|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
44576680|NCT01370655|79599626|FG009|Period 2|Withdrawal by Subject|0|||
44576681|NCT01370655|79599627|FG010|Period 2|Withdrawal by Subject|0|||
44576682|NCT01370655|79599628|FG011|Period 2|Withdrawal by Subject|0|||
44576683|NCT02612194|79599641|FG000|Overall Study|Death|5|||
44118540|NCT03049813|78902048|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
44118541|NCT03022981|78902059|FG000|Overall Study|Adverse Event|0|||
44239130|NCT01565707|79065916|FG002|Overall Study|Withdrawal by Subject|1|||
44239131|NCT01565707|79065917|FG003|Overall Study|Withdrawal by Subject|1|||
44576684|NCT02612194|79599642|FG001|Overall Study|Death|0|||
44576685|NCT02612194|79599643|FG002|Overall Study|Death|2|||
44576686|NCT02612194|79599641|FG000|Overall Study|Early Study Termination|1|||
44576687|NCT02612194|79599642|FG001|Overall Study|Early Study Termination|0|||
44576688|NCT02612194|79599643|FG002|Overall Study|Early Study Termination|0|||
44576689|NCT02798211|79599653|FG000|Period 1|Adverse Event|1|||
44576690|NCT02798211|79599654|FG001|Period 1|Adverse Event|1|||
44576691|NCT02798211|79599655|FG002|Period 1|Adverse Event|0|||
44576692|NCT02798211|79599656|FG003|Period 1|Adverse Event|0|||
44576693|NCT02798211|79599657|FG004|Period 1|Adverse Event|0|||
44576694|NCT02798211|79599658|FG005|Period 1|Adverse Event|0|||
44576695|NCT02798211|79599653|FG000|Period 1|Lost to Follow-up|2|||
44576696|NCT02798211|79599654|FG001|Period 1|Lost to Follow-up|1|||
44576697|NCT02798211|79599655|FG002|Period 1|Lost to Follow-up|0|||
44576698|NCT02798211|79599656|FG003|Period 1|Lost to Follow-up|0|||
44576699|NCT02798211|79599657|FG004|Period 1|Lost to Follow-up|0|||
44576700|NCT02798211|79599658|FG005|Period 1|Lost to Follow-up|0|||
44576701|NCT02798211|79599653|FG000|Period 1|Protocol Violation|0|||
44576702|NCT02798211|79599654|FG001|Period 1|Protocol Violation|0|||
44576703|NCT02798211|79599655|FG002|Period 1|Protocol Violation|2|||
44576704|NCT02798211|79599656|FG003|Period 1|Protocol Violation|0|||
44576705|NCT02798211|79599657|FG004|Period 1|Protocol Violation|0|||
44576706|NCT02798211|79599658|FG005|Period 1|Protocol Violation|0|||
44576707|NCT02798211|79599653|FG000|Period 1|Withdrawal by Subject|1|||
44576708|NCT02798211|79599654|FG001|Period 1|Withdrawal by Subject|1|||
44576709|NCT02798211|79599655|FG002|Period 1|Withdrawal by Subject|0|||
44576710|NCT02798211|79599656|FG003|Period 1|Withdrawal by Subject|0|||
44576711|NCT02798211|79599657|FG004|Period 1|Withdrawal by Subject|0|||
44576712|NCT02798211|79599658|FG005|Period 1|Withdrawal by Subject|0|||
44576713|NCT02798211|79599653|FG000|Period 1|Death|0|||
44576714|NCT02798211|79599654|FG001|Period 1|Death|0|||
44576715|NCT02798211|79599655|FG002|Period 1|Death|1|||
44576716|NCT02798211|79599656|FG003|Period 1|Death|0|||
44576717|NCT02798211|79599657|FG004|Period 1|Death|0|||
44576718|NCT02798211|79599658|FG005|Period 1|Death|0|||
44576719|NCT02798211|79599653|FG000|Period 1|Withdrawal of Informed Consent|2|||
44576720|NCT02798211|79599654|FG001|Period 1|Withdrawal of Informed Consent|7|||
44576721|NCT02798211|79599655|FG002|Period 1|Withdrawal of Informed Consent|3|||
44576722|NCT02798211|79599656|FG003|Period 1|Withdrawal of Informed Consent|0|||
44576723|NCT02798211|79599657|FG004|Period 1|Withdrawal of Informed Consent|0|||
44576724|NCT02798211|79599658|FG005|Period 1|Withdrawal of Informed Consent|0|||
44576725|NCT02798211|79599653|FG000|Period 2|Withdrawal by Subject|2|||
44576726|NCT02798211|79599654|FG001|Period 2|Withdrawal by Subject|0|||
44576727|NCT02798211|79599655|FG002|Period 2|Withdrawal by Subject|0|||
44576728|NCT02798211|79599656|FG003|Period 2|Withdrawal by Subject|0|||
44576729|NCT02798211|79599657|FG004|Period 2|Withdrawal by Subject|2|||
44576730|NCT02798211|79599658|FG005|Period 2|Withdrawal by Subject|2|||
44576731|NCT02798211|79599653|FG000|Period 2|Adverse Event|5|||
44576732|NCT02798211|79599654|FG001|Period 2|Adverse Event|0|||
44576733|NCT02798211|79599655|FG002|Period 2|Adverse Event|0|||
44576734|NCT02798211|79599656|FG003|Period 2|Adverse Event|0|||
44576735|NCT02798211|79599657|FG004|Period 2|Adverse Event|1|||
44576736|NCT02798211|79599658|FG005|Period 2|Adverse Event|0|||
44576737|NCT02798211|79599653|FG000|Period 2|Lack of Efficacy|1|||
44576738|NCT02798211|79599654|FG001|Period 2|Lack of Efficacy|0|||
44576739|NCT02798211|79599655|FG002|Period 2|Lack of Efficacy|0|||
44576740|NCT02798211|79599656|FG003|Period 2|Lack of Efficacy|1|||
44576741|NCT02798211|79599657|FG004|Period 2|Lack of Efficacy|0|||
44576742|NCT02798211|79599658|FG005|Period 2|Lack of Efficacy|1|||
44576743|NCT02798211|79599653|FG000|Period 2|Lost to Follow-up|3|||
44576744|NCT02798211|79599654|FG001|Period 2|Lost to Follow-up|0|||
44239132|NCT01565707|79065914|FG000|Overall Study|Randomized but not evaluable|2|||
44507380|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
44507381|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
44507382|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
44507383|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
44507384|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
44507385|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
44507386|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
44507387|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
44507388|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
44576745|NCT02798211|79599655|FG002|Period 2|Lost to Follow-up|0|||
44576746|NCT02798211|79599656|FG003|Period 2|Lost to Follow-up|0|||
44576747|NCT02798211|79599657|FG004|Period 2|Lost to Follow-up|2|||
44576748|NCT02798211|79599658|FG005|Period 2|Lost to Follow-up|0|||
44576749|NCT02798211|79599653|FG000|Period 2|Physician Decision|1|||
44576750|NCT02798211|79599654|FG001|Period 2|Physician Decision|0|||
44576751|NCT02798211|79599655|FG002|Period 2|Physician Decision|0|||
44576752|NCT02798211|79599656|FG003|Period 2|Physician Decision|1|||
44576753|NCT02798211|79599657|FG004|Period 2|Physician Decision|1|||
44576754|NCT02798211|79599658|FG005|Period 2|Physician Decision|0|||
44576755|NCT02798211|79599653|FG000|Period 2|Pregnancy|0|||
44576756|NCT02798211|79599654|FG001|Period 2|Pregnancy|0|||
44576757|NCT02798211|79599655|FG002|Period 2|Pregnancy|0|||
44576758|NCT02798211|79599656|FG003|Period 2|Pregnancy|2|||
44576759|NCT02798211|79599657|FG004|Period 2|Pregnancy|0|||
44576760|NCT02798211|79599658|FG005|Period 2|Pregnancy|0|||
44576761|NCT02798211|79599653|FG000|Period 2|Technical problems|1|||
44576762|NCT02798211|79599654|FG001|Period 2|Technical problems|0|||
44576763|NCT02798211|79599655|FG002|Period 2|Technical problems|0|||
44576764|NCT02798211|79599656|FG003|Period 2|Technical problems|1|||
44118542|NCT03022981|78902060|FG001|Overall Study|Adverse Event|1|||
44118543|NCT03022981|78902061|FG002|Overall Study|Adverse Event|0|||
44118544|NCT03022981|78902059|FG000|Overall Study|Investigator's Discretion|0|||
44118545|NCT03022981|78902060|FG001|Overall Study|Investigator's Discretion|1|||
44118546|NCT03022981|78902061|FG002|Overall Study|Investigator's Discretion|2|||
44118547|NCT03022981|78902059|FG000|Overall Study|Lost to Follow-up|6|||
44118548|NCT03022981|78902060|FG001|Overall Study|Lost to Follow-up|2|||
44378321|NCT00833794|79383593|FG001|Double-blind Phase|Lack of Efficacy|22|||
44576765|NCT02798211|79599657|FG004|Period 2|Technical problems|0|||
44576766|NCT02798211|79599658|FG005|Period 2|Technical problems|0|||
44576767|NCT02798211|79599653|FG000|Period 2|Withdrawal of Informed Consent|1|||
44576768|NCT02798211|79599654|FG001|Period 2|Withdrawal of Informed Consent|0|||
44576769|NCT02798211|79599655|FG002|Period 2|Withdrawal of Informed Consent|0|||
44576770|NCT02798211|79599656|FG003|Period 2|Withdrawal of Informed Consent|2|||
44576771|NCT02798211|79599657|FG004|Period 2|Withdrawal of Informed Consent|2|||
44576772|NCT02798211|79599658|FG005|Period 2|Withdrawal of Informed Consent|3|||
44576773|NCT02799069|79599673|FG000|Overall Study|Adverse Event|0|||
44576774|NCT02799069|79599674|FG001|Overall Study|Adverse Event|2|||
44576775|NCT02799069|79599675|FG002|Overall Study|Adverse Event|2|||
44576776|NCT02799069|79599673|FG000|Overall Study|Lack of Efficacy|2|||
44576777|NCT02799069|79599674|FG001|Overall Study|Lack of Efficacy|0|||
44576778|NCT02799069|79599675|FG002|Overall Study|Lack of Efficacy|0|||
44576779|NCT02799069|79599673|FG000|Overall Study|Lost to Follow-up|1|||
44576780|NCT02799069|79599674|FG001|Overall Study|Lost to Follow-up|1|||
44576781|NCT02799069|79599675|FG002|Overall Study|Lost to Follow-up|0|||
44576782|NCT02799069|79599673|FG000|Overall Study|Withdrawal by Subject|4|||
44576783|NCT02799069|79599674|FG001|Overall Study|Withdrawal by Subject|4|||
44576784|NCT02799069|79599675|FG002|Overall Study|Withdrawal by Subject|3|||
44576785|NCT02799069|79599673|FG000|Overall Study|Protocol Violation|1|||
44576786|NCT02799069|79599674|FG001|Overall Study|Protocol Violation|0|||
44576787|NCT02799069|79599675|FG002|Overall Study|Protocol Violation|2|||
44576788|NCT01669174|79599685|FG000|Overall Study|Subject withdrew consent|2|||
44576789|NCT01669174|79599686|FG001|Overall Study|Subject withdrew consent|2|||
44576790|NCT01669174|79599685|FG000|Overall Study|Lost to Follow-up|1|||
44576791|NCT01669174|79599686|FG001|Overall Study|Lost to Follow-up|0|||
44576792|NCT01669174|79599685|FG000|Overall Study|Adverse Event|2|||
44576793|NCT01669174|79599686|FG001|Overall Study|Adverse Event|2|||
44576794|NCT01669174|79599685|FG000|Overall Study|Administrative problems|1|||
44576795|NCT01669174|79599686|FG001|Overall Study|Administrative problems|2|||
44576796|NCT02798835|79599695|FG000|Overall Study|Protocol Violation|0|||
44576797|NCT02798835|79599696|FG001|Overall Study|Protocol Violation|0|||
44576798|NCT02798835|79599697|FG002|Overall Study|Protocol Violation|3|||
44576799|NCT02611882|79599708|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
44576800|NCT02611882|79599709|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
44576801|NCT02611882|79599710|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
44576802|NCT02796963|79599721|FG000|Overall Study|Lost to Follow-up|89|||
44576803|NCT02796963|79599722|FG001|Overall Study|Lost to Follow-up|76|||
44576804|NCT02796963|79599723|FG002|Overall Study|Lost to Follow-up|69|||
44576805|NCT02796963|79599724|FG003|Overall Study|Lost to Follow-up|72|||
44576806|NCT02796651|79599734|FG000|Overall Study|Adverse Event|6|||
44576807|NCT02796651|79599734|FG000|Overall Study|Lost to Follow-up|1|||
44576808|NCT02796651|79599734|FG000|Overall Study|Withdrawal by Subject|4|||
44576809|NCT02796651|79599734|FG000|Overall Study|Protocol Violation|4|||
44576810|NCT02796651|79599734|FG000|Overall Study|Lack of Efficacy|1|||
44576811|NCT02796651|79599734|FG000|Overall Study|Other|10|||
44576812|NCT02613208|79599749|FG000|Overall Study|Withdrawal by Subject|1|||
44576813|NCT02613208|79599749|FG000|Overall Study|Change of address|2|||
44576814|NCT02613208|79599749|FG000|Overall Study|Physician Decision|2|||
44576815|NCT02613208|79599749|FG000|Overall Study|Lost to Follow-up|5|||
44576816|NCT02613208|79599749|FG000|Overall Study|Death|37|||
44576817|NCT01668784|79599755|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
44576818|NCT01668784|79599756|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
44576819|NCT01668784|79599755|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
44576820|NCT01668784|79599756|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
44118549|NCT03022981|78902061|FG002|Overall Study|Lost to Follow-up|1|||
44118550|NCT03022981|78902059|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44118551|NCT03022981|78902060|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44118552|NCT03022981|78902061|FG002|Overall Study|Non-Compliance With Study Drug|2|||
44118553|NCT03022981|78902059|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
44118554|NCT03022981|78902060|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
44118555|NCT03022981|78902061|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
44118556|NCT03377699|78902081|FG000|Overall Study|Withdrawal by Subject|2|||
44118557|NCT03377699|78902082|FG001|Overall Study|Withdrawal by Subject|9|||
44118558|NCT03377699|78902081|FG000|Overall Study|Lost to Follow-up|1|||
44118559|NCT03377699|78902082|FG001|Overall Study|Lost to Follow-up|1|||
44118560|NCT03377699|78902081|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
44118561|NCT03377699|78902082|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
44118562|NCT03377699|78902081|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
44239133|NCT01565707|79065915|FG001|Overall Study|Randomized but not evaluable|0|||
44239134|NCT01565707|79065916|FG002|Overall Study|Randomized but not evaluable|0|||
44239135|NCT01565707|79065917|FG003|Overall Study|Randomized but not evaluable|0|||
44118563|NCT03377699|78902082|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
44118564|NCT03377699|78902081|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
44118565|NCT03377699|78902082|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
44118566|NCT03377699|78902081|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
44118567|NCT03377699|78902082|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
44118568|NCT01314443|78902094|FG000|Overall Study|Withdrawal by Subject|2|||
44118569|NCT01314443|78902095|FG001|Overall Study|Withdrawal by Subject|1|||
44118570|NCT01314443|78902096|FG002|Overall Study|Withdrawal by Subject|1|||
44118571|NCT01314443|78902097|FG003|Overall Study|Withdrawal by Subject|1|||
44118572|NCT01314443|78902094|FG000|Overall Study|Protocol Violation|2|||
44118573|NCT01314443|78902095|FG001|Overall Study|Protocol Violation|2|||
44118574|NCT01314443|78902096|FG002|Overall Study|Protocol Violation|1|||
44118575|NCT01314443|78902097|FG003|Overall Study|Protocol Violation|1|||
44118576|NCT02923921|78902109|FG000|Overall Study|Sponsor Decision|39|||
44118577|NCT02923921|78902110|FG001|Overall Study|Sponsor Decision|38|||
44118578|NCT02923921|78902109|FG000|Overall Study|Lost to Follow-up|1|||
44118579|NCT02923921|78902110|FG001|Overall Study|Lost to Follow-up|0|||
44118580|NCT02923921|78902109|FG000|Overall Study|Withdrawal by Subject|6|||
44118581|NCT02923921|78902110|FG001|Overall Study|Withdrawal by Subject|13|||
44118582|NCT02923921|78902109|FG000|Overall Study|Unknown, Not Collected|7|||
44118583|NCT02923921|78902110|FG001|Overall Study|Unknown, Not Collected|6|||
44118584|NCT03039023|78902121|FG000|Overall Study|Withdrawal by Subject|1|||
44118585|NCT03039023|78902122|FG001|Overall Study|Withdrawal by Subject|0|||
44118586|NCT03039023|78902123|FG002|Overall Study|Withdrawal by Subject|1|||
44118587|NCT03039023|78902124|FG003|Overall Study|Withdrawal by Subject|1|||
44118588|NCT03039023|78902125|FG004|Overall Study|Withdrawal by Subject|0|||
44118589|NCT03039023|78902121|FG000|Overall Study|Physician Decision|0|||
44239136|NCT01565707|79065914|FG000|Overall Study|Miscellaneous|1|||
44239137|NCT01565707|79065915|FG001|Overall Study|Miscellaneous|1|||
44239138|NCT01565707|79065916|FG002|Overall Study|Miscellaneous|0|||
44239139|NCT01565707|79065917|FG003|Overall Study|Miscellaneous|2|||
44378322|NCT00833794|79383592|FG000|Double-blind Phase|Withdrawal by Subject|23|||
44378323|NCT00833794|79383593|FG001|Double-blind Phase|Withdrawal by Subject|6|||
44378324|NCT00833794|79383592|FG000|Double-blind Phase|Physician Decision|4|||
44378325|NCT00833794|79383593|FG001|Double-blind Phase|Physician Decision|7|||
44378326|NCT00833794|79383592|FG000|Double-blind Phase|Administrative reason|1|||
44378327|NCT00833794|79383593|FG001|Double-blind Phase|Administrative reason|3|||
44378328|NCT00912288|79383603|FG000|Overall Study|Death|0|||
44378329|NCT00912288|79383604|FG001|Overall Study|Death|1|||
44378330|NCT00912288|79383603|FG000|Overall Study|Adverse Event|1|||
44378331|NCT00912288|79383604|FG001|Overall Study|Adverse Event|1|||
44378332|NCT00912288|79383603|FG000|Overall Study|Lost to Follow-up|1|||
44378333|NCT00912288|79383604|FG001|Overall Study|Lost to Follow-up|0|||
44507389|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
44507390|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
44378334|NCT00912288|79383603|FG000|Overall Study|Protocol Violation|1|||
44378335|NCT00912288|79383604|FG001|Overall Study|Protocol Violation|0|||
44378336|NCT00912288|79383603|FG000|Overall Study|Withdrawal by Subject|3|||
44378337|NCT00912288|79383604|FG001|Overall Study|Withdrawal by Subject|3|||
44118590|NCT03039023|78902122|FG001|Overall Study|Physician Decision|0|||
44118591|NCT03039023|78902123|FG002|Overall Study|Physician Decision|0|||
44118592|NCT03039023|78902124|FG003|Overall Study|Physician Decision|1|||
44118593|NCT03039023|78902125|FG004|Overall Study|Physician Decision|0|||
44118594|NCT03022045|78902139|FG000|Overall Study|Adverse Event|0|||
44118595|NCT03022045|78902140|FG001|Overall Study|Adverse Event|1|||
44239140|NCT01557569|79065936|FG000|Overall Study|Adverse Event|2|||
44378338|NCT00912288|79383603|FG000|Overall Study|Study terminated by sponsor|34|||
44507391|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
44378339|NCT00912288|79383604|FG001|Overall Study|Study terminated by sponsor|35|||
44378340|NCT00912288|79383603|FG000|Overall Study|Other|1|||
44378341|NCT00912288|79383604|FG001|Overall Study|Other|0|||
44576821|NCT01668784|79599755|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
44576822|NCT01668784|79599756|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
44576823|NCT01668784|79599755|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
44576824|NCT01668784|79599756|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
44576825|NCT01668784|79599755|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
44576826|NCT01668784|79599756|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
44576827|NCT01668784|79599755|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
44576828|NCT01668784|79599756|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
44576829|NCT01668784|79599755|FG000|Treatment Period|Disease Progression|316|||
44576830|NCT01668784|79599756|FG001|Treatment Period|Disease Progression|293|||
44576831|NCT01668784|79599755|FG000|Treatment Period|Study Drug Toxicity|46|||
44576832|NCT01668784|79599756|FG001|Treatment Period|Study Drug Toxicity|53|||
44576833|NCT01668784|79599755|FG000|Treatment Period|Death|1|||
44576834|NCT01668784|79599756|FG001|Treatment Period|Death|1|||
44576835|NCT01668784|79599755|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
44576836|NCT01668784|79599756|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
44576837|NCT01668784|79599755|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
44576838|NCT01668784|79599756|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
44576839|NCT01668784|79599755|FG000|Treatment Period|Withdrawal by Subject|5|||
44576840|NCT01668784|79599756|FG001|Treatment Period|Withdrawal by Subject|3|||
44576841|NCT01668784|79599755|FG000|Treatment Period|Maximal Clinical Benefit|3|||
44576842|NCT01668784|79599756|FG001|Treatment Period|Maximal Clinical Benefit|3|||
44576843|NCT01668784|79599755|FG000|Treatment Period|Other|2|||
44576844|NCT01668784|79599756|FG001|Treatment Period|Other|8|||
44576845|NCT01668784|79599755|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
44576846|NCT01668784|79599756|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
44576847|NCT02750514|79599767|FG000|Track 1|Disease progression|20|||
44576848|NCT02750514|79599768|FG001|Track 1|Disease progression|1|||
44576849|NCT02750514|79599769|FG002|Track 1|Disease progression|0|||
44576850|NCT02750514|79599770|FG003|Track 1|Disease progression|1|||
44576851|NCT02750514|79599771|FG004|Track 1|Disease progression|0|||
44576852|NCT02750514|79599767|FG000|Track 1|Adverse event unrelated to study drug|1|||
44576853|NCT02750514|79599768|FG001|Track 1|Adverse event unrelated to study drug|0|||
44576854|NCT02750514|79599769|FG002|Track 1|Adverse event unrelated to study drug|0|||
44576855|NCT02750514|79599770|FG003|Track 1|Adverse event unrelated to study drug|0|||
44576856|NCT02750514|79599771|FG004|Track 1|Adverse event unrelated to study drug|0|||
44378342|NCT00778375|79383610|FG000|Overall Study|Ineligible|3|||
44378343|NCT00777829|79383616|FG000|Overall Study|Withdrawal by Subject|0|||
44378344|NCT00777829|79383617|FG001|Overall Study|Withdrawal by Subject|2|||
44378345|NCT00775021|79383625|FG000|First Intervention|Lost to Follow-up|1|||
44378346|NCT00775021|79383626|FG001|First Intervention|Lost to Follow-up|0|||
44378347|NCT00775021|79383625|FG000|Second Intervention|Adverse Event|0|||
44378348|NCT00775021|79383626|FG001|Second Intervention|Adverse Event|1|||
44378349|NCT00777205|79383634|FG000|Overall Study|Lost to Follow-up|25|||
44576857|NCT02750514|79599767|FG000|Track 1|Study drug toxicity|4|||
44576858|NCT02750514|79599768|FG001|Track 1|Study drug toxicity|1|||
44576859|NCT02750514|79599769|FG002|Track 1|Study drug toxicity|0|||
44576860|NCT02750514|79599770|FG003|Track 1|Study drug toxicity|1|||
44576861|NCT02750514|79599771|FG004|Track 1|Study drug toxicity|0|||
44576862|NCT02750514|79599767|FG000|Track 1|Participant request to discontinue|1|||
44576863|NCT02750514|79599768|FG001|Track 1|Participant request to discontinue|0|||
44576864|NCT02750514|79599769|FG002|Track 1|Participant request to discontinue|0|||
44576865|NCT02750514|79599770|FG003|Track 1|Participant request to discontinue|0|||
44576866|NCT02750514|79599771|FG004|Track 1|Participant request to discontinue|0|||
44576867|NCT02750514|79599767|FG000|Track 1|Other reasons|1|||
44576868|NCT02750514|79599768|FG001|Track 1|Other reasons|0|||
44239141|NCT01557569|79065937|FG001|Overall Study|Adverse Event|0|||
44239142|NCT01557569|79065936|FG000|Overall Study|high blood pressure|0|||
44576869|NCT02750514|79599769|FG002|Track 1|Other reasons|0|||
44576870|NCT02750514|79599770|FG003|Track 1|Other reasons|0|||
44576871|NCT02750514|79599771|FG004|Track 1|Other reasons|0|||
44576872|NCT02750514|79599767|FG000|Track 2|Disease progression|4|||
44576873|NCT02750514|79599768|FG001|Track 2|Disease progression|5|||
44576874|NCT02750514|79599769|FG002|Track 2|Disease progression|2|||
44378350|NCT00777205|79383635|FG001|Overall Study|Lost to Follow-up|9|||
44378351|NCT00777205|79383634|FG000|Overall Study|Withdrawal by Subject|6|||
44378352|NCT00777205|79383635|FG001|Overall Study|Withdrawal by Subject|4|||
44378353|NCT00777205|79383634|FG000|Overall Study|Death|0|||
44576875|NCT02750514|79599770|FG003|Track 2|Disease progression|5|||
44576876|NCT02750514|79599771|FG004|Track 2|Disease progression|0|||
44378354|NCT00777205|79383635|FG001|Overall Study|Death|2|||
44576877|NCT02750514|79599767|FG000|Track 2|Adverse event unrelated to study drug|1|||
44576878|NCT02750514|79599768|FG001|Track 2|Adverse event unrelated to study drug|0|||
44576879|NCT02750514|79599769|FG002|Track 2|Adverse event unrelated to study drug|0|||
44576880|NCT02750514|79599770|FG003|Track 2|Adverse event unrelated to study drug|0|||
44576881|NCT02750514|79599771|FG004|Track 2|Adverse event unrelated to study drug|0|||
44576882|NCT02750514|79599767|FG000|Track 2|Study drug toxicity|1|||
44576883|NCT02750514|79599768|FG001|Track 2|Study drug toxicity|2|||
44576884|NCT02750514|79599769|FG002|Track 2|Study drug toxicity|0|||
44576885|NCT02750514|79599770|FG003|Track 2|Study drug toxicity|2|||
44576886|NCT02750514|79599771|FG004|Track 2|Study drug toxicity|0|||
44576887|NCT02750514|79599767|FG000|Track 2|Participant withdrew consent|0|||
44576888|NCT02750514|79599768|FG001|Track 2|Participant withdrew consent|1|||
44576889|NCT02750514|79599769|FG002|Track 2|Participant withdrew consent|0|||
44576890|NCT02750514|79599770|FG003|Track 2|Participant withdrew consent|0|||
44576891|NCT02750514|79599771|FG004|Track 2|Participant withdrew consent|0|||
44576892|NCT02750514|79599767|FG000|Track 3|Disease progression|0|||
44576893|NCT02750514|79599768|FG001|Track 3|Disease progression|24|||
44576894|NCT02750514|79599769|FG002|Track 3|Disease progression|13|||
44576895|NCT02750514|79599770|FG003|Track 3|Disease progression|14|||
44576896|NCT02750514|79599771|FG004|Track 3|Disease progression|0|||
44576897|NCT02750514|79599767|FG000|Track 3|Adverse event unrelated to study drug|0|||
44378355|NCT00777205|79383634|FG000|Overall Study|Protocol Violation|0|||
44378356|NCT00777205|79383635|FG001|Overall Study|Protocol Violation|56|||
44378357|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
44378358|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
44378359|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
44378360|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
44378361|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
44378362|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
44378363|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
44378364|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
44576898|NCT02750514|79599768|FG001|Track 3|Adverse event unrelated to study drug|1|||
44576899|NCT02750514|79599769|FG002|Track 3|Adverse event unrelated to study drug|1|||
44576900|NCT02750514|79599770|FG003|Track 3|Adverse event unrelated to study drug|1|||
44576901|NCT02750514|79599771|FG004|Track 3|Adverse event unrelated to study drug|0|||
44576902|NCT02750514|79599767|FG000|Track 3|Study drug toxicity|0|||
44576903|NCT02750514|79599768|FG001|Track 3|Study drug toxicity|3|||
44576904|NCT02750514|79599769|FG002|Track 3|Study drug toxicity|0|||
44576905|NCT02750514|79599770|FG003|Track 3|Study drug toxicity|1|||
44576906|NCT02750514|79599771|FG004|Track 3|Study drug toxicity|0|||
44576907|NCT02750514|79599767|FG000|Track 3|Participant request to discontinue|0|||
44576908|NCT02750514|79599768|FG001|Track 3|Participant request to discontinue|2|||
44576909|NCT02750514|79599769|FG002|Track 3|Participant request to discontinue|0|||
44576910|NCT02750514|79599770|FG003|Track 3|Participant request to discontinue|0|||
44576911|NCT02750514|79599771|FG004|Track 3|Participant request to discontinue|0|||
44576912|NCT02750514|79599767|FG000|Track 3|Participant withdrew consent|0|||
44576913|NCT02750514|79599768|FG001|Track 3|Participant withdrew consent|3|||
44576914|NCT02750514|79599769|FG002|Track 3|Participant withdrew consent|1|||
44576915|NCT02750514|79599770|FG003|Track 3|Participant withdrew consent|0|||
44576916|NCT02750514|79599771|FG004|Track 3|Participant withdrew consent|0|||
44576917|NCT02750514|79599767|FG000|Track 3|Other reasons|0|||
44576918|NCT02750514|79599768|FG001|Track 3|Other reasons|3|||
44576919|NCT02750514|79599769|FG002|Track 3|Other reasons|0|||
44507392|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
44507393|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
44507394|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
44507395|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
44507396|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
44507397|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
44507398|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
44507399|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
44507400|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
44507401|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
44507402|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
44507403|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
44507404|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
44507405|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
44507406|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
44507407|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
44507408|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
44507409|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
44507410|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
44239143|NCT01557569|79065937|FG001|Overall Study|high blood pressure|1|||
44576920|NCT02750514|79599770|FG003|Track 3|Other reasons|0|||
44576921|NCT02750514|79599771|FG004|Track 3|Other reasons|0|||
44576922|NCT02750514|79599767|FG000|Track 4|Study drug toxicity|0|||
44576923|NCT02750514|79599768|FG001|Track 4|Study drug toxicity|6|||
44576924|NCT02750514|79599769|FG002|Track 4|Study drug toxicity|0|||
44576925|NCT02750514|79599770|FG003|Track 4|Study drug toxicity|5|||
44576926|NCT02750514|79599771|FG004|Track 4|Study drug toxicity|0|||
44576927|NCT02750514|79599767|FG000|Track 4|Participant request to discontinue|0|||
44576928|NCT02750514|79599768|FG001|Track 4|Participant request to discontinue|1|||
44576929|NCT02750514|79599769|FG002|Track 4|Participant request to discontinue|0|||
44576930|NCT02750514|79599770|FG003|Track 4|Participant request to discontinue|1|||
44576931|NCT02750514|79599771|FG004|Track 4|Participant request to discontinue|0|||
44576932|NCT02750514|79599767|FG000|Track 4|Participant withdrew consent|0|||
44576933|NCT02750514|79599768|FG001|Track 4|Participant withdrew consent|1|||
44576934|NCT02750514|79599769|FG002|Track 4|Participant withdrew consent|0|||
44576935|NCT02750514|79599770|FG003|Track 4|Participant withdrew consent|0|||
44576936|NCT02750514|79599771|FG004|Track 4|Participant withdrew consent|0|||
44576937|NCT02750514|79599767|FG000|Track 4|Other reasons|0|||
44576938|NCT02750514|79599768|FG001|Track 4|Other reasons|5|||
44576939|NCT02750514|79599769|FG002|Track 4|Other reasons|0|||
44576940|NCT02750514|79599770|FG003|Track 4|Other reasons|3|||
44576941|NCT02750514|79599771|FG004|Track 4|Other reasons|0|||
44576942|NCT02750514|79599767|FG000|Track 4|Disease progression|0|||
44576943|NCT02750514|79599768|FG001|Track 4|Disease progression|33|||
44576944|NCT02750514|79599769|FG002|Track 4|Disease progression|0|||
44576945|NCT02750514|79599770|FG003|Track 4|Disease progression|32|||
44576946|NCT02750514|79599771|FG004|Track 4|Disease progression|0|||
44576947|NCT02750514|79599767|FG000|Track 4|Adverse event unrelated to study drug|0|||
44576948|NCT02750514|79599768|FG001|Track 4|Adverse event unrelated to study drug|5|||
44576949|NCT02750514|79599769|FG002|Track 4|Adverse event unrelated to study drug|0|||
44576950|NCT02750514|79599770|FG003|Track 4|Adverse event unrelated to study drug|0|||
44576951|NCT02750514|79599771|FG004|Track 4|Adverse event unrelated to study drug|0|||
44576952|NCT02750514|79599767|FG000|Track 4|Death|0|||
44576953|NCT02750514|79599768|FG001|Track 4|Death|0|||
44576954|NCT02750514|79599769|FG002|Track 4|Death|0|||
44576955|NCT02750514|79599770|FG003|Track 4|Death|1|||
44576956|NCT02750514|79599771|FG004|Track 4|Death|0|||
44576957|NCT02750514|79599767|FG000|Track 5|Disease progression|0|||
44576958|NCT02750514|79599768|FG001|Track 5|Disease progression|0|||
44576959|NCT02750514|79599769|FG002|Track 5|Disease progression|0|||
44576960|NCT02750514|79599770|FG003|Track 5|Disease progression|0|||
44576961|NCT02750514|79599771|FG004|Track 5|Disease progression|34|||
44576962|NCT02750514|79599767|FG000|Track 5|Adverse event unrelated to study drug|0|||
44576963|NCT02750514|79599768|FG001|Track 5|Adverse event unrelated to study drug|0|||
44576964|NCT02750514|79599769|FG002|Track 5|Adverse event unrelated to study drug|0|||
44576965|NCT02750514|79599770|FG003|Track 5|Adverse event unrelated to study drug|0|||
44576966|NCT02750514|79599771|FG004|Track 5|Adverse event unrelated to study drug|2|||
44576967|NCT02750514|79599767|FG000|Track 5|Study drug toxicity|0|||
44118596|NCT03022045|78902139|FG000|Overall Study|Withdrawal by Subject|1|||
44118597|NCT03022045|78902140|FG001|Overall Study|Withdrawal by Subject|1|||
44118598|NCT03037619|78902152|FG000|Overall Study|Lost to Follow-up|0|||
44118599|NCT03037619|78902153|FG001|Overall Study|Lost to Follow-up|1|||
44378365|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
44378366|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
44507411|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
44507412|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
44507413|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
44507414|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
44507415|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
44507416|NCT03370133|79512302|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
44507417|NCT03370133|79512303|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
44507418|NCT03370133|79512304|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
44507419|NCT03370133|79512305|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
44507420|NCT03370133|79512306|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
44507421|NCT03370133|79512307|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
44507422|NCT03227757|79512325|FG000|Overall Study|Death|7|||
44576968|NCT02750514|79599768|FG001|Track 5|Study drug toxicity|0|||
44576969|NCT02750514|79599769|FG002|Track 5|Study drug toxicity|0|||
44118600|NCT04771013|78902161|FG000|Overall Study|Withdrawal by Subject|2|||
44118601|NCT04771013|78902162|FG001|Overall Study|Withdrawal by Subject|0|||
44576970|NCT02750514|79599770|FG003|Track 5|Study drug toxicity|0|||
44576971|NCT02750514|79599771|FG004|Track 5|Study drug toxicity|2|||
44576972|NCT02750514|79599767|FG000|Track 5|Participant request to discontinue|0|||
44576973|NCT02750514|79599768|FG001|Track 5|Participant request to discontinue|0|||
44118602|NCT04771013|78902161|FG000|Overall Study|Death|0|||
44576974|NCT02750514|79599769|FG002|Track 5|Participant request to discontinue|0|||
44576975|NCT02750514|79599770|FG003|Track 5|Participant request to discontinue|0|||
44576976|NCT02750514|79599771|FG004|Track 5|Participant request to discontinue|3|||
44576977|NCT02750514|79599767|FG000|Track 5|Other reasons|0|||
44576978|NCT02750514|79599768|FG001|Track 5|Other reasons|0|||
44576979|NCT02750514|79599769|FG002|Track 5|Other reasons|0|||
44576980|NCT02750514|79599770|FG003|Track 5|Other reasons|0|||
44576981|NCT02750514|79599771|FG004|Track 5|Other reasons|2|||
44576982|NCT03340974|79599795|FG000|Completion of Study -Long Term Follow up|Death|8|||
44576983|NCT03340974|79599796|FG001|Completion of Study -Long Term Follow up|Death|5|||
44576984|NCT03340974|79599797|FG002|Completion of Study -Long Term Follow up|Death|5|||
44576985|NCT03340974|79599798|FG003|Completion of Study -Long Term Follow up|Death|7|||
44576986|NCT03340974|79599795|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
44576987|NCT03340974|79599796|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
44576988|NCT03340974|79599797|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
44576989|NCT03340974|79599798|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
44576990|NCT03340974|79599795|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
44576991|NCT03340974|79599796|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
44576992|NCT03340974|79599797|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
44276081|NCT02187744|79228886|FG001|Study|Participant refused further follow-up|0|||
44276082|NCT02187744|79228885|FG000|Study|Other|2|||
44276083|NCT02187744|79228886|FG001|Study|Other|1|||
44276084|NCT02187744|79228885|FG000|Study|Lost to Follow-up|0|||
44276085|NCT02187744|79228886|FG001|Study|Lost to Follow-up|2|||
44276086|NCT02187744|79228885|FG000|Study|Related adverse event, not serious|0|||
44276087|NCT02187744|79228886|FG001|Study|Related adverse event, not serious|2|||
44378367|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
44378368|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
44378369|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
44378370|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
44378371|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
44378372|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
44378373|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
44378374|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
44378375|NCT00833638|79383646|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
44378376|NCT00833638|79383647|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
44378377|NCT00833638|79383648|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
44378378|NCT00833638|79383646|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
44507423|NCT03227757|79512325|FG000|Overall Study|Withdrawal|5|||
44507424|NCT03227757|79512325|FG000|Overall Study|Missed visits|4|||
44507425|NCT03149549|79512342|FG000|Study Discontinuation--Treatment Period|Death|0|||
44507426|NCT03149549|79512343|FG001|Study Discontinuation--Treatment Period|Death|0|||
44507427|NCT03149549|79512344|FG002|Study Discontinuation--Treatment Period|Death|0|||
44507428|NCT03149549|79512345|FG003|Study Discontinuation--Treatment Period|Death|1|||
44507429|NCT03149549|79512346|FG004|Study Discontinuation--Treatment Period|Death|2|||
44507430|NCT03149549|79512347|FG005|Study Discontinuation--Treatment Period|Death|1|||
44507431|NCT03149549|79512348|FG006|Study Discontinuation--Treatment Period|Death|1|||
44507432|NCT03149549|79512349|FG007|Study Discontinuation--Treatment Period|Death|2|||
44507433|NCT03149549|79512350|FG008|Study Discontinuation--Treatment Period|Death|4|||
44507434|NCT03149549|79512351|FG009|Study Discontinuation--Treatment Period|Death|1|||
44507435|NCT03149549|79512352|FG010|Study Discontinuation--Treatment Period|Death|0|||
44507436|NCT03149549|79512353|FG011|Study Discontinuation--Treatment Period|Death|0|||
44507437|NCT03149549|79512354|FG012|Study Discontinuation--Treatment Period|Death|1|||
44507438|NCT03149549|79512342|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507439|NCT03149549|79512343|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507440|NCT03149549|79512344|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507441|NCT03149549|79512345|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507442|NCT03149549|79512346|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507443|NCT03149549|79512347|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507444|NCT03149549|79512348|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507445|NCT03149549|79512349|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
44507446|NCT03149549|79512350|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44576993|NCT03340974|79599798|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
44576994|NCT03340974|79599795|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
44576995|NCT03340974|79599796|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
44576996|NCT03340974|79599797|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
44576997|NCT03340974|79599798|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
44276088|NCT02187744|79228885|FG000|Study|Death|1|||
44276089|NCT02187744|79228886|FG001|Study|Death|0|||
44378379|NCT00833638|79383647|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
44378380|NCT00833638|79383648|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
44378381|NCT00833638|79383646|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
44378382|NCT00833638|79383647|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
44378383|NCT00833638|79383648|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
44507447|NCT03149549|79512351|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507448|NCT03149549|79512352|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44576998|NCT02612428|79599814|FG000|VTL-308|Death|14|||
44576999|NCT02612428|79599815|FG001|VTL-308|Death|16|||
44577000|NCT02612428|79599814|FG000|VTL-308|Withdrawal by Subject|0|||
44577001|NCT02612428|79599815|FG001|VTL-308|Withdrawal by Subject|1|||
44577002|NCT02612428|79599814|FG000|VTL-308E|Death|9|||
44577003|NCT02612428|79599815|FG001|VTL-308E|Death|7|||
44577004|NCT02612428|79599814|FG000|VTL-308E|Lost to Follow-up|2|||
44577005|NCT02612428|79599815|FG001|VTL-308E|Lost to Follow-up|0|||
44577006|NCT03679884|79599826|FG000|Overall Study|Other|12|||
44577007|NCT03679884|79599827|FG001|Overall Study|Other|12|||
44577008|NCT03679884|79599828|FG002|Overall Study|Other|12|||
44577009|NCT03679884|79599829|FG003|Overall Study|Other|7|||
44577010|NCT03679884|79599830|FG004|Overall Study|Other|8|||
44577011|NCT03679884|79599826|FG000|Overall Study|Lack of Efficacy|15|||
44577012|NCT03679884|79599827|FG001|Overall Study|Lack of Efficacy|29|||
44577013|NCT03679884|79599828|FG002|Overall Study|Lack of Efficacy|13|||
44577014|NCT03679884|79599829|FG003|Overall Study|Lack of Efficacy|29|||
44577015|NCT03679884|79599830|FG004|Overall Study|Lack of Efficacy|10|||
44577016|NCT03679884|79599826|FG000|Overall Study|Death|1|||
44577017|NCT03679884|79599827|FG001|Overall Study|Death|0|||
44577018|NCT03679884|79599828|FG002|Overall Study|Death|0|||
44577019|NCT03679884|79599829|FG003|Overall Study|Death|0|||
44577020|NCT03679884|79599830|FG004|Overall Study|Death|0|||
44577021|NCT03679884|79599826|FG000|Overall Study|Adverse Event|2|||
44577022|NCT03679884|79599827|FG001|Overall Study|Adverse Event|10|||
44577023|NCT03679884|79599828|FG002|Overall Study|Adverse Event|9|||
44577024|NCT03679884|79599829|FG003|Overall Study|Adverse Event|6|||
44577025|NCT03679884|79599830|FG004|Overall Study|Adverse Event|6|||
44577026|NCT03679884|79599826|FG000|Overall Study|Withdrawal by Subject|12|||
44577027|NCT03679884|79599827|FG001|Overall Study|Withdrawal by Subject|23|||
44577028|NCT03679884|79599828|FG002|Overall Study|Withdrawal by Subject|8|||
44577029|NCT03679884|79599829|FG003|Overall Study|Withdrawal by Subject|8|||
44577030|NCT03679884|79599830|FG004|Overall Study|Withdrawal by Subject|9|||
44577031|NCT03679884|79599826|FG000|Overall Study|Lost to Follow-up|1|||
44577032|NCT03679884|79599827|FG001|Overall Study|Lost to Follow-up|4|||
44577033|NCT03679884|79599828|FG002|Overall Study|Lost to Follow-up|2|||
44577034|NCT03679884|79599829|FG003|Overall Study|Lost to Follow-up|0|||
44577035|NCT03679884|79599830|FG004|Overall Study|Lost to Follow-up|3|||
44577036|NCT01329978|79599845|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
44577037|NCT01329978|79599846|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
44577038|NCT01329978|79599847|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
44577039|NCT01329978|79599848|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
44577040|NCT01329978|79599849|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
44378384|NCT01041404|79383666|FG000|Overall Study|Adverse Event|45|||
44378385|NCT01041404|79383667|FG001|Overall Study|Adverse Event|35|||
44378386|NCT01041404|79383666|FG000|Overall Study|Lack of Efficacy|200|||
44507449|NCT03149549|79512353|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
44507450|NCT03149549|79512354|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
44507451|NCT03149549|79512342|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507452|NCT03149549|79512343|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507453|NCT03149549|79512344|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507454|NCT03149549|79512345|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
44507455|NCT03149549|79512346|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
44507456|NCT03149549|79512347|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
44507457|NCT03149549|79512348|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
44507458|NCT03149549|79512349|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507459|NCT03149549|79512350|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
44507460|NCT03149549|79512351|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507461|NCT03149549|79512352|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44577041|NCT01329978|79599845|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
44577042|NCT01329978|79599846|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
44577043|NCT01329978|79599847|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
44577044|NCT01329978|79599848|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
44577045|NCT01329978|79599849|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
44577046|NCT01329978|79599845|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
44378387|NCT01041404|79383667|FG001|Overall Study|Lack of Efficacy|210|||
44577047|NCT01329978|79599846|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
44577048|NCT01329978|79599847|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
44577049|NCT01329978|79599848|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
44577050|NCT01329978|79599849|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
44577051|NCT01329978|79599845|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
44577052|NCT01329978|79599846|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
44577053|NCT01329978|79599847|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
44577054|NCT01329978|79599848|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
44577055|NCT01329978|79599849|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
44577056|NCT01329978|79599845|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
44577057|NCT01329978|79599846|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
44577058|NCT01329978|79599847|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
44577059|NCT01329978|79599848|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
44577060|NCT01329978|79599849|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
44577061|NCT01329978|79599845|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
44577062|NCT01329978|79599846|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
44577063|NCT01329978|79599847|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
44577064|NCT01329978|79599848|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
44577065|NCT01329978|79599849|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
44577066|NCT01329978|79599845|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
44577067|NCT01329978|79599846|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
44577068|NCT01329978|79599847|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
44577069|NCT01329978|79599848|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
44577070|NCT01329978|79599849|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
44577071|NCT01338012|79599861|FG000|Overall Study|Death|4|||
44577072|NCT01338012|79599861|FG000|Overall Study|Study terminated|4|||
44577073|NCT04905498|79599867|FG000|Overall Study|Lost to Follow-up|0|||
44577074|NCT04905498|79599868|FG001|Overall Study|Lost to Follow-up|2|||
44577075|NCT04905498|79599867|FG000|Overall Study|COVID lockdown|1|||
44577076|NCT04905498|79599868|FG001|Overall Study|COVID lockdown|0|||
44577077|NCT02607280|79599876|FG000|Overall Study|Adverse Event|4|||
44577078|NCT02607280|79599877|FG001|Overall Study|Adverse Event|0|||
44577079|NCT02607280|79599876|FG000|Overall Study|Decrease in CrCl <15|0|||
44577080|NCT02607280|79599877|FG001|Overall Study|Decrease in CrCl <15|1|||
44577081|NCT02202434|79599887|FG000|Overall Study|Death|70|||
44577082|NCT02202434|79599888|FG001|Overall Study|Death|39|||
44577083|NCT02202434|79599889|FG002|Overall Study|Death|13|||
44577084|NCT02202434|79599890|FG003|Overall Study|Death|27|||
44577085|NCT02202434|79599887|FG000|Overall Study|Lost to Follow-up|1|||
44577086|NCT02202434|79599888|FG001|Overall Study|Lost to Follow-up|1|||
44577087|NCT02202434|79599889|FG002|Overall Study|Lost to Follow-up|1|||
44577088|NCT02202434|79599890|FG003|Overall Study|Lost to Follow-up|0|||
44577089|NCT02202434|79599887|FG000|Overall Study|Physician Decision|2|||
44577090|NCT02202434|79599888|FG001|Overall Study|Physician Decision|3|||
44577091|NCT02202434|79599889|FG002|Overall Study|Physician Decision|0|||
44577092|NCT02202434|79599890|FG003|Overall Study|Physician Decision|0|||
44577093|NCT02202434|79599887|FG000|Overall Study|Withdrawal by Subject|13|||
44577094|NCT02202434|79599888|FG001|Overall Study|Withdrawal by Subject|14|||
44577095|NCT02202434|79599889|FG002|Overall Study|Withdrawal by Subject|1|||
44577096|NCT02202434|79599890|FG003|Overall Study|Withdrawal by Subject|4|||
44577097|NCT02202434|79599887|FG000|Overall Study|Completed Study|1|||
44577098|NCT02202434|79599888|FG001|Overall Study|Completed Study|0|||
44577099|NCT02202434|79599889|FG002|Overall Study|Completed Study|0|||
44577100|NCT02202434|79599890|FG003|Overall Study|Completed Study|0|||
44577101|NCT02202434|79599887|FG000|Overall Study|Visit Missed|21|||
44577102|NCT02202434|79599888|FG001|Overall Study|Visit Missed|12|||
44577103|NCT02202434|79599889|FG002|Overall Study|Visit Missed|0|||
44577104|NCT02202434|79599890|FG003|Overall Study|Visit Missed|5|||
44577105|NCT02202434|79599887|FG000|Overall Study|Other|1|||
44577106|NCT02202434|79599888|FG001|Overall Study|Other|0|||
44577107|NCT02202434|79599889|FG002|Overall Study|Other|0|||
44577108|NCT02202434|79599890|FG003|Overall Study|Other|1|||
44577109|NCT02784288|79599900|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
44577110|NCT01230242|79599905|FG000|Overall Study|Physician Decision|2|||
44577111|NCT01230242|79599905|FG000|Overall Study|Withdrawal by Subject|1|||
44239144|NCT01557569|79065936|FG000|Overall Study|Withdrawal by Subject|3|||
44577112|NCT02608450|79599911|FG000|Overall Study|Lost to Follow-up|39|||
44577113|NCT02608450|79599912|FG001|Overall Study|Lost to Follow-up|32|||
44577114|NCT02608450|79599911|FG000|Overall Study|Withdrawal by Subject|21|||
44577115|NCT02608450|79599912|FG001|Overall Study|Withdrawal by Subject|15|||
44577116|NCT02608450|79599911|FG000|Overall Study|Adverse Event|3|||
44577117|NCT02608450|79599912|FG001|Overall Study|Adverse Event|6|||
44577118|NCT02608450|79599911|FG000|Overall Study|Withdrawal by parent|2|||
44577119|NCT02608450|79599912|FG001|Overall Study|Withdrawal by parent|3|||
44577120|NCT02608450|79599911|FG000|Overall Study|Lack of Efficacy|0|||
44577121|NCT02608450|79599912|FG001|Overall Study|Lack of Efficacy|3|||
44577122|NCT02608450|79599911|FG000|Overall Study|Noncompliance with study drug|0|||
44577123|NCT02608450|79599912|FG001|Overall Study|Noncompliance with study drug|2|||
44577124|NCT02608450|79599911|FG000|Overall Study|Physician Decision|0|||
44577125|NCT02608450|79599912|FG001|Overall Study|Physician Decision|1|||
44577126|NCT02608450|79599911|FG000|Overall Study|Pregnancy|0|||
44577127|NCT02608450|79599912|FG001|Overall Study|Pregnancy|1|||
44577128|NCT02608450|79599911|FG000|Overall Study|Progressive disease|1|||
44577129|NCT02608450|79599912|FG001|Overall Study|Progressive disease|0|||
44577130|NCT02608450|79599911|FG000|Overall Study|Multiple reasons|0|||
44577131|NCT02608450|79599912|FG001|Overall Study|Multiple reasons|2|||
44577132|NCT04918784|79599920|FG000|Overall Study|Amputation - no longer eligible|1|||
44577133|NCT04918784|79599921|FG001|Overall Study|Amputation - no longer eligible|2|||
44577134|NCT04918784|79599920|FG000|Overall Study|Death|1|||
44577135|NCT04918784|79599921|FG001|Overall Study|Death|0|||
44577136|NCT04918784|79599920|FG000|Overall Study|patient non-compliance|3|||
44577137|NCT04918784|79599921|FG001|Overall Study|patient non-compliance|1|||
44577138|NCT04918784|79599920|FG000|Overall Study|Adverse Event|1|||
44577139|NCT04918784|79599921|FG001|Overall Study|Adverse Event|0|||
44577140|NCT04786444|79599954|FG000|Overall Study|Withdrawal by Subject|4|||
44577141|NCT04786444|79599955|FG001|Overall Study|Withdrawal by Subject|7|||
44577142|NCT04786444|79599956|FG002|Overall Study|Withdrawal by Subject|2|||
44577143|NCT04786444|79599954|FG000|Overall Study|Lost to Follow-up|11|||
44577144|NCT04786444|79599955|FG001|Overall Study|Lost to Follow-up|9|||
44577145|NCT04786444|79599956|FG002|Overall Study|Lost to Follow-up|10|||
44577146|NCT04786444|79599954|FG000|Overall Study|Subject would like to become pregnant|0|||
44577147|NCT04786444|79599955|FG001|Overall Study|Subject would like to become pregnant|1|||
44577148|NCT04786444|79599956|FG002|Overall Study|Subject would like to become pregnant|0|||
44577149|NCT04692155|79599973|FG000|Overall Study|Death|1|||
44577150|NCT04499963|79599979|FG000|Overall Study|Adverse Event|3|||
44577151|NCT04499963|79599980|FG001|Overall Study|Adverse Event|0|||
44577152|NCT04499963|79599979|FG000|Overall Study|Death|3|||
44577153|NCT04499963|79599980|FG001|Overall Study|Death|0|||
44577154|NCT04499963|79599979|FG000|Overall Study|Lack of Efficacy|7|||
44577155|NCT04499963|79599980|FG001|Overall Study|Lack of Efficacy|0|||
44577156|NCT04499963|79599979|FG000|Overall Study|Lost to Follow-up|2|||
44577157|NCT04499963|79599980|FG001|Overall Study|Lost to Follow-up|0|||
44577158|NCT04330482|79599997|FG000|Overall Study|Lost to Follow-up|2|||
44577159|NCT04330482|79599998|FG001|Overall Study|Lost to Follow-up|1|||
44577160|NCT04330482|79599997|FG000|Overall Study|Withdrawal by Subject|0|||
44577161|NCT04330482|79599998|FG001|Overall Study|Withdrawal by Subject|3|||
44577162|NCT04325503|79600004|FG000|Overall Study|Withdrawal by Subject|1|||
44577163|NCT04325503|79600004|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
44577164|NCT04109222|79600015|FG000|Overall Study|Adverse Event|1|||
44577165|NCT04109222|79600016|FG001|Overall Study|Adverse Event|0|||
44577166|NCT04109222|79600017|FG002|Overall Study|Adverse Event|0|||
44577167|NCT03573297|79600056|FG000|Open Label Treatment Period|Adverse Event|67|||
44577168|NCT03573297|79600057|FG001|Open Label Treatment Period|Adverse Event|0|||
44577169|NCT03573297|79600058|FG002|Open Label Treatment Period|Adverse Event|0|||
44577170|NCT03573297|79600059|FG003|Open Label Treatment Period|Adverse Event|0|||
44577171|NCT03573297|79600056|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
44577172|NCT03573297|79600057|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
44577173|NCT03573297|79600058|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
44577174|NCT03573297|79600059|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
44577175|NCT03573297|79600056|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
44577176|NCT03573297|79600057|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
44577177|NCT03573297|79600058|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
44577178|NCT03573297|79600059|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
44378388|NCT01041404|79383666|FG000|Overall Study|Violation of Selection Criteria|0|||
44378389|NCT01041404|79383667|FG001|Overall Study|Violation of Selection Criteria|1|||
44378390|NCT01041404|79383666|FG000|Overall Study|Protocol Violation|4|||
44577179|NCT03573297|79600056|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
44577180|NCT03573297|79600057|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
44577181|NCT03573297|79600058|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
44577182|NCT03573297|79600059|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
44577183|NCT03573297|79600056|FG000|Open Label Treatment Period|Pregnancy|1|||
44577184|NCT03573297|79600057|FG001|Open Label Treatment Period|Pregnancy|0|||
44577185|NCT03573297|79600058|FG002|Open Label Treatment Period|Pregnancy|0|||
44577186|NCT03573297|79600059|FG003|Open Label Treatment Period|Pregnancy|0|||
44577187|NCT03573297|79600056|FG000|Open Label Treatment Period|Protocol Violation|17|||
44577188|NCT03573297|79600057|FG001|Open Label Treatment Period|Protocol Violation|0|||
44577189|NCT03573297|79600058|FG002|Open Label Treatment Period|Protocol Violation|0|||
44577190|NCT03573297|79600059|FG003|Open Label Treatment Period|Protocol Violation|0|||
44577191|NCT03573297|79600056|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
44577192|NCT03573297|79600057|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
44577193|NCT03573297|79600058|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
44577194|NCT03573297|79600059|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
44577195|NCT03573297|79600056|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
44577196|NCT03573297|79600057|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
44577197|NCT03573297|79600058|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
44118603|NCT04771013|78902162|FG001|Overall Study|Death|5|||
44378391|NCT01041404|79383667|FG001|Overall Study|Protocol Violation|0|||
44378392|NCT01041404|79383666|FG000|Overall Study|Withdrawal by Subject|29|||
44118604|NCT04771013|78902161|FG000|Overall Study|Referred to another hospital before day 20|0|||
44118605|NCT04771013|78902162|FG001|Overall Study|Referred to another hospital before day 20|1|||
44118606|NCT03021265|78902168|FG000|Overall Study|Adverse Event|29|||
44118607|NCT03021265|78902168|FG000|Overall Study|Lack of Efficacy|3|||
44118608|NCT03021265|78902168|FG000|Overall Study|Improved|17|||
44118609|NCT03021265|78902168|FG000|Overall Study|Lost to Follow-up|67|||
44118610|NCT03021265|78902168|FG000|Overall Study|No reason given|2|||
44118611|NCT03021265|78902168|FG000|Overall Study|No visit since the first visit|4|||
44118612|NCT04611789|78902175|FG000|Overall Study|Lost to Follow-up|1|||
44118613|NCT04611789|78902176|FG001|Overall Study|Lost to Follow-up|0|||
44118614|NCT04611789|78902177|FG002|Overall Study|Lost to Follow-up|0|||
44118615|NCT03561597|78902193|FG000|Overall Study|Lost to Follow-up|20|||
44118616|NCT03034967|78902216|FG000|Overall Study|Withdrawal by Subject|9|||
44118617|NCT03034967|78902217|FG001|Overall Study|Withdrawal by Subject|2|||
44118618|NCT03034967|78902218|FG002|Overall Study|Withdrawal by Subject|6|||
44118619|NCT03034967|78902219|FG003|Overall Study|Withdrawal by Subject|6|||
44118620|NCT03034967|78902220|FG004|Overall Study|Withdrawal by Subject|9|||
44118621|NCT03034967|78902221|FG005|Overall Study|Withdrawal by Subject|2|||
44118622|NCT03034967|78902216|FG000|Overall Study|Physician Decision|1|||
44118623|NCT03034967|78902217|FG001|Overall Study|Physician Decision|0|||
44118624|NCT03034967|78902218|FG002|Overall Study|Physician Decision|1|||
44118625|NCT03034967|78902219|FG003|Overall Study|Physician Decision|1|||
44118626|NCT03034967|78902220|FG004|Overall Study|Physician Decision|1|||
44239145|NCT01557569|79065937|FG001|Overall Study|Withdrawal by Subject|5|||
44378393|NCT01041404|79383667|FG001|Overall Study|Withdrawal by Subject|23|||
44577198|NCT03573297|79600059|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
44577199|NCT03573297|79600056|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
44577200|NCT03573297|79600057|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
44577201|NCT03573297|79600058|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
44577202|NCT03573297|79600059|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
44577203|NCT03573297|79600056|FG000|Open Label Treatment Period|Other, Not Specified|7|||
44577204|NCT03573297|79600057|FG001|Open Label Treatment Period|Other, Not Specified|0|||
44577205|NCT03573297|79600058|FG002|Open Label Treatment Period|Other, Not Specified|0|||
44577206|NCT03573297|79600059|FG003|Open Label Treatment Period|Other, Not Specified|0|||
44577207|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
44577208|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
44577209|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
44577210|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
44577211|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44577212|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44577213|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Adverse Event|5|||
44577214|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Adverse Event|1|||
44577215|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
44577216|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
44577217|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
44577218|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
44577219|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44577220|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
44577221|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
44577222|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
44577223|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44577224|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
44577225|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
44577226|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
44378394|NCT01041404|79383666|FG000|Overall Study|Failure to Return|1|||
44118627|NCT03034967|78902221|FG005|Overall Study|Physician Decision|0|||
44118628|NCT03034967|78902216|FG000|Overall Study|Lost to Follow-up|0|||
44118629|NCT03034967|78902217|FG001|Overall Study|Lost to Follow-up|0|||
44118630|NCT03034967|78902218|FG002|Overall Study|Lost to Follow-up|0|||
44118631|NCT03034967|78902219|FG003|Overall Study|Lost to Follow-up|1|||
44378395|NCT01041404|79383667|FG001|Overall Study|Failure to Return|2|||
44378396|NCT01041404|79383666|FG000|Overall Study|Other|11|||
44378397|NCT01041404|79383667|FG001|Overall Study|Other|23|||
44239146|NCT01557569|79065936|FG000|Overall Study|noncompliance with rules of residential|0|||
44239147|NCT01557569|79065937|FG001|Overall Study|noncompliance with rules of residential|1|||
44577227|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
44577228|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
44577229|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
44577230|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
44577231|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
44577232|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
44577233|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
44577234|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
44577235|NCT03573297|79600056|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
44577236|NCT03573297|79600057|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
44577237|NCT03573297|79600058|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
44577238|NCT03573297|79600059|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
44577239|NCT03536884|79600070|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
44577240|NCT03536884|79600071|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
44577241|NCT03536884|79600072|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
44577242|NCT03536884|79600073|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
44577243|NCT03536884|79600074|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
44577244|NCT03536884|79600070|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
44577245|NCT03536884|79600071|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
44577246|NCT03536884|79600072|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
44577247|NCT03536884|79600073|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
44577248|NCT03536884|79600074|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
44577249|NCT03536884|79600070|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
44577250|NCT03536884|79600071|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
44577251|NCT03536884|79600072|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
44577252|NCT03536884|79600073|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
44577253|NCT03536884|79600074|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
44577254|NCT03536884|79600070|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
44577255|NCT03536884|79600071|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
44577256|NCT03536884|79600072|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
44118632|NCT03034967|78902220|FG004|Overall Study|Lost to Follow-up|0|||
44118633|NCT03034967|78902221|FG005|Overall Study|Lost to Follow-up|2|||
44118634|NCT03034967|78902216|FG000|Overall Study|Liver function test abnormality|0|||
44118635|NCT03034967|78902217|FG001|Overall Study|Liver function test abnormality|0|||
44118636|NCT03034967|78902218|FG002|Overall Study|Liver function test abnormality|1|||
44118637|NCT03034967|78902219|FG003|Overall Study|Liver function test abnormality|0|||
44118638|NCT03034967|78902220|FG004|Overall Study|Liver function test abnormality|0|||
44118639|NCT03034967|78902221|FG005|Overall Study|Liver function test abnormality|0|||
44118640|NCT03034967|78902216|FG000|Overall Study|Protocol Violation|1|||
44577257|NCT03536884|79600073|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
44577258|NCT03536884|79600074|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
44577259|NCT03536884|79600070|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
44577260|NCT03536884|79600071|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
44577261|NCT03536884|79600072|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
44577262|NCT03536884|79600073|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
44577263|NCT03536884|79600074|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
44577264|NCT03536884|79600070|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
44577265|NCT03536884|79600071|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
44577266|NCT03536884|79600072|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
44577267|NCT03536884|79600073|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
44577268|NCT03536884|79600074|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
44577269|NCT03536884|79600070|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
44577270|NCT03536884|79600071|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
44577271|NCT03536884|79600072|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
44577272|NCT03536884|79600073|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
44577273|NCT03536884|79600074|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
44577274|NCT03536884|79600070|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
44577275|NCT03536884|79600071|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
44577276|NCT03536884|79600072|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
44577277|NCT03536884|79600073|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
44577278|NCT03536884|79600074|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
44118641|NCT03034967|78902217|FG001|Overall Study|Protocol Violation|0|||
44118642|NCT03034967|78902218|FG002|Overall Study|Protocol Violation|0|||
44507462|NCT03149549|79512353|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507463|NCT03149549|79512354|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
44507464|NCT03149549|79512342|FG000|Study Discontinuation--Treatment Period|Other|0|||
44507465|NCT03149549|79512343|FG001|Study Discontinuation--Treatment Period|Other|0|||
44507466|NCT03149549|79512344|FG002|Study Discontinuation--Treatment Period|Other|0|||
44507467|NCT03149549|79512345|FG003|Study Discontinuation--Treatment Period|Other|0|||
44507468|NCT03149549|79512346|FG004|Study Discontinuation--Treatment Period|Other|0|||
44507469|NCT03149549|79512347|FG005|Study Discontinuation--Treatment Period|Other|0|||
44507470|NCT03149549|79512348|FG006|Study Discontinuation--Treatment Period|Other|0|||
44507471|NCT03149549|79512349|FG007|Study Discontinuation--Treatment Period|Other|1|||
44507472|NCT03149549|79512350|FG008|Study Discontinuation--Treatment Period|Other|0|||
44507473|NCT03149549|79512351|FG009|Study Discontinuation--Treatment Period|Other|1|||
44118643|NCT03034967|78902219|FG003|Overall Study|Protocol Violation|0|||
44118644|NCT03034967|78902220|FG004|Overall Study|Protocol Violation|0|||
44118645|NCT03034967|78902221|FG005|Overall Study|Protocol Violation|2|||
44118646|NCT03034967|78902216|FG000|Overall Study|Lack of Efficacy|0|||
44118647|NCT03034967|78902217|FG001|Overall Study|Lack of Efficacy|1|||
44118648|NCT03034967|78902218|FG002|Overall Study|Lack of Efficacy|2|||
44118649|NCT03034967|78902219|FG003|Overall Study|Lack of Efficacy|1|||
44118650|NCT03034967|78902220|FG004|Overall Study|Lack of Efficacy|1|||
44118651|NCT03034967|78902221|FG005|Overall Study|Lack of Efficacy|0|||
44118652|NCT03034967|78902216|FG000|Overall Study|Adverse Event, non-fatal|3|||
44118653|NCT03034967|78902217|FG001|Overall Study|Adverse Event, non-fatal|1|||
44118654|NCT03034967|78902218|FG002|Overall Study|Adverse Event, non-fatal|2|||
44118655|NCT03034967|78902219|FG003|Overall Study|Adverse Event, non-fatal|0|||
44118656|NCT03034967|78902220|FG004|Overall Study|Adverse Event, non-fatal|2|||
44118657|NCT03034967|78902221|FG005|Overall Study|Adverse Event, non-fatal|8|||
44118658|NCT03034967|78902216|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
44118659|NCT03034967|78902217|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
44118660|NCT03034967|78902218|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
44118661|NCT03034967|78902219|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
44118662|NCT03034967|78902220|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
44118663|NCT03034967|78902221|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
44118664|NCT03021187|78902244|FG000|Overall Study|Death|0|||
44118665|NCT03021187|78902245|FG001|Overall Study|Death|0|||
44118666|NCT03021187|78902246|FG002|Overall Study|Death|3|||
44118667|NCT03021187|78902247|FG003|Overall Study|Death|0|||
44118668|NCT03021187|78902244|FG000|Overall Study|Withdrawal by Subject|0|||
44118669|NCT03021187|78902245|FG001|Overall Study|Withdrawal by Subject|6|||
44118670|NCT03021187|78902246|FG002|Overall Study|Withdrawal by Subject|2|||
44118671|NCT03021187|78902247|FG003|Overall Study|Withdrawal by Subject|5|||
44118672|NCT03021187|78902244|FG000|Overall Study|Lost to Follow-up|10|||
44118673|NCT03021187|78902245|FG001|Overall Study|Lost to Follow-up|3|||
44118674|NCT03021187|78902246|FG002|Overall Study|Lost to Follow-up|1|||
44118675|NCT03021187|78902247|FG003|Overall Study|Lost to Follow-up|4|||
44118676|NCT04766333|78902259|FG000|Overall Study|Lost to Follow-up|40|||
44118677|NCT04766333|78902260|FG001|Overall Study|Lost to Follow-up|826|||
44118678|NCT03020641|78902268|FG000|Overall Study|Lost to Follow-up|0|||
44118679|NCT03020641|78902269|FG001|Overall Study|Lost to Follow-up|1|||
44118680|NCT03020641|78902268|FG000|Overall Study|Converted to open surgery|2|||
44118681|NCT03020641|78902269|FG001|Overall Study|Converted to open surgery|1|||
44118682|NCT03020641|78902268|FG000|Overall Study|for surgery not performed|0|||
44118683|NCT03020641|78902269|FG001|Overall Study|for surgery not performed|1|||
44118684|NCT03020407|78902280|FG000|Overall Study|Withdrawal by Subject|2|||
44118685|NCT03020407|78902281|FG001|Overall Study|Withdrawal by Subject|1|||
44507474|NCT03149549|79512352|FG010|Study Discontinuation--Treatment Period|Other|0|||
44507475|NCT03149549|79512353|FG011|Study Discontinuation--Treatment Period|Other|0|||
44507476|NCT03149549|79512354|FG012|Study Discontinuation--Treatment Period|Other|0|||
44507477|NCT03149549|79512342|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507478|NCT03149549|79512343|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44118686|NCT03020407|78902280|FG000|Overall Study|Lost to Follow-up|2|||
44118687|NCT03020407|78902281|FG001|Overall Study|Lost to Follow-up|3|||
44118688|NCT03020407|78902280|FG000|Overall Study|Protocol Violation|0|||
44118689|NCT03020407|78902281|FG001|Overall Study|Protocol Violation|1|||
44118690|NCT02536846|78902287|FG000|Overall Study|Withdrawal by Subject|1|||
44507479|NCT03149549|79512344|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44118691|NCT03014011|78902292|FG000|First Intervention|Withdrawal by Subject|1|||
44118692|NCT03014011|78902293|FG001|First Intervention|Withdrawal by Subject|0|||
44118693|NCT03014011|78902292|FG000|Washout|Withdrawal by Subject|1|||
44118694|NCT03014011|78902293|FG001|Washout|Withdrawal by Subject|0|||
44118695|NCT03012841|78902299|FG000|Overall Study|Protocol Violation|0|||
44118696|NCT03012841|78902300|FG001|Overall Study|Protocol Violation|10|||
44118697|NCT03012841|78902299|FG000|Overall Study|Lost to Follow-up|6|||
44118698|NCT03012841|78902300|FG001|Overall Study|Lost to Follow-up|1|||
44507480|NCT03149549|79512345|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44378398|NCT00777049|79383678|FG000|Overall Study|Withdrawal by Subject|1|||
44378399|NCT00777049|79383679|FG001|Overall Study|Withdrawal by Subject|0|||
44507481|NCT03149549|79512346|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507482|NCT03149549|79512347|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
44378400|NCT00777049|79383678|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
44378401|NCT00777049|79383679|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
44378402|NCT00774787|79383685|FG000|Overall Study|Lost to Follow-up|1|||
44507483|NCT03149549|79512348|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
44507484|NCT03149549|79512349|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507485|NCT03149549|79512350|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
44507486|NCT03149549|79512351|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507487|NCT03149549|79512352|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507488|NCT03149549|79512353|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507489|NCT03149549|79512354|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
44507490|NCT03149549|79512342|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507491|NCT03149549|79512343|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507492|NCT03149549|79512344|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507493|NCT03149549|79512345|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507494|NCT03149549|79512346|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
44507495|NCT03149549|79512347|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507496|NCT03149549|79512348|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507497|NCT03149549|79512349|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
44507498|NCT03149549|79512350|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
44507499|NCT03149549|79512351|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507500|NCT03149549|79512352|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
44507501|NCT03149549|79512353|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
44507502|NCT03149549|79512354|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
44507503|NCT03149549|79512342|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507504|NCT03149549|79512343|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507505|NCT03149549|79512344|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507506|NCT03149549|79512345|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507507|NCT03149549|79512346|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
44507508|NCT03149549|79512347|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507509|NCT03149549|79512348|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507510|NCT03149549|79512349|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
44507511|NCT03149549|79512350|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
44507512|NCT03149549|79512351|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
44507513|NCT03149549|79512352|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
44507514|NCT03149549|79512353|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
44507515|NCT03149549|79512354|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
44507516|NCT03149549|79512342|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
44507517|NCT03149549|79512343|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
44507518|NCT03149549|79512344|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
44507519|NCT03149549|79512345|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
44507520|NCT03149549|79512346|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
44577279|NCT03536884|79600070|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
44577280|NCT03536884|79600071|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
44577281|NCT03536884|79600072|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
44577282|NCT03536884|79600073|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
44577283|NCT03536884|79600074|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
44577284|NCT03536884|79600070|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
44577285|NCT03536884|79600071|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
44577286|NCT03536884|79600072|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
44577287|NCT03536884|79600073|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
44577288|NCT03536884|79600074|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
44577289|NCT03536884|79600070|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
44577290|NCT03536884|79600071|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
44577291|NCT03536884|79600072|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
44577292|NCT03536884|79600073|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
44577293|NCT03536884|79600074|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
44577294|NCT03536884|79600070|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
44577295|NCT03536884|79600071|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
44577296|NCT03536884|79600072|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
44378403|NCT00888927|79383693|FG000|Overall Study|Adverse Event|0|||
44507521|NCT03149549|79512347|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
44507522|NCT03149549|79512348|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
44507523|NCT03149549|79512349|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
44507524|NCT03149549|79512350|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
44507525|NCT03149549|79512351|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
44507526|NCT03149549|79512352|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
44507527|NCT03149549|79512353|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
44507528|NCT03149549|79512354|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
44507529|NCT03149549|79512342|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
44507530|NCT03149549|79512343|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
44507531|NCT03149549|79512344|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
44507532|NCT03149549|79512345|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
44507533|NCT03149549|79512346|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
44507534|NCT03149549|79512347|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
44507535|NCT03149549|79512348|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
44507536|NCT03149549|79512349|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
44507537|NCT03149549|79512350|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
44507538|NCT03149549|79512351|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
44507539|NCT03149549|79512352|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
44507540|NCT03149549|79512353|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
44507541|NCT03149549|79512354|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
44507542|NCT02316340|79512398|FG000|First Progression|Clinical progression|2|||
44507543|NCT02316340|79512399|FG001|First Progression|Clinical progression|1|||
44507544|NCT02316340|79512398|FG000|First Progression|Withdrawal by Subject|1|||
44507545|NCT02316340|79512399|FG001|First Progression|Withdrawal by Subject|0|||
44507546|NCT02063724|79512405|FG000|Overall Study|Disease progression|1|||
44507547|NCT01722266|79512413|FG000|Overall Study|Withdrawal by Subject|1|||
44507548|NCT01722266|79512414|FG001|Overall Study|Withdrawal by Subject|2|||
44507549|NCT01722266|79512415|FG002|Overall Study|Withdrawal by Subject|0|||
44507550|NCT01722266|79512416|FG003|Overall Study|Withdrawal by Subject|0|||
44507551|NCT01722266|79512413|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
44507552|NCT01722266|79512414|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
44507553|NCT01722266|79512415|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
44507554|NCT01722266|79512416|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
44507555|NCT01722266|79512413|FG000|Overall Study|Dropped out due to Nausea|0|||
44507556|NCT01722266|79512414|FG001|Overall Study|Dropped out due to Nausea|0|||
44507557|NCT01722266|79512415|FG002|Overall Study|Dropped out due to Nausea|2|||
44507558|NCT01722266|79512416|FG003|Overall Study|Dropped out due to Nausea|0|||
44507559|NCT00953771|79512438|FG000|Overall Study|Death|1|||
44507560|NCT00953771|79512439|FG001|Overall Study|Death|0|||
44507561|NCT00673816|79512451|FG000|Overall Study|Adverse Event|1|||
44507562|NCT00673816|79512451|FG000|Overall Study|Withdrawal by Subject|1|||
44507563|NCT00026312|79512476|FG000|Overall Study|Adverse Event|0|||
44507564|NCT00026312|79512477|FG001|Overall Study|Adverse Event|32|||
44507565|NCT00026312|79512476|FG000|Overall Study|Death|1|||
44507566|NCT00026312|79512477|FG001|Overall Study|Death|7|||
44378404|NCT00888927|79383694|FG001|Overall Study|Adverse Event|0|||
44507567|NCT00026312|79512476|FG000|Overall Study|Lack of Efficacy|19|||
44507568|NCT00026312|79512477|FG001|Overall Study|Lack of Efficacy|114|||
44507569|NCT00026312|79512476|FG000|Overall Study|Lost to Follow-up|0|||
44507570|NCT00026312|79512477|FG001|Overall Study|Lost to Follow-up|5|||
44507571|NCT00026312|79512476|FG000|Overall Study|Physician Decision|1|||
44507572|NCT00026312|79512477|FG001|Overall Study|Physician Decision|37|||
44507573|NCT00026312|79512476|FG000|Overall Study|Protocol Violation|0|||
44507574|NCT00026312|79512477|FG001|Overall Study|Protocol Violation|3|||
44507575|NCT00026312|79512476|FG000|Overall Study|Withdrawal by Subject|1|||
44507576|NCT00026312|79512477|FG001|Overall Study|Withdrawal by Subject|6|||
44507577|NCT00026312|79512476|FG000|Overall Study|Ineligible|4|||
44507578|NCT00026312|79512477|FG001|Overall Study|Ineligible|5|||
44507579|NCT00026312|79512476|FG000|Overall Study|Entry onto another COG study|0|||
44507580|NCT00026312|79512477|FG001|Overall Study|Entry onto another COG study|1|||
44507581|NCT00026312|79512476|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
44507582|NCT00026312|79512477|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
44378405|NCT00888927|79383695|FG002|Overall Study|Adverse Event|0|||
44507583|NCT03280264|79512487|FG000|Overall Study|Adverse Event|1|||
44507584|NCT03280264|79512487|FG000|Overall Study|Physician Decision|1|||
44507585|NCT03280264|79512487|FG000|Overall Study|Withdrawal by Subject|1|||
44507586|NCT00060840|79512494|FG000|Overall Study|Change in surgical plan|2|||
44507587|NCT00060840|79512495|FG001|Overall Study|Change in surgical plan|6|||
44378406|NCT00888927|79383696|FG003|Overall Study|Adverse Event|1|||
44378407|NCT00888927|79383693|FG000|Overall Study|Withdrawal of consent|0|||
44507588|NCT00060840|79512494|FG000|Overall Study|Death|0|||
44507589|NCT00060840|79512495|FG001|Overall Study|Death|1|||
44507590|NCT00060840|79512494|FG000|Overall Study|Withdrawal by Subject|0|||
44507591|NCT00060840|79512495|FG001|Overall Study|Withdrawal by Subject|1|||
44507592|NCT00060840|79512494|FG000|Overall Study|Subinvestigator unavailable|0|||
44507593|NCT00060840|79512495|FG001|Overall Study|Subinvestigator unavailable|1|||
44507594|NCT00060840|79512494|FG000|Overall Study|Physician Decision|1|||
44507595|NCT00060840|79512495|FG001|Overall Study|Physician Decision|0|||
44507596|NCT00060840|79512494|FG000|Overall Study|Other|1|||
44507597|NCT00060840|79512495|FG001|Overall Study|Other|0|||
44507598|NCT03280108|79512503|FG000|Overall Study|Lost to Follow-up|2|||
44507599|NCT03280108|79512504|FG001|Overall Study|Lost to Follow-up|0|||
44507600|NCT00059202|79512517|FG000|Overall Study|Withdrawal by Subject|5|||
44507601|NCT00059202|79512518|FG001|Overall Study|Withdrawal by Subject|9|||
44507602|NCT00059202|79512517|FG000|Overall Study|Protocol Violation|1|||
44507603|NCT00059202|79512518|FG001|Overall Study|Protocol Violation|3|||
44507604|NCT00059202|79512517|FG000|Overall Study|drug toxicity|0|||
44507605|NCT00059202|79512518|FG001|Overall Study|drug toxicity|3|||
44507606|NCT03278626|79512527|FG000|Overall Study|Death|2|||
44507607|NCT03278626|79512527|FG000|Overall Study|Toxicity|1|||
44507608|NCT03278626|79512527|FG000|Overall Study|Disease Progression|2|||
44507609|NCT03277846|79512533|FG000|Overall Study|Inpatient stay too brief|12|||
44239148|NCT01538719|79065945|FG000|Overall Study|Lost to Follow-up|2|||
44239149|NCT01538719|79065946|FG001|Overall Study|Lost to Follow-up|0|||
44239150|NCT01537783|79065954|FG000|Overall Study|Lost to Follow-up|11|||
44239151|NCT01537783|79065955|FG001|Overall Study|Lost to Follow-up|2|||
44239152|NCT01556165|79065963|FG000|Overall Study|Adverse Event|5|||
44239153|NCT01556165|79065964|FG001|Overall Study|Adverse Event|3|||
44239154|NCT01556165|79065963|FG000|Overall Study|Protocol Violation|0|||
44239155|NCT01556165|79065964|FG001|Overall Study|Protocol Violation|3|||
44239156|NCT01556165|79065963|FG000|Overall Study|Withdrawal of Consent|7|||
44507610|NCT03277846|79512534|FG001|Overall Study|Inpatient stay too brief|11|||
44507611|NCT00073008|79512542|FG000|Overall Study|Missing|6|||
44577297|NCT03536884|79600073|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
44577298|NCT03536884|79600074|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
44577299|NCT03225287|79600110|FG000|Overall Study|Adverse Event|0|||
44577300|NCT03225287|79600111|FG001|Overall Study|Adverse Event|0|||
44577301|NCT03225287|79600112|FG002|Overall Study|Adverse Event|1|||
44577302|NCT03225287|79600110|FG000|Overall Study|Protocol non-compliance|0|||
44577303|NCT03225287|79600111|FG001|Overall Study|Protocol non-compliance|0|||
44577304|NCT03225287|79600112|FG002|Overall Study|Protocol non-compliance|1|||
44577305|NCT03225287|79600110|FG000|Overall Study|Subject withdraws consent|3|||
44577306|NCT03225287|79600111|FG001|Overall Study|Subject withdraws consent|0|||
44577307|NCT03225287|79600112|FG002|Overall Study|Subject withdraws consent|0|||
44577308|NCT03225287|79600110|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
44577309|NCT03225287|79600111|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
44577310|NCT03225287|79600112|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
44577311|NCT03225287|79600110|FG000|Overall Study|Trial drug not effective|0|||
44577312|NCT03225287|79600111|FG001|Overall Study|Trial drug not effective|1|||
44577313|NCT03225287|79600112|FG002|Overall Study|Trial drug not effective|0|||
44577314|NCT03225287|79600110|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
44577315|NCT03225287|79600111|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
44577316|NCT03225287|79600112|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
44577317|NCT03225287|79600110|FG000|Overall Study|Stem cell transplantation|0|||
44577318|NCT03225287|79600111|FG001|Overall Study|Stem cell transplantation|1|||
44577319|NCT03225287|79600112|FG002|Overall Study|Stem cell transplantation|0|||
44577320|NCT03140670|79600120|FG000|Overall Study|Withdrawal by Subject|2|||
44577321|NCT03140670|79600120|FG000|Overall Study|Lost to Follow-up|1|||
44577322|NCT03140670|79600120|FG000|Overall Study|Physician Decision|1|||
44239157|NCT01556165|79065964|FG001|Overall Study|Withdrawal of Consent|1|||
44507612|NCT00073008|79512543|FG001|Overall Study|Missing|6|||
44507613|NCT00073008|79512542|FG000|Overall Study|Withdrawal by Subject|2|||
44507614|NCT00073008|79512543|FG001|Overall Study|Withdrawal by Subject|2|||
44507615|NCT00073008|79512542|FG000|Overall Study|Lost to Follow-up|1|||
44507616|NCT00073008|79512543|FG001|Overall Study|Lost to Follow-up|3|||
44507617|NCT00073008|79512542|FG000|Overall Study|Death|46|||
44507618|NCT00073008|79512543|FG001|Overall Study|Death|47|||
44507619|NCT00073008|79512542|FG000|Overall Study|"Other selected on Case Report Form"|7|||
44507620|NCT00073008|79512543|FG001|Overall Study|"Other selected on Case Report Form"|5|||
44507621|NCT00058422|79512549|FG000|Overall Study|Not treated|2|||
44507622|NCT00072384|79512553|FG000|Overall Study|Physician Decision|1|||
44507623|NCT00072384|79512553|FG000|Overall Study|Ineligible|8|||
44577323|NCT02682927|79600130|FG000|Overall Study|Adverse Event|0|||
44577324|NCT02682927|79600131|FG001|Overall Study|Adverse Event|0|||
44577325|NCT02682927|79600132|FG002|Overall Study|Adverse Event|5|||
44577326|NCT02682927|79600133|FG003|Overall Study|Adverse Event|1|||
44577327|NCT02682927|79600134|FG004|Overall Study|Adverse Event|0|||
44239158|NCT01537549|79065970|FG000|Overall Study|Lost to Follow-up|1|||
44239159|NCT01537549|79065970|FG000|Overall Study|Withdrawal by Subject|2|||
44507624|NCT00054132|79512559|FG000|Overall Study|Not Treated|1|||
44507625|NCT00053898|79512566|FG000|Overall Study|No follow-up data from any source|9|||
44577328|NCT02682927|79600135|FG005|Overall Study|Adverse Event|2|||
44577329|NCT02682927|79600130|FG000|Overall Study|Death|0|||
44118699|NCT03012841|78902299|FG000|Overall Study|Withdrawal by Subject|6|||
44118700|NCT03012841|78902300|FG001|Overall Study|Withdrawal by Subject|0|||
44118701|NCT03012841|78902299|FG000|Overall Study|Unable to complete 12 month visit|6|||
44118702|NCT03012841|78902300|FG001|Overall Study|Unable to complete 12 month visit|0|||
44118703|NCT03012841|78902299|FG000|Overall Study|Subject relocation|1|||
44118704|NCT03012841|78902300|FG001|Overall Study|Subject relocation|0|||
44118705|NCT03012841|78902299|FG000|Overall Study|Seasonal winter travel|1|||
44118706|NCT03012841|78902300|FG001|Overall Study|Seasonal winter travel|0|||
44118707|NCT03012841|78902299|FG000|Overall Study|Physician Decision|0|||
44118708|NCT03012841|78902300|FG001|Overall Study|Physician Decision|2|||
44118709|NCT03012841|78902299|FG000|Overall Study|No ablation performed|0|||
44118710|NCT03012841|78902300|FG001|Overall Study|No ablation performed|2|||
44118711|NCT03012841|78902299|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
44118712|NCT03012841|78902300|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
44118713|NCT03012841|78902299|FG000|Overall Study|Insurance change|0|||
44118714|NCT03012841|78902300|FG001|Overall Study|Insurance change|1|||
44118715|NCT02359864|78902307|FG000|Overall Study|Withdrawal by Subject|1|||
44118716|NCT02359864|78902308|FG001|Overall Study|Withdrawal by Subject|0|||
44118717|NCT02533258|78902314|FG000|Overall Study|Adverse Event|1|||
44118718|NCT02533258|78902314|FG000|Overall Study|Death|2|||
44118719|NCT02533258|78902314|FG000|Overall Study|Other|1|||
44118720|NCT02533258|78902314|FG000|Overall Study|Economic factor|1|||
44118721|NCT02533258|78902314|FG000|Overall Study|Progression of pleural effusion|1|||
44118722|NCT02533258|78902314|FG000|Overall Study|Lack of Efficacy|2|||
44118723|NCT03019627|78902333|FG000|Overall Study|Adverse Event|8|||
44118724|NCT03019627|78902334|FG001|Overall Study|Adverse Event|0|||
44118725|NCT03019627|78902333|FG000|Overall Study|Unrelated to adverse event|1|||
44577330|NCT02682927|79600131|FG001|Overall Study|Death|0|||
44577331|NCT02682927|79600132|FG002|Overall Study|Death|0|||
44577332|NCT02682927|79600133|FG003|Overall Study|Death|1|||
44577333|NCT02682927|79600134|FG004|Overall Study|Death|0|||
44577334|NCT02682927|79600135|FG005|Overall Study|Death|0|||
44577335|NCT02682927|79600130|FG000|Overall Study|Lack of Efficacy|1|||
44577336|NCT02682927|79600131|FG001|Overall Study|Lack of Efficacy|0|||
44577337|NCT02682927|79600132|FG002|Overall Study|Lack of Efficacy|0|||
44577338|NCT02682927|79600133|FG003|Overall Study|Lack of Efficacy|1|||
44577339|NCT02682927|79600134|FG004|Overall Study|Lack of Efficacy|0|||
44577340|NCT02682927|79600135|FG005|Overall Study|Lack of Efficacy|0|||
44577341|NCT02682927|79600130|FG000|Overall Study|Other|0|||
44577342|NCT02682927|79600131|FG001|Overall Study|Other|0|||
44577343|NCT02682927|79600132|FG002|Overall Study|Other|0|||
44577344|NCT02682927|79600133|FG003|Overall Study|Other|2|||
44577345|NCT02682927|79600134|FG004|Overall Study|Other|0|||
44577346|NCT02682927|79600135|FG005|Overall Study|Other|0|||
44577347|NCT02682927|79600130|FG000|Overall Study|Withdrawal by Subject|2|||
44577348|NCT02682927|79600131|FG001|Overall Study|Withdrawal by Subject|0|||
44577349|NCT02682927|79600132|FG002|Overall Study|Withdrawal by Subject|1|||
44577350|NCT02682927|79600133|FG003|Overall Study|Withdrawal by Subject|0|||
44577351|NCT02682927|79600134|FG004|Overall Study|Withdrawal by Subject|1|||
44577352|NCT02682927|79600135|FG005|Overall Study|Withdrawal by Subject|1|||
44577353|NCT02566850|79600190|FG000|Overall Study|Protocol Violation|1|||
44577354|NCT02408120|79600209|FG000|Overall Study|Withdrawal by Subject|0|||
44577355|NCT02408120|79600210|FG001|Overall Study|Withdrawal by Subject|1|||
44577356|NCT02408120|79600209|FG000|Overall Study|Treatment Refusal|1|||
44577357|NCT02408120|79600210|FG001|Overall Study|Treatment Refusal|0|||
44577358|NCT02408120|79600209|FG000|Overall Study|Received Steroids|1|||
44577359|NCT02408120|79600210|FG001|Overall Study|Received Steroids|1|||
44577360|NCT02408120|79600209|FG000|Overall Study|Discharged same day|1|||
44577361|NCT02408120|79600210|FG001|Overall Study|Discharged same day|1|||
44118726|NCT03019627|78902334|FG001|Overall Study|Unrelated to adverse event|3|||
44118727|NCT03019627|78902333|FG000|Overall Study|Lost to Follow-up|2|||
44118728|NCT03019627|78902334|FG001|Overall Study|Lost to Follow-up|1|||
44118729|NCT03019627|78902333|FG000|Overall Study|not compliance|2|||
44118730|NCT03019627|78902334|FG001|Overall Study|not compliance|2|||
44118731|NCT03019627|78902333|FG000|Overall Study|Other|2|||
44118732|NCT03019627|78902334|FG001|Overall Study|Other|2|||
44118733|NCT01661140|78902340|FG000|Open-Label Period|Adverse Event|44|||
44118734|NCT01661140|78902341|FG001|Open-Label Period|Adverse Event|0|||
44577362|NCT02408120|79600209|FG000|Overall Study|Did not receive insulin|1|||
44577363|NCT02408120|79600210|FG001|Overall Study|Did not receive insulin|2|||
44577364|NCT02391545|79600218|FG000|Overall Study|Death|0|||
44577365|NCT02391545|79600219|FG001|Overall Study|Death|2|||
44577366|NCT02391545|79600218|FG000|Overall Study|Lost to Follow-up|0|||
44577367|NCT02391545|79600219|FG001|Overall Study|Lost to Follow-up|1|||
44577368|NCT02391545|79600218|FG000|Overall Study|Termination of study by sponsor|20|||
44577369|NCT02391545|79600219|FG001|Overall Study|Termination of study by sponsor|20|||
44118735|NCT01661140|78902342|FG002|Open-Label Period|Adverse Event|0|||
44577370|NCT02391545|79600218|FG000|Overall Study|Withdrawal by Subject|0|||
44577371|NCT02391545|79600219|FG001|Overall Study|Withdrawal by Subject|1|||
44577372|NCT02391545|79600218|FG000|Overall Study|Other Reasons|6|||
44577373|NCT02391545|79600219|FG001|Overall Study|Other Reasons|4|||
44577374|NCT01920932|79600226|FG000|Overall Study|Death|1|||
44577375|NCT01920932|79600226|FG000|Overall Study|Withdrawal of consent|1|||
44577376|NCT01774253|79600247|FG000|Overall Study|Lack of Efficacy|4|||
44577377|NCT01774253|79600247|FG000|Overall Study|Physician Decision|2|||
44577378|NCT01774253|79600247|FG000|Overall Study|Withdrawal by Subject|2|||
44577379|NCT01774253|79600247|FG000|Overall Study|Death|1|||
44577380|NCT01505608|79600253|FG000|Phase I|Lack of Efficacy|0|||
44577381|NCT01505608|79600254|FG001|Phase I|Lack of Efficacy|4|||
44577382|NCT01505608|79600253|FG000|Phase I|Adverse Event|0|||
44577383|NCT01505608|79600254|FG001|Phase I|Adverse Event|1|||
44577384|NCT01505608|79600253|FG000|Phase I|Withdrawal by Subject|0|||
44577385|NCT01505608|79600254|FG001|Phase I|Withdrawal by Subject|1|||
44577386|NCT01505608|79600253|FG000|Phase II|Lack of Efficacy|2|||
44577387|NCT01505608|79600254|FG001|Phase II|Lack of Efficacy|1|||
44577388|NCT01505608|79600253|FG000|Phase II|Protocol Violation|0|||
44577389|NCT01505608|79600254|FG001|Phase II|Protocol Violation|1|||
44577390|NCT01483820|79600288|FG000|Overall Study|Lack of Efficacy|6|||
44577391|NCT01483820|79600288|FG000|Overall Study|Adverse Event|1|||
44577392|NCT01483820|79600288|FG000|Overall Study|Death|1|||
44577393|NCT01106898|79600303|FG000|Overall Study|Adverse Event|6|||
44577394|NCT01059071|79600307|FG000|Overall Study|Lack of Efficacy|1|||
44577395|NCT01059071|79600308|FG001|Overall Study|Lack of Efficacy|4|||
44577396|NCT01059071|79600309|FG002|Overall Study|Lack of Efficacy|2|||
44577397|NCT01059071|79600310|FG003|Overall Study|Lack of Efficacy|3|||
44577398|NCT01059071|79600307|FG000|Overall Study|Withdrawal by Subject|1|||
44577399|NCT01059071|79600308|FG001|Overall Study|Withdrawal by Subject|0|||
44577400|NCT01059071|79600309|FG002|Overall Study|Withdrawal by Subject|0|||
44577401|NCT01059071|79600310|FG003|Overall Study|Withdrawal by Subject|2|||
44577402|NCT01059071|79600307|FG000|Overall Study|Physician Decision|0|||
44577403|NCT01059071|79600308|FG001|Overall Study|Physician Decision|0|||
44577404|NCT01059071|79600309|FG002|Overall Study|Physician Decision|0|||
44577405|NCT01059071|79600310|FG003|Overall Study|Physician Decision|1|||
44577406|NCT00923702|79600323|FG000|Overall Study|Ongoing enrollment|0|||
44577407|NCT00923702|79600324|FG001|Overall Study|Ongoing enrollment|0|||
44577408|NCT00923702|79600325|FG002|Overall Study|Ongoing enrollment|0|||
44577409|NCT00923702|79600326|FG003|Overall Study|Ongoing enrollment|0|||
44577410|NCT00923702|79600327|FG004|Overall Study|Ongoing enrollment|354|||
44577411|NCT00867568|79600339|FG000|Overall Study|Lack of Efficacy|10|||
44577412|NCT00867568|79600339|FG000|Overall Study|Adverse Event|4|||
44577413|NCT00867568|79600339|FG000|Overall Study|Withdrawal by Subject|1|||
44577414|NCT00737698|79600346|FG000|Overall Study|Withdrawal by Subject|6|||
44577415|NCT00737698|79600347|FG001|Overall Study|Withdrawal by Subject|5|||
44577416|NCT00737698|79600348|FG002|Overall Study|Withdrawal by Subject|3|||
44577417|NCT00737698|79600346|FG000|Overall Study|Death|0|||
44276090|NCT02187744|79228885|FG000|Study|Related adverse event, serious non-fatal|0|||
44507626|NCT00053898|79512567|FG001|Overall Study|No follow-up data from any source|12|||
44507627|NCT00053898|79512566|FG000|Overall Study|Follow-up from telephone contact only|5|||
44507628|NCT00053898|79512567|FG001|Overall Study|Follow-up from telephone contact only|1|||
44507629|NCT03256552|79512603|FG000|Overall Study|Protocol Violation|1|||
44507630|NCT03256552|79512603|FG000|Overall Study|Physician Decision|1|||
44507631|NCT03256552|79512603|FG000|Overall Study|Adverse Event|1|||
44507632|NCT03256552|79512603|FG000|Overall Study|Withdrawal by Subject|2|||
44507633|NCT00071058|79512613|FG000|Overall Study|brain tumor-removed from study|1|||
44507634|NCT00053352|79512620|FG000|Overall Study|Lost to Follow-up|0|||
44507635|NCT00053352|79512621|FG001|Overall Study|Lost to Follow-up|1|||
44507636|NCT00053352|79512620|FG000|Overall Study|Physician Decision|11|||
44507637|NCT00053352|79512621|FG001|Overall Study|Physician Decision|1|||
44507638|NCT00053352|79512620|FG000|Overall Study|Withdrawal by Subject|1|||
44507639|NCT00053352|79512621|FG001|Overall Study|Withdrawal by Subject|0|||
44507640|NCT00053352|79512620|FG000|Overall Study|Ineligible|8|||
44507641|NCT00053352|79512621|FG001|Overall Study|Ineligible|8|||
44507642|NCT00053352|79512620|FG000|Overall Study|Disease at new site|1|||
44507643|NCT00053352|79512621|FG001|Overall Study|Disease at new site|0|||
44507644|NCT03245398|79512630|FG000|Overall Study|Travelled to another island|1|||
44507645|NCT03245398|79512631|FG001|Overall Study|Travelled to another island|0|||
44577418|NCT00737698|79600347|FG001|Overall Study|Death|0|||
44577419|NCT00737698|79600348|FG002|Overall Study|Death|1|||
44577420|NCT01668004|79600383|FG000|Overall Study|Adverse Event|7|||
44577421|NCT01668004|79600383|FG000|Overall Study|Withdrawal by Subject|2|||
44577422|NCT01668004|79600383|FG000|Overall Study|Lost to Follow-up|5|||
44577423|NCT01668004|79600383|FG000|Overall Study|Lack of Efficacy|9|||
44577424|NCT01668004|79600383|FG000|Overall Study|Non-compliance with treatment|2|||
44577425|NCT01667926|79600391|FG000|Overall Study|Withdrawal by Subject|1|||
44577426|NCT01667926|79600392|FG001|Overall Study|Withdrawal by Subject|2|||
44577427|NCT01667926|79600393|FG002|Overall Study|Withdrawal by Subject|2|||
44577428|NCT01667926|79600391|FG000|Overall Study|Physician Decision|0|||
44577429|NCT01667926|79600392|FG001|Overall Study|Physician Decision|0|||
44577430|NCT01667926|79600393|FG002|Overall Study|Physician Decision|1|||
44577431|NCT01667926|79600391|FG000|Overall Study|Time committment|0|||
44577432|NCT01667926|79600392|FG001|Overall Study|Time committment|0|||
44577433|NCT01667926|79600393|FG002|Overall Study|Time committment|2|||
44577434|NCT01667926|79600391|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
44577435|NCT01667926|79600392|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
44577436|NCT01667926|79600393|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
44577437|NCT01667926|79600391|FG000|Overall Study|Lost to Follow-up|1|||
44577438|NCT01667926|79600392|FG001|Overall Study|Lost to Follow-up|2|||
44577439|NCT01667926|79600393|FG002|Overall Study|Lost to Follow-up|1|||
44577440|NCT01667926|79600391|FG000|Overall Study|Side effects|3|||
44577441|NCT01667926|79600392|FG001|Overall Study|Side effects|0|||
44577442|NCT01667926|79600393|FG002|Overall Study|Side effects|0|||
44577443|NCT02604160|79600401|FG000|Overall Study|Protocol Violation|0|||
44577444|NCT02604160|79600402|FG001|Overall Study|Protocol Violation|1|||
44577445|NCT02604160|79600401|FG000|Overall Study|Physician Decision|0|||
44577446|NCT02604160|79600402|FG001|Overall Study|Physician Decision|1|||
44577447|NCT01359904|79600412|FG000|Overall Study|Withdrawal by Subject|1|||
44577448|NCT01359904|79600413|FG001|Overall Study|Withdrawal by Subject|0|||
44577449|NCT05044234|79600490|FG000|Overall Study|Lost to Follow-up|2|||
44577450|NCT05044234|79600491|FG001|Overall Study|Lost to Follow-up|1|||
44577451|NCT05044234|79600492|FG002|Overall Study|Lost to Follow-up|1|||
44577452|NCT05044234|79600493|FG003|Overall Study|Lost to Follow-up|2|||
44577453|NCT05044234|79600490|FG000|Overall Study|Withdrawal by Subject|6|||
44577454|NCT05044234|79600491|FG001|Overall Study|Withdrawal by Subject|4|||
44577455|NCT05044234|79600492|FG002|Overall Study|Withdrawal by Subject|5|||
44577456|NCT05044234|79600493|FG003|Overall Study|Withdrawal by Subject|8|||
44577457|NCT05044234|79600490|FG000|Overall Study|Study terminated by Sponsor|21|||
44577458|NCT05044234|79600491|FG001|Overall Study|Study terminated by Sponsor|21|||
44577459|NCT05044234|79600492|FG002|Overall Study|Study terminated by Sponsor|20|||
44577460|NCT05044234|79600493|FG003|Overall Study|Study terminated by Sponsor|14|||
44577461|NCT05044234|79600490|FG000|Overall Study|Other, not specified|0|||
44577462|NCT05044234|79600491|FG001|Overall Study|Other, not specified|0|||
44577463|NCT05044234|79600492|FG002|Overall Study|Other, not specified|1|||
44577464|NCT05044234|79600493|FG003|Overall Study|Other, not specified|2|||
44577465|NCT05044234|79600490|FG000|Overall Study|Delayed data entry|0|||
44577466|NCT05044234|79600491|FG001|Overall Study|Delayed data entry|0|||
44577467|NCT05044234|79600492|FG002|Overall Study|Delayed data entry|0|||
44577468|NCT05044234|79600493|FG003|Overall Study|Delayed data entry|1|||
44577469|NCT04725812|79600507|FG000|Overall Study|Withdrawal by Subject|1|||
44577470|NCT04147247|79600538|FG000|Overall Study|Progressive disease|3|||
44577471|NCT04147247|79600539|FG001|Overall Study|Progressive disease|3|||
44577472|NCT04147247|79600540|FG002|Overall Study|Progressive disease|4|||
44577473|NCT04147247|79600541|FG003|Overall Study|Progressive disease|4|||
44577474|NCT04147247|79600542|FG004|Overall Study|Progressive disease|3|||
44577475|NCT04147247|79600538|FG000|Overall Study|Physician Decision|0|||
44577476|NCT04147247|79600539|FG001|Overall Study|Physician Decision|1|||
44577477|NCT04147247|79600540|FG002|Overall Study|Physician Decision|0|||
44577478|NCT04147247|79600541|FG003|Overall Study|Physician Decision|0|||
44577479|NCT04147247|79600542|FG004|Overall Study|Physician Decision|0|||
44577480|NCT04147247|79600538|FG000|Overall Study|Clinical Disease Progression|0|||
44577481|NCT04147247|79600539|FG001|Overall Study|Clinical Disease Progression|0|||
44577482|NCT04147247|79600540|FG002|Overall Study|Clinical Disease Progression|0|||
44577483|NCT04147247|79600541|FG003|Overall Study|Clinical Disease Progression|0|||
44577484|NCT04147247|79600542|FG004|Overall Study|Clinical Disease Progression|1|||
44577485|NCT04147247|79600538|FG000|Overall Study|Adverse Event|0|||
44577486|NCT04147247|79600539|FG001|Overall Study|Adverse Event|0|||
44577487|NCT04147247|79600540|FG002|Overall Study|Adverse Event|1|||
44577488|NCT04147247|79600541|FG003|Overall Study|Adverse Event|0|||
44577489|NCT04147247|79600542|FG004|Overall Study|Adverse Event|1|||
44577490|NCT04080167|79600557|FG000|Overall Study|Lost to Follow-up-Patients|7|||
44118736|NCT01661140|78902340|FG000|Open-Label Period|Protocol Violation|3|||
44239160|NCT01555931|79065978|FG000|Overall Study|Lost to Follow-up|2|||
44577491|NCT04080167|79600558|FG001|Overall Study|Lost to Follow-up-Patients|14|||
44577492|NCT04080167|79600559|FG002|Overall Study|Lost to Follow-up-Patients|0|||
44577493|NCT04080167|79600557|FG000|Overall Study|Lost to Follow-up-Providers|2|||
44577494|NCT04080167|79600558|FG001|Overall Study|Lost to Follow-up-Providers|2|||
44577495|NCT04080167|79600559|FG002|Overall Study|Lost to Follow-up-Providers|0|||
44577496|NCT04080167|79600557|FG000|Overall Study|Withdrawal by Subject|1|||
44577497|NCT04080167|79600558|FG001|Overall Study|Withdrawal by Subject|2|||
44577498|NCT04080167|79600559|FG002|Overall Study|Withdrawal by Subject|0|||
44577499|NCT04080167|79600557|FG000|Overall Study|Withdrawal by Provider|0|||
44577500|NCT04080167|79600558|FG001|Overall Study|Withdrawal by Provider|0|||
44577501|NCT04080167|79600559|FG002|Overall Study|Withdrawal by Provider|4|||
44577502|NCT04080167|79600557|FG000|Overall Study|Death-Patient|2|||
44577503|NCT04080167|79600558|FG001|Overall Study|Death-Patient|1|||
44577504|NCT04080167|79600559|FG002|Overall Study|Death-Patient|0|||
44577505|NCT04080167|79600557|FG000|Overall Study|Hydroxyurea New Starts|0|||
44577506|NCT04080167|79600558|FG001|Overall Study|Hydroxyurea New Starts|0|||
44577507|NCT04080167|79600559|FG002|Overall Study|Hydroxyurea New Starts|1|||
44577508|NCT04080167|79600557|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
44577509|NCT04080167|79600558|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
44276091|NCT02187744|79228886|FG001|Study|Related adverse event, serious non-fatal|1|||
44276092|NCT02187744|79228885|FG000|Treatment|Death|1|||
44276093|NCT02187744|79228886|FG001|Treatment|Death|0|||
44276094|NCT02187744|79228885|FG000|Treatment|Related adverse event, serious non-fatal|0|||
44276095|NCT02187744|79228886|FG001|Treatment|Related adverse event, serious non-fatal|1|||
44378408|NCT00888927|79383694|FG001|Overall Study|Withdrawal of consent|0|||
44378409|NCT00888927|79383695|FG002|Overall Study|Withdrawal of consent|0|||
44507646|NCT03244618|79512641|FG000|Overall Study|Lost to Follow-up|3|||
44507647|NCT03244618|79512642|FG001|Overall Study|Lost to Follow-up|4|||
44507648|NCT03244618|79512641|FG000|Overall Study|Protocol Violation|4|||
44507649|NCT03244618|79512642|FG001|Overall Study|Protocol Violation|3|||
44507650|NCT03244618|79512641|FG000|Overall Study|Withdrawal by Subject|0|||
44507651|NCT03244618|79512642|FG001|Overall Study|Withdrawal by Subject|2|||
44507652|NCT00052962|79512650|FG000|Overall Study|Not evaluable|0|||
44507653|NCT00052962|79512651|FG001|Overall Study|Not evaluable|2|||
44507654|NCT00052962|79512650|FG000|Overall Study|Not randomized/not evaluable|1|||
44507655|NCT00052962|79512651|FG001|Overall Study|Not randomized/not evaluable|0|||
44507656|NCT00051636|79512659|FG000|Period 1 - Core|Adverse Event|2|||
44507657|NCT00051636|79512660|FG001|Period 1 - Core|Adverse Event|2|||
44507658|NCT00051636|79512659|FG000|Period 1 - Core|Protocol Violation|1|||
44507659|NCT00051636|79512660|FG001|Period 1 - Core|Protocol Violation|0|||
44507660|NCT00051636|79512659|FG000|Period 1 - Core|Withdrawal by Subject|1|||
44507661|NCT00051636|79512660|FG001|Period 1 - Core|Withdrawal by Subject|2|||
44507662|NCT00051636|79512659|FG000|Period 1 - Core|Lost to Follow-up|0|||
44507663|NCT00051636|79512660|FG001|Period 1 - Core|Lost to Follow-up|2|||
44507664|NCT00051636|79512659|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
44507665|NCT00051636|79512660|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
44507666|NCT00051636|79512659|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
44507667|NCT00051636|79512660|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
44507668|NCT00051636|79512659|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
44507669|NCT00051636|79512660|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
44507670|NCT00051636|79512659|FG000|Period 2- Extended Observation Period|Death|4|||
44507671|NCT00051636|79512660|FG001|Period 2- Extended Observation Period|Death|5|||
44507672|NCT00051636|79512659|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
44507673|NCT00051636|79512660|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
44507674|NCT03255382|79512668|FG000|Overall Study|Adverse Event|3|||
44507675|NCT03255382|79512669|FG001|Overall Study|Adverse Event|0|||
44507676|NCT03255382|79512668|FG000|Overall Study|Lost to Follow-up|2|||
44507677|NCT03255382|79512669|FG001|Overall Study|Lost to Follow-up|0|||
44507678|NCT03255382|79512668|FG000|Overall Study|Withdrawal by Subject|2|||
44507679|NCT03255382|79512669|FG001|Overall Study|Withdrawal by Subject|0|||
44507680|NCT03255382|79512668|FG000|Overall Study|Other|6|||
44507681|NCT03255382|79512669|FG001|Overall Study|Other|0|||
44507682|NCT03254602|79512676|FG000|Overall Study|Lost to Follow-up|4|||
44507683|NCT00038142|79512682|FG000|Overall Study|Ineligible|1|||
44507684|NCT00038142|79512683|FG001|Overall Study|Ineligible|0|||
44507685|NCT00038142|79512682|FG000|Overall Study|Progressive Disease|11|||
44507686|NCT00038142|79512683|FG001|Overall Study|Progressive Disease|7|||
44507687|NCT00038142|79512682|FG000|Overall Study|Death|1|||
44507688|NCT00038142|79512683|FG001|Overall Study|Death|0|||
44507689|NCT00038142|79512682|FG000|Overall Study|Adverse Event|1|||
44507690|NCT00038142|79512683|FG001|Overall Study|Adverse Event|0|||
44507691|NCT00038142|79512682|FG000|Overall Study|Unknown Reason|8|||
44507692|NCT00038142|79512683|FG001|Overall Study|Unknown Reason|0|||
44507693|NCT00366899|79512691|FG000|Infant Series|Withdrawal by Subject|4|||
44507694|NCT00366899|79512692|FG001|Infant Series|Withdrawal by Subject|7|||
44577510|NCT04080167|79600559|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
44577511|NCT04070378|79600566|FG000|Overall Study|Withdrawal by Subject|2|||
44577512|NCT04070378|79600566|FG000|Overall Study|Screen Failure|6|||
44577513|NCT04070378|79600566|FG000|Overall Study|Physician Decision|1|||
44507695|NCT00366899|79512691|FG000|Infant Series|Protocol Violation|2|||
44507696|NCT00366899|79512692|FG001|Infant Series|Protocol Violation|1|||
44378410|NCT00888927|79383696|FG003|Overall Study|Withdrawal of consent|1|||
44507697|NCT00366899|79512691|FG000|Infant Series|Failed to return|1|||
44507698|NCT00366899|79512692|FG001|Infant Series|Failed to return|1|||
44507699|NCT00366899|79512691|FG000|Infant Series|Lost to Follow-up|0|||
44507700|NCT00366899|79512692|FG001|Infant Series|Lost to Follow-up|2|||
44507701|NCT00366899|79512691|FG000|Infant Series|Adverse Event|0|||
44507702|NCT00366899|79512692|FG001|Infant Series|Adverse Event|1|||
44507703|NCT00366899|79512691|FG000|Infant Series|Physician Decision|1|||
44507704|NCT00366899|79512692|FG001|Infant Series|Physician Decision|0|||
44577514|NCT04070378|79600566|FG000|Overall Study|Adverse Event|1|||
44577515|NCT04007367|79600570|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
44577516|NCT04007367|79600571|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
44577517|NCT04007367|79600572|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
44577518|NCT04007367|79600570|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
44577519|NCT04007367|79600571|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
44577520|NCT04007367|79600572|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
44577521|NCT04007367|79600570|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
44577522|NCT04007367|79600571|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
44577523|NCT04007367|79600572|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
44577524|NCT04007367|79600570|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
44577525|NCT04007367|79600571|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
44577526|NCT04007367|79600572|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
44577527|NCT04007367|79600570|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
44577528|NCT04007367|79600571|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
44577529|NCT04007367|79600572|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
44577530|NCT03900650|79600599|FG000|Overall Study|Withdrawal by Subject|1|||
44577531|NCT03900650|79600600|FG001|Overall Study|Withdrawal by Subject|1|||
44577532|NCT03900650|79600601|FG002|Overall Study|Withdrawal by Subject|0|||
44577533|NCT03900650|79600602|FG003|Overall Study|Withdrawal by Subject|0|||
44577534|NCT03900650|79600599|FG000|Overall Study|Withdrawn by staff|1|||
44577535|NCT03900650|79600600|FG001|Overall Study|Withdrawn by staff|0|||
44577536|NCT03900650|79600601|FG002|Overall Study|Withdrawn by staff|0|||
44577537|NCT03900650|79600602|FG003|Overall Study|Withdrawn by staff|0|||
44577538|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
44577539|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
44577540|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
44577541|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
44577542|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
44577543|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
44577544|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
44577545|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
44577546|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
44577547|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
44577548|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
44577549|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
44577550|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
44577551|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
44577552|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
44577553|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
44577554|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
44577555|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
44577556|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
44577557|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
44577558|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
44577559|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
44577560|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
44118737|NCT01661140|78902341|FG001|Open-Label Period|Protocol Violation|0|||
44118738|NCT01661140|78902342|FG002|Open-Label Period|Protocol Violation|0|||
44118739|NCT01661140|78902340|FG000|Open-Label Period|Withdrawal by Subject|5|||
44118740|NCT01661140|78902341|FG001|Open-Label Period|Withdrawal by Subject|0|||
44118741|NCT01661140|78902342|FG002|Open-Label Period|Withdrawal by Subject|0|||
44118742|NCT01661140|78902340|FG000|Open-Label Period|Investigator Decision|3|||
44118743|NCT01661140|78902341|FG001|Open-Label Period|Investigator Decision|0|||
44118744|NCT01661140|78902342|FG002|Open-Label Period|Investigator Decision|0|||
44118745|NCT01661140|78902340|FG000|Open-Label Period|Death|1|||
44118746|NCT01661140|78902341|FG001|Open-Label Period|Death|0|||
44118747|NCT01661140|78902342|FG002|Open-Label Period|Death|0|||
44118748|NCT01661140|78902340|FG000|Open-Label Period|Administrative/Other|1|||
44118749|NCT01661140|78902341|FG001|Open-Label Period|Administrative/Other|0|||
44118750|NCT01661140|78902342|FG002|Open-Label Period|Administrative/Other|0|||
44118751|NCT01661140|78902340|FG000|Open-Label Period|Sponsor termination|16|||
44378411|NCT01040780|79383708|FG000|Overall Study|Protocol Violation|1|||
44577561|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
44577562|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
44577563|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
44118752|NCT01661140|78902341|FG001|Open-Label Period|Sponsor termination|0|||
44118753|NCT01661140|78902342|FG002|Open-Label Period|Sponsor termination|0|||
44118754|NCT01661140|78902340|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
44276096|NCT02187744|79228885|FG000|Treatment|Related adverse event, not serious|0|||
44577564|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
44577565|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
44577566|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
44577567|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
44118755|NCT01661140|78902341|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
44118756|NCT01661140|78902342|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
44118757|NCT01661140|78902340|FG000|Open-Label Period|Lost to Follow-up|2|||
44507705|NCT00366899|79512691|FG000|Infant Series|Randomized but not consented|1|||
44507706|NCT00366899|79512692|FG001|Infant Series|Randomized but not consented|0|||
44507707|NCT00366899|79512691|FG000|After Infant Series|Lost to Follow-up|4|||
44507708|NCT00366899|79512692|FG001|After Infant Series|Lost to Follow-up|3|||
44507709|NCT00366899|79512691|FG000|After Infant Series|Withdrawal by Subject|1|||
44507710|NCT00366899|79512692|FG001|After Infant Series|Withdrawal by Subject|4|||
44507711|NCT00366899|79512691|FG000|After Infant Series|Adverse Event|1|||
44507712|NCT00366899|79512692|FG001|After Infant Series|Adverse Event|2|||
44507713|NCT00366899|79512691|FG000|After Infant Series|Protocol Violation|1|||
44507714|NCT00366899|79512692|FG001|After Infant Series|Protocol Violation|0|||
44507715|NCT00366899|79512691|FG000|Toddler Dose|Withdrawal by Subject|1|||
44507716|NCT00366899|79512692|FG001|Toddler Dose|Withdrawal by Subject|1|||
44507717|NCT00366899|79512691|FG000|Toddler Dose|Protocol Violation|1|||
44507718|NCT00366899|79512692|FG001|Toddler Dose|Protocol Violation|0|||
44507719|NCT03254134|79512726|FG000|Overall Study|Not eligible patients|599|||
44507720|NCT03254134|79512727|FG001|Overall Study|Not eligible patients|3630|||
44507721|NCT00037830|79512736|FG000|Overall Study|Adverse Event|2|||
44507722|NCT00037830|79512737|FG001|Overall Study|Adverse Event|0|||
44507723|NCT00037830|79512738|FG002|Overall Study|Adverse Event|0|||
44507724|NCT00037830|79512736|FG000|Overall Study|Withdrawal by Subject|4|||
44507725|NCT00037830|79512737|FG001|Overall Study|Withdrawal by Subject|5|||
44507726|NCT00037830|79512738|FG002|Overall Study|Withdrawal by Subject|1|||
44507727|NCT00037830|79512736|FG000|Overall Study|Protocol Violation|2|||
44507728|NCT00037830|79512737|FG001|Overall Study|Protocol Violation|2|||
44507729|NCT00037830|79512738|FG002|Overall Study|Protocol Violation|0|||
44507730|NCT00037830|79512736|FG000|Overall Study|Unrelated Medical Problem|2|||
44507731|NCT00037830|79512737|FG001|Overall Study|Unrelated Medical Problem|0|||
44507732|NCT00037830|79512738|FG002|Overall Study|Unrelated Medical Problem|0|||
44507733|NCT03242434|79512748|FG000|Overall Study|Death|0|||
44507734|NCT03242434|79512749|FG001|Overall Study|Death|2|||
44507735|NCT02939014|79512758|FG000|Overall Study|Lost to Follow-up|1|||
44507736|NCT02939014|79512759|FG001|Overall Study|Lost to Follow-up|0|||
44507737|NCT02939014|79512758|FG000|Overall Study|Death|4|||
44507738|NCT02939014|79512759|FG001|Overall Study|Death|3|||
44507739|NCT00051558|79512768|FG000|Overall Study|Adverse Event|30|||
44507740|NCT00051558|79512769|FG001|Overall Study|Adverse Event|18|||
44507741|NCT00051558|79512768|FG000|Overall Study|Withdrawal by Subject|29|||
44507742|NCT00051558|79512769|FG001|Overall Study|Withdrawal by Subject|42|||
44507743|NCT00051558|79512768|FG000|Overall Study|Death|9|||
44507744|NCT00051558|79512769|FG001|Overall Study|Death|15|||
44507745|NCT00051558|79512768|FG000|Overall Study|Lost to Follow-up|4|||
44507746|NCT00051558|79512769|FG001|Overall Study|Lost to Follow-up|13|||
44507747|NCT00051558|79512768|FG000|Overall Study|Protocol Violation|3|||
44507748|NCT00051558|79512769|FG001|Overall Study|Protocol Violation|4|||
44507749|NCT00051558|79512768|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
44507750|NCT00051558|79512769|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
44507751|NCT00051558|79512768|FG000|Overall Study|Sponsor Decision|6|||
44507752|NCT00051558|79512769|FG001|Overall Study|Sponsor Decision|1|||
44507753|NCT00051558|79512768|FG000|Overall Study|Other|2|||
44507754|NCT00051558|79512769|FG001|Overall Study|Other|1|||
44507755|NCT00051558|79512768|FG000|Overall Study|Significant Lab Value|2|||
44507756|NCT00051558|79512769|FG001|Overall Study|Significant Lab Value|0|||
44507757|NCT00051558|79512768|FG000|Overall Study|Physician Decision|5|||
44507758|NCT00051558|79512769|FG001|Overall Study|Physician Decision|0|||
44507759|NCT03251482|79512780|FG000|Overall Study|Withdrawal by Subject|0|||
44507760|NCT03251482|79512781|FG001|Overall Study|Withdrawal by Subject|1|||
44507761|NCT03251482|79512782|FG002|Overall Study|Withdrawal by Subject|0|||
44507762|NCT03251482|79512783|FG003|Overall Study|Withdrawal by Subject|0|||
44507763|NCT03251482|79512784|FG004|Overall Study|Withdrawal by Subject|0|||
44507764|NCT03249454|79512796|FG000|Overall Study|Withdrawal by Subject|0|||
44507765|NCT03249454|79512797|FG001|Overall Study|Withdrawal by Subject|0|||
44507766|NCT03249454|79512798|FG002|Overall Study|Withdrawal by Subject|0|||
44507767|NCT03249454|79512799|FG003|Overall Study|Withdrawal by Subject|0|||
44507768|NCT03249454|79512800|FG004|Overall Study|Withdrawal by Subject|0|||
44507769|NCT03249454|79512801|FG005|Overall Study|Withdrawal by Subject|0|||
44507770|NCT03249454|79512802|FG006|Overall Study|Withdrawal by Subject|0|||
44507771|NCT03249454|79512803|FG007|Overall Study|Withdrawal by Subject|0|||
44507772|NCT03249454|79512804|FG008|Overall Study|Withdrawal by Subject|0|||
44507773|NCT03249454|79512805|FG009|Overall Study|Withdrawal by Subject|1|||
44577568|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
44577569|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
44577570|NCT03890120|79600614|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
44577571|NCT03890120|79600615|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
44577572|NCT03890120|79600616|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
44577573|NCT03890120|79600617|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
44577574|NCT03890120|79600614|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
44577575|NCT03890120|79600615|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
44577576|NCT03890120|79600616|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
44577577|NCT03890120|79600617|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
44577578|NCT03890120|79600614|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
44577579|NCT03890120|79600615|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
44577580|NCT03890120|79600616|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
44577581|NCT03890120|79600617|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
44577582|NCT03890120|79600614|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
44577583|NCT03890120|79600615|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
44577584|NCT03890120|79600616|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
44577585|NCT03890120|79600617|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
44577586|NCT03890120|79600614|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
44577587|NCT03890120|79600615|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
44577588|NCT03890120|79600616|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
44577589|NCT03890120|79600617|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
44577590|NCT03783689|79600635|FG000|Overall Study|Adverse Event|2|||
44577591|NCT03783689|79600636|FG001|Overall Study|Adverse Event|0|||
44577592|NCT03783689|79600635|FG000|Overall Study|Lost to Follow-up|2|||
44577593|NCT03783689|79600636|FG001|Overall Study|Lost to Follow-up|1|||
44577594|NCT03783689|79600635|FG000|Overall Study|Physician Decision|2|||
44577595|NCT03783689|79600636|FG001|Overall Study|Physician Decision|1|||
44577596|NCT03783689|79600635|FG000|Overall Study|Withdrawal by Subject|3|||
44577597|NCT03783689|79600636|FG001|Overall Study|Withdrawal by Subject|3|||
44577598|NCT03771664|79600645|FG000|Overall Study|Adverse Event|1|||
44577599|NCT03771664|79600646|FG001|Overall Study|Adverse Event|0|||
44577600|NCT03771664|79600645|FG000|Overall Study|Lost to Follow-up|1|||
44577601|NCT03771664|79600646|FG001|Overall Study|Lost to Follow-up|0|||
44577602|NCT03771664|79600645|FG000|Overall Study|Withdrawal by Participant|1|||
44577603|NCT03771664|79600646|FG001|Overall Study|Withdrawal by Participant|4|||
44577604|NCT03771664|79600645|FG000|Overall Study|Randomized but not Treated|0|||
44577605|NCT03771664|79600646|FG001|Overall Study|Randomized but not Treated|1|||
44577606|NCT03743415|79600662|FG000|Overall Study|Death|5|||
44577607|NCT03743415|79600663|FG001|Overall Study|Death|3|||
44577608|NCT03743415|79600664|FG002|Overall Study|Death|1|||
44577609|NCT03743415|79600665|FG003|Overall Study|Death|4|||
44577610|NCT03743415|79600666|FG004|Overall Study|Death|0|||
44118758|NCT01661140|78902341|FG001|Open-Label Period|Lost to Follow-up|0|||
44507774|NCT03249454|79512806|FG010|Overall Study|Withdrawal by Subject|1|||
44507775|NCT03732248|79512819|FG000|Overall Study|Withdrawal by Subject|1|||
44507776|NCT03732248|79512820|FG001|Overall Study|Withdrawal by Subject|0|||
44118759|NCT01661140|78902342|FG002|Open-Label Period|Lost to Follow-up|0|||
44118760|NCT01661140|78902340|FG000|Double-Blind Period|Refused Treatment|0|||
44378412|NCT01040780|79383709|FG001|Overall Study|Protocol Violation|3|||
44507777|NCT00310037|79512828|FG000|Overall Study|Adverse Event|7|||
44507778|NCT00310037|79512829|FG001|Overall Study|Adverse Event|14|||
44507779|NCT00310037|79512828|FG000|Overall Study|Withdrawal by Subject|4|||
44507780|NCT00310037|79512829|FG001|Overall Study|Withdrawal by Subject|3|||
44507781|NCT00310037|79512828|FG000|Overall Study|Progression|6|||
44507782|NCT00310037|79512829|FG001|Overall Study|Progression|0|||
44507783|NCT00310037|79512828|FG000|Overall Study|Non-protocol treatment|1|||
44507784|NCT00310037|79512829|FG001|Overall Study|Non-protocol treatment|0|||
44507785|NCT00309959|79512835|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
44507786|NCT03238924|79512846|FG000|Overall Study|Withdrawal by Subject|2|||
44507787|NCT03238924|79512847|FG001|Overall Study|Withdrawal by Subject|2|||
44507788|NCT03247816|79512853|FG000|Overall Study|Adverse Event|12|||
44507789|NCT03247816|79512853|FG000|Overall Study|Physician Decision|3|||
44577611|NCT03743415|79600667|FG005|Overall Study|Death|0|||
44577612|NCT03743415|79600668|FG006|Overall Study|Death|0|||
44577613|NCT03743415|79600669|FG007|Overall Study|Death|0|||
44118761|NCT01661140|78902341|FG001|Double-Blind Period|Refused Treatment|0|||
44118762|NCT01661140|78902342|FG002|Double-Blind Period|Refused Treatment|1|||
44577614|NCT03743415|79600670|FG008|Overall Study|Death|1|||
44577615|NCT03743415|79600671|FG009|Overall Study|Death|0|||
44577616|NCT03743415|79600662|FG000|Overall Study|Withdrawal by Subject|1|||
44577617|NCT03743415|79600663|FG001|Overall Study|Withdrawal by Subject|0|||
44507790|NCT03247816|79512853|FG000|Overall Study|Lack of Efficacy|1|||
44507791|NCT03247816|79512853|FG000|Overall Study|Lost to Follow-up|10|||
44577618|NCT03743415|79600664|FG002|Overall Study|Withdrawal by Subject|4|||
44577619|NCT03743415|79600665|FG003|Overall Study|Withdrawal by Subject|5|||
44577620|NCT03743415|79600666|FG004|Overall Study|Withdrawal by Subject|5|||
44577621|NCT03743415|79600667|FG005|Overall Study|Withdrawal by Subject|2|||
44577622|NCT03743415|79600668|FG006|Overall Study|Withdrawal by Subject|2|||
44577623|NCT03743415|79600669|FG007|Overall Study|Withdrawal by Subject|5|||
44577624|NCT03743415|79600670|FG008|Overall Study|Withdrawal by Subject|9|||
44577625|NCT03743415|79600671|FG009|Overall Study|Withdrawal by Subject|10|||
44577626|NCT03743415|79600662|FG000|Overall Study|Lost to Follow-up|2|||
44577627|NCT03743415|79600663|FG001|Overall Study|Lost to Follow-up|0|||
44577628|NCT03743415|79600664|FG002|Overall Study|Lost to Follow-up|2|||
44577629|NCT03743415|79600665|FG003|Overall Study|Lost to Follow-up|1|||
44577630|NCT03743415|79600666|FG004|Overall Study|Lost to Follow-up|1|||
44577631|NCT03743415|79600667|FG005|Overall Study|Lost to Follow-up|0|||
44577632|NCT03743415|79600668|FG006|Overall Study|Lost to Follow-up|1|||
44577633|NCT03743415|79600669|FG007|Overall Study|Lost to Follow-up|4|||
44577634|NCT03743415|79600670|FG008|Overall Study|Lost to Follow-up|13|||
44577635|NCT03743415|79600671|FG009|Overall Study|Lost to Follow-up|13|||
44577636|NCT03672175|79600690|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
44577637|NCT03672175|79600691|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
44577638|NCT03672175|79600692|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
44577639|NCT03672175|79600690|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
44577640|NCT03672175|79600691|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
44577641|NCT03672175|79600692|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
44577642|NCT03672175|79600690|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
44577643|NCT03672175|79600691|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
44577644|NCT03672175|79600692|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
44577645|NCT03672175|79600690|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
44577646|NCT03672175|79600691|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
44577647|NCT03672175|79600692|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
44577648|NCT03672175|79600690|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
44577649|NCT03672175|79600691|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
44577650|NCT03672175|79600692|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
44577651|NCT03672175|79600690|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
44577652|NCT03672175|79600691|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
44577653|NCT03672175|79600692|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
44577654|NCT03672175|79600690|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
44577655|NCT03672175|79600691|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
44577656|NCT03672175|79600692|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
44577657|NCT03672175|79600690|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
44577658|NCT03672175|79600691|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
44577659|NCT03672175|79600692|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
44577660|NCT03672175|79600690|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
44577661|NCT03672175|79600691|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
44577662|NCT03672175|79600692|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
44118763|NCT01661140|78902340|FG000|Double-Blind Period|Adverse Event|0|||
44118764|NCT01661140|78902341|FG001|Double-Blind Period|Adverse Event|16|||
44118765|NCT01661140|78902342|FG002|Double-Blind Period|Adverse Event|18|||
44118766|NCT01661140|78902340|FG000|Double-Blind Period|Protocol Violation|0|||
44118767|NCT01661140|78902341|FG001|Double-Blind Period|Protocol Violation|2|||
44118768|NCT01661140|78902342|FG002|Double-Blind Period|Protocol Violation|3|||
44118769|NCT01661140|78902340|FG000|Double-Blind Period|Withdrawal by Subject|0|||
44118770|NCT01661140|78902341|FG001|Double-Blind Period|Withdrawal by Subject|1|||
44118771|NCT01661140|78902342|FG002|Double-Blind Period|Withdrawal by Subject|3|||
44118772|NCT01661140|78902340|FG000|Double-Blind Period|Investigator's Decision|0|||
44118773|NCT01661140|78902341|FG001|Double-Blind Period|Investigator's Decision|1|||
44118774|NCT01661140|78902342|FG002|Double-Blind Period|Investigator's Decision|2|||
44118775|NCT01661140|78902340|FG000|Double-Blind Period|Sponsor Termination|0|||
44118776|NCT01661140|78902341|FG001|Double-Blind Period|Sponsor Termination|14|||
44118777|NCT01661140|78902342|FG002|Double-Blind Period|Sponsor Termination|17|||
44577663|NCT03672175|79600690|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
44577664|NCT03672175|79600691|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
44577665|NCT03672175|79600692|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
44118778|NCT01661140|78902340|FG000|Double-Blind Period|Administrative/Other|0|||
44118779|NCT01661140|78902341|FG001|Double-Blind Period|Administrative/Other|7|||
44239161|NCT01555931|79065979|FG001|Overall Study|Lost to Follow-up|5|||
44577666|NCT03672175|79600690|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
44577667|NCT03672175|79600691|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
44239162|NCT01583179|79065987|FG000|Overall Study|Screen failure|1|||
44239163|NCT01583179|79065988|FG001|Overall Study|Screen failure|2|||
44239164|NCT01582945|79065994|FG000|Overall Study|Intolerable side-effects|1|||
44239165|NCT01582945|79065994|FG000|Overall Study|Scheduling conflicts|1|||
44507792|NCT03247816|79512853|FG000|Overall Study|Missing Feraccru stop date|3|||
44577668|NCT03672175|79600692|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
44577669|NCT03672175|79600690|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
44577670|NCT03672175|79600691|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
44577671|NCT03672175|79600692|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
44577672|NCT03524118|79600733|FG000|Overall Study|Lost to Follow-up|0|||
44577673|NCT03524118|79600734|FG001|Overall Study|Lost to Follow-up|0|||
44577674|NCT03524118|79600735|FG002|Overall Study|Lost to Follow-up|0|||
44577675|NCT03524118|79600736|FG003|Overall Study|Lost to Follow-up|0|||
44118780|NCT01661140|78902342|FG002|Double-Blind Period|Administrative/Other|6|||
44118781|NCT03019549|78902350|FG000|Washout|DId not meet genotype criteria|11|||
44118782|NCT03019549|78902350|FG000|Period 2|Adverse Event|2|||
44118783|NCT03019549|78902350|FG000|Period 2|Physician Decision|2|||
44118784|NCT03019549|78902350|FG000|Period 2|Withdrawal by Subject|1|||
44118785|NCT01661062|78902359|FG000|Overall Study|Completed Treatment Off Study|3|||
44118786|NCT01661062|78902359|FG000|Overall Study|Withdrawal by Subject|2|||
44118787|NCT02536378|78902365|FG000|Overall Study|Physician Decision|0|||
44118788|NCT02536378|78902366|FG001|Overall Study|Physician Decision|2|||
44118789|NCT02536378|78902365|FG000|Overall Study|Withdrawal by Subject|0|||
44118790|NCT02536378|78902366|FG001|Overall Study|Withdrawal by Subject|1|||
44118791|NCT02536378|78902365|FG000|Overall Study|Death|1|||
44507793|NCT00333359|79512871|FG000|Overall Study|Adverse Event|29|||
44507794|NCT00333359|79512872|FG001|Overall Study|Adverse Event|35|||
44507795|NCT00333359|79512871|FG000|Overall Study|Withdrawal by Subject|19|||
44577676|NCT03524118|79600737|FG004|Overall Study|Lost to Follow-up|1|||
44577677|NCT03524118|79600738|FG005|Overall Study|Lost to Follow-up|0|||
44577678|NCT03524118|79600733|FG000|Overall Study|Other|0|||
44577679|NCT03524118|79600734|FG001|Overall Study|Other|1|||
44577680|NCT03524118|79600735|FG002|Overall Study|Other|0|||
44577681|NCT03524118|79600736|FG003|Overall Study|Other|0|||
44577682|NCT03524118|79600737|FG004|Overall Study|Other|1|||
44577683|NCT03524118|79600738|FG005|Overall Study|Other|1|||
44577684|NCT03524118|79600733|FG000|Overall Study|Physician Decision|0|||
44577685|NCT03524118|79600734|FG001|Overall Study|Physician Decision|0|||
44577686|NCT03524118|79600735|FG002|Overall Study|Physician Decision|0|||
44577687|NCT03524118|79600736|FG003|Overall Study|Physician Decision|0|||
44577688|NCT03524118|79600737|FG004|Overall Study|Physician Decision|1|||
44577689|NCT03524118|79600738|FG005|Overall Study|Physician Decision|0|||
44577690|NCT03524118|79600733|FG000|Overall Study|Protocol Violation|0|||
44577691|NCT03524118|79600734|FG001|Overall Study|Protocol Violation|0|||
44577692|NCT03524118|79600735|FG002|Overall Study|Protocol Violation|1|||
44577693|NCT03524118|79600736|FG003|Overall Study|Protocol Violation|0|||
44118792|NCT02536378|78902366|FG001|Overall Study|Death|2|||
44118793|NCT02536378|78902365|FG000|Overall Study|Patient refused further follow up|6|||
44118794|NCT02536378|78902366|FG001|Overall Study|Patient refused further follow up|2|||
44118795|NCT01373151|78902381|FG000|Period 1|Lack of Efficacy|3|||
44507796|NCT00333359|79512872|FG001|Overall Study|Withdrawal by Subject|37|||
44507797|NCT00333359|79512871|FG000|Overall Study|Physician Decision|2|||
44507798|NCT00333359|79512872|FG001|Overall Study|Physician Decision|2|||
44507799|NCT00333359|79512871|FG000|Overall Study|Protocol Non-compliance|2|||
44507800|NCT00333359|79512872|FG001|Overall Study|Protocol Non-compliance|8|||
44507801|NCT00333359|79512871|FG000|Overall Study|Lost to Follow-up|15|||
44507802|NCT00333359|79512872|FG001|Overall Study|Lost to Follow-up|25|||
44507803|NCT00333359|79512871|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
44507804|NCT00333359|79512872|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
44507805|NCT00333359|79512871|FG000|Overall Study|Treatment Failure|3|||
44507806|NCT00333359|79512872|FG001|Overall Study|Treatment Failure|8|||
44507807|NCT00333359|79512871|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
44507808|NCT00333359|79512872|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
44507809|NCT03246724|79512884|FG000|Overall Study|Withdrawal by Subject|5|||
44118796|NCT01373151|78902382|FG001|Period 1|Lack of Efficacy|0|||
44118797|NCT01373151|78902383|FG002|Period 1|Lack of Efficacy|0|||
44118798|NCT01373151|78902384|FG003|Period 1|Lack of Efficacy|0|||
44507810|NCT03246724|79512885|FG001|Overall Study|Withdrawal by Subject|2|||
44507811|NCT03246724|79512886|FG002|Overall Study|Withdrawal by Subject|4|||
44507812|NCT03246724|79512887|FG003|Overall Study|Withdrawal by Subject|2|||
44577694|NCT03524118|79600737|FG004|Overall Study|Protocol Violation|1|||
44577695|NCT03524118|79600738|FG005|Overall Study|Protocol Violation|0|||
44577696|NCT03524118|79600733|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44577697|NCT03524118|79600734|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44577698|NCT03524118|79600735|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44577699|NCT03524118|79600736|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
44577700|NCT03524118|79600737|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
44577701|NCT03524118|79600738|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
44577702|NCT03472586|79600752|FG000|Overall Study|Physician Decision|6|||
44577703|NCT03472586|79600752|FG000|Overall Study|Death|6|||
44118799|NCT01373151|78902385|FG004|Period 1|Lack of Efficacy|1|||
44118800|NCT01373151|78902386|FG005|Period 1|Lack of Efficacy|0|||
44577704|NCT03472586|79600752|FG000|Overall Study|Adverse Event|1|||
44577705|NCT03437265|79600756|FG000|Overall Study|Protocol Violation|6|||
44577706|NCT03414424|79600762|FG000|Overall Study|Screened out after consent|0|||
44577707|NCT03414424|79600763|FG001|Overall Study|Screened out after consent|2|||
44577708|NCT03414424|79600762|FG000|Overall Study|Lost to Follow-up|0|||
44577709|NCT03414424|79600763|FG001|Overall Study|Lost to Follow-up|1|||
44577710|NCT03349476|79600769|FG000|Overall Study|Physician Decision|3|||
44577711|NCT03312634|79600775|FG000|Overall Study|Adverse Event|11|||
44118801|NCT01373151|78902387|FG006|Period 1|Lack of Efficacy|0|||
44118802|NCT01373151|78902381|FG000|Period 1|Adverse Event|0|||
44118803|NCT01373151|78902382|FG001|Period 1|Adverse Event|0|||
44118804|NCT01373151|78902383|FG002|Period 1|Adverse Event|1|||
44118805|NCT01373151|78902384|FG003|Period 1|Adverse Event|0|||
44118806|NCT01373151|78902385|FG004|Period 1|Adverse Event|4|||
44118807|NCT01373151|78902386|FG005|Period 1|Adverse Event|3|||
44118808|NCT01373151|78902387|FG006|Period 1|Adverse Event|0|||
44577712|NCT03312634|79600776|FG001|Overall Study|Adverse Event|0|||
44577713|NCT03312634|79600775|FG000|Overall Study|Sponsor request|2|||
44577714|NCT03312634|79600776|FG001|Overall Study|Sponsor request|0|||
44577715|NCT03312634|79600775|FG000|Overall Study|Withdrawal by Subject|31|||
44577716|NCT03312634|79600776|FG001|Overall Study|Withdrawal by Subject|9|||
44577717|NCT03312634|79600775|FG000|Overall Study|Enrolled in an interventional study|0|||
44577718|NCT03312634|79600776|FG001|Overall Study|Enrolled in an interventional study|52|||
44577719|NCT03312634|79600775|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
44577720|NCT03312634|79600776|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
44577721|NCT03312634|79600775|FG000|Overall Study|Death|0|||
44577722|NCT03312634|79600776|FG001|Overall Study|Death|1|||
44577723|NCT03312634|79600775|FG000|Overall Study|Non-compliance|0|||
44577724|NCT03312634|79600776|FG001|Overall Study|Non-compliance|2|||
44577725|NCT03312634|79600775|FG000|Overall Study|Lost to Follow-up|0|||
44577726|NCT03312634|79600776|FG001|Overall Study|Lost to Follow-up|1|||
44577727|NCT03312634|79600775|FG000|Overall Study|Enrolled into non-interventional study|0|||
44577728|NCT03312634|79600776|FG001|Overall Study|Enrolled into non-interventional study|5|||
44577729|NCT03312634|79600775|FG000|Overall Study|Worsening clinical condition|0|||
44577730|NCT03312634|79600776|FG001|Overall Study|Worsening clinical condition|1|||
44577731|NCT03312634|79600775|FG000|Overall Study|Participant did not want to travel|0|||
44577732|NCT03312634|79600776|FG001|Overall Study|Participant did not want to travel|1|||
44577733|NCT03312634|79600775|FG000|Overall Study|Physician Decision|1|||
44577734|NCT03312634|79600776|FG001|Overall Study|Physician Decision|0|||
44577735|NCT03312634|79600775|FG000|Overall Study|Other|13|||
44577736|NCT03312634|79600776|FG001|Overall Study|Other|0|||
44577737|NCT03000569|79600785|FG000|Overall Study|Withdrawal by Subject|1|||
44577738|NCT03000569|79600786|FG001|Overall Study|Withdrawal by Subject|0|||
44577739|NCT02205359|79600824|FG000|Overall Study|Death|293|||
44577740|NCT02205359|79600825|FG001|Overall Study|Death|327|||
44577741|NCT02205359|79600824|FG000|Overall Study|Lost to Follow-up|182|||
44577742|NCT02205359|79600825|FG001|Overall Study|Lost to Follow-up|162|||
44577743|NCT02205359|79600824|FG000|Overall Study|Physician Decision|51|||
44577744|NCT02205359|79600825|FG001|Overall Study|Physician Decision|53|||
44577745|NCT02205359|79600824|FG000|Overall Study|Withdrawal by Subject|167|||
44577746|NCT02205359|79600825|FG001|Overall Study|Withdrawal by Subject|169|||
44118809|NCT01373151|78902381|FG000|Period 1|Withdrawal by Subject|2|||
44118810|NCT01373151|78902382|FG001|Period 1|Withdrawal by Subject|0|||
44118811|NCT01373151|78902383|FG002|Period 1|Withdrawal by Subject|3|||
44118812|NCT01373151|78902384|FG003|Period 1|Withdrawal by Subject|1|||
44118813|NCT01373151|78902385|FG004|Period 1|Withdrawal by Subject|0|||
44239166|NCT01565083|79066000|FG000|Overall Study|Withdrawal by Subject|6|||
44577747|NCT02101775|79600835|FG000|Overall Study|Adverse Event|4|||
44577748|NCT02101775|79600836|FG001|Overall Study|Adverse Event|0|||
44577749|NCT02101775|79600837|FG002|Overall Study|Adverse Event|0|||
44577750|NCT02101775|79600835|FG000|Overall Study|Admission to Hospital|0|||
44577751|NCT02101775|79600836|FG001|Overall Study|Admission to Hospital|1|||
44577752|NCT02101775|79600837|FG002|Overall Study|Admission to Hospital|0|||
44577753|NCT01979536|79600853|FG000|Overall Study|Physician Decision|2|||
44577754|NCT01979536|79600854|FG001|Overall Study|Physician Decision|3|||
44577755|NCT01979536|79600853|FG000|Overall Study|Withdrawal by Subject|0|||
44577756|NCT01979536|79600854|FG001|Overall Study|Withdrawal by Subject|1|||
44577757|NCT01979536|79600853|FG000|Overall Study|Refusal|0|||
44577758|NCT01979536|79600854|FG001|Overall Study|Refusal|1|||
44577759|NCT01979536|79600853|FG000|Overall Study|Relapse|0|||
44577760|NCT01979536|79600854|FG001|Overall Study|Relapse|1|||
44577761|NCT01979536|79600853|FG000|Overall Study|Study terminated by Sponsor|0|||
44118814|NCT01373151|78902386|FG005|Period 1|Withdrawal by Subject|1|||
44118815|NCT01373151|78902387|FG006|Period 1|Withdrawal by Subject|0|||
44118816|NCT01373151|78902381|FG000|Period 2|Lack of Efficacy|9|||
44577762|NCT01979536|79600854|FG001|Overall Study|Study terminated by Sponsor|1|||
44577763|NCT01979536|79600853|FG000|Overall Study|Did not start treatment|0|||
44577764|NCT01979536|79600854|FG001|Overall Study|Did not start treatment|1|||
44577765|NCT01798992|79600877|FG000|Overall Study|Administrative withdrawal|0|||
44577766|NCT01798992|79600878|FG001|Overall Study|Administrative withdrawal|1|||
44577767|NCT01798992|79600879|FG002|Overall Study|Administrative withdrawal|0|||
44577768|NCT01798992|79600880|FG003|Overall Study|Administrative withdrawal|1|||
44577769|NCT01798992|79600877|FG000|Overall Study|Lost to Follow-up|0|||
44577770|NCT01798992|79600878|FG001|Overall Study|Lost to Follow-up|1|||
44577771|NCT01798992|79600879|FG002|Overall Study|Lost to Follow-up|1|||
44577772|NCT01798992|79600880|FG003|Overall Study|Lost to Follow-up|0|||
44577773|NCT01798992|79600877|FG000|Overall Study|Insufficient biopsy tissue|0|||
44577774|NCT01798992|79600878|FG001|Overall Study|Insufficient biopsy tissue|0|||
44577775|NCT01798992|79600879|FG002|Overall Study|Insufficient biopsy tissue|1|||
44577776|NCT01798992|79600880|FG003|Overall Study|Insufficient biopsy tissue|0|||
44577777|NCT01570868|79600891|FG000|Overall Study|Adverse Event|8|||
44577778|NCT01570868|79600892|FG001|Overall Study|Adverse Event|1|||
44577779|NCT01570868|79600891|FG000|Overall Study|FDA Recommendation|23|||
44577780|NCT01570868|79600892|FG001|Overall Study|FDA Recommendation|3|||
44577781|NCT01570868|79600891|FG000|Overall Study|Physician Decision|10|||
44577782|NCT01570868|79600892|FG001|Overall Study|Physician Decision|4|||
44577783|NCT01570868|79600891|FG000|Overall Study|Lost to Follow-up|1|||
44577784|NCT01570868|79600892|FG001|Overall Study|Lost to Follow-up|0|||
44577785|NCT01570868|79600891|FG000|Overall Study|Withdrawal by Subject|1|||
44577786|NCT01570868|79600892|FG001|Overall Study|Withdrawal by Subject|0|||
44577787|NCT01251965|79600905|FG000|Overall Study|Participant/physician decision|1|||
44577788|NCT01251965|79600906|FG001|Overall Study|Participant/physician decision|2|||
44239167|NCT01565083|79066001|FG001|Overall Study|Withdrawal by Subject|4|||
44239168|NCT01565083|79066000|FG000|Overall Study|Lost to Follow-up|2|||
44239169|NCT01565083|79066001|FG001|Overall Study|Lost to Follow-up|7|||
44239170|NCT01565083|79066000|FG000|Overall Study|Death|22|||
44239171|NCT01565083|79066001|FG001|Overall Study|Death|23|||
44577789|NCT01251965|79600907|FG002|Overall Study|Participant/physician decision|0|||
44577790|NCT01251965|79600905|FG000|Overall Study|Death|0|||
44577791|NCT01251965|79600906|FG001|Overall Study|Death|0|||
44577792|NCT01251965|79600907|FG002|Overall Study|Death|11|||
44577793|NCT01190644|79600916|FG000|Overall Study|Death|2|||
44577794|NCT01190644|79600916|FG000|Overall Study|Disease progression|1|||
44577795|NCT00849290|79600921|FG000|Overall Study|Adverse Event|3|||
44577796|NCT00849290|79600921|FG000|Overall Study|Death|14|||
44577797|NCT00849290|79600921|FG000|Overall Study|Withdrawal by Subject|11|||
44577798|NCT00849290|79600921|FG000|Overall Study|Lost to Follow-up|2|||
44577799|NCT00849290|79600921|FG000|Overall Study|Protocol Violation|5|||
44577800|NCT00849290|79600921|FG000|Overall Study|Disease Progression|20|||
44577801|NCT00542451|79600929|FG000|Overall Study|Adverse Event|31|||
44577802|NCT00542451|79600929|FG000|Overall Study|Withdrawal by Subject|30|||
44577803|NCT00542451|79600929|FG000|Overall Study|Physician Decision|4|||
44577804|NCT00542451|79600929|FG000|Overall Study|Recurrent disease|1|||
44577805|NCT00542451|79600929|FG000|Overall Study|unknown reason|1|||
44577806|NCT00542451|79600929|FG000|Overall Study|Death|2|||
44577807|NCT00542451|79600929|FG000|Overall Study|Lost to Follow-up|10|||
44577808|NCT00506493|79600936|FG000|Overall Study|Death|6|||
44577809|NCT00506493|79600936|FG000|Overall Study|Withdrawal by Subject|5|||
44577810|NCT00157248|79600950|FG000|Overall Study|Adverse Event|36|||
44118817|NCT01373151|78902382|FG001|Period 2|Lack of Efficacy|0|||
44118818|NCT01373151|78902383|FG002|Period 2|Lack of Efficacy|0|||
44118819|NCT01373151|78902384|FG003|Period 2|Lack of Efficacy|1|||
44577811|NCT00157248|79600951|FG001|Overall Study|Adverse Event|25|||
44577812|NCT00157248|79600952|FG002|Overall Study|Adverse Event|13|||
44577813|NCT00157248|79600953|FG003|Overall Study|Adverse Event|33|||
44577814|NCT00157248|79600950|FG000|Overall Study|Protocol Violation|4|||
44577815|NCT00157248|79600951|FG001|Overall Study|Protocol Violation|0|||
44577816|NCT00157248|79600952|FG002|Overall Study|Protocol Violation|2|||
44577817|NCT00157248|79600953|FG003|Overall Study|Protocol Violation|2|||
44577818|NCT00157248|79600950|FG000|Overall Study|Lost to Follow-up|0|||
44577819|NCT00157248|79600951|FG001|Overall Study|Lost to Follow-up|1|||
44577820|NCT00157248|79600952|FG002|Overall Study|Lost to Follow-up|0|||
44577821|NCT00157248|79600953|FG003|Overall Study|Lost to Follow-up|0|||
44577822|NCT00157248|79600950|FG000|Overall Study|Withdrawal by Subject|1|||
44577823|NCT00157248|79600951|FG001|Overall Study|Withdrawal by Subject|4|||
44239172|NCT01565083|79066000|FG000|Overall Study|Other|3|||
44577824|NCT00157248|79600952|FG002|Overall Study|Withdrawal by Subject|3|||
44118820|NCT01373151|78902385|FG004|Period 2|Lack of Efficacy|2|||
44239173|NCT01565083|79066001|FG001|Overall Study|Other|5|||
44577825|NCT00157248|79600953|FG003|Overall Study|Withdrawal by Subject|3|||
44577826|NCT00157248|79600950|FG000|Overall Study|site closures, subject moving|7|||
44118821|NCT01373151|78902386|FG005|Period 2|Lack of Efficacy|0|||
44118822|NCT01373151|78902387|FG006|Period 2|Lack of Efficacy|3|||
44239174|NCT01582789|79066007|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
44577827|NCT00157248|79600951|FG001|Overall Study|site closures, subject moving|7|||
44577828|NCT00157248|79600952|FG002|Overall Study|site closures, subject moving|3|||
44577829|NCT00157248|79600953|FG003|Overall Study|site closures, subject moving|9|||
44577830|NCT02504580|79600975|FG000|Overall Study|Other|1|||
44577831|NCT02504580|79600976|FG001|Overall Study|Other|0|||
44577832|NCT02504580|79600977|FG002|Overall Study|Other|0|||
44577833|NCT02504580|79600978|FG003|Overall Study|Other|2|||
44577834|NCT02504580|79600979|FG004|Overall Study|Other|1|||
44118823|NCT01373151|78902381|FG000|Period 2|Adverse Event|0|||
44577835|NCT02504580|79600980|FG005|Overall Study|Other|1|||
44577836|NCT02504580|79600981|FG006|Overall Study|Other|1|||
44577837|NCT02504580|79600982|FG007|Overall Study|Other|2|||
44577838|NCT02504580|79600983|FG008|Overall Study|Other|0|||
44577839|NCT02504580|79600984|FG009|Overall Study|Other|0|||
44577840|NCT02504580|79600985|FG010|Overall Study|Other|0|||
44239175|NCT01582789|79066008|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
44239176|NCT01537393|79066018|FG000|Overall Study|Exclude prior to study|32|||
44507813|NCT03246724|79512884|FG000|Overall Study|Ineligible on day of surgery|7|||
44507814|NCT03246724|79512885|FG001|Overall Study|Ineligible on day of surgery|2|||
44577841|NCT02504580|79600986|FG011|Overall Study|Other|2|||
44577842|NCT02504580|79600975|FG000|Overall Study|Subject refusal to continue|0|||
44577843|NCT02504580|79600976|FG001|Overall Study|Subject refusal to continue|1|||
44577844|NCT02504580|79600977|FG002|Overall Study|Subject refusal to continue|0|||
44577845|NCT02504580|79600978|FG003|Overall Study|Subject refusal to continue|0|||
44577846|NCT02504580|79600979|FG004|Overall Study|Subject refusal to continue|0|||
44577847|NCT02504580|79600980|FG005|Overall Study|Subject refusal to continue|0|||
44577848|NCT02504580|79600981|FG006|Overall Study|Subject refusal to continue|0|||
44577849|NCT02504580|79600982|FG007|Overall Study|Subject refusal to continue|0|||
44577850|NCT02504580|79600983|FG008|Overall Study|Subject refusal to continue|0|||
44577851|NCT02504580|79600984|FG009|Overall Study|Subject refusal to continue|0|||
44577852|NCT02504580|79600985|FG010|Overall Study|Subject refusal to continue|0|||
44577853|NCT02504580|79600986|FG011|Overall Study|Subject refusal to continue|0|||
44577854|NCT01328756|79601008|FG000|Overall Study|Protocol Violation|4|||
44577855|NCT01328756|79601008|FG000|Overall Study|Adverse Event|39|||
44577856|NCT01328756|79601008|FG000|Overall Study|Lack of Efficacy|5|||
44577857|NCT01328756|79601008|FG000|Overall Study|Withdrawal by Subject|41|||
44577858|NCT01328756|79601008|FG000|Overall Study|Lost to Follow-up|5|||
44577859|NCT01328756|79601008|FG000|Overall Study|Other|29|||
44577860|NCT03922308|79601015|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
44577861|NCT03922308|79601016|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
44577862|NCT03922308|79601017|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
44577863|NCT03922308|79601015|FG000|Overall Study|Lost to Follow-up|1|||
44577864|NCT03922308|79601016|FG001|Overall Study|Lost to Follow-up|0|||
44577865|NCT03922308|79601017|FG002|Overall Study|Lost to Follow-up|0|||
44577866|NCT03922308|79601015|FG000|Overall Study|Reason not Specified|0|||
44577867|NCT03922308|79601016|FG001|Overall Study|Reason not Specified|2|||
44577868|NCT03922308|79601017|FG002|Overall Study|Reason not Specified|1|||
44577869|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
44577870|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
44577871|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
44577872|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
44507815|NCT03246724|79512886|FG002|Overall Study|Ineligible on day of surgery|0|||
44507816|NCT03246724|79512887|FG003|Overall Study|Ineligible on day of surgery|3|||
44507817|NCT03246724|79512884|FG000|Overall Study|Study completed before surgical date|2|||
44507818|NCT03246724|79512885|FG001|Overall Study|Study completed before surgical date|1|||
44507819|NCT03246724|79512886|FG002|Overall Study|Study completed before surgical date|8|||
44507820|NCT03246724|79512887|FG003|Overall Study|Study completed before surgical date|1|||
44507821|NCT03246724|79512884|FG000|Overall Study|Transferred to other arm|0|||
44507822|NCT03246724|79512885|FG001|Overall Study|Transferred to other arm|0|||
44507823|NCT03246724|79512886|FG002|Overall Study|Transferred to other arm|1|||
44507824|NCT03246724|79512887|FG003|Overall Study|Transferred to other arm|0|||
44507825|NCT03246724|79512884|FG000|Overall Study|Unable to obtain medication timely|0|||
44507826|NCT03246724|79512885|FG001|Overall Study|Unable to obtain medication timely|2|||
44507827|NCT03246724|79512886|FG002|Overall Study|Unable to obtain medication timely|2|||
44507828|NCT03246724|79512887|FG003|Overall Study|Unable to obtain medication timely|1|||
44577873|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
44118824|NCT01373151|78902382|FG001|Period 2|Adverse Event|0|||
44239177|NCT01537393|79066019|FG001|Overall Study|Exclude prior to study|44|||
44239178|NCT01537393|79066018|FG000|Overall Study|Death|20|||
44507829|NCT03246724|79512884|FG000|Overall Study|Re-consented to participate|0|||
44507830|NCT03246724|79512885|FG001|Overall Study|Re-consented to participate|0|||
44507831|NCT03246724|79512886|FG002|Overall Study|Re-consented to participate|0|||
44577874|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
44577875|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
44577876|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
44577877|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
44577878|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
44577879|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
44577880|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
44577881|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
44577882|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
44577883|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
44577884|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
44577885|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
44577886|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
44577887|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
44577888|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
44577889|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
44577890|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
44577891|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
44577892|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
44577893|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Death|2|||
44577894|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Death|1|||
44577895|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Death|0|||
44577896|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Death|0|||
44577897|NCT02607930|79601030|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
44577898|NCT02607930|79601031|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
44577899|NCT02607930|79601032|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
44577900|NCT02607930|79601033|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
44577901|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
44577902|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
44577903|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
44577904|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
44577905|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
44577906|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
44577907|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
44577908|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
44577909|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
44577910|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
44577911|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
44577912|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
44577913|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
44577914|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
44577915|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
44577916|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
44577917|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
44577918|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
44577919|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
44577920|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
44577921|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
44577922|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
44577923|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
44577924|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
44577925|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
44577926|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
44577927|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
44577928|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
44577929|NCT02607930|79601030|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
44577930|NCT02607930|79601031|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
44577931|NCT02607930|79601032|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
44577932|NCT02607930|79601033|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
44577933|NCT02736188|79601064|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
44577934|NCT02736188|79601064|FG000|Overall Study|Adverse Event|1|||
44577935|NCT02736188|79601064|FG000|Overall Study|Withdrawal by Subject|1|||
44577936|NCT02736188|79601064|FG000|Overall Study|Other|6|||
44577937|NCT00154284|79601072|FG000|Overall Study|Adverse Event|6|||
44577938|NCT00154284|79601073|FG001|Overall Study|Adverse Event|9|||
44577939|NCT00154284|79601072|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44577940|NCT00154284|79601073|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44577941|NCT00154284|79601072|FG000|Overall Study|Lack of Efficacy|1|||
44378413|NCT00888849|79383720|FG000|Overall Study|Death|4|||
44577942|NCT00154284|79601073|FG001|Overall Study|Lack of Efficacy|2|||
44577943|NCT00154284|79601072|FG000|Overall Study|Protocol Violation|0|||
44577944|NCT00154284|79601073|FG001|Overall Study|Protocol Violation|1|||
44378414|NCT00888849|79383721|FG001|Overall Study|Death|7|||
44118825|NCT01373151|78902383|FG002|Period 2|Adverse Event|3|||
44118826|NCT01373151|78902384|FG003|Period 2|Adverse Event|3|||
44378415|NCT00888849|79383720|FG000|Overall Study|Lost to Follow-up|1|||
44118827|NCT01373151|78902385|FG004|Period 2|Adverse Event|0|||
44577945|NCT02735096|79601081|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
44577946|NCT00905346|79601094|FG000|Period 1|Withdrawal by Subject|1|||
44577947|NCT00905346|79601095|FG001|Period 1|Withdrawal by Subject|0|||
44577948|NCT01328444|79601108|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
44577949|NCT01328444|79601109|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
44577950|NCT01328444|79601110|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
44118828|NCT01373151|78902386|FG005|Period 2|Adverse Event|0|||
44118829|NCT01373151|78902387|FG006|Period 2|Adverse Event|1|||
44118830|NCT01373151|78902381|FG000|Period 2|subject request to discontinue|0|||
44118831|NCT01373151|78902382|FG001|Period 2|subject request to discontinue|1|||
44118832|NCT01373151|78902383|FG002|Period 2|subject request to discontinue|0|||
44118833|NCT01373151|78902384|FG003|Period 2|subject request to discontinue|0|||
44118834|NCT01373151|78902385|FG004|Period 2|subject request to discontinue|0|||
44118835|NCT01373151|78902386|FG005|Period 2|subject request to discontinue|0|||
44118836|NCT01373151|78902387|FG006|Period 2|subject request to discontinue|0|||
44118837|NCT01373151|78902381|FG000|Period 2|Withdrawal by Subject|0|||
44118838|NCT01373151|78902382|FG001|Period 2|Withdrawal by Subject|0|||
44118839|NCT01373151|78902383|FG002|Period 2|Withdrawal by Subject|0|||
44118840|NCT01373151|78902384|FG003|Period 2|Withdrawal by Subject|1|||
44118841|NCT01373151|78902385|FG004|Period 2|Withdrawal by Subject|0|||
44239179|NCT01537393|79066019|FG001|Overall Study|Death|32|||
44239180|NCT01537393|79066018|FG000|Overall Study|Withdrawal by Subject|18|||
44507832|NCT03246724|79512887|FG003|Overall Study|Re-consented to participate|1|||
44507833|NCT03246646|79512899|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
44507834|NCT03246646|79512900|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
44507835|NCT03246646|79512899|FG000|Overall Study|Withdrawal by Subject|3|||
44507836|NCT03246646|79512900|FG001|Overall Study|Withdrawal by Subject|0|||
44507837|NCT03246646|79512899|FG000|Overall Study|Lost to Follow-up|7|||
44507838|NCT03246646|79512900|FG001|Overall Study|Lost to Follow-up|0|||
44507839|NCT01347112|79512908|FG000|Overall Study|Withdrawal by Subject|1|||
44507840|NCT01347112|79512909|FG001|Overall Study|Withdrawal by Subject|7|||
44507841|NCT01347112|79512908|FG000|Overall Study|Lost to Follow-up|3|||
44507842|NCT01347112|79512909|FG001|Overall Study|Lost to Follow-up|5|||
44507843|NCT00308711|79512919|FG000|Overall Study|Withdrawal by Subject|1|||
44507844|NCT00308711|79512920|FG001|Overall Study|Withdrawal by Subject|0|||
44507845|NCT00308711|79512921|FG002|Overall Study|Withdrawal by Subject|1|||
44507846|NCT00308711|79512919|FG000|Overall Study|Protocol Violation|0|||
44507847|NCT00308711|79512920|FG001|Overall Study|Protocol Violation|1|||
44507848|NCT00308711|79512921|FG002|Overall Study|Protocol Violation|1|||
44507849|NCT00308711|79512919|FG000|Overall Study|Lost to Follow-up|0|||
44507850|NCT00308711|79512920|FG001|Overall Study|Lost to Follow-up|1|||
44507851|NCT00308711|79512921|FG002|Overall Study|Lost to Follow-up|0|||
44507852|NCT00308711|79512919|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
44507853|NCT00308711|79512920|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
44507854|NCT00308711|79512921|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
44507855|NCT00308711|79512919|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
44507856|NCT00308711|79512920|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
44507857|NCT00308711|79512921|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
44507858|NCT00308555|79512931|FG000|Overall Study|Withdrawal by Subject|1|||
44507859|NCT00308555|79512932|FG001|Overall Study|Withdrawal by Subject|0|||
44507860|NCT00308555|79512931|FG000|Overall Study|Physician Decision|2|||
44507861|NCT00308555|79512932|FG001|Overall Study|Physician Decision|0|||
44507862|NCT00050778|79512941|FG000|Overall Study|Adverse Event|13|||
44507863|NCT00050778|79512942|FG001|Overall Study|Adverse Event|3|||
44507864|NCT00050778|79512943|FG002|Overall Study|Adverse Event|2|||
44577951|NCT01328444|79601111|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
44239181|NCT01537393|79066019|FG001|Overall Study|Withdrawal by Subject|17|||
44239182|NCT01537393|79066018|FG000|Overall Study|Lost to Follow-up|53|||
44239183|NCT01537393|79066019|FG001|Overall Study|Lost to Follow-up|48|||
44239184|NCT01537393|79066018|FG000|Overall Study|Failure - Regrafted|28|||
44239185|NCT01537393|79066019|FG001|Overall Study|Failure - Regrafted|43|||
44239186|NCT01537393|79066018|FG000|Overall Study|Failure - Not regrafted|2|||
44239187|NCT01537393|79066019|FG001|Overall Study|Failure - Not regrafted|6|||
44239188|NCT01537393|79066018|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
44239189|NCT01537393|79066019|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
44239190|NCT01555151|79066029|FG000|Overall Study|Withdrawal by Subject|6|||
44239191|NCT01555151|79066030|FG001|Overall Study|Withdrawal by Subject|2|||
44276097|NCT02187744|79228886|FG001|Treatment|Related adverse event, not serious|2|||
44118842|NCT01373151|78902386|FG005|Period 2|Withdrawal by Subject|0|||
44118843|NCT01373151|78902387|FG006|Period 2|Withdrawal by Subject|0|||
44118844|NCT01373151|78902381|FG000|Period 2|Other|0|||
44118845|NCT01373151|78902382|FG001|Period 2|Other|0|||
44118846|NCT01373151|78902383|FG002|Period 2|Other|1|||
44118847|NCT01373151|78902384|FG003|Period 2|Other|0|||
44118848|NCT01373151|78902385|FG004|Period 2|Other|0|||
44239192|NCT01555151|79066031|FG002|Overall Study|Withdrawal by Subject|0|||
44239193|NCT01555151|79066032|FG003|Overall Study|Withdrawal by Subject|2|||
44577952|NCT01328444|79601112|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
44577953|NCT01328444|79601113|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
44118849|NCT01373151|78902386|FG005|Period 2|Other|0|||
44118850|NCT01373151|78902387|FG006|Period 2|Other|1|||
44118851|NCT01660906|78902403|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
44118852|NCT03015181|78902423|FG000|Overall Study|Enrolled, but product never administered|1|||
44118853|NCT03015181|78902424|FG001|Overall Study|Enrolled, but product never administered|0|||
44118854|NCT03015181|78902425|FG002|Overall Study|Enrolled, but product never administered|0|||
44118855|NCT03015181|78902426|FG003|Overall Study|Enrolled, but product never administered|0|||
44118856|NCT03015181|78902427|FG004|Overall Study|Enrolled, but product never administered|0|||
44118857|NCT03015181|78902428|FG005|Overall Study|Enrolled, but product never administered|0|||
44239194|NCT01555151|79066029|FG000|Overall Study|Administrative|3|||
44239195|NCT01555151|79066030|FG001|Overall Study|Administrative|1|||
44239196|NCT01555151|79066031|FG002|Overall Study|Administrative|2|||
44239197|NCT01555151|79066032|FG003|Overall Study|Administrative|0|||
44239198|NCT01555151|79066029|FG000|Overall Study|Protocol Violation|3|||
44239199|NCT01555151|79066030|FG001|Overall Study|Protocol Violation|3|||
44239200|NCT01555151|79066031|FG002|Overall Study|Protocol Violation|3|||
44239201|NCT01555151|79066032|FG003|Overall Study|Protocol Violation|5|||
44239202|NCT01555151|79066029|FG000|Overall Study|Adverse Event|1|||
44239203|NCT01555151|79066030|FG001|Overall Study|Adverse Event|2|||
44239204|NCT01555151|79066031|FG002|Overall Study|Adverse Event|1|||
44239205|NCT01555151|79066032|FG003|Overall Study|Adverse Event|2|||
44239206|NCT01555151|79066029|FG000|Overall Study|Lost to Follow-up|0|||
44239207|NCT01555151|79066030|FG001|Overall Study|Lost to Follow-up|0|||
44239208|NCT01555151|79066031|FG002|Overall Study|Lost to Follow-up|0|||
44239209|NCT01555151|79066032|FG003|Overall Study|Lost to Follow-up|1|||
44239210|NCT01537081|79066046|FG000|Overall Study|Adverse Event|5|||
44239211|NCT01537081|79066047|FG001|Overall Study|Adverse Event|2|||
44239212|NCT01537081|79066048|FG002|Overall Study|Adverse Event|2|||
44239213|NCT01537081|79066046|FG000|Overall Study|Lack of Efficacy|2|||
44239214|NCT01537081|79066047|FG001|Overall Study|Lack of Efficacy|1|||
44239215|NCT01537081|79066048|FG002|Overall Study|Lack of Efficacy|0|||
44239216|NCT01537081|79066046|FG000|Overall Study|Lost to Follow-up|17|||
44239217|NCT01537081|79066047|FG001|Overall Study|Lost to Follow-up|15|||
44239218|NCT01537081|79066048|FG002|Overall Study|Lost to Follow-up|9|||
44239219|NCT01537081|79066046|FG000|Overall Study|Protocol Violation|3|||
44239220|NCT01537081|79066047|FG001|Overall Study|Protocol Violation|2|||
44239221|NCT01537081|79066048|FG002|Overall Study|Protocol Violation|2|||
44239222|NCT01537081|79066046|FG000|Overall Study|Withdrawal by Subject|6|||
44239223|NCT01537081|79066047|FG001|Overall Study|Withdrawal by Subject|11|||
44239224|NCT01537081|79066048|FG002|Overall Study|Withdrawal by Subject|3|||
44239225|NCT01537081|79066046|FG000|Overall Study|Physician Decision|5|||
44239226|NCT01537081|79066047|FG001|Overall Study|Physician Decision|6|||
44239227|NCT01537081|79066048|FG002|Overall Study|Physician Decision|0|||
44239228|NCT01537081|79066046|FG000|Overall Study|Sponsor decision|0|||
44239229|NCT01537081|79066047|FG001|Overall Study|Sponsor decision|1|||
44239230|NCT01537081|79066048|FG002|Overall Study|Sponsor decision|0|||
44239231|NCT01537081|79066046|FG000|Overall Study|Assigned but never dosed|1|||
44239232|NCT01537081|79066047|FG001|Overall Study|Assigned but never dosed|0|||
44239233|NCT01537081|79066048|FG002|Overall Study|Assigned but never dosed|0|||
44239234|NCT01564459|79066060|FG000|Run-In|Adverse Event|7|||
44239235|NCT01564459|79066061|FG001|Run-In|Adverse Event|0|||
44507865|NCT00050778|79512941|FG000|Overall Study|Death|0|||
44507866|NCT00050778|79512942|FG001|Overall Study|Death|1|||
44507867|NCT00050778|79512943|FG002|Overall Study|Death|1|||
44507868|NCT00050778|79512941|FG000|Overall Study|Lack of Efficacy|16|||
44507869|NCT00050778|79512942|FG001|Overall Study|Lack of Efficacy|2|||
44507870|NCT00050778|79512943|FG002|Overall Study|Lack of Efficacy|2|||
44507871|NCT00050778|79512941|FG000|Overall Study|Lost to Follow-up|0|||
44507872|NCT00050778|79512942|FG001|Overall Study|Lost to Follow-up|2|||
44507873|NCT00050778|79512943|FG002|Overall Study|Lost to Follow-up|4|||
44507874|NCT00050778|79512941|FG000|Overall Study|Physician Decision|3|||
44507875|NCT00050778|79512942|FG001|Overall Study|Physician Decision|0|||
44507876|NCT00050778|79512943|FG002|Overall Study|Physician Decision|2|||
44118858|NCT03015181|78902429|FG006|Overall Study|Enrolled, but product never administered|0|||
44118859|NCT03015181|78902423|FG000|Overall Study|Withdrawal by Subject|0|||
44239236|NCT01564459|79066062|FG002|Run-In|Adverse Event|0|||
44239237|NCT01564459|79066060|FG000|Run-In|Lost to Follow-up|1|||
44239238|NCT01564459|79066061|FG001|Run-In|Lost to Follow-up|0|||
44239239|NCT01564459|79066062|FG002|Run-In|Lost to Follow-up|0|||
44239240|NCT01564459|79066060|FG000|Run-In|Non-compliance with study drug|2|||
44239241|NCT01564459|79066061|FG001|Run-In|Non-compliance with study drug|0|||
44239242|NCT01564459|79066062|FG002|Run-In|Non-compliance with study drug|0|||
44239243|NCT01564459|79066060|FG000|Run-In|Protocol Violation|1|||
44239244|NCT01564459|79066061|FG001|Run-In|Protocol Violation|0|||
44239245|NCT01564459|79066062|FG002|Run-In|Protocol Violation|0|||
44239246|NCT01564459|79066060|FG000|Run-In|Withdrawal by Subject|1|||
44507877|NCT00050778|79512941|FG000|Overall Study|Protocol Violation|2|||
44118860|NCT03015181|78902424|FG001|Overall Study|Withdrawal by Subject|0|||
44118861|NCT03015181|78902425|FG002|Overall Study|Withdrawal by Subject|0|||
44118862|NCT03015181|78902426|FG003|Overall Study|Withdrawal by Subject|0|||
44118863|NCT03015181|78902427|FG004|Overall Study|Withdrawal by Subject|0|||
44118864|NCT03015181|78902428|FG005|Overall Study|Withdrawal by Subject|1|||
44118865|NCT03015181|78902429|FG006|Overall Study|Withdrawal by Subject|0|||
44118866|NCT03015181|78902423|FG000|Overall Study|Physician Decision|0|||
44118867|NCT03015181|78902424|FG001|Overall Study|Physician Decision|0|||
44118868|NCT03015181|78902425|FG002|Overall Study|Physician Decision|0|||
44118869|NCT03015181|78902426|FG003|Overall Study|Physician Decision|0|||
44118870|NCT03015181|78902427|FG004|Overall Study|Physician Decision|0|||
44118871|NCT03015181|78902428|FG005|Overall Study|Physician Decision|0|||
44118872|NCT03015181|78902429|FG006|Overall Study|Physician Decision|1|||
44118873|NCT00960297|78902478|FG000|Overall Study|Physician Decision|1|||
44118874|NCT00960297|78902478|FG000|Overall Study|Venous port infection|1|||
44118875|NCT00960297|78902478|FG000|Overall Study|Disease progression|1|||
44118876|NCT03018691|78902485|FG000|Overall Study|Adverse Event|1|||
44118877|NCT03018691|78902486|FG001|Overall Study|Adverse Event|1|||
44118878|NCT03018691|78902487|FG002|Overall Study|Adverse Event|4|||
44118879|NCT03018691|78902485|FG000|Overall Study|Lack of Efficacy|0|||
44118880|NCT03018691|78902486|FG001|Overall Study|Lack of Efficacy|0|||
44118881|NCT03018691|78902487|FG002|Overall Study|Lack of Efficacy|1|||
44118882|NCT03018691|78902485|FG000|Overall Study|Withdrawal by Subject|0|||
44118883|NCT03018691|78902486|FG001|Overall Study|Withdrawal by Subject|0|||
44118884|NCT03018691|78902487|FG002|Overall Study|Withdrawal by Subject|1|||
44118885|NCT03018691|78902485|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44118886|NCT03018691|78902486|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44118887|NCT03018691|78902487|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44118888|NCT03012061|78902500|FG000|Overall Study|Withdrawal by Subject|1|||
44118889|NCT03012061|78902501|FG001|Overall Study|Withdrawal by Subject|5|||
44118890|NCT03012061|78902502|FG002|Overall Study|Withdrawal by Subject|4|||
44118891|NCT03012061|78902500|FG000|Overall Study|Investigator Site Closed|1|||
44118892|NCT03012061|78902501|FG001|Overall Study|Investigator Site Closed|2|||
44118893|NCT03012061|78902502|FG002|Overall Study|Investigator Site Closed|0|||
44118894|NCT03012061|78902500|FG000|Overall Study|Lost to Follow-up|2|||
44118895|NCT03012061|78902501|FG001|Overall Study|Lost to Follow-up|1|||
44118896|NCT03012061|78902502|FG002|Overall Study|Lost to Follow-up|0|||
44118897|NCT03012061|78902500|FG000|Overall Study|Study closed/ Terminated|0|||
44118898|NCT03012061|78902501|FG001|Overall Study|Study closed/ Terminated|0|||
44118899|NCT03012061|78902502|FG002|Overall Study|Study closed/ Terminated|1|||
44118900|NCT03012061|78902500|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
44118901|NCT03012061|78902501|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
44118902|NCT03012061|78902502|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
44118903|NCT03012061|78902500|FG000|Overall Study|Protocol Violation|0|||
44118904|NCT03012061|78902501|FG001|Overall Study|Protocol Violation|0|||
44118905|NCT03012061|78902502|FG002|Overall Study|Protocol Violation|2|||
44118906|NCT03012061|78902500|FG000|Overall Study|Lack of Efficacy|0|||
44118907|NCT03012061|78902501|FG001|Overall Study|Lack of Efficacy|1|||
44118908|NCT03012061|78902502|FG002|Overall Study|Lack of Efficacy|0|||
44118909|NCT03012061|78902500|FG000|Overall Study|Adverse Event|2|||
44118910|NCT03012061|78902501|FG001|Overall Study|Adverse Event|0|||
44118911|NCT03012061|78902502|FG002|Overall Study|Adverse Event|0|||
44118912|NCT03010501|78902510|FG000|Study Week 1|Withdrawal by Subject|2|||
44118913|NCT03010501|78902511|FG001|Study Week 1|Withdrawal by Subject|1|||
44118914|NCT03010501|78902512|FG002|Study Week 1|Withdrawal by Subject|0|||
44118915|NCT03010501|78902513|FG003|Study Week 1|Withdrawal by Subject|2|||
44118916|NCT03010501|78902514|FG004|Study Week 1|Withdrawal by Subject|0|||
44118917|NCT03010501|78902515|FG005|Study Week 1|Withdrawal by Subject|0|||
44118918|NCT03010501|78902510|FG000|Study Week 3|Withdrawal by Subject|0|||
44118919|NCT03010501|78902511|FG001|Study Week 3|Withdrawal by Subject|0|||
44118920|NCT03010501|78902512|FG002|Study Week 3|Withdrawal by Subject|0|||
44118921|NCT03010501|78902513|FG003|Study Week 3|Withdrawal by Subject|1|||
44118922|NCT03010501|78902514|FG004|Study Week 3|Withdrawal by Subject|0|||
44239247|NCT01564459|79066061|FG001|Run-In|Withdrawal by Subject|0|||
44118923|NCT03010501|78902515|FG005|Study Week 3|Withdrawal by Subject|0|||
44239248|NCT01564459|79066062|FG002|Run-In|Withdrawal by Subject|0|||
44239249|NCT01564459|79066060|FG000|Double-blind Treatment|Adverse Event|0|||
44239250|NCT01564459|79066061|FG001|Double-blind Treatment|Adverse Event|0|||
44239251|NCT01564459|79066062|FG002|Double-blind Treatment|Adverse Event|1|||
44239252|NCT01555073|79066077|FG000|Overall Study|Lost to Follow-up|1|||
44239253|NCT01555073|79066078|FG001|Overall Study|Lost to Follow-up|2|||
44118924|NCT03002623|78902525|FG000|Overall Study|Lost to Follow-up|1|||
44118925|NCT03002623|78902526|FG001|Overall Study|Lost to Follow-up|0|||
44118926|NCT03002623|78902525|FG000|Overall Study|Physician Decision|1|||
44118927|NCT03002623|78902526|FG001|Overall Study|Physician Decision|1|||
44118928|NCT03010423|78902534|FG000|Overall Study|Study termination|8|||
44239254|NCT01555073|79066079|FG002|Overall Study|Lost to Follow-up|0|||
44239255|NCT01555073|79066080|FG003|Overall Study|Lost to Follow-up|5|||
44118929|NCT03002311|78902540|FG000|Overall Study|Lost to Follow-up|13|||
44118930|NCT03002311|78902541|FG001|Overall Study|Lost to Follow-up|26|||
44118931|NCT03002311|78902540|FG000|Overall Study|Referral provider called to schedule app|3|||
44118932|NCT03002311|78902541|FG001|Overall Study|Referral provider called to schedule app|3|||
44118933|NCT03002311|78902540|FG000|Overall Study|Physician Decision|3|||
44118934|NCT03002311|78902541|FG001|Overall Study|Physician Decision|1|||
44118935|NCT03002077|78902547|FG000|Overall Study|Non-compliance with Study Drug|4|||
44118936|NCT03002077|78902547|FG000|Overall Study|Non-compliance w/Background ADT|1|||
44118937|NCT03002077|78902547|FG000|Overall Study|Study Terminated by Sponsor|257|||
44118938|NCT03002077|78902547|FG000|Overall Study|Site Terminated by Sponsor|5|||
44118939|NCT03002077|78902547|FG000|Overall Study|Miscellaneous Reasons|10|||
44118940|NCT03002077|78902547|FG000|Overall Study|Adverse Event|23|||
44118941|NCT03002077|78902547|FG000|Overall Study|Lack of Efficacy|20|||
44577954|NCT01328444|79601108|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
44577955|NCT01328444|79601109|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
44577956|NCT01328444|79601110|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
44577957|NCT01328444|79601111|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
44577958|NCT01328444|79601112|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
44577959|NCT01328444|79601113|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
44118942|NCT03002077|78902547|FG000|Overall Study|Withdrawal by Subject|72|||
44118943|NCT03002077|78902547|FG000|Overall Study|Lost to Follow-up|21|||
44118944|NCT03002077|78902547|FG000|Overall Study|Pregnancy|4|||
44118945|NCT03002077|78902547|FG000|Overall Study|Protocol Violation|21|||
44118946|NCT03008005|78902554|FG000|Overall Study|Physician Decision|1|||
44118947|NCT03008005|78902555|FG001|Overall Study|Physician Decision|0|||
44118948|NCT03008005|78902556|FG002|Overall Study|Physician Decision|0|||
44118949|NCT03008005|78902554|FG000|Overall Study|Withdrawal by Subject|1|||
44118950|NCT03008005|78902555|FG001|Overall Study|Withdrawal by Subject|0|||
44118951|NCT03008005|78902556|FG002|Overall Study|Withdrawal by Subject|0|||
44118952|NCT03008005|78902554|FG000|Overall Study|Ineligible|0|||
44118953|NCT03008005|78902555|FG001|Overall Study|Ineligible|1|||
44118954|NCT03008005|78902556|FG002|Overall Study|Ineligible|0|||
44118955|NCT02440425|78902573|FG000|Overall Study|Death likely due to disease progression|1|||
44118956|NCT02440425|78902573|FG000|Overall Study|Withdrawal by Subject|2|||
44118957|NCT02440425|78902573|FG000|Overall Study|Adverse Event|1|||
44118958|NCT02440425|78902573|FG000|Overall Study|Adverse Event/Ineligible|1|||
44118959|NCT03001219|78902588|FG000|Proof of Concept|Study Termination by Sponsor|0|||
44118960|NCT03001219|78902589|FG001|Proof of Concept|Study Termination by Sponsor|1|||
44118961|NCT03001219|78902588|FG000|Proof of Concept|Withdrawal by Subject|0|||
44118962|NCT03001219|78902589|FG001|Proof of Concept|Withdrawal by Subject|4|||
44118963|NCT03001219|78902588|FG000|Proof of Concept|Protocol Deviation|0|||
44118964|NCT03001219|78902589|FG001|Proof of Concept|Protocol Deviation|1|||
44118965|NCT03001219|78902588|FG000|Proof of Concept|Adverse Event|1|||
44118966|NCT03001219|78902589|FG001|Proof of Concept|Adverse Event|1|||
44118967|NCT03001219|78902588|FG000|Proof of Concept|Physician Decision|1|||
44118968|NCT03001219|78902589|FG001|Proof of Concept|Physician Decision|0|||
44118969|NCT03001219|78902588|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
44118970|NCT03001219|78902589|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
44118971|NCT03001219|78902588|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
44118972|NCT03001219|78902589|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
44118973|NCT03001219|78902588|FG000|Extension Period Analysis|Physician Decision|0|||
44118974|NCT03001219|78902589|FG001|Extension Period Analysis|Physician Decision|1|||
44118975|NCT03001219|78902588|FG000|Extension Period Analysis|Adverse Event|1|||
44118976|NCT03001219|78902589|FG001|Extension Period Analysis|Adverse Event|1|||
44118977|NCT03001219|78902588|FG000|Extension Period Analysis|Protocol Deviation|0|||
44118978|NCT03001219|78902589|FG001|Extension Period Analysis|Protocol Deviation|1|||
44118979|NCT03001219|78902588|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
44118980|NCT03001219|78902589|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
44118981|NCT03000673|78902604|FG000|Overall Study|Withdrawal by Subject|1|||
44118982|NCT03000673|78902605|FG001|Overall Study|Withdrawal by Subject|0|||
44118983|NCT03000673|78902606|FG002|Overall Study|Withdrawal by Subject|0|||
44239256|NCT01582243|79066090|FG000|Overall Study|Withdrawal by Subject|1|||
44239257|NCT01582243|79066090|FG000|Overall Study|Adverse Event|1|||
44577960|NCT01328444|79601108|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
44118984|NCT03000673|78902607|FG003|Overall Study|Withdrawal by Subject|0|||
44118985|NCT02912455|78902620|FG000|Overall Study|Withdrawal by Subject|0|||
44118986|NCT02912455|78902621|FG001|Overall Study|Withdrawal by Subject|1|||
44577961|NCT01328444|79601109|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
44577962|NCT01328444|79601110|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
44118987|NCT02912455|78902620|FG000|Overall Study|Lack of Efficacy|0|||
44118988|NCT02912455|78902621|FG001|Overall Study|Lack of Efficacy|1|||
44118989|NCT02912455|78902620|FG000|Overall Study|Lost to Follow-up|2|||
44118990|NCT02912455|78902621|FG001|Overall Study|Lost to Follow-up|1|||
44118991|NCT04524507|78902629|FG000|Overall Study|Lost to Follow-up|2|||
44118992|NCT04524507|78902630|FG001|Overall Study|Lost to Follow-up|4|||
44118993|NCT04524507|78902629|FG000|Overall Study|Withdrawal by Subject|2|||
44118994|NCT04524507|78902630|FG001|Overall Study|Withdrawal by Subject|9|||
44118995|NCT04524507|78902629|FG000|Overall Study|Death|2|||
44118996|NCT04524507|78902630|FG001|Overall Study|Death|10|||
44118997|NCT02999191|78902639|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
44577963|NCT01328444|79601111|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
44577964|NCT01328444|79601112|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
44577965|NCT01328444|79601113|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
44577966|NCT01328444|79601108|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
44577967|NCT01328444|79601109|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
44577968|NCT01328444|79601110|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
44577969|NCT01328444|79601111|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
44577970|NCT01328444|79601112|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
44577971|NCT01328444|79601113|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
44577972|NCT01328444|79601108|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
44577973|NCT01328444|79601109|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44577974|NCT01328444|79601110|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44577975|NCT01328444|79601111|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
44577976|NCT01328444|79601112|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44577977|NCT01328444|79601113|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
44577978|NCT01328444|79601108|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44577979|NCT01328444|79601109|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
44577980|NCT01328444|79601110|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
44577981|NCT01328444|79601111|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
44577982|NCT01328444|79601112|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
44577983|NCT01328444|79601113|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44577984|NCT01328444|79601108|FG000|Washout Period (14 Days)|Adverse Event|1|||
44378416|NCT00888849|79383721|FG001|Overall Study|Lost to Follow-up|2|||
44577985|NCT01328444|79601109|FG001|Washout Period (14 Days)|Adverse Event|1|||
44577986|NCT01328444|79601110|FG002|Washout Period (14 Days)|Adverse Event|0|||
44118998|NCT02999191|78902640|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
44118999|NCT02999191|78902641|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
44119000|NCT02531698|78902651|FG000|Overall Study|Adverse Event|2|||
44119001|NCT02531698|78902652|FG001|Overall Study|Adverse Event|1|||
44119002|NCT02531698|78902651|FG000|Overall Study|Withdrawal by Subject|6|||
44577987|NCT01328444|79601111|FG003|Washout Period (14 Days)|Adverse Event|1|||
44577988|NCT01328444|79601112|FG004|Washout Period (14 Days)|Adverse Event|1|||
44577989|NCT01328444|79601113|FG005|Washout Period (14 Days)|Adverse Event|2|||
44577990|NCT01328444|79601108|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
44119003|NCT02531698|78902652|FG001|Overall Study|Withdrawal by Subject|1|||
44119004|NCT02531698|78902651|FG000|Overall Study|Protocol Violation|2|||
44119005|NCT02531698|78902652|FG001|Overall Study|Protocol Violation|0|||
44119006|NCT02531698|78902651|FG000|Overall Study|Lost to Follow-up|1|||
44119007|NCT02531698|78902652|FG001|Overall Study|Lost to Follow-up|0|||
44119008|NCT02998021|78902669|FG000|Overall Study|Withdrawal by Subject|3|||
44119009|NCT02998021|78902670|FG001|Overall Study|Withdrawal by Subject|1|||
44119010|NCT02998021|78902669|FG000|Overall Study|unsafe home|0|||
44119011|NCT02998021|78902670|FG001|Overall Study|unsafe home|1|||
44119012|NCT03034577|78902684|FG000|Overall Study|Withdrawal by Subject|6|||
44119013|NCT03034577|78902685|FG001|Overall Study|Withdrawal by Subject|9|||
44119014|NCT03034577|78902684|FG000|Overall Study|Lost to Follow-up|25|||
44119015|NCT03034577|78902685|FG001|Overall Study|Lost to Follow-up|26|||
44119016|NCT01659736|78902695|FG000|Treatment Period|Adverse Event|1|||
44119017|NCT01659736|78902696|FG001|Treatment Period|Adverse Event|1|||
44119018|NCT01659736|78902695|FG000|Treatment Period|Protocol Violation|3|||
44119019|NCT01659736|78902696|FG001|Treatment Period|Protocol Violation|1|||
44119020|NCT01659736|78902695|FG000|Treatment Period|Withdrawal by Subject|1|||
44119021|NCT01659736|78902696|FG001|Treatment Period|Withdrawal by Subject|0|||
44119022|NCT01659736|78902695|FG000|3-month Follow-up|Lost to Follow-up|0|||
44119023|NCT01659736|78902696|FG001|3-month Follow-up|Lost to Follow-up|1|||
44119024|NCT02997163|78902708|FG000|Overall Study|Adverse Event|1|||
44276098|NCT02187744|79228885|FG000|Treatment|Lost to Follow-up|0|||
44276099|NCT02187744|79228886|FG001|Treatment|Lost to Follow-up|1|||
44276100|NCT02187744|79228885|FG000|Treatment|Other|2|||
44276101|NCT02187744|79228886|FG001|Treatment|Other|0|||
44276102|NCT02187744|79228885|FG000|Treatment|Participant refused continued treatment|1|||
44276103|NCT02187744|79228886|FG001|Treatment|Participant refused continued treatment|1|||
44378417|NCT01059812|79383729|FG000|Overall Study|Adverse Event|9|||
44378418|NCT01059812|79383730|FG001|Overall Study|Adverse Event|5|||
44577991|NCT01328444|79601109|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
44119025|NCT02997163|78902709|FG001|Overall Study|Adverse Event|0|||
44119026|NCT02997163|78902710|FG002|Overall Study|Adverse Event|0|||
44119027|NCT02997163|78902711|FG003|Overall Study|Adverse Event|1|||
44119028|NCT00458536|78902721|FG000|Overall Study|Disease progression prior to treatment|7|||
44577992|NCT01328444|79601110|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
44577993|NCT01328444|79601111|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
44577994|NCT01328444|79601112|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
44577995|NCT01328444|79601113|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
44577996|NCT01328444|79601108|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
44577997|NCT01328444|79601109|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
44577998|NCT01328444|79601110|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
44577999|NCT01328444|79601111|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
44578000|NCT01328444|79601112|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
44578001|NCT01328444|79601113|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
44578002|NCT01328444|79601108|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
44578003|NCT01328444|79601109|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
44578004|NCT01328444|79601110|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
44578005|NCT01328444|79601111|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
44578006|NCT01328444|79601112|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
44578007|NCT01328444|79601113|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
44578008|NCT01328444|79601108|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
44578009|NCT01328444|79601109|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
44578010|NCT01328444|79601110|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
44578011|NCT01328444|79601111|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
44578012|NCT01328444|79601112|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
44578013|NCT01328444|79601113|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
44578014|NCT01328444|79601108|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
44578015|NCT01328444|79601109|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
44578016|NCT01328444|79601110|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
44578017|NCT01328444|79601111|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
44578018|NCT01328444|79601112|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
44578019|NCT01328444|79601113|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
44578020|NCT01328444|79601108|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
44578021|NCT01328444|79601109|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
44578022|NCT01328444|79601110|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
44578023|NCT01328444|79601111|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
44578024|NCT01328444|79601112|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
44578025|NCT01328444|79601113|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
44578026|NCT01328444|79601108|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
44578027|NCT01328444|79601109|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
44578028|NCT01328444|79601110|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
44578029|NCT01328444|79601111|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
44578030|NCT01328444|79601112|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
44578031|NCT01328444|79601113|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
44578032|NCT01328444|79601108|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44578033|NCT01328444|79601109|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44578034|NCT01328444|79601110|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44578035|NCT01328444|79601111|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44119029|NCT00458536|78902721|FG000|Overall Study|Unable to make vaccine|3|||
44119030|NCT00458536|78902721|FG000|Overall Study|No measurable disease after surgery|2|||
44119031|NCT00458536|78902721|FG000|Overall Study|Did not have renal cell carcinoma|2|||
44119032|NCT00458536|78902721|FG000|Overall Study|Patient did not have surgery|1|||
44119033|NCT00458536|78902721|FG000|Overall Study|Ineligible due to toxicity|1|||
44119034|NCT00458536|78902721|FG000|Overall Study|Withdrawal by Subject|1|||
44119035|NCT00458536|78902721|FG000|Overall Study|Progressive disease during treatment|2|||
44239258|NCT01582243|79066090|FG000|Overall Study|Lost to Follow-up|1|||
44239259|NCT01536535|79066096|FG000|Overall Study|Withdrawal by Subject|10|||
44239260|NCT01536535|79066097|FG001|Overall Study|Withdrawal by Subject|5|||
44239261|NCT01536535|79066096|FG000|Overall Study|Lost to Follow-up|4|||
44239262|NCT01536535|79066097|FG001|Overall Study|Lost to Follow-up|6|||
44239263|NCT01536535|79066096|FG000|Overall Study|Physician Decision|1|||
44239264|NCT01536535|79066097|FG001|Overall Study|Physician Decision|1|||
44239265|NCT01536535|79066096|FG000|Overall Study|Participant moved|0|||
44507878|NCT00050778|79512942|FG001|Overall Study|Protocol Violation|0|||
44119036|NCT02526550|78902725|FG000|Overall Study|Lost to Follow-up|1|||
44239266|NCT01536535|79066097|FG001|Overall Study|Participant moved|1|||
44239267|NCT01554527|79066107|FG000|Overall Study|Withdrawal by Subject|1|||
44507879|NCT00050778|79512943|FG002|Overall Study|Protocol Violation|1|||
44507880|NCT00050778|79512941|FG000|Overall Study|Withdrawal by Subject|6|||
44507881|NCT00050778|79512942|FG001|Overall Study|Withdrawal by Subject|8|||
44507882|NCT00050778|79512943|FG002|Overall Study|Withdrawal by Subject|4|||
44507883|NCT00050778|79512941|FG000|Overall Study|Randomized but not treated|4|||
44507884|NCT00050778|79512942|FG001|Overall Study|Randomized but not treated|5|||
44507885|NCT00050778|79512943|FG002|Overall Study|Randomized but not treated|2|||
44507886|NCT00050778|79512941|FG000|Overall Study|Familial and personal reasons|1|||
44578036|NCT01328444|79601112|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44119037|NCT03030989|78902740|FG000|Overall Study|Fever|2|||
44119038|NCT03030989|78902741|FG001|Overall Study|Fever|2|||
44119039|NCT03030989|78902740|FG000|Overall Study|Rash|2|||
44119040|NCT03030989|78902741|FG001|Overall Study|Rash|1|||
44119041|NCT03030989|78902740|FG000|Overall Study|Fatigue/Overwhelmed|1|||
44119042|NCT03030989|78902741|FG001|Overall Study|Fatigue/Overwhelmed|5|||
44119043|NCT03030989|78902740|FG000|Overall Study|Positive Blood Cultures|2|||
44119044|NCT03030989|78902741|FG001|Overall Study|Positive Blood Cultures|1|||
44119045|NCT03030989|78902740|FG000|Overall Study|Line Removed|0|||
44119046|NCT03030989|78902741|FG001|Overall Study|Line Removed|2|||
44578037|NCT01328444|79601113|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44578038|NCT00887250|79601130|FG000|Overall Study|Adverse Event|3|||
44578039|NCT00887250|79601131|FG001|Overall Study|Adverse Event|0|||
44578040|NCT00887250|79601132|FG002|Overall Study|Adverse Event|7|||
44578041|NCT00887250|79601130|FG000|Overall Study|Lack of Efficacy|9|||
44578042|NCT00887250|79601131|FG001|Overall Study|Lack of Efficacy|6|||
44578043|NCT00887250|79601132|FG002|Overall Study|Lack of Efficacy|1|||
44119047|NCT03030989|78902740|FG000|Overall Study|No longer interested|5|||
44239268|NCT01554527|79066108|FG001|Overall Study|Withdrawal by Subject|0|||
44239269|NCT01554527|79066109|FG002|Overall Study|Withdrawal by Subject|3|||
44239270|NCT01554527|79066107|FG000|Overall Study|Lost to Follow-up|0|||
44239271|NCT01554527|79066108|FG001|Overall Study|Lost to Follow-up|0|||
44239272|NCT01554527|79066109|FG002|Overall Study|Lost to Follow-up|4|||
44239273|NCT01554527|79066107|FG000|Overall Study|Physician Decision|0|||
44276104|NCT02186652|79229067|FG000|Overall Study|Lost to Follow-up|2|||
44119048|NCT03030989|78902741|FG001|Overall Study|No longer interested|3|||
44276105|NCT02186652|79229068|FG001|Overall Study|Lost to Follow-up|0|||
44276106|NCT02185794|79229104|FG000|Overall Study|Enrolled but Never Dosed|1|||
44276107|NCT02185794|79229105|FG001|Overall Study|Enrolled but Never Dosed|6|||
44276108|NCT02185794|79229106|FG002|Overall Study|Enrolled but Never Dosed|3|||
44276109|NCT02185794|79229107|FG003|Overall Study|Enrolled but Never Dosed|1|||
44276110|NCT02185794|79229108|FG004|Overall Study|Enrolled but Never Dosed|1|||
44276111|NCT02185794|79229109|FG005|Overall Study|Enrolled but Never Dosed|0|||
44276112|NCT02185794|79229104|FG000|Overall Study|Investigator's Discretion|1|||
44276113|NCT02185794|79229105|FG001|Overall Study|Investigator's Discretion|0|||
44276114|NCT02185794|79229106|FG002|Overall Study|Investigator's Discretion|1|||
44276115|NCT02185794|79229107|FG003|Overall Study|Investigator's Discretion|2|||
44276116|NCT02185794|79229108|FG004|Overall Study|Investigator's Discretion|2|||
44276117|NCT02185794|79229109|FG005|Overall Study|Investigator's Discretion|15|||
44276118|NCT02185794|79229104|FG000|Overall Study|Withdrew Consent|2|||
44276119|NCT02185794|79229105|FG001|Overall Study|Withdrew Consent|5|||
44276120|NCT02185794|79229106|FG002|Overall Study|Withdrew Consent|10|||
44276121|NCT02185794|79229107|FG003|Overall Study|Withdrew Consent|2|||
44276122|NCT02185794|79229108|FG004|Overall Study|Withdrew Consent|0|||
44276123|NCT02185794|79229109|FG005|Overall Study|Withdrew Consent|0|||
44276124|NCT02185794|79229104|FG000|Overall Study|Lost to Follow-up|1|||
44276125|NCT02185794|79229105|FG001|Overall Study|Lost to Follow-up|2|||
44276126|NCT02185794|79229106|FG002|Overall Study|Lost to Follow-up|2|||
44276127|NCT02185794|79229107|FG003|Overall Study|Lost to Follow-up|3|||
44276128|NCT02185794|79229108|FG004|Overall Study|Lost to Follow-up|0|||
44276129|NCT02185794|79229109|FG005|Overall Study|Lost to Follow-up|1|||
44578044|NCT00887250|79601130|FG000|Overall Study|Lost to Follow-up|2|||
44578045|NCT00887250|79601131|FG001|Overall Study|Lost to Follow-up|3|||
44119049|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
44119050|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
44119051|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
44119052|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Other|1|||
44119053|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Other|0|||
44119054|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Other|0|||
44119055|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Physician Decision|3|||
44119056|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Physician Decision|0|||
44119057|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Physician Decision|0|||
44239274|NCT01554527|79066108|FG001|Overall Study|Physician Decision|0|||
44276130|NCT02221674|79229140|FG000|Overall Study|Lost to Follow-up|1|||
44239275|NCT01554527|79066109|FG002|Overall Study|Physician Decision|1|||
44578046|NCT00887250|79601132|FG002|Overall Study|Lost to Follow-up|1|||
44119058|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
44239276|NCT01563913|79066120|FG000|Overall Study|Physician Decision|1|||
44239277|NCT01563913|79066121|FG001|Overall Study|Physician Decision|0|||
44239278|NCT01563913|79066120|FG000|Overall Study|Spouse Passed Away|1|||
44276131|NCT02221674|79229141|FG001|Overall Study|Lost to Follow-up|0|||
44276132|NCT02221674|79229142|FG002|Overall Study|Lost to Follow-up|0|||
44276133|NCT02221284|79229157|FG000|Overall Study|Case Report Forms Uncollected|56|||
44276134|NCT02221284|79229157|FG000|Overall Study|Protocol Deviation|5|||
44578047|NCT00887250|79601130|FG000|Overall Study|Protocol Violation|2|||
44239279|NCT01563913|79066121|FG001|Overall Study|Spouse Passed Away|0|||
44276135|NCT02187042|79229314|FG000|Overall Study|Death|1|||
44578048|NCT00887250|79601131|FG001|Overall Study|Protocol Violation|2|||
44578049|NCT00887250|79601132|FG002|Overall Study|Protocol Violation|1|||
44578050|NCT00887250|79601130|FG000|Overall Study|Withdrawal by Subject|2|||
44578051|NCT00887250|79601131|FG001|Overall Study|Withdrawal by Subject|1|||
44578052|NCT00887250|79601132|FG002|Overall Study|Withdrawal by Subject|2|||
44578053|NCT00887250|79601130|FG000|Overall Study|Patient uncooperative|0|||
44578054|NCT00887250|79601131|FG001|Overall Study|Patient uncooperative|0|||
44578055|NCT00887250|79601132|FG002|Overall Study|Patient uncooperative|1|||
44578056|NCT02599402|79601137|FG000|Overall Study|Disease progression|153|||
44578057|NCT02599402|79601137|FG000|Overall Study|Study drug toxicity|201|||
44578058|NCT02599402|79601137|FG000|Overall Study|Death|26|||
44578059|NCT02599402|79601137|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
44578060|NCT02599402|79601137|FG000|Overall Study|Participant request to discontinue study treatment|13|||
44578061|NCT02599402|79601137|FG000|Overall Study|Participant withdrew consent|5|||
44578062|NCT02599402|79601137|FG000|Overall Study|Lost to Follow-up|1|||
44578063|NCT02599402|79601137|FG000|Overall Study|Maximum Clinical Benefit|7|||
44578064|NCT02599402|79601137|FG000|Overall Study|Poor/non-compliance|1|||
44578065|NCT02599402|79601137|FG000|Overall Study|Pregnancy|1|||
44578066|NCT02599402|79601137|FG000|Overall Study|Participant no longer met study criteria|7|||
44578067|NCT02599402|79601137|FG000|Overall Study|Other Reasons|95|||
44578068|NCT02734862|79601177|FG000|Part A|Death|3|||
44578069|NCT02734862|79601178|FG001|Part A|Death|4|||
44578070|NCT02734862|79601179|FG002|Part A|Death|6|||
44578071|NCT02734862|79601177|FG000|Part A|Lost to Follow-up|2|||
44239280|NCT01553747|79066130|FG000|Overall Study|Protocol Violation|0|||
44239281|NCT01553747|79066131|FG001|Overall Study|Protocol Violation|2|||
44239282|NCT01553747|79066132|FG002|Overall Study|Protocol Violation|0|||
44239283|NCT01553747|79066130|FG000|Overall Study|Voluntarily withdrew|70|||
44239284|NCT01553747|79066131|FG001|Overall Study|Voluntarily withdrew|66|||
44578072|NCT02734862|79601178|FG001|Part A|Lost to Follow-up|1|||
44578073|NCT02734862|79601179|FG002|Part A|Lost to Follow-up|1|||
44578074|NCT02734862|79601177|FG000|Part A|Withdrawal by Subject|1|||
44578075|NCT02734862|79601178|FG001|Part A|Withdrawal by Subject|1|||
44578076|NCT02734862|79601179|FG002|Part A|Withdrawal by Subject|2|||
44578077|NCT02734862|79601177|FG000|Part A|Physician Decision|2|||
44507887|NCT00050778|79512942|FG001|Overall Study|Familial and personal reasons|0|||
44507888|NCT00050778|79512943|FG002|Overall Study|Familial and personal reasons|0|||
44507889|NCT00050622|79512953|FG000|Overall Study|Adverse Event|1|||
44507890|NCT00308087|79512979|FG000|Overall Study|Progressive Disease|19|||
44507891|NCT00308087|79512980|FG001|Overall Study|Progressive Disease|21|||
44507892|NCT00308087|79512979|FG000|Overall Study|Study Closure|11|||
44507893|NCT00308087|79512980|FG001|Overall Study|Study Closure|12|||
44507894|NCT00308087|79512979|FG000|Overall Study|Withdrawal by Subject|2|||
44507895|NCT00308087|79512980|FG001|Overall Study|Withdrawal by Subject|1|||
44507896|NCT00308087|79512979|FG000|Overall Study|Other|4|||
44507897|NCT00308087|79512980|FG001|Overall Study|Other|3|||
44507898|NCT00307931|79512986|FG000|Overall Study|Adverse Event|1|||
44507899|NCT02796170|79512992|FG000|Overall Study|Lost to Follow-up|3|||
44507900|NCT02796170|79512993|FG001|Overall Study|Lost to Follow-up|0|||
44507901|NCT00049842|79513001|FG000|Treatment Phase|Adverse Event|47|||
44507902|NCT00049842|79513002|FG001|Treatment Phase|Adverse Event|12|||
44507903|NCT00049842|79513001|FG000|Treatment Phase|Withdrawal by Subject|35|||
44507904|NCT00049842|79513002|FG001|Treatment Phase|Withdrawal by Subject|46|||
44507905|NCT00049842|79513001|FG000|Treatment Phase|Non-compliance with protocol|7|||
44507906|NCT00049842|79513002|FG001|Treatment Phase|Non-compliance with protocol|8|||
44507907|NCT00049842|79513001|FG000|Treatment Phase|Lost to Follow-up|4|||
44507908|NCT00049842|79513002|FG001|Treatment Phase|Lost to Follow-up|8|||
44507909|NCT00049842|79513001|FG000|Treatment Phase|Administrative|0|||
44507910|NCT00049842|79513002|FG001|Treatment Phase|Administrative|3|||
44507911|NCT00049842|79513001|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
44507912|NCT00049842|79513002|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
44507913|NCT00049842|79513001|FG000|Follow-up Phase|Adverse Event|6|||
44507914|NCT00049842|79513002|FG001|Follow-up Phase|Adverse Event|1|||
44507915|NCT00049842|79513001|FG000|Follow-up Phase|Other|1|||
44507916|NCT00049842|79513002|FG001|Follow-up Phase|Other|4|||
44507917|NCT00307151|79513012|FG000|Overall Study|Death|4|||
44507918|NCT00307151|79513013|FG001|Overall Study|Death|3|||
44507919|NCT00307151|79513014|FG002|Overall Study|Death|10|||
44507920|NCT00307151|79513015|FG003|Overall Study|Death|3|||
44578078|NCT02734862|79601178|FG001|Part A|Physician Decision|0|||
44578079|NCT02734862|79601179|FG002|Part A|Physician Decision|1|||
44578080|NCT02734862|79601177|FG000|Part A|Adverse Event|2|||
44507921|NCT00307151|79513012|FG000|Overall Study|Severe debilitation, unable to continue|1|||
44507922|NCT00307151|79513013|FG001|Overall Study|Severe debilitation, unable to continue|0|||
44507923|NCT00307151|79513014|FG002|Overall Study|Severe debilitation, unable to continue|0|||
44578081|NCT02734862|79601178|FG001|Part A|Adverse Event|0|||
44578082|NCT02734862|79601179|FG002|Part A|Adverse Event|1|||
44578083|NCT02734862|79601177|FG000|Part A|Noncompliance|1|||
44578084|NCT02734862|79601178|FG001|Part A|Noncompliance|1|||
44239285|NCT01553747|79066132|FG002|Overall Study|Voluntarily withdrew|74|||
44578085|NCT02734862|79601179|FG002|Part A|Noncompliance|0|||
44578086|NCT02734862|79601177|FG000|Part A|Other|1|||
44578087|NCT02734862|79601178|FG001|Part A|Other|1|||
44578088|NCT02734862|79601179|FG002|Part A|Other|3|||
44578089|NCT02734862|79601177|FG000|Part B|Death|8|||
44578090|NCT02734862|79601178|FG001|Part B|Death|3|||
44578091|NCT02734862|79601179|FG002|Part B|Death|5|||
44578092|NCT02734862|79601177|FG000|Part B|Lost to Follow-up|2|||
44578093|NCT02734862|79601178|FG001|Part B|Lost to Follow-up|2|||
44578094|NCT02734862|79601179|FG002|Part B|Lost to Follow-up|0|||
44578095|NCT02734862|79601177|FG000|Part B|Withdrawal by Subject|3|||
44578096|NCT02734862|79601178|FG001|Part B|Withdrawal by Subject|1|||
44578097|NCT02734862|79601179|FG002|Part B|Withdrawal by Subject|0|||
44578098|NCT02734862|79601177|FG000|Part B|Other|0|||
44578099|NCT02734862|79601178|FG001|Part B|Other|1|||
44578100|NCT02734862|79601179|FG002|Part B|Other|0|||
44578101|NCT00858702|79601190|FG000|Overall Study|Lack of Efficacy|1|||
44578102|NCT00858702|79601191|FG001|Overall Study|Lack of Efficacy|0|||
44578103|NCT00858702|79601190|FG000|Overall Study|Protocol Violation|1|||
44578104|NCT00858702|79601191|FG001|Overall Study|Protocol Violation|1|||
44578105|NCT00858702|79601190|FG000|Overall Study|Other|2|||
44578106|NCT00858702|79601191|FG001|Overall Study|Other|1|||
44578107|NCT00858702|79601190|FG000|Overall Study|Withdrawal by Subject|1|||
44578108|NCT00858702|79601191|FG001|Overall Study|Withdrawal by Subject|0|||
44578109|NCT02598934|79601199|FG000|Overall Study|Adverse Event|11|||
44578110|NCT02598934|79601200|FG001|Overall Study|Adverse Event|13|||
44578111|NCT02598934|79601199|FG000|Overall Study|Failure to Return|3|||
44578112|NCT02598934|79601200|FG001|Overall Study|Failure to Return|3|||
44578113|NCT02598934|79601199|FG000|Overall Study|Withdrawal by Subject|2|||
44578114|NCT02598934|79601200|FG001|Overall Study|Withdrawal by Subject|3|||
44578115|NCT02598934|79601199|FG000|Overall Study|Administrative|2|||
44578116|NCT02598934|79601200|FG001|Overall Study|Administrative|1|||
44578117|NCT02598934|79601199|FG000|Overall Study|Protocol Violation|1|||
44578118|NCT02598934|79601200|FG001|Overall Study|Protocol Violation|2|||
44578119|NCT02598622|79601208|FG000|Overall Study|Withdrawal by Subject|3|||
44578120|NCT02598622|79601209|FG001|Overall Study|Withdrawal by Subject|0|||
44578121|NCT02598622|79601208|FG000|Overall Study|Physician Decision|3|||
44578122|NCT02598622|79601209|FG001|Overall Study|Physician Decision|0|||
44578123|NCT00841698|79601217|FG000|First Intervention|Withdrawal by Subject|1|||
44578124|NCT00841698|79601218|FG001|First Intervention|Withdrawal by Subject|0|||
44239286|NCT01553747|79066130|FG000|Overall Study|Adverse event or SAE|32|||
44239287|NCT01553747|79066131|FG001|Overall Study|Adverse event or SAE|28|||
44239288|NCT01553747|79066132|FG002|Overall Study|Adverse event or SAE|19|||
44239289|NCT01553747|79066130|FG000|Overall Study|Physician decision: other|10|||
44239290|NCT01553747|79066131|FG001|Overall Study|Physician decision: other|8|||
44239291|NCT01553747|79066132|FG002|Overall Study|Physician decision: other|7|||
44239292|NCT01553747|79066130|FG000|Overall Study|Lost to Follow-up|11|||
44239293|NCT01553747|79066131|FG001|Overall Study|Lost to Follow-up|5|||
44239294|NCT01553747|79066132|FG002|Overall Study|Lost to Follow-up|6|||
44239295|NCT01553747|79066130|FG000|Overall Study|Sponsor decision, specify|7|||
44239296|NCT01553747|79066131|FG001|Overall Study|Sponsor decision, specify|5|||
44276136|NCT02187042|79229315|FG001|Overall Study|Death|1|||
44239297|NCT01553747|79066132|FG002|Overall Study|Sponsor decision, specify|0|||
44239298|NCT01553747|79066130|FG000|Overall Study|Physician decision: lack of efficacy|1|||
44239299|NCT01553747|79066131|FG001|Overall Study|Physician decision: lack of efficacy|5|||
44239300|NCT01553747|79066132|FG002|Overall Study|Physician decision: lack of efficacy|3|||
44276137|NCT02187042|79229314|FG000|Overall Study|Toxicity|6|||
44276138|NCT02187042|79229315|FG001|Overall Study|Toxicity|5|||
44276139|NCT02187042|79229314|FG000|Overall Study|Participant choice|1|||
44276140|NCT02187042|79229315|FG001|Overall Study|Participant choice|0|||
44276141|NCT02187042|79229314|FG000|Overall Study|Doctor choice|1|||
44276142|NCT02187042|79229315|FG001|Overall Study|Doctor choice|0|||
44276143|NCT02187042|79229314|FG000|Overall Study|Progressive disease|4|||
44276144|NCT02187042|79229315|FG001|Overall Study|Progressive disease|8|||
44578125|NCT00841542|79601224|FG000|Period 1|Adverse Event|1|||
44578126|NCT00841542|79601225|FG001|Period 1|Adverse Event|0|||
44578127|NCT00840216|79601247|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
44578128|NCT00840216|79601248|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
44578129|NCT00836706|79601258|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
44578130|NCT00836706|79601259|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
44578131|NCT00836472|79601265|FG000|Washout|Adverse Event|1|||
44239301|NCT01536379|79066145|FG000|Overall Study|Adverse Event|1|||
44276145|NCT02219334|79229498|FG000|Overall Study|Withdrawal by Subject|1|||
44276146|NCT02219334|79229499|FG001|Overall Study|Withdrawal by Subject|0|||
44239302|NCT01536379|79066146|FG001|Overall Study|Adverse Event|2|||
44276147|NCT02219334|79229498|FG000|Overall Study|Protocol Violation|7|||
44578132|NCT00836472|79601266|FG001|Washout|Adverse Event|2|||
44578133|NCT00836472|79601265|FG000|Washout|Withdrawal by Subject|1|||
44578134|NCT00836472|79601266|FG001|Washout|Withdrawal by Subject|1|||
44578135|NCT02598388|79601282|FG000|Overall Study|Lost to Follow-up|1|||
44578136|NCT02598388|79601283|FG001|Overall Study|Lost to Follow-up|0|||
44578137|NCT02598388|79601284|FG002|Overall Study|Lost to Follow-up|1|||
44578138|NCT02598388|79601285|FG003|Overall Study|Lost to Follow-up|0|||
44578139|NCT02598388|79601286|FG004|Overall Study|Lost to Follow-up|5|||
44578140|NCT02598388|79601287|FG005|Overall Study|Lost to Follow-up|1|||
44578141|NCT02598388|79601288|FG006|Overall Study|Lost to Follow-up|2|||
44578142|NCT02598388|79601289|FG007|Overall Study|Lost to Follow-up|1|||
44578143|NCT02598388|79601290|FG008|Overall Study|Lost to Follow-up|0|||
44578144|NCT02598388|79601291|FG009|Overall Study|Lost to Follow-up|0|||
44578145|NCT02598388|79601292|FG010|Overall Study|Lost to Follow-up|1|||
44578146|NCT02598388|79601293|FG011|Overall Study|Lost to Follow-up|0|||
44578147|NCT02598388|79601282|FG000|Overall Study|Withdrawal by Subject|0|||
44578148|NCT02598388|79601283|FG001|Overall Study|Withdrawal by Subject|0|||
44578149|NCT02598388|79601284|FG002|Overall Study|Withdrawal by Subject|0|||
44578150|NCT02598388|79601285|FG003|Overall Study|Withdrawal by Subject|0|||
44578151|NCT02598388|79601286|FG004|Overall Study|Withdrawal by Subject|2|||
44578152|NCT02598388|79601287|FG005|Overall Study|Withdrawal by Subject|0|||
44578153|NCT02598388|79601288|FG006|Overall Study|Withdrawal by Subject|2|||
44578154|NCT02598388|79601289|FG007|Overall Study|Withdrawal by Subject|0|||
44119059|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
44119060|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
44119061|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
44119062|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
44119063|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
44578155|NCT02598388|79601290|FG008|Overall Study|Withdrawal by Subject|0|||
44578156|NCT02598388|79601291|FG009|Overall Study|Withdrawal by Subject|1|||
44578157|NCT02598388|79601292|FG010|Overall Study|Withdrawal by Subject|0|||
44578158|NCT02598388|79601293|FG011|Overall Study|Withdrawal by Subject|0|||
44578159|NCT02598388|79601282|FG000|Overall Study|Other|0|||
44578160|NCT02598388|79601283|FG001|Overall Study|Other|0|||
44578161|NCT02598388|79601284|FG002|Overall Study|Other|1|||
44578162|NCT02598388|79601285|FG003|Overall Study|Other|0|||
44578163|NCT02598388|79601286|FG004|Overall Study|Other|3|||
44578164|NCT02598388|79601287|FG005|Overall Study|Other|0|||
44578165|NCT02598388|79601288|FG006|Overall Study|Other|1|||
44578166|NCT02598388|79601289|FG007|Overall Study|Other|0|||
44578167|NCT02598388|79601290|FG008|Overall Study|Other|0|||
44578168|NCT02598388|79601291|FG009|Overall Study|Other|0|||
44578169|NCT02598388|79601292|FG010|Overall Study|Other|0|||
44578170|NCT02598388|79601293|FG011|Overall Study|Other|0|||
44578171|NCT00835692|79601333|FG000|First Intervention|Withdrawal by Subject|1|||
44578172|NCT00835692|79601334|FG001|First Intervention|Withdrawal by Subject|0|||
44578173|NCT00835536|79601347|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
44578174|NCT00835536|79601348|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
44578175|NCT03865316|79601352|FG000|Overall Study|Procedure Cancelled|4|||
44578176|NCT03865316|79601352|FG000|Overall Study|Equipment failure|4|||
44578177|NCT02598076|79601358|FG000|Overall Study|Lost to Follow-up|2|||
44578178|NCT02598076|79601359|FG001|Overall Study|Lost to Follow-up|3|||
44578179|NCT02602288|79601367|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
44578180|NCT02602288|79601368|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
44578181|NCT02602288|79601367|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
44578182|NCT02602288|79601368|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
44578183|NCT02602288|79601367|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
44578184|NCT02602288|79601368|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
44578185|NCT02602288|79601367|FG000|12 Month Follow-up|Lost to Follow-up|0|||
44578186|NCT02602288|79601368|FG001|12 Month Follow-up|Lost to Follow-up|4|||
44578187|NCT02602288|79601367|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
44578188|NCT02602288|79601368|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
44578189|NCT02601820|79601374|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
44119064|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Adverse Event|18|||
44119065|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Adverse Event|0|||
44119066|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Adverse Event|0|||
44578190|NCT02601820|79601374|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
44119067|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
44578191|NCT02601820|79601374|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
44119068|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
44119069|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
44119070|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
44239303|NCT01536379|79066145|FG000|Overall Study|Withdrawal by Subject|1|||
44239304|NCT01536379|79066146|FG001|Overall Study|Withdrawal by Subject|1|||
44578192|NCT02601820|79601374|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
44578193|NCT02807454|79601393|FG000|Overall Study|Adverse Event|1|||
44578194|NCT02807454|79601394|FG001|Overall Study|Adverse Event|0|||
44578195|NCT02807454|79601393|FG000|Overall Study|Withdrawal by Subject|0|||
44578196|NCT02807454|79601394|FG001|Overall Study|Withdrawal by Subject|1|||
44578197|NCT02807454|79601393|FG000|Overall Study|Progressive Disease|30|||
44578198|NCT02807454|79601394|FG001|Overall Study|Progressive Disease|3|||
44578199|NCT02807454|79601393|FG000|Overall Study|Other Reasons|1|||
44578200|NCT02807454|79601394|FG001|Overall Study|Other Reasons|1|||
44578201|NCT02597920|79601409|FG000|Overall Study|Worsening of other pre-existing disease|0|||
44578202|NCT02597920|79601410|FG001|Overall Study|Worsening of other pre-existing disease|1|||
44578203|NCT02597920|79601411|FG002|Overall Study|Worsening of other pre-existing disease|0|||
44578204|NCT02597920|79601409|FG000|Overall Study|Other adverse event|20|||
44578205|NCT02597920|79601410|FG001|Overall Study|Other adverse event|30|||
44578206|NCT02597920|79601411|FG002|Overall Study|Other adverse event|0|||
44578207|NCT02597920|79601409|FG000|Overall Study|Lost to Follow-up|7|||
44578208|NCT02597920|79601410|FG001|Overall Study|Lost to Follow-up|9|||
44578209|NCT02597920|79601411|FG002|Overall Study|Lost to Follow-up|0|||
44578210|NCT02597920|79601409|FG000|Overall Study|Refuse to continue in the study|3|||
44578211|NCT02597920|79601410|FG001|Overall Study|Refuse to continue in the study|13|||
44578212|NCT02597920|79601411|FG002|Overall Study|Refuse to continue in the study|1|||
44578213|NCT02597920|79601409|FG000|Overall Study|Other than specified|10|||
44119071|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
44119072|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
44119073|NCT03030599|78902747|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
44119074|NCT03030599|78902748|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
44119075|NCT03030599|78902749|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
44119076|NCT03030599|78902747|FG000|Stable Dose|Protocol deviation|3|||
44119077|NCT03030599|78902748|FG001|Stable Dose|Protocol deviation|0|||
44578214|NCT02597920|79601410|FG001|Overall Study|Other than specified|31|||
44578215|NCT02597920|79601411|FG002|Overall Study|Other than specified|5|||
44578216|NCT02597920|79601409|FG000|Overall Study|Other|1|||
44578217|NCT02597920|79601410|FG001|Overall Study|Other|0|||
44578218|NCT02597920|79601411|FG002|Overall Study|Other|0|||
44578219|NCT01235234|79601431|FG000|Overall Study|Adverse Event|2|||
44578220|NCT01235234|79601432|FG001|Overall Study|Adverse Event|2|||
44578221|NCT01235234|79601433|FG002|Overall Study|Adverse Event|1|||
44578222|NCT02597452|79601448|FG000|Overall Study|testing incomplete|30|||
44119078|NCT03030599|78902749|FG002|Stable Dose|Protocol deviation|0|||
44119079|NCT03030599|78902747|FG000|Stable Dose|Adverse Event|1|||
44119080|NCT03030599|78902748|FG001|Stable Dose|Adverse Event|0|||
44119081|NCT03030599|78902749|FG002|Stable Dose|Adverse Event|0|||
44119082|NCT03030599|78902747|FG000|Stable Dose|Lost to Follow-up|1|||
44119083|NCT03030599|78902748|FG001|Stable Dose|Lost to Follow-up|0|||
44119084|NCT03030599|78902749|FG002|Stable Dose|Lost to Follow-up|0|||
44119085|NCT03030599|78902747|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
44119086|NCT03030599|78902748|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
44119087|NCT03030599|78902749|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
44119088|NCT03030599|78902747|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
44119089|NCT03030599|78902748|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
44119090|NCT03030599|78902749|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
44119091|NCT03030599|78902747|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
44119092|NCT03030599|78902748|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
44119093|NCT03030599|78902749|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
44119094|NCT03030599|78902747|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
44119095|NCT03030599|78902748|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
44119096|NCT03030599|78902749|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
44119097|NCT03030599|78902747|FG000|Open-label Extension|Adverse Event|3|||
44119098|NCT03030599|78902748|FG001|Open-label Extension|Adverse Event|0|||
44119099|NCT03030599|78902749|FG002|Open-label Extension|Adverse Event|0|||
44119100|NCT03030599|78902747|FG000|Open-label Extension|Lost to Follow-up|2|||
44119101|NCT03030599|78902748|FG001|Open-label Extension|Lost to Follow-up|0|||
44119102|NCT03030599|78902749|FG002|Open-label Extension|Lost to Follow-up|0|||
44119103|NCT03030599|78902747|FG000|Open-label Extension|Lack of Efficacy|1|||
44119104|NCT03030599|78902748|FG001|Open-label Extension|Lack of Efficacy|0|||
44507924|NCT00307151|79513015|FG003|Overall Study|Severe debilitation, unable to continue|0|||
44507925|NCT00307151|79513012|FG000|Overall Study|Subject unable to get to clinic|1|||
44507926|NCT00307151|79513013|FG001|Overall Study|Subject unable to get to clinic|0|||
44507927|NCT00307151|79513014|FG002|Overall Study|Subject unable to get to clinic|6|||
44507928|NCT00307151|79513015|FG003|Overall Study|Subject unable to get to clinic|2|||
44507929|NCT00307151|79513012|FG000|Overall Study|Withdrew consent|0|||
44507930|NCT00307151|79513013|FG001|Overall Study|Withdrew consent|1|||
44507931|NCT00307151|79513014|FG002|Overall Study|Withdrew consent|1|||
44507932|NCT00307151|79513015|FG003|Overall Study|Withdrew consent|3|||
44507933|NCT00307151|79513012|FG000|Overall Study|Not willing to adhere to study reqs|2|||
44507934|NCT00307151|79513013|FG001|Overall Study|Not willing to adhere to study reqs|0|||
44507935|NCT00307151|79513014|FG002|Overall Study|Not willing to adhere to study reqs|2|||
44507936|NCT00307151|79513015|FG003|Overall Study|Not willing to adhere to study reqs|2|||
44578223|NCT00834756|79601454|FG000|First Intervention|Adverse Event|1|||
44578224|NCT00834756|79601455|FG001|First Intervention|Adverse Event|0|||
44578225|NCT00834756|79601454|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
44578226|NCT00834756|79601455|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
44578227|NCT00828854|79601459|FG000|Overall Study|Disease Progression|17|||
44578228|NCT00828854|79601459|FG000|Overall Study|Adverse Event|9|||
44578229|NCT00828854|79601459|FG000|Overall Study|Reason not Specified|1|||
44578230|NCT00834522|79601465|FG000|Washout|Adverse Event|1|||
44119105|NCT03030599|78902749|FG002|Open-label Extension|Lack of Efficacy|0|||
44119106|NCT03030599|78902747|FG000|Open-label Extension|Other Reason|1|||
44578231|NCT00834522|79601466|FG001|Washout|Adverse Event|0|||
44578232|NCT00834522|79601465|FG000|Washout|Withdrawal by Subject|2|||
44578233|NCT00834522|79601466|FG001|Washout|Withdrawal by Subject|1|||
44578234|NCT00834444|79601472|FG000|First Intervention|Adverse Event|1|||
44119107|NCT03030599|78902748|FG001|Open-label Extension|Other Reason|0|||
44119108|NCT03030599|78902749|FG002|Open-label Extension|Other Reason|0|||
44119109|NCT03028415|78902757|FG000|Overall Study|Lost to Follow-up|6|||
44119110|NCT03028415|78902758|FG001|Overall Study|Lost to Follow-up|3|||
44578235|NCT00834444|79601473|FG001|First Intervention|Adverse Event|0|||
44578236|NCT00834444|79601472|FG000|First Intervention|Intolerance to Venopuncture|0|||
44578237|NCT00834444|79601473|FG001|First Intervention|Intolerance to Venopuncture|1|||
44578238|NCT00834444|79601472|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
44578239|NCT00834444|79601473|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
44119111|NCT03028415|78902757|FG000|Overall Study|Withdrawal by Subject|1|||
44119112|NCT03028415|78902758|FG001|Overall Study|Withdrawal by Subject|0|||
44119113|NCT03028415|78902757|FG000|Overall Study|Discontinued due to COVID-19|1|||
44119114|NCT03028415|78902758|FG001|Overall Study|Discontinued due to COVID-19|0|||
44119115|NCT02692040|78902782|FG000|Overall Study|Protocol Violation|0|||
44119116|NCT02692040|78902783|FG001|Overall Study|Protocol Violation|0|||
44119117|NCT02692040|78902784|FG002|Overall Study|Protocol Violation|0|||
44119118|NCT02692040|78902785|FG003|Overall Study|Protocol Violation|0|||
44119119|NCT02692040|78902786|FG004|Overall Study|Protocol Violation|0|||
44119120|NCT02692040|78902787|FG005|Overall Study|Protocol Violation|0|||
44119121|NCT02692040|78902788|FG006|Overall Study|Protocol Violation|0|||
44119122|NCT02692040|78902789|FG007|Overall Study|Protocol Violation|0|||
44119123|NCT02692040|78902790|FG008|Overall Study|Protocol Violation|0|||
44119124|NCT02692040|78902791|FG009|Overall Study|Protocol Violation|0|||
44119125|NCT02692040|78902792|FG010|Overall Study|Protocol Violation|0|||
44119126|NCT02692040|78902793|FG011|Overall Study|Protocol Violation|0|||
44119127|NCT02692040|78902794|FG012|Overall Study|Protocol Violation|1|||
44119128|NCT02692040|78902795|FG013|Overall Study|Protocol Violation|0|||
44378419|NCT01059812|79383729|FG000|Overall Study|Lack of Efficacy|2|||
44378420|NCT01059812|79383730|FG001|Overall Study|Lack of Efficacy|2|||
44378421|NCT01059812|79383729|FG000|Overall Study|Protocol Violation|3|||
44378422|NCT01059812|79383730|FG001|Overall Study|Protocol Violation|1|||
44378423|NCT01059812|79383729|FG000|Overall Study|Withdrawal Criteria|9|||
44378424|NCT01059812|79383730|FG001|Overall Study|Withdrawal Criteria|4|||
44378425|NCT01059812|79383729|FG000|Overall Study|Unclassified|14|||
44507937|NCT00307151|79513012|FG000|Overall Study|Clinic unable to contact subject|3|||
44507938|NCT00307151|79513013|FG001|Overall Study|Clinic unable to contact subject|3|||
44507939|NCT00307151|79513014|FG002|Overall Study|Clinic unable to contact subject|1|||
44507940|NCT00307151|79513015|FG003|Overall Study|Clinic unable to contact subject|1|||
44507941|NCT02654132|79513027|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
44507942|NCT02654132|79513028|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
44507943|NCT02654132|79513027|FG000|Treatment Period|Disease progression|43|||
44507944|NCT02654132|79513028|FG001|Treatment Period|Disease progression|38|||
44507945|NCT02654132|79513027|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
44507946|NCT02654132|79513028|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
44507947|NCT02654132|79513027|FG000|Treatment Period|Other reasons|4|||
44507948|NCT02654132|79513028|FG001|Treatment Period|Other reasons|2|||
44507949|NCT02654132|79513027|FG000|Treatment Period|Study drug toxicity|2|||
44507950|NCT02654132|79513028|FG001|Treatment Period|Study drug toxicity|2|||
44507951|NCT02654132|79513027|FG000|Treatment Period|Withdrawal by Subject|2|||
44507952|NCT02654132|79513028|FG001|Treatment Period|Withdrawal by Subject|1|||
44507953|NCT02654132|79513027|FG000|Treatment Period|Maximum Clinical Benefit|0|||
44507954|NCT02654132|79513028|FG001|Treatment Period|Maximum Clinical Benefit|2|||
44507955|NCT02654132|79513027|FG000|Treatment Period|Participant request to discontinue|2|||
44507956|NCT02654132|79513028|FG001|Treatment Period|Participant request to discontinue|0|||
44507957|NCT02654132|79513027|FG000|Treatment Period|Administrative reasons by sponsor|0|||
44507958|NCT02654132|79513028|FG001|Treatment Period|Administrative reasons by sponsor|1|||
44507959|NCT02654132|79513027|FG000|Treatment Period|Death|1|||
44507960|NCT02654132|79513028|FG001|Treatment Period|Death|0|||
44507961|NCT03241342|79513037|FG000|Overall Study|Adverse Event|5|||
44507962|NCT03241342|79513038|FG001|Overall Study|Adverse Event|8|||
44507963|NCT03241342|79513039|FG002|Overall Study|Adverse Event|4|||
44507964|NCT03241342|79513037|FG000|Overall Study|Lack of Efficacy|0|||
44578240|NCT00834444|79601472|FG000|Second Intervention|Adverse Event|1|||
44578241|NCT00834444|79601473|FG001|Second Intervention|Adverse Event|0|||
44578242|NCT02605954|79601493|FG000|Overall Study|Adverse Event|5|||
44578243|NCT02605954|79601494|FG001|Overall Study|Adverse Event|1|||
44578244|NCT02605954|79601493|FG000|Overall Study|Investigator's Discretion|1|||
44578245|NCT02605954|79601494|FG001|Overall Study|Investigator's Discretion|0|||
44578246|NCT02605954|79601493|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44578247|NCT02605954|79601494|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44578248|NCT02605954|79601493|FG000|Overall Study|Withdrew Consent|2|||
44578249|NCT02605954|79601494|FG001|Overall Study|Withdrew Consent|2|||
44578250|NCT02605954|79601493|FG000|Overall Study|Lost to Follow-up|3|||
44578251|NCT02605954|79601494|FG001|Overall Study|Lost to Follow-up|0|||
44578252|NCT02605954|79601493|FG000|Overall Study|Randomized but not treated|0|||
44578253|NCT02605954|79601494|FG001|Overall Study|Randomized but not treated|1|||
44578254|NCT00724698|79601503|FG000|Overall Study|Adverse Event|9|||
44578255|NCT00724698|79601503|FG000|Overall Study|Failure of Therapy|4|||
44578256|NCT00724698|79601503|FG000|Overall Study|Poor Compliance|16|||
44578257|NCT00724698|79601503|FG000|Overall Study|Lost to Follow-up|36|||
44239305|NCT01536145|79066152|FG000|Overall Study|Progressive disease|3|||
44239306|NCT01536145|79066153|FG001|Overall Study|Progressive disease|4|||
44239307|NCT01536145|79066154|FG002|Overall Study|Progressive disease|1|||
44239308|NCT01536145|79066155|FG003|Overall Study|Progressive disease|2|||
44239309|NCT01536145|79066156|FG004|Overall Study|Progressive disease|1|||
44239310|NCT01536145|79066157|FG005|Overall Study|Progressive disease|2|||
44239311|NCT01536145|79066158|FG006|Overall Study|Progressive disease|1|||
44239312|NCT01536145|79066159|FG007|Overall Study|Progressive disease|2|||
44239313|NCT01536145|79066160|FG008|Overall Study|Progressive disease|1|||
44239314|NCT01536145|79066161|FG009|Overall Study|Progressive disease|3|||
44578258|NCT00724698|79601503|FG000|Overall Study|No Info|25|||
44578259|NCT00829998|79601508|FG000|Washout|Adverse Event|0|||
44578260|NCT00829998|79601509|FG001|Washout|Adverse Event|1|||
44578261|NCT00829764|79601520|FG000|First Intervention|Adverse Event|1|||
44578262|NCT00829764|79601521|FG001|First Intervention|Adverse Event|0|||
44578263|NCT00829764|79601520|FG000|First Intervention|Withdrawal by Subject|1|||
44578264|NCT00829764|79601521|FG001|First Intervention|Withdrawal by Subject|1|||
44578265|NCT00829530|79601543|FG000|First Intervention|Adverse Event|0|||
44578266|NCT00829530|79601544|FG001|First Intervention|Adverse Event|1|||
44578267|NCT00829530|79601543|FG000|First Intervention|Intolerance to Venopuncture|0|||
44578268|NCT00829530|79601544|FG001|First Intervention|Intolerance to Venopuncture|1|||
44578269|NCT00829530|79601543|FG000|Second Intervention|Intolerance to Venopuncture|1|||
44578270|NCT00829530|79601544|FG001|Second Intervention|Intolerance to Venopuncture|0|||
44119129|NCT02692040|78902796|FG014|Overall Study|Protocol Violation|0|||
44119130|NCT02692040|78902797|FG015|Overall Study|Protocol Violation|0|||
44119131|NCT02692040|78902798|FG016|Overall Study|Protocol Violation|0|||
44119132|NCT02692040|78902782|FG000|Overall Study|Adverse Event|0|||
44119133|NCT02692040|78902783|FG001|Overall Study|Adverse Event|0|||
44119134|NCT02692040|78902784|FG002|Overall Study|Adverse Event|0|||
44119135|NCT02692040|78902785|FG003|Overall Study|Adverse Event|0|||
44119136|NCT02692040|78902786|FG004|Overall Study|Adverse Event|0|||
44119137|NCT02692040|78902787|FG005|Overall Study|Adverse Event|0|||
44119138|NCT02692040|78902788|FG006|Overall Study|Adverse Event|0|||
44119139|NCT02692040|78902789|FG007|Overall Study|Adverse Event|0|||
44119140|NCT02692040|78902790|FG008|Overall Study|Adverse Event|0|||
44578271|NCT01377194|79601551|FG000|Overall Study|Adverse Event|3|||
44578272|NCT01377194|79601552|FG001|Overall Study|Adverse Event|12|||
44119141|NCT02692040|78902791|FG009|Overall Study|Adverse Event|0|||
44119142|NCT02692040|78902792|FG010|Overall Study|Adverse Event|0|||
44119143|NCT02692040|78902793|FG011|Overall Study|Adverse Event|0|||
44119144|NCT02692040|78902794|FG012|Overall Study|Adverse Event|0|||
44119145|NCT02692040|78902795|FG013|Overall Study|Adverse Event|3|||
44119146|NCT02692040|78902796|FG014|Overall Study|Adverse Event|1|||
44239315|NCT01536145|79066162|FG010|Overall Study|Progressive disease|3|||
44239316|NCT01536145|79066152|FG000|Overall Study|Withdrawal by Subject|0|||
44239317|NCT01536145|79066153|FG001|Overall Study|Withdrawal by Subject|0|||
44239318|NCT01536145|79066154|FG002|Overall Study|Withdrawal by Subject|1|||
44507965|NCT03241342|79513038|FG001|Overall Study|Lack of Efficacy|0|||
44507966|NCT03241342|79513039|FG002|Overall Study|Lack of Efficacy|1|||
44507967|NCT03241342|79513037|FG000|Overall Study|noncompliance with study drug|2|||
44507968|NCT03241342|79513038|FG001|Overall Study|noncompliance with study drug|1|||
44507969|NCT03241342|79513039|FG002|Overall Study|noncompliance with study drug|1|||
44507970|NCT03241342|79513037|FG000|Overall Study|sponsor decision|0|||
44507971|NCT03241342|79513038|FG001|Overall Study|sponsor decision|1|||
44507972|NCT03241342|79513039|FG002|Overall Study|sponsor decision|2|||
44239319|NCT01536145|79066155|FG003|Overall Study|Withdrawal by Subject|0|||
44239320|NCT01536145|79066156|FG004|Overall Study|Withdrawal by Subject|0|||
44507973|NCT03241342|79513037|FG000|Overall Study|not reported|15|||
44507974|NCT03241342|79513038|FG001|Overall Study|not reported|21|||
44578273|NCT01377194|79601553|FG002|Overall Study|Adverse Event|19|||
44578274|NCT01377194|79601551|FG000|Overall Study|Lack of Efficacy|3|||
44578275|NCT01377194|79601552|FG001|Overall Study|Lack of Efficacy|3|||
44578276|NCT01377194|79601553|FG002|Overall Study|Lack of Efficacy|3|||
44578277|NCT01377194|79601551|FG000|Overall Study|Protocol Violation|4|||
44578278|NCT01377194|79601552|FG001|Overall Study|Protocol Violation|10|||
44578279|NCT01377194|79601553|FG002|Overall Study|Protocol Violation|6|||
44578280|NCT01377194|79601551|FG000|Overall Study|Withdrawal by Subject|8|||
44578281|NCT01377194|79601552|FG001|Overall Study|Withdrawal by Subject|10|||
44578282|NCT01377194|79601553|FG002|Overall Study|Withdrawal by Subject|7|||
44578283|NCT01377194|79601551|FG000|Overall Study|Lost to Follow-up|14|||
44578284|NCT01377194|79601552|FG001|Overall Study|Lost to Follow-up|8|||
44119147|NCT02692040|78902797|FG015|Overall Study|Adverse Event|1|||
44276148|NCT02219334|79229499|FG001|Overall Study|Protocol Violation|3|||
44276149|NCT02159040|79229517|FG000|Overall Study|Death|1|||
44276150|NCT02218008|79229542|FG000|Stage 1 (S1)|Adverse Event|6|||
44276151|NCT02218008|79229543|FG001|Stage 1 (S1)|Adverse Event|5|||
44276152|NCT02218008|79229544|FG002|Stage 1 (S1)|Adverse Event|11|||
44276153|NCT02218008|79229545|FG003|Stage 1 (S1)|Adverse Event|0|||
44276154|NCT02218008|79229546|FG004|Stage 1 (S1)|Adverse Event|0|||
44276155|NCT02218008|79229547|FG005|Stage 1 (S1)|Adverse Event|0|||
44276156|NCT02218008|79229542|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
44276157|NCT02218008|79229543|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
44276158|NCT02218008|79229544|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
44378426|NCT01059812|79383730|FG001|Overall Study|Unclassified|4|||
44378427|NCT00888615|79383736|FG000|Overall Study|No treatment|2|||
44378428|NCT00845650|79383746|FG000|Overall Study|Withdrawal by Subject|0|||
44378429|NCT00845650|79383747|FG001|Overall Study|Withdrawal by Subject|0|||
44507975|NCT03241342|79513039|FG002|Overall Study|not reported|19|||
44507976|NCT00306995|79513054|FG000|Study Part I|Withdrawal by Subject|0|||
44507977|NCT00306995|79513055|FG001|Study Part I|Withdrawal by Subject|0|||
44507978|NCT00306995|79513056|FG002|Study Part I|Withdrawal by Subject|0|||
44507979|NCT00306995|79513057|FG003|Study Part I|Withdrawal by Subject|0|||
44507980|NCT00306995|79513058|FG004|Study Part I|Withdrawal by Subject|0|||
44507981|NCT00306995|79513059|FG005|Study Part I|Withdrawal by Subject|0|||
44507982|NCT00306995|79513060|FG006|Study Part I|Withdrawal by Subject|1|||
44507983|NCT00306995|79513054|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
44507984|NCT00306995|79513055|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
44507985|NCT00306995|79513056|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
44507986|NCT00306995|79513057|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
44507987|NCT00306995|79513058|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
44507988|NCT00306995|79513059|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
44507989|NCT00306995|79513060|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
44507990|NCT00121108|79513107|FG000|Overall Study|Lost to Follow-up|10|||
44507991|NCT00121108|79513108|FG001|Overall Study|Lost to Follow-up|22|||
44507992|NCT00121108|79513107|FG000|Overall Study|Withdrawal by Subject|106|||
44507993|NCT00121108|79513108|FG001|Overall Study|Withdrawal by Subject|195|||
44507994|NCT00121108|79513107|FG000|Overall Study|Death|5|||
44507995|NCT00121108|79513108|FG001|Overall Study|Death|8|||
44507996|NCT02387996|79513115|FG000|Overall Study|Disease Progression|167|||
44507997|NCT02387996|79513115|FG000|Overall Study|Study Drug Toxicity|31|||
44507998|NCT02387996|79513115|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
44507999|NCT02387996|79513115|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
44508000|NCT02387996|79513115|FG000|Overall Study|Subject Withdrew Consent|5|||
44508001|NCT02387996|79513115|FG000|Overall Study|Lost to Follow-up|1|||
44508002|NCT02387996|79513115|FG000|Overall Study|Poor/Non-Compliance|1|||
44508003|NCT02387996|79513115|FG000|Overall Study|Other Reasons|5|||
44508004|NCT02387996|79513115|FG000|Overall Study|Death|1|||
44508005|NCT03212326|79513119|FG000|Overall Study|Physician Decision|4|||
44508006|NCT03229486|79513158|FG000|Overall Study|Protocol Violation|0|||
44508007|NCT03229486|79513159|FG001|Overall Study|Protocol Violation|1|||
44508008|NCT01779050|79513167|FG000|Overall Study|Withdrawal by Subject|1|||
44508009|NCT01779050|79513168|FG001|Overall Study|Withdrawal by Subject|0|||
44508010|NCT00306527|79513178|FG000|Overall Study|Lost to Follow-up|3|||
44508011|NCT00306527|79513179|FG001|Overall Study|Lost to Follow-up|4|||
44508012|NCT00306527|79513180|FG002|Overall Study|Lost to Follow-up|3|||
44508013|NCT00306527|79513181|FG003|Overall Study|Lost to Follow-up|0|||
44508014|NCT00306527|79513178|FG000|Overall Study|Withdrawal by Subject|2|||
44508015|NCT00306527|79513179|FG001|Overall Study|Withdrawal by Subject|3|||
44578285|NCT01377194|79601553|FG002|Overall Study|Lost to Follow-up|11|||
44578286|NCT00829452|79601566|FG000|First Intervention|Withdrawal by Subject|0|||
44119148|NCT02692040|78902798|FG016|Overall Study|Adverse Event|0|||
44119149|NCT03029819|78902877|FG000|Overall Study|Lost to Follow-up|3|||
44378430|NCT00845650|79383748|FG002|Overall Study|Withdrawal by Subject|0|||
44378431|NCT00845650|79383749|FG003|Overall Study|Withdrawal by Subject|0|||
44378432|NCT00845650|79383750|FG004|Overall Study|Withdrawal by Subject|2|||
44508016|NCT00306527|79513180|FG002|Overall Study|Withdrawal by Subject|0|||
44508017|NCT00306527|79513181|FG003|Overall Study|Withdrawal by Subject|3|||
44508018|NCT00306527|79513178|FG000|Overall Study|Adverse Event|0|||
44508019|NCT00306527|79513179|FG001|Overall Study|Adverse Event|0|||
44508020|NCT00306527|79513180|FG002|Overall Study|Adverse Event|1|||
44508021|NCT00306527|79513181|FG003|Overall Study|Adverse Event|1|||
44508022|NCT00306527|79513178|FG000|Overall Study|Death|1|||
44578287|NCT00829452|79601567|FG001|First Intervention|Withdrawal by Subject|1|||
44578288|NCT00829452|79601566|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
44578289|NCT00829452|79601567|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
44578290|NCT00829452|79601566|FG000|Second Intervention|Physician Decision|0|||
44578291|NCT00829452|79601567|FG001|Second Intervention|Physician Decision|1|||
44239321|NCT01536145|79066157|FG005|Overall Study|Withdrawal by Subject|1|||
44578292|NCT04600076|79601571|FG000|Overall Study|Lost to Follow-up|3|||
44578293|NCT02064387|79601587|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44239322|NCT01536145|79066158|FG006|Overall Study|Withdrawal by Subject|0|||
44578294|NCT02064387|79601588|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44239323|NCT01536145|79066159|FG007|Overall Study|Withdrawal by Subject|0|||
44239324|NCT01536145|79066160|FG008|Overall Study|Withdrawal by Subject|2|||
44378433|NCT00845650|79383751|FG005|Overall Study|Withdrawal by Subject|0|||
44378434|NCT00845650|79383746|FG000|Overall Study|Lost to Follow-up|0|||
44378435|NCT00845650|79383747|FG001|Overall Study|Lost to Follow-up|0|||
44378436|NCT00845650|79383748|FG002|Overall Study|Lost to Follow-up|3|||
44378437|NCT00845650|79383749|FG003|Overall Study|Lost to Follow-up|1|||
44378438|NCT00845650|79383750|FG004|Overall Study|Lost to Follow-up|0|||
44378439|NCT00845650|79383751|FG005|Overall Study|Lost to Follow-up|1|||
44378440|NCT00845650|79383746|FG000|Overall Study|Sponsor hold on dosing|0|||
44378441|NCT00845650|79383747|FG001|Overall Study|Sponsor hold on dosing|0|||
44378442|NCT00845650|79383748|FG002|Overall Study|Sponsor hold on dosing|0|||
44378443|NCT00845650|79383749|FG003|Overall Study|Sponsor hold on dosing|0|||
44378444|NCT00845650|79383750|FG004|Overall Study|Sponsor hold on dosing|1|||
44378445|NCT00845650|79383751|FG005|Overall Study|Sponsor hold on dosing|1|||
44378446|NCT00845650|79383746|FG000|Overall Study|Unable to access IV line|1|||
44378447|NCT00845650|79383747|FG001|Overall Study|Unable to access IV line|0|||
44378448|NCT00845650|79383748|FG002|Overall Study|Unable to access IV line|0|||
44378449|NCT00845650|79383749|FG003|Overall Study|Unable to access IV line|0|||
44378450|NCT00845650|79383750|FG004|Overall Study|Unable to access IV line|0|||
44378451|NCT00845650|79383751|FG005|Overall Study|Unable to access IV line|0|||
44378452|NCT00888381|79383769|FG000|Overall Study|Lost to Follow-up|0|||
44378453|NCT00888381|79383770|FG001|Overall Study|Lost to Follow-up|1|||
44378454|NCT00887913|79383776|FG000|Overall Study|Withdrawal by Subject|6|||
44378455|NCT00833560|79383780|FG000|Overall Study|Toxicity|13|||
44378456|NCT00833560|79383780|FG000|Overall Study|Adverse Event|11|||
44378457|NCT00833560|79383780|FG000|Overall Study|Protocol Violation|6|||
44378458|NCT00833560|79383780|FG000|Overall Study|Lack of Efficacy|4|||
44378459|NCT00833560|79383780|FG000|Overall Study|Death|2|||
44378460|NCT00833560|79383780|FG000|Overall Study|Pregression of other disease|1|||
44378461|NCT00833560|79383780|FG000|Overall Study|Other|5|||
44378462|NCT00887679|79383784|FG000|Overall Study|Withdrawal by Subject|1|||
44378463|NCT00887679|79383784|FG000|Overall Study|Lost to Follow-up|4|||
44378464|NCT00887679|79383784|FG000|Overall Study|Physician Decision|5|||
44578295|NCT02064387|79601589|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578296|NCT02064387|79601590|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578297|NCT02064387|79601591|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578298|NCT02064387|79601592|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578299|NCT02064387|79601593|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578300|NCT02064387|79601594|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
44578301|NCT02064387|79601595|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578302|NCT02064387|79601596|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
44239325|NCT01536145|79066161|FG009|Overall Study|Withdrawal by Subject|0|||
44239326|NCT01536145|79066162|FG010|Overall Study|Withdrawal by Subject|2|||
44239327|NCT01536145|79066152|FG000|Overall Study|Other|0|||
44239328|NCT01536145|79066153|FG001|Overall Study|Other|0|||
44239329|NCT01536145|79066154|FG002|Overall Study|Other|0|||
44239330|NCT01536145|79066155|FG003|Overall Study|Other|0|||
44239331|NCT01536145|79066156|FG004|Overall Study|Other|1|||
44239332|NCT01536145|79066157|FG005|Overall Study|Other|0|||
44239333|NCT01536145|79066158|FG006|Overall Study|Other|0|||
44239334|NCT01536145|79066159|FG007|Overall Study|Other|0|||
44239335|NCT01536145|79066160|FG008|Overall Study|Other|0|||
44239336|NCT01536145|79066161|FG009|Overall Study|Other|3|||
44239337|NCT01536145|79066162|FG010|Overall Study|Other|2|||
44239338|NCT01536145|79066152|FG000|Overall Study|Death|0|||
44239339|NCT01536145|79066153|FG001|Overall Study|Death|0|||
44378465|NCT00833482|79383791|FG000|Days 11-20|Adverse Event|0|||
44378466|NCT00833482|79383792|FG001|Days 11-20|Adverse Event|2|||
44378467|NCT00833482|79383793|FG002|Days 11-20|Adverse Event|0|||
44378468|NCT00833482|79383794|FG003|Days 11-20|Adverse Event|0|||
44239340|NCT01536145|79066154|FG002|Overall Study|Death|0|||
44239341|NCT01536145|79066155|FG003|Overall Study|Death|0|||
44239342|NCT01536145|79066156|FG004|Overall Study|Death|0|||
44239343|NCT01536145|79066157|FG005|Overall Study|Death|0|||
44239344|NCT01536145|79066158|FG006|Overall Study|Death|1|||
44239345|NCT01536145|79066159|FG007|Overall Study|Death|0|||
44239346|NCT01536145|79066160|FG008|Overall Study|Death|0|||
44378469|NCT00833482|79383795|FG004|Days 11-20|Adverse Event|0|||
44378470|NCT00833482|79383796|FG005|Days 11-20|Adverse Event|0|||
44378471|NCT00833482|79383791|FG000|Days 11-20|Withdrawal by Subject|0|||
44378472|NCT00833482|79383792|FG001|Days 11-20|Withdrawal by Subject|1|||
44378473|NCT00833482|79383793|FG002|Days 11-20|Withdrawal by Subject|0|||
44378474|NCT00833482|79383794|FG003|Days 11-20|Withdrawal by Subject|0|||
44378475|NCT00833482|79383795|FG004|Days 11-20|Withdrawal by Subject|0|||
44378476|NCT00833482|79383796|FG005|Days 11-20|Withdrawal by Subject|0|||
44378477|NCT00833482|79383791|FG000|Days 21-30|Adverse Event|0|||
44378478|NCT00833482|79383792|FG001|Days 21-30|Adverse Event|0|||
44378479|NCT00833482|79383793|FG002|Days 21-30|Adverse Event|1|||
44378480|NCT00833482|79383794|FG003|Days 21-30|Adverse Event|0|||
44378481|NCT00833482|79383795|FG004|Days 21-30|Adverse Event|0|||
44378482|NCT00833482|79383796|FG005|Days 21-30|Adverse Event|0|||
44378483|NCT00833482|79383791|FG000|Days 21-30|Withdrawal by Subject|0|||
44378484|NCT00833482|79383792|FG001|Days 21-30|Withdrawal by Subject|0|||
44378485|NCT00833482|79383793|FG002|Days 21-30|Withdrawal by Subject|0|||
44378486|NCT00833482|79383794|FG003|Days 21-30|Withdrawal by Subject|0|||
44378487|NCT00833482|79383795|FG004|Days 21-30|Withdrawal by Subject|1|||
44378488|NCT00833482|79383796|FG005|Days 21-30|Withdrawal by Subject|0|||
44378489|NCT00845182|79383821|FG000|Overall Study|Lost to Follow-up|3|||
44378490|NCT00845182|79383822|FG001|Overall Study|Lost to Follow-up|3|||
44378491|NCT00845182|79383823|FG002|Overall Study|Lost to Follow-up|4|||
44378492|NCT00845182|79383821|FG000|Overall Study|Adverse Event|0|||
44378493|NCT00845182|79383822|FG001|Overall Study|Adverse Event|1|||
44378494|NCT00845182|79383823|FG002|Overall Study|Adverse Event|1|||
44378495|NCT00845182|79383821|FG000|Overall Study|Physician Decision|0|||
44378496|NCT00845182|79383822|FG001|Overall Study|Physician Decision|0|||
44378497|NCT00845182|79383823|FG002|Overall Study|Physician Decision|1|||
44378498|NCT00833248|79383837|FG000|Overall Study|Adverse Event|3|||
44378499|NCT00833248|79383838|FG001|Overall Study|Adverse Event|0|||
44378500|NCT00833248|79383837|FG000|Overall Study|Protocol Violation|1|||
44378501|NCT00833248|79383838|FG001|Overall Study|Protocol Violation|2|||
44378502|NCT00833248|79383837|FG000|Overall Study|Withdrawal by Subject|0|||
44378503|NCT00833248|79383838|FG001|Overall Study|Withdrawal by Subject|1|||
44378504|NCT00887289|79383844|FG000|Overall Study|Lack of Efficacy|14|||
44378505|NCT00887289|79383844|FG000|Overall Study|Adverse Event|27|||
44378506|NCT00887289|79383844|FG000|Overall Study|Withdrawal by Subject|26|||
44378507|NCT00887289|79383844|FG000|Overall Study|Lost to Follow-up|8|||
44378508|NCT00887289|79383844|FG000|Overall Study|Other|20|||
44378509|NCT00833092|79383850|FG000|Overall Study|Withdrawal by Subject|2|||
44378510|NCT00833092|79383851|FG001|Overall Study|Withdrawal by Subject|3|||
44378511|NCT00833092|79383850|FG000|Overall Study|Protocol Violation|2|||
44378512|NCT00833092|79383851|FG001|Overall Study|Protocol Violation|1|||
44276159|NCT02218008|79229545|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
44276160|NCT02218008|79229546|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
44578303|NCT02064387|79601597|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44378513|NCT00833092|79383850|FG000|Overall Study|Diarrhea|0|||
44378514|NCT00833092|79383851|FG001|Overall Study|Diarrhea|2|||
44378515|NCT00833092|79383850|FG000|Overall Study|constipation|0|||
44378516|NCT00833092|79383851|FG001|Overall Study|constipation|1|||
44508023|NCT00306527|79513179|FG001|Overall Study|Death|0|||
44508024|NCT00306527|79513180|FG002|Overall Study|Death|1|||
44508025|NCT00306527|79513181|FG003|Overall Study|Death|2|||
44508026|NCT00306293|79513195|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
44508027|NCT00306293|79513196|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
44508028|NCT00306293|79513195|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
44508029|NCT00306293|79513196|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
44508030|NCT00306293|79513195|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
44508031|NCT00306293|79513196|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
44508032|NCT00306293|79513195|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
44508033|NCT00306293|79513196|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
44508034|NCT00306293|79513195|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
44508035|NCT00306293|79513196|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
44508036|NCT00306293|79513195|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
44508037|NCT00306293|79513196|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
44578304|NCT02064387|79601598|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
44578305|NCT02064387|79601587|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578306|NCT02064387|79601588|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44378517|NCT00823264|79383859|FG000|Overall Study|Protocol Violation|2|||
44378518|NCT00823264|79383860|FG001|Overall Study|Protocol Violation|0|||
44378519|NCT00832780|79383866|FG000|Overall Study|Death|16|||
44378520|NCT00832780|79383866|FG000|Overall Study|Lost to Follow-up|4|||
44378521|NCT00832780|79383866|FG000|Overall Study|no reason given|2|||
44378522|NCT00832780|79383866|FG000|Overall Study|other complicating condition|2|||
44378523|NCT00832780|79383866|FG000|Overall Study|Physician Decision|1|||
44508038|NCT00306293|79513195|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
44378524|NCT00591838|79383875|FG000|Overall Study|Withdrawal by Subject|0|||
44378525|NCT00591838|79383876|FG001|Overall Study|Withdrawal by Subject|0|||
44378526|NCT00591838|79383877|FG002|Overall Study|Withdrawal by Subject|0|||
44378527|NCT00591838|79383878|FG003|Overall Study|Withdrawal by Subject|1|||
44378528|NCT00591838|79383879|FG004|Overall Study|Withdrawal by Subject|0|||
44378529|NCT00832624|79383892|FG000|Overall Study|Study Terminated|10|||
44378530|NCT00832078|79383896|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
44378531|NCT00832078|79383897|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
44378532|NCT00832078|79383896|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
44378533|NCT00832078|79383897|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
44378534|NCT00822172|79383905|FG000|Overall Study|Adverse Event|10|||
44378535|NCT00822172|79383906|FG001|Overall Study|Adverse Event|12|||
44378536|NCT00822172|79383905|FG000|Overall Study|Death|1|||
44378537|NCT00822172|79383906|FG001|Overall Study|Death|0|||
44378538|NCT00822172|79383905|FG000|Overall Study|Lost to Follow-up|3|||
44378539|NCT00822172|79383906|FG001|Overall Study|Lost to Follow-up|1|||
44378540|NCT00822172|79383905|FG000|Overall Study|Withdrawal by Subject|1|||
44378541|NCT00822172|79383906|FG001|Overall Study|Withdrawal by Subject|4|||
44378542|NCT00822172|79383905|FG000|Overall Study|site closed|0|||
44378543|NCT00822172|79383906|FG001|Overall Study|site closed|1|||
44378544|NCT00822172|79383905|FG000|Overall Study|Other|0|||
44378545|NCT00822172|79383906|FG001|Overall Study|Other|1|||
44378546|NCT00832000|79383912|FG000|Overall Study|Adverse Event|2|||
44378547|NCT00832000|79383913|FG001|Overall Study|Adverse Event|0|||
44378548|NCT00832000|79383912|FG000|Overall Study|Withdrawal by Subject|1|||
44378549|NCT00832000|79383913|FG001|Overall Study|Withdrawal by Subject|0|||
44378550|NCT00832000|79383912|FG000|Overall Study|No calls to IVR in either period|1|||
44378551|NCT00832000|79383913|FG001|Overall Study|No calls to IVR in either period|1|||
44378552|NCT00832000|79383912|FG000|Overall Study|No calls to IVR in period 2|2|||
44378553|NCT00832000|79383913|FG001|Overall Study|No calls to IVR in period 2|0|||
44378554|NCT00911508|79383950|FG000|Overall Study|Lost to Follow-up|27|||
44378555|NCT00911508|79383951|FG001|Overall Study|Lost to Follow-up|18|||
44378556|NCT00911508|79383950|FG000|Overall Study|Withdrawal by Subject|79|||
44378557|NCT00911508|79383951|FG001|Overall Study|Withdrawal by Subject|112|||
44378558|NCT00774397|79383977|FG000|Overall Study|Adverse Event|1|||
44378559|NCT00774397|79383978|FG001|Overall Study|Adverse Event|3|||
44378560|NCT00774397|79383979|FG002|Overall Study|Adverse Event|16|||
44378561|NCT00774397|79383980|FG003|Overall Study|Adverse Event|8|||
44378562|NCT00774397|79383981|FG004|Overall Study|Adverse Event|8|||
44378563|NCT00774397|79383982|FG005|Overall Study|Adverse Event|3|||
44378564|NCT00774397|79383983|FG006|Overall Study|Adverse Event|16|||
44378565|NCT00774397|79383977|FG000|Overall Study|Lack of Efficacy|11|||
44378566|NCT00774397|79383978|FG001|Overall Study|Lack of Efficacy|4|||
44378567|NCT00774397|79383979|FG002|Overall Study|Lack of Efficacy|5|||
44378568|NCT00774397|79383980|FG003|Overall Study|Lack of Efficacy|3|||
44378569|NCT00774397|79383981|FG004|Overall Study|Lack of Efficacy|27|||
44378570|NCT00774397|79383982|FG005|Overall Study|Lack of Efficacy|15|||
44378571|NCT00774397|79383983|FG006|Overall Study|Lack of Efficacy|9|||
44378572|NCT00774397|79383977|FG000|Overall Study|Protocol Violation|0|||
44378573|NCT00774397|79383978|FG001|Overall Study|Protocol Violation|1|||
44378574|NCT00774397|79383979|FG002|Overall Study|Protocol Violation|3|||
44378575|NCT00774397|79383980|FG003|Overall Study|Protocol Violation|1|||
44378576|NCT00774397|79383981|FG004|Overall Study|Protocol Violation|2|||
44378577|NCT00774397|79383982|FG005|Overall Study|Protocol Violation|1|||
44378578|NCT00774397|79383983|FG006|Overall Study|Protocol Violation|0|||
44378579|NCT00774397|79383977|FG000|Overall Study|Lost to Follow-up|0|||
44378580|NCT00774397|79383978|FG001|Overall Study|Lost to Follow-up|1|||
44378581|NCT00774397|79383979|FG002|Overall Study|Lost to Follow-up|1|||
44378582|NCT00774397|79383980|FG003|Overall Study|Lost to Follow-up|1|||
44378583|NCT00774397|79383981|FG004|Overall Study|Lost to Follow-up|0|||
44378584|NCT00774397|79383982|FG005|Overall Study|Lost to Follow-up|1|||
44378585|NCT00774397|79383983|FG006|Overall Study|Lost to Follow-up|0|||
44378586|NCT00774397|79383977|FG000|Overall Study|Refused to continue trial medication|1|||
44378587|NCT00774397|79383978|FG001|Overall Study|Refused to continue trial medication|3|||
44378588|NCT00774397|79383979|FG002|Overall Study|Refused to continue trial medication|2|||
44378589|NCT00774397|79383980|FG003|Overall Study|Refused to continue trial medication|2|||
44378590|NCT00774397|79383981|FG004|Overall Study|Refused to continue trial medication|6|||
44378591|NCT00774397|79383982|FG005|Overall Study|Refused to continue trial medication|2|||
44378592|NCT00774397|79383983|FG006|Overall Study|Refused to continue trial medication|3|||
44378593|NCT00774397|79383977|FG000|Overall Study|Not treated|0|||
44378594|NCT00774397|79383978|FG001|Overall Study|Not treated|0|||
44378595|NCT00774397|79383979|FG002|Overall Study|Not treated|0|||
44378596|NCT00774397|79383980|FG003|Overall Study|Not treated|0|||
44378597|NCT00774397|79383981|FG004|Overall Study|Not treated|1|||
44378598|NCT00774397|79383982|FG005|Overall Study|Not treated|0|||
44378599|NCT00774397|79383983|FG006|Overall Study|Not treated|1|||
44378600|NCT00774397|79383977|FG000|Overall Study|Other than those stated above|1|||
44378601|NCT00774397|79383978|FG001|Overall Study|Other than those stated above|1|||
44378602|NCT00774397|79383979|FG002|Overall Study|Other than those stated above|3|||
44378603|NCT00774397|79383980|FG003|Overall Study|Other than those stated above|2|||
44378604|NCT00774397|79383981|FG004|Overall Study|Other than those stated above|2|||
44378605|NCT00774397|79383982|FG005|Overall Study|Other than those stated above|0|||
44378606|NCT00774397|79383983|FG006|Overall Study|Other than those stated above|1|||
44378607|NCT00909870|79384038|FG000|Overall Study|Adverse Event|13|||
44378608|NCT00909870|79384039|FG001|Overall Study|Adverse Event|7|||
44378609|NCT00909870|79384038|FG000|Overall Study|Protocol Violation|1|||
44378610|NCT00909870|79384039|FG001|Overall Study|Protocol Violation|2|||
44378611|NCT00909870|79384038|FG000|Overall Study|Withdrawal by Subject|5|||
44378612|NCT00909870|79384039|FG001|Overall Study|Withdrawal by Subject|8|||
44378613|NCT00909870|79384038|FG000|Overall Study|Lost to Follow-up|3|||
44378614|NCT00909870|79384039|FG001|Overall Study|Lost to Follow-up|3|||
44378615|NCT00909870|79384038|FG000|Overall Study|Physician Decision|0|||
44378616|NCT00909870|79384039|FG001|Overall Study|Physician Decision|2|||
44378617|NCT00909870|79384038|FG000|Overall Study|Other|1|||
44378618|NCT00909870|79384039|FG001|Overall Study|Other|5|||
44378619|NCT00768469|79384048|FG000|Overall Study|Adverse Event|0|||
44378620|NCT00768469|79384049|FG001|Overall Study|Adverse Event|2|||
44378621|NCT00768469|79384048|FG000|Overall Study|Disease Progression|3|||
44378622|NCT00768469|79384049|FG001|Overall Study|Disease Progression|4|||
44378623|NCT00768469|79384048|FG000|Overall Study|Withdrawal by Subject|0|||
44378624|NCT00768469|79384049|FG001|Overall Study|Withdrawal by Subject|1|||
44378625|NCT00886821|79384070|FG000|Stage 2|Adverse Event|0|||
44378626|NCT00886821|79384071|FG001|Stage 2|Adverse Event|0|||
44378627|NCT00886821|79384072|FG002|Stage 2|Adverse Event|0|||
44378628|NCT00886821|79384073|FG003|Stage 2|Adverse Event|0|||
44378629|NCT00886821|79384074|FG004|Stage 2|Adverse Event|0|||
44378630|NCT00886821|79384075|FG005|Stage 2|Adverse Event|0|||
44378631|NCT00886821|79384076|FG006|Stage 2|Adverse Event|0|||
44378632|NCT00886821|79384077|FG007|Stage 2|Adverse Event|0|||
44378633|NCT00886821|79384078|FG008|Stage 2|Adverse Event|0|||
44378634|NCT00886821|79384079|FG009|Stage 2|Adverse Event|0|||
44378635|NCT00886821|79384080|FG010|Stage 2|Adverse Event|0|||
44378636|NCT00886821|79384081|FG011|Stage 2|Adverse Event|1|||
44378637|NCT00886821|79384082|FG012|Stage 2|Adverse Event|3|||
44378638|NCT00886821|79384083|FG013|Stage 2|Adverse Event|0|||
44378639|NCT00886821|79384070|FG000|Stage 2|Lost to Follow-up|0|||
44378640|NCT00886821|79384071|FG001|Stage 2|Lost to Follow-up|0|||
44378641|NCT00886821|79384072|FG002|Stage 2|Lost to Follow-up|0|||
44378642|NCT00886821|79384073|FG003|Stage 2|Lost to Follow-up|0|||
44378643|NCT00886821|79384074|FG004|Stage 2|Lost to Follow-up|0|||
44378644|NCT00886821|79384075|FG005|Stage 2|Lost to Follow-up|0|||
44378645|NCT00886821|79384076|FG006|Stage 2|Lost to Follow-up|0|||
44378646|NCT00886821|79384077|FG007|Stage 2|Lost to Follow-up|0|||
44378647|NCT00886821|79384078|FG008|Stage 2|Lost to Follow-up|0|||
44378648|NCT00886821|79384079|FG009|Stage 2|Lost to Follow-up|0|||
44378649|NCT00886821|79384080|FG010|Stage 2|Lost to Follow-up|0|||
44378650|NCT00886821|79384081|FG011|Stage 2|Lost to Follow-up|0|||
44378651|NCT00886821|79384082|FG012|Stage 2|Lost to Follow-up|2|||
44378652|NCT00886821|79384083|FG013|Stage 2|Lost to Follow-up|1|||
44378653|NCT00886743|79384127|FG000|Overall Study|Adverse Event|3|||
44378654|NCT00886743|79384127|FG000|Overall Study|Other|1|||
44378655|NCT00886587|79384133|FG000|Overall Study|Adverse Event|2|||
44378656|NCT00886587|79384134|FG001|Overall Study|Adverse Event|1|||
44378657|NCT00886587|79384133|FG000|Overall Study|Protocol Violation|2|||
44378658|NCT00886587|79384134|FG001|Overall Study|Protocol Violation|0|||
44378659|NCT00886587|79384133|FG000|Overall Study|Withdrawal by Subject|0|||
44378660|NCT00886587|79384134|FG001|Overall Study|Withdrawal by Subject|1|||
44378661|NCT00886119|79384140|FG000|Period 1|Did not meet inclusion criteria|1|||
44378662|NCT00886119|79384141|FG001|Period 1|Did not meet inclusion criteria|0|||
44378663|NCT00768079|79384150|FG000|Overall Study|Lost to Follow-up|2|||
44508039|NCT00306293|79513196|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
44508040|NCT00306293|79513195|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
44508041|NCT00306293|79513196|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
44508042|NCT00294671|79513206|FG000|Overall Study|Lack of Efficacy|11|||
44508043|NCT00294671|79513207|FG001|Overall Study|Lack of Efficacy|23|||
44378664|NCT00768079|79384151|FG001|Overall Study|Lost to Follow-up|0|||
44378665|NCT00768079|79384152|FG002|Overall Study|Lost to Follow-up|4|||
44378666|NCT00768079|79384150|FG000|Overall Study|Participant incarcerated|0|||
44378667|NCT00768079|79384151|FG001|Overall Study|Participant incarcerated|1|||
44378668|NCT00768079|79384152|FG002|Overall Study|Participant incarcerated|0|||
44378669|NCT00767455|79384162|FG000|Overall Study|Investigator error|19|||
44378670|NCT00766831|79384168|FG000|Overall Study|Withdrawal by Subject|4|||
44378671|NCT00766831|79384168|FG000|Overall Study|Lost to Follow-up|3|||
44378672|NCT00766831|79384168|FG000|Overall Study|Adverse Event|20|||
44378673|NCT00766831|79384168|FG000|Overall Study|Protocol Violation|15|||
44378674|NCT00766831|79384168|FG000|Overall Study|Physician Decision|5|||
44378675|NCT00766831|79384168|FG000|Overall Study|Withdrawal of consent|26|||
44378676|NCT00766831|79384168|FG000|Overall Study|Non cooperation by participants|14|||
44378677|NCT00766831|79384168|FG000|Overall Study|Other|28|||
44378678|NCT00766675|79384172|FG000|Overall Study|Adverse Event|16|||
44378679|NCT00766675|79384172|FG000|Overall Study|Lost to Follow-up|2|||
44508044|NCT00294671|79513206|FG000|Overall Study|Liver transplant|7|||
44378680|NCT00766675|79384172|FG000|Overall Study|Withdrawal by Subject|11|||
44378681|NCT00766675|79384172|FG000|Overall Study|Protocol Violation|8|||
44378682|NCT00766675|79384172|FG000|Overall Study|Participant took prohibited medication|1|||
44378683|NCT00766675|79384172|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
44378684|NCT00766675|79384172|FG000|Overall Study|Insufficient therapy|1|||
44378685|NCT00766597|79384176|FG000|Overall Study|Unexpected closure of study|4|||
44378686|NCT00766597|79384176|FG000|Overall Study|Without CCR5-tropic virus|5|||
44378687|NCT00910962|79384185|FG000|Overall Study|Adverse Event|5|||
44378688|NCT00910962|79384186|FG001|Overall Study|Adverse Event|20|||
44378689|NCT00910962|79384187|FG002|Overall Study|Adverse Event|17|||
44378690|NCT00910962|79384185|FG000|Overall Study|Protocol Violation|1|||
44378691|NCT00910962|79384186|FG001|Overall Study|Protocol Violation|3|||
44378692|NCT00910962|79384187|FG002|Overall Study|Protocol Violation|3|||
44378693|NCT00910962|79384185|FG000|Overall Study|Lost to Follow-up|0|||
44378694|NCT00910962|79384186|FG001|Overall Study|Lost to Follow-up|3|||
44378695|NCT00910962|79384187|FG002|Overall Study|Lost to Follow-up|1|||
44378696|NCT00910962|79384185|FG000|Overall Study|Physician Decision|0|||
44378697|NCT00910962|79384186|FG001|Overall Study|Physician Decision|6|||
44378698|NCT00910962|79384187|FG002|Overall Study|Physician Decision|6|||
44378699|NCT00910962|79384185|FG000|Overall Study|Withdrawal by Subject|25|||
44378700|NCT00910962|79384186|FG001|Overall Study|Withdrawal by Subject|32|||
44378701|NCT00910962|79384187|FG002|Overall Study|Withdrawal by Subject|32|||
44378702|NCT00910962|79384185|FG000|Overall Study|Reached defined stopping criteria|12|||
44378703|NCT00910962|79384186|FG001|Overall Study|Reached defined stopping criteria|14|||
44378704|NCT00910962|79384187|FG002|Overall Study|Reached defined stopping criteria|17|||
44378705|NCT00773461|79384199|FG000|Overall Study|Adverse Event|1|||
44378706|NCT00773461|79384200|FG001|Overall Study|Adverse Event|3|||
44378707|NCT00773461|79384199|FG000|Overall Study|Withdrawal by Subject|4|||
44378708|NCT00773461|79384200|FG001|Overall Study|Withdrawal by Subject|1|||
44378709|NCT00773383|79384207|FG000|Overall Study|Adverse Event|4|||
44378710|NCT00773383|79384207|FG000|Overall Study|Death|1|||
44378711|NCT00773383|79384207|FG000|Overall Study|Progression of Disease|23|||
44378712|NCT00773383|79384207|FG000|Overall Study|Other|2|||
44378713|NCT00773383|79384207|FG000|Overall Study|No study dose received|1|||
44378714|NCT00757003|79384215|FG000|Overall Study|Death|33|||
44378715|NCT00757003|79384215|FG000|Overall Study|Lost to Follow-up|9|||
44378716|NCT00757003|79384215|FG000|Overall Study|Withdrawal by Subject|4|||
44378717|NCT00757003|79384215|FG000|Overall Study|Surgically explanted|2|||
44378718|NCT00757003|79384215|FG000|Overall Study|Not implanted|1|||
44378719|NCT00766363|79384224|FG000|Overall Study|Withdrawal by Subject|1|||
44378720|NCT00766363|79384225|FG001|Overall Study|Withdrawal by Subject|0|||
44378721|NCT00766363|79384226|FG002|Overall Study|Withdrawal by Subject|0|||
44378722|NCT00766363|79384227|FG003|Overall Study|Withdrawal by Subject|0|||
44378723|NCT00766363|79384224|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
44378724|NCT00766363|79384225|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
44378725|NCT00766363|79384226|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
44508045|NCT00294671|79513207|FG001|Overall Study|Liver transplant|9|||
44508046|NCT00294671|79513206|FG000|Overall Study|Drug related adverse event (AE)|4|||
44508047|NCT00294671|79513207|FG001|Overall Study|Drug related adverse event (AE)|2|||
44508048|NCT00294671|79513206|FG000|Overall Study|Non-drug related AE|3|||
44508049|NCT00294671|79513207|FG001|Overall Study|Non-drug related AE|2|||
44508050|NCT00294671|79513206|FG000|Overall Study|Lost to Follow-up|1|||
44508051|NCT00294671|79513207|FG001|Overall Study|Lost to Follow-up|3|||
44508052|NCT00294671|79513206|FG000|Overall Study|Non-compliance|1|||
44239347|NCT01536145|79066161|FG009|Overall Study|Death|0|||
44239348|NCT01536145|79066162|FG010|Overall Study|Death|0|||
44239349|NCT01536145|79066152|FG000|Overall Study|Adverse Event|0|||
44239350|NCT01536145|79066153|FG001|Overall Study|Adverse Event|0|||
44239351|NCT01536145|79066154|FG002|Overall Study|Adverse Event|0|||
44239352|NCT01536145|79066155|FG003|Overall Study|Adverse Event|0|||
44239353|NCT01536145|79066156|FG004|Overall Study|Adverse Event|0|||
44508053|NCT00294671|79513207|FG001|Overall Study|Non-compliance|0|||
44239354|NCT01536145|79066157|FG005|Overall Study|Adverse Event|0|||
44239355|NCT01536145|79066158|FG006|Overall Study|Adverse Event|0|||
44239356|NCT01536145|79066159|FG007|Overall Study|Adverse Event|2|||
44239357|NCT01536145|79066160|FG008|Overall Study|Adverse Event|0|||
44378726|NCT00766363|79384227|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
44378727|NCT02636946|79384240|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
44378728|NCT02636946|79384241|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
44378729|NCT02636946|79384240|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
44378730|NCT02636946|79384241|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
44378731|NCT02636946|79384240|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
44378732|NCT02636946|79384241|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
44508054|NCT00294671|79513206|FG000|Overall Study|Death|0|||
44508055|NCT00294671|79513207|FG001|Overall Study|Death|1|||
44239358|NCT01536145|79066161|FG009|Overall Study|Adverse Event|0|||
44239359|NCT01536145|79066162|FG010|Overall Study|Adverse Event|3|||
44239360|NCT01536067|79066193|FG000|Overall Study|Disease Progression|1|||
44239361|NCT01582009|79066197|FG000|Overall Study|Withdrawal by Subject|1|||
44239362|NCT01582009|79066197|FG000|Overall Study|Physician Decision|1|||
44378733|NCT02636946|79384240|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
44508056|NCT01495598|79513213|FG000|Overall Study|Death during follow up period|2|||
44378734|NCT02636946|79384241|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
44378735|NCT02636946|79384240|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
44378736|NCT02636946|79384241|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
44378737|NCT02636946|79384240|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
44378738|NCT02636946|79384241|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
44378739|NCT00766051|79384249|FG000|Overall Study|Withdrawal by Subject|2|||
44378740|NCT00766051|79384250|FG001|Overall Study|Withdrawal by Subject|0|||
44378741|NCT00909792|79384258|FG000|Period 1|Did not meet inclusion criteria|0|||
44378742|NCT00909792|79384259|FG001|Period 1|Did not meet inclusion criteria|1|||
44378743|NCT00909792|79384258|FG000|Period 2|Biomicroscopy|1|||
44508057|NCT01495598|79513213|FG000|Overall Study|Death on study|1|||
44508058|NCT01495598|79513213|FG000|Overall Study|Lost to Follow-up|3|||
44508059|NCT01495598|79513213|FG000|Overall Study|Physician Decision|8|||
44508060|NCT02937454|79513244|FG000|Overall Study|Adverse Event|0|||
44508061|NCT02937454|79513245|FG001|Overall Study|Adverse Event|1|||
44578307|NCT02064387|79601589|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578308|NCT02064387|79601590|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578309|NCT02064387|79601591|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578310|NCT02064387|79601592|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578311|NCT02064387|79601593|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578312|NCT02064387|79601594|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
44578313|NCT02064387|79601595|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578314|NCT02064387|79601596|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578315|NCT02064387|79601597|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44578316|NCT02064387|79601598|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
44119150|NCT03029819|78902878|FG001|Overall Study|Lost to Follow-up|5|||
44119151|NCT03029819|78902877|FG000|Overall Study|Removed due to disruptive behavior|0|||
44119152|NCT03029819|78902878|FG001|Overall Study|Removed due to disruptive behavior|1|||
44119153|NCT02678390|78902889|FG000|AE (1 Day)|Withdrawal by Subject|0|||
44119154|NCT02678390|78902890|FG001|AE (1 Day)|Withdrawal by Subject|1|||
44239363|NCT01553591|79066204|FG000|Overall Study|Voluntarily withdrew|94|||
44239364|NCT01553591|79066205|FG001|Overall Study|Voluntarily withdrew|79|||
44508062|NCT02937454|79513244|FG000|Overall Study|Death|98|||
44378744|NCT00909792|79384259|FG001|Period 2|Biomicroscopy|0|||
44378745|NCT00909792|79384258|FG000|Period 2|Lost to Follow-up|0|||
44508063|NCT02937454|79513245|FG001|Overall Study|Death|95|||
44508064|NCT02937454|79513244|FG000|Overall Study|Lost to Follow-up|1|||
44508065|NCT02937454|79513245|FG001|Overall Study|Lost to Follow-up|1|||
44508066|NCT02937454|79513244|FG000|Overall Study|Physician Decision|0|||
44508067|NCT02937454|79513245|FG001|Overall Study|Physician Decision|1|||
44508068|NCT02937454|79513244|FG000|Overall Study|Protocol Violation|6|||
44508069|NCT02937454|79513245|FG001|Overall Study|Protocol Violation|10|||
44508070|NCT02937454|79513244|FG000|Overall Study|Withdrawal by Subject|27|||
44578317|NCT02064387|79601587|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578318|NCT02064387|79601588|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578319|NCT02064387|79601589|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578320|NCT02064387|79601590|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578321|NCT02064387|79601591|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578322|NCT02064387|79601592|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578323|NCT02064387|79601593|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578324|NCT02064387|79601594|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578325|NCT02064387|79601595|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
44578326|NCT02064387|79601596|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578327|NCT02064387|79601597|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578328|NCT02064387|79601598|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
44578329|NCT02064387|79601587|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
44578330|NCT02064387|79601588|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
44578331|NCT02064387|79601589|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
44578332|NCT02064387|79601590|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
44578333|NCT02064387|79601591|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
44578334|NCT02064387|79601592|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
44578335|NCT02064387|79601593|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
44578336|NCT02064387|79601594|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
44508071|NCT02937454|79513245|FG001|Overall Study|Withdrawal by Subject|15|||
44239365|NCT01553591|79066206|FG002|Overall Study|Voluntarily withdrew|96|||
44578337|NCT02064387|79601595|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
44578338|NCT02064387|79601596|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
44578339|NCT02064387|79601597|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
44578340|NCT02064387|79601598|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
44578341|NCT02064387|79601587|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578342|NCT02064387|79601588|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578343|NCT02064387|79601589|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578344|NCT02064387|79601590|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578345|NCT02064387|79601591|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578346|NCT02064387|79601592|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578347|NCT02064387|79601593|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578348|NCT02064387|79601594|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578349|NCT02064387|79601595|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578350|NCT02064387|79601596|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578351|NCT02064387|79601597|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
44578352|NCT02064387|79601598|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
44578353|NCT01328366|79601637|FG000|Overall Study|Death|1|||
44578354|NCT01328366|79601637|FG000|Overall Study|Withdrawal by Subject|2|||
44578355|NCT01328366|79601637|FG000|Overall Study|Lost to Follow-up|7|||
44578356|NCT01370499|79601643|FG000|Overall Study|Adverse Event|38|||
44578357|NCT01370499|79601644|FG001|Overall Study|Adverse Event|12|||
44578358|NCT01370499|79601643|FG000|Overall Study|Lack of Efficacy|4|||
44578359|NCT01370499|79601644|FG001|Overall Study|Lack of Efficacy|2|||
44578360|NCT01370499|79601643|FG000|Overall Study|Lost to Follow-up|2|||
44578361|NCT01370499|79601644|FG001|Overall Study|Lost to Follow-up|1|||
44119155|NCT03027557|78902899|FG000|Overall Study|Adverse Event|1|||
44119156|NCT03027557|78902900|FG001|Overall Study|Adverse Event|0|||
44119157|NCT03027557|78902901|FG002|Overall Study|Adverse Event|0|||
44119158|NCT03029585|78902911|FG000|Overall Study|Death|1|||
44119159|NCT03029585|78902912|FG001|Overall Study|Death|1|||
44119160|NCT03029585|78902911|FG000|Overall Study|Withdrawal by Subject|1|||
44119161|NCT03029585|78902912|FG001|Overall Study|Withdrawal by Subject|0|||
44119162|NCT02678000|78902923|FG000|PART 2|Adverse Event|0|||
44119163|NCT02678000|78902924|FG001|PART 2|Adverse Event|0|||
44119164|NCT02678000|78902925|FG002|PART 2|Adverse Event|2|||
44119165|NCT02678000|78902926|FG003|PART 2|Adverse Event|1|||
44119166|NCT02678000|78902927|FG004|PART 2|Adverse Event|0|||
44119167|NCT02678000|78902923|FG000|PART 2|Withdrawal by Subject|0|||
44119168|NCT02678000|78902924|FG001|PART 2|Withdrawal by Subject|0|||
44239366|NCT01553591|79066204|FG000|Overall Study|Adverse Event|36|||
44239367|NCT01553591|79066205|FG001|Overall Study|Adverse Event|45|||
44239368|NCT01553591|79066206|FG002|Overall Study|Adverse Event|16|||
44239369|NCT01553591|79066204|FG000|Overall Study|Lost to Follow-up|25|||
44239370|NCT01553591|79066205|FG001|Overall Study|Lost to Follow-up|23|||
44508072|NCT02937454|79513244|FG000|Overall Study|Other|8|||
44508073|NCT02937454|79513245|FG001|Overall Study|Other|5|||
44508074|NCT03211858|79513264|FG000|Overall Study|Adverse Event|8|||
44508075|NCT03211858|79513265|FG001|Overall Study|Adverse Event|6|||
44508076|NCT03211858|79513264|FG000|Overall Study|Lack of Efficacy|0|||
44508077|NCT03211858|79513265|FG001|Overall Study|Lack of Efficacy|4|||
44508078|NCT03211858|79513264|FG000|Overall Study|Poor compliance to protocol|6|||
44508079|NCT03211858|79513265|FG001|Overall Study|Poor compliance to protocol|2|||
44578362|NCT01370499|79601643|FG000|Overall Study|Physician Decision|3|||
44578363|NCT01370499|79601644|FG001|Overall Study|Physician Decision|3|||
44578364|NCT01370499|79601643|FG000|Overall Study|Protocol Violation|5|||
44578365|NCT01370499|79601644|FG001|Overall Study|Protocol Violation|4|||
44578366|NCT01370499|79601643|FG000|Overall Study|Withdrawal by Subject|18|||
44578367|NCT01370499|79601644|FG001|Overall Study|Withdrawal by Subject|7|||
44578368|NCT01370499|79601643|FG000|Overall Study|Sponsor Decision|41|||
44578369|NCT01370499|79601644|FG001|Overall Study|Sponsor Decision|15|||
44578370|NCT01370265|79601652|FG000|First Intervention|Adverse Event|1|||
44578371|NCT01370265|79601653|FG001|First Intervention|Adverse Event|1|||
44578372|NCT02792829|79601691|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44578373|NCT02792829|79601692|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
44119169|NCT02678000|78902925|FG002|PART 2|Withdrawal by Subject|1|||
44119170|NCT02678000|78902926|FG003|PART 2|Withdrawal by Subject|0|||
44239371|NCT01553591|79066206|FG002|Overall Study|Lost to Follow-up|16|||
44578374|NCT02792829|79601693|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44578375|NCT02792829|79601694|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44119171|NCT02678000|78902927|FG004|PART 2|Withdrawal by Subject|0|||
44508080|NCT03211858|79513264|FG000|Overall Study|Non-serious Hypoglycemia|1|||
44508081|NCT03211858|79513265|FG001|Overall Study|Non-serious Hypoglycemia|0|||
44119172|NCT02691572|78902954|FG000|Overall Study|Withdrawal by Subject|1|||
44119173|NCT02691572|78902955|FG001|Overall Study|Withdrawal by Subject|0|||
44239372|NCT01553591|79066204|FG000|Overall Study|Physician decision: other|11|||
44578376|NCT02792829|79601695|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44578377|NCT02792829|79601696|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44578378|NCT02792829|79601697|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44578379|NCT02792829|79601698|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
44578380|NCT02792829|79601691|FG000|Treatment Period 2|Adverse Event|0|||
44578381|NCT02792829|79601692|FG001|Treatment Period 2|Adverse Event|0|||
44578382|NCT02792829|79601693|FG002|Treatment Period 2|Adverse Event|0|||
44578383|NCT02792829|79601694|FG003|Treatment Period 2|Adverse Event|0|||
44578384|NCT02792829|79601695|FG004|Treatment Period 2|Adverse Event|1|||
44578385|NCT02792829|79601696|FG005|Treatment Period 2|Adverse Event|0|||
44578386|NCT02792829|79601697|FG006|Treatment Period 2|Adverse Event|1|||
44578387|NCT02792829|79601698|FG007|Treatment Period 2|Adverse Event|1|||
44578388|NCT02792829|79601691|FG000|Treatment Period 2|Use of proscribed medications|0|||
44578389|NCT02792829|79601692|FG001|Treatment Period 2|Use of proscribed medications|0|||
44578390|NCT02792829|79601693|FG002|Treatment Period 2|Use of proscribed medications|0|||
44578391|NCT02792829|79601694|FG003|Treatment Period 2|Use of proscribed medications|0|||
44578392|NCT02792829|79601695|FG004|Treatment Period 2|Use of proscribed medications|0|||
44578393|NCT02792829|79601696|FG005|Treatment Period 2|Use of proscribed medications|0|||
44578394|NCT02792829|79601697|FG006|Treatment Period 2|Use of proscribed medications|0|||
44578395|NCT02792829|79601698|FG007|Treatment Period 2|Use of proscribed medications|1|||
44578396|NCT02867592|79601730|FG000|Overall Study|Adverse Event|3|||
44578397|NCT02867592|79601731|FG001|Overall Study|Adverse Event|0|||
44119174|NCT02691572|78902954|FG000|Overall Study|Protocol Violation|0|||
44119175|NCT02691572|78902955|FG001|Overall Study|Protocol Violation|1|||
44119176|NCT02677844|78902963|FG000|Period 3|Withdrawal by Subject|0|||
44119177|NCT02677844|78902964|FG001|Period 3|Withdrawal by Subject|0|||
44119178|NCT02677844|78902965|FG002|Period 3|Withdrawal by Subject|0|||
44239373|NCT01553591|79066205|FG001|Overall Study|Physician decision: other|14|||
44508082|NCT03211858|79513264|FG000|Overall Study|Other than specified above|22|||
44508083|NCT03211858|79513265|FG001|Overall Study|Other than specified above|21|||
44508084|NCT03211156|79513277|FG000|Overall Study|Withdrawal by Subject|0|||
44508085|NCT03211156|79513278|FG001|Overall Study|Withdrawal by Subject|2|||
44508086|NCT03211156|79513277|FG000|Overall Study|Lost to Follow-up|1|||
44508087|NCT03211156|79513278|FG001|Overall Study|Lost to Follow-up|1|||
44508088|NCT03211156|79513277|FG000|Overall Study|Adverse Event|1|||
44508089|NCT03211156|79513278|FG001|Overall Study|Adverse Event|0|||
44508090|NCT04472494|79513286|FG000|Pre-treatment|Other reasons|2|||
44508091|NCT04472494|79513287|FG001|Pre-treatment|Other reasons|0|||
44508092|NCT04472494|79513286|FG000|Treatment|Death|5|||
44508093|NCT04472494|79513287|FG001|Treatment|Death|2|||
44508094|NCT04472494|79513286|FG000|Treatment|Hospital discharge|1|||
44508095|NCT04472494|79513287|FG001|Treatment|Hospital discharge|1|||
44508096|NCT04419506|79513297|FG000|Overall Study|Adverse Event|0|||
44508097|NCT04419506|79513298|FG001|Overall Study|Adverse Event|10|||
44508098|NCT04419506|79513299|FG002|Overall Study|Adverse Event|0|||
44508099|NCT04419506|79513300|FG003|Overall Study|Adverse Event|3|||
44508100|NCT04419506|79513297|FG000|Overall Study|Withdrawal by Subject|0|||
44508101|NCT04419506|79513298|FG001|Overall Study|Withdrawal by Subject|0|||
44508102|NCT04419506|79513299|FG002|Overall Study|Withdrawal by Subject|0|||
44508103|NCT04419506|79513300|FG003|Overall Study|Withdrawal by Subject|1|||
44508104|NCT04419506|79513297|FG000|Overall Study|poor-compliance|0|||
44508105|NCT04419506|79513298|FG001|Overall Study|poor-compliance|0|||
44508106|NCT04419506|79513299|FG002|Overall Study|poor-compliance|0|||
44508107|NCT04419506|79513300|FG003|Overall Study|poor-compliance|1|||
44508108|NCT03236506|79513313|FG000|Overall Study|Death|1|||
44508109|NCT03236506|79513314|FG001|Overall Study|Death|1|||
44508110|NCT03236506|79513315|FG002|Overall Study|Death|1|||
44508111|NCT03236506|79513313|FG000|Overall Study|Withdrawal by Subject|3|||
44508112|NCT03236506|79513314|FG001|Overall Study|Withdrawal by Subject|3|||
44508113|NCT03236506|79513315|FG002|Overall Study|Withdrawal by Subject|4|||
44508114|NCT03236506|79513313|FG000|Overall Study|Did not initiate treatment|2|||
44508115|NCT03236506|79513314|FG001|Overall Study|Did not initiate treatment|1|||
44508116|NCT03236506|79513315|FG002|Overall Study|Did not initiate treatment|2|||
44508117|NCT03227692|79513334|FG000|Overall Study|Protocol Violation|1|||
44508118|NCT03227692|79513335|FG001|Overall Study|Protocol Violation|1|||
44578398|NCT02867592|79601732|FG002|Overall Study|Adverse Event|2|||
44578399|NCT02867592|79601733|FG003|Overall Study|Adverse Event|1|||
44239374|NCT01553591|79066206|FG002|Overall Study|Physician decision: other|16|||
44239375|NCT01553591|79066204|FG000|Overall Study|Physician decision: lack of efficacy|2|||
44578400|NCT02867592|79601734|FG004|Overall Study|Adverse Event|1|||
44578401|NCT02867592|79601735|FG005|Overall Study|Adverse Event|5|||
44578402|NCT02867592|79601730|FG000|Overall Study|Death|0|||
44578403|NCT02867592|79601731|FG001|Overall Study|Death|0|||
44119179|NCT02677844|78902966|FG003|Period 3|Withdrawal by Subject|1|||
44378746|NCT00909792|79384259|FG001|Period 2|Lost to Follow-up|1|||
44508119|NCT03227692|79513334|FG000|Overall Study|Lost to Follow-up|4|||
44508120|NCT03227692|79513335|FG001|Overall Study|Lost to Follow-up|2|||
44508121|NCT03227692|79513334|FG000|Overall Study|Adverse Event|0|||
44119180|NCT02677844|78902967|FG004|Period 3|Withdrawal by Subject|0|||
44119181|NCT02677844|78902968|FG005|Period 3|Withdrawal by Subject|0|||
44119182|NCT02677844|78902969|FG006|Period 3|Withdrawal by Subject|0|||
44119183|NCT02691494|78902991|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
44119184|NCT02691494|78902992|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
44119185|NCT02691494|78902993|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
44119186|NCT02691494|78902991|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
44119187|NCT02691494|78902992|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
44119188|NCT02691494|78902993|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
44119189|NCT02691494|78902991|FG000|Post-Treatment Follow-Up Period|Other|2|||
44119190|NCT02691494|78902992|FG001|Post-Treatment Follow-Up Period|Other|1|||
44578404|NCT02867592|79601732|FG002|Overall Study|Death|0|||
44578405|NCT02867592|79601733|FG003|Overall Study|Death|1|||
44578406|NCT02867592|79601734|FG004|Overall Study|Death|0|||
44578407|NCT02867592|79601735|FG005|Overall Study|Death|1|||
44578408|NCT02867592|79601730|FG000|Overall Study|Lack of Efficacy|8|||
44578409|NCT02867592|79601731|FG001|Overall Study|Lack of Efficacy|10|||
44578410|NCT02867592|79601732|FG002|Overall Study|Lack of Efficacy|8|||
44578411|NCT02867592|79601733|FG003|Overall Study|Lack of Efficacy|8|||
44578412|NCT02867592|79601734|FG004|Overall Study|Lack of Efficacy|12|||
44578413|NCT02867592|79601735|FG005|Overall Study|Lack of Efficacy|17|||
44578414|NCT02867592|79601730|FG000|Overall Study|Physician Decision|1|||
44578415|NCT02867592|79601731|FG001|Overall Study|Physician Decision|2|||
44578416|NCT02867592|79601732|FG002|Overall Study|Physician Decision|2|||
44578417|NCT02867592|79601733|FG003|Overall Study|Physician Decision|0|||
44578418|NCT02867592|79601734|FG004|Overall Study|Physician Decision|5|||
44578419|NCT02867592|79601735|FG005|Overall Study|Physician Decision|1|||
44578420|NCT02867592|79601730|FG000|Overall Study|Protocol Violation|0|||
44578421|NCT02867592|79601731|FG001|Overall Study|Protocol Violation|0|||
44578422|NCT02867592|79601732|FG002|Overall Study|Protocol Violation|0|||
44578423|NCT02867592|79601733|FG003|Overall Study|Protocol Violation|0|||
44578424|NCT02867592|79601734|FG004|Overall Study|Protocol Violation|1|||
44578425|NCT02867592|79601735|FG005|Overall Study|Protocol Violation|1|||
44578426|NCT02867592|79601730|FG000|Overall Study|Withdrawal by Subject|0|||
44578427|NCT02867592|79601731|FG001|Overall Study|Withdrawal by Subject|1|||
44578428|NCT02867592|79601732|FG002|Overall Study|Withdrawal by Subject|0|||
44578429|NCT02867592|79601733|FG003|Overall Study|Withdrawal by Subject|1|||
44578430|NCT02867592|79601734|FG004|Overall Study|Withdrawal by Subject|3|||
44578431|NCT02867592|79601735|FG005|Overall Study|Withdrawal by Subject|3|||
44578432|NCT02867592|79601730|FG000|Overall Study|Ineligible|1|||
44578433|NCT02867592|79601731|FG001|Overall Study|Ineligible|1|||
44578434|NCT02867592|79601732|FG002|Overall Study|Ineligible|0|||
44578435|NCT02867592|79601733|FG003|Overall Study|Ineligible|0|||
44119191|NCT02691494|78902993|FG002|Post-Treatment Follow-Up Period|Other|1|||
44119192|NCT02691494|78902991|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
44119193|NCT02691494|78902992|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
44119194|NCT02691494|78902993|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
44239376|NCT01553591|79066205|FG001|Overall Study|Physician decision: lack of efficacy|3|||
44239377|NCT01553591|79066206|FG002|Overall Study|Physician decision: lack of efficacy|7|||
44239378|NCT01553591|79066204|FG000|Overall Study|Protocol Violation|3|||
44239379|NCT01553591|79066205|FG001|Overall Study|Protocol Violation|4|||
44578436|NCT02867592|79601734|FG004|Overall Study|Ineligible|2|||
44578437|NCT02867592|79601735|FG005|Overall Study|Ineligible|0|||
44578438|NCT02867592|79601730|FG000|Overall Study|No Treatment|1|||
44578439|NCT02867592|79601731|FG001|Overall Study|No Treatment|0|||
44578440|NCT02867592|79601732|FG002|Overall Study|No Treatment|0|||
44578441|NCT02867592|79601733|FG003|Overall Study|No Treatment|0|||
44578442|NCT02867592|79601734|FG004|Overall Study|No Treatment|0|||
44578443|NCT02867592|79601735|FG005|Overall Study|No Treatment|0|||
44578444|NCT02867592|79601730|FG000|Overall Study|Still on Therapy|0|||
44578445|NCT02867592|79601731|FG001|Overall Study|Still on Therapy|0|||
44119195|NCT02691494|78902991|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
44119196|NCT02691494|78902992|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
44508122|NCT03227692|79513335|FG001|Overall Study|Adverse Event|2|||
44508123|NCT03210220|79513343|FG000|Overall Study|Physician Decision|1|||
44508124|NCT03210220|79513344|FG001|Overall Study|Physician Decision|0|||
44508125|NCT03209518|79513350|FG000|Overall Study|Case Report Forms Uncollected|1|||
44508126|NCT03209518|79513350|FG000|Overall Study|Protocol Deviation|1|||
44508127|NCT03725852|79513356|FG000|Overall Study|Death|1|||
44508128|NCT03725852|79513357|FG001|Overall Study|Death|0|||
44508129|NCT03725852|79513356|FG000|Overall Study|Withdrawal by Subject|1|||
44508130|NCT03725852|79513357|FG001|Overall Study|Withdrawal by Subject|0|||
44578446|NCT02867592|79601732|FG002|Overall Study|Still on Therapy|0|||
44578447|NCT02867592|79601733|FG003|Overall Study|Still on Therapy|0|||
44578448|NCT02867592|79601734|FG004|Overall Study|Still on Therapy|1|||
44578449|NCT02867592|79601735|FG005|Overall Study|Still on Therapy|0|||
44578450|NCT02867592|79601730|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
44119197|NCT02691494|78902993|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
44119198|NCT02677220|78903001|FG000|Overall Study|Adverse Event|1|||
44119199|NCT02682602|78903008|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
44119200|NCT02682602|78903009|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
44119201|NCT02682602|78903008|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
44119202|NCT02682602|78903009|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
44119203|NCT02681510|78903019|FG000|Overall Study|Withdrawal by Subject|1|||
44119204|NCT02681510|78903019|FG000|Overall Study|Lost to Follow-up|9|||
44119205|NCT02690714|78903023|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
44119206|NCT02690714|78903023|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
44119207|NCT01791543|78903031|FG000|Overall Study|Lost to Follow-up|1|||
44119208|NCT01791543|78903031|FG000|Overall Study|Adverse Event|1|||
44119209|NCT02925455|78903038|FG000|Overall Study|Withdrawal by Subject|2|||
44119210|NCT02925455|78903039|FG001|Overall Study|Withdrawal by Subject|0|||
44119211|NCT03033069|78903049|FG000|Overall Study|Adverse Event|6|||
44119212|NCT03033069|78903050|FG001|Overall Study|Adverse Event|7|||
44578451|NCT02867592|79601731|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
44578452|NCT02867592|79601732|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
44578453|NCT02867592|79601733|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
44578454|NCT02867592|79601734|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
44578455|NCT02867592|79601735|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
44578456|NCT02867592|79601730|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
44578457|NCT02867592|79601731|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
44578458|NCT02867592|79601732|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
44578459|NCT02867592|79601733|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
44578460|NCT02867592|79601734|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
44578461|NCT02867592|79601735|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
44578462|NCT00676494|79601751|FG000|Overall Study|Missed Visit|8|||
44578463|NCT00676494|79601751|FG000|Overall Study|Withdrawal by Subject|6|||
44508131|NCT03725852|79513356|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
44119213|NCT03033069|78903051|FG002|Overall Study|Adverse Event|4|||
44119214|NCT03033069|78903052|FG003|Overall Study|Adverse Event|6|||
44119215|NCT03033069|78903049|FG000|Overall Study|Lack of Efficacy|0|||
44119216|NCT03033069|78903050|FG001|Overall Study|Lack of Efficacy|0|||
44119217|NCT03033069|78903051|FG002|Overall Study|Lack of Efficacy|1|||
44119218|NCT03033069|78903052|FG003|Overall Study|Lack of Efficacy|0|||
44119219|NCT03033069|78903049|FG000|Overall Study|Lost to Follow-up|6|||
44119220|NCT03033069|78903050|FG001|Overall Study|Lost to Follow-up|5|||
44119221|NCT03033069|78903051|FG002|Overall Study|Lost to Follow-up|5|||
44119222|NCT03033069|78903052|FG003|Overall Study|Lost to Follow-up|6|||
44119223|NCT03033069|78903049|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44119224|NCT03033069|78903050|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44578464|NCT02605642|79601756|FG000|Overall Study|Other|11|||
44578465|NCT02605642|79601757|FG001|Overall Study|Other|1|||
44578466|NCT02605642|79601756|FG000|Overall Study|Participant non-compliance|2|||
44119225|NCT03033069|78903051|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44119226|NCT03033069|78903052|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44119227|NCT03033069|78903049|FG000|Overall Study|Protocol Deviation|0|||
44276161|NCT02218008|79229547|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
44276162|NCT02218008|79229542|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
44508132|NCT03725852|79513357|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
44508133|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
44508134|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
44508135|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
44508136|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
44508137|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
44508138|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
44508139|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
44508140|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
44276163|NCT02218008|79229543|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
44276164|NCT02218008|79229544|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
44119228|NCT03033069|78903050|FG001|Overall Study|Protocol Deviation|1|||
44276165|NCT02218008|79229545|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
44378747|NCT00765817|79384267|FG000|Overall Study|Adverse Event|13|||
44119229|NCT03033069|78903051|FG002|Overall Study|Protocol Deviation|0|||
44276166|NCT02218008|79229546|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
44119230|NCT03033069|78903052|FG003|Overall Study|Protocol Deviation|0|||
44276167|NCT02218008|79229547|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
44276168|NCT02218008|79229542|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
44276169|NCT02218008|79229543|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
44276170|NCT02218008|79229544|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
44276171|NCT02218008|79229545|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
44276172|NCT02218008|79229546|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
44276173|NCT02218008|79229547|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
44276174|NCT02218008|79229542|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
44276175|NCT02218008|79229543|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
44276176|NCT02218008|79229544|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
44276177|NCT02218008|79229545|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
44276178|NCT02218008|79229546|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
44276179|NCT02218008|79229547|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
44276180|NCT02218008|79229542|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
44276181|NCT02218008|79229543|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
44276182|NCT02218008|79229544|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
44276183|NCT02218008|79229545|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
44276184|NCT02218008|79229546|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
44578467|NCT02605642|79601757|FG001|Overall Study|Participant non-compliance|4|||
44578468|NCT02605642|79601756|FG000|Overall Study|Physician Decision|10|||
44578469|NCT02605642|79601757|FG001|Overall Study|Physician Decision|0|||
44578470|NCT02605642|79601756|FG000|Overall Study|Lost to Follow-up|12|||
44578471|NCT02605642|79601757|FG001|Overall Study|Lost to Follow-up|1|||
44578472|NCT02605642|79601756|FG000|Overall Study|Adverse Event|14|||
44578473|NCT02605642|79601757|FG001|Overall Study|Adverse Event|2|||
44578474|NCT02605642|79601756|FG000|Overall Study|Withdrawal by Subject|23|||
44578475|NCT02605642|79601757|FG001|Overall Study|Withdrawal by Subject|2|||
44578476|NCT02605642|79601756|FG000|Overall Study|Lack of response|24|||
44578477|NCT02605642|79601757|FG001|Overall Study|Lack of response|11|||
44578478|NCT02253810|79601765|FG000|Overall Study|Withdrawal by Subject|2|||
44578479|NCT02253810|79601766|FG001|Overall Study|Withdrawal by Subject|1|||
44578480|NCT02253810|79601765|FG000|Overall Study|Unknown concomitant procedure|3|||
44578481|NCT02253810|79601766|FG001|Overall Study|Unknown concomitant procedure|2|||
44578482|NCT02732912|79601790|FG000|Overall Study|Discharged before night|2|||
44578483|NCT02732912|79601791|FG001|Overall Study|Discharged before night|6|||
44578484|NCT02732912|79601790|FG000|Overall Study|Incomplete completion of questionnaire|2|||
44578485|NCT02732912|79601791|FG001|Overall Study|Incomplete completion of questionnaire|3|||
44578486|NCT02732912|79601790|FG000|Overall Study|No outcome; discharged or refused|6|||
44578487|NCT02732912|79601791|FG001|Overall Study|No outcome; discharged or refused|9|||
44578488|NCT02792517|79601797|FG000|Overall Study|Withdrawal by Subject|10|||
44578489|NCT02792517|79601797|FG000|Overall Study|Decision by Sponsor|7|||
44119231|NCT03033069|78903049|FG000|Overall Study|Withdrawal by Subject|10|||
44119232|NCT03033069|78903050|FG001|Overall Study|Withdrawal by Subject|10|||
44508141|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
44508142|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
44508143|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
44508144|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
44508145|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
44508146|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
44508147|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
44508148|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
44508149|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
44508150|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
44508151|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
44508152|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
44508153|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
44508154|NCT00304031|79513366|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
44508155|NCT00304031|79513367|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
44508156|NCT00304031|79513368|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
44508157|NCT00304031|79513366|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
44508158|NCT00304031|79513367|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
44508159|NCT00304031|79513368|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
44508160|NCT00332189|79513383|FG000|Overall Study|Adverse Event|3|||
44508161|NCT00332189|79513383|FG000|Overall Study|Uncooperative/Noncompliant|3|||
44508162|NCT00332189|79513383|FG000|Overall Study|Withdrawal by Subject|9|||
44508163|NCT00332189|79513383|FG000|Overall Study|Lack of Efficacy|4|||
44508164|NCT00332189|79513383|FG000|Overall Study|Moved out of country|2|||
44578490|NCT02792517|79601797|FG000|Overall Study|Lost to Follow-up|3|||
44276185|NCT02218008|79229547|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
44276186|NCT02218008|79229542|FG000|Stage 1 (S1)|Pregnancy|0|||
44276187|NCT02218008|79229543|FG001|Stage 1 (S1)|Pregnancy|0|||
44276188|NCT02218008|79229544|FG002|Stage 1 (S1)|Pregnancy|1|||
44578491|NCT01369485|79601832|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
44578492|NCT01369485|79601833|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
44578493|NCT01369485|79601832|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
44578494|NCT01369485|79601833|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
44578495|NCT01369485|79601832|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
44578496|NCT01369485|79601833|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
44578497|NCT01369485|79601832|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
44239380|NCT01553591|79066206|FG002|Overall Study|Protocol Violation|4|||
44239381|NCT01553591|79066204|FG000|Overall Study|Sponsor decision|1|||
44578498|NCT01369485|79601833|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
44578499|NCT01369485|79601832|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
44578500|NCT01369485|79601833|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
44578501|NCT01369485|79601832|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
44578502|NCT01369485|79601833|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
44578503|NCT01369485|79601832|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
44578504|NCT01369485|79601833|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
44578505|NCT01369485|79601832|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
44578506|NCT01369485|79601833|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
44578507|NCT01369485|79601832|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
44578508|NCT01369485|79601833|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
44578509|NCT01369485|79601832|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
44578510|NCT01369485|79601833|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
44578511|NCT02886572|79601860|FG000|Overall Study|Death|8|||
44578512|NCT02741700|79601873|FG000|Overall Study|Lost to Follow-up|17|||
44578513|NCT02741700|79601874|FG001|Overall Study|Lost to Follow-up|8|||
44578514|NCT02741700|79601873|FG000|Overall Study|Withdrawal by Subject|2|||
44578515|NCT02741700|79601874|FG001|Overall Study|Withdrawal by Subject|5|||
44578516|NCT02741700|79601873|FG000|Overall Study|Physician Decision|3|||
44578517|NCT02741700|79601874|FG001|Overall Study|Physician Decision|0|||
44578518|NCT02741700|79601873|FG000|Overall Study|Moved out of State|0|||
44578519|NCT02741700|79601874|FG001|Overall Study|Moved out of State|1|||
44578520|NCT02741700|79601873|FG000|Overall Study|Death|4|||
44578521|NCT02741700|79601874|FG001|Overall Study|Death|5|||
44578522|NCT00430950|79601882|FG000|Overall Study|Adverse Event|7|||
44578523|NCT00430950|79601883|FG001|Overall Study|Adverse Event|6|||
44578524|NCT00430950|79601882|FG000|Overall Study|Withdrawal by Subject|1|||
44578525|NCT00430950|79601883|FG001|Overall Study|Withdrawal by Subject|0|||
44578526|NCT00430950|79601882|FG000|Overall Study|concomitant medication,etc.|5|||
44578527|NCT00430950|79601883|FG001|Overall Study|concomitant medication,etc.|7|||
44578528|NCT02081391|79601891|FG000|12-hour Treatment|Withdrawal by Subject|3|||
44578529|NCT02081391|79601892|FG001|12-hour Treatment|Withdrawal by Subject|2|||
44578530|NCT02081391|79601893|FG002|12-hour Treatment|Withdrawal by Subject|0|||
44578531|NCT02081391|79601894|FG003|12-hour Treatment|Withdrawal by Subject|0|||
44578532|NCT02081391|79601891|FG000|12-hour Treatment|Physician Decision|4|||
44578533|NCT02081391|79601892|FG001|12-hour Treatment|Physician Decision|1|||
44578534|NCT02081391|79601893|FG002|12-hour Treatment|Physician Decision|0|||
44578535|NCT02081391|79601894|FG003|12-hour Treatment|Physician Decision|0|||
44578536|NCT02081391|79601891|FG000|12-hour Treatment|Lack of Efficacy|3|||
44578537|NCT02081391|79601892|FG001|12-hour Treatment|Lack of Efficacy|0|||
44578538|NCT02081391|79601893|FG002|12-hour Treatment|Lack of Efficacy|0|||
44578539|NCT02081391|79601894|FG003|12-hour Treatment|Lack of Efficacy|0|||
44578540|NCT02081391|79601891|FG000|12-hour Treatment|Adverse Event|4|||
44578541|NCT02081391|79601892|FG001|12-hour Treatment|Adverse Event|2|||
44578542|NCT02081391|79601893|FG002|12-hour Treatment|Adverse Event|0|||
44578543|NCT02081391|79601894|FG003|12-hour Treatment|Adverse Event|0|||
44578544|NCT02081391|79601891|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
44239382|NCT01553591|79066205|FG001|Overall Study|Sponsor decision|0|||
44239383|NCT01553591|79066206|FG002|Overall Study|Sponsor decision|3|||
44239384|NCT01553591|79066204|FG000|Overall Study|Randomized and never dispensed drug|0|||
44239385|NCT01553591|79066205|FG001|Overall Study|Randomized and never dispensed drug|1|||
44239386|NCT01553591|79066206|FG002|Overall Study|Randomized and never dispensed drug|0|||
44239387|NCT01581931|79066214|FG000|Washout|Adverse Event|0|||
44239388|NCT01581931|79066215|FG001|Washout|Adverse Event|1|||
44508165|NCT00331799|79513388|FG000|Overall Study|Withdrawal by Subject|2|||
44239389|NCT01581619|79066221|FG000|Overall Study|Withdrawal by Subject|1|||
44239390|NCT01581619|79066221|FG000|Overall Study|Lost to Follow-up|1|||
44508166|NCT00331799|79513388|FG000|Overall Study|Sedation|1|||
44508167|NCT00303719|79513394|FG000|Overall Study|Not evaluable, prior therapies|0|||
44508168|NCT00303719|79513395|FG001|Overall Study|Not evaluable, prior therapies|30|||
44508169|NCT00303719|79513394|FG000|Overall Study|Lost to Follow-up|0|||
44508170|NCT00303719|79513395|FG001|Overall Study|Lost to Follow-up|7|||
44508171|NCT00331409|79513402|FG000|Overall Study|Lack of Efficacy|4|||
44508172|NCT00303485|79513408|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
44578545|NCT02081391|79601892|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
44578546|NCT02081391|79601893|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
44578547|NCT02081391|79601894|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
44578548|NCT02081391|79601891|FG000|12-hour Treatment|Further reasons|2|||
44578549|NCT02081391|79601892|FG001|12-hour Treatment|Further reasons|1|||
44578550|NCT02081391|79601893|FG002|12-hour Treatment|Further reasons|0|||
44578551|NCT02081391|79601894|FG003|12-hour Treatment|Further reasons|0|||
44578552|NCT02081391|79601891|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
44578553|NCT02081391|79601892|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
44578554|NCT02081391|79601893|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
44578555|NCT02081391|79601894|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
44578556|NCT02081391|79601891|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
44578557|NCT02081391|79601892|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
44578558|NCT02081391|79601893|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
44578559|NCT02081391|79601894|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
44578560|NCT02081391|79601891|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
44578561|NCT02081391|79601892|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
44578562|NCT02081391|79601893|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
44578563|NCT02081391|79601894|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
44578564|NCT02081391|79601891|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
44578565|NCT02081391|79601892|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
44578566|NCT02081391|79601893|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
44578567|NCT02081391|79601894|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
44578568|NCT02081391|79601891|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
44578569|NCT02081391|79601892|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
44578570|NCT02081391|79601893|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
44578571|NCT02081391|79601894|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
44578572|NCT02081391|79601891|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
44578573|NCT02081391|79601892|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
44578574|NCT02081391|79601893|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
44578575|NCT02081391|79601894|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
44578576|NCT00430092|79601917|FG000|Overall Study|Adverse Event|0|||
44578577|NCT00430092|79601918|FG001|Overall Study|Adverse Event|0|||
44578578|NCT00430092|79601919|FG002|Overall Study|Adverse Event|1|||
44578579|NCT00430092|79601917|FG000|Overall Study|Lack of Efficacy|5|||
44578580|NCT00430092|79601918|FG001|Overall Study|Lack of Efficacy|2|||
44578581|NCT00430092|79601919|FG002|Overall Study|Lack of Efficacy|54|||
44578582|NCT00430092|79601917|FG000|Overall Study|Lost to Follow-up|1|||
44578583|NCT00430092|79601918|FG001|Overall Study|Lost to Follow-up|0|||
44578584|NCT00430092|79601919|FG002|Overall Study|Lost to Follow-up|0|||
44239391|NCT01581307|79066227|FG000|Overall Study|Withdrawal by Subject|1|||
44239392|NCT01580995|79066233|FG000|Overall Study|Lost to Follow-up|2|||
44378748|NCT00765817|79384268|FG001|Overall Study|Adverse Event|1|||
44578585|NCT00430092|79601917|FG000|Overall Study|Protocol Violation|0|||
44578586|NCT00430092|79601918|FG001|Overall Study|Protocol Violation|1|||
44578587|NCT00430092|79601919|FG002|Overall Study|Protocol Violation|1|||
44578588|NCT00430092|79601917|FG000|Overall Study|Withdrawal by Subject|0|||
44578589|NCT00430092|79601918|FG001|Overall Study|Withdrawal by Subject|1|||
44578590|NCT00430092|79601919|FG002|Overall Study|Withdrawal by Subject|1|||
44578591|NCT00425100|79601924|FG000|Overall Study|Adverse Event|36|||
44578592|NCT00425100|79601924|FG000|Overall Study|Lack of Efficacy|4|||
44578593|NCT00425100|79601924|FG000|Overall Study|Lost to Follow-up|2|||
44578594|NCT00425100|79601924|FG000|Overall Study|Protocol Violation|4|||
44578595|NCT00425100|79601924|FG000|Overall Study|Withdrawal by Subject|7|||
44578596|NCT00412932|79601929|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
44578597|NCT00412932|79601929|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
44578598|NCT00412932|79601929|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
44239393|NCT01580995|79066234|FG001|Overall Study|Lost to Follow-up|2|||
44239394|NCT01535599|79066242|FG000|Overall Study|Adverse Event|6|||
44239395|NCT01535599|79066243|FG001|Overall Study|Adverse Event|15|||
44239396|NCT01535599|79066242|FG000|Overall Study|Lost to Follow-up|3|||
44239397|NCT01535599|79066243|FG001|Overall Study|Lost to Follow-up|4|||
44239398|NCT01535599|79066242|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
44239399|NCT01535599|79066243|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
44239400|NCT01535599|79066242|FG000|Overall Study|Treatment Failure|33|||
44239401|NCT01535599|79066243|FG001|Overall Study|Treatment Failure|66|||
44239402|NCT01535599|79066242|FG000|Overall Study|BL Culture + for Group A Strep|0|||
44378749|NCT00765817|79384267|FG000|Overall Study|Death|0|||
44378750|NCT00765817|79384268|FG001|Overall Study|Death|1|||
44239403|NCT01535599|79066243|FG001|Overall Study|BL Culture + for Group A Strep|1|||
44239404|NCT01535599|79066242|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
44378751|NCT00765817|79384267|FG000|Overall Study|Entry criteria not met|2|||
44119233|NCT03033069|78903051|FG002|Overall Study|Withdrawal by Subject|11|||
44119234|NCT03033069|78903052|FG003|Overall Study|Withdrawal by Subject|6|||
44578599|NCT00412932|79601929|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
44578600|NCT00412932|79601929|FG000|Olmesartan (Olm) 20 mg|Other|1|||
44578601|NCT00412932|79601929|FG000|Olmesartan 40 mg|Adverse Event|4|||
44578602|NCT00412932|79601929|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
44119235|NCT03033069|78903049|FG000|Overall Study|Withdrawal By Caregiver|1|||
44119236|NCT03033069|78903050|FG001|Overall Study|Withdrawal By Caregiver|0|||
44119237|NCT03033069|78903051|FG002|Overall Study|Withdrawal By Caregiver|0|||
44119238|NCT03033069|78903052|FG003|Overall Study|Withdrawal By Caregiver|0|||
44119239|NCT03033069|78903049|FG000|Overall Study|Reason not Specified|0|||
44119240|NCT03033069|78903050|FG001|Overall Study|Reason not Specified|1|||
44578603|NCT00412932|79601929|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
44578604|NCT00412932|79601929|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
44119241|NCT03033069|78903051|FG002|Overall Study|Reason not Specified|0|||
44119242|NCT03033069|78903052|FG003|Overall Study|Reason not Specified|1|||
44119243|NCT02917265|78903064|FG000|Overall Study|Physician Decision|1|||
44119244|NCT02917265|78903065|FG001|Overall Study|Physician Decision|0|||
44119245|NCT02917265|78903064|FG000|Overall Study|Withdrawal by Subject|1|||
44119246|NCT02917265|78903065|FG001|Overall Study|Withdrawal by Subject|0|||
44119247|NCT02136069|78903075|FG000|Overall Study|UC flare-up|1|||
44119248|NCT02136069|78903076|FG001|Overall Study|UC flare-up|0|||
44119249|NCT02136069|78903075|FG000|Overall Study|Adverse Event|6|||
44119250|NCT02136069|78903076|FG001|Overall Study|Adverse Event|8|||
44119251|NCT02136069|78903075|FG000|Overall Study|Death|0|||
44119252|NCT02136069|78903076|FG001|Overall Study|Death|1|||
44119253|NCT02136069|78903075|FG000|Overall Study|Lack of Efficacy|10|||
44119254|NCT02136069|78903076|FG001|Overall Study|Lack of Efficacy|4|||
44119255|NCT02136069|78903075|FG000|Overall Study|Lost to Follow-up|1|||
44119256|NCT02136069|78903076|FG001|Overall Study|Lost to Follow-up|0|||
44119257|NCT02136069|78903075|FG000|Overall Study|Non-Compliance|1|||
44119258|NCT02136069|78903076|FG001|Overall Study|Non-Compliance|0|||
44119259|NCT02136069|78903075|FG000|Overall Study|Physician Decision|5|||
44119260|NCT02136069|78903076|FG001|Overall Study|Physician Decision|4|||
44119261|NCT02136069|78903075|FG000|Overall Study|Withdrawal by Subject|10|||
44578605|NCT00412932|79601929|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
44578606|NCT00412932|79601929|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
44578607|NCT00412932|79601929|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
44578608|NCT02696031|79601935|FG000|Up to Week 24|Adverse Event|2|||
44578609|NCT02696031|79601936|FG001|Up to Week 24|Adverse Event|4|||
44578610|NCT02696031|79601937|FG002|Up to Week 24|Adverse Event|2|||
44578611|NCT02696031|79601938|FG003|Up to Week 24|Adverse Event|0|||
44578612|NCT02696031|79601939|FG004|Up to Week 24|Adverse Event|0|||
44578613|NCT02696031|79601940|FG005|Up to Week 24|Adverse Event|0|||
44578614|NCT02696031|79601935|FG000|Up to Week 24|Lack of Efficacy|2|||
44119262|NCT02136069|78903076|FG001|Overall Study|Withdrawal by Subject|11|||
44119263|NCT02917031|78903085|FG000|Overall Study|Reason not specified|7|||
44119264|NCT02917031|78903086|FG001|Overall Study|Reason not specified|5|||
44119265|NCT02917031|78903087|FG002|Overall Study|Reason not specified|6|||
44119266|NCT02917031|78903085|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
44119267|NCT02917031|78903086|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
44119268|NCT02917031|78903087|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
44119269|NCT02917031|78903085|FG000|Overall Study|Withdrawal by Subject|3|||
44119270|NCT02917031|78903086|FG001|Overall Study|Withdrawal by Subject|3|||
44508173|NCT00303485|79513409|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
44508174|NCT00303485|79513408|FG000|Overall Study|Failure to return|0|||
44508175|NCT00303485|79513409|FG001|Overall Study|Failure to return|1|||
44508176|NCT00303485|79513408|FG000|Overall Study|Withdrawal by Subject|1|||
44508177|NCT00303485|79513409|FG001|Overall Study|Withdrawal by Subject|0|||
44508178|NCT03235726|79513423|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508179|NCT03235726|79513424|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508180|NCT03235726|79513425|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508181|NCT03235726|79513426|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508182|NCT03235726|79513427|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
44508183|NCT03235726|79513428|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508184|NCT03235726|79513429|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508185|NCT03235726|79513430|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508186|NCT03235726|79513431|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44508187|NCT03235726|79513432|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
44119271|NCT02917031|78903087|FG002|Overall Study|Withdrawal by Subject|0|||
44119272|NCT02917031|78903085|FG000|Overall Study|Physician Decision|1|||
44119273|NCT02917031|78903086|FG001|Overall Study|Physician Decision|0|||
44119274|NCT02917031|78903087|FG002|Overall Study|Physician Decision|0|||
44119275|NCT02917031|78903085|FG000|Overall Study|Adverse Event|4|||
44119276|NCT02917031|78903086|FG001|Overall Study|Adverse Event|1|||
44119277|NCT02917031|78903087|FG002|Overall Study|Adverse Event|5|||
44119278|NCT02917031|78903085|FG000|Overall Study|Death|2|||
44119279|NCT02917031|78903086|FG001|Overall Study|Death|3|||
44119280|NCT02917031|78903087|FG002|Overall Study|Death|4|||
44578615|NCT02696031|79601936|FG001|Up to Week 24|Lack of Efficacy|1|||
44578616|NCT02696031|79601937|FG002|Up to Week 24|Lack of Efficacy|2|||
44578617|NCT02696031|79601938|FG003|Up to Week 24|Lack of Efficacy|0|||
44578618|NCT02696031|79601939|FG004|Up to Week 24|Lack of Efficacy|0|||
44578619|NCT02696031|79601940|FG005|Up to Week 24|Lack of Efficacy|0|||
44578620|NCT02696031|79601935|FG000|Up to Week 24|Lost to Follow-up|0|||
44578621|NCT02696031|79601936|FG001|Up to Week 24|Lost to Follow-up|1|||
44578622|NCT02696031|79601937|FG002|Up to Week 24|Lost to Follow-up|1|||
44578623|NCT02696031|79601938|FG003|Up to Week 24|Lost to Follow-up|0|||
44578624|NCT02696031|79601939|FG004|Up to Week 24|Lost to Follow-up|0|||
44578625|NCT02696031|79601940|FG005|Up to Week 24|Lost to Follow-up|0|||
44578626|NCT02696031|79601935|FG000|Up to Week 24|Physician Decision|1|||
44119281|NCT01018563|78903096|FG000|Overall Study|Termination of the study by Sponsor|2|||
44119282|NCT01018563|78903097|FG001|Overall Study|Termination of the study by Sponsor|1|||
44578627|NCT02696031|79601936|FG001|Up to Week 24|Physician Decision|0|||
44578628|NCT02696031|79601937|FG002|Up to Week 24|Physician Decision|1|||
44578629|NCT02696031|79601938|FG003|Up to Week 24|Physician Decision|0|||
44578630|NCT02696031|79601939|FG004|Up to Week 24|Physician Decision|0|||
44578631|NCT02696031|79601940|FG005|Up to Week 24|Physician Decision|0|||
44578632|NCT02696031|79601935|FG000|Up to Week 24|Protocol Violation|1|||
44578633|NCT02696031|79601936|FG001|Up to Week 24|Protocol Violation|0|||
44578634|NCT02696031|79601937|FG002|Up to Week 24|Protocol Violation|0|||
44578635|NCT02696031|79601938|FG003|Up to Week 24|Protocol Violation|0|||
44578636|NCT02696031|79601939|FG004|Up to Week 24|Protocol Violation|0|||
44578637|NCT02696031|79601940|FG005|Up to Week 24|Protocol Violation|0|||
44578638|NCT02696031|79601935|FG000|Up to Week 24|Withdrawal by Subject|4|||
44578639|NCT02696031|79601936|FG001|Up to Week 24|Withdrawal by Subject|1|||
44578640|NCT02696031|79601937|FG002|Up to Week 24|Withdrawal by Subject|5|||
44578641|NCT02696031|79601938|FG003|Up to Week 24|Withdrawal by Subject|0|||
44578642|NCT02696031|79601939|FG004|Up to Week 24|Withdrawal by Subject|0|||
44578643|NCT02696031|79601940|FG005|Up to Week 24|Withdrawal by Subject|0|||
44578644|NCT02696031|79601935|FG000|Up to Week 52|Adverse Event|4|||
44578645|NCT02696031|79601936|FG001|Up to Week 52|Adverse Event|5|||
44578646|NCT02696031|79601937|FG002|Up to Week 52|Adverse Event|3|||
44578647|NCT02696031|79601938|FG003|Up to Week 52|Adverse Event|0|||
44578648|NCT02696031|79601939|FG004|Up to Week 52|Adverse Event|0|||
44578649|NCT02696031|79601940|FG005|Up to Week 52|Adverse Event|0|||
44578650|NCT02696031|79601935|FG000|Up to Week 52|Lack of Efficacy|10|||
44578651|NCT02696031|79601936|FG001|Up to Week 52|Lack of Efficacy|7|||
44578652|NCT02696031|79601937|FG002|Up to Week 52|Lack of Efficacy|11|||
44578653|NCT02696031|79601938|FG003|Up to Week 52|Lack of Efficacy|0|||
44578654|NCT02696031|79601939|FG004|Up to Week 52|Lack of Efficacy|0|||
44578655|NCT02696031|79601940|FG005|Up to Week 52|Lack of Efficacy|0|||
44578656|NCT02696031|79601935|FG000|Up to Week 52|Lost to Follow-up|1|||
44578657|NCT02696031|79601936|FG001|Up to Week 52|Lost to Follow-up|1|||
44578658|NCT02696031|79601937|FG002|Up to Week 52|Lost to Follow-up|1|||
44578659|NCT02696031|79601938|FG003|Up to Week 52|Lost to Follow-up|0|||
44578660|NCT02696031|79601939|FG004|Up to Week 52|Lost to Follow-up|0|||
44578661|NCT02696031|79601940|FG005|Up to Week 52|Lost to Follow-up|0|||
44578662|NCT02696031|79601935|FG000|Up to Week 52|Physician Decision|1|||
44578663|NCT02696031|79601936|FG001|Up to Week 52|Physician Decision|1|||
44578664|NCT02696031|79601937|FG002|Up to Week 52|Physician Decision|2|||
44578665|NCT02696031|79601938|FG003|Up to Week 52|Physician Decision|0|||
44578666|NCT02696031|79601939|FG004|Up to Week 52|Physician Decision|0|||
44578667|NCT02696031|79601940|FG005|Up to Week 52|Physician Decision|0|||
44578668|NCT02696031|79601935|FG000|Up to Week 52|Pregnancy|0|||
44578669|NCT02696031|79601936|FG001|Up to Week 52|Pregnancy|2|||
44578670|NCT02696031|79601937|FG002|Up to Week 52|Pregnancy|0|||
44578671|NCT02696031|79601938|FG003|Up to Week 52|Pregnancy|0|||
44578672|NCT02696031|79601939|FG004|Up to Week 52|Pregnancy|0|||
44578673|NCT02696031|79601940|FG005|Up to Week 52|Pregnancy|0|||
44578674|NCT02696031|79601935|FG000|Up to Week 52|Protocol Violation|1|||
44578675|NCT02696031|79601936|FG001|Up to Week 52|Protocol Violation|0|||
44578676|NCT02696031|79601937|FG002|Up to Week 52|Protocol Violation|0|||
44578677|NCT02696031|79601938|FG003|Up to Week 52|Protocol Violation|0|||
44578678|NCT02696031|79601939|FG004|Up to Week 52|Protocol Violation|0|||
44578679|NCT02696031|79601940|FG005|Up to Week 52|Protocol Violation|0|||
44578680|NCT02696031|79601935|FG000|Up to Week 52|Withdrawal by Subject|12|||
44578681|NCT02696031|79601936|FG001|Up to Week 52|Withdrawal by Subject|3|||
44578682|NCT02696031|79601937|FG002|Up to Week 52|Withdrawal by Subject|9|||
44578683|NCT02696031|79601938|FG003|Up to Week 52|Withdrawal by Subject|0|||
44578684|NCT02696031|79601939|FG004|Up to Week 52|Withdrawal by Subject|0|||
44578685|NCT02696031|79601940|FG005|Up to Week 52|Withdrawal by Subject|0|||
44578686|NCT02696031|79601935|FG000|Up to Week 104|Pregnancy|0|||
44578687|NCT02696031|79601936|FG001|Up to Week 104|Pregnancy|2|||
44119283|NCT02528188|78903110|FG000|Overall Study|Adverse Event|23|||
44578688|NCT02696031|79601937|FG002|Up to Week 104|Pregnancy|1|||
44578689|NCT02696031|79601938|FG003|Up to Week 104|Pregnancy|0|||
44578690|NCT02696031|79601939|FG004|Up to Week 104|Pregnancy|0|||
44578691|NCT02696031|79601940|FG005|Up to Week 104|Pregnancy|0|||
44578692|NCT02696031|79601935|FG000|Up to Week 104|Withdrawal by Subject|15|||
44578693|NCT02696031|79601936|FG001|Up to Week 104|Withdrawal by Subject|10|||
44578694|NCT02696031|79601937|FG002|Up to Week 104|Withdrawal by Subject|16|||
44578695|NCT02696031|79601938|FG003|Up to Week 104|Withdrawal by Subject|0|||
44578696|NCT02696031|79601939|FG004|Up to Week 104|Withdrawal by Subject|0|||
44578697|NCT02696031|79601940|FG005|Up to Week 104|Withdrawal by Subject|0|||
44578698|NCT02696031|79601935|FG000|Up to Week 104|Protocol Violation|1|||
44578699|NCT02696031|79601936|FG001|Up to Week 104|Protocol Violation|0|||
44578700|NCT02696031|79601937|FG002|Up to Week 104|Protocol Violation|0|||
44578701|NCT02696031|79601938|FG003|Up to Week 104|Protocol Violation|0|||
44578702|NCT02696031|79601939|FG004|Up to Week 104|Protocol Violation|0|||
44578703|NCT02696031|79601940|FG005|Up to Week 104|Protocol Violation|0|||
44578704|NCT02696031|79601935|FG000|Up to Week 104|Physician Decision|1|||
44578705|NCT02696031|79601936|FG001|Up to Week 104|Physician Decision|2|||
44578706|NCT02696031|79601937|FG002|Up to Week 104|Physician Decision|3|||
44578707|NCT02696031|79601938|FG003|Up to Week 104|Physician Decision|0|||
44578708|NCT02696031|79601939|FG004|Up to Week 104|Physician Decision|0|||
44578709|NCT02696031|79601940|FG005|Up to Week 104|Physician Decision|0|||
44578710|NCT02696031|79601935|FG000|Up to Week 104|Lost to Follow-up|2|||
44578711|NCT02696031|79601936|FG001|Up to Week 104|Lost to Follow-up|3|||
44578712|NCT02696031|79601937|FG002|Up to Week 104|Lost to Follow-up|1|||
44578713|NCT02696031|79601938|FG003|Up to Week 104|Lost to Follow-up|0|||
44578714|NCT02696031|79601939|FG004|Up to Week 104|Lost to Follow-up|0|||
44578715|NCT02696031|79601940|FG005|Up to Week 104|Lost to Follow-up|0|||
44578716|NCT02696031|79601935|FG000|Up to Week 104|Lack of Efficacy|13|||
44119284|NCT02528188|78903111|FG001|Overall Study|Adverse Event|22|||
44119285|NCT02528188|78903112|FG002|Overall Study|Adverse Event|8|||
44119286|NCT02528188|78903110|FG000|Overall Study|Protocol Violation|4|||
44119287|NCT02528188|78903111|FG001|Overall Study|Protocol Violation|6|||
44119288|NCT02528188|78903112|FG002|Overall Study|Protocol Violation|4|||
44119289|NCT02528188|78903110|FG000|Overall Study|Lack of Efficacy|19|||
44119290|NCT02528188|78903111|FG001|Overall Study|Lack of Efficacy|21|||
44119291|NCT02528188|78903112|FG002|Overall Study|Lack of Efficacy|22|||
44119292|NCT02528188|78903110|FG000|Overall Study|Withdrawal by Subject|97|||
44119293|NCT02528188|78903111|FG001|Overall Study|Withdrawal by Subject|104|||
44119294|NCT02528188|78903112|FG002|Overall Study|Withdrawal by Subject|100|||
44119295|NCT02528188|78903110|FG000|Overall Study|Lost to Follow-up|25|||
44119296|NCT02528188|78903111|FG001|Overall Study|Lost to Follow-up|21|||
44119297|NCT02528188|78903112|FG002|Overall Study|Lost to Follow-up|31|||
44119298|NCT02528188|78903110|FG000|Overall Study|Death|4|||
44119299|NCT02528188|78903111|FG001|Overall Study|Death|4|||
44119300|NCT02528188|78903112|FG002|Overall Study|Death|0|||
44119301|NCT02528188|78903110|FG000|Overall Study|Other|89|||
44119302|NCT02528188|78903111|FG001|Overall Study|Other|91|||
44119303|NCT02528188|78903112|FG002|Overall Study|Other|74|||
44239405|NCT01535599|79066243|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
44239406|NCT01535599|79066242|FG000|Overall Study|Randomized in Error|2|||
44239407|NCT01535599|79066243|FG001|Overall Study|Randomized in Error|4|||
44119304|NCT02528188|78903110|FG000|Overall Study|Randomized but not treated|6|||
44119305|NCT02528188|78903111|FG001|Overall Study|Randomized but not treated|7|||
44119306|NCT02528188|78903112|FG002|Overall Study|Randomized but not treated|12|||
44119307|NCT03896165|78903120|FG000|Overall Study|Withdrawal by Subject|2|||
44119308|NCT05361304|78903133|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
44119309|NCT05361304|78903134|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
44119310|NCT05361304|78903133|FG000|Overall Study|COVID-19 Related|1|||
44578717|NCT02696031|79601936|FG001|Up to Week 104|Lack of Efficacy|12|||
44578718|NCT02696031|79601937|FG002|Up to Week 104|Lack of Efficacy|11|||
44578719|NCT02696031|79601938|FG003|Up to Week 104|Lack of Efficacy|0|||
44578720|NCT02696031|79601939|FG004|Up to Week 104|Lack of Efficacy|0|||
44578721|NCT02696031|79601940|FG005|Up to Week 104|Lack of Efficacy|0|||
44578722|NCT02696031|79601935|FG000|Up to Week 104|Adverse Event|7|||
44119311|NCT05361304|78903134|FG001|Overall Study|COVID-19 Related|2|||
44119312|NCT05361304|78903133|FG000|Overall Study|Withdrawal by Subject|1|||
44378752|NCT00765817|79384268|FG001|Overall Study|Entry criteria not met|2|||
44578723|NCT02696031|79601936|FG001|Up to Week 104|Adverse Event|11|||
44578724|NCT02696031|79601937|FG002|Up to Week 104|Adverse Event|5|||
44578725|NCT02696031|79601938|FG003|Up to Week 104|Adverse Event|0|||
44578726|NCT02696031|79601939|FG004|Up to Week 104|Adverse Event|0|||
44578727|NCT02696031|79601940|FG005|Up to Week 104|Adverse Event|0|||
44119313|NCT05361304|78903134|FG001|Overall Study|Withdrawal by Subject|0|||
44239408|NCT01535599|79066242|FG000|Overall Study|Did not use product|1|||
44378753|NCT00765817|79384267|FG000|Overall Study|Loss of glucose control|0|||
44578728|NCT02696031|79601935|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
44378754|NCT00765817|79384268|FG001|Overall Study|Loss of glucose control|2|||
44578729|NCT02696031|79601936|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
44578730|NCT02696031|79601937|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
44578731|NCT02696031|79601938|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
44578732|NCT02696031|79601939|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
44578733|NCT02696031|79601940|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
44578734|NCT02696031|79601935|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
44578735|NCT02696031|79601936|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
44578736|NCT02696031|79601937|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
44578737|NCT02696031|79601938|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
44578738|NCT02696031|79601939|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
44578739|NCT02696031|79601940|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
44578740|NCT02696031|79601935|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
44276189|NCT02218008|79229545|FG003|Stage 1 (S1)|Pregnancy|0|||
44276190|NCT02218008|79229546|FG004|Stage 1 (S1)|Pregnancy|0|||
44276191|NCT02218008|79229547|FG005|Stage 1 (S1)|Pregnancy|0|||
44276192|NCT02218008|79229542|FG000|Stage 1 (S1)|Protocol Violation|0|||
44276193|NCT02218008|79229543|FG001|Stage 1 (S1)|Protocol Violation|0|||
44276194|NCT02218008|79229544|FG002|Stage 1 (S1)|Protocol Violation|1|||
44276195|NCT02218008|79229545|FG003|Stage 1 (S1)|Protocol Violation|0|||
44276196|NCT02218008|79229546|FG004|Stage 1 (S1)|Protocol Violation|0|||
44276197|NCT02218008|79229547|FG005|Stage 1 (S1)|Protocol Violation|0|||
44276198|NCT02218008|79229542|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
44378755|NCT00765817|79384267|FG000|Overall Study|Lost to Follow-up|1|||
44378756|NCT00765817|79384268|FG001|Overall Study|Lost to Follow-up|3|||
44508188|NCT03235726|79513423|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508189|NCT03235726|79513424|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508190|NCT03235726|79513425|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508191|NCT03235726|79513426|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508192|NCT03235726|79513427|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
44508193|NCT03235726|79513428|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508194|NCT03235726|79513429|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508195|NCT03235726|79513430|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508196|NCT03235726|79513431|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44578741|NCT02696031|79601936|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
44578742|NCT02696031|79601937|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
44578743|NCT02696031|79601938|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
44578744|NCT02696031|79601939|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
44578745|NCT02696031|79601940|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
44578746|NCT02696031|79601935|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
44578747|NCT02696031|79601936|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
44578748|NCT02696031|79601937|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
44578749|NCT02696031|79601938|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
44578750|NCT02696031|79601939|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
44578751|NCT02696031|79601940|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
44578752|NCT02696031|79601935|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
44578753|NCT02696031|79601936|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
44578754|NCT02696031|79601937|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
44578755|NCT02696031|79601938|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
44578756|NCT02696031|79601939|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
44578757|NCT02696031|79601940|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
44578758|NCT02696031|79601935|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
44578759|NCT02696031|79601936|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
44578760|NCT02696031|79601937|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
44578761|NCT02696031|79601938|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
44578762|NCT02696031|79601939|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
44578763|NCT02696031|79601940|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
44578764|NCT02696031|79601935|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
44578765|NCT02696031|79601936|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
44578766|NCT02696031|79601937|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
44578767|NCT02696031|79601938|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
44578768|NCT02696031|79601939|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
44578769|NCT02696031|79601940|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
44378757|NCT00765817|79384267|FG000|Overall Study|Physician Decision|2|||
44276199|NCT02218008|79229543|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
44276200|NCT02218008|79229544|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
44578770|NCT00397254|79601949|FG000|Overall Study|Lost to Follow-up|2|||
44578771|NCT00397254|79601950|FG001|Overall Study|Lost to Follow-up|2|||
44578772|NCT01369641|79601954|FG000|Overall Study|Withdrawal by Subject|1|||
44578773|NCT00529152|79601958|FG000|Overall Study|Adverse Event|2|||
44578774|NCT00529152|79601958|FG000|Overall Study|Withdrawal by Subject|2|||
44578775|NCT00529152|79601958|FG000|Overall Study|Lost to Follow-up|1|||
44578776|NCT02605174|79601965|FG000|Overall Study|Adverse Event|0|||
44578777|NCT02605174|79601966|FG001|Overall Study|Adverse Event|0|||
44578778|NCT02605174|79601967|FG002|Overall Study|Adverse Event|1|||
44578779|NCT02605174|79601968|FG003|Overall Study|Adverse Event|0|||
44578780|NCT02605174|79601969|FG004|Overall Study|Adverse Event|4|||
44508197|NCT03235726|79513432|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
44508198|NCT00303953|79513467|FG000|Overall Study|Ineligible|1|||
44508199|NCT00303953|79513467|FG000|Overall Study|Death|1|||
44508200|NCT00303953|79513467|FG000|Overall Study|Adverse Event|4|||
44508201|NCT00303953|79513467|FG000|Overall Study|Lack of Efficacy|12|||
44508202|NCT00303953|79513467|FG000|Overall Study|Physician Decision|1|||
44578781|NCT02605174|79601970|FG005|Overall Study|Adverse Event|0|||
44578782|NCT02605174|79601971|FG006|Overall Study|Adverse Event|0|||
44578783|NCT02605174|79601965|FG000|Overall Study|Lost to Follow-up|20|||
44508203|NCT02935894|79513471|FG000|Overall Study|Subject dismissed|1|||
44508204|NCT03224182|79513477|FG000|Overall Study|Study Drug Not Instilled|6|||
44508205|NCT03224182|79513478|FG001|Overall Study|Study Drug Not Instilled|1|||
44508206|NCT03224182|79513477|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
44508207|NCT03224182|79513478|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
44508208|NCT03224182|79513477|FG000|Overall Study|Withdrew of Consent|4|||
44508209|NCT03224182|79513478|FG001|Overall Study|Withdrew of Consent|2|||
44508210|NCT03224182|79513477|FG000|Overall Study|Investigator Decision|3|||
44508211|NCT03224182|79513478|FG001|Overall Study|Investigator Decision|1|||
44508212|NCT03224182|79513477|FG000|Overall Study|Sponsor Decision|26|||
44508213|NCT03224182|79513478|FG001|Overall Study|Sponsor Decision|12|||
44508214|NCT03224182|79513477|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
44508215|NCT03224182|79513478|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
44508216|NCT03224182|79513477|FG000|Overall Study|Lost to Follow-up|1|||
44508217|NCT03224182|79513478|FG001|Overall Study|Lost to Follow-up|0|||
44578784|NCT02605174|79601966|FG001|Overall Study|Lost to Follow-up|7|||
44578785|NCT02605174|79601967|FG002|Overall Study|Lost to Follow-up|27|||
44578786|NCT02605174|79601968|FG003|Overall Study|Lost to Follow-up|10|||
44578787|NCT02605174|79601969|FG004|Overall Study|Lost to Follow-up|20|||
44508218|NCT03224182|79513477|FG000|Overall Study|Participant Had Recurrence|11|||
44508219|NCT03224182|79513478|FG001|Overall Study|Participant Had Recurrence|5|||
44508220|NCT03224182|79513477|FG000|Overall Study|Death|0|||
44578788|NCT02605174|79601970|FG005|Overall Study|Lost to Follow-up|10|||
44578789|NCT02605174|79601971|FG006|Overall Study|Lost to Follow-up|29|||
44578790|NCT02605174|79601965|FG000|Overall Study|Protocol Violation|10|||
44578791|NCT02605174|79601966|FG001|Overall Study|Protocol Violation|4|||
44578792|NCT02605174|79601967|FG002|Overall Study|Protocol Violation|14|||
44578793|NCT02605174|79601968|FG003|Overall Study|Protocol Violation|6|||
44578794|NCT02605174|79601969|FG004|Overall Study|Protocol Violation|7|||
44578795|NCT02605174|79601970|FG005|Overall Study|Protocol Violation|7|||
44578796|NCT02605174|79601971|FG006|Overall Study|Protocol Violation|12|||
44578797|NCT02605174|79601965|FG000|Overall Study|Pregnancy|1|||
44578798|NCT02605174|79601966|FG001|Overall Study|Pregnancy|0|||
44578799|NCT02605174|79601967|FG002|Overall Study|Pregnancy|0|||
44578800|NCT02605174|79601968|FG003|Overall Study|Pregnancy|2|||
44578801|NCT02605174|79601969|FG004|Overall Study|Pregnancy|0|||
44578802|NCT02605174|79601970|FG005|Overall Study|Pregnancy|0|||
44578803|NCT02605174|79601971|FG006|Overall Study|Pregnancy|0|||
44578804|NCT02605174|79601965|FG000|Overall Study|Withdrawal by Subject|9|||
44119314|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
44119315|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
44378758|NCT00765817|79384268|FG001|Overall Study|Physician Decision|1|||
44508221|NCT03224182|79513478|FG001|Overall Study|Death|1|||
44508222|NCT03224182|79513477|FG000|Overall Study|Reason not Specified|3|||
44508223|NCT03224182|79513478|FG001|Overall Study|Reason not Specified|3|||
44578805|NCT02605174|79601966|FG001|Overall Study|Withdrawal by Subject|6|||
44578806|NCT02605174|79601967|FG002|Overall Study|Withdrawal by Subject|14|||
44578807|NCT02605174|79601968|FG003|Overall Study|Withdrawal by Subject|11|||
44578808|NCT02605174|79601969|FG004|Overall Study|Withdrawal by Subject|6|||
44578809|NCT02605174|79601970|FG005|Overall Study|Withdrawal by Subject|4|||
44578810|NCT02605174|79601971|FG006|Overall Study|Withdrawal by Subject|15|||
44378759|NCT00765817|79384267|FG000|Overall Study|Protocol Violation|1|||
44378760|NCT00765817|79384268|FG001|Overall Study|Protocol Violation|1|||
44508224|NCT03224182|79513477|FG000|Overall Study|Other|1|||
44578811|NCT02605174|79601965|FG000|Overall Study|Physician Decision|2|||
44578812|NCT02605174|79601966|FG001|Overall Study|Physician Decision|0|||
44578813|NCT02605174|79601967|FG002|Overall Study|Physician Decision|0|||
44578814|NCT02605174|79601968|FG003|Overall Study|Physician Decision|0|||
44578815|NCT02605174|79601969|FG004|Overall Study|Physician Decision|0|||
44578816|NCT02605174|79601970|FG005|Overall Study|Physician Decision|0|||
44578817|NCT02605174|79601971|FG006|Overall Study|Physician Decision|3|||
44578818|NCT02605174|79601965|FG000|Overall Study|Randomization Failure|22|||
44578819|NCT02605174|79601966|FG001|Overall Study|Randomization Failure|6|||
44578820|NCT02605174|79601967|FG002|Overall Study|Randomization Failure|20|||
44578821|NCT02605174|79601968|FG003|Overall Study|Randomization Failure|7|||
44578822|NCT02605174|79601969|FG004|Overall Study|Randomization Failure|16|||
44578823|NCT02605174|79601970|FG005|Overall Study|Randomization Failure|11|||
44508225|NCT03224182|79513478|FG001|Overall Study|Other|0|||
44508226|NCT02935192|79513486|FG000|Overall Study|Withdrawal by Subject|8|||
44508227|NCT02935192|79513487|FG001|Overall Study|Withdrawal by Subject|4|||
44508228|NCT03722264|79513493|FG000|Overall Study|Physician Decision|3|||
44508229|NCT03722030|79513501|FG000|Overall Study|Withdrawal by Subject|1|||
44508230|NCT03722030|79513502|FG001|Overall Study|Withdrawal by Subject|0|||
44508231|NCT03221842|79513509|FG000|Period 1 (Open-label)|Adverse Event|4|||
44508232|NCT03221842|79513510|FG001|Period 1 (Open-label)|Adverse Event|0|||
44508233|NCT03221842|79513509|FG000|Period 1 (Open-label)|Physician Decision|2|||
44508234|NCT03221842|79513510|FG001|Period 1 (Open-label)|Physician Decision|0|||
44508235|NCT03221842|79513509|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
44508236|NCT03221842|79513510|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
44508237|NCT03221842|79513509|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
44508238|NCT03221842|79513510|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
44508239|NCT03221842|79513509|FG000|Period 1 (Open-label)|Other|2|||
44508240|NCT03221842|79513510|FG001|Period 1 (Open-label)|Other|0|||
44508241|NCT03221842|79513509|FG000|Period 2 (Randomized, Blinded)|Death|0|||
44508242|NCT03221842|79513510|FG001|Period 2 (Randomized, Blinded)|Death|1|||
44508243|NCT03221842|79513509|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
44508244|NCT03221842|79513510|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
44508245|NCT03364738|79513520|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
44508246|NCT03364738|79513520|FG000|Overall Study|Withdrawal by Subject|1|||
44508247|NCT03364738|79513520|FG000|Overall Study|Adverse Event|1|||
44508248|NCT00303329|79513527|FG000|Overall Study|Adverse Event|7|||
44508249|NCT00303329|79513528|FG001|Overall Study|Adverse Event|14|||
44119316|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
44119317|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
44119318|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
44119319|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
44119320|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
44119321|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
44119322|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
44119323|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
44119324|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
44119325|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
44119326|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
44578824|NCT02605174|79601971|FG006|Overall Study|Randomization Failure|30|||
44578825|NCT02604550|79601999|FG000|Overall Study|Lost to Follow-up|7|||
44578826|NCT02604550|79602000|FG001|Overall Study|Lost to Follow-up|6|||
44578827|NCT02604550|79601999|FG000|Overall Study|Withdrawal by Subject|0|||
44578828|NCT02604550|79602000|FG001|Overall Study|Withdrawal by Subject|1|||
44578829|NCT02604550|79601999|FG000|Overall Study|Incomplete data using paper journal|18|||
44119327|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
44119328|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
44239409|NCT01535599|79066243|FG001|Overall Study|Did not use product|0|||
44508250|NCT00303329|79513527|FG000|Overall Study|Abnormal Laboratory Values|0|||
44508251|NCT00303329|79513528|FG001|Overall Study|Abnormal Laboratory Values|1|||
44508252|NCT00303329|79513527|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
44508253|NCT00303329|79513528|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44508254|NCT00303329|79513527|FG000|Overall Study|Condition no longer requires study drug|0|||
44508255|NCT00303329|79513528|FG001|Overall Study|Condition no longer requires study drug|8|||
44239410|NCT01535599|79066242|FG000|Overall Study|Other|1|||
44239411|NCT01535599|79066243|FG001|Overall Study|Other|0|||
44239412|NCT01535599|79066242|FG000|Overall Study|Stopped medication|0|||
44508256|NCT00303329|79513527|FG000|Overall Study|Protocol Violation|3|||
44578830|NCT02604550|79602000|FG001|Overall Study|Incomplete data using paper journal|19|||
44578831|NCT02591290|79602006|FG000|Overall Study|Withdrawal by Subject|2|||
44578832|NCT02791893|79602012|FG000|Blinded Phase|Lost to Follow-up|2|||
44578833|NCT02791893|79602013|FG001|Blinded Phase|Lost to Follow-up|2|||
44578834|NCT02791893|79602012|FG000|Blinded Phase|Withdrawal by Subject|1|||
44578835|NCT02791893|79602013|FG001|Blinded Phase|Withdrawal by Subject|2|||
44578836|NCT02791893|79602012|FG000|Open Label Phase|Lost to Follow-up|3|||
44578837|NCT02791893|79602013|FG001|Open Label Phase|Lost to Follow-up|0|||
44508257|NCT00303329|79513528|FG001|Overall Study|Protocol Violation|0|||
44578838|NCT02791893|79602012|FG000|Open Label Phase|Withdrawal by Subject|0|||
44578839|NCT02791893|79602013|FG001|Open Label Phase|Withdrawal by Subject|2|||
44578840|NCT00120042|79602022|FG000|Overall Study|all completed protocl|0|||
44578841|NCT00120042|79602023|FG001|Overall Study|all completed protocl|0|||
44578842|NCT00120042|79602024|FG002|Overall Study|all completed protocl|0|||
44578843|NCT02476851|79602031|FG000|Overall Study|Protocol Violation|1|||
44578844|NCT02476851|79602032|FG001|Overall Study|Protocol Violation|1|||
44578845|NCT02595970|79602038|FG000|Overall Study|Withdrawal by Subject|2|||
44578846|NCT02595970|79602038|FG000|Overall Study|Physician Decision|2|||
44578847|NCT02595970|79602038|FG000|Overall Study|Protocol Violation|4|||
44578848|NCT02595970|79602038|FG000|Overall Study|Adverse Event|5|||
44578849|NCT02595970|79602038|FG000|Overall Study|Lack of Efficacy|7|||
44578850|NCT01866111|79602046|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
44578851|NCT01866111|79602047|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
44578852|NCT01866111|79602048|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
44578853|NCT01866111|79602049|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
44578854|NCT01866111|79602046|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
44578855|NCT01866111|79602047|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
44578856|NCT01866111|79602048|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
44578857|NCT01866111|79602049|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
44578858|NCT02595502|79602059|FG000|Period 1|Adverse Event|0|||
44578859|NCT02595502|79602060|FG001|Period 1|Adverse Event|1|||
44578860|NCT02595502|79602059|FG000|Period 1|Withdrawal by Subject|1|||
44578861|NCT02595502|79602060|FG001|Period 1|Withdrawal by Subject|0|||
44578862|NCT02595502|79602059|FG000|Period 1|Lost to Follow-up|0|||
44578863|NCT02595502|79602060|FG001|Period 1|Lost to Follow-up|1|||
44578864|NCT02595502|79602059|FG000|Period 2|Adverse Event|1|||
44578865|NCT02595502|79602060|FG001|Period 2|Adverse Event|1|||
44578866|NCT02595502|79602059|FG000|Period 2|Received incorrect lens at Period 1|0|||
44578867|NCT02595502|79602060|FG001|Period 2|Received incorrect lens at Period 1|1|||
44578868|NCT02595502|79602059|FG000|Period 3|Protocol Violation|0|||
44578869|NCT02595502|79602060|FG001|Period 3|Protocol Violation|1|||
44578870|NCT02595502|79602059|FG000|Period 3|Lost to Follow-up|1|||
44578871|NCT02595502|79602060|FG001|Period 3|Lost to Follow-up|0|||
44578872|NCT02595502|79602059|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
44578873|NCT02595502|79602060|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
44578874|NCT01369329|79602069|FG000|Overall Study|Withdrawal by Subject|8|||
44119329|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
44119330|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
44119331|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
44119332|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
44119333|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
44119334|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
44119335|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
44508258|NCT00303329|79513527|FG000|Overall Study|Withdrawal by Subject|9|||
44508259|NCT00303329|79513528|FG001|Overall Study|Withdrawal by Subject|15|||
44578875|NCT01369329|79602070|FG001|Overall Study|Withdrawal by Subject|6|||
44578876|NCT01369329|79602071|FG002|Overall Study|Withdrawal by Subject|10|||
44578877|NCT01369329|79602069|FG000|Overall Study|Lost to Follow-up|2|||
44578878|NCT01369329|79602070|FG001|Overall Study|Lost to Follow-up|2|||
44578879|NCT01369329|79602071|FG002|Overall Study|Lost to Follow-up|2|||
44578880|NCT01369329|79602069|FG000|Overall Study|Other|2|||
44578881|NCT01369329|79602070|FG001|Overall Study|Other|3|||
44578882|NCT01369329|79602071|FG002|Overall Study|Other|2|||
44578883|NCT02791659|79602081|FG000|Overall Study|Protocol Violation|0|||
44119336|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
44119337|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
44508260|NCT00303329|79513527|FG000|Overall Study|Lost to Follow-up|0|||
44508261|NCT00303329|79513528|FG001|Overall Study|Lost to Follow-up|1|||
44508262|NCT00303329|79513527|FG000|Overall Study|Administrative problems|1|||
44508263|NCT00303329|79513528|FG001|Overall Study|Administrative problems|0|||
44508264|NCT00303329|79513527|FG000|Overall Study|Death|2|||
44508265|NCT00303329|79513528|FG001|Overall Study|Death|12|||
44508266|NCT00303329|79513527|FG000|Overall Study|Stopped at end of core|3|||
44578884|NCT02791659|79602082|FG001|Overall Study|Protocol Violation|1|||
44578885|NCT02594098|79602090|FG000|Overall Study|Lack of Efficacy|17|||
44119338|NCT02269917|78903157|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
44119339|NCT02269917|78903158|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
44508267|NCT00303329|79513528|FG001|Overall Study|Stopped at end of core|9|||
44508268|NCT00303329|79513527|FG000|Overall Study|Stopped at end of extension 1|1|||
44578886|NCT02594098|79602091|FG001|Overall Study|Lack of Efficacy|6|||
44578887|NCT02594098|79602090|FG000|Overall Study|Withdrawal by Subject|1|||
44578888|NCT02594098|79602091|FG001|Overall Study|Withdrawal by Subject|3|||
44578889|NCT02594098|79602090|FG000|Overall Study|Terminated participation|6|||
44578890|NCT02594098|79602091|FG001|Overall Study|Terminated participation|2|||
44578891|NCT02594098|79602090|FG000|Overall Study|Seek alternative treatment|2|||
44578892|NCT02594098|79602091|FG001|Overall Study|Seek alternative treatment|1|||
44578893|NCT02594098|79602090|FG000|Overall Study|Other|0|||
44578894|NCT02594098|79602091|FG001|Overall Study|Other|1|||
44578895|NCT02593864|79602099|FG000|Overall Study|Withdrawal by Subject|3|||
44578896|NCT02593864|79602099|FG000|Overall Study|Lost to Follow-up|3|||
44578897|NCT02590588|79602103|FG000|Overall Study|Adverse Event|1|||
44578898|NCT01434602|79602112|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
44578899|NCT01434602|79602113|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
44578900|NCT01434602|79602114|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
44578901|NCT01434602|79602115|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
44578902|NCT01434602|79602116|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
44578903|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
44578904|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
44578905|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
44578906|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
44578907|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
44578908|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
44578909|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
44578910|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
44578911|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
44578912|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
44578913|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
44578914|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
44578915|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
44578916|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
44578917|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
44578918|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
44578919|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
44578920|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
44119340|NCT02269917|78903159|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
44578921|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
44578922|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
44578923|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
44578924|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
44578925|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
44578926|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
44578927|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
44578928|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
44578929|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
44119341|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
44578930|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
44578931|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
44578932|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
44578933|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
44578934|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
44119342|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
44508269|NCT00303329|79513528|FG001|Overall Study|Stopped at end of extension 1|0|||
44508270|NCT00329849|79513536|FG000|Overall Study|Withdrawal by Subject|6|||
44508271|NCT00329849|79513537|FG001|Overall Study|Withdrawal by Subject|4|||
44508272|NCT02934178|79513549|FG000|Received Vaccination 2|Death|0|||
44508273|NCT02934178|79513550|FG001|Received Vaccination 2|Death|1|||
44508274|NCT02934178|79513549|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
44508275|NCT02934178|79513550|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
44508276|NCT00329303|79513559|FG000|Overall Study|Lack of Efficacy|1|||
44508277|NCT00329303|79513560|FG001|Overall Study|Lack of Efficacy|0|||
44119343|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
44119344|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
44508278|NCT00329303|79513559|FG000|Overall Study|Decision of the sponsor|0|||
44578935|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
44578936|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
44578937|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
44578938|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
44578939|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
44578940|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
44578941|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
44578942|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
44578943|NCT01434602|79602112|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
44578944|NCT01434602|79602113|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
44578945|NCT01434602|79602114|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
44578946|NCT01434602|79602115|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
44578947|NCT01434602|79602116|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
44578948|NCT01767129|79602138|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
44578949|NCT01767129|79602139|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
44578950|NCT02791269|79602148|FG000|Overall Study|Lost to Follow-up|0|||
44578951|NCT02791269|79602149|FG001|Overall Study|Lost to Follow-up|1|||
44578952|NCT02696564|79602159|FG000|Overall Study|Death|1|||
44578953|NCT02696564|79602160|FG001|Overall Study|Death|2|||
44578954|NCT02696564|79602159|FG000|Overall Study|Withdrawal by Subject|3|||
44119345|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
44119346|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
44578955|NCT02696564|79602160|FG001|Overall Study|Withdrawal by Subject|2|||
44578956|NCT02696564|79602159|FG000|Overall Study|Lost to Follow-up|3|||
44578957|NCT02696564|79602160|FG001|Overall Study|Lost to Follow-up|3|||
44578958|NCT02696564|79602159|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
44578959|NCT02696564|79602160|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
44578960|NCT02696564|79602159|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
44578961|NCT02696564|79602160|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
44578962|NCT02696564|79602159|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
44119347|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
44119348|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
44119349|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
44119350|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
44119351|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
44119352|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
44119353|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
44119354|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
44119355|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
44119356|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
44119357|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
44119358|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
44119359|NCT02269917|78903157|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
44119360|NCT02269917|78903158|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
44119361|NCT02269917|78903159|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
44119362|NCT02522494|78903170|FG000|Overall Study|Lost to Follow-up|6|||
44578963|NCT02696564|79602160|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
44578964|NCT02696564|79602159|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
44578965|NCT02696564|79602160|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
44578966|NCT02696564|79602159|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
44578967|NCT02696564|79602160|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
44119363|NCT02522494|78903171|FG001|Overall Study|Lost to Follow-up|2|||
44578968|NCT02640950|79602166|FG000|Overall Study|Adverse Event|1|||
44578969|NCT02640950|79602166|FG000|Overall Study|Withdrawal by Subject|1|||
44578970|NCT02593786|79602174|FG000|Overall Study|Disease progression|12|||
44119364|NCT02522494|78903170|FG000|Overall Study|Withdrawal by Subject|1|||
44119365|NCT02522494|78903171|FG001|Overall Study|Withdrawal by Subject|0|||
44119366|NCT02522494|78903170|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
44119367|NCT02522494|78903171|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
44119368|NCT02522494|78903170|FG000|Overall Study|Participant did not watch the video|1|||
44119369|NCT02522494|78903171|FG001|Overall Study|Participant did not watch the video|0|||
44119370|NCT02522494|78903170|FG000|Overall Study|Death|0|||
44578971|NCT02593786|79602175|FG001|Overall Study|Disease progression|16|||
44578972|NCT02593786|79602176|FG002|Overall Study|Disease progression|10|||
44119371|NCT02522494|78903171|FG001|Overall Study|Death|1|||
44119372|NCT01658020|78903179|FG000|Overall Study|Adverse Event|3|||
44119373|NCT01658020|78903180|FG001|Overall Study|Adverse Event|3|||
44578973|NCT02593786|79602177|FG003|Overall Study|Disease progression|7|||
44578974|NCT02593786|79602174|FG000|Overall Study|Study drug toxicity|1|||
44578975|NCT02593786|79602175|FG001|Overall Study|Study drug toxicity|0|||
44578976|NCT02593786|79602176|FG002|Overall Study|Study drug toxicity|0|||
44578977|NCT02593786|79602177|FG003|Overall Study|Study drug toxicity|0|||
44578978|NCT02593786|79602174|FG000|Overall Study|Adverse event unrelated to study drug|1|||
44578979|NCT02593786|79602175|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44578980|NCT02593786|79602176|FG002|Overall Study|Adverse event unrelated to study drug|1|||
44578981|NCT02593786|79602177|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44578982|NCT02593786|79602174|FG000|Overall Study|Participant request to discontinue study therapy|0|||
44578983|NCT02593786|79602175|FG001|Overall Study|Participant request to discontinue study therapy|2|||
44578984|NCT02593786|79602176|FG002|Overall Study|Participant request to discontinue study therapy|0|||
44578985|NCT02593786|79602177|FG003|Overall Study|Participant request to discontinue study therapy|0|||
44508279|NCT00329303|79513560|FG001|Overall Study|Decision of the sponsor|1|||
44578986|NCT02593786|79602174|FG000|Overall Study|Other reasons|1|||
44578987|NCT02593786|79602175|FG001|Overall Study|Other reasons|1|||
44578988|NCT02593786|79602176|FG002|Overall Study|Other reasons|0|||
44578989|NCT02593786|79602177|FG003|Overall Study|Other reasons|5|||
44578990|NCT04829331|79602199|FG000|Overall Study|Lost to Follow-up|1|||
44578991|NCT04829331|79602200|FG001|Overall Study|Lost to Follow-up|0|||
44578992|NCT04602546|79602215|FG000|Overall Study|Training|2|||
44578993|NCT04602546|79602216|FG001|Overall Study|Training|2|||
44578994|NCT04602546|79602217|FG002|Overall Study|Training|1|||
44578995|NCT04602546|79602218|FG003|Overall Study|Training|2|||
44578996|NCT04602546|79602219|FG004|Overall Study|Training|0|||
44578997|NCT04602546|79602215|FG000|Overall Study|Randomized with disqualified data|2|||
44578998|NCT04602546|79602216|FG001|Overall Study|Randomized with disqualified data|0|||
44578999|NCT04602546|79602217|FG002|Overall Study|Randomized with disqualified data|2|||
44579000|NCT04602546|79602218|FG003|Overall Study|Randomized with disqualified data|5|||
44579001|NCT04602546|79602219|FG004|Overall Study|Randomized with disqualified data|3|||
44579002|NCT04004988|79602279|FG000|Period 1|Physician Decision|2|||
44579003|NCT04004988|79602280|FG001|Period 1|Physician Decision|0|||
44579004|NCT04004988|79602279|FG000|Period 1|Withdrawal by Subject|0|||
44579005|NCT04004988|79602280|FG001|Period 1|Withdrawal by Subject|1|||
44579006|NCT04004988|79602279|FG000|Period 1|Adverse Event|1|||
44579007|NCT04004988|79602280|FG001|Period 1|Adverse Event|2|||
44579008|NCT03898700|79602287|FG000|Overall Study|Withdrawal by Subject|2|||
44579009|NCT03586973|79602302|FG000|Overall Study|Death|15|||
44579010|NCT03586973|79602303|FG001|Overall Study|Death|8|||
44579011|NCT03586973|79602302|FG000|Overall Study|Site Terminated by Sponsor|3|||
44579012|NCT03586973|79602303|FG001|Overall Study|Site Terminated by Sponsor|6|||
44579013|NCT03586973|79602302|FG000|Overall Study|Withdrawal by Subject|1|||
44579014|NCT03586973|79602303|FG001|Overall Study|Withdrawal by Subject|0|||
44579015|NCT03586973|79602302|FG000|Overall Study|Lost to Follow-up|1|||
44119374|NCT01658020|78903179|FG000|Overall Study|Lost to Follow-up|1|||
44119375|NCT01658020|78903180|FG001|Overall Study|Lost to Follow-up|0|||
44579016|NCT03586973|79602303|FG001|Overall Study|Lost to Follow-up|0|||
44579017|NCT02669212|79602311|FG000|Overall Study|Lost to Follow-up|1|||
44579018|NCT02669212|79602312|FG001|Overall Study|Lost to Follow-up|0|||
44579019|NCT02669212|79602311|FG000|Overall Study|Medical Condition|3|||
44119376|NCT01658020|78903179|FG000|Overall Study|Withdrawal by Subject|4|||
44119377|NCT01658020|78903180|FG001|Overall Study|Withdrawal by Subject|5|||
44508280|NCT00329303|79513559|FG000|Overall Study|Patient no longer available|1|||
44508281|NCT00329303|79513560|FG001|Overall Study|Patient no longer available|0|||
44508282|NCT00329303|79513559|FG000|Overall Study|Patient relocated|0|||
44508283|NCT00329303|79513560|FG001|Overall Study|Patient relocated|1|||
44508284|NCT03216850|79513567|FG000|Overall Study|Pre-analytical error|6|||
44508285|NCT00302159|79513571|FG000|Overall Study|pt declined before treatment started|1|||
44508286|NCT00302159|79513571|FG000|Overall Study|pt started Avastin|1|||
44508287|NCT00302081|79513579|FG000|Overall Study|Adverse Event|6|||
44508288|NCT00302081|79513580|FG001|Overall Study|Adverse Event|5|||
44508289|NCT00302081|79513581|FG002|Overall Study|Adverse Event|4|||
44508290|NCT00302081|79513579|FG000|Overall Study|Lost to Follow-up|21|||
44508291|NCT00302081|79513580|FG001|Overall Study|Lost to Follow-up|18|||
44508292|NCT00302081|79513581|FG002|Overall Study|Lost to Follow-up|28|||
44508293|NCT00302081|79513579|FG000|Overall Study|Withdrawal by Subject|8|||
44508294|NCT00302081|79513580|FG001|Overall Study|Withdrawal by Subject|12|||
44579020|NCT02669212|79602312|FG001|Overall Study|Medical Condition|4|||
44579021|NCT02669212|79602311|FG000|Overall Study|Withdrawal by Subject|0|||
44579022|NCT02669212|79602312|FG001|Overall Study|Withdrawal by Subject|2|||
44579023|NCT02669212|79602311|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
44579024|NCT02669212|79602312|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
44579025|NCT02536664|79602334|FG000|Overall Study|Inadequate completion of documentation|2|||
44119378|NCT01658020|78903179|FG000|Overall Study|Protocol Violation|0|||
44508295|NCT00302081|79513581|FG002|Overall Study|Withdrawal by Subject|8|||
44508296|NCT00302081|79513579|FG000|Overall Study|Protocol Violation|5|||
44579026|NCT02536664|79602335|FG001|Overall Study|Inadequate completion of documentation|4|||
44579027|NCT02536664|79602334|FG000|Overall Study|Progression|13|||
44579028|NCT02536664|79602335|FG001|Overall Study|Progression|18|||
44579029|NCT02536664|79602334|FG000|Overall Study|Death due to lymphoma|2|||
44579030|NCT02536664|79602335|FG001|Overall Study|Death due to lymphoma|1|||
44579031|NCT02536664|79602334|FG000|Overall Study|Death due to other reason|3|||
44579032|NCT02536664|79602335|FG001|Overall Study|Death due to other reason|2|||
44579033|NCT02536664|79602334|FG000|Overall Study|Intolerability|8|||
44579034|NCT02536664|79602335|FG001|Overall Study|Intolerability|6|||
44579035|NCT02536664|79602334|FG000|Overall Study|Withdrawal by Subject|8|||
44579036|NCT02536664|79602335|FG001|Overall Study|Withdrawal by Subject|5|||
44579037|NCT02536664|79602334|FG000|Overall Study|Other|18|||
44579038|NCT02536664|79602335|FG001|Overall Study|Other|24|||
44579039|NCT02536664|79602334|FG000|Overall Study|Missing|53|||
44579040|NCT02536664|79602335|FG001|Overall Study|Missing|20|||
44579041|NCT02426892|79602341|FG000|Overall Study|Adverse Event|2|||
44579042|NCT02426892|79602341|FG000|Overall Study|Lack of Efficacy|17|||
44579043|NCT02426892|79602341|FG000|Overall Study|Withdrawal by Subject|1|||
44579044|NCT02312687|79602345|FG000|Overall Study|Other, Not Specified|1|||
44579045|NCT02304367|79602349|FG000|Overall Study|Lack of Response to Bruosumab|1|||
44579046|NCT02304367|79602349|FG000|Overall Study|Sponsor Decision|3|||
44579047|NCT02304367|79602349|FG000|Overall Study|Death|2|||
44579048|NCT02304367|79602349|FG000|Overall Study|Physician Decision|1|||
44579049|NCT02304367|79602349|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
44579050|NCT02054520|79602366|FG000|Overall Study|Adverse Event|1|||
44579051|NCT02054520|79602367|FG001|Overall Study|Adverse Event|4|||
44579052|NCT02054520|79602368|FG002|Overall Study|Adverse Event|2|||
44579053|NCT02054520|79602369|FG003|Overall Study|Adverse Event|1|||
44579054|NCT02054520|79602370|FG004|Overall Study|Adverse Event|1|||
44579055|NCT02054520|79602371|FG005|Overall Study|Adverse Event|0|||
44579056|NCT02054520|79602366|FG000|Overall Study|Lack of Efficacy|7|||
44579057|NCT02054520|79602367|FG001|Overall Study|Lack of Efficacy|0|||
44579058|NCT02054520|79602368|FG002|Overall Study|Lack of Efficacy|2|||
44119379|NCT01658020|78903180|FG001|Overall Study|Protocol Violation|1|||
44119380|NCT02680574|78903198|FG000|Overall Study|Death|137|||
44119381|NCT02680574|78903199|FG001|Overall Study|Death|137|||
44119382|NCT02680574|78903198|FG000|Overall Study|Withdrawal by Subject|17|||
44119383|NCT02680574|78903199|FG001|Overall Study|Withdrawal by Subject|9|||
44579059|NCT02054520|79602369|FG003|Overall Study|Lack of Efficacy|1|||
44579060|NCT02054520|79602370|FG004|Overall Study|Lack of Efficacy|3|||
44579061|NCT02054520|79602371|FG005|Overall Study|Lack of Efficacy|2|||
44579062|NCT02054520|79602366|FG000|Overall Study|Withdrawal by Subject|1|||
44119384|NCT02680574|78903198|FG000|Overall Study|Lost to Follow-up|4|||
44119385|NCT02680574|78903199|FG001|Overall Study|Lost to Follow-up|6|||
44119386|NCT02522884|78903205|FG000|Overall Study|Withdrawal by Subject|6|||
44119387|NCT02522884|78903205|FG000|Overall Study|Death|3|||
44119388|NCT02522884|78903205|FG000|Overall Study|Missed 12-month Follow-up|9|||
44239413|NCT01535599|79066243|FG001|Overall Study|Stopped medication|1|||
44239414|NCT01535599|79066242|FG000|Overall Study|Noncompliance|0|||
44239415|NCT01535599|79066243|FG001|Overall Study|Noncompliance|1|||
44239416|NCT01553279|79066251|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
44239417|NCT01553279|79066252|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
44239418|NCT01553279|79066251|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
44239419|NCT01553279|79066252|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
44508297|NCT00302081|79513580|FG001|Overall Study|Protocol Violation|1|||
44508298|NCT00302081|79513581|FG002|Overall Study|Protocol Violation|2|||
44508299|NCT00302081|79513579|FG000|Overall Study|Lack of Efficacy|1|||
44508300|NCT00302081|79513580|FG001|Overall Study|Lack of Efficacy|0|||
44508301|NCT00302081|79513581|FG002|Overall Study|Lack of Efficacy|5|||
44508302|NCT00302081|79513579|FG000|Overall Study|Death|2|||
44508303|NCT00302081|79513580|FG001|Overall Study|Death|1|||
44508304|NCT00302081|79513581|FG002|Overall Study|Death|0|||
44508305|NCT00302081|79513579|FG000|Overall Study|Other|13|||
44508306|NCT00302081|79513580|FG001|Overall Study|Other|6|||
44508307|NCT00302081|79513581|FG002|Overall Study|Other|5|||
44508308|NCT00302003|79513589|FG000|Overall Study|Lack of Efficacy|62|||
44508309|NCT00302003|79513589|FG000|Overall Study|Lost to Follow-up|1|||
44508310|NCT00302003|79513589|FG000|Overall Study|Physician Decision|2|||
44508311|NCT00302003|79513589|FG000|Overall Study|Withdrawal by Subject|5|||
44508312|NCT00302003|79513589|FG000|Overall Study|Ineligible|9|||
44508313|NCT00302003|79513589|FG000|Overall Study|Protocol Violation|1|||
44508314|NCT00036270|79513595|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
44579063|NCT02054520|79602367|FG001|Overall Study|Withdrawal by Subject|0|||
44579064|NCT02054520|79602368|FG002|Overall Study|Withdrawal by Subject|0|||
44579065|NCT02054520|79602369|FG003|Overall Study|Withdrawal by Subject|2|||
44579066|NCT02054520|79602370|FG004|Overall Study|Withdrawal by Subject|1|||
44579067|NCT02054520|79602371|FG005|Overall Study|Withdrawal by Subject|0|||
44579068|NCT02054520|79602366|FG000|Overall Study|Physician Decision|0|||
44579069|NCT02054520|79602367|FG001|Overall Study|Physician Decision|1|||
44579070|NCT02054520|79602368|FG002|Overall Study|Physician Decision|0|||
44579071|NCT02054520|79602369|FG003|Overall Study|Physician Decision|1|||
44579072|NCT02054520|79602370|FG004|Overall Study|Physician Decision|0|||
44579073|NCT02054520|79602371|FG005|Overall Study|Physician Decision|1|||
44579074|NCT02054520|79602366|FG000|Overall Study|Study terminated by Sponsor|0|||
44119389|NCT02674568|78903222|FG000|Overall Study|Withdrawal by Subject|5|||
44119390|NCT02674568|78903222|FG000|Overall Study|Death|303|||
44119391|NCT02674568|78903222|FG000|Overall Study|Physician Decision|2|||
44119392|NCT02674568|78903222|FG000|Overall Study|Lost to Follow-up|9|||
44119393|NCT02674568|78903222|FG000|Overall Study|Other, Not Specified|20|||
44119394|NCT03022799|78903251|FG000|Overall Study|Adverse Event|0|||
44119395|NCT03022799|78903252|FG001|Overall Study|Adverse Event|0|||
44119396|NCT03022799|78903253|FG002|Overall Study|Adverse Event|0|||
44119397|NCT03022799|78903254|FG003|Overall Study|Adverse Event|0|||
44119398|NCT03022799|78903255|FG004|Overall Study|Adverse Event|0|||
44119399|NCT03022799|78903256|FG005|Overall Study|Adverse Event|0|||
44119400|NCT03022799|78903257|FG006|Overall Study|Adverse Event|0|||
44119401|NCT03022799|78903258|FG007|Overall Study|Adverse Event|0|||
44119402|NCT03022799|78903259|FG008|Overall Study|Adverse Event|0|||
44119403|NCT03022799|78903260|FG009|Overall Study|Adverse Event|1|||
44119404|NCT03022799|78903261|FG010|Overall Study|Adverse Event|1|||
44119405|NCT03022799|78903262|FG011|Overall Study|Adverse Event|0|||
44119406|NCT03022799|78903263|FG012|Overall Study|Adverse Event|0|||
44119407|NCT02674334|78903310|FG000|Overall Study|Lost to Follow-up|5|||
44119408|NCT02674334|78903311|FG001|Overall Study|Lost to Follow-up|3|||
44119409|NCT02674334|78903310|FG000|Overall Study|participant difficulty breathing|1|||
44119410|NCT02674334|78903311|FG001|Overall Study|participant difficulty breathing|0|||
44119411|NCT02674334|78903310|FG000|Overall Study|NIRS not recording|1|||
44119412|NCT02674334|78903311|FG001|Overall Study|NIRS not recording|0|||
44119413|NCT03026075|78903317|FG000|Overall Study|Physician Decision|1|||
44119414|NCT01373918|78903323|FG000|Overall Study|Physician Decision|0|||
44119415|NCT01373918|78903324|FG001|Overall Study|Physician Decision|1|||
44119416|NCT02667626|78903332|FG000|Overall Study|Withdrawal by Subject|0|||
44119417|NCT02667626|78903333|FG001|Overall Study|Withdrawal by Subject|1|||
44119418|NCT03025217|78903351|FG000|Overall Study|Pregnancy|1|||
44119419|NCT03025217|78903351|FG000|Overall Study|Lost to Follow-up|1|||
44239420|NCT01553279|79066251|FG000|Interim Period|Withdrawal by Subject|2|||
44239421|NCT01553279|79066252|FG001|Interim Period|Withdrawal by Subject|2|||
44239422|NCT01553279|79066251|FG000|Interim Period|Lost to Follow-up|1|||
44239423|NCT01553279|79066252|FG001|Interim Period|Lost to Follow-up|0|||
44119420|NCT03025217|78903351|FG000|Overall Study|Not eligible, poor English|2|||
44119421|NCT03023813|78903358|FG000|Overall Study|Lost to Follow-up|1|||
44239424|NCT01553279|79066251|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
44239425|NCT01553279|79066252|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
44239426|NCT01553279|79066251|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
44239427|NCT01553279|79066252|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
44239428|NCT01562743|79066259|FG000|Overall Study|Adverse Event|29|||
44239429|NCT01562743|79066259|FG000|Overall Study|Lack of Efficacy|3|||
44239430|NCT01562743|79066259|FG000|Overall Study|Withdrawal by Subject|13|||
44239431|NCT01562743|79066259|FG000|Overall Study|Protocol Violation|1|||
44239432|NCT01562743|79066259|FG000|Overall Study|Discontinuation criteria|2|||
44239433|NCT01562743|79066259|FG000|Overall Study|Lost to Follow-up|2|||
44239434|NCT01562743|79066259|FG000|Overall Study|Physician Decision|2|||
44239435|NCT01535443|79066263|FG000|Overall Study|Physician Decision|3|||
44239436|NCT01535287|79066270|FG000|Overall Study|drug not prepared in time|5|||
44239437|NCT01535287|79066271|FG001|Overall Study|drug not prepared in time|6|||
44239438|NCT01551173|79066279|FG000|Overall Study|Withdrawal by Subject|11|||
44239439|NCT01551173|79066280|FG001|Overall Study|Withdrawal by Subject|16|||
44119422|NCT03023813|78903359|FG001|Overall Study|Lost to Follow-up|2|||
44119423|NCT03023813|78903360|FG002|Overall Study|Lost to Follow-up|0|||
44239440|NCT01551173|79066279|FG000|Overall Study|Adverse Event|7|||
44239441|NCT01551173|79066280|FG001|Overall Study|Adverse Event|6|||
44239442|NCT01551173|79066279|FG000|Overall Study|Lost to Follow-up|5|||
44579075|NCT02054520|79602367|FG001|Overall Study|Study terminated by Sponsor|0|||
44579076|NCT02054520|79602368|FG002|Overall Study|Study terminated by Sponsor|2|||
44119424|NCT01365130|78903369|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
44119425|NCT01657162|78903375|FG000|Overall Study|Adverse Event|26|||
44119426|NCT01657162|78903376|FG001|Overall Study|Adverse Event|36|||
44119427|NCT01657162|78903375|FG000|Overall Study|Withdrawal by Subject|13|||
44119428|NCT01657162|78903376|FG001|Overall Study|Withdrawal by Subject|13|||
44119429|NCT01657162|78903375|FG000|Overall Study|Continuing Significant Deterioration|9|||
44239443|NCT01551173|79066280|FG001|Overall Study|Lost to Follow-up|7|||
44239444|NCT01551173|79066279|FG000|Overall Study|Other|5|||
44239445|NCT01551173|79066280|FG001|Overall Study|Other|3|||
44239446|NCT01549613|79066289|FG000|Overall Study|Lost to Follow-up|11|||
44239447|NCT01549613|79066290|FG001|Overall Study|Lost to Follow-up|11|||
44239448|NCT01548599|79066298|FG000|Overall Study|Lost to Follow-up|0|||
44579077|NCT02054520|79602369|FG003|Overall Study|Study terminated by Sponsor|1|||
44579078|NCT02054520|79602370|FG004|Overall Study|Study terminated by Sponsor|0|||
44579079|NCT02054520|79602371|FG005|Overall Study|Study terminated by Sponsor|0|||
44579080|NCT01546987|79602400|FG000|Overall Study|Protocol Violation|3|||
44579081|NCT01546987|79602401|FG001|Overall Study|Protocol Violation|4|||
44579082|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
44579083|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
44579084|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
44579085|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
44579086|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
44579087|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
44579088|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
44579089|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
44579090|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
44579091|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
44579092|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
44579093|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
44579094|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
44579095|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
44579096|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
44579097|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
44579098|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
44579099|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
44579100|NCT00261443|79602409|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
44579101|NCT00261443|79602410|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
44579102|NCT00261443|79602411|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
44579103|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
44579104|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
44579105|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
44579106|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
44579107|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
44579108|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
44579109|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
44579110|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
44579111|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
44378761|NCT00765817|79384267|FG000|Overall Study|Subject decision|7|||
44378762|NCT00765817|79384268|FG001|Overall Study|Subject decision|11|||
44378763|NCT00772603|79384277|FG000|Overall Study|Withdrawal by Subject|11|||
44378764|NCT00772603|79384278|FG001|Overall Study|Withdrawal by Subject|10|||
44239449|NCT01548599|79066299|FG001|Overall Study|Lost to Follow-up|1|||
44239450|NCT01548599|79066298|FG000|Overall Study|Withdrawal by Subject|4|||
44239451|NCT01548599|79066299|FG001|Overall Study|Withdrawal by Subject|0|||
44239452|NCT01548599|79066298|FG000|Overall Study|Death|2|||
44239453|NCT01548599|79066299|FG001|Overall Study|Death|1|||
44239454|NCT01548287|79066312|FG000|Screening|No reason provided|0|||
44239455|NCT01548287|79066313|FG001|Screening|No reason provided|0|||
44239456|NCT01548287|79066314|FG002|Screening|No reason provided|0|||
44239457|NCT01548287|79066315|FG003|Screening|No reason provided|0|||
44239458|NCT01548287|79066316|FG004|Screening|No reason provided|9|||
44239459|NCT01548287|79066312|FG000|Screening|Did not meet eligibility criteria|0|||
44239460|NCT01548287|79066313|FG001|Screening|Did not meet eligibility criteria|0|||
44239461|NCT01548287|79066314|FG002|Screening|Did not meet eligibility criteria|0|||
44239462|NCT01548287|79066315|FG003|Screening|Did not meet eligibility criteria|0|||
44239463|NCT01548287|79066316|FG004|Screening|Did not meet eligibility criteria|74|||
44239464|NCT01548287|79066312|FG000|Randomized Period|Did not meet inclusion criteria|0|||
44239465|NCT01548287|79066313|FG001|Randomized Period|Did not meet inclusion criteria|0|||
44239466|NCT01548287|79066314|FG002|Randomized Period|Did not meet inclusion criteria|2|||
44239467|NCT01548287|79066315|FG003|Randomized Period|Did not meet inclusion criteria|0|||
44239468|NCT01548287|79066316|FG004|Randomized Period|Did not meet inclusion criteria|0|||
44239469|NCT01548287|79066312|FG000|Randomized Period|Adverse Event|0|||
44239470|NCT01548287|79066313|FG001|Randomized Period|Adverse Event|2|||
44239471|NCT01548287|79066314|FG002|Randomized Period|Adverse Event|5|||
44239472|NCT01548287|79066315|FG003|Randomized Period|Adverse Event|0|||
44239473|NCT01548287|79066316|FG004|Randomized Period|Adverse Event|0|||
44378765|NCT00772603|79384279|FG002|Overall Study|Withdrawal by Subject|6|||
44378766|NCT00772603|79384277|FG000|Overall Study|Adverse Event|37|||
44239474|NCT01546883|79066326|FG000|Overall Study|Withdrawal by Subject|3|||
44239475|NCT01546883|79066326|FG000|Overall Study|Adverse Event|4|||
44239476|NCT01546883|79066326|FG000|Overall Study|Lost to Follow-up|2|||
44239477|NCT01546883|79066326|FG000|Overall Study|early closure of study|2|||
44239478|NCT01546883|79066326|FG000|Overall Study|other unrelated illness|1|||
44239479|NCT01546649|79066332|FG000|Overall Study|Adverse Event|4|||
44508315|NCT00036270|79513596|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
44119430|NCT01657162|78903376|FG001|Overall Study|Continuing Significant Deterioration|3|||
44119431|NCT01657162|78903375|FG000|Overall Study|Refusal of Treatment|4|||
44119432|NCT01657162|78903376|FG001|Overall Study|Refusal of Treatment|6|||
44119433|NCT01657162|78903375|FG000|Overall Study|Lost to Follow-up|3|||
44119434|NCT01657162|78903376|FG001|Overall Study|Lost to Follow-up|4|||
44119435|NCT01657162|78903375|FG000|Overall Study|Death|2|||
44579112|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
44579113|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
44579114|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
44579115|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
44579116|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
44579117|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
44579118|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
44579119|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
44579120|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
44579121|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
44579122|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
44579123|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
44579124|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
44579125|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
44579126|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
44579127|NCT00261443|79602409|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
44579128|NCT00261443|79602410|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
44579129|NCT00261443|79602411|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
44579130|NCT00261443|79602409|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
44579131|NCT00261443|79602410|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
44579132|NCT00261443|79602411|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
44579133|NCT00261443|79602409|FG000|3: Assessment of Relapse|Adverse Event|0|||
44579134|NCT00261443|79602410|FG001|3: Assessment of Relapse|Adverse Event|15|||
44119436|NCT01657162|78903376|FG001|Overall Study|Death|3|||
44119437|NCT01657162|78903375|FG000|Overall Study|Inability to Complete Study Procedures|1|||
44119438|NCT01657162|78903376|FG001|Overall Study|Inability to Complete Study Procedures|7|||
44119439|NCT01657162|78903375|FG000|Overall Study|Protocol Violation|1|||
44119440|NCT01657162|78903376|FG001|Overall Study|Protocol Violation|0|||
44119441|NCT01657162|78903375|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
44119442|NCT01657162|78903376|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
44119443|NCT01657162|78903375|FG000|Overall Study|Other than Specified|0|||
44119444|NCT01657162|78903376|FG001|Overall Study|Other than Specified|2|||
44119445|NCT01373294|78903401|FG000|Overall Study|Adverse Event|1|||
44119446|NCT01373294|78903402|FG001|Overall Study|Adverse Event|0|||
44119447|NCT01656304|78903408|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
44119448|NCT03023423|78903415|FG000|Overall Study|Death|5|||
44119449|NCT03023423|78903416|FG001|Overall Study|Death|12|||
44119450|NCT03023423|78903417|FG002|Overall Study|Death|20|||
44239480|NCT01546649|79066333|FG001|Overall Study|Adverse Event|5|||
44239481|NCT01546649|79066332|FG000|Overall Study|Protocol Violation|1|||
44579135|NCT00261443|79602411|FG002|3: Assessment of Relapse|Adverse Event|19|||
44579136|NCT00261443|79602409|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
44239482|NCT01546649|79066333|FG001|Overall Study|Protocol Violation|0|||
44119451|NCT03023423|78903415|FG000|Overall Study|Other|0|||
44119452|NCT03023423|78903416|FG001|Overall Study|Other|2|||
44119453|NCT03023423|78903417|FG002|Overall Study|Other|2|||
44239483|NCT01546649|79066332|FG000|Overall Study|Lack of Efficacy|1|||
44239484|NCT01546649|79066333|FG001|Overall Study|Lack of Efficacy|0|||
44239485|NCT01546649|79066332|FG000|Overall Study|Recurrence|1|||
44239486|NCT01546649|79066333|FG001|Overall Study|Recurrence|1|||
44239487|NCT01546649|79066332|FG000|Overall Study|Discovery of secondary cancer|0|||
44239488|NCT01546649|79066333|FG001|Overall Study|Discovery of secondary cancer|1|||
44239489|NCT01546649|79066332|FG000|Overall Study|Withdrawal by Subject|1|||
44239490|NCT01546649|79066333|FG001|Overall Study|Withdrawal by Subject|2|||
44378767|NCT00772603|79384278|FG001|Overall Study|Adverse Event|18|||
44508316|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
44508317|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
44508318|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
44508319|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
44508320|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
44508321|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
44508322|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Other|277|||
44239491|NCT01544309|79066341|FG000|Overall Study|Withdrawal by Subject|12|||
44239492|NCT01544309|79066342|FG001|Overall Study|Withdrawal by Subject|7|||
44239493|NCT01544309|79066341|FG000|Overall Study|Protocol Violation|2|||
44579137|NCT00261443|79602410|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
44579138|NCT00261443|79602411|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
44579139|NCT00261443|79602409|FG000|3: Assessment of Relapse|Death|0|||
44579140|NCT00261443|79602410|FG001|3: Assessment of Relapse|Death|0|||
44579141|NCT00261443|79602411|FG002|3: Assessment of Relapse|Death|1|||
44579142|NCT00261443|79602409|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
44579143|NCT00261443|79602410|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
44579144|NCT00261443|79602411|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
44579145|NCT00261443|79602409|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
44579146|NCT00261443|79602410|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
44579147|NCT00261443|79602411|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
44579148|NCT00261443|79602409|FG000|3: Assessment of Relapse|Pregnancy|0|||
44579149|NCT00261443|79602410|FG001|3: Assessment of Relapse|Pregnancy|2|||
44579150|NCT00261443|79602411|FG002|3: Assessment of Relapse|Pregnancy|1|||
44579151|NCT00261443|79602409|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
44579152|NCT00261443|79602410|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
44579153|NCT00261443|79602411|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
44579154|NCT00261443|79602409|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
44579155|NCT00261443|79602410|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
44579156|NCT00261443|79602411|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
44579157|NCT00261443|79602409|FG000|3: Assessment of Relapse|Other Reasons|0|||
44579158|NCT00261443|79602410|FG001|3: Assessment of Relapse|Other Reasons|4|||
44579159|NCT00261443|79602411|FG002|3: Assessment of Relapse|Other Reasons|3|||
44579160|NCT00261443|79602409|FG000|4: Extension Phase|Adverse Event|0|||
44579161|NCT00261443|79602410|FG001|4: Extension Phase|Adverse Event|1|||
44579162|NCT00261443|79602411|FG002|4: Extension Phase|Adverse Event|0|||
44579163|NCT00261443|79602409|FG000|4: Extension Phase|Withdrawal by Subject|0|||
44579164|NCT00261443|79602410|FG001|4: Extension Phase|Withdrawal by Subject|1|||
44579165|NCT00261443|79602411|FG002|4: Extension Phase|Withdrawal by Subject|2|||
44579166|NCT00261443|79602409|FG000|4: Extension Phase|Lost to Follow-up|0|||
44579167|NCT00261443|79602410|FG001|4: Extension Phase|Lost to Follow-up|1|||
44579168|NCT00261443|79602411|FG002|4: Extension Phase|Lost to Follow-up|0|||
44579169|NCT02593318|79602428|FG000|Overall Study|Withdrawal by Subject|1|||
44579170|NCT02593318|79602429|FG001|Overall Study|Withdrawal by Subject|1|||
44579171|NCT02343302|79602443|FG000|Overall Study|Physician Decision|1|||
44579172|NCT02343302|79602444|FG001|Overall Study|Physician Decision|1|||
44579173|NCT02590432|79602452|FG000|Open-label Treatment Period|Adverse Event|97|||
44579174|NCT02590432|79602453|FG001|Open-label Treatment Period|Adverse Event|79|||
44579175|NCT02590432|79602454|FG002|Open-label Treatment Period|Adverse Event|0|||
44579176|NCT02590432|79602455|FG003|Open-label Treatment Period|Adverse Event|0|||
44579177|NCT02590432|79602456|FG004|Open-label Treatment Period|Adverse Event|0|||
44579178|NCT02590432|79602457|FG005|Open-label Treatment Period|Adverse Event|0|||
44579179|NCT02590432|79602458|FG006|Open-label Treatment Period|Adverse Event|0|||
44579180|NCT02590432|79602459|FG007|Open-label Treatment Period|Adverse Event|0|||
44579181|NCT02590432|79602460|FG008|Open-label Treatment Period|Adverse Event|0|||
44579182|NCT02590432|79602452|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
44579183|NCT02590432|79602453|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
44579184|NCT02590432|79602454|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
44579185|NCT02590432|79602455|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
44579186|NCT02590432|79602456|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
44579187|NCT02590432|79602457|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
44579188|NCT02590432|79602458|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
44579189|NCT02590432|79602459|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
44579190|NCT02590432|79602460|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
44579191|NCT02590432|79602452|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
44579192|NCT02590432|79602453|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
44579193|NCT02590432|79602454|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
44579194|NCT02590432|79602455|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
44579195|NCT02590432|79602456|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
44579196|NCT02590432|79602457|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
44579197|NCT02590432|79602458|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
44579198|NCT02590432|79602459|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
44579199|NCT02590432|79602460|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
44579200|NCT02590432|79602452|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
44579201|NCT02590432|79602453|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
44579202|NCT02590432|79602454|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
44579203|NCT02590432|79602455|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
44579204|NCT02590432|79602456|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
44579205|NCT02590432|79602457|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
44579206|NCT02590432|79602458|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
44579207|NCT02590432|79602459|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
44579208|NCT02590432|79602460|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
44119454|NCT03023423|78903415|FG000|Overall Study|Ongoing|2|||
44119455|NCT03023423|78903416|FG001|Overall Study|Ongoing|32|||
44119456|NCT03023423|78903417|FG002|Overall Study|Ongoing|24|||
44119457|NCT03185741|78903432|FG000|Baseline|Withdrawal by Subject|1|||
44119458|NCT03185741|78903433|FG001|Baseline|Withdrawal by Subject|3|||
44119459|NCT03185741|78903434|FG002|Baseline|Withdrawal by Subject|2|||
44119460|NCT03185741|78903432|FG000|Baseline|Lost to Follow-up|1|||
44119461|NCT03185741|78903433|FG001|Baseline|Lost to Follow-up|2|||
44119462|NCT03185741|78903434|FG002|Baseline|Lost to Follow-up|3|||
44119463|NCT03185741|78903432|FG000|3Month|Death|1|||
44119464|NCT03185741|78903433|FG001|3Month|Death|1|||
44119465|NCT03185741|78903434|FG002|3Month|Death|2|||
44119466|NCT03185741|78903432|FG000|3Month|Withdrawal by Subject|1|||
44119467|NCT03185741|78903433|FG001|3Month|Withdrawal by Subject|5|||
44119468|NCT03185741|78903434|FG002|3Month|Withdrawal by Subject|1|||
44119469|NCT03185741|78903432|FG000|3Month|Lost to Follow-up|7|||
44119470|NCT03185741|78903433|FG001|3Month|Lost to Follow-up|9|||
44119471|NCT03185741|78903434|FG002|3Month|Lost to Follow-up|8|||
44119472|NCT03185741|78903432|FG000|3Month|Unavailable for 3Month|11|||
44119473|NCT03185741|78903433|FG001|3Month|Unavailable for 3Month|10|||
44119474|NCT03185741|78903434|FG002|3Month|Unavailable for 3Month|11|||
44119475|NCT03185741|78903432|FG000|3Month|Protocol Violation|0|||
44119476|NCT03185741|78903433|FG001|3Month|Protocol Violation|0|||
44119477|NCT03185741|78903434|FG002|3Month|Protocol Violation|3|||
44119478|NCT03185741|78903432|FG000|6Month|Death|1|||
44119479|NCT03185741|78903433|FG001|6Month|Death|1|||
44119480|NCT03185741|78903434|FG002|6Month|Death|2|||
44119481|NCT03185741|78903432|FG000|6Month|Withdrawal by Subject|2|||
44119482|NCT03185741|78903433|FG001|6Month|Withdrawal by Subject|3|||
44119483|NCT03185741|78903434|FG002|6Month|Withdrawal by Subject|1|||
44119484|NCT03185741|78903432|FG000|6Month|Lost to Follow-up|16|||
44119485|NCT03185741|78903433|FG001|6Month|Lost to Follow-up|15|||
44119486|NCT03185741|78903434|FG002|6Month|Lost to Follow-up|16|||
44119487|NCT02672852|78903444|FG000|Part A1|Disease Worsening|1|||
44119488|NCT02672852|78903445|FG001|Part A1|Disease Worsening|0|||
44119489|NCT02672852|78903446|FG002|Part A1|Disease Worsening|0|||
44119490|NCT02672852|78903447|FG003|Part A1|Disease Worsening|0|||
44119491|NCT02672852|78903448|FG004|Part A1|Disease Worsening|0|||
44119492|NCT02672852|78903449|FG005|Part A1|Disease Worsening|0|||
44119493|NCT02672852|78903450|FG006|Part A1|Disease Worsening|0|||
44119494|NCT02672852|78903444|FG000|Part A1|Adverse Event|0|||
44119495|NCT02672852|78903445|FG001|Part A1|Adverse Event|1|||
44119496|NCT02672852|78903446|FG002|Part A1|Adverse Event|0|||
44119497|NCT02672852|78903447|FG003|Part A1|Adverse Event|0|||
44119498|NCT02672852|78903448|FG004|Part A1|Adverse Event|0|||
44119499|NCT02672852|78903449|FG005|Part A1|Adverse Event|0|||
44119500|NCT02672852|78903450|FG006|Part A1|Adverse Event|0|||
44119501|NCT02672852|78903444|FG000|Part A1|Lost to Follow-up|1|||
44119502|NCT02672852|78903445|FG001|Part A1|Lost to Follow-up|2|||
44119503|NCT02672852|78903446|FG002|Part A1|Lost to Follow-up|0|||
44119504|NCT02672852|78903447|FG003|Part A1|Lost to Follow-up|0|||
44119505|NCT02672852|78903448|FG004|Part A1|Lost to Follow-up|0|||
44119506|NCT02672852|78903449|FG005|Part A1|Lost to Follow-up|0|||
44119507|NCT02672852|78903450|FG006|Part A1|Lost to Follow-up|0|||
44119508|NCT02672852|78903444|FG000|Part A1|Withdrawal by Subject|1|||
44378768|NCT00772603|79384279|FG002|Overall Study|Adverse Event|10|||
44239494|NCT01544309|79066342|FG001|Overall Study|Protocol Violation|1|||
44239495|NCT01544309|79066341|FG000|Overall Study|Physician Decision|4|||
44239496|NCT01544309|79066342|FG001|Overall Study|Physician Decision|1|||
44239497|NCT01544309|79066341|FG000|Overall Study|Not performed pre-dose examination|1|||
44239498|NCT01544309|79066342|FG001|Overall Study|Not performed pre-dose examination|2|||
44239499|NCT01544309|79066341|FG000|Overall Study|Administered prohibit prior medication|1|||
44239500|NCT01544309|79066342|FG001|Overall Study|Administered prohibit prior medication|0|||
44239501|NCT01544153|79066354|FG000|Overall Study|Under 18|0|||
44276201|NCT02218008|79229545|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
44119509|NCT02672852|78903445|FG001|Part A1|Withdrawal by Subject|1|||
44119510|NCT02672852|78903446|FG002|Part A1|Withdrawal by Subject|0|||
44119511|NCT02672852|78903447|FG003|Part A1|Withdrawal by Subject|0|||
44119512|NCT02672852|78903448|FG004|Part A1|Withdrawal by Subject|0|||
44119513|NCT02672852|78903449|FG005|Part A1|Withdrawal by Subject|0|||
44119514|NCT02672852|78903450|FG006|Part A1|Withdrawal by Subject|0|||
44119515|NCT02672852|78903444|FG000|Part A2|Disease worsening|0|||
44378769|NCT00772603|79384277|FG000|Overall Study|Subject Non-compliance|1|||
44378770|NCT00772603|79384278|FG001|Overall Study|Subject Non-compliance|6|||
44119516|NCT02672852|78903445|FG001|Part A2|Disease worsening|0|||
44119517|NCT02672852|78903446|FG002|Part A2|Disease worsening|1|||
44119518|NCT02672852|78903447|FG003|Part A2|Disease worsening|0|||
44119519|NCT02672852|78903448|FG004|Part A2|Disease worsening|0|||
44119520|NCT02672852|78903449|FG005|Part A2|Disease worsening|0|||
44119521|NCT02672852|78903450|FG006|Part A2|Disease worsening|0|||
44119522|NCT02672852|78903444|FG000|Part A2|Adverse Event|0|||
44119523|NCT02672852|78903445|FG001|Part A2|Adverse Event|0|||
44119524|NCT02672852|78903446|FG002|Part A2|Adverse Event|3|||
44119525|NCT02672852|78903447|FG003|Part A2|Adverse Event|0|||
44239502|NCT01544153|79066355|FG001|Overall Study|Under 18|1|||
44119526|NCT02672852|78903448|FG004|Part A2|Adverse Event|0|||
44119527|NCT02672852|78903449|FG005|Part A2|Adverse Event|0|||
44119528|NCT02672852|78903450|FG006|Part A2|Adverse Event|0|||
44119529|NCT02672852|78903444|FG000|Part A2|Lost to Follow-up|0|||
44119530|NCT02672852|78903445|FG001|Part A2|Lost to Follow-up|0|||
44119531|NCT02672852|78903446|FG002|Part A2|Lost to Follow-up|2|||
44119532|NCT02672852|78903447|FG003|Part A2|Lost to Follow-up|0|||
44119533|NCT02672852|78903448|FG004|Part A2|Lost to Follow-up|0|||
44119534|NCT02672852|78903449|FG005|Part A2|Lost to Follow-up|0|||
44119535|NCT02672852|78903450|FG006|Part A2|Lost to Follow-up|0|||
44579209|NCT02590432|79602452|FG000|Open-label Treatment Period|Protocol Violation|10|||
44579210|NCT02590432|79602453|FG001|Open-label Treatment Period|Protocol Violation|4|||
44579211|NCT02590432|79602454|FG002|Open-label Treatment Period|Protocol Violation|0|||
44579212|NCT02590432|79602455|FG003|Open-label Treatment Period|Protocol Violation|0|||
44579213|NCT02590432|79602456|FG004|Open-label Treatment Period|Protocol Violation|0|||
44579214|NCT02590432|79602457|FG005|Open-label Treatment Period|Protocol Violation|0|||
44579215|NCT02590432|79602458|FG006|Open-label Treatment Period|Protocol Violation|0|||
44579216|NCT02590432|79602459|FG007|Open-label Treatment Period|Protocol Violation|0|||
44579217|NCT02590432|79602460|FG008|Open-label Treatment Period|Protocol Violation|0|||
44579218|NCT02590432|79602452|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
44579219|NCT02590432|79602453|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
44579220|NCT02590432|79602454|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579221|NCT02590432|79602455|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579222|NCT02590432|79602456|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579223|NCT02590432|79602457|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579224|NCT02590432|79602458|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579225|NCT02590432|79602459|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579226|NCT02590432|79602460|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
44579227|NCT02590432|79602452|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
44119536|NCT02672852|78903444|FG000|Part A2|Withdrawal by Subject|0|||
44119537|NCT02672852|78903445|FG001|Part A2|Withdrawal by Subject|0|||
44119538|NCT02672852|78903446|FG002|Part A2|Withdrawal by Subject|1|||
44119539|NCT02672852|78903447|FG003|Part A2|Withdrawal by Subject|0|||
44119540|NCT02672852|78903448|FG004|Part A2|Withdrawal by Subject|0|||
44119541|NCT02672852|78903449|FG005|Part A2|Withdrawal by Subject|0|||
44119542|NCT02672852|78903450|FG006|Part A2|Withdrawal by Subject|0|||
44119543|NCT02672852|78903444|FG000|Part A2|Other|0|||
44119544|NCT02672852|78903445|FG001|Part A2|Other|0|||
44239503|NCT01544153|79066356|FG002|Overall Study|Under 18|0|||
44239504|NCT01544153|79066357|FG003|Overall Study|Under 18|0|||
44508323|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Other|288|||
44508324|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
44508325|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
44508326|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
44508327|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
44508328|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
44508329|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
44508330|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
44508331|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
44508332|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
44508333|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
44508334|NCT00036270|79513595|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
44508335|NCT00036270|79513596|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
44508336|NCT00301067|79513602|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
44508337|NCT00301067|79513603|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
44508338|NCT00301067|79513604|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
44508339|NCT00301067|79513605|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
44508340|NCT00301067|79513602|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
44119545|NCT02672852|78903446|FG002|Part A2|Other|3|||
44119546|NCT02672852|78903447|FG003|Part A2|Other|0|||
44119547|NCT02672852|78903448|FG004|Part A2|Other|0|||
44119548|NCT02672852|78903449|FG005|Part A2|Other|0|||
44239505|NCT01544153|79066354|FG000|Overall Study|Non-smoker|0|||
44239506|NCT01544153|79066355|FG001|Overall Study|Non-smoker|0|||
44508341|NCT00301067|79513603|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
44508342|NCT00301067|79513604|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
44579228|NCT02590432|79602453|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
44119549|NCT02672852|78903450|FG006|Part A2|Other|0|||
44119550|NCT02672852|78903444|FG000|Part A2|Not entered in Part B|0|||
44119551|NCT02672852|78903445|FG001|Part A2|Not entered in Part B|0|||
44119552|NCT02672852|78903446|FG002|Part A2|Not entered in Part B|0|||
44119553|NCT02672852|78903447|FG003|Part A2|Not entered in Part B|4|||
44239507|NCT01544153|79066356|FG002|Overall Study|Non-smoker|1|||
44579229|NCT02590432|79602454|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579230|NCT02590432|79602455|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579231|NCT02590432|79602456|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579232|NCT02590432|79602457|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579233|NCT02590432|79602458|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579234|NCT02590432|79602459|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579235|NCT02590432|79602460|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
44579236|NCT02590432|79602452|FG000|Double-blind Treatment Period|Adverse Event|0|||
44579237|NCT02590432|79602453|FG001|Double-blind Treatment Period|Adverse Event|0|||
44579238|NCT02590432|79602454|FG002|Double-blind Treatment Period|Adverse Event|14|||
44119554|NCT02672852|78903448|FG004|Part A2|Not entered in Part B|0|||
44119555|NCT02672852|78903449|FG005|Part A2|Not entered in Part B|0|||
44119556|NCT02672852|78903450|FG006|Part A2|Not entered in Part B|0|||
44119557|NCT02672852|78903444|FG000|Part B|Disease worsening|0|||
44119558|NCT02672852|78903445|FG001|Part B|Disease worsening|0|||
44119559|NCT02672852|78903446|FG002|Part B|Disease worsening|0|||
44579239|NCT02590432|79602455|FG003|Double-blind Treatment Period|Adverse Event|12|||
44579240|NCT02590432|79602456|FG004|Double-blind Treatment Period|Adverse Event|6|||
44579241|NCT02590432|79602457|FG005|Double-blind Treatment Period|Adverse Event|22|||
44579242|NCT02590432|79602458|FG006|Double-blind Treatment Period|Adverse Event|20|||
44579243|NCT02590432|79602459|FG007|Double-blind Treatment Period|Adverse Event|0|||
44579244|NCT02590432|79602460|FG008|Double-blind Treatment Period|Adverse Event|0|||
44579245|NCT02590432|79602452|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
44579246|NCT02590432|79602453|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
44579247|NCT02590432|79602454|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
44579248|NCT02590432|79602455|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
44579249|NCT02590432|79602456|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
44579250|NCT02590432|79602457|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
44579251|NCT02590432|79602458|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
44579252|NCT02590432|79602459|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
44579253|NCT02590432|79602460|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
44579254|NCT02590432|79602452|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
44579255|NCT02590432|79602453|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
44579256|NCT02590432|79602454|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
44579257|NCT02590432|79602455|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
44508343|NCT00301067|79513605|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
44508344|NCT00301067|79513602|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
44579258|NCT02590432|79602456|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
44119560|NCT02672852|78903447|FG003|Part B|Disease worsening|0|||
44119561|NCT02672852|78903448|FG004|Part B|Disease worsening|1|||
44119562|NCT02672852|78903449|FG005|Part B|Disease worsening|0|||
44119563|NCT02672852|78903450|FG006|Part B|Disease worsening|1|||
44119564|NCT02672852|78903444|FG000|Part B|Worsening pre-existing condition|0|||
44508345|NCT00301067|79513603|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
44508346|NCT00301067|79513604|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
44508347|NCT00301067|79513605|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
44508348|NCT00301067|79513602|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
44508349|NCT00301067|79513603|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
44579259|NCT02590432|79602457|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
44579260|NCT02590432|79602458|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
44579261|NCT02590432|79602459|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
44579262|NCT02590432|79602460|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
44579263|NCT02590432|79602452|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44579264|NCT02590432|79602453|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
44579265|NCT02590432|79602454|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
44579266|NCT02590432|79602455|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
44579267|NCT02590432|79602456|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
44579268|NCT02590432|79602457|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
44579269|NCT02590432|79602458|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
44579270|NCT02590432|79602459|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
44579271|NCT02590432|79602460|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
44579272|NCT02590432|79602452|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579273|NCT02590432|79602453|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579274|NCT02590432|79602454|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44119565|NCT02672852|78903445|FG001|Part B|Worsening pre-existing condition|0|||
44119566|NCT02672852|78903446|FG002|Part B|Worsening pre-existing condition|0|||
44119567|NCT02672852|78903447|FG003|Part B|Worsening pre-existing condition|0|||
44119568|NCT02672852|78903448|FG004|Part B|Worsening pre-existing condition|0|||
44579275|NCT02590432|79602455|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579276|NCT02590432|79602456|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579277|NCT02590432|79602457|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
44579278|NCT02590432|79602458|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579279|NCT02590432|79602459|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579280|NCT02590432|79602460|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
44579281|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579282|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579283|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579284|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579285|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579286|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579287|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
44579288|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
44579289|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
44579290|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579291|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579292|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579293|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579294|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579295|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579296|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579297|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
44579298|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
44579299|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579300|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579301|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579302|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579303|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579304|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579305|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
44579306|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
44579307|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
44579308|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579309|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579310|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579311|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579312|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579313|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579314|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579315|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
44579316|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
44579317|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579318|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579319|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579320|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579321|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579322|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579323|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579324|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
44579325|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
44579326|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579327|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579328|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579329|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579330|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44276202|NCT02218008|79229546|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
44579331|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579332|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579333|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
44579334|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
44579335|NCT02590432|79602452|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579336|NCT02590432|79602453|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44276203|NCT02218008|79229547|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
44508350|NCT00301067|79513604|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
44579337|NCT02590432|79602454|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579338|NCT02590432|79602455|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579339|NCT02590432|79602456|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579340|NCT02590432|79602457|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579341|NCT02590432|79602458|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579342|NCT02590432|79602459|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
44579343|NCT02590432|79602460|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
44579344|NCT02590354|79602472|FG000|Phase 1|Active hepatitis B or C infection|1|||
44579345|NCT02590354|79602472|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
44579346|NCT02590354|79602472|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
44579347|NCT02590354|79602472|FG000|Phase 1|Subject does not want to participate|20|||
44579348|NCT02590354|79602472|FG000|Phase 1|Lost to Follow-up|1|||
44579349|NCT02590354|79602472|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
44579350|NCT01667224|79602479|FG000|Overall Study|Withdrawal by Subject|3|||
44579351|NCT01667224|79602480|FG001|Overall Study|Withdrawal by Subject|1|||
44579352|NCT01667224|79602479|FG000|Overall Study|Protocol Violation|1|||
44579353|NCT01667224|79602480|FG001|Overall Study|Protocol Violation|1|||
44579354|NCT03923738|79602488|FG000|Period 1|Adverse Event|1|||
44508351|NCT00301067|79513605|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
44508352|NCT00301067|79513602|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
44579355|NCT03923738|79602488|FG000|Period 1|Withdrawal by Subject|1|||
44579356|NCT02588248|79602496|FG000|Overall Study|Physician Decision|4|||
44579357|NCT02588248|79602497|FG001|Overall Study|Physician Decision|3|||
44579358|NCT01328054|79602508|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
44579359|NCT01328054|79602509|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
44579360|NCT01328054|79602508|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
44579361|NCT01328054|79602509|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
44579362|NCT01328054|79602508|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
44579363|NCT01328054|79602509|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
44579364|NCT01849250|79602532|FG000|Overall Study|Withdrawal by Subject|1|||
44579365|NCT01849250|79602533|FG001|Overall Study|Withdrawal by Subject|0|||
44579366|NCT01849250|79602532|FG000|Overall Study|Not Evaluable|5|||
44579367|NCT01849250|79602533|FG001|Overall Study|Not Evaluable|3|||
44579368|NCT01849250|79602532|FG000|Overall Study|Screen Failure|1|||
44579369|NCT01849250|79602533|FG001|Overall Study|Screen Failure|0|||
44579370|NCT02791191|79602543|FG000|Overall Study|Adverse Event|2|||
44579371|NCT02791191|79602544|FG001|Overall Study|Adverse Event|4|||
44579372|NCT02791191|79602545|FG002|Overall Study|Adverse Event|5|||
44579373|NCT02791191|79602543|FG000|Overall Study|Lack of Efficacy|0|||
44579374|NCT02791191|79602544|FG001|Overall Study|Lack of Efficacy|1|||
44579375|NCT02791191|79602545|FG002|Overall Study|Lack of Efficacy|0|||
44579376|NCT02791191|79602543|FG000|Overall Study|Study Drug Non-Compliance|0|||
44579377|NCT02791191|79602544|FG001|Overall Study|Study Drug Non-Compliance|2|||
44579378|NCT02791191|79602545|FG002|Overall Study|Study Drug Non-Compliance|0|||
44579379|NCT02791191|79602543|FG000|Overall Study|Site Closed by Sponsor|1|||
44579380|NCT02791191|79602544|FG001|Overall Study|Site Closed by Sponsor|1|||
44508353|NCT00301067|79513603|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
44508354|NCT00301067|79513604|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
44508355|NCT00301067|79513605|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
44508356|NCT00301067|79513602|FG000|Follow up Until Death|Alive at last data cut point|1|||
44508357|NCT00301067|79513603|FG001|Follow up Until Death|Alive at last data cut point|0|||
44508358|NCT00301067|79513604|FG002|Follow up Until Death|Alive at last data cut point|0|||
44508359|NCT00301067|79513605|FG003|Follow up Until Death|Alive at last data cut point|1|||
44508360|NCT00007020|79513616|FG000|Overall Study|Death|16|||
44508361|NCT00007020|79513616|FG000|Overall Study|Lost to Follow-up|13|||
44508362|NCT00007020|79513616|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
44508363|NCT00007020|79513616|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
44508364|NCT00007020|79513616|FG000|Overall Study|Pt cared for by outside physician|4|||
44508365|NCT00007020|79513616|FG000|Overall Study|No evidence of treatment|6|||
44508366|NCT00300755|79513625|FG000|Overall Study|Adverse Event|1|||
44579381|NCT02791191|79602545|FG002|Overall Study|Site Closed by Sponsor|3|||
44579382|NCT02791191|79602543|FG000|Overall Study|Progressive Disease|1|||
44119569|NCT02672852|78903449|FG005|Part B|Worsening pre-existing condition|1|||
44579383|NCT02791191|79602544|FG001|Overall Study|Progressive Disease|0|||
44579384|NCT02791191|79602545|FG002|Overall Study|Progressive Disease|0|||
44579385|NCT02791191|79602543|FG000|Overall Study|Study Terminated by Sponsor|29|||
44508367|NCT00300755|79513626|FG001|Overall Study|Adverse Event|2|||
44579386|NCT02791191|79602544|FG001|Overall Study|Study Terminated by Sponsor|101|||
44579387|NCT02791191|79602545|FG002|Overall Study|Study Terminated by Sponsor|109|||
44579388|NCT02791191|79602543|FG000|Overall Study|Withdrawal by Subject|3|||
44119570|NCT02672852|78903450|FG006|Part B|Worsening pre-existing condition|0|||
44378771|NCT00772603|79384279|FG002|Overall Study|Subject Non-compliance|4|||
44119571|NCT02672852|78903444|FG000|Part B|Other adverse event|0|||
44119572|NCT02672852|78903445|FG001|Part B|Other adverse event|0|||
44579389|NCT02791191|79602544|FG001|Overall Study|Withdrawal by Subject|1|||
44579390|NCT02791191|79602545|FG002|Overall Study|Withdrawal by Subject|3|||
44579391|NCT02791191|79602543|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
44119573|NCT02672852|78903446|FG002|Part B|Other adverse event|0|||
44119574|NCT02672852|78903447|FG003|Part B|Other adverse event|0|||
44119575|NCT02672852|78903448|FG004|Part B|Other adverse event|3|||
44119576|NCT02672852|78903449|FG005|Part B|Other adverse event|5|||
44119577|NCT02672852|78903450|FG006|Part B|Other adverse event|1|||
44119578|NCT02672852|78903444|FG000|Part B|Lost to Follow-up|0|||
44119579|NCT02672852|78903445|FG001|Part B|Lost to Follow-up|0|||
44119580|NCT02672852|78903446|FG002|Part B|Lost to Follow-up|0|||
44119581|NCT02672852|78903447|FG003|Part B|Lost to Follow-up|0|||
44119582|NCT02672852|78903448|FG004|Part B|Lost to Follow-up|3|||
44119583|NCT02672852|78903449|FG005|Part B|Lost to Follow-up|4|||
44119584|NCT02672852|78903450|FG006|Part B|Lost to Follow-up|1|||
44119585|NCT02672852|78903444|FG000|Part B|Withdrawal by Subject|0|||
44119586|NCT02672852|78903445|FG001|Part B|Withdrawal by Subject|0|||
44119587|NCT02672852|78903446|FG002|Part B|Withdrawal by Subject|0|||
44119588|NCT02672852|78903447|FG003|Part B|Withdrawal by Subject|0|||
44119589|NCT02672852|78903448|FG004|Part B|Withdrawal by Subject|5|||
44119590|NCT02672852|78903449|FG005|Part B|Withdrawal by Subject|0|||
44119591|NCT02672852|78903450|FG006|Part B|Withdrawal by Subject|7|||
44119592|NCT02672852|78903444|FG000|Part B|Other|0|||
44119593|NCT02672852|78903445|FG001|Part B|Other|0|||
44119594|NCT02672852|78903446|FG002|Part B|Other|0|||
44119595|NCT02672852|78903447|FG003|Part B|Other|0|||
44119596|NCT02672852|78903448|FG004|Part B|Other|4|||
44119597|NCT02672852|78903449|FG005|Part B|Other|1|||
44119598|NCT02672852|78903450|FG006|Part B|Other|2|||
44508368|NCT00300755|79513627|FG002|Overall Study|Adverse Event|1|||
44579392|NCT02791191|79602544|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
44579393|NCT02791191|79602545|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
44579394|NCT02114697|79602568|FG000|Overall Study|Study terminated|5|||
44579395|NCT02114697|79602569|FG001|Overall Study|Study terminated|4|||
44579396|NCT01330017|79602580|FG000|Overall Study|Adverse Event|0|||
44579397|NCT01330017|79602581|FG001|Overall Study|Adverse Event|1|||
44579398|NCT01330017|79602582|FG002|Overall Study|Adverse Event|1|||
44579399|NCT01330017|79602583|FG003|Overall Study|Adverse Event|4|||
44579400|NCT01330017|79602584|FG004|Overall Study|Adverse Event|0|||
44579401|NCT01330017|79602580|FG000|Overall Study|Withdrawal by Subject|0|||
44579402|NCT01330017|79602581|FG001|Overall Study|Withdrawal by Subject|0|||
44579403|NCT01330017|79602582|FG002|Overall Study|Withdrawal by Subject|1|||
44579404|NCT01330017|79602583|FG003|Overall Study|Withdrawal by Subject|0|||
44579405|NCT01330017|79602584|FG004|Overall Study|Withdrawal by Subject|1|||
44579406|NCT01330017|79602580|FG000|Overall Study|Lost to Follow-up|0|||
44579407|NCT01330017|79602581|FG001|Overall Study|Lost to Follow-up|0|||
44579408|NCT01330017|79602582|FG002|Overall Study|Lost to Follow-up|1|||
44579409|NCT01330017|79602583|FG003|Overall Study|Lost to Follow-up|0|||
44579410|NCT01330017|79602584|FG004|Overall Study|Lost to Follow-up|0|||
44508369|NCT00300755|79513625|FG000|Overall Study|Withdrawal by Subject|0|||
44508370|NCT00300755|79513626|FG001|Overall Study|Withdrawal by Subject|2|||
44579411|NCT01330017|79602580|FG000|Overall Study|Protocol Violation|0|||
44579412|NCT01330017|79602581|FG001|Overall Study|Protocol Violation|0|||
44508371|NCT00300755|79513627|FG002|Overall Study|Withdrawal by Subject|0|||
44508372|NCT00300755|79513625|FG000|Overall Study|Protocol Violation|0|||
44508373|NCT00300755|79513626|FG001|Overall Study|Protocol Violation|0|||
44508374|NCT00300755|79513627|FG002|Overall Study|Protocol Violation|1|||
44508375|NCT00033540|79513635|FG000|Overall Study|Adverse Event|14|||
44508376|NCT00033540|79513635|FG000|Overall Study|Death|1|||
44508377|NCT00033540|79513635|FG000|Overall Study|Progression|26|||
44508378|NCT00033540|79513635|FG000|Overall Study|Withdrawal by Subject|6|||
44508379|NCT00033540|79513635|FG000|Overall Study|Other|5|||
44508380|NCT00033540|79513635|FG000|Overall Study|Ineligible|3|||
44579413|NCT01330017|79602582|FG002|Overall Study|Protocol Violation|0|||
44579414|NCT01330017|79602583|FG003|Overall Study|Protocol Violation|1|||
44579415|NCT01330017|79602584|FG004|Overall Study|Protocol Violation|0|||
44119599|NCT02671760|78903461|FG000|Overall Study|Lost to Follow-up|0|||
44119600|NCT02671760|78903462|FG001|Overall Study|Lost to Follow-up|1|||
44119601|NCT02671760|78903463|FG002|Overall Study|Lost to Follow-up|0|||
44119602|NCT02667236|78903473|FG000|Overall Study|Adverse Event|1|||
44119603|NCT02667236|78903474|FG001|Overall Study|Adverse Event|1|||
44119604|NCT02667236|78903473|FG000|Overall Study|Withdrawal by Subject|2|||
44119605|NCT02667236|78903474|FG001|Overall Study|Withdrawal by Subject|0|||
44119606|NCT01126749|78903484|FG000|Phase 1b|Other|0|||
44119607|NCT01126749|78903485|FG001|Phase 1b|Other|1|||
44119608|NCT01126749|78903486|FG002|Phase 1b|Other|0|||
44119609|NCT01126749|78903487|FG003|Phase 1b|Other|0|||
44579416|NCT01330017|79602580|FG000|Overall Study|Unknown Reason|5|||
44579417|NCT01330017|79602581|FG001|Overall Study|Unknown Reason|3|||
44579418|NCT01330017|79602582|FG002|Overall Study|Unknown Reason|5|||
44579419|NCT01330017|79602583|FG003|Overall Study|Unknown Reason|7|||
44579420|NCT01330017|79602584|FG004|Overall Study|Unknown Reason|2|||
44579421|NCT05375838|79602615|FG000|Overall Study|Other|0|||
44579422|NCT05375838|79602616|FG001|Overall Study|Other|0|||
44579423|NCT05375838|79602617|FG002|Overall Study|Other|0|||
44579424|NCT05375838|79602618|FG003|Overall Study|Other|1|||
44579425|NCT05375838|79602619|FG004|Overall Study|Other|1|||
44579426|NCT05375838|79602620|FG005|Overall Study|Other|0|||
44579427|NCT05375838|79602615|FG000|Overall Study|Withdrawal by Subject|2|||
44579428|NCT05375838|79602616|FG001|Overall Study|Withdrawal by Subject|1|||
44579429|NCT05375838|79602617|FG002|Overall Study|Withdrawal by Subject|3|||
44119610|NCT01126749|78903484|FG000|Phase 1b|Withdrawal by Subject|0|||
44119611|NCT01126749|78903485|FG001|Phase 1b|Withdrawal by Subject|1|||
44119612|NCT01126749|78903486|FG002|Phase 1b|Withdrawal by Subject|0|||
44119613|NCT01126749|78903487|FG003|Phase 1b|Withdrawal by Subject|0|||
44119614|NCT01126749|78903484|FG000|Phase 1b|Death|3|||
44119615|NCT01126749|78903485|FG001|Phase 1b|Death|4|||
44119616|NCT01126749|78903486|FG002|Phase 1b|Death|0|||
44119617|NCT01126749|78903487|FG003|Phase 1b|Death|0|||
44119618|NCT01126749|78903484|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
44119619|NCT01126749|78903485|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
44119620|NCT01126749|78903486|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
44119621|NCT01126749|78903487|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
44119622|NCT01126749|78903484|FG000|Phase 2|Study Termination by Sponsor|0|||
44119623|NCT01126749|78903485|FG001|Phase 2|Study Termination by Sponsor|0|||
44119624|NCT01126749|78903486|FG002|Phase 2|Study Termination by Sponsor|12|||
44119625|NCT01126749|78903487|FG003|Phase 2|Study Termination by Sponsor|6|||
44119626|NCT01126749|78903484|FG000|Phase 2|Other|0|||
44119627|NCT01126749|78903485|FG001|Phase 2|Other|0|||
44119628|NCT01126749|78903486|FG002|Phase 2|Other|4|||
44119629|NCT01126749|78903487|FG003|Phase 2|Other|2|||
44119630|NCT01126749|78903484|FG000|Phase 2|Withdrawal by Subject|0|||
44119631|NCT01126749|78903485|FG001|Phase 2|Withdrawal by Subject|0|||
44119632|NCT01126749|78903486|FG002|Phase 2|Withdrawal by Subject|0|||
44119633|NCT01126749|78903487|FG003|Phase 2|Withdrawal by Subject|2|||
44119634|NCT01126749|78903484|FG000|Phase 2|Lost to Follow-up|0|||
44119635|NCT01126749|78903485|FG001|Phase 2|Lost to Follow-up|0|||
44119636|NCT01126749|78903486|FG002|Phase 2|Lost to Follow-up|0|||
44579430|NCT05375838|79602618|FG003|Overall Study|Withdrawal by Subject|2|||
44579431|NCT05375838|79602619|FG004|Overall Study|Withdrawal by Subject|2|||
44579432|NCT05375838|79602620|FG005|Overall Study|Withdrawal by Subject|0|||
44579433|NCT05375838|79602615|FG000|Overall Study|Protocol Violation|0|||
44579434|NCT05375838|79602616|FG001|Overall Study|Protocol Violation|0|||
44579435|NCT05375838|79602617|FG002|Overall Study|Protocol Violation|0|||
44579436|NCT05375838|79602618|FG003|Overall Study|Protocol Violation|0|||
44579437|NCT05375838|79602619|FG004|Overall Study|Protocol Violation|1|||
44579438|NCT05375838|79602620|FG005|Overall Study|Protocol Violation|0|||
44579439|NCT05375838|79602615|FG000|Overall Study|Physician Decision|0|||
44579440|NCT05375838|79602616|FG001|Overall Study|Physician Decision|1|||
44579441|NCT05375838|79602617|FG002|Overall Study|Physician Decision|0|||
44579442|NCT05375838|79602618|FG003|Overall Study|Physician Decision|0|||
44579443|NCT05375838|79602619|FG004|Overall Study|Physician Decision|0|||
44579444|NCT05375838|79602620|FG005|Overall Study|Physician Decision|1|||
44579445|NCT05375838|79602615|FG000|Overall Study|Lost to Follow-up|2|||
44579446|NCT05375838|79602616|FG001|Overall Study|Lost to Follow-up|7|||
44579447|NCT05375838|79602617|FG002|Overall Study|Lost to Follow-up|0|||
44579448|NCT05375838|79602618|FG003|Overall Study|Lost to Follow-up|4|||
44579449|NCT05375838|79602619|FG004|Overall Study|Lost to Follow-up|2|||
44119637|NCT01126749|78903487|FG003|Phase 2|Lost to Follow-up|1|||
44119638|NCT01126749|78903484|FG000|Phase 2|Death|0|||
44378772|NCT00772603|79384277|FG000|Overall Study|Protocol Violation|0|||
44508381|NCT00033540|79513635|FG000|Overall Study|Never received treatment|2|||
44508382|NCT00300365|79513642|FG000|Overall Study|Lost to Follow-up|1|||
44508383|NCT00300365|79513643|FG001|Overall Study|Lost to Follow-up|0|||
44508384|NCT00300365|79513642|FG000|Overall Study|Physician Decision|2|||
44508385|NCT00300365|79513643|FG001|Overall Study|Physician Decision|0|||
44508386|NCT00300365|79513642|FG000|Overall Study|Withdrawal by Subject|1|||
44508387|NCT00300365|79513643|FG001|Overall Study|Withdrawal by Subject|0|||
44508388|NCT00300365|79513642|FG000|Overall Study|Adverse Event|0|||
44508389|NCT00300365|79513643|FG001|Overall Study|Adverse Event|2|||
44579450|NCT05375838|79602620|FG005|Overall Study|Lost to Follow-up|3|||
44119639|NCT01126749|78903485|FG001|Phase 2|Death|0|||
44119640|NCT01126749|78903486|FG002|Phase 2|Death|22|||
44119641|NCT01126749|78903487|FG003|Phase 2|Death|22|||
44119642|NCT01126749|78903484|FG000|Phase 2|Adverse Event|0|||
44119643|NCT01126749|78903485|FG001|Phase 2|Adverse Event|0|||
44119644|NCT01126749|78903486|FG002|Phase 2|Adverse Event|0|||
44119645|NCT01126749|78903487|FG003|Phase 2|Adverse Event|1|||
44119646|NCT02521948|78903497|FG000|Overall Study|Adverse Event|2|||
44119647|NCT02521948|78903497|FG000|Overall Study|Death|4|||
44119648|NCT02521948|78903497|FG000|Overall Study|Lost to Follow-up|1|||
44119649|NCT02521948|78903497|FG000|Overall Study|Did not attend one or both follow-ups|6|||
44119650|NCT04446429|78903506|FG000|Overall Study|Lost to Follow-up|6|||
44119651|NCT04446429|78903507|FG001|Overall Study|Lost to Follow-up|0|||
44119652|NCT02832687|78903515|FG000|Overall Study|Adverse Event|0|||
44119653|NCT02832687|78903516|FG001|Overall Study|Adverse Event|2|||
44119654|NCT01656850|78903541|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
44119655|NCT01656850|78903542|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
44119656|NCT03116685|78903554|FG000|Overall Study|Physician Decision|0|||
44119657|NCT03116685|78903555|FG001|Overall Study|Physician Decision|1|||
44119658|NCT02666222|78903575|FG000|Overall Study|Death|2|||
44119659|NCT00739401|78903579|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
44119660|NCT00739401|78903579|FG000|Overall Study|Death|3|||
44119661|NCT00739401|78903579|FG000|Overall Study|Withdrawal by Subject|4|||
44119662|NCT01365052|78903585|FG000|Overall Study|Adverse Event|4|||
44119663|NCT01365052|78903586|FG001|Overall Study|Adverse Event|4|||
44119664|NCT01372748|78903594|FG000|Overall Study|Lost to Follow-up|16|||
44119665|NCT01372748|78903595|FG001|Overall Study|Lost to Follow-up|34|||
44119666|NCT01372748|78903594|FG000|Overall Study|Withdrawal by Subject|7|||
44119667|NCT01372748|78903595|FG001|Overall Study|Withdrawal by Subject|5|||
44119668|NCT02736825|78903603|FG000|Overall Study|Lost to Follow-up|10|||
44579451|NCT05332392|79602639|FG000|Overall Study|Did not meet inclusion criteria|25|||
44579452|NCT05332392|79602639|FG000|Overall Study|Principal Investigator's decision|17|||
44579453|NCT05332392|79602639|FG000|Overall Study|Adverse Event|1|||
44579454|NCT05332392|79602639|FG000|Overall Study|Subject's decision|1|||
44579455|NCT05315908|79602649|FG000|Overall Study|Lost to Follow-up|4477|||
44579456|NCT05315908|79602650|FG001|Overall Study|Lost to Follow-up|4606|||
44579457|NCT05005273|79602699|FG000|Overall Study|Study Terminated|1|||
44579458|NCT05005273|79602700|FG001|Overall Study|Study Terminated|0|||
44579459|NCT04907227|79602708|FG000|Overall Study|Death|10|||
44119669|NCT02736825|78903604|FG001|Overall Study|Lost to Follow-up|11|||
44119670|NCT02736825|78903603|FG000|Overall Study|Early Termination|0|||
44119671|NCT02736825|78903604|FG001|Overall Study|Early Termination|1|||
44119672|NCT02670122|78903611|FG000|Overall Study|Lost to Follow-up|4|||
44119673|NCT03283371|78903624|FG000|Placebo-controlled|Adverse Event|1|||
44119674|NCT03283371|78903625|FG001|Placebo-controlled|Adverse Event|1|||
44119675|NCT03283371|78903626|FG002|Placebo-controlled|Adverse Event|0|||
44119676|NCT03283371|78903627|FG003|Placebo-controlled|Adverse Event|0|||
44119677|NCT03283371|78903624|FG000|Placebo-controlled|Lack of Efficacy|1|||
44119678|NCT03283371|78903625|FG001|Placebo-controlled|Lack of Efficacy|0|||
44119679|NCT03283371|78903626|FG002|Placebo-controlled|Lack of Efficacy|0|||
44119680|NCT03283371|78903627|FG003|Placebo-controlled|Lack of Efficacy|0|||
44119681|NCT03283371|78903624|FG000|Placebo-controlled|Withdrawal by Subject|1|||
44119682|NCT03283371|78903625|FG001|Placebo-controlled|Withdrawal by Subject|1|||
44119683|NCT03283371|78903626|FG002|Placebo-controlled|Withdrawal by Subject|0|||
44119684|NCT03283371|78903627|FG003|Placebo-controlled|Withdrawal by Subject|0|||
44119685|NCT03283371|78903624|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
44119686|NCT03283371|78903625|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
44508390|NCT00048048|79513658|FG000|Core Treatment|Withdrawal by Subject|0|||
44508391|NCT00048048|79513659|FG001|Core Treatment|Withdrawal by Subject|0|||
44508392|NCT00048048|79513660|FG002|Core Treatment|Withdrawal by Subject|1|||
44508393|NCT00048048|79513661|FG003|Core Treatment|Withdrawal by Subject|0|||
44508394|NCT00048048|79513662|FG004|Core Treatment|Withdrawal by Subject|0|||
44508395|NCT00048048|79513663|FG005|Core Treatment|Withdrawal by Subject|0|||
44508396|NCT00048048|79513664|FG006|Core Treatment|Withdrawal by Subject|0|||
44508397|NCT00048048|79513665|FG007|Core Treatment|Withdrawal by Subject|0|||
44508398|NCT00048048|79513666|FG008|Core Treatment|Withdrawal by Subject|0|||
44508399|NCT00048048|79513667|FG009|Core Treatment|Withdrawal by Subject|0|||
44508400|NCT00048048|79513668|FG010|Core Treatment|Withdrawal by Subject|0|||
44579460|NCT04907227|79602709|FG001|Overall Study|Death|7|||
44579461|NCT04907227|79602708|FG000|Overall Study|Withdrawal by Subject|1|||
44579462|NCT04907227|79602709|FG001|Overall Study|Withdrawal by Subject|0|||
44579463|NCT04907227|79602708|FG000|Overall Study|Participants ongoing in the study|30|||
44579464|NCT04907227|79602709|FG001|Overall Study|Participants ongoing in the study|33|||
44579465|NCT04846569|79602717|FG000|Overall Study|Withdrawal by Subject|3|||
44119687|NCT03283371|78903626|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
44276204|NCT02218008|79229542|FG000|Stage 2 (S2)|Adverse Event|0|||
44378773|NCT00772603|79384278|FG001|Overall Study|Protocol Violation|1|||
44508401|NCT00048048|79513669|FG011|Core Treatment|Withdrawal by Subject|0|||
44579466|NCT04846569|79602718|FG001|Overall Study|Withdrawal by Subject|1|||
44579467|NCT04741802|79602724|FG000|Overall Study|Death|1|||
44579468|NCT04741802|79602724|FG000|Overall Study|Lost to Follow-up|11|||
44579469|NCT04623086|79602730|FG000|Overall Study|Withdrawal by Subject|0|||
44119688|NCT03283371|78903627|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
44119689|NCT03283371|78903624|FG000|Open-label Phase|Adverse Event|0|||
44119690|NCT03283371|78903625|FG001|Open-label Phase|Adverse Event|0|||
44119691|NCT03283371|78903626|FG002|Open-label Phase|Adverse Event|2|||
44579470|NCT04623086|79602731|FG001|Overall Study|Withdrawal by Subject|0|||
44579471|NCT04623086|79602732|FG002|Overall Study|Withdrawal by Subject|10|||
44579472|NCT04587193|79602741|FG000|Overall Study|Screen failure after consent|3|||
44579473|NCT04587193|79602742|FG001|Overall Study|Screen failure after consent|0|||
44579474|NCT04587193|79602741|FG000|Overall Study|Device broke during study|3|||
44579475|NCT04587193|79602742|FG001|Overall Study|Device broke during study|2|||
44579476|NCT04576455|79602750|FG000|Overall Study|Ongoing in the Study|122|||
44579477|NCT04576455|79602751|FG001|Overall Study|Ongoing in the Study|135|||
44579478|NCT04576455|79602750|FG000|Overall Study|Death|18|||
44579479|NCT04576455|79602751|FG001|Overall Study|Death|12|||
44579480|NCT04576455|79602750|FG000|Overall Study|Lost to Follow-up|1|||
44579481|NCT04576455|79602751|FG001|Overall Study|Lost to Follow-up|0|||
44579482|NCT04576455|79602750|FG000|Overall Study|Withdrawal by Subject|10|||
44579483|NCT04576455|79602751|FG001|Overall Study|Withdrawal by Subject|5|||
44579484|NCT04338269|79602795|FG000|Overall Study|Death|86|||
44579485|NCT04338269|79602796|FG001|Overall Study|Death|89|||
44579486|NCT04338269|79602795|FG000|Overall Study|Lost to Follow-up|1|||
44579487|NCT04338269|79602796|FG001|Overall Study|Lost to Follow-up|2|||
44579488|NCT04338269|79602795|FG000|Overall Study|Physician Decision|1|||
44579489|NCT04338269|79602796|FG001|Overall Study|Physician Decision|0|||
44579490|NCT04338269|79602795|FG000|Overall Study|Withdrawal by Subject|14|||
44579491|NCT04338269|79602796|FG001|Overall Study|Withdrawal by Subject|11|||
44579492|NCT04325828|79602802|FG000|Overall Study|Ongoing|26|||
44579493|NCT04305327|79602810|FG000|Overall Study|Study early termination|2|||
44579494|NCT04305327|79602811|FG001|Overall Study|Study early termination|5|||
44579495|NCT04305327|79602812|FG002|Overall Study|Study early termination|2|||
44579496|NCT04305327|79602813|FG003|Overall Study|Study early termination|2|||
44579497|NCT04305327|79602810|FG000|Overall Study|Withdrawal by Subject|0|||
44579498|NCT04305327|79602811|FG001|Overall Study|Withdrawal by Subject|1|||
44579499|NCT04305327|79602812|FG002|Overall Study|Withdrawal by Subject|0|||
44579500|NCT04305327|79602813|FG003|Overall Study|Withdrawal by Subject|0|||
44579501|NCT04281030|79602825|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
44579502|NCT04281030|79602826|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
44579503|NCT04281030|79602825|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
44579504|NCT04281030|79602826|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
44579505|NCT04129242|79602838|FG000|Overall Study|Physician Decision|1|||
44579506|NCT04129242|79602839|FG001|Overall Study|Physician Decision|1|||
44579507|NCT04129242|79602838|FG000|Overall Study|Protocol Violation|0|||
44579508|NCT04129242|79602839|FG001|Overall Study|Protocol Violation|1|||
44579509|NCT04122443|79602847|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
44579510|NCT04122443|79602848|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
44579511|NCT04122443|79602849|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
44579512|NCT04122443|79602847|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
44579513|NCT04122443|79602848|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
44579514|NCT04122443|79602849|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
44579515|NCT04075396|79602858|FG000|Overall Study|Death|11|||
44579516|NCT04075396|79602859|FG001|Overall Study|Death|9|||
44579517|NCT04075396|79602858|FG000|Overall Study|Withdrawal by Subject|1|||
44579518|NCT04075396|79602859|FG001|Overall Study|Withdrawal by Subject|2|||
44579519|NCT04075396|79602858|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
44579520|NCT04075396|79602859|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
44579521|NCT04075396|79602858|FG000|Overall Study|Enrolled but not-treated|0|||
44579522|NCT04075396|79602859|FG001|Overall Study|Enrolled but not-treated|1|||
44579523|NCT03979313|79602867|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
44579524|NCT03979313|79602868|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
44579525|NCT03979313|79602867|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
44579526|NCT03979313|79602868|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
44579527|NCT03979313|79602867|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
44579528|NCT03979313|79602868|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
44579529|NCT03979313|79602867|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
44579530|NCT03979313|79602868|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
44579531|NCT03979313|79602867|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
44579532|NCT03979313|79602868|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
44579533|NCT03979313|79602867|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
44239508|NCT01544153|79066357|FG003|Overall Study|Non-smoker|0|||
44579534|NCT03979313|79602868|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
44579535|NCT03979313|79602867|FG000|All Subjects|Any Other Reason|16|||
44579536|NCT03979313|79602868|FG001|All Subjects|Any Other Reason|23|||
44579537|NCT03979313|79602867|FG000|All Subjects|Covid-19|1|||
44239509|NCT01543685|79066372|FG000|Overall Study|Lack of Efficacy|1|||
44378774|NCT00772603|79384279|FG002|Overall Study|Protocol Violation|1|||
44579538|NCT03979313|79602868|FG001|All Subjects|Covid-19|3|||
44579539|NCT03979313|79602867|FG000|All Subjects|Withdrawal by Subject|35|||
44579540|NCT03979313|79602868|FG001|All Subjects|Withdrawal by Subject|44|||
44579541|NCT03979313|79602867|FG000|All Subjects|Death|0|||
44579542|NCT03979313|79602868|FG001|All Subjects|Death|5|||
44579543|NCT03979313|79602867|FG000|All Subjects|Lost to Follow-up|28|||
44579544|NCT03979313|79602868|FG001|All Subjects|Lost to Follow-up|61|||
44579545|NCT03930732|79602896|FG000|Overall Study|Adverse Event|9|||
44579546|NCT03930732|79602897|FG001|Overall Study|Adverse Event|7|||
44579547|NCT03930732|79602896|FG000|Overall Study|Poor compliance to protocol|0|||
44579548|NCT03930732|79602897|FG001|Overall Study|Poor compliance to protocol|1|||
44579549|NCT03930732|79602896|FG000|Overall Study|Withdrawal by Subject|23|||
44579550|NCT03930732|79602897|FG001|Overall Study|Withdrawal by Subject|11|||
44579551|NCT03930732|79602896|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
44579552|NCT03930732|79602897|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
44579553|NCT03930732|79602896|FG000|Overall Study|Other reason not related to COVID-19|5|||
44579554|NCT03930732|79602897|FG001|Overall Study|Other reason not related to COVID-19|8|||
44579555|NCT03783078|79602914|FG000|Overall Study|Participants Ongoing|29|||
44579556|NCT03783078|79602914|FG000|Overall Study|Death|26|||
44579557|NCT03732820|79602920|FG000|Overall Study|Death|168|||
44579558|NCT03732820|79602921|FG001|Overall Study|Death|203|||
44579559|NCT03732820|79602920|FG000|Overall Study|Other|2|||
44579560|NCT03732820|79602921|FG001|Overall Study|Other|2|||
44579561|NCT03732820|79602920|FG000|Overall Study|Failure to meet randomisation criteria|1|||
44579562|NCT03732820|79602921|FG001|Overall Study|Failure to meet randomisation criteria|1|||
44579563|NCT03732820|79602920|FG000|Overall Study|Patient decision|14|||
44579564|NCT03732820|79602921|FG001|Overall Study|Patient decision|10|||
44579565|NCT03732820|79602920|FG000|Overall Study|Screen failure|0|||
44119692|NCT03283371|78903627|FG003|Open-label Phase|Adverse Event|0|||
44119693|NCT03283371|78903624|FG000|Open-label Phase|Withdrawal by Subject|0|||
44119694|NCT03283371|78903625|FG001|Open-label Phase|Withdrawal by Subject|0|||
44119695|NCT03283371|78903626|FG002|Open-label Phase|Withdrawal by Subject|1|||
44119696|NCT03283371|78903627|FG003|Open-label Phase|Withdrawal by Subject|0|||
44119697|NCT03283371|78903624|FG000|Open-label Phase|Other|0|||
44119698|NCT03283371|78903625|FG001|Open-label Phase|Other|0|||
44119699|NCT03283371|78903626|FG002|Open-label Phase|Other|1|||
44119700|NCT03283371|78903627|FG003|Open-label Phase|Other|1|||
44119701|NCT03069417|78903639|FG000|Overall Study|Lost to Follow-up|2|||
44119702|NCT03069417|78903640|FG001|Overall Study|Lost to Follow-up|0|||
44119703|NCT03069417|78903639|FG000|Overall Study|Reason Unknown|4|||
44119704|NCT03069417|78903640|FG001|Overall Study|Reason Unknown|7|||
44119705|NCT04930263|78903649|FG000|Overall Study|Withdrawal by Subject|3|||
44119706|NCT04930263|78903650|FG001|Overall Study|Withdrawal by Subject|5|||
44119707|NCT02665286|78903659|FG000|Overall Study|Lost to Follow-up|3|||
44119708|NCT02665286|78903660|FG001|Overall Study|Lost to Follow-up|2|||
44119709|NCT02665286|78903661|FG002|Overall Study|Lost to Follow-up|1|||
44119710|NCT02911519|78903671|FG000|Overall Study|Lost to Follow-up|2|||
44119711|NCT02911519|78903672|FG001|Overall Study|Lost to Follow-up|2|||
44119712|NCT02911519|78903671|FG000|Overall Study|Death|0|||
44119713|NCT02911519|78903672|FG001|Overall Study|Death|2|||
44119714|NCT02911285|78903680|FG000|Overall Study|Lost to Follow-up|8|||
44119715|NCT02911285|78903681|FG001|Overall Study|Lost to Follow-up|5|||
44119716|NCT02911285|78903680|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
44579566|NCT03732820|79602921|FG001|Overall Study|Screen failure|1|||
44579567|NCT03732820|79602920|FG000|Overall Study|Patients ongoing study at data cut off|210|||
44119717|NCT02911285|78903681|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
44119718|NCT02910739|78903693|FG000|Overall Study|Adverse Event|1|||
44119719|NCT02910739|78903694|FG001|Overall Study|Adverse Event|0|||
44119720|NCT02910739|78903695|FG002|Overall Study|Adverse Event|0|||
44119721|NCT02910739|78903696|FG003|Overall Study|Adverse Event|0|||
44119722|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
44579568|NCT03732820|79602921|FG001|Overall Study|Patients ongoing study at data cut off|178|||
44579569|NCT03732820|79602920|FG000|Overall Study|Lost to Follow-up|4|||
44579570|NCT03732820|79602921|FG001|Overall Study|Lost to Follow-up|2|||
44579571|NCT03704051|79602927|FG000|Overall Study|Withdrawal by Subject|4|||
44579572|NCT03704051|79602928|FG001|Overall Study|Withdrawal by Subject|0|||
44579573|NCT03694522|79602938|FG000|Overall Study|Withdrawal by Subject|8|||
44119723|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
44579574|NCT03694522|79602939|FG001|Overall Study|Withdrawal by Subject|10|||
44579575|NCT03694522|79602938|FG000|Overall Study|Physician Decision|53|||
44119724|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
44119725|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
44239510|NCT01543685|79066373|FG001|Overall Study|Lack of Efficacy|2|||
44579576|NCT03694522|79602939|FG001|Overall Study|Physician Decision|54|||
44579577|NCT03694522|79602938|FG000|Overall Study|Other|1|||
44579578|NCT03694522|79602939|FG001|Overall Study|Other|1|||
44579579|NCT03694522|79602938|FG000|Overall Study|Lost to Follow-up|0|||
44579580|NCT03694522|79602939|FG001|Overall Study|Lost to Follow-up|1|||
44119726|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
44119727|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
44119728|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
44119729|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
44119730|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
44119731|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
44119732|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
44119733|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
44119734|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
44119735|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
44119736|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
44119737|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
44119738|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
44119739|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
44119740|NCT01069939|78903704|FG000|Randomised and Included in the Analyses|Removal|1|||
44119741|NCT01069939|78903705|FG001|Randomised and Included in the Analyses|Removal|0|||
44119742|NCT01069705|78903711|FG000|Overall Study|Adverse Event|1|||
44119743|NCT01069705|78903711|FG000|Overall Study|Withdrawal by Subject|2|||
44119744|NCT01069627|78903715|FG000|Overall Study|Disease progression|7|||
44119745|NCT01069627|78903715|FG000|Overall Study|Adverse Event|12|||
44119746|NCT01069627|78903715|FG000|Overall Study|Protocol Violation|1|||
44119747|NCT03021551|78903719|FG000|Overall Study|Equipment Issues|2|||
44119748|NCT03021551|78903719|FG000|Overall Study|Protocol Violation|1|||
44119749|NCT01585025|78903726|FG000|Overall Study|Withdrawal by Subject|0|||
44119750|NCT01585025|78903727|FG001|Overall Study|Withdrawal by Subject|3|||
44119751|NCT01585025|78903728|FG002|Overall Study|Withdrawal by Subject|4|||
44119752|NCT01068769|78903736|FG000|Overall Study|Ineligible|1|||
44119753|NCT05114564|78903755|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
44119754|NCT05114564|78903756|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
44579581|NCT03664960|79602947|FG000|Overall Study|Adverse Event|0|||
44579582|NCT03664960|79602948|FG001|Overall Study|Adverse Event|3|||
44579583|NCT03664960|79602947|FG000|Overall Study|Lost to Follow-up|3|||
44119755|NCT05114564|78903755|FG000|First Intervention|Adverse Event|0|||
44119756|NCT05114564|78903756|FG001|First Intervention|Adverse Event|1|||
44119757|NCT04706416|78903764|FG000|Overall Study|Lost to Follow-up|2|||
44119758|NCT04706416|78903765|FG001|Overall Study|Lost to Follow-up|0|||
44119759|NCT04683926|78903778|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
44119760|NCT04683926|78903779|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
44119761|NCT04683926|78903780|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
44119762|NCT04683926|78903781|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
44119763|NCT04343755|78903793|FG000|Overall Study|Death|11|||
44119764|NCT04343755|78903793|FG000|Overall Study|Screen Failure|1|||
44119765|NCT04285346|78903797|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
44119766|NCT04285346|78903798|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
44119767|NCT04285346|78903797|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
44119768|NCT04285346|78903798|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
44119769|NCT04285346|78903797|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
44119770|NCT04285346|78903798|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
44119771|NCT04148287|78903813|FG000|Overall Study|Death|2|||
44579584|NCT03664960|79602948|FG001|Overall Study|Lost to Follow-up|2|||
44579585|NCT03664960|79602947|FG000|Overall Study|Physician Decision|1|||
44579586|NCT03664960|79602948|FG001|Overall Study|Physician Decision|0|||
44579587|NCT03664960|79602947|FG000|Overall Study|Withdrawal by Subject|3|||
44579588|NCT03664960|79602948|FG001|Overall Study|Withdrawal by Subject|14|||
44579589|NCT03664960|79602947|FG000|Overall Study|Sponsor Decision|1|||
44579590|NCT03664960|79602948|FG001|Overall Study|Sponsor Decision|1|||
44579591|NCT03664960|79602947|FG000|Overall Study|Other|1|||
44579592|NCT03664960|79602948|FG001|Overall Study|Other|2|||
44579593|NCT03652051|79602970|FG000|Stage 1|Adverse Event|0|||
44119772|NCT03772613|78903841|FG000|Overall Study|Lost to Follow-up|0|||
44119773|NCT03772613|78903842|FG001|Overall Study|Lost to Follow-up|1|||
44119774|NCT03772613|78903843|FG002|Overall Study|Lost to Follow-up|1|||
44119775|NCT03739437|78903853|FG000|Overall Study|Lost to Follow-up|2|||
44119776|NCT03739437|78903854|FG001|Overall Study|Lost to Follow-up|5|||
44119777|NCT03701555|78903896|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
44119778|NCT03701555|78903897|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
44119779|NCT03701555|78903898|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
44579594|NCT03652051|79602971|FG001|Stage 1|Adverse Event|5|||
44579595|NCT03652051|79602972|FG002|Stage 1|Adverse Event|7|||
44579596|NCT03652051|79602973|FG003|Stage 1|Adverse Event|1|||
44579597|NCT03652051|79602970|FG000|Stage 1|Withdrawal by Subject|0|||
44579598|NCT03652051|79602971|FG001|Stage 1|Withdrawal by Subject|0|||
44579599|NCT03652051|79602972|FG002|Stage 1|Withdrawal by Subject|1|||
44579600|NCT03652051|79602973|FG003|Stage 1|Withdrawal by Subject|0|||
44119780|NCT03701555|78903899|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
44119781|NCT03701555|78903900|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
44119782|NCT03701555|78903901|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
44119783|NCT03701555|78903902|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
44119784|NCT03701555|78903903|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
44119785|NCT03701555|78903904|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
44119786|NCT03701555|78903905|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
44119787|NCT03701555|78903906|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
44119788|NCT03701555|78903907|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
44119789|NCT03701555|78903908|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
44119790|NCT03701555|78903909|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
44119791|NCT03701555|78903910|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
44119792|NCT03701555|78903911|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
44119793|NCT03701555|78903912|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
44119794|NCT03701555|78903913|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
44119795|NCT03701555|78903914|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
44119796|NCT03701555|78903915|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
44119797|NCT03701555|78903916|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
44119798|NCT03701555|78903917|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
44119799|NCT03701555|78903918|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
44119800|NCT03701555|78903919|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
44239511|NCT01543685|79066374|FG002|Overall Study|Lack of Efficacy|2|||
44508402|NCT00048048|79513658|FG000|Core Treatment|Adverse Event|0|||
44508403|NCT00048048|79513659|FG001|Core Treatment|Adverse Event|0|||
44508404|NCT00048048|79513660|FG002|Core Treatment|Adverse Event|0|||
44508405|NCT00048048|79513661|FG003|Core Treatment|Adverse Event|0|||
44579601|NCT03652051|79602970|FG000|Stage 2|Adverse Event|0|||
44579602|NCT03652051|79602971|FG001|Stage 2|Adverse Event|2|||
44579603|NCT03652051|79602972|FG002|Stage 2|Adverse Event|1|||
44579604|NCT03652051|79602973|FG003|Stage 2|Adverse Event|0|||
44579605|NCT03652051|79602970|FG000|Stage 2|Protocol Violation|0|||
44579606|NCT03652051|79602971|FG001|Stage 2|Protocol Violation|1|||
44579607|NCT03652051|79602972|FG002|Stage 2|Protocol Violation|6|||
44579608|NCT03652051|79602973|FG003|Stage 2|Protocol Violation|0|||
44579609|NCT03652051|79602970|FG000|Stage 2|Lost to Follow-up|0|||
44579610|NCT03652051|79602971|FG001|Stage 2|Lost to Follow-up|2|||
44579611|NCT03652051|79602972|FG002|Stage 2|Lost to Follow-up|0|||
44579612|NCT03652051|79602973|FG003|Stage 2|Lost to Follow-up|3|||
44579613|NCT03652051|79602970|FG000|Stage 2|Withdrawal by Subject|0|||
44579614|NCT03652051|79602971|FG001|Stage 2|Withdrawal by Subject|11|||
44579615|NCT03652051|79602972|FG002|Stage 2|Withdrawal by Subject|9|||
44579616|NCT03652051|79602973|FG003|Stage 2|Withdrawal by Subject|3|||
44579617|NCT03610737|79602991|FG000|Overall Study|Withdrawal by Subject|1|||
44579618|NCT03610737|79602992|FG001|Overall Study|Withdrawal by Subject|5|||
44579619|NCT03610737|79602991|FG000|Overall Study|Death|1|||
44579620|NCT03610737|79602992|FG001|Overall Study|Death|0|||
44579621|NCT03610737|79602991|FG000|Overall Study|Not treated|5|||
44579622|NCT03610737|79602992|FG001|Overall Study|Not treated|2|||
44579623|NCT03610737|79602991|FG000|Overall Study|Missed Visit|1|||
44579624|NCT03610737|79602992|FG001|Overall Study|Missed Visit|2|||
44579625|NCT03554018|79603000|FG000|Overall Study|Lost to Follow-up|3|||
44579626|NCT03554018|79603001|FG001|Overall Study|Lost to Follow-up|7|||
44579627|NCT03520036|79603010|FG000|Overall Study|Adverse Event|1|||
44579628|NCT03520036|79603011|FG001|Overall Study|Adverse Event|2|||
44579629|NCT03520036|79603012|FG002|Overall Study|Adverse Event|0|||
44579630|NCT03520036|79603010|FG000|Overall Study|Protocol Violation|1|||
44579631|NCT03520036|79603011|FG001|Overall Study|Protocol Violation|0|||
44119801|NCT03701555|78903920|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
44119802|NCT03701555|78903921|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
44119803|NCT03701555|78903922|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
44119804|NCT03701555|78903923|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
44119805|NCT03701555|78903924|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
44378775|NCT00772603|79384277|FG000|Overall Study|Lost to Follow-up|1|||
44508406|NCT00048048|79513662|FG004|Core Treatment|Adverse Event|0|||
44508407|NCT00048048|79513663|FG005|Core Treatment|Adverse Event|0|||
44508408|NCT00048048|79513664|FG006|Core Treatment|Adverse Event|0|||
44508409|NCT00048048|79513665|FG007|Core Treatment|Adverse Event|1|||
44508410|NCT00048048|79513666|FG008|Core Treatment|Adverse Event|0|||
44508411|NCT00048048|79513667|FG009|Core Treatment|Adverse Event|0|||
44579632|NCT03520036|79603012|FG002|Overall Study|Protocol Violation|0|||
44579633|NCT03520036|79603010|FG000|Overall Study|Withdrawal by Subject|0|||
44579634|NCT03520036|79603011|FG001|Overall Study|Withdrawal by Subject|1|||
44579635|NCT03520036|79603012|FG002|Overall Study|Withdrawal by Subject|4|||
44119806|NCT03701555|78903925|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
44508412|NCT00048048|79513668|FG010|Core Treatment|Adverse Event|0|||
44508413|NCT00048048|79513669|FG011|Core Treatment|Adverse Event|0|||
44119807|NCT03701555|78903926|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
44579636|NCT03520036|79603010|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
44579637|NCT03520036|79603011|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
44119808|NCT03701555|78903927|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
44119809|NCT03701555|78903928|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
44119810|NCT03701555|78903929|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
44119811|NCT03701555|78903930|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
44119812|NCT03701555|78903931|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
44119813|NCT03701555|78903896|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
44119814|NCT03701555|78903897|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
44119815|NCT03701555|78903898|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
44119816|NCT03701555|78903899|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
44119817|NCT03701555|78903900|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
44119818|NCT03701555|78903901|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
44119819|NCT03701555|78903902|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
44119820|NCT03701555|78903903|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
44119821|NCT03701555|78903904|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
44119822|NCT03701555|78903905|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
44119823|NCT03701555|78903906|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
44119824|NCT03701555|78903907|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
44119825|NCT03701555|78903908|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
44119826|NCT03701555|78903909|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
44119827|NCT03701555|78903910|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
44119828|NCT03701555|78903911|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
44119829|NCT03701555|78903912|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
44119830|NCT03701555|78903913|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
44119831|NCT03701555|78903914|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
44119832|NCT03701555|78903915|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
44119833|NCT03701555|78903916|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
44119834|NCT03701555|78903917|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
44119835|NCT03701555|78903918|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
44119836|NCT03701555|78903919|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
44119837|NCT03701555|78903920|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
44119838|NCT03701555|78903921|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
44119839|NCT03701555|78903922|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
44119840|NCT03701555|78903923|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
44119841|NCT03701555|78903924|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
44119842|NCT03701555|78903925|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
44119843|NCT03701555|78903926|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
44119844|NCT03701555|78903927|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
44119845|NCT03701555|78903928|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
44119846|NCT03701555|78903929|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
44378776|NCT00772603|79384278|FG001|Overall Study|Lost to Follow-up|5|||
44579638|NCT03520036|79603012|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
44579639|NCT03396822|79603048|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
44579640|NCT03396822|79603048|FG000|Overall Study|Physician Decision|1|||
44579641|NCT03382639|79603056|FG000|Overall Study|Adverse Event|2|||
44579642|NCT03382639|79603057|FG001|Overall Study|Adverse Event|0|||
44579643|NCT03382639|79603058|FG002|Overall Study|Adverse Event|1|||
44579644|NCT03382639|79603059|FG003|Overall Study|Adverse Event|1|||
44579645|NCT03382639|79603056|FG000|Overall Study|Lost to Follow-up|1|||
44579646|NCT03382639|79603057|FG001|Overall Study|Lost to Follow-up|0|||
44579647|NCT03382639|79603058|FG002|Overall Study|Lost to Follow-up|0|||
44579648|NCT03382639|79603059|FG003|Overall Study|Lost to Follow-up|0|||
44579649|NCT03382639|79603056|FG000|Overall Study|Withdrawal by Subject|4|||
44579650|NCT03382639|79603057|FG001|Overall Study|Withdrawal by Subject|3|||
44579651|NCT03382639|79603058|FG002|Overall Study|Withdrawal by Subject|2|||
44579652|NCT03382639|79603059|FG003|Overall Study|Withdrawal by Subject|3|||
44579653|NCT03382639|79603056|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
44579654|NCT03382639|79603057|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
44579655|NCT03382639|79603058|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
44579656|NCT03382639|79603059|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
44579657|NCT03382639|79603056|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
44579658|NCT03382639|79603057|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
44119847|NCT03701555|78903930|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
44119848|NCT03701555|78903931|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
44119849|NCT03701555|78903896|FG000|Part 2 (Day 1)|Other|0|||
44119850|NCT03701555|78903897|FG001|Part 2 (Day 1)|Other|0|||
44119851|NCT03701555|78903898|FG002|Part 2 (Day 1)|Other|0|||
44119852|NCT03701555|78903899|FG003|Part 2 (Day 1)|Other|0|||
44119853|NCT03701555|78903900|FG004|Part 2 (Day 1)|Other|0|||
44119854|NCT03701555|78903901|FG005|Part 2 (Day 1)|Other|0|||
44119855|NCT03701555|78903902|FG006|Part 2 (Day 1)|Other|0|||
44579659|NCT03382639|79603058|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
44579660|NCT03382639|79603059|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
44579661|NCT03382639|79603056|FG000|Overall Study|Other|2|||
44119856|NCT03701555|78903903|FG007|Part 2 (Day 1)|Other|0|||
44119857|NCT03701555|78903904|FG008|Part 2 (Day 1)|Other|0|||
44119858|NCT03701555|78903905|FG009|Part 2 (Day 1)|Other|0|||
44579662|NCT03382639|79603057|FG001|Overall Study|Other|0|||
44579663|NCT03382639|79603058|FG002|Overall Study|Other|0|||
44579664|NCT03382639|79603059|FG003|Overall Study|Other|3|||
44579665|NCT03359785|79603076|FG000|Overall Study|Protocol Violation|0|||
44579666|NCT03359785|79603077|FG001|Overall Study|Protocol Violation|1|||
44579667|NCT03359785|79603078|FG002|Overall Study|Protocol Violation|0|||
44579668|NCT03359785|79603079|FG003|Overall Study|Protocol Violation|0|||
44579669|NCT03359785|79603076|FG000|Overall Study|Early study termination due to study pause|0|||
44579670|NCT03359785|79603077|FG001|Overall Study|Early study termination due to study pause|0|||
44579671|NCT03359785|79603078|FG002|Overall Study|Early study termination due to study pause|2|||
44579672|NCT03359785|79603079|FG003|Overall Study|Early study termination due to study pause|0|||
44579673|NCT03359785|79603076|FG000|Overall Study|Withdrawal by Subject|2|||
44579674|NCT03359785|79603077|FG001|Overall Study|Withdrawal by Subject|2|||
44579675|NCT03359785|79603078|FG002|Overall Study|Withdrawal by Subject|0|||
44579676|NCT03359785|79603079|FG003|Overall Study|Withdrawal by Subject|0|||
44579677|NCT03343535|79603089|FG000|Overall Study|Lost to Follow-up|1|||
44119859|NCT03701555|78903906|FG010|Part 2 (Day 1)|Other|3|||
44119860|NCT03701555|78903907|FG011|Part 2 (Day 1)|Other|1|||
44119861|NCT03701555|78903908|FG012|Part 2 (Day 1)|Other|0|||
44119862|NCT03701555|78903909|FG013|Part 2 (Day 1)|Other|1|||
44119863|NCT03701555|78903910|FG014|Part 2 (Day 1)|Other|0|||
44119864|NCT03701555|78903911|FG015|Part 2 (Day 1)|Other|2|||
44119865|NCT03701555|78903912|FG016|Part 2 (Day 1)|Other|2|||
44119866|NCT03701555|78903913|FG017|Part 2 (Day 1)|Other|0|||
44119867|NCT03701555|78903914|FG018|Part 2 (Day 1)|Other|0|||
44579678|NCT03343535|79603089|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
44579679|NCT03343535|79603089|FG000|Overall Study|Death|12|||
44579680|NCT03343301|79603095|FG000|Overall Study|Withdrawal by Subject|1|||
44579681|NCT03343301|79603096|FG001|Overall Study|Withdrawal by Subject|1|||
44579682|NCT03343301|79603095|FG000|Overall Study|Death|0|||
44579683|NCT03343301|79603096|FG001|Overall Study|Death|2|||
44579684|NCT03343301|79603095|FG000|Overall Study|Other|0|||
44579685|NCT03343301|79603096|FG001|Overall Study|Other|6|||
44579686|NCT03343301|79603095|FG000|Overall Study|Missing|2|||
44579687|NCT03343301|79603096|FG001|Overall Study|Missing|0|||
44579688|NCT02823652|79603134|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
44579689|NCT02823652|79603135|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
44579690|NCT02823652|79603136|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
44579691|NCT02823652|79603134|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
44579692|NCT02823652|79603135|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
44579693|NCT02823652|79603136|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
44579694|NCT02823652|79603134|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
44579695|NCT02823652|79603135|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
44579696|NCT02823652|79603136|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
44579697|NCT02823652|79603134|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
44579698|NCT02823652|79603135|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
44579699|NCT02823652|79603136|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
44579700|NCT02656823|79603155|FG000|Overall Study|Adverse Event|3|||
44119868|NCT03701555|78903915|FG019|Part 2 (Day 1)|Other|0|||
44119869|NCT03701555|78903916|FG020|Part 2 (Day 1)|Other|0|||
44119870|NCT03701555|78903917|FG021|Part 2 (Day 1)|Other|0|||
44119871|NCT03701555|78903918|FG022|Part 2 (Day 1)|Other|0|||
44119872|NCT03701555|78903919|FG023|Part 2 (Day 1)|Other|0|||
44119873|NCT03701555|78903920|FG024|Part 2 (Day 1)|Other|0|||
44508414|NCT00048048|79513658|FG000|Extension Year 1|Early withdrawals|0|||
44508415|NCT00048048|79513659|FG001|Extension Year 1|Early withdrawals|0|||
44508416|NCT00048048|79513660|FG002|Extension Year 1|Early withdrawals|0|||
44508417|NCT00048048|79513661|FG003|Extension Year 1|Early withdrawals|0|||
44508418|NCT00048048|79513662|FG004|Extension Year 1|Early withdrawals|0|||
44508419|NCT00048048|79513663|FG005|Extension Year 1|Early withdrawals|0|||
44119874|NCT03701555|78903921|FG025|Part 2 (Day 1)|Other|0|||
44119875|NCT03701555|78903922|FG026|Part 2 (Day 1)|Other|0|||
44508420|NCT00048048|79513664|FG006|Extension Year 1|Early withdrawals|0|||
44508421|NCT00048048|79513665|FG007|Extension Year 1|Early withdrawals|0|||
44508422|NCT00048048|79513666|FG008|Extension Year 1|Early withdrawals|0|||
44579701|NCT02656823|79603155|FG000|Overall Study|Lost to Follow-up|2|||
44579702|NCT02652949|79603159|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
44579703|NCT02652949|79603159|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
44579704|NCT02652949|79603159|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
44579705|NCT02652949|79603159|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
44579706|NCT02652949|79603159|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
44579707|NCT02652949|79603159|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
44579708|NCT02652949|79603159|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
44579709|NCT02652949|79603159|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
44119876|NCT03701555|78903923|FG027|Part 2 (Day 1)|Other|0|||
44119877|NCT03701555|78903924|FG028|Part 2 (Day 1)|Other|0|||
44119878|NCT03701555|78903925|FG029|Part 2 (Day 1)|Other|0|||
44119879|NCT03701555|78903926|FG030|Part 2 (Day 1)|Other|0|||
44119880|NCT03701555|78903927|FG031|Part 2 (Day 1)|Other|0|||
44119881|NCT03701555|78903928|FG032|Part 2 (Day 1)|Other|0|||
44119882|NCT03701555|78903929|FG033|Part 2 (Day 1)|Other|0|||
44119883|NCT03701555|78903930|FG034|Part 2 (Day 1)|Other|0|||
44119884|NCT03701555|78903931|FG035|Part 2 (Day 1)|Other|0|||
44119885|NCT03701555|78903896|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
44119886|NCT03701555|78903897|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
44119887|NCT03701555|78903898|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
44119888|NCT03701555|78903899|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
44119889|NCT03701555|78903900|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
44119890|NCT03701555|78903901|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
44119891|NCT03701555|78903902|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
44119892|NCT03701555|78903903|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
44119893|NCT03701555|78903904|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
44119894|NCT03701555|78903905|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
44119895|NCT03701555|78903906|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
44119896|NCT03701555|78903907|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
44119897|NCT03701555|78903908|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
44119898|NCT03701555|78903909|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
44119899|NCT03701555|78903910|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
44119900|NCT03701555|78903911|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
44119901|NCT03701555|78903912|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
44119902|NCT03701555|78903913|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
44119903|NCT03701555|78903914|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
44119904|NCT03701555|78903915|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
44119905|NCT03701555|78903916|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
44119906|NCT03701555|78903917|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
44119907|NCT03701555|78903918|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
44119908|NCT03701555|78903919|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
44119909|NCT03701555|78903920|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
44119910|NCT03701555|78903921|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
44119911|NCT03701555|78903922|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
44119912|NCT03701555|78903923|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
44119913|NCT03701555|78903924|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
44119914|NCT03701555|78903925|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
44119915|NCT03701555|78903926|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
44119916|NCT03701555|78903927|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
44119917|NCT03701555|78903928|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
44119918|NCT03701555|78903929|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
44119919|NCT03701555|78903930|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
44119920|NCT03701555|78903931|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
44119921|NCT03701555|78903896|FG000|Part 3 (Day 1)|Subject Decision|0|||
44119922|NCT03701555|78903897|FG001|Part 3 (Day 1)|Subject Decision|0|||
44119923|NCT03701555|78903898|FG002|Part 3 (Day 1)|Subject Decision|0|||
44119924|NCT03701555|78903899|FG003|Part 3 (Day 1)|Subject Decision|0|||
44119925|NCT03701555|78903900|FG004|Part 3 (Day 1)|Subject Decision|0|||
44119926|NCT03701555|78903901|FG005|Part 3 (Day 1)|Subject Decision|0|||
44119927|NCT03701555|78903902|FG006|Part 3 (Day 1)|Subject Decision|0|||
44119928|NCT03701555|78903903|FG007|Part 3 (Day 1)|Subject Decision|0|||
44508423|NCT00048048|79513667|FG009|Extension Year 1|Early withdrawals|2|||
44508424|NCT00048048|79513668|FG010|Extension Year 1|Early withdrawals|2|||
44508425|NCT00048048|79513669|FG011|Extension Year 1|Early withdrawals|4|||
44508426|NCT00048048|79513658|FG000|Extension Year 2|Early withdrawals|0|||
44508427|NCT00048048|79513659|FG001|Extension Year 2|Early withdrawals|0|||
44508428|NCT00048048|79513660|FG002|Extension Year 2|Early withdrawals|0|||
44508429|NCT00048048|79513661|FG003|Extension Year 2|Early withdrawals|0|||
44508430|NCT00048048|79513662|FG004|Extension Year 2|Early withdrawals|0|||
44508431|NCT00048048|79513663|FG005|Extension Year 2|Early withdrawals|0|||
44508432|NCT00048048|79513664|FG006|Extension Year 2|Early withdrawals|0|||
44508433|NCT00048048|79513665|FG007|Extension Year 2|Early withdrawals|0|||
44119929|NCT03701555|78903904|FG008|Part 3 (Day 1)|Subject Decision|0|||
44508434|NCT00048048|79513666|FG008|Extension Year 2|Early withdrawals|0|||
44508435|NCT00048048|79513667|FG009|Extension Year 2|Early withdrawals|0|||
44579710|NCT02652949|79603159|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
44579711|NCT02652949|79603159|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
44579712|NCT02652949|79603159|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
44579713|NCT02652949|79603159|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
44579714|NCT02652949|79603159|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
44579715|NCT02652949|79603159|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
44119930|NCT03701555|78903905|FG009|Part 3 (Day 1)|Subject Decision|0|||
44119931|NCT03701555|78903906|FG010|Part 3 (Day 1)|Subject Decision|0|||
44119932|NCT03701555|78903907|FG011|Part 3 (Day 1)|Subject Decision|0|||
44119933|NCT03701555|78903908|FG012|Part 3 (Day 1)|Subject Decision|0|||
44119934|NCT03701555|78903909|FG013|Part 3 (Day 1)|Subject Decision|0|||
44508436|NCT00048048|79513668|FG010|Extension Year 2|Early withdrawals|4|||
44119935|NCT03701555|78903910|FG014|Part 3 (Day 1)|Subject Decision|0|||
44119936|NCT03701555|78903911|FG015|Part 3 (Day 1)|Subject Decision|0|||
44119937|NCT03701555|78903912|FG016|Part 3 (Day 1)|Subject Decision|0|||
44119938|NCT03701555|78903913|FG017|Part 3 (Day 1)|Subject Decision|0|||
44119939|NCT03701555|78903914|FG018|Part 3 (Day 1)|Subject Decision|0|||
44119940|NCT03701555|78903915|FG019|Part 3 (Day 1)|Subject Decision|0|||
44119941|NCT03701555|78903916|FG020|Part 3 (Day 1)|Subject Decision|0|||
44119942|NCT03701555|78903917|FG021|Part 3 (Day 1)|Subject Decision|0|||
44119943|NCT03701555|78903918|FG022|Part 3 (Day 1)|Subject Decision|0|||
44119944|NCT03701555|78903919|FG023|Part 3 (Day 1)|Subject Decision|0|||
44119945|NCT03701555|78903920|FG024|Part 3 (Day 1)|Subject Decision|0|||
44119946|NCT03701555|78903921|FG025|Part 3 (Day 1)|Subject Decision|0|||
44119947|NCT03701555|78903922|FG026|Part 3 (Day 1)|Subject Decision|1|||
44119948|NCT03701555|78903923|FG027|Part 3 (Day 1)|Subject Decision|0|||
44119949|NCT03701555|78903924|FG028|Part 3 (Day 1)|Subject Decision|0|||
44119950|NCT03701555|78903925|FG029|Part 3 (Day 1)|Subject Decision|0|||
44119951|NCT03701555|78903926|FG030|Part 3 (Day 1)|Subject Decision|0|||
44119952|NCT03701555|78903927|FG031|Part 3 (Day 1)|Subject Decision|2|||
44119953|NCT03701555|78903928|FG032|Part 3 (Day 1)|Subject Decision|1|||
44119954|NCT03701555|78903929|FG033|Part 3 (Day 1)|Subject Decision|1|||
44119955|NCT03701555|78903930|FG034|Part 3 (Day 1)|Subject Decision|0|||
44119956|NCT03701555|78903931|FG035|Part 3 (Day 1)|Subject Decision|0|||
44119957|NCT03701555|78903896|FG000|Part 3 (Day 1)|Other|0|||
44119958|NCT03701555|78903897|FG001|Part 3 (Day 1)|Other|0|||
44119959|NCT03701555|78903898|FG002|Part 3 (Day 1)|Other|0|||
44119960|NCT03701555|78903899|FG003|Part 3 (Day 1)|Other|0|||
44119961|NCT03701555|78903900|FG004|Part 3 (Day 1)|Other|0|||
44119962|NCT03701555|78903901|FG005|Part 3 (Day 1)|Other|0|||
44119963|NCT03701555|78903902|FG006|Part 3 (Day 1)|Other|0|||
44119964|NCT03701555|78903903|FG007|Part 3 (Day 1)|Other|0|||
44119965|NCT03701555|78903904|FG008|Part 3 (Day 1)|Other|0|||
44508437|NCT00048048|79513669|FG011|Extension Year 2|Early withdrawals|2|||
44508438|NCT00300053|79513699|FG000|Overall Study|Patient/Caregiver Preference|2|||
44508439|NCT00300053|79513700|FG001|Overall Study|Patient/Caregiver Preference|2|||
44508440|NCT00300053|79513701|FG002|Overall Study|Patient/Caregiver Preference|3|||
44508441|NCT00300053|79513699|FG000|Overall Study|Death|0|||
44508442|NCT00300053|79513700|FG001|Overall Study|Death|0|||
44508443|NCT00300053|79513701|FG002|Overall Study|Death|3|||
44579716|NCT02652949|79603159|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
44579717|NCT02652949|79603159|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
44579718|NCT02652949|79603159|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
44579719|NCT02625324|79603171|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
44579720|NCT02625324|79603171|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
44579721|NCT02625324|79603171|FG000|6-Month Follow-up Subject Accountability|Death|5|||
44579722|NCT02625324|79603171|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
44579723|NCT02625324|79603171|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
44579724|NCT02625324|79603171|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
44579725|NCT02625324|79603171|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
44579726|NCT02625324|79603171|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
44579727|NCT02625324|79603171|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
44579728|NCT02625324|79603171|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
44119966|NCT03701555|78903905|FG009|Part 3 (Day 1)|Other|0|||
44119967|NCT03701555|78903906|FG010|Part 3 (Day 1)|Other|0|||
44119968|NCT03701555|78903907|FG011|Part 3 (Day 1)|Other|0|||
44119969|NCT03701555|78903908|FG012|Part 3 (Day 1)|Other|0|||
44119970|NCT03701555|78903909|FG013|Part 3 (Day 1)|Other|0|||
44119971|NCT03701555|78903910|FG014|Part 3 (Day 1)|Other|0|||
44119972|NCT03701555|78903911|FG015|Part 3 (Day 1)|Other|0|||
44119973|NCT03701555|78903912|FG016|Part 3 (Day 1)|Other|0|||
44119974|NCT03701555|78903913|FG017|Part 3 (Day 1)|Other|0|||
44119975|NCT03701555|78903914|FG018|Part 3 (Day 1)|Other|0|||
44119976|NCT03701555|78903915|FG019|Part 3 (Day 1)|Other|0|||
44508444|NCT00300053|79513699|FG000|Overall Study|Lost to Follow-up|0|||
44508445|NCT00300053|79513700|FG001|Overall Study|Lost to Follow-up|1|||
44508446|NCT00300053|79513701|FG002|Overall Study|Lost to Follow-up|0|||
44119977|NCT03701555|78903916|FG020|Part 3 (Day 1)|Other|0|||
44508447|NCT00299975|79513713|FG000|Overall Study|Adverse Event|1|||
44508448|NCT00299975|79513714|FG001|Overall Study|Adverse Event|0|||
44508449|NCT00299975|79513715|FG002|Overall Study|Adverse Event|2|||
44508450|NCT00299975|79513713|FG000|Overall Study|Pregnancy|0|||
44508451|NCT00299975|79513714|FG001|Overall Study|Pregnancy|0|||
44119978|NCT03701555|78903917|FG021|Part 3 (Day 1)|Other|0|||
44119979|NCT03701555|78903918|FG022|Part 3 (Day 1)|Other|0|||
44119980|NCT03701555|78903919|FG023|Part 3 (Day 1)|Other|0|||
44119981|NCT03701555|78903920|FG024|Part 3 (Day 1)|Other|1|||
44119982|NCT03701555|78903921|FG025|Part 3 (Day 1)|Other|1|||
44119983|NCT03701555|78903922|FG026|Part 3 (Day 1)|Other|0|||
44508452|NCT00299975|79513715|FG002|Overall Study|Pregnancy|1|||
44508453|NCT00299975|79513713|FG000|Overall Study|Lack of Efficacy|1|||
44119984|NCT03701555|78903923|FG027|Part 3 (Day 1)|Other|0|||
44119985|NCT03701555|78903924|FG028|Part 3 (Day 1)|Other|0|||
44119986|NCT03701555|78903925|FG029|Part 3 (Day 1)|Other|1|||
44119987|NCT03701555|78903926|FG030|Part 3 (Day 1)|Other|1|||
44119988|NCT03701555|78903927|FG031|Part 3 (Day 1)|Other|0|||
44119989|NCT03701555|78903928|FG032|Part 3 (Day 1)|Other|1|||
44119990|NCT03701555|78903929|FG033|Part 3 (Day 1)|Other|1|||
44119991|NCT03701555|78903930|FG034|Part 3 (Day 1)|Other|0|||
44119992|NCT03701555|78903931|FG035|Part 3 (Day 1)|Other|0|||
44119993|NCT02178098|78904058|FG000|Overall Study|Withdrawal by Subject|0|||
44119994|NCT02178098|78904059|FG001|Overall Study|Withdrawal by Subject|6|||
44119995|NCT02178098|78904058|FG000|Overall Study|Adverse Event|1|||
44119996|NCT02178098|78904059|FG001|Overall Study|Adverse Event|2|||
44119997|NCT02178098|78904058|FG000|Overall Study|Protocol Violation|1|||
44119998|NCT02178098|78904059|FG001|Overall Study|Protocol Violation|1|||
44119999|NCT02178098|78904058|FG000|Overall Study|Lost to Follow-up|0|||
44120000|NCT02178098|78904059|FG001|Overall Study|Lost to Follow-up|1|||
44120001|NCT02178098|78904058|FG000|Overall Study|Sponsor Request|1|||
44120002|NCT02178098|78904059|FG001|Overall Study|Sponsor Request|0|||
44120003|NCT02178098|78904058|FG000|Overall Study|Other|2|||
44120004|NCT02178098|78904059|FG001|Overall Study|Other|2|||
44120005|NCT01798004|78904071|FG000|Overall Study|Death|2|||
44120006|NCT01798004|78904071|FG000|Overall Study|Lack of Efficacy|8|||
44120007|NCT01798004|78904071|FG000|Overall Study|Physician Decision|25|||
44120008|NCT01798004|78904071|FG000|Overall Study|Withdrawal by Subject|4|||
44120009|NCT01798004|78904071|FG000|Overall Study|Ineligible|4|||
44120010|NCT01798004|78904071|FG000|Overall Study|Patient/parent refusal|7|||
44120011|NCT01798004|78904071|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
44120012|NCT01798004|78904071|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
44120013|NCT01630434|78904077|FG000|Overall Study|Donor lungs turned down|1|||
44120014|NCT01630434|78904078|FG001|Overall Study|Donor lungs turned down|0|||
44120015|NCT01630434|78904077|FG000|Overall Study|Protocol Violation|9|||
44120016|NCT01630434|78904078|FG001|Overall Study|Protocol Violation|4|||
44120017|NCT01630434|78904077|FG000|Overall Study|Death|20|||
44120018|NCT01630434|78904078|FG001|Overall Study|Death|26|||
44120019|NCT01256398|78904088|FG000|Overall Study|Withdrawal by Subject|1|||
44120020|NCT01151423|78904096|FG000|Overall Study|Study terminated by Sponsor|9|||
44120021|NCT01151423|78904097|FG001|Overall Study|Study terminated by Sponsor|10|||
44120022|NCT01151423|78904096|FG000|Overall Study|Protocol Violation|0|||
44120023|NCT01151423|78904097|FG001|Overall Study|Protocol Violation|1|||
44120024|NCT01151423|78904096|FG000|Overall Study|Physician Decision|1|||
44120025|NCT01151423|78904097|FG001|Overall Study|Physician Decision|1|||
44120026|NCT01151423|78904096|FG000|Overall Study|Pregnancy|0|||
44120027|NCT01151423|78904097|FG001|Overall Study|Pregnancy|1|||
44120028|NCT01151423|78904096|FG000|Overall Study|Death|0|||
44120029|NCT01151423|78904097|FG001|Overall Study|Death|1|||
44120030|NCT01151423|78904096|FG000|Overall Study|Adverse Event|3|||
44120031|NCT01151423|78904097|FG001|Overall Study|Adverse Event|0|||
44120032|NCT01151423|78904096|FG000|Overall Study|Withdrawal by Subject|1|||
44120033|NCT01151423|78904097|FG001|Overall Study|Withdrawal by Subject|3|||
44120034|NCT01151423|78904096|FG000|Overall Study|Lost to Follow-up|1|||
44120035|NCT01151423|78904097|FG001|Overall Study|Lost to Follow-up|0|||
44120036|NCT01151423|78904096|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
44120037|NCT01151423|78904097|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
44120038|NCT01151423|78904096|FG000|Overall Study|Participated in other clinical trial|1|||
44120039|NCT01151423|78904097|FG001|Overall Study|Participated in other clinical trial|0|||
44120040|NCT00565617|78904108|FG000|Overall Study|Withdrawal by Subject|1|||
44120041|NCT00453154|78904115|FG000|Double BIind Maintenance|Adverse Event|0|||
44120042|NCT00453154|78904116|FG001|Double BIind Maintenance|Adverse Event|0|||
44120043|NCT00453154|78904117|FG002|Double BIind Maintenance|Adverse Event|3|||
44120044|NCT00453154|78904118|FG003|Double BIind Maintenance|Adverse Event|12|||
44120045|NCT00453154|78904115|FG000|Double BIind Maintenance|Death|0|||
44120046|NCT00453154|78904116|FG001|Double BIind Maintenance|Death|0|||
44120047|NCT00453154|78904117|FG002|Double BIind Maintenance|Death|2|||
44120048|NCT00453154|78904118|FG003|Double BIind Maintenance|Death|1|||
44120049|NCT00453154|78904115|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
44120050|NCT00453154|78904116|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
44120051|NCT00453154|78904117|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
44120052|NCT00453154|78904118|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
44120053|NCT00453154|78904115|FG000|Double BIind Maintenance|Progression|0|||
44120054|NCT00453154|78904116|FG001|Double BIind Maintenance|Progression|0|||
44120055|NCT00453154|78904117|FG002|Double BIind Maintenance|Progression|29|||
44120056|NCT00453154|78904118|FG003|Double BIind Maintenance|Progression|26|||
44120057|NCT00453154|78904115|FG000|Double BIind Maintenance|Medical Issues|0|||
44120058|NCT00453154|78904116|FG001|Double BIind Maintenance|Medical Issues|0|||
44120059|NCT00453154|78904117|FG002|Double BIind Maintenance|Medical Issues|3|||
44120060|NCT00453154|78904118|FG003|Double BIind Maintenance|Medical Issues|1|||
44120061|NCT00453154|78904115|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
44239512|NCT01543685|79066375|FG003|Overall Study|Lack of Efficacy|0|||
44120062|NCT00453154|78904116|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
44120063|NCT00453154|78904117|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
44120064|NCT00453154|78904118|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
44120065|NCT00258960|78904127|FG000|Overall Study|Death|2|||
44120066|NCT00258960|78904127|FG000|Overall Study|Disease Progression|7|||
44120067|NCT00258960|78904127|FG000|Overall Study|Adverse Event|4|||
44120068|NCT00258960|78904127|FG000|Overall Study|Physician Decision|1|||
44508454|NCT00299975|79513714|FG001|Overall Study|Lack of Efficacy|0|||
44508455|NCT00299975|79513715|FG002|Overall Study|Lack of Efficacy|1|||
44508456|NCT00299975|79513713|FG000|Overall Study|Lost to Follow-up|1|||
44508457|NCT00299975|79513714|FG001|Overall Study|Lost to Follow-up|0|||
44508458|NCT00299975|79513715|FG002|Overall Study|Lost to Follow-up|0|||
44508459|NCT00299975|79513713|FG000|Overall Study|Withdrawal by Subject|0|||
44508460|NCT00299975|79513714|FG001|Overall Study|Withdrawal by Subject|1|||
44508461|NCT00299975|79513715|FG002|Overall Study|Withdrawal by Subject|3|||
44508462|NCT00299975|79513713|FG000|Overall Study|Physician Decision|0|||
44508463|NCT00299975|79513714|FG001|Overall Study|Physician Decision|0|||
44508464|NCT00299975|79513715|FG002|Overall Study|Physician Decision|1|||
44508465|NCT00004980|79513725|FG000|Overall Study|Withdrawal by Subject|1|||
44508466|NCT00004980|79513726|FG001|Overall Study|Withdrawal by Subject|0|||
44508467|NCT00004980|79513725|FG000|Overall Study|memory difficulties|1|||
44508468|NCT00004980|79513726|FG001|Overall Study|memory difficulties|1|||
44508469|NCT00004980|79513725|FG000|Overall Study|Physician Decision|0|||
44508470|NCT00004980|79513726|FG001|Overall Study|Physician Decision|1|||
44508471|NCT00326963|79513732|FG000|Overall Study|Adverse Event|2|||
44579729|NCT02625324|79603171|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
44579730|NCT02625324|79603171|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
44579731|NCT02625324|79603171|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
44579732|NCT02625324|79603171|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
44579733|NCT02625324|79603171|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
44579734|NCT02625324|79603171|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
44579735|NCT02625324|79603171|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
44579736|NCT02567227|79603186|FG000|9 Weeks|Adverse Event|5|||
44579737|NCT02567227|79603187|FG001|9 Weeks|Adverse Event|5|||
44579738|NCT02567227|79603186|FG000|9 Weeks|Withdrawal by Subject|18|||
44579739|NCT02567227|79603187|FG001|9 Weeks|Withdrawal by Subject|8|||
44579740|NCT02567227|79603186|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
44579741|NCT02567227|79603187|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
44579742|NCT02567227|79603186|FG000|6 Month|Death|2|||
44579743|NCT02567227|79603187|FG001|6 Month|Death|0|||
44579744|NCT02567227|79603186|FG000|6 Month|Lost to Follow-up|43|||
44579745|NCT02567227|79603187|FG001|6 Month|Lost to Follow-up|40|||
44579746|NCT02567227|79603186|FG000|12 Months|Lost to Follow-up|31|||
44579747|NCT02567227|79603187|FG001|12 Months|Lost to Follow-up|32|||
44579748|NCT02567227|79603186|FG000|12 Months|Death|0|||
44579749|NCT02567227|79603187|FG001|12 Months|Death|2|||
44579750|NCT02362464|79603206|FG000|Overall Study|Switched to alternative therapy|1|||
44579751|NCT02362464|79603206|FG000|Overall Study|Refused further treatment|1|||
44579752|NCT02362464|79603206|FG000|Overall Study|Physician Decision|4|||
44579753|NCT02326974|79603210|FG000|Overall Study|Withdrawal by Subject|2|||
44579754|NCT02326974|79603210|FG000|Overall Study|failed heterogenity evaluation|5|||
44579755|NCT02281084|79603222|FG000|Overall Study|Adverse Event|1|||
44579756|NCT02281084|79603223|FG001|Overall Study|Adverse Event|0|||
44579757|NCT02281084|79603224|FG002|Overall Study|Adverse Event|0|||
44579758|NCT02281084|79603225|FG003|Overall Study|Adverse Event|0|||
44579759|NCT02281084|79603222|FG000|Overall Study|Withdrawal by Subject|1|||
44579760|NCT02281084|79603223|FG001|Overall Study|Withdrawal by Subject|2|||
44579761|NCT02281084|79603224|FG002|Overall Study|Withdrawal by Subject|0|||
44579762|NCT02281084|79603225|FG003|Overall Study|Withdrawal by Subject|0|||
44508472|NCT00326963|79513732|FG000|Overall Study|Injection site reaction|1|||
44508473|NCT00326963|79513732|FG000|Overall Study|Death|1|||
44579763|NCT02281084|79603222|FG000|Overall Study|Death|20|||
44579764|NCT02281084|79603223|FG001|Overall Study|Death|16|||
44579765|NCT02281084|79603224|FG002|Overall Study|Death|3|||
44579766|NCT02281084|79603225|FG003|Overall Study|Death|5|||
44579767|NCT02281084|79603222|FG000|Overall Study|Physician Decision|0|||
44579768|NCT02281084|79603223|FG001|Overall Study|Physician Decision|0|||
44579769|NCT02281084|79603224|FG002|Overall Study|Physician Decision|1|||
44579770|NCT02281084|79603225|FG003|Overall Study|Physician Decision|0|||
44579771|NCT02126579|79603242|FG000|Overall Study|disease progression|0|||
44579772|NCT02126579|79603243|FG001|Overall Study|disease progression|0|||
44579773|NCT02126579|79603244|FG002|Overall Study|disease progression|0|||
44579774|NCT02126579|79603245|FG003|Overall Study|disease progression|1|||
44120069|NCT00258960|78904127|FG000|Overall Study|Withdrawal by Subject|1|||
44120070|NCT00258960|78904127|FG000|Overall Study|Mistake|2|||
44120071|NCT00121992|78904133|FG000|Overall Study|Treatment not received|2|||
44508474|NCT00326963|79513732|FG000|Overall Study|Failure to return|10|||
44579775|NCT02126579|79603246|FG004|Overall Study|disease progression|0|||
44120072|NCT00121992|78904134|FG001|Overall Study|Treatment not received|11|||
44120073|NCT00070564|78904146|FG000|Overall Study|Progression|2|||
44120074|NCT00070564|78904147|FG001|Overall Study|Progression|4|||
44120075|NCT00070564|78904148|FG002|Overall Study|Progression|7|||
44120076|NCT00070564|78904149|FG003|Overall Study|Progression|7|||
44579776|NCT02126579|79603247|FG005|Overall Study|disease progression|0|||
44579777|NCT02126579|79603248|FG006|Overall Study|disease progression|1|||
44579778|NCT01886872|79603286|FG000|Overall Study|Ineligible|7|||
44579779|NCT01886872|79603287|FG001|Overall Study|Ineligible|4|||
44579780|NCT01886872|79603288|FG002|Overall Study|Ineligible|12|||
44579781|NCT01854775|79603309|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
44120077|NCT00070564|78904150|FG004|Overall Study|Progression|1|||
44120078|NCT00070564|78904151|FG005|Overall Study|Progression|0|||
44120079|NCT00070564|78904146|FG000|Overall Study|Delinquent|1|||
44120080|NCT00070564|78904147|FG001|Overall Study|Delinquent|4|||
44120081|NCT00070564|78904148|FG002|Overall Study|Delinquent|2|||
44120082|NCT00070564|78904149|FG003|Overall Study|Delinquent|0|||
44120083|NCT00070564|78904150|FG004|Overall Study|Delinquent|0|||
44120084|NCT00070564|78904151|FG005|Overall Study|Delinquent|0|||
44120085|NCT00070564|78904146|FG000|Overall Study|Adverse Event|150|||
44120086|NCT00070564|78904147|FG001|Overall Study|Adverse Event|142|||
44508475|NCT00326963|79513732|FG000|Overall Study|Withdrawal by Subject|10|||
44508476|NCT00326963|79513732|FG000|Overall Study|Refused treatment / did not cooperate|5|||
44508477|NCT00326963|79513732|FG000|Overall Study|Violation of selection criteria at entry|2|||
44508478|NCT00326963|79513732|FG000|Overall Study|Other protocol violation|1|||
44508479|NCT00326963|79513732|FG000|Overall Study|Administrative / other|1|||
44508480|NCT00326885|79513737|FG000|Overall Study|Adverse Event|1|||
44508481|NCT00326885|79513737|FG000|Overall Study|Withdrawal by Subject|3|||
44508482|NCT00326885|79513737|FG000|Overall Study|Physician Decision|1|||
44579782|NCT01854775|79603310|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
44508483|NCT00326885|79513737|FG000|Overall Study|Hospice withdrew consent|2|||
44508484|NCT00326495|79513742|FG000|Overall Study|Switched to alternative treatment|1|||
44508485|NCT00326495|79513742|FG000|Overall Study|Disease progression before treatment|1|||
44508486|NCT00326495|79513742|FG000|Overall Study|Refused further treatment|2|||
44508487|NCT00326495|79513742|FG000|Overall Study|Subject off study before assessment|1|||
44508488|NCT00326417|79513748|FG000|Overall Study|Withdrawal by Subject|0|||
44508489|NCT00326417|79513749|FG001|Overall Study|Withdrawal by Subject|0|||
44508490|NCT00326417|79513750|FG002|Overall Study|Withdrawal by Subject|1|||
44508491|NCT00326417|79513751|FG003|Overall Study|Withdrawal by Subject|0|||
44508492|NCT00326417|79513748|FG000|Overall Study|Arm Closed|7|||
44508493|NCT00326417|79513749|FG001|Overall Study|Arm Closed|0|||
44508494|NCT00326417|79513750|FG002|Overall Study|Arm Closed|0|||
44508495|NCT00326417|79513751|FG003|Overall Study|Arm Closed|3|||
44508496|NCT00326417|79513748|FG000|Overall Study|Death|7|||
44579783|NCT01854775|79603311|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
44579784|NCT01854775|79603309|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
44579785|NCT01854775|79603310|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
44579786|NCT01854775|79603311|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
44579787|NCT01854775|79603309|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
44579788|NCT01854775|79603310|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
44579789|NCT01854775|79603311|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
44579790|NCT01854775|79603309|FG000|Extension Phase|Pregnancy|3|||
44579791|NCT01854775|79603310|FG001|Extension Phase|Pregnancy|0|||
44579792|NCT01854775|79603311|FG002|Extension Phase|Pregnancy|0|||
44579793|NCT01854775|79603309|FG000|Extension Phase|Investigator's Discretion|1|||
44579794|NCT01854775|79603310|FG001|Extension Phase|Investigator's Discretion|0|||
44579795|NCT01854775|79603311|FG002|Extension Phase|Investigator's Discretion|0|||
44579796|NCT01854775|79603309|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
44579797|NCT01854775|79603310|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
44579798|NCT01854775|79603311|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
44579799|NCT01854775|79603309|FG000|Extension Phase|Lost to Follow-up|2|||
44579800|NCT01854775|79603310|FG001|Extension Phase|Lost to Follow-up|0|||
44579801|NCT01854775|79603311|FG002|Extension Phase|Lost to Follow-up|0|||
44579802|NCT01854775|79603309|FG000|Extension Phase|Still on Study|32|||
44579803|NCT01854775|79603310|FG001|Extension Phase|Still on Study|47|||
44579804|NCT01854775|79603311|FG002|Extension Phase|Still on Study|18|||
44579805|NCT01764633|79603321|FG000|Overall Study|Withdrawal by Subject|105|||
44508497|NCT00326417|79513749|FG001|Overall Study|Death|0|||
44579806|NCT01764633|79603322|FG001|Overall Study|Withdrawal by Subject|88|||
44579807|NCT01764633|79603321|FG000|Overall Study|Lost to Follow-up|13|||
44579808|NCT01764633|79603322|FG001|Overall Study|Lost to Follow-up|5|||
44579809|NCT01116648|79603390|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
44579810|NCT01116648|79603391|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
44120087|NCT00070564|78904148|FG002|Overall Study|Adverse Event|120|||
44120088|NCT00070564|78904149|FG003|Overall Study|Adverse Event|108|||
44508498|NCT00326417|79513750|FG002|Overall Study|Death|0|||
44508499|NCT00326417|79513751|FG003|Overall Study|Death|0|||
44508500|NCT03825341|79513761|FG000|Overall Study|Withdrawal by Subject|0|||
44120089|NCT00070564|78904150|FG004|Overall Study|Adverse Event|63|||
44120090|NCT00070564|78904151|FG005|Overall Study|Adverse Event|36|||
44120091|NCT00070564|78904146|FG000|Overall Study|Death|4|||
44120092|NCT00070564|78904147|FG001|Overall Study|Death|1|||
44120093|NCT00070564|78904148|FG002|Overall Study|Death|5|||
44120094|NCT00070564|78904149|FG003|Overall Study|Death|3|||
44120095|NCT00070564|78904150|FG004|Overall Study|Death|0|||
44120096|NCT00070564|78904151|FG005|Overall Study|Death|1|||
44120097|NCT00070564|78904146|FG000|Overall Study|Other, not protocol specified|17|||
44579811|NCT01116648|79603392|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
44579812|NCT01116648|79603393|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
44579813|NCT01116648|79603394|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
44579814|NCT01116648|79603395|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
44579815|NCT01116648|79603396|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
44579816|NCT01116648|79603397|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
44579817|NCT01116648|79603398|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
44579818|NCT01116648|79603399|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
44579819|NCT01116648|79603400|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
44579820|NCT01116648|79603401|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
44579821|NCT01116648|79603402|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
44120098|NCT00070564|78904147|FG001|Overall Study|Other, not protocol specified|15|||
44579822|NCT01116648|79603403|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
44120099|NCT00070564|78904148|FG002|Overall Study|Other, not protocol specified|14|||
44120100|NCT00070564|78904149|FG003|Overall Study|Other, not protocol specified|19|||
44120101|NCT00070564|78904150|FG004|Overall Study|Other, not protocol specified|6|||
44120102|NCT00070564|78904151|FG005|Overall Study|Other, not protocol specified|7|||
44120103|NCT00070564|78904146|FG000|Overall Study|Withdrawal by Subject|26|||
44579823|NCT01116648|79603404|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
44579824|NCT01001910|79603433|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
44579825|NCT00609154|79603450|FG000|Overall Study|Protocol Violation|1|||
44579826|NCT00609154|79603451|FG001|Overall Study|Protocol Violation|2|||
44579827|NCT00609154|79603450|FG000|Overall Study|Unable to establish IV access|0|||
44579828|NCT00609154|79603451|FG001|Overall Study|Unable to establish IV access|4|||
44579829|NCT00609154|79603450|FG000|Overall Study|Adverse Event|0|||
44579830|NCT00609154|79603451|FG001|Overall Study|Adverse Event|2|||
44579831|NCT00304070|79603460|FG000|Overall Study|Death|0|||
44579832|NCT00304070|79603461|FG001|Overall Study|Death|0|||
44579833|NCT00304070|79603462|FG002|Overall Study|Death|3|||
44120104|NCT00070564|78904147|FG001|Overall Study|Withdrawal by Subject|37|||
44120105|NCT00070564|78904148|FG002|Overall Study|Withdrawal by Subject|23|||
44120106|NCT00070564|78904149|FG003|Overall Study|Withdrawal by Subject|30|||
44120107|NCT00070564|78904150|FG004|Overall Study|Withdrawal by Subject|8|||
44120108|NCT00070564|78904151|FG005|Overall Study|Withdrawal by Subject|8|||
44120109|NCT00070564|78904146|FG000|Overall Study|Not reported|0|||
44120110|NCT00070564|78904147|FG001|Overall Study|Not reported|0|||
44120111|NCT00070564|78904148|FG002|Overall Study|Not reported|0|||
44120112|NCT00070564|78904149|FG003|Overall Study|Not reported|0|||
44120113|NCT00070564|78904150|FG004|Overall Study|Not reported|1|||
44120114|NCT00070564|78904151|FG005|Overall Study|Not reported|0|||
44120115|NCT02738151|78904177|FG000|Overall Study|Randomized but not treated|4|||
44120116|NCT02738151|78904178|FG001|Overall Study|Randomized but not treated|1|||
44120117|NCT02738151|78904177|FG000|Overall Study|Adverse Event|4|||
44120118|NCT02738151|78904178|FG001|Overall Study|Adverse Event|5|||
44120119|NCT02738151|78904177|FG000|Overall Study|Hypoglycemia|0|||
44120120|NCT02738151|78904178|FG001|Overall Study|Hypoglycemia|1|||
44120121|NCT02738151|78904177|FG000|Overall Study|Poor Compliance to Protocol|4|||
44120122|NCT02738151|78904178|FG001|Overall Study|Poor Compliance to Protocol|3|||
44120123|NCT02738151|78904177|FG000|Overall Study|Other than specified above|11|||
44579834|NCT00304070|79603460|FG000|Overall Study|Lost to Follow-up|0|||
44579835|NCT00304070|79603461|FG001|Overall Study|Lost to Follow-up|0|||
44239513|NCT01543685|79066376|FG004|Overall Study|Lack of Efficacy|2|||
44579836|NCT00304070|79603462|FG002|Overall Study|Lost to Follow-up|1|||
44579837|NCT00304070|79603460|FG000|Overall Study|Physician Decision|0|||
44239514|NCT01543685|79066372|FG000|Overall Study|Adverse Event|2|||
44239515|NCT01543685|79066373|FG001|Overall Study|Adverse Event|1|||
44239516|NCT01543685|79066374|FG002|Overall Study|Adverse Event|0|||
44378777|NCT00772603|79384279|FG002|Overall Study|Lost to Follow-up|2|||
44579838|NCT00304070|79603461|FG001|Overall Study|Physician Decision|0|||
44579839|NCT00304070|79603462|FG002|Overall Study|Physician Decision|3|||
44579840|NCT00304070|79603460|FG000|Overall Study|Withdrawal by Subject|0|||
44579841|NCT00304070|79603461|FG001|Overall Study|Withdrawal by Subject|0|||
44579842|NCT00304070|79603462|FG002|Overall Study|Withdrawal by Subject|1|||
44120124|NCT02738151|78904178|FG001|Overall Study|Other than specified above|21|||
44120125|NCT02915159|78904186|FG000|Overall Study|Participant no longer meets criteria|2|||
44120126|NCT02915159|78904187|FG001|Overall Study|Participant no longer meets criteria|0|||
44120127|NCT02915159|78904186|FG000|Overall Study|poor/non-compliance|1|||
44579843|NCT00304070|79603460|FG000|Overall Study|Progressive Disease|3|||
44579844|NCT00304070|79603461|FG001|Overall Study|Progressive Disease|7|||
44579845|NCT00304070|79603462|FG002|Overall Study|Progressive Disease|4|||
44276205|NCT02218008|79229543|FG001|Stage 2 (S2)|Adverse Event|0|||
44276206|NCT02218008|79229544|FG002|Stage 2 (S2)|Adverse Event|0|||
44276207|NCT02218008|79229545|FG003|Stage 2 (S2)|Adverse Event|2|||
44120128|NCT02915159|78904187|FG001|Overall Study|poor/non-compliance|0|||
44120129|NCT02915159|78904186|FG000|Overall Study|Participant withdrew consent|5|||
44120130|NCT02915159|78904187|FG001|Overall Study|Participant withdrew consent|1|||
44276208|NCT02218008|79229546|FG004|Stage 2 (S2)|Adverse Event|3|||
44508501|NCT03825341|79513762|FG001|Overall Study|Withdrawal by Subject|1|||
44508502|NCT00297479|79513773|FG000|Overall Study|Lost to Follow-up|37|||
44508503|NCT00297479|79513774|FG001|Overall Study|Lost to Follow-up|54|||
44508504|NCT00297479|79513775|FG002|Overall Study|Lost to Follow-up|51|||
44508505|NCT00688870|79513785|FG000|Infant Series|Parent or legal guardian request|4|||
44508506|NCT00688870|79513786|FG001|Infant Series|Parent or legal guardian request|0|||
44508507|NCT00297167|79513796|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
44508508|NCT00297167|79513797|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
44508509|NCT00297167|79513798|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
44508510|NCT00297167|79513796|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
44508511|NCT00297167|79513797|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
44508512|NCT00297167|79513798|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
44508513|NCT03216226|79513807|FG000|Overall Study|Adverse Event|3|||
44508514|NCT03216226|79513808|FG001|Overall Study|Adverse Event|0|||
44508515|NCT03216226|79513807|FG000|Overall Study|Protocol Violation|1|||
44508516|NCT03216226|79513808|FG001|Overall Study|Protocol Violation|3|||
44508517|NCT03216226|79513807|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
44508518|NCT03216226|79513808|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
44508519|NCT03216226|79513807|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
44508520|NCT03216226|79513808|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
44508521|NCT03216226|79513807|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
44508522|NCT03216226|79513808|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
44508523|NCT03215758|79513816|FG000|Overall Study|Technical Problems|1|||
44508524|NCT03215758|79513817|FG001|Overall Study|Technical Problems|0|||
44378778|NCT00772603|79384277|FG000|Overall Study|Physician Decision|0|||
44508525|NCT03215758|79513816|FG000|Overall Study|Protocol deviation|0|||
44120131|NCT02915159|78904186|FG000|Overall Study|Request to discontinue treatment|1|||
44276209|NCT02218008|79229547|FG005|Stage 2 (S2)|Adverse Event|3|||
44120132|NCT02915159|78904187|FG001|Overall Study|Request to discontinue treatment|2|||
44120133|NCT02915159|78904186|FG000|Overall Study|Adverse Event|2|||
44120134|NCT02915159|78904187|FG001|Overall Study|Adverse Event|2|||
44120135|NCT02915159|78904186|FG000|Overall Study|Lack of Efficacy|0|||
44120136|NCT02915159|78904187|FG001|Overall Study|Lack of Efficacy|3|||
44120137|NCT02924051|78904199|FG000|Overall Study|Withdrawal by Subject|1|||
44120138|NCT02924051|78904200|FG001|Overall Study|Withdrawal by Subject|9|||
44120139|NCT02923427|78904214|FG000|Overall Study|convert to laparatomy|2|||
44120140|NCT02923427|78904215|FG001|Overall Study|convert to laparatomy|2|||
44120141|NCT02923427|78904214|FG000|Overall Study|destaturation|1|||
44120142|NCT02923427|78904215|FG001|Overall Study|destaturation|0|||
44120143|NCT02923427|78904214|FG000|Overall Study|can not replace LMA|1|||
44120144|NCT02923427|78904215|FG001|Overall Study|can not replace LMA|0|||
44120145|NCT02669264|78904228|FG000|Overall Study|Death|5|||
44120146|NCT02669264|78904229|FG001|Overall Study|Death|5|||
44120147|NCT02669264|78904230|FG002|Overall Study|Death|3|||
44120148|NCT02669264|78904231|FG003|Overall Study|Death|3|||
44120149|NCT02669264|78904232|FG004|Overall Study|Death|3|||
44120150|NCT02669264|78904233|FG005|Overall Study|Death|6|||
44120151|NCT02669264|78904234|FG006|Overall Study|Death|3|||
44120152|NCT02669264|78904228|FG000|Overall Study|Withdrawal by Subject|0|||
44120153|NCT02669264|78904229|FG001|Overall Study|Withdrawal by Subject|1|||
44120154|NCT02669264|78904230|FG002|Overall Study|Withdrawal by Subject|0|||
44120155|NCT02669264|78904231|FG003|Overall Study|Withdrawal by Subject|0|||
44120156|NCT02669264|78904232|FG004|Overall Study|Withdrawal by Subject|1|||
44120157|NCT02669264|78904233|FG005|Overall Study|Withdrawal by Subject|0|||
44120158|NCT02669264|78904234|FG006|Overall Study|Withdrawal by Subject|0|||
44120159|NCT02669264|78904228|FG000|Overall Study|Lost to Follow-up|0|||
44120160|NCT02669264|78904229|FG001|Overall Study|Lost to Follow-up|0|||
44120161|NCT02669264|78904230|FG002|Overall Study|Lost to Follow-up|0|||
44378779|NCT00772603|79384278|FG001|Overall Study|Physician Decision|0|||
44508526|NCT03215758|79513817|FG001|Overall Study|Protocol deviation|1|||
44508527|NCT03215758|79513816|FG000|Overall Study|Physician Decision|0|||
44508528|NCT03215758|79513817|FG001|Overall Study|Physician Decision|1|||
44508529|NCT03215758|79513816|FG000|Overall Study|Death|0|||
44508530|NCT03215758|79513817|FG001|Overall Study|Death|1|||
44508531|NCT03215758|79513816|FG000|Overall Study|Adverse Event|1|||
44508532|NCT03215758|79513817|FG001|Overall Study|Adverse Event|2|||
44508533|NCT03215758|79513816|FG000|Overall Study|Subject/Guardian Decision|3|||
44508534|NCT03215758|79513817|FG001|Overall Study|Subject/Guardian Decision|3|||
44508535|NCT00290771|79513825|FG000|Overall Study|Disease progression|95|||
44508536|NCT00290771|79513826|FG001|Overall Study|Disease progression|73|||
44508537|NCT00290771|79513825|FG000|Overall Study|Death|11|||
44508538|NCT00290771|79513826|FG001|Overall Study|Death|10|||
44508539|NCT00290771|79513825|FG000|Overall Study|Adverse Event|12|||
44508540|NCT00290771|79513826|FG001|Overall Study|Adverse Event|6|||
44508541|NCT00290771|79513825|FG000|Overall Study|Withdrawal by Subject|5|||
44508542|NCT00290771|79513826|FG001|Overall Study|Withdrawal by Subject|6|||
44508543|NCT00290771|79513825|FG000|Overall Study|Administrative problems|2|||
44508544|NCT00290771|79513826|FG001|Overall Study|Administrative problems|1|||
44508545|NCT00290771|79513825|FG000|Overall Study|Protocol Violation|2|||
44508546|NCT00290771|79513826|FG001|Overall Study|Protocol Violation|0|||
44508547|NCT00290771|79513825|FG000|Overall Study|Lost to Follow-up|0|||
44508548|NCT00290771|79513826|FG001|Overall Study|Lost to Follow-up|1|||
44508549|NCT00274625|79513835|FG000|Overall Study|Lost to Follow-up|46|||
44508550|NCT00274625|79513836|FG001|Overall Study|Lost to Follow-up|54|||
44508551|NCT00274625|79513835|FG000|Overall Study|Excluded from analysis|14|||
44508552|NCT00274625|79513836|FG001|Overall Study|Excluded from analysis|8|||
44508553|NCT00290693|79513842|FG000|Overall Study|Withdrawal by Subject|2|||
44508554|NCT03214666|79513853|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
44508555|NCT03214666|79513854|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
44508556|NCT03214666|79513855|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
44508557|NCT03214666|79513856|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
44508558|NCT03214666|79513857|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
44508559|NCT03214666|79513858|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
44508560|NCT00274469|79513875|FG000|Overall Study|Death|63|||
44508561|NCT00274469|79513876|FG001|Overall Study|Death|74|||
44508562|NCT00274469|79513875|FG000|Overall Study|Did not consent to OS follow-up|16|||
44120162|NCT02669264|78904231|FG003|Overall Study|Lost to Follow-up|0|||
44120163|NCT02669264|78904232|FG004|Overall Study|Lost to Follow-up|1|||
44120164|NCT02669264|78904233|FG005|Overall Study|Lost to Follow-up|0|||
44120165|NCT02669264|78904234|FG006|Overall Study|Lost to Follow-up|0|||
44120166|NCT02669264|78904228|FG000|Overall Study|Miscellaneous|0|||
44120167|NCT02669264|78904229|FG001|Overall Study|Miscellaneous|0|||
44120168|NCT02669264|78904230|FG002|Overall Study|Miscellaneous|0|||
44120169|NCT02669264|78904231|FG003|Overall Study|Miscellaneous|0|||
44120170|NCT02669264|78904232|FG004|Overall Study|Miscellaneous|0|||
44120171|NCT02669264|78904233|FG005|Overall Study|Miscellaneous|0|||
44508563|NCT00274469|79513876|FG001|Overall Study|Did not consent to OS follow-up|19|||
44120172|NCT02669264|78904234|FG006|Overall Study|Miscellaneous|2|||
44120173|NCT02521870|78904260|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120174|NCT02521870|78904261|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
44120175|NCT02521870|78904262|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120176|NCT02521870|78904263|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120177|NCT02521870|78904264|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120178|NCT02521870|78904265|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120179|NCT02521870|78904266|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120180|NCT02521870|78904267|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120181|NCT02521870|78904268|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120182|NCT02521870|78904269|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120183|NCT02521870|78904270|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120184|NCT02521870|78904271|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
44120185|NCT02521870|78904260|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
44120186|NCT02521870|78904261|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
44120187|NCT02521870|78904262|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
44120188|NCT02521870|78904263|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
44120189|NCT02521870|78904264|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
44120190|NCT02521870|78904265|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
44120191|NCT02521870|78904266|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
44120192|NCT02521870|78904267|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
44120193|NCT02521870|78904268|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
44120194|NCT02521870|78904269|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
44120195|NCT02521870|78904270|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
44120196|NCT02521870|78904271|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
44239517|NCT01543685|79066375|FG003|Overall Study|Adverse Event|0|||
44508564|NCT03214588|79513885|FG000|Overall Study|Adverse Event|1|||
44508565|NCT03214588|79513886|FG001|Overall Study|Adverse Event|0|||
44508566|NCT03214588|79513887|FG002|Overall Study|Adverse Event|2|||
44508567|NCT03214588|79513885|FG000|Overall Study|Reason Not Specified|0|||
44508568|NCT03214588|79513886|FG001|Overall Study|Reason Not Specified|1|||
44508569|NCT03214588|79513887|FG002|Overall Study|Reason Not Specified|0|||
44508570|NCT03166618|79513897|FG000|Overall Study|Study was Terminated|0|||
44508571|NCT03166618|79513898|FG001|Overall Study|Study was Terminated|1|||
44120197|NCT02521870|78904260|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
44378780|NCT00772603|79384279|FG002|Overall Study|Physician Decision|1|||
44120198|NCT02521870|78904261|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
44120199|NCT02521870|78904262|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
44378781|NCT00772603|79384277|FG000|Overall Study|Other|2|||
44120200|NCT02521870|78904263|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
44120201|NCT02521870|78904264|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
44508572|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
44239518|NCT01543685|79066376|FG004|Overall Study|Adverse Event|2|||
44120202|NCT02521870|78904265|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
44120203|NCT02521870|78904266|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
44120204|NCT02521870|78904267|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
44120205|NCT02521870|78904268|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
44120206|NCT02521870|78904269|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
44120207|NCT02521870|78904270|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
44120208|NCT02521870|78904271|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
44120209|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
44120210|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
44120211|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
44120212|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
44120213|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
44120214|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
44120215|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
44120216|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
44120217|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
44120218|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
44120219|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
44120220|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
44120221|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
44120222|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
44120223|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
44120224|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
44120225|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
44120226|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
44120227|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
44120228|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
44120229|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
44120230|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
44120231|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
44120232|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
44120233|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
44120234|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
44120235|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
44120236|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
44120237|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
44120238|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
44120239|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
44120240|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
44120241|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
44120242|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
44120243|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
44120244|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
44120245|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Death|0|||
44120246|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Death|0|||
44120247|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Death|0|||
44120248|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Death|0|||
44120249|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Death|1|||
44120250|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Death|1|||
44120251|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Death|3|||
44120252|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Death|1|||
44120253|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Death|1|||
44120254|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Death|5|||
44120255|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Death|2|||
44120256|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Death|2|||
44120257|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Other|0|||
44120258|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Other|0|||
44120259|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Other|0|||
44120260|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Other|0|||
44120261|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Other|10|||
44120262|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Other|3|||
44120263|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Other|2|||
44120264|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Other|0|||
44120265|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Other|10|||
44120266|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Other|5|||
44120267|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Other|1|||
44120268|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Other|7|||
44120269|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120270|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120271|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120272|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120273|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
44120274|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120275|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120276|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120277|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120278|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120279|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120280|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
44120281|NCT02521870|78904260|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120282|NCT02521870|78904261|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120283|NCT02521870|78904262|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120284|NCT02521870|78904263|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120285|NCT02521870|78904264|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
44120286|NCT02521870|78904265|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120287|NCT02521870|78904266|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120288|NCT02521870|78904267|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120289|NCT02521870|78904268|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120290|NCT02521870|78904269|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120291|NCT02521870|78904270|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44378782|NCT00772603|79384278|FG001|Overall Study|Other|0|||
44378783|NCT00772603|79384279|FG002|Overall Study|Other|2|||
44378784|NCT00772447|79384292|FG000|Overall Study|Withdrawal by Subject|9|||
44378785|NCT00772447|79384293|FG001|Overall Study|Withdrawal by Subject|5|||
44378786|NCT00772447|79384292|FG000|Overall Study|Physician Decision|4|||
44378787|NCT00772447|79384293|FG001|Overall Study|Physician Decision|8|||
44120292|NCT02521870|78904271|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
44120293|NCT02923349|78904308|FG000|Overall Study|Other|1|||
44120294|NCT02923349|78904309|FG001|Overall Study|Other|2|||
44120295|NCT02923349|78904310|FG002|Overall Study|Other|4|||
44120296|NCT02923349|78904311|FG003|Overall Study|Other|1|||
44120297|NCT02923349|78904312|FG004|Overall Study|Other|3|||
44120298|NCT02923349|78904313|FG005|Overall Study|Other|0|||
44120299|NCT02923349|78904314|FG006|Overall Study|Other|1|||
44120300|NCT02923349|78904308|FG000|Overall Study|Withdrawal by Subject|2|||
44120301|NCT02923349|78904309|FG001|Overall Study|Withdrawal by Subject|2|||
44120302|NCT02923349|78904310|FG002|Overall Study|Withdrawal by Subject|8|||
44378788|NCT00772447|79384292|FG000|Overall Study|Lost to Follow-up|2|||
44378789|NCT00772447|79384293|FG001|Overall Study|Lost to Follow-up|4|||
44378790|NCT00772447|79384292|FG000|Overall Study|incorrect enrolment|3|||
44120303|NCT02923349|78904311|FG003|Overall Study|Withdrawal by Subject|10|||
44120304|NCT02923349|78904312|FG004|Overall Study|Withdrawal by Subject|12|||
44120305|NCT02923349|78904313|FG005|Overall Study|Withdrawal by Subject|3|||
44120306|NCT02923349|78904314|FG006|Overall Study|Withdrawal by Subject|0|||
44378791|NCT00772447|79384293|FG001|Overall Study|incorrect enrolment|4|||
44508573|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
44508574|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
44120307|NCT02923349|78904308|FG000|Overall Study|Physician Decision|0|||
44120308|NCT02923349|78904309|FG001|Overall Study|Physician Decision|0|||
44120309|NCT02923349|78904310|FG002|Overall Study|Physician Decision|0|||
44239519|NCT01541969|79066390|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
44120310|NCT02923349|78904311|FG003|Overall Study|Physician Decision|1|||
44120311|NCT02923349|78904312|FG004|Overall Study|Physician Decision|1|||
44120312|NCT02923349|78904313|FG005|Overall Study|Physician Decision|0|||
44378792|NCT00772447|79384292|FG000|Overall Study|Protocol Violation|0|||
44120313|NCT02923349|78904314|FG006|Overall Study|Physician Decision|2|||
44120314|NCT02923349|78904308|FG000|Overall Study|Lost to Follow-up|0|||
44120315|NCT02923349|78904309|FG001|Overall Study|Lost to Follow-up|0|||
44120316|NCT02923349|78904310|FG002|Overall Study|Lost to Follow-up|3|||
44120317|NCT02923349|78904311|FG003|Overall Study|Lost to Follow-up|0|||
44120318|NCT02923349|78904312|FG004|Overall Study|Lost to Follow-up|1|||
44120319|NCT02923349|78904313|FG005|Overall Study|Lost to Follow-up|1|||
44120320|NCT02923349|78904314|FG006|Overall Study|Lost to Follow-up|0|||
44120321|NCT02923349|78904308|FG000|Overall Study|Death|1|||
44120322|NCT02923349|78904309|FG001|Overall Study|Death|0|||
44120323|NCT02923349|78904310|FG002|Overall Study|Death|2|||
44120324|NCT02923349|78904311|FG003|Overall Study|Death|4|||
44120325|NCT02923349|78904312|FG004|Overall Study|Death|2|||
44120326|NCT02923349|78904313|FG005|Overall Study|Death|3|||
44120327|NCT02923349|78904314|FG006|Overall Study|Death|0|||
44120328|NCT02521792|78904330|FG000|Overall Study|Study Terminated|6|||
44120329|NCT03020615|78904337|FG000|Overall Study|Physician Decision|3|||
44120330|NCT03020615|78904338|FG001|Overall Study|Physician Decision|1|||
44120331|NCT03020615|78904339|FG002|Overall Study|Physician Decision|2|||
44120332|NCT03020615|78904337|FG000|Overall Study|Parent/guardian/patient choice|3|||
44120333|NCT03020615|78904338|FG001|Overall Study|Parent/guardian/patient choice|0|||
44120334|NCT03020615|78904339|FG002|Overall Study|Parent/guardian/patient choice|4|||
44120335|NCT03020615|78904337|FG000|Overall Study|Screen failure|0|||
44120336|NCT03020615|78904338|FG001|Overall Study|Screen failure|0|||
44120337|NCT03020615|78904339|FG002|Overall Study|Screen failure|1|||
44120338|NCT03020615|78904337|FG000|Overall Study|Death|1|||
44120339|NCT03020615|78904338|FG001|Overall Study|Death|0|||
44120340|NCT03020615|78904339|FG002|Overall Study|Death|0|||
44120341|NCT03020615|78904337|FG000|Overall Study|Lost to Follow-up|0|||
44120342|NCT03020615|78904338|FG001|Overall Study|Lost to Follow-up|1|||
44120343|NCT03020615|78904339|FG002|Overall Study|Lost to Follow-up|0|||
44120344|NCT03020069|78904352|FG000|Overall Study|Lost to Follow-up|0|||
44120345|NCT03020069|78904353|FG001|Overall Study|Lost to Follow-up|1|||
44120346|NCT03021005|78904361|FG000|Overall Study|Lost to Follow-up|39|||
44120347|NCT03021005|78904362|FG001|Overall Study|Lost to Follow-up|26|||
44120348|NCT02914457|78904368|FG000|Overall Study|Withdrawal by Subject|1|||
44239520|NCT01541969|79066391|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
44239521|NCT01541969|79066390|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
44239522|NCT01541969|79066391|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
44120349|NCT02914457|78904368|FG000|Overall Study|Physician Decision|1|||
44120350|NCT02914457|78904368|FG000|Overall Study|No veins available for lead placement|1|||
44120351|NCT02914457|78904368|FG000|Overall Study|Electrical instability of patient|1|||
44239523|NCT01541969|79066390|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
44120352|NCT02914457|78904368|FG000|Overall Study|ECG acquisition error due to sweating|1|||
44120353|NCT02914457|78904368|FG000|Overall Study|Protocol Violation|1|||
44120354|NCT02665052|78904376|FG000|Overall Study|Lost to Follow-up|1|||
44120355|NCT02665052|78904377|FG001|Overall Study|Lost to Follow-up|0|||
44120356|NCT02665052|78904378|FG002|Overall Study|Lost to Follow-up|0|||
44120357|NCT02665052|78904379|FG003|Overall Study|Lost to Follow-up|0|||
44120358|NCT02665052|78904376|FG000|Overall Study|Withdrawal by Subject|1|||
44120359|NCT02665052|78904377|FG001|Overall Study|Withdrawal by Subject|1|||
44120360|NCT02665052|78904378|FG002|Overall Study|Withdrawal by Subject|0|||
44120361|NCT02665052|78904379|FG003|Overall Study|Withdrawal by Subject|5|||
44120362|NCT02665052|78904376|FG000|Overall Study|Adverse Event|1|||
44120363|NCT02665052|78904377|FG001|Overall Study|Adverse Event|1|||
44120364|NCT02665052|78904378|FG002|Overall Study|Adverse Event|0|||
44120365|NCT02665052|78904379|FG003|Overall Study|Adverse Event|0|||
44120366|NCT03019289|78904399|FG000|Overall Study|Adverse Event|1|||
44120367|NCT03019289|78904400|FG001|Overall Study|Adverse Event|0|||
44120368|NCT03019289|78904401|FG002|Overall Study|Adverse Event|0|||
44120369|NCT03019289|78904402|FG003|Overall Study|Adverse Event|0|||
44120370|NCT03019289|78904403|FG004|Overall Study|Adverse Event|0|||
44120371|NCT03019289|78904404|FG005|Overall Study|Adverse Event|0|||
44120372|NCT03019289|78904405|FG006|Overall Study|Adverse Event|0|||
44120373|NCT03019289|78904406|FG007|Overall Study|Adverse Event|0|||
44120374|NCT03019289|78904407|FG008|Overall Study|Adverse Event|1|||
44120375|NCT03019289|78904399|FG000|Overall Study|Other|1|||
44120376|NCT03019289|78904400|FG001|Overall Study|Other|0|||
44120377|NCT03019289|78904401|FG002|Overall Study|Other|0|||
44120378|NCT03019289|78904402|FG003|Overall Study|Other|0|||
44508575|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
44508576|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
44508577|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
44508578|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
44120379|NCT03019289|78904403|FG004|Overall Study|Other|0|||
44120380|NCT03019289|78904404|FG005|Overall Study|Other|0|||
44120381|NCT03019289|78904405|FG006|Overall Study|Other|0|||
44508579|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
44508580|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
44508581|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
44508582|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
44508583|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
44508584|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
44508585|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
44508586|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
44508587|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
44120382|NCT03019289|78904406|FG007|Overall Study|Other|0|||
44378793|NCT00772447|79384293|FG001|Overall Study|Protocol Violation|1|||
44120383|NCT03019289|78904407|FG008|Overall Study|Other|0|||
44120384|NCT02520388|78904430|FG000|Overall Study|Physician Decision|1|||
44508588|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
44508589|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
44120385|NCT02520388|78904431|FG001|Overall Study|Physician Decision|0|||
44120386|NCT02520388|78904430|FG000|Overall Study|Subject or parent/guardian request|0|||
44120387|NCT02520388|78904431|FG001|Overall Study|Subject or parent/guardian request|6|||
44120388|NCT02520388|78904430|FG000|Overall Study|Adverse Event|1|||
44378794|NCT00772447|79384292|FG000|Overall Study|all others|2|||
44508590|NCT03162796|79513915|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
44508591|NCT03162796|79513916|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
44508592|NCT03162796|79513917|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
44508593|NCT03162796|79513915|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
44120389|NCT02520388|78904431|FG001|Overall Study|Adverse Event|4|||
44120390|NCT02520388|78904430|FG000|Overall Study|Lost to Follow-up|3|||
44120391|NCT02520388|78904431|FG001|Overall Study|Lost to Follow-up|2|||
44120392|NCT02520388|78904430|FG000|Overall Study|Other (reason not defined)|4|||
44120393|NCT02520388|78904431|FG001|Overall Study|Other (reason not defined)|4|||
44120394|NCT02668640|78904437|FG000|Overall Study|Lost to Follow-up|13|||
44120395|NCT02668640|78904437|FG000|Overall Study|Other, not specified|1|||
44120396|NCT03014453|78904441|FG000|Overall Study|Lost to Follow-up|12|||
44120397|NCT03014453|78904441|FG000|Overall Study|Discontinued GER|3|||
44120398|NCT03014453|78904441|FG000|Overall Study|Excluded|19|||
44120399|NCT03014453|78904441|FG000|Overall Study|Refused to take part in|37|||
44120400|NCT02664272|78904445|FG000|Overall Study|Fluoroscopic images not made available|2|||
44120401|NCT02663882|78904451|FG000|Overall Study|Lost to Follow-up|4|||
44120402|NCT02663882|78904452|FG001|Overall Study|Lost to Follow-up|2|||
44120403|NCT03011333|78904465|FG000|Overall Study|Lost to Follow-up|0|||
44120404|NCT03011333|78904466|FG001|Overall Study|Lost to Follow-up|1|||
44120405|NCT03011333|78904467|FG002|Overall Study|Lost to Follow-up|0|||
44120406|NCT03011333|78904468|FG003|Overall Study|Lost to Follow-up|1|||
44120407|NCT03011333|78904469|FG004|Overall Study|Lost to Follow-up|4|||
44120408|NCT03011333|78904470|FG005|Overall Study|Lost to Follow-up|4|||
44120409|NCT03011333|78904471|FG006|Overall Study|Lost to Follow-up|5|||
44120410|NCT03011099|78904489|FG000|Overall Study|Withdrawal by Subject|0|||
44120411|NCT03011099|78904490|FG001|Overall Study|Withdrawal by Subject|2|||
44120412|NCT03013985|78904500|FG000|Overall Study|Protocol Violation|2|||
44120413|NCT03013985|78904501|FG001|Overall Study|Protocol Violation|2|||
44120414|NCT03013985|78904500|FG000|Overall Study|Withdrawal by Subject|14|||
44120415|NCT03013985|78904501|FG001|Overall Study|Withdrawal by Subject|17|||
44120416|NCT03016403|78904511|FG000|Baseline|Death|5|||
44120417|NCT03016403|78904512|FG001|Baseline|Death|8|||
44120418|NCT03016403|78904513|FG002|Baseline|Death|1|||
44120419|NCT03016403|78904514|FG003|Baseline|Death|0|||
44120420|NCT03016403|78904511|FG000|Baseline|Withdrawal by Subject|2|||
44120421|NCT03016403|78904512|FG001|Baseline|Withdrawal by Subject|8|||
44120422|NCT03016403|78904513|FG002|Baseline|Withdrawal by Subject|4|||
44120423|NCT03016403|78904514|FG003|Baseline|Withdrawal by Subject|10|||
44120424|NCT03016403|78904511|FG000|Baseline|Lost to Follow-up|9|||
44508594|NCT03162796|79513916|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
44508595|NCT03162796|79513917|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
44120425|NCT03016403|78904512|FG001|Baseline|Lost to Follow-up|11|||
44120426|NCT03016403|78904513|FG002|Baseline|Lost to Follow-up|6|||
44120427|NCT03016403|78904514|FG003|Baseline|Lost to Follow-up|24|||
44120428|NCT03016403|78904511|FG000|6-week Follow-up|Death|1|||
44120429|NCT03016403|78904512|FG001|6-week Follow-up|Death|4|||
44120430|NCT03016403|78904513|FG002|6-week Follow-up|Death|0|||
44120431|NCT03016403|78904514|FG003|6-week Follow-up|Death|0|||
44120432|NCT03016403|78904511|FG000|6-week Follow-up|Lost to Follow-up|2|||
44120433|NCT03016403|78904512|FG001|6-week Follow-up|Lost to Follow-up|7|||
44120434|NCT03016403|78904513|FG002|6-week Follow-up|Lost to Follow-up|4|||
44508596|NCT03162796|79513915|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
44120435|NCT03016403|78904514|FG003|6-week Follow-up|Lost to Follow-up|8|||
44120436|NCT03016403|78904511|FG000|6-week Follow-up|Withdrawal by Subject|0|||
44120437|NCT03016403|78904512|FG001|6-week Follow-up|Withdrawal by Subject|2|||
44120438|NCT03016403|78904513|FG002|6-week Follow-up|Withdrawal by Subject|0|||
44120439|NCT03016403|78904514|FG003|6-week Follow-up|Withdrawal by Subject|1|||
44120440|NCT03016403|78904511|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
44120441|NCT03016403|78904512|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
44120442|NCT03016403|78904513|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
44120443|NCT03016403|78904514|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
44120444|NCT03016403|78904511|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
44120445|NCT03016403|78904512|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
44120446|NCT03016403|78904513|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
44120447|NCT03016403|78904514|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
44120448|NCT03016403|78904511|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
44120449|NCT03016403|78904512|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
44508597|NCT03162796|79513916|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
44508598|NCT03162796|79513917|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
44508599|NCT03162796|79513915|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
44508600|NCT03162796|79513916|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
44508601|NCT03162796|79513917|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
44508602|NCT03162796|79513915|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
44508603|NCT03162796|79513916|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
44508604|NCT03162796|79513917|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
44508605|NCT03162328|79513930|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
44508606|NCT03162328|79513931|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
44508607|NCT03162328|79513932|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
44120450|NCT03016403|78904513|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
44120451|NCT03016403|78904514|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
44508608|NCT03162328|79513930|FG000|Screening Period|Withdrawal by Subject|1|||
44120452|NCT02520310|78904526|FG000|At 6 Months Clinical Follow-up|Death|1|||
44120453|NCT02520310|78904526|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
44508609|NCT03162328|79513931|FG001|Screening Period|Withdrawal by Subject|0|||
44508610|NCT03162328|79513932|FG002|Screening Period|Withdrawal by Subject|0|||
44120454|NCT02520310|78904526|FG000|AT 3 Year Clinical Follow-up|Death|2|||
44120455|NCT02520310|78904526|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
44120456|NCT02520310|78904526|FG000|AT 4 Year Clinical Follow-up|Death|1|||
44508611|NCT03162328|79513930|FG000|Study Period|Withdrawal by Subject|0|||
44508612|NCT03162328|79513931|FG001|Study Period|Withdrawal by Subject|0|||
44508613|NCT03162328|79513932|FG002|Study Period|Withdrawal by Subject|1|||
44508614|NCT00272987|79513946|FG000|Overall Study|Adverse Event|1|||
44508615|NCT00272987|79513947|FG001|Overall Study|Adverse Event|0|||
44508616|NCT00272987|79513948|FG002|Overall Study|Adverse Event|0|||
44120457|NCT02520310|78904526|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
44120458|NCT02662556|78904532|FG000|Overall Study|Adverse Event|4|||
44120459|NCT02662556|78904532|FG000|Overall Study|Lack of Efficacy|4|||
44120460|NCT02516098|78904539|FG000|Period 1|Protocol Violation|1|||
44120461|NCT02516098|78904540|FG001|Period 1|Protocol Violation|0|||
44120462|NCT02516098|78904539|FG000|Washout After Period 1|Adverse Event|0|||
44120463|NCT02516098|78904540|FG001|Washout After Period 1|Adverse Event|1|||
44120464|NCT02516098|78904539|FG000|Period 2|Withdrawal by Subject|0|||
44120465|NCT02516098|78904540|FG001|Period 2|Withdrawal by Subject|1|||
44120466|NCT01364428|78904548|FG000|Overall Study|Adverse Event|1|||
44120467|NCT01364428|78904549|FG001|Overall Study|Adverse Event|2|||
44120468|NCT01364428|78904548|FG000|Overall Study|Protocol Violation|2|||
44120469|NCT01364428|78904549|FG001|Overall Study|Protocol Violation|0|||
44120470|NCT01364428|78904548|FG000|Overall Study|Withdrawal Criteria|14|||
44120471|NCT01364428|78904549|FG001|Overall Study|Withdrawal Criteria|10|||
44120472|NCT01364428|78904548|FG000|Overall Study|Other|3|||
44120473|NCT01364428|78904549|FG001|Overall Study|Other|3|||
44120474|NCT02515942|78904558|FG000|Overall Study|Adverse Event|5|||
44120475|NCT02515942|78904559|FG001|Overall Study|Adverse Event|0|||
44120476|NCT02515942|78904560|FG002|Overall Study|Adverse Event|0|||
44120477|NCT02515942|78904558|FG000|Overall Study|Death|0|||
44120478|NCT02515942|78904559|FG001|Overall Study|Death|0|||
44120479|NCT02515942|78904560|FG002|Overall Study|Death|1|||
44120480|NCT02515942|78904558|FG000|Overall Study|Lack of Efficacy|0|||
44120481|NCT02515942|78904559|FG001|Overall Study|Lack of Efficacy|0|||
44120482|NCT02515942|78904560|FG002|Overall Study|Lack of Efficacy|1|||
44120483|NCT02515942|78904558|FG000|Overall Study|Lost to Follow-up|2|||
44120484|NCT02515942|78904559|FG001|Overall Study|Lost to Follow-up|0|||
44120485|NCT02515942|78904560|FG002|Overall Study|Lost to Follow-up|0|||
44120486|NCT02515942|78904558|FG000|Overall Study|Withdrawal by Subject|0|||
44120487|NCT02515942|78904559|FG001|Overall Study|Withdrawal by Subject|3|||
44120488|NCT02515942|78904560|FG002|Overall Study|Withdrawal by Subject|2|||
44239524|NCT01541969|79066391|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
44239525|NCT01541969|79066390|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
44508617|NCT00272987|79513946|FG000|Overall Study|Lost to Follow-up|3|||
44508618|NCT00272987|79513947|FG001|Overall Study|Lost to Follow-up|1|||
44508619|NCT00272987|79513948|FG002|Overall Study|Lost to Follow-up|1|||
44508620|NCT00272987|79513946|FG000|Overall Study|Withdrawal by Subject|1|||
44508621|NCT00272987|79513947|FG001|Overall Study|Withdrawal by Subject|0|||
44508622|NCT00272987|79513948|FG002|Overall Study|Withdrawal by Subject|3|||
44508623|NCT00272987|79513946|FG000|Overall Study|Sponsor Terminated study|0|||
44508624|NCT00272987|79513947|FG001|Overall Study|Sponsor Terminated study|1|||
44508625|NCT00272987|79513948|FG002|Overall Study|Sponsor Terminated study|1|||
44508626|NCT00272987|79513946|FG000|Overall Study|Disease progression|1|||
44120489|NCT02991859|78904587|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44239526|NCT01541969|79066391|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
44120490|NCT02991859|78904588|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
44508627|NCT00272987|79513947|FG001|Overall Study|Disease progression|1|||
44508628|NCT00272987|79513948|FG002|Overall Study|Disease progression|2|||
44120491|NCT02991859|78904589|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120492|NCT02991859|78904590|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120493|NCT02991859|78904591|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
44120494|NCT02991859|78904592|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120495|NCT02991859|78904593|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120496|NCT02991859|78904594|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120497|NCT02991859|78904595|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120498|NCT02991859|78904596|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120499|NCT02991859|78904597|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120500|NCT02991859|78904598|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120501|NCT02991859|78904599|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120502|NCT02991859|78904600|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120503|NCT02991859|78904601|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120504|NCT02991859|78904602|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120505|NCT02991859|78904603|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
44120506|NCT02991859|78904587|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120507|NCT02991859|78904588|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120508|NCT02991859|78904589|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120509|NCT02991859|78904590|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120510|NCT02991859|78904591|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120511|NCT02991859|78904592|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120512|NCT02991859|78904593|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120513|NCT02991859|78904594|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120514|NCT02991859|78904595|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120515|NCT02991859|78904596|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120516|NCT02991859|78904597|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120517|NCT02991859|78904598|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120518|NCT02991859|78904599|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
44120519|NCT02991859|78904600|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
44120520|NCT02991859|78904601|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120521|NCT02991859|78904602|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44239527|NCT01541969|79066390|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
44378795|NCT00772447|79384293|FG001|Overall Study|all others|2|||
44378796|NCT00765037|79384300|FG000|Overall Study|Lost to Follow-up|5|||
44378797|NCT00765037|79384300|FG000|Overall Study|Adverse Event|1|||
44378798|NCT04682353|79384317|FG000|Overall Study|Lost to Follow-up|0|||
44378799|NCT04682353|79384318|FG001|Overall Study|Lost to Follow-up|1|||
44378800|NCT04682353|79384319|FG002|Overall Study|Lost to Follow-up|0|||
44378801|NCT04682353|79384320|FG003|Overall Study|Lost to Follow-up|1|||
44378802|NCT04682353|79384317|FG000|Overall Study|Personal reasons|0|||
44378803|NCT04682353|79384318|FG001|Overall Study|Personal reasons|1|||
44378804|NCT04682353|79384319|FG002|Overall Study|Personal reasons|0|||
44378805|NCT04682353|79384320|FG003|Overall Study|Personal reasons|0|||
44378806|NCT04227405|79384341|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
44378807|NCT04227405|79384342|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
44378808|NCT04227405|79384341|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
44378809|NCT04227405|79384342|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
44508629|NCT00272987|79513946|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
44508630|NCT00272987|79513947|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
44508631|NCT00272987|79513948|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
44508632|NCT00272987|79513946|FG000|Overall Study|Death|1|||
44508633|NCT00272987|79513947|FG001|Overall Study|Death|0|||
44508634|NCT00272987|79513948|FG002|Overall Study|Death|0|||
44378810|NCT04227405|79384341|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
44508635|NCT01730950|79513958|FG000|Overall Study|Protocol Violation|6|||
44508636|NCT01730950|79513959|FG001|Overall Study|Protocol Violation|6|||
44508637|NCT00271505|79513966|FG000|Overall Study|Screen Failure|3|||
44508638|NCT00271505|79513966|FG000|Overall Study|Adverse Event|1|||
44508639|NCT00271505|79513966|FG000|Overall Study|Death|1|||
44508640|NCT01642186|79513974|FG000|Overall Study|Death|0|||
44508641|NCT01642186|79513975|FG001|Overall Study|Death|2|||
44508642|NCT01642186|79513976|FG002|Overall Study|Death|2|||
44508643|NCT01642186|79513974|FG000|Overall Study|Lost to Follow-up|0|||
44378811|NCT04227405|79384342|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
44378812|NCT03875235|79384352|FG000|Overall Study|Ongoing study treatment|63|||
44378813|NCT03875235|79384353|FG001|Overall Study|Ongoing study treatment|20|||
44378814|NCT03875235|79384352|FG000|Overall Study|Off treatment|77|||
44378815|NCT03875235|79384353|FG001|Overall Study|Off treatment|91|||
44378816|NCT03875235|79384352|FG000|Overall Study|Withdrawal by Subject|3|||
44378817|NCT03875235|79384353|FG001|Overall Study|Withdrawal by Subject|10|||
44378818|NCT03875235|79384352|FG000|Overall Study|Death|198|||
44378819|NCT03875235|79384353|FG001|Overall Study|Death|223|||
44378820|NCT03748420|79384361|FG000|Overall Study|No 12 month medication adherence data available|0|||
44378821|NCT03748420|79384362|FG001|Overall Study|No 12 month medication adherence data available|1|||
44378822|NCT03748420|79384361|FG000|Overall Study|Death|24|||
44378823|NCT03748420|79384362|FG001|Overall Study|Death|28|||
44508644|NCT01642186|79513975|FG001|Overall Study|Lost to Follow-up|0|||
44508645|NCT01642186|79513976|FG002|Overall Study|Lost to Follow-up|1|||
44120522|NCT02991859|78904603|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
44120523|NCT02991859|78904587|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120524|NCT02991859|78904588|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120525|NCT02991859|78904589|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44239528|NCT01541969|79066391|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
44239529|NCT01541969|79066390|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
44239530|NCT01541969|79066391|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
44239531|NCT01541969|79066390|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
44239532|NCT01541969|79066391|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
44239533|NCT01541969|79066390|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
44239534|NCT01541969|79066391|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
44239535|NCT01541969|79066390|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
44239536|NCT01541969|79066391|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
44239537|NCT01541969|79066390|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
44239538|NCT01541969|79066391|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
44239539|NCT01540565|79066400|FG000|Overall Study|Ineligible|2|||
44239540|NCT01540487|79066406|FG000|Overall Study|Protocol Violation|1|||
44239541|NCT01540487|79066407|FG001|Overall Study|Protocol Violation|0|||
44239542|NCT01539317|79066419|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
44239543|NCT01539317|79066420|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
44239544|NCT01539239|79066431|FG000|Overall Study|Death|5|||
44239545|NCT01539239|79066432|FG001|Overall Study|Death|5|||
44239546|NCT01539239|79066431|FG000|Overall Study|Lost to Follow-up|7|||
44239547|NCT01539239|79066432|FG001|Overall Study|Lost to Follow-up|12|||
44239548|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
44239549|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
44239550|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
44239551|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
44239552|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
44239553|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
44239554|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Death|6|||
44239555|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Death|0|||
44239556|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Death|0|||
44239557|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
44239558|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
44239559|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
44239560|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
44508646|NCT00423514|79513986|FG000|Overall Study|Ineligible|1|||
44508647|NCT00423514|79513987|FG001|Overall Study|Ineligible|0|||
44508648|NCT00289991|79513995|FG000|Overall Study|Death|35|||
44508649|NCT00289991|79513996|FG001|Overall Study|Death|38|||
44508650|NCT00289991|79513995|FG000|Overall Study|Adverse Event|15|||
44508651|NCT00289991|79513996|FG001|Overall Study|Adverse Event|13|||
44508652|NCT00289991|79513995|FG000|Overall Study|Failure of prophylaxis|1|||
44508653|NCT00289991|79513996|FG001|Overall Study|Failure of prophylaxis|1|||
44508654|NCT00289991|79513995|FG000|Overall Study|Fungal breakthrough infection|0|||
44508655|NCT00289991|79513996|FG001|Overall Study|Fungal breakthrough infection|1|||
44508656|NCT00289991|79513995|FG000|Overall Study|Lost to Follow-up|0|||
44508657|NCT00289991|79513996|FG001|Overall Study|Lost to Follow-up|1|||
44508658|NCT00289991|79513995|FG000|Overall Study|Withdrawal by Subject|2|||
44508659|NCT00289991|79513996|FG001|Overall Study|Withdrawal by Subject|12|||
44508660|NCT00289991|79513995|FG000|Overall Study|Other|5|||
44508661|NCT00289991|79513996|FG001|Overall Study|Other|14|||
44120526|NCT02991859|78904590|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44239561|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
44239562|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
44378824|NCT03748420|79384361|FG000|Overall Study|Lost to Follow-up|231|||
44239563|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
44239564|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
44239565|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
44239566|NCT01539083|79066438|FG000|Before Randomization (VCD Induction)|Other|5|||
44239567|NCT01539083|79066439|FG001|Before Randomization (VCD Induction)|Other|0|||
44239568|NCT01539083|79066440|FG002|Before Randomization (VCD Induction)|Other|0|||
44239569|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
44239570|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
44239571|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
44239572|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Other|0|||
44239573|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Other|1|||
44239574|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Other|1|||
44239575|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
44239576|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
44239577|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
44239578|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
44239579|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
44239580|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
44239581|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
44239582|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
44239583|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
44239584|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
44239585|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
44239586|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
44239587|NCT01539083|79066438|FG000|After Randomization (TP and VTP)|Death|0|||
44239588|NCT01539083|79066439|FG001|After Randomization (TP and VTP)|Death|6|||
44120527|NCT02991859|78904591|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120528|NCT02991859|78904592|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
44120529|NCT02991859|78904593|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44239589|NCT01539083|79066440|FG002|After Randomization (TP and VTP)|Death|11|||
44239590|NCT01537211|79066449|FG000|Overall Study|Lost to Follow-up|0|||
44239591|NCT01537211|79066450|FG001|Overall Study|Lost to Follow-up|1|||
44239592|NCT01537133|79066464|FG000|Overall Study|Withdrawal by Subject|2|||
44239593|NCT01537133|79066465|FG001|Overall Study|Withdrawal by Subject|0|||
44239594|NCT01537133|79066466|FG002|Overall Study|Withdrawal by Subject|0|||
44239595|NCT01537133|79066467|FG003|Overall Study|Withdrawal by Subject|0|||
44239596|NCT01537133|79066464|FG000|Overall Study|Lost to Follow-up|1|||
44378825|NCT03748420|79384362|FG001|Overall Study|Lost to Follow-up|230|||
44378826|NCT03631706|79384372|FG000|Overall Study|Randomized, not treated|1|||
44239597|NCT01537133|79066465|FG001|Overall Study|Lost to Follow-up|0|||
44239598|NCT01537133|79066466|FG002|Overall Study|Lost to Follow-up|0|||
44239599|NCT01537133|79066467|FG003|Overall Study|Lost to Follow-up|0|||
44239600|NCT01536587|79066475|FG000|Overall Study|Adverse Event|2|||
44239601|NCT01536119|79066481|FG000|Overall Study|Lost to Follow-up|17|||
44239602|NCT01536119|79066482|FG001|Overall Study|Lost to Follow-up|14|||
44239603|NCT01535729|79066488|FG000|Overall Study|Withdrawal by Subject|2|||
44239604|NCT01535729|79066488|FG000|Overall Study|Disease progression|230|||
44239605|NCT01535729|79066488|FG000|Overall Study|Discontinued treatment|25|||
44239606|NCT01535729|79066488|FG000|Overall Study|Lost to Follow-up|8|||
44239607|NCT01535729|79066488|FG000|Overall Study|Death|52|||
44239608|NCT01535729|79066488|FG000|Overall Study|Other|19|||
44239609|NCT01535729|79066488|FG000|Overall Study|Did not sign informed consent|1|||
44239610|NCT01535729|79066488|FG000|Overall Study|No previous chemotherapy|33|||
44239611|NCT01535729|79066488|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
44239612|NCT01535729|79066488|FG000|Overall Study|Protocol Violation|11|||
44239613|NCT01535729|79066488|FG000|Overall Study|Screening failure|1|||
44378827|NCT03631706|79384373|FG001|Overall Study|Randomized, not treated|0|||
44378828|NCT03631706|79384372|FG000|Overall Study|Treatment ongoing|26|||
44378829|NCT03631706|79384373|FG001|Overall Study|Treatment ongoing|57|||
44120530|NCT02991859|78904594|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44239614|NCT01535729|79066488|FG000|Overall Study|Not treated|9|||
44239615|NCT01535729|79066488|FG000|Overall Study|No participant record available|5|||
44239616|NCT01535261|79066492|FG000|Overall Study|Physician Decision|8|||
44239617|NCT01535261|79066492|FG000|Overall Study|Protocol Violation|3|||
44239618|NCT01535261|79066492|FG000|Overall Study|Death|5|||
44239619|NCT01535261|79066492|FG000|Overall Study|Lost to Follow-up|8|||
44239620|NCT01535261|79066492|FG000|Overall Study|Withdrawal by Subject|14|||
44239621|NCT01535261|79066492|FG000|Overall Study|Adverse Event|12|||
44239622|NCT01534637|79066496|FG000|Overall Study|Physician Decision|3|||
44239623|NCT01534637|79066496|FG000|Overall Study|Lack of Efficacy|3|||
44239624|NCT01534637|79066496|FG000|Overall Study|Withdrawal by Subject|1|||
44239625|NCT01534637|79066496|FG000|Overall Study|Adverse Event|1|||
44239626|NCT01534637|79066496|FG000|Overall Study|Liver Mets before treatment|1|||
44239627|NCT02655016|79066502|FG000|Overall Study|Disease progression|6|||
44239628|NCT02655016|79066503|FG001|Overall Study|Disease progression|4|||
44239629|NCT02655016|79066502|FG000|Overall Study|Site closed|0|||
44239630|NCT02655016|79066503|FG001|Overall Study|Site closed|1|||
44239631|NCT02655016|79066502|FG000|Overall Study|Death|30|||
44239632|NCT02655016|79066503|FG001|Overall Study|Death|48|||
44239633|NCT02655016|79066502|FG000|Overall Study|Lost to Follow-up|1|||
44120531|NCT02991859|78904595|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44239634|NCT02655016|79066503|FG001|Overall Study|Lost to Follow-up|1|||
44239635|NCT02655016|79066502|FG000|Overall Study|Withdrawal by Subject|18|||
44239636|NCT02655016|79066503|FG001|Overall Study|Withdrawal by Subject|36|||
44239637|NCT01533935|79066510|FG000|Overall Study|Adverse Event|5|||
44239638|NCT01533935|79066511|FG001|Overall Study|Adverse Event|7|||
44239639|NCT01533935|79066512|FG002|Overall Study|Adverse Event|1|||
44120532|NCT02991859|78904596|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120533|NCT02991859|78904597|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120534|NCT02991859|78904598|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120535|NCT02991859|78904599|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120536|NCT02991859|78904600|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120537|NCT02991859|78904601|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120538|NCT02991859|78904602|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120539|NCT02991859|78904603|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
44120540|NCT02991859|78904587|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120541|NCT02991859|78904588|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120542|NCT02991859|78904589|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120543|NCT02991859|78904590|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120544|NCT02991859|78904591|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120545|NCT02991859|78904592|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120546|NCT02991859|78904593|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120547|NCT02991859|78904594|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120548|NCT02991859|78904595|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120549|NCT02991859|78904596|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
44120550|NCT02991859|78904597|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120551|NCT02991859|78904598|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120552|NCT02991859|78904599|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120553|NCT02991859|78904600|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120554|NCT02991859|78904601|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120555|NCT02991859|78904602|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44120556|NCT02991859|78904603|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
44508662|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508663|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
44508664|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508665|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508666|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508667|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
44508668|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
44508669|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
44508670|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
44508671|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
44508672|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
44508673|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
44508674|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508675|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
44120557|NCT02991859|78904587|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120558|NCT02991859|78904588|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120559|NCT02991859|78904589|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120560|NCT02991859|78904590|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120561|NCT02991859|78904591|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120562|NCT02991859|78904592|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44239640|NCT01533935|79066513|FG003|Overall Study|Adverse Event|5|||
44239641|NCT01533935|79066514|FG004|Overall Study|Adverse Event|3|||
44239642|NCT01533935|79066510|FG000|Overall Study|Protocol Violation|0|||
44239643|NCT01533935|79066511|FG001|Overall Study|Protocol Violation|2|||
44239644|NCT01533935|79066512|FG002|Overall Study|Protocol Violation|0|||
44239645|NCT01533935|79066513|FG003|Overall Study|Protocol Violation|0|||
44239646|NCT01533935|79066514|FG004|Overall Study|Protocol Violation|0|||
44239647|NCT01533935|79066510|FG000|Overall Study|Lost to Follow-up|0|||
44120563|NCT02991859|78904593|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120564|NCT02991859|78904594|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120565|NCT02991859|78904595|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
44120566|NCT02991859|78904596|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120567|NCT02991859|78904597|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120568|NCT02991859|78904598|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120569|NCT02991859|78904599|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120570|NCT02991859|78904600|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120571|NCT02991859|78904601|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120572|NCT02991859|78904602|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44120573|NCT02991859|78904603|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
44239648|NCT01533935|79066511|FG001|Overall Study|Lost to Follow-up|0|||
44239649|NCT01533935|79066512|FG002|Overall Study|Lost to Follow-up|1|||
44120574|NCT03016325|78904686|FG000|Treatment Period|Participant withdrew consent|0|||
44120575|NCT03016325|78904687|FG001|Treatment Period|Participant withdrew consent|1|||
44120576|NCT03016325|78904688|FG002|Treatment Period|Participant withdrew consent|0|||
44120577|NCT03016325|78904689|FG003|Treatment Period|Participant withdrew consent|0|||
44120578|NCT03016325|78904690|FG004|Treatment Period|Participant withdrew consent|0|||
44239650|NCT01533935|79066513|FG003|Overall Study|Lost to Follow-up|0|||
44239651|NCT01533935|79066514|FG004|Overall Study|Lost to Follow-up|0|||
44239652|NCT01533935|79066510|FG000|Overall Study|Withdrawal by Subject|0|||
44508676|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
44508677|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
44508678|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
44508679|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
44508680|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
44508681|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
44508682|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508683|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508684|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508685|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
44508686|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508687|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
44239653|NCT01533935|79066511|FG001|Overall Study|Withdrawal by Subject|4|||
44239654|NCT01533935|79066512|FG002|Overall Study|Withdrawal by Subject|5|||
44239655|NCT01533935|79066513|FG003|Overall Study|Withdrawal by Subject|2|||
44239656|NCT01533935|79066514|FG004|Overall Study|Withdrawal by Subject|4|||
44239657|NCT01533935|79066510|FG000|Overall Study|Other reason not defined above|1|||
44239658|NCT01533935|79066511|FG001|Overall Study|Other reason not defined above|0|||
44239659|NCT01533935|79066512|FG002|Overall Study|Other reason not defined above|1|||
44239660|NCT01533935|79066513|FG003|Overall Study|Other reason not defined above|0|||
44239661|NCT01533935|79066514|FG004|Overall Study|Other reason not defined above|1|||
44508688|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
44508689|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
44508690|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
44508691|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
44508692|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
44508693|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
44508694|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
44508695|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
44508696|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
44508697|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
44508698|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
44508699|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
44508700|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
44508701|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
44508702|NCT00289913|79514007|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
44508703|NCT00289913|79514008|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44508704|NCT00289913|79514009|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
44239662|NCT01532999|79066528|FG000|Overall Study|Lost to Follow-up|14|||
44239663|NCT01532999|79066529|FG001|Overall Study|Lost to Follow-up|8|||
44239664|NCT01532999|79066528|FG000|Overall Study|Physician Decision|1|||
44508705|NCT00289913|79514010|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44239665|NCT01532999|79066529|FG001|Overall Study|Physician Decision|2|||
44239666|NCT01532999|79066528|FG000|Overall Study|Withdrawal by Subject|5|||
44239667|NCT01532999|79066529|FG001|Overall Study|Withdrawal by Subject|0|||
44239668|NCT01532999|79066528|FG000|Overall Study|Relocated|2|||
44239669|NCT01532999|79066529|FG001|Overall Study|Relocated|0|||
44239670|NCT01532999|79066528|FG000|Overall Study|should not have been randomized|1|||
44239671|NCT01532999|79066529|FG001|Overall Study|should not have been randomized|0|||
44239672|NCT01532999|79066528|FG000|Overall Study|substantial noncompliance|2|||
44239673|NCT01532999|79066529|FG001|Overall Study|substantial noncompliance|0|||
44239674|NCT01532999|79066528|FG000|Overall Study|no show for week 9 assessments|6|||
44239675|NCT01532999|79066529|FG001|Overall Study|no show for week 9 assessments|4|||
44239676|NCT01532999|79066528|FG000|Overall Study|Adverse Event|0|||
44239677|NCT01532999|79066529|FG001|Overall Study|Adverse Event|1|||
44239678|NCT01532999|79066528|FG000|Overall Study|incarcerated|0|||
44239679|NCT01532999|79066529|FG001|Overall Study|incarcerated|1|||
44239680|NCT01532999|79066528|FG000|Overall Study|New job|0|||
44239681|NCT01532999|79066529|FG001|Overall Study|New job|2|||
44239682|NCT01532921|79066535|FG000|Overall Study|Death|3|||
44239683|NCT01532921|79066535|FG000|Overall Study|Withdrawal by Subject|2|||
44239684|NCT01532921|79066535|FG000|Overall Study|Lost to Follow-up|3|||
44239685|NCT01532921|79066535|FG000|Overall Study|Physician Decision|7|||
44239686|NCT01532921|79066535|FG000|Overall Study|Device was explanted during procedure|1|||
44239687|NCT01532687|79066545|FG000|Overall Study|Death|2|||
44239688|NCT01532687|79066546|FG001|Overall Study|Death|0|||
44239689|NCT01532687|79066545|FG000|Overall Study|Adverse Event|6|||
44239690|NCT01532687|79066546|FG001|Overall Study|Adverse Event|1|||
44239691|NCT01532687|79066545|FG000|Overall Study|Withdrawal by Subject|1|||
44239692|NCT01532687|79066546|FG001|Overall Study|Withdrawal by Subject|0|||
44239693|NCT01532687|79066545|FG000|Overall Study|Physician Decision|2|||
44239694|NCT01532687|79066546|FG001|Overall Study|Physician Decision|1|||
44239695|NCT01532687|79066545|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
44239696|NCT01532687|79066546|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
44239697|NCT02677116|79066563|FG000|Overall Study|Adverse Event|0|||
44276210|NCT02218008|79229542|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
44276211|NCT02218008|79229543|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
44276212|NCT02218008|79229544|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
44276213|NCT02218008|79229545|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
44276214|NCT02218008|79229546|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
44276215|NCT02218008|79229547|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
44276216|NCT02218008|79229542|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
44276217|NCT02218008|79229543|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
44276218|NCT02218008|79229544|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
44276219|NCT02218008|79229545|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
44276220|NCT02218008|79229546|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
44239698|NCT02677116|79066564|FG001|Overall Study|Adverse Event|1|||
44239699|NCT02677116|79066565|FG002|Overall Study|Adverse Event|0|||
44276221|NCT02218008|79229547|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
44276222|NCT02218008|79229542|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
44276223|NCT02218008|79229543|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
44276224|NCT02218008|79229544|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
44276225|NCT02218008|79229545|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
44276226|NCT02218008|79229546|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
44276227|NCT02218008|79229547|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
44276228|NCT02218008|79229542|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
44508706|NCT00289913|79514011|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44508707|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508708|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508709|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
44508710|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508711|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44276229|NCT02218008|79229543|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
44276230|NCT02218008|79229544|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
44276231|NCT02218008|79229545|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
44378830|NCT03631706|79384372|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
44239700|NCT02677116|79066566|FG003|Overall Study|Adverse Event|0|||
44239701|NCT02677116|79066567|FG004|Overall Study|Adverse Event|0|||
44239702|NCT02677116|79066568|FG005|Overall Study|Adverse Event|1|||
44239703|NCT02677116|79066569|FG006|Overall Study|Adverse Event|1|||
44239704|NCT02677116|79066570|FG007|Overall Study|Adverse Event|0|||
44239705|NCT02677116|79066571|FG008|Overall Study|Adverse Event|0|||
44239706|NCT02677116|79066563|FG000|Overall Study|Physician Decision|0|||
44239707|NCT02677116|79066564|FG001|Overall Study|Physician Decision|2|||
44239708|NCT02677116|79066565|FG002|Overall Study|Physician Decision|3|||
44276232|NCT02218008|79229546|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
44276233|NCT02218008|79229547|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
44276234|NCT01632150|79229644|FG000|Overall Study|Disease progression|27|||
44508712|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
44239709|NCT02677116|79066566|FG003|Overall Study|Physician Decision|2|||
44239710|NCT02677116|79066567|FG004|Overall Study|Physician Decision|1|||
44239711|NCT02677116|79066568|FG005|Overall Study|Physician Decision|3|||
44239712|NCT02677116|79066569|FG006|Overall Study|Physician Decision|1|||
44239713|NCT02677116|79066570|FG007|Overall Study|Physician Decision|1|||
44239714|NCT02677116|79066571|FG008|Overall Study|Physician Decision|2|||
44239715|NCT02677116|79066563|FG000|Overall Study|Withdrawal by parent or guardian|2|||
44239716|NCT02677116|79066564|FG001|Overall Study|Withdrawal by parent or guardian|1|||
44239717|NCT02677116|79066565|FG002|Overall Study|Withdrawal by parent or guardian|0|||
44239718|NCT02677116|79066566|FG003|Overall Study|Withdrawal by parent or guardian|1|||
44239719|NCT02677116|79066567|FG004|Overall Study|Withdrawal by parent or guardian|0|||
44239720|NCT02677116|79066568|FG005|Overall Study|Withdrawal by parent or guardian|0|||
44239721|NCT02677116|79066569|FG006|Overall Study|Withdrawal by parent or guardian|2|||
44239722|NCT02677116|79066570|FG007|Overall Study|Withdrawal by parent or guardian|1|||
44239723|NCT02677116|79066571|FG008|Overall Study|Withdrawal by parent or guardian|0|||
44239724|NCT02677116|79066563|FG000|Overall Study|Withdrawal by Subject|1|||
44239725|NCT02677116|79066564|FG001|Overall Study|Withdrawal by Subject|0|||
44239726|NCT02677116|79066565|FG002|Overall Study|Withdrawal by Subject|0|||
44239727|NCT02677116|79066566|FG003|Overall Study|Withdrawal by Subject|0|||
44239728|NCT02677116|79066567|FG004|Overall Study|Withdrawal by Subject|0|||
44239729|NCT02677116|79066568|FG005|Overall Study|Withdrawal by Subject|0|||
44239730|NCT02677116|79066569|FG006|Overall Study|Withdrawal by Subject|0|||
44276235|NCT01632150|79229644|FG000|Overall Study|Study drug toxicity|1|||
44508713|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
44508714|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
44508715|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
44508716|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
44508717|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
44508718|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
44508719|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
44508720|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
44508721|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
44508722|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
44508723|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
44508724|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
44508725|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508726|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508727|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
44508728|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508729|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
44508730|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508731|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508732|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
44508733|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
44508734|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
44508735|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
44508736|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
44508737|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
44508738|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
44239731|NCT02677116|79066570|FG007|Overall Study|Withdrawal by Subject|0|||
44239732|NCT02677116|79066571|FG008|Overall Study|Withdrawal by Subject|0|||
44276236|NCT01632150|79229644|FG000|Overall Study|Unrelated adverse event|7|||
44508739|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
44508740|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
44239733|NCT02689518|79066614|FG000|Overall Study|Withdrawal by Subject|3|||
44239734|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
44276237|NCT01632150|79229644|FG000|Overall Study|Withdrawal by Subject|2|||
44508741|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
44508742|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
44239735|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
44239736|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
44239737|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
44239738|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
44239739|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
44239740|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
44239741|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
44239742|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
44239743|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
44239744|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
44239745|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
44239746|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
44239747|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
44239748|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
44239749|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|Other|6|||
44239750|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|Other|6|||
44239751|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|Other|7|||
44239752|NCT02681094|79066621|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
44239753|NCT02681094|79066622|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
44239754|NCT02681094|79066623|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
44239755|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|Participant decision|7|||
44239756|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|Participant decision|10|||
44239757|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|Participant decision|9|||
44239758|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
44239759|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
44239760|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
44239761|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
44239762|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
44239763|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
44239764|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
44276238|NCT01632150|79229644|FG000|Overall Study|Patient underwent autologous transplant|1|||
44276239|NCT01632150|79229644|FG000|Overall Study|Moved to compassionate program|2|||
44276240|NCT02185014|79229669|FG000|Overall Study|Adverse Event|18|||
44276241|NCT02185014|79229669|FG000|Overall Study|Withdrew Consent|8|||
44276242|NCT02185014|79229669|FG000|Overall Study|Lost to Follow-up|4|||
44276243|NCT02185014|79229669|FG000|Overall Study|Lack of Efficacy|14|||
44239765|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
44239766|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
44239767|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
44239768|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
44239769|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
44239770|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|Other|6|||
44239771|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|Other|6|||
44239772|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|Other|7|||
44239773|NCT02681094|79066621|FG000|2 - Enrolled Participants Set|No treatment given|0|||
44239774|NCT02681094|79066622|FG001|2 - Enrolled Participants Set|No treatment given|1|||
44239775|NCT02681094|79066623|FG002|2 - Enrolled Participants Set|No treatment given|1|||
44276244|NCT02185014|79229669|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
44276245|NCT02185014|79229669|FG000|Overall Study|Subject Noncompliance|1|||
44276246|NCT02185014|79229669|FG000|Overall Study|Other|4|||
44508743|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
44508744|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
44508745|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
44508746|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
44508747|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
44508748|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
44508749|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
44508750|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
44508751|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
44508752|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
44508753|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
44508754|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
44508755|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
44508756|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
44508757|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
44508758|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
44508759|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
44276247|NCT02184156|79229719|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
44239776|NCT02689284|79066634|FG000|Overall Study|Adverse Event|1|||
44276248|NCT02184156|79229720|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
44276249|NCT02184156|79229719|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
44276250|NCT02184156|79229720|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
44276251|NCT02158884|79229743|FG000|Baseline Assessment|Missed performance assessment|3|||
44276252|NCT02158884|79229743|FG000|Baseline Assessment|Missed SMFA|1|||
44276253|NCT02158884|79229743|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
44276254|NCT02158884|79229743|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
44276255|NCT02158884|79229743|FG000|6 Month Assessment|Missed SMFA|20|||
44276256|NCT02158884|79229743|FG000|12 Month Assessment|Missed SMFA|17|||
44120579|NCT03016325|78904691|FG005|Treatment Period|Participant withdrew consent|0|||
44239777|NCT02689284|79066635|FG001|Overall Study|Adverse Event|8|||
44239778|NCT02689284|79066634|FG000|Overall Study|Death|0|||
44239779|NCT02689284|79066635|FG001|Overall Study|Death|1|||
44239780|NCT02689284|79066634|FG000|Overall Study|Physician Decision|1|||
44239781|NCT02689284|79066635|FG001|Overall Study|Physician Decision|2|||
44239782|NCT02689284|79066634|FG000|Overall Study|Withdrawal by Subject|0|||
44239783|NCT02689284|79066635|FG001|Overall Study|Withdrawal by Subject|1|||
44239784|NCT02689284|79066634|FG000|Overall Study|progression of cancer|1|||
44239785|NCT02689284|79066635|FG001|Overall Study|progression of cancer|72|||
44239786|NCT02689284|79066634|FG000|Overall Study|decreased heart function|0|||
44239787|NCT02689284|79066635|FG001|Overall Study|decreased heart function|1|||
44239788|NCT02689284|79066634|FG000|Overall Study|concern for anemia|0|||
44239789|NCT02689284|79066635|FG001|Overall Study|concern for anemia|1|||
44239790|NCT02689284|79066634|FG000|Overall Study|no measurable cancer for evaluation|0|||
44239791|NCT02689284|79066635|FG001|Overall Study|no measurable cancer for evaluation|1|||
44239792|NCT02676882|79066644|FG000|Overall Study|Adverse Event|1|||
44239793|NCT02676882|79066645|FG001|Overall Study|Adverse Event|0|||
44239794|NCT02676882|79066644|FG000|Overall Study|Lost to Follow-up|1|||
44239795|NCT02676882|79066645|FG001|Overall Study|Lost to Follow-up|0|||
44239796|NCT02676882|79066644|FG000|Overall Study|Withdrawal by Subject|1|||
44239797|NCT02676882|79066645|FG001|Overall Study|Withdrawal by Subject|2|||
44239798|NCT02674386|79066654|FG000|Overall Study|Lost to Follow-up|0|||
44239799|NCT02674386|79066655|FG001|Overall Study|Lost to Follow-up|1|||
44239800|NCT02674386|79066656|FG002|Overall Study|Lost to Follow-up|1|||
44239801|NCT02674386|79066654|FG000|Overall Study|Withdrawal by Subject|0|||
44239802|NCT02674386|79066655|FG001|Overall Study|Withdrawal by Subject|4|||
44239803|NCT02674386|79066656|FG002|Overall Study|Withdrawal by Subject|0|||
44239804|NCT02674386|79066654|FG000|Overall Study|Other|0|||
44239805|NCT02674386|79066655|FG001|Overall Study|Other|1|||
44239806|NCT02674386|79066656|FG002|Overall Study|Other|0|||
44239807|NCT02674386|79066654|FG000|Overall Study|Enrolled but not evaluated|0|||
44239808|NCT02674386|79066655|FG001|Overall Study|Enrolled but not evaluated|4|||
44239809|NCT02674386|79066656|FG002|Overall Study|Enrolled but not evaluated|0|||
44239810|NCT02680002|79066675|FG000|Overall Study|Lost to Follow-up|5|||
44120580|NCT03016325|78904692|FG006|Treatment Period|Participant withdrew consent|0|||
44120581|NCT03016325|78904693|FG007|Treatment Period|Participant withdrew consent|0|||
44120582|NCT03016325|78904686|FG000|Treatment Period|Death|0|||
44120583|NCT03016325|78904687|FG001|Treatment Period|Death|0|||
44120584|NCT03016325|78904688|FG002|Treatment Period|Death|0|||
44120585|NCT03016325|78904689|FG003|Treatment Period|Death|0|||
44120586|NCT03016325|78904690|FG004|Treatment Period|Death|2|||
44120587|NCT03016325|78904691|FG005|Treatment Period|Death|0|||
44239811|NCT02680002|79066676|FG001|Overall Study|Lost to Follow-up|1|||
44239812|NCT02680002|79066677|FG002|Overall Study|Lost to Follow-up|4|||
44239813|NCT02680002|79066678|FG003|Overall Study|Lost to Follow-up|2|||
44239814|NCT02680002|79066679|FG004|Overall Study|Lost to Follow-up|0|||
44239815|NCT02680002|79066680|FG005|Overall Study|Lost to Follow-up|2|||
44239816|NCT02680002|79066675|FG000|Overall Study|Physician Decision|5|||
44239817|NCT02680002|79066676|FG001|Overall Study|Physician Decision|1|||
44239818|NCT02680002|79066677|FG002|Overall Study|Physician Decision|1|||
44239819|NCT02680002|79066678|FG003|Overall Study|Physician Decision|1|||
44239820|NCT02680002|79066679|FG004|Overall Study|Physician Decision|1|||
44239821|NCT02680002|79066680|FG005|Overall Study|Physician Decision|1|||
44276257|NCT02158806|79229786|FG000|Overall Study|Death|2|||
44120588|NCT03016325|78904692|FG006|Treatment Period|Death|0|||
44276258|NCT02158806|79229787|FG001|Overall Study|Death|0|||
44120589|NCT03016325|78904693|FG007|Treatment Period|Death|0|||
44120590|NCT03016325|78904686|FG000|Treatment Period|Participant refuses assessments|0|||
44239822|NCT02680002|79066675|FG000|Overall Study|Protocol Violation|1|||
44239823|NCT02680002|79066676|FG001|Overall Study|Protocol Violation|0|||
44239824|NCT02680002|79066677|FG002|Overall Study|Protocol Violation|1|||
44239825|NCT02680002|79066678|FG003|Overall Study|Protocol Violation|0|||
44239826|NCT02680002|79066679|FG004|Overall Study|Protocol Violation|1|||
44239827|NCT02680002|79066680|FG005|Overall Study|Protocol Violation|2|||
44239828|NCT02680002|79066675|FG000|Overall Study|Withdrawal by Subject|0|||
44239829|NCT02680002|79066676|FG001|Overall Study|Withdrawal by Subject|0|||
44239830|NCT02680002|79066677|FG002|Overall Study|Withdrawal by Subject|1|||
44239831|NCT02680002|79066678|FG003|Overall Study|Withdrawal by Subject|0|||
44276259|NCT02158806|79229786|FG000|Overall Study|Withdrawal by Subject|2|||
44276260|NCT02158806|79229787|FG001|Overall Study|Withdrawal by Subject|0|||
44276261|NCT02158806|79229786|FG000|Overall Study|Lost to Follow-up|0|||
44276262|NCT02158806|79229787|FG001|Overall Study|Lost to Follow-up|3|||
44276263|NCT02158806|79229786|FG000|Overall Study|Moved out of area|0|||
44276264|NCT02158806|79229787|FG001|Overall Study|Moved out of area|1|||
44276265|NCT02158806|79229786|FG000|Overall Study|Transferred to palliative care|0|||
44276266|NCT02158806|79229787|FG001|Overall Study|Transferred to palliative care|1|||
44276267|NCT02158728|79229818|FG000|Overall Study|no procedure according to CIP done|3|||
44276268|NCT02158728|79229818|FG000|Overall Study|no qualified dataset|24|||
44276269|NCT02157948|79229863|FG000|Overall Study|Withdrawal by Subject|4|||
44276270|NCT02157948|79229864|FG001|Overall Study|Withdrawal by Subject|5|||
44276271|NCT02157948|79229863|FG000|Overall Study|Lost to Follow-up|3|||
44276272|NCT02157948|79229864|FG001|Overall Study|Lost to Follow-up|2|||
44276273|NCT02157948|79229863|FG000|Overall Study|Protocol Specified Criteria|2|||
44276274|NCT02157948|79229864|FG001|Overall Study|Protocol Specified Criteria|1|||
44276275|NCT02157948|79229863|FG000|Overall Study|Decision by Sponsor|0|||
44276276|NCT02157948|79229864|FG001|Overall Study|Decision by Sponsor|1|||
44276277|NCT02182830|79229905|FG000|Overall Study|Not Treated|1|||
44276278|NCT02182830|79229906|FG001|Overall Study|Not Treated|1|||
44276279|NCT02182830|79229905|FG000|Overall Study|Trial stopped, reason missing|3|||
44508760|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
44508761|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
44239832|NCT02680002|79066679|FG004|Overall Study|Withdrawal by Subject|2|||
44239833|NCT02680002|79066680|FG005|Overall Study|Withdrawal by Subject|2|||
44239834|NCT02680002|79066675|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
44239835|NCT02680002|79066676|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
44239836|NCT02680002|79066677|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
44239837|NCT02680002|79066678|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
44239838|NCT02680002|79066679|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
44239839|NCT02680002|79066680|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
44239840|NCT02680002|79066675|FG000|Overall Study|Other|0|||
44239841|NCT02680002|79066676|FG001|Overall Study|Other|1|||
44239842|NCT02680002|79066677|FG002|Overall Study|Other|0|||
44239843|NCT02680002|79066678|FG003|Overall Study|Other|0|||
44239844|NCT02680002|79066679|FG004|Overall Study|Other|1|||
44239845|NCT02680002|79066680|FG005|Overall Study|Other|0|||
44239846|NCT02680002|79066675|FG000|Overall Study|Adverse Event|0|||
44239847|NCT02680002|79066676|FG001|Overall Study|Adverse Event|0|||
44239848|NCT02680002|79066677|FG002|Overall Study|Adverse Event|0|||
44239849|NCT02680002|79066678|FG003|Overall Study|Adverse Event|0|||
44239850|NCT02680002|79066679|FG004|Overall Study|Adverse Event|1|||
44239851|NCT02680002|79066680|FG005|Overall Study|Adverse Event|2|||
44239852|NCT04557384|79066697|FG000|Overall Study|Study Terminated by Sponsor|1|||
44239853|NCT04557384|79066697|FG000|Overall Study|Death|1|||
44239854|NCT02673684|79066703|FG000|Overall Study|Study not completed d/t loss of funding|9|||
44239855|NCT02673684|79066704|FG001|Overall Study|Study not completed d/t loss of funding|8|||
44239856|NCT02675634|79066712|FG000|Test Period 1|Adverse Event|0|||
44239857|NCT02675634|79066713|FG001|Test Period 1|Adverse Event|1|||
44239858|NCT02675634|79066714|FG002|Test Period 1|Adverse Event|0|||
44120591|NCT03016325|78904687|FG001|Treatment Period|Participant refuses assessments|0|||
44120592|NCT03016325|78904688|FG002|Treatment Period|Participant refuses assessments|1|||
44120593|NCT03016325|78904689|FG003|Treatment Period|Participant refuses assessments|0|||
44239859|NCT02675634|79066715|FG003|Test Period 1|Adverse Event|1|||
44239860|NCT02675634|79066716|FG004|Test Period 1|Adverse Event|0|||
44276280|NCT02182830|79229906|FG001|Overall Study|Trial stopped, reason missing|3|||
44508762|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
44508763|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
44508764|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
44508765|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
44508766|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
44508767|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
44508768|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
44508769|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
44508770|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
44508771|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
44508772|NCT00289913|79514007|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
44120594|NCT03016325|78904690|FG004|Treatment Period|Participant refuses assessments|0|||
44239861|NCT02675634|79066717|FG005|Test Period 1|Adverse Event|0|||
44239862|NCT02675634|79066712|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
44276281|NCT02182830|79229905|FG000|Overall Study|Consent withdrawn|8|||
44276282|NCT02182830|79229906|FG001|Overall Study|Consent withdrawn|8|||
44276283|NCT02182830|79229905|FG000|Overall Study|Lost to Follow-up|3|||
44239863|NCT02675634|79066713|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
44276284|NCT02182830|79229906|FG001|Overall Study|Lost to Follow-up|3|||
44378831|NCT03631706|79384373|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
44378832|NCT03462030|79384381|FG000|Overall Study|Withdrawal by Subject|1|||
44378833|NCT03462030|79384382|FG001|Overall Study|Withdrawal by Subject|1|||
44378834|NCT03459729|79384388|FG000|Overall Study|Physician Decision|2|||
44378835|NCT03267277|79384396|FG000|Overall Study|Withdrawal by Subject|1|||
44378836|NCT03221751|79384402|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
44378837|NCT03221751|79384403|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
44378838|NCT03194646|79384413|FG000|Overall Study|Adverse Event|24|||
44378839|NCT03194646|79384414|FG001|Overall Study|Adverse Event|25|||
44378840|NCT03194646|79384415|FG002|Overall Study|Adverse Event|14|||
44378841|NCT03194646|79384416|FG003|Overall Study|Adverse Event|17|||
44378842|NCT03194646|79384413|FG000|Overall Study|Lack of Efficacy|4|||
44378843|NCT03194646|79384414|FG001|Overall Study|Lack of Efficacy|2|||
44378844|NCT03194646|79384415|FG002|Overall Study|Lack of Efficacy|2|||
44378845|NCT03194646|79384416|FG003|Overall Study|Lack of Efficacy|12|||
44378846|NCT03194646|79384413|FG000|Overall Study|Lost to Follow-up|30|||
44120595|NCT03016325|78904691|FG005|Treatment Period|Participant refuses assessments|0|||
44120596|NCT03016325|78904692|FG006|Treatment Period|Participant refuses assessments|0|||
44120597|NCT03016325|78904693|FG007|Treatment Period|Participant refuses assessments|0|||
44120598|NCT03016325|78904686|FG000|32-Day Follow-Up Period|Death|2|||
44120599|NCT03016325|78904687|FG001|32-Day Follow-Up Period|Death|0|||
44120600|NCT03016325|78904688|FG002|32-Day Follow-Up Period|Death|5|||
44120601|NCT03016325|78904689|FG003|32-Day Follow-Up Period|Death|6|||
44120602|NCT03016325|78904690|FG004|32-Day Follow-Up Period|Death|3|||
44120603|NCT03016325|78904691|FG005|32-Day Follow-Up Period|Death|0|||
44120604|NCT03016325|78904692|FG006|32-Day Follow-Up Period|Death|0|||
44120605|NCT03016325|78904693|FG007|32-Day Follow-Up Period|Death|0|||
44120606|NCT03016325|78904686|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
44120607|NCT03016325|78904687|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
44239864|NCT02675634|79066714|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
44239865|NCT02675634|79066715|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
44120608|NCT03016325|78904688|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
44120609|NCT03016325|78904689|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
44120610|NCT03016325|78904690|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
44120611|NCT03016325|78904691|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
44120612|NCT03016325|78904692|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
44120613|NCT03016325|78904693|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
44120614|NCT03016325|78904686|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
44239866|NCT02675634|79066716|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
44239867|NCT02675634|79066717|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
44239868|NCT02675634|79066712|FG000|Test Period 2|Lack of Efficacy|1|||
44239869|NCT02675634|79066713|FG001|Test Period 2|Lack of Efficacy|0|||
44239870|NCT02675634|79066714|FG002|Test Period 2|Lack of Efficacy|0|||
44239871|NCT02675634|79066715|FG003|Test Period 2|Lack of Efficacy|0|||
44239872|NCT02675634|79066716|FG004|Test Period 2|Lack of Efficacy|0|||
44239873|NCT02675634|79066717|FG005|Test Period 2|Lack of Efficacy|0|||
44239874|NCT02675634|79066712|FG000|Test Period 2|Adverse Event|0|||
44239875|NCT02675634|79066713|FG001|Test Period 2|Adverse Event|0|||
44239876|NCT02675634|79066714|FG002|Test Period 2|Adverse Event|0|||
44239877|NCT02675634|79066715|FG003|Test Period 2|Adverse Event|0|||
44239878|NCT02675634|79066716|FG004|Test Period 2|Adverse Event|0|||
44239879|NCT02675634|79066717|FG005|Test Period 2|Adverse Event|1|||
44239880|NCT02671500|79066725|FG000|Overall Study|Lack of Efficacy|12|||
44239881|NCT02671500|79066725|FG000|Overall Study|Lost to Follow-up|2|||
44239882|NCT02671422|79066733|FG000|Overall Study|Lost to Follow-up|1|||
44239883|NCT02671422|79066733|FG000|Overall Study|Adverse Event|68|||
44239884|NCT02671422|79066733|FG000|Overall Study|Lack of Efficacy|1|||
44239885|NCT02671422|79066733|FG000|Overall Study|Lost to Follow-up|4|||
44239886|NCT02671422|79066733|FG000|Overall Study|Withdrawal by Subject|7|||
44239887|NCT02671422|79066733|FG000|Overall Study|Progressive Disease|156|||
44239888|NCT02671422|79066733|FG000|Overall Study|Worsening of Disease|4|||
44239889|NCT02671422|79066733|FG000|Overall Study|Sponsor decision|5|||
44378847|NCT03194646|79384414|FG001|Overall Study|Lost to Follow-up|22|||
44378848|NCT03194646|79384415|FG002|Overall Study|Lost to Follow-up|12|||
44378849|NCT03194646|79384416|FG003|Overall Study|Lost to Follow-up|35|||
44378850|NCT03194646|79384413|FG000|Overall Study|Non-compliance with study drug|4|||
44378851|NCT03194646|79384414|FG001|Overall Study|Non-compliance with study drug|0|||
44378852|NCT03194646|79384415|FG002|Overall Study|Non-compliance with study drug|1|||
44378853|NCT03194646|79384416|FG003|Overall Study|Non-compliance with study drug|1|||
44120615|NCT03016325|78904687|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
44239890|NCT02671422|79066733|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
44508773|NCT00289913|79514008|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
44239891|NCT02671422|79066733|FG000|Overall Study|Not treated with Vargatef®|3|||
44239892|NCT02671422|79066733|FG000|Overall Study|Other not defined above|3|||
44239893|NCT02671266|79066739|FG000|Overall Study|Withdrawal by Subject|1|||
44239894|NCT02671266|79066740|FG001|Overall Study|Withdrawal by Subject|1|||
44120616|NCT03016325|78904688|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
44120617|NCT03016325|78904689|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
44120618|NCT03016325|78904690|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
44120619|NCT03016325|78904691|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
44120620|NCT03016325|78904692|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
44120621|NCT03016325|78904693|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
44120622|NCT03016325|78904686|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
44120623|NCT03016325|78904687|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
44276285|NCT02182440|79230480|FG000|Overall Study|Adverse Event|0|||
44276286|NCT02182440|79230481|FG001|Overall Study|Adverse Event|1|||
44120624|NCT03016325|78904688|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
44120625|NCT03016325|78904689|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
44120626|NCT03016325|78904690|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
44120627|NCT03016325|78904691|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
44120628|NCT03016325|78904692|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
44120629|NCT03016325|78904693|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
44120630|NCT03016325|78904686|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
44120631|NCT03016325|78904687|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
44120632|NCT03016325|78904688|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
44120633|NCT03016325|78904689|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
44120634|NCT03016325|78904690|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
44120635|NCT03016325|78904691|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
44239895|NCT03320070|79066748|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
44239896|NCT03320070|79066749|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
44239897|NCT03320070|79066748|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
44239898|NCT03320070|79066749|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
44239899|NCT03320070|79066748|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
44276287|NCT02182440|79230482|FG002|Overall Study|Adverse Event|0|||
44276288|NCT02182440|79230483|FG003|Overall Study|Adverse Event|0|||
44276289|NCT02182440|79230480|FG000|Overall Study|Death|31|||
44276290|NCT02182440|79230481|FG001|Overall Study|Death|8|||
44276291|NCT02182440|79230482|FG002|Overall Study|Death|5|||
44276292|NCT02182440|79230483|FG003|Overall Study|Death|16|||
44276293|NCT02182440|79230480|FG000|Overall Study|Protocol Violation|0|||
44276294|NCT02182440|79230481|FG001|Overall Study|Protocol Violation|1|||
44276295|NCT02182440|79230482|FG002|Overall Study|Protocol Violation|0|||
44276296|NCT02182440|79230483|FG003|Overall Study|Protocol Violation|0|||
44276297|NCT02182440|79230480|FG000|Overall Study|Physician Decision|1|||
44276298|NCT02182440|79230481|FG001|Overall Study|Physician Decision|0|||
44276299|NCT02182440|79230482|FG002|Overall Study|Physician Decision|0|||
44508774|NCT00289913|79514009|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
44508775|NCT00289913|79514010|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
44508776|NCT00289913|79514011|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
44508777|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508778|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
44120636|NCT03016325|78904692|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
44239900|NCT03320070|79066749|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
44239901|NCT03320070|79066748|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
44239902|NCT03320070|79066749|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
44239903|NCT03320070|79066748|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
44239904|NCT03320070|79066749|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
44239905|NCT03320070|79066748|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
44239906|NCT03320070|79066749|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
44239907|NCT02667912|79066760|FG000|Overall Study|Death|3|||
44239908|NCT02667912|79066761|FG001|Overall Study|Death|1|||
44239909|NCT02667912|79066760|FG000|Overall Study|Withdrawal by Subject|1|||
44239910|NCT02667912|79066761|FG001|Overall Study|Withdrawal by Subject|2|||
44239911|NCT02667912|79066760|FG000|Overall Study|Withdrawal by Subject|1|||
44239912|NCT02667912|79066761|FG001|Overall Study|Withdrawal by Subject|0|||
44239913|NCT01373346|79066767|FG000|Overall Study|Death|1|||
44239914|NCT03284424|79066778|FG000|Overall Study|Death|56|||
44239915|NCT03284424|79066779|FG001|Overall Study|Death|13|||
44239916|NCT03284424|79066778|FG000|Overall Study|Lost to Follow-up|1|||
44239917|NCT03284424|79066779|FG001|Overall Study|Lost to Follow-up|0|||
44239918|NCT03284424|79066778|FG000|Overall Study|Physician Decision|1|||
44239919|NCT03284424|79066779|FG001|Overall Study|Physician Decision|0|||
44276300|NCT02182440|79230483|FG003|Overall Study|Physician Decision|0|||
44276301|NCT02182440|79230480|FG000|Overall Study|Withdrawal by Subject|1|||
44276302|NCT02182440|79230481|FG001|Overall Study|Withdrawal by Subject|1|||
44120637|NCT03016325|78904693|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
44276303|NCT02182440|79230482|FG002|Overall Study|Withdrawal by Subject|3|||
44276304|NCT02182440|79230483|FG003|Overall Study|Withdrawal by Subject|4|||
44239920|NCT03284424|79066778|FG000|Overall Study|Withdrawal by Subject|3|||
44239921|NCT03284424|79066779|FG001|Overall Study|Withdrawal by Subject|2|||
44239922|NCT03284424|79066778|FG000|Overall Study|Ongoing in study|44|||
44239923|NCT03284424|79066779|FG001|Overall Study|Ongoing in study|39|||
44239924|NCT02674854|79066787|FG000|Overall Study|Adverse Event|17|||
44239925|NCT02674854|79066788|FG001|Overall Study|Adverse Event|15|||
44239926|NCT02674854|79066789|FG002|Overall Study|Adverse Event|5|||
44239927|NCT02674854|79066787|FG000|Overall Study|Withdrawal by Subject|1|||
44239928|NCT02674854|79066788|FG001|Overall Study|Withdrawal by Subject|5|||
44239929|NCT02674854|79066789|FG002|Overall Study|Withdrawal by Subject|4|||
44239930|NCT02674854|79066787|FG000|Overall Study|No-compliant subject|1|||
44276305|NCT02182440|79230480|FG000|Overall Study|different, e.g adm other hospital|12|||
44276306|NCT02182440|79230481|FG001|Overall Study|different, e.g adm other hospital|3|||
44276307|NCT02182440|79230482|FG002|Overall Study|different, e.g adm other hospital|3|||
44276308|NCT02182440|79230483|FG003|Overall Study|different, e.g adm other hospital|10|||
44276309|NCT02181816|79230525|FG000|Overall Study|Case Report Forms Uncollected|38|||
44276310|NCT02181816|79230525|FG000|Overall Study|Protocol Deviation|21|||
44276311|NCT02156466|79230681|FG000|Overall Study|Adverse Event|0|||
44276312|NCT02156466|79230682|FG001|Overall Study|Adverse Event|0|||
44239931|NCT02674854|79066788|FG001|Overall Study|No-compliant subject|0|||
44239932|NCT02674854|79066789|FG002|Overall Study|No-compliant subject|1|||
44239933|NCT02674854|79066787|FG000|Overall Study|Lost to Follow-up|1|||
44239934|NCT02674854|79066788|FG001|Overall Study|Lost to Follow-up|0|||
44239935|NCT02674854|79066789|FG002|Overall Study|Lost to Follow-up|2|||
44239936|NCT02674854|79066787|FG000|Overall Study|Lack of Efficacy|0|||
44239937|NCT02674854|79066788|FG001|Overall Study|Lack of Efficacy|3|||
44239938|NCT02674854|79066789|FG002|Overall Study|Lack of Efficacy|0|||
44276313|NCT02156466|79230683|FG002|Overall Study|Adverse Event|1|||
44276314|NCT02156466|79230684|FG003|Overall Study|Adverse Event|1|||
44276315|NCT02156466|79230685|FG004|Overall Study|Adverse Event|0|||
44276316|NCT02156466|79230681|FG000|Overall Study|Quantiferon Positivity|0|||
44276317|NCT02156466|79230682|FG001|Overall Study|Quantiferon Positivity|0|||
44276318|NCT02156466|79230683|FG002|Overall Study|Quantiferon Positivity|0|||
44276319|NCT02156466|79230684|FG003|Overall Study|Quantiferon Positivity|1|||
44239939|NCT02674854|79066787|FG000|Overall Study|Disallowed Concurrent Medication|2|||
44239940|NCT02674854|79066788|FG001|Overall Study|Disallowed Concurrent Medication|2|||
44239941|NCT02674854|79066789|FG002|Overall Study|Disallowed Concurrent Medication|0|||
44276320|NCT02156466|79230685|FG004|Overall Study|Quantiferon Positivity|0|||
44276321|NCT02216526|79230724|FG000|Overall Study|Adverse Event|1|||
44276322|NCT02216526|79230725|FG001|Overall Study|Adverse Event|1|||
44276323|NCT02216526|79230726|FG002|Overall Study|Adverse Event|0|||
44276324|NCT02216526|79230724|FG000|Overall Study|Death|0|||
44276325|NCT02216526|79230725|FG001|Overall Study|Death|1|||
44276326|NCT02216526|79230726|FG002|Overall Study|Death|3|||
44276327|NCT02216526|79230724|FG000|Overall Study|Protocol Violation|2|||
44276328|NCT02216526|79230725|FG001|Overall Study|Protocol Violation|0|||
44508779|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44239942|NCT02674854|79066787|FG000|Overall Study|Protocol Violation|1|||
44239943|NCT02674854|79066788|FG001|Overall Study|Protocol Violation|1|||
44239944|NCT02674854|79066789|FG002|Overall Study|Protocol Violation|2|||
44508780|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508781|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
44508782|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
44508783|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
44508784|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
44508785|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
44508786|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
44508787|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508788|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508789|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508790|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
44508791|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
44508792|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44239945|NCT02674854|79066787|FG000|Overall Study|Death|0|||
44239946|NCT02674854|79066788|FG001|Overall Study|Death|1|||
44239947|NCT02674854|79066789|FG002|Overall Study|Death|0|||
44239948|NCT02674854|79066787|FG000|Overall Study|Subject missed V6.2|1|||
44276329|NCT02216526|79230726|FG002|Overall Study|Protocol Violation|2|||
44276330|NCT02216526|79230724|FG000|Overall Study|Hospitalization|2|||
44276331|NCT02216526|79230725|FG001|Overall Study|Hospitalization|1|||
44276332|NCT02216526|79230726|FG002|Overall Study|Hospitalization|3|||
44276333|NCT02216214|79230766|FG000|Overall Study|Randomized Never Received Study Drug|1|||
44276334|NCT02216214|79230767|FG001|Overall Study|Randomized Never Received Study Drug|0|||
44276335|NCT02216214|79230766|FG000|Overall Study|Adverse Event|10|||
44239949|NCT02674854|79066788|FG001|Overall Study|Subject missed V6.2|0|||
44239950|NCT02674854|79066789|FG002|Overall Study|Subject missed V6.2|0|||
44239951|NCT02667288|79066797|FG000|Overall Study|Protocol Violation|5|||
44239952|NCT02667288|79066797|FG000|Overall Study|Lost to Follow-up|3|||
44239953|NCT02667288|79066797|FG000|Overall Study|Withdrawal by Subject|5|||
44239954|NCT02670330|79066803|FG000|Overall Study|Protocol Deviation|1|||
44239955|NCT02670330|79066804|FG001|Overall Study|Protocol Deviation|0|||
44239956|NCT02670330|79066803|FG000|Overall Study|Study Terminated By Sponsor|36|||
44239957|NCT02670330|79066804|FG001|Overall Study|Study Terminated By Sponsor|43|||
44239958|NCT02670330|79066803|FG000|Overall Study|Adverse Event|1|||
44239959|NCT02670330|79066804|FG001|Overall Study|Adverse Event|3|||
44239960|NCT02670330|79066803|FG000|Overall Study|Withdrawal by Subject|34|||
44239961|NCT02670330|79066804|FG001|Overall Study|Withdrawal by Subject|29|||
44239962|NCT02670330|79066803|FG000|Overall Study|Lost to Follow-up|3|||
44239963|NCT02670330|79066804|FG001|Overall Study|Lost to Follow-up|2|||
44239964|NCT02669940|79066812|FG000|Overall Study|Failure to return|0|||
44239965|NCT02669940|79066813|FG001|Overall Study|Failure to return|3|||
44239966|NCT02669940|79066812|FG000|Overall Study|Insufficient follow-up data|1|||
44239967|NCT02669940|79066813|FG001|Overall Study|Insufficient follow-up data|0|||
44239968|NCT02669862|79066829|FG000|Overall Study|Lost to Follow-up|0|||
44239969|NCT02669862|79066830|FG001|Overall Study|Lost to Follow-up|2|||
44239970|NCT02669862|79066831|FG002|Overall Study|Lost to Follow-up|1|||
44239971|NCT02669862|79066829|FG000|Overall Study|Withdrawal by Subject|2|||
44239972|NCT02669862|79066830|FG001|Overall Study|Withdrawal by Subject|2|||
44239973|NCT02669862|79066831|FG002|Overall Study|Withdrawal by Subject|3|||
44239974|NCT02669862|79066829|FG000|Overall Study|moved|0|||
44239975|NCT02669862|79066830|FG001|Overall Study|moved|1|||
44239976|NCT02669862|79066831|FG002|Overall Study|moved|0|||
44239977|NCT02669862|79066829|FG000|Overall Study|Protocol Violation|0|||
44239978|NCT02669862|79066830|FG001|Overall Study|Protocol Violation|0|||
44239979|NCT02669862|79066831|FG002|Overall Study|Protocol Violation|1|||
44239980|NCT01531673|79066855|FG000|Overall Study|Non-Compliance|0|||
44239981|NCT01531673|79066856|FG001|Overall Study|Non-Compliance|0|||
44239982|NCT01531673|79066857|FG002|Overall Study|Non-Compliance|0|||
44239983|NCT01531673|79066858|FG003|Overall Study|Non-Compliance|0|||
44239984|NCT01531673|79066859|FG004|Overall Study|Non-Compliance|0|||
44239985|NCT01531673|79066860|FG005|Overall Study|Non-Compliance|1|||
44239986|NCT01531673|79066861|FG006|Overall Study|Non-Compliance|0|||
44239987|NCT01531673|79066862|FG007|Overall Study|Non-Compliance|0|||
44239988|NCT01531673|79066863|FG008|Overall Study|Non-Compliance|0|||
44239989|NCT01531673|79066864|FG009|Overall Study|Non-Compliance|0|||
44239990|NCT01531673|79066865|FG010|Overall Study|Non-Compliance|0|||
44239991|NCT01531673|79066866|FG011|Overall Study|Non-Compliance|0|||
44239992|NCT01531673|79066867|FG012|Overall Study|Non-Compliance|0|||
44239993|NCT01531673|79066855|FG000|Overall Study|Adverse Event|0|||
44239994|NCT01531673|79066856|FG001|Overall Study|Adverse Event|1|||
44239995|NCT01531673|79066857|FG002|Overall Study|Adverse Event|0|||
44239996|NCT01531673|79066858|FG003|Overall Study|Adverse Event|0|||
44239997|NCT01531673|79066859|FG004|Overall Study|Adverse Event|0|||
44239998|NCT01531673|79066860|FG005|Overall Study|Adverse Event|0|||
44239999|NCT01531673|79066861|FG006|Overall Study|Adverse Event|0|||
44240000|NCT01531673|79066862|FG007|Overall Study|Adverse Event|0|||
44240001|NCT01531673|79066863|FG008|Overall Study|Adverse Event|0|||
44240002|NCT01531673|79066864|FG009|Overall Study|Adverse Event|0|||
44240003|NCT01531673|79066865|FG010|Overall Study|Adverse Event|0|||
44240004|NCT01531673|79066866|FG011|Overall Study|Adverse Event|0|||
44240005|NCT01531673|79066867|FG012|Overall Study|Adverse Event|0|||
44240006|NCT01531673|79066855|FG000|Overall Study|Lost to Follow-up|0|||
44240007|NCT01531673|79066856|FG001|Overall Study|Lost to Follow-up|0|||
44240008|NCT01531673|79066857|FG002|Overall Study|Lost to Follow-up|0|||
44240009|NCT01531673|79066858|FG003|Overall Study|Lost to Follow-up|0|||
44240010|NCT01531673|79066859|FG004|Overall Study|Lost to Follow-up|1|||
44240011|NCT01531673|79066860|FG005|Overall Study|Lost to Follow-up|0|||
44240012|NCT01531673|79066861|FG006|Overall Study|Lost to Follow-up|0|||
44240013|NCT01531673|79066862|FG007|Overall Study|Lost to Follow-up|0|||
44240014|NCT01531673|79066863|FG008|Overall Study|Lost to Follow-up|0|||
44240015|NCT01531673|79066864|FG009|Overall Study|Lost to Follow-up|0|||
44240016|NCT01531673|79066865|FG010|Overall Study|Lost to Follow-up|0|||
44240017|NCT01531673|79066866|FG011|Overall Study|Lost to Follow-up|0|||
44240018|NCT01531673|79066867|FG012|Overall Study|Lost to Follow-up|0|||
44240019|NCT01531673|79066855|FG000|Overall Study|Other|0|||
44240020|NCT01531673|79066856|FG001|Overall Study|Other|0|||
44240021|NCT01531673|79066857|FG002|Overall Study|Other|0|||
44240022|NCT01531673|79066858|FG003|Overall Study|Other|1|||
44240023|NCT01531673|79066859|FG004|Overall Study|Other|0|||
44240024|NCT01531673|79066860|FG005|Overall Study|Other|0|||
44240025|NCT01531673|79066861|FG006|Overall Study|Other|0|||
44240026|NCT01531673|79066862|FG007|Overall Study|Other|0|||
44240027|NCT01531673|79066863|FG008|Overall Study|Other|0|||
44240028|NCT01531673|79066864|FG009|Overall Study|Other|1|||
44240029|NCT01531673|79066865|FG010|Overall Study|Other|0|||
44240030|NCT01531673|79066866|FG011|Overall Study|Other|0|||
44240031|NCT01531673|79066867|FG012|Overall Study|Other|0|||
44508793|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508794|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508795|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
44508796|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
44508797|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
44508798|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
44508799|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
44508800|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
44508801|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
44508802|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
44240032|NCT01531205|79066919|FG000|Overall Study|Did not proceed to surgery|1|||
44378854|NCT03194646|79384413|FG000|Overall Study|Other|89|||
44508803|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
44508804|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
44508805|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
44508806|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
44508807|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
44508808|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
44508809|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
44508810|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
44508811|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
44508812|NCT00289913|79514007|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44508813|NCT00289913|79514008|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
44508814|NCT00289913|79514009|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44508815|NCT00289913|79514010|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44508816|NCT00289913|79514011|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
44508817|NCT00289289|79514029|FG000|Overall Study|Withdrawal by Subject|5|||
44508818|NCT00289289|79514030|FG001|Overall Study|Withdrawal by Subject|3|||
44508819|NCT00289289|79514031|FG002|Overall Study|Withdrawal by Subject|15|||
44508820|NCT00289289|79514029|FG000|Overall Study|Lost to Follow-up|1|||
44240033|NCT01529645|79066935|FG000|Overall Study|Lost to Follow-up|0|||
44240034|NCT01529645|79066936|FG001|Overall Study|Lost to Follow-up|1|||
44240035|NCT01529645|79066937|FG002|Overall Study|Lost to Follow-up|1|||
44240036|NCT01529645|79066938|FG003|Overall Study|Lost to Follow-up|1|||
44240037|NCT01529645|79066939|FG004|Overall Study|Lost to Follow-up|1|||
44240038|NCT01529645|79066940|FG005|Overall Study|Lost to Follow-up|0|||
44240039|NCT01529645|79066941|FG006|Overall Study|Lost to Follow-up|2|||
44240040|NCT01529645|79066942|FG007|Overall Study|Lost to Follow-up|0|||
44240041|NCT01529645|79066943|FG008|Overall Study|Lost to Follow-up|1|||
44240042|NCT01529645|79066944|FG009|Overall Study|Lost to Follow-up|0|||
44240043|NCT01529645|79066935|FG000|Overall Study|SAE - Premature contractions|0|||
44240044|NCT01529645|79066936|FG001|Overall Study|SAE - Premature contractions|0|||
44508821|NCT00289289|79514030|FG001|Overall Study|Lost to Follow-up|0|||
44508822|NCT00289289|79514031|FG002|Overall Study|Lost to Follow-up|1|||
44508823|NCT00289289|79514029|FG000|Overall Study|Death|4|||
44508824|NCT00289289|79514030|FG001|Overall Study|Death|2|||
44508825|NCT00289289|79514031|FG002|Overall Study|Death|5|||
44508826|NCT00289289|79514029|FG000|Overall Study|No implant attempted|0|||
44508827|NCT00289289|79514030|FG001|Overall Study|No implant attempted|0|||
44508828|NCT00289289|79514031|FG002|Overall Study|No implant attempted|1|||
44508829|NCT00289289|79514029|FG000|Overall Study|Physician Decision|1|||
44508830|NCT00289289|79514030|FG001|Overall Study|Physician Decision|0|||
44508831|NCT00289289|79514031|FG002|Overall Study|Physician Decision|6|||
44508832|NCT00289289|79514029|FG000|Overall Study|Non-study device implanted|2|||
44508833|NCT00289289|79514030|FG001|Overall Study|Non-study device implanted|1|||
44508834|NCT00289289|79514031|FG002|Overall Study|Non-study device implanted|3|||
44508835|NCT00289289|79514029|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
44508836|NCT00289289|79514030|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
44508837|NCT00289289|79514031|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
44508838|NCT00289289|79514029|FG000|Overall Study|Other Exit Reason|6|||
44240045|NCT01529645|79066937|FG002|Overall Study|SAE - Premature contractions|1|||
44240046|NCT01529645|79066938|FG003|Overall Study|SAE - Premature contractions|0|||
44240047|NCT01529645|79066939|FG004|Overall Study|SAE - Premature contractions|0|||
44240048|NCT01529645|79066940|FG005|Overall Study|SAE - Premature contractions|0|||
44240049|NCT01529645|79066941|FG006|Overall Study|SAE - Premature contractions|0|||
44240050|NCT01529645|79066942|FG007|Overall Study|SAE - Premature contractions|0|||
44240051|NCT01529645|79066943|FG008|Overall Study|SAE - Premature contractions|0|||
44240052|NCT01529645|79066944|FG009|Overall Study|SAE - Premature contractions|0|||
44240053|NCT01529645|79066935|FG000|Overall Study|Withdrawal by Subject|2|||
44240054|NCT01529645|79066936|FG001|Overall Study|Withdrawal by Subject|0|||
44240055|NCT01529645|79066937|FG002|Overall Study|Withdrawal by Subject|0|||
44240056|NCT01529645|79066938|FG003|Overall Study|Withdrawal by Subject|1|||
44240057|NCT01529645|79066939|FG004|Overall Study|Withdrawal by Subject|1|||
44240058|NCT01529645|79066940|FG005|Overall Study|Withdrawal by Subject|1|||
44240059|NCT01529645|79066941|FG006|Overall Study|Withdrawal by Subject|0|||
44240060|NCT01529645|79066942|FG007|Overall Study|Withdrawal by Subject|0|||
44240061|NCT01529645|79066943|FG008|Overall Study|Withdrawal by Subject|0|||
44240062|NCT01529645|79066944|FG009|Overall Study|Withdrawal by Subject|0|||
44240063|NCT01528787|79066978|FG000|Overall Study|Withdrawal by Subject|0|||
44240064|NCT01528787|79066979|FG001|Overall Study|Withdrawal by Subject|0|||
44240065|NCT01528787|79066980|FG002|Overall Study|Withdrawal by Subject|0|||
44240066|NCT01528787|79066981|FG003|Overall Study|Withdrawal by Subject|1|||
44240067|NCT01528787|79066978|FG000|Overall Study|Family Emergency|0|||
44240068|NCT01528787|79066979|FG001|Overall Study|Family Emergency|0|||
44240069|NCT01528787|79066980|FG002|Overall Study|Family Emergency|1|||
44240070|NCT01528787|79066981|FG003|Overall Study|Family Emergency|0|||
44240071|NCT01528709|79066993|FG000|Overall Study|Death|2|||
44240072|NCT01528709|79066994|FG001|Overall Study|Death|0|||
44240073|NCT01528709|79066993|FG000|Overall Study|Withdrawal by Subject|10|||
44240074|NCT01528709|79066994|FG001|Overall Study|Withdrawal by Subject|15|||
44240075|NCT01528709|79066993|FG000|Overall Study|allergy|1|||
44240076|NCT01528709|79066994|FG001|Overall Study|allergy|0|||
44508839|NCT00289289|79514030|FG001|Overall Study|Other Exit Reason|4|||
44120638|NCT03016325|78904686|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120639|NCT03016325|78904687|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120640|NCT03016325|78904688|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
44240077|NCT01527383|79067002|FG000|Overall Study|Adverse Event|5|||
44240078|NCT01527383|79067003|FG001|Overall Study|Adverse Event|0|||
44240079|NCT01527383|79067002|FG000|Overall Study|Lost to Follow-up|3|||
44240080|NCT01527383|79067003|FG001|Overall Study|Lost to Follow-up|0|||
44240081|NCT01527383|79067002|FG000|Overall Study|Physician Decision|2|||
44240082|NCT01527383|79067003|FG001|Overall Study|Physician Decision|0|||
44240083|NCT01527383|79067002|FG000|Overall Study|Pregnancy|1|||
44240084|NCT01527383|79067003|FG001|Overall Study|Pregnancy|0|||
44120641|NCT03016325|78904689|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120642|NCT03016325|78904690|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120643|NCT03016325|78904691|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120644|NCT03016325|78904692|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120645|NCT03016325|78904693|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
44120646|NCT03016325|78904686|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120647|NCT03016325|78904687|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
44120648|NCT03016325|78904688|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120649|NCT03016325|78904689|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120650|NCT03016325|78904690|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120651|NCT03016325|78904691|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120652|NCT03016325|78904692|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120653|NCT03016325|78904693|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
44120654|NCT03016325|78904686|FG000|182-Day Follow-Up Period|Death|3|||
44120655|NCT03016325|78904687|FG001|182-Day Follow-Up Period|Death|3|||
44240085|NCT01527383|79067002|FG000|Overall Study|Protocol Violation|1|||
44240086|NCT01527383|79067003|FG001|Overall Study|Protocol Violation|0|||
44240087|NCT01527383|79067002|FG000|Overall Study|Screen failure|1|||
44240088|NCT01527383|79067003|FG001|Overall Study|Screen failure|0|||
44240089|NCT01527383|79067002|FG000|Overall Study|Participant moved|0|||
44240090|NCT01527383|79067003|FG001|Overall Study|Participant moved|1|||
44240091|NCT01527383|79067002|FG000|Overall Study|Withdrawal by Subject|2|||
44240092|NCT01527383|79067003|FG001|Overall Study|Withdrawal by Subject|3|||
44240093|NCT01526057|79067012|FG000|Overall Study|Withdrawal by Subject|3|||
44240094|NCT01526057|79067013|FG001|Overall Study|Withdrawal by Subject|2|||
44508840|NCT00289289|79514031|FG002|Overall Study|Other Exit Reason|12|||
44508841|NCT00270257|79514040|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
44508842|NCT00270257|79514041|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
44508843|NCT00269633|79514051|FG000|Overall Study|Withdrawal by Subject|1|||
44508844|NCT00269633|79514052|FG001|Overall Study|Withdrawal by Subject|0|||
44508845|NCT00269477|79514062|FG000|Overall Study|Protocol Violation|5|||
44508846|NCT00269477|79514063|FG001|Overall Study|Protocol Violation|5|||
44508847|NCT00269477|79514064|FG002|Overall Study|Protocol Violation|1|||
44508848|NCT00269477|79514065|FG003|Overall Study|Protocol Violation|0|||
44508849|NCT00269477|79514062|FG000|Overall Study|Missed post-vaccination blood draw|0|||
44508850|NCT00269477|79514063|FG001|Overall Study|Missed post-vaccination blood draw|1|||
44508851|NCT00269477|79514064|FG002|Overall Study|Missed post-vaccination blood draw|0|||
44508852|NCT00269477|79514065|FG003|Overall Study|Missed post-vaccination blood draw|0|||
44240095|NCT01526057|79067014|FG002|Overall Study|Withdrawal by Subject|2|||
44240096|NCT01526057|79067012|FG000|Overall Study|Adverse Event|3|||
44240097|NCT01526057|79067013|FG001|Overall Study|Adverse Event|1|||
44240098|NCT01526057|79067014|FG002|Overall Study|Adverse Event|1|||
44240099|NCT01526057|79067012|FG000|Overall Study|Death|1|||
44508853|NCT00269399|79514077|FG000|Overall Study|Lack of Efficacy|27|||
44508854|NCT00269399|79514078|FG001|Overall Study|Lack of Efficacy|10|||
44240100|NCT01526057|79067013|FG001|Overall Study|Death|0|||
44508855|NCT00269399|79514077|FG000|Overall Study|Adverse Event|10|||
44508856|NCT00269399|79514078|FG001|Overall Study|Adverse Event|4|||
44508857|NCT00269399|79514077|FG000|Overall Study|Withdrawal by Subject|2|||
44508858|NCT00269399|79514078|FG001|Overall Study|Withdrawal by Subject|5|||
44508859|NCT00269399|79514077|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
44508860|NCT00269399|79514078|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
44508861|NCT00269399|79514077|FG000|Overall Study|Other|0|||
44508862|NCT00269399|79514078|FG001|Overall Study|Other|4|||
44508863|NCT00269399|79514077|FG000|Overall Study|Development of exclusion criteria|0|||
44508864|NCT00269399|79514078|FG001|Overall Study|Development of exclusion criteria|1|||
44508865|NCT00269087|79514084|FG000|Overall Study|Adverse Event|20|||
44508866|NCT00269087|79514084|FG000|Overall Study|Withdrawal by Subject|1|||
44508867|NCT00269087|79514084|FG000|Overall Study|Exacerbation of COPD|13|||
44508868|NCT00289133|79514090|FG000|Overall Study|Non-study device implanted|12|||
44508869|NCT00289133|79514091|FG001|Overall Study|Non-study device implanted|0|||
44120656|NCT03016325|78904688|FG002|182-Day Follow-Up Period|Death|11|||
44120657|NCT03016325|78904689|FG003|182-Day Follow-Up Period|Death|12|||
44120658|NCT03016325|78904690|FG004|182-Day Follow-Up Period|Death|9|||
44120659|NCT03016325|78904691|FG005|182-Day Follow-Up Period|Death|0|||
44120660|NCT03016325|78904692|FG006|182-Day Follow-Up Period|Death|0|||
44120661|NCT03016325|78904693|FG007|182-Day Follow-Up Period|Death|1|||
44120662|NCT03016325|78904686|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
44120663|NCT03016325|78904687|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44120664|NCT03016325|78904688|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44240101|NCT01526057|79067014|FG002|Overall Study|Death|0|||
44240102|NCT01526057|79067012|FG000|Overall Study|Lost to Follow-up|1|||
44240103|NCT01526057|79067013|FG001|Overall Study|Lost to Follow-up|0|||
44508870|NCT00289133|79514090|FG000|Overall Study|Protocol Violation|32|||
44508871|NCT00289133|79514091|FG001|Overall Study|Protocol Violation|38|||
44508872|NCT00289133|79514090|FG000|Overall Study|Withdrawal by Subject|9|||
44508873|NCT00289133|79514091|FG001|Overall Study|Withdrawal by Subject|10|||
44508874|NCT00289133|79514090|FG000|Overall Study|Death|5|||
44508875|NCT00289133|79514091|FG001|Overall Study|Death|10|||
44508876|NCT00289133|79514090|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
44508877|NCT00289133|79514091|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
44508878|NCT00289133|79514090|FG000|Overall Study|Physician Decision|41|||
44378855|NCT03194646|79384414|FG001|Overall Study|Other|68|||
44378856|NCT03194646|79384415|FG002|Overall Study|Other|34|||
44378857|NCT03194646|79384416|FG003|Overall Study|Other|31|||
44378858|NCT03194646|79384413|FG000|Overall Study|Physician Decision|7|||
44378859|NCT03194646|79384414|FG001|Overall Study|Physician Decision|9|||
44378860|NCT03194646|79384415|FG002|Overall Study|Physician Decision|5|||
44378861|NCT03194646|79384416|FG003|Overall Study|Physician Decision|4|||
44378862|NCT03194646|79384413|FG000|Overall Study|Pregnancy|4|||
44508879|NCT00289133|79514091|FG001|Overall Study|Physician Decision|45|||
44508880|NCT00289133|79514090|FG000|Overall Study|Revision|8|||
44508881|NCT00289133|79514091|FG001|Overall Study|Revision|6|||
44508882|NCT00289133|79514090|FG000|Overall Study|Lost to Follow-up|92|||
44508883|NCT00289133|79514091|FG001|Overall Study|Lost to Follow-up|115|||
44508884|NCT00288587|79514103|FG000|Overall Study|Death|4|||
44508885|NCT00288587|79514104|FG001|Overall Study|Death|4|||
44240104|NCT01526057|79067014|FG002|Overall Study|Lost to Follow-up|1|||
44240105|NCT01526057|79067012|FG000|Overall Study|Other|1|||
44240106|NCT01526057|79067013|FG001|Overall Study|Other|0|||
44378863|NCT03194646|79384414|FG001|Overall Study|Pregnancy|5|||
44378864|NCT03194646|79384415|FG002|Overall Study|Pregnancy|1|||
44378865|NCT03194646|79384416|FG003|Overall Study|Pregnancy|2|||
44508886|NCT00288587|79514103|FG000|Overall Study|Transplant|0|||
44508887|NCT00288587|79514104|FG001|Overall Study|Transplant|3|||
44508888|NCT00288587|79514103|FG000|Overall Study|Adverse Event|0|||
44508889|NCT00288587|79514104|FG001|Overall Study|Adverse Event|1|||
44508890|NCT00288587|79514103|FG000|Overall Study|Physician Decision|0|||
44508891|NCT00288587|79514104|FG001|Overall Study|Physician Decision|2|||
44508892|NCT00288587|79514103|FG000|Overall Study|Severe Aortic Stenosis|1|||
44508893|NCT00288587|79514104|FG001|Overall Study|Severe Aortic Stenosis|0|||
44508894|NCT00268463|79514112|FG000|Overall Study|study terminated due to low accrual|10|||
44120665|NCT03016325|78904689|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44240107|NCT01526057|79067014|FG002|Overall Study|Other|1|||
44240108|NCT01526057|79067012|FG000|Overall Study|Protocol Violation|0|||
44508895|NCT00268463|79514113|FG001|Overall Study|study terminated due to low accrual|12|||
44508896|NCT00288509|79514119|FG000|Treatment Cycle 1|Adverse Event|1|||
44508897|NCT00288509|79514119|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
44508898|NCT00288509|79514119|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
44508899|NCT00288509|79514119|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
44508900|NCT00288509|79514119|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
44508901|NCT00288509|79514119|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
44378866|NCT03194646|79384413|FG000|Overall Study|Protocol Violation|4|||
44240109|NCT01526057|79067013|FG001|Overall Study|Protocol Violation|0|||
44240110|NCT01526057|79067014|FG002|Overall Study|Protocol Violation|1|||
44240111|NCT01525901|79067026|FG000|Period 2: 12 Weeks|Adverse Event|0|||
44240112|NCT01525901|79067027|FG001|Period 2: 12 Weeks|Adverse Event|1|||
44240113|NCT01525901|79067028|FG002|Period 2: 12 Weeks|Adverse Event|0|||
44240114|NCT01525901|79067029|FG003|Period 2: 12 Weeks|Adverse Event|0|||
44240115|NCT01525589|79067142|FG000|Overall Study|Non-treatment-related AE|1|||
44240116|NCT01525589|79067143|FG001|Overall Study|Non-treatment-related AE|0|||
44240117|NCT01525589|79067144|FG002|Overall Study|Non-treatment-related AE|0|||
44240118|NCT01525589|79067142|FG000|Overall Study|Progressive disease|48|||
44240119|NCT01525589|79067143|FG001|Overall Study|Progressive disease|15|||
44240120|NCT01525589|79067144|FG002|Overall Study|Progressive disease|29|||
44240121|NCT01525589|79067142|FG000|Overall Study|Never treated|2|||
44240122|NCT01525589|79067143|FG001|Overall Study|Never treated|0|||
44240123|NCT01525589|79067144|FG002|Overall Study|Never treated|0|||
44240124|NCT01525589|79067142|FG000|Overall Study|Physician Decision|4|||
44240125|NCT01525589|79067143|FG001|Overall Study|Physician Decision|2|||
44240126|NCT01525589|79067144|FG002|Overall Study|Physician Decision|2|||
44240127|NCT01525589|79067142|FG000|Overall Study|Death|0|||
44240128|NCT01525589|79067143|FG001|Overall Study|Death|0|||
44240129|NCT01525589|79067144|FG002|Overall Study|Death|2|||
44240130|NCT01525589|79067142|FG000|Overall Study|Treatment-related AE|1|||
44240131|NCT01525589|79067143|FG001|Overall Study|Treatment-related AE|1|||
44240132|NCT01525589|79067144|FG002|Overall Study|Treatment-related AE|2|||
44240133|NCT01525589|79067142|FG000|Overall Study|Other reasons|0|||
44240134|NCT01525589|79067143|FG001|Overall Study|Other reasons|1|||
44240135|NCT01525589|79067144|FG002|Overall Study|Other reasons|0|||
44240136|NCT01525589|79067142|FG000|Overall Study|Withdrawal by Subject|0|||
44508902|NCT00288509|79514119|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
44508903|NCT00288509|79514119|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
44508904|NCT00288509|79514119|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
44508905|NCT00288509|79514119|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
44120666|NCT03016325|78904690|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44240137|NCT01525589|79067143|FG001|Overall Study|Withdrawal by Subject|1|||
44240138|NCT01525589|79067144|FG002|Overall Study|Withdrawal by Subject|0|||
44240139|NCT01524887|79067155|FG000|Overall Study|Withdrawal by Subject|6|||
44240140|NCT01524887|79067156|FG001|Overall Study|Withdrawal by Subject|2|||
44240141|NCT01524887|79067157|FG002|Overall Study|Withdrawal by Subject|3|||
44240142|NCT01524887|79067155|FG000|Overall Study|Adverse Event|5|||
44240143|NCT01524887|79067156|FG001|Overall Study|Adverse Event|1|||
44508906|NCT00288509|79514119|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
44508907|NCT00288509|79514119|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
44508908|NCT00288509|79514119|FG000|Treatment Cycle 4|Physician Decision|4|||
44240144|NCT01524887|79067157|FG002|Overall Study|Adverse Event|1|||
44240145|NCT01524887|79067155|FG000|Overall Study|Protocol Violation|0|||
44276336|NCT02216214|79230767|FG001|Overall Study|Adverse Event|8|||
44240146|NCT01524887|79067156|FG001|Overall Study|Protocol Violation|0|||
44240147|NCT01524887|79067157|FG002|Overall Study|Protocol Violation|1|||
44240148|NCT01524887|79067155|FG000|Overall Study|Study termination|73|||
44240149|NCT01524887|79067156|FG001|Overall Study|Study termination|87|||
44240150|NCT01524887|79067157|FG002|Overall Study|Study termination|79|||
44240151|NCT01524887|79067155|FG000|Overall Study|Withdrawal by Caregiver|0|||
44240152|NCT01524887|79067156|FG001|Overall Study|Withdrawal by Caregiver|0|||
44240153|NCT01524887|79067157|FG002|Overall Study|Withdrawal by Caregiver|2|||
44508909|NCT00288509|79514119|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
44508910|NCT00266825|79514125|FG000|Completed Follow-Up|Lost to Follow-up|14|||
44120667|NCT03016325|78904691|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44120668|NCT03016325|78904692|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44120669|NCT03016325|78904693|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
44120670|NCT03016325|78904686|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
44120671|NCT03016325|78904687|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
44120672|NCT03016325|78904688|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
44120673|NCT03016325|78904689|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
44120674|NCT03016325|78904690|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
44120675|NCT03016325|78904691|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
44120676|NCT03016325|78904692|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
44120677|NCT03016325|78904693|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
44120678|NCT03016325|78904686|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120679|NCT03016325|78904687|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120680|NCT03016325|78904688|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120681|NCT03016325|78904689|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120682|NCT03016325|78904690|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
44120683|NCT03016325|78904691|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120684|NCT03016325|78904692|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120685|NCT03016325|78904693|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
44120686|NCT03016325|78904686|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120687|NCT03016325|78904687|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120688|NCT03016325|78904688|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120689|NCT03016325|78904689|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120690|NCT03016325|78904690|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
44120691|NCT03016325|78904691|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120692|NCT03016325|78904692|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120693|NCT03016325|78904693|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
44120694|NCT03016325|78904686|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120695|NCT03016325|78904687|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120696|NCT03016325|78904688|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120697|NCT03016325|78904689|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
44120698|NCT03016325|78904690|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120699|NCT03016325|78904691|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120700|NCT03016325|78904692|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120701|NCT03016325|78904693|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
44120702|NCT03016325|78904686|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120703|NCT03016325|78904687|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
44120704|NCT03016325|78904688|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120705|NCT03016325|78904689|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120706|NCT03016325|78904690|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120707|NCT03016325|78904691|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120708|NCT03016325|78904692|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120709|NCT03016325|78904693|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
44120710|NCT03016325|78904686|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
44120711|NCT03016325|78904687|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
44120712|NCT03016325|78904688|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
44120713|NCT03016325|78904689|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
44120714|NCT03016325|78904690|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
44120715|NCT03016325|78904691|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
44120716|NCT03016325|78904692|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
44120717|NCT03016325|78904693|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
44120718|NCT02988115|78904716|FG000|Overall Study|Adverse Event|6|||
44120719|NCT02988115|78904717|FG001|Overall Study|Adverse Event|1|||
44120720|NCT02988115|78904716|FG000|Overall Study|Sponsor Decision|5|||
44120721|NCT02988115|78904717|FG001|Overall Study|Sponsor Decision|2|||
44120722|NCT02988115|78904716|FG000|Overall Study|Withdrawal by Subject|1|||
44120723|NCT02988115|78904717|FG001|Overall Study|Withdrawal by Subject|1|||
44120724|NCT02988115|78904716|FG000|Overall Study|Withdrawn by Mistake|1|||
44120725|NCT02988115|78904717|FG001|Overall Study|Withdrawn by Mistake|0|||
44240154|NCT01524887|79067155|FG000|Overall Study|Use of prohibited medication|1|||
44240155|NCT01524887|79067156|FG001|Overall Study|Use of prohibited medication|0|||
44240156|NCT01524887|79067157|FG002|Overall Study|Use of prohibited medication|0|||
44240157|NCT01523873|79067183|FG000|Overall Study|Protocol Violation|422|||
44240158|NCT01522235|79067208|FG000|Overall Study|Physician Decision|1|||
44240159|NCT01522235|79067209|FG001|Overall Study|Physician Decision|1|||
44508911|NCT00266825|79514126|FG001|Completed Follow-Up|Lost to Follow-up|19|||
44508912|NCT00266825|79514125|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
44240160|NCT01521923|79067246|FG000|Overall Study|AE, serious fatal|1|||
44120726|NCT02988115|78904716|FG000|Overall Study|Lost to Follow-up|1|||
44120727|NCT02988115|78904717|FG001|Overall Study|Lost to Follow-up|0|||
44120728|NCT02921425|78904723|FG000|Overall Study|Protocol Violation|9|||
44120729|NCT03008915|78904727|FG000|Treatment 1|Withdrawal by Subject|0|||
44120730|NCT03008915|78904728|FG001|Treatment 1|Withdrawal by Subject|1|||
44120731|NCT02920957|78904739|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
44120732|NCT02920957|78904740|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
44120733|NCT02920957|78904739|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
44120734|NCT02920957|78904740|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
44120735|NCT02920957|78904739|FG000|First Intervention : 1 Month|Adverse Event|1|||
44120736|NCT02920957|78904740|FG001|First Intervention : 1 Month|Adverse Event|0|||
44120737|NCT02920957|78904739|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
44120738|NCT02920957|78904740|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
44120739|NCT03006887|78904757|FG000|Overall Study|Adverse Event|1|||
44120740|NCT02514772|78904763|FG000|Overall Study|Adverse Event|1|||
44120741|NCT02514772|78904764|FG001|Overall Study|Adverse Event|0|||
44120742|NCT02514772|78904763|FG000|Overall Study|Death|0|||
44120743|NCT02514772|78904764|FG001|Overall Study|Death|1|||
44120744|NCT02514772|78904763|FG000|Overall Study|Withdrawal by Subject|2|||
44120745|NCT02514772|78904764|FG001|Overall Study|Withdrawal by Subject|1|||
44120746|NCT03000179|78904772|FG000|Overall Study|Lost to Follow-up|2|||
44120747|NCT02920177|78904778|FG000|Overall Study|Withdrawal by Subject|1|||
44120748|NCT02920177|78904779|FG001|Overall Study|Withdrawal by Subject|1|||
44120749|NCT02920177|78904778|FG000|Overall Study|Physician Decision|1|||
44120750|NCT02920177|78904779|FG001|Overall Study|Physician Decision|0|||
44120751|NCT02920177|78904778|FG000|Overall Study|Lost to Follow-up|0|||
44120752|NCT02920177|78904779|FG001|Overall Study|Lost to Follow-up|1|||
44120753|NCT03006341|78904789|FG000|Overall Study|Not linked in the EMR|25069|||
44120754|NCT03006341|78904790|FG001|Overall Study|Not linked in the EMR|67505|||
44120755|NCT03006341|78904791|FG002|Overall Study|Not linked in the EMR|30993|||
44120756|NCT03006341|78904792|FG003|Overall Study|Not linked in the EMR|10685|||
44120757|NCT03935594|78904800|FG000|Overall Study|Physician Decision|3|||
44120758|NCT02512042|78904808|FG000|Overall Study|Adverse Event|0|||
44120759|NCT02512042|78904809|FG001|Overall Study|Adverse Event|4|||
44120760|NCT02512042|78904808|FG000|Overall Study|Withdrawal by Subject|6|||
44120761|NCT02512042|78904809|FG001|Overall Study|Withdrawal by Subject|6|||
44120762|NCT02512042|78904808|FG000|Overall Study|Non-compliance with study drug|1|||
44120763|NCT02512042|78904809|FG001|Overall Study|Non-compliance with study drug|2|||
44120764|NCT02512042|78904808|FG000|Overall Study|Lost to Follow-up|5|||
44120765|NCT02512042|78904809|FG001|Overall Study|Lost to Follow-up|2|||
44240161|NCT01521923|79067247|FG001|Overall Study|AE, serious fatal|0|||
44240162|NCT01521923|79067248|FG002|Overall Study|AE, serious fatal|0|||
44240163|NCT01521923|79067249|FG003|Overall Study|AE, serious fatal|0|||
44240164|NCT01521923|79067246|FG000|Overall Study|SAE, non-fatal|0|||
44240165|NCT01521923|79067247|FG001|Overall Study|SAE, non-fatal|2|||
44240166|NCT01521923|79067248|FG002|Overall Study|SAE, non-fatal|2|||
44240167|NCT01521923|79067249|FG003|Overall Study|SAE, non-fatal|0|||
44240168|NCT01521923|79067246|FG000|Overall Study|AE, non-serious, non-fatal|1|||
44240169|NCT01521923|79067247|FG001|Overall Study|AE, non-serious, non-fatal|3|||
44240170|NCT01521923|79067248|FG002|Overall Study|AE, non-serious, non-fatal|6|||
44240171|NCT01521923|79067249|FG003|Overall Study|AE, non-serious, non-fatal|2|||
44240172|NCT01521923|79067246|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
44240173|NCT01521923|79067247|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
44240174|NCT01521923|79067248|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
44240175|NCT01521923|79067249|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
44240176|NCT01521923|79067246|FG000|Overall Study|Lack of Efficacy|1|||
44240177|NCT01521923|79067247|FG001|Overall Study|Lack of Efficacy|1|||
44240178|NCT01521923|79067248|FG002|Overall Study|Lack of Efficacy|0|||
44240179|NCT01521923|79067249|FG003|Overall Study|Lack of Efficacy|0|||
44240180|NCT01521923|79067246|FG000|Overall Study|Protocol Violation|0|||
44240181|NCT01521923|79067247|FG001|Overall Study|Protocol Violation|0|||
44240182|NCT01521923|79067248|FG002|Overall Study|Protocol Violation|1|||
44240183|NCT01521923|79067249|FG003|Overall Study|Protocol Violation|0|||
44240184|NCT01521923|79067246|FG000|Overall Study|Lost to Follow-up|1|||
44240185|NCT01521923|79067247|FG001|Overall Study|Lost to Follow-up|0|||
44240186|NCT01521923|79067248|FG002|Overall Study|Lost to Follow-up|2|||
44240187|NCT01521923|79067249|FG003|Overall Study|Lost to Follow-up|1|||
44240188|NCT01521923|79067246|FG000|Overall Study|Withdrawal by Subject|1|||
44240189|NCT01521923|79067247|FG001|Overall Study|Withdrawal by Subject|1|||
44240190|NCT01521923|79067248|FG002|Overall Study|Withdrawal by Subject|1|||
44240191|NCT01521923|79067249|FG003|Overall Study|Withdrawal by Subject|2|||
44276337|NCT02216214|79230766|FG000|Overall Study|Lack of Efficacy|2|||
44120766|NCT02512042|78904808|FG000|Overall Study|Other|11|||
44120767|NCT02512042|78904809|FG001|Overall Study|Other|11|||
44120768|NCT02911025|78904815|FG000|Overall Study|Lost to Follow-up|3|||
44120769|NCT02919475|78904824|FG000|Overall Study|Adverse Event|3|||
44120770|NCT02919475|78904825|FG001|Overall Study|Adverse Event|3|||
44120771|NCT02919475|78904826|FG002|Overall Study|Adverse Event|3|||
44120772|NCT02919475|78904827|FG003|Overall Study|Adverse Event|9|||
44120773|NCT02919475|78904828|FG004|Overall Study|Adverse Event|2|||
44120774|NCT02919475|78904824|FG000|Overall Study|Death|0|||
44120775|NCT02919475|78904825|FG001|Overall Study|Death|1|||
44120776|NCT02919475|78904826|FG002|Overall Study|Death|0|||
44120777|NCT02919475|78904827|FG003|Overall Study|Death|0|||
44120778|NCT02919475|78904828|FG004|Overall Study|Death|0|||
44120779|NCT02919475|78904824|FG000|Overall Study|Lost to Follow-up|0|||
44120780|NCT02919475|78904825|FG001|Overall Study|Lost to Follow-up|0|||
44120781|NCT02919475|78904826|FG002|Overall Study|Lost to Follow-up|0|||
44120782|NCT02919475|78904827|FG003|Overall Study|Lost to Follow-up|1|||
44240192|NCT01521923|79067246|FG000|Overall Study|Other|2|||
44240193|NCT01521923|79067247|FG001|Overall Study|Other|1|||
44240194|NCT01521923|79067248|FG002|Overall Study|Other|3|||
44240195|NCT01521923|79067249|FG003|Overall Study|Other|6|||
44240196|NCT01521923|79067246|FG000|Overall Study|AE, captured in Period 1|0|||
44240197|NCT01521923|79067247|FG001|Overall Study|AE, captured in Period 1|1|||
44120783|NCT02919475|78904828|FG004|Overall Study|Lost to Follow-up|0|||
44120784|NCT02919475|78904824|FG000|Overall Study|Withdrawal by Subject|2|||
44120785|NCT02919475|78904825|FG001|Overall Study|Withdrawal by Subject|3|||
44120786|NCT02919475|78904826|FG002|Overall Study|Withdrawal by Subject|1|||
44120787|NCT02919475|78904827|FG003|Overall Study|Withdrawal by Subject|2|||
44120788|NCT02919475|78904828|FG004|Overall Study|Withdrawal by Subject|2|||
44120789|NCT02919475|78904824|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
44120790|NCT02919475|78904825|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
44240198|NCT01521923|79067248|FG002|Overall Study|AE, captured in Period 1|0|||
44240199|NCT01521923|79067249|FG003|Overall Study|AE, captured in Period 1|1|||
44240200|NCT01520987|79067373|FG000|Overall Study|Withdrawal by Subject|1|||
44240201|NCT01520987|79067374|FG001|Overall Study|Withdrawal by Subject|0|||
44240202|NCT01520987|79067375|FG002|Overall Study|Withdrawal by Subject|0|||
44240203|NCT01520987|79067376|FG003|Overall Study|Withdrawal by Subject|0|||
44240204|NCT01520987|79067377|FG004|Overall Study|Withdrawal by Subject|0|||
44240205|NCT01520987|79067378|FG005|Overall Study|Withdrawal by Subject|1|||
44240206|NCT01520987|79067379|FG006|Overall Study|Withdrawal by Subject|0|||
44240207|NCT01520987|79067380|FG007|Overall Study|Withdrawal by Subject|0|||
44240208|NCT01562275|79067454|FG000|Stage 1|Adverse Event|0|||
44240209|NCT01562275|79067455|FG001|Stage 1|Adverse Event|0|||
44240210|NCT01562275|79067456|FG002|Stage 1|Adverse Event|0|||
44240211|NCT01562275|79067457|FG003|Stage 1|Adverse Event|1|||
44120791|NCT02919475|78904826|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
44120792|NCT02919475|78904827|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
44240212|NCT01562275|79067458|FG004|Stage 1|Adverse Event|1|||
44240213|NCT01562275|79067459|FG005|Stage 1|Adverse Event|0|||
44508913|NCT00266825|79514126|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
44508914|NCT00265889|79514134|FG000|Overall Study|Physician Decision|1|||
44508915|NCT00265889|79514134|FG000|Overall Study|Protocol Violation|1|||
44508916|NCT00265889|79514134|FG000|Overall Study|Insurance denied the request|3|||
44508917|NCT03209362|79514140|FG000|Overall Study|Adverse Event|0|||
44508918|NCT03209362|79514141|FG001|Overall Study|Adverse Event|1|||
44508919|NCT03209362|79514140|FG000|Overall Study|Lost to Follow-up|0|||
44508920|NCT03209362|79514141|FG001|Overall Study|Lost to Follow-up|1|||
44508921|NCT03209362|79514140|FG000|Overall Study|Withdrawal by Subject|2|||
44508922|NCT03209362|79514141|FG001|Overall Study|Withdrawal by Subject|0|||
44508923|NCT03209362|79514140|FG000|Overall Study|Other|0|||
44508924|NCT03209362|79514141|FG001|Overall Study|Other|1|||
44508925|NCT02932462|79514149|FG000|Overall Study|Adverse Event|1|||
44508926|NCT02932462|79514150|FG001|Overall Study|Adverse Event|2|||
44508927|NCT02932462|79514149|FG000|Overall Study|Lost to Follow-up|4|||
44508928|NCT02932462|79514150|FG001|Overall Study|Lost to Follow-up|1|||
44508929|NCT02932462|79514149|FG000|Overall Study|Protocol Violation|0|||
44508930|NCT02932462|79514150|FG001|Overall Study|Protocol Violation|5|||
44508931|NCT02932462|79514149|FG000|Overall Study|Withdrawal by Subject|1|||
44508932|NCT02932462|79514150|FG001|Overall Study|Withdrawal by Subject|4|||
44508933|NCT02932462|79514149|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44508934|NCT02932462|79514150|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44240214|NCT01562275|79067460|FG006|Stage 1|Adverse Event|0|||
44240215|NCT01562275|79067461|FG007|Stage 1|Adverse Event|0|||
44508935|NCT02932462|79514149|FG000|Overall Study|Progressive Disease|1|||
44508936|NCT02932462|79514150|FG001|Overall Study|Progressive Disease|0|||
44508937|NCT03206788|79514158|FG000|Overall Study|Withdrawal by Subject|0|||
44240216|NCT01562275|79067462|FG008|Stage 1|Adverse Event|0|||
44240217|NCT01562275|79067463|FG009|Stage 1|Adverse Event|1|||
44240218|NCT01562275|79067464|FG010|Stage 1|Adverse Event|0|||
44240219|NCT01562275|79067465|FG011|Stage 1|Adverse Event|0|||
44508938|NCT03206788|79514159|FG001|Overall Study|Withdrawal by Subject|1|||
44120793|NCT02919475|78904828|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44120794|NCT01066897|78904842|FG000|Overall Study|Withdrawal by Subject|1|||
44240220|NCT01562275|79067466|FG012|Stage 1|Adverse Event|0|||
44240221|NCT01562275|79067454|FG000|Stage 1|Death|1|||
44120795|NCT01066897|78904843|FG001|Overall Study|Withdrawal by Subject|0|||
44120796|NCT01066897|78904842|FG000|Overall Study|stopped study after developing the flu.|1|||
44120797|NCT01066897|78904843|FG001|Overall Study|stopped study after developing the flu.|0|||
44120798|NCT02985541|78904850|FG000|Overall Study|Withdrawal by Subject|33|||
44508939|NCT03206788|79514158|FG000|Overall Study|Adverse Event|0|||
44508940|NCT03206788|79514159|FG001|Overall Study|Adverse Event|1|||
44508941|NCT03206788|79514158|FG000|Overall Study|Physician Decision|0|||
44508942|NCT03206788|79514159|FG001|Overall Study|Physician Decision|1|||
44240222|NCT01562275|79067455|FG001|Stage 1|Death|0|||
44120799|NCT02985541|78904850|FG000|Overall Study|Lost to Follow-up|26|||
44120800|NCT02985541|78904850|FG000|Overall Study|Adverse Event|27|||
44120801|NCT02985541|78904850|FG000|Overall Study|Physician Decision|2|||
44120802|NCT02985541|78904850|FG000|Overall Study|Pregnancy|2|||
44120803|NCT02985541|78904850|FG000|Overall Study|Wish for pregnancy|44|||
44120804|NCT02985541|78904850|FG000|Overall Study|Other reason|5|||
44120805|NCT02985541|78904850|FG000|Overall Study|Not valid for analysis|2|||
44120806|NCT02910037|78904863|FG000|Overall Study|Withdrawal by Subject|4|||
44120807|NCT02910037|78904863|FG000|Overall Study|Lost to Follow-up|6|||
44120808|NCT02511184|78904898|FG000|Overall Study|Death|1|||
44120809|NCT02511184|78904899|FG001|Overall Study|Death|0|||
44120810|NCT02511184|78904898|FG000|Overall Study|Lost to Follow-up|0|||
44120811|NCT02511184|78904899|FG001|Overall Study|Lost to Follow-up|1|||
44120812|NCT02511184|78904898|FG000|Overall Study|Study terminated by sponsor|1|||
44120813|NCT02511184|78904899|FG001|Overall Study|Study terminated by sponsor|5|||
44120814|NCT02511184|78904898|FG000|Overall Study|Withdrawal by Subject|0|||
44120815|NCT02511184|78904899|FG001|Overall Study|Withdrawal by Subject|1|||
44120816|NCT02984995|78904908|FG000|Overall Study|Required stem cell transplant|13|||
44120817|NCT02984995|78904909|FG001|Overall Study|Required stem cell transplant|2|||
44120818|NCT02984995|78904908|FG000|Overall Study|Progressive disease|11|||
44120819|NCT02984995|78904909|FG001|Overall Study|Progressive disease|1|||
44120820|NCT02984995|78904908|FG000|Overall Study|Adverse Event|1|||
44120821|NCT02984995|78904909|FG001|Overall Study|Adverse Event|0|||
44120822|NCT02984683|78904933|FG000|Overall Study|Adverse Event|3|||
44120823|NCT02984683|78904934|FG001|Overall Study|Adverse Event|3|||
44120824|NCT02984683|78904933|FG000|Overall Study|Withdrawal by Subject|1|||
44120825|NCT02984683|78904934|FG001|Overall Study|Withdrawal by Subject|0|||
44120826|NCT02984683|78904933|FG000|Overall Study|Disease progression|7|||
44120827|NCT02984683|78904934|FG001|Overall Study|Disease progression|9|||
44120828|NCT02909101|78904942|FG000|Overall Study|Lost to Follow-up|1|||
44120829|NCT02909101|78904943|FG001|Overall Study|Lost to Follow-up|1|||
44120830|NCT03004469|78904952|FG000|Overall Study|Adverse Event|6|||
44120831|NCT03004469|78904953|FG001|Overall Study|Adverse Event|4|||
44120832|NCT03004469|78904954|FG002|Overall Study|Adverse Event|6|||
44240223|NCT01562275|79067456|FG002|Stage 1|Death|0|||
44240224|NCT01562275|79067457|FG003|Stage 1|Death|0|||
44240225|NCT01562275|79067458|FG004|Stage 1|Death|0|||
44240226|NCT01562275|79067459|FG005|Stage 1|Death|0|||
44240227|NCT01562275|79067460|FG006|Stage 1|Death|0|||
44508943|NCT03205150|79514168|FG000|Overall Study|Protocol deviation|1|||
44508944|NCT03205150|79514169|FG001|Overall Study|Protocol deviation|3|||
44508945|NCT03205150|79514170|FG002|Overall Study|Protocol deviation|0|||
44240228|NCT01562275|79067461|FG007|Stage 1|Death|0|||
44240229|NCT01562275|79067462|FG008|Stage 1|Death|0|||
44240230|NCT01562275|79067463|FG009|Stage 1|Death|0|||
44240231|NCT01562275|79067464|FG010|Stage 1|Death|0|||
44240232|NCT01562275|79067465|FG011|Stage 1|Death|0|||
44240233|NCT01562275|79067466|FG012|Stage 1|Death|0|||
44508946|NCT03205150|79514168|FG000|Overall Study|Patient/guardian decision|0|||
44508947|NCT03205150|79514169|FG001|Overall Study|Patient/guardian decision|3|||
44508948|NCT03205150|79514170|FG002|Overall Study|Patient/guardian decision|0|||
44240234|NCT01562275|79067454|FG000|Stage 1|Non Compliance|0|||
44240235|NCT01562275|79067455|FG001|Stage 1|Non Compliance|0|||
44240236|NCT01562275|79067456|FG002|Stage 1|Non Compliance|1|||
44120833|NCT03004469|78904952|FG000|Overall Study|Lack of Efficacy|1|||
44120834|NCT03004469|78904953|FG001|Overall Study|Lack of Efficacy|0|||
44120835|NCT03004469|78904954|FG002|Overall Study|Lack of Efficacy|1|||
44120836|NCT03004469|78904952|FG000|Overall Study|Lost to Follow-up|23|||
44120837|NCT03004469|78904953|FG001|Overall Study|Lost to Follow-up|14|||
44120838|NCT03004469|78904954|FG002|Overall Study|Lost to Follow-up|6|||
44120839|NCT03004469|78904952|FG000|Overall Study|Non-Compliance with Study Drug|2|||
44240237|NCT01562275|79067457|FG003|Stage 1|Non Compliance|0|||
44240238|NCT01562275|79067458|FG004|Stage 1|Non Compliance|0|||
44508949|NCT03205150|79514168|FG000|Overall Study|Adverse Event|1|||
44120840|NCT03004469|78904953|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44120841|NCT03004469|78904954|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44120842|NCT03004469|78904952|FG000|Overall Study|Protocol Violation|0|||
44120843|NCT03004469|78904953|FG001|Overall Study|Protocol Violation|0|||
44240239|NCT01562275|79067459|FG005|Stage 1|Non Compliance|0|||
44240240|NCT01562275|79067460|FG006|Stage 1|Non Compliance|0|||
44240241|NCT01562275|79067461|FG007|Stage 1|Non Compliance|0|||
44240242|NCT01562275|79067462|FG008|Stage 1|Non Compliance|0|||
44240243|NCT01562275|79067463|FG009|Stage 1|Non Compliance|0|||
44276338|NCT02216214|79230767|FG001|Overall Study|Lack of Efficacy|2|||
44276339|NCT02216214|79230766|FG000|Overall Study|Lost to Follow-up|3|||
44276340|NCT02216214|79230767|FG001|Overall Study|Lost to Follow-up|2|||
44276341|NCT02216214|79230766|FG000|Overall Study|Protocol Violation|4|||
44276342|NCT02216214|79230767|FG001|Overall Study|Protocol Violation|2|||
44276343|NCT02216214|79230766|FG000|Overall Study|Withdrawal by Subject|22|||
44276344|NCT02216214|79230767|FG001|Overall Study|Withdrawal by Subject|20|||
44276345|NCT02216214|79230766|FG000|Overall Study|Study Terminated By Sponsor|0|||
44276346|NCT02216214|79230767|FG001|Overall Study|Study Terminated By Sponsor|1|||
44276347|NCT02216214|79230766|FG000|Overall Study|Miscellaneous|1|||
44276348|NCT02216214|79230767|FG001|Overall Study|Miscellaneous|1|||
44276349|NCT02214186|79230798|FG000|Overall Study|Lost to Follow-up|1|||
44276350|NCT02214186|79230799|FG001|Overall Study|Lost to Follow-up|1|||
44276351|NCT02214186|79230798|FG000|Overall Study|Protocol Violation|1|||
44276352|NCT02214186|79230799|FG001|Overall Study|Protocol Violation|1|||
44276353|NCT02181504|79230855|FG000|Overall Study|Adverse Event|1|||
44276354|NCT02181504|79230856|FG001|Overall Study|Adverse Event|1|||
44276355|NCT02181504|79230857|FG002|Overall Study|Adverse Event|1|||
44276356|NCT02179398|79230887|FG000|Overall Study|Lack of obligatory data|3|||
44120844|NCT03004469|78904954|FG002|Overall Study|Protocol Violation|1|||
44120845|NCT03004469|78904952|FG000|Overall Study|Withdrawal by Subject|29|||
44120846|NCT03004469|78904953|FG001|Overall Study|Withdrawal by Subject|27|||
44120847|NCT03004469|78904954|FG002|Overall Study|Withdrawal by Subject|10|||
44120848|NCT03004469|78904952|FG000|Overall Study|Other unspecified reason|0|||
44120849|NCT03004469|78904953|FG001|Overall Study|Other unspecified reason|4|||
44120850|NCT03004469|78904954|FG002|Overall Study|Other unspecified reason|1|||
44120851|NCT02910713|78904963|FG000|Overall Study|Protocol Violation|2|||
44120852|NCT02910713|78904963|FG000|Overall Study|Subject Choice|4|||
44120853|NCT02910713|78904963|FG000|Overall Study|Received One Application|10|||
44240244|NCT01562275|79067464|FG010|Stage 1|Non Compliance|0|||
44240245|NCT01562275|79067465|FG011|Stage 1|Non Compliance|0|||
44120854|NCT02910713|78904963|FG000|Overall Study|Received Neither Application|18|||
44120855|NCT02910713|78904963|FG000|Overall Study|Enrollment cap|7|||
44120856|NCT02910713|78904963|FG000|Overall Study|Investigator Discretion|1|||
44120857|NCT02998541|78904971|FG000|Overall Study|Adverse Event|4|||
44120858|NCT02998541|78904972|FG001|Overall Study|Adverse Event|5|||
44120859|NCT02998541|78904973|FG002|Overall Study|Adverse Event|1|||
44120860|NCT02998541|78904971|FG000|Overall Study|Protocol Violation|1|||
44120861|NCT02998541|78904972|FG001|Overall Study|Protocol Violation|0|||
44120862|NCT02998541|78904973|FG002|Overall Study|Protocol Violation|0|||
44120863|NCT02998541|78904971|FG000|Overall Study|Withdrawal by Subject|3|||
44120864|NCT02998541|78904972|FG001|Overall Study|Withdrawal by Subject|1|||
44120865|NCT02998541|78904973|FG002|Overall Study|Withdrawal by Subject|0|||
44120866|NCT02998541|78904971|FG000|Overall Study|Lost to Follow-up|0|||
44240246|NCT01562275|79067466|FG012|Stage 1|Non Compliance|0|||
44240247|NCT01562275|79067454|FG000|Stage 1|Physician Decision|0|||
44240248|NCT01562275|79067455|FG001|Stage 1|Physician Decision|0|||
44240249|NCT01562275|79067456|FG002|Stage 1|Physician Decision|0|||
44120867|NCT02998541|78904972|FG001|Overall Study|Lost to Follow-up|3|||
44120868|NCT02998541|78904973|FG002|Overall Study|Lost to Follow-up|1|||
44120869|NCT02998541|78904971|FG000|Overall Study|Physician Decision|0|||
44120870|NCT02998541|78904972|FG001|Overall Study|Physician Decision|0|||
44120871|NCT02998541|78904973|FG002|Overall Study|Physician Decision|3|||
44240250|NCT01562275|79067457|FG003|Stage 1|Physician Decision|0|||
44240251|NCT01562275|79067458|FG004|Stage 1|Physician Decision|1|||
44240252|NCT01562275|79067459|FG005|Stage 1|Physician Decision|0|||
44240253|NCT01562275|79067460|FG006|Stage 1|Physician Decision|1|||
44120872|NCT02998541|78904971|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44120873|NCT02998541|78904972|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44120874|NCT02998541|78904973|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
44120875|NCT02998151|78904981|FG000|Overall Study|Withdrawal by Subject|3|||
44120876|NCT02998151|78904981|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
44120877|NCT02998151|78904981|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
44120878|NCT01066819|78905012|FG000|Overall Study|Adverse Event|18|||
44120879|NCT01066819|78905013|FG001|Overall Study|Adverse Event|1|||
44120880|NCT01066819|78905014|FG002|Overall Study|Adverse Event|6|||
44240254|NCT01562275|79067461|FG007|Stage 1|Physician Decision|0|||
44276357|NCT02179398|79230888|FG001|Overall Study|Lack of obligatory data|3|||
44276358|NCT02179398|79230887|FG000|Overall Study|Lost to Follow-up|0|||
44276359|NCT02179398|79230888|FG001|Overall Study|Lost to Follow-up|1|||
44120881|NCT01066819|78905015|FG003|Overall Study|Adverse Event|0|||
44120882|NCT01066819|78905016|FG004|Overall Study|Adverse Event|0|||
44120883|NCT01066819|78905017|FG005|Overall Study|Adverse Event|0|||
44120884|NCT01066819|78905012|FG000|Overall Study|Death|5|||
44240255|NCT01562275|79067462|FG008|Stage 1|Physician Decision|1|||
44276360|NCT02156076|79230902|FG000|Treatment Period|no longer meets study criteria|0|||
44276361|NCT02156076|79230903|FG001|Treatment Period|no longer meets study criteria|0|||
44276362|NCT02156076|79230904|FG002|Treatment Period|no longer meets study criteria|1|||
44120885|NCT01066819|78905013|FG001|Overall Study|Death|0|||
44120886|NCT01066819|78905014|FG002|Overall Study|Death|1|||
44120887|NCT01066819|78905015|FG003|Overall Study|Death|0|||
44120888|NCT01066819|78905016|FG004|Overall Study|Death|0|||
44120889|NCT01066819|78905017|FG005|Overall Study|Death|0|||
44120890|NCT01066819|78905012|FG000|Overall Study|Lack of Efficacy|22|||
44120891|NCT01066819|78905013|FG001|Overall Study|Lack of Efficacy|1|||
44120892|NCT01066819|78905014|FG002|Overall Study|Lack of Efficacy|2|||
44120893|NCT01066819|78905015|FG003|Overall Study|Lack of Efficacy|1|||
44120894|NCT01066819|78905016|FG004|Overall Study|Lack of Efficacy|0|||
44120895|NCT01066819|78905017|FG005|Overall Study|Lack of Efficacy|0|||
44120896|NCT01066819|78905012|FG000|Overall Study|Physician Decision|6|||
44120897|NCT01066819|78905013|FG001|Overall Study|Physician Decision|2|||
44120898|NCT01066819|78905014|FG002|Overall Study|Physician Decision|3|||
44120899|NCT01066819|78905015|FG003|Overall Study|Physician Decision|0|||
44120900|NCT01066819|78905016|FG004|Overall Study|Physician Decision|0|||
44120901|NCT01066819|78905017|FG005|Overall Study|Physician Decision|0|||
44120902|NCT01066819|78905012|FG000|Overall Study|Protocol Violation|12|||
44120903|NCT01066819|78905013|FG001|Overall Study|Protocol Violation|6|||
44120904|NCT01066819|78905014|FG002|Overall Study|Protocol Violation|0|||
44120905|NCT01066819|78905015|FG003|Overall Study|Protocol Violation|0|||
44120906|NCT01066819|78905016|FG004|Overall Study|Protocol Violation|0|||
44120907|NCT01066819|78905017|FG005|Overall Study|Protocol Violation|0|||
44120908|NCT01066819|78905012|FG000|Overall Study|Withdrawal by Subject|29|||
44120909|NCT01066819|78905013|FG001|Overall Study|Withdrawal by Subject|11|||
44120910|NCT01066819|78905014|FG002|Overall Study|Withdrawal by Subject|6|||
44120911|NCT01066819|78905015|FG003|Overall Study|Withdrawal by Subject|0|||
44120912|NCT01066819|78905016|FG004|Overall Study|Withdrawal by Subject|0|||
44120913|NCT01066819|78905017|FG005|Overall Study|Withdrawal by Subject|0|||
44120914|NCT01066819|78905012|FG000|Overall Study|Administrative|6|||
44120915|NCT01066819|78905013|FG001|Overall Study|Administrative|4|||
44120916|NCT01066819|78905014|FG002|Overall Study|Administrative|2|||
44120917|NCT01066819|78905015|FG003|Overall Study|Administrative|0|||
44120918|NCT01066819|78905016|FG004|Overall Study|Administrative|0|||
44120919|NCT01066819|78905017|FG005|Overall Study|Administrative|0|||
44120920|NCT01066819|78905012|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
44120921|NCT01066819|78905013|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
44120922|NCT01066819|78905014|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
44120923|NCT01066819|78905015|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
44120924|NCT01066819|78905016|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
44120925|NCT01066819|78905017|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
44120926|NCT01066819|78905012|FG000|Overall Study|Early termination|2|||
44120927|NCT01066819|78905013|FG001|Overall Study|Early termination|0|||
44120928|NCT01066819|78905014|FG002|Overall Study|Early termination|0|||
44120929|NCT01066819|78905015|FG003|Overall Study|Early termination|0|||
44120930|NCT01066819|78905016|FG004|Overall Study|Early termination|0|||
44120931|NCT01066819|78905017|FG005|Overall Study|Early termination|0|||
44120932|NCT01066819|78905012|FG000|Overall Study|Failed to return|298|||
44120933|NCT01066819|78905013|FG001|Overall Study|Failed to return|107|||
44120934|NCT01066819|78905014|FG002|Overall Study|Failed to return|68|||
44120935|NCT01066819|78905015|FG003|Overall Study|Failed to return|7|||
44120936|NCT01066819|78905016|FG004|Overall Study|Failed to return|2|||
44508950|NCT03205150|79514169|FG001|Overall Study|Adverse Event|1|||
44508951|NCT03205150|79514170|FG002|Overall Study|Adverse Event|1|||
44508952|NCT03205150|79514168|FG000|Overall Study|Lost to Follow-up|0|||
44508953|NCT03205150|79514169|FG001|Overall Study|Lost to Follow-up|0|||
44508954|NCT03205150|79514170|FG002|Overall Study|Lost to Follow-up|1|||
44508955|NCT02932306|79514181|FG000|Overall Study|Withdrawal by Subject|16|||
44508956|NCT02932306|79514182|FG001|Overall Study|Withdrawal by Subject|25|||
44508957|NCT02932306|79514181|FG000|Overall Study|Adverse Event|3|||
44508958|NCT02932306|79514182|FG001|Overall Study|Adverse Event|0|||
44508959|NCT02932306|79514181|FG000|Overall Study|Pregnancy|2|||
44508960|NCT02932306|79514182|FG001|Overall Study|Pregnancy|0|||
44508961|NCT02932306|79514181|FG000|Overall Study|Protocol Violation|1|||
44120937|NCT01066819|78905017|FG005|Overall Study|Failed to return|3|||
44120938|NCT01066819|78905012|FG000|Overall Study|Lab test not done|9|||
44120939|NCT01066819|78905013|FG001|Overall Study|Lab test not done|0|||
44120940|NCT01066819|78905014|FG002|Overall Study|Lab test not done|2|||
44120941|NCT01066819|78905015|FG003|Overall Study|Lab test not done|1|||
44120942|NCT01066819|78905016|FG004|Overall Study|Lab test not done|0|||
44120943|NCT01066819|78905017|FG005|Overall Study|Lab test not done|0|||
44120944|NCT01066819|78905012|FG000|Overall Study|Miscellaneous|28|||
44120945|NCT01066819|78905013|FG001|Overall Study|Miscellaneous|10|||
44120946|NCT01066819|78905014|FG002|Overall Study|Miscellaneous|18|||
44120947|NCT01066819|78905015|FG003|Overall Study|Miscellaneous|1|||
44120948|NCT01066819|78905016|FG004|Overall Study|Miscellaneous|0|||
44378867|NCT03194646|79384414|FG001|Overall Study|Protocol Violation|2|||
44120949|NCT01066819|78905017|FG005|Overall Study|Miscellaneous|0|||
44508962|NCT02932306|79514182|FG001|Overall Study|Protocol Violation|1|||
44508963|NCT02932306|79514181|FG000|Overall Study|Noncompliance with Study Drug|1|||
44120950|NCT01066819|78905012|FG000|Overall Study|Non responders|123|||
44120951|NCT01066819|78905013|FG001|Overall Study|Non responders|2|||
44120952|NCT01066819|78905014|FG002|Overall Study|Non responders|7|||
44120953|NCT01066819|78905015|FG003|Overall Study|Non responders|2|||
44120954|NCT01066819|78905016|FG004|Overall Study|Non responders|0|||
44120955|NCT01066819|78905017|FG005|Overall Study|Non responders|1|||
44120956|NCT01066819|78905012|FG000|Overall Study|Not categorised|9|||
44120957|NCT01066819|78905013|FG001|Overall Study|Not categorised|2|||
44240256|NCT01562275|79067463|FG009|Stage 1|Physician Decision|0|||
44240257|NCT01562275|79067464|FG010|Stage 1|Physician Decision|0|||
44240258|NCT01562275|79067465|FG011|Stage 1|Physician Decision|0|||
44240259|NCT01562275|79067466|FG012|Stage 1|Physician Decision|0|||
44240260|NCT01562275|79067454|FG000|Stage 1|Progression of Disease|2|||
44240261|NCT01562275|79067455|FG001|Stage 1|Progression of Disease|6|||
44120958|NCT01066819|78905014|FG002|Overall Study|Not categorised|6|||
44120959|NCT01066819|78905015|FG003|Overall Study|Not categorised|1|||
44120960|NCT01066819|78905016|FG004|Overall Study|Not categorised|0|||
44276363|NCT02156076|79230905|FG003|Treatment Period|no longer meets study criteria|0|||
44240262|NCT01562275|79067456|FG002|Stage 1|Progression of Disease|2|||
44240263|NCT01562275|79067457|FG003|Stage 1|Progression of Disease|1|||
44240264|NCT01562275|79067458|FG004|Stage 1|Progression of Disease|2|||
44240265|NCT01562275|79067459|FG005|Stage 1|Progression of Disease|4|||
44240266|NCT01562275|79067460|FG006|Stage 1|Progression of Disease|1|||
44240267|NCT01562275|79067461|FG007|Stage 1|Progression of Disease|7|||
44240268|NCT01562275|79067462|FG008|Stage 1|Progression of Disease|2|||
44240269|NCT01562275|79067463|FG009|Stage 1|Progression of Disease|5|||
44240270|NCT01562275|79067464|FG010|Stage 1|Progression of Disease|3|||
44240271|NCT01562275|79067465|FG011|Stage 1|Progression of Disease|0|||
44240272|NCT01562275|79067466|FG012|Stage 1|Progression of Disease|0|||
44240273|NCT01562275|79067454|FG000|Stage 1|Withdrawal by Subject|0|||
44240274|NCT01562275|79067455|FG001|Stage 1|Withdrawal by Subject|1|||
44240275|NCT01562275|79067456|FG002|Stage 1|Withdrawal by Subject|0|||
44240276|NCT01562275|79067457|FG003|Stage 1|Withdrawal by Subject|2|||
44240277|NCT01562275|79067458|FG004|Stage 1|Withdrawal by Subject|0|||
44240278|NCT01562275|79067459|FG005|Stage 1|Withdrawal by Subject|0|||
44240279|NCT01562275|79067460|FG006|Stage 1|Withdrawal by Subject|1|||
44240280|NCT01562275|79067461|FG007|Stage 1|Withdrawal by Subject|0|||
44276364|NCT02156076|79230902|FG000|Treatment Period|Poor/non-compliance|0|||
44508964|NCT02932306|79514182|FG001|Overall Study|Noncompliance with Study Drug|1|||
44120961|NCT01066819|78905017|FG005|Overall Study|Not categorised|0|||
44120962|NCT01066819|78905012|FG000|Overall Study|Relapse|16|||
44120963|NCT01066819|78905013|FG001|Overall Study|Relapse|4|||
44240281|NCT01562275|79067462|FG008|Stage 1|Withdrawal by Subject|0|||
44508965|NCT02932306|79514181|FG000|Overall Study|Lost to Follow-up|36|||
44508966|NCT02932306|79514182|FG001|Overall Study|Lost to Follow-up|40|||
44508967|NCT02932306|79514181|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
44508968|NCT02932306|79514182|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
44508969|NCT02932306|79514181|FG000|Overall Study|Lack of Efficacy|0|||
44508970|NCT02932306|79514182|FG001|Overall Study|Lack of Efficacy|2|||
44508971|NCT02932306|79514181|FG000|Overall Study|Worsening condition|2|||
44508972|NCT02932306|79514182|FG001|Overall Study|Worsening condition|0|||
44120964|NCT01066819|78905014|FG002|Overall Study|Relapse|3|||
44120965|NCT01066819|78905015|FG003|Overall Study|Relapse|0|||
44120966|NCT01066819|78905016|FG004|Overall Study|Relapse|0|||
44120967|NCT01066819|78905017|FG005|Overall Study|Relapse|0|||
44240282|NCT01562275|79067463|FG009|Stage 1|Withdrawal by Subject|1|||
44240283|NCT01562275|79067464|FG010|Stage 1|Withdrawal by Subject|0|||
44240284|NCT01562275|79067465|FG011|Stage 1|Withdrawal by Subject|0|||
44240285|NCT01562275|79067466|FG012|Stage 1|Withdrawal by Subject|0|||
44240286|NCT01562275|79067454|FG000|Stage 2|Death|0|||
44240287|NCT01562275|79067455|FG001|Stage 2|Death|0|||
44120968|NCT01066819|78905012|FG000|Overall Study|Results not available|1|||
44120969|NCT01066819|78905013|FG001|Overall Study|Results not available|0|||
44120970|NCT01066819|78905014|FG002|Overall Study|Results not available|0|||
44120971|NCT01066819|78905015|FG003|Overall Study|Results not available|0|||
44120972|NCT01066819|78905016|FG004|Overall Study|Results not available|0|||
44120973|NCT01066819|78905017|FG005|Overall Study|Results not available|0|||
44120974|NCT01066819|78905012|FG000|Overall Study|Screen failure|1|||
44120975|NCT01066819|78905013|FG001|Overall Study|Screen failure|0|||
44508973|NCT02932306|79514181|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
44120976|NCT01066819|78905014|FG002|Overall Study|Screen failure|0|||
44120977|NCT01066819|78905015|FG003|Overall Study|Screen failure|0|||
44120978|NCT01066819|78905016|FG004|Overall Study|Screen failure|0|||
44120979|NCT01066819|78905017|FG005|Overall Study|Screen failure|0|||
44120980|NCT01066819|78905012|FG000|Overall Study|Spontaneous cure|1|||
44120981|NCT01066819|78905013|FG001|Overall Study|Spontaneous cure|0|||
44120982|NCT01066819|78905014|FG002|Overall Study|Spontaneous cure|0|||
44120983|NCT01066819|78905015|FG003|Overall Study|Spontaneous cure|0|||
44120984|NCT01066819|78905016|FG004|Overall Study|Spontaneous cure|0|||
44120985|NCT01066819|78905017|FG005|Overall Study|Spontaneous cure|0|||
44120986|NCT01066819|78905012|FG000|Overall Study|Treatment never started|85|||
44120987|NCT01066819|78905013|FG001|Overall Study|Treatment never started|19|||
44120988|NCT01066819|78905014|FG002|Overall Study|Treatment never started|19|||
44120989|NCT01066819|78905015|FG003|Overall Study|Treatment never started|3|||
44120990|NCT01066819|78905016|FG004|Overall Study|Treatment never started|2|||
44120991|NCT01066819|78905017|FG005|Overall Study|Treatment never started|2|||
44120992|NCT01066819|78905012|FG000|Overall Study|Treatment stopped|12|||
44120993|NCT01066819|78905013|FG001|Overall Study|Treatment stopped|1|||
44120994|NCT01066819|78905014|FG002|Overall Study|Treatment stopped|2|||
44120995|NCT01066819|78905015|FG003|Overall Study|Treatment stopped|1|||
44120996|NCT01066819|78905016|FG004|Overall Study|Treatment stopped|0|||
44120997|NCT01066819|78905017|FG005|Overall Study|Treatment stopped|0|||
44120998|NCT01066819|78905012|FG000|Overall Study|Other|5|||
44120999|NCT01066819|78905013|FG001|Overall Study|Other|1|||
44121000|NCT01066819|78905014|FG002|Overall Study|Other|1|||
44121001|NCT01066819|78905015|FG003|Overall Study|Other|0|||
44121002|NCT01066819|78905016|FG004|Overall Study|Other|0|||
44121003|NCT01066819|78905017|FG005|Overall Study|Other|0|||
44121004|NCT04056299|78905031|FG000|Overall Study|Sponsor discontinued study|3|||
44508974|NCT02932306|79514182|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
44508975|NCT02932228|79514190|FG000|Overall Study|Death|8|||
44508976|NCT02932228|79514191|FG001|Overall Study|Death|23|||
44508977|NCT02932228|79514190|FG000|Overall Study|not eligible upon chart review|2|||
44508978|NCT02932228|79514191|FG001|Overall Study|not eligible upon chart review|5|||
44508979|NCT02931838|79514205|FG000|Overall Study|Reason not provided by investigator|1|||
44508980|NCT02931838|79514206|FG001|Overall Study|Reason not provided by investigator|0|||
44508981|NCT02931838|79514207|FG002|Overall Study|Reason not provided by investigator|1|||
44508982|NCT02931838|79514208|FG003|Overall Study|Reason not provided by investigator|0|||
44508983|NCT02931838|79514209|FG004|Overall Study|Reason not provided by investigator|0|||
44508984|NCT02931838|79514210|FG005|Overall Study|Reason not provided by investigator|0|||
44508985|NCT02931838|79514205|FG000|Overall Study|Poor/non-compliance|0|||
44508986|NCT02931838|79514206|FG001|Overall Study|Poor/non-compliance|0|||
44121005|NCT04056299|78905032|FG001|Overall Study|Sponsor discontinued study|3|||
44121006|NCT04057937|78905040|FG000|Placebo-controlled Phase|Adverse Event|3|||
44121007|NCT04057937|78905041|FG001|Placebo-controlled Phase|Adverse Event|0|||
44121008|NCT04057937|78905040|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
44121009|NCT04057937|78905041|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
44121010|NCT04057937|78905040|FG000|Active-treatment Phase|Pregnancy|0|||
44121011|NCT04057937|78905041|FG001|Active-treatment Phase|Pregnancy|1|||
44121012|NCT04057937|78905040|FG000|Active-treatment Phase|Physician Decision|0|||
44121013|NCT04057937|78905041|FG001|Active-treatment Phase|Physician Decision|1|||
44378868|NCT03194646|79384415|FG002|Overall Study|Protocol Violation|1|||
44240288|NCT01562275|79067456|FG002|Stage 2|Death|0|||
44240289|NCT01562275|79067457|FG003|Stage 2|Death|0|||
44240290|NCT01562275|79067458|FG004|Stage 2|Death|0|||
44240291|NCT01562275|79067459|FG005|Stage 2|Death|0|||
44240292|NCT01562275|79067460|FG006|Stage 2|Death|0|||
44240293|NCT01562275|79067461|FG007|Stage 2|Death|0|||
44240294|NCT01562275|79067462|FG008|Stage 2|Death|0|||
44240295|NCT01562275|79067463|FG009|Stage 2|Death|0|||
44240296|NCT01562275|79067464|FG010|Stage 2|Death|0|||
44240297|NCT01562275|79067465|FG011|Stage 2|Death|2|||
44240298|NCT01562275|79067466|FG012|Stage 2|Death|1|||
44240299|NCT01562275|79067454|FG000|Stage 2|Progression of Disease|0|||
44240300|NCT01562275|79067455|FG001|Stage 2|Progression of Disease|0|||
44240301|NCT01562275|79067456|FG002|Stage 2|Progression of Disease|0|||
44240302|NCT01562275|79067457|FG003|Stage 2|Progression of Disease|0|||
44240303|NCT01562275|79067458|FG004|Stage 2|Progression of Disease|0|||
44240304|NCT01562275|79067459|FG005|Stage 2|Progression of Disease|0|||
44240305|NCT01562275|79067460|FG006|Stage 2|Progression of Disease|0|||
44240306|NCT01562275|79067461|FG007|Stage 2|Progression of Disease|0|||
44240307|NCT01562275|79067462|FG008|Stage 2|Progression of Disease|0|||
44240308|NCT01562275|79067463|FG009|Stage 2|Progression of Disease|0|||
44240309|NCT01562275|79067464|FG010|Stage 2|Progression of Disease|0|||
44240310|NCT01562275|79067465|FG011|Stage 2|Progression of Disease|12|||
44240311|NCT01562275|79067466|FG012|Stage 2|Progression of Disease|4|||
44240312|NCT01535053|79067498|FG000|Overall Study|Ineligible|1|||
44240313|NCT01535053|79067499|FG001|Overall Study|Ineligible|2|||
44240314|NCT01534663|79067507|FG000|Overall Study|Lost to Follow-up|0|||
44240315|NCT01534663|79067508|FG001|Overall Study|Lost to Follow-up|2|||
44508987|NCT02931838|79514207|FG002|Overall Study|Poor/non-compliance|1|||
44508988|NCT02931838|79514208|FG003|Overall Study|Poor/non-compliance|0|||
44508989|NCT02931838|79514209|FG004|Overall Study|Poor/non-compliance|0|||
44508990|NCT02931838|79514210|FG005|Overall Study|Poor/non-compliance|0|||
44508991|NCT02931838|79514205|FG000|Overall Study|Lack of Efficacy|5|||
44508992|NCT02931838|79514206|FG001|Overall Study|Lack of Efficacy|4|||
44508993|NCT02931838|79514207|FG002|Overall Study|Lack of Efficacy|0|||
44508994|NCT02931838|79514208|FG003|Overall Study|Lack of Efficacy|0|||
44508995|NCT02931838|79514209|FG004|Overall Study|Lack of Efficacy|0|||
44508996|NCT02931838|79514210|FG005|Overall Study|Lack of Efficacy|1|||
44508997|NCT02931838|79514205|FG000|Overall Study|Lost to Follow-up|1|||
44508998|NCT02931838|79514206|FG001|Overall Study|Lost to Follow-up|0|||
44508999|NCT02931838|79514207|FG002|Overall Study|Lost to Follow-up|1|||
44509000|NCT02931838|79514208|FG003|Overall Study|Lost to Follow-up|1|||
44509001|NCT02931838|79514209|FG004|Overall Study|Lost to Follow-up|2|||
44509002|NCT02931838|79514210|FG005|Overall Study|Lost to Follow-up|0|||
44509003|NCT02931838|79514205|FG000|Overall Study|Subject request to discontinue treatment|4|||
44509004|NCT02931838|79514206|FG001|Overall Study|Subject request to discontinue treatment|3|||
44509005|NCT02931838|79514207|FG002|Overall Study|Subject request to discontinue treatment|3|||
44509006|NCT02931838|79514208|FG003|Overall Study|Subject request to discontinue treatment|0|||
44509007|NCT02931838|79514209|FG004|Overall Study|Subject request to discontinue treatment|1|||
44509008|NCT02931838|79514210|FG005|Overall Study|Subject request to discontinue treatment|0|||
44509009|NCT02931838|79514205|FG000|Overall Study|Withdrawal by Subject|1|||
44509010|NCT02931838|79514206|FG001|Overall Study|Withdrawal by Subject|2|||
44509011|NCT02931838|79514207|FG002|Overall Study|Withdrawal by Subject|0|||
44509012|NCT02931838|79514208|FG003|Overall Study|Withdrawal by Subject|1|||
44509013|NCT02931838|79514209|FG004|Overall Study|Withdrawal by Subject|0|||
44509014|NCT02931838|79514210|FG005|Overall Study|Withdrawal by Subject|0|||
44509015|NCT02931838|79514205|FG000|Overall Study|Adverse Event|2|||
44509016|NCT02931838|79514206|FG001|Overall Study|Adverse Event|1|||
44509017|NCT02931838|79514207|FG002|Overall Study|Adverse Event|2|||
44509018|NCT02931838|79514208|FG003|Overall Study|Adverse Event|1|||
44509019|NCT02931838|79514209|FG004|Overall Study|Adverse Event|3|||
44509020|NCT02931838|79514210|FG005|Overall Study|Adverse Event|1|||
44509021|NCT03201562|79514232|FG000|Overall Study|Physician Decision|0|||
44240316|NCT01534663|79067507|FG000|Overall Study|Adverse Event|2|||
44240317|NCT01534663|79067508|FG001|Overall Study|Adverse Event|1|||
44240318|NCT01520909|79067516|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
44509022|NCT03201562|79514233|FG001|Overall Study|Physician Decision|0|||
44509023|NCT03201562|79514234|FG002|Overall Study|Physician Decision|1|||
44509024|NCT03201562|79514232|FG000|Overall Study|Adverse Event|0|||
44509025|NCT03201562|79514233|FG001|Overall Study|Adverse Event|0|||
44509026|NCT03201562|79514234|FG002|Overall Study|Adverse Event|1|||
44240319|NCT01520909|79067517|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
44240320|NCT01520909|79067518|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
44240321|NCT01520909|79067516|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
44240322|NCT01520909|79067517|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
44240323|NCT01520909|79067518|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
44240324|NCT01520909|79067516|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
44509027|NCT03201562|79514232|FG000|Overall Study|Lost to Follow-up|0|||
44509028|NCT03201562|79514233|FG001|Overall Study|Lost to Follow-up|1|||
44121014|NCT01069523|78905050|FG000|Overall Study|Withdrawal by Subject|4|||
44121015|NCT01069523|78905051|FG001|Overall Study|Withdrawal by Subject|7|||
44121016|NCT01069289|78905061|FG000|Overall Study|Withdrawal by Subject|15|||
44121017|NCT01069289|78905062|FG001|Overall Study|Withdrawal by Subject|26|||
44121018|NCT01069289|78905061|FG000|Overall Study|Adverse Event|21|||
44121019|NCT01069289|78905062|FG001|Overall Study|Adverse Event|28|||
44121020|NCT01069289|78905061|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44121021|NCT01069289|78905062|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44121022|NCT01069289|78905061|FG000|Overall Study|Severe non-compliance to protocol|3|||
44121023|NCT01069289|78905062|FG001|Overall Study|Severe non-compliance to protocol|2|||
44121024|NCT01069289|78905061|FG000|Overall Study|Due to deteriorating health condition|1|||
44121025|NCT01069289|78905062|FG001|Overall Study|Due to deteriorating health condition|0|||
44121026|NCT02510794|78905081|FG000|Overall Study|Adverse Event|0|||
44121027|NCT02510794|78905082|FG001|Overall Study|Adverse Event|1|||
44121028|NCT02510794|78905083|FG002|Overall Study|Adverse Event|0|||
44121029|NCT02510794|78905084|FG003|Overall Study|Adverse Event|0|||
44121030|NCT02510794|78905081|FG000|Overall Study|Death|1|||
44121031|NCT02510794|78905082|FG001|Overall Study|Death|2|||
44121032|NCT02510794|78905083|FG002|Overall Study|Death|1|||
44121033|NCT02510794|78905084|FG003|Overall Study|Death|1|||
44121034|NCT02510794|78905081|FG000|Overall Study|Lack of Efficacy|3|||
44121035|NCT02510794|78905082|FG001|Overall Study|Lack of Efficacy|1|||
44121036|NCT02510794|78905083|FG002|Overall Study|Lack of Efficacy|1|||
44121037|NCT02510794|78905084|FG003|Overall Study|Lack of Efficacy|0|||
44121038|NCT02510794|78905081|FG000|Overall Study|Participant moved out of the area|0|||
44121039|NCT02510794|78905082|FG001|Overall Study|Participant moved out of the area|0|||
44121040|NCT02510794|78905083|FG002|Overall Study|Participant moved out of the area|0|||
44121041|NCT02510794|78905084|FG003|Overall Study|Participant moved out of the area|1|||
44121042|NCT02510794|78905081|FG000|Overall Study|Physician Decision|3|||
44121043|NCT02510794|78905082|FG001|Overall Study|Physician Decision|0|||
44121044|NCT02510794|78905083|FG002|Overall Study|Physician Decision|0|||
44121045|NCT02510794|78905084|FG003|Overall Study|Physician Decision|0|||
44121046|NCT02510794|78905081|FG000|Overall Study|Protocol Violation|0|||
44121047|NCT02510794|78905082|FG001|Overall Study|Protocol Violation|0|||
44121048|NCT02510794|78905083|FG002|Overall Study|Protocol Violation|1|||
44121049|NCT02510794|78905084|FG003|Overall Study|Protocol Violation|0|||
44121050|NCT02510794|78905081|FG000|Overall Study|Withdrawal by Subject|1|||
44121051|NCT02510794|78905082|FG001|Overall Study|Withdrawal by Subject|2|||
44121052|NCT02510794|78905083|FG002|Overall Study|Withdrawal by Subject|4|||
44121053|NCT02510794|78905084|FG003|Overall Study|Withdrawal by Subject|3|||
44509029|NCT03201562|79514234|FG002|Overall Study|Lost to Follow-up|2|||
44509030|NCT03200860|79514244|FG000|Overall Study|Withdrawal by Subject|1|||
44509031|NCT03200860|79514245|FG001|Overall Study|Withdrawal by Subject|0|||
44509032|NCT03198754|79514253|FG000|Overall Study|Withdrawal by Subject|5|||
44121054|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
44240325|NCT01520909|79067517|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
44378869|NCT03194646|79384416|FG003|Overall Study|Protocol Violation|1|||
44509033|NCT03198754|79514254|FG001|Overall Study|Withdrawal by Subject|4|||
44509034|NCT03198754|79514253|FG000|Overall Study|Lost to Follow-up|4|||
44509035|NCT03198754|79514254|FG001|Overall Study|Lost to Follow-up|3|||
44509036|NCT03198754|79514253|FG000|Overall Study|Ineligible|2|||
44509037|NCT03198754|79514254|FG001|Overall Study|Ineligible|1|||
44509038|NCT03198520|79514260|FG000|Overall Study|Physician Decision|2|||
44509039|NCT03198520|79514260|FG000|Overall Study|Protocol Violation|2|||
44509040|NCT03198520|79514260|FG000|Overall Study|Withdrawal by Subject|1|||
44509041|NCT03198520|79514260|FG000|Overall Study|Study Ended|1|||
44509042|NCT03194464|79514272|FG000|Overall Study|data not usable|2|||
44509043|NCT03192904|79514280|FG000|Overall Study|Physician Decision|3|||
44121055|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
44121056|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
44121057|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
44121058|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
44121059|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
44121060|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
44121061|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
44509044|NCT03192904|79514281|FG001|Overall Study|Physician Decision|1|||
44509045|NCT03192904|79514280|FG000|Overall Study|Lost to Follow-up|0|||
44121062|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
44121063|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
44121064|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
44121065|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
44121066|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
44121067|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
44121068|NCT02510014|78905109|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
44121069|NCT02510014|78905110|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
44121070|NCT02510014|78905109|FG000|Treatment Period|Adverse Event|11|||
44121071|NCT02510014|78905110|FG001|Treatment Period|Adverse Event|4|||
44121072|NCT02510014|78905109|FG000|Treatment Period|Withdrawal symptoms|3|||
44121073|NCT02510014|78905110|FG001|Treatment Period|Withdrawal symptoms|0|||
44121074|NCT02510014|78905109|FG000|Treatment Period|Lost to Follow-up|80|||
44121075|NCT02510014|78905110|FG001|Treatment Period|Lost to Follow-up|19|||
44121076|NCT02510014|78905109|FG000|Treatment Period|Physician Decision|5|||
44121077|NCT02510014|78905110|FG001|Treatment Period|Physician Decision|0|||
44121078|NCT02510014|78905109|FG000|Treatment Period|Withdrawal by Subject|67|||
44121079|NCT02510014|78905110|FG001|Treatment Period|Withdrawal by Subject|24|||
44121080|NCT02510014|78905109|FG000|Treatment Period|Withdrawn by the investigator|7|||
44121081|NCT02510014|78905110|FG001|Treatment Period|Withdrawn by the investigator|1|||
44121082|NCT02510014|78905109|FG000|Treatment Period|Protocol Violation|4|||
44121083|NCT02510014|78905110|FG001|Treatment Period|Protocol Violation|4|||
44121084|NCT02510014|78905109|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
44121085|NCT02510014|78905110|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
44121086|NCT02509312|78905118|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
44121087|NCT02509312|78905119|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
44121088|NCT02509312|78905118|FG000|Overall Study|Obstetrician refusal|0|||
44121089|NCT02509312|78905119|FG001|Overall Study|Obstetrician refusal|1|||
44121090|NCT02509312|78905118|FG000|Overall Study|Patient elected for TOLAC|1|||
44121091|NCT02509312|78905119|FG001|Overall Study|Patient elected for TOLAC|0|||
44121092|NCT02509312|78905118|FG000|Overall Study|Cesarean deemed stat|1|||
44121093|NCT02509312|78905119|FG001|Overall Study|Cesarean deemed stat|0|||
44121094|NCT02509312|78905118|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
44121095|NCT02509312|78905119|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
44121096|NCT02509156|78905129|FG000|Randomized Phase|Death|1|||
44121097|NCT02509156|78905130|FG001|Randomized Phase|Death|0|||
44121098|NCT02509156|78905129|FG000|Randomized Phase|Withdrawal by Subject|1|||
44121099|NCT02509156|78905130|FG001|Randomized Phase|Withdrawal by Subject|1|||
44121100|NCT01654666|78905139|FG000|Overall Study|Protocol Violation|7|||
44121101|NCT01654666|78905140|FG001|Overall Study|Protocol Violation|4|||
44121102|NCT01654666|78905141|FG002|Overall Study|Protocol Violation|8|||
44121103|NCT01654666|78905139|FG000|Overall Study|Lost to Follow-up|4|||
44121104|NCT01654666|78905140|FG001|Overall Study|Lost to Follow-up|5|||
44121105|NCT01654666|78905141|FG002|Overall Study|Lost to Follow-up|5|||
44121106|NCT01654666|78905139|FG000|Overall Study|Withdrawal by Subject|4|||
44121107|NCT01654666|78905140|FG001|Overall Study|Withdrawal by Subject|4|||
44121108|NCT01654666|78905141|FG002|Overall Study|Withdrawal by Subject|1|||
44121109|NCT02519842|78905151|FG000|Base Study: Cycle 1|Screening Failure|1|||
44121110|NCT02519842|78905152|FG001|Base Study: Cycle 1|Screening Failure|1|||
44121111|NCT02519842|78905153|FG002|Base Study: Cycle 1|Screening Failure|0|||
44121112|NCT02519842|78905151|FG000|Base Study: Cycle 1|Adverse Event|1|||
44121113|NCT02519842|78905152|FG001|Base Study: Cycle 1|Adverse Event|0|||
44121114|NCT02519842|78905153|FG002|Base Study: Cycle 1|Adverse Event|0|||
44121115|NCT02519842|78905151|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
44121116|NCT02519842|78905152|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
44121117|NCT02519842|78905153|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
44121118|NCT02519842|78905151|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
44240326|NCT01520909|79067518|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
44121119|NCT02519842|78905152|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
44121120|NCT02519842|78905153|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
44240327|NCT01520909|79067516|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
44121121|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
44121122|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
44121123|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
44509046|NCT03192904|79514281|FG001|Overall Study|Lost to Follow-up|1|||
44509047|NCT03188536|79514287|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
44509048|NCT03188536|79514287|FG000|Overall Study|Not participated/met inclusion criteria|1|||
44509049|NCT03187756|79514291|FG000|Overall Study|Termination of study|4|||
44509050|NCT03187132|79514297|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
44509051|NCT03187132|79514298|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
44509052|NCT03187132|79514297|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
44509053|NCT03187132|79514298|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
44121124|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
44121125|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
44121126|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
44121127|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44121128|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
44121129|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
44121130|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
44121131|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
44121132|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
44121133|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Death|0|||
44121134|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Death|0|||
44121135|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Death|1|||
44121136|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
44121137|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
44121138|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
44121139|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
44121140|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
44121141|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
44121142|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
44121143|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
44121144|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
44121145|NCT02519842|78905151|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
44121146|NCT02519842|78905152|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
44121147|NCT02519842|78905153|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
44121148|NCT02509078|78905163|FG000|Overall Study|Protocol Violation|1|||
44121149|NCT02509078|78905164|FG001|Overall Study|Protocol Violation|1|||
44121150|NCT02993783|78905174|FG000|Overall Study|Reason not Specified|6|||
44121151|NCT02993783|78905175|FG001|Overall Study|Reason not Specified|9|||
44121152|NCT02993471|78905181|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
44121153|NCT02993471|78905181|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
44121154|NCT02988713|78905203|FG000|Overall Study|Withdrawal by Subject|1|||
44121155|NCT02988713|78905203|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
44121156|NCT01068743|78905207|FG000|Period 3|Adverse Event|0|||
44121157|NCT01068743|78905208|FG001|Period 3|Adverse Event|1|||
44121158|NCT01068743|78905209|FG002|Period 3|Adverse Event|0|||
44121159|NCT01068743|78905210|FG003|Period 3|Adverse Event|0|||
44121160|NCT02992691|78905223|FG000|Overall Study|Adverse Event|2|||
44121161|NCT02992691|78905223|FG000|Overall Study|Withdrawal by Subject|1|||
44121162|NCT02921087|78905240|FG000|Overall Study|Withdrawal by Subject|0|||
44121163|NCT02921087|78905241|FG001|Overall Study|Withdrawal by Subject|1|||
44240328|NCT01520909|79067517|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
44240329|NCT01520909|79067518|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
44240330|NCT01520363|79067540|FG000|Overall Study|Withdrawal by Subject|2|||
44240331|NCT01520363|79067541|FG001|Overall Study|Withdrawal by Subject|0|||
44240332|NCT01578499|79067573|FG000|Overall Study|Reason not Specified|0|||
44240333|NCT01578499|79067574|FG001|Overall Study|Reason not Specified|1|||
44121164|NCT02907619|78905260|FG000|Overall Study|Study terminated by sponsor|18|||
44121165|NCT02907619|78905261|FG001|Overall Study|Study terminated by sponsor|18|||
44240334|NCT01578499|79067573|FG000|Overall Study|Lost to Follow-up|2|||
44240335|NCT01578499|79067574|FG001|Overall Study|Lost to Follow-up|1|||
44240336|NCT01578499|79067573|FG000|Overall Study|Withdrawal by Subject|10|||
44240337|NCT01578499|79067574|FG001|Overall Study|Withdrawal by Subject|16|||
44240338|NCT01578499|79067573|FG000|Overall Study|Death|20|||
44240339|NCT01578499|79067574|FG001|Overall Study|Death|25|||
44240340|NCT01578499|79067573|FG000|Overall Study|Died and End of Study Page not Completed|2|||
44240341|NCT01578499|79067574|FG001|Overall Study|Died and End of Study Page not Completed|0|||
44240342|NCT01578187|79067584|FG000|Usability Phase|Withdrawal by Subject|1|||
44240343|NCT01561963|79067590|FG000|Overall Study|Adverse Event|1|||
44240344|NCT01576783|79067601|FG000|Overall Study|Change in Medical Care|1|||
44240345|NCT01576783|79067602|FG001|Overall Study|Change in Medical Care|0|||
44240346|NCT01576783|79067601|FG000|Overall Study|Lost to Follow-up|14|||
44276365|NCT02156076|79230903|FG001|Treatment Period|Poor/non-compliance|1|||
44240347|NCT01576783|79067602|FG001|Overall Study|Lost to Follow-up|16|||
44240348|NCT01576783|79067601|FG000|Overall Study|Withdrawal by Subject|5|||
44240349|NCT01576783|79067602|FG001|Overall Study|Withdrawal by Subject|1|||
44240350|NCT01534351|79067611|FG000|Overall Study|Study Terminated Early|1|||
44240351|NCT01534351|79067612|FG001|Overall Study|Study Terminated Early|0|||
44240352|NCT01534351|79067613|FG002|Overall Study|Study Terminated Early|0|||
44240353|NCT01534273|79067625|FG000|Period 1|Physician Decision|0|||
44240354|NCT01534273|79067626|FG001|Period 1|Physician Decision|0|||
44240355|NCT01534273|79067627|FG002|Period 1|Physician Decision|0|||
44240356|NCT01534273|79067628|FG003|Period 1|Physician Decision|1|||
44240357|NCT01534273|79067629|FG004|Period 1|Physician Decision|0|||
44240358|NCT01534273|79067630|FG005|Period 1|Physician Decision|0|||
44240359|NCT01534273|79067631|FG006|Period 1|Physician Decision|0|||
44240360|NCT01534195|79067654|FG000|Overall Study|Withdrawal by Subject|1|||
44240361|NCT01534195|79067655|FG001|Overall Study|Withdrawal by Subject|1|||
44240362|NCT01560949|79067661|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
44240363|NCT01560949|79067661|FG000|Surgery Phase|Physician Decision|3|||
44240364|NCT01372878|79067669|FG000|Overall Study|Withdrawal by Subject|63|||
44240365|NCT01372878|79067669|FG000|Overall Study|Protocol Violation|17|||
44240366|NCT01372878|79067669|FG000|Overall Study|incomplete study procedure|104|||
44240367|NCT01533493|79067675|FG000|Overall Study|Adverse Event|2|||
44240368|NCT01533493|79067676|FG001|Overall Study|Adverse Event|1|||
44240369|NCT01533493|79067675|FG000|Overall Study|Withdrawal by Subject|1|||
44240370|NCT01533493|79067676|FG001|Overall Study|Withdrawal by Subject|2|||
44240371|NCT01533493|79067675|FG000|Overall Study|Lost to Follow-up|2|||
44240372|NCT01533493|79067676|FG001|Overall Study|Lost to Follow-up|0|||
44240373|NCT01533181|79067752|FG000|Overall Study|Disease progression pre-active treatment|0|||
44240374|NCT01533181|79067753|FG001|Overall Study|Disease progression pre-active treatment|1|||
44240375|NCT01533181|79067752|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
44240376|NCT01533181|79067753|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
44121166|NCT02907619|78905262|FG002|Overall Study|Study terminated by sponsor|19|||
44121167|NCT02907619|78905260|FG000|Overall Study|Death|0|||
44121168|NCT02907619|78905261|FG001|Overall Study|Death|0|||
44121169|NCT02907619|78905262|FG002|Overall Study|Death|1|||
44121170|NCT02907619|78905260|FG000|Overall Study|Withdrawal by Subject|1|||
44121171|NCT02907619|78905261|FG001|Overall Study|Withdrawal by Subject|1|||
44121172|NCT02907619|78905262|FG002|Overall Study|Withdrawal by Subject|0|||
44121173|NCT02907619|78905260|FG000|Overall Study|Other|0|||
44121174|NCT02907619|78905261|FG001|Overall Study|Other|1|||
44121175|NCT02907619|78905262|FG002|Overall Study|Other|0|||
44121176|NCT02986373|78905272|FG000|Overall Study|Adverse Event|4|||
44121177|NCT02986373|78905272|FG000|Overall Study|Lost to Follow-up|1|||
44121178|NCT02986373|78905272|FG000|Overall Study|Withdrawal by Subject|10|||
44240377|NCT02669082|79067759|FG000|Overall Study|Adverse Event|1|||
44240378|NCT02668692|79067823|FG000|Overall Study|Adverse Event|1|||
44240379|NCT02668692|79067824|FG001|Overall Study|Adverse Event|0|||
44240380|NCT02662764|79067838|FG000|Overall Study|Adverse Event|6|||
44240381|NCT02662764|79067838|FG000|Overall Study|Lack of Efficacy|8|||
44240382|NCT02662764|79067838|FG000|Overall Study|Protocol Violation|1|||
44240383|NCT02662764|79067838|FG000|Overall Study|Withdrawal by Subject|5|||
44240384|NCT02662764|79067838|FG000|Overall Study|Device failure|4|||
44240385|NCT02662764|79067838|FG000|Overall Study|Patient changed treatment|1|||
44240386|NCT02662764|79067838|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
44240387|NCT01519817|79067847|FG000|Overall Study|Withdrawal by Subject|1|||
44509054|NCT03187132|79514297|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
44509055|NCT03187132|79514298|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
44509056|NCT03187132|79514297|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
44509057|NCT03187132|79514298|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
44509058|NCT03187132|79514297|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
44509059|NCT03187132|79514298|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
44509060|NCT03187132|79514297|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
44509061|NCT03187132|79514298|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
44509062|NCT03187132|79514297|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
44509063|NCT03187132|79514298|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
44240388|NCT01519817|79067848|FG001|Overall Study|Withdrawal by Subject|0|||
44240389|NCT01519817|79067849|FG002|Overall Study|Withdrawal by Subject|0|||
44276366|NCT02156076|79230904|FG002|Treatment Period|Poor/non-compliance|0|||
44509064|NCT03187132|79514297|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
44121179|NCT02986373|78905272|FG000|Overall Study|Other|24|||
44121180|NCT02986139|78905278|FG000|Overall Study|Sponsor Decision|1|||
44121181|NCT02986139|78905279|FG001|Overall Study|Sponsor Decision|2|||
44121182|NCT02986139|78905278|FG000|Overall Study|Withdrawal by Subject|0|||
44240390|NCT01519817|79067850|FG003|Overall Study|Withdrawal by Subject|0|||
44240391|NCT01519817|79067847|FG000|Overall Study|Off study due to infection|0|||
44240392|NCT01519817|79067848|FG001|Overall Study|Off study due to infection|0|||
44240393|NCT01519817|79067849|FG002|Overall Study|Off study due to infection|0|||
44240394|NCT01519817|79067850|FG003|Overall Study|Off study due to infection|1|||
44240395|NCT01519661|79067860|FG000|Overall Study|Protocol deviation|6|||
44240396|NCT01519661|79067860|FG000|Overall Study|Lost to Follow-up|3|||
44509065|NCT03187132|79514298|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
44509066|NCT03187132|79514297|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
44509067|NCT03187132|79514298|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
44509068|NCT03187132|79514297|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
44509069|NCT03187132|79514298|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
44509070|NCT03187132|79514297|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
44509071|NCT03187132|79514298|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
44509072|NCT03184558|79514304|FG000|Overall Study|Withdrawal by Subject|2|||
44509073|NCT03184558|79514304|FG000|Overall Study|Death|16|||
44509074|NCT03184558|79514304|FG000|Overall Study|Lost to Follow-up|2|||
44509075|NCT03184558|79514304|FG000|Overall Study|Other|9|||
44509076|NCT03183778|79514308|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
44509077|NCT03182686|79514314|FG000|Overall Study|Lost to Follow-up|2|||
44509078|NCT03182686|79514315|FG001|Overall Study|Lost to Follow-up|0|||
44509079|NCT03182686|79514314|FG000|Overall Study|Adverse Event|2|||
44509080|NCT03182686|79514315|FG001|Overall Study|Adverse Event|0|||
44509081|NCT03182686|79514314|FG000|Overall Study|Withdrawal by Subject|3|||
44509082|NCT03182686|79514315|FG001|Overall Study|Withdrawal by Subject|0|||
44509083|NCT03181594|79514321|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
44509084|NCT03181594|79514321|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
44240397|NCT01519661|79067860|FG000|Overall Study|Withdrawal by Subject|17|||
44240398|NCT01519661|79067860|FG000|Overall Study|Lack of Efficacy|6|||
44240399|NCT01519661|79067860|FG000|Overall Study|Adverse Event|29|||
44240400|NCT01519427|79067865|FG000|Overall Study|disease progression|2|||
44240401|NCT01518257|79067871|FG000|Overall Study|Lost to Follow-up|1|||
44240402|NCT01518257|79067872|FG001|Overall Study|Lost to Follow-up|0|||
44240403|NCT01518257|79067871|FG000|Overall Study|Other Miscellaneous Reason|1|||
44240404|NCT01518257|79067872|FG001|Overall Study|Other Miscellaneous Reason|0|||
44240405|NCT02668302|79067880|FG000|Overall Study|Withdrawal by Subject|1|||
44240406|NCT02668302|79067881|FG001|Overall Study|Withdrawal by Subject|0|||
44240407|NCT01517867|79067889|FG000|Overall Study|never started treatment|29|||
44240408|NCT01517867|79067890|FG001|Overall Study|never started treatment|32|||
44240409|NCT01517867|79067889|FG000|Overall Study|Withdrawal by Subject|34|||
44240410|NCT01517867|79067890|FG001|Overall Study|Withdrawal by Subject|30|||
44240411|NCT01517867|79067889|FG000|Overall Study|Still in treatment at study end|0|||
44240412|NCT01517867|79067890|FG001|Overall Study|Still in treatment at study end|3|||
44240413|NCT01514357|79067898|FG000|Overall Study|Screen failure|2|||
44240414|NCT01514357|79067899|FG001|Overall Study|Screen failure|0|||
44240415|NCT01514357|79067898|FG000|Overall Study|Withdrawal by Subject|2|||
44240416|NCT01514357|79067899|FG001|Overall Study|Withdrawal by Subject|0|||
44509085|NCT03181594|79514321|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
44509086|NCT03181594|79514321|FG000|Initial Study Protocol (12-month FU)|Death|1|||
44240417|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
44240418|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
44240419|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
44240420|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
44509087|NCT03181594|79514321|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
44509088|NCT03181594|79514321|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
44121183|NCT02986139|78905279|FG001|Overall Study|Withdrawal by Subject|1|||
44121184|NCT02986139|78905278|FG000|Overall Study|Lost to Follow-up|0|||
44121185|NCT02986139|78905279|FG001|Overall Study|Lost to Follow-up|1|||
44121186|NCT02989805|78905291|FG000|Overall Study|invalid consent|6|||
44121187|NCT02989805|78905292|FG001|Overall Study|invalid consent|4|||
44121188|NCT02907463|78905298|FG000|Overall Study|Lost to Follow-up|17|||
44121189|NCT02907463|78905298|FG000|Overall Study|Death|10|||
44121190|NCT02907463|78905298|FG000|Overall Study|Withdrawal by Subject|4|||
44121191|NCT02907463|78905298|FG000|Overall Study|MIS Approach was not used|2|||
44121192|NCT02907463|78905298|FG000|Overall Study|Not Implanted with Study Device|2|||
44121193|NCT02907463|78905298|FG000|Overall Study|Device Explanted|1|||
44121194|NCT02907463|78905298|FG000|Overall Study|Missing Exit Form|1|||
44121195|NCT02906917|78905312|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
44121196|NCT02906917|78905313|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
44121197|NCT02906917|78905312|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
44121198|NCT02906917|78905313|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
44121199|NCT02906917|78905312|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
44121200|NCT02906917|78905313|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
44121201|NCT02906917|78905312|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
44121202|NCT02906917|78905313|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
44121203|NCT02906917|78905312|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
44121204|NCT02906917|78905313|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
44121205|NCT02906917|78905312|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
44121206|NCT02906917|78905313|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
44121207|NCT02906917|78905312|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
44121208|NCT02906917|78905313|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
44121209|NCT02906917|78905312|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
44121210|NCT02906917|78905313|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
44121211|NCT02982187|78905321|FG000|Overall Study|Withdrawal by Subject|0|||
44121212|NCT02982187|78905322|FG001|Overall Study|Withdrawal by Subject|0|||
44121213|NCT02982187|78905323|FG002|Overall Study|Withdrawal by Subject|0|||
44121214|NCT02982187|78905324|FG003|Overall Study|Withdrawal by Subject|0|||
44121215|NCT02982187|78905325|FG004|Overall Study|Withdrawal by Subject|0|||
44121216|NCT02982187|78905326|FG005|Overall Study|Withdrawal by Subject|0|||
44121217|NCT02982187|78905327|FG006|Overall Study|Withdrawal by Subject|1|||
44121218|NCT02982187|78905328|FG007|Overall Study|Withdrawal by Subject|0|||
44121219|NCT02981953|78905338|FG000|Overall Study|Death|9|||
44121220|NCT02981953|78905338|FG000|Overall Study|Withdrawal by Subject|1|||
44121221|NCT02981953|78905338|FG000|Overall Study|Withdrawal to non-compliance|1|||
44276367|NCT02156076|79230905|FG003|Treatment Period|Poor/non-compliance|0|||
44509089|NCT03180736|79514327|FG000|Overall Study|Adverse Event|3|||
44276368|NCT02156076|79230902|FG000|Treatment Period|Lost to Follow-up|0|||
44509090|NCT03180736|79514328|FG001|Overall Study|Adverse Event|4|||
44509091|NCT03180736|79514327|FG000|Overall Study|Death|10|||
44509092|NCT03180736|79514328|FG001|Overall Study|Death|7|||
44509093|NCT03180736|79514327|FG000|Overall Study|Withdrawal by Subject|5|||
44509094|NCT03180736|79514328|FG001|Overall Study|Withdrawal by Subject|12|||
44509095|NCT03180736|79514327|FG000|Overall Study|Lost to Follow-up|1|||
44276369|NCT02156076|79230903|FG001|Treatment Period|Lost to Follow-up|0|||
44276370|NCT02156076|79230904|FG002|Treatment Period|Lost to Follow-up|0|||
44276371|NCT02156076|79230905|FG003|Treatment Period|Lost to Follow-up|1|||
44509096|NCT03180736|79514328|FG001|Overall Study|Lost to Follow-up|0|||
44121222|NCT01066585|78905354|FG000|Overall Study|Protocol Violation|1|||
44121223|NCT01066585|78905355|FG001|Overall Study|Protocol Violation|0|||
44121224|NCT01066585|78905354|FG000|Overall Study|Withdrawal by Subject|0|||
44121225|NCT01066585|78905355|FG001|Overall Study|Withdrawal by Subject|3|||
44121226|NCT02980783|78905361|FG000|Overall Study|Lost to Follow-up|1|||
44121227|NCT02980705|78905367|FG000|Overall Study|Adverse Event|0|||
44509097|NCT03180736|79514327|FG000|Overall Study|Lack of Efficacy|66|||
44509098|NCT03180736|79514328|FG001|Overall Study|Lack of Efficacy|87|||
44121228|NCT02980705|78905368|FG001|Overall Study|Adverse Event|1|||
44121229|NCT02980705|78905367|FG000|Overall Study|Withdrawal by Subject|6|||
44121230|NCT02980705|78905368|FG001|Overall Study|Withdrawal by Subject|9|||
44121231|NCT02980705|78905367|FG000|Overall Study|withdrew participation|0|||
44121232|NCT02980705|78905368|FG001|Overall Study|withdrew participation|1|||
44121233|NCT02980705|78905367|FG000|Overall Study|Lost to Follow-up|2|||
44121234|NCT02980705|78905368|FG001|Overall Study|Lost to Follow-up|0|||
44121235|NCT02989649|78905375|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
44121236|NCT02989649|78905375|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
44121237|NCT02989649|78905375|FG000|Overall Study|Lost For Observation During Study|3|||
44121238|NCT02989649|78905375|FG000|Overall Study|Reason Not Specified|13|||
44121239|NCT02905435|78905379|FG000|Overall Study|Death|2|||
44240421|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
44240422|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
44121240|NCT02905435|78905379|FG000|Overall Study|Physician Decision|1|||
44121241|NCT02905435|78905379|FG000|Overall Study|Lost to Follow-up|4|||
44121242|NCT02978833|78905386|FG000|Overall Study|Study terminated|1|||
44121243|NCT02978833|78905387|FG001|Overall Study|Study terminated|1|||
44121244|NCT01067339|78905396|FG000|Overall Study|Withdrawal by Subject|6|||
44121245|NCT01067339|78905397|FG001|Overall Study|Withdrawal by Subject|5|||
44121246|NCT02573259|78905410|FG000|Overall Study|Death|1|||
44121247|NCT02573259|78905411|FG001|Overall Study|Death|6|||
44121248|NCT02573259|78905412|FG002|Overall Study|Death|5|||
44121249|NCT02573259|78905413|FG003|Overall Study|Death|6|||
44121250|NCT02573259|78905414|FG004|Overall Study|Death|9|||
44121251|NCT02573259|78905415|FG005|Overall Study|Death|32|||
44121252|NCT02573259|78905416|FG006|Overall Study|Death|21|||
44121253|NCT02573259|78905410|FG000|Overall Study|Lost to Follow-up|0|||
44121254|NCT02573259|78905411|FG001|Overall Study|Lost to Follow-up|0|||
44240423|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
44240424|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
44509099|NCT03180736|79514327|FG000|Overall Study|Physician Decision|4|||
44509100|NCT03180736|79514328|FG001|Overall Study|Physician Decision|7|||
44509101|NCT03180736|79514327|FG000|Overall Study|randomized but not treated|2|||
44509102|NCT03180736|79514328|FG001|Overall Study|randomized but not treated|3|||
44509103|NCT03178942|79514341|FG000|Overall Study|Withdrawal by Subject|2|||
44509104|NCT03178942|79514342|FG001|Overall Study|Withdrawal by Subject|0|||
44509105|NCT03178942|79514341|FG000|Overall Study|Lost to Follow-up|1|||
44509106|NCT03178942|79514342|FG001|Overall Study|Lost to Follow-up|2|||
44509107|NCT03175198|79514348|FG000|Overall Study|Adverse Event|480|||
44240425|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
44240426|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
44240427|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
44240428|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
44240429|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
44240430|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
44240431|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
44509108|NCT03175198|79514348|FG000|Overall Study|No actual visit|120|||
44121255|NCT02573259|78905412|FG002|Overall Study|Lost to Follow-up|0|||
44509109|NCT03175198|79514348|FG000|Overall Study|Registration rule not followed|4|||
44509110|NCT03175198|79514348|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
44121256|NCT02573259|78905413|FG003|Overall Study|Lost to Follow-up|0|||
44121257|NCT02573259|78905414|FG004|Overall Study|Lost to Follow-up|0|||
44121258|NCT02573259|78905415|FG005|Overall Study|Lost to Follow-up|2|||
44121259|NCT02573259|78905416|FG006|Overall Study|Lost to Follow-up|1|||
44121260|NCT02573259|78905410|FG000|Overall Study|Participant refused further follow-up|0|||
44121261|NCT02573259|78905411|FG001|Overall Study|Participant refused further follow-up|2|||
44121262|NCT02573259|78905412|FG002|Overall Study|Participant refused further follow-up|1|||
44121263|NCT02573259|78905413|FG003|Overall Study|Participant refused further follow-up|0|||
44121264|NCT02573259|78905414|FG004|Overall Study|Participant refused further follow-up|3|||
44509111|NCT03175198|79514348|FG000|Overall Study|Other personal reason|509|||
44509112|NCT03175198|79514348|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
44509113|NCT03175198|79514348|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
44509114|NCT03175198|79514348|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
44509115|NCT03175198|79514348|FG000|Overall Study|To conduct invasive treatment of operation|53|||
44509116|NCT03175198|79514348|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
44509117|NCT03175120|79514354|FG000|Overall Study|Adverse Event|2|||
44509118|NCT03175120|79514355|FG001|Overall Study|Adverse Event|2|||
44509119|NCT03175120|79514354|FG000|Overall Study|Protocol Violation|5|||
44509120|NCT03175120|79514355|FG001|Overall Study|Protocol Violation|2|||
44509121|NCT03175120|79514354|FG000|Overall Study|Lost to Follow-up|1|||
44509122|NCT03175120|79514355|FG001|Overall Study|Lost to Follow-up|0|||
44509123|NCT03175120|79514354|FG000|Overall Study|Withdrawal by Subject|2|||
44509124|NCT03175120|79514355|FG001|Overall Study|Withdrawal by Subject|5|||
44509125|NCT03175120|79514354|FG000|Overall Study|Other|2|||
44509126|NCT03175120|79514355|FG001|Overall Study|Other|3|||
44509127|NCT03172702|79514361|FG000|Overall Study|Adverse Event|9|||
44509128|NCT03172702|79514361|FG000|Overall Study|Death|2|||
44509129|NCT03172702|79514361|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
44509130|NCT03172702|79514361|FG000|Overall Study|Withdrawal by Subject|5|||
44509131|NCT03172702|79514361|FG000|Overall Study|Other|2|||
44509132|NCT02795182|79514370|FG000|Overall Study|Death|5|||
44509133|NCT02795182|79514371|FG001|Overall Study|Death|4|||
44509134|NCT02795182|79514372|FG002|Overall Study|Death|4|||
44509135|NCT02795182|79514373|FG003|Overall Study|Death|18|||
44509136|NCT02795182|79514370|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
44509137|NCT02795182|79514371|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
44509138|NCT02795182|79514372|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
44509139|NCT02795182|79514373|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
44509140|NCT02795182|79514370|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
44509141|NCT02795182|79514371|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
44509142|NCT02795182|79514372|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
44509143|NCT02795182|79514373|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
44509144|NCT02795182|79514370|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
44509145|NCT02795182|79514371|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
44509146|NCT02795182|79514372|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
44509147|NCT02795182|79514373|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
44509148|NCT02795182|79514370|FG000|Overall Study|Withdrawal by Subject|4|||
44509149|NCT02795182|79514371|FG001|Overall Study|Withdrawal by Subject|0|||
44509150|NCT02795182|79514372|FG002|Overall Study|Withdrawal by Subject|0|||
44509151|NCT02795182|79514373|FG003|Overall Study|Withdrawal by Subject|3|||
44509152|NCT02795182|79514370|FG000|Overall Study|Lost to Follow-up|0|||
44509153|NCT02795182|79514371|FG001|Overall Study|Lost to Follow-up|0|||
44509154|NCT02795182|79514372|FG002|Overall Study|Lost to Follow-up|1|||
44509155|NCT02795182|79514373|FG003|Overall Study|Lost to Follow-up|1|||
44509156|NCT02795182|79514370|FG000|Overall Study|Roll Over to Long Term Extension|3|||
44509157|NCT02795182|79514371|FG001|Overall Study|Roll Over to Long Term Extension|3|||
44509158|NCT02795182|79514372|FG002|Overall Study|Roll Over to Long Term Extension|2|||
44509159|NCT02795182|79514373|FG003|Overall Study|Roll Over to Long Term Extension|5|||
44509160|NCT02795182|79514370|FG000|Overall Study|Progressive Disease|0|||
44509161|NCT02795182|79514371|FG001|Overall Study|Progressive Disease|1|||
44509162|NCT02795182|79514372|FG002|Overall Study|Progressive Disease|0|||
44509163|NCT02795182|79514373|FG003|Overall Study|Progressive Disease|4|||
44509164|NCT02795182|79514370|FG000|Overall Study|Physician Decision|0|||
44509165|NCT02795182|79514371|FG001|Overall Study|Physician Decision|0|||
44509166|NCT02795182|79514372|FG002|Overall Study|Physician Decision|0|||
44509167|NCT02795182|79514373|FG003|Overall Study|Physician Decision|1|||
44121265|NCT02573259|78905415|FG005|Overall Study|Participant refused further follow-up|20|||
44121266|NCT02573259|78905416|FG006|Overall Study|Participant refused further follow-up|7|||
44121267|NCT02573259|78905410|FG000|Overall Study|Other|0|||
44240432|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
44509168|NCT03167242|79514402|FG000|Overall Study|Patient/Guardian Decision|0|||
44509169|NCT03167242|79514403|FG001|Overall Study|Patient/Guardian Decision|1|||
44121268|NCT02573259|78905411|FG001|Overall Study|Other|0|||
44509170|NCT03167242|79514404|FG002|Overall Study|Patient/Guardian Decision|2|||
44509171|NCT03167242|79514405|FG003|Overall Study|Patient/Guardian Decision|1|||
44509172|NCT03167242|79514406|FG004|Overall Study|Patient/Guardian Decision|1|||
44509173|NCT03167242|79514407|FG005|Overall Study|Patient/Guardian Decision|1|||
44509174|NCT03167242|79514408|FG006|Overall Study|Patient/Guardian Decision|0|||
44509175|NCT03167242|79514409|FG007|Overall Study|Patient/Guardian Decision|0|||
44509176|NCT03167242|79514410|FG008|Overall Study|Patient/Guardian Decision|0|||
44509177|NCT03167242|79514411|FG009|Overall Study|Patient/Guardian Decision|0|||
44509178|NCT03167242|79514412|FG010|Overall Study|Patient/Guardian Decision|1|||
44509179|NCT03167242|79514413|FG011|Overall Study|Patient/Guardian Decision|0|||
44509180|NCT03167242|79514402|FG000|Overall Study|Lost to Follow-up|0|||
44509181|NCT03167242|79514403|FG001|Overall Study|Lost to Follow-up|0|||
44509182|NCT03167242|79514404|FG002|Overall Study|Lost to Follow-up|1|||
44509183|NCT03167242|79514405|FG003|Overall Study|Lost to Follow-up|0|||
44509184|NCT03167242|79514406|FG004|Overall Study|Lost to Follow-up|0|||
44509185|NCT03167242|79514407|FG005|Overall Study|Lost to Follow-up|1|||
44509186|NCT03167242|79514408|FG006|Overall Study|Lost to Follow-up|2|||
44509187|NCT03167242|79514409|FG007|Overall Study|Lost to Follow-up|1|||
44509188|NCT03167242|79514410|FG008|Overall Study|Lost to Follow-up|0|||
44509189|NCT03167242|79514411|FG009|Overall Study|Lost to Follow-up|0|||
44509190|NCT03167242|79514412|FG010|Overall Study|Lost to Follow-up|1|||
44509191|NCT03167242|79514413|FG011|Overall Study|Lost to Follow-up|1|||
44509192|NCT03167242|79514402|FG000|Overall Study|Reason not provided|0|||
44509193|NCT03167242|79514403|FG001|Overall Study|Reason not provided|0|||
44509194|NCT03167242|79514404|FG002|Overall Study|Reason not provided|0|||
44509195|NCT03167242|79514405|FG003|Overall Study|Reason not provided|0|||
44509196|NCT03167242|79514406|FG004|Overall Study|Reason not provided|0|||
44509197|NCT03167242|79514407|FG005|Overall Study|Reason not provided|0|||
44509198|NCT03167242|79514408|FG006|Overall Study|Reason not provided|0|||
44509199|NCT03167242|79514409|FG007|Overall Study|Reason not provided|0|||
44509200|NCT03167242|79514410|FG008|Overall Study|Reason not provided|1|||
44509201|NCT03167242|79514411|FG009|Overall Study|Reason not provided|0|||
44509202|NCT03167242|79514412|FG010|Overall Study|Reason not provided|0|||
44509203|NCT03167242|79514413|FG011|Overall Study|Reason not provided|0|||
44509204|NCT03286426|79514449|FG000|Overall Study|Physician Decision|3|||
44509205|NCT02882152|79514468|FG000|Overall Study|Lost to Follow-up|1|||
44121269|NCT02573259|78905412|FG002|Overall Study|Other|0|||
44240433|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
44240434|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
44509206|NCT02882152|79514469|FG001|Overall Study|Lost to Follow-up|0|||
44509207|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
44240435|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
44240436|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
44240437|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
44240438|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
44240439|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
44240440|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
44240441|NCT01532869|79067907|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
44240442|NCT01532869|79067908|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
44240443|NCT01532869|79067907|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
44240444|NCT01532869|79067908|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
44240445|NCT01532869|79067907|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
44240446|NCT01532869|79067908|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
44240447|NCT01532869|79067907|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
44240448|NCT01532869|79067908|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
44240449|NCT01532869|79067907|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
44240450|NCT01532869|79067908|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
44240451|NCT01531387|79067921|FG000|Overall Study|Early termination of study|11|||
44240452|NCT01531387|79067922|FG001|Overall Study|Early termination of study|11|||
44240453|NCT01531153|79067931|FG000|Overall Study|Withdrawal by Subject|10|||
44240454|NCT01531153|79067932|FG001|Overall Study|Withdrawal by Subject|9|||
44240455|NCT01531153|79067933|FG002|Overall Study|Withdrawal by Subject|15|||
44240456|NCT01529749|79067948|FG000|Overall Study|Lost to Follow-up|0|||
44276372|NCT02156076|79230902|FG000|Treatment Period|Withdrawal by Subject|0|||
44509208|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
44509209|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
44276373|NCT02156076|79230903|FG001|Treatment Period|Withdrawal by Subject|0|||
44509210|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
44509211|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Death|58|||
44509212|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Death|65|||
44509213|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Adverse Event|28|||
44509214|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Adverse Event|40|||
44121270|NCT02573259|78905413|FG003|Overall Study|Other|0|||
44121271|NCT02573259|78905414|FG004|Overall Study|Other|1|||
44121272|NCT02573259|78905415|FG005|Overall Study|Other|4|||
44121273|NCT02573259|78905416|FG006|Overall Study|Other|5|||
44121274|NCT02977507|78905453|FG000|Overall Study|Protocol Deviation|1|||
44121275|NCT02977507|78905454|FG001|Overall Study|Protocol Deviation|0|||
44121276|NCT02977507|78905453|FG000|Overall Study|Lost to Follow-up|1|||
44240457|NCT01529749|79067949|FG001|Overall Study|Lost to Follow-up|1|||
44240458|NCT01529749|79067950|FG002|Overall Study|Lost to Follow-up|1|||
44240459|NCT01529749|79067951|FG003|Overall Study|Lost to Follow-up|0|||
44240460|NCT01529749|79067948|FG000|Overall Study|Physician Decision|0|||
44240461|NCT01529749|79067949|FG001|Overall Study|Physician Decision|0|||
44240462|NCT01529749|79067950|FG002|Overall Study|Physician Decision|0|||
44240463|NCT01529749|79067951|FG003|Overall Study|Physician Decision|1|||
44240464|NCT01529749|79067948|FG000|Overall Study|Withdrawal by Subject|0|||
44240465|NCT01529749|79067949|FG001|Overall Study|Withdrawal by Subject|1|||
44240466|NCT01529749|79067950|FG002|Overall Study|Withdrawal by Subject|1|||
44240467|NCT01529749|79067951|FG003|Overall Study|Withdrawal by Subject|0|||
44240468|NCT01529749|79067948|FG000|Overall Study|Protocol Violation|0|||
44240469|NCT01529749|79067949|FG001|Overall Study|Protocol Violation|0|||
44240470|NCT01529749|79067950|FG002|Overall Study|Protocol Violation|0|||
44240471|NCT01529749|79067951|FG003|Overall Study|Protocol Violation|1|||
44240472|NCT01529515|79067963|FG000|TRANSITION PHASE|Adverse Event|16|||
44240473|NCT01529515|79067964|FG001|TRANSITION PHASE|Adverse Event|0|||
44240474|NCT01529515|79067965|FG002|TRANSITION PHASE|Adverse Event|0|||
44240475|NCT01529515|79067966|FG003|TRANSITION PHASE|Adverse Event|0|||
44240476|NCT01529515|79067963|FG000|TRANSITION PHASE|Death|1|||
44240477|NCT01529515|79067964|FG001|TRANSITION PHASE|Death|0|||
44240478|NCT01529515|79067965|FG002|TRANSITION PHASE|Death|0|||
44240479|NCT01529515|79067966|FG003|TRANSITION PHASE|Death|0|||
44240480|NCT01529515|79067963|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
44240481|NCT01529515|79067964|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
44240482|NCT01529515|79067965|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
44240483|NCT01529515|79067966|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
44240484|NCT01529515|79067963|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
44240485|NCT01529515|79067964|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
44240486|NCT01529515|79067965|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
44240487|NCT01529515|79067966|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
44240488|NCT01529515|79067963|FG000|TRANSITION PHASE|Protocol Violation|4|||
44240489|NCT01529515|79067964|FG001|TRANSITION PHASE|Protocol Violation|0|||
44240490|NCT01529515|79067965|FG002|TRANSITION PHASE|Protocol Violation|0|||
44240491|NCT01529515|79067966|FG003|TRANSITION PHASE|Protocol Violation|0|||
44240492|NCT01529515|79067963|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
44240493|NCT01529515|79067964|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
44240494|NCT01529515|79067965|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
44240495|NCT01529515|79067966|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
44240496|NCT01529515|79067963|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
44240497|NCT01529515|79067964|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
44240498|NCT01529515|79067965|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
44240499|NCT01529515|79067966|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
44240500|NCT01529515|79067963|FG000|TRANSITION PHASE|Other|9|||
44240501|NCT01529515|79067964|FG001|TRANSITION PHASE|Other|0|||
44240502|NCT01529515|79067965|FG002|TRANSITION PHASE|Other|0|||
44240503|NCT01529515|79067966|FG003|TRANSITION PHASE|Other|0|||
44240504|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Adverse Event|0|||
44240505|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Adverse Event|10|||
44240506|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Adverse Event|0|||
44240507|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Adverse Event|0|||
44240508|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
44240509|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
44240510|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
44240511|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
44121277|NCT02977507|78905454|FG001|Overall Study|Lost to Follow-up|0|||
44121278|NCT02976103|78905463|FG000|Overall Study|Withdrawal by Subject|1|||
44240512|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
44240513|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
44121279|NCT02976103|78905464|FG001|Overall Study|Withdrawal by Subject|0|||
44240514|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
44121280|NCT02976103|78905463|FG000|Overall Study|Lost to Follow-up|12|||
44121281|NCT02976103|78905464|FG001|Overall Study|Lost to Follow-up|8|||
44240515|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
44240516|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
44240517|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
44240518|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
44240519|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
44240520|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
44240521|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
44240522|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
44240523|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
44240524|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
44240525|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
44240526|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
44240527|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
44240528|NCT01529515|79067963|FG000|MAINTENANCE PHASE|Other|0|||
44240529|NCT01529515|79067964|FG001|MAINTENANCE PHASE|Other|10|||
44240530|NCT01529515|79067965|FG002|MAINTENANCE PHASE|Other|0|||
44240531|NCT01529515|79067966|FG003|MAINTENANCE PHASE|Other|0|||
44240532|NCT01529515|79067963|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
44240533|NCT01529515|79067964|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
44240534|NCT01529515|79067965|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
44240535|NCT01529515|79067966|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
44240536|NCT01529515|79067963|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
44240537|NCT01529515|79067964|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
44240538|NCT01529515|79067965|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
44240539|NCT01529515|79067966|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
44240540|NCT01529515|79067963|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
44240541|NCT01529515|79067964|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
44240542|NCT01529515|79067965|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
44240543|NCT01529515|79067966|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
44240544|NCT01529515|79067963|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
44240545|NCT01529515|79067964|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
44240546|NCT01529515|79067965|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
44240547|NCT01529515|79067966|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
44240548|NCT01529515|79067963|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
44240549|NCT01529515|79067964|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
44240550|NCT01529515|79067965|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
44240551|NCT01529515|79067966|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
44240552|NCT01529515|79067963|FG000|DOUBLE BLIND PHASE|Other|0|||
44240553|NCT01529515|79067964|FG001|DOUBLE BLIND PHASE|Other|0|||
44240554|NCT01529515|79067965|FG002|DOUBLE BLIND PHASE|Other|9|||
44240555|NCT01529515|79067966|FG003|DOUBLE BLIND PHASE|Other|2|||
44240556|NCT01528969|79067975|FG000|Overall Study|absent from the school at baseline|2|||
44240557|NCT01528969|79067976|FG001|Overall Study|absent from the school at baseline|0|||
44240558|NCT01514201|79067986|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
44240559|NCT01514201|79067987|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
44240560|NCT01514201|79067988|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
44240561|NCT01514201|79067989|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
44240562|NCT01514201|79067986|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
44240563|NCT01514201|79067987|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
44240564|NCT01514201|79067988|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
44240565|NCT01514201|79067989|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
44240566|NCT01514201|79067986|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
44240567|NCT01514201|79067987|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
44240568|NCT01514201|79067988|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
44240569|NCT01514201|79067989|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
44240570|NCT01514201|79067986|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
44240571|NCT01514201|79067987|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
44240572|NCT01514201|79067988|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
44240573|NCT01514201|79067989|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
44240574|NCT01514201|79067986|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
44240575|NCT01514201|79067987|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
44240576|NCT01514201|79067988|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
44240577|NCT01514201|79067989|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
44240578|NCT01514201|79067986|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
44240579|NCT01514201|79067987|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
44240580|NCT01514201|79067988|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
44240581|NCT01514201|79067989|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
44276374|NCT02156076|79230904|FG002|Treatment Period|Withdrawal by Subject|1|||
44121282|NCT01066039|78905471|FG000|Overall Study|Adverse Event|6|||
44240582|NCT01514201|79067986|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
44240583|NCT01514201|79067987|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
44240584|NCT01514201|79067988|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
44240585|NCT01514201|79067989|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
44240586|NCT01514201|79067986|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
44240587|NCT01514201|79067987|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
44240588|NCT01514201|79067988|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
44240589|NCT01514201|79067989|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
44240590|NCT01514201|79067986|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
44240591|NCT01514201|79067987|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
44240592|NCT01514201|79067988|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
44240593|NCT01514201|79067989|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
44240594|NCT01514201|79067986|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
44240595|NCT01514201|79067987|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
44240596|NCT01514201|79067988|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
44240597|NCT01514201|79067989|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
44240598|NCT01514201|79067986|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
44240599|NCT01514201|79067987|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
44240600|NCT01514201|79067988|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
44240601|NCT01514201|79067989|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
44240602|NCT01514201|79067986|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
44240603|NCT01514201|79067987|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
44240604|NCT01514201|79067988|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
44240605|NCT01514201|79067989|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
44240606|NCT02666664|79068011|FG000|Overall Study|Physician Decision|0|||
44240607|NCT02666664|79068012|FG001|Overall Study|Physician Decision|1|||
44240608|NCT02666664|79068011|FG000|Overall Study|Protocol Violation|0|||
44240609|NCT02666664|79068012|FG001|Overall Study|Protocol Violation|2|||
44240610|NCT02666664|79068011|FG000|Overall Study|Other|0|||
44240611|NCT02666664|79068012|FG001|Overall Study|Other|1|||
44240612|NCT02666664|79068011|FG000|Overall Study|Adverse Event|12|||
44240613|NCT02666664|79068012|FG001|Overall Study|Adverse Event|37|||
44240614|NCT02666664|79068011|FG000|Overall Study|Withdrawal by participant|23|||
44240615|NCT02666664|79068012|FG001|Overall Study|Withdrawal by participant|40|||
44240616|NCT02666664|79068011|FG000|Overall Study|Sponsor decision|0|||
44240617|NCT02666664|79068012|FG001|Overall Study|Sponsor decision|1|||
44240618|NCT02666664|79068011|FG000|Overall Study|Lost to Follow-up|1|||
44240619|NCT02666664|79068012|FG001|Overall Study|Lost to Follow-up|2|||
44240620|NCT01528735|79068020|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
44240621|NCT01528735|79068021|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
44240622|NCT01528735|79068020|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
44240623|NCT01528735|79068021|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
44240624|NCT02661594|79068033|FG000|Overall Study|Protocol Violation|1|||
44240625|NCT02661594|79068034|FG001|Overall Study|Protocol Violation|0|||
44240626|NCT02661594|79068035|FG002|Overall Study|Protocol Violation|1|||
44240627|NCT02661594|79068036|FG003|Overall Study|Protocol Violation|0|||
44240628|NCT01528345|79068048|FG000|Overall Study|Adverse Event|10|||
44240629|NCT01528345|79068049|FG001|Overall Study|Adverse Event|1|||
44240630|NCT01528345|79068048|FG000|Overall Study|Death|1|||
44240631|NCT01528345|79068049|FG001|Overall Study|Death|1|||
44240632|NCT01528345|79068048|FG000|Overall Study|Non-compliance with study treatment|1|||
44240633|NCT01528345|79068049|FG001|Overall Study|Non-compliance with study treatment|0|||
44240634|NCT01528345|79068048|FG000|Overall Study|Progressive Disease|26|||
44240635|NCT01528345|79068049|FG001|Overall Study|Progressive Disease|40|||
44240636|NCT01528345|79068048|FG000|Overall Study|Study Terminated by Sponsor|4|||
44240637|NCT01528345|79068049|FG001|Overall Study|Study Terminated by Sponsor|8|||
44240638|NCT01528345|79068048|FG000|Overall Study|Subject/Guardian Decision|5|||
44240639|NCT01528345|79068049|FG001|Overall Study|Subject/Guardian Decision|0|||
44240640|NCT01513967|79068063|FG000|Overall Study|Pregnancy|0|||
44240641|NCT01513967|79068064|FG001|Overall Study|Pregnancy|0|||
44509215|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Disease Progression|22|||
44509216|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Disease Progression|35|||
44509217|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Other|25|||
44509218|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Other|33|||
44509219|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
44509220|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
44509221|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Noncompliance|8|||
44509222|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Noncompliance|8|||
44240642|NCT01513967|79068065|FG002|Overall Study|Pregnancy|0|||
44240643|NCT01513967|79068066|FG003|Overall Study|Pregnancy|0|||
44240644|NCT01513967|79068067|FG004|Overall Study|Pregnancy|0|||
44240645|NCT01513967|79068068|FG005|Overall Study|Pregnancy|0|||
44240646|NCT01513967|79068069|FG006|Overall Study|Pregnancy|1|||
44378870|NCT03194646|79384413|FG000|Overall Study|Site terminated by sponsor|0|||
44509223|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
44240647|NCT01513967|79068070|FG007|Overall Study|Pregnancy|0|||
44240648|NCT01513967|79068063|FG000|Overall Study|missed a study visit|0|||
44240649|NCT01513967|79068064|FG001|Overall Study|missed a study visit|0|||
44240650|NCT01513967|79068065|FG002|Overall Study|missed a study visit|0|||
44240651|NCT01513967|79068066|FG003|Overall Study|missed a study visit|0|||
44240652|NCT01513967|79068067|FG004|Overall Study|missed a study visit|0|||
44240653|NCT01513967|79068068|FG005|Overall Study|missed a study visit|0|||
44240654|NCT01513967|79068069|FG006|Overall Study|missed a study visit|1|||
44240655|NCT01513967|79068070|FG007|Overall Study|missed a study visit|0|||
44240656|NCT01513967|79068063|FG000|Overall Study|excluded due to positive drug screen|0|||
44240657|NCT01513967|79068064|FG001|Overall Study|excluded due to positive drug screen|0|||
44240658|NCT01513967|79068065|FG002|Overall Study|excluded due to positive drug screen|0|||
44240659|NCT01513967|79068066|FG003|Overall Study|excluded due to positive drug screen|0|||
44240660|NCT01513967|79068067|FG004|Overall Study|excluded due to positive drug screen|0|||
44240661|NCT01513967|79068068|FG005|Overall Study|excluded due to positive drug screen|0|||
44240662|NCT01513967|79068069|FG006|Overall Study|excluded due to positive drug screen|0|||
44240663|NCT01513967|79068070|FG007|Overall Study|excluded due to positive drug screen|2|||
44240664|NCT01513967|79068063|FG000|Overall Study|Physician Decision|0|||
44240665|NCT01513967|79068064|FG001|Overall Study|Physician Decision|0|||
44240666|NCT01513967|79068065|FG002|Overall Study|Physician Decision|0|||
44240667|NCT01513967|79068066|FG003|Overall Study|Physician Decision|0|||
44240668|NCT01513967|79068067|FG004|Overall Study|Physician Decision|0|||
44240669|NCT01513967|79068068|FG005|Overall Study|Physician Decision|1|||
44240670|NCT01513967|79068069|FG006|Overall Study|Physician Decision|0|||
44240671|NCT01513967|79068070|FG007|Overall Study|Physician Decision|0|||
44240672|NCT01511939|79068114|FG000|Overall Study|Withdrawal by Subject|2|||
44240673|NCT01511939|79068115|FG001|Overall Study|Withdrawal by Subject|1|||
44240674|NCT01511939|79068116|FG002|Overall Study|Withdrawal by Subject|0|||
44240675|NCT01576705|79068128|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
44240676|NCT01576705|79068129|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
44240677|NCT01576705|79068130|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
44240678|NCT01576705|79068131|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
44240679|NCT01576705|79068128|FG000|Overall Study|invalid ICF|0|||
44509224|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
44509225|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
44509226|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
44509227|NCT00286091|79514477|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
44509228|NCT00286091|79514478|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
44509229|NCT00286091|79514477|FG000|Open-label Treatment Phase|Physician Decision|24|||
44509230|NCT00286091|79514478|FG001|Open-label Treatment Phase|Physician Decision|21|||
44509231|NCT00286091|79514477|FG000|Open-label Treatment Phase|Adverse Event|5|||
44509232|NCT00286091|79514478|FG001|Open-label Treatment Phase|Adverse Event|16|||
44509233|NCT00286091|79514477|FG000|Open-label Treatment Phase|Other|11|||
44509234|NCT00286091|79514478|FG001|Open-label Treatment Phase|Other|11|||
44509235|NCT00286091|79514477|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
44509236|NCT00286091|79514478|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
44509237|NCT00286091|79514477|FG000|Open-label Treatment Phase|Death|10|||
44509238|NCT00286091|79514478|FG001|Open-label Treatment Phase|Death|7|||
44509239|NCT00286091|79514477|FG000|Open-label Treatment Phase|Disease Progression|9|||
44509240|NCT00286091|79514478|FG001|Open-label Treatment Phase|Disease Progression|3|||
44509241|NCT00286091|79514477|FG000|Open-label Treatment Phase|Noncompliance|3|||
44509242|NCT00286091|79514478|FG001|Open-label Treatment Phase|Noncompliance|1|||
44509243|NCT00286091|79514477|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
44509244|NCT00286091|79514478|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
44509245|NCT00286091|79514477|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
44509246|NCT00286091|79514478|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
44509247|NCT00286091|79514477|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
44509248|NCT00286091|79514478|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
44509249|NCT00285857|79514486|FG000|Overall Study|Withdrawal by Subject|2|||
44509250|NCT00285857|79514486|FG000|Overall Study|Inadequate initial breast cytology|1|||
44509251|NCT00285857|79514486|FG000|Overall Study|Adverse Event|1|||
44509252|NCT00284141|79514495|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
44509253|NCT00284141|79514495|FG000|Overall Study|Adverse Event|19|||
44509254|NCT00284141|79514495|FG000|Overall Study|Participant's request|9|||
44509255|NCT00284141|79514495|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
44509256|NCT00284141|79514495|FG000|Overall Study|Clinical deterioration / death|2|||
44509257|NCT00284141|79514495|FG000|Overall Study|General decline|1|||
44509258|NCT00284141|79514495|FG000|Overall Study|Pneumonia|1|||
44509259|NCT00284141|79514495|FG000|Overall Study|Did not take study medication|2|||
44240680|NCT01576705|79068129|FG001|Overall Study|invalid ICF|1|||
44240681|NCT01576705|79068130|FG002|Overall Study|invalid ICF|0|||
44240682|NCT01576705|79068131|FG003|Overall Study|invalid ICF|0|||
44240683|NCT02666430|79068143|FG000|Period 1|Lost to Follow-up|1|||
44240684|NCT02666430|79068144|FG001|Period 1|Lost to Follow-up|0|||
44509260|NCT00284141|79514495|FG000|Overall Study|Ongoing treatment|2|||
44509261|NCT00265343|79514503|FG000|Overall Study|Adverse Event|10|||
44121283|NCT01066039|78905471|FG000|Overall Study|Withdrawal by Subject|17|||
44240685|NCT02666430|79068143|FG000|Period 1|Adverse Event|0|||
44240686|NCT02666430|79068144|FG001|Period 1|Adverse Event|1|||
44240687|NCT02666430|79068143|FG000|Period 2|Withdrawal by Subject|1|||
44240688|NCT02666430|79068144|FG001|Period 2|Withdrawal by Subject|4|||
44240689|NCT02666430|79068143|FG000|Period 3|Lost to Follow-up|1|||
44240690|NCT02666430|79068144|FG001|Period 3|Lost to Follow-up|0|||
44240691|NCT01576549|79068150|FG000|Overall Study|Sponsor Decision|2|||
44240692|NCT01576159|79068163|FG000|Overall Study|Withdrawal by Subject|0|||
44240693|NCT01576159|79068164|FG001|Overall Study|Withdrawal by Subject|1|||
44240694|NCT01576159|79068165|FG002|Overall Study|Withdrawal by Subject|0|||
44240695|NCT01576159|79068166|FG003|Overall Study|Withdrawal by Subject|0|||
44240696|NCT01576159|79068163|FG000|Overall Study|Physician Decision|0|||
44240697|NCT01576159|79068164|FG001|Overall Study|Physician Decision|0|||
44121284|NCT01066039|78905471|FG000|Overall Study|Protocol Violation|2|||
44121285|NCT01066039|78905471|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
44121286|NCT01066039|78905471|FG000|Overall Study|Investigator's Request|1|||
44121287|NCT01066039|78905471|FG000|Overall Study|Dropout due to Insulin Administration|1|||
44121288|NCT01066039|78905471|FG000|Overall Study|Additional Antihypertensive Required|4|||
44121289|NCT01066039|78905471|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
44121290|NCT01066039|78905471|FG000|Overall Study|Failure to Control Blood Pressure|1|||
44121291|NCT01066039|78905471|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
44121292|NCT02919995|78905481|FG000|Overall Study|Adverse Event|0|||
44121293|NCT02919995|78905482|FG001|Overall Study|Adverse Event|0|||
44121294|NCT02919995|78905483|FG002|Overall Study|Adverse Event|0|||
44121295|NCT02919995|78905484|FG003|Overall Study|Adverse Event|0|||
44121296|NCT02919995|78905485|FG004|Overall Study|Adverse Event|0|||
44121297|NCT02919995|78905486|FG005|Overall Study|Adverse Event|1|||
44121298|NCT02919761|78905494|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
44121299|NCT02919761|78905495|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
44121300|NCT02919761|78905496|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
44509262|NCT00265343|79514504|FG001|Overall Study|Adverse Event|7|||
44509263|NCT00265343|79514503|FG000|Overall Study|Withdrawal by Subject|3|||
44509264|NCT00265343|79514504|FG001|Overall Study|Withdrawal by Subject|9|||
44509265|NCT00265343|79514503|FG000|Overall Study|Other|8|||
44509266|NCT00265343|79514504|FG001|Overall Study|Other|3|||
44509267|NCT00283595|79514512|FG000|Overall Study|Withdrawal by Subject|1|||
44509268|NCT00283595|79514513|FG001|Overall Study|Withdrawal by Subject|2|||
44509269|NCT00265109|79514519|FG000|Overall Study|Withdrawal by Subject|5|||
44509270|NCT00265109|79514519|FG000|Overall Study|Adverse Event|1|||
44240698|NCT01576159|79068165|FG002|Overall Study|Physician Decision|1|||
44240699|NCT01576159|79068166|FG003|Overall Study|Physician Decision|0|||
44240700|NCT01576159|79068163|FG000|Overall Study|Lost to Follow-up|0|||
44240701|NCT01576159|79068164|FG001|Overall Study|Lost to Follow-up|0|||
44240702|NCT01576159|79068165|FG002|Overall Study|Lost to Follow-up|0|||
44240703|NCT01576159|79068166|FG003|Overall Study|Lost to Follow-up|1|||
44240704|NCT01576159|79068163|FG000|Overall Study|Protocol Violation|1|||
44240705|NCT01576159|79068164|FG001|Overall Study|Protocol Violation|0|||
44240706|NCT01576159|79068165|FG002|Overall Study|Protocol Violation|0|||
44240707|NCT01576159|79068166|FG003|Overall Study|Protocol Violation|0|||
44240708|NCT01510769|79068197|FG000|Overall Study|Adverse Event|7|||
44240709|NCT01510769|79068198|FG001|Overall Study|Adverse Event|6|||
44240710|NCT01510769|79068199|FG002|Overall Study|Adverse Event|4|||
44240711|NCT01510769|79068197|FG000|Overall Study|Gout Flare|0|||
44240712|NCT01510769|79068198|FG001|Overall Study|Gout Flare|3|||
44240713|NCT01510769|79068199|FG002|Overall Study|Gout Flare|1|||
44240714|NCT01510769|79068197|FG000|Overall Study|Protocol Violation|11|||
44240715|NCT01510769|79068198|FG001|Overall Study|Protocol Violation|10|||
44509271|NCT03235024|79514526|FG000|Overall Study|Adverse Event|2|||
44509272|NCT03235024|79514527|FG001|Overall Study|Adverse Event|2|||
44121301|NCT02919761|78905494|FG000|Part 1: Open Label|Adverse Event|1|||
44121302|NCT02919761|78905495|FG001|Part 1: Open Label|Adverse Event|0|||
44509273|NCT03235024|79514526|FG000|Overall Study|Death|1|||
44509274|NCT03235024|79514527|FG001|Overall Study|Death|0|||
44509275|NCT03235024|79514526|FG000|Overall Study|Lost to Follow-up|2|||
44509276|NCT03235024|79514527|FG001|Overall Study|Lost to Follow-up|5|||
44509277|NCT03235024|79514526|FG000|Overall Study|Protocol Violation|1|||
44509278|NCT03235024|79514527|FG001|Overall Study|Protocol Violation|0|||
44509279|NCT03235024|79514526|FG000|Overall Study|Withdrawal by Subject|0|||
44509280|NCT03235024|79514527|FG001|Overall Study|Withdrawal by Subject|3|||
44509281|NCT03233308|79514533|FG000|Overall Study|Adverse Event|1|||
44509282|NCT03233308|79514533|FG000|Overall Study|Protocol Violation|1|||
44240716|NCT01510769|79068199|FG002|Overall Study|Protocol Violation|9|||
44509283|NCT00283439|79514548|FG000|Overall Study|Adverse Event|0|||
44509284|NCT00283439|79514549|FG001|Overall Study|Adverse Event|0|||
44121303|NCT02919761|78905496|FG002|Part 1: Open Label|Adverse Event|0|||
44121304|NCT02919761|78905494|FG000|Part 1: Open Label|Lost to Follow-up|1|||
44121305|NCT02919761|78905495|FG001|Part 1: Open Label|Lost to Follow-up|0|||
44240717|NCT01510769|79068197|FG000|Overall Study|Lost to Follow-up|5|||
44240718|NCT01510769|79068198|FG001|Overall Study|Lost to Follow-up|1|||
44240719|NCT01510769|79068199|FG002|Overall Study|Lost to Follow-up|5|||
44509285|NCT00283439|79514550|FG002|Overall Study|Adverse Event|0|||
44509286|NCT00283439|79514551|FG003|Overall Study|Adverse Event|1|||
44240720|NCT01510769|79068197|FG000|Overall Study|Withdrawal by Subject|3|||
44240721|NCT01510769|79068198|FG001|Overall Study|Withdrawal by Subject|4|||
44240722|NCT01510769|79068199|FG002|Overall Study|Withdrawal by Subject|3|||
44121306|NCT02919761|78905496|FG002|Part 1: Open Label|Lost to Follow-up|0|||
44121307|NCT02919761|78905494|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
44121308|NCT02919761|78905495|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
44121309|NCT02919761|78905496|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
44121310|NCT02919761|78905494|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
44121311|NCT02919761|78905495|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
44121312|NCT02919761|78905496|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
44121313|NCT02919761|78905494|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
44121314|NCT02919761|78905495|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
44121315|NCT02919761|78905496|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
44121316|NCT02919761|78905494|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
44121317|NCT02919761|78905495|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
44121318|NCT02919761|78905496|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
44121319|NCT02919761|78905494|FG000|Part 1: Open Label|Termination by Sponsor|1|||
44121320|NCT02919761|78905495|FG001|Part 1: Open Label|Termination by Sponsor|0|||
44121321|NCT02919761|78905496|FG002|Part 1: Open Label|Termination by Sponsor|0|||
44121322|NCT02919761|78905494|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
44121323|NCT02919761|78905495|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
44121324|NCT02919761|78905496|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
44121325|NCT02919761|78905494|FG000|Part 2: Double-blind|Adverse Event|0|||
44121326|NCT02919761|78905495|FG001|Part 2: Double-blind|Adverse Event|1|||
44121327|NCT02919761|78905496|FG002|Part 2: Double-blind|Adverse Event|0|||
44121328|NCT02919761|78905494|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
44121329|NCT02919761|78905495|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
44121330|NCT02919761|78905496|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
44121331|NCT02919761|78905494|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
44121332|NCT02919761|78905495|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
44121333|NCT02919761|78905496|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
44121334|NCT02919761|78905494|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
44121335|NCT02919761|78905495|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
44121336|NCT02919761|78905496|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
44121337|NCT02919761|78905494|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
44121338|NCT02919761|78905495|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
44121339|NCT02919761|78905496|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
44121340|NCT02919761|78905494|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
44121341|NCT02919761|78905495|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
44121342|NCT02919761|78905496|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
44121343|NCT02919761|78905494|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
44121344|NCT02919761|78905495|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
44121345|NCT02919761|78905496|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
44121346|NCT02910167|78905507|FG000|Overall Study|Adverse Event|1|||
44121347|NCT02910167|78905507|FG000|Overall Study|Lost to Follow-up|18|||
44121348|NCT01067105|78905511|FG000|Overall Study|Adverse Event|14|||
44509287|NCT00283439|79514548|FG000|Overall Study|Death|0|||
44509288|NCT00283439|79514549|FG001|Overall Study|Death|0|||
44509289|NCT00283439|79514550|FG002|Overall Study|Death|1|||
44509290|NCT00283439|79514551|FG003|Overall Study|Death|0|||
44509291|NCT00283439|79514548|FG000|Overall Study|Disease progression|0|||
44509292|NCT00283439|79514549|FG001|Overall Study|Disease progression|1|||
44509293|NCT00283439|79514550|FG002|Overall Study|Disease progression|0|||
44509294|NCT00283439|79514551|FG003|Overall Study|Disease progression|0|||
44509295|NCT00283439|79514548|FG000|Overall Study|Requirement for alternative therapy|1|||
44509296|NCT00283439|79514549|FG001|Overall Study|Requirement for alternative therapy|2|||
44509297|NCT00283439|79514550|FG002|Overall Study|Requirement for alternative therapy|5|||
44509298|NCT00283439|79514551|FG003|Overall Study|Requirement for alternative therapy|2|||
44509299|NCT00283439|79514548|FG000|Overall Study|Stem cell transplant|6|||
44509300|NCT00283439|79514549|FG001|Overall Study|Stem cell transplant|6|||
44509301|NCT00283439|79514550|FG002|Overall Study|Stem cell transplant|4|||
44509302|NCT00283439|79514551|FG003|Overall Study|Stem cell transplant|3|||
44509303|NCT00283439|79514548|FG000|Overall Study|Treatment discontinued|0|||
44509304|NCT00283439|79514549|FG001|Overall Study|Treatment discontinued|2|||
44509305|NCT00283439|79514550|FG002|Overall Study|Treatment discontinued|1|||
44509306|NCT00283439|79514551|FG003|Overall Study|Treatment discontinued|3|||
44509307|NCT00283439|79514548|FG000|Overall Study|Other|1|||
44121349|NCT01067105|78905511|FG000|Overall Study|Protocol Violation|48|||
44121350|NCT01067105|78905511|FG000|Overall Study|Withdrawal by Subject|36|||
44121351|NCT01067105|78905511|FG000|Overall Study|Lost to Follow-up|6|||
44121352|NCT01067105|78905511|FG000|Overall Study|Physician Decision|6|||
44121353|NCT01067105|78905511|FG000|Overall Study|Other|31|||
44509308|NCT00283439|79514549|FG001|Overall Study|Other|0|||
44509309|NCT00283439|79514550|FG002|Overall Study|Other|0|||
44509310|NCT00283439|79514551|FG003|Overall Study|Other|0|||
44509311|NCT03233230|79514565|FG000|Overall Study|Adverse Event|6|||
44509312|NCT03233230|79514566|FG001|Overall Study|Adverse Event|3|||
44121354|NCT02910089|78905521|FG000|Overall Study|Lost insurance eligibility|22|||
44121355|NCT02910089|78905522|FG001|Overall Study|Lost insurance eligibility|16|||
44121356|NCT02985515|78905530|FG000|Olfaction Testing|Lost to Follow-up|0|||
44121357|NCT02985515|78905531|FG001|Olfaction Testing|Lost to Follow-up|5|||
44121358|NCT02985515|78905530|FG000|Olfaction Testing|Protocol Violation|0|||
44121359|NCT02985515|78905531|FG001|Olfaction Testing|Protocol Violation|3|||
44121360|NCT02910011|78905544|FG000|Overall Study|Physician Decision|2|||
44240723|NCT01510769|79068197|FG000|Overall Study|Death|1|||
44121361|NCT02908841|78905552|FG000|Overall Study|Physician Decision|4|||
44121362|NCT02908841|78905553|FG001|Overall Study|Physician Decision|0|||
44121363|NCT02909153|78905564|FG000|Overall Study|Withdrawal by Subject|0|||
44121364|NCT02909153|78905565|FG001|Overall Study|Withdrawal by Subject|1|||
44121365|NCT02909153|78905566|FG002|Overall Study|Withdrawal by Subject|0|||
44121366|NCT02909153|78905567|FG003|Overall Study|Withdrawal by Subject|0|||
44121367|NCT02909153|78905568|FG004|Overall Study|Withdrawal by Subject|0|||
44121368|NCT02908529|78905580|FG000|Overall Study|Lost to Follow-up|0|||
44121369|NCT02908529|78905581|FG001|Overall Study|Lost to Follow-up|2|||
44121370|NCT02984267|78905591|FG000|Overall Study|Protocol Violation|1|||
44121371|NCT02984267|78905592|FG001|Overall Study|Protocol Violation|0|||
44121372|NCT02984267|78905591|FG000|Overall Study|Withdrawal by Subject|0|||
44121373|NCT02984267|78905592|FG001|Overall Study|Withdrawal by Subject|1|||
44121374|NCT02675751|78905598|FG000|Overall Study|Lost to Follow-up|16|||
44121375|NCT02974855|78905615|FG000|Overall Study|Adverse Event|0|||
44121376|NCT02974855|78905616|FG001|Overall Study|Adverse Event|1|||
44121377|NCT02974855|78905617|FG002|Overall Study|Adverse Event|0|||
44121378|NCT02974855|78905618|FG003|Overall Study|Adverse Event|1|||
44121379|NCT00455403|78905643|FG000|Overall Study|Lost to Follow-up|2|||
44121380|NCT00455403|78905644|FG001|Overall Study|Lost to Follow-up|1|||
44121381|NCT00455403|78905643|FG000|Overall Study|Withdrawal by Subject|1|||
44121382|NCT00455403|78905644|FG001|Overall Study|Withdrawal by Subject|3|||
44121383|NCT00455403|78905643|FG000|Overall Study|Protocol Violation|0|||
44121384|NCT00455403|78905644|FG001|Overall Study|Protocol Violation|2|||
44121385|NCT02979613|78905652|FG000|Double-Blind Phase|Withdrew Consent|2|||
44121386|NCT02979613|78905653|FG001|Double-Blind Phase|Withdrew Consent|4|||
44121387|NCT02979613|78905652|FG000|Double-Blind Phase|Pregnancy|2|||
44121388|NCT02979613|78905653|FG001|Double-Blind Phase|Pregnancy|2|||
44121389|NCT02979613|78905652|FG000|Double-Blind Phase|Adverse Event|2|||
44121390|NCT02979613|78905653|FG001|Double-Blind Phase|Adverse Event|0|||
44240724|NCT01510769|79068198|FG001|Overall Study|Death|1|||
44240725|NCT01510769|79068199|FG002|Overall Study|Death|0|||
44240726|NCT01575769|79068207|FG000|Overall Study|Adverse Event|1|||
44240727|NCT01575769|79068207|FG000|Overall Study|Study terminated by sponsor|40|||
44240728|NCT01510145|79068213|FG000|Overall Study|Adverse Event|6|||
44240729|NCT01510145|79068213|FG000|Overall Study|Lost to Follow-up|5|||
44121391|NCT02979613|78905652|FG000|Double-Blind Phase|Lost to Follow-up|1|||
44121392|NCT02979613|78905653|FG001|Double-Blind Phase|Lost to Follow-up|1|||
44121393|NCT02979613|78905652|FG000|Double-Blind Phase|Protocol Violation|1|||
44121394|NCT02979613|78905653|FG001|Double-Blind Phase|Protocol Violation|1|||
44121395|NCT02979613|78905652|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
44121396|NCT02979613|78905653|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
44121397|NCT02979613|78905652|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
44240730|NCT01510145|79068213|FG000|Overall Study|Withdrawal by Subject|6|||
44509313|NCT03233230|79514567|FG002|Overall Study|Adverse Event|6|||
44509314|NCT03233230|79514568|FG003|Overall Study|Adverse Event|3|||
44509315|NCT03233230|79514565|FG000|Overall Study|Protocol Violation|1|||
44509316|NCT03233230|79514566|FG001|Overall Study|Protocol Violation|2|||
44509317|NCT03233230|79514567|FG002|Overall Study|Protocol Violation|1|||
44509318|NCT03233230|79514568|FG003|Overall Study|Protocol Violation|1|||
44509319|NCT03233230|79514565|FG000|Overall Study|Lack of Efficacy|1|||
44509320|NCT03233230|79514566|FG001|Overall Study|Lack of Efficacy|0|||
44509321|NCT03233230|79514567|FG002|Overall Study|Lack of Efficacy|0|||
44509322|NCT03233230|79514568|FG003|Overall Study|Lack of Efficacy|0|||
44121398|NCT02979613|78905653|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
44121399|NCT02979613|78905652|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
44121400|NCT02979613|78905653|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
44121401|NCT02979613|78905652|FG000|Open-Label Extension (OLE) Phase|Death|0|||
44121402|NCT02979613|78905653|FG001|Open-Label Extension (OLE) Phase|Death|1|||
44121403|NCT02979613|78905652|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
44121404|NCT02979613|78905653|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
44121405|NCT01064167|78905663|FG000|Overall Study|Protocol Violation|14|||
44121406|NCT01064167|78905664|FG001|Overall Study|Protocol Violation|15|||
44121407|NCT02974543|78905672|FG000|Overall Study|Withdrawal by Subject|1|||
44240731|NCT01510145|79068213|FG000|Overall Study|Relative reported subject withdrew|1|||
44509323|NCT03233230|79514565|FG000|Overall Study|Other|5|||
44509324|NCT03233230|79514566|FG001|Overall Study|Other|5|||
44240732|NCT01528033|79068219|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
44509325|NCT03233230|79514567|FG002|Overall Study|Other|5|||
44121408|NCT02974543|78905673|FG001|Overall Study|Withdrawal by Subject|0|||
44121409|NCT01064947|78905687|FG000|Overall Study|negative culture|41|||
44121410|NCT02974153|78905698|FG000|Overall Study|Adverse Event|6|||
44121411|NCT02974153|78905699|FG001|Overall Study|Adverse Event|0|||
44121412|NCT02974153|78905700|FG002|Overall Study|Adverse Event|1|||
44121413|NCT02974153|78905698|FG000|Overall Study|Lack of Efficacy|6|||
44121414|NCT02974153|78905699|FG001|Overall Study|Lack of Efficacy|5|||
44121415|NCT02974153|78905700|FG002|Overall Study|Lack of Efficacy|10|||
44121416|NCT02974153|78905698|FG000|Overall Study|Lost to Follow-up|9|||
44121417|NCT02974153|78905699|FG001|Overall Study|Lost to Follow-up|10|||
44121418|NCT02974153|78905700|FG002|Overall Study|Lost to Follow-up|17|||
44121419|NCT02974153|78905698|FG000|Overall Study|Physician Decision|0|||
44121420|NCT02974153|78905699|FG001|Overall Study|Physician Decision|2|||
44121421|NCT02974153|78905700|FG002|Overall Study|Physician Decision|1|||
44240733|NCT01528033|79068220|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
44240734|NCT01528033|79068219|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
44240735|NCT01528033|79068220|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
44240736|NCT01528033|79068219|FG000|Primary Endpoint Assessment ITT|Death|2|||
44240737|NCT01528033|79068220|FG001|Primary Endpoint Assessment ITT|Death|2|||
44240738|NCT01528033|79068219|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
44240739|NCT01528033|79068220|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
44240740|NCT01528033|79068219|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
44240741|NCT01528033|79068220|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
44240742|NCT01528033|79068219|FG000|Follow Up|No data available|46|||
44240743|NCT01528033|79068220|FG001|Follow Up|No data available|44|||
44240744|NCT01560871|79068237|FG000|Overall Study|transportation issues|2|||
44240745|NCT01560871|79068238|FG001|Overall Study|transportation issues|1|||
44240746|NCT01560871|79068237|FG000|Overall Study|relocation|1|||
44240747|NCT01560871|79068238|FG001|Overall Study|relocation|0|||
44240748|NCT01560871|79068237|FG000|Overall Study|readmission to a hospital|2|||
44240749|NCT01560871|79068238|FG001|Overall Study|readmission to a hospital|1|||
44240750|NCT01560871|79068237|FG000|Overall Study|Lost to Follow-up|1|||
44240751|NCT01560871|79068238|FG001|Overall Study|Lost to Follow-up|0|||
44240752|NCT01509053|79068245|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
44240753|NCT01509053|79068245|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
44240754|NCT01509053|79068245|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
44240755|NCT01509053|79068245|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
44240756|NCT01509053|79068245|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
44240757|NCT01509053|79068245|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
44240758|NCT01560403|79068259|FG000|Overall Study|Lost to Follow-up|0|||
44240759|NCT01560403|79068260|FG001|Overall Study|Lost to Follow-up|1|||
44240760|NCT01527487|79068307|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
44240761|NCT01527487|79068308|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
44240762|NCT01527487|79068307|FG000|Overall Study|Disease Progression|4|||
44240763|NCT01527487|79068308|FG001|Overall Study|Disease Progression|1|||
44240764|NCT01527487|79068307|FG000|Overall Study|Adverse Event|1|||
44240765|NCT01527487|79068308|FG001|Overall Study|Adverse Event|1|||
44240766|NCT01527487|79068307|FG000|Overall Study|Death|0|||
44240767|NCT01527487|79068308|FG001|Overall Study|Death|1|||
44240768|NCT01506947|79068319|FG000|Overall Study|Lost to Follow-up|7|||
44240769|NCT01506947|79068319|FG000|Overall Study|Adverse Event|5|||
44240770|NCT01506947|79068319|FG000|Overall Study|Death|1|||
44240771|NCT01506947|79068319|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
44240772|NCT02665338|79068336|FG000|Overall Study|Withdrawal by Subject|0|||
44240773|NCT02665338|79068337|FG001|Overall Study|Withdrawal by Subject|1|||
44240774|NCT01506479|79068346|FG000|Overall Study|Lost to Follow-up|1|||
44240775|NCT01506479|79068347|FG001|Overall Study|Lost to Follow-up|2|||
44240776|NCT01506479|79068348|FG002|Overall Study|Lost to Follow-up|2|||
44240777|NCT01506479|79068346|FG000|Overall Study|Withdrawal by Subject|1|||
44240778|NCT01506479|79068347|FG001|Overall Study|Withdrawal by Subject|2|||
44509326|NCT03233230|79514568|FG003|Overall Study|Other|3|||
44121422|NCT02974153|78905698|FG000|Overall Study|Withdrawal by Subject|9|||
44121423|NCT02974153|78905699|FG001|Overall Study|Withdrawal by Subject|16|||
44240779|NCT01506479|79068348|FG002|Overall Study|Withdrawal by Subject|1|||
44509327|NCT03233230|79514565|FG000|Overall Study|Withdrawal by Subject|2|||
44509328|NCT03233230|79514566|FG001|Overall Study|Withdrawal by Subject|2|||
44509329|NCT03233230|79514567|FG002|Overall Study|Withdrawal by Subject|0|||
44121424|NCT02974153|78905700|FG002|Overall Study|Withdrawal by Subject|11|||
44240780|NCT01506479|79068346|FG000|Overall Study|Missing assessment|1|||
44240781|NCT01506479|79068347|FG001|Overall Study|Missing assessment|0|||
44509330|NCT03233230|79514568|FG003|Overall Study|Withdrawal by Subject|1|||
44240782|NCT01506479|79068348|FG002|Overall Study|Missing assessment|0|||
44240783|NCT01506479|79068346|FG000|Overall Study|Adverse Event|0|||
44240784|NCT01506479|79068347|FG001|Overall Study|Adverse Event|1|||
44240785|NCT01506479|79068348|FG002|Overall Study|Adverse Event|0|||
44509331|NCT03233230|79514565|FG000|Overall Study|Lost to Follow-up|0|||
44240786|NCT01506323|79068372|FG000|Overall Study|Lost to Follow-up|5|||
44240787|NCT01506323|79068373|FG001|Overall Study|Lost to Follow-up|4|||
44240788|NCT01506323|79068372|FG000|Overall Study|Withdrawal by Subject|4|||
44121425|NCT02974153|78905698|FG000|Overall Study|Study Burden|8|||
44121426|NCT02974153|78905699|FG001|Overall Study|Study Burden|7|||
44121427|NCT02974153|78905700|FG002|Overall Study|Study Burden|3|||
44121428|NCT02974153|78905698|FG000|Overall Study|Other|14|||
44121429|NCT02974153|78905699|FG001|Overall Study|Other|8|||
44121430|NCT02974153|78905700|FG002|Overall Study|Other|7|||
44121431|NCT02508532|78905715|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44121432|NCT02508532|78905716|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44121433|NCT02508532|78905717|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44121434|NCT02508532|78905718|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44240789|NCT01506323|79068373|FG001|Overall Study|Withdrawal by Subject|4|||
44240790|NCT01506323|79068372|FG000|Overall Study|Lack of Efficacy|1|||
44240791|NCT01506323|79068373|FG001|Overall Study|Lack of Efficacy|3|||
44378871|NCT03194646|79384414|FG001|Overall Study|Site terminated by sponsor|0|||
44378872|NCT03194646|79384415|FG002|Overall Study|Site terminated by sponsor|2|||
44378873|NCT03194646|79384416|FG003|Overall Study|Site terminated by sponsor|0|||
44378874|NCT03194646|79384413|FG000|Overall Study|Study terminated by sponsor|62|||
44378875|NCT03194646|79384414|FG001|Overall Study|Study terminated by sponsor|61|||
44378876|NCT03194646|79384415|FG002|Overall Study|Study terminated by sponsor|30|||
44378877|NCT03194646|79384416|FG003|Overall Study|Study terminated by sponsor|34|||
44378878|NCT03194646|79384413|FG000|Overall Study|Withdrawal by Subject|75|||
44378879|NCT03194646|79384414|FG001|Overall Study|Withdrawal by Subject|74|||
44378880|NCT03194646|79384415|FG002|Overall Study|Withdrawal by Subject|36|||
44378881|NCT03194646|79384416|FG003|Overall Study|Withdrawal by Subject|131|||
44378882|NCT03194646|79384413|FG000|Overall Study|Missing|1|||
44121435|NCT02508532|78905719|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44378883|NCT03194646|79384414|FG001|Overall Study|Missing|0|||
44378884|NCT03194646|79384415|FG002|Overall Study|Missing|1|||
44240792|NCT01506323|79068372|FG000|Overall Study|Moved out of area|5|||
44240793|NCT01506323|79068373|FG001|Overall Study|Moved out of area|2|||
44378885|NCT03194646|79384416|FG003|Overall Study|Missing|12|||
44121436|NCT02508532|78905720|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44121437|NCT02508532|78905721|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
44121438|NCT02508532|78905722|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44121439|NCT02508532|78905723|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
44121440|NCT02508532|78905715|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121441|NCT02508532|78905716|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121442|NCT02508532|78905717|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121443|NCT02508532|78905718|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121444|NCT02508532|78905719|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121445|NCT02508532|78905720|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121446|NCT02508532|78905721|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121447|NCT02508532|78905722|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
44121448|NCT02508532|78905723|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
44121449|NCT02508532|78905715|FG000|Part 2 - Treatment|Disease Progression|0|||
44121450|NCT02508532|78905716|FG001|Part 2 - Treatment|Disease Progression|0|||
44121451|NCT02508532|78905717|FG002|Part 2 - Treatment|Disease Progression|0|||
44121452|NCT02508532|78905718|FG003|Part 2 - Treatment|Disease Progression|0|||
44121453|NCT02508532|78905719|FG004|Part 2 - Treatment|Disease Progression|0|||
44121454|NCT02508532|78905720|FG005|Part 2 - Treatment|Disease Progression|0|||
44509332|NCT03233230|79514566|FG001|Overall Study|Lost to Follow-up|3|||
44121455|NCT02508532|78905721|FG006|Part 2 - Treatment|Disease Progression|0|||
44121456|NCT02508532|78905722|FG007|Part 2 - Treatment|Disease Progression|0|||
44121457|NCT02508532|78905723|FG008|Part 2 - Treatment|Disease Progression|118|||
44121458|NCT02508532|78905715|FG000|Part 2 - Treatment|Adverse Event|0|||
44121459|NCT02508532|78905716|FG001|Part 2 - Treatment|Adverse Event|0|||
44121460|NCT02508532|78905717|FG002|Part 2 - Treatment|Adverse Event|0|||
44121461|NCT02508532|78905718|FG003|Part 2 - Treatment|Adverse Event|0|||
44121462|NCT02508532|78905719|FG004|Part 2 - Treatment|Adverse Event|0|||
44121463|NCT02508532|78905720|FG005|Part 2 - Treatment|Adverse Event|0|||
44121464|NCT02508532|78905721|FG006|Part 2 - Treatment|Adverse Event|0|||
44121465|NCT02508532|78905722|FG007|Part 2 - Treatment|Adverse Event|0|||
44121466|NCT02508532|78905723|FG008|Part 2 - Treatment|Adverse Event|49|||
44121467|NCT02508532|78905715|FG000|Part 2 - Treatment|Physician Decision|0|||
44121468|NCT02508532|78905716|FG001|Part 2 - Treatment|Physician Decision|0|||
44121469|NCT02508532|78905717|FG002|Part 2 - Treatment|Physician Decision|0|||
44121470|NCT02508532|78905718|FG003|Part 2 - Treatment|Physician Decision|0|||
44240794|NCT01506323|79068372|FG000|Overall Study|Schedule or Transportation conflict|8|||
44509333|NCT03233230|79514567|FG002|Overall Study|Lost to Follow-up|0|||
44509334|NCT03233230|79514568|FG003|Overall Study|Lost to Follow-up|0|||
44509335|NCT00283049|79514581|FG000|Overall Study|Adverse Event|6|||
44509336|NCT00283049|79514582|FG001|Overall Study|Adverse Event|1|||
44509337|NCT00283049|79514583|FG002|Overall Study|Adverse Event|4|||
44509338|NCT00283049|79514581|FG000|Overall Study|Protocol Violation|3|||
44509339|NCT00283049|79514582|FG001|Overall Study|Protocol Violation|0|||
44509340|NCT00283049|79514583|FG002|Overall Study|Protocol Violation|3|||
44509341|NCT00283049|79514581|FG000|Overall Study|Death|1|||
44509342|NCT00283049|79514582|FG001|Overall Study|Death|1|||
44121471|NCT02508532|78905719|FG004|Part 2 - Treatment|Physician Decision|0|||
44121472|NCT02508532|78905720|FG005|Part 2 - Treatment|Physician Decision|0|||
44121473|NCT02508532|78905721|FG006|Part 2 - Treatment|Physician Decision|0|||
44121474|NCT02508532|78905722|FG007|Part 2 - Treatment|Physician Decision|0|||
44121475|NCT02508532|78905723|FG008|Part 2 - Treatment|Physician Decision|12|||
44121476|NCT02508532|78905715|FG000|Part 2 - Treatment|Administrative|0|||
44121477|NCT02508532|78905716|FG001|Part 2 - Treatment|Administrative|0|||
44121478|NCT02508532|78905717|FG002|Part 2 - Treatment|Administrative|0|||
44121479|NCT02508532|78905718|FG003|Part 2 - Treatment|Administrative|0|||
44121480|NCT02508532|78905719|FG004|Part 2 - Treatment|Administrative|0|||
44121481|NCT02508532|78905720|FG005|Part 2 - Treatment|Administrative|0|||
44121482|NCT02508532|78905721|FG006|Part 2 - Treatment|Administrative|0|||
44121483|NCT02508532|78905722|FG007|Part 2 - Treatment|Administrative|0|||
44121484|NCT02508532|78905723|FG008|Part 2 - Treatment|Administrative|3|||
44121485|NCT02508532|78905715|FG000|Part 2 - Treatment|Sponsor Decision|0|||
44121486|NCT02508532|78905716|FG001|Part 2 - Treatment|Sponsor Decision|0|||
44121487|NCT02508532|78905717|FG002|Part 2 - Treatment|Sponsor Decision|0|||
44121488|NCT02508532|78905718|FG003|Part 2 - Treatment|Sponsor Decision|0|||
44121489|NCT02508532|78905719|FG004|Part 2 - Treatment|Sponsor Decision|0|||
44240795|NCT01506323|79068373|FG001|Overall Study|Schedule or Transportation conflict|0|||
44240796|NCT01506323|79068372|FG000|Overall Study|Started another treatment|1|||
44240797|NCT01506323|79068373|FG001|Overall Study|Started another treatment|0|||
44240798|NCT01505387|79068386|FG000|Overall Study|Protocol Violation|1|||
44121490|NCT02508532|78905720|FG005|Part 2 - Treatment|Sponsor Decision|0|||
44121491|NCT02508532|78905721|FG006|Part 2 - Treatment|Sponsor Decision|0|||
44121492|NCT02508532|78905722|FG007|Part 2 - Treatment|Sponsor Decision|0|||
44121493|NCT02508532|78905723|FG008|Part 2 - Treatment|Sponsor Decision|28|||
44121494|NCT02508532|78905715|FG000|Part 2 - Treatment|Death|0|||
44121495|NCT02508532|78905716|FG001|Part 2 - Treatment|Death|0|||
44240799|NCT01505387|79068387|FG001|Overall Study|Protocol Violation|0|||
44240800|NCT01505387|79068386|FG000|Overall Study|Withdrawal by Subject|1|||
44240801|NCT01505387|79068387|FG001|Overall Study|Withdrawal by Subject|1|||
44121496|NCT02508532|78905717|FG002|Part 2 - Treatment|Death|0|||
44121497|NCT02508532|78905718|FG003|Part 2 - Treatment|Death|0|||
44240802|NCT01504841|79068475|FG000|Overall Study|Withdrawal by Subject|1|||
44240803|NCT01504841|79068476|FG001|Overall Study|Withdrawal by Subject|1|||
44240804|NCT01504841|79068477|FG002|Overall Study|Withdrawal by Subject|0|||
44378886|NCT03137303|79384473|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
44378887|NCT03137303|79384474|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
44121498|NCT02508532|78905719|FG004|Part 2 - Treatment|Death|0|||
44121499|NCT02508532|78905720|FG005|Part 2 - Treatment|Death|0|||
44121500|NCT02508532|78905721|FG006|Part 2 - Treatment|Death|0|||
44121501|NCT02508532|78905722|FG007|Part 2 - Treatment|Death|0|||
44121502|NCT02508532|78905723|FG008|Part 2 - Treatment|Death|1|||
44121503|NCT02508532|78905715|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
44240805|NCT01502423|79068490|FG000|Overall Study|Withdrawal by Subject|0|||
44240806|NCT01502423|79068491|FG001|Overall Study|Withdrawal by Subject|1|||
44509343|NCT00283049|79514583|FG002|Overall Study|Death|1|||
44240807|NCT01502033|79068497|FG000|Overall Study|1 participant had scalp discomfort|1|||
44240808|NCT01502033|79068497|FG000|Overall Study|1 participant had worsening depression|1|||
44240809|NCT01502033|79068497|FG000|Overall Study|1 participant went back to school|1|||
44240810|NCT01500629|79068505|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
44240811|NCT01500629|79068506|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
44240812|NCT01500317|79068522|FG000|Overall Study|Withdrawal by Subject|3|||
44240813|NCT01500317|79068523|FG001|Overall Study|Withdrawal by Subject|2|||
44240814|NCT01500317|79068524|FG002|Overall Study|Withdrawal by Subject|0|||
44240815|NCT01500083|79068579|FG000|Overall Study|Adverse Event|4|||
44240816|NCT01500083|79068580|FG001|Overall Study|Adverse Event|17|||
44240817|NCT01500083|79068579|FG000|Overall Study|Death|0|||
44240818|NCT01500083|79068580|FG001|Overall Study|Death|2|||
44240819|NCT01500083|79068579|FG000|Overall Study|Lost to Follow-up|1|||
44240820|NCT01500083|79068580|FG001|Overall Study|Lost to Follow-up|0|||
44240821|NCT01500083|79068579|FG000|Overall Study|Withdrawal of Consent|0|||
44240822|NCT01500083|79068580|FG001|Overall Study|Withdrawal of Consent|1|||
44240823|NCT01500083|79068579|FG000|Overall Study|Disease Progression|2|||
44240824|NCT01500083|79068580|FG001|Overall Study|Disease Progression|10|||
44240825|NCT01500083|79068579|FG000|Overall Study|Investigator Discretion|3|||
44240826|NCT01500083|79068580|FG001|Overall Study|Investigator Discretion|8|||
44240827|NCT01500083|79068579|FG000|Overall Study|Other Reasons|2|||
44240828|NCT01500083|79068580|FG001|Overall Study|Other Reasons|5|||
44240829|NCT01499849|79068610|FG000|Overall Study|Adverse Event|28|||
44240830|NCT01499849|79068611|FG001|Overall Study|Adverse Event|32|||
44240831|NCT01499849|79068610|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
44240832|NCT01499849|79068611|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
44240833|NCT01499849|79068610|FG000|Overall Study|Withdrawal by Subject|43|||
44240834|NCT01499849|79068611|FG001|Overall Study|Withdrawal by Subject|43|||
44240835|NCT01499849|79068610|FG000|Overall Study|Death|5|||
44240836|NCT01499849|79068611|FG001|Overall Study|Death|7|||
44240837|NCT01499849|79068610|FG000|Overall Study|Disease Progression|11|||
44240838|NCT01499849|79068611|FG001|Overall Study|Disease Progression|10|||
44240839|NCT01499849|79068610|FG000|Overall Study|Protocol Violation|11|||
44509344|NCT00283049|79514581|FG000|Overall Study|Lack of Efficacy|0|||
44509345|NCT00283049|79514582|FG001|Overall Study|Lack of Efficacy|1|||
44509346|NCT00283049|79514583|FG002|Overall Study|Lack of Efficacy|1|||
44509347|NCT00283049|79514581|FG000|Overall Study|Lost to Follow-up|4|||
44509348|NCT00283049|79514582|FG001|Overall Study|Lost to Follow-up|2|||
44509349|NCT00283049|79514583|FG002|Overall Study|Lost to Follow-up|5|||
44509350|NCT00283049|79514581|FG000|Overall Study|Withdrawal by Subject|26|||
44509351|NCT00283049|79514582|FG001|Overall Study|Withdrawal by Subject|24|||
44509352|NCT00283049|79514583|FG002|Overall Study|Withdrawal by Subject|19|||
44509353|NCT00283049|79514581|FG000|Overall Study|Discontinuation of Study|18|||
44509354|NCT00283049|79514582|FG001|Overall Study|Discontinuation of Study|16|||
44509355|NCT00283049|79514583|FG002|Overall Study|Discontinuation of Study|20|||
44509356|NCT00283049|79514581|FG000|Overall Study|No longer requires study treatment|0|||
44509357|NCT00283049|79514582|FG001|Overall Study|No longer requires study treatment|0|||
44121504|NCT02508532|78905716|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
44121505|NCT02508532|78905717|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
44240840|NCT01499849|79068611|FG001|Overall Study|Protocol Violation|11|||
44240841|NCT01499849|79068610|FG000|Overall Study|Physician Decision|20|||
44240842|NCT01499849|79068611|FG001|Overall Study|Physician Decision|19|||
44240843|NCT01499849|79068610|FG000|Overall Study|Lack of Efficacy|3|||
44240844|NCT01499849|79068611|FG001|Overall Study|Lack of Efficacy|4|||
44240845|NCT01499849|79068610|FG000|Overall Study|Lost to Follow-up|6|||
44509358|NCT00283049|79514583|FG002|Overall Study|No longer requires study treatment|1|||
44240846|NCT01499849|79068611|FG001|Overall Study|Lost to Follow-up|3|||
44509359|NCT00264875|79514591|FG000|Overall Study|Adverse Event|6|||
44509360|NCT00264875|79514591|FG000|Overall Study|Lost to Follow-up|6|||
44509361|NCT00264875|79514591|FG000|Overall Study|Protocol Violation|11|||
44240847|NCT01499849|79068610|FG000|Overall Study|Other Reasons|27|||
44240848|NCT01499849|79068611|FG001|Overall Study|Other Reasons|30|||
44121506|NCT02508532|78905718|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
44121507|NCT02508532|78905719|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
44121508|NCT02508532|78905720|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
44121509|NCT02508532|78905721|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
44121510|NCT02508532|78905722|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
44121511|NCT02508532|78905723|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
44509362|NCT00264875|79514591|FG000|Overall Study|Withdrawal by Subject|7|||
44509363|NCT03152110|79514595|FG000|Overall Study|Withdrawal by Subject|3|||
44509364|NCT03151408|79514602|FG000|Overall Study|Adverse Event|24|||
44509365|NCT03151408|79514603|FG001|Overall Study|Adverse Event|23|||
44509366|NCT03151408|79514602|FG000|Overall Study|Death|46|||
44509367|NCT03151408|79514603|FG001|Overall Study|Death|26|||
44509368|NCT03151408|79514602|FG000|Overall Study|Physician Decision|13|||
44509369|NCT03151408|79514603|FG001|Overall Study|Physician Decision|19|||
44509370|NCT03151408|79514602|FG000|Overall Study|Withdrawal by Subject|16|||
44509371|NCT03151408|79514603|FG001|Overall Study|Withdrawal by Subject|20|||
44509372|NCT03151408|79514602|FG000|Overall Study|Progressive disease|45|||
44509373|NCT03151408|79514603|FG001|Overall Study|Progressive disease|61|||
44509374|NCT03151408|79514602|FG000|Overall Study|non-compliance by patient|1|||
44509375|NCT03151408|79514603|FG001|Overall Study|non-compliance by patient|0|||
44509376|NCT03151408|79514602|FG000|Overall Study|other reasons|56|||
44509377|NCT03151408|79514603|FG001|Overall Study|other reasons|52|||
44509378|NCT03151408|79514602|FG000|Overall Study|randomized and not treated|2|||
44509379|NCT03151408|79514603|FG001|Overall Study|randomized and not treated|2|||
44509380|NCT00546754|79514611|FG000|Overall Study|Serious Adverse Event|1|||
44509381|NCT00546754|79514612|FG001|Overall Study|Serious Adverse Event|1|||
44509382|NCT00546754|79514611|FG000|Overall Study|Adverse Event|11|||
44509383|NCT00546754|79514612|FG001|Overall Study|Adverse Event|16|||
44509384|NCT00546754|79514611|FG000|Overall Study|Lack of Efficacy|1|||
44509385|NCT00546754|79514612|FG001|Overall Study|Lack of Efficacy|1|||
44509386|NCT00546754|79514611|FG000|Overall Study|Lost to Follow-up|9|||
44509387|NCT00546754|79514612|FG001|Overall Study|Lost to Follow-up|15|||
44121512|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
44121513|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
44121514|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
44121515|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
44121516|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
44121517|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
44509388|NCT00546754|79514611|FG000|Overall Study|Protocol Violation|3|||
44509389|NCT00546754|79514612|FG001|Overall Study|Protocol Violation|0|||
44509390|NCT00546754|79514611|FG000|Overall Study|Withdrawal by Subject|6|||
44509391|NCT00546754|79514612|FG001|Overall Study|Withdrawal by Subject|7|||
44509392|NCT00546754|79514611|FG000|Overall Study|Dyspnea|1|||
44509393|NCT00546754|79514612|FG001|Overall Study|Dyspnea|0|||
44509394|NCT00546754|79514611|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
44509395|NCT00546754|79514612|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
44509396|NCT00546754|79514611|FG000|Overall Study|Hip Replacement|1|||
44509397|NCT00546754|79514612|FG001|Overall Study|Hip Replacement|0|||
44509398|NCT00546754|79514611|FG000|Overall Study|Suicide|1|||
44509399|NCT00546754|79514612|FG001|Overall Study|Suicide|0|||
44509400|NCT00546754|79514611|FG000|Overall Study|Missing Cooperation|1|||
44509401|NCT00546754|79514612|FG001|Overall Study|Missing Cooperation|0|||
44121518|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
44121519|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
44121520|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
44121521|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
44121522|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
44121523|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
44121524|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
44121525|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
44121526|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
44121527|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
44121528|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
44121529|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
44509402|NCT00546754|79514611|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
44509403|NCT00546754|79514612|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
44509404|NCT00546754|79514611|FG000|Overall Study|Patient's Decision|0|||
44121530|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Death|0|||
44121531|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Death|4|||
44121532|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Death|2|||
44121533|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Death|4|||
44121534|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Death|3|||
44121535|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Death|0|||
44121536|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Death|0|||
44121537|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Death|1|||
44121538|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Death|111|||
44121539|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
44121540|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
44121541|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
44121542|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
44121543|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
44121544|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
44121545|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
44121546|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
44121547|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
44121548|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121549|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121550|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121551|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121552|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121553|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121554|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121555|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
44121556|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
44121557|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
44121558|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
44121559|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
44121560|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
44121561|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
44121562|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
44121563|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
44121564|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
44121565|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
44121566|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121567|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121568|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121569|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121570|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121571|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121572|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121573|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
44121574|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
44121575|NCT02508532|78905715|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
44121576|NCT02508532|78905716|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
44121577|NCT02508532|78905717|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
44121578|NCT02508532|78905718|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
44121579|NCT02508532|78905719|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
44121580|NCT02508532|78905720|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
44121581|NCT02508532|78905721|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
44121582|NCT02508532|78905722|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
44121583|NCT02508532|78905723|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
44121584|NCT02918071|78905752|FG000|Overall Study|Withdrawal by Subject|2|||
44509405|NCT00546754|79514612|FG001|Overall Study|Patient's Decision|1|||
44509406|NCT00546754|79514611|FG000|Overall Study|Missing|14|||
44509407|NCT00546754|79514612|FG001|Overall Study|Missing|7|||
44509408|NCT00282347|79514620|FG000|Treatment Period|Death|2|||
44509409|NCT00282347|79514621|FG001|Treatment Period|Death|0|||
44509410|NCT00282347|79514620|FG000|Treatment Period|Lost to Follow-up|2|||
44509411|NCT00282347|79514621|FG001|Treatment Period|Lost to Follow-up|5|||
44509412|NCT00282347|79514620|FG000|Treatment Period|Withdrawal by Subject|1|||
44509413|NCT00282347|79514621|FG001|Treatment Period|Withdrawal by Subject|3|||
44509414|NCT00282347|79514620|FG000|Treatment Period|Physician Decision|0|||
44121585|NCT02918071|78905752|FG000|Overall Study|Lost to Follow-up|1|||
44121586|NCT02507752|78905756|FG000|Overall Study|Adverse Event|1|||
44121587|NCT02507752|78905756|FG000|Overall Study|Protocol Violation|6|||
44121588|NCT02507752|78905756|FG000|Overall Study|Lost to Follow-up|7|||
44121589|NCT02507752|78905756|FG000|Overall Study|Infusion reaction at first infusion|1|||
44121590|NCT02507752|78905756|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
44240849|NCT01499303|79068630|FG000|Overall Study|Ongoing|2|||
44121591|NCT02507752|78905756|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
44121592|NCT02506816|78905760|FG000|Overall Study|Adverse Event|3|||
44121593|NCT02506036|78905766|FG000|First Intervention (4-6 Weeks)|Death|1|||
44121594|NCT02506036|78905767|FG001|First Intervention (4-6 Weeks)|Death|0|||
44121595|NCT02506036|78905766|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
44240850|NCT01499303|79068631|FG001|Overall Study|Ongoing|1|||
44240851|NCT01499303|79068630|FG000|Overall Study|Withdrawal by Subject|0|||
44240852|NCT01499303|79068631|FG001|Overall Study|Withdrawal by Subject|1|||
44240853|NCT01499303|79068630|FG000|Overall Study|Adverse Event|1|||
44240854|NCT01499303|79068631|FG001|Overall Study|Adverse Event|4|||
44240855|NCT01499303|79068630|FG000|Overall Study|Other|0|||
44240856|NCT01499303|79068631|FG001|Overall Study|Other|1|||
44240857|NCT01498679|79068652|FG000|Overall Study|Adverse Event|1|||
44240858|NCT01498679|79068653|FG001|Overall Study|Adverse Event|4|||
44240859|NCT01498679|79068652|FG000|Overall Study|Lack of Efficacy|72|||
44240860|NCT01498679|79068653|FG001|Overall Study|Lack of Efficacy|12|||
44240861|NCT01498679|79068652|FG000|Overall Study|Protocol Violation|4|||
44240862|NCT01498679|79068653|FG001|Overall Study|Protocol Violation|0|||
44240863|NCT01498679|79068652|FG000|Overall Study|Physician Decision|0|||
44378888|NCT03137303|79384473|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
44121596|NCT02506036|78905767|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
44121597|NCT02506036|78905766|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
44121598|NCT02506036|78905767|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
44121599|NCT01063855|78905775|FG000|Overall Study|Adverse Event|4|||
44121600|NCT01063855|78905776|FG001|Overall Study|Adverse Event|4|||
44121601|NCT01063855|78905775|FG000|Overall Study|Death|0|||
44121602|NCT01063855|78905776|FG001|Overall Study|Death|1|||
44121603|NCT01063855|78905775|FG000|Overall Study|Lost to Follow-up|8|||
44121604|NCT01063855|78905776|FG001|Overall Study|Lost to Follow-up|4|||
44240864|NCT01498679|79068653|FG001|Overall Study|Physician Decision|2|||
44240865|NCT01498679|79068652|FG000|Overall Study|Withdrawal by Subject|12|||
44378889|NCT03137303|79384474|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
44378890|NCT03137303|79384473|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
44121605|NCT01063855|78905775|FG000|Overall Study|Pregnancy|1|||
44121606|NCT01063855|78905776|FG001|Overall Study|Pregnancy|0|||
44121607|NCT01063855|78905775|FG000|Overall Study|Lack of Efficacy|0|||
44121608|NCT01063855|78905776|FG001|Overall Study|Lack of Efficacy|1|||
44121609|NCT01063855|78905775|FG000|Overall Study|Withdrawal by Subject|11|||
44121610|NCT01063855|78905776|FG001|Overall Study|Withdrawal by Subject|8|||
44121611|NCT01063855|78905775|FG000|Overall Study|Reason not specified|13|||
44121612|NCT01063855|78905776|FG001|Overall Study|Reason not specified|11|||
44121613|NCT01063153|78905788|FG000|Overall Study|Found Ineligible During Screening|2|||
44121614|NCT01063153|78905789|FG001|Overall Study|Found Ineligible During Screening|0|||
44121615|NCT01063153|78905788|FG000|Overall Study|Lost to Follow-up|0|||
44121616|NCT01063153|78905789|FG001|Overall Study|Lost to Follow-up|7|||
44121617|NCT01063153|78905788|FG000|Overall Study|Withdrawal by Subject|0|||
44121618|NCT01063153|78905789|FG001|Overall Study|Withdrawal by Subject|1|||
44121619|NCT01063153|78905788|FG000|Overall Study|Physician Decision|0|||
44121620|NCT01063153|78905789|FG001|Overall Study|Physician Decision|4|||
44121621|NCT01062841|78905801|FG000|Overall Study|Indwelling Device Removed|41|||
44121622|NCT01062841|78905802|FG001|Overall Study|Indwelling Device Removed|48|||
44121623|NCT01062841|78905801|FG000|Overall Study|Death|3|||
44121624|NCT01062841|78905802|FG001|Overall Study|Death|5|||
44121625|NCT01062841|78905801|FG000|Overall Study|Withdrawal by Subject|2|||
44121626|NCT01062841|78905802|FG001|Overall Study|Withdrawal by Subject|0|||
44121627|NCT01062841|78905801|FG000|Overall Study|Withdrawal by Study|3|||
44121628|NCT01062841|78905802|FG001|Overall Study|Withdrawal by Study|0|||
44121629|NCT02505334|78905810|FG000|Main Treatment Period|Adverse Event|3|||
44121630|NCT02505334|78905811|FG001|Main Treatment Period|Adverse Event|3|||
44240866|NCT01498679|79068653|FG001|Overall Study|Withdrawal by Subject|4|||
44240867|NCT01526785|79068676|FG000|Overall Study|Study Terminated by Sponsor|8|||
44240868|NCT01526785|79068676|FG000|Overall Study|Death|2|||
44240869|NCT01526785|79068676|FG000|Overall Study|Physician Decision|1|||
44121631|NCT02505334|78905810|FG000|Main Treatment Period|Lack of Efficacy|7|||
44121632|NCT02505334|78905811|FG001|Main Treatment Period|Lack of Efficacy|17|||
44121633|NCT02505334|78905810|FG000|Main Treatment Period|Protocol Violation|0|||
44121634|NCT02505334|78905811|FG001|Main Treatment Period|Protocol Violation|1|||
44121635|NCT02505334|78905810|FG000|Main Treatment Period|Withdrawal by Subject|1|||
44121636|NCT02505334|78905811|FG001|Main Treatment Period|Withdrawal by Subject|8|||
44121637|NCT02505334|78905810|FG000|Main Treatment Period|Unclassified|4|||
44240870|NCT01526785|79068676|FG000|Overall Study|Withdrawal by Subject|2|||
44121638|NCT02505334|78905811|FG001|Main Treatment Period|Unclassified|10|||
44121639|NCT02505334|78905810|FG000|Extension Treatment Period|Adverse Event|5|||
44240871|NCT01559389|79068682|FG000|Overall Study|Withdrawal by Subject|20|||
44121640|NCT02505334|78905811|FG001|Extension Treatment Period|Adverse Event|0|||
44121641|NCT02505334|78905810|FG000|Extension Treatment Period|Lack of Efficacy|4|||
44240872|NCT01559389|79068683|FG001|Overall Study|Withdrawal by Subject|20|||
44240873|NCT01526551|79068693|FG000|Overall Study|Lack of returned parental consent form|424|||
44240874|NCT01559311|79068771|FG000|Overall Study|Protocol Violation|0|||
44240875|NCT01559311|79068772|FG001|Overall Study|Protocol Violation|0|||
44240876|NCT01559311|79068773|FG002|Overall Study|Protocol Violation|2|||
44240877|NCT01559311|79068771|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
44240878|NCT01559311|79068772|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
44240879|NCT01559311|79068773|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
44378891|NCT03137303|79384474|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
44378892|NCT03137303|79384473|FG000|T3: 9-month Follow-up|Death|1|||
44121642|NCT02505334|78905811|FG001|Extension Treatment Period|Lack of Efficacy|0|||
44121643|NCT02505334|78905810|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
44509415|NCT00282347|79514621|FG001|Treatment Period|Physician Decision|1|||
44509416|NCT00282347|79514620|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
44509417|NCT00282347|79514621|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
44509418|NCT00282347|79514620|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
44509419|NCT00282347|79514621|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
44509420|NCT00282347|79514620|FG000|Safety Follow-up Period|Physician Decision|1|||
44509421|NCT00282347|79514621|FG001|Safety Follow-up Period|Physician Decision|1|||
44509422|NCT00282347|79514620|FG000|Safety Follow-up Period|Protocol Deviation|0|||
44509423|NCT00282347|79514621|FG001|Safety Follow-up Period|Protocol Deviation|2|||
44121644|NCT02505334|78905811|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
44121645|NCT02505334|78905810|FG000|Extension Treatment Period|Unclassified|3|||
44121646|NCT02505334|78905811|FG001|Extension Treatment Period|Unclassified|0|||
44240880|NCT01559311|79068771|FG000|Overall Study|Withdrawal by Subject|2|||
44509424|NCT00282347|79514620|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
44121647|NCT01062061|78905817|FG000|Overall Study|Enrolled more than once|2|||
44121648|NCT01062061|78905817|FG000|Overall Study|Investigated before study start|13|||
44121649|NCT01062061|78905817|FG000|Overall Study|Outside chief indications|10|||
44121650|NCT01062061|78905817|FG000|Overall Study|Failed to meet inclusion criteria|2|||
44378893|NCT03137303|79384474|FG001|T3: 9-month Follow-up|Death|0|||
44378894|NCT03137303|79384473|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
44378895|NCT03137303|79384474|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
44378896|NCT03137303|79384473|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
44378897|NCT03137303|79384474|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
44378898|NCT03137303|79384473|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
44378899|NCT03137303|79384474|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
44378900|NCT03064126|79384484|FG000|Overall Study|Death|6|||
44378901|NCT03064126|79384485|FG001|Overall Study|Death|2|||
44378902|NCT03064126|79384486|FG002|Overall Study|Death|2|||
44378903|NCT03064126|79384487|FG003|Overall Study|Death|1|||
44378904|NCT03064126|79384484|FG000|Overall Study|Investigator Discretion|1|||
44378905|NCT03064126|79384485|FG001|Overall Study|Investigator Discretion|0|||
44378906|NCT03064126|79384486|FG002|Overall Study|Investigator Discretion|0|||
44240881|NCT01559311|79068772|FG001|Overall Study|Withdrawal by Subject|1|||
44240882|NCT01559311|79068773|FG002|Overall Study|Withdrawal by Subject|0|||
44121651|NCT02504320|78905829|FG000|Treatment Period 1|Positive Drug Screen|0|||
44121652|NCT02504320|78905830|FG001|Treatment Period 1|Positive Drug Screen|0|||
44509425|NCT00282347|79514621|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
44509426|NCT00282347|79514620|FG000|B Cell Follow-up Period|Physician Decision|1|||
44509427|NCT00282347|79514621|FG001|B Cell Follow-up Period|Physician Decision|0|||
44509428|NCT00282347|79514620|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
44121653|NCT02504320|78905831|FG002|Treatment Period 1|Positive Drug Screen|1|||
44121654|NCT02504320|78905832|FG003|Treatment Period 1|Positive Drug Screen|0|||
44121655|NCT02504320|78905829|FG000|Treatment Period 2|Positive Drug Screen|0|||
44121656|NCT02504320|78905830|FG001|Treatment Period 2|Positive Drug Screen|1|||
44121657|NCT02504320|78905831|FG002|Treatment Period 2|Positive Drug Screen|0|||
44121658|NCT02504320|78905832|FG003|Treatment Period 2|Positive Drug Screen|0|||
44121659|NCT02504320|78905829|FG000|Treatment Period 3|Positive Drug Screen|0|||
44121660|NCT02504320|78905830|FG001|Treatment Period 3|Positive Drug Screen|0|||
44121661|NCT02504320|78905831|FG002|Treatment Period 3|Positive Drug Screen|0|||
44121662|NCT02504320|78905832|FG003|Treatment Period 3|Positive Drug Screen|1|||
44121663|NCT02504320|78905829|FG000|Treatment Period 3|Adverse Event|0|||
44121664|NCT02504320|78905830|FG001|Treatment Period 3|Adverse Event|0|||
44121665|NCT02504320|78905831|FG002|Treatment Period 3|Adverse Event|1|||
44121666|NCT02504320|78905832|FG003|Treatment Period 3|Adverse Event|0|||
44121667|NCT01061671|78905844|FG000|Overall Study|Withdrawal by Subject|16|||
44240883|NCT01559311|79068771|FG000|Overall Study|Death|0|||
44240884|NCT01559311|79068772|FG001|Overall Study|Death|2|||
44240885|NCT01559311|79068773|FG002|Overall Study|Death|3|||
44509429|NCT00282347|79514621|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
44509430|NCT00405964|79514631|FG000|Overall Study|Treatment Failure|17|||
44509431|NCT00405964|79514632|FG001|Overall Study|Treatment Failure|45|||
44509432|NCT00405964|79514631|FG000|Overall Study|Adverse Event|7|||
44509433|NCT00405964|79514632|FG001|Overall Study|Adverse Event|16|||
44509434|NCT00405964|79514631|FG000|Overall Study|Lost to Follow-up|5|||
44509435|NCT00405964|79514632|FG001|Overall Study|Lost to Follow-up|5|||
44509436|NCT00405964|79514631|FG000|Overall Study|Withdrawal by Subject|19|||
44509437|NCT00405964|79514632|FG001|Overall Study|Withdrawal by Subject|23|||
44509438|NCT00405964|79514631|FG000|Overall Study|Protocol Violation|11|||
44509439|NCT00405964|79514632|FG001|Overall Study|Protocol Violation|6|||
44509440|NCT00264797|79514640|FG000|Overall Study|Withdrawal by Subject|11|||
44509441|NCT00264797|79514641|FG001|Overall Study|Withdrawal by Subject|11|||
44509442|NCT00264797|79514640|FG000|Overall Study|Lost to Follow-up|9|||
44509443|NCT00264797|79514641|FG001|Overall Study|Lost to Follow-up|17|||
44509444|NCT00264797|79514640|FG000|Overall Study|Moved from area|3|||
44509445|NCT00264797|79514641|FG001|Overall Study|Moved from area|1|||
44378907|NCT03064126|79384487|FG003|Overall Study|Investigator Discretion|0|||
44509446|NCT00264797|79514640|FG000|Overall Study|Practical Problems|2|||
44509447|NCT00264797|79514641|FG001|Overall Study|Practical Problems|3|||
44509448|NCT00264797|79514640|FG000|Overall Study|Incarceration|4|||
44509449|NCT00264797|79514641|FG001|Overall Study|Incarceration|5|||
44121668|NCT01061671|78905845|FG001|Overall Study|Withdrawal by Subject|20|||
44240886|NCT01559311|79068771|FG000|Overall Study|Lost to Follow-up|0|||
44240887|NCT01559311|79068772|FG001|Overall Study|Lost to Follow-up|3|||
44240888|NCT01559311|79068773|FG002|Overall Study|Lost to Follow-up|2|||
44121669|NCT01061671|78905844|FG000|Overall Study|Lost to Follow-up|3|||
44121670|NCT01061671|78905845|FG001|Overall Study|Lost to Follow-up|5|||
44121671|NCT01061671|78905844|FG000|Overall Study|Death|28|||
44121672|NCT01061671|78905845|FG001|Overall Study|Death|30|||
44121673|NCT00709995|78905853|FG000|Overall Study|Adverse Event|4|||
44121674|NCT00709995|78905854|FG001|Overall Study|Adverse Event|2|||
44121675|NCT00709995|78905853|FG000|Overall Study|Withdrawal by Subject|1|||
44121676|NCT00709995|78905854|FG001|Overall Study|Withdrawal by Subject|3|||
44121677|NCT02503540|78905863|FG000|Overall Study|Death|2|||
44121678|NCT02503540|78905863|FG000|Overall Study|Withdrawal by Subject|1|||
44121679|NCT02502526|78905870|FG000|Overall Study|Lost to Follow-up|2|||
44240889|NCT01559311|79068771|FG000|Overall Study|Adverse Event|0|||
44509450|NCT00264797|79514640|FG000|Overall Study|Pressure/advice from Outsiders|1|||
44509451|NCT00264797|79514641|FG001|Overall Study|Pressure/advice from Outsiders|1|||
44509452|NCT00264797|79514640|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
44509453|NCT00264797|79514641|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
44509454|NCT00264797|79514640|FG000|Overall Study|Other|3|||
44509455|NCT00264797|79514641|FG001|Overall Study|Other|4|||
44121680|NCT02502526|78905871|FG001|Overall Study|Lost to Follow-up|2|||
44121681|NCT02502526|78905872|FG002|Overall Study|Lost to Follow-up|3|||
44121682|NCT02502526|78905870|FG000|Overall Study|Withdrawal by Subject|0|||
44121683|NCT02502526|78905871|FG001|Overall Study|Withdrawal by Subject|1|||
44240890|NCT01559311|79068772|FG001|Overall Study|Adverse Event|0|||
44240891|NCT01559311|79068773|FG002|Overall Study|Adverse Event|1|||
44240892|NCT01498445|79068796|FG000|Overall Study|Lack of Efficacy|0|||
44240893|NCT01498445|79068797|FG001|Overall Study|Lack of Efficacy|0|||
44240894|NCT01498445|79068798|FG002|Overall Study|Lack of Efficacy|1|||
44509456|NCT03148756|79514649|FG000|Overall Study|Study Terminated|0|||
44509457|NCT03148756|79514650|FG001|Overall Study|Study Terminated|1|||
44509458|NCT00282113|79514659|FG000|Overall Study|Removed at parents request|1|||
44509459|NCT00282113|79514660|FG001|Overall Study|Removed at parents request|0|||
44509460|NCT00282113|79514661|FG002|Overall Study|Removed at parents request|0|||
44509461|NCT00281957|79514671|FG000|Overall Study|Adverse Event|7|||
44121684|NCT02502526|78905872|FG002|Overall Study|Withdrawal by Subject|1|||
44121685|NCT02502526|78905870|FG000|Overall Study|Disqualified due to cataract grading|0|||
44121686|NCT02502526|78905871|FG001|Overall Study|Disqualified due to cataract grading|0|||
44121687|NCT02502526|78905872|FG002|Overall Study|Disqualified due to cataract grading|1|||
44121688|NCT02502526|78905870|FG000|Overall Study|Enrollment suspension|4|||
44240895|NCT01498445|79068799|FG003|Overall Study|Lack of Efficacy|2|||
44240896|NCT01498445|79068800|FG004|Overall Study|Lack of Efficacy|0|||
44240897|NCT01498445|79068801|FG005|Overall Study|Lack of Efficacy|0|||
44240898|NCT01498445|79068796|FG000|Overall Study|Screen Failure|0|||
44240899|NCT01498445|79068797|FG001|Overall Study|Screen Failure|0|||
44240900|NCT01498445|79068798|FG002|Overall Study|Screen Failure|0|||
44240901|NCT01498445|79068799|FG003|Overall Study|Screen Failure|0|||
44240902|NCT01498445|79068800|FG004|Overall Study|Screen Failure|1|||
44240903|NCT01498445|79068801|FG005|Overall Study|Screen Failure|1|||
44240904|NCT01558297|79068818|FG000|Overall Study|Withdrawal by Subject|2|||
44240905|NCT01558297|79068819|FG001|Overall Study|Withdrawal by Subject|2|||
44240906|NCT01558297|79068820|FG002|Overall Study|Withdrawal by Subject|1|||
44240907|NCT01525849|79068830|FG000|Overall Study|Lost to Follow-up|3|||
44240908|NCT01525849|79068831|FG001|Overall Study|Lost to Follow-up|2|||
44240909|NCT01525849|79068830|FG000|Overall Study|Withdrawal by Subject|1|||
44240910|NCT01525849|79068831|FG001|Overall Study|Withdrawal by Subject|9|||
44240911|NCT01525849|79068830|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
44240912|NCT01525849|79068831|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
44240913|NCT01525849|79068830|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
44240914|NCT01525849|79068831|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
44240915|NCT01525615|79068850|FG000|Overall Study|Adverse Event|11|||
44240916|NCT01525615|79068851|FG001|Overall Study|Adverse Event|7|||
44240917|NCT01525615|79068852|FG002|Overall Study|Adverse Event|5|||
44240918|NCT01525615|79068850|FG000|Overall Study|Lost to Follow-up|1|||
44240919|NCT01525615|79068851|FG001|Overall Study|Lost to Follow-up|0|||
44240920|NCT01525615|79068852|FG002|Overall Study|Lost to Follow-up|0|||
44240921|NCT01525615|79068850|FG000|Overall Study|Withdrawal by Subject|1|||
44240922|NCT01525615|79068851|FG001|Overall Study|Withdrawal by Subject|0|||
44240923|NCT01525615|79068852|FG002|Overall Study|Withdrawal by Subject|0|||
44240924|NCT01525615|79068850|FG000|Overall Study|Other reason not described above|1|||
44240925|NCT01525615|79068851|FG001|Overall Study|Other reason not described above|0|||
44240926|NCT01525615|79068852|FG002|Overall Study|Other reason not described above|1|||
44240927|NCT01525225|79068894|FG000|Enrollment|No longer met study criteria|1|||
44240928|NCT01525225|79068894|FG000|Enrollment|Other|1|||
44240929|NCT01524991|79068911|FG000|Overall Study|Adverse Event|12|||
44240930|NCT01524991|79068911|FG000|Overall Study|Death|1|||
44240931|NCT01524991|79068911|FG000|Overall Study|Disease ProgressionDu|17|||
44240932|NCT01524991|79068911|FG000|Overall Study|Other complicating disease|1|||
44240933|NCT01524991|79068911|FG000|Overall Study|Withdrawal by Subject|2|||
44509462|NCT00281957|79514672|FG001|Overall Study|Adverse Event|2|||
44509463|NCT00281957|79514671|FG000|Overall Study|Death|1|||
44509464|NCT00281957|79514672|FG001|Overall Study|Death|0|||
44509465|NCT00281957|79514671|FG000|Overall Study|Progression/relapse|47|||
44509466|NCT00281957|79514672|FG001|Overall Study|Progression/relapse|35|||
44509467|NCT00281957|79514671|FG000|Overall Study|Not protocol specified|8|||
44509468|NCT00281957|79514672|FG001|Overall Study|Not protocol specified|1|||
44509469|NCT00281957|79514671|FG000|Overall Study|Not eligible|1|||
44509470|NCT00281957|79514672|FG001|Overall Study|Not eligible|2|||
44509471|NCT00281957|79514671|FG000|Overall Study|Did not start treatment|3|||
44509472|NCT00281957|79514672|FG001|Overall Study|Did not start treatment|1|||
44509473|NCT00281957|79514671|FG000|Overall Study|Refusal unrelated to adverse events|0|||
44509474|NCT00281957|79514672|FG001|Overall Study|Refusal unrelated to adverse events|1|||
44121689|NCT02502526|78905871|FG001|Overall Study|Enrollment suspension|1|||
44121690|NCT02502526|78905872|FG002|Overall Study|Enrollment suspension|1|||
44509475|NCT00281099|79514682|FG000|Overall Study|Death|46|||
44509476|NCT00281099|79514683|FG001|Overall Study|Death|57|||
44509477|NCT00281099|79514682|FG000|Overall Study|Lost to Follow-up|10|||
44509478|NCT00281099|79514683|FG001|Overall Study|Lost to Follow-up|19|||
44240934|NCT01524991|79068911|FG000|Overall Study|Symptomatic Deterioration|1|||
44240935|NCT01524913|79068918|FG000|Overall Study|Lost to Follow-up|4|||
44509479|NCT00281099|79514682|FG000|Overall Study|Withdrawal by Subject|65|||
44509480|NCT00281099|79514683|FG001|Overall Study|Withdrawal by Subject|70|||
44240936|NCT01524913|79068919|FG001|Overall Study|Lost to Follow-up|0|||
44240937|NCT01524913|79068920|FG002|Overall Study|Lost to Follow-up|0|||
44509481|NCT00281099|79514682|FG000|Overall Study|Physician Decision|79|||
44121691|NCT02972515|78905881|FG000|Overall Study|Lost to Follow-up|78|||
44240938|NCT01524679|79068930|FG000|Overall Study|Lost to Follow-up|1|||
44240939|NCT01524679|79068931|FG001|Overall Study|Lost to Follow-up|4|||
44509482|NCT00281099|79514683|FG001|Overall Study|Physician Decision|72|||
44509483|NCT00281099|79514682|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
44240940|NCT01524679|79068930|FG000|Overall Study|Withdrawal by Subject|4|||
44509484|NCT00281099|79514683|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
44509485|NCT00262925|79514690|FG000|Overall Study|Lack of Efficacy|3|||
44240941|NCT01524679|79068931|FG001|Overall Study|Withdrawal by Subject|4|||
44240942|NCT01524679|79068930|FG000|Overall Study|Adverse Event|9|||
44121692|NCT02972359|78905885|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
44121693|NCT02972359|78905885|FG000|Overall Study|Lack of Efficacy|1|||
44121694|NCT02972359|78905885|FG000|Overall Study|Adverse Event|4|||
44121695|NCT02972359|78905885|FG000|Overall Study|Death|1|||
44121696|NCT02972359|78905885|FG000|Overall Study|Withdrawal by Subject|30|||
44121697|NCT02972359|78905885|FG000|Overall Study|Protocol Violation|1|||
44121698|NCT02972359|78905885|FG000|Overall Study|Lost to Follow-up|26|||
44121699|NCT02972359|78905885|FG000|Overall Study|Other reasons|5|||
44121700|NCT02972359|78905885|FG000|Overall Study|Missing|1|||
44121701|NCT01060111|78905892|FG000|Overall Study|Adverse Event|9|||
44121702|NCT01060111|78905893|FG001|Overall Study|Adverse Event|5|||
44121703|NCT01060111|78905894|FG002|Overall Study|Adverse Event|18|||
44121704|NCT01060111|78905892|FG000|Overall Study|Lack of Efficacy|2|||
44121705|NCT01060111|78905893|FG001|Overall Study|Lack of Efficacy|1|||
44121706|NCT01060111|78905894|FG002|Overall Study|Lack of Efficacy|0|||
44121707|NCT01060111|78905892|FG000|Overall Study|Inappropriate participant|5|||
44121708|NCT01060111|78905893|FG001|Overall Study|Inappropriate participant|4|||
44121709|NCT01060111|78905894|FG002|Overall Study|Inappropriate participant|5|||
44121710|NCT01060111|78905892|FG000|Overall Study|Participants' evasion for hospital visit|0|||
44121711|NCT01060111|78905893|FG001|Overall Study|Participants' evasion for hospital visit|3|||
44121712|NCT01060111|78905894|FG002|Overall Study|Participants' evasion for hospital visit|2|||
44121713|NCT01060111|78905892|FG000|Overall Study|Participants' non-cooperation|8|||
44121714|NCT01060111|78905893|FG001|Overall Study|Participants' non-cooperation|6|||
44121715|NCT01060111|78905894|FG002|Overall Study|Participants' non-cooperation|6|||
44121716|NCT01060111|78905892|FG000|Overall Study|Adverse event and insufficient effect|0|||
44121717|NCT01060111|78905893|FG001|Overall Study|Adverse event and insufficient effect|1|||
44121718|NCT01060111|78905894|FG002|Overall Study|Adverse event and insufficient effect|0|||
44121719|NCT01060111|78905892|FG000|Overall Study|Participants' non-cooperation|1|||
44121720|NCT01060111|78905893|FG001|Overall Study|Participants' non-cooperation|0|||
44121721|NCT01060111|78905894|FG002|Overall Study|Participants' non-cooperation|0|||
44121722|NCT01060111|78905892|FG000|Overall Study|Other|2|||
44121723|NCT01060111|78905893|FG001|Overall Study|Other|3|||
44121724|NCT01060111|78905894|FG002|Overall Study|Other|4|||
44121725|NCT02969863|78905905|FG000|Overall Study|Physician Decision|1|||
44121726|NCT02969863|78905906|FG001|Overall Study|Physician Decision|0|||
44121727|NCT02969863|78905907|FG002|Overall Study|Physician Decision|0|||
44121728|NCT02969863|78905908|FG003|Overall Study|Physician Decision|0|||
44121729|NCT02969863|78905909|FG004|Overall Study|Physician Decision|0|||
44121730|NCT02969863|78905910|FG005|Overall Study|Physician Decision|0|||
44121731|NCT02969707|78905926|FG000|Overall Study|Adverse Event|1|||
44121732|NCT02969707|78905927|FG001|Overall Study|Adverse Event|2|||
44121733|NCT02969707|78905926|FG000|Overall Study|Lost to Follow-up|3|||
44121734|NCT02969707|78905927|FG001|Overall Study|Lost to Follow-up|0|||
44121735|NCT02969707|78905926|FG000|Overall Study|Physician Decision|0|||
44121736|NCT02969707|78905927|FG001|Overall Study|Physician Decision|1|||
44121737|NCT02969707|78905926|FG000|Overall Study|Protocol Violation|1|||
44121738|NCT02969707|78905927|FG001|Overall Study|Protocol Violation|1|||
44121739|NCT02969707|78905926|FG000|Overall Study|Withdrawal by Subject|3|||
44121740|NCT02969707|78905927|FG001|Overall Study|Withdrawal by Subject|4|||
44121741|NCT02967055|78905938|FG000|Overall Study|Excluded|40|||
44121742|NCT02967055|78905938|FG000|Overall Study|Screen fail|3|||
44240943|NCT01524679|79068931|FG001|Overall Study|Adverse Event|0|||
44509486|NCT00262925|79514690|FG000|Overall Study|Adverse Event|4|||
44509487|NCT00262925|79514690|FG000|Overall Study|Death|2|||
44509488|NCT00262925|79514690|FG000|Overall Study|alternative therapy|1|||
44509489|NCT00262925|79514690|FG000|Overall Study|Other|1|||
44509490|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
44509491|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
44509492|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
44509493|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
44509494|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
44509495|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
44509496|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
44509497|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
44509498|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
44121743|NCT02967055|78905938|FG000|Overall Study|Lost to Follow-up|2|||
44121744|NCT02967055|78905938|FG000|Overall Study|Stopped due to side effects|3|||
44121745|NCT02967055|78905938|FG000|Overall Study|Stopped due to drug cost|1|||
44121746|NCT02904265|78905944|FG000|Overall Study|Physician Decision|1|||
44121747|NCT02904265|78905945|FG001|Overall Study|Physician Decision|2|||
44121748|NCT03461211|78905953|FG000|Overall Study|Adverse Event|1|||
44121749|NCT03461211|78905954|FG001|Overall Study|Adverse Event|1|||
44121750|NCT03461211|78905953|FG000|Overall Study|Lack of Efficacy|0|||
44240944|NCT01524679|79068930|FG000|Overall Study|Protocol Violation|1|||
44240945|NCT01524679|79068931|FG001|Overall Study|Protocol Violation|0|||
44240946|NCT01524679|79068930|FG000|Overall Study|Lack of Efficacy|2|||
44240947|NCT01524679|79068931|FG001|Overall Study|Lack of Efficacy|0|||
44240948|NCT01524679|79068930|FG000|Overall Study|e.g.wish for children, relocation|6|||
44121751|NCT03461211|78905954|FG001|Overall Study|Lack of Efficacy|1|||
44121752|NCT02967679|78905962|FG000|Overall Study|Adverse Event|1|||
44121753|NCT02966509|78905972|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
44121754|NCT02966509|78905973|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
44121755|NCT02966509|78905972|FG000|Baseline Satisfaction Survey|Death|0|||
44121756|NCT02966509|78905973|FG001|Baseline Satisfaction Survey|Death|1|||
44121757|NCT02966509|78905972|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
44121758|NCT02966509|78905973|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
44121759|NCT02966509|78905972|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
44121760|NCT02966509|78905973|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
44121761|NCT02966509|78905972|FG000|6 Month Satisfaction Decision Survey|Death|22|||
44121762|NCT02966509|78905973|FG001|6 Month Satisfaction Decision Survey|Death|25|||
44121763|NCT02966509|78905972|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
44121764|NCT02966509|78905973|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
44121765|NCT02966509|78905972|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
44121766|NCT02966509|78905973|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
44121767|NCT02966509|78905972|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
44121768|NCT02966509|78905973|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
44240949|NCT01524679|79068931|FG001|Overall Study|e.g.wish for children, relocation|1|||
44240950|NCT01524289|79068948|FG000|Overall Study|Lost to Follow-up|0|||
44240951|NCT01524289|79068949|FG001|Overall Study|Lost to Follow-up|1|||
44240952|NCT01524289|79068948|FG000|Overall Study|Physician Decision|1|||
44378908|NCT03064126|79384484|FG000|Overall Study|Withdrawal by Subject|7|||
44378909|NCT03064126|79384485|FG001|Overall Study|Withdrawal by Subject|4|||
44378910|NCT03064126|79384486|FG002|Overall Study|Withdrawal by Subject|0|||
44378911|NCT03064126|79384487|FG003|Overall Study|Withdrawal by Subject|0|||
44509499|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
44509500|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
44509501|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
44509502|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
44509503|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
44509504|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
44509505|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
44121769|NCT02966509|78905972|FG000|6 Month Satisfaction Survey|Death|36|||
44121770|NCT02966509|78905973|FG001|6 Month Satisfaction Survey|Death|33|||
44378912|NCT03064126|79384484|FG000|Overall Study|Subject moved|1|||
44378913|NCT03064126|79384485|FG001|Overall Study|Subject moved|0|||
44378914|NCT03064126|79384486|FG002|Overall Study|Subject moved|0|||
44240953|NCT01524289|79068949|FG001|Overall Study|Physician Decision|0|||
44378915|NCT03064126|79384487|FG003|Overall Study|Subject moved|0|||
44378916|NCT03064126|79384484|FG000|Overall Study|Protocol Violation|11|||
44240954|NCT01524289|79068948|FG000|Overall Study|Protocol Violation|5|||
44240955|NCT01524289|79068949|FG001|Overall Study|Protocol Violation|1|||
44240956|NCT01524289|79068948|FG000|Overall Study|Withdrawal by Subject|11|||
44240957|NCT01524289|79068949|FG001|Overall Study|Withdrawal by Subject|7|||
44240958|NCT01524289|79068948|FG000|Overall Study|Adverse Event|12|||
44240959|NCT01524289|79068949|FG001|Overall Study|Adverse Event|5|||
44240960|NCT01524289|79068948|FG000|Overall Study|Did not take study medication|1|||
44240961|NCT01524289|79068949|FG001|Overall Study|Did not take study medication|0|||
44240962|NCT01498289|79068959|FG000|Overall Study|Adverse Event|16|||
44240963|NCT01498289|79068960|FG001|Overall Study|Adverse Event|18|||
44121771|NCT02966509|78905972|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
44121772|NCT02966509|78905973|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
44121773|NCT02966509|78905972|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
44121774|NCT02966509|78905973|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
44121775|NCT02966509|78905972|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
44121776|NCT02966509|78905973|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
44121777|NCT02966509|78905972|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
44121778|NCT02966509|78905973|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
44121779|NCT02966509|78905972|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
44121780|NCT02966509|78905973|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
44240964|NCT01498289|79068959|FG000|Overall Study|Death|6|||
44240965|NCT01498289|79068960|FG001|Overall Study|Death|8|||
44240966|NCT01498289|79068959|FG000|Overall Study|Withdrawal unrelated to AE|16|||
44240967|NCT01498289|79068960|FG001|Overall Study|Withdrawal unrelated to AE|16|||
44240968|NCT01498289|79068959|FG000|Overall Study|Progression/relapse|53|||
44240969|NCT01498289|79068960|FG001|Overall Study|Progression/relapse|59|||
44240970|NCT01498289|79068959|FG000|Overall Study|Not protocol specified|7|||
44276375|NCT02156076|79230905|FG003|Treatment Period|Withdrawal by Subject|0|||
44276376|NCT02156076|79230902|FG000|Treatment Period|Subject request to discontinue treatment|0|||
44276377|NCT02156076|79230903|FG001|Treatment Period|Subject request to discontinue treatment|1|||
44276378|NCT02156076|79230904|FG002|Treatment Period|Subject request to discontinue treatment|0|||
44240971|NCT01498289|79068960|FG001|Overall Study|Not protocol specified|2|||
44240972|NCT01498289|79068959|FG000|Overall Study|Reason under review|0|||
44240973|NCT01498289|79068960|FG001|Overall Study|Reason under review|1|||
44276379|NCT02156076|79230905|FG003|Treatment Period|Subject request to discontinue treatment|0|||
44276380|NCT02156076|79230902|FG000|Treatment Period|Adverse Event|0|||
44121781|NCT02966353|78905979|FG000|Overall Study|Withdrawal by Subject|7|||
44121782|NCT02966353|78905979|FG000|Overall Study|Adverse Event|4|||
44121783|NCT02966353|78905979|FG000|Overall Study|Death|4|||
44121784|NCT02966353|78905979|FG000|Overall Study|Physician Decision|3|||
44121785|NCT02966353|78905979|FG000|Overall Study|Progressive disease|2|||
44121786|NCT02966353|78905979|FG000|Overall Study|Protocol deviation|2|||
44121787|NCT02965573|78906012|FG000|Overall Study|Lack of Efficacy|1|||
44121788|NCT02965573|78906013|FG001|Overall Study|Lack of Efficacy|0|||
44121789|NCT02964325|78906021|FG000|Overall Study|Lost to Follow-up|3|||
44121790|NCT02964325|78906022|FG001|Overall Study|Lost to Follow-up|3|||
44121791|NCT02964325|78906021|FG000|Overall Study|Physician Decision|5|||
44121792|NCT02964325|78906022|FG001|Overall Study|Physician Decision|4|||
44121793|NCT02964325|78906021|FG000|Overall Study|Death|1|||
44121794|NCT02964325|78906022|FG001|Overall Study|Death|3|||
44121795|NCT02964325|78906021|FG000|Overall Study|Withdrawal by Subject|2|||
44121796|NCT02964325|78906022|FG001|Overall Study|Withdrawal by Subject|1|||
44121797|NCT02964325|78906021|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
44121798|NCT02964325|78906022|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
44121799|NCT02964247|78906030|FG000|Overall Study|Lost to Follow-up|2|||
44121800|NCT02964247|78906031|FG001|Overall Study|Lost to Follow-up|0|||
44121801|NCT02964247|78906030|FG000|Overall Study|Withdrawal by Subject|1|||
44121802|NCT02964247|78906031|FG001|Overall Study|Withdrawal by Subject|2|||
44121803|NCT03654729|78906040|FG000|Overall Study|Death|9|||
44121804|NCT03654729|78906041|FG001|Overall Study|Death|9|||
44121805|NCT03654729|78906042|FG002|Overall Study|Death|16|||
44121806|NCT03654729|78906040|FG000|Overall Study|Withdrawal by Subject|8|||
44121807|NCT03654729|78906041|FG001|Overall Study|Withdrawal by Subject|6|||
44121808|NCT03654729|78906042|FG002|Overall Study|Withdrawal by Subject|4|||
44121809|NCT03654729|78906040|FG000|Overall Study|Study terminated by Sponsor|3|||
44121810|NCT03654729|78906041|FG001|Overall Study|Study terminated by Sponsor|5|||
44121811|NCT03654729|78906042|FG002|Overall Study|Study terminated by Sponsor|4|||
44121812|NCT03654729|78906040|FG000|Overall Study|Not reported|2|||
44121813|NCT03654729|78906041|FG001|Overall Study|Not reported|4|||
44121814|NCT03654729|78906042|FG002|Overall Study|Not reported|5|||
44121815|NCT03654729|78906040|FG000|Overall Study|Progressive disease|3|||
44121816|NCT03654729|78906041|FG001|Overall Study|Progressive disease|0|||
44378917|NCT03064126|79384485|FG001|Overall Study|Protocol Violation|1|||
44378918|NCT03064126|79384486|FG002|Overall Study|Protocol Violation|1|||
44240974|NCT01524133|79068973|FG000|Treatment Phase|Withdrawal by Subject|13|||
44378919|NCT03064126|79384487|FG003|Overall Study|Protocol Violation|0|||
44378920|NCT03040999|79384500|FG000|Overall Study|Lost to Follow-up|1|||
44378921|NCT03040999|79384501|FG001|Overall Study|Lost to Follow-up|0|||
44121817|NCT03654729|78906042|FG002|Overall Study|Progressive disease|0|||
44240975|NCT01524133|79068974|FG001|Treatment Phase|Withdrawal by Subject|28|||
44240976|NCT01524133|79068975|FG002|Treatment Phase|Withdrawal by Subject|31|||
44240977|NCT01524133|79068973|FG000|Treatment Phase|Physician Decision|6|||
44240978|NCT01524133|79068974|FG001|Treatment Phase|Physician Decision|3|||
44378922|NCT03040999|79384500|FG000|Overall Study|Withdrawal by Subject|7|||
44378923|NCT03040999|79384501|FG001|Overall Study|Withdrawal by Subject|12|||
44378924|NCT03040999|79384500|FG000|Overall Study|Death|128|||
44509506|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
44509507|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
44509508|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
44509509|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
44509510|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
44509511|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
44509512|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
44509513|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
44509514|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
44509515|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
44509516|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
44509517|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
44509518|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
44509519|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
44509520|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
44509521|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
44121818|NCT03654729|78906040|FG000|Overall Study|Lost to Follow-up|2|||
44121819|NCT03654729|78906041|FG001|Overall Study|Lost to Follow-up|0|||
44121820|NCT03654729|78906042|FG002|Overall Study|Lost to Follow-up|0|||
44509522|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
44121821|NCT03654729|78906040|FG000|Overall Study|Physician Decision|2|||
44121822|NCT03654729|78906041|FG001|Overall Study|Physician Decision|0|||
44240979|NCT01524133|79068975|FG002|Treatment Phase|Physician Decision|3|||
44378925|NCT03040999|79384501|FG001|Overall Study|Death|138|||
44121823|NCT03654729|78906042|FG002|Overall Study|Physician Decision|0|||
44121824|NCT03654729|78906040|FG000|Overall Study|Protocol Violation|1|||
44378926|NCT03040999|79384500|FG000|Overall Study|Participants Ongoing in Trial|266|||
44121825|NCT03654729|78906041|FG001|Overall Study|Protocol Violation|1|||
44121826|NCT03654729|78906042|FG002|Overall Study|Protocol Violation|0|||
44121827|NCT03654729|78906040|FG000|Overall Study|Non-compliance with study drug|0|||
44121828|NCT03654729|78906041|FG001|Overall Study|Non-compliance with study drug|1|||
44121829|NCT03654729|78906042|FG002|Overall Study|Non-compliance with study drug|0|||
44121830|NCT03654729|78906040|FG000|Overall Study|Site terminated by Sponsor|1|||
44121831|NCT03654729|78906041|FG001|Overall Study|Site terminated by Sponsor|0|||
44121832|NCT03654729|78906042|FG002|Overall Study|Site terminated by Sponsor|0|||
44121833|NCT01377987|78906050|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
44121834|NCT01377987|78906051|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
44121835|NCT02898259|78906062|FG000|Overall Study|Adverse Event|0|||
44121836|NCT02898259|78906063|FG001|Overall Study|Adverse Event|0|||
44240980|NCT01524133|79068973|FG000|Treatment Phase|Lost to Follow-up|0|||
44378927|NCT03040999|79384501|FG001|Overall Study|Participants Ongoing in Trial|252|||
44378928|NCT03010176|79384513|FG000|Overall Study|Death|21|||
44509523|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
44509524|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
44509525|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
44509526|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
44509527|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
44509528|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
44509529|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
44509530|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
44509531|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
44509532|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
44121837|NCT02898259|78906064|FG002|Overall Study|Adverse Event|1|||
44121838|NCT02898259|78906065|FG003|Overall Study|Adverse Event|0|||
44121839|NCT02898259|78906066|FG004|Overall Study|Adverse Event|0|||
44121840|NCT02898259|78906062|FG000|Overall Study|Lack of Efficacy|1|||
44121841|NCT02898259|78906063|FG001|Overall Study|Lack of Efficacy|1|||
44121842|NCT02898259|78906064|FG002|Overall Study|Lack of Efficacy|3|||
44240981|NCT01524133|79068974|FG001|Treatment Phase|Lost to Follow-up|1|||
44240982|NCT01524133|79068975|FG002|Treatment Phase|Lost to Follow-up|2|||
44240983|NCT01524133|79068973|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
44240984|NCT01524133|79068974|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
44240985|NCT01524133|79068975|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
44240986|NCT01524133|79068973|FG000|Overall Study 52 Weeks|Physician Decision|1|||
44240987|NCT01524133|79068974|FG001|Overall Study 52 Weeks|Physician Decision|0|||
44240988|NCT01524133|79068975|FG002|Overall Study 52 Weeks|Physician Decision|2|||
44240989|NCT01524133|79068973|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
44240990|NCT01524133|79068974|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
44240991|NCT01524133|79068975|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
44240992|NCT04304534|79069009|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
44378929|NCT03010176|79384514|FG001|Overall Study|Death|35|||
44378930|NCT03010176|79384515|FG002|Overall Study|Death|19|||
44378931|NCT03010176|79384516|FG003|Overall Study|Death|19|||
44378932|NCT03010176|79384517|FG004|Overall Study|Death|14|||
44240993|NCT04304534|79069010|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
44240994|NCT04304534|79069011|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
44240995|NCT04304534|79069012|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
44240996|NCT04304534|79069009|FG000|Overall Study|Non-Compliance with study drug|0|||
44240997|NCT04304534|79069010|FG001|Overall Study|Non-Compliance with study drug|1|||
44240998|NCT04304534|79069011|FG002|Overall Study|Non-Compliance with study drug|1|||
44240999|NCT04304534|79069012|FG003|Overall Study|Non-Compliance with study drug|1|||
44241000|NCT04304534|79069009|FG000|Overall Study|Lost to Follow-up|0|||
44241001|NCT04304534|79069010|FG001|Overall Study|Lost to Follow-up|1|||
44241002|NCT04304534|79069011|FG002|Overall Study|Lost to Follow-up|2|||
44241003|NCT04304534|79069012|FG003|Overall Study|Lost to Follow-up|3|||
44241004|NCT04304534|79069009|FG000|Overall Study|Unspecific|4|||
44241005|NCT04304534|79069010|FG001|Overall Study|Unspecific|2|||
44241006|NCT04304534|79069011|FG002|Overall Study|Unspecific|2|||
44241007|NCT04304534|79069012|FG003|Overall Study|Unspecific|2|||
44241008|NCT04304534|79069009|FG000|Overall Study|Technical Problems|2|||
44241009|NCT04304534|79069010|FG001|Overall Study|Technical Problems|2|||
44241010|NCT04304534|79069011|FG002|Overall Study|Technical Problems|3|||
44241011|NCT04304534|79069012|FG003|Overall Study|Technical Problems|4|||
44241012|NCT04304534|79069009|FG000|Overall Study|Death|7|||
44509533|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
44509534|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
44509535|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
44509536|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
44509537|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
44509538|NCT03720470|79514700|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
44509539|NCT03720470|79514701|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
44509540|NCT03720470|79514702|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
44509541|NCT03720470|79514703|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
44509542|NCT03720470|79514704|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
44509543|NCT03720470|79514705|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
44509544|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
44509545|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
44509546|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
44509547|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
44509548|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
44509549|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
44509550|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
44509551|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
44509552|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
44509553|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
44509554|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
44509555|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
44509556|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
44509557|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
44509558|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
44509559|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
44378933|NCT03010176|79384518|FG005|Overall Study|Death|0|||
44509560|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
44241013|NCT04304534|79069010|FG001|Overall Study|Death|2|||
44241014|NCT04304534|79069011|FG002|Overall Study|Death|4|||
44509561|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
44509562|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
44378934|NCT03010176|79384513|FG000|Overall Study|Lost to Follow-up|0|||
44241015|NCT04304534|79069012|FG003|Overall Study|Death|3|||
44378935|NCT03010176|79384514|FG001|Overall Study|Lost to Follow-up|0|||
44509563|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
44509564|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
44509565|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
44509566|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
44509567|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
44509568|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
44509569|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
44509570|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
44509571|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
44241016|NCT04304534|79069009|FG000|Overall Study|Withdrawal by Subject|7|||
44241017|NCT04304534|79069010|FG001|Overall Study|Withdrawal by Subject|2|||
44241018|NCT04304534|79069011|FG002|Overall Study|Withdrawal by Subject|7|||
44241019|NCT04304534|79069012|FG003|Overall Study|Withdrawal by Subject|4|||
44241020|NCT04304534|79069009|FG000|Overall Study|Physician Decision|4|||
44241021|NCT04304534|79069010|FG001|Overall Study|Physician Decision|9|||
44241022|NCT04304534|79069011|FG002|Overall Study|Physician Decision|9|||
44241023|NCT04304534|79069012|FG003|Overall Study|Physician Decision|5|||
44241024|NCT04304534|79069009|FG000|Overall Study|Subject Decision|34|||
44241025|NCT04304534|79069010|FG001|Overall Study|Subject Decision|25|||
44241026|NCT04304534|79069011|FG002|Overall Study|Subject Decision|25|||
44241027|NCT04304534|79069012|FG003|Overall Study|Subject Decision|26|||
44241028|NCT04304534|79069009|FG000|Overall Study|Adverse Event|35|||
44241029|NCT04304534|79069010|FG001|Overall Study|Adverse Event|40|||
44241030|NCT04304534|79069011|FG002|Overall Study|Adverse Event|39|||
44241031|NCT04304534|79069012|FG003|Overall Study|Adverse Event|44|||
44241032|NCT04223609|79069025|FG000|Overall Study|Adverse Event|0|||
44241033|NCT04223609|79069026|FG001|Overall Study|Adverse Event|1|||
44241034|NCT04223609|79069025|FG000|Overall Study|Missed last visit|0|||
44241035|NCT04223609|79069026|FG001|Overall Study|Missed last visit|1|||
44241036|NCT04176458|79069032|FG000|Overall Study|Covid 19|4|||
44241037|NCT03941548|79069038|FG000|Overall Study|Adverse Event|0|||
44241038|NCT03941548|79069039|FG001|Overall Study|Adverse Event|1|||
44241039|NCT03941548|79069038|FG000|Overall Study|Lost to Follow-up|0|||
44241040|NCT03941548|79069039|FG001|Overall Study|Lost to Follow-up|1|||
44241041|NCT03941548|79069038|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
44241042|NCT03941548|79069039|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
44241043|NCT03925727|79069048|FG000|Overall Study|Adverse Event|4|||
44241044|NCT03925727|79069049|FG001|Overall Study|Adverse Event|0|||
44241045|NCT03925727|79069050|FG002|Overall Study|Adverse Event|3|||
44241046|NCT03925727|79069048|FG000|Overall Study|Protocol Violation|1|||
44241047|NCT03925727|79069049|FG001|Overall Study|Protocol Violation|2|||
44241048|NCT03925727|79069050|FG002|Overall Study|Protocol Violation|2|||
44241049|NCT03925727|79069048|FG000|Overall Study|Withdrawal by Subject|3|||
44241050|NCT03925727|79069049|FG001|Overall Study|Withdrawal by Subject|2|||
44241051|NCT03925727|79069050|FG002|Overall Study|Withdrawal by Subject|4|||
44241052|NCT03925727|79069048|FG000|Overall Study|Administrative Reasons|3|||
44241053|NCT03925727|79069049|FG001|Overall Study|Administrative Reasons|1|||
44241054|NCT03925727|79069050|FG002|Overall Study|Administrative Reasons|2|||
44241055|NCT03925727|79069048|FG000|Overall Study|Randomized in error or Disqualified|8|||
44241056|NCT03925727|79069049|FG001|Overall Study|Randomized in error or Disqualified|1|||
44241057|NCT03925727|79069050|FG002|Overall Study|Randomized in error or Disqualified|7|||
44241058|NCT03387150|79069067|FG000|Overall Study|Withdrawal by Subject|3|||
44241059|NCT03387150|79069068|FG001|Overall Study|Withdrawal by Subject|0|||
44241060|NCT03387150|79069069|FG002|Overall Study|Withdrawal by Subject|3|||
44509572|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
44509573|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
44121843|NCT02898259|78906065|FG003|Overall Study|Lack of Efficacy|0|||
44276381|NCT02156076|79230903|FG001|Treatment Period|Adverse Event|0|||
44276382|NCT02156076|79230904|FG002|Treatment Period|Adverse Event|0|||
44509574|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
44241061|NCT03387150|79069070|FG003|Overall Study|Withdrawal by Subject|4|||
44241062|NCT03387150|79069071|FG004|Overall Study|Withdrawal by Subject|1|||
44241063|NCT03387150|79069072|FG005|Overall Study|Withdrawal by Subject|2|||
44241064|NCT03387150|79069073|FG006|Overall Study|Withdrawal by Subject|0|||
44241065|NCT03387150|79069067|FG000|Overall Study|Lost to Follow-up|3|||
44241066|NCT03387150|79069068|FG001|Overall Study|Lost to Follow-up|2|||
44241067|NCT03387150|79069069|FG002|Overall Study|Lost to Follow-up|2|||
44241068|NCT03387150|79069070|FG003|Overall Study|Lost to Follow-up|3|||
44509575|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
44509576|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
44509577|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
44509578|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
44509579|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
44509580|NCT03720470|79514700|FG000|Treatment Period: Final 4 Weeks|Other|0|||
44509581|NCT03720470|79514701|FG001|Treatment Period: Final 4 Weeks|Other|1|||
44509582|NCT03720470|79514702|FG002|Treatment Period: Final 4 Weeks|Other|0|||
44509583|NCT03720470|79514703|FG003|Treatment Period: Final 4 Weeks|Other|2|||
44509584|NCT03720470|79514704|FG004|Treatment Period: Final 4 Weeks|Other|1|||
44509585|NCT03720470|79514705|FG005|Treatment Period: Final 4 Weeks|Other|0|||
44509586|NCT00262847|79514728|FG000|Overall Study|Disease Progression|309|||
44509587|NCT00262847|79514729|FG001|Overall Study|Disease Progression|274|||
44509588|NCT00262847|79514730|FG002|Overall Study|Disease Progression|195|||
44509589|NCT00262847|79514728|FG000|Overall Study|Patient Refusal|41|||
44121844|NCT02898259|78906066|FG004|Overall Study|Lack of Efficacy|0|||
44121845|NCT02898259|78906062|FG000|Overall Study|Lost to Follow-up|0|||
44121846|NCT02898259|78906063|FG001|Overall Study|Lost to Follow-up|0|||
44121847|NCT02898259|78906064|FG002|Overall Study|Lost to Follow-up|1|||
44121848|NCT02898259|78906065|FG003|Overall Study|Lost to Follow-up|0|||
44121849|NCT02898259|78906066|FG004|Overall Study|Lost to Follow-up|0|||
44121850|NCT02898259|78906062|FG000|Overall Study|Transformation before study began|0|||
44121851|NCT02898259|78906063|FG001|Overall Study|Transformation before study began|0|||
44241069|NCT03387150|79069071|FG004|Overall Study|Lost to Follow-up|3|||
44241070|NCT03387150|79069072|FG005|Overall Study|Lost to Follow-up|3|||
44241071|NCT03387150|79069073|FG006|Overall Study|Lost to Follow-up|0|||
44241072|NCT03387150|79069067|FG000|Overall Study|Participant unable to adhere to visit|0|||
44241073|NCT03387150|79069068|FG001|Overall Study|Participant unable to adhere to visit|1|||
44241074|NCT03387150|79069069|FG002|Overall Study|Participant unable to adhere to visit|0|||
44241075|NCT03387150|79069070|FG003|Overall Study|Participant unable to adhere to visit|0|||
44241076|NCT03387150|79069071|FG004|Overall Study|Participant unable to adhere to visit|2|||
44241077|NCT03387150|79069072|FG005|Overall Study|Participant unable to adhere to visit|2|||
44241078|NCT03387150|79069073|FG006|Overall Study|Participant unable to adhere to visit|0|||
44241079|NCT03289208|79069105|FG000|Overall Study|Adverse Event|1|||
44509590|NCT00262847|79514729|FG001|Overall Study|Patient Refusal|52|||
44509591|NCT00262847|79514730|FG002|Overall Study|Patient Refusal|47|||
44509592|NCT00262847|79514728|FG000|Overall Study|Adverse Event|74|||
44509593|NCT00262847|79514729|FG001|Overall Study|Adverse Event|88|||
44509594|NCT00262847|79514730|FG002|Overall Study|Adverse Event|108|||
44509595|NCT00262847|79514728|FG000|Overall Study|Death|8|||
44509596|NCT00262847|79514729|FG001|Overall Study|Death|8|||
44509597|NCT00262847|79514730|FG002|Overall Study|Death|11|||
44509598|NCT00262847|79514728|FG000|Overall Study|Concomitant disease|3|||
44509599|NCT00262847|79514729|FG001|Overall Study|Concomitant disease|2|||
44509600|NCT00262847|79514730|FG002|Overall Study|Concomitant disease|4|||
44509601|NCT00262847|79514728|FG000|Overall Study|Other Reasons|79|||
44509602|NCT00262847|79514729|FG001|Overall Study|Other Reasons|88|||
44509603|NCT00262847|79514730|FG002|Overall Study|Other Reasons|27|||
44509604|NCT00262847|79514728|FG000|Overall Study|Did not receive study treatment|4|||
44509605|NCT00262847|79514729|FG001|Overall Study|Did not receive study treatment|1|||
44509606|NCT00262847|79514730|FG002|Overall Study|Did not receive study treatment|4|||
44509607|NCT00280397|79514741|FG000|Overall Study|Adverse Event|1|||
44509608|NCT00262301|79514750|FG000|Double-blind Phase|Lost to Follow-up|1|||
44509609|NCT00262301|79514751|FG001|Double-blind Phase|Lost to Follow-up|0|||
44509610|NCT00262301|79514752|FG002|Double-blind Phase|Lost to Follow-up|0|||
44509611|NCT00262301|79514750|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
44509612|NCT00262301|79514751|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
44509613|NCT00262301|79514752|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
44509614|NCT00279305|79514762|FG000|Overall Study|Pregnancy|1|||
44509615|NCT00279305|79514763|FG001|Overall Study|Pregnancy|0|||
44509616|NCT00279305|79514762|FG000|Overall Study|Withdrawal by Subject|2|||
44509617|NCT00279305|79514763|FG001|Overall Study|Withdrawal by Subject|0|||
44509618|NCT00279305|79514762|FG000|Overall Study|Dificulting establishing IV|1|||
44509619|NCT00279305|79514763|FG001|Overall Study|Dificulting establishing IV|0|||
44509620|NCT00279305|79514762|FG000|Overall Study|FDA Safety Alert|4|||
44509621|NCT00279305|79514763|FG001|Overall Study|FDA Safety Alert|1|||
44509622|NCT00278993|79514769|FG000|Overall Study|Adverse Event|24|||
44509623|NCT00278993|79514769|FG000|Overall Study|Withdrawal by Subject|5|||
44241080|NCT03289208|79069106|FG001|Overall Study|Adverse Event|0|||
44509624|NCT00278993|79514769|FG000|Overall Study|Progressive Disease|65|||
44509625|NCT00278993|79514769|FG000|Overall Study|Physician Decision|9|||
44509626|NCT00278993|79514769|FG000|Overall Study|Not Otherwise Specified|4|||
44509627|NCT00277355|79514775|FG000|Overall Study|Withdrawal by Subject|3|||
44509628|NCT00277355|79514776|FG001|Overall Study|Withdrawal by Subject|3|||
44509629|NCT00277355|79514775|FG000|Overall Study|Lost to Follow-up|2|||
44121852|NCT02898259|78906064|FG002|Overall Study|Transformation before study began|0|||
44378936|NCT03010176|79384515|FG002|Overall Study|Lost to Follow-up|0|||
44378937|NCT03010176|79384516|FG003|Overall Study|Lost to Follow-up|0|||
44378938|NCT03010176|79384517|FG004|Overall Study|Lost to Follow-up|1|||
44378939|NCT03010176|79384518|FG005|Overall Study|Lost to Follow-up|0|||
44378940|NCT03010176|79384513|FG000|Overall Study|Physician Decision|0|||
44241081|NCT03289208|79069107|FG002|Overall Study|Adverse Event|0|||
44241082|NCT03244059|79069117|FG000|Specific Aim 1|Physician Decision|1|||
44241083|NCT03244059|79069118|FG001|Specific Aim 1|Physician Decision|0|||
44241084|NCT03244059|79069117|FG000|Specific Aim 2|Physician Decision|1|||
44241085|NCT03244059|79069118|FG001|Specific Aim 2|Physician Decision|0|||
44241086|NCT03036566|79069124|FG000|Overall Study|Lost to Follow-up|3|||
44121853|NCT02898259|78906065|FG003|Overall Study|Transformation before study began|1|||
44121854|NCT02898259|78906066|FG004|Overall Study|Transformation before study began|0|||
44121855|NCT02963935|78906081|FG000|Overall Study|Adverse Event|12|||
44121856|NCT02963935|78906082|FG001|Overall Study|Adverse Event|6|||
44121857|NCT02963935|78906081|FG000|Overall Study|Protocol Violation|2|||
44121858|NCT02963935|78906082|FG001|Overall Study|Protocol Violation|1|||
44121859|NCT02963935|78906081|FG000|Overall Study|Lack of Efficacy|0|||
44121860|NCT02963935|78906082|FG001|Overall Study|Lack of Efficacy|2|||
44121861|NCT02963935|78906081|FG000|Overall Study|Lost to Follow-up|1|||
44121862|NCT02963935|78906082|FG001|Overall Study|Lost to Follow-up|6|||
44121863|NCT02963935|78906081|FG000|Overall Study|Unclassified|13|||
44121864|NCT02963935|78906082|FG001|Overall Study|Unclassified|22|||
44121865|NCT02963701|78906090|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
44121866|NCT02963701|78906091|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
44121867|NCT01345591|78906097|FG000|Overall Study|Lost to Follow-up|1|||
44121868|NCT02961751|78906106|FG000|Overall Study|Lost to Follow-up|11|||
44241087|NCT02754141|79069155|FG000|Overall Study|Disease progression|11|||
44241088|NCT02754141|79069156|FG001|Overall Study|Disease progression|7|||
44241089|NCT02754141|79069157|FG002|Overall Study|Disease progression|8|||
44121869|NCT02961751|78906106|FG000|Overall Study|Physician Decision|2|||
44241090|NCT02754141|79069158|FG003|Overall Study|Disease progression|5|||
44241091|NCT02754141|79069159|FG004|Overall Study|Disease progression|7|||
44378941|NCT03010176|79384514|FG001|Overall Study|Physician Decision|4|||
44241092|NCT02754141|79069160|FG005|Overall Study|Disease progression|7|||
44121870|NCT02961751|78906106|FG000|Overall Study|Not Eligible at Enrollment|1|||
44121871|NCT02961751|78906106|FG000|Overall Study|Protocol Violation|1|||
44121872|NCT02963311|78906110|FG000|Overall Study|Withdrawal by Subject|1|||
44121873|NCT02963311|78906110|FG000|Overall Study|Screen Failure|4|||
44121874|NCT02962765|78906114|FG000|Overall Study|Protocol Violation|9|||
44121875|NCT02962765|78906114|FG000|Overall Study|Withdrawal by Subject|3|||
44121876|NCT02962765|78906114|FG000|Overall Study|Lost to Follow-up|1|||
44241093|NCT02754141|79069161|FG006|Overall Study|Disease progression|7|||
44241094|NCT02754141|79069162|FG007|Overall Study|Disease progression|6|||
44241095|NCT02754141|79069163|FG008|Overall Study|Disease progression|11|||
44241096|NCT02754141|79069164|FG009|Overall Study|Disease progression|16|||
44241097|NCT02754141|79069165|FG010|Overall Study|Disease progression|18|||
44241098|NCT02754141|79069166|FG011|Overall Study|Disease progression|13|||
44241099|NCT02754141|79069167|FG012|Overall Study|Disease progression|10|||
44241100|NCT02754141|79069168|FG013|Overall Study|Disease progression|12|||
44241101|NCT02754141|79069169|FG014|Overall Study|Disease progression|12|||
44241102|NCT02754141|79069170|FG015|Overall Study|Disease progression|14|||
44241103|NCT02754141|79069171|FG016|Overall Study|Disease progression|0|||
44241104|NCT02754141|79069172|FG017|Overall Study|Disease progression|1|||
44241105|NCT02754141|79069155|FG000|Overall Study|Study drug toxicity|1|||
44241106|NCT02754141|79069156|FG001|Overall Study|Study drug toxicity|1|||
44241107|NCT02754141|79069157|FG002|Overall Study|Study drug toxicity|0|||
44241108|NCT02754141|79069158|FG003|Overall Study|Study drug toxicity|0|||
44241109|NCT02754141|79069159|FG004|Overall Study|Study drug toxicity|0|||
44121877|NCT02962765|78906114|FG000|Overall Study|Death|1|||
44121878|NCT02962765|78906114|FG000|Overall Study|Limited access to study medication|3|||
44241110|NCT02754141|79069160|FG005|Overall Study|Study drug toxicity|0|||
44241111|NCT02754141|79069161|FG006|Overall Study|Study drug toxicity|0|||
44241112|NCT02754141|79069162|FG007|Overall Study|Study drug toxicity|0|||
44241113|NCT02754141|79069163|FG008|Overall Study|Study drug toxicity|0|||
44241114|NCT02754141|79069164|FG009|Overall Study|Study drug toxicity|0|||
44241115|NCT02754141|79069165|FG010|Overall Study|Study drug toxicity|2|||
44241116|NCT02754141|79069166|FG011|Overall Study|Study drug toxicity|1|||
44241117|NCT02754141|79069167|FG012|Overall Study|Study drug toxicity|1|||
44241118|NCT02754141|79069168|FG013|Overall Study|Study drug toxicity|0|||
44509630|NCT00277355|79514776|FG001|Overall Study|Lost to Follow-up|2|||
44121879|NCT00965757|78906127|FG000|Double-blind Phase|Progression of concomitant disease|1|||
44121880|NCT00965757|78906128|FG001|Double-blind Phase|Progression of concomitant disease|2|||
44121881|NCT00965757|78906129|FG002|Double-blind Phase|Progression of concomitant disease|0|||
44121882|NCT00965757|78906130|FG003|Double-blind Phase|Progression of concomitant disease|0|||
44121883|NCT00965757|78906127|FG000|Double-blind Phase|Adverse drug reaction|2|||
44121884|NCT00965757|78906128|FG001|Double-blind Phase|Adverse drug reaction|1|||
44121885|NCT00965757|78906129|FG002|Double-blind Phase|Adverse drug reaction|0|||
44121886|NCT00965757|78906130|FG003|Double-blind Phase|Adverse drug reaction|0|||
44121887|NCT00965757|78906127|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
44121888|NCT00965757|78906128|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
44121889|NCT00965757|78906129|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
44121890|NCT00965757|78906130|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
44121891|NCT00965757|78906127|FG000|Double-blind Phase|Lack of Efficacy|7|||
44121892|NCT00965757|78906128|FG001|Double-blind Phase|Lack of Efficacy|11|||
44121893|NCT00965757|78906129|FG002|Double-blind Phase|Lack of Efficacy|0|||
44121894|NCT00965757|78906130|FG003|Double-blind Phase|Lack of Efficacy|0|||
44121895|NCT00965757|78906127|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
44121896|NCT00965757|78906128|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
44121897|NCT00965757|78906129|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
44121898|NCT00965757|78906130|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
44121899|NCT00965757|78906127|FG000|Double-blind Phase|Lost to Follow-up|0|||
44121900|NCT00965757|78906128|FG001|Double-blind Phase|Lost to Follow-up|1|||
44241119|NCT02754141|79069169|FG014|Overall Study|Study drug toxicity|0|||
44241120|NCT02754141|79069170|FG015|Overall Study|Study drug toxicity|0|||
44241121|NCT02754141|79069171|FG016|Overall Study|Study drug toxicity|0|||
44509631|NCT00277355|79514775|FG000|Overall Study|Adverse Event|5|||
44509632|NCT00277355|79514776|FG001|Overall Study|Adverse Event|0|||
44509633|NCT00277355|79514775|FG000|Overall Study|Death|3|||
44509634|NCT00277355|79514776|FG001|Overall Study|Death|0|||
44509635|NCT00277355|79514775|FG000|Overall Study|Physician Decision|1|||
44509636|NCT00277355|79514776|FG001|Overall Study|Physician Decision|0|||
44509637|NCT00262223|79514785|FG000|Treatment Phase|Withdrawal by Subject|3|||
44509638|NCT00262223|79514786|FG001|Treatment Phase|Withdrawal by Subject|6|||
44509639|NCT00262223|79514785|FG000|Treatment Phase|Adverse Event|1|||
44509640|NCT00262223|79514786|FG001|Treatment Phase|Adverse Event|2|||
44509641|NCT00262223|79514785|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
44509642|NCT00262223|79514786|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
44509643|NCT00262223|79514785|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
44509644|NCT00262223|79514786|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
44509645|NCT00262223|79514785|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
44241122|NCT02754141|79069172|FG017|Overall Study|Study drug toxicity|0|||
44241123|NCT02754141|79069155|FG000|Overall Study|AE unrelated to study drug|1|||
44509646|NCT00262223|79514786|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
44509647|NCT00276419|79514795|FG000|First Intervention|Adverse Event|1|||
44121901|NCT00965757|78906129|FG002|Double-blind Phase|Lost to Follow-up|0|||
44241124|NCT02754141|79069156|FG001|Overall Study|AE unrelated to study drug|1|||
44241125|NCT02754141|79069157|FG002|Overall Study|AE unrelated to study drug|0|||
44509648|NCT00276419|79514796|FG001|First Intervention|Adverse Event|0|||
44509649|NCT00276419|79514795|FG000|First Intervention|Withdrawal by Subject|0|||
44509650|NCT00276419|79514796|FG001|First Intervention|Withdrawal by Subject|2|||
44509651|NCT00262067|79514817|FG000|Overall Study|Death|190|||
44509652|NCT00262067|79514818|FG001|Overall Study|Death|89|||
44509653|NCT00262067|79514819|FG002|Overall Study|Death|186|||
44121902|NCT00965757|78906130|FG003|Double-blind Phase|Lost to Follow-up|0|||
44121903|NCT00965757|78906127|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
44121904|NCT00965757|78906128|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
44121905|NCT00965757|78906129|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
44121906|NCT00965757|78906130|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
44121907|NCT00965757|78906127|FG000|Double-blind Phase|Other|1|||
44121908|NCT00965757|78906128|FG001|Double-blind Phase|Other|0|||
44121909|NCT00965757|78906129|FG002|Double-blind Phase|Other|0|||
44121910|NCT00965757|78906130|FG003|Double-blind Phase|Other|0|||
44378942|NCT03010176|79384515|FG002|Overall Study|Physician Decision|0|||
44378943|NCT03010176|79384516|FG003|Overall Study|Physician Decision|1|||
44378944|NCT03010176|79384517|FG004|Overall Study|Physician Decision|0|||
44378945|NCT03010176|79384518|FG005|Overall Study|Physician Decision|0|||
44378946|NCT03010176|79384513|FG000|Overall Study|Sponsor Decision|0|||
44378947|NCT03010176|79384514|FG001|Overall Study|Sponsor Decision|4|||
44378948|NCT03010176|79384515|FG002|Overall Study|Sponsor Decision|4|||
44378949|NCT03010176|79384516|FG003|Overall Study|Sponsor Decision|1|||
44378950|NCT03010176|79384517|FG004|Overall Study|Sponsor Decision|6|||
44378951|NCT03010176|79384518|FG005|Overall Study|Sponsor Decision|0|||
44378952|NCT03010176|79384513|FG000|Overall Study|Withdrawal by Subject|11|||
44378953|NCT03010176|79384514|FG001|Overall Study|Withdrawal by Subject|9|||
44378954|NCT03010176|79384515|FG002|Overall Study|Withdrawal by Subject|3|||
44509654|NCT00262067|79514820|FG003|Overall Study|Death|99|||
44509655|NCT00262067|79514817|FG000|Overall Study|Lost to Follow-up|5|||
44509656|NCT00262067|79514818|FG001|Overall Study|Lost to Follow-up|4|||
44509657|NCT00262067|79514819|FG002|Overall Study|Lost to Follow-up|7|||
44509658|NCT00262067|79514820|FG003|Overall Study|Lost to Follow-up|5|||
44509659|NCT00262067|79514817|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
44509660|NCT00262067|79514818|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
44509661|NCT00262067|79514819|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
44509662|NCT00262067|79514820|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
44121911|NCT00965757|78906127|FG000|Extension Phase|Progression of concomitant disease|0|||
44121912|NCT00965757|78906128|FG001|Extension Phase|Progression of concomitant disease|0|||
44378955|NCT03010176|79384516|FG003|Overall Study|Withdrawal by Subject|0|||
44378956|NCT03010176|79384517|FG004|Overall Study|Withdrawal by Subject|4|||
44121913|NCT00965757|78906129|FG002|Extension Phase|Progression of concomitant disease|4|||
44378957|NCT03010176|79384518|FG005|Overall Study|Withdrawal by Subject|0|||
44509663|NCT00262067|79514817|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
44509664|NCT00262067|79514818|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
44509665|NCT00262067|79514819|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
44121914|NCT00965757|78906130|FG003|Extension Phase|Progression of concomitant disease|2|||
44121915|NCT00965757|78906127|FG000|Extension Phase|Adverse drug reaction|0|||
44121916|NCT00965757|78906128|FG001|Extension Phase|Adverse drug reaction|0|||
44121917|NCT00965757|78906129|FG002|Extension Phase|Adverse drug reaction|6|||
44121918|NCT00965757|78906130|FG003|Extension Phase|Adverse drug reaction|3|||
44121919|NCT00965757|78906127|FG000|Extension Phase|Abnormal Laboratory Value|0|||
44121920|NCT00965757|78906128|FG001|Extension Phase|Abnormal Laboratory Value|0|||
44121921|NCT00965757|78906129|FG002|Extension Phase|Abnormal Laboratory Value|6|||
44121922|NCT00965757|78906130|FG003|Extension Phase|Abnormal Laboratory Value|1|||
44121923|NCT00965757|78906127|FG000|Extension Phase|Lack of Efficacy|0|||
44121924|NCT00965757|78906128|FG001|Extension Phase|Lack of Efficacy|0|||
44121925|NCT00965757|78906129|FG002|Extension Phase|Lack of Efficacy|8|||
44121926|NCT00965757|78906130|FG003|Extension Phase|Lack of Efficacy|12|||
44121927|NCT00965757|78906127|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
44121928|NCT00965757|78906128|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
44121929|NCT00965757|78906129|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
44121930|NCT00965757|78906130|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
44121931|NCT00965757|78906127|FG000|Extension Phase|Lost to Follow-up|0|||
44121932|NCT00965757|78906128|FG001|Extension Phase|Lost to Follow-up|0|||
44121933|NCT00965757|78906129|FG002|Extension Phase|Lost to Follow-up|0|||
44121934|NCT00965757|78906130|FG003|Extension Phase|Lost to Follow-up|1|||
44121935|NCT00965757|78906127|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
44121936|NCT00965757|78906128|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
44121937|NCT00965757|78906129|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
44241126|NCT02754141|79069158|FG003|Overall Study|AE unrelated to study drug|1|||
44241127|NCT02754141|79069159|FG004|Overall Study|AE unrelated to study drug|3|||
44241128|NCT02754141|79069160|FG005|Overall Study|AE unrelated to study drug|2|||
44241129|NCT02754141|79069161|FG006|Overall Study|AE unrelated to study drug|1|||
44241130|NCT02754141|79069162|FG007|Overall Study|AE unrelated to study drug|0|||
44241131|NCT02754141|79069163|FG008|Overall Study|AE unrelated to study drug|0|||
44241132|NCT02754141|79069164|FG009|Overall Study|AE unrelated to study drug|0|||
44241133|NCT02754141|79069165|FG010|Overall Study|AE unrelated to study drug|0|||
44378958|NCT02954055|79384537|FG000|Overall Study|Did not initiate therapy|6|||
44509666|NCT00262067|79514820|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
44509667|NCT00275561|79514832|FG000|Overall Study|Withdrawal by Subject|0|||
44509668|NCT00275561|79514833|FG001|Overall Study|Withdrawal by Subject|1|||
44509669|NCT00275561|79514832|FG000|Overall Study|Travel|1|||
44509670|NCT00275561|79514833|FG001|Overall Study|Travel|1|||
44509671|NCT00275561|79514832|FG000|Overall Study|Scheduling|1|||
44509672|NCT00275561|79514833|FG001|Overall Study|Scheduling|2|||
44509673|NCT00275561|79514832|FG000|Overall Study|Family Issues|0|||
44509674|NCT00275561|79514833|FG001|Overall Study|Family Issues|2|||
44121938|NCT00965757|78906130|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
44241134|NCT02754141|79069166|FG011|Overall Study|AE unrelated to study drug|0|||
44509675|NCT00274937|79514843|FG000|Overall Study|Physician Decision|10|||
44509676|NCT00274937|79514843|FG000|Overall Study|Withdrawal by Subject|6|||
44121939|NCT00965757|78906127|FG000|Extension Phase|Protocol Violation|0|||
44509677|NCT00274937|79514843|FG000|Overall Study|Progressive Disease|4|||
44241135|NCT02754141|79069167|FG012|Overall Study|AE unrelated to study drug|0|||
44241136|NCT02754141|79069168|FG013|Overall Study|AE unrelated to study drug|0|||
44241137|NCT02754141|79069169|FG014|Overall Study|AE unrelated to study drug|0|||
44241138|NCT02754141|79069170|FG015|Overall Study|AE unrelated to study drug|0|||
44241139|NCT02754141|79069171|FG016|Overall Study|AE unrelated to study drug|0|||
44241140|NCT02754141|79069172|FG017|Overall Study|AE unrelated to study drug|0|||
44241141|NCT02754141|79069155|FG000|Overall Study|Request to discontinue|0|||
44241142|NCT02754141|79069156|FG001|Overall Study|Request to discontinue|0|||
44241143|NCT02754141|79069157|FG002|Overall Study|Request to discontinue|0|||
44241144|NCT02754141|79069158|FG003|Overall Study|Request to discontinue|0|||
44241145|NCT02754141|79069159|FG004|Overall Study|Request to discontinue|0|||
44241146|NCT02754141|79069160|FG005|Overall Study|Request to discontinue|0|||
44241147|NCT02754141|79069161|FG006|Overall Study|Request to discontinue|0|||
44121940|NCT00965757|78906128|FG001|Extension Phase|Protocol Violation|0|||
44121941|NCT00965757|78906129|FG002|Extension Phase|Protocol Violation|0|||
44121942|NCT00965757|78906130|FG003|Extension Phase|Protocol Violation|1|||
44121943|NCT00965757|78906127|FG000|Extension Phase|Other|0|||
44241148|NCT02754141|79069162|FG007|Overall Study|Request to discontinue|0|||
44241149|NCT02754141|79069163|FG008|Overall Study|Request to discontinue|1|||
44241150|NCT02754141|79069164|FG009|Overall Study|Request to discontinue|0|||
44241151|NCT02754141|79069165|FG010|Overall Study|Request to discontinue|0|||
44121944|NCT00965757|78906128|FG001|Extension Phase|Other|0|||
44241152|NCT02754141|79069166|FG011|Overall Study|Request to discontinue|0|||
44241153|NCT02754141|79069167|FG012|Overall Study|Request to discontinue|0|||
44241154|NCT02754141|79069168|FG013|Overall Study|Request to discontinue|1|||
44241155|NCT02754141|79069169|FG014|Overall Study|Request to discontinue|1|||
44241156|NCT02754141|79069170|FG015|Overall Study|Request to discontinue|0|||
44241157|NCT02754141|79069171|FG016|Overall Study|Request to discontinue|0|||
44241158|NCT02754141|79069172|FG017|Overall Study|Request to discontinue|0|||
44241159|NCT02754141|79069155|FG000|Overall Study|Withdrew consent|0|||
44241160|NCT02754141|79069156|FG001|Overall Study|Withdrew consent|0|||
44121945|NCT00965757|78906129|FG002|Extension Phase|Other|2|||
44121946|NCT00965757|78906130|FG003|Extension Phase|Other|1|||
44121947|NCT03072459|78906138|FG000|Overall Study|Device revised/removed|1|||
44121948|NCT03072459|78906138|FG000|Overall Study|Subject not able to return|1|||
44121949|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
44241161|NCT02754141|79069157|FG002|Overall Study|Withdrew consent|0|||
44241162|NCT02754141|79069158|FG003|Overall Study|Withdrew consent|0|||
44241163|NCT02754141|79069159|FG004|Overall Study|Withdrew consent|0|||
44241164|NCT02754141|79069160|FG005|Overall Study|Withdrew consent|0|||
44241165|NCT02754141|79069161|FG006|Overall Study|Withdrew consent|0|||
44241166|NCT02754141|79069162|FG007|Overall Study|Withdrew consent|0|||
44241167|NCT02754141|79069163|FG008|Overall Study|Withdrew consent|0|||
44509678|NCT00251693|79514850|FG000|Overall Study|Adverse Event|17|||
44509679|NCT00251693|79514851|FG001|Overall Study|Adverse Event|9|||
44509680|NCT00251693|79514852|FG002|Overall Study|Adverse Event|9|||
44509681|NCT00251693|79514850|FG000|Overall Study|Protocol Violation|2|||
44509682|NCT00251693|79514851|FG001|Overall Study|Protocol Violation|0|||
44509683|NCT00251693|79514852|FG002|Overall Study|Protocol Violation|2|||
44509684|NCT00251693|79514850|FG000|Overall Study|Lost to Follow-up|12|||
44509685|NCT00251693|79514851|FG001|Overall Study|Lost to Follow-up|7|||
44509686|NCT00251693|79514852|FG002|Overall Study|Lost to Follow-up|8|||
44509687|NCT00251693|79514850|FG000|Overall Study|Withdrawal by Subject|11|||
44509688|NCT00251693|79514851|FG001|Overall Study|Withdrawal by Subject|17|||
44509689|NCT00251693|79514852|FG002|Overall Study|Withdrawal by Subject|14|||
44509690|NCT00251693|79514850|FG000|Overall Study|Lack of Efficacy|0|||
44509691|NCT00251693|79514851|FG001|Overall Study|Lack of Efficacy|1|||
44509692|NCT00251693|79514852|FG002|Overall Study|Lack of Efficacy|0|||
44509693|NCT00251693|79514850|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
44509694|NCT00251693|79514851|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
44509695|NCT00251693|79514852|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
44509696|NCT00251693|79514850|FG000|Overall Study|Noncompliant|0|||
44509697|NCT00251693|79514851|FG001|Overall Study|Noncompliant|0|||
44509698|NCT00251693|79514852|FG002|Overall Study|Noncompliant|2|||
44509699|NCT00251693|79514850|FG000|Overall Study|Possible Barrett's esophagus|3|||
44509700|NCT00251693|79514851|FG001|Overall Study|Possible Barrett's esophagus|5|||
44509701|NCT00251693|79514852|FG002|Overall Study|Possible Barrett's esophagus|2|||
44509702|NCT00251693|79514850|FG000|Overall Study|Subject request/subject unavailable|1|||
44509703|NCT00251693|79514851|FG001|Overall Study|Subject request/subject unavailable|2|||
44509704|NCT00251693|79514852|FG002|Overall Study|Subject request/subject unavailable|0|||
44509705|NCT00251693|79514850|FG000|Overall Study|Abnormal laboratory findings|0|||
44509706|NCT00251693|79514851|FG001|Overall Study|Abnormal laboratory findings|0|||
44509707|NCT00251693|79514852|FG002|Overall Study|Abnormal laboratory findings|1|||
44509708|NCT00250835|79514860|FG000|Overall Study|Withdrawal by Subject|1|||
44509709|NCT03716024|79514870|FG000|Overall Study|Randomized, not Treated|7|||
44509710|NCT03716024|79514871|FG001|Overall Study|Randomized, not Treated|8|||
44509711|NCT03716024|79514870|FG000|Overall Study|Adverse Event|1|||
44509712|NCT03716024|79514871|FG001|Overall Study|Adverse Event|2|||
44509713|NCT03716024|79514870|FG000|Overall Study|Treatment Failure|1|||
44509714|NCT03716024|79514871|FG001|Overall Study|Treatment Failure|0|||
44241168|NCT02754141|79069164|FG009|Overall Study|Withdrew consent|1|||
44509715|NCT03716024|79514870|FG000|Overall Study|Lost to Follow-up|2|||
44509716|NCT03716024|79514871|FG001|Overall Study|Lost to Follow-up|6|||
44509717|NCT03716024|79514870|FG000|Overall Study|Withdrawal by Subject|0|||
44509718|NCT03716024|79514871|FG001|Overall Study|Withdrawal by Subject|1|||
44509719|NCT03716024|79514870|FG000|Overall Study|Missing Reason|0|||
44509720|NCT03716024|79514871|FG001|Overall Study|Missing Reason|1|||
44241169|NCT02754141|79069165|FG010|Overall Study|Withdrew consent|0|||
44241170|NCT02754141|79069166|FG011|Overall Study|Withdrew consent|0|||
44241171|NCT02754141|79069167|FG012|Overall Study|Withdrew consent|0|||
44241172|NCT02754141|79069168|FG013|Overall Study|Withdrew consent|0|||
44241173|NCT02754141|79069169|FG014|Overall Study|Withdrew consent|0|||
44509721|NCT00250679|79514880|FG000|Overall Study|Adverse Event|12|||
44509722|NCT00250679|79514881|FG001|Overall Study|Adverse Event|15|||
44509723|NCT00250679|79514882|FG002|Overall Study|Adverse Event|16|||
44509724|NCT00250679|79514880|FG000|Overall Study|Protocol Violation|2|||
44509725|NCT00250679|79514881|FG001|Overall Study|Protocol Violation|4|||
44509726|NCT00250679|79514882|FG002|Overall Study|Protocol Violation|3|||
44509727|NCT00250679|79514880|FG000|Overall Study|Withdrawal by Subject|15|||
44509728|NCT00250679|79514881|FG001|Overall Study|Withdrawal by Subject|18|||
44509729|NCT00250679|79514882|FG002|Overall Study|Withdrawal by Subject|15|||
44509730|NCT00250679|79514880|FG000|Overall Study|Lost to Follow-up|3|||
44509731|NCT00250679|79514881|FG001|Overall Study|Lost to Follow-up|4|||
44509732|NCT00250679|79514882|FG002|Overall Study|Lost to Follow-up|2|||
44509733|NCT00250679|79514880|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
44509734|NCT00250679|79514881|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
44509735|NCT00250679|79514882|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
44509736|NCT00250679|79514880|FG000|Overall Study|Lack of Efficacy|0|||
44509737|NCT00250679|79514881|FG001|Overall Study|Lack of Efficacy|1|||
44509738|NCT00250679|79514882|FG002|Overall Study|Lack of Efficacy|3|||
44241174|NCT02754141|79069170|FG015|Overall Study|Withdrew consent|0|||
44241175|NCT02754141|79069171|FG016|Overall Study|Withdrew consent|0|||
44241176|NCT02754141|79069172|FG017|Overall Study|Withdrew consent|0|||
44241177|NCT02754141|79069155|FG000|Overall Study|Maximum clinical benefit|0|||
44509739|NCT00250679|79514880|FG000|Overall Study|Technical Holter issues|1|||
44509740|NCT00250679|79514881|FG001|Overall Study|Technical Holter issues|0|||
44509741|NCT00250679|79514882|FG002|Overall Study|Technical Holter issues|2|||
44509742|NCT00250679|79514880|FG000|Overall Study|Moved|1|||
44509743|NCT00250679|79514881|FG001|Overall Study|Moved|1|||
44509744|NCT00250679|79514882|FG002|Overall Study|Moved|0|||
44509745|NCT00250679|79514880|FG000|Overall Study|Non-compliance|1|||
44509746|NCT00250679|79514881|FG001|Overall Study|Non-compliance|1|||
44509747|NCT00250679|79514882|FG002|Overall Study|Non-compliance|0|||
44121950|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
44121951|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
44121952|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
44121953|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
44121954|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
44121955|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
44121956|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
44121957|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
44121958|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
44121959|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
44121960|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
44121961|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
44121962|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
44241178|NCT02754141|79069156|FG001|Overall Study|Maximum clinical benefit|0|||
44276383|NCT02156076|79230905|FG003|Treatment Period|Adverse Event|1|||
44241179|NCT02754141|79069157|FG002|Overall Study|Maximum clinical benefit|0|||
44241180|NCT02754141|79069158|FG003|Overall Study|Maximum clinical benefit|1|||
44241181|NCT02754141|79069159|FG004|Overall Study|Maximum clinical benefit|0|||
44241182|NCT02754141|79069160|FG005|Overall Study|Maximum clinical benefit|0|||
44241183|NCT02754141|79069161|FG006|Overall Study|Maximum clinical benefit|0|||
44378959|NCT02954055|79384538|FG001|Overall Study|Did not initiate therapy|1|||
44378960|NCT02589392|79384552|FG000|Overall Study|Adverse Event|1|||
44378961|NCT02589392|79384553|FG001|Overall Study|Adverse Event|1|||
44378962|NCT02589392|79384552|FG000|Overall Study|Withdrawal by Subject|1|||
44378963|NCT02589392|79384553|FG001|Overall Study|Withdrawal by Subject|2|||
44378964|NCT02589392|79384552|FG000|Overall Study|Protocol Violation|1|||
44378965|NCT02589392|79384553|FG001|Overall Study|Protocol Violation|1|||
44378966|NCT02589392|79384552|FG000|Overall Study|Lost to Follow-up|2|||
44378967|NCT02589392|79384553|FG001|Overall Study|Lost to Follow-up|2|||
44378968|NCT02589392|79384552|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
44378969|NCT02589392|79384553|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
44378970|NCT02536742|79384559|FG000|Overall Study|Did not start protocol therapy|1|||
44378971|NCT02536742|79384559|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
44378972|NCT02091960|79384563|FG000|Overall Study|Death|7|||
44378973|NCT02091960|79384563|FG000|Overall Study|Withdrawal by Subject|1|||
44378974|NCT02091960|79384563|FG000|Overall Study|Miscellaneous Reasons|31|||
44378975|NCT02091960|79384563|FG000|Overall Study|On Study at Data Cut-off|12|||
44378976|NCT02043678|79384569|FG000|Overall Study|Never treated|11|||
44378977|NCT02043678|79384570|FG001|Overall Study|Never treated|9|||
44378978|NCT02043678|79384569|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
44378979|NCT02043678|79384570|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
44378980|NCT02043678|79384569|FG000|Overall Study|AE without clinical PD|51|||
44378981|NCT02043678|79384570|FG001|Overall Study|AE without clinical PD|34|||
44378982|NCT02043678|79384569|FG000|Overall Study|Lost to Follow-up|1|||
44241184|NCT02754141|79069162|FG007|Overall Study|Maximum clinical benefit|0|||
44241185|NCT02754141|79069163|FG008|Overall Study|Maximum clinical benefit|0|||
44241186|NCT02754141|79069164|FG009|Overall Study|Maximum clinical benefit|0|||
44241187|NCT02754141|79069165|FG010|Overall Study|Maximum clinical benefit|0|||
44241188|NCT02754141|79069166|FG011|Overall Study|Maximum clinical benefit|0|||
44241189|NCT02754141|79069167|FG012|Overall Study|Maximum clinical benefit|0|||
44241190|NCT02754141|79069168|FG013|Overall Study|Maximum clinical benefit|0|||
44241191|NCT02754141|79069169|FG014|Overall Study|Maximum clinical benefit|0|||
44241192|NCT02754141|79069170|FG015|Overall Study|Maximum clinical benefit|0|||
44241193|NCT02754141|79069171|FG016|Overall Study|Maximum clinical benefit|0|||
44241194|NCT02754141|79069172|FG017|Overall Study|Maximum clinical benefit|0|||
44241195|NCT02754141|79069155|FG000|Overall Study|No longer meets study criteria|0|||
44241196|NCT02754141|79069156|FG001|Overall Study|No longer meets study criteria|0|||
44241197|NCT02754141|79069157|FG002|Overall Study|No longer meets study criteria|0|||
44241198|NCT02754141|79069158|FG003|Overall Study|No longer meets study criteria|1|||
44241199|NCT02754141|79069159|FG004|Overall Study|No longer meets study criteria|0|||
44241200|NCT02754141|79069160|FG005|Overall Study|No longer meets study criteria|0|||
44241201|NCT02754141|79069161|FG006|Overall Study|No longer meets study criteria|0|||
44241202|NCT02754141|79069162|FG007|Overall Study|No longer meets study criteria|0|||
44241203|NCT02754141|79069163|FG008|Overall Study|No longer meets study criteria|0|||
44241204|NCT02754141|79069164|FG009|Overall Study|No longer meets study criteria|0|||
44241205|NCT02754141|79069165|FG010|Overall Study|No longer meets study criteria|0|||
44241206|NCT02754141|79069166|FG011|Overall Study|No longer meets study criteria|0|||
44241207|NCT02754141|79069167|FG012|Overall Study|No longer meets study criteria|0|||
44241208|NCT02754141|79069168|FG013|Overall Study|No longer meets study criteria|0|||
44241209|NCT02754141|79069169|FG014|Overall Study|No longer meets study criteria|0|||
44241210|NCT02754141|79069170|FG015|Overall Study|No longer meets study criteria|0|||
44241211|NCT02754141|79069171|FG016|Overall Study|No longer meets study criteria|0|||
44241212|NCT02754141|79069172|FG017|Overall Study|No longer meets study criteria|0|||
44241213|NCT02754141|79069155|FG000|Overall Study|Other reasons|0|||
44241214|NCT02754141|79069156|FG001|Overall Study|Other reasons|0|||
44276384|NCT02156076|79230902|FG000|Follow-up Period|Withdrawal by Subject|1|||
44509748|NCT00250679|79514880|FG000|Overall Study|various single events: hip surgery,diary|3|||
44509749|NCT00250679|79514881|FG001|Overall Study|various single events: hip surgery,diary|1|||
44509750|NCT00250679|79514882|FG002|Overall Study|various single events: hip surgery,diary|1|||
44276385|NCT02156076|79230903|FG001|Follow-up Period|Withdrawal by Subject|0|||
44378983|NCT02043678|79384570|FG001|Overall Study|Lost to Follow-up|1|||
44378984|NCT02043678|79384569|FG000|Overall Study|Other|19|||
44378985|NCT02043678|79384570|FG001|Overall Study|Other|16|||
44241215|NCT02754141|79069157|FG002|Overall Study|Other reasons|0|||
44241216|NCT02754141|79069158|FG003|Overall Study|Other reasons|0|||
44241217|NCT02754141|79069159|FG004|Overall Study|Other reasons|0|||
44241218|NCT02754141|79069160|FG005|Overall Study|Other reasons|0|||
44241219|NCT02754141|79069161|FG006|Overall Study|Other reasons|0|||
44241220|NCT02754141|79069162|FG007|Overall Study|Other reasons|1|||
44509751|NCT00261833|79514892|FG000|Overall Study|Death|1|||
44378986|NCT02043678|79384569|FG000|Overall Study|Clinical PD|108|||
44378987|NCT02043678|79384570|FG001|Overall Study|Clinical PD|138|||
44378988|NCT02043678|79384569|FG000|Overall Study|Radiological PD|91|||
44378989|NCT02043678|79384570|FG001|Overall Study|Radiological PD|80|||
44378990|NCT02043678|79384569|FG000|Overall Study|Protocol-driven decision point|56|||
44378991|NCT02043678|79384570|FG001|Overall Study|Protocol-driven decision point|56|||
44378992|NCT02043678|79384569|FG000|Overall Study|Withdrawal by Subject|12|||
44378993|NCT02043678|79384570|FG001|Overall Study|Withdrawal by Subject|15|||
44378994|NCT02043678|79384569|FG000|Overall Study|Ongoing with treatment|34|||
44378995|NCT02043678|79384570|FG001|Overall Study|Ongoing with treatment|38|||
44378996|NCT02029443|79384581|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
44378997|NCT02029443|79384582|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
44378998|NCT02029443|79384583|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
44509752|NCT00261833|79514893|FG001|Overall Study|Death|3|||
44509753|NCT00261833|79514892|FG000|Overall Study|Adverse Event|1|||
44509754|NCT00261833|79514893|FG001|Overall Study|Adverse Event|4|||
44509755|NCT00261833|79514892|FG000|Overall Study|Withdrawal by Subject|5|||
44509756|NCT00261833|79514893|FG001|Overall Study|Withdrawal by Subject|7|||
44509757|NCT00261833|79514892|FG000|Overall Study|Protocol Violation|0|||
44509758|NCT00261833|79514893|FG001|Overall Study|Protocol Violation|1|||
44509759|NCT00261833|79514892|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
44509760|NCT00261833|79514893|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
44509761|NCT00261833|79514892|FG000|Overall Study|Lung transplantation|1|||
44509762|NCT00261833|79514893|FG001|Overall Study|Lung transplantation|1|||
44509763|NCT00261833|79514892|FG000|Overall Study|Missing reason|1|||
44509764|NCT00261833|79514893|FG001|Overall Study|Missing reason|0|||
44509765|NCT00261833|79514892|FG000|Overall Study|Not interested in being participant|0|||
44509766|NCT00261833|79514893|FG001|Overall Study|Not interested in being participant|1|||
44509767|NCT03713684|79514904|FG000|Overall Study|Adverse Event|1|||
44509768|NCT03713684|79514905|FG001|Overall Study|Adverse Event|3|||
44509769|NCT03713684|79514906|FG002|Overall Study|Adverse Event|1|||
44509770|NCT03713684|79514907|FG003|Overall Study|Adverse Event|0|||
44509771|NCT03713684|79514904|FG000|Overall Study|Poor compliance to protocol|2|||
44509772|NCT03713684|79514905|FG001|Overall Study|Poor compliance to protocol|1|||
44509773|NCT03713684|79514906|FG002|Overall Study|Poor compliance to protocol|0|||
44509774|NCT03713684|79514907|FG003|Overall Study|Poor compliance to protocol|1|||
44509775|NCT03713684|79514904|FG000|Overall Study|Withdrawal by Subject|14|||
44509776|NCT03713684|79514905|FG001|Overall Study|Withdrawal by Subject|6|||
44509777|NCT03713684|79514906|FG002|Overall Study|Withdrawal by Subject|14|||
44509778|NCT03713684|79514907|FG003|Overall Study|Withdrawal by Subject|16|||
44509779|NCT03713684|79514904|FG000|Overall Study|Other than specified|69|||
44509780|NCT03713684|79514905|FG001|Overall Study|Other than specified|77|||
44509781|NCT03713684|79514906|FG002|Overall Study|Other than specified|73|||
44509782|NCT03713684|79514907|FG003|Overall Study|Other than specified|70|||
44509783|NCT03711266|79514917|FG000|Overall Study|Lost to Follow-up|10|||
44509784|NCT03150862|79514929|FG000|Overall Study|Death|2|||
44509785|NCT03150862|79514930|FG001|Overall Study|Death|7|||
44509786|NCT03150862|79514931|FG002|Overall Study|Death|8|||
44509787|NCT03150862|79514932|FG003|Overall Study|Death|27|||
44509788|NCT03150862|79514933|FG004|Overall Study|Death|4|||
44509789|NCT03150862|79514934|FG005|Overall Study|Death|8|||
44509790|NCT03150862|79514935|FG006|Overall Study|Death|6|||
44509791|NCT03150862|79514936|FG007|Overall Study|Death|21|||
44509792|NCT03150862|79514929|FG000|Overall Study|Withdrawal by Subject|1|||
44509793|NCT03150862|79514930|FG001|Overall Study|Withdrawal by Subject|1|||
44509794|NCT03150862|79514931|FG002|Overall Study|Withdrawal by Subject|0|||
44509795|NCT03150862|79514932|FG003|Overall Study|Withdrawal by Subject|3|||
44509796|NCT03150862|79514933|FG004|Overall Study|Withdrawal by Subject|1|||
44509797|NCT03150862|79514934|FG005|Overall Study|Withdrawal by Subject|1|||
44509798|NCT03150862|79514935|FG006|Overall Study|Withdrawal by Subject|1|||
44509799|NCT03150862|79514936|FG007|Overall Study|Withdrawal by Subject|3|||
44378999|NCT02029443|79384584|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
44379000|NCT02029443|79384585|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
44379001|NCT02029443|79384581|FG000|Overall Study|Death|13|||
44379002|NCT02029443|79384582|FG001|Overall Study|Death|2|||
44379003|NCT02029443|79384583|FG002|Overall Study|Death|2|||
44379004|NCT02029443|79384584|FG003|Overall Study|Death|11|||
44509800|NCT03150862|79514929|FG000|Overall Study|Lost to Follow-up|0|||
44509801|NCT03150862|79514930|FG001|Overall Study|Lost to Follow-up|0|||
44509802|NCT03150862|79514931|FG002|Overall Study|Lost to Follow-up|1|||
44509803|NCT03150862|79514932|FG003|Overall Study|Lost to Follow-up|0|||
44509804|NCT03150862|79514933|FG004|Overall Study|Lost to Follow-up|0|||
44509805|NCT03150862|79514934|FG005|Overall Study|Lost to Follow-up|0|||
44509806|NCT03150862|79514935|FG006|Overall Study|Lost to Follow-up|0|||
44509807|NCT03150862|79514936|FG007|Overall Study|Lost to Follow-up|2|||
44509808|NCT03150862|79514929|FG000|Overall Study|Sponsor's decision|0|||
44509809|NCT03150862|79514930|FG001|Overall Study|Sponsor's decision|0|||
44241221|NCT02754141|79069163|FG008|Overall Study|Other reasons|0|||
44241222|NCT02754141|79069164|FG009|Overall Study|Other reasons|0|||
44241223|NCT02754141|79069165|FG010|Overall Study|Other reasons|0|||
44241224|NCT02754141|79069166|FG011|Overall Study|Other reasons|0|||
44241225|NCT02754141|79069167|FG012|Overall Study|Other reasons|2|||
44241226|NCT02754141|79069168|FG013|Overall Study|Other reasons|0|||
44241227|NCT02754141|79069169|FG014|Overall Study|Other reasons|0|||
44379005|NCT02029443|79384585|FG004|Overall Study|Death|2|||
44379006|NCT02029443|79384581|FG000|Overall Study|Lost to Follow-up|1|||
44379007|NCT02029443|79384582|FG001|Overall Study|Lost to Follow-up|0|||
44509810|NCT03150862|79514931|FG002|Overall Study|Sponsor's decision|0|||
44509811|NCT03150862|79514932|FG003|Overall Study|Sponsor's decision|10|||
44509812|NCT03150862|79514933|FG004|Overall Study|Sponsor's decision|3|||
44241228|NCT02754141|79069170|FG015|Overall Study|Other reasons|0|||
44241229|NCT02754141|79069171|FG016|Overall Study|Other reasons|0|||
44241230|NCT02754141|79069172|FG017|Overall Study|Other reasons|0|||
44241231|NCT02754141|79069155|FG000|Overall Study|Completed treatment as per protocol|0|||
44241232|NCT02754141|79069156|FG001|Overall Study|Completed treatment as per protocol|1|||
44241233|NCT02754141|79069157|FG002|Overall Study|Completed treatment as per protocol|0|||
44241234|NCT02754141|79069158|FG003|Overall Study|Completed treatment as per protocol|0|||
44241235|NCT02754141|79069159|FG004|Overall Study|Completed treatment as per protocol|0|||
44241236|NCT02754141|79069160|FG005|Overall Study|Completed treatment as per protocol|0|||
44241237|NCT02754141|79069161|FG006|Overall Study|Completed treatment as per protocol|0|||
44241238|NCT02754141|79069162|FG007|Overall Study|Completed treatment as per protocol|0|||
44509813|NCT03150862|79514934|FG005|Overall Study|Sponsor's decision|0|||
44241239|NCT02754141|79069163|FG008|Overall Study|Completed treatment as per protocol|0|||
44241240|NCT02754141|79069164|FG009|Overall Study|Completed treatment as per protocol|0|||
44241241|NCT02754141|79069165|FG010|Overall Study|Completed treatment as per protocol|0|||
44241242|NCT02754141|79069166|FG011|Overall Study|Completed treatment as per protocol|0|||
44241243|NCT02754141|79069167|FG012|Overall Study|Completed treatment as per protocol|1|||
44241244|NCT02754141|79069168|FG013|Overall Study|Completed treatment as per protocol|0|||
44241245|NCT02754141|79069169|FG014|Overall Study|Completed treatment as per protocol|0|||
44241246|NCT02754141|79069170|FG015|Overall Study|Completed treatment as per protocol|0|||
44241247|NCT02754141|79069171|FG016|Overall Study|Completed treatment as per protocol|0|||
44241248|NCT02754141|79069172|FG017|Overall Study|Completed treatment as per protocol|0|||
44241249|NCT02754141|79069155|FG000|Overall Study|Not completing monotherapy|0|||
44379008|NCT02029443|79384583|FG002|Overall Study|Lost to Follow-up|1|||
44509814|NCT03150862|79514935|FG006|Overall Study|Sponsor's decision|1|||
44509815|NCT03150862|79514936|FG007|Overall Study|Sponsor's decision|1|||
44509816|NCT03150862|79514929|FG000|Overall Study|Change in Methylation status|0|||
44509817|NCT03150862|79514930|FG001|Overall Study|Change in Methylation status|0|||
44241250|NCT02754141|79069156|FG001|Overall Study|Not completing monotherapy|0|||
44241251|NCT02754141|79069157|FG002|Overall Study|Not completing monotherapy|0|||
44241252|NCT02754141|79069158|FG003|Overall Study|Not completing monotherapy|0|||
44241253|NCT02754141|79069159|FG004|Overall Study|Not completing monotherapy|0|||
44379009|NCT02029443|79384584|FG003|Overall Study|Lost to Follow-up|1|||
44379010|NCT02029443|79384585|FG004|Overall Study|Lost to Follow-up|0|||
44379011|NCT02029443|79384581|FG000|Overall Study|Started other anti-cancer therapy|17|||
44379012|NCT02029443|79384582|FG001|Overall Study|Started other anti-cancer therapy|4|||
44241254|NCT02754141|79069160|FG005|Overall Study|Not completing monotherapy|0|||
44241255|NCT02754141|79069161|FG006|Overall Study|Not completing monotherapy|0|||
44241256|NCT02754141|79069162|FG007|Overall Study|Not completing monotherapy|0|||
44241257|NCT02754141|79069163|FG008|Overall Study|Not completing monotherapy|0|||
44241258|NCT02754141|79069164|FG009|Overall Study|Not completing monotherapy|0|||
44241259|NCT02754141|79069165|FG010|Overall Study|Not completing monotherapy|0|||
44241260|NCT02754141|79069166|FG011|Overall Study|Not completing monotherapy|0|||
44241261|NCT02754141|79069167|FG012|Overall Study|Not completing monotherapy|0|||
44241262|NCT02754141|79069168|FG013|Overall Study|Not completing monotherapy|1|||
44241263|NCT02754141|79069169|FG014|Overall Study|Not completing monotherapy|0|||
44241264|NCT02754141|79069170|FG015|Overall Study|Not completing monotherapy|0|||
44241265|NCT02754141|79069171|FG016|Overall Study|Not completing monotherapy|0|||
44241266|NCT02754141|79069172|FG017|Overall Study|Not completing monotherapy|0|||
44241267|NCT02659059|79069251|FG000|Overall Study|Other reasons|6|||
44241268|NCT02659059|79069252|FG001|Overall Study|Other reasons|1|||
44241269|NCT02659059|79069251|FG000|Overall Study|Disease Progression|143|||
44241270|NCT02659059|79069252|FG001|Overall Study|Disease Progression|16|||
44241271|NCT02659059|79069251|FG000|Overall Study|Study Drug toxicity|56|||
44241272|NCT02659059|79069252|FG001|Overall Study|Study Drug toxicity|9|||
44241273|NCT02659059|79069251|FG000|Overall Study|Death|3|||
44241274|NCT02659059|79069252|FG001|Overall Study|Death|1|||
44241275|NCT02659059|79069251|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
44241276|NCT02659059|79069252|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
44241277|NCT02659059|79069251|FG000|Overall Study|Participant request to discontinue study treatment|5|||
44379013|NCT02029443|79384583|FG002|Overall Study|Started other anti-cancer therapy|7|||
44509818|NCT03150862|79514931|FG002|Overall Study|Change in Methylation status|0|||
44509819|NCT03150862|79514932|FG003|Overall Study|Change in Methylation status|0|||
44509820|NCT03150862|79514933|FG004|Overall Study|Change in Methylation status|1|||
44509821|NCT03150862|79514934|FG005|Overall Study|Change in Methylation status|0|||
44121963|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
44121964|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
44121965|NCT01067521|78906144|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
44121966|NCT01067521|78906145|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
44121967|NCT01067521|78906144|FG000|Open-Label Period|Death|3|||
44121968|NCT01067521|78906145|FG001|Open-Label Period|Death|1|||
44121969|NCT01067521|78906144|FG000|Open-Label Period|Adverse Event|30|||
44121970|NCT01067521|78906145|FG001|Open-Label Period|Adverse Event|28|||
44509822|NCT03150862|79514935|FG006|Overall Study|Change in Methylation status|0|||
44509823|NCT03150862|79514936|FG007|Overall Study|Change in Methylation status|0|||
44509824|NCT03150862|79514929|FG000|Overall Study|Roll over in to Long Term Extension|0|||
44509825|NCT03150862|79514930|FG001|Overall Study|Roll over in to Long Term Extension|0|||
44509826|NCT03150862|79514931|FG002|Overall Study|Roll over in to Long Term Extension|0|||
44509827|NCT03150862|79514932|FG003|Overall Study|Roll over in to Long Term Extension|0|||
44509828|NCT03150862|79514933|FG004|Overall Study|Roll over in to Long Term Extension|0|||
44509829|NCT03150862|79514934|FG005|Overall Study|Roll over in to Long Term Extension|0|||
44121971|NCT01067521|78906144|FG000|Open-Label Period|Withdrawal by Subject|160|||
44121972|NCT01067521|78906145|FG001|Open-Label Period|Withdrawal by Subject|88|||
44241278|NCT02659059|79069252|FG001|Overall Study|Participant request to discontinue study treatment|0|||
44379014|NCT02029443|79384584|FG003|Overall Study|Started other anti-cancer therapy|9|||
44241279|NCT02659059|79069251|FG000|Overall Study|Participant withdrew consent|6|||
44379015|NCT02029443|79384585|FG004|Overall Study|Started other anti-cancer therapy|3|||
44509830|NCT03150862|79514935|FG006|Overall Study|Roll over in to Long Term Extension|0|||
44241280|NCT02659059|79069252|FG001|Overall Study|Participant withdrew consent|1|||
44241281|NCT01164891|79069267|FG000|Overall Study|Disease Progression|5|||
44241282|NCT01164891|79069267|FG000|Overall Study|Adverse Event|1|||
44241283|NCT01497899|79069276|FG000|Double-Blind Phase|Randomized but not Treated|1|||
44241284|NCT01497899|79069277|FG001|Double-Blind Phase|Randomized but not Treated|0|||
44241285|NCT01497899|79069278|FG002|Double-Blind Phase|Randomized but not Treated|0|||
44241286|NCT01497899|79069279|FG003|Double-Blind Phase|Randomized but not Treated|0|||
44379016|NCT02029443|79384581|FG000|Overall Study|Withdrawal by Subject|3|||
44121973|NCT01067521|78906144|FG000|Open-Label Period|Physician Decision|13|||
44121974|NCT01067521|78906145|FG001|Open-Label Period|Physician Decision|11|||
44121975|NCT01067521|78906144|FG000|Open-Label Period|Non-compliance with study drug|5|||
44121976|NCT01067521|78906145|FG001|Open-Label Period|Non-compliance with study drug|0|||
44121977|NCT01067521|78906144|FG000|Open-Label Period|Protocol Violation|3|||
44121978|NCT01067521|78906145|FG001|Open-Label Period|Protocol Violation|0|||
44121979|NCT01067521|78906144|FG000|Open-Label Period|Pregnancy|14|||
44121980|NCT01067521|78906145|FG001|Open-Label Period|Pregnancy|8|||
44121981|NCT01067521|78906144|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
44121982|NCT01067521|78906145|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
44121983|NCT01067521|78906144|FG000|Open-Label Period|Lost to Follow-up|21|||
44121984|NCT01067521|78906145|FG001|Open-Label Period|Lost to Follow-up|20|||
44121985|NCT02735577|78906156|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
44121986|NCT02735577|78906156|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
44121987|NCT01345123|78906163|FG000|Overall Study|participants no longer with health plan|79|||
44121988|NCT01345123|78906164|FG001|Overall Study|participants no longer with health plan|85|||
44121989|NCT01345123|78906165|FG002|Overall Study|participants no longer with health plan|88|||
44121990|NCT02735421|78906174|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
44121991|NCT02735421|78906174|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
44121992|NCT02735421|78906174|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
44121993|NCT02735421|78906174|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
44121994|NCT02735421|78906174|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
44121995|NCT02735421|78906174|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
44121996|NCT02735421|78906174|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
44121997|NCT02983799|78906191|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
44121998|NCT02983799|78906192|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
44121999|NCT02983799|78906193|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
44122000|NCT02983799|78906194|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
44122001|NCT02983799|78906195|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
44122002|NCT02983799|78906191|FG000|Overall Study|Death|20|||
44122003|NCT02983799|78906192|FG001|Overall Study|Death|5|||
44122004|NCT02983799|78906193|FG002|Overall Study|Death|23|||
44122005|NCT02983799|78906194|FG003|Overall Study|Death|47|||
44122006|NCT02983799|78906195|FG004|Overall Study|Death|7|||
44122007|NCT02983799|78906191|FG000|Overall Study|Withdrawal by Subject|1|||
44122008|NCT02983799|78906192|FG001|Overall Study|Withdrawal by Subject|0|||
44122009|NCT02983799|78906193|FG002|Overall Study|Withdrawal by Subject|3|||
44122010|NCT02983799|78906194|FG003|Overall Study|Withdrawal by Subject|4|||
44122011|NCT02983799|78906195|FG004|Overall Study|Withdrawal by Subject|1|||
44122012|NCT02983799|78906191|FG000|Overall Study|Protocol Violation|0|||
44122013|NCT02983799|78906192|FG001|Overall Study|Protocol Violation|1|||
44122014|NCT02983799|78906193|FG002|Overall Study|Protocol Violation|0|||
44122015|NCT02983799|78906194|FG003|Overall Study|Protocol Violation|0|||
44509831|NCT03150862|79514936|FG007|Overall Study|Roll over in to Long Term Extension|1|||
44509832|NCT03150862|79514929|FG000|Overall Study|Progressive Disease|0|||
44509833|NCT03150862|79514930|FG001|Overall Study|Progressive Disease|0|||
44509834|NCT03150862|79514931|FG002|Overall Study|Progressive Disease|0|||
44509835|NCT03150862|79514932|FG003|Overall Study|Progressive Disease|0|||
44509836|NCT03150862|79514933|FG004|Overall Study|Progressive Disease|0|||
44509837|NCT03150862|79514934|FG005|Overall Study|Progressive Disease|0|||
44509838|NCT03150862|79514935|FG006|Overall Study|Progressive Disease|0|||
44509839|NCT03150862|79514936|FG007|Overall Study|Progressive Disease|2|||
44509840|NCT00260429|79514965|FG000|Overall Study|failure to follow appointments|1|||
44509841|NCT00260429|79514966|FG001|Overall Study|failure to follow appointments|0|||
44509842|NCT00260429|79514965|FG000|Overall Study|scheduled hand surgery|1|||
44509843|NCT00260429|79514966|FG001|Overall Study|scheduled hand surgery|0|||
44509844|NCT00379288|79514976|FG000|Overall Study|Adverse Event|5|||
44509845|NCT00379288|79514977|FG001|Overall Study|Adverse Event|6|||
44509846|NCT00379288|79514978|FG002|Overall Study|Adverse Event|2|||
44122016|NCT02983799|78906195|FG004|Overall Study|Protocol Violation|1|||
44122017|NCT02983799|78906191|FG000|Overall Study|Lost to Follow-up|1|||
44122018|NCT02983799|78906192|FG001|Overall Study|Lost to Follow-up|0|||
44122019|NCT02983799|78906193|FG002|Overall Study|Lost to Follow-up|1|||
44122020|NCT02983799|78906194|FG003|Overall Study|Lost to Follow-up|0|||
44122021|NCT02983799|78906195|FG004|Overall Study|Lost to Follow-up|0|||
44122022|NCT02186847|78906213|FG000|Overall Study|Protocol Violation|3|||
44122023|NCT02186847|78906214|FG001|Overall Study|Protocol Violation|0|||
44241287|NCT01497899|79069276|FG000|Double-Blind Phase|Adverse Event|1|||
44509847|NCT00379288|79514979|FG003|Overall Study|Adverse Event|0|||
44509848|NCT00379288|79514976|FG000|Overall Study|Treatment Failure|0|||
44241288|NCT01497899|79069277|FG001|Double-Blind Phase|Adverse Event|0|||
44241289|NCT01497899|79069278|FG002|Double-Blind Phase|Adverse Event|0|||
44241290|NCT01497899|79069279|FG003|Double-Blind Phase|Adverse Event|0|||
44241291|NCT01497899|79069276|FG000|Double-Blind Phase|Lack of Efficacy|0|||
44241292|NCT01497899|79069277|FG001|Double-Blind Phase|Lack of Efficacy|1|||
44241293|NCT01497899|79069278|FG002|Double-Blind Phase|Lack of Efficacy|0|||
44241294|NCT01497899|79069279|FG003|Double-Blind Phase|Lack of Efficacy|0|||
44241295|NCT01497899|79069276|FG000|Double-Blind Phase|Investigator's Discretion|1|||
44241296|NCT01497899|79069277|FG001|Double-Blind Phase|Investigator's Discretion|0|||
44241297|NCT01497899|79069278|FG002|Double-Blind Phase|Investigator's Discretion|0|||
44241298|NCT01497899|79069279|FG003|Double-Blind Phase|Investigator's Discretion|0|||
44241299|NCT01497899|79069276|FG000|Double-Blind Phase|Withdrew Consent|0|||
44241300|NCT01497899|79069277|FG001|Double-Blind Phase|Withdrew Consent|1|||
44241301|NCT01497899|79069278|FG002|Double-Blind Phase|Withdrew Consent|0|||
44241302|NCT01497899|79069279|FG003|Double-Blind Phase|Withdrew Consent|0|||
44241303|NCT01497899|79069276|FG000|Double-Blind Phase|Lost to Follow-up|3|||
44241304|NCT01497899|79069277|FG001|Double-Blind Phase|Lost to Follow-up|2|||
44509849|NCT00379288|79514977|FG001|Overall Study|Treatment Failure|1|||
44509850|NCT00379288|79514978|FG002|Overall Study|Treatment Failure|0|||
44509851|NCT00379288|79514979|FG003|Overall Study|Treatment Failure|1|||
44509852|NCT00379288|79514976|FG000|Overall Study|Lost to Follow-up|3|||
44509853|NCT00379288|79514977|FG001|Overall Study|Lost to Follow-up|3|||
44509854|NCT00379288|79514978|FG002|Overall Study|Lost to Follow-up|2|||
44509855|NCT00379288|79514979|FG003|Overall Study|Lost to Follow-up|0|||
44509856|NCT00379288|79514976|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
44509857|NCT00379288|79514977|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
44509858|NCT00379288|79514978|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
44241305|NCT01497899|79069278|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44241306|NCT01497899|79069279|FG003|Double-Blind Phase|Lost to Follow-up|0|||
44241307|NCT01497899|79069276|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
44241308|NCT01497899|79069277|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
44509859|NCT00379288|79514979|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
44509860|NCT00379288|79514976|FG000|Overall Study|Subject withdrew-related to study drug|1|||
44509861|NCT00379288|79514977|FG001|Overall Study|Subject withdrew-related to study drug|0|||
44509862|NCT00379288|79514978|FG002|Overall Study|Subject withdrew-related to study drug|0|||
44509863|NCT00379288|79514979|FG003|Overall Study|Subject withdrew-related to study drug|1|||
44509864|NCT00379288|79514976|FG000|Overall Study|Noncompliance with protocol|8|||
44509865|NCT00379288|79514977|FG001|Overall Study|Noncompliance with protocol|6|||
44509866|NCT00379288|79514978|FG002|Overall Study|Noncompliance with protocol|2|||
44509867|NCT00379288|79514979|FG003|Overall Study|Noncompliance with protocol|1|||
44509868|NCT00379288|79514976|FG000|Overall Study|Did not meet protocol eligibility|0|||
44509869|NCT00379288|79514977|FG001|Overall Study|Did not meet protocol eligibility|1|||
44509870|NCT00379288|79514978|FG002|Overall Study|Did not meet protocol eligibility|0|||
44509871|NCT00379288|79514979|FG003|Overall Study|Did not meet protocol eligibility|2|||
44509872|NCT00379288|79514976|FG000|Overall Study|Administrative|2|||
44509873|NCT00379288|79514977|FG001|Overall Study|Administrative|2|||
44509874|NCT00379288|79514978|FG002|Overall Study|Administrative|0|||
44509875|NCT00379288|79514979|FG003|Overall Study|Administrative|1|||
44509876|NCT00243503|79514989|FG000|Overall Study|Adverse Event|11|||
44509877|NCT00243503|79514989|FG000|Overall Study|Withdrawal by Subject|1|||
44509878|NCT00243503|79514989|FG000|Overall Study|Lack of Efficacy|44|||
44509879|NCT00243503|79514989|FG000|Overall Study|Death|1|||
44509880|NCT00243503|79514989|FG000|Overall Study|Other|1|||
44509881|NCT00239837|79514996|FG000|Overall Study|Lost to Follow-up|3|||
44509882|NCT00239837|79514997|FG001|Overall Study|Lost to Follow-up|7|||
44509883|NCT00259649|79515005|FG000|Overall Study|Lost to Follow-up|7|||
44509884|NCT00259649|79515005|FG000|Overall Study|irregular menses|3|||
44509885|NCT03712280|79515013|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
44509886|NCT03712280|79515014|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
44509887|NCT03712280|79515015|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
44509888|NCT03712280|79515016|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
44241309|NCT01497899|79069278|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
44241310|NCT01497899|79069279|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
44509889|NCT03712280|79515013|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
44509890|NCT03712280|79515014|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
44509891|NCT03712280|79515015|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
44509892|NCT03712280|79515016|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
44241311|NCT01497899|79069276|FG000|Open-Label Extension Phase|Adverse Event|1|||
44241312|NCT01497899|79069277|FG001|Open-Label Extension Phase|Adverse Event|0|||
44509893|NCT03712280|79515013|FG000|Overall Study|Adverse Event|0|||
44509894|NCT03712280|79515014|FG001|Overall Study|Adverse Event|0|||
44241313|NCT01497899|79069278|FG002|Open-Label Extension Phase|Adverse Event|0|||
44241314|NCT01497899|79069279|FG003|Open-Label Extension Phase|Adverse Event|0|||
44122024|NCT01066871|78906224|FG000|Overall Study|Lost to Follow-up|0|||
44122025|NCT01066871|78906225|FG001|Overall Study|Lost to Follow-up|2|||
44122026|NCT01066871|78906226|FG002|Overall Study|Lost to Follow-up|2|||
44122027|NCT01066871|78906227|FG003|Overall Study|Lost to Follow-up|0|||
44122028|NCT01066871|78906224|FG000|Overall Study|Protocol Violation|1|||
44122029|NCT01066871|78906225|FG001|Overall Study|Protocol Violation|0|||
44122030|NCT01066871|78906226|FG002|Overall Study|Protocol Violation|3|||
44122031|NCT01066871|78906227|FG003|Overall Study|Protocol Violation|2|||
44122032|NCT01066871|78906224|FG000|Overall Study|Lack of Efficacy|0|||
44122033|NCT01066871|78906225|FG001|Overall Study|Lack of Efficacy|0|||
44122034|NCT01066871|78906226|FG002|Overall Study|Lack of Efficacy|0|||
44122035|NCT01066871|78906227|FG003|Overall Study|Lack of Efficacy|1|||
44122036|NCT01066871|78906224|FG000|Overall Study|Withdrawal by Subject|3|||
44122037|NCT01066871|78906225|FG001|Overall Study|Withdrawal by Subject|1|||
44122038|NCT01066871|78906226|FG002|Overall Study|Withdrawal by Subject|0|||
44241315|NCT01497899|79069276|FG000|Open-Label Extension Phase|Death|1|||
44122039|NCT01066871|78906227|FG003|Overall Study|Withdrawal by Subject|0|||
44122040|NCT01066871|78906224|FG000|Overall Study|Other|0|||
44122041|NCT01066871|78906225|FG001|Overall Study|Other|2|||
44122042|NCT01066871|78906226|FG002|Overall Study|Other|1|||
44122043|NCT01066871|78906227|FG003|Overall Study|Other|2|||
44122044|NCT02982863|78906247|FG000|Overall Study|Not eligible patients|809|||
44122045|NCT02982863|78906248|FG001|Overall Study|Not eligible patients|4261|||
44122046|NCT02982863|78906249|FG002|Overall Study|Not eligible patients|1852|||
44122047|NCT02982863|78906250|FG003|Overall Study|Not eligible patients|1400|||
44122048|NCT02982863|78906251|FG004|Overall Study|Not eligible patients|492|||
44241316|NCT01497899|79069277|FG001|Open-Label Extension Phase|Death|0|||
44241317|NCT01497899|79069278|FG002|Open-Label Extension Phase|Death|0|||
44241318|NCT01497899|79069279|FG003|Open-Label Extension Phase|Death|0|||
44241319|NCT01497899|79069276|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
44379017|NCT02029443|79384582|FG001|Overall Study|Withdrawal by Subject|1|||
44379018|NCT02029443|79384583|FG002|Overall Study|Withdrawal by Subject|1|||
44379019|NCT02029443|79384584|FG003|Overall Study|Withdrawal by Subject|1|||
44379020|NCT02029443|79384585|FG004|Overall Study|Withdrawal by Subject|0|||
44379021|NCT02029443|79384581|FG000|Overall Study|Other|6|||
44379022|NCT02029443|79384582|FG001|Overall Study|Other|6|||
44379023|NCT02029443|79384583|FG002|Overall Study|Other|4|||
44379024|NCT02029443|79384584|FG003|Overall Study|Other|2|||
44241320|NCT01497899|79069277|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
44241321|NCT01497899|79069278|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
44241322|NCT01497899|79069279|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
44241323|NCT01497899|79069276|FG000|Open-Label Extension Phase|Pregnancy|0|||
44241324|NCT01497899|79069277|FG001|Open-Label Extension Phase|Pregnancy|1|||
44379025|NCT02029443|79384585|FG004|Overall Study|Other|0|||
44379026|NCT00937924|79384622|FG000|Overall Study|Lost to Follow-up|44|||
44379027|NCT00937924|79384623|FG001|Overall Study|Lost to Follow-up|44|||
44379028|NCT00937924|79384624|FG002|Overall Study|Lost to Follow-up|41|||
44379029|NCT00792948|79384635|FG000|Overall Study|Adverse Event|6|||
44379030|NCT00792948|79384635|FG000|Overall Study|Death|4|||
44379031|NCT00792948|79384635|FG000|Overall Study|Withdrawal by Subject|3|||
44379032|NCT00792948|79384635|FG000|Overall Study|Ineligible|2|||
44379033|NCT00792948|79384635|FG000|Overall Study|Insurance denial - not treated|1|||
44379034|NCT00792948|79384635|FG000|Overall Study|Physician Decision|11|||
44122049|NCT04343651|78906294|FG000|Overall Study|Physician Decision|2|||
44122050|NCT04343651|78906295|FG001|Overall Study|Physician Decision|1|||
44122051|NCT04343651|78906294|FG000|Overall Study|Lost to Follow-up|2|||
44122052|NCT04343651|78906295|FG001|Overall Study|Lost to Follow-up|1|||
44122053|NCT04343651|78906294|FG000|Overall Study|Protocol Violation|4|||
44122054|NCT04343651|78906295|FG001|Overall Study|Protocol Violation|6|||
44122055|NCT04343651|78906294|FG000|Overall Study|Missing|3|||
44241325|NCT01497899|79069278|FG002|Open-Label Extension Phase|Pregnancy|1|||
44379035|NCT00792948|79384635|FG000|Overall Study|Protocol Violation|1|||
44122056|NCT04343651|78906295|FG001|Overall Study|Missing|9|||
44381670|NCT00733291|79387802|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
44381671|NCT00733291|79387803|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
44241326|NCT01497899|79069279|FG003|Open-Label Extension Phase|Pregnancy|0|||
44241327|NCT01497899|79069276|FG000|Open-Label Extension Phase|Protocol Violation|0|||
44241328|NCT01497899|79069277|FG001|Open-Label Extension Phase|Protocol Violation|0|||
44241329|NCT01497899|79069278|FG002|Open-Label Extension Phase|Protocol Violation|1|||
44241330|NCT01497899|79069279|FG003|Open-Label Extension Phase|Protocol Violation|0|||
44241331|NCT01497899|79069276|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
44241332|NCT01497899|79069277|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
44241333|NCT01497899|79069278|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
44241334|NCT01497899|79069279|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
44241335|NCT01497275|79069286|FG000|Overall Study|Death|1|||
44241336|NCT01497275|79069286|FG000|Overall Study|Adverse Event|1|||
44241337|NCT01557517|79069292|FG000|Overall Study|Death|1|||
44241338|NCT01557517|79069293|FG001|Overall Study|Death|0|||
44241339|NCT01557517|79069292|FG000|Overall Study|Refused further treatment|0|||
44241340|NCT01557517|79069293|FG001|Overall Study|Refused further treatment|2|||
44241341|NCT01557517|79069292|FG000|Overall Study|Adverse Event|0|||
44241342|NCT01557517|79069293|FG001|Overall Study|Adverse Event|2|||
44241343|NCT01557517|79069292|FG000|Overall Study|Pt declined before treatment started|1|||
44241344|NCT01557517|79069293|FG001|Overall Study|Pt declined before treatment started|0|||
44241345|NCT01497197|79069308|FG000|Overall Study|Lost to Follow-up|1|||
44241346|NCT01497197|79069309|FG001|Overall Study|Lost to Follow-up|0|||
44241347|NCT01497197|79069308|FG000|Overall Study|Protocol Violation|0|||
44241348|NCT01497197|79069309|FG001|Overall Study|Protocol Violation|2|||
44379036|NCT00831844|79384665|FG000|Overall Study|Adverse Event|2|||
44379037|NCT00831844|79384666|FG001|Overall Study|Adverse Event|0|||
44379038|NCT00831844|79384667|FG002|Overall Study|Adverse Event|0|||
44379039|NCT00831844|79384668|FG003|Overall Study|Adverse Event|0|||
44379040|NCT00831844|79384669|FG004|Overall Study|Adverse Event|1|||
44379041|NCT00831844|79384670|FG005|Overall Study|Adverse Event|1|||
44379042|NCT00831844|79384671|FG006|Overall Study|Adverse Event|2|||
44379043|NCT00831844|79384672|FG007|Overall Study|Adverse Event|0|||
44509895|NCT03712280|79515015|FG002|Overall Study|Adverse Event|1|||
44509896|NCT03712280|79515016|FG003|Overall Study|Adverse Event|0|||
44509897|NCT01345240|79515031|FG000|Overall Study|Adverse Event|3|||
44509898|NCT01345240|79515032|FG001|Overall Study|Adverse Event|5|||
44509899|NCT01345240|79515033|FG002|Overall Study|Adverse Event|4|||
44509900|NCT01345240|79515034|FG003|Overall Study|Adverse Event|2|||
44509901|NCT01345240|79515035|FG004|Overall Study|Adverse Event|1|||
44509902|NCT01345240|79515031|FG000|Overall Study|Lost to Follow-up|8|||
44509903|NCT01345240|79515032|FG001|Overall Study|Lost to Follow-up|9|||
44509904|NCT01345240|79515033|FG002|Overall Study|Lost to Follow-up|14|||
44509905|NCT01345240|79515034|FG003|Overall Study|Lost to Follow-up|7|||
44509906|NCT01345240|79515035|FG004|Overall Study|Lost to Follow-up|9|||
44509907|NCT03707912|79515067|FG000|Overall Study|Violation of inclusion criteria|1|||
44509908|NCT03707912|79515068|FG001|Overall Study|Violation of inclusion criteria|0|||
44509909|NCT02883244|79515076|FG000|Overall Study|Lost to Follow-up|0|||
44509910|NCT02883244|79515077|FG001|Overall Study|Lost to Follow-up|1|||
44509911|NCT02882854|79515085|FG000|Overall Study|Lost to Follow-up|1|||
44509912|NCT02882854|79515086|FG001|Overall Study|Lost to Follow-up|2|||
44509913|NCT02882854|79515085|FG000|Overall Study|Physician Decision|0|||
44509914|NCT02882854|79515086|FG001|Overall Study|Physician Decision|1|||
44509915|NCT03707522|79515096|FG000|Overall Study|Lost to Follow-up|24|||
44509916|NCT03707522|79515097|FG001|Overall Study|Lost to Follow-up|27|||
44509917|NCT03707522|79515098|FG002|Overall Study|Lost to Follow-up|41|||
44509918|NCT03707522|79515099|FG003|Overall Study|Lost to Follow-up|36|||
44509919|NCT03150082|79515109|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
44509920|NCT03150082|79515110|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
44509921|NCT03142750|79515138|FG000|Overall Study|Lost to Follow-up|4|||
44509922|NCT03142750|79515139|FG001|Overall Study|Lost to Follow-up|1|||
44509923|NCT03149848|79515149|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
44509924|NCT03149848|79515149|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
44241349|NCT01497197|79069308|FG000|Overall Study|Withdrawal by Subject|2|||
44509925|NCT03706040|79515159|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
44509926|NCT03706040|79515160|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
44509927|NCT03706040|79515161|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
44509928|NCT03706040|79515162|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
44509929|NCT03706040|79515163|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
44509930|NCT03706040|79515164|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
44509931|NCT03706040|79515165|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
44509932|NCT03706040|79515159|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
44241350|NCT01497197|79069309|FG001|Overall Study|Withdrawal by Subject|1|||
44241351|NCT01497197|79069308|FG000|Overall Study|Excessive/lack of response to treatment|1|||
44241352|NCT01497197|79069309|FG001|Overall Study|Excessive/lack of response to treatment|0|||
44241353|NCT01497197|79069308|FG000|Overall Study|Risk of OHSS|1|||
44241354|NCT01497197|79069309|FG001|Overall Study|Risk of OHSS|0|||
44241355|NCT01497197|79069308|FG000|Overall Study|No oocytes retrieved|3|||
44241356|NCT01497197|79069309|FG001|Overall Study|No oocytes retrieved|2|||
44241357|NCT01497197|79069308|FG000|Overall Study|No fertilisation|6|||
44241358|NCT01497197|79069309|FG001|Overall Study|No fertilisation|5|||
44241359|NCT01497197|79069308|FG000|Overall Study|Intention to freeze all embryos|0|||
44241360|NCT01497197|79069309|FG001|Overall Study|Intention to freeze all embryos|1|||
44241361|NCT01497197|79069308|FG000|Overall Study|All embryos discarded|0|||
44241362|NCT01497197|79069309|FG001|Overall Study|All embryos discarded|3|||
44241363|NCT01497197|79069308|FG000|Overall Study|Other|3|||
44241364|NCT01497197|79069309|FG001|Overall Study|Other|1|||
44241365|NCT01496885|79069315|FG000|Overall Study|Lost to Follow-up|13|||
44241366|NCT01496885|79069315|FG000|Overall Study|Withdrawal by Subject|7|||
44241367|NCT01496885|79069315|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
44241368|NCT01496885|79069315|FG000|Overall Study|Death|1|||
44241369|NCT01557283|79069319|FG000|Overall Study|Lost to Follow-up|7|||
44241370|NCT01557283|79069319|FG000|Overall Study|Non-responder|19|||
44241371|NCT01557283|79069319|FG000|Overall Study|Adverse Event|7|||
44241372|NCT01557283|79069319|FG000|Overall Study|Lack of Efficacy|1|||
44241373|NCT01557283|79069319|FG000|Overall Study|Non-compliance|1|||
44241374|NCT01557283|79069319|FG000|Overall Study|Withdrawal by Subject|1|||
44241375|NCT01557283|79069319|FG000|Overall Study|Participant's weight too high for dose|1|||
44241376|NCT01557283|79069319|FG000|Overall Study|Worsening of psoriasis|1|||
44241377|NCT01557283|79069319|FG000|Overall Study|Other|6|||
44241378|NCT01523743|79069336|FG000|Period 1|Adverse Event|1|||
44241379|NCT01523743|79069337|FG001|Period 1|Adverse Event|0|||
44241380|NCT01523743|79069336|FG000|Period 1|Withdrawal by Subject|6|||
44241381|NCT01523743|79069337|FG001|Period 1|Withdrawal by Subject|2|||
44241382|NCT01523743|79069336|FG000|Period 1|Lost to Follow-up|1|||
44241383|NCT01523743|79069337|FG001|Period 1|Lost to Follow-up|0|||
44241384|NCT01523743|79069336|FG000|Period 1|Lack of Efficacy|1|||
44241385|NCT01523743|79069337|FG001|Period 1|Lack of Efficacy|0|||
44241386|NCT01523743|79069336|FG000|Period 1|Felt unable to empty bladder|1|||
44241387|NCT01523743|79069337|FG001|Period 1|Felt unable to empty bladder|0|||
44241388|NCT01523743|79069336|FG000|Period 2|Withdrawal by Subject|0|||
44241389|NCT01523743|79069337|FG001|Period 2|Withdrawal by Subject|2|||
44241390|NCT01523743|79069336|FG000|Period 2|Adverse Event|1|||
44241391|NCT01523743|79069337|FG001|Period 2|Adverse Event|0|||
44241392|NCT01496807|79069352|FG000|Overall Study|Progressive Disease|21|||
44241393|NCT01496807|79069352|FG000|Overall Study|Participant preference/toxicity|8|||
44241394|NCT01496807|79069352|FG000|Overall Study|Change in diagnosis|1|||
44241395|NCT01496183|79069358|FG000|Overall Study|Physician Decision|3|||
44241396|NCT01496183|79069359|FG001|Overall Study|Physician Decision|1|||
44241397|NCT01496183|79069358|FG000|Overall Study|Withdrawal by Subject|0|||
44241398|NCT01496183|79069359|FG001|Overall Study|Withdrawal by Subject|1|||
44241399|NCT01495793|79069366|FG000|Overall Study|Lost to Follow-up|1|||
44241400|NCT01495793|79069366|FG000|Overall Study|Violation of inclusion criteria|1|||
44241401|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
44241402|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
44241403|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
44241404|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
44241405|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
44241406|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
44241407|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
44241408|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
44241409|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
44509933|NCT03706040|79515160|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
44509934|NCT03706040|79515161|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
44509935|NCT03706040|79515162|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
44509936|NCT03706040|79515163|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
44509937|NCT03706040|79515164|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
44509938|NCT03706040|79515165|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
44509939|NCT03706040|79515159|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
44509940|NCT03706040|79515160|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
44509941|NCT03706040|79515161|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
44509942|NCT03706040|79515162|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
44509943|NCT03706040|79515163|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
44241410|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
44241411|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
44241412|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
44241413|NCT01494467|79069372|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
44241414|NCT01494467|79069373|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
44241415|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
44509944|NCT03706040|79515164|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
44241416|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
44241417|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
44241418|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
44241419|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
44241420|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
44241421|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
44241422|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
44241423|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
44241424|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
44241425|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
44241426|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
44241427|NCT01494467|79069372|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
44241428|NCT01494467|79069373|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
44241429|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
44241430|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
44241431|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
44241432|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
44241433|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
44241434|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
44241435|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
44241436|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
44241437|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
44241438|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
44241439|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
44241440|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
44241441|NCT01493687|79069387|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
44241442|NCT01493687|79069388|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
44241443|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
44241444|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
44509945|NCT03706040|79515165|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
44509946|NCT03706040|79515159|FG000|Period A (Week 0 to Week 16)|Other|2|||
44509947|NCT03706040|79515160|FG001|Period A (Week 0 to Week 16)|Other|0|||
44379044|NCT00831844|79384673|FG008|Overall Study|Adverse Event|0|||
44379045|NCT00831844|79384674|FG009|Overall Study|Adverse Event|0|||
44379046|NCT00831844|79384665|FG000|Overall Study|Death|0|||
44379047|NCT00831844|79384666|FG001|Overall Study|Death|0|||
44379048|NCT00831844|79384667|FG002|Overall Study|Death|0|||
44379049|NCT00831844|79384668|FG003|Overall Study|Death|1|||
44379050|NCT00831844|79384669|FG004|Overall Study|Death|0|||
44509948|NCT03706040|79515161|FG002|Period A (Week 0 to Week 16)|Other|2|||
44509949|NCT03706040|79515162|FG003|Period A (Week 0 to Week 16)|Other|0|||
44509950|NCT03706040|79515163|FG004|Period A (Week 0 to Week 16)|Other|0|||
44241445|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
44241446|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
44509951|NCT03706040|79515164|FG005|Period A (Week 0 to Week 16)|Other|0|||
44509952|NCT03706040|79515165|FG006|Period A (Week 0 to Week 16)|Other|0|||
44509953|NCT03706040|79515159|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
44509954|NCT03706040|79515160|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
44509955|NCT03706040|79515161|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
44241447|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
44509956|NCT03706040|79515162|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
44509957|NCT03706040|79515163|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
44509958|NCT03706040|79515164|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
44241448|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
44241449|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
44241450|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
44241451|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
44241452|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
44241453|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
44241454|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
44241455|NCT01493687|79069387|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
44241456|NCT01493687|79069388|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
44241457|NCT01493687|79069387|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
44241458|NCT01493687|79069388|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
44241459|NCT01523587|79069420|FG000|Overall Study|Other than listed|5|||
44241460|NCT01523587|79069421|FG001|Overall Study|Other than listed|5|||
44241461|NCT01523587|79069420|FG000|Overall Study|Worsening of underlying cancer disease|19|||
44241462|NCT01523587|79069421|FG001|Overall Study|Worsening of underlying cancer disease|34|||
44241463|NCT01523587|79069420|FG000|Overall Study|Adverse Event|68|||
44241464|NCT01523587|79069421|FG001|Overall Study|Adverse Event|52|||
44241465|NCT01523587|79069420|FG000|Overall Study|Protocol Violation|5|||
44241466|NCT01523587|79069421|FG001|Overall Study|Protocol Violation|3|||
44241467|NCT01523587|79069420|FG000|Overall Study|Lost to Follow-up|2|||
44241468|NCT01523587|79069421|FG001|Overall Study|Lost to Follow-up|2|||
44241469|NCT01523587|79069420|FG000|Overall Study|Withdrawal by Subject|28|||
44241470|NCT01523587|79069421|FG001|Overall Study|Withdrawal by Subject|20|||
44241471|NCT01523587|79069420|FG000|Overall Study|Withdrew due to Progressive disease|265|||
44241472|NCT01523587|79069421|FG001|Overall Study|Withdrew due to Progressive disease|279|||
44241473|NCT01523587|79069420|FG000|Overall Study|Randomised but bot treated|6|||
44241474|NCT01523587|79069421|FG001|Overall Study|Randomised but bot treated|2|||
44241475|NCT01493531|79069450|FG000|Overall Study|Adverse Event|4|||
44241476|NCT01493531|79069451|FG001|Overall Study|Adverse Event|12|||
44241477|NCT01493531|79069452|FG002|Overall Study|Adverse Event|9|||
44241478|NCT01493531|79069450|FG000|Overall Study|Gout flare|3|||
44241479|NCT01493531|79069451|FG001|Overall Study|Gout flare|0|||
44241480|NCT01493531|79069452|FG002|Overall Study|Gout flare|2|||
44241481|NCT01493531|79069450|FG000|Overall Study|Protocol Violation|8|||
44509959|NCT03706040|79515165|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
44509960|NCT03706040|79515159|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
44509961|NCT03706040|79515160|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
44509962|NCT03706040|79515161|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
44509963|NCT03706040|79515162|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
44509964|NCT03706040|79515163|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
44509965|NCT03706040|79515164|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
44509966|NCT03706040|79515165|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
44509967|NCT03706040|79515159|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
44509968|NCT03706040|79515160|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
44509969|NCT03706040|79515161|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
44379051|NCT00831844|79384670|FG005|Overall Study|Death|0|||
44241482|NCT01493531|79069451|FG001|Overall Study|Protocol Violation|15|||
44379052|NCT00831844|79384671|FG006|Overall Study|Death|0|||
44122057|NCT04343651|78906294|FG000|Overall Study|Withdrawal by Subject|0|||
44241483|NCT01493531|79069452|FG002|Overall Study|Protocol Violation|12|||
44379053|NCT00831844|79384672|FG007|Overall Study|Death|0|||
44379054|NCT00831844|79384673|FG008|Overall Study|Death|0|||
44241484|NCT01493531|79069450|FG000|Overall Study|Sponsor terminated study|5|||
44241485|NCT01493531|79069451|FG001|Overall Study|Sponsor terminated study|2|||
44241486|NCT01493531|79069452|FG002|Overall Study|Sponsor terminated study|3|||
44241487|NCT01493531|79069450|FG000|Overall Study|Lost to Follow-up|5|||
44379055|NCT00831844|79384674|FG009|Overall Study|Death|0|||
44379056|NCT00831844|79384665|FG000|Overall Study|Lack of Efficacy|8|||
44379057|NCT00831844|79384666|FG001|Overall Study|Lack of Efficacy|10|||
44379058|NCT00831844|79384667|FG002|Overall Study|Lack of Efficacy|15|||
44379059|NCT00831844|79384668|FG003|Overall Study|Lack of Efficacy|8|||
44379060|NCT00831844|79384669|FG004|Overall Study|Lack of Efficacy|11|||
44379061|NCT00831844|79384670|FG005|Overall Study|Lack of Efficacy|17|||
44379062|NCT00831844|79384671|FG006|Overall Study|Lack of Efficacy|8|||
44379063|NCT00831844|79384672|FG007|Overall Study|Lack of Efficacy|9|||
44379064|NCT00831844|79384673|FG008|Overall Study|Lack of Efficacy|7|||
44379065|NCT00831844|79384674|FG009|Overall Study|Lack of Efficacy|0|||
44379066|NCT00831844|79384665|FG000|Overall Study|Physician Decision|0|||
44122058|NCT04343651|78906295|FG001|Overall Study|Withdrawal by Subject|4|||
44122059|NCT04343651|78906294|FG000|Overall Study|Death|0|||
44122060|NCT04343651|78906295|FG001|Overall Study|Death|1|||
44122061|NCT04343651|78906294|FG000|Overall Study|Did not start treatment|1|||
44122062|NCT04343651|78906295|FG001|Overall Study|Did not start treatment|1|||
44122063|NCT04343651|78906294|FG000|Overall Study|Patient did not complete visits 3-6|0|||
44122064|NCT04343651|78906295|FG001|Overall Study|Patient did not complete visits 3-6|1|||
44122065|NCT02906579|78906303|FG000|Overall Study|Adverse Event|1|||
44122066|NCT02906579|78906303|FG000|Overall Study|Physician Decision|1|||
44122067|NCT01328535|78906323|FG000|Overall Study|Ineligible|1|||
44122068|NCT02905331|78906331|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
44122069|NCT02905331|78906332|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
44122070|NCT02905331|78906333|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
44122071|NCT02905331|78906331|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
44122072|NCT02905331|78906332|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
44122073|NCT02905331|78906333|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
44122074|NCT02905331|78906331|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
44122075|NCT02905331|78906332|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
44122076|NCT02905331|78906333|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
44122077|NCT02905331|78906331|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
44122078|NCT02905331|78906332|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
44122079|NCT02905331|78906333|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
44122080|NCT02905331|78906331|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
44122081|NCT02905331|78906332|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
44122082|NCT02905331|78906333|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
44122083|NCT02979197|78906344|FG000|Overall Study|Adverse Event|4|||
44122084|NCT02979197|78906345|FG001|Overall Study|Adverse Event|2|||
44122085|NCT02979197|78906346|FG002|Overall Study|Adverse Event|0|||
44122086|NCT02979197|78906344|FG000|Overall Study|Protocol Violation|0|||
44122087|NCT02979197|78906345|FG001|Overall Study|Protocol Violation|1|||
44122088|NCT02979197|78906346|FG002|Overall Study|Protocol Violation|0|||
44241488|NCT01493531|79069451|FG001|Overall Study|Lost to Follow-up|7|||
44241489|NCT01493531|79069452|FG002|Overall Study|Lost to Follow-up|11|||
44122089|NCT02979197|78906344|FG000|Overall Study|Subject unable to commit to study dates|0|||
44122090|NCT02979197|78906345|FG001|Overall Study|Subject unable to commit to study dates|1|||
44122091|NCT02979197|78906346|FG002|Overall Study|Subject unable to commit to study dates|0|||
44122092|NCT02982239|78906356|FG000|Overall Study|Lost to Follow-up|3|||
44122093|NCT02982239|78906357|FG001|Overall Study|Lost to Follow-up|2|||
44122094|NCT01066793|78906370|FG000|Overall Study|Death|4|||
44122095|NCT01066793|78906371|FG001|Overall Study|Death|1|||
44122096|NCT01066793|78906372|FG002|Overall Study|Death|1|||
44122097|NCT01066793|78906373|FG003|Overall Study|Death|0|||
44122098|NCT01066793|78906374|FG004|Overall Study|Death|0|||
44241490|NCT01493531|79069450|FG000|Overall Study|Withdrawal by Subject|16|||
44241491|NCT01493531|79069451|FG001|Overall Study|Withdrawal by Subject|13|||
44241492|NCT01493531|79069452|FG002|Overall Study|Withdrawal by Subject|11|||
44241493|NCT01493531|79069450|FG000|Overall Study|Death|0|||
44241494|NCT01493531|79069451|FG001|Overall Study|Death|1|||
44241495|NCT01493531|79069452|FG002|Overall Study|Death|0|||
44379067|NCT00831844|79384666|FG001|Overall Study|Physician Decision|1|||
44379068|NCT00831844|79384667|FG002|Overall Study|Physician Decision|3|||
44379069|NCT00831844|79384668|FG003|Overall Study|Physician Decision|1|||
44379070|NCT00831844|79384669|FG004|Overall Study|Physician Decision|1|||
44122099|NCT01066793|78906375|FG005|Overall Study|Death|0|||
44122100|NCT01066793|78906370|FG000|Overall Study|Lack of Efficacy|2|||
44122101|NCT01066793|78906371|FG001|Overall Study|Lack of Efficacy|1|||
44122102|NCT01066793|78906372|FG002|Overall Study|Lack of Efficacy|0|||
44122103|NCT01066793|78906373|FG003|Overall Study|Lack of Efficacy|0|||
44241496|NCT01523275|79069476|FG000|Overall Study|Lost to Follow-up|1|||
44379071|NCT00831844|79384670|FG005|Overall Study|Physician Decision|1|||
44122104|NCT01066793|78906374|FG004|Overall Study|Lack of Efficacy|0|||
44122105|NCT01066793|78906375|FG005|Overall Study|Lack of Efficacy|0|||
44122106|NCT01066793|78906370|FG000|Overall Study|Lost to Follow-up|180|||
44122107|NCT01066793|78906371|FG001|Overall Study|Lost to Follow-up|39|||
44122108|NCT01066793|78906372|FG002|Overall Study|Lost to Follow-up|82|||
44122109|NCT01066793|78906373|FG003|Overall Study|Lost to Follow-up|16|||
44122110|NCT01066793|78906374|FG004|Overall Study|Lost to Follow-up|0|||
44122111|NCT01066793|78906375|FG005|Overall Study|Lost to Follow-up|1|||
44122112|NCT01066793|78906370|FG000|Overall Study|Physician Decision|3|||
44122113|NCT01066793|78906371|FG001|Overall Study|Physician Decision|0|||
44122114|NCT01066793|78906372|FG002|Overall Study|Physician Decision|0|||
44122115|NCT01066793|78906373|FG003|Overall Study|Physician Decision|0|||
44122116|NCT01066793|78906374|FG004|Overall Study|Physician Decision|0|||
44122117|NCT01066793|78906375|FG005|Overall Study|Physician Decision|0|||
44122118|NCT01066793|78906370|FG000|Overall Study|Protocol Violation|3|||
44122119|NCT01066793|78906371|FG001|Overall Study|Protocol Violation|2|||
44122120|NCT01066793|78906372|FG002|Overall Study|Protocol Violation|2|||
44122121|NCT01066793|78906373|FG003|Overall Study|Protocol Violation|0|||
44122122|NCT01066793|78906374|FG004|Overall Study|Protocol Violation|0|||
44122123|NCT01066793|78906375|FG005|Overall Study|Protocol Violation|0|||
44122124|NCT01066793|78906370|FG000|Overall Study|Withdrawal by Subject|7|||
44122125|NCT01066793|78906371|FG001|Overall Study|Withdrawal by Subject|4|||
44241497|NCT01523275|79069477|FG001|Overall Study|Lost to Follow-up|2|||
44241498|NCT01523275|79069476|FG000|Overall Study|Withdrawal by Subject|1|||
44241499|NCT01523275|79069477|FG001|Overall Study|Withdrawal by Subject|0|||
44241500|NCT01492439|79069494|FG000|Overall Study|Withdrew from RTE|4|||
44241501|NCT01492439|79069495|FG001|Overall Study|Withdrew from RTE|9|||
44241502|NCT01572727|79069530|FG000|Overall Study|Adverse Event|43|||
44241503|NCT01572727|79069531|FG001|Overall Study|Adverse Event|15|||
44241504|NCT01572727|79069530|FG000|Overall Study|Lost to Follow-up|1|||
44241505|NCT01572727|79069531|FG001|Overall Study|Lost to Follow-up|1|||
44241506|NCT01572727|79069530|FG000|Overall Study|Physician Decision|23|||
44241507|NCT01572727|79069531|FG001|Overall Study|Physician Decision|9|||
44241508|NCT01572727|79069530|FG000|Overall Study|Progressive disease|59|||
44241509|NCT01572727|79069531|FG001|Overall Study|Progressive disease|82|||
44122126|NCT01066793|78906372|FG002|Overall Study|Withdrawal by Subject|1|||
44122127|NCT01066793|78906373|FG003|Overall Study|Withdrawal by Subject|0|||
44122128|NCT01066793|78906374|FG004|Overall Study|Withdrawal by Subject|0|||
44122129|NCT01066793|78906375|FG005|Overall Study|Withdrawal by Subject|0|||
44122130|NCT01066793|78906370|FG000|Overall Study|Early Termination|3|||
44122131|NCT01066793|78906371|FG001|Overall Study|Early Termination|0|||
44122132|NCT01066793|78906372|FG002|Overall Study|Early Termination|0|||
44122133|NCT01066793|78906373|FG003|Overall Study|Early Termination|0|||
44122134|NCT01066793|78906374|FG004|Overall Study|Early Termination|0|||
44241510|NCT01572727|79069530|FG000|Overall Study|Protocol Violation|0|||
44122135|NCT01066793|78906375|FG005|Overall Study|Early Termination|0|||
44122136|NCT01066793|78906370|FG000|Overall Study|Lab test not done|7|||
44122137|NCT01066793|78906371|FG001|Overall Study|Lab test not done|0|||
44122138|NCT01066793|78906372|FG002|Overall Study|Lab test not done|0|||
44122139|NCT01066793|78906373|FG003|Overall Study|Lab test not done|1|||
44122140|NCT01066793|78906374|FG004|Overall Study|Lab test not done|0|||
44122141|NCT01066793|78906375|FG005|Overall Study|Lab test not done|0|||
44122142|NCT01066793|78906370|FG000|Overall Study|Miscellaneous|4|||
44241511|NCT01572727|79069531|FG001|Overall Study|Protocol Violation|1|||
44241512|NCT01572727|79069530|FG000|Overall Study|Study terminated by sponsor|61|||
44122143|NCT01066793|78906371|FG001|Overall Study|Miscellaneous|5|||
44122144|NCT01066793|78906372|FG002|Overall Study|Miscellaneous|6|||
44122145|NCT01066793|78906373|FG003|Overall Study|Miscellaneous|0|||
44241513|NCT01572727|79069531|FG001|Overall Study|Study terminated by sponsor|83|||
44122146|NCT01066793|78906374|FG004|Overall Study|Miscellaneous|0|||
44122147|NCT01066793|78906375|FG005|Overall Study|Miscellaneous|0|||
44122148|NCT01066793|78906370|FG000|Overall Study|Non-responders|104|||
44122149|NCT01066793|78906371|FG001|Overall Study|Non-responders|5|||
44122150|NCT01066793|78906372|FG002|Overall Study|Non-responders|11|||
44122151|NCT01066793|78906373|FG003|Overall Study|Non-responders|25|||
44122152|NCT01066793|78906374|FG004|Overall Study|Non-responders|0|||
44122153|NCT01066793|78906375|FG005|Overall Study|Non-responders|0|||
44122154|NCT01066793|78906370|FG000|Overall Study|Other|15|||
44122155|NCT01066793|78906371|FG001|Overall Study|Other|5|||
44122156|NCT01066793|78906372|FG002|Overall Study|Other|6|||
44122157|NCT01066793|78906373|FG003|Overall Study|Other|2|||
44122158|NCT01066793|78906374|FG004|Overall Study|Other|0|||
44122159|NCT01066793|78906375|FG005|Overall Study|Other|0|||
44122160|NCT01066793|78906370|FG000|Overall Study|Relapse|20|||
44122161|NCT01066793|78906371|FG001|Overall Study|Relapse|8|||
44122162|NCT01066793|78906372|FG002|Overall Study|Relapse|2|||
44122163|NCT01066793|78906373|FG003|Overall Study|Relapse|3|||
44122164|NCT01066793|78906374|FG004|Overall Study|Relapse|0|||
44122165|NCT01066793|78906375|FG005|Overall Study|Relapse|0|||
44122166|NCT01066793|78906370|FG000|Overall Study|Result Not Available|1|||
44122167|NCT01066793|78906371|FG001|Overall Study|Result Not Available|0|||
44122168|NCT01066793|78906372|FG002|Overall Study|Result Not Available|0|||
44122169|NCT01066793|78906373|FG003|Overall Study|Result Not Available|0|||
44122170|NCT01066793|78906374|FG004|Overall Study|Result Not Available|0|||
44122171|NCT01066793|78906375|FG005|Overall Study|Result Not Available|0|||
44122172|NCT01066793|78906370|FG000|Overall Study|Treatment Interrupted|1|||
44122173|NCT01066793|78906371|FG001|Overall Study|Treatment Interrupted|1|||
44122174|NCT01066793|78906372|FG002|Overall Study|Treatment Interrupted|0|||
44122175|NCT01066793|78906373|FG003|Overall Study|Treatment Interrupted|0|||
44122176|NCT01066793|78906374|FG004|Overall Study|Treatment Interrupted|0|||
44122177|NCT01066793|78906375|FG005|Overall Study|Treatment Interrupted|0|||
44122178|NCT01066793|78906370|FG000|Overall Study|Treatment Never Started|18|||
44122179|NCT01066793|78906371|FG001|Overall Study|Treatment Never Started|5|||
44122180|NCT01066793|78906372|FG002|Overall Study|Treatment Never Started|4|||
44122181|NCT01066793|78906373|FG003|Overall Study|Treatment Never Started|1|||
44122182|NCT01066793|78906374|FG004|Overall Study|Treatment Never Started|0|||
44122183|NCT01066793|78906375|FG005|Overall Study|Treatment Never Started|0|||
44122184|NCT01066793|78906370|FG000|Overall Study|Treatment Stopped|2|||
44122185|NCT01066793|78906371|FG001|Overall Study|Treatment Stopped|1|||
44122186|NCT01066793|78906372|FG002|Overall Study|Treatment Stopped|0|||
44122187|NCT01066793|78906373|FG003|Overall Study|Treatment Stopped|1|||
44122188|NCT01066793|78906374|FG004|Overall Study|Treatment Stopped|0|||
44122189|NCT01066793|78906375|FG005|Overall Study|Treatment Stopped|0|||
44122190|NCT03985293|78906396|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
44122191|NCT03985293|78906397|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
44122192|NCT03985293|78906398|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
44122193|NCT03985293|78906399|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
44122194|NCT03985293|78906400|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
44122195|NCT03985293|78906401|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
44122196|NCT03985293|78906396|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
44122197|NCT03985293|78906397|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
44241514|NCT01572727|79069530|FG000|Overall Study|Parent/guardian decision|14|||
44241515|NCT01572727|79069531|FG001|Overall Study|Parent/guardian decision|9|||
44241516|NCT01572727|79069530|FG000|Overall Study|Death|2|||
44509970|NCT03706040|79515162|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
44122198|NCT03985293|78906398|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
44122199|NCT03985293|78906399|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
44122200|NCT03985293|78906400|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
44122201|NCT03985293|78906401|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
44122202|NCT03985293|78906396|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
44122203|NCT03985293|78906397|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
44122204|NCT03985293|78906398|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
44122205|NCT03985293|78906399|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
44122206|NCT03985293|78906400|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
44122207|NCT03985293|78906401|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
44241517|NCT01572727|79069531|FG001|Overall Study|Death|2|||
44122208|NCT03985293|78906396|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
44122209|NCT03985293|78906397|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
44122210|NCT03985293|78906398|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
44122211|NCT03985293|78906399|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
44122212|NCT03985293|78906400|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
44122213|NCT03985293|78906401|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
44122214|NCT03985293|78906396|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
44241518|NCT01572727|79069530|FG000|Overall Study|Untreated|4|||
44122215|NCT03985293|78906397|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
44241519|NCT01572727|79069531|FG001|Overall Study|Untreated|7|||
44122216|NCT03985293|78906398|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
44122217|NCT03985293|78906399|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
44122218|NCT03985293|78906400|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
44122219|NCT03985293|78906401|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
44122220|NCT03985293|78906396|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
44122221|NCT03985293|78906397|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
44122222|NCT03985293|78906398|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
44122223|NCT03985293|78906399|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
44122224|NCT03985293|78906400|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
44122225|NCT03985293|78906401|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
44122226|NCT03985293|78906396|FG000|FOLLOW-UP|Lost to Follow-up|0|||
44122227|NCT03985293|78906397|FG001|FOLLOW-UP|Lost to Follow-up|0|||
44122228|NCT03985293|78906398|FG002|FOLLOW-UP|Lost to Follow-up|1|||
44122229|NCT03985293|78906399|FG003|FOLLOW-UP|Lost to Follow-up|0|||
44122230|NCT03985293|78906400|FG004|FOLLOW-UP|Lost to Follow-up|0|||
44122231|NCT03985293|78906401|FG005|FOLLOW-UP|Lost to Follow-up|0|||
44122232|NCT03654755|78906418|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
44122233|NCT03654755|78906419|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
44122234|NCT03654755|78906420|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
44122235|NCT03654755|78906418|FG000|Overall Study|Withdrawal by Subject|2|||
44122236|NCT03654755|78906419|FG001|Overall Study|Withdrawal by Subject|4|||
44122237|NCT03654755|78906420|FG002|Overall Study|Withdrawal by Subject|8|||
44122238|NCT03654755|78906418|FG000|Overall Study|Lost to Follow-up|1|||
44122239|NCT03654755|78906419|FG001|Overall Study|Lost to Follow-up|3|||
44122240|NCT03654755|78906420|FG002|Overall Study|Lost to Follow-up|7|||
44122241|NCT03654755|78906418|FG000|Overall Study|Physician Decision|0|||
44241520|NCT01522651|79069578|FG000|Overall Study|Adverse Event|3|||
44122242|NCT03654755|78906419|FG001|Overall Study|Physician Decision|1|||
44122243|NCT03654755|78906420|FG002|Overall Study|Physician Decision|0|||
44122244|NCT03654755|78906418|FG000|Overall Study|Adverse Event|0|||
44122245|NCT03654755|78906419|FG001|Overall Study|Adverse Event|0|||
44122246|NCT03654755|78906420|FG002|Overall Study|Adverse Event|4|||
44122247|NCT03654755|78906418|FG000|Overall Study|Lack of Efficacy|0|||
44122248|NCT03654755|78906419|FG001|Overall Study|Lack of Efficacy|0|||
44122249|NCT03654755|78906420|FG002|Overall Study|Lack of Efficacy|1|||
44122250|NCT02980601|78906430|FG000|Overall Study|Lost to Follow-up|2|||
44122251|NCT02980601|78906431|FG001|Overall Study|Lost to Follow-up|2|||
44122252|NCT02980601|78906430|FG000|Overall Study|Death|0|||
44122253|NCT02980601|78906431|FG001|Overall Study|Death|1|||
44122254|NCT02980601|78906430|FG000|Overall Study|Graft loss|1|||
44122255|NCT02980601|78906431|FG001|Overall Study|Graft loss|0|||
44122256|NCT02980601|78906430|FG000|Overall Study|Failed to sign consent|2|||
44122257|NCT02980601|78906431|FG001|Overall Study|Failed to sign consent|0|||
44122258|NCT02980523|78906442|FG000|Overall Study|Lost to Follow-up|1|||
44122259|NCT02980523|78906443|FG001|Overall Study|Lost to Follow-up|4|||
44122260|NCT02980523|78906444|FG002|Overall Study|Lost to Follow-up|1|||
44122261|NCT02980523|78906445|FG003|Overall Study|Lost to Follow-up|2|||
44241521|NCT01522651|79069579|FG001|Overall Study|Adverse Event|4|||
44241522|NCT01522651|79069580|FG002|Overall Study|Adverse Event|4|||
44241523|NCT01522651|79069581|FG003|Overall Study|Adverse Event|5|||
44122262|NCT02980523|78906446|FG004|Overall Study|Lost to Follow-up|1|||
44122263|NCT02980523|78906442|FG000|Overall Study|Excluded from analysis|1|||
44122264|NCT02980523|78906443|FG001|Overall Study|Excluded from analysis|3|||
44122265|NCT02980523|78906444|FG002|Overall Study|Excluded from analysis|1|||
44122266|NCT02980523|78906445|FG003|Overall Study|Excluded from analysis|1|||
44122267|NCT02980523|78906446|FG004|Overall Study|Excluded from analysis|1|||
44122268|NCT02980523|78906442|FG000|Overall Study|Lack of Efficacy|1|||
44122269|NCT02980523|78906443|FG001|Overall Study|Lack of Efficacy|4|||
44122270|NCT02980523|78906444|FG002|Overall Study|Lack of Efficacy|4|||
44122271|NCT02980523|78906445|FG003|Overall Study|Lack of Efficacy|5|||
44241524|NCT01522651|79069582|FG004|Overall Study|Adverse Event|4|||
44122272|NCT02980523|78906446|FG004|Overall Study|Lack of Efficacy|8|||
44122273|NCT02980523|78906442|FG000|Overall Study|Did not receive intervention|0|||
44122274|NCT02980523|78906443|FG001|Overall Study|Did not receive intervention|0|||
44122275|NCT02980523|78906444|FG002|Overall Study|Did not receive intervention|0|||
44122276|NCT02980523|78906445|FG003|Overall Study|Did not receive intervention|1|||
44122277|NCT02980523|78906446|FG004|Overall Study|Did not receive intervention|0|||
44122278|NCT02980133|78906465|FG000|Overall Study|Other than specified|1|||
44122279|NCT02980133|78906466|FG001|Overall Study|Other than specified|1|||
44122280|NCT02980133|78906467|FG002|Overall Study|Other than specified|2|||
44122281|NCT02980133|78906468|FG003|Overall Study|Other than specified|2|||
44122282|NCT02980133|78906465|FG000|Overall Study|Lost to Follow-up|0|||
44122283|NCT02980133|78906466|FG001|Overall Study|Lost to Follow-up|0|||
44122284|NCT02980133|78906467|FG002|Overall Study|Lost to Follow-up|1|||
44122285|NCT02980133|78906468|FG003|Overall Study|Lost to Follow-up|3|||
44122286|NCT02980133|78906465|FG000|Overall Study|Protocol Violation|0|||
44122287|NCT02980133|78906466|FG001|Overall Study|Protocol Violation|1|||
44122288|NCT02980133|78906467|FG002|Overall Study|Protocol Violation|0|||
44122289|NCT02980133|78906468|FG003|Overall Study|Protocol Violation|0|||
44122290|NCT02980133|78906465|FG000|Overall Study|Withdrawal by parent/guardian|6|||
44122291|NCT02980133|78906466|FG001|Overall Study|Withdrawal by parent/guardian|3|||
44122292|NCT02980133|78906467|FG002|Overall Study|Withdrawal by parent/guardian|3|||
44122293|NCT02980133|78906468|FG003|Overall Study|Withdrawal by parent/guardian|1|||
44122294|NCT02980133|78906465|FG000|Overall Study|Withdrawal by Subject|0|||
44122295|NCT02980133|78906466|FG001|Overall Study|Withdrawal by Subject|0|||
44122296|NCT02980133|78906467|FG002|Overall Study|Withdrawal by Subject|1|||
44122297|NCT02980133|78906468|FG003|Overall Study|Withdrawal by Subject|0|||
44122298|NCT02979431|78906485|FG000|Overall Study|Parent/guardian withdrew consent|2|||
44122299|NCT02979431|78906486|FG001|Overall Study|Parent/guardian withdrew consent|1|||
44122300|NCT02979431|78906487|FG002|Overall Study|Parent/guardian withdrew consent|1|||
44122301|NCT02979431|78906488|FG003|Overall Study|Parent/guardian withdrew consent|1|||
44122302|NCT02979431|78906485|FG000|Overall Study|Randomized but received no study drug|1|||
44122303|NCT02979431|78906486|FG001|Overall Study|Randomized but received no study drug|1|||
44122304|NCT02979431|78906487|FG002|Overall Study|Randomized but received no study drug|0|||
44122305|NCT02979431|78906488|FG003|Overall Study|Randomized but received no study drug|0|||
44122306|NCT02979431|78906485|FG000|Overall Study|Adverse Event|0|||
44122307|NCT02979431|78906486|FG001|Overall Study|Adverse Event|0|||
44122308|NCT02979431|78906487|FG002|Overall Study|Adverse Event|1|||
44122309|NCT02979431|78906488|FG003|Overall Study|Adverse Event|0|||
44122310|NCT02979431|78906485|FG000|Overall Study|Subject left country after Day14|1|||
44122311|NCT02979431|78906486|FG001|Overall Study|Subject left country after Day14|0|||
44122312|NCT02979431|78906487|FG002|Overall Study|Subject left country after Day14|0|||
44122313|NCT02979431|78906488|FG003|Overall Study|Subject left country after Day14|0|||
44122314|NCT02978417|78906500|FG000|Overall Study|Lost to Follow-up|2|||
44379072|NCT00831844|79384671|FG006|Overall Study|Physician Decision|0|||
44241525|NCT01522651|79069578|FG000|Overall Study|Cardioversion|1|||
44241526|NCT01522651|79069579|FG001|Overall Study|Cardioversion|0|||
44241527|NCT01522651|79069580|FG002|Overall Study|Cardioversion|0|||
44241528|NCT01522651|79069581|FG003|Overall Study|Cardioversion|0|||
44241529|NCT01522651|79069582|FG004|Overall Study|Cardioversion|0|||
44241530|NCT01522651|79069578|FG000|Overall Study|Device Malfunction|0|||
44241531|NCT01522651|79069579|FG001|Overall Study|Device Malfunction|1|||
44241532|NCT01522651|79069580|FG002|Overall Study|Device Malfunction|0|||
44241533|NCT01522651|79069581|FG003|Overall Study|Device Malfunction|0|||
44241534|NCT01522651|79069582|FG004|Overall Study|Device Malfunction|0|||
44241535|NCT01522651|79069578|FG000|Overall Study|Investigator's Discretion|0|||
44241536|NCT01522651|79069579|FG001|Overall Study|Investigator's Discretion|1|||
44241537|NCT01522651|79069580|FG002|Overall Study|Investigator's Discretion|0|||
44241538|NCT01522651|79069581|FG003|Overall Study|Investigator's Discretion|0|||
44241539|NCT01522651|79069582|FG004|Overall Study|Investigator's Discretion|0|||
44241540|NCT01522651|79069578|FG000|Overall Study|Protocol Violation|3|||
44241541|NCT01522651|79069579|FG001|Overall Study|Protocol Violation|0|||
44241542|NCT01522651|79069580|FG002|Overall Study|Protocol Violation|0|||
44241543|NCT01522651|79069581|FG003|Overall Study|Protocol Violation|0|||
44241544|NCT01522651|79069582|FG004|Overall Study|Protocol Violation|0|||
44241545|NCT01522651|79069578|FG000|Overall Study|Reason Not Specified|0|||
44241546|NCT01522651|79069579|FG001|Overall Study|Reason Not Specified|0|||
44241547|NCT01522651|79069580|FG002|Overall Study|Reason Not Specified|0|||
44241548|NCT01522651|79069581|FG003|Overall Study|Reason Not Specified|1|||
44241549|NCT01522651|79069582|FG004|Overall Study|Reason Not Specified|0|||
44241550|NCT01522651|79069578|FG000|Overall Study|Participant Non-Compliance|1|||
44241551|NCT01522651|79069579|FG001|Overall Study|Participant Non-Compliance|0|||
44241552|NCT01522651|79069580|FG002|Overall Study|Participant Non-Compliance|0|||
44241553|NCT01522651|79069581|FG003|Overall Study|Participant Non-Compliance|0|||
44241554|NCT01522651|79069582|FG004|Overall Study|Participant Non-Compliance|0|||
44241555|NCT01522651|79069578|FG000|Overall Study|Withdrew Consent|1|||
44241556|NCT01522651|79069579|FG001|Overall Study|Withdrew Consent|1|||
44241557|NCT01522651|79069580|FG002|Overall Study|Withdrew Consent|0|||
44241558|NCT01522651|79069581|FG003|Overall Study|Withdrew Consent|1|||
44241559|NCT01522651|79069582|FG004|Overall Study|Withdrew Consent|1|||
44241560|NCT01522651|79069578|FG000|Overall Study|Randomized but Never Treated|0|||
44241561|NCT01522651|79069579|FG001|Overall Study|Randomized but Never Treated|1|||
44241562|NCT01522651|79069580|FG002|Overall Study|Randomized but Never Treated|0|||
44241563|NCT01522651|79069581|FG003|Overall Study|Randomized but Never Treated|1|||
44241564|NCT01522651|79069582|FG004|Overall Study|Randomized but Never Treated|1|||
44276386|NCT02156076|79230904|FG002|Follow-up Period|Withdrawal by Subject|0|||
44509971|NCT03706040|79515163|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
44509972|NCT03706040|79515164|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
44509973|NCT03706040|79515165|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
44122315|NCT02978417|78906501|FG001|Overall Study|Lost to Follow-up|2|||
44122316|NCT02733627|78906524|FG000|Overall Study|Adverse Event|0|||
44122317|NCT02733627|78906525|FG001|Overall Study|Adverse Event|1|||
44122318|NCT02733627|78906526|FG002|Overall Study|Adverse Event|1|||
44122319|NCT02733627|78906527|FG003|Overall Study|Adverse Event|0|||
44241565|NCT01554241|79069609|FG000|Overall Study|Death|3|||
44241566|NCT01554241|79069610|FG001|Overall Study|Death|1|||
44241567|NCT01554241|79069611|FG002|Overall Study|Death|1|||
44241568|NCT01554241|79069612|FG003|Overall Study|Death|0|||
44241569|NCT01554241|79069609|FG000|Overall Study|protocol specified renal stone|0|||
44276387|NCT02156076|79230905|FG003|Follow-up Period|Withdrawal by Subject|0|||
44276388|NCT02213094|79230917|FG000|Overall Study|Adverse Event|1|||
44379073|NCT00831844|79384672|FG007|Overall Study|Physician Decision|0|||
44509974|NCT03706040|79515159|FG000|Period B (Week 16 to Week 52)|Other|0|||
44509975|NCT03706040|79515160|FG001|Period B (Week 16 to Week 52)|Other|0|||
44509976|NCT03706040|79515161|FG002|Period B (Week 16 to Week 52)|Other|0|||
44509977|NCT03706040|79515162|FG003|Period B (Week 16 to Week 52)|Other|4|||
44509978|NCT03706040|79515163|FG004|Period B (Week 16 to Week 52)|Other|5|||
44509979|NCT03706040|79515164|FG005|Period B (Week 16 to Week 52)|Other|23|||
44509980|NCT03706040|79515165|FG006|Period B (Week 16 to Week 52)|Other|17|||
44509981|NCT03770000|79515186|FG000|Overall Study|Premature discontinuation due to PD|0|||
44509982|NCT03770000|79515187|FG001|Overall Study|Premature discontinuation due to PD|0|||
44509983|NCT03770000|79515188|FG002|Overall Study|Premature discontinuation due to PD|1|||
44509984|NCT03770000|79515189|FG003|Overall Study|Premature discontinuation due to PD|3|||
44241570|NCT01554241|79069610|FG001|Overall Study|protocol specified renal stone|0|||
44241571|NCT01554241|79069611|FG002|Overall Study|protocol specified renal stone|0|||
44241572|NCT01554241|79069612|FG003|Overall Study|protocol specified renal stone|1|||
44241573|NCT01554241|79069609|FG000|Overall Study|protocol specified change in eGFR|0|||
44241574|NCT01554241|79069610|FG001|Overall Study|protocol specified change in eGFR|0|||
44143855|NCT00462943|78933154|FG000|Overall Study|Failure to achieve a response|5|||
44241575|NCT01554241|79069611|FG002|Overall Study|protocol specified change in eGFR|1|||
44276389|NCT02213094|79230918|FG001|Overall Study|Adverse Event|0|||
44241576|NCT01554241|79069612|FG003|Overall Study|protocol specified change in eGFR|0|||
44241577|NCT01554241|79069609|FG000|Overall Study|Withdrawal by Subject|0|||
44241578|NCT01554241|79069610|FG001|Overall Study|Withdrawal by Subject|0|||
44241579|NCT01554241|79069611|FG002|Overall Study|Withdrawal by Subject|2|||
44241580|NCT01554241|79069612|FG003|Overall Study|Withdrawal by Subject|0|||
44241581|NCT01521559|79069624|FG000|Overall Study|Adverse Event|0|||
44241582|NCT01521559|79069625|FG001|Overall Study|Adverse Event|4|||
44241583|NCT01521559|79069624|FG000|Overall Study|Death|1|||
44241584|NCT01521559|79069625|FG001|Overall Study|Death|0|||
44241585|NCT01521559|79069624|FG000|Overall Study|Withdrawal by Subject|9|||
44241586|NCT01521559|79069625|FG001|Overall Study|Withdrawal by Subject|11|||
44241587|NCT01521559|79069624|FG000|Overall Study|Lost to Follow-up|3|||
44241588|NCT01521559|79069625|FG001|Overall Study|Lost to Follow-up|1|||
44241589|NCT01521559|79069624|FG000|Overall Study|Protocol Violation|1|||
44241590|NCT01521559|79069625|FG001|Overall Study|Protocol Violation|0|||
44241591|NCT01521559|79069624|FG000|Overall Study|Other|1|||
44241592|NCT01521559|79069625|FG001|Overall Study|Other|2|||
44241593|NCT01554163|79069634|FG000|Overall Study|Adverse Event|3|||
44241594|NCT01554163|79069635|FG001|Overall Study|Adverse Event|0|||
44241595|NCT01554163|79069634|FG000|Overall Study|Lack of Efficacy|1|||
44241596|NCT01554163|79069635|FG001|Overall Study|Lack of Efficacy|0|||
44241597|NCT01554163|79069634|FG000|Overall Study|Lost to Follow-up|1|||
44241598|NCT01554163|79069635|FG001|Overall Study|Lost to Follow-up|0|||
44241599|NCT01554163|79069634|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44241600|NCT01554163|79069635|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44241601|NCT01554163|79069634|FG000|Overall Study|Protocol Violation|0|||
44241602|NCT01554163|79069635|FG001|Overall Study|Protocol Violation|4|||
44241603|NCT01554163|79069634|FG000|Overall Study|Withdrawal by Subject|1|||
44241604|NCT01554163|79069635|FG001|Overall Study|Withdrawal by Subject|5|||
44122320|NCT02733627|78906524|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
44122321|NCT02733627|78906525|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
44122322|NCT02733627|78906526|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
44122323|NCT02733627|78906527|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
44122324|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122325|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
44122326|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122327|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
44122328|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
44122329|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
44122330|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
44122331|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122332|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44241605|NCT01554163|79069634|FG000|Overall Study|Not Treated|1|||
44241606|NCT01554163|79069635|FG001|Overall Study|Not Treated|0|||
44241607|NCT01553851|79069641|FG000|Overall Study|Adverse Event|2|||
44241608|NCT01553851|79069641|FG000|Overall Study|constipation|1|||
44241609|NCT03842163|79069658|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
44241610|NCT03842163|79069658|FG000|Overall Study|Scintigraphy was not performed|44|||
44241611|NCT01552915|79069665|FG000|Overall Study|Adverse Event|3|||
44241612|NCT01552915|79069666|FG001|Overall Study|Adverse Event|14|||
44241613|NCT01552915|79069667|FG002|Overall Study|Adverse Event|3|||
44241614|NCT01552915|79069665|FG000|Overall Study|Lost to Follow-up|4|||
44241615|NCT01552915|79069666|FG001|Overall Study|Lost to Follow-up|6|||
44241616|NCT01552915|79069667|FG002|Overall Study|Lost to Follow-up|5|||
44122333|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122334|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44241617|NCT01552915|79069665|FG000|Overall Study|Withdrawal by Subject|6|||
44241618|NCT01552915|79069666|FG001|Overall Study|Withdrawal by Subject|4|||
44241619|NCT01552915|79069667|FG002|Overall Study|Withdrawal by Subject|5|||
44241620|NCT01552915|79069665|FG000|Overall Study|Protocol Violation|0|||
44241621|NCT01552915|79069666|FG001|Overall Study|Protocol Violation|4|||
44241622|NCT01552915|79069667|FG002|Overall Study|Protocol Violation|4|||
44241623|NCT01552915|79069665|FG000|Overall Study|Lack of Efficacy|8|||
44241624|NCT01552915|79069666|FG001|Overall Study|Lack of Efficacy|1|||
44241625|NCT01552915|79069667|FG002|Overall Study|Lack of Efficacy|4|||
44241626|NCT01552915|79069665|FG000|Overall Study|Other|2|||
44241627|NCT01552915|79069666|FG001|Overall Study|Other|0|||
44241628|NCT01552915|79069667|FG002|Overall Study|Other|6|||
44241629|NCT01552681|79069696|FG000|Overall Study|Withdrawal by Subject|4|||
44379074|NCT00831844|79384673|FG008|Overall Study|Physician Decision|1|||
44241630|NCT01552681|79069697|FG001|Overall Study|Withdrawal by Subject|0|||
44241631|NCT01552681|79069696|FG000|Overall Study|Physician Decision|1|||
44241632|NCT01552681|79069697|FG001|Overall Study|Physician Decision|0|||
44241633|NCT01552681|79069696|FG000|Overall Study|Subject moved away|0|||
44241634|NCT01552681|79069697|FG001|Overall Study|Subject moved away|1|||
44241635|NCT01570387|79069729|FG000|Overall Study|Adverse Event|1|||
44241636|NCT01570387|79069730|FG001|Overall Study|Adverse Event|0|||
44241637|NCT01570387|79069731|FG002|Overall Study|Adverse Event|0|||
44241638|NCT01570387|79069732|FG003|Overall Study|Adverse Event|0|||
44241639|NCT01570387|79069729|FG000|Overall Study|Death|0|||
44241640|NCT01570387|79069730|FG001|Overall Study|Death|0|||
44241641|NCT01570387|79069731|FG002|Overall Study|Death|0|||
44241642|NCT01570387|79069732|FG003|Overall Study|Death|1|||
44241643|NCT01570387|79069729|FG000|Overall Study|Withdrawal by Subject|0|||
44241644|NCT01570387|79069730|FG001|Overall Study|Withdrawal by Subject|0|||
44241645|NCT01570387|79069731|FG002|Overall Study|Withdrawal by Subject|0|||
44241646|NCT01570387|79069732|FG003|Overall Study|Withdrawal by Subject|1|||
44241647|NCT01570309|79069741|FG000|Overall Study|Withdrawal by Subject|3|||
44241648|NCT01570309|79069742|FG001|Overall Study|Withdrawal by Subject|3|||
44241649|NCT01519921|79069754|FG000|Overall Study|Adverse Event|10|||
44241650|NCT01519921|79069755|FG001|Overall Study|Adverse Event|9|||
44241651|NCT01519921|79069754|FG000|Overall Study|Lack of Efficacy|4|||
44241652|NCT01519921|79069755|FG001|Overall Study|Lack of Efficacy|3|||
44241653|NCT01519921|79069754|FG000|Overall Study|Withdrawal by Subject|3|||
44241654|NCT01519921|79069755|FG001|Overall Study|Withdrawal by Subject|0|||
44241655|NCT01519921|79069754|FG000|Overall Study|Lost to Follow-up|2|||
44241656|NCT01519921|79069755|FG001|Overall Study|Lost to Follow-up|1|||
44241657|NCT01519921|79069754|FG000|Overall Study|Treatment refusal|2|||
44241658|NCT01519921|79069755|FG001|Overall Study|Treatment refusal|1|||
44241659|NCT01519921|79069754|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
44241660|NCT01519921|79069755|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
44241661|NCT01519765|79069763|FG000|Overall Study|Adverse Event|0|||
44241662|NCT01519765|79069764|FG001|Overall Study|Adverse Event|1|||
44241663|NCT01519765|79069763|FG000|Overall Study|Lack of Efficacy|2|||
44241664|NCT01519765|79069764|FG001|Overall Study|Lack of Efficacy|0|||
44241665|NCT01519765|79069763|FG000|Overall Study|Protocol Violation|1|||
44241666|NCT01519765|79069764|FG001|Overall Study|Protocol Violation|0|||
44241667|NCT01519765|79069763|FG000|Overall Study|Withdrawal by Subject|0|||
44241668|NCT01519765|79069764|FG001|Overall Study|Withdrawal by Subject|1|||
44241669|NCT01552603|79069771|FG000|Overall Study|Physician Decision|1|||
44241670|NCT01552369|79069777|FG000|Overall Study|Did not consent to extended follow up|8|||
44241671|NCT01552369|79069778|FG001|Overall Study|Did not consent to extended follow up|9|||
44241672|NCT01552057|79069788|FG000|Overall Study|Adverse Event|14|||
44241673|NCT01552057|79069789|FG001|Overall Study|Adverse Event|15|||
44122335|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44509985|NCT03770000|79515190|FG004|Overall Study|Premature discontinuation due to PD|2|||
44509986|NCT03158272|79515209|FG000|Overall Study|Disease progression|3|||
44509987|NCT03158272|79515210|FG001|Overall Study|Disease progression|3|||
44509988|NCT03158272|79515211|FG002|Overall Study|Disease progression|4|||
44509989|NCT03158272|79515212|FG003|Overall Study|Disease progression|6|||
44509990|NCT03158272|79515209|FG000|Overall Study|Death|0|||
44509991|NCT03158272|79515210|FG001|Overall Study|Death|0|||
44509992|NCT03158272|79515211|FG002|Overall Study|Death|1|||
44509993|NCT03158272|79515212|FG003|Overall Study|Death|0|||
44122336|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122337|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122338|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44509994|NCT03158272|79515209|FG000|Overall Study|Other reasons|0|||
44122339|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
44122340|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
44241674|NCT01552057|79069788|FG000|Overall Study|Lack of Efficacy|8|||
44241675|NCT01552057|79069789|FG001|Overall Study|Lack of Efficacy|23|||
44241676|NCT01552057|79069788|FG000|Overall Study|Withdrawal by Subject|5|||
44241677|NCT01552057|79069789|FG001|Overall Study|Withdrawal by Subject|8|||
44241678|NCT01552057|79069788|FG000|Overall Study|Entry Criteria Not Met|2|||
44241679|NCT01552057|79069789|FG001|Overall Study|Entry Criteria Not Met|2|||
44241680|NCT01552057|79069788|FG000|Overall Study|Physician Decision|1|||
44241681|NCT01552057|79069789|FG001|Overall Study|Physician Decision|0|||
44509995|NCT03158272|79515210|FG001|Overall Study|Other reasons|0|||
44509996|NCT03158272|79515211|FG002|Overall Study|Other reasons|1|||
44509997|NCT03158272|79515212|FG003|Overall Study|Other reasons|0|||
44122341|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
44122342|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
44122343|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
44122344|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
44122345|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
44122346|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
44122347|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
44122348|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
44122349|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
44122350|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
44122351|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
44122352|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
44122353|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
44122354|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
44122355|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
44122356|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
44122357|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
44122358|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122359|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122360|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122361|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122362|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122363|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122364|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122365|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122366|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122367|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122368|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122369|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122370|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122371|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
44122372|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
44122373|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44122374|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
44122375|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
44122376|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
44241682|NCT01551745|79069795|FG000|Overall Study|Withdrawal by Subject|1|||
44241683|NCT01551745|79069795|FG000|Overall Study|Disease Progression|2|||
44241684|NCT01551355|79069805|FG000|Overall Study|Lost to Follow-up|51|||
44241685|NCT01551355|79069806|FG001|Overall Study|Lost to Follow-up|49|||
44241686|NCT01551355|79069807|FG002|Overall Study|Lost to Follow-up|34|||
44241687|NCT01551355|79069808|FG003|Overall Study|Lost to Follow-up|24|||
44241688|NCT01551355|79069809|FG004|Overall Study|Lost to Follow-up|9|||
44241689|NCT01551355|79069810|FG005|Overall Study|Lost to Follow-up|6|||
44241690|NCT01569841|79069818|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
44241691|NCT01569841|79069819|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
44241692|NCT01569763|79069829|FG000|Overall Study|Lack of Efficacy|2|||
44241693|NCT01569763|79069830|FG001|Overall Study|Lack of Efficacy|7|||
44241694|NCT01569763|79069829|FG000|Overall Study|Adverse Event|1|||
44241695|NCT01569763|79069830|FG001|Overall Study|Adverse Event|0|||
44241696|NCT01550965|79069836|FG000|Overall Study|Adverse Event|26|||
44241697|NCT01550965|79069836|FG000|Overall Study|Withdrawal by Subject|10|||
44241698|NCT01550965|79069836|FG000|Overall Study|Lost to Follow-up|2|||
44241699|NCT01550965|79069836|FG000|Overall Study|Lack of Efficacy|59|||
44241700|NCT01550965|79069836|FG000|Overall Study|Other|13|||
44241701|NCT01569295|79069957|FG000|Overall Study|Progressive Disease|75|||
44241702|NCT01569295|79069958|FG001|Overall Study|Progressive Disease|139|||
44241703|NCT01569295|79069957|FG000|Overall Study|Adverse Event|39|||
44241704|NCT01569295|79069958|FG001|Overall Study|Adverse Event|14|||
44241705|NCT01569295|79069957|FG000|Overall Study|Withdrawal by Subject|25|||
44241706|NCT01569295|79069958|FG001|Overall Study|Withdrawal by Subject|12|||
44241707|NCT01569295|79069957|FG000|Overall Study|Death|19|||
44241708|NCT01569295|79069958|FG001|Overall Study|Death|15|||
44241709|NCT01569295|79069957|FG000|Overall Study|Physician Decision|13|||
44122377|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
44122378|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
44122379|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44122380|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44122381|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44241710|NCT01569295|79069958|FG001|Overall Study|Physician Decision|18|||
44241711|NCT01569295|79069957|FG000|Overall Study|Study Terminated by Sponsor|24|||
44241712|NCT01569295|79069958|FG001|Overall Study|Study Terminated by Sponsor|2|||
44241713|NCT01569295|79069957|FG000|Overall Study|Other Reason not Specified|3|||
44241714|NCT01569295|79069958|FG001|Overall Study|Other Reason not Specified|5|||
44241715|NCT01569295|79069957|FG000|Overall Study|Non-Compliance with Study Drug|6|||
44241716|NCT01569295|79069958|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44241717|NCT01569295|79069957|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
44241718|NCT01569295|79069958|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
44241719|NCT01569295|79069957|FG000|Overall Study|Lost to Follow-up|1|||
44241720|NCT01569295|79069958|FG001|Overall Study|Lost to Follow-up|1|||
44241721|NCT01549951|79070015|FG000|Overall Study|Adverse Event|15|||
44241722|NCT01549951|79070015|FG000|Overall Study|Withdrawal by Subject|2|||
44241723|NCT01549951|79070015|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
44241724|NCT01549951|79070015|FG000|Overall Study|Progressive disease|29|||
44241725|NCT01549951|79070015|FG000|Overall Study|Symptomatic deterioration|1|||
44241726|NCT01549951|79070015|FG000|Overall Study|Other|2|||
44241727|NCT01517893|79070021|FG000|Overall Study|Withdrawal by Subject|3|||
44122382|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44122383|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44241728|NCT01517893|79070022|FG001|Overall Study|Withdrawal by Subject|0|||
44241729|NCT01489891|79070030|FG000|Overall Study|Endoscopy failure|1|||
44122384|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44241730|NCT01489891|79070031|FG001|Overall Study|Endoscopy failure|0|||
44241731|NCT04062240|79070113|FG000|Overall Study|equipment malfunction|1|||
44241732|NCT02790138|79070119|FG000|Overall Study|Adverse Event|5|||
44241733|NCT02790138|79070120|FG001|Overall Study|Adverse Event|2|||
44241734|NCT02790138|79070119|FG000|Overall Study|Significant Protocol Deviation|0|||
44241735|NCT02790138|79070120|FG001|Overall Study|Significant Protocol Deviation|1|||
44241736|NCT02790138|79070119|FG000|Overall Study|Lost to Follow-up|1|||
44241737|NCT02790138|79070120|FG001|Overall Study|Lost to Follow-up|0|||
44241738|NCT02790138|79070119|FG000|Overall Study|Voluntary Withdrawal|8|||
44241739|NCT02790138|79070120|FG001|Overall Study|Voluntary Withdrawal|9|||
44241740|NCT02790138|79070119|FG000|Overall Study|Lack of Efficacy|6|||
44241741|NCT02790138|79070120|FG001|Overall Study|Lack of Efficacy|7|||
44241742|NCT02790138|79070119|FG000|Overall Study|Reason not Specified|1|||
44241743|NCT02790138|79070120|FG001|Overall Study|Reason not Specified|0|||
44241744|NCT05385224|79070273|FG000|Overall Study|Unable to swallow capsule|2|||
44241745|NCT05385224|79070273|FG000|Overall Study|Withdrawal by Subject|2|||
44241746|NCT05385224|79070273|FG000|Overall Study|Did not meet study criteria|1|||
44241747|NCT04710979|79070279|FG000|Overall Study|Lost to Follow-up|2|||
44241748|NCT04710979|79070280|FG001|Overall Study|Lost to Follow-up|4|||
44241749|NCT04710979|79070279|FG000|Overall Study|Withdrawal by Subject|1|||
44241750|NCT04710979|79070280|FG001|Overall Study|Withdrawal by Subject|0|||
44241751|NCT04682639|79070290|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
44241752|NCT04682639|79070291|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
44241753|NCT04682639|79070292|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
44241754|NCT04682639|79070293|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
44241755|NCT04682639|79070294|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
44509998|NCT03158272|79515209|FG000|Overall Study|Adverse event unrelated to the drug|0|||
44509999|NCT03158272|79515210|FG001|Overall Study|Adverse event unrelated to the drug|1|||
44510000|NCT03158272|79515211|FG002|Overall Study|Adverse event unrelated to the drug|0|||
44510001|NCT03158272|79515212|FG003|Overall Study|Adverse event unrelated to the drug|0|||
44241756|NCT04682639|79070290|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
44276390|NCT02155608|79230926|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
44276391|NCT02155608|79230927|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
44276392|NCT02155608|79230926|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
44276393|NCT02155608|79230927|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
44276394|NCT01629966|79230942|FG000|Overall Study|Pregnancy|0|||
44510002|NCT03705494|79515226|FG000|Overall Study|Lost to Follow-up|2|||
44510003|NCT03705494|79515227|FG001|Overall Study|Lost to Follow-up|1|||
44510004|NCT03705494|79515226|FG000|Overall Study|Withdrawal by Subject|5|||
44510005|NCT03705494|79515227|FG001|Overall Study|Withdrawal by Subject|2|||
44510006|NCT01431508|79515233|FG000|Overall Study|Lack of Efficacy|1|||
44510007|NCT01431508|79515233|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
44510008|NCT00654628|79515237|FG000|6-week Active Treatment Period|Adverse Event|9|||
44510009|NCT00654628|79515237|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
44510010|NCT00654628|79515237|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
44276395|NCT01629966|79230943|FG001|Overall Study|Pregnancy|1|||
44122385|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44241757|NCT04682639|79070291|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
44241758|NCT04682639|79070292|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
44241759|NCT04682639|79070293|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44276396|NCT01629966|79230944|FG002|Overall Study|Pregnancy|0|||
44241760|NCT04682639|79070294|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44276397|NCT01629966|79230942|FG000|Overall Study|Lost to Follow-up|10|||
44122386|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44122387|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
44122388|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122389|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122390|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122391|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
44241761|NCT04682639|79070290|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
44241762|NCT04682639|79070291|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
44241763|NCT04682639|79070292|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44241764|NCT04682639|79070293|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44241765|NCT04682639|79070294|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44241766|NCT04682639|79070290|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
44241767|NCT04682639|79070291|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
44241768|NCT04682639|79070292|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
44241769|NCT04682639|79070293|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
44241770|NCT04682639|79070294|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
44241771|NCT04682639|79070290|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
44241772|NCT04682639|79070291|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
44241773|NCT04682639|79070292|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
44122392|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122393|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44241774|NCT04682639|79070293|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
44241775|NCT04682639|79070294|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
44241776|NCT04682639|79070290|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
44241777|NCT04682639|79070291|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
44241778|NCT04682639|79070292|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
44241779|NCT04682639|79070293|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44241780|NCT04682639|79070294|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44241781|NCT04682639|79070290|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
44241782|NCT04682639|79070291|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
44241783|NCT04682639|79070292|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
44276398|NCT01629966|79230943|FG001|Overall Study|Lost to Follow-up|13|||
44276399|NCT01629966|79230944|FG002|Overall Study|Lost to Follow-up|9|||
44379075|NCT00831844|79384674|FG009|Overall Study|Physician Decision|0|||
44379076|NCT00831844|79384665|FG000|Overall Study|Withdrawal by Subject|0|||
44379077|NCT00831844|79384666|FG001|Overall Study|Withdrawal by Subject|0|||
44122394|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
44241784|NCT04682639|79070293|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
44122395|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122396|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122397|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44241785|NCT04682639|79070294|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
44241786|NCT04682639|79070290|FG000|OLE Period (28 Weeks)|Other|1|||
44379078|NCT00831844|79384667|FG002|Overall Study|Withdrawal by Subject|1|||
44379079|NCT00831844|79384668|FG003|Overall Study|Withdrawal by Subject|0|||
44379080|NCT00831844|79384669|FG004|Overall Study|Withdrawal by Subject|0|||
44379081|NCT00831844|79384670|FG005|Overall Study|Withdrawal by Subject|0|||
44379082|NCT00831844|79384671|FG006|Overall Study|Withdrawal by Subject|0|||
44379083|NCT00831844|79384672|FG007|Overall Study|Withdrawal by Subject|1|||
44379084|NCT00831844|79384673|FG008|Overall Study|Withdrawal by Subject|1|||
44379085|NCT00831844|79384674|FG009|Overall Study|Withdrawal by Subject|0|||
44379086|NCT00831844|79384665|FG000|Overall Study|Ineligible|0|||
44379087|NCT00831844|79384666|FG001|Overall Study|Ineligible|1|||
44379088|NCT00831844|79384667|FG002|Overall Study|Ineligible|1|||
44379089|NCT00831844|79384668|FG003|Overall Study|Ineligible|0|||
44379090|NCT00831844|79384669|FG004|Overall Study|Ineligible|1|||
44379091|NCT00831844|79384670|FG005|Overall Study|Ineligible|0|||
44241787|NCT04682639|79070291|FG001|OLE Period (28 Weeks)|Other|2|||
44241788|NCT04682639|79070292|FG002|OLE Period (28 Weeks)|Other|0|||
44241789|NCT04682639|79070293|FG003|OLE Period (28 Weeks)|Other|0|||
44241790|NCT04682639|79070294|FG004|OLE Period (28 Weeks)|Other|1|||
44241791|NCT04682639|79070290|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
44241792|NCT04682639|79070291|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
44241793|NCT04682639|79070292|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
44379092|NCT00831844|79384671|FG006|Overall Study|Ineligible|0|||
44379093|NCT00831844|79384672|FG007|Overall Study|Ineligible|0|||
44379094|NCT00831844|79384673|FG008|Overall Study|Ineligible|0|||
44379095|NCT00831844|79384674|FG009|Overall Study|Ineligible|0|||
44379096|NCT00764881|79384698|FG000|Overall Study|Adverse Event|5|||
44379097|NCT00764881|79384699|FG001|Overall Study|Adverse Event|1|||
44379098|NCT00764881|79384698|FG000|Overall Study|Withdrawal by Subject|1|||
44379099|NCT00764881|79384699|FG001|Overall Study|Withdrawal by Subject|3|||
44379100|NCT00764881|79384698|FG000|Overall Study|Protocol Violation|2|||
44379101|NCT00764881|79384699|FG001|Overall Study|Protocol Violation|2|||
44379102|NCT00764881|79384698|FG000|Overall Study|Lost to Follow-up|2|||
44379103|NCT00764881|79384699|FG001|Overall Study|Lost to Follow-up|0|||
44276400|NCT01629966|79230942|FG000|Overall Study|Withdrawal by Subject|8|||
44276401|NCT01629966|79230943|FG001|Overall Study|Withdrawal by Subject|9|||
44276402|NCT01629966|79230944|FG002|Overall Study|Withdrawal by Subject|16|||
44276403|NCT01629966|79230942|FG000|Overall Study|Protocol Violation|7|||
44276404|NCT01629966|79230943|FG001|Overall Study|Protocol Violation|9|||
44276405|NCT01629966|79230944|FG002|Overall Study|Protocol Violation|7|||
44276406|NCT01629966|79230942|FG000|Overall Study|Lack of Efficacy|5|||
44276407|NCT01629966|79230943|FG001|Overall Study|Lack of Efficacy|2|||
44276408|NCT01629966|79230944|FG002|Overall Study|Lack of Efficacy|4|||
44379104|NCT00764881|79384698|FG000|Overall Study|Noncompliant|1|||
44379105|NCT00764881|79384699|FG001|Overall Study|Noncompliant|0|||
44379106|NCT00764881|79384698|FG000|Overall Study|Accidentally discontinued study drug|1|||
44379107|NCT00764881|79384699|FG001|Overall Study|Accidentally discontinued study drug|0|||
44379108|NCT00764881|79384698|FG000|Overall Study|Wished to become pregnant|1|||
44379109|NCT00764881|79384699|FG001|Overall Study|Wished to become pregnant|0|||
44379110|NCT00764881|79384698|FG000|Overall Study|Carcinoma detected|1|||
44379111|NCT00764881|79384699|FG001|Overall Study|Carcinoma detected|0|||
44241794|NCT04682639|79070293|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
44241795|NCT04682639|79070294|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
44241796|NCT04682639|79070290|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
44241797|NCT04682639|79070291|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
44241798|NCT04682639|79070292|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
44241799|NCT04682639|79070293|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
44241800|NCT04682639|79070294|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
44241801|NCT04682639|79070290|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
44241802|NCT04682639|79070291|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
44241803|NCT04682639|79070292|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
44241804|NCT04682639|79070293|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
44241805|NCT04682639|79070294|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
44241806|NCT04682639|79070290|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
44276409|NCT01629966|79230942|FG000|Overall Study|Adverse Event|11|||
44276410|NCT01629966|79230943|FG001|Overall Study|Adverse Event|18|||
44379112|NCT00764881|79384698|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
44379113|NCT00764881|79384699|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
44510011|NCT00654628|79515237|FG000|6-week Active Treatment Period|Out of window period|1|||
44510012|NCT00654628|79515237|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
44510013|NCT00654628|79515237|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
44510014|NCT00536380|79515244|FG000|Overall Study|Adverse Event|0|||
44510015|NCT00536380|79515245|FG001|Overall Study|Adverse Event|2|||
44122398|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122399|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122400|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122401|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122402|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122403|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
44122404|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44241807|NCT04682639|79070291|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
44241808|NCT04682639|79070292|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
44241809|NCT04682639|79070293|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
44510016|NCT00536380|79515246|FG002|Overall Study|Adverse Event|2|||
44510017|NCT00536380|79515244|FG000|Overall Study|Lost to Follow-up|0|||
44510018|NCT00536380|79515245|FG001|Overall Study|Lost to Follow-up|0|||
44510019|NCT00536380|79515246|FG002|Overall Study|Lost to Follow-up|1|||
44510020|NCT00536380|79515244|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
44510021|NCT00536380|79515245|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
44510022|NCT00536380|79515246|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
44510023|NCT00536380|79515244|FG000|Overall Study|Withdrawal related to study drug|7|||
44510024|NCT00536380|79515245|FG001|Overall Study|Withdrawal related to study drug|5|||
44510025|NCT00536380|79515246|FG002|Overall Study|Withdrawal related to study drug|2|||
44241810|NCT04682639|79070294|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
44241811|NCT04470050|79070313|FG000|Double-blind Treatment Phase|Adverse Event|0|||
44241812|NCT04470050|79070314|FG001|Double-blind Treatment Phase|Adverse Event|0|||
44276411|NCT01629966|79230944|FG002|Overall Study|Adverse Event|30|||
44276412|NCT02177838|79230984|FG000|Overall Study|Withdrawal by Subject|1|||
44276413|NCT02177838|79230984|FG000|Overall Study|Physician Decision|1|||
44379114|NCT00764881|79384698|FG000|Overall Study|no treatment or no observation|2|||
44379115|NCT00764881|79384699|FG001|Overall Study|no treatment or no observation|2|||
44510026|NCT00536380|79515244|FG000|Overall Study|Noncompliance with protocol|3|||
44122405|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122406|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
44122407|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122408|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122409|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122410|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122411|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122412|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122413|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122414|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122415|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122416|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122417|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122418|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122419|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
44122420|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
44122421|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
44122422|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
44122423|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122424|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122425|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122426|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122427|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122428|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122429|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122430|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122431|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122432|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122433|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122434|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122435|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
44122436|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
44122437|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
44122438|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
44379116|NCT00844558|79384707|FG000|Overall Study|Withdrawal by Subject|9|||
44379117|NCT00844558|79384708|FG001|Overall Study|Withdrawal by Subject|2|||
44379118|NCT00844558|79384707|FG000|Overall Study|Death|1|||
44379119|NCT00844558|79384708|FG001|Overall Study|Death|0|||
44379120|NCT00844558|79384707|FG000|Overall Study|Protocol Violation|1|||
44379121|NCT00844558|79384708|FG001|Overall Study|Protocol Violation|1|||
44379122|NCT00844558|79384707|FG000|Overall Study|Lost to Follow-up|0|||
44379123|NCT00844558|79384708|FG001|Overall Study|Lost to Follow-up|1|||
44122439|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
44379124|NCT00844558|79384707|FG000|Overall Study|Physician Decision|1|||
44379125|NCT00844558|79384708|FG001|Overall Study|Physician Decision|0|||
44379126|NCT00772369|79384719|FG000|Overall Study|Did not return record release form|1|||
44379127|NCT00821236|79384726|FG000|Overall Study|Lost to Follow-up|3|||
44379128|NCT00756457|79384736|FG000|Overall Study|Lost to Follow-up|1|||
44379129|NCT00756457|79384737|FG001|Overall Study|Lost to Follow-up|2|||
44122440|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
44122441|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
44122442|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
44122443|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
44122444|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
44122445|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
44122446|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
44122447|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
44122448|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
44122449|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
44122450|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
44122451|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
44122452|NCT02958865|78906544|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44379130|NCT00844480|79384761|FG000|Overall Study|Withdrawal by Subject|2|||
44379131|NCT00844480|79384762|FG001|Overall Study|Withdrawal by Subject|3|||
44379132|NCT00771901|79384771|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
44379133|NCT00771901|79384772|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
44379134|NCT00771901|79384773|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
44122453|NCT02958865|78906545|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122454|NCT02958865|78906546|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122455|NCT02958865|78906547|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122456|NCT02958865|78906548|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
44122457|NCT02958865|78906549|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122458|NCT02958865|78906550|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122459|NCT02958865|78906551|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122460|NCT02958865|78906552|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122461|NCT02958865|78906553|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122462|NCT02958865|78906554|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122463|NCT02958865|78906555|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122464|NCT02958865|78906556|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122465|NCT02958865|78906557|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122466|NCT02958865|78906558|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122467|NCT02958865|78906559|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
44122468|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122469|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122470|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122471|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122472|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122473|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44276414|NCT02177838|79230984|FG000|Overall Study|Death|1|||
44276415|NCT02177136|79231081|FG000|DB Phase|Withdrawal by Subject|2|||
44276416|NCT02177136|79231082|FG001|DB Phase|Withdrawal by Subject|0|||
44276417|NCT02177136|79231083|FG002|DB Phase|Withdrawal by Subject|0|||
44276418|NCT02177136|79231084|FG003|DB Phase|Withdrawal by Subject|0|||
44276419|NCT02177136|79231081|FG000|DB Phase|Discontinued Due to Pruritus|1|||
44276420|NCT02177136|79231082|FG001|DB Phase|Discontinued Due to Pruritus|3|||
44276421|NCT02177136|79231083|FG002|DB Phase|Discontinued Due to Pruritus|0|||
44276422|NCT02177136|79231084|FG003|DB Phase|Discontinued Due to Pruritus|0|||
44276423|NCT02177136|79231081|FG000|DB Phase|Adverse Event|3|||
44276424|NCT02177136|79231082|FG001|DB Phase|Adverse Event|2|||
44276425|NCT02177136|79231083|FG002|DB Phase|Adverse Event|3|||
44510027|NCT00536380|79515245|FG001|Overall Study|Noncompliance with protocol|2|||
44510028|NCT00536380|79515246|FG002|Overall Study|Noncompliance with protocol|2|||
44510029|NCT00536380|79515244|FG000|Overall Study|Did not meet protocol eligibility|0|||
44122474|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122475|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
44122476|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
44122477|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
44122478|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
44122479|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
44122480|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
44241813|NCT04470050|79070315|FG002|Double-blind Treatment Phase|Adverse Event|0|||
44241814|NCT04470050|79070316|FG003|Double-blind Treatment Phase|Adverse Event|1|||
44241815|NCT04470050|79070317|FG004|Double-blind Treatment Phase|Adverse Event|0|||
44241816|NCT04470050|79070318|FG005|Double-blind Treatment Phase|Adverse Event|0|||
44241817|NCT04470050|79070319|FG006|Double-blind Treatment Phase|Adverse Event|0|||
44241818|NCT04470050|79070313|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
44241819|NCT04470050|79070314|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
44241820|NCT04470050|79070315|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
44241821|NCT04470050|79070316|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
44241822|NCT04470050|79070317|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
44241823|NCT04470050|79070318|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
44241824|NCT04470050|79070319|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
44241825|NCT04470050|79070313|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
44122481|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
44122482|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
44241826|NCT04470050|79070314|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
44241827|NCT04470050|79070315|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
44241828|NCT04470050|79070316|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
44241829|NCT04470050|79070317|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
44241830|NCT04470050|79070318|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
44122483|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
44122484|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122485|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122486|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44276426|NCT02177136|79231084|FG003|DB Phase|Adverse Event|0|||
44276427|NCT02177136|79231081|FG000|DB Phase|Protocol Violation|0|||
44276428|NCT02177136|79231082|FG001|DB Phase|Protocol Violation|0|||
44276429|NCT02177136|79231083|FG002|DB Phase|Protocol Violation|1|||
44276430|NCT02177136|79231084|FG003|DB Phase|Protocol Violation|0|||
44276431|NCT02177136|79231081|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
44276432|NCT02177136|79231082|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
44241831|NCT04470050|79070319|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
44241832|NCT03887052|79070451|FG000|Overall Study|Adverse Event|2|||
44241833|NCT03887052|79070451|FG000|Overall Study|Physician Decision|2|||
44241834|NCT03887052|79070451|FG000|Overall Study|Withdrawal by Subject|3|||
44241835|NCT03887052|79070451|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
44241836|NCT03887052|79070451|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
44241837|NCT03758066|79070455|FG000|Overall Study|Lost to Follow-up|14|||
44241838|NCT03728933|79070474|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
44241839|NCT03728933|79070475|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44241840|NCT03728933|79070476|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44241841|NCT03728933|79070474|FG000|Overall Study|Withdrawal by Subject|0|||
44241842|NCT03728933|79070475|FG001|Overall Study|Withdrawal by Subject|0|||
44241843|NCT03728933|79070476|FG002|Overall Study|Withdrawal by Subject|1|||
44241844|NCT03728933|79070474|FG000|Overall Study|Lost to Follow-up|0|||
44241845|NCT03728933|79070475|FG001|Overall Study|Lost to Follow-up|1|||
44241846|NCT03728933|79070476|FG002|Overall Study|Lost to Follow-up|0|||
44241847|NCT03728933|79070474|FG000|Overall Study|Adverse Event|1|||
44122487|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122488|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122489|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122490|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122491|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44241848|NCT03728933|79070475|FG001|Overall Study|Adverse Event|0|||
44241849|NCT03728933|79070476|FG002|Overall Study|Adverse Event|0|||
44241850|NCT03599713|79070495|FG000|Overall Study|Death|26|||
44241851|NCT03599713|79070496|FG001|Overall Study|Death|3|||
44241852|NCT03599713|79070495|FG000|Overall Study|Withdrawal by Subject|6|||
44241853|NCT03599713|79070496|FG001|Overall Study|Withdrawal by Subject|0|||
44241854|NCT03599713|79070495|FG000|Overall Study|Ongoing|69|||
44241855|NCT03599713|79070496|FG001|Overall Study|Ongoing|3|||
44241856|NCT03557281|79070513|FG000|Overall Study|Investigator discretion|0|||
44241857|NCT03557281|79070514|FG001|Overall Study|Investigator discretion|0|||
44241858|NCT03557281|79070515|FG002|Overall Study|Investigator discretion|1|||
44241859|NCT03557281|79070516|FG003|Overall Study|Investigator discretion|0|||
44241860|NCT03557281|79070517|FG004|Overall Study|Investigator discretion|0|||
44241861|NCT03557281|79070513|FG000|Overall Study|Withdrawal by Subject|0|||
44241862|NCT03557281|79070514|FG001|Overall Study|Withdrawal by Subject|1|||
44241863|NCT03557281|79070515|FG002|Overall Study|Withdrawal by Subject|1|||
44241864|NCT03557281|79070516|FG003|Overall Study|Withdrawal by Subject|1|||
44241865|NCT03557281|79070517|FG004|Overall Study|Withdrawal by Subject|2|||
44241866|NCT03557281|79070513|FG000|Overall Study|Randomized, but did not receive treatment|0|||
44241867|NCT03557281|79070514|FG001|Overall Study|Randomized, but did not receive treatment|0|||
44241868|NCT03557281|79070515|FG002|Overall Study|Randomized, but did not receive treatment|0|||
44241869|NCT03557281|79070516|FG003|Overall Study|Randomized, but did not receive treatment|0|||
44241870|NCT03557281|79070517|FG004|Overall Study|Randomized, but did not receive treatment|1|||
44241871|NCT03538041|79070535|FG000|12-Week Treatment Period|Adverse Event|1|||
44241872|NCT03538041|79070536|FG001|12-Week Treatment Period|Adverse Event|1|||
44241873|NCT03538041|79070535|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
44122492|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
44122493|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
44122494|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44241874|NCT03538041|79070536|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
44241875|NCT03538041|79070535|FG000|Treatment Extension Period|Adverse Event|4|||
44241876|NCT03538041|79070536|FG001|Treatment Extension Period|Adverse Event|0|||
44241877|NCT03538041|79070535|FG000|Treatment Extension Period|Physician Decision|1|||
44241878|NCT03538041|79070536|FG001|Treatment Extension Period|Physician Decision|0|||
44241879|NCT03538041|79070535|FG000|Treatment Extension Period|Lack of Efficacy|1|||
44241880|NCT03538041|79070536|FG001|Treatment Extension Period|Lack of Efficacy|3|||
44241881|NCT03538041|79070535|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
44241882|NCT03538041|79070536|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
44241883|NCT03260894|79070551|FG000|Overall Study|Death|6|||
44241884|NCT03260894|79070552|FG001|Overall Study|Death|8|||
44241885|NCT03260894|79070551|FG000|Overall Study|Withdrawal by Subject|4|||
44241886|NCT03260894|79070552|FG001|Overall Study|Withdrawal by Subject|11|||
44241887|NCT03260894|79070551|FG000|Overall Study|On-going at clinical cut off date|36|||
44241888|NCT03260894|79070552|FG001|Overall Study|On-going at clinical cut off date|31|||
44241889|NCT03197935|79070560|FG000|Overall Study|Death due to any cause|26|||
44241890|NCT03197935|79070561|FG001|Overall Study|Death due to any cause|15|||
44241891|NCT03197935|79070560|FG000|Overall Study|Lost to Follow-up|3|||
44241892|NCT03197935|79070561|FG001|Overall Study|Lost to Follow-up|5|||
44241893|NCT03197935|79070560|FG000|Overall Study|Physician Decision|2|||
44241894|NCT03197935|79070561|FG001|Overall Study|Physician Decision|1|||
44241895|NCT03197935|79070560|FG000|Overall Study|Withdrawal by Subject|16|||
44241896|NCT03197935|79070561|FG001|Overall Study|Withdrawal by Subject|8|||
44241897|NCT03136965|79070572|FG000|Overall Study|Lost to Follow-up|0|||
44241898|NCT03136965|79070573|FG001|Overall Study|Lost to Follow-up|1|||
44241899|NCT03136965|79070574|FG002|Overall Study|Lost to Follow-up|0|||
44241900|NCT03115151|79070584|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
44241901|NCT03115151|79070585|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
44241902|NCT03115151|79070584|FG000|Overall Study|Epidural catheter removal|1|||
44241903|NCT03115151|79070585|FG001|Overall Study|Epidural catheter removal|0|||
44241904|NCT03115151|79070584|FG000|Overall Study|Withdrawal by Subject|0|||
44241905|NCT03115151|79070585|FG001|Overall Study|Withdrawal by Subject|1|||
44241906|NCT03115151|79070584|FG000|Overall Study|Intervention not received according to the protocol.|1|||
44241907|NCT03115151|79070585|FG001|Overall Study|Intervention not received according to the protocol.|1|||
44122495|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
44122496|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122497|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
44122498|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
44122499|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
44122500|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122501|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122502|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122503|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122504|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122505|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122506|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122507|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122508|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122509|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
44122510|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44241908|NCT03115151|79070584|FG000|Overall Study|Physician Decision|1|||
44241909|NCT03115151|79070585|FG001|Overall Study|Physician Decision|0|||
44241910|NCT03115151|79070584|FG000|Overall Study|Randomization not applied|1|||
44241911|NCT03115151|79070585|FG001|Overall Study|Randomization not applied|1|||
44241912|NCT02908685|79070603|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
44241913|NCT02908685|79070604|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
44241914|NCT02908685|79070605|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
44241915|NCT02908685|79070606|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
44241916|NCT02908685|79070607|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
44241917|NCT02908685|79070608|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
44241918|NCT02908685|79070609|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
44241919|NCT02908685|79070610|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
44241920|NCT02908685|79070611|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
44241921|NCT02908685|79070612|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
44241922|NCT02908685|79070613|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
44241923|NCT02908685|79070614|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
44241924|NCT02908685|79070603|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
44241925|NCT02908685|79070604|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
44241926|NCT02908685|79070605|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
44241927|NCT02908685|79070606|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
44241928|NCT02908685|79070607|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
44241929|NCT02908685|79070608|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
44241930|NCT02908685|79070609|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
44379135|NCT00843856|79384783|FG000|Overall Study|Lost to Follow-up|1|||
44379136|NCT00843856|79384784|FG001|Overall Study|Lost to Follow-up|2|||
44379137|NCT00764491|79384792|FG000|Overall Study|Lost to Follow-up|35|||
44379138|NCT00764491|79384793|FG001|Overall Study|Lost to Follow-up|17|||
44510030|NCT00536380|79515245|FG001|Overall Study|Did not meet protocol eligibility|0|||
44241931|NCT02908685|79070610|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
44241932|NCT02908685|79070611|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
44241933|NCT02908685|79070612|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
44241934|NCT02908685|79070613|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
44241935|NCT02908685|79070614|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
44241936|NCT02908685|79070603|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
44241937|NCT02908685|79070604|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
44510031|NCT00536380|79515246|FG002|Overall Study|Did not meet protocol eligibility|1|||
44241938|NCT02908685|79070605|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
44241939|NCT02908685|79070606|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
44241940|NCT02908685|79070607|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
44241941|NCT02908685|79070608|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
44241942|NCT02908685|79070609|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
44241943|NCT02908685|79070610|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
44241944|NCT02908685|79070611|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
44241945|NCT02908685|79070612|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
44241946|NCT02908685|79070613|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
44241947|NCT02908685|79070614|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
44241948|NCT02772276|79070644|FG000|Overall Study|Lost to Follow-up|0|||
44241949|NCT02772276|79070645|FG001|Overall Study|Lost to Follow-up|0|||
44241950|NCT02772276|79070646|FG002|Overall Study|Lost to Follow-up|0|||
44241951|NCT02772276|79070647|FG003|Overall Study|Lost to Follow-up|0|||
44241952|NCT02772276|79070648|FG004|Overall Study|Lost to Follow-up|0|||
44241953|NCT02772276|79070649|FG005|Overall Study|Lost to Follow-up|0|||
44241954|NCT02772276|79070650|FG006|Overall Study|Lost to Follow-up|1|||
44241955|NCT02772276|79070651|FG007|Overall Study|Lost to Follow-up|0|||
44241956|NCT02772276|79070652|FG008|Overall Study|Lost to Follow-up|0|||
44241957|NCT02772276|79070653|FG009|Overall Study|Lost to Follow-up|0|||
44241958|NCT02772276|79070654|FG010|Overall Study|Lost to Follow-up|0|||
44241959|NCT02772276|79070655|FG011|Overall Study|Lost to Follow-up|0|||
44241960|NCT02772276|79070656|FG012|Overall Study|Lost to Follow-up|0|||
44241961|NCT02772276|79070644|FG000|Overall Study|Withdrew consent|0|||
44241962|NCT02772276|79070645|FG001|Overall Study|Withdrew consent|0|||
44241963|NCT02772276|79070646|FG002|Overall Study|Withdrew consent|0|||
44241964|NCT02772276|79070647|FG003|Overall Study|Withdrew consent|0|||
44241965|NCT02772276|79070648|FG004|Overall Study|Withdrew consent|0|||
44241966|NCT02772276|79070649|FG005|Overall Study|Withdrew consent|0|||
44241967|NCT02772276|79070650|FG006|Overall Study|Withdrew consent|0|||
44241968|NCT02772276|79070651|FG007|Overall Study|Withdrew consent|1|||
44241969|NCT02772276|79070652|FG008|Overall Study|Withdrew consent|0|||
44241970|NCT02772276|79070653|FG009|Overall Study|Withdrew consent|0|||
44241971|NCT02772276|79070654|FG010|Overall Study|Withdrew consent|0|||
44241972|NCT02772276|79070655|FG011|Overall Study|Withdrew consent|0|||
44241973|NCT02772276|79070656|FG012|Overall Study|Withdrew consent|0|||
44241974|NCT02601313|79070709|FG000|Overall Study|Death|2|||
44241975|NCT02601313|79070710|FG001|Overall Study|Death|16|||
44241976|NCT02601313|79070711|FG002|Overall Study|Death|4|||
44241977|NCT02601313|79070709|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
44241978|NCT02601313|79070710|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
44241979|NCT02601313|79070711|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
44241980|NCT02601313|79070709|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
44241981|NCT02601313|79070710|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
44241982|NCT02601313|79070711|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
44241983|NCT02601313|79070709|FG000|Overall Study|Still on study|0|||
44241984|NCT02601313|79070710|FG001|Overall Study|Still on study|52|||
44241985|NCT02601313|79070711|FG002|Overall Study|Still on study|10|||
44241986|NCT02601313|79070709|FG000|Overall Study|Enrolled, did not initiate AC|4|||
44241987|NCT02601313|79070710|FG001|Overall Study|Enrolled, did not initiate AC|0|||
44241988|NCT02601313|79070711|FG002|Overall Study|Enrolled, did not initiate AC|0|||
44241989|NCT02550652|79070721|FG000|Overall Study|Death|1|||
44241990|NCT02550652|79070722|FG001|Overall Study|Death|4|||
44241991|NCT02550652|79070721|FG000|Overall Study|Lack of Efficacy|1|||
44241992|NCT02550652|79070722|FG001|Overall Study|Lack of Efficacy|0|||
44241993|NCT02550652|79070721|FG000|Overall Study|Withdrawal by Subject|3|||
44241994|NCT02550652|79070722|FG001|Overall Study|Withdrawal by Subject|7|||
44241995|NCT02550652|79070721|FG000|Overall Study|Post Trial Access|1|||
44241996|NCT02550652|79070722|FG001|Overall Study|Post Trial Access|0|||
44241997|NCT02550652|79070721|FG000|Overall Study|Lost to Follow-up|1|||
44510032|NCT00536380|79515244|FG000|Overall Study|Administrative|0|||
44510033|NCT00536380|79515245|FG001|Overall Study|Administrative|0|||
44510034|NCT00536380|79515246|FG002|Overall Study|Administrative|1|||
44510035|NCT00496834|79515256|FG000|Overall Study|Withdrawal by Subject|4|||
44510036|NCT00496834|79515257|FG001|Overall Study|Withdrawal by Subject|6|||
44510037|NCT00496834|79515256|FG000|Overall Study|Contraindicated medication administered|0|||
44510038|NCT00496834|79515257|FG001|Overall Study|Contraindicated medication administered|1|||
44241998|NCT02550652|79070722|FG001|Overall Study|Lost to Follow-up|3|||
44241999|NCT02550652|79070721|FG000|Overall Study|Physician Decision|0|||
44242000|NCT02550652|79070722|FG001|Overall Study|Physician Decision|2|||
44242001|NCT02550652|79070721|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
44242002|NCT02550652|79070722|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
44242003|NCT02484443|79070728|FG000|Overall Study|Lack of Efficacy|28|||
44242004|NCT02484443|79070728|FG000|Overall Study|Physician Decision|2|||
44242005|NCT02484443|79070728|FG000|Overall Study|Ineligible|2|||
44510039|NCT00496834|79515256|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
44510040|NCT00496834|79515257|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
44122511|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44242006|NCT01041027|79070758|FG000|Overall Study|Withdrawal by Subject|2|||
44242007|NCT01041027|79070758|FG000|Overall Study|Protocol Violation|1|||
44242008|NCT01041027|79070758|FG000|Overall Study|Delayed Radiation Therapy|1|||
44242009|NCT01041027|79070758|FG000|Overall Study|Adverse Event|4|||
44242010|NCT00389610|79070764|FG000|Overall Study|Disease Progression|0|||
44242011|NCT00389610|79070765|FG001|Overall Study|Disease Progression|19|||
44242012|NCT00389610|79070764|FG000|Overall Study|Death|0|||
44242013|NCT00389610|79070765|FG001|Overall Study|Death|1|||
44242014|NCT00389610|79070764|FG000|Overall Study|Physician Decision|0|||
44242015|NCT00389610|79070765|FG001|Overall Study|Physician Decision|1|||
44242016|NCT00389610|79070764|FG000|Overall Study|Withdrawal by Subject|0|||
44242017|NCT00389610|79070765|FG001|Overall Study|Withdrawal by Subject|1|||
44242018|NCT01489189|79070773|FG000|Overall Study|Withdrawal by Subject|20|||
44242019|NCT01489189|79070774|FG001|Overall Study|Withdrawal by Subject|23|||
44242020|NCT01489189|79070773|FG000|Overall Study|Death|10|||
44242021|NCT01489189|79070774|FG001|Overall Study|Death|8|||
44242022|NCT01489189|79070773|FG000|Overall Study|Missed Visit|1|||
44242023|NCT01489189|79070774|FG001|Overall Study|Missed Visit|4|||
44242024|NCT01549873|79070783|FG000|Overall Study|Physician Decision|0|||
44242025|NCT01549873|79070784|FG001|Overall Study|Physician Decision|1|||
44242026|NCT01489111|79070790|FG000|Overall Study|Withdrawal criterion|1|||
44242027|NCT01488487|79070794|FG000|Overall Study|Adverse Event|6|||
44242028|NCT01488487|79070794|FG000|Overall Study|Death|1|||
44242029|NCT01488487|79070794|FG000|Overall Study|Withdrawal by Subject|2|||
44242030|NCT01488097|79070798|FG000|Overall Study|Lost to Follow-up|1|||
44242031|NCT01516879|79070804|FG000|Overall Study|Withdrawal by Subject|9|||
44242032|NCT01516879|79070805|FG001|Overall Study|Withdrawal by Subject|11|||
44242033|NCT01516879|79070804|FG000|Overall Study|Death|0|||
44242034|NCT01516879|79070805|FG001|Overall Study|Death|2|||
44242035|NCT01516879|79070804|FG000|Overall Study|Lost to Follow-up|2|||
44242036|NCT01516879|79070805|FG001|Overall Study|Lost to Follow-up|11|||
44242037|NCT01516879|79070804|FG000|Overall Study|Other|5|||
44242038|NCT01516879|79070805|FG001|Overall Study|Other|10|||
44242039|NCT01515865|79070811|FG000|Part A (Open-label)|Other|3|||
44242040|NCT01515865|79070812|FG001|Part A (Open-label)|Other|0|||
44242041|NCT01515865|79070813|FG002|Part A (Open-label)|Other|0|||
44242042|NCT01515865|79070811|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
44242043|NCT01515865|79070812|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
44242044|NCT01515865|79070813|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
44242045|NCT01515865|79070811|FG000|Part B (Open-label)|Other|1|||
44242046|NCT01515865|79070812|FG001|Part B (Open-label)|Other|0|||
44242047|NCT01515865|79070813|FG002|Part B (Open-label)|Other|0|||
44242048|NCT01547299|79070823|FG000|Overall Study|Withdrawal by Subject|2|||
44242049|NCT01547299|79070824|FG001|Overall Study|Withdrawal by Subject|2|||
44242050|NCT01515475|79070834|FG000|Overall Study|Lost to Follow-up|20|||
44242051|NCT01515475|79070835|FG001|Overall Study|Lost to Follow-up|15|||
44242052|NCT01515475|79070836|FG002|Overall Study|Lost to Follow-up|12|||
44242053|NCT01515475|79070837|FG003|Overall Study|Lost to Follow-up|12|||
44276433|NCT02177136|79231083|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
44276434|NCT02177136|79231084|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
44510041|NCT00496834|79515256|FG000|Overall Study|Adverse Event|5|||
44242054|NCT01515319|79070923|FG000|Overall Study|Withdrawal by Subject|0|||
44242055|NCT01515319|79070924|FG001|Overall Study|Withdrawal by Subject|0|||
44242056|NCT01515319|79070925|FG002|Overall Study|Withdrawal by Subject|0|||
44242057|NCT01515319|79070926|FG003|Overall Study|Withdrawal by Subject|0|||
44242058|NCT01515319|79070927|FG004|Overall Study|Withdrawal by Subject|0|||
44242059|NCT01515319|79070928|FG005|Overall Study|Withdrawal by Subject|0|||
44242060|NCT01515319|79070929|FG006|Overall Study|Withdrawal by Subject|1|||
44242061|NCT01515319|79070930|FG007|Overall Study|Withdrawal by Subject|0|||
44242062|NCT01515319|79070931|FG008|Overall Study|Withdrawal by Subject|0|||
44242063|NCT01515319|79070932|FG009|Overall Study|Withdrawal by Subject|0|||
44242064|NCT01515319|79070923|FG000|Overall Study|Adverse Event|0|||
44242065|NCT01515319|79070924|FG001|Overall Study|Adverse Event|0|||
44242066|NCT01515319|79070925|FG002|Overall Study|Adverse Event|0|||
44242067|NCT01515319|79070926|FG003|Overall Study|Adverse Event|0|||
44242068|NCT01515319|79070927|FG004|Overall Study|Adverse Event|0|||
44242069|NCT01515319|79070928|FG005|Overall Study|Adverse Event|0|||
44242070|NCT01515319|79070929|FG006|Overall Study|Adverse Event|0|||
44242071|NCT01515319|79070930|FG007|Overall Study|Adverse Event|0|||
44242072|NCT01515319|79070931|FG008|Overall Study|Adverse Event|3|||
44242073|NCT01515319|79070932|FG009|Overall Study|Adverse Event|0|||
44242074|NCT01515319|79070923|FG000|Overall Study|Protocol Violation|0|||
44242075|NCT01515319|79070924|FG001|Overall Study|Protocol Violation|0|||
44276435|NCT02177136|79231081|FG000|LTSE Phase|Withdrawal by Subject|0|||
44242076|NCT01515319|79070925|FG002|Overall Study|Protocol Violation|0|||
44242077|NCT01515319|79070926|FG003|Overall Study|Protocol Violation|0|||
44242078|NCT01515319|79070927|FG004|Overall Study|Protocol Violation|0|||
44242079|NCT01515319|79070928|FG005|Overall Study|Protocol Violation|0|||
44242080|NCT01515319|79070929|FG006|Overall Study|Protocol Violation|0|||
44242081|NCT01515319|79070930|FG007|Overall Study|Protocol Violation|0|||
44242082|NCT01515319|79070931|FG008|Overall Study|Protocol Violation|2|||
44242083|NCT01515319|79070932|FG009|Overall Study|Protocol Violation|0|||
44242084|NCT01492361|79070969|FG000|Overall Study|Withdrawal by Subject|281|||
44242085|NCT01492361|79070970|FG001|Overall Study|Withdrawal by Subject|297|||
44242086|NCT01492361|79070969|FG000|Overall Study|Physician Decision|12|||
44242087|NCT01492361|79070970|FG001|Overall Study|Physician Decision|12|||
44242088|NCT01492361|79070969|FG000|Overall Study|Lost to Follow-up|6|||
44242089|NCT01492361|79070970|FG001|Overall Study|Lost to Follow-up|13|||
44242090|NCT01492361|79070969|FG000|Overall Study|Other than specified above|106|||
44242091|NCT01492361|79070970|FG001|Overall Study|Other than specified above|138|||
44242092|NCT01514461|79071049|FG000|Overall Study|Adverse Event|2|||
44242093|NCT01514461|79071050|FG001|Overall Study|Adverse Event|1|||
44242094|NCT01514461|79071051|FG002|Overall Study|Adverse Event|3|||
44242095|NCT01514461|79071049|FG000|Overall Study|Physician Decision|1|||
44242096|NCT01514461|79071050|FG001|Overall Study|Physician Decision|1|||
44242097|NCT01514461|79071051|FG002|Overall Study|Physician Decision|0|||
44242098|NCT01514461|79071049|FG000|Overall Study|Patient/guardian decision|1|||
44242099|NCT01514461|79071050|FG001|Overall Study|Patient/guardian decision|1|||
44242100|NCT01514461|79071051|FG002|Overall Study|Patient/guardian decision|1|||
44242101|NCT01514461|79071049|FG000|Overall Study|Death|1|||
44242102|NCT01514461|79071050|FG001|Overall Study|Death|0|||
44242103|NCT01514461|79071051|FG002|Overall Study|Death|0|||
44242104|NCT01491737|79071097|FG000|Overall Study|Withdrawal by Subject|20|||
44242105|NCT01491737|79071098|FG001|Overall Study|Withdrawal by Subject|17|||
44242106|NCT01491737|79071097|FG000|Overall Study|Lost to Follow-up|2|||
44242107|NCT01491737|79071098|FG001|Overall Study|Lost to Follow-up|10|||
44242108|NCT01491737|79071097|FG000|Overall Study|Death|63|||
44242109|NCT01491737|79071098|FG001|Overall Study|Death|57|||
44242110|NCT01491737|79071097|FG000|Overall Study|Study Termination by Sponsor|36|||
44242111|NCT01491737|79071098|FG001|Overall Study|Study Termination by Sponsor|36|||
44242112|NCT01491737|79071097|FG000|Overall Study|Reason Not Specified|8|||
44242113|NCT01491737|79071098|FG001|Overall Study|Reason Not Specified|9|||
44242114|NCT01487863|79071110|FG000|Overall Study|Death|19|||
44242115|NCT01487863|79071111|FG001|Overall Study|Death|19|||
44242116|NCT01487161|79071130|FG000|Overall Study|Adverse Event|1|||
44242117|NCT01487161|79071131|FG001|Overall Study|Adverse Event|0|||
44242118|NCT01487161|79071132|FG002|Overall Study|Adverse Event|0|||
44242119|NCT01487161|79071133|FG003|Overall Study|Adverse Event|0|||
44242120|NCT01487161|79071130|FG000|Overall Study|Withdrawal by Subject|1|||
44242121|NCT01487161|79071131|FG001|Overall Study|Withdrawal by Subject|1|||
44242122|NCT01487161|79071132|FG002|Overall Study|Withdrawal by Subject|1|||
44242123|NCT01487161|79071133|FG003|Overall Study|Withdrawal by Subject|2|||
44242124|NCT01487161|79071130|FG000|Overall Study|missing data|0|||
44242125|NCT01487161|79071131|FG001|Overall Study|missing data|1|||
44242126|NCT01487161|79071132|FG002|Overall Study|missing data|0|||
44242127|NCT01487161|79071133|FG003|Overall Study|missing data|0|||
44242128|NCT01491035|79071188|FG000|Overall Study|Lost to Follow-up|0|||
44242129|NCT01491035|79071189|FG001|Overall Study|Lost to Follow-up|0|||
44242130|NCT01491035|79071190|FG002|Overall Study|Lost to Follow-up|0|||
44122512|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122513|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44122514|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
44242131|NCT01491035|79071191|FG003|Overall Study|Lost to Follow-up|0|||
44242132|NCT01491035|79071192|FG004|Overall Study|Lost to Follow-up|1|||
44242133|NCT01491035|79071193|FG005|Overall Study|Lost to Follow-up|0|||
44242134|NCT01491035|79071194|FG006|Overall Study|Lost to Follow-up|0|||
44242135|NCT01491035|79071195|FG007|Overall Study|Lost to Follow-up|0|||
44242136|NCT01488071|79071219|FG000|Overall Study|Adverse Event|15|||
44242137|NCT01488071|79071220|FG001|Overall Study|Adverse Event|23|||
44242138|NCT01488071|79071219|FG000|Overall Study|Lack of Efficacy|11|||
44242139|NCT01488071|79071220|FG001|Overall Study|Lack of Efficacy|17|||
44242140|NCT01488071|79071219|FG000|Overall Study|Non-compliance with study drug|2|||
44242141|NCT01488071|79071220|FG001|Overall Study|Non-compliance with study drug|0|||
44242142|NCT01488071|79071219|FG000|Overall Study|Protocol Violation|5|||
44242143|NCT01488071|79071220|FG001|Overall Study|Protocol Violation|7|||
44242144|NCT01488071|79071219|FG000|Overall Study|Withdrawal of Consent|14|||
44242145|NCT01488071|79071220|FG001|Overall Study|Withdrawal of Consent|12|||
44242146|NCT01488071|79071219|FG000|Overall Study|Lost to Follow-up|1|||
44242147|NCT01488071|79071220|FG001|Overall Study|Lost to Follow-up|0|||
44242148|NCT01488071|79071219|FG000|Overall Study|Administrative or Other Reason(s)|5|||
44242149|NCT01488071|79071220|FG001|Overall Study|Administrative or Other Reason(s)|4|||
44242150|NCT01487525|79071228|FG000|Overall Study|Withdrawal by Subject|0|||
44242151|NCT01487525|79071229|FG001|Overall Study|Withdrawal by Subject|1|||
44242152|NCT01486199|79071237|FG000|Two Year Period Between Study Days|Physician Decision|1|||
44242153|NCT01486199|79071238|FG001|Two Year Period Between Study Days|Physician Decision|0|||
44122515|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
44242154|NCT01485887|79071244|FG000|Overall Study|Withdrawal by Subject|2|||
44242155|NCT01485887|79071244|FG000|Overall Study|Adverse Event|8|||
44242156|NCT01485887|79071244|FG000|Overall Study|Deterioration of primary disease|1|||
44242157|NCT01485887|79071244|FG000|Overall Study|Primary disease markedly improved|1|||
44242158|NCT01546519|79071252|FG000|Overall Study|Adverse Event|0|||
44242159|NCT01546519|79071253|FG001|Overall Study|Adverse Event|0|||
44242160|NCT01546519|79071254|FG002|Overall Study|Adverse Event|1|||
44242161|NCT01546519|79071255|FG003|Overall Study|Adverse Event|1|||
44242162|NCT01546519|79071252|FG000|Overall Study|Death|0|||
44242163|NCT01546519|79071253|FG001|Overall Study|Death|1|||
44242164|NCT01546519|79071254|FG002|Overall Study|Death|3|||
44242165|NCT01546519|79071255|FG003|Overall Study|Death|1|||
44242166|NCT01546519|79071252|FG000|Overall Study|related to disease progression|2|||
44242167|NCT01546519|79071253|FG001|Overall Study|related to disease progression|2|||
44242168|NCT01546519|79071254|FG002|Overall Study|related to disease progression|2|||
44242169|NCT01546519|79071255|FG003|Overall Study|related to disease progression|1|||
44242170|NCT01546519|79071252|FG000|Overall Study|Physician Decision|6|||
44242171|NCT01546519|79071253|FG001|Overall Study|Physician Decision|5|||
44242172|NCT01546519|79071254|FG002|Overall Study|Physician Decision|2|||
44242173|NCT01546519|79071255|FG003|Overall Study|Physician Decision|3|||
44242174|NCT01546519|79071252|FG000|Overall Study|Withdrawal by Subject|1|||
44242175|NCT01546519|79071253|FG001|Overall Study|Withdrawal by Subject|0|||
44242176|NCT01546519|79071254|FG002|Overall Study|Withdrawal by Subject|0|||
44242177|NCT01546519|79071255|FG003|Overall Study|Withdrawal by Subject|0|||
44242178|NCT01484951|79071269|FG000|Overall Study|Adverse Event|3|||
44242179|NCT01484951|79071269|FG000|Overall Study|Personal Reasons|1|||
44242180|NCT01484951|79071269|FG000|Overall Study|Non-Compliance|1|||
44510042|NCT00496834|79515257|FG001|Overall Study|Adverse Event|3|||
44510043|NCT00496834|79515256|FG000|Overall Study|IP administration violation|2|||
44510044|NCT00496834|79515257|FG001|Overall Study|IP administration violation|0|||
44510045|NCT00496834|79515256|FG000|Overall Study|Lost to Follow-up|2|||
44122516|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122517|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44510046|NCT00496834|79515257|FG001|Overall Study|Lost to Follow-up|0|||
44510047|NCT00496834|79515256|FG000|Overall Study|Blood Pressure control failure|2|||
44510048|NCT00496834|79515257|FG001|Overall Study|Blood Pressure control failure|1|||
44510049|NCT05244122|79515265|FG000|Overall Study|Withdrawal by Subject|318|||
44510050|NCT00166504|79515286|FG000|Overall Study|Adverse Event|3|||
44122518|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122519|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122520|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122521|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122522|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122523|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122524|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122525|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44242181|NCT01484873|79071273|FG000|Overall Study|Withdrawal by Subject|2|||
44242182|NCT01486927|79071278|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
44242183|NCT01486927|79071278|FG000|Overall Study|Physician Decision|1|||
44242184|NCT01486927|79071278|FG000|Overall Study|50 Exposure days not reached|2|||
44242185|NCT01486927|79071278|FG000|Overall Study|Withdrawal by Subject|8|||
44242186|NCT01486927|79071278|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
44242187|NCT01513759|79071311|FG000|Overall Study|Protocol Violation|4|||
44242188|NCT01513759|79071311|FG000|Overall Study|Death during catheter placement|1|||
44510051|NCT00166504|79515287|FG001|Overall Study|Adverse Event|3|||
44510052|NCT00166504|79515286|FG000|Overall Study|Lost to Follow-up|1|||
44242189|NCT01484561|79071317|FG000|Overall Study|Lack of Efficacy|3|||
44242190|NCT01484561|79071318|FG001|Overall Study|Lack of Efficacy|1|||
44242191|NCT01484561|79071317|FG000|Overall Study|Lost to Follow-up|1|||
44242192|NCT01484561|79071318|FG001|Overall Study|Lost to Follow-up|0|||
44379139|NCT00843778|79384799|FG000|Overall Study|Adverse Event|15|||
44379140|NCT00843778|79384799|FG000|Overall Study|Lack of Efficacy|14|||
44379141|NCT00843778|79384799|FG000|Overall Study|Loss of efficacy|2|||
44379142|NCT00843778|79384799|FG000|Overall Study|Withdrawal by Subject|4|||
44242193|NCT01484561|79071317|FG000|Overall Study|Withdrawal by Subject|3|||
44242194|NCT01484561|79071318|FG001|Overall Study|Withdrawal by Subject|0|||
44242195|NCT01484561|79071317|FG000|Overall Study|Other|1|||
44242196|NCT01484561|79071318|FG001|Overall Study|Other|1|||
44242197|NCT01484561|79071317|FG000|Overall Study|Adverse Event|1|||
44242198|NCT01484561|79071318|FG001|Overall Study|Adverse Event|4|||
44242199|NCT01546207|79071324|FG000|Overall Study|Death|1|||
44242200|NCT01513291|79071330|FG000|Treatment Period|Adverse Event|8|||
44242201|NCT01513291|79071331|FG001|Treatment Period|Adverse Event|4|||
44242202|NCT01513291|79071332|FG002|Treatment Period|Adverse Event|0|||
44242203|NCT01513291|79071333|FG003|Treatment Period|Adverse Event|0|||
44242204|NCT01513291|79071334|FG004|Treatment Period|Adverse Event|0|||
44242205|NCT01513291|79071330|FG000|Treatment Period|Lack of Efficacy|3|||
44242206|NCT01513291|79071331|FG001|Treatment Period|Lack of Efficacy|0|||
44242207|NCT01513291|79071332|FG002|Treatment Period|Lack of Efficacy|0|||
44242208|NCT01513291|79071333|FG003|Treatment Period|Lack of Efficacy|0|||
44242209|NCT01513291|79071334|FG004|Treatment Period|Lack of Efficacy|0|||
44242210|NCT01513291|79071330|FG000|Treatment Period|Lost to Follow-up|2|||
44242211|NCT01513291|79071331|FG001|Treatment Period|Lost to Follow-up|3|||
44242212|NCT01513291|79071332|FG002|Treatment Period|Lost to Follow-up|0|||
44242213|NCT01513291|79071333|FG003|Treatment Period|Lost to Follow-up|0|||
44122526|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
44122527|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
44122528|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
44122529|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
44122530|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
44242214|NCT01513291|79071334|FG004|Treatment Period|Lost to Follow-up|0|||
44242215|NCT01513291|79071330|FG000|Treatment Period|Physician Decision|1|||
44242216|NCT01513291|79071331|FG001|Treatment Period|Physician Decision|0|||
44242217|NCT01513291|79071332|FG002|Treatment Period|Physician Decision|0|||
44242218|NCT01513291|79071333|FG003|Treatment Period|Physician Decision|0|||
44242219|NCT01513291|79071334|FG004|Treatment Period|Physician Decision|0|||
44242220|NCT01513291|79071330|FG000|Treatment Period|Protocol Violation|1|||
44242221|NCT01513291|79071331|FG001|Treatment Period|Protocol Violation|2|||
44242222|NCT01513291|79071332|FG002|Treatment Period|Protocol Violation|0|||
44242223|NCT01513291|79071333|FG003|Treatment Period|Protocol Violation|0|||
44242224|NCT01513291|79071334|FG004|Treatment Period|Protocol Violation|0|||
44242225|NCT01513291|79071330|FG000|Treatment Period|Withdrawal by Subject|8|||
44242226|NCT01513291|79071331|FG001|Treatment Period|Withdrawal by Subject|5|||
44242227|NCT01513291|79071332|FG002|Treatment Period|Withdrawal by Subject|0|||
44242228|NCT01513291|79071333|FG003|Treatment Period|Withdrawal by Subject|0|||
44379143|NCT00910728|79384812|FG000|Overall Study|Lack of Efficacy|2|||
44379144|NCT00910728|79384813|FG001|Overall Study|Lack of Efficacy|3|||
44379145|NCT00910728|79384814|FG002|Overall Study|Lack of Efficacy|1|||
44379146|NCT00910728|79384815|FG003|Overall Study|Lack of Efficacy|2|||
44242229|NCT01513291|79071334|FG004|Treatment Period|Withdrawal by Subject|0|||
44510053|NCT00166504|79515287|FG001|Overall Study|Lost to Follow-up|1|||
44510054|NCT00166504|79515286|FG000|Overall Study|Withdrawal by Subject|1|||
44510055|NCT00166504|79515287|FG001|Overall Study|Withdrawal by Subject|0|||
44510056|NCT03137992|79515293|FG000|Washout Period 1|Adverse Event|1|||
44510057|NCT03137992|79515294|FG001|Washout Period 1|Adverse Event|1|||
44510058|NCT03137992|79515295|FG002|Washout Period 1|Adverse Event|0|||
44510059|NCT03137992|79515296|FG003|Washout Period 1|Adverse Event|0|||
44510060|NCT03137992|79515297|FG004|Washout Period 1|Adverse Event|0|||
44242230|NCT01513291|79071330|FG000|Treatment Period|Randomized not treated|0|||
44242231|NCT01513291|79071331|FG001|Treatment Period|Randomized not treated|2|||
44242232|NCT01513291|79071332|FG002|Treatment Period|Randomized not treated|0|||
44242233|NCT01513291|79071333|FG003|Treatment Period|Randomized not treated|0|||
44242234|NCT01513291|79071334|FG004|Treatment Period|Randomized not treated|0|||
44242235|NCT01513291|79071330|FG000|Run-out Period|Lost to Follow-up|0|||
44242236|NCT01513291|79071331|FG001|Run-out Period|Lost to Follow-up|0|||
44242237|NCT01513291|79071332|FG002|Run-out Period|Lost to Follow-up|0|||
44242238|NCT01513291|79071333|FG003|Run-out Period|Lost to Follow-up|1|||
44242239|NCT01513291|79071334|FG004|Run-out Period|Lost to Follow-up|0|||
44379147|NCT00910728|79384816|FG004|Overall Study|Lack of Efficacy|1|||
44510061|NCT03137992|79515298|FG005|Washout Period 1|Adverse Event|1|||
44510062|NCT03137992|79515293|FG000|Washout Period 1|Withdrawal by Subject|0|||
44242240|NCT01513291|79071330|FG000|Run-out Period|Withdrawal by Subject|0|||
44379148|NCT00910728|79384817|FG005|Overall Study|Lack of Efficacy|0|||
44510063|NCT03137992|79515294|FG001|Washout Period 1|Withdrawal by Subject|1|||
44242241|NCT01513291|79071331|FG001|Run-out Period|Withdrawal by Subject|0|||
44242242|NCT01513291|79071332|FG002|Run-out Period|Withdrawal by Subject|0|||
44242243|NCT01513291|79071333|FG003|Run-out Period|Withdrawal by Subject|1|||
44122531|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
44122532|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
44122533|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
44122534|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
44122535|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
44122536|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
44122537|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
44122538|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
44122539|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
44122540|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
44122541|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
44122542|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
44122543|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
44122544|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
44122545|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
44122546|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
44122547|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
44122548|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122549|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122550|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122551|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122552|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122553|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122554|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122555|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44242244|NCT01513291|79071334|FG004|Run-out Period|Withdrawal by Subject|0|||
44242245|NCT01483937|79071348|FG000|Overall Study|Withdrawal by Subject|4|||
44242246|NCT01483937|79071349|FG001|Overall Study|Withdrawal by Subject|3|||
44242247|NCT01483625|79071360|FG000|Overall Study|Adverse Event|1|||
44242248|NCT01483625|79071361|FG001|Overall Study|Adverse Event|1|||
44242249|NCT01483625|79071360|FG000|Overall Study|Refused to continue medication|2|||
44242250|NCT01483625|79071361|FG001|Overall Study|Refused to continue medication|1|||
44242251|NCT01483625|79071360|FG000|Overall Study|Due to other reason|1|||
44510064|NCT03137992|79515295|FG002|Washout Period 1|Withdrawal by Subject|1|||
44510065|NCT03137992|79515296|FG003|Washout Period 1|Withdrawal by Subject|0|||
44510066|NCT03137992|79515297|FG004|Washout Period 1|Withdrawal by Subject|0|||
44510067|NCT03137992|79515298|FG005|Washout Period 1|Withdrawal by Subject|0|||
44510068|NCT03137992|79515293|FG000|Washout Period 1|Principal Investigator Discretion|0|||
44510069|NCT03137992|79515294|FG001|Washout Period 1|Principal Investigator Discretion|1|||
44510070|NCT03137992|79515295|FG002|Washout Period 1|Principal Investigator Discretion|0|||
44122556|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122557|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122558|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122559|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122560|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44242252|NCT01483625|79071361|FG001|Overall Study|Due to other reason|0|||
44242253|NCT01485991|79071369|FG000|Overall Study|Adverse Event|0|||
44242254|NCT01485991|79071370|FG001|Overall Study|Adverse Event|4|||
44510071|NCT03137992|79515296|FG003|Washout Period 1|Principal Investigator Discretion|0|||
44122561|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
44122562|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122563|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
44122564|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122565|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122566|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122567|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122568|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122569|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122570|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122571|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122572|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122573|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122574|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122575|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122576|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122577|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
44122578|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122579|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
44122580|NCT02958865|78906544|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122581|NCT02958865|78906545|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122582|NCT02958865|78906546|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122583|NCT02958865|78906547|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122584|NCT02958865|78906548|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122585|NCT02958865|78906549|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122586|NCT02958865|78906550|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122587|NCT02958865|78906551|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122588|NCT02958865|78906552|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122589|NCT02958865|78906553|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
44122590|NCT02958865|78906554|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44242255|NCT01485991|79071369|FG000|Overall Study|Lost to Follow-up|13|||
44242256|NCT01485991|79071370|FG001|Overall Study|Lost to Follow-up|10|||
44242257|NCT01485991|79071369|FG000|Overall Study|Withdrawal by Subject|13|||
44242258|NCT01485991|79071370|FG001|Overall Study|Withdrawal by Subject|20|||
44242259|NCT01485991|79071369|FG000|Overall Study|randomized but not treated|6|||
44510072|NCT03137992|79515297|FG004|Washout Period 1|Principal Investigator Discretion|0|||
44510073|NCT03137992|79515298|FG005|Washout Period 1|Principal Investigator Discretion|0|||
44510074|NCT03137992|79515293|FG000|Washout Period 1|COPD Exacerbation|1|||
44510075|NCT03137992|79515294|FG001|Washout Period 1|COPD Exacerbation|1|||
44510076|NCT03137992|79515295|FG002|Washout Period 1|COPD Exacerbation|1|||
44510077|NCT03137992|79515296|FG003|Washout Period 1|COPD Exacerbation|0|||
44510078|NCT03137992|79515297|FG004|Washout Period 1|COPD Exacerbation|1|||
44510079|NCT03137992|79515298|FG005|Washout Period 1|COPD Exacerbation|1|||
44510080|NCT03137992|79515293|FG000|Washout Period 1|Subject Noncompliance|1|||
44510081|NCT03137992|79515294|FG001|Washout Period 1|Subject Noncompliance|0|||
44510082|NCT03137992|79515295|FG002|Washout Period 1|Subject Noncompliance|0|||
44510083|NCT03137992|79515296|FG003|Washout Period 1|Subject Noncompliance|0|||
44510084|NCT03137992|79515297|FG004|Washout Period 1|Subject Noncompliance|1|||
44510085|NCT03137992|79515298|FG005|Washout Period 1|Subject Noncompliance|0|||
44510086|NCT03137992|79515293|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
44510087|NCT03137992|79515294|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
44510088|NCT03137992|79515295|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
44510089|NCT03137992|79515296|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
44242260|NCT01485991|79071370|FG001|Overall Study|randomized but not treated|2|||
44510090|NCT03137992|79515297|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
44510091|NCT03137992|79515298|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
44510092|NCT03137992|79515293|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
44510093|NCT03137992|79515294|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
44510094|NCT03137992|79515295|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
44510095|NCT03137992|79515296|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
44510096|NCT03137992|79515297|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
44242261|NCT01482767|79071402|FG000|Overall Study|Death|1|||
44242262|NCT01482767|79071403|FG001|Overall Study|Death|1|||
44242263|NCT01482767|79071402|FG000|Overall Study|Withdrawal by Subject|7|||
44242264|NCT01482767|79071403|FG001|Overall Study|Withdrawal by Subject|5|||
44242265|NCT01482767|79071402|FG000|Overall Study|Lost to Follow-up|12|||
44242266|NCT01482767|79071403|FG001|Overall Study|Lost to Follow-up|6|||
44242267|NCT01482767|79071402|FG000|Overall Study|Adverse Event|0|||
44122591|NCT02958865|78906555|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122592|NCT02958865|78906556|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122593|NCT02958865|78906557|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122594|NCT02958865|78906558|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122595|NCT02958865|78906559|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
44122596|NCT02958553|78906611|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
44122597|NCT02958553|78906611|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
44122598|NCT02501902|78906624|FG000|Overall Study|Subject Refused Further Follow-up|0|||
44122599|NCT02501902|78906625|FG001|Overall Study|Subject Refused Further Follow-up|0|||
44122600|NCT02501902|78906626|FG002|Overall Study|Subject Refused Further Follow-up|0|||
44122601|NCT02501902|78906627|FG003|Overall Study|Subject Refused Further Follow-up|0|||
44122602|NCT02501902|78906628|FG004|Overall Study|Subject Refused Further Follow-up|0|||
44122603|NCT02501902|78906629|FG005|Overall Study|Subject Refused Further Follow-up|0|||
44122604|NCT02501902|78906630|FG006|Overall Study|Subject Refused Further Follow-up|0|||
44122605|NCT02501902|78906631|FG007|Overall Study|Subject Refused Further Follow-up|1|||
44122606|NCT02501902|78906624|FG000|Overall Study|Study Terminated by Sponsor|0|||
44122607|NCT02501902|78906625|FG001|Overall Study|Study Terminated by Sponsor|3|||
44122608|NCT02501902|78906626|FG002|Overall Study|Study Terminated by Sponsor|0|||
44122609|NCT02501902|78906627|FG003|Overall Study|Study Terminated by Sponsor|1|||
44242268|NCT01482767|79071403|FG001|Overall Study|Adverse Event|3|||
44242269|NCT01482767|79071402|FG000|Overall Study|Site closure|22|||
44242270|NCT01482767|79071403|FG001|Overall Study|Site closure|14|||
44242271|NCT01482767|79071402|FG000|Overall Study|Non-adherence to study requirements|4|||
44242272|NCT01482767|79071403|FG001|Overall Study|Non-adherence to study requirements|7|||
44242273|NCT01482767|79071402|FG000|Overall Study|Alternate HCV treatment|7|||
44242274|NCT01482767|79071403|FG001|Overall Study|Alternate HCV treatment|8|||
44242275|NCT01482767|79071402|FG000|Overall Study|Ineligible|0|||
44242276|NCT01482767|79071403|FG001|Overall Study|Ineligible|5|||
44242277|NCT01482767|79071402|FG000|Overall Study|Nurse error|1|||
44242278|NCT01482767|79071403|FG001|Overall Study|Nurse error|0|||
44242279|NCT01482221|79071432|FG000|Overall Study|Lack of Efficacy|1|||
44242280|NCT01482221|79071433|FG001|Overall Study|Lack of Efficacy|0|||
44242281|NCT01482221|79071434|FG002|Overall Study|Lack of Efficacy|1|||
44242282|NCT01482221|79071432|FG000|Overall Study|Lost to Follow-up|3|||
44242283|NCT01482221|79071433|FG001|Overall Study|Lost to Follow-up|2|||
44242284|NCT01482221|79071434|FG002|Overall Study|Lost to Follow-up|1|||
44242285|NCT01482221|79071432|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
44242286|NCT01482221|79071433|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
44242287|NCT01482221|79071434|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
44242288|NCT01482221|79071432|FG000|Overall Study|Condition under Investigation Worsened|3|||
44242289|NCT01482221|79071433|FG001|Overall Study|Condition under Investigation Worsened|2|||
44276436|NCT02177136|79231082|FG001|LTSE Phase|Withdrawal by Subject|0|||
44276437|NCT02177136|79231083|FG002|LTSE Phase|Withdrawal by Subject|0|||
44276438|NCT02177136|79231084|FG003|LTSE Phase|Withdrawal by Subject|6|||
44276439|NCT02177136|79231081|FG000|LTSE Phase|Adverse Event|0|||
44276440|NCT02177136|79231082|FG001|LTSE Phase|Adverse Event|0|||
44510097|NCT03137992|79515298|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
44510098|NCT03137992|79515293|FG000|Period 2 (Visit 3)|Adverse Event|0|||
44510099|NCT03137992|79515294|FG001|Period 2 (Visit 3)|Adverse Event|1|||
44510100|NCT03137992|79515295|FG002|Period 2 (Visit 3)|Adverse Event|0|||
44122610|NCT02501902|78906628|FG004|Overall Study|Study Terminated by Sponsor|1|||
44242290|NCT01482221|79071434|FG002|Overall Study|Condition under Investigation Worsened|4|||
44242291|NCT01482221|79071432|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
44242292|NCT01482221|79071433|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
44242293|NCT01482221|79071434|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
44242294|NCT01482221|79071432|FG000|Overall Study|Adverse Event|1|||
44242295|NCT01482221|79071433|FG001|Overall Study|Adverse Event|7|||
44242296|NCT01482221|79071434|FG002|Overall Study|Adverse Event|3|||
44242297|NCT01482221|79071432|FG000|Overall Study|Withdrawal by Subject|10|||
44242298|NCT01482221|79071433|FG001|Overall Study|Withdrawal by Subject|7|||
44242299|NCT01482221|79071434|FG002|Overall Study|Withdrawal by Subject|12|||
44242300|NCT01482221|79071432|FG000|Overall Study|Incorrect randomization|0|||
44242301|NCT01482221|79071433|FG001|Overall Study|Incorrect randomization|1|||
44242302|NCT01482221|79071434|FG002|Overall Study|Incorrect randomization|0|||
44276441|NCT02177136|79231083|FG002|LTSE Phase|Adverse Event|0|||
44510101|NCT03137992|79515296|FG003|Period 2 (Visit 3)|Adverse Event|0|||
44510102|NCT03137992|79515297|FG004|Period 2 (Visit 3)|Adverse Event|0|||
44510103|NCT03137992|79515298|FG005|Period 2 (Visit 3)|Adverse Event|0|||
44242303|NCT01482221|79071432|FG000|Overall Study|Physician Decision|0|||
44242304|NCT01482221|79071433|FG001|Overall Study|Physician Decision|1|||
44242305|NCT01482221|79071434|FG002|Overall Study|Physician Decision|0|||
44242306|NCT01482065|79071444|FG000|Overall Study|Withdrawal by Subject|0|||
44242307|NCT01482065|79071445|FG001|Overall Study|Withdrawal by Subject|1|||
44242308|NCT01545817|79071460|FG000|Pazopanib|Disease progression|51|||
44242309|NCT01545817|79071461|FG001|Pazopanib|Disease progression|0|||
44242310|NCT01545817|79071460|FG000|Pazopanib|Adverse Event|19|||
44242311|NCT01545817|79071461|FG001|Pazopanib|Adverse Event|0|||
44242312|NCT01545817|79071460|FG000|Pazopanib|Other reason|4|||
44242313|NCT01545817|79071461|FG001|Pazopanib|Other reason|0|||
44242314|NCT01545817|79071460|FG000|Everolimus|Other reason|0|||
44242315|NCT01545817|79071461|FG001|Everolimus|Other reason|7|||
44242316|NCT01545817|79071460|FG000|Everolimus|Disease progression|0|||
44510104|NCT03137992|79515293|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
44510105|NCT03137992|79515294|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
44510106|NCT03137992|79515295|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
44510107|NCT03137992|79515296|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
44510108|NCT03137992|79515297|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
44510109|NCT03137992|79515298|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
44510110|NCT03137992|79515293|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
44510111|NCT03137992|79515294|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
44510112|NCT03137992|79515295|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
44510113|NCT03137992|79515296|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
44510114|NCT03137992|79515297|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
44510115|NCT03137992|79515298|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
44510116|NCT03137992|79515293|FG000|Washout Period 2|COPD Exacerbation|1|||
44510117|NCT03137992|79515294|FG001|Washout Period 2|COPD Exacerbation|1|||
44510118|NCT03137992|79515295|FG002|Washout Period 2|COPD Exacerbation|0|||
44510119|NCT03137992|79515296|FG003|Washout Period 2|COPD Exacerbation|0|||
44510120|NCT03137992|79515297|FG004|Washout Period 2|COPD Exacerbation|1|||
44510121|NCT03137992|79515298|FG005|Washout Period 2|COPD Exacerbation|0|||
44510122|NCT03137992|79515293|FG000|Washout Period 2|Subject Non-compliance|0|||
44510123|NCT03137992|79515294|FG001|Washout Period 2|Subject Non-compliance|1|||
44510124|NCT03137992|79515295|FG002|Washout Period 2|Subject Non-compliance|0|||
44510125|NCT03137992|79515296|FG003|Washout Period 2|Subject Non-compliance|0|||
44510126|NCT03137992|79515297|FG004|Washout Period 2|Subject Non-compliance|0|||
44510127|NCT03137992|79515298|FG005|Washout Period 2|Subject Non-compliance|0|||
44510128|NCT03137992|79515293|FG000|Washout Period 2|Adverse Event|0|||
44510129|NCT03137992|79515294|FG001|Washout Period 2|Adverse Event|0|||
44510130|NCT03137992|79515295|FG002|Washout Period 2|Adverse Event|0|||
44510131|NCT03137992|79515296|FG003|Washout Period 2|Adverse Event|1|||
44242317|NCT01545817|79071461|FG001|Everolimus|Disease progression|25|||
44242318|NCT01545817|79071460|FG000|Everolimus|Adverse Event|0|||
44242319|NCT01545817|79071461|FG001|Everolimus|Adverse Event|6|||
44242320|NCT01512979|79071480|FG000|Overall Study|Adverse Event|2|||
44510132|NCT03137992|79515297|FG004|Washout Period 2|Adverse Event|1|||
44510133|NCT03137992|79515298|FG005|Washout Period 2|Adverse Event|0|||
44510134|NCT03137992|79515293|FG000|Washout Period 2|Withdrawal by Subject|1|||
44510135|NCT03137992|79515294|FG001|Washout Period 2|Withdrawal by Subject|0|||
44510136|NCT03137992|79515295|FG002|Washout Period 2|Withdrawal by Subject|0|||
44510137|NCT03137992|79515296|FG003|Washout Period 2|Withdrawal by Subject|0|||
44242321|NCT01512979|79071481|FG001|Overall Study|Adverse Event|2|||
44242322|NCT01512979|79071480|FG000|Overall Study|Protocol Violation|1|||
44242323|NCT01512979|79071481|FG001|Overall Study|Protocol Violation|4|||
44242324|NCT01512979|79071480|FG000|Overall Study|Lost to Follow-up|2|||
44242325|NCT01512979|79071481|FG001|Overall Study|Lost to Follow-up|5|||
44242326|NCT01512979|79071480|FG000|Overall Study|Withdrawal by Subject|1|||
44242327|NCT01512979|79071481|FG001|Overall Study|Withdrawal by Subject|2|||
44242328|NCT01512979|79071480|FG000|Overall Study|Reason other than stated above|13|||
44242329|NCT01512979|79071481|FG001|Overall Study|Reason other than stated above|9|||
44242330|NCT01512745|79071493|FG000|Overall Study|Adverse Event|22|||
44242331|NCT01512745|79071494|FG001|Overall Study|Adverse Event|3|||
44242332|NCT01512745|79071493|FG000|Overall Study|Death|9|||
44242333|NCT01512745|79071494|FG001|Overall Study|Death|13|||
44242334|NCT01512745|79071493|FG000|Overall Study|Withdrawal by Subject|2|||
44242335|NCT01512745|79071494|FG001|Overall Study|Withdrawal by Subject|2|||
44242336|NCT01512745|79071493|FG000|Overall Study|Lost to Follow-up|4|||
44122611|NCT02501902|78906629|FG005|Overall Study|Study Terminated by Sponsor|0|||
44122612|NCT02501902|78906630|FG006|Overall Study|Study Terminated by Sponsor|2|||
44122613|NCT02501902|78906631|FG007|Overall Study|Study Terminated by Sponsor|4|||
44122614|NCT02501902|78906624|FG000|Overall Study|Death|3|||
44122615|NCT02501902|78906625|FG001|Overall Study|Death|4|||
44122616|NCT02501902|78906626|FG002|Overall Study|Death|4|||
44122617|NCT02501902|78906627|FG003|Overall Study|Death|10|||
44242337|NCT01512745|79071494|FG001|Overall Study|Lost to Follow-up|0|||
44242338|NCT01512745|79071493|FG000|Overall Study|Lack of Efficacy|2|||
44242339|NCT01512745|79071494|FG001|Overall Study|Lack of Efficacy|2|||
44242340|NCT01512745|79071493|FG000|Overall Study|Protocol Violation|1|||
44242341|NCT01512745|79071494|FG001|Overall Study|Protocol Violation|0|||
44242342|NCT01478321|79071500|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
44242343|NCT01478321|79071500|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
44242344|NCT01478321|79071500|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
44242345|NCT01478321|79071500|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
44242346|NCT01478321|79071500|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
44242347|NCT01478321|79071500|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
44242348|NCT01478321|79071500|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
44510138|NCT03137992|79515297|FG004|Washout Period 2|Withdrawal by Subject|1|||
44510139|NCT03137992|79515298|FG005|Washout Period 2|Withdrawal by Subject|0|||
44510140|NCT03137992|79515293|FG000|Washout Period 2|Sponsor Decision|0|||
44510141|NCT03137992|79515294|FG001|Washout Period 2|Sponsor Decision|0|||
44510142|NCT03137992|79515295|FG002|Washout Period 2|Sponsor Decision|0|||
44510143|NCT03137992|79515296|FG003|Washout Period 2|Sponsor Decision|0|||
44122618|NCT02501902|78906628|FG004|Overall Study|Death|10|||
44122619|NCT02501902|78906629|FG005|Overall Study|Death|11|||
44122620|NCT02501902|78906630|FG006|Overall Study|Death|7|||
44122621|NCT02501902|78906631|FG007|Overall Study|Death|15|||
44122622|NCT01955109|78906656|FG000|Overall Study|Adverse Event|2|||
44122623|NCT01955109|78906657|FG001|Overall Study|Adverse Event|0|||
44242349|NCT01478321|79071500|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
44242350|NCT01544491|79071506|FG000|Overall Study|Withdrawal by Subject|3|||
44242351|NCT01544491|79071507|FG001|Overall Study|Withdrawal by Subject|2|||
44242352|NCT01544491|79071506|FG000|Overall Study|Lost to Follow-up|0|||
44242353|NCT01544491|79071507|FG001|Overall Study|Lost to Follow-up|1|||
44242354|NCT01544491|79071506|FG000|Overall Study|administrative problems|2|||
44242355|NCT01544491|79071507|FG001|Overall Study|administrative problems|0|||
44242356|NCT01478087|79071526|FG000|Overall Study|due to sponsor closing study|1|||
44242357|NCT01477853|79071544|FG000|Phase A|Adverse Event|1|||
44242358|NCT01477853|79071545|FG001|Phase A|Adverse Event|2|||
44242359|NCT01477853|79071546|FG002|Phase A|Adverse Event|2|||
44510144|NCT03137992|79515297|FG004|Washout Period 2|Sponsor Decision|0|||
44510145|NCT03137992|79515298|FG005|Washout Period 2|Sponsor Decision|1|||
44242360|NCT01477853|79071544|FG000|Phase A|Lost to Follow-up|4|||
44242361|NCT01477853|79071545|FG001|Phase A|Lost to Follow-up|3|||
44122624|NCT01955109|78906656|FG000|Overall Study|Participant unwilling to continue|35|||
44122625|NCT01955109|78906657|FG001|Overall Study|Participant unwilling to continue|7|||
44122626|NCT01955109|78906656|FG000|Overall Study|Physician Decision|2|||
44122627|NCT01955109|78906657|FG001|Overall Study|Physician Decision|0|||
44122628|NCT01955109|78906656|FG000|Overall Study|Lost to Follow-up|3|||
44122629|NCT01955109|78906657|FG001|Overall Study|Lost to Follow-up|1|||
44122630|NCT01955109|78906656|FG000|Overall Study|Non-compliance|3|||
44122631|NCT01955109|78906657|FG001|Overall Study|Non-compliance|1|||
44242362|NCT01477853|79071546|FG002|Phase A|Lost to Follow-up|2|||
44242363|NCT01477853|79071544|FG000|Phase A|Physician Decision|1|||
44242364|NCT01477853|79071545|FG001|Phase A|Physician Decision|0|||
44242365|NCT01477853|79071546|FG002|Phase A|Physician Decision|1|||
44242366|NCT01477853|79071544|FG000|Phase A|Study terminated by sponsor|37|||
44242367|NCT01477853|79071545|FG001|Phase A|Study terminated by sponsor|40|||
44242368|NCT01477853|79071546|FG002|Phase A|Study terminated by sponsor|39|||
44242369|NCT01477853|79071544|FG000|Phase B|Lost to Follow-up|0|||
44242370|NCT01477853|79071545|FG001|Phase B|Lost to Follow-up|1|||
44242371|NCT01477853|79071546|FG002|Phase B|Lost to Follow-up|0|||
44242372|NCT01477853|79071544|FG000|Phase B|Study terminated by sponsor|12|||
44242373|NCT01477853|79071545|FG001|Phase B|Study terminated by sponsor|10|||
44242374|NCT01477853|79071546|FG002|Phase B|Study terminated by sponsor|11|||
44242375|NCT01511419|79071578|FG000|Dose 2|Physician Decision|1|||
44242376|NCT01511419|79071579|FG001|Dose 2|Physician Decision|0|||
44242377|NCT01511107|79071641|FG000|Overall Study|Ineligible|3|||
44242378|NCT01511107|79071642|FG001|Overall Study|Ineligible|2|||
44242379|NCT01511107|79071641|FG000|Overall Study|Lost to Follow-up|10|||
44242380|NCT01511107|79071642|FG001|Overall Study|Lost to Follow-up|19|||
44242381|NCT01511107|79071641|FG000|Overall Study|Withdrawal by Subject|9|||
44242382|NCT01511107|79071642|FG001|Overall Study|Withdrawal by Subject|20|||
44242383|NCT01484977|79071677|FG000|Overall Study|Adverse Event|8|||
44242384|NCT01484977|79071677|FG000|Overall Study|Lack of Efficacy|4|||
44242385|NCT01484977|79071677|FG000|Overall Study|Protocol Violation|6|||
44242386|NCT01484977|79071677|FG000|Overall Study|Lost to Follow-up|1|||
44242387|NCT01484977|79071677|FG000|Overall Study|Withdrawal by Subject|4|||
44242388|NCT01484977|79071677|FG000|Overall Study|Subject Protocol Non-compliant|1|||
44242389|NCT01484977|79071677|FG000|Overall Study|Moving Overseas|1|||
44242390|NCT01484977|79071677|FG000|Overall Study|Low White Blood Cell Count|1|||
44242391|NCT01484977|79071677|FG000|Overall Study|Lack of Compliance|1|||
44242392|NCT01475825|79071757|FG000|Overall Study|Adverse Event|41|||
44242393|NCT01475825|79071758|FG001|Overall Study|Adverse Event|15|||
44242394|NCT01475825|79071759|FG002|Overall Study|Adverse Event|27|||
44242395|NCT01475825|79071760|FG003|Overall Study|Adverse Event|11|||
44242396|NCT01475825|79071757|FG000|Overall Study|Death|1|||
44242397|NCT01475825|79071758|FG001|Overall Study|Death|0|||
44242398|NCT01475825|79071759|FG002|Overall Study|Death|1|||
44242399|NCT01475825|79071760|FG003|Overall Study|Death|0|||
44242400|NCT01475825|79071757|FG000|Overall Study|Lack of Efficacy|0|||
44242401|NCT01475825|79071758|FG001|Overall Study|Lack of Efficacy|0|||
44242402|NCT01475825|79071759|FG002|Overall Study|Lack of Efficacy|1|||
44242403|NCT01475825|79071760|FG003|Overall Study|Lack of Efficacy|0|||
44510146|NCT03137992|79515293|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
44510147|NCT03137992|79515294|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
44510148|NCT03137992|79515295|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
44510149|NCT03137992|79515296|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
44510150|NCT03137992|79515297|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
44510151|NCT03137992|79515298|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
44122632|NCT02500732|78906665|FG000|Overall Study|Physician Decision|0|||
44122633|NCT02500732|78906666|FG001|Overall Study|Physician Decision|1|||
44122634|NCT02518048|78906672|FG000|Overall Study|Withdrawal by Subject|1|||
44122635|NCT02499952|78906677|FG000|Overall Study|Lost to Follow-up|1|||
44122636|NCT02499952|78906677|FG000|Overall Study|Death|9|||
44122637|NCT02499406|78906681|FG000|Overall Study|missed 3 treatment sessions|4|||
44122638|NCT02498392|78906687|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
44242404|NCT01475825|79071757|FG000|Overall Study|Lost to Follow-up|0|||
44122639|NCT02498392|78906688|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
44242405|NCT01475825|79071758|FG001|Overall Study|Lost to Follow-up|0|||
44122640|NCT02498392|78906687|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
44242406|NCT01475825|79071759|FG002|Overall Study|Lost to Follow-up|3|||
44242407|NCT01475825|79071760|FG003|Overall Study|Lost to Follow-up|1|||
44242408|NCT01475825|79071757|FG000|Overall Study|Non-compliance with Study Drug|1|||
44242409|NCT01475825|79071758|FG001|Overall Study|Non-compliance with Study Drug|2|||
44242410|NCT01475825|79071759|FG002|Overall Study|Non-compliance with Study Drug|4|||
44242411|NCT01475825|79071760|FG003|Overall Study|Non-compliance with Study Drug|0|||
44242412|NCT01475825|79071757|FG000|Overall Study|Other: Not available|0|||
44242413|NCT01475825|79071758|FG001|Overall Study|Other: Not available|0|||
44510152|NCT03137992|79515293|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
44242414|NCT01475825|79071759|FG002|Overall Study|Other: Not available|2|||
44242415|NCT01475825|79071760|FG003|Overall Study|Other: Not available|0|||
44242416|NCT01475825|79071757|FG000|Overall Study|Protocol Violation|1|||
44242417|NCT01475825|79071758|FG001|Overall Study|Protocol Violation|0|||
44242418|NCT01475825|79071759|FG002|Overall Study|Protocol Violation|0|||
44242419|NCT01475825|79071760|FG003|Overall Study|Protocol Violation|0|||
44242420|NCT01475825|79071757|FG000|Overall Study|Physician Decision|0|||
44242421|NCT01475825|79071758|FG001|Overall Study|Physician Decision|1|||
44242422|NCT01475825|79071759|FG002|Overall Study|Physician Decision|0|||
44242423|NCT01475825|79071760|FG003|Overall Study|Physician Decision|0|||
44242424|NCT01475825|79071757|FG000|Overall Study|Withdrawal by Subject|8|||
44242425|NCT01475825|79071758|FG001|Overall Study|Withdrawal by Subject|3|||
44242426|NCT01475825|79071759|FG002|Overall Study|Withdrawal by Subject|11|||
44242427|NCT01475825|79071760|FG003|Overall Study|Withdrawal by Subject|7|||
44242428|NCT01475825|79071757|FG000|Overall Study|Did not enter OLC|15|||
44242429|NCT01475825|79071758|FG001|Overall Study|Did not enter OLC|11|||
44242430|NCT01475825|79071759|FG002|Overall Study|Did not enter OLC|15|||
44242431|NCT01475825|79071760|FG003|Overall Study|Did not enter OLC|11|||
44242432|NCT01484431|79071782|FG000|Period 1: High Dose|Physician Decision|0|||
44242433|NCT01484431|79071783|FG001|Period 1: High Dose|Physician Decision|1|||
44242434|NCT01484431|79071784|FG002|Period 1: High Dose|Physician Decision|0|||
44242435|NCT01484431|79071782|FG000|Period 2|Death|0|||
44242436|NCT01484431|79071783|FG001|Period 2|Death|1|||
44242437|NCT01484431|79071784|FG002|Period 2|Death|1|||
44242438|NCT01484431|79071782|FG000|Period 2|Physician Decision|0|||
44242439|NCT01484431|79071783|FG001|Period 2|Physician Decision|0|||
44242440|NCT01484431|79071784|FG002|Period 2|Physician Decision|1|||
44242441|NCT01484431|79071782|FG000|Period 2|Non-Compliance with Study Drug|1|||
44242442|NCT01484431|79071783|FG001|Period 2|Non-Compliance with Study Drug|0|||
44242443|NCT01484431|79071784|FG002|Period 2|Non-Compliance with Study Drug|0|||
44242444|NCT01473953|79071832|FG000|Overall Study|Other|1|||
44242445|NCT01473953|79071833|FG001|Overall Study|Other|0|||
44242446|NCT01473953|79071834|FG002|Overall Study|Other|0|||
44242447|NCT01473953|79071835|FG003|Overall Study|Other|0|||
44242448|NCT01473953|79071836|FG004|Overall Study|Other|0|||
44242449|NCT01510717|79071850|FG000|Overall Study|Adverse Event|1|||
44242450|NCT01510717|79071851|FG001|Overall Study|Adverse Event|2|||
44242451|NCT01510717|79071850|FG000|Overall Study|Death|1|||
44242452|NCT01510717|79071851|FG001|Overall Study|Death|0|||
44242453|NCT01510717|79071850|FG000|Overall Study|Lost to Follow-up|0|||
44242454|NCT01510717|79071851|FG001|Overall Study|Lost to Follow-up|1|||
44242455|NCT01510717|79071850|FG000|Overall Study|Withdrawal by Subject|0|||
44242456|NCT01510717|79071851|FG001|Overall Study|Withdrawal by Subject|2|||
44242457|NCT01473563|79071867|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
44242458|NCT01484275|79071885|FG000|Overall Study|Study terminated by sponsor|28|||
44242459|NCT01484275|79071886|FG001|Overall Study|Study terminated by sponsor|32|||
44242460|NCT01484275|79071885|FG000|Overall Study|Other|10|||
44242461|NCT01484275|79071886|FG001|Overall Study|Other|0|||
44242462|NCT01484275|79071885|FG000|Overall Study|Death|3|||
44242463|NCT01484275|79071886|FG001|Overall Study|Death|4|||
44242464|NCT01484275|79071885|FG000|Overall Study|Withdrawal by Subject|1|||
44242465|NCT01484275|79071886|FG001|Overall Study|Withdrawal by Subject|5|||
44242466|NCT01484275|79071885|FG000|Overall Study|Lost to Follow-up|1|||
44242467|NCT01484275|79071886|FG001|Overall Study|Lost to Follow-up|1|||
44242468|NCT01544335|79071892|FG000|Overall Study|Lost to Follow-up|27|||
44242469|NCT01544335|79071892|FG000|Overall Study|Death|4|||
44242470|NCT01544335|79071892|FG000|Overall Study|Disease progression|3|||
44242471|NCT01544335|79071892|FG000|Overall Study|Baseline Measurements not Available|19|||
44242472|NCT01484197|79071896|FG000|Treatment Period 1|Adverse Event|1|||
44510153|NCT03137992|79515294|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
44510154|NCT03137992|79515295|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
44510155|NCT03137992|79515296|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
44242473|NCT01484197|79071897|FG001|Treatment Period 1|Adverse Event|0|||
44242474|NCT01484197|79071898|FG002|Treatment Period 1|Adverse Event|0|||
44242475|NCT01484197|79071899|FG003|Treatment Period 1|Adverse Event|0|||
44242476|NCT01484197|79071896|FG000|Treatment Period 2|Subject withdrew consent|0|||
44242477|NCT01484197|79071897|FG001|Treatment Period 2|Subject withdrew consent|0|||
44242478|NCT01484197|79071898|FG002|Treatment Period 2|Subject withdrew consent|0|||
44242479|NCT01484197|79071899|FG003|Treatment Period 2|Subject withdrew consent|1|||
44242480|NCT01473407|79071911|FG000|Overall Study|Physician Decision|1|||
44242481|NCT01473407|79071912|FG001|Overall Study|Physician Decision|4|||
44242482|NCT01473407|79071911|FG000|Overall Study|Lost to Follow-up|10|||
44242483|NCT01473407|79071912|FG001|Overall Study|Lost to Follow-up|4|||
44242484|NCT01473407|79071911|FG000|Overall Study|Adverse Event|8|||
44242485|NCT01473407|79071912|FG001|Overall Study|Adverse Event|8|||
44510156|NCT03137992|79515297|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
44242486|NCT01473407|79071911|FG000|Overall Study|Randomization Error|3|||
44242487|NCT01473407|79071912|FG001|Overall Study|Randomization Error|1|||
44242488|NCT01473407|79071911|FG000|Overall Study|Withdrawal by Subject|4|||
44242489|NCT01473407|79071912|FG001|Overall Study|Withdrawal by Subject|7|||
44242490|NCT01473407|79071911|FG000|Overall Study|Kidney Transplant|7|||
44242491|NCT01473407|79071912|FG001|Overall Study|Kidney Transplant|6|||
44242492|NCT01473407|79071911|FG000|Overall Study|Vacation/Travel|1|||
44242493|NCT01473407|79071912|FG001|Overall Study|Vacation/Travel|1|||
44242494|NCT01473407|79071911|FG000|Overall Study|Elevated Hemoglobin|1|||
44242495|NCT01473407|79071912|FG001|Overall Study|Elevated Hemoglobin|0|||
44242496|NCT01473407|79071911|FG000|Overall Study|Patient Received Aranesp|1|||
44242497|NCT01473407|79071912|FG001|Overall Study|Patient Received Aranesp|0|||
44242498|NCT01473407|79071911|FG000|Overall Study|Patient Lost Green Card Status|1|||
44242499|NCT01473407|79071912|FG001|Overall Study|Patient Lost Green Card Status|0|||
44242500|NCT01473407|79071911|FG000|Overall Study|Temperature Excursion|2|||
44242501|NCT01473407|79071912|FG001|Overall Study|Temperature Excursion|3|||
44242502|NCT01473407|79071911|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
44242503|NCT01473407|79071912|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
44242504|NCT01473407|79071911|FG000|Overall Study|Sponsor's Decision|10|||
44242505|NCT01473407|79071912|FG001|Overall Study|Sponsor's Decision|10|||
44242506|NCT01473407|79071911|FG000|Overall Study|Site Closure|1|||
44242507|NCT01473407|79071912|FG001|Overall Study|Site Closure|0|||
44242508|NCT01472939|79071922|FG000|Overall Study|Adverse Event|3|||
44242509|NCT01472939|79071923|FG001|Overall Study|Adverse Event|7|||
44242510|NCT01472939|79071924|FG002|Overall Study|Adverse Event|7|||
44242511|NCT01472939|79071925|FG003|Overall Study|Adverse Event|14|||
44242512|NCT01472939|79071922|FG000|Overall Study|Lack of Efficacy|1|||
44379149|NCT00910728|79384818|FG006|Overall Study|Lack of Efficacy|2|||
44379150|NCT00910728|79384819|FG007|Overall Study|Lack of Efficacy|2|||
44379151|NCT00910728|79384820|FG008|Overall Study|Lack of Efficacy|2|||
44510157|NCT03137992|79515298|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
44510158|NCT03137992|79515293|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
44510159|NCT03137992|79515294|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
44510160|NCT03137992|79515295|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
44510161|NCT03137992|79515296|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
44510162|NCT03137992|79515297|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
44510163|NCT03137992|79515298|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
44510164|NCT03137992|79515293|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
44510165|NCT03137992|79515294|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
44510166|NCT03137992|79515295|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
44510167|NCT03137992|79515296|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
44510168|NCT03137992|79515297|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
44510169|NCT03137992|79515298|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
44510170|NCT03137992|79515293|FG000|Part 2 (Open-label Extension)|Per study team|1|||
44510171|NCT03137992|79515294|FG001|Part 2 (Open-label Extension)|Per study team|0|||
44510172|NCT03137992|79515295|FG002|Part 2 (Open-label Extension)|Per study team|0|||
44122641|NCT02498392|78906688|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
44122642|NCT02498392|78906687|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
44122643|NCT02498392|78906688|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
44122644|NCT02498392|78906687|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
44242513|NCT01472939|79071923|FG001|Overall Study|Lack of Efficacy|0|||
44242514|NCT01472939|79071924|FG002|Overall Study|Lack of Efficacy|0|||
44242515|NCT01472939|79071925|FG003|Overall Study|Lack of Efficacy|1|||
44242516|NCT01472939|79071922|FG000|Overall Study|Lost to Follow-up|3|||
44242517|NCT01472939|79071923|FG001|Overall Study|Lost to Follow-up|0|||
44242518|NCT01472939|79071924|FG002|Overall Study|Lost to Follow-up|2|||
44242519|NCT01472939|79071925|FG003|Overall Study|Lost to Follow-up|0|||
44242520|NCT01472939|79071922|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
44242521|NCT01472939|79071923|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
44379152|NCT00910728|79384812|FG000|Overall Study|Withdrawal by Subject|0|||
44510173|NCT03137992|79515296|FG003|Part 2 (Open-label Extension)|Per study team|0|||
44510174|NCT03137992|79515297|FG004|Part 2 (Open-label Extension)|Per study team|0|||
44510175|NCT03137992|79515298|FG005|Part 2 (Open-label Extension)|Per study team|0|||
44510176|NCT03137992|79515293|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
44510177|NCT03137992|79515294|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
44510178|NCT03137992|79515295|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
44510179|NCT03137992|79515296|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
44510180|NCT03137992|79515297|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
44510181|NCT03137992|79515298|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
44510182|NCT03704636|79515306|FG000|Overall Study|Inadequate Venous Flow|3|||
44510183|NCT05096312|79515321|FG000|Overall Study|Lost to Follow-up|2|||
44510184|NCT05096312|79515322|FG001|Overall Study|Lost to Follow-up|4|||
44510185|NCT05096312|79515321|FG000|Overall Study|Adverse Event|1|||
44510186|NCT05096312|79515322|FG001|Overall Study|Adverse Event|0|||
44510187|NCT04908488|79515330|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
44510188|NCT04908488|79515331|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
44510189|NCT04908488|79515330|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
44242522|NCT01472939|79071924|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
44242523|NCT01472939|79071925|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
44242524|NCT01472939|79071922|FG000|Overall Study|Prohibited Medication|0|||
44242525|NCT01472939|79071923|FG001|Overall Study|Prohibited Medication|1|||
44242526|NCT01472939|79071924|FG002|Overall Study|Prohibited Medication|0|||
44242527|NCT01472939|79071925|FG003|Overall Study|Prohibited Medication|0|||
44242528|NCT01472939|79071922|FG000|Overall Study|Withdrawal By PI|1|||
44242529|NCT01472939|79071923|FG001|Overall Study|Withdrawal By PI|0|||
44242530|NCT01472939|79071924|FG002|Overall Study|Withdrawal By PI|0|||
44242531|NCT01472939|79071925|FG003|Overall Study|Withdrawal By PI|0|||
44242532|NCT01472939|79071922|FG000|Overall Study|Protocol Violation|3|||
44242533|NCT01472939|79071923|FG001|Overall Study|Protocol Violation|3|||
44242534|NCT01472939|79071924|FG002|Overall Study|Protocol Violation|0|||
44242535|NCT01472939|79071925|FG003|Overall Study|Protocol Violation|1|||
44242536|NCT01472939|79071922|FG000|Overall Study|Withdrawal by Subject|9|||
44242537|NCT01472939|79071923|FG001|Overall Study|Withdrawal by Subject|3|||
44242538|NCT01472939|79071924|FG002|Overall Study|Withdrawal by Subject|1|||
44242539|NCT01472939|79071925|FG003|Overall Study|Withdrawal by Subject|4|||
44242540|NCT01544179|79071940|FG000|Overall Study|Death|50|||
44242541|NCT01544179|79071941|FG001|Overall Study|Death|37|||
44242542|NCT01544179|79071940|FG000|Overall Study|Lost to Follow-up|0|||
44242543|NCT01544179|79071941|FG001|Overall Study|Lost to Follow-up|1|||
44242544|NCT01544179|79071940|FG000|Overall Study|Adverse Event|0|||
44242545|NCT01544179|79071941|FG001|Overall Study|Adverse Event|1|||
44242546|NCT01544179|79071940|FG000|Overall Study|Withdrawal by Subject|12|||
44510190|NCT04908488|79515331|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
44510191|NCT04876274|79515342|FG000|Overall Study|Lost to Follow-up|9|||
44510192|NCT04876274|79515343|FG001|Overall Study|Lost to Follow-up|12|||
44510193|NCT04865354|79515351|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
44510194|NCT04865354|79515352|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
44510195|NCT04865354|79515351|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
44510196|NCT04865354|79515352|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
44510197|NCT04865354|79515351|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
44510198|NCT04865354|79515352|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
44510199|NCT04860518|79515363|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
44510200|NCT04860518|79515364|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
44510201|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
44510202|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
44510203|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
44510204|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
44510205|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
44510206|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
44510207|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44510208|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44510209|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
44242547|NCT01544179|79071941|FG001|Overall Study|Withdrawal by Subject|7|||
44242548|NCT01544179|79071940|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
44510210|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
44510211|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
44510212|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
44242549|NCT01544179|79071941|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44242550|NCT01483651|79071947|FG000|Overall Study|Withdrawal by Subject|0|||
44242551|NCT01483651|79071948|FG001|Overall Study|Withdrawal by Subject|1|||
44242552|NCT01483651|79071949|FG002|Overall Study|Withdrawal by Subject|1|||
44242553|NCT01483651|79071950|FG003|Overall Study|Withdrawal by Subject|0|||
44242554|NCT01483651|79071951|FG004|Overall Study|Withdrawal by Subject|0|||
44242555|NCT01483651|79071952|FG005|Overall Study|Withdrawal by Subject|1|||
44242556|NCT01464307|79071962|FG000|Main Period|Death|0|||
44242557|NCT01464307|79071963|FG001|Main Period|Death|1|||
44242558|NCT01464307|79071962|FG000|Main Period|Adverse Event|6|||
44242559|NCT01464307|79071963|FG001|Main Period|Adverse Event|1|||
44242560|NCT01464307|79071962|FG000|Main Period|Lack of Efficacy|2|||
44242561|NCT01464307|79071963|FG001|Main Period|Lack of Efficacy|0|||
44242562|NCT01464307|79071962|FG000|Main Period|Withdrawal by Subject|5|||
44242563|NCT01464307|79071963|FG001|Main Period|Withdrawal by Subject|2|||
44242564|NCT01464307|79071962|FG000|Main Period|Predefined discontinuation criteria|2|||
44242565|NCT01464307|79071963|FG001|Main Period|Predefined discontinuation criteria|1|||
44242566|NCT01464307|79071962|FG000|Open-Label Extension Period|Adverse Event|15|||
44242567|NCT01464307|79071963|FG001|Open-Label Extension Period|Adverse Event|0|||
44122645|NCT02498392|78906688|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
44122646|NCT02498392|78906687|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
44242568|NCT01464307|79071962|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
44242569|NCT01464307|79071963|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
44242570|NCT01464307|79071962|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
44242571|NCT01464307|79071963|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
44242572|NCT01464307|79071962|FG000|Open-Label Extension Period|Death|1|||
44242573|NCT01464307|79071963|FG001|Open-Label Extension Period|Death|0|||
44242574|NCT01464307|79071962|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
44242575|NCT01464307|79071963|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
44242576|NCT01464307|79071962|FG000|Open-Label Extension Period|Non-compliance|9|||
44242577|NCT01464307|79071963|FG001|Open-Label Extension Period|Non-compliance|0|||
44242578|NCT01464307|79071962|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
44242579|NCT01464307|79071963|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
44242580|NCT01483183|79071980|FG000|Overall Study|Physician Decision|0|||
44242581|NCT01483183|79071981|FG001|Overall Study|Physician Decision|0|||
44242582|NCT01483183|79071982|FG002|Overall Study|Physician Decision|0|||
44242583|NCT01483183|79071983|FG003|Overall Study|Physician Decision|0|||
44242584|NCT01483183|79071984|FG004|Overall Study|Physician Decision|0|||
44510213|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
44510214|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
44510215|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
44122647|NCT02498392|78906688|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
44122648|NCT02498392|78906687|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
44510216|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
44510217|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Death|2|||
44510218|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Death|1|||
44510219|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Death|0|||
44510220|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Death|0|||
44510221|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
44510222|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
44510223|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
44510224|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
44122649|NCT02498392|78906688|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
44122650|NCT03205605|78906696|FG000|Overall Study|Withdrawal by Subject|1|||
44122651|NCT02498236|78906714|FG000|Overall Study|Did not show for testing|1|||
44122652|NCT02498236|78906715|FG001|Overall Study|Did not show for testing|0|||
44242585|NCT01483183|79071985|FG005|Overall Study|Physician Decision|0|||
44242586|NCT01483183|79071986|FG006|Overall Study|Physician Decision|2|||
44510225|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
44242587|NCT01483183|79071987|FG007|Overall Study|Physician Decision|0|||
44242588|NCT01483183|79071988|FG008|Overall Study|Physician Decision|0|||
44242589|NCT01483183|79071989|FG009|Overall Study|Physician Decision|0|||
44242590|NCT01483183|79071980|FG000|Overall Study|Withdrawal by Subject|0|||
44242591|NCT01483183|79071981|FG001|Overall Study|Withdrawal by Subject|0|||
44122653|NCT02498236|78906716|FG002|Overall Study|Did not show for testing|0|||
44122654|NCT02498236|78906717|FG003|Overall Study|Did not show for testing|0|||
44122655|NCT02498236|78906718|FG004|Overall Study|Did not show for testing|0|||
44122656|NCT02498236|78906719|FG005|Overall Study|Did not show for testing|0|||
44122657|NCT02498236|78906720|FG006|Overall Study|Did not show for testing|0|||
44242592|NCT01483183|79071982|FG002|Overall Study|Withdrawal by Subject|0|||
44242593|NCT01483183|79071983|FG003|Overall Study|Withdrawal by Subject|0|||
44242594|NCT01483183|79071984|FG004|Overall Study|Withdrawal by Subject|0|||
44242595|NCT01483183|79071985|FG005|Overall Study|Withdrawal by Subject|0|||
44242596|NCT01483183|79071986|FG006|Overall Study|Withdrawal by Subject|0|||
44242597|NCT01483183|79071987|FG007|Overall Study|Withdrawal by Subject|0|||
44242598|NCT01483183|79071988|FG008|Overall Study|Withdrawal by Subject|0|||
44242599|NCT01483183|79071989|FG009|Overall Study|Withdrawal by Subject|1|||
44242600|NCT01483027|79072019|FG000|Overall Study|Administrative Reasons|2|||
44242601|NCT01483027|79072020|FG001|Overall Study|Administrative Reasons|1|||
44242602|NCT01483027|79072019|FG000|Overall Study|Withdrawal by Subject|21|||
44276442|NCT02177136|79231084|FG003|LTSE Phase|Adverse Event|10|||
44276443|NCT02177136|79231081|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
44510226|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
44510227|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
44510228|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
44510229|NCT03110380|79515372|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
44510230|NCT03110380|79515373|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
44510231|NCT03110380|79515374|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
44510232|NCT03110380|79515375|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
44510233|NCT03110380|79515372|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
44510234|NCT03110380|79515373|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
44510235|NCT03110380|79515374|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
44510236|NCT03110380|79515375|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
44510237|NCT03110380|79515372|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
44510238|NCT03110380|79515373|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
44510239|NCT03110380|79515374|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
44510240|NCT03110380|79515375|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
44510241|NCT03110380|79515372|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
44510242|NCT03110380|79515373|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
44510243|NCT03110380|79515374|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
44510244|NCT03110380|79515375|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
44510245|NCT04851314|79515385|FG000|Overall Study|Unable to complete research set-up procedures|0|||
44510246|NCT04851314|79515386|FG001|Overall Study|Unable to complete research set-up procedures|2|||
44510247|NCT04851314|79515385|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
44510248|NCT04851314|79515386|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
44510249|NCT04848662|79515394|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
44510250|NCT04848662|79515395|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
44510251|NCT03701516|79515401|FG000|Period 1|Lost to Follow-up|0|||
44510252|NCT03701516|79515402|FG001|Period 1|Lost to Follow-up|1|||
44510253|NCT03701516|79515401|FG000|Period 1|Adverse Event|0|||
44510254|NCT03701516|79515402|FG001|Period 1|Adverse Event|2|||
44510255|NCT03701516|79515401|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
44510256|NCT03701516|79515402|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
44510257|NCT03701516|79515401|FG000|Period 1|Non Compliance to Protocol|2|||
44510258|NCT03701516|79515402|FG001|Period 1|Non Compliance to Protocol|1|||
44510259|NCT03701516|79515401|FG000|Period 1|Withdrawal by Subject|0|||
44242603|NCT01483027|79072020|FG001|Overall Study|Withdrawal by Subject|32|||
44242604|NCT01483027|79072019|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
44276444|NCT02177136|79231082|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
44510260|NCT03701516|79515402|FG001|Period 1|Withdrawal by Subject|1|||
44510261|NCT03701516|79515401|FG000|Period 2|failed to meet all eligibility creiteria|1|||
44510262|NCT03701516|79515402|FG001|Period 2|failed to meet all eligibility creiteria|0|||
44510263|NCT03701516|79515401|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
44510264|NCT03701516|79515402|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
44510265|NCT03700892|79515410|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
44510266|NCT03700892|79515411|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
44510267|NCT03700892|79515412|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
44276445|NCT02177136|79231083|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
44510268|NCT03700736|79515423|FG000|Overall Study|Pregnancy|1|||
44122658|NCT02498236|78906721|FG007|Overall Study|Did not show for testing|1|||
44122659|NCT02498236|78906714|FG000|Overall Study|Equipment failure|0|||
44122660|NCT02498236|78906715|FG001|Overall Study|Equipment failure|0|||
44242605|NCT01483027|79072020|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
44242606|NCT01483027|79072019|FG000|Overall Study|Lost to Follow-up|1|||
44242607|NCT01483027|79072020|FG001|Overall Study|Lost to Follow-up|1|||
44242608|NCT01483027|79072019|FG000|Overall Study|Adverse Event|0|||
44242609|NCT01483027|79072020|FG001|Overall Study|Adverse Event|1|||
44242610|NCT01483027|79072019|FG000|Overall Study|Withdrawal by Subject|0|||
44242611|NCT01483027|79072020|FG001|Overall Study|Withdrawal by Subject|1|||
44242612|NCT01463683|79072029|FG000|Overall Study|Adverse Event|2|||
44242613|NCT01463683|79072030|FG001|Overall Study|Adverse Event|0|||
44242614|NCT01463683|79072031|FG002|Overall Study|Adverse Event|0|||
44242615|NCT01463683|79072029|FG000|Overall Study|Lost to Follow-up|10|||
44242616|NCT01463683|79072030|FG001|Overall Study|Lost to Follow-up|9|||
44242617|NCT01463683|79072031|FG002|Overall Study|Lost to Follow-up|7|||
44242618|NCT01463683|79072029|FG000|Overall Study|Physician Decision|0|||
44242619|NCT01463683|79072030|FG001|Overall Study|Physician Decision|3|||
44242620|NCT01463683|79072031|FG002|Overall Study|Physician Decision|1|||
44242621|NCT01463683|79072029|FG000|Overall Study|Pregnancy|2|||
44242622|NCT01463683|79072030|FG001|Overall Study|Pregnancy|2|||
44242623|NCT01463683|79072031|FG002|Overall Study|Pregnancy|1|||
44122661|NCT02498236|78906716|FG002|Overall Study|Equipment failure|0|||
44122662|NCT02498236|78906717|FG003|Overall Study|Equipment failure|0|||
44122663|NCT02498236|78906718|FG004|Overall Study|Equipment failure|0|||
44122664|NCT02498236|78906719|FG005|Overall Study|Equipment failure|0|||
44242624|NCT01463683|79072029|FG000|Overall Study|Withdrawal by Subject|5|||
44242625|NCT01463683|79072030|FG001|Overall Study|Withdrawal by Subject|17|||
44242626|NCT01463683|79072031|FG002|Overall Study|Withdrawal by Subject|2|||
44242627|NCT01482169|79072039|FG000|Overall Study|Physician Decision|2|||
44242628|NCT01481779|79072048|FG000|Overall Study|Adverse Event|23|||
44242629|NCT01481779|79072049|FG001|Overall Study|Adverse Event|5|||
44242630|NCT01481779|79072048|FG000|Overall Study|Lost to Follow-up|3|||
44242631|NCT01481779|79072049|FG001|Overall Study|Lost to Follow-up|2|||
44242632|NCT01481779|79072048|FG000|Overall Study|Protocol Violation|2|||
44242633|NCT01481779|79072049|FG001|Overall Study|Protocol Violation|3|||
44242634|NCT01481779|79072048|FG000|Overall Study|Withdrawal by Subject|26|||
44242635|NCT01481779|79072049|FG001|Overall Study|Withdrawal by Subject|13|||
44242636|NCT01481779|79072048|FG000|Overall Study|Physician Decision|13|||
44242637|NCT01481779|79072049|FG001|Overall Study|Physician Decision|4|||
44242638|NCT01481779|79072048|FG000|Overall Study|Sponsor Decision|3|||
44242639|NCT01481779|79072049|FG001|Overall Study|Sponsor Decision|1|||
44242640|NCT01463527|79072057|FG000|Overall Study|Protocol Violation|1|||
44242641|NCT01463527|79072058|FG001|Overall Study|Protocol Violation|1|||
44242642|NCT01463527|79072057|FG000|Overall Study|Crying >20% of sedation|5|||
44242643|NCT01463527|79072058|FG001|Overall Study|Crying >20% of sedation|6|||
44242644|NCT01509547|79072066|FG000|Overall Study|Lost to Follow-up|24|||
44242645|NCT01509547|79072067|FG001|Overall Study|Lost to Follow-up|14|||
44122665|NCT02498236|78906720|FG006|Overall Study|Equipment failure|1|||
44242646|NCT01509547|79072066|FG000|Overall Study|Withdrawal by Subject|11|||
44242647|NCT01509547|79072067|FG001|Overall Study|Withdrawal by Subject|24|||
44242648|NCT01509547|79072066|FG000|Overall Study|Physician Decision|0|||
44242649|NCT01509547|79072067|FG001|Overall Study|Physician Decision|1|||
44242650|NCT01509079|79072075|FG000|Overall Study|Lack of Efficacy|0|||
44242651|NCT01509079|79072076|FG001|Overall Study|Lack of Efficacy|2|||
44242652|NCT01509079|79072075|FG000|Overall Study|started an excluded medication|0|||
44242653|NCT01509079|79072076|FG001|Overall Study|started an excluded medication|1|||
44122666|NCT02498236|78906721|FG007|Overall Study|Equipment failure|0|||
44122667|NCT02498236|78906714|FG000|Overall Study|Withdrawal by Subject|0|||
44242654|NCT01463293|79072085|FG000|Overall Study|Lost to Follow-up|1|||
44242655|NCT01463293|79072086|FG001|Overall Study|Lost to Follow-up|4|||
44242656|NCT01463293|79072087|FG002|Overall Study|Lost to Follow-up|5|||
44242657|NCT01463293|79072085|FG000|Overall Study|Adverse Event|1|||
44242658|NCT01463293|79072086|FG001|Overall Study|Adverse Event|2|||
44242659|NCT01463293|79072087|FG002|Overall Study|Adverse Event|0|||
44242660|NCT01463293|79072085|FG000|Overall Study|Withdrawal by Subject|4|||
44242661|NCT01463293|79072086|FG001|Overall Study|Withdrawal by Subject|10|||
44242662|NCT01463293|79072087|FG002|Overall Study|Withdrawal by Subject|5|||
44242663|NCT01463293|79072085|FG000|Overall Study|Other|0|||
44242664|NCT01463293|79072086|FG001|Overall Study|Other|0|||
44242665|NCT01463293|79072087|FG002|Overall Study|Other|2|||
44242666|NCT01479985|79072118|FG000|Overall Study|Tablet malfunction, no data saved|1|||
44242667|NCT01479985|79072119|FG001|Overall Study|Tablet malfunction, no data saved|1|||
44242668|NCT01479985|79072118|FG000|Overall Study|No decisional conflict scale responses|0|||
44242669|NCT01479985|79072119|FG001|Overall Study|No decisional conflict scale responses|2|||
44242670|NCT01479985|79072118|FG000|Overall Study|No post-visit survey|5|||
44242671|NCT01479985|79072119|FG001|Overall Study|No post-visit survey|3|||
44242672|NCT01462435|79072133|FG000|Overall Study|Lack of Efficacy|1|||
44242673|NCT01462435|79072134|FG001|Overall Study|Lack of Efficacy|0|||
44242674|NCT01462435|79072135|FG002|Overall Study|Lack of Efficacy|0|||
44242675|NCT01462435|79072136|FG003|Overall Study|Lack of Efficacy|3|||
44242676|NCT01462435|79072133|FG000|Overall Study|Physician Decision|0|||
44242677|NCT01462435|79072134|FG001|Overall Study|Physician Decision|0|||
44242678|NCT01462435|79072135|FG002|Overall Study|Physician Decision|1|||
44242679|NCT01462435|79072136|FG003|Overall Study|Physician Decision|0|||
44242680|NCT01462435|79072133|FG000|Overall Study|Withdrawal by Subject|0|||
44242681|NCT01462435|79072134|FG001|Overall Study|Withdrawal by Subject|0|||
44242682|NCT01462435|79072135|FG002|Overall Study|Withdrawal by Subject|0|||
44242683|NCT01462435|79072136|FG003|Overall Study|Withdrawal by Subject|1|||
44242684|NCT01462435|79072133|FG000|Overall Study|Lost to Follow-up|0|||
44242685|NCT01462435|79072134|FG001|Overall Study|Lost to Follow-up|0|||
44242686|NCT01462435|79072135|FG002|Overall Study|Lost to Follow-up|0|||
44242687|NCT01462435|79072136|FG003|Overall Study|Lost to Follow-up|1|||
44242688|NCT01472081|79072152|FG000|Overall Study|Continuing treatment at time of analysis|1|||
44242689|NCT01472081|79072153|FG001|Overall Study|Continuing treatment at time of analysis|4|||
44242690|NCT01472081|79072154|FG002|Overall Study|Continuing treatment at time of analysis|1|||
44242691|NCT01472081|79072155|FG003|Overall Study|Continuing treatment at time of analysis|8|||
44242692|NCT01472081|79072156|FG004|Overall Study|Continuing treatment at time of analysis|9|||
44242693|NCT01472081|79072157|FG005|Overall Study|Continuing treatment at time of analysis|0|||
44242694|NCT01472081|79072152|FG000|Overall Study|Disease Progression|4|||
44242695|NCT01472081|79072153|FG001|Overall Study|Disease Progression|10|||
44242696|NCT01472081|79072154|FG002|Overall Study|Disease Progression|12|||
44242697|NCT01472081|79072155|FG003|Overall Study|Disease Progression|31|||
44242698|NCT01472081|79072156|FG004|Overall Study|Disease Progression|22|||
44242699|NCT01472081|79072157|FG005|Overall Study|Disease Progression|3|||
44242700|NCT01472081|79072152|FG000|Overall Study|Study drug toxicity|2|||
44242701|NCT01472081|79072153|FG001|Overall Study|Study drug toxicity|9|||
44242702|NCT01472081|79072154|FG002|Overall Study|Study drug toxicity|4|||
44242703|NCT01472081|79072155|FG003|Overall Study|Study drug toxicity|6|||
44242704|NCT01472081|79072156|FG004|Overall Study|Study drug toxicity|13|||
44510269|NCT03700736|79515424|FG001|Overall Study|Pregnancy|1|||
44510270|NCT03700736|79515423|FG000|Overall Study|Withdrawal by Subject|2|||
44510271|NCT03700736|79515424|FG001|Overall Study|Withdrawal by Subject|6|||
44510272|NCT04737278|79515435|FG000|Overall Study|Lost to Follow-up|1|||
44510273|NCT04737278|79515436|FG001|Overall Study|Lost to Follow-up|1|||
44510274|NCT04737278|79515435|FG000|Overall Study|Withdrawal by Subject|1|||
44510275|NCT04737278|79515436|FG001|Overall Study|Withdrawal by Subject|0|||
44510276|NCT04737278|79515435|FG000|Overall Study|Protocol Violation|1|||
44510277|NCT04737278|79515436|FG001|Overall Study|Protocol Violation|1|||
44510278|NCT04737278|79515435|FG000|Overall Study|failure to complete questionnaire|1|||
44510279|NCT04737278|79515436|FG001|Overall Study|failure to complete questionnaire|1|||
44510280|NCT04725500|79515442|FG000|Screening|Screen Failure|26|||
44510281|NCT04725500|79515442|FG000|Screening|Withdrawal by Subject|1|||
44510282|NCT04725500|79515442|FG000|2 Week Take Home|Screen Fail|5|||
44510283|NCT04684394|79515448|FG000|Overall Study|Death|1|||
44510284|NCT04684394|79515449|FG001|Overall Study|Death|2|||
44510285|NCT04684394|79515448|FG000|Overall Study|Lost to Follow-up|1|||
44510286|NCT04684394|79515449|FG001|Overall Study|Lost to Follow-up|0|||
44510287|NCT04684394|79515448|FG000|Overall Study|Withdrawal by Subject|2|||
44510288|NCT04684394|79515449|FG001|Overall Study|Withdrawal by Subject|0|||
44510289|NCT04684394|79515448|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
44510290|NCT04684394|79515449|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
44510291|NCT04674644|79515455|FG000|Overall Study|with missing data|37|||
44510292|NCT04668950|79515462|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
44242705|NCT01472081|79072157|FG005|Overall Study|Study drug toxicity|2|||
44242706|NCT01472081|79072152|FG000|Overall Study|Death|0|||
44242707|NCT01472081|79072153|FG001|Overall Study|Death|0|||
44242708|NCT01472081|79072154|FG002|Overall Study|Death|0|||
44242709|NCT01472081|79072155|FG003|Overall Study|Death|0|||
44242710|NCT01472081|79072156|FG004|Overall Study|Death|1|||
44242711|NCT01472081|79072157|FG005|Overall Study|Death|0|||
44242712|NCT01472081|79072152|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
44242713|NCT01472081|79072153|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
44242714|NCT01472081|79072154|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
44242715|NCT01472081|79072155|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
44510293|NCT04668950|79515463|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
44510294|NCT04668950|79515462|FG000|Overall Study|Could not confirm started study medication|15|||
44510295|NCT04668950|79515463|FG001|Overall Study|Could not confirm started study medication|15|||
44242716|NCT01472081|79072156|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
44242717|NCT01472081|79072157|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
44242718|NCT01472081|79072152|FG000|Overall Study|Withdrawal by Subject|0|||
44242719|NCT01472081|79072153|FG001|Overall Study|Withdrawal by Subject|0|||
44242720|NCT01472081|79072154|FG002|Overall Study|Withdrawal by Subject|0|||
44242721|NCT01472081|79072155|FG003|Overall Study|Withdrawal by Subject|0|||
44242722|NCT01472081|79072156|FG004|Overall Study|Withdrawal by Subject|0|||
44242723|NCT01472081|79072157|FG005|Overall Study|Withdrawal by Subject|1|||
44242724|NCT01472081|79072152|FG000|Overall Study|Poor/non-compliance|0|||
44242725|NCT01472081|79072153|FG001|Overall Study|Poor/non-compliance|0|||
44242726|NCT01472081|79072154|FG002|Overall Study|Poor/non-compliance|1|||
44242727|NCT01472081|79072155|FG003|Overall Study|Poor/non-compliance|0|||
44242728|NCT01472081|79072156|FG004|Overall Study|Poor/non-compliance|1|||
44242729|NCT01472081|79072157|FG005|Overall Study|Poor/non-compliance|0|||
44242730|NCT01472081|79072152|FG000|Overall Study|No longer meets study criteria|0|||
44242731|NCT01472081|79072153|FG001|Overall Study|No longer meets study criteria|0|||
44242732|NCT01472081|79072154|FG002|Overall Study|No longer meets study criteria|1|||
44242733|NCT01472081|79072155|FG003|Overall Study|No longer meets study criteria|0|||
44242734|NCT01472081|79072156|FG004|Overall Study|No longer meets study criteria|0|||
44242735|NCT01472081|79072157|FG005|Overall Study|No longer meets study criteria|0|||
44242736|NCT01472081|79072152|FG000|Overall Study|Subject request to discontinue treatment|0|||
44242737|NCT01472081|79072153|FG001|Overall Study|Subject request to discontinue treatment|3|||
44242738|NCT01472081|79072154|FG002|Overall Study|Subject request to discontinue treatment|1|||
44242739|NCT01472081|79072155|FG003|Overall Study|Subject request to discontinue treatment|1|||
44242740|NCT01472081|79072156|FG004|Overall Study|Subject request to discontinue treatment|0|||
44242741|NCT01472081|79072157|FG005|Overall Study|Subject request to discontinue treatment|0|||
44242742|NCT01471691|79072172|FG000|Overall Study|Lack of Efficacy|0|||
44242743|NCT01471691|79072173|FG001|Overall Study|Lack of Efficacy|1|||
44242744|NCT01471379|79072182|FG000|Overall Study|Adverse Event|1|||
44242745|NCT01471379|79072183|FG001|Overall Study|Adverse Event|0|||
44242746|NCT01471379|79072184|FG002|Overall Study|Adverse Event|0|||
44242747|NCT01471379|79072182|FG000|Overall Study|Study terminated|0|||
44242748|NCT01471379|79072183|FG001|Overall Study|Study terminated|1|||
44242749|NCT01471379|79072184|FG002|Overall Study|Study terminated|0|||
44242750|NCT01470989|79072195|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
44242751|NCT01470989|79072196|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
44242752|NCT01470989|79072195|FG000|Overall Study|Adverse Event|2|||
44242753|NCT01470989|79072196|FG001|Overall Study|Adverse Event|5|||
44242754|NCT01470989|79072195|FG000|Overall Study|Abnormal laboratory value|1|||
44242755|NCT01470989|79072196|FG001|Overall Study|Abnormal laboratory value|1|||
44242756|NCT01470989|79072195|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44242757|NCT01470989|79072196|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
44242758|NCT01470989|79072195|FG000|Overall Study|Withdrawal by Subject|19|||
44242759|NCT01470989|79072196|FG001|Overall Study|Withdrawal by Subject|17|||
44242760|NCT01470989|79072195|FG000|Overall Study|Lost to Follow-up|18|||
44510296|NCT04668950|79515462|FG000|Overall Study|Could not confirm baseline status|6|||
44242761|NCT01470989|79072196|FG001|Overall Study|Lost to Follow-up|13|||
44510297|NCT04668950|79515463|FG001|Overall Study|Could not confirm baseline status|2|||
44510298|NCT04668950|79515462|FG000|Overall Study|Drop out and did not start medication|15|||
44510299|NCT04668950|79515463|FG001|Overall Study|Drop out and did not start medication|17|||
44510300|NCT04668950|79515462|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
44510301|NCT04668950|79515463|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
44510302|NCT04668950|79515462|FG000|Overall Study|Other|2|||
44510303|NCT04668950|79515463|FG001|Overall Study|Other|4|||
44510304|NCT03078478|79515471|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
44510305|NCT03078478|79515472|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
44510306|NCT03078478|79515471|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
44510307|NCT03078478|79515472|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
44510308|NCT03078478|79515471|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
44510309|NCT03078478|79515472|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
44510310|NCT03078478|79515471|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
44510311|NCT03078478|79515472|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
44510312|NCT03078478|79515471|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
44510313|NCT03078478|79515472|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
44510314|NCT03078478|79515471|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
44510315|NCT03078478|79515472|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
44510316|NCT03078478|79515471|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
44510317|NCT03078478|79515472|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
44510318|NCT03078478|79515471|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
44510319|NCT03078478|79515472|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
44510320|NCT02879578|79515481|FG000|Overall Study|Adverse Event|1|||
44242762|NCT01470989|79072195|FG000|Overall Study|Administrative problems|2|||
44242763|NCT01470989|79072196|FG001|Overall Study|Administrative problems|4|||
44242764|NCT01470989|79072195|FG000|Overall Study|Death|2|||
44242765|NCT01470989|79072196|FG001|Overall Study|Death|2|||
44242766|NCT01470989|79072195|FG000|Overall Study|Protocol deviation|1|||
44242767|NCT01470989|79072196|FG001|Overall Study|Protocol deviation|2|||
44242768|NCT01470599|79072206|FG000|Overall Study|Did not meet entrance criteria|1|||
44242769|NCT01470599|79072207|FG001|Overall Study|Did not meet entrance criteria|0|||
44242770|NCT01470599|79072206|FG000|Overall Study|Lost to Follow-up|2|||
44242771|NCT01470599|79072207|FG001|Overall Study|Lost to Follow-up|1|||
44242772|NCT01470599|79072206|FG000|Overall Study|Withdrawal by Subject|3|||
44510321|NCT02879578|79515482|FG001|Overall Study|Adverse Event|2|||
44510322|NCT02879578|79515483|FG002|Overall Study|Adverse Event|14|||
44510323|NCT02879578|79515481|FG000|Overall Study|Protocol Violation|0|||
44510324|NCT02879578|79515482|FG001|Overall Study|Protocol Violation|1|||
44510325|NCT02879578|79515483|FG002|Overall Study|Protocol Violation|1|||
44510326|NCT02879578|79515481|FG000|Overall Study|Withdrawal by Subject|8|||
44510327|NCT02879578|79515482|FG001|Overall Study|Withdrawal by Subject|6|||
44510328|NCT02879578|79515483|FG002|Overall Study|Withdrawal by Subject|9|||
44510329|NCT02879578|79515481|FG000|Overall Study|Lost to Follow-up|1|||
44510330|NCT02879578|79515482|FG001|Overall Study|Lost to Follow-up|0|||
44510331|NCT02879578|79515483|FG002|Overall Study|Lost to Follow-up|4|||
44510332|NCT02879578|79515481|FG000|Overall Study|Physician Decision|0|||
44510333|NCT02879578|79515482|FG001|Overall Study|Physician Decision|0|||
44510334|NCT02879578|79515483|FG002|Overall Study|Physician Decision|4|||
44510335|NCT00045942|79515500|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
44510336|NCT00045942|79515501|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510337|NCT00045942|79515502|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510338|NCT00045942|79515503|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510339|NCT00045942|79515504|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510340|NCT00045942|79515505|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510341|NCT00045942|79515506|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510342|NCT00045942|79515507|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510343|NCT00045942|79515508|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
44510344|NCT00045942|79515500|FG000|PKC412A2104 (Core)|Adverse Event|5|||
44510345|NCT00045942|79515501|FG001|PKC412A2104 (Core)|Adverse Event|0|||
44510346|NCT00045942|79515502|FG002|PKC412A2104 (Core)|Adverse Event|0|||
44510347|NCT00045942|79515503|FG003|PKC412A2104 (Core)|Adverse Event|0|||
44510348|NCT00045942|79515504|FG004|PKC412A2104 (Core)|Adverse Event|0|||
44510349|NCT00045942|79515505|FG005|PKC412A2104 (Core)|Adverse Event|0|||
44510350|NCT00045942|79515506|FG006|PKC412A2104 (Core)|Adverse Event|0|||
44510351|NCT00045942|79515507|FG007|PKC412A2104 (Core)|Adverse Event|0|||
44510352|NCT00045942|79515508|FG008|PKC412A2104 (Core)|Adverse Event|0|||
44510353|NCT00045942|79515500|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
44510354|NCT00045942|79515501|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510355|NCT00045942|79515502|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510356|NCT00045942|79515503|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510357|NCT00045942|79515504|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510358|NCT00045942|79515505|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510359|NCT00045942|79515506|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510360|NCT00045942|79515507|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510361|NCT00045942|79515508|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
44510362|NCT00045942|79515500|FG000|PKC412A2104 (Core)|Death|1|||
44510363|NCT00045942|79515501|FG001|PKC412A2104 (Core)|Death|0|||
44510364|NCT00045942|79515502|FG002|PKC412A2104 (Core)|Death|0|||
44510365|NCT00045942|79515503|FG003|PKC412A2104 (Core)|Death|0|||
44510366|NCT00045942|79515504|FG004|PKC412A2104 (Core)|Death|0|||
44510367|NCT00045942|79515505|FG005|PKC412A2104 (Core)|Death|0|||
44510368|NCT00045942|79515506|FG006|PKC412A2104 (Core)|Death|0|||
44242773|NCT01470599|79072207|FG001|Overall Study|Withdrawal by Subject|4|||
44510369|NCT00045942|79515507|FG007|PKC412A2104 (Core)|Death|0|||
44510370|NCT00045942|79515508|FG008|PKC412A2104 (Core)|Death|0|||
44510371|NCT00045942|79515500|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
44242774|NCT01470599|79072206|FG000|Overall Study|Other|1|||
44242775|NCT01470599|79072207|FG001|Overall Study|Other|0|||
44242776|NCT01470599|79072206|FG000|Overall Study|Protocol Violation|3|||
44276446|NCT02177136|79231084|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
44510372|NCT00045942|79515501|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
44510373|NCT00045942|79515502|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
44510374|NCT00045942|79515503|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
44510375|NCT00045942|79515504|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
44510376|NCT00045942|79515505|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
44510377|NCT00045942|79515506|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
44242777|NCT01470599|79072207|FG001|Overall Study|Protocol Violation|1|||
44242778|NCT01470599|79072206|FG000|Overall Study|Adverse event related to study drug|2|||
44242779|NCT01470599|79072207|FG001|Overall Study|Adverse event related to study drug|5|||
44242780|NCT01470599|79072206|FG000|Overall Study|Insufficient clinical response|6|||
44122668|NCT02498236|78906715|FG001|Overall Study|Withdrawal by Subject|0|||
44122669|NCT02498236|78906716|FG002|Overall Study|Withdrawal by Subject|0|||
44122670|NCT02498236|78906717|FG003|Overall Study|Withdrawal by Subject|0|||
44122671|NCT02498236|78906718|FG004|Overall Study|Withdrawal by Subject|1|||
44122672|NCT02498236|78906719|FG005|Overall Study|Withdrawal by Subject|0|||
44122673|NCT02498236|78906720|FG006|Overall Study|Withdrawal by Subject|0|||
44122674|NCT02498236|78906721|FG007|Overall Study|Withdrawal by Subject|0|||
44122675|NCT02496676|78906744|FG000|Phase 1 - Period 1|Adverse Event|0|||
44122676|NCT02496676|78906745|FG001|Phase 1 - Period 1|Adverse Event|1|||
44242781|NCT01470599|79072207|FG001|Overall Study|Insufficient clinical response|27|||
44242782|NCT01470599|79072206|FG000|Overall Study|Adverse event not related to study drug|1|||
44242783|NCT01470599|79072207|FG001|Overall Study|Adverse event not related to study drug|5|||
44242784|NCT01469819|79072213|FG000|Overall Study|Withdrawal by Subject|1|||
44242785|NCT01469819|79072213|FG000|Overall Study|Did not meet inclusionary criteria|2|||
44242786|NCT01469819|79072213|FG000|Overall Study|Could not swallow SmartPill|2|||
44242787|NCT01469819|79072213|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
44242788|NCT01507831|79072225|FG000|Overall Study|Randomized but not treated|0|||
44242789|NCT01507831|79072226|FG001|Overall Study|Randomized but not treated|3|||
44242790|NCT01507831|79072225|FG000|Overall Study|Adverse Event|48|||
44242791|NCT01507831|79072226|FG001|Overall Study|Adverse Event|113|||
44242792|NCT01507831|79072225|FG000|Overall Study|Death|6|||
44242793|NCT01507831|79072226|FG001|Overall Study|Death|2|||
44242794|NCT01507831|79072225|FG000|Overall Study|Poor compliance to protocol|38|||
44242795|NCT01507831|79072226|FG001|Overall Study|Poor compliance to protocol|60|||
44242796|NCT01507831|79072225|FG000|Overall Study|Physician Decision|0|||
44242797|NCT01507831|79072226|FG001|Overall Study|Physician Decision|4|||
44242798|NCT01507831|79072225|FG000|Overall Study|Participant moved|5|||
44242799|NCT01507831|79072226|FG001|Overall Study|Participant moved|19|||
44242800|NCT01507831|79072225|FG000|Overall Study|Consent withdrawn by participant|34|||
44242801|NCT01507831|79072226|FG001|Overall Study|Consent withdrawn by participant|72|||
44242802|NCT01507831|79072225|FG000|Overall Study|Related to study drug administration|5|||
44242803|NCT01507831|79072226|FG001|Overall Study|Related to study drug administration|14|||
44242804|NCT01507831|79072225|FG000|Overall Study|Last visit outside protocol visit window|51|||
44242805|NCT01507831|79072226|FG001|Overall Study|Last visit outside protocol visit window|143|||
44242806|NCT01507831|79072225|FG000|Overall Study|Selection criteria finally not met|0|||
44242807|NCT01507831|79072226|FG001|Overall Study|Selection criteria finally not met|1|||
44242808|NCT01507831|79072225|FG000|Overall Study|Site closure|0|||
44242809|NCT01507831|79072226|FG001|Overall Study|Site closure|3|||
44242810|NCT01507831|79072225|FG000|Overall Study|Potential lost to follow-up|3|||
44242811|NCT01507831|79072226|FG001|Overall Study|Potential lost to follow-up|0|||
44242812|NCT01507831|79072225|FG000|Overall Study|Other|3|||
44242813|NCT01507831|79072226|FG001|Overall Study|Other|6|||
44242814|NCT01479595|79072234|FG000|Overall Study|Protocol deviation|0|||
44242815|NCT01479595|79072235|FG001|Overall Study|Protocol deviation|1|||
44242816|NCT01479595|79072234|FG000|Overall Study|Adverse Event|2|||
44122677|NCT02496676|78906744|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
44242817|NCT01479595|79072235|FG001|Overall Study|Adverse Event|1|||
44242818|NCT01462357|79072244|FG000|Overall Study|Death|0|||
44242819|NCT01462357|79072245|FG001|Overall Study|Death|0|||
44242820|NCT01462357|79072246|FG002|Overall Study|Death|1|||
44242821|NCT01462357|79072244|FG000|Overall Study|Withdrawal by Subject|3|||
44242822|NCT01462357|79072245|FG001|Overall Study|Withdrawal by Subject|11|||
44242823|NCT01462357|79072246|FG002|Overall Study|Withdrawal by Subject|3|||
44242824|NCT01462357|79072244|FG000|Overall Study|Migrated/moved from study area|2|||
44122678|NCT02496676|78906745|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
44242825|NCT01462357|79072245|FG001|Overall Study|Migrated/moved from study area|3|||
44242826|NCT01462357|79072246|FG002|Overall Study|Migrated/moved from study area|1|||
44242827|NCT01462357|79072244|FG000|Overall Study|Lost to Follow-up|3|||
44242828|NCT01462357|79072245|FG001|Overall Study|Lost to Follow-up|5|||
44242829|NCT01462357|79072246|FG002|Overall Study|Lost to Follow-up|7|||
44122679|NCT02517268|78906761|FG000|Overall Study|Withdrawal by Subject|1|||
44122680|NCT02517268|78906762|FG001|Overall Study|Withdrawal by Subject|0|||
44122681|NCT01160211|78906771|FG000|Overall Study|ongoing|90|||
44122682|NCT01160211|78906772|FG001|Overall Study|ongoing|75|||
44122683|NCT01160211|78906773|FG002|Overall Study|ongoing|79|||
44122684|NCT01160211|78906771|FG000|Overall Study|Withdrawal by Subject|3|||
44122685|NCT01160211|78906772|FG001|Overall Study|Withdrawal by Subject|5|||
44122686|NCT01160211|78906773|FG002|Overall Study|Withdrawal by Subject|3|||
44122687|NCT01160211|78906771|FG000|Overall Study|Physician Decision|2|||
44122688|NCT01160211|78906772|FG001|Overall Study|Physician Decision|0|||
44122689|NCT01160211|78906773|FG002|Overall Study|Physician Decision|0|||
44242830|NCT01479439|79072257|FG000|Overall Study|Adverse Event|1|||
44242831|NCT01479439|79072258|FG001|Overall Study|Adverse Event|0|||
44242832|NCT01479439|79072259|FG002|Overall Study|Adverse Event|0|||
44242833|NCT01479439|79072257|FG000|Overall Study|Lost to Follow-up|0|||
44242834|NCT01479439|79072258|FG001|Overall Study|Lost to Follow-up|1|||
44242835|NCT01479439|79072259|FG002|Overall Study|Lost to Follow-up|0|||
44242836|NCT01479439|79072257|FG000|Overall Study|Protocol Violation|0|||
44242837|NCT01479439|79072258|FG001|Overall Study|Protocol Violation|0|||
44242838|NCT01479439|79072259|FG002|Overall Study|Protocol Violation|2|||
44242839|NCT01478971|79072270|FG000|Standard of Care Period|Adverse Event|1|||
44242840|NCT01478971|79072270|FG000|Standard of Care Period|Withdrawal by Subject|3|||
44242841|NCT01478971|79072270|FG000|Standard of Care Period|Death|8|||
44242842|NCT01478971|79072270|FG000|Standard of Care Period|Lost to Follow-up|9|||
44242843|NCT01478971|79072270|FG000|Standard of Care Period|Other|4|||
44242844|NCT01478971|79072270|FG000|Peginesatide Treatment Period|Adverse Event|1|||
44242845|NCT01478971|79072270|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
44276447|NCT02177136|79231081|FG000|LTSE Phase|Physician Decision|0|||
44276448|NCT02177136|79231082|FG001|LTSE Phase|Physician Decision|0|||
44510378|NCT00045942|79515507|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
44510379|NCT00045942|79515508|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
44510380|NCT00045942|79515500|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
44510381|NCT00045942|79515501|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
44510382|NCT00045942|79515502|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
44510383|NCT00045942|79515503|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
44510384|NCT00045942|79515504|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
44510385|NCT00045942|79515505|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
44510386|NCT00045942|79515506|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
44510387|NCT00045942|79515507|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
44510388|NCT00045942|79515508|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
44510389|NCT00045942|79515500|FG000|PKC412A2104E1|Lack of Efficacy|0|||
44510390|NCT00045942|79515501|FG001|PKC412A2104E1|Lack of Efficacy|11|||
44242846|NCT01478971|79072270|FG000|Peginesatide Treatment Period|Death|4|||
44242847|NCT01478971|79072270|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
44242848|NCT01478971|79072270|FG000|Peginesatide Treatment Period|Other|4|||
44242849|NCT01507051|79072282|FG000|Overall Study|Withdrawal by Subject|1|||
44242850|NCT01507051|79072283|FG001|Overall Study|Withdrawal by Subject|3|||
44510391|NCT00045942|79515502|FG002|PKC412A2104E1|Lack of Efficacy|11|||
44122690|NCT01160211|78906771|FG000|Overall Study|Lost to Follow-up|4|||
44122691|NCT01160211|78906772|FG001|Overall Study|Lost to Follow-up|7|||
44242851|NCT01507051|79072284|FG002|Overall Study|Withdrawal by Subject|1|||
44276449|NCT02177136|79231083|FG002|LTSE Phase|Physician Decision|0|||
44242852|NCT01507051|79072285|FG003|Overall Study|Withdrawal by Subject|6|||
44242853|NCT01507051|79072282|FG000|Overall Study|Physician Decision|0|||
44242854|NCT01507051|79072283|FG001|Overall Study|Physician Decision|0|||
44242855|NCT01507051|79072284|FG002|Overall Study|Physician Decision|0|||
44242856|NCT01507051|79072285|FG003|Overall Study|Physician Decision|1|||
44242857|NCT01507051|79072282|FG000|Overall Study|Adverse Event|1|||
44242858|NCT01507051|79072283|FG001|Overall Study|Adverse Event|0|||
44242859|NCT01507051|79072284|FG002|Overall Study|Adverse Event|0|||
44242860|NCT01507051|79072285|FG003|Overall Study|Adverse Event|0|||
44242861|NCT01478347|79072295|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
44242862|NCT01478347|79072295|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
44242863|NCT01478347|79072295|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
44242864|NCT01478113|79072301|FG000|Overall Study|Withdrawal by Subject|0|||
44242865|NCT01478113|79072302|FG001|Overall Study|Withdrawal by Subject|1|||
44242866|NCT01478113|79072301|FG000|Overall Study|Physician Decision|1|||
44242867|NCT01478113|79072302|FG001|Overall Study|Physician Decision|0|||
44242868|NCT01506271|79072313|FG000|Overall Study|Progressive disease|0|||
44242869|NCT01506271|79072314|FG001|Overall Study|Progressive disease|1|||
44242870|NCT01506271|79072315|FG002|Overall Study|Progressive disease|0|||
44242871|NCT01506271|79072313|FG000|Overall Study|Protocol Violation|3|||
44242872|NCT01506271|79072314|FG001|Overall Study|Protocol Violation|1|||
44242873|NCT01506271|79072315|FG002|Overall Study|Protocol Violation|0|||
44242874|NCT01506271|79072313|FG000|Overall Study|Death|0|||
44242875|NCT01506271|79072314|FG001|Overall Study|Death|1|||
44242876|NCT01506271|79072315|FG002|Overall Study|Death|0|||
44242877|NCT01506271|79072313|FG000|Overall Study|Adverse Event|0|||
44242878|NCT01506271|79072314|FG001|Overall Study|Adverse Event|2|||
44242879|NCT01506271|79072315|FG002|Overall Study|Adverse Event|0|||
44242880|NCT01506271|79072313|FG000|Overall Study|Insufficient supply of study drug|1|||
44242881|NCT01506271|79072314|FG001|Overall Study|Insufficient supply of study drug|0|||
44242882|NCT01506271|79072315|FG002|Overall Study|Insufficient supply of study drug|0|||
44242883|NCT01506271|79072313|FG000|Overall Study|Withdrawal by Subject|0|||
44242884|NCT01506271|79072314|FG001|Overall Study|Withdrawal by Subject|1|||
44242885|NCT01506271|79072315|FG002|Overall Study|Withdrawal by Subject|1|||
44242886|NCT01506271|79072313|FG000|Overall Study|Lost to Follow-up|0|||
44242887|NCT01506271|79072314|FG001|Overall Study|Lost to Follow-up|1|||
44242888|NCT01506271|79072315|FG002|Overall Study|Lost to Follow-up|2|||
44242889|NCT01506193|79072326|FG000|Overall Study|Protocol Violation|1|||
44242890|NCT01506193|79072327|FG001|Overall Study|Protocol Violation|0|||
44242891|NCT01506193|79072328|FG002|Overall Study|Protocol Violation|1|||
44242892|NCT01506193|79072326|FG000|Overall Study|Migrated/moved from study area|0|||
44242893|NCT01506193|79072327|FG001|Overall Study|Migrated/moved from study area|0|||
44379153|NCT00910728|79384813|FG001|Overall Study|Withdrawal by Subject|0|||
44379154|NCT00910728|79384814|FG002|Overall Study|Withdrawal by Subject|0|||
44242894|NCT01506193|79072328|FG002|Overall Study|Migrated/moved from study area|1|||
44242895|NCT01506193|79072326|FG000|Overall Study|Adverse event, non-fatal|0|||
44242896|NCT01506193|79072327|FG001|Overall Study|Adverse event, non-fatal|0|||
44242897|NCT01506193|79072328|FG002|Overall Study|Adverse event, non-fatal|1|||
44242898|NCT01506193|79072326|FG000|Overall Study|Withdrawal by Subject|5|||
44242899|NCT01506193|79072327|FG001|Overall Study|Withdrawal by Subject|1|||
44242900|NCT01506193|79072328|FG002|Overall Study|Withdrawal by Subject|8|||
44242901|NCT01506193|79072326|FG000|Overall Study|Lost to Follow-up|8|||
44242902|NCT01506193|79072327|FG001|Overall Study|Lost to Follow-up|3|||
44242903|NCT01506193|79072328|FG002|Overall Study|Lost to Follow-up|3|||
44242904|NCT01505881|79072339|FG000|Overall Study|Adverse Event|0|||
44242905|NCT01505881|79072340|FG001|Overall Study|Adverse Event|1|||
44242906|NCT01505881|79072339|FG000|Overall Study|Lost to Follow-up|2|||
44242907|NCT01505881|79072340|FG001|Overall Study|Lost to Follow-up|0|||
44242908|NCT01505881|79072339|FG000|Overall Study|Withdrawal by Subject|2|||
44242909|NCT01505881|79072340|FG001|Overall Study|Withdrawal by Subject|0|||
44242910|NCT01462045|79072350|FG000|Overall Study|Family matter|0|||
44242911|NCT01462045|79072351|FG001|Overall Study|Family matter|1|||
44510392|NCT00045942|79515503|FG003|PKC412A2104E1|Lack of Efficacy|23|||
44510393|NCT00045942|79515504|FG004|PKC412A2104E1|Lack of Efficacy|17|||
44510394|NCT00045942|79515505|FG005|PKC412A2104E1|Lack of Efficacy|0|||
44510395|NCT00045942|79515506|FG006|PKC412A2104E1|Lack of Efficacy|0|||
44510396|NCT00045942|79515507|FG007|PKC412A2104E1|Lack of Efficacy|0|||
44510397|NCT00045942|79515508|FG008|PKC412A2104E1|Lack of Efficacy|0|||
44510398|NCT00045942|79515500|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
44510399|NCT00045942|79515501|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
44510400|NCT00045942|79515502|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
44242912|NCT01462045|79072352|FG002|Overall Study|Family matter|0|||
44242913|NCT01505647|79072362|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
44242914|NCT01505647|79072363|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
44276450|NCT02177136|79231084|FG003|LTSE Phase|Physician Decision|2|||
44242915|NCT01505647|79072362|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
44242916|NCT01505647|79072363|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
44242917|NCT01505647|79072362|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
44242918|NCT01505647|79072363|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
44242919|NCT01505647|79072362|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
44242920|NCT01505647|79072363|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
44242921|NCT01505647|79072362|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
44242922|NCT01505647|79072363|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
44242923|NCT01461811|79072371|FG000|Overall Study|Adverse Event|2|||
44242924|NCT01461811|79072372|FG001|Overall Study|Adverse Event|1|||
44242925|NCT01461811|79072371|FG000|Overall Study|Subject decision unrelated to an AE|1|||
44242926|NCT01461811|79072372|FG001|Overall Study|Subject decision unrelated to an AE|1|||
44242927|NCT01461811|79072371|FG000|Overall Study|Noncompliance|1|||
44242928|NCT01461811|79072372|FG001|Overall Study|Noncompliance|1|||
44242929|NCT01505491|79072381|FG000|Overall Study|Other reason not listed|1|||
44242930|NCT01505491|79072382|FG001|Overall Study|Other reason not listed|0|||
44242931|NCT01505491|79072383|FG002|Overall Study|Other reason not listed|0|||
44242932|NCT01505491|79072381|FG000|Overall Study|Withdrawal by Subject|1|||
44242933|NCT01505491|79072382|FG001|Overall Study|Withdrawal by Subject|1|||
44242934|NCT01505491|79072383|FG002|Overall Study|Withdrawal by Subject|4|||
44242935|NCT01505491|79072381|FG000|Overall Study|Lost to Follow-up|0|||
44242936|NCT01505491|79072382|FG001|Overall Study|Lost to Follow-up|0|||
44242937|NCT01505491|79072383|FG002|Overall Study|Lost to Follow-up|1|||
44242938|NCT01504867|79072393|FG000|Overall Study|Inclusion criteria not met|2|||
44242939|NCT01504867|79072394|FG001|Overall Study|Inclusion criteria not met|2|||
44242940|NCT01504867|79072393|FG000|Overall Study|Consent revoked|5|||
44242941|NCT01504867|79072394|FG001|Overall Study|Consent revoked|1|||
44242942|NCT01476475|79072402|FG000|Overall Study|Adverse Event|6|||
44122692|NCT01160211|78906773|FG002|Overall Study|Lost to Follow-up|5|||
44122693|NCT01064687|78906786|FG000|Overall Study|Adverse Event|9|||
44122694|NCT01064687|78906787|FG001|Overall Study|Adverse Event|4|||
44122695|NCT01064687|78906788|FG002|Overall Study|Adverse Event|10|||
44122696|NCT01064687|78906789|FG003|Overall Study|Adverse Event|3|||
44122697|NCT01064687|78906786|FG000|Overall Study|Death|1|||
44122698|NCT01064687|78906787|FG001|Overall Study|Death|1|||
44122699|NCT01064687|78906788|FG002|Overall Study|Death|0|||
44122700|NCT01064687|78906789|FG003|Overall Study|Death|0|||
44122701|NCT01064687|78906786|FG000|Overall Study|Entry Criteria Not Met|3|||
44122702|NCT01064687|78906787|FG001|Overall Study|Entry Criteria Not Met|0|||
44122703|NCT01064687|78906788|FG002|Overall Study|Entry Criteria Not Met|0|||
44122704|NCT01064687|78906789|FG003|Overall Study|Entry Criteria Not Met|0|||
44122705|NCT01064687|78906786|FG000|Overall Study|Lack of Efficacy|1|||
44122706|NCT01064687|78906787|FG001|Overall Study|Lack of Efficacy|0|||
44122707|NCT01064687|78906788|FG002|Overall Study|Lack of Efficacy|2|||
44122708|NCT01064687|78906789|FG003|Overall Study|Lack of Efficacy|3|||
44122709|NCT01064687|78906786|FG000|Overall Study|Lost to Follow-up|7|||
44122710|NCT01064687|78906787|FG001|Overall Study|Lost to Follow-up|10|||
44122711|NCT01064687|78906788|FG002|Overall Study|Lost to Follow-up|13|||
44122712|NCT01064687|78906789|FG003|Overall Study|Lost to Follow-up|5|||
44122713|NCT01064687|78906786|FG000|Overall Study|Physician Decision|2|||
44122714|NCT01064687|78906787|FG001|Overall Study|Physician Decision|2|||
44122715|NCT01064687|78906788|FG002|Overall Study|Physician Decision|0|||
44122716|NCT01064687|78906789|FG003|Overall Study|Physician Decision|0|||
44122717|NCT01064687|78906786|FG000|Overall Study|Protocol Violation|1|||
44122718|NCT01064687|78906787|FG001|Overall Study|Protocol Violation|1|||
44242943|NCT01476475|79072403|FG001|Overall Study|Adverse Event|0|||
44242944|NCT01476475|79072402|FG000|Overall Study|Poor compliance to protocol|1|||
44242945|NCT01476475|79072403|FG001|Overall Study|Poor compliance to protocol|1|||
44242946|NCT01476475|79072402|FG000|Overall Study|Other reasons|4|||
44122719|NCT01064687|78906788|FG002|Overall Study|Protocol Violation|0|||
44122720|NCT01064687|78906789|FG003|Overall Study|Protocol Violation|1|||
44122721|NCT01064687|78906786|FG000|Overall Study|Sponsor Decision|0|||
44122722|NCT01064687|78906787|FG001|Overall Study|Sponsor Decision|0|||
44242947|NCT01476475|79072403|FG001|Overall Study|Other reasons|2|||
44242948|NCT01475851|79072412|FG000|Overall Study|Protocol defined stopping criteria|1|||
44242949|NCT01475851|79072413|FG001|Overall Study|Protocol defined stopping criteria|0|||
44242950|NCT01460719|79072419|FG000|Overall Study|Adverse Event|1|||
44242951|NCT01460719|79072419|FG000|Overall Study|Withdrawal by Subject|1|||
44242952|NCT01468181|79072489|FG000|Overall Study|Adverse Event|8|||
44122723|NCT01064687|78906788|FG002|Overall Study|Sponsor Decision|3|||
44122724|NCT01064687|78906789|FG003|Overall Study|Sponsor Decision|0|||
44122725|NCT01064687|78906786|FG000|Overall Study|Withdrawal by Subject|9|||
44122726|NCT01064687|78906787|FG001|Overall Study|Withdrawal by Subject|7|||
44122727|NCT01064687|78906788|FG002|Overall Study|Withdrawal by Subject|12|||
44122728|NCT01064687|78906789|FG003|Overall Study|Withdrawal by Subject|5|||
44122729|NCT01064687|78906786|FG000|Overall Study|Treatment Noncompliance|1|||
44242953|NCT01468181|79072490|FG001|Overall Study|Adverse Event|1|||
44242954|NCT01468181|79072491|FG002|Overall Study|Adverse Event|6|||
44122730|NCT01064687|78906787|FG001|Overall Study|Treatment Noncompliance|1|||
44122731|NCT01064687|78906788|FG002|Overall Study|Treatment Noncompliance|1|||
44122732|NCT01064687|78906789|FG003|Overall Study|Treatment Noncompliance|0|||
44122733|NCT02493946|78906813|FG000|DB Period|Withdrawal by Subject|8|||
44122734|NCT02493946|78906814|FG001|DB Period|Withdrawal by Subject|5|||
44122735|NCT02493946|78906815|FG002|DB Period|Withdrawal by Subject|0|||
44122736|NCT02493946|78906813|FG000|Open Label Period|Withdrawal by Subject|0|||
44122737|NCT02493946|78906814|FG001|Open Label Period|Withdrawal by Subject|0|||
44122738|NCT02493946|78906815|FG002|Open Label Period|Withdrawal by Subject|74|||
44122739|NCT02493946|78906813|FG000|Open Label Period|Adverse Event|0|||
44122740|NCT02493946|78906814|FG001|Open Label Period|Adverse Event|0|||
44122741|NCT02493946|78906815|FG002|Open Label Period|Adverse Event|4|||
44122742|NCT02493946|78906813|FG000|Open Label Period|Lost to Follow-up|0|||
44122743|NCT02493946|78906814|FG001|Open Label Period|Lost to Follow-up|0|||
44122744|NCT02493946|78906815|FG002|Open Label Period|Lost to Follow-up|1|||
44122745|NCT02493946|78906813|FG000|Open Label Period|Investigator decision, non-compliance|0|||
44122746|NCT02493946|78906814|FG001|Open Label Period|Investigator decision, non-compliance|0|||
44122747|NCT02493946|78906815|FG002|Open Label Period|Investigator decision, non-compliance|2|||
44122748|NCT02493946|78906813|FG000|Open Label Period|Investigator decision, non-availability|0|||
44122749|NCT02493946|78906814|FG001|Open Label Period|Investigator decision, non-availability|0|||
44122750|NCT02493946|78906815|FG002|Open Label Period|Investigator decision, non-availability|1|||
44122751|NCT02493946|78906813|FG000|Open Label Period|Pregnancy|0|||
44122752|NCT02493946|78906814|FG001|Open Label Period|Pregnancy|0|||
44242955|NCT01468181|79072492|FG003|Overall Study|Adverse Event|2|||
44122753|NCT02493946|78906815|FG002|Open Label Period|Pregnancy|3|||
44122754|NCT02493946|78906813|FG000|Open Label Period|Site error|0|||
44122755|NCT02493946|78906814|FG001|Open Label Period|Site error|0|||
44122756|NCT02493946|78906815|FG002|Open Label Period|Site error|1|||
44122757|NCT01064531|78906825|FG000|Overall Study|Lost to Follow-up|0|||
44122758|NCT01064531|78906826|FG001|Overall Study|Lost to Follow-up|2|||
44122759|NCT01064531|78906825|FG000|Overall Study|Physician Decision|0|||
44122760|NCT01064531|78906826|FG001|Overall Study|Physician Decision|1|||
44122761|NCT01064531|78906825|FG000|Overall Study|Withdrawal by Subject|2|||
44122762|NCT01064531|78906826|FG001|Overall Study|Withdrawal by Subject|2|||
44122763|NCT01064531|78906825|FG000|Overall Study|Revision due to femoral stem loosening|1|||
44122764|NCT01064531|78906826|FG001|Overall Study|Revision due to femoral stem loosening|0|||
44242956|NCT01468181|79072493|FG004|Overall Study|Adverse Event|2|||
44276451|NCT02177136|79231081|FG000|LTSE Phase|Lost to Follow-up|0|||
44510401|NCT00045942|79515503|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
44510402|NCT00045942|79515504|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
44510403|NCT00045942|79515505|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
44510404|NCT00045942|79515506|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
44510405|NCT00045942|79515507|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
44510406|NCT00045942|79515508|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
44510407|NCT00045942|79515500|FG000|PKC412A2104E1|Adverse Event|0|||
44510408|NCT00045942|79515501|FG001|PKC412A2104E1|Adverse Event|1|||
44510409|NCT00045942|79515502|FG002|PKC412A2104E1|Adverse Event|1|||
44510410|NCT00045942|79515503|FG003|PKC412A2104E1|Adverse Event|3|||
44510411|NCT00045942|79515504|FG004|PKC412A2104E1|Adverse Event|6|||
44510412|NCT00045942|79515505|FG005|PKC412A2104E1|Adverse Event|0|||
44510413|NCT00045942|79515506|FG006|PKC412A2104E1|Adverse Event|0|||
44510414|NCT00045942|79515507|FG007|PKC412A2104E1|Adverse Event|0|||
44510415|NCT00045942|79515508|FG008|PKC412A2104E1|Adverse Event|0|||
44510416|NCT00045942|79515500|FG000|PKC412A2104E1|Death|0|||
44510417|NCT00045942|79515501|FG001|PKC412A2104E1|Death|4|||
44122765|NCT01064531|78906825|FG000|Overall Study|Revision due to dislocation|0|||
44122766|NCT01064531|78906826|FG001|Overall Study|Revision due to dislocation|1|||
44510418|NCT00045942|79515502|FG002|PKC412A2104E1|Death|1|||
44122767|NCT01064531|78906825|FG000|Overall Study|Death|0|||
44122768|NCT01064531|78906826|FG001|Overall Study|Death|1|||
44276452|NCT02177136|79231082|FG001|LTSE Phase|Lost to Follow-up|0|||
44276453|NCT02177136|79231083|FG002|LTSE Phase|Lost to Follow-up|0|||
44510419|NCT00045942|79515503|FG003|PKC412A2104E1|Death|1|||
44122769|NCT02220855|78906832|FG000|Overall Study|Adverse Event|8|||
44242957|NCT01468181|79072489|FG000|Overall Study|Protocol Violation|2|||
44242958|NCT01468181|79072490|FG001|Overall Study|Protocol Violation|0|||
44510420|NCT00045942|79515504|FG004|PKC412A2104E1|Death|1|||
44122770|NCT02220855|78906832|FG000|Overall Study|Disease Progression|5|||
44122771|NCT02220855|78906832|FG000|Overall Study|Withdrawal by Subject|1|||
44122772|NCT02918279|78906838|FG000|Overall Study|Lost to Follow-up|3|||
44122773|NCT02918279|78906839|FG001|Overall Study|Lost to Follow-up|6|||
44122774|NCT02918279|78906838|FG000|Overall Study|Withdrawal by Subject|5|||
44122775|NCT02918279|78906839|FG001|Overall Study|Withdrawal by Subject|15|||
44122776|NCT02918279|78906838|FG000|Overall Study|Withdrawal by parent/guardian|2|||
44122777|NCT02918279|78906839|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44122778|NCT02918279|78906838|FG000|Overall Study|Other|3|||
44122779|NCT02918279|78906839|FG001|Overall Study|Other|1|||
44122780|NCT04268745|78906847|FG000|Overall Study|Lost to Follow-up|2|||
44122781|NCT04268745|78906848|FG001|Overall Study|Lost to Follow-up|3|||
44122782|NCT04268745|78906847|FG000|Overall Study|Withdrawal by Subject|4|||
44122783|NCT04268745|78906848|FG001|Overall Study|Withdrawal by Subject|2|||
44122784|NCT04268745|78906847|FG000|Overall Study|Death in the family|1|||
44122785|NCT04268745|78906848|FG001|Overall Study|Death in the family|0|||
44122786|NCT02956837|78906858|FG000|Overall Study|Serious Adverse Events|0|||
44122787|NCT02956837|78906859|FG001|Overall Study|Serious Adverse Events|1|||
44122788|NCT02956837|78906860|FG002|Overall Study|Serious Adverse Events|0|||
44122789|NCT02956837|78906861|FG003|Overall Study|Serious Adverse Events|0|||
44122790|NCT02956837|78906858|FG000|Overall Study|Withdrawal by Subject|0|||
44122791|NCT02956837|78906859|FG001|Overall Study|Withdrawal by Subject|1|||
44242959|NCT01468181|79072491|FG002|Overall Study|Protocol Violation|1|||
44242960|NCT01468181|79072492|FG003|Overall Study|Protocol Violation|0|||
44242961|NCT01468181|79072493|FG004|Overall Study|Protocol Violation|1|||
44242962|NCT01468181|79072489|FG000|Overall Study|Physician Decision|0|||
44242963|NCT01468181|79072490|FG001|Overall Study|Physician Decision|0|||
44242964|NCT01468181|79072491|FG002|Overall Study|Physician Decision|0|||
44379155|NCT00910728|79384815|FG003|Overall Study|Withdrawal by Subject|0|||
44379156|NCT00910728|79384816|FG004|Overall Study|Withdrawal by Subject|3|||
44379157|NCT00910728|79384817|FG005|Overall Study|Withdrawal by Subject|1|||
44510421|NCT00045942|79515505|FG005|PKC412A2104E1|Death|0|||
44510422|NCT00045942|79515506|FG006|PKC412A2104E1|Death|0|||
44510423|NCT00045942|79515507|FG007|PKC412A2104E1|Death|0|||
44510424|NCT00045942|79515508|FG008|PKC412A2104E1|Death|0|||
44510425|NCT00045942|79515500|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510426|NCT00045942|79515501|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510427|NCT00045942|79515502|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
44510428|NCT00045942|79515503|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
44510429|NCT00045942|79515504|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510430|NCT00045942|79515505|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510431|NCT00045942|79515506|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510432|NCT00045942|79515507|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510433|NCT00045942|79515508|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
44510434|NCT00045942|79515500|FG000|PKC412A2104E2|Lost to Follow-up|0|||
44510435|NCT00045942|79515501|FG001|PKC412A2104E2|Lost to Follow-up|0|||
44510436|NCT00045942|79515502|FG002|PKC412A2104E2|Lost to Follow-up|0|||
44510437|NCT00045942|79515503|FG003|PKC412A2104E2|Lost to Follow-up|0|||
44510438|NCT00045942|79515504|FG004|PKC412A2104E2|Lost to Follow-up|0|||
44122792|NCT02956837|78906860|FG002|Overall Study|Withdrawal by Subject|0|||
44122793|NCT02956837|78906861|FG003|Overall Study|Withdrawal by Subject|3|||
44122794|NCT02956837|78906858|FG000|Overall Study|Lost to Follow-up|0|||
44122795|NCT02956837|78906859|FG001|Overall Study|Lost to Follow-up|1|||
44122796|NCT02956837|78906860|FG002|Overall Study|Lost to Follow-up|2|||
44122797|NCT02956837|78906861|FG003|Overall Study|Lost to Follow-up|0|||
44379158|NCT00910728|79384818|FG006|Overall Study|Withdrawal by Subject|2|||
44510439|NCT00045942|79515505|FG005|PKC412A2104E2|Lost to Follow-up|0|||
44510440|NCT00045942|79515506|FG006|PKC412A2104E2|Lost to Follow-up|0|||
44510441|NCT00045942|79515507|FG007|PKC412A2104E2|Lost to Follow-up|3|||
44122798|NCT01063595|78906874|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
44122799|NCT01063595|78906875|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
44122800|NCT01063595|78906874|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
44122801|NCT01063595|78906875|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
44242965|NCT01468181|79072492|FG003|Overall Study|Physician Decision|1|||
44379159|NCT00910728|79384819|FG007|Overall Study|Withdrawal by Subject|0|||
44242966|NCT01468181|79072493|FG004|Overall Study|Physician Decision|1|||
44242967|NCT01468181|79072489|FG000|Overall Study|Lost to Follow-up|0|||
44242968|NCT01468181|79072490|FG001|Overall Study|Lost to Follow-up|0|||
44242969|NCT01468181|79072491|FG002|Overall Study|Lost to Follow-up|1|||
44242970|NCT01468181|79072492|FG003|Overall Study|Lost to Follow-up|0|||
44242971|NCT01468181|79072493|FG004|Overall Study|Lost to Follow-up|1|||
44242972|NCT01468181|79072489|FG000|Overall Study|Withdrawal by Subject|0|||
44242973|NCT01468181|79072490|FG001|Overall Study|Withdrawal by Subject|1|||
44242974|NCT01468181|79072491|FG002|Overall Study|Withdrawal by Subject|0|||
44242975|NCT01468181|79072492|FG003|Overall Study|Withdrawal by Subject|0|||
44242976|NCT01468181|79072493|FG004|Overall Study|Withdrawal by Subject|0|||
44242977|NCT01693562|79072528|FG000|Escalation Phase|Withdrawal by Subject|0|||
44242978|NCT01693562|79072529|FG001|Escalation Phase|Withdrawal by Subject|1|||
44242979|NCT01693562|79072530|FG002|Escalation Phase|Withdrawal by Subject|0|||
44242980|NCT01693562|79072531|FG003|Escalation Phase|Withdrawal by Subject|0|||
44242981|NCT01693562|79072532|FG004|Escalation Phase|Withdrawal by Subject|0|||
44242982|NCT01693562|79072533|FG005|Escalation Phase|Withdrawal by Subject|2|||
44242983|NCT01693562|79072534|FG006|Escalation Phase|Withdrawal by Subject|0|||
44122802|NCT01063595|78906874|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
44122803|NCT01063595|78906875|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
44122804|NCT01063595|78906874|FG000|First Intervention|Adverse Event|1|||
44122805|NCT01063595|78906875|FG001|First Intervention|Adverse Event|4|||
44122806|NCT01063595|78906874|FG000|First Intervention|Withdrawal by Subject|1|||
44122807|NCT01063595|78906875|FG001|First Intervention|Withdrawal by Subject|0|||
44122808|NCT01063595|78906874|FG000|First Intervention|Reason not Specified|0|||
44122809|NCT01063595|78906875|FG001|First Intervention|Reason not Specified|1|||
44122810|NCT01063283|78906883|FG000|Cycle 1|Adverse Event|2|||
44242984|NCT01693562|79072535|FG007|Escalation Phase|Withdrawal by Subject|0|||
44242985|NCT01693562|79072536|FG008|Escalation Phase|Withdrawal by Subject|0|||
44242986|NCT01693562|79072537|FG009|Escalation Phase|Withdrawal by Subject|0|||
44242987|NCT01693562|79072538|FG010|Escalation Phase|Withdrawal by Subject|0|||
44242988|NCT01693562|79072539|FG011|Escalation Phase|Withdrawal by Subject|0|||
44242989|NCT01693562|79072540|FG012|Escalation Phase|Withdrawal by Subject|0|||
44379160|NCT00910728|79384820|FG008|Overall Study|Withdrawal by Subject|0|||
44122811|NCT01063283|78906884|FG001|Cycle 1|Adverse Event|0|||
44122812|NCT01063283|78906885|FG002|Cycle 1|Adverse Event|0|||
44379161|NCT00910728|79384812|FG000|Overall Study|(not specified)|2|||
44379162|NCT00910728|79384813|FG001|Overall Study|(not specified)|0|||
44379163|NCT00910728|79384814|FG002|Overall Study|(not specified)|1|||
44379164|NCT00910728|79384815|FG003|Overall Study|(not specified)|0|||
44379165|NCT00910728|79384816|FG004|Overall Study|(not specified)|1|||
44379166|NCT00910728|79384817|FG005|Overall Study|(not specified)|0|||
44122813|NCT01063283|78906883|FG000|Cycle 1|Technical failure in data collection|1|||
44122814|NCT01063283|78906884|FG001|Cycle 1|Technical failure in data collection|0|||
44122815|NCT01063283|78906885|FG002|Cycle 1|Technical failure in data collection|0|||
44122816|NCT01062971|78906893|FG000|Overall Study|Protocol Violation|1|||
44122817|NCT01062971|78906894|FG001|Overall Study|Protocol Violation|3|||
44122818|NCT01062971|78906893|FG000|Overall Study|Lost to Follow-up|3|||
44122819|NCT01062971|78906894|FG001|Overall Study|Lost to Follow-up|4|||
44242990|NCT01693562|79072541|FG013|Escalation Phase|Withdrawal by Subject|0|||
44379167|NCT00910728|79384818|FG006|Overall Study|(not specified)|0|||
44510442|NCT00045942|79515508|FG008|PKC412A2104E2|Lost to Follow-up|0|||
44510443|NCT00045942|79515500|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
44510444|NCT00045942|79515501|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
44510445|NCT00045942|79515502|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
44510446|NCT00045942|79515503|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
44510447|NCT00045942|79515504|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
44510448|NCT00045942|79515505|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
44510449|NCT00045942|79515506|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
44122820|NCT01348165|78906907|FG000|Overall Study|Adverse Event|0|||
44379168|NCT00910728|79384819|FG007|Overall Study|(not specified)|0|||
44379169|NCT00910728|79384820|FG008|Overall Study|(not specified)|0|||
44379170|NCT00910728|79384812|FG000|Overall Study|Adverse Event|2|||
44510450|NCT00045942|79515507|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
44242991|NCT01693562|79072542|FG014|Escalation Phase|Withdrawal by Subject|0|||
44242992|NCT01693562|79072543|FG015|Escalation Phase|Withdrawal by Subject|0|||
44242993|NCT01693562|79072544|FG016|Escalation Phase|Withdrawal by Subject|0|||
44242994|NCT01693562|79072545|FG017|Escalation Phase|Withdrawal by Subject|0|||
44242995|NCT01693562|79072546|FG018|Escalation Phase|Withdrawal by Subject|0|||
44122821|NCT01348165|78906908|FG001|Overall Study|Adverse Event|0|||
44122822|NCT01348165|78906909|FG002|Overall Study|Adverse Event|0|||
44122823|NCT01348165|78906910|FG003|Overall Study|Adverse Event|0|||
44122824|NCT01348165|78906911|FG004|Overall Study|Adverse Event|0|||
44122825|NCT01348165|78906912|FG005|Overall Study|Adverse Event|0|||
44122826|NCT01348165|78906913|FG006|Overall Study|Adverse Event|1|||
44122827|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Adverse Event|22|||
44122828|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Adverse Event|0|||
44122829|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
44122830|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
44122831|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
44122832|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
44122833|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
44122834|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
44122835|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
44122836|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
44122837|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
44122838|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
44122839|NCT02493868|78906933|FG000|Induction Phase: DE Participants|Other|8|||
44122840|NCT02493868|78906934|FG001|Induction Phase: DE Participants|Other|0|||
44122841|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
44122842|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
44122843|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
44122844|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
44122845|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
44122846|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
44122847|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
44122848|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
44122849|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
44122850|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
44122851|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
44122852|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
44122853|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
44122854|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
44122855|NCT02493868|78906933|FG000|Optimization Phase: DE+TE Participants|Other|10|||
44122856|NCT02493868|78906934|FG001|Optimization Phase: DE+TE Participants|Other|2|||
44122857|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
44122858|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
44122859|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
44122860|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
44122861|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
44122862|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
44122863|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
44122864|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
44122865|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
44122866|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
44122867|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
44122868|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
44242996|NCT01693562|79072547|FG019|Escalation Phase|Withdrawal by Subject|0|||
44242997|NCT01693562|79072548|FG020|Escalation Phase|Withdrawal by Subject|0|||
44242998|NCT01693562|79072549|FG021|Escalation Phase|Withdrawal by Subject|0|||
44242999|NCT01693562|79072550|FG022|Escalation Phase|Withdrawal by Subject|0|||
44243000|NCT01693562|79072528|FG000|Escalation Phase|Death|4|||
44243001|NCT01693562|79072529|FG001|Escalation Phase|Death|2|||
44122869|NCT02493868|78906933|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
44122870|NCT02493868|78906934|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
44122871|NCT02493868|78906933|FG000|Follow-up Phase|Lost to Follow-up|1|||
44122872|NCT02493868|78906934|FG001|Follow-up Phase|Lost to Follow-up|0|||
44122873|NCT02493868|78906933|FG000|Follow-up Phase|Withdrawal by Subject|3|||
44122874|NCT02493868|78906934|FG001|Follow-up Phase|Withdrawal by Subject|0|||
44122875|NCT02493868|78906933|FG000|Follow-up Phase|Investigator Decision|5|||
44122876|NCT02493868|78906934|FG001|Follow-up Phase|Investigator Decision|1|||
44122877|NCT02493868|78906933|FG000|Follow-up Phase|Other|2|||
44122878|NCT02493868|78906934|FG001|Follow-up Phase|Other|1|||
44122879|NCT02516410|78906948|FG000|Overall Study|Adverse Event|0|||
44510451|NCT00045942|79515508|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
44510452|NCT00045942|79515500|FG000|PKC412A2104E2|Lack of Efficacy|0|||
44510453|NCT00045942|79515501|FG001|PKC412A2104E2|Lack of Efficacy|0|||
44510454|NCT00045942|79515502|FG002|PKC412A2104E2|Lack of Efficacy|0|||
44510455|NCT00045942|79515503|FG003|PKC412A2104E2|Lack of Efficacy|0|||
44510456|NCT00045942|79515504|FG004|PKC412A2104E2|Lack of Efficacy|0|||
44510457|NCT00045942|79515505|FG005|PKC412A2104E2|Lack of Efficacy|3|||
44510458|NCT00045942|79515506|FG006|PKC412A2104E2|Lack of Efficacy|2|||
44510459|NCT00045942|79515507|FG007|PKC412A2104E2|Lack of Efficacy|2|||
44510460|NCT00045942|79515508|FG008|PKC412A2104E2|Lack of Efficacy|6|||
44510461|NCT00045942|79515500|FG000|PKC412A2104E2|Adverse Event|0|||
44510462|NCT00045942|79515501|FG001|PKC412A2104E2|Adverse Event|0|||
44510463|NCT00045942|79515502|FG002|PKC412A2104E2|Adverse Event|0|||
44510464|NCT00045942|79515503|FG003|PKC412A2104E2|Adverse Event|0|||
44510465|NCT00045942|79515504|FG004|PKC412A2104E2|Adverse Event|0|||
44510466|NCT00045942|79515505|FG005|PKC412A2104E2|Adverse Event|4|||
44510467|NCT00045942|79515506|FG006|PKC412A2104E2|Adverse Event|3|||
44122880|NCT02516410|78906949|FG001|Overall Study|Adverse Event|1|||
44122881|NCT02516410|78906948|FG000|Overall Study|Withdrawal by Subject|0|||
44122882|NCT02516410|78906949|FG001|Overall Study|Withdrawal by Subject|1|||
44122883|NCT02493712|78906959|FG000|Overall Study|Withdrawal by Subject|1|||
44510468|NCT00045942|79515507|FG007|PKC412A2104E2|Adverse Event|1|||
44510469|NCT00045942|79515508|FG008|PKC412A2104E2|Adverse Event|0|||
44510470|NCT00045942|79515500|FG000|PKC412A2104E2|Death|0|||
44510471|NCT00045942|79515501|FG001|PKC412A2104E2|Death|0|||
44122884|NCT02493712|78906960|FG001|Overall Study|Withdrawal by Subject|0|||
44510472|NCT00045942|79515502|FG002|PKC412A2104E2|Death|0|||
44122885|NCT02493712|78906961|FG002|Overall Study|Withdrawal by Subject|2|||
44122886|NCT02493712|78906959|FG000|Overall Study|Protocol Violation|0|||
44122887|NCT02493712|78906960|FG001|Overall Study|Protocol Violation|0|||
44122888|NCT02493712|78906961|FG002|Overall Study|Protocol Violation|1|||
44122889|NCT02493712|78906959|FG000|Overall Study|Lost to Follow-up|1|||
44122890|NCT02493712|78906960|FG001|Overall Study|Lost to Follow-up|0|||
44122891|NCT02493712|78906961|FG002|Overall Study|Lost to Follow-up|0|||
44122892|NCT02493712|78906959|FG000|Overall Study|Physician Decision|0|||
44122893|NCT02493712|78906960|FG001|Overall Study|Physician Decision|1|||
44122894|NCT02493712|78906961|FG002|Overall Study|Physician Decision|0|||
44122895|NCT02493712|78906959|FG000|Overall Study|Lack of Efficacy|0|||
44122896|NCT02493712|78906960|FG001|Overall Study|Lack of Efficacy|5|||
44122897|NCT02493712|78906961|FG002|Overall Study|Lack of Efficacy|3|||
44122898|NCT02516332|78906972|FG000|Overall Study|Withdrawal by Subject|2|||
44122899|NCT02516332|78906973|FG001|Overall Study|Withdrawal by Subject|1|||
44122900|NCT02516332|78906974|FG002|Overall Study|Withdrawal by Subject|2|||
44122901|NCT02483572|78906984|FG000|Overall Study|Withdrawal by Subject|1|||
44510473|NCT00045942|79515503|FG003|PKC412A2104E2|Death|0|||
44510474|NCT00045942|79515504|FG004|PKC412A2104E2|Death|0|||
44510475|NCT00045942|79515505|FG005|PKC412A2104E2|Death|1|||
44510476|NCT00045942|79515506|FG006|PKC412A2104E2|Death|2|||
44510477|NCT00045942|79515507|FG007|PKC412A2104E2|Death|0|||
44510478|NCT00045942|79515508|FG008|PKC412A2104E2|Death|0|||
44510479|NCT04386616|79515535|FG000|Overall Study|Death|22|||
44510480|NCT04386616|79515536|FG001|Overall Study|Death|22|||
44510481|NCT04386616|79515537|FG002|Overall Study|Death|21|||
44510482|NCT04386616|79515535|FG000|Overall Study|Lost to Follow-up|5|||
44510483|NCT04386616|79515536|FG001|Overall Study|Lost to Follow-up|8|||
44122902|NCT02483572|78906985|FG001|Overall Study|Withdrawal by Subject|0|||
44122903|NCT02483572|78906984|FG000|Overall Study|Lost to Follow-up|1|||
44122904|NCT02483572|78906985|FG001|Overall Study|Lost to Follow-up|0|||
44122905|NCT02483572|78906984|FG000|Overall Study|Physician Decision|0|||
44122906|NCT02483572|78906985|FG001|Overall Study|Physician Decision|1|||
44510484|NCT04386616|79515537|FG002|Overall Study|Lost to Follow-up|6|||
44122907|NCT01062425|78906993|FG000|Overall Study|Protocol Violation|3|||
44122908|NCT01062425|78906994|FG001|Overall Study|Protocol Violation|6|||
44122909|NCT01060553|78907000|FG000|Overall Study|Lost to Follow-up|3|||
44122910|NCT01060553|78907001|FG001|Overall Study|Lost to Follow-up|5|||
44122911|NCT01060553|78907000|FG000|Overall Study|Withdrawal by Subject|5|||
44122912|NCT01060553|78907001|FG001|Overall Study|Withdrawal by Subject|5|||
44122913|NCT01060553|78907000|FG000|Overall Study|Lack of Efficacy|1|||
44122914|NCT01060553|78907001|FG001|Overall Study|Lack of Efficacy|0|||
44122915|NCT02491684|78907008|FG000|Treatment Phase|Adverse Event|2|||
44122916|NCT02491684|78907009|FG001|Treatment Phase|Adverse Event|2|||
44122917|NCT02491684|78907008|FG000|Treatment Phase|Incorrect randomisation|1|||
44122918|NCT02491684|78907009|FG001|Treatment Phase|Incorrect randomisation|0|||
44122919|NCT02491684|78907008|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
44122920|NCT02491684|78907009|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
44122921|NCT01061723|78907021|FG000|Overall Study|Adverse Event|0|||
44122922|NCT01061723|78907022|FG001|Overall Study|Adverse Event|2|||
44122923|NCT01061723|78907023|FG002|Overall Study|Adverse Event|5|||
44122924|NCT01061723|78907024|FG003|Overall Study|Adverse Event|5|||
44122925|NCT01061723|78907025|FG004|Overall Study|Adverse Event|2|||
44122926|NCT01061723|78907026|FG005|Overall Study|Adverse Event|6|||
44122927|NCT01061723|78907021|FG000|Overall Study|Lack of Efficacy|2|||
44122928|NCT01061723|78907022|FG001|Overall Study|Lack of Efficacy|3|||
44122929|NCT01061723|78907023|FG002|Overall Study|Lack of Efficacy|4|||
44379171|NCT00910728|79384813|FG001|Overall Study|Adverse Event|0|||
44510485|NCT04386616|79515535|FG000|Overall Study|Withdrawal by Subject|2|||
44510486|NCT04386616|79515536|FG001|Overall Study|Withdrawal by Subject|4|||
44510487|NCT04386616|79515537|FG002|Overall Study|Withdrawal by Subject|1|||
44510488|NCT04386616|79515535|FG000|Overall Study|Adverse Event|1|||
44510489|NCT04386616|79515536|FG001|Overall Study|Adverse Event|1|||
44510490|NCT04386616|79515537|FG002|Overall Study|Adverse Event|0|||
44510491|NCT00045708|79515557|FG000|Phase 1|early progressive disease|0|||
44510492|NCT00045708|79515558|FG001|Phase 1|early progressive disease|1|||
44510493|NCT00045708|79515559|FG002|Phase 1|early progressive disease|0|||
44510494|NCT00045630|79515576|FG000|Overall Study|Adverse Event|1|||
44510495|NCT00045630|79515576|FG000|Overall Study|Refusal unrelated to adverse event|1|||
44510496|NCT00045630|79515576|FG000|Overall Study|Progression/relapse|1|||
44510497|NCT00045630|79515576|FG000|Overall Study|Death|1|||
44510498|NCT00045630|79515576|FG000|Overall Study|Ineligible|2|||
44510499|NCT00003702|79515582|FG000|Overall Study|Ineligible cell types|2|||
44510500|NCT00003702|79515583|FG001|Overall Study|Ineligible cell types|2|||
44510501|NCT00003702|79515582|FG000|Overall Study|Did not meet criteria for persistence|8|||
44510502|NCT00003702|79515583|FG001|Overall Study|Did not meet criteria for persistence|5|||
44510503|NCT00003702|79515582|FG000|Overall Study|WHO score > 6|2|||
44510504|NCT00003702|79515583|FG001|Overall Study|WHO score > 6|1|||
44510505|NCT00003702|79515582|FG000|Overall Study|Inadequate documentation of disease|1|||
44510506|NCT00003702|79515583|FG001|Overall Study|Inadequate documentation of disease|3|||
44510507|NCT00031590|79515590|FG000|Overall Study|Adverse Event|1|||
44510508|NCT00031590|79515590|FG000|Overall Study|Withdrawal by parents|2|||
44510509|NCT00239681|79515597|FG000|Overall Study|Adverse Event|100|||
44510510|NCT00239681|79515598|FG001|Overall Study|Adverse Event|99|||
44510511|NCT00239681|79515597|FG000|Overall Study|Withdrawal by Subject|458|||
44510512|NCT00239681|79515598|FG001|Overall Study|Withdrawal by Subject|489|||
44510513|NCT00239681|79515597|FG000|Overall Study|Lost to Follow-up|28|||
44510514|NCT00239681|79515598|FG001|Overall Study|Lost to Follow-up|22|||
44510515|NCT00239681|79515597|FG000|Overall Study|Protocol Violation|4|||
44510516|NCT00239681|79515598|FG001|Overall Study|Protocol Violation|4|||
44510517|NCT00239681|79515597|FG000|Overall Study|Physician Decision|13|||
44510518|NCT00239681|79515598|FG001|Overall Study|Physician Decision|17|||
44510519|NCT00239681|79515597|FG000|Overall Study|No information chacked on CaseReportForm|90|||
44510520|NCT00239681|79515598|FG001|Overall Study|No information chacked on CaseReportForm|84|||
44510521|NCT02878330|79515606|FG000|Overall Study|Death|3|||
44510522|NCT02878330|79515607|FG001|Overall Study|Death|2|||
44122930|NCT01061723|78907024|FG003|Overall Study|Lack of Efficacy|2|||
44122931|NCT01061723|78907025|FG004|Overall Study|Lack of Efficacy|1|||
44122932|NCT01061723|78907026|FG005|Overall Study|Lack of Efficacy|1|||
44122933|NCT01061723|78907021|FG000|Overall Study|Randomized but not treated|0|||
44122934|NCT01061723|78907022|FG001|Overall Study|Randomized but not treated|0|||
44122935|NCT01061723|78907023|FG002|Overall Study|Randomized but not treated|0|||
44510523|NCT02878330|79515606|FG000|Overall Study|Lost to Follow-up|11|||
44510524|NCT02878330|79515607|FG001|Overall Study|Lost to Follow-up|26|||
44510525|NCT02878330|79515606|FG000|Overall Study|Withdrawal by Subject|11|||
44510526|NCT02878330|79515607|FG001|Overall Study|Withdrawal by Subject|21|||
44510527|NCT02878330|79515606|FG000|Overall Study|Other|4|||
44510528|NCT02878330|79515607|FG001|Overall Study|Other|7|||
44510529|NCT00238433|79515614|FG000|Overall Study|Screen failure|1|||
44510530|NCT00238433|79515614|FG000|Overall Study|Lost to Follow-up|1|||
44510531|NCT00238433|79515614|FG000|Overall Study|Death|1|||
44510532|NCT00045162|79515621|FG000|Overall Study|Ineligible|12|||
44510533|NCT00045162|79515622|FG001|Overall Study|Ineligible|8|||
44510534|NCT00045162|79515621|FG000|Overall Study|Not treated|7|||
44510535|NCT00045162|79515622|FG001|Overall Study|Not treated|2|||
44379172|NCT00910728|79384814|FG002|Overall Study|Adverse Event|1|||
44379173|NCT00910728|79384815|FG003|Overall Study|Adverse Event|1|||
44379174|NCT00910728|79384816|FG004|Overall Study|Adverse Event|0|||
44379175|NCT00910728|79384817|FG005|Overall Study|Adverse Event|0|||
44379176|NCT00910728|79384818|FG006|Overall Study|Adverse Event|2|||
44379177|NCT00910728|79384819|FG007|Overall Study|Adverse Event|1|||
44379178|NCT00910728|79384820|FG008|Overall Study|Adverse Event|1|||
44379179|NCT00820222|79384842|FG000|Overall Study|Lost to Follow-up|10|||
44379180|NCT00820222|79384843|FG001|Overall Study|Lost to Follow-up|9|||
44510536|NCT00045162|79515621|FG000|Overall Study|Adverse Event|55|||
44510537|NCT00045162|79515622|FG001|Overall Study|Adverse Event|50|||
44510538|NCT00045162|79515621|FG000|Overall Study|Lack of Efficacy|32|||
44379181|NCT00820222|79384842|FG000|Overall Study|Withdrawal by Subject|19|||
44379182|NCT00820222|79384843|FG001|Overall Study|Withdrawal by Subject|21|||
44510539|NCT00045162|79515622|FG001|Overall Study|Lack of Efficacy|29|||
44510540|NCT00045162|79515621|FG000|Overall Study|Death|10|||
44379183|NCT00820222|79384842|FG000|Overall Study|Physician Decision|93|||
44510541|NCT00045162|79515622|FG001|Overall Study|Death|10|||
44379184|NCT00820222|79384843|FG001|Overall Study|Physician Decision|88|||
44379185|NCT00820222|79384842|FG000|Overall Study|Sponsor Terminated Study|43|||
44379186|NCT00820222|79384843|FG001|Overall Study|Sponsor Terminated Study|65|||
44379187|NCT00820222|79384842|FG000|Overall Study|Unkown|11|||
44379188|NCT00820222|79384843|FG001|Overall Study|Unkown|7|||
44379189|NCT01039688|79384852|FG000|Overall Study|Adverse Event|38|||
44510542|NCT00045162|79515621|FG000|Overall Study|Withdrawal by Subject|5|||
44510543|NCT00045162|79515622|FG001|Overall Study|Withdrawal by Subject|3|||
44510544|NCT00045162|79515621|FG000|Overall Study|Other|21|||
44122936|NCT01061723|78907024|FG003|Overall Study|Randomized but not treated|0|||
44122937|NCT01061723|78907025|FG004|Overall Study|Randomized but not treated|0|||
44122938|NCT01061723|78907026|FG005|Overall Study|Randomized but not treated|1|||
44122939|NCT01061723|78907021|FG000|Overall Study|Other than specified above|2|||
44122940|NCT01061723|78907022|FG001|Overall Study|Other than specified above|1|||
44122941|NCT01061723|78907023|FG002|Overall Study|Other than specified above|1|||
44122942|NCT01061723|78907024|FG003|Overall Study|Other than specified above|1|||
44122943|NCT01061723|78907025|FG004|Overall Study|Other than specified above|0|||
44122944|NCT01061723|78907026|FG005|Overall Study|Other than specified above|1|||
44122945|NCT01061567|78907045|FG000|Overall Study|Adverse Event|32|||
44122946|NCT01061567|78907045|FG000|Overall Study|Death|2|||
44122947|NCT01061567|78907045|FG000|Overall Study|Lack of Efficacy|3|||
44122948|NCT01061567|78907045|FG000|Overall Study|Lost to Follow-up|24|||
44122949|NCT01061567|78907045|FG000|Overall Study|Protocol Violation|1|||
44122950|NCT01061567|78907045|FG000|Overall Study|Withdrawal by Subject|11|||
44122951|NCT01061567|78907045|FG000|Overall Study|Other reason than stated above|3|||
44122952|NCT01061333|78907049|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
44122953|NCT01061333|78907050|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
44510545|NCT00045162|79515622|FG001|Overall Study|Other|16|||
44510546|NCT02748616|79515628|FG000|Overall Study|Lost to Follow-up|1|||
44510547|NCT02748616|79515628|FG000|Overall Study|Withdrawal by Subject|2|||
44510548|NCT02748616|79515628|FG000|Overall Study|Physician Decision|2|||
44510549|NCT02748616|79515628|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
44122954|NCT02489968|78907063|FG000|Open-label Treatment Period|Adverse Event|14|||
44122955|NCT02489968|78907064|FG001|Open-label Treatment Period|Adverse Event|7|||
44379190|NCT01039688|79384853|FG001|Overall Study|Adverse Event|39|||
44510550|NCT00238121|79515634|FG000|Overall Study|Withdrawal by Subject|1|||
44510551|NCT00238121|79515635|FG001|Overall Study|Withdrawal by Subject|1|||
44510552|NCT00238121|79515634|FG000|Overall Study|Adverse Event|2|||
44510553|NCT00238121|79515635|FG001|Overall Study|Adverse Event|1|||
44122956|NCT02489968|78907065|FG002|Open-label Treatment Period|Adverse Event|0|||
44122957|NCT02489968|78907066|FG003|Open-label Treatment Period|Adverse Event|0|||
44122958|NCT02489968|78907067|FG004|Open-label Treatment Period|Adverse Event|0|||
44122959|NCT02489968|78907068|FG005|Open-label Treatment Period|Adverse Event|0|||
44122960|NCT02489968|78907063|FG000|Open-label Treatment Period|Protocol Violation|2|||
44122961|NCT02489968|78907064|FG001|Open-label Treatment Period|Protocol Violation|2|||
44122962|NCT02489968|78907065|FG002|Open-label Treatment Period|Protocol Violation|0|||
44122963|NCT02489968|78907066|FG003|Open-label Treatment Period|Protocol Violation|0|||
44122964|NCT02489968|78907067|FG004|Open-label Treatment Period|Protocol Violation|0|||
44122965|NCT02489968|78907068|FG005|Open-label Treatment Period|Protocol Violation|0|||
44122966|NCT02489968|78907063|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
44122967|NCT02489968|78907064|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
44122968|NCT02489968|78907065|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
44122969|NCT02489968|78907066|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
44122970|NCT02489968|78907067|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
44122971|NCT02489968|78907068|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
44122972|NCT02489968|78907063|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
44122973|NCT02489968|78907064|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
44122974|NCT02489968|78907065|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
44122975|NCT02489968|78907066|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
44122976|NCT02489968|78907067|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
44122977|NCT02489968|78907068|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
44122978|NCT02489968|78907063|FG000|Open-label Treatment Period|Other than specified above|204|||
44122979|NCT02489968|78907064|FG001|Open-label Treatment Period|Other than specified above|189|||
44122980|NCT02489968|78907065|FG002|Open-label Treatment Period|Other than specified above|0|||
44122981|NCT02489968|78907066|FG003|Open-label Treatment Period|Other than specified above|0|||
44122982|NCT02489968|78907067|FG004|Open-label Treatment Period|Other than specified above|0|||
44122983|NCT02489968|78907068|FG005|Open-label Treatment Period|Other than specified above|0|||
44122984|NCT02489968|78907063|FG000|Double-blind Treatment Period|Adverse Event|0|||
44122985|NCT02489968|78907064|FG001|Double-blind Treatment Period|Adverse Event|0|||
44122986|NCT02489968|78907065|FG002|Double-blind Treatment Period|Adverse Event|2|||
44122987|NCT02489968|78907066|FG003|Double-blind Treatment Period|Adverse Event|6|||
44122988|NCT02489968|78907067|FG004|Double-blind Treatment Period|Adverse Event|4|||
44122989|NCT02489968|78907068|FG005|Double-blind Treatment Period|Adverse Event|5|||
44122990|NCT02489968|78907063|FG000|Double-blind Treatment Period|Protocol Violation|0|||
44122991|NCT02489968|78907064|FG001|Double-blind Treatment Period|Protocol Violation|0|||
44122992|NCT02489968|78907065|FG002|Double-blind Treatment Period|Protocol Violation|0|||
44122993|NCT02489968|78907066|FG003|Double-blind Treatment Period|Protocol Violation|0|||
44122994|NCT02489968|78907067|FG004|Double-blind Treatment Period|Protocol Violation|1|||
44122995|NCT02489968|78907068|FG005|Double-blind Treatment Period|Protocol Violation|1|||
44122996|NCT02489968|78907063|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
44122997|NCT02489968|78907064|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
44122998|NCT02489968|78907065|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44122999|NCT02489968|78907066|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
44123000|NCT02489968|78907067|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
44123001|NCT02489968|78907068|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
44123002|NCT02489968|78907063|FG000|Double-blind Treatment Period|Other than specified above|0|||
44123003|NCT02489968|78907064|FG001|Double-blind Treatment Period|Other than specified above|0|||
44123004|NCT02489968|78907065|FG002|Double-blind Treatment Period|Other than specified above|0|||
44123005|NCT02489968|78907066|FG003|Double-blind Treatment Period|Other than specified above|0|||
44123006|NCT02489968|78907067|FG004|Double-blind Treatment Period|Other than specified above|1|||
44123007|NCT02489968|78907068|FG005|Double-blind Treatment Period|Other than specified above|0|||
44123008|NCT02483416|78907082|FG000|Overall Study|Other reason|0|||
44123009|NCT02483416|78907083|FG001|Overall Study|Other reason|1|||
44123010|NCT02483416|78907082|FG000|Overall Study|Treatment stop|3|||
44123011|NCT02483416|78907083|FG001|Overall Study|Treatment stop|0|||
44123012|NCT01061177|78907090|FG000|Overall Study|Adverse Event|117|||
44123013|NCT01061177|78907090|FG000|Overall Study|Withdrawal by Subject|27|||
44123014|NCT01061177|78907090|FG000|Overall Study|Disease progression|17|||
44123015|NCT01061177|78907090|FG000|Overall Study|Protocol Violation|11|||
44123016|NCT01061177|78907090|FG000|Overall Study|Lost to Follow-up|9|||
44123017|NCT01061177|78907090|FG000|Overall Study|New cancer therapy|9|||
44123018|NCT01061177|78907090|FG000|Overall Study|Abnormal laboratory values|6|||
44123019|NCT01061177|78907090|FG000|Overall Study|Abnormal test procedure results|4|||
44123020|NCT01061177|78907090|FG000|Overall Study|Administratie problems|4|||
44123021|NCT01061177|78907090|FG000|Overall Study|Death|4|||
44123022|NCT02481934|78907094|FG000|Overall Study|Death|2|||
44123023|NCT02973425|78907100|FG000|Overall Study|Lost to Follow-up|49|||
44123024|NCT02973425|78907101|FG001|Overall Study|Lost to Follow-up|53|||
44123025|NCT02489500|78907110|FG000|Overall Study|Death|1|||
44123026|NCT02489500|78907111|FG001|Overall Study|Death|1|||
44123027|NCT02732847|78907119|FG000|Overall Study|some filled early|42|||
44123028|NCT02732847|78907120|FG001|Overall Study|some filled early|42|||
44123029|NCT02489344|78907126|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
44123030|NCT02489344|78907126|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
44123031|NCT02489344|78907126|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
44123032|NCT02489344|78907126|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
44123033|NCT02488330|78907130|FG000|Overall Study|Adverse Event|1|||
44123034|NCT02488330|78907130|FG000|Overall Study|Physician Decision|2|||
44123035|NCT02488330|78907130|FG000|Overall Study|Death|2|||
44123036|NCT02488330|78907130|FG000|Overall Study|Disease Progression|3|||
44123037|NCT02488330|78907130|FG000|Overall Study|Study Termination by Sponsor|4|||
44123038|NCT02481310|78907137|FG000|Follow up|Still in follow up|0|||
44123039|NCT02481310|78907138|FG001|Follow up|Still in follow up|3|||
44123040|NCT02481310|78907139|FG002|Follow up|Still in follow up|0|||
44123041|NCT02480764|78907146|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
44123042|NCT02480764|78907147|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
44123043|NCT02480764|78907148|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
44123044|NCT02480764|78907146|FG000|Overall Study|Major Protocol Deviation|1|||
44123045|NCT02480764|78907147|FG001|Overall Study|Major Protocol Deviation|4|||
44123046|NCT02480764|78907148|FG002|Overall Study|Major Protocol Deviation|3|||
44123047|NCT02480764|78907146|FG000|Overall Study|Lost to Follow-up|0|||
44123048|NCT02480764|78907147|FG001|Overall Study|Lost to Follow-up|1|||
44123049|NCT02480764|78907148|FG002|Overall Study|Lost to Follow-up|2|||
44123050|NCT02480764|78907146|FG000|Overall Study|Voluntary Withdrawal|6|||
44123051|NCT02480764|78907147|FG001|Overall Study|Voluntary Withdrawal|5|||
44123052|NCT02480764|78907148|FG002|Overall Study|Voluntary Withdrawal|10|||
44123053|NCT02480764|78907146|FG000|Overall Study|Lack of Efficacy|0|||
44123054|NCT02480764|78907147|FG001|Overall Study|Lack of Efficacy|3|||
44123055|NCT02480764|78907148|FG002|Overall Study|Lack of Efficacy|3|||
44123056|NCT02480764|78907146|FG000|Overall Study|Reason not Specified|0|||
44123057|NCT02480764|78907147|FG001|Overall Study|Reason not Specified|1|||
44123058|NCT02480764|78907148|FG002|Overall Study|Reason not Specified|0|||
44123059|NCT02487472|78907156|FG000|Overall Study|Did not complete telephonic interviews|9|||
44123060|NCT02487472|78907156|FG000|Overall Study|Other|2|||
44123061|NCT02451670|78907164|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
44123062|NCT02451670|78907165|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
44123063|NCT02486692|78907173|FG000|Overall Study|did not login for randomization|4|||
44123064|NCT02486692|78907174|FG001|Overall Study|did not login for randomization|7|||
44123065|NCT01060007|78907191|FG000|Overall Study|Withdrawal by Subject|1|||
44123066|NCT01060007|78907191|FG000|Overall Study|Inevaluable for response at surgery|3|||
44123067|NCT02971163|78907200|FG000|Overall Study|Lost to Follow-up|4|||
44123068|NCT02971163|78907201|FG001|Overall Study|Lost to Follow-up|2|||
44123069|NCT02971007|78907210|FG000|Overall Study|Adverse Event|1|||
44123070|NCT02971007|78907211|FG001|Overall Study|Adverse Event|0|||
44123071|NCT02971007|78907212|FG002|Overall Study|Adverse Event|0|||
44123072|NCT02971007|78907210|FG000|Overall Study|Lost to Follow-up|0|||
44123073|NCT02971007|78907211|FG001|Overall Study|Lost to Follow-up|1|||
44123074|NCT02971007|78907212|FG002|Overall Study|Lost to Follow-up|1|||
44123075|NCT02971007|78907210|FG000|Overall Study|Withdrawal by Subject|0|||
44123076|NCT02971007|78907211|FG001|Overall Study|Withdrawal by Subject|1|||
44123077|NCT02971007|78907212|FG002|Overall Study|Withdrawal by Subject|0|||
44123078|NCT02971007|78907210|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
44123079|NCT02971007|78907211|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
44123080|NCT02971007|78907212|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
44123081|NCT02971007|78907210|FG000|Overall Study|Patient discontinued study drug|0|||
44123082|NCT02971007|78907211|FG001|Overall Study|Patient discontinued study drug|1|||
44123083|NCT02971007|78907212|FG002|Overall Study|Patient discontinued study drug|0|||
44123084|NCT03881553|78907223|FG000|Overall Study|Discharged prior to participation|1|||
44123085|NCT03881553|78907224|FG001|Overall Study|Discharged prior to participation|1|||
44123086|NCT03881553|78907225|FG002|Overall Study|Discharged prior to participation|0|||
44123087|NCT03881553|78907223|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
44123088|NCT03881553|78907224|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
44123089|NCT03881553|78907225|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
44123090|NCT02970929|78907233|FG000|Overall Study|Adverse Event|18|||
44123091|NCT02970929|78907233|FG000|Overall Study|Lack of Efficacy|8|||
44123092|NCT02970929|78907233|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
44123093|NCT02970929|78907233|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
44123094|NCT02970929|78907233|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
44123095|NCT02970929|78907233|FG000|Overall Study|LOST TO FOLLOWUP|6|||
44123096|NCT02970929|78907233|FG000|Overall Study|MOVED OUT OF STATE|1|||
44123097|NCT02970929|78907233|FG000|Overall Study|Withdrawal by Subject|16|||
44123098|NCT02970305|78907250|FG000|Overall Study|Adverse Event|10|||
44123099|NCT02970305|78907251|FG001|Overall Study|Adverse Event|6|||
44123100|NCT02970305|78907250|FG000|Overall Study|Lack of Efficacy|1|||
44123101|NCT02970305|78907251|FG001|Overall Study|Lack of Efficacy|1|||
44123102|NCT02970305|78907250|FG000|Overall Study|Noncompliance with study drug|2|||
44123103|NCT02970305|78907251|FG001|Overall Study|Noncompliance with study drug|4|||
44123104|NCT02970305|78907250|FG000|Overall Study|Protocol Violation|2|||
44123105|NCT02970305|78907251|FG001|Overall Study|Protocol Violation|2|||
44123106|NCT02970305|78907250|FG000|Overall Study|Withdrawal by Subject|12|||
44123107|NCT02970305|78907251|FG001|Overall Study|Withdrawal by Subject|11|||
44123108|NCT02970305|78907250|FG000|Overall Study|Not further specified|1|||
44123109|NCT02970305|78907251|FG001|Overall Study|Not further specified|2|||
44123110|NCT02970305|78907250|FG000|Overall Study|Lost to Follow-up|1|||
44123111|NCT02970305|78907251|FG001|Overall Study|Lost to Follow-up|2|||
44123112|NCT02022033|78907270|FG000|Overall Study|Physician Decision|1|||
44123113|NCT03505671|78907276|FG000|Overall Study|Withdrawal by Subject|2|||
44123114|NCT03505671|78907277|FG001|Overall Study|Withdrawal by Subject|1|||
44123115|NCT03505671|78907276|FG000|Overall Study|Lost to Follow-up|1|||
44123116|NCT03505671|78907277|FG001|Overall Study|Lost to Follow-up|0|||
44123117|NCT01103349|78907298|FG000|Overall Study|Adverse Event|8|||
44123118|NCT01103349|78907299|FG001|Overall Study|Adverse Event|5|||
44123119|NCT01103349|78907300|FG002|Overall Study|Adverse Event|3|||
44123120|NCT01103349|78907298|FG000|Overall Study|Consent withdrawn|1|||
44123121|NCT01103349|78907299|FG001|Overall Study|Consent withdrawn|0|||
44123122|NCT01103349|78907300|FG002|Overall Study|Consent withdrawn|0|||
44123123|NCT01103349|78907298|FG000|Overall Study|Incorrectly included in the trial|1|||
44123124|NCT01103349|78907299|FG001|Overall Study|Incorrectly included in the trial|0|||
44123125|NCT01103349|78907300|FG002|Overall Study|Incorrectly included in the trial|0|||
44123126|NCT01103349|78907298|FG000|Overall Study|Withdrawal by Subject|1|||
44123127|NCT01103349|78907299|FG001|Overall Study|Withdrawal by Subject|1|||
44123128|NCT01103349|78907300|FG002|Overall Study|Withdrawal by Subject|0|||
44123129|NCT01103349|78907298|FG000|Overall Study|did not want to take trial medication|0|||
44123130|NCT01103349|78907299|FG001|Overall Study|did not want to take trial medication|1|||
44123131|NCT01103349|78907300|FG002|Overall Study|did not want to take trial medication|0|||
44123132|NCT01103349|78907298|FG000|Overall Study|forgot to take medication|0|||
44123133|NCT01103349|78907299|FG001|Overall Study|forgot to take medication|0|||
44123134|NCT01103349|78907300|FG002|Overall Study|forgot to take medication|1|||
44123135|NCT02959177|78907311|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
44123136|NCT02959177|78907312|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
44123137|NCT02959177|78907313|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
44123138|NCT02959177|78907311|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
44123139|NCT02959177|78907312|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
44123140|NCT02959177|78907313|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
44123141|NCT02959177|78907311|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
44123142|NCT02959177|78907312|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
44123143|NCT02959177|78907313|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
44123144|NCT02959177|78907311|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
44123145|NCT02959177|78907312|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44123146|NCT02959177|78907313|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
44123147|NCT02959177|78907311|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
44123148|NCT02959177|78907312|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
44123149|NCT02959177|78907313|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
44123150|NCT02959177|78907311|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
44123151|NCT02959177|78907312|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
44123152|NCT02959177|78907313|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
44123153|NCT02959177|78907311|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
44123154|NCT02959177|78907312|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
44123155|NCT02959177|78907313|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
44123156|NCT04706403|78907330|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
44123157|NCT04706403|78907331|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
44123158|NCT04706403|78907332|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
44123159|NCT04706403|78907333|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
44123160|NCT04706403|78907334|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
44123161|NCT02983617|78907348|FG000|Overall Study|Adverse Event|0|||
44123162|NCT02983617|78907349|FG001|Overall Study|Adverse Event|7|||
44123163|NCT02983617|78907348|FG000|Overall Study|Death|0|||
44123164|NCT02983617|78907349|FG001|Overall Study|Death|1|||
44123165|NCT02983617|78907348|FG000|Overall Study|Investigator's Discretion|0|||
44123166|NCT02983617|78907349|FG001|Overall Study|Investigator's Discretion|1|||
44123167|NCT02873689|78907357|FG000|Overall Study|Lack of Efficacy|1|||
44123168|NCT02873689|78907358|FG001|Overall Study|Lack of Efficacy|0|||
44123169|NCT02873689|78907357|FG000|Overall Study|Withdrawal by Subject|2|||
44243002|NCT01693562|79072530|FG002|Escalation Phase|Death|0|||
44243003|NCT01693562|79072531|FG003|Escalation Phase|Death|3|||
44243004|NCT01693562|79072532|FG004|Escalation Phase|Death|6|||
44243005|NCT01693562|79072533|FG005|Escalation Phase|Death|4|||
44243006|NCT01693562|79072534|FG006|Escalation Phase|Death|0|||
44243007|NCT01693562|79072535|FG007|Escalation Phase|Death|0|||
44243008|NCT01693562|79072536|FG008|Escalation Phase|Death|0|||
44243009|NCT01693562|79072537|FG009|Escalation Phase|Death|0|||
44123170|NCT02873689|78907358|FG001|Overall Study|Withdrawal by Subject|2|||
44123171|NCT02873689|78907357|FG000|Overall Study|Protocol Violation|1|||
44243010|NCT01693562|79072538|FG010|Escalation Phase|Death|0|||
44243011|NCT01693562|79072539|FG011|Escalation Phase|Death|0|||
44243012|NCT01693562|79072540|FG012|Escalation Phase|Death|0|||
44123172|NCT02873689|78907358|FG001|Overall Study|Protocol Violation|0|||
44123173|NCT02873689|78907357|FG000|Overall Study|Adverse Event|2|||
44123174|NCT02873689|78907358|FG001|Overall Study|Adverse Event|2|||
44123175|NCT02873689|78907357|FG000|Overall Study|Randomized but not Treated|1|||
44123176|NCT02873689|78907358|FG001|Overall Study|Randomized but not Treated|1|||
44123177|NCT02901431|78907372|FG000|PK Part|Adverse Event|0|||
44123178|NCT02901431|78907373|FG001|PK Part|Adverse Event|1|||
44123179|NCT02901431|78907374|FG002|PK Part|Adverse Event|0|||
44123180|NCT02901431|78907375|FG003|PK Part|Adverse Event|0|||
44123181|NCT02901431|78907376|FG004|PK Part|Adverse Event|0|||
44123182|NCT02901431|78907377|FG005|PK Part|Adverse Event|0|||
44123183|NCT02901431|78907378|FG006|PK Part|Adverse Event|0|||
44123184|NCT02901431|78907379|FG007|PK Part|Adverse Event|0|||
44123185|NCT02901431|78907380|FG008|PK Part|Adverse Event|0|||
44123186|NCT02901431|78907381|FG009|PK Part|Adverse Event|0|||
44123187|NCT02901431|78907382|FG010|PK Part|Adverse Event|0|||
44123188|NCT02901431|78907383|FG011|PK Part|Adverse Event|0|||
44123189|NCT02901431|78907384|FG012|PK Part|Adverse Event|0|||
44123190|NCT02901431|78907372|FG000|PK Part|Lost to Follow-up|0|||
44123191|NCT02901431|78907373|FG001|PK Part|Lost to Follow-up|0|||
44123192|NCT02901431|78907374|FG002|PK Part|Lost to Follow-up|1|||
44123193|NCT02901431|78907375|FG003|PK Part|Lost to Follow-up|0|||
44123194|NCT02901431|78907376|FG004|PK Part|Lost to Follow-up|0|||
44123195|NCT02901431|78907377|FG005|PK Part|Lost to Follow-up|0|||
44123196|NCT02901431|78907378|FG006|PK Part|Lost to Follow-up|0|||
44123197|NCT02901431|78907379|FG007|PK Part|Lost to Follow-up|0|||
44123198|NCT02901431|78907380|FG008|PK Part|Lost to Follow-up|0|||
44123199|NCT02901431|78907381|FG009|PK Part|Lost to Follow-up|0|||
44123200|NCT02901431|78907382|FG010|PK Part|Lost to Follow-up|0|||
44123201|NCT02901431|78907383|FG011|PK Part|Lost to Follow-up|0|||
44123202|NCT02901431|78907384|FG012|PK Part|Lost to Follow-up|0|||
44123203|NCT02901431|78907372|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
44123204|NCT02901431|78907373|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123205|NCT02901431|78907374|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123206|NCT02901431|78907375|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123207|NCT02901431|78907376|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44379191|NCT01039688|79384854|FG002|Overall Study|Adverse Event|24|||
44379192|NCT01039688|79384852|FG000|Overall Study|Lack of Efficacy|20|||
44123208|NCT02901431|78907377|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123209|NCT02901431|78907378|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123210|NCT02901431|78907379|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123211|NCT02901431|78907380|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123212|NCT02901431|78907381|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123213|NCT02901431|78907382|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123214|NCT02901431|78907383|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123215|NCT02901431|78907384|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
44123216|NCT02901431|78907372|FG000|PK Part|Pending dose confirmation|0|||
44123217|NCT02901431|78907373|FG001|PK Part|Pending dose confirmation|1|||
44123218|NCT02901431|78907374|FG002|PK Part|Pending dose confirmation|0|||
44510554|NCT03139552|79515640|FG000|Overall Study|unable to attend tasting due to schedule|3|||
44510555|NCT03804918|79515651|FG000|Overall Study|Participant did not use the app|1|||
44510556|NCT03139240|79515659|FG000|Overall Study|Lost to Follow-up|0|||
44510557|NCT03139240|79515660|FG001|Overall Study|Lost to Follow-up|1|||
44510558|NCT03139240|79515661|FG002|Overall Study|Lost to Follow-up|1|||
44510559|NCT03139240|79515662|FG003|Overall Study|Lost to Follow-up|0|||
44510560|NCT00237809|79515674|FG000|Overall Study|Lost to Follow-up|11|||
44510561|NCT00237809|79515675|FG001|Overall Study|Lost to Follow-up|10|||
44510562|NCT00237809|79515676|FG002|Overall Study|Lost to Follow-up|9|||
44510563|NCT00237809|79515677|FG003|Overall Study|Lost to Follow-up|9|||
44510564|NCT00003498|79515687|FG000|Overall Study|Not evaluable.|4|||
44123219|NCT02901431|78907375|FG003|PK Part|Pending dose confirmation|0|||
44123220|NCT02901431|78907376|FG004|PK Part|Pending dose confirmation|0|||
44243013|NCT01693562|79072541|FG013|Escalation Phase|Death|0|||
44243014|NCT01693562|79072542|FG014|Escalation Phase|Death|0|||
44243015|NCT01693562|79072543|FG015|Escalation Phase|Death|0|||
44243016|NCT01693562|79072544|FG016|Escalation Phase|Death|0|||
44243017|NCT01693562|79072545|FG017|Escalation Phase|Death|0|||
44243018|NCT01693562|79072546|FG018|Escalation Phase|Death|0|||
44243019|NCT01693562|79072547|FG019|Escalation Phase|Death|0|||
44243020|NCT01693562|79072548|FG020|Escalation Phase|Death|0|||
44243021|NCT01693562|79072549|FG021|Escalation Phase|Death|0|||
44243022|NCT01693562|79072550|FG022|Escalation Phase|Death|0|||
44123221|NCT02901431|78907377|FG005|PK Part|Pending dose confirmation|0|||
44243023|NCT01693562|79072528|FG000|Escalation Phase|Lost to Follow-up|0|||
44243024|NCT01693562|79072529|FG001|Escalation Phase|Lost to Follow-up|1|||
44276454|NCT02177136|79231084|FG003|LTSE Phase|Lost to Follow-up|1|||
44123222|NCT02901431|78907378|FG006|PK Part|Pending dose confirmation|0|||
44123223|NCT02901431|78907379|FG007|PK Part|Pending dose confirmation|0|||
44123224|NCT02901431|78907380|FG008|PK Part|Pending dose confirmation|0|||
44123225|NCT02901431|78907381|FG009|PK Part|Pending dose confirmation|0|||
44123226|NCT02901431|78907382|FG010|PK Part|Pending dose confirmation|0|||
44123227|NCT02901431|78907383|FG011|PK Part|Pending dose confirmation|0|||
44123228|NCT02901431|78907384|FG012|PK Part|Pending dose confirmation|0|||
44123229|NCT02901431|78907372|FG000|PK Part|8 weeks of treatment ran out|2|||
44123230|NCT02901431|78907373|FG001|PK Part|8 weeks of treatment ran out|0|||
44123231|NCT02901431|78907374|FG002|PK Part|8 weeks of treatment ran out|0|||
44123232|NCT02901431|78907375|FG003|PK Part|8 weeks of treatment ran out|0|||
44123233|NCT02901431|78907376|FG004|PK Part|8 weeks of treatment ran out|0|||
44123234|NCT02901431|78907377|FG005|PK Part|8 weeks of treatment ran out|0|||
44123235|NCT02901431|78907378|FG006|PK Part|8 weeks of treatment ran out|0|||
44123236|NCT02901431|78907379|FG007|PK Part|8 weeks of treatment ran out|0|||
44123237|NCT02901431|78907380|FG008|PK Part|8 weeks of treatment ran out|0|||
44123238|NCT02901431|78907381|FG009|PK Part|8 weeks of treatment ran out|0|||
44123239|NCT02901431|78907382|FG010|PK Part|8 weeks of treatment ran out|0|||
44123240|NCT02901431|78907383|FG011|PK Part|8 weeks of treatment ran out|0|||
44123241|NCT02901431|78907384|FG012|PK Part|8 weeks of treatment ran out|0|||
44123242|NCT02901431|78907372|FG000|PK Part|Stopped treatment after 8 weeks|1|||
44123243|NCT02901431|78907373|FG001|PK Part|Stopped treatment after 8 weeks|0|||
44123244|NCT02901431|78907374|FG002|PK Part|Stopped treatment after 8 weeks|1|||
44123245|NCT02901431|78907375|FG003|PK Part|Stopped treatment after 8 weeks|0|||
44123246|NCT02901431|78907376|FG004|PK Part|Stopped treatment after 8 weeks|0|||
44123247|NCT02901431|78907377|FG005|PK Part|Stopped treatment after 8 weeks|0|||
44123248|NCT02901431|78907378|FG006|PK Part|Stopped treatment after 8 weeks|0|||
44123249|NCT02901431|78907379|FG007|PK Part|Stopped treatment after 8 weeks|0|||
44123250|NCT02901431|78907380|FG008|PK Part|Stopped treatment after 8 weeks|0|||
44123251|NCT02901431|78907381|FG009|PK Part|Stopped treatment after 8 weeks|0|||
44123252|NCT02901431|78907382|FG010|PK Part|Stopped treatment after 8 weeks|0|||
44123253|NCT02901431|78907383|FG011|PK Part|Stopped treatment after 8 weeks|0|||
44123254|NCT02901431|78907384|FG012|PK Part|Stopped treatment after 8 weeks|0|||
44123255|NCT02901431|78907372|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
44123256|NCT02901431|78907373|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123257|NCT02901431|78907374|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
44123258|NCT02901431|78907375|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123259|NCT02901431|78907376|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123260|NCT02901431|78907377|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123261|NCT02901431|78907378|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123262|NCT02901431|78907379|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123263|NCT02901431|78907380|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123264|NCT02901431|78907381|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123265|NCT02901431|78907382|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123266|NCT02901431|78907383|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123267|NCT02901431|78907384|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
44123268|NCT02901431|78907372|FG000|PK Part|Discontinued per Sponsor|0|||
44123269|NCT02901431|78907373|FG001|PK Part|Discontinued per Sponsor|3|||
44123270|NCT02901431|78907374|FG002|PK Part|Discontinued per Sponsor|0|||
44123271|NCT02901431|78907375|FG003|PK Part|Discontinued per Sponsor|0|||
44123272|NCT02901431|78907376|FG004|PK Part|Discontinued per Sponsor|0|||
44123273|NCT02901431|78907377|FG005|PK Part|Discontinued per Sponsor|0|||
44123274|NCT02901431|78907378|FG006|PK Part|Discontinued per Sponsor|0|||
44123275|NCT02901431|78907379|FG007|PK Part|Discontinued per Sponsor|0|||
44123276|NCT02901431|78907380|FG008|PK Part|Discontinued per Sponsor|0|||
44123277|NCT02901431|78907381|FG009|PK Part|Discontinued per Sponsor|0|||
44123278|NCT02901431|78907382|FG010|PK Part|Discontinued per Sponsor|0|||
44123279|NCT02901431|78907383|FG011|PK Part|Discontinued per Sponsor|0|||
44243025|NCT01693562|79072530|FG002|Escalation Phase|Lost to Follow-up|1|||
44243026|NCT01693562|79072531|FG003|Escalation Phase|Lost to Follow-up|0|||
44243027|NCT01693562|79072532|FG004|Escalation Phase|Lost to Follow-up|0|||
44243028|NCT01693562|79072533|FG005|Escalation Phase|Lost to Follow-up|0|||
44243029|NCT01693562|79072534|FG006|Escalation Phase|Lost to Follow-up|0|||
44243030|NCT01693562|79072535|FG007|Escalation Phase|Lost to Follow-up|0|||
44123280|NCT02901431|78907384|FG012|PK Part|Discontinued per Sponsor|0|||
44123281|NCT02901431|78907372|FG000|PK Part|Withdrawal by Subject|1|||
44123282|NCT02901431|78907373|FG001|PK Part|Withdrawal by Subject|1|||
44123283|NCT02901431|78907374|FG002|PK Part|Withdrawal by Subject|3|||
44123284|NCT02901431|78907375|FG003|PK Part|Withdrawal by Subject|0|||
44123285|NCT02901431|78907376|FG004|PK Part|Withdrawal by Subject|0|||
44123286|NCT02901431|78907377|FG005|PK Part|Withdrawal by Subject|0|||
44123287|NCT02901431|78907378|FG006|PK Part|Withdrawal by Subject|0|||
44123288|NCT02901431|78907379|FG007|PK Part|Withdrawal by Subject|0|||
44123289|NCT02901431|78907380|FG008|PK Part|Withdrawal by Subject|0|||
44123290|NCT02901431|78907381|FG009|PK Part|Withdrawal by Subject|0|||
44123291|NCT02901431|78907382|FG010|PK Part|Withdrawal by Subject|0|||
44123292|NCT02901431|78907383|FG011|PK Part|Withdrawal by Subject|0|||
44123293|NCT02901431|78907384|FG012|PK Part|Withdrawal by Subject|0|||
44123294|NCT02901431|78907372|FG000|Main Treatment Part|Adverse Event|0|||
44123295|NCT02901431|78907373|FG001|Main Treatment Part|Adverse Event|0|||
44123296|NCT02901431|78907374|FG002|Main Treatment Part|Adverse Event|0|||
44123297|NCT02901431|78907375|FG003|Main Treatment Part|Adverse Event|3|||
44123298|NCT02901431|78907376|FG004|Main Treatment Part|Adverse Event|3|||
44123299|NCT02901431|78907377|FG005|Main Treatment Part|Adverse Event|4|||
44123300|NCT02901431|78907378|FG006|Main Treatment Part|Adverse Event|1|||
44123301|NCT02901431|78907379|FG007|Main Treatment Part|Adverse Event|0|||
44123302|NCT02901431|78907380|FG008|Main Treatment Part|Adverse Event|0|||
44123303|NCT02901431|78907381|FG009|Main Treatment Part|Adverse Event|0|||
44123304|NCT02901431|78907382|FG010|Main Treatment Part|Adverse Event|0|||
44123305|NCT02901431|78907383|FG011|Main Treatment Part|Adverse Event|0|||
44123306|NCT02901431|78907384|FG012|Main Treatment Part|Adverse Event|0|||
44123307|NCT02901431|78907372|FG000|Main Treatment Part|Lack of Efficacy|0|||
44123308|NCT02901431|78907373|FG001|Main Treatment Part|Lack of Efficacy|0|||
44123309|NCT02901431|78907374|FG002|Main Treatment Part|Lack of Efficacy|0|||
44123310|NCT02901431|78907375|FG003|Main Treatment Part|Lack of Efficacy|1|||
44123311|NCT02901431|78907376|FG004|Main Treatment Part|Lack of Efficacy|0|||
44123312|NCT02901431|78907377|FG005|Main Treatment Part|Lack of Efficacy|0|||
44123313|NCT02901431|78907378|FG006|Main Treatment Part|Lack of Efficacy|0|||
44123314|NCT02901431|78907379|FG007|Main Treatment Part|Lack of Efficacy|0|||
44123315|NCT02901431|78907380|FG008|Main Treatment Part|Lack of Efficacy|0|||
44123316|NCT02901431|78907381|FG009|Main Treatment Part|Lack of Efficacy|0|||
44123317|NCT02901431|78907382|FG010|Main Treatment Part|Lack of Efficacy|0|||
44123318|NCT02901431|78907383|FG011|Main Treatment Part|Lack of Efficacy|0|||
44123319|NCT02901431|78907384|FG012|Main Treatment Part|Lack of Efficacy|0|||
44123320|NCT02901431|78907372|FG000|Main Treatment Part|Lost to Follow-up|0|||
44123321|NCT02901431|78907373|FG001|Main Treatment Part|Lost to Follow-up|0|||
44123322|NCT02901431|78907374|FG002|Main Treatment Part|Lost to Follow-up|0|||
44123323|NCT02901431|78907375|FG003|Main Treatment Part|Lost to Follow-up|3|||
44123324|NCT02901431|78907376|FG004|Main Treatment Part|Lost to Follow-up|1|||
44123325|NCT02901431|78907377|FG005|Main Treatment Part|Lost to Follow-up|2|||
44123326|NCT02901431|78907378|FG006|Main Treatment Part|Lost to Follow-up|3|||
44123327|NCT02901431|78907379|FG007|Main Treatment Part|Lost to Follow-up|0|||
44123328|NCT02901431|78907380|FG008|Main Treatment Part|Lost to Follow-up|0|||
44123329|NCT02901431|78907381|FG009|Main Treatment Part|Lost to Follow-up|0|||
44123330|NCT02901431|78907382|FG010|Main Treatment Part|Lost to Follow-up|0|||
44123331|NCT02901431|78907383|FG011|Main Treatment Part|Lost to Follow-up|0|||
44123332|NCT02901431|78907384|FG012|Main Treatment Part|Lost to Follow-up|0|||
44123333|NCT02901431|78907372|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
44123334|NCT02901431|78907373|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
44123335|NCT02901431|78907374|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
44276455|NCT02177136|79231081|FG000|LTSE Phase|Participant Moved|0|||
44510565|NCT00003492|79515691|FG000|Overall Study|Not evaluable|6|||
44510566|NCT03136198|79515697|FG000|Overall Study|Withdrawal by Subject|0|||
44510567|NCT03136198|79515698|FG001|Overall Study|Withdrawal by Subject|1|||
44510568|NCT00042666|79515704|FG000|Overall Study|Adverse Event|2|||
44510569|NCT00042666|79515704|FG000|Overall Study|Death|4|||
44510570|NCT00042666|79515704|FG000|Overall Study|Protocol Violation|1|||
44510571|NCT00042666|79515704|FG000|Overall Study|Participant/Physician Perception|1|||
44510572|NCT00042666|79515704|FG000|Overall Study|Progressive Disease|41|||
44510573|NCT00042666|79515704|FG000|Overall Study|Other|1|||
44510574|NCT00042666|79515704|FG000|Overall Study|Other|4|||
44123336|NCT02901431|78907375|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
44510575|NCT00042432|79515711|FG000|Overall Study|Adverse Event|4|||
44123337|NCT02901431|78907376|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
44123338|NCT02901431|78907377|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
44123339|NCT02901431|78907378|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
44123340|NCT02901431|78907379|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
44123341|NCT02901431|78907380|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
44123342|NCT02901431|78907381|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
44123343|NCT02901431|78907382|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
44123344|NCT02901431|78907383|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
44123345|NCT02901431|78907384|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
44123346|NCT02901431|78907372|FG000|Main Treatment Part|Physician Decision|0|||
44123347|NCT02901431|78907373|FG001|Main Treatment Part|Physician Decision|0|||
44123348|NCT02901431|78907374|FG002|Main Treatment Part|Physician Decision|0|||
44123349|NCT02901431|78907375|FG003|Main Treatment Part|Physician Decision|1|||
44123350|NCT02901431|78907376|FG004|Main Treatment Part|Physician Decision|0|||
44123351|NCT02901431|78907377|FG005|Main Treatment Part|Physician Decision|0|||
44123352|NCT02901431|78907378|FG006|Main Treatment Part|Physician Decision|1|||
44123353|NCT02901431|78907379|FG007|Main Treatment Part|Physician Decision|0|||
44123354|NCT02901431|78907380|FG008|Main Treatment Part|Physician Decision|0|||
44123355|NCT02901431|78907381|FG009|Main Treatment Part|Physician Decision|0|||
44123356|NCT02901431|78907382|FG010|Main Treatment Part|Physician Decision|0|||
44123357|NCT02901431|78907383|FG011|Main Treatment Part|Physician Decision|0|||
44123358|NCT02901431|78907384|FG012|Main Treatment Part|Physician Decision|0|||
44123359|NCT02901431|78907372|FG000|Main Treatment Part|Withdrawal by Subject|0|||
44123360|NCT02901431|78907373|FG001|Main Treatment Part|Withdrawal by Subject|0|||
44123361|NCT02901431|78907374|FG002|Main Treatment Part|Withdrawal by Subject|0|||
44123362|NCT02901431|78907375|FG003|Main Treatment Part|Withdrawal by Subject|18|||
44123363|NCT02901431|78907376|FG004|Main Treatment Part|Withdrawal by Subject|3|||
44123364|NCT02901431|78907377|FG005|Main Treatment Part|Withdrawal by Subject|5|||
44123365|NCT02901431|78907378|FG006|Main Treatment Part|Withdrawal by Subject|6|||
44123366|NCT02901431|78907379|FG007|Main Treatment Part|Withdrawal by Subject|0|||
44123367|NCT02901431|78907380|FG008|Main Treatment Part|Withdrawal by Subject|0|||
44123368|NCT02901431|78907381|FG009|Main Treatment Part|Withdrawal by Subject|0|||
44123369|NCT02901431|78907382|FG010|Main Treatment Part|Withdrawal by Subject|0|||
44123370|NCT02901431|78907383|FG011|Main Treatment Part|Withdrawal by Subject|0|||
44123371|NCT02901431|78907384|FG012|Main Treatment Part|Withdrawal by Subject|0|||
44123372|NCT02901431|78907372|FG000|Open Label Part|Adverse Event|0|||
44123373|NCT02901431|78907373|FG001|Open Label Part|Adverse Event|0|||
44123374|NCT02901431|78907374|FG002|Open Label Part|Adverse Event|0|||
44123375|NCT02901431|78907375|FG003|Open Label Part|Adverse Event|0|||
44123376|NCT02901431|78907376|FG004|Open Label Part|Adverse Event|0|||
44123377|NCT02901431|78907377|FG005|Open Label Part|Adverse Event|0|||
44243031|NCT01693562|79072536|FG008|Escalation Phase|Lost to Follow-up|0|||
44243032|NCT01693562|79072537|FG009|Escalation Phase|Lost to Follow-up|0|||
44243033|NCT01693562|79072538|FG010|Escalation Phase|Lost to Follow-up|0|||
44243034|NCT01693562|79072539|FG011|Escalation Phase|Lost to Follow-up|0|||
44510576|NCT00042432|79515712|FG001|Overall Study|Adverse Event|1|||
44510577|NCT00042432|79515711|FG000|Overall Study|Withdrawal by Subject|1|||
44510578|NCT00042432|79515712|FG001|Overall Study|Withdrawal by Subject|3|||
44510579|NCT00042432|79515711|FG000|Overall Study|Death|0|||
44510580|NCT00042432|79515712|FG001|Overall Study|Death|2|||
44510581|NCT00042432|79515711|FG000|Overall Study|Ineligibility determined|1|||
44510582|NCT00042432|79515712|FG001|Overall Study|Ineligibility determined|0|||
44510583|NCT00042432|79515711|FG000|Overall Study|Initiation of maintenance dialysis|1|||
44510584|NCT00042432|79515712|FG001|Overall Study|Initiation of maintenance dialysis|1|||
44510585|NCT00042432|79515711|FG000|Overall Study|Other|2|||
44510586|NCT00042432|79515712|FG001|Overall Study|Other|0|||
44510587|NCT00003474|79515718|FG000|Overall Study|Not Evaluable|14|||
44510588|NCT01542736|79515722|FG000|Overall Study|Death|1|||
44510589|NCT01346410|79515726|FG000|Overall Study|Death|1|||
44123378|NCT02901431|78907378|FG006|Open Label Part|Adverse Event|0|||
44123379|NCT02901431|78907379|FG007|Open Label Part|Adverse Event|0|||
44123380|NCT02901431|78907380|FG008|Open Label Part|Adverse Event|4|||
44123381|NCT02901431|78907381|FG009|Open Label Part|Adverse Event|4|||
44243035|NCT01693562|79072540|FG012|Escalation Phase|Lost to Follow-up|0|||
44510590|NCT00003456|79515730|FG000|Overall Study|Not evaluable|8|||
44510591|NCT02719522|79515734|FG000|Overall Study|Implant Failure|4|||
44510592|NCT02719522|79515734|FG000|Overall Study|Death|2|||
44123382|NCT02901431|78907382|FG010|Open Label Part|Adverse Event|0|||
44123383|NCT02901431|78907383|FG011|Open Label Part|Adverse Event|4|||
44123384|NCT02901431|78907384|FG012|Open Label Part|Adverse Event|1|||
44123385|NCT02901431|78907372|FG000|Open Label Part|Lost to Follow-up|0|||
44123386|NCT02901431|78907373|FG001|Open Label Part|Lost to Follow-up|0|||
44123387|NCT02901431|78907374|FG002|Open Label Part|Lost to Follow-up|0|||
44123388|NCT02901431|78907375|FG003|Open Label Part|Lost to Follow-up|0|||
44123389|NCT02901431|78907376|FG004|Open Label Part|Lost to Follow-up|0|||
44123390|NCT02901431|78907377|FG005|Open Label Part|Lost to Follow-up|0|||
44123391|NCT02901431|78907378|FG006|Open Label Part|Lost to Follow-up|0|||
44123392|NCT02901431|78907379|FG007|Open Label Part|Lost to Follow-up|0|||
44123393|NCT02901431|78907380|FG008|Open Label Part|Lost to Follow-up|2|||
44123394|NCT02901431|78907381|FG009|Open Label Part|Lost to Follow-up|2|||
44123395|NCT02901431|78907382|FG010|Open Label Part|Lost to Follow-up|1|||
44123396|NCT02901431|78907383|FG011|Open Label Part|Lost to Follow-up|1|||
44123397|NCT02901431|78907384|FG012|Open Label Part|Lost to Follow-up|1|||
44123398|NCT02901431|78907372|FG000|Open Label Part|Physician Decision|0|||
44123399|NCT02901431|78907373|FG001|Open Label Part|Physician Decision|0|||
44123400|NCT02901431|78907374|FG002|Open Label Part|Physician Decision|0|||
44123401|NCT02901431|78907375|FG003|Open Label Part|Physician Decision|0|||
44123402|NCT02901431|78907376|FG004|Open Label Part|Physician Decision|0|||
44123403|NCT02901431|78907377|FG005|Open Label Part|Physician Decision|0|||
44123404|NCT02901431|78907378|FG006|Open Label Part|Physician Decision|0|||
44123405|NCT02901431|78907379|FG007|Open Label Part|Physician Decision|0|||
44123406|NCT02901431|78907380|FG008|Open Label Part|Physician Decision|1|||
44123407|NCT02901431|78907381|FG009|Open Label Part|Physician Decision|1|||
44123408|NCT02901431|78907382|FG010|Open Label Part|Physician Decision|0|||
44123409|NCT02901431|78907383|FG011|Open Label Part|Physician Decision|0|||
44123410|NCT02901431|78907384|FG012|Open Label Part|Physician Decision|0|||
44243036|NCT01693562|79072541|FG013|Escalation Phase|Lost to Follow-up|0|||
44379193|NCT01039688|79384853|FG001|Overall Study|Lack of Efficacy|11|||
44379194|NCT01039688|79384854|FG002|Overall Study|Lack of Efficacy|26|||
44123411|NCT02901431|78907372|FG000|Open Label Part|Study Terminated By Sponsor|0|||
44123412|NCT02901431|78907373|FG001|Open Label Part|Study Terminated By Sponsor|0|||
44123413|NCT02901431|78907374|FG002|Open Label Part|Study Terminated By Sponsor|0|||
44243037|NCT01693562|79072542|FG014|Escalation Phase|Lost to Follow-up|0|||
44243038|NCT01693562|79072543|FG015|Escalation Phase|Lost to Follow-up|0|||
44243039|NCT01693562|79072544|FG016|Escalation Phase|Lost to Follow-up|0|||
44243040|NCT01693562|79072545|FG017|Escalation Phase|Lost to Follow-up|0|||
44243041|NCT01693562|79072546|FG018|Escalation Phase|Lost to Follow-up|0|||
44243042|NCT01693562|79072547|FG019|Escalation Phase|Lost to Follow-up|0|||
44243043|NCT01693562|79072548|FG020|Escalation Phase|Lost to Follow-up|0|||
44243044|NCT01693562|79072549|FG021|Escalation Phase|Lost to Follow-up|0|||
44243045|NCT01693562|79072550|FG022|Escalation Phase|Lost to Follow-up|0|||
44243046|NCT01693562|79072528|FG000|Escalation Phase|Other|0|||
44243047|NCT01693562|79072529|FG001|Escalation Phase|Other|0|||
44243048|NCT01693562|79072530|FG002|Escalation Phase|Other|2|||
44379195|NCT01039688|79384852|FG000|Overall Study|Lost to Follow-up|11|||
44379196|NCT01039688|79384853|FG001|Overall Study|Lost to Follow-up|9|||
44510593|NCT02719522|79515734|FG000|Overall Study|Lost to Follow-up|5|||
44510594|NCT00237185|79515740|FG000|Core|Adverse Event|3|||
44510595|NCT00237185|79515741|FG001|Core|Adverse Event|4|||
44510596|NCT00237185|79515740|FG000|Core|Abnormal laboratory value|0|||
44510597|NCT00237185|79515741|FG001|Core|Abnormal laboratory value|4|||
44510598|NCT00237185|79515740|FG000|Core|Abnormal test procedure results|1|||
44510599|NCT00237185|79515741|FG001|Core|Abnormal test procedure results|0|||
44510600|NCT00237185|79515740|FG000|Core|Lack of Efficacy|30|||
44510601|NCT00237185|79515741|FG001|Core|Lack of Efficacy|23|||
44510602|NCT00237185|79515740|FG000|Core|Protocol Violation|1|||
44510603|NCT00237185|79515741|FG001|Core|Protocol Violation|1|||
44510604|NCT00237185|79515740|FG000|Core|Withdrawal by Subject|4|||
44510605|NCT00237185|79515741|FG001|Core|Withdrawal by Subject|4|||
44123414|NCT02901431|78907375|FG003|Open Label Part|Study Terminated By Sponsor|0|||
44123415|NCT02901431|78907376|FG004|Open Label Part|Study Terminated By Sponsor|0|||
44243049|NCT01693562|79072531|FG003|Escalation Phase|Other|0|||
44243050|NCT01693562|79072532|FG004|Escalation Phase|Other|0|||
44510606|NCT00237185|79515740|FG000|Core|Administrative problems|0|||
44123416|NCT02901431|78907377|FG005|Open Label Part|Study Terminated By Sponsor|0|||
44510607|NCT00237185|79515741|FG001|Core|Administrative problems|1|||
44510608|NCT00237185|79515740|FG000|Core|Death|4|||
44243051|NCT01693562|79072533|FG005|Escalation Phase|Other|1|||
44510609|NCT00237185|79515741|FG001|Core|Death|0|||
44510610|NCT00237185|79515740|FG000|Core|Determined ineligible post randomization|1|||
44276456|NCT02177136|79231082|FG001|LTSE Phase|Participant Moved|0|||
44276457|NCT02177136|79231083|FG002|LTSE Phase|Participant Moved|0|||
44276458|NCT02177136|79231084|FG003|LTSE Phase|Participant Moved|1|||
44276459|NCT02176356|79231112|FG000|Overall Study|Screen Failure|14|||
44276460|NCT02176356|79231112|FG000|Overall Study|Lost to Follow-up|4|||
44276461|NCT02176356|79231112|FG000|Overall Study|Personal Reasons|3|||
44276462|NCT02176356|79231112|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44276463|NCT02210208|79231122|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
44123417|NCT02901431|78907378|FG006|Open Label Part|Study Terminated By Sponsor|0|||
44123418|NCT02901431|78907379|FG007|Open Label Part|Study Terminated By Sponsor|0|||
44123419|NCT02901431|78907380|FG008|Open Label Part|Study Terminated By Sponsor|35|||
44123420|NCT02901431|78907381|FG009|Open Label Part|Study Terminated By Sponsor|12|||
44123421|NCT02901431|78907382|FG010|Open Label Part|Study Terminated By Sponsor|21|||
44123422|NCT02901431|78907383|FG011|Open Label Part|Study Terminated By Sponsor|31|||
44123423|NCT02901431|78907384|FG012|Open Label Part|Study Terminated By Sponsor|0|||
44123424|NCT02901431|78907372|FG000|Open Label Part|Withdrawal by Subject|0|||
44123425|NCT02901431|78907373|FG001|Open Label Part|Withdrawal by Subject|0|||
44123426|NCT02901431|78907374|FG002|Open Label Part|Withdrawal by Subject|0|||
44123427|NCT02901431|78907375|FG003|Open Label Part|Withdrawal by Subject|0|||
44123428|NCT02901431|78907376|FG004|Open Label Part|Withdrawal by Subject|0|||
44123429|NCT02901431|78907377|FG005|Open Label Part|Withdrawal by Subject|0|||
44123430|NCT02901431|78907378|FG006|Open Label Part|Withdrawal by Subject|0|||
44123431|NCT02901431|78907379|FG007|Open Label Part|Withdrawal by Subject|0|||
44123432|NCT02901431|78907380|FG008|Open Label Part|Withdrawal by Subject|6|||
44123433|NCT02901431|78907381|FG009|Open Label Part|Withdrawal by Subject|5|||
44243052|NCT01693562|79072534|FG006|Escalation Phase|Other|0|||
44243053|NCT01693562|79072535|FG007|Escalation Phase|Other|0|||
44243054|NCT01693562|79072536|FG008|Escalation Phase|Other|0|||
44243055|NCT01693562|79072537|FG009|Escalation Phase|Other|0|||
44243056|NCT01693562|79072538|FG010|Escalation Phase|Other|0|||
44243057|NCT01693562|79072539|FG011|Escalation Phase|Other|0|||
44243058|NCT01693562|79072540|FG012|Escalation Phase|Other|0|||
44243059|NCT01693562|79072541|FG013|Escalation Phase|Other|0|||
44243060|NCT01693562|79072542|FG014|Escalation Phase|Other|0|||
44243061|NCT01693562|79072543|FG015|Escalation Phase|Other|0|||
44243062|NCT01693562|79072544|FG016|Escalation Phase|Other|0|||
44243063|NCT01693562|79072545|FG017|Escalation Phase|Other|0|||
44243064|NCT01693562|79072546|FG018|Escalation Phase|Other|0|||
44243065|NCT01693562|79072547|FG019|Escalation Phase|Other|0|||
44243066|NCT01693562|79072548|FG020|Escalation Phase|Other|0|||
44243067|NCT01693562|79072549|FG021|Escalation Phase|Other|0|||
44276464|NCT02210208|79231122|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
44276465|NCT02210208|79231122|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
44276466|NCT02209506|79231142|FG000|Overall Study|Withdrawal by Subject|0|||
44243068|NCT01693562|79072550|FG022|Escalation Phase|Other|0|||
44243069|NCT01693562|79072528|FG000|Exploration Phase|Withdrawal by Subject|0|||
44123434|NCT02901431|78907382|FG010|Open Label Part|Withdrawal by Subject|7|||
44123435|NCT02901431|78907383|FG011|Open Label Part|Withdrawal by Subject|3|||
44123436|NCT02901431|78907384|FG012|Open Label Part|Withdrawal by Subject|1|||
44123437|NCT02873377|78907411|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
44123438|NCT02873377|78907412|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
44123439|NCT02873377|78907411|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
44123440|NCT02873377|78907412|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
44123441|NCT02966795|78907421|FG000|Overall Study|Patient Left the Country|0|||
44123442|NCT02966795|78907422|FG001|Overall Study|Patient Left the Country|1|||
44123443|NCT02873221|78907430|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
44123444|NCT02873221|78907431|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
44123445|NCT02873221|78907432|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
44123446|NCT02873221|78907430|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
44123447|NCT02873221|78907431|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
44123448|NCT02873221|78907432|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
44123449|NCT02873221|78907430|FG000|Treatment Period|Protocol Violation|2|||
44123450|NCT02873221|78907431|FG001|Treatment Period|Protocol Violation|5|||
44123451|NCT02873221|78907432|FG002|Treatment Period|Protocol Violation|8|||
44123452|NCT02873221|78907430|FG000|Treatment Period|Pregnancy|4|||
44123453|NCT02873221|78907431|FG001|Treatment Period|Pregnancy|6|||
44123454|NCT02873221|78907432|FG002|Treatment Period|Pregnancy|3|||
44123455|NCT02873221|78907430|FG000|Treatment Period|Lack of Qualifying Event|0|||
44123456|NCT02873221|78907431|FG001|Treatment Period|Lack of Qualifying Event|3|||
44123457|NCT02873221|78907432|FG002|Treatment Period|Lack of Qualifying Event|1|||
44123458|NCT02873221|78907430|FG000|Treatment Period|Withdrawal of Consent|52|||
44123459|NCT02873221|78907431|FG001|Treatment Period|Withdrawal of Consent|51|||
44123460|NCT02873221|78907432|FG002|Treatment Period|Withdrawal of Consent|41|||
44123461|NCT02873221|78907430|FG000|Treatment Period|Lack of Efficacy|0|||
44123462|NCT02873221|78907431|FG001|Treatment Period|Lack of Efficacy|17|||
44123463|NCT02873221|78907432|FG002|Treatment Period|Lack of Efficacy|12|||
44123464|NCT02873221|78907430|FG000|Treatment Period|Adverse Event|4|||
44123465|NCT02873221|78907431|FG001|Treatment Period|Adverse Event|9|||
44123466|NCT02873221|78907432|FG002|Treatment Period|Adverse Event|11|||
44123467|NCT02873221|78907430|FG000|Treatment Period|Lost to Follow-up|26|||
44123468|NCT02873221|78907431|FG001|Treatment Period|Lost to Follow-up|30|||
44123469|NCT02873221|78907432|FG002|Treatment Period|Lost to Follow-up|26|||
44510611|NCT00237185|79515741|FG001|Core|Determined ineligible post randomization|0|||
44510612|NCT00237185|79515740|FG000|Extension|Adverse Event|1|||
44510613|NCT00237185|79515741|FG001|Extension|Adverse Event|0|||
44510614|NCT00237185|79515740|FG000|Extension|Abnormal laboratory value|0|||
44510615|NCT00237185|79515741|FG001|Extension|Abnormal laboratory value|1|||
44510616|NCT00237185|79515740|FG000|Extension|Lack of Efficacy|9|||
44510617|NCT00237185|79515741|FG001|Extension|Lack of Efficacy|14|||
44510618|NCT00237185|79515740|FG000|Extension|Condition no longer required study drug|0|||
44510619|NCT00237185|79515741|FG001|Extension|Condition no longer required study drug|1|||
44510620|NCT00237185|79515740|FG000|Extension|Withdrawal by Subject|3|||
44510621|NCT00237185|79515741|FG001|Extension|Withdrawal by Subject|2|||
44510622|NCT00237185|79515740|FG000|Extension|Lost to Follow-up|1|||
44510623|NCT00237185|79515741|FG001|Extension|Lost to Follow-up|0|||
44510624|NCT00237185|79515740|FG000|Extension|Administrative problems|1|||
44510625|NCT00237185|79515741|FG001|Extension|Administrative problems|0|||
44510626|NCT00237185|79515740|FG000|Extension|Death|1|||
44243070|NCT01693562|79072529|FG001|Exploration Phase|Withdrawal by Subject|0|||
44243071|NCT01693562|79072530|FG002|Exploration Phase|Withdrawal by Subject|0|||
44510627|NCT00237185|79515741|FG001|Extension|Death|1|||
44510628|NCT00003222|79515749|FG000|Overall Study|Physician Decision|0|||
44510629|NCT00003222|79515750|FG001|Overall Study|Physician Decision|1|||
44510630|NCT02877082|79515756|FG000|Overall Study|Trial was closed early|5|||
44123470|NCT02873221|78907430|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
44123471|NCT02873221|78907431|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
44123472|NCT02873221|78907432|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
44123473|NCT02873221|78907430|FG000|Safety Follow-up Period|Protocol Violation|0|||
44510631|NCT02875834|79515764|FG000|Open-label Phase|Withdrawal by Subject|3|||
44123474|NCT02873221|78907431|FG001|Safety Follow-up Period|Protocol Violation|0|||
44123475|NCT02873221|78907432|FG002|Safety Follow-up Period|Protocol Violation|1|||
44123476|NCT02873221|78907430|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
44123477|NCT02873221|78907431|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
44123478|NCT02873221|78907432|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
44123479|NCT02873221|78907430|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
44123480|NCT02873221|78907431|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
44123481|NCT02873221|78907432|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
44123482|NCT02968979|78907440|FG000|Overall Study|Protocol Violation|7|||
44123483|NCT02968979|78907440|FG000|Overall Study|Withdrawal by Subject|1|||
44123484|NCT02966015|78907492|FG000|Inclusion Visit|did not answer questionnaire|8|||
44123485|NCT02966015|78907493|FG001|Inclusion Visit|did not answer questionnaire|3|||
44123486|NCT02968433|78907499|FG000|Overall Study|Withdrawal by Subject|1|||
44123487|NCT02872285|78907511|FG000|Overall Study|Withdrawal by Subject|2|||
44123488|NCT02872285|78907512|FG001|Overall Study|Withdrawal by Subject|0|||
44123489|NCT02872285|78907511|FG000|Overall Study|Lost to Follow-up|2|||
44123490|NCT02872285|78907512|FG001|Overall Study|Lost to Follow-up|2|||
44123491|NCT02872285|78907511|FG000|Overall Study|Discontinued due to back surgery|1|||
44123492|NCT02872285|78907512|FG001|Overall Study|Discontinued due to back surgery|0|||
44123493|NCT02871739|78907522|FG000|Overall Study|Lost to Follow-up|3|||
44123494|NCT02871739|78907523|FG001|Overall Study|Lost to Follow-up|2|||
44123495|NCT02871739|78907524|FG002|Overall Study|Lost to Follow-up|0|||
44123496|NCT02871739|78907525|FG003|Overall Study|Lost to Follow-up|2|||
44123497|NCT02896361|78907535|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
44123498|NCT02896361|78907536|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
44123499|NCT02896361|78907537|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
44123500|NCT02896361|78907535|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
44123501|NCT02896361|78907536|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
44123502|NCT02896361|78907537|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
44123503|NCT02962739|78907560|FG000|Overall Study|Withdrawal by Subject|0|||
44123504|NCT02962739|78907561|FG001|Overall Study|Withdrawal by Subject|1|||
44123505|NCT02962739|78907562|FG002|Overall Study|Withdrawal by Subject|0|||
44123506|NCT02962739|78907563|FG003|Overall Study|Withdrawal by Subject|0|||
44123507|NCT02962739|78907564|FG004|Overall Study|Withdrawal by Subject|0|||
44123508|NCT02962739|78907565|FG005|Overall Study|Withdrawal by Subject|0|||
44123509|NCT02962739|78907560|FG000|Overall Study|Protocol Violation|0|||
44123510|NCT02962739|78907561|FG001|Overall Study|Protocol Violation|0|||
44123511|NCT02962739|78907562|FG002|Overall Study|Protocol Violation|1|||
44123512|NCT02962739|78907563|FG003|Overall Study|Protocol Violation|0|||
44123513|NCT02962739|78907564|FG004|Overall Study|Protocol Violation|1|||
44123514|NCT02962739|78907565|FG005|Overall Study|Protocol Violation|0|||
44123515|NCT01344629|78907573|FG000|Crossover Period 2|Withdrawal by Subject|0|||
44123516|NCT01344629|78907574|FG001|Crossover Period 2|Withdrawal by Subject|1|||
44123517|NCT01092117|78907580|FG000|Index Procedure to 1 Month|Death|1|||
44123518|NCT01092117|78907580|FG000|1 Month|Death|1|||
44123519|NCT01092117|78907580|FG000|1 Month|Withdrawal by Subject|1|||
44123520|NCT01092117|78907580|FG000|1 Month|Lost to Follow-up|1|||
44123521|NCT01092117|78907580|FG000|6 Months|Death|2|||
44123522|NCT01092117|78907580|FG000|6 Months|Withdrawal by Subject|3|||
44123523|NCT01092117|78907580|FG000|12 Month|Death|11|||
44123524|NCT01092117|78907580|FG000|12 Month|Withdrawal by Subject|2|||
44123525|NCT01092117|78907580|FG000|12 Month|Lost to Follow-up|1|||
44123526|NCT01092117|78907580|FG000|Year 2|Death|5|||
44123527|NCT01092117|78907580|FG000|Year 2|Withdrawal by Subject|4|||
44243072|NCT01693562|79072531|FG003|Exploration Phase|Withdrawal by Subject|0|||
44243073|NCT01693562|79072532|FG004|Exploration Phase|Withdrawal by Subject|0|||
44243074|NCT01693562|79072533|FG005|Exploration Phase|Withdrawal by Subject|0|||
44243075|NCT01693562|79072534|FG006|Exploration Phase|Withdrawal by Subject|2|||
44243076|NCT01693562|79072535|FG007|Exploration Phase|Withdrawal by Subject|0|||
44123528|NCT01092117|78907580|FG000|Year 2|Lost to Follow-up|1|||
44123529|NCT01092117|78907580|FG000|Year 3|Death|7|||
44123530|NCT01092117|78907580|FG000|Year 3|Withdrawal by Subject|9|||
44123531|NCT01092117|78907580|FG000|Year 3|Lost to Follow-up|3|||
44123532|NCT01092117|78907580|FG000|Year 4|Death|8|||
44123533|NCT01092117|78907580|FG000|Year 4|Withdrawal by Subject|4|||
44123534|NCT01092117|78907580|FG000|Year 4|Lost to Follow-up|4|||
44123535|NCT01065779|78907593|FG000|Overall Study|Duplicate Investigation|1|||
44123536|NCT01065779|78907593|FG000|Overall Study|Investigation Before Contract Date|37|||
44123537|NCT01065779|78907593|FG000|Overall Study|Non-enrollment Period Administration|10|||
44123538|NCT01065779|78907593|FG000|Overall Study|Not Administered With Study Drug|17|||
44123539|NCT01065779|78907593|FG000|Overall Study|Failed to Follow-up|10|||
44123540|NCT01065779|78907593|FG000|Overall Study|Inclusion Criteria Violation|7|||
44123541|NCT02963441|78907597|FG000|Overall Study|Protocol violation or withdrawn|8|||
44123542|NCT02963441|78907597|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
44123543|NCT02963441|78907597|FG000|Overall Study|IDx-DR insufficient quality|33|||
44123544|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
44123545|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
44123546|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
44123547|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
44123548|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
44123549|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
44123550|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
44123551|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
44123552|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
44123553|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
44123554|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
44123555|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
44276467|NCT02209506|79231143|FG001|Overall Study|Withdrawal by Subject|0|||
44276468|NCT02209506|79231144|FG002|Overall Study|Withdrawal by Subject|0|||
44276469|NCT02209506|79231145|FG003|Overall Study|Withdrawal by Subject|0|||
44123556|NCT01345253|78907604|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
44123557|NCT01345253|78907605|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
44123558|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
44123559|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
44243077|NCT01693562|79072536|FG008|Exploration Phase|Withdrawal by Subject|0|||
44243078|NCT01693562|79072537|FG009|Exploration Phase|Withdrawal by Subject|0|||
44243079|NCT01693562|79072538|FG010|Exploration Phase|Withdrawal by Subject|0|||
44243080|NCT01693562|79072539|FG011|Exploration Phase|Withdrawal by Subject|0|||
44243081|NCT01693562|79072540|FG012|Exploration Phase|Withdrawal by Subject|0|||
44243082|NCT01693562|79072541|FG013|Exploration Phase|Withdrawal by Subject|0|||
44243083|NCT01693562|79072542|FG014|Exploration Phase|Withdrawal by Subject|0|||
44276470|NCT02209506|79231146|FG004|Overall Study|Withdrawal by Subject|1|||
44123560|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
44123561|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
44123562|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
44123563|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
44123564|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
44123565|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
44123566|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
44123567|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
44123568|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
44123569|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
44123570|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
44123571|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
44123572|NCT01345253|78907604|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
44123573|NCT01345253|78907605|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
44123574|NCT02477800|78907616|FG000|Placebo-Controlled Period|Adverse Event|16|||
44123575|NCT02477800|78907617|FG001|Placebo-Controlled Period|Adverse Event|25|||
44123576|NCT02477800|78907618|FG002|Placebo-Controlled Period|Adverse Event|28|||
44123577|NCT02477800|78907619|FG003|Placebo-Controlled Period|Adverse Event|0|||
44123578|NCT02477800|78907620|FG004|Placebo-Controlled Period|Adverse Event|0|||
44123579|NCT02477800|78907621|FG005|Placebo-Controlled Period|Adverse Event|0|||
44123580|NCT02477800|78907622|FG006|Placebo-Controlled Period|Adverse Event|0|||
44123581|NCT02477800|78907616|FG000|Placebo-Controlled Period|Change of Treatment|1|||
44243084|NCT01693562|79072543|FG015|Exploration Phase|Withdrawal by Subject|0|||
44123582|NCT02477800|78907617|FG001|Placebo-Controlled Period|Change of Treatment|2|||
44123583|NCT02477800|78907618|FG002|Placebo-Controlled Period|Change of Treatment|1|||
44123584|NCT02477800|78907619|FG003|Placebo-Controlled Period|Change of Treatment|0|||
44123585|NCT02477800|78907620|FG004|Placebo-Controlled Period|Change of Treatment|0|||
44123586|NCT02477800|78907621|FG005|Placebo-Controlled Period|Change of Treatment|0|||
44123587|NCT02477800|78907622|FG006|Placebo-Controlled Period|Change of Treatment|0|||
44123588|NCT02477800|78907616|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
44123589|NCT02477800|78907617|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
44123590|NCT02477800|78907618|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
44123591|NCT02477800|78907619|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
44123592|NCT02477800|78907620|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
44123593|NCT02477800|78907621|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
44123594|NCT02477800|78907622|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
44123595|NCT02477800|78907616|FG000|Placebo-Controlled Period|Death|0|||
44123596|NCT02477800|78907617|FG001|Placebo-Controlled Period|Death|3|||
44123597|NCT02477800|78907618|FG002|Placebo-Controlled Period|Death|2|||
44123598|NCT02477800|78907619|FG003|Placebo-Controlled Period|Death|0|||
44123599|NCT02477800|78907620|FG004|Placebo-Controlled Period|Death|0|||
44123600|NCT02477800|78907621|FG005|Placebo-Controlled Period|Death|0|||
44123601|NCT02477800|78907622|FG006|Placebo-Controlled Period|Death|0|||
44243085|NCT01693562|79072544|FG016|Exploration Phase|Withdrawal by Subject|0|||
44123602|NCT02477800|78907616|FG000|Placebo-Controlled Period|Disease Progression|1|||
44123603|NCT02477800|78907617|FG001|Placebo-Controlled Period|Disease Progression|0|||
44379197|NCT01039688|79384854|FG002|Overall Study|Lost to Follow-up|5|||
44379198|NCT01039688|79384852|FG000|Overall Study|Other|13|||
44379199|NCT01039688|79384853|FG001|Overall Study|Other|25|||
44123604|NCT02477800|78907618|FG002|Placebo-Controlled Period|Disease Progression|1|||
44123605|NCT02477800|78907619|FG003|Placebo-Controlled Period|Disease Progression|0|||
44123606|NCT02477800|78907620|FG004|Placebo-Controlled Period|Disease Progression|0|||
44123607|NCT02477800|78907621|FG005|Placebo-Controlled Period|Disease Progression|0|||
44123608|NCT02477800|78907622|FG006|Placebo-Controlled Period|Disease Progression|0|||
44123609|NCT02477800|78907616|FG000|Placebo-Controlled Period|Investigator Decision|3|||
44123610|NCT02477800|78907617|FG001|Placebo-Controlled Period|Investigator Decision|2|||
44123611|NCT02477800|78907618|FG002|Placebo-Controlled Period|Investigator Decision|1|||
44123612|NCT02477800|78907619|FG003|Placebo-Controlled Period|Investigator Decision|0|||
44123613|NCT02477800|78907620|FG004|Placebo-Controlled Period|Investigator Decision|0|||
44123614|NCT02477800|78907621|FG005|Placebo-Controlled Period|Investigator Decision|0|||
44123615|NCT02477800|78907622|FG006|Placebo-Controlled Period|Investigator Decision|0|||
44123616|NCT02477800|78907616|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
44123617|NCT02477800|78907617|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
44123618|NCT02477800|78907618|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
44123619|NCT02477800|78907619|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
44123620|NCT02477800|78907620|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
44123621|NCT02477800|78907621|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
44123622|NCT02477800|78907622|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
44123623|NCT02477800|78907616|FG000|Placebo-Controlled Period|Relocation|2|||
44123624|NCT02477800|78907617|FG001|Placebo-Controlled Period|Relocation|0|||
44123625|NCT02477800|78907618|FG002|Placebo-Controlled Period|Relocation|0|||
44123626|NCT02477800|78907619|FG003|Placebo-Controlled Period|Relocation|0|||
44123627|NCT02477800|78907620|FG004|Placebo-Controlled Period|Relocation|0|||
44123628|NCT02477800|78907621|FG005|Placebo-Controlled Period|Relocation|0|||
44123629|NCT02477800|78907622|FG006|Placebo-Controlled Period|Relocation|0|||
44123630|NCT02477800|78907616|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
44123631|NCT02477800|78907617|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
44123632|NCT02477800|78907618|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
44123633|NCT02477800|78907619|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
44123634|NCT02477800|78907620|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
44123635|NCT02477800|78907621|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
44123636|NCT02477800|78907622|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
44123637|NCT02477800|78907616|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
44123638|NCT02477800|78907617|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
44123639|NCT02477800|78907618|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
44123640|NCT02477800|78907619|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
44123641|NCT02477800|78907620|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
44123642|NCT02477800|78907621|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
44123643|NCT02477800|78907622|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
44123644|NCT02477800|78907616|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
44123645|NCT02477800|78907617|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
44123646|NCT02477800|78907618|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
44123647|NCT02477800|78907619|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
44123648|NCT02477800|78907620|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
44123649|NCT02477800|78907621|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
44123650|NCT02477800|78907622|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
44123651|NCT02477800|78907616|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
44123652|NCT02477800|78907617|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
44123653|NCT02477800|78907618|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
44123654|NCT02477800|78907619|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44123655|NCT02477800|78907620|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44243086|NCT01693562|79072545|FG017|Exploration Phase|Withdrawal by Subject|0|||
44243087|NCT01693562|79072546|FG018|Exploration Phase|Withdrawal by Subject|0|||
44243088|NCT01693562|79072547|FG019|Exploration Phase|Withdrawal by Subject|0|||
44123656|NCT02477800|78907621|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44123657|NCT02477800|78907622|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44123658|NCT02477800|78907616|FG000|Placebo-Controlled Period|Reason not Specified|161|||
44123659|NCT02477800|78907617|FG001|Placebo-Controlled Period|Reason not Specified|161|||
44123660|NCT02477800|78907618|FG002|Placebo-Controlled Period|Reason not Specified|189|||
44123661|NCT02477800|78907619|FG003|Placebo-Controlled Period|Reason not Specified|0|||
44123662|NCT02477800|78907620|FG004|Placebo-Controlled Period|Reason not Specified|0|||
44123663|NCT02477800|78907621|FG005|Placebo-Controlled Period|Reason not Specified|0|||
44123664|NCT02477800|78907622|FG006|Placebo-Controlled Period|Reason not Specified|0|||
44123665|NCT02477800|78907616|FG000|Long Term Extension Period|Adverse Event|0|||
44123666|NCT02477800|78907617|FG001|Long Term Extension Period|Adverse Event|0|||
44123667|NCT02477800|78907618|FG002|Long Term Extension Period|Adverse Event|0|||
44123668|NCT02477800|78907619|FG003|Long Term Extension Period|Adverse Event|6|||
44123669|NCT02477800|78907620|FG004|Long Term Extension Period|Adverse Event|2|||
44123670|NCT02477800|78907621|FG005|Long Term Extension Period|Adverse Event|4|||
44123671|NCT02477800|78907622|FG006|Long Term Extension Period|Adverse Event|3|||
44123672|NCT02477800|78907616|FG000|Long Term Extension Period|Death|0|||
44123673|NCT02477800|78907617|FG001|Long Term Extension Period|Death|0|||
44123674|NCT02477800|78907618|FG002|Long Term Extension Period|Death|0|||
44123675|NCT02477800|78907619|FG003|Long Term Extension Period|Death|1|||
44123676|NCT02477800|78907620|FG004|Long Term Extension Period|Death|1|||
44123677|NCT02477800|78907621|FG005|Long Term Extension Period|Death|1|||
44123678|NCT02477800|78907622|FG006|Long Term Extension Period|Death|2|||
44123679|NCT02477800|78907616|FG000|Long Term Extension Period|Consent Withdrawn|0|||
44379200|NCT01039688|79384854|FG002|Overall Study|Other|12|||
44510632|NCT02875834|79515765|FG001|Open-label Phase|Withdrawal by Subject|0|||
44510633|NCT02875834|79515766|FG002|Open-label Phase|Withdrawal by Subject|0|||
44510634|NCT02875834|79515767|FG003|Open-label Phase|Withdrawal by Subject|0|||
44510635|NCT02875834|79515764|FG000|Open-label Phase|(Not collected)|4|||
44123680|NCT02477800|78907617|FG001|Long Term Extension Period|Consent Withdrawn|0|||
44510636|NCT02875834|79515765|FG001|Open-label Phase|(Not collected)|0|||
44510637|NCT02875834|79515766|FG002|Open-label Phase|(Not collected)|0|||
44510638|NCT02875834|79515767|FG003|Open-label Phase|(Not collected)|0|||
44510639|NCT02875834|79515764|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
44510640|NCT02875834|79515765|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
44123681|NCT02477800|78907618|FG002|Long Term Extension Period|Consent Withdrawn|0|||
44123682|NCT02477800|78907619|FG003|Long Term Extension Period|Consent Withdrawn|10|||
44123683|NCT02477800|78907620|FG004|Long Term Extension Period|Consent Withdrawn|4|||
44123684|NCT02477800|78907621|FG005|Long Term Extension Period|Consent Withdrawn|13|||
44123685|NCT02477800|78907622|FG006|Long Term Extension Period|Consent Withdrawn|16|||
44379201|NCT01039688|79384852|FG000|Overall Study|Withdrawal by Subject|23|||
44510641|NCT02875834|79515766|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
44123686|NCT02477800|78907616|FG000|Long Term Extension Period|Disease Progression|0|||
44123687|NCT02477800|78907617|FG001|Long Term Extension Period|Disease Progression|0|||
44123688|NCT02477800|78907618|FG002|Long Term Extension Period|Disease Progression|0|||
44123689|NCT02477800|78907619|FG003|Long Term Extension Period|Disease Progression|3|||
44123690|NCT02477800|78907620|FG004|Long Term Extension Period|Disease Progression|1|||
44123691|NCT02477800|78907621|FG005|Long Term Extension Period|Disease Progression|1|||
44123692|NCT02477800|78907622|FG006|Long Term Extension Period|Disease Progression|0|||
44123693|NCT02477800|78907616|FG000|Long Term Extension Period|Investigator Decision|0|||
44123694|NCT02477800|78907617|FG001|Long Term Extension Period|Investigator Decision|0|||
44243089|NCT01693562|79072548|FG020|Exploration Phase|Withdrawal by Subject|0|||
44510642|NCT02875834|79515767|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
44510643|NCT02875834|79515764|FG000|Randomized Treatment Phase|Protocol Violation|0|||
44510644|NCT02875834|79515765|FG001|Randomized Treatment Phase|Protocol Violation|2|||
44510645|NCT02875834|79515766|FG002|Randomized Treatment Phase|Protocol Violation|0|||
44510646|NCT02875834|79515767|FG003|Randomized Treatment Phase|Protocol Violation|0|||
44510647|NCT02875834|79515764|FG000|Randomized Treatment Phase|(Not collected)|0|||
44510648|NCT02875834|79515765|FG001|Randomized Treatment Phase|(Not collected)|9|||
44510649|NCT02875834|79515766|FG002|Randomized Treatment Phase|(Not collected)|10|||
44510650|NCT02875834|79515767|FG003|Randomized Treatment Phase|(Not collected)|9|||
44510651|NCT02875366|79515779|FG000|Overall Study|Adverse Event|0|||
44510652|NCT02875366|79515780|FG001|Overall Study|Adverse Event|2|||
44510653|NCT02875366|79515779|FG000|Overall Study|Noncompliance|0|||
44510654|NCT02875366|79515780|FG001|Overall Study|Noncompliance|1|||
44510655|NCT00002850|79515789|FG000|Overall Study|Death|4|||
44510656|NCT00002850|79515790|FG001|Overall Study|Death|1|||
44510657|NCT00002850|79515791|FG002|Overall Study|Death|3|||
44510658|NCT00002850|79515789|FG000|Overall Study|Protocol Violation|1|||
44510659|NCT00002850|79515790|FG001|Overall Study|Protocol Violation|0|||
44510660|NCT00002850|79515791|FG002|Overall Study|Protocol Violation|1|||
44510661|NCT00002850|79515789|FG000|Overall Study|Withdrawal by Subject|0|||
44510662|NCT00002850|79515790|FG001|Overall Study|Withdrawal by Subject|1|||
44510663|NCT00002850|79515791|FG002|Overall Study|Withdrawal by Subject|0|||
44510664|NCT00002766|79515801|FG000|Overall Study|Withdrawal by Subject|0|||
44510665|NCT00002766|79515802|FG001|Overall Study|Withdrawal by Subject|1|||
44510666|NCT00002766|79515801|FG000|Overall Study|Patient Not Treated|1|||
44510667|NCT00002766|79515802|FG001|Overall Study|Patient Not Treated|2|||
44123695|NCT02477800|78907618|FG002|Long Term Extension Period|Investigator Decision|0|||
44243090|NCT01693562|79072549|FG021|Exploration Phase|Withdrawal by Subject|0|||
44243091|NCT01693562|79072550|FG022|Exploration Phase|Withdrawal by Subject|0|||
44243092|NCT01693562|79072528|FG000|Exploration Phase|Death|0|||
44243093|NCT01693562|79072529|FG001|Exploration Phase|Death|0|||
44243094|NCT01693562|79072530|FG002|Exploration Phase|Death|0|||
44510668|NCT00002766|79515801|FG000|Overall Study|Adverse Event|1|||
44510669|NCT00002766|79515802|FG001|Overall Study|Adverse Event|1|||
44510670|NCT00002766|79515801|FG000|Overall Study|Protocol Violation|1|||
44243095|NCT01693562|79072531|FG003|Exploration Phase|Death|0|||
44243096|NCT01693562|79072532|FG004|Exploration Phase|Death|0|||
44510671|NCT00002766|79515802|FG001|Overall Study|Protocol Violation|0|||
44510672|NCT02306122|79515815|FG000|Initial Physician Randomization|Physician Decision|0|||
44510673|NCT02306122|79515816|FG001|Initial Physician Randomization|Physician Decision|0|||
44123696|NCT02477800|78907619|FG003|Long Term Extension Period|Investigator Decision|0|||
44123697|NCT02477800|78907620|FG004|Long Term Extension Period|Investigator Decision|0|||
44123698|NCT02477800|78907621|FG005|Long Term Extension Period|Investigator Decision|0|||
44123699|NCT02477800|78907622|FG006|Long Term Extension Period|Investigator Decision|2|||
44123700|NCT02477800|78907616|FG000|Long Term Extension Period|Lost to Follow-up|0|||
44123701|NCT02477800|78907617|FG001|Long Term Extension Period|Lost to Follow-up|0|||
44123702|NCT02477800|78907618|FG002|Long Term Extension Period|Lost to Follow-up|0|||
44123703|NCT02477800|78907619|FG003|Long Term Extension Period|Lost to Follow-up|0|||
44123704|NCT02477800|78907620|FG004|Long Term Extension Period|Lost to Follow-up|1|||
44123705|NCT02477800|78907621|FG005|Long Term Extension Period|Lost to Follow-up|3|||
44123706|NCT02477800|78907622|FG006|Long Term Extension Period|Lost to Follow-up|0|||
44123707|NCT02477800|78907616|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
44123708|NCT02477800|78907617|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
44123709|NCT02477800|78907618|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
44123710|NCT02477800|78907619|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
44123711|NCT02477800|78907620|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
44123712|NCT02477800|78907621|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
44123713|NCT02477800|78907622|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
44123714|NCT02477800|78907616|FG000|Long Term Extension Period|Study Visit Burden|0|||
44123715|NCT02477800|78907617|FG001|Long Term Extension Period|Study Visit Burden|0|||
44123716|NCT02477800|78907618|FG002|Long Term Extension Period|Study Visit Burden|0|||
44123717|NCT02477800|78907619|FG003|Long Term Extension Period|Study Visit Burden|3|||
44123718|NCT02477800|78907620|FG004|Long Term Extension Period|Study Visit Burden|0|||
44123719|NCT02477800|78907621|FG005|Long Term Extension Period|Study Visit Burden|2|||
44123720|NCT02477800|78907622|FG006|Long Term Extension Period|Study Visit Burden|2|||
44123721|NCT02477800|78907616|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
44123722|NCT02477800|78907617|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
44123723|NCT02477800|78907618|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
44123724|NCT02477800|78907619|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
44123725|NCT02477800|78907620|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
44123726|NCT02477800|78907621|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
44123727|NCT02477800|78907622|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
44123728|NCT02477800|78907616|FG000|Long Term Extension Period|Reason not Specified|0|||
44123729|NCT02477800|78907617|FG001|Long Term Extension Period|Reason not Specified|0|||
44123730|NCT02477800|78907618|FG002|Long Term Extension Period|Reason not Specified|0|||
44123731|NCT02477800|78907619|FG003|Long Term Extension Period|Reason not Specified|126|||
44123732|NCT02477800|78907620|FG004|Long Term Extension Period|Reason not Specified|140|||
44123733|NCT02477800|78907621|FG005|Long Term Extension Period|Reason not Specified|270|||
44123734|NCT02477800|78907622|FG006|Long Term Extension Period|Reason not Specified|224|||
44123735|NCT02957747|78907636|FG000|Overall Study|Withdrawal by Subject|0|||
44123736|NCT02957747|78907637|FG001|Overall Study|Withdrawal by Subject|3|||
44123737|NCT02957747|78907636|FG000|Overall Study|Lost to Follow-up|10|||
44123738|NCT02957747|78907637|FG001|Overall Study|Lost to Follow-up|5|||
44123739|NCT01344161|78907646|FG000|Overall Study|Lost to Follow-up|4|||
44123740|NCT01344161|78907647|FG001|Overall Study|Lost to Follow-up|1|||
44123741|NCT01344161|78907646|FG000|Overall Study|Pregnancy|0|||
44123742|NCT01344161|78907647|FG001|Overall Study|Pregnancy|1|||
44123743|NCT01344161|78907646|FG000|Overall Study|Protocol Violation|1|||
44243097|NCT01693562|79072533|FG005|Exploration Phase|Death|0|||
44243098|NCT01693562|79072534|FG006|Exploration Phase|Death|17|||
44510674|NCT02306122|79515817|FG002|Initial Physician Randomization|Physician Decision|0|||
44510675|NCT02306122|79515818|FG003|Initial Physician Randomization|Physician Decision|0|||
44510676|NCT02306122|79515819|FG004|Initial Physician Randomization|Physician Decision|0|||
44510677|NCT02306122|79515820|FG005|Initial Physician Randomization|Physician Decision|0|||
44510678|NCT02306122|79515821|FG006|Initial Physician Randomization|Physician Decision|0|||
44510679|NCT02306122|79515822|FG007|Initial Physician Randomization|Physician Decision|0|||
44510680|NCT02306122|79515823|FG008|Initial Physician Randomization|Physician Decision|1|||
44123744|NCT01344161|78907647|FG001|Overall Study|Protocol Violation|1|||
44243099|NCT01693562|79072535|FG007|Exploration Phase|Death|0|||
44123745|NCT02451358|78907657|FG000|Overall Study|Withdrawal by Subject|1|||
44123746|NCT02451358|78907658|FG001|Overall Study|Withdrawal by Subject|1|||
44243100|NCT01693562|79072536|FG008|Exploration Phase|Death|0|||
44123747|NCT02451358|78907659|FG002|Overall Study|Withdrawal by Subject|0|||
44123748|NCT02451358|78907660|FG003|Overall Study|Withdrawal by Subject|0|||
44123749|NCT02451358|78907657|FG000|Overall Study|Protocol Violation|0|||
44123750|NCT02451358|78907658|FG001|Overall Study|Protocol Violation|1|||
44123751|NCT02451358|78907659|FG002|Overall Study|Protocol Violation|1|||
44123752|NCT02451358|78907660|FG003|Overall Study|Protocol Violation|0|||
44123753|NCT02749721|78907670|FG000|Screening|Withdrawal by Subject|1|||
44123754|NCT02749721|78907670|FG000|Screening|Lost to Follow-up|2|||
44123755|NCT02749721|78907670|FG000|Screening|Protocol Violation|3|||
44123756|NCT02749721|78907670|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
44123757|NCT02749721|78907670|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
44123758|NCT01348139|78907676|FG000|Period 1|Adverse Event|1|||
44123759|NCT01348139|78907677|FG001|Period 1|Adverse Event|0|||
44123760|NCT01348139|78907678|FG002|Period 1|Adverse Event|0|||
44123761|NCT01348139|78907679|FG003|Period 1|Adverse Event|0|||
44123762|NCT01348139|78907680|FG004|Period 1|Adverse Event|0|||
44123763|NCT01348139|78907681|FG005|Period 1|Adverse Event|0|||
44123764|NCT02868229|78907699|FG000|Overall Study|Adverse Event|1|||
44123765|NCT02868229|78907700|FG001|Overall Study|Adverse Event|0|||
44123766|NCT02868229|78907701|FG002|Overall Study|Adverse Event|0|||
44123767|NCT02868229|78907702|FG003|Overall Study|Adverse Event|1|||
44123768|NCT02868229|78907699|FG000|Overall Study|Death|0|||
44123769|NCT02868229|78907700|FG001|Overall Study|Death|0|||
44123770|NCT02868229|78907701|FG002|Overall Study|Death|1|||
44123771|NCT02868229|78907702|FG003|Overall Study|Death|1|||
44123772|NCT02868229|78907699|FG000|Overall Study|Missed dose|0|||
44123773|NCT02868229|78907700|FG001|Overall Study|Missed dose|0|||
44123774|NCT02868229|78907701|FG002|Overall Study|Missed dose|0|||
44123775|NCT02868229|78907702|FG003|Overall Study|Missed dose|3|||
44123776|NCT02956967|78907717|FG000|Overall Study|Adverse Event|3|||
44123777|NCT02956967|78907717|FG000|Overall Study|Reason non-related to neutropenia|10|||
44123778|NCT02956967|78907717|FG000|Overall Study|Lost to Follow-up|5|||
44123779|NCT02956967|78907717|FG000|Overall Study|Missing|1|||
44123780|NCT02956967|78907717|FG000|Overall Study|Termination of Nivestim administration|29|||
44123781|NCT02867995|78907741|FG000|Overall Study|Withdrawal by Subject|0|||
44123782|NCT02867995|78907742|FG001|Overall Study|Withdrawal by Subject|1|||
44123783|NCT02867995|78907741|FG000|Overall Study|Lost to Follow-up|0|||
44123784|NCT02867995|78907742|FG001|Overall Study|Lost to Follow-up|2|||
44243101|NCT01693562|79072537|FG009|Exploration Phase|Death|0|||
44243102|NCT01693562|79072538|FG010|Exploration Phase|Death|0|||
44379202|NCT01039688|79384853|FG001|Overall Study|Withdrawal by Subject|27|||
44510681|NCT02306122|79515824|FG009|Initial Physician Randomization|Physician Decision|0|||
44510682|NCT02306122|79515825|FG010|Initial Physician Randomization|Physician Decision|0|||
44510683|NCT00001962|79515843|FG000|Overall Study|Lack of Efficacy|18|||
44510684|NCT00001962|79515843|FG000|Overall Study|Lack of Accrual|6|||
44510685|NCT00001962|79515843|FG000|Overall Study|Death|1|||
44510686|NCT00001962|79515843|FG000|Overall Study|Lost to Follow-up|2|||
44510687|NCT00001962|79515843|FG000|Overall Study|Adverse Event|1|||
44510688|NCT00028002|79515847|FG000|Overall Study|Withdrawal by Subject|3|||
44510689|NCT00028002|79515847|FG000|Overall Study|Ineligible|8|||
44510690|NCT00256997|79515854|FG000|Overall Study|Protocol Violation|1|||
44510691|NCT00256997|79515855|FG001|Overall Study|Protocol Violation|4|||
44510692|NCT00256997|79515854|FG000|Overall Study|Lack of Efficacy|1|||
44123785|NCT03392883|78907755|FG000|Overall Study|Lost to Follow-up|122|||
44123786|NCT03392883|78907756|FG001|Overall Study|Lost to Follow-up|13|||
44123787|NCT03392883|78907757|FG002|Overall Study|Lost to Follow-up|9|||
44123788|NCT03392883|78907755|FG000|Overall Study|Death|4|||
44123789|NCT03392883|78907756|FG001|Overall Study|Death|0|||
44123790|NCT03392883|78907757|FG002|Overall Study|Death|0|||
44123791|NCT03392883|78907755|FG000|Overall Study|Lack of Efficacy|29|||
44123792|NCT03392883|78907756|FG001|Overall Study|Lack of Efficacy|0|||
44123793|NCT03392883|78907757|FG002|Overall Study|Lack of Efficacy|0|||
44123794|NCT03392883|78907755|FG000|Overall Study|Withdrawal by Subject|180|||
44123795|NCT03392883|78907756|FG001|Overall Study|Withdrawal by Subject|0|||
44123796|NCT03392883|78907757|FG002|Overall Study|Withdrawal by Subject|0|||
44123797|NCT03392883|78907755|FG000|Overall Study|Adverse Event|1|||
44123798|NCT03392883|78907756|FG001|Overall Study|Adverse Event|0|||
44243103|NCT01693562|79072539|FG011|Exploration Phase|Death|0|||
44243104|NCT01693562|79072540|FG012|Exploration Phase|Death|0|||
44243105|NCT01693562|79072541|FG013|Exploration Phase|Death|0|||
44123799|NCT03392883|78907757|FG002|Overall Study|Adverse Event|0|||
44123800|NCT02748863|78907768|FG000|Treatment Period 1|Adverse Event|0|||
44123801|NCT02748863|78907769|FG001|Treatment Period 1|Adverse Event|1|||
44379203|NCT01039688|79384854|FG002|Overall Study|Withdrawal by Subject|13|||
44510693|NCT00256997|79515855|FG001|Overall Study|Lack of Efficacy|4|||
44510694|NCT00256997|79515854|FG000|Overall Study|Death|2|||
44510695|NCT00256997|79515855|FG001|Overall Study|Death|0|||
44510696|NCT00256997|79515854|FG000|Overall Study|Adverse Event|4|||
44510697|NCT00256997|79515855|FG001|Overall Study|Adverse Event|0|||
44510698|NCT00256997|79515854|FG000|Overall Study|Lost to Follow-up|3|||
44510699|NCT00256997|79515855|FG001|Overall Study|Lost to Follow-up|5|||
44510700|NCT00256997|79515854|FG000|Overall Study|Withdrawal by Subject|13|||
44510701|NCT00256997|79515855|FG001|Overall Study|Withdrawal by Subject|3|||
44510702|NCT00256997|79515854|FG000|Overall Study|Started but not treated|2|||
44510703|NCT00256997|79515855|FG001|Overall Study|Started but not treated|0|||
44510704|NCT00256997|79515854|FG000|Overall Study|Other|5|||
44123802|NCT02748863|78907770|FG002|Treatment Period 1|Adverse Event|0|||
44510705|NCT00256997|79515855|FG001|Overall Study|Other|8|||
44123803|NCT02748863|78907771|FG003|Treatment Period 1|Adverse Event|0|||
44123804|NCT02748863|78907772|FG004|Treatment Period 1|Adverse Event|0|||
44510706|NCT00256997|79515854|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
44123805|NCT02748863|78907768|FG000|Treatment Period 1|Lack of Efficacy|0|||
44123806|NCT02748863|78907769|FG001|Treatment Period 1|Lack of Efficacy|0|||
44123807|NCT02748863|78907770|FG002|Treatment Period 1|Lack of Efficacy|1|||
44123808|NCT02748863|78907771|FG003|Treatment Period 1|Lack of Efficacy|0|||
44123809|NCT02748863|78907772|FG004|Treatment Period 1|Lack of Efficacy|0|||
44123810|NCT02748863|78907768|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44123811|NCT02748863|78907769|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44510707|NCT00256997|79515855|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
44510708|NCT00256997|79515854|FG000|Overall Study|Participant Non-compliant|3|||
44510709|NCT00256997|79515855|FG001|Overall Study|Participant Non-compliant|6|||
44510710|NCT00256997|79515854|FG000|Overall Study|Investigator Withdrew Participant|2|||
44510711|NCT00256997|79515855|FG001|Overall Study|Investigator Withdrew Participant|1|||
44510712|NCT00027846|79515865|FG000|Overall Study|Lost to Follow-up|0|||
44510713|NCT00027846|79515866|FG001|Overall Study|Lost to Follow-up|41|||
44510714|NCT00027846|79515867|FG002|Overall Study|Lost to Follow-up|9|||
44510715|NCT00027846|79515865|FG000|Overall Study|Withdrawal by Subject|0|||
44510716|NCT00027846|79515866|FG001|Overall Study|Withdrawal by Subject|14|||
44510717|NCT00027846|79515867|FG002|Overall Study|Withdrawal by Subject|7|||
44510718|NCT00027846|79515865|FG000|Overall Study|Ineligible for study|2|||
44510719|NCT00027846|79515866|FG001|Overall Study|Ineligible for study|6|||
44510720|NCT00027846|79515867|FG002|Overall Study|Ineligible for study|14|||
44510721|NCT00027846|79515865|FG000|Overall Study|Entry into another COG therapeutic study|0|||
44510722|NCT00027846|79515866|FG001|Overall Study|Entry into another COG therapeutic study|5|||
44510723|NCT00027846|79515867|FG002|Overall Study|Entry into another COG therapeutic study|2|||
44510724|NCT00027846|79515865|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
44510725|NCT00027846|79515866|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
44510726|NCT00027846|79515867|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
44510727|NCT00027378|79515879|FG000|Overall Study|Physician Decision|0|||
44510728|NCT00027378|79515880|FG001|Overall Study|Physician Decision|3|||
44510729|NCT00235391|79515892|FG000|Overall Study|Adverse Event|4|||
44510730|NCT00235391|79515893|FG001|Overall Study|Adverse Event|5|||
44510731|NCT00235391|79515894|FG002|Overall Study|Adverse Event|10|||
44510732|NCT00235391|79515895|FG003|Overall Study|Adverse Event|72|||
44510733|NCT00235391|79515896|FG004|Overall Study|Adverse Event|5|||
44510734|NCT00235391|79515897|FG005|Overall Study|Adverse Event|2|||
44510735|NCT00235391|79515892|FG000|Overall Study|Abnormal laboratory value(s)|3|||
44510736|NCT00235391|79515893|FG001|Overall Study|Abnormal laboratory value(s)|5|||
44510737|NCT00235391|79515894|FG002|Overall Study|Abnormal laboratory value(s)|4|||
44510738|NCT00235391|79515895|FG003|Overall Study|Abnormal laboratory value(s)|27|||
44510739|NCT00235391|79515896|FG004|Overall Study|Abnormal laboratory value(s)|1|||
44510740|NCT00235391|79515897|FG005|Overall Study|Abnormal laboratory value(s)|2|||
44510741|NCT00235391|79515892|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44510742|NCT00235391|79515893|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44510743|NCT00235391|79515894|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44510744|NCT00235391|79515895|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
44510745|NCT00235391|79515896|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
44510746|NCT00235391|79515897|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
44510747|NCT00235391|79515892|FG000|Overall Study|Condition no longer requires treatment|3|||
44510748|NCT00235391|79515893|FG001|Overall Study|Condition no longer requires treatment|0|||
44510749|NCT00235391|79515894|FG002|Overall Study|Condition no longer requires treatment|0|||
44510750|NCT00235391|79515895|FG003|Overall Study|Condition no longer requires treatment|11|||
44510751|NCT00235391|79515896|FG004|Overall Study|Condition no longer requires treatment|1|||
44510752|NCT00235391|79515897|FG005|Overall Study|Condition no longer requires treatment|0|||
44510753|NCT00235391|79515892|FG000|Overall Study|Protocol deviation|0|||
44510754|NCT00235391|79515893|FG001|Overall Study|Protocol deviation|0|||
44510755|NCT00235391|79515894|FG002|Overall Study|Protocol deviation|1|||
44510756|NCT00235391|79515895|FG003|Overall Study|Protocol deviation|11|||
44510757|NCT00235391|79515896|FG004|Overall Study|Protocol deviation|0|||
44510758|NCT00235391|79515897|FG005|Overall Study|Protocol deviation|0|||
44510759|NCT00235391|79515892|FG000|Overall Study|Withdrawal by Subject|2|||
44510760|NCT00235391|79515893|FG001|Overall Study|Withdrawal by Subject|3|||
44510761|NCT00235391|79515894|FG002|Overall Study|Withdrawal by Subject|3|||
44510762|NCT00235391|79515895|FG003|Overall Study|Withdrawal by Subject|61|||
44510763|NCT00235391|79515896|FG004|Overall Study|Withdrawal by Subject|5|||
44123812|NCT02748863|78907770|FG002|Treatment Period 1|Withdrawal by Subject|1|||
44510764|NCT00235391|79515897|FG005|Overall Study|Withdrawal by Subject|0|||
44510765|NCT00235391|79515892|FG000|Overall Study|Lost to Follow-up|0|||
44510766|NCT00235391|79515893|FG001|Overall Study|Lost to Follow-up|3|||
44510767|NCT00235391|79515894|FG002|Overall Study|Lost to Follow-up|3|||
44510768|NCT00235391|79515895|FG003|Overall Study|Lost to Follow-up|16|||
44510769|NCT00235391|79515896|FG004|Overall Study|Lost to Follow-up|0|||
44510770|NCT00235391|79515897|FG005|Overall Study|Lost to Follow-up|0|||
44510771|NCT00235391|79515892|FG000|Overall Study|Administrative problems|0|||
44123813|NCT02748863|78907771|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44123814|NCT02748863|78907772|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44123815|NCT02748863|78907768|FG000|Treatment Period 2|Lost to Follow-up|2|||
44123816|NCT02748863|78907769|FG001|Treatment Period 2|Lost to Follow-up|0|||
44123817|NCT02748863|78907770|FG002|Treatment Period 2|Lost to Follow-up|0|||
44123818|NCT02748863|78907771|FG003|Treatment Period 2|Lost to Follow-up|0|||
44123819|NCT02748863|78907772|FG004|Treatment Period 2|Lost to Follow-up|0|||
44123820|NCT02748863|78907768|FG000|Treatment Period 2|Adverse Event|3|||
44123821|NCT02748863|78907769|FG001|Treatment Period 2|Adverse Event|2|||
44123822|NCT02748863|78907770|FG002|Treatment Period 2|Adverse Event|0|||
44123823|NCT02748863|78907771|FG003|Treatment Period 2|Adverse Event|2|||
44123824|NCT02748863|78907772|FG004|Treatment Period 2|Adverse Event|0|||
44123825|NCT02748863|78907768|FG000|Treatment Period 2|Lack of Efficacy|0|||
44123826|NCT02748863|78907769|FG001|Treatment Period 2|Lack of Efficacy|1|||
44123827|NCT02748863|78907770|FG002|Treatment Period 2|Lack of Efficacy|0|||
44123828|NCT02748863|78907771|FG003|Treatment Period 2|Lack of Efficacy|0|||
44123829|NCT02748863|78907772|FG004|Treatment Period 2|Lack of Efficacy|0|||
44123830|NCT02748863|78907768|FG000|Treatment Period 2|Pregnancy|0|||
44123831|NCT02748863|78907769|FG001|Treatment Period 2|Pregnancy|0|||
44123832|NCT02748863|78907770|FG002|Treatment Period 2|Pregnancy|0|||
44123833|NCT02748863|78907771|FG003|Treatment Period 2|Pregnancy|0|||
44123834|NCT02748863|78907772|FG004|Treatment Period 2|Pregnancy|1|||
44276471|NCT02153736|79231163|FG000|Overall Study|Lost to Follow-up|1|||
44276472|NCT02153736|79231164|FG001|Overall Study|Lost to Follow-up|0|||
44276473|NCT02153736|79231163|FG000|Overall Study|Medical status change made ineligible|1|||
44276474|NCT02153736|79231164|FG001|Overall Study|Medical status change made ineligible|0|||
44276475|NCT02153736|79231163|FG000|Overall Study|Death|0|||
44276476|NCT02153736|79231164|FG001|Overall Study|Death|1|||
44276477|NCT02153736|79231163|FG000|Overall Study|Withdrawal by Subject|0|||
44276478|NCT02153736|79231164|FG001|Overall Study|Withdrawal by Subject|1|||
44276479|NCT02175966|79231172|FG000|Follow-up Period|Lack of Efficacy|10|||
44123835|NCT02865499|78907793|FG000|Baseline|Adverse Event|1|||
44123836|NCT02865499|78907793|FG000|Baseline|Withdrawal by Subject|1|||
44123837|NCT02870933|78907799|FG000|Overall Study|Death|2|||
44123838|NCT02870933|78907800|FG001|Overall Study|Death|1|||
44123839|NCT02870933|78907799|FG000|Overall Study|Withdrawal by Subject|0|||
44123840|NCT02870933|78907800|FG001|Overall Study|Withdrawal by Subject|1|||
44510772|NCT00235391|79515893|FG001|Overall Study|Administrative problems|0|||
44510773|NCT00235391|79515894|FG002|Overall Study|Administrative problems|0|||
44510774|NCT00235391|79515895|FG003|Overall Study|Administrative problems|1|||
44123841|NCT02864407|78907807|FG000|Overall Study|Protocol Violation|3|||
44123842|NCT02864407|78907807|FG000|Overall Study|Lost to Follow-up|115|||
44123843|NCT02864407|78907807|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
44123844|NCT02864407|78907807|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
44123845|NCT02864407|78907807|FG000|Overall Study|Consent prior to the contract date|1|||
44123846|NCT02873429|78907813|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
44123847|NCT02873429|78907814|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
44123848|NCT02873429|78907813|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
44123849|NCT02873429|78907814|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
44123850|NCT02873429|78907813|FG000|16 Weeks|Lost to Follow-up|3|||
44123851|NCT02873429|78907814|FG001|16 Weeks|Lost to Follow-up|0|||
44243106|NCT01693562|79072542|FG014|Exploration Phase|Death|0|||
44510775|NCT00235391|79515896|FG004|Overall Study|Administrative problems|0|||
44510776|NCT00235391|79515897|FG005|Overall Study|Administrative problems|0|||
44510777|NCT00235391|79515892|FG000|Overall Study|Death|0|||
44510778|NCT00235391|79515893|FG001|Overall Study|Death|0|||
44243107|NCT01693562|79072543|FG015|Exploration Phase|Death|0|||
44243108|NCT01693562|79072544|FG016|Exploration Phase|Death|0|||
44510779|NCT00235391|79515894|FG002|Overall Study|Death|1|||
44510780|NCT00235391|79515895|FG003|Overall Study|Death|4|||
44510781|NCT00235391|79515896|FG004|Overall Study|Death|0|||
44510782|NCT00235391|79515897|FG005|Overall Study|Death|0|||
44510783|NCT00234533|79515941|FG000|Overall Study|Withdrawal by Subject|6|||
44510784|NCT00234533|79515941|FG000|Overall Study|Adverse Event|2|||
44510785|NCT00234533|79515941|FG000|Overall Study|Enrolled but not treated|3|||
44510786|NCT00026208|79515948|FG000|Overall Study|Complications of auto accident|1|||
44510787|NCT00026208|79515949|FG001|Overall Study|Complications of auto accident|0|||
44510788|NCT00025662|79515955|FG000|Overall Study|Withdrawal by Subject|2|||
44510789|NCT00025662|79515955|FG000|Overall Study|Technical failure of manipulation|1|||
44510790|NCT00025506|79515959|FG000|Overall Study|Ineligible: clerical error|1|||
44510791|NCT00025506|79515959|FG000|Overall Study|Ineligible: wrong cell type|5|||
44510792|NCT00025506|79515959|FG000|Overall Study|Ineligible: inadequate pathology|2|||
44510793|NCT00025506|79515959|FG000|Overall Study|Never Treated|2|||
44510794|NCT00024258|79515968|FG000|Overall Study|Withdrawal by Subject|1|||
44510795|NCT00024258|79515968|FG000|Overall Study|Disease Progression|8|||
44510796|NCT00023712|79515974|FG000|Overall Study|Not platinum sensitive|1|||
44510797|NCT00023712|79515975|FG001|Overall Study|Not platinum sensitive|0|||
44510798|NCT00023712|79515974|FG000|Overall Study|Never treated|1|||
44510799|NCT00023712|79515975|FG001|Overall Study|Never treated|1|||
44510800|NCT00023322|79515991|FG000|Overall Study|Lost to Follow-up|1|||
44510801|NCT04640168|79515997|FG000|Overall Study|Withdrawal by Subject|8|||
44510802|NCT04640168|79515998|FG001|Overall Study|Withdrawal by Subject|7|||
44510803|NCT04640168|79515997|FG000|Overall Study|Lost to Follow-up|1|||
44510804|NCT04640168|79515998|FG001|Overall Study|Lost to Follow-up|0|||
44510805|NCT04640168|79515997|FG000|Overall Study|Enrolled but not treated|12|||
44510806|NCT04640168|79515998|FG001|Overall Study|Enrolled but not treated|12|||
44510807|NCT00022698|79516006|FG000|Overall Study|Adverse Event|5|||
44510808|NCT00022698|79516007|FG001|Overall Study|Adverse Event|9|||
44510809|NCT00022698|79516006|FG000|Overall Study|Death|0|||
44510810|NCT00022698|79516007|FG001|Overall Study|Death|2|||
44510811|NCT00022698|79516006|FG000|Overall Study|Failure to return|0|||
44510812|NCT00022698|79516007|FG001|Overall Study|Failure to return|1|||
44510813|NCT00022698|79516006|FG000|Overall Study|Refused treatment|0|||
44510814|NCT00022698|79516007|FG001|Overall Study|Refused treatment|2|||
44510815|NCT00022698|79516006|FG000|Overall Study|Insufficient therapeutic response|2|||
44510816|NCT00022698|79516007|FG001|Overall Study|Insufficient therapeutic response|14|||
44510817|NCT00022698|79516006|FG000|Overall Study|Administrative /other|1|||
44510818|NCT00022698|79516007|FG001|Overall Study|Administrative /other|7|||
44510819|NCT05261126|79516024|FG000|Overall Study|Death|0|||
44510820|NCT05261126|79516025|FG001|Overall Study|Death|0|||
44510821|NCT05261126|79516026|FG002|Overall Study|Death|1|||
44510822|NCT05261126|79516027|FG003|Overall Study|Death|0|||
44510823|NCT05261126|79516028|FG004|Overall Study|Death|0|||
44510824|NCT05261126|79516024|FG000|Overall Study|Lost to Follow-up|0|||
44123852|NCT02486302|78907820|FG000|Overall Study|Discontinued prematurely|410|||
44243109|NCT01693562|79072545|FG017|Exploration Phase|Death|0|||
44510825|NCT05261126|79516025|FG001|Overall Study|Lost to Follow-up|0|||
44123853|NCT02486302|78907820|FG000|Overall Study|Documentation not completed|255|||
44123854|NCT02486302|78907820|FG000|Overall Study|Excluded due to legal reasons|8|||
44123855|NCT02486302|78907820|FG000|Overall Study|Not treated|3|||
44123856|NCT02747875|78907835|FG000|Overall Study|Physician Decision|1|||
44123857|NCT02747875|78907836|FG001|Overall Study|Physician Decision|0|||
44123858|NCT02747875|78907835|FG000|Overall Study|Adverse Event|0|||
44123859|NCT02747875|78907836|FG001|Overall Study|Adverse Event|1|||
44123860|NCT02451124|78907862|FG000|Overall Study|Withdrawal by Subject|1|||
44123861|NCT02450578|78907874|FG000|Overall Study|ECG abnormality so not treated|1|||
44123862|NCT02450578|78907875|FG001|Overall Study|ECG abnormality so not treated|0|||
44123863|NCT02450578|78907876|FG002|Overall Study|ECG abnormality so not treated|0|||
44123864|NCT02450578|78907877|FG003|Overall Study|ECG abnormality so not treated|0|||
44123865|NCT02449018|78907904|FG000|Overall Study|Abnormal laboratory value|0|||
44123866|NCT02449018|78907905|FG001|Overall Study|Abnormal laboratory value|1|||
44123867|NCT02449018|78907904|FG000|Overall Study|Administrative problems|1|||
44123868|NCT02449018|78907905|FG001|Overall Study|Administrative problems|0|||
44123869|NCT02449018|78907904|FG000|Overall Study|Adverse Event|5|||
44123870|NCT02449018|78907905|FG001|Overall Study|Adverse Event|1|||
44123871|NCT02449018|78907904|FG000|Overall Study|Protocol deviation|4|||
44123872|NCT02449018|78907905|FG001|Overall Study|Protocol deviation|0|||
44123873|NCT02449018|78907904|FG000|Overall Study|Patient decision|2|||
44123874|NCT02449018|78907905|FG001|Overall Study|Patient decision|0|||
44123875|NCT02859415|78907913|FG000|Overall Study|Physician Decision|1|||
44123876|NCT02859415|78907914|FG001|Overall Study|Physician Decision|0|||
44123877|NCT02859415|78907913|FG000|Overall Study|Off treatment due to cardiac event|0|||
44123878|NCT02859415|78907914|FG001|Overall Study|Off treatment due to cardiac event|1|||
44123879|NCT02871791|78907924|FG000|Phase 1b|Death|0|||
44123880|NCT02871791|78907925|FG001|Phase 1b|Death|1|||
44123881|NCT02871791|78907924|FG000|Phase 1b|progressive disease|6|||
44123882|NCT02871791|78907925|FG001|Phase 1b|progressive disease|2|||
44123883|NCT02871791|78907924|FG000|Phase 2|Death|1|||
44123884|NCT02871791|78907925|FG001|Phase 2|Death|0|||
44123885|NCT02871791|78907924|FG000|Phase 2|Lost to Follow-up|2|||
44123886|NCT02871791|78907925|FG001|Phase 2|Lost to Follow-up|0|||
44123887|NCT02871635|78907933|FG000|Overall Study|Primary lack of efficacy|4|||
44123888|NCT02871635|78907934|FG001|Overall Study|Primary lack of efficacy|4|||
44123889|NCT02871635|78907933|FG000|Overall Study|Protocol Violation|3|||
44123890|NCT02871635|78907934|FG001|Overall Study|Protocol Violation|1|||
44123891|NCT02871635|78907933|FG000|Overall Study|Lost to Follow-up|1|||
44123892|NCT02871635|78907934|FG001|Overall Study|Lost to Follow-up|2|||
44123893|NCT02871635|78907933|FG000|Overall Study|Pregnancy|0|||
44123894|NCT02871635|78907934|FG001|Overall Study|Pregnancy|2|||
44123895|NCT02871635|78907933|FG000|Overall Study|Physician Decision|1|||
44123896|NCT02871635|78907934|FG001|Overall Study|Physician Decision|1|||
44123897|NCT02871635|78907933|FG000|Overall Study|Withdrawal by Subject|3|||
44123898|NCT02871635|78907934|FG001|Overall Study|Withdrawal by Subject|4|||
44123899|NCT02871635|78907933|FG000|Overall Study|Adverse Event|4|||
44243110|NCT01693562|79072546|FG018|Exploration Phase|Death|0|||
44123900|NCT02871635|78907934|FG001|Overall Study|Adverse Event|4|||
44123901|NCT02871635|78907933|FG000|Overall Study|Secondary lack of efficacy|2|||
44123902|NCT02871635|78907934|FG001|Overall Study|Secondary lack of efficacy|1|||
44379204|NCT01039688|79384852|FG000|Overall Study|Death|2|||
44123903|NCT02477332|78907948|FG000|Overall Study|Adverse Event|0|||
44123904|NCT02477332|78907949|FG001|Overall Study|Adverse Event|1|||
44123905|NCT02477332|78907950|FG002|Overall Study|Adverse Event|1|||
44123906|NCT02477332|78907951|FG003|Overall Study|Adverse Event|2|||
44123907|NCT02477332|78907952|FG004|Overall Study|Adverse Event|1|||
44123908|NCT02477332|78907953|FG005|Overall Study|Adverse Event|2|||
44123909|NCT02477332|78907948|FG000|Overall Study|Lack of Efficacy|1|||
44123910|NCT02477332|78907949|FG001|Overall Study|Lack of Efficacy|2|||
44123911|NCT02477332|78907950|FG002|Overall Study|Lack of Efficacy|1|||
44379205|NCT01039688|79384853|FG001|Overall Study|Death|0|||
44123912|NCT02477332|78907951|FG003|Overall Study|Lack of Efficacy|2|||
44123913|NCT02477332|78907952|FG004|Overall Study|Lack of Efficacy|1|||
44123914|NCT02477332|78907953|FG005|Overall Study|Lack of Efficacy|1|||
44123915|NCT02477332|78907948|FG000|Overall Study|Non-compliance with study treatment|0|||
44123916|NCT02477332|78907949|FG001|Overall Study|Non-compliance with study treatment|1|||
44123917|NCT02477332|78907950|FG002|Overall Study|Non-compliance with study treatment|2|||
44123918|NCT02477332|78907951|FG003|Overall Study|Non-compliance with study treatment|0|||
44123919|NCT02477332|78907952|FG004|Overall Study|Non-compliance with study treatment|0|||
44379206|NCT01039688|79384854|FG002|Overall Study|Death|0|||
44379207|NCT02237508|79384875|FG000|Overall Study|Withdrawal by Subject|0|||
44379208|NCT02237508|79384876|FG001|Overall Study|Withdrawal by Subject|2|||
44379209|NCT02237508|79384877|FG002|Overall Study|Withdrawal by Subject|0|||
44379210|NCT02237508|79384878|FG003|Overall Study|Withdrawal by Subject|1|||
44123920|NCT02477332|78907953|FG005|Overall Study|Non-compliance with study treatment|0|||
44123921|NCT02477332|78907948|FG000|Overall Study|Pregnancy|0|||
44123922|NCT02477332|78907949|FG001|Overall Study|Pregnancy|0|||
44123923|NCT02477332|78907950|FG002|Overall Study|Pregnancy|0|||
44123924|NCT02477332|78907951|FG003|Overall Study|Pregnancy|1|||
44123925|NCT02477332|78907952|FG004|Overall Study|Pregnancy|0|||
44123926|NCT02477332|78907953|FG005|Overall Study|Pregnancy|0|||
44123927|NCT02477332|78907948|FG000|Overall Study|Protocol Violation|2|||
44123928|NCT02477332|78907949|FG001|Overall Study|Protocol Violation|0|||
44123929|NCT02477332|78907950|FG002|Overall Study|Protocol Violation|3|||
44123930|NCT02477332|78907951|FG003|Overall Study|Protocol Violation|3|||
44123931|NCT02477332|78907952|FG004|Overall Study|Protocol Violation|1|||
44123932|NCT02477332|78907953|FG005|Overall Study|Protocol Violation|1|||
44123933|NCT02477332|78907948|FG000|Overall Study|Technical problems|0|||
44123934|NCT02477332|78907949|FG001|Overall Study|Technical problems|0|||
44123935|NCT02477332|78907950|FG002|Overall Study|Technical problems|1|||
44123936|NCT02477332|78907951|FG003|Overall Study|Technical problems|0|||
44123937|NCT02477332|78907952|FG004|Overall Study|Technical problems|0|||
44123938|NCT02477332|78907953|FG005|Overall Study|Technical problems|0|||
44123939|NCT02477332|78907948|FG000|Overall Study|Lost to Follow-up|0|||
44123940|NCT02477332|78907949|FG001|Overall Study|Lost to Follow-up|0|||
44123941|NCT02477332|78907950|FG002|Overall Study|Lost to Follow-up|2|||
44123942|NCT02477332|78907951|FG003|Overall Study|Lost to Follow-up|0|||
44123943|NCT02477332|78907952|FG004|Overall Study|Lost to Follow-up|0|||
44123944|NCT02477332|78907953|FG005|Overall Study|Lost to Follow-up|0|||
44123945|NCT02477332|78907948|FG000|Overall Study|Physician Decision|0|||
44243111|NCT01693562|79072547|FG019|Exploration Phase|Death|0|||
44243112|NCT01693562|79072548|FG020|Exploration Phase|Death|0|||
44379211|NCT02237508|79384879|FG004|Overall Study|Withdrawal by Subject|0|||
44379212|NCT02237508|79384880|FG005|Overall Study|Withdrawal by Subject|1|||
44243113|NCT01693562|79072549|FG021|Exploration Phase|Death|0|||
44379213|NCT02237508|79384881|FG006|Overall Study|Withdrawal by Subject|1|||
44379214|NCT02237508|79384882|FG007|Overall Study|Withdrawal by Subject|0|||
44123946|NCT02477332|78907949|FG001|Overall Study|Physician Decision|0|||
44123947|NCT02477332|78907950|FG002|Overall Study|Physician Decision|1|||
44123948|NCT02477332|78907951|FG003|Overall Study|Physician Decision|3|||
44123949|NCT02477332|78907952|FG004|Overall Study|Physician Decision|0|||
44123950|NCT02477332|78907953|FG005|Overall Study|Physician Decision|1|||
44123951|NCT02477332|78907948|FG000|Overall Study|Withdrawal by Subject|0|||
44123952|NCT02477332|78907949|FG001|Overall Study|Withdrawal by Subject|3|||
44123953|NCT02477332|78907950|FG002|Overall Study|Withdrawal by Subject|1|||
44123954|NCT02477332|78907951|FG003|Overall Study|Withdrawal by Subject|2|||
44123955|NCT02477332|78907952|FG004|Overall Study|Withdrawal by Subject|1|||
44123956|NCT02477332|78907953|FG005|Overall Study|Withdrawal by Subject|0|||
44123957|NCT02477020|78907971|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
44123958|NCT02477020|78907972|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
44123959|NCT02477020|78907971|FG000|Overall Study|Voluntary Withdrawal|7|||
44123960|NCT02477020|78907972|FG001|Overall Study|Voluntary Withdrawal|16|||
44123961|NCT02477020|78907971|FG000|Overall Study|Reason not Specified|3|||
44123962|NCT02477020|78907972|FG001|Overall Study|Reason not Specified|1|||
44123963|NCT02477020|78907971|FG000|Overall Study|Lack of Efficacy|14|||
44123964|NCT02477020|78907972|FG001|Overall Study|Lack of Efficacy|5|||
44123965|NCT02862535|78907982|FG000|Overall Study|Death|7|||
44123966|NCT02862535|78907983|FG001|Overall Study|Death|3|||
44123967|NCT02862535|78907984|FG002|Overall Study|Death|2|||
44123968|NCT02862535|78907985|FG003|Overall Study|Death|5|||
44123969|NCT02862535|78907982|FG000|Overall Study|Study Terminated by Sponsor|1|||
44123970|NCT02862535|78907983|FG001|Overall Study|Study Terminated by Sponsor|3|||
44123971|NCT02862535|78907984|FG002|Overall Study|Study Terminated by Sponsor|8|||
44123972|NCT02862535|78907985|FG003|Overall Study|Study Terminated by Sponsor|5|||
44123973|NCT02862535|78907982|FG000|Overall Study|Enrolled, not Treated|1|||
44123974|NCT02862535|78907983|FG001|Overall Study|Enrolled, not Treated|0|||
44123975|NCT02862535|78907984|FG002|Overall Study|Enrolled, not Treated|0|||
44123976|NCT02862535|78907985|FG003|Overall Study|Enrolled, not Treated|1|||
44123977|NCT02448706|78907995|FG000|Overall Study|Withdrawal by Subject|4|||
44123978|NCT02448706|78907996|FG001|Overall Study|Withdrawal by Subject|3|||
44123979|NCT02448706|78907995|FG000|Overall Study|Protocol Violation|1|||
44123980|NCT02448706|78907996|FG001|Overall Study|Protocol Violation|1|||
44123981|NCT02868281|78908006|FG000|Overall Study|Adverse Event|2|||
44123982|NCT02868281|78908007|FG001|Overall Study|Adverse Event|2|||
44123983|NCT02868281|78908006|FG000|Overall Study|Protocol Violation|13|||
44123984|NCT02868281|78908007|FG001|Overall Study|Protocol Violation|10|||
44123985|NCT02868281|78908006|FG000|Overall Study|Lost to Follow-up|3|||
44123986|NCT02868281|78908007|FG001|Overall Study|Lost to Follow-up|6|||
44123987|NCT02868281|78908006|FG000|Overall Study|Withdrawal by Subject|11|||
44123988|NCT02868281|78908007|FG001|Overall Study|Withdrawal by Subject|15|||
44123989|NCT02868281|78908006|FG000|Overall Study|Physician Decision|2|||
44123990|NCT02868281|78908007|FG001|Overall Study|Physician Decision|0|||
44123991|NCT02868281|78908006|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
44123992|NCT02868281|78908007|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
44123993|NCT02868281|78908006|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
44123994|NCT02868281|78908007|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
44123995|NCT02868281|78908006|FG000|Overall Study|Long journey/moving away|1|||
44123996|NCT02868281|78908007|FG001|Overall Study|Long journey/moving away|1|||
44123997|NCT02476006|78908013|FG000|Overall Study|Death|4|||
44123998|NCT02476006|78908013|FG000|Overall Study|Lack of treatment efficacy|2|||
44123999|NCT02476006|78908013|FG000|Overall Study|Pregnancy|1|||
44124000|NCT02476006|78908013|FG000|Overall Study|Participant did not wish to continue|39|||
44124001|NCT02476006|78908013|FG000|Overall Study|Adverse Event|41|||
44124002|NCT02476006|78908013|FG000|Overall Study|Poor compliance to study protocol|3|||
44124003|NCT02476006|78908013|FG000|Overall Study|Sponsor decision|6|||
44124004|NCT02476006|78908013|FG000|Overall Study|Lost to Follow-up|5|||
44124005|NCT02476006|78908013|FG000|Overall Study|Physician Decision|5|||
44124006|NCT02476006|78908013|FG000|Overall Study|Study ended treatment not available|4|||
44124007|NCT02476006|78908013|FG000|Overall Study|Switched to commercial drug|4|||
44124008|NCT02476006|78908013|FG000|Overall Study|Excluded from study|1|||
44124009|NCT02476006|78908013|FG000|Overall Study|Protocol Violation|1|||
44379215|NCT02237508|79384883|FG008|Overall Study|Withdrawal by Subject|1|||
44379216|NCT02237508|79384884|FG009|Overall Study|Withdrawal by Subject|0|||
44379217|NCT02237508|79384875|FG000|Overall Study|Physician Decision|0|||
44379218|NCT02237508|79384876|FG001|Overall Study|Physician Decision|1|||
44379219|NCT02237508|79384877|FG002|Overall Study|Physician Decision|0|||
44379220|NCT02237508|79384878|FG003|Overall Study|Physician Decision|0|||
44379221|NCT02237508|79384879|FG004|Overall Study|Physician Decision|0|||
44379222|NCT02237508|79384880|FG005|Overall Study|Physician Decision|0|||
44379223|NCT02237508|79384881|FG006|Overall Study|Physician Decision|0|||
44379224|NCT02237508|79384882|FG007|Overall Study|Physician Decision|0|||
44124010|NCT02476006|78908013|FG000|Overall Study|Enrolled but not treated|4|||
44124011|NCT02475850|78908019|FG000|Overall Study|Death|155|||
44124012|NCT02475850|78908020|FG001|Overall Study|Death|141|||
44124013|NCT02475850|78908019|FG000|Overall Study|Lost to Follow-up|217|||
44124014|NCT02475850|78908020|FG001|Overall Study|Lost to Follow-up|188|||
44124015|NCT02475850|78908019|FG000|Overall Study|Withdrawal by Subject|221|||
44124016|NCT02475850|78908020|FG001|Overall Study|Withdrawal by Subject|155|||
44124017|NCT02419612|78908029|FG000|Short-term Treatment Period|Adverse Event|1|||
44124018|NCT02419612|78908030|FG001|Short-term Treatment Period|Adverse Event|1|||
44379225|NCT02237508|79384883|FG008|Overall Study|Physician Decision|0|||
44124019|NCT02419612|78908029|FG000|Short-term Treatment Period|Death|0|||
44124020|NCT02419612|78908030|FG001|Short-term Treatment Period|Death|2|||
44124021|NCT02419612|78908029|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
44124022|NCT02419612|78908030|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
44243114|NCT01693562|79072550|FG022|Exploration Phase|Death|0|||
44124023|NCT02419612|78908029|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
44124024|NCT02419612|78908030|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
44124025|NCT02419612|78908029|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
44276480|NCT02175966|79231173|FG001|Follow-up Period|Lack of Efficacy|6|||
44276481|NCT02153346|79231179|FG000|Overall Study|Lost to Follow-up|11|||
44510826|NCT05261126|79516026|FG002|Overall Study|Lost to Follow-up|0|||
44510827|NCT05261126|79516027|FG003|Overall Study|Lost to Follow-up|0|||
44510828|NCT05261126|79516028|FG004|Overall Study|Lost to Follow-up|1|||
44510829|NCT05261126|79516024|FG000|Overall Study|Physician Decision|1|||
44510830|NCT05261126|79516025|FG001|Overall Study|Physician Decision|0|||
44510831|NCT05261126|79516026|FG002|Overall Study|Physician Decision|0|||
44510832|NCT05261126|79516027|FG003|Overall Study|Physician Decision|0|||
44510833|NCT05261126|79516028|FG004|Overall Study|Physician Decision|0|||
44510834|NCT05261126|79516024|FG000|Overall Study|Screen Failure|0|||
44510835|NCT05261126|79516025|FG001|Overall Study|Screen Failure|0|||
44510836|NCT05261126|79516026|FG002|Overall Study|Screen Failure|0|||
44276482|NCT02174562|79231186|FG000|Overall Study|Withdrawal by Subject|7|||
44276483|NCT02174562|79231187|FG001|Overall Study|Withdrawal by Subject|2|||
44276484|NCT02174562|79231186|FG000|Overall Study|Death|2|||
44276485|NCT02174562|79231187|FG001|Overall Study|Death|0|||
44276486|NCT02174562|79231186|FG000|Overall Study|Lost to Follow-up|0|||
44276487|NCT02174562|79231187|FG001|Overall Study|Lost to Follow-up|3|||
44276488|NCT02136576|79231196|FG000|Overall Study|Lost to Follow-up|2|||
44276489|NCT02136576|79231197|FG001|Overall Study|Lost to Follow-up|0|||
44276490|NCT02136576|79231198|FG002|Overall Study|Lost to Follow-up|0|||
44276491|NCT02153112|79231455|FG000|Overall Study|Adverse Event|0|||
44379226|NCT02237508|79384884|FG009|Overall Study|Physician Decision|0|||
44379227|NCT02237508|79384875|FG000|Overall Study|Protocol Violation|0|||
44510837|NCT05261126|79516027|FG003|Overall Study|Screen Failure|0|||
44510838|NCT05261126|79516028|FG004|Overall Study|Screen Failure|1|||
44510839|NCT05261126|79516024|FG000|Overall Study|Withdrawal by Subject|1|||
44124026|NCT02419612|78908030|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
44124027|NCT02419612|78908029|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
44276492|NCT02153112|79231456|FG001|Overall Study|Adverse Event|0|||
44276493|NCT02153112|79231457|FG002|Overall Study|Adverse Event|1|||
44379228|NCT02237508|79384876|FG001|Overall Study|Protocol Violation|0|||
44510840|NCT05261126|79516025|FG001|Overall Study|Withdrawal by Subject|0|||
44510841|NCT05261126|79516026|FG002|Overall Study|Withdrawal by Subject|1|||
44124028|NCT02419612|78908030|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
44124029|NCT02419612|78908029|FG000|Short-term Treatment Period|Worsening of liver function|0|||
44124030|NCT02419612|78908030|FG001|Short-term Treatment Period|Worsening of liver function|1|||
44124031|NCT02419612|78908029|FG000|Short-term Treatment Period|Subject moved out of state|0|||
44379229|NCT02237508|79384877|FG002|Overall Study|Protocol Violation|1|||
44510842|NCT05261126|79516027|FG003|Overall Study|Withdrawal by Subject|1|||
44510843|NCT05261126|79516028|FG004|Overall Study|Withdrawal by Subject|0|||
44510844|NCT05261126|79516024|FG000|Overall Study|Not Recorded|0|||
44510845|NCT05261126|79516025|FG001|Overall Study|Not Recorded|0|||
44510846|NCT05261126|79516026|FG002|Overall Study|Not Recorded|0|||
44510847|NCT05261126|79516027|FG003|Overall Study|Not Recorded|1|||
44510848|NCT05261126|79516028|FG004|Overall Study|Not Recorded|0|||
44510849|NCT05116683|79516040|FG000|Overall Study|Physician Decision|4|||
44379230|NCT02237508|79384878|FG003|Overall Study|Protocol Violation|0|||
44379231|NCT02237508|79384879|FG004|Overall Study|Protocol Violation|0|||
44510850|NCT04585815|79516054|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
44124032|NCT02419612|78908030|FG001|Short-term Treatment Period|Subject moved out of state|1|||
44124033|NCT02419612|78908029|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
44124034|NCT02419612|78908030|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
44124035|NCT02419612|78908029|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
44124036|NCT02419612|78908030|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
44124037|NCT02419612|78908029|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
44124038|NCT02419612|78908030|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
44124039|NCT02419612|78908029|FG000|Long-term Treatment Period|Death|0|||
44124040|NCT02419612|78908030|FG001|Long-term Treatment Period|Death|1|||
44124041|NCT02419612|78908029|FG000|Long-term Treatment Period|Adverse Event|0|||
44124042|NCT02419612|78908030|FG001|Long-term Treatment Period|Adverse Event|5|||
44124043|NCT02419612|78908029|FG000|Long-term Treatment Period|Other|4|||
44124044|NCT02419612|78908030|FG001|Long-term Treatment Period|Other|4|||
44124045|NCT02419612|78908029|FG000|Long-term Treatment Period|Subject Decision|2|||
44124046|NCT02419612|78908030|FG001|Long-term Treatment Period|Subject Decision|4|||
44124047|NCT02419612|78908029|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
44124048|NCT02419612|78908030|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
44124049|NCT02447848|78908036|FG000|Overall Study|Patient discharged|3|||
44124050|NCT02447848|78908036|FG000|Overall Study|Lack of Efficacy|4|||
44124051|NCT02447848|78908036|FG000|Overall Study|Withdrawal by Subject|4|||
44124052|NCT02418910|78908040|FG000|Overall Study|Lost to Follow-up|3|||
44124053|NCT02418910|78908040|FG000|Overall Study|Withdrawal by Subject|4|||
44124054|NCT02418754|78908056|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
44124055|NCT02418754|78908057|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
44124056|NCT02418754|78908058|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
44124057|NCT02418754|78908059|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
44124058|NCT02418754|78908060|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
44124059|NCT02418754|78908056|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
44124060|NCT02418754|78908057|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
44124061|NCT02418754|78908058|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
44124062|NCT02418754|78908059|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
44124063|NCT02418754|78908060|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
44124064|NCT02418754|78908056|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
44124065|NCT02418754|78908057|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
44124066|NCT02418754|78908058|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
44124067|NCT02418754|78908059|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
44124068|NCT02418754|78908060|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
44124069|NCT02418754|78908056|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
44124070|NCT02418754|78908057|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
44124071|NCT02418754|78908058|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
44124072|NCT02418754|78908059|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
44124073|NCT02418754|78908060|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
44124074|NCT02418754|78908056|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
44124075|NCT02418754|78908057|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
44124076|NCT02418754|78908058|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
44124077|NCT02418754|78908059|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
44124078|NCT02418754|78908060|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
44124079|NCT02418754|78908056|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
44124080|NCT02418754|78908057|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
44124081|NCT02418754|78908058|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
44124082|NCT02418754|78908059|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
44124083|NCT02418754|78908060|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
44124084|NCT02418754|78908056|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
44124085|NCT02418754|78908057|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
44124086|NCT02418754|78908058|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
44124087|NCT02418754|78908059|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
44124088|NCT02418754|78908060|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
44124089|NCT02418754|78908056|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
44124090|NCT02418754|78908057|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
44124091|NCT02418754|78908058|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
44124092|NCT02418754|78908059|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
44124093|NCT02418754|78908060|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
44124094|NCT02418754|78908056|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
44124095|NCT02418754|78908057|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
44243115|NCT01693562|79072528|FG000|Exploration Phase|Other|0|||
44243116|NCT01693562|79072529|FG001|Exploration Phase|Other|0|||
44243117|NCT01693562|79072530|FG002|Exploration Phase|Other|0|||
44243118|NCT01693562|79072531|FG003|Exploration Phase|Other|0|||
44243119|NCT01693562|79072532|FG004|Exploration Phase|Other|0|||
44243120|NCT01693562|79072533|FG005|Exploration Phase|Other|0|||
44243121|NCT01693562|79072534|FG006|Exploration Phase|Other|2|||
44243122|NCT01693562|79072535|FG007|Exploration Phase|Other|0|||
44379232|NCT02237508|79384880|FG005|Overall Study|Protocol Violation|0|||
44243123|NCT01693562|79072536|FG008|Exploration Phase|Other|0|||
44124096|NCT02418754|78908058|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
44124097|NCT02418754|78908059|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
44124098|NCT02418754|78908060|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
44124099|NCT02418754|78908056|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
44124100|NCT02418754|78908057|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
44124101|NCT02418754|78908058|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
44124102|NCT02418754|78908059|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
44124103|NCT02418754|78908060|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
44124104|NCT02418754|78908056|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
44124105|NCT02418754|78908057|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
44124106|NCT02418754|78908058|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
44124107|NCT02418754|78908059|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
44124108|NCT02418754|78908060|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
44124109|NCT02447458|78908076|FG000|Overall Study|Other|0|||
44124110|NCT02447458|78908077|FG001|Overall Study|Other|0|||
44124111|NCT02447458|78908078|FG002|Overall Study|Other|1|||
44124112|NCT02447458|78908079|FG003|Overall Study|Other|0|||
44124113|NCT02447458|78908080|FG004|Overall Study|Other|0|||
44124114|NCT02447458|78908081|FG005|Overall Study|Other|0|||
44124115|NCT02862457|78908107|FG000|Overall Study|Death|1|||
44124116|NCT02862457|78908108|FG001|Overall Study|Death|3|||
44124117|NCT02862457|78908109|FG002|Overall Study|Death|2|||
44124118|NCT02862457|78908110|FG003|Overall Study|Death|3|||
44124119|NCT02862457|78908111|FG004|Overall Study|Death|0|||
44124120|NCT02862457|78908112|FG005|Overall Study|Death|2|||
44124121|NCT02862457|78908113|FG006|Overall Study|Death|1|||
44124122|NCT02862457|78908107|FG000|Overall Study|Lost to Follow-up|1|||
44124123|NCT02862457|78908108|FG001|Overall Study|Lost to Follow-up|0|||
44124124|NCT02862457|78908109|FG002|Overall Study|Lost to Follow-up|0|||
44124125|NCT02862457|78908110|FG003|Overall Study|Lost to Follow-up|1|||
44124126|NCT02862457|78908111|FG004|Overall Study|Lost to Follow-up|0|||
44124127|NCT02862457|78908112|FG005|Overall Study|Lost to Follow-up|0|||
44124128|NCT02862457|78908113|FG006|Overall Study|Lost to Follow-up|0|||
44124129|NCT02862457|78908107|FG000|Overall Study|Withdrawal by Subject|0|||
44124130|NCT02862457|78908108|FG001|Overall Study|Withdrawal by Subject|0|||
44124131|NCT02862457|78908109|FG002|Overall Study|Withdrawal by Subject|1|||
44124132|NCT02862457|78908110|FG003|Overall Study|Withdrawal by Subject|0|||
44124133|NCT02862457|78908111|FG004|Overall Study|Withdrawal by Subject|0|||
44124134|NCT02862457|78908112|FG005|Overall Study|Withdrawal by Subject|1|||
44124135|NCT02862457|78908113|FG006|Overall Study|Withdrawal by Subject|0|||
44124136|NCT02447302|78908140|FG000|Overall Study|Physician Decision|1|||
44124137|NCT02447302|78908141|FG001|Overall Study|Physician Decision|0|||
44124138|NCT02447302|78908142|FG002|Overall Study|Physician Decision|0|||
44124139|NCT02447302|78908140|FG000|Overall Study|Adverse Event|4|||
44124140|NCT02447302|78908141|FG001|Overall Study|Adverse Event|3|||
44124141|NCT02447302|78908142|FG002|Overall Study|Adverse Event|0|||
44124142|NCT02447302|78908140|FG000|Overall Study|Withdrawal by Subject|0|||
44124143|NCT02447302|78908141|FG001|Overall Study|Withdrawal by Subject|1|||
44124144|NCT02447302|78908142|FG002|Overall Study|Withdrawal by Subject|5|||
44124145|NCT02447302|78908140|FG000|Overall Study|Sponsor Decision|0|||
44124146|NCT02447302|78908141|FG001|Overall Study|Sponsor Decision|0|||
44243124|NCT01693562|79072537|FG009|Exploration Phase|Other|0|||
44243125|NCT01693562|79072538|FG010|Exploration Phase|Other|0|||
44379233|NCT02237508|79384881|FG006|Overall Study|Protocol Violation|0|||
44124147|NCT02447302|78908142|FG002|Overall Study|Sponsor Decision|1|||
44124148|NCT02454517|78908152|FG000|Overall Study|Withdrawal by Subject|3|||
44124149|NCT02454517|78908153|FG001|Overall Study|Withdrawal by Subject|0|||
44124150|NCT02454517|78908152|FG000|Overall Study|Lost to Follow-up|4|||
44124151|NCT02454517|78908153|FG001|Overall Study|Lost to Follow-up|7|||
44124152|NCT02454517|78908152|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
44124153|NCT02454517|78908153|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
44124154|NCT03861039|78908164|FG000|Overall Study|Adverse Event|2|||
44124155|NCT03861039|78908165|FG001|Overall Study|Adverse Event|5|||
44124156|NCT03861039|78908166|FG002|Overall Study|Adverse Event|11|||
44124157|NCT03861039|78908164|FG000|Overall Study|Withdrawal by Subject|1|||
44124158|NCT03861039|78908165|FG001|Overall Study|Withdrawal by Subject|3|||
44124159|NCT03861039|78908166|FG002|Overall Study|Withdrawal by Subject|4|||
44124160|NCT02731755|78908176|FG000|First Intervention|Withdrawal by Subject|0|||
44124161|NCT02731755|78908177|FG001|First Intervention|Withdrawal by Subject|2|||
44124162|NCT02866175|78908206|FG000|Overall Study|Adverse Event|56|||
44124163|NCT02866175|78908207|FG001|Overall Study|Adverse Event|54|||
44124164|NCT02866175|78908206|FG000|Overall Study|Withdrawal by Subject|31|||
44124165|NCT02866175|78908207|FG001|Overall Study|Withdrawal by Subject|52|||
44124166|NCT02866175|78908206|FG000|Overall Study|Death|30|||
44124167|NCT02866175|78908207|FG001|Overall Study|Death|23|||
44124168|NCT02866175|78908206|FG000|Overall Study|Other|7|||
44124169|NCT02866175|78908207|FG001|Overall Study|Other|14|||
44124170|NCT02866175|78908206|FG000|Overall Study|Progressive disease|1|||
44379234|NCT02237508|79384882|FG007|Overall Study|Protocol Violation|0|||
44510851|NCT04585815|79516055|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
44510852|NCT04585815|79516054|FG000|Sub-study A- Treatment Phase|Death|0|||
44510853|NCT04585815|79516055|FG001|Sub-study A- Treatment Phase|Death|1|||
44510854|NCT04585815|79516054|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
44510855|NCT04585815|79516055|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
44510856|NCT04585815|79516054|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
44510857|NCT04585815|79516055|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
44510858|NCT04585815|79516054|FG000|Sub-study A- Treatment Phase|Other|1|||
44510859|NCT04585815|79516055|FG001|Sub-study A- Treatment Phase|Other|0|||
44510860|NCT04585815|79516054|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
44124171|NCT02866175|78908207|FG001|Overall Study|Progressive disease|1|||
44124172|NCT02866175|78908206|FG000|Overall Study|Lost to Follow-up|2|||
44124173|NCT02866175|78908207|FG001|Overall Study|Lost to Follow-up|0|||
44124174|NCT02866175|78908206|FG000|Overall Study|Lack of Efficacy|0|||
44124175|NCT02866175|78908207|FG001|Overall Study|Lack of Efficacy|1|||
44124176|NCT02866175|78908206|FG000|Overall Study|Physician Decision|3|||
44124177|NCT02866175|78908207|FG001|Overall Study|Physician Decision|15|||
44124178|NCT02866175|78908206|FG000|Overall Study|Did not receive treatment|5|||
44124179|NCT02866175|78908207|FG001|Overall Study|Did not receive treatment|15|||
44124180|NCT01336205|78908220|FG000|Overall Study|Other|22|||
44124181|NCT01336205|78908221|FG001|Overall Study|Other|9|||
44124182|NCT01336205|78908220|FG000|Overall Study|Lost to Follow-up|40|||
44124183|NCT01336205|78908221|FG001|Overall Study|Lost to Follow-up|20|||
44124184|NCT01336205|78908220|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
44124185|NCT01336205|78908221|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
44124186|NCT01336205|78908220|FG000|Overall Study|Lack of Efficacy|4|||
44124187|NCT01336205|78908221|FG001|Overall Study|Lack of Efficacy|0|||
44124188|NCT01336205|78908220|FG000|Overall Study|Severe noncompliance with protocol|9|||
44124189|NCT01336205|78908221|FG001|Overall Study|Severe noncompliance with protocol|2|||
44124190|NCT01336205|78908220|FG000|Overall Study|Adverse Event|56|||
44124191|NCT01336205|78908221|FG001|Overall Study|Adverse Event|6|||
44124192|NCT01336205|78908220|FG000|Overall Study|Death|1|||
44124193|NCT01336205|78908221|FG001|Overall Study|Death|1|||
44124194|NCT01336205|78908220|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
44124195|NCT01336205|78908221|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
44124196|NCT01336205|78908220|FG000|Overall Study|Withdrawal by Subject|72|||
44124197|NCT01336205|78908221|FG001|Overall Study|Withdrawal by Subject|38|||
44124198|NCT01336205|78908220|FG000|Overall Study|Did not receive treatment|4|||
44124199|NCT01336205|78908221|FG001|Overall Study|Did not receive treatment|0|||
44124200|NCT02865395|78908230|FG000|Overall Study|Physician Decision|6|||
44124201|NCT02865395|78908231|FG001|Overall Study|Physician Decision|10|||
44124202|NCT02865395|78908232|FG002|Overall Study|Physician Decision|7|||
44124203|NCT01123707|78908244|FG000|Overall Study|Lost to Follow-up|3|||
44124204|NCT01123707|78908245|FG001|Overall Study|Lost to Follow-up|1|||
44124205|NCT01123707|78908246|FG002|Overall Study|Lost to Follow-up|3|||
44124206|NCT01123707|78908247|FG003|Overall Study|Lost to Follow-up|2|||
44124207|NCT01123707|78908244|FG000|Overall Study|Adverse Event|5|||
44124208|NCT01123707|78908245|FG001|Overall Study|Adverse Event|7|||
44124209|NCT01123707|78908246|FG002|Overall Study|Adverse Event|5|||
44124210|NCT01123707|78908247|FG003|Overall Study|Adverse Event|3|||
44124211|NCT01123707|78908244|FG000|Overall Study|Sponsor Discontinued Study|30|||
44124212|NCT01123707|78908245|FG001|Overall Study|Sponsor Discontinued Study|24|||
44124213|NCT01123707|78908246|FG002|Overall Study|Sponsor Discontinued Study|25|||
44124214|NCT01123707|78908247|FG003|Overall Study|Sponsor Discontinued Study|40|||
44124215|NCT01123707|78908244|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
44124216|NCT01123707|78908245|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
44124217|NCT01123707|78908246|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
44124218|NCT01123707|78908247|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
44124219|NCT01123707|78908244|FG000|Overall Study|Investigator Withdrew Participant|0|||
44124220|NCT01123707|78908245|FG001|Overall Study|Investigator Withdrew Participant|1|||
44124221|NCT01123707|78908246|FG002|Overall Study|Investigator Withdrew Participant|1|||
44124222|NCT01123707|78908247|FG003|Overall Study|Investigator Withdrew Participant|1|||
44124223|NCT01123707|78908244|FG000|Overall Study|Subject Withdrew Consent|4|||
44124224|NCT01123707|78908245|FG001|Overall Study|Subject Withdrew Consent|5|||
44124225|NCT01123707|78908246|FG002|Overall Study|Subject Withdrew Consent|1|||
44124226|NCT01123707|78908247|FG003|Overall Study|Subject Withdrew Consent|2|||
44124227|NCT01123707|78908244|FG000|Overall Study|Lack of Efficacy|1|||
44124228|NCT01123707|78908245|FG001|Overall Study|Lack of Efficacy|2|||
44124229|NCT01123707|78908246|FG002|Overall Study|Lack of Efficacy|1|||
44124230|NCT01123707|78908247|FG003|Overall Study|Lack of Efficacy|0|||
44124231|NCT01123707|78908244|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
44124232|NCT01123707|78908245|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
44124233|NCT01123707|78908246|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
44124234|NCT01123707|78908247|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
44124235|NCT02755103|78908259|FG000|Overall Study|Lost to Follow-up|17|||
44124236|NCT02755103|78908260|FG001|Overall Study|Lost to Follow-up|15|||
44124237|NCT02755103|78908259|FG000|Overall Study|Death|0|||
44124238|NCT02755103|78908260|FG001|Overall Study|Death|1|||
44124239|NCT02755103|78908259|FG000|Overall Study|Physician Decision|0|||
44124240|NCT02755103|78908260|FG001|Overall Study|Physician Decision|1|||
44124241|NCT02755103|78908259|FG000|Overall Study|Pregnancy|0|||
44124242|NCT02755103|78908260|FG001|Overall Study|Pregnancy|1|||
44124243|NCT02755103|78908259|FG000|Overall Study|Withdrawal by Subject|3|||
44124244|NCT02755103|78908260|FG001|Overall Study|Withdrawal by Subject|0|||
44124245|NCT01258803|78908270|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
44124246|NCT01258803|78908271|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
44124247|NCT01258803|78908272|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
44124248|NCT01258803|78908273|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
44124249|NCT01258803|78908274|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
44124250|NCT01258803|78908275|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
44124251|NCT01258803|78908270|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
44124252|NCT01258803|78908271|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
44124253|NCT01258803|78908272|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
44124254|NCT01258803|78908273|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
44124255|NCT01258803|78908274|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
44124256|NCT01258803|78908275|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
44124257|NCT01258803|78908270|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
44124258|NCT01258803|78908271|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
44124259|NCT01258803|78908272|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
44510861|NCT04585815|79516055|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
44124260|NCT01258803|78908273|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
44124261|NCT01258803|78908274|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
44124262|NCT01258803|78908275|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
44124263|NCT02865083|78908291|FG000|Overall Study|Early Termination|3|||
44124264|NCT02865083|78908292|FG001|Overall Study|Early Termination|1|||
44124265|NCT00862251|78908301|FG000|Overall Study|Adverse Event|8|||
44124266|NCT00862251|78908302|FG001|Overall Study|Adverse Event|3|||
44124267|NCT00862251|78908303|FG002|Overall Study|Adverse Event|1|||
44124268|NCT00862251|78908301|FG000|Overall Study|Lost to Follow-up|0|||
44124269|NCT00862251|78908302|FG001|Overall Study|Lost to Follow-up|0|||
44124270|NCT00862251|78908303|FG002|Overall Study|Lost to Follow-up|1|||
44124271|NCT00862251|78908301|FG000|Overall Study|Protocol Violation|2|||
44124272|NCT00862251|78908302|FG001|Overall Study|Protocol Violation|0|||
44124273|NCT00862251|78908303|FG002|Overall Study|Protocol Violation|1|||
44124274|NCT00862251|78908301|FG000|Overall Study|Withdrawal by Subject|9|||
44124275|NCT00862251|78908302|FG001|Overall Study|Withdrawal by Subject|2|||
44124276|NCT00862251|78908303|FG002|Overall Study|Withdrawal by Subject|6|||
44124277|NCT02864381|78908332|FG000|Overall Study|Death|58|||
44124278|NCT02864381|78908333|FG001|Overall Study|Death|61|||
44124279|NCT02864381|78908332|FG000|Overall Study|Withdrew Consent|5|||
44124280|NCT02864381|78908333|FG001|Overall Study|Withdrew Consent|6|||
44124281|NCT02864381|78908332|FG000|Overall Study|Reason Unknown|7|||
44124282|NCT02864381|78908333|FG001|Overall Study|Reason Unknown|3|||
44124283|NCT02864381|78908332|FG000|Overall Study|Lost to Follow-up|1|||
44124284|NCT02864381|78908333|FG001|Overall Study|Lost to Follow-up|1|||
44124285|NCT02864381|78908332|FG000|Overall Study|Investigator's Discretion|1|||
44124286|NCT02864381|78908333|FG001|Overall Study|Investigator's Discretion|0|||
44124287|NCT02864381|78908332|FG000|Overall Study|Protocol Violation|0|||
44124288|NCT02864381|78908333|FG001|Overall Study|Protocol Violation|1|||
44124289|NCT02860169|78908341|FG000|Part A|Withdrawal by Subject|1|||
44124290|NCT02860169|78908341|FG000|Part A|Other (Screening failure)|6|||
44124291|NCT02860169|78908341|FG000|Part A|Other (Survey not completed)|3|||
44124292|NCT02860169|78908341|FG000|Part A|Other (did not completed consent)|1|||
44124293|NCT02860169|78908341|FG000|Part B|Other (Screening failure)|10|||
44124294|NCT02860169|78908341|FG000|Part B|Withdrawal by Subject|1|||
44124295|NCT02860169|78908341|FG000|Part C|Other (Screening failure)|1|||
44124296|NCT00409773|78908352|FG000|Overall Study|Adverse Event|3|||
44124297|NCT00409773|78908353|FG001|Overall Study|Adverse Event|4|||
44124298|NCT00409773|78908354|FG002|Overall Study|Adverse Event|4|||
44124299|NCT00409773|78908355|FG003|Overall Study|Adverse Event|2|||
44124300|NCT00409773|78908356|FG004|Overall Study|Adverse Event|6|||
44510862|NCT04585815|79516054|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
44510863|NCT04585815|79516055|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
44510864|NCT04570436|79516063|FG000|Overall Study|Adverse Event|0|||
44510865|NCT04570436|79516064|FG001|Overall Study|Adverse Event|0|||
44510866|NCT04570436|79516065|FG002|Overall Study|Adverse Event|1|||
44510867|NCT04570436|79516066|FG003|Overall Study|Adverse Event|0|||
44510868|NCT04570436|79516067|FG004|Overall Study|Adverse Event|0|||
44124301|NCT00409773|78908352|FG000|Overall Study|Lost to Follow-up|6|||
44124302|NCT00409773|78908353|FG001|Overall Study|Lost to Follow-up|1|||
44124303|NCT00409773|78908354|FG002|Overall Study|Lost to Follow-up|2|||
44124304|NCT00409773|78908355|FG003|Overall Study|Lost to Follow-up|3|||
44124305|NCT00409773|78908356|FG004|Overall Study|Lost to Follow-up|1|||
44124306|NCT00409773|78908352|FG000|Overall Study|Physician Decision|0|||
44124307|NCT00409773|78908353|FG001|Overall Study|Physician Decision|0|||
44124308|NCT00409773|78908354|FG002|Overall Study|Physician Decision|0|||
44124309|NCT00409773|78908355|FG003|Overall Study|Physician Decision|2|||
44124310|NCT00409773|78908356|FG004|Overall Study|Physician Decision|0|||
44124311|NCT00409773|78908352|FG000|Overall Study|Protocol Violation|0|||
44124312|NCT00409773|78908353|FG001|Overall Study|Protocol Violation|2|||
44124313|NCT00409773|78908354|FG002|Overall Study|Protocol Violation|3|||
44124314|NCT00409773|78908355|FG003|Overall Study|Protocol Violation|3|||
44124315|NCT00409773|78908356|FG004|Overall Study|Protocol Violation|1|||
44124316|NCT00409773|78908352|FG000|Overall Study|Withdrawal by Subject|0|||
44124317|NCT00409773|78908353|FG001|Overall Study|Withdrawal by Subject|0|||
44124318|NCT00409773|78908354|FG002|Overall Study|Withdrawal by Subject|0|||
44124319|NCT00409773|78908355|FG003|Overall Study|Withdrawal by Subject|2|||
44124320|NCT00409773|78908356|FG004|Overall Study|Withdrawal by Subject|1|||
44124321|NCT00409773|78908352|FG000|Overall Study|Lack of Eligibility|0|||
44124322|NCT00409773|78908353|FG001|Overall Study|Lack of Eligibility|0|||
44124323|NCT00409773|78908354|FG002|Overall Study|Lack of Eligibility|0|||
44124324|NCT00409773|78908355|FG003|Overall Study|Lack of Eligibility|0|||
44124325|NCT00409773|78908356|FG004|Overall Study|Lack of Eligibility|1|||
44124326|NCT02861807|78908370|FG000|Overall Study|Lost to Follow-up|7|||
44243126|NCT01693562|79072539|FG011|Exploration Phase|Other|0|||
44124327|NCT02861807|78908371|FG001|Overall Study|Lost to Follow-up|6|||
44124328|NCT02861807|78908370|FG000|Overall Study|Withdrawal by Subject|5|||
44510869|NCT04570436|79516068|FG005|Overall Study|Adverse Event|0|||
44124329|NCT02861807|78908371|FG001|Overall Study|Withdrawal by Subject|8|||
44124330|NCT02858401|78908384|FG000|Overall Study|Withdrew Consent|0|||
44124331|NCT02858401|78908385|FG001|Overall Study|Withdrew Consent|0|||
44124332|NCT02858401|78908386|FG002|Overall Study|Withdrew Consent|0|||
44124333|NCT02858401|78908387|FG003|Overall Study|Withdrew Consent|0|||
44124334|NCT02858401|78908388|FG004|Overall Study|Withdrew Consent|0|||
44124335|NCT02858401|78908389|FG005|Overall Study|Withdrew Consent|1|||
44124336|NCT02858401|78908390|FG006|Overall Study|Withdrew Consent|0|||
44124337|NCT02858401|78908384|FG000|Overall Study|Lost to Follow-up|0|||
44510870|NCT04570436|79516069|FG006|Overall Study|Adverse Event|0|||
44124338|NCT02858401|78908385|FG001|Overall Study|Lost to Follow-up|1|||
44124339|NCT02858401|78908386|FG002|Overall Study|Lost to Follow-up|0|||
44124340|NCT02858401|78908387|FG003|Overall Study|Lost to Follow-up|0|||
44124341|NCT02858401|78908388|FG004|Overall Study|Lost to Follow-up|0|||
44124342|NCT02858401|78908389|FG005|Overall Study|Lost to Follow-up|0|||
44124343|NCT02858401|78908390|FG006|Overall Study|Lost to Follow-up|0|||
44124344|NCT02857283|78908417|FG000|First Exposure|Withdrawal by Subject|1|||
44124345|NCT02857283|78908418|FG001|First Exposure|Withdrawal by Subject|0|||
44124346|NCT02746679|78908436|FG000|Overall Study|Lost to Follow-up|4|||
44124347|NCT02746679|78908437|FG001|Overall Study|Lost to Follow-up|6|||
44124348|NCT02731131|78908445|FG000|Overall Study|Psychiatric Disorder|0|||
44124349|NCT02731131|78908446|FG001|Overall Study|Psychiatric Disorder|1|||
44124350|NCT02731131|78908445|FG000|Overall Study|Refused Therapy|0|||
44124351|NCT02731131|78908446|FG001|Overall Study|Refused Therapy|1|||
44124352|NCT02746705|78908454|FG000|Overall Study|Physician Decision|1|||
44124353|NCT02746705|78908455|FG001|Overall Study|Physician Decision|1|||
44124354|NCT02746705|78908454|FG000|Overall Study|Lost to Follow-up|1|||
44124355|NCT02746705|78908455|FG001|Overall Study|Lost to Follow-up|0|||
44124356|NCT02746705|78908454|FG000|Overall Study|outlier scores deemed not valid|0|||
44124357|NCT02746705|78908455|FG001|Overall Study|outlier scores deemed not valid|1|||
44124358|NCT02746627|78908464|FG000|Overall Study|Withdrawal by Subject|1|||
44124359|NCT02746627|78908465|FG001|Overall Study|Withdrawal by Subject|1|||
44124360|NCT02746627|78908466|FG002|Overall Study|Withdrawal by Subject|1|||
44124361|NCT02856113|78908476|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
44124362|NCT02856113|78908477|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
44124363|NCT02856113|78908476|FG000|Overall Study|Significant Protocol Deviation|1|||
44124364|NCT02856113|78908477|FG001|Overall Study|Significant Protocol Deviation|0|||
44124365|NCT02856113|78908476|FG000|Overall Study|Lost to Follow-up|3|||
44124366|NCT02856113|78908477|FG001|Overall Study|Lost to Follow-up|5|||
44124367|NCT02856113|78908476|FG000|Overall Study|Voluntary Withdrawal|3|||
44124368|NCT02856113|78908477|FG001|Overall Study|Voluntary Withdrawal|5|||
44124369|NCT02856113|78908476|FG000|Overall Study|Pregnancy|0|||
44124370|NCT02856113|78908477|FG001|Overall Study|Pregnancy|1|||
44124371|NCT02856113|78908476|FG000|Overall Study|Principal Investigator Discretion|2|||
44124372|NCT02856113|78908477|FG001|Overall Study|Principal Investigator Discretion|1|||
44124373|NCT02856113|78908476|FG000|Overall Study|Randomized but not Treated|1|||
44124374|NCT02856113|78908477|FG001|Overall Study|Randomized but not Treated|0|||
44124375|NCT02856113|78908476|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
44124376|NCT02856113|78908477|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
44124377|NCT02855411|78908484|FG000|Overall Study|Study terminated by sponsor|21|||
44124378|NCT02855411|78908484|FG000|Overall Study|Does not meet entrance criteria|14|||
44124379|NCT02745145|78908491|FG000|Overall Study|Adverse Event|1|||
44124380|NCT02745145|78908492|FG001|Overall Study|Adverse Event|0|||
44124381|NCT02745145|78908493|FG002|Overall Study|Adverse Event|0|||
44124382|NCT02745145|78908491|FG000|Overall Study|Death|0|||
44124383|NCT02745145|78908492|FG001|Overall Study|Death|1|||
44124384|NCT02745145|78908493|FG002|Overall Study|Death|0|||
44124385|NCT02745145|78908491|FG000|Overall Study|Progressive disease|0|||
44124386|NCT02745145|78908492|FG001|Overall Study|Progressive disease|0|||
44124387|NCT02745145|78908493|FG002|Overall Study|Progressive disease|1|||
44124388|NCT02745145|78908491|FG000|Overall Study|Withdrew consent|1|||
44124389|NCT02745145|78908492|FG001|Overall Study|Withdrew consent|1|||
44124390|NCT02745145|78908493|FG002|Overall Study|Withdrew consent|1|||
44124391|NCT02745145|78908491|FG000|Overall Study|Study Termination|8|||
44124392|NCT02745145|78908492|FG001|Overall Study|Study Termination|3|||
44124393|NCT02745145|78908493|FG002|Overall Study|Study Termination|7|||
44124394|NCT02854631|78908512|FG000|Overall Study|Adverse Event|1|||
44124395|NCT02854631|78908513|FG001|Overall Study|Adverse Event|2|||
44124396|NCT02854631|78908512|FG000|Overall Study|Withdrew Consent|3|||
44124397|NCT02854631|78908513|FG001|Overall Study|Withdrew Consent|2|||
44124398|NCT02854631|78908512|FG000|Overall Study|Investigator's Discretion|2|||
44124399|NCT02854631|78908513|FG001|Overall Study|Investigator's Discretion|0|||
44124400|NCT02854631|78908512|FG000|Overall Study|Death|12|||
44124401|NCT02854631|78908513|FG001|Overall Study|Death|8|||
44124402|NCT02854631|78908512|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
44124403|NCT02854631|78908513|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
44124404|NCT02854631|78908512|FG000|Overall Study|Protocol Violation|0|||
44124405|NCT02854631|78908513|FG001|Overall Study|Protocol Violation|1|||
44124406|NCT02854631|78908512|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
44124407|NCT02854631|78908513|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
44124408|NCT02854631|78908512|FG000|Overall Study|Lost to Follow-up|4|||
44124409|NCT02854631|78908513|FG001|Overall Study|Lost to Follow-up|2|||
44124410|NCT02855359|78908521|FG000|Overall Study|Death|2|||
44124411|NCT02855359|78908522|FG001|Overall Study|Death|2|||
44124412|NCT02855359|78908523|FG002|Overall Study|Death|0|||
44124413|NCT02855359|78908524|FG003|Overall Study|Death|0|||
44124414|NCT02855359|78908521|FG000|Overall Study|Study Termination by Sponsor|9|||
44124415|NCT02855359|78908522|FG001|Overall Study|Study Termination by Sponsor|11|||
44124416|NCT02855359|78908523|FG002|Overall Study|Study Termination by Sponsor|0|||
44124417|NCT02855359|78908524|FG003|Overall Study|Study Termination by Sponsor|0|||
44124418|NCT02853929|78908538|FG000|Overall Study|Lost to Follow-up|3|||
44124419|NCT02853929|78908539|FG001|Overall Study|Lost to Follow-up|0|||
44124420|NCT02853929|78908538|FG000|Overall Study|Withdrawal by Subject|1|||
44124421|NCT02853929|78908539|FG001|Overall Study|Withdrawal by Subject|0|||
44124422|NCT02853929|78908538|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
44124423|NCT02853929|78908539|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
44124424|NCT02730819|78908575|FG000|Overall Study|Lost to Follow-up|9|||
44124425|NCT02038946|78908579|FG000|Overall Study|Death|5|||
44124426|NCT02038946|78908579|FG000|Overall Study|Withdrawal by Subject|3|||
44124427|NCT02038946|78908579|FG000|Overall Study|Lost to Follow-up|2|||
44124428|NCT02038946|78908579|FG000|Overall Study|Other reasons|2|||
44124429|NCT03143829|78908585|FG000|Overall Study|Withdrawal by Subject|2|||
44124430|NCT03143829|78908586|FG001|Overall Study|Withdrawal by Subject|5|||
44124431|NCT03143829|78908585|FG000|Overall Study|Lost to Follow-up|0|||
44124432|NCT03143829|78908586|FG001|Overall Study|Lost to Follow-up|2|||
44124433|NCT03143829|78908585|FG000|Overall Study|Death|1|||
44124434|NCT03143829|78908586|FG001|Overall Study|Death|1|||
44124435|NCT03143829|78908585|FG000|Overall Study|changed treatment, no longer eligible|2|||
44124436|NCT03143829|78908586|FG001|Overall Study|changed treatment, no longer eligible|2|||
44124437|NCT02853331|78908594|FG000|Overall Study|Death|59|||
44124438|NCT02853331|78908595|FG001|Overall Study|Death|95|||
44124439|NCT02853331|78908594|FG000|Overall Study|Withdrawal by Subject|5|||
44124440|NCT02853331|78908595|FG001|Overall Study|Withdrawal by Subject|9|||
44124441|NCT02853331|78908594|FG000|Overall Study|Ongoing in study|368|||
44124442|NCT02853331|78908595|FG001|Overall Study|Ongoing in study|325|||
44124443|NCT05896761|78908603|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
44124444|NCT05896761|78908604|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
44124445|NCT05896761|78908603|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
44124446|NCT05896761|78908604|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
44124447|NCT05048784|78908629|FG000|Period 1|Adverse Event|3|||
44124448|NCT05048784|78908630|FG001|Period 1|Adverse Event|1|||
44124449|NCT05048784|78908631|FG002|Period 1|Adverse Event|0|||
44124450|NCT05048784|78908632|FG003|Period 1|Adverse Event|0|||
44124451|NCT05048784|78908629|FG000|Period 2|Lost to Follow-up|0|||
44124452|NCT05048784|78908630|FG001|Period 2|Lost to Follow-up|1|||
44124453|NCT05048784|78908631|FG002|Period 2|Lost to Follow-up|0|||
44124454|NCT05048784|78908632|FG003|Period 2|Lost to Follow-up|0|||
44124455|NCT04700280|78908661|FG000|Overall Study|Adverse Event|4|||
44124456|NCT04700280|78908662|FG001|Overall Study|Adverse Event|0|||
44124457|NCT04700280|78908661|FG000|Overall Study|Lack of Efficacy|1|||
44124458|NCT04700280|78908662|FG001|Overall Study|Lack of Efficacy|0|||
44124459|NCT04700280|78908661|FG000|Overall Study|Study terminated by sponsor|5|||
44124460|NCT04700280|78908662|FG001|Overall Study|Study terminated by sponsor|3|||
44124461|NCT04700280|78908661|FG000|Overall Study|Other than specified|1|||
44124462|NCT04700280|78908662|FG001|Overall Study|Other than specified|0|||
44124463|NCT04679675|78908672|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
44124464|NCT04679675|78908673|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
44124465|NCT04679675|78908674|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
44124466|NCT04679675|78908675|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
44124467|NCT04679675|78908672|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
44124468|NCT04679675|78908673|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
44124469|NCT04679675|78908674|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
44124470|NCT04679675|78908675|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
44124471|NCT04626128|78908689|FG000|Overall Study|Withdrawal by Subject|0|||
44124472|NCT04626128|78908690|FG001|Overall Study|Withdrawal by Subject|1|||
44124473|NCT04626128|78908691|FG002|Overall Study|Withdrawal by Subject|0|||
44124474|NCT04626128|78908692|FG003|Overall Study|Withdrawal by Subject|0|||
44124475|NCT04523571|78908708|FG000|Received 2 Doses|Withdrawal by Subject|0|||
44124476|NCT04523571|78908709|FG001|Received 2 Doses|Withdrawal by Subject|0|||
44124477|NCT04523571|78908710|FG002|Received 2 Doses|Withdrawal by Subject|0|||
44124478|NCT04523571|78908711|FG003|Received 2 Doses|Withdrawal by Subject|1|||
44124479|NCT04523571|78908712|FG004|Received 2 Doses|Withdrawal by Subject|1|||
44124480|NCT04523571|78908713|FG005|Received 2 Doses|Withdrawal by Subject|0|||
44124481|NCT04523571|78908708|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
44124482|NCT04523571|78908709|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
44124483|NCT04523571|78908710|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
44124484|NCT04523571|78908711|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
44124485|NCT04523571|78908712|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
44510871|NCT04570436|79516070|FG007|Overall Study|Adverse Event|0|||
44124486|NCT04523571|78908713|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
44124487|NCT04523571|78908708|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
44124488|NCT04523571|78908709|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
44124489|NCT04523571|78908710|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
44124490|NCT04523571|78908711|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
44124491|NCT04523571|78908712|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
44124492|NCT04523571|78908713|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
44124493|NCT04523571|78908708|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
44124494|NCT04523571|78908709|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
44124495|NCT04523571|78908710|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
44124496|NCT04523571|78908711|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
44124497|NCT04523571|78908712|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
44124498|NCT04523571|78908713|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
44124499|NCT04361617|78908729|FG000|Overall Study|Withdrawal by Subject|0|||
44124500|NCT04361617|78908730|FG001|Overall Study|Withdrawal by Subject|1|||
44124501|NCT04021914|78908736|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
44124502|NCT03850444|78908762|FG000|Overall Study|Adverse Event|16|||
44124503|NCT03850444|78908763|FG001|Overall Study|Adverse Event|10|||
44124504|NCT03850444|78908762|FG000|Overall Study|Death|87|||
44124505|NCT03850444|78908763|FG001|Overall Study|Death|107|||
44124506|NCT03850444|78908762|FG000|Overall Study|Lost to Follow-up|1|||
44124507|NCT03850444|78908763|FG001|Overall Study|Lost to Follow-up|1|||
44124508|NCT03850444|78908762|FG000|Overall Study|Withdrawal by Subject|1|||
44124509|NCT03850444|78908763|FG001|Overall Study|Withdrawal by Subject|5|||
44124510|NCT03850444|78908762|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
44124511|NCT03850444|78908763|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
44124512|NCT03781804|78908773|FG000|Overall Study|Adverse Event|2|||
44124513|NCT03781804|78908774|FG001|Overall Study|Adverse Event|2|||
44124514|NCT03781804|78908775|FG002|Overall Study|Adverse Event|3|||
44124515|NCT03781804|78908773|FG000|Overall Study|Lost to Follow-up|1|||
44124516|NCT03781804|78908774|FG001|Overall Study|Lost to Follow-up|1|||
44379235|NCT02237508|79384883|FG008|Overall Study|Protocol Violation|0|||
44379236|NCT02237508|79384884|FG009|Overall Study|Protocol Violation|0|||
44379237|NCT00909090|79384904|FG000|Overall Study|Lost to Follow-up|17|||
44379238|NCT00909090|79384905|FG001|Overall Study|Lost to Follow-up|17|||
44379239|NCT00909480|79384916|FG000|Overall Study|Adverse Event|5|||
44379240|NCT00909480|79384917|FG001|Overall Study|Adverse Event|3|||
44379241|NCT00909480|79384916|FG000|Overall Study|Protocol Violation|6|||
44379242|NCT00909480|79384917|FG001|Overall Study|Protocol Violation|8|||
44379243|NCT00909480|79384916|FG000|Overall Study|Withdrawal criteria|9|||
44379244|NCT00909480|79384917|FG001|Overall Study|Withdrawal criteria|11|||
44124517|NCT03781804|78908775|FG002|Overall Study|Lost to Follow-up|2|||
44124518|NCT03781804|78908773|FG000|Overall Study|Lack of Efficacy|4|||
44124519|NCT03781804|78908774|FG001|Overall Study|Lack of Efficacy|2|||
44124520|NCT03781804|78908775|FG002|Overall Study|Lack of Efficacy|9|||
44124521|NCT03781804|78908773|FG000|Overall Study|Protocol Violation|0|||
44124522|NCT03781804|78908774|FG001|Overall Study|Protocol Violation|0|||
44124523|NCT03781804|78908775|FG002|Overall Study|Protocol Violation|1|||
44124524|NCT03781804|78908773|FG000|Overall Study|Withdrawal by Subject|0|||
44124525|NCT03781804|78908774|FG001|Overall Study|Withdrawal by Subject|1|||
44124526|NCT03781804|78908775|FG002|Overall Study|Withdrawal by Subject|1|||
44124527|NCT03781804|78908773|FG000|Overall Study|Reason not provided|2|||
44124528|NCT03781804|78908774|FG001|Overall Study|Reason not provided|2|||
44124529|NCT03781804|78908775|FG002|Overall Study|Reason not provided|0|||
44124530|NCT03507686|78908787|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
44124531|NCT03507686|78908788|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
44379245|NCT00909480|79384916|FG000|Overall Study|Unclassified|18|||
44379246|NCT00909480|79384917|FG001|Overall Study|Unclassified|19|||
44379247|NCT01058096|79384925|FG000|Double-blind Treatment Phase|Adverse Event|11|||
44510872|NCT04570436|79516071|FG008|Overall Study|Adverse Event|0|||
44510873|NCT04570436|79516072|FG009|Overall Study|Adverse Event|0|||
44510874|NCT04570436|79516063|FG000|Overall Study|Physician Decision|1|||
44510875|NCT04570436|79516064|FG001|Overall Study|Physician Decision|0|||
44510876|NCT04570436|79516065|FG002|Overall Study|Physician Decision|0|||
44510877|NCT04570436|79516066|FG003|Overall Study|Physician Decision|0|||
44510878|NCT04570436|79516067|FG004|Overall Study|Physician Decision|0|||
44510879|NCT04570436|79516068|FG005|Overall Study|Physician Decision|0|||
44510880|NCT04570436|79516069|FG006|Overall Study|Physician Decision|0|||
44124532|NCT03507686|78908787|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
44124533|NCT03507686|78908788|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
44124534|NCT03507686|78908787|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
44124535|NCT03507686|78908788|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
44243127|NCT01693562|79072540|FG012|Exploration Phase|Other|0|||
44510881|NCT04570436|79516070|FG007|Overall Study|Physician Decision|0|||
44124536|NCT03507686|78908787|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
44124537|NCT03507686|78908788|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
44124538|NCT03507686|78908787|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
44124539|NCT03507686|78908788|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
44124540|NCT03507686|78908787|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
44124541|NCT03507686|78908788|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
44124542|NCT03471507|78908796|FG000|Overall Study|Lost to Follow-up|1|||
44124543|NCT03471507|78908797|FG001|Overall Study|Lost to Follow-up|3|||
44124544|NCT03471507|78908796|FG000|Overall Study|Physician Decision|0|||
44124545|NCT03471507|78908797|FG001|Overall Study|Physician Decision|1|||
44124546|NCT03471507|78908796|FG000|Overall Study|Withdrawal by Subject|2|||
44124547|NCT03471507|78908797|FG001|Overall Study|Withdrawal by Subject|1|||
44124548|NCT03338894|78908803|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
44124549|NCT03138564|78908811|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
44124550|NCT03138564|78908812|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
44124551|NCT03138564|78908811|FG000|Overall Study|Lost to Follow-up|16|||
44124552|NCT03138564|78908812|FG001|Overall Study|Lost to Follow-up|2|||
44124553|NCT03138564|78908811|FG000|Overall Study|Withdrawal by Subject|48|||
44124554|NCT03138564|78908812|FG001|Overall Study|Withdrawal by Subject|4|||
44124555|NCT03138564|78908811|FG000|Overall Study|No longer met eligibility criteria|2|||
44124556|NCT03138564|78908812|FG001|Overall Study|No longer met eligibility criteria|0|||
44124557|NCT03138564|78908811|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
44124558|NCT03138564|78908812|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
44124559|NCT03138564|78908811|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
44124560|NCT03138564|78908812|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
44124561|NCT03138564|78908811|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
44124562|NCT03138564|78908812|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
44124563|NCT03138564|78908811|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
44124564|NCT03138564|78908812|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
44124565|NCT02923180|78908835|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
44124566|NCT02923180|78908835|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
44124567|NCT02836717|78908842|FG000|Test Phase|Lack of Efficacy|14|||
44124568|NCT02836717|78908843|FG001|Test Phase|Lack of Efficacy|8|||
44124569|NCT02836717|78908844|FG002|Test Phase|Lack of Efficacy|0|||
44124570|NCT02836717|78908842|FG000|Study Phase|Adverse Event|2|||
44124571|NCT02836717|78908843|FG001|Study Phase|Adverse Event|0|||
44124572|NCT02836717|78908844|FG002|Study Phase|Adverse Event|0|||
44124573|NCT02836717|78908842|FG000|Study Phase|Lack of Efficacy|8|||
44124574|NCT02836717|78908843|FG001|Study Phase|Lack of Efficacy|6|||
44124575|NCT02836717|78908844|FG002|Study Phase|Lack of Efficacy|1|||
44124576|NCT02836717|78908842|FG000|Study Phase|Withdrawal by Subject|1|||
44124577|NCT02836717|78908843|FG001|Study Phase|Withdrawal by Subject|0|||
44124578|NCT02836717|78908844|FG002|Study Phase|Withdrawal by Subject|0|||
44124579|NCT02836717|78908842|FG000|Study Phase|Death|1|||
44124580|NCT02836717|78908843|FG001|Study Phase|Death|0|||
44124581|NCT02836717|78908844|FG002|Study Phase|Death|0|||
44124582|NCT02836717|78908842|FG000|Study Phase|abdominal surgeries|2|||
44124583|NCT02836717|78908843|FG001|Study Phase|abdominal surgeries|1|||
44124584|NCT02836717|78908844|FG002|Study Phase|abdominal surgeries|0|||
44124585|NCT02743494|78908855|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
44124586|NCT02743494|78908856|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
44124587|NCT02743494|78908855|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
44124588|NCT02743494|78908856|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
44124589|NCT02743494|78908855|FG000|Treatment Period|Completed treatment|229|||
44124590|NCT02743494|78908856|FG001|Treatment Period|Completed treatment|99|||
44124591|NCT02743494|78908855|FG000|Treatment Period|Disease recurrence|149|||
44124592|NCT02743494|78908856|FG001|Treatment Period|Disease recurrence|113|||
44124593|NCT02743494|78908855|FG000|Treatment Period|Study drug toxicity|57|||
44124594|NCT02743494|78908856|FG001|Treatment Period|Study drug toxicity|8|||
44124595|NCT02743494|78908855|FG000|Treatment Period|Death|1|||
44124596|NCT02743494|78908856|FG001|Treatment Period|Death|0|||
44124597|NCT02743494|78908855|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
44379248|NCT01058096|79384926|FG001|Double-blind Treatment Phase|Adverse Event|15|||
44124598|NCT02743494|78908856|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
44124599|NCT02743494|78908855|FG000|Treatment Period|Participant request to discontinue treatment|30|||
44124600|NCT02743494|78908856|FG001|Treatment Period|Participant request to discontinue treatment|5|||
44124601|NCT02743494|78908855|FG000|Treatment Period|Participant withdrew consent|12|||
44124602|NCT02743494|78908856|FG001|Treatment Period|Participant withdrew consent|4|||
44124603|NCT02743494|78908855|FG000|Treatment Period|Lost to Follow-up|0|||
44124604|NCT02743494|78908856|FG001|Treatment Period|Lost to Follow-up|1|||
44124605|NCT02743494|78908855|FG000|Treatment Period|Poor/Non-compliance|1|||
44124606|NCT02743494|78908856|FG001|Treatment Period|Poor/Non-compliance|0|||
44124607|NCT02743494|78908855|FG000|Treatment Period|Other reasons|7|||
44124608|NCT02743494|78908856|FG001|Treatment Period|Other reasons|2|||
44379249|NCT01058096|79384925|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
44379250|NCT01058096|79384926|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
44124609|NCT02336282|78908862|FG000|Overall Study|Unrelated illness|1|||
44379251|NCT01058096|79384925|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
44124610|NCT02336282|78908862|FG000|Overall Study|Uncomfortable with technology|1|||
44124611|NCT02336282|78908862|FG000|Overall Study|Lost to Follow-up|1|||
44124612|NCT02336282|78908862|FG000|Overall Study|Not enough time to complete sessions|2|||
44124613|NCT02272842|78908876|FG000|Overall Study|Lost to Follow-up|8|||
44124614|NCT02272842|78908877|FG001|Overall Study|Lost to Follow-up|8|||
44124615|NCT02272842|78908876|FG000|Overall Study|Withdrawal by Subject|8|||
44124616|NCT02272842|78908877|FG001|Overall Study|Withdrawal by Subject|2|||
44124617|NCT02258659|78908884|FG000|Overall Study|Withdrawal by Subject|1|||
44124618|NCT01990300|78908888|FG000|Overall Study|Case Report Forms Uncollected|89|||
44124619|NCT01990300|78908888|FG000|Overall Study|Protocol Deviation|53|||
44124620|NCT01909934|78908892|FG000|Overall Study|Ongoing|23|||
44124621|NCT01909934|78908892|FG000|Overall Study|Withdrawal by Subject|3|||
44124622|NCT01909934|78908892|FG000|Overall Study|Lost to Follow-up|1|||
44124623|NCT01909934|78908892|FG000|Overall Study|Withdrawal of Informed Consent|1|||
44124624|NCT01909934|78908892|FG000|Overall Study|Death|22|||
44124625|NCT01076400|78908907|FG000|Overall Study|Adverse Event|2|||
44124626|NCT01076400|78908908|FG001|Overall Study|Adverse Event|0|||
44124627|NCT01076400|78908909|FG002|Overall Study|Adverse Event|0|||
44124628|NCT01076400|78908907|FG000|Overall Study|Progressive Disease|5|||
44124629|NCT01076400|78908908|FG001|Overall Study|Progressive Disease|0|||
44124630|NCT01076400|78908909|FG002|Overall Study|Progressive Disease|0|||
44124631|NCT01000051|78908915|FG000|Overall Study|Withdrawal by Subject|1|||
44124632|NCT01000051|78908916|FG001|Overall Study|Withdrawal by Subject|1|||
44124633|NCT01000051|78908915|FG000|Overall Study|Disease Progression|1|||
44124634|NCT01000051|78908916|FG001|Overall Study|Disease Progression|0|||
44124635|NCT01000051|78908915|FG000|Overall Study|Serious noncompliance|1|||
44124636|NCT01000051|78908916|FG001|Overall Study|Serious noncompliance|0|||
44124637|NCT00953160|78908922|FG000|Overall Study|Lost to Follow-up|23|||
44124638|NCT00953160|78908922|FG000|Overall Study|Withdrawal by Subject|4|||
44124639|NCT00913497|78908949|FG000|Overall Study|Adverse Event|1|||
44124640|NCT00913497|78908949|FG000|Overall Study|Withdrawal by Subject|2|||
44124641|NCT00874822|78908955|FG000|Overall Study|excluded by criteria|8|||
44124642|NCT00556933|78908972|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
44124643|NCT00556933|78908973|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
44124644|NCT00556933|78908974|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
44124645|NCT00556933|78908975|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
44124646|NCT00556933|78908972|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
44124647|NCT00556933|78908973|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
44124648|NCT00556933|78908974|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
44124649|NCT00556933|78908975|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
44124650|NCT00556933|78908972|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
44124651|NCT00556933|78908973|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
44124652|NCT00556933|78908974|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
44124653|NCT00556933|78908975|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
44124654|NCT00556933|78908972|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
44124655|NCT00556933|78908973|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
44124656|NCT00556933|78908974|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
44124657|NCT00556933|78908975|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
44124658|NCT00556933|78908972|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
44124659|NCT00556933|78908973|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
44124660|NCT00556933|78908974|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
44124661|NCT00556933|78908975|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
44124662|NCT00556933|78908972|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
44243128|NCT01693562|79072541|FG013|Exploration Phase|Other|0|||
44243129|NCT01693562|79072542|FG014|Exploration Phase|Other|0|||
44243130|NCT01693562|79072543|FG015|Exploration Phase|Other|0|||
44243131|NCT01693562|79072544|FG016|Exploration Phase|Other|0|||
44243132|NCT01693562|79072545|FG017|Exploration Phase|Other|0|||
44124663|NCT00556933|78908973|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
44243133|NCT01693562|79072546|FG018|Exploration Phase|Other|0|||
44243134|NCT01693562|79072547|FG019|Exploration Phase|Other|0|||
44124664|NCT00556933|78908974|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
44124665|NCT00556933|78908975|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
44124666|NCT00556933|78908972|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
44124667|NCT00556933|78908973|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
44124668|NCT00556933|78908974|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
44124669|NCT00556933|78908975|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
44124670|NCT00556933|78908972|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
44124671|NCT00556933|78908973|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
44124672|NCT00556933|78908974|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
44124673|NCT00556933|78908975|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
44124674|NCT00556933|78908972|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
44124675|NCT00556933|78908973|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
44124676|NCT00556933|78908974|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
44124677|NCT00556933|78908975|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
44124678|NCT00556933|78908972|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
44124679|NCT00556933|78908973|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
44124680|NCT00556933|78908974|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
44124681|NCT00556933|78908975|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
44243135|NCT01693562|79072548|FG020|Exploration Phase|Other|0|||
44243136|NCT01693562|79072549|FG021|Exploration Phase|Other|0|||
44243137|NCT01693562|79072550|FG022|Exploration Phase|Other|0|||
44243138|NCT01693562|79072528|FG000|Expansion Phase|Withdrawal by Subject|0|||
44243139|NCT01693562|79072529|FG001|Expansion Phase|Withdrawal by Subject|0|||
44243140|NCT01693562|79072530|FG002|Expansion Phase|Withdrawal by Subject|0|||
44379252|NCT01058096|79384926|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
44379253|NCT01058096|79384925|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
44379254|NCT01058096|79384926|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
44379255|NCT01058096|79384925|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
44379256|NCT01058096|79384926|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
44379257|NCT01058096|79384925|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
44379258|NCT01058096|79384926|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
44379259|NCT01057862|79384934|FG000|Overall Study|Withdrawal by Subject|1|||
44379260|NCT01057862|79384935|FG001|Overall Study|Withdrawal by Subject|2|||
44379261|NCT01038128|79384941|FG000|Overall Study|Lack of Efficacy|1|||
44379262|NCT01038128|79384941|FG000|Overall Study|Lost to Follow-up|1|||
44379263|NCT01038128|79384941|FG000|Overall Study|Withdrawal by Subject|2|||
44379264|NCT00842530|79384962|FG000|Overall Study|Serious adverse event|0|||
44379265|NCT00842530|79384963|FG001|Overall Study|Serious adverse event|6|||
44379266|NCT00842530|79384962|FG000|Overall Study|Other adverse event|6|||
44379267|NCT00842530|79384963|FG001|Overall Study|Other adverse event|1|||
44379268|NCT00842530|79384962|FG000|Overall Study|Protocol Violation|32|||
44379269|NCT00842530|79384963|FG001|Overall Study|Protocol Violation|14|||
44379270|NCT00842530|79384962|FG000|Overall Study|Lost to Follow-up|6|||
44379271|NCT00842530|79384963|FG001|Overall Study|Lost to Follow-up|8|||
44379272|NCT00842530|79384962|FG000|Overall Study|Withdrawal by Subject|73|||
44379273|NCT00842530|79384963|FG001|Overall Study|Withdrawal by Subject|28|||
44379274|NCT00819910|79384974|FG000|Overall Study|Adverse Event|0|||
44243141|NCT01693562|79072531|FG003|Expansion Phase|Withdrawal by Subject|0|||
44243142|NCT01693562|79072532|FG004|Expansion Phase|Withdrawal by Subject|0|||
44276494|NCT02153112|79231458|FG003|Overall Study|Adverse Event|0|||
44276495|NCT02153112|79231459|FG004|Overall Study|Adverse Event|0|||
44276496|NCT02153112|79231460|FG005|Overall Study|Adverse Event|0|||
44276497|NCT02153112|79231461|FG006|Overall Study|Adverse Event|0|||
44276498|NCT02153112|79231462|FG007|Overall Study|Adverse Event|0|||
44276499|NCT02153112|79231463|FG008|Overall Study|Adverse Event|0|||
44276500|NCT02153112|79231464|FG009|Overall Study|Adverse Event|0|||
44276501|NCT02153112|79231455|FG000|Overall Study|Lost to Follow-up|1|||
44124682|NCT00556933|78908972|FG000|CNI Withdrawal vs. Minimization|Death|0|||
44243143|NCT01693562|79072533|FG005|Expansion Phase|Withdrawal by Subject|0|||
44243144|NCT01693562|79072534|FG006|Expansion Phase|Withdrawal by Subject|0|||
44243145|NCT01693562|79072535|FG007|Expansion Phase|Withdrawal by Subject|16|||
44243146|NCT01693562|79072536|FG008|Expansion Phase|Withdrawal by Subject|2|||
44276502|NCT02153112|79231456|FG001|Overall Study|Lost to Follow-up|1|||
44276503|NCT02153112|79231457|FG002|Overall Study|Lost to Follow-up|0|||
44243147|NCT01693562|79072537|FG009|Expansion Phase|Withdrawal by Subject|54|||
44243148|NCT01693562|79072538|FG010|Expansion Phase|Withdrawal by Subject|2|||
44243149|NCT01693562|79072539|FG011|Expansion Phase|Withdrawal by Subject|2|||
44243150|NCT01693562|79072540|FG012|Expansion Phase|Withdrawal by Subject|3|||
44276504|NCT02153112|79231458|FG003|Overall Study|Lost to Follow-up|0|||
44276505|NCT02153112|79231459|FG004|Overall Study|Lost to Follow-up|2|||
44379275|NCT00819910|79384975|FG001|Overall Study|Adverse Event|0|||
44379276|NCT00819910|79384976|FG002|Overall Study|Adverse Event|2|||
44379277|NCT00819910|79384977|FG003|Overall Study|Adverse Event|1|||
44379278|NCT00819910|79384974|FG000|Overall Study|Withdrawal by Subject|1|||
44379279|NCT00819910|79384975|FG001|Overall Study|Withdrawal by Subject|1|||
44379280|NCT00819910|79384976|FG002|Overall Study|Withdrawal by Subject|1|||
44379281|NCT00819910|79384977|FG003|Overall Study|Withdrawal by Subject|0|||
44379282|NCT00819910|79384974|FG000|Overall Study|Lost to Follow-up|1|||
44379283|NCT00819910|79384975|FG001|Overall Study|Lost to Follow-up|0|||
44379284|NCT00819910|79384976|FG002|Overall Study|Lost to Follow-up|0|||
44379285|NCT00819910|79384977|FG003|Overall Study|Lost to Follow-up|0|||
44379286|NCT00830518|79384991|FG000|Overall Study|Progressive Disease|18|||
44379287|NCT00830518|79384992|FG001|Overall Study|Progressive Disease|8|||
44379288|NCT00830518|79384991|FG000|Overall Study|Symptomatic Deterioration|4|||
44379289|NCT00830518|79384992|FG001|Overall Study|Symptomatic Deterioration|1|||
44379290|NCT00830518|79384991|FG000|Overall Study|Adverse Event|14|||
44379291|NCT00830518|79384992|FG001|Overall Study|Adverse Event|1|||
44379292|NCT00830518|79384991|FG000|Overall Study|Withdrawal by Patient|2|||
44379293|NCT00830518|79384992|FG001|Overall Study|Withdrawal by Patient|0|||
44379294|NCT00830518|79384991|FG000|Overall Study|Reason not Specified|8|||
44379295|NCT00830518|79384992|FG001|Overall Study|Reason not Specified|1|||
44379296|NCT00908544|79385001|FG000|Overall Study|Withdrawal by Subject|2|||
44379297|NCT00908544|79385002|FG001|Overall Study|Withdrawal by Subject|4|||
44379298|NCT00908544|79385001|FG000|Overall Study|Lack of Efficacy|0|||
44379299|NCT00908544|79385002|FG001|Overall Study|Lack of Efficacy|1|||
44379300|NCT00908544|79385001|FG000|Overall Study|Pregnancy|1|||
44379301|NCT00908544|79385002|FG001|Overall Study|Pregnancy|0|||
44379302|NCT00908544|79385001|FG000|Overall Study|Relocation abroad|1|||
44379303|NCT00908544|79385002|FG001|Overall Study|Relocation abroad|1|||
44379304|NCT00908544|79385001|FG000|Overall Study|Unable to visit sutdy center|1|||
44510882|NCT04570436|79516071|FG008|Overall Study|Physician Decision|0|||
44510883|NCT04570436|79516072|FG009|Overall Study|Physician Decision|0|||
44124683|NCT00556933|78908973|FG001|CNI Withdrawal vs. Minimization|Death|0|||
44124684|NCT00556933|78908974|FG002|CNI Withdrawal vs. Minimization|Death|0|||
44124685|NCT00556933|78908975|FG003|CNI Withdrawal vs. Minimization|Death|1|||
44124686|NCT00280917|78909014|FG000|Overall Study|Adverse Event|1|||
44243151|NCT01693562|79072541|FG013|Expansion Phase|Withdrawal by Subject|5|||
44243152|NCT01693562|79072542|FG014|Expansion Phase|Withdrawal by Subject|16|||
44243153|NCT01693562|79072543|FG015|Expansion Phase|Withdrawal by Subject|7|||
44510884|NCT04563845|79516106|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510885|NCT04563845|79516107|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510886|NCT04563845|79516108|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510887|NCT04563845|79516109|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510888|NCT04563845|79516110|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510889|NCT04563845|79516111|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510890|NCT04563845|79516112|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510891|NCT04563845|79516113|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
44510892|NCT04563845|79516114|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510893|NCT04563845|79516115|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510894|NCT04563845|79516116|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510895|NCT04563845|79516117|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510896|NCT04563845|79516118|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510897|NCT04563845|79516119|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
44510898|NCT04563845|79516106|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44243154|NCT01693562|79072544|FG016|Expansion Phase|Withdrawal by Subject|40|||
44243155|NCT01693562|79072545|FG017|Expansion Phase|Withdrawal by Subject|4|||
44379305|NCT00908544|79385002|FG001|Overall Study|Unable to visit sutdy center|0|||
44379306|NCT00830440|79385010|FG000|Overall Study|Protocol Violation|1|||
44379307|NCT00830440|79385011|FG001|Overall Study|Protocol Violation|0|||
44124687|NCT00280917|78909015|FG001|Overall Study|Adverse Event|1|||
44379308|NCT00830440|79385010|FG000|Overall Study|Withdrawal by Subject|1|||
44379309|NCT00830440|79385011|FG001|Overall Study|Withdrawal by Subject|0|||
44510899|NCT04563845|79516107|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510900|NCT04563845|79516108|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510901|NCT04563845|79516109|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510902|NCT04563845|79516110|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
44510903|NCT04563845|79516111|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510904|NCT04563845|79516112|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510905|NCT04563845|79516113|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510906|NCT04563845|79516114|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510907|NCT04563845|79516115|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510908|NCT04563845|79516116|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510909|NCT04563845|79516117|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510910|NCT04563845|79516118|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510911|NCT04563845|79516119|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
44510912|NCT04517253|79516150|FG000|Overall Study|Adverse Event|1|||
44510913|NCT04517253|79516151|FG001|Overall Study|Adverse Event|0|||
44510914|NCT04517253|79516152|FG002|Overall Study|Adverse Event|0|||
44510915|NCT04517253|79516150|FG000|Overall Study|Death|0|||
44510916|NCT04517253|79516151|FG001|Overall Study|Death|1|||
44510917|NCT04517253|79516152|FG002|Overall Study|Death|0|||
44510918|NCT04433767|79516162|FG000|Overall Study|Adverse Event|1|||
44510919|NCT04419467|79516169|FG000|Overall Study|Not treated with IP|0|||
44510920|NCT04419467|79516170|FG001|Overall Study|Not treated with IP|0|||
44510921|NCT04419467|79516171|FG002|Overall Study|Not treated with IP|2|||
44510922|NCT04419467|79516169|FG000|Overall Study|Adverse Event|0|||
44510923|NCT04419467|79516170|FG001|Overall Study|Adverse Event|2|||
44510924|NCT04419467|79516171|FG002|Overall Study|Adverse Event|0|||
44510925|NCT04419467|79516169|FG000|Overall Study|Death|1|||
44510926|NCT04419467|79516170|FG001|Overall Study|Death|0|||
44510927|NCT04419467|79516171|FG002|Overall Study|Death|0|||
44510928|NCT04419467|79516169|FG000|Overall Study|Lost to Follow-up|0|||
44510929|NCT04419467|79516170|FG001|Overall Study|Lost to Follow-up|1|||
44510930|NCT04419467|79516171|FG002|Overall Study|Lost to Follow-up|2|||
44510931|NCT04419467|79516169|FG000|Overall Study|Withdrawal by Subject|0|||
44510932|NCT04419467|79516170|FG001|Overall Study|Withdrawal by Subject|0|||
44510933|NCT04419467|79516171|FG002|Overall Study|Withdrawal by Subject|4|||
44510934|NCT04419467|79516169|FG000|Overall Study|Pandemic related|0|||
44510935|NCT04419467|79516170|FG001|Overall Study|Pandemic related|0|||
44510936|NCT04419467|79516171|FG002|Overall Study|Pandemic related|1|||
44510937|NCT04419467|79516169|FG000|Overall Study|Reason not known|1|||
44510938|NCT04419467|79516170|FG001|Overall Study|Reason not known|0|||
44510939|NCT04419467|79516171|FG002|Overall Study|Reason not known|0|||
44510940|NCT04382326|79516190|FG000|Overall Study|Adverse Event, not serious|1|||
44510941|NCT04382326|79516191|FG001|Overall Study|Adverse Event, not serious|2|||
44510942|NCT04382326|79516190|FG000|Overall Study|Other|1|||
44510943|NCT04382326|79516191|FG001|Overall Study|Other|0|||
44510944|NCT04382326|79516190|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
44510945|NCT04382326|79516191|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
44510946|NCT04382326|79516190|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
44510947|NCT04382326|79516191|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
44510948|NCT04382326|79516190|FG000|Overall Study|Protocol Violation|29|||
44510949|NCT04382326|79516191|FG001|Overall Study|Protocol Violation|23|||
44510950|NCT04382326|79516190|FG000|Overall Study|Physician Decision|0|||
44510951|NCT04382326|79516191|FG001|Overall Study|Physician Decision|1|||
44510952|NCT04382326|79516190|FG000|Overall Study|Lost to Follow-up|48|||
44510953|NCT04382326|79516191|FG001|Overall Study|Lost to Follow-up|63|||
44510954|NCT04382326|79516190|FG000|Overall Study|Adverse Event, non-fatal|1|||
44510955|NCT04382326|79516191|FG001|Overall Study|Adverse Event, non-fatal|1|||
44510956|NCT04359901|79516199|FG000|Overall Study|Withdrawal by Subject|0|||
44510957|NCT04359901|79516200|FG001|Overall Study|Withdrawal by Subject|1|||
44510958|NCT04359901|79516199|FG000|Overall Study|Death|6|||
44510959|NCT04359901|79516200|FG001|Overall Study|Death|2|||
44510960|NCT03945591|79516215|FG000|Overall Study|Participant not transplanted|1|||
44510961|NCT03945591|79516215|FG000|Overall Study|Change in treatment plan|3|||
44510962|NCT03945591|79516215|FG000|Overall Study|Adverse Event|1|||
44510963|NCT03744676|79516219|FG000|Pre-Treatment Phase|Death|7|||
44510964|NCT03744676|79516219|FG000|Pre-Treatment Phase|Disease related complications|2|||
44124688|NCT00280917|78909016|FG002|Overall Study|Adverse Event|4|||
44124689|NCT00280917|78909017|FG003|Overall Study|Adverse Event|1|||
44124690|NCT00280917|78909014|FG000|Overall Study|Change Therapy|1|||
44124691|NCT00280917|78909015|FG001|Overall Study|Change Therapy|2|||
44124692|NCT00280917|78909016|FG002|Overall Study|Change Therapy|0|||
44124693|NCT00280917|78909017|FG003|Overall Study|Change Therapy|0|||
44124694|NCT00280917|78909014|FG000|Overall Study|Withdrawal by Subject|0|||
44124695|NCT00280917|78909015|FG001|Overall Study|Withdrawal by Subject|2|||
44124696|NCT00280917|78909016|FG002|Overall Study|Withdrawal by Subject|0|||
44124697|NCT00280917|78909017|FG003|Overall Study|Withdrawal by Subject|1|||
44124698|NCT00280917|78909014|FG000|Overall Study|Noncompliance|0|||
44124699|NCT00280917|78909015|FG001|Overall Study|Noncompliance|1|||
44243156|NCT01693562|79072546|FG018|Expansion Phase|Withdrawal by Subject|8|||
44243157|NCT01693562|79072547|FG019|Expansion Phase|Withdrawal by Subject|3|||
44379310|NCT00830440|79385010|FG000|Overall Study|unsuccessful procedure|4|||
44379311|NCT00830440|79385011|FG001|Overall Study|unsuccessful procedure|0|||
44379312|NCT00830440|79385010|FG000|Overall Study|Adverse Event|2|||
44379313|NCT00830440|79385011|FG001|Overall Study|Adverse Event|0|||
44379314|NCT00908310|79385018|FG000|Overall Study|Death|37|||
44379315|NCT00908310|79385018|FG000|Overall Study|Withdrawal by Subject|7|||
44379316|NCT00908310|79385018|FG000|Overall Study|Lost to Follow-up|7|||
44379317|NCT00908310|79385018|FG000|Overall Study|Screening failure|5|||
44510965|NCT03744676|79516219|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
44510966|NCT03744676|79516219|FG000|Pre-Treatment Phase|Other reasons|8|||
44510967|NCT03744676|79516219|FG000|Treatment Phase|Ongoing in study|18|||
44510968|NCT03744676|79516219|FG000|Treatment Phase|Death|31|||
44510969|NCT03744676|79516219|FG000|Treatment Phase|Withdrawal of consent|8|||
44510970|NCT03744676|79516219|FG000|Treatment Phase|Other reasons|6|||
44124700|NCT00280917|78909016|FG002|Overall Study|Noncompliance|2|||
44243158|NCT01693562|79072548|FG020|Expansion Phase|Withdrawal by Subject|1|||
44379318|NCT00908310|79385018|FG000|Overall Study|Other reasons|4|||
44124701|NCT00280917|78909017|FG003|Overall Study|Noncompliance|0|||
44243159|NCT01693562|79072549|FG021|Expansion Phase|Withdrawal by Subject|8|||
44124702|NCT00006478|78909036|FG000|Overall Study|Vaccine could not be produced|1|||
44124703|NCT00006478|78909036|FG000|Overall Study|Physician Decision|6|||
44124704|NCT05718466|78909042|FG000|Overall Study|Withdrawal by Subject|1|||
44124705|NCT05718466|78909043|FG001|Overall Study|Withdrawal by Subject|2|||
44124706|NCT05718466|78909042|FG000|Overall Study|Death|0|||
44124707|NCT05718466|78909043|FG001|Overall Study|Death|1|||
44124708|NCT04938453|78909051|FG000|Washout Period 1|Adverse Event|1|||
44124709|NCT04938453|78909052|FG001|Washout Period 1|Adverse Event|0|||
44124710|NCT04938453|78909051|FG000|Washout Period 1|Physician Decision|0|||
44124711|NCT04938453|78909052|FG001|Washout Period 1|Physician Decision|1|||
44124712|NCT04147260|78909097|FG000|Overall Study|Adverse Event|1|||
44124713|NCT04147260|78909098|FG001|Overall Study|Adverse Event|0|||
44124714|NCT04147260|78909099|FG002|Overall Study|Adverse Event|1|||
44124715|NCT04147260|78909100|FG003|Overall Study|Adverse Event|2|||
44124716|NCT04147260|78909101|FG004|Overall Study|Adverse Event|0|||
44124717|NCT04147260|78909097|FG000|Overall Study|Withdrawal by Subject|0|||
44124718|NCT04147260|78909098|FG001|Overall Study|Withdrawal by Subject|0|||
44124719|NCT04147260|78909099|FG002|Overall Study|Withdrawal by Subject|1|||
44124720|NCT04147260|78909100|FG003|Overall Study|Withdrawal by Subject|1|||
44124721|NCT04147260|78909101|FG004|Overall Study|Withdrawal by Subject|0|||
44124722|NCT04134728|78909118|FG000|Overall Study|Adverse Event|3|||
44124723|NCT04134728|78909119|FG001|Overall Study|Adverse Event|2|||
44124724|NCT04134728|78909120|FG002|Overall Study|Adverse Event|9|||
44124725|NCT04134728|78909121|FG003|Overall Study|Adverse Event|0|||
44124726|NCT04134728|78909122|FG004|Overall Study|Adverse Event|0|||
44124727|NCT04134728|78909123|FG005|Overall Study|Adverse Event|0|||
44124728|NCT04134728|78909118|FG000|Overall Study|Lack of Efficacy|3|||
44124729|NCT04134728|78909119|FG001|Overall Study|Lack of Efficacy|3|||
44124730|NCT04134728|78909120|FG002|Overall Study|Lack of Efficacy|1|||
44124731|NCT04134728|78909121|FG003|Overall Study|Lack of Efficacy|2|||
44124732|NCT04134728|78909122|FG004|Overall Study|Lack of Efficacy|0|||
44124733|NCT04134728|78909123|FG005|Overall Study|Lack of Efficacy|0|||
44124734|NCT04134728|78909118|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
44124735|NCT04134728|78909119|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44124736|NCT04134728|78909120|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
44124737|NCT04134728|78909121|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44124738|NCT04134728|78909122|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44243160|NCT01693562|79072550|FG022|Expansion Phase|Withdrawal by Subject|1|||
44243161|NCT01693562|79072528|FG000|Expansion Phase|Death|0|||
44510985|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
44510986|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
44510987|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
44510988|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
44510989|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
44124739|NCT04134728|78909123|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44124740|NCT04134728|78909118|FG000|Overall Study|Protocol Deviation|0|||
44124741|NCT04134728|78909119|FG001|Overall Study|Protocol Deviation|0|||
44124742|NCT04134728|78909120|FG002|Overall Study|Protocol Deviation|1|||
44243162|NCT01693562|79072529|FG001|Expansion Phase|Death|0|||
44510990|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
44510991|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
44124743|NCT04134728|78909121|FG003|Overall Study|Protocol Deviation|0|||
44124744|NCT04134728|78909122|FG004|Overall Study|Protocol Deviation|0|||
44124745|NCT04134728|78909123|FG005|Overall Study|Protocol Deviation|0|||
44124746|NCT04134728|78909118|FG000|Overall Study|Informed Consent Withdrawn|3|||
44124747|NCT04134728|78909119|FG001|Overall Study|Informed Consent Withdrawn|6|||
44124748|NCT04134728|78909120|FG002|Overall Study|Informed Consent Withdrawn|8|||
44124749|NCT04134728|78909121|FG003|Overall Study|Informed Consent Withdrawn|1|||
44124750|NCT04134728|78909122|FG004|Overall Study|Informed Consent Withdrawn|1|||
44124751|NCT04134728|78909123|FG005|Overall Study|Informed Consent Withdrawn|0|||
44124752|NCT04134728|78909118|FG000|Overall Study|Physician Decision|2|||
44124753|NCT04134728|78909119|FG001|Overall Study|Physician Decision|0|||
44124754|NCT04134728|78909120|FG002|Overall Study|Physician Decision|0|||
44124755|NCT04134728|78909121|FG003|Overall Study|Physician Decision|0|||
44124756|NCT04134728|78909122|FG004|Overall Study|Physician Decision|0|||
44124757|NCT04134728|78909123|FG005|Overall Study|Physician Decision|0|||
44124758|NCT04134728|78909118|FG000|Overall Study|Lost to Follow-up|1|||
44124759|NCT04134728|78909119|FG001|Overall Study|Lost to Follow-up|2|||
44124760|NCT04134728|78909120|FG002|Overall Study|Lost to Follow-up|1|||
44124761|NCT04134728|78909121|FG003|Overall Study|Lost to Follow-up|0|||
44124762|NCT04134728|78909122|FG004|Overall Study|Lost to Follow-up|0|||
44124763|NCT04134728|78909123|FG005|Overall Study|Lost to Follow-up|1|||
44124764|NCT04134728|78909118|FG000|Overall Study|Investigator Site Closed|0|||
44124765|NCT04134728|78909119|FG001|Overall Study|Investigator Site Closed|1|||
44124766|NCT04134728|78909120|FG002|Overall Study|Investigator Site Closed|1|||
44124767|NCT04134728|78909121|FG003|Overall Study|Investigator Site Closed|0|||
44124768|NCT04134728|78909122|FG004|Overall Study|Investigator Site Closed|0|||
44124769|NCT04134728|78909123|FG005|Overall Study|Investigator Site Closed|0|||
44124770|NCT03886272|78909157|FG000|Period 1|Withdrawal by Subject|0|||
44124771|NCT03886272|78909158|FG001|Period 1|Withdrawal by Subject|0|||
44124772|NCT03886272|78909159|FG002|Period 1|Withdrawal by Subject|0|||
44124773|NCT03886272|78909160|FG003|Period 1|Withdrawal by Subject|0|||
44124774|NCT03886272|78909161|FG004|Period 1|Withdrawal by Subject|0|||
44124775|NCT03886272|78909162|FG005|Period 1|Withdrawal by Subject|1|||
44124776|NCT03886272|78909163|FG006|Period 1|Withdrawal by Subject|0|||
44124777|NCT03732833|78909182|FG000|Overall Study|Adverse Event|0|||
44124778|NCT03732833|78909183|FG001|Overall Study|Adverse Event|3|||
44124779|NCT03732833|78909184|FG002|Overall Study|Adverse Event|1|||
44124780|NCT03732833|78909182|FG000|Overall Study|Withdrawal by Subject|11|||
44124781|NCT03732833|78909183|FG001|Overall Study|Withdrawal by Subject|13|||
44124782|NCT03732833|78909184|FG002|Overall Study|Withdrawal by Subject|8|||
44124783|NCT03732833|78909182|FG000|Overall Study|Lost to Follow-up|3|||
44124784|NCT03732833|78909183|FG001|Overall Study|Lost to Follow-up|5|||
44124785|NCT03732833|78909184|FG002|Overall Study|Lost to Follow-up|4|||
44124786|NCT03732833|78909182|FG000|Overall Study|Pregnancy|0|||
44124787|NCT03732833|78909183|FG001|Overall Study|Pregnancy|2|||
44124788|NCT03732833|78909184|FG002|Overall Study|Pregnancy|0|||
44124789|NCT03732833|78909182|FG000|Overall Study|Physician Decision|2|||
44124790|NCT03732833|78909183|FG001|Overall Study|Physician Decision|3|||
44124791|NCT03732833|78909184|FG002|Overall Study|Physician Decision|1|||
44124792|NCT03732833|78909182|FG000|Overall Study|Covid-19 related and other reasons|2|||
44124793|NCT03732833|78909183|FG001|Overall Study|Covid-19 related and other reasons|7|||
44124794|NCT03732833|78909184|FG002|Overall Study|Covid-19 related and other reasons|3|||
44124795|NCT03493919|78909201|FG000|Overall Study|Other|2|||
44124796|NCT03493919|78909202|FG001|Overall Study|Other|0|||
44124797|NCT03493919|78909203|FG002|Overall Study|Other|1|||
44379319|NCT00830128|79385022|FG000|Overall Study|Adverse Event|5|||
44379320|NCT00830128|79385022|FG000|Overall Study|Lack of Efficacy|7|||
44379321|NCT00830128|79385022|FG000|Overall Study|Protocol Violation|1|||
44124798|NCT03493919|78909204|FG003|Overall Study|Other|0|||
44124799|NCT03493919|78909201|FG000|Overall Study|Withdrawal by Subject|9|||
44124800|NCT03493919|78909202|FG001|Overall Study|Withdrawal by Subject|3|||
44124801|NCT03493919|78909203|FG002|Overall Study|Withdrawal by Subject|1|||
44124802|NCT03493919|78909204|FG003|Overall Study|Withdrawal by Subject|1|||
44124803|NCT03493919|78909201|FG000|Overall Study|Lost to Follow-up|5|||
44124804|NCT03493919|78909202|FG001|Overall Study|Lost to Follow-up|0|||
44124805|NCT03493919|78909203|FG002|Overall Study|Lost to Follow-up|0|||
44124806|NCT03493919|78909204|FG003|Overall Study|Lost to Follow-up|3|||
44124807|NCT03493919|78909201|FG000|Overall Study|Adverse Event|0|||
44124808|NCT03493919|78909202|FG001|Overall Study|Adverse Event|1|||
44124809|NCT03493919|78909203|FG002|Overall Study|Adverse Event|0|||
44124810|NCT03493919|78909204|FG003|Overall Study|Adverse Event|0|||
44124811|NCT03280628|78909222|FG000|Overall Study|Lost to Follow-up|8|||
44124812|NCT03280628|78909223|FG001|Overall Study|Lost to Follow-up|6|||
44124813|NCT03280628|78909224|FG002|Overall Study|Lost to Follow-up|11|||
44124814|NCT03058146|78909251|FG000|Overall Study|Withdrawal by Subject|4|||
44124815|NCT03058146|78909252|FG001|Overall Study|Withdrawal by Subject|1|||
44124816|NCT03058146|78909251|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
44124817|NCT03058146|78909252|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
44124818|NCT02851511|78909264|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
44124819|NCT02851511|78909265|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
44124820|NCT02851511|78909266|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
44124821|NCT02851511|78909267|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
44124822|NCT02851511|78909264|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
44124823|NCT02851511|78909265|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
44124824|NCT02851511|78909266|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
44124825|NCT02851511|78909267|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
44124826|NCT02851511|78909264|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
44124827|NCT02851511|78909265|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
44124828|NCT02851511|78909266|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
44124829|NCT02851511|78909267|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
44124830|NCT02851511|78909264|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
44243163|NCT01693562|79072530|FG002|Expansion Phase|Death|0|||
44243164|NCT01693562|79072531|FG003|Expansion Phase|Death|0|||
44243165|NCT01693562|79072532|FG004|Expansion Phase|Death|0|||
44379322|NCT00830128|79385022|FG000|Overall Study|Withdrawal by Subject|2|||
44379323|NCT00830128|79385022|FG000|Overall Study|Family obligation|1|||
44379324|NCT00830128|79385022|FG000|Overall Study|Relocation|1|||
44379325|NCT00830128|79385022|FG000|Overall Study|Work obligation|1|||
44379326|NCT00830128|79385022|FG000|Overall Study|Operating a vehicle|1|||
44510992|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
44510993|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
44510994|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
44510995|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
44510996|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
44510997|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
44124831|NCT02851511|78909265|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
44379327|NCT00841906|79385028|FG000|Overall Study|Withdrawal by Subject|2|||
44124832|NCT02851511|78909266|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
44243166|NCT01693562|79072533|FG005|Expansion Phase|Death|0|||
44243167|NCT01693562|79072534|FG006|Expansion Phase|Death|0|||
44379328|NCT00841906|79385029|FG001|Overall Study|Withdrawal by Subject|0|||
44379329|NCT00771667|79385041|FG000|Induction Phase|Adverse Event|5|||
44379330|NCT00771667|79385042|FG001|Induction Phase|Adverse Event|2|||
44510998|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
44124833|NCT02851511|78909267|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
44124834|NCT02851511|78909264|FG000|Phase I|Physician Decision|0|||
44124835|NCT02851511|78909265|FG001|Phase I|Physician Decision|0|||
44124836|NCT02851511|78909266|FG002|Phase I|Physician Decision|0|||
44124837|NCT02851511|78909267|FG003|Phase I|Physician Decision|1|||
44124838|NCT02851511|78909264|FG000|Phase I|Withdrawal by Subject|2|||
44124839|NCT02851511|78909265|FG001|Phase I|Withdrawal by Subject|1|||
44124840|NCT02851511|78909266|FG002|Phase I|Withdrawal by Subject|0|||
44124841|NCT02851511|78909267|FG003|Phase I|Withdrawal by Subject|3|||
44124842|NCT02851511|78909264|FG000|Phase II|Physician Decision|18|||
44124843|NCT02851511|78909265|FG001|Phase II|Physician Decision|16|||
44124844|NCT02851511|78909266|FG002|Phase II|Physician Decision|0|||
44124845|NCT02851511|78909267|FG003|Phase II|Physician Decision|0|||
44124846|NCT02851511|78909264|FG000|Phase II|Withdrawal by Subject|18|||
44124847|NCT02851511|78909265|FG001|Phase II|Withdrawal by Subject|16|||
44124848|NCT02851511|78909266|FG002|Phase II|Withdrawal by Subject|0|||
44124849|NCT02851511|78909267|FG003|Phase II|Withdrawal by Subject|0|||
44124850|NCT02851511|78909264|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
44124851|NCT02851511|78909265|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
44124852|NCT02851511|78909266|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
44124853|NCT02851511|78909267|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
44124854|NCT02851511|78909264|FG000|Phase II|Lost to Follow-up|0|||
44124855|NCT02851511|78909265|FG001|Phase II|Lost to Follow-up|1|||
44124856|NCT02851511|78909266|FG002|Phase II|Lost to Follow-up|0|||
44124857|NCT02851511|78909267|FG003|Phase II|Lost to Follow-up|0|||
44124858|NCT02478320|78909288|FG000|Overall Study|Adverse Event|2|||
44124859|NCT02478320|78909289|FG001|Overall Study|Adverse Event|0|||
44124860|NCT02478320|78909288|FG000|Overall Study|Death|1|||
44124861|NCT02478320|78909289|FG001|Overall Study|Death|0|||
44124862|NCT02478320|78909288|FG000|Overall Study|Lack of Efficacy|4|||
44124863|NCT02478320|78909289|FG001|Overall Study|Lack of Efficacy|0|||
44124864|NCT02478320|78909288|FG000|Overall Study|Withdrawal by Subject|2|||
44124865|NCT02478320|78909289|FG001|Overall Study|Withdrawal by Subject|0|||
44124866|NCT02478320|78909288|FG000|Overall Study|Screen Failure|3|||
44124867|NCT02478320|78909289|FG001|Overall Study|Screen Failure|0|||
44124868|NCT02252042|78909314|FG000|Overall Study|Adverse Event|9|||
44124869|NCT02252042|78909315|FG001|Overall Study|Adverse Event|6|||
44124870|NCT02252042|78909314|FG000|Overall Study|Death|209|||
44124871|NCT02252042|78909315|FG001|Overall Study|Death|217|||
44124872|NCT02252042|78909314|FG000|Overall Study|Physician Decision|0|||
44124873|NCT02252042|78909315|FG001|Overall Study|Physician Decision|2|||
44124874|NCT02252042|78909314|FG000|Overall Study|Transferred to Extension Study|7|||
44124875|NCT02252042|78909315|FG001|Overall Study|Transferred to Extension Study|1|||
44124876|NCT02252042|78909314|FG000|Overall Study|Did Not Continue on Extension Study|7|||
44124877|NCT02252042|78909315|FG001|Overall Study|Did Not Continue on Extension Study|2|||
44124878|NCT02252042|78909314|FG000|Overall Study|Withdrawal by Subject|15|||
44124879|NCT02252042|78909315|FG001|Overall Study|Withdrawal by Subject|20|||
44124880|NCT00378482|78909342|FG000|Overall Study|Lost to Follow-up|1|||
44124881|NCT00378482|78909342|FG000|Overall Study|Lack of Efficacy|8|||
44124882|NCT00378482|78909342|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
44124883|NCT00378482|78909342|FG000|Overall Study|Withdrawal by Subject|4|||
44124884|NCT00378482|78909342|FG000|Overall Study|Adverse Event|9|||
44124885|NCT05288673|78909349|FG000|Overall Study|Consent withdrawn by subject|0|||
44124886|NCT05288673|78909350|FG001|Overall Study|Consent withdrawn by subject|0|||
44124887|NCT05288673|78909351|FG002|Overall Study|Consent withdrawn by subject|1|||
44124888|NCT04604795|78909397|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
44124889|NCT04604795|78909398|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
44124890|NCT04604795|78909399|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124891|NCT04604795|78909400|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44379331|NCT00771667|79385043|FG002|Induction Phase|Adverse Event|4|||
44379332|NCT00771667|79385044|FG003|Induction Phase|Adverse Event|1|||
44124892|NCT04604795|78909401|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124893|NCT04604795|78909402|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124894|NCT04604795|78909403|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124895|NCT04604795|78909404|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124896|NCT04604795|78909405|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124897|NCT04604795|78909406|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
44124898|NCT04604795|78909397|FG000|Part B: Up to Day 14|Adverse Event|0|||
44124899|NCT04604795|78909398|FG001|Part B: Up to Day 14|Adverse Event|0|||
44124900|NCT04604795|78909399|FG002|Part B: Up to Day 14|Adverse Event|0|||
44124901|NCT04604795|78909400|FG003|Part B: Up to Day 14|Adverse Event|0|||
44124902|NCT04604795|78909401|FG004|Part B: Up to Day 14|Adverse Event|2|||
44124903|NCT04604795|78909402|FG005|Part B: Up to Day 14|Adverse Event|1|||
44124904|NCT04604795|78909403|FG006|Part B: Up to Day 14|Adverse Event|0|||
44124905|NCT04604795|78909404|FG007|Part B: Up to Day 14|Adverse Event|0|||
44379333|NCT00771667|79385045|FG004|Induction Phase|Adverse Event|0|||
44124906|NCT04604795|78909405|FG008|Part B: Up to Day 14|Adverse Event|0|||
44124907|NCT04604795|78909406|FG009|Part B: Up to Day 14|Adverse Event|0|||
44124908|NCT04604795|78909397|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124909|NCT04604795|78909398|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124910|NCT04604795|78909399|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124911|NCT04604795|78909400|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124912|NCT04604795|78909401|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124913|NCT04604795|78909402|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124914|NCT04604795|78909403|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124915|NCT04604795|78909404|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124916|NCT04604795|78909405|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
44124917|NCT04604795|78909406|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
44124918|NCT04604795|78909397|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124919|NCT04604795|78909398|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124920|NCT04604795|78909399|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124921|NCT04604795|78909400|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124922|NCT04604795|78909401|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124923|NCT04604795|78909402|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124924|NCT04604795|78909403|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124925|NCT04604795|78909404|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124926|NCT04604795|78909405|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
44124927|NCT04604795|78909406|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
44124928|NCT04604795|78909397|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124929|NCT04604795|78909398|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124930|NCT04604795|78909399|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124931|NCT04604795|78909400|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124932|NCT04604795|78909401|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124933|NCT04604795|78909402|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124934|NCT04604795|78909403|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124935|NCT04604795|78909404|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124936|NCT04604795|78909405|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
44124937|NCT04604795|78909406|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
44124938|NCT04604795|78909397|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124939|NCT04604795|78909398|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124940|NCT04604795|78909399|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124941|NCT04604795|78909400|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124942|NCT04604795|78909401|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124943|NCT04604795|78909402|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124944|NCT04604795|78909403|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124945|NCT04604795|78909404|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124946|NCT04604795|78909405|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
44124947|NCT04604795|78909406|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
44124948|NCT04314284|78909502|FG000|Overall Study|Withdrawal by Subject|4|||
44124949|NCT04314284|78909503|FG001|Overall Study|Withdrawal by Subject|7|||
44124950|NCT04314284|78909502|FG000|Overall Study|Consented but did not complete survey|0|||
44124951|NCT04314284|78909503|FG001|Overall Study|Consented but did not complete survey|6|||
44124952|NCT04203823|78909511|FG000|Overall Study|Withdrawal by Subject|2|||
44124953|NCT04203823|78909512|FG001|Overall Study|Withdrawal by Subject|2|||
44124954|NCT04203823|78909511|FG000|Overall Study|Adverse Event|1|||
44124955|NCT04203823|78909512|FG001|Overall Study|Adverse Event|1|||
44124956|NCT04203823|78909511|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44124957|NCT04203823|78909512|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
44124958|NCT03703466|78909565|FG000|Overall Study|Death|2|||
44124959|NCT03703466|78909566|FG001|Overall Study|Death|1|||
44124960|NCT03703466|78909567|FG002|Overall Study|Death|0|||
44124961|NCT03703466|78909565|FG000|Overall Study|Protocol Violation|1|||
44124962|NCT03703466|78909566|FG001|Overall Study|Protocol Violation|0|||
44124963|NCT03703466|78909567|FG002|Overall Study|Protocol Violation|0|||
44124964|NCT03703466|78909565|FG000|Overall Study|Withdrawal by Subject|0|||
44510999|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
44511000|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
44511001|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
44511002|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
44511003|NCT03605667|79516234|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
44511004|NCT03605667|79516235|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
44511005|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
44511006|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
44511007|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Other|6|||
44511008|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Other|8|||
44511009|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
44511010|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
44511011|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
44511012|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
44124965|NCT03703466|78909566|FG001|Overall Study|Withdrawal by Subject|3|||
44124966|NCT03703466|78909567|FG002|Overall Study|Withdrawal by Subject|0|||
44124967|NCT03703466|78909565|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
44124968|NCT03703466|78909566|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
44124969|NCT03703466|78909567|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
44124970|NCT03248128|78909626|FG000|Overall Study|Lost to Follow-up|1|||
44124971|NCT03248128|78909627|FG001|Overall Study|Lost to Follow-up|0|||
44124972|NCT03248128|78909626|FG000|Overall Study|Withdrawal by Subject|16|||
44124973|NCT03248128|78909627|FG001|Overall Study|Withdrawal by Subject|14|||
44124974|NCT03248128|78909626|FG000|Overall Study|Site Closed|4|||
44124975|NCT03248128|78909627|FG001|Overall Study|Site Closed|3|||
44124976|NCT03248128|78909626|FG000|Overall Study|Randomized, but did not receive treatment|1|||
44124977|NCT03248128|78909627|FG001|Overall Study|Randomized, but did not receive treatment|3|||
44124978|NCT02802631|78909670|FG000|Overall Study|Withdrawal by Subject|1|||
44124979|NCT02802631|78909671|FG001|Overall Study|Withdrawal by Subject|0|||
44124980|NCT02802631|78909672|FG002|Overall Study|Withdrawal by Subject|0|||
44124981|NCT02802631|78909673|FG003|Overall Study|Withdrawal by Subject|0|||
44124982|NCT02802631|78909674|FG004|Overall Study|Withdrawal by Subject|0|||
44124983|NCT02802631|78909675|FG005|Overall Study|Withdrawal by Subject|0|||
44124984|NCT02802631|78909676|FG006|Overall Study|Withdrawal by Subject|0|||
44124985|NCT02802631|78909677|FG007|Overall Study|Withdrawal by Subject|0|||
44124986|NCT02802631|78909670|FG000|Overall Study|Physician Decision|1|||
44124987|NCT02802631|78909671|FG001|Overall Study|Physician Decision|0|||
44124988|NCT02802631|78909672|FG002|Overall Study|Physician Decision|0|||
44124989|NCT02802631|78909673|FG003|Overall Study|Physician Decision|0|||
44124990|NCT02802631|78909674|FG004|Overall Study|Physician Decision|0|||
44124991|NCT02802631|78909675|FG005|Overall Study|Physician Decision|0|||
44124992|NCT02802631|78909676|FG006|Overall Study|Physician Decision|1|||
44124993|NCT02802631|78909677|FG007|Overall Study|Physician Decision|0|||
44124994|NCT02802631|78909670|FG000|Overall Study|Adverse Event|0|||
44124995|NCT02802631|78909671|FG001|Overall Study|Adverse Event|2|||
44124996|NCT02802631|78909672|FG002|Overall Study|Adverse Event|0|||
44124997|NCT02802631|78909673|FG003|Overall Study|Adverse Event|1|||
44124998|NCT02802631|78909674|FG004|Overall Study|Adverse Event|6|||
44124999|NCT02802631|78909675|FG005|Overall Study|Adverse Event|1|||
44125000|NCT02802631|78909676|FG006|Overall Study|Adverse Event|4|||
44511013|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
44511014|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
44511015|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
44125001|NCT02802631|78909677|FG007|Overall Study|Adverse Event|0|||
44125002|NCT02802631|78909670|FG000|Overall Study|Sponsor Decision|0|||
44379334|NCT00771667|79385046|FG005|Induction Phase|Adverse Event|0|||
44511016|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
44125003|NCT02802631|78909671|FG001|Overall Study|Sponsor Decision|0|||
44125004|NCT02802631|78909672|FG002|Overall Study|Sponsor Decision|6|||
44125005|NCT02802631|78909673|FG003|Overall Study|Sponsor Decision|0|||
44125006|NCT02802631|78909674|FG004|Overall Study|Sponsor Decision|2|||
44125007|NCT02802631|78909675|FG005|Overall Study|Sponsor Decision|0|||
44125008|NCT02802631|78909676|FG006|Overall Study|Sponsor Decision|0|||
44125009|NCT02802631|78909677|FG007|Overall Study|Sponsor Decision|4|||
44125010|NCT02754479|78909709|FG000|Overall Study|Lost to Follow-up|1|||
44125011|NCT02036476|78909722|FG000|Overall Study|Withdrawal by Subject|2|||
44125012|NCT02036476|78909722|FG000|Overall Study|Progressive Disease|4|||
44125013|NCT02036476|78909722|FG000|Overall Study|Unacceptable Toxicity|2|||
44125014|NCT00643994|78909747|FG000|Overall Study|Death|24|||
44125015|NCT00643994|78909747|FG000|Overall Study|Lost to Follow-up|72|||
44125016|NCT00643617|78909753|FG000|Overall Study|Death|6|||
44125017|NCT00643617|78909754|FG001|Overall Study|Death|9|||
44125018|NCT00643617|78909753|FG000|Overall Study|Lost to Follow-up|42|||
44125019|NCT00643617|78909754|FG001|Overall Study|Lost to Follow-up|51|||
44125020|NCT00504582|78909781|FG000|Overall Study|Lost to Follow-up|1|||
44125021|NCT00504582|78909782|FG001|Overall Study|Lost to Follow-up|0|||
44125022|NCT00504582|78909783|FG002|Overall Study|Lost to Follow-up|0|||
44125023|NCT00314366|78909806|FG000|Overall Study|not treated due to patient medical condi|1|||
44125024|NCT00314366|78909807|FG001|Overall Study|not treated due to patient medical condi|0|||
44125025|NCT01595061|78909816|FG000|Overall Study|Never Treated|3|||
44125026|NCT01595061|78909816|FG000|Overall Study|Inadequate Pathology|1|||
44125027|NCT02852005|78909825|FG000|Overall Study|Lost to Follow-up|0|||
44125028|NCT02852005|78909826|FG001|Overall Study|Lost to Follow-up|0|||
44125029|NCT02852005|78909827|FG002|Overall Study|Lost to Follow-up|0|||
44125030|NCT02852005|78909828|FG003|Overall Study|Lost to Follow-up|0|||
44125031|NCT02852005|78909829|FG004|Overall Study|Lost to Follow-up|1|||
44125032|NCT02852005|78909825|FG000|Overall Study|Withdrawal by Subject|1|||
44125033|NCT02852005|78909826|FG001|Overall Study|Withdrawal by Subject|0|||
44125034|NCT02852005|78909827|FG002|Overall Study|Withdrawal by Subject|0|||
44125035|NCT02852005|78909828|FG003|Overall Study|Withdrawal by Subject|0|||
44125036|NCT02852005|78909829|FG004|Overall Study|Withdrawal by Subject|0|||
44125037|NCT02851615|78909845|FG000|Overall Study|Cognitive Issue|1|||
44125038|NCT02851615|78909846|FG001|Overall Study|Cognitive Issue|0|||
44125039|NCT02851615|78909845|FG000|Overall Study|Lost to Follow-up|0|||
44125040|NCT02851615|78909846|FG001|Overall Study|Lost to Follow-up|4|||
44125041|NCT02849743|78909855|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
44125042|NCT02849743|78909856|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
44125043|NCT02849743|78909855|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
44125044|NCT02849743|78909856|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
44125045|NCT02851069|78909891|FG000|Overall Study|Failure to Return|3|||
44125046|NCT02851069|78909891|FG000|Overall Study|Other|3|||
44125047|NCT02849509|78909899|FG000|Overall Study|Worsening of disease under study|1|||
44125048|NCT02849509|78909900|FG001|Overall Study|Worsening of disease under study|1|||
44125049|NCT02849509|78909901|FG002|Overall Study|Worsening of disease under study|1|||
44125050|NCT02849509|78909899|FG000|Overall Study|Worsening of other pre-existing disease|0|||
44125051|NCT02849509|78909900|FG001|Overall Study|Worsening of other pre-existing disease|1|||
44511017|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
44511018|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
44511019|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
44511020|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
44511021|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Death|0|||
44511022|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Death|2|||
44511023|NCT03605667|79516234|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
44125052|NCT02849509|78909901|FG002|Overall Study|Worsening of other pre-existing disease|2|||
44125053|NCT02849509|78909899|FG000|Overall Study|Other adverse event|36|||
44125054|NCT02849509|78909900|FG001|Overall Study|Other adverse event|41|||
44125055|NCT02849509|78909901|FG002|Overall Study|Other adverse event|8|||
44125056|NCT02849509|78909899|FG000|Overall Study|Withdrawal by Subject|6|||
44125057|NCT02849509|78909900|FG001|Overall Study|Withdrawal by Subject|17|||
44125058|NCT02849509|78909901|FG002|Overall Study|Withdrawal by Subject|12|||
44125059|NCT02849509|78909899|FG000|Overall Study|Lost to Follow-up|27|||
44125060|NCT02849509|78909900|FG001|Overall Study|Lost to Follow-up|67|||
44125061|NCT02849509|78909901|FG002|Overall Study|Lost to Follow-up|36|||
44125062|NCT02849509|78909899|FG000|Overall Study|Other, reason not specified|14|||
44125063|NCT02849509|78909900|FG001|Overall Study|Other, reason not specified|29|||
44125064|NCT02849509|78909901|FG002|Overall Study|Other, reason not specified|25|||
44125065|NCT02849509|78909899|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
44125066|NCT02849509|78909900|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
44125067|NCT02849509|78909901|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
44125068|NCT02848729|78909913|FG000|Overall Study|Withdrawal by Subject|1|||
44125069|NCT02848729|78909914|FG001|Overall Study|Withdrawal by Subject|0|||
44125070|NCT02848729|78909913|FG000|Overall Study|Emesis|15|||
44125071|NCT02848729|78909914|FG001|Overall Study|Emesis|11|||
44125072|NCT00158756|78909932|FG000|Overall Study|Withdrawal by Subject|5|||
44125073|NCT00158756|78909933|FG001|Overall Study|Withdrawal by Subject|0|||
44125074|NCT00158756|78909934|FG002|Overall Study|Withdrawal by Subject|6|||
44125075|NCT00158756|78909935|FG003|Overall Study|Withdrawal by Subject|1|||
44511024|NCT03605667|79516235|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
44511025|NCT03600350|79516247|FG000|Overall Study|Death|1|||
44125076|NCT00158756|78909936|FG004|Overall Study|Withdrawal by Subject|3|||
44125077|NCT00158756|78909932|FG000|Overall Study|Adverse Event|0|||
44125078|NCT00158756|78909933|FG001|Overall Study|Adverse Event|0|||
44125079|NCT00158756|78909934|FG002|Overall Study|Adverse Event|1|||
44125080|NCT00158756|78909935|FG003|Overall Study|Adverse Event|0|||
44125081|NCT00158756|78909936|FG004|Overall Study|Adverse Event|0|||
44125082|NCT00158756|78909932|FG000|Overall Study|Serious adverse event|0|||
44125083|NCT00158756|78909933|FG001|Overall Study|Serious adverse event|0|||
44125084|NCT00158756|78909934|FG002|Overall Study|Serious adverse event|1|||
44125085|NCT00158756|78909935|FG003|Overall Study|Serious adverse event|0|||
44125086|NCT00158756|78909936|FG004|Overall Study|Serious adverse event|0|||
44125087|NCT02730195|78909948|FG000|Overall Study|Withdrawal by Subject|1|||
44125088|NCT02730351|78909956|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
44125089|NCT02730351|78909957|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
44125090|NCT02730351|78909956|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
44125091|NCT02730351|78909957|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
44125092|NCT02730351|78909956|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
44125093|NCT02730351|78909957|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
44125094|NCT02730351|78909956|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
44125095|NCT02730351|78909957|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
44125096|NCT02730351|78909956|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
44125097|NCT02730351|78909957|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
44125098|NCT01376349|78909966|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
44125099|NCT01376349|78909967|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
44125100|NCT01376349|78909968|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
44125101|NCT01376349|78909966|FG000|Raondomized Treatment|Adverse Event|13|||
44125102|NCT01376349|78909967|FG001|Raondomized Treatment|Adverse Event|17|||
44125103|NCT01376349|78909968|FG002|Raondomized Treatment|Adverse Event|14|||
44125104|NCT01376349|78909966|FG000|Raondomized Treatment|Unkown|1|||
44125105|NCT01376349|78909967|FG001|Raondomized Treatment|Unkown|2|||
44125106|NCT01376349|78909968|FG002|Raondomized Treatment|Unkown|1|||
44125107|NCT01376349|78909966|FG000|Raondomized Treatment|Alternative Treatment|0|||
44125108|NCT01376349|78909967|FG001|Raondomized Treatment|Alternative Treatment|0|||
44125109|NCT01376349|78909968|FG002|Raondomized Treatment|Alternative Treatment|1|||
44125110|NCT03030261|78909977|FG000|Overall Study|Still receiving continuation therapy|5|||
44125111|NCT00158600|78910012|FG000|Overall Study|unable to commit time to study|0|||
44125112|NCT00158600|78910013|FG001|Overall Study|unable to commit time to study|1|||
44125113|NCT00158600|78910012|FG000|Overall Study|Adverse Event|2|||
44125114|NCT00158600|78910013|FG001|Overall Study|Adverse Event|1|||
44125115|NCT00158600|78910012|FG000|Overall Study|Death|1|||
44125116|NCT00158600|78910013|FG001|Overall Study|Death|0|||
44125117|NCT00158600|78910012|FG000|Overall Study|Withdrawal by Subject|2|||
44125118|NCT00158600|78910013|FG001|Overall Study|Withdrawal by Subject|2|||
44125119|NCT01680458|78910020|FG000|Overall Study|Protocol Violation|3|||
44125120|NCT04543136|78910024|FG000|Overall Study|Withdrawal by Subject|0|||
44125121|NCT04543136|78910025|FG001|Overall Study|Withdrawal by Subject|1|||
44276506|NCT02153112|79231460|FG005|Overall Study|Lost to Follow-up|1|||
44276507|NCT02153112|79231461|FG006|Overall Study|Lost to Follow-up|1|||
44511026|NCT03600350|79516247|FG000|Overall Study|On Follow Up|18|||
44511027|NCT03201445|79516272|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
44511028|NCT03201445|79516273|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
44511029|NCT03201445|79516272|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
44511030|NCT03201445|79516273|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
44511031|NCT03201445|79516272|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
44511032|NCT03201445|79516273|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
44511033|NCT03201445|79516272|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
44511034|NCT03201445|79516273|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
44511035|NCT03201445|79516272|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
44511036|NCT03201445|79516273|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
44511037|NCT03201445|79516272|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
44125122|NCT04543136|78910026|FG002|Overall Study|Withdrawal by Subject|0|||
44125123|NCT04543136|78910027|FG003|Overall Study|Withdrawal by Subject|1|||
44125124|NCT04543136|78910028|FG004|Overall Study|Withdrawal by Subject|0|||
44125125|NCT04543136|78910029|FG005|Overall Study|Withdrawal by Subject|0|||
44125126|NCT00709761|78910037|FG000|Overall Study|Withdrawal by Subject|8|||
44125127|NCT00709761|78910037|FG000|Overall Study|study closed/terminated|17|||
44125128|NCT00709761|78910037|FG000|Overall Study|Lost to Follow-up|2|||
44125129|NCT02848651|78910047|FG000|Overall Study|Death|85|||
44276508|NCT02153112|79231462|FG007|Overall Study|Lost to Follow-up|0|||
44125130|NCT02848651|78910047|FG000|Overall Study|Lost to Follow-up|1|||
44125131|NCT02848651|78910047|FG000|Overall Study|Non-Compliance|1|||
44125132|NCT02848651|78910047|FG000|Overall Study|Symptomatic Deterioration|1|||
44125133|NCT02848651|78910047|FG000|Overall Study|Physician Decision|4|||
44125134|NCT02848651|78910047|FG000|Overall Study|Withdrawal by Subject|14|||
44125135|NCT00709059|78910067|FG000|Overall Study|Lost to Follow-up|34|||
44125136|NCT00709059|78910067|FG000|Overall Study|Withdrawal by Subject|19|||
44125137|NCT00709059|78910067|FG000|Overall Study|Physician Decision|7|||
44125138|NCT00709059|78910067|FG000|Overall Study|Disease complication|3|||
44125139|NCT00709059|78910067|FG000|Overall Study|Side effects|20|||
44125140|NCT00709059|78910067|FG000|Overall Study|Serious side effects|11|||
44125141|NCT01678820|78910074|FG000|Overall Study|Study Terminated by Sponsor|45|||
44125142|NCT01678820|78910075|FG001|Overall Study|Study Terminated by Sponsor|43|||
44125143|NCT01678820|78910076|FG002|Overall Study|Study Terminated by Sponsor|43|||
44125144|NCT01678820|78910074|FG000|Overall Study|Withdrawal by Subject|2|||
44125145|NCT01678820|78910075|FG001|Overall Study|Withdrawal by Subject|5|||
44125146|NCT01678820|78910076|FG002|Overall Study|Withdrawal by Subject|2|||
44125147|NCT01678820|78910074|FG000|Overall Study|Protocol Specified Criteria|2|||
44125148|NCT01678820|78910075|FG001|Overall Study|Protocol Specified Criteria|3|||
44125149|NCT01678820|78910076|FG002|Overall Study|Protocol Specified Criteria|1|||
44125150|NCT01678820|78910074|FG000|Overall Study|Adverse Event|2|||
44125151|NCT01678820|78910075|FG001|Overall Study|Adverse Event|2|||
44125152|NCT01678820|78910076|FG002|Overall Study|Adverse Event|2|||
44125153|NCT01678820|78910074|FG000|Overall Study|Lost to Follow-up|7|||
44125154|NCT01678820|78910075|FG001|Overall Study|Lost to Follow-up|2|||
44125155|NCT01678820|78910076|FG002|Overall Study|Lost to Follow-up|2|||
44125156|NCT01678820|78910074|FG000|Overall Study|Non-compliance with study drug|0|||
44125157|NCT01678820|78910075|FG001|Overall Study|Non-compliance with study drug|1|||
44125158|NCT01678820|78910076|FG002|Overall Study|Non-compliance with study drug|0|||
44125159|NCT01678820|78910074|FG000|Overall Study|Physician Decision|0|||
44125160|NCT01678820|78910075|FG001|Overall Study|Physician Decision|0|||
44125161|NCT01678820|78910076|FG002|Overall Study|Physician Decision|1|||
44125162|NCT01678820|78910074|FG000|Overall Study|Protocol Violation|4|||
44125163|NCT01678820|78910075|FG001|Overall Study|Protocol Violation|5|||
44125164|NCT01678820|78910076|FG002|Overall Study|Protocol Violation|4|||
44125165|NCT01678820|78910074|FG000|Overall Study|Not treated with double-blind study drug|0|||
44125166|NCT01678820|78910075|FG001|Overall Study|Not treated with double-blind study drug|2|||
44125167|NCT01678820|78910076|FG002|Overall Study|Not treated with double-blind study drug|2|||
44125168|NCT02660138|78910088|FG000|Overall Study|Adverse Event|0|||
44125169|NCT02660138|78910089|FG001|Overall Study|Adverse Event|3|||
44125170|NCT02660138|78910090|FG002|Overall Study|Adverse Event|2|||
44276509|NCT02153112|79231463|FG008|Overall Study|Lost to Follow-up|1|||
44276510|NCT02153112|79231464|FG009|Overall Study|Lost to Follow-up|1|||
44125171|NCT02660138|78910088|FG000|Overall Study|Lack of Efficacy|1|||
44125172|NCT02660138|78910089|FG001|Overall Study|Lack of Efficacy|2|||
44125173|NCT02660138|78910090|FG002|Overall Study|Lack of Efficacy|1|||
44125174|NCT02660138|78910088|FG000|Overall Study|Withdrawal by Subject|7|||
44125175|NCT02660138|78910089|FG001|Overall Study|Withdrawal by Subject|6|||
44125176|NCT02660138|78910090|FG002|Overall Study|Withdrawal by Subject|6|||
44125177|NCT02660138|78910088|FG000|Overall Study|Lost to Follow-up|4|||
44125178|NCT02660138|78910089|FG001|Overall Study|Lost to Follow-up|4|||
44125179|NCT02660138|78910090|FG002|Overall Study|Lost to Follow-up|1|||
44125180|NCT02660138|78910088|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
44125181|NCT02660138|78910089|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
44125182|NCT02660138|78910090|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
44125183|NCT02660138|78910088|FG000|Overall Study|Other|1|||
44125184|NCT02660138|78910089|FG001|Overall Study|Other|1|||
44125185|NCT02660138|78910090|FG002|Overall Study|Other|0|||
44125186|NCT02660138|78910088|FG000|Overall Study|Not treated|0|||
44125187|NCT02660138|78910089|FG001|Overall Study|Not treated|1|||
44125188|NCT02660138|78910090|FG002|Overall Study|Not treated|0|||
44125189|NCT01603394|78910101|FG000|Overall Study|Adverse Event|1|||
44125190|NCT02729025|78910107|FG000|Overall Study|Sponsor Decision|0|||
44125191|NCT02729025|78910108|FG001|Overall Study|Sponsor Decision|1|||
44125192|NCT01603082|78910116|FG000|Overall Study|Adverse Event|0|||
44125193|NCT01603082|78910117|FG001|Overall Study|Adverse Event|1|||
44125194|NCT01603082|78910116|FG000|Overall Study|Withdrawal by Subject|1|||
44125195|NCT01603082|78910117|FG001|Overall Study|Withdrawal by Subject|0|||
44125196|NCT01603082|78910116|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
44125197|NCT01603082|78910117|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
44125198|NCT02846779|78910130|FG000|Overall Study|Lost Enrollment|83|||
44125199|NCT02846779|78910131|FG001|Overall Study|Lost Enrollment|82|||
44125200|NCT02846779|78910132|FG002|Overall Study|Lost Enrollment|86|||
44125201|NCT02846779|78910130|FG000|Overall Study|Less than 31 days of follow-up|56|||
44125202|NCT02846779|78910131|FG001|Overall Study|Less than 31 days of follow-up|45|||
44125203|NCT02846779|78910132|FG002|Overall Study|Less than 31 days of follow-up|52|||
44125204|NCT00406393|78910142|FG000|Overall Study|Did not undergo transplantation|2|||
44125205|NCT00406393|78910143|FG001|Overall Study|Did not undergo transplantation|1|||
44125206|NCT02845375|78910152|FG000|Overall Study|upper airway obstruction|1|||
44125207|NCT02845375|78910153|FG001|Overall Study|upper airway obstruction|2|||
44125208|NCT02845375|78910154|FG002|Overall Study|upper airway obstruction|1|||
44125209|NCT02658734|78910162|FG000|Overall Study|Adverse Event|2|||
44125210|NCT02658734|78910162|FG000|Overall Study|Death|4|||
44125211|NCT02658734|78910162|FG000|Overall Study|Lost to Follow-up|7|||
44125212|NCT02658734|78910162|FG000|Overall Study|Withdrawal of Consent|16|||
44125213|NCT02658734|78910162|FG000|Overall Study|Disease Progression|28|||
44125214|NCT02844439|78910166|FG000|Overall Study|Withdrawal by Subject|1|||
44125215|NCT02844439|78910166|FG000|Overall Study|Lost to Follow-up|2|||
44125216|NCT02844439|78910166|FG000|Overall Study|Termination by Sponsor|4|||
44125217|NCT02844439|78910166|FG000|Overall Study|Death|28|||
44125218|NCT02844439|78910166|FG000|Overall Study|Other|5|||
44125219|NCT01677182|78910180|FG000|Overall Study|Adverse Event|2|||
44125220|NCT01677182|78910181|FG001|Overall Study|Adverse Event|1|||
44125221|NCT01677182|78910182|FG002|Overall Study|Adverse Event|8|||
44125222|NCT01677182|78910180|FG000|Overall Study|Protocol Violation|5|||
44125223|NCT01677182|78910181|FG001|Overall Study|Protocol Violation|1|||
44125224|NCT01677182|78910182|FG002|Overall Study|Protocol Violation|4|||
44125225|NCT01677182|78910180|FG000|Overall Study|Lost to Follow-up|4|||
44125226|NCT01677182|78910181|FG001|Overall Study|Lost to Follow-up|0|||
44125227|NCT01677182|78910182|FG002|Overall Study|Lost to Follow-up|3|||
44125228|NCT01677182|78910180|FG000|Overall Study|Withdrawal by Subject|7|||
44125229|NCT01677182|78910181|FG001|Overall Study|Withdrawal by Subject|12|||
44125230|NCT01677182|78910182|FG002|Overall Study|Withdrawal by Subject|10|||
44125231|NCT01677182|78910180|FG000|Overall Study|Study termination|12|||
44125232|NCT01677182|78910181|FG001|Overall Study|Study termination|9|||
44125233|NCT01677182|78910182|FG002|Overall Study|Study termination|11|||
44125234|NCT01677182|78910180|FG000|Overall Study|Lack of Efficacy|3|||
44125235|NCT01677182|78910181|FG001|Overall Study|Lack of Efficacy|0|||
44125236|NCT01677182|78910182|FG002|Overall Study|Lack of Efficacy|1|||
44125237|NCT01677182|78910180|FG000|Overall Study|Other reasons|1|||
44125238|NCT01677182|78910181|FG001|Overall Study|Other reasons|5|||
44125239|NCT01677182|78910182|FG002|Overall Study|Other reasons|2|||
44125240|NCT02843659|78910193|FG000|Overall Study|Subject Withdrew Consent|0|||
44125241|NCT02843659|78910194|FG001|Overall Study|Subject Withdrew Consent|0|||
44276511|NCT02153112|79231455|FG000|Overall Study|Withdrawal by Subject|3|||
44276512|NCT02153112|79231456|FG001|Overall Study|Withdrawal by Subject|1|||
44379335|NCT00771667|79385047|FG006|Induction Phase|Adverse Event|0|||
44125242|NCT02843659|78910195|FG002|Overall Study|Subject Withdrew Consent|1|||
44125243|NCT02843659|78910193|FG000|Overall Study|Administrative Reason by Sponsor|4|||
44125244|NCT02843659|78910194|FG001|Overall Study|Administrative Reason by Sponsor|5|||
44125245|NCT02843659|78910195|FG002|Overall Study|Administrative Reason by Sponsor|4|||
44125246|NCT02843659|78910193|FG000|Overall Study|Adverse Event|0|||
44125247|NCT02843659|78910194|FG001|Overall Study|Adverse Event|1|||
44125248|NCT02843659|78910195|FG002|Overall Study|Adverse Event|0|||
44125249|NCT00708435|78910205|FG000|Overall Study|Death / Serious Adverse Event|10|||
44125250|NCT00708435|78910206|FG001|Overall Study|Death / Serious Adverse Event|5|||
44125251|NCT00708435|78910205|FG000|Overall Study|Lost to Follow-up|9|||
44125252|NCT00708435|78910206|FG001|Overall Study|Lost to Follow-up|4|||
44276513|NCT02153112|79231457|FG002|Overall Study|Withdrawal by Subject|2|||
44379336|NCT00771667|79385048|FG007|Induction Phase|Adverse Event|0|||
44379337|NCT00771667|79385049|FG008|Induction Phase|Adverse Event|0|||
44379338|NCT00771667|79385050|FG009|Induction Phase|Adverse Event|0|||
44379339|NCT00771667|79385041|FG000|Induction Phase|Lack of Efficacy|9|||
44511038|NCT03201445|79516273|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
44511039|NCT03201445|79516272|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
44511040|NCT03201445|79516273|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
44511041|NCT02839720|79516298|FG000|Overall Study|Adverse Event|2|||
44511042|NCT02839720|79516298|FG000|Overall Study|Non-compliance|2|||
44511043|NCT02839720|79516298|FG000|Overall Study|Intercurrent Illness|1|||
44511044|NCT02839720|79516298|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
44511045|NCT02642042|79516308|FG000|Overall Study|Adverse Event|22|||
44511046|NCT02642042|79516308|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
44511047|NCT02642042|79516308|FG000|Overall Study|Progression/Relapse|28|||
44511048|NCT02642042|79516308|FG000|Overall Study|Death|1|||
44511049|NCT02642042|79516308|FG000|Overall Study|Not Protocol Specified|2|||
44511050|NCT02608268|79516342|FG000|Overall Study|Adverse Event|0|||
44511051|NCT02608268|79516343|FG001|Overall Study|Adverse Event|0|||
44379340|NCT00771667|79385042|FG001|Induction Phase|Lack of Efficacy|2|||
44511052|NCT02608268|79516344|FG002|Overall Study|Adverse Event|1|||
44511053|NCT02608268|79516345|FG003|Overall Study|Adverse Event|0|||
44125253|NCT00708435|78910205|FG000|Overall Study|Withdrawal by Subject|3|||
44125254|NCT00708435|78910206|FG001|Overall Study|Withdrawal by Subject|7|||
44125255|NCT00708435|78910205|FG000|Overall Study|Adverse Event|1|||
44125256|NCT00708435|78910206|FG001|Overall Study|Adverse Event|0|||
44125257|NCT00708435|78910205|FG000|Overall Study|Protocol Violation|0|||
44125258|NCT00708435|78910206|FG001|Overall Study|Protocol Violation|1|||
44125259|NCT00708435|78910205|FG000|Overall Study|Intervention by primary care physician|1|||
44125260|NCT00708435|78910206|FG001|Overall Study|Intervention by primary care physician|0|||
44125261|NCT00708435|78910205|FG000|Overall Study|Refused hospitalization|1|||
44125262|NCT00708435|78910206|FG001|Overall Study|Refused hospitalization|0|||
44125263|NCT02841787|78910217|FG000|Overall Study|Lost to Follow-up|1|||
44125264|NCT02841787|78910218|FG001|Overall Study|Lost to Follow-up|0|||
44125265|NCT02841787|78910219|FG002|Overall Study|Lost to Follow-up|0|||
44125266|NCT02841787|78910217|FG000|Overall Study|Symptoms dropped below threshold|1|||
44125267|NCT02841787|78910218|FG001|Overall Study|Symptoms dropped below threshold|0|||
44125268|NCT02841787|78910219|FG002|Overall Study|Symptoms dropped below threshold|0|||
44125269|NCT02841787|78910217|FG000|Overall Study|Withdrawal by Subject|1|||
44125270|NCT02841787|78910218|FG001|Overall Study|Withdrawal by Subject|4|||
44511054|NCT02608268|79516346|FG004|Overall Study|Adverse Event|0|||
44511055|NCT02608268|79516347|FG005|Overall Study|Adverse Event|0|||
44511056|NCT02608268|79516348|FG006|Overall Study|Adverse Event|0|||
44511057|NCT02608268|79516349|FG007|Overall Study|Adverse Event|0|||
44511058|NCT02608268|79516350|FG008|Overall Study|Adverse Event|0|||
44125271|NCT02841787|78910219|FG002|Overall Study|Withdrawal by Subject|0|||
44125272|NCT01376037|78910229|FG000|Overall Study|Lost to Follow-up|0|||
44125273|NCT01376037|78910230|FG001|Overall Study|Lost to Follow-up|2|||
44125274|NCT02657408|78910238|FG000|Overall Study|Adverse Event|3|||
44125275|NCT02657408|78910239|FG001|Overall Study|Adverse Event|7|||
44125276|NCT02841709|78910245|FG000|5th Intervention|Adverse Event|2|||
44125277|NCT02841709|78910246|FG001|5th Intervention|Adverse Event|0|||
44125278|NCT02841709|78910247|FG002|5th Intervention|Adverse Event|0|||
44125279|NCT02841709|78910248|FG003|5th Intervention|Adverse Event|0|||
44125280|NCT02841709|78910249|FG004|5th Intervention|Adverse Event|2|||
44125281|NCT01353859|78910262|FG000|Overall Study|Adverse Event|3|||
44125282|NCT01353859|78910262|FG000|Overall Study|Lack of Efficacy|1|||
44125283|NCT02850965|78910268|FG000|Overall Study|Other than listed|3|||
44125284|NCT02850965|78910269|FG001|Overall Study|Other than listed|4|||
44125285|NCT02850965|78910268|FG000|Overall Study|Protocol Violation|0|||
44125286|NCT02850965|78910269|FG001|Overall Study|Protocol Violation|2|||
44125287|NCT02850965|78910268|FG000|Overall Study|Lost to Follow-up|5|||
44125288|NCT02850965|78910269|FG001|Overall Study|Lost to Follow-up|3|||
44125289|NCT02850965|78910268|FG000|Overall Study|Lack of Efficacy|4|||
44125290|NCT02850965|78910269|FG001|Overall Study|Lack of Efficacy|8|||
44125291|NCT02850965|78910268|FG000|Overall Study|Adverse Event|3|||
44125292|NCT02850965|78910269|FG001|Overall Study|Adverse Event|2|||
44125293|NCT02850965|78910268|FG000|Overall Study|Withdrawal by Subject|3|||
44125294|NCT02850965|78910269|FG001|Overall Study|Withdrawal by Subject|4|||
44125295|NCT02850965|78910268|FG000|Overall Study|Physician Decision|0|||
44125296|NCT02850965|78910269|FG001|Overall Study|Physician Decision|1|||
44125297|NCT02850965|78910268|FG000|Overall Study|Randomized but not treated|0|||
44125298|NCT02850965|78910269|FG001|Overall Study|Randomized but not treated|1|||
44125299|NCT01375959|78910277|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
44125300|NCT01375959|78910278|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
44125301|NCT01375959|78910277|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
44125302|NCT01375959|78910278|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
44125303|NCT01375959|78910277|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
44125304|NCT01375959|78910278|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
44125305|NCT00708201|78910288|FG000|Overall Study|Adverse Event|4|||
44125306|NCT00708201|78910289|FG001|Overall Study|Adverse Event|4|||
44125307|NCT00708201|78910288|FG000|Overall Study|Withdrawal by Subject|1|||
44125308|NCT00708201|78910289|FG001|Overall Study|Withdrawal by Subject|1|||
44125309|NCT00708201|78910288|FG000|Overall Study|Lost to Follow-up|2|||
44125310|NCT00708201|78910289|FG001|Overall Study|Lost to Follow-up|0|||
44125311|NCT00708201|78910288|FG000|Overall Study|Protocol Violation|0|||
44125312|NCT00708201|78910289|FG001|Overall Study|Protocol Violation|1|||
44125313|NCT02848313|78910297|FG000|Overall Study|Adverse Event|1|||
44125314|NCT02848313|78910298|FG001|Overall Study|Adverse Event|2|||
44125315|NCT02848313|78910297|FG000|Overall Study|Lack of Efficacy|0|||
44125316|NCT02848313|78910298|FG001|Overall Study|Lack of Efficacy|1|||
44125317|NCT02848313|78910297|FG000|Overall Study|Withdrawal by Subject|1|||
44125318|NCT02848313|78910298|FG001|Overall Study|Withdrawal by Subject|1|||
44125319|NCT02848313|78910297|FG000|Overall Study|Lost to follow up|1|||
44125320|NCT02848313|78910298|FG001|Overall Study|Lost to follow up|0|||
44379341|NCT00771667|79385043|FG002|Induction Phase|Lack of Efficacy|4|||
44511059|NCT02608268|79516351|FG009|Overall Study|Adverse Event|0|||
44511060|NCT02608268|79516352|FG010|Overall Study|Adverse Event|0|||
44125321|NCT02728089|78910304|FG000|Overall Study|Physician Decision|2|||
44125322|NCT02728089|78910304|FG000|Overall Study|Withdrawal by Subject|1|||
44125323|NCT02840461|78910311|FG000|Overall Study|Adverse Event|1|||
44125324|NCT02840461|78910312|FG001|Overall Study|Adverse Event|5|||
44125325|NCT02840461|78910313|FG002|Overall Study|Adverse Event|3|||
44125326|NCT02840461|78910311|FG000|Overall Study|Lost to Follow-up|10|||
44125327|NCT02840461|78910312|FG001|Overall Study|Lost to Follow-up|7|||
44125328|NCT02840461|78910313|FG002|Overall Study|Lost to Follow-up|6|||
44125329|NCT02840461|78910311|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
44125330|NCT02840461|78910312|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
44125331|NCT02840461|78910313|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
44125332|NCT02840461|78910311|FG000|Overall Study|Protocol Violation|2|||
44125333|NCT02840461|78910312|FG001|Overall Study|Protocol Violation|3|||
44125334|NCT02840461|78910313|FG002|Overall Study|Protocol Violation|1|||
44125335|NCT02840461|78910311|FG000|Overall Study|Withdrawal by Subject|10|||
44125336|NCT02840461|78910312|FG001|Overall Study|Withdrawal by Subject|6|||
44125337|NCT02840461|78910313|FG002|Overall Study|Withdrawal by Subject|2|||
44125338|NCT02840461|78910311|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
44125339|NCT02840461|78910312|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
44125340|NCT02840461|78910313|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
44125341|NCT02839681|78910322|FG000|Overall Study|Death|2|||
44125342|NCT01676012|78910326|FG000|Overall Study|Adverse Event|2|||
44125343|NCT01676012|78910326|FG000|Overall Study|incomplete set of videos|1|||
44125344|NCT02727777|78910342|FG000|Overall Study|Screen Failure|2|||
44125345|NCT02727777|78910343|FG001|Overall Study|Screen Failure|0|||
44125346|NCT02727777|78910344|FG002|Overall Study|Screen Failure|0|||
44125347|NCT02727777|78910342|FG000|Overall Study|Progressive disease|2|||
44125348|NCT02727777|78910343|FG001|Overall Study|Progressive disease|0|||
44125349|NCT02727777|78910344|FG002|Overall Study|Progressive disease|0|||
44125350|NCT00707577|78910354|FG000|Overall Study|Withdrawal by Subject|3|||
44125351|NCT00707577|78910355|FG001|Overall Study|Withdrawal by Subject|2|||
44125352|NCT00707577|78910354|FG000|Overall Study|Lost to Follow-up|34|||
44125353|NCT00707577|78910355|FG001|Overall Study|Lost to Follow-up|25|||
44125354|NCT00707577|78910354|FG000|Overall Study|Left employment|13|||
44125355|NCT00707577|78910355|FG001|Overall Study|Left employment|10|||
44125356|NCT00707577|78910354|FG000|Overall Study|Pregnancy|4|||
44125357|NCT00707577|78910355|FG001|Overall Study|Pregnancy|1|||
44125358|NCT01675622|78910363|FG000|Overall Study|Withdrawal by Subject|2|||
44125359|NCT01675622|78910364|FG001|Overall Study|Withdrawal by Subject|2|||
44125360|NCT01675622|78910363|FG000|Overall Study|Adverse Event|12|||
44125361|NCT01675622|78910364|FG001|Overall Study|Adverse Event|10|||
44125362|NCT01675622|78910363|FG000|Overall Study|Protocol Violation|4|||
44125363|NCT01675622|78910364|FG001|Overall Study|Protocol Violation|1|||
44125364|NCT01675622|78910363|FG000|Overall Study|Lack of Efficacy|2|||
44125365|NCT01675622|78910364|FG001|Overall Study|Lack of Efficacy|4|||
44125366|NCT01675622|78910363|FG000|Overall Study|Lost to Follow-up|1|||
44125367|NCT01675622|78910364|FG001|Overall Study|Lost to Follow-up|3|||
44125368|NCT01675622|78910363|FG000|Overall Study|Other|5|||
44125369|NCT01675622|78910364|FG001|Overall Study|Other|4|||
44125370|NCT02655224|78910372|FG000|Overall Study|Adverse Event|1|||
44125371|NCT02655224|78910373|FG001|Overall Study|Adverse Event|1|||
44125372|NCT01675544|78910379|FG000|Overall Study|Withdrawal by Subject|2|||
44125373|NCT02838901|78910422|FG000|Overall Study|Withdrawal by Subject|1|||
44125374|NCT02838901|78910423|FG001|Overall Study|Withdrawal by Subject|1|||
44125375|NCT02838901|78910422|FG000|Overall Study|Lost to Follow-up|1|||
44125376|NCT02838901|78910423|FG001|Overall Study|Lost to Follow-up|1|||
44125377|NCT00706797|78910451|FG000|Overall Study|Lack of Efficacy|3|||
44125378|NCT00706797|78910452|FG001|Overall Study|Lack of Efficacy|0|||
44125379|NCT00706797|78910451|FG000|Overall Study|Adverse Event|0|||
44125380|NCT00706797|78910452|FG001|Overall Study|Adverse Event|3|||
44125381|NCT00706797|78910451|FG000|Overall Study|Withdrawal by Subject|8|||
44125382|NCT00706797|78910452|FG001|Overall Study|Withdrawal by Subject|1|||
44125383|NCT00706797|78910451|FG000|Overall Study|Death|1|||
44125384|NCT00706797|78910452|FG001|Overall Study|Death|0|||
44125385|NCT00706797|78910451|FG000|Overall Study|Discontinuation of study by sponsor|52|||
44125386|NCT00706797|78910452|FG001|Overall Study|Discontinuation of study by sponsor|63|||
44125387|NCT00706797|78910451|FG000|Overall Study|Protocol Violation|3|||
44125388|NCT00706797|78910452|FG001|Overall Study|Protocol Violation|2|||
44125389|NCT00706797|78910451|FG000|Overall Study|Lost to Follow-up|1|||
44125390|NCT00706797|78910452|FG001|Overall Study|Lost to Follow-up|2|||
44125391|NCT00706797|78910451|FG000|Overall Study|Other|1|||
44125392|NCT00706797|78910452|FG001|Overall Study|Other|0|||
44125393|NCT00706641|78910458|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
44125394|NCT00706641|78910458|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
44125395|NCT00706641|78910458|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
44125396|NCT01362530|78910464|FG000|Base Study (Cycle 1)|Adverse Event|2|||
44125397|NCT01362530|78910465|FG001|Base Study (Cycle 1)|Adverse Event|0|||
44125398|NCT01362530|78910464|FG000|Base Study (Cycle 1)|Physician Decision|0|||
44125399|NCT01362530|78910465|FG001|Base Study (Cycle 1)|Physician Decision|1|||
44125400|NCT01362530|78910464|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
44125401|NCT01362530|78910465|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
44125402|NCT01362530|78910464|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
44125403|NCT01362530|78910465|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
44125404|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
44125405|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
44125406|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
44125407|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
44125408|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
44125409|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
44125410|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
44125411|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
44125412|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
44125413|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
44125414|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
44125415|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
44125416|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
44125417|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
44125418|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
44125419|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
44125420|NCT01362530|78910464|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
44125421|NCT01362530|78910465|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
44125422|NCT02654054|78910475|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
44125423|NCT02654054|78910476|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
44125424|NCT02654054|78910477|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
44125425|NCT02654054|78910475|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
44125426|NCT02654054|78910476|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
44125427|NCT02654054|78910477|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
44125428|NCT02654054|78910475|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
44125429|NCT02654054|78910476|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
44125430|NCT02654054|78910477|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
44125431|NCT02654054|78910475|FG000|Post-Treatment Follow-Up Period|Other|1|||
44125432|NCT02654054|78910476|FG001|Post-Treatment Follow-Up Period|Other|0|||
44125433|NCT02654054|78910477|FG002|Post-Treatment Follow-Up Period|Other|4|||
44125434|NCT02654054|78910475|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
44125435|NCT02654054|78910476|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
44125436|NCT02654054|78910477|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
44125437|NCT02653664|78910498|FG000|Post-Treatment|Withdrawal by Subject|6|||
44125438|NCT02653664|78910499|FG001|Post-Treatment|Withdrawal by Subject|5|||
44125439|NCT02653664|78910500|FG002|Post-Treatment|Withdrawal by Subject|7|||
44125440|NCT02653664|78910498|FG000|Post-Treatment|Lost to Follow-up|8|||
44125441|NCT02653664|78910499|FG001|Post-Treatment|Lost to Follow-up|1|||
44125442|NCT02653664|78910500|FG002|Post-Treatment|Lost to Follow-up|7|||
44125443|NCT02653664|78910498|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
44125444|NCT02653664|78910499|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
44125445|NCT02653664|78910500|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
44125446|NCT02653664|78910498|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
44125447|NCT02653664|78910499|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
44125448|NCT02653664|78910500|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
44125449|NCT02653664|78910498|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
44125450|NCT02653664|78910499|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
44125451|NCT02653664|78910500|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
44125452|NCT02653664|78910498|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
44125453|NCT02653664|78910499|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
44125454|NCT02653664|78910500|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
44125455|NCT02653664|78910498|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
44125456|NCT02653664|78910499|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
44125457|NCT02653664|78910500|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
44125458|NCT02653664|78910498|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
44125459|NCT02653664|78910499|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
44125460|NCT02653664|78910500|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
44125461|NCT02653664|78910498|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
44125462|NCT02653664|78910499|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
44125463|NCT02653664|78910500|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
44511061|NCT02608268|79516353|FG011|Overall Study|Adverse Event|0|||
44511062|NCT02608268|79516354|FG012|Overall Study|Adverse Event|2|||
44511063|NCT02608268|79516355|FG013|Overall Study|Adverse Event|0|||
44511064|NCT02608268|79516356|FG014|Overall Study|Adverse Event|0|||
44511065|NCT02608268|79516357|FG015|Overall Study|Adverse Event|0|||
44511066|NCT02608268|79516358|FG016|Overall Study|Adverse Event|0|||
44511067|NCT02608268|79516359|FG017|Overall Study|Adverse Event|0|||
44125464|NCT02653664|78910498|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
44125465|NCT02653664|78910499|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
44243168|NCT01693562|79072535|FG007|Expansion Phase|Death|42|||
44379342|NCT00771667|79385044|FG003|Induction Phase|Lack of Efficacy|3|||
44511068|NCT02608268|79516360|FG018|Overall Study|Adverse Event|0|||
44511069|NCT02608268|79516361|FG019|Overall Study|Adverse Event|0|||
44511070|NCT02608268|79516362|FG020|Overall Study|Adverse Event|1|||
44511071|NCT02608268|79516363|FG021|Overall Study|Adverse Event|1|||
44276514|NCT02153112|79231458|FG003|Overall Study|Withdrawal by Subject|2|||
44511072|NCT02608268|79516364|FG022|Overall Study|Adverse Event|0|||
44511073|NCT02608268|79516365|FG023|Overall Study|Adverse Event|0|||
44511074|NCT02608268|79516366|FG024|Overall Study|Adverse Event|1|||
44511075|NCT02608268|79516367|FG025|Overall Study|Adverse Event|0|||
44511076|NCT02608268|79516368|FG026|Overall Study|Adverse Event|0|||
44511077|NCT02608268|79516369|FG027|Overall Study|Adverse Event|0|||
44511078|NCT02608268|79516370|FG028|Overall Study|Adverse Event|1|||
44511079|NCT02608268|79516371|FG029|Overall Study|Adverse Event|0|||
44511080|NCT02608268|79516342|FG000|Overall Study|Death|1|||
44511081|NCT02608268|79516343|FG001|Overall Study|Death|0|||
44511082|NCT02608268|79516344|FG002|Overall Study|Death|0|||
44511083|NCT02608268|79516345|FG003|Overall Study|Death|0|||
44511084|NCT02608268|79516346|FG004|Overall Study|Death|0|||
44511085|NCT02608268|79516347|FG005|Overall Study|Death|0|||
44511086|NCT02608268|79516348|FG006|Overall Study|Death|0|||
44511087|NCT02608268|79516349|FG007|Overall Study|Death|0|||
44511088|NCT02608268|79516350|FG008|Overall Study|Death|1|||
44511089|NCT02608268|79516351|FG009|Overall Study|Death|1|||
44511090|NCT02608268|79516352|FG010|Overall Study|Death|0|||
44511091|NCT02608268|79516353|FG011|Overall Study|Death|0|||
44511092|NCT02608268|79516354|FG012|Overall Study|Death|0|||
44511093|NCT02608268|79516355|FG013|Overall Study|Death|0|||
44511094|NCT02608268|79516356|FG014|Overall Study|Death|0|||
44511095|NCT02608268|79516357|FG015|Overall Study|Death|1|||
44511096|NCT02608268|79516358|FG016|Overall Study|Death|0|||
44511097|NCT02608268|79516359|FG017|Overall Study|Death|1|||
44511098|NCT02608268|79516360|FG018|Overall Study|Death|0|||
44511099|NCT02608268|79516361|FG019|Overall Study|Death|1|||
44511100|NCT02608268|79516362|FG020|Overall Study|Death|1|||
44511101|NCT02608268|79516363|FG021|Overall Study|Death|0|||
44511102|NCT02608268|79516364|FG022|Overall Study|Death|0|||
44511103|NCT02608268|79516365|FG023|Overall Study|Death|0|||
44511104|NCT02608268|79516366|FG024|Overall Study|Death|1|||
44511105|NCT02608268|79516367|FG025|Overall Study|Death|2|||
44511106|NCT02608268|79516368|FG026|Overall Study|Death|0|||
44511107|NCT02608268|79516369|FG027|Overall Study|Death|1|||
44511108|NCT02608268|79516370|FG028|Overall Study|Death|4|||
44511109|NCT02608268|79516371|FG029|Overall Study|Death|0|||
44511110|NCT02608268|79516342|FG000|Overall Study|Physician Decision|0|||
44511111|NCT02608268|79516343|FG001|Overall Study|Physician Decision|0|||
44511112|NCT02608268|79516344|FG002|Overall Study|Physician Decision|0|||
44511113|NCT02608268|79516345|FG003|Overall Study|Physician Decision|0|||
44511114|NCT02608268|79516346|FG004|Overall Study|Physician Decision|0|||
44511115|NCT02608268|79516347|FG005|Overall Study|Physician Decision|0|||
44511116|NCT02608268|79516348|FG006|Overall Study|Physician Decision|0|||
44511117|NCT02608268|79516349|FG007|Overall Study|Physician Decision|0|||
44511118|NCT02608268|79516350|FG008|Overall Study|Physician Decision|0|||
44511119|NCT02608268|79516351|FG009|Overall Study|Physician Decision|0|||
44511120|NCT02608268|79516352|FG010|Overall Study|Physician Decision|1|||
44511121|NCT02608268|79516353|FG011|Overall Study|Physician Decision|0|||
44511122|NCT02608268|79516354|FG012|Overall Study|Physician Decision|0|||
44511123|NCT02608268|79516355|FG013|Overall Study|Physician Decision|1|||
44511124|NCT02608268|79516356|FG014|Overall Study|Physician Decision|0|||
44511125|NCT02608268|79516357|FG015|Overall Study|Physician Decision|0|||
44511126|NCT02608268|79516358|FG016|Overall Study|Physician Decision|0|||
44125466|NCT02653664|78910500|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
44125467|NCT02488629|78910518|FG000|Overall Study|Lack of Efficacy|3|||
44125468|NCT02488629|78910519|FG001|Overall Study|Lack of Efficacy|1|||
44125469|NCT02488629|78910520|FG002|Overall Study|Lack of Efficacy|0|||
44125470|NCT02488629|78910521|FG003|Overall Study|Lack of Efficacy|0|||
44125471|NCT02488629|78910518|FG000|Overall Study|Withdrawal by Subject|0|||
44125472|NCT02488629|78910519|FG001|Overall Study|Withdrawal by Subject|1|||
44511127|NCT02608268|79516359|FG017|Overall Study|Physician Decision|0|||
44511128|NCT02608268|79516360|FG018|Overall Study|Physician Decision|0|||
44511129|NCT02608268|79516361|FG019|Overall Study|Physician Decision|0|||
44511130|NCT02608268|79516362|FG020|Overall Study|Physician Decision|0|||
44511131|NCT02608268|79516363|FG021|Overall Study|Physician Decision|0|||
44511132|NCT02608268|79516364|FG022|Overall Study|Physician Decision|1|||
44125473|NCT02488629|78910520|FG002|Overall Study|Withdrawal by Subject|0|||
44276515|NCT02153112|79231459|FG004|Overall Study|Withdrawal by Subject|1|||
44511133|NCT02608268|79516365|FG023|Overall Study|Physician Decision|1|||
44511134|NCT02608268|79516366|FG024|Overall Study|Physician Decision|1|||
44276516|NCT02153112|79231460|FG005|Overall Study|Withdrawal by Subject|1|||
44511135|NCT02608268|79516367|FG025|Overall Study|Physician Decision|0|||
44125474|NCT02488629|78910521|FG003|Overall Study|Withdrawal by Subject|0|||
44511136|NCT02608268|79516368|FG026|Overall Study|Physician Decision|0|||
44511137|NCT02608268|79516369|FG027|Overall Study|Physician Decision|2|||
44511138|NCT02608268|79516370|FG028|Overall Study|Physician Decision|1|||
44511139|NCT02608268|79516371|FG029|Overall Study|Physician Decision|1|||
44511140|NCT02608268|79516342|FG000|Overall Study|Progressive disease|12|||
44511141|NCT02608268|79516343|FG001|Overall Study|Progressive disease|8|||
44511142|NCT02608268|79516344|FG002|Overall Study|Progressive disease|13|||
44125475|NCT02727699|78910532|FG000|Overall Study|Adverse Event|2|||
44125476|NCT02727699|78910533|FG001|Overall Study|Adverse Event|0|||
44125477|NCT02727699|78910532|FG000|Overall Study|Withdrawal by Subject|5|||
44125478|NCT02727699|78910533|FG001|Overall Study|Withdrawal by Subject|3|||
44125479|NCT02727699|78910532|FG000|Overall Study|Protocol Violation|0|||
44125480|NCT02727699|78910533|FG001|Overall Study|Protocol Violation|1|||
44125481|NCT02727699|78910532|FG000|Overall Study|Physician Decision|0|||
44125482|NCT02727699|78910533|FG001|Overall Study|Physician Decision|1|||
44125483|NCT02727699|78910532|FG000|Overall Study|Lost to Follow-up|1|||
44125484|NCT02727699|78910533|FG001|Overall Study|Lost to Follow-up|0|||
44125485|NCT02727699|78910532|FG000|Overall Study|Sponsor Decision|1|||
44125486|NCT02727699|78910533|FG001|Overall Study|Sponsor Decision|0|||
44125487|NCT03576716|78910551|FG000|Overall Study|Withdrawal by Subject|0|||
44125488|NCT03576716|78910552|FG001|Overall Study|Withdrawal by Subject|1|||
44125489|NCT02847637|78910571|FG000|Overall Study|Withdrawal by Subject|0|||
44125490|NCT02847637|78910572|FG001|Overall Study|Withdrawal by Subject|1|||
44125491|NCT02847637|78910573|FG002|Overall Study|Withdrawal by Subject|1|||
44125492|NCT02847637|78910574|FG003|Overall Study|Withdrawal by Subject|0|||
44125493|NCT02847637|78910571|FG000|Overall Study|Lost to Follow-up|1|||
44125494|NCT02847637|78910572|FG001|Overall Study|Lost to Follow-up|1|||
44125495|NCT02847637|78910573|FG002|Overall Study|Lost to Follow-up|0|||
44125496|NCT02847637|78910574|FG003|Overall Study|Lost to Follow-up|0|||
44125497|NCT00706095|78910601|FG000|Overall Study|Progressive Disease|4|||
44125498|NCT00706095|78910602|FG001|Overall Study|Progressive Disease|5|||
44125499|NCT00706095|78910603|FG002|Overall Study|Progressive Disease|3|||
44125500|NCT00706095|78910601|FG000|Overall Study|Clinical Progression|1|||
44125501|NCT00706095|78910602|FG001|Overall Study|Clinical Progression|2|||
44125502|NCT00706095|78910603|FG002|Overall Study|Clinical Progression|2|||
44125503|NCT00706095|78910601|FG000|Overall Study|Withdrawal by Subject|1|||
44125504|NCT00706095|78910602|FG001|Overall Study|Withdrawal by Subject|0|||
44125505|NCT00706095|78910603|FG002|Overall Study|Withdrawal by Subject|0|||
44125506|NCT02837731|78910613|FG000|Allocation|Admitted to General Floor|3|||
44125507|NCT02837731|78910614|FG001|Allocation|Admitted to General Floor|4|||
44125508|NCT02837731|78910613|FG000|Allocation|Immediate surgery/withdrew|2|||
44125509|NCT02837731|78910614|FG001|Allocation|Immediate surgery/withdrew|0|||
44125510|NCT02837731|78910613|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
44125511|NCT02837731|78910614|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
44125512|NCT02837731|78910613|FG000|Allocation|Withdrawal by Subject|2|||
44125513|NCT02837731|78910614|FG001|Allocation|Withdrawal by Subject|0|||
44125514|NCT02837731|78910613|FG000|Allocation|Device not available|1|||
44125515|NCT02837731|78910614|FG001|Allocation|Device not available|0|||
44125516|NCT02837731|78910613|FG000|Allocation|Protocol not implemented|7|||
44125517|NCT02837731|78910614|FG001|Allocation|Protocol not implemented|0|||
44125518|NCT02837731|78910613|FG000|Allocation|Moribund/Do not resuscitate|2|||
44125519|NCT02837731|78910614|FG001|Allocation|Moribund/Do not resuscitate|0|||
44125520|NCT02837731|78910613|FG000|Allocation|Did not meet sepsis criteria|1|||
44125521|NCT02837731|78910614|FG001|Allocation|Did not meet sepsis criteria|2|||
44511143|NCT02608268|79516345|FG003|Overall Study|Progressive disease|5|||
44511144|NCT02608268|79516346|FG004|Overall Study|Progressive disease|2|||
44511145|NCT02608268|79516347|FG005|Overall Study|Progressive disease|4|||
44511146|NCT02608268|79516348|FG006|Overall Study|Progressive disease|6|||
44511147|NCT02608268|79516349|FG007|Overall Study|Progressive disease|2|||
44511148|NCT02608268|79516350|FG008|Overall Study|Progressive disease|5|||
44511149|NCT02608268|79516351|FG009|Overall Study|Progressive disease|6|||
44511150|NCT02608268|79516352|FG010|Overall Study|Progressive disease|5|||
44511151|NCT02608268|79516353|FG011|Overall Study|Progressive disease|5|||
44511152|NCT02608268|79516354|FG012|Overall Study|Progressive disease|4|||
44511153|NCT02608268|79516355|FG013|Overall Study|Progressive disease|11|||
44125522|NCT02837731|78910613|FG000|Allocation|Known aortic abnormalities|0|||
44125523|NCT02837731|78910614|FG001|Allocation|Known aortic abnormalities|1|||
44125524|NCT02836873|78910622|FG000|Overall Study|Protocol Violation|0|||
44125525|NCT02836873|78910623|FG001|Overall Study|Protocol Violation|1|||
44125526|NCT02836873|78910622|FG000|Overall Study|Adverse Event|1|||
44125527|NCT02836873|78910623|FG001|Overall Study|Adverse Event|4|||
44125528|NCT02836873|78910622|FG000|Overall Study|Withdrawal by Subject|2|||
44125529|NCT02836873|78910623|FG001|Overall Study|Withdrawal by Subject|2|||
44511154|NCT02608268|79516356|FG014|Overall Study|Progressive disease|6|||
44125530|NCT02836873|78910622|FG000|Overall Study|Lost to Follow-up|1|||
44125531|NCT02836873|78910623|FG001|Overall Study|Lost to Follow-up|3|||
44125532|NCT02836873|78910622|FG000|Overall Study|Physician Decision|0|||
44125533|NCT02836873|78910623|FG001|Overall Study|Physician Decision|1|||
44125534|NCT02836873|78910622|FG000|Overall Study|Other|1|||
44125535|NCT02836873|78910623|FG001|Overall Study|Other|0|||
44125536|NCT01342081|78910641|FG000|Overall Study|Did not receive allocated intervention|0|||
44125537|NCT01342081|78910642|FG001|Overall Study|Did not receive allocated intervention|0|||
44511155|NCT02608268|79516357|FG015|Overall Study|Progressive disease|3|||
44125538|NCT01342081|78910643|FG002|Overall Study|Did not receive allocated intervention|1|||
44511156|NCT02608268|79516358|FG016|Overall Study|Progressive disease|5|||
44125539|NCT01342081|78910641|FG000|Overall Study|Adverse Event|1|||
44125540|NCT01342081|78910642|FG001|Overall Study|Adverse Event|0|||
44125541|NCT01342081|78910643|FG002|Overall Study|Adverse Event|0|||
44125542|NCT01342081|78910641|FG000|Overall Study|Physician Decision|0|||
44125543|NCT01342081|78910642|FG001|Overall Study|Physician Decision|1|||
44125544|NCT01342081|78910643|FG002|Overall Study|Physician Decision|0|||
44125545|NCT01342081|78910641|FG000|Overall Study|Withdrawal by Subject|1|||
44125546|NCT01342081|78910642|FG001|Overall Study|Withdrawal by Subject|1|||
44125547|NCT01342081|78910643|FG002|Overall Study|Withdrawal by Subject|0|||
44125548|NCT01341457|78910653|FG000|Overall Study|Adverse Event|2|||
44125549|NCT01341457|78910654|FG001|Overall Study|Adverse Event|0|||
44125550|NCT02832037|78910666|FG000|Overall Study|Administrative reasons|0|||
44125551|NCT02832037|78910667|FG001|Overall Study|Administrative reasons|0|||
44125552|NCT02832037|78910668|FG002|Overall Study|Administrative reasons|1|||
44125553|NCT02832037|78910669|FG003|Overall Study|Administrative reasons|0|||
44125554|NCT02832037|78910670|FG004|Overall Study|Administrative reasons|0|||
44125555|NCT02832037|78910666|FG000|Overall Study|Protocol Violation|3|||
44125556|NCT02832037|78910667|FG001|Overall Study|Protocol Violation|0|||
44125557|NCT02832037|78910668|FG002|Overall Study|Protocol Violation|4|||
44125558|NCT02832037|78910669|FG003|Overall Study|Protocol Violation|1|||
44125559|NCT02832037|78910670|FG004|Overall Study|Protocol Violation|2|||
44125560|NCT02832037|78910666|FG000|Overall Study|Lost to Follow-up|2|||
44125561|NCT02832037|78910667|FG001|Overall Study|Lost to Follow-up|0|||
44125562|NCT02832037|78910668|FG002|Overall Study|Lost to Follow-up|3|||
44125563|NCT02832037|78910669|FG003|Overall Study|Lost to Follow-up|0|||
44125564|NCT02832037|78910670|FG004|Overall Study|Lost to Follow-up|5|||
44125565|NCT02832037|78910666|FG000|Overall Study|Withdrawal by Subject|9|||
44125566|NCT02832037|78910667|FG001|Overall Study|Withdrawal by Subject|8|||
44125567|NCT02832037|78910668|FG002|Overall Study|Withdrawal by Subject|0|||
44125568|NCT02832037|78910669|FG003|Overall Study|Withdrawal by Subject|4|||
44125569|NCT02832037|78910670|FG004|Overall Study|Withdrawal by Subject|8|||
44125570|NCT02832037|78910666|FG000|Overall Study|Adverse Event|5|||
44125571|NCT02832037|78910667|FG001|Overall Study|Adverse Event|4|||
44125572|NCT02832037|78910668|FG002|Overall Study|Adverse Event|0|||
44125573|NCT02832037|78910669|FG003|Overall Study|Adverse Event|2|||
44125574|NCT02832037|78910670|FG004|Overall Study|Adverse Event|4|||
44511157|NCT02608268|79516359|FG017|Overall Study|Progressive disease|5|||
44511158|NCT02608268|79516360|FG018|Overall Study|Progressive disease|5|||
44511159|NCT02608268|79516361|FG019|Overall Study|Progressive disease|2|||
44511160|NCT02608268|79516362|FG020|Overall Study|Progressive disease|10|||
44511161|NCT02608268|79516363|FG021|Overall Study|Progressive disease|4|||
44511162|NCT02608268|79516364|FG022|Overall Study|Progressive disease|5|||
44511163|NCT02608268|79516365|FG023|Overall Study|Progressive disease|5|||
44511164|NCT02608268|79516366|FG024|Overall Study|Progressive disease|3|||
44511165|NCT02608268|79516367|FG025|Overall Study|Progressive disease|11|||
44511166|NCT02608268|79516368|FG026|Overall Study|Progressive disease|16|||
44511167|NCT02608268|79516369|FG027|Overall Study|Progressive disease|11|||
44511168|NCT02608268|79516370|FG028|Overall Study|Progressive disease|10|||
44125575|NCT01675154|78910686|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
44125576|NCT01675154|78910687|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
44125577|NCT01675154|78910688|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
44125578|NCT01675154|78910689|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
44125579|NCT02744755|78910713|FG000|Study Period 1|Protocol Violation|2|||
44511169|NCT02608268|79516371|FG029|Overall Study|Progressive disease|15|||
44511170|NCT02608268|79516342|FG000|Overall Study|Subject/guardian decision|1|||
44511171|NCT02608268|79516343|FG001|Overall Study|Subject/guardian decision|1|||
44511172|NCT02608268|79516344|FG002|Overall Study|Subject/guardian decision|2|||
44511173|NCT02608268|79516345|FG003|Overall Study|Subject/guardian decision|0|||
44511174|NCT02608268|79516346|FG004|Overall Study|Subject/guardian decision|0|||
44511175|NCT02608268|79516347|FG005|Overall Study|Subject/guardian decision|0|||
44511176|NCT02608268|79516348|FG006|Overall Study|Subject/guardian decision|0|||
44511177|NCT02608268|79516349|FG007|Overall Study|Subject/guardian decision|0|||
44125580|NCT02744755|78910714|FG001|Study Period 1|Protocol Violation|1|||
44511178|NCT02608268|79516350|FG008|Overall Study|Subject/guardian decision|2|||
44511179|NCT02608268|79516351|FG009|Overall Study|Subject/guardian decision|2|||
44511180|NCT02608268|79516352|FG010|Overall Study|Subject/guardian decision|0|||
44125581|NCT02744755|78910713|FG000|Study Period 1|not defined|0|||
44125582|NCT02744755|78910714|FG001|Study Period 1|not defined|1|||
44125583|NCT02744755|78910713|FG000|Study Period 1|Pregnancy|1|||
44125584|NCT02744755|78910714|FG001|Study Period 1|Pregnancy|0|||
44125585|NCT02744755|78910713|FG000|Study Period 1|Adverse Event|1|||
44125586|NCT02744755|78910714|FG001|Study Period 1|Adverse Event|1|||
44125587|NCT02744755|78910713|FG000|Study Period 1|Lost to Follow-up|1|||
44125588|NCT02744755|78910714|FG001|Study Period 1|Lost to Follow-up|1|||
44511181|NCT02608268|79516353|FG011|Overall Study|Subject/guardian decision|1|||
44125589|NCT02744755|78910713|FG000|Study Period 1|Lack of Efficacy|1|||
44276517|NCT02153112|79231461|FG006|Overall Study|Withdrawal by Subject|7|||
44125590|NCT02744755|78910714|FG001|Study Period 1|Lack of Efficacy|0|||
44125591|NCT02744755|78910713|FG000|Study Period 1|Withdrawal by Subject|8|||
44125592|NCT02744755|78910714|FG001|Study Period 1|Withdrawal by Subject|4|||
44125593|NCT02744755|78910713|FG000|Study Period 2|Adverse Event|5|||
44125594|NCT02744755|78910714|FG001|Study Period 2|Adverse Event|0|||
44125595|NCT02744755|78910713|FG000|Study Period 2|Protocol Violation|1|||
44125596|NCT02744755|78910714|FG001|Study Period 2|Protocol Violation|0|||
44125597|NCT02744755|78910713|FG000|Study Period 2|not defined|3|||
44125598|NCT02744755|78910714|FG001|Study Period 2|not defined|2|||
44125599|NCT02744755|78910713|FG000|Study Period 2|Lost to Follow-up|0|||
44125600|NCT02744755|78910714|FG001|Study Period 2|Lost to Follow-up|2|||
44125601|NCT02744755|78910713|FG000|Study Period 2|Withdrawal by Subject|2|||
44125602|NCT02744755|78910714|FG001|Study Period 2|Withdrawal by Subject|2|||
44125603|NCT02744755|78910713|FG000|Study Period 2|Lack of Efficacy|3|||
44125604|NCT02744755|78910714|FG001|Study Period 2|Lack of Efficacy|2|||
44125605|NCT01356589|78910728|FG000|Overall Study|Enrolled, but not treated|3|||
44125606|NCT01356589|78910728|FG000|Overall Study|Dose data not recorded|2|||
44125607|NCT02830087|78910738|FG000|Overall Study|No study staff to follow-up patients|4|||
44125608|NCT02830087|78910739|FG001|Overall Study|No study staff to follow-up patients|4|||
44125609|NCT02830087|78910740|FG002|Overall Study|No study staff to follow-up patients|4|||
44125610|NCT02830087|78910741|FG003|Overall Study|No study staff to follow-up patients|3|||
44125611|NCT02830087|78910742|FG004|Overall Study|No study staff to follow-up patients|3|||
44125612|NCT02830087|78910743|FG005|Overall Study|No study staff to follow-up patients|3|||
44125613|NCT02829775|78910766|FG000|Overall Study|Death|1|||
44125614|NCT02829775|78910766|FG000|Overall Study|Withdrawal by Subject|3|||
44125615|NCT02829775|78910766|FG000|Overall Study|Disease remission|1|||
44125616|NCT01355497|78910787|FG000|Overall Study|Death|19|||
44125617|NCT01355497|78910788|FG001|Overall Study|Death|18|||
44125618|NCT01355497|78910787|FG000|Overall Study|Lost to Follow-up|3|||
44125619|NCT01355497|78910788|FG001|Overall Study|Lost to Follow-up|0|||
44125620|NCT01355497|78910787|FG000|Overall Study|Protocol Violation|0|||
44125621|NCT01355497|78910788|FG001|Overall Study|Protocol Violation|1|||
44125622|NCT01355497|78910787|FG000|Overall Study|other-not provided|9|||
44125623|NCT01355497|78910788|FG001|Overall Study|other-not provided|4|||
44125624|NCT01355497|78910787|FG000|Overall Study|Withdrawal by Subject|12|||
44125625|NCT01355497|78910788|FG001|Overall Study|Withdrawal by Subject|20|||
44125626|NCT01355497|78910787|FG000|Overall Study|noncompliance|1|||
44125627|NCT01355497|78910788|FG001|Overall Study|noncompliance|2|||
44125628|NCT01355497|78910787|FG000|Overall Study|progressive disease|11|||
44125629|NCT01355497|78910788|FG001|Overall Study|progressive disease|8|||
44125630|NCT01355497|78910787|FG000|Overall Study|Adverse Event|11|||
44125631|NCT01355497|78910788|FG001|Overall Study|Adverse Event|10|||
44125632|NCT01355575|78910794|FG000|Overall Study|Withdrawal by Subject|2|||
44125633|NCT02826421|78910806|FG000|Overall Study|Adverse Event|1|||
44125634|NCT02826421|78910807|FG001|Overall Study|Adverse Event|0|||
44125635|NCT02826421|78910808|FG002|Overall Study|Adverse Event|0|||
44125636|NCT02826421|78910809|FG003|Overall Study|Adverse Event|1|||
44125637|NCT02826421|78910806|FG000|Overall Study|Withdrawal by Subject|1|||
44125638|NCT02826421|78910807|FG001|Overall Study|Withdrawal by Subject|3|||
44125639|NCT02826421|78910808|FG002|Overall Study|Withdrawal by Subject|1|||
44125640|NCT02826421|78910809|FG003|Overall Study|Withdrawal by Subject|1|||
44125641|NCT02826421|78910806|FG000|Overall Study|Reason not given|1|||
44125642|NCT02826421|78910807|FG001|Overall Study|Reason not given|0|||
44125643|NCT02826421|78910808|FG002|Overall Study|Reason not given|1|||
44125644|NCT02826421|78910809|FG003|Overall Study|Reason not given|0|||
44243169|NCT01693562|79072536|FG008|Expansion Phase|Death|17|||
44379343|NCT00771667|79385045|FG004|Induction Phase|Lack of Efficacy|0|||
44379344|NCT00771667|79385046|FG005|Induction Phase|Lack of Efficacy|0|||
44379345|NCT00771667|79385047|FG006|Induction Phase|Lack of Efficacy|0|||
44379346|NCT00771667|79385048|FG007|Induction Phase|Lack of Efficacy|0|||
44379347|NCT00771667|79385049|FG008|Induction Phase|Lack of Efficacy|0|||
44511182|NCT02608268|79516354|FG012|Overall Study|Subject/guardian decision|0|||
44511183|NCT02608268|79516355|FG013|Overall Study|Subject/guardian decision|1|||
44511184|NCT02608268|79516356|FG014|Overall Study|Subject/guardian decision|0|||
44511185|NCT02608268|79516357|FG015|Overall Study|Subject/guardian decision|1|||
44511186|NCT02608268|79516358|FG016|Overall Study|Subject/guardian decision|0|||
44379348|NCT00771667|79385050|FG009|Induction Phase|Lack of Efficacy|0|||
44125645|NCT02825251|78910822|FG000|Overall Study|Adverse Event|0|||
44125646|NCT02825251|78910823|FG001|Overall Study|Adverse Event|1|||
44125647|NCT02825251|78910822|FG000|Overall Study|Lost to Follow-up|0|||
44125648|NCT02825251|78910823|FG001|Overall Study|Lost to Follow-up|1|||
44125649|NCT02825251|78910822|FG000|Overall Study|Withdrawal by Subject|1|||
44125650|NCT02825251|78910823|FG001|Overall Study|Withdrawal by Subject|4|||
44125651|NCT02825251|78910822|FG000|Overall Study|Unclassified|2|||
44125652|NCT02825251|78910823|FG001|Overall Study|Unclassified|0|||
44125653|NCT04860505|78910829|FG000|Overall Study|Lost to Follow-up|2|||
44125654|NCT04063865|78910835|FG000|Overall Study|Physician Decision|1|||
44379349|NCT00771667|79385041|FG000|Induction Phase|Lost to Follow-up|1|||
44125655|NCT04063865|78910836|FG001|Overall Study|Physician Decision|3|||
44125656|NCT04063865|78910835|FG000|Overall Study|Study Closed Prior to Completion|4|||
44125657|NCT04063865|78910836|FG001|Overall Study|Study Closed Prior to Completion|4|||
44125658|NCT04063865|78910835|FG000|Overall Study|Withdrawal by Subject|1|||
44125659|NCT04063865|78910836|FG001|Overall Study|Withdrawal by Subject|1|||
44125660|NCT03994211|78910844|FG000|Core Phase|Adverse Event|0|||
44125661|NCT03994211|78910845|FG001|Core Phase|Adverse Event|1|||
44125662|NCT03994211|78910846|FG002|Core Phase|Adverse Event|0|||
44125663|NCT03994211|78910844|FG000|Extension Phase|Adverse Event|0|||
44125664|NCT03994211|78910845|FG001|Extension Phase|Adverse Event|0|||
44125665|NCT03994211|78910846|FG002|Extension Phase|Adverse Event|1|||
44125666|NCT03994211|78910844|FG000|Extension Phase|Physician Decision|0|||
44125667|NCT03994211|78910845|FG001|Extension Phase|Physician Decision|0|||
44125668|NCT03994211|78910846|FG002|Extension Phase|Physician Decision|1|||
44125669|NCT03994211|78910844|FG000|Extension Phase|Progressive Disease|0|||
44125670|NCT03994211|78910845|FG001|Extension Phase|Progressive Disease|0|||
44125671|NCT03994211|78910846|FG002|Extension Phase|Progressive Disease|20|||
44125672|NCT03994211|78910844|FG000|Extension Phase|Withdrawal by Subject|0|||
44125673|NCT03994211|78910845|FG001|Extension Phase|Withdrawal by Subject|0|||
44125674|NCT03994211|78910846|FG002|Extension Phase|Withdrawal by Subject|2|||
44125675|NCT03818607|78910861|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
44125676|NCT03818607|78910862|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
44125677|NCT03818607|78910861|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
44125678|NCT03818607|78910862|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
44125679|NCT03818607|78910861|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
44125680|NCT03818607|78910862|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
44125681|NCT02422615|78910902|FG000|Treatment Period|Progressive disease|314|||
44125682|NCT02422615|78910903|FG001|Treatment Period|Progressive disease|200|||
44125683|NCT02422615|78910902|FG000|Treatment Period|Adverse Event|51|||
44125684|NCT02422615|78910903|FG001|Treatment Period|Adverse Event|9|||
44125685|NCT02422615|78910902|FG000|Treatment Period|Physician Decision|32|||
44125686|NCT02422615|78910903|FG001|Treatment Period|Physician Decision|8|||
44125687|NCT02422615|78910902|FG000|Treatment Period|Subject/guardian decision|38|||
44125688|NCT02422615|78910903|FG001|Treatment Period|Subject/guardian decision|8|||
44125689|NCT02422615|78910902|FG000|Treatment Period|Death|2|||
44125690|NCT02422615|78910903|FG001|Treatment Period|Death|1|||
44125691|NCT02422615|78910902|FG000|Treatment Period|Technical problems|0|||
44125692|NCT02422615|78910903|FG001|Treatment Period|Technical problems|1|||
44125693|NCT02422615|78910902|FG000|Treatment Period|Protocol deviation|1|||
44125694|NCT02422615|78910903|FG001|Treatment Period|Protocol deviation|1|||
44125695|NCT02422615|78910902|FG000|Treatment Period|Study terminated as per protocol|46|||
44125696|NCT02422615|78910903|FG001|Treatment Period|Study terminated as per protocol|14|||
44125697|NCT02422615|78910902|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
44125698|NCT02422615|78910903|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
44125699|NCT02422615|78910902|FG000|Post-treatment Efficacy Follow-up|Death|2|||
44125700|NCT02422615|78910903|FG001|Post-treatment Efficacy Follow-up|Death|1|||
44125701|NCT02422615|78910902|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
44125702|NCT02422615|78910903|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
44125703|NCT02422615|78910902|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
44125704|NCT02422615|78910903|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
44125705|NCT02422615|78910902|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
44125706|NCT02422615|78910903|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
44125707|NCT02422615|78910902|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
44125708|NCT02422615|78910903|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
44125709|NCT02382406|78910918|FG000|Study Treatment|Disease Progression|8|||
44125710|NCT02382406|78910919|FG001|Study Treatment|Disease Progression|0|||
44125711|NCT02382406|78910920|FG002|Study Treatment|Disease Progression|20|||
44243170|NCT01693562|79072537|FG009|Expansion Phase|Death|208|||
44243171|NCT01693562|79072538|FG010|Expansion Phase|Death|30|||
44243172|NCT01693562|79072539|FG011|Expansion Phase|Death|8|||
44243173|NCT01693562|79072540|FG012|Expansion Phase|Death|19|||
44125712|NCT02382406|78910918|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
44125713|NCT02382406|78910919|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
44125714|NCT02382406|78910920|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
44379350|NCT00771667|79385042|FG001|Induction Phase|Lost to Follow-up|0|||
44511187|NCT02608268|79516359|FG017|Overall Study|Subject/guardian decision|0|||
44511188|NCT02608268|79516360|FG018|Overall Study|Subject/guardian decision|1|||
44511189|NCT02608268|79516361|FG019|Overall Study|Subject/guardian decision|0|||
44125715|NCT02382406|78910918|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
44125716|NCT02382406|78910919|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
44125717|NCT02382406|78910920|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
44125718|NCT02382406|78910918|FG000|Study Treatment|symptomatic deterioration|1|||
44243174|NCT01693562|79072541|FG013|Expansion Phase|Death|42|||
44243175|NCT01693562|79072542|FG014|Expansion Phase|Death|23|||
44125719|NCT02382406|78910919|FG001|Study Treatment|symptomatic deterioration|0|||
44125720|NCT02382406|78910920|FG002|Study Treatment|symptomatic deterioration|1|||
44125721|NCT02382406|78910918|FG000|Study Treatment|Death|0|||
44125722|NCT02382406|78910919|FG001|Study Treatment|Death|0|||
44125723|NCT02382406|78910920|FG002|Study Treatment|Death|2|||
44125724|NCT02382406|78910918|FG000|Follow up|Death|11|||
44125725|NCT02382406|78910919|FG001|Follow up|Death|0|||
44125726|NCT02382406|78910920|FG002|Follow up|Death|19|||
44125727|NCT02382406|78910918|FG000|Follow up|Symptomatic deterioration|1|||
44125728|NCT02382406|78910919|FG001|Follow up|Symptomatic deterioration|0|||
44125729|NCT02382406|78910920|FG002|Follow up|Symptomatic deterioration|1|||
44125730|NCT02382406|78910918|FG000|Follow up|Patient Refused Follow-up|1|||
44125731|NCT02382406|78910919|FG001|Follow up|Patient Refused Follow-up|0|||
44125732|NCT02382406|78910920|FG002|Follow up|Patient Refused Follow-up|0|||
44125733|NCT02382406|78910918|FG000|Follow up|Study Terminated|1|||
44125734|NCT02382406|78910919|FG001|Follow up|Study Terminated|0|||
44125735|NCT02382406|78910920|FG002|Follow up|Study Terminated|8|||
44125736|NCT02382406|78910918|FG000|Follow up|Withdrawal by Subject|0|||
44125737|NCT02382406|78910919|FG001|Follow up|Withdrawal by Subject|0|||
44125738|NCT02382406|78910920|FG002|Follow up|Withdrawal by Subject|2|||
44125739|NCT02101268|78910940|FG000|Randomized Treatment Phase|Subject Decision|8|||
44125740|NCT02101268|78910941|FG001|Randomized Treatment Phase|Subject Decision|4|||
44125741|NCT02101268|78910942|FG002|Randomized Treatment Phase|Subject Decision|0|||
44125742|NCT02101268|78910943|FG003|Randomized Treatment Phase|Subject Decision|0|||
44125743|NCT02101268|78910940|FG000|Randomized Treatment Phase|Physician Decision|4|||
44125744|NCT02101268|78910941|FG001|Randomized Treatment Phase|Physician Decision|1|||
44125745|NCT02101268|78910942|FG002|Randomized Treatment Phase|Physician Decision|0|||
44125746|NCT02101268|78910943|FG003|Randomized Treatment Phase|Physician Decision|0|||
44125747|NCT02101268|78910940|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
44125748|NCT02101268|78910941|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
44125749|NCT02101268|78910942|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
44125750|NCT02101268|78910943|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
44125751|NCT02101268|78910940|FG000|Randomized Treatment Phase|Adverse Event|6|||
44125752|NCT02101268|78910941|FG001|Randomized Treatment Phase|Adverse Event|0|||
44125753|NCT02101268|78910942|FG002|Randomized Treatment Phase|Adverse Event|0|||
44125754|NCT02101268|78910943|FG003|Randomized Treatment Phase|Adverse Event|0|||
44125755|NCT02101268|78910940|FG000|Randomized Treatment Phase|Death|5|||
44125756|NCT02101268|78910941|FG001|Randomized Treatment Phase|Death|4|||
44125757|NCT02101268|78910942|FG002|Randomized Treatment Phase|Death|0|||
44125758|NCT02101268|78910943|FG003|Randomized Treatment Phase|Death|0|||
44125759|NCT02101268|78910940|FG000|Randomized Treatment Phase|Disease Progression|4|||
44125760|NCT02101268|78910941|FG001|Randomized Treatment Phase|Disease Progression|1|||
44243176|NCT01693562|79072543|FG015|Expansion Phase|Death|23|||
44243177|NCT01693562|79072544|FG016|Expansion Phase|Death|128|||
44511190|NCT02608268|79516362|FG020|Overall Study|Subject/guardian decision|0|||
44511191|NCT02608268|79516363|FG021|Overall Study|Subject/guardian decision|0|||
44511192|NCT02608268|79516364|FG022|Overall Study|Subject/guardian decision|1|||
44511193|NCT02608268|79516365|FG023|Overall Study|Subject/guardian decision|0|||
44511194|NCT02608268|79516366|FG024|Overall Study|Subject/guardian decision|0|||
44511195|NCT02608268|79516367|FG025|Overall Study|Subject/guardian decision|1|||
44511196|NCT02608268|79516368|FG026|Overall Study|Subject/guardian decision|1|||
44511197|NCT02608268|79516369|FG027|Overall Study|Subject/guardian decision|1|||
44511198|NCT02608268|79516370|FG028|Overall Study|Subject/guardian decision|1|||
44511199|NCT02608268|79516371|FG029|Overall Study|Subject/guardian decision|0|||
44511200|NCT02510261|79516484|FG000|Overall Study|Adverse Event|5|||
44511201|NCT02510261|79516485|FG001|Overall Study|Adverse Event|8|||
44511202|NCT02510261|79516486|FG002|Overall Study|Adverse Event|0|||
44511203|NCT02510261|79516484|FG000|Overall Study|Physician Decision|1|||
44511204|NCT02510261|79516485|FG001|Overall Study|Physician Decision|5|||
44511205|NCT02510261|79516486|FG002|Overall Study|Physician Decision|0|||
44511206|NCT02510261|79516484|FG000|Overall Study|Death|19|||
44125761|NCT02101268|78910942|FG002|Randomized Treatment Phase|Disease Progression|0|||
44125762|NCT02101268|78910943|FG003|Randomized Treatment Phase|Disease Progression|0|||
44125763|NCT02101268|78910940|FG000|Extended Treatment Phase|Subject Decision|0|||
44125764|NCT02101268|78910941|FG001|Extended Treatment Phase|Subject Decision|0|||
44125765|NCT02101268|78910942|FG002|Extended Treatment Phase|Subject Decision|3|||
44125766|NCT02101268|78910943|FG003|Extended Treatment Phase|Subject Decision|2|||
44125767|NCT02101268|78910940|FG000|Extended Treatment Phase|Physician Decision|0|||
44243178|NCT01693562|79072545|FG017|Expansion Phase|Death|16|||
44511207|NCT02510261|79516485|FG001|Overall Study|Death|19|||
44125768|NCT02101268|78910941|FG001|Extended Treatment Phase|Physician Decision|0|||
44125769|NCT02101268|78910942|FG002|Extended Treatment Phase|Physician Decision|5|||
44125770|NCT02101268|78910943|FG003|Extended Treatment Phase|Physician Decision|2|||
44125771|NCT02101268|78910940|FG000|Extended Treatment Phase|Adverse Event|0|||
44125772|NCT02101268|78910941|FG001|Extended Treatment Phase|Adverse Event|0|||
44125773|NCT02101268|78910942|FG002|Extended Treatment Phase|Adverse Event|14|||
44243179|NCT01693562|79072546|FG018|Expansion Phase|Death|36|||
44125774|NCT02101268|78910943|FG003|Extended Treatment Phase|Adverse Event|18|||
44125775|NCT02101268|78910940|FG000|Extended Treatment Phase|Death|0|||
44125776|NCT02101268|78910941|FG001|Extended Treatment Phase|Death|0|||
44125777|NCT02101268|78910942|FG002|Extended Treatment Phase|Death|5|||
44125778|NCT02101268|78910943|FG003|Extended Treatment Phase|Death|1|||
44125779|NCT02101268|78910940|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
44125780|NCT02101268|78910941|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
44125781|NCT02101268|78910942|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
44125782|NCT02101268|78910943|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
44125783|NCT02101268|78910940|FG000|Extended Treatment Phase|Disease Progression|0|||
44125784|NCT02101268|78910941|FG001|Extended Treatment Phase|Disease Progression|0|||
44125785|NCT02101268|78910942|FG002|Extended Treatment Phase|Disease Progression|13|||
44125786|NCT02101268|78910943|FG003|Extended Treatment Phase|Disease Progression|6|||
44125787|NCT02101268|78910940|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
44125788|NCT02101268|78910941|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
44125789|NCT02101268|78910942|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
44125790|NCT02101268|78910943|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
44125791|NCT01898650|78910960|FG000|Overall Study|the subject would not lie still for imaging|1|||
44125792|NCT01880515|78910966|FG000|Overall Study|Lost to Follow-up|3|||
44125793|NCT01880515|78910967|FG001|Overall Study|Lost to Follow-up|2|||
44125794|NCT01880515|78910966|FG000|Overall Study|Disease Progression|5|||
44125795|NCT01880515|78910967|FG001|Overall Study|Disease Progression|7|||
44125796|NCT01668719|78910977|FG000|Phase I|On treatment|1|||
44125797|NCT01668719|78910978|FG001|Phase I|On treatment|0|||
44125798|NCT01668719|78910979|FG002|Phase I|On treatment|0|||
44125799|NCT01668719|78910977|FG000|Phase I|Adverse Event|2|||
44125800|NCT01668719|78910978|FG001|Phase I|Adverse Event|0|||
44125801|NCT01668719|78910979|FG002|Phase I|Adverse Event|0|||
44125802|NCT01668719|78910977|FG000|Phase I|Progression/relapse|1|||
44125803|NCT01668719|78910978|FG001|Phase I|Progression/relapse|0|||
44125804|NCT01668719|78910979|FG002|Phase I|Progression/relapse|0|||
44125805|NCT01668719|78910977|FG000|Phase I|not protocol specified|2|||
44125806|NCT01668719|78910978|FG001|Phase I|not protocol specified|0|||
44125807|NCT01668719|78910979|FG002|Phase I|not protocol specified|0|||
44125808|NCT01668719|78910977|FG000|Phase II|On treatment|0|||
44125809|NCT01668719|78910978|FG001|Phase II|On treatment|4|||
44125810|NCT01668719|78910979|FG002|Phase II|On treatment|3|||
44125811|NCT01668719|78910977|FG000|Phase II|Adverse Event|0|||
44125812|NCT01668719|78910978|FG001|Phase II|Adverse Event|18|||
44125813|NCT01668719|78910979|FG002|Phase II|Adverse Event|18|||
44125814|NCT01668719|78910977|FG000|Phase II|Refusal unrelated to adverse event|0|||
44125815|NCT01668719|78910978|FG001|Phase II|Refusal unrelated to adverse event|4|||
44125816|NCT01668719|78910979|FG002|Phase II|Refusal unrelated to adverse event|1|||
44125817|NCT01668719|78910977|FG000|Phase II|Progression/relapse|0|||
44125818|NCT01668719|78910978|FG001|Phase II|Progression/relapse|13|||
44125819|NCT01668719|78910979|FG002|Phase II|Progression/relapse|17|||
44125820|NCT01668719|78910977|FG000|Phase II|Death|0|||
44125821|NCT01668719|78910978|FG001|Phase II|Death|0|||
44125822|NCT01668719|78910979|FG002|Phase II|Death|2|||
44511208|NCT02510261|79516486|FG002|Overall Study|Death|0|||
44511209|NCT02510261|79516484|FG000|Overall Study|Withdrawal by Subject|3|||
44511210|NCT02510261|79516485|FG001|Overall Study|Withdrawal by Subject|10|||
44511211|NCT02510261|79516486|FG002|Overall Study|Withdrawal by Subject|3|||
44511212|NCT02506192|79516497|FG000|Overall Study|Withdrawal by Subject|1|||
44511213|NCT02506192|79516498|FG001|Overall Study|Withdrawal by Subject|1|||
44511214|NCT02395666|79516506|FG000|Overall Study|Physician Decision|3|||
44511215|NCT02395666|79516507|FG001|Overall Study|Physician Decision|0|||
44511216|NCT02395666|79516506|FG000|Overall Study|Lost to Follow-up|1|||
44511217|NCT02395666|79516507|FG001|Overall Study|Lost to Follow-up|0|||
44511218|NCT02395666|79516506|FG000|Overall Study|Withdrawal by Subject|2|||
44125823|NCT01668719|78910977|FG000|Phase II|not protocol specified|0|||
44125824|NCT01668719|78910978|FG001|Phase II|not protocol specified|13|||
44125825|NCT01668719|78910979|FG002|Phase II|not protocol specified|7|||
44125826|NCT01642901|78910991|FG000|12-month Follow-up|Withdrawal by Subject|1|||
44125827|NCT01642901|78910992|FG001|12-month Follow-up|Withdrawal by Subject|0|||
44125828|NCT01488045|78911000|FG000|Overall Study|Withdrawal by Subject|6|||
44125829|NCT01488045|78911001|FG001|Overall Study|Withdrawal by Subject|11|||
44125830|NCT01488045|78911000|FG000|Overall Study|Failure to present for colonoscopy|3|||
44125831|NCT01488045|78911001|FG001|Overall Study|Failure to present for colonoscopy|6|||
44125832|NCT01488045|78911000|FG000|Overall Study|Failure to report exclusion criteria|0|||
44125833|NCT01488045|78911001|FG001|Overall Study|Failure to report exclusion criteria|1|||
44125834|NCT00946712|78911020|FG000|Overall Study|Adverse Event|118|||
44125835|NCT00946712|78911021|FG001|Overall Study|Adverse Event|124|||
44125836|NCT00946712|78911020|FG000|Overall Study|Disease progression|308|||
44511219|NCT02395666|79516507|FG001|Overall Study|Withdrawal by Subject|1|||
44125837|NCT00946712|78911021|FG001|Overall Study|Disease progression|404|||
44511220|NCT02257528|79516517|FG000|Overall Study|Never received study treatment|1|||
44511221|NCT02223819|79516521|FG000|Overall Study|Lost to Follow-up|2|||
44125838|NCT00946712|78911020|FG000|Overall Study|Death|21|||
44125839|NCT00946712|78911021|FG001|Overall Study|Death|22|||
44125840|NCT00946712|78911020|FG000|Overall Study|No treatment given|25|||
44125841|NCT00946712|78911021|FG001|Overall Study|No treatment given|29|||
44125842|NCT00946712|78911020|FG000|Overall Study|Other reasons|61|||
44125843|NCT00946712|78911021|FG001|Overall Study|Other reasons|73|||
44125844|NCT00946712|78911020|FG000|Overall Study|On Treatment|0|||
44125845|NCT00946712|78911021|FG001|Overall Study|On Treatment|4|||
44125846|NCT00946712|78911020|FG000|Overall Study|Ineligible|14|||
44125847|NCT00946712|78911021|FG001|Overall Study|Ineligible|6|||
44125848|NCT00656669|78911028|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
44125849|NCT00656669|78911028|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
44125850|NCT00656669|78911028|FG000|AC (Cycles 6-9)|Adverse Event|1|||
44125851|NCT00656669|78911028|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
44125852|NCT01338493|78911037|FG000|Enrolled|Withdrawal by Subject|1|||
44125853|NCT01338493|78911037|FG000|Enrolled|Patient not implanted|4|||
44125854|NCT01338493|78911037|FG000|Discharge|Death|1|||
44125855|NCT01338493|78911037|FG000|Discharge|Missed visit|1|||
44125856|NCT01338493|78911037|FG000|6 Months Follow up|Lost to Follow-up|11|||
44125857|NCT01338493|78911037|FG000|6 Months Follow up|Missed visit|8|||
44125858|NCT01338493|78911037|FG000|12 Months Follow up|Lost to Follow-up|9|||
44125859|NCT01362296|78911043|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
44125860|NCT01362296|78911044|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
44125861|NCT01362296|78911045|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
44125862|NCT01362296|78911046|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
44125863|NCT01362296|78911043|FG000|Randomized Phase (RP)|Physician Decision|1|||
44125864|NCT01362296|78911044|FG001|Randomized Phase (RP)|Physician Decision|9|||
44125865|NCT01362296|78911045|FG002|Randomized Phase (RP)|Physician Decision|0|||
44125866|NCT01362296|78911046|FG003|Randomized Phase (RP)|Physician Decision|0|||
44125867|NCT01362296|78911043|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
44125868|NCT01362296|78911044|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
44125869|NCT01362296|78911045|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
44125870|NCT01362296|78911046|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
44125871|NCT01362296|78911043|FG000|Randomized Phase (RP)|Adverse Event|20|||
44125872|NCT01362296|78911044|FG001|Randomized Phase (RP)|Adverse Event|4|||
44125873|NCT01362296|78911045|FG002|Randomized Phase (RP)|Adverse Event|0|||
44125874|NCT01362296|78911046|FG003|Randomized Phase (RP)|Adverse Event|0|||
44125875|NCT01362296|78911043|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
44125876|NCT01362296|78911044|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
44125877|NCT01362296|78911045|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
44125878|NCT01362296|78911046|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
44125879|NCT01362296|78911043|FG000|Crossover Phase|PD including Death due to PD|0|||
44125880|NCT01362296|78911044|FG001|Crossover Phase|PD including Death due to PD|0|||
44511222|NCT02030067|79516547|FG000|Overall Study|Disease Progression|1|||
44511223|NCT02030067|79516548|FG001|Overall Study|Disease Progression|1|||
44511224|NCT02030067|79516549|FG002|Overall Study|Disease Progression|2|||
44511225|NCT02030067|79516550|FG003|Overall Study|Disease Progression|2|||
44511226|NCT02030067|79516551|FG004|Overall Study|Disease Progression|3|||
44125881|NCT01362296|78911045|FG002|Crossover Phase|PD including Death due to PD|16|||
44125882|NCT01362296|78911046|FG003|Crossover Phase|PD including Death due to PD|1|||
44125883|NCT01362296|78911043|FG000|Crossover Phase|Withdrawal by Subject|0|||
44125884|NCT01362296|78911044|FG001|Crossover Phase|Withdrawal by Subject|0|||
44125885|NCT01362296|78911045|FG002|Crossover Phase|Withdrawal by Subject|2|||
44125886|NCT01362296|78911046|FG003|Crossover Phase|Withdrawal by Subject|1|||
44125887|NCT01362296|78911043|FG000|Crossover Phase|Adverse Event|0|||
44125888|NCT01362296|78911044|FG001|Crossover Phase|Adverse Event|0|||
44125889|NCT01362296|78911045|FG002|Crossover Phase|Adverse Event|4|||
44125890|NCT01362296|78911046|FG003|Crossover Phase|Adverse Event|0|||
44125891|NCT01362296|78911043|FG000|Crossover Phase|Study Closed/Terminated|0|||
44125892|NCT01362296|78911044|FG001|Crossover Phase|Study Closed/Terminated|0|||
44511227|NCT02030067|79516552|FG005|Overall Study|Disease Progression|2|||
44511228|NCT02030067|79516553|FG006|Overall Study|Disease Progression|3|||
44125893|NCT01362296|78911045|FG002|Crossover Phase|Study Closed/Terminated|1|||
44125894|NCT01362296|78911046|FG003|Crossover Phase|Study Closed/Terminated|0|||
44125895|NCT01338415|78911058|FG000|Core + Extension|Adverse Event|8|||
44125896|NCT01338415|78911059|FG001|Core + Extension|Adverse Event|6|||
44125897|NCT01338415|78911060|FG002|Core + Extension|Adverse Event|0|||
44125898|NCT01338415|78911058|FG000|Core + Extension|Withdrawal by Subject|1|||
44125899|NCT01338415|78911059|FG001|Core + Extension|Withdrawal by Subject|1|||
44125900|NCT01338415|78911060|FG002|Core + Extension|Withdrawal by Subject|0|||
44125901|NCT01338415|78911058|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
44511229|NCT02030067|79516554|FG007|Overall Study|Disease Progression|3|||
44125902|NCT01338415|78911059|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
44511230|NCT02030067|79516555|FG008|Overall Study|Disease Progression|4|||
44125903|NCT01338415|78911060|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
44125904|NCT01338415|78911058|FG000|Core + Extension|Other (administrative reason)|1|||
44125905|NCT01338415|78911059|FG001|Core + Extension|Other (administrative reason)|0|||
44125906|NCT01338415|78911060|FG002|Core + Extension|Other (administrative reason)|0|||
44125907|NCT01338415|78911058|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
44125908|NCT01338415|78911059|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
44125909|NCT01338415|78911060|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
44125910|NCT01338415|78911058|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
44125911|NCT01338415|78911059|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
44125912|NCT01338415|78911060|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
44125913|NCT01338415|78911058|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
44125914|NCT01338415|78911059|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
44125915|NCT01338415|78911060|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
44125916|NCT01338415|78911058|FG000|Exceptional Use Treatment Period|Death|0|||
44125917|NCT01338415|78911059|FG001|Exceptional Use Treatment Period|Death|0|||
44125918|NCT01338415|78911060|FG002|Exceptional Use Treatment Period|Death|1|||
44125919|NCT05258149|78911070|FG000|Period 1|Protocol Deviation|1|||
44125920|NCT05258149|78911071|FG001|Period 1|Protocol Deviation|0|||
44125921|NCT05258149|78911070|FG000|Period 1|Adverse Event|0|||
44125922|NCT05258149|78911071|FG001|Period 1|Adverse Event|1|||
44125923|NCT05258149|78911070|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
44125924|NCT05258149|78911071|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
44125925|NCT05258149|78911070|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
44125926|NCT05258149|78911071|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
44125927|NCT05258149|78911070|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
44125928|NCT05258149|78911071|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
44125929|NCT01371643|78911079|FG000|Overall Study|Withdrawal by Subject|3|||
44125930|NCT01371643|78911080|FG001|Overall Study|Withdrawal by Subject|0|||
44125931|NCT01371565|78911086|FG000|Overall Study|Withdrawal by Subject|1|||
44125932|NCT01371565|78911086|FG000|Overall Study|Death|1|||
44125933|NCT01371565|78911086|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
44125934|NCT02821819|78911094|FG000|Overall Study|Protocol Violation|1|||
44125935|NCT03926611|78911105|FG000|Overall Study|Adverse Event|0|||
44125936|NCT03926611|78911106|FG001|Overall Study|Adverse Event|0|||
44125937|NCT03926611|78911107|FG002|Overall Study|Adverse Event|0|||
44125938|NCT03926611|78911108|FG003|Overall Study|Adverse Event|3|||
44125939|NCT03926611|78911109|FG004|Overall Study|Adverse Event|1|||
44125940|NCT03926611|78911110|FG005|Overall Study|Adverse Event|3|||
44125941|NCT03926611|78911111|FG006|Overall Study|Adverse Event|0|||
44125942|NCT03926611|78911105|FG000|Overall Study|Lack of Efficacy|1|||
44125943|NCT03926611|78911106|FG001|Overall Study|Lack of Efficacy|2|||
44125944|NCT03926611|78911107|FG002|Overall Study|Lack of Efficacy|0|||
44125945|NCT03926611|78911108|FG003|Overall Study|Lack of Efficacy|0|||
44125946|NCT03926611|78911109|FG004|Overall Study|Lack of Efficacy|1|||
44125947|NCT03926611|78911110|FG005|Overall Study|Lack of Efficacy|0|||
44511231|NCT02030067|79516556|FG009|Overall Study|Disease Progression|3|||
44511232|NCT02030067|79516557|FG010|Overall Study|Disease Progression|7|||
44511233|NCT02030067|79516558|FG011|Overall Study|Disease Progression|2|||
44511234|NCT02030067|79516559|FG012|Overall Study|Disease Progression|59|||
44511235|NCT02030067|79516547|FG000|Overall Study|Withdrawal by Subject|0|||
44511236|NCT02030067|79516548|FG001|Overall Study|Withdrawal by Subject|0|||
44511237|NCT02030067|79516549|FG002|Overall Study|Withdrawal by Subject|0|||
44511238|NCT02030067|79516550|FG003|Overall Study|Withdrawal by Subject|1|||
44511239|NCT02030067|79516551|FG004|Overall Study|Withdrawal by Subject|0|||
44511240|NCT02030067|79516552|FG005|Overall Study|Withdrawal by Subject|0|||
44511241|NCT02030067|79516553|FG006|Overall Study|Withdrawal by Subject|0|||
44511242|NCT02030067|79516554|FG007|Overall Study|Withdrawal by Subject|1|||
44125948|NCT03926611|78911111|FG006|Overall Study|Lack of Efficacy|1|||
44125949|NCT03926611|78911105|FG000|Overall Study|Physician Decision|0|||
44125950|NCT03926611|78911106|FG001|Overall Study|Physician Decision|0|||
44511243|NCT02030067|79516555|FG008|Overall Study|Withdrawal by Subject|0|||
44511244|NCT02030067|79516556|FG009|Overall Study|Withdrawal by Subject|0|||
44511245|NCT02030067|79516557|FG010|Overall Study|Withdrawal by Subject|3|||
44511246|NCT02030067|79516558|FG011|Overall Study|Withdrawal by Subject|0|||
44511247|NCT02030067|79516559|FG012|Overall Study|Withdrawal by Subject|6|||
44125951|NCT03926611|78911107|FG002|Overall Study|Physician Decision|0|||
44125952|NCT03926611|78911108|FG003|Overall Study|Physician Decision|0|||
44125953|NCT03926611|78911109|FG004|Overall Study|Physician Decision|0|||
44125954|NCT03926611|78911110|FG005|Overall Study|Physician Decision|1|||
44125955|NCT03926611|78911111|FG006|Overall Study|Physician Decision|0|||
44125956|NCT03926611|78911105|FG000|Overall Study|Protocol Violation|1|||
44125957|NCT03926611|78911106|FG001|Overall Study|Protocol Violation|0|||
44125958|NCT03926611|78911107|FG002|Overall Study|Protocol Violation|0|||
44125959|NCT03926611|78911108|FG003|Overall Study|Protocol Violation|1|||
44511248|NCT02030067|79516547|FG000|Overall Study|Physician Decision|0|||
44125960|NCT03926611|78911109|FG004|Overall Study|Protocol Violation|1|||
44125961|NCT03926611|78911110|FG005|Overall Study|Protocol Violation|1|||
44125962|NCT03926611|78911111|FG006|Overall Study|Protocol Violation|1|||
44125963|NCT03926611|78911105|FG000|Overall Study|Technical problems|0|||
44125964|NCT03926611|78911106|FG001|Overall Study|Technical problems|0|||
44125965|NCT03926611|78911107|FG002|Overall Study|Technical problems|0|||
44125966|NCT03926611|78911108|FG003|Overall Study|Technical problems|0|||
44125967|NCT03926611|78911109|FG004|Overall Study|Technical problems|0|||
44125968|NCT03926611|78911110|FG005|Overall Study|Technical problems|1|||
44125969|NCT03926611|78911111|FG006|Overall Study|Technical problems|0|||
44125970|NCT03926611|78911105|FG000|Overall Study|Withdrawal by Subject|1|||
44125971|NCT03926611|78911106|FG001|Overall Study|Withdrawal by Subject|1|||
44125972|NCT03926611|78911107|FG002|Overall Study|Withdrawal by Subject|1|||
44125973|NCT03926611|78911108|FG003|Overall Study|Withdrawal by Subject|0|||
44125974|NCT03926611|78911109|FG004|Overall Study|Withdrawal by Subject|0|||
44125975|NCT03926611|78911110|FG005|Overall Study|Withdrawal by Subject|1|||
44125976|NCT03926611|78911111|FG006|Overall Study|Withdrawal by Subject|3|||
44125977|NCT03926611|78911105|FG000|Overall Study|Covid-19 pandemic|0|||
44125978|NCT03926611|78911106|FG001|Overall Study|Covid-19 pandemic|0|||
44125979|NCT03926611|78911107|FG002|Overall Study|Covid-19 pandemic|1|||
44125980|NCT03926611|78911108|FG003|Overall Study|Covid-19 pandemic|0|||
44125981|NCT03926611|78911109|FG004|Overall Study|Covid-19 pandemic|1|||
44125982|NCT03926611|78911110|FG005|Overall Study|Covid-19 pandemic|2|||
44125983|NCT03926611|78911111|FG006|Overall Study|Covid-19 pandemic|0|||
44125984|NCT02818777|78911140|FG000|Overall Study|Adverse Event|3|||
44125985|NCT02817841|78911154|FG000|Overall Study|Lost to Follow-up|287|||
44125986|NCT02817841|78911154|FG000|Overall Study|Withdrawal by Subject|183|||
44125987|NCT02817841|78911154|FG000|Overall Study|Adverse event not related to bleeding|131|||
44125988|NCT02817841|78911154|FG000|Overall Study|Adverse event related to bleeding|51|||
44125989|NCT02817841|78911154|FG000|Overall Study|Pregnancy|32|||
44125990|NCT02817841|78911154|FG000|Overall Study|Pregnancy wish|17|||
44125991|NCT02817841|78911154|FG000|Overall Study|Other reasons|53|||
44125992|NCT02817841|78911154|FG000|Overall Study|Protocol Violation|94|||
44125993|NCT02814565|78911164|FG000|Overall Study|Lack of Efficacy|0|||
44125994|NCT02814565|78911165|FG001|Overall Study|Lack of Efficacy|1|||
44125995|NCT02814565|78911164|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
44125996|NCT02814565|78911165|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
44125997|NCT02650466|78911171|FG000|Overall Study|Physician Decision|1|||
44125998|NCT02650466|78911171|FG000|Overall Study|Withdrawal by Subject|5|||
44125999|NCT02650466|78911171|FG000|Overall Study|Lost to Follow-up|1|||
44126000|NCT02815735|78911177|FG000|First Intervention (4 Weeks)|Discomfort|1|||
44126001|NCT02815735|78911178|FG001|First Intervention (4 Weeks)|Discomfort|0|||
44126002|NCT02815735|78911177|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
44126003|NCT02815735|78911178|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
44126004|NCT02815735|78911177|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
44126005|NCT02815735|78911178|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
44126006|NCT02815735|78911177|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
44126007|NCT02815735|78911178|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
44126008|NCT02814643|78911195|FG000|Overall Study|Lost to Follow-up|0|||
44126009|NCT02814643|78911196|FG001|Overall Study|Lost to Follow-up|1|||
44126010|NCT02814643|78911195|FG000|Overall Study|Withdrawal by Subject|1|||
44126011|NCT02814643|78911196|FG001|Overall Study|Withdrawal by Subject|2|||
44126012|NCT02724111|78911204|FG000|Overall Study|Protocol Violation|2|||
44126013|NCT02724111|78911205|FG001|Overall Study|Protocol Violation|5|||
44126014|NCT02649218|78911211|FG000|Overall Study|Adverse Event|8|||
44126015|NCT02649218|78911211|FG000|Overall Study|Lack of Efficacy|8|||
44126016|NCT02649218|78911211|FG000|Overall Study|Pregnancy|3|||
44126017|NCT02649218|78911211|FG000|Overall Study|Protocol Violation|3|||
44126018|NCT02649218|78911211|FG000|Overall Study|Physician Decision|1|||
44126019|NCT02649218|78911211|FG000|Overall Study|Withdrawal by Subject|2|||
44126020|NCT02814175|78911218|FG000|Part 1|Adverse Event|2|||
44126021|NCT02814175|78911219|FG001|Part 1|Adverse Event|3|||
44243180|NCT01693562|79072547|FG019|Expansion Phase|Death|16|||
44243181|NCT01693562|79072548|FG020|Expansion Phase|Death|17|||
44126022|NCT02814175|78911220|FG002|Part 1|Adverse Event|0|||
44126023|NCT02814175|78911221|FG003|Part 1|Adverse Event|0|||
44126024|NCT02814175|78911222|FG004|Part 1|Adverse Event|0|||
44126025|NCT02814175|78911223|FG005|Part 1|Adverse Event|0|||
44126026|NCT02814175|78911218|FG000|Part 1|Withdrawal Consent|8|||
44126027|NCT02814175|78911219|FG001|Part 1|Withdrawal Consent|1|||
44126028|NCT02814175|78911220|FG002|Part 1|Withdrawal Consent|0|||
44126029|NCT02814175|78911221|FG003|Part 1|Withdrawal Consent|0|||
44126030|NCT02814175|78911222|FG004|Part 1|Withdrawal Consent|0|||
44126031|NCT02814175|78911223|FG005|Part 1|Withdrawal Consent|0|||
44126032|NCT02814175|78911218|FG000|Part 1|Lost to Follow-up|1|||
44126033|NCT02814175|78911219|FG001|Part 1|Lost to Follow-up|0|||
44126034|NCT02814175|78911220|FG002|Part 1|Lost to Follow-up|0|||
44126035|NCT02814175|78911221|FG003|Part 1|Lost to Follow-up|0|||
44126036|NCT02814175|78911222|FG004|Part 1|Lost to Follow-up|0|||
44126037|NCT02814175|78911223|FG005|Part 1|Lost to Follow-up|0|||
44126038|NCT02814175|78911218|FG000|Part 1|Lack of Efficacy|1|||
44126039|NCT02814175|78911219|FG001|Part 1|Lack of Efficacy|2|||
44126040|NCT02814175|78911220|FG002|Part 1|Lack of Efficacy|0|||
44126041|NCT02814175|78911221|FG003|Part 1|Lack of Efficacy|0|||
44126042|NCT02814175|78911222|FG004|Part 1|Lack of Efficacy|0|||
44126043|NCT02814175|78911223|FG005|Part 1|Lack of Efficacy|0|||
44126044|NCT02814175|78911218|FG000|Part 2|Adverse Event|0|||
44126045|NCT02814175|78911219|FG001|Part 2|Adverse Event|0|||
44126046|NCT02814175|78911220|FG002|Part 2|Adverse Event|0|||
44126047|NCT02814175|78911221|FG003|Part 2|Adverse Event|1|||
44126048|NCT02814175|78911222|FG004|Part 2|Adverse Event|1|||
44126049|NCT02814175|78911223|FG005|Part 2|Adverse Event|2|||
44126050|NCT02814175|78911218|FG000|Part 2|Withdrawal Consent|0|||
44126051|NCT02814175|78911219|FG001|Part 2|Withdrawal Consent|0|||
44126052|NCT02814175|78911220|FG002|Part 2|Withdrawal Consent|0|||
44126053|NCT02814175|78911221|FG003|Part 2|Withdrawal Consent|2|||
44126054|NCT02814175|78911222|FG004|Part 2|Withdrawal Consent|1|||
44126055|NCT02814175|78911223|FG005|Part 2|Withdrawal Consent|1|||
44126056|NCT02814175|78911218|FG000|Part 2|Lost to Follow-up|0|||
44126057|NCT02814175|78911219|FG001|Part 2|Lost to Follow-up|0|||
44126058|NCT02814175|78911220|FG002|Part 2|Lost to Follow-up|0|||
44126059|NCT02814175|78911221|FG003|Part 2|Lost to Follow-up|1|||
44126060|NCT02814175|78911222|FG004|Part 2|Lost to Follow-up|0|||
44126061|NCT02814175|78911223|FG005|Part 2|Lost to Follow-up|0|||
44126062|NCT02814175|78911218|FG000|Part 2|Lack of Efficacy|0|||
44126063|NCT02814175|78911219|FG001|Part 2|Lack of Efficacy|0|||
44126064|NCT02814175|78911220|FG002|Part 2|Lack of Efficacy|0|||
44126065|NCT02814175|78911221|FG003|Part 2|Lack of Efficacy|0|||
44126066|NCT02814175|78911222|FG004|Part 2|Lack of Efficacy|0|||
44126067|NCT02814175|78911223|FG005|Part 2|Lack of Efficacy|3|||
44126068|NCT01335997|78911239|FG000|Period I and II|Adverse Event|63|||
44126069|NCT01335997|78911240|FG001|Period I and II|Adverse Event|43|||
44126070|NCT01335997|78911239|FG000|Period I and II|Noncompliance with Study Drug|1|||
44126071|NCT01335997|78911240|FG001|Period I and II|Noncompliance with Study Drug|1|||
44126072|NCT01335997|78911239|FG000|Period I and II|Lost to Follow-up|3|||
44126073|NCT01335997|78911240|FG001|Period I and II|Lost to Follow-up|5|||
44126074|NCT01335997|78911239|FG000|Period I and II|Withdrawal by Subject|9|||
44126075|NCT01335997|78911240|FG001|Period I and II|Withdrawal by Subject|4|||
44126076|NCT01335997|78911239|FG000|Period I and II|Study Terminated by Sponsor|406|||
44126077|NCT01335997|78911240|FG001|Period I and II|Study Terminated by Sponsor|415|||
44126078|NCT01335997|78911239|FG000|Period I and II|Protocol Violation|9|||
44126079|NCT01335997|78911240|FG001|Period I and II|Protocol Violation|10|||
44126080|NCT01335997|78911239|FG000|Period I and II|Physician Decision|2|||
44126081|NCT01335997|78911240|FG001|Period I and II|Physician Decision|1|||
44126082|NCT01335997|78911239|FG000|Period III|Adverse Event|0|||
44126083|NCT01335997|78911240|FG001|Period III|Adverse Event|2|||
44126084|NCT01335997|78911239|FG000|Period III|Study Terminated by Sponsor|77|||
44126085|NCT01335997|78911240|FG001|Period III|Study Terminated by Sponsor|76|||
44126086|NCT01335997|78911239|FG000|Period III|Protocol Violation|0|||
44126087|NCT01335997|78911240|FG001|Period III|Protocol Violation|1|||
44126088|NCT01335997|78911239|FG000|Period III|Lost to Follow-up|1|||
44126089|NCT01335997|78911240|FG001|Period III|Lost to Follow-up|0|||
44126090|NCT02725671|78911248|FG000|Overall Study|Lost to Follow-up|1|||
44126091|NCT02446990|78911256|FG000|Overall Study|Death|485|||
44126092|NCT02446990|78911257|FG001|Overall Study|Death|458|||
44126093|NCT02446990|78911256|FG000|Overall Study|Lost to Follow-up|3|||
44126094|NCT02446990|78911257|FG001|Overall Study|Lost to Follow-up|1|||
44126095|NCT02446990|78911256|FG000|Overall Study|Physician Decision|1|||
44126096|NCT02446990|78911257|FG001|Overall Study|Physician Decision|0|||
44126097|NCT02446990|78911256|FG000|Overall Study|Withdrawal by Subject|231|||
44126098|NCT02446990|78911257|FG001|Overall Study|Withdrawal by Subject|199|||
44126099|NCT02725515|78911265|FG000|Overall Study|Refused infusion (no study treatment)|1|||
44126100|NCT02725515|78911266|FG001|Overall Study|Refused infusion (no study treatment)|0|||
44126101|NCT02725515|78911265|FG000|Overall Study|Loss of Improvement per Protocol|14|||
44126102|NCT02725515|78911266|FG001|Overall Study|Loss of Improvement per Protocol|25|||
44126103|NCT02725515|78911265|FG000|Overall Study|Withdrawal by Subject|2|||
44126104|NCT02725515|78911266|FG001|Overall Study|Withdrawal by Subject|1|||
44126105|NCT02725515|78911265|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44126106|NCT02725515|78911266|FG001|Overall Study|Non-Compliance With Study Drug|3|||
44126107|NCT02725515|78911265|FG000|Overall Study|Lost to Follow-up|1|||
44126108|NCT02725515|78911266|FG001|Overall Study|Lost to Follow-up|1|||
44126109|NCT02725515|78911265|FG000|Overall Study|Adverse Event|7|||
44126110|NCT02725515|78911266|FG001|Overall Study|Adverse Event|2|||
44126111|NCT02725515|78911265|FG000|Overall Study|No Documented Disease Improvement|0|||
44126112|NCT02725515|78911266|FG001|Overall Study|No Documented Disease Improvement|1|||
44126113|NCT02725515|78911265|FG000|Overall Study|Completed Study Under Original Protocol|0|||
44126114|NCT02725515|78911266|FG001|Overall Study|Completed Study Under Original Protocol|1|||
44126115|NCT02725515|78911265|FG000|Overall Study|Lack of Response|0|||
44126116|NCT02725515|78911266|FG001|Overall Study|Lack of Response|1|||
44126117|NCT02416180|78911272|FG000|Overall Study|Withdrawal by Subject|1|||
44126118|NCT02473510|78911278|FG000|Overall Study|Lost to Follow-up|1|||
44126119|NCT02473510|78911279|FG001|Overall Study|Lost to Follow-up|2|||
44511249|NCT02030067|79516548|FG001|Overall Study|Physician Decision|0|||
44511250|NCT02030067|79516549|FG002|Overall Study|Physician Decision|0|||
44511251|NCT02030067|79516550|FG003|Overall Study|Physician Decision|0|||
44511252|NCT02030067|79516551|FG004|Overall Study|Physician Decision|0|||
44511253|NCT02030067|79516552|FG005|Overall Study|Physician Decision|0|||
44126120|NCT02445586|78911285|FG000|Overall Study|Death|14|||
44126121|NCT02445586|78911285|FG000|Overall Study|Withdrawal by Subject|13|||
44126122|NCT02445586|78911285|FG000|Overall Study|Disease Progression|10|||
44126123|NCT02445586|78911285|FG000|Overall Study|Protocol Violation|1|||
44126124|NCT02445586|78911285|FG000|Overall Study|Medical Condition|1|||
44126125|NCT01674062|78911291|FG000|Overall Study|Insufficient Therapeutic Response|56|||
44126126|NCT01674062|78911292|FG001|Overall Study|Insufficient Therapeutic Response|26|||
44126127|NCT01674062|78911291|FG000|Overall Study|Other|8|||
44126128|NCT01674062|78911292|FG001|Overall Study|Other|1|||
44126129|NCT01674062|78911291|FG000|Overall Study|Adverse Event|1|||
44126130|NCT01674062|78911292|FG001|Overall Study|Adverse Event|1|||
44126131|NCT01674062|78911291|FG000|Overall Study|Death|0|||
44126132|NCT01674062|78911292|FG001|Overall Study|Death|1|||
44126133|NCT01674062|78911291|FG000|Overall Study|Programming Error|1|||
44126134|NCT01674062|78911292|FG001|Overall Study|Programming Error|0|||
44126135|NCT02472886|78911301|FG000|Overall Study|Lack of Efficacy|0|||
44126136|NCT02472886|78911302|FG001|Overall Study|Lack of Efficacy|2|||
44126137|NCT02472886|78911303|FG002|Overall Study|Lack of Efficacy|1|||
44126138|NCT02472652|78911316|FG000|Overall Study|Lost to Follow-up|1|||
44126139|NCT02807857|78911320|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
44126140|NCT02807857|78911320|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
44126141|NCT02807857|78911320|FG000|Follow-Up Set|Withdrawal by Subject|8|||
44126142|NCT02807857|78911320|FG000|Follow-Up Set|Lost to Follow-up|7|||
44126143|NCT02807857|78911320|FG000|Follow-Up Set|Physician Decision|6|||
44126144|NCT02807857|78911320|FG000|Follow-Up Set|Adverse Event|3|||
44126145|NCT02807857|78911320|FG000|Follow-Up Set|Death|27|||
44126146|NCT02807857|78911320|FG000|Follow-Up Set|Relocation|2|||
44126147|NCT02648438|78911333|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44126148|NCT02648438|78911334|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
44126149|NCT02648438|78911335|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
44126150|NCT02648438|78911333|FG000|Overall Study|Protocol Violation|2|||
44126151|NCT02648438|78911334|FG001|Overall Study|Protocol Violation|0|||
44126152|NCT02648438|78911335|FG002|Overall Study|Protocol Violation|0|||
44126153|NCT02648438|78911333|FG000|Overall Study|Withdrawal by Subject|1|||
44511254|NCT02030067|79516553|FG006|Overall Study|Physician Decision|0|||
44511255|NCT02030067|79516554|FG007|Overall Study|Physician Decision|0|||
44126154|NCT02648438|78911334|FG001|Overall Study|Withdrawal by Subject|1|||
44126155|NCT02648438|78911335|FG002|Overall Study|Withdrawal by Subject|0|||
44126156|NCT02415556|78911355|FG000|Overall Study|Adverse Event|3|||
44126157|NCT02415556|78911356|FG001|Overall Study|Adverse Event|4|||
44126158|NCT02415556|78911357|FG002|Overall Study|Adverse Event|2|||
44126159|NCT02415556|78911358|FG003|Overall Study|Adverse Event|4|||
44126160|NCT02415556|78911355|FG000|Overall Study|Lost to Follow-up|4|||
44126161|NCT02415556|78911356|FG001|Overall Study|Lost to Follow-up|5|||
44126162|NCT02415556|78911357|FG002|Overall Study|Lost to Follow-up|4|||
44126163|NCT02415556|78911358|FG003|Overall Study|Lost to Follow-up|1|||
44126164|NCT02415556|78911355|FG000|Overall Study|Withdrawal by Subject|13|||
44126165|NCT02415556|78911356|FG001|Overall Study|Withdrawal by Subject|4|||
44126166|NCT02415556|78911357|FG002|Overall Study|Withdrawal by Subject|14|||
44126167|NCT02415556|78911358|FG003|Overall Study|Withdrawal by Subject|12|||
44126168|NCT02415556|78911355|FG000|Overall Study|Physician Decision|1|||
44126169|NCT02415556|78911356|FG001|Overall Study|Physician Decision|3|||
44511256|NCT02030067|79516555|FG008|Overall Study|Physician Decision|0|||
44126170|NCT02415556|78911357|FG002|Overall Study|Physician Decision|1|||
44126171|NCT02415556|78911358|FG003|Overall Study|Physician Decision|2|||
44126172|NCT02415556|78911355|FG000|Overall Study|Censored - study completion|4|||
44126173|NCT02415556|78911356|FG001|Overall Study|Censored - study completion|5|||
44126174|NCT02415556|78911357|FG002|Overall Study|Censored - study completion|1|||
44243182|NCT01693562|79072549|FG021|Expansion Phase|Death|35|||
44243183|NCT01693562|79072550|FG022|Expansion Phase|Death|7|||
44511257|NCT02030067|79516556|FG009|Overall Study|Physician Decision|0|||
44511258|NCT02030067|79516557|FG010|Overall Study|Physician Decision|1|||
44126175|NCT02415556|78911358|FG003|Overall Study|Censored - study completion|0|||
44126176|NCT02415556|78911355|FG000|Overall Study|Family-related issues|0|||
44126177|NCT02415556|78911356|FG001|Overall Study|Family-related issues|0|||
44126178|NCT02415556|78911357|FG002|Overall Study|Family-related issues|0|||
44126179|NCT02415556|78911358|FG003|Overall Study|Family-related issues|1|||
44126180|NCT02807623|78911371|FG000|Overall Study|Lost to Follow-up|23|||
44126181|NCT02807623|78911372|FG001|Overall Study|Lost to Follow-up|18|||
44511259|NCT02030067|79516558|FG011|Overall Study|Physician Decision|0|||
44511260|NCT02030067|79516559|FG012|Overall Study|Physician Decision|3|||
44126182|NCT02807623|78911373|FG002|Overall Study|Lost to Follow-up|22|||
44511261|NCT02030067|79516547|FG000|Overall Study|other reasons|0|||
44126183|NCT02807623|78911371|FG000|Overall Study|Drug intolerance|0|||
44126184|NCT02807623|78911372|FG001|Overall Study|Drug intolerance|1|||
44511262|NCT02030067|79516548|FG001|Overall Study|other reasons|0|||
44511263|NCT02030067|79516549|FG002|Overall Study|other reasons|0|||
44511264|NCT02030067|79516550|FG003|Overall Study|other reasons|0|||
44126185|NCT02807623|78911373|FG002|Overall Study|Drug intolerance|0|||
44126186|NCT02807623|78911371|FG000|Overall Study|incomplete blood draw|0|||
44126187|NCT02807623|78911372|FG001|Overall Study|incomplete blood draw|2|||
44126188|NCT02807623|78911373|FG002|Overall Study|incomplete blood draw|1|||
44126189|NCT02805907|78911392|FG000|Overall Study|Lost to Follow-up|3|||
44126190|NCT02805907|78911393|FG001|Overall Study|Lost to Follow-up|3|||
44126191|NCT02723175|78911401|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
44126192|NCT02723175|78911402|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
44126193|NCT02723175|78911401|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
44126194|NCT02723175|78911402|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
44126195|NCT02801617|78911410|FG000|Overall Study|Protocol Violation|2|||
44126196|NCT02801617|78911411|FG001|Overall Study|Protocol Violation|6|||
44126197|NCT01334515|78911423|FG000|Overall Study|Adverse Event|1|||
44126198|NCT01334515|78911424|FG001|Overall Study|Adverse Event|6|||
44126199|NCT01334515|78911423|FG000|Overall Study|Death|1|||
44126200|NCT01334515|78911424|FG001|Overall Study|Death|0|||
44126201|NCT01334515|78911423|FG000|Overall Study|Lack of Efficacy|8|||
44126202|NCT01334515|78911424|FG001|Overall Study|Lack of Efficacy|21|||
44126203|NCT01334515|78911423|FG000|Overall Study|Physician Decision|1|||
44126204|NCT01334515|78911424|FG001|Overall Study|Physician Decision|1|||
44126205|NCT01334515|78911423|FG000|Overall Study|Withdrawal by Subject|1|||
44126206|NCT01334515|78911424|FG001|Overall Study|Withdrawal by Subject|1|||
44126207|NCT02802319|78911432|FG000|Overall Study|Physician Decision|2|||
44126208|NCT02802319|78911433|FG001|Overall Study|Physician Decision|1|||
44126209|NCT02802319|78911432|FG000|Overall Study|Lost to Follow-up|0|||
44126210|NCT02802319|78911433|FG001|Overall Study|Lost to Follow-up|4|||
44126211|NCT02415400|78911443|FG000|Overall Study|Adverse Event|0|||
44126212|NCT02415400|78911444|FG001|Overall Study|Adverse Event|1|||
44126213|NCT02415400|78911445|FG002|Overall Study|Adverse Event|1|||
44126214|NCT02415400|78911446|FG003|Overall Study|Adverse Event|2|||
44126215|NCT02415400|78911443|FG000|Overall Study|Participant request to stop therapy|4|||
44126216|NCT02415400|78911444|FG001|Overall Study|Participant request to stop therapy|3|||
44126217|NCT02415400|78911445|FG002|Overall Study|Participant request to stop therapy|8|||
44126218|NCT02415400|78911446|FG003|Overall Study|Participant request to stop therapy|6|||
44126219|NCT02415400|78911443|FG000|Overall Study|Participant withdrew consent|14|||
44126220|NCT02415400|78911444|FG001|Overall Study|Participant withdrew consent|12|||
44126221|NCT02415400|78911445|FG002|Overall Study|Participant withdrew consent|30|||
44126222|NCT02415400|78911446|FG003|Overall Study|Participant withdrew consent|21|||
44126223|NCT02415400|78911443|FG000|Overall Study|Death|39|||
44126224|NCT02415400|78911444|FG001|Overall Study|Death|41|||
44126225|NCT02415400|78911445|FG002|Overall Study|Death|35|||
44126226|NCT02415400|78911446|FG003|Overall Study|Death|42|||
44126227|NCT02415400|78911443|FG000|Overall Study|Lost to Follow-up|3|||
44126228|NCT02415400|78911444|FG001|Overall Study|Lost to Follow-up|3|||
44126229|NCT02415400|78911445|FG002|Overall Study|Lost to Follow-up|2|||
44126230|NCT02415400|78911446|FG003|Overall Study|Lost to Follow-up|5|||
44126231|NCT02415400|78911443|FG000|Overall Study|Poor/Non-Compliance|0|||
44126232|NCT02415400|78911444|FG001|Overall Study|Poor/Non-Compliance|1|||
44126233|NCT02415400|78911445|FG002|Overall Study|Poor/Non-Compliance|3|||
44126234|NCT02415400|78911446|FG003|Overall Study|Poor/Non-Compliance|4|||
44126235|NCT02415400|78911443|FG000|Overall Study|Participant no longer meets criteria|2|||
44126236|NCT02415400|78911444|FG001|Overall Study|Participant no longer meets criteria|0|||
44126237|NCT02415400|78911445|FG002|Overall Study|Participant no longer meets criteria|0|||
44126238|NCT02415400|78911446|FG003|Overall Study|Participant no longer meets criteria|1|||
44126239|NCT02415400|78911443|FG000|Overall Study|Participant doesn't answer phone|1|||
44126240|NCT02415400|78911444|FG001|Overall Study|Participant doesn't answer phone|0|||
44126241|NCT02415400|78911445|FG002|Overall Study|Participant doesn't answer phone|0|||
44243184|NCT01693562|79072528|FG000|Expansion Phase|Lost to Follow-up|0|||
44511265|NCT02030067|79516551|FG004|Overall Study|other reasons|0|||
44511266|NCT02030067|79516552|FG005|Overall Study|other reasons|1|||
44511267|NCT02030067|79516553|FG006|Overall Study|other reasons|0|||
44126242|NCT02415400|78911446|FG003|Overall Study|Participant doesn't answer phone|0|||
44126243|NCT02415400|78911443|FG000|Overall Study|Participant wanted home visits|1|||
44126244|NCT02415400|78911444|FG001|Overall Study|Participant wanted home visits|0|||
44126245|NCT02415400|78911445|FG002|Overall Study|Participant wanted home visits|0|||
44126246|NCT02415400|78911446|FG003|Overall Study|Participant wanted home visits|0|||
44126247|NCT02415400|78911443|FG000|Overall Study|Randomized in error|2|||
44126248|NCT02415400|78911444|FG001|Overall Study|Randomized in error|0|||
44126249|NCT02415400|78911445|FG002|Overall Study|Randomized in error|0|||
44126250|NCT02415400|78911446|FG003|Overall Study|Randomized in error|0|||
44126251|NCT02415400|78911443|FG000|Overall Study|No study drug on site|0|||
44126252|NCT02415400|78911444|FG001|Overall Study|No study drug on site|1|||
44126253|NCT02415400|78911445|FG002|Overall Study|No study drug on site|0|||
44126254|NCT02415400|78911446|FG003|Overall Study|No study drug on site|0|||
44126255|NCT02415400|78911443|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
44126256|NCT02415400|78911444|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
44126257|NCT02415400|78911445|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
44126258|NCT02415400|78911446|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
44126259|NCT02415400|78911443|FG000|Overall Study|Coagulation values cannot be set|0|||
44126260|NCT02415400|78911444|FG001|Overall Study|Coagulation values cannot be set|0|||
44126261|NCT02415400|78911445|FG002|Overall Study|Coagulation values cannot be set|1|||
44126262|NCT02415400|78911446|FG003|Overall Study|Coagulation values cannot be set|0|||
44126263|NCT02415400|78911443|FG000|Overall Study|State regulations prevent participation|0|||
44126264|NCT02415400|78911444|FG001|Overall Study|State regulations prevent participation|0|||
44126265|NCT02415400|78911445|FG002|Overall Study|State regulations prevent participation|1|||
44126266|NCT02415400|78911446|FG003|Overall Study|State regulations prevent participation|0|||
44126267|NCT02415400|78911443|FG000|Overall Study|Poor treatment monitoring|0|||
44126268|NCT02415400|78911444|FG001|Overall Study|Poor treatment monitoring|0|||
44126269|NCT02415400|78911445|FG002|Overall Study|Poor treatment monitoring|1|||
44126270|NCT02415400|78911446|FG003|Overall Study|Poor treatment monitoring|0|||
44126271|NCT02415400|78911443|FG000|Overall Study|Participant in jail|0|||
44126272|NCT02415400|78911444|FG001|Overall Study|Participant in jail|0|||
44126273|NCT02415400|78911445|FG002|Overall Study|Participant in jail|1|||
44126274|NCT02415400|78911446|FG003|Overall Study|Participant in jail|0|||
44126275|NCT02415400|78911443|FG000|Overall Study|Investigator decision|0|||
44126276|NCT02415400|78911444|FG001|Overall Study|Investigator decision|0|||
44126277|NCT02415400|78911445|FG002|Overall Study|Investigator decision|1|||
44126278|NCT02415400|78911446|FG003|Overall Study|Investigator decision|1|||
44126279|NCT02415400|78911443|FG000|Overall Study|Site closure; participant won't transfer|0|||
44126280|NCT02415400|78911444|FG001|Overall Study|Site closure; participant won't transfer|0|||
44126281|NCT02415400|78911445|FG002|Overall Study|Site closure; participant won't transfer|0|||
44126282|NCT02415400|78911446|FG003|Overall Study|Site closure; participant won't transfer|1|||
44126283|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
44126284|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
44126285|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
44126286|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
44126287|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
44126288|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
44126289|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
44126290|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
44126291|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
44126292|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
44126293|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
44126294|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
44126295|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
44511268|NCT02030067|79516554|FG007|Overall Study|other reasons|0|||
44511269|NCT02030067|79516555|FG008|Overall Study|other reasons|2|||
44511270|NCT02030067|79516556|FG009|Overall Study|other reasons|0|||
44511271|NCT02030067|79516557|FG010|Overall Study|other reasons|0|||
44511272|NCT02030067|79516558|FG011|Overall Study|other reasons|0|||
44511273|NCT02030067|79516559|FG012|Overall Study|other reasons|4|||
44511274|NCT02030067|79516547|FG000|Overall Study|Adverse Event|0|||
44511275|NCT02030067|79516548|FG001|Overall Study|Adverse Event|0|||
44511276|NCT02030067|79516549|FG002|Overall Study|Adverse Event|0|||
44511277|NCT02030067|79516550|FG003|Overall Study|Adverse Event|0|||
44511278|NCT02030067|79516551|FG004|Overall Study|Adverse Event|0|||
44511279|NCT02030067|79516552|FG005|Overall Study|Adverse Event|0|||
44511280|NCT02030067|79516553|FG006|Overall Study|Adverse Event|0|||
44511281|NCT02030067|79516554|FG007|Overall Study|Adverse Event|0|||
44511282|NCT02030067|79516555|FG008|Overall Study|Adverse Event|0|||
44511283|NCT02030067|79516556|FG009|Overall Study|Adverse Event|0|||
44511284|NCT02030067|79516557|FG010|Overall Study|Adverse Event|0|||
44511285|NCT02030067|79516558|FG011|Overall Study|Adverse Event|1|||
44511286|NCT02030067|79516559|FG012|Overall Study|Adverse Event|8|||
44511287|NCT02003209|79516591|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
44511288|NCT02003209|79516592|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
44143856|NCT00462943|78933155|FG001|Overall Study|Failure to achieve a response|5|||
44243185|NCT01693562|79072529|FG001|Expansion Phase|Lost to Follow-up|0|||
44243186|NCT01693562|79072530|FG002|Expansion Phase|Lost to Follow-up|0|||
44243187|NCT01693562|79072531|FG003|Expansion Phase|Lost to Follow-up|0|||
44243188|NCT01693562|79072532|FG004|Expansion Phase|Lost to Follow-up|0|||
44243189|NCT01693562|79072533|FG005|Expansion Phase|Lost to Follow-up|0|||
44511289|NCT01708941|79516602|FG000|Overall Study|Adverse Event|4|||
44243190|NCT01693562|79072534|FG006|Expansion Phase|Lost to Follow-up|0|||
44126296|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
44126297|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
44126298|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
44126299|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
44126300|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
44126301|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
44126302|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
44126303|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
44511290|NCT01708941|79516603|FG001|Overall Study|Adverse Event|6|||
44511291|NCT01708941|79516604|FG002|Overall Study|Adverse Event|1|||
44126304|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
44126305|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
44126306|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
44126307|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
44126308|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
44126309|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
44126310|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
44126311|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
44126312|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
44126313|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
44511292|NCT01708941|79516605|FG003|Overall Study|Adverse Event|0|||
44511293|NCT01708941|79516602|FG000|Overall Study|Death|1|||
44511294|NCT01708941|79516603|FG001|Overall Study|Death|1|||
44511295|NCT01708941|79516604|FG002|Overall Study|Death|2|||
44511296|NCT01708941|79516605|FG003|Overall Study|Death|14|||
44511297|NCT01708941|79516602|FG000|Overall Study|Withdrawal by Subject|1|||
44511298|NCT01708941|79516603|FG001|Overall Study|Withdrawal by Subject|0|||
44511299|NCT01708941|79516604|FG002|Overall Study|Withdrawal by Subject|3|||
44511300|NCT01708941|79516605|FG003|Overall Study|Withdrawal by Subject|4|||
44511301|NCT01708941|79516602|FG000|Overall Study|Disease progression|9|||
44126314|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
44126315|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
44126316|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
44126317|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
44126318|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
44126319|NCT04194801|78911463|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
44126320|NCT04194801|78911464|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
44126321|NCT04194801|78911465|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
44126322|NCT04194801|78911463|FG000|Part Ib/II End of Study|Death|2|||
44126323|NCT04194801|78911464|FG001|Part Ib/II End of Study|Death|3|||
44126324|NCT04194801|78911465|FG002|Part Ib/II End of Study|Death|3|||
44126325|NCT04194801|78911463|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
44126326|NCT04194801|78911464|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
44126327|NCT04194801|78911465|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
44126328|NCT04194801|78911463|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
44126329|NCT04194801|78911464|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
44126330|NCT04194801|78911465|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
44126331|NCT04194801|78911463|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
44126332|NCT04194801|78911464|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
44126333|NCT04194801|78911465|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
44126334|NCT04194801|78911463|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
44126335|NCT04194801|78911464|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
44126336|NCT04194801|78911465|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
44126337|NCT02802865|78911489|FG000|Overall Study|Pregnancy|1|||
44126338|NCT02802865|78911490|FG001|Overall Study|Pregnancy|1|||
44126339|NCT02802865|78911489|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
44126340|NCT02802865|78911490|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
44126341|NCT02414932|78911498|FG000|Overall Study|Withdrawal by Subject|2|||
44126342|NCT02414932|78911499|FG001|Overall Study|Withdrawal by Subject|3|||
44126343|NCT02414932|78911498|FG000|Overall Study|Adverse Event|1|||
44126344|NCT02414932|78911499|FG001|Overall Study|Adverse Event|0|||
44126345|NCT00704535|78911505|FG000|Overall Study|Adverse Event|2|||
44126346|NCT00704535|78911505|FG000|Overall Study|Death|2|||
44126347|NCT00704535|78911505|FG000|Overall Study|Lost to Follow-up|8|||
44126348|NCT00704535|78911505|FG000|Overall Study|Protocol Violation|10|||
44126349|NCT00704535|78911505|FG000|Overall Study|Completed status not on Case Report Form|124|||
44243191|NCT01693562|79072535|FG007|Expansion Phase|Lost to Follow-up|1|||
44379351|NCT00771667|79385043|FG002|Induction Phase|Lost to Follow-up|1|||
44379352|NCT00771667|79385044|FG003|Induction Phase|Lost to Follow-up|0|||
44511302|NCT01708941|79516603|FG001|Overall Study|Disease progression|10|||
44511303|NCT01708941|79516604|FG002|Overall Study|Disease progression|8|||
44511304|NCT01708941|79516605|FG003|Overall Study|Disease progression|0|||
44126350|NCT01740687|78911509|FG000|Overall Study|Lost to Follow-up|11|||
44126351|NCT01740687|78911509|FG000|Overall Study|Withdrawal by Subject|2|||
44126352|NCT01740687|78911509|FG000|Overall Study|other reason|22|||
44126353|NCT01740687|78911509|FG000|Overall Study|treatment not received|2|||
44126354|NCT02648204|78911517|FG000|Overall Study|Withdrawal by Subject|12|||
44126355|NCT02648204|78911518|FG001|Overall Study|Withdrawal by Subject|8|||
44126356|NCT02648204|78911519|FG002|Overall Study|Withdrawal by Subject|2|||
44126357|NCT02648204|78911520|FG003|Overall Study|Withdrawal by Subject|6|||
44126358|NCT02648204|78911517|FG000|Overall Study|Lost to Follow-up|5|||
44126359|NCT02648204|78911518|FG001|Overall Study|Lost to Follow-up|8|||
44126360|NCT02648204|78911519|FG002|Overall Study|Lost to Follow-up|4|||
44126361|NCT02648204|78911520|FG003|Overall Study|Lost to Follow-up|6|||
44126362|NCT02648204|78911517|FG000|Overall Study|Missing follow-up information|4|||
44126363|NCT02648204|78911518|FG001|Overall Study|Missing follow-up information|4|||
44126364|NCT02648204|78911519|FG002|Overall Study|Missing follow-up information|4|||
44126365|NCT02648204|78911520|FG003|Overall Study|Missing follow-up information|2|||
44126366|NCT02648204|78911517|FG000|Overall Study|Death|1|||
44126367|NCT02648204|78911518|FG001|Overall Study|Death|1|||
44126368|NCT02648204|78911519|FG002|Overall Study|Death|2|||
44126369|NCT02648204|78911520|FG003|Overall Study|Death|2|||
44126370|NCT02648204|78911517|FG000|Overall Study|Adverse Event|0|||
44126371|NCT02648204|78911518|FG001|Overall Study|Adverse Event|0|||
44126372|NCT02648204|78911519|FG002|Overall Study|Adverse Event|1|||
44126373|NCT02648204|78911520|FG003|Overall Study|Adverse Event|0|||
44126374|NCT02799745|78911532|FG000|Overall Study|Participant moved out of state|1|||
44126375|NCT02799745|78911533|FG001|Overall Study|Participant moved out of state|0|||
44511305|NCT01708941|79516602|FG000|Overall Study|Alternative therapy|0|||
44511306|NCT01708941|79516603|FG001|Overall Study|Alternative therapy|0|||
44511307|NCT01708941|79516604|FG002|Overall Study|Alternative therapy|2|||
44511308|NCT01708941|79516605|FG003|Overall Study|Alternative therapy|0|||
44511309|NCT01708941|79516602|FG000|Overall Study|Ineligible and never started treatment|1|||
44511310|NCT01708941|79516603|FG001|Overall Study|Ineligible and never started treatment|0|||
44511311|NCT01708941|79516604|FG002|Overall Study|Ineligible and never started treatment|1|||
44511312|NCT01708941|79516605|FG003|Overall Study|Ineligible and never started treatment|0|||
44511313|NCT01708941|79516602|FG000|Overall Study|Never started treatment|2|||
44511314|NCT01708941|79516603|FG001|Overall Study|Never started treatment|1|||
44126376|NCT02799745|78911532|FG000|Overall Study|Discontinued due to planned surgery|1|||
44126377|NCT02799745|78911533|FG001|Overall Study|Discontinued due to planned surgery|0|||
44511315|NCT01708941|79516604|FG002|Overall Study|Never started treatment|0|||
44511316|NCT01708941|79516605|FG003|Overall Study|Never started treatment|0|||
44126378|NCT02799745|78911532|FG000|Overall Study|Withdrawal by Subject|16|||
44126379|NCT02799745|78911533|FG001|Overall Study|Withdrawal by Subject|25|||
44126380|NCT02799745|78911532|FG000|Overall Study|Protocol Deviation|4|||
44126381|NCT02799745|78911533|FG001|Overall Study|Protocol Deviation|5|||
44126382|NCT02799745|78911532|FG000|Overall Study|Progressive Disease|28|||
44511317|NCT01708941|79516602|FG000|Overall Study|Ineligible|0|||
44126383|NCT02799745|78911533|FG001|Overall Study|Progressive Disease|38|||
44126384|NCT02799745|78911532|FG000|Overall Study|Lost to Follow-up|3|||
44126385|NCT02799745|78911533|FG001|Overall Study|Lost to Follow-up|2|||
44126386|NCT02799745|78911532|FG000|Overall Study|Death|3|||
44126387|NCT02799745|78911533|FG001|Overall Study|Death|0|||
44126388|NCT02799745|78911532|FG000|Overall Study|Adverse Event|0|||
44126389|NCT02799745|78911533|FG001|Overall Study|Adverse Event|1|||
44126390|NCT00705159|78911543|FG000|Overall Study|Withdrawal by Subject|0|||
44126391|NCT00705159|78911544|FG001|Overall Study|Withdrawal by Subject|1|||
44126392|NCT00705159|78911545|FG002|Overall Study|Withdrawal by Subject|1|||
44126393|NCT00705159|78911546|FG003|Overall Study|Withdrawal by Subject|1|||
44126394|NCT00705159|78911543|FG000|Overall Study|Protocol Violation|0|||
44126395|NCT00705159|78911544|FG001|Overall Study|Protocol Violation|1|||
44126396|NCT00705159|78911545|FG002|Overall Study|Protocol Violation|0|||
44126397|NCT00705159|78911546|FG003|Overall Study|Protocol Violation|0|||
44126398|NCT00705159|78911543|FG000|Overall Study|Adverse Event|0|||
44126399|NCT00705159|78911544|FG001|Overall Study|Adverse Event|0|||
44126400|NCT00705159|78911545|FG002|Overall Study|Adverse Event|1|||
44126401|NCT00705159|78911546|FG003|Overall Study|Adverse Event|0|||
44126402|NCT00705159|78911543|FG000|Overall Study|Lost to Follow-up|0|||
44126403|NCT00705159|78911544|FG001|Overall Study|Lost to Follow-up|0|||
44126404|NCT00705159|78911545|FG002|Overall Study|Lost to Follow-up|3|||
44126405|NCT00705159|78911546|FG003|Overall Study|Lost to Follow-up|2|||
44126406|NCT00705159|78911543|FG000|Overall Study|Screen Failure|0|||
44126407|NCT00705159|78911544|FG001|Overall Study|Screen Failure|0|||
44126408|NCT00705159|78911545|FG002|Overall Study|Screen Failure|0|||
44126409|NCT00705159|78911546|FG003|Overall Study|Screen Failure|1|||
44126410|NCT01673984|78911558|FG000|Overall Study|Adverse Event|1|||
44126411|NCT01673984|78911559|FG001|Overall Study|Adverse Event|0|||
44126412|NCT01673984|78911558|FG000|Overall Study|Study termination|9|||
44126413|NCT01673984|78911559|FG001|Overall Study|Study termination|6|||
44126414|NCT02332928|78911578|FG000|Overall Study|Withdrawal by Subject|0|||
44126415|NCT02332928|78911579|FG001|Overall Study|Withdrawal by Subject|2|||
44126416|NCT02332928|78911578|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
44126417|NCT02332928|78911579|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
44126418|NCT02647658|78911587|FG000|Overall Study|Consent refusal|15|||
44126419|NCT02647658|78911588|FG001|Overall Study|Consent refusal|24|||
44126420|NCT00703677|78911594|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
44126421|NCT00703911|78911602|FG000|Overall Study|Death|1|||
44126422|NCT00703911|78911602|FG000|Overall Study|Physician Decision|6|||
44126423|NCT00703911|78911602|FG000|Overall Study|Lost to Follow-up|1|||
44126424|NCT00703911|78911602|FG000|Overall Study|Withdrawal by Subject|2|||
44126425|NCT02055547|78911606|FG000|Overall Study|Protocol Violation|0|||
44511318|NCT01708941|79516603|FG001|Overall Study|Ineligible|0|||
44511319|NCT01708941|79516604|FG002|Overall Study|Ineligible|2|||
44511320|NCT01708941|79516605|FG003|Overall Study|Ineligible|0|||
44511321|NCT00234065|79516626|FG000|Overall Study|Adverse Event|268|||
44511322|NCT00234065|79516627|FG001|Overall Study|Adverse Event|166|||
44511323|NCT00234065|79516626|FG000|Overall Study|Withdrawal by Subject|73|||
44511324|NCT00234065|79516627|FG001|Overall Study|Withdrawal by Subject|56|||
44511325|NCT00234065|79516626|FG000|Overall Study|Physician Decision|23|||
44511326|NCT00234065|79516627|FG001|Overall Study|Physician Decision|22|||
44511327|NCT00234065|79516626|FG000|Overall Study|Not Classified|111|||
44511328|NCT00234065|79516627|FG001|Overall Study|Not Classified|112|||
44511329|NCT00233987|79516633|FG000|Overall Study|Withdrawal by Subject|1|||
44511330|NCT00233987|79516633|FG000|Overall Study|Lack of Efficacy|2|||
44511331|NCT00233987|79516633|FG000|Overall Study|Reason Under Review|1|||
44511332|NCT00233987|79516633|FG000|Overall Study|Other - Not Protocol Specified|5|||
44126426|NCT02055547|78911607|FG001|Overall Study|Protocol Violation|0|||
44126427|NCT02055547|78911608|FG002|Overall Study|Protocol Violation|1|||
44126428|NCT02055547|78911609|FG003|Overall Study|Protocol Violation|0|||
44126429|NCT02055547|78911610|FG004|Overall Study|Protocol Violation|0|||
44126430|NCT02055547|78911611|FG005|Overall Study|Protocol Violation|0|||
44126431|NCT02055547|78911612|FG006|Overall Study|Protocol Violation|1|||
44126432|NCT02055547|78911613|FG007|Overall Study|Protocol Violation|0|||
44126433|NCT02055547|78911614|FG008|Overall Study|Protocol Violation|0|||
44511333|NCT00233987|79516633|FG000|Overall Study|Eligible but No Treatment Received|2|||
44126434|NCT02055547|78911615|FG009|Overall Study|Protocol Violation|0|||
44126435|NCT02055547|78911616|FG010|Overall Study|Protocol Violation|0|||
44126436|NCT02055547|78911617|FG011|Overall Study|Protocol Violation|0|||
44126437|NCT02055547|78911618|FG012|Overall Study|Protocol Violation|0|||
44126438|NCT02055547|78911619|FG013|Overall Study|Protocol Violation|0|||
44511334|NCT00233987|79516633|FG000|Overall Study|Ineligible|4|||
44511335|NCT04623242|79516642|FG000|Overall Study|Withdrawal by Subject|7|||
44511336|NCT04623242|79516643|FG001|Overall Study|Withdrawal by Subject|12|||
44511337|NCT04623242|79516644|FG002|Overall Study|Withdrawal by Subject|5|||
44126439|NCT02055547|78911620|FG014|Overall Study|Protocol Violation|0|||
44126440|NCT02055547|78911621|FG015|Overall Study|Protocol Violation|0|||
44126441|NCT02055547|78911622|FG016|Overall Study|Protocol Violation|0|||
44126442|NCT02055547|78911623|FG017|Overall Study|Protocol Violation|0|||
44511338|NCT04623242|79516645|FG003|Overall Study|Withdrawal by Subject|7|||
44126443|NCT02055547|78911624|FG018|Overall Study|Protocol Violation|0|||
44126444|NCT02055547|78911606|FG000|Overall Study|Physician Decision|0|||
44126445|NCT02055547|78911607|FG001|Overall Study|Physician Decision|1|||
44126446|NCT02055547|78911608|FG002|Overall Study|Physician Decision|1|||
44126447|NCT02055547|78911609|FG003|Overall Study|Physician Decision|0|||
44126448|NCT02055547|78911610|FG004|Overall Study|Physician Decision|1|||
44126449|NCT02055547|78911611|FG005|Overall Study|Physician Decision|0|||
44126450|NCT02055547|78911612|FG006|Overall Study|Physician Decision|0|||
44126451|NCT02055547|78911613|FG007|Overall Study|Physician Decision|0|||
44126452|NCT02055547|78911614|FG008|Overall Study|Physician Decision|0|||
44126453|NCT02055547|78911615|FG009|Overall Study|Physician Decision|1|||
44126454|NCT02055547|78911616|FG010|Overall Study|Physician Decision|1|||
44126455|NCT02055547|78911617|FG011|Overall Study|Physician Decision|0|||
44126456|NCT02055547|78911618|FG012|Overall Study|Physician Decision|0|||
44126457|NCT02055547|78911619|FG013|Overall Study|Physician Decision|0|||
44126458|NCT02055547|78911620|FG014|Overall Study|Physician Decision|0|||
44126459|NCT02055547|78911621|FG015|Overall Study|Physician Decision|0|||
44126460|NCT02055547|78911622|FG016|Overall Study|Physician Decision|0|||
44126461|NCT02055547|78911623|FG017|Overall Study|Physician Decision|0|||
44243192|NCT01693562|79072536|FG008|Expansion Phase|Lost to Follow-up|2|||
44243193|NCT01693562|79072537|FG009|Expansion Phase|Lost to Follow-up|10|||
44243194|NCT01693562|79072538|FG010|Expansion Phase|Lost to Follow-up|4|||
44243195|NCT01693562|79072539|FG011|Expansion Phase|Lost to Follow-up|4|||
44243196|NCT01693562|79072540|FG012|Expansion Phase|Lost to Follow-up|1|||
44243197|NCT01693562|79072541|FG013|Expansion Phase|Lost to Follow-up|3|||
44243198|NCT01693562|79072542|FG014|Expansion Phase|Lost to Follow-up|0|||
44243199|NCT01693562|79072543|FG015|Expansion Phase|Lost to Follow-up|1|||
44511339|NCT04623242|79516646|FG004|Overall Study|Withdrawal by Subject|0|||
44511340|NCT04623242|79516642|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
44511341|NCT04623242|79516643|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
44511342|NCT04623242|79516644|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
44511343|NCT04623242|79516645|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
44511344|NCT04623242|79516646|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
44511345|NCT04623242|79516642|FG000|Overall Study|Subject unblinded to mutation status|0|||
44511346|NCT04623242|79516643|FG001|Overall Study|Subject unblinded to mutation status|0|||
44511347|NCT04623242|79516644|FG002|Overall Study|Subject unblinded to mutation status|0|||
44511348|NCT04623242|79516645|FG003|Overall Study|Subject unblinded to mutation status|13|||
44511349|NCT04623242|79516646|FG004|Overall Study|Subject unblinded to mutation status|0|||
44511350|NCT00233363|79516663|FG000|Overall Study|Adverse Event|1|||
44511351|NCT00233363|79516664|FG001|Overall Study|Adverse Event|2|||
44511352|NCT00233363|79516663|FG000|Overall Study|Lack of Efficacy|0|||
44511353|NCT00233363|79516664|FG001|Overall Study|Lack of Efficacy|2|||
44511354|NCT00233363|79516663|FG000|Overall Study|Withdrawal by Subject|1|||
44511355|NCT00233363|79516664|FG001|Overall Study|Withdrawal by Subject|1|||
44511356|NCT00233363|79516663|FG000|Overall Study|Aggravation of complication|1|||
44511357|NCT00233363|79516664|FG001|Overall Study|Aggravation of complication|0|||
44511358|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
44511359|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
44511360|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
44511361|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511362|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511363|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511364|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511365|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511366|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511367|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511368|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44126462|NCT02055547|78911624|FG018|Overall Study|Physician Decision|0|||
44126463|NCT02055547|78911606|FG000|Overall Study|Adverse Event|0|||
44126464|NCT02055547|78911607|FG001|Overall Study|Adverse Event|0|||
44126465|NCT02055547|78911608|FG002|Overall Study|Adverse Event|0|||
44126466|NCT02055547|78911609|FG003|Overall Study|Adverse Event|0|||
44126467|NCT02055547|78911610|FG004|Overall Study|Adverse Event|0|||
44243200|NCT01693562|79072544|FG016|Expansion Phase|Lost to Follow-up|1|||
44126468|NCT02055547|78911611|FG005|Overall Study|Adverse Event|0|||
44126469|NCT02055547|78911612|FG006|Overall Study|Adverse Event|1|||
44126470|NCT02055547|78911613|FG007|Overall Study|Adverse Event|0|||
44126471|NCT02055547|78911614|FG008|Overall Study|Adverse Event|1|||
44126472|NCT02055547|78911615|FG009|Overall Study|Adverse Event|0|||
44126473|NCT02055547|78911616|FG010|Overall Study|Adverse Event|0|||
44126474|NCT02055547|78911617|FG011|Overall Study|Adverse Event|0|||
44126475|NCT02055547|78911618|FG012|Overall Study|Adverse Event|0|||
44126476|NCT02055547|78911619|FG013|Overall Study|Adverse Event|0|||
44379353|NCT00771667|79385045|FG004|Induction Phase|Lost to Follow-up|0|||
44379354|NCT00771667|79385046|FG005|Induction Phase|Lost to Follow-up|0|||
44379355|NCT00771667|79385047|FG006|Induction Phase|Lost to Follow-up|0|||
44379356|NCT00771667|79385048|FG007|Induction Phase|Lost to Follow-up|0|||
44379357|NCT00771667|79385049|FG008|Induction Phase|Lost to Follow-up|0|||
44379358|NCT00771667|79385050|FG009|Induction Phase|Lost to Follow-up|0|||
44379359|NCT00771667|79385041|FG000|Induction Phase|Other|4|||
44379360|NCT00771667|79385042|FG001|Induction Phase|Other|6|||
44379361|NCT00771667|79385043|FG002|Induction Phase|Other|3|||
44379362|NCT00771667|79385044|FG003|Induction Phase|Other|4|||
44379363|NCT00771667|79385045|FG004|Induction Phase|Other|0|||
44379364|NCT00771667|79385046|FG005|Induction Phase|Other|0|||
44379365|NCT00771667|79385047|FG006|Induction Phase|Other|0|||
44379366|NCT00771667|79385048|FG007|Induction Phase|Other|0|||
44511369|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511370|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
44511371|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44511372|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
44126477|NCT02055547|78911620|FG014|Overall Study|Adverse Event|0|||
44126478|NCT02055547|78911621|FG015|Overall Study|Adverse Event|0|||
44126479|NCT02055547|78911622|FG016|Overall Study|Adverse Event|0|||
44126480|NCT02055547|78911623|FG017|Overall Study|Adverse Event|0|||
44126481|NCT02055547|78911624|FG018|Overall Study|Adverse Event|0|||
44126482|NCT02055547|78911606|FG000|Overall Study|Withdrawal by Subject|0|||
44126483|NCT02055547|78911607|FG001|Overall Study|Withdrawal by Subject|0|||
44126484|NCT02055547|78911608|FG002|Overall Study|Withdrawal by Subject|0|||
44126485|NCT02055547|78911609|FG003|Overall Study|Withdrawal by Subject|0|||
44126486|NCT02055547|78911610|FG004|Overall Study|Withdrawal by Subject|0|||
44126487|NCT02055547|78911611|FG005|Overall Study|Withdrawal by Subject|1|||
44126488|NCT02055547|78911612|FG006|Overall Study|Withdrawal by Subject|0|||
44126489|NCT02055547|78911613|FG007|Overall Study|Withdrawal by Subject|0|||
44126490|NCT02055547|78911614|FG008|Overall Study|Withdrawal by Subject|1|||
44126491|NCT02055547|78911615|FG009|Overall Study|Withdrawal by Subject|0|||
44126492|NCT02055547|78911616|FG010|Overall Study|Withdrawal by Subject|0|||
44126493|NCT02055547|78911617|FG011|Overall Study|Withdrawal by Subject|0|||
44126494|NCT02055547|78911618|FG012|Overall Study|Withdrawal by Subject|0|||
44126495|NCT02055547|78911619|FG013|Overall Study|Withdrawal by Subject|1|||
44126496|NCT02055547|78911620|FG014|Overall Study|Withdrawal by Subject|0|||
44126497|NCT02055547|78911621|FG015|Overall Study|Withdrawal by Subject|1|||
44126498|NCT02055547|78911622|FG016|Overall Study|Withdrawal by Subject|0|||
44126499|NCT02055547|78911623|FG017|Overall Study|Withdrawal by Subject|0|||
44126500|NCT02055547|78911624|FG018|Overall Study|Withdrawal by Subject|0|||
44126501|NCT02055547|78911606|FG000|Overall Study|Lost to Follow-up|0|||
44126502|NCT02055547|78911607|FG001|Overall Study|Lost to Follow-up|0|||
44126503|NCT02055547|78911608|FG002|Overall Study|Lost to Follow-up|1|||
44243201|NCT01693562|79072545|FG017|Expansion Phase|Lost to Follow-up|0|||
44511373|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44511374|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
44511375|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44511376|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44511377|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
44511378|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
44126504|NCT02055547|78911609|FG003|Overall Study|Lost to Follow-up|0|||
44243202|NCT01693562|79072546|FG018|Expansion Phase|Lost to Follow-up|2|||
44243203|NCT01693562|79072547|FG019|Expansion Phase|Lost to Follow-up|1|||
44379367|NCT00771667|79385049|FG008|Induction Phase|Other|0|||
44126505|NCT02055547|78911610|FG004|Overall Study|Lost to Follow-up|0|||
44126506|NCT02055547|78911611|FG005|Overall Study|Lost to Follow-up|0|||
44126507|NCT02055547|78911612|FG006|Overall Study|Lost to Follow-up|0|||
44126508|NCT02055547|78911613|FG007|Overall Study|Lost to Follow-up|0|||
44126509|NCT02055547|78911614|FG008|Overall Study|Lost to Follow-up|0|||
44126510|NCT02055547|78911615|FG009|Overall Study|Lost to Follow-up|0|||
44126511|NCT02055547|78911616|FG010|Overall Study|Lost to Follow-up|0|||
44126512|NCT02055547|78911617|FG011|Overall Study|Lost to Follow-up|0|||
44126513|NCT02055547|78911618|FG012|Overall Study|Lost to Follow-up|0|||
44379368|NCT00771667|79385050|FG009|Induction Phase|Other|0|||
44379369|NCT00771667|79385041|FG000|Maintenance Phase|Adverse Event|0|||
44379370|NCT00771667|79385042|FG001|Maintenance Phase|Adverse Event|0|||
44379371|NCT00771667|79385043|FG002|Maintenance Phase|Adverse Event|0|||
44126514|NCT02055547|78911619|FG013|Overall Study|Lost to Follow-up|0|||
44126515|NCT02055547|78911620|FG014|Overall Study|Lost to Follow-up|0|||
44126516|NCT02055547|78911621|FG015|Overall Study|Lost to Follow-up|0|||
44126517|NCT02055547|78911622|FG016|Overall Study|Lost to Follow-up|0|||
44126518|NCT02055547|78911623|FG017|Overall Study|Lost to Follow-up|0|||
44126519|NCT02055547|78911624|FG018|Overall Study|Lost to Follow-up|0|||
44126520|NCT02414854|78911662|FG000|Overall Study|Adverse Event|9|||
44126521|NCT02414854|78911663|FG001|Overall Study|Adverse Event|7|||
44126522|NCT02414854|78911664|FG002|Overall Study|Adverse Event|1|||
44126523|NCT02414854|78911665|FG003|Overall Study|Adverse Event|12|||
44126524|NCT02414854|78911662|FG000|Overall Study|Poor compliance to protocol|1|||
44126525|NCT02414854|78911663|FG001|Overall Study|Poor compliance to protocol|1|||
44126526|NCT02414854|78911664|FG002|Overall Study|Poor compliance to protocol|2|||
44126527|NCT02414854|78911665|FG003|Overall Study|Poor compliance to protocol|2|||
44126528|NCT02414854|78911662|FG000|Overall Study|Other than specified above|12|||
44126529|NCT02414854|78911663|FG001|Overall Study|Other than specified above|37|||
44126530|NCT02414854|78911664|FG002|Overall Study|Other than specified above|17|||
44126531|NCT02414854|78911665|FG003|Overall Study|Other than specified above|37|||
44126532|NCT03332498|78911678|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
44126533|NCT03332498|78911679|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
44126534|NCT03332498|78911680|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
44126535|NCT01334125|78911689|FG000|Overall Study|Lost to Follow-up|3|||
44126536|NCT01334125|78911690|FG001|Overall Study|Lost to Follow-up|3|||
44126537|NCT02414152|78911697|FG000|Overall Study|Withdrawal by Subject|1|||
44126538|NCT02414152|78911697|FG000|Overall Study|Lack of Efficacy|1|||
44126539|NCT02413996|78911703|FG000|Overall Study|not comfortable with the intervention|9|||
44126540|NCT02413996|78911704|FG001|Overall Study|not comfortable with the intervention|2|||
44126541|NCT01333501|78911712|FG000|Overall Study|Adverse Event|3|||
44126542|NCT01333501|78911713|FG001|Overall Study|Adverse Event|1|||
44126543|NCT01333501|78911712|FG000|Overall Study|Abnormal laboratory value|2|||
44126544|NCT01333501|78911713|FG001|Overall Study|Abnormal laboratory value|1|||
44126545|NCT01333501|78911712|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44126546|NCT01333501|78911713|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
44511379|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
44511380|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
44511381|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44511382|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
44511383|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44511384|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44126547|NCT01333501|78911712|FG000|Overall Study|Withdrawn consent|3|||
44511385|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
44511386|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
44511387|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
44511388|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
44511389|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
44511390|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
44511391|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
44511392|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
44511393|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
44511394|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
44511395|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
44511396|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
44126548|NCT01333501|78911713|FG001|Overall Study|Withdrawn consent|12|||
44126549|NCT01362140|78911721|FG000|Overall Study|Noncompliance|1|||
44126550|NCT01362140|78911722|FG001|Overall Study|Noncompliance|0|||
44126551|NCT01362140|78911721|FG000|Overall Study|Adverse Event|2|||
44126552|NCT01362140|78911722|FG001|Overall Study|Adverse Event|2|||
44126553|NCT01362140|78911721|FG000|Overall Study|Withdrawal by Subject|3|||
44511397|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
44126554|NCT01362140|78911722|FG001|Overall Study|Withdrawal by Subject|3|||
44126555|NCT01362140|78911721|FG000|Overall Study|Administrative Decision|0|||
44126556|NCT01362140|78911722|FG001|Overall Study|Administrative Decision|1|||
44126557|NCT01362140|78911721|FG000|Overall Study|Death|2|||
44126558|NCT01362140|78911722|FG001|Overall Study|Death|1|||
44126559|NCT01362140|78911721|FG000|Overall Study|Other|1|||
44126560|NCT01362140|78911722|FG001|Overall Study|Other|1|||
44126561|NCT01362140|78911721|FG000|Overall Study|Protocol-specified Criteria|1|||
44126562|NCT01362140|78911722|FG001|Overall Study|Protocol-specified Criteria|2|||
44126563|NCT01362140|78911721|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
44126564|NCT01362140|78911722|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
44126565|NCT01333189|78911730|FG000|Overall Study|Time constraints|1|||
44126566|NCT01333189|78911731|FG001|Overall Study|Time constraints|0|||
44126567|NCT01333189|78911730|FG000|Overall Study|Adverse Event|1|||
44126568|NCT01333189|78911731|FG001|Overall Study|Adverse Event|0|||
44126569|NCT01333189|78911730|FG000|Overall Study|Transportation difficulties|0|||
44126570|NCT01333189|78911731|FG001|Overall Study|Transportation difficulties|1|||
44126571|NCT01333189|78911730|FG000|Overall Study|Moved from region|0|||
44126572|NCT01333189|78911731|FG001|Overall Study|Moved from region|1|||
44126573|NCT01333111|78911740|FG000|Overall Study|patient undergoing major surgery|0|||
44243204|NCT01693562|79072548|FG020|Expansion Phase|Lost to Follow-up|2|||
44243205|NCT01693562|79072549|FG021|Expansion Phase|Lost to Follow-up|2|||
44243206|NCT01693562|79072550|FG022|Expansion Phase|Lost to Follow-up|1|||
44243207|NCT01693562|79072528|FG000|Expansion Phase|Other|0|||
44243208|NCT01693562|79072529|FG001|Expansion Phase|Other|0|||
44126574|NCT01333111|78911741|FG001|Overall Study|patient undergoing major surgery|2|||
44126575|NCT01333111|78911742|FG002|Overall Study|patient undergoing major surgery|0|||
44126576|NCT01333111|78911740|FG000|Overall Study|personal reasons|0|||
44126577|NCT01333111|78911741|FG001|Overall Study|personal reasons|0|||
44126578|NCT01333111|78911742|FG002|Overall Study|personal reasons|1|||
44126579|NCT01333111|78911740|FG000|Overall Study|unclassified|1|||
44243209|NCT01693562|79072530|FG002|Expansion Phase|Other|0|||
44243210|NCT01693562|79072531|FG003|Expansion Phase|Other|0|||
44126580|NCT01333111|78911741|FG001|Overall Study|unclassified|0|||
44126581|NCT01333111|78911742|FG002|Overall Study|unclassified|0|||
44126582|NCT01333111|78911740|FG000|Overall Study|withdrawal criteria|0|||
44126583|NCT01333111|78911741|FG001|Overall Study|withdrawal criteria|1|||
44126584|NCT01333111|78911742|FG002|Overall Study|withdrawal criteria|0|||
44126585|NCT01333111|78911740|FG000|Overall Study|Non-compliance|1|||
44126586|NCT01333111|78911741|FG001|Overall Study|Non-compliance|0|||
44126587|NCT01333111|78911742|FG002|Overall Study|Non-compliance|0|||
44126588|NCT01333111|78911740|FG000|Overall Study|Ineffective therapy|0|||
44126589|NCT01333111|78911741|FG001|Overall Study|Ineffective therapy|0|||
44126590|NCT01333111|78911742|FG002|Overall Study|Ineffective therapy|1|||
44126591|NCT00702507|78911750|FG000|Initial Treatment Phase|Adverse Event|2|||
44126592|NCT00702507|78911750|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
44126593|NCT00702507|78911750|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
44126594|NCT00702507|78911750|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
44126595|NCT00702507|78911750|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
44126596|NCT00702507|78911750|FG000|Follow-up Phase|Protocol Violation|2|||
44126597|NCT00702507|78911750|FG000|Follow-up Phase|Lost to Follow-up|23|||
44126598|NCT00702507|78911750|FG000|Follow-up Phase|Late Enrollment|1|||
44126599|NCT01673594|78911766|FG000|Overall Study|Adverse Event|3|||
44126600|NCT01673594|78911767|FG001|Overall Study|Adverse Event|1|||
44126601|NCT01673594|78911766|FG000|Overall Study|Lost to Follow-up|1|||
44126602|NCT01673594|78911767|FG001|Overall Study|Lost to Follow-up|0|||
44126603|NCT01673594|78911766|FG000|Overall Study|Physician Decision|2|||
44126604|NCT01673594|78911767|FG001|Overall Study|Physician Decision|4|||
44126605|NCT01673594|78911766|FG000|Overall Study|Withdrawal by Subject|0|||
44126606|NCT01673594|78911767|FG001|Overall Study|Withdrawal by Subject|1|||
44126607|NCT02721147|78911776|FG000|Overall Study|Lost to Follow-up|2|||
44126608|NCT02721147|78911777|FG001|Overall Study|Lost to Follow-up|0|||
44126609|NCT02721147|78911778|FG002|Overall Study|Lost to Follow-up|0|||
44126610|NCT02720757|78911786|FG000|Overall Study|Other reason|5|||
44126611|NCT02720757|78911786|FG000|Overall Study|Loss of contact|4|||
44126612|NCT02720757|78911786|FG000|Overall Study|Informed consent withdrawal|1|||
44126613|NCT02720757|78911786|FG000|Overall Study|Patients wish to withdraw|2|||
44126614|NCT02720757|78911786|FG000|Overall Study|Missing|3|||
44126615|NCT02720757|78911786|FG000|Overall Study|General exclusion|3|||
44126616|NCT02646566|78911816|FG000|Overall Study|Lost to Follow-up|5|||
44126617|NCT02646566|78911817|FG001|Overall Study|Lost to Follow-up|4|||
44126618|NCT02646566|78911818|FG002|Overall Study|Lost to Follow-up|5|||
44126619|NCT02646566|78911816|FG000|Overall Study|Treatment failure|1|||
44126620|NCT02646566|78911817|FG001|Overall Study|Treatment failure|0|||
44126621|NCT02646566|78911818|FG002|Overall Study|Treatment failure|0|||
44126622|NCT02720523|78911834|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
44126623|NCT02720523|78911835|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
44126624|NCT02720523|78911836|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
44126625|NCT02720523|78911837|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
44126626|NCT02720523|78911838|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
44126627|NCT02720523|78911839|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
44126628|NCT02720523|78911840|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
44126629|NCT02720523|78911834|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
44126630|NCT02720523|78911835|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44126631|NCT02720523|78911836|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44126632|NCT02720523|78911837|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44126633|NCT02720523|78911838|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44126634|NCT02720523|78911839|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44126635|NCT02720523|78911840|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44126636|NCT02720523|78911834|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
44126637|NCT02720523|78911835|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
44126638|NCT02720523|78911836|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
44126639|NCT02720523|78911837|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
44126640|NCT02720523|78911838|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
44126641|NCT02720523|78911839|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
44126642|NCT02720523|78911840|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
44126643|NCT02720523|78911834|FG000|Period 1: Placebo-controlled Period|Other|0|||
44126644|NCT02720523|78911835|FG001|Period 1: Placebo-controlled Period|Other|0|||
44126645|NCT02720523|78911836|FG002|Period 1: Placebo-controlled Period|Other|1|||
44126646|NCT02720523|78911837|FG003|Period 1: Placebo-controlled Period|Other|1|||
44126647|NCT02720523|78911838|FG004|Period 1: Placebo-controlled Period|Other|0|||
44126648|NCT02720523|78911839|FG005|Period 1: Placebo-controlled Period|Other|0|||
44126649|NCT02720523|78911840|FG006|Period 1: Placebo-controlled Period|Other|0|||
44126650|NCT02720523|78911834|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
44126651|NCT02720523|78911835|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
44126652|NCT02720523|78911836|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
44126653|NCT02720523|78911837|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
44126654|NCT02720523|78911838|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
44126655|NCT02720523|78911839|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
44126656|NCT02720523|78911840|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
44126657|NCT02720523|78911834|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
44126658|NCT02720523|78911835|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
44126659|NCT02720523|78911836|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
44126660|NCT02720523|78911837|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
44126661|NCT02720523|78911838|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
44126662|NCT02720523|78911839|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
44126663|NCT02720523|78911840|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
44126664|NCT02720523|78911834|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
44126665|NCT02720523|78911835|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
44126666|NCT02720523|78911836|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
44126667|NCT02720523|78911837|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
44126668|NCT02720523|78911838|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
44126669|NCT02720523|78911839|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
44126670|NCT02720523|78911840|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
44243211|NCT01693562|79072532|FG004|Expansion Phase|Other|0|||
44243212|NCT01693562|79072533|FG005|Expansion Phase|Other|0|||
44511398|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
44511399|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
44126671|NCT02720523|78911834|FG000|Period 2: Long-term Extension Period|Other|0|||
44126672|NCT02720523|78911835|FG001|Period 2: Long-term Extension Period|Other|0|||
44126673|NCT02720523|78911836|FG002|Period 2: Long-term Extension Period|Other|0|||
44511400|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
44126674|NCT02720523|78911837|FG003|Period 2: Long-term Extension Period|Other|0|||
44126675|NCT02720523|78911838|FG004|Period 2: Long-term Extension Period|Other|2|||
44126676|NCT02720523|78911839|FG005|Period 2: Long-term Extension Period|Other|0|||
44126677|NCT02720523|78911840|FG006|Period 2: Long-term Extension Period|Other|3|||
44126678|NCT02646332|78911855|FG000|Overall Study|Lost to Follow-up|0|||
44126679|NCT02646332|78911856|FG001|Overall Study|Lost to Follow-up|3|||
44243213|NCT01693562|79072534|FG006|Expansion Phase|Other|0|||
44126680|NCT02471716|78911867|FG000|Overall Study|Withdrawal by Subject|0|||
44126681|NCT02471716|78911868|FG001|Overall Study|Withdrawal by Subject|1|||
44126682|NCT02471716|78911869|FG002|Overall Study|Withdrawal by Subject|0|||
44126683|NCT02471716|78911870|FG003|Overall Study|Withdrawal by Subject|2|||
44126684|NCT02471716|78911871|FG004|Overall Study|Withdrawal by Subject|5|||
44126685|NCT02471716|78911867|FG000|Overall Study|Study Terminiated by sponsor|0|||
44126686|NCT02471716|78911868|FG001|Overall Study|Study Terminiated by sponsor|0|||
44126687|NCT02471716|78911869|FG002|Overall Study|Study Terminiated by sponsor|0|||
44126688|NCT02471716|78911870|FG003|Overall Study|Study Terminiated by sponsor|1|||
44126689|NCT02471716|78911871|FG004|Overall Study|Study Terminiated by sponsor|0|||
44126690|NCT02471716|78911867|FG000|Overall Study|Lost to Follow-up|0|||
44126691|NCT02471716|78911868|FG001|Overall Study|Lost to Follow-up|0|||
44126692|NCT02471716|78911869|FG002|Overall Study|Lost to Follow-up|0|||
44126693|NCT02471716|78911870|FG003|Overall Study|Lost to Follow-up|3|||
44126694|NCT02471716|78911871|FG004|Overall Study|Lost to Follow-up|2|||
44126695|NCT02471716|78911867|FG000|Overall Study|Death|0|||
44126696|NCT02471716|78911868|FG001|Overall Study|Death|0|||
44126697|NCT02471716|78911869|FG002|Overall Study|Death|0|||
44126698|NCT02471716|78911870|FG003|Overall Study|Death|1|||
44126699|NCT02471716|78911871|FG004|Overall Study|Death|0|||
44126700|NCT02471716|78911867|FG000|Overall Study|Other|0|||
44126701|NCT02471716|78911868|FG001|Overall Study|Other|0|||
44126702|NCT02471716|78911869|FG002|Overall Study|Other|0|||
44126703|NCT02471716|78911870|FG003|Overall Study|Other|8|||
44126704|NCT02471716|78911871|FG004|Overall Study|Other|9|||
44126705|NCT01370863|78911887|FG000|Overall Study|Adverse Event|1|||
44126706|NCT01370863|78911888|FG001|Overall Study|Adverse Event|1|||
44126707|NCT01370863|78911887|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
44126708|NCT01370863|78911888|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
44126709|NCT01370863|78911887|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
44126710|NCT01370863|78911888|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
44126711|NCT02444182|78911896|FG000|Overall Study|non-compliance|2|||
44126712|NCT02444182|78911897|FG001|Overall Study|non-compliance|1|||
44126713|NCT02444182|78911896|FG000|Overall Study|Lost to Follow-up|0|||
44126714|NCT02444182|78911897|FG001|Overall Study|Lost to Follow-up|4|||
44126715|NCT02471404|78911906|FG000|Overall Study|Adverse Event|7|||
44126716|NCT02471404|78911907|FG001|Overall Study|Adverse Event|1|||
44126717|NCT02471404|78911908|FG002|Overall Study|Adverse Event|2|||
44126718|NCT02471404|78911906|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
44126719|NCT02471404|78911907|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
44126720|NCT02471404|78911908|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
44126721|NCT02471404|78911906|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
44126722|NCT02471404|78911907|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
44126723|NCT02471404|78911908|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
44126724|NCT02471404|78911906|FG000|Overall Study|Lost to Follow-up|1|||
44511401|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
44511402|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
44511403|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
44511404|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511405|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511406|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
44511407|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511408|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511409|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44126725|NCT02471404|78911907|FG001|Overall Study|Lost to Follow-up|1|||
44126726|NCT02471404|78911908|FG002|Overall Study|Lost to Follow-up|3|||
44126727|NCT02471404|78911906|FG000|Overall Study|Protocol Violation|1|||
44126728|NCT02471404|78911907|FG001|Overall Study|Protocol Violation|0|||
44126729|NCT02471404|78911908|FG002|Overall Study|Protocol Violation|0|||
44126730|NCT02471404|78911906|FG000|Overall Study|Withdrawal by Subject|8|||
44126731|NCT02471404|78911907|FG001|Overall Study|Withdrawal by Subject|4|||
44126732|NCT02471404|78911908|FG002|Overall Study|Withdrawal by Subject|5|||
44126733|NCT02471404|78911906|FG000|Overall Study|Other reasons not specified|10|||
44126734|NCT02471404|78911907|FG001|Overall Study|Other reasons not specified|7|||
44126735|NCT02471404|78911908|FG002|Overall Study|Other reasons not specified|12|||
44126736|NCT02471014|78911918|FG000|Overall Study|Lost to Follow-up|2|||
44126737|NCT02471014|78911919|FG001|Overall Study|Lost to Follow-up|2|||
44126738|NCT02413372|78911928|FG000|Treatment|Lost to Follow-up|0|||
44126739|NCT02413372|78911929|FG001|Treatment|Lost to Follow-up|2|||
44126740|NCT02413372|78911930|FG002|Treatment|Lost to Follow-up|1|||
44126741|NCT02413372|78911928|FG000|Treatment|Withdrawal by Subject|1|||
44126742|NCT02413372|78911929|FG001|Treatment|Withdrawal by Subject|0|||
44126743|NCT02413372|78911930|FG002|Treatment|Withdrawal by Subject|0|||
44126744|NCT02413372|78911928|FG000|Follow-up|Lost to Follow-up|1|||
44126745|NCT02413372|78911929|FG001|Follow-up|Lost to Follow-up|1|||
44126746|NCT02413372|78911930|FG002|Follow-up|Lost to Follow-up|0|||
44126747|NCT02413372|78911928|FG000|Follow-up|Subject Withdrew Consent|1|||
44126748|NCT02413372|78911929|FG001|Follow-up|Subject Withdrew Consent|0|||
44126749|NCT02413372|78911930|FG002|Follow-up|Subject Withdrew Consent|1|||
44126750|NCT02413372|78911928|FG000|Follow-up|Subject unable to return for visit|0|||
44126751|NCT02413372|78911929|FG001|Follow-up|Subject unable to return for visit|0|||
44126752|NCT02413372|78911930|FG002|Follow-up|Subject unable to return for visit|1|||
44126753|NCT02413294|78911938|FG000|Overall Study|Withdrawal by Subject|1|||
44126754|NCT02719353|78911951|FG000|First Intervention|Physician Decision|0|||
44126755|NCT02719353|78911952|FG001|First Intervention|Physician Decision|1|||
44126756|NCT01362062|78911961|FG000|Overall Study|Adverse Event|1|||
44126757|NCT01362062|78911962|FG001|Overall Study|Adverse Event|0|||
44126758|NCT01362062|78911961|FG000|Overall Study|Lost to Follow-up|11|||
44126759|NCT01362062|78911962|FG001|Overall Study|Lost to Follow-up|0|||
44126760|NCT01362062|78911961|FG000|Overall Study|Withdrawal by Subject|2|||
44126761|NCT01362062|78911962|FG001|Overall Study|Withdrawal by Subject|0|||
44126762|NCT01362062|78911961|FG000|Overall Study|Non-compliant participant|2|||
44126763|NCT01362062|78911962|FG001|Overall Study|Non-compliant participant|0|||
44126764|NCT01362062|78911961|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
44126765|NCT01362062|78911962|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
44126766|NCT01362062|78911961|FG000|Overall Study|Had significant improvement|9|||
44126767|NCT01362062|78911962|FG001|Overall Study|Had significant improvement|0|||
44126768|NCT01361594|78911969|FG000|Overall Study|Withdrawal by Subject|1|||
44126769|NCT01361594|78911970|FG001|Overall Study|Withdrawal by Subject|2|||
44126770|NCT02642432|78911976|FG000|Overall Study|Adverse Event|2|||
44126771|NCT02642432|78911976|FG000|Overall Study|Withdrew Consent|1|||
44126772|NCT02642432|78911976|FG000|Overall Study|Lost to Follow-up|2|||
44126773|NCT02642432|78911976|FG000|Overall Study|Other|3|||
44126774|NCT02640482|78911982|FG000|Overall Study|Lost to Follow-up|3|||
44126775|NCT02640482|78911983|FG001|Overall Study|Lost to Follow-up|0|||
44126776|NCT02719743|78911994|FG000|Overall Study|Consent withdrawal|0|||
44126777|NCT02719743|78911995|FG001|Overall Study|Consent withdrawal|2|||
44126778|NCT02719743|78911996|FG002|Overall Study|Consent withdrawal|0|||
44276518|NCT02153112|79231462|FG007|Overall Study|Withdrawal by Subject|2|||
44511410|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511411|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511412|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511413|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
44511414|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511415|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511416|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511417|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
44511418|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511419|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511420|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511421|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511422|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
44511423|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
44511424|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511425|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
44511426|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44126779|NCT02719743|78911997|FG003|Overall Study|Consent withdrawal|1|||
44126780|NCT02719743|78911998|FG004|Overall Study|Consent withdrawal|0|||
44126781|NCT02719743|78911994|FG000|Overall Study|Migrated/moved from study area|0|||
44126782|NCT02719743|78911995|FG001|Overall Study|Migrated/moved from study area|0|||
44126783|NCT02719743|78911996|FG002|Overall Study|Migrated/moved from study area|0|||
44126784|NCT02719743|78911997|FG003|Overall Study|Migrated/moved from study area|0|||
44511427|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
44126785|NCT02719743|78911998|FG004|Overall Study|Migrated/moved from study area|2|||
44126786|NCT02719743|78911994|FG000|Overall Study|Lost to Follow-up|1|||
44126787|NCT02719743|78911995|FG001|Overall Study|Lost to Follow-up|1|||
44126788|NCT02719743|78911996|FG002|Overall Study|Lost to Follow-up|0|||
44379372|NCT00771667|79385044|FG003|Maintenance Phase|Adverse Event|0|||
44379373|NCT00771667|79385045|FG004|Maintenance Phase|Adverse Event|1|||
44379374|NCT00771667|79385046|FG005|Maintenance Phase|Adverse Event|3|||
44379375|NCT00771667|79385047|FG006|Maintenance Phase|Adverse Event|5|||
44379376|NCT00771667|79385048|FG007|Maintenance Phase|Adverse Event|1|||
44379377|NCT00771667|79385049|FG008|Maintenance Phase|Adverse Event|8|||
44379378|NCT00771667|79385050|FG009|Maintenance Phase|Adverse Event|7|||
44379379|NCT00771667|79385041|FG000|Maintenance Phase|Lack of Efficacy|0|||
44379380|NCT00771667|79385042|FG001|Maintenance Phase|Lack of Efficacy|0|||
44126789|NCT02719743|78911997|FG003|Overall Study|Lost to Follow-up|0|||
44126790|NCT02719743|78911998|FG004|Overall Study|Lost to Follow-up|0|||
44126791|NCT02641730|78912013|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
44126792|NCT02641730|78912014|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44126793|NCT02641730|78912015|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
44126794|NCT02641730|78912016|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
44126795|NCT02641730|78912017|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
44126796|NCT02641730|78912013|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
44126797|NCT02641730|78912014|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
44126798|NCT02641730|78912015|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
44126799|NCT02641730|78912016|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
44126800|NCT02641730|78912017|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
44126801|NCT02641730|78912013|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
44126802|NCT02641730|78912014|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
44126803|NCT02641730|78912015|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
44126804|NCT02641730|78912016|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
44126805|NCT02641730|78912017|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
44126806|NCT02641730|78912013|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44126807|NCT02641730|78912014|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44126808|NCT02641730|78912015|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44126809|NCT02641730|78912016|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
44126810|NCT02641730|78912017|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
44126811|NCT02641730|78912013|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
44126812|NCT02641730|78912014|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
44126813|NCT02641730|78912015|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
44126814|NCT02641730|78912016|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
44126815|NCT02641730|78912017|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
44126816|NCT02641730|78912013|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
44126817|NCT02641730|78912014|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
44126818|NCT02641730|78912015|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
44126819|NCT02641730|78912016|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
44126820|NCT02641730|78912017|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
44126821|NCT02797171|78912037|FG000|Overall Study|Lost to Follow-up|2|||
44126822|NCT02797171|78912038|FG001|Overall Study|Lost to Follow-up|0|||
44126823|NCT02797171|78912039|FG002|Overall Study|Lost to Follow-up|2|||
44126824|NCT02797171|78912040|FG003|Overall Study|Lost to Follow-up|1|||
44126825|NCT02797171|78912041|FG004|Overall Study|Lost to Follow-up|2|||
44126826|NCT02797171|78912042|FG005|Overall Study|Lost to Follow-up|0|||
44126827|NCT02797171|78912037|FG000|Overall Study|Withdrawal by Subject|1|||
44379381|NCT00771667|79385043|FG002|Maintenance Phase|Lack of Efficacy|0|||
44511428|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511429|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
44511430|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511431|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
44511432|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
44511433|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511434|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44126828|NCT02797171|78912038|FG001|Overall Study|Withdrawal by Subject|1|||
44511435|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44126829|NCT02797171|78912039|FG002|Overall Study|Withdrawal by Subject|0|||
44126830|NCT02797171|78912040|FG003|Overall Study|Withdrawal by Subject|0|||
44126831|NCT02797171|78912041|FG004|Overall Study|Withdrawal by Subject|0|||
44126832|NCT02797171|78912042|FG005|Overall Study|Withdrawal by Subject|0|||
44379382|NCT00771667|79385044|FG003|Maintenance Phase|Lack of Efficacy|0|||
44126833|NCT02797171|78912037|FG000|Overall Study|Protocol Violation|1|||
44126834|NCT02797171|78912038|FG001|Overall Study|Protocol Violation|0|||
44126835|NCT02797171|78912039|FG002|Overall Study|Protocol Violation|0|||
44126836|NCT02797171|78912040|FG003|Overall Study|Protocol Violation|0|||
44126837|NCT02797171|78912041|FG004|Overall Study|Protocol Violation|0|||
44126838|NCT02797171|78912042|FG005|Overall Study|Protocol Violation|0|||
44126839|NCT02797171|78912037|FG000|Overall Study|Participant unable to adhere|0|||
44379383|NCT00771667|79385045|FG004|Maintenance Phase|Lack of Efficacy|1|||
44126840|NCT02797171|78912038|FG001|Overall Study|Participant unable to adhere|1|||
44511436|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
44511437|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511438|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511439|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511440|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511441|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511442|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511443|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
44511444|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511445|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511446|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511447|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
44511448|NCT01147666|79516685|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511449|NCT01147666|79516686|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511450|NCT01147666|79516687|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511451|NCT01147666|79516688|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511452|NCT01147666|79516689|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511453|NCT01147666|79516690|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511454|NCT01147666|79516691|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511455|NCT01147666|79516692|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511456|NCT01147666|79516693|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511457|NCT01147666|79516694|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44276519|NCT02153112|79231463|FG008|Overall Study|Withdrawal by Subject|13|||
44511458|NCT01147666|79516695|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511459|NCT01147666|79516696|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
44126841|NCT02797171|78912039|FG002|Overall Study|Participant unable to adhere|0|||
44276520|NCT02153112|79231464|FG009|Overall Study|Withdrawal by Subject|12|||
44276521|NCT02153112|79231455|FG000|Overall Study|Reason not Specified|0|||
44276522|NCT02153112|79231456|FG001|Overall Study|Reason not Specified|0|||
44276523|NCT02153112|79231457|FG002|Overall Study|Reason not Specified|0|||
44276524|NCT02153112|79231458|FG003|Overall Study|Reason not Specified|0|||
44276525|NCT02153112|79231459|FG004|Overall Study|Reason not Specified|0|||
44276526|NCT02153112|79231460|FG005|Overall Study|Reason not Specified|0|||
44276527|NCT02153112|79231461|FG006|Overall Study|Reason not Specified|0|||
44276528|NCT02153112|79231462|FG007|Overall Study|Reason not Specified|0|||
44276529|NCT02153112|79231463|FG008|Overall Study|Reason not Specified|1|||
44276530|NCT02153112|79231464|FG009|Overall Study|Reason not Specified|1|||
44276531|NCT02133924|79231514|FG000|Overall Study|Death|38|||
44276532|NCT02133924|79231514|FG000|Overall Study|Physician Decision|1|||
44276533|NCT02133924|79231514|FG000|Overall Study|Withdrawal by Subject|3|||
44276534|NCT02173704|79231605|FG000|Overall Study|Adverse Event|1|||
44276535|NCT02173704|79231606|FG001|Overall Study|Adverse Event|0|||
44276536|NCT02173704|79231605|FG000|Overall Study|Lost to Follow-up|1|||
44276537|NCT02173704|79231606|FG001|Overall Study|Lost to Follow-up|0|||
44511460|NCT01147666|79516697|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
44511461|NCT01147666|79516698|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
44511462|NCT01147666|79516699|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
44511463|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
44511464|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
44511465|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
44511466|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
44511467|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
44511468|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
44511469|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
44511470|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
44511471|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
44126842|NCT02797171|78912040|FG003|Overall Study|Participant unable to adhere|0|||
44243214|NCT01693562|79072535|FG007|Expansion Phase|Other|3|||
44243215|NCT01693562|79072536|FG008|Expansion Phase|Other|1|||
44243216|NCT01693562|79072537|FG009|Expansion Phase|Other|28|||
44243217|NCT01693562|79072538|FG010|Expansion Phase|Other|4|||
44511472|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
44511473|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
44511474|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
44511475|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
44511476|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
44511477|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
44511478|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511479|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511480|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511481|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511482|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
44243218|NCT01693562|79072539|FG011|Expansion Phase|Other|7|||
44511483|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
44511484|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
44511485|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
44511486|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511487|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
44511488|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511489|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511490|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
44511491|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
44511492|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
44126843|NCT02797171|78912041|FG004|Overall Study|Participant unable to adhere|0|||
44126844|NCT02797171|78912042|FG005|Overall Study|Participant unable to adhere|0|||
44126845|NCT02797171|78912037|FG000|Overall Study|Not Randomized|0|||
44126846|NCT02797171|78912038|FG001|Overall Study|Not Randomized|0|||
44126847|NCT02797171|78912039|FG002|Overall Study|Not Randomized|0|||
44126848|NCT02797171|78912040|FG003|Overall Study|Not Randomized|0|||
44126849|NCT02797171|78912041|FG004|Overall Study|Not Randomized|0|||
44126850|NCT02797171|78912042|FG005|Overall Study|Not Randomized|1|||
44126851|NCT02797951|78912056|FG000|Overall Study|Adverse Event|4|||
44126852|NCT02797951|78912056|FG000|Overall Study|Death|1|||
44126853|NCT02797951|78912056|FG000|Overall Study|Lack of Efficacy|19|||
44126854|NCT02797951|78912056|FG000|Overall Study|Lost to Follow-up|4|||
44126855|NCT02797951|78912056|FG000|Overall Study|Physician Decision|6|||
44126856|NCT02797951|78912056|FG000|Overall Study|Withdrawal by Subject|15|||
44126857|NCT00701805|78912064|FG000|Overall Study|Withdrawal by Subject|3|||
44126858|NCT00701805|78912065|FG001|Overall Study|Withdrawal by Subject|1|||
44126859|NCT00701805|78912066|FG002|Overall Study|Withdrawal by Subject|4|||
44126860|NCT00701805|78912067|FG003|Overall Study|Withdrawal by Subject|3|||
44126861|NCT00701805|78912064|FG000|Overall Study|Adverse Event|0|||
44126862|NCT00701805|78912065|FG001|Overall Study|Adverse Event|1|||
44126863|NCT00701805|78912066|FG002|Overall Study|Adverse Event|1|||
44126864|NCT00701805|78912067|FG003|Overall Study|Adverse Event|0|||
44126865|NCT00701805|78912064|FG000|Overall Study|Missed 7 consecutive doses|0|||
44126866|NCT00701805|78912065|FG001|Overall Study|Missed 7 consecutive doses|1|||
44511493|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511494|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511495|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511496|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
44511497|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511498|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511499|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511500|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44126867|NCT00701805|78912066|FG002|Overall Study|Missed 7 consecutive doses|0|||
44126868|NCT00701805|78912067|FG003|Overall Study|Missed 7 consecutive doses|0|||
44126869|NCT00701805|78912064|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
44126870|NCT00701805|78912065|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
44126871|NCT00701805|78912066|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
44511501|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511502|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44126872|NCT00701805|78912067|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
44126873|NCT00701805|78912064|FG000|Overall Study|Physician decision, change of therapy|0|||
44126874|NCT00701805|78912065|FG001|Overall Study|Physician decision, change of therapy|0|||
44126875|NCT00701805|78912066|FG002|Overall Study|Physician decision, change of therapy|0|||
44126876|NCT00701805|78912067|FG003|Overall Study|Physician decision, change of therapy|1|||
44126877|NCT00701805|78912064|FG000|Overall Study|Difficult to travel to dialysis site|0|||
44126878|NCT00701805|78912065|FG001|Overall Study|Difficult to travel to dialysis site|0|||
44126879|NCT00701805|78912066|FG002|Overall Study|Difficult to travel to dialysis site|1|||
44126880|NCT00701805|78912067|FG003|Overall Study|Difficult to travel to dialysis site|0|||
44126881|NCT00701805|78912064|FG000|Overall Study|Resumption criteria were not met|0|||
44126882|NCT00701805|78912065|FG001|Overall Study|Resumption criteria were not met|1|||
44126883|NCT00701805|78912066|FG002|Overall Study|Resumption criteria were not met|0|||
44126884|NCT00701805|78912067|FG003|Overall Study|Resumption criteria were not met|0|||
44126885|NCT02715765|78912080|FG000|Overall Study|Study Termination|3|||
44126886|NCT02715765|78912081|FG001|Overall Study|Study Termination|0|||
44126887|NCT02715765|78912082|FG002|Overall Study|Study Termination|0|||
44511503|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511504|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511505|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511506|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44126888|NCT04542291|78912090|FG000|Overall Study|Adverse Event|1|||
44511507|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
44511508|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511509|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511510|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511511|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511512|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
44126889|NCT04542291|78912090|FG000|Overall Study|Physician Decision|2|||
44126890|NCT02795767|78912097|FG000|Overall Study|Received Commercial Emicizumab|1|||
44126891|NCT02795767|78912098|FG001|Overall Study|Received Commercial Emicizumab|0|||
44126892|NCT02795767|78912099|FG002|Overall Study|Received Commercial Emicizumab|0|||
44126893|NCT02796391|78912126|FG000|Overall Study|Lost to Follow-up|2|||
44126894|NCT02796391|78912127|FG001|Overall Study|Lost to Follow-up|2|||
44511513|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
44126895|NCT02796391|78912128|FG002|Overall Study|Lost to Follow-up|13|||
44126896|NCT02796391|78912129|FG003|Overall Study|Lost to Follow-up|8|||
44126897|NCT02796391|78912130|FG004|Overall Study|Lost to Follow-up|14|||
44126898|NCT02796391|78912131|FG005|Overall Study|Lost to Follow-up|13|||
44126899|NCT02796391|78912126|FG000|Overall Study|COVID|0|||
44126900|NCT02796391|78912127|FG001|Overall Study|COVID|0|||
44126901|NCT02796391|78912128|FG002|Overall Study|COVID|5|||
44126902|NCT02796391|78912129|FG003|Overall Study|COVID|5|||
44126903|NCT02796391|78912130|FG004|Overall Study|COVID|2|||
44126904|NCT02796391|78912131|FG005|Overall Study|COVID|4|||
44126905|NCT02796391|78912126|FG000|Overall Study|Participant did not like study cigarettes|0|||
44126906|NCT02796391|78912127|FG001|Overall Study|Participant did not like study cigarettes|0|||
44126907|NCT02796391|78912128|FG002|Overall Study|Participant did not like study cigarettes|3|||
44126908|NCT02796391|78912129|FG003|Overall Study|Participant did not like study cigarettes|0|||
44126909|NCT02796391|78912130|FG004|Overall Study|Participant did not like study cigarettes|0|||
44126910|NCT02796391|78912131|FG005|Overall Study|Participant did not like study cigarettes|0|||
44379384|NCT00771667|79385046|FG005|Maintenance Phase|Lack of Efficacy|3|||
44379385|NCT00771667|79385047|FG006|Maintenance Phase|Lack of Efficacy|3|||
44126911|NCT02796391|78912126|FG000|Overall Study|Withdrawal by Subject|1|||
44126912|NCT02796391|78912127|FG001|Overall Study|Withdrawal by Subject|1|||
44126913|NCT02796391|78912128|FG002|Overall Study|Withdrawal by Subject|4|||
44126914|NCT02796391|78912129|FG003|Overall Study|Withdrawal by Subject|3|||
44126915|NCT02796391|78912130|FG004|Overall Study|Withdrawal by Subject|4|||
44126916|NCT02796391|78912131|FG005|Overall Study|Withdrawal by Subject|3|||
44126917|NCT02796391|78912126|FG000|Overall Study|Adverse Event|0|||
44126918|NCT02796391|78912127|FG001|Overall Study|Adverse Event|0|||
44126919|NCT02796391|78912128|FG002|Overall Study|Adverse Event|0|||
44126920|NCT02796391|78912129|FG003|Overall Study|Adverse Event|1|||
44126921|NCT02796391|78912130|FG004|Overall Study|Adverse Event|0|||
44126922|NCT02796391|78912131|FG005|Overall Study|Adverse Event|0|||
44126923|NCT02796391|78912126|FG000|Overall Study|Protocol Violation|0|||
44126924|NCT02796391|78912127|FG001|Overall Study|Protocol Violation|0|||
44126925|NCT02796391|78912128|FG002|Overall Study|Protocol Violation|0|||
44126926|NCT02796391|78912129|FG003|Overall Study|Protocol Violation|1|||
44126927|NCT02796391|78912130|FG004|Overall Study|Protocol Violation|0|||
44126928|NCT02796391|78912131|FG005|Overall Study|Protocol Violation|0|||
44126929|NCT01370317|78912147|FG000|Overall Study|Participant withdrew consent|1|||
44126930|NCT01370317|78912148|FG001|Overall Study|Participant withdrew consent|0|||
44243219|NCT01693562|79072540|FG012|Expansion Phase|Other|0|||
44243220|NCT01693562|79072541|FG013|Expansion Phase|Other|1|||
44243221|NCT01693562|79072542|FG014|Expansion Phase|Other|1|||
44126931|NCT01370317|78912147|FG000|Overall Study|Protocol deviation|0|||
44126932|NCT01370317|78912148|FG001|Overall Study|Protocol deviation|1|||
44126933|NCT01370083|78912156|FG000|Overall Study|Lost to Follow-up|2|||
44126934|NCT01370083|78912157|FG001|Overall Study|Lost to Follow-up|0|||
44126935|NCT01370083|78912156|FG000|Overall Study|Adverse Event|0|||
44126936|NCT01370083|78912157|FG001|Overall Study|Adverse Event|1|||
44126937|NCT03350815|78912163|FG000|Period 1|Adverse Event|10|||
44126938|NCT03350815|78912164|FG001|Period 1|Adverse Event|0|||
44126939|NCT03350815|78912165|FG002|Period 1|Adverse Event|0|||
44126940|NCT03350815|78912166|FG003|Period 1|Adverse Event|0|||
44126941|NCT03350815|78912163|FG000|Period 1|Technical problems|1|||
44126942|NCT03350815|78912164|FG001|Period 1|Technical problems|0|||
44126943|NCT03350815|78912165|FG002|Period 1|Technical problems|0|||
44126944|NCT03350815|78912166|FG003|Period 1|Technical problems|0|||
44126945|NCT03350815|78912163|FG000|Period 1|Lost to Follow-up|3|||
44126946|NCT03350815|78912164|FG001|Period 1|Lost to Follow-up|0|||
44126947|NCT03350815|78912165|FG002|Period 1|Lost to Follow-up|0|||
44243222|NCT01693562|79072543|FG015|Expansion Phase|Other|0|||
44243223|NCT01693562|79072544|FG016|Expansion Phase|Other|28|||
44243224|NCT01693562|79072545|FG017|Expansion Phase|Other|0|||
44243225|NCT01693562|79072546|FG018|Expansion Phase|Other|1|||
44243226|NCT01693562|79072547|FG019|Expansion Phase|Other|0|||
44243227|NCT01693562|79072548|FG020|Expansion Phase|Other|1|||
44243228|NCT01693562|79072549|FG021|Expansion Phase|Other|17|||
44243229|NCT01693562|79072550|FG022|Expansion Phase|Other|1|||
44243230|NCT01467713|79072647|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
44243231|NCT01467713|79072648|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
44243232|NCT01467713|79072649|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
44243233|NCT01467713|79072650|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
44243234|NCT01467713|79072647|FG000|Overall Study|Major Protocol Deviation|2|||
44243235|NCT01467713|79072648|FG001|Overall Study|Major Protocol Deviation|4|||
44243236|NCT01467713|79072649|FG002|Overall Study|Major Protocol Deviation|4|||
44243237|NCT01467713|79072650|FG003|Overall Study|Major Protocol Deviation|1|||
44379386|NCT00771667|79385048|FG007|Maintenance Phase|Lack of Efficacy|2|||
44511514|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511515|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
44511516|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511517|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
44511518|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44126948|NCT03350815|78912166|FG003|Period 1|Lost to Follow-up|0|||
44126949|NCT03350815|78912163|FG000|Period 1|Physician Decision|1|||
44126950|NCT03350815|78912164|FG001|Period 1|Physician Decision|0|||
44126951|NCT03350815|78912165|FG002|Period 1|Physician Decision|0|||
44126952|NCT03350815|78912166|FG003|Period 1|Physician Decision|0|||
44126953|NCT03350815|78912163|FG000|Period 1|Withdrawal by Subject|8|||
44126954|NCT03350815|78912164|FG001|Period 1|Withdrawal by Subject|0|||
44126955|NCT03350815|78912165|FG002|Period 1|Withdrawal by Subject|0|||
44243238|NCT01467713|79072647|FG000|Overall Study|Lost to Follow-up|9|||
44243239|NCT01467713|79072648|FG001|Overall Study|Lost to Follow-up|12|||
44243240|NCT01467713|79072649|FG002|Overall Study|Lost to Follow-up|6|||
44243241|NCT01467713|79072650|FG003|Overall Study|Lost to Follow-up|9|||
44243242|NCT01467713|79072647|FG000|Overall Study|Voluntary Withdrawal|18|||
44243243|NCT01467713|79072648|FG001|Overall Study|Voluntary Withdrawal|14|||
44379387|NCT00771667|79385049|FG008|Maintenance Phase|Lack of Efficacy|11|||
44511519|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44126956|NCT03350815|78912166|FG003|Period 1|Withdrawal by Subject|0|||
44126957|NCT03350815|78912163|FG000|Period 1|Lack of Efficacy|15|||
44243244|NCT01467713|79072649|FG002|Overall Study|Voluntary Withdrawal|21|||
44379388|NCT00771667|79385050|FG009|Maintenance Phase|Lack of Efficacy|7|||
44126958|NCT03350815|78912164|FG001|Period 1|Lack of Efficacy|0|||
44126959|NCT03350815|78912165|FG002|Period 1|Lack of Efficacy|0|||
44126960|NCT03350815|78912166|FG003|Period 1|Lack of Efficacy|0|||
44243245|NCT01467713|79072650|FG003|Overall Study|Voluntary Withdrawal|20|||
44243246|NCT01467713|79072647|FG000|Overall Study|Study Termination|23|||
44126961|NCT03350815|78912163|FG000|Period 1|Non-compliance with study treatment|2|||
44126962|NCT03350815|78912164|FG001|Period 1|Non-compliance with study treatment|0|||
44126963|NCT03350815|78912165|FG002|Period 1|Non-compliance with study treatment|0|||
44126964|NCT03350815|78912166|FG003|Period 1|Non-compliance with study treatment|0|||
44126965|NCT03350815|78912163|FG000|Period 1|Protocol Violation|3|||
44126966|NCT03350815|78912164|FG001|Period 1|Protocol Violation|0|||
44126967|NCT03350815|78912165|FG002|Period 1|Protocol Violation|0|||
44126968|NCT03350815|78912166|FG003|Period 1|Protocol Violation|0|||
44126969|NCT03350815|78912163|FG000|Period 2|Adverse Event|0|||
44126970|NCT03350815|78912164|FG001|Period 2|Adverse Event|3|||
44126971|NCT03350815|78912165|FG002|Period 2|Adverse Event|5|||
44126972|NCT03350815|78912166|FG003|Period 2|Adverse Event|0|||
44126973|NCT03350815|78912163|FG000|Period 2|Technical problem|0|||
44126974|NCT03350815|78912164|FG001|Period 2|Technical problem|1|||
44126975|NCT03350815|78912165|FG002|Period 2|Technical problem|0|||
44126976|NCT03350815|78912166|FG003|Period 2|Technical problem|0|||
44126977|NCT03350815|78912163|FG000|Period 2|Lost to Follow-up|0|||
44126978|NCT03350815|78912164|FG001|Period 2|Lost to Follow-up|3|||
44126979|NCT03350815|78912165|FG002|Period 2|Lost to Follow-up|3|||
44126980|NCT03350815|78912166|FG003|Period 2|Lost to Follow-up|0|||
44126981|NCT03350815|78912163|FG000|Period 2|Physician Decision|0|||
44126982|NCT03350815|78912164|FG001|Period 2|Physician Decision|0|||
44126983|NCT03350815|78912165|FG002|Period 2|Physician Decision|1|||
44126984|NCT03350815|78912166|FG003|Period 2|Physician Decision|0|||
44126985|NCT03350815|78912163|FG000|Period 2|Withdrawal by Subject|0|||
44126986|NCT03350815|78912164|FG001|Period 2|Withdrawal by Subject|3|||
44126987|NCT03350815|78912165|FG002|Period 2|Withdrawal by Subject|4|||
44126988|NCT03350815|78912166|FG003|Period 2|Withdrawal by Subject|0|||
44126989|NCT03350815|78912163|FG000|Period 2|Lack of Efficacy|0|||
44126990|NCT03350815|78912164|FG001|Period 2|Lack of Efficacy|6|||
44126991|NCT03350815|78912165|FG002|Period 2|Lack of Efficacy|2|||
44126992|NCT03350815|78912166|FG003|Period 2|Lack of Efficacy|0|||
44126993|NCT03350815|78912163|FG000|Period 2|Protocol Violation|0|||
44126994|NCT03350815|78912164|FG001|Period 2|Protocol Violation|0|||
44126995|NCT03350815|78912165|FG002|Period 2|Protocol Violation|1|||
44126996|NCT03350815|78912166|FG003|Period 2|Protocol Violation|0|||
44126997|NCT03350815|78912163|FG000|Period 2|New therapy for study indication|0|||
44126998|NCT03350815|78912164|FG001|Period 2|New therapy for study indication|0|||
44126999|NCT03350815|78912165|FG002|Period 2|New therapy for study indication|1|||
44127000|NCT03350815|78912166|FG003|Period 2|New therapy for study indication|0|||
44511520|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511521|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
44511522|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
44511523|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511524|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511525|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511526|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
44511527|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44127001|NCT00854295|78912181|FG000|Overall Study|Death|7|||
44127002|NCT00854295|78912182|FG001|Overall Study|Death|0|||
44127003|NCT00854295|78912183|FG002|Overall Study|Death|1|||
44127004|NCT00854295|78912184|FG003|Overall Study|Death|1|||
44127005|NCT00854295|78912181|FG000|Overall Study|Adverse Event|6|||
44127006|NCT00854295|78912182|FG001|Overall Study|Adverse Event|1|||
44511528|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44127007|NCT00854295|78912183|FG002|Overall Study|Adverse Event|1|||
44127008|NCT00854295|78912184|FG003|Overall Study|Adverse Event|3|||
44127009|NCT00854295|78912181|FG000|Overall Study|Lost to Follow-up|18|||
44127010|NCT00854295|78912182|FG001|Overall Study|Lost to Follow-up|5|||
44127011|NCT00854295|78912183|FG002|Overall Study|Lost to Follow-up|21|||
44127012|NCT00854295|78912184|FG003|Overall Study|Lost to Follow-up|21|||
44127013|NCT00854295|78912181|FG000|Overall Study|Physician Decision|10|||
44379389|NCT00771667|79385041|FG000|Maintenance Phase|Other|0|||
44127014|NCT00854295|78912182|FG001|Overall Study|Physician Decision|0|||
44127015|NCT00854295|78912183|FG002|Overall Study|Physician Decision|0|||
44127016|NCT00854295|78912184|FG003|Overall Study|Physician Decision|0|||
44127017|NCT02792959|78912195|FG000|Overall Study|Protocol Violation|1|||
44127018|NCT01652872|78912201|FG000|Overall Study|Death|36|||
44127019|NCT01652872|78912202|FG001|Overall Study|Death|39|||
44127020|NCT01652872|78912201|FG000|Overall Study|Lost to Follow-up|28|||
44127021|NCT01652872|78912202|FG001|Overall Study|Lost to Follow-up|23|||
44127022|NCT01652872|78912201|FG000|Overall Study|Decision by sponsor|5|||
44127023|NCT01652872|78912202|FG001|Overall Study|Decision by sponsor|7|||
44127024|NCT01652872|78912201|FG000|Overall Study|Withdrawal by Subject|76|||
44127025|NCT01652872|78912202|FG001|Overall Study|Withdrawal by Subject|84|||
44127026|NCT04251273|78912210|FG000|Overall Study|Lost to Follow-up|331|||
44127027|NCT04251273|78912211|FG001|Overall Study|Lost to Follow-up|290|||
44127028|NCT02443402|78912219|FG000|Overall Study|Withdrawal by Subject|3|||
44127029|NCT02443402|78912220|FG001|Overall Study|Withdrawal by Subject|1|||
44127030|NCT02443402|78912219|FG000|Overall Study|Screen Failure|1|||
44127031|NCT02443402|78912220|FG001|Overall Study|Screen Failure|2|||
44127032|NCT01370005|78912229|FG000|Overall Study|Not treated|1|||
44127033|NCT01370005|78912230|FG001|Overall Study|Not treated|0|||
44127034|NCT01370005|78912231|FG002|Overall Study|Not treated|0|||
44127035|NCT01370005|78912229|FG000|Overall Study|Adverse Event|5|||
44127036|NCT01370005|78912230|FG001|Overall Study|Adverse Event|5|||
44127037|NCT01370005|78912231|FG002|Overall Study|Adverse Event|6|||
44127038|NCT01370005|78912229|FG000|Overall Study|Lack of Efficacy|1|||
44127039|NCT01370005|78912230|FG001|Overall Study|Lack of Efficacy|0|||
44127040|NCT01370005|78912231|FG002|Overall Study|Lack of Efficacy|0|||
44127041|NCT01370005|78912229|FG000|Overall Study|Non compliant with protocol|0|||
44127042|NCT01370005|78912230|FG001|Overall Study|Non compliant with protocol|1|||
44127043|NCT01370005|78912231|FG002|Overall Study|Non compliant with protocol|2|||
44127044|NCT01370005|78912229|FG000|Overall Study|Lost to Follow-up|1|||
44127045|NCT01370005|78912230|FG001|Overall Study|Lost to Follow-up|1|||
44127046|NCT01370005|78912231|FG002|Overall Study|Lost to Follow-up|1|||
44127047|NCT01370005|78912229|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
44127048|NCT01370005|78912230|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
44127049|NCT01370005|78912231|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
44127050|NCT01370005|78912229|FG000|Overall Study|Other reason not defined above|3|||
44127051|NCT01370005|78912230|FG001|Overall Study|Other reason not defined above|0|||
44127052|NCT01370005|78912231|FG002|Overall Study|Other reason not defined above|2|||
44127053|NCT02442778|78912242|FG000|Overall Study|Adverse Event|2|||
44127054|NCT02442778|78912243|FG001|Overall Study|Adverse Event|6|||
44127055|NCT02442778|78912244|FG002|Overall Study|Adverse Event|6|||
44127056|NCT02442778|78912242|FG000|Overall Study|Death|0|||
44127057|NCT02442778|78912243|FG001|Overall Study|Death|2|||
44127058|NCT02442778|78912244|FG002|Overall Study|Death|0|||
44127059|NCT02442778|78912242|FG000|Overall Study|Lack of Efficacy|1|||
44127060|NCT02442778|78912243|FG001|Overall Study|Lack of Efficacy|0|||
44127061|NCT02442778|78912244|FG002|Overall Study|Lack of Efficacy|0|||
44127062|NCT02442778|78912242|FG000|Overall Study|Lost to Follow-up|1|||
44127063|NCT02442778|78912243|FG001|Overall Study|Lost to Follow-up|1|||
44127064|NCT02442778|78912244|FG002|Overall Study|Lost to Follow-up|1|||
44127065|NCT02442778|78912242|FG000|Overall Study|Non-compliance with study drug|2|||
44127066|NCT02442778|78912243|FG001|Overall Study|Non-compliance with study drug|0|||
44127067|NCT02442778|78912244|FG002|Overall Study|Non-compliance with study drug|1|||
44127068|NCT02442778|78912242|FG000|Overall Study|Physician Decision|1|||
44127069|NCT02442778|78912243|FG001|Overall Study|Physician Decision|1|||
44127070|NCT02442778|78912244|FG002|Overall Study|Physician Decision|1|||
44127071|NCT02442778|78912242|FG000|Overall Study|Protocol Deviation|3|||
44127072|NCT02442778|78912243|FG001|Overall Study|Protocol Deviation|0|||
44127073|NCT02442778|78912244|FG002|Overall Study|Protocol Deviation|1|||
44127074|NCT02442778|78912242|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
44127075|NCT02442778|78912243|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
44127076|NCT02442778|78912244|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
44127077|NCT02442778|78912242|FG000|Overall Study|Withdrawal by Subject|4|||
44127078|NCT02442778|78912243|FG001|Overall Study|Withdrawal by Subject|4|||
44127079|NCT02442778|78912244|FG002|Overall Study|Withdrawal by Subject|3|||
44127080|NCT02442778|78912242|FG000|Overall Study|Reason not specified|1|||
44127081|NCT02442778|78912243|FG001|Overall Study|Reason not specified|4|||
44379390|NCT00771667|79385042|FG001|Maintenance Phase|Other|0|||
44127082|NCT02442778|78912244|FG002|Overall Study|Reason not specified|0|||
44127083|NCT02412436|78912252|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
44127084|NCT02412436|78912252|FG000|Overall Study|Lost to Follow-up|6|||
44127085|NCT02412436|78912252|FG000|Overall Study|Unable to get to clinic|3|||
44127086|NCT02412436|78912252|FG000|Overall Study|Death|1|||
44127087|NCT02412436|78912252|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
44127088|NCT01651000|78912258|FG000|Overall Study|Adverse Event|2|||
44379391|NCT00771667|79385043|FG002|Maintenance Phase|Other|0|||
44127089|NCT01651000|78912259|FG001|Overall Study|Adverse Event|8|||
44127090|NCT01651000|78912258|FG000|Overall Study|Lost to Follow-up|3|||
44127091|NCT01651000|78912259|FG001|Overall Study|Lost to Follow-up|2|||
44127092|NCT01651000|78912258|FG000|Overall Study|Protocol Violation|0|||
44127093|NCT01651000|78912259|FG001|Overall Study|Protocol Violation|3|||
44127094|NCT01651000|78912258|FG000|Overall Study|Withdrawal by Subject|2|||
44127095|NCT01651000|78912259|FG001|Overall Study|Withdrawal by Subject|10|||
44127096|NCT01651000|78912258|FG000|Overall Study|Subject noncompliance|0|||
44127097|NCT01651000|78912259|FG001|Overall Study|Subject noncompliance|3|||
44127098|NCT01651000|78912258|FG000|Overall Study|Lack of Efficacy|1|||
44127099|NCT01651000|78912259|FG001|Overall Study|Lack of Efficacy|1|||
44127100|NCT01651000|78912258|FG000|Overall Study|Physician Decision|1|||
44127101|NCT01651000|78912259|FG001|Overall Study|Physician Decision|0|||
44127102|NCT01651000|78912258|FG000|Overall Study|Administrative reason|1|||
44127103|NCT01651000|78912259|FG001|Overall Study|Administrative reason|0|||
44127104|NCT01651000|78912258|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
44127105|NCT01651000|78912259|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
44127106|NCT02469610|78912267|FG000|Overall Study|Death|1|||
44127107|NCT02469610|78912268|FG001|Overall Study|Death|0|||
44127108|NCT02469610|78912267|FG000|Overall Study|Lost to Follow-up|1|||
44127109|NCT02469610|78912268|FG001|Overall Study|Lost to Follow-up|0|||
44127110|NCT02469610|78912267|FG000|Overall Study|exclusion criteria|2|||
44127111|NCT02469610|78912268|FG001|Overall Study|exclusion criteria|1|||
44127112|NCT02469298|78912278|FG000|Overall Study|Protocol Violation|0|||
44127113|NCT02469298|78912279|FG001|Overall Study|Protocol Violation|1|||
44127114|NCT02469298|78912280|FG002|Overall Study|Protocol Violation|1|||
44127115|NCT02469298|78912281|FG003|Overall Study|Protocol Violation|0|||
44127116|NCT02469298|78912278|FG000|Overall Study|Lost to Follow-up|1|||
44127117|NCT02469298|78912279|FG001|Overall Study|Lost to Follow-up|0|||
44127118|NCT02469298|78912280|FG002|Overall Study|Lost to Follow-up|1|||
44127119|NCT02469298|78912281|FG003|Overall Study|Lost to Follow-up|0|||
44127120|NCT02469298|78912278|FG000|Overall Study|Physician Decision|0|||
44127121|NCT02469298|78912279|FG001|Overall Study|Physician Decision|0|||
44127122|NCT02469298|78912280|FG002|Overall Study|Physician Decision|0|||
44127123|NCT02469298|78912281|FG003|Overall Study|Physician Decision|1|||
44127124|NCT02469298|78912278|FG000|Overall Study|Withdrawal by Subject|0|||
44127125|NCT02469298|78912279|FG001|Overall Study|Withdrawal by Subject|0|||
44127126|NCT02469298|78912280|FG002|Overall Study|Withdrawal by Subject|0|||
44127127|NCT02469298|78912281|FG003|Overall Study|Withdrawal by Subject|1|||
44127128|NCT04163991|78912303|FG000|Overall Study|Adverse Event|0|||
44127129|NCT04163991|78912304|FG001|Overall Study|Adverse Event|0|||
44127130|NCT04163991|78912305|FG002|Overall Study|Adverse Event|0|||
44127131|NCT04163991|78912306|FG003|Overall Study|Adverse Event|1|||
44127132|NCT04163991|78912307|FG004|Overall Study|Adverse Event|0|||
44127133|NCT04163991|78912303|FG000|Overall Study|Death|0|||
44127134|NCT04163991|78912304|FG001|Overall Study|Death|0|||
44127135|NCT04163991|78912305|FG002|Overall Study|Death|1|||
44127136|NCT04163991|78912306|FG003|Overall Study|Death|0|||
44127137|NCT04163991|78912307|FG004|Overall Study|Death|0|||
44243247|NCT01467713|79072648|FG001|Overall Study|Study Termination|33|||
44127138|NCT04163991|78912303|FG000|Overall Study|Lost to Follow-up|0|||
44127139|NCT04163991|78912304|FG001|Overall Study|Lost to Follow-up|1|||
44127140|NCT04163991|78912305|FG002|Overall Study|Lost to Follow-up|0|||
44127141|NCT04163991|78912306|FG003|Overall Study|Lost to Follow-up|0|||
44127142|NCT04163991|78912307|FG004|Overall Study|Lost to Follow-up|0|||
44127143|NCT04163991|78912303|FG000|Overall Study|Withdrawal by Subject|1|||
44127144|NCT04163991|78912304|FG001|Overall Study|Withdrawal by Subject|1|||
44243248|NCT01467713|79072649|FG002|Overall Study|Study Termination|28|||
44127145|NCT04163991|78912305|FG002|Overall Study|Withdrawal by Subject|3|||
44127146|NCT04163991|78912306|FG003|Overall Study|Withdrawal by Subject|1|||
44127147|NCT04163991|78912307|FG004|Overall Study|Withdrawal by Subject|1|||
44127148|NCT04163991|78912303|FG000|Overall Study|Other, Not Specified|0|||
44127149|NCT04163991|78912304|FG001|Overall Study|Other, Not Specified|1|||
44243249|NCT01467713|79072650|FG003|Overall Study|Study Termination|29|||
44127150|NCT04163991|78912305|FG002|Overall Study|Other, Not Specified|1|||
44127151|NCT04163991|78912306|FG003|Overall Study|Other, Not Specified|1|||
44127152|NCT04163991|78912307|FG004|Overall Study|Other, Not Specified|0|||
44243250|NCT01467713|79072647|FG000|Overall Study|Pregnancy|0|||
44127153|NCT02442622|78912325|FG000|Overall Study|Withdrawal by Subject|3|||
44127154|NCT02442622|78912326|FG001|Overall Study|Withdrawal by Subject|1|||
44127155|NCT02411578|78912334|FG000|Crossover Trial Phase|Pregnancy|0|||
44127156|NCT02411578|78912335|FG001|Crossover Trial Phase|Pregnancy|1|||
44127157|NCT02442310|78912343|FG000|Overall Study|Adverse Event|2|||
44127158|NCT02442310|78912343|FG000|Overall Study|Withdrawal by Subject|1|||
44127159|NCT02411110|78912355|FG000|Treatment Period 1|Adverse Event|4|||
44127160|NCT02411110|78912356|FG001|Treatment Period 1|Adverse Event|2|||
44127161|NCT02411110|78912355|FG000|Treatment Period 1|Lost to Follow-up|1|||
44127162|NCT02411110|78912356|FG001|Treatment Period 1|Lost to Follow-up|0|||
44127163|NCT02411110|78912355|FG000|Treatment Period 1|Personal Reasons|2|||
44127164|NCT02411110|78912356|FG001|Treatment Period 1|Personal Reasons|5|||
44127165|NCT02411110|78912355|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
44127166|NCT02411110|78912356|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
44127167|NCT02411110|78912355|FG000|Treatment Period 2|Adverse Event|1|||
44127168|NCT02411110|78912356|FG001|Treatment Period 2|Adverse Event|0|||
44127169|NCT02411110|78912355|FG000|Treatment Period 2|Lost to Follow-up|0|||
44511529|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511530|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511531|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511532|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511533|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
44511534|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511535|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511536|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511537|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
44511538|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511539|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511540|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511541|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511542|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511543|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44127170|NCT02411110|78912356|FG001|Treatment Period 2|Lost to Follow-up|2|||
44127171|NCT02411110|78912355|FG000|Treatment Period 2|Personal Reasons|0|||
44127172|NCT02411110|78912356|FG001|Treatment Period 2|Personal Reasons|2|||
44127173|NCT01369849|78912367|FG000|Overall Study|Ineligible prior to treatment|0|||
44511544|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44127174|NCT01369849|78912368|FG001|Overall Study|Ineligible prior to treatment|0|||
44127175|NCT01369849|78912369|FG002|Overall Study|Ineligible prior to treatment|1|||
44127176|NCT01369849|78912367|FG000|Overall Study|Ineligible after receiving treatment|0|||
44127177|NCT01369849|78912368|FG001|Overall Study|Ineligible after receiving treatment|1|||
44127178|NCT01369849|78912369|FG002|Overall Study|Ineligible after receiving treatment|0|||
44127179|NCT02716779|78912382|FG000|Monotherapy|Adverse Event|0|||
44127180|NCT02716779|78912383|FG001|Monotherapy|Adverse Event|1|||
44127181|NCT02716779|78912384|FG002|Monotherapy|Adverse Event|1|||
44127182|NCT02716779|78912382|FG000|Combination Therapy|Adverse Event|0|||
44127183|NCT02716779|78912383|FG001|Combination Therapy|Adverse Event|2|||
44127184|NCT02716779|78912384|FG002|Combination Therapy|Adverse Event|1|||
44127185|NCT01369615|78912400|FG000|Overall Study|Withdrawal by Subject|0|||
44127186|NCT01369615|78912401|FG001|Overall Study|Withdrawal by Subject|1|||
44127187|NCT01369615|78912400|FG000|Overall Study|Lost to Follow-up|0|||
44127188|NCT01369615|78912401|FG001|Overall Study|Lost to Follow-up|1|||
44127189|NCT02468674|78912425|FG000|Overall Study|Adverse Event|0|||
44127190|NCT02468674|78912426|FG001|Overall Study|Adverse Event|0|||
44127191|NCT02468674|78912427|FG002|Overall Study|Adverse Event|0|||
44127192|NCT02468674|78912428|FG003|Overall Study|Adverse Event|1|||
44127193|NCT02468674|78912429|FG004|Overall Study|Adverse Event|0|||
44127194|NCT02468674|78912430|FG005|Overall Study|Adverse Event|1|||
44127195|NCT02468674|78912431|FG006|Overall Study|Adverse Event|0|||
44127196|NCT02468674|78912432|FG007|Overall Study|Adverse Event|0|||
44127197|NCT02468674|78912433|FG008|Overall Study|Adverse Event|0|||
44127198|NCT02468674|78912425|FG000|Overall Study|Lost to Follow-up|1|||
44127199|NCT02468674|78912426|FG001|Overall Study|Lost to Follow-up|0|||
44127200|NCT02468674|78912427|FG002|Overall Study|Lost to Follow-up|0|||
44127201|NCT02468674|78912428|FG003|Overall Study|Lost to Follow-up|0|||
44127202|NCT02468674|78912429|FG004|Overall Study|Lost to Follow-up|0|||
44127203|NCT02468674|78912430|FG005|Overall Study|Lost to Follow-up|0|||
44127204|NCT02468674|78912431|FG006|Overall Study|Lost to Follow-up|0|||
44127205|NCT02468674|78912432|FG007|Overall Study|Lost to Follow-up|1|||
44127206|NCT02468674|78912433|FG008|Overall Study|Lost to Follow-up|1|||
44127207|NCT02468674|78912425|FG000|Overall Study|Physician Decision|0|||
44127208|NCT02468674|78912426|FG001|Overall Study|Physician Decision|0|||
44127209|NCT02468674|78912427|FG002|Overall Study|Physician Decision|0|||
44127210|NCT02468674|78912428|FG003|Overall Study|Physician Decision|0|||
44127211|NCT02468674|78912429|FG004|Overall Study|Physician Decision|0|||
44127212|NCT02468674|78912430|FG005|Overall Study|Physician Decision|0|||
44127213|NCT02468674|78912431|FG006|Overall Study|Physician Decision|1|||
44127214|NCT02468674|78912432|FG007|Overall Study|Physician Decision|0|||
44127215|NCT02468674|78912433|FG008|Overall Study|Physician Decision|0|||
44127216|NCT02468674|78912425|FG000|Overall Study|Patient/Guardian Decision|0|||
44127217|NCT02468674|78912426|FG001|Overall Study|Patient/Guardian Decision|0|||
44127218|NCT02468674|78912427|FG002|Overall Study|Patient/Guardian Decision|0|||
44127219|NCT02468674|78912428|FG003|Overall Study|Patient/Guardian Decision|0|||
44127220|NCT02468674|78912429|FG004|Overall Study|Patient/Guardian Decision|1|||
44127221|NCT02468674|78912430|FG005|Overall Study|Patient/Guardian Decision|0|||
44127222|NCT02468674|78912431|FG006|Overall Study|Patient/Guardian Decision|0|||
44127223|NCT02468674|78912432|FG007|Overall Study|Patient/Guardian Decision|2|||
44127224|NCT02468674|78912433|FG008|Overall Study|Patient/Guardian Decision|1|||
44127225|NCT02468674|78912425|FG000|Overall Study|Protocol Deviation|0|||
44127226|NCT02468674|78912426|FG001|Overall Study|Protocol Deviation|0|||
44127227|NCT02468674|78912427|FG002|Overall Study|Protocol Deviation|0|||
44127228|NCT02468674|78912428|FG003|Overall Study|Protocol Deviation|0|||
44127229|NCT02468674|78912429|FG004|Overall Study|Protocol Deviation|0|||
44127230|NCT02468674|78912430|FG005|Overall Study|Protocol Deviation|0|||
44127231|NCT02468674|78912431|FG006|Overall Study|Protocol Deviation|0|||
44127232|NCT02468674|78912432|FG007|Overall Study|Protocol Deviation|1|||
44127233|NCT02468674|78912433|FG008|Overall Study|Protocol Deviation|1|||
44127234|NCT02467192|78912453|FG000|Overall Study|Death|1|||
44511545|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511546|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511547|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511548|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511549|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511550|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
44511551|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44511552|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
44127235|NCT02467192|78912453|FG000|Overall Study|revealed to have pneumonia before|2|||
44127236|NCT02410954|78912463|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
44127237|NCT02410954|78912464|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
44127238|NCT02410954|78912463|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
44511553|NCT01147666|79516685|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44127239|NCT02410954|78912464|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
44127240|NCT05153499|78912485|FG000|Overall Study|Withdrawal by Subject|1|||
44127241|NCT05153499|78912486|FG001|Overall Study|Withdrawal by Subject|0|||
44127242|NCT05153499|78912485|FG000|Overall Study|Clinical Hold|1|||
44127243|NCT05153499|78912486|FG001|Overall Study|Clinical Hold|0|||
44127244|NCT05153499|78912485|FG000|Overall Study|Study Termination|6|||
44127245|NCT05153499|78912486|FG001|Overall Study|Study Termination|5|||
44127246|NCT05047770|78912496|FG000|Overall Study|Withdrawal by Subject|15|||
44127247|NCT05047770|78912497|FG001|Overall Study|Withdrawal by Subject|10|||
44127248|NCT05047770|78912498|FG002|Overall Study|Withdrawal by Subject|6|||
44127249|NCT05047770|78912499|FG003|Overall Study|Withdrawal by Subject|12|||
44127250|NCT05047770|78912496|FG000|Overall Study|Lost to Follow-up|7|||
44127251|NCT05047770|78912497|FG001|Overall Study|Lost to Follow-up|5|||
44127252|NCT05047770|78912498|FG002|Overall Study|Lost to Follow-up|12|||
44127253|NCT05047770|78912499|FG003|Overall Study|Lost to Follow-up|13|||
44127254|NCT05047770|78912496|FG000|Overall Study|Other|1|||
44127255|NCT05047770|78912497|FG001|Overall Study|Other|0|||
44127256|NCT05047770|78912498|FG002|Overall Study|Other|1|||
44127257|NCT05047770|78912499|FG003|Overall Study|Other|0|||
44127258|NCT04624672|78912545|FG000|Overall Study|Early Study Closure|2|||
44127259|NCT04624672|78912546|FG001|Overall Study|Early Study Closure|1|||
44127260|NCT04476108|78912583|FG000|Overall Study|Adverse Event|4|||
44127261|NCT04476108|78912584|FG001|Overall Study|Adverse Event|1|||
44127262|NCT04476108|78912583|FG000|Overall Study|Lost to Follow-up|1|||
44127263|NCT04476108|78912584|FG001|Overall Study|Lost to Follow-up|0|||
44127264|NCT04476108|78912583|FG000|Overall Study|Inadvertent Enrollment|1|||
44127265|NCT04476108|78912584|FG001|Overall Study|Inadvertent Enrollment|0|||
44127266|NCT04476108|78912583|FG000|Overall Study|Protocol Violation|1|||
44127267|NCT04476108|78912584|FG001|Overall Study|Protocol Violation|1|||
44127268|NCT04476108|78912583|FG000|Overall Study|Withdrawal by Subject|1|||
44127269|NCT04476108|78912584|FG001|Overall Study|Withdrawal by Subject|1|||
44127270|NCT04456686|78912592|FG000|Overall Study|Adverse Event|2|||
44127271|NCT04456686|78912593|FG001|Overall Study|Adverse Event|1|||
44127272|NCT04456686|78912592|FG000|Overall Study|Lack of Efficacy|3|||
44127273|NCT04456686|78912593|FG001|Overall Study|Lack of Efficacy|1|||
44127274|NCT04456686|78912592|FG000|Overall Study|Withdrew consent|3|||
44127275|NCT04456686|78912593|FG001|Overall Study|Withdrew consent|1|||
44127276|NCT04456686|78912592|FG000|Overall Study|Physician Decision|2|||
44127277|NCT04456686|78912593|FG001|Overall Study|Physician Decision|2|||
44127278|NCT04456686|78912592|FG000|Overall Study|Withdrawal by Subject|5|||
44127279|NCT04456686|78912593|FG001|Overall Study|Withdrawal by Subject|1|||
44127280|NCT04456686|78912592|FG000|Overall Study|Protocol Violation|0|||
44127281|NCT04456686|78912593|FG001|Overall Study|Protocol Violation|1|||
44127282|NCT04269889|78912632|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
44127283|NCT04269889|78912632|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
44379392|NCT00771667|79385044|FG003|Maintenance Phase|Other|0|||
44127284|NCT04099251|78912654|FG000|Pre-Treatment|Other reasons|1|||
44127285|NCT04099251|78912655|FG001|Pre-Treatment|Other reasons|0|||
44379393|NCT00771667|79385045|FG004|Maintenance Phase|Other|0|||
44127286|NCT04099251|78912654|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
44127287|NCT04099251|78912655|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
44127288|NCT04099251|78912654|FG000|Blinded Treatment Phase|Other reasons|16|||
44127289|NCT04099251|78912655|FG001|Blinded Treatment Phase|Other reasons|7|||
44127290|NCT04099251|78912654|FG000|Blinded Treatment Phase|Disease recurrence|26|||
44127291|NCT04099251|78912655|FG001|Blinded Treatment Phase|Disease recurrence|41|||
44127292|NCT04099251|78912654|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
44379394|NCT00771667|79385046|FG005|Maintenance Phase|Other|1|||
44127293|NCT04099251|78912655|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
44127294|NCT04099251|78912654|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
44127295|NCT04099251|78912655|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
44127296|NCT04099251|78912654|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
44127297|NCT04099251|78912655|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
44127298|NCT04099251|78912654|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
44127299|NCT04099251|78912655|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
44127300|NCT04099251|78912654|FG000|Blinded Treatment Phase|Death|6|||
44127301|NCT04099251|78912655|FG001|Blinded Treatment Phase|Death|2|||
44127302|NCT04099251|78912654|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
44127303|NCT04099251|78912655|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
44127304|NCT04099251|78912654|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
44243251|NCT01467713|79072648|FG001|Overall Study|Pregnancy|1|||
44243252|NCT01467713|79072649|FG002|Overall Study|Pregnancy|1|||
44243253|NCT01467713|79072650|FG003|Overall Study|Pregnancy|3|||
44243254|NCT01467713|79072647|FG000|Overall Study|Relapse|35|||
44511554|NCT01147666|79516686|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511555|NCT01147666|79516687|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511556|NCT01147666|79516688|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511557|NCT01147666|79516689|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511558|NCT01147666|79516690|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511559|NCT01147666|79516691|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511560|NCT01147666|79516692|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511561|NCT01147666|79516693|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511562|NCT01147666|79516694|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511563|NCT01147666|79516695|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511564|NCT01147666|79516696|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511565|NCT01147666|79516697|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
44511566|NCT01147666|79516698|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
44511567|NCT01147666|79516699|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
44511568|NCT00256295|79516761|FG000|Overall Study|Withdrawal by Subject|3|||
44511569|NCT00256295|79516761|FG000|Overall Study|Death|1|||
44511570|NCT02877004|79516768|FG000|Overall Study|Pregnancy|0|||
44511571|NCT02877004|79516769|FG001|Overall Study|Pregnancy|0|||
44511572|NCT02877004|79516770|FG002|Overall Study|Pregnancy|1|||
44511573|NCT04617860|79516800|FG000|Overall Study|Adverse Event|0|||
44511574|NCT04617860|79516801|FG001|Overall Study|Adverse Event|2|||
44511575|NCT04617860|79516802|FG002|Overall Study|Adverse Event|2|||
44243255|NCT01467713|79072648|FG001|Overall Study|Relapse|25|||
44127305|NCT04099251|78912655|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
44127306|NCT04099251|78912654|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
44127307|NCT04099251|78912655|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
44127308|NCT04099251|78912654|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
44127309|NCT04099251|78912655|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
44127310|NCT04099251|78912654|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
44127311|NCT04099251|78912655|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
44127312|NCT04099251|78912654|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
44127313|NCT04099251|78912655|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
44127314|NCT04099251|78912654|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
44127315|NCT04099251|78912655|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
44127316|NCT04099251|78912654|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
44127317|NCT04099251|78912655|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
44127318|NCT04099251|78912654|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
44127319|NCT04099251|78912655|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
44127320|NCT04066491|78912665|FG000|Overall Study|Randomized, not treated|0|||
44127321|NCT04066491|78912666|FG001|Overall Study|Randomized, not treated|0|||
44127322|NCT04066491|78912667|FG002|Overall Study|Randomized, not treated|2|||
44127323|NCT03883828|78912678|FG000|Overall Study|Did not start radiotherapy|1|||
44127324|NCT03883828|78912679|FG001|Overall Study|Did not start radiotherapy|2|||
44127325|NCT03844269|78912685|FG000|Overall Study|Withdrawal pre-intervention|1|||
44127326|NCT03844269|78912685|FG000|Overall Study|Did not complete the intervention|2|||
44127327|NCT03777917|78912702|FG000|Overall Study|Withdrawal by Subject|1|||
44127328|NCT03777917|78912703|FG001|Overall Study|Withdrawal by Subject|0|||
44127329|NCT03777917|78912702|FG000|Overall Study|Physician Decision|1|||
44127330|NCT03777917|78912703|FG001|Overall Study|Physician Decision|0|||
44127331|NCT03777917|78912702|FG000|Overall Study|Lost to Follow-up|6|||
44127332|NCT03777917|78912703|FG001|Overall Study|Lost to Follow-up|2|||
44127333|NCT03777917|78912702|FG000|Overall Study|Other|1|||
44127334|NCT03777917|78912703|FG001|Overall Study|Other|0|||
44127335|NCT03594123|78912712|FG000|Overall Study|Lost to Follow-up|0|||
44127336|NCT03594123|78912713|FG001|Overall Study|Lost to Follow-up|1|||
44127337|NCT03594123|78912712|FG000|Overall Study|Adverse Event|8|||
44127338|NCT03594123|78912713|FG001|Overall Study|Adverse Event|5|||
44127339|NCT03594123|78912712|FG000|Overall Study|Site Terminated by Sponsor|4|||
44127340|NCT03594123|78912713|FG001|Overall Study|Site Terminated by Sponsor|1|||
44127341|NCT03594123|78912712|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
44127342|NCT03594123|78912713|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
44127343|NCT03594123|78912712|FG000|Overall Study|Lack of Efficacy|1|||
44127344|NCT03594123|78912713|FG001|Overall Study|Lack of Efficacy|0|||
44127345|NCT03594123|78912712|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
44127346|NCT03594123|78912713|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
44127347|NCT03583359|78912721|FG000|Overall Study|Withdrawal by Subject|15|||
44127348|NCT03583359|78912722|FG001|Overall Study|Withdrawal by Subject|6|||
44127349|NCT03583359|78912721|FG000|Overall Study|Lost to Follow-up|12|||
44127350|NCT03583359|78912722|FG001|Overall Study|Lost to Follow-up|3|||
44127351|NCT03583359|78912721|FG000|Overall Study|Adverse Event|0|||
44127352|NCT03583359|78912722|FG001|Overall Study|Adverse Event|1|||
44127353|NCT03583359|78912721|FG000|Overall Study|Protocol Violation|0|||
44127354|NCT03583359|78912722|FG001|Overall Study|Protocol Violation|1|||
44127355|NCT03583359|78912721|FG000|Overall Study|Other|2|||
44127356|NCT03583359|78912722|FG001|Overall Study|Other|1|||
44127357|NCT03537651|78912728|FG000|Overall Study|Adverse Event|2|||
44127358|NCT03537651|78912728|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
44127359|NCT03537651|78912728|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
44127360|NCT03537651|78912728|FG000|Overall Study|Other|1|||
44127361|NCT03506438|78912741|FG000|Overall Study|Lost to Follow-up|8|||
44127362|NCT03506438|78912742|FG001|Overall Study|Lost to Follow-up|7|||
44127363|NCT03506438|78912743|FG002|Overall Study|Lost to Follow-up|8|||
44127364|NCT03506438|78912744|FG003|Overall Study|Lost to Follow-up|7|||
44127365|NCT03506438|78912745|FG004|Overall Study|Lost to Follow-up|0|||
44127366|NCT03506438|78912746|FG005|Overall Study|Lost to Follow-up|0|||
44127367|NCT03493542|78912759|FG000|Overall Study|Ongoing|2|||
44127368|NCT03493542|78912760|FG001|Overall Study|Ongoing|3|||
44127369|NCT03493542|78912759|FG000|Overall Study|Withdrawal by parent or guardian|3|||
44127370|NCT03493542|78912760|FG001|Overall Study|Withdrawal by parent or guardian|0|||
44127371|NCT03493542|78912759|FG000|Overall Study|Withdrawal by Subject|2|||
44127372|NCT03493542|78912760|FG001|Overall Study|Withdrawal by Subject|6|||
44127373|NCT03253744|78912802|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
44127374|NCT03253744|78912803|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
44127375|NCT03253744|78912804|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
44127376|NCT03253744|78912805|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
44127377|NCT03104400|78912834|FG000|Overall Study|Adverse Event|5|||
44127378|NCT03104400|78912835|FG001|Overall Study|Adverse Event|7|||
44127379|NCT03104400|78912836|FG002|Overall Study|Adverse Event|11|||
44127380|NCT03104400|78912837|FG003|Overall Study|Adverse Event|9|||
44127381|NCT03104400|78912838|FG004|Overall Study|Adverse Event|21|||
44127382|NCT03104400|78912834|FG000|Overall Study|Withdrawal by Subject|17|||
44127383|NCT03104400|78912835|FG001|Overall Study|Withdrawal by Subject|19|||
44127384|NCT03104400|78912836|FG002|Overall Study|Withdrawal by Subject|29|||
44127385|NCT03104400|78912837|FG003|Overall Study|Withdrawal by Subject|25|||
44127386|NCT03104400|78912838|FG004|Overall Study|Withdrawal by Subject|24|||
44127387|NCT03104400|78912834|FG000|Overall Study|Lost to Follow-up|4|||
44127388|NCT03104400|78912835|FG001|Overall Study|Lost to Follow-up|1|||
44127389|NCT03104400|78912836|FG002|Overall Study|Lost to Follow-up|4|||
44127390|NCT03104400|78912837|FG003|Overall Study|Lost to Follow-up|8|||
44127391|NCT03104400|78912838|FG004|Overall Study|Lost to Follow-up|7|||
44127392|NCT03104400|78912834|FG000|Overall Study|Lack of Efficacy|6|||
44127393|NCT03104400|78912835|FG001|Overall Study|Lack of Efficacy|3|||
44127394|NCT03104400|78912836|FG002|Overall Study|Lack of Efficacy|8|||
44127395|NCT03104400|78912837|FG003|Overall Study|Lack of Efficacy|2|||
44127396|NCT03104400|78912838|FG004|Overall Study|Lack of Efficacy|1|||
44127397|NCT03104400|78912834|FG000|Overall Study|COVID Logistical Restrictions|0|||
44127398|NCT03104400|78912835|FG001|Overall Study|COVID Logistical Restrictions|0|||
44127399|NCT03104400|78912836|FG002|Overall Study|COVID Logistical Restrictions|0|||
44127400|NCT03104400|78912837|FG003|Overall Study|COVID Logistical Restrictions|1|||
44127401|NCT03104400|78912838|FG004|Overall Study|COVID Logistical Restrictions|0|||
44127402|NCT03104400|78912834|FG000|Overall Study|Other|2|||
44127403|NCT03104400|78912835|FG001|Overall Study|Other|3|||
44127404|NCT03104400|78912836|FG002|Overall Study|Other|7|||
44127405|NCT03104400|78912837|FG003|Overall Study|Other|6|||
44127406|NCT03104400|78912838|FG004|Overall Study|Other|4|||
44127407|NCT03104400|78912834|FG000|Overall Study|Other|0|||
44127408|NCT03104400|78912835|FG001|Overall Study|Other|1|||
44127409|NCT03104400|78912836|FG002|Overall Study|Other|0|||
44127410|NCT03104400|78912837|FG003|Overall Study|Other|0|||
44127411|NCT03104400|78912838|FG004|Overall Study|Other|0|||
44127412|NCT03034044|78912861|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
44127413|NCT02878798|78912867|FG000|Overall Study|Withdrawal by Subject|5|||
44127414|NCT02878798|78912868|FG001|Overall Study|Withdrawal by Subject|4|||
44127415|NCT02878798|78912867|FG000|Overall Study|Lost to Follow-up|2|||
44127416|NCT02878798|78912868|FG001|Overall Study|Lost to Follow-up|2|||
44127417|NCT02878798|78912867|FG000|Overall Study|Protocol Violation|0|||
44127418|NCT02878798|78912868|FG001|Overall Study|Protocol Violation|1|||
44127419|NCT02854436|78912874|FG000|Overall Study|Adverse Event|1|||
44127420|NCT02854436|78912874|FG000|Overall Study|Death|208|||
44127421|NCT02854436|78912874|FG000|Overall Study|Lost to Follow-up|5|||
44243256|NCT01467713|79072649|FG002|Overall Study|Relapse|28|||
44243257|NCT01467713|79072650|FG003|Overall Study|Relapse|35|||
44511576|NCT04617860|79516800|FG000|Overall Study|Withdrawal by Subject|0|||
44511577|NCT04617860|79516801|FG001|Overall Study|Withdrawal by Subject|0|||
44511578|NCT04617860|79516802|FG002|Overall Study|Withdrawal by Subject|2|||
44511579|NCT04617860|79516800|FG000|Overall Study|Physician Decision|0|||
44511580|NCT04617860|79516801|FG001|Overall Study|Physician Decision|1|||
44511581|NCT04617860|79516802|FG002|Overall Study|Physician Decision|0|||
44511582|NCT04617860|79516800|FG000|Overall Study|Sponsor Decision|0|||
44511583|NCT04617860|79516801|FG001|Overall Study|Sponsor Decision|3|||
44511584|NCT04617860|79516802|FG002|Overall Study|Sponsor Decision|1|||
44511585|NCT04617860|79516800|FG000|Overall Study|Termination of Study by Sponsor|8|||
44511586|NCT04617860|79516801|FG001|Overall Study|Termination of Study by Sponsor|4|||
44127422|NCT02854436|78912874|FG000|Overall Study|Withdrawal by Subject|12|||
44127423|NCT02854436|78912874|FG000|Overall Study|Other|45|||
44127424|NCT02854436|78912874|FG000|Overall Study|Ongoing|18|||
44127425|NCT02741193|78912878|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
44127426|NCT02741193|78912878|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
44127427|NCT02725177|78912882|FG000|Overall Study|Physician Decision|4|||
44127428|NCT02725177|78912882|FG000|Overall Study|Adverse Event|1|||
44127429|NCT02488759|78912892|FG000|Overall Study|Disease progression|73|||
44127430|NCT02488759|78912893|FG001|Overall Study|Disease progression|111|||
44127431|NCT02488759|78912894|FG002|Overall Study|Disease progression|62|||
44127432|NCT02488759|78912895|FG003|Overall Study|Disease progression|7|||
44127433|NCT02488759|78912896|FG004|Overall Study|Disease progression|4|||
44127434|NCT02488759|78912897|FG005|Overall Study|Disease progression|2|||
44127435|NCT02488759|78912892|FG000|Overall Study|Study drug toxicity|11|||
44127436|NCT02488759|78912893|FG001|Overall Study|Study drug toxicity|33|||
44127437|NCT02488759|78912894|FG002|Overall Study|Study drug toxicity|31|||
44127438|NCT02488759|78912895|FG003|Overall Study|Study drug toxicity|0|||
44127439|NCT02488759|78912896|FG004|Overall Study|Study drug toxicity|0|||
44127440|NCT02488759|78912897|FG005|Overall Study|Study drug toxicity|2|||
44127441|NCT02488759|78912892|FG000|Overall Study|Adverse event unrelated to study drug|9|||
44127442|NCT02488759|78912893|FG001|Overall Study|Adverse event unrelated to study drug|11|||
44127443|NCT02488759|78912894|FG002|Overall Study|Adverse event unrelated to study drug|7|||
44127444|NCT02488759|78912895|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44127445|NCT02488759|78912896|FG004|Overall Study|Adverse event unrelated to study drug|1|||
44127446|NCT02488759|78912897|FG005|Overall Study|Adverse event unrelated to study drug|0|||
44127447|NCT02488759|78912892|FG000|Overall Study|Participant request to discontinue study treatment|6|||
44127448|NCT02488759|78912893|FG001|Overall Study|Participant request to discontinue study treatment|8|||
44127449|NCT02488759|78912894|FG002|Overall Study|Participant request to discontinue study treatment|4|||
44127450|NCT02488759|78912895|FG003|Overall Study|Participant request to discontinue study treatment|0|||
44127451|NCT02488759|78912896|FG004|Overall Study|Participant request to discontinue study treatment|0|||
44127452|NCT02488759|78912897|FG005|Overall Study|Participant request to discontinue study treatment|0|||
44127453|NCT02488759|78912892|FG000|Overall Study|Withdrawal by Subject|4|||
44127454|NCT02488759|78912893|FG001|Overall Study|Withdrawal by Subject|0|||
44127455|NCT02488759|78912894|FG002|Overall Study|Withdrawal by Subject|3|||
44127456|NCT02488759|78912895|FG003|Overall Study|Withdrawal by Subject|0|||
44127457|NCT02488759|78912896|FG004|Overall Study|Withdrawal by Subject|0|||
44127458|NCT02488759|78912897|FG005|Overall Study|Withdrawal by Subject|2|||
44127459|NCT02488759|78912892|FG000|Overall Study|Lost to Follow-up|0|||
44127460|NCT02488759|78912893|FG001|Overall Study|Lost to Follow-up|0|||
44127461|NCT02488759|78912894|FG002|Overall Study|Lost to Follow-up|2|||
44127462|NCT02488759|78912895|FG003|Overall Study|Lost to Follow-up|0|||
44127463|NCT02488759|78912896|FG004|Overall Study|Lost to Follow-up|0|||
44127464|NCT02488759|78912897|FG005|Overall Study|Lost to Follow-up|0|||
44127465|NCT02488759|78912892|FG000|Overall Study|Maximum clinical benefit|3|||
44127466|NCT02488759|78912893|FG001|Overall Study|Maximum clinical benefit|0|||
44127467|NCT02488759|78912894|FG002|Overall Study|Maximum clinical benefit|1|||
44127468|NCT02488759|78912895|FG003|Overall Study|Maximum clinical benefit|0|||
44127469|NCT02488759|78912896|FG004|Overall Study|Maximum clinical benefit|0|||
44127470|NCT02488759|78912897|FG005|Overall Study|Maximum clinical benefit|0|||
44127471|NCT02488759|78912892|FG000|Overall Study|Other reasons|7|||
44127472|NCT02488759|78912893|FG001|Overall Study|Other reasons|32|||
44127473|NCT02488759|78912894|FG002|Overall Study|Other reasons|23|||
44127474|NCT02488759|78912895|FG003|Overall Study|Other reasons|1|||
44127475|NCT02488759|78912896|FG004|Overall Study|Other reasons|1|||
44379395|NCT00771667|79385047|FG006|Maintenance Phase|Other|2|||
44379396|NCT00771667|79385048|FG007|Maintenance Phase|Other|2|||
44379397|NCT00771667|79385049|FG008|Maintenance Phase|Other|3|||
44379398|NCT00771667|79385050|FG009|Maintenance Phase|Other|3|||
44379399|NCT00770965|79385072|FG000|Safety Set|Withdrawal by Subject|0|||
44511587|NCT04617860|79516802|FG002|Overall Study|Termination of Study by Sponsor|13|||
44511588|NCT04608500|79516814|FG000|Overall Study|Adverse Event|2|||
44511589|NCT04608500|79516815|FG001|Overall Study|Adverse Event|0|||
44511590|NCT04608500|79516814|FG000|Overall Study|Lost to Follow-up|15|||
44511591|NCT04608500|79516815|FG001|Overall Study|Lost to Follow-up|9|||
44511592|NCT04608500|79516814|FG000|Overall Study|Participant request|11|||
44511593|NCT04608500|79516815|FG001|Overall Study|Participant request|7|||
44511594|NCT04608500|79516814|FG000|Overall Study|Protocol Violation|1|||
44511595|NCT04608500|79516815|FG001|Overall Study|Protocol Violation|0|||
44511596|NCT04608500|79516814|FG000|Overall Study|Other|6|||
44511597|NCT04608500|79516815|FG001|Overall Study|Other|2|||
44511598|NCT04585646|79516821|FG000|First Intervention|Physician Decision|1|||
44511599|NCT04585646|79516822|FG001|First Intervention|Physician Decision|0|||
44511600|NCT04585646|79516821|FG000|First Intervention|Lost to Follow-up|0|||
44127476|NCT02488759|78912897|FG005|Overall Study|Other reasons|1|||
44127477|NCT02466685|78912913|FG000|Overall Study|Adverse Event|5|||
44127478|NCT02466685|78912914|FG001|Overall Study|Adverse Event|2|||
44127479|NCT02466685|78912913|FG000|Overall Study|Lost to Follow-up|1|||
44127480|NCT02466685|78912914|FG001|Overall Study|Lost to Follow-up|1|||
44127481|NCT02466685|78912913|FG000|Overall Study|Withdrawal by Subject|1|||
44127482|NCT02466685|78912914|FG001|Overall Study|Withdrawal by Subject|0|||
44379400|NCT00770965|79385073|FG001|Safety Set|Withdrawal by Subject|0|||
44511601|NCT04585646|79516822|FG001|First Intervention|Lost to Follow-up|3|||
44511602|NCT04585646|79516821|FG000|First Intervention|Withdrawal by Subject|0|||
44127483|NCT02466685|78912913|FG000|Overall Study|Physician Decision|1|||
44127484|NCT02466685|78912914|FG001|Overall Study|Physician Decision|1|||
44379401|NCT00770965|79385074|FG002|Safety Set|Withdrawal by Subject|0|||
44127485|NCT02312206|78912925|FG000|Overall Study|Adverse Event|3|||
44127486|NCT02312206|78912926|FG001|Overall Study|Adverse Event|6|||
44127487|NCT02312206|78912925|FG000|Overall Study|Withdrawal by Subject|6|||
44127488|NCT02312206|78912926|FG001|Overall Study|Withdrawal by Subject|6|||
44127489|NCT02312206|78912925|FG000|Overall Study|Physician Decision|7|||
44127490|NCT02312206|78912926|FG001|Overall Study|Physician Decision|6|||
44127491|NCT02312206|78912925|FG000|Overall Study|Death|31|||
44127492|NCT02312206|78912926|FG001|Overall Study|Death|36|||
44127493|NCT02312206|78912925|FG000|Overall Study|Study Terminated by Sponsor|81|||
44127494|NCT02312206|78912926|FG001|Overall Study|Study Terminated by Sponsor|74|||
44127495|NCT02312206|78912925|FG000|Overall Study|Patient transferred to hospice|0|||
44127496|NCT02312206|78912926|FG001|Overall Study|Patient transferred to hospice|1|||
44127497|NCT02312206|78912925|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
44127498|NCT02312206|78912926|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
44127499|NCT02312206|78912925|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
44127500|NCT02312206|78912926|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
44127501|NCT02312206|78912925|FG000|Overall Study|Disease Progression|1|||
44127502|NCT02312206|78912926|FG001|Overall Study|Disease Progression|0|||
44127503|NCT02264665|78912937|FG000|Overall Study|Other|0|||
44127504|NCT02264665|78912938|FG001|Overall Study|Other|0|||
44127505|NCT02264665|78912939|FG002|Overall Study|Other|3|||
44127506|NCT02264665|78912940|FG003|Overall Study|Other|0|||
44127507|NCT02264665|78912941|FG004|Overall Study|Other|0|||
44127508|NCT02264665|78912942|FG005|Overall Study|Other|0|||
44127509|NCT02264665|78912943|FG006|Overall Study|Other|0|||
44127510|NCT02264665|78912937|FG000|Overall Study|Death|9|||
44127511|NCT02264665|78912938|FG001|Overall Study|Death|8|||
44127512|NCT02264665|78912939|FG002|Overall Study|Death|13|||
44127513|NCT02264665|78912940|FG003|Overall Study|Death|5|||
44127514|NCT02264665|78912941|FG004|Overall Study|Death|0|||
44379402|NCT00770965|79385075|FG003|Safety Set|Withdrawal by Subject|1|||
44379403|NCT00770965|79385072|FG000|Safety Set|Protocol deviation|0|||
44379404|NCT00770965|79385073|FG001|Safety Set|Protocol deviation|0|||
44127515|NCT02264665|78912942|FG005|Overall Study|Death|0|||
44127516|NCT02264665|78912943|FG006|Overall Study|Death|1|||
44243258|NCT01467713|79072647|FG000|Overall Study|Reason not Specified|6|||
44511603|NCT04585646|79516822|FG001|First Intervention|Withdrawal by Subject|1|||
44511604|NCT04584788|79516838|FG000|Overall Study|Physician Decision|8|||
44511605|NCT04584788|79516838|FG000|Overall Study|Withdrawal by Subject|1|||
44511606|NCT04584788|79516838|FG000|Overall Study|Adverse Event|3|||
44511607|NCT04575038|79516844|FG000|Overall Study|Withdrawal by Subject|1|||
44511608|NCT04575038|79516845|FG001|Overall Study|Withdrawal by Subject|1|||
44511609|NCT03066622|79516853|FG000|Overall Study|Lost to Follow-up|24|||
44127517|NCT02264665|78912937|FG000|Overall Study|Lost to Follow-up|1|||
44127518|NCT02264665|78912938|FG001|Overall Study|Lost to Follow-up|0|||
44127519|NCT02264665|78912939|FG002|Overall Study|Lost to Follow-up|2|||
44511610|NCT03066622|79516854|FG001|Overall Study|Lost to Follow-up|25|||
44127520|NCT02264665|78912940|FG003|Overall Study|Lost to Follow-up|1|||
44127521|NCT02264665|78912941|FG004|Overall Study|Lost to Follow-up|0|||
44243259|NCT01467713|79072648|FG001|Overall Study|Reason not Specified|11|||
44379405|NCT00770965|79385074|FG002|Safety Set|Protocol deviation|1|||
44511611|NCT03066622|79516853|FG000|Overall Study|Withdrawal by Subject|2|||
44127522|NCT02264665|78912942|FG005|Overall Study|Lost to Follow-up|0|||
44127523|NCT02264665|78912943|FG006|Overall Study|Lost to Follow-up|0|||
44127524|NCT02264665|78912937|FG000|Overall Study|Participant decision|0|||
44127525|NCT02264665|78912938|FG001|Overall Study|Participant decision|0|||
44127526|NCT02264665|78912939|FG002|Overall Study|Participant decision|0|||
44127527|NCT02264665|78912940|FG003|Overall Study|Participant decision|1|||
44127528|NCT02264665|78912941|FG004|Overall Study|Participant decision|0|||
44127529|NCT02264665|78912942|FG005|Overall Study|Participant decision|0|||
44127530|NCT02264665|78912943|FG006|Overall Study|Participant decision|0|||
44127531|NCT02264665|78912937|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
44127532|NCT02264665|78912938|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
44127533|NCT02264665|78912939|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
44127534|NCT02264665|78912940|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
44127535|NCT02264665|78912941|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
44127536|NCT02264665|78912942|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
44127537|NCT02264665|78912943|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
44127538|NCT02264665|78912937|FG000|Overall Study|Data Missing|0|||
44127539|NCT02264665|78912938|FG001|Overall Study|Data Missing|0|||
44127540|NCT02264665|78912939|FG002|Overall Study|Data Missing|1|||
44127541|NCT02264665|78912940|FG003|Overall Study|Data Missing|0|||
44127542|NCT02264665|78912941|FG004|Overall Study|Data Missing|0|||
44127543|NCT02264665|78912942|FG005|Overall Study|Data Missing|0|||
44127544|NCT02264665|78912943|FG006|Overall Study|Data Missing|0|||
44127545|NCT02155712|78912970|FG000|Overall Study|Death|12|||
44127546|NCT02155712|78912971|FG001|Overall Study|Death|0|||
44127547|NCT02155712|78912970|FG000|Overall Study|Lost to Follow-up|37|||
44127548|NCT02155712|78912971|FG001|Overall Study|Lost to Follow-up|22|||
44127549|NCT02155712|78912970|FG000|Overall Study|Revision of device|4|||
44127550|NCT02155712|78912971|FG001|Overall Study|Revision of device|3|||
44127551|NCT02155712|78912970|FG000|Overall Study|Withdrawal by Subject|39|||
44127552|NCT02155712|78912971|FG001|Overall Study|Withdrawal by Subject|21|||
44127553|NCT02155712|78912970|FG000|Overall Study|Site termination|77|||
44127554|NCT02155712|78912971|FG001|Overall Study|Site termination|19|||
44127555|NCT02155712|78912970|FG000|Overall Study|Sponsor terminated study early|150|||
44379406|NCT00770965|79385075|FG003|Safety Set|Protocol deviation|0|||
44379407|NCT00770965|79385072|FG000|Excluded Set|Administrative problems|14|||
44379408|NCT00770965|79385073|FG001|Excluded Set|Administrative problems|12|||
44127556|NCT02155712|78912971|FG001|Overall Study|Sponsor terminated study early|0|||
44127557|NCT02155712|78912970|FG000|Overall Study|Missed final 5-year protocol visit|0|||
44127558|NCT02155712|78912971|FG001|Overall Study|Missed final 5-year protocol visit|32|||
44127559|NCT02155712|78912970|FG000|Overall Study|Censored because surgery cancelled|6|||
44127560|NCT02155712|78912971|FG001|Overall Study|Censored because surgery cancelled|10|||
44127561|NCT02155712|78912970|FG000|Overall Study|Censored because study device was not implanted|61|||
44379409|NCT00770965|79385074|FG002|Excluded Set|Administrative problems|12|||
44127562|NCT02155712|78912971|FG001|Overall Study|Censored because study device was not implanted|66|||
44127563|NCT02155712|78912970|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
44127564|NCT02155712|78912971|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
44127565|NCT01972217|78912985|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
44127566|NCT01972217|78912986|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
44127567|NCT01972217|78912987|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
44127568|NCT01972217|78912988|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
44127569|NCT01972217|78912985|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
44127570|NCT01972217|78912986|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
44127571|NCT01972217|78912987|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
44127572|NCT01972217|78912988|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
44127573|NCT01972217|78912985|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
44127574|NCT01972217|78912986|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
44127575|NCT01972217|78912987|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
44127576|NCT01972217|78912988|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
44127577|NCT01972217|78912985|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
44127578|NCT01972217|78912986|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
44127579|NCT01972217|78912987|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
44127580|NCT01972217|78912988|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
44127581|NCT01972217|78912985|FG000|Part B Double-blind, Randomised Period|Death|0|||
44127582|NCT01972217|78912986|FG001|Part B Double-blind, Randomised Period|Death|0|||
44127583|NCT01972217|78912987|FG002|Part B Double-blind, Randomised Period|Death|43|||
44127584|NCT01972217|78912988|FG003|Part B Double-blind, Randomised Period|Death|44|||
44127585|NCT01972217|78912985|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
44127586|NCT01972217|78912986|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
44127587|NCT01972217|78912987|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
44127588|NCT01972217|78912988|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
44127589|NCT01972217|78912985|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
44127590|NCT01972217|78912986|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
44127591|NCT01972217|78912987|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
44127592|NCT01972217|78912988|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
44127593|NCT01972217|78912985|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
44127594|NCT01972217|78912986|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
44127595|NCT01972217|78912987|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
44127596|NCT01972217|78912988|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
44127597|NCT01972217|78912985|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
44127598|NCT01972217|78912986|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
44127599|NCT01972217|78912987|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
44127600|NCT01972217|78912988|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
44127601|NCT01918007|78913011|FG000|Overall Study|Baseline oximetry not acceptable|11|||
44127602|NCT01918007|78913012|FG001|Overall Study|Baseline oximetry not acceptable|7|||
44127603|NCT01918007|78913011|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
44127604|NCT01918007|78913012|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
44127605|NCT01918007|78913011|FG000|Overall Study|Lost to Follow-up|4|||
44243260|NCT01467713|79072649|FG002|Overall Study|Reason not Specified|8|||
44243261|NCT01467713|79072650|FG003|Overall Study|Reason not Specified|7|||
44127606|NCT01918007|78913012|FG001|Overall Study|Lost to Follow-up|7|||
44127607|NCT01863446|78913022|FG000|Overall Study|Withdrawal by Subject|1|||
44127608|NCT01863446|78913023|FG001|Overall Study|Withdrawal by Subject|0|||
44127609|NCT01863446|78913024|FG002|Overall Study|Withdrawal by Subject|1|||
44127610|NCT01863446|78913025|FG003|Overall Study|Withdrawal by Subject|2|||
44127611|NCT01863446|78913022|FG000|Overall Study|Physician Decision|0|||
44127612|NCT01863446|78913023|FG001|Overall Study|Physician Decision|0|||
44127613|NCT01863446|78913024|FG002|Overall Study|Physician Decision|1|||
44127614|NCT01863446|78913025|FG003|Overall Study|Physician Decision|0|||
44127615|NCT01809691|78913037|FG000|Overall Study|Currently on Treatment|192|||
44127616|NCT01809691|78913038|FG001|Overall Study|Currently on Treatment|100|||
44511612|NCT03066622|79516854|FG001|Overall Study|Withdrawal by Subject|1|||
44511613|NCT04501952|79516886|FG000|Overall Study|Adverse Event|0|||
44511614|NCT04501952|79516887|FG001|Overall Study|Adverse Event|3|||
44511615|NCT04501952|79516886|FG000|Overall Study|Investigator's Discretion|0|||
44511616|NCT04501952|79516887|FG001|Overall Study|Investigator's Discretion|1|||
44511617|NCT04501952|79516886|FG000|Overall Study|Protocol Violation|1|||
44511618|NCT04501952|79516887|FG001|Overall Study|Protocol Violation|1|||
44511619|NCT04501952|79516886|FG000|Overall Study|Withdrew Consent|5|||
44511620|NCT04501952|79516887|FG001|Overall Study|Withdrew Consent|4|||
44511621|NCT04501952|79516886|FG000|Overall Study|Lost to Follow-up|7|||
44511622|NCT04501952|79516887|FG001|Overall Study|Lost to Follow-up|2|||
44511623|NCT04501952|79516886|FG000|Overall Study|Randomized and Never Treated|13|||
44511624|NCT04501952|79516887|FG001|Overall Study|Randomized and Never Treated|9|||
44511625|NCT02930122|79516905|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
44511626|NCT02930122|79516906|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
44511627|NCT03697460|79516913|FG000|Overall Study|Withdrawal by Subject|3|||
44511628|NCT00070018|79516917|FG000|Overall Study|Adverse Event|2|||
44127617|NCT01809691|78913037|FG000|Overall Study|No Protocol Treatment|10|||
44127618|NCT01809691|78913038|FG001|Overall Study|No Protocol Treatment|11|||
44127619|NCT01809691|78913037|FG000|Overall Study|Adverse Event|80|||
44127620|NCT01809691|78913038|FG001|Overall Study|Adverse Event|21|||
44127621|NCT01809691|78913037|FG000|Overall Study|Disease Progression|226|||
44127622|NCT01809691|78913038|FG001|Overall Study|Disease Progression|372|||
44127623|NCT01809691|78913037|FG000|Overall Study|Death|26|||
44127624|NCT01809691|78913038|FG001|Overall Study|Death|13|||
44127625|NCT01809691|78913037|FG000|Overall Study|Participant Refusal|70|||
44127626|NCT01809691|78913038|FG001|Overall Study|Participant Refusal|72|||
44127627|NCT01809691|78913037|FG000|Overall Study|Other, Not Specified|34|||
44127628|NCT01809691|78913038|FG001|Overall Study|Other, Not Specified|52|||
44127629|NCT01532388|78913055|FG000|3-month Follow-up|Lost to Follow-up|68|||
44127630|NCT01532388|78913056|FG001|3-month Follow-up|Lost to Follow-up|68|||
44127631|NCT01532388|78913055|FG000|6-month Follow-up|Lost to Follow-up|74|||
44127632|NCT01532388|78913056|FG001|6-month Follow-up|Lost to Follow-up|66|||
44127633|NCT01532388|78913055|FG000|12-month Follow-up|Lost to Follow-up|69|||
44127634|NCT01532388|78913056|FG001|12-month Follow-up|Lost to Follow-up|67|||
44127635|NCT01106534|78913071|FG000|Overall Study|Withdrawal by Subject|18|||
44127636|NCT01106534|78913071|FG000|Overall Study|Lost to Follow-up|2|||
44127637|NCT01106534|78913071|FG000|Overall Study|Death|16|||
44127638|NCT01106534|78913071|FG000|Overall Study|Physician Decision|1|||
44127639|NCT00961064|78913076|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
44127640|NCT00961064|78913076|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
44127641|NCT00961064|78913076|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
44127642|NCT00961064|78913076|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
44127643|NCT00961064|78913076|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
44127644|NCT00961064|78913076|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
44127645|NCT00961064|78913076|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
44127646|NCT00961064|78913076|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
44127647|NCT00321555|78913088|FG000|Overall Study|Developed antibodies|1|||
44127648|NCT00321555|78913088|FG000|Overall Study|Switched to alternative treatment|3|||
44127649|NCT00321555|78913088|FG000|Overall Study|Physician Decision|1|||
44127650|NCT00321555|78913088|FG000|Overall Study|Disease progression on study|1|||
44127651|NCT02689453|78913118|FG000|Overall Study|Progressive disease|0|||
44127652|NCT02689453|78913119|FG001|Overall Study|Progressive disease|1|||
44127653|NCT02689453|78913120|FG002|Overall Study|Progressive disease|1|||
44127654|NCT00701103|78913155|FG000|Overall Study|Adverse Event|0|||
44127655|NCT00701103|78913156|FG001|Overall Study|Adverse Event|0|||
44127656|NCT00701103|78913157|FG002|Overall Study|Adverse Event|1|||
44127657|NCT00701103|78913158|FG003|Overall Study|Adverse Event|1|||
44127658|NCT00701103|78913159|FG004|Overall Study|Adverse Event|0|||
44127659|NCT00701103|78913160|FG005|Overall Study|Adverse Event|1|||
44511629|NCT00070018|79516917|FG000|Overall Study|Lack of Efficacy|1|||
44511630|NCT00070018|79516917|FG000|Overall Study|Withdrawal by Subject|1|||
44127660|NCT00701103|78913161|FG006|Overall Study|Adverse Event|1|||
44127661|NCT00701103|78913162|FG007|Overall Study|Adverse Event|0|||
44127662|NCT00701103|78913163|FG008|Overall Study|Adverse Event|0|||
44127663|NCT00701103|78913164|FG009|Overall Study|Adverse Event|2|||
44127664|NCT00701103|78913165|FG010|Overall Study|Adverse Event|0|||
44127665|NCT00701103|78913155|FG000|Overall Study|Progressive Disease|5|||
44127666|NCT00701103|78913156|FG001|Overall Study|Progressive Disease|2|||
44127667|NCT00701103|78913157|FG002|Overall Study|Progressive Disease|6|||
44127668|NCT00701103|78913158|FG003|Overall Study|Progressive Disease|5|||
44127669|NCT00701103|78913159|FG004|Overall Study|Progressive Disease|6|||
44127670|NCT00701103|78913160|FG005|Overall Study|Progressive Disease|5|||
44127671|NCT00701103|78913161|FG006|Overall Study|Progressive Disease|7|||
44127672|NCT00701103|78913162|FG007|Overall Study|Progressive Disease|7|||
44127673|NCT00701103|78913163|FG008|Overall Study|Progressive Disease|8|||
44127674|NCT00701103|78913164|FG009|Overall Study|Progressive Disease|8|||
44127675|NCT00701103|78913165|FG010|Overall Study|Progressive Disease|11|||
44127676|NCT00701103|78913155|FG000|Overall Study|Withdrawal by Subject|0|||
44243262|NCT01693250|79072680|FG000|Overall Study|Lost to Follow-up|2|||
44243263|NCT01693250|79072681|FG001|Overall Study|Lost to Follow-up|2|||
44243264|NCT01590758|79072704|FG000|Overall Study|Withdrawal by Subject|0|||
44243265|NCT01590758|79072705|FG001|Overall Study|Withdrawal by Subject|3|||
44379410|NCT00770965|79385075|FG003|Excluded Set|Administrative problems|10|||
44379411|NCT00770965|79385072|FG000|Excluded Set|Withdrawal by Subject|1|||
44379412|NCT00770965|79385073|FG001|Excluded Set|Withdrawal by Subject|1|||
44511631|NCT00231413|79516928|FG000|Overall Study|Non-serious AE|0|||
44511632|NCT00231413|79516929|FG001|Overall Study|Non-serious AE|0|||
44511633|NCT00231413|79516930|FG002|Overall Study|Non-serious AE|1|||
44511634|NCT00231413|79516931|FG003|Overall Study|Non-serious AE|0|||
44127677|NCT00701103|78913156|FG001|Overall Study|Withdrawal by Subject|1|||
44127678|NCT00701103|78913157|FG002|Overall Study|Withdrawal by Subject|1|||
44127679|NCT00701103|78913158|FG003|Overall Study|Withdrawal by Subject|0|||
44127680|NCT00701103|78913159|FG004|Overall Study|Withdrawal by Subject|0|||
44127681|NCT00701103|78913160|FG005|Overall Study|Withdrawal by Subject|0|||
44127682|NCT00701103|78913161|FG006|Overall Study|Withdrawal by Subject|0|||
44127683|NCT00701103|78913162|FG007|Overall Study|Withdrawal by Subject|0|||
44127684|NCT00701103|78913163|FG008|Overall Study|Withdrawal by Subject|0|||
44127685|NCT00701103|78913164|FG009|Overall Study|Withdrawal by Subject|0|||
44127686|NCT00701103|78913165|FG010|Overall Study|Withdrawal by Subject|0|||
44127687|NCT00701103|78913155|FG000|Overall Study|Other|0|||
44127688|NCT00701103|78913156|FG001|Overall Study|Other|0|||
44127689|NCT00701103|78913157|FG002|Overall Study|Other|0|||
44127690|NCT00701103|78913158|FG003|Overall Study|Other|0|||
44127691|NCT00701103|78913159|FG004|Overall Study|Other|0|||
44127692|NCT00701103|78913160|FG005|Overall Study|Other|0|||
44127693|NCT00701103|78913161|FG006|Overall Study|Other|0|||
44127694|NCT00701103|78913162|FG007|Overall Study|Other|0|||
44127695|NCT00701103|78913163|FG008|Overall Study|Other|1|||
44127696|NCT00701103|78913164|FG009|Overall Study|Other|1|||
44127697|NCT00701103|78913165|FG010|Overall Study|Other|0|||
44127698|NCT01369225|78913199|FG000|Overall Study|Withdrawal by Subject|1|||
44127699|NCT01369225|78913200|FG001|Overall Study|Withdrawal by Subject|0|||
44127700|NCT01369225|78913201|FG002|Overall Study|Withdrawal by Subject|2|||
44127701|NCT01369225|78913202|FG003|Overall Study|Withdrawal by Subject|1|||
44127702|NCT01369225|78913203|FG004|Overall Study|Withdrawal by Subject|0|||
44127703|NCT01369225|78913204|FG005|Overall Study|Withdrawal by Subject|0|||
44127704|NCT01369225|78913199|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
44127705|NCT01369225|78913200|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
44127706|NCT01369225|78913201|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
44127707|NCT01369225|78913202|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
44127708|NCT01369225|78913203|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
44511635|NCT00231413|79516932|FG004|Overall Study|Non-serious AE|0|||
44511636|NCT00231413|79516933|FG005|Overall Study|Non-serious AE|0|||
44511637|NCT00231413|79516934|FG006|Overall Study|Non-serious AE|1|||
44511638|NCT00231413|79516928|FG000|Overall Study|Withdrawal by Subject|3|||
44511639|NCT00231413|79516929|FG001|Overall Study|Withdrawal by Subject|1|||
44511640|NCT00231413|79516930|FG002|Overall Study|Withdrawal by Subject|4|||
44511641|NCT00231413|79516931|FG003|Overall Study|Withdrawal by Subject|2|||
44511642|NCT00231413|79516932|FG004|Overall Study|Withdrawal by Subject|2|||
44511643|NCT00231413|79516933|FG005|Overall Study|Withdrawal by Subject|0|||
44511644|NCT00231413|79516934|FG006|Overall Study|Withdrawal by Subject|3|||
44127709|NCT01369225|78913204|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
44127710|NCT01369225|78913199|FG000|Overall Study|Other|1|||
44127711|NCT01369225|78913200|FG001|Overall Study|Other|0|||
44511645|NCT00231413|79516928|FG000|Overall Study|Migrated/moved from study area|0|||
44127712|NCT01369225|78913201|FG002|Overall Study|Other|0|||
44127713|NCT01369225|78913202|FG003|Overall Study|Other|0|||
44127714|NCT01369225|78913203|FG004|Overall Study|Other|1|||
44127715|NCT01369225|78913204|FG005|Overall Study|Other|0|||
44127716|NCT01369225|78913199|FG000|Overall Study|Adverse Event|0|||
44127717|NCT01369225|78913200|FG001|Overall Study|Adverse Event|0|||
44127718|NCT01369225|78913201|FG002|Overall Study|Adverse Event|0|||
44127719|NCT01369225|78913202|FG003|Overall Study|Adverse Event|1|||
44127720|NCT01369225|78913203|FG004|Overall Study|Adverse Event|1|||
44127721|NCT01369225|78913204|FG005|Overall Study|Adverse Event|0|||
44127722|NCT02639546|78913226|FG000|Overall Study|Death|2|||
44243266|NCT01590758|79072704|FG000|Overall Study|Physician Decision|1|||
44127723|NCT02639546|78913227|FG001|Overall Study|Death|2|||
44127724|NCT02639546|78913228|FG002|Overall Study|Death|1|||
44127725|NCT02639546|78913229|FG003|Overall Study|Death|2|||
44127726|NCT02639546|78913230|FG004|Overall Study|Death|2|||
44127727|NCT02639546|78913231|FG005|Overall Study|Death|2|||
44127728|NCT02639546|78913232|FG006|Overall Study|Death|0|||
44127729|NCT02639546|78913233|FG007|Overall Study|Death|0|||
44127730|NCT02639546|78913226|FG000|Overall Study|Lost to Follow-up|0|||
44127731|NCT02639546|78913227|FG001|Overall Study|Lost to Follow-up|0|||
44127732|NCT02639546|78913228|FG002|Overall Study|Lost to Follow-up|1|||
44127733|NCT02639546|78913229|FG003|Overall Study|Lost to Follow-up|0|||
44127734|NCT02639546|78913230|FG004|Overall Study|Lost to Follow-up|1|||
44127735|NCT02639546|78913231|FG005|Overall Study|Lost to Follow-up|1|||
44127736|NCT02639546|78913232|FG006|Overall Study|Lost to Follow-up|0|||
44127737|NCT02639546|78913233|FG007|Overall Study|Lost to Follow-up|1|||
44127738|NCT02639546|78913226|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
44127739|NCT02639546|78913227|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
44127740|NCT02639546|78913228|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
44127741|NCT02639546|78913229|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
44127742|NCT02639546|78913230|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
44127743|NCT02639546|78913231|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
44127744|NCT02639546|78913232|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
44127745|NCT02639546|78913233|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
44127746|NCT02639546|78913226|FG000|Overall Study|Study Terminated By Sponsor|0|||
44127747|NCT02639546|78913227|FG001|Overall Study|Study Terminated By Sponsor|2|||
44127748|NCT02639546|78913228|FG002|Overall Study|Study Terminated By Sponsor|3|||
44127749|NCT02639546|78913229|FG003|Overall Study|Study Terminated By Sponsor|4|||
44127750|NCT02639546|78913230|FG004|Overall Study|Study Terminated By Sponsor|4|||
44127751|NCT02639546|78913231|FG005|Overall Study|Study Terminated By Sponsor|3|||
44127752|NCT02639546|78913232|FG006|Overall Study|Study Terminated By Sponsor|3|||
44127753|NCT02639546|78913233|FG007|Overall Study|Study Terminated By Sponsor|9|||
44127754|NCT02639546|78913226|FG000|Overall Study|Withdrawal by Subject|2|||
44127755|NCT02639546|78913227|FG001|Overall Study|Withdrawal by Subject|2|||
44127756|NCT02639546|78913228|FG002|Overall Study|Withdrawal by Subject|1|||
44127757|NCT02639546|78913229|FG003|Overall Study|Withdrawal by Subject|0|||
44127758|NCT02639546|78913230|FG004|Overall Study|Withdrawal by Subject|0|||
44127759|NCT02639546|78913231|FG005|Overall Study|Withdrawal by Subject|1|||
44127760|NCT02639546|78913232|FG006|Overall Study|Withdrawal by Subject|2|||
44127761|NCT02639546|78913233|FG007|Overall Study|Withdrawal by Subject|1|||
44127762|NCT02639390|78913267|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
44127763|NCT02639390|78913268|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
44127764|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
44127765|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
44127766|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
44127767|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
44127768|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
44127769|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
44127770|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
44127771|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
44127772|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
44511646|NCT00231413|79516929|FG001|Overall Study|Migrated/moved from study area|0|||
44511647|NCT00231413|79516930|FG002|Overall Study|Migrated/moved from study area|1|||
44511648|NCT00231413|79516931|FG003|Overall Study|Migrated/moved from study area|0|||
44511649|NCT00231413|79516932|FG004|Overall Study|Migrated/moved from study area|0|||
44511650|NCT00231413|79516933|FG005|Overall Study|Migrated/moved from study area|1|||
44511651|NCT00231413|79516934|FG006|Overall Study|Migrated/moved from study area|0|||
44511652|NCT00231413|79516928|FG000|Overall Study|Lost to Follow-up|4|||
44511653|NCT00231413|79516929|FG001|Overall Study|Lost to Follow-up|4|||
44511654|NCT00231413|79516930|FG002|Overall Study|Lost to Follow-up|1|||
44511655|NCT00231413|79516931|FG003|Overall Study|Lost to Follow-up|1|||
44511656|NCT00231413|79516932|FG004|Overall Study|Lost to Follow-up|1|||
44127773|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
44127774|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
44127775|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
44511657|NCT00231413|79516933|FG005|Overall Study|Lost to Follow-up|4|||
44511658|NCT00231413|79516934|FG006|Overall Study|Lost to Follow-up|0|||
44127776|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
44127777|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
44127778|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
44127779|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
44127780|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
44127781|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
44127782|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
44127783|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
44127784|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
44127785|NCT02718417|78913277|FG000|Chemotherapy Phase (CP)|Other|2|||
44127786|NCT02718417|78913278|FG001|Chemotherapy Phase (CP)|Other|0|||
44127787|NCT02718417|78913279|FG002|Chemotherapy Phase (CP)|Other|1|||
44127788|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Adverse Event|21|||
44127789|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Adverse Event|26|||
44127790|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Adverse Event|0|||
44127791|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
44127792|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
44127793|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
44127794|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
44127795|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
44127796|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
44127797|NCT02718417|78913277|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
44127798|NCT02718417|78913278|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
44127799|NCT02718417|78913279|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
44127800|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Physician's decision|6|||
44127801|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Physician's decision|7|||
44127802|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Physician's decision|0|||
44127803|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Progressive disease|100|||
44127804|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Progressive disease|88|||
44127805|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Progressive disease|0|||
44127806|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Other|2|||
44127807|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Other|1|||
44127808|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Other|0|||
44127809|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
44127810|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
44127811|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
44127812|NCT02718417|78913277|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
44127813|NCT02718417|78913278|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
44511659|NCT00231413|79516928|FG000|Overall Study|Pregnancy|1|||
44511660|NCT00231413|79516929|FG001|Overall Study|Pregnancy|0|||
44511661|NCT00231413|79516930|FG002|Overall Study|Pregnancy|0|||
44511662|NCT00231413|79516931|FG003|Overall Study|Pregnancy|0|||
44511663|NCT00231413|79516932|FG004|Overall Study|Pregnancy|0|||
44511664|NCT00231413|79516933|FG005|Overall Study|Pregnancy|0|||
44511665|NCT00231413|79516934|FG006|Overall Study|Pregnancy|0|||
44511666|NCT04494646|79516952|FG000|Overall Study|Adverse Event|0|||
44511667|NCT04494646|79516953|FG001|Overall Study|Adverse Event|1|||
44511668|NCT04494646|79516952|FG000|Overall Study|Withdrawal by Subject|0|||
44511669|NCT04494646|79516953|FG001|Overall Study|Withdrawal by Subject|1|||
44511670|NCT00231179|79516961|FG000|Overall Study|Lost to Follow-up|21|||
44511671|NCT00231179|79516962|FG001|Overall Study|Lost to Follow-up|21|||
44511672|NCT00231179|79516961|FG000|Overall Study|Withdrawal by Subject|3|||
44511673|NCT00231179|79516962|FG001|Overall Study|Withdrawal by Subject|3|||
44511674|NCT03135028|79516968|FG000|Overall Study|Death|6|||
44511675|NCT03135028|79516968|FG000|Overall Study|Study Terminated by Sponsor|2|||
44511676|NCT03135028|79516968|FG000|Overall Study|Withdrew Consent|1|||
44511677|NCT00228917|79516980|FG000|Overall Study|Migrated/moved from study area|0|||
44511678|NCT00228917|79516981|FG001|Overall Study|Migrated/moved from study area|0|||
44511679|NCT00228917|79516982|FG002|Overall Study|Migrated/moved from study area|0|||
44511680|NCT00228917|79516983|FG003|Overall Study|Migrated/moved from study area|0|||
44511681|NCT00228917|79516984|FG004|Overall Study|Migrated/moved from study area|0|||
44511682|NCT00228917|79516985|FG005|Overall Study|Migrated/moved from study area|2|||
44511683|NCT00228917|79516986|FG006|Overall Study|Migrated/moved from study area|0|||
44127814|NCT02718417|78913279|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
44127815|NCT02718417|78913277|FG000|Observation Phase (OP)|Adverse Event|0|||
44127816|NCT02718417|78913278|FG001|Observation Phase (OP)|Adverse Event|0|||
44127817|NCT02718417|78913279|FG002|Observation Phase (OP)|Adverse Event|1|||
44127818|NCT02718417|78913277|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
44511684|NCT00228917|79516987|FG007|Overall Study|Migrated/moved from study area|0|||
44511685|NCT00227903|79517003|FG000|Overall Study|Withdrawal by Subject|2|||
44127819|NCT02718417|78913278|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
44127820|NCT02718417|78913279|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
44127821|NCT02718417|78913277|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
44127822|NCT02718417|78913278|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
44127823|NCT02718417|78913279|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
44127824|NCT02718417|78913277|FG000|Observation Phase (OP)|Physician Decision|0|||
44243267|NCT01590758|79072705|FG001|Overall Study|Physician Decision|2|||
44276538|NCT02173704|79231605|FG000|Overall Study|Other|1|||
44127825|NCT02718417|78913278|FG001|Observation Phase (OP)|Physician Decision|0|||
44127826|NCT02718417|78913279|FG002|Observation Phase (OP)|Physician Decision|9|||
44127827|NCT02718417|78913277|FG000|Observation Phase (OP)|Progressive disease|0|||
44127828|NCT02718417|78913278|FG001|Observation Phase (OP)|Progressive disease|0|||
44127829|NCT02718417|78913279|FG002|Observation Phase (OP)|Progressive disease|92|||
44127830|NCT02718417|78913277|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
44127831|NCT02718417|78913278|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
44127832|NCT02718417|78913279|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
44127833|NCT02718417|78913277|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
44127834|NCT02718417|78913278|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
44127835|NCT02718417|78913279|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
44127836|NCT02718417|78913277|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
44127837|NCT02718417|78913278|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
44127838|NCT02718417|78913279|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
44127839|NCT02718417|78913277|FG000|Observation Phase (OP)|Other|0|||
44127840|NCT02718417|78913278|FG001|Observation Phase (OP)|Other|0|||
44127841|NCT02718417|78913279|FG002|Observation Phase (OP)|Other|7|||
44127842|NCT02718417|78913277|FG000|Follow-up Phase|Adverse Event|3|||
44127843|NCT02718417|78913278|FG001|Follow-up Phase|Adverse Event|1|||
44127844|NCT02718417|78913279|FG002|Follow-up Phase|Adverse Event|1|||
44127845|NCT02718417|78913277|FG000|Follow-up Phase|Other|4|||
44127846|NCT02718417|78913278|FG001|Follow-up Phase|Other|6|||
44127847|NCT02718417|78913279|FG002|Follow-up Phase|Other|4|||
44127848|NCT02718417|78913277|FG000|Follow-up Phase|Withdrawal by Subject|19|||
44127849|NCT02718417|78913278|FG001|Follow-up Phase|Withdrawal by Subject|17|||
44127850|NCT02718417|78913279|FG002|Follow-up Phase|Withdrawal by Subject|5|||
44127851|NCT02718417|78913277|FG000|Follow-up Phase|Study terminated by sponsor|100|||
44127852|NCT02718417|78913278|FG001|Follow-up Phase|Study terminated by sponsor|138|||
44127853|NCT02718417|78913279|FG002|Follow-up Phase|Study terminated by sponsor|6|||
44127854|NCT02718417|78913277|FG000|Follow-up Phase|Lost to Follow-up|2|||
44127855|NCT02718417|78913278|FG001|Follow-up Phase|Lost to Follow-up|3|||
44127856|NCT02718417|78913279|FG002|Follow-up Phase|Lost to Follow-up|0|||
44127857|NCT02718417|78913277|FG000|Follow-up Phase|Death leading to discontinuation|7|||
44127858|NCT02718417|78913278|FG001|Follow-up Phase|Death leading to discontinuation|7|||
44127859|NCT02718417|78913279|FG002|Follow-up Phase|Death leading to discontinuation|3|||
44127860|NCT02718417|78913277|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
44127861|NCT02718417|78913278|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
44127862|NCT02718417|78913279|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
44127863|NCT02718417|78913277|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
44127864|NCT02718417|78913278|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
44127865|NCT02718417|78913279|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
44127866|NCT02718417|78913277|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
44127867|NCT02718417|78913278|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
44243268|NCT01590758|79072704|FG000|Overall Study|Lost to Follow-up|4|||
44379413|NCT00770965|79385074|FG002|Excluded Set|Withdrawal by Subject|2|||
44379414|NCT00770965|79385075|FG003|Excluded Set|Withdrawal by Subject|3|||
44511686|NCT00227903|79517004|FG001|Overall Study|Withdrawal by Subject|5|||
44511687|NCT00227903|79517003|FG000|Overall Study|Subject moved out of area|1|||
44511688|NCT00227903|79517004|FG001|Overall Study|Subject moved out of area|2|||
44511689|NCT00227903|79517003|FG000|Overall Study|Lost to Follow-up|1|||
44511690|NCT00227903|79517004|FG001|Overall Study|Lost to Follow-up|3|||
44511691|NCT00227903|79517003|FG000|Overall Study|Miscarriage|1|||
44511692|NCT00227903|79517004|FG001|Overall Study|Miscarriage|0|||
44511693|NCT04411628|79517014|FG000|Overall Study|Withdrawal by Subject|1|||
44511694|NCT04411628|79517015|FG001|Overall Study|Withdrawal by Subject|1|||
44511695|NCT04411628|79517016|FG002|Overall Study|Withdrawal by Subject|2|||
44511696|NCT04411628|79517017|FG003|Overall Study|Withdrawal by Subject|0|||
44511697|NCT04411628|79517014|FG000|Overall Study|Lost to Follow-up|0|||
44511698|NCT04411628|79517015|FG001|Overall Study|Lost to Follow-up|1|||
44511699|NCT04411628|79517016|FG002|Overall Study|Lost to Follow-up|0|||
44511700|NCT04411628|79517017|FG003|Overall Study|Lost to Follow-up|0|||
44511701|NCT00227591|79517030|FG000|Overall Study|Withdrawal by Subject|1|||
44511702|NCT04512482|79517036|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
44511703|NCT04512482|79517037|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
44511704|NCT00226811|79517043|FG000|Overall Study|Death|8|||
44511705|NCT00226811|79517043|FG000|Overall Study|Adverse Event|11|||
44511706|NCT00226811|79517043|FG000|Overall Study|Lack of Efficacy|55|||
44511707|NCT00226811|79517043|FG000|Overall Study|Withdrawal by Subject|2|||
44127868|NCT02718417|78913279|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
44127869|NCT02718417|78913277|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
44379415|NCT00763555|79385087|FG000|Overall Study|Adverse Event|2|||
44511708|NCT00226655|79517047|FG000|Overall Study|Death|13|||
44511709|NCT00226655|79517047|FG000|Overall Study|Withdrawal by Subject|15|||
44511710|NCT00226655|79517047|FG000|Overall Study|Adverse Event|35|||
44127870|NCT02718417|78913278|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
44127871|NCT02718417|78913279|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
44127872|NCT02718417|78913277|FG000|Long-term Follow-up Phase|Other|0|||
44127873|NCT02718417|78913278|FG001|Long-term Follow-up Phase|Other|2|||
44127874|NCT02718417|78913279|FG002|Long-term Follow-up Phase|Other|0|||
44127875|NCT02640404|78913296|FG000|Overall Study|Protocol Violation|1|||
44127876|NCT02640404|78913297|FG001|Overall Study|Protocol Violation|0|||
44127877|NCT02640404|78913296|FG000|Overall Study|Withdrawal by Subject|1|||
44127878|NCT02640404|78913297|FG001|Overall Study|Withdrawal by Subject|0|||
44127879|NCT00701727|78913303|FG000|First Treatment Period|Adverse Event|0|||
44127880|NCT00701727|78913304|FG001|First Treatment Period|Adverse Event|0|||
44127881|NCT00701727|78913303|FG000|First Treatment Period|Withdrawal by Subject|1|||
44127882|NCT00701727|78913304|FG001|First Treatment Period|Withdrawal by Subject|0|||
44127883|NCT00701727|78913303|FG000|First Treatment Period|sponsor decision|0|||
44127884|NCT00701727|78913304|FG001|First Treatment Period|sponsor decision|1|||
44127885|NCT00701727|78913303|FG000|First Treatment Period|Lost to Follow-up|0|||
44127886|NCT00701727|78913304|FG001|First Treatment Period|Lost to Follow-up|1|||
44127887|NCT00701727|78913303|FG000|Second Treatment Period|Withdrawal by Subject|2|||
44127888|NCT00701727|78913304|FG001|Second Treatment Period|Withdrawal by Subject|0|||
44127889|NCT01369069|78913321|FG000|Overall Study|Lost to Follow-up|8|||
44127890|NCT01369069|78913322|FG001|Overall Study|Lost to Follow-up|9|||
44127891|NCT01369069|78913321|FG000|Overall Study|Withdrawal by Subject|9|||
44127892|NCT01369069|78913322|FG001|Overall Study|Withdrawal by Subject|7|||
44127893|NCT02441218|78913330|FG000|Overall Study|Death|503|||
44127894|NCT02441218|78913331|FG001|Overall Study|Death|553|||
44127895|NCT02441218|78913330|FG000|Overall Study|Withdrawal by Subject|73|||
44127896|NCT02441218|78913331|FG001|Overall Study|Withdrawal by Subject|58|||
44127897|NCT02441218|78913330|FG000|Overall Study|Lost to Follow-up|2|||
44127898|NCT02441218|78913331|FG001|Overall Study|Lost to Follow-up|1|||
44127899|NCT02410252|78913337|FG000|Overall Study|Withdrawal by Subject|4|||
44127900|NCT02410252|78913337|FG000|Overall Study|Physician Decision|2|||
44127901|NCT02440594|78913351|FG000|Overall Study|Lost to Follow-up|34|||
44127902|NCT02440594|78913352|FG001|Overall Study|Lost to Follow-up|33|||
44127903|NCT02440594|78913353|FG002|Overall Study|Lost to Follow-up|54|||
44127904|NCT02440594|78913354|FG003|Overall Study|Lost to Follow-up|47|||
44127905|NCT02440594|78913355|FG004|Overall Study|Lost to Follow-up|5|||
44127906|NCT02440594|78913356|FG005|Overall Study|Lost to Follow-up|4|||
44127907|NCT02440594|78913357|FG006|Overall Study|Lost to Follow-up|28|||
44127908|NCT02440594|78913358|FG007|Overall Study|Lost to Follow-up|48|||
44127909|NCT02440594|78913351|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
44127910|NCT02440594|78913352|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
44127911|NCT02440594|78913353|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
44127912|NCT02440594|78913354|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
44127913|NCT02440594|78913355|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
44127914|NCT02440594|78913356|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
44127915|NCT02440594|78913357|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
44127916|NCT02440594|78913358|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
44127917|NCT02440594|78913351|FG000|Overall Study|Withdrawal by Subject|81|||
44127918|NCT02440594|78913352|FG001|Overall Study|Withdrawal by Subject|67|||
44127919|NCT02440594|78913353|FG002|Overall Study|Withdrawal by Subject|59|||
44127920|NCT02440594|78913354|FG003|Overall Study|Withdrawal by Subject|38|||
44127921|NCT02440594|78913355|FG004|Overall Study|Withdrawal by Subject|2|||
44127922|NCT02440594|78913356|FG005|Overall Study|Withdrawal by Subject|2|||
44127923|NCT02440594|78913357|FG006|Overall Study|Withdrawal by Subject|7|||
44127924|NCT02440594|78913358|FG007|Overall Study|Withdrawal by Subject|7|||
44127925|NCT02440594|78913351|FG000|Overall Study|Administratively w/drawn|3|||
44127926|NCT02440594|78913352|FG001|Overall Study|Administratively w/drawn|2|||
44127927|NCT02440594|78913353|FG002|Overall Study|Administratively w/drawn|0|||
44127928|NCT02440594|78913354|FG003|Overall Study|Administratively w/drawn|0|||
44127929|NCT02440594|78913355|FG004|Overall Study|Administratively w/drawn|0|||
44127930|NCT02440594|78913356|FG005|Overall Study|Administratively w/drawn|0|||
44127931|NCT02440594|78913357|FG006|Overall Study|Administratively w/drawn|2|||
44127932|NCT02440594|78913358|FG007|Overall Study|Administratively w/drawn|1|||
44127933|NCT03836001|78913385|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
44127934|NCT03836001|78913386|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
44127935|NCT03836001|78913387|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
44127936|NCT03836001|78913385|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
44127937|NCT03836001|78913386|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
44127938|NCT03836001|78913387|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
44127939|NCT03836001|78913385|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
44127940|NCT03836001|78913386|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
44127941|NCT03836001|78913387|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
44127942|NCT03836001|78913385|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
44127943|NCT03836001|78913386|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
44127944|NCT03836001|78913387|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
44127945|NCT02465866|78913394|FG000|Period 3|Withdrawal by Subject|0|||
44127946|NCT02465866|78913395|FG001|Period 3|Withdrawal by Subject|1|||
44127947|NCT02465866|78913396|FG002|Period 3|Withdrawal by Subject|0|||
44127948|NCT02465866|78913397|FG003|Period 3|Withdrawal by Subject|0|||
44127949|NCT02439970|78913409|FG000|Overall Study|Study Terminated|2|||
44127950|NCT02439970|78913410|FG001|Overall Study|Study Terminated|3|||
44127951|NCT02437864|78913418|FG000|Overall Study|Protocol Violation|4|||
44127952|NCT02437864|78913419|FG001|Overall Study|Protocol Violation|0|||
44127953|NCT02408068|78913425|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
44127954|NCT02408068|78913426|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
44127955|NCT02408068|78913427|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
44127956|NCT02408068|78913428|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
44127957|NCT02408068|78913429|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
44511711|NCT00226655|79517047|FG000|Overall Study|Physician Decision|6|||
44511712|NCT00226655|79517047|FG000|Overall Study|Clinical deterioration|10|||
44511713|NCT03124108|79517063|FG000|Overall Study|Adverse Event|0|||
44511714|NCT03124108|79517064|FG001|Overall Study|Adverse Event|1|||
44127958|NCT02408068|78913430|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
44511715|NCT03124108|79517065|FG002|Overall Study|Adverse Event|0|||
44511716|NCT04475588|79517077|FG000|Overall Study|Adverse Event|2|||
44511717|NCT04475588|79517078|FG001|Overall Study|Adverse Event|0|||
44511718|NCT04353596|79517087|FG000|Overall Study|Protocol Violation|4|||
44511719|NCT04353596|79517088|FG001|Overall Study|Protocol Violation|4|||
44511720|NCT04353596|79517087|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
44511721|NCT04353596|79517088|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
44127959|NCT01361126|78913443|FG000|Overall Study|Sponsor decision|0|||
44127960|NCT01361126|78913444|FG001|Overall Study|Sponsor decision|2|||
44127961|NCT04428645|78913451|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
44243269|NCT01590758|79072705|FG001|Overall Study|Lost to Follow-up|2|||
44243270|NCT01590212|79072714|FG000|Overall Study|Withdrawal by Subject|2|||
44511722|NCT04350788|79517096|FG000|Overall Study|Lost to Follow-up|6|||
44127962|NCT01368835|78913455|FG000|Overall Study|Inclusion criteria/photography quality|22|||
44127963|NCT01368835|78913455|FG000|Overall Study|Lost to Follow-up|11|||
44127964|NCT02407990|78913474|FG000|Overall Study|Death|2|||
44127965|NCT02407990|78913475|FG001|Overall Study|Death|22|||
44127966|NCT02407990|78913476|FG002|Overall Study|Death|23|||
44127967|NCT02407990|78913477|FG003|Overall Study|Death|7|||
44127968|NCT02407990|78913478|FG004|Overall Study|Death|17|||
44127969|NCT02407990|78913479|FG005|Overall Study|Death|16|||
44127970|NCT02407990|78913480|FG006|Overall Study|Death|10|||
44127971|NCT02407990|78913481|FG007|Overall Study|Death|248|||
44127972|NCT02407990|78913474|FG000|Overall Study|Lost to Follow-up|0|||
44127973|NCT02407990|78913475|FG001|Overall Study|Lost to Follow-up|1|||
44127974|NCT02407990|78913476|FG002|Overall Study|Lost to Follow-up|0|||
44127975|NCT02407990|78913477|FG003|Overall Study|Lost to Follow-up|0|||
44127976|NCT02407990|78913478|FG004|Overall Study|Lost to Follow-up|0|||
44127977|NCT02407990|78913479|FG005|Overall Study|Lost to Follow-up|0|||
44127978|NCT02407990|78913480|FG006|Overall Study|Lost to Follow-up|0|||
44127979|NCT02407990|78913481|FG007|Overall Study|Lost to Follow-up|17|||
44127980|NCT02407990|78913474|FG000|Overall Study|Progressive Disease|0|||
44127981|NCT02407990|78913475|FG001|Overall Study|Progressive Disease|0|||
44127982|NCT02407990|78913476|FG002|Overall Study|Progressive Disease|0|||
44127983|NCT02407990|78913477|FG003|Overall Study|Progressive Disease|0|||
44127984|NCT02407990|78913478|FG004|Overall Study|Progressive Disease|0|||
44127985|NCT02407990|78913479|FG005|Overall Study|Progressive Disease|0|||
44127986|NCT02407990|78913480|FG006|Overall Study|Progressive Disease|0|||
44127987|NCT02407990|78913481|FG007|Overall Study|Progressive Disease|1|||
44127988|NCT02407990|78913474|FG000|Overall Study|Withdrawal by Subject|0|||
44127989|NCT02407990|78913475|FG001|Overall Study|Withdrawal by Subject|0|||
44127990|NCT02407990|78913476|FG002|Overall Study|Withdrawal by Subject|0|||
44127991|NCT02407990|78913477|FG003|Overall Study|Withdrawal by Subject|0|||
44127992|NCT02407990|78913478|FG004|Overall Study|Withdrawal by Subject|1|||
44127993|NCT02407990|78913479|FG005|Overall Study|Withdrawal by Subject|0|||
44127994|NCT02407990|78913480|FG006|Overall Study|Withdrawal by Subject|0|||
44127995|NCT02407990|78913481|FG007|Overall Study|Withdrawal by Subject|30|||
44127996|NCT02407990|78913474|FG000|Overall Study|Study Terminated by Sponsor|1|||
44127997|NCT02407990|78913475|FG001|Overall Study|Study Terminated by Sponsor|3|||
44127998|NCT02407990|78913476|FG002|Overall Study|Study Terminated by Sponsor|3|||
44127999|NCT02407990|78913477|FG003|Overall Study|Study Terminated by Sponsor|0|||
44128000|NCT02407990|78913478|FG004|Overall Study|Study Terminated by Sponsor|3|||
44128001|NCT02407990|78913479|FG005|Overall Study|Study Terminated by Sponsor|4|||
44128002|NCT02407990|78913480|FG006|Overall Study|Study Terminated by Sponsor|3|||
44128003|NCT02407990|78913481|FG007|Overall Study|Study Terminated by Sponsor|37|||
44128004|NCT02407990|78913474|FG000|Overall Study|Logistics|0|||
44128005|NCT02407990|78913475|FG001|Overall Study|Logistics|0|||
44128006|NCT02407990|78913476|FG002|Overall Study|Logistics|0|||
44128007|NCT02407990|78913477|FG003|Overall Study|Logistics|0|||
44128008|NCT02407990|78913478|FG004|Overall Study|Logistics|0|||
44128009|NCT02407990|78913479|FG005|Overall Study|Logistics|0|||
44128010|NCT02407990|78913480|FG006|Overall Study|Logistics|0|||
44128011|NCT02407990|78913481|FG007|Overall Study|Logistics|1|||
44128012|NCT02407990|78913474|FG000|Overall Study|Rolled into long-term extension study|0|||
44128013|NCT02407990|78913475|FG001|Overall Study|Rolled into long-term extension study|0|||
44379416|NCT00763555|79385088|FG001|Overall Study|Adverse Event|1|||
44379417|NCT00763555|79385087|FG000|Overall Study|Withdrawal by Subject|2|||
44379418|NCT00763555|79385088|FG001|Overall Study|Withdrawal by Subject|6|||
44511723|NCT04350788|79517097|FG001|Overall Study|Lost to Follow-up|2|||
44511724|NCT04350788|79517096|FG000|Overall Study|Withdrawal by Subject|2|||
44511725|NCT04350788|79517097|FG001|Overall Study|Withdrawal by Subject|4|||
44511726|NCT04350788|79517096|FG000|Overall Study|Protocol Violation|4|||
44511727|NCT04350788|79517097|FG001|Overall Study|Protocol Violation|0|||
44511728|NCT03852316|79517108|FG000|Overall Study|Protocol Violation|1|||
44511729|NCT03852316|79517108|FG000|Overall Study|Withdrawal by Subject|2|||
44511730|NCT03852316|79517108|FG000|Overall Study|Enrolled but Device not Utilized|1|||
44511731|NCT04335812|79517114|FG000|Overall Study|Withdrawal by Subject|1|||
44128014|NCT02407990|78913476|FG002|Overall Study|Rolled into long-term extension study|0|||
44128015|NCT02407990|78913477|FG003|Overall Study|Rolled into long-term extension study|0|||
44128016|NCT02407990|78913478|FG004|Overall Study|Rolled into long-term extension study|0|||
44128017|NCT02407990|78913479|FG005|Overall Study|Rolled into long-term extension study|0|||
44128018|NCT02407990|78913480|FG006|Overall Study|Rolled into long-term extension study|0|||
44511732|NCT04335812|79517115|FG001|Overall Study|Withdrawal by Subject|3|||
44128019|NCT02407990|78913481|FG007|Overall Study|Rolled into long-term extension study|1|||
44128020|NCT03288129|78913505|FG000|Overall Study|Adverse Event|10|||
44128021|NCT03288129|78913505|FG000|Overall Study|Lost to Follow-up|3|||
44128022|NCT03288129|78913505|FG000|Overall Study|Withdrawal by Subject|3|||
44128023|NCT03288129|78913505|FG000|Overall Study|Withdrawal of consent/assent|1|||
44128024|NCT03288129|78913505|FG000|Overall Study|Other|5|||
44128025|NCT01673282|78913511|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
44128026|NCT01673282|78913512|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
44128027|NCT01673282|78913511|FG000|Overall Study|Lack of Efficacy|9|||
44128028|NCT01673282|78913512|FG001|Overall Study|Lack of Efficacy|2|||
44128029|NCT01673282|78913511|FG000|Overall Study|Lost to Follow-up|11|||
44128030|NCT01673282|78913512|FG001|Overall Study|Lost to Follow-up|10|||
44128031|NCT01673282|78913511|FG000|Overall Study|Withdrawal by Subject|3|||
44128032|NCT01673282|78913512|FG001|Overall Study|Withdrawal by Subject|3|||
44128033|NCT01673282|78913511|FG000|Overall Study|Other|1|||
44128034|NCT01673282|78913512|FG001|Overall Study|Other|6|||
44128035|NCT04157751|78913520|FG000|Overall Study|Withdrawal by Subject|12|||
44128036|NCT04157751|78913521|FG001|Overall Study|Withdrawal by Subject|17|||
44128037|NCT04157751|78913520|FG000|Overall Study|Lost to Follow-up|6|||
44128038|NCT04157751|78913521|FG001|Overall Study|Lost to Follow-up|2|||
44128039|NCT04157751|78913520|FG000|Overall Study|Adverse Event|34|||
44128040|NCT04157751|78913521|FG001|Overall Study|Adverse Event|23|||
44128041|NCT04157751|78913520|FG000|Overall Study|Not treated|1|||
44128042|NCT04157751|78913521|FG001|Overall Study|Not treated|5|||
44128043|NCT04157751|78913520|FG000|Overall Study|Other reason not stated above|10|||
44128044|NCT04157751|78913521|FG001|Overall Study|Other reason not stated above|10|||
44128045|NCT01673126|78913529|FG000|Overall Study|change of diagnosis|4|||
44128046|NCT01673126|78913530|FG001|Overall Study|change of diagnosis|3|||
44128047|NCT02407054|78913539|FG000|Overall Study|Adverse Event|1|||
44128048|NCT02407054|78913540|FG001|Overall Study|Adverse Event|4|||
44128049|NCT02407054|78913541|FG002|Overall Study|Adverse Event|1|||
44128050|NCT02407054|78913539|FG000|Overall Study|Non-compliance with Study|0|||
44128051|NCT02407054|78913540|FG001|Overall Study|Non-compliance with Study|2|||
44128052|NCT02407054|78913541|FG002|Overall Study|Non-compliance with Study|1|||
44128053|NCT02407054|78913539|FG000|Overall Study|Physician Decision|1|||
44128054|NCT02407054|78913540|FG001|Overall Study|Physician Decision|3|||
44128055|NCT02407054|78913541|FG002|Overall Study|Physician Decision|3|||
44128056|NCT02407054|78913539|FG000|Overall Study|Withdrawal by Subject|5|||
44128057|NCT02407054|78913540|FG001|Overall Study|Withdrawal by Subject|9|||
44128058|NCT02407054|78913541|FG002|Overall Study|Withdrawal by Subject|2|||
44128059|NCT01652716|78913552|FG000|Overall Study|Loss of glucose control|1|||
44128060|NCT01652716|78913553|FG001|Overall Study|Loss of glucose control|0|||
44128061|NCT01652716|78913552|FG000|Overall Study|Administrative|0|||
44128062|NCT01652716|78913553|FG001|Overall Study|Administrative|2|||
44128063|NCT01652716|78913552|FG000|Overall Study|Investigator decision|1|||
44128064|NCT01652716|78913553|FG001|Overall Study|Investigator decision|4|||
44128065|NCT01652716|78913552|FG000|Overall Study|Lost to Follow-up|12|||
44128066|NCT01652716|78913553|FG001|Overall Study|Lost to Follow-up|11|||
44128067|NCT01652716|78913552|FG000|Overall Study|Protocol Violation|2|||
44128068|NCT01652716|78913553|FG001|Overall Study|Protocol Violation|1|||
44128069|NCT01652716|78913552|FG000|Overall Study|Adverse Event|7|||
44128070|NCT01652716|78913553|FG001|Overall Study|Adverse Event|10|||
44128071|NCT01652716|78913552|FG000|Overall Study|Withdrawal by Subject|33|||
44128072|NCT01652716|78913553|FG001|Overall Study|Withdrawal by Subject|18|||
44128073|NCT02790073|78913559|FG000|Overall Study|Death|1|||
44128074|NCT02790073|78913559|FG000|Overall Study|Withdrawal from HD|1|||
44128075|NCT02790073|78913559|FG000|Overall Study|Withdrawal by Subject|1|||
44128076|NCT02789137|78913563|FG000|Overall Study|Dropped out/Died|58|||
44128077|NCT01672970|78913568|FG000|Overall Study|Lack of Efficacy|12|||
44128078|NCT01672970|78913568|FG000|Overall Study|Adverse Event|18|||
44128079|NCT01672970|78913568|FG000|Overall Study|Withdrawal by Subject|2|||
44128080|NCT01672970|78913568|FG000|Overall Study|Lost to Follow-up|5|||
44128081|NCT01672970|78913568|FG000|Overall Study|Other|9|||
44128082|NCT01672970|78913568|FG000|Overall Study|Enrolled but not treated|1|||
44128083|NCT02788747|78913575|FG000|Overall Study|Adverse Event|1|||
44128084|NCT02788747|78913576|FG001|Overall Study|Adverse Event|0|||
44128085|NCT02788747|78913577|FG002|Overall Study|Adverse Event|0|||
44128086|NCT02406742|78913591|FG000|Overall Study|Progression of Disease|5|||
44128087|NCT02406742|78913592|FG001|Overall Study|Progression of Disease|1|||
44128088|NCT02406742|78913593|FG002|Overall Study|Progression of Disease|6|||
44128089|NCT02406742|78913591|FG000|Overall Study|Adverse Event|3|||
44379419|NCT00763555|79385087|FG000|Overall Study|Lost to Follow-up|0|||
44128090|NCT02406742|78913592|FG001|Overall Study|Adverse Event|0|||
44128091|NCT02406742|78913593|FG002|Overall Study|Adverse Event|2|||
44128092|NCT02406742|78913591|FG000|Overall Study|Death|1|||
44128093|NCT02406742|78913592|FG001|Overall Study|Death|0|||
44128094|NCT02406742|78913593|FG002|Overall Study|Death|0|||
44128095|NCT02406742|78913591|FG000|Overall Study|Lack of Efficacy|0|||
44128096|NCT02406742|78913592|FG001|Overall Study|Lack of Efficacy|0|||
44128097|NCT02406742|78913593|FG002|Overall Study|Lack of Efficacy|1|||
44128098|NCT02406742|78913591|FG000|Overall Study|Withdrawal by Participant|1|||
44128099|NCT02406742|78913592|FG001|Overall Study|Withdrawal by Participant|2|||
44128100|NCT02406742|78913593|FG002|Overall Study|Withdrawal by Participant|0|||
44128101|NCT02406742|78913591|FG000|Overall Study|Physician Decision|1|||
44128102|NCT02406742|78913592|FG001|Overall Study|Physician Decision|2|||
44128103|NCT02406742|78913593|FG002|Overall Study|Physician Decision|1|||
44128104|NCT02406742|78913591|FG000|Overall Study|Transition to other treatment|2|||
44128105|NCT02406742|78913592|FG001|Overall Study|Transition to other treatment|0|||
44128106|NCT02406742|78913593|FG002|Overall Study|Transition to other treatment|1|||
44128107|NCT02406742|78913591|FG000|Overall Study|Other Reasons|1|||
44128108|NCT02406742|78913592|FG001|Overall Study|Other Reasons|11|||
44128109|NCT02406742|78913593|FG002|Overall Study|Other Reasons|5|||
44128110|NCT02714595|78913603|FG000|Overall Study|Lost to Follow-up|1|||
44128111|NCT02714595|78913604|FG001|Overall Study|Lost to Follow-up|0|||
44128112|NCT02714595|78913603|FG000|Overall Study|Withdrawal by Subject|1|||
44128113|NCT02714595|78913604|FG001|Overall Study|Withdrawal by Subject|2|||
44128114|NCT02714595|78913603|FG000|Overall Study|Lack of Efficacy|0|||
44128115|NCT02714595|78913604|FG001|Overall Study|Lack of Efficacy|1|||
44128116|NCT02714595|78913603|FG000|Overall Study|Death|30|||
44128117|NCT02714595|78913604|FG001|Overall Study|Death|9|||
44128118|NCT02714595|78913603|FG000|Overall Study|Other-Miscellaneous|0|||
44128119|NCT02714595|78913604|FG001|Overall Study|Other-Miscellaneous|1|||
44128120|NCT02437162|78913631|FG000|Overall Study|Protocol Violation|0|||
44128121|NCT02437162|78913632|FG001|Overall Study|Protocol Violation|1|||
44128122|NCT02437162|78913633|FG002|Overall Study|Protocol Violation|0|||
44128123|NCT02437162|78913631|FG000|Overall Study|Randomized but not treated|0|||
44128124|NCT02437162|78913632|FG001|Overall Study|Randomized but not treated|0|||
44128125|NCT02437162|78913633|FG002|Overall Study|Randomized but not treated|1|||
44128126|NCT02437162|78913631|FG000|Overall Study|Study discontinued by Sponsor|93|||
44128127|NCT02437162|78913632|FG001|Overall Study|Study discontinued by Sponsor|98|||
44128128|NCT02437162|78913633|FG002|Overall Study|Study discontinued by Sponsor|97|||
44128129|NCT02437162|78913631|FG000|Overall Study|Withdrawal by Subject|13|||
44128130|NCT02437162|78913632|FG001|Overall Study|Withdrawal by Subject|7|||
44128131|NCT02437162|78913633|FG002|Overall Study|Withdrawal by Subject|9|||
44128132|NCT02437162|78913631|FG000|Overall Study|Adverse Event|0|||
44128133|NCT02437162|78913632|FG001|Overall Study|Adverse Event|1|||
44128134|NCT02437162|78913633|FG002|Overall Study|Adverse Event|0|||
44128135|NCT02437162|78913631|FG000|Overall Study|Lost to Follow-up|1|||
44128136|NCT02437162|78913632|FG001|Overall Study|Lost to Follow-up|0|||
44128137|NCT02437162|78913633|FG002|Overall Study|Lost to Follow-up|1|||
44128138|NCT02437162|78913631|FG000|Overall Study|Death|0|||
44128139|NCT02437162|78913632|FG001|Overall Study|Death|1|||
44511733|NCT04335812|79517114|FG000|Overall Study|Lost to Follow-up|12|||
44128140|NCT02437162|78913633|FG002|Overall Study|Death|0|||
44128141|NCT02437162|78913631|FG000|Overall Study|Other|0|||
44128142|NCT02437162|78913632|FG001|Overall Study|Other|0|||
44128143|NCT02437162|78913633|FG002|Overall Study|Other|1|||
44128144|NCT01368211|78913648|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
44511734|NCT04335812|79517115|FG001|Overall Study|Lost to Follow-up|12|||
44511735|NCT04335812|79517114|FG000|Overall Study|Did not engage in the intervention|22|||
44511736|NCT04335812|79517115|FG001|Overall Study|Did not engage in the intervention|18|||
44511737|NCT03127384|79517121|FG000|Overall Study|Lost to Follow-up|4|||
44511738|NCT03127384|79517121|FG000|Overall Study|Subject request|2|||
44128145|NCT01368211|78913649|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
44511739|NCT04398134|79517148|FG000|Overall Study|Adverse Event|0|||
44511740|NCT04398134|79517149|FG001|Overall Study|Adverse Event|0|||
44511741|NCT04398134|79517150|FG002|Overall Study|Adverse Event|1|||
44511742|NCT04398134|79517151|FG003|Overall Study|Adverse Event|0|||
44511743|NCT04398134|79517148|FG000|Overall Study|Withdrawal by Subject|2|||
44511744|NCT04398134|79517149|FG001|Overall Study|Withdrawal by Subject|0|||
44511745|NCT04398134|79517150|FG002|Overall Study|Withdrawal by Subject|0|||
44511746|NCT04398134|79517151|FG003|Overall Study|Withdrawal by Subject|1|||
44511747|NCT04398134|79517148|FG000|Overall Study|Study Terminated by Sponsor|30|||
44511748|NCT04398134|79517149|FG001|Overall Study|Study Terminated by Sponsor|11|||
44511749|NCT04398134|79517150|FG002|Overall Study|Study Terminated by Sponsor|32|||
44511750|NCT04398134|79517151|FG003|Overall Study|Study Terminated by Sponsor|11|||
44511751|NCT03122860|79517167|FG000|Overall Study|Discontinued Before Treatment|1|||
44511752|NCT03122860|79517168|FG001|Overall Study|Discontinued Before Treatment|1|||
44511753|NCT03122860|79517169|FG002|Overall Study|Discontinued Before Treatment|2|||
44128146|NCT02437084|78913655|FG000|Overall Study|Withdrawal by Subject|2|||
44128147|NCT02437084|78913655|FG000|Overall Study|Physician Decision|1|||
44128148|NCT02406586|78913662|FG000|Overall Study|Lost to Follow-up|0|||
44128149|NCT02406586|78913663|FG001|Overall Study|Lost to Follow-up|4|||
44128150|NCT02406586|78913664|FG002|Overall Study|Lost to Follow-up|2|||
44128151|NCT02406586|78913662|FG000|Overall Study|Withdrawal by Subject|1|||
44128152|NCT02406586|78913663|FG001|Overall Study|Withdrawal by Subject|0|||
44128153|NCT02406586|78913664|FG002|Overall Study|Withdrawal by Subject|0|||
44128154|NCT02460562|78913677|FG000|Overall Study|Lost to Follow-up|15|||
44128155|NCT02460562|78913678|FG001|Overall Study|Lost to Follow-up|16|||
44128156|NCT02788357|78913686|FG000|Overall Study|Lost to Follow-up|3|||
44128157|NCT02788357|78913687|FG001|Overall Study|Lost to Follow-up|0|||
44128158|NCT02457910|78913699|FG000|Overall Study|Withdrawal by Subject|0|||
44128159|NCT02457910|78913700|FG001|Overall Study|Withdrawal by Subject|0|||
44128160|NCT02457910|78913701|FG002|Overall Study|Withdrawal by Subject|0|||
44128161|NCT02457910|78913702|FG003|Overall Study|Withdrawal by Subject|0|||
44128162|NCT02457910|78913703|FG004|Overall Study|Withdrawal by Subject|0|||
44128163|NCT02457910|78913704|FG005|Overall Study|Withdrawal by Subject|1|||
44128164|NCT02457910|78913699|FG000|Overall Study|Adverse Event|0|||
44128165|NCT02457910|78913700|FG001|Overall Study|Adverse Event|2|||
44128166|NCT02457910|78913701|FG002|Overall Study|Adverse Event|1|||
44128167|NCT02457910|78913702|FG003|Overall Study|Adverse Event|1|||
44128168|NCT02457910|78913703|FG004|Overall Study|Adverse Event|1|||
44128169|NCT02457910|78913704|FG005|Overall Study|Adverse Event|3|||
44128170|NCT02457910|78913699|FG000|Overall Study|Disease progression|3|||
44128171|NCT02457910|78913700|FG001|Overall Study|Disease progression|3|||
44128172|NCT02457910|78913701|FG002|Overall Study|Disease progression|1|||
44128173|NCT02457910|78913702|FG003|Overall Study|Disease progression|1|||
44128174|NCT02457910|78913703|FG004|Overall Study|Disease progression|4|||
44128175|NCT02457910|78913704|FG005|Overall Study|Disease progression|6|||
44128176|NCT02457910|78913699|FG000|Overall Study|Other complicating illness|0|||
44128177|NCT02457910|78913700|FG001|Overall Study|Other complicating illness|0|||
44128178|NCT02457910|78913701|FG002|Overall Study|Other complicating illness|0|||
44128179|NCT02457910|78913702|FG003|Overall Study|Other complicating illness|0|||
44128180|NCT02457910|78913703|FG004|Overall Study|Other complicating illness|0|||
44128181|NCT02457910|78913704|FG005|Overall Study|Other complicating illness|1|||
44128182|NCT02457910|78913699|FG000|Overall Study|Death|0|||
44128183|NCT02457910|78913700|FG001|Overall Study|Death|0|||
44128184|NCT02457910|78913701|FG002|Overall Study|Death|1|||
44128185|NCT02457910|78913702|FG003|Overall Study|Death|0|||
44128186|NCT02457910|78913703|FG004|Overall Study|Death|0|||
44128187|NCT02457910|78913704|FG005|Overall Study|Death|0|||
44128188|NCT02405962|78913723|FG000|Overall Study|Lost to Follow-up|1|||
44128189|NCT02405962|78913724|FG001|Overall Study|Lost to Follow-up|4|||
44128190|NCT02405962|78913723|FG000|Overall Study|A participant has moved to another place|0|||
44128191|NCT02405962|78913724|FG001|Overall Study|A participant has moved to another place|1|||
44128192|NCT02436304|78913733|FG000|Overall Study|Lost to Follow-up|0|||
44128193|NCT02436304|78913734|FG001|Overall Study|Lost to Follow-up|1|||
44128194|NCT02436304|78913735|FG002|Overall Study|Lost to Follow-up|0|||
44128195|NCT02436304|78913733|FG000|Overall Study|Withdrawal by Subject|0|||
44511754|NCT03122860|79517170|FG003|Overall Study|Discontinued Before Treatment|0|||
44511755|NCT03122860|79517171|FG004|Overall Study|Discontinued Before Treatment|1|||
44511756|NCT03122860|79517172|FG005|Overall Study|Discontinued Before Treatment|0|||
44511757|NCT03122860|79517167|FG000|Overall Study|Adverse Event|1|||
44511758|NCT03122860|79517168|FG001|Overall Study|Adverse Event|0|||
44128196|NCT02436304|78913734|FG001|Overall Study|Withdrawal by Subject|1|||
44128197|NCT02436304|78913735|FG002|Overall Study|Withdrawal by Subject|0|||
44128198|NCT02436304|78913733|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
44128199|NCT02436304|78913734|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
44128200|NCT02436304|78913735|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
44128201|NCT02402218|78913747|FG000|Overall Study|Did not pickup study medication|12|||
44128202|NCT02402218|78913748|FG001|Overall Study|Did not pickup study medication|9|||
44128203|NCT02402218|78913749|FG002|Overall Study|Did not pickup study medication|13|||
44128204|NCT02402218|78913747|FG000|Overall Study|Lack of Efficacy|0|||
44128205|NCT02402218|78913748|FG001|Overall Study|Lack of Efficacy|1|||
44128206|NCT02402218|78913749|FG002|Overall Study|Lack of Efficacy|1|||
44128207|NCT02402218|78913747|FG000|Overall Study|Death|1|||
44128208|NCT02402218|78913748|FG001|Overall Study|Death|0|||
44128209|NCT02402218|78913749|FG002|Overall Study|Death|0|||
44511759|NCT03122860|79517169|FG002|Overall Study|Adverse Event|1|||
44511760|NCT03122860|79517170|FG003|Overall Study|Adverse Event|1|||
44511761|NCT03122860|79517171|FG004|Overall Study|Adverse Event|0|||
44128210|NCT02402218|78913747|FG000|Overall Study|Reinfection|0|||
44511762|NCT03122860|79517172|FG005|Overall Study|Adverse Event|0|||
44128211|NCT02402218|78913748|FG001|Overall Study|Reinfection|0|||
44128212|NCT02402218|78913749|FG002|Overall Study|Reinfection|1|||
44128213|NCT02402218|78913747|FG000|Overall Study|Adverse Event|0|||
44128214|NCT02402218|78913748|FG001|Overall Study|Adverse Event|2|||
44128215|NCT02402218|78913749|FG002|Overall Study|Adverse Event|1|||
44128216|NCT02402218|78913747|FG000|Overall Study|Withdrawal by Subject|1|||
44128217|NCT02402218|78913748|FG001|Overall Study|Withdrawal by Subject|1|||
44128218|NCT02402218|78913749|FG002|Overall Study|Withdrawal by Subject|1|||
44128219|NCT02457520|78913757|FG000|Active Treatment Phase|Adverse Event|10|||
44128220|NCT02457520|78913757|FG000|Active Treatment Phase|Lost to Follow-up|8|||
44128221|NCT02457520|78913757|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
44128222|NCT02457520|78913757|FG000|Active Treatment Phase|other|4|||
44128223|NCT02457520|78913757|FG000|Active Treatment Phase|Physician Decision|1|||
44128224|NCT02457520|78913757|FG000|Active Treatment Phase|Protocol Violation|1|||
44128225|NCT02457520|78913757|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
44128226|NCT02457520|78913757|FG000|Post-treatment Period|Other: Retreatment Required|7|||
44128227|NCT02457520|78913757|FG000|Post-treatment Period|Lost to Follow-up|23|||
44128228|NCT02457520|78913757|FG000|Post-treatment Period|Other|3|||
44128229|NCT02457520|78913757|FG000|Post-treatment Period|Physician Decision|1|||
44128230|NCT02457520|78913757|FG000|Post-treatment Period|Withdrawal by Subject|14|||
44128231|NCT02788279|78913790|FG000|Overall Study|Death|62|||
44128232|NCT02788279|78913791|FG001|Overall Study|Death|136|||
44128233|NCT02788279|78913792|FG002|Overall Study|Death|72|||
44128234|NCT02788279|78913790|FG000|Overall Study|Withdrawal by Subject|10|||
44128235|NCT02788279|78913791|FG001|Overall Study|Withdrawal by Subject|15|||
44128236|NCT02788279|78913792|FG002|Overall Study|Withdrawal by Subject|5|||
44128237|NCT02788279|78913790|FG000|Overall Study|Lost to Follow-up|0|||
44128238|NCT02788279|78913791|FG001|Overall Study|Lost to Follow-up|3|||
44128239|NCT02788279|78913792|FG002|Overall Study|Lost to Follow-up|2|||
44128240|NCT02788279|78913790|FG000|Overall Study|Sponsor decision|18|||
44128241|NCT02788279|78913791|FG001|Overall Study|Sponsor decision|29|||
44128242|NCT02788279|78913792|FG002|Overall Study|Sponsor decision|11|||
44128243|NCT02435992|78913808|FG000|Overall Study|non compliance with protocol|2|||
44128244|NCT02435992|78913809|FG001|Overall Study|non compliance with protocol|0|||
44128245|NCT02435992|78913810|FG002|Overall Study|non compliance with protocol|1|||
44128246|NCT02435992|78913811|FG003|Overall Study|non compliance with protocol|0|||
44128247|NCT02435992|78913812|FG004|Overall Study|non compliance with protocol|0|||
44128248|NCT02435992|78913808|FG000|Overall Study|Adverse Event|11|||
44128249|NCT02435992|78913809|FG001|Overall Study|Adverse Event|6|||
44128250|NCT02435992|78913810|FG002|Overall Study|Adverse Event|12|||
44128251|NCT02435992|78913811|FG003|Overall Study|Adverse Event|0|||
44128252|NCT02435992|78913812|FG004|Overall Study|Adverse Event|0|||
44128253|NCT02435992|78913808|FG000|Overall Study|Lack of Efficacy|4|||
44128254|NCT02435992|78913809|FG001|Overall Study|Lack of Efficacy|10|||
44128255|NCT02435992|78913810|FG002|Overall Study|Lack of Efficacy|9|||
44128256|NCT02435992|78913811|FG003|Overall Study|Lack of Efficacy|0|||
44128257|NCT02435992|78913812|FG004|Overall Study|Lack of Efficacy|0|||
44128258|NCT02435992|78913808|FG000|Overall Study|Withdrawal by Subject|10|||
44128259|NCT02435992|78913809|FG001|Overall Study|Withdrawal by Subject|8|||
44128260|NCT02435992|78913810|FG002|Overall Study|Withdrawal by Subject|20|||
44128261|NCT02435992|78913811|FG003|Overall Study|Withdrawal by Subject|0|||
44128262|NCT02435992|78913812|FG004|Overall Study|Withdrawal by Subject|0|||
44128263|NCT02435992|78913808|FG000|Overall Study|Other Reason|1|||
44128264|NCT02435992|78913809|FG001|Overall Study|Other Reason|0|||
44128265|NCT02435992|78913810|FG002|Overall Study|Other Reason|0|||
44128266|NCT02435992|78913811|FG003|Overall Study|Other Reason|0|||
44128267|NCT02435992|78913812|FG004|Overall Study|Other Reason|0|||
44128268|NCT02435992|78913808|FG000|Overall Study|Physician Decision|0|||
44128269|NCT02435992|78913809|FG001|Overall Study|Physician Decision|0|||
44128270|NCT02435992|78913810|FG002|Overall Study|Physician Decision|1|||
44128271|NCT02435992|78913811|FG003|Overall Study|Physician Decision|0|||
44128272|NCT02435992|78913812|FG004|Overall Study|Physician Decision|0|||
44128273|NCT02788513|78913829|FG000|Overall Study|Withdrawal by Subject|3|||
44128274|NCT02788513|78913830|FG001|Overall Study|Withdrawal by Subject|0|||
44128275|NCT02788513|78913831|FG002|Overall Study|Withdrawal by Subject|2|||
44128276|NCT02788513|78913832|FG003|Overall Study|Withdrawal by Subject|3|||
44128277|NCT02788513|78913833|FG004|Overall Study|Withdrawal by Subject|1|||
44128278|NCT02788513|78913829|FG000|Overall Study|Lost to Follow-up|1|||
44128279|NCT02788513|78913830|FG001|Overall Study|Lost to Follow-up|0|||
44128280|NCT02788513|78913831|FG002|Overall Study|Lost to Follow-up|0|||
44379420|NCT00763555|79385088|FG001|Overall Study|Lost to Follow-up|3|||
44379421|NCT00763321|79385097|FG000|Open-label Period|Adverse Event|24|||
44128281|NCT02788513|78913832|FG003|Overall Study|Lost to Follow-up|0|||
44128282|NCT02788513|78913833|FG004|Overall Study|Lost to Follow-up|1|||
44128283|NCT02788513|78913829|FG000|Overall Study|Adverse Event|5|||
44379422|NCT00763321|79385098|FG001|Open-label Period|Adverse Event|0|||
44128284|NCT02788513|78913830|FG001|Overall Study|Adverse Event|8|||
44128285|NCT02788513|78913831|FG002|Overall Study|Adverse Event|4|||
44128286|NCT02788513|78913832|FG003|Overall Study|Adverse Event|2|||
44128287|NCT02788513|78913833|FG004|Overall Study|Adverse Event|2|||
44128288|NCT02788513|78913829|FG000|Overall Study|Protocol Violation|0|||
44128289|NCT02788513|78913830|FG001|Overall Study|Protocol Violation|0|||
44128290|NCT02788513|78913831|FG002|Overall Study|Protocol Violation|1|||
44128291|NCT02788513|78913832|FG003|Overall Study|Protocol Violation|1|||
44128292|NCT02788513|78913833|FG004|Overall Study|Protocol Violation|0|||
44128293|NCT02788513|78913829|FG000|Overall Study|Subject decided to stop taking treatment|0|||
44128294|NCT02788513|78913830|FG001|Overall Study|Subject decided to stop taking treatment|0|||
44276539|NCT02173704|79231606|FG001|Overall Study|Other|0|||
44128295|NCT02788513|78913831|FG002|Overall Study|Subject decided to stop taking treatment|1|||
44128296|NCT02788513|78913832|FG003|Overall Study|Subject decided to stop taking treatment|0|||
44128297|NCT02788513|78913833|FG004|Overall Study|Subject decided to stop taking treatment|0|||
44128298|NCT02788513|78913829|FG000|Overall Study|Decision by the study team|0|||
44128299|NCT02788513|78913830|FG001|Overall Study|Decision by the study team|0|||
44128300|NCT02788513|78913831|FG002|Overall Study|Decision by the study team|0|||
44128301|NCT02788513|78913832|FG003|Overall Study|Decision by the study team|0|||
44128302|NCT02788513|78913833|FG004|Overall Study|Decision by the study team|1|||
44128303|NCT03077828|78913845|FG000|Treatment Cycles|Death|1|||
44128304|NCT03077828|78913845|FG000|Treatment Cycles|Withdrawal by Subject|1|||
44128305|NCT03077828|78913845|FG000|Treatment Cycles|Screen Fail|2|||
44128306|NCT03077828|78913845|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
44128307|NCT03077828|78913845|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
44128308|NCT03077828|78913845|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
44128309|NCT03077828|78913845|FG000|Follow-up|Patients still in follow-up|15|||
44128310|NCT02401672|78913851|FG000|Overall Study|Withdrawal by Subject|1|||
44128311|NCT02401672|78913852|FG001|Overall Study|Withdrawal by Subject|3|||
44128312|NCT02435914|78913862|FG000|Overall Study|Ocular Adverse Event|1|||
44128313|NCT02435914|78913863|FG001|Overall Study|Ocular Adverse Event|0|||
44128314|NCT02435914|78913864|FG002|Overall Study|Ocular Adverse Event|0|||
44128315|NCT02435914|78913865|FG003|Overall Study|Ocular Adverse Event|0|||
44128316|NCT02435914|78913862|FG000|Overall Study|Withdrawal by Subject|0|||
44128317|NCT02435914|78913863|FG001|Overall Study|Withdrawal by Subject|1|||
44128318|NCT02435914|78913864|FG002|Overall Study|Withdrawal by Subject|0|||
44128319|NCT02435914|78913865|FG003|Overall Study|Withdrawal by Subject|0|||
44128320|NCT02435914|78913862|FG000|Overall Study|Other Miscellaneous Reason|0|||
44128321|NCT02435914|78913863|FG001|Overall Study|Other Miscellaneous Reason|0|||
44128322|NCT02435914|78913864|FG002|Overall Study|Other Miscellaneous Reason|1|||
44128323|NCT02435914|78913865|FG003|Overall Study|Other Miscellaneous Reason|0|||
44128324|NCT02786953|78913877|FG000|Overall Study|Withdrawal by Subject|3|||
44128325|NCT02786953|78913878|FG001|Overall Study|Withdrawal by Subject|0|||
44128326|NCT02786953|78913877|FG000|Overall Study|Physician Decision|0|||
44128327|NCT02786953|78913878|FG001|Overall Study|Physician Decision|1|||
44128328|NCT02435836|78913884|FG000|Overall Study|Lost to Follow-up|21|||
44128329|NCT02435836|78913884|FG000|Overall Study|Lack of Efficacy|1|||
44128330|NCT02435836|78913884|FG000|Overall Study|Withdrawal by Subject|236|||
44128331|NCT02435836|78913884|FG000|Overall Study|Insufficient Clinical Response|26|||
44128332|NCT02435836|78913884|FG000|Overall Study|Adverse Event|44|||
44128333|NCT02435836|78913884|FG000|Overall Study|Sponsor discontinued trial|167|||
44128334|NCT02435836|78913884|FG000|Overall Study|Noncompliance|27|||
44128335|NCT02435836|78913884|FG000|Overall Study|Protocol Violation|6|||
44243271|NCT01590212|79072715|FG001|Overall Study|Withdrawal by Subject|2|||
44243272|NCT01590212|79072716|FG002|Overall Study|Withdrawal by Subject|2|||
44243273|NCT01590212|79072714|FG000|Overall Study|Lost to Follow-up|1|||
44243274|NCT01590212|79072715|FG001|Overall Study|Lost to Follow-up|2|||
44511763|NCT03122860|79517167|FG000|Overall Study|Lost to Follow-up|5|||
44511764|NCT03122860|79517168|FG001|Overall Study|Lost to Follow-up|2|||
44511765|NCT03122860|79517169|FG002|Overall Study|Lost to Follow-up|3|||
44511766|NCT03122860|79517170|FG003|Overall Study|Lost to Follow-up|3|||
44511767|NCT03122860|79517171|FG004|Overall Study|Lost to Follow-up|5|||
44511768|NCT03122860|79517172|FG005|Overall Study|Lost to Follow-up|4|||
44511769|NCT03122860|79517167|FG000|Overall Study|Subject Non-Compliance|0|||
44511770|NCT03122860|79517168|FG001|Overall Study|Subject Non-Compliance|0|||
44511771|NCT03122860|79517169|FG002|Overall Study|Subject Non-Compliance|1|||
44511772|NCT03122860|79517170|FG003|Overall Study|Subject Non-Compliance|0|||
44511773|NCT03122860|79517171|FG004|Overall Study|Subject Non-Compliance|0|||
44128336|NCT02435836|78913884|FG000|Overall Study|Met Withdrawal Criteria|7|||
44128337|NCT02435836|78913884|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
44128338|NCT02788201|78913894|FG000|Overall Study|Death|1|||
44128339|NCT02788201|78913895|FG001|Overall Study|Death|1|||
44128340|NCT02788201|78913896|FG002|Overall Study|Death|1|||
44128341|NCT02788201|78913897|FG003|Overall Study|Death|1|||
44128342|NCT02788201|78913898|FG004|Overall Study|Death|0|||
44128343|NCT02788201|78913899|FG005|Overall Study|Death|1|||
44128344|NCT02788201|78913894|FG000|Overall Study|Ineligible|0|||
44128345|NCT02788201|78913895|FG001|Overall Study|Ineligible|0|||
44511774|NCT03122860|79517172|FG005|Overall Study|Subject Non-Compliance|0|||
44511775|NCT03122860|79517167|FG000|Overall Study|Withdrawal by Subject|3|||
44128346|NCT02788201|78913896|FG002|Overall Study|Ineligible|0|||
44128347|NCT02788201|78913897|FG003|Overall Study|Ineligible|0|||
44128348|NCT02788201|78913898|FG004|Overall Study|Ineligible|0|||
44128349|NCT02788201|78913899|FG005|Overall Study|Ineligible|1|||
44128350|NCT02788201|78913894|FG000|Overall Study|Withdrawal by Subject|0|||
44243275|NCT01590212|79072716|FG002|Overall Study|Lost to Follow-up|3|||
44511776|NCT03122860|79517168|FG001|Overall Study|Withdrawal by Subject|2|||
44511777|NCT03122860|79517169|FG002|Overall Study|Withdrawal by Subject|5|||
44511778|NCT03122860|79517170|FG003|Overall Study|Withdrawal by Subject|7|||
44511779|NCT03122860|79517171|FG004|Overall Study|Withdrawal by Subject|9|||
44511780|NCT03122860|79517172|FG005|Overall Study|Withdrawal by Subject|8|||
44511781|NCT03798366|79517189|FG000|Overall Study|Lost to Follow-up|0|||
44128351|NCT02788201|78913895|FG001|Overall Study|Withdrawal by Subject|0|||
44128352|NCT02788201|78913896|FG002|Overall Study|Withdrawal by Subject|0|||
44128353|NCT02788201|78913897|FG003|Overall Study|Withdrawal by Subject|0|||
44128354|NCT02788201|78913898|FG004|Overall Study|Withdrawal by Subject|0|||
44128355|NCT02788201|78913899|FG005|Overall Study|Withdrawal by Subject|1|||
44128356|NCT02456740|78913918|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
44128357|NCT02456740|78913919|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
44128358|NCT02456740|78913920|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
44128359|NCT02456740|78913921|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
44128360|NCT02456740|78913922|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
44128361|NCT02456740|78913923|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
44128362|NCT02456740|78913924|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
44128363|NCT02456740|78913925|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
44128364|NCT02456740|78913926|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
44128365|NCT02456740|78913918|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
44128366|NCT02456740|78913919|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
44128367|NCT02456740|78913920|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
44128368|NCT02456740|78913921|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
44128369|NCT02456740|78913922|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
44128370|NCT02456740|78913923|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
44128371|NCT02456740|78913924|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
44128372|NCT02456740|78913925|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
44128373|NCT02456740|78913926|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
44128374|NCT02456740|78913918|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
44128375|NCT02456740|78913919|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
44128376|NCT02456740|78913920|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
44128377|NCT02456740|78913921|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
44128378|NCT02456740|78913922|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
44128379|NCT02456740|78913923|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
44128380|NCT02456740|78913924|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
44128381|NCT02456740|78913925|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
44128382|NCT02456740|78913926|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
44128383|NCT02456740|78913918|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
44128384|NCT02456740|78913919|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
44128385|NCT02456740|78913920|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
44128386|NCT02456740|78913921|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
44128387|NCT02456740|78913922|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
44128388|NCT02456740|78913923|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
44128389|NCT02456740|78913924|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
44128390|NCT02456740|78913925|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
44243276|NCT01692938|79072727|FG000|Overall Study|Protocol Deviation|1|||
44243277|NCT01692938|79072728|FG001|Overall Study|Protocol Deviation|1|||
44243278|NCT01692938|79072727|FG000|Overall Study|Study completed prior to site completion|3|||
44243279|NCT01692938|79072728|FG001|Overall Study|Study completed prior to site completion|3|||
44243280|NCT01692782|79072741|FG000|Overall Study|Adverse Event|12|||
44243281|NCT01692782|79072742|FG001|Overall Study|Adverse Event|32|||
44379423|NCT00763321|79385099|FG002|Open-label Period|Adverse Event|0|||
44379424|NCT00763321|79385097|FG000|Open-label Period|Lost to Follow-up|14|||
44511782|NCT03798366|79517190|FG001|Overall Study|Lost to Follow-up|1|||
44379425|NCT00763321|79385098|FG001|Open-label Period|Lost to Follow-up|0|||
44511783|NCT04327388|79517199|FG000|Overall Study|Adverse Event|17|||
44511784|NCT04327388|79517200|FG001|Overall Study|Adverse Event|18|||
44511785|NCT04327388|79517201|FG002|Overall Study|Adverse Event|9|||
44511786|NCT04327388|79517199|FG000|Overall Study|Other|1|||
44511787|NCT04327388|79517200|FG001|Overall Study|Other|2|||
44511788|NCT04327388|79517201|FG002|Overall Study|Other|0|||
44511789|NCT04327388|79517199|FG000|Overall Study|Randomized and not treated|2|||
44511790|NCT04327388|79517200|FG001|Overall Study|Randomized and not treated|0|||
44511791|NCT04327388|79517201|FG002|Overall Study|Randomized and not treated|2|||
44511792|NCT03796728|79517209|FG000|Overall Study|Lost to Follow-up|8|||
44511793|NCT03796728|79517209|FG000|Overall Study|Reason not Specified|16|||
44511794|NCT04323800|79517215|FG000|Overall Study|Withdrawal by Subject|4|||
44128391|NCT02456740|78913926|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
44128392|NCT02456740|78913918|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44128393|NCT02456740|78913919|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44128394|NCT02456740|78913920|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44128395|NCT02456740|78913921|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
44128396|NCT02456740|78913922|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
44128397|NCT02456740|78913923|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
44128398|NCT02456740|78913924|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
44128399|NCT02456740|78913925|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
44128400|NCT02456740|78913926|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
44128401|NCT02456740|78913918|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128402|NCT02456740|78913919|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128403|NCT02456740|78913920|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128404|NCT02456740|78913921|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128405|NCT02456740|78913922|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128406|NCT02456740|78913923|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128407|NCT02456740|78913924|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128408|NCT02456740|78913925|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
44128409|NCT02456740|78913926|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
44128410|NCT02456740|78913918|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44128411|NCT02456740|78913919|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44128412|NCT02456740|78913920|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44128413|NCT02456740|78913921|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
44128414|NCT02456740|78913922|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
44128415|NCT02456740|78913923|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
44128416|NCT02456740|78913924|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
44128417|NCT02456740|78913925|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
44128418|NCT02456740|78913926|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
44128419|NCT02400580|78913938|FG000|Overall Study|Withdrawal by Subject|1|||
44128420|NCT02400580|78913939|FG001|Overall Study|Withdrawal by Subject|1|||
44128421|NCT02400580|78913938|FG000|Overall Study|Adverse Event|1|||
44128422|NCT02400580|78913939|FG001|Overall Study|Adverse Event|0|||
44128423|NCT01367119|78913947|FG000|Overall Study|Adverse Event|1|||
44128424|NCT01367119|78913948|FG001|Overall Study|Adverse Event|0|||
44128425|NCT01367119|78913947|FG000|Overall Study|Withdrawal by Subject|1|||
44128426|NCT01367119|78913948|FG001|Overall Study|Withdrawal by Subject|1|||
44128427|NCT02635724|78913957|FG000|Overall Study|Withdrawal by Subject|0|||
44128428|NCT02635724|78913958|FG001|Overall Study|Withdrawal by Subject|1|||
44128429|NCT02635724|78913959|FG002|Overall Study|Withdrawal by Subject|0|||
44379426|NCT00763321|79385099|FG002|Open-label Period|Lost to Follow-up|0|||
44379427|NCT00763321|79385097|FG000|Open-label Period|Withdrawal by Subject|7|||
44511795|NCT04323800|79517216|FG001|Overall Study|Withdrawal by Subject|4|||
44379428|NCT00763321|79385098|FG001|Open-label Period|Withdrawal by Subject|0|||
44379429|NCT00763321|79385099|FG002|Open-label Period|Withdrawal by Subject|0|||
44379430|NCT00763321|79385097|FG000|Open-label Period|Subject noncompliant|7|||
44379431|NCT00763321|79385098|FG001|Open-label Period|Subject noncompliant|0|||
44379432|NCT00763321|79385099|FG002|Open-label Period|Subject noncompliant|0|||
44511796|NCT04323800|79517215|FG000|Overall Study|Incomplete transfusion|1|||
44379433|NCT00763321|79385097|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
44511797|NCT04323800|79517216|FG001|Overall Study|Incomplete transfusion|0|||
44511798|NCT04323800|79517215|FG000|Overall Study|Other|0|||
44511799|NCT04323800|79517216|FG001|Overall Study|Other|1|||
44511800|NCT04323800|79517215|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
44511801|NCT04323800|79517216|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
44511802|NCT04321460|79517224|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
44511803|NCT04321460|79517225|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
44511804|NCT03122548|79517231|FG000|Overall Study|Death|2|||
44511805|NCT03122548|79517231|FG000|Overall Study|Progression - subject went into hospice|1|||
44511806|NCT03122548|79517231|FG000|Overall Study|Study Terminated by Sponsor|2|||
44511807|NCT04459598|79517237|FG000|Overall Study|Adverse Event|1|||
44511808|NCT04459598|79517238|FG001|Overall Study|Adverse Event|1|||
44128430|NCT02635646|78913969|FG000|Overall Study|Lost to Follow-up|24|||
44128431|NCT02635646|78913970|FG001|Overall Study|Lost to Follow-up|25|||
44128432|NCT02635646|78913969|FG000|Overall Study|Pregnancy|1|||
44128433|NCT02635646|78913970|FG001|Overall Study|Pregnancy|1|||
44128434|NCT02634788|78913986|FG000|Overall Study|Adverse Event|0|||
44128435|NCT02634788|78913987|FG001|Overall Study|Adverse Event|8|||
44128436|NCT02634788|78913988|FG002|Overall Study|Adverse Event|3|||
44128437|NCT02634788|78913989|FG003|Overall Study|Adverse Event|1|||
44128438|NCT02634788|78913986|FG000|Overall Study|Lack of Efficacy|4|||
44128439|NCT02634788|78913987|FG001|Overall Study|Lack of Efficacy|0|||
44128440|NCT02634788|78913988|FG002|Overall Study|Lack of Efficacy|1|||
44128441|NCT02634788|78913989|FG003|Overall Study|Lack of Efficacy|4|||
44128442|NCT02634788|78913986|FG000|Overall Study|Lost to Follow-up|0|||
44128443|NCT02634788|78913987|FG001|Overall Study|Lost to Follow-up|1|||
44128444|NCT02634788|78913988|FG002|Overall Study|Lost to Follow-up|0|||
44128445|NCT02634788|78913989|FG003|Overall Study|Lost to Follow-up|0|||
44128446|NCT02634788|78913986|FG000|Overall Study|Withdrawal by Subject|0|||
44128447|NCT02634788|78913987|FG001|Overall Study|Withdrawal by Subject|1|||
44128448|NCT02634788|78913988|FG002|Overall Study|Withdrawal by Subject|1|||
44128449|NCT02634788|78913989|FG003|Overall Study|Withdrawal by Subject|0|||
44128450|NCT02785939|78914001|FG000|Overall Study|Progression|25|||
44128451|NCT02785939|78914002|FG001|Overall Study|Progression|8|||
44128452|NCT02785939|78914001|FG000|Overall Study|Adverse Event|3|||
44128453|NCT02785939|78914002|FG001|Overall Study|Adverse Event|1|||
44128454|NCT02785939|78914001|FG000|Overall Study|Death|1|||
44128455|NCT02785939|78914002|FG001|Overall Study|Death|0|||
44128456|NCT02785939|78914001|FG000|Overall Study|Refusal|1|||
44128457|NCT02785939|78914002|FG001|Overall Study|Refusal|0|||
44128458|NCT02785939|78914001|FG000|Overall Study|Deteriorating health|1|||
44128459|NCT02785939|78914002|FG001|Overall Study|Deteriorating health|0|||
44128460|NCT02785939|78914001|FG000|Overall Study|Not protocol specified|0|||
44128461|NCT02785939|78914002|FG001|Overall Study|Not protocol specified|1|||
44128462|NCT02634320|78914016|FG000|Overall Study|Adverse Event|2|||
44128463|NCT02634320|78914016|FG000|Overall Study|Lost to Follow-up|3|||
44128464|NCT02634320|78914016|FG000|Overall Study|Moved out of area|2|||
44128465|NCT02634320|78914016|FG000|Overall Study|Out of window for study visits|1|||
44128466|NCT02634320|78914016|FG000|Overall Study|Protocol Violation|1|||
44128467|NCT02634320|78914016|FG000|Overall Study|Withdrawal by Subject|5|||
44128468|NCT02634320|78914016|FG000|Overall Study|Lack of Efficacy|2|||
44128469|NCT02435680|78914023|FG000|Overall Study|Physician Decision|3|||
44128470|NCT02435680|78914024|FG001|Overall Study|Physician Decision|0|||
44128471|NCT02435680|78914025|FG002|Overall Study|Physician Decision|0|||
44128472|NCT02435680|78914023|FG000|Overall Study|subject / guardian decision|0|||
44128473|NCT02435680|78914024|FG001|Overall Study|subject / guardian decision|3|||
44128474|NCT02435680|78914025|FG002|Overall Study|subject / guardian decision|2|||
44128475|NCT02435680|78914023|FG000|Overall Study|Adverse Event|8|||
44128476|NCT02435680|78914024|FG001|Overall Study|Adverse Event|3|||
44128477|NCT02435680|78914025|FG002|Overall Study|Adverse Event|2|||
44128478|NCT02435680|78914023|FG000|Overall Study|progressive disease|10|||
44128479|NCT02435680|78914024|FG001|Overall Study|progressive disease|7|||
44128480|NCT02435680|78914025|FG002|Overall Study|progressive disease|11|||
44128481|NCT02435680|78914023|FG000|Overall Study|not treated|0|||
44128482|NCT02435680|78914024|FG001|Overall Study|not treated|0|||
44128483|NCT02435680|78914025|FG002|Overall Study|not treated|1|||
44128484|NCT03371732|78914039|FG000|Overall Study|Withdrawal by Subject|9|||
44128485|NCT03371732|78914040|FG001|Overall Study|Withdrawal by Subject|3|||
44128486|NCT03371732|78914039|FG000|Overall Study|Refusal to continue|3|||
44128487|NCT03371732|78914040|FG001|Overall Study|Refusal to continue|4|||
44128488|NCT02745119|78914052|FG000|Overall Study|Adverse Event|1|||
44128489|NCT02745119|78914053|FG001|Overall Study|Adverse Event|0|||
44128490|NCT02745119|78914054|FG002|Overall Study|Adverse Event|1|||
44128491|NCT02745119|78914055|FG003|Overall Study|Adverse Event|3|||
44128492|NCT02745119|78914052|FG000|Overall Study|Death|3|||
44128493|NCT02745119|78914053|FG001|Overall Study|Death|3|||
44128494|NCT02745119|78914054|FG002|Overall Study|Death|0|||
44128495|NCT02745119|78914055|FG003|Overall Study|Death|4|||
44128496|NCT02745119|78914052|FG000|Overall Study|Lost to Follow-up|0|||
44128497|NCT02745119|78914053|FG001|Overall Study|Lost to Follow-up|0|||
44128498|NCT02745119|78914054|FG002|Overall Study|Lost to Follow-up|0|||
44128499|NCT02745119|78914055|FG003|Overall Study|Lost to Follow-up|1|||
44128500|NCT02745119|78914052|FG000|Overall Study|Protocol Deviation|0|||
44128501|NCT02745119|78914053|FG001|Overall Study|Protocol Deviation|0|||
44128502|NCT02745119|78914054|FG002|Overall Study|Protocol Deviation|0|||
44128503|NCT02745119|78914055|FG003|Overall Study|Protocol Deviation|1|||
44128504|NCT02745119|78914052|FG000|Overall Study|Withdrawal by Subject|7|||
44128505|NCT02745119|78914053|FG001|Overall Study|Withdrawal by Subject|15|||
44128506|NCT02745119|78914054|FG002|Overall Study|Withdrawal by Subject|8|||
44128507|NCT02745119|78914055|FG003|Overall Study|Withdrawal by Subject|14|||
44128508|NCT02745119|78914052|FG000|Overall Study|Study Terminated by Sponsor|134|||
44128509|NCT02745119|78914053|FG001|Overall Study|Study Terminated by Sponsor|252|||
44128510|NCT02745119|78914054|FG002|Overall Study|Study Terminated by Sponsor|135|||
44128511|NCT02745119|78914055|FG003|Overall Study|Study Terminated by Sponsor|251|||
44128512|NCT02745119|78914052|FG000|Overall Study|Physician Decision|0|||
44128513|NCT02745119|78914053|FG001|Overall Study|Physician Decision|2|||
44128514|NCT02745119|78914054|FG002|Overall Study|Physician Decision|2|||
44128515|NCT02745119|78914055|FG003|Overall Study|Physician Decision|2|||
44128516|NCT02745119|78914052|FG000|Overall Study|Reason Not Specified|0|||
44128517|NCT02745119|78914053|FG001|Overall Study|Reason Not Specified|2|||
44128518|NCT02745119|78914054|FG002|Overall Study|Reason Not Specified|0|||
44379434|NCT00763321|79385098|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
44379435|NCT00763321|79385099|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
44379436|NCT00763321|79385097|FG000|Open-label Period|Lack of Efficacy|2|||
44379437|NCT00763321|79385098|FG001|Open-label Period|Lack of Efficacy|0|||
44379438|NCT00763321|79385099|FG002|Open-label Period|Lack of Efficacy|0|||
44379439|NCT00763321|79385097|FG000|Open-label Period|Other|4|||
44379440|NCT00763321|79385098|FG001|Open-label Period|Other|0|||
44379441|NCT00763321|79385099|FG002|Open-label Period|Other|0|||
44379442|NCT00763321|79385097|FG000|Double-blind Period|Lack of Efficacy|0|||
44379443|NCT00763321|79385098|FG001|Double-blind Period|Lack of Efficacy|9|||
44379444|NCT00763321|79385099|FG002|Double-blind Period|Lack of Efficacy|17|||
44379445|NCT00763321|79385097|FG000|Double-blind Period|Adverse Event|0|||
44379446|NCT00763321|79385098|FG001|Double-blind Period|Adverse Event|4|||
44379447|NCT00763321|79385099|FG002|Double-blind Period|Adverse Event|4|||
44379448|NCT00763321|79385097|FG000|Double-blind Period|Lost to Follow-up|0|||
44379449|NCT00763321|79385098|FG001|Double-blind Period|Lost to Follow-up|4|||
44379450|NCT00763321|79385099|FG002|Double-blind Period|Lost to Follow-up|2|||
44379451|NCT00763321|79385097|FG000|Double-blind Period|Withdrawal by Subject|0|||
44379452|NCT00763321|79385098|FG001|Double-blind Period|Withdrawal by Subject|2|||
44379453|NCT00763321|79385099|FG002|Double-blind Period|Withdrawal by Subject|3|||
44379454|NCT00763321|79385097|FG000|Double-blind Period|Other|0|||
44379455|NCT00763321|79385098|FG001|Double-blind Period|Other|2|||
44379456|NCT00763321|79385099|FG002|Double-blind Period|Other|3|||
44379457|NCT00770653|79385108|FG000|Overall Study|Adverse Event|13|||
44379458|NCT00770653|79385109|FG001|Overall Study|Adverse Event|5|||
44379459|NCT00770653|79385108|FG000|Overall Study|Protocol Violation|8|||
44379460|NCT00770653|79385109|FG001|Overall Study|Protocol Violation|6|||
44379461|NCT00770653|79385108|FG000|Overall Study|Withdrawal by Subject|4|||
44379462|NCT00770653|79385109|FG001|Overall Study|Withdrawal by Subject|7|||
44379463|NCT00770653|79385108|FG000|Overall Study|Lack of Compliance|1|||
44379464|NCT00770653|79385109|FG001|Overall Study|Lack of Compliance|4|||
44379465|NCT00770653|79385108|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
44379466|NCT00770653|79385109|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
44379467|NCT00770653|79385108|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
44379468|NCT00770653|79385109|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
44379469|NCT00770653|79385108|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
44379470|NCT00770653|79385109|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
44379471|NCT00770653|79385108|FG000|Overall Study|Lost to Follow-up|1|||
44379472|NCT00770653|79385109|FG001|Overall Study|Lost to Follow-up|2|||
44379473|NCT00770653|79385108|FG000|Overall Study|Physician Decision|1|||
44379474|NCT00770653|79385109|FG001|Overall Study|Physician Decision|0|||
44379475|NCT00819052|79385117|FG000|Overall Study|Adverse Event|0|||
44379476|NCT00819052|79385118|FG001|Overall Study|Adverse Event|5|||
44379477|NCT00819052|79385117|FG000|Overall Study|Protocol Violation|1|||
44379478|NCT00819052|79385118|FG001|Overall Study|Protocol Violation|2|||
44128519|NCT02745119|78914055|FG003|Overall Study|Reason Not Specified|1|||
44128520|NCT01367665|78914069|FG000|Overall Study|Death|102|||
44128521|NCT01367665|78914070|FG001|Overall Study|Death|19|||
44128522|NCT01367665|78914069|FG000|Overall Study|Lost to Follow-up|222|||
44128523|NCT01367665|78914070|FG001|Overall Study|Lost to Follow-up|22|||
44128524|NCT01367665|78914069|FG000|Overall Study|Not Done|118|||
44128525|NCT01367665|78914070|FG001|Overall Study|Not Done|14|||
44128526|NCT02576847|78914077|FG000|Overall Study|Adverse Event|27|||
44128527|NCT02576847|78914077|FG000|Overall Study|Lost to Follow-up|22|||
44128528|NCT02576847|78914077|FG000|Overall Study|Physician Decision|1|||
44379479|NCT00819052|79385117|FG000|Overall Study|Lost to Follow-up|1|||
44379480|NCT00819052|79385118|FG001|Overall Study|Lost to Follow-up|2|||
44379481|NCT00819052|79385117|FG000|Overall Study|Withdrawal by Subject|1|||
44379482|NCT00819052|79385118|FG001|Overall Study|Withdrawal by Subject|2|||
44379483|NCT00819052|79385117|FG000|Overall Study|Lack of Efficacy|1|||
44379484|NCT00819052|79385118|FG001|Overall Study|Lack of Efficacy|1|||
44128529|NCT02576847|78914077|FG000|Overall Study|Pregnancy|1|||
44128530|NCT02576847|78914077|FG000|Overall Study|Protocol Violation|3|||
44128531|NCT02576847|78914077|FG000|Overall Study|Withdrawal by Subject|78|||
44128532|NCT02576847|78914077|FG000|Overall Study|Other|5|||
44128533|NCT02135029|78914093|FG000|Overall Study|Adverse Event|2|||
44379485|NCT00819052|79385117|FG000|Overall Study|Pregnancy|1|||
44379486|NCT00819052|79385118|FG001|Overall Study|Pregnancy|2|||
44128534|NCT02135029|78914094|FG001|Overall Study|Adverse Event|2|||
44128535|NCT02135029|78914095|FG002|Overall Study|Adverse Event|2|||
44128536|NCT02135029|78914093|FG000|Overall Study|Lost to Follow-up|0|||
44128537|NCT02135029|78914094|FG001|Overall Study|Lost to Follow-up|1|||
44128538|NCT02135029|78914095|FG002|Overall Study|Lost to Follow-up|0|||
44128539|NCT02135029|78914093|FG000|Overall Study|Withdrawal by Subject|2|||
44128540|NCT02135029|78914094|FG001|Overall Study|Withdrawal by Subject|0|||
44128541|NCT02135029|78914095|FG002|Overall Study|Withdrawal by Subject|1|||
44128542|NCT02135029|78914093|FG000|Overall Study|Other|0|||
44128543|NCT02135029|78914094|FG001|Overall Study|Other|1|||
44128544|NCT02135029|78914095|FG002|Overall Study|Other|0|||
44128545|NCT02135029|78914093|FG000|Overall Study|Death|0|||
44128546|NCT02135029|78914094|FG001|Overall Study|Death|1|||
44128547|NCT02135029|78914095|FG002|Overall Study|Death|0|||
44128548|NCT02842151|78914104|FG000|Overall Study|Adverse Event|1|||
44128549|NCT02842151|78914104|FG000|Overall Study|Subject moved too far away|1|||
44128550|NCT02842073|78914110|FG000|Overall Study|Withdrawal by Subject|1|||
44128551|NCT01367275|78914114|FG000|Overall Study|Ineligible|1|||
44128552|NCT01367275|78914114|FG000|Overall Study|Disease Progression|2|||
44128553|NCT02842853|78914122|FG000|Overall Study|Non-compliance with the protocol|3|||
44128554|NCT02842853|78914123|FG001|Overall Study|Non-compliance with the protocol|7|||
44128555|NCT02842853|78914124|FG002|Overall Study|Non-compliance with the protocol|2|||
44128556|NCT02842853|78914125|FG003|Overall Study|Non-compliance with the protocol|5|||
44128557|NCT02842853|78914122|FG000|Overall Study|Subject met exclusion criteria|0|||
44128558|NCT02842853|78914123|FG001|Overall Study|Subject met exclusion criteria|1|||
44128559|NCT02842853|78914124|FG002|Overall Study|Subject met exclusion criteria|0|||
44128560|NCT02842853|78914125|FG003|Overall Study|Subject met exclusion criteria|0|||
44128561|NCT02842853|78914122|FG000|Overall Study|Withdrawal by Subject|11|||
44128562|NCT02842853|78914123|FG001|Overall Study|Withdrawal by Subject|13|||
44128563|NCT02842853|78914124|FG002|Overall Study|Withdrawal by Subject|9|||
44128564|NCT02842853|78914125|FG003|Overall Study|Withdrawal by Subject|8|||
44128565|NCT02842853|78914122|FG000|Overall Study|Lost to Follow-up|9|||
44128566|NCT02842853|78914123|FG001|Overall Study|Lost to Follow-up|13|||
44128567|NCT02842853|78914124|FG002|Overall Study|Lost to Follow-up|10|||
44128568|NCT02842853|78914125|FG003|Overall Study|Lost to Follow-up|11|||
44128569|NCT02433340|78914141|FG000|Overall Study|Adverse Event|0|||
44243282|NCT01692782|79072743|FG002|Overall Study|Adverse Event|2|||
44243283|NCT01692782|79072741|FG000|Overall Study|Lack of Efficacy|1|||
44379487|NCT00819052|79385117|FG000|Overall Study|Death or events leading to death|1|||
44128570|NCT02433340|78914142|FG001|Overall Study|Adverse Event|0|||
44243284|NCT01692782|79072742|FG001|Overall Study|Lack of Efficacy|2|||
44243285|NCT01692782|79072743|FG002|Overall Study|Lack of Efficacy|0|||
44243286|NCT01692782|79072741|FG000|Overall Study|Lost to Follow-up|2|||
44128571|NCT02433340|78914143|FG002|Overall Study|Adverse Event|1|||
44128572|NCT02433340|78914144|FG003|Overall Study|Adverse Event|0|||
44128573|NCT02433340|78914141|FG000|Overall Study|Withdrawal by Subject|1|||
44128574|NCT02433340|78914142|FG001|Overall Study|Withdrawal by Subject|0|||
44243287|NCT01692782|79072742|FG001|Overall Study|Lost to Follow-up|7|||
44243288|NCT01692782|79072743|FG002|Overall Study|Lost to Follow-up|1|||
44128575|NCT02433340|78914143|FG002|Overall Study|Withdrawal by Subject|1|||
44128576|NCT02433340|78914144|FG003|Overall Study|Withdrawal by Subject|2|||
44128577|NCT02433340|78914141|FG000|Overall Study|Lost to Follow-up|0|||
44128578|NCT02433340|78914142|FG001|Overall Study|Lost to Follow-up|1|||
44128579|NCT02433340|78914143|FG002|Overall Study|Lost to Follow-up|0|||
44128580|NCT02433340|78914144|FG003|Overall Study|Lost to Follow-up|0|||
44128581|NCT02433340|78914141|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
44128582|NCT02433340|78914142|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
44128583|NCT02433340|78914143|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
44128584|NCT02433340|78914144|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
44128585|NCT02433340|78914141|FG000|Overall Study|Other|0|||
44128586|NCT02433340|78914142|FG001|Overall Study|Other|1|||
44128587|NCT02433340|78914143|FG002|Overall Study|Other|0|||
44128588|NCT02433340|78914144|FG003|Overall Study|Other|0|||
44128589|NCT02400346|78914156|FG000|Overall Study|Adverse Event|24|||
44128590|NCT02400346|78914156|FG000|Overall Study|Lack of Efficacy|9|||
44128591|NCT02400346|78914156|FG000|Overall Study|Non-compliance with IMP|1|||
44128592|NCT02400346|78914156|FG000|Overall Study|Withdrawal by Subject|7|||
44128593|NCT02400346|78914156|FG000|Overall Study|Administrative or other reason(s)|2|||
44128594|NCT02400346|78914156|FG000|Overall Study|Lost to Follow-up|1|||
44128595|NCT02399254|78914160|FG000|Overall Study|Physician Decision|2|||
44128596|NCT02456662|78914167|FG000|Overall Study|Lost to Follow-up|2|||
44128597|NCT02456662|78914168|FG001|Overall Study|Lost to Follow-up|1|||
44128598|NCT01653262|78914174|FG000|Overall Study|Lack of Efficacy|1|||
44128599|NCT01653262|78914174|FG000|Overall Study|SAE, non-fatal|1|||
44128600|NCT01653262|78914174|FG000|Overall Study|AE, non-serious non-fatal|1|||
44128601|NCT02455336|78914180|FG000|Overall Study|Withdrawal by Subject|0|||
44128602|NCT02455336|78914181|FG001|Overall Study|Withdrawal by Subject|2|||
44128603|NCT02455336|78914180|FG000|Overall Study|Adverse Event|3|||
44128604|NCT02455336|78914181|FG001|Overall Study|Adverse Event|0|||
44128605|NCT02455336|78914180|FG000|Overall Study|Non-responder to treatment|2|||
44128606|NCT02455336|78914181|FG001|Overall Study|Non-responder to treatment|0|||
44128607|NCT04525703|78914208|FG000|Overall Study|Lost to Follow-up|6|||
44128608|NCT04525703|78914209|FG001|Overall Study|Lost to Follow-up|15|||
44128609|NCT04525703|78914210|FG002|Overall Study|Lost to Follow-up|8|||
44128610|NCT04509076|78914223|FG000|Overall Study|Withdrawal by Subject|1|||
44128611|NCT04509076|78914224|FG001|Overall Study|Withdrawal by Subject|2|||
44128612|NCT04509076|78914223|FG000|Overall Study|Lost to Follow-up|1|||
44128613|NCT04509076|78914224|FG001|Overall Study|Lost to Follow-up|2|||
44128614|NCT04267614|78914238|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
44128615|NCT04267614|78914238|FG000|Overall Study|Lost to Follow-up|115|||
44128616|NCT03735680|78914249|FG000|Overall Study|Withdrawal by Subject|0|||
44128617|NCT03735680|78914250|FG001|Overall Study|Withdrawal by Subject|1|||
44128618|NCT03735680|78914251|FG002|Overall Study|Withdrawal by Subject|0|||
44128619|NCT03735680|78914252|FG003|Overall Study|Withdrawal by Subject|0|||
44128620|NCT03735680|78914253|FG004|Overall Study|Withdrawal by Subject|0|||
44128621|NCT03735680|78914254|FG005|Overall Study|Withdrawal by Subject|1|||
44128622|NCT03735680|78914249|FG000|Overall Study|Patient unable or unwilling to continue|0|||
44128623|NCT03735680|78914250|FG001|Overall Study|Patient unable or unwilling to continue|0|||
44128624|NCT03735680|78914251|FG002|Overall Study|Patient unable or unwilling to continue|1|||
44128625|NCT03735680|78914252|FG003|Overall Study|Patient unable or unwilling to continue|0|||
44128626|NCT03735680|78914253|FG004|Overall Study|Patient unable or unwilling to continue|0|||
44128627|NCT03735680|78914254|FG005|Overall Study|Patient unable or unwilling to continue|0|||
44128628|NCT03726658|78914290|FG000|Overall Study|Lost to Follow-up|0|||
44128629|NCT03726658|78914291|FG001|Overall Study|Lost to Follow-up|0|||
44128630|NCT03726658|78914292|FG002|Overall Study|Lost to Follow-up|2|||
44128631|NCT03726658|78914293|FG003|Overall Study|Lost to Follow-up|0|||
44128632|NCT03726658|78914294|FG004|Overall Study|Lost to Follow-up|0|||
44128633|NCT03726658|78914295|FG005|Overall Study|Lost to Follow-up|1|||
44128634|NCT03726658|78914296|FG006|Overall Study|Lost to Follow-up|1|||
44128635|NCT03726658|78914290|FG000|Overall Study|Withdrawal by Subject|1|||
44128636|NCT03726658|78914291|FG001|Overall Study|Withdrawal by Subject|0|||
44128637|NCT03726658|78914292|FG002|Overall Study|Withdrawal by Subject|0|||
44128638|NCT03726658|78914293|FG003|Overall Study|Withdrawal by Subject|0|||
44128639|NCT03726658|78914294|FG004|Overall Study|Withdrawal by Subject|6|||
44128640|NCT03726658|78914295|FG005|Overall Study|Withdrawal by Subject|4|||
44128641|NCT03726658|78914296|FG006|Overall Study|Withdrawal by Subject|2|||
44128642|NCT03726658|78914290|FG000|Overall Study|Pregnancy|0|||
44128643|NCT03726658|78914291|FG001|Overall Study|Pregnancy|0|||
44128644|NCT03726658|78914292|FG002|Overall Study|Pregnancy|0|||
44128645|NCT03726658|78914293|FG003|Overall Study|Pregnancy|0|||
44128646|NCT03726658|78914294|FG004|Overall Study|Pregnancy|0|||
44128647|NCT03726658|78914295|FG005|Overall Study|Pregnancy|0|||
44128648|NCT03726658|78914296|FG006|Overall Study|Pregnancy|1|||
44128649|NCT03726658|78914290|FG000|Overall Study|Not Reported|0|||
44128650|NCT03726658|78914291|FG001|Overall Study|Not Reported|0|||
44128651|NCT03726658|78914292|FG002|Overall Study|Not Reported|0|||
44128652|NCT03726658|78914293|FG003|Overall Study|Not Reported|0|||
44128653|NCT03726658|78914294|FG004|Overall Study|Not Reported|0|||
44128654|NCT03726658|78914295|FG005|Overall Study|Not Reported|0|||
44128655|NCT03726658|78914296|FG006|Overall Study|Not Reported|1|||
44128656|NCT03062358|78914356|FG000|Overall Study|Death|220|||
44128657|NCT03062358|78914357|FG001|Overall Study|Death|127|||
44128658|NCT03062358|78914356|FG000|Overall Study|Withdrawal by Subject|2|||
44128659|NCT03062358|78914357|FG001|Overall Study|Withdrawal by Subject|1|||
44128660|NCT03062358|78914356|FG000|Overall Study|Ongoing in Trial|78|||
44128661|NCT03062358|78914357|FG001|Overall Study|Ongoing in Trial|25|||
44128662|NCT02706873|78914368|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
44128663|NCT02706873|78914369|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
44128664|NCT02706873|78914370|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
44128665|NCT02706873|78914371|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
44128666|NCT02706873|78914368|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
44128667|NCT02706873|78914369|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
44128668|NCT02706873|78914370|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
44128669|NCT02706873|78914371|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
44128670|NCT02706873|78914368|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
44128671|NCT02706873|78914369|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
44128672|NCT02706873|78914370|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
44128673|NCT02706873|78914371|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
44128674|NCT02706873|78914368|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
44128675|NCT02706873|78914369|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
44128676|NCT02706873|78914370|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
44128677|NCT02706873|78914371|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
44128678|NCT02706873|78914368|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
44128679|NCT02706873|78914369|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
44128680|NCT02706873|78914370|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
44128681|NCT02706873|78914371|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
44128682|NCT02706873|78914368|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
44128683|NCT02706873|78914369|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
44128684|NCT02706873|78914370|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
44128685|NCT02706873|78914371|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
44128686|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
44128687|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
44128688|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
44128689|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
44128690|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
44128691|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
44128692|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
44128693|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
44128694|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
44128695|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
44128696|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
44128697|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
44128698|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
44128699|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
44128700|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
44128701|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
44128702|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
44128703|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
44128704|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
44128705|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
44128706|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
44128707|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
44128708|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
44511809|NCT02929498|79517247|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
44511810|NCT02929498|79517248|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
44511811|NCT02929498|79517249|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
44511812|NCT02929498|79517247|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
44511813|NCT02929498|79517248|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
44511814|NCT02929498|79517249|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
44511815|NCT03792672|79517255|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
44511816|NCT03792672|79517256|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
44511817|NCT03792672|79517257|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
44511818|NCT03792672|79517258|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
44511819|NCT03792672|79517259|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
44511820|NCT03792672|79517260|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
44511821|NCT03792672|79517255|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
44511822|NCT03792672|79517256|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
44511823|NCT03792672|79517257|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
44511824|NCT03792672|79517258|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
44511825|NCT03792672|79517259|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
44128709|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
44128710|NCT02706873|78914368|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
44128711|NCT02706873|78914369|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
44128712|NCT02706873|78914370|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
44128713|NCT02706873|78914371|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
44128714|NCT02584634|78914394|FG000|Overall Study|Adverse Event|3|||
44128715|NCT02584634|78914395|FG001|Overall Study|Adverse Event|5|||
44128716|NCT02584634|78914394|FG000|Overall Study|Death|0|||
44128717|NCT02584634|78914395|FG001|Overall Study|Death|1|||
44128718|NCT02584634|78914394|FG000|Overall Study|Lost to Follow-up|0|||
44128719|NCT02584634|78914395|FG001|Overall Study|Lost to Follow-up|1|||
44128720|NCT02584634|78914394|FG000|Overall Study|Physician Decision|1|||
44128721|NCT02584634|78914395|FG001|Overall Study|Physician Decision|2|||
44128722|NCT02584634|78914394|FG000|Overall Study|Progressive disease|7|||
44128723|NCT02584634|78914395|FG001|Overall Study|Progressive disease|15|||
44128724|NCT02584634|78914394|FG000|Overall Study|Withdrawal by Subject|1|||
44128725|NCT02584634|78914395|FG001|Overall Study|Withdrawal by Subject|1|||
44128726|NCT02584634|78914394|FG000|Overall Study|Other|0|||
44128727|NCT02584634|78914395|FG001|Overall Study|Other|6|||
44128728|NCT01275729|78914409|FG000|Overall Study|Death|3|||
44128729|NCT01275729|78914409|FG000|Overall Study|Withdrawal by Subject|1|||
44128730|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
44128731|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
44128732|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
44128733|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
44128734|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Adverse Event|198|||
44128735|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Adverse Event|0|||
44128736|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Adverse Event|0|||
44128737|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Adverse Event|0|||
44128738|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Death|62|||
44128739|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Death|0|||
44128740|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Death|0|||
44128741|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Death|0|||
44128742|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
44128743|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
44128744|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
44128745|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
44128746|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Complicating disease|13|||
44128747|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Complicating disease|0|||
44128748|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Complicating disease|0|||
44128749|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Complicating disease|0|||
44128750|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
44128751|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
44128752|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
44128753|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
44128754|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
44128755|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
44128756|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
44128757|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
44128758|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Non-compliance|4|||
44128759|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Non-compliance|0|||
44128760|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Non-compliance|0|||
44511826|NCT03792672|79517260|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
44128761|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Non-compliance|0|||
44128762|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Pain|4|||
44128763|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Pain|0|||
44128764|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Pain|0|||
44128765|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Pain|0|||
44128766|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
44128767|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
44128768|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
44511827|NCT03792672|79517255|FG000|Treatment Period 4 (2 Days)|Other|1|||
44128769|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
44128770|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Hospice care|1|||
44128771|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Hospice care|0|||
44128772|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Hospice care|0|||
44128773|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Hospice care|0|||
44243289|NCT01692782|79072741|FG000|Overall Study|Pregnancy|1|||
44511828|NCT03792672|79517256|FG001|Treatment Period 4 (2 Days)|Other|0|||
44511829|NCT03792672|79517257|FG002|Treatment Period 4 (2 Days)|Other|0|||
44511830|NCT03792672|79517258|FG003|Treatment Period 4 (2 Days)|Other|0|||
44511831|NCT03792672|79517259|FG004|Treatment Period 4 (2 Days)|Other|0|||
44511832|NCT03792672|79517260|FG005|Treatment Period 4 (2 Days)|Other|0|||
44511833|NCT03120676|79517275|FG000|Overall Study|Not treated|1|||
44511834|NCT03120520|79517283|FG000|Overall Study|Lost to Follow-up|1|||
44511835|NCT03120520|79517284|FG001|Overall Study|Lost to Follow-up|1|||
44128774|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Physician Decision|1|||
44128775|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Physician Decision|0|||
44128776|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Physician Decision|0|||
44128777|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Physician Decision|0|||
44128778|NCT01107626|78914417|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
44128779|NCT01107626|78914418|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
44128780|NCT01107626|78914419|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
44128781|NCT01107626|78914420|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
44128782|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
44128783|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
44128784|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
44128785|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
44128786|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
44128787|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
44128788|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
44128789|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
44128790|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Death|0|||
44128791|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Death|8|||
44128792|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Death|2|||
44128793|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Death|13|||
44128794|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
44128795|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
44128796|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
44128797|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
44128798|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
44128799|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
44128800|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
44128801|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
44128802|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
44128803|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
44128804|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
44128805|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
44128806|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
44128807|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
44128808|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
44128809|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
44128810|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
44128811|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
44128812|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
44128813|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
44128814|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
44128815|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
44128816|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
44128817|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
44128818|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
44128819|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
44379488|NCT00819052|79385118|FG001|Overall Study|Death or events leading to death|0|||
44379489|NCT00763009|79385127|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
44379490|NCT00841672|79385134|FG000|Overall Study|Adverse Event|7|||
44379491|NCT00841672|79385135|FG001|Overall Study|Adverse Event|16|||
44128820|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
44128821|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
44128822|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
44128823|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
44128824|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
44128825|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
44128826|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
44128827|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
44128828|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
44128829|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
44128830|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
44128831|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
44128832|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
44128833|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
44128834|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Pain|0|||
44128835|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Pain|0|||
44128836|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Pain|0|||
44128837|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Pain|1|||
44511836|NCT03120520|79517285|FG002|Overall Study|Lost to Follow-up|1|||
44511837|NCT03120520|79517286|FG003|Overall Study|Lost to Follow-up|1|||
44128838|NCT01107626|78914417|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
44128839|NCT01107626|78914418|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
44128840|NCT01107626|78914419|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
44128841|NCT01107626|78914420|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
44128842|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
44128843|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
44128844|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
44128845|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
44128846|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
44128847|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
44128848|NCT00828009|78914429|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
44128849|NCT00828009|78914429|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
44128850|NCT00828009|78914429|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
44128851|NCT00828009|78914429|FG000|Step 2 - Maintenance Therapy|Death|1|||
44128852|NCT00828009|78914429|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
44128853|NCT00828009|78914429|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
44128854|NCT00828009|78914429|FG000|Step 2 - Maintenance Therapy|Other|1|||
44128855|NCT00068393|78914449|FG000|Overall Study|Adverse Event|2|||
44128856|NCT00068393|78914449|FG000|Overall Study|Death|3|||
44128857|NCT00068393|78914449|FG000|Overall Study|Withdrawal by Subject|3|||
44128858|NCT00068393|78914449|FG000|Overall Study|Alternative treatment|1|||
44128859|NCT00068393|78914449|FG000|Overall Study|Quality of life worsening|1|||
44128860|NCT00062010|78914453|FG000|Overall Study|Ineligible|3|||
44128861|NCT00047008|78914459|FG000|Overall Study|Withdrawn consent|2|||
44128862|NCT00047008|78914460|FG001|Overall Study|Withdrawn consent|3|||
44128863|NCT00047008|78914459|FG000|Overall Study|Ineligible|9|||
44128864|NCT00047008|78914460|FG001|Overall Study|Ineligible|8|||
44128865|NCT02397694|78914468|FG000|Double-Blinded Phase|Adverse Event|1|||
44128866|NCT02397694|78914469|FG001|Double-Blinded Phase|Adverse Event|0|||
44128867|NCT02397694|78914468|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
44128868|NCT02397694|78914469|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
44128869|NCT02397694|78914468|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
44128870|NCT02397694|78914469|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
44128871|NCT02397694|78914468|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
44128872|NCT02397694|78914469|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
44128873|NCT02397694|78914468|FG000|Open Label Extension Phase|Protocol Violation|1|||
44128874|NCT02397694|78914469|FG001|Open Label Extension Phase|Protocol Violation|0|||
44511838|NCT03120520|79517283|FG000|Overall Study|Withdrawal by Subject|3|||
44511839|NCT03120520|79517284|FG001|Overall Study|Withdrawal by Subject|2|||
44511840|NCT03120520|79517285|FG002|Overall Study|Withdrawal by Subject|3|||
44511841|NCT03120520|79517286|FG003|Overall Study|Withdrawal by Subject|2|||
44128875|NCT02397694|78914468|FG000|Open Label Extension Phase|Withdrew Consent|3|||
44128876|NCT02397694|78914469|FG001|Open Label Extension Phase|Withdrew Consent|1|||
44128877|NCT02397694|78914468|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
44511842|NCT03120520|79517283|FG000|Overall Study|Other|0|||
44511843|NCT03120520|79517284|FG001|Overall Study|Other|1|||
44511844|NCT03120520|79517285|FG002|Overall Study|Other|0|||
44128878|NCT02397694|78914469|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
44128879|NCT02783599|78914479|FG000|Overall Study|Progressive disease|23|||
44128880|NCT02783599|78914479|FG000|Overall Study|Surgical Resection|10|||
44128881|NCT02783599|78914479|FG000|Overall Study|Adverse Event|4|||
44128882|NCT02783599|78914479|FG000|Overall Study|Physician Decision|2|||
44511845|NCT03120520|79517286|FG003|Overall Study|Other|0|||
44128883|NCT02783599|78914479|FG000|Overall Study|Death|1|||
44128884|NCT02838017|78914492|FG000|Overall Study|Lost to Follow-up|14|||
44128885|NCT02838017|78914493|FG001|Overall Study|Lost to Follow-up|11|||
44128886|NCT03188666|78914501|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
44128887|NCT03188666|78914502|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
44128888|NCT03188666|78914503|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
44128889|NCT03188666|78914504|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
44128890|NCT03188666|78914501|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
44128891|NCT03188666|78914502|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
44128892|NCT03188666|78914503|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
44128893|NCT03188666|78914504|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
44128894|NCT03188666|78914501|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
44128895|NCT03188666|78914502|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
44128896|NCT03188666|78914503|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
44128897|NCT03188666|78914504|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
44128898|NCT03188666|78914501|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
44128899|NCT03188666|78914502|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
44128900|NCT03188666|78914503|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
44128901|NCT03188666|78914504|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
44128902|NCT02836769|78914518|FG000|Overall Study|Lost to Follow-up|10|||
44128903|NCT02836769|78914518|FG000|Overall Study|Medical withdrawal|2|||
44128904|NCT02836769|78914518|FG000|Overall Study|Withdrawal by Subject|3|||
44511846|NCT03787212|79517296|FG000|Period 1|Study Termination|2|||
44511847|NCT03787212|79517297|FG001|Period 1|Study Termination|2|||
44511848|NCT03125200|79517310|FG000|Overall Study|Study Termination|0|||
44379492|NCT00841672|79385134|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44379493|NCT00841672|79385135|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44128905|NCT02836613|78914524|FG000|Overall Study|Accidental drowning|1|||
44128906|NCT02836613|78914525|FG001|Overall Study|Accidental drowning|0|||
44128907|NCT02836613|78914524|FG000|Overall Study|Lost to Follow-up|0|||
44128908|NCT02836613|78914525|FG001|Overall Study|Lost to Follow-up|1|||
44128909|NCT02836613|78914524|FG000|Overall Study|Withdrawal by Subject|0|||
44128910|NCT02836613|78914525|FG001|Overall Study|Withdrawal by Subject|2|||
44128911|NCT02397460|78914539|FG000|Treatment Period 2|Adverse Event|0|||
44128912|NCT02397460|78914540|FG001|Treatment Period 2|Adverse Event|0|||
44128913|NCT02397460|78914541|FG002|Treatment Period 2|Adverse Event|0|||
44128914|NCT02397460|78914542|FG003|Treatment Period 2|Adverse Event|0|||
44128915|NCT02397460|78914543|FG004|Treatment Period 2|Adverse Event|0|||
44128916|NCT02397460|78914544|FG005|Treatment Period 2|Adverse Event|0|||
44128917|NCT02397460|78914545|FG006|Treatment Period 2|Adverse Event|0|||
44128918|NCT02397460|78914546|FG007|Treatment Period 2|Adverse Event|1|||
44128919|NCT02397460|78914539|FG000|Treatment Period 4|Adverse Event|0|||
44128920|NCT02397460|78914540|FG001|Treatment Period 4|Adverse Event|1|||
44128921|NCT02397460|78914541|FG002|Treatment Period 4|Adverse Event|0|||
44128922|NCT02397460|78914542|FG003|Treatment Period 4|Adverse Event|0|||
44128923|NCT02397460|78914543|FG004|Treatment Period 4|Adverse Event|0|||
44128924|NCT02397460|78914544|FG005|Treatment Period 4|Adverse Event|0|||
44128925|NCT02397460|78914545|FG006|Treatment Period 4|Adverse Event|0|||
44128926|NCT02397460|78914546|FG007|Treatment Period 4|Adverse Event|0|||
44128927|NCT02397460|78914539|FG000|Treatment Period 4|Physician Decision|0|||
44243290|NCT01692782|79072742|FG001|Overall Study|Pregnancy|0|||
44511849|NCT03125200|79517311|FG001|Overall Study|Study Termination|0|||
44128928|NCT02397460|78914540|FG001|Treatment Period 4|Physician Decision|0|||
44511850|NCT03125200|79517312|FG002|Overall Study|Study Termination|0|||
44511851|NCT03125200|79517313|FG003|Overall Study|Study Termination|1|||
44511852|NCT03125200|79517314|FG004|Overall Study|Study Termination|1|||
44511853|NCT03125200|79517315|FG005|Overall Study|Study Termination|2|||
44511854|NCT03125200|79517316|FG006|Overall Study|Study Termination|1|||
44511855|NCT03125200|79517310|FG000|Overall Study|Clinical Progression|0|||
44511856|NCT03125200|79517311|FG001|Overall Study|Clinical Progression|0|||
44243291|NCT01692782|79072743|FG002|Overall Study|Pregnancy|0|||
44379494|NCT00841672|79385134|FG000|Overall Study|Subject withdrew consent|2|||
44511857|NCT03125200|79517312|FG002|Overall Study|Clinical Progression|0|||
44128929|NCT02397460|78914541|FG002|Treatment Period 4|Physician Decision|0|||
44128930|NCT02397460|78914542|FG003|Treatment Period 4|Physician Decision|0|||
44128931|NCT02397460|78914543|FG004|Treatment Period 4|Physician Decision|1|||
44128932|NCT02397460|78914544|FG005|Treatment Period 4|Physician Decision|0|||
44128933|NCT02397460|78914545|FG006|Treatment Period 4|Physician Decision|0|||
44128934|NCT02397460|78914546|FG007|Treatment Period 4|Physician Decision|0|||
44243292|NCT01692782|79072741|FG000|Overall Study|Protocol Violation|1|||
44128935|NCT02834819|78914622|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
44128936|NCT02834819|78914623|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
44128937|NCT02454478|78914629|FG000|Overall Study|Incomplete DLT Evaluation|1|||
44128938|NCT01341587|78914635|FG000|Overall Study|Lost to Follow-up|2|||
44128939|NCT01341587|78914636|FG001|Overall Study|Lost to Follow-up|0|||
44128940|NCT01341587|78914635|FG000|Overall Study|stopped using the meters|2|||
44128941|NCT01341587|78914636|FG001|Overall Study|stopped using the meters|10|||
44128942|NCT01358825|78914644|FG000|Overall Study|Blood sample not drawn|0|||
44128943|NCT01358825|78914645|FG001|Overall Study|Blood sample not drawn|1|||
44128944|NCT02453386|78914654|FG000|Overall Study|Adverse Event|22|||
44128945|NCT02453386|78914655|FG001|Overall Study|Adverse Event|30|||
44128946|NCT02453386|78914656|FG002|Overall Study|Adverse Event|15|||
44128947|NCT02453386|78914654|FG000|Overall Study|Protocol Violation|1|||
44128948|NCT02453386|78914655|FG001|Overall Study|Protocol Violation|0|||
44128949|NCT02453386|78914656|FG002|Overall Study|Protocol Violation|1|||
44128950|NCT02453386|78914654|FG000|Overall Study|Withdrawal by Subject|10|||
44128951|NCT02453386|78914655|FG001|Overall Study|Withdrawal by Subject|9|||
44128952|NCT02453386|78914656|FG002|Overall Study|Withdrawal by Subject|9|||
44128953|NCT02453386|78914654|FG000|Overall Study|Sponsor Terminated Study|14|||
44128954|NCT02453386|78914655|FG001|Overall Study|Sponsor Terminated Study|8|||
44128955|NCT02453386|78914656|FG002|Overall Study|Sponsor Terminated Study|11|||
44128956|NCT02453386|78914654|FG000|Overall Study|Subject Terminated by Sponsor|1|||
44128957|NCT02453386|78914655|FG001|Overall Study|Subject Terminated by Sponsor|1|||
44128958|NCT02453386|78914656|FG002|Overall Study|Subject Terminated by Sponsor|1|||
44128959|NCT02453386|78914654|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
44128960|NCT02453386|78914655|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
44128961|NCT02453386|78914656|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
44128962|NCT02453386|78914654|FG000|Overall Study|Lost to Follow-up|0|||
44128963|NCT02453386|78914655|FG001|Overall Study|Lost to Follow-up|0|||
44128964|NCT02453386|78914656|FG002|Overall Study|Lost to Follow-up|1|||
44128965|NCT02453386|78914654|FG000|Overall Study|Other|1|||
44128966|NCT02453386|78914655|FG001|Overall Study|Other|0|||
44128967|NCT02453386|78914656|FG002|Overall Study|Other|1|||
44128968|NCT02431468|78914674|FG000|Overall Study|Adverse Event|2|||
44128969|NCT02431468|78914675|FG001|Overall Study|Adverse Event|4|||
44128970|NCT02431468|78914676|FG002|Overall Study|Adverse Event|5|||
44128971|NCT02431468|78914674|FG000|Overall Study|Withdrawal by Subject|4|||
44128972|NCT02431468|78914675|FG001|Overall Study|Withdrawal by Subject|12|||
44128973|NCT02431468|78914676|FG002|Overall Study|Withdrawal by Subject|2|||
44128974|NCT02431468|78914674|FG000|Overall Study|noncompliance, investigator termination,|2|||
44128975|NCT02431468|78914675|FG001|Overall Study|noncompliance, investigator termination,|2|||
44128976|NCT02431468|78914676|FG002|Overall Study|noncompliance, investigator termination,|2|||
44128977|NCT02452762|78914692|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
44128978|NCT02452762|78914693|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
44128979|NCT02452762|78914692|FG000|Overall Study|Withdrawal by Subject|1|||
44128980|NCT02452762|78914693|FG001|Overall Study|Withdrawal by Subject|0|||
44128981|NCT02633306|78914700|FG000|Overall Study|Withdrawal by Subject|3|||
44128982|NCT02396758|78914709|FG000|Overall Study|Withdrawal by Subject|2|||
44128983|NCT02396758|78914710|FG001|Overall Study|Withdrawal by Subject|0|||
44128984|NCT02396758|78914711|FG002|Overall Study|Withdrawal by Subject|0|||
44128985|NCT02396758|78914712|FG003|Overall Study|Withdrawal by Subject|1|||
44128986|NCT02396758|78914709|FG000|Overall Study|Lost to Follow-up|8|||
44128987|NCT02396758|78914710|FG001|Overall Study|Lost to Follow-up|5|||
44128988|NCT02396758|78914711|FG002|Overall Study|Lost to Follow-up|3|||
44128989|NCT02396758|78914712|FG003|Overall Study|Lost to Follow-up|3|||
44128990|NCT02396758|78914709|FG000|Overall Study|Death|1|||
44128991|NCT02396758|78914710|FG001|Overall Study|Death|1|||
44379495|NCT00841672|79385135|FG001|Overall Study|Subject withdrew consent|4|||
44379496|NCT00841672|79385134|FG000|Overall Study|Lost to Follow-up|1|||
44128992|NCT02396758|78914711|FG002|Overall Study|Death|0|||
44128993|NCT02396758|78914712|FG003|Overall Study|Death|1|||
44128994|NCT02396758|78914709|FG000|Overall Study|Randomized but not treated|1|||
44128995|NCT02396758|78914710|FG001|Overall Study|Randomized but not treated|0|||
44128996|NCT02396758|78914711|FG002|Overall Study|Randomized but not treated|1|||
44128997|NCT02396758|78914712|FG003|Overall Study|Randomized but not treated|0|||
44128998|NCT02632838|78914724|FG000|Overall Study|Withdrawal by Subject|3|||
44128999|NCT02632838|78914725|FG001|Overall Study|Withdrawal by Subject|0|||
44129000|NCT02632838|78914724|FG000|Overall Study|Lost to Follow-up|0|||
44129001|NCT02632838|78914725|FG001|Overall Study|Lost to Follow-up|2|||
44129002|NCT02396212|78914735|FG000|Overall Study|Adverse Event|1|||
44129003|NCT02396212|78914735|FG000|Overall Study|Lack of Efficacy|2|||
44129004|NCT02395822|78914739|FG000|Overall Study|Withdrawal by Subject|1|||
44129005|NCT02395822|78914739|FG000|Overall Study|Death|1|||
44129006|NCT01651936|78914745|FG000|Base Study|Adverse Event|3|||
44129007|NCT01651936|78914746|FG001|Base Study|Adverse Event|0|||
44129008|NCT01651936|78914747|FG002|Base Study|Adverse Event|0|||
44129009|NCT01651936|78914745|FG000|Base Study|Withdrawal by Subject|1|||
44129010|NCT01651936|78914746|FG001|Base Study|Withdrawal by Subject|1|||
44129011|NCT01651936|78914747|FG002|Base Study|Withdrawal by Subject|0|||
44129012|NCT01651936|78914745|FG000|Base Study|Early Escape|2|||
44129013|NCT01651936|78914746|FG001|Base Study|Early Escape|8|||
44129014|NCT01651936|78914747|FG002|Base Study|Early Escape|0|||
44129015|NCT01651936|78914745|FG000|Base Study|Study terminated by sponsor|21|||
44129016|NCT01651936|78914746|FG001|Base Study|Study terminated by sponsor|16|||
44129017|NCT01651936|78914747|FG002|Base Study|Study terminated by sponsor|0|||
44129018|NCT01651936|78914745|FG000|Extension Study|Lack of Efficacy|0|||
44129019|NCT01651936|78914746|FG001|Extension Study|Lack of Efficacy|0|||
44129020|NCT01651936|78914747|FG002|Extension Study|Lack of Efficacy|1|||
44129021|NCT01651936|78914745|FG000|Extension Study|Study terminated by sponsor|0|||
44129022|NCT01651936|78914746|FG001|Extension Study|Study terminated by sponsor|0|||
44129023|NCT01651936|78914747|FG002|Extension Study|Study terminated by sponsor|13|||
44129024|NCT02395042|78914757|FG000|Treatment 1 Period|Adverse Event|1|||
44129025|NCT02395042|78914758|FG001|Treatment 1 Period|Adverse Event|3|||
44129026|NCT02395042|78914759|FG002|Treatment 1 Period|Adverse Event|1|||
44129027|NCT02395042|78914757|FG000|Treatment 1 Period|Lack of Efficacy|1|||
44129028|NCT02395042|78914758|FG001|Treatment 1 Period|Lack of Efficacy|1|||
44129029|NCT02395042|78914759|FG002|Treatment 1 Period|Lack of Efficacy|0|||
44129030|NCT02395042|78914757|FG000|Treatment 1 Period|Lost to Follow-up|1|||
44129031|NCT02395042|78914758|FG001|Treatment 1 Period|Lost to Follow-up|0|||
44129032|NCT02395042|78914759|FG002|Treatment 1 Period|Lost to Follow-up|0|||
44129033|NCT02395042|78914757|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
44129034|NCT02395042|78914758|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
44129035|NCT02395042|78914759|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
44129036|NCT02395042|78914757|FG000|Treatment 2 Period|Lack of Efficacy|1|||
44129037|NCT02395042|78914758|FG001|Treatment 2 Period|Lack of Efficacy|1|||
44129038|NCT02395042|78914759|FG002|Treatment 2 Period|Lack of Efficacy|0|||
44129039|NCT02394808|78914770|FG000|Period 1|Unsatisfactory lens fitting|0|||
44129040|NCT02394808|78914771|FG001|Period 1|Unsatisfactory lens fitting|1|||
44129041|NCT02394808|78914770|FG000|Period 2|Lost to Follow-up|1|||
44129042|NCT02394808|78914771|FG001|Period 2|Lost to Follow-up|0|||
44129043|NCT02630966|78914779|FG000|Overall Study|Adverse Event|1|||
44129044|NCT02630966|78914780|FG001|Overall Study|Adverse Event|3|||
44129045|NCT02630966|78914779|FG000|Overall Study|Significant Protocol Deviation|0|||
44129046|NCT02630966|78914780|FG001|Overall Study|Significant Protocol Deviation|2|||
44129047|NCT02630966|78914779|FG000|Overall Study|Voluntary Withdrawal|1|||
44511858|NCT03125200|79517313|FG003|Overall Study|Clinical Progression|1|||
44511859|NCT03125200|79517314|FG004|Overall Study|Clinical Progression|0|||
44511860|NCT03125200|79517315|FG005|Overall Study|Clinical Progression|1|||
44511861|NCT03125200|79517316|FG006|Overall Study|Clinical Progression|0|||
44511862|NCT03125200|79517310|FG000|Overall Study|Progressive Disease|2|||
44511863|NCT03125200|79517311|FG001|Overall Study|Progressive Disease|1|||
44129048|NCT02630966|78914780|FG001|Overall Study|Voluntary Withdrawal|1|||
44129049|NCT02630966|78914779|FG000|Overall Study|Lack of Efficacy|0|||
44129050|NCT02630966|78914780|FG001|Overall Study|Lack of Efficacy|2|||
44129051|NCT01651780|78914788|FG000|Overall Study|Physician decision: No 30-day visit|2|||
44511864|NCT03125200|79517312|FG002|Overall Study|Progressive Disease|2|||
44129052|NCT01651780|78914789|FG001|Overall Study|Physician decision: No 30-day visit|1|||
44511865|NCT03125200|79517313|FG003|Overall Study|Progressive Disease|1|||
44511866|NCT03125200|79517314|FG004|Overall Study|Progressive Disease|2|||
44511867|NCT03125200|79517315|FG005|Overall Study|Progressive Disease|0|||
44129053|NCT01651780|78914788|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
44129054|NCT01651780|78914789|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
44129055|NCT01651780|78914788|FG000|Overall Study|Withdrawal by Subject|2|||
44129056|NCT01651780|78914789|FG001|Overall Study|Withdrawal by Subject|0|||
44129057|NCT01651780|78914788|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
44129058|NCT01651780|78914789|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44129059|NCT01651780|78914788|FG000|Overall Study|Lost to Follow-up|1|||
44129060|NCT01651780|78914789|FG001|Overall Study|Lost to Follow-up|2|||
44129061|NCT01651780|78914788|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
44129062|NCT01651780|78914789|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
44129063|NCT02394730|78914801|FG000|Overall Study|Lost to Follow-up|1|||
44129064|NCT02394730|78914802|FG001|Overall Study|Lost to Follow-up|0|||
44129065|NCT02394730|78914801|FG000|Overall Study|Withdrawal by Subject|0|||
44129066|NCT02394730|78914802|FG001|Overall Study|Withdrawal by Subject|1|||
44129067|NCT02430532|78914810|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
44129068|NCT02430532|78914811|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
44129069|NCT02430532|78914810|FG000|Overall Study|Consent Withdrawn|0|||
44129070|NCT02430532|78914811|FG001|Overall Study|Consent Withdrawn|2|||
44129071|NCT02430532|78914810|FG000|Overall Study|Adverse Event|0|||
44129072|NCT02430532|78914811|FG001|Overall Study|Adverse Event|1|||
44129073|NCT02394340|78914819|FG000|Overall Study|Failed drug screen test|1|||
44129074|NCT02394340|78914819|FG000|Overall Study|Adverse Event|1|||
44129075|NCT01672736|78914823|FG000|Overall Study|Available drug expired on 31 May 16|3|||
44129076|NCT01560637|78914827|FG000|Overall Study|Adverse Event|63|||
44129077|NCT01560637|78914827|FG000|Overall Study|Death|69|||
44129078|NCT01560637|78914827|FG000|Overall Study|Lost to Follow-up|8|||
44129079|NCT01560637|78914827|FG000|Overall Study|Protocol Violation|8|||
44129080|NCT01560637|78914827|FG000|Overall Study|Withdrawal by Subject|24|||
44129081|NCT01560637|78914827|FG000|Overall Study|Progressive Disease|20|||
44129082|NCT01560637|78914827|FG000|Overall Study|Other Reason Not Specified|6|||
44129083|NCT01353911|78914839|FG000|Overall Study|Lost to Follow-up|2|||
44129084|NCT01353911|78914840|FG001|Overall Study|Lost to Follow-up|6|||
44129085|NCT01353911|78914841|FG002|Overall Study|Lost to Follow-up|4|||
44129086|NCT01353911|78914842|FG003|Overall Study|Lost to Follow-up|0|||
44129087|NCT01353911|78914843|FG004|Overall Study|Lost to Follow-up|4|||
44511868|NCT03125200|79517316|FG006|Overall Study|Progressive Disease|1|||
44511869|NCT03125200|79517310|FG000|Overall Study|Lack of Efficacy|0|||
44511870|NCT03125200|79517311|FG001|Overall Study|Lack of Efficacy|0|||
44511871|NCT03125200|79517312|FG002|Overall Study|Lack of Efficacy|0|||
44511872|NCT03125200|79517313|FG003|Overall Study|Lack of Efficacy|1|||
44511873|NCT03125200|79517314|FG004|Overall Study|Lack of Efficacy|0|||
44511874|NCT03125200|79517315|FG005|Overall Study|Lack of Efficacy|0|||
44511875|NCT03125200|79517316|FG006|Overall Study|Lack of Efficacy|0|||
44511876|NCT03125200|79517310|FG000|Overall Study|Toxicity|0|||
44511877|NCT03125200|79517311|FG001|Overall Study|Toxicity|0|||
44511878|NCT03125200|79517312|FG002|Overall Study|Toxicity|0|||
44511879|NCT03125200|79517313|FG003|Overall Study|Toxicity|1|||
44511880|NCT03125200|79517314|FG004|Overall Study|Toxicity|0|||
44511881|NCT03125200|79517315|FG005|Overall Study|Toxicity|0|||
44511882|NCT03125200|79517316|FG006|Overall Study|Toxicity|0|||
44511883|NCT03125200|79517310|FG000|Overall Study|Consent Withdrawn by Subject|0|||
44511884|NCT03125200|79517311|FG001|Overall Study|Consent Withdrawn by Subject|1|||
44511885|NCT03125200|79517312|FG002|Overall Study|Consent Withdrawn by Subject|0|||
44511886|NCT03125200|79517313|FG003|Overall Study|Consent Withdrawn by Subject|0|||
44129088|NCT01353911|78914844|FG005|Overall Study|Lost to Follow-up|4|||
44129089|NCT01353911|78914845|FG006|Overall Study|Lost to Follow-up|3|||
44129090|NCT01353911|78914846|FG007|Overall Study|Lost to Follow-up|6|||
44129091|NCT01353911|78914839|FG000|Overall Study|Withdrawal by Subject|2|||
44129092|NCT01353911|78914840|FG001|Overall Study|Withdrawal by Subject|3|||
44129093|NCT01353911|78914841|FG002|Overall Study|Withdrawal by Subject|4|||
44511887|NCT03125200|79517314|FG004|Overall Study|Consent Withdrawn by Subject|1|||
44511888|NCT03125200|79517315|FG005|Overall Study|Consent Withdrawn by Subject|0|||
44129094|NCT01353911|78914842|FG003|Overall Study|Withdrawal by Subject|2|||
44129095|NCT01353911|78914843|FG004|Overall Study|Withdrawal by Subject|2|||
44129096|NCT01353911|78914844|FG005|Overall Study|Withdrawal by Subject|3|||
44129097|NCT01353911|78914845|FG006|Overall Study|Withdrawal by Subject|3|||
44129098|NCT01353911|78914846|FG007|Overall Study|Withdrawal by Subject|9|||
44129099|NCT01353911|78914839|FG000|Overall Study|Status Not Recorded|4|||
44129100|NCT01353911|78914840|FG001|Overall Study|Status Not Recorded|0|||
44129101|NCT01353911|78914841|FG002|Overall Study|Status Not Recorded|1|||
44129102|NCT01353911|78914842|FG003|Overall Study|Status Not Recorded|0|||
44129103|NCT01353911|78914843|FG004|Overall Study|Status Not Recorded|0|||
44129104|NCT01353911|78914844|FG005|Overall Study|Status Not Recorded|0|||
44129105|NCT01353911|78914845|FG006|Overall Study|Status Not Recorded|0|||
44129106|NCT01353911|78914846|FG007|Overall Study|Status Not Recorded|0|||
44129107|NCT01671488|78914864|FG000|Overall Study|Withdrawal by Subject|1|||
44129108|NCT02783911|78914870|FG000|Overall Study|Lost to Follow-up|3|||
44129109|NCT02783911|78914871|FG001|Overall Study|Lost to Follow-up|32|||
44129110|NCT01358357|78914879|FG000|Open Label Phase|Adverse Event|0|||
44129111|NCT01358357|78914880|FG001|Open Label Phase|Adverse Event|0|||
44129112|NCT01358357|78914881|FG002|Open Label Phase|Adverse Event|59|||
44129113|NCT01358357|78914879|FG000|Open Label Phase|Lack of Efficacy|0|||
44129114|NCT01358357|78914880|FG001|Open Label Phase|Lack of Efficacy|0|||
44129115|NCT01358357|78914881|FG002|Open Label Phase|Lack of Efficacy|107|||
44129116|NCT01358357|78914879|FG000|Open Label Phase|Lost to Follow-up|0|||
44129117|NCT01358357|78914880|FG001|Open Label Phase|Lost to Follow-up|0|||
44129118|NCT01358357|78914881|FG002|Open Label Phase|Lost to Follow-up|76|||
44129119|NCT01358357|78914879|FG000|Open Label Phase|Protocol Violation|0|||
44129120|NCT01358357|78914880|FG001|Open Label Phase|Protocol Violation|0|||
44129121|NCT01358357|78914881|FG002|Open Label Phase|Protocol Violation|45|||
44129122|NCT01358357|78914879|FG000|Open Label Phase|Withdrawal by Subject|0|||
44129123|NCT01358357|78914880|FG001|Open Label Phase|Withdrawal by Subject|0|||
44129124|NCT01358357|78914881|FG002|Open Label Phase|Withdrawal by Subject|112|||
44129125|NCT01358357|78914879|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
44129126|NCT01358357|78914880|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
44129127|NCT01358357|78914881|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
44129128|NCT01358357|78914879|FG000|Open Label Phase|Terminated at study completion|0|||
44129129|NCT01358357|78914880|FG001|Open Label Phase|Terminated at study completion|0|||
44129130|NCT01358357|78914881|FG002|Open Label Phase|Terminated at study completion|5|||
44129131|NCT01358357|78914879|FG000|Open Label Phase|Mood episode|0|||
44129132|NCT01358357|78914880|FG001|Open Label Phase|Mood episode|0|||
44129133|NCT01358357|78914881|FG002|Open Label Phase|Mood episode|42|||
44129134|NCT01358357|78914879|FG000|Double-Blind Phase|Adverse Event|8|||
44129135|NCT01358357|78914880|FG001|Double-Blind Phase|Adverse Event|5|||
44129136|NCT01358357|78914881|FG002|Double-Blind Phase|Adverse Event|0|||
44129137|NCT01358357|78914879|FG000|Double-Blind Phase|Lost to Follow-up|5|||
44129138|NCT01358357|78914880|FG001|Double-Blind Phase|Lost to Follow-up|7|||
44129139|NCT01358357|78914881|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44129140|NCT01358357|78914879|FG000|Double-Blind Phase|Protocol Violation|1|||
44129141|NCT01358357|78914880|FG001|Double-Blind Phase|Protocol Violation|11|||
44129142|NCT01358357|78914881|FG002|Double-Blind Phase|Protocol Violation|0|||
44129143|NCT01358357|78914879|FG000|Double-Blind Phase|Protocol Violation|16|||
44129144|NCT01358357|78914880|FG001|Double-Blind Phase|Protocol Violation|12|||
44129145|NCT01358357|78914881|FG002|Double-Blind Phase|Protocol Violation|0|||
44129146|NCT01358357|78914879|FG000|Double-Blind Phase|Terminated at study completion|2|||
44129147|NCT01358357|78914880|FG001|Double-Blind Phase|Terminated at study completion|0|||
44129148|NCT01358357|78914881|FG002|Double-Blind Phase|Terminated at study completion|0|||
44129149|NCT01358357|78914879|FG000|Double-Blind Phase|Recurrence of mood event|48|||
44129150|NCT01358357|78914880|FG001|Double-Blind Phase|Recurrence of mood event|64|||
44129151|NCT01358357|78914881|FG002|Double-Blind Phase|Recurrence of mood event|0|||
44129152|NCT01358357|78914879|FG000|Double-Blind Phase|Administrative|0|||
44129153|NCT01358357|78914880|FG001|Double-Blind Phase|Administrative|1|||
44129154|NCT01358357|78914881|FG002|Double-Blind Phase|Administrative|0|||
44129155|NCT02831387|78914890|FG000|Overall Study|Withdrawal by Subject|1|||
44129156|NCT02831387|78914891|FG001|Overall Study|Withdrawal by Subject|1|||
44129157|NCT02831387|78914890|FG000|Overall Study|Discontinued due to stock recovery|0|||
44129158|NCT02831387|78914891|FG001|Overall Study|Discontinued due to stock recovery|1|||
44129159|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
44129160|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
44129161|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
44129162|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
44243293|NCT01692782|79072742|FG001|Overall Study|Protocol Violation|0|||
44129163|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
44129164|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
44129165|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
44129166|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
44129167|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
44129168|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
44129169|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
44129170|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
44129171|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
44129172|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
44129173|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
44129174|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
44129175|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
44129176|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
44129177|NCT02831855|78914897|FG000|Open Label Phase (24 Weeks)|Other|4|||
44129178|NCT02831855|78914898|FG001|Open Label Phase (24 Weeks)|Other|0|||
44129179|NCT02831855|78914899|FG002|Open Label Phase (24 Weeks)|Other|0|||
44129180|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
44129181|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
44129182|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
44129183|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Death|0|||
44129184|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Death|0|||
44129185|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Death|2|||
44129186|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
44129187|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
44129188|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
44129189|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
44129190|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
44129191|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
44129192|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
44129193|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
44129194|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
44129195|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Other|0|||
44129196|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Other|2|||
44129197|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Other|5|||
44129198|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
44129199|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
44129200|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
44129201|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
44129202|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
44129203|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
44129204|NCT02831855|78914897|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
44129205|NCT02831855|78914898|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
44129206|NCT02831855|78914899|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
44129207|NCT02628938|78914912|FG000|Overall Study|Did not attend the follow up recall|2|||
44129208|NCT02628938|78914913|FG001|Overall Study|Did not attend the follow up recall|2|||
44129209|NCT02628938|78914914|FG002|Overall Study|Did not attend the follow up recall|1|||
44129210|NCT02628938|78914912|FG000|Overall Study|Failure to comply with the instructions|3|||
44129211|NCT02628938|78914913|FG001|Overall Study|Failure to comply with the instructions|0|||
44129212|NCT02628938|78914914|FG002|Overall Study|Failure to comply with the instructions|3|||
44129213|NCT01356407|78914928|FG000|Overall Study|Lost to Follow-up|2|||
44129214|NCT01356407|78914929|FG001|Overall Study|Lost to Follow-up|0|||
44129215|NCT01356407|78914928|FG000|Overall Study|Patient Withdrew Consent|2|||
44129216|NCT01356407|78914929|FG001|Overall Study|Patient Withdrew Consent|1|||
44129217|NCT01356407|78914928|FG000|Overall Study|Could not afford IMP administration|0|||
44129218|NCT01356407|78914929|FG001|Overall Study|Could not afford IMP administration|1|||
44129219|NCT01356407|78914928|FG000|Overall Study|Not complete Endoscopy|2|||
44129220|NCT01356407|78914929|FG001|Overall Study|Not complete Endoscopy|2|||
44129221|NCT00109837|78914935|FG000|Overall Study|Adverse Event|2|||
44129222|NCT00109837|78914935|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
44129223|NCT00109837|78914935|FG000|Overall Study|Death|1|||
44243294|NCT01692782|79072743|FG002|Overall Study|Protocol Violation|2|||
44243295|NCT01692782|79072741|FG000|Overall Study|Non-complance with study drug|0|||
44243296|NCT01692782|79072742|FG001|Overall Study|Non-complance with study drug|4|||
44243297|NCT01692782|79072743|FG002|Overall Study|Non-complance with study drug|1|||
44243298|NCT01692782|79072741|FG000|Overall Study|Non-compliant with study visits|0|||
44379497|NCT00841672|79385135|FG001|Overall Study|Lost to Follow-up|1|||
44129224|NCT00109837|78914935|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
44129225|NCT00109837|78914935|FG000|Overall Study|Not treated|1|||
44129226|NCT00109837|78914935|FG000|Overall Study|Ineligible|1|||
44129227|NCT02828111|78914948|FG000|Overall Study|Withdrawal by Subject|0|||
44129228|NCT02828111|78914949|FG001|Overall Study|Withdrawal by Subject|0|||
44129229|NCT02828111|78914950|FG002|Overall Study|Withdrawal by Subject|2|||
44129230|NCT02828111|78914951|FG003|Overall Study|Withdrawal by Subject|0|||
44129231|NCT02828111|78914952|FG004|Overall Study|Withdrawal by Subject|0|||
44129232|NCT02828111|78914948|FG000|Overall Study|Lost to Follow-up|0|||
44129233|NCT02828111|78914949|FG001|Overall Study|Lost to Follow-up|0|||
44129234|NCT02828111|78914950|FG002|Overall Study|Lost to Follow-up|0|||
44129235|NCT02828111|78914951|FG003|Overall Study|Lost to Follow-up|1|||
44129236|NCT02828111|78914952|FG004|Overall Study|Lost to Follow-up|1|||
44129237|NCT01671332|78914975|FG000|Overall Study|Withdrawal by Subject|1|||
44129238|NCT01671332|78914976|FG001|Overall Study|Withdrawal by Subject|1|||
44129239|NCT01355627|78914984|FG000|Overall Study|Request By the Patient to Discontinue|5|||
44129240|NCT01355627|78914985|FG001|Overall Study|Request By the Patient to Discontinue|7|||
44129241|NCT01355627|78914984|FG000|Overall Study|Lost to Follow-up|8|||
44129242|NCT01355627|78914985|FG001|Overall Study|Lost to Follow-up|7|||
44129243|NCT01355627|78914984|FG000|Overall Study|Fatal Adverse Event|19|||
44129244|NCT01355627|78914985|FG001|Overall Study|Fatal Adverse Event|23|||
44129245|NCT01355627|78914984|FG000|Overall Study|Other|1|||
44129246|NCT01355627|78914985|FG001|Overall Study|Other|1|||
44129247|NCT00100802|78914991|FG000|Overall Study|Adverse Event|9|||
44129248|NCT00100802|78914991|FG000|Overall Study|Death|1|||
44129249|NCT00100802|78914991|FG000|Overall Study|Lack of Efficacy|47|||
44129250|NCT00100802|78914991|FG000|Overall Study|Physician Decision|5|||
44129251|NCT00100802|78914991|FG000|Overall Study|Protocol Violation|1|||
44129252|NCT00100802|78914991|FG000|Overall Study|Withdrawal by Subject|5|||
44129253|NCT00100802|78914991|FG000|Overall Study|Ineligible|12|||
44129254|NCT01355159|78914997|FG000|Overall Study|Withdrew consent|39|||
44129255|NCT01355159|78914998|FG001|Overall Study|Withdrew consent|47|||
44129256|NCT01355159|78914997|FG000|Overall Study|No primary outcome data|17|||
44129257|NCT01355159|78914998|FG001|Overall Study|No primary outcome data|11|||
44129258|NCT01355159|78914997|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
44129259|NCT01355159|78914998|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
44129260|NCT01355159|78914997|FG000|Overall Study|Early intrauterine fetal death|6|||
44129261|NCT01355159|78914998|FG001|Overall Study|Early intrauterine fetal death|6|||
44129262|NCT02630186|78915004|FG000|Overall Study|Withdrawal by Subject|1|||
44129263|NCT01669928|78915010|FG000|First Intervention|Withdrawal by Subject|3|||
44129264|NCT01669928|78915011|FG001|First Intervention|Withdrawal by Subject|5|||
44129265|NCT01355081|78915022|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
44129266|NCT01355081|78915023|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
44129267|NCT01355081|78915024|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
44129268|NCT01355081|78915022|FG000|Overall Study|Major Protocol Deviation|0|||
44129269|NCT01355081|78915023|FG001|Overall Study|Major Protocol Deviation|1|||
44129270|NCT01355081|78915024|FG002|Overall Study|Major Protocol Deviation|0|||
44129271|NCT01355081|78915022|FG000|Overall Study|Lost to Follow-up|0|||
44129272|NCT01355081|78915023|FG001|Overall Study|Lost to Follow-up|0|||
44129273|NCT01355081|78915024|FG002|Overall Study|Lost to Follow-up|1|||
44129274|NCT01355081|78915022|FG000|Overall Study|Withdrawal of Consent|2|||
44129275|NCT01355081|78915023|FG001|Overall Study|Withdrawal of Consent|3|||
44129276|NCT01355081|78915024|FG002|Overall Study|Withdrawal of Consent|3|||
44129277|NCT01355081|78915022|FG000|Overall Study|Lack of Efficacy|2|||
44129278|NCT01355081|78915023|FG001|Overall Study|Lack of Efficacy|1|||
44129279|NCT01355081|78915024|FG002|Overall Study|Lack of Efficacy|1|||
44129280|NCT01355081|78915022|FG000|Overall Study|Non Compliance with Study Medication|0|||
44129281|NCT01355081|78915023|FG001|Overall Study|Non Compliance with Study Medication|1|||
44129282|NCT01355081|78915024|FG002|Overall Study|Non Compliance with Study Medication|0|||
44243299|NCT01692782|79072742|FG001|Overall Study|Non-compliant with study visits|0|||
44243300|NCT01692782|79072743|FG002|Overall Study|Non-compliant with study visits|1|||
44243301|NCT01692782|79072741|FG000|Overall Study|SAE not related to study drug|0|||
44243302|NCT01692782|79072742|FG001|Overall Study|SAE not related to study drug|1|||
44243303|NCT01692782|79072743|FG002|Overall Study|SAE not related to study drug|0|||
44243304|NCT01692782|79072741|FG000|Overall Study|Withdrawal by Subject|3|||
44129283|NCT01354223|78915034|FG000|Overall Study|Withdrawal by Subject|3|||
44129284|NCT01354223|78915035|FG001|Overall Study|Withdrawal by Subject|1|||
44129285|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
44129286|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
44129287|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
44129288|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
44129289|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
44129290|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
44129291|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
44243305|NCT01692782|79072742|FG001|Overall Study|Withdrawal by Subject|10|||
44129292|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
44243306|NCT01692782|79072743|FG002|Overall Study|Withdrawal by Subject|3|||
44129293|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
44129294|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
44129295|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
44129296|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
44129297|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
44129298|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
44129299|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
44129300|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
44129301|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
44129302|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
44129303|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
44129304|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
44129305|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
44129306|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
44129307|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
44129308|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
44129309|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
44129310|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
44129311|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
44129312|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
44129313|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
44129314|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
44129315|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
44129316|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
44129317|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
44129318|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
44129319|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
44129320|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
44129321|NCT04043455|78915045|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
44129322|NCT04043455|78915046|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
44129323|NCT04043455|78915047|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
44129324|NCT04043455|78915048|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
44129325|NCT04043455|78915049|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
44129326|NCT04043455|78915050|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
44129327|NCT04043455|78915045|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
44129328|NCT04043455|78915046|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
44129329|NCT04043455|78915047|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
44129330|NCT04043455|78915048|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
44129331|NCT04043455|78915049|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
44129332|NCT04043455|78915050|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
44129333|NCT04043455|78915045|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
44129334|NCT04043455|78915046|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
44129335|NCT04043455|78915047|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
44129336|NCT04043455|78915048|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
44129337|NCT04043455|78915049|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
44129338|NCT04043455|78915050|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
44129339|NCT04043455|78915045|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
44129340|NCT04043455|78915046|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
44129341|NCT04043455|78915047|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
44129342|NCT04043455|78915048|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
44129343|NCT04043455|78915049|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
44129344|NCT04043455|78915050|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
44129345|NCT04043455|78915045|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
44129346|NCT04043455|78915046|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
44129347|NCT04043455|78915047|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
44129348|NCT04043455|78915048|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
44129349|NCT04043455|78915049|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
44511889|NCT03125200|79517316|FG006|Overall Study|Consent Withdrawn by Subject|1|||
44511890|NCT03132220|79517337|FG000|Overall Study|Lost to Follow-up|17|||
44511891|NCT03132220|79517338|FG001|Overall Study|Lost to Follow-up|8|||
44511892|NCT03132220|79517337|FG000|Overall Study|Withdrawal by Subject|1|||
44511893|NCT03132220|79517338|FG001|Overall Study|Withdrawal by Subject|4|||
44511894|NCT03119662|79517346|FG000|Overall Study|Withdrawal by Subject|0|||
44129350|NCT04043455|78915050|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
44129351|NCT02627144|78915068|FG000|Overall Study|Serious adverse event|32|||
44129352|NCT02627144|78915068|FG000|Overall Study|Cancer progression|171|||
44129353|NCT02627144|78915068|FG000|Overall Study|Death from cancer|20|||
44129354|NCT02627144|78915068|FG000|Overall Study|Death from other cause|8|||
44129355|NCT02627144|78915068|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
44129356|NCT02627144|78915068|FG000|Overall Study|Administrative reasons|65|||
44129357|NCT02627144|78915068|FG000|Overall Study|Lost to Follow-up|8|||
44129358|NCT02627144|78915068|FG000|Overall Study|Enrolled, not treated|6|||
44129359|NCT02627144|78915068|FG000|Overall Study|Other|17|||
44129360|NCT02626520|78915074|FG000|Overall Study|Physician Decision|1|||
44129361|NCT02626520|78915075|FG001|Overall Study|Physician Decision|1|||
44129362|NCT02626520|78915074|FG000|Overall Study|Adverse Event|0|||
44129363|NCT02626520|78915075|FG001|Overall Study|Adverse Event|4|||
44129364|NCT02626520|78915074|FG000|Overall Study|Lack of Efficacy|0|||
44129365|NCT02626520|78915075|FG001|Overall Study|Lack of Efficacy|2|||
44129366|NCT02626520|78915074|FG000|Overall Study|Did not start protocol therapy|0|||
44129367|NCT02626520|78915075|FG001|Overall Study|Did not start protocol therapy|2|||
44129368|NCT02626520|78915074|FG000|Overall Study|Study terminated|0|||
44129369|NCT02626520|78915075|FG001|Overall Study|Study terminated|1|||
44129370|NCT04522141|78915083|FG000|Overall Study|Withdrawal by Subject|1|||
44129371|NCT04522141|78915084|FG001|Overall Study|Withdrawal by Subject|0|||
44129372|NCT01329029|78915107|FG000|Overall Study|Withdrawal by Subject|117|||
44129373|NCT01329029|78915108|FG001|Overall Study|Withdrawal by Subject|87|||
44129374|NCT01329029|78915107|FG000|Overall Study|Adverse Event|82|||
44129375|NCT01329029|78915108|FG001|Overall Study|Adverse Event|29|||
44129376|NCT01329029|78915107|FG000|Overall Study|Death|16|||
44129377|NCT01329029|78915108|FG001|Overall Study|Death|19|||
44129378|NCT01329029|78915107|FG000|Overall Study|Other|14|||
44129379|NCT01329029|78915108|FG001|Overall Study|Other|20|||
44129380|NCT01329029|78915107|FG000|Overall Study|COPD Exacerbation|11|||
44129381|NCT01329029|78915108|FG001|Overall Study|COPD Exacerbation|18|||
44129382|NCT01329029|78915107|FG000|Overall Study|Physician Decision|16|||
44129383|NCT01329029|78915108|FG001|Overall Study|Physician Decision|13|||
44129384|NCT01329029|78915107|FG000|Overall Study|Lost to Follow-up|8|||
44129385|NCT01329029|78915108|FG001|Overall Study|Lost to Follow-up|5|||
44129386|NCT01329029|78915107|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
44243307|NCT01692626|79072751|FG000|Overall Study|Death|0|||
44243308|NCT01692626|79072752|FG001|Overall Study|Death|1|||
44243309|NCT01692626|79072751|FG000|Overall Study|Adverse Event|2|||
44243310|NCT01692626|79072752|FG001|Overall Study|Adverse Event|3|||
44129387|NCT01329029|78915108|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
44129388|NCT01372085|78915124|FG000|Washout Period 2|Physician Decision|0|||
44129389|NCT01372085|78915125|FG001|Washout Period 2|Physician Decision|0|||
44129390|NCT01372085|78915126|FG002|Washout Period 2|Physician Decision|0|||
44129391|NCT01372085|78915127|FG003|Washout Period 2|Physician Decision|0|||
44129392|NCT01372085|78915128|FG004|Washout Period 2|Physician Decision|1|||
44129393|NCT01372085|78915129|FG005|Washout Period 2|Physician Decision|0|||
44243311|NCT01692626|79072751|FG000|Overall Study|Protocol Violation|1|||
44129394|NCT01372085|78915130|FG006|Washout Period 2|Physician Decision|0|||
44129395|NCT01372085|78915131|FG007|Washout Period 2|Physician Decision|0|||
44129396|NCT01372085|78915132|FG008|Washout Period 2|Physician Decision|0|||
44129397|NCT01372085|78915133|FG009|Washout Period 2|Physician Decision|0|||
44129398|NCT01372085|78915124|FG000|Washout Period 3|Withdrawal by Subject|0|||
44129399|NCT01372085|78915125|FG001|Washout Period 3|Withdrawal by Subject|0|||
44129400|NCT01372085|78915126|FG002|Washout Period 3|Withdrawal by Subject|0|||
44129401|NCT01372085|78915127|FG003|Washout Period 3|Withdrawal by Subject|0|||
44129402|NCT01372085|78915128|FG004|Washout Period 3|Withdrawal by Subject|0|||
44129403|NCT01372085|78915129|FG005|Washout Period 3|Withdrawal by Subject|2|||
44129404|NCT01372085|78915130|FG006|Washout Period 3|Withdrawal by Subject|0|||
44129405|NCT01372085|78915131|FG007|Washout Period 3|Withdrawal by Subject|0|||
44129406|NCT01372085|78915132|FG008|Washout Period 3|Withdrawal by Subject|0|||
44129407|NCT01372085|78915133|FG009|Washout Period 3|Withdrawal by Subject|0|||
44129408|NCT04012853|78915159|FG000|Overall Study|Withdrawal by Subject|1|||
44129409|NCT04012853|78915160|FG001|Overall Study|Withdrawal by Subject|1|||
44129410|NCT04012853|78915159|FG000|Overall Study|Protocol Violation|1|||
44129411|NCT04012853|78915160|FG001|Overall Study|Protocol Violation|0|||
44129412|NCT04012853|78915159|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
44129413|NCT04012853|78915160|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
44129414|NCT02941549|78915169|FG000|Overall Study|Adverse Event|1|||
44129415|NCT02941549|78915170|FG001|Overall Study|Adverse Event|0|||
44129416|NCT02941549|78915171|FG002|Overall Study|Adverse Event|0|||
44129417|NCT02941549|78915169|FG000|Overall Study|Withdrawal by Subject|2|||
44511895|NCT03119662|79517347|FG001|Overall Study|Withdrawal by Subject|1|||
44511896|NCT02728804|79517353|FG000|Overall Study|Ineligible|3|||
44511897|NCT02728804|79517353|FG000|Overall Study|Did not complete baseline questionnaire|9|||
44511898|NCT02728804|79517353|FG000|Overall Study|Death|99|||
44511899|NCT02699554|79517369|FG000|Overall Study|Lost to Follow-up|9|||
44511900|NCT03783780|79517383|FG000|Overall Study|Withdrawn prior to completion|1|||
44511901|NCT03783702|79517390|FG000|Overall Study|Lost to Follow-up|6|||
44511902|NCT03783702|79517391|FG001|Overall Study|Lost to Follow-up|8|||
44511903|NCT03783702|79517390|FG000|Overall Study|Protocol Violation|1|||
44511904|NCT03783702|79517391|FG001|Overall Study|Protocol Violation|3|||
44511905|NCT03575572|79517399|FG000|Overall Study|Withdrawal by Subject|2|||
44511906|NCT03575572|79517399|FG000|Overall Study|Physician Decision|2|||
44511907|NCT03116698|79517425|FG000|Overall Study|Adverse Event|1|||
44511908|NCT03116698|79517426|FG001|Overall Study|Adverse Event|1|||
44511909|NCT03116698|79517427|FG002|Overall Study|Adverse Event|1|||
44511910|NCT03116698|79517428|FG003|Overall Study|Adverse Event|0|||
44511911|NCT03116698|79517425|FG000|Overall Study|Withdrawal by Subject|1|||
44511912|NCT03116698|79517426|FG001|Overall Study|Withdrawal by Subject|4|||
44511913|NCT03116698|79517427|FG002|Overall Study|Withdrawal by Subject|5|||
44511914|NCT03116698|79517428|FG003|Overall Study|Withdrawal by Subject|2|||
44511915|NCT03116698|79517425|FG000|Overall Study|Lost to Follow-up|2|||
44511916|NCT03116698|79517426|FG001|Overall Study|Lost to Follow-up|0|||
44511917|NCT03116698|79517427|FG002|Overall Study|Lost to Follow-up|0|||
44511918|NCT03116698|79517428|FG003|Overall Study|Lost to Follow-up|0|||
44511919|NCT03116698|79517425|FG000|Overall Study|Physician Decision|1|||
44511920|NCT03116698|79517426|FG001|Overall Study|Physician Decision|1|||
44511921|NCT03116698|79517427|FG002|Overall Study|Physician Decision|0|||
44511922|NCT03116698|79517428|FG003|Overall Study|Physician Decision|0|||
44511923|NCT03116698|79517425|FG000|Overall Study|Protocol Violation|1|||
44511924|NCT03116698|79517426|FG001|Overall Study|Protocol Violation|0|||
44511925|NCT03116698|79517427|FG002|Overall Study|Protocol Violation|0|||
44511926|NCT03116698|79517428|FG003|Overall Study|Protocol Violation|0|||
44511927|NCT03116698|79517425|FG000|Overall Study|Death|0|||
44511928|NCT03116698|79517426|FG001|Overall Study|Death|0|||
44511929|NCT03116698|79517427|FG002|Overall Study|Death|2|||
44511930|NCT03116698|79517428|FG003|Overall Study|Death|0|||
44511931|NCT03116152|79517440|FG000|Overall Study|Disease Progression|49|||
44511932|NCT03116152|79517441|FG001|Overall Study|Disease Progression|47|||
44129418|NCT02941549|78915170|FG001|Overall Study|Withdrawal by Subject|1|||
44129419|NCT02941549|78915171|FG002|Overall Study|Withdrawal by Subject|2|||
44511933|NCT03116152|79517440|FG000|Overall Study|Death|5|||
44511934|NCT03116152|79517441|FG001|Overall Study|Death|2|||
44511935|NCT03116152|79517440|FG000|Overall Study|Adverse Event|21|||
44511936|NCT03116152|79517441|FG001|Overall Study|Adverse Event|7|||
44129420|NCT02394028|78915193|FG000|Induction Phase|Adverse Event|2|||
44129421|NCT02394028|78915194|FG001|Induction Phase|Adverse Event|4|||
44129422|NCT02394028|78915195|FG002|Induction Phase|Adverse Event|1|||
44511937|NCT03116152|79517440|FG000|Overall Study|Protocol Violation|2|||
44511938|NCT03116152|79517441|FG001|Overall Study|Protocol Violation|2|||
44511939|NCT03116152|79517440|FG000|Overall Study|Withdrawal by Subject|0|||
44511940|NCT03116152|79517441|FG001|Overall Study|Withdrawal by Subject|1|||
44511941|NCT03116152|79517440|FG000|Overall Study|Physician Decision|3|||
44511942|NCT03116152|79517441|FG001|Overall Study|Physician Decision|2|||
44511943|NCT03116152|79517440|FG000|Overall Study|other|11|||
44511944|NCT03116152|79517441|FG001|Overall Study|other|34|||
44243312|NCT01692626|79072752|FG001|Overall Study|Protocol Violation|2|||
44243313|NCT01692626|79072751|FG000|Overall Study|Withdrawal by Subject|1|||
44243314|NCT01692626|79072752|FG001|Overall Study|Withdrawal by Subject|0|||
44243315|NCT01475461|79072778|FG000|Run-in Period|Not meet eligibility criteria|16|||
44243316|NCT01475461|79072779|FG001|Run-in Period|Not meet eligibility criteria|0|||
44243317|NCT01475461|79072780|FG002|Run-in Period|Not meet eligibility criteria|0|||
44243318|NCT01475461|79072781|FG003|Run-in Period|Not meet eligibility criteria|0|||
44243319|NCT01475461|79072782|FG004|Run-in Period|Not meet eligibility criteria|0|||
44511945|NCT00226499|79517452|FG000|Overall Study|Adverse Event|10|||
44511946|NCT00226499|79517453|FG001|Overall Study|Adverse Event|6|||
44511947|NCT00226499|79517454|FG002|Overall Study|Adverse Event|3|||
44511948|NCT00226499|79517452|FG000|Overall Study|Others|1064|||
44511949|NCT00226499|79517453|FG001|Overall Study|Others|1066|||
44129423|NCT02394028|78915196|FG003|Induction Phase|Adverse Event|2|||
44129424|NCT02394028|78915197|FG004|Induction Phase|Adverse Event|5|||
44129425|NCT02394028|78915198|FG005|Induction Phase|Adverse Event|2|||
44129426|NCT02394028|78915199|FG006|Induction Phase|Adverse Event|0|||
44129427|NCT02394028|78915200|FG007|Induction Phase|Adverse Event|0|||
44129428|NCT02394028|78915201|FG008|Induction Phase|Adverse Event|0|||
44129429|NCT02394028|78915202|FG009|Induction Phase|Adverse Event|0|||
44129430|NCT02394028|78915203|FG010|Induction Phase|Adverse Event|0|||
44511950|NCT00226499|79517454|FG002|Overall Study|Others|356|||
44511951|NCT01400776|79517468|FG000|Overall Study|Adverse Event|7|||
44511952|NCT01400776|79517469|FG001|Overall Study|Adverse Event|2|||
44511953|NCT01400776|79517470|FG002|Overall Study|Adverse Event|9|||
44511954|NCT01400776|79517471|FG003|Overall Study|Adverse Event|2|||
44129431|NCT02394028|78915193|FG000|Induction Phase|Lack of Efficacy|3|||
44511955|NCT01400776|79517468|FG000|Overall Study|Lost to Follow-up|1|||
44129432|NCT02394028|78915194|FG001|Induction Phase|Lack of Efficacy|6|||
44243320|NCT01475461|79072783|FG005|Run-in Period|Not meet eligibility criteria|0|||
44511956|NCT01400776|79517469|FG001|Overall Study|Lost to Follow-up|0|||
44511957|NCT01400776|79517470|FG002|Overall Study|Lost to Follow-up|4|||
44511958|NCT01400776|79517471|FG003|Overall Study|Lost to Follow-up|1|||
44511959|NCT01400776|79517468|FG000|Overall Study|Withdrew Consent|4|||
44129433|NCT02394028|78915195|FG002|Induction Phase|Lack of Efficacy|2|||
44129434|NCT02394028|78915196|FG003|Induction Phase|Lack of Efficacy|17|||
44129435|NCT02394028|78915197|FG004|Induction Phase|Lack of Efficacy|14|||
44129436|NCT02394028|78915198|FG005|Induction Phase|Lack of Efficacy|8|||
44129437|NCT02394028|78915199|FG006|Induction Phase|Lack of Efficacy|17|||
44129438|NCT02394028|78915200|FG007|Induction Phase|Lack of Efficacy|23|||
44129439|NCT02394028|78915201|FG008|Induction Phase|Lack of Efficacy|0|||
44129440|NCT02394028|78915202|FG009|Induction Phase|Lack of Efficacy|0|||
44129441|NCT02394028|78915203|FG010|Induction Phase|Lack of Efficacy|0|||
44129442|NCT02394028|78915193|FG000|Induction Phase|Lost to Follow-up|1|||
44129443|NCT02394028|78915194|FG001|Induction Phase|Lost to Follow-up|0|||
44129444|NCT02394028|78915195|FG002|Induction Phase|Lost to Follow-up|0|||
44129445|NCT02394028|78915196|FG003|Induction Phase|Lost to Follow-up|1|||
44129446|NCT02394028|78915197|FG004|Induction Phase|Lost to Follow-up|0|||
44129447|NCT02394028|78915198|FG005|Induction Phase|Lost to Follow-up|0|||
44243321|NCT01475461|79072784|FG006|Run-in Period|Not meet eligibility criteria|0|||
44243322|NCT01475461|79072778|FG000|Run-in Period|Lost to Follow-up|7|||
44243323|NCT01475461|79072779|FG001|Run-in Period|Lost to Follow-up|0|||
44243324|NCT01475461|79072780|FG002|Run-in Period|Lost to Follow-up|0|||
44243325|NCT01475461|79072781|FG003|Run-in Period|Lost to Follow-up|0|||
44243326|NCT01475461|79072782|FG004|Run-in Period|Lost to Follow-up|0|||
44243327|NCT01475461|79072783|FG005|Run-in Period|Lost to Follow-up|0|||
44243328|NCT01475461|79072784|FG006|Run-in Period|Lost to Follow-up|0|||
44243329|NCT01475461|79072778|FG000|Run-in Period|Withdrawal by Subject|11|||
44243330|NCT01475461|79072779|FG001|Run-in Period|Withdrawal by Subject|0|||
44243331|NCT01475461|79072780|FG002|Run-in Period|Withdrawal by Subject|0|||
44511960|NCT01400776|79517469|FG001|Overall Study|Withdrew Consent|2|||
44511961|NCT01400776|79517470|FG002|Overall Study|Withdrew Consent|6|||
44511962|NCT01400776|79517471|FG003|Overall Study|Withdrew Consent|1|||
44511963|NCT01400776|79517468|FG000|Overall Study|Protocol Deviation|6|||
44511964|NCT01400776|79517469|FG001|Overall Study|Protocol Deviation|1|||
44511965|NCT01400776|79517470|FG002|Overall Study|Protocol Deviation|5|||
44511966|NCT01400776|79517471|FG003|Overall Study|Protocol Deviation|2|||
44511967|NCT01400776|79517468|FG000|Overall Study|Reason not Specified|3|||
44511968|NCT01400776|79517469|FG001|Overall Study|Reason not Specified|0|||
44511969|NCT01400776|79517470|FG002|Overall Study|Reason not Specified|4|||
44511970|NCT01400776|79517471|FG003|Overall Study|Reason not Specified|3|||
44511971|NCT03131596|79517483|FG000|Overall Study|Protocol Violation|3|||
44511972|NCT03131596|79517484|FG001|Overall Study|Protocol Violation|3|||
44511973|NCT03131596|79517483|FG000|Overall Study|Lost to Follow-up|3|||
44511974|NCT03131596|79517484|FG001|Overall Study|Lost to Follow-up|0|||
44511975|NCT00255047|79517498|FG000|Overall Study|Serious Adverse Events|2|||
44511976|NCT00255047|79517499|FG001|Overall Study|Serious Adverse Events|1|||
44511977|NCT00255047|79517500|FG002|Overall Study|Serious Adverse Events|2|||
44511978|NCT00255047|79517501|FG003|Overall Study|Serious Adverse Events|1|||
44511979|NCT00255047|79517498|FG000|Overall Study|Adverse Event|0|||
44511980|NCT00255047|79517499|FG001|Overall Study|Adverse Event|3|||
44511981|NCT00255047|79517500|FG002|Overall Study|Adverse Event|2|||
44511982|NCT00255047|79517501|FG003|Overall Study|Adverse Event|1|||
44511983|NCT00255047|79517498|FG000|Overall Study|Protocol Violation|13|||
44511984|NCT00255047|79517499|FG001|Overall Study|Protocol Violation|13|||
44511985|NCT00255047|79517500|FG002|Overall Study|Protocol Violation|16|||
44511986|NCT00255047|79517501|FG003|Overall Study|Protocol Violation|20|||
44511987|NCT00255047|79517498|FG000|Overall Study|Lost to Follow-up|9|||
44511988|NCT00255047|79517499|FG001|Overall Study|Lost to Follow-up|8|||
44129448|NCT02394028|78915199|FG006|Induction Phase|Lost to Follow-up|1|||
44129449|NCT02394028|78915200|FG007|Induction Phase|Lost to Follow-up|0|||
44129450|NCT02394028|78915201|FG008|Induction Phase|Lost to Follow-up|0|||
44129451|NCT02394028|78915202|FG009|Induction Phase|Lost to Follow-up|0|||
44243332|NCT01475461|79072781|FG003|Run-in Period|Withdrawal by Subject|0|||
44243333|NCT01475461|79072782|FG004|Run-in Period|Withdrawal by Subject|0|||
44243334|NCT01475461|79072783|FG005|Run-in Period|Withdrawal by Subject|0|||
44276540|NCT02173704|79231605|FG000|Overall Study|Protocol Violation|1|||
44276541|NCT02173704|79231606|FG001|Overall Study|Protocol Violation|0|||
44379498|NCT00841672|79385134|FG000|Overall Study|Administrative problems|9|||
44379499|NCT00841672|79385135|FG001|Overall Study|Administrative problems|9|||
44511989|NCT00255047|79517500|FG002|Overall Study|Lost to Follow-up|5|||
44511990|NCT00255047|79517501|FG003|Overall Study|Lost to Follow-up|6|||
44511991|NCT00255047|79517498|FG000|Overall Study|Withdrawal by Subject|24|||
44511992|NCT00255047|79517499|FG001|Overall Study|Withdrawal by Subject|23|||
44243335|NCT01475461|79072784|FG006|Run-in Period|Withdrawal by Subject|0|||
44243336|NCT01475461|79072778|FG000|Run-in Period|Other|3|||
44511993|NCT00255047|79517500|FG002|Overall Study|Withdrawal by Subject|25|||
44511994|NCT00255047|79517501|FG003|Overall Study|Withdrawal by Subject|18|||
44129452|NCT02394028|78915203|FG010|Induction Phase|Lost to Follow-up|0|||
44129453|NCT02394028|78915193|FG000|Induction Phase|Non-compliance|0|||
44511995|NCT00225251|79517513|FG000|Overall Study|Withdrawal by Subject|1|||
44511996|NCT00225251|79517514|FG001|Overall Study|Withdrawal by Subject|1|||
44511997|NCT00254501|79517522|FG000|Overall Study|Lost to Follow-up|1|||
44129454|NCT02394028|78915194|FG001|Induction Phase|Non-compliance|1|||
44129455|NCT02394028|78915195|FG002|Induction Phase|Non-compliance|3|||
44129456|NCT02394028|78915196|FG003|Induction Phase|Non-compliance|1|||
44129457|NCT02394028|78915197|FG004|Induction Phase|Non-compliance|3|||
44129458|NCT02394028|78915198|FG005|Induction Phase|Non-compliance|0|||
44129459|NCT02394028|78915199|FG006|Induction Phase|Non-compliance|1|||
44129460|NCT02394028|78915200|FG007|Induction Phase|Non-compliance|1|||
44129461|NCT02394028|78915201|FG008|Induction Phase|Non-compliance|0|||
44129462|NCT02394028|78915202|FG009|Induction Phase|Non-compliance|0|||
44129463|NCT02394028|78915203|FG010|Induction Phase|Non-compliance|0|||
44129464|NCT02394028|78915193|FG000|Induction Phase|Physician Decision|0|||
44129465|NCT02394028|78915194|FG001|Induction Phase|Physician Decision|0|||
44129466|NCT02394028|78915195|FG002|Induction Phase|Physician Decision|1|||
44129467|NCT02394028|78915196|FG003|Induction Phase|Physician Decision|4|||
44129468|NCT02394028|78915197|FG004|Induction Phase|Physician Decision|0|||
44129469|NCT02394028|78915198|FG005|Induction Phase|Physician Decision|2|||
44129470|NCT02394028|78915199|FG006|Induction Phase|Physician Decision|1|||
44129471|NCT02394028|78915200|FG007|Induction Phase|Physician Decision|0|||
44129472|NCT02394028|78915201|FG008|Induction Phase|Physician Decision|0|||
44129473|NCT02394028|78915202|FG009|Induction Phase|Physician Decision|0|||
44129474|NCT02394028|78915203|FG010|Induction Phase|Physician Decision|0|||
44129475|NCT02394028|78915193|FG000|Induction Phase|Protocol Violation|0|||
44129476|NCT02394028|78915194|FG001|Induction Phase|Protocol Violation|2|||
44129477|NCT02394028|78915195|FG002|Induction Phase|Protocol Violation|0|||
44129478|NCT02394028|78915196|FG003|Induction Phase|Protocol Violation|3|||
44129479|NCT02394028|78915197|FG004|Induction Phase|Protocol Violation|0|||
44129480|NCT02394028|78915198|FG005|Induction Phase|Protocol Violation|1|||
44129481|NCT02394028|78915199|FG006|Induction Phase|Protocol Violation|1|||
44129482|NCT02394028|78915200|FG007|Induction Phase|Protocol Violation|0|||
44129483|NCT02394028|78915201|FG008|Induction Phase|Protocol Violation|0|||
44129484|NCT02394028|78915202|FG009|Induction Phase|Protocol Violation|0|||
44129485|NCT02394028|78915203|FG010|Induction Phase|Protocol Violation|0|||
44129486|NCT02394028|78915193|FG000|Induction Phase|Withdrawal by Subject|1|||
44129487|NCT02394028|78915194|FG001|Induction Phase|Withdrawal by Subject|2|||
44129488|NCT02394028|78915195|FG002|Induction Phase|Withdrawal by Subject|4|||
44129489|NCT02394028|78915196|FG003|Induction Phase|Withdrawal by Subject|6|||
44129490|NCT02394028|78915197|FG004|Induction Phase|Withdrawal by Subject|7|||
44129491|NCT02394028|78915198|FG005|Induction Phase|Withdrawal by Subject|4|||
44129492|NCT02394028|78915199|FG006|Induction Phase|Withdrawal by Subject|3|||
44129493|NCT02394028|78915200|FG007|Induction Phase|Withdrawal by Subject|6|||
44129494|NCT02394028|78915201|FG008|Induction Phase|Withdrawal by Subject|0|||
44129495|NCT02394028|78915202|FG009|Induction Phase|Withdrawal by Subject|0|||
44129496|NCT02394028|78915203|FG010|Induction Phase|Withdrawal by Subject|0|||
44379500|NCT00841672|79385134|FG000|Overall Study|Misrandomized|1|||
44379501|NCT00841672|79385135|FG001|Overall Study|Misrandomized|0|||
44379502|NCT00841672|79385134|FG000|Overall Study|Protocol Deviation|0|||
44379503|NCT00841672|79385135|FG001|Overall Study|Protocol Deviation|1|||
44379504|NCT00908232|79385141|FG000|Cycle 1 to 4|Death|5|||
44511998|NCT00254501|79517523|FG001|Overall Study|Lost to Follow-up|1|||
44511999|NCT00253643|79517535|FG000|Overall Study|Withdrawal by Subject|0|||
44512000|NCT00253643|79517536|FG001|Overall Study|Withdrawal by Subject|0|||
44512001|NCT00253643|79517537|FG002|Overall Study|Withdrawal by Subject|1|||
44512002|NCT00253643|79517538|FG003|Overall Study|Withdrawal by Subject|1|||
44512003|NCT00253643|79517535|FG000|Overall Study|Non-Compliance|0|||
44512004|NCT00253643|79517536|FG001|Overall Study|Non-Compliance|0|||
44512005|NCT00253643|79517537|FG002|Overall Study|Non-Compliance|0|||
44512006|NCT00253643|79517538|FG003|Overall Study|Non-Compliance|2|||
44129497|NCT02394028|78915193|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129498|NCT02394028|78915194|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129499|NCT02394028|78915195|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129500|NCT02394028|78915196|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129501|NCT02394028|78915197|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129502|NCT02394028|78915198|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129503|NCT02394028|78915199|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
44129504|NCT02394028|78915200|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129505|NCT02394028|78915201|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129506|NCT02394028|78915202|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
44379505|NCT00908232|79385142|FG001|Cycle 1 to 4|Death|0|||
44379506|NCT00908232|79385143|FG002|Cycle 1 to 4|Death|0|||
44379507|NCT00908232|79385144|FG003|Cycle 1 to 4|Death|0|||
44379508|NCT00908232|79385141|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
44379509|NCT00908232|79385142|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
44379510|NCT00908232|79385143|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
44379511|NCT00908232|79385144|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
44379512|NCT00908232|79385141|FG000|Cycle 1 to 4|Progressive Disease|6|||
44379513|NCT00908232|79385142|FG001|Cycle 1 to 4|Progressive Disease|0|||
44379514|NCT00908232|79385143|FG002|Cycle 1 to 4|Progressive Disease|0|||
44379515|NCT00908232|79385144|FG003|Cycle 1 to 4|Progressive Disease|0|||
44379516|NCT00908232|79385141|FG000|Cycle 1 to 4|Adverse Event|12|||
44379517|NCT00908232|79385142|FG001|Cycle 1 to 4|Adverse Event|0|||
44379518|NCT00908232|79385143|FG002|Cycle 1 to 4|Adverse Event|0|||
44379519|NCT00908232|79385144|FG003|Cycle 1 to 4|Adverse Event|0|||
44379520|NCT00908232|79385141|FG000|Cycle 1 to 4|Other|1|||
44379521|NCT00908232|79385142|FG001|Cycle 1 to 4|Other|0|||
44379522|NCT00908232|79385143|FG002|Cycle 1 to 4|Other|0|||
44379523|NCT00908232|79385144|FG003|Cycle 1 to 4|Other|0|||
44379524|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
44379525|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
44129507|NCT02394028|78915203|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
44129508|NCT02394028|78915193|FG000|Induction Phase|Sponsor decision|0|||
44129509|NCT02394028|78915194|FG001|Induction Phase|Sponsor decision|1|||
44129510|NCT02394028|78915195|FG002|Induction Phase|Sponsor decision|2|||
44129511|NCT02394028|78915196|FG003|Induction Phase|Sponsor decision|0|||
44129512|NCT02394028|78915197|FG004|Induction Phase|Sponsor decision|0|||
44129513|NCT02394028|78915198|FG005|Induction Phase|Sponsor decision|0|||
44129514|NCT02394028|78915199|FG006|Induction Phase|Sponsor decision|0|||
44129515|NCT02394028|78915200|FG007|Induction Phase|Sponsor decision|0|||
44129516|NCT02394028|78915201|FG008|Induction Phase|Sponsor decision|0|||
44129517|NCT02394028|78915202|FG009|Induction Phase|Sponsor decision|0|||
44129518|NCT02394028|78915203|FG010|Induction Phase|Sponsor decision|0|||
44129519|NCT02394028|78915193|FG000|Induction Phase|Technical reason|0|||
44129520|NCT02394028|78915194|FG001|Induction Phase|Technical reason|0|||
44129521|NCT02394028|78915195|FG002|Induction Phase|Technical reason|0|||
44129522|NCT02394028|78915196|FG003|Induction Phase|Technical reason|1|||
44129523|NCT02394028|78915197|FG004|Induction Phase|Technical reason|0|||
44129524|NCT02394028|78915198|FG005|Induction Phase|Technical reason|0|||
44129525|NCT02394028|78915199|FG006|Induction Phase|Technical reason|0|||
44129526|NCT02394028|78915200|FG007|Induction Phase|Technical reason|0|||
44129527|NCT02394028|78915201|FG008|Induction Phase|Technical reason|0|||
44129528|NCT02394028|78915202|FG009|Induction Phase|Technical reason|0|||
44129529|NCT02394028|78915203|FG010|Induction Phase|Technical reason|0|||
44129530|NCT02394028|78915193|FG000|Induction Phase|:ack of calculation|0|||
44129531|NCT02394028|78915194|FG001|Induction Phase|:ack of calculation|0|||
44129532|NCT02394028|78915195|FG002|Induction Phase|:ack of calculation|0|||
44129533|NCT02394028|78915196|FG003|Induction Phase|:ack of calculation|0|||
44129534|NCT02394028|78915197|FG004|Induction Phase|:ack of calculation|0|||
44129535|NCT02394028|78915198|FG005|Induction Phase|:ack of calculation|0|||
44129536|NCT02394028|78915199|FG006|Induction Phase|:ack of calculation|0|||
44129537|NCT02394028|78915200|FG007|Induction Phase|:ack of calculation|1|||
44129538|NCT02394028|78915201|FG008|Induction Phase|:ack of calculation|0|||
44129539|NCT02394028|78915202|FG009|Induction Phase|:ack of calculation|0|||
44129540|NCT02394028|78915203|FG010|Induction Phase|:ack of calculation|0|||
44129541|NCT02394028|78915193|FG000|Maintenance Phase|Protocol Violation|0|||
44129542|NCT02394028|78915194|FG001|Maintenance Phase|Protocol Violation|0|||
44129543|NCT02394028|78915195|FG002|Maintenance Phase|Protocol Violation|0|||
44129544|NCT02394028|78915196|FG003|Maintenance Phase|Protocol Violation|0|||
44129545|NCT02394028|78915197|FG004|Maintenance Phase|Protocol Violation|0|||
44129546|NCT02394028|78915198|FG005|Maintenance Phase|Protocol Violation|0|||
44379526|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
44379527|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
44379528|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
44379529|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
44379530|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
44379531|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
44379532|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
44379533|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
44379534|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
44129547|NCT02394028|78915199|FG006|Maintenance Phase|Protocol Violation|0|||
44129548|NCT02394028|78915200|FG007|Maintenance Phase|Protocol Violation|0|||
44129549|NCT02394028|78915201|FG008|Maintenance Phase|Protocol Violation|0|||
44129550|NCT02394028|78915202|FG009|Maintenance Phase|Protocol Violation|0|||
44129551|NCT02394028|78915203|FG010|Maintenance Phase|Protocol Violation|1|||
44129552|NCT02394028|78915193|FG000|Maintenance Phase|Physician Decision|0|||
44129553|NCT02394028|78915194|FG001|Maintenance Phase|Physician Decision|0|||
44129554|NCT02394028|78915195|FG002|Maintenance Phase|Physician Decision|0|||
44129555|NCT02394028|78915196|FG003|Maintenance Phase|Physician Decision|0|||
44129556|NCT02394028|78915197|FG004|Maintenance Phase|Physician Decision|0|||
44129557|NCT02394028|78915198|FG005|Maintenance Phase|Physician Decision|0|||
44129558|NCT02394028|78915199|FG006|Maintenance Phase|Physician Decision|0|||
44129559|NCT02394028|78915200|FG007|Maintenance Phase|Physician Decision|0|||
44129560|NCT02394028|78915201|FG008|Maintenance Phase|Physician Decision|1|||
44129561|NCT02394028|78915202|FG009|Maintenance Phase|Physician Decision|3|||
44129562|NCT02394028|78915203|FG010|Maintenance Phase|Physician Decision|2|||
44129563|NCT02394028|78915193|FG000|Maintenance Phase|Lack of Efficacy|0|||
44129564|NCT02394028|78915194|FG001|Maintenance Phase|Lack of Efficacy|0|||
44129565|NCT02394028|78915195|FG002|Maintenance Phase|Lack of Efficacy|0|||
44129566|NCT02394028|78915196|FG003|Maintenance Phase|Lack of Efficacy|0|||
44129567|NCT02394028|78915197|FG004|Maintenance Phase|Lack of Efficacy|0|||
44129568|NCT02394028|78915198|FG005|Maintenance Phase|Lack of Efficacy|0|||
44129569|NCT02394028|78915199|FG006|Maintenance Phase|Lack of Efficacy|0|||
44129570|NCT02394028|78915200|FG007|Maintenance Phase|Lack of Efficacy|0|||
44129571|NCT02394028|78915201|FG008|Maintenance Phase|Lack of Efficacy|7|||
44129572|NCT02394028|78915202|FG009|Maintenance Phase|Lack of Efficacy|25|||
44129573|NCT02394028|78915203|FG010|Maintenance Phase|Lack of Efficacy|33|||
44129574|NCT02394028|78915193|FG000|Maintenance Phase|Death|0|||
44129575|NCT02394028|78915194|FG001|Maintenance Phase|Death|0|||
44129576|NCT02394028|78915195|FG002|Maintenance Phase|Death|0|||
44129577|NCT02394028|78915196|FG003|Maintenance Phase|Death|0|||
44129578|NCT02394028|78915197|FG004|Maintenance Phase|Death|0|||
44129579|NCT02394028|78915198|FG005|Maintenance Phase|Death|0|||
44129580|NCT02394028|78915199|FG006|Maintenance Phase|Death|0|||
44129581|NCT02394028|78915200|FG007|Maintenance Phase|Death|0|||
44129582|NCT02394028|78915201|FG008|Maintenance Phase|Death|0|||
44129583|NCT02394028|78915202|FG009|Maintenance Phase|Death|0|||
44129584|NCT02394028|78915203|FG010|Maintenance Phase|Death|1|||
44129585|NCT02394028|78915193|FG000|Maintenance Phase|Adverse Event|0|||
44129586|NCT02394028|78915194|FG001|Maintenance Phase|Adverse Event|0|||
44129587|NCT02394028|78915195|FG002|Maintenance Phase|Adverse Event|0|||
44129588|NCT02394028|78915196|FG003|Maintenance Phase|Adverse Event|0|||
44129589|NCT02394028|78915197|FG004|Maintenance Phase|Adverse Event|0|||
44129590|NCT02394028|78915198|FG005|Maintenance Phase|Adverse Event|0|||
44129591|NCT02394028|78915199|FG006|Maintenance Phase|Adverse Event|0|||
44129592|NCT02394028|78915200|FG007|Maintenance Phase|Adverse Event|0|||
44129593|NCT02394028|78915201|FG008|Maintenance Phase|Adverse Event|1|||
44129594|NCT02394028|78915202|FG009|Maintenance Phase|Adverse Event|1|||
44129595|NCT02394028|78915203|FG010|Maintenance Phase|Adverse Event|3|||
44129596|NCT02394028|78915193|FG000|Maintenance Phase|Site closure|0|||
44129597|NCT02394028|78915194|FG001|Maintenance Phase|Site closure|0|||
44129598|NCT02394028|78915195|FG002|Maintenance Phase|Site closure|0|||
44129599|NCT02394028|78915196|FG003|Maintenance Phase|Site closure|0|||
44129600|NCT02394028|78915197|FG004|Maintenance Phase|Site closure|0|||
44129601|NCT02394028|78915198|FG005|Maintenance Phase|Site closure|0|||
44379535|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
44379536|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
44512007|NCT00221195|79517550|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
44512008|NCT00221195|79517551|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
44512009|NCT00221195|79517550|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
44512010|NCT00221195|79517551|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
44512011|NCT00221195|79517550|FG000|Washout Period (Months 7-9)|Death|0|||
44512012|NCT00221195|79517551|FG001|Washout Period (Months 7-9)|Death|1|||
44512013|NCT00221195|79517550|FG000|Therapy 2 (Months 10-15)|Death|1|||
44512014|NCT00221195|79517551|FG001|Therapy 2 (Months 10-15)|Death|0|||
44512015|NCT00221195|79517550|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
44512016|NCT00221195|79517551|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
44512017|NCT00220805|79517560|FG000|Overall Study|Adverse Event|1|||
44512018|NCT00220805|79517561|FG001|Overall Study|Adverse Event|3|||
44512019|NCT00220805|79517560|FG000|Overall Study|Withdrawal by Subject|3|||
44512020|NCT00220805|79517561|FG001|Overall Study|Withdrawal by Subject|0|||
44129602|NCT02394028|78915199|FG006|Maintenance Phase|Site closure|0|||
44129603|NCT02394028|78915200|FG007|Maintenance Phase|Site closure|0|||
44129604|NCT02394028|78915201|FG008|Maintenance Phase|Site closure|0|||
44129605|NCT02394028|78915202|FG009|Maintenance Phase|Site closure|1|||
44129606|NCT02394028|78915203|FG010|Maintenance Phase|Site closure|0|||
44512021|NCT00220805|79517560|FG000|Overall Study|Lack of Efficacy|1|||
44512022|NCT00220805|79517561|FG001|Overall Study|Lack of Efficacy|0|||
44512023|NCT00220805|79517560|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
44129607|NCT02394028|78915193|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44129608|NCT02394028|78915194|FG001|Maintenance Phase|Withdrawal by Subject|0|||
44129609|NCT02394028|78915195|FG002|Maintenance Phase|Withdrawal by Subject|0|||
44129610|NCT02394028|78915196|FG003|Maintenance Phase|Withdrawal by Subject|0|||
44129611|NCT02394028|78915197|FG004|Maintenance Phase|Withdrawal by Subject|0|||
44129612|NCT02394028|78915198|FG005|Maintenance Phase|Withdrawal by Subject|0|||
44129613|NCT02394028|78915199|FG006|Maintenance Phase|Withdrawal by Subject|0|||
44129614|NCT02394028|78915200|FG007|Maintenance Phase|Withdrawal by Subject|0|||
44129615|NCT02394028|78915201|FG008|Maintenance Phase|Withdrawal by Subject|3|||
44129616|NCT02394028|78915202|FG009|Maintenance Phase|Withdrawal by Subject|12|||
44129617|NCT02394028|78915203|FG010|Maintenance Phase|Withdrawal by Subject|12|||
44129618|NCT01371539|78915257|FG000|Period One: One Week|Lost to Follow-up|0|||
44129619|NCT01371539|78915258|FG001|Period One: One Week|Lost to Follow-up|1|||
44129620|NCT01371539|78915257|FG000|Period Two: One Week|Lost to Follow-up|0|||
44129621|NCT01371539|78915258|FG001|Period Two: One Week|Lost to Follow-up|1|||
44129622|NCT01371539|78915257|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
44129623|NCT01371539|78915258|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
44129624|NCT01371539|78915257|FG000|Period Two: One Week|Time/job conflict|0|||
44129625|NCT01371539|78915258|FG001|Period Two: One Week|Time/job conflict|1|||
44129626|NCT02819297|78915266|FG000|Overall Study|Withdrawal by Subject|25|||
44129627|NCT02819297|78915267|FG001|Overall Study|Withdrawal by Subject|13|||
44129628|NCT02819297|78915266|FG000|Overall Study|Lost to Follow-up|12|||
44129629|NCT02819297|78915267|FG001|Overall Study|Lost to Follow-up|14|||
44129630|NCT02819297|78915266|FG000|Overall Study|Adverse Event|12|||
44129631|NCT02819297|78915267|FG001|Overall Study|Adverse Event|10|||
44129632|NCT02819297|78915266|FG000|Overall Study|Physician Decision|5|||
44129633|NCT02819297|78915267|FG001|Overall Study|Physician Decision|5|||
44129634|NCT02819297|78915266|FG000|Overall Study|Lack of Efficacy|5|||
44129635|NCT02819297|78915267|FG001|Overall Study|Lack of Efficacy|8|||
44129636|NCT02819297|78915266|FG000|Overall Study|Protocol Violation|1|||
44129637|NCT02819297|78915267|FG001|Overall Study|Protocol Violation|2|||
44129638|NCT02429830|78915273|FG000|Overall Study|Lost to Follow-up|1|||
44129639|NCT02429830|78915273|FG000|Overall Study|Device Explant|2|||
44129640|NCT02821715|78915277|FG000|Overall Study|Protocol Violation|1|||
44129641|NCT02821715|78915278|FG001|Overall Study|Protocol Violation|0|||
44129642|NCT02821715|78915279|FG002|Overall Study|Protocol Violation|0|||
44129643|NCT02821715|78915280|FG003|Overall Study|Protocol Violation|0|||
44129644|NCT02821715|78915281|FG004|Overall Study|Protocol Violation|0|||
44129645|NCT02821715|78915282|FG005|Overall Study|Protocol Violation|0|||
44129646|NCT02813681|78915293|FG000|Overall Study|Physician Decision|5|||
44129647|NCT02813681|78915294|FG001|Overall Study|Physician Decision|5|||
44129648|NCT02813681|78915295|FG002|Overall Study|Physician Decision|0|||
44129649|NCT02813681|78915293|FG000|Overall Study|Lost to Follow-up|0|||
44129650|NCT02813681|78915294|FG001|Overall Study|Lost to Follow-up|1|||
44129651|NCT02813681|78915295|FG002|Overall Study|Lost to Follow-up|0|||
44129652|NCT02393950|78915307|FG000|Overall Study|Adverse Event|1|||
44129653|NCT02393950|78915308|FG001|Overall Study|Adverse Event|0|||
44129654|NCT02393950|78915307|FG000|Overall Study|Withdrawal by Subject|0|||
44129655|NCT02393950|78915308|FG001|Overall Study|Withdrawal by Subject|1|||
44129656|NCT02815397|78915343|FG000|Overall Study|Physician Decision|2|||
44129657|NCT02427958|78915347|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
44129658|NCT02427958|78915347|FG000|Overall Study|Lost to Follow-up|6|||
44129659|NCT02427958|78915347|FG000|Overall Study|Withdrawal by Subject|14|||
44129660|NCT02427958|78915347|FG000|Overall Study|Lack of Efficacy|1|||
44129661|NCT02392624|78915354|FG000|Overall Study|Withdrawal by Subject|15|||
44129662|NCT02392624|78915355|FG001|Overall Study|Withdrawal by Subject|12|||
44129663|NCT02392624|78915356|FG002|Overall Study|Withdrawal by Subject|9|||
44129664|NCT02392624|78915354|FG000|Overall Study|Adverse Event|4|||
44129665|NCT02392624|78915355|FG001|Overall Study|Adverse Event|1|||
44129666|NCT02392624|78915356|FG002|Overall Study|Adverse Event|2|||
44129667|NCT02392624|78915354|FG000|Overall Study|Pregnancy|1|||
44243337|NCT01475461|79072779|FG001|Run-in Period|Other|0|||
44243338|NCT01475461|79072780|FG002|Run-in Period|Other|0|||
44243339|NCT01475461|79072781|FG003|Run-in Period|Other|0|||
44243340|NCT01475461|79072782|FG004|Run-in Period|Other|0|||
44243341|NCT01475461|79072783|FG005|Run-in Period|Other|0|||
44129668|NCT02392624|78915355|FG001|Overall Study|Pregnancy|0|||
44129669|NCT02392624|78915356|FG002|Overall Study|Pregnancy|0|||
44129670|NCT02392624|78915354|FG000|Overall Study|Protocol Violation|0|||
44129671|NCT02392624|78915355|FG001|Overall Study|Protocol Violation|0|||
44129672|NCT02392624|78915356|FG002|Overall Study|Protocol Violation|1|||
44129673|NCT02392624|78915354|FG000|Overall Study|Sponsor/Investigator Decision|2|||
44129674|NCT02392624|78915355|FG001|Overall Study|Sponsor/Investigator Decision|1|||
44243342|NCT01475461|79072784|FG006|Run-in Period|Other|0|||
44129675|NCT02392624|78915356|FG002|Overall Study|Sponsor/Investigator Decision|0|||
44129676|NCT02392624|78915354|FG000|Overall Study|Other|49|||
44129677|NCT02392624|78915355|FG001|Overall Study|Other|1|||
44129678|NCT02392624|78915356|FG002|Overall Study|Other|1|||
44129679|NCT02387164|78915366|FG000|Overall Study|Lost to Follow-up|2|||
44129680|NCT02387164|78915367|FG001|Overall Study|Lost to Follow-up|0|||
44129681|NCT02387164|78915366|FG000|Overall Study|Diagnosed|1|||
44129682|NCT02387164|78915367|FG001|Overall Study|Diagnosed|2|||
44129683|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
44243343|NCT01475461|79072778|FG000|Run-in Period|Protocol Violation|4|||
44129684|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
44129685|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
44129686|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
44129687|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
44129688|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
44129689|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
44129690|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
44129691|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
44129692|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
44129693|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
44129694|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
44129695|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44129696|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44129697|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44276542|NCT02173704|79231605|FG000|Overall Study|Withdrawal by Subject|9|||
44129698|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44129699|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
44129700|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
44129701|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
44129702|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
44512024|NCT00220805|79517561|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
44512025|NCT00220727|79517569|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
44512026|NCT00220727|79517570|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
44512027|NCT03971357|79517580|FG000|Overall Study|Lack of Efficacy|0|||
44512028|NCT03971357|79517581|FG001|Overall Study|Lack of Efficacy|1|||
44512029|NCT04310566|79517587|FG000|Period 1|Study Termination due to COVID-19|15|||
44512030|NCT04310566|79517588|FG001|Period 1|Study Termination due to COVID-19|17|||
44512031|NCT04310566|79517587|FG000|Period 1|Protocol Violation|0|||
44129703|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
44129704|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
44129705|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
44129706|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
44129707|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
44129708|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
44129709|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
44512032|NCT04310566|79517588|FG001|Period 1|Protocol Violation|1|||
44512033|NCT04310566|79517587|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
44512034|NCT04310566|79517588|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
44512035|NCT04310566|79517587|FG000|Period 1|Lost to Follow-up|1|||
44512036|NCT04310566|79517588|FG001|Period 1|Lost to Follow-up|0|||
44512037|NCT04310566|79517587|FG000|Period 1|Withdrawal by Subject|0|||
44512038|NCT04310566|79517588|FG001|Period 1|Withdrawal by Subject|1|||
44512039|NCT04310566|79517587|FG000|Period 2|Study Termination|7|||
44512040|NCT04310566|79517588|FG001|Period 2|Study Termination|5|||
44512041|NCT00252239|79517598|FG000|Overall Study|Withdrawal by Subject|1|||
44512042|NCT00252239|79517599|FG001|Overall Study|Withdrawal by Subject|0|||
44512043|NCT00252239|79517600|FG002|Overall Study|Withdrawal by Subject|0|||
44512044|NCT00252239|79517601|FG003|Overall Study|Withdrawal by Subject|1|||
44512045|NCT00252239|79517598|FG000|Overall Study|Lost to Follow-up|0|||
44512046|NCT00252239|79517599|FG001|Overall Study|Lost to Follow-up|0|||
44512047|NCT00252239|79517600|FG002|Overall Study|Lost to Follow-up|2|||
44512048|NCT00252239|79517601|FG003|Overall Study|Lost to Follow-up|0|||
44512049|NCT03103906|79517613|FG000|Overall Study|Adverse Event|2|||
44512050|NCT03103906|79517614|FG001|Overall Study|Adverse Event|3|||
44512051|NCT03103906|79517613|FG000|Overall Study|Other|2|||
44512052|NCT03103906|79517614|FG001|Overall Study|Other|0|||
44512053|NCT04799158|79517624|FG000|Run-In Period|Adverse Event|6|||
44512054|NCT04799158|79517625|FG001|Run-In Period|Adverse Event|0|||
44512055|NCT04799158|79517626|FG002|Run-In Period|Adverse Event|0|||
44512056|NCT04799158|79517627|FG003|Run-In Period|Adverse Event|0|||
44512057|NCT04799158|79517628|FG004|Run-In Period|Adverse Event|0|||
44129710|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
44129711|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
44129712|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
44512058|NCT04799158|79517624|FG000|Run-In Period|Lost to Follow-up|4|||
44512059|NCT04799158|79517625|FG001|Run-In Period|Lost to Follow-up|0|||
44512060|NCT04799158|79517626|FG002|Run-In Period|Lost to Follow-up|0|||
44512061|NCT04799158|79517627|FG003|Run-In Period|Lost to Follow-up|0|||
44512062|NCT04799158|79517628|FG004|Run-In Period|Lost to Follow-up|0|||
44512063|NCT04799158|79517624|FG000|Run-In Period|Significant Protocol Deviation|1|||
44129713|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
44129714|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
44129715|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
44129716|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
44129717|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
44129718|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
44129719|NCT02392234|78915385|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
44129720|NCT02392234|78915386|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
44129721|NCT02392234|78915387|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
44129722|NCT02392234|78915388|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
44129723|NCT02392234|78915389|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
44129724|NCT02392234|78915390|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
44129725|NCT02392234|78915385|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
44129726|NCT02392234|78915386|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
44129727|NCT02392234|78915387|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
44129728|NCT02392234|78915388|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
44129729|NCT02392234|78915389|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
44129730|NCT02392234|78915390|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
44129731|NCT02963090|78915404|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
44129732|NCT02963090|78915405|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
44129733|NCT02427802|78915417|FG000|Overall Study|Adverse Event|11|||
44129734|NCT02427802|78915418|FG001|Overall Study|Adverse Event|3|||
44129735|NCT02427802|78915419|FG002|Overall Study|Adverse Event|7|||
44129736|NCT02427802|78915417|FG000|Overall Study|Death|0|||
44129737|NCT02427802|78915418|FG001|Overall Study|Death|4|||
44129738|NCT02427802|78915419|FG002|Overall Study|Death|1|||
44129739|NCT02427802|78915417|FG000|Overall Study|Lost to Follow-up|13|||
44129740|NCT02427802|78915418|FG001|Overall Study|Lost to Follow-up|8|||
44129741|NCT02427802|78915419|FG002|Overall Study|Lost to Follow-up|8|||
44129742|NCT02427802|78915417|FG000|Overall Study|Physician Decision|4|||
44129743|NCT02427802|78915418|FG001|Overall Study|Physician Decision|2|||
44129744|NCT02427802|78915419|FG002|Overall Study|Physician Decision|4|||
44129745|NCT02427802|78915417|FG000|Overall Study|Withdrawal by Subject|10|||
44129746|NCT02427802|78915418|FG001|Overall Study|Withdrawal by Subject|5|||
44129747|NCT02427802|78915419|FG002|Overall Study|Withdrawal by Subject|11|||
44129748|NCT02427802|78915417|FG000|Overall Study|Protocol Violation|3|||
44129749|NCT02427802|78915418|FG001|Overall Study|Protocol Violation|1|||
44129750|NCT02427802|78915419|FG002|Overall Study|Protocol Violation|1|||
44129751|NCT02427802|78915417|FG000|Overall Study|protocol specific treatment unrelated|18|||
44129752|NCT02427802|78915418|FG001|Overall Study|protocol specific treatment unrelated|11|||
44129753|NCT02427802|78915419|FG002|Overall Study|protocol specific treatment unrelated|11|||
44129754|NCT02427646|78915429|FG000|Overall Study|Lack of Efficacy|2|||
44129755|NCT02427646|78915430|FG001|Overall Study|Lack of Efficacy|3|||
44129756|NCT02427646|78915429|FG000|Overall Study|Physician Decision|1|||
44129757|NCT02427646|78915430|FG001|Overall Study|Physician Decision|4|||
44129758|NCT02427646|78915429|FG000|Overall Study|Protocol Violation|3|||
44129759|NCT02427646|78915430|FG001|Overall Study|Protocol Violation|3|||
44129760|NCT02427646|78915429|FG000|Overall Study|Bothersome hand weakness|2|||
44243344|NCT01475461|79072779|FG001|Run-in Period|Protocol Violation|0|||
44243345|NCT01475461|79072780|FG002|Run-in Period|Protocol Violation|0|||
44243346|NCT01475461|79072781|FG003|Run-in Period|Protocol Violation|0|||
44243347|NCT01475461|79072782|FG004|Run-in Period|Protocol Violation|0|||
44129761|NCT02427646|78915430|FG001|Overall Study|Bothersome hand weakness|4|||
44129762|NCT02392000|78915438|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
44129763|NCT02392000|78915438|FG000|Overall Study|Withdrawal by Subject|1|||
44129764|NCT02392000|78915438|FG000|Overall Study|Lost to Follow-up|8|||
44129765|NCT02385526|78915446|FG000|Overall Study|Withdrawal by Subject|0|||
44129766|NCT02385526|78915447|FG001|Overall Study|Withdrawal by Subject|2|||
44129767|NCT02385526|78915448|FG002|Overall Study|Withdrawal by Subject|0|||
44129768|NCT02385526|78915446|FG000|Overall Study|Lost to Follow-up|0|||
44129769|NCT02385526|78915447|FG001|Overall Study|Lost to Follow-up|1|||
44129770|NCT02385526|78915448|FG002|Overall Study|Lost to Follow-up|0|||
44243348|NCT01475461|79072783|FG005|Run-in Period|Protocol Violation|0|||
44129771|NCT02385526|78915446|FG000|Overall Study|Physician Decision|1|||
44129772|NCT02385526|78915447|FG001|Overall Study|Physician Decision|0|||
44129773|NCT02385526|78915448|FG002|Overall Study|Physician Decision|0|||
44129774|NCT02385526|78915446|FG000|Overall Study|Protocol Violation|1|||
44129775|NCT02385526|78915447|FG001|Overall Study|Protocol Violation|0|||
44129776|NCT02385526|78915448|FG002|Overall Study|Protocol Violation|0|||
44129777|NCT02808143|78915458|FG000|Maintenance Phase|Disease recurrence|1|||
44129778|NCT02808143|78915459|FG001|Maintenance Phase|Disease recurrence|3|||
44129779|NCT02808143|78915458|FG000|Maintenance Phase|Disease progression|1|||
44129780|NCT02808143|78915459|FG001|Maintenance Phase|Disease progression|2|||
44129781|NCT02808143|78915458|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
44129782|NCT02808143|78915459|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
44129783|NCT02808143|78915458|FG000|Survival Follow-Up|Disease recurrence|0|||
44129784|NCT02808143|78915459|FG001|Survival Follow-Up|Disease recurrence|2|||
44129785|NCT02808143|78915458|FG000|Survival Follow-Up|Adverse Event|0|||
44129786|NCT02808143|78915459|FG001|Survival Follow-Up|Adverse Event|1|||
44129787|NCT02808143|78915458|FG000|Survival Follow-Up|Death|1|||
44129788|NCT02808143|78915459|FG001|Survival Follow-Up|Death|0|||
44129789|NCT02427100|78915469|FG000|Overall Study|Lost to Follow-up|0|||
44129790|NCT02427100|78915470|FG001|Overall Study|Lost to Follow-up|2|||
44129791|NCT02806973|78915476|FG000|Period 1|Withdrawal by Subject|0|||
44129792|NCT02806973|78915477|FG001|Period 1|Withdrawal by Subject|2|||
44129793|NCT02806973|78915478|FG002|Period 1|Withdrawal by Subject|1|||
44129794|NCT02806973|78915479|FG003|Period 1|Withdrawal by Subject|1|||
44129795|NCT02806973|78915476|FG000|Period 1|Adverse Event|0|||
44129796|NCT02806973|78915477|FG001|Period 1|Adverse Event|0|||
44129797|NCT02806973|78915478|FG002|Period 1|Adverse Event|0|||
44129798|NCT02806973|78915479|FG003|Period 1|Adverse Event|1|||
44129799|NCT02806973|78915476|FG000|Period 3|Withdrawal by Subject|0|||
44129800|NCT02806973|78915477|FG001|Period 3|Withdrawal by Subject|0|||
44129801|NCT02806973|78915478|FG002|Period 3|Withdrawal by Subject|0|||
44129802|NCT02806973|78915479|FG003|Period 3|Withdrawal by Subject|3|||
44129803|NCT02806973|78915476|FG000|Period 3|Adverse Event|0|||
44129804|NCT02806973|78915477|FG001|Period 3|Adverse Event|0|||
44129805|NCT02806973|78915478|FG002|Period 3|Adverse Event|1|||
44129806|NCT02806973|78915479|FG003|Period 3|Adverse Event|0|||
44129807|NCT02806505|78915491|FG000|Overall Study|Adverse event/intercurrent illness|1|||
44129808|NCT02806505|78915492|FG001|Overall Study|Adverse event/intercurrent illness|3|||
44129809|NCT02806505|78915491|FG000|Overall Study|Death|4|||
44129810|NCT02806505|78915492|FG001|Overall Study|Death|0|||
44129811|NCT02806505|78915491|FG000|Overall Study|Did not cooperate/refused treatment|3|||
44129812|NCT02806505|78915492|FG001|Overall Study|Did not cooperate/refused treatment|3|||
44129813|NCT02806505|78915491|FG000|Overall Study|Failure to return|0|||
44129814|NCT02806505|78915492|FG001|Overall Study|Failure to return|1|||
44129815|NCT02806505|78915491|FG000|Overall Study|Insufficient therapeutic response|2|||
44129816|NCT02806505|78915492|FG001|Overall Study|Insufficient therapeutic response|4|||
44129817|NCT02807363|78915502|FG000|Dosing Period|Adverse Event|0|||
44129818|NCT02807363|78915503|FG001|Dosing Period|Adverse Event|1|||
44129819|NCT02807363|78915504|FG002|Dosing Period|Adverse Event|0|||
44129820|NCT02807363|78915505|FG003|Dosing Period|Adverse Event|0|||
44129821|NCT02383966|78915519|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
44129822|NCT02383966|78915520|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
44129823|NCT02383966|78915519|FG000|Overall Study|Randomized, but not treated|1|||
44129824|NCT02383966|78915520|FG001|Overall Study|Randomized, but not treated|3|||
44129825|NCT02383576|78915528|FG000|Overall Study|Death|53|||
44129826|NCT02383576|78915529|FG001|Overall Study|Death|33|||
44129827|NCT02383576|78915528|FG000|Overall Study|Lost to Follow-up|7|||
44243349|NCT01475461|79072784|FG006|Run-in Period|Protocol Violation|0|||
44243350|NCT01475461|79072778|FG000|Treatment Period|Death|0|||
44129828|NCT02383576|78915529|FG001|Overall Study|Lost to Follow-up|1|||
44129829|NCT02383576|78915528|FG000|Overall Study|Withdrew Consent|1|||
44129830|NCT02383576|78915529|FG001|Overall Study|Withdrew Consent|6|||
44129831|NCT02383576|78915528|FG000|Overall Study|Investigator's Decision|0|||
44129832|NCT02383576|78915529|FG001|Overall Study|Investigator's Decision|1|||
44129833|NCT02383576|78915528|FG000|Overall Study|Administrative/Other|2|||
44129834|NCT02383576|78915529|FG001|Overall Study|Administrative/Other|4|||
44129835|NCT02748317|78915535|FG000|Overall Study|Withdrawal by Subject|14|||
44129836|NCT02748317|78915535|FG000|Overall Study|Lost to Follow-up|8|||
44129837|NCT02748317|78915535|FG000|Overall Study|Death|1|||
44129838|NCT02426086|78915541|FG000|Overall Study|Death|33|||
44129839|NCT02426086|78915542|FG001|Overall Study|Death|36|||
44129840|NCT02426086|78915541|FG000|Overall Study|Lost to Follow-up|2|||
44129841|NCT02426086|78915542|FG001|Overall Study|Lost to Follow-up|0|||
44243351|NCT01475461|79072779|FG001|Treatment Period|Death|0|||
44129842|NCT02426086|78915541|FG000|Overall Study|Study Terminated by Sponsor|5|||
44243352|NCT01475461|79072780|FG002|Treatment Period|Death|0|||
44129843|NCT02426086|78915542|FG001|Overall Study|Study Terminated by Sponsor|14|||
44129844|NCT02426086|78915541|FG000|Overall Study|Withdrawal by Subject|8|||
44129845|NCT02426086|78915542|FG001|Overall Study|Withdrawal by Subject|9|||
44129846|NCT02422264|78915555|FG000|Overall Study|Serious Adverse Event|1|||
44129847|NCT02422264|78915556|FG001|Overall Study|Serious Adverse Event|0|||
44129848|NCT02422264|78915555|FG000|Overall Study|Withdrawal by Subject|1|||
44129849|NCT02422264|78915556|FG001|Overall Study|Withdrawal by Subject|2|||
44129850|NCT02422264|78915555|FG000|Overall Study|Migrated/moved from study area|3|||
44379537|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
44379538|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
44379539|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
44379540|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
44379541|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
44379542|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
44379543|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
44379544|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
44379545|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
44379546|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
44379547|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
44129851|NCT02422264|78915556|FG001|Overall Study|Migrated/moved from study area|1|||
44129852|NCT02422264|78915555|FG000|Overall Study|Subject vaccinated outside of the study|0|||
44379548|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
44379549|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
44379550|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
44379551|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
44379552|NCT00908232|79385141|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
44379553|NCT00908232|79385142|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
44379554|NCT00908232|79385143|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
44512064|NCT04799158|79517625|FG001|Run-In Period|Significant Protocol Deviation|0|||
44512065|NCT04799158|79517626|FG002|Run-In Period|Significant Protocol Deviation|0|||
44512066|NCT04799158|79517627|FG003|Run-In Period|Significant Protocol Deviation|0|||
44512067|NCT04799158|79517628|FG004|Run-In Period|Significant Protocol Deviation|0|||
44512068|NCT04799158|79517624|FG000|Run-In Period|Withdrawal by Subject|11|||
44512069|NCT04799158|79517625|FG001|Run-In Period|Withdrawal by Subject|0|||
44512070|NCT04799158|79517626|FG002|Run-In Period|Withdrawal by Subject|0|||
44512071|NCT04799158|79517627|FG003|Run-In Period|Withdrawal by Subject|0|||
44512072|NCT04799158|79517628|FG004|Run-In Period|Withdrawal by Subject|0|||
44512073|NCT04799158|79517624|FG000|Run-In Period|Miscellaneous|3|||
44512074|NCT04799158|79517625|FG001|Run-In Period|Miscellaneous|0|||
44512075|NCT04799158|79517626|FG002|Run-In Period|Miscellaneous|0|||
44512076|NCT04799158|79517627|FG003|Run-In Period|Miscellaneous|0|||
44512077|NCT04799158|79517628|FG004|Run-In Period|Miscellaneous|0|||
44512078|NCT04799158|79517624|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
44512079|NCT04799158|79517625|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
44512080|NCT04799158|79517626|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
44512081|NCT04799158|79517627|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
44512082|NCT04799158|79517628|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
44512083|NCT04799158|79517624|FG000|On-Demand Treatment Period|Adverse Event|0|||
44512084|NCT04799158|79517625|FG001|On-Demand Treatment Period|Adverse Event|1|||
44512085|NCT04799158|79517626|FG002|On-Demand Treatment Period|Adverse Event|0|||
44512086|NCT04799158|79517627|FG003|On-Demand Treatment Period|Adverse Event|0|||
44512087|NCT04799158|79517628|FG004|On-Demand Treatment Period|Adverse Event|1|||
44512088|NCT04799158|79517624|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
44512089|NCT04799158|79517625|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
44512090|NCT04799158|79517626|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
44512091|NCT04799158|79517627|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
44512092|NCT04799158|79517628|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
44512093|NCT04799158|79517624|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
44512094|NCT04799158|79517625|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
44512095|NCT04799158|79517626|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
44512096|NCT04799158|79517627|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
44512097|NCT04799158|79517628|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
44512098|NCT04799158|79517624|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
44512099|NCT04799158|79517625|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
44512100|NCT04799158|79517626|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
44512101|NCT04799158|79517627|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
44512102|NCT04799158|79517628|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
44512103|NCT04799158|79517624|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
44512104|NCT04799158|79517625|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
44512105|NCT04799158|79517626|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
44243353|NCT01475461|79072781|FG003|Treatment Period|Death|1|||
44379555|NCT00908232|79385144|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
44379556|NCT00770341|79385153|FG000|Overall Study|Did not meet eligibility criteria|1|||
44379557|NCT00770341|79385154|FG001|Overall Study|Did not meet eligibility criteria|0|||
44379558|NCT00770341|79385155|FG002|Overall Study|Did not meet eligibility criteria|0|||
44129853|NCT02422264|78915556|FG001|Overall Study|Subject vaccinated outside of the study|1|||
44129854|NCT02390362|78915564|FG000|Overall Study|Withdrawal by Subject|0|||
44129855|NCT02390362|78915565|FG001|Overall Study|Withdrawal by Subject|1|||
44129856|NCT02389894|78915574|FG000|Overall Study|Death|4|||
44129857|NCT02389894|78915575|FG001|Overall Study|Death|5|||
44129858|NCT02389894|78915576|FG002|Overall Study|Death|3|||
44129859|NCT02389894|78915574|FG000|Overall Study|Withdrawal by Subject|2|||
44129860|NCT02389894|78915575|FG001|Overall Study|Withdrawal by Subject|4|||
44129861|NCT02389894|78915576|FG002|Overall Study|Withdrawal by Subject|5|||
44129862|NCT02389894|78915574|FG000|Overall Study|Lost to Follow-up|2|||
44129863|NCT02389894|78915575|FG001|Overall Study|Lost to Follow-up|1|||
44129864|NCT02389894|78915576|FG002|Overall Study|Lost to Follow-up|1|||
44129865|NCT02389816|78915587|FG000|Overall Study|Randomized but Not Treated|1|||
44129866|NCT02389816|78915588|FG001|Overall Study|Randomized but Not Treated|0|||
44129867|NCT02389816|78915589|FG002|Overall Study|Randomized but Not Treated|0|||
44129868|NCT02389816|78915587|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
44129869|NCT02389816|78915588|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
44129870|NCT02389816|78915589|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
44129871|NCT02389816|78915587|FG000|Overall Study|Major Protocol Deviation|1|||
44129872|NCT02389816|78915588|FG001|Overall Study|Major Protocol Deviation|0|||
44129873|NCT02389816|78915589|FG002|Overall Study|Major Protocol Deviation|0|||
44129874|NCT02389816|78915587|FG000|Overall Study|Lost to Follow-up|1|||
44129875|NCT02389816|78915588|FG001|Overall Study|Lost to Follow-up|0|||
44129876|NCT02389816|78915589|FG002|Overall Study|Lost to Follow-up|0|||
44129877|NCT02389816|78915587|FG000|Overall Study|Withdrawal of Consent|6|||
44129878|NCT02389816|78915588|FG001|Overall Study|Withdrawal of Consent|4|||
44129879|NCT02389816|78915589|FG002|Overall Study|Withdrawal of Consent|4|||
44129880|NCT02389816|78915587|FG000|Overall Study|Lack of Efficacy|1|||
44129881|NCT02389816|78915588|FG001|Overall Study|Lack of Efficacy|0|||
44129882|NCT02389816|78915589|FG002|Overall Study|Lack of Efficacy|0|||
44129883|NCT02389816|78915587|FG000|Overall Study|Non Compliance with Study Drug|1|||
44129884|NCT02389816|78915588|FG001|Overall Study|Non Compliance with Study Drug|1|||
44129885|NCT02389816|78915589|FG002|Overall Study|Non Compliance with Study Drug|1|||
44129886|NCT02389816|78915587|FG000|Overall Study|Reason not Specified|0|||
44129887|NCT02389816|78915588|FG001|Overall Study|Reason not Specified|2|||
44129888|NCT02389816|78915589|FG002|Overall Study|Reason not Specified|0|||
44129889|NCT02388724|78915599|FG000|Overall Study|Reason not Specified|0|||
44129890|NCT02388724|78915600|FG001|Overall Study|Reason not Specified|1|||
44129891|NCT02388724|78915599|FG000|Overall Study|Major Protocol Deviation|3|||
44129892|NCT02388724|78915600|FG001|Overall Study|Major Protocol Deviation|3|||
44129893|NCT02388724|78915599|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
44129894|NCT02388724|78915600|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
44129895|NCT02388724|78915599|FG000|Overall Study|Voluntary Withdrawal|6|||
44243354|NCT01475461|79072782|FG004|Treatment Period|Death|0|||
44379559|NCT00770341|79385153|FG000|Overall Study|Withdrawal by Subject|0|||
44129896|NCT02388724|78915600|FG001|Overall Study|Voluntary Withdrawal|5|||
44129897|NCT02388724|78915599|FG000|Overall Study|Randomized but not Treated|0|||
44243355|NCT01475461|79072783|FG005|Treatment Period|Death|0|||
44129898|NCT02388724|78915600|FG001|Overall Study|Randomized but not Treated|2|||
44129899|NCT02382796|78915606|FG000|Overall Study|Global deterioration of health status|1|||
44129900|NCT02382796|78915606|FG000|Overall Study|Objective progression or relapse|3|||
44129901|NCT02382796|78915606|FG000|Overall Study|Commercial dacomitinib became available|3|||
44129902|NCT02382640|78915614|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
44129903|NCT02382640|78915615|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
44129904|NCT02382640|78915616|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
44129905|NCT02382640|78915617|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
44129906|NCT02801669|78915629|FG000|Overall Study|Death|66|||
44129907|NCT02801669|78915630|FG001|Overall Study|Death|69|||
44129908|NCT02801669|78915629|FG000|Overall Study|Withdrawal by Subject|81|||
44129909|NCT02801669|78915630|FG001|Overall Study|Withdrawal by Subject|77|||
44129910|NCT02801669|78915629|FG000|Overall Study|Other|4|||
44129911|NCT02801669|78915630|FG001|Overall Study|Other|6|||
44129912|NCT02804399|78915636|FG000|Period 2|Adverse Event|0|||
44129913|NCT02804399|78915637|FG001|Period 2|Adverse Event|1|||
44129914|NCT01333943|78915648|FG000|Overall Study|Known neuropathy|1|||
44129915|NCT01333943|78915649|FG001|Overall Study|Known neuropathy|0|||
44129916|NCT01333865|78915655|FG000|Overall Study|Adverse Event|2|||
44129917|NCT01333475|78915661|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
44129918|NCT01333475|78915662|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
44129919|NCT01333475|78915661|FG000|Overall Study|Toxicity|1|||
44129920|NCT01333475|78915662|FG001|Overall Study|Toxicity|3|||
44129921|NCT01333397|78915674|FG000|Overall Study|Lost to Follow-up|1|||
44129922|NCT01333397|78915675|FG001|Overall Study|Lost to Follow-up|0|||
44129923|NCT01333397|78915676|FG002|Overall Study|Lost to Follow-up|0|||
44129924|NCT01333397|78915677|FG003|Overall Study|Lost to Follow-up|1|||
44129925|NCT01333397|78915678|FG004|Overall Study|Lost to Follow-up|0|||
44129926|NCT02798861|78915699|FG000|Overall Study|Lost to Follow-up|22|||
44129927|NCT02798861|78915699|FG000|Overall Study|Withdrawal by Subject|1|||
44129928|NCT02798315|78915703|FG000|Overall Study|Failure to return|1|||
44129929|NCT02796755|78915709|FG000|Overall Study|Adverse Event|2|||
44243356|NCT01475461|79072784|FG006|Treatment Period|Death|0|||
44243357|NCT01475461|79072778|FG000|Treatment Period|Lost to Follow-up|0|||
44512106|NCT04799158|79517627|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
44512107|NCT04799158|79517628|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
44512108|NCT04799158|79517624|FG000|On-Demand Treatment Period|Miscellaneous|0|||
44512109|NCT04799158|79517625|FG001|On-Demand Treatment Period|Miscellaneous|0|||
44512110|NCT04799158|79517626|FG002|On-Demand Treatment Period|Miscellaneous|0|||
44512111|NCT04799158|79517627|FG003|On-Demand Treatment Period|Miscellaneous|0|||
44512112|NCT04799158|79517628|FG004|On-Demand Treatment Period|Miscellaneous|1|||
44512113|NCT01319422|79517641|FG000|Overall Study|Withdrawal by Subject|1|||
44512114|NCT01319422|79517642|FG001|Overall Study|Withdrawal by Subject|0|||
44512115|NCT03102034|79517650|FG000|Overall Study|Withdrawal by Subject|1|||
44512116|NCT03102034|79517651|FG001|Overall Study|Withdrawal by Subject|0|||
44512117|NCT03774576|79517657|FG000|Period 2|Adverse Event|1|||
44512118|NCT02928952|79517668|FG000|Overall Study|Lost to Follow-up|5|||
44512119|NCT02928952|79517669|FG001|Overall Study|Lost to Follow-up|5|||
44512120|NCT02928952|79517668|FG000|Overall Study|Withdrawal by Subject|5|||
44512121|NCT02928952|79517669|FG001|Overall Study|Withdrawal by Subject|1|||
44129930|NCT02796755|78915710|FG001|Overall Study|Adverse Event|0|||
44129931|NCT02382016|78915718|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
44129932|NCT02382016|78915719|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
44129933|NCT02382016|78915718|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
44129934|NCT02382016|78915719|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
44129935|NCT02382016|78915718|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
44512122|NCT02928952|79517668|FG000|Overall Study|Physician Decision|0|||
44512123|NCT02928952|79517669|FG001|Overall Study|Physician Decision|1|||
44512124|NCT03773796|79517675|FG000|Overall Study|Adverse Event|1|||
44129936|NCT02382016|78915719|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
44129937|NCT02382016|78915718|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
44129938|NCT02382016|78915719|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
44129939|NCT02382016|78915718|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
44129940|NCT02382016|78915719|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
44129941|NCT02382016|78915718|FG000|Open-label (OL) Treatment Period|Death|4|||
44129942|NCT02382016|78915719|FG001|Open-label (OL) Treatment Period|Death|0|||
44129943|NCT02382016|78915718|FG000|OL Extension Period|Physician Decision|3|||
44129944|NCT02382016|78915719|FG001|OL Extension Period|Physician Decision|0|||
44129945|NCT02382016|78915718|FG000|OL Extension Period|Death|2|||
44129946|NCT02382016|78915719|FG001|OL Extension Period|Death|0|||
44129947|NCT02382016|78915718|FG000|OL Extension Period|Withdrawal by Subject|1|||
44129948|NCT02382016|78915719|FG001|OL Extension Period|Withdrawal by Subject|0|||
44129949|NCT02422186|78915729|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
44129950|NCT02422186|78915730|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
44129951|NCT02422186|78915729|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
44129952|NCT02422186|78915730|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
44129953|NCT02422186|78915729|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
44129954|NCT02422186|78915730|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
44129955|NCT02422186|78915729|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
44129956|NCT02422186|78915730|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
44129957|NCT02422186|78915729|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
44129958|NCT02422186|78915730|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
44129959|NCT02422186|78915729|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
44129960|NCT02422186|78915730|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
44129961|NCT02422186|78915729|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
44129962|NCT02422186|78915730|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
44129963|NCT02422186|78915729|FG000|Follow-up Phase (2 Weeks)|Other|3|||
44129964|NCT02422186|78915730|FG001|Follow-up Phase (2 Weeks)|Other|0|||
44129965|NCT02421952|78915738|FG000|Overall Study|Diary Not Returned|93|||
44129966|NCT02421952|78915738|FG000|Overall Study|Failed seriation task|13|||
44129967|NCT02421952|78915738|FG000|Overall Study|Subject uncooperative for baseline test|2|||
44129968|NCT02421952|78915738|FG000|Overall Study|Surgery cancelled|1|||
44129969|NCT02796677|78915749|FG000|Overall Study|Adverse Event|11|||
44129970|NCT02796677|78915750|FG001|Overall Study|Adverse Event|22|||
44129971|NCT02796677|78915751|FG002|Overall Study|Adverse Event|14|||
44129972|NCT02796677|78915752|FG003|Overall Study|Adverse Event|14|||
44512125|NCT03773796|79517675|FG000|Overall Study|Withdrawal by Subject|1|||
44512126|NCT03773796|79517675|FG000|Overall Study|Lack of Efficacy|1|||
44512127|NCT02927938|79517683|FG000|Overall Study|Death|0|||
44512128|NCT02927938|79517684|FG001|Overall Study|Death|1|||
44512129|NCT02927938|79517685|FG002|Overall Study|Death|0|||
44512130|NCT02927938|79517686|FG003|Overall Study|Death|4|||
44512131|NCT02927938|79517683|FG000|Overall Study|Early Study Termination|1|||
44512132|NCT02927938|79517684|FG001|Overall Study|Early Study Termination|5|||
44512133|NCT02927938|79517685|FG002|Overall Study|Early Study Termination|4|||
44512134|NCT02927938|79517686|FG003|Overall Study|Early Study Termination|3|||
44512135|NCT03765138|79517694|FG000|Overall Study|Lost to Follow-up|1|||
44512136|NCT03768726|79517701|FG000|Treatment Phase|Adverse Event|2|||
44512137|NCT03768726|79517702|FG001|Treatment Phase|Adverse Event|2|||
44512138|NCT03768726|79517701|FG000|Treatment Phase|Lost to Follow-up|1|||
44512139|NCT03768726|79517702|FG001|Treatment Phase|Lost to Follow-up|0|||
44129973|NCT02796677|78915749|FG000|Overall Study|Protocol Violation|7|||
44129974|NCT02796677|78915750|FG001|Overall Study|Protocol Violation|5|||
44129975|NCT02796677|78915751|FG002|Overall Study|Protocol Violation|4|||
44512140|NCT03768726|79517701|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
44512141|NCT03768726|79517702|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
44129976|NCT02796677|78915752|FG003|Overall Study|Protocol Violation|8|||
44129977|NCT02796677|78915749|FG000|Overall Study|Lost to Follow-up|1|||
44129978|NCT02796677|78915750|FG001|Overall Study|Lost to Follow-up|5|||
44512142|NCT03768726|79517701|FG000|Treatment Phase|Withdrawal by Subject|3|||
44512143|NCT03768726|79517702|FG001|Treatment Phase|Withdrawal by Subject|1|||
44512144|NCT03768726|79517701|FG000|Follow-Up|Adverse Event|2|||
44512145|NCT03768726|79517702|FG001|Follow-Up|Adverse Event|2|||
44512146|NCT03768726|79517701|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
44512147|NCT03768726|79517702|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
44512148|NCT03768726|79517701|FG000|Follow-Up|Withdrawal by Subject|2|||
44512149|NCT03768726|79517702|FG001|Follow-Up|Withdrawal by Subject|0|||
44512150|NCT03768726|79517701|FG000|Follow-Up|Other|1|||
44512151|NCT03768726|79517702|FG001|Follow-Up|Other|0|||
44512152|NCT03769896|79517710|FG000|Open-label Phase|Lack of Efficacy|5|||
44512153|NCT03769896|79517711|FG001|Open-label Phase|Lack of Efficacy|0|||
44512154|NCT03769896|79517710|FG000|Open-label Phase|Adverse Event|3|||
44512155|NCT03769896|79517711|FG001|Open-label Phase|Adverse Event|0|||
44512156|NCT03769896|79517710|FG000|Open-label Phase|Withdrawal by Subject|1|||
44512157|NCT03769896|79517711|FG001|Open-label Phase|Withdrawal by Subject|0|||
44512158|NCT05047601|79517721|FG000|Overall Study|Lost to Follow-up|9|||
44512159|NCT05047601|79517722|FG001|Overall Study|Lost to Follow-up|11|||
44512160|NCT05047601|79517723|FG002|Overall Study|Lost to Follow-up|7|||
44512161|NCT05047601|79517721|FG000|Overall Study|Withdrawal by Subject|25|||
44512162|NCT05047601|79517722|FG001|Overall Study|Withdrawal by Subject|36|||
44512163|NCT05047601|79517723|FG002|Overall Study|Withdrawal by Subject|23|||
44512164|NCT05047601|79517721|FG000|Overall Study|Other|10|||
44512165|NCT05047601|79517722|FG001|Overall Study|Other|6|||
44512166|NCT05047601|79517723|FG002|Overall Study|Other|5|||
44512167|NCT04658784|79517733|FG000|6-month Follow-up|Lost to Follow-up|2|||
44512168|NCT04658784|79517734|FG001|6-month Follow-up|Lost to Follow-up|5|||
44129979|NCT02796677|78915751|FG002|Overall Study|Lost to Follow-up|2|||
44129980|NCT02796677|78915752|FG003|Overall Study|Lost to Follow-up|2|||
44129981|NCT02796677|78915749|FG000|Overall Study|Lack of Efficacy|7|||
44129982|NCT02796677|78915750|FG001|Overall Study|Lack of Efficacy|9|||
44129983|NCT02796677|78915751|FG002|Overall Study|Lack of Efficacy|14|||
44129984|NCT02796677|78915752|FG003|Overall Study|Lack of Efficacy|20|||
44129985|NCT02796677|78915749|FG000|Overall Study|Withdrawal by Subject|4|||
44129986|NCT02796677|78915750|FG001|Overall Study|Withdrawal by Subject|14|||
44129987|NCT02796677|78915751|FG002|Overall Study|Withdrawal by Subject|6|||
44512169|NCT04606394|79517740|FG000|Overall Study|Withdrawal by Subject|3|||
44512170|NCT04606394|79517740|FG000|Overall Study|Exclusion criteria screen failure|12|||
44512171|NCT04585451|79517754|FG000|Overall Study|Withdrawal by Subject|26|||
44129988|NCT02796677|78915752|FG003|Overall Study|Withdrawal by Subject|7|||
44129989|NCT02796677|78915749|FG000|Overall Study|Progressive disease|6|||
44129990|NCT02796677|78915750|FG001|Overall Study|Progressive disease|15|||
44129991|NCT02796677|78915751|FG002|Overall Study|Progressive disease|13|||
44129992|NCT02796677|78915752|FG003|Overall Study|Progressive disease|18|||
44129993|NCT02796677|78915749|FG000|Overall Study|Reason not mentioned|2|||
44512172|NCT04585451|79517755|FG001|Overall Study|Withdrawal by Subject|0|||
44512173|NCT04362189|79517780|FG000|Overall Study|Lost to Follow-up|0|||
44512174|NCT04362189|79517781|FG001|Overall Study|Lost to Follow-up|1|||
44243358|NCT01475461|79072779|FG001|Treatment Period|Lost to Follow-up|3|||
44243359|NCT01475461|79072780|FG002|Treatment Period|Lost to Follow-up|2|||
44243360|NCT01475461|79072781|FG003|Treatment Period|Lost to Follow-up|3|||
44243361|NCT01475461|79072782|FG004|Treatment Period|Lost to Follow-up|1|||
44243362|NCT01475461|79072783|FG005|Treatment Period|Lost to Follow-up|2|||
44243363|NCT01475461|79072784|FG006|Treatment Period|Lost to Follow-up|1|||
44243364|NCT01475461|79072778|FG000|Treatment Period|Withdrawal by Subject|0|||
44243365|NCT01475461|79072779|FG001|Treatment Period|Withdrawal by Subject|2|||
44512175|NCT04362189|79517780|FG000|Overall Study|Withdrawal by Subject|1|||
44129994|NCT02796677|78915750|FG001|Overall Study|Reason not mentioned|3|||
44129995|NCT02796677|78915751|FG002|Overall Study|Reason not mentioned|0|||
44129996|NCT02796677|78915752|FG003|Overall Study|Reason not mentioned|5|||
44129997|NCT02421172|78915766|FG000|Period 1|Adverse Event|1|||
44129998|NCT02421172|78915767|FG001|Period 1|Adverse Event|0|||
44129999|NCT02421172|78915768|FG002|Period 1|Adverse Event|0|||
44130000|NCT02421172|78915769|FG003|Period 1|Adverse Event|0|||
44130001|NCT02421172|78915770|FG004|Period 1|Adverse Event|0|||
44130002|NCT02421172|78915766|FG000|Period 1|Lost to Follow-up|3|||
44130003|NCT02421172|78915767|FG001|Period 1|Lost to Follow-up|1|||
44130004|NCT02421172|78915768|FG002|Period 1|Lost to Follow-up|0|||
44130005|NCT02421172|78915769|FG003|Period 1|Lost to Follow-up|0|||
44130006|NCT02421172|78915770|FG004|Period 1|Lost to Follow-up|0|||
44130007|NCT02421172|78915766|FG000|Period 1|Patient/guardian decision|0|||
44130008|NCT02421172|78915767|FG001|Period 1|Patient/guardian decision|1|||
44130009|NCT02421172|78915768|FG002|Period 1|Patient/guardian decision|0|||
44130010|NCT02421172|78915769|FG003|Period 1|Patient/guardian decision|0|||
44130011|NCT02421172|78915770|FG004|Period 1|Patient/guardian decision|0|||
44130012|NCT02421172|78915766|FG000|Period 2|Adverse Event|0|||
44243366|NCT01475461|79072780|FG002|Treatment Period|Withdrawal by Subject|2|||
44243367|NCT01475461|79072781|FG003|Treatment Period|Withdrawal by Subject|0|||
44512176|NCT04362189|79517781|FG001|Overall Study|Withdrawal by Subject|0|||
44512177|NCT04362189|79517780|FG000|Overall Study|FDA Clinical Hold|7|||
44512178|NCT04362189|79517781|FG001|Overall Study|FDA Clinical Hold|2|||
44512179|NCT04362189|79517780|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
44512180|NCT04362189|79517781|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
44512181|NCT04362189|79517780|FG000|Overall Study|Adverse Event|0|||
44512182|NCT04362189|79517781|FG001|Overall Study|Adverse Event|2|||
44512183|NCT04362189|79517780|FG000|Overall Study|Death|4|||
44512184|NCT04362189|79517781|FG001|Overall Study|Death|1|||
44512185|NCT04181788|79517855|FG000|TREATMENT|Adverse Event|0|||
44512186|NCT04181788|79517856|FG001|TREATMENT|Adverse Event|2|||
44512187|NCT04181788|79517857|FG002|TREATMENT|Adverse Event|1|||
44512188|NCT04181788|79517858|FG003|TREATMENT|Adverse Event|0|||
44512189|NCT04181788|79517859|FG004|TREATMENT|Adverse Event|1|||
44512190|NCT04181788|79517860|FG005|TREATMENT|Adverse Event|3|||
44512191|NCT04181788|79517855|FG000|TREATMENT|Death|0|||
44512192|NCT04181788|79517856|FG001|TREATMENT|Death|0|||
44512193|NCT04181788|79517857|FG002|TREATMENT|Death|0|||
44512194|NCT04181788|79517858|FG003|TREATMENT|Death|0|||
44512195|NCT04181788|79517859|FG004|TREATMENT|Death|8|||
44130013|NCT02421172|78915767|FG001|Period 2|Adverse Event|0|||
44130014|NCT02421172|78915768|FG002|Period 2|Adverse Event|4|||
44130015|NCT02421172|78915769|FG003|Period 2|Adverse Event|0|||
44512196|NCT04181788|79517860|FG005|TREATMENT|Death|8|||
44130016|NCT02421172|78915770|FG004|Period 2|Adverse Event|0|||
44130017|NCT02421172|78915766|FG000|Period 2|Lost to Follow-up|0|||
44243368|NCT01475461|79072782|FG004|Treatment Period|Withdrawal by Subject|2|||
44243369|NCT01475461|79072783|FG005|Treatment Period|Withdrawal by Subject|2|||
44512197|NCT04181788|79517855|FG000|TREATMENT|Physician Decision|0|||
44512198|NCT04181788|79517856|FG001|TREATMENT|Physician Decision|0|||
44512199|NCT04181788|79517857|FG002|TREATMENT|Physician Decision|0|||
44512200|NCT04181788|79517858|FG003|TREATMENT|Physician Decision|0|||
44512201|NCT04181788|79517859|FG004|TREATMENT|Physician Decision|0|||
44512202|NCT04181788|79517860|FG005|TREATMENT|Physician Decision|1|||
44512203|NCT04181788|79517855|FG000|TREATMENT|Progressive disease|3|||
44130018|NCT02421172|78915767|FG001|Period 2|Lost to Follow-up|0|||
44130019|NCT02421172|78915768|FG002|Period 2|Lost to Follow-up|0|||
44130020|NCT02421172|78915769|FG003|Period 2|Lost to Follow-up|1|||
44130021|NCT02421172|78915770|FG004|Period 2|Lost to Follow-up|0|||
44130022|NCT02421172|78915766|FG000|Period 2|Patient/guardian decision|0|||
44130023|NCT02421172|78915767|FG001|Period 2|Patient/guardian decision|0|||
44130024|NCT02421172|78915768|FG002|Period 2|Patient/guardian decision|3|||
44130025|NCT02421172|78915769|FG003|Period 2|Patient/guardian decision|2|||
44130026|NCT02421172|78915770|FG004|Period 2|Patient/guardian decision|1|||
44130027|NCT02379052|78915783|FG000|Overall Study|Protocol Violation|0|||
44130028|NCT02379052|78915784|FG001|Overall Study|Protocol Violation|1|||
44243370|NCT01475461|79072784|FG006|Treatment Period|Withdrawal by Subject|0|||
44243371|NCT01475461|79072778|FG000|Treatment Period|Other|0|||
44243372|NCT01475461|79072779|FG001|Treatment Period|Other|1|||
44243373|NCT01475461|79072780|FG002|Treatment Period|Other|0|||
44512204|NCT04181788|79517856|FG001|TREATMENT|Progressive disease|3|||
44512205|NCT04181788|79517857|FG002|TREATMENT|Progressive disease|5|||
44512206|NCT04181788|79517858|FG003|TREATMENT|Progressive disease|7|||
44512207|NCT04181788|79517859|FG004|TREATMENT|Progressive disease|20|||
44243374|NCT01475461|79072781|FG003|Treatment Period|Other|0|||
44512208|NCT04181788|79517860|FG005|TREATMENT|Progressive disease|38|||
44512209|NCT04181788|79517855|FG000|TREATMENT|Global deterioration of health status|0|||
44512210|NCT04181788|79517856|FG001|TREATMENT|Global deterioration of health status|2|||
44512211|NCT04181788|79517857|FG002|TREATMENT|Global deterioration of health status|0|||
44512212|NCT04181788|79517858|FG003|TREATMENT|Global deterioration of health status|0|||
44512213|NCT04181788|79517859|FG004|TREATMENT|Global deterioration of health status|2|||
44512214|NCT04181788|79517860|FG005|TREATMENT|Global deterioration of health status|8|||
44512215|NCT04181788|79517855|FG000|TREATMENT|Withdrawal by Subject|1|||
44130029|NCT02379052|78915783|FG000|Overall Study|Adverse Event|0|||
44130030|NCT02379052|78915784|FG001|Overall Study|Adverse Event|1|||
44243375|NCT01475461|79072782|FG004|Treatment Period|Other|0|||
44243376|NCT01475461|79072783|FG005|Treatment Period|Other|0|||
44512216|NCT04181788|79517856|FG001|TREATMENT|Withdrawal by Subject|2|||
44512217|NCT04181788|79517857|FG002|TREATMENT|Withdrawal by Subject|0|||
44130031|NCT02379052|78915783|FG000|Overall Study|Physician Decision|1|||
44379560|NCT00770341|79385154|FG001|Overall Study|Withdrawal by Subject|1|||
44379561|NCT00770341|79385155|FG002|Overall Study|Withdrawal by Subject|0|||
44512218|NCT04181788|79517858|FG003|TREATMENT|Withdrawal by Subject|0|||
44512219|NCT04181788|79517859|FG004|TREATMENT|Withdrawal by Subject|3|||
44512220|NCT04181788|79517860|FG005|TREATMENT|Withdrawal by Subject|5|||
44512221|NCT04181788|79517855|FG000|TREATMENT|Other unspecified|0|||
44512222|NCT04181788|79517856|FG001|TREATMENT|Other unspecified|0|||
44512223|NCT04181788|79517857|FG002|TREATMENT|Other unspecified|0|||
44512224|NCT04181788|79517858|FG003|TREATMENT|Other unspecified|0|||
44512225|NCT04181788|79517859|FG004|TREATMENT|Other unspecified|0|||
44512226|NCT04181788|79517860|FG005|TREATMENT|Other unspecified|2|||
44512227|NCT04181788|79517855|FG000|TREATMENT|Ongoing|0|||
44130032|NCT02379052|78915784|FG001|Overall Study|Physician Decision|1|||
44243377|NCT01475461|79072784|FG006|Treatment Period|Other|0|||
44512228|NCT04181788|79517856|FG001|TREATMENT|Ongoing|3|||
44512229|NCT04181788|79517857|FG002|TREATMENT|Ongoing|0|||
44512230|NCT04181788|79517858|FG003|TREATMENT|Ongoing|5|||
44512231|NCT04181788|79517859|FG004|TREATMENT|Ongoing|7|||
44512232|NCT04181788|79517860|FG005|TREATMENT|Ongoing|15|||
44512233|NCT04181788|79517855|FG000|FOLLOW-UP|Death|0|||
44512234|NCT04181788|79517856|FG001|FOLLOW-UP|Death|0|||
44512235|NCT04181788|79517857|FG002|FOLLOW-UP|Death|1|||
44512236|NCT04181788|79517858|FG003|FOLLOW-UP|Death|2|||
44512237|NCT04181788|79517859|FG004|FOLLOW-UP|Death|8|||
44512238|NCT04181788|79517860|FG005|FOLLOW-UP|Death|20|||
44512239|NCT04181788|79517855|FG000|FOLLOW-UP|Lost to Follow-up|0|||
44512240|NCT04181788|79517856|FG001|FOLLOW-UP|Lost to Follow-up|0|||
44512241|NCT04181788|79517857|FG002|FOLLOW-UP|Lost to Follow-up|0|||
44512242|NCT04181788|79517858|FG003|FOLLOW-UP|Lost to Follow-up|0|||
44512243|NCT04181788|79517859|FG004|FOLLOW-UP|Lost to Follow-up|0|||
44512244|NCT04181788|79517860|FG005|FOLLOW-UP|Lost to Follow-up|2|||
44512245|NCT04181788|79517855|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
44512246|NCT04181788|79517856|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
44512247|NCT04181788|79517857|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
44512248|NCT04181788|79517858|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
44512249|NCT04181788|79517859|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
44512250|NCT04181788|79517860|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
44512251|NCT04181788|79517855|FG000|FOLLOW-UP|Other unspecified|0|||
44512252|NCT04181788|79517856|FG001|FOLLOW-UP|Other unspecified|1|||
44512253|NCT04181788|79517857|FG002|FOLLOW-UP|Other unspecified|0|||
44512254|NCT04181788|79517858|FG003|FOLLOW-UP|Other unspecified|0|||
44512255|NCT04181788|79517859|FG004|FOLLOW-UP|Other unspecified|0|||
44512256|NCT04181788|79517860|FG005|FOLLOW-UP|Other unspecified|3|||
44130033|NCT02379052|78915783|FG000|Overall Study|Withdrawal by Subject|2|||
44130034|NCT02379052|78915784|FG001|Overall Study|Withdrawal by Subject|0|||
44130035|NCT02379052|78915783|FG000|Overall Study|Lost to Follow-up|2|||
44130036|NCT02379052|78915784|FG001|Overall Study|Lost to Follow-up|1|||
44130037|NCT02379052|78915783|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
44130038|NCT02379052|78915784|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
44130039|NCT02379052|78915783|FG000|Overall Study|Subject was Incarcerated|0|||
44130040|NCT02379052|78915784|FG001|Overall Study|Subject was Incarcerated|1|||
44130041|NCT02378662|78915792|FG000|Overall Study|Early Discontinuation|2|||
44130042|NCT02378662|78915793|FG001|Overall Study|Early Discontinuation|0|||
44130043|NCT02378506|78915799|FG000|Overall Study|Lack of Efficacy|3|||
44130044|NCT02378506|78915799|FG000|Overall Study|Withdrawal by Subject|4|||
44130045|NCT02378506|78915799|FG000|Overall Study|Protocol Violation|2|||
44130046|NCT02378506|78915799|FG000|Overall Study|Death|1|||
44130047|NCT02378506|78915799|FG000|Overall Study|Adverse Event|14|||
44130048|NCT02378506|78915799|FG000|Overall Study|Randomized But Not Treated|1|||
44130049|NCT02347774|78915806|FG000|Study Participation|Lost to Follow-up|3|||
44130050|NCT02347774|78915807|FG001|Study Participation|Lost to Follow-up|6|||
44130051|NCT02347774|78915808|FG002|Study Participation|Lost to Follow-up|2|||
44130052|NCT02347774|78915806|FG000|Study Participation|Withdrawal by Subject|8|||
44130053|NCT02347774|78915807|FG001|Study Participation|Withdrawal by Subject|9|||
44130054|NCT02347774|78915808|FG002|Study Participation|Withdrawal by Subject|15|||
44130055|NCT02347774|78915806|FG000|Study Participation|Adverse Event|1|||
44130056|NCT02347774|78915807|FG001|Study Participation|Adverse Event|4|||
44130057|NCT02347774|78915808|FG002|Study Participation|Adverse Event|6|||
44130058|NCT02347774|78915806|FG000|Study Participation|withdrew consent|1|||
44130059|NCT02347774|78915807|FG001|Study Participation|withdrew consent|1|||
44130060|NCT02347774|78915808|FG002|Study Participation|withdrew consent|1|||
44130061|NCT02347774|78915806|FG000|Study Participation|Met Prolonged QT criteria|1|||
44130062|NCT02347774|78915807|FG001|Study Participation|Met Prolonged QT criteria|0|||
44130063|NCT02347774|78915808|FG002|Study Participation|Met Prolonged QT criteria|0|||
44130064|NCT02347774|78915806|FG000|Study Participation|non-compliance with study drug|0|||
44130065|NCT02347774|78915807|FG001|Study Participation|non-compliance with study drug|1|||
44130066|NCT02347774|78915808|FG002|Study Participation|non-compliance with study drug|0|||
44130067|NCT02347774|78915806|FG000|Study Participation|incarceration|1|||
44130068|NCT02347774|78915807|FG001|Study Participation|incarceration|0|||
44130069|NCT02347774|78915808|FG002|Study Participation|incarceration|0|||
44130070|NCT02347774|78915806|FG000|Study Participation|randomized in error|0|||
44130071|NCT02347774|78915807|FG001|Study Participation|randomized in error|0|||
44130072|NCT02347774|78915808|FG002|Study Participation|randomized in error|1|||
44130073|NCT02347774|78915806|FG000|On Study Treatment|Adverse Event|9|||
44130074|NCT02347774|78915807|FG001|On Study Treatment|Adverse Event|15|||
44130075|NCT02347774|78915808|FG002|On Study Treatment|Adverse Event|19|||
44130076|NCT02347774|78915806|FG000|On Study Treatment|Lack of Efficacy|3|||
44130077|NCT02347774|78915807|FG001|On Study Treatment|Lack of Efficacy|0|||
44130078|NCT02347774|78915808|FG002|On Study Treatment|Lack of Efficacy|2|||
44130079|NCT02347774|78915806|FG000|On Study Treatment|non-complicance with study medication|0|||
44130080|NCT02347774|78915807|FG001|On Study Treatment|non-complicance with study medication|2|||
44130081|NCT02347774|78915808|FG002|On Study Treatment|non-complicance with study medication|0|||
44130082|NCT02347774|78915806|FG000|On Study Treatment|Protocol Violation|0|||
44130083|NCT02347774|78915807|FG001|On Study Treatment|Protocol Violation|0|||
44130084|NCT02347774|78915808|FG002|On Study Treatment|Protocol Violation|1|||
44130085|NCT02347774|78915806|FG000|On Study Treatment|withdrew consent|9|||
44130086|NCT02347774|78915807|FG001|On Study Treatment|withdrew consent|8|||
44130087|NCT02347774|78915808|FG002|On Study Treatment|withdrew consent|12|||
44130088|NCT02347774|78915806|FG000|On Study Treatment|Lost to Follow-up|2|||
44130089|NCT02347774|78915807|FG001|On Study Treatment|Lost to Follow-up|6|||
44130090|NCT02347774|78915808|FG002|On Study Treatment|Lost to Follow-up|1|||
44130091|NCT02347774|78915806|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
44130092|NCT02347774|78915807|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
44130093|NCT02347774|78915808|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
44130094|NCT02347774|78915806|FG000|On Study Treatment|ranomized in error|0|||
44130095|NCT02347774|78915807|FG001|On Study Treatment|ranomized in error|0|||
44130096|NCT02347774|78915808|FG002|On Study Treatment|ranomized in error|1|||
44130097|NCT02794883|78915819|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
44130098|NCT02794883|78915820|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
44130099|NCT02794883|78915821|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
44130100|NCT02794883|78915819|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
44130101|NCT02794883|78915820|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
44130102|NCT02794883|78915821|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
44130103|NCT02794883|78915819|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
44130104|NCT02794883|78915820|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
44130105|NCT02794883|78915821|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
44130106|NCT02794883|78915819|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
44130107|NCT02794883|78915820|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
44130108|NCT02794883|78915821|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
44130109|NCT02794883|78915819|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
44130110|NCT02794883|78915820|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
44130111|NCT02794883|78915821|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
44130112|NCT02794883|78915819|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
44130113|NCT02794883|78915820|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
44130114|NCT02794883|78915821|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
44130115|NCT02794883|78915819|FG000|Follow-up Period (up to 2 Years)|Death|12|||
44130116|NCT02794883|78915820|FG001|Follow-up Period (up to 2 Years)|Death|10|||
44130117|NCT02794883|78915821|FG002|Follow-up Period (up to 2 Years)|Death|10|||
44130118|NCT01370603|78915831|FG000|Period 1|Adverse Event|5|||
44130119|NCT01370603|78915832|FG001|Period 1|Adverse Event|3|||
44130120|NCT01370603|78915831|FG000|Period 1|Lost to Follow-up|2|||
44130121|NCT01370603|78915832|FG001|Period 1|Lost to Follow-up|0|||
44512257|NCT04181788|79517855|FG000|FOLLOW-UP|Ongoing|0|||
44512258|NCT04181788|79517856|FG001|FOLLOW-UP|Ongoing|0|||
44512259|NCT04181788|79517857|FG002|FOLLOW-UP|Ongoing|1|||
44512260|NCT04181788|79517858|FG003|FOLLOW-UP|Ongoing|3|||
44512261|NCT04181788|79517859|FG004|FOLLOW-UP|Ongoing|2|||
44512262|NCT04181788|79517860|FG005|FOLLOW-UP|Ongoing|2|||
44512263|NCT04120194|79517883|FG000|Overall Study|Lost to Follow-up|11|||
44512264|NCT04120194|79517884|FG001|Overall Study|Lost to Follow-up|8|||
44512265|NCT04120194|79517883|FG000|Overall Study|Adverse Event|4|||
44512266|NCT04120194|79517884|FG001|Overall Study|Adverse Event|5|||
44512267|NCT04120194|79517883|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
44130122|NCT01370603|78915831|FG000|Period 1|Protocol Violation|2|||
44130123|NCT01370603|78915832|FG001|Period 1|Protocol Violation|2|||
44130124|NCT01370603|78915831|FG000|Period 1|Withdrawal by Subject|5|||
44130125|NCT01370603|78915832|FG001|Period 1|Withdrawal by Subject|5|||
44130126|NCT01370603|78915831|FG000|Crossover Washout|Adverse Event|2|||
44130127|NCT01370603|78915832|FG001|Crossover Washout|Adverse Event|1|||
44130128|NCT01370603|78915831|FG000|Crossover Washout|Lost to Follow-up|2|||
44130129|NCT01370603|78915832|FG001|Crossover Washout|Lost to Follow-up|0|||
44130130|NCT01370603|78915831|FG000|Crossover Washout|Protocol Violation|1|||
44512268|NCT04120194|79517884|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
44130131|NCT01370603|78915832|FG001|Crossover Washout|Protocol Violation|0|||
44130132|NCT01370603|78915831|FG000|Crossover Washout|Withdrawal by Subject|4|||
44130133|NCT01370603|78915832|FG001|Crossover Washout|Withdrawal by Subject|1|||
44130134|NCT01370603|78915831|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
44130135|NCT01370603|78915832|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
44130136|NCT01370603|78915831|FG000|Period 2|Adverse Event|1|||
44130137|NCT01370603|78915832|FG001|Period 2|Adverse Event|4|||
44130138|NCT01370603|78915831|FG000|Period 2|Lost to Follow-up|1|||
44130139|NCT01370603|78915832|FG001|Period 2|Lost to Follow-up|0|||
44130140|NCT01370603|78915831|FG000|Period 2|Withdrawal by Subject|1|||
44130141|NCT01370603|78915832|FG001|Period 2|Withdrawal by Subject|0|||
44130142|NCT02347072|78915838|FG000|Overall Study|Adverse Event|2|||
44130143|NCT02347072|78915838|FG000|Overall Study|Withdrawal by Subject|6|||
44130144|NCT02347072|78915838|FG000|Overall Study|Physician Decision|1|||
44130145|NCT02347072|78915838|FG000|Overall Study|Lost to Follow-up|2|||
44130146|NCT02347072|78915838|FG000|Overall Study|Protocol Violation|1|||
44130147|NCT02347072|78915838|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
44130148|NCT02794103|78915846|FG000|Overall Study|Loss to follow up due to high sedation|3|||
44130149|NCT02346370|78915853|FG000|Overall Study|Not treated|1|||
44130150|NCT02346370|78915854|FG001|Overall Study|Not treated|0|||
44130151|NCT02346370|78915855|FG002|Overall Study|Not treated|0|||
44130152|NCT02346370|78915853|FG000|Overall Study|Withdrawal of consent|1|||
44130153|NCT02346370|78915854|FG001|Overall Study|Withdrawal of consent|0|||
44130154|NCT02346370|78915855|FG002|Overall Study|Withdrawal of consent|0|||
44130155|NCT02346370|78915853|FG000|Overall Study|Death|1|||
44130156|NCT02346370|78915854|FG001|Overall Study|Death|3|||
44130157|NCT02346370|78915855|FG002|Overall Study|Death|1|||
44130158|NCT02346370|78915853|FG000|Overall Study|Sponsor discontinued study|5|||
44130159|NCT02346370|78915854|FG001|Overall Study|Sponsor discontinued study|0|||
44130160|NCT02346370|78915855|FG002|Overall Study|Sponsor discontinued study|2|||
44130161|NCT02346370|78915853|FG000|Overall Study|Radiologic progression|0|||
44130162|NCT02346370|78915854|FG001|Overall Study|Radiologic progression|0|||
44130163|NCT02346370|78915855|FG002|Overall Study|Radiologic progression|1|||
44130164|NCT02346370|78915853|FG000|Overall Study|Physician Decision|0|||
44130165|NCT02346370|78915854|FG001|Overall Study|Physician Decision|1|||
44130166|NCT02346370|78915855|FG002|Overall Study|Physician Decision|0|||
44130167|NCT02346136|78915867|FG000|Overall Study|Withdrawal by Subject|7|||
44130168|NCT02346136|78915868|FG001|Overall Study|Withdrawal by Subject|5|||
44130169|NCT02346136|78915867|FG000|Overall Study|Death|1|||
44130170|NCT02346136|78915868|FG001|Overall Study|Death|0|||
44130171|NCT02346136|78915867|FG000|Overall Study|Study termination|14|||
44130172|NCT02346136|78915868|FG001|Overall Study|Study termination|18|||
44130173|NCT02793947|78915876|FG000|Overall Study|Death|1|||
44130174|NCT02793947|78915877|FG001|Overall Study|Death|0|||
44130175|NCT02793947|78915876|FG000|Overall Study|Physician Decision|1|||
44130176|NCT02793947|78915877|FG001|Overall Study|Physician Decision|5|||
44130177|NCT02345512|78915883|FG000|Overall Study|Adverse Event|1|||
44130178|NCT02345512|78915883|FG000|Overall Study|Withdrawal by Subject|1|||
44130179|NCT02345434|78915894|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
44130180|NCT02345434|78915895|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
44512269|NCT04120194|79517883|FG000|Overall Study|Miscellaneous|4|||
44512270|NCT04120194|79517884|FG001|Overall Study|Miscellaneous|5|||
44512271|NCT04050670|79517890|FG000|Period 3|Physician Decision|0|||
44512272|NCT04050670|79517891|FG001|Period 3|Physician Decision|1|||
44512273|NCT04050670|79517892|FG002|Period 3|Physician Decision|0|||
44512274|NCT04016714|79517915|FG000|Overall Study|Death|1|||
44512275|NCT04016714|79517916|FG001|Overall Study|Death|0|||
44512276|NCT04016714|79517915|FG000|Overall Study|Lost to Follow-up|3|||
44512277|NCT04016714|79517916|FG001|Overall Study|Lost to Follow-up|1|||
44512278|NCT04016714|79517915|FG000|Overall Study|Physician Decision|3|||
44512279|NCT04016714|79517916|FG001|Overall Study|Physician Decision|3|||
44512280|NCT04016714|79517915|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
44130181|NCT01370213|78915904|FG000|Overall Study|Early Death|1|||
44130182|NCT01370213|78915905|FG001|Overall Study|Early Death|0|||
44130183|NCT01370213|78915906|FG002|Overall Study|Early Death|0|||
44512281|NCT04016714|79517916|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
44512282|NCT03997409|79517925|FG000|Overall Study|Protocol Violation|1|||
44512283|NCT03997409|79517926|FG001|Overall Study|Protocol Violation|1|||
44130184|NCT01370213|78915904|FG000|Overall Study|Not evaluable|0|||
44130185|NCT01370213|78915905|FG001|Overall Study|Not evaluable|2|||
44130186|NCT01370213|78915906|FG002|Overall Study|Not evaluable|0|||
44130187|NCT01370525|78915915|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
44130188|NCT01370525|78915916|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
44130189|NCT01370525|78915915|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44130190|NCT01370525|78915916|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44130191|NCT01370525|78915915|FG000|Overall Study|Adverse Event|0|||
44130192|NCT01370525|78915916|FG001|Overall Study|Adverse Event|1|||
44130193|NCT01370525|78915915|FG000|Overall Study|Protocol Violation|2|||
44130194|NCT01370525|78915916|FG001|Overall Study|Protocol Violation|1|||
44130195|NCT01370525|78915915|FG000|Overall Study|Lost to follow up|2|||
44130196|NCT01370525|78915916|FG001|Overall Study|Lost to follow up|6|||
44130197|NCT02792777|78915924|FG000|Overall Study|Withdrawal by Subject|2|||
44130198|NCT02792777|78915925|FG001|Overall Study|Withdrawal by Subject|0|||
44130199|NCT02792777|78915924|FG000|Overall Study|Recording malfunction|2|||
44130200|NCT02792777|78915925|FG001|Overall Study|Recording malfunction|0|||
44130201|NCT02792777|78915924|FG000|Overall Study|Later determined to be ineligible|2|||
44130202|NCT02792777|78915925|FG001|Overall Study|Later determined to be ineligible|0|||
44130203|NCT02792777|78915924|FG000|Overall Study|Participant interviewed twice|1|||
44130204|NCT02792777|78915925|FG001|Overall Study|Participant interviewed twice|0|||
44130205|NCT02625974|78915934|FG000|Overall Study|Adverse Event|12|||
44130206|NCT02625974|78915935|FG001|Overall Study|Adverse Event|2|||
44130207|NCT02625974|78915934|FG000|Overall Study|Withdrawal by Subject|3|||
44130208|NCT02625974|78915935|FG001|Overall Study|Withdrawal by Subject|1|||
44130209|NCT02625974|78915934|FG000|Overall Study|positive parasitemia|1|||
44130210|NCT02625974|78915935|FG001|Overall Study|positive parasitemia|0|||
44130211|NCT02625974|78915934|FG000|Overall Study|non-compliance with study drug|0|||
44130212|NCT02625974|78915935|FG001|Overall Study|non-compliance with study drug|2|||
44130213|NCT02625974|78915934|FG000|Overall Study|Protocol Violation|0|||
44130214|NCT02625974|78915935|FG001|Overall Study|Protocol Violation|1|||
44130215|NCT02792699|78915980|FG000|Overall Study|Adverse Event|1|||
44130216|NCT02792699|78915981|FG001|Overall Study|Adverse Event|2|||
44130217|NCT02792699|78915982|FG002|Overall Study|Adverse Event|4|||
44130218|NCT02792699|78915980|FG000|Overall Study|Withdrawal by Subject|4|||
44130219|NCT02792699|78915981|FG001|Overall Study|Withdrawal by Subject|4|||
44130220|NCT02792699|78915982|FG002|Overall Study|Withdrawal by Subject|3|||
44130221|NCT02792699|78915980|FG000|Overall Study|Lost to Follow-up|0|||
44130222|NCT02792699|78915981|FG001|Overall Study|Lost to Follow-up|1|||
44130223|NCT02792699|78915982|FG002|Overall Study|Lost to Follow-up|2|||
44130224|NCT02792699|78915980|FG000|Overall Study|Physician Decision|2|||
44130225|NCT02792699|78915981|FG001|Overall Study|Physician Decision|0|||
44130226|NCT02792699|78915982|FG002|Overall Study|Physician Decision|0|||
44130227|NCT02792699|78915980|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
44130228|NCT02792699|78915981|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
44130229|NCT02792699|78915982|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
44130230|NCT02792699|78915980|FG000|Overall Study|Other|1|||
44130231|NCT02792699|78915981|FG001|Overall Study|Other|0|||
44130232|NCT02792699|78915982|FG002|Overall Study|Other|0|||
44130233|NCT03010319|78915999|FG000|Overall Study|Adverse Event|15|||
44130234|NCT03010319|78916000|FG001|Overall Study|Adverse Event|9|||
44130235|NCT03010319|78915999|FG000|Overall Study|Withdrawal by Subject|1|||
44130236|NCT03010319|78916000|FG001|Overall Study|Withdrawal by Subject|6|||
44130237|NCT03010319|78915999|FG000|Overall Study|Physician Decision|2|||
44130238|NCT03010319|78916000|FG001|Overall Study|Physician Decision|4|||
44130239|NCT03010319|78915999|FG000|Overall Study|Sponsor requested withdrawal|2|||
44130240|NCT03010319|78916000|FG001|Overall Study|Sponsor requested withdrawal|2|||
44130241|NCT03010319|78915999|FG000|Overall Study|Death|1|||
44130242|NCT03010319|78916000|FG001|Overall Study|Death|0|||
44130243|NCT03010319|78915999|FG000|Overall Study|Lost to Follow-up|0|||
44130244|NCT03010319|78916000|FG001|Overall Study|Lost to Follow-up|1|||
44130245|NCT03010319|78915999|FG000|Overall Study|Other Reason|5|||
44130246|NCT03010319|78916000|FG001|Overall Study|Other Reason|7|||
44130247|NCT01369511|78916010|FG000|Overall Study|Adverse Event|1|||
44130248|NCT01369511|78916011|FG001|Overall Study|Adverse Event|1|||
44130249|NCT01369511|78916012|FG002|Overall Study|Adverse Event|5|||
44130250|NCT01369511|78916013|FG003|Overall Study|Adverse Event|0|||
44130251|NCT01369511|78916010|FG000|Overall Study|Entry criteria not met|2|||
44130252|NCT01369511|78916011|FG001|Overall Study|Entry criteria not met|0|||
44130253|NCT01369511|78916012|FG002|Overall Study|Entry criteria not met|0|||
44130254|NCT01369511|78916013|FG003|Overall Study|Entry criteria not met|1|||
44130255|NCT01369511|78916010|FG000|Overall Study|Lost to Follow-up|0|||
44130256|NCT01369511|78916011|FG001|Overall Study|Lost to Follow-up|1|||
44130257|NCT01369511|78916012|FG002|Overall Study|Lost to Follow-up|1|||
44130258|NCT01369511|78916013|FG003|Overall Study|Lost to Follow-up|2|||
44130259|NCT01369511|78916010|FG000|Overall Study|Protocol Violation|0|||
44130260|NCT01369511|78916011|FG001|Overall Study|Protocol Violation|1|||
44130261|NCT01369511|78916012|FG002|Overall Study|Protocol Violation|0|||
44130262|NCT01369511|78916013|FG003|Overall Study|Protocol Violation|2|||
44130263|NCT01369511|78916010|FG000|Overall Study|Physician Decision|3|||
44243378|NCT01475461|79072778|FG000|Treatment Period|Protocol Violation|0|||
44243379|NCT01475461|79072779|FG001|Treatment Period|Protocol Violation|1|||
44130264|NCT01369511|78916011|FG001|Overall Study|Physician Decision|4|||
44130265|NCT01369511|78916012|FG002|Overall Study|Physician Decision|0|||
44130266|NCT01369511|78916013|FG003|Overall Study|Physician Decision|0|||
44130267|NCT01369511|78916010|FG000|Overall Study|Sponsor decision|2|||
44130268|NCT01369511|78916011|FG001|Overall Study|Sponsor decision|0|||
44130269|NCT01369511|78916012|FG002|Overall Study|Sponsor decision|1|||
44130270|NCT01369511|78916013|FG003|Overall Study|Sponsor decision|0|||
44130271|NCT01369511|78916010|FG000|Overall Study|Withdrawal by Subject|5|||
44130272|NCT01369511|78916011|FG001|Overall Study|Withdrawal by Subject|6|||
44130273|NCT01369511|78916012|FG002|Overall Study|Withdrawal by Subject|4|||
44130274|NCT01369511|78916013|FG003|Overall Study|Withdrawal by Subject|6|||
44130275|NCT01369433|78916025|FG000|Overall Study|Adverse Event|31|||
44130276|NCT01369433|78916026|FG001|Overall Study|Adverse Event|1|||
44130277|NCT01369433|78916025|FG000|Overall Study|Required significant surgical procedure|1|||
44130278|NCT01369433|78916026|FG001|Overall Study|Required significant surgical procedure|0|||
44130279|NCT01369433|78916025|FG000|Overall Study|Non-compliance|1|||
44130280|NCT01369433|78916026|FG001|Overall Study|Non-compliance|0|||
44130281|NCT01369433|78916025|FG000|Overall Study|Withdrawal by Subject|5|||
44130282|NCT01369433|78916026|FG001|Overall Study|Withdrawal by Subject|2|||
44130283|NCT01369433|78916025|FG000|Overall Study|Study terminated by Sponsor|67|||
44130284|NCT01369433|78916026|FG001|Overall Study|Study terminated by Sponsor|0|||
44130285|NCT01369433|78916025|FG000|Overall Study|Lost to Follow-up|1|||
44130286|NCT01369433|78916026|FG001|Overall Study|Lost to Follow-up|0|||
44379562|NCT00770341|79385153|FG000|Overall Study|Clinical Adverse Event|3|||
44379563|NCT00770341|79385154|FG001|Overall Study|Clinical Adverse Event|1|||
44379564|NCT00770341|79385155|FG002|Overall Study|Clinical Adverse Event|2|||
44379565|NCT00770341|79385153|FG000|Overall Study|Laboratory adverse event|3|||
44379566|NCT00770341|79385154|FG001|Overall Study|Laboratory adverse event|3|||
44379567|NCT00770341|79385155|FG002|Overall Study|Laboratory adverse event|0|||
44130287|NCT01369433|78916025|FG000|Overall Study|Death|5|||
44130288|NCT01369433|78916026|FG001|Overall Study|Death|0|||
44130289|NCT01369433|78916025|FG000|Overall Study|Investigator discretion|6|||
44130290|NCT01369433|78916026|FG001|Overall Study|Investigator discretion|1|||
44130291|NCT01369433|78916025|FG000|Overall Study|Progressive Disease|92|||
44130292|NCT01369433|78916026|FG001|Overall Study|Progressive Disease|12|||
44130293|NCT02624492|78916035|FG000|Overall Study|Adverse Event|2|||
44130294|NCT02624492|78916036|FG001|Overall Study|Adverse Event|2|||
44130295|NCT02624492|78916037|FG002|Overall Study|Adverse Event|2|||
44130296|NCT02624492|78916035|FG000|Overall Study|Progressive disease|0|||
44243380|NCT01475461|79072780|FG002|Treatment Period|Protocol Violation|0|||
44243381|NCT01475461|79072781|FG003|Treatment Period|Protocol Violation|0|||
44243382|NCT01475461|79072782|FG004|Treatment Period|Protocol Violation|0|||
44243383|NCT01475461|79072783|FG005|Treatment Period|Protocol Violation|0|||
44243384|NCT01475461|79072784|FG006|Treatment Period|Protocol Violation|1|||
44243385|NCT01475461|79072778|FG000|Treatment Period|Lack of Efficacy|0|||
44243386|NCT01475461|79072779|FG001|Treatment Period|Lack of Efficacy|2|||
44243387|NCT01475461|79072780|FG002|Treatment Period|Lack of Efficacy|0|||
44243388|NCT01475461|79072781|FG003|Treatment Period|Lack of Efficacy|2|||
44243389|NCT01475461|79072782|FG004|Treatment Period|Lack of Efficacy|1|||
44512284|NCT03997409|79517927|FG002|Overall Study|Protocol Violation|0|||
44512285|NCT03997409|79517925|FG000|Overall Study|Withdrawal by Subject|3|||
44512286|NCT03997409|79517926|FG001|Overall Study|Withdrawal by Subject|0|||
44512287|NCT03997409|79517927|FG002|Overall Study|Withdrawal by Subject|0|||
44512288|NCT03997409|79517925|FG000|Overall Study|Lost to Follow-up|0|||
44512289|NCT03997409|79517926|FG001|Overall Study|Lost to Follow-up|0|||
44512290|NCT03997409|79517927|FG002|Overall Study|Lost to Follow-up|1|||
44379568|NCT00770341|79385153|FG000|Overall Study|Lack of Efficacy|3|||
44379569|NCT00770341|79385154|FG001|Overall Study|Lack of Efficacy|0|||
44379570|NCT00770341|79385155|FG002|Overall Study|Lack of Efficacy|1|||
44512291|NCT03946124|79517935|FG000|Overall Study|Withdrawal by Subject|19|||
44130297|NCT02624492|78916036|FG001|Overall Study|Progressive disease|2|||
44130298|NCT02624492|78916037|FG002|Overall Study|Progressive disease|3|||
44130299|NCT01975831|78916054|FG000|Overall Study|Adverse Event|1|||
44130300|NCT01975831|78916055|FG001|Overall Study|Adverse Event|2|||
44130301|NCT01975831|78916056|FG002|Overall Study|Adverse Event|2|||
44130302|NCT01975831|78916057|FG003|Overall Study|Adverse Event|0|||
44130303|NCT01975831|78916058|FG004|Overall Study|Adverse Event|1|||
44130304|NCT01975831|78916059|FG005|Overall Study|Adverse Event|1|||
44130305|NCT01975831|78916060|FG006|Overall Study|Adverse Event|3|||
44130306|NCT01975831|78916061|FG007|Overall Study|Adverse Event|4|||
44130307|NCT01975831|78916062|FG008|Overall Study|Adverse Event|1|||
44130308|NCT01975831|78916054|FG000|Overall Study|Death|1|||
44130309|NCT01975831|78916055|FG001|Overall Study|Death|1|||
44130310|NCT01975831|78916056|FG002|Overall Study|Death|0|||
44130311|NCT01975831|78916057|FG003|Overall Study|Death|0|||
44130312|NCT01975831|78916058|FG004|Overall Study|Death|1|||
44130313|NCT01975831|78916059|FG005|Overall Study|Death|0|||
44130314|NCT01975831|78916060|FG006|Overall Study|Death|1|||
44243390|NCT01475461|79072783|FG005|Treatment Period|Lack of Efficacy|1|||
44243391|NCT01475461|79072784|FG006|Treatment Period|Lack of Efficacy|0|||
44243392|NCT01475461|79072778|FG000|Treatment Period|Medication Error|0|||
44379571|NCT00770341|79385153|FG000|Overall Study|Other|1|||
44379572|NCT00770341|79385154|FG001|Overall Study|Other|0|||
44379573|NCT00770341|79385155|FG002|Overall Study|Other|0|||
44130315|NCT01975831|78916061|FG007|Overall Study|Death|0|||
44130316|NCT01975831|78916062|FG008|Overall Study|Death|0|||
44130317|NCT01975831|78916054|FG000|Overall Study|Progressive Disease|1|||
44130318|NCT01975831|78916055|FG001|Overall Study|Progressive Disease|3|||
44130319|NCT01975831|78916056|FG002|Overall Study|Progressive Disease|2|||
44130320|NCT01975831|78916057|FG003|Overall Study|Progressive Disease|4|||
44512292|NCT03812029|79517944|FG000|Overall Study|Protocol Violation|1|||
44243393|NCT01475461|79072779|FG001|Treatment Period|Medication Error|0|||
44512293|NCT03812029|79517945|FG001|Overall Study|Protocol Violation|0|||
44130321|NCT01975831|78916058|FG004|Overall Study|Progressive Disease|13|||
44130322|NCT01975831|78916059|FG005|Overall Study|Progressive Disease|9|||
44130323|NCT01975831|78916060|FG006|Overall Study|Progressive Disease|10|||
44130324|NCT01975831|78916061|FG007|Overall Study|Progressive Disease|8|||
44130325|NCT01975831|78916062|FG008|Overall Study|Progressive Disease|10|||
44130326|NCT01975831|78916054|FG000|Overall Study|Withdrawal by Subject|0|||
44130327|NCT01975831|78916055|FG001|Overall Study|Withdrawal by Subject|3|||
44130328|NCT01975831|78916056|FG002|Overall Study|Withdrawal by Subject|0|||
44130329|NCT01975831|78916057|FG003|Overall Study|Withdrawal by Subject|0|||
44130330|NCT01975831|78916058|FG004|Overall Study|Withdrawal by Subject|3|||
44130331|NCT01975831|78916059|FG005|Overall Study|Withdrawal by Subject|1|||
44130332|NCT01975831|78916060|FG006|Overall Study|Withdrawal by Subject|1|||
44130333|NCT01975831|78916061|FG007|Overall Study|Withdrawal by Subject|0|||
44130334|NCT01975831|78916062|FG008|Overall Study|Withdrawal by Subject|0|||
44130335|NCT01975831|78916054|FG000|Overall Study|Physician Decision|0|||
44130336|NCT01975831|78916055|FG001|Overall Study|Physician Decision|0|||
44130337|NCT01975831|78916056|FG002|Overall Study|Physician Decision|0|||
44130338|NCT01975831|78916057|FG003|Overall Study|Physician Decision|0|||
44130339|NCT01975831|78916058|FG004|Overall Study|Physician Decision|0|||
44130340|NCT01975831|78916059|FG005|Overall Study|Physician Decision|1|||
44130341|NCT01975831|78916060|FG006|Overall Study|Physician Decision|0|||
44130342|NCT01975831|78916061|FG007|Overall Study|Physician Decision|1|||
44130343|NCT01975831|78916062|FG008|Overall Study|Physician Decision|0|||
44130344|NCT01975831|78916054|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
44130345|NCT01975831|78916055|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
44130346|NCT01975831|78916056|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
44130347|NCT01975831|78916057|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
44130348|NCT01975831|78916058|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
44130349|NCT01975831|78916059|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
44130350|NCT01975831|78916060|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
44130351|NCT01975831|78916061|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
44130352|NCT01975831|78916062|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
44130353|NCT01975831|78916054|FG000|Overall Study|Entered Hospice|0|||
44130354|NCT01975831|78916055|FG001|Overall Study|Entered Hospice|0|||
44130355|NCT01975831|78916056|FG002|Overall Study|Entered Hospice|0|||
44130356|NCT01975831|78916057|FG003|Overall Study|Entered Hospice|0|||
44130357|NCT01975831|78916058|FG004|Overall Study|Entered Hospice|0|||
44130358|NCT01975831|78916059|FG005|Overall Study|Entered Hospice|1|||
44130359|NCT01975831|78916060|FG006|Overall Study|Entered Hospice|0|||
44130360|NCT01975831|78916061|FG007|Overall Study|Entered Hospice|0|||
44130361|NCT01975831|78916062|FG008|Overall Study|Entered Hospice|0|||
44130362|NCT01975831|78916054|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130363|NCT01975831|78916055|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130364|NCT01975831|78916056|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130365|NCT01975831|78916057|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130366|NCT01975831|78916058|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130367|NCT01975831|78916059|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130368|NCT01975831|78916060|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
44130369|NCT01975831|78916061|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
44130370|NCT01975831|78916062|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
44130371|NCT00700713|78916085|FG000|Overall Study|Protocol Violation|1|||
44130372|NCT00700713|78916086|FG001|Overall Study|Protocol Violation|0|||
44130373|NCT00700713|78916087|FG002|Overall Study|Protocol Violation|1|||
44130374|NCT00700713|78916085|FG000|Overall Study|Withdrawal by Subject|0|||
44130375|NCT00700713|78916086|FG001|Overall Study|Withdrawal by Subject|0|||
44130376|NCT00700713|78916087|FG002|Overall Study|Withdrawal by Subject|1|||
44130377|NCT02622386|78916095|FG000|First Assignment|Withdrawal by Subject|3|||
44130378|NCT02622386|78916096|FG001|First Assignment|Withdrawal by Subject|2|||
44130379|NCT02622386|78916095|FG000|Washout|Withdrawal by Subject|4|||
44130380|NCT02622386|78916096|FG001|Washout|Withdrawal by Subject|4|||
44130381|NCT02622386|78916095|FG000|Second Assignment|Withdrawal by Subject|0|||
44130382|NCT02622386|78916096|FG001|Second Assignment|Withdrawal by Subject|2|||
44130383|NCT02792231|78916104|FG000|Overall Study|Patient/guardian decision|32|||
44130384|NCT02792231|78916105|FG001|Overall Study|Patient/guardian decision|42|||
44130385|NCT02792231|78916104|FG000|Overall Study|Adverse Event|15|||
44130386|NCT02792231|78916105|FG001|Overall Study|Adverse Event|11|||
44130387|NCT02792231|78916104|FG000|Overall Study|Physician Decision|14|||
44130388|NCT02792231|78916105|FG001|Overall Study|Physician Decision|12|||
44130389|NCT02792231|78916104|FG000|Overall Study|Lack of Efficacy|7|||
44130390|NCT02792231|78916105|FG001|Overall Study|Lack of Efficacy|9|||
44130391|NCT02792231|78916104|FG000|Overall Study|Lost to Follow-up|9|||
44130392|NCT02792231|78916105|FG001|Overall Study|Lost to Follow-up|5|||
44130393|NCT02792231|78916104|FG000|Overall Study|Pregnancy|1|||
44130394|NCT02792231|78916105|FG001|Overall Study|Pregnancy|3|||
44130395|NCT02792231|78916104|FG000|Overall Study|Non-compliance with study treatment|2|||
44130396|NCT02792231|78916105|FG001|Overall Study|Non-compliance with study treatment|1|||
44130397|NCT02792231|78916104|FG000|Overall Study|Protocol deviation|2|||
44130398|NCT02792231|78916105|FG001|Overall Study|Protocol deviation|0|||
44130399|NCT02792231|78916104|FG000|Overall Study|Technical problems|0|||
44130400|NCT02792231|78916105|FG001|Overall Study|Technical problems|1|||
44130401|NCT00700401|78916111|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
44130402|NCT00700401|78916111|FG000|Overall Study|Adverse Event|5|||
44130403|NCT00700401|78916111|FG000|Overall Study|Refused Treatment|2|||
44130404|NCT00700401|78916111|FG000|Overall Study|Lost to Follow-up|1|||
44130405|NCT00700401|78916111|FG000|Overall Study|Treatment never started|1|||
44130406|NCT00700401|78916111|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
44130407|NCT00700401|78916111|FG000|Overall Study|Withdrawal by Subject|2|||
44130408|NCT02621606|78916118|FG000|Overall Study|Withdrawal by Subject|0|||
44130409|NCT02621606|78916119|FG001|Overall Study|Withdrawal by Subject|1|||
44130410|NCT02621606|78916120|FG002|Overall Study|Withdrawal by Subject|0|||
44130411|NCT02871401|78916130|FG000|Overall Study|Adverse Event|1|||
44130412|NCT02871401|78916131|FG001|Overall Study|Adverse Event|0|||
44130413|NCT02619812|78916141|FG000|Overall Study|Withdrawal by Subject|0|||
44130414|NCT02619812|78916142|FG001|Overall Study|Withdrawal by Subject|0|||
44130415|NCT02619812|78916143|FG002|Overall Study|Withdrawal by Subject|1|||
44243394|NCT01475461|79072780|FG002|Treatment Period|Medication Error|0|||
44243395|NCT01475461|79072781|FG003|Treatment Period|Medication Error|1|||
44379574|NCT00770341|79385153|FG000|Overall Study|Not treated|1|||
44130416|NCT02619812|78916144|FG003|Overall Study|Withdrawal by Subject|2|||
44130417|NCT02623322|78916157|FG000|Overall Study|Lost to Follow-up|2|||
44130418|NCT02623322|78916158|FG001|Overall Study|Lost to Follow-up|1|||
44130419|NCT02623322|78916159|FG002|Overall Study|Lost to Follow-up|0|||
44130420|NCT00105157|78916173|FG000|Double-Blind (DB)|Never Treated|1|||
44130421|NCT00105157|78916174|FG001|Double-Blind (DB)|Never Treated|0|||
44130422|NCT00105157|78916175|FG002|Double-Blind (DB)|Never Treated|0|||
44512294|NCT03812029|79517946|FG002|Overall Study|Protocol Violation|0|||
44130423|NCT00105157|78916176|FG003|Double-Blind (DB)|Never Treated|0|||
44130424|NCT00105157|78916173|FG000|Double-Blind (DB)|Adverse Event|2|||
44130425|NCT00105157|78916174|FG001|Double-Blind (DB)|Adverse Event|0|||
44130426|NCT00105157|78916175|FG002|Double-Blind (DB)|Adverse Event|1|||
44130427|NCT00105157|78916176|FG003|Double-Blind (DB)|Adverse Event|1|||
44130428|NCT00105157|78916173|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
44130429|NCT00105157|78916174|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
44130430|NCT00105157|78916175|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
44130431|NCT00105157|78916176|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
44130432|NCT00105157|78916173|FG000|Open-Label Continuation of DB|Adverse Event|3|||
44130433|NCT00105157|78916174|FG001|Open-Label Continuation of DB|Adverse Event|1|||
44130434|NCT00105157|78916175|FG002|Open-Label Continuation of DB|Adverse Event|0|||
44130435|NCT00105157|78916176|FG003|Open-Label Continuation of DB|Adverse Event|0|||
44130436|NCT00105157|78916173|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
44130437|NCT00105157|78916174|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
44130438|NCT00105157|78916175|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
44130439|NCT00105157|78916176|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
44130440|NCT00105157|78916173|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
44130441|NCT00105157|78916174|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
44130442|NCT00105157|78916175|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
44130443|NCT00105157|78916176|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
44130444|NCT00105157|78916173|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
44130445|NCT00105157|78916174|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
44130446|NCT00105157|78916175|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
44130447|NCT00105157|78916176|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
44130448|NCT00105157|78916173|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
44130449|NCT00105157|78916174|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
44130450|NCT00105157|78916175|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
44130451|NCT00105157|78916176|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
44130452|NCT00105157|78916173|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
44130453|NCT00105157|78916174|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
44130454|NCT00105157|78916175|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
44130455|NCT00105157|78916176|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
44130456|NCT00105157|78916173|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
44130457|NCT00105157|78916174|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
44130458|NCT00105157|78916175|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
44130459|NCT00105157|78916176|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
44130460|NCT00105157|78916173|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
44130461|NCT00105157|78916174|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
44130462|NCT00105157|78916175|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
44130463|NCT00105157|78916176|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
44130464|NCT00105157|78916173|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
44276543|NCT02173704|79231606|FG001|Overall Study|Withdrawal by Subject|4|||
44276544|NCT02173548|79231627|FG000|Overall Study|Lost to Follow-up|0|||
44276545|NCT02173548|79231628|FG001|Overall Study|Lost to Follow-up|2|||
44276546|NCT02173548|79231627|FG000|Overall Study|Withdrawal by Subject|1|||
44276547|NCT02173548|79231628|FG001|Overall Study|Withdrawal by Subject|0|||
44276548|NCT02173158|79231644|FG000|Efficacy Phase|Adverse Event|1|||
44276549|NCT02152566|79231666|FG000|Overall Study|Lost to Follow-up|1|||
44276550|NCT02152566|79231666|FG000|Overall Study|Withdrawal by Subject|2|||
44276551|NCT02171130|79231695|FG000|Overall Study|Death|1|||
44276552|NCT02171130|79231695|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
44512295|NCT03812029|79517947|FG003|Overall Study|Protocol Violation|1|||
44512296|NCT03812029|79517948|FG004|Overall Study|Protocol Violation|0|||
44512297|NCT03812029|79517944|FG000|Overall Study|Withdrawal by Subject|1|||
44512298|NCT03812029|79517945|FG001|Overall Study|Withdrawal by Subject|0|||
44512299|NCT03812029|79517946|FG002|Overall Study|Withdrawal by Subject|0|||
44512300|NCT03812029|79517947|FG003|Overall Study|Withdrawal by Subject|2|||
44512301|NCT03812029|79517948|FG004|Overall Study|Withdrawal by Subject|2|||
44512302|NCT03812029|79517944|FG000|Overall Study|Stopping rules|0|||
44512303|NCT03812029|79517945|FG001|Overall Study|Stopping rules|1|||
44512304|NCT03812029|79517946|FG002|Overall Study|Stopping rules|0|||
44512305|NCT03812029|79517947|FG003|Overall Study|Stopping rules|0|||
44512306|NCT03812029|79517948|FG004|Overall Study|Stopping rules|0|||
44512307|NCT03812029|79517944|FG000|Overall Study|Adverse Event|0|||
44512308|NCT03812029|79517945|FG001|Overall Study|Adverse Event|9|||
44512309|NCT03812029|79517946|FG002|Overall Study|Adverse Event|0|||
44512310|NCT03812029|79517947|FG003|Overall Study|Adverse Event|3|||
44130465|NCT00105157|78916174|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
44130466|NCT00105157|78916175|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
44243396|NCT01475461|79072782|FG004|Treatment Period|Medication Error|0|||
44512311|NCT03812029|79517948|FG004|Overall Study|Adverse Event|5|||
44512312|NCT03812029|79517944|FG000|Overall Study|Lost to Follow-up|0|||
44130467|NCT00105157|78916176|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
44243397|NCT01475461|79072783|FG005|Treatment Period|Medication Error|0|||
44243398|NCT01475461|79072784|FG006|Treatment Period|Medication Error|0|||
44243399|NCT01475461|79072778|FG000|Treatment Period|Adverse Event|0|||
44243400|NCT01475461|79072779|FG001|Treatment Period|Adverse Event|0|||
44243401|NCT01475461|79072780|FG002|Treatment Period|Adverse Event|0|||
44243402|NCT01475461|79072781|FG003|Treatment Period|Adverse Event|1|||
44243403|NCT01475461|79072782|FG004|Treatment Period|Adverse Event|0|||
44243404|NCT01475461|79072783|FG005|Treatment Period|Adverse Event|0|||
44243405|NCT01475461|79072784|FG006|Treatment Period|Adverse Event|0|||
44243406|NCT01589822|79072820|FG000|Overall Study|Withdrawal by Subject|1|||
44243407|NCT01589822|79072821|FG001|Overall Study|Withdrawal by Subject|2|||
44243408|NCT01589822|79072822|FG002|Overall Study|Withdrawal by Subject|0|||
44512313|NCT03812029|79517945|FG001|Overall Study|Lost to Follow-up|0|||
44512314|NCT03812029|79517946|FG002|Overall Study|Lost to Follow-up|0|||
44512315|NCT03812029|79517947|FG003|Overall Study|Lost to Follow-up|0|||
44512316|NCT03812029|79517948|FG004|Overall Study|Lost to Follow-up|3|||
44512317|NCT03747575|79517966|FG000|Overall Study|Withdrawal by Subject|6|||
44512318|NCT03747575|79517967|FG001|Overall Study|Withdrawal by Subject|3|||
44512319|NCT03747575|79517966|FG000|Overall Study|Lost to Follow-up|3|||
44512320|NCT03747575|79517967|FG001|Overall Study|Lost to Follow-up|3|||
44512321|NCT03747575|79517966|FG000|Overall Study|Adverse Event|0|||
44512322|NCT03747575|79517967|FG001|Overall Study|Adverse Event|1|||
44512323|NCT03657043|79517976|FG000|Overall Study|Withdrawal by Subject|1|||
44512324|NCT03657043|79517977|FG001|Overall Study|Withdrawal by Subject|1|||
44512325|NCT03657043|79517978|FG002|Overall Study|Withdrawal by Subject|0|||
44512326|NCT03657043|79517979|FG003|Overall Study|Withdrawal by Subject|0|||
44512327|NCT03657043|79517980|FG004|Overall Study|Withdrawal by Subject|4|||
44512328|NCT03657043|79517976|FG000|Overall Study|Study closure by Sponsor|0|||
44130468|NCT00105157|78916173|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
44243409|NCT01589822|79072820|FG000|Overall Study|Death|1|||
44512329|NCT03657043|79517977|FG001|Overall Study|Study closure by Sponsor|2|||
44243410|NCT01589822|79072821|FG001|Overall Study|Death|0|||
44512330|NCT03657043|79517978|FG002|Overall Study|Study closure by Sponsor|0|||
44243411|NCT01589822|79072822|FG002|Overall Study|Death|0|||
44243412|NCT01589822|79072820|FG000|Overall Study|Missed 90 day visit|2|||
44243413|NCT01589822|79072821|FG001|Overall Study|Missed 90 day visit|1|||
44130469|NCT00105157|78916174|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
44130470|NCT00105157|78916175|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
44130471|NCT00105157|78916176|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
44130472|NCT00105157|78916173|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
44130473|NCT00105157|78916174|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
44130474|NCT00105157|78916175|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
44130475|NCT00105157|78916176|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
44130476|NCT02148133|78916197|FG000|Overall Study|Investigator discretion|1|||
44130477|NCT02148133|78916197|FG000|Overall Study|Lack of Efficacy|1|||
44130478|NCT02148133|78916197|FG000|Overall Study|Protocol deviation|1|||
44130479|NCT02148133|78916197|FG000|Overall Study|Protocol-defined stopping criteria|2|||
44130480|NCT00803569|78916201|FG000|Overall Study|Progressive Disease|3|||
44130481|NCT00803569|78916201|FG000|Overall Study|Noncompliance|1|||
44130482|NCT00112957|78916205|FG000|Overall Study|Progressive disease|18|||
44130483|NCT00112957|78916205|FG000|Overall Study|Physician Decision|1|||
44130484|NCT02376790|78916212|FG000|Overall Study|Withdrawal by Subject|43|||
44130485|NCT02376790|78916213|FG001|Overall Study|Withdrawal by Subject|36|||
44130486|NCT02376790|78916214|FG002|Overall Study|Withdrawal by Subject|37|||
44130487|NCT02376790|78916212|FG000|Overall Study|Decision by Sponsor|2|||
44130488|NCT02376790|78916213|FG001|Overall Study|Decision by Sponsor|1|||
44130489|NCT02376790|78916214|FG002|Overall Study|Decision by Sponsor|4|||
44130490|NCT02376790|78916212|FG000|Overall Study|Lost to Follow-up|15|||
44130491|NCT02376790|78916213|FG001|Overall Study|Lost to Follow-up|10|||
44130492|NCT02376790|78916214|FG002|Overall Study|Lost to Follow-up|12|||
44130493|NCT02376166|78916222|FG000|Overall Study|Adverse Event|1|||
44130494|NCT02376166|78916222|FG000|Overall Study|Discontinued metformin early|2|||
44130495|NCT02311894|78916226|FG000|Overall Study|Discontinued in error|1|||
44130496|NCT02311894|78916226|FG000|Overall Study|Lost to Follow-up|1|||
44130497|NCT02311894|78916226|FG000|Overall Study|Adverse Event|1|||
44130498|NCT02311894|78916226|FG000|Overall Study|Withdrawal by Subject|1|||
44130499|NCT02310646|78916232|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
44130500|NCT02310646|78916233|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
44130501|NCT02310646|78916232|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
44130502|NCT02310646|78916233|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
44130503|NCT02375698|78916257|FG000|Overall Study|Withdrawal by Subject|0|||
44130504|NCT02375698|78916258|FG001|Overall Study|Withdrawal by Subject|2|||
44130505|NCT02375698|78916257|FG000|Overall Study|Physician Decision|2|||
44130506|NCT02375698|78916258|FG001|Overall Study|Physician Decision|0|||
44130507|NCT02374918|78916268|FG000|Overall Study|Protocol Violation|2|||
44130508|NCT02374918|78916269|FG001|Overall Study|Protocol Violation|0|||
44512331|NCT03657043|79517979|FG003|Overall Study|Study closure by Sponsor|0|||
44512332|NCT03657043|79517980|FG004|Overall Study|Study closure by Sponsor|17|||
44512333|NCT03657043|79517976|FG000|Overall Study|Lost to Follow-up|0|||
44512334|NCT03657043|79517977|FG001|Overall Study|Lost to Follow-up|0|||
44512335|NCT03657043|79517978|FG002|Overall Study|Lost to Follow-up|0|||
44512336|NCT03657043|79517979|FG003|Overall Study|Lost to Follow-up|0|||
44130509|NCT02374918|78916270|FG002|Overall Study|Protocol Violation|2|||
44130510|NCT02374918|78916271|FG003|Overall Study|Protocol Violation|1|||
44130511|NCT02374918|78916268|FG000|Overall Study|Withdrawal by Subject|1|||
44130512|NCT02374918|78916269|FG001|Overall Study|Withdrawal by Subject|1|||
44130513|NCT02374918|78916270|FG002|Overall Study|Withdrawal by Subject|1|||
44130514|NCT02374918|78916271|FG003|Overall Study|Withdrawal by Subject|0|||
44130515|NCT02374918|78916268|FG000|Overall Study|Lack of Efficacy|0|||
44130516|NCT02374918|78916269|FG001|Overall Study|Lack of Efficacy|0|||
44379575|NCT00770341|79385154|FG001|Overall Study|Not treated|0|||
44379576|NCT00770341|79385155|FG002|Overall Study|Not treated|0|||
44379577|NCT00762463|79385172|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
44130517|NCT02374918|78916270|FG002|Overall Study|Lack of Efficacy|1|||
44512337|NCT03657043|79517980|FG004|Overall Study|Lost to Follow-up|4|||
44130518|NCT02374918|78916271|FG003|Overall Study|Lack of Efficacy|1|||
44130519|NCT02344576|78916283|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
44130520|NCT02344576|78916284|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
44130521|NCT02344576|78916285|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
44512338|NCT03657043|79517976|FG000|Overall Study|Death|6|||
44512339|NCT03657043|79517977|FG001|Overall Study|Death|5|||
44512340|NCT03657043|79517978|FG002|Overall Study|Death|0|||
44512341|NCT03657043|79517979|FG003|Overall Study|Death|0|||
44379578|NCT00762463|79385173|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
44379579|NCT00762463|79385174|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
44379580|NCT00762463|79385175|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
44379581|NCT00762463|79385172|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
44379582|NCT00762463|79385173|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
44379583|NCT00762463|79385174|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
44379584|NCT00762463|79385175|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
44379585|NCT00762463|79385172|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
44379586|NCT00762463|79385173|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
44130522|NCT02344576|78916286|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
44379587|NCT00762463|79385174|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
44379588|NCT00762463|79385175|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
44379589|NCT00762463|79385172|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
44379590|NCT00762463|79385173|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
44379591|NCT00762463|79385174|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
44379592|NCT00762463|79385175|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
44379593|NCT00762463|79385172|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
44379594|NCT00762463|79385173|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
44379595|NCT00762463|79385174|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
44379596|NCT00762463|79385175|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
44379597|NCT00762463|79385172|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
44379598|NCT00762463|79385173|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
44379599|NCT00762463|79385174|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
44379600|NCT00762463|79385175|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
44379601|NCT00762463|79385172|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
44379602|NCT00762463|79385173|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
44379603|NCT00762463|79385174|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
44379604|NCT00762463|79385175|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
44512342|NCT03657043|79517980|FG004|Overall Study|Death|53|||
44512343|NCT03657043|79517976|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
44130523|NCT02344576|78916283|FG000|1-Month Follow-Up|Death|13|||
44130524|NCT02344576|78916284|FG001|1-Month Follow-Up|Death|8|||
44130525|NCT02344576|78916285|FG002|1-Month Follow-Up|Death|0|||
44130526|NCT02344576|78916286|FG003|1-Month Follow-Up|Death|0|||
44130527|NCT02344576|78916283|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
44130528|NCT02344576|78916284|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
44130529|NCT02344576|78916285|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
44130530|NCT02344576|78916286|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
44130531|NCT02344576|78916283|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
44130532|NCT02344576|78916284|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
44130533|NCT02344576|78916285|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
44130534|NCT02344576|78916286|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
44130535|NCT02344576|78916283|FG000|6-Month Follow-Up|Death|14|||
44130536|NCT02344576|78916284|FG001|6-Month Follow-Up|Death|14|||
44130537|NCT02344576|78916285|FG002|6-Month Follow-Up|Death|0|||
44130538|NCT02344576|78916286|FG003|6-Month Follow-Up|Death|0|||
44130539|NCT02344576|78916283|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
44130540|NCT02344576|78916284|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
44130541|NCT02344576|78916285|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
44512344|NCT03657043|79517977|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
44512345|NCT03657043|79517978|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
44512346|NCT03657043|79517979|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
44512347|NCT03657043|79517980|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
44512348|NCT03657043|79517976|FG000|Overall Study|Adverse Event|0|||
44512349|NCT03657043|79517977|FG001|Overall Study|Adverse Event|0|||
44512350|NCT03657043|79517978|FG002|Overall Study|Adverse Event|0|||
44512351|NCT03657043|79517979|FG003|Overall Study|Adverse Event|0|||
44512352|NCT03657043|79517980|FG004|Overall Study|Adverse Event|2|||
44130542|NCT02344576|78916286|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
44130543|NCT02344576|78916283|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
44130544|NCT02344576|78916284|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
44130545|NCT02344576|78916285|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
44130546|NCT02344576|78916286|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
44130547|NCT02344342|78916302|FG000|Overall Study|Industry partner dropped out|11|||
44130548|NCT02344342|78916303|FG001|Overall Study|Industry partner dropped out|9|||
44130549|NCT02344342|78916304|FG002|Overall Study|Industry partner dropped out|14|||
44512353|NCT03657043|79517976|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
44130550|NCT02344342|78916305|FG003|Overall Study|Industry partner dropped out|10|||
44130551|NCT02310568|78916324|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
44130552|NCT02310568|78916325|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
44130553|NCT02310568|78916326|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
44130554|NCT02310568|78916327|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
44130555|NCT02310568|78916328|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
44130556|NCT02310568|78916324|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
44130557|NCT02310568|78916325|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
44130558|NCT02310568|78916326|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
44130559|NCT02310568|78916327|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
44130560|NCT02310568|78916328|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
44130561|NCT02310568|78916324|FG000|Stage 1 ( 4 Weeks)|Other|1|||
44130562|NCT02310568|78916325|FG001|Stage 1 ( 4 Weeks)|Other|1|||
44130563|NCT02310568|78916326|FG002|Stage 1 ( 4 Weeks)|Other|0|||
44130564|NCT02310568|78916327|FG003|Stage 1 ( 4 Weeks)|Other|0|||
44130565|NCT02310568|78916328|FG004|Stage 1 ( 4 Weeks)|Other|0|||
44130566|NCT02310568|78916324|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
44130567|NCT02310568|78916325|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
44130568|NCT02310568|78916326|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
44130569|NCT02310568|78916327|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
44130570|NCT02310568|78916328|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
44130571|NCT02310568|78916324|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
44130572|NCT02310568|78916325|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
44130573|NCT02310568|78916326|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
44130574|NCT02310568|78916327|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
44130575|NCT02310568|78916328|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
44130576|NCT02310568|78916324|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
44130577|NCT02310568|78916325|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
44130578|NCT02310568|78916326|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
44130579|NCT02310568|78916327|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
44130580|NCT02310568|78916328|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
44130581|NCT02310568|78916324|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
44130582|NCT02310568|78916325|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
44130583|NCT02310568|78916326|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
44130584|NCT02310568|78916327|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
44130585|NCT02310568|78916328|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
44130586|NCT02310568|78916324|FG000|Stage 2 (4 Weeks)|Other|0|||
44130587|NCT02310568|78916325|FG001|Stage 2 (4 Weeks)|Other|1|||
44130588|NCT02310568|78916326|FG002|Stage 2 (4 Weeks)|Other|1|||
44130589|NCT02310568|78916327|FG003|Stage 2 (4 Weeks)|Other|0|||
44130590|NCT02310568|78916328|FG004|Stage 2 (4 Weeks)|Other|0|||
44130591|NCT02310568|78916324|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
44130592|NCT02310568|78916325|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
44130593|NCT02310568|78916326|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
44130594|NCT02310568|78916327|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
44130595|NCT02310568|78916328|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
44130596|NCT02310568|78916324|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
44130597|NCT02310568|78916325|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
44130598|NCT02310568|78916326|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
44243414|NCT01589822|79072822|FG002|Overall Study|Missed 90 day visit|1|||
44243415|NCT01565642|79072834|FG000|Overall Study|Withdrawal by Subject|2|||
44243416|NCT01565642|79072835|FG001|Overall Study|Withdrawal by Subject|1|||
44512354|NCT03657043|79517977|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
44512355|NCT03657043|79517978|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
44512356|NCT03657043|79517979|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
44512357|NCT03657043|79517980|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
44512358|NCT03657043|79517976|FG000|Overall Study|Withdrawal - declined follow-up|0|||
44379605|NCT00762463|79385172|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
44379606|NCT00762463|79385173|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
44512359|NCT03657043|79517977|FG001|Overall Study|Withdrawal - declined follow-up|0|||
44130599|NCT02310568|78916327|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
44130600|NCT02310568|78916328|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
44130601|NCT02310568|78916324|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
44130602|NCT02310568|78916325|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
44130603|NCT02310568|78916326|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
44130604|NCT02310568|78916327|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
44130605|NCT02310568|78916328|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
44130606|NCT02310100|78916346|FG000|Overall Study|Physician Decision|3|||
44130607|NCT02310100|78916346|FG000|Overall Study|Withdrawal by Subject|10|||
44130608|NCT02310100|78916346|FG000|Overall Study|Enrollment closure|1|||
44130609|NCT02310100|78916346|FG000|Overall Study|Unapproved ablation operator|1|||
44130610|NCT02310100|78916346|FG000|Overall Study|Visit compliance|1|||
44512360|NCT03657043|79517978|FG002|Overall Study|Withdrawal - declined follow-up|0|||
44512361|NCT03657043|79517979|FG003|Overall Study|Withdrawal - declined follow-up|0|||
44130611|NCT02310100|78916346|FG000|Overall Study|Lost to Follow-up|2|||
44130612|NCT02780167|78916356|FG000|Overall Study|Adverse Event|9|||
44130613|NCT02780167|78916357|FG001|Overall Study|Adverse Event|8|||
44130614|NCT02780167|78916358|FG002|Overall Study|Adverse Event|8|||
44130615|NCT02780167|78916359|FG003|Overall Study|Adverse Event|12|||
44130616|NCT02780167|78916360|FG004|Overall Study|Adverse Event|8|||
44130617|NCT02780167|78916356|FG000|Overall Study|Lack of Efficacy|6|||
44130618|NCT02780167|78916357|FG001|Overall Study|Lack of Efficacy|5|||
44130619|NCT02780167|78916358|FG002|Overall Study|Lack of Efficacy|6|||
44130620|NCT02780167|78916359|FG003|Overall Study|Lack of Efficacy|1|||
44130621|NCT02780167|78916360|FG004|Overall Study|Lack of Efficacy|0|||
44130622|NCT02780167|78916356|FG000|Overall Study|Lost to Follow-up|2|||
44130623|NCT02780167|78916357|FG001|Overall Study|Lost to Follow-up|0|||
44130624|NCT02780167|78916358|FG002|Overall Study|Lost to Follow-up|1|||
44130625|NCT02780167|78916359|FG003|Overall Study|Lost to Follow-up|0|||
44130626|NCT02780167|78916360|FG004|Overall Study|Lost to Follow-up|0|||
44130627|NCT02780167|78916356|FG000|Overall Study|Does not meet entrance criteria|0|||
44130628|NCT02780167|78916357|FG001|Overall Study|Does not meet entrance criteria|0|||
44130629|NCT02780167|78916358|FG002|Overall Study|Does not meet entrance criteria|1|||
44130630|NCT02780167|78916359|FG003|Overall Study|Does not meet entrance criteria|0|||
44130631|NCT02780167|78916360|FG004|Overall Study|Does not meet entrance criteria|0|||
44130632|NCT02780167|78916356|FG000|Overall Study|No longer meets eligibility criteria|0|||
44130633|NCT02780167|78916357|FG001|Overall Study|No longer meets eligibility criteria|0|||
44130634|NCT02780167|78916358|FG002|Overall Study|No longer meets eligibility criteria|0|||
44130635|NCT02780167|78916359|FG003|Overall Study|No longer meets eligibility criteria|1|||
44130636|NCT02780167|78916360|FG004|Overall Study|No longer meets eligibility criteria|1|||
44130637|NCT02780167|78916356|FG000|Overall Study|Protocol Violation|5|||
44130638|NCT02780167|78916357|FG001|Overall Study|Protocol Violation|5|||
44130639|NCT02780167|78916358|FG002|Overall Study|Protocol Violation|1|||
44130640|NCT02780167|78916359|FG003|Overall Study|Protocol Violation|1|||
44130641|NCT02780167|78916360|FG004|Overall Study|Protocol Violation|2|||
44130642|NCT02780167|78916356|FG000|Overall Study|Withdrawal by Subject|6|||
44130643|NCT02780167|78916357|FG001|Overall Study|Withdrawal by Subject|4|||
44130644|NCT02780167|78916358|FG002|Overall Study|Withdrawal by Subject|4|||
44130645|NCT02780167|78916359|FG003|Overall Study|Withdrawal by Subject|3|||
44130646|NCT02780167|78916360|FG004|Overall Study|Withdrawal by Subject|4|||
44130647|NCT02780167|78916356|FG000|Overall Study|Other|0|||
44130648|NCT02780167|78916357|FG001|Overall Study|Other|0|||
44130649|NCT02780167|78916358|FG002|Overall Study|Other|3|||
44130650|NCT02780167|78916359|FG003|Overall Study|Other|1|||
44130651|NCT02780167|78916360|FG004|Overall Study|Other|2|||
44130652|NCT02779075|78916372|FG000|Overall Study|Withdrawal by Subject|1|||
44130653|NCT02779075|78916373|FG001|Overall Study|Withdrawal by Subject|3|||
44130654|NCT02779075|78916372|FG000|Overall Study|IV lost during 2nd study|1|||
44130655|NCT02779075|78916373|FG001|Overall Study|IV lost during 2nd study|0|||
44130656|NCT00105079|78916385|FG000|Overall Study|Adverse Event|5|||
44512362|NCT03657043|79517980|FG004|Overall Study|Withdrawal - declined follow-up|1|||
44512363|NCT03646669|79517990|FG000|Overall Study|Withdrawal by Subject|5|||
44512364|NCT03646669|79517991|FG001|Overall Study|Withdrawal by Subject|0|||
44512365|NCT03619876|79517999|FG000|Overall Study|Withdrawal by Subject|1|||
44512366|NCT03619876|79518000|FG001|Overall Study|Withdrawal by Subject|2|||
44512367|NCT03619876|79517999|FG000|Overall Study|Withdrawal due to incidental finding|0|||
44512368|NCT03619876|79518000|FG001|Overall Study|Withdrawal due to incidental finding|2|||
44512369|NCT03526861|79518022|FG000|Initial Treatment Period|Not dosed|1|||
44512370|NCT03526861|79518023|FG001|Initial Treatment Period|Not dosed|1|||
44512371|NCT03526861|79518024|FG002|Initial Treatment Period|Not dosed|1|||
44512372|NCT03526861|79518025|FG003|Initial Treatment Period|Not dosed|0|||
44512373|NCT03526861|79518026|FG004|Initial Treatment Period|Not dosed|0|||
44512374|NCT03526861|79518027|FG005|Initial Treatment Period|Not dosed|0|||
44512375|NCT03526861|79518028|FG006|Initial Treatment Period|Not dosed|0|||
44130657|NCT00105079|78916386|FG001|Overall Study|Adverse Event|12|||
44130658|NCT00105079|78916385|FG000|Overall Study|Death|3|||
44130659|NCT00105079|78916386|FG001|Overall Study|Death|1|||
44130660|NCT00105079|78916385|FG000|Overall Study|Lost to Follow-up|12|||
44130661|NCT00105079|78916386|FG001|Overall Study|Lost to Follow-up|12|||
44130662|NCT00105079|78916385|FG000|Overall Study|Lack of Efficacy|9|||
44243417|NCT01475071|79072841|FG000|Overall Study|Physician Decision|1|||
44130663|NCT00105079|78916386|FG001|Overall Study|Lack of Efficacy|3|||
44130664|NCT00105079|78916385|FG000|Overall Study|Refused treatment|6|||
44130665|NCT00105079|78916386|FG001|Overall Study|Refused treatment|4|||
44130666|NCT00105079|78916385|FG000|Overall Study|Violation of selection criteria at entry|0|||
44130667|NCT00105079|78916386|FG001|Overall Study|Violation of selection criteria at entry|2|||
44130668|NCT00105079|78916385|FG000|Overall Study|Protocol Violation|1|||
44130669|NCT00105079|78916386|FG001|Overall Study|Protocol Violation|0|||
44130670|NCT00105079|78916385|FG000|Overall Study|Other|3|||
44130671|NCT00105079|78916386|FG001|Overall Study|Other|1|||
44130672|NCT02777827|78916392|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
44130673|NCT02777827|78916393|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
44130674|NCT02777827|78916394|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
44130675|NCT02777827|78916395|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
44130676|NCT02777827|78916396|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
44130677|NCT02777827|78916397|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
44130678|NCT02712333|78916413|FG000|First Period|Withdrawal by Subject|3|||
44130679|NCT02712333|78916414|FG001|First Period|Withdrawal by Subject|2|||
44130680|NCT02343406|78916430|FG000|Overall Study|Progressive disease|72|||
44130681|NCT02343406|78916431|FG001|Overall Study|Progressive disease|70|||
44130682|NCT02343406|78916432|FG002|Overall Study|Progressive disease|43|||
44130683|NCT02343406|78916433|FG003|Overall Study|Progressive disease|15|||
44130684|NCT02343406|78916434|FG004|Overall Study|Progressive disease|5|||
44130685|NCT02343406|78916430|FG000|Overall Study|Adverse Event|6|||
44130686|NCT02343406|78916431|FG001|Overall Study|Adverse Event|8|||
44130687|NCT02343406|78916432|FG002|Overall Study|Adverse Event|6|||
44130688|NCT02343406|78916433|FG003|Overall Study|Adverse Event|3|||
44130689|NCT02343406|78916434|FG004|Overall Study|Adverse Event|0|||
44130690|NCT02343406|78916430|FG000|Overall Study|Withdrawal by Subject|6|||
44130691|NCT02343406|78916431|FG001|Overall Study|Withdrawal by Subject|4|||
44130692|NCT02343406|78916432|FG002|Overall Study|Withdrawal by Subject|8|||
44130693|NCT02343406|78916433|FG003|Overall Study|Withdrawal by Subject|3|||
44130694|NCT02343406|78916434|FG004|Overall Study|Withdrawal by Subject|0|||
44130695|NCT02343406|78916430|FG000|Overall Study|Death|2|||
44130696|NCT02343406|78916431|FG001|Overall Study|Death|1|||
44130697|NCT02343406|78916432|FG002|Overall Study|Death|0|||
44130698|NCT02343406|78916433|FG003|Overall Study|Death|0|||
44130699|NCT02343406|78916434|FG004|Overall Study|Death|0|||
44130700|NCT02343406|78916430|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
44130701|NCT02343406|78916431|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
44130702|NCT02343406|78916432|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
44130703|NCT02343406|78916433|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
44130704|NCT02343406|78916434|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
44130705|NCT02343406|78916430|FG000|Overall Study|Other primary malignancy|0|||
44130706|NCT02343406|78916431|FG001|Overall Study|Other primary malignancy|1|||
44130707|NCT02343406|78916432|FG002|Overall Study|Other primary malignancy|0|||
44130708|NCT02343406|78916433|FG003|Overall Study|Other primary malignancy|0|||
44130709|NCT02343406|78916434|FG004|Overall Study|Other primary malignancy|0|||
44130710|NCT02343406|78916430|FG000|Overall Study|Other, not specified|2|||
44130711|NCT02343406|78916431|FG001|Overall Study|Other, not specified|1|||
44130712|NCT02343406|78916432|FG002|Overall Study|Other, not specified|1|||
44130713|NCT02343406|78916433|FG003|Overall Study|Other, not specified|4|||
44130714|NCT02343406|78916434|FG004|Overall Study|Other, not specified|0|||
44130715|NCT02710071|78916447|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
44130716|NCT02710071|78916448|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
44130717|NCT02710071|78916447|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
44130718|NCT02710071|78916448|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
44243418|NCT01475071|79072841|FG000|Overall Study|Withdrawal by Subject|6|||
44243419|NCT01475071|79072841|FG000|Overall Study|Lost to Follow-up|1|||
44130719|NCT02373202|78916459|FG000|Overall Study|Adverse Event|2|||
44243420|NCT01474993|79072849|FG000|Overall Study|Lost to Follow-up|1|||
44243421|NCT01474993|79072850|FG001|Overall Study|Lost to Follow-up|2|||
44243422|NCT01474993|79072849|FG000|Overall Study|Adverse Event|0|||
44243423|NCT01474993|79072850|FG001|Overall Study|Adverse Event|1|||
44243424|NCT01691768|79072860|FG000|Overall Study|Death|0|||
44512376|NCT03526861|79518029|FG007|Initial Treatment Period|Not dosed|0|||
44512377|NCT03526861|79518030|FG008|Initial Treatment Period|Not dosed|0|||
44512378|NCT03526861|79518022|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
44512379|NCT03526861|79518023|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
44512380|NCT03526861|79518024|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
44512381|NCT03526861|79518025|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512382|NCT03526861|79518026|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44243425|NCT01691768|79072861|FG001|Overall Study|Death|2|||
44130720|NCT02373202|78916460|FG001|Overall Study|Adverse Event|5|||
44130721|NCT02373202|78916461|FG002|Overall Study|Adverse Event|2|||
44130722|NCT02373202|78916462|FG003|Overall Study|Adverse Event|1|||
44130723|NCT02373202|78916459|FG000|Overall Study|Lack of Efficacy|0|||
44130724|NCT02373202|78916460|FG001|Overall Study|Lack of Efficacy|0|||
44130725|NCT02373202|78916461|FG002|Overall Study|Lack of Efficacy|1|||
44130726|NCT02373202|78916462|FG003|Overall Study|Lack of Efficacy|0|||
44243426|NCT01691768|79072860|FG000|Overall Study|Lost to Follow-up|4|||
44243427|NCT01691768|79072861|FG001|Overall Study|Lost to Follow-up|3|||
44130727|NCT02373202|78916459|FG000|Overall Study|Other|0|||
44130728|NCT02373202|78916460|FG001|Overall Study|Other|1|||
44130729|NCT02373202|78916461|FG002|Overall Study|Other|0|||
44130730|NCT02373202|78916462|FG003|Overall Study|Other|0|||
44130731|NCT02622074|78916478|FG000|Overall Study|Death|4|||
44130732|NCT02622074|78916479|FG001|Overall Study|Death|0|||
44130733|NCT02622074|78916480|FG002|Overall Study|Death|0|||
44130734|NCT02622074|78916481|FG003|Overall Study|Death|1|||
44130735|NCT02622074|78916482|FG004|Overall Study|Death|1|||
44130736|NCT02622074|78916483|FG005|Overall Study|Death|0|||
44130737|NCT02622074|78916478|FG000|Overall Study|Withdrawal by Subject|0|||
44130738|NCT02622074|78916479|FG001|Overall Study|Withdrawal by Subject|1|||
44130739|NCT02622074|78916480|FG002|Overall Study|Withdrawal by Subject|0|||
44130740|NCT02622074|78916481|FG003|Overall Study|Withdrawal by Subject|0|||
44130741|NCT02622074|78916482|FG004|Overall Study|Withdrawal by Subject|0|||
44130742|NCT02622074|78916483|FG005|Overall Study|Withdrawal by Subject|0|||
44130743|NCT02308696|78916499|FG000|Overall Study|Lost to Follow-up|28|||
44130744|NCT02308696|78916500|FG001|Overall Study|Lost to Follow-up|21|||
44130745|NCT02308696|78916499|FG000|Overall Study|Death|8|||
44130746|NCT02308696|78916500|FG001|Overall Study|Death|4|||
44130747|NCT02308696|78916499|FG000|Overall Study|Moved to a Higher Level of Care|17|||
44130748|NCT02308696|78916500|FG001|Overall Study|Moved to a Higher Level of Care|6|||
44130749|NCT02342704|78916508|FG000|Overall Study|Physician Decision|0|||
44130750|NCT02342704|78916509|FG001|Overall Study|Physician Decision|3|||
44130751|NCT02342704|78916508|FG000|Overall Study|Sponsor Termination|49|||
44130752|NCT02342704|78916509|FG001|Overall Study|Sponsor Termination|43|||
44130753|NCT02342704|78916508|FG000|Overall Study|Other|0|||
44130754|NCT02342704|78916509|FG001|Overall Study|Other|1|||
44130755|NCT02342704|78916508|FG000|Overall Study|Withdrawal by Subject|1|||
44130756|NCT02342704|78916509|FG001|Overall Study|Withdrawal by Subject|0|||
44130757|NCT02342704|78916508|FG000|Overall Study|Lost to Follow-up|2|||
44130758|NCT02342704|78916509|FG001|Overall Study|Lost to Follow-up|1|||
44130759|NCT02342704|78916508|FG000|Overall Study|Adverse Event|1|||
44130760|NCT02342704|78916509|FG001|Overall Study|Adverse Event|3|||
44130761|NCT02342548|78916518|FG000|Overall Study|Adverse Event|12|||
44130762|NCT02342548|78916519|FG001|Overall Study|Adverse Event|17|||
44130763|NCT02342548|78916520|FG002|Overall Study|Adverse Event|13|||
44130764|NCT02342548|78916518|FG000|Overall Study|Lost to Follow-up|0|||
44130765|NCT02342548|78916519|FG001|Overall Study|Lost to Follow-up|1|||
44130766|NCT02342548|78916520|FG002|Overall Study|Lost to Follow-up|0|||
44130767|NCT02342548|78916518|FG000|Overall Study|Study terminated by sponsor|20|||
44130768|NCT02342548|78916519|FG001|Overall Study|Study terminated by sponsor|39|||
44130769|NCT02342548|78916520|FG002|Overall Study|Study terminated by sponsor|25|||
44243428|NCT01691768|79072860|FG000|Overall Study|Withdrawal by Subject|10|||
44243429|NCT01691768|79072861|FG001|Overall Study|Withdrawal by Subject|9|||
44243430|NCT01691768|79072860|FG000|Overall Study|Relocated|0|||
44243431|NCT01691768|79072861|FG001|Overall Study|Relocated|1|||
44243432|NCT01691768|79072860|FG000|Overall Study|Investigator decision|1|||
44243433|NCT01691768|79072861|FG001|Overall Study|Investigator decision|1|||
44243434|NCT01503229|79072868|FG000|Overall Study|Withdrew consent|1|||
44243435|NCT01691612|79072872|FG000|Overall Study|deemed ineligible after 1st visit|6|||
44243436|NCT01691612|79072872|FG000|Overall Study|Adverse Event|1|||
44243437|NCT01565564|79072878|FG000|Overall Study|Lost to Follow-up|5|||
44243438|NCT01565564|79072879|FG001|Overall Study|Lost to Follow-up|1|||
44243439|NCT01460407|79072885|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
44243440|NCT01460407|79072886|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
44243441|NCT01502371|79072898|FG000|Overall Study|Withdrawal by Subject|1|||
44243442|NCT01502371|79072899|FG001|Overall Study|Withdrawal by Subject|2|||
44243443|NCT01502371|79072900|FG002|Overall Study|Withdrawal by Subject|1|||
44243444|NCT01502371|79072901|FG003|Overall Study|Withdrawal by Subject|1|||
44243445|NCT01502371|79072902|FG004|Overall Study|Withdrawal by Subject|1|||
44243446|NCT01502371|79072898|FG000|Overall Study|Adverse Event|2|||
44243447|NCT01502371|79072899|FG001|Overall Study|Adverse Event|1|||
44243448|NCT01502371|79072900|FG002|Overall Study|Adverse Event|0|||
44514955|NCT02865850|79520850|FG000|Overall Study|Withdrawal by Subject|3|||
44243449|NCT01502371|79072901|FG003|Overall Study|Adverse Event|4|||
44243450|NCT01502371|79072902|FG004|Overall Study|Adverse Event|3|||
44243451|NCT01502371|79072898|FG000|Overall Study|Treatment Failure|22|||
44243452|NCT01502371|79072899|FG001|Overall Study|Treatment Failure|20|||
44243453|NCT01502371|79072900|FG002|Overall Study|Treatment Failure|12|||
44130770|NCT02342548|78916518|FG000|Overall Study|Protocol Violation|0|||
44130771|NCT02342548|78916519|FG001|Overall Study|Protocol Violation|1|||
44130772|NCT02342548|78916520|FG002|Overall Study|Protocol Violation|0|||
44130773|NCT02342548|78916518|FG000|Overall Study|Withdrawal by Subject|1|||
44130774|NCT02342548|78916519|FG001|Overall Study|Withdrawal by Subject|3|||
44130775|NCT02342548|78916520|FG002|Overall Study|Withdrawal by Subject|4|||
44243454|NCT01502371|79072901|FG003|Overall Study|Treatment Failure|19|||
44243455|NCT01502371|79072902|FG004|Overall Study|Treatment Failure|30|||
44243456|NCT01502371|79072898|FG000|Overall Study|Lack of Efficacy|3|||
44243457|NCT01502371|79072899|FG001|Overall Study|Lack of Efficacy|3|||
44130776|NCT02342548|78916518|FG000|Overall Study|Other|1|||
44130777|NCT02342548|78916519|FG001|Overall Study|Other|1|||
44130778|NCT02342548|78916520|FG002|Overall Study|Other|1|||
44130779|NCT03142191|78916533|FG000|Placebo Controlled Period|Death|0|||
44130780|NCT03142191|78916534|FG001|Placebo Controlled Period|Death|1|||
44130781|NCT03142191|78916535|FG002|Placebo Controlled Period|Death|1|||
44130782|NCT03142191|78916536|FG003|Placebo Controlled Period|Death|0|||
44130783|NCT03142191|78916537|FG004|Placebo Controlled Period|Death|0|||
44130784|NCT03142191|78916533|FG000|Placebo Controlled Period|Adverse Event|4|||
44130785|NCT03142191|78916534|FG001|Placebo Controlled Period|Adverse Event|5|||
44130786|NCT03142191|78916535|FG002|Placebo Controlled Period|Adverse Event|1|||
44130787|NCT03142191|78916536|FG003|Placebo Controlled Period|Adverse Event|0|||
44130788|NCT03142191|78916537|FG004|Placebo Controlled Period|Adverse Event|0|||
44130789|NCT03142191|78916533|FG000|Placebo Controlled Period|Progressive Disease|1|||
44130790|NCT03142191|78916534|FG001|Placebo Controlled Period|Progressive Disease|0|||
44130791|NCT03142191|78916535|FG002|Placebo Controlled Period|Progressive Disease|1|||
44130792|NCT03142191|78916536|FG003|Placebo Controlled Period|Progressive Disease|0|||
44130793|NCT03142191|78916537|FG004|Placebo Controlled Period|Progressive Disease|0|||
44130794|NCT03142191|78916533|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
44130795|NCT03142191|78916534|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
44130796|NCT03142191|78916535|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
44130797|NCT03142191|78916536|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
44130798|NCT03142191|78916537|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
44243458|NCT01502371|79072900|FG002|Overall Study|Lack of Efficacy|2|||
44512383|NCT03526861|79518027|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512384|NCT03526861|79518028|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512385|NCT03526861|79518029|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512386|NCT03526861|79518030|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512387|NCT03526861|79518022|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
44512388|NCT03526861|79518023|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
44512389|NCT03526861|79518024|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
44512390|NCT03526861|79518025|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
44512391|NCT03526861|79518026|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
44512392|NCT03526861|79518027|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
44512393|NCT03526861|79518028|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
44512394|NCT03526861|79518029|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
44512395|NCT03526861|79518030|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
44512396|NCT03526861|79518022|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44243459|NCT01502371|79072901|FG003|Overall Study|Lack of Efficacy|2|||
44243460|NCT01502371|79072902|FG004|Overall Study|Lack of Efficacy|4|||
44243461|NCT01502371|79072898|FG000|Overall Study|Physician Decision|3|||
44512397|NCT03526861|79518023|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512398|NCT03526861|79518024|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512399|NCT03526861|79518025|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
44512400|NCT03526861|79518026|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
44512401|NCT03526861|79518027|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512402|NCT03526861|79518028|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
44243462|NCT01502371|79072899|FG001|Overall Study|Physician Decision|0|||
44243463|NCT01502371|79072900|FG002|Overall Study|Physician Decision|0|||
44243464|NCT01502371|79072901|FG003|Overall Study|Physician Decision|0|||
44243465|NCT01502371|79072902|FG004|Overall Study|Physician Decision|1|||
44243466|NCT01502371|79072898|FG000|Overall Study|Noncompliance with Study Drug|0|||
44243467|NCT01502371|79072899|FG001|Overall Study|Noncompliance with Study Drug|0|||
44243468|NCT01502371|79072900|FG002|Overall Study|Noncompliance with Study Drug|1|||
44243469|NCT01502371|79072901|FG003|Overall Study|Noncompliance with Study Drug|2|||
44243470|NCT01502371|79072902|FG004|Overall Study|Noncompliance with Study Drug|1|||
44243471|NCT01502371|79072898|FG000|Overall Study|Technical Problems|1|||
44243472|NCT01502371|79072899|FG001|Overall Study|Technical Problems|0|||
44130799|NCT03142191|78916533|FG000|Placebo Controlled Period|Other Reasons|1|||
44130800|NCT03142191|78916534|FG001|Placebo Controlled Period|Other Reasons|0|||
44130801|NCT03142191|78916535|FG002|Placebo Controlled Period|Other Reasons|0|||
44243473|NCT01502371|79072900|FG002|Overall Study|Technical Problems|2|||
44243474|NCT01502371|79072901|FG003|Overall Study|Technical Problems|4|||
44130802|NCT03142191|78916536|FG003|Placebo Controlled Period|Other Reasons|0|||
44130803|NCT03142191|78916537|FG004|Placebo Controlled Period|Other Reasons|0|||
44243475|NCT01502371|79072902|FG004|Overall Study|Technical Problems|1|||
44243476|NCT01502371|79072898|FG000|Overall Study|Protocol Violation|9|||
44130804|NCT03142191|78916533|FG000|Active Treatment Extension Period|Death|2|||
44130805|NCT03142191|78916534|FG001|Active Treatment Extension Period|Death|1|||
44130806|NCT03142191|78916535|FG002|Active Treatment Extension Period|Death|1|||
44130807|NCT03142191|78916536|FG003|Active Treatment Extension Period|Death|1|||
44130808|NCT03142191|78916537|FG004|Active Treatment Extension Period|Death|0|||
44276553|NCT02171130|79231695|FG000|Overall Study|Discontinued; Site Termination|5|||
44276554|NCT02171130|79231695|FG000|Overall Study|Withdrawal by Subject|3|||
44276555|NCT02171130|79231695|FG000|Overall Study|Physician Decision|1|||
44276556|NCT02171130|79231695|FG000|Overall Study|Lost to Follow-up|1|||
44130809|NCT03142191|78916533|FG000|Active Treatment Extension Period|Adverse Event|6|||
44130810|NCT03142191|78916534|FG001|Active Treatment Extension Period|Adverse Event|5|||
44130811|NCT03142191|78916535|FG002|Active Treatment Extension Period|Adverse Event|4|||
44130812|NCT03142191|78916536|FG003|Active Treatment Extension Period|Adverse Event|1|||
44130813|NCT03142191|78916537|FG004|Active Treatment Extension Period|Adverse Event|0|||
44130814|NCT03142191|78916533|FG000|Active Treatment Extension Period|Progressive Disease|10|||
44130815|NCT03142191|78916534|FG001|Active Treatment Extension Period|Progressive Disease|5|||
44130816|NCT03142191|78916535|FG002|Active Treatment Extension Period|Progressive Disease|4|||
44130817|NCT03142191|78916536|FG003|Active Treatment Extension Period|Progressive Disease|1|||
44130818|NCT03142191|78916537|FG004|Active Treatment Extension Period|Progressive Disease|2|||
44130819|NCT03142191|78916533|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
44130820|NCT03142191|78916534|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
44130821|NCT03142191|78916535|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
44130822|NCT03142191|78916536|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
44130823|NCT03142191|78916537|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
44130824|NCT03142191|78916533|FG000|Active Treatment Extension Period|Physician Decision|2|||
44130825|NCT03142191|78916534|FG001|Active Treatment Extension Period|Physician Decision|0|||
44130826|NCT03142191|78916535|FG002|Active Treatment Extension Period|Physician Decision|0|||
44130827|NCT03142191|78916536|FG003|Active Treatment Extension Period|Physician Decision|0|||
44130828|NCT03142191|78916537|FG004|Active Treatment Extension Period|Physician Decision|0|||
44130829|NCT03142191|78916533|FG000|Active Treatment Extension Period|Other Reasons|3|||
44130830|NCT03142191|78916534|FG001|Active Treatment Extension Period|Other Reasons|3|||
44130831|NCT03142191|78916535|FG002|Active Treatment Extension Period|Other Reasons|3|||
44130832|NCT03142191|78916536|FG003|Active Treatment Extension Period|Other Reasons|8|||
44130833|NCT03142191|78916537|FG004|Active Treatment Extension Period|Other Reasons|3|||
44130834|NCT03142191|78916533|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
44130835|NCT03142191|78916534|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
44130836|NCT03142191|78916535|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
44130837|NCT03142191|78916536|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
44130838|NCT03142191|78916537|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
44130839|NCT02617628|78916566|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
44130840|NCT02617628|78916567|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
44130841|NCT02308540|78916583|FG000|Overall Study|Lost to Follow-up|0|||
44130842|NCT02308540|78916584|FG001|Overall Study|Lost to Follow-up|0|||
44130843|NCT02308540|78916585|FG002|Overall Study|Lost to Follow-up|0|||
44130844|NCT02308540|78916586|FG003|Overall Study|Lost to Follow-up|0|||
44130845|NCT02308540|78916587|FG004|Overall Study|Lost to Follow-up|0|||
44130846|NCT02308540|78916588|FG005|Overall Study|Lost to Follow-up|1|||
44130847|NCT02308228|78916639|FG000|Overall Study|Adverse Event|3|||
44130848|NCT02308228|78916640|FG001|Overall Study|Adverse Event|4|||
44130849|NCT02308228|78916639|FG000|Overall Study|Withdrawal by Subject|5|||
44130850|NCT02308228|78916640|FG001|Overall Study|Withdrawal by Subject|3|||
44130851|NCT02616614|78916658|FG000|Overall Study|Withdrawal by Subject|10|||
44130852|NCT02616614|78916659|FG001|Overall Study|Withdrawal by Subject|5|||
44130853|NCT02616614|78916660|FG002|Overall Study|Withdrawal by Subject|6|||
44130854|NCT02616614|78916658|FG000|Overall Study|Physician Decision|2|||
44130855|NCT02616614|78916659|FG001|Overall Study|Physician Decision|1|||
44276557|NCT02171130|79231695|FG000|Overall Study|Met Exclusion Criteria|1|||
44512403|NCT03526861|79518029|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44130856|NCT02616614|78916660|FG002|Overall Study|Physician Decision|0|||
44130857|NCT02616614|78916658|FG000|Overall Study|Adverse Event|1|||
44130858|NCT02616614|78916659|FG001|Overall Study|Adverse Event|4|||
44130859|NCT02616614|78916660|FG002|Overall Study|Adverse Event|1|||
44130860|NCT02616614|78916658|FG000|Overall Study|Protocol Violation|0|||
44130861|NCT02616614|78916659|FG001|Overall Study|Protocol Violation|3|||
44512404|NCT03526861|79518030|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512405|NCT03526861|79518022|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
44512406|NCT03526861|79518023|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
44512407|NCT03526861|79518024|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
44512408|NCT03526861|79518025|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
44276558|NCT03603314|79237529|FG000|Overall Study|Lost to Follow-up|0|||
44130862|NCT02616614|78916660|FG002|Overall Study|Protocol Violation|1|||
44130863|NCT02616614|78916658|FG000|Overall Study|Prohibited Medication|12|||
44130864|NCT02616614|78916659|FG001|Overall Study|Prohibited Medication|9|||
44130865|NCT02616614|78916660|FG002|Overall Study|Prohibited Medication|5|||
44130866|NCT02616614|78916658|FG000|Overall Study|More than 3 applications missed|6|||
44130867|NCT02616614|78916659|FG001|Overall Study|More than 3 applications missed|8|||
44130868|NCT02616614|78916660|FG002|Overall Study|More than 3 applications missed|1|||
44130869|NCT02616614|78916658|FG000|Overall Study|Lost to Follow-up|31|||
44130870|NCT02616614|78916659|FG001|Overall Study|Lost to Follow-up|28|||
44130871|NCT02616614|78916660|FG002|Overall Study|Lost to Follow-up|13|||
44130872|NCT02616614|78916658|FG000|Overall Study|Pregnancy|2|||
44130873|NCT02616614|78916659|FG001|Overall Study|Pregnancy|0|||
44130874|NCT02616614|78916660|FG002|Overall Study|Pregnancy|1|||
44130875|NCT02616614|78916658|FG000|Overall Study|Other|1|||
44130876|NCT02616614|78916659|FG001|Overall Study|Other|2|||
44130877|NCT02616614|78916660|FG002|Overall Study|Other|1|||
44130878|NCT02616380|78916686|FG000|Overall Study|Lost to Follow-up|1|||
44130879|NCT02616380|78916686|FG000|Overall Study|Other|2|||
44130880|NCT04436822|78916696|FG000|Overall Study|Physician Decision|2|||
44130881|NCT04436822|78916697|FG001|Overall Study|Physician Decision|0|||
44130882|NCT04436822|78916696|FG000|Overall Study|Sponsor request|1|||
44130883|NCT04436822|78916697|FG001|Overall Study|Sponsor request|0|||
44130884|NCT04436822|78916696|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44130885|NCT04436822|78916697|FG001|Overall Study|Withdrawal by parent/guardian|3|||
44130886|NCT04436822|78916696|FG000|Overall Study|Unsuccessful procedure|0|||
44130887|NCT04436822|78916697|FG001|Overall Study|Unsuccessful procedure|1|||
44130888|NCT04436822|78916696|FG000|Overall Study|Withdrawal due to Covid-19|8|||
44130889|NCT04436822|78916697|FG001|Overall Study|Withdrawal due to Covid-19|1|||
44130890|NCT04436822|78916696|FG000|Overall Study|Withdrawal by Subject|1|||
44379607|NCT00762463|79385174|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
44512409|NCT03526861|79518026|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
44130891|NCT04436822|78916697|FG001|Overall Study|Withdrawal by Subject|0|||
44130892|NCT04436822|78916696|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
44130893|NCT04436822|78916697|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
44130894|NCT01596062|78916707|FG000|Overall Study|Adverse Event|1|||
44130895|NCT01596062|78916708|FG001|Overall Study|Adverse Event|0|||
44130896|NCT01596062|78916709|FG002|Overall Study|Adverse Event|2|||
44130897|NCT01596062|78916707|FG000|Overall Study|Lack of Efficacy|0|||
44130898|NCT01596062|78916708|FG001|Overall Study|Lack of Efficacy|0|||
44130899|NCT01596062|78916709|FG002|Overall Study|Lack of Efficacy|1|||
44243477|NCT01502371|79072899|FG001|Overall Study|Protocol Violation|5|||
44243478|NCT01502371|79072900|FG002|Overall Study|Protocol Violation|6|||
44243479|NCT01502371|79072901|FG003|Overall Study|Protocol Violation|5|||
44243480|NCT01502371|79072902|FG004|Overall Study|Protocol Violation|10|||
44379608|NCT00762463|79385175|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
44379609|NCT00762385|79385188|FG000|First Intervention|Lens Issue|1|||
44512410|NCT03526861|79518027|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
44512411|NCT03526861|79518028|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
44512412|NCT03526861|79518029|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
44512413|NCT03526861|79518030|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
44512414|NCT03526861|79518022|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512415|NCT03526861|79518023|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512416|NCT03526861|79518024|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512417|NCT03526861|79518025|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
44512418|NCT03526861|79518026|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512419|NCT03526861|79518027|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512420|NCT03526861|79518028|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44130900|NCT02614898|78916728|FG000|Overall Study|Participated until study termination|10|||
44130901|NCT02614898|78916729|FG001|Overall Study|Participated until study termination|26|||
44130902|NCT02614898|78916728|FG000|Overall Study|Lost to Follow-up|0|||
44130903|NCT02614898|78916729|FG001|Overall Study|Lost to Follow-up|2|||
44130904|NCT02614898|78916728|FG000|Overall Study|Physician Decision|1|||
44130905|NCT02614898|78916729|FG001|Overall Study|Physician Decision|8|||
44379610|NCT00762385|79385189|FG001|First Intervention|Lens Issue|1|||
44130906|NCT02614898|78916728|FG000|Overall Study|Study Terminated by Sponsor|3|||
44130907|NCT02614898|78916729|FG001|Overall Study|Study Terminated by Sponsor|0|||
44130908|NCT02614898|78916728|FG000|Overall Study|Withdrawal by Subject|0|||
44130909|NCT02614898|78916729|FG001|Overall Study|Withdrawal by Subject|2|||
44130910|NCT02614898|78916728|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44130911|NCT02614898|78916729|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44130912|NCT02614898|78916728|FG000|Overall Study|Other-Additional Information Unavailable|0|||
44130913|NCT02614898|78916729|FG001|Overall Study|Other-Additional Information Unavailable|11|||
44130914|NCT02614898|78916728|FG000|Overall Study|Missing|0|||
44130915|NCT02614898|78916729|FG001|Overall Study|Missing|1|||
44130916|NCT02776033|78916749|FG000|Overall Study|Withdrawal by Subject|0|||
44130917|NCT02776033|78916750|FG001|Overall Study|Withdrawal by Subject|0|||
44130918|NCT02776033|78916751|FG002|Overall Study|Withdrawal by Subject|2|||
44130919|NCT02776033|78916749|FG000|Overall Study|Physician Decision|2|||
44130920|NCT02776033|78916750|FG001|Overall Study|Physician Decision|0|||
44130921|NCT02776033|78916751|FG002|Overall Study|Physician Decision|0|||
44130922|NCT02776033|78916749|FG000|Overall Study|Lost to Follow-up|1|||
44130923|NCT02776033|78916750|FG001|Overall Study|Lost to Follow-up|0|||
44130924|NCT02776033|78916751|FG002|Overall Study|Lost to Follow-up|0|||
44130925|NCT02776033|78916749|FG000|Overall Study|Adverse Event|1|||
44130926|NCT02776033|78916750|FG001|Overall Study|Adverse Event|2|||
44130927|NCT02776033|78916751|FG002|Overall Study|Adverse Event|0|||
44130928|NCT02777125|78916767|FG000|Overall Study|Consent form violation|14|||
44130929|NCT02777125|78916768|FG001|Overall Study|Consent form violation|12|||
44130930|NCT02777125|78916767|FG000|Overall Study|Assent form violation|21|||
44130931|NCT02777125|78916768|FG001|Overall Study|Assent form violation|23|||
44130932|NCT02777125|78916767|FG000|Overall Study|Protocol Violation|8|||
44130933|NCT02777125|78916768|FG001|Overall Study|Protocol Violation|12|||
44130934|NCT02769481|78916793|FG000|Overall Study|Protocol Violation|1|||
44130935|NCT02769481|78916794|FG001|Overall Study|Protocol Violation|0|||
44130936|NCT02769481|78916793|FG000|Overall Study|Adverse Event|3|||
44130937|NCT02769481|78916794|FG001|Overall Study|Adverse Event|6|||
44130938|NCT02769481|78916793|FG000|Overall Study|Entry Criteria Not Met|1|||
44130939|NCT02769481|78916794|FG001|Overall Study|Entry Criteria Not Met|2|||
44130940|NCT02769481|78916793|FG000|Overall Study|Withdrawal by Subject|14|||
44243481|NCT01502371|79072898|FG000|Overall Study|Excluded Medication|0|||
44243482|NCT01502371|79072899|FG001|Overall Study|Excluded Medication|1|||
44243483|NCT01502371|79072900|FG002|Overall Study|Excluded Medication|1|||
44243484|NCT01502371|79072901|FG003|Overall Study|Excluded Medication|0|||
44243485|NCT01502371|79072902|FG004|Overall Study|Excluded Medication|1|||
44243486|NCT01588496|79072918|FG000|Overall Study|Withdrawal by Subject|0|||
44130941|NCT02769481|78916794|FG001|Overall Study|Withdrawal by Subject|16|||
44130942|NCT02769481|78916793|FG000|Overall Study|Lost to Follow-up|9|||
44130943|NCT02769481|78916794|FG001|Overall Study|Lost to Follow-up|9|||
44130944|NCT02769481|78916793|FG000|Overall Study|Physician Decision|0|||
44130945|NCT02769481|78916794|FG001|Overall Study|Physician Decision|1|||
44243487|NCT01588496|79072919|FG001|Overall Study|Withdrawal by Subject|1|||
44243488|NCT01588496|79072920|FG002|Overall Study|Withdrawal by Subject|0|||
44243489|NCT01502293|79072931|FG000|Overall Study|Progressive Disease|20|||
44276559|NCT03603314|79237530|FG001|Overall Study|Lost to Follow-up|3|||
44130946|NCT02769481|78916793|FG000|Overall Study|Terminated by Sponsor|1|||
44243490|NCT01502293|79072932|FG001|Overall Study|Progressive Disease|12|||
44512421|NCT03526861|79518029|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512422|NCT03526861|79518030|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512423|NCT03526861|79518022|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512424|NCT03526861|79518023|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512425|NCT03526861|79518024|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512426|NCT03526861|79518025|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512427|NCT03526861|79518026|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44379611|NCT00762385|79385188|FG000|First Intervention|Lost to Follow-up|0|||
44379612|NCT00762385|79385189|FG001|First Intervention|Lost to Follow-up|2|||
44379613|NCT00762385|79385188|FG000|First Intervention|Ineligible|1|||
44379614|NCT00762385|79385189|FG001|First Intervention|Ineligible|0|||
44379615|NCT00762385|79385188|FG000|First Intervention|Protocol Violation|0|||
44379616|NCT00762385|79385189|FG001|First Intervention|Protocol Violation|1|||
44379617|NCT00762385|79385188|FG000|Second Intervention|Protocol Violation|3|||
44379618|NCT00762385|79385189|FG001|Second Intervention|Protocol Violation|3|||
44379619|NCT00906282|79385198|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
44130947|NCT02769481|78916794|FG001|Overall Study|Terminated by Sponsor|0|||
44130948|NCT02769481|78916793|FG000|Overall Study|Death|0|||
44130949|NCT02769481|78916794|FG001|Overall Study|Death|1|||
44130950|NCT02769481|78916793|FG000|Overall Study|Undefined|4|||
44130951|NCT02769481|78916794|FG001|Overall Study|Undefined|1|||
44130952|NCT02769247|78916804|FG000|Overall Study|Withdrawal by Subject|1|||
44130953|NCT02769247|78916805|FG001|Overall Study|Withdrawal by Subject|0|||
44130954|NCT02769247|78916806|FG002|Overall Study|Withdrawal by Subject|0|||
44130955|NCT02769247|78916807|FG003|Overall Study|Withdrawal by Subject|1|||
44130956|NCT02769247|78916804|FG000|Overall Study|Protocol Violation|0|||
44130957|NCT02769247|78916805|FG001|Overall Study|Protocol Violation|0|||
44130958|NCT02769247|78916806|FG002|Overall Study|Protocol Violation|1|||
44130959|NCT02769247|78916807|FG003|Overall Study|Protocol Violation|0|||
44130960|NCT02769247|78916804|FG000|Overall Study|Physician Decision|1|||
44130961|NCT02769247|78916805|FG001|Overall Study|Physician Decision|0|||
44379620|NCT00906282|79385198|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
44130962|NCT02769247|78916806|FG002|Overall Study|Physician Decision|0|||
44130963|NCT02769247|78916807|FG003|Overall Study|Physician Decision|0|||
44130964|NCT02773537|78916824|FG000|Overall Study|Lost to Follow-up|0|||
44130965|NCT02773537|78916825|FG001|Overall Study|Lost to Follow-up|1|||
44379621|NCT00906282|79385198|FG000|Preoperative Chemotherapy|Progressive disease|6|||
44512428|NCT03526861|79518027|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512429|NCT03526861|79518028|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512430|NCT03526861|79518029|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
44512431|NCT03526861|79518030|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
44512432|NCT03526861|79518022|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44379622|NCT00906282|79385198|FG000|Preoperative Chemotherapy|Toxicity|1|||
44512433|NCT03526861|79518023|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512434|NCT03526861|79518024|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512435|NCT03526861|79518025|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512436|NCT03526861|79518026|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512437|NCT03526861|79518027|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512438|NCT03526861|79518028|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512439|NCT03526861|79518029|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
44512440|NCT03526861|79518030|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
44512441|NCT03526861|79518022|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512442|NCT03526861|79518023|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512443|NCT03526861|79518024|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512444|NCT03526861|79518025|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44514956|NCT02865850|79520851|FG001|Overall Study|Withdrawal by Subject|2|||
44130966|NCT02773537|78916826|FG002|Overall Study|Lost to Follow-up|4|||
44130967|NCT02780713|78916834|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
44130968|NCT02780713|78916835|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
44130969|NCT02780713|78916836|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
44130970|NCT02780713|78916837|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
44130971|NCT02780713|78916838|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
44130972|NCT02767765|78916857|FG000|Overall Study|Adverse Event|4|||
44130973|NCT02767765|78916857|FG000|Overall Study|Death|1|||
44130974|NCT02767765|78916857|FG000|Overall Study|Insufficient response|1|||
44130975|NCT02767765|78916857|FG000|Overall Study|Lost to Follow-up|2|||
44130976|NCT02767765|78916857|FG000|Overall Study|Investigator decision|1|||
44130977|NCT02767765|78916857|FG000|Overall Study|Non-Compliance|1|||
44130978|NCT02767765|78916857|FG000|Overall Study|Withdrawal by Subject|1|||
44130979|NCT02772757|78916864|FG000|Overall Study|Withdrawal by Subject|1|||
44130980|NCT02772757|78916865|FG001|Overall Study|Withdrawal by Subject|0|||
44130981|NCT02772757|78916866|FG002|Overall Study|Withdrawal by Subject|1|||
44130982|NCT02772757|78916864|FG000|Overall Study|Protocol Violation|0|||
44130983|NCT02772757|78916865|FG001|Overall Study|Protocol Violation|0|||
44130984|NCT02772757|78916866|FG002|Overall Study|Protocol Violation|1|||
44130985|NCT02772757|78916864|FG000|Overall Study|Physician Decision|0|||
44130986|NCT02772757|78916865|FG001|Overall Study|Physician Decision|3|||
44130987|NCT02772757|78916866|FG002|Overall Study|Physician Decision|3|||
44130988|NCT00103207|78916875|FG000|Overall Study|Adverse Event|3|||
44130989|NCT00103207|78916875|FG000|Overall Study|Death|1|||
44130990|NCT00103207|78916875|FG000|Overall Study|Withdrawal by Subject|2|||
44130991|NCT00103207|78916875|FG000|Overall Study|Other complicating disease|1|||
44130992|NCT00103207|78916875|FG000|Overall Study|Ineligible|4|||
44130993|NCT00103207|78916875|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
44130994|NCT01369355|78916887|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
44130995|NCT01369355|78916888|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
44130996|NCT01369355|78916889|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
44130997|NCT01369355|78916890|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
44130998|NCT01369355|78916891|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
44130999|NCT01369355|78916892|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
44379623|NCT00762229|79385205|FG000|Overall Study|Lost to Follow-up|1|||
44512445|NCT03526861|79518026|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512446|NCT03526861|79518027|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512447|NCT03526861|79518028|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512448|NCT03526861|79518029|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
44512449|NCT03526861|79518030|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
44512450|NCT03510884|79518054|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
44131000|NCT01369355|78916893|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
44131001|NCT01369355|78916894|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
44131002|NCT01369355|78916895|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
44131003|NCT01369355|78916887|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
44131004|NCT01369355|78916888|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
44131005|NCT01369355|78916889|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
44131006|NCT01369355|78916890|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
44131007|NCT01369355|78916891|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
44131008|NCT01369355|78916892|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
44131009|NCT01369355|78916893|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
44131010|NCT01369355|78916894|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
44131011|NCT01369355|78916895|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
44131012|NCT01369355|78916887|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
44131013|NCT01369355|78916888|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
44131014|NCT01369355|78916889|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
44131015|NCT01369355|78916890|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
44131016|NCT01369355|78916891|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
44131017|NCT01369355|78916892|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
44131018|NCT01369355|78916893|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
44131019|NCT01369355|78916894|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
44131020|NCT01369355|78916895|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
44131021|NCT01369355|78916887|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
44131022|NCT01369355|78916888|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
44131023|NCT01369355|78916889|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
44131024|NCT01369355|78916890|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
44131025|NCT01369355|78916891|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
44131026|NCT01369355|78916892|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
44131027|NCT01369355|78916893|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
44131028|NCT01369355|78916894|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
44131029|NCT01369355|78916895|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
44131030|NCT01369355|78916887|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
44131031|NCT01369355|78916888|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
44131032|NCT01369355|78916889|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
44131033|NCT01369355|78916890|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
44131034|NCT01369355|78916891|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
44131035|NCT01369355|78916892|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
44131036|NCT01369355|78916893|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
44131037|NCT01369355|78916894|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
44131038|NCT01369355|78916895|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
44131039|NCT01369355|78916887|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
44131040|NCT01369355|78916888|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
44131041|NCT01369355|78916889|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
44131042|NCT01369355|78916890|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
44131043|NCT01369355|78916891|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
44131044|NCT01369355|78916892|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
44131045|NCT01369355|78916893|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
44131046|NCT01369355|78916894|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
44131047|NCT01369355|78916895|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
44131048|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
44131049|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
44131050|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
44131051|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
44131052|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
44131053|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
44131054|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
44131055|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
44243491|NCT01502293|79072933|FG002|Overall Study|Progressive Disease|2|||
44243492|NCT01502293|79072931|FG000|Overall Study|Withdrawal by Subject|3|||
44243493|NCT01502293|79072932|FG001|Overall Study|Withdrawal by Subject|3|||
44379624|NCT00762229|79385206|FG001|Overall Study|Lost to Follow-up|1|||
44131056|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
44379625|NCT00762229|79385205|FG000|Overall Study|did not recveive intervention|0|||
44131057|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Death|0|||
44131058|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Death|0|||
44243494|NCT01502293|79072933|FG002|Overall Study|Withdrawal by Subject|1|||
44131059|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Death|0|||
44131060|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Death|0|||
44131061|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Death|0|||
44131062|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Death|0|||
44131063|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Death|0|||
44131064|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Death|1|||
44131065|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Death|3|||
44131066|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
44131067|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
44131068|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
44131069|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
44131070|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
44131071|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
44131072|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
44131073|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
44131074|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
44131075|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131076|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131077|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131078|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131079|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131080|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131081|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
44131082|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
44131083|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
44131084|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
44131085|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
44131086|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
44131087|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
44131088|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
44131089|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
44131090|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
44131091|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
44131092|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
44131093|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
44131094|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
44131095|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
44131096|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
44131097|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
44131098|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
44131099|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
44131100|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
44131101|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
44131102|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
44131103|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
44243495|NCT01502293|79072931|FG000|Overall Study|Adverse Event|0|||
44379626|NCT00762229|79385206|FG001|Overall Study|did not recveive intervention|1|||
44379627|NCT00907374|79385214|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
44514957|NCT02865850|79520850|FG000|Overall Study|Lost to Follow-up|3|||
44514958|NCT02865850|79520851|FG001|Overall Study|Lost to Follow-up|2|||
44514959|NCT03711162|79520860|FG000|Overall Study|Adverse Event|5|||
44514960|NCT03711162|79520861|FG001|Overall Study|Adverse Event|2|||
44514961|NCT03711162|79520862|FG002|Overall Study|Adverse Event|4|||
44514962|NCT03711162|79520860|FG000|Overall Study|Death|11|||
44514963|NCT03711162|79520861|FG001|Overall Study|Death|7|||
44514964|NCT03711162|79520862|FG002|Overall Study|Death|8|||
44514965|NCT03711162|79520860|FG000|Overall Study|Lost to Follow-up|1|||
44131104|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
44131105|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
44131106|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
44131107|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
44131108|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
44131109|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
44131110|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
44131111|NCT01369355|78916887|FG000|Long-term Extension (Week 44-272)|Other|0|||
44131112|NCT01369355|78916888|FG001|Long-term Extension (Week 44-272)|Other|0|||
44131113|NCT01369355|78916889|FG002|Long-term Extension (Week 44-272)|Other|0|||
44131114|NCT01369355|78916890|FG003|Long-term Extension (Week 44-272)|Other|0|||
44131115|NCT01369355|78916891|FG004|Long-term Extension (Week 44-272)|Other|0|||
44131116|NCT01369355|78916892|FG005|Long-term Extension (Week 44-272)|Other|0|||
44131117|NCT01369355|78916893|FG006|Long-term Extension (Week 44-272)|Other|110|||
44131118|NCT01369355|78916894|FG007|Long-term Extension (Week 44-272)|Other|9|||
44131119|NCT01369355|78916895|FG008|Long-term Extension (Week 44-272)|Other|17|||
44131120|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Adverse Event|8|||
44131121|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Adverse Event|5|||
44131122|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Adverse Event|9|||
44131123|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Adverse Event|0|||
44131124|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Adverse Event|0|||
44131125|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Adverse Event|0|||
44131126|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
44131127|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
44131128|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
44131129|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
44131130|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
44131131|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
44131132|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
44131133|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
44131134|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
44131135|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
44131136|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
44131137|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
44131138|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Physician Decision|4|||
44131139|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Physician Decision|0|||
44131140|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Physician Decision|2|||
44131141|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Physician Decision|0|||
44131142|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Physician Decision|0|||
44131143|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Physician Decision|0|||
44131144|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Pregnancy|1|||
44131145|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Pregnancy|2|||
44131146|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Pregnancy|0|||
44131147|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Pregnancy|0|||
44131148|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Pregnancy|0|||
44131149|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Pregnancy|0|||
44131150|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
44131151|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
44131152|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
44512451|NCT03510884|79518055|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
44512452|NCT03510884|79518056|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
44512453|NCT03510884|79518057|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
44512454|NCT03510884|79518054|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
44512455|NCT03510884|79518055|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
44512456|NCT03510884|79518056|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
44512457|NCT03510884|79518057|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
44512458|NCT03510884|79518054|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
44131153|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
44131154|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
44131155|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
44131156|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
44131157|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
44131158|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
44131159|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
44131160|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
44131161|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
44131162|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
44131163|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
44131164|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
44131165|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
44131166|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
44131167|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
44131168|NCT02614196|78916918|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
44131169|NCT02614196|78916919|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
44131170|NCT02614196|78916920|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
44131171|NCT02614196|78916921|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
44131172|NCT02614196|78916922|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
44131173|NCT02614196|78916923|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
44131174|NCT02614196|78916918|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
44131175|NCT02614196|78916919|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
44131176|NCT02614196|78916920|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
44131177|NCT02614196|78916921|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
44131178|NCT02614196|78916922|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
44131179|NCT02614196|78916923|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
44131180|NCT02614196|78916918|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
44131181|NCT02614196|78916919|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
44131182|NCT02614196|78916920|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
44131183|NCT02614196|78916921|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
44131184|NCT02614196|78916922|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
44131185|NCT02614196|78916923|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
44131186|NCT02614196|78916918|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
44512459|NCT03510884|79518055|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
44512460|NCT03510884|79518056|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
44512461|NCT03510884|79518057|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
44512462|NCT03510884|79518054|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
44512463|NCT03510884|79518055|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
44512464|NCT03510884|79518056|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
44512465|NCT03510884|79518057|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
44512466|NCT03510884|79518054|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
44512467|NCT03510884|79518055|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
44512468|NCT03510884|79518056|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
44512469|NCT03510884|79518057|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
44514966|NCT03711162|79520861|FG001|Overall Study|Lost to Follow-up|0|||
44131187|NCT02614196|78916919|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
44131188|NCT02614196|78916920|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
44131189|NCT02614196|78916921|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
44131190|NCT02614196|78916922|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
44131191|NCT02614196|78916923|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
44131192|NCT02614196|78916918|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
44131193|NCT02614196|78916919|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
44131194|NCT02614196|78916920|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
44131195|NCT02614196|78916921|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
44131196|NCT02614196|78916922|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
44131197|NCT02614196|78916923|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
44131198|NCT02765035|78916953|FG000|First Intervention (90 Days)|Adverse Event|1|||
44131199|NCT02765035|78916954|FG001|First Intervention (90 Days)|Adverse Event|1|||
44131200|NCT02765035|78916953|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
44131201|NCT02765035|78916954|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
44131202|NCT02307682|78916964|FG000|Overall Study|Adverse Event|9|||
44131203|NCT02307682|78916965|FG001|Overall Study|Adverse Event|8|||
44131204|NCT02307682|78916966|FG002|Overall Study|Adverse Event|12|||
44131205|NCT02307682|78916964|FG000|Overall Study|Lack of Efficacy|1|||
44131206|NCT02307682|78916965|FG001|Overall Study|Lack of Efficacy|0|||
44131207|NCT02307682|78916966|FG002|Overall Study|Lack of Efficacy|1|||
44131208|NCT02307682|78916964|FG000|Overall Study|Physician Decision|2|||
44131209|NCT02307682|78916965|FG001|Overall Study|Physician Decision|2|||
44131210|NCT02307682|78916966|FG002|Overall Study|Physician Decision|8|||
44131211|NCT02307682|78916964|FG000|Overall Study|Progressive Disease|1|||
44131212|NCT02307682|78916965|FG001|Overall Study|Progressive Disease|0|||
44131213|NCT02307682|78916966|FG002|Overall Study|Progressive Disease|0|||
44131214|NCT02307682|78916964|FG000|Overall Study|Withdrawal by Subject|26|||
44131215|NCT02307682|78916965|FG001|Overall Study|Withdrawal by Subject|34|||
44131216|NCT02307682|78916966|FG002|Overall Study|Withdrawal by Subject|23|||
44131217|NCT02307682|78916964|FG000|Overall Study|Death|9|||
44131218|NCT02307682|78916965|FG001|Overall Study|Death|7|||
44243496|NCT01502293|79072932|FG001|Overall Study|Adverse Event|2|||
44512470|NCT03510884|79518054|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
44512471|NCT03510884|79518055|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
44512472|NCT03510884|79518056|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
44512473|NCT03510884|79518057|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
44512474|NCT03510884|79518054|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
44512475|NCT03510884|79518055|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
44512476|NCT03510884|79518056|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
44512477|NCT03510884|79518057|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
44131219|NCT02307682|78916966|FG002|Overall Study|Death|12|||
44131220|NCT02307682|78916964|FG000|Overall Study|Lost to Follow-up|1|||
44131221|NCT02307682|78916965|FG001|Overall Study|Lost to Follow-up|5|||
44131222|NCT02307682|78916966|FG002|Overall Study|Lost to Follow-up|6|||
44131223|NCT02307682|78916964|FG000|Overall Study|Protocol Deviation|0|||
44131224|NCT02307682|78916965|FG001|Overall Study|Protocol Deviation|0|||
44379628|NCT00907374|79385215|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
44512478|NCT03510884|79518054|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
44131225|NCT02307682|78916966|FG002|Overall Study|Protocol Deviation|2|||
44379629|NCT00818662|79385225|FG000|Overall Study|Adverse Event|5|||
44379630|NCT00818662|79385226|FG001|Overall Study|Adverse Event|14|||
44131226|NCT02307682|78916964|FG000|Overall Study|Other|1|||
44131227|NCT02307682|78916965|FG001|Overall Study|Other|1|||
44131228|NCT02307682|78916966|FG002|Overall Study|Other|0|||
44131229|NCT02615990|78916976|FG000|Overall Study|study terminated|1|||
44131230|NCT02615990|78916977|FG001|Overall Study|study terminated|1|||
44131231|NCT02613884|78916983|FG000|Overall Study|Death|1|||
44131232|NCT02613884|78916983|FG000|Overall Study|Lost to Follow-up|1|||
44131233|NCT02791763|78916991|FG000|Overall Study|Protocol Violation|0|||
44131234|NCT02791763|78916992|FG001|Overall Study|Protocol Violation|0|||
44131235|NCT02791763|78916993|FG002|Overall Study|Protocol Violation|1|||
44131236|NCT02791763|78916991|FG000|Overall Study|Withdrawal by Subject|5|||
44131237|NCT02791763|78916992|FG001|Overall Study|Withdrawal by Subject|1|||
44131238|NCT02791763|78916993|FG002|Overall Study|Withdrawal by Subject|0|||
44131239|NCT02791763|78916991|FG000|Overall Study|Physician Decision|0|||
44131240|NCT02791763|78916992|FG001|Overall Study|Physician Decision|1|||
44131241|NCT02791763|78916993|FG002|Overall Study|Physician Decision|0|||
44131242|NCT02791763|78916991|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
44131243|NCT02791763|78916992|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
44131244|NCT02791763|78916993|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
44131245|NCT02791763|78916991|FG000|Overall Study|Cancer event|1|||
44131246|NCT02791763|78916992|FG001|Overall Study|Cancer event|3|||
44131247|NCT02791763|78916993|FG002|Overall Study|Cancer event|0|||
44131248|NCT02791763|78916991|FG000|Overall Study|Participant had renal transplant|3|||
44131249|NCT02791763|78916992|FG001|Overall Study|Participant had renal transplant|0|||
44131250|NCT02791763|78916993|FG002|Overall Study|Participant had renal transplant|0|||
44131251|NCT02791763|78916991|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
44131252|NCT02791763|78916992|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
44243497|NCT01502293|79072933|FG002|Overall Study|Adverse Event|0|||
44131253|NCT02791763|78916993|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
44131254|NCT02791763|78916991|FG000|Overall Study|Adverse Event|12|||
44131255|NCT02791763|78916992|FG001|Overall Study|Adverse Event|13|||
44131256|NCT02791763|78916993|FG002|Overall Study|Adverse Event|7|||
44131257|NCT02613572|78917013|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
44131258|NCT02613572|78917014|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
44131259|NCT02613572|78917015|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
44243498|NCT01502293|79072931|FG000|Overall Study|Reason Not Specified|2|||
44243499|NCT01502293|79072932|FG001|Overall Study|Reason Not Specified|0|||
44243500|NCT01502293|79072933|FG002|Overall Study|Reason Not Specified|0|||
44131260|NCT02613572|78917013|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
44131261|NCT02613572|78917014|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
44131262|NCT02613572|78917015|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
44131263|NCT02087189|78917027|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
44131264|NCT02341456|78917034|FG000|Overall Study|Disease progression|2|||
44131265|NCT02341456|78917035|FG001|Overall Study|Disease progression|3|||
44131266|NCT02341456|78917036|FG002|Overall Study|Disease progression|1|||
44131267|NCT02341456|78917034|FG000|Overall Study|Death|1|||
44131268|NCT02341456|78917035|FG001|Overall Study|Death|1|||
44131269|NCT02341456|78917036|FG002|Overall Study|Death|1|||
44131270|NCT02341456|78917034|FG000|Overall Study|Withdrawal by Subject|0|||
44131271|NCT02341456|78917035|FG001|Overall Study|Withdrawal by Subject|1|||
44131272|NCT02341456|78917036|FG002|Overall Study|Withdrawal by Subject|1|||
44131273|NCT02341456|78917034|FG000|Overall Study|Moved to local access programme.|0|||
44131274|NCT02341456|78917035|FG001|Overall Study|Moved to local access programme.|1|||
44131275|NCT02341456|78917036|FG002|Overall Study|Moved to local access programme.|1|||
44131276|NCT02341456|78917034|FG000|Overall Study|Physician Decision|1|||
44131277|NCT02341456|78917035|FG001|Overall Study|Physician Decision|0|||
44131278|NCT02341456|78917036|FG002|Overall Study|Physician Decision|0|||
44131279|NCT02370784|78917046|FG000|Overall Study|Patient started prohibited medication|0|||
44512479|NCT03510884|79518055|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
44512480|NCT03510884|79518056|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
44512481|NCT03510884|79518057|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
44512482|NCT03510884|79518054|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
44512483|NCT03510884|79518055|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
44512484|NCT03510884|79518056|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
44512485|NCT03510884|79518057|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
44131280|NCT02370784|78917047|FG001|Overall Study|Patient started prohibited medication|1|||
44131281|NCT02307370|78917055|FG000|Overall Study|Death|5|||
44131282|NCT02307370|78917055|FG000|Overall Study|Lost to Follow-up|1|||
44131283|NCT02307370|78917055|FG000|Overall Study|Withdrawal by Subject|1|||
44131284|NCT02307370|78917055|FG000|Overall Study|Declined Addendum ICF|6|||
44131285|NCT02307370|78917055|FG000|Overall Study|No response during telephone contact|5|||
44131286|NCT02307370|78917055|FG000|Overall Study|Protocol Violation|1|||
44131287|NCT02370394|78917063|FG000|Overall Study|Lost to Follow-up|2|||
44131288|NCT02370394|78917064|FG001|Overall Study|Lost to Follow-up|1|||
44131289|NCT02370394|78917063|FG000|Overall Study|Withdrawal by Subject|0|||
44131290|NCT02370394|78917064|FG001|Overall Study|Withdrawal by Subject|1|||
44131291|NCT01595438|78917073|FG000|Overall Study|Lost to Follow-up|20|||
44131292|NCT01595438|78917074|FG001|Overall Study|Lost to Follow-up|20|||
44512486|NCT03510884|79518054|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
44512487|NCT03510884|79518055|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
44131293|NCT01595438|78917073|FG000|Overall Study|Withdrawal by Subject|12|||
44514967|NCT03711162|79520862|FG002|Overall Study|Lost to Follow-up|1|||
44131294|NCT01595438|78917074|FG001|Overall Study|Withdrawal by Subject|12|||
44131295|NCT01595438|78917073|FG000|Overall Study|Other Eligibility criteria|11|||
44131296|NCT01595438|78917074|FG001|Overall Study|Other Eligibility criteria|9|||
44131297|NCT02340520|78917080|FG000|Overall Study|Lost to Follow-up|1|||
44131298|NCT02340520|78917080|FG000|Overall Study|Patient did not take drug as specified|1|||
44131299|NCT02340520|78917080|FG000|Overall Study|Withdrawal by Subject|1|||
44131300|NCT02339584|78917086|FG000|Overall Study|Adverse Event|11|||
44131301|NCT02339584|78917087|FG001|Overall Study|Adverse Event|7|||
44131302|NCT02339584|78917086|FG000|Overall Study|Lack of Efficacy|0|||
44131303|NCT02339584|78917087|FG001|Overall Study|Lack of Efficacy|1|||
44131304|NCT02339584|78917086|FG000|Overall Study|Physician Decision|1|||
44131305|NCT02339584|78917087|FG001|Overall Study|Physician Decision|2|||
44131306|NCT02339584|78917086|FG000|Overall Study|Protocol Violation|1|||
44131307|NCT02339584|78917087|FG001|Overall Study|Protocol Violation|1|||
44131308|NCT02339584|78917086|FG000|Overall Study|Withdrawal by Subject|2|||
44131309|NCT02339584|78917087|FG001|Overall Study|Withdrawal by Subject|4|||
44131310|NCT02339506|78917093|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
44131311|NCT02339506|78917094|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
44131312|NCT02339506|78917093|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
44131313|NCT02339506|78917094|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
44131314|NCT02305888|78917103|FG000|Overall Study|Lost to Follow-up|0|||
44131315|NCT02305888|78917104|FG001|Overall Study|Lost to Follow-up|0|||
44131316|NCT02305888|78917105|FG002|Overall Study|Lost to Follow-up|1|||
44131317|NCT02305888|78917103|FG000|Overall Study|Adverse Event|0|||
44131318|NCT02305888|78917104|FG001|Overall Study|Adverse Event|1|||
44131319|NCT02305888|78917105|FG002|Overall Study|Adverse Event|0|||
44131320|NCT02338882|78917115|FG000|Overall Study|Death|1|||
44131321|NCT02338882|78917116|FG001|Overall Study|Death|0|||
44131322|NCT02338882|78917115|FG000|Overall Study|Lost to Follow-up|6|||
44131323|NCT02338882|78917116|FG001|Overall Study|Lost to Follow-up|3|||
44131324|NCT01594970|78917128|FG000|Overall Study|Non-Adverse Event Related|4|||
44131325|NCT01594970|78917129|FG001|Overall Study|Non-Adverse Event Related|5|||
44131326|NCT01594970|78917130|FG002|Overall Study|Non-Adverse Event Related|6|||
44131327|NCT01594970|78917128|FG000|Overall Study|Adverse Event|17|||
44131328|NCT01594970|78917129|FG001|Overall Study|Adverse Event|23|||
44131329|NCT01594970|78917130|FG002|Overall Study|Adverse Event|23|||
44131330|NCT01594970|78917128|FG000|Overall Study|Lost to Follow-up|54|||
44131331|NCT01594970|78917129|FG001|Overall Study|Lost to Follow-up|54|||
44131332|NCT01594970|78917130|FG002|Overall Study|Lost to Follow-up|37|||
44131333|NCT02338492|78917138|FG000|Overall Study|Death|32|||
44131334|NCT02338492|78917138|FG000|Overall Study|Adverse Event|3|||
44131335|NCT02338492|78917138|FG000|Overall Study|Lost to Follow-up|4|||
44131336|NCT02338492|78917138|FG000|Overall Study|Reason not captured above|6|||
44131337|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
44131338|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
44131339|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
44131340|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
44131341|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
44131342|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
44131343|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
44131344|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
44131345|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
44131346|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
44131347|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
44131348|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
44131349|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
44131350|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
44131351|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
44379631|NCT00818662|79385227|FG002|Overall Study|Adverse Event|4|||
44379632|NCT00818662|79385228|FG003|Overall Study|Adverse Event|3|||
44379633|NCT00818662|79385225|FG000|Overall Study|Withdrawal by Subject|5|||
44379634|NCT00818662|79385226|FG001|Overall Study|Withdrawal by Subject|4|||
44131352|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
44131353|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
44131354|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
44131355|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
44131356|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
44131357|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
44131358|NCT02337946|78917142|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
44131359|NCT02337946|78917143|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
44131360|NCT02337946|78917144|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
44131361|NCT02337946|78917142|FG000|In-between Period|Without Informed Consent|1|||
44131362|NCT02337946|78917143|FG001|In-between Period|Without Informed Consent|0|||
44131363|NCT02337946|78917144|FG002|In-between Period|Without Informed Consent|0|||
44379635|NCT00818662|79385227|FG002|Overall Study|Withdrawal by Subject|2|||
44131364|NCT02337946|78917142|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
44131365|NCT02337946|78917143|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
44131366|NCT02337946|78917144|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
44131367|NCT02337946|78917142|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
44131368|NCT02337946|78917143|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
44131369|NCT02337946|78917144|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
44131370|NCT02337946|78917142|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
44131371|NCT02337946|78917143|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
44131372|NCT02337946|78917144|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
44131373|NCT02337946|78917142|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
44131374|NCT02337946|78917143|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
44131375|NCT02337946|78917144|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
44131376|NCT02337946|78917142|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
44131377|NCT02337946|78917143|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
44131378|NCT02337946|78917144|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
44131379|NCT02337946|78917142|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
44131380|NCT02337946|78917143|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
44131381|NCT02337946|78917144|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
44131382|NCT01369199|78917150|FG000|Overall Study|Withdrawal by Subject|1|||
44131383|NCT01369199|78917150|FG000|Overall Study|Lost to Follow-up|2|||
44131384|NCT01368965|78917154|FG000|Overall Study|Lost to Follow-up|12|||
44131385|NCT02610140|78917162|FG000|Randomization and Treatment Period|Radiological progression|23|||
44131386|NCT02610140|78917163|FG001|Randomization and Treatment Period|Radiological progression|15|||
44131387|NCT02610140|78917162|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
44131388|NCT02610140|78917163|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
44131389|NCT02610140|78917162|FG000|Randomization and Treatment Period|Protocol Violation|1|||
44131390|NCT02610140|78917163|FG001|Randomization and Treatment Period|Protocol Violation|0|||
44131391|NCT02610140|78917162|FG000|Randomization and Treatment Period|Physician Decision|0|||
44131392|NCT02610140|78917163|FG001|Randomization and Treatment Period|Physician Decision|1|||
44131393|NCT02610140|78917162|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
44131394|NCT02610140|78917163|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
44131395|NCT02610140|78917162|FG000|Randomization and Treatment Period|Death|7|||
44131396|NCT02610140|78917163|FG001|Randomization and Treatment Period|Death|1|||
44131397|NCT02610140|78917162|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
44131398|NCT02610140|78917163|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
44131399|NCT02610140|78917162|FG000|Randomization and Treatment Period|Adverse Event|44|||
44131400|NCT02610140|78917163|FG001|Randomization and Treatment Period|Adverse Event|13|||
44131401|NCT02610140|78917162|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
44131402|NCT02610140|78917163|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
44131403|NCT02610140|78917162|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
44131404|NCT02610140|78917163|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
44131405|NCT02610140|78917162|FG000|Randomization and Treatment Period|Not treated|3|||
44131406|NCT02610140|78917163|FG001|Randomization and Treatment Period|Not treated|10|||
44131407|NCT02610140|78917162|FG000|Safety Follow-up|Other|0|||
44131408|NCT02610140|78917163|FG001|Safety Follow-up|Other|2|||
44379636|NCT00818662|79385228|FG003|Overall Study|Withdrawal by Subject|2|||
44131409|NCT02610140|78917162|FG000|Safety Follow-up|Lost to Follow-up|1|||
44379637|NCT00818662|79385225|FG000|Overall Study|Death|1|||
44131410|NCT02610140|78917163|FG001|Safety Follow-up|Lost to Follow-up|0|||
44131411|NCT02610140|78917162|FG000|Safety Follow-up|No follow-up|5|||
44131412|NCT02610140|78917163|FG001|Safety Follow-up|No follow-up|3|||
44512488|NCT03510884|79518056|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
44512489|NCT03510884|79518057|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
44512490|NCT03488472|79518091|FG000|Overall Study|disease progression additional mets|1|||
44512491|NCT03456453|79518097|FG000|Overall Study|Withdrawal by Subject|2|||
44512492|NCT03456453|79518098|FG001|Overall Study|Withdrawal by Subject|0|||
44512493|NCT03456453|79518097|FG000|Overall Study|Not released to community|1|||
44512494|NCT03456453|79518098|FG001|Overall Study|Not released to community|5|||
44512495|NCT03456453|79518097|FG000|Overall Study|Lost to Follow-up|0|||
44512496|NCT03456453|79518098|FG001|Overall Study|Lost to Follow-up|2|||
44512497|NCT03455829|79518109|FG000|Overall Study|Death|2|||
44512498|NCT03455829|79518110|FG001|Overall Study|Death|3|||
44512499|NCT03455829|79518111|FG002|Overall Study|Death|2|||
44512500|NCT03455829|79518112|FG003|Overall Study|Death|4|||
44512501|NCT03455829|79518113|FG004|Overall Study|Death|2|||
44512502|NCT03455829|79518109|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
44512503|NCT03455829|79518110|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
44512504|NCT03455829|79518111|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
44512505|NCT03455829|79518112|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
44512506|NCT03455829|79518113|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
44512507|NCT03455829|79518109|FG000|Overall Study|Disease progression|0|||
44512508|NCT03455829|79518110|FG001|Overall Study|Disease progression|0|||
44379638|NCT00818662|79385226|FG001|Overall Study|Death|3|||
44379639|NCT00818662|79385227|FG002|Overall Study|Death|0|||
44379640|NCT00818662|79385228|FG003|Overall Study|Death|0|||
44379641|NCT00818662|79385225|FG000|Overall Study|Physician Decision|1|||
44379642|NCT00818662|79385226|FG001|Overall Study|Physician Decision|0|||
44379643|NCT00818662|79385227|FG002|Overall Study|Physician Decision|0|||
44379644|NCT00818662|79385228|FG003|Overall Study|Physician Decision|0|||
44131413|NCT02610140|78917162|FG000|Safety Follow-up|Death|12|||
44131414|NCT02610140|78917163|FG001|Safety Follow-up|Death|2|||
44131415|NCT02610140|78917162|FG000|Safety Follow-up|Deterioration of general conditions|15|||
44131416|NCT02610140|78917163|FG001|Safety Follow-up|Deterioration of general conditions|5|||
44131417|NCT02610140|78917162|FG000|Safety Follow-up|Withdrawal by Subject|12|||
44131418|NCT02610140|78917163|FG001|Safety Follow-up|Withdrawal by Subject|12|||
44131419|NCT02610140|78917162|FG000|Active Follow-up|Progressive disease - radiological|30|||
44131420|NCT02610140|78917163|FG001|Active Follow-up|Progressive disease - radiological|22|||
44131421|NCT02610140|78917162|FG000|Active Follow-up|Death|8|||
44131422|NCT02610140|78917163|FG001|Active Follow-up|Death|1|||
44131423|NCT02610140|78917162|FG000|Active Follow-up|Withdrawal by Subject|4|||
44131424|NCT02610140|78917163|FG001|Active Follow-up|Withdrawal by Subject|0|||
44131425|NCT02610140|78917162|FG000|Active Follow-up|Progressive disease - clinical|1|||
44131426|NCT02610140|78917163|FG001|Active Follow-up|Progressive disease - clinical|2|||
44131427|NCT02610140|78917162|FG000|Active Follow-up|Deterioration of general conditions|1|||
44131428|NCT02610140|78917163|FG001|Active Follow-up|Deterioration of general conditions|0|||
44131429|NCT02610140|78917162|FG000|Active Follow-up|Ongoing but not completed|4|||
44131430|NCT02610140|78917163|FG001|Active Follow-up|Ongoing but not completed|1|||
44131431|NCT02610140|78917162|FG000|Long-term Follow-up|Death|86|||
44131432|NCT02610140|78917163|FG001|Long-term Follow-up|Death|44|||
44131433|NCT02610140|78917162|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
44379645|NCT00818662|79385225|FG000|Overall Study|Lost to Follow-up|0|||
44379646|NCT00818662|79385226|FG001|Overall Study|Lost to Follow-up|0|||
44512509|NCT03455829|79518111|FG002|Overall Study|Disease progression|0|||
44131434|NCT02610140|78917163|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
44379647|NCT00818662|79385227|FG002|Overall Study|Lost to Follow-up|0|||
44379648|NCT00818662|79385228|FG003|Overall Study|Lost to Follow-up|1|||
44379649|NCT00818662|79385225|FG000|Overall Study|Unwilling or Unable to Participate|4|||
44379650|NCT00818662|79385226|FG001|Overall Study|Unwilling or Unable to Participate|6|||
44131435|NCT02610140|78917162|FG000|Long-term Follow-up|Lost to Follow-up|1|||
44131436|NCT02610140|78917163|FG001|Long-term Follow-up|Lost to Follow-up|2|||
44131437|NCT02610140|78917162|FG000|Long-term Follow-up|Ongoing but not completed|30|||
44131438|NCT02610140|78917163|FG001|Long-term Follow-up|Ongoing but not completed|17|||
44379651|NCT00818662|79385227|FG002|Overall Study|Unwilling or Unable to Participate|2|||
44379652|NCT00818662|79385228|FG003|Overall Study|Unwilling or Unable to Participate|4|||
44379653|NCT00818662|79385225|FG000|Overall Study|Protocol Violation|1|||
44512510|NCT03455829|79518112|FG003|Overall Study|Disease progression|1|||
44512511|NCT03455829|79518113|FG004|Overall Study|Disease progression|1|||
44131439|NCT02789657|78917173|FG000|Overall Study|Withdrawal by Subject|2|||
44131440|NCT02789657|78917174|FG001|Overall Study|Withdrawal by Subject|0|||
44131441|NCT02789657|78917175|FG002|Overall Study|Withdrawal by Subject|0|||
44131442|NCT02789657|78917176|FG003|Overall Study|Withdrawal by Subject|0|||
44131443|NCT02609984|78917187|FG000|Overall Study|Death|29|||
44512512|NCT03441334|79518127|FG000|Overall Study|Withdrawal by Subject|1|||
44512513|NCT03441334|79518128|FG001|Overall Study|Withdrawal by Subject|0|||
44512514|NCT03429244|79518159|FG000|Overall Study|Withdrawal by Subject|2|||
44512515|NCT03429244|79518160|FG001|Overall Study|Withdrawal by Subject|1|||
44512516|NCT03429244|79518161|FG002|Overall Study|Withdrawal by Subject|1|||
44512517|NCT03250117|79518174|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
44512518|NCT03250117|79518175|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
44512519|NCT03250117|79518176|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
44512520|NCT03250117|79518177|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
44512521|NCT03230838|79518183|FG000|Overall Study|Withdrawal by Subject|3|||
44512522|NCT03230838|79518184|FG001|Overall Study|Withdrawal by Subject|0|||
44512523|NCT03230838|79518183|FG000|Overall Study|Temperature excursion|1|||
44512524|NCT03230838|79518184|FG001|Overall Study|Temperature excursion|0|||
44512525|NCT03217136|79518192|FG000|Overall Study|Lost to Follow-up|2|||
44512526|NCT03217136|79518193|FG001|Overall Study|Lost to Follow-up|1|||
44512527|NCT03217136|79518192|FG000|Overall Study|Site Randomized Participant in Error|0|||
44512528|NCT03217136|79518193|FG001|Overall Study|Site Randomized Participant in Error|1|||
44131444|NCT02609984|78917188|FG001|Overall Study|Death|26|||
44131445|NCT02609984|78917187|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
44243501|NCT01502293|79072931|FG000|Overall Study|Physician Decision|0|||
44243502|NCT01502293|79072932|FG001|Overall Study|Physician Decision|0|||
44243503|NCT01502293|79072933|FG002|Overall Study|Physician Decision|1|||
44243504|NCT01474681|79072946|FG000|Overall Study|Death|0|||
44243505|NCT01474681|79072947|FG001|Overall Study|Death|3|||
44243506|NCT01474681|79072948|FG002|Overall Study|Death|2|||
44243507|NCT01474681|79072949|FG003|Overall Study|Death|6|||
44243508|NCT01459783|79072965|FG000|Baseline to 6 Months|Death|1|||
44243509|NCT01459783|79072966|FG001|Baseline to 6 Months|Death|0|||
44243510|NCT01459783|79072965|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
44243511|NCT01459783|79072966|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
44243512|NCT01459783|79072965|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
44243513|NCT01459783|79072966|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
44243514|NCT01459783|79072965|FG000|6 Months to 12 Months|Death|0|||
44243515|NCT01459783|79072966|FG001|6 Months to 12 Months|Death|1|||
44243516|NCT01459783|79072965|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
44131446|NCT02609984|78917188|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
44131447|NCT02609984|78917187|FG000|Overall Study|Lost to Follow-up|1|||
44131448|NCT02609984|78917188|FG001|Overall Study|Lost to Follow-up|2|||
44131449|NCT02609984|78917187|FG000|Overall Study|Withdrawal by Subject|0|||
44243517|NCT01459783|79072966|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
44243518|NCT01459783|79072965|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
44243519|NCT01459783|79072966|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
44243520|NCT01459783|79072965|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
44243521|NCT01459783|79072966|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
44243522|NCT01588184|79072978|FG000|Overall Study|Death|1|||
44243523|NCT01588184|79072979|FG001|Overall Study|Death|0|||
44243524|NCT01588184|79072980|FG002|Overall Study|Death|0|||
44243525|NCT01588184|79072981|FG003|Overall Study|Death|1|||
44512529|NCT03217136|79518192|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
44512530|NCT03217136|79518193|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
44512531|NCT03217136|79518192|FG000|Overall Study|Dispensing Error|1|||
44512532|NCT03217136|79518193|FG001|Overall Study|Dispensing Error|0|||
44131450|NCT02609984|78917188|FG001|Overall Study|Withdrawal by Subject|1|||
44131451|NCT02609984|78917187|FG000|Overall Study|Disease Progression|2|||
44131452|NCT02609984|78917188|FG001|Overall Study|Disease Progression|0|||
44131453|NCT02609672|78917196|FG000|Overall Study|Lost to Follow-up|3|||
44131454|NCT02609672|78917197|FG001|Overall Study|Lost to Follow-up|1|||
44131455|NCT02611778|78917205|FG000|Overall Study|Withdrawal by Subject|2|||
44131456|NCT02611778|78917206|FG001|Overall Study|Withdrawal by Subject|8|||
44131457|NCT02611778|78917205|FG000|Overall Study|Adverse Event|1|||
44131458|NCT02611778|78917206|FG001|Overall Study|Adverse Event|2|||
44131459|NCT02611778|78917205|FG000|Overall Study|Death|2|||
44131460|NCT02611778|78917206|FG001|Overall Study|Death|1|||
44131461|NCT02611778|78917205|FG000|Overall Study|Protocol Violation|1|||
44131462|NCT02611778|78917206|FG001|Overall Study|Protocol Violation|0|||
44131463|NCT02611778|78917205|FG000|Overall Study|Lost to Follow-up|3|||
44131464|NCT02611778|78917206|FG001|Overall Study|Lost to Follow-up|1|||
44131465|NCT02611778|78917205|FG000|Overall Study|Need for alternative treatment|1|||
44131466|NCT02611778|78917206|FG001|Overall Study|Need for alternative treatment|0|||
44131467|NCT02611778|78917205|FG000|Overall Study|Other Reason|2|||
44131468|NCT02611778|78917206|FG001|Overall Study|Other Reason|1|||
44131469|NCT02709369|78917213|FG000|Overall Study|Lost to Follow-up|15|||
44131470|NCT02709369|78917213|FG000|Overall Study|Withdrawal by Subject|10|||
44131471|NCT02709369|78917213|FG000|Overall Study|Did not received intervention|2|||
44131472|NCT02613182|78917217|FG000|Overall Study|Death|6|||
44131473|NCT02613182|78917217|FG000|Overall Study|Physician Decision|1|||
44131474|NCT02613182|78917217|FG000|Overall Study|Study Terminated by Sponsor|21|||
44131475|NCT02613182|78917217|FG000|Overall Study|Withdrawal by Subject|6|||
44131476|NCT04843579|78917243|FG000|Overall Study|Adverse Event|1|||
44131477|NCT04843579|78917243|FG000|Overall Study|Disease Progression|1|||
44131478|NCT04649359|78917249|FG000|Overall Study|Withdrawal by Subject|7|||
44131479|NCT04649359|78917250|FG001|Overall Study|Withdrawal by Subject|7|||
44131480|NCT04649359|78917249|FG000|Overall Study|Death|41|||
44131481|NCT04649359|78917250|FG001|Overall Study|Death|26|||
44131482|NCT04649359|78917249|FG000|Overall Study|Ongoing in the study|75|||
44131483|NCT04649359|78917250|FG001|Overall Study|Ongoing in the study|31|||
44131484|NCT04567693|78917272|FG000|Overall Study|Death|0|||
44131485|NCT04567693|78917273|FG001|Overall Study|Death|0|||
44131486|NCT04567693|78917274|FG002|Overall Study|Death|2|||
44131487|NCT04567693|78917272|FG000|Overall Study|Lost to Follow-up|1|||
44131488|NCT04567693|78917273|FG001|Overall Study|Lost to Follow-up|0|||
44131489|NCT04567693|78917274|FG002|Overall Study|Lost to Follow-up|2|||
44131490|NCT04567693|78917272|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
44131491|NCT04567693|78917273|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
44131492|NCT04567693|78917274|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
44131493|NCT04238663|78917285|FG000|Overall Study|Lost to Follow-up|0|||
44131494|NCT04238663|78917286|FG001|Overall Study|Lost to Follow-up|1|||
44131495|NCT04238663|78917287|FG002|Overall Study|Lost to Follow-up|0|||
44131496|NCT04139642|78917307|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
44131497|NCT04139642|78917308|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
44131498|NCT03980483|78917351|FG000|Overall Study|Adverse Event|13|||
44131499|NCT03980483|78917352|FG001|Overall Study|Adverse Event|29|||
44131500|NCT03980483|78917353|FG002|Overall Study|Adverse Event|11|||
44131501|NCT03980483|78917354|FG003|Overall Study|Adverse Event|2|||
44131502|NCT03980483|78917355|FG004|Overall Study|Adverse Event|2|||
44131503|NCT03980483|78917356|FG005|Overall Study|Adverse Event|2|||
44131504|NCT03980483|78917351|FG000|Overall Study|Lack of Efficacy|7|||
44131505|NCT03980483|78917352|FG001|Overall Study|Lack of Efficacy|6|||
44131506|NCT03980483|78917353|FG002|Overall Study|Lack of Efficacy|0|||
44131507|NCT03980483|78917354|FG003|Overall Study|Lack of Efficacy|3|||
44243526|NCT01588184|79072982|FG004|Overall Study|Death|1|||
44243527|NCT01588184|79072983|FG005|Overall Study|Death|1|||
44131508|NCT03980483|78917355|FG004|Overall Study|Lack of Efficacy|1|||
44131509|NCT03980483|78917356|FG005|Overall Study|Lack of Efficacy|1|||
44243528|NCT01588184|79072978|FG000|Overall Study|Withdrawal by Subject|2|||
44131510|NCT03980483|78917351|FG000|Overall Study|Lost to Follow-up|2|||
44131511|NCT03980483|78917352|FG001|Overall Study|Lost to Follow-up|4|||
44131512|NCT03980483|78917353|FG002|Overall Study|Lost to Follow-up|2|||
44131513|NCT03980483|78917354|FG003|Overall Study|Lost to Follow-up|1|||
44131514|NCT03980483|78917355|FG004|Overall Study|Lost to Follow-up|2|||
44131515|NCT03980483|78917356|FG005|Overall Study|Lost to Follow-up|0|||
44243529|NCT01588184|79072979|FG001|Overall Study|Withdrawal by Subject|4|||
44131516|NCT03980483|78917351|FG000|Overall Study|Protocol Violation|4|||
44131517|NCT03980483|78917352|FG001|Overall Study|Protocol Violation|2|||
44131518|NCT03980483|78917353|FG002|Overall Study|Protocol Violation|1|||
44131519|NCT03980483|78917354|FG003|Overall Study|Protocol Violation|1|||
44131520|NCT03980483|78917355|FG004|Overall Study|Protocol Violation|0|||
44131521|NCT03980483|78917356|FG005|Overall Study|Protocol Violation|0|||
44243530|NCT01588184|79072980|FG002|Overall Study|Withdrawal by Subject|0|||
44131522|NCT03980483|78917351|FG000|Overall Study|Physician Decision|14|||
44131523|NCT03980483|78917352|FG001|Overall Study|Physician Decision|10|||
44131524|NCT03980483|78917353|FG002|Overall Study|Physician Decision|7|||
44131525|NCT03980483|78917354|FG003|Overall Study|Physician Decision|4|||
44131526|NCT03980483|78917355|FG004|Overall Study|Physician Decision|4|||
44131527|NCT03980483|78917356|FG005|Overall Study|Physician Decision|2|||
44131528|NCT03980483|78917351|FG000|Overall Study|Withdrawal by Subject|38|||
44131529|NCT03980483|78917352|FG001|Overall Study|Withdrawal by Subject|21|||
44131530|NCT03980483|78917353|FG002|Overall Study|Withdrawal by Subject|15|||
44131531|NCT03980483|78917354|FG003|Overall Study|Withdrawal by Subject|5|||
44131532|NCT03980483|78917355|FG004|Overall Study|Withdrawal by Subject|3|||
44131533|NCT03980483|78917356|FG005|Overall Study|Withdrawal by Subject|4|||
44131534|NCT03980483|78917351|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
44131535|NCT03980483|78917352|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
44131536|NCT03980483|78917353|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44131537|NCT03980483|78917354|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
44131538|NCT03980483|78917355|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44131539|NCT03980483|78917356|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44131540|NCT03980483|78917351|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
44131541|NCT03980483|78917352|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
44131542|NCT03980483|78917353|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
44131543|NCT03980483|78917354|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
44131544|NCT03980483|78917355|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
44131545|NCT03980483|78917356|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
44131546|NCT03980483|78917351|FG000|Overall Study|Other|0|||
44131547|NCT03980483|78917352|FG001|Overall Study|Other|1|||
44131548|NCT03980483|78917353|FG002|Overall Study|Other|0|||
44131549|NCT03980483|78917354|FG003|Overall Study|Other|0|||
44131550|NCT03980483|78917355|FG004|Overall Study|Other|0|||
44131551|NCT03980483|78917356|FG005|Overall Study|Other|0|||
44131552|NCT03510468|78917397|FG000|Overall Study|Lost to Follow-up|1|||
44131553|NCT03510468|78917397|FG000|Overall Study|Adverse Event|5|||
44131554|NCT03510468|78917397|FG000|Overall Study|Physician Decision|1|||
44131555|NCT03510468|78917397|FG000|Overall Study|non-compliant with treatment|2|||
44131556|NCT03510468|78917397|FG000|Overall Study|Missed visit|1|||
44131557|NCT03374202|78917404|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
44131558|NCT03374202|78917405|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
44131559|NCT03374202|78917406|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
44131560|NCT03374202|78917404|FG000|Five Year Long Term Follow Up|Death|0|||
44131561|NCT03374202|78917405|FG001|Five Year Long Term Follow Up|Death|1|||
44131562|NCT03374202|78917406|FG002|Five Year Long Term Follow Up|Death|0|||
44131563|NCT03218826|78917428|FG000|Overall Study|Non-compliance with protocol|1|||
44131564|NCT03218826|78917429|FG001|Overall Study|Non-compliance with protocol|0|||
44131565|NCT03218826|78917430|FG002|Overall Study|Non-compliance with protocol|2|||
44131566|NCT03218826|78917431|FG003|Overall Study|Non-compliance with protocol|1|||
44131567|NCT03218826|78917432|FG004|Overall Study|Non-compliance with protocol|1|||
44131568|NCT03075215|78917444|FG000|12-Month Primary Endpoint|Death|152|||
44131569|NCT03075215|78917444|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
44131570|NCT03075215|78917444|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
44131571|NCT03075215|78917444|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
44243531|NCT01588184|79072981|FG003|Overall Study|Withdrawal by Subject|1|||
44243532|NCT01588184|79072982|FG004|Overall Study|Withdrawal by Subject|0|||
44131572|NCT03063632|78917450|FG000|Overall Study|Death|4|||
44131573|NCT03063632|78917451|FG001|Overall Study|Death|6|||
44131574|NCT03063632|78917450|FG000|Overall Study|Lost to Follow-up|0|||
44243533|NCT01588184|79072983|FG005|Overall Study|Withdrawal by Subject|0|||
44243534|NCT01588184|79072978|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
44512533|NCT03217136|79518192|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44512534|NCT03217136|79518193|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44512535|NCT03179761|79518201|FG000|Overall Study|Death|2|||
44131575|NCT03063632|78917451|FG001|Overall Study|Lost to Follow-up|1|||
44131576|NCT03063632|78917450|FG000|Overall Study|Withdrawal by Subject|0|||
44512536|NCT03179761|79518202|FG001|Overall Study|Death|5|||
44512537|NCT03179761|79518201|FG000|Overall Study|Lost to Follow-up|2|||
44512538|NCT03179761|79518202|FG001|Overall Study|Lost to Follow-up|2|||
44512539|NCT03179761|79518201|FG000|Overall Study|Protocol Violation|1|||
44512540|NCT03179761|79518202|FG001|Overall Study|Protocol Violation|0|||
44512541|NCT03179761|79518201|FG000|Overall Study|Withdrawal by Subject|1|||
44512542|NCT03179761|79518202|FG001|Overall Study|Withdrawal by Subject|4|||
44512543|NCT03179761|79518201|FG000|Overall Study|Investigator Request|0|||
44131577|NCT03063632|78917451|FG001|Overall Study|Withdrawal by Subject|2|||
44131578|NCT03063632|78917450|FG000|Overall Study|Physician Decision|2|||
44131579|NCT03063632|78917451|FG001|Overall Study|Physician Decision|0|||
44131580|NCT03063632|78917450|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
44276560|NCT03603314|79237531|FG002|Overall Study|Lost to Follow-up|0|||
44131581|NCT03063632|78917451|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
44131582|NCT02759731|78917471|FG000|Overall Study|Did not complete treatment.|8|||
44131583|NCT02665117|78917479|FG000|Overall Study|Physician Decision|1|||
44131584|NCT02665117|78917480|FG001|Overall Study|Physician Decision|0|||
44131585|NCT02617485|78917488|FG000|Treatment and Observation Period|Adverse Event|9|||
44131586|NCT02617485|78917489|FG001|Treatment and Observation Period|Adverse Event|1|||
44131587|NCT02617485|78917488|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
44131588|NCT02617485|78917489|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
44131589|NCT02617485|78917488|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
44131590|NCT02617485|78917489|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
44131591|NCT02617485|78917488|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
44131592|NCT02617485|78917489|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
44131593|NCT02617485|78917488|FG000|Treatment and Observation Period|Physician Decision|0|||
44131594|NCT02617485|78917489|FG001|Treatment and Observation Period|Physician Decision|1|||
44131595|NCT02617485|78917488|FG000|Follow-up Period|Adverse Event|1|||
44131596|NCT02617485|78917489|FG001|Follow-up Period|Adverse Event|0|||
44131597|NCT02617485|78917488|FG000|Follow-up Period|Withdrawal by Subject|1|||
44131598|NCT02617485|78917489|FG001|Follow-up Period|Withdrawal by Subject|0|||
44131599|NCT02617485|78917488|FG000|Follow-up Period|Disease progression|2|||
44131600|NCT02617485|78917489|FG001|Follow-up Period|Disease progression|1|||
44131601|NCT02617485|78917488|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
44131602|NCT02617485|78917489|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
44131603|NCT02617485|78917488|FG000|Follow-up Period|Patient needed radiotherapy|9|||
44131604|NCT02617485|78917489|FG001|Follow-up Period|Patient needed radiotherapy|5|||
44131605|NCT02617485|78917488|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
44131606|NCT02617485|78917489|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
44131607|NCT02589522|78917498|FG000|Overall Study|Physician Decision|1|||
44131608|NCT02589522|78917499|FG001|Overall Study|Physician Decision|2|||
44131609|NCT02589522|78917500|FG002|Overall Study|Physician Decision|0|||
44131610|NCT02589522|78917498|FG000|Overall Study|Did not start treatment|1|||
44131611|NCT02589522|78917499|FG001|Overall Study|Did not start treatment|0|||
44131612|NCT02589522|78917500|FG002|Overall Study|Did not start treatment|0|||
44131613|NCT02485860|78917510|FG000|Overall Study|Lost to Follow-up|4|||
44131614|NCT02485860|78917511|FG001|Overall Study|Lost to Follow-up|1|||
44131615|NCT02485860|78917510|FG000|Overall Study|Physician Decision|1|||
44131616|NCT02485860|78917511|FG001|Overall Study|Physician Decision|2|||
44131617|NCT02485860|78917510|FG000|Overall Study|Health context (COVID-19)|1|||
44131618|NCT02485860|78917511|FG001|Overall Study|Health context (COVID-19)|0|||
44131619|NCT02385123|78917517|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
44131620|NCT02337686|78917521|FG000|Overall Study|Adverse Event|1|||
44131621|NCT02097420|78917525|FG000|Overall Study|Death|6|||
44131622|NCT02097420|78917525|FG000|Overall Study|Valve explanted|13|||
44131623|NCT02097420|78917525|FG000|Overall Study|Other Reason|1|||
44131624|NCT02000115|78917532|FG000|Overall Study|Death|56|||
44131625|NCT02000115|78917533|FG001|Overall Study|Death|45|||
44131626|NCT02000115|78917534|FG002|Overall Study|Death|0|||
44131627|NCT02000115|78917535|FG003|Overall Study|Death|0|||
44131628|NCT02000115|78917532|FG000|Overall Study|Missed Visit|6|||
44131629|NCT02000115|78917533|FG001|Overall Study|Missed Visit|8|||
44131630|NCT02000115|78917534|FG002|Overall Study|Missed Visit|1|||
44131631|NCT02000115|78917535|FG003|Overall Study|Missed Visit|0|||
44131632|NCT02000115|78917532|FG000|Overall Study|Protocol Violation|2|||
44131633|NCT02000115|78917533|FG001|Overall Study|Protocol Violation|1|||
44131634|NCT02000115|78917534|FG002|Overall Study|Protocol Violation|0|||
44131635|NCT02000115|78917535|FG003|Overall Study|Protocol Violation|0|||
44131636|NCT02000115|78917532|FG000|Overall Study|Physician Decision|2|||
44131637|NCT02000115|78917533|FG001|Overall Study|Physician Decision|0|||
44131638|NCT02000115|78917534|FG002|Overall Study|Physician Decision|0|||
44131639|NCT02000115|78917535|FG003|Overall Study|Physician Decision|0|||
44131640|NCT02000115|78917532|FG000|Overall Study|Withdrawal by Subject|11|||
44131641|NCT02000115|78917533|FG001|Overall Study|Withdrawal by Subject|11|||
44131642|NCT02000115|78917534|FG002|Overall Study|Withdrawal by Subject|0|||
44131643|NCT02000115|78917535|FG003|Overall Study|Withdrawal by Subject|0|||
44131644|NCT02000115|78917532|FG000|Overall Study|Lost to Follow-up|0|||
44131645|NCT02000115|78917533|FG001|Overall Study|Lost to Follow-up|1|||
44131646|NCT02000115|78917534|FG002|Overall Study|Lost to Follow-up|0|||
44131647|NCT02000115|78917535|FG003|Overall Study|Lost to Follow-up|0|||
44131648|NCT02000115|78917532|FG000|Overall Study|Non-compliance|2|||
44131649|NCT02000115|78917533|FG001|Overall Study|Non-compliance|1|||
44131650|NCT02000115|78917534|FG002|Overall Study|Non-compliance|0|||
44131651|NCT02000115|78917535|FG003|Overall Study|Non-compliance|0|||
44131652|NCT02000115|78917532|FG000|Overall Study|Withdrawn on day of randomization|0|||
44131653|NCT02000115|78917533|FG001|Overall Study|Withdrawn on day of randomization|1|||
44243535|NCT01588184|79072979|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
44131654|NCT02000115|78917534|FG002|Overall Study|Withdrawn on day of randomization|0|||
44131655|NCT02000115|78917535|FG003|Overall Study|Withdrawn on day of randomization|0|||
44131656|NCT02000115|78917532|FG000|Overall Study|Still on Study|0|||
44131657|NCT02000115|78917533|FG001|Overall Study|Still on Study|0|||
44131658|NCT02000115|78917534|FG002|Overall Study|Still on Study|0|||
44131659|NCT02000115|78917535|FG003|Overall Study|Still on Study|53|||
44131660|NCT00113360|78917571|FG000|Overall Study|Adverse Event|3|||
44131661|NCT00113360|78917571|FG000|Overall Study|Subject required surgery|1|||
44131662|NCT00113360|78917571|FG000|Overall Study|Did not meet eligibility criteria|3|||
44131663|NCT00087685|78917575|FG000|Overall Study|Adverse Event|5|||
44131664|NCT00087685|78917575|FG000|Overall Study|Non-Compliance|1|||
44131665|NCT00087685|78917575|FG000|Overall Study|Progressive Disease|5|||
44131666|NCT00087685|78917575|FG000|Overall Study|Withdrawal by Subject|3|||
44131667|NCT02610842|78917579|FG000|Overall Study|Lost to Follow-up|5|||
44131668|NCT01648582|78917588|FG000|Overall Study|Adverse Event|6|||
44131669|NCT01648582|78917589|FG001|Overall Study|Adverse Event|11|||
44131670|NCT01648582|78917590|FG002|Overall Study|Adverse Event|2|||
44131671|NCT01648582|78917588|FG000|Overall Study|Lost to Follow-up|9|||
44131672|NCT01648582|78917589|FG001|Overall Study|Lost to Follow-up|6|||
44131673|NCT01648582|78917590|FG002|Overall Study|Lost to Follow-up|8|||
44512544|NCT03179761|79518202|FG001|Overall Study|Investigator Request|2|||
44512545|NCT03155841|79518210|FG000|Overall Study|Protocol Violation|3|||
44512546|NCT03155841|79518211|FG001|Overall Study|Protocol Violation|4|||
44512547|NCT03114891|79518221|FG000|First Treatment Round|Lost to Follow-up|0|||
44512548|NCT03114891|79518222|FG001|First Treatment Round|Lost to Follow-up|1|||
44512549|NCT03114891|79518223|FG002|First Treatment Round|Lost to Follow-up|1|||
44512550|NCT03114891|79518224|FG003|First Treatment Round|Lost to Follow-up|0|||
44512551|NCT03114891|79518221|FG000|First Treatment Round|Withdrawal by Subject|0|||
44512552|NCT03114891|79518222|FG001|First Treatment Round|Withdrawal by Subject|2|||
44512553|NCT03114891|79518223|FG002|First Treatment Round|Withdrawal by Subject|0|||
44512554|NCT03114891|79518224|FG003|First Treatment Round|Withdrawal by Subject|1|||
44512555|NCT03114891|79518221|FG000|3 Week Break|Lost to Follow-up|1|||
44512556|NCT03114891|79518222|FG001|3 Week Break|Lost to Follow-up|0|||
44512557|NCT03114891|79518223|FG002|3 Week Break|Lost to Follow-up|0|||
44512558|NCT03114891|79518224|FG003|3 Week Break|Lost to Follow-up|1|||
44512559|NCT03114891|79518221|FG000|3 Week Break|Withdrawal by Subject|0|||
44512560|NCT03114891|79518222|FG001|3 Week Break|Withdrawal by Subject|1|||
44512561|NCT03114891|79518223|FG002|3 Week Break|Withdrawal by Subject|0|||
44512562|NCT03114891|79518224|FG003|3 Week Break|Withdrawal by Subject|0|||
44131674|NCT01648582|78917588|FG000|Overall Study|Protocol Violation|1|||
44131675|NCT01648582|78917589|FG001|Overall Study|Protocol Violation|2|||
44131676|NCT01648582|78917590|FG002|Overall Study|Protocol Violation|1|||
44131677|NCT01648582|78917588|FG000|Overall Study|Withdrawal by Subject|15|||
44131678|NCT01648582|78917589|FG001|Overall Study|Withdrawal by Subject|17|||
44131679|NCT01648582|78917590|FG002|Overall Study|Withdrawal by Subject|17|||
44131680|NCT01648582|78917588|FG000|Overall Study|Physician Decision|0|||
44131681|NCT01648582|78917589|FG001|Overall Study|Physician Decision|1|||
44131682|NCT01648582|78917590|FG002|Overall Study|Physician Decision|3|||
44131683|NCT01648582|78917588|FG000|Overall Study|Death|1|||
44131684|NCT01648582|78917589|FG001|Overall Study|Death|0|||
44131685|NCT01648582|78917590|FG002|Overall Study|Death|0|||
44131686|NCT01648582|78917588|FG000|Overall Study|Sponsor Decision|0|||
44131687|NCT01648582|78917589|FG001|Overall Study|Sponsor Decision|1|||
44131688|NCT01648582|78917590|FG002|Overall Study|Sponsor Decision|1|||
44131689|NCT02607800|78917603|FG000|Overall Study|Lost to Follow-up|7|||
44131690|NCT02607800|78917604|FG001|Overall Study|Lost to Follow-up|10|||
44131691|NCT02607800|78917603|FG000|Overall Study|Withdrew Consent|2|||
44131692|NCT02607800|78917604|FG001|Overall Study|Withdrew Consent|0|||
44131693|NCT02607800|78917603|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
44131694|NCT02607800|78917604|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
44131695|NCT02304484|78917611|FG000|Overall Study|Death|9|||
44131696|NCT02304484|78917611|FG000|Overall Study|Withdrawal by Subject|14|||
44131697|NCT02304484|78917611|FG000|Overall Study|Lost to Follow-up|2|||
44131698|NCT02708355|78917618|FG000|Overall Study|Adverse Event|1|||
44131699|NCT02708355|78917619|FG001|Overall Study|Adverse Event|0|||
44131700|NCT02708355|78917620|FG002|Overall Study|Adverse Event|0|||
44131701|NCT02708277|78917630|FG000|Overall Study|Lost to Follow-up|7|||
44131702|NCT02708277|78917631|FG001|Overall Study|Lost to Follow-up|4|||
44131703|NCT02337478|78917637|FG000|Overall Study|Lack of Efficacy|5|||
44131704|NCT02303704|78917643|FG000|Overall Study|Protocol Violation|5|||
44131705|NCT02303704|78917644|FG001|Overall Study|Protocol Violation|9|||
44131706|NCT02608892|78917652|FG000|Overall Study|Lost to Follow-up|1|||
44131707|NCT02608892|78917653|FG001|Overall Study|Lost to Follow-up|0|||
44131708|NCT02708121|78917662|FG000|Overall Study|Withdrawn by Study Team|1|||
44131709|NCT02708121|78917663|FG001|Overall Study|Withdrawn by Study Team|1|||
44131710|NCT02708121|78917662|FG000|Overall Study|Withdrawal by Subject|0|||
44131711|NCT02708121|78917663|FG001|Overall Study|Withdrawal by Subject|4|||
44131712|NCT02707965|78917678|FG000|Overall Study|Withdrawal by Subject|0|||
44131713|NCT02707965|78917679|FG001|Overall Study|Withdrawal by Subject|0|||
44131714|NCT02707965|78917680|FG002|Overall Study|Withdrawal by Subject|1|||
44131715|NCT02707965|78917681|FG003|Overall Study|Withdrawal by Subject|0|||
44131716|NCT02707965|78917682|FG004|Overall Study|Withdrawal by Subject|0|||
44131717|NCT02707965|78917683|FG005|Overall Study|Withdrawal by Subject|0|||
44131718|NCT02707965|78917684|FG006|Overall Study|Withdrawal by Subject|0|||
44131719|NCT02707965|78917685|FG007|Overall Study|Withdrawal by Subject|2|||
44131720|NCT02707965|78917686|FG008|Overall Study|Withdrawal by Subject|0|||
44131721|NCT02707965|78917687|FG009|Overall Study|Withdrawal by Subject|0|||
44131722|NCT02707965|78917688|FG010|Overall Study|Withdrawal by Subject|0|||
44131723|NCT02707965|78917689|FG011|Overall Study|Withdrawal by Subject|0|||
44131724|NCT02707965|78917690|FG012|Overall Study|Withdrawal by Subject|0|||
44131725|NCT02707965|78917691|FG013|Overall Study|Withdrawal by Subject|0|||
44131726|NCT02707965|78917692|FG014|Overall Study|Withdrawal by Subject|0|||
44131727|NCT02707965|78917693|FG015|Overall Study|Withdrawal by Subject|0|||
44131728|NCT02707965|78917678|FG000|Overall Study|PI decisions|0|||
44131729|NCT02707965|78917679|FG001|Overall Study|PI decisions|0|||
44131730|NCT02707965|78917680|FG002|Overall Study|PI decisions|0|||
44131731|NCT02707965|78917681|FG003|Overall Study|PI decisions|0|||
44131732|NCT02707965|78917682|FG004|Overall Study|PI decisions|0|||
44131733|NCT02707965|78917683|FG005|Overall Study|PI decisions|0|||
44131734|NCT02707965|78917684|FG006|Overall Study|PI decisions|0|||
44131735|NCT02707965|78917685|FG007|Overall Study|PI decisions|0|||
44131736|NCT02707965|78917686|FG008|Overall Study|PI decisions|0|||
44131737|NCT02707965|78917687|FG009|Overall Study|PI decisions|0|||
44512563|NCT03114891|79518221|FG000|Second Treatment Round|Lost to Follow-up|1|||
44512564|NCT03114891|79518222|FG001|Second Treatment Round|Lost to Follow-up|0|||
44512565|NCT03114891|79518223|FG002|Second Treatment Round|Lost to Follow-up|0|||
44512566|NCT03114891|79518224|FG003|Second Treatment Round|Lost to Follow-up|0|||
44512567|NCT03114891|79518221|FG000|Second Treatment Round|Physician Decision|1|||
44512568|NCT03114891|79518222|FG001|Second Treatment Round|Physician Decision|0|||
44512569|NCT03114891|79518223|FG002|Second Treatment Round|Physician Decision|0|||
44512570|NCT03114891|79518224|FG003|Second Treatment Round|Physician Decision|0|||
44512571|NCT03057847|79518266|FG000|Overall Study|Lost to Follow-up|16|||
44131738|NCT02707965|78917688|FG010|Overall Study|PI decisions|0|||
44131739|NCT02707965|78917689|FG011|Overall Study|PI decisions|0|||
44512572|NCT02946463|79518281|FG000|Primary Evaluation Period|Physician Decision|0|||
44512573|NCT02946463|79518282|FG001|Primary Evaluation Period|Physician Decision|1|||
44131740|NCT02707965|78917690|FG012|Overall Study|PI decisions|0|||
44131741|NCT02707965|78917691|FG013|Overall Study|PI decisions|0|||
44131742|NCT02707965|78917692|FG014|Overall Study|PI decisions|2|||
44131743|NCT02707965|78917693|FG015|Overall Study|PI decisions|0|||
44131744|NCT02707965|78917678|FG000|Overall Study|Protocol deviation|1|||
44131745|NCT02707965|78917679|FG001|Overall Study|Protocol deviation|1|||
44131746|NCT02707965|78917680|FG002|Overall Study|Protocol deviation|0|||
44131747|NCT02707965|78917681|FG003|Overall Study|Protocol deviation|0|||
44131748|NCT02707965|78917682|FG004|Overall Study|Protocol deviation|0|||
44131749|NCT02707965|78917683|FG005|Overall Study|Protocol deviation|0|||
44131750|NCT02707965|78917684|FG006|Overall Study|Protocol deviation|0|||
44131751|NCT02707965|78917685|FG007|Overall Study|Protocol deviation|1|||
44131752|NCT02707965|78917686|FG008|Overall Study|Protocol deviation|0|||
44131753|NCT02707965|78917687|FG009|Overall Study|Protocol deviation|0|||
44131754|NCT02707965|78917688|FG010|Overall Study|Protocol deviation|0|||
44131755|NCT02707965|78917689|FG011|Overall Study|Protocol deviation|0|||
44131756|NCT02707965|78917690|FG012|Overall Study|Protocol deviation|0|||
44131757|NCT02707965|78917691|FG013|Overall Study|Protocol deviation|0|||
44131758|NCT02707965|78917692|FG014|Overall Study|Protocol deviation|0|||
44131759|NCT02707965|78917693|FG015|Overall Study|Protocol deviation|0|||
44131760|NCT01667900|78917731|FG000|Part B|Death|0|||
44131761|NCT01667900|78917732|FG001|Part B|Death|0|||
44131762|NCT01667900|78917733|FG002|Part B|Death|0|||
44131763|NCT01667900|78917734|FG003|Part B|Death|0|||
44131764|NCT01667900|78917735|FG004|Part B|Death|0|||
44131765|NCT01667900|78917736|FG005|Part B|Death|0|||
44131766|NCT01667900|78917737|FG006|Part B|Death|0|||
44131767|NCT01667900|78917738|FG007|Part B|Death|0|||
44131768|NCT01667900|78917739|FG008|Part B|Death|0|||
44131769|NCT01667900|78917740|FG009|Part B|Death|0|||
44131770|NCT01667900|78917741|FG010|Part B|Death|0|||
44131771|NCT01667900|78917742|FG011|Part B|Death|0|||
44131772|NCT01667900|78917743|FG012|Part B|Death|0|||
44131773|NCT01667900|78917744|FG013|Part B|Death|0|||
44131774|NCT01667900|78917745|FG014|Part B|Death|0|||
44131775|NCT01667900|78917746|FG015|Part B|Death|0|||
44131776|NCT01667900|78917747|FG016|Part B|Death|1|||
44131777|NCT01667900|78917748|FG017|Part B|Death|0|||
44131778|NCT01667900|78917749|FG018|Part B|Death|0|||
44131779|NCT01667900|78917750|FG019|Part B|Death|0|||
44379654|NCT00818662|79385226|FG001|Overall Study|Protocol Violation|1|||
44379655|NCT00818662|79385227|FG002|Overall Study|Protocol Violation|0|||
44379656|NCT00818662|79385228|FG003|Overall Study|Protocol Violation|0|||
44379657|NCT00818662|79385225|FG000|Overall Study|Requires a Prohibited Medication|1|||
44379658|NCT00818662|79385226|FG001|Overall Study|Requires a Prohibited Medication|0|||
44379659|NCT00818662|79385227|FG002|Overall Study|Requires a Prohibited Medication|0|||
44379660|NCT00818662|79385228|FG003|Overall Study|Requires a Prohibited Medication|0|||
44379661|NCT00818662|79385225|FG000|Overall Study|Safety Risk|1|||
44379662|NCT00818662|79385226|FG001|Overall Study|Safety Risk|1|||
44379663|NCT00818662|79385227|FG002|Overall Study|Safety Risk|0|||
44379664|NCT00818662|79385228|FG003|Overall Study|Safety Risk|1|||
44512574|NCT02946463|79518281|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
44512575|NCT02946463|79518282|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
44512576|NCT02761694|79518335|FG000|Overall Study|Lack of Efficacy|0|||
44512577|NCT02761694|79518336|FG001|Overall Study|Lack of Efficacy|0|||
44512578|NCT02761694|79518337|FG002|Overall Study|Lack of Efficacy|0|||
44512579|NCT02761694|79518338|FG003|Overall Study|Lack of Efficacy|0|||
44512580|NCT02761694|79518339|FG004|Overall Study|Lack of Efficacy|0|||
44512581|NCT02761694|79518340|FG005|Overall Study|Lack of Efficacy|0|||
44512582|NCT02761694|79518341|FG006|Overall Study|Lack of Efficacy|6|||
44512583|NCT02761694|79518342|FG007|Overall Study|Lack of Efficacy|0|||
44512584|NCT02761694|79518343|FG008|Overall Study|Lack of Efficacy|0|||
44512585|NCT02761694|79518344|FG009|Overall Study|Lack of Efficacy|1|||
44512586|NCT02761694|79518345|FG010|Overall Study|Lack of Efficacy|1|||
44512587|NCT02761694|79518346|FG011|Overall Study|Lack of Efficacy|4|||
44512588|NCT02761694|79518335|FG000|Overall Study|Death|0|||
44512589|NCT02761694|79518336|FG001|Overall Study|Death|0|||
44512590|NCT02761694|79518337|FG002|Overall Study|Death|0|||
44512591|NCT02761694|79518338|FG003|Overall Study|Death|0|||
44512592|NCT02761694|79518339|FG004|Overall Study|Death|0|||
44512593|NCT02761694|79518340|FG005|Overall Study|Death|0|||
44512594|NCT02761694|79518341|FG006|Overall Study|Death|2|||
44512595|NCT02761694|79518342|FG007|Overall Study|Death|0|||
44512596|NCT02761694|79518343|FG008|Overall Study|Death|2|||
44512597|NCT02761694|79518344|FG009|Overall Study|Death|2|||
44131780|NCT02605928|78917779|FG000|Overall Study|Model tuning phase|28|||
44131781|NCT02605928|78917779|FG000|Overall Study|Lack of Efficacy|5|||
44131782|NCT02706717|78917785|FG000|Overall Study|Withdrawal by Subject|1|||
44131783|NCT02706717|78917786|FG001|Overall Study|Withdrawal by Subject|8|||
44379665|NCT00818662|79385225|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
44131784|NCT02706717|78917785|FG000|Overall Study|Lost to Follow-up|0|||
44131785|NCT02706717|78917786|FG001|Overall Study|Lost to Follow-up|1|||
44131786|NCT02706717|78917785|FG000|Overall Study|Physician Decision|0|||
44131787|NCT02706717|78917786|FG001|Overall Study|Physician Decision|1|||
44512598|NCT02761694|79518345|FG010|Overall Study|Death|1|||
44512599|NCT02761694|79518346|FG011|Overall Study|Death|0|||
44512600|NCT02761694|79518335|FG000|Overall Study|Physician Decision|0|||
44379666|NCT00818662|79385226|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
44379667|NCT00818662|79385227|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
44379668|NCT00818662|79385228|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
44379669|NCT00818662|79385225|FG000|Overall Study|Participant's health declined|0|||
44379670|NCT00818662|79385226|FG001|Overall Study|Participant's health declined|0|||
44379671|NCT00818662|79385227|FG002|Overall Study|Participant's health declined|0|||
44379672|NCT00818662|79385228|FG003|Overall Study|Participant's health declined|1|||
44379673|NCT00818662|79385225|FG000|Overall Study|Caregiver to pursue other treatment|0|||
44379674|NCT00818662|79385226|FG001|Overall Study|Caregiver to pursue other treatment|1|||
44379675|NCT00818662|79385227|FG002|Overall Study|Caregiver to pursue other treatment|0|||
44379676|NCT00818662|79385228|FG003|Overall Study|Caregiver to pursue other treatment|0|||
44379677|NCT00818662|79385225|FG000|Overall Study|Moving out of state|0|||
44379678|NCT00818662|79385226|FG001|Overall Study|Moving out of state|0|||
44379679|NCT00818662|79385227|FG002|Overall Study|Moving out of state|0|||
44379680|NCT00818662|79385228|FG003|Overall Study|Moving out of state|1|||
44379681|NCT00818662|79385225|FG000|Overall Study|Declined move to another study site|1|||
44379682|NCT00818662|79385226|FG001|Overall Study|Declined move to another study site|0|||
44379683|NCT00818662|79385227|FG002|Overall Study|Declined move to another study site|0|||
44379684|NCT00818662|79385228|FG003|Overall Study|Declined move to another study site|0|||
44379685|NCT00818662|79385225|FG000|Overall Study|Change in living situation|0|||
44379686|NCT00818662|79385226|FG001|Overall Study|Change in living situation|0|||
44379687|NCT00818662|79385227|FG002|Overall Study|Change in living situation|0|||
44379688|NCT00818662|79385228|FG003|Overall Study|Change in living situation|1|||
44512601|NCT02761694|79518336|FG001|Overall Study|Physician Decision|0|||
44512602|NCT02761694|79518337|FG002|Overall Study|Physician Decision|0|||
44131788|NCT02706717|78917785|FG000|Overall Study|Death|0|||
44131789|NCT02706717|78917786|FG001|Overall Study|Death|1|||
44131790|NCT01331837|78917794|FG000|Overall Study|Death|30|||
44131791|NCT01331837|78917795|FG001|Overall Study|Death|34|||
44131792|NCT01331837|78917794|FG000|Overall Study|Lost to Follow-up|3|||
44131793|NCT01331837|78917795|FG001|Overall Study|Lost to Follow-up|1|||
44131794|NCT01331837|78917794|FG000|Overall Study|Info not recorded|10|||
44131795|NCT01331837|78917795|FG001|Overall Study|Info not recorded|16|||
44131796|NCT01331837|78917794|FG000|Overall Study|Withdrawal by Subject|13|||
44131797|NCT01331837|78917795|FG001|Overall Study|Withdrawal by Subject|16|||
44131798|NCT02706483|78917801|FG000|Overall Study|Adverse Event|97|||
44131799|NCT02706483|78917801|FG000|Overall Study|Death|1|||
44131800|NCT02706483|78917801|FG000|Overall Study|Lack of Efficacy|39|||
44131801|NCT02706483|78917801|FG000|Overall Study|Lost to Follow-up|101|||
44131802|NCT02706483|78917801|FG000|Overall Study|Non-compliance with study drug|15|||
44131803|NCT02706483|78917801|FG000|Overall Study|Physician Decision|6|||
44131804|NCT02706483|78917801|FG000|Overall Study|Pregnancy|6|||
44131805|NCT02706483|78917801|FG000|Overall Study|Protocol Violation|18|||
44131806|NCT02706483|78917801|FG000|Overall Study|Withdrawal by Subject|136|||
44131807|NCT02706483|78917801|FG000|Overall Study|Non-compliance with visits|6|||
44131808|NCT02706483|78917801|FG000|Overall Study|Site closure|4|||
44131809|NCT02706483|78917801|FG000|Overall Study|Subject moved|1|||
44131810|NCT01648348|78917808|FG000|Overall Study|Cancel|1|||
44131811|NCT01648348|78917809|FG001|Overall Study|Cancel|0|||
44131812|NCT01648348|78917810|FG002|Overall Study|Cancel|0|||
44131813|NCT01648348|78917811|FG003|Overall Study|Cancel|0|||
44131814|NCT01648348|78917812|FG004|Overall Study|Cancel|3|||
44131815|NCT01648348|78917813|FG005|Overall Study|Cancel|6|||
44131816|NCT01648348|78917808|FG000|Overall Study|Replaced for MTD analysis|1|||
44131817|NCT01648348|78917809|FG001|Overall Study|Replaced for MTD analysis|0|||
44131818|NCT01648348|78917810|FG002|Overall Study|Replaced for MTD analysis|1|||
44131819|NCT01648348|78917811|FG003|Overall Study|Replaced for MTD analysis|0|||
44131820|NCT01648348|78917812|FG004|Overall Study|Replaced for MTD analysis|0|||
44131821|NCT01648348|78917813|FG005|Overall Study|Replaced for MTD analysis|0|||
44131822|NCT01648270|78917826|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
44131823|NCT02302846|78917836|FG000|Overall Study|Withdrawal by Subject|1|||
44131824|NCT02336230|78917840|FG000|Overall Study|Adverse Event|1|||
44131825|NCT02336230|78917840|FG000|Overall Study|Withdrawal of consent|1|||
44131826|NCT02336230|78917840|FG000|Overall Study|Death|9|||
44131827|NCT02336230|78917840|FG000|Overall Study|Dose not received due to shipping delay|1|||
44131828|NCT02336230|78917840|FG000|Overall Study|Discontinuation of MSC infusion|1|||
44131829|NCT02302222|78917846|FG000|Overall Study|Physician Decision|0|||
44131830|NCT02302222|78917847|FG001|Overall Study|Physician Decision|4|||
44131831|NCT02302222|78917846|FG000|Overall Study|Lost to Follow-up|1|||
44131832|NCT02302222|78917847|FG001|Overall Study|Lost to Follow-up|0|||
44379689|NCT00818662|79385225|FG000|Overall Study|Study partner decision|0|||
44379690|NCT00818662|79385226|FG001|Overall Study|Study partner decision|0|||
44131833|NCT02302222|78917846|FG000|Overall Study|Treatment discontinued before day 5|0|||
44512603|NCT02761694|79518338|FG003|Overall Study|Physician Decision|0|||
44512604|NCT02761694|79518339|FG004|Overall Study|Physician Decision|0|||
44131834|NCT02302222|78917847|FG001|Overall Study|Treatment discontinued before day 5|1|||
44131835|NCT02302222|78917846|FG000|Overall Study|Withdrawn prior to any treatment|0|||
44131836|NCT02302222|78917847|FG001|Overall Study|Withdrawn prior to any treatment|1|||
44131837|NCT02335450|78917853|FG000|Overall Study|Pregnancy|1|||
44131838|NCT02302066|78917867|FG000|Overall Study|Adverse Event|1|||
44131839|NCT02302066|78917868|FG001|Overall Study|Adverse Event|1|||
44131840|NCT02302066|78917869|FG002|Overall Study|Adverse Event|3|||
44131841|NCT02302066|78917870|FG003|Overall Study|Adverse Event|0|||
44131842|NCT02302066|78917867|FG000|Overall Study|Lost to Follow-up|4|||
44131843|NCT02302066|78917868|FG001|Overall Study|Lost to Follow-up|5|||
44131844|NCT02302066|78917869|FG002|Overall Study|Lost to Follow-up|24|||
44131845|NCT02302066|78917870|FG003|Overall Study|Lost to Follow-up|7|||
44131846|NCT02302066|78917867|FG000|Overall Study|Withdrawal by Subject|25|||
44131847|NCT02302066|78917868|FG001|Overall Study|Withdrawal by Subject|58|||
44131848|NCT02302066|78917869|FG002|Overall Study|Withdrawal by Subject|124|||
44131849|NCT02302066|78917870|FG003|Overall Study|Withdrawal by Subject|33|||
44131850|NCT02302066|78917867|FG000|Overall Study|Pregnancy|2|||
44131851|NCT02302066|78917868|FG001|Overall Study|Pregnancy|10|||
44131852|NCT02302066|78917869|FG002|Overall Study|Pregnancy|12|||
44131853|NCT02302066|78917870|FG003|Overall Study|Pregnancy|0|||
44131854|NCT02302066|78917867|FG000|Overall Study|Reason Not Specified|1|||
44131855|NCT02302066|78917868|FG001|Overall Study|Reason Not Specified|1|||
44131856|NCT02302066|78917869|FG002|Overall Study|Reason Not Specified|9|||
44131857|NCT02302066|78917870|FG003|Overall Study|Reason Not Specified|1|||
44131858|NCT02301988|78917892|FG000|Overall Study|Withdrawal by Subject|2|||
44131859|NCT02301988|78917893|FG001|Overall Study|Withdrawal by Subject|1|||
44131860|NCT02301988|78917892|FG000|Overall Study|Physician Decision|2|||
44131861|NCT02301988|78917893|FG001|Overall Study|Physician Decision|2|||
44131862|NCT02301988|78917892|FG000|Overall Study|Unknown Reason|1|||
44131863|NCT02301988|78917893|FG001|Overall Study|Unknown Reason|3|||
44131864|NCT02301988|78917892|FG000|Overall Study|Lack of Efficacy|3|||
44131865|NCT02301988|78917893|FG001|Overall Study|Lack of Efficacy|2|||
44131866|NCT02301988|78917892|FG000|Overall Study|Death|1|||
44131867|NCT02301988|78917893|FG001|Overall Study|Death|0|||
44131868|NCT02301988|78917892|FG000|Overall Study|Adverse Event|1|||
44131869|NCT02301988|78917893|FG001|Overall Study|Adverse Event|1|||
44131870|NCT02334748|78917908|FG000|Overall Study|Adverse Event|1|||
44131871|NCT02334748|78917908|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
44131872|NCT02334748|78917908|FG000|Overall Study|Patient no longer required study drug|2|||
44131873|NCT02334748|78917908|FG000|Overall Study|Lack of Efficacy|4|||
44131874|NCT02332876|78917914|FG000|Overall Study|Lost to Follow-up|1|||
44131875|NCT02332876|78917915|FG001|Overall Study|Lost to Follow-up|1|||
44131876|NCT02332798|78917924|FG000|Overall Study|Unwilling to Participate in Study|0|||
44131877|NCT02332798|78917925|FG001|Overall Study|Unwilling to Participate in Study|1|||
44131878|NCT02332798|78917926|FG002|Overall Study|Unwilling to Participate in Study|1|||
44131879|NCT02332798|78917924|FG000|Overall Study|Positive Urine Drug Test|0|||
44131880|NCT02332798|78917925|FG001|Overall Study|Positive Urine Drug Test|1|||
44131881|NCT02332798|78917926|FG002|Overall Study|Positive Urine Drug Test|0|||
44131882|NCT02332798|78917924|FG000|Overall Study|Abnormal Laboratory Findings|1|||
44131883|NCT02332798|78917925|FG001|Overall Study|Abnormal Laboratory Findings|0|||
44131884|NCT02332798|78917926|FG002|Overall Study|Abnormal Laboratory Findings|0|||
44131885|NCT02790437|78917936|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
44131886|NCT02790437|78917937|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
44131887|NCT02790437|78917936|FG000|Overall Study|Adverse Event|1|||
44131888|NCT02790437|78917937|FG001|Overall Study|Adverse Event|0|||
44131889|NCT02790437|78917936|FG000|Overall Study|Withdrawal by Subject|1|||
44131890|NCT02790437|78917937|FG001|Overall Study|Withdrawal by Subject|0|||
44131891|NCT02604212|78917954|FG000|Overall Study|Study Terminated by Sponsor|2|||
44131892|NCT02604212|78917955|FG001|Overall Study|Study Terminated by Sponsor|1|||
44131893|NCT02604212|78917956|FG002|Overall Study|Study Terminated by Sponsor|3|||
44131894|NCT02604212|78917957|FG003|Overall Study|Study Terminated by Sponsor|3|||
44131895|NCT02604212|78917954|FG000|Overall Study|Withdrawal by Subject|0|||
44131896|NCT02604212|78917955|FG001|Overall Study|Withdrawal by Subject|0|||
44131897|NCT02604212|78917956|FG002|Overall Study|Withdrawal by Subject|1|||
44131898|NCT02604212|78917957|FG003|Overall Study|Withdrawal by Subject|0|||
44131899|NCT02789111|78917974|FG000|Overall Study|Withdrawal by Subject|1|||
44131900|NCT02789111|78917975|FG001|Overall Study|Withdrawal by Subject|4|||
44131901|NCT01359644|78917993|FG000|Treatment Period|Lack of Efficacy|0|||
44131902|NCT01359644|78917994|FG001|Treatment Period|Lack of Efficacy|1|||
44131903|NCT01359644|78917995|FG002|Treatment Period|Lack of Efficacy|0|||
44131904|NCT01359644|78917996|FG003|Treatment Period|Lack of Efficacy|0|||
44131905|NCT01359644|78917997|FG004|Treatment Period|Lack of Efficacy|0|||
44131906|NCT01359644|78917998|FG005|Treatment Period|Lack of Efficacy|0|||
44131907|NCT01359644|78917999|FG006|Treatment Period|Lack of Efficacy|0|||
44131908|NCT01359644|78918000|FG007|Treatment Period|Lack of Efficacy|0|||
44131909|NCT01359644|78918001|FG008|Treatment Period|Lack of Efficacy|0|||
44131910|NCT01359644|78918002|FG009|Treatment Period|Lack of Efficacy|0|||
44131911|NCT01359644|78917993|FG000|Treatment Period|Adverse Event|0|||
44131912|NCT01359644|78917994|FG001|Treatment Period|Adverse Event|0|||
44131913|NCT01359644|78917995|FG002|Treatment Period|Adverse Event|1|||
44131914|NCT01359644|78917996|FG003|Treatment Period|Adverse Event|0|||
44131915|NCT01359644|78917997|FG004|Treatment Period|Adverse Event|0|||
44131916|NCT01359644|78917998|FG005|Treatment Period|Adverse Event|1|||
44131917|NCT01359644|78917999|FG006|Treatment Period|Adverse Event|0|||
44131918|NCT01359644|78918000|FG007|Treatment Period|Adverse Event|0|||
44131919|NCT01359644|78918001|FG008|Treatment Period|Adverse Event|0|||
44131920|NCT01359644|78918002|FG009|Treatment Period|Adverse Event|0|||
44131921|NCT01359644|78917993|FG000|Treatment Period|Lost to Follow-up|0|||
44131922|NCT01359644|78917994|FG001|Treatment Period|Lost to Follow-up|0|||
44131923|NCT01359644|78917995|FG002|Treatment Period|Lost to Follow-up|0|||
44131924|NCT01359644|78917996|FG003|Treatment Period|Lost to Follow-up|0|||
44131925|NCT01359644|78917997|FG004|Treatment Period|Lost to Follow-up|0|||
44131926|NCT01359644|78917998|FG005|Treatment Period|Lost to Follow-up|1|||
44131927|NCT01359644|78917999|FG006|Treatment Period|Lost to Follow-up|0|||
44131928|NCT01359644|78918000|FG007|Treatment Period|Lost to Follow-up|0|||
44131929|NCT01359644|78918001|FG008|Treatment Period|Lost to Follow-up|0|||
44131930|NCT01359644|78918002|FG009|Treatment Period|Lost to Follow-up|0|||
44131931|NCT01359644|78917993|FG000|Follow-up Period|Withdrawal by Subject|0|||
44131932|NCT01359644|78917994|FG001|Follow-up Period|Withdrawal by Subject|0|||
44131933|NCT01359644|78917995|FG002|Follow-up Period|Withdrawal by Subject|0|||
44131934|NCT01359644|78917996|FG003|Follow-up Period|Withdrawal by Subject|0|||
44131935|NCT01359644|78917997|FG004|Follow-up Period|Withdrawal by Subject|0|||
44131936|NCT01359644|78917998|FG005|Follow-up Period|Withdrawal by Subject|1|||
44131937|NCT01359644|78917999|FG006|Follow-up Period|Withdrawal by Subject|0|||
44131938|NCT01359644|78918000|FG007|Follow-up Period|Withdrawal by Subject|0|||
44276561|NCT03603314|79237529|FG000|Overall Study|Protocol Violation|0|||
44276562|NCT03603314|79237530|FG001|Overall Study|Protocol Violation|1|||
44276563|NCT03603314|79237531|FG002|Overall Study|Protocol Violation|0|||
44131939|NCT01359644|78918001|FG008|Follow-up Period|Withdrawal by Subject|0|||
44131940|NCT01359644|78918002|FG009|Follow-up Period|Withdrawal by Subject|0|||
44131941|NCT01359644|78917993|FG000|Follow-up Period|Lost to Follow-up|0|||
44276564|NCT03603314|79237529|FG000|Overall Study|Adverse Event|2|||
44131942|NCT01359644|78917994|FG001|Follow-up Period|Lost to Follow-up|0|||
44131943|NCT01359644|78917995|FG002|Follow-up Period|Lost to Follow-up|0|||
44131944|NCT01359644|78917996|FG003|Follow-up Period|Lost to Follow-up|0|||
44131945|NCT01359644|78917997|FG004|Follow-up Period|Lost to Follow-up|0|||
44131946|NCT01359644|78917998|FG005|Follow-up Period|Lost to Follow-up|0|||
44131947|NCT01359644|78917999|FG006|Follow-up Period|Lost to Follow-up|1|||
44131948|NCT01359644|78918000|FG007|Follow-up Period|Lost to Follow-up|2|||
44131949|NCT01359644|78918001|FG008|Follow-up Period|Lost to Follow-up|0|||
44131950|NCT01359644|78918002|FG009|Follow-up Period|Lost to Follow-up|0|||
44131951|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
44276565|NCT03603314|79237530|FG001|Overall Study|Adverse Event|0|||
44131952|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
44131953|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
44131954|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
44131955|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
44131956|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
44379691|NCT00818662|79385227|FG002|Overall Study|Study partner decision|0|||
44379692|NCT00818662|79385228|FG003|Overall Study|Study partner decision|1|||
44379693|NCT00818662|79385225|FG000|Overall Study|Admitted to long term nursing care|0|||
44379694|NCT00818662|79385226|FG001|Overall Study|Admitted to long term nursing care|1|||
44379695|NCT00818662|79385227|FG002|Overall Study|Admitted to long term nursing care|0|||
44379696|NCT00818662|79385228|FG003|Overall Study|Admitted to long term nursing care|0|||
44379697|NCT00903786|79385239|FG000|Overall Study|Physician Decision|6|||
44379698|NCT00903786|79385239|FG000|Overall Study|Lack of Efficacy|5|||
44379699|NCT00903786|79385239|FG000|Overall Study|Reason other than lack of efficacy|4|||
44379700|NCT00762073|79385248|FG000|Overall Study|Lack of Efficacy|1|||
44379701|NCT00762073|79385249|FG001|Overall Study|Lack of Efficacy|1|||
44131957|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Death|2|||
44379702|NCT00762073|79385250|FG002|Overall Study|Lack of Efficacy|0|||
44379703|NCT00762073|79385251|FG003|Overall Study|Lack of Efficacy|0|||
44131958|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Death|0|||
44131959|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
44131960|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
44131961|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
44131962|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
44131963|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
44131964|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
44131965|NCT02603120|78918037|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
44131966|NCT02603120|78918038|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
44379704|NCT00762073|79385248|FG000|Overall Study|Adverse Event|1|||
44379705|NCT00762073|79385249|FG001|Overall Study|Adverse Event|0|||
44379706|NCT00762073|79385250|FG002|Overall Study|Adverse Event|1|||
44379707|NCT00762073|79385251|FG003|Overall Study|Adverse Event|1|||
44379708|NCT00762073|79385248|FG000|Overall Study|Significant Subject Noncompliance|0|||
44379709|NCT00762073|79385249|FG001|Overall Study|Significant Subject Noncompliance|1|||
44379710|NCT00762073|79385250|FG002|Overall Study|Significant Subject Noncompliance|0|||
44379711|NCT00762073|79385251|FG003|Overall Study|Significant Subject Noncompliance|1|||
44379712|NCT00762073|79385248|FG000|Overall Study|Withdrawal by Subject|1|||
44379713|NCT00762073|79385249|FG001|Overall Study|Withdrawal by Subject|2|||
44379714|NCT00762073|79385250|FG002|Overall Study|Withdrawal by Subject|1|||
44379715|NCT00762073|79385251|FG003|Overall Study|Withdrawal by Subject|1|||
44379716|NCT00762073|79385248|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
44131967|NCT02603120|78918037|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
44131968|NCT02603120|78918038|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
44379717|NCT00762073|79385249|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
44379718|NCT00762073|79385250|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
44379719|NCT00762073|79385251|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
44379720|NCT00761761|79385270|FG000|Overall Study|Lost to Follow-up|3|||
44379721|NCT00761761|79385271|FG001|Overall Study|Lost to Follow-up|1|||
44379722|NCT00761761|79385270|FG000|Overall Study|Withdrawal by Subject|3|||
44131969|NCT02603120|78918037|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
44131970|NCT02603120|78918038|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
44379723|NCT00761761|79385271|FG001|Overall Study|Withdrawal by Subject|0|||
44379724|NCT00761605|79385279|FG000|Overall Study|Adverse Event|26|||
44379725|NCT00761605|79385279|FG000|Overall Study|Death|2|||
44379726|NCT00761605|79385279|FG000|Overall Study|Lack of Efficacy|26|||
44131971|NCT02603120|78918037|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
44131972|NCT02603120|78918038|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
44131973|NCT02603120|78918037|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
44131974|NCT02603120|78918038|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
44131975|NCT02603120|78918037|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
44131976|NCT02603120|78918038|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
44131977|NCT02603120|78918037|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
44131978|NCT02603120|78918038|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
44131979|NCT02599688|78918046|FG000|Overall Study|Lack of Efficacy|1|||
44131980|NCT02599688|78918046|FG000|Overall Study|Withdrawal by Subject|1|||
44131981|NCT02599688|78918046|FG000|Overall Study|Termination by Sponsor|2|||
44131982|NCT01331291|78918052|FG000|Overall Study|Lack of Efficacy|2|||
44131983|NCT01331291|78918053|FG001|Overall Study|Lack of Efficacy|8|||
44131984|NCT01331291|78918052|FG000|Overall Study|Death|0|||
44131985|NCT01331291|78918053|FG001|Overall Study|Death|1|||
44131986|NCT02601560|78918066|FG000|Overall Study|Other|0|||
44379727|NCT00761605|79385279|FG000|Overall Study|Lost to Follow-up|29|||
44131987|NCT02601560|78918067|FG001|Overall Study|Other|0|||
44131988|NCT02601560|78918068|FG002|Overall Study|Other|0|||
44131989|NCT02601560|78918069|FG003|Overall Study|Other|0|||
44131990|NCT02601560|78918070|FG004|Overall Study|Other|0|||
44131991|NCT02601560|78918071|FG005|Overall Study|Other|0|||
44379728|NCT00761605|79385279|FG000|Overall Study|Withdrawal by Subject|37|||
44379729|NCT00761605|79385279|FG000|Overall Study|Other|21|||
44379730|NCT00761527|79385287|FG000|Overall Study|Adverse Event|3|||
44379731|NCT00761527|79385287|FG000|Overall Study|Poor Compliance|8|||
44512605|NCT02761694|79518340|FG005|Overall Study|Physician Decision|0|||
44512606|NCT02761694|79518341|FG006|Overall Study|Physician Decision|1|||
44131992|NCT02601560|78918072|FG006|Overall Study|Other|1|||
44276566|NCT03603314|79237531|FG002|Overall Study|Adverse Event|0|||
44512607|NCT02761694|79518342|FG007|Overall Study|Physician Decision|0|||
44512608|NCT02761694|79518343|FG008|Overall Study|Physician Decision|0|||
44512609|NCT02761694|79518344|FG009|Overall Study|Physician Decision|0|||
44512610|NCT02761694|79518345|FG010|Overall Study|Physician Decision|0|||
44512611|NCT02761694|79518346|FG011|Overall Study|Physician Decision|0|||
44512612|NCT02761694|79518335|FG000|Overall Study|Withdrawal by Subject|0|||
44512613|NCT02761694|79518336|FG001|Overall Study|Withdrawal by Subject|0|||
44512614|NCT02761694|79518337|FG002|Overall Study|Withdrawal by Subject|0|||
44512615|NCT02761694|79518338|FG003|Overall Study|Withdrawal by Subject|1|||
44512616|NCT02761694|79518339|FG004|Overall Study|Withdrawal by Subject|0|||
44512617|NCT02761694|79518340|FG005|Overall Study|Withdrawal by Subject|0|||
44512618|NCT02761694|79518341|FG006|Overall Study|Withdrawal by Subject|4|||
44512619|NCT02761694|79518342|FG007|Overall Study|Withdrawal by Subject|0|||
44512620|NCT02761694|79518343|FG008|Overall Study|Withdrawal by Subject|2|||
44512621|NCT02761694|79518344|FG009|Overall Study|Withdrawal by Subject|1|||
44512622|NCT02761694|79518345|FG010|Overall Study|Withdrawal by Subject|0|||
44379732|NCT00761527|79385287|FG000|Overall Study|Lost to Follow-up|9|||
44379733|NCT00761527|79385287|FG000|Overall Study|Unknown reason|2|||
44379734|NCT00770029|79385293|FG000|Overall Study|Lost to Follow-up|2|||
44512623|NCT02761694|79518346|FG011|Overall Study|Withdrawal by Subject|0|||
44512624|NCT02761694|79518335|FG000|Overall Study|Lost to Follow-up|0|||
44512625|NCT02761694|79518336|FG001|Overall Study|Lost to Follow-up|0|||
44131993|NCT02601560|78918073|FG007|Overall Study|Other|0|||
44131994|NCT02595398|78918104|FG000|Overall Study|Non-compliance|1|||
44131995|NCT02595398|78918105|FG001|Overall Study|Non-compliance|0|||
44131996|NCT02595398|78918104|FG000|Overall Study|Withdrawal by Subject|2|||
44131997|NCT02595398|78918105|FG001|Overall Study|Withdrawal by Subject|1|||
44131998|NCT02595398|78918104|FG000|Overall Study|Lost to Follow-up|1|||
44131999|NCT02595398|78918105|FG001|Overall Study|Lost to Follow-up|0|||
44132000|NCT01368497|78918111|FG000|Overall Study|Lost to Follow-up|2|||
44132001|NCT02595008|78918117|FG000|Overall Study|Enrolled In Error|1|||
44132002|NCT02595008|78918118|FG001|Overall Study|Enrolled In Error|0|||
44132003|NCT02598128|78918124|FG000|Period A: Days -7 to -1|Adverse Event|1|||
44132004|NCT02598128|78918125|FG001|Period A: Days -7 to -1|Adverse Event|0|||
44132005|NCT02598128|78918126|FG002|Period A: Days -7 to -1|Adverse Event|0|||
44132006|NCT02598128|78918127|FG003|Period A: Days -7 to -1|Adverse Event|0|||
44132007|NCT05041439|78918171|FG000|Overall Study|Withdrawal by Subject|1|||
44132008|NCT05041439|78918172|FG001|Overall Study|Withdrawal by Subject|1|||
44132009|NCT05041439|78918171|FG000|Overall Study|Death|1|||
44132010|NCT05041439|78918172|FG001|Overall Study|Death|0|||
44132011|NCT05037409|78918181|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
44132012|NCT05037409|78918182|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
44132013|NCT05037409|78918183|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
44132014|NCT04999111|78918197|FG000|Overall Study|Lost to Follow-up|21|||
44132015|NCT04999111|78918198|FG001|Overall Study|Lost to Follow-up|16|||
44132016|NCT04999111|78918199|FG002|Overall Study|Lost to Follow-up|2|||
44132017|NCT04999111|78918200|FG003|Overall Study|Lost to Follow-up|26|||
44132018|NCT04999111|78918201|FG004|Overall Study|Lost to Follow-up|30|||
44132019|NCT04999111|78918202|FG005|Overall Study|Lost to Follow-up|6|||
44132020|NCT04999111|78918197|FG000|Overall Study|Physician Decision|1|||
44132021|NCT04999111|78918198|FG001|Overall Study|Physician Decision|3|||
44132022|NCT04999111|78918199|FG002|Overall Study|Physician Decision|0|||
44132023|NCT04999111|78918200|FG003|Overall Study|Physician Decision|1|||
44132024|NCT04999111|78918201|FG004|Overall Study|Physician Decision|2|||
44132025|NCT04999111|78918202|FG005|Overall Study|Physician Decision|0|||
44132026|NCT04999111|78918197|FG000|Overall Study|Withdrawal by Subject|23|||
44132027|NCT04999111|78918198|FG001|Overall Study|Withdrawal by Subject|29|||
44132028|NCT04999111|78918199|FG002|Overall Study|Withdrawal by Subject|15|||
44132029|NCT04999111|78918200|FG003|Overall Study|Withdrawal by Subject|30|||
44132030|NCT04999111|78918201|FG004|Overall Study|Withdrawal by Subject|35|||
44132031|NCT04999111|78918202|FG005|Overall Study|Withdrawal by Subject|10|||
44132032|NCT04999111|78918197|FG000|Overall Study|Other|6|||
44132033|NCT04999111|78918198|FG001|Overall Study|Other|6|||
44132034|NCT04999111|78918199|FG002|Overall Study|Other|3|||
44132035|NCT04999111|78918200|FG003|Overall Study|Other|8|||
44132036|NCT04999111|78918201|FG004|Overall Study|Other|8|||
44132037|NCT04999111|78918202|FG005|Overall Study|Other|5|||
44132038|NCT04999111|78918197|FG000|Overall Study|Non-compliance with study schedule|1|||
44132039|NCT04999111|78918198|FG001|Overall Study|Non-compliance with study schedule|0|||
44132040|NCT04999111|78918199|FG002|Overall Study|Non-compliance with study schedule|0|||
44132041|NCT04999111|78918200|FG003|Overall Study|Non-compliance with study schedule|1|||
44132042|NCT04999111|78918201|FG004|Overall Study|Non-compliance with study schedule|1|||
44132043|NCT04999111|78918202|FG005|Overall Study|Non-compliance with study schedule|1|||
44132044|NCT04999111|78918197|FG000|Overall Study|Randomized but not vaccinated|1|||
44132045|NCT04999111|78918198|FG001|Overall Study|Randomized but not vaccinated|2|||
44132046|NCT04999111|78918199|FG002|Overall Study|Randomized but not vaccinated|0|||
44132047|NCT04999111|78918200|FG003|Overall Study|Randomized but not vaccinated|3|||
44132048|NCT04999111|78918201|FG004|Overall Study|Randomized but not vaccinated|3|||
44132049|NCT04999111|78918202|FG005|Overall Study|Randomized but not vaccinated|0|||
44132050|NCT04999111|78918197|FG000|Overall Study|Adverse Event|1|||
44132051|NCT04999111|78918198|FG001|Overall Study|Adverse Event|1|||
44132052|NCT04999111|78918199|FG002|Overall Study|Adverse Event|0|||
44132053|NCT04999111|78918200|FG003|Overall Study|Adverse Event|0|||
44132054|NCT04999111|78918201|FG004|Overall Study|Adverse Event|0|||
44132055|NCT04999111|78918202|FG005|Overall Study|Adverse Event|0|||
44132056|NCT04999111|78918197|FG000|Overall Study|Initiated prohibited medication|0|||
44512626|NCT02761694|79518337|FG002|Overall Study|Lost to Follow-up|0|||
44512627|NCT02761694|79518338|FG003|Overall Study|Lost to Follow-up|0|||
44512628|NCT02761694|79518339|FG004|Overall Study|Lost to Follow-up|0|||
44512629|NCT02761694|79518340|FG005|Overall Study|Lost to Follow-up|0|||
44512630|NCT02761694|79518341|FG006|Overall Study|Lost to Follow-up|1|||
44512631|NCT02761694|79518342|FG007|Overall Study|Lost to Follow-up|0|||
44512632|NCT02761694|79518343|FG008|Overall Study|Lost to Follow-up|0|||
44132057|NCT04999111|78918198|FG001|Overall Study|Initiated prohibited medication|0|||
44132058|NCT04999111|78918199|FG002|Overall Study|Initiated prohibited medication|0|||
44132059|NCT04999111|78918200|FG003|Overall Study|Initiated prohibited medication|0|||
44132060|NCT04999111|78918201|FG004|Overall Study|Initiated prohibited medication|1|||
44132061|NCT04999111|78918202|FG005|Overall Study|Initiated prohibited medication|0|||
44512633|NCT02761694|79518344|FG009|Overall Study|Lost to Follow-up|0|||
44132062|NCT04964557|78918222|FG000|Overall Study|Withdrawal by Subject|3|||
44132063|NCT04964557|78918223|FG001|Overall Study|Withdrawal by Subject|2|||
44132064|NCT04964557|78918222|FG000|Overall Study|Lost to Follow-up|1|||
44132065|NCT04964557|78918223|FG001|Overall Study|Lost to Follow-up|2|||
44132066|NCT04964557|78918222|FG000|Overall Study|Physician Decision|2|||
44132067|NCT04964557|78918223|FG001|Overall Study|Physician Decision|0|||
44132068|NCT04964557|78918222|FG000|Overall Study|Death|3|||
44132069|NCT04964557|78918223|FG001|Overall Study|Death|0|||
44132070|NCT04964557|78918222|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
44132071|NCT04964557|78918223|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
44132072|NCT04798027|78918236|FG000|Overall Study|Protocol Violation|0|||
44132073|NCT04798027|78918237|FG001|Overall Study|Protocol Violation|0|||
44132074|NCT04798027|78918238|FG002|Overall Study|Protocol Violation|0|||
44132075|NCT04798027|78918239|FG003|Overall Study|Protocol Violation|0|||
44132076|NCT04798027|78918240|FG004|Overall Study|Protocol Violation|1|||
44132077|NCT04798027|78918241|FG005|Overall Study|Protocol Violation|0|||
44132078|NCT04798027|78918242|FG006|Overall Study|Protocol Violation|0|||
44132079|NCT04798027|78918243|FG007|Overall Study|Protocol Violation|1|||
44132080|NCT04798027|78918244|FG008|Overall Study|Protocol Violation|0|||
44132081|NCT04798027|78918236|FG000|Overall Study|Withdrawal by Subject|1|||
44132082|NCT04798027|78918237|FG001|Overall Study|Withdrawal by Subject|0|||
44132083|NCT04798027|78918238|FG002|Overall Study|Withdrawal by Subject|1|||
44132084|NCT04798027|78918239|FG003|Overall Study|Withdrawal by Subject|1|||
44132085|NCT04798027|78918240|FG004|Overall Study|Withdrawal by Subject|1|||
44132086|NCT04798027|78918241|FG005|Overall Study|Withdrawal by Subject|1|||
44132087|NCT04798027|78918242|FG006|Overall Study|Withdrawal by Subject|3|||
44132088|NCT04798027|78918243|FG007|Overall Study|Withdrawal by Subject|2|||
44132089|NCT04798027|78918244|FG008|Overall Study|Withdrawal by Subject|2|||
44132090|NCT04798027|78918236|FG000|Overall Study|Lost to Follow-up|1|||
44132091|NCT04798027|78918237|FG001|Overall Study|Lost to Follow-up|3|||
44132092|NCT04798027|78918238|FG002|Overall Study|Lost to Follow-up|0|||
44132093|NCT04798027|78918239|FG003|Overall Study|Lost to Follow-up|0|||
44132094|NCT04798027|78918240|FG004|Overall Study|Lost to Follow-up|0|||
44132095|NCT04798027|78918241|FG005|Overall Study|Lost to Follow-up|1|||
44132096|NCT04798027|78918242|FG006|Overall Study|Lost to Follow-up|0|||
44132097|NCT04798027|78918243|FG007|Overall Study|Lost to Follow-up|0|||
44379735|NCT00770029|79385294|FG001|Overall Study|Lost to Follow-up|0|||
44132098|NCT04798027|78918244|FG008|Overall Study|Lost to Follow-up|1|||
44132099|NCT04798027|78918236|FG000|Overall Study|Withdrawal by Sponsor|8|||
44132100|NCT04798027|78918237|FG001|Overall Study|Withdrawal by Sponsor|22|||
44132101|NCT04798027|78918238|FG002|Overall Study|Withdrawal by Sponsor|9|||
44132102|NCT04798027|78918239|FG003|Overall Study|Withdrawal by Sponsor|26|||
44379736|NCT00770029|79385293|FG000|Overall Study|Withdrawal by Subject|3|||
44379737|NCT00770029|79385294|FG001|Overall Study|Withdrawal by Subject|3|||
44379738|NCT00770029|79385293|FG000|Overall Study|Adverse Event|1|||
44379739|NCT00770029|79385294|FG001|Overall Study|Adverse Event|0|||
44132103|NCT04798027|78918240|FG004|Overall Study|Withdrawal by Sponsor|24|||
44132104|NCT04798027|78918241|FG005|Overall Study|Withdrawal by Sponsor|11|||
44132105|NCT04798027|78918242|FG006|Overall Study|Withdrawal by Sponsor|25|||
44379740|NCT00817414|79385305|FG000|Overall Study|Adverse Event|1|||
44132106|NCT04798027|78918243|FG007|Overall Study|Withdrawal by Sponsor|26|||
44132107|NCT04798027|78918244|FG008|Overall Study|Withdrawal by Sponsor|11|||
44132108|NCT04682405|78918271|FG000|Overall Study|Adverse Event|0|||
44132109|NCT04682405|78918272|FG001|Overall Study|Adverse Event|1|||
44132110|NCT04607980|78918284|FG000|Overall Study|Adverse Event|3|||
44379741|NCT00817414|79385306|FG001|Overall Study|Adverse Event|1|||
44132111|NCT04607980|78918285|FG001|Overall Study|Adverse Event|4|||
44132112|NCT04607980|78918284|FG000|Overall Study|Death|0|||
44132113|NCT04607980|78918285|FG001|Overall Study|Death|1|||
44132114|NCT04607980|78918284|FG000|Overall Study|Withdrawal by Subject|2|||
44132115|NCT04607980|78918285|FG001|Overall Study|Withdrawal by Subject|5|||
44132116|NCT04607980|78918284|FG000|Overall Study|Lost to Follow-up|4|||
44132117|NCT04607980|78918285|FG001|Overall Study|Lost to Follow-up|8|||
44132118|NCT04607980|78918284|FG000|Overall Study|Protocol Violation|0|||
44132119|NCT04607980|78918285|FG001|Overall Study|Protocol Violation|3|||
44132120|NCT04607980|78918284|FG000|Overall Study|Other|3|||
44132121|NCT04607980|78918285|FG001|Overall Study|Other|0|||
44132122|NCT04543279|78918305|FG000|Overall Study|Withdrawal by Subject|1|||
44132123|NCT04543279|78918306|FG001|Overall Study|Withdrawal by Subject|0|||
44132124|NCT04543279|78918305|FG000|Overall Study|Adverse Event|1|||
44132125|NCT04543279|78918306|FG001|Overall Study|Adverse Event|0|||
44132126|NCT04543279|78918305|FG000|Overall Study|Physician Decision|1|||
44132127|NCT04543279|78918306|FG001|Overall Study|Physician Decision|0|||
44132128|NCT04540913|78918314|FG000|Overall Study|Withdrawal by Subject|14|||
44132129|NCT04540913|78918315|FG001|Overall Study|Withdrawal by Subject|3|||
44132130|NCT04540133|78918326|FG000|Overall Study|Lost to Follow-up|1|||
44132131|NCT04540133|78918327|FG001|Overall Study|Lost to Follow-up|0|||
44132132|NCT04494633|78918335|FG000|Overall Study|Lost to Follow-up|5|||
44132133|NCT04494633|78918336|FG001|Overall Study|Lost to Follow-up|3|||
44132134|NCT04494633|78918335|FG000|Overall Study|Protocol Violation|1|||
44132135|NCT04494633|78918336|FG001|Overall Study|Protocol Violation|1|||
44132136|NCT04233801|78918346|FG000|Overall Study|Other than listed|0|||
44132137|NCT04233801|78918347|FG001|Overall Study|Other than listed|0|||
44132138|NCT04233801|78918348|FG002|Overall Study|Other than listed|1|||
44132139|NCT04233801|78918346|FG000|Overall Study|Withdrawal by Subject|0|||
44379742|NCT00817414|79385307|FG002|Overall Study|Adverse Event|1|||
44379743|NCT00817414|79385308|FG003|Overall Study|Adverse Event|0|||
44379744|NCT00817414|79385309|FG004|Overall Study|Adverse Event|0|||
44379745|NCT00817414|79385305|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
44132140|NCT04233801|78918347|FG001|Overall Study|Withdrawal by Subject|2|||
44132141|NCT04233801|78918348|FG002|Overall Study|Withdrawal by Subject|3|||
44132142|NCT04225039|78918361|FG000|Overall Study|Withdrawal by Subject|1|||
44132143|NCT04225039|78918362|FG001|Overall Study|Withdrawal by Subject|0|||
44132144|NCT04225039|78918363|FG002|Overall Study|Withdrawal by Subject|0|||
44132145|NCT04225039|78918364|FG003|Overall Study|Withdrawal by Subject|1|||
44132146|NCT04225039|78918361|FG000|Overall Study|Currently active on study treatment|0|||
44132147|NCT04225039|78918362|FG001|Overall Study|Currently active on study treatment|1|||
44132148|NCT04225039|78918363|FG002|Overall Study|Currently active on study treatment|0|||
44132149|NCT04225039|78918364|FG003|Overall Study|Currently active on study treatment|0|||
44132150|NCT04225039|78918361|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
44132151|NCT04225039|78918362|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
44379746|NCT00817414|79385306|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
44379747|NCT00817414|79385307|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
44379748|NCT00817414|79385308|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
44379749|NCT00817414|79385309|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
44132152|NCT04225039|78918363|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
44132153|NCT04225039|78918364|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
44132154|NCT04225039|78918361|FG000|Overall Study|Ineligible for treatment|0|||
44132155|NCT04225039|78918362|FG001|Overall Study|Ineligible for treatment|0|||
44132156|NCT04225039|78918363|FG002|Overall Study|Ineligible for treatment|0|||
44132157|NCT04225039|78918364|FG003|Overall Study|Ineligible for treatment|4|||
44132158|NCT04033003|78918382|FG000|T1 3rd Trimester|Lost to Follow-up|113|||
44132159|NCT04033003|78918383|FG001|T1 3rd Trimester|Lost to Follow-up|190|||
44132160|NCT04033003|78918382|FG000|T1 3rd Trimester|Protocol Violation|115|||
44512634|NCT02761694|79518345|FG010|Overall Study|Lost to Follow-up|0|||
44512635|NCT02761694|79518346|FG011|Overall Study|Lost to Follow-up|1|||
44512636|NCT02761694|79518335|FG000|Overall Study|Adverse Event|0|||
44512637|NCT02761694|79518336|FG001|Overall Study|Adverse Event|0|||
44512638|NCT02761694|79518337|FG002|Overall Study|Adverse Event|0|||
44512639|NCT02761694|79518338|FG003|Overall Study|Adverse Event|0|||
44512640|NCT02761694|79518339|FG004|Overall Study|Adverse Event|0|||
44512641|NCT02761694|79518340|FG005|Overall Study|Adverse Event|0|||
44512642|NCT02761694|79518341|FG006|Overall Study|Adverse Event|1|||
44512643|NCT02761694|79518342|FG007|Overall Study|Adverse Event|0|||
44512644|NCT02761694|79518343|FG008|Overall Study|Adverse Event|1|||
44512645|NCT02761694|79518344|FG009|Overall Study|Adverse Event|0|||
44512646|NCT02761694|79518345|FG010|Overall Study|Adverse Event|0|||
44512647|NCT02761694|79518346|FG011|Overall Study|Adverse Event|1|||
44512648|NCT02761694|79518335|FG000|Overall Study|Other|4|||
44512649|NCT02761694|79518336|FG001|Overall Study|Other|4|||
44512650|NCT02761694|79518337|FG002|Overall Study|Other|1|||
44512651|NCT02761694|79518338|FG003|Overall Study|Other|2|||
44512652|NCT02761694|79518339|FG004|Overall Study|Other|3|||
44512653|NCT02761694|79518340|FG005|Overall Study|Other|3|||
44512654|NCT02761694|79518341|FG006|Overall Study|Other|18|||
44512655|NCT02761694|79518342|FG007|Overall Study|Other|8|||
44512656|NCT02761694|79518343|FG008|Overall Study|Other|0|||
44132161|NCT04033003|78918383|FG001|T1 3rd Trimester|Protocol Violation|0|||
44132162|NCT04033003|78918382|FG000|T1 3rd Trimester|Withdrawal by Subject|2|||
44132163|NCT04033003|78918383|FG001|T1 3rd Trimester|Withdrawal by Subject|6|||
44132164|NCT04033003|78918382|FG000|T1 3rd Trimester|No longer meets criteria|30|||
44512657|NCT02761694|79518344|FG009|Overall Study|Other|1|||
44512658|NCT02761694|79518345|FG010|Overall Study|Other|1|||
44512659|NCT02761694|79518346|FG011|Overall Study|Other|0|||
44512660|NCT02574481|79518389|FG000|Overall Study|Withdrawal by Subject|29|||
44512661|NCT02574481|79518390|FG001|Overall Study|Withdrawal by Subject|15|||
44132165|NCT04033003|78918383|FG001|T1 3rd Trimester|No longer meets criteria|19|||
44132166|NCT04033003|78918382|FG000|T1 3rd Trimester|Death|0|||
44512662|NCT02574481|79518391|FG002|Overall Study|Withdrawal by Subject|4|||
44512663|NCT02574481|79518392|FG003|Overall Study|Withdrawal by Subject|1|||
44512664|NCT02574481|79518389|FG000|Overall Study|Adverse Event|5|||
44512665|NCT02574481|79518390|FG001|Overall Study|Adverse Event|1|||
44132167|NCT04033003|78918383|FG001|T1 3rd Trimester|Death|1|||
44512666|NCT02574481|79518391|FG002|Overall Study|Adverse Event|1|||
44512667|NCT02574481|79518392|FG003|Overall Study|Adverse Event|0|||
44512668|NCT02574481|79518389|FG000|Overall Study|Visit Missed|15|||
44132168|NCT04033003|78918382|FG000|T2 Post Delivery|Lost to Follow-up|133|||
44132169|NCT04033003|78918383|FG001|T2 Post Delivery|Lost to Follow-up|247|||
44132170|NCT04033003|78918382|FG000|T2 Post Delivery|Protocol Violation|4|||
44132171|NCT04033003|78918383|FG001|T2 Post Delivery|Protocol Violation|0|||
44132172|NCT04033003|78918382|FG000|T2 Post Delivery|Withdrawal by Subject|5|||
44132173|NCT04033003|78918383|FG001|T2 Post Delivery|Withdrawal by Subject|3|||
44132174|NCT04033003|78918382|FG000|T2 Post Delivery|No longer meets criteria|1|||
44132175|NCT04033003|78918383|FG001|T2 Post Delivery|No longer meets criteria|10|||
44132176|NCT04033003|78918382|FG000|T2 Post Delivery|Death|2|||
44132177|NCT04033003|78918383|FG001|T2 Post Delivery|Death|2|||
44132178|NCT03221257|78918410|FG000|Overall Study|Lost to Follow-up|0|||
44132179|NCT03221257|78918411|FG001|Overall Study|Lost to Follow-up|1|||
44132180|NCT03221257|78918410|FG000|Overall Study|Withdrawal by Subject|1|||
44132181|NCT03221257|78918411|FG001|Overall Study|Withdrawal by Subject|1|||
44132182|NCT02978326|78918420|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
44132183|NCT02978326|78918421|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
44132184|NCT02978326|78918422|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
44132185|NCT02978326|78918420|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
44132186|NCT02978326|78918421|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
44132187|NCT02978326|78918422|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
44243536|NCT01588184|79072980|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
44512669|NCT02574481|79518390|FG001|Overall Study|Visit Missed|7|||
44276567|NCT03603314|79237529|FG000|Overall Study|Physician Decision|1|||
44132188|NCT02978326|78918420|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
44132189|NCT02978326|78918421|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
44132190|NCT02978326|78918422|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
44132191|NCT02978326|78918420|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
44132192|NCT02978326|78918421|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
44512670|NCT02574481|79518391|FG002|Overall Study|Visit Missed|5|||
44512671|NCT02574481|79518392|FG003|Overall Study|Visit Missed|0|||
44512672|NCT02574481|79518389|FG000|Overall Study|Other|7|||
44512673|NCT02574481|79518390|FG001|Overall Study|Other|2|||
44512674|NCT02574481|79518391|FG002|Overall Study|Other|0|||
44512675|NCT02574481|79518392|FG003|Overall Study|Other|0|||
44512676|NCT02574481|79518389|FG000|Overall Study|Death|48|||
44512677|NCT02574481|79518390|FG001|Overall Study|Death|26|||
44512678|NCT02574481|79518391|FG002|Overall Study|Death|12|||
44512679|NCT02574481|79518392|FG003|Overall Study|Death|4|||
44512680|NCT02574481|79518389|FG000|Overall Study|Physician Decision|5|||
44512681|NCT02574481|79518390|FG001|Overall Study|Physician Decision|2|||
44512682|NCT02574481|79518391|FG002|Overall Study|Physician Decision|0|||
44512683|NCT02574481|79518392|FG003|Overall Study|Physician Decision|0|||
44512684|NCT02574481|79518389|FG000|Overall Study|Lost to Follow-up|5|||
44512685|NCT02574481|79518390|FG001|Overall Study|Lost to Follow-up|1|||
44512686|NCT02574481|79518391|FG002|Overall Study|Lost to Follow-up|3|||
44512687|NCT02574481|79518392|FG003|Overall Study|Lost to Follow-up|0|||
44512688|NCT02376829|79518416|FG000|Overall Study|Withdrawal by Subject|27|||
44512689|NCT02376829|79518417|FG001|Overall Study|Withdrawal by Subject|44|||
44512690|NCT02297438|79518426|FG000|Overall Study|Death|79|||
44512691|NCT02297438|79518427|FG001|Overall Study|Death|86|||
44512692|NCT02297438|79518426|FG000|Overall Study|Lost to Follow-up|9|||
44512693|NCT02297438|79518427|FG001|Overall Study|Lost to Follow-up|7|||
44512694|NCT02297438|79518426|FG000|Overall Study|Withdrawal by Subject|7|||
44512695|NCT02297438|79518427|FG001|Overall Study|Withdrawal by Subject|0|||
44512696|NCT02297438|79518426|FG000|Overall Study|Other|9|||
44512697|NCT02297438|79518427|FG001|Overall Study|Other|5|||
44512698|NCT02297438|79518426|FG000|Overall Study|Ongoing|65|||
44243537|NCT01588184|79072981|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
44243538|NCT01588184|79072982|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
44243539|NCT01588184|79072983|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
44243540|NCT01588184|79072978|FG000|Overall Study|multiple reasons|0|||
44243541|NCT01588184|79072979|FG001|Overall Study|multiple reasons|3|||
44243542|NCT01588184|79072980|FG002|Overall Study|multiple reasons|0|||
44243543|NCT01588184|79072981|FG003|Overall Study|multiple reasons|1|||
44243544|NCT01588184|79072982|FG004|Overall Study|multiple reasons|0|||
44243545|NCT01588184|79072983|FG005|Overall Study|multiple reasons|0|||
44243546|NCT01588106|79072999|FG000|Overall Study|Withdrawal by Subject|5|||
44243547|NCT01588106|79073000|FG001|Overall Study|Withdrawal by Subject|4|||
44132193|NCT02978326|78918422|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
44132194|NCT02834403|78918448|FG000|Overall Study|Physician Decision|2|||
44132195|NCT02834403|78918449|FG001|Overall Study|Physician Decision|1|||
44132196|NCT02834403|78918450|FG002|Overall Study|Physician Decision|2|||
44132197|NCT02834403|78918451|FG003|Overall Study|Physician Decision|1|||
44132198|NCT02834403|78918452|FG004|Overall Study|Physician Decision|1|||
44132199|NCT02834403|78918453|FG005|Overall Study|Physician Decision|2|||
44132200|NCT02834403|78918454|FG006|Overall Study|Physician Decision|12|||
44512699|NCT02297438|79518427|FG001|Overall Study|Ongoing|73|||
44512700|NCT02297139|79518435|FG000|Overall Study|Disease progression|0|||
44512701|NCT02297139|79518436|FG001|Overall Study|Disease progression|1|||
44512702|NCT02297139|79518435|FG000|Overall Study|Study drug toxicity|0|||
44512703|NCT02297139|79518436|FG001|Overall Study|Study drug toxicity|4|||
44512704|NCT02297139|79518435|FG000|Overall Study|Participant request to discontinue study treatment|0|||
44512705|NCT02297139|79518436|FG001|Overall Study|Participant request to discontinue study treatment|1|||
44512706|NCT02297139|79518435|FG000|Overall Study|Maximum clinical benefit|1|||
44512707|NCT02297139|79518436|FG001|Overall Study|Maximum clinical benefit|0|||
44243548|NCT01564862|79073009|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
44243549|NCT01564862|79073010|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
44132201|NCT02834403|78918448|FG000|Overall Study|Adverse Event|0|||
44132202|NCT02834403|78918449|FG001|Overall Study|Adverse Event|0|||
44132203|NCT02834403|78918450|FG002|Overall Study|Adverse Event|0|||
44132204|NCT02834403|78918451|FG003|Overall Study|Adverse Event|0|||
44132205|NCT02834403|78918452|FG004|Overall Study|Adverse Event|1|||
44243550|NCT01564862|79073011|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
44243551|NCT01564862|79073009|FG000|Overall Study|Major Protocol Deviation|3|||
44276568|NCT03603314|79237530|FG001|Overall Study|Physician Decision|1|||
44276569|NCT03603314|79237531|FG002|Overall Study|Physician Decision|0|||
44379750|NCT00817414|79385305|FG000|Overall Study|Withdrawal by Subject|1|||
44379751|NCT00817414|79385306|FG001|Overall Study|Withdrawal by Subject|1|||
44379752|NCT00817414|79385307|FG002|Overall Study|Withdrawal by Subject|0|||
44379753|NCT00817414|79385308|FG003|Overall Study|Withdrawal by Subject|0|||
44379754|NCT00817414|79385309|FG004|Overall Study|Withdrawal by Subject|0|||
44379755|NCT00817414|79385305|FG000|Overall Study|Lost to Follow-up|0|||
44379756|NCT00817414|79385306|FG001|Overall Study|Lost to Follow-up|0|||
44379757|NCT00817414|79385307|FG002|Overall Study|Lost to Follow-up|1|||
44379758|NCT00817414|79385308|FG003|Overall Study|Lost to Follow-up|1|||
44379759|NCT00817414|79385309|FG004|Overall Study|Lost to Follow-up|1|||
44379760|NCT00817414|79385305|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
44379761|NCT00817414|79385306|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
44379762|NCT00817414|79385307|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
44379763|NCT00817414|79385308|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
44379764|NCT00817414|79385309|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
44379765|NCT00817414|79385305|FG000|Overall Study|Protocol Violation|0|||
44379766|NCT00817414|79385306|FG001|Overall Study|Protocol Violation|0|||
44379767|NCT00817414|79385307|FG002|Overall Study|Protocol Violation|0|||
44379768|NCT00817414|79385308|FG003|Overall Study|Protocol Violation|0|||
44379769|NCT00817414|79385309|FG004|Overall Study|Protocol Violation|1|||
44379770|NCT00769561|79385328|FG000|Overall Study|Withdrawal by Subject|2|||
44379771|NCT00769561|79385329|FG001|Overall Study|Withdrawal by Subject|2|||
44379772|NCT00769561|79385328|FG000|Overall Study|Lost to Follow-up|1|||
44379773|NCT00769561|79385329|FG001|Overall Study|Lost to Follow-up|3|||
44379774|NCT00817336|79385337|FG000|Overall Study|Withdrawal by Subject|1|||
44379775|NCT00817336|79385338|FG001|Overall Study|Withdrawal by Subject|1|||
44512708|NCT02297139|79518435|FG000|Overall Study|Administrative reason by sponsor|0|||
44132206|NCT02834403|78918453|FG005|Overall Study|Adverse Event|1|||
44132207|NCT02834403|78918454|FG006|Overall Study|Adverse Event|3|||
44243552|NCT01564862|79073010|FG001|Overall Study|Major Protocol Deviation|3|||
44379776|NCT00761215|79385346|FG000|Overall Study|Randomized but didn't receive drug|1|||
44379777|NCT00761215|79385347|FG001|Overall Study|Randomized but didn't receive drug|1|||
44379778|NCT00761215|79385348|FG002|Overall Study|Randomized but didn't receive drug|2|||
44243553|NCT01564862|79073011|FG002|Overall Study|Major Protocol Deviation|4|||
44243554|NCT01564862|79073009|FG000|Overall Study|Lost to Follow-up|10|||
44132208|NCT02834403|78918448|FG000|Overall Study|Withdrawal by Subject|0|||
44132209|NCT02834403|78918449|FG001|Overall Study|Withdrawal by Subject|1|||
44132210|NCT02834403|78918450|FG002|Overall Study|Withdrawal by Subject|0|||
44132211|NCT02834403|78918451|FG003|Overall Study|Withdrawal by Subject|0|||
44132212|NCT02834403|78918452|FG004|Overall Study|Withdrawal by Subject|1|||
44132213|NCT02834403|78918453|FG005|Overall Study|Withdrawal by Subject|0|||
44132214|NCT02834403|78918454|FG006|Overall Study|Withdrawal by Subject|0|||
44132215|NCT02834403|78918448|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
44132216|NCT02834403|78918449|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
44132217|NCT02834403|78918450|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
44243555|NCT01564862|79073010|FG001|Overall Study|Lost to Follow-up|8|||
44132218|NCT02834403|78918451|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
44132219|NCT02834403|78918452|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
44132220|NCT02834403|78918453|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
44132221|NCT02834403|78918454|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
44132222|NCT01966731|78918476|FG000|Overall Study|Death|2|||
44132223|NCT01966731|78918476|FG000|Overall Study|Lost to Follow-up|1|||
44132224|NCT01966731|78918476|FG000|Overall Study|Physician Decision|2|||
44132225|NCT01966731|78918476|FG000|Overall Study|Follow up is not complete|600|||
44132226|NCT01966731|78918476|FG000|Overall Study|Screening Failure|29|||
44132227|NCT01966731|78918476|FG000|Overall Study|Found to be ineligible|1|||
44132228|NCT02788175|78918489|FG000|Overall Study|Protocol Violation|3|||
44132229|NCT02788175|78918489|FG000|Overall Study|Withdrawal by Subject|4|||
44132230|NCT02788175|78918489|FG000|Overall Study|Ineligible prior to study agent|6|||
44132231|NCT02787083|78918495|FG000|Overall Study|Adverse Event|1|||
44132232|NCT02787083|78918496|FG001|Overall Study|Adverse Event|0|||
44132233|NCT02787083|78918495|FG000|Overall Study|Withdrawal by Subject|2|||
44132234|NCT02787083|78918496|FG001|Overall Study|Withdrawal by Subject|2|||
44132235|NCT02787863|78918510|FG000|Overall Study|Death|1|||
44132236|NCT02787863|78918511|FG001|Overall Study|Death|0|||
44132237|NCT02787863|78918512|FG002|Overall Study|Death|1|||
44132238|NCT02787863|78918513|FG003|Overall Study|Death|0|||
44132239|NCT02787863|78918514|FG004|Overall Study|Death|0|||
44132240|NCT02787863|78918515|FG005|Overall Study|Death|0|||
44132241|NCT02787863|78918516|FG006|Overall Study|Death|0|||
44132242|NCT02787863|78918517|FG007|Overall Study|Death|0|||
44132243|NCT02787863|78918510|FG000|Overall Study|Withdrawal by Subject|0|||
44132244|NCT02787863|78918511|FG001|Overall Study|Withdrawal by Subject|1|||
44132245|NCT02787863|78918512|FG002|Overall Study|Withdrawal by Subject|1|||
44132246|NCT02787863|78918513|FG003|Overall Study|Withdrawal by Subject|0|||
44132247|NCT02787863|78918514|FG004|Overall Study|Withdrawal by Subject|0|||
44132248|NCT02787863|78918515|FG005|Overall Study|Withdrawal by Subject|0|||
44132249|NCT02787863|78918516|FG006|Overall Study|Withdrawal by Subject|0|||
44132250|NCT02787863|78918517|FG007|Overall Study|Withdrawal by Subject|0|||
44243556|NCT01564862|79073011|FG002|Overall Study|Lost to Follow-up|6|||
44243557|NCT01564862|79073009|FG000|Overall Study|Voluntary Withdrawal|9|||
44243558|NCT01564862|79073010|FG001|Overall Study|Voluntary Withdrawal|6|||
44243559|NCT01564862|79073011|FG002|Overall Study|Voluntary Withdrawal|8|||
44243560|NCT01564862|79073009|FG000|Overall Study|Lack of Efficacy|1|||
44243561|NCT01564862|79073010|FG001|Overall Study|Lack of Efficacy|5|||
44243562|NCT01564862|79073011|FG002|Overall Study|Lack of Efficacy|6|||
44243563|NCT01564862|79073009|FG000|Overall Study|Other reason(s)|1|||
44243564|NCT01564862|79073010|FG001|Overall Study|Other reason(s)|0|||
44243565|NCT01564862|79073011|FG002|Overall Study|Other reason(s)|0|||
44243566|NCT01691378|79073021|FG000|Overall Study|Withdrawal by Subject|2|||
44512709|NCT02297139|79518436|FG001|Overall Study|Administrative reason by sponsor|2|||
44512710|NCT02297139|79518435|FG000|Overall Study|Other reasons|0|||
44512711|NCT02297139|79518436|FG001|Overall Study|Other reasons|8|||
44512712|NCT02100722|79518453|FG000|Overall Study|Withdrawal pre-procedure|4|||
44512713|NCT02100722|79518454|FG001|Overall Study|Withdrawal pre-procedure|9|||
44512714|NCT02100722|79518453|FG000|Overall Study|Withdrawal post-procedure|0|||
44512715|NCT02100722|79518454|FG001|Overall Study|Withdrawal post-procedure|3|||
44512716|NCT02100722|79518453|FG000|Overall Study|Lost to Follow-up|2|||
44512717|NCT02100722|79518454|FG001|Overall Study|Lost to Follow-up|2|||
44512718|NCT02100722|79518453|FG000|Overall Study|Continuing on study|751|||
44512719|NCT02100722|79518454|FG001|Overall Study|Continuing on study|729|||
44243567|NCT01691378|79073022|FG001|Overall Study|Withdrawal by Subject|0|||
44512720|NCT02028988|79518470|FG000|Overall Study|Withdrawal by Subject|2|||
44512721|NCT02004236|79518477|FG000|Overall Study|Lack of Efficacy|0|||
44512722|NCT02004236|79518478|FG001|Overall Study|Lack of Efficacy|0|||
44132251|NCT02596958|78918558|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
44132252|NCT02596958|78918558|FG000|Overall Study|Cancer Progression|441|||
44132253|NCT02596958|78918558|FG000|Overall Study|Death From Cancer|112|||
44132254|NCT02596958|78918558|FG000|Overall Study|Death From Other Cause|33|||
44132255|NCT02596958|78918558|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
44132256|NCT02596958|78918558|FG000|Overall Study|Administrative Reasons/Other|231|||
44132257|NCT02596958|78918558|FG000|Overall Study|Lost to Follow-up|33|||
44132258|NCT02596958|78918558|FG000|Overall Study|Missing|32|||
44132259|NCT02596958|78918558|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
44132260|NCT01367249|78918564|FG000|Overall Study|Withdrawal by Subject|6|||
44132261|NCT01367249|78918565|FG001|Overall Study|Withdrawal by Subject|6|||
44132262|NCT01367249|78918564|FG000|Overall Study|Other|3|||
44132263|NCT01367249|78918565|FG001|Overall Study|Other|10|||
44132264|NCT02786927|78918571|FG000|Overall Study|Adverse Event|1|||
44132265|NCT02786927|78918571|FG000|Overall Study|Protocol Violation|4|||
44132266|NCT02592434|78918576|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
44132267|NCT02592434|78918577|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
44132268|NCT02592434|78918578|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
44132269|NCT02592434|78918576|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
44132270|NCT02592434|78918577|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
44132271|NCT02592434|78918578|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
44132272|NCT02592434|78918576|FG000|Open-Label Phase (18 Weeks)|Other|3|||
44132273|NCT02592434|78918577|FG001|Open-Label Phase (18 Weeks)|Other|0|||
44132274|NCT02592434|78918578|FG002|Open-Label Phase (18 Weeks)|Other|0|||
44132275|NCT02592434|78918576|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
44243568|NCT01691378|79073021|FG000|Overall Study|Lost to Follow-up|5|||
44243569|NCT01691378|79073022|FG001|Overall Study|Lost to Follow-up|2|||
44243570|NCT01467479|79073031|FG000|Overall Study|No Study Medication|1|||
44243571|NCT01467479|79073032|FG001|Overall Study|No Study Medication|0|||
44243572|NCT01467479|79073033|FG002|Overall Study|No Study Medication|2|||
44243573|NCT01467479|79073031|FG000|Overall Study|Adverse Event|1|||
44243574|NCT01467479|79073032|FG001|Overall Study|Adverse Event|2|||
44243575|NCT01467479|79073033|FG002|Overall Study|Adverse Event|0|||
44132276|NCT02592434|78918577|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
44243576|NCT01467479|79073031|FG000|Overall Study|Death|0|||
44243577|NCT01467479|79073032|FG001|Overall Study|Death|0|||
44243578|NCT01467479|79073033|FG002|Overall Study|Death|1|||
44243579|NCT01467479|79073031|FG000|Overall Study|Lost to Follow-up|2|||
44243580|NCT01467479|79073032|FG001|Overall Study|Lost to Follow-up|5|||
44243581|NCT01467479|79073033|FG002|Overall Study|Lost to Follow-up|3|||
44243582|NCT01467479|79073031|FG000|Overall Study|Withdrawal of Consent|3|||
44243583|NCT01467479|79073032|FG001|Overall Study|Withdrawal of Consent|7|||
44243584|NCT01467479|79073033|FG002|Overall Study|Withdrawal of Consent|7|||
44243585|NCT01467479|79073031|FG000|Overall Study|Study Terminated by Sponsor|1|||
44243586|NCT01467479|79073032|FG001|Overall Study|Study Terminated by Sponsor|3|||
44512723|NCT02004236|79518479|FG002|Overall Study|Lack of Efficacy|16|||
44243587|NCT01467479|79073033|FG002|Overall Study|Study Terminated by Sponsor|3|||
44512724|NCT01642251|79518509|FG000|Overall Study|Progressive disease|0|||
44512725|NCT01642251|79518510|FG001|Overall Study|Progressive disease|0|||
44512726|NCT01642251|79518511|FG002|Overall Study|Progressive disease|3|||
44512727|NCT01642251|79518512|FG003|Overall Study|Progressive disease|3|||
44512728|NCT01642251|79518509|FG000|Overall Study|Adverse Event|0|||
44512729|NCT01642251|79518510|FG001|Overall Study|Adverse Event|0|||
44512730|NCT01642251|79518511|FG002|Overall Study|Adverse Event|5|||
44512731|NCT01642251|79518512|FG003|Overall Study|Adverse Event|4|||
44512732|NCT01642251|79518509|FG000|Overall Study|Death|0|||
44512733|NCT01642251|79518510|FG001|Overall Study|Death|0|||
44243588|NCT01467479|79073031|FG000|Overall Study|Other|1|||
44512734|NCT01642251|79518511|FG002|Overall Study|Death|1|||
44512735|NCT01642251|79518512|FG003|Overall Study|Death|3|||
44512736|NCT01642251|79518509|FG000|Overall Study|Withdrawal by Subject|0|||
44512737|NCT01642251|79518510|FG001|Overall Study|Withdrawal by Subject|0|||
44512738|NCT01642251|79518511|FG002|Overall Study|Withdrawal by Subject|1|||
44512739|NCT01642251|79518512|FG003|Overall Study|Withdrawal by Subject|3|||
44512740|NCT01642251|79518509|FG000|Overall Study|Alternative therapy|0|||
44243589|NCT01467479|79073032|FG001|Overall Study|Other|0|||
44243590|NCT01467479|79073033|FG002|Overall Study|Other|0|||
44243591|NCT01466387|79073048|FG000|Overall Study|Adverse Event|0|||
44512741|NCT01642251|79518510|FG001|Overall Study|Alternative therapy|0|||
44512742|NCT01642251|79518511|FG002|Overall Study|Alternative therapy|0|||
44243592|NCT01466387|79073049|FG001|Overall Study|Adverse Event|0|||
44243593|NCT01466387|79073050|FG002|Overall Study|Adverse Event|1|||
44512743|NCT01642251|79518512|FG003|Overall Study|Alternative therapy|2|||
44132277|NCT02592434|78918578|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
44132278|NCT02592434|78918576|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
44243594|NCT01466387|79073051|FG003|Overall Study|Adverse Event|1|||
44512744|NCT01642251|79518509|FG000|Overall Study|Other complicating disease|0|||
44512745|NCT01642251|79518510|FG001|Overall Study|Other complicating disease|0|||
44512746|NCT01642251|79518511|FG002|Overall Study|Other complicating disease|1|||
44512747|NCT01642251|79518512|FG003|Overall Study|Other complicating disease|0|||
44512748|NCT01642251|79518509|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
44512749|NCT01642251|79518510|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
44512750|NCT01642251|79518511|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
44512751|NCT01642251|79518512|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
44512752|NCT01606137|79518521|FG000|Overall Study|Adverse Event|85|||
44132279|NCT02592434|78918577|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
44132280|NCT02592434|78918578|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
44132281|NCT02592434|78918576|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
44132282|NCT02592434|78918577|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
44276570|NCT03603314|79237529|FG000|Overall Study|Withdrawal by Subject|4|||
44379779|NCT00761215|79385346|FG000|Overall Study|Lost to Follow-up|6|||
44379780|NCT00761215|79385347|FG001|Overall Study|Lost to Follow-up|3|||
44379781|NCT00761215|79385348|FG002|Overall Study|Lost to Follow-up|6|||
44379782|NCT00761215|79385346|FG000|Overall Study|Withdrawal by Subject|1|||
44379783|NCT00761215|79385347|FG001|Overall Study|Withdrawal by Subject|0|||
44379784|NCT00761215|79385348|FG002|Overall Study|Withdrawal by Subject|0|||
44379785|NCT00761215|79385346|FG000|Overall Study|Bacteremia|1|||
44379786|NCT00761215|79385347|FG001|Overall Study|Bacteremia|0|||
44512753|NCT01606137|79518521|FG000|Overall Study|Withdrawal by Subject|74|||
44512754|NCT01606137|79518521|FG000|Overall Study|Lack of Efficacy|56|||
44276571|NCT03603314|79237530|FG001|Overall Study|Withdrawal by Subject|5|||
44512755|NCT01606137|79518521|FG000|Overall Study|Lost to Follow-up|15|||
44512756|NCT01606137|79518521|FG000|Overall Study|Protocol Violation|1|||
44512757|NCT01606137|79518521|FG000|Overall Study|Patient non-compliance|9|||
44512758|NCT01606137|79518521|FG000|Overall Study|Death|1|||
44132283|NCT02592434|78918578|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
44132284|NCT02592434|78918576|FG000|Double Blind Phase (26 Weeks)|Other|0|||
44132285|NCT02592434|78918577|FG001|Double Blind Phase (26 Weeks)|Other|1|||
44132286|NCT02592434|78918578|FG002|Double Blind Phase (26 Weeks)|Other|0|||
44132287|NCT02592434|78918576|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
44132288|NCT02592434|78918577|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
44132289|NCT02592434|78918578|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
44132290|NCT02592434|78918576|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
44132291|NCT02592434|78918577|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
44132292|NCT02592434|78918578|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
44132293|NCT02592434|78918576|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
44132294|NCT02592434|78918577|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
44132295|NCT02592434|78918578|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
44132296|NCT02785913|78918586|FG000|Overall Study|Adverse Event|5|||
44132297|NCT02785913|78918586|FG000|Overall Study|Death|2|||
44132298|NCT02785913|78918586|FG000|Overall Study|Progression|18|||
44132299|NCT02785913|78918586|FG000|Overall Study|Not protocol specified|1|||
44132300|NCT02590562|78918595|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
44132301|NCT02783729|78918622|FG000|Overall Study|Lack of Efficacy|1|||
44132302|NCT02783729|78918623|FG001|Overall Study|Lack of Efficacy|0|||
44132303|NCT02783729|78918624|FG002|Overall Study|Lack of Efficacy|0|||
44132304|NCT02783729|78918625|FG003|Overall Study|Lack of Efficacy|0|||
44132305|NCT02783729|78918622|FG000|Overall Study|Adverse Event|2|||
44132306|NCT02783729|78918623|FG001|Overall Study|Adverse Event|6|||
44132307|NCT02783729|78918624|FG002|Overall Study|Adverse Event|2|||
44512759|NCT01606137|79518521|FG000|Overall Study|Decreased/no pain|4|||
44512760|NCT01606137|79518521|FG000|Overall Study|Issues with driving|4|||
44512761|NCT01606137|79518521|FG000|Overall Study|multiple sclerosis less stable|1|||
44512762|NCT01606137|79518521|FG000|Overall Study|Increased bilirubin|1|||
44512763|NCT01606137|79518521|FG000|Overall Study|Spray causes nausea|1|||
44512764|NCT01606137|79518521|FG000|Overall Study|Not enough improvement|4|||
44512765|NCT01606137|79518521|FG000|Overall Study|Wanted to try another treatment|1|||
44512766|NCT01606137|79518521|FG000|Overall Study|Patient leaving country|1|||
44132308|NCT02783729|78918625|FG003|Overall Study|Adverse Event|3|||
44132309|NCT02783729|78918622|FG000|Overall Study|Other|1|||
44132310|NCT02783729|78918623|FG001|Overall Study|Other|6|||
44132311|NCT02783729|78918624|FG002|Overall Study|Other|2|||
44132312|NCT02783729|78918625|FG003|Overall Study|Other|3|||
44132313|NCT02783729|78918622|FG000|Overall Study|Withdrawal by Subject|2|||
44132314|NCT02783729|78918623|FG001|Overall Study|Withdrawal by Subject|3|||
44132315|NCT02783729|78918624|FG002|Overall Study|Withdrawal by Subject|1|||
44512767|NCT01606137|79518521|FG000|Overall Study|Personal reasons|1|||
44512768|NCT01606137|79518521|FG000|Overall Study|Unable to tolerate study med. taste|1|||
44132316|NCT02783729|78918625|FG003|Overall Study|Withdrawal by Subject|2|||
44132317|NCT02783729|78918622|FG000|Overall Study|Participant's choice|2|||
44379787|NCT00761215|79385348|FG002|Overall Study|Bacteremia|0|||
44379788|NCT05101122|79385381|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
44379789|NCT05101122|79385381|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
44379790|NCT05101122|79385381|FG000|AD313 80/5|Withdrawal by Subject|1|||
44379791|NCT05101122|79385381|FG000|AD313 80/10|Physician Decision|1|||
44379792|NCT05038163|79385394|FG000|Stage 1|Did not complete survey|374|||
44379793|NCT05038163|79385395|FG001|Stage 1|Did not complete survey|0|||
44379794|NCT05038163|79385396|FG002|Stage 1|Did not complete survey|0|||
44379795|NCT05038163|79385397|FG003|Stage 1|Did not complete survey|0|||
44379796|NCT05038163|79385398|FG004|Stage 1|Did not complete survey|0|||
44379797|NCT05038163|79385399|FG005|Stage 1|Did not complete survey|0|||
44379798|NCT05038163|79385394|FG000|Stage 2|Did not complete Stage 2 survey|0|||
44379799|NCT05038163|79385395|FG001|Stage 2|Did not complete Stage 2 survey|29|||
44379800|NCT05038163|79385396|FG002|Stage 2|Did not complete Stage 2 survey|30|||
44379801|NCT05038163|79385397|FG003|Stage 2|Did not complete Stage 2 survey|24|||
44379802|NCT05038163|79385398|FG004|Stage 2|Did not complete Stage 2 survey|21|||
44379803|NCT05038163|79385399|FG005|Stage 2|Did not complete Stage 2 survey|100|||
44379804|NCT04413617|79385449|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
44379805|NCT04413617|79385450|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
44379806|NCT04413617|79385451|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
44379807|NCT04413617|79385452|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
44379808|NCT04413617|79385453|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
44379809|NCT04413617|79385449|FG000|Overall Study|Protocol Violation|0|||
44379810|NCT04413617|79385450|FG001|Overall Study|Protocol Violation|1|||
44379811|NCT04413617|79385451|FG002|Overall Study|Protocol Violation|0|||
44379812|NCT04413617|79385452|FG003|Overall Study|Protocol Violation|0|||
44379813|NCT04413617|79385453|FG004|Overall Study|Protocol Violation|1|||
44379814|NCT04413617|79385449|FG000|Overall Study|Lack of Efficacy|2|||
44379815|NCT04413617|79385450|FG001|Overall Study|Lack of Efficacy|0|||
44379816|NCT04413617|79385451|FG002|Overall Study|Lack of Efficacy|2|||
44379817|NCT04413617|79385452|FG003|Overall Study|Lack of Efficacy|1|||
44379818|NCT04413617|79385453|FG004|Overall Study|Lack of Efficacy|0|||
44379819|NCT04413617|79385449|FG000|Overall Study|Withdrawal by Subject|3|||
44379820|NCT04413617|79385450|FG001|Overall Study|Withdrawal by Subject|4|||
44379821|NCT04413617|79385451|FG002|Overall Study|Withdrawal by Subject|2|||
44379822|NCT04413617|79385452|FG003|Overall Study|Withdrawal by Subject|5|||
44379823|NCT04413617|79385453|FG004|Overall Study|Withdrawal by Subject|3|||
44379824|NCT04413617|79385449|FG000|Overall Study|Death|1|||
44379825|NCT04413617|79385450|FG001|Overall Study|Death|0|||
44379826|NCT04413617|79385451|FG002|Overall Study|Death|0|||
44379827|NCT04413617|79385452|FG003|Overall Study|Death|0|||
44379828|NCT04413617|79385453|FG004|Overall Study|Death|0|||
44379829|NCT04413617|79385449|FG000|Overall Study|Adverse Event|1|||
44379830|NCT04413617|79385450|FG001|Overall Study|Adverse Event|0|||
44379831|NCT04413617|79385451|FG002|Overall Study|Adverse Event|0|||
44379832|NCT04413617|79385452|FG003|Overall Study|Adverse Event|1|||
44379833|NCT04413617|79385453|FG004|Overall Study|Adverse Event|1|||
44379834|NCT04413617|79385449|FG000|Overall Study|COVID-19|0|||
44379835|NCT04413617|79385450|FG001|Overall Study|COVID-19|1|||
44379836|NCT04413617|79385451|FG002|Overall Study|COVID-19|0|||
44379837|NCT04413617|79385452|FG003|Overall Study|COVID-19|0|||
44379838|NCT04413617|79385453|FG004|Overall Study|COVID-19|0|||
44379839|NCT04055116|79385485|FG000|First Intervention|Physician Decision|2|||
44379840|NCT04055116|79385486|FG001|First Intervention|Physician Decision|7|||
44379841|NCT03512262|79385532|FG000|Overall Study|Adverse Event|8|||
44379842|NCT03512262|79385533|FG001|Overall Study|Adverse Event|3|||
44379843|NCT03512262|79385532|FG000|Overall Study|Death (non-treatment emergent)|1|||
44379844|NCT03512262|79385533|FG001|Overall Study|Death (non-treatment emergent)|0|||
44379845|NCT03512262|79385532|FG000|Overall Study|Withdrawal by Subject|17|||
44379846|NCT03512262|79385533|FG001|Overall Study|Withdrawal by Subject|9|||
44379847|NCT03512262|79385532|FG000|Overall Study|Lost to Follow-up|7|||
44379848|NCT03512262|79385533|FG001|Overall Study|Lost to Follow-up|1|||
44379849|NCT03512262|79385532|FG000|Overall Study|Other than Specified|2|||
44379850|NCT03512262|79385533|FG001|Overall Study|Other than Specified|2|||
44379851|NCT03499600|79385541|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
44512769|NCT01606137|79518521|FG000|Overall Study|Patient moving|1|||
44132318|NCT02783729|78918623|FG001|Overall Study|Participant's choice|1|||
44132319|NCT02783729|78918624|FG002|Overall Study|Participant's choice|2|||
44132320|NCT02783729|78918625|FG003|Overall Study|Participant's choice|1|||
44132321|NCT02783729|78918622|FG000|Overall Study|Lost to Follow-up|2|||
44132322|NCT02783729|78918623|FG001|Overall Study|Lost to Follow-up|1|||
44132323|NCT02783729|78918624|FG002|Overall Study|Lost to Follow-up|1|||
44132324|NCT02783729|78918625|FG003|Overall Study|Lost to Follow-up|0|||
44132325|NCT02784431|78918664|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
44132326|NCT02784431|78918664|FG000|Overall Study|Early Study Termination|19|||
44132327|NCT02590406|78918670|FG000|Overall Study|Adverse Event|1|||
44132328|NCT02590406|78918671|FG001|Overall Study|Adverse Event|0|||
44132329|NCT02590406|78918670|FG000|Overall Study|Saturometer malfunction|0|||
44132330|NCT02590406|78918671|FG001|Overall Study|Saturometer malfunction|1|||
44132331|NCT01359254|78918679|FG000|Overall Study|Death|1|||
44132332|NCT01359254|78918680|FG001|Overall Study|Death|0|||
44132333|NCT01667432|78918686|FG000|Overall Study|Premature Study Termination|26|||
44132334|NCT01667432|78918686|FG000|Overall Study|Failure to Return|10|||
44132335|NCT01667432|78918686|FG000|Overall Study|Moved to Another Center|3|||
44132336|NCT01667432|78918686|FG000|Overall Study|Lost to Follow-up|3|||
44132337|NCT01667432|78918686|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
44132338|NCT01667432|78918686|FG000|Overall Study|Insufficient Therapeutic Response|4|||
44132339|NCT01667432|78918686|FG000|Overall Study|Adverse Event|1|||
44132340|NCT01667432|78918686|FG000|Overall Study|Protocol Deviation|2|||
44243595|NCT01466387|79073052|FG004|Overall Study|Adverse Event|0|||
44243596|NCT01466387|79073053|FG005|Overall Study|Adverse Event|0|||
44243597|NCT01466387|79073048|FG000|Overall Study|Lost to Follow-up|0|||
44512770|NCT01606137|79518521|FG000|Overall Study|Unable to collect consistent data|1|||
44512771|NCT01532518|79518528|FG000|Overall Study|Withdrawal by Subject|0|||
44132341|NCT01667432|78918686|FG000|Overall Study|Principal Investigator Decision|1|||
44132342|NCT01667432|78918686|FG000|Overall Study|Reason Not Specified|2|||
44132343|NCT01667432|78918686|FG000|Overall Study|Missing Information|4|||
44132344|NCT01563107|78918694|FG000|Overall Study|Physician Decision|0|||
44132345|NCT01563107|78918695|FG001|Overall Study|Physician Decision|1|||
44132346|NCT01563107|78918696|FG002|Overall Study|Physician Decision|1|||
44132347|NCT01563107|78918697|FG003|Overall Study|Physician Decision|3|||
44132348|NCT01563107|78918694|FG000|Overall Study|Withdrawal by Subject|1|||
44132349|NCT01563107|78918695|FG001|Overall Study|Withdrawal by Subject|2|||
44132350|NCT01563107|78918696|FG002|Overall Study|Withdrawal by Subject|1|||
44132351|NCT01563107|78918697|FG003|Overall Study|Withdrawal by Subject|2|||
44132352|NCT02589626|78918759|FG000|Overall Study|Other than the reason specified|1|||
44132353|NCT02589626|78918760|FG001|Overall Study|Other than the reason specified|0|||
44132354|NCT02589626|78918759|FG000|Overall Study|Withdrawal by Subject|1|||
44132355|NCT02589626|78918760|FG001|Overall Study|Withdrawal by Subject|1|||
44132356|NCT02589626|78918759|FG000|Overall Study|Adverse Event|1|||
44132357|NCT02589626|78918760|FG001|Overall Study|Adverse Event|1|||
44132358|NCT01666730|78918775|FG000|Overall Study|Adverse Event|16|||
44132359|NCT01666730|78918775|FG000|Overall Study|Death|2|||
44132360|NCT01666730|78918775|FG000|Overall Study|Physician Decision|5|||
44132361|NCT01666730|78918775|FG000|Overall Study|Withdrawal by Subject|9|||
44132362|NCT01666730|78918775|FG000|Overall Study|Disease progression/relapse|18|||
44132363|NCT00103285|78918788|FG000|Induction|Adverse Event|14|||
44132364|NCT00103285|78918789|FG001|Induction|Adverse Event|0|||
44132365|NCT00103285|78918790|FG002|Induction|Adverse Event|0|||
44132366|NCT00103285|78918791|FG003|Induction|Adverse Event|0|||
44243598|NCT01466387|79073049|FG001|Overall Study|Lost to Follow-up|0|||
44243599|NCT01466387|79073050|FG002|Overall Study|Lost to Follow-up|0|||
44512772|NCT01532518|79518529|FG001|Overall Study|Withdrawal by Subject|0|||
44512773|NCT01532518|79518530|FG002|Overall Study|Withdrawal by Subject|1|||
44512774|NCT00844285|79518558|FG000|Overall Study|Other|0|||
44512775|NCT00844285|79518559|FG001|Overall Study|Other|1|||
44512776|NCT00844285|79518560|FG002|Overall Study|Other|0|||
44132367|NCT00103285|78918792|FG004|Induction|Adverse Event|0|||
44132368|NCT00103285|78918793|FG005|Induction|Adverse Event|0|||
44132369|NCT00103285|78918794|FG006|Induction|Adverse Event|0|||
44132370|NCT00103285|78918795|FG007|Induction|Adverse Event|0|||
44132371|NCT00103285|78918788|FG000|Induction|Death|24|||
44512777|NCT00844285|79518558|FG000|Overall Study|Other than specified|95|||
44512778|NCT00844285|79518559|FG001|Overall Study|Other than specified|129|||
44132372|NCT00103285|78918789|FG001|Induction|Death|0|||
44132373|NCT00103285|78918790|FG002|Induction|Death|0|||
44132374|NCT00103285|78918791|FG003|Induction|Death|0|||
44132375|NCT00103285|78918792|FG004|Induction|Death|0|||
44243600|NCT01466387|79073051|FG003|Overall Study|Lost to Follow-up|0|||
44512779|NCT00844285|79518560|FG002|Overall Study|Other than specified|12|||
44243601|NCT01466387|79073052|FG004|Overall Study|Lost to Follow-up|0|||
44132376|NCT00103285|78918793|FG005|Induction|Death|0|||
44132377|NCT00103285|78918794|FG006|Induction|Death|0|||
44132378|NCT00103285|78918795|FG007|Induction|Death|0|||
44132379|NCT00103285|78918788|FG000|Induction|Physician Decision|103|||
44132380|NCT00103285|78918789|FG001|Induction|Physician Decision|0|||
44132381|NCT00103285|78918790|FG002|Induction|Physician Decision|0|||
44132382|NCT00103285|78918791|FG003|Induction|Physician Decision|0|||
44132383|NCT00103285|78918792|FG004|Induction|Physician Decision|0|||
44132384|NCT00103285|78918793|FG005|Induction|Physician Decision|0|||
44132385|NCT00103285|78918794|FG006|Induction|Physician Decision|0|||
44132386|NCT00103285|78918795|FG007|Induction|Physician Decision|0|||
44132387|NCT00103285|78918788|FG000|Induction|Withdrawal by Subject|1|||
44132388|NCT00103285|78918789|FG001|Induction|Withdrawal by Subject|0|||
44132389|NCT00103285|78918790|FG002|Induction|Withdrawal by Subject|0|||
44132390|NCT00103285|78918791|FG003|Induction|Withdrawal by Subject|0|||
44132391|NCT00103285|78918792|FG004|Induction|Withdrawal by Subject|0|||
44132392|NCT00103285|78918793|FG005|Induction|Withdrawal by Subject|0|||
44132393|NCT00103285|78918794|FG006|Induction|Withdrawal by Subject|0|||
44132394|NCT00103285|78918795|FG007|Induction|Withdrawal by Subject|0|||
44132395|NCT00103285|78918788|FG000|Induction|Ineligible|43|||
44132396|NCT00103285|78918789|FG001|Induction|Ineligible|0|||
44132397|NCT00103285|78918790|FG002|Induction|Ineligible|0|||
44132398|NCT00103285|78918791|FG003|Induction|Ineligible|0|||
44132399|NCT00103285|78918792|FG004|Induction|Ineligible|0|||
44132400|NCT00103285|78918793|FG005|Induction|Ineligible|0|||
44132401|NCT00103285|78918794|FG006|Induction|Ineligible|0|||
44132402|NCT00103285|78918795|FG007|Induction|Ineligible|0|||
44132403|NCT00103285|78918788|FG000|Induction|Refusal|906|||
44132404|NCT00103285|78918789|FG001|Induction|Refusal|0|||
44132405|NCT00103285|78918790|FG002|Induction|Refusal|0|||
44132406|NCT00103285|78918791|FG003|Induction|Refusal|0|||
44132407|NCT00103285|78918792|FG004|Induction|Refusal|0|||
44132408|NCT00103285|78918793|FG005|Induction|Refusal|0|||
44132409|NCT00103285|78918794|FG006|Induction|Refusal|0|||
44132410|NCT00103285|78918795|FG007|Induction|Refusal|0|||
44132411|NCT00103285|78918788|FG000|Induction|Other|258|||
44132412|NCT00103285|78918789|FG001|Induction|Other|0|||
44132413|NCT00103285|78918790|FG002|Induction|Other|0|||
44132414|NCT00103285|78918791|FG003|Induction|Other|0|||
44132415|NCT00103285|78918792|FG004|Induction|Other|0|||
44132416|NCT00103285|78918793|FG005|Induction|Other|0|||
44512780|NCT00844285|79518558|FG000|Overall Study|Site closure|256|||
44512781|NCT00844285|79518559|FG001|Overall Study|Site closure|450|||
44132417|NCT00103285|78918794|FG006|Induction|Other|0|||
44132418|NCT00103285|78918795|FG007|Induction|Other|0|||
44132419|NCT00103285|78918788|FG000|Response Assignment|Adverse Event|0|||
44132420|NCT00103285|78918789|FG001|Response Assignment|Adverse Event|8|||
44132421|NCT00103285|78918790|FG002|Response Assignment|Adverse Event|3|||
44132422|NCT00103285|78918791|FG003|Response Assignment|Adverse Event|2|||
44132423|NCT00103285|78918792|FG004|Response Assignment|Adverse Event|3|||
44132424|NCT00103285|78918793|FG005|Response Assignment|Adverse Event|1|||
44132425|NCT00103285|78918794|FG006|Response Assignment|Adverse Event|1|||
44132426|NCT00103285|78918795|FG007|Response Assignment|Adverse Event|2|||
44132427|NCT00103285|78918788|FG000|Response Assignment|Death|0|||
44132428|NCT00103285|78918789|FG001|Response Assignment|Death|5|||
44132429|NCT00103285|78918790|FG002|Response Assignment|Death|2|||
44132430|NCT00103285|78918791|FG003|Response Assignment|Death|2|||
44132431|NCT00103285|78918792|FG004|Response Assignment|Death|3|||
44132432|NCT00103285|78918793|FG005|Response Assignment|Death|1|||
44132433|NCT00103285|78918794|FG006|Response Assignment|Death|0|||
44132434|NCT00103285|78918795|FG007|Response Assignment|Death|8|||
44132435|NCT00103285|78918788|FG000|Response Assignment|Lost to Follow-up|0|||
44132436|NCT00103285|78918789|FG001|Response Assignment|Lost to Follow-up|9|||
44132437|NCT00103285|78918790|FG002|Response Assignment|Lost to Follow-up|5|||
44132438|NCT00103285|78918791|FG003|Response Assignment|Lost to Follow-up|5|||
44243602|NCT01466387|79073053|FG005|Overall Study|Lost to Follow-up|1|||
44243603|NCT01466387|79073048|FG000|Overall Study|Protocol Violation|1|||
44379852|NCT03499600|79385542|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
44379853|NCT03007979|79385556|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
44379854|NCT02960893|79385562|FG000|Randomization Phase (8-week)|Adverse Event|5|||
44512782|NCT00844285|79518560|FG002|Overall Study|Site closure|50|||
44512783|NCT00844285|79518558|FG000|Overall Study|Follow-up < 8 years|16|||
44512784|NCT00844285|79518559|FG001|Overall Study|Follow-up < 8 years|23|||
44132439|NCT00103285|78918792|FG004|Response Assignment|Lost to Follow-up|1|||
44132440|NCT00103285|78918793|FG005|Response Assignment|Lost to Follow-up|2|||
44132441|NCT00103285|78918794|FG006|Response Assignment|Lost to Follow-up|2|||
44132442|NCT00103285|78918795|FG007|Response Assignment|Lost to Follow-up|5|||
44132443|NCT00103285|78918788|FG000|Response Assignment|Physician Decision|0|||
44132444|NCT00103285|78918789|FG001|Response Assignment|Physician Decision|13|||
44132445|NCT00103285|78918790|FG002|Response Assignment|Physician Decision|14|||
44132446|NCT00103285|78918791|FG003|Response Assignment|Physician Decision|9|||
44132447|NCT00103285|78918792|FG004|Response Assignment|Physician Decision|13|||
44132448|NCT00103285|78918793|FG005|Response Assignment|Physician Decision|7|||
44132449|NCT00103285|78918794|FG006|Response Assignment|Physician Decision|4|||
44132450|NCT00103285|78918795|FG007|Response Assignment|Physician Decision|35|||
44132451|NCT00103285|78918788|FG000|Response Assignment|Protocol Violation|0|||
44132452|NCT00103285|78918789|FG001|Response Assignment|Protocol Violation|2|||
44132453|NCT00103285|78918790|FG002|Response Assignment|Protocol Violation|0|||
44132454|NCT00103285|78918791|FG003|Response Assignment|Protocol Violation|0|||
44132455|NCT00103285|78918792|FG004|Response Assignment|Protocol Violation|0|||
44132456|NCT00103285|78918793|FG005|Response Assignment|Protocol Violation|0|||
44132457|NCT00103285|78918794|FG006|Response Assignment|Protocol Violation|0|||
44132458|NCT00103285|78918795|FG007|Response Assignment|Protocol Violation|0|||
44132459|NCT00103285|78918788|FG000|Response Assignment|Withdrawal by Subject|0|||
44132460|NCT00103285|78918789|FG001|Response Assignment|Withdrawal by Subject|4|||
44132461|NCT00103285|78918790|FG002|Response Assignment|Withdrawal by Subject|1|||
44132462|NCT00103285|78918791|FG003|Response Assignment|Withdrawal by Subject|1|||
44132463|NCT00103285|78918792|FG004|Response Assignment|Withdrawal by Subject|2|||
44132464|NCT00103285|78918793|FG005|Response Assignment|Withdrawal by Subject|2|||
44132465|NCT00103285|78918794|FG006|Response Assignment|Withdrawal by Subject|0|||
44132466|NCT00103285|78918795|FG007|Response Assignment|Withdrawal by Subject|2|||
44132467|NCT00103285|78918788|FG000|Response Assignment|Ineligible|0|||
44132468|NCT00103285|78918789|FG001|Response Assignment|Ineligible|8|||
44132469|NCT00103285|78918790|FG002|Response Assignment|Ineligible|6|||
44132470|NCT00103285|78918791|FG003|Response Assignment|Ineligible|2|||
44132471|NCT00103285|78918792|FG004|Response Assignment|Ineligible|0|||
44379855|NCT02960893|79385563|FG001|Randomization Phase (8-week)|Adverse Event|0|||
44379856|NCT02960893|79385562|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
44379857|NCT02960893|79385563|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
44379858|NCT02960893|79385562|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
44379859|NCT02960893|79385563|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
44379860|NCT02960893|79385562|FG000|Extension Phase (48-week)|Adverse Event|2|||
44512785|NCT00844285|79518560|FG002|Overall Study|Follow-up < 8 years|4|||
44512786|NCT00844285|79518558|FG000|Overall Study|Protocol Violation|26|||
44132472|NCT00103285|78918793|FG005|Response Assignment|Ineligible|3|||
44132473|NCT00103285|78918794|FG006|Response Assignment|Ineligible|1|||
44132474|NCT00103285|78918795|FG007|Response Assignment|Ineligible|5|||
44132475|NCT00103285|78918788|FG000|Response Assignment|Refusal|0|||
44132476|NCT00103285|78918789|FG001|Response Assignment|Refusal|53|||
44132477|NCT00103285|78918790|FG002|Response Assignment|Refusal|5|||
44132478|NCT00103285|78918791|FG003|Response Assignment|Refusal|3|||
44132479|NCT00103285|78918792|FG004|Response Assignment|Refusal|25|||
44132480|NCT00103285|78918793|FG005|Response Assignment|Refusal|15|||
44132481|NCT00103285|78918794|FG006|Response Assignment|Refusal|30|||
44243604|NCT01466387|79073049|FG001|Overall Study|Protocol Violation|0|||
44243605|NCT01466387|79073050|FG002|Overall Study|Protocol Violation|0|||
44243606|NCT01466387|79073051|FG003|Overall Study|Protocol Violation|1|||
44243607|NCT01466387|79073052|FG004|Overall Study|Protocol Violation|0|||
44512787|NCT00844285|79518559|FG001|Overall Study|Protocol Violation|28|||
44512788|NCT00844285|79518560|FG002|Overall Study|Protocol Violation|54|||
44512789|NCT00844285|79518558|FG000|Overall Study|Death|22|||
44512790|NCT00844285|79518559|FG001|Overall Study|Death|21|||
44512791|NCT00844285|79518560|FG002|Overall Study|Death|8|||
44512792|NCT00844285|79518558|FG000|Overall Study|Withdrew Consent|344|||
44512793|NCT00844285|79518559|FG001|Overall Study|Withdrew Consent|466|||
44512794|NCT00844285|79518560|FG002|Overall Study|Withdrew Consent|70|||
44512795|NCT00844285|79518558|FG000|Overall Study|Lost to Follow-up|330|||
44512796|NCT00844285|79518559|FG001|Overall Study|Lost to Follow-up|486|||
44512797|NCT00844285|79518560|FG002|Overall Study|Lost to Follow-up|74|||
44512798|NCT00711646|79518588|FG000|Overall Study|Adverse Event|6|||
44512799|NCT00711646|79518589|FG001|Overall Study|Adverse Event|1|||
44512800|NCT00711646|79518588|FG000|Overall Study|Withdrawal by Subject|4|||
44512801|NCT00711646|79518589|FG001|Overall Study|Withdrawal by Subject|0|||
44512802|NCT00711646|79518588|FG000|Overall Study|Protocol Violation|0|||
44512803|NCT00711646|79518589|FG001|Overall Study|Protocol Violation|1|||
44512804|NCT00711646|79518588|FG000|Overall Study|Lost to Follow-up|1|||
44512805|NCT00711646|79518589|FG001|Overall Study|Lost to Follow-up|0|||
44512806|NCT00711646|79518588|FG000|Overall Study|administrative decision|0|||
44243608|NCT01466387|79073053|FG005|Overall Study|Protocol Violation|0|||
44243609|NCT01564784|79073184|FG000|Overall Study|Other|1|||
44243610|NCT01564784|79073185|FG001|Overall Study|Other|0|||
44512807|NCT00711646|79518589|FG001|Overall Study|administrative decision|1|||
44512808|NCT00711646|79518588|FG000|Overall Study|patient non-compliance|1|||
44512809|NCT00711646|79518589|FG001|Overall Study|patient non-compliance|0|||
44132482|NCT00103285|78918795|FG007|Response Assignment|Refusal|10|||
44132483|NCT00103285|78918788|FG000|Response Assignment|Other|0|||
44132484|NCT00103285|78918789|FG001|Response Assignment|Other|30|||
44132485|NCT00103285|78918790|FG002|Response Assignment|Other|48|||
44132486|NCT00103285|78918791|FG003|Response Assignment|Other|38|||
44512810|NCT00640133|79518615|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
44512811|NCT00640133|79518616|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
44132487|NCT00103285|78918792|FG004|Response Assignment|Other|37|||
44132488|NCT00103285|78918793|FG005|Response Assignment|Other|17|||
44243611|NCT01564784|79073184|FG000|Overall Study|Subject refused further follow-up|1|||
44243612|NCT01564784|79073185|FG001|Overall Study|Subject refused further follow-up|6|||
44512812|NCT00640133|79518615|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
44379861|NCT02960893|79385563|FG001|Extension Phase (48-week)|Adverse Event|3|||
44379862|NCT02960893|79385562|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
44379863|NCT02960893|79385563|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
44379864|NCT02960893|79385562|FG000|Extension Phase (48-week)|Other Reason|2|||
44379865|NCT02960893|79385563|FG001|Extension Phase (48-week)|Other Reason|1|||
44379866|NCT02960893|79385562|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
44379867|NCT02960893|79385563|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
44379868|NCT02960893|79385562|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
44379869|NCT02960893|79385563|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
44379870|NCT02867813|79385578|FG000|Overall Study|Withdrawal by Subject|57|||
44379871|NCT02867813|79385579|FG001|Overall Study|Withdrawal by Subject|56|||
44379872|NCT02867813|79385578|FG000|Overall Study|Decision by Sponsor|7|||
44379873|NCT02867813|79385579|FG001|Overall Study|Decision by Sponsor|7|||
44379874|NCT02867813|79385578|FG000|Overall Study|Lost to Follow-up|91|||
44379875|NCT02867813|79385579|FG001|Overall Study|Lost to Follow-up|78|||
44379876|NCT02867813|79385578|FG000|Overall Study|Missing|2|||
44379877|NCT02867813|79385579|FG001|Overall Study|Missing|1|||
44379878|NCT02867813|79385578|FG000|Overall Study|Death|294|||
44379879|NCT02867813|79385579|FG001|Overall Study|Death|268|||
44132489|NCT00103285|78918794|FG006|Response Assignment|Other|11|||
44132490|NCT00103285|78918795|FG007|Response Assignment|Other|53|||
44132491|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
44132492|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
44243613|NCT01564784|79073184|FG000|Overall Study|Lost to Follow-up|1|||
44512813|NCT00640133|79518616|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
44379880|NCT02278055|79385591|FG000|Overall Study|Adverse Event|1|||
44379881|NCT02278055|79385591|FG000|Overall Study|Lost to Follow-up|1|||
44379882|NCT02278055|79385591|FG000|Overall Study|Withdrawal by Subject|2|||
44379883|NCT02278055|79385591|FG000|Overall Study|Progressive Disease|4|||
44379884|NCT02231879|79385597|FG000|Overall Study|Adverse Event|2|||
44379885|NCT02231879|79385598|FG001|Overall Study|Adverse Event|1|||
44379886|NCT02231879|79385597|FG000|Overall Study|Lack of Efficacy|0|||
44379887|NCT02231879|79385598|FG001|Overall Study|Lack of Efficacy|1|||
44379888|NCT01833806|79385619|FG000|Overall Study|Alternative treatment|2|||
44379889|NCT01833806|79385619|FG000|Overall Study|Death|5|||
44379890|NCT01833806|79385619|FG000|Overall Study|Physician Decision|1|||
44379891|NCT01833806|79385619|FG000|Overall Study|Lost to Follow-up|1|||
44379892|NCT01439802|79385623|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
44379893|NCT01439802|79385623|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
44379894|NCT00816556|79385634|FG000|Overall Study|Adverse Event|1|||
44379895|NCT00816556|79385635|FG001|Overall Study|Adverse Event|1|||
44379896|NCT00816556|79385636|FG002|Overall Study|Adverse Event|1|||
44379897|NCT00816556|79385634|FG000|Overall Study|Withdrawal by Subject|1|||
44379898|NCT00816556|79385635|FG001|Overall Study|Withdrawal by Subject|1|||
44379899|NCT00816556|79385636|FG002|Overall Study|Withdrawal by Subject|1|||
44379900|NCT00816556|79385634|FG000|Overall Study|Lost to Follow-up|0|||
44379901|NCT00816556|79385635|FG001|Overall Study|Lost to Follow-up|0|||
44379902|NCT00816556|79385636|FG002|Overall Study|Lost to Follow-up|1|||
44132493|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
44132494|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Death|4|||
44132495|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Death|2|||
44132496|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Death|3|||
44243614|NCT01564784|79073185|FG001|Overall Study|Lost to Follow-up|1|||
44379903|NCT00760747|79385646|FG000|Study Period II|Adverse Event|3|||
44512814|NCT00640133|79518615|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
44512815|NCT00640133|79518616|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
44512816|NCT00379340|79518629|FG000|Overall Study|Death|0|||
44512817|NCT00379340|79518630|FG001|Overall Study|Death|0|||
44512818|NCT00379340|79518631|FG002|Overall Study|Death|0|||
44512819|NCT00379340|79518632|FG003|Overall Study|Death|2|||
44512820|NCT00379340|79518633|FG004|Overall Study|Death|0|||
44512821|NCT00379340|79518629|FG000|Overall Study|Lack of Efficacy|6|||
44512822|NCT00379340|79518630|FG001|Overall Study|Lack of Efficacy|1|||
44512823|NCT00379340|79518631|FG002|Overall Study|Lack of Efficacy|0|||
44512824|NCT00379340|79518632|FG003|Overall Study|Lack of Efficacy|4|||
44132497|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
44379904|NCT00760747|79385647|FG001|Study Period II|Adverse Event|4|||
44379905|NCT00760747|79385646|FG000|Study Period II|Lack of Efficacy|0|||
44512825|NCT00379340|79518633|FG004|Overall Study|Lack of Efficacy|3|||
44243615|NCT01564784|79073184|FG000|Overall Study|Death|131|||
44243616|NCT01564784|79073185|FG001|Overall Study|Death|126|||
44512826|NCT00379340|79518629|FG000|Overall Study|Physician Decision|6|||
44379906|NCT00760747|79385647|FG001|Study Period II|Lack of Efficacy|6|||
44379907|NCT00760747|79385646|FG000|Study Period II|Parent/Caregiver Decision|3|||
44379908|NCT00760747|79385647|FG001|Study Period II|Parent/Caregiver Decision|0|||
44379909|NCT00760747|79385646|FG000|Study Period II|Protocol Violation|6|||
44379910|NCT00760747|79385647|FG001|Study Period II|Protocol Violation|3|||
44379911|NCT00760747|79385646|FG000|Study Period II|Withdrawal by Subject|1|||
44132498|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
44132499|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
44132500|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
44132501|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
44132502|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
44132503|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
44132504|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
44132505|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
44132506|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
44132507|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
44132508|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
44132509|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
44132510|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
44132511|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
44132512|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
44132513|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
44132514|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
44132515|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
44132516|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
44132517|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
44132518|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
44132519|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
44132520|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
44132521|NCT02783573|78918823|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
44132522|NCT02783573|78918824|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
44132523|NCT02783573|78918825|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
44132524|NCT02783573|78918823|FG000|Delayed-Start Period|Sponsor Decision|0|||
44132525|NCT02783573|78918824|FG001|Delayed-Start Period|Sponsor Decision|17|||
44132526|NCT02783573|78918825|FG002|Delayed-Start Period|Sponsor Decision|12|||
44132527|NCT01666652|78918841|FG000|Overall Study|Serious Adverse Event|0|||
44132528|NCT01666652|78918842|FG001|Overall Study|Serious Adverse Event|0|||
44132529|NCT01666652|78918843|FG002|Overall Study|Serious Adverse Event|0|||
44132530|NCT01666652|78918844|FG003|Overall Study|Serious Adverse Event|1|||
44132531|NCT01666652|78918845|FG004|Overall Study|Serious Adverse Event|0|||
44132532|NCT01666652|78918841|FG000|Overall Study|Withdrawal by Subject|0|||
44132533|NCT01666652|78918842|FG001|Overall Study|Withdrawal by Subject|0|||
44132534|NCT01666652|78918843|FG002|Overall Study|Withdrawal by Subject|0|||
44132535|NCT01666652|78918844|FG003|Overall Study|Withdrawal by Subject|0|||
44132536|NCT01666652|78918845|FG004|Overall Study|Withdrawal by Subject|1|||
44132537|NCT01666652|78918841|FG000|Overall Study|Moved from study area|1|||
44132538|NCT01666652|78918842|FG001|Overall Study|Moved from study area|0|||
44132539|NCT01666652|78918843|FG002|Overall Study|Moved from study area|0|||
44132540|NCT01666652|78918844|FG003|Overall Study|Moved from study area|2|||
44132541|NCT01666652|78918845|FG004|Overall Study|Moved from study area|0|||
44132542|NCT01666652|78918841|FG000|Overall Study|Lost to Follow-up|1|||
44132543|NCT01666652|78918842|FG001|Overall Study|Lost to Follow-up|1|||
44132544|NCT01666652|78918843|FG002|Overall Study|Lost to Follow-up|1|||
44132545|NCT01666652|78918844|FG003|Overall Study|Lost to Follow-up|1|||
44132546|NCT01666652|78918845|FG004|Overall Study|Lost to Follow-up|0|||
44132547|NCT00109733|78918859|FG000|Overall Study|Protocol Violation|0|||
44132548|NCT00109733|78918860|FG001|Overall Study|Protocol Violation|1|||
44132549|NCT00109733|78918859|FG000|Overall Study|Stopped taking study drug|1|||
44132550|NCT00109733|78918860|FG001|Overall Study|Stopped taking study drug|1|||
44132551|NCT00109733|78918859|FG000|Overall Study|Non-compliant|0|||
44132552|NCT00109733|78918860|FG001|Overall Study|Non-compliant|1|||
44132553|NCT00109733|78918859|FG000|Overall Study|Could not commit time for study|1|||
44132554|NCT00109733|78918860|FG001|Overall Study|Could not commit time for study|1|||
44132555|NCT02706405|78918874|FG000|Overall Study|Death|3|||
44132556|NCT02706405|78918875|FG001|Overall Study|Death|2|||
44132557|NCT02706405|78918876|FG002|Overall Study|Death|0|||
44132558|NCT02706405|78918877|FG003|Overall Study|Death|1|||
44132559|NCT02706405|78918878|FG004|Overall Study|Death|0|||
44132560|NCT02706405|78918879|FG005|Overall Study|Death|0|||
44132561|NCT02706405|78918880|FG006|Overall Study|Death|3|||
44132562|NCT02706405|78918881|FG007|Overall Study|Death|4|||
44132563|NCT02706405|78918874|FG000|Overall Study|Disease progression|0|||
44132564|NCT02706405|78918875|FG001|Overall Study|Disease progression|0|||
44132565|NCT02706405|78918876|FG002|Overall Study|Disease progression|0|||
44132566|NCT02706405|78918877|FG003|Overall Study|Disease progression|0|||
44132567|NCT02706405|78918878|FG004|Overall Study|Disease progression|0|||
44132568|NCT02706405|78918879|FG005|Overall Study|Disease progression|0|||
44132569|NCT02706405|78918880|FG006|Overall Study|Disease progression|0|||
44132570|NCT02706405|78918881|FG007|Overall Study|Disease progression|1|||
44379912|NCT00760747|79385647|FG001|Study Period II|Withdrawal by Subject|0|||
44379913|NCT00760747|79385646|FG000|Study Period II|No drug administered|0|||
44132571|NCT02706405|78918874|FG000|Overall Study|Pt moved to new therapy|0|||
44132572|NCT02706405|78918875|FG001|Overall Study|Pt moved to new therapy|0|||
44132573|NCT02706405|78918876|FG002|Overall Study|Pt moved to new therapy|0|||
44132574|NCT02706405|78918877|FG003|Overall Study|Pt moved to new therapy|0|||
44132575|NCT02706405|78918878|FG004|Overall Study|Pt moved to new therapy|0|||
44132576|NCT02706405|78918879|FG005|Overall Study|Pt moved to new therapy|1|||
44132577|NCT02706405|78918880|FG006|Overall Study|Pt moved to new therapy|0|||
44132578|NCT02706405|78918881|FG007|Overall Study|Pt moved to new therapy|1|||
44132579|NCT02706405|78918874|FG000|Overall Study|Physician Decision|1|||
44132580|NCT02706405|78918875|FG001|Overall Study|Physician Decision|0|||
44132581|NCT02706405|78918876|FG002|Overall Study|Physician Decision|0|||
44132582|NCT02706405|78918877|FG003|Overall Study|Physician Decision|0|||
44132583|NCT02706405|78918878|FG004|Overall Study|Physician Decision|0|||
44132584|NCT02706405|78918879|FG005|Overall Study|Physician Decision|0|||
44132585|NCT02706405|78918880|FG006|Overall Study|Physician Decision|0|||
44132586|NCT02706405|78918881|FG007|Overall Study|Physician Decision|0|||
44132587|NCT02761993|78918910|FG000|Overall Study|Adverse Event|0|||
44132588|NCT02761993|78918911|FG001|Overall Study|Adverse Event|2|||
44132589|NCT02761993|78918912|FG002|Overall Study|Adverse Event|0|||
44132590|NCT02761993|78918910|FG000|Overall Study|Lost to Follow-up|1|||
44132591|NCT02761993|78918911|FG001|Overall Study|Lost to Follow-up|3|||
44132592|NCT02761993|78918912|FG002|Overall Study|Lost to Follow-up|2|||
44132593|NCT02761993|78918910|FG000|Overall Study|Withdrawal by Subject|1|||
44132594|NCT02761993|78918911|FG001|Overall Study|Withdrawal by Subject|1|||
44132595|NCT02761993|78918912|FG002|Overall Study|Withdrawal by Subject|2|||
44132596|NCT02766283|78918920|FG000|Overall Study|Lost to Follow-up|27|||
44132597|NCT02761915|78918954|FG000|Overall Study|Death|3|||
44132598|NCT02761915|78918955|FG001|Overall Study|Death|1|||
44132599|NCT02761915|78918956|FG002|Overall Study|Death|1|||
44132600|NCT02761915|78918957|FG003|Overall Study|Death|1|||
44132601|NCT02761915|78918958|FG004|Overall Study|Death|0|||
44132602|NCT02761915|78918959|FG005|Overall Study|Death|1|||
44132603|NCT02761915|78918954|FG000|Overall Study|Withdrawal by Subject|1|||
44132604|NCT02761915|78918955|FG001|Overall Study|Withdrawal by Subject|0|||
44132605|NCT02761915|78918956|FG002|Overall Study|Withdrawal by Subject|0|||
44132606|NCT02761915|78918957|FG003|Overall Study|Withdrawal by Subject|0|||
44132607|NCT02761915|78918958|FG004|Overall Study|Withdrawal by Subject|1|||
44132608|NCT02761915|78918959|FG005|Overall Study|Withdrawal by Subject|2|||
44132609|NCT02761915|78918954|FG000|Overall Study|Disease Progression|0|||
44132610|NCT02761915|78918955|FG001|Overall Study|Disease Progression|0|||
44132611|NCT02761915|78918956|FG002|Overall Study|Disease Progression|0|||
44132612|NCT02761915|78918957|FG003|Overall Study|Disease Progression|2|||
44132613|NCT02761915|78918958|FG004|Overall Study|Disease Progression|2|||
44132614|NCT02761915|78918959|FG005|Overall Study|Disease Progression|2|||
44132615|NCT02706327|78918980|FG000|Overall Study|Lost to Follow-up|1|||
44132616|NCT02706327|78918981|FG001|Overall Study|Lost to Follow-up|1|||
44132617|NCT02706327|78918982|FG002|Overall Study|Lost to Follow-up|2|||
44132618|NCT02764333|78918990|FG000|Overall Study|Ineligible|1|||
44132619|NCT02705625|78918997|FG000|Overall Study|Protocol Violation|1|||
44512827|NCT00379340|79518630|FG001|Overall Study|Physician Decision|2|||
44512828|NCT00379340|79518631|FG002|Overall Study|Physician Decision|1|||
44512829|NCT00379340|79518632|FG003|Overall Study|Physician Decision|2|||
44512830|NCT00379340|79518633|FG004|Overall Study|Physician Decision|3|||
44512831|NCT00379340|79518629|FG000|Overall Study|Withdrawal by Subject|0|||
44512832|NCT00379340|79518630|FG001|Overall Study|Withdrawal by Subject|0|||
44512833|NCT00379340|79518631|FG002|Overall Study|Withdrawal by Subject|0|||
44512834|NCT00379340|79518632|FG003|Overall Study|Withdrawal by Subject|1|||
44512835|NCT00379340|79518633|FG004|Overall Study|Withdrawal by Subject|0|||
44512836|NCT00379340|79518629|FG000|Overall Study|Refusal of further protocol therapy|1|||
44512837|NCT00379340|79518630|FG001|Overall Study|Refusal of further protocol therapy|0|||
44512838|NCT00379340|79518631|FG002|Overall Study|Refusal of further protocol therapy|1|||
44512839|NCT00379340|79518632|FG003|Overall Study|Refusal of further protocol therapy|1|||
44512840|NCT00379340|79518633|FG004|Overall Study|Refusal of further protocol therapy|7|||
44512841|NCT00379340|79518629|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
44132620|NCT02705625|78918998|FG001|Overall Study|Protocol Violation|0|||
44132621|NCT02705625|78918999|FG002|Overall Study|Protocol Violation|0|||
44132622|NCT02705625|78918997|FG000|Overall Study|Adverse Event|6|||
44132623|NCT02705625|78918998|FG001|Overall Study|Adverse Event|5|||
44512842|NCT00379340|79518630|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
44132624|NCT02705625|78918999|FG002|Overall Study|Adverse Event|2|||
44512843|NCT00379340|79518631|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
44132625|NCT02705625|78918997|FG000|Overall Study|Death|0|||
44132626|NCT02705625|78918998|FG001|Overall Study|Death|0|||
44379914|NCT00760747|79385647|FG001|Study Period II|No drug administered|1|||
44379915|NCT00760747|79385646|FG000|Study Period III|Adverse Event|1|||
44379916|NCT00760747|79385647|FG001|Study Period III|Adverse Event|0|||
44379917|NCT00760747|79385646|FG000|Study Period III|Lack of Efficacy|1|||
44379918|NCT00760747|79385647|FG001|Study Period III|Lack of Efficacy|0|||
44379919|NCT00760747|79385646|FG000|Study Period III|Parent/Caregiver Decision|0|||
44379920|NCT00760747|79385647|FG001|Study Period III|Parent/Caregiver Decision|1|||
44379921|NCT00760747|79385646|FG000|Study Period III|Protocol Violation|1|||
44379922|NCT00760747|79385647|FG001|Study Period III|Protocol Violation|1|||
44379923|NCT00760747|79385646|FG000|Study Period III|Physician Decision|0|||
44379924|NCT00760747|79385647|FG001|Study Period III|Physician Decision|1|||
44379925|NCT00760669|79385653|FG000|Overall Study|Not assessed for overall improvement|18|||
44379926|NCT00760669|79385653|FG000|Overall Study|Participants missing efficacy assessment|6|||
44379927|NCT00760669|79385653|FG000|Overall Study|Participants with overlapping cases|1|||
44379928|NCT00760669|79385653|FG000|Overall Study|Took drug before entering in contract|5|||
44379929|NCT00769483|79385663|FG000|Overall Study|Withdrawal by Subject|0|||
44379930|NCT00769483|79385664|FG001|Overall Study|Withdrawal by Subject|1|||
44379931|NCT00769483|79385665|FG002|Overall Study|Withdrawal by Subject|0|||
44379932|NCT00769483|79385666|FG003|Overall Study|Withdrawal by Subject|0|||
44379933|NCT00769483|79385667|FG004|Overall Study|Withdrawal by Subject|1|||
44379934|NCT00769483|79385668|FG005|Overall Study|Withdrawal by Subject|0|||
44379935|NCT00760513|79385686|FG000|Overall Study|Withdrawal by Subject|5|||
44379936|NCT00760513|79385687|FG001|Overall Study|Withdrawal by Subject|7|||
44379937|NCT00907296|79385705|FG000|Overall Study|Ineligibility Determined|1|||
44379938|NCT00907296|79385706|FG001|Overall Study|Ineligibility Determined|0|||
44379939|NCT00907296|79385707|FG002|Overall Study|Ineligibility Determined|0|||
44379940|NCT00907296|79385708|FG003|Overall Study|Ineligibility Determined|1|||
44379941|NCT00907296|79385709|FG004|Overall Study|Ineligibility Determined|0|||
44379942|NCT00907296|79385710|FG005|Overall Study|Ineligibility Determined|0|||
44379943|NCT00907296|79385711|FG006|Overall Study|Ineligibility Determined|0|||
44379944|NCT00907296|79385712|FG007|Overall Study|Ineligibility Determined|1|||
44379945|NCT00907296|79385713|FG008|Overall Study|Ineligibility Determined|0|||
44379946|NCT00907296|79385714|FG009|Overall Study|Ineligibility Determined|0|||
44379947|NCT00907296|79385705|FG000|Overall Study|Protocol Deviation|0|||
44379948|NCT00907296|79385706|FG001|Overall Study|Protocol Deviation|1|||
44379949|NCT00907296|79385707|FG002|Overall Study|Protocol Deviation|0|||
44379950|NCT00907296|79385708|FG003|Overall Study|Protocol Deviation|0|||
44379951|NCT00907296|79385709|FG004|Overall Study|Protocol Deviation|0|||
44379952|NCT00907296|79385710|FG005|Overall Study|Protocol Deviation|0|||
44379953|NCT00907296|79385711|FG006|Overall Study|Protocol Deviation|0|||
44379954|NCT00907296|79385712|FG007|Overall Study|Protocol Deviation|0|||
44379955|NCT00907296|79385713|FG008|Overall Study|Protocol Deviation|0|||
44379956|NCT00907296|79385714|FG009|Overall Study|Protocol Deviation|0|||
44379957|NCT00907296|79385705|FG000|Overall Study|Noncompliance|1|||
44379958|NCT00907296|79385706|FG001|Overall Study|Noncompliance|1|||
44379959|NCT00907296|79385707|FG002|Overall Study|Noncompliance|1|||
44379960|NCT00907296|79385708|FG003|Overall Study|Noncompliance|0|||
44379961|NCT00907296|79385709|FG004|Overall Study|Noncompliance|0|||
44379962|NCT00907296|79385710|FG005|Overall Study|Noncompliance|1|||
44379963|NCT00907296|79385711|FG006|Overall Study|Noncompliance|0|||
44379964|NCT00907296|79385712|FG007|Overall Study|Noncompliance|2|||
44379965|NCT00907296|79385713|FG008|Overall Study|Noncompliance|0|||
44379966|NCT00907296|79385714|FG009|Overall Study|Noncompliance|0|||
44379967|NCT00907296|79385705|FG000|Overall Study|Adverse Event|2|||
44379968|NCT00907296|79385706|FG001|Overall Study|Adverse Event|0|||
44379969|NCT00907296|79385707|FG002|Overall Study|Adverse Event|0|||
44379970|NCT00907296|79385708|FG003|Overall Study|Adverse Event|0|||
44379971|NCT00907296|79385709|FG004|Overall Study|Adverse Event|0|||
44379972|NCT00907296|79385710|FG005|Overall Study|Adverse Event|0|||
44379973|NCT00907296|79385711|FG006|Overall Study|Adverse Event|1|||
44379974|NCT00907296|79385712|FG007|Overall Study|Adverse Event|0|||
44379975|NCT00907296|79385713|FG008|Overall Study|Adverse Event|0|||
44379976|NCT00907296|79385714|FG009|Overall Study|Adverse Event|1|||
44379977|NCT00907296|79385705|FG000|Overall Study|Withdrawal by Subject|7|||
44379978|NCT00907296|79385706|FG001|Overall Study|Withdrawal by Subject|2|||
44379979|NCT00907296|79385707|FG002|Overall Study|Withdrawal by Subject|1|||
44379980|NCT00907296|79385708|FG003|Overall Study|Withdrawal by Subject|1|||
44379981|NCT00907296|79385709|FG004|Overall Study|Withdrawal by Subject|1|||
44379982|NCT00907296|79385710|FG005|Overall Study|Withdrawal by Subject|5|||
44379983|NCT00907296|79385711|FG006|Overall Study|Withdrawal by Subject|3|||
44379984|NCT00907296|79385712|FG007|Overall Study|Withdrawal by Subject|2|||
44379985|NCT00907296|79385713|FG008|Overall Study|Withdrawal by Subject|4|||
44379986|NCT00907296|79385714|FG009|Overall Study|Withdrawal by Subject|2|||
44379987|NCT00907296|79385705|FG000|Overall Study|Lost to Follow-up|9|||
44379988|NCT00907296|79385706|FG001|Overall Study|Lost to Follow-up|1|||
44379989|NCT00907296|79385707|FG002|Overall Study|Lost to Follow-up|0|||
44379990|NCT00907296|79385708|FG003|Overall Study|Lost to Follow-up|2|||
44379991|NCT00907296|79385709|FG004|Overall Study|Lost to Follow-up|0|||
44379992|NCT00907296|79385710|FG005|Overall Study|Lost to Follow-up|3|||
44379993|NCT00907296|79385711|FG006|Overall Study|Lost to Follow-up|2|||
44379994|NCT00907296|79385712|FG007|Overall Study|Lost to Follow-up|2|||
44379995|NCT00907296|79385713|FG008|Overall Study|Lost to Follow-up|0|||
44379996|NCT00907296|79385714|FG009|Overall Study|Lost to Follow-up|4|||
44379997|NCT00816400|79385745|FG000|Overall Study|Death|2|||
44379998|NCT00816400|79385746|FG001|Overall Study|Death|3|||
44379999|NCT00816400|79385747|FG002|Overall Study|Death|3|||
44380000|NCT00816400|79385748|FG003|Overall Study|Death|3|||
44380001|NCT00816400|79385749|FG004|Overall Study|Death|2|||
44380002|NCT00816400|79385750|FG005|Overall Study|Death|3|||
44380003|NCT00816400|79385751|FG006|Overall Study|Death|2|||
44380004|NCT00816400|79385752|FG007|Overall Study|Death|5|||
44380005|NCT00816400|79385753|FG008|Overall Study|Death|6|||
44380006|NCT00816400|79385745|FG000|Overall Study|In hospice care at the end of the study|0|||
44380007|NCT00816400|79385746|FG001|Overall Study|In hospice care at the end of the study|0|||
44380008|NCT00816400|79385747|FG002|Overall Study|In hospice care at the end of the study|2|||
44380009|NCT00816400|79385748|FG003|Overall Study|In hospice care at the end of the study|0|||
44380010|NCT00816400|79385749|FG004|Overall Study|In hospice care at the end of the study|0|||
44380011|NCT00816400|79385750|FG005|Overall Study|In hospice care at the end of the study|0|||
44380012|NCT00816400|79385751|FG006|Overall Study|In hospice care at the end of the study|0|||
44380013|NCT00816400|79385752|FG007|Overall Study|In hospice care at the end of the study|0|||
44380014|NCT00816400|79385753|FG008|Overall Study|In hospice care at the end of the study|0|||
44380015|NCT00906204|79385776|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
44380016|NCT00906204|79385777|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
44380017|NCT00906204|79385776|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
44380018|NCT00906204|79385777|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
44380019|NCT00906204|79385776|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
44380020|NCT00906204|79385777|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
44380021|NCT00906204|79385776|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
44380022|NCT00906204|79385777|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
44380023|NCT00906204|79385776|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
44380024|NCT00906204|79385777|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
44380025|NCT00905424|79385814|FG000|Overall Study|Lost to Follow-up|3|||
44380026|NCT00905424|79385815|FG001|Overall Study|Lost to Follow-up|3|||
44380027|NCT00905424|79385814|FG000|Overall Study|Withdrawal by Subject|1|||
44380028|NCT00905424|79385815|FG001|Overall Study|Withdrawal by Subject|2|||
44380029|NCT00905424|79385814|FG000|Overall Study|Adverse Event|4|||
44380030|NCT00905424|79385815|FG001|Overall Study|Adverse Event|2|||
44380031|NCT00905424|79385814|FG000|Overall Study|Non-compliance with study medication|2|||
44380032|NCT00905424|79385815|FG001|Overall Study|Non-compliance with study medication|0|||
44380033|NCT00905424|79385814|FG000|Overall Study|Sponsor decision|1|||
44380034|NCT00905424|79385815|FG001|Overall Study|Sponsor decision|0|||
44380035|NCT00905424|79385814|FG000|Overall Study|Positive urine drug screen|0|||
44380036|NCT00905424|79385815|FG001|Overall Study|Positive urine drug screen|1|||
44380037|NCT00905424|79385814|FG000|Overall Study|Non-adherence to visit schedule|0|||
44380038|NCT00905424|79385815|FG001|Overall Study|Non-adherence to visit schedule|1|||
44380039|NCT00816166|79385825|FG000|Overall Study|Lost to Follow-up|6|||
44380040|NCT00816166|79385826|FG001|Overall Study|Lost to Follow-up|10|||
44380041|NCT00816166|79385825|FG000|Overall Study|Death|4|||
44380042|NCT00816166|79385826|FG001|Overall Study|Death|2|||
44380043|NCT00815308|79385832|FG000|Overall Study|Adverse Event|4|||
44380044|NCT00815308|79385832|FG000|Overall Study|Withdrawal by Subject|0|||
44380045|NCT00815308|79385832|FG000|Overall Study|Protocol Violation|6|||
44380046|NCT01039376|79385838|FG000|Overall Study|Lost to Follow-up|5|||
44380047|NCT01039376|79385839|FG001|Overall Study|Lost to Follow-up|12|||
44380048|NCT01039376|79385838|FG000|Overall Study|Physician Decision|15|||
44380049|NCT01039376|79385839|FG001|Overall Study|Physician Decision|10|||
44132627|NCT02705625|78918999|FG002|Overall Study|Death|1|||
44243617|NCT01564394|79073236|FG000|Overall Study|Withdrawal by Subject|6|||
44243618|NCT01564394|79073237|FG001|Overall Study|Withdrawal by Subject|10|||
44380050|NCT01039376|79385838|FG000|Overall Study|Withdrawal by Subject|20|||
44380051|NCT01039376|79385839|FG001|Overall Study|Withdrawal by Subject|32|||
44380052|NCT01039376|79385838|FG000|Overall Study|Study terminated by Sponsor|90|||
44380053|NCT01039376|79385839|FG001|Overall Study|Study terminated by Sponsor|72|||
44512844|NCT00379340|79518632|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
44243619|NCT01690988|79073251|FG000|Overall Study|Withdrawal by Subject|2|||
44243620|NCT01690988|79073252|FG001|Overall Study|Withdrawal by Subject|2|||
44380054|NCT00905034|79385846|FG000|Overall Study|Withdrawal by Subject|1|||
44380055|NCT00828568|79385853|FG000|Randomized|Withdrawal by Subject|1|||
44380056|NCT00828568|79385854|FG001|Randomized|Withdrawal by Subject|0|||
44380057|NCT00828568|79385855|FG002|Randomized|Withdrawal by Subject|2|||
44132628|NCT02705625|78918997|FG000|Overall Study|Withdrawal by Subject|1|||
44132629|NCT02705625|78918998|FG001|Overall Study|Withdrawal by Subject|4|||
44132630|NCT02705625|78918999|FG002|Overall Study|Withdrawal by Subject|5|||
44132631|NCT02705625|78918997|FG000|Overall Study|Lost to Follow-up|0|||
44132632|NCT02705625|78918998|FG001|Overall Study|Lost to Follow-up|0|||
44132633|NCT02705625|78918999|FG002|Overall Study|Lost to Follow-up|1|||
44132634|NCT02705625|78918997|FG000|Overall Study|Non-compliance|0|||
44132635|NCT02705625|78918998|FG001|Overall Study|Non-compliance|1|||
44132636|NCT02705625|78918999|FG002|Overall Study|Non-compliance|1|||
44132637|NCT02705625|78918997|FG000|Overall Study|Overdosing|0|||
44132638|NCT02705625|78918998|FG001|Overall Study|Overdosing|0|||
44132639|NCT02705625|78918999|FG002|Overall Study|Overdosing|1|||
44132640|NCT02588612|78919007|FG000|Overall Study|Physician Decision|1|||
44132641|NCT02588612|78919007|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
44132642|NCT02588612|78919007|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
44132643|NCT02588612|78919007|FG000|Overall Study|Death prior to T-cell infusion|1|||
44132644|NCT02704689|78919020|FG000|Overall Study|Physician Decision|1|||
44132645|NCT02704689|78919020|FG000|Overall Study|Study device not implanted|2|||
44132646|NCT02704143|78919024|FG000|Overall Study|disease progression|10|||
44132647|NCT02586506|78919028|FG000|Overall Study|Protocol Violation|6|||
44132648|NCT02586506|78919028|FG000|Overall Study|Lost to Follow-up|1|||
44132649|NCT02586506|78919028|FG000|Overall Study|Other Reason|2|||
44132650|NCT00109031|78919036|FG000|Overall Study|Adverse Event|0|||
44132651|NCT00109031|78919037|FG001|Overall Study|Adverse Event|0|||
44132652|NCT00109031|78919038|FG002|Overall Study|Adverse Event|1|||
44132653|NCT00109031|78919039|FG003|Overall Study|Adverse Event|0|||
44132654|NCT00109031|78919036|FG000|Overall Study|Withdrawal by Subject|0|||
44132655|NCT00109031|78919037|FG001|Overall Study|Withdrawal by Subject|1|||
44132656|NCT00109031|78919038|FG002|Overall Study|Withdrawal by Subject|0|||
44132657|NCT00109031|78919039|FG003|Overall Study|Withdrawal by Subject|0|||
44132658|NCT00109031|78919036|FG000|Overall Study|Physician Decision|0|||
44132659|NCT00109031|78919037|FG001|Overall Study|Physician Decision|1|||
44132660|NCT00109031|78919038|FG002|Overall Study|Physician Decision|0|||
44132661|NCT00109031|78919039|FG003|Overall Study|Physician Decision|0|||
44132662|NCT00109031|78919036|FG000|Overall Study|Protocol Violation|0|||
44132663|NCT00109031|78919037|FG001|Overall Study|Protocol Violation|0|||
44132664|NCT00109031|78919038|FG002|Overall Study|Protocol Violation|1|||
44132665|NCT00109031|78919039|FG003|Overall Study|Protocol Violation|0|||
44132666|NCT01664624|78919053|FG000|Overall Study|Adverse Event|0|||
44132667|NCT01664624|78919054|FG001|Overall Study|Adverse Event|1|||
44132668|NCT01664624|78919055|FG002|Overall Study|Adverse Event|0|||
44132669|NCT01664624|78919056|FG003|Overall Study|Adverse Event|0|||
44132670|NCT02702193|78919068|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
44132671|NCT02702193|78919069|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
44243621|NCT01690988|79073253|FG002|Overall Study|Withdrawal by Subject|3|||
44243622|NCT01690988|79073251|FG000|Overall Study|Physician Decision|0|||
44380058|NCT00828568|79385853|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
44512845|NCT00379340|79518633|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
44512846|NCT00379340|79518629|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
44512847|NCT00379340|79518630|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
44512848|NCT00379340|79518631|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
44512849|NCT00379340|79518632|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
44512850|NCT00379340|79518633|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
44512851|NCT00301808|79518646|FG000|Overall Study|Adverse Event|5|||
44512852|NCT00301808|79518646|FG000|Overall Study|Death|3|||
44512853|NCT00301808|79518646|FG000|Overall Study|Lack of Efficacy|4|||
44512854|NCT04979858|79518661|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
44512855|NCT04979858|79518662|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
44512856|NCT04953728|79518668|FG000|Overall Study|Withdrawal by Subject|3|||
44512857|NCT04953728|79518668|FG000|Overall Study|Physician Decision|1|||
44512858|NCT04030598|79518718|FG000|Overall Study|Voluntary Withdrawal|0|||
44243623|NCT01690988|79073252|FG001|Overall Study|Physician Decision|0|||
44132672|NCT02702193|78919068|FG000|4 Month Follow up|Withdrawal by Subject|1|||
44132673|NCT02702193|78919069|FG001|4 Month Follow up|Withdrawal by Subject|0|||
44132674|NCT02702193|78919068|FG000|4 Month Follow up|Lost to Follow-up|17|||
44132675|NCT02702193|78919069|FG001|4 Month Follow up|Lost to Follow-up|18|||
44243624|NCT01690988|79073253|FG002|Overall Study|Physician Decision|1|||
44132676|NCT02702193|78919068|FG000|8 Month Follow up|Withdrawal by Subject|1|||
44132677|NCT02702193|78919069|FG001|8 Month Follow up|Withdrawal by Subject|0|||
44243625|NCT01690988|79073251|FG000|Overall Study|Operation Cancelled|1|||
44132678|NCT02702193|78919068|FG000|8 Month Follow up|Lost to Follow-up|14|||
44132679|NCT02702193|78919069|FG001|8 Month Follow up|Lost to Follow-up|18|||
44512859|NCT04030598|79518719|FG001|Overall Study|Voluntary Withdrawal|1|||
44380059|NCT00828568|79385854|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
44132680|NCT02702193|78919068|FG000|12 Month Follow up|Withdrawal by Subject|1|||
44132681|NCT02702193|78919069|FG001|12 Month Follow up|Withdrawal by Subject|0|||
44132682|NCT02702193|78919068|FG000|12 Month Follow up|Lost to Follow-up|16|||
44132683|NCT02702193|78919069|FG001|12 Month Follow up|Lost to Follow-up|18|||
44132684|NCT02761057|78919079|FG000|Overall Study|Currently On Study Treatment|0|||
44132685|NCT02761057|78919080|FG001|Overall Study|Currently On Study Treatment|3|||
44132686|NCT02761057|78919081|FG002|Overall Study|Currently On Study Treatment|0|||
44132687|NCT02761057|78919082|FG003|Overall Study|Currently On Study Treatment|0|||
44132688|NCT02761057|78919079|FG000|Overall Study|Adverse Event|11|||
44132689|NCT02761057|78919080|FG001|Overall Study|Adverse Event|9|||
44132690|NCT02761057|78919081|FG002|Overall Study|Adverse Event|5|||
44132691|NCT02761057|78919082|FG003|Overall Study|Adverse Event|3|||
44132692|NCT02761057|78919079|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
44132693|NCT02761057|78919080|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
44132694|NCT02761057|78919081|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
44132695|NCT02761057|78919082|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
44132696|NCT02761057|78919079|FG000|Overall Study|Progression/Relapse|29|||
44132697|NCT02761057|78919080|FG001|Overall Study|Progression/Relapse|27|||
44132698|NCT02761057|78919081|FG002|Overall Study|Progression/Relapse|20|||
44132699|NCT02761057|78919082|FG003|Overall Study|Progression/Relapse|23|||
44132700|NCT02761057|78919079|FG000|Overall Study|Death|2|||
44132701|NCT02761057|78919080|FG001|Overall Study|Death|2|||
44132702|NCT02761057|78919081|FG002|Overall Study|Death|1|||
44132703|NCT02761057|78919082|FG003|Overall Study|Death|1|||
44132704|NCT02761057|78919079|FG000|Overall Study|Other - Not Protocol Specified|2|||
44132705|NCT02761057|78919080|FG001|Overall Study|Other - Not Protocol Specified|1|||
44132706|NCT02761057|78919081|FG002|Overall Study|Other - Not Protocol Specified|2|||
44132707|NCT02761057|78919082|FG003|Overall Study|Other - Not Protocol Specified|0|||
44132708|NCT05085730|78919092|FG000|Overall Study|Withdrawal by Subject|4|||
44132709|NCT05085730|78919092|FG000|Overall Study|Physician Decision|1|||
44132710|NCT04886596|78919104|FG000|Overall Study|Adverse Event|73|||
44132711|NCT04886596|78919105|FG001|Overall Study|Adverse Event|78|||
44132712|NCT04886596|78919104|FG000|Overall Study|Lost to Follow-up|104|||
44132713|NCT04886596|78919105|FG001|Overall Study|Lost to Follow-up|104|||
44132714|NCT04886596|78919104|FG000|Overall Study|Ongoing|12095|||
44132715|NCT04886596|78919105|FG001|Overall Study|Ongoing|12107|||
44132716|NCT04886596|78919104|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
44132717|NCT04886596|78919105|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
44132718|NCT04886596|78919104|FG000|Overall Study|Migrated / Moved from the study area|17|||
44132719|NCT04886596|78919105|FG001|Overall Study|Migrated / Moved from the study area|14|||
44132720|NCT04886596|78919104|FG000|Overall Study|Unknown reason|16|||
44132721|NCT04886596|78919105|FG001|Overall Study|Unknown reason|23|||
44132722|NCT04839380|78919111|FG000|Overall Study|Withdrawal by Subject|2|||
44132723|NCT04839380|78919111|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
44132724|NCT04788147|78919117|FG000|Overall Study|Screen Failure|3|||
44132725|NCT04788147|78919118|FG001|Overall Study|Screen Failure|10|||
44132726|NCT04788147|78919117|FG000|Overall Study|Incomplete RMRS image session|2|||
44132727|NCT04788147|78919118|FG001|Overall Study|Incomplete RMRS image session|0|||
44132728|NCT04770155|78919139|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132729|NCT04770155|78919140|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132730|NCT04770155|78919141|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132731|NCT04770155|78919142|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132732|NCT04770155|78919143|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132733|NCT04770155|78919144|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132734|NCT04770155|78919145|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132735|NCT04770155|78919146|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
44132736|NCT04576988|78919166|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
44132737|NCT04576988|78919167|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
44132738|NCT04576988|78919166|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
44132739|NCT04576988|78919167|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
44132740|NCT04576988|78919166|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
44132741|NCT04576988|78919167|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
44132742|NCT04576988|78919166|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
44132743|NCT04576988|78919167|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
44380060|NCT00828568|79385855|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
44380061|NCT00828568|79385853|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
44132744|NCT04576988|78919166|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
44132745|NCT04576988|78919167|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
44132746|NCT04576988|78919166|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
44132747|NCT04576988|78919167|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
44132748|NCT04576988|78919166|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
44132749|NCT04576988|78919167|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
44132750|NCT04576988|78919166|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
44132751|NCT04576988|78919167|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
44132752|NCT04576988|78919166|FG000|Long Term Double Blind (LTDB)|Death|2|||
44132753|NCT04576988|78919167|FG001|Long Term Double Blind (LTDB)|Death|1|||
44132754|NCT04576988|78919166|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
44132755|NCT04576988|78919167|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
44132756|NCT04471207|78919181|FG000|Overall Study|Lost to Follow-up|4|||
44132757|NCT04471207|78919182|FG001|Overall Study|Lost to Follow-up|1|||
44132758|NCT04471207|78919181|FG000|Overall Study|Medication Contraindication|0|||
44132759|NCT04471207|78919182|FG001|Overall Study|Medication Contraindication|1|||
44132760|NCT04471207|78919181|FG000|Overall Study|Loss of Interest|2|||
44132761|NCT04471207|78919182|FG001|Overall Study|Loss of Interest|1|||
44132762|NCT04471207|78919181|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
44132763|NCT04471207|78919182|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
44132764|NCT04471207|78919181|FG000|Overall Study|Scheduling Conflicts|3|||
44132765|NCT04471207|78919182|FG001|Overall Study|Scheduling Conflicts|1|||
44132766|NCT04471207|78919181|FG000|Overall Study|Physician Decision|1|||
44132767|NCT04471207|78919182|FG001|Overall Study|Physician Decision|0|||
44132768|NCT04471207|78919181|FG000|Overall Study|Unwilling to Use System|0|||
44132769|NCT04471207|78919182|FG001|Overall Study|Unwilling to Use System|1|||
44132770|NCT04356040|78919194|FG000|Overall Study|Death|2|||
44132771|NCT04356040|78919195|FG001|Overall Study|Death|0|||
44132772|NCT04356040|78919194|FG000|Overall Study|Lost to Follow-up|1|||
44132773|NCT04356040|78919195|FG001|Overall Study|Lost to Follow-up|0|||
44132774|NCT04356040|78919194|FG000|Overall Study|Physician Decision|0|||
44132775|NCT04356040|78919195|FG001|Overall Study|Physician Decision|1|||
44132776|NCT04356040|78919194|FG000|Overall Study|Withdrawal by Subject|13|||
44132777|NCT04356040|78919195|FG001|Overall Study|Withdrawal by Subject|1|||
44132778|NCT04356040|78919194|FG000|Overall Study|Enrollment Pause|10|||
44132779|NCT04356040|78919195|FG001|Overall Study|Enrollment Pause|0|||
44132780|NCT04356040|78919194|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
44132781|NCT04356040|78919195|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
44132782|NCT04356040|78919194|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
44132783|NCT04356040|78919195|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
44132784|NCT04356040|78919194|FG000|Overall Study|PI left institution|3|||
44132785|NCT04356040|78919195|FG001|Overall Study|PI left institution|0|||
44132786|NCT04349631|78919201|FG000|Overall Study|Lost to Follow-up|3|||
44132787|NCT04349631|78919201|FG000|Overall Study|Withdrawal by Subject|7|||
44132788|NCT03961204|78919205|FG000|Overall Study|Withdrawal by Subject|2|||
44132789|NCT03961204|78919205|FG000|Overall Study|Lost to Follow-up|3|||
44132790|NCT03961204|78919205|FG000|Overall Study|Other|1|||
44132791|NCT03961204|78919205|FG000|Overall Study|Missing|1|||
44132792|NCT03816007|78919211|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
44132793|NCT03816007|78919212|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
44132794|NCT03816007|78919211|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
44132795|NCT03816007|78919212|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
44132796|NCT03816007|78919211|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
44132797|NCT03816007|78919212|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
44132798|NCT03712449|78919220|FG000|Overall Study|Withdraw Consent|0|||
44132799|NCT03712449|78919221|FG001|Overall Study|Withdraw Consent|1|||
44132800|NCT03343483|78919229|FG000|Overall Study|Death|0|||
44132801|NCT03343483|78919230|FG001|Overall Study|Death|3|||
44132802|NCT03343483|78919229|FG000|Overall Study|Lost to Follow-up|9|||
44132803|NCT03343483|78919230|FG001|Overall Study|Lost to Follow-up|13|||
44132804|NCT03343483|78919229|FG000|Overall Study|Withdrawal by Subject|8|||
44132805|NCT03343483|78919230|FG001|Overall Study|Withdrawal by Subject|17|||
44132806|NCT03035409|78919236|FG000|Overall Study|Adverse Event|5|||
44132807|NCT03035409|78919236|FG000|Overall Study|Death|2|||
44132808|NCT03035409|78919236|FG000|Overall Study|Withdrawal by Subject|2|||
44132809|NCT03035409|78919236|FG000|Overall Study|Non compliance|4|||
44132810|NCT03035409|78919236|FG000|Overall Study|Patient was jittery|1|||
44132811|NCT03035409|78919236|FG000|Overall Study|Did not like Questionnaire|1|||
44132812|NCT03035409|78919236|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
44132813|NCT03035409|78919236|FG000|Overall Study|Did not like taking drugs|1|||
44132814|NCT02948088|78919240|FG000|Overall Study|Lost to Follow-up|8|||
44132815|NCT02948088|78919240|FG000|Overall Study|Death|1|||
44132816|NCT02948088|78919240|FG000|Overall Study|Withdrawal by Subject|4|||
44132817|NCT02948088|78919240|FG000|Overall Study|Other|2|||
44132818|NCT02943915|78919279|FG000|Overall Study|Withdrawal by Subject|2|||
44243626|NCT01690988|79073252|FG001|Overall Study|Operation Cancelled|1|||
44132819|NCT02943915|78919280|FG001|Overall Study|Withdrawal by Subject|1|||
44132820|NCT02943915|78919281|FG002|Overall Study|Withdrawal by Subject|0|||
44132821|NCT02943915|78919282|FG003|Overall Study|Withdrawal by Subject|0|||
44132822|NCT02943915|78919279|FG000|Overall Study|Lost to Follow-up|3|||
44132823|NCT02943915|78919280|FG001|Overall Study|Lost to Follow-up|1|||
44132824|NCT02943915|78919281|FG002|Overall Study|Lost to Follow-up|0|||
44132825|NCT02943915|78919282|FG003|Overall Study|Lost to Follow-up|0|||
44132826|NCT02943915|78919279|FG000|Overall Study|excluded|0|||
44132827|NCT02943915|78919280|FG001|Overall Study|excluded|1|||
44132828|NCT02943915|78919281|FG002|Overall Study|excluded|0|||
44132829|NCT02943915|78919282|FG003|Overall Study|excluded|0|||
44132830|NCT02763384|78919291|FG000|Overall Study|Physician Decision|1|||
44132831|NCT02763384|78919291|FG000|Overall Study|Rapid decline - went on hospice|1|||
44132832|NCT02649855|78919298|FG000|Overall Study|Refused further treatment|2|||
44132833|NCT02649855|78919299|FG001|Overall Study|Refused further treatment|1|||
44132834|NCT02649855|78919300|FG002|Overall Study|Refused further treatment|1|||
44132835|NCT02649855|78919298|FG000|Overall Study|Withdrew consent|0|||
44132836|NCT02649855|78919299|FG001|Overall Study|Withdrew consent|1|||
44132837|NCT02649855|78919300|FG002|Overall Study|Withdrew consent|0|||
44132838|NCT02649855|78919298|FG000|Overall Study|Switched to alternative treatment|0|||
44132839|NCT02649855|78919299|FG001|Overall Study|Switched to alternative treatment|1|||
44132840|NCT02649855|78919300|FG002|Overall Study|Switched to alternative treatment|1|||
44132841|NCT02649855|78919298|FG000|Overall Study|Principal investigator discretion|0|||
44132842|NCT02649855|78919299|FG001|Overall Study|Principal investigator discretion|1|||
44132843|NCT02649855|78919300|FG002|Overall Study|Principal investigator discretion|1|||
44132844|NCT02649855|78919298|FG000|Overall Study|No treatment, per protocol|1|||
44132845|NCT02649855|78919299|FG001|Overall Study|No treatment, per protocol|0|||
44132846|NCT02649855|78919300|FG002|Overall Study|No treatment, per protocol|0|||
44132847|NCT02649855|78919298|FG000|Overall Study|Initiate new treatment|1|||
44132848|NCT02649855|78919299|FG001|Overall Study|Initiate new treatment|0|||
44132849|NCT02649855|78919300|FG002|Overall Study|Initiate new treatment|0|||
44132850|NCT02619682|78919308|FG000|Overall Study|Withdrawal by Subject|3|||
44132851|NCT02619682|78919308|FG000|Overall Study|Lack of Efficacy|8|||
44132852|NCT02619682|78919308|FG000|Overall Study|new secondary cancer|1|||
44132853|NCT02619682|78919308|FG000|Overall Study|post surgery complications|2|||
44132854|NCT02613507|78919315|FG000|Overall Study|Disease Progression|237|||
44132855|NCT02613507|78919316|FG001|Overall Study|Disease Progression|109|||
44132856|NCT02613507|78919315|FG000|Overall Study|Study Drug Toxicity|15|||
44132857|NCT02613507|78919316|FG001|Overall Study|Study Drug Toxicity|14|||
44132858|NCT02613507|78919315|FG000|Overall Study|Death|3|||
44132859|NCT02613507|78919316|FG001|Overall Study|Death|0|||
44132860|NCT02613507|78919315|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
44132861|NCT02613507|78919316|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
44132862|NCT02613507|78919315|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
44132863|NCT02613507|78919316|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
44132864|NCT02613507|78919315|FG000|Overall Study|Participant Withdrew Consent|0|||
44132865|NCT02613507|78919316|FG001|Overall Study|Participant Withdrew Consent|2|||
44132866|NCT02613507|78919315|FG000|Overall Study|Lost to Follow-up|1|||
44132867|NCT02613507|78919316|FG001|Overall Study|Lost to Follow-up|0|||
44132868|NCT02613507|78919315|FG000|Overall Study|Maximum Clinical Benefit|4|||
44132869|NCT02613507|78919316|FG001|Overall Study|Maximum Clinical Benefit|10|||
44132870|NCT02613507|78919315|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
44132871|NCT02613507|78919316|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
44132872|NCT02613507|78919315|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
44132873|NCT02613507|78919316|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
44132874|NCT02613507|78919315|FG000|Overall Study|Randomized but not Treated|1|||
44132875|NCT02613507|78919316|FG001|Overall Study|Randomized but not Treated|10|||
44132876|NCT02521285|78919337|FG000|Overall Study|Lost to Follow-up|1|||
44132877|NCT02521285|78919338|FG001|Overall Study|Lost to Follow-up|1|||
44132878|NCT02521285|78919337|FG000|Overall Study|Withdrawal by Subject|1|||
44132879|NCT02521285|78919338|FG001|Overall Study|Withdrawal by Subject|1|||
44243627|NCT01690988|79073253|FG002|Overall Study|Operation Cancelled|0|||
44512860|NCT04030598|79518720|FG002|Overall Study|Voluntary Withdrawal|0|||
44512861|NCT03777436|79518739|FG000|Placebo-controlled Phase|Adverse Event|8|||
44512862|NCT03777436|79518740|FG001|Placebo-controlled Phase|Adverse Event|10|||
44132880|NCT02521285|78919337|FG000|Overall Study|Adverse Event|0|||
44132881|NCT02521285|78919338|FG001|Overall Study|Adverse Event|1|||
44132882|NCT02331134|78919371|FG000|Overall Study|Withdrawal by Subject|1|||
44132883|NCT02243605|78919377|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
44132884|NCT02243605|78919378|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
44132885|NCT02243605|78919377|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
44243628|NCT01690988|79073251|FG000|Overall Study|Determined ineligible|1|||
44132886|NCT02243605|78919378|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
44512863|NCT03777436|79518741|FG002|Placebo-controlled Phase|Adverse Event|0|||
44512864|NCT03777436|79518739|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
44132887|NCT02243605|78919377|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
44132888|NCT02243605|78919378|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
44132889|NCT02243605|78919377|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
44132890|NCT02243605|78919378|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
44132891|NCT02243605|78919377|FG000|Stage 2 - Final Analysis Population|Progression|0|||
44132892|NCT02243605|78919378|FG001|Stage 2 - Final Analysis Population|Progression|1|||
44132893|NCT01284348|78919405|FG000|Overall Study|Death|1|||
44132894|NCT01284348|78919406|FG001|Overall Study|Death|1|||
44132895|NCT01284348|78919405|FG000|Overall Study|Withdrew consent|0|||
44132896|NCT01284348|78919406|FG001|Overall Study|Withdrew consent|1|||
44132897|NCT01284348|78919405|FG000|Overall Study|Status not recorded|9|||
44132898|NCT01284348|78919406|FG001|Overall Study|Status not recorded|10|||
44132899|NCT00727025|78919412|FG000|Overall Study|Physician Decision|23|||
44132900|NCT02701413|78919422|FG000|Overall Study|Withdrawal by Subject|7|||
44132901|NCT02701413|78919423|FG001|Overall Study|Withdrawal by Subject|11|||
44132902|NCT02582684|78919429|FG000|Overall Study|Unable to contact subject/parent|4|||
44132903|NCT02582684|78919429|FG000|Overall Study|Subject not able to get to clinic|10|||
44132904|NCT02582684|78919429|FG000|Overall Study|Subject withdrew consent|1|||
44132905|NCT02582684|78919429|FG000|Overall Study|Found to be ineligible after enrollment|2|||
44132906|NCT02585960|78919436|FG000|PK/Safety Assessment Period|Physician Decision|0|||
44132907|NCT02585960|78919437|FG001|PK/Safety Assessment Period|Physician Decision|1|||
44132908|NCT02585960|78919438|FG002|PK/Safety Assessment Period|Physician Decision|0|||
44132909|NCT02585960|78919436|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
44132910|NCT02585960|78919437|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
44132911|NCT02585960|78919438|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
44132912|NCT02585960|78919436|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
44132913|NCT02585960|78919437|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
44132914|NCT02585960|78919438|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
44132915|NCT02585960|78919436|FG000|PK/Safety Assessment Period|Other|4|||
44132916|NCT02585960|78919437|FG001|PK/Safety Assessment Period|Other|4|||
44132917|NCT02585960|78919438|FG002|PK/Safety Assessment Period|Other|0|||
44132918|NCT02585960|78919436|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
44132919|NCT02585960|78919437|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
44132920|NCT02585960|78919438|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
44132921|NCT02585960|78919436|FG000|PK/Safety Assessment Period|Screen Failure|0|||
44132922|NCT02585960|78919437|FG001|PK/Safety Assessment Period|Screen Failure|0|||
44132923|NCT02585960|78919438|FG002|PK/Safety Assessment Period|Screen Failure|1|||
44132924|NCT02585960|78919436|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
44132925|NCT02585960|78919437|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
44132926|NCT02585960|78919438|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
44132927|NCT02585960|78919436|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
44132928|NCT02585960|78919437|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
44132929|NCT02585960|78919438|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
44132930|NCT02699463|78919451|FG000|Overall Study|Lost to Follow-up|11|||
44132931|NCT02699463|78919452|FG001|Overall Study|Lost to Follow-up|8|||
44243629|NCT01690988|79073252|FG001|Overall Study|Determined ineligible|0|||
44243630|NCT01690988|79073253|FG002|Overall Study|Determined ineligible|0|||
44380062|NCT00828568|79385854|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
44380063|NCT00828568|79385855|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
44380064|NCT00828568|79385853|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
44380065|NCT00828568|79385854|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
44380066|NCT00828568|79385855|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
44380067|NCT00828568|79385853|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
44380068|NCT00828568|79385854|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
44380069|NCT00828568|79385855|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
44380070|NCT01038752|79385866|FG000|Overall Study|Tumor Progression|2|||
44380071|NCT01038752|79385867|FG001|Overall Study|Tumor Progression|2|||
44380072|NCT01038752|79385866|FG000|Overall Study|Lost to Follow-up|3|||
44380073|NCT01038752|79385867|FG001|Overall Study|Lost to Follow-up|3|||
44380074|NCT00903630|79385876|FG000|Phase 2|Adverse Event|0|||
44380075|NCT00903630|79385877|FG001|Phase 2|Adverse Event|0|||
44380076|NCT00903630|79385878|FG002|Phase 2|Adverse Event|1|||
44380077|NCT01037114|79385888|FG000|Year 20|Others|1|||
44132932|NCT02699463|78919451|FG000|Overall Study|Withdrawal by Subject|4|||
44243631|NCT01690988|79073251|FG000|Overall Study|Death|1|||
44380078|NCT00840970|79385892|FG000|Overall Study|Adverse Event|0|||
44132933|NCT02699463|78919452|FG001|Overall Study|Withdrawal by Subject|1|||
44132934|NCT00100789|78919458|FG000|Overall Study|Adverse Event|10|||
44132935|NCT00100789|78919458|FG000|Overall Study|Withdrawal by Subject|1|||
44132936|NCT00100789|78919458|FG000|Overall Study|Progression/relapse|42|||
44380079|NCT00840970|79385893|FG001|Overall Study|Adverse Event|0|||
44380080|NCT00840970|79385894|FG002|Overall Study|Adverse Event|1|||
44380081|NCT01054820|79385904|FG000|Overall Study|Withdrawal by Subject|2|||
44380082|NCT00840658|79385912|FG000|Overall Study|Death|2|||
44380083|NCT00840658|79385913|FG001|Overall Study|Death|2|||
44380084|NCT00840658|79385914|FG002|Overall Study|Death|3|||
44380085|NCT00840658|79385915|FG003|Overall Study|Death|3|||
44380086|NCT00840658|79385912|FG000|Overall Study|Lost to Follow-up|3|||
44380087|NCT00840658|79385913|FG001|Overall Study|Lost to Follow-up|1|||
44132937|NCT00100789|78919458|FG000|Overall Study|Death|2|||
44132938|NCT00100789|78919458|FG000|Overall Study|Not protocol specified|5|||
44132939|NCT00100789|78919458|FG000|Overall Study|Ineligible|3|||
44132940|NCT00100789|78919458|FG000|Overall Study|Never received treatment|1|||
44132941|NCT00708123|78919463|FG000|Period 1|Protocol Violation|0|||
44132942|NCT00708123|78919464|FG001|Period 1|Protocol Violation|1|||
44132943|NCT00708123|78919465|FG002|Period 1|Protocol Violation|0|||
44132944|NCT00708123|78919466|FG003|Period 1|Protocol Violation|1|||
44132945|NCT00708123|78919467|FG004|Period 1|Protocol Violation|0|||
44132946|NCT00708123|78919463|FG000|Period 1|Adverse Event|0|||
44132947|NCT00708123|78919464|FG001|Period 1|Adverse Event|0|||
44132948|NCT00708123|78919465|FG002|Period 1|Adverse Event|1|||
44132949|NCT00708123|78919466|FG003|Period 1|Adverse Event|0|||
44132950|NCT00708123|78919467|FG004|Period 1|Adverse Event|0|||
44132951|NCT00708123|78919463|FG000|Period 2|Protocol Violation|0|||
44132952|NCT00708123|78919464|FG001|Period 2|Protocol Violation|0|||
44132953|NCT00708123|78919465|FG002|Period 2|Protocol Violation|0|||
44132954|NCT00708123|78919466|FG003|Period 2|Protocol Violation|1|||
44132955|NCT00708123|78919467|FG004|Period 2|Protocol Violation|0|||
44132956|NCT00708123|78919463|FG000|Period 2|Other Reason|1|||
44132957|NCT00708123|78919464|FG001|Period 2|Other Reason|0|||
44132958|NCT00708123|78919465|FG002|Period 2|Other Reason|0|||
44132959|NCT00708123|78919466|FG003|Period 2|Other Reason|0|||
44132960|NCT00708123|78919467|FG004|Period 2|Other Reason|0|||
44132961|NCT00708123|78919463|FG000|Period 3|Lost to Follow-up|0|||
44132962|NCT00708123|78919464|FG001|Period 3|Lost to Follow-up|0|||
44132963|NCT00708123|78919465|FG002|Period 3|Lost to Follow-up|1|||
44132964|NCT00708123|78919466|FG003|Period 3|Lost to Follow-up|1|||
44132965|NCT00708123|78919467|FG004|Period 3|Lost to Follow-up|0|||
44132966|NCT00708123|78919463|FG000|Period 4|Protocol Violation|0|||
44132967|NCT00708123|78919464|FG001|Period 4|Protocol Violation|1|||
44132968|NCT00708123|78919465|FG002|Period 4|Protocol Violation|0|||
44132969|NCT00708123|78919466|FG003|Period 4|Protocol Violation|0|||
44132970|NCT00708123|78919467|FG004|Period 4|Protocol Violation|0|||
44132971|NCT02165215|78919486|FG000|Induction Phase|Adverse Event|1|||
44132972|NCT02165215|78919487|FG001|Induction Phase|Adverse Event|0|||
44132973|NCT02165215|78919488|FG002|Induction Phase|Adverse Event|0|||
44132974|NCT02165215|78919486|FG000|Induction Phase|Withdrawal by Subject|10|||
44132975|NCT02165215|78919487|FG001|Induction Phase|Withdrawal by Subject|0|||
44132976|NCT02165215|78919488|FG002|Induction Phase|Withdrawal by Subject|0|||
44132977|NCT02165215|78919486|FG000|Induction Phase|Protocol Violation|1|||
44132978|NCT02165215|78919487|FG001|Induction Phase|Protocol Violation|0|||
44132979|NCT02165215|78919488|FG002|Induction Phase|Protocol Violation|0|||
44132980|NCT02165215|78919486|FG000|Induction Phase|Physician Decision|1|||
44132981|NCT02165215|78919487|FG001|Induction Phase|Physician Decision|0|||
44132982|NCT02165215|78919488|FG002|Induction Phase|Physician Decision|0|||
44132983|NCT02165215|78919486|FG000|Induction Phase|Lack of Efficacy|2|||
44132984|NCT02165215|78919487|FG001|Induction Phase|Lack of Efficacy|0|||
44132985|NCT02165215|78919488|FG002|Induction Phase|Lack of Efficacy|0|||
44132986|NCT02165215|78919486|FG000|Induction Phase|Non-Compliance|2|||
44132987|NCT02165215|78919487|FG001|Induction Phase|Non-Compliance|0|||
44132988|NCT02165215|78919488|FG002|Induction Phase|Non-Compliance|0|||
44132989|NCT02165215|78919486|FG000|Induction Phase|Lost to Follow-up|6|||
44132990|NCT02165215|78919487|FG001|Induction Phase|Lost to Follow-up|0|||
44132991|NCT02165215|78919488|FG002|Induction Phase|Lost to Follow-up|0|||
44132992|NCT02165215|78919486|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44132993|NCT02165215|78919487|FG001|Maintenance Phase|Withdrawal by Subject|7|||
44132994|NCT02165215|78919488|FG002|Maintenance Phase|Withdrawal by Subject|3|||
44132995|NCT02165215|78919486|FG000|Maintenance Phase|Multiple reasons|0|||
44132996|NCT02165215|78919487|FG001|Maintenance Phase|Multiple reasons|2|||
44132997|NCT02165215|78919488|FG002|Maintenance Phase|Multiple reasons|1|||
44132998|NCT02165215|78919486|FG000|Maintenance Phase|Lost to Follow-up|0|||
44132999|NCT02165215|78919487|FG001|Maintenance Phase|Lost to Follow-up|2|||
44380088|NCT00840658|79385914|FG002|Overall Study|Lost to Follow-up|2|||
44380089|NCT00840658|79385915|FG003|Overall Study|Lost to Follow-up|1|||
44133000|NCT02165215|78919488|FG002|Maintenance Phase|Lost to Follow-up|0|||
44133001|NCT02165215|78919486|FG000|Maintenance Phase|Adverse Event|0|||
44133002|NCT02165215|78919487|FG001|Maintenance Phase|Adverse Event|1|||
44133003|NCT02165215|78919488|FG002|Maintenance Phase|Adverse Event|1|||
44380090|NCT01036724|79385931|FG000|Overall Study|Adverse Event|1|||
44133004|NCT02757625|78919503|FG000|Overall Study|Investigator's discretion|0|||
44133005|NCT02757625|78919504|FG001|Overall Study|Investigator's discretion|0|||
44133006|NCT02757625|78919505|FG002|Overall Study|Investigator's discretion|1|||
44133007|NCT02757625|78919506|FG003|Overall Study|Investigator's discretion|0|||
44380091|NCT01036724|79385932|FG001|Overall Study|Adverse Event|2|||
44133008|NCT02757625|78919503|FG000|Overall Study|Adverse Event|0|||
44133009|NCT02757625|78919504|FG001|Overall Study|Adverse Event|0|||
44133010|NCT02757625|78919505|FG002|Overall Study|Adverse Event|1|||
44133011|NCT02757625|78919506|FG003|Overall Study|Adverse Event|0|||
44133012|NCT02581202|78919518|FG000|Overall Study|Lack of Efficacy|2|||
44133013|NCT02581202|78919518|FG000|Overall Study|Withdrawal by Subject|4|||
44133014|NCT02581202|78919518|FG000|Overall Study|Lost to Follow-up|5|||
44133015|NCT02581202|78919518|FG000|Overall Study|Pregnancy|3|||
44133016|NCT02758171|78919525|FG000|Wash-out|Withdrawal by Subject|1|||
44133017|NCT02758171|78919526|FG001|Wash-out|Withdrawal by Subject|0|||
44133018|NCT02758171|78919525|FG000|Wash-out|Other reason|1|||
44133019|NCT02758171|78919526|FG001|Wash-out|Other reason|0|||
44133020|NCT01664078|78919541|FG000|Overall Study|Death|9|||
44133021|NCT01664078|78919541|FG000|Overall Study|Withdrawal by Subject|4|||
44133022|NCT01664078|78919541|FG000|Overall Study|Lost to Follow-up|2|||
44133023|NCT01664078|78919541|FG000|Overall Study|missed 5 year visit|1|||
44133024|NCT01664078|78919541|FG000|Overall Study|Other|53|||
44133025|NCT03367403|78919594|FG000|Overall Study|Adverse Event|20|||
44133026|NCT03367403|78919595|FG001|Overall Study|Adverse Event|6|||
44133027|NCT03367403|78919596|FG002|Overall Study|Adverse Event|2|||
44133028|NCT03367403|78919594|FG000|Overall Study|Withdrawal by Subject|12|||
44133029|NCT03367403|78919595|FG001|Overall Study|Withdrawal by Subject|13|||
44133030|NCT03367403|78919596|FG002|Overall Study|Withdrawal by Subject|1|||
44133031|NCT03367403|78919594|FG000|Overall Study|Death|1|||
44133032|NCT03367403|78919595|FG001|Overall Study|Death|2|||
44133033|NCT03367403|78919596|FG002|Overall Study|Death|0|||
44133034|NCT03367403|78919594|FG000|Overall Study|Physician Decision|0|||
44133035|NCT03367403|78919595|FG001|Overall Study|Physician Decision|1|||
44133036|NCT03367403|78919596|FG002|Overall Study|Physician Decision|0|||
44133037|NCT03367403|78919594|FG000|Overall Study|Protocol Violation|1|||
44133038|NCT03367403|78919595|FG001|Overall Study|Protocol Violation|1|||
44133039|NCT03367403|78919596|FG002|Overall Study|Protocol Violation|0|||
44133040|NCT03367403|78919594|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
44133041|NCT03367403|78919595|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
44133042|NCT03367403|78919596|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
44133043|NCT03367403|78919594|FG000|Overall Study|COVID-19|3|||
44133044|NCT03367403|78919595|FG001|Overall Study|COVID-19|6|||
44133045|NCT03367403|78919596|FG002|Overall Study|COVID-19|0|||
44133046|NCT03367403|78919594|FG000|Overall Study|Abuse of Alcohol Intake|0|||
44133047|NCT03367403|78919595|FG001|Overall Study|Abuse of Alcohol Intake|1|||
44133048|NCT03367403|78919596|FG002|Overall Study|Abuse of Alcohol Intake|0|||
44133049|NCT03367403|78919594|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
44133050|NCT03367403|78919595|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
44133051|NCT03367403|78919596|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
44133052|NCT02577146|78919604|FG000|Overall Study|Lost to Follow-up|8|||
44133053|NCT02577146|78919604|FG000|Overall Study|Physician Decision|3|||
44133054|NCT02577146|78919604|FG000|Overall Study|Screen Failure|17|||
44133055|NCT00109967|78919610|FG000|Overall Study|Cancel Prior to Treatment|2|||
44133056|NCT00109967|78919611|FG001|Overall Study|Cancel Prior to Treatment|0|||
44133057|NCT00109967|78919610|FG000|Overall Study|Adverse Event|12|||
44133058|NCT00109967|78919611|FG001|Overall Study|Adverse Event|1|||
44133059|NCT00109967|78919610|FG000|Overall Study|Withdrawal by Subject|5|||
44133060|NCT00109967|78919611|FG001|Overall Study|Withdrawal by Subject|0|||
44512865|NCT03777436|79518740|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
44512866|NCT03777436|79518741|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
44512867|NCT03777436|79518739|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
44512868|NCT03777436|79518740|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
44512869|NCT03777436|79518741|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
44512870|NCT03777436|79518739|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
44512871|NCT03777436|79518740|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
44512872|NCT03777436|79518741|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
44512873|NCT03777436|79518739|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
44512874|NCT03777436|79518740|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
44512875|NCT03777436|79518741|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
44133061|NCT00109967|78919610|FG000|Overall Study|Physician Decision|1|||
44133062|NCT00109967|78919611|FG001|Overall Study|Physician Decision|3|||
44133063|NCT00109967|78919610|FG000|Overall Study|Death|0|||
44512876|NCT03777436|79518739|FG000|Placebo-controlled Phase|Physician Decision|0|||
44133064|NCT00109967|78919611|FG001|Overall Study|Death|2|||
44133065|NCT02579096|78919619|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
44133066|NCT02579096|78919620|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
44133067|NCT02579096|78919619|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
44133068|NCT02579096|78919620|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
44133069|NCT02579096|78919619|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
44133070|NCT02579096|78919620|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
44133071|NCT02579096|78919619|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
44133072|NCT02579096|78919620|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
44133073|NCT02579096|78919619|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
44133074|NCT02579096|78919620|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
44133075|NCT02579096|78919619|FG000|Phase 2, Weeks 25 - 48|Death|2|||
44133076|NCT02579096|78919620|FG001|Phase 2, Weeks 25 - 48|Death|4|||
44133077|NCT02579096|78919619|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
44133078|NCT02579096|78919620|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
44133079|NCT02579096|78919619|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
44133080|NCT02579096|78919620|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
44133081|NCT02579096|78919619|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
44133082|NCT02579096|78919620|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
44133083|NCT02579096|78919619|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
44133084|NCT02579096|78919620|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
44133085|NCT02579096|78919619|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
44133086|NCT02579096|78919620|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
44133087|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Death|3|||
44133088|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Death|2|||
44133089|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
44133090|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
44133091|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
44133092|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
44133093|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
44133094|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
44133095|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
44133096|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
44133097|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
44133098|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
44133099|NCT02579096|78919619|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
44133100|NCT02579096|78919620|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
44133101|NCT02578940|78919626|FG000|Overall Study|Screening failure|5|||
44133102|NCT02578940|78919626|FG000|Overall Study|Lost to Follow-up|1|||
44133103|NCT02578862|78919634|FG000|Overall Study|Withdrawal by Subject|0|||
44133104|NCT02578862|78919635|FG001|Overall Study|Withdrawal by Subject|1|||
44133105|NCT02578862|78919634|FG000|Overall Study|Unplanned unilateral procedure|0|||
44133106|NCT02578862|78919635|FG001|Overall Study|Unplanned unilateral procedure|1|||
44133107|NCT02578706|78919644|FG000|Overall Study|Withdrawal by Subject|1|||
44133108|NCT02578706|78919645|FG001|Overall Study|Withdrawal by Subject|0|||
44133109|NCT02578706|78919646|FG002|Overall Study|Withdrawal by Subject|0|||
44380092|NCT01036724|79385931|FG000|Overall Study|Lack of Efficacy|1|||
44380093|NCT01036724|79385932|FG001|Overall Study|Lack of Efficacy|1|||
44380094|NCT01036724|79385931|FG000|Overall Study|Protocol Violation|4|||
44380095|NCT01036724|79385932|FG001|Overall Study|Protocol Violation|5|||
44380096|NCT01052714|79385940|FG000|Overall Study|Adverse Event|6|||
44380097|NCT01052714|79385941|FG001|Overall Study|Adverse Event|3|||
44380098|NCT01052714|79385942|FG002|Overall Study|Adverse Event|0|||
44380099|NCT01052714|79385940|FG000|Overall Study|Death|1|||
44380100|NCT01052714|79385941|FG001|Overall Study|Death|2|||
44380101|NCT01052714|79385942|FG002|Overall Study|Death|0|||
44380102|NCT01052714|79385940|FG000|Overall Study|Lost to Follow-up|2|||
44380103|NCT01052714|79385941|FG001|Overall Study|Lost to Follow-up|3|||
44133110|NCT02578706|78919644|FG000|Overall Study|Lost to Follow-up|0|||
44133111|NCT02578706|78919645|FG001|Overall Study|Lost to Follow-up|4|||
44133112|NCT02578706|78919646|FG002|Overall Study|Lost to Follow-up|0|||
44133113|NCT02578706|78919644|FG000|Overall Study|Physician Decision|0|||
44133114|NCT02578706|78919645|FG001|Overall Study|Physician Decision|1|||
44133115|NCT02578706|78919646|FG002|Overall Study|Physician Decision|0|||
44133116|NCT00108953|78919656|FG000|Follow-up|Death|18|||
44133117|NCT00108953|78919657|FG001|Follow-up|Death|26|||
44133118|NCT00108953|78919656|FG000|Follow-up|Lost to Follow-up|1|||
44133119|NCT00108953|78919657|FG001|Follow-up|Lost to Follow-up|1|||
44133120|NCT00108953|78919656|FG000|Follow-up|Study terminated by sponsor|10|||
44133121|NCT00108953|78919657|FG001|Follow-up|Study terminated by sponsor|6|||
44133122|NCT02578316|78919665|FG000|Extension Phase|Progression of disease|6|||
44133123|NCT02576678|78919676|FG000|Overall Study|Adverse Event|0|||
44133124|NCT02576678|78919677|FG001|Overall Study|Adverse Event|0|||
44133125|NCT02576678|78919678|FG002|Overall Study|Adverse Event|2|||
44133126|NCT02576678|78919676|FG000|Overall Study|Withdrawal by Subject|3|||
44133127|NCT02576678|78919677|FG001|Overall Study|Withdrawal by Subject|1|||
44133128|NCT02576678|78919678|FG002|Overall Study|Withdrawal by Subject|2|||
44133129|NCT02576678|78919676|FG000|Overall Study|Lost to Follow-up|0|||
44133130|NCT02576678|78919677|FG001|Overall Study|Lost to Follow-up|0|||
44133131|NCT02576678|78919678|FG002|Overall Study|Lost to Follow-up|1|||
44133132|NCT02576678|78919676|FG000|Overall Study|Miscellaneous|2|||
44133133|NCT02576678|78919677|FG001|Overall Study|Miscellaneous|0|||
44133134|NCT02576678|78919678|FG002|Overall Study|Miscellaneous|0|||
44133135|NCT00108745|78919689|FG000|Overall Study|Withdrawal by Subject|19|||
44133136|NCT00108745|78919690|FG001|Overall Study|Withdrawal by Subject|12|||
44133137|NCT00108745|78919691|FG002|Overall Study|Withdrawal by Subject|12|||
44133138|NCT00108745|78919689|FG000|Overall Study|Never Treated|8|||
44133139|NCT00108745|78919690|FG001|Overall Study|Never Treated|10|||
44133140|NCT00108745|78919691|FG002|Overall Study|Never Treated|12|||
44133141|NCT00108745|78919689|FG000|Overall Study|Ineligible|7|||
44133142|NCT00108745|78919690|FG001|Overall Study|Ineligible|13|||
44133143|NCT00108745|78919691|FG002|Overall Study|Ineligible|13|||
44133144|NCT02716805|78919721|FG000|Overall Study|Progressive disease|2|||
44133145|NCT02716805|78919722|FG001|Overall Study|Progressive disease|0|||
44133146|NCT02716805|78919723|FG002|Overall Study|Progressive disease|0|||
44133147|NCT02716805|78919724|FG003|Overall Study|Progressive disease|0|||
44133148|NCT02581982|78919728|FG000|Overall Study|Lack of Efficacy|12|||
44133149|NCT02581982|78919728|FG000|Overall Study|Adverse Event|3|||
44133150|NCT02581982|78919728|FG000|Overall Study|Physician Decision|1|||
44133151|NCT04318132|78919782|FG000|Overall Study|Protocol Violation|0|||
44133152|NCT04318132|78919783|FG001|Overall Study|Protocol Violation|0|||
44133153|NCT04318132|78919784|FG002|Overall Study|Protocol Violation|3|||
44133154|NCT04318132|78919785|FG003|Overall Study|Protocol Violation|0|||
44133155|NCT04271254|78919801|FG000|Overall Study|Withdrawal by Subject|3|||
44133156|NCT03970837|78919821|FG000|Overall Study|Adverse Event|23|||
44133157|NCT03970837|78919822|FG001|Overall Study|Adverse Event|20|||
44133158|NCT03970837|78919823|FG002|Overall Study|Adverse Event|16|||
44133159|NCT03970837|78919824|FG003|Overall Study|Adverse Event|6|||
44133160|NCT03970837|78919825|FG004|Overall Study|Adverse Event|4|||
44133161|NCT03970837|78919826|FG005|Overall Study|Adverse Event|5|||
44512877|NCT03777436|79518740|FG001|Placebo-controlled Phase|Physician Decision|1|||
44512878|NCT03777436|79518741|FG002|Placebo-controlled Phase|Physician Decision|0|||
44512879|NCT03777436|79518739|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
44512880|NCT03777436|79518740|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
44512881|NCT03777436|79518741|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
44133162|NCT03970837|78919827|FG006|Overall Study|Adverse Event|1|||
44133163|NCT03970837|78919828|FG007|Overall Study|Adverse Event|5|||
44133164|NCT03970837|78919829|FG008|Overall Study|Adverse Event|0|||
44133165|NCT03970837|78919830|FG009|Overall Study|Adverse Event|0|||
44512882|NCT03777436|79518739|FG000|Apremilast Extension Phase|Adverse Event|0|||
44512883|NCT03777436|79518740|FG001|Apremilast Extension Phase|Adverse Event|0|||
44512884|NCT03777436|79518741|FG002|Apremilast Extension Phase|Adverse Event|6|||
44512885|NCT03777436|79518739|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
44276572|NCT03603314|79237531|FG002|Overall Study|Withdrawal by Subject|3|||
44380104|NCT01052714|79385942|FG002|Overall Study|Lost to Follow-up|0|||
44512886|NCT03777436|79518740|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
44133166|NCT03970837|78919831|FG010|Overall Study|Adverse Event|1|||
44133167|NCT03970837|78919832|FG011|Overall Study|Adverse Event|1|||
44133168|NCT03970837|78919821|FG000|Overall Study|Lack of Efficacy|14|||
44133169|NCT03970837|78919822|FG001|Overall Study|Lack of Efficacy|12|||
44133170|NCT03970837|78919823|FG002|Overall Study|Lack of Efficacy|1|||
44133171|NCT03970837|78919824|FG003|Overall Study|Lack of Efficacy|2|||
44133172|NCT03970837|78919825|FG004|Overall Study|Lack of Efficacy|3|||
44133173|NCT03970837|78919826|FG005|Overall Study|Lack of Efficacy|4|||
44133174|NCT03970837|78919827|FG006|Overall Study|Lack of Efficacy|6|||
44133175|NCT03970837|78919828|FG007|Overall Study|Lack of Efficacy|1|||
44133176|NCT03970837|78919829|FG008|Overall Study|Lack of Efficacy|1|||
44133177|NCT03970837|78919830|FG009|Overall Study|Lack of Efficacy|0|||
44133178|NCT03970837|78919831|FG010|Overall Study|Lack of Efficacy|0|||
44133179|NCT03970837|78919832|FG011|Overall Study|Lack of Efficacy|0|||
44133180|NCT03970837|78919821|FG000|Overall Study|Lost to Follow-up|6|||
44133181|NCT03970837|78919822|FG001|Overall Study|Lost to Follow-up|5|||
44133182|NCT03970837|78919823|FG002|Overall Study|Lost to Follow-up|5|||
44133183|NCT03970837|78919824|FG003|Overall Study|Lost to Follow-up|1|||
44133184|NCT03970837|78919825|FG004|Overall Study|Lost to Follow-up|0|||
44133185|NCT03970837|78919826|FG005|Overall Study|Lost to Follow-up|2|||
44133186|NCT03970837|78919827|FG006|Overall Study|Lost to Follow-up|0|||
44133187|NCT03970837|78919828|FG007|Overall Study|Lost to Follow-up|0|||
44133188|NCT03970837|78919829|FG008|Overall Study|Lost to Follow-up|0|||
44133189|NCT03970837|78919830|FG009|Overall Study|Lost to Follow-up|0|||
44133190|NCT03970837|78919831|FG010|Overall Study|Lost to Follow-up|0|||
44133191|NCT03970837|78919832|FG011|Overall Study|Lost to Follow-up|0|||
44133192|NCT03970837|78919821|FG000|Overall Study|Protocol Violation|1|||
44133193|NCT03970837|78919822|FG001|Overall Study|Protocol Violation|0|||
44133194|NCT03970837|78919823|FG002|Overall Study|Protocol Violation|0|||
44133195|NCT03970837|78919824|FG003|Overall Study|Protocol Violation|0|||
44133196|NCT03970837|78919825|FG004|Overall Study|Protocol Violation|0|||
44133197|NCT03970837|78919826|FG005|Overall Study|Protocol Violation|0|||
44133198|NCT03970837|78919827|FG006|Overall Study|Protocol Violation|0|||
44133199|NCT03970837|78919828|FG007|Overall Study|Protocol Violation|0|||
44133200|NCT03970837|78919829|FG008|Overall Study|Protocol Violation|0|||
44133201|NCT03970837|78919830|FG009|Overall Study|Protocol Violation|0|||
44133202|NCT03970837|78919831|FG010|Overall Study|Protocol Violation|0|||
44133203|NCT03970837|78919832|FG011|Overall Study|Protocol Violation|0|||
44133204|NCT03970837|78919821|FG000|Overall Study|Physician Decision|5|||
44133205|NCT03970837|78919822|FG001|Overall Study|Physician Decision|8|||
44133206|NCT03970837|78919823|FG002|Overall Study|Physician Decision|4|||
44133207|NCT03970837|78919824|FG003|Overall Study|Physician Decision|1|||
44133208|NCT03970837|78919825|FG004|Overall Study|Physician Decision|5|||
44133209|NCT03970837|78919826|FG005|Overall Study|Physician Decision|2|||
44133210|NCT03970837|78919827|FG006|Overall Study|Physician Decision|4|||
44133211|NCT03970837|78919828|FG007|Overall Study|Physician Decision|5|||
44133212|NCT03970837|78919829|FG008|Overall Study|Physician Decision|0|||
44133213|NCT03970837|78919830|FG009|Overall Study|Physician Decision|1|||
44133214|NCT03970837|78919831|FG010|Overall Study|Physician Decision|0|||
44133215|NCT03970837|78919832|FG011|Overall Study|Physician Decision|0|||
44512887|NCT03777436|79518741|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
44512888|NCT03777436|79518739|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
44512889|NCT03777436|79518740|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
44512890|NCT03777436|79518741|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
44512891|NCT03777436|79518739|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
44512892|NCT03777436|79518740|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
44512893|NCT03777436|79518741|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
44512894|NCT03777436|79518739|FG000|Apremilast Extension Phase|Miscellaneous|0|||
44512895|NCT03777436|79518740|FG001|Apremilast Extension Phase|Miscellaneous|0|||
44133216|NCT03970837|78919821|FG000|Overall Study|Withdrawal by Subject|32|||
44133217|NCT03970837|78919822|FG001|Overall Study|Withdrawal by Subject|35|||
44133218|NCT03970837|78919823|FG002|Overall Study|Withdrawal by Subject|12|||
44133219|NCT03970837|78919824|FG003|Overall Study|Withdrawal by Subject|8|||
44133220|NCT03970837|78919825|FG004|Overall Study|Withdrawal by Subject|6|||
44133221|NCT03970837|78919826|FG005|Overall Study|Withdrawal by Subject|8|||
44133222|NCT03970837|78919827|FG006|Overall Study|Withdrawal by Subject|2|||
44133223|NCT03970837|78919828|FG007|Overall Study|Withdrawal by Subject|3|||
44133224|NCT03970837|78919829|FG008|Overall Study|Withdrawal by Subject|0|||
44133225|NCT03970837|78919830|FG009|Overall Study|Withdrawal by Subject|0|||
44133226|NCT03970837|78919831|FG010|Overall Study|Withdrawal by Subject|0|||
44133227|NCT03970837|78919832|FG011|Overall Study|Withdrawal by Subject|1|||
44133228|NCT03970837|78919821|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
44133229|NCT03970837|78919822|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
44133230|NCT03970837|78919823|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
44133231|NCT03970837|78919824|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
44380105|NCT01052714|79385940|FG000|Overall Study|Physician Decision|9|||
44380106|NCT01052714|79385941|FG001|Overall Study|Physician Decision|9|||
44380107|NCT01052714|79385942|FG002|Overall Study|Physician Decision|1|||
44380108|NCT01052714|79385940|FG000|Overall Study|Withdrawal by Subject|7|||
44133232|NCT03970837|78919825|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
44133233|NCT03970837|78919826|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44133234|NCT03970837|78919827|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44133235|NCT03970837|78919828|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44133236|NCT03970837|78919829|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
44133237|NCT03970837|78919830|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
44133238|NCT03970837|78919831|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
44133239|NCT03970837|78919832|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
44133240|NCT03970837|78919821|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44133241|NCT03970837|78919822|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44133242|NCT03970837|78919823|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44133243|NCT03970837|78919824|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44133244|NCT03970837|78919825|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44133245|NCT03970837|78919826|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44133246|NCT03970837|78919827|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
44133247|NCT03970837|78919828|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
44133248|NCT03970837|78919829|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
44133249|NCT03970837|78919830|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
44133250|NCT03970837|78919831|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
44380109|NCT01052714|79385941|FG001|Overall Study|Withdrawal by Subject|12|||
44380110|NCT01052714|79385942|FG002|Overall Study|Withdrawal by Subject|1|||
44380111|NCT01052480|79385959|FG000|Overall Study|Lost to Follow-up|3|||
44380112|NCT01052480|79385960|FG001|Overall Study|Lost to Follow-up|3|||
44380113|NCT01052480|79385959|FG000|Overall Study|Protocol Violation|1|||
44380114|NCT01052480|79385960|FG001|Overall Study|Protocol Violation|0|||
44380115|NCT01052480|79385959|FG000|Overall Study|Withdrawal by Subject|3|||
44380116|NCT01052480|79385960|FG001|Overall Study|Withdrawal by Subject|7|||
44380117|NCT01052480|79385959|FG000|Overall Study|Physician Decision|0|||
44380118|NCT01052480|79385960|FG001|Overall Study|Physician Decision|2|||
44512896|NCT03777436|79518741|FG002|Apremilast Extension Phase|Miscellaneous|1|||
44512897|NCT03156023|79518757|FG000|Overall Study|Withdrawal by Subject|1|||
44512898|NCT03156023|79518758|FG001|Overall Study|Withdrawal by Subject|0|||
44512899|NCT03156023|79518759|FG002|Overall Study|Withdrawal by Subject|2|||
44512900|NCT03156023|79518760|FG003|Overall Study|Withdrawal by Subject|1|||
44512901|NCT03156023|79518761|FG004|Overall Study|Withdrawal by Subject|1|||
44512902|NCT03156023|79518757|FG000|Overall Study|Lost to Follow-up|0|||
44512903|NCT03156023|79518758|FG001|Overall Study|Lost to Follow-up|0|||
44512904|NCT03156023|79518759|FG002|Overall Study|Lost to Follow-up|0|||
44512905|NCT03156023|79518760|FG003|Overall Study|Lost to Follow-up|0|||
44512906|NCT03156023|79518761|FG004|Overall Study|Lost to Follow-up|1|||
44133251|NCT03970837|78919832|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
44133252|NCT03938636|78919887|FG000|Overall Study|Protocol Violation|0|||
44380119|NCT01052480|79385959|FG000|Overall Study|Death|1|||
44380120|NCT01052480|79385960|FG001|Overall Study|Death|5|||
44380121|NCT00904722|79385966|FG000|Overall Study|Physician Decision|1|||
44380122|NCT01029782|79385972|FG000|Overall Study|Lost to Follow-up|2|||
44512907|NCT03025880|79518779|FG000|Overall Study|Adverse Event|1|||
44512908|NCT03025880|79518780|FG001|Overall Study|Adverse Event|0|||
44512909|NCT03025880|79518779|FG000|Overall Study|Death|1|||
44512910|NCT03025880|79518780|FG001|Overall Study|Death|1|||
44380123|NCT01029782|79385973|FG001|Overall Study|Lost to Follow-up|2|||
44133253|NCT03938636|78919888|FG001|Overall Study|Protocol Violation|1|||
44133254|NCT03938636|78919889|FG002|Overall Study|Protocol Violation|1|||
44133255|NCT03938636|78919887|FG000|Overall Study|Subject withdrew due to death in family|0|||
44133256|NCT03938636|78919888|FG001|Overall Study|Subject withdrew due to death in family|1|||
44133257|NCT03938636|78919889|FG002|Overall Study|Subject withdrew due to death in family|0|||
44133258|NCT03938636|78919887|FG000|Overall Study|Missed visit|0|||
44133259|NCT03938636|78919888|FG001|Overall Study|Missed visit|1|||
44133260|NCT03938636|78919889|FG002|Overall Study|Missed visit|0|||
44133261|NCT03938636|78919887|FG000|Overall Study|Adverse Event|0|||
44133262|NCT03938636|78919888|FG001|Overall Study|Adverse Event|0|||
44133263|NCT03938636|78919889|FG002|Overall Study|Adverse Event|1|||
44133264|NCT03938636|78919887|FG000|Overall Study|Lost to Follow-up|0|||
44133265|NCT03938636|78919888|FG001|Overall Study|Lost to Follow-up|0|||
44133266|NCT03938636|78919889|FG002|Overall Study|Lost to Follow-up|1|||
44133267|NCT03836716|78919914|FG000|Overall Study|Adverse Event|3|||
44133268|NCT03836716|78919914|FG000|Overall Study|Death|22|||
44133269|NCT03836716|78919914|FG000|Overall Study|Withdrawal by Subject|8|||
44133270|NCT03836716|78919914|FG000|Overall Study|Study terminated by sponsor|87|||
44133271|NCT03686215|78919921|FG000|Overall Study|Adverse Event|0|||
44133272|NCT03686215|78919922|FG001|Overall Study|Adverse Event|0|||
44133273|NCT03686215|78919923|FG002|Overall Study|Adverse Event|7|||
44133274|NCT03686215|78919921|FG000|Overall Study|Physician Decision|0|||
44133275|NCT03686215|78919922|FG001|Overall Study|Physician Decision|0|||
44133276|NCT03686215|78919923|FG002|Overall Study|Physician Decision|1|||
44133277|NCT03686215|78919921|FG000|Overall Study|Protocol Violation|0|||
44133278|NCT03686215|78919922|FG001|Overall Study|Protocol Violation|0|||
44133279|NCT03686215|78919923|FG002|Overall Study|Protocol Violation|4|||
44133280|NCT03686215|78919921|FG000|Overall Study|Device issue|1|||
44133281|NCT03686215|78919922|FG001|Overall Study|Device issue|0|||
44133282|NCT03686215|78919923|FG002|Overall Study|Device issue|2|||
44133283|NCT03665077|78919931|FG000|Overall Study|Lost to Follow-up|2|||
44133284|NCT03665077|78919931|FG000|Overall Study|Physician Decision|2|||
44133285|NCT03606174|78919946|FG000|Overall Study|Death|37|||
44133286|NCT03606174|78919947|FG001|Overall Study|Death|15|||
44133287|NCT03606174|78919948|FG002|Overall Study|Death|15|||
44133288|NCT03606174|78919949|FG003|Overall Study|Death|7|||
44133289|NCT03606174|78919950|FG004|Overall Study|Death|35|||
44133290|NCT03606174|78919951|FG005|Overall Study|Death|12|||
44133291|NCT03606174|78919952|FG006|Overall Study|Death|35|||
44133292|NCT03606174|78919953|FG007|Overall Study|Death|8|||
44133293|NCT03606174|78919954|FG008|Overall Study|Death|5|||
44133294|NCT03606174|78919955|FG009|Overall Study|Death|3|||
44133295|NCT03606174|78919956|FG010|Overall Study|Death|0|||
44133296|NCT03606174|78919946|FG000|Overall Study|Lost to Follow-up|0|||
44133297|NCT03606174|78919947|FG001|Overall Study|Lost to Follow-up|0|||
44133298|NCT03606174|78919948|FG002|Overall Study|Lost to Follow-up|0|||
44133299|NCT03606174|78919949|FG003|Overall Study|Lost to Follow-up|0|||
44133300|NCT03606174|78919950|FG004|Overall Study|Lost to Follow-up|1|||
44133301|NCT03606174|78919951|FG005|Overall Study|Lost to Follow-up|1|||
44133302|NCT03606174|78919952|FG006|Overall Study|Lost to Follow-up|0|||
44133303|NCT03606174|78919953|FG007|Overall Study|Lost to Follow-up|0|||
44133304|NCT03606174|78919954|FG008|Overall Study|Lost to Follow-up|0|||
44133305|NCT03606174|78919955|FG009|Overall Study|Lost to Follow-up|0|||
44133306|NCT03606174|78919956|FG010|Overall Study|Lost to Follow-up|0|||
44133307|NCT03606174|78919946|FG000|Overall Study|Withdrawal by Subject|6|||
44133308|NCT03606174|78919947|FG001|Overall Study|Withdrawal by Subject|0|||
44133309|NCT03606174|78919948|FG002|Overall Study|Withdrawal by Subject|0|||
44133310|NCT03606174|78919949|FG003|Overall Study|Withdrawal by Subject|1|||
44380124|NCT01029782|79385972|FG000|Overall Study|Diagnosis changed|1|||
44133311|NCT03606174|78919950|FG004|Overall Study|Withdrawal by Subject|2|||
44133312|NCT03606174|78919951|FG005|Overall Study|Withdrawal by Subject|1|||
44133313|NCT03606174|78919952|FG006|Overall Study|Withdrawal by Subject|4|||
44133314|NCT03606174|78919953|FG007|Overall Study|Withdrawal by Subject|0|||
44133315|NCT03606174|78919954|FG008|Overall Study|Withdrawal by Subject|0|||
44133316|NCT03606174|78919955|FG009|Overall Study|Withdrawal by Subject|0|||
44133317|NCT03606174|78919956|FG010|Overall Study|Withdrawal by Subject|1|||
44133318|NCT03606174|78919946|FG000|Overall Study|Study Terminated by Sponsor|5|||
44133319|NCT03606174|78919947|FG001|Overall Study|Study Terminated by Sponsor|7|||
44133320|NCT03606174|78919948|FG002|Overall Study|Study Terminated by Sponsor|3|||
44133321|NCT03606174|78919949|FG003|Overall Study|Study Terminated by Sponsor|0|||
44133322|NCT03606174|78919950|FG004|Overall Study|Study Terminated by Sponsor|11|||
44133323|NCT03606174|78919951|FG005|Overall Study|Study Terminated by Sponsor|6|||
44133324|NCT03606174|78919952|FG006|Overall Study|Study Terminated by Sponsor|12|||
44133325|NCT03606174|78919953|FG007|Overall Study|Study Terminated by Sponsor|1|||
44133326|NCT03606174|78919954|FG008|Overall Study|Study Terminated by Sponsor|3|||
44133327|NCT03606174|78919955|FG009|Overall Study|Study Terminated by Sponsor|1|||
44133328|NCT03606174|78919956|FG010|Overall Study|Study Terminated by Sponsor|2|||
44133329|NCT03606174|78919946|FG000|Overall Study|Miscellaneous|1|||
44133330|NCT03606174|78919947|FG001|Overall Study|Miscellaneous|1|||
44133331|NCT03606174|78919948|FG002|Overall Study|Miscellaneous|0|||
44133332|NCT03606174|78919949|FG003|Overall Study|Miscellaneous|1|||
44133333|NCT03606174|78919950|FG004|Overall Study|Miscellaneous|4|||
44243632|NCT01690988|79073252|FG001|Overall Study|Death|1|||
44243633|NCT01690988|79073253|FG002|Overall Study|Death|1|||
44243634|NCT01690988|79073251|FG000|Overall Study|Sedated|1|||
44380125|NCT01029782|79385973|FG001|Overall Study|Diagnosis changed|1|||
44380126|NCT01029782|79385972|FG000|Overall Study|Adverse Event|0|||
44380127|NCT01029782|79385973|FG001|Overall Study|Adverse Event|1|||
44380128|NCT01029782|79385972|FG000|Overall Study|Physician Decision|0|||
44380129|NCT01029782|79385973|FG001|Overall Study|Physician Decision|1|||
44380130|NCT01029782|79385972|FG000|Overall Study|Protocol Violation|0|||
44380131|NCT01029782|79385973|FG001|Overall Study|Protocol Violation|2|||
44380132|NCT01029782|79385972|FG000|Overall Study|Withdrawal by Subject|0|||
44380133|NCT01029782|79385973|FG001|Overall Study|Withdrawal by Subject|1|||
44133334|NCT03606174|78919951|FG005|Overall Study|Miscellaneous|7|||
44133335|NCT03606174|78919952|FG006|Overall Study|Miscellaneous|5|||
44133336|NCT03606174|78919953|FG007|Overall Study|Miscellaneous|0|||
44133337|NCT03606174|78919954|FG008|Overall Study|Miscellaneous|0|||
44243635|NCT01690988|79073252|FG001|Overall Study|Sedated|1|||
44380134|NCT01029704|79385988|FG000|Overall Study|Adverse Event|0|||
44380135|NCT01029704|79385989|FG001|Overall Study|Adverse Event|0|||
44380136|NCT01029704|79385990|FG002|Overall Study|Adverse Event|0|||
44380137|NCT01029704|79385991|FG003|Overall Study|Adverse Event|0|||
44380138|NCT01029704|79385992|FG004|Overall Study|Adverse Event|0|||
44380139|NCT01029704|79385993|FG005|Overall Study|Adverse Event|0|||
44380140|NCT01029704|79385994|FG006|Overall Study|Adverse Event|1|||
44380141|NCT01029704|79385995|FG007|Overall Study|Adverse Event|1|||
44133338|NCT03606174|78919955|FG009|Overall Study|Miscellaneous|0|||
44133339|NCT03606174|78919956|FG010|Overall Study|Miscellaneous|1|||
44133340|NCT03450707|78919986|FG000|Overall Study|Outside enrollment window|4|||
44133341|NCT03450707|78919987|FG001|Overall Study|Outside enrollment window|1|||
44133342|NCT03450707|78919986|FG000|Overall Study|Death|1|||
44133343|NCT03450707|78919987|FG001|Overall Study|Death|0|||
44133344|NCT03450707|78919986|FG000|Overall Study|Indication for thiamine|1|||
44133345|NCT03450707|78919987|FG001|Overall Study|Indication for thiamine|1|||
44133346|NCT03450707|78919986|FG000|Overall Study|Evidence of traumatic brain injury|1|||
44133347|NCT03450707|78919987|FG001|Overall Study|Evidence of traumatic brain injury|0|||
44133348|NCT03450707|78919986|FG000|Overall Study|Following commands|0|||
44133349|NCT03450707|78919987|FG001|Overall Study|Following commands|3|||
44133350|NCT03450707|78919986|FG000|Overall Study|Lactate < 3.5|0|||
44133351|NCT03450707|78919987|FG001|Overall Study|Lactate < 3.5|2|||
44133352|NCT03450707|78919986|FG000|Overall Study|Rearrest with ECMO|0|||
44133353|NCT03450707|78919987|FG001|Overall Study|Rearrest with ECMO|1|||
44133354|NCT03450707|78919986|FG000|Overall Study|Indication for thiamine + head CT results|0|||
44133355|NCT03450707|78919987|FG001|Overall Study|Indication for thiamine + head CT results|1|||
44133356|NCT03450707|78919986|FG000|Overall Study|Family/patient goals of care|0|||
44133357|NCT03450707|78919987|FG001|Overall Study|Family/patient goals of care|1|||
44133358|NCT03296527|78919995|FG000|Overall Study|Adverse Event|15|||
44133359|NCT03296527|78919996|FG001|Overall Study|Adverse Event|33|||
44133360|NCT03296527|78919995|FG000|Overall Study|Protocol Deviation|4|||
44380142|NCT01029704|79385996|FG008|Overall Study|Adverse Event|0|||
44380143|NCT01029704|79385988|FG000|Overall Study|Withdrawal by Subject|0|||
44380144|NCT01029704|79385989|FG001|Overall Study|Withdrawal by Subject|0|||
44133361|NCT03296527|78919996|FG001|Overall Study|Protocol Deviation|0|||
44133362|NCT03296527|78919995|FG000|Overall Study|Participant withdrew consent|3|||
44133363|NCT03296527|78919996|FG001|Overall Study|Participant withdrew consent|1|||
44133364|NCT03296527|78919995|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
44133365|NCT03296527|78919996|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
44133366|NCT03296527|78919995|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
44380145|NCT01029704|79385990|FG002|Overall Study|Withdrawal by Subject|0|||
44380146|NCT01029704|79385991|FG003|Overall Study|Withdrawal by Subject|0|||
44133367|NCT03296527|78919996|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
44133368|NCT03296527|78919995|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
44133369|NCT03296527|78919996|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
44133370|NCT03296527|78919995|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
44133371|NCT03296527|78919996|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
44133372|NCT03296527|78919995|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
44133373|NCT03296527|78919996|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
44133374|NCT03228680|78920005|FG000|Overall Study|Adverse Event|13|||
44133375|NCT03228680|78920006|FG001|Overall Study|Adverse Event|18|||
44133376|NCT03228680|78920005|FG000|Overall Study|Randomization failure|0|||
44133377|NCT03228680|78920006|FG001|Overall Study|Randomization failure|1|||
44133378|NCT03228680|78920005|FG000|Overall Study|Withdrawal by Subject|1|||
44133379|NCT03228680|78920006|FG001|Overall Study|Withdrawal by Subject|0|||
44133380|NCT03228680|78920005|FG000|Overall Study|Other|9|||
44133381|NCT03228680|78920006|FG001|Overall Study|Other|16|||
44133382|NCT03194542|78920017|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
44133383|NCT03194542|78920018|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
44133384|NCT03194542|78920019|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
44133385|NCT03194542|78920020|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
44133386|NCT03194542|78920017|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
44133387|NCT03194542|78920018|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
44133388|NCT03194542|78920019|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
44133389|NCT03194542|78920020|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
44133390|NCT03194542|78920017|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
44133391|NCT03194542|78920018|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
44133392|NCT03194542|78920019|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
44133393|NCT03194542|78920020|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
44133394|NCT03194542|78920017|FG000|Overall Study|Loss of Response|4|||
44133395|NCT03194542|78920018|FG001|Overall Study|Loss of Response|2|||
44133396|NCT03194542|78920019|FG002|Overall Study|Loss of Response|3|||
44133397|NCT03194542|78920020|FG003|Overall Study|Loss of Response|4|||
44133398|NCT03194542|78920017|FG000|Overall Study|Physician Decision|0|||
44133399|NCT03194542|78920018|FG001|Overall Study|Physician Decision|1|||
44133400|NCT03194542|78920019|FG002|Overall Study|Physician Decision|0|||
44133401|NCT03194542|78920020|FG003|Overall Study|Physician Decision|0|||
44133402|NCT03194542|78920017|FG000|Overall Study|Lack of Efficacy|2|||
44133403|NCT03194542|78920018|FG001|Overall Study|Lack of Efficacy|2|||
44133404|NCT03194542|78920019|FG002|Overall Study|Lack of Efficacy|2|||
44133405|NCT03194542|78920020|FG003|Overall Study|Lack of Efficacy|6|||
44133406|NCT03194542|78920017|FG000|Overall Study|Withdrawal by Subject|2|||
44133407|NCT03194542|78920018|FG001|Overall Study|Withdrawal by Subject|1|||
44133408|NCT03194542|78920019|FG002|Overall Study|Withdrawal by Subject|5|||
44133409|NCT03194542|78920020|FG003|Overall Study|Withdrawal by Subject|4|||
44133410|NCT03194542|78920017|FG000|Overall Study|Progressive Disease|1|||
44133411|NCT03194542|78920018|FG001|Overall Study|Progressive Disease|0|||
44133412|NCT03194542|78920019|FG002|Overall Study|Progressive Disease|1|||
44133413|NCT03194542|78920020|FG003|Overall Study|Progressive Disease|1|||
44133414|NCT03194542|78920017|FG000|Overall Study|Adverse Event|1|||
44133415|NCT03194542|78920018|FG001|Overall Study|Adverse Event|2|||
44133416|NCT03194542|78920019|FG002|Overall Study|Adverse Event|0|||
44512911|NCT03025880|79518779|FG000|Overall Study|Withdrawal by Subject|0|||
44512912|NCT03025880|79518780|FG001|Overall Study|Withdrawal by Subject|1|||
44512913|NCT03025880|79518779|FG000|Overall Study|Physician Decision|0|||
44512914|NCT03025880|79518780|FG001|Overall Study|Physician Decision|1|||
44512915|NCT03025880|79518779|FG000|Overall Study|Progressive Disease|12|||
44512916|NCT03025880|79518780|FG001|Overall Study|Progressive Disease|19|||
44512917|NCT02027376|79518797|FG000|Overall Study|Death|1|||
44512918|NCT02027376|79518798|FG001|Overall Study|Death|0|||
44512919|NCT02027376|79518799|FG002|Overall Study|Death|0|||
44512920|NCT01924533|79518811|FG000|Overall Study|Death|181|||
44512921|NCT01924533|79518812|FG001|Overall Study|Death|200|||
44512922|NCT01924533|79518811|FG000|Overall Study|Lost to Follow-up|0|||
44133417|NCT03194542|78920020|FG003|Overall Study|Adverse Event|5|||
44512923|NCT01924533|79518812|FG001|Overall Study|Lost to Follow-up|1|||
44512924|NCT01924533|79518811|FG000|Overall Study|Withdrawal by Subject|7|||
44512925|NCT01924533|79518812|FG001|Overall Study|Withdrawal by Subject|3|||
44133418|NCT03194542|78920017|FG000|Overall Study|Death|1|||
44133419|NCT03194542|78920018|FG001|Overall Study|Death|2|||
44133420|NCT03194542|78920019|FG002|Overall Study|Death|0|||
44133421|NCT03194542|78920020|FG003|Overall Study|Death|5|||
44133422|NCT03194542|78920017|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
44243636|NCT01690988|79073253|FG002|Overall Study|Sedated|2|||
44512926|NCT01924533|79518811|FG000|Overall Study|Other Eligibility criteria|1|||
44512927|NCT01924533|79518812|FG001|Overall Study|Other Eligibility criteria|1|||
44276573|NCT03603314|79237529|FG000|Overall Study|Other|0|||
44276574|NCT03603314|79237530|FG001|Overall Study|Other|1|||
44276575|NCT03603314|79237531|FG002|Overall Study|Other|0|||
44276576|NCT04302350|79237546|FG000|Overall Study|Physician Decision|1|||
44276577|NCT04302350|79237547|FG001|Overall Study|Physician Decision|1|||
44276578|NCT04302350|79237548|FG002|Overall Study|Physician Decision|2|||
44276579|NCT04302350|79237546|FG000|Overall Study|Lack of Efficacy|1|||
44276580|NCT04302350|79237547|FG001|Overall Study|Lack of Efficacy|1|||
44276581|NCT04302350|79237548|FG002|Overall Study|Lack of Efficacy|4|||
44276582|NCT04302350|79237546|FG000|Overall Study|Adverse Event|0|||
44276583|NCT04302350|79237547|FG001|Overall Study|Adverse Event|1|||
44276584|NCT04302350|79237548|FG002|Overall Study|Adverse Event|2|||
44276585|NCT02335424|79237583|FG000|Overall Study|Withdrawal by Subject|19|||
44276586|NCT02335424|79237583|FG000|Overall Study|Adverse Event|25|||
44276587|NCT02335424|79237583|FG000|Overall Study|Death|273|||
44276588|NCT02335424|79237583|FG000|Overall Study|Lost to Follow-up|3|||
44512928|NCT01606436|79518818|FG000|Overall Study|Withdrawal by Subject|0|||
44512929|NCT01606436|79518819|FG001|Overall Study|Withdrawal by Subject|0|||
44512930|NCT01606436|79518820|FG002|Overall Study|Withdrawal by Subject|1|||
44512931|NCT01606436|79518821|FG003|Overall Study|Withdrawal by Subject|1|||
44133423|NCT03194542|78920018|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
44133424|NCT03194542|78920019|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
44133425|NCT03194542|78920020|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
44133426|NCT02328014|78920041|FG000|Overall Study|Adverse Event|1|||
44133427|NCT02328014|78920042|FG001|Overall Study|Adverse Event|0|||
44133428|NCT02328014|78920043|FG002|Overall Study|Adverse Event|0|||
44133429|NCT02328014|78920044|FG003|Overall Study|Adverse Event|1|||
44133430|NCT02328014|78920041|FG000|Overall Study|Death|0|||
44133431|NCT02328014|78920042|FG001|Overall Study|Death|0|||
44133432|NCT02328014|78920043|FG002|Overall Study|Death|0|||
44133433|NCT02328014|78920044|FG003|Overall Study|Death|4|||
44133434|NCT02328014|78920041|FG000|Overall Study|Physician Decision|0|||
44133435|NCT02328014|78920042|FG001|Overall Study|Physician Decision|0|||
44133436|NCT02328014|78920043|FG002|Overall Study|Physician Decision|0|||
44133437|NCT02328014|78920044|FG003|Overall Study|Physician Decision|1|||
44133438|NCT02328014|78920041|FG000|Overall Study|Disease Progression|1|||
44133439|NCT02328014|78920042|FG001|Overall Study|Disease Progression|0|||
44133440|NCT02328014|78920043|FG002|Overall Study|Disease Progression|1|||
44133441|NCT02328014|78920044|FG003|Overall Study|Disease Progression|3|||
44133442|NCT02328014|78920041|FG000|Overall Study|Study Terminated by Sponsor|4|||
44133443|NCT02328014|78920042|FG001|Overall Study|Study Terminated by Sponsor|1|||
44512932|NCT01606436|79518822|FG004|Overall Study|Withdrawal by Subject|1|||
44133444|NCT02328014|78920043|FG002|Overall Study|Study Terminated by Sponsor|1|||
44133445|NCT02328014|78920044|FG003|Overall Study|Study Terminated by Sponsor|0|||
44133446|NCT02328014|78920041|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
44133447|NCT02328014|78920042|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
44133448|NCT02328014|78920043|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
44133449|NCT02328014|78920044|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
44276589|NCT02335424|79237583|FG000|Overall Study|Physician Decision|13|||
44276590|NCT02335424|79237583|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
44512933|NCT01606436|79518823|FG005|Overall Study|Withdrawal by Subject|0|||
44512934|NCT01606436|79518818|FG000|Overall Study|Adverse Event|0|||
44512935|NCT01606436|79518819|FG001|Overall Study|Adverse Event|0|||
44512936|NCT01606436|79518820|FG002|Overall Study|Adverse Event|1|||
44512937|NCT01606436|79518821|FG003|Overall Study|Adverse Event|0|||
44512938|NCT01606436|79518822|FG004|Overall Study|Adverse Event|0|||
44512939|NCT01606436|79518823|FG005|Overall Study|Adverse Event|0|||
44133450|NCT02328014|78920041|FG000|Overall Study|Withdrawal by Subject|0|||
44276591|NCT02335424|79237583|FG000|Overall Study|Protocol Violation|1|||
44276592|NCT02335424|79237583|FG000|Overall Study|Screen failure|1|||
44512940|NCT01606436|79518818|FG000|Overall Study|Sponsor Decision|0|||
44133451|NCT02328014|78920042|FG001|Overall Study|Withdrawal by Subject|0|||
44276593|NCT03805412|79237590|FG000|Overall Study|Lost to Follow-up|0|||
44512941|NCT01606436|79518819|FG001|Overall Study|Sponsor Decision|0|||
44276594|NCT03805412|79237591|FG001|Overall Study|Lost to Follow-up|1|||
44133452|NCT02328014|78920043|FG002|Overall Study|Withdrawal by Subject|0|||
44133453|NCT02328014|78920044|FG003|Overall Study|Withdrawal by Subject|1|||
44133454|NCT02213926|78920054|FG000|Overall Study|Death|59|||
44133455|NCT02213926|78920054|FG000|Overall Study|Withdrawal by Subject|10|||
44133456|NCT02213926|78920054|FG000|Overall Study|study terminated by sponsor|51|||
44133457|NCT02213926|78920054|FG000|Overall Study|Lost to Follow-up|3|||
44133458|NCT02213926|78920054|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
44133459|NCT01892085|78920061|FG000|Overall Study|Death|4|||
44133460|NCT01892085|78920062|FG001|Overall Study|Death|1|||
44133461|NCT01892085|78920063|FG002|Overall Study|Death|3|||
44133462|NCT01892085|78920061|FG000|Overall Study|Withdrawal by Subject|2|||
44133463|NCT01892085|78920062|FG001|Overall Study|Withdrawal by Subject|0|||
44133464|NCT01892085|78920063|FG002|Overall Study|Withdrawal by Subject|2|||
44133465|NCT04510285|78920080|FG000|Overall Study|Death|1|||
44133466|NCT02576054|78920084|FG000|Overall Study|Withdrawal by Subject|1|||
44133467|NCT01606202|78920092|FG000|Overall Study|Adverse Event|5|||
44133468|NCT01606202|78920093|FG001|Overall Study|Adverse Event|0|||
44512942|NCT01606436|79518820|FG002|Overall Study|Sponsor Decision|0|||
44512943|NCT01606436|79518821|FG003|Overall Study|Sponsor Decision|1|||
44133469|NCT01606202|78920092|FG000|Overall Study|Withdrawal by Subject|2|||
44133470|NCT01606202|78920093|FG001|Overall Study|Withdrawal by Subject|1|||
44512944|NCT01606436|79518822|FG004|Overall Study|Sponsor Decision|0|||
44512945|NCT01606436|79518823|FG005|Overall Study|Sponsor Decision|0|||
44133471|NCT01606202|78920092|FG000|Overall Study|Personal problems|0|||
44512946|NCT00219557|79518843|FG000|Phase 1|Lack of Efficacy|3|||
44512947|NCT00219557|79518844|FG001|Phase 1|Lack of Efficacy|0|||
44512948|NCT00219557|79518845|FG002|Phase 1|Lack of Efficacy|0|||
44512949|NCT00219557|79518843|FG000|Phase 1|Adverse Event|2|||
44512950|NCT00219557|79518844|FG001|Phase 1|Adverse Event|0|||
44512951|NCT00219557|79518845|FG002|Phase 1|Adverse Event|0|||
44133472|NCT01606202|78920093|FG001|Overall Study|Personal problems|1|||
44133473|NCT01606202|78920092|FG000|Overall Study|Problems with administration|0|||
44133474|NCT01606202|78920093|FG001|Overall Study|Problems with administration|1|||
44133475|NCT01493960|78920101|FG000|Overall Study|Adverse Event|0|||
44133476|NCT01493960|78920102|FG001|Overall Study|Adverse Event|1|||
44133477|NCT01493960|78920101|FG000|Overall Study|Lack of Efficacy|15|||
44133478|NCT01493960|78920102|FG001|Overall Study|Lack of Efficacy|9|||
44133479|NCT01493960|78920101|FG000|Overall Study|Protocol Violation|3|||
44512952|NCT00219557|79518843|FG000|Phase 1|Withdrawal by Subject|1|||
44512953|NCT00219557|79518844|FG001|Phase 1|Withdrawal by Subject|0|||
44512954|NCT00219557|79518845|FG002|Phase 1|Withdrawal by Subject|0|||
44133480|NCT01493960|78920102|FG001|Overall Study|Protocol Violation|0|||
44133481|NCT01493960|78920101|FG000|Overall Study|Withdrawal by Subject|10|||
44133482|NCT01493960|78920102|FG001|Overall Study|Withdrawal by Subject|4|||
44133483|NCT01493960|78920101|FG000|Overall Study|Non-specified|4|||
44133484|NCT01493960|78920102|FG001|Overall Study|Non-specified|4|||
44133485|NCT02630459|78920112|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
44512955|NCT00219557|79518843|FG000|Phase 1|Started chemotherapy at other institute|1|||
44512956|NCT00219557|79518844|FG001|Phase 1|Started chemotherapy at other institute|0|||
44133486|NCT02630459|78920113|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
44133487|NCT02630459|78920114|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
44512957|NCT00219557|79518845|FG002|Phase 1|Started chemotherapy at other institute|0|||
44512958|NCT00219557|79518843|FG000|Phase 2|Lack of Efficacy|0|||
44512959|NCT00219557|79518844|FG001|Phase 2|Lack of Efficacy|21|||
44512960|NCT00219557|79518845|FG002|Phase 2|Lack of Efficacy|15|||
44133488|NCT02630459|78920115|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
44133489|NCT02630459|78920116|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
44133490|NCT02630459|78920117|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
44133491|NCT02630459|78920118|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
44133492|NCT02630459|78920119|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
44133493|NCT02630459|78920112|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44133494|NCT02630459|78920113|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44133495|NCT02630459|78920114|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
44133496|NCT02630459|78920115|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44276595|NCT04791319|79237611|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
44380147|NCT01029704|79385992|FG004|Overall Study|Withdrawal by Subject|2|||
44380148|NCT01029704|79385993|FG005|Overall Study|Withdrawal by Subject|1|||
44380149|NCT01029704|79385994|FG006|Overall Study|Withdrawal by Subject|1|||
44380150|NCT01029704|79385995|FG007|Overall Study|Withdrawal by Subject|1|||
44380151|NCT01029704|79385996|FG008|Overall Study|Withdrawal by Subject|0|||
44380152|NCT01029704|79385988|FG000|Overall Study|Lost to Follow-up|0|||
44380153|NCT01029704|79385989|FG001|Overall Study|Lost to Follow-up|0|||
44380154|NCT01029704|79385990|FG002|Overall Study|Lost to Follow-up|0|||
44380155|NCT01029704|79385991|FG003|Overall Study|Lost to Follow-up|0|||
44380156|NCT01029704|79385992|FG004|Overall Study|Lost to Follow-up|0|||
44380157|NCT01029704|79385993|FG005|Overall Study|Lost to Follow-up|0|||
44380158|NCT01029704|79385994|FG006|Overall Study|Lost to Follow-up|1|||
44380159|NCT01029704|79385995|FG007|Overall Study|Lost to Follow-up|1|||
44380160|NCT01029704|79385996|FG008|Overall Study|Lost to Follow-up|1|||
44380161|NCT01029704|79385988|FG000|Overall Study|Lack of Efficacy|0|||
44380162|NCT01029704|79385989|FG001|Overall Study|Lack of Efficacy|0|||
44380163|NCT01029704|79385990|FG002|Overall Study|Lack of Efficacy|0|||
44380164|NCT01029704|79385991|FG003|Overall Study|Lack of Efficacy|0|||
44380165|NCT01029704|79385992|FG004|Overall Study|Lack of Efficacy|2|||
44512961|NCT00219557|79518843|FG000|Phase 2|Adverse Event|0|||
44512962|NCT00219557|79518844|FG001|Phase 2|Adverse Event|22|||
44512963|NCT00219557|79518845|FG002|Phase 2|Adverse Event|2|||
44512964|NCT00219557|79518843|FG000|Phase 2|Death|0|||
44512965|NCT00219557|79518844|FG001|Phase 2|Death|8|||
44512966|NCT00219557|79518845|FG002|Phase 2|Death|2|||
44512967|NCT00219557|79518843|FG000|Phase 2|Other|0|||
44380166|NCT01029704|79385993|FG005|Overall Study|Lack of Efficacy|3|||
44380167|NCT01029704|79385994|FG006|Overall Study|Lack of Efficacy|1|||
44380168|NCT01029704|79385995|FG007|Overall Study|Lack of Efficacy|2|||
44512968|NCT00219557|79518844|FG001|Phase 2|Other|8|||
44512969|NCT00219557|79518845|FG002|Phase 2|Other|6|||
44512970|NCT00219557|79518843|FG000|Phase 2|Withdrawal by Subject|0|||
44512971|NCT00219557|79518844|FG001|Phase 2|Withdrawal by Subject|9|||
44380169|NCT01029704|79385996|FG008|Overall Study|Lack of Efficacy|0|||
44380170|NCT01029704|79385988|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
44380171|NCT01029704|79385989|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
44380172|NCT01029704|79385990|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
44380173|NCT01029704|79385991|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
44380174|NCT01029704|79385992|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
44380175|NCT01029704|79385993|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
44380176|NCT01029704|79385994|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
44380177|NCT01029704|79385995|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
44380178|NCT01029704|79385996|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
44380179|NCT00840034|79386018|FG000|Acute Treatment Phase|Adverse Event|6|||
44380180|NCT00840034|79386019|FG001|Acute Treatment Phase|Adverse Event|8|||
44380181|NCT00840034|79386018|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
44380182|NCT00840034|79386019|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
44380183|NCT00840034|79386018|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
44380184|NCT00840034|79386019|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
44380185|NCT00840034|79386018|FG000|Acute Treatment Phase|Physician Decision|0|||
44380186|NCT00840034|79386019|FG001|Acute Treatment Phase|Physician Decision|1|||
44380187|NCT00840034|79386018|FG000|Acute Treatment Phase|Protocol Violation|2|||
44380188|NCT00840034|79386019|FG001|Acute Treatment Phase|Protocol Violation|4|||
44380189|NCT00840034|79386018|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
44380190|NCT00840034|79386019|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
44380191|NCT00840034|79386018|FG000|Taper Phase|Adverse Event|1|||
44380192|NCT00840034|79386019|FG001|Taper Phase|Adverse Event|0|||
44380193|NCT00840034|79386018|FG000|Taper Phase|Lost to Follow-up|1|||
44380194|NCT00840034|79386019|FG001|Taper Phase|Lost to Follow-up|1|||
44380195|NCT00840034|79386018|FG000|Taper Phase|Withdrawal by Subject|1|||
44380196|NCT00840034|79386019|FG001|Taper Phase|Withdrawal by Subject|1|||
44380197|NCT00813904|79386027|FG000|Overall Study|Death|1|||
44380198|NCT00839956|79386031|FG000|Overall Study|Adverse Event|2|||
44512972|NCT00219557|79518845|FG002|Phase 2|Withdrawal by Subject|5|||
44512973|NCT00219557|79518843|FG000|Phase 2|Treatment not received|0|||
44512974|NCT00219557|79518844|FG001|Phase 2|Treatment not received|1|||
44512975|NCT00219557|79518845|FG002|Phase 2|Treatment not received|3|||
44512976|NCT00251927|79518860|FG000|Overall Study|Adverse Event|3|||
44512977|NCT00251927|79518861|FG001|Overall Study|Adverse Event|15|||
44512978|NCT00251927|79518860|FG000|Overall Study|Lack of Efficacy|22|||
44512979|NCT00251927|79518861|FG001|Overall Study|Lack of Efficacy|16|||
44512980|NCT00251927|79518860|FG000|Overall Study|Lost to Follow-up|22|||
44512981|NCT00251927|79518861|FG001|Overall Study|Lost to Follow-up|8|||
44512982|NCT00251927|79518860|FG000|Overall Study|Protocol Violation|1|||
44512983|NCT00251927|79518861|FG001|Overall Study|Protocol Violation|2|||
44512984|NCT00251927|79518860|FG000|Overall Study|Pregnancy|2|||
44380199|NCT00839956|79386031|FG000|Overall Study|Lack of Efficacy|6|||
44380200|NCT00839956|79386031|FG000|Overall Study|Physician Decision|1|||
44380201|NCT00839956|79386031|FG000|Overall Study|Withdrawal by Subject|3|||
44380202|NCT00839800|79386037|FG000|Overall Study|Adverse Event|8|||
44380203|NCT00839800|79386038|FG001|Overall Study|Adverse Event|12|||
44380204|NCT00839800|79386037|FG000|Overall Study|Lost to Follow-up|31|||
44380205|NCT00839800|79386038|FG001|Overall Study|Lost to Follow-up|26|||
44380206|NCT00839800|79386037|FG000|Overall Study|Withdrawal by Subject|28|||
44380207|NCT00839800|79386038|FG001|Overall Study|Withdrawal by Subject|34|||
44380208|NCT00839800|79386037|FG000|Overall Study|Incorrect Enrolment|3|||
44380209|NCT00839800|79386038|FG001|Overall Study|Incorrect Enrolment|3|||
44380210|NCT00839800|79386037|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
44380211|NCT00839800|79386038|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
44380212|NCT00839800|79386037|FG000|Overall Study|Safety Reasons|2|||
44380213|NCT00839800|79386038|FG001|Overall Study|Safety Reasons|1|||
44380214|NCT00839800|79386037|FG000|Overall Study|Other|8|||
44243637|NCT01466153|79073284|FG000|Overall Study|Disease Progression|2|||
44243638|NCT01466153|79073285|FG001|Overall Study|Disease Progression|2|||
44243639|NCT01466153|79073286|FG002|Overall Study|Disease Progression|0|||
44243640|NCT01466153|79073284|FG000|Overall Study|Adverse Event|14|||
44243641|NCT01466153|79073285|FG001|Overall Study|Adverse Event|13|||
44243642|NCT01466153|79073286|FG002|Overall Study|Adverse Event|17|||
44380215|NCT00839800|79386038|FG001|Overall Study|Other|14|||
44243643|NCT01466153|79073284|FG000|Overall Study|Withdrawal of Consent|2|||
44243644|NCT01466153|79073285|FG001|Overall Study|Withdrawal of Consent|0|||
44243645|NCT01466153|79073286|FG002|Overall Study|Withdrawal of Consent|0|||
44380216|NCT00839800|79386037|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
44380217|NCT00839800|79386038|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
44380218|NCT00753415|79386072|FG000|Part A|Disease progression|1|||
44380219|NCT00753415|79386073|FG001|Part A|Disease progression|0|||
44380220|NCT00753415|79386074|FG002|Part A|Disease progression|1|||
44380221|NCT00753415|79386075|FG003|Part A|Disease progression|2|||
44380222|NCT00753415|79386076|FG004|Part A|Disease progression|0|||
44380223|NCT00753415|79386077|FG005|Part A|Disease progression|0|||
44380224|NCT00753415|79386078|FG006|Part A|Disease progression|0|||
44380225|NCT00753415|79386079|FG007|Part A|Disease progression|0|||
44380226|NCT00753415|79386080|FG008|Part A|Disease progression|0|||
44380227|NCT00753415|79386081|FG009|Part A|Disease progression|0|||
44380228|NCT00753415|79386072|FG000|Part A|Withdrawal by Subject|0|||
44380229|NCT00753415|79386073|FG001|Part A|Withdrawal by Subject|0|||
44380230|NCT00753415|79386074|FG002|Part A|Withdrawal by Subject|1|||
44512985|NCT00251927|79518861|FG001|Overall Study|Pregnancy|0|||
44380231|NCT00753415|79386075|FG003|Part A|Withdrawal by Subject|0|||
44512986|NCT00251927|79518860|FG000|Overall Study|Withdrawal by Subject|40|||
44512987|NCT00251927|79518861|FG001|Overall Study|Withdrawal by Subject|25|||
44512988|NCT00251927|79518860|FG000|Overall Study|Study-specific discont. achieved|13|||
44512989|NCT00251927|79518861|FG001|Overall Study|Study-specific discont. achieved|2|||
44512990|NCT00251927|79518860|FG000|Overall Study|Study procedure non-compliance|5|||
44512991|NCT00251927|79518861|FG001|Overall Study|Study procedure non-compliance|6|||
44512992|NCT00165503|79518868|FG000|Overall Study|Death|1|||
44512993|NCT00165503|79518868|FG000|Overall Study|Lost to Follow-up|12|||
44512994|NCT00165503|79518868|FG000|Overall Study|Unresectable|3|||
44512995|NCT00162773|79518872|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
44243646|NCT01466153|79073284|FG000|Overall Study|Investigator Discretion|3|||
44243647|NCT01466153|79073285|FG001|Overall Study|Investigator Discretion|2|||
44380232|NCT00753415|79386076|FG004|Part A|Withdrawal by Subject|0|||
44380233|NCT00753415|79386077|FG005|Part A|Withdrawal by Subject|0|||
44380234|NCT00753415|79386078|FG006|Part A|Withdrawal by Subject|0|||
44380235|NCT00753415|79386079|FG007|Part A|Withdrawal by Subject|0|||
44380236|NCT00753415|79386080|FG008|Part A|Withdrawal by Subject|0|||
44380237|NCT00753415|79386081|FG009|Part A|Withdrawal by Subject|0|||
44380238|NCT00753415|79386072|FG000|Part B|Lost to Follow-up|0|||
44380239|NCT00753415|79386073|FG001|Part B|Lost to Follow-up|0|||
44380240|NCT00753415|79386074|FG002|Part B|Lost to Follow-up|0|||
44380241|NCT00753415|79386075|FG003|Part B|Lost to Follow-up|0|||
44380242|NCT00753415|79386076|FG004|Part B|Lost to Follow-up|0|||
44380243|NCT00753415|79386077|FG005|Part B|Lost to Follow-up|0|||
44380244|NCT00753415|79386078|FG006|Part B|Lost to Follow-up|0|||
44380245|NCT00753415|79386079|FG007|Part B|Lost to Follow-up|1|||
44380246|NCT00753415|79386080|FG008|Part B|Lost to Follow-up|1|||
44380247|NCT00753415|79386081|FG009|Part B|Lost to Follow-up|0|||
44380248|NCT00753415|79386072|FG000|Part B|Disease progression|0|||
44133497|NCT02630459|78920116|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44133498|NCT02630459|78920117|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44133499|NCT02630459|78920118|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44133500|NCT02630459|78920119|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
44133501|NCT02630459|78920112|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
44133502|NCT02630459|78920113|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
44133503|NCT02630459|78920114|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
44133504|NCT02630459|78920115|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
44133505|NCT02630459|78920116|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
44243648|NCT01466153|79073286|FG002|Overall Study|Investigator Discretion|2|||
44380249|NCT00753415|79386073|FG001|Part B|Disease progression|0|||
44380250|NCT00753415|79386074|FG002|Part B|Disease progression|0|||
44380251|NCT00753415|79386075|FG003|Part B|Disease progression|0|||
44380252|NCT00753415|79386076|FG004|Part B|Disease progression|0|||
44380253|NCT00753415|79386077|FG005|Part B|Disease progression|0|||
44380254|NCT00753415|79386078|FG006|Part B|Disease progression|0|||
44380255|NCT00753415|79386079|FG007|Part B|Disease progression|0|||
44380256|NCT00753415|79386080|FG008|Part B|Disease progression|2|||
44512996|NCT00209339|79518876|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
44512997|NCT00209339|79518876|FG000|At 12 Months Follow-up|Death|1|||
44512998|NCT00209339|79518876|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
44380257|NCT00753415|79386081|FG009|Part B|Disease progression|1|||
44380258|NCT00754741|79386108|FG000|Overall Study|Died or disenrolled|57|||
44380259|NCT00754741|79386109|FG001|Overall Study|Died or disenrolled|69|||
44512999|NCT00209339|79518876|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
44513000|NCT00209339|79518876|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
44513001|NCT00209339|79518876|FG000|At 24 Months Follow-up|Death|1|||
44513002|NCT00209339|79518876|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
44513003|NCT00209339|79518876|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
44513004|NCT00209339|79518876|FG000|At 4 Years Follow-up|Death|1|||
44513005|NCT00209339|79518876|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
44513006|NCT00209339|79518876|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
44513007|NCT00209339|79518876|FG000|At 5 Years Follow-up|Death|1|||
44513008|NCT03823391|79518882|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
44513009|NCT03823391|79518883|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
44513010|NCT03823391|79518882|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
44513011|NCT03823391|79518883|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
44513012|NCT00209027|79518893|FG000|Overall Study|study terminated|10|||
44380260|NCT00754741|79386110|FG002|Overall Study|Died or disenrolled|54|||
44380261|NCT00752791|79386118|FG000|Overall Study|Adverse Event|7|||
44380262|NCT00752791|79386118|FG000|Overall Study|Withdrawal by Subject|1|||
44380263|NCT00752791|79386118|FG000|Overall Study|Physician Decision|1|||
44380264|NCT00752791|79386118|FG000|Overall Study|Death|1|||
44513013|NCT00209027|79518894|FG001|Overall Study|study terminated|0|||
44513014|NCT00208325|79518904|FG000|Overall Study|Death|18|||
44513015|NCT00208325|79518905|FG001|Overall Study|Death|19|||
44513016|NCT00208325|79518906|FG002|Overall Study|Death|7|||
44513017|NCT00208325|79518907|FG003|Overall Study|Death|5|||
44513018|NCT00208325|79518904|FG000|Overall Study|Withdrawal by Subject|0|||
44513019|NCT00208325|79518905|FG001|Overall Study|Withdrawal by Subject|1|||
44513020|NCT00208325|79518906|FG002|Overall Study|Withdrawal by Subject|0|||
44513021|NCT00208325|79518907|FG003|Overall Study|Withdrawal by Subject|0|||
44513022|NCT00208325|79518904|FG000|Overall Study|Revision|4|||
44513023|NCT00208325|79518905|FG001|Overall Study|Revision|1|||
44513024|NCT00208325|79518906|FG002|Overall Study|Revision|0|||
44513025|NCT00208325|79518907|FG003|Overall Study|Revision|4|||
44513026|NCT00208325|79518904|FG000|Overall Study|Lost to Follow-up|1|||
44513027|NCT00208325|79518905|FG001|Overall Study|Lost to Follow-up|0|||
44513028|NCT00208325|79518906|FG002|Overall Study|Lost to Follow-up|2|||
44513029|NCT00208325|79518907|FG003|Overall Study|Lost to Follow-up|0|||
44513030|NCT00208325|79518904|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
44513031|NCT00208325|79518905|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
44243649|NCT01466153|79073284|FG000|Overall Study|Randomized-Not Treated|2|||
44243650|NCT01466153|79073285|FG001|Overall Study|Randomized-Not Treated|3|||
44513032|NCT00208325|79518906|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
44513033|NCT00208325|79518907|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
44133506|NCT02630459|78920117|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
44133507|NCT02630459|78920118|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
44133508|NCT02630459|78920119|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
44133509|NCT02630459|78920112|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
44133510|NCT02630459|78920113|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133511|NCT02630459|78920114|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133512|NCT02630459|78920115|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133513|NCT02630459|78920116|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133514|NCT02630459|78920117|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133515|NCT02630459|78920118|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133516|NCT02630459|78920119|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
44133517|NCT02630459|78920112|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
44243651|NCT01466153|79073286|FG002|Overall Study|Randomized-Not Treated|4|||
44243652|NCT01466153|79073284|FG000|Overall Study|Other-Unspecified|6|||
44133518|NCT02630459|78920113|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
44243653|NCT01466153|79073285|FG001|Overall Study|Other-Unspecified|4|||
44133519|NCT02630459|78920114|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
44133520|NCT02630459|78920115|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
44133521|NCT02630459|78920116|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
44133522|NCT02630459|78920117|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
44133523|NCT02630459|78920118|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
44133524|NCT02630459|78920119|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
44133525|NCT02630459|78920112|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
44133526|NCT02630459|78920113|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
44133527|NCT02630459|78920114|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
44133528|NCT02630459|78920115|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
44133529|NCT02630459|78920116|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
44133530|NCT02630459|78920117|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
44133531|NCT02630459|78920118|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
44133532|NCT02630459|78920119|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
44133533|NCT02630459|78920112|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133534|NCT02630459|78920113|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133535|NCT02630459|78920114|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133536|NCT02630459|78920115|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133537|NCT02630459|78920116|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
44133538|NCT02630459|78920117|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133539|NCT02630459|78920118|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133540|NCT02630459|78920119|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
44133541|NCT02573948|78920144|FG000|Longitudinal Cohort|Death|9|||
44133542|NCT02573948|78920144|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
44133543|NCT02573948|78920144|FG000|Longitudinal Cohort|Incarcerated|25|||
44133544|NCT01464593|78920151|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
44133545|NCT05279131|78920155|FG000|Overall Study|Lost to Follow-up|1|||
44133546|NCT05279131|78920155|FG000|Overall Study|Death|1|||
44133547|NCT05279131|78920155|FG000|Overall Study|Physician Decision|1|||
44133548|NCT05028517|78920166|FG000|Overall Study|Lost to Follow-up|13|||
44133549|NCT05028517|78920167|FG001|Overall Study|Lost to Follow-up|20|||
44133550|NCT05028517|78920168|FG002|Overall Study|Lost to Follow-up|12|||
44133551|NCT05028517|78920166|FG000|Overall Study|Withdrawal by Subject|0|||
44133552|NCT05028517|78920167|FG001|Overall Study|Withdrawal by Subject|0|||
44133553|NCT05028517|78920168|FG002|Overall Study|Withdrawal by Subject|1|||
44133554|NCT04363944|78920191|FG000|Overall Study|Withdrawal by Subject|2|||
44133555|NCT04363944|78920192|FG001|Overall Study|Withdrawal by Subject|0|||
44380265|NCT00752791|79386118|FG000|Overall Study|Renal transplant|3|||
44380266|NCT00752791|79386118|FG000|Overall Study|Switched to hemodialysis|2|||
44513034|NCT00208325|79518904|FG000|Overall Study|Does not wish to Continue in Study|5|||
44513035|NCT00208325|79518905|FG001|Overall Study|Does not wish to Continue in Study|8|||
44513036|NCT00208325|79518906|FG002|Overall Study|Does not wish to Continue in Study|3|||
44513037|NCT00208325|79518907|FG003|Overall Study|Does not wish to Continue in Study|2|||
44513038|NCT00208325|79518904|FG000|Overall Study|Other|2|||
44513039|NCT00208325|79518905|FG001|Overall Study|Other|1|||
44513040|NCT00208325|79518906|FG002|Overall Study|Other|1|||
44513041|NCT00208325|79518907|FG003|Overall Study|Other|0|||
44513042|NCT00208325|79518904|FG000|Overall Study|Mis-Randomized|17|||
44513043|NCT00208325|79518905|FG001|Overall Study|Mis-Randomized|20|||
44513044|NCT00208325|79518906|FG002|Overall Study|Mis-Randomized|0|||
44133556|NCT04335110|78920205|FG000|Overall Study|Withdrawal by Subject|1|||
44133557|NCT04335110|78920206|FG001|Overall Study|Withdrawal by Subject|1|||
44133558|NCT04335110|78920205|FG000|Overall Study|Death|0|||
44133559|NCT04335110|78920206|FG001|Overall Study|Death|1|||
44133560|NCT04156620|78920222|FG000|Overall Study|Adverse event - TP 1|5|||
44133561|NCT04156620|78920223|FG001|Overall Study|Adverse event - TP 1|2|||
44133562|NCT04156620|78920222|FG000|Overall Study|Lost to follow-up TP 1|1|||
44133563|NCT04156620|78920223|FG001|Overall Study|Lost to follow-up TP 1|1|||
44133564|NCT04156620|78920222|FG000|Overall Study|Progressive disease - TP 1|0|||
44133565|NCT04156620|78920223|FG001|Overall Study|Progressive disease - TP 1|1|||
44133566|NCT04156620|78920222|FG000|Overall Study|Subject decision - TP 1|3|||
44133567|NCT04156620|78920223|FG001|Overall Study|Subject decision - TP 1|5|||
44133568|NCT04156620|78920222|FG000|Overall Study|Adverse event - TP 2|5|||
44380267|NCT00752791|79386118|FG000|Overall Study|Protocol deviation|1|||
44380268|NCT00902304|79386129|FG000|Overall Study|Adverse Event|4|||
44380269|NCT00902304|79386130|FG001|Overall Study|Adverse Event|10|||
44513045|NCT00208325|79518907|FG003|Overall Study|Mis-Randomized|0|||
44133569|NCT04156620|78920223|FG001|Overall Study|Adverse event - TP 2|6|||
44133570|NCT04156620|78920222|FG000|Overall Study|Death - TP 2|1|||
44133571|NCT04156620|78920223|FG001|Overall Study|Death - TP 2|0|||
44133572|NCT04156620|78920222|FG000|Overall Study|Lost to follow-up - TP 2|5|||
44133573|NCT04156620|78920223|FG001|Overall Study|Lost to follow-up - TP 2|2|||
44133574|NCT04156620|78920222|FG000|Overall Study|Physician decision - TP 2|4|||
44133575|NCT04156620|78920223|FG001|Overall Study|Physician decision - TP 2|2|||
44133576|NCT04156620|78920222|FG000|Overall Study|Pregnancy - TP 2|1|||
44133577|NCT04156620|78920223|FG001|Overall Study|Pregnancy - TP 2|1|||
44133578|NCT04156620|78920222|FG000|Overall Study|Subject decision - TP 2|11|||
44133579|NCT04156620|78920223|FG001|Overall Study|Subject decision - TP 2|9|||
44133580|NCT04156620|78920222|FG000|Overall Study|New therapy for study indication - TP 2|1|||
44133581|NCT04156620|78920223|FG001|Overall Study|New therapy for study indication - TP 2|0|||
44133582|NCT03816332|78920233|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
44133583|NCT03816332|78920233|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
44133584|NCT03621189|78920250|FG000|Overall Study|Withdrawal by Subject|0|||
44133585|NCT03621189|78920251|FG001|Overall Study|Withdrawal by Subject|3|||
44133586|NCT03621189|78920250|FG000|Overall Study|Physician Decision|0|||
44133587|NCT03621189|78920251|FG001|Overall Study|Physician Decision|2|||
44133588|NCT03486834|78920261|FG000|Overall Study|Withdrawal by Subject|46|||
44133589|NCT03486834|78920262|FG001|Overall Study|Withdrawal by Subject|46|||
44133590|NCT03486834|78920263|FG002|Overall Study|Withdrawal by Subject|52|||
44133591|NCT03486834|78920261|FG000|Overall Study|Adverse Event|8|||
44133592|NCT03486834|78920262|FG001|Overall Study|Adverse Event|7|||
44133593|NCT03486834|78920263|FG002|Overall Study|Adverse Event|0|||
44133594|NCT03486834|78920261|FG000|Overall Study|Lost to Follow-up|41|||
44133595|NCT03486834|78920262|FG001|Overall Study|Lost to Follow-up|24|||
44133596|NCT03486834|78920263|FG002|Overall Study|Lost to Follow-up|39|||
44133597|NCT03486834|78920261|FG000|Overall Study|Non-compliance with Study Drug|2|||
44133598|NCT03486834|78920262|FG001|Overall Study|Non-compliance with Study Drug|2|||
44133599|NCT03486834|78920263|FG002|Overall Study|Non-compliance with Study Drug|0|||
44133600|NCT03486834|78920261|FG000|Overall Study|Physician Decision|5|||
44133601|NCT03486834|78920262|FG001|Overall Study|Physician Decision|2|||
44133602|NCT03486834|78920263|FG002|Overall Study|Physician Decision|3|||
44133603|NCT03486834|78920261|FG000|Overall Study|Pregnancy|10|||
44133604|NCT03486834|78920262|FG001|Overall Study|Pregnancy|12|||
44133605|NCT03486834|78920263|FG002|Overall Study|Pregnancy|12|||
44133606|NCT03486834|78920261|FG000|Overall Study|Protocol Deviation|2|||
44133607|NCT03486834|78920262|FG001|Overall Study|Protocol Deviation|3|||
44133608|NCT03486834|78920263|FG002|Overall Study|Protocol Deviation|3|||
44133609|NCT03486834|78920261|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44133610|NCT03486834|78920262|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
44133611|NCT03486834|78920263|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
44133612|NCT03486834|78920261|FG000|Overall Study|Randomized but not treated|4|||
44133613|NCT03486834|78920262|FG001|Overall Study|Randomized but not treated|4|||
44133614|NCT03486834|78920263|FG002|Overall Study|Randomized but not treated|1|||
44133615|NCT03356145|78920279|FG000|Overall Study|Withdrawal by Subject|2|||
44133616|NCT03356145|78920280|FG001|Overall Study|Withdrawal by Subject|1|||
44133617|NCT03356145|78920279|FG000|Overall Study|Did not meet inclusion criteria|1|||
44133618|NCT03356145|78920280|FG001|Overall Study|Did not meet inclusion criteria|0|||
44133619|NCT03312738|78920288|FG000|Overall Study|Progressive disease|58|||
44133620|NCT03312738|78920289|FG001|Overall Study|Progressive disease|67|||
44133621|NCT03312738|78920288|FG000|Overall Study|Patient/guardian decision|13|||
44133622|NCT03312738|78920289|FG001|Overall Study|Patient/guardian decision|5|||
44133623|NCT03312738|78920288|FG000|Overall Study|Adverse Event|5|||
44133624|NCT03312738|78920289|FG001|Overall Study|Adverse Event|3|||
44133625|NCT03312738|78920288|FG000|Overall Study|Protocol deviation|2|||
44133626|NCT03312738|78920289|FG001|Overall Study|Protocol deviation|0|||
44133627|NCT03312738|78920288|FG000|Overall Study|Technical problems|0|||
44243654|NCT01466153|79073286|FG002|Overall Study|Other-Unspecified|2|||
44513046|NCT00160667|79518920|FG000|Overall Study|Adverse Event|3|||
44513047|NCT00160667|79518921|FG001|Overall Study|Adverse Event|1|||
44513048|NCT00160667|79518922|FG002|Overall Study|Adverse Event|4|||
44133628|NCT03312738|78920289|FG001|Overall Study|Technical problems|1|||
44133629|NCT03312738|78920288|FG000|Overall Study|Physician Decision|2|||
44133630|NCT03312738|78920289|FG001|Overall Study|Physician Decision|3|||
44133631|NCT03268954|78920299|FG000|Overall Study|Ongoing|23|||
44133632|NCT03268954|78920300|FG001|Overall Study|Ongoing|31|||
44133633|NCT03268954|78920299|FG000|Overall Study|Adverse Event|53|||
44133634|NCT03268954|78920300|FG001|Overall Study|Adverse Event|62|||
44133635|NCT03268954|78920299|FG000|Overall Study|Withdrawal by Subject|25|||
44133636|NCT03268954|78920300|FG001|Overall Study|Withdrawal by Subject|16|||
44133637|NCT03268954|78920299|FG000|Overall Study|Progressive Disease|61|||
44133638|NCT03268954|78920300|FG001|Overall Study|Progressive Disease|48|||
44133639|NCT03268954|78920299|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
44133640|NCT03268954|78920300|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
44133641|NCT03268954|78920299|FG000|Overall Study|Reason not Specified|40|||
44133642|NCT03268954|78920300|FG001|Overall Study|Reason not Specified|40|||
44513049|NCT00160667|79518920|FG000|Overall Study|Withdrawal by Subject|2|||
44243655|NCT01474291|79073307|FG000|Overall Study|Not Evaluable for Efficacy|26|||
44513050|NCT00160667|79518921|FG001|Overall Study|Withdrawal by Subject|0|||
44513051|NCT00160667|79518922|FG002|Overall Study|Withdrawal by Subject|1|||
44513052|NCT00160667|79518920|FG000|Overall Study|Lack of Efficacy|0|||
44513053|NCT00160667|79518921|FG001|Overall Study|Lack of Efficacy|1|||
44513054|NCT00160667|79518922|FG002|Overall Study|Lack of Efficacy|0|||
44513055|NCT00160667|79518920|FG000|Overall Study|Protocol Violation|0|||
44513056|NCT00160667|79518921|FG001|Overall Study|Protocol Violation|1|||
44513057|NCT00160667|79518922|FG002|Overall Study|Protocol Violation|0|||
44513058|NCT00160667|79518920|FG000|Overall Study|Patient decision|0|||
44513059|NCT00160667|79518921|FG001|Overall Study|Patient decision|0|||
44513060|NCT00160667|79518922|FG002|Overall Study|Patient decision|1|||
44513061|NCT00206375|79518934|FG000|Overall Study|Lost to Follow-up|1|||
44513062|NCT00206375|79518935|FG001|Overall Study|Lost to Follow-up|0|||
44513063|NCT00206375|79518936|FG002|Overall Study|Lost to Follow-up|0|||
44513064|NCT00206375|79518934|FG000|Overall Study|Withdrawal by Subject|2|||
44513065|NCT00206375|79518935|FG001|Overall Study|Withdrawal by Subject|1|||
44513066|NCT00206375|79518936|FG002|Overall Study|Withdrawal by Subject|3|||
44513067|NCT00206375|79518934|FG000|Overall Study|Study terminated due to lack of funds|0|||
44513068|NCT00206375|79518935|FG001|Overall Study|Study terminated due to lack of funds|1|||
44513069|NCT00206375|79518936|FG002|Overall Study|Study terminated due to lack of funds|1|||
44513070|NCT00160199|79518946|FG000|Overall Study|Adverse Event|5|||
44513071|NCT00160199|79518947|FG001|Overall Study|Adverse Event|14|||
44513072|NCT00160199|79518946|FG000|Overall Study|Lack of Efficacy|0|||
44513073|NCT00160199|79518947|FG001|Overall Study|Lack of Efficacy|1|||
44513074|NCT00160199|79518946|FG000|Overall Study|Lost to Follow-up|7|||
44513075|NCT00160199|79518947|FG001|Overall Study|Lost to Follow-up|7|||
44513076|NCT00160199|79518946|FG000|Overall Study|Withdrawal by Subject|4|||
44513077|NCT00160199|79518947|FG001|Overall Study|Withdrawal by Subject|6|||
44513078|NCT00160199|79518946|FG000|Overall Study|Administrative|0|||
44513079|NCT00160199|79518947|FG001|Overall Study|Administrative|1|||
44513080|NCT00160199|79518946|FG000|Overall Study|Protocol Violation|8|||
44513081|NCT00160199|79518947|FG001|Overall Study|Protocol Violation|8|||
44513082|NCT00157157|79518953|FG000|Overall Study|Withdrawal by Subject|6|||
44513083|NCT00157157|79518953|FG000|Overall Study|Physician Decision|1|||
44513084|NCT00157157|79518953|FG000|Overall Study|Lost to Follow-up|1|||
44513085|NCT00157157|79518953|FG000|Overall Study|Enrolled in another study|1|||
44513086|NCT00157157|79518953|FG000|Overall Study|Met exclusion criteria|1|||
44513087|NCT00157157|79518953|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
44513088|NCT00203411|79518964|FG000|Follow-up|Progressive Disease|4|||
44513089|NCT00203021|79518971|FG000|Overall Study|Death|4|||
44513090|NCT00203021|79518972|FG001|Overall Study|Death|1|||
44513091|NCT00203021|79518971|FG000|Overall Study|Adverse Event|10|||
44513092|NCT00203021|79518972|FG001|Overall Study|Adverse Event|5|||
44513093|NCT00203021|79518971|FG000|Overall Study|Withdrawal by Subject|45|||
44513094|NCT00203021|79518972|FG001|Overall Study|Withdrawal by Subject|48|||
44513095|NCT00203021|79518971|FG000|Overall Study|Lost to Follow-up|9|||
44513096|NCT00203021|79518972|FG001|Overall Study|Lost to Follow-up|7|||
44513097|NCT00203021|79518971|FG000|Overall Study|Other than specified|11|||
44513098|NCT00203021|79518972|FG001|Overall Study|Other than specified|16|||
44513099|NCT00201851|79518981|FG000|Overall Study|Lost to Follow-up|2|||
44513100|NCT00201851|79518982|FG001|Overall Study|Lost to Follow-up|1|||
44513101|NCT00201851|79518983|FG002|Overall Study|Lost to Follow-up|0|||
44513102|NCT00201851|79518981|FG000|Overall Study|Ineligible post enrollment|6|||
44513103|NCT00201851|79518982|FG001|Overall Study|Ineligible post enrollment|1|||
44133691|NCT02927262|78920365|FG000|Overall Study|Adverse Event|7|||
44133692|NCT02927262|78920366|FG001|Overall Study|Adverse Event|1|||
44133693|NCT02927262|78920365|FG000|Overall Study|Death|1|||
44133694|NCT02927262|78920366|FG001|Overall Study|Death|0|||
44133695|NCT02927262|78920365|FG000|Overall Study|Withdrawal by Subject|3|||
44133696|NCT02927262|78920366|FG001|Overall Study|Withdrawal by Subject|0|||
44133697|NCT02927262|78920365|FG000|Overall Study|Disease Relapse|23|||
44133698|NCT02927262|78920366|FG001|Overall Study|Disease Relapse|18|||
44133699|NCT02927262|78920365|FG000|Overall Study|Miscellaneous|5|||
44133700|NCT02927262|78920366|FG001|Overall Study|Miscellaneous|4|||
44133701|NCT02927262|78920365|FG000|Overall Study|Ongoing|4|||
44133702|NCT02927262|78920366|FG001|Overall Study|Ongoing|0|||
44133703|NCT02663622|78920376|FG000|Overall Study|Death|3|||
44133704|NCT02663622|78920377|FG001|Overall Study|Death|1|||
44133705|NCT02663622|78920378|FG002|Overall Study|Death|1|||
44133706|NCT02663622|78920379|FG003|Overall Study|Death|8|||
44133707|NCT02663622|78920376|FG000|Overall Study|Protocol Violation|0|||
44133708|NCT02663622|78920377|FG001|Overall Study|Protocol Violation|0|||
44133709|NCT02663622|78920378|FG002|Overall Study|Protocol Violation|0|||
44133710|NCT02663622|78920379|FG003|Overall Study|Protocol Violation|1|||
44133711|NCT02637713|78920390|FG000|Overall Study|Screen Failure|2|||
44133712|NCT01651208|78920427|FG000|Overall Study|Lost to Follow-up|14|||
44133713|NCT01651208|78920428|FG001|Overall Study|Lost to Follow-up|16|||
44133714|NCT01361711|78920435|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
44133715|NCT01361711|78920435|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
44133716|NCT01361711|78920435|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
44133717|NCT01361711|78920435|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
44133718|NCT01361711|78920435|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
44133719|NCT01361711|78920435|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
44133720|NCT01361711|78920435|FG000|Completed Week 18 of Treatment|Other|9|||
44133721|NCT01361711|78920435|FG000|10 Year Follow-up|Still in follow-up|22|||
44133722|NCT01361711|78920435|FG000|10 Year Follow-up|Death|7|||
44133723|NCT01361711|78920435|FG000|10 Year Follow-up|Developed new cancer|1|||
44133724|NCT01361711|78920435|FG000|10 Year Follow-up|Lost to Follow-up|2|||
44133725|NCT01361711|78920435|FG000|10 Year Follow-up|New treatment started|6|||
44133726|NCT01361711|78920435|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
44133727|NCT01361711|78920435|FG000|10 Year Follow-up|Progressive Disease|1|||
44133728|NCT02572388|78920443|FG000|Overall Study|Withdrawal by Subject|1|||
44133729|NCT02572388|78920444|FG001|Overall Study|Withdrawal by Subject|1|||
44133730|NCT02572388|78920445|FG002|Overall Study|Withdrawal by Subject|2|||
44133731|NCT02572388|78920446|FG003|Overall Study|Withdrawal by Subject|2|||
44133732|NCT02573870|78920458|FG000|Overall Study|Adverse Event|0|||
44133733|NCT02573870|78920459|FG001|Overall Study|Adverse Event|2|||
44133734|NCT02573870|78920458|FG000|Overall Study|Lack of Efficacy|0|||
44133735|NCT02573870|78920459|FG001|Overall Study|Lack of Efficacy|1|||
44133736|NCT02573870|78920458|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
44133737|NCT02573870|78920459|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
44133738|NCT02573870|78920458|FG000|Overall Study|Lost to Follow-up|0|||
44133739|NCT02573870|78920459|FG001|Overall Study|Lost to Follow-up|1|||
44133740|NCT02573870|78920458|FG000|Overall Study|Other: Fail to Meet Visit|0|||
44133741|NCT02573870|78920459|FG001|Overall Study|Other: Fail to Meet Visit|2|||
44133742|NCT02572076|78920465|FG000|Overall Study|Protocol Violation|1|||
44133743|NCT02571452|78920471|FG000|Overall Study Treatment|Protocol Violation|0|||
44133744|NCT02571452|78920472|FG001|Overall Study Treatment|Protocol Violation|1|||
44133745|NCT02571452|78920471|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
44133746|NCT02571452|78920472|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
44133747|NCT02571452|78920471|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
44133748|NCT02571452|78920472|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
44133749|NCT02574260|78920478|FG000|Overall Study|Disease Progression|1|||
44133750|NCT02570126|78920484|FG000|Overall Study|Lost to Follow-up|2|||
44133751|NCT02570126|78920485|FG001|Overall Study|Lost to Follow-up|0|||
44133752|NCT02570126|78920484|FG000|Overall Study|Unable To Arrange Visit 3|1|||
44133753|NCT02570126|78920485|FG001|Overall Study|Unable To Arrange Visit 3|0|||
44133754|NCT02570126|78920484|FG000|Overall Study|Violation Of Procedures GSK|0|||
44133755|NCT02570126|78920485|FG001|Overall Study|Violation Of Procedures GSK|1|||
44513104|NCT00201851|79518983|FG002|Overall Study|Ineligible post enrollment|1|||
44513105|NCT00200057|79518991|FG000|Overall Study|Lack of Efficacy|3|||
44513106|NCT00200057|79518991|FG000|Overall Study|Exited due to terminal illness of PI|2|||
44513107|NCT00200057|79518991|FG000|Overall Study|Withdrawal by Subject|1|||
44133756|NCT02570126|78920484|FG000|Overall Study|Protocol Violation|0|||
44133757|NCT02570126|78920485|FG001|Overall Study|Protocol Violation|1|||
44133758|NCT02570126|78920484|FG000|Overall Study|Withdrawal by Subject|3|||
44133759|NCT02570126|78920485|FG001|Overall Study|Withdrawal by Subject|7|||
44133760|NCT02755831|78920493|FG000|Overall Study|Lost to Follow-up|3|||
44133761|NCT02755831|78920494|FG001|Overall Study|Lost to Follow-up|3|||
44133762|NCT02573246|78920505|FG000|Overall Study|Lost to Follow-up|2|||
44133763|NCT02573246|78920506|FG001|Overall Study|Lost to Follow-up|0|||
44133764|NCT02573246|78920507|FG002|Overall Study|Lost to Follow-up|0|||
44513108|NCT00200057|79518991|FG000|Overall Study|Change in medical condition|1|||
44513109|NCT00200057|79518991|FG000|Overall Study|Infection|1|||
44513110|NCT00200057|79518991|FG000|Overall Study|Death|1|||
44133765|NCT02573246|78920508|FG003|Overall Study|Lost to Follow-up|0|||
44133766|NCT02573246|78920509|FG004|Overall Study|Lost to Follow-up|1|||
44133767|NCT02573246|78920505|FG000|Overall Study|Withdrawal by Subject|0|||
44133768|NCT02573246|78920506|FG001|Overall Study|Withdrawal by Subject|0|||
44513111|NCT03129100|79519000|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
44133769|NCT02573246|78920507|FG002|Overall Study|Withdrawal by Subject|0|||
44513112|NCT03129100|79519001|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
44133770|NCT02573246|78920508|FG003|Overall Study|Withdrawal by Subject|0|||
44133771|NCT02573246|78920509|FG004|Overall Study|Withdrawal by Subject|1|||
44133772|NCT02573246|78920505|FG000|Overall Study|Physician Decision|1|||
44133773|NCT02573246|78920506|FG001|Overall Study|Physician Decision|1|||
44133774|NCT02573246|78920507|FG002|Overall Study|Physician Decision|3|||
44133775|NCT02573246|78920508|FG003|Overall Study|Physician Decision|2|||
44133776|NCT02573246|78920509|FG004|Overall Study|Physician Decision|2|||
44133777|NCT02570750|78920528|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
44133778|NCT02570750|78920529|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
44133779|NCT02570750|78920528|FG000|Overall Study|Protocol deviation|4|||
44133780|NCT02570750|78920529|FG001|Overall Study|Protocol deviation|2|||
44133781|NCT02570750|78920528|FG000|Overall Study|Withdrawal by Subject|5|||
44133782|NCT02570750|78920529|FG001|Overall Study|Withdrawal by Subject|0|||
44133783|NCT02570750|78920528|FG000|Overall Study|Lost to Follow-up|2|||
44133784|NCT02570750|78920529|FG001|Overall Study|Lost to Follow-up|2|||
44133785|NCT02570750|78920528|FG000|Overall Study|Adverse Event|2|||
44133786|NCT02570750|78920529|FG001|Overall Study|Adverse Event|1|||
44133787|NCT02573012|78920537|FG000|Overall Study|Adverse Event|5|||
44133788|NCT02573012|78920538|FG001|Overall Study|Adverse Event|5|||
44133789|NCT02573012|78920537|FG000|Overall Study|Lack of Efficacy|5|||
44133790|NCT02573012|78920538|FG001|Overall Study|Lack of Efficacy|4|||
44133791|NCT02573012|78920537|FG000|Overall Study|Non-compliance|1|||
44133792|NCT02573012|78920538|FG001|Overall Study|Non-compliance|2|||
44133793|NCT02573012|78920537|FG000|Overall Study|Withdrawal by Subject|2|||
44133794|NCT02573012|78920538|FG001|Overall Study|Withdrawal by Subject|2|||
44133795|NCT02573012|78920537|FG000|Overall Study|Study Ended per Protocol|1|||
44133796|NCT02573012|78920538|FG001|Overall Study|Study Ended per Protocol|0|||
44133797|NCT02573012|78920537|FG000|Overall Study|Physician Decision|1|||
44133798|NCT02573012|78920538|FG001|Overall Study|Physician Decision|2|||
44133799|NCT02752633|78920544|FG000|Overall Study|Withdrawal by Subject|1|||
44133800|NCT02752087|78920548|FG000|Washout|Physician Decision|1|||
44133801|NCT02752087|78920549|FG001|Washout|Physician Decision|0|||
44133802|NCT04766996|78920558|FG000|Overall Study|Withdrawal by Subject|1|||
44133803|NCT04766996|78920559|FG001|Overall Study|Withdrawal by Subject|0|||
44133804|NCT04766996|78920560|FG002|Overall Study|Withdrawal by Subject|13|||
44133805|NCT02563028|78920566|FG000|Overall Study|Lack of equipment|1|||
44133806|NCT02563028|78920566|FG000|Overall Study|Unable to elicit VEP post induction|1|||
44133807|NCT02192827|78920572|FG000|Overall Study|Lost to Follow-up|25|||
44133808|NCT02192827|78920573|FG001|Overall Study|Lost to Follow-up|27|||
44133809|NCT02192827|78920572|FG000|Overall Study|Given additional steroids with admission|13|||
44133810|NCT02192827|78920573|FG001|Overall Study|Given additional steroids with admission|11|||
44133811|NCT02562482|78920581|FG000|Overall Study|Enrolled, but did not receive product|4|||
44133812|NCT02562482|78920582|FG001|Overall Study|Enrolled, but did not receive product|0|||
44133813|NCT02562482|78920581|FG000|Overall Study|Lost to Follow-up|9|||
44133814|NCT02562482|78920582|FG001|Overall Study|Lost to Follow-up|6|||
44133815|NCT02562482|78920581|FG000|Overall Study|Moved from area|2|||
44133816|NCT02562482|78920582|FG001|Overall Study|Moved from area|3|||
44133817|NCT02562482|78920581|FG000|Overall Study|Withdrawal by Subject|5|||
44133818|NCT02562482|78920582|FG001|Overall Study|Withdrawal by Subject|3|||
44133819|NCT02562482|78920581|FG000|Overall Study|Physician Decision|1|||
44133820|NCT02562482|78920582|FG001|Overall Study|Physician Decision|3|||
44133821|NCT02562482|78920581|FG000|Overall Study|Illness/Injury unrelated to product|0|||
44133822|NCT02562482|78920582|FG001|Overall Study|Illness/Injury unrelated to product|1|||
44133823|NCT02568254|78920597|FG000|Period 2|Adverse Event|0|||
44133824|NCT02568254|78920598|FG001|Period 2|Adverse Event|0|||
44133825|NCT02568254|78920599|FG002|Period 2|Adverse Event|1|||
44133826|NCT02568254|78920600|FG003|Period 2|Adverse Event|0|||
44133827|NCT02568254|78920601|FG004|Period 2|Adverse Event|0|||
44133828|NCT02568254|78920602|FG005|Period 2|Adverse Event|0|||
44133829|NCT02568254|78920597|FG000|Period 3|Unstatisfactory Lens fitting|0|||
44243656|NCT01474291|79073307|FG000|Overall Study|Lack of Treatment Efficacy|88|||
44133830|NCT02568254|78920598|FG001|Period 3|Unstatisfactory Lens fitting|0|||
44133831|NCT02568254|78920599|FG002|Period 3|Unstatisfactory Lens fitting|0|||
44133832|NCT02568254|78920600|FG003|Period 3|Unstatisfactory Lens fitting|0|||
44133833|NCT02568254|78920601|FG004|Period 3|Unstatisfactory Lens fitting|1|||
44133834|NCT02568254|78920602|FG005|Period 3|Unstatisfactory Lens fitting|0|||
44133835|NCT02567708|78920610|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
44133836|NCT02567708|78920611|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
44133837|NCT02567708|78920610|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
44133838|NCT02567708|78920611|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
44133839|NCT02567708|78920610|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
44133840|NCT02567708|78920611|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
44243657|NCT01474291|79073307|FG000|Overall Study|Adverse Event|53|||
44243658|NCT01474291|79073307|FG000|Overall Study|Lost to Follow-up|29|||
44133841|NCT02567708|78920610|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
44133842|NCT02567708|78920611|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
44380270|NCT00902304|79386131|FG002|Overall Study|Adverse Event|25|||
44513113|NCT03129100|79519002|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
44513114|NCT03129100|79519003|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
44513115|NCT03129100|79519004|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
44513116|NCT03129100|79519005|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
44513117|NCT03129100|79519006|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
44513118|NCT03129100|79519007|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
44513119|NCT03129100|79519008|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
44513120|NCT03129100|79519009|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
44513121|NCT03129100|79519010|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
44513122|NCT03129100|79519011|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
44513123|NCT03129100|79519012|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
44513124|NCT03129100|79519013|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
44513125|NCT03129100|79519014|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
44513126|NCT03129100|79519015|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
44513127|NCT03129100|79519016|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
44513128|NCT03129100|79519017|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
44513129|NCT03129100|79519018|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
44513130|NCT03129100|79519019|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
44513131|NCT03129100|79519020|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
44513132|NCT03129100|79519021|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
44513133|NCT03129100|79519022|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
44513134|NCT03129100|79519023|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
44513135|NCT03129100|79519024|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
44513136|NCT03129100|79519025|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
44513137|NCT03129100|79519000|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
44133843|NCT02562716|78920620|FG000|Overall Study|Adverse Event|7|||
44133844|NCT02562716|78920621|FG001|Overall Study|Adverse Event|14|||
44133845|NCT02562716|78920620|FG000|Overall Study|Withdrawal unrelated to AE|7|||
44133846|NCT02562716|78920621|FG001|Overall Study|Withdrawal unrelated to AE|1|||
44133847|NCT02562716|78920620|FG000|Overall Study|Progression|8|||
44133848|NCT02562716|78920621|FG001|Overall Study|Progression|10|||
44133849|NCT02562716|78920620|FG000|Overall Study|Death|2|||
44133850|NCT02562716|78920621|FG001|Overall Study|Death|1|||
44133851|NCT02562716|78920620|FG000|Overall Study|Not protocol specified|4|||
44133852|NCT02562716|78920621|FG001|Overall Study|Not protocol specified|2|||
44133853|NCT02751931|78920631|FG000|Overall Study|Adverse Event|3|||
44133854|NCT02751931|78920632|FG001|Overall Study|Adverse Event|0|||
44133855|NCT02751931|78920631|FG000|Overall Study|Other: Miscelleneous|10|||
44133856|NCT02751931|78920632|FG001|Overall Study|Other: Miscelleneous|8|||
44133857|NCT02561156|78920657|FG000|Part 2|Adverse Event|0|||
44133858|NCT02561156|78920658|FG001|Part 2|Adverse Event|0|||
44133859|NCT02561156|78920659|FG002|Part 2|Adverse Event|0|||
44133860|NCT02561156|78920660|FG003|Part 2|Adverse Event|0|||
44133861|NCT02561156|78920661|FG004|Part 2|Adverse Event|0|||
44133862|NCT02561156|78920662|FG005|Part 2|Adverse Event|0|||
44133863|NCT02561156|78920663|FG006|Part 2|Adverse Event|0|||
44133864|NCT02561156|78920664|FG007|Part 2|Adverse Event|0|||
44133865|NCT02561156|78920665|FG008|Part 2|Adverse Event|0|||
44133866|NCT02561156|78920666|FG009|Part 2|Adverse Event|0|||
44133867|NCT02561156|78920667|FG010|Part 2|Adverse Event|0|||
44133868|NCT02561156|78920668|FG011|Part 2|Adverse Event|1|||
44133869|NCT02561156|78920669|FG012|Part 2|Adverse Event|0|||
44133870|NCT02561078|78920715|FG000|Overall Study|Adverse Event|5|||
44133871|NCT02561078|78920716|FG001|Overall Study|Adverse Event|2|||
44133872|NCT02561078|78920715|FG000|Overall Study|Death|2|||
44133873|NCT02561078|78920716|FG001|Overall Study|Death|1|||
44133874|NCT02561078|78920715|FG000|Overall Study|Lost to Follow-up|2|||
44133875|NCT02561078|78920716|FG001|Overall Study|Lost to Follow-up|6|||
44133876|NCT02561078|78920715|FG000|Overall Study|Non-Compliance with Study Drug|6|||
44133877|NCT02561078|78920716|FG001|Overall Study|Non-Compliance with Study Drug|3|||
44133878|NCT02561078|78920715|FG000|Overall Study|Physician Decision|2|||
44133879|NCT02561078|78920716|FG001|Overall Study|Physician Decision|3|||
44133880|NCT02561078|78920715|FG000|Overall Study|Withdrawal by Subject|13|||
44133881|NCT02561078|78920716|FG001|Overall Study|Withdrawal by Subject|10|||
44133888|NCT04881448|78920731|FG000|Overall Study|Study cancelled by sponsor|220|||
44133889|NCT04881448|78920731|FG000|Overall Study|Withdrawal by Subject|2|||
44133890|NCT04881448|78920731|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
44133891|NCT04275310|78920762|FG000|Overall Study|Non-randomized due to running out of funding|4|||
44133892|NCT04275310|78920763|FG001|Overall Study|Non-randomized due to running out of funding|0|||
44133893|NCT04157088|78920769|FG000|Overall Study|Study terminated by sponsor|23|||
44133894|NCT04157088|78920769|FG000|Overall Study|Withdrawal by Subject|4|||
44133895|NCT04157088|78920769|FG000|Overall Study|Lost to Follow-up|2|||
44133896|NCT04157088|78920769|FG000|Overall Study|Death|1|||
44133897|NCT04140266|78920777|FG000|Overall Study|Physician Decision|2|||
44133898|NCT04140266|78920778|FG001|Overall Study|Physician Decision|0|||
44133899|NCT04140266|78920777|FG000|Overall Study|Withdrawal by Subject|4|||
44133900|NCT04140266|78920778|FG001|Overall Study|Withdrawal by Subject|2|||
44133901|NCT03926143|78920801|FG000|Overall Study|Physician Decision|3|||
44133902|NCT03926143|78920801|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
44133903|NCT03926143|78920801|FG000|Overall Study|Adverse Event|2|||
44133904|NCT03926143|78920801|FG000|Overall Study|Progressive disease|3|||
44133905|NCT03018080|78920818|FG000|Overall Study|Death|12|||
44133906|NCT03018080|78920819|FG001|Overall Study|Death|19|||
44133907|NCT02781090|78920827|FG000|3-Month Follow-Up|Missed Visit|20|||
44133908|NCT02781090|78920828|FG001|3-Month Follow-Up|Missed Visit|20|||
44133909|NCT02781090|78920827|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
44133910|NCT02781090|78920828|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
44133911|NCT02781090|78920827|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
44133912|NCT02781090|78920828|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
44133913|NCT02781090|78920827|FG000|3-Month Follow-Up|Death|1|||
44133914|NCT02781090|78920828|FG001|3-Month Follow-Up|Death|0|||
44133915|NCT02781090|78920827|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
44133916|NCT02781090|78920828|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
44133917|NCT02781090|78920827|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
44133918|NCT02781090|78920828|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
44133919|NCT02781090|78920827|FG000|6-Month Follow-Up|Death|0|||
44133920|NCT02781090|78920828|FG001|6-Month Follow-Up|Death|1|||
44133921|NCT02774291|78920836|FG000|Overall Study|Lost to Follow-up|1|||
44133922|NCT01897571|78920852|FG000|Overall Study|Lost to Follow-up|3|||
44133923|NCT01897571|78920853|FG001|Overall Study|Lost to Follow-up|0|||
44133924|NCT01897571|78920854|FG002|Overall Study|Lost to Follow-up|0|||
44133925|NCT01897571|78920855|FG003|Overall Study|Lost to Follow-up|0|||
44133926|NCT01897571|78920856|FG004|Overall Study|Lost to Follow-up|2|||
44133927|NCT01897571|78920857|FG005|Overall Study|Lost to Follow-up|0|||
44133928|NCT01897571|78920858|FG006|Overall Study|Lost to Follow-up|0|||
44133929|NCT01897571|78920859|FG007|Overall Study|Lost to Follow-up|0|||
44133930|NCT01897571|78920860|FG008|Overall Study|Lost to Follow-up|1|||
44133931|NCT01897571|78920861|FG009|Overall Study|Lost to Follow-up|2|||
44133932|NCT01897571|78920862|FG010|Overall Study|Lost to Follow-up|4|||
44133933|NCT01897571|78920852|FG000|Overall Study|Withdrawal by Subject|0|||
44133934|NCT01897571|78920853|FG001|Overall Study|Withdrawal by Subject|0|||
44133935|NCT01897571|78920854|FG002|Overall Study|Withdrawal by Subject|0|||
44133936|NCT01897571|78920855|FG003|Overall Study|Withdrawal by Subject|0|||
44133937|NCT01897571|78920856|FG004|Overall Study|Withdrawal by Subject|0|||
44133938|NCT01897571|78920857|FG005|Overall Study|Withdrawal by Subject|0|||
44133939|NCT01897571|78920858|FG006|Overall Study|Withdrawal by Subject|0|||
44133940|NCT01897571|78920859|FG007|Overall Study|Withdrawal by Subject|1|||
44133941|NCT01897571|78920860|FG008|Overall Study|Withdrawal by Subject|4|||
44133942|NCT01897571|78920861|FG009|Overall Study|Withdrawal by Subject|3|||
44133943|NCT01897571|78920862|FG010|Overall Study|Withdrawal by Subject|1|||
44133944|NCT01897571|78920852|FG000|Overall Study|Other|1|||
44133945|NCT01897571|78920853|FG001|Overall Study|Other|0|||
44133946|NCT01897571|78920854|FG002|Overall Study|Other|0|||
44133947|NCT01897571|78920855|FG003|Overall Study|Other|3|||
44133948|NCT01897571|78920856|FG004|Overall Study|Other|3|||
44133949|NCT01897571|78920857|FG005|Overall Study|Other|4|||
44133950|NCT01897571|78920858|FG006|Overall Study|Other|7|||
44133951|NCT01897571|78920859|FG007|Overall Study|Other|0|||
44133952|NCT01897571|78920860|FG008|Overall Study|Other|0|||
44133953|NCT01897571|78920861|FG009|Overall Study|Other|0|||
44133954|NCT01897571|78920862|FG010|Overall Study|Other|0|||
44133955|NCT01897571|78920852|FG000|Overall Study|Enrolled in rollover study|0|||
44133956|NCT01897571|78920853|FG001|Overall Study|Enrolled in rollover study|0|||
44133957|NCT01897571|78920854|FG002|Overall Study|Enrolled in rollover study|0|||
44133958|NCT01897571|78920855|FG003|Overall Study|Enrolled in rollover study|0|||
44133959|NCT01897571|78920856|FG004|Overall Study|Enrolled in rollover study|0|||
44133960|NCT01897571|78920857|FG005|Overall Study|Enrolled in rollover study|0|||
44133961|NCT01897571|78920858|FG006|Overall Study|Enrolled in rollover study|0|||
44133962|NCT01897571|78920859|FG007|Overall Study|Enrolled in rollover study|9|||
44133963|NCT01897571|78920860|FG008|Overall Study|Enrolled in rollover study|7|||
44133964|NCT01897571|78920861|FG009|Overall Study|Enrolled in rollover study|9|||
44133965|NCT01897571|78920862|FG010|Overall Study|Enrolled in rollover study|1|||
44133966|NCT01897571|78920852|FG000|Overall Study|Death|2|||
44133967|NCT01897571|78920853|FG001|Overall Study|Death|2|||
44133968|NCT01897571|78920854|FG002|Overall Study|Death|3|||
44133969|NCT01897571|78920855|FG003|Overall Study|Death|6|||
44133970|NCT01897571|78920856|FG004|Overall Study|Death|7|||
44133971|NCT01897571|78920857|FG005|Overall Study|Death|9|||
44133972|NCT01897571|78920858|FG006|Overall Study|Death|5|||
44133973|NCT01897571|78920859|FG007|Overall Study|Death|22|||
44133974|NCT01897571|78920860|FG008|Overall Study|Death|23|||
44133975|NCT01897571|78920861|FG009|Overall Study|Death|129|||
44133976|NCT01897571|78920862|FG010|Overall Study|Death|59|||
44133977|NCT01207778|78920884|FG000|Overall Study|Lost to Follow-up|0|||
44133978|NCT01207778|78920885|FG001|Overall Study|Lost to Follow-up|3|||
44133979|NCT01207778|78920886|FG002|Overall Study|Lost to Follow-up|3|||
44133980|NCT02567552|78920896|FG000|Overall Study|Adverse Event|0|||
44133981|NCT02567552|78920897|FG001|Overall Study|Adverse Event|1|||
44513138|NCT03129100|79519001|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44133982|NCT02561000|78920911|FG000|Overall Study|Withdrawal by Subject|2|||
44133983|NCT02561000|78920912|FG001|Overall Study|Withdrawal by Subject|3|||
44133984|NCT02561000|78920913|FG002|Overall Study|Withdrawal by Subject|0|||
44133985|NCT02561000|78920911|FG000|Overall Study|Adverse Event|0|||
44133986|NCT02561000|78920912|FG001|Overall Study|Adverse Event|1|||
44133987|NCT02561000|78920913|FG002|Overall Study|Adverse Event|0|||
44513139|NCT03129100|79519002|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513140|NCT03129100|79519003|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44133988|NCT01663532|78920923|FG000|Overall Study|Lost to Follow-up|9|||
44133989|NCT01663532|78920924|FG001|Overall Study|Lost to Follow-up|10|||
44133990|NCT01663532|78920923|FG000|Overall Study|Adverse Event|7|||
44133991|NCT01663532|78920924|FG001|Overall Study|Adverse Event|13|||
44513141|NCT03129100|79519004|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44133992|NCT01663532|78920923|FG000|Overall Study|Met Withdrawal Criteria|7|||
44133993|NCT01663532|78920924|FG001|Overall Study|Met Withdrawal Criteria|6|||
44133994|NCT01663532|78920923|FG000|Overall Study|Physician Decision|1|||
44133995|NCT01663532|78920924|FG001|Overall Study|Physician Decision|1|||
44133996|NCT01663532|78920923|FG000|Overall Study|Withdrawal by Subject|35|||
44133997|NCT01663532|78920924|FG001|Overall Study|Withdrawal by Subject|17|||
44133998|NCT01663532|78920923|FG000|Overall Study|Lack of Efficacy|15|||
44133999|NCT01663532|78920924|FG001|Overall Study|Lack of Efficacy|60|||
44134000|NCT02525939|78920932|FG000|Overall Study|Lost to Follow-up|27|||
44134001|NCT02525939|78920933|FG001|Overall Study|Lost to Follow-up|24|||
44134002|NCT02525939|78920932|FG000|Overall Study|Physician Decision|0|||
44134003|NCT02525939|78920933|FG001|Overall Study|Physician Decision|1|||
44134004|NCT02525939|78920932|FG000|Overall Study|Withdrawal by Subject|24|||
44134005|NCT02525939|78920933|FG001|Overall Study|Withdrawal by Subject|39|||
44134006|NCT02525939|78920932|FG000|Overall Study|Death|180|||
44134007|NCT02525939|78920933|FG001|Overall Study|Death|179|||
44134008|NCT02697591|78920970|FG000|Overall Study|Lost to Follow-up|0|||
44134009|NCT02697591|78920971|FG001|Overall Study|Lost to Follow-up|0|||
44134010|NCT02697591|78920972|FG002|Overall Study|Lost to Follow-up|0|||
44134011|NCT02697591|78920973|FG003|Overall Study|Lost to Follow-up|0|||
44134012|NCT02697591|78920974|FG004|Overall Study|Lost to Follow-up|0|||
44134013|NCT02697591|78920975|FG005|Overall Study|Lost to Follow-up|1|||
44134014|NCT02697591|78920976|FG006|Overall Study|Lost to Follow-up|1|||
44134015|NCT02697591|78920977|FG007|Overall Study|Lost to Follow-up|0|||
44134016|NCT02697591|78920978|FG008|Overall Study|Lost to Follow-up|0|||
44134017|NCT02697591|78920979|FG009|Overall Study|Lost to Follow-up|1|||
44134018|NCT02697591|78920970|FG000|Overall Study|Withdrawal by Subject|1|||
44134019|NCT02697591|78920971|FG001|Overall Study|Withdrawal by Subject|1|||
44134020|NCT02697591|78920972|FG002|Overall Study|Withdrawal by Subject|2|||
44134021|NCT02697591|78920973|FG003|Overall Study|Withdrawal by Subject|1|||
44134022|NCT02697591|78920974|FG004|Overall Study|Withdrawal by Subject|7|||
44134023|NCT02697591|78920975|FG005|Overall Study|Withdrawal by Subject|6|||
44134024|NCT02697591|78920976|FG006|Overall Study|Withdrawal by Subject|9|||
44134025|NCT02697591|78920977|FG007|Overall Study|Withdrawal by Subject|1|||
44134026|NCT02697591|78920978|FG008|Overall Study|Withdrawal by Subject|6|||
44134027|NCT02697591|78920979|FG009|Overall Study|Withdrawal by Subject|10|||
44134028|NCT02697591|78920970|FG000|Overall Study|Physician Decision|1|||
44134029|NCT02697591|78920971|FG001|Overall Study|Physician Decision|0|||
44134030|NCT02697591|78920972|FG002|Overall Study|Physician Decision|0|||
44134031|NCT02697591|78920973|FG003|Overall Study|Physician Decision|0|||
44134032|NCT02697591|78920974|FG004|Overall Study|Physician Decision|1|||
44134033|NCT02697591|78920975|FG005|Overall Study|Physician Decision|2|||
44134034|NCT02697591|78920976|FG006|Overall Study|Physician Decision|0|||
44134035|NCT02697591|78920977|FG007|Overall Study|Physician Decision|0|||
44134036|NCT02697591|78920978|FG008|Overall Study|Physician Decision|1|||
44134037|NCT02697591|78920979|FG009|Overall Study|Physician Decision|1|||
44134038|NCT02697591|78920970|FG000|Overall Study|Death|2|||
44134039|NCT02697591|78920971|FG001|Overall Study|Death|3|||
44134040|NCT02697591|78920972|FG002|Overall Study|Death|1|||
44134041|NCT02697591|78920973|FG003|Overall Study|Death|1|||
44134042|NCT02697591|78920974|FG004|Overall Study|Death|4|||
44134043|NCT02697591|78920975|FG005|Overall Study|Death|5|||
44134044|NCT02697591|78920976|FG006|Overall Study|Death|3|||
44134045|NCT02697591|78920977|FG007|Overall Study|Death|1|||
44134046|NCT02697591|78920978|FG008|Overall Study|Death|1|||
44134047|NCT02697591|78920979|FG009|Overall Study|Death|5|||
44134048|NCT02697591|78920970|FG000|Overall Study|Reason not Specified|0|||
44134049|NCT02697591|78920971|FG001|Overall Study|Reason not Specified|0|||
44134050|NCT02697591|78920972|FG002|Overall Study|Reason not Specified|0|||
44134051|NCT02697591|78920973|FG003|Overall Study|Reason not Specified|1|||
44134052|NCT02697591|78920974|FG004|Overall Study|Reason not Specified|1|||
44134053|NCT02697591|78920975|FG005|Overall Study|Reason not Specified|2|||
44134054|NCT02697591|78920976|FG006|Overall Study|Reason not Specified|3|||
44134055|NCT02697591|78920977|FG007|Overall Study|Reason not Specified|1|||
44134056|NCT02697591|78920978|FG008|Overall Study|Reason not Specified|1|||
44134057|NCT02697591|78920979|FG009|Overall Study|Reason not Specified|3|||
44134058|NCT02697435|78921004|FG000|Overall Study|Withdrawal by Subject|1|||
44134059|NCT02697435|78921005|FG001|Overall Study|Withdrawal by Subject|0|||
44134060|NCT02697435|78921004|FG000|Overall Study|Physician Decision|0|||
44134061|NCT02697435|78921005|FG001|Overall Study|Physician Decision|4|||
44134062|NCT02174861|78921012|FG000|Overall Study|Decision by sponsor|8|||
44134063|NCT02174861|78921012|FG000|Overall Study|Withdrawal by Subject|124|||
44134064|NCT02174861|78921012|FG000|Overall Study|Lost to Follow-up|26|||
44134065|NCT00140855|78921018|FG000|Overall Study|Progressive disease|2|||
44134066|NCT00700635|78921025|FG000|Overall Study|Adverse Event|1|||
44134067|NCT00700635|78921026|FG001|Overall Study|Adverse Event|0|||
44134068|NCT00700635|78921027|FG002|Overall Study|Adverse Event|0|||
44134069|NCT00700635|78921025|FG000|Overall Study|Lost to Follow-up|1|||
44134070|NCT00700635|78921026|FG001|Overall Study|Lost to Follow-up|3|||
44134071|NCT00700635|78921027|FG002|Overall Study|Lost to Follow-up|0|||
44134072|NCT00700635|78921025|FG000|Overall Study|Protocol Violation|2|||
44134073|NCT00700635|78921026|FG001|Overall Study|Protocol Violation|2|||
44134074|NCT00700635|78921027|FG002|Overall Study|Protocol Violation|0|||
44134075|NCT00700635|78921025|FG000|Overall Study|Withdrawal by Subject|7|||
44134076|NCT00700635|78921026|FG001|Overall Study|Withdrawal by Subject|3|||
44134077|NCT00700635|78921027|FG002|Overall Study|Withdrawal by Subject|1|||
44134078|NCT02780687|78921037|FG000|Overall Study|Adverse Event|1|||
44134079|NCT02780687|78921038|FG001|Overall Study|Adverse Event|1|||
44134080|NCT02780687|78921037|FG000|Overall Study|Withdrawal by Subject|2|||
44134081|NCT02780687|78921038|FG001|Overall Study|Withdrawal by Subject|1|||
44134082|NCT02780687|78921037|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
44134083|NCT02780687|78921038|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
44134084|NCT02780687|78921037|FG000|Overall Study|progressive disease|29|||
44134085|NCT02780687|78921038|FG001|Overall Study|progressive disease|6|||
44134086|NCT02698371|78921043|FG000|All Participants Flow|Lost to Follow-up|3|||
44134087|NCT02698371|78921043|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
44134088|NCT02698371|78921043|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
44134089|NCT02698371|78921043|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
44134090|NCT02698371|78921043|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
44134091|NCT02698371|78921043|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
44134092|NCT02698371|78921043|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
44134093|NCT02781311|78921062|FG000|Overall Study|Adverse Event|2|||
44134094|NCT02781311|78921063|FG001|Overall Study|Adverse Event|6|||
44134095|NCT02781311|78921064|FG002|Overall Study|Adverse Event|1|||
44134096|NCT02781311|78921062|FG000|Overall Study|Withdrawal of Consent|11|||
44134097|NCT02781311|78921063|FG001|Overall Study|Withdrawal of Consent|12|||
44134098|NCT02781311|78921064|FG002|Overall Study|Withdrawal of Consent|2|||
44134099|NCT02781311|78921062|FG000|Overall Study|Lost to Follow-up|11|||
44134100|NCT02781311|78921063|FG001|Overall Study|Lost to Follow-up|8|||
44134101|NCT02781311|78921064|FG002|Overall Study|Lost to Follow-up|1|||
44134102|NCT02781311|78921062|FG000|Overall Study|Non-Compliance with Study Drug|2|||
44134103|NCT02781311|78921063|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44134104|NCT02781311|78921064|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44134105|NCT02564198|78921074|FG000|Overall Study|Withdrawal by Subject|2|||
44134106|NCT02564198|78921075|FG001|Overall Study|Withdrawal by Subject|4|||
44134107|NCT02564198|78921076|FG002|Overall Study|Withdrawal by Subject|0|||
44134108|NCT02564198|78921074|FG000|Overall Study|Adverse Event|0|||
44134109|NCT02564198|78921075|FG001|Overall Study|Adverse Event|1|||
44134110|NCT02564198|78921076|FG002|Overall Study|Adverse Event|0|||
44134111|NCT02564120|78921091|FG000|Overall Study|Did not return release forms|160|||
44134112|NCT02564120|78921091|FG000|Overall Study|Death|58|||
44134113|NCT02564120|78921091|FG000|Overall Study|Withdrawal by Subject|204|||
44134114|NCT02564120|78921091|FG000|Overall Study|Other medical condition|24|||
44134115|NCT00705783|78921107|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
44134116|NCT00705783|78921108|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
44134117|NCT00705783|78921109|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
44134118|NCT00705783|78921107|FG000|Conversion Phase|Lost to Follow-up|13|||
44134119|NCT00705783|78921108|FG001|Conversion Phase|Lost to Follow-up|0|||
44134120|NCT00705783|78921109|FG002|Conversion Phase|Lost to Follow-up|0|||
44134121|NCT00705783|78921107|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
44134122|NCT00705783|78921108|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
44134123|NCT00705783|78921109|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
44134124|NCT00705783|78921107|FG000|Conversion Phase|Withdrawn by Investigator|4|||
44134125|NCT00705783|78921108|FG001|Conversion Phase|Withdrawn by Investigator|0|||
44134126|NCT00705783|78921109|FG002|Conversion Phase|Withdrawn by Investigator|0|||
44134127|NCT00705783|78921107|FG000|Conversion Phase|Withdrew Consent|24|||
44134128|NCT00705783|78921108|FG001|Conversion Phase|Withdrew Consent|0|||
44134129|NCT00705783|78921109|FG002|Conversion Phase|Withdrew Consent|0|||
44134130|NCT00705783|78921107|FG000|Conversion Phase|Protocol Deviation|2|||
44134131|NCT00705783|78921108|FG001|Conversion Phase|Protocol Deviation|0|||
44134132|NCT00705783|78921109|FG002|Conversion Phase|Protocol Deviation|0|||
44134133|NCT00705783|78921107|FG000|Conversion Phase|Adverse Event|11|||
44134134|NCT00705783|78921108|FG001|Conversion Phase|Adverse Event|0|||
44134135|NCT00705783|78921109|FG002|Conversion Phase|Adverse Event|0|||
44134136|NCT00705783|78921107|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
44134137|NCT00705783|78921108|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
44134138|NCT00705783|78921109|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
44134139|NCT00705783|78921107|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
44134140|NCT00705783|78921108|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
44134141|NCT00705783|78921109|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
44134142|NCT00705783|78921107|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
44134143|NCT00705783|78921108|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
44134144|NCT00705783|78921109|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
44134145|NCT00705783|78921107|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
44134146|NCT00705783|78921108|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
44134147|NCT00705783|78921109|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
44134148|NCT00705783|78921107|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
44134149|NCT00705783|78921108|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
44134150|NCT00705783|78921109|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
44134151|NCT00705783|78921107|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
44134152|NCT00705783|78921108|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
44134153|NCT00705783|78921109|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
44134154|NCT00705783|78921107|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
44134155|NCT00705783|78921108|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
44134156|NCT00705783|78921109|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
44134157|NCT00705783|78921107|FG000|Oral Stabilization Phase|Adverse Event|14|||
44134158|NCT00705783|78921108|FG001|Oral Stabilization Phase|Adverse Event|0|||
44134159|NCT00705783|78921109|FG002|Oral Stabilization Phase|Adverse Event|0|||
44134160|NCT00705783|78921107|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
44134161|NCT00705783|78921108|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44134162|NCT00705783|78921109|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44134163|NCT00705783|78921107|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
44134164|NCT00705783|78921108|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44276596|NCT04791319|79237612|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
44276597|NCT04791319|79237613|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
44134165|NCT00705783|78921109|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44134166|NCT00705783|78921107|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
44134167|NCT00705783|78921108|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
44134168|NCT00705783|78921109|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
44134169|NCT00705783|78921107|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
44134170|NCT00705783|78921108|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
44134171|NCT00705783|78921109|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
44134172|NCT00705783|78921107|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
44134173|NCT00705783|78921108|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
44134174|NCT00705783|78921109|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
44134175|NCT00705783|78921107|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
44134176|NCT00705783|78921108|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
44134177|NCT00705783|78921109|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
44134178|NCT00705783|78921107|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
44134179|NCT00705783|78921108|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
44134180|NCT00705783|78921109|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
44134181|NCT00705783|78921107|FG000|Depot Stabilization Phase|Adverse Event|17|||
44134182|NCT00705783|78921108|FG001|Depot Stabilization Phase|Adverse Event|0|||
44134183|NCT00705783|78921109|FG002|Depot Stabilization Phase|Adverse Event|0|||
44134184|NCT00705783|78921107|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
44134185|NCT00705783|78921108|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44134186|NCT00705783|78921109|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
44134187|NCT00705783|78921107|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
44134188|NCT00705783|78921108|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44134189|NCT00705783|78921109|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
44134190|NCT00705783|78921107|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
44134191|NCT00705783|78921108|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
44134192|NCT00705783|78921109|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
44134193|NCT00705783|78921107|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
44134194|NCT00705783|78921108|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
44134195|NCT00705783|78921109|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
44134196|NCT00705783|78921107|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
44134197|NCT00705783|78921108|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
44134198|NCT00705783|78921109|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
44134199|NCT00705783|78921107|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
44134200|NCT00705783|78921108|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
44134201|NCT00705783|78921109|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
44134202|NCT00705783|78921107|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
44134203|NCT00705783|78921108|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
44134204|NCT00705783|78921109|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
44134205|NCT00705783|78921107|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
44134206|NCT00705783|78921108|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
44134207|NCT00705783|78921109|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
44134208|NCT00705783|78921107|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
44134209|NCT00705783|78921108|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
44134210|NCT00705783|78921109|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
44134211|NCT00705783|78921107|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
44276598|NCT04791319|79237614|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
44134212|NCT00705783|78921108|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
44134213|NCT00705783|78921109|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
44134214|NCT00705783|78921107|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
44134215|NCT00705783|78921108|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
44134216|NCT00705783|78921109|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
44134217|NCT02694549|78921118|FG000|Overall Study|screen failures|2|||
44134218|NCT02782325|78921124|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
44134219|NCT02782325|78921125|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
44134220|NCT02782325|78921126|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
44134221|NCT02782325|78921124|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
44134222|NCT02782325|78921125|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
44134223|NCT02782325|78921126|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
44134224|NCT02693691|78921134|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
44134225|NCT02693691|78921134|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
44134226|NCT02693691|78921134|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
44134227|NCT02693691|78921134|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
44134228|NCT02693691|78921134|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
44134229|NCT02693691|78921134|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
44134230|NCT02693691|78921134|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
44134231|NCT04203667|78921138|FG000|Overall Study|Withdrawal by Subject|1|||
44134232|NCT04203667|78921138|FG000|Overall Study|Lost to Follow-up|1|||
44134233|NCT04203667|78921138|FG000|Overall Study|Death|1|||
44134234|NCT04203667|78921138|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
44134235|NCT02782169|78921145|FG000|Overall Study|Lost to Follow-up|1|||
44134236|NCT02782169|78921146|FG001|Overall Study|Lost to Follow-up|2|||
44134237|NCT02564042|78921158|FG000|Overall Study|Adverse Event|4|||
44134238|NCT02564042|78921159|FG001|Overall Study|Adverse Event|4|||
44134239|NCT02564042|78921160|FG002|Overall Study|Adverse Event|3|||
44134240|NCT02564042|78921161|FG003|Overall Study|Adverse Event|0|||
44134241|NCT02564042|78921162|FG004|Overall Study|Adverse Event|0|||
44134242|NCT02564042|78921163|FG005|Overall Study|Adverse Event|1|||
44134243|NCT02564042|78921158|FG000|Overall Study|Lost to Follow-up|1|||
44134244|NCT02564042|78921159|FG001|Overall Study|Lost to Follow-up|1|||
44134245|NCT02564042|78921160|FG002|Overall Study|Lost to Follow-up|1|||
44134246|NCT02564042|78921161|FG003|Overall Study|Lost to Follow-up|0|||
44134247|NCT02564042|78921162|FG004|Overall Study|Lost to Follow-up|1|||
44134248|NCT02564042|78921163|FG005|Overall Study|Lost to Follow-up|1|||
44134249|NCT02564042|78921158|FG000|Overall Study|Physician Decision|1|||
44134250|NCT02564042|78921159|FG001|Overall Study|Physician Decision|0|||
44134251|NCT02564042|78921160|FG002|Overall Study|Physician Decision|0|||
44134252|NCT02564042|78921161|FG003|Overall Study|Physician Decision|1|||
44134253|NCT02564042|78921162|FG004|Overall Study|Physician Decision|0|||
44134254|NCT02564042|78921163|FG005|Overall Study|Physician Decision|0|||
44134255|NCT02564042|78921158|FG000|Overall Study|Withdrawal by Subject|5|||
44134256|NCT02564042|78921159|FG001|Overall Study|Withdrawal by Subject|3|||
44134257|NCT02564042|78921160|FG002|Overall Study|Withdrawal by Subject|2|||
44134258|NCT02564042|78921161|FG003|Overall Study|Withdrawal by Subject|2|||
44134259|NCT02564042|78921162|FG004|Overall Study|Withdrawal by Subject|10|||
44134260|NCT02564042|78921163|FG005|Overall Study|Withdrawal by Subject|12|||
44134261|NCT02695719|78921196|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
44134262|NCT02695719|78921197|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
44134263|NCT02695719|78921196|FG000|Overall Study|Significant Protocol Deviation|0|||
44134264|NCT02695719|78921197|FG001|Overall Study|Significant Protocol Deviation|1|||
44134265|NCT02695719|78921196|FG000|Overall Study|Voluntary Withdrawal|1|||
44134266|NCT02695719|78921197|FG001|Overall Study|Voluntary Withdrawal|0|||
44134267|NCT02563106|78921214|FG000|Overall Study|Withdrawal by Subject|7|||
44134268|NCT02563106|78921215|FG001|Overall Study|Withdrawal by Subject|8|||
44134269|NCT02563106|78921214|FG000|Overall Study|Adverse Event|17|||
44134270|NCT02563106|78921215|FG001|Overall Study|Adverse Event|15|||
44134271|NCT02563106|78921214|FG000|Overall Study|Protocol Violation|1|||
44134272|NCT02563106|78921215|FG001|Overall Study|Protocol Violation|0|||
44134273|NCT02563106|78921214|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
44134274|NCT02563106|78921215|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
44134275|NCT02563106|78921214|FG000|Overall Study|Lost to Follow-up|3|||
44243659|NCT01474291|79073307|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
44134276|NCT02563106|78921215|FG001|Overall Study|Lost to Follow-up|2|||
44243660|NCT01474291|79073307|FG000|Overall Study|No Reason Reported|10|||
44243661|NCT01474291|79073307|FG000|Overall Study|Death|2|||
44134277|NCT02563106|78921214|FG000|Overall Study|Physician Decision|3|||
44134278|NCT02563106|78921215|FG001|Overall Study|Physician Decision|1|||
44134279|NCT02563106|78921214|FG000|Overall Study|Other reason - not specified|2|||
44134280|NCT02563106|78921215|FG001|Overall Study|Other reason - not specified|1|||
44134281|NCT02691741|78921223|FG000|Overall Study|Adverse Event|0|||
44134282|NCT02691741|78921224|FG001|Overall Study|Adverse Event|2|||
44134283|NCT02691741|78921223|FG000|Overall Study|Lost to Follow-up|1|||
44134284|NCT02691741|78921224|FG001|Overall Study|Lost to Follow-up|0|||
44134285|NCT02691741|78921223|FG000|Overall Study|Physician Decision|0|||
44134286|NCT02691741|78921224|FG001|Overall Study|Physician Decision|1|||
44134287|NCT02691741|78921223|FG000|Overall Study|Withdrawal by Subject|0|||
44134288|NCT02691741|78921224|FG001|Overall Study|Withdrawal by Subject|4|||
44134289|NCT02691507|78921237|FG000|Overall Study|Missed Visit 3|0|||
44134290|NCT02691507|78921238|FG001|Overall Study|Missed Visit 3|1|||
44134291|NCT04579393|78921246|FG000|Overall Study|Withdrawal by Subject|2|||
44134292|NCT04579393|78921247|FG001|Overall Study|Withdrawal by Subject|2|||
44134293|NCT04579393|78921246|FG000|Overall Study|Death|1|||
44134294|NCT04579393|78921247|FG001|Overall Study|Death|3|||
44134295|NCT02776553|78921256|FG000|Overall Study|Lost to Follow-up|1|||
44134296|NCT02776553|78921257|FG001|Overall Study|Lost to Follow-up|0|||
44134297|NCT02776553|78921256|FG000|Overall Study|got liver transplant|1|||
44134298|NCT02776553|78921257|FG001|Overall Study|got liver transplant|2|||
44134299|NCT02776553|78921256|FG000|Overall Study|had other surgery|1|||
44134300|NCT02776553|78921257|FG001|Overall Study|had other surgery|0|||
44134301|NCT02776553|78921256|FG000|Overall Study|Protocol Violation|0|||
44134302|NCT02776553|78921257|FG001|Overall Study|Protocol Violation|1|||
44134303|NCT02690727|78921263|FG000|Overall Study|Adverse Event|2|||
44134304|NCT02690727|78921264|FG001|Overall Study|Adverse Event|2|||
44134305|NCT02777333|78921274|FG000|Overall Study|Withdrawal by Subject|0|||
44134306|NCT02777333|78921275|FG001|Overall Study|Withdrawal by Subject|1|||
44134307|NCT02777333|78921274|FG000|Overall Study|Lost to Follow-up|0|||
44134308|NCT02777333|78921275|FG001|Overall Study|Lost to Follow-up|1|||
44134309|NCT02695329|78921283|FG000|Overall Study|Adverse Event|1|||
44134310|NCT02695329|78921284|FG001|Overall Study|Adverse Event|0|||
44134311|NCT02695329|78921283|FG000|Overall Study|Poor X-ray quality for measurement|4|||
44134312|NCT02695329|78921284|FG001|Overall Study|Poor X-ray quality for measurement|5|||
44134313|NCT02690649|78921292|FG000|Overall Study|Withdrawal by Subject|1|||
44134314|NCT02690649|78921293|FG001|Overall Study|Withdrawal by Subject|1|||
44134315|NCT02690649|78921292|FG000|Overall Study|Protocol Violation|0|||
44134316|NCT02690649|78921293|FG001|Overall Study|Protocol Violation|3|||
44134317|NCT01358864|78921309|FG000|Overall Study|Adverse Event|0|||
44134318|NCT01358864|78921310|FG001|Overall Study|Adverse Event|6|||
44134319|NCT01358864|78921311|FG002|Overall Study|Adverse Event|9|||
44134320|NCT01358864|78921312|FG003|Overall Study|Adverse Event|0|||
44134321|NCT01358864|78921313|FG004|Overall Study|Adverse Event|4|||
44134322|NCT01358864|78921314|FG005|Overall Study|Adverse Event|8|||
44134323|NCT01358864|78921315|FG006|Overall Study|Adverse Event|12|||
44134324|NCT01358864|78921316|FG007|Overall Study|Adverse Event|7|||
44134325|NCT01358864|78921309|FG000|Overall Study|Lack of Efficacy|26|||
44134326|NCT01358864|78921310|FG001|Overall Study|Lack of Efficacy|3|||
44134327|NCT01358864|78921311|FG002|Overall Study|Lack of Efficacy|4|||
44134328|NCT01358864|78921312|FG003|Overall Study|Lack of Efficacy|19|||
44134329|NCT01358864|78921313|FG004|Overall Study|Lack of Efficacy|7|||
44134330|NCT01358864|78921314|FG005|Overall Study|Lack of Efficacy|4|||
44134331|NCT01358864|78921315|FG006|Overall Study|Lack of Efficacy|49|||
44134332|NCT01358864|78921316|FG007|Overall Study|Lack of Efficacy|44|||
44134333|NCT01358864|78921309|FG000|Overall Study|Lost to Follow-up|0|||
44134334|NCT01358864|78921310|FG001|Overall Study|Lost to Follow-up|0|||
44134335|NCT01358864|78921311|FG002|Overall Study|Lost to Follow-up|1|||
44134336|NCT01358864|78921312|FG003|Overall Study|Lost to Follow-up|0|||
44134337|NCT01358864|78921313|FG004|Overall Study|Lost to Follow-up|0|||
44134338|NCT01358864|78921314|FG005|Overall Study|Lost to Follow-up|0|||
44134339|NCT01358864|78921315|FG006|Overall Study|Lost to Follow-up|0|||
44134340|NCT01358864|78921316|FG007|Overall Study|Lost to Follow-up|1|||
44134341|NCT01358864|78921309|FG000|Overall Study|Withdrawal by Subject|3|||
44134342|NCT01358864|78921310|FG001|Overall Study|Withdrawal by Subject|4|||
44134343|NCT01358864|78921311|FG002|Overall Study|Withdrawal by Subject|2|||
44134344|NCT01358864|78921312|FG003|Overall Study|Withdrawal by Subject|0|||
44134345|NCT01358864|78921313|FG004|Overall Study|Withdrawal by Subject|0|||
44134346|NCT01358864|78921314|FG005|Overall Study|Withdrawal by Subject|1|||
44134347|NCT01358864|78921315|FG006|Overall Study|Withdrawal by Subject|1|||
44134348|NCT01358864|78921316|FG007|Overall Study|Withdrawal by Subject|3|||
44134349|NCT01358864|78921309|FG000|Overall Study|Other reason not defined above|2|||
44134350|NCT01358864|78921310|FG001|Overall Study|Other reason not defined above|0|||
44134351|NCT01358864|78921311|FG002|Overall Study|Other reason not defined above|0|||
44134352|NCT01358864|78921312|FG003|Overall Study|Other reason not defined above|0|||
44134353|NCT01358864|78921313|FG004|Overall Study|Other reason not defined above|0|||
44134354|NCT01358864|78921314|FG005|Overall Study|Other reason not defined above|0|||
44134355|NCT01358864|78921315|FG006|Overall Study|Other reason not defined above|2|||
44134356|NCT01358864|78921316|FG007|Overall Study|Other reason not defined above|0|||
44243662|NCT01465997|79073316|FG000|Overall Study|Adverse Event|12|||
44134357|NCT01358864|78921309|FG000|Overall Study|Not treated|0|||
44134358|NCT01358864|78921310|FG001|Overall Study|Not treated|0|||
44134359|NCT01358864|78921311|FG002|Overall Study|Not treated|0|||
44134360|NCT01358864|78921312|FG003|Overall Study|Not treated|0|||
44134361|NCT01358864|78921313|FG004|Overall Study|Not treated|0|||
44134362|NCT01358864|78921314|FG005|Overall Study|Not treated|0|||
44134363|NCT01358864|78921315|FG006|Overall Study|Not treated|1|||
44134364|NCT01358864|78921316|FG007|Overall Study|Not treated|0|||
44134365|NCT02750761|78921342|FG000|Overall Study|Lost to Follow-up|0|||
44134366|NCT02750761|78921343|FG001|Overall Study|Lost to Follow-up|0|||
44134367|NCT02750761|78921344|FG002|Overall Study|Lost to Follow-up|1|||
44134368|NCT02750761|78921345|FG003|Overall Study|Lost to Follow-up|0|||
44134369|NCT02750761|78921346|FG004|Overall Study|Lost to Follow-up|0|||
44134370|NCT02750761|78921347|FG005|Overall Study|Lost to Follow-up|0|||
44134371|NCT02688933|78921390|FG000|Overall Study|Adverse Event|3|||
44134372|NCT02688933|78921391|FG001|Overall Study|Adverse Event|1|||
44134373|NCT02688933|78921390|FG000|Overall Study|Lack of Efficacy|2|||
44134374|NCT02688933|78921391|FG001|Overall Study|Lack of Efficacy|2|||
44134375|NCT02688933|78921390|FG000|Overall Study|Poor compliance to protocol|7|||
44134376|NCT02688933|78921391|FG001|Overall Study|Poor compliance to protocol|4|||
44134377|NCT02688933|78921390|FG000|Overall Study|Hypoglycemia|2|||
44134378|NCT02688933|78921391|FG001|Overall Study|Hypoglycemia|0|||
44134379|NCT02688933|78921390|FG000|Overall Study|Other than Specified|14|||
44134380|NCT02688933|78921391|FG001|Overall Study|Other than Specified|25|||
44134381|NCT02688933|78921390|FG000|Overall Study|Lost to Follow-up|1|||
44134382|NCT02688933|78921391|FG001|Overall Study|Lost to Follow-up|5|||
44134383|NCT02688621|78921411|FG000|Overall Study|Pregnancy|1|||
44134384|NCT02688621|78921412|FG001|Overall Study|Pregnancy|3|||
44134385|NCT02688621|78921411|FG000|Overall Study|Lost to Follow-up|38|||
44134386|NCT02688621|78921412|FG001|Overall Study|Lost to Follow-up|15|||
44134387|NCT02688621|78921411|FG000|Overall Study|Withdrawal by Subject|1|||
44134388|NCT02688621|78921412|FG001|Overall Study|Withdrawal by Subject|0|||
44134389|NCT04227704|78921424|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
44134390|NCT04227704|78921425|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
44134391|NCT04227704|78921426|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
44134392|NCT04227704|78921424|FG000|Overall Study|due to C/S being cancelled|1|||
44134393|NCT04227704|78921425|FG001|Overall Study|due to C/S being cancelled|0|||
44134394|NCT04227704|78921426|FG002|Overall Study|due to C/S being cancelled|0|||
44134395|NCT03530293|78921447|FG000|Pre-randomization|Adverse Event|12|||
44134396|NCT03530293|78921448|FG001|Pre-randomization|Adverse Event|0|||
44134397|NCT03530293|78921449|FG002|Pre-randomization|Adverse Event|0|||
44134398|NCT03530293|78921447|FG000|Pre-randomization|Protocol Violation|2|||
44134399|NCT03530293|78921448|FG001|Pre-randomization|Protocol Violation|0|||
44134400|NCT03530293|78921449|FG002|Pre-randomization|Protocol Violation|0|||
44134401|NCT03530293|78921447|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
44134402|NCT03530293|78921448|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
44134403|NCT03530293|78921449|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
44134404|NCT03530293|78921447|FG000|Pre-randomization|Withdrawal by Subject|5|||
44134405|NCT03530293|78921448|FG001|Pre-randomization|Withdrawal by Subject|0|||
44134406|NCT03530293|78921449|FG002|Pre-randomization|Withdrawal by Subject|0|||
44134407|NCT03530293|78921447|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
44134408|NCT03530293|78921448|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
44134409|NCT03530293|78921449|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
44134410|NCT03530293|78921447|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
44134411|NCT03530293|78921448|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
44134412|NCT03530293|78921449|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
44134413|NCT03530293|78921447|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
44134414|NCT03530293|78921448|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
44134415|NCT03530293|78921449|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
44134416|NCT03530293|78921447|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
44134417|NCT03530293|78921448|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
44134418|NCT03530293|78921449|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
44134419|NCT03530293|78921447|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
44134420|NCT03530293|78921448|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
44134421|NCT03530293|78921449|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
44134422|NCT03335371|78921478|FG000|Overall Study|Lost to Follow-up|0|||
44134423|NCT03335371|78921479|FG001|Overall Study|Lost to Follow-up|0|||
44134424|NCT03335371|78921480|FG002|Overall Study|Lost to Follow-up|0|||
44134425|NCT03335371|78921481|FG003|Overall Study|Lost to Follow-up|0|||
44134426|NCT03335371|78921482|FG004|Overall Study|Lost to Follow-up|1|||
44134427|NCT03335371|78921478|FG000|Overall Study|Withdrawal by Subject|0|||
44134428|NCT03335371|78921479|FG001|Overall Study|Withdrawal by Subject|0|||
44134429|NCT03335371|78921480|FG002|Overall Study|Withdrawal by Subject|0|||
44134430|NCT03335371|78921481|FG003|Overall Study|Withdrawal by Subject|0|||
44134431|NCT03335371|78921482|FG004|Overall Study|Withdrawal by Subject|1|||
44134432|NCT03335371|78921478|FG000|Overall Study|Randomization Error|0|||
44134433|NCT03335371|78921479|FG001|Overall Study|Randomization Error|0|||
44243663|NCT01465997|79073317|FG001|Overall Study|Adverse Event|22|||
44243664|NCT01465997|79073316|FG000|Overall Study|Lack of Efficacy|13|||
44134434|NCT03335371|78921480|FG002|Overall Study|Randomization Error|1|||
44134435|NCT03335371|78921481|FG003|Overall Study|Randomization Error|0|||
44134436|NCT03335371|78921482|FG004|Overall Study|Randomization Error|0|||
44134437|NCT02762929|78921514|FG000|Overall Study|Adverse Event|0|||
44134438|NCT02762929|78921515|FG001|Overall Study|Adverse Event|0|||
44134439|NCT02762929|78921516|FG002|Overall Study|Adverse Event|0|||
44134440|NCT02762929|78921517|FG003|Overall Study|Adverse Event|1|||
44134441|NCT02762929|78921518|FG004|Overall Study|Adverse Event|0|||
44134442|NCT02762929|78921519|FG005|Overall Study|Adverse Event|0|||
44134443|NCT02762929|78921514|FG000|Overall Study|Lost to Follow-up|1|||
44134444|NCT02762929|78921515|FG001|Overall Study|Lost to Follow-up|2|||
44134445|NCT02762929|78921516|FG002|Overall Study|Lost to Follow-up|0|||
44134446|NCT02762929|78921517|FG003|Overall Study|Lost to Follow-up|1|||
44134447|NCT02762929|78921518|FG004|Overall Study|Lost to Follow-up|0|||
44134448|NCT02762929|78921519|FG005|Overall Study|Lost to Follow-up|0|||
44134449|NCT02762929|78921514|FG000|Overall Study|Withdrawal by Subject|0|||
44134450|NCT02762929|78921515|FG001|Overall Study|Withdrawal by Subject|1|||
44134451|NCT02762929|78921516|FG002|Overall Study|Withdrawal by Subject|0|||
44134452|NCT02762929|78921517|FG003|Overall Study|Withdrawal by Subject|0|||
44134453|NCT02762929|78921518|FG004|Overall Study|Withdrawal by Subject|0|||
44134454|NCT02762929|78921519|FG005|Overall Study|Withdrawal by Subject|0|||
44134455|NCT02762929|78921514|FG000|Overall Study|exclusionary medication disclosed late|0|||
44134456|NCT02762929|78921515|FG001|Overall Study|exclusionary medication disclosed late|0|||
44134457|NCT02762929|78921516|FG002|Overall Study|exclusionary medication disclosed late|0|||
44134458|NCT02762929|78921517|FG003|Overall Study|exclusionary medication disclosed late|1|||
44134459|NCT02762929|78921518|FG004|Overall Study|exclusionary medication disclosed late|0|||
44134460|NCT02762929|78921519|FG005|Overall Study|exclusionary medication disclosed late|0|||
44134461|NCT03301051|78921540|FG000|Overall Study|Adverse Event|0|||
44134462|NCT03301051|78921541|FG001|Overall Study|Adverse Event|4|||
44134463|NCT03301051|78921540|FG000|Overall Study|Withdrawal by Subject|59|||
44134464|NCT03301051|78921541|FG001|Overall Study|Withdrawal by Subject|65|||
44134465|NCT03301051|78921540|FG000|Overall Study|Lost to Follow-up|263|||
44134466|NCT03301051|78921541|FG001|Overall Study|Lost to Follow-up|282|||
44134467|NCT03301051|78921540|FG000|Overall Study|Protocol Violation|1|||
44134468|NCT03301051|78921541|FG001|Overall Study|Protocol Violation|3|||
44134469|NCT03301051|78921540|FG000|Overall Study|Physician Decision|1|||
44134470|NCT03301051|78921541|FG001|Overall Study|Physician Decision|3|||
44134471|NCT03301051|78921540|FG000|Overall Study|Death|1|||
44134472|NCT03301051|78921541|FG001|Overall Study|Death|1|||
44134473|NCT03301051|78921540|FG000|Overall Study|Miscellaneous|8|||
44134474|NCT03301051|78921541|FG001|Overall Study|Miscellaneous|4|||
44134475|NCT03301051|78921540|FG000|Overall Study|Randomized, not vaccinated|13|||
44134476|NCT03301051|78921541|FG001|Overall Study|Randomized, not vaccinated|10|||
44134477|NCT01662986|78921549|FG000|Overall Study|Adverse Event|5|||
44134478|NCT01662986|78921550|FG001|Overall Study|Adverse Event|4|||
44134479|NCT01662986|78921549|FG000|Overall Study|Protocol Violation|2|||
44134480|NCT01662986|78921550|FG001|Overall Study|Protocol Violation|3|||
44134481|NCT01662986|78921549|FG000|Overall Study|Lost to Follow-up|5|||
44134482|NCT01662986|78921550|FG001|Overall Study|Lost to Follow-up|4|||
44134483|NCT01662986|78921549|FG000|Overall Study|Withdrawal by Subject|2|||
44134484|NCT01662986|78921550|FG001|Overall Study|Withdrawal by Subject|2|||
44134485|NCT01662986|78921549|FG000|Overall Study|Not Treated|1|||
44134486|NCT01662986|78921550|FG001|Overall Study|Not Treated|0|||
44134487|NCT01662986|78921549|FG000|Overall Study|Other than stated above|3|||
44134488|NCT01662986|78921550|FG001|Overall Study|Other than stated above|0|||
44134489|NCT01337167|78921558|FG000|Infant Series|Adverse Event|1|||
44134490|NCT01337167|78921559|FG001|Infant Series|Adverse Event|1|||
44134491|NCT01337167|78921558|FG000|Infant Series|Death|1|||
44134492|NCT01337167|78921559|FG001|Infant Series|Death|1|||
44134493|NCT01337167|78921558|FG000|Infant Series|Lost to Follow-up|13|||
44134494|NCT01337167|78921559|FG001|Infant Series|Lost to Follow-up|7|||
44134495|NCT01337167|78921558|FG000|Infant Series|Non-compliance with study drug|2|||
44134496|NCT01337167|78921559|FG001|Infant Series|Non-compliance with study drug|1|||
44134497|NCT01337167|78921558|FG000|Infant Series|Physician Decision|3|||
44134498|NCT01337167|78921559|FG001|Infant Series|Physician Decision|1|||
44134499|NCT01337167|78921558|FG000|Infant Series|Protocol Violation|22|||
44134500|NCT01337167|78921559|FG001|Infant Series|Protocol Violation|9|||
44134501|NCT01337167|78921558|FG000|Infant Series|Withdrawal by Subject|15|||
44134502|NCT01337167|78921559|FG001|Infant Series|Withdrawal by Subject|4|||
44134503|NCT01337167|78921558|FG000|Infant Series|Randomized but not vaccinated|5|||
44243665|NCT01465997|79073317|FG001|Overall Study|Lack of Efficacy|1|||
44243666|NCT01465997|79073316|FG000|Overall Study|Protocol Violation|1|||
44134504|NCT01337167|78921559|FG001|Infant Series|Randomized but not vaccinated|3|||
44134505|NCT01337167|78921558|FG000|Interim Period|Lost to Follow-up|51|||
44134506|NCT01337167|78921559|FG001|Interim Period|Lost to Follow-up|23|||
44134507|NCT01337167|78921558|FG000|Interim Period|Non-compliance with study drug|1|||
44134508|NCT01337167|78921559|FG001|Interim Period|Non-compliance with study drug|0|||
44134509|NCT01337167|78921558|FG000|Interim Period|Physician Decision|6|||
44134510|NCT01337167|78921559|FG001|Interim Period|Physician Decision|3|||
44134511|NCT01337167|78921558|FG000|Interim Period|Protocol Violation|5|||
44134512|NCT01337167|78921559|FG001|Interim Period|Protocol Violation|3|||
44134513|NCT01337167|78921558|FG000|Interim Period|Withdrawal by Subject|18|||
44134514|NCT01337167|78921559|FG001|Interim Period|Withdrawal by Subject|10|||
44134515|NCT01337167|78921558|FG000|Interim Period|Other protocol criterion not met|0|||
44134516|NCT01337167|78921559|FG001|Interim Period|Other protocol criterion not met|1|||
44134517|NCT01337167|78921558|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
44134518|NCT01337167|78921559|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
44134519|NCT01337167|78921558|FG000|Toddler Vaccinations|Protocol Violation|0|||
44134520|NCT01337167|78921559|FG001|Toddler Vaccinations|Protocol Violation|1|||
44134521|NCT01337167|78921558|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
44134522|NCT01337167|78921559|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
44134523|NCT01338025|78921567|FG000|Overall Study|Unexpected closure of study|10|||
44134524|NCT01338025|78921568|FG001|Overall Study|Unexpected closure of study|9|||
44134525|NCT01338025|78921567|FG000|Overall Study|Withdrawal by Subject|0|||
44134526|NCT01338025|78921568|FG001|Overall Study|Withdrawal by Subject|2|||
44134527|NCT01338025|78921567|FG000|Overall Study|Found ineligible after starting|1|||
44134528|NCT01338025|78921568|FG001|Overall Study|Found ineligible after starting|0|||
44134529|NCT02559206|78921612|FG000|Overall Study|Adverse Event|0|||
44134530|NCT02559206|78921613|FG001|Overall Study|Adverse Event|4|||
44134531|NCT02559206|78921614|FG002|Overall Study|Adverse Event|1|||
44134532|NCT02559206|78921615|FG003|Overall Study|Adverse Event|5|||
44134533|NCT02559206|78921616|FG004|Overall Study|Adverse Event|3|||
44134534|NCT02559206|78921617|FG005|Overall Study|Adverse Event|0|||
44134535|NCT02559206|78921618|FG006|Overall Study|Adverse Event|1|||
44134536|NCT02559206|78921619|FG007|Overall Study|Adverse Event|0|||
44134537|NCT02559206|78921612|FG000|Overall Study|Protocol Violation|1|||
44134538|NCT02559206|78921613|FG001|Overall Study|Protocol Violation|0|||
44134539|NCT02559206|78921614|FG002|Overall Study|Protocol Violation|1|||
44134540|NCT02559206|78921615|FG003|Overall Study|Protocol Violation|0|||
44134541|NCT02559206|78921616|FG004|Overall Study|Protocol Violation|0|||
44134542|NCT02559206|78921617|FG005|Overall Study|Protocol Violation|2|||
44134543|NCT02559206|78921618|FG006|Overall Study|Protocol Violation|0|||
44134544|NCT02559206|78921619|FG007|Overall Study|Protocol Violation|0|||
44134545|NCT02559206|78921612|FG000|Overall Study|Withdrawal by Subject|3|||
44134546|NCT02559206|78921613|FG001|Overall Study|Withdrawal by Subject|3|||
44134547|NCT02559206|78921614|FG002|Overall Study|Withdrawal by Subject|1|||
44134548|NCT02559206|78921615|FG003|Overall Study|Withdrawal by Subject|3|||
44134549|NCT02559206|78921616|FG004|Overall Study|Withdrawal by Subject|5|||
44134550|NCT02559206|78921617|FG005|Overall Study|Withdrawal by Subject|4|||
44134551|NCT02559206|78921618|FG006|Overall Study|Withdrawal by Subject|1|||
44134552|NCT02559206|78921619|FG007|Overall Study|Withdrawal by Subject|2|||
44134553|NCT02559206|78921612|FG000|Overall Study|Lost to Follow-up|3|||
44134554|NCT02559206|78921613|FG001|Overall Study|Lost to Follow-up|5|||
44134555|NCT02559206|78921614|FG002|Overall Study|Lost to Follow-up|3|||
44134556|NCT02559206|78921615|FG003|Overall Study|Lost to Follow-up|3|||
44134557|NCT02559206|78921616|FG004|Overall Study|Lost to Follow-up|2|||
44134558|NCT02559206|78921617|FG005|Overall Study|Lost to Follow-up|5|||
44134559|NCT02559206|78921618|FG006|Overall Study|Lost to Follow-up|1|||
44134560|NCT02559206|78921619|FG007|Overall Study|Lost to Follow-up|4|||
44134561|NCT02559206|78921612|FG000|Overall Study|Lack of Efficacy|1|||
44134562|NCT02559206|78921613|FG001|Overall Study|Lack of Efficacy|0|||
44134563|NCT02559206|78921614|FG002|Overall Study|Lack of Efficacy|3|||
44134564|NCT02559206|78921615|FG003|Overall Study|Lack of Efficacy|2|||
44134565|NCT02559206|78921616|FG004|Overall Study|Lack of Efficacy|2|||
44134566|NCT02559206|78921617|FG005|Overall Study|Lack of Efficacy|3|||
44134567|NCT02559206|78921618|FG006|Overall Study|Lack of Efficacy|3|||
44134568|NCT02559206|78921619|FG007|Overall Study|Lack of Efficacy|3|||
44134569|NCT02559206|78921612|FG000|Overall Study|Other Not Specified|0|||
44513142|NCT03129100|79519005|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513143|NCT03129100|79519006|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44134570|NCT02559206|78921613|FG001|Overall Study|Other Not Specified|0|||
44380271|NCT00902304|79386129|FG000|Overall Study|Investigator discretion|3|||
44513144|NCT03129100|79519007|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44134571|NCT02559206|78921614|FG002|Overall Study|Other Not Specified|0|||
44134572|NCT02559206|78921615|FG003|Overall Study|Other Not Specified|1|||
44134573|NCT02559206|78921616|FG004|Overall Study|Other Not Specified|0|||
44134574|NCT02559206|78921617|FG005|Overall Study|Other Not Specified|0|||
44134575|NCT02559206|78921618|FG006|Overall Study|Other Not Specified|0|||
44134576|NCT02559206|78921619|FG007|Overall Study|Other Not Specified|0|||
44134577|NCT02558894|78921639|FG000|Overall Study|Death; any cause, entire study duration|28|||
44134578|NCT02558894|78921640|FG001|Overall Study|Death; any cause, entire study duration|31|||
44134579|NCT02558894|78921639|FG000|Overall Study|Withdrawal by Subject|2|||
44134580|NCT02558894|78921640|FG001|Overall Study|Withdrawal by Subject|1|||
44134581|NCT02558894|78921639|FG000|Overall Study|Closure of Part A|2|||
44134582|NCT02558894|78921640|FG001|Overall Study|Closure of Part A|1|||
44134583|NCT02688387|78921650|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134584|NCT02688387|78921651|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134585|NCT02688387|78921652|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
44134586|NCT02688387|78921653|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134587|NCT02688387|78921654|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134588|NCT02688387|78921655|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134589|NCT02688387|78921656|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134590|NCT02688387|78921657|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134591|NCT02688387|78921658|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134592|NCT02688387|78921659|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134593|NCT02688387|78921660|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134594|NCT02688387|78921661|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134595|NCT02688387|78921662|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134596|NCT02688387|78921663|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134597|NCT02688387|78921664|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134598|NCT02688387|78921665|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134599|NCT02688387|78921666|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134600|NCT02688387|78921667|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134601|NCT02688387|78921668|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134602|NCT02688387|78921669|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134603|NCT02688387|78921670|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134604|NCT02688387|78921671|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
44134605|NCT02688387|78921650|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134606|NCT02688387|78921651|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134607|NCT02688387|78921652|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134608|NCT02688387|78921653|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
44134609|NCT02688387|78921654|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134610|NCT02688387|78921655|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134611|NCT02688387|78921656|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134612|NCT02688387|78921657|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134613|NCT02688387|78921658|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134614|NCT02688387|78921659|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134615|NCT02688387|78921660|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134616|NCT02688387|78921661|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134617|NCT02688387|78921662|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134618|NCT02688387|78921663|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134619|NCT02688387|78921664|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134620|NCT02688387|78921665|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134621|NCT02688387|78921666|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134622|NCT02688387|78921667|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134623|NCT02688387|78921668|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134624|NCT02688387|78921669|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134625|NCT02688387|78921670|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134626|NCT02688387|78921671|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134627|NCT02688387|78921650|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134628|NCT02688387|78921651|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
44134629|NCT02688387|78921652|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134630|NCT02688387|78921653|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134631|NCT02688387|78921654|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134632|NCT02688387|78921655|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134633|NCT02688387|78921656|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134634|NCT02688387|78921657|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134635|NCT02688387|78921658|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134636|NCT02688387|78921659|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134637|NCT02688387|78921660|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134638|NCT02688387|78921661|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134639|NCT02688387|78921662|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134640|NCT02688387|78921663|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134641|NCT02688387|78921664|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134642|NCT02688387|78921665|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134643|NCT02688387|78921666|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134644|NCT02688387|78921667|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44243667|NCT01465997|79073317|FG001|Overall Study|Protocol Violation|4|||
44243668|NCT01465997|79073316|FG000|Overall Study|Lost to Follow-up|6|||
44513145|NCT03129100|79519008|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44243669|NCT01465997|79073317|FG001|Overall Study|Lost to Follow-up|9|||
44243670|NCT01465997|79073316|FG000|Overall Study|Withdrawal by Subject|32|||
44134645|NCT02688387|78921668|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134646|NCT02688387|78921669|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134647|NCT02688387|78921670|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134648|NCT02688387|78921671|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
44134649|NCT02688387|78921650|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134650|NCT02688387|78921651|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134651|NCT02688387|78921652|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
44134652|NCT02688387|78921653|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134653|NCT02688387|78921654|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
44134654|NCT02688387|78921655|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134655|NCT02688387|78921656|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134656|NCT02688387|78921657|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134657|NCT02688387|78921658|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134658|NCT02688387|78921659|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134659|NCT02688387|78921660|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134660|NCT02688387|78921661|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134661|NCT02688387|78921662|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134662|NCT02688387|78921663|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134663|NCT02688387|78921664|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134664|NCT02688387|78921665|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134665|NCT02688387|78921666|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134666|NCT02688387|78921667|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134667|NCT02688387|78921668|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134668|NCT02688387|78921669|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134669|NCT02688387|78921670|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134670|NCT02688387|78921671|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
44134671|NCT02688387|78921650|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
44134672|NCT02688387|78921651|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134673|NCT02688387|78921652|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134674|NCT02688387|78921653|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134675|NCT02688387|78921654|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134676|NCT02688387|78921655|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134677|NCT02688387|78921656|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134678|NCT02688387|78921657|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134679|NCT02688387|78921658|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134680|NCT02688387|78921659|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134681|NCT02688387|78921660|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134682|NCT02688387|78921661|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134683|NCT02688387|78921662|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134684|NCT02688387|78921663|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134685|NCT02688387|78921664|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134686|NCT02688387|78921665|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134687|NCT02688387|78921666|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134688|NCT02688387|78921667|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134689|NCT02688387|78921668|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134690|NCT02688387|78921669|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134691|NCT02688387|78921670|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134692|NCT02688387|78921671|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
44134693|NCT02688387|78921650|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134694|NCT02688387|78921651|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134695|NCT02688387|78921652|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134696|NCT02688387|78921653|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134697|NCT02688387|78921654|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134698|NCT02688387|78921655|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134699|NCT02688387|78921656|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134700|NCT02688387|78921657|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134701|NCT02688387|78921658|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134702|NCT02688387|78921659|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134703|NCT02688387|78921660|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
44134704|NCT02688387|78921661|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134705|NCT02688387|78921662|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134706|NCT02688387|78921663|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134707|NCT02688387|78921664|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134708|NCT02688387|78921665|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134709|NCT02688387|78921666|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134710|NCT02688387|78921667|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134711|NCT02688387|78921668|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134712|NCT02688387|78921669|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134713|NCT02688387|78921670|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134714|NCT02688387|78921671|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
44134715|NCT02688387|78921650|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134716|NCT02688387|78921651|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134717|NCT02688387|78921652|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134718|NCT02688387|78921653|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134719|NCT02688387|78921654|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134720|NCT02688387|78921655|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134721|NCT02688387|78921656|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134722|NCT02688387|78921657|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134723|NCT02688387|78921658|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134724|NCT02688387|78921659|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134725|NCT02688387|78921660|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134726|NCT02688387|78921661|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134727|NCT02688387|78921662|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134728|NCT02688387|78921663|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134729|NCT02688387|78921664|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
44134730|NCT02688387|78921665|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134731|NCT02688387|78921666|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134732|NCT02688387|78921667|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134733|NCT02688387|78921668|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134734|NCT02688387|78921669|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134735|NCT02688387|78921670|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134736|NCT02688387|78921671|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
44134737|NCT02688387|78921650|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134738|NCT02688387|78921651|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134739|NCT02688387|78921652|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134740|NCT02688387|78921653|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134741|NCT02688387|78921654|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134742|NCT02688387|78921655|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134743|NCT02688387|78921656|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134744|NCT02688387|78921657|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134745|NCT02688387|78921658|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134746|NCT02688387|78921659|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134747|NCT02688387|78921660|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134748|NCT02688387|78921661|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134749|NCT02688387|78921662|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134750|NCT02688387|78921663|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134751|NCT02688387|78921664|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134752|NCT02688387|78921665|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134753|NCT02688387|78921666|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134754|NCT02688387|78921667|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134755|NCT02688387|78921668|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134756|NCT02688387|78921669|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134757|NCT02688387|78921670|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
44134758|NCT02688387|78921671|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
44134759|NCT02688387|78921650|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134760|NCT02688387|78921651|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134761|NCT02688387|78921652|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134762|NCT02688387|78921653|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134763|NCT02688387|78921654|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134764|NCT02688387|78921655|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134765|NCT02688387|78921656|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134766|NCT02688387|78921657|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134767|NCT02688387|78921658|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134768|NCT02688387|78921659|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44243671|NCT01465997|79073317|FG001|Overall Study|Withdrawal by Subject|35|||
44243672|NCT01465997|79073316|FG000|Overall Study|investigator's decision|1|||
44243673|NCT01465997|79073317|FG001|Overall Study|investigator's decision|1|||
44243674|NCT01465997|79073316|FG000|Overall Study|Death|0|||
44134769|NCT02688387|78921660|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134770|NCT02688387|78921661|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134771|NCT02688387|78921662|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44243675|NCT01465997|79073317|FG001|Overall Study|Death|1|||
44243676|NCT01465997|79073316|FG000|Overall Study|sponsor's decision|1|||
44243677|NCT01465997|79073317|FG001|Overall Study|sponsor's decision|1|||
44243678|NCT01465997|79073316|FG000|Overall Study|subject withdrew consent|1|||
44243679|NCT01465997|79073317|FG001|Overall Study|subject withdrew consent|0|||
44243680|NCT01465997|79073316|FG000|Overall Study|local lab unblinded site|1|||
44243681|NCT01465997|79073317|FG001|Overall Study|local lab unblinded site|0|||
44134772|NCT02688387|78921663|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134773|NCT02688387|78921664|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134774|NCT02688387|78921665|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134775|NCT02688387|78921666|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134776|NCT02688387|78921667|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134777|NCT02688387|78921668|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
44134778|NCT02688387|78921669|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134779|NCT02688387|78921670|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
44134780|NCT02688387|78921671|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
44134781|NCT02688387|78921650|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134782|NCT02688387|78921651|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134783|NCT02688387|78921652|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134784|NCT02688387|78921653|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134785|NCT02688387|78921654|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134786|NCT02688387|78921655|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134787|NCT02688387|78921656|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44243682|NCT01465997|79073316|FG000|Overall Study|withdrew before follow-up|0|||
44513146|NCT03129100|79519009|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513147|NCT03129100|79519010|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44134788|NCT02688387|78921657|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44243683|NCT01465997|79073317|FG001|Overall Study|withdrew before follow-up|13|||
44243684|NCT01465997|79073316|FG000|Overall Study|decision by site staff|0|||
44243685|NCT01465997|79073317|FG001|Overall Study|decision by site staff|1|||
44134789|NCT02688387|78921658|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134790|NCT02688387|78921659|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134791|NCT02688387|78921660|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134792|NCT02688387|78921661|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134793|NCT02688387|78921662|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134794|NCT02688387|78921663|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134795|NCT02688387|78921664|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134796|NCT02688387|78921665|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134797|NCT02688387|78921666|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134798|NCT02688387|78921667|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134799|NCT02688387|78921668|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134800|NCT02688387|78921669|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
44134801|NCT02688387|78921670|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134802|NCT02688387|78921671|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
44134803|NCT02476201|78921717|FG000|Overall Study|Unable to program MPP|9|||
44134804|NCT02476201|78921717|FG000|Overall Study|Study echo not performed|5|||
44134805|NCT02476201|78921717|FG000|Overall Study|Adverse Event|4|||
44134806|NCT02476201|78921717|FG000|Overall Study|Death|2|||
44134807|NCT02476201|78921717|FG000|Overall Study|Lost to Follow-up|2|||
44134808|NCT02476201|78921717|FG000|Overall Study|MPP programmed to OFF|2|||
44134809|NCT02476201|78921717|FG000|Overall Study|Withdrawal by Subject|1|||
44134810|NCT02476201|78921717|FG000|Overall Study|Unsuccessful implant|1|||
44134811|NCT02688153|78921724|FG000|Overall Study|Death|7|||
44134812|NCT02688153|78921725|FG001|Overall Study|Death|5|||
44134813|NCT02688153|78921724|FG000|Overall Study|Withdrawal by Subject|4|||
44134814|NCT02688153|78921725|FG001|Overall Study|Withdrawal by Subject|2|||
44134815|NCT02688153|78921724|FG000|Overall Study|Valve Explant|1|||
44134816|NCT02688153|78921725|FG001|Overall Study|Valve Explant|0|||
44134817|NCT02688153|78921724|FG000|Overall Study|Conversion to Commercial Valve|3|||
44134818|NCT02688153|78921725|FG001|Overall Study|Conversion to Commercial Valve|0|||
44134819|NCT02687919|78921734|FG000|Overall Study|Withdrawal by Subject|6|||
44134820|NCT02687919|78921735|FG001|Overall Study|Withdrawal by Subject|6|||
44134821|NCT02687919|78921734|FG000|Overall Study|Protocol Violation|2|||
44134822|NCT02687919|78921735|FG001|Overall Study|Protocol Violation|0|||
44134823|NCT02687451|78921747|FG000|Overall Study|Withdrawal by Subject|1|||
44134824|NCT02687451|78921748|FG001|Overall Study|Withdrawal by Subject|0|||
44134825|NCT02687451|78921749|FG002|Overall Study|Withdrawal by Subject|0|||
44134826|NCT02687451|78921750|FG003|Overall Study|Withdrawal by Subject|0|||
44134827|NCT02687451|78921751|FG004|Overall Study|Withdrawal by Subject|0|||
44134828|NCT02687451|78921752|FG005|Overall Study|Withdrawal by Subject|1|||
44513148|NCT03129100|79519011|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44134829|NCT02557646|78921768|FG000|Overall Study|Adverse Event|40|||
44134830|NCT02557646|78921768|FG000|Overall Study|Death|1|||
44134831|NCT02557646|78921768|FG000|Overall Study|Lack of Efficacy|186|||
44134832|NCT02557646|78921768|FG000|Overall Study|Withdrawal by Subject|18|||
44513149|NCT03129100|79519012|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513150|NCT03129100|79519013|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513151|NCT03129100|79519014|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513152|NCT03129100|79519015|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513153|NCT03129100|79519016|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513154|NCT03129100|79519017|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513155|NCT03129100|79519018|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513156|NCT03129100|79519019|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513157|NCT03129100|79519020|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513158|NCT03129100|79519021|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513159|NCT03129100|79519022|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513160|NCT03129100|79519023|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513161|NCT03129100|79519024|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44134833|NCT02557646|78921768|FG000|Overall Study|Lost to Follow-up|17|||
44134834|NCT02557646|78921768|FG000|Overall Study|Other|14|||
44134835|NCT02679573|78921774|FG000|Overall Study|Adverse Event|13|||
44134836|NCT02679573|78921775|FG001|Overall Study|Adverse Event|6|||
44134837|NCT02679573|78921774|FG000|Overall Study|Lack of Efficacy|12|||
44134838|NCT02679573|78921775|FG001|Overall Study|Lack of Efficacy|15|||
44134839|NCT02679573|78921774|FG000|Overall Study|Could not complete required study visits|6|||
44134840|NCT02679573|78921775|FG001|Overall Study|Could not complete required study visits|2|||
44134841|NCT02679573|78921774|FG000|Overall Study|Withdrawal by Subject|2|||
44134842|NCT02679573|78921775|FG001|Overall Study|Withdrawal by Subject|9|||
44134843|NCT02679573|78921774|FG000|Overall Study|Death|2|||
44380272|NCT00902304|79386130|FG001|Overall Study|Investigator discretion|5|||
44380273|NCT00902304|79386131|FG002|Overall Study|Investigator discretion|13|||
44380274|NCT00902304|79386129|FG000|Overall Study|Lost to Follow-up|7|||
44380275|NCT00902304|79386130|FG001|Overall Study|Lost to Follow-up|7|||
44380276|NCT00902304|79386131|FG002|Overall Study|Lost to Follow-up|7|||
44380277|NCT00902304|79386129|FG000|Overall Study|Protocol Violation|9|||
44380278|NCT00902304|79386130|FG001|Overall Study|Protocol Violation|18|||
44380279|NCT00902304|79386131|FG002|Overall Study|Protocol Violation|20|||
44513162|NCT03129100|79519025|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
44513163|NCT03129100|79519000|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
44134844|NCT02679573|78921775|FG001|Overall Study|Death|0|||
44134845|NCT02679573|78921774|FG000|Overall Study|Physician Decision|2|||
44134846|NCT02679573|78921775|FG001|Overall Study|Physician Decision|4|||
44134847|NCT02679573|78921774|FG000|Overall Study|Lost to Follow-up|0|||
44134848|NCT02679573|78921775|FG001|Overall Study|Lost to Follow-up|3|||
44134849|NCT02685033|78921783|FG000|Overall Study|Withdrawal of Consent|0|||
44134850|NCT02685033|78921784|FG001|Overall Study|Withdrawal of Consent|1|||
44134851|NCT02685033|78921783|FG000|Overall Study|Lost to Follow-up|2|||
44134852|NCT02685033|78921784|FG001|Overall Study|Lost to Follow-up|1|||
44134853|NCT02685033|78921783|FG000|Overall Study|Adverse Event|1|||
44134854|NCT02685033|78921784|FG001|Overall Study|Adverse Event|0|||
44134855|NCT02684097|78921792|FG000|Overall Study|Lack of Efficacy|13|||
44134856|NCT02684097|78921793|FG001|Overall Study|Lack of Efficacy|6|||
44134857|NCT02555618|78921801|FG000|Overall Study|Sponsor's Circumstances|1|||
44134858|NCT02555618|78921802|FG001|Overall Study|Sponsor's Circumstances|0|||
44134859|NCT02557100|78921828|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
44134860|NCT02557100|78921829|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
44134861|NCT02557100|78921830|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
44134862|NCT02557100|78921828|FG000|Single Blind Treatment Period|Death|0|||
44134863|NCT02557100|78921829|FG001|Single Blind Treatment Period|Death|1|||
44134864|NCT02557100|78921830|FG002|Single Blind Treatment Period|Death|0|||
44134865|NCT02557100|78921828|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
44134866|NCT02557100|78921829|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
44134867|NCT02557100|78921830|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
44134868|NCT02557100|78921828|FG000|Single Blind Treatment Period|Adverse Event|0|||
44134869|NCT02557100|78921829|FG001|Single Blind Treatment Period|Adverse Event|1|||
44134870|NCT02557100|78921830|FG002|Single Blind Treatment Period|Adverse Event|0|||
44134871|NCT02557100|78921828|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
44134872|NCT02557100|78921829|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
44134873|NCT02557100|78921830|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
44513164|NCT03129100|79519001|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
44513165|NCT03129100|79519002|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513166|NCT03129100|79519003|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513167|NCT03129100|79519004|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513168|NCT03129100|79519005|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513169|NCT03129100|79519006|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513170|NCT03129100|79519007|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44134874|NCT02557100|78921828|FG000|Cumulative Abatacept Period|Other Reasons|0|||
44134875|NCT02557100|78921829|FG001|Cumulative Abatacept Period|Other Reasons|0|||
44134876|NCT02557100|78921830|FG002|Cumulative Abatacept Period|Other Reasons|1|||
44380280|NCT00902304|79386129|FG000|Overall Study|Withdrawal by Subject|32|||
44380281|NCT00902304|79386130|FG001|Overall Study|Withdrawal by Subject|22|||
44513171|NCT03129100|79519008|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44134877|NCT02557100|78921828|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
44134878|NCT02557100|78921829|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
44134879|NCT02557100|78921830|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
44134880|NCT02557100|78921828|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
44134881|NCT02557100|78921829|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
44134882|NCT02557100|78921830|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
44134883|NCT01337635|78921840|FG000|Overall Study|Lost to Follow-up|0|||
44134884|NCT01337635|78921841|FG001|Overall Study|Lost to Follow-up|1|||
44134885|NCT02556710|78921849|FG000|Overall Study|Surgical treatment|3|||
44134886|NCT02556710|78921850|FG001|Overall Study|Surgical treatment|0|||
44134887|NCT02556710|78921849|FG000|Overall Study|Required proscribed pain medication|2|||
44134888|NCT02556710|78921850|FG001|Overall Study|Required proscribed pain medication|1|||
44134889|NCT02556710|78921849|FG000|Overall Study|Lack of Efficacy|1|||
44134890|NCT02556710|78921850|FG001|Overall Study|Lack of Efficacy|0|||
44134891|NCT02556710|78921849|FG000|Overall Study|Worsening osteoarthritis|1|||
44134892|NCT02556710|78921850|FG001|Overall Study|Worsening osteoarthritis|0|||
44134893|NCT02556710|78921849|FG000|Overall Study|Moved out of state|1|||
44134894|NCT02556710|78921850|FG001|Overall Study|Moved out of state|0|||
44134895|NCT02556710|78921849|FG000|Overall Study|Missing reason|3|||
44134896|NCT02556710|78921850|FG001|Overall Study|Missing reason|1|||
44134897|NCT02556710|78921849|FG000|Overall Study|Pain as lack of efficacy|0|||
44134898|NCT02556710|78921850|FG001|Overall Study|Pain as lack of efficacy|4|||
44134899|NCT02556632|78921861|FG000|Overall Study|Lost to Follow-up|1|||
44134900|NCT02556632|78921862|FG001|Overall Study|Lost to Follow-up|0|||
44134901|NCT02556632|78921863|FG002|Overall Study|Lost to Follow-up|0|||
44134902|NCT02556632|78921861|FG000|Overall Study|Disliked Intervention|1|||
44134903|NCT02556632|78921862|FG001|Overall Study|Disliked Intervention|1|||
44134904|NCT02556632|78921863|FG002|Overall Study|Disliked Intervention|1|||
44134905|NCT02556632|78921861|FG000|Overall Study|No Reason|1|||
44134906|NCT02556632|78921862|FG001|Overall Study|No Reason|0|||
44134907|NCT02556632|78921863|FG002|Overall Study|No Reason|1|||
44134908|NCT02556632|78921861|FG000|Overall Study|Personal Issues|0|||
44134909|NCT02556632|78921862|FG001|Overall Study|Personal Issues|1|||
44134910|NCT02556632|78921863|FG002|Overall Study|Personal Issues|1|||
44134911|NCT02556632|78921861|FG000|Overall Study|Changed Mind|0|||
44134912|NCT02556632|78921862|FG001|Overall Study|Changed Mind|1|||
44134913|NCT02556632|78921863|FG002|Overall Study|Changed Mind|0|||
44134914|NCT02556632|78921861|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
44134915|NCT02556632|78921862|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
44134916|NCT02556632|78921863|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
44134917|NCT02556632|78921861|FG000|Overall Study|Unrelated Adverse Event|1|||
44134918|NCT02556632|78921862|FG001|Overall Study|Unrelated Adverse Event|0|||
44134919|NCT02556632|78921863|FG002|Overall Study|Unrelated Adverse Event|3|||
44134920|NCT02556632|78921861|FG000|Overall Study|Related Adverse Event|0|||
44134921|NCT02556632|78921862|FG001|Overall Study|Related Adverse Event|1|||
44134922|NCT02556632|78921863|FG002|Overall Study|Related Adverse Event|0|||
44134923|NCT02556632|78921861|FG000|Overall Study|Possibly Related Adverse Event|0|||
44134924|NCT02556632|78921862|FG001|Overall Study|Possibly Related Adverse Event|0|||
44134925|NCT02556632|78921863|FG002|Overall Study|Possibly Related Adverse Event|1|||
44134926|NCT02556632|78921861|FG000|Overall Study|Did Not Start RT|0|||
44134927|NCT02556632|78921862|FG001|Overall Study|Did Not Start RT|1|||
44134928|NCT02556632|78921863|FG002|Overall Study|Did Not Start RT|0|||
44134929|NCT02556632|78921861|FG000|Overall Study|Ineligible|0|||
44134930|NCT02556632|78921862|FG001|Overall Study|Ineligible|1|||
44134931|NCT02556632|78921863|FG002|Overall Study|Ineligible|0|||
44134932|NCT02556632|78921861|FG000|Overall Study|Disliked Study Procedures|0|||
44134933|NCT02556632|78921862|FG001|Overall Study|Disliked Study Procedures|0|||
44134934|NCT02556632|78921863|FG002|Overall Study|Disliked Study Procedures|1|||
44513172|NCT03129100|79519009|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513173|NCT03129100|79519010|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44134935|NCT02556632|78921861|FG000|Overall Study|Treatment or Change Delay|0|||
44134936|NCT02556632|78921862|FG001|Overall Study|Treatment or Change Delay|0|||
44134937|NCT02556632|78921863|FG002|Overall Study|Treatment or Change Delay|1|||
44134938|NCT01662440|78921875|FG000|Overall Study|Adverse Event|1|||
44134939|NCT01662440|78921876|FG001|Overall Study|Adverse Event|0|||
44134940|NCT01662440|78921877|FG002|Overall Study|Adverse Event|0|||
44134941|NCT01662440|78921878|FG003|Overall Study|Adverse Event|1|||
44134942|NCT01662440|78921875|FG000|Overall Study|Death|0|||
44134943|NCT01662440|78921876|FG001|Overall Study|Death|1|||
44134944|NCT01662440|78921877|FG002|Overall Study|Death|0|||
44134945|NCT01662440|78921878|FG003|Overall Study|Death|0|||
44134946|NCT01662440|78921875|FG000|Overall Study|Lost to Follow-up|2|||
44134947|NCT01662440|78921876|FG001|Overall Study|Lost to Follow-up|2|||
44134948|NCT01662440|78921877|FG002|Overall Study|Lost to Follow-up|4|||
44134949|NCT01662440|78921878|FG003|Overall Study|Lost to Follow-up|1|||
44134950|NCT01662440|78921875|FG000|Overall Study|Subject moved to another country.|0|||
44243686|NCT01465997|79073316|FG000|Overall Study|subject left participation SP0993|0|||
44134951|NCT01662440|78921876|FG001|Overall Study|Subject moved to another country.|1|||
44134952|NCT01662440|78921877|FG002|Overall Study|Subject moved to another country.|0|||
44134953|NCT01662440|78921878|FG003|Overall Study|Subject moved to another country.|0|||
44134954|NCT01662440|78921875|FG000|Overall Study|Protocol Violation|1|||
44134955|NCT01662440|78921876|FG001|Overall Study|Protocol Violation|0|||
44134956|NCT01662440|78921877|FG002|Overall Study|Protocol Violation|0|||
44134957|NCT01662440|78921878|FG003|Overall Study|Protocol Violation|0|||
44134958|NCT01662440|78921875|FG000|Overall Study|Withdrawal by Subject|5|||
44134959|NCT01662440|78921876|FG001|Overall Study|Withdrawal by Subject|2|||
44134960|NCT01662440|78921877|FG002|Overall Study|Withdrawal by Subject|2|||
44134961|NCT01662440|78921878|FG003|Overall Study|Withdrawal by Subject|2|||
44134962|NCT01662362|78921898|FG000|Overall Study|Lost to Follow-up|38|||
44134963|NCT02554682|78921913|FG000|Overall Study|Lost to Follow-up|11|||
44134964|NCT02554682|78921914|FG001|Overall Study|Lost to Follow-up|9|||
44134965|NCT02554682|78921915|FG002|Overall Study|Lost to Follow-up|4|||
44134966|NCT02554682|78921916|FG003|Overall Study|Lost to Follow-up|3|||
44134967|NCT02554682|78921917|FG004|Overall Study|Lost to Follow-up|2|||
44134968|NCT02554682|78921918|FG005|Overall Study|Lost to Follow-up|1|||
44134969|NCT02554682|78921919|FG006|Overall Study|Lost to Follow-up|6|||
44134970|NCT02554682|78921920|FG007|Overall Study|Lost to Follow-up|6|||
44134971|NCT02554682|78921921|FG008|Overall Study|Lost to Follow-up|2|||
44134972|NCT02554682|78921922|FG009|Overall Study|Lost to Follow-up|2|||
44134973|NCT02554682|78921913|FG000|Overall Study|Withdrawal by Subject|2|||
44134974|NCT02554682|78921914|FG001|Overall Study|Withdrawal by Subject|1|||
44134975|NCT02554682|78921915|FG002|Overall Study|Withdrawal by Subject|0|||
44134976|NCT02554682|78921916|FG003|Overall Study|Withdrawal by Subject|0|||
44134977|NCT02554682|78921917|FG004|Overall Study|Withdrawal by Subject|0|||
44134978|NCT02554682|78921918|FG005|Overall Study|Withdrawal by Subject|0|||
44134979|NCT02554682|78921919|FG006|Overall Study|Withdrawal by Subject|0|||
44134980|NCT02554682|78921920|FG007|Overall Study|Withdrawal by Subject|0|||
44134981|NCT02554682|78921921|FG008|Overall Study|Withdrawal by Subject|0|||
44134982|NCT02554682|78921922|FG009|Overall Study|Withdrawal by Subject|0|||
44134983|NCT02554682|78921913|FG000|Overall Study|Physician Decision|2|||
44134984|NCT02554682|78921914|FG001|Overall Study|Physician Decision|2|||
44134985|NCT02554682|78921915|FG002|Overall Study|Physician Decision|0|||
44134986|NCT02554682|78921916|FG003|Overall Study|Physician Decision|0|||
44134987|NCT02554682|78921917|FG004|Overall Study|Physician Decision|0|||
44134988|NCT02554682|78921918|FG005|Overall Study|Physician Decision|0|||
44380282|NCT00902304|79386131|FG002|Overall Study|Withdrawal by Subject|43|||
44380283|NCT00902304|79386129|FG000|Overall Study|includes pregnancy|3|||
44134989|NCT02554682|78921919|FG006|Overall Study|Physician Decision|0|||
44134990|NCT02554682|78921920|FG007|Overall Study|Physician Decision|0|||
44134991|NCT02554682|78921921|FG008|Overall Study|Physician Decision|0|||
44134992|NCT02554682|78921922|FG009|Overall Study|Physician Decision|0|||
44134993|NCT00154063|78921958|FG000|Overall Study|Adverse Event|4|||
44134994|NCT00154063|78921959|FG001|Overall Study|Adverse Event|8|||
44134995|NCT00154063|78921958|FG000|Overall Study|Protocol Violation|1|||
44380284|NCT00902304|79386130|FG001|Overall Study|includes pregnancy|9|||
44380285|NCT00902304|79386131|FG002|Overall Study|includes pregnancy|2|||
44134996|NCT00154063|78921959|FG001|Overall Study|Protocol Violation|1|||
44134997|NCT00154063|78921958|FG000|Overall Study|Investigator or Sponsor Request|0|||
44134998|NCT00154063|78921959|FG001|Overall Study|Investigator or Sponsor Request|1|||
44134999|NCT00154063|78921958|FG000|Overall Study|Withdrawal by Subject|4|||
44135000|NCT00154063|78921959|FG001|Overall Study|Withdrawal by Subject|9|||
44135001|NCT00154063|78921958|FG000|Overall Study|Other|3|||
44135002|NCT00154063|78921959|FG001|Overall Study|Other|3|||
44135003|NCT02683941|78921971|FG000|Double-blind Phase|Adverse Event|0|||
44135004|NCT02683941|78921972|FG001|Double-blind Phase|Adverse Event|1|||
44135005|NCT02683941|78921971|FG000|Double-blind Phase|Withdrawal by Subject|4|||
44135006|NCT02683941|78921972|FG001|Double-blind Phase|Withdrawal by Subject|2|||
44135007|NCT02683941|78921971|FG000|Double-blind Phase|Lost to Follow-up|1|||
44135008|NCT02683941|78921972|FG001|Double-blind Phase|Lost to Follow-up|0|||
44135009|NCT02683941|78921971|FG000|Double-blind Phase|Disease Progression|5|||
44135010|NCT02683941|78921972|FG001|Double-blind Phase|Disease Progression|2|||
44135011|NCT02683941|78921971|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
44135012|NCT02683941|78921972|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
44135013|NCT02683941|78921971|FG000|Open-label Treatment Phase|Disease Progression|1|||
44135014|NCT02683941|78921972|FG001|Open-label Treatment Phase|Disease Progression|2|||
44135015|NCT02683941|78921971|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
44135016|NCT02683941|78921972|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
44135017|NCT02683941|78921971|FG000|Open-label Treatment Phase|Other|1|||
44135018|NCT02683941|78921972|FG001|Open-label Treatment Phase|Other|0|||
44135019|NCT02683941|78921971|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
44135020|NCT02683941|78921972|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
44135021|NCT02683941|78921971|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
44135022|NCT02683941|78921972|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
44135023|NCT02683941|78921971|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
44135024|NCT02683941|78921972|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
44135025|NCT02683941|78921971|FG000|Open-label Follow-up Phase|Other|8|||
44135026|NCT02683941|78921972|FG001|Open-label Follow-up Phase|Other|1|||
44135027|NCT02678247|78921984|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
44135028|NCT02678247|78921985|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
44135029|NCT02678247|78921984|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
44135030|NCT02678247|78921985|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
44135031|NCT02678247|78921984|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
44276599|NCT04791319|79237615|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44513174|NCT03129100|79519011|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513175|NCT03129100|79519012|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513176|NCT03129100|79519013|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513177|NCT03129100|79519014|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513178|NCT03129100|79519015|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513179|NCT03129100|79519016|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513180|NCT03129100|79519017|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513181|NCT03129100|79519018|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513182|NCT03129100|79519019|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513183|NCT03129100|79519020|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513184|NCT03129100|79519021|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513185|NCT03129100|79519022|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513186|NCT03129100|79519023|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513187|NCT03129100|79519024|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513188|NCT03129100|79519025|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
44513189|NCT03129100|79519000|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
44513190|NCT03129100|79519001|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
44513191|NCT03129100|79519002|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513192|NCT03129100|79519003|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513193|NCT03129100|79519004|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513194|NCT03129100|79519005|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513195|NCT03129100|79519006|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513196|NCT03129100|79519007|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513197|NCT03129100|79519008|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513198|NCT03129100|79519009|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513199|NCT03129100|79519010|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513200|NCT03129100|79519011|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513201|NCT03129100|79519012|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513202|NCT03129100|79519013|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513203|NCT03129100|79519014|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513204|NCT03129100|79519015|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513205|NCT03129100|79519016|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44135032|NCT02678247|78921985|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
44135033|NCT02678247|78921984|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
44135034|NCT02678247|78921985|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
44135035|NCT02678247|78921984|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
44135036|NCT02678247|78921985|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
44135037|NCT02678247|78921984|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
44135038|NCT02678247|78921985|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
44135039|NCT02683785|78921998|FG000|Overall Study|Withdrawal by Subject|1|||
44135040|NCT02683785|78921999|FG001|Overall Study|Withdrawal by Subject|1|||
44135041|NCT02683785|78921998|FG000|Overall Study|Lost to Follow-up|0|||
44135042|NCT02683785|78921999|FG001|Overall Study|Lost to Follow-up|1|||
44135043|NCT02683785|78921998|FG000|Overall Study|Adverse Event|0|||
44135044|NCT02683785|78921999|FG001|Overall Study|Adverse Event|2|||
44135045|NCT02543294|78922007|FG000|Overall Study|Lost to Follow-up|3|||
44135046|NCT02543294|78922007|FG000|Overall Study|Physician Decision|2|||
44135047|NCT02543294|78922007|FG000|Overall Study|Withdrawal by Subject|7|||
44135048|NCT02551874|78922014|FG000|Overall Study|Lost to Follow-up|0|||
44135049|NCT02551874|78922015|FG001|Overall Study|Lost to Follow-up|2|||
44135050|NCT02551874|78922014|FG000|Overall Study|Pregnancy|0|||
44135051|NCT02551874|78922015|FG001|Overall Study|Pregnancy|1|||
44135052|NCT02551874|78922014|FG000|Overall Study|Reason not reported|10|||
44135053|NCT02551874|78922015|FG001|Overall Study|Reason not reported|4|||
44135054|NCT02551874|78922014|FG000|Overall Study|Did not receive randomized treatment|0|||
44135055|NCT02551874|78922015|FG001|Overall Study|Did not receive randomized treatment|7|||
44135056|NCT02551874|78922014|FG000|Overall Study|Did not enter long-term study|18|||
44135057|NCT02551874|78922015|FG001|Overall Study|Did not enter long-term study|25|||
44135058|NCT02550938|78922038|FG000|Overall Study|Lost to Follow-up|8|||
44135059|NCT02550938|78922039|FG001|Overall Study|Lost to Follow-up|7|||
44135060|NCT02550938|78922040|FG002|Overall Study|Lost to Follow-up|12|||
44135061|NCT02550938|78922041|FG003|Overall Study|Lost to Follow-up|11|||
44135062|NCT02769065|78922081|FG000|Overall Study|Voluntary Withdrawal|1|||
44135063|NCT02769065|78922082|FG001|Overall Study|Voluntary Withdrawal|0|||
44135064|NCT02769065|78922083|FG002|Overall Study|Voluntary Withdrawal|0|||
44135065|NCT02769065|78922084|FG003|Overall Study|Voluntary Withdrawal|0|||
44135066|NCT02769065|78922085|FG004|Overall Study|Voluntary Withdrawal|0|||
44135067|NCT02769065|78922086|FG005|Overall Study|Voluntary Withdrawal|0|||
44135068|NCT02769065|78922087|FG006|Overall Study|Voluntary Withdrawal|0|||
44513206|NCT03129100|79519017|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513207|NCT03129100|79519018|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513208|NCT03129100|79519019|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513209|NCT03129100|79519020|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44135069|NCT02769065|78922088|FG007|Overall Study|Voluntary Withdrawal|0|||
44513210|NCT03129100|79519021|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513211|NCT03129100|79519022|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513212|NCT03129100|79519023|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513213|NCT03129100|79519024|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513214|NCT03129100|79519025|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
44513215|NCT03129100|79519000|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513216|NCT03129100|79519001|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
44513217|NCT03129100|79519002|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513218|NCT03129100|79519003|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135070|NCT02769065|78922089|FG008|Overall Study|Voluntary Withdrawal|0|||
44135071|NCT02769065|78922090|FG009|Overall Study|Voluntary Withdrawal|0|||
44135072|NCT02769065|78922091|FG010|Overall Study|Voluntary Withdrawal|0|||
44135073|NCT02769065|78922092|FG011|Overall Study|Voluntary Withdrawal|0|||
44135074|NCT02769065|78922093|FG012|Overall Study|Voluntary Withdrawal|0|||
44135075|NCT02769065|78922094|FG013|Overall Study|Voluntary Withdrawal|0|||
44135076|NCT02769065|78922095|FG014|Overall Study|Voluntary Withdrawal|0|||
44135077|NCT02769065|78922096|FG015|Overall Study|Voluntary Withdrawal|0|||
44135078|NCT02769065|78922097|FG016|Overall Study|Voluntary Withdrawal|0|||
44135079|NCT02769065|78922098|FG017|Overall Study|Voluntary Withdrawal|0|||
44135080|NCT02769065|78922099|FG018|Overall Study|Voluntary Withdrawal|0|||
44135081|NCT02769065|78922100|FG019|Overall Study|Voluntary Withdrawal|0|||
44135082|NCT02769065|78922101|FG020|Overall Study|Voluntary Withdrawal|0|||
44135083|NCT02769065|78922102|FG021|Overall Study|Voluntary Withdrawal|0|||
44135084|NCT02769065|78922103|FG022|Overall Study|Voluntary Withdrawal|0|||
44135085|NCT02769065|78922104|FG023|Overall Study|Voluntary Withdrawal|0|||
44135086|NCT02769065|78922105|FG024|Overall Study|Voluntary Withdrawal|0|||
44135087|NCT02769065|78922106|FG025|Overall Study|Voluntary Withdrawal|0|||
44135088|NCT02769065|78922107|FG026|Overall Study|Voluntary Withdrawal|0|||
44135089|NCT02769065|78922108|FG027|Overall Study|Voluntary Withdrawal|0|||
44135090|NCT02769065|78922109|FG028|Overall Study|Voluntary Withdrawal|0|||
44135091|NCT02769065|78922110|FG029|Overall Study|Voluntary Withdrawal|0|||
44135092|NCT02769065|78922081|FG000|Overall Study|Reason Not Specified|0|||
44135093|NCT02769065|78922082|FG001|Overall Study|Reason Not Specified|0|||
44135094|NCT02769065|78922083|FG002|Overall Study|Reason Not Specified|0|||
44135095|NCT02769065|78922084|FG003|Overall Study|Reason Not Specified|0|||
44135096|NCT02769065|78922085|FG004|Overall Study|Reason Not Specified|0|||
44135097|NCT02769065|78922086|FG005|Overall Study|Reason Not Specified|0|||
44135098|NCT02769065|78922087|FG006|Overall Study|Reason Not Specified|1|||
44135099|NCT02769065|78922088|FG007|Overall Study|Reason Not Specified|0|||
44135100|NCT02769065|78922089|FG008|Overall Study|Reason Not Specified|0|||
44135101|NCT02769065|78922090|FG009|Overall Study|Reason Not Specified|0|||
44135102|NCT02769065|78922091|FG010|Overall Study|Reason Not Specified|0|||
44135103|NCT02769065|78922092|FG011|Overall Study|Reason Not Specified|0|||
44135104|NCT02769065|78922093|FG012|Overall Study|Reason Not Specified|0|||
44135105|NCT02769065|78922094|FG013|Overall Study|Reason Not Specified|0|||
44135106|NCT02769065|78922095|FG014|Overall Study|Reason Not Specified|0|||
44135107|NCT02769065|78922096|FG015|Overall Study|Reason Not Specified|0|||
44135108|NCT02769065|78922097|FG016|Overall Study|Reason Not Specified|0|||
44135109|NCT02769065|78922098|FG017|Overall Study|Reason Not Specified|0|||
44135110|NCT02769065|78922099|FG018|Overall Study|Reason Not Specified|0|||
44135111|NCT02769065|78922100|FG019|Overall Study|Reason Not Specified|0|||
44135112|NCT02769065|78922101|FG020|Overall Study|Reason Not Specified|0|||
44135113|NCT02769065|78922102|FG021|Overall Study|Reason Not Specified|0|||
44135114|NCT02769065|78922103|FG022|Overall Study|Reason Not Specified|0|||
44135115|NCT02769065|78922104|FG023|Overall Study|Reason Not Specified|0|||
44135116|NCT02769065|78922105|FG024|Overall Study|Reason Not Specified|0|||
44135117|NCT02769065|78922106|FG025|Overall Study|Reason Not Specified|0|||
44135118|NCT02769065|78922107|FG026|Overall Study|Reason Not Specified|0|||
44135119|NCT02769065|78922108|FG027|Overall Study|Reason Not Specified|0|||
44135120|NCT02769065|78922109|FG028|Overall Study|Reason Not Specified|0|||
44135121|NCT02769065|78922110|FG029|Overall Study|Reason Not Specified|0|||
44135122|NCT02769065|78922081|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135123|NCT02769065|78922082|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135124|NCT02769065|78922083|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135125|NCT02769065|78922084|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135126|NCT02769065|78922085|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135127|NCT02769065|78922086|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135128|NCT02769065|78922087|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135129|NCT02769065|78922088|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135130|NCT02769065|78922089|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135131|NCT02769065|78922090|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135132|NCT02769065|78922091|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
44380286|NCT00759109|79386142|FG000|Overall Study|Adverse Event|17|||
44135133|NCT02769065|78922092|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135134|NCT02769065|78922093|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135135|NCT02769065|78922094|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135136|NCT02769065|78922095|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135137|NCT02769065|78922096|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135138|NCT02769065|78922097|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135139|NCT02769065|78922098|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135140|NCT02769065|78922099|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135141|NCT02769065|78922100|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135142|NCT02769065|78922101|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135143|NCT02769065|78922102|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135144|NCT02769065|78922103|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135145|NCT02769065|78922104|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135146|NCT02769065|78922105|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135147|NCT02769065|78922106|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135148|NCT02769065|78922107|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135149|NCT02769065|78922108|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135150|NCT02769065|78922109|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135151|NCT02769065|78922110|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
44135152|NCT02681523|78922203|FG000|Overall Study|Adverse Event|1|||
44135153|NCT02681523|78922203|FG000|Overall Study|Patient Non-compliance|1|||
44135154|NCT02540954|78922209|FG000|Overall Study|Physician Decision|3|||
44135155|NCT02540954|78922210|FG001|Overall Study|Physician Decision|1|||
44135156|NCT02540954|78922209|FG000|Overall Study|Withdrawal by Subject|6|||
44135157|NCT02540954|78922210|FG001|Overall Study|Withdrawal by Subject|5|||
44135158|NCT02540954|78922209|FG000|Overall Study|Lost to Follow-up|1|||
44135159|NCT02540954|78922210|FG001|Overall Study|Lost to Follow-up|1|||
44135160|NCT02540954|78922209|FG000|Overall Study|Adverse Event|4|||
44135161|NCT02540954|78922210|FG001|Overall Study|Adverse Event|2|||
44135162|NCT02540954|78922209|FG000|Overall Study|Death|0|||
44135163|NCT02540954|78922210|FG001|Overall Study|Death|3|||
44135164|NCT02540954|78922209|FG000|Overall Study|Treatment failure|1|||
44135165|NCT02540954|78922210|FG001|Overall Study|Treatment failure|0|||
44135166|NCT02540954|78922209|FG000|Overall Study|Other reason|4|||
44135167|NCT02540954|78922210|FG001|Overall Study|Other reason|2|||
44135168|NCT02658812|78922216|FG000|Overall Study|Disease Progression|7|||
44135169|NCT02658812|78922216|FG000|Overall Study|Unrelated to study treatment|1|||
44135170|NCT02658812|78922216|FG000|Overall Study|Adverse Event|1|||
44135171|NCT02680665|78922220|FG000|Overall Study|No visit after the first prescription|5|||
44135172|NCT00154375|78922226|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
44135173|NCT00154375|78922227|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
44135174|NCT00154375|78922226|FG000|Overall Study|Adverse Event|18|||
44135175|NCT00154375|78922227|FG001|Overall Study|Adverse Event|20|||
44135176|NCT00154375|78922226|FG000|Overall Study|Withdrawal by Subject|14|||
44135177|NCT00154375|78922227|FG001|Overall Study|Withdrawal by Subject|10|||
44135178|NCT00154375|78922226|FG000|Overall Study|Death|5|||
44135179|NCT00154375|78922227|FG001|Overall Study|Death|13|||
44135180|NCT00154375|78922226|FG000|Overall Study|Study drug no longer required|5|||
44135181|NCT00154375|78922227|FG001|Overall Study|Study drug no longer required|3|||
44135182|NCT00154375|78922226|FG000|Overall Study|Lost to Follow-up|2|||
44135183|NCT00154375|78922227|FG001|Overall Study|Lost to Follow-up|1|||
44135184|NCT00154375|78922226|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44135185|NCT00154375|78922227|FG001|Overall Study|Abnormal laboratory value(s)|2|||
44135186|NCT00154375|78922226|FG000|Overall Study|Protocol Violation|0|||
44135187|NCT00154375|78922227|FG001|Overall Study|Protocol Violation|1|||
44135188|NCT00154375|78922226|FG000|Overall Study|Suspected progression of disease|44|||
44135189|NCT00154375|78922227|FG001|Overall Study|Suspected progression of disease|30|||
44135190|NCT02765399|78922236|FG000|Overall Study|Nausea|1|||
44135191|NCT02765399|78922237|FG001|Overall Study|Nausea|0|||
44135192|NCT02676765|78922245|FG000|Overall Study|Lost to Follow-up|0|||
44135193|NCT02676765|78922246|FG001|Overall Study|Lost to Follow-up|1|||
44135194|NCT02680041|78922252|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
44135195|NCT02680041|78922252|FG000|Overall Study|Lost to Follow-up|2|||
44135196|NCT02547974|78922261|FG000|Overall Study|Withdrawal by Subject|1|||
44135197|NCT02547974|78922262|FG001|Overall Study|Withdrawal by Subject|0|||
44135198|NCT02547974|78922263|FG002|Overall Study|Withdrawal by Subject|0|||
44135199|NCT02547974|78922264|FG003|Overall Study|Withdrawal by Subject|0|||
44135200|NCT00154297|78922279|FG000|Overall Study|Death|5|||
44135201|NCT00154297|78922280|FG001|Overall Study|Death|2|||
44135202|NCT00154297|78922279|FG000|Overall Study|Withdrawal by Subject|0|||
44135203|NCT00154297|78922280|FG001|Overall Study|Withdrawal by Subject|5|||
44135204|NCT00154297|78922279|FG000|Overall Study|Lost to Follow-up|3|||
44135205|NCT00154297|78922280|FG001|Overall Study|Lost to Follow-up|0|||
44135206|NCT02679729|78922295|FG000|Overall Study|Lost to Follow-up|0|||
44135207|NCT02679729|78922296|FG001|Overall Study|Lost to Follow-up|1|||
44135208|NCT02679729|78922297|FG002|Overall Study|Lost to Follow-up|0|||
44135209|NCT02679729|78922298|FG003|Overall Study|Lost to Follow-up|0|||
44135210|NCT02679729|78922299|FG004|Overall Study|Lost to Follow-up|1|||
44135211|NCT02679729|78922300|FG005|Overall Study|Lost to Follow-up|0|||
44135212|NCT02679729|78922301|FG006|Overall Study|Lost to Follow-up|0|||
44135213|NCT02679729|78922302|FG007|Overall Study|Lost to Follow-up|0|||
44135214|NCT02679729|78922303|FG008|Overall Study|Lost to Follow-up|0|||
44135215|NCT02679729|78922295|FG000|Overall Study|Participant decision|0|||
44135216|NCT02679729|78922296|FG001|Overall Study|Participant decision|1|||
44135217|NCT02679729|78922297|FG002|Overall Study|Participant decision|0|||
44135218|NCT02679729|78922298|FG003|Overall Study|Participant decision|0|||
44135219|NCT02679729|78922299|FG004|Overall Study|Participant decision|0|||
44135220|NCT02679729|78922300|FG005|Overall Study|Participant decision|0|||
44135221|NCT02679729|78922301|FG006|Overall Study|Participant decision|1|||
44135222|NCT02679729|78922302|FG007|Overall Study|Participant decision|0|||
44135223|NCT02679729|78922303|FG008|Overall Study|Participant decision|0|||
44135224|NCT02765165|78922342|FG000|Treatment Period|Progressive disease|3|||
44135225|NCT02765165|78922343|FG001|Treatment Period|Progressive disease|2|||
44135226|NCT02765165|78922344|FG002|Treatment Period|Progressive disease|3|||
44135227|NCT02765165|78922345|FG003|Treatment Period|Progressive disease|3|||
44135228|NCT02765165|78922346|FG004|Treatment Period|Progressive disease|4|||
44135229|NCT02765165|78922347|FG005|Treatment Period|Progressive disease|2|||
44135230|NCT02765165|78922348|FG006|Treatment Period|Progressive disease|2|||
44135231|NCT02765165|78922342|FG000|Treatment Period|Physician Decision|0|||
44135232|NCT02765165|78922343|FG001|Treatment Period|Physician Decision|1|||
44135233|NCT02765165|78922344|FG002|Treatment Period|Physician Decision|0|||
44135234|NCT02765165|78922345|FG003|Treatment Period|Physician Decision|0|||
44135235|NCT02765165|78922346|FG004|Treatment Period|Physician Decision|0|||
44135236|NCT02765165|78922347|FG005|Treatment Period|Physician Decision|0|||
44135237|NCT02765165|78922348|FG006|Treatment Period|Physician Decision|0|||
44135238|NCT02765165|78922342|FG000|Treatment Period|Adverse Event|0|||
44135239|NCT02765165|78922343|FG001|Treatment Period|Adverse Event|1|||
44135240|NCT02765165|78922344|FG002|Treatment Period|Adverse Event|0|||
44135241|NCT02765165|78922345|FG003|Treatment Period|Adverse Event|0|||
44135242|NCT02765165|78922346|FG004|Treatment Period|Adverse Event|0|||
44135243|NCT02765165|78922347|FG005|Treatment Period|Adverse Event|0|||
44135244|NCT02765165|78922348|FG006|Treatment Period|Adverse Event|0|||
44135245|NCT02765165|78922342|FG000|Treatment Period|Withdrawal by Subject|0|||
44135246|NCT02765165|78922343|FG001|Treatment Period|Withdrawal by Subject|0|||
44135247|NCT02765165|78922344|FG002|Treatment Period|Withdrawal by Subject|0|||
44135248|NCT02765165|78922345|FG003|Treatment Period|Withdrawal by Subject|0|||
44135249|NCT02765165|78922346|FG004|Treatment Period|Withdrawal by Subject|2|||
44135250|NCT02765165|78922347|FG005|Treatment Period|Withdrawal by Subject|0|||
44135251|NCT02765165|78922348|FG006|Treatment Period|Withdrawal by Subject|0|||
44135252|NCT02765165|78922342|FG000|Treatment Period|Study terminated|0|||
44135253|NCT02765165|78922343|FG001|Treatment Period|Study terminated|0|||
44135254|NCT02765165|78922344|FG002|Treatment Period|Study terminated|0|||
44135255|NCT02765165|78922345|FG003|Treatment Period|Study terminated|0|||
44135256|NCT02765165|78922346|FG004|Treatment Period|Study terminated|0|||
44135257|NCT02765165|78922347|FG005|Treatment Period|Study terminated|1|||
44135258|NCT02765165|78922348|FG006|Treatment Period|Study terminated|2|||
44135259|NCT02765165|78922342|FG000|Post-treatment Follow-up|Death|1|||
44135260|NCT02765165|78922343|FG001|Post-treatment Follow-up|Death|2|||
44135261|NCT02765165|78922344|FG002|Post-treatment Follow-up|Death|1|||
44135262|NCT02765165|78922345|FG003|Post-treatment Follow-up|Death|1|||
44135263|NCT02765165|78922346|FG004|Post-treatment Follow-up|Death|1|||
44135264|NCT02765165|78922347|FG005|Post-treatment Follow-up|Death|1|||
44135265|NCT02765165|78922348|FG006|Post-treatment Follow-up|Death|0|||
44135266|NCT02765165|78922342|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
44135267|NCT02765165|78922343|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
44135268|NCT02765165|78922344|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
44135269|NCT02765165|78922345|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
44135270|NCT02765165|78922346|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
44135271|NCT02765165|78922347|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
44135272|NCT02765165|78922348|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
44135273|NCT02765165|78922342|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
44135274|NCT02765165|78922343|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
44135275|NCT02765165|78922344|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
44135276|NCT02765165|78922345|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
44135277|NCT02765165|78922346|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
44135278|NCT02765165|78922347|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
44135279|NCT02765165|78922348|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
44135280|NCT02765165|78922342|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
44135281|NCT02765165|78922343|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
44135282|NCT02765165|78922344|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
44135283|NCT02765165|78922345|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
44135284|NCT02765165|78922346|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
44243687|NCT01465997|79073317|FG001|Overall Study|subject left participation SP0993|1|||
44243688|NCT01465763|79073338|FG000|Overall Study|Withdrawal by Subject|4|||
44243689|NCT01465763|79073339|FG001|Overall Study|Withdrawal by Subject|0|||
44243690|NCT01465763|79073340|FG002|Overall Study|Withdrawal by Subject|1|||
44243691|NCT01465763|79073338|FG000|Overall Study|Insufficient Clinical Response|11|||
44243692|NCT01465763|79073339|FG001|Overall Study|Insufficient Clinical Response|0|||
44243693|NCT01465763|79073340|FG002|Overall Study|Insufficient Clinical Response|1|||
44243694|NCT01465763|79073338|FG000|Overall Study|Adverse Event|9|||
44243695|NCT01465763|79073339|FG001|Overall Study|Adverse Event|0|||
44243696|NCT01465763|79073340|FG002|Overall Study|Adverse Event|1|||
44243697|NCT01465763|79073338|FG000|Overall Study|Other|2|||
44243698|NCT01465763|79073339|FG001|Overall Study|Other|0|||
44243699|NCT01465763|79073340|FG002|Overall Study|Other|0|||
44243700|NCT01465763|79073338|FG000|Overall Study|Protocol Violation|4|||
44243701|NCT01465763|79073339|FG001|Overall Study|Protocol Violation|1|||
44243702|NCT01465763|79073340|FG002|Overall Study|Protocol Violation|1|||
44243703|NCT01465763|79073338|FG000|Overall Study|Death|1|||
44243704|NCT01465763|79073339|FG001|Overall Study|Death|0|||
44135285|NCT02765165|78922347|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
44135286|NCT02765165|78922348|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
44135287|NCT02765165|78922342|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
44243705|NCT01465763|79073340|FG002|Overall Study|Death|0|||
44135288|NCT02765165|78922343|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
44135289|NCT02765165|78922344|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
44135290|NCT02765165|78922345|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
44135291|NCT02765165|78922346|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
44135292|NCT02765165|78922347|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
44135293|NCT02765165|78922348|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
44135294|NCT02765165|78922342|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
44135295|NCT02765165|78922343|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
44135296|NCT02765165|78922344|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
44135297|NCT02765165|78922345|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
44135298|NCT02765165|78922346|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
44135299|NCT02765165|78922347|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
44135300|NCT02765165|78922348|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
44135301|NCT02675907|78922370|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
44135302|NCT02675907|78922371|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
44135303|NCT02675907|78922370|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
44135304|NCT02675907|78922371|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
44135305|NCT02675907|78922370|FG000|Study Overall|Lack of Efficacy|1|||
44135306|NCT02675907|78922371|FG001|Study Overall|Lack of Efficacy|0|||
44135307|NCT02675907|78922370|FG000|Study Overall|Withdrawal by Subject|2|||
44135308|NCT02675907|78922371|FG001|Study Overall|Withdrawal by Subject|2|||
44135309|NCT02675907|78922370|FG000|Study Overall|Lost to Follow-up|0|||
44135310|NCT02675907|78922371|FG001|Study Overall|Lost to Follow-up|2|||
44135311|NCT02675517|78922377|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
44135312|NCT02675517|78922377|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
44135313|NCT02764775|78922381|FG000|Overall Study|Death|1|||
44135314|NCT02764775|78922381|FG000|Overall Study|Lost to Follow-up|2|||
44135315|NCT02764775|78922381|FG000|Overall Study|Withdrawal by Subject|3|||
44135316|NCT02774681|78922385|FG000|Treatment on Study|Progressive Disease|7|||
44135317|NCT02774681|78922385|FG000|Follow-Up for 3 Years|Death|11|||
44135318|NCT02774681|78922385|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
44135319|NCT02547428|78922391|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
44135320|NCT02547428|78922392|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
44135321|NCT02547428|78922391|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
44135322|NCT02547428|78922392|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
44135323|NCT02547428|78922391|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
44135324|NCT02547428|78922392|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
44135325|NCT02547428|78922391|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
44135326|NCT02547428|78922392|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
44135327|NCT02547428|78922391|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
44135328|NCT02547428|78922392|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
44135329|NCT02547428|78922391|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
44135330|NCT02547428|78922392|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
44135331|NCT02547428|78922391|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
44135332|NCT02547428|78922392|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
44135333|NCT02547428|78922391|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
44135334|NCT02547428|78922392|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
44135335|NCT01374087|78922407|FG000|Overall Study|Adverse Event|1|||
44135336|NCT01374087|78922408|FG001|Overall Study|Adverse Event|0|||
44135337|NCT01374087|78922407|FG000|Overall Study|Disease progression|2|||
44135338|NCT01374087|78922408|FG001|Overall Study|Disease progression|2|||
44135339|NCT01374087|78922407|FG000|Overall Study|Study discontinued|13|||
44135340|NCT01374087|78922408|FG001|Overall Study|Study discontinued|13|||
44135341|NCT00152971|78922417|FG000|Overall Study|Adverse Event|12|||
44135342|NCT00152971|78922418|FG001|Overall Study|Adverse Event|10|||
44135343|NCT00152971|78922419|FG002|Overall Study|Adverse Event|9|||
44135344|NCT00152971|78922417|FG000|Overall Study|Protocol Violation|10|||
44135345|NCT00152971|78922418|FG001|Overall Study|Protocol Violation|11|||
44135346|NCT00152971|78922419|FG002|Overall Study|Protocol Violation|8|||
44135347|NCT00152971|78922417|FG000|Overall Study|Lost to Follow-up|17|||
44135348|NCT00152971|78922418|FG001|Overall Study|Lost to Follow-up|14|||
44135349|NCT00152971|78922419|FG002|Overall Study|Lost to Follow-up|13|||
44135350|NCT00152971|78922417|FG000|Overall Study|Withdrawal by Subject|9|||
44135351|NCT00152971|78922418|FG001|Overall Study|Withdrawal by Subject|8|||
44135352|NCT00152971|78922419|FG002|Overall Study|Withdrawal by Subject|14|||
44135353|NCT00152971|78922417|FG000|Overall Study|Other|3|||
44243706|NCT01690520|79073373|FG000|Overall Study|Death|25|||
44135354|NCT00152971|78922418|FG001|Overall Study|Other|5|||
44135355|NCT00152971|78922419|FG002|Overall Study|Other|5|||
44135356|NCT00152971|78922417|FG000|Treatment|Adverse Event|49|||
44135357|NCT00152971|78922418|FG001|Treatment|Adverse Event|40|||
44135358|NCT00152971|78922419|FG002|Treatment|Adverse Event|54|||
44135359|NCT00152971|78922417|FG000|Treatment|Protocol Violation|8|||
44135360|NCT00152971|78922418|FG001|Treatment|Protocol Violation|6|||
44135361|NCT00152971|78922419|FG002|Treatment|Protocol Violation|10|||
44135362|NCT00152971|78922417|FG000|Treatment|Lost to Follow-up|1|||
44135363|NCT00152971|78922418|FG001|Treatment|Lost to Follow-up|2|||
44135364|NCT00152971|78922419|FG002|Treatment|Lost to Follow-up|1|||
44135365|NCT00152971|78922417|FG000|Treatment|Withdrawal by Subject|4|||
44135366|NCT00152971|78922418|FG001|Treatment|Withdrawal by Subject|4|||
44135367|NCT00152971|78922419|FG002|Treatment|Withdrawal by Subject|5|||
44135368|NCT00152971|78922417|FG000|Treatment|Other|9|||
44135369|NCT00152971|78922418|FG001|Treatment|Other|11|||
44135370|NCT00152971|78922419|FG002|Treatment|Other|10|||
44135371|NCT02538614|78922427|FG000|Overall Study|Progressive Disease|2|||
44135372|NCT04620135|78922435|FG000|Study Completion|Adverse Event|2|||
44135373|NCT04620135|78922436|FG001|Study Completion|Adverse Event|3|||
44135374|NCT04620135|78922435|FG000|Study Completion|Withdrawal by Subject|2|||
44135375|NCT04620135|78922436|FG001|Study Completion|Withdrawal by Subject|0|||
44135376|NCT02552966|78922442|FG000|Overall Study|Lost to Follow-up|2|||
44135377|NCT02552966|78922442|FG000|Overall Study|Withdrawal by Subject|3|||
44135378|NCT02552888|78922448|FG000|Overall Study|Lost to Follow-up|1|||
44135379|NCT02552888|78922449|FG001|Overall Study|Lost to Follow-up|1|||
44135380|NCT01373931|78922468|FG000|Lead-in Period|Adverse Event|2|||
44135381|NCT01373931|78922469|FG001|Lead-in Period|Adverse Event|0|||
44135382|NCT01373931|78922468|FG000|Period 1|Adverse Event|2|||
44135383|NCT01373931|78922469|FG001|Period 1|Adverse Event|0|||
44135384|NCT01373931|78922468|FG000|Period 1|Withdrawal by Subject|0|||
44135385|NCT01373931|78922469|FG001|Period 1|Withdrawal by Subject|2|||
44135386|NCT02552732|78922476|FG000|Overall Study|Lost to Follow-up|2|||
44135387|NCT02552732|78922476|FG000|Overall Study|Physician Decision|1|||
44135388|NCT02552732|78922476|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
44135389|NCT02552732|78922476|FG000|Overall Study|Withdrawal by Subject|6|||
44135390|NCT02547038|78922483|FG000|Overall Study|Lost to Follow-up|3|||
44135391|NCT02547038|78922484|FG001|Overall Study|Lost to Follow-up|2|||
44135392|NCT02764697|78922490|FG000|Overall Study|Lack of Efficacy|3|||
44135393|NCT02673489|78922496|FG000|Treatment Period|Lost to Follow-up|3|||
44135394|NCT02673489|78922497|FG001|Treatment Period|Lost to Follow-up|0|||
44135395|NCT02673489|78922496|FG000|Treatment Period|Participant request to discontinue|1|||
44135396|NCT02673489|78922497|FG001|Treatment Period|Participant request to discontinue|1|||
44135397|NCT02673489|78922496|FG000|Treatment Period|Participant moved to another province|1|||
44135398|NCT02673489|78922497|FG001|Treatment Period|Participant moved to another province|0|||
44135399|NCT02673489|78922496|FG000|Treatment Period|Participant was incarcerated|0|||
44135400|NCT02673489|78922497|FG001|Treatment Period|Participant was incarcerated|1|||
44135401|NCT02673489|78922496|FG000|Treatment Period|Adverse Event|0|||
44135402|NCT02673489|78922497|FG001|Treatment Period|Adverse Event|1|||
44135403|NCT02673489|78922496|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
44135404|NCT02673489|78922497|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
44135405|NCT02673489|78922496|FG000|Follow Up Period|Unable to return for follow-up|0|||
44135406|NCT02673489|78922497|FG001|Follow Up Period|Unable to return for follow-up|1|||
44135407|NCT02772809|78922504|FG000|Overall Study|not completed some tasks|6|||
44135408|NCT02537678|78922515|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
44135409|NCT02537678|78922516|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
44135410|NCT02537678|78922515|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
44135411|NCT02537678|78922516|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
44135412|NCT02537678|78922515|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
44135413|NCT02537678|78922516|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
44135414|NCT02537678|78922515|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
44135415|NCT02537678|78922516|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
44243707|NCT01690520|79073374|FG001|Overall Study|Death|21|||
44135416|NCT02537678|78922515|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
44135417|NCT02537678|78922516|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
44135418|NCT02537678|78922515|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
44135419|NCT02537678|78922516|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
44135420|NCT02537678|78922515|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
44135421|NCT02537678|78922516|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
44135422|NCT02766023|78922528|FG000|Overall Study|Lost to Follow-up|23|||
44135423|NCT02766023|78922529|FG001|Overall Study|Lost to Follow-up|11|||
44135424|NCT02766023|78922528|FG000|Overall Study|Pregnancy|1|||
44135425|NCT02766023|78922529|FG001|Overall Study|Pregnancy|0|||
44135426|NCT02766023|78922528|FG000|Overall Study|Adverse Event|1|||
44135427|NCT02766023|78922529|FG001|Overall Study|Adverse Event|0|||
44135428|NCT02766023|78922528|FG000|Overall Study|Withdrawal by Subject|4|||
44135429|NCT02766023|78922529|FG001|Overall Study|Withdrawal by Subject|5|||
44135430|NCT02766023|78922528|FG000|Overall Study|Physician Decision|1|||
44135431|NCT02766023|78922529|FG001|Overall Study|Physician Decision|0|||
44135432|NCT02766023|78922528|FG000|Overall Study|Not Eligible at Enrollment|0|||
44135433|NCT02766023|78922529|FG001|Overall Study|Not Eligible at Enrollment|1|||
44135434|NCT02764229|78922535|FG000|Overall Study|Withdrawal by Subject|15|||
44135435|NCT02764229|78922535|FG000|Overall Study|Adverse Event|9|||
44135436|NCT02764229|78922535|FG000|Overall Study|Physician Decision|5|||
44135437|NCT02764229|78922535|FG000|Overall Study|Lost to Follow-up|3|||
44135438|NCT02764229|78922535|FG000|Overall Study|Lack of Efficacy|1|||
44135439|NCT02764229|78922535|FG000|Overall Study|Study Stopped by Sponsor|69|||
44135440|NCT02537522|78922539|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
44135441|NCT02537522|78922540|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
44135442|NCT02537522|78922541|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
44135443|NCT02537522|78922542|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
44135444|NCT02537522|78922539|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
44135445|NCT02537522|78922540|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
44135446|NCT02537522|78922541|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
44135447|NCT02537522|78922542|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
44135448|NCT02537522|78922539|FG000|Phase I - Contralateral|incorrect randomization|0|||
44135449|NCT02537522|78922540|FG001|Phase I - Contralateral|incorrect randomization|1|||
44135450|NCT02537522|78922541|FG002|Phase I - Contralateral|incorrect randomization|0|||
44135451|NCT02537522|78922542|FG003|Phase I - Contralateral|incorrect randomization|0|||
44135452|NCT02537522|78922539|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
44135453|NCT02537522|78922540|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
44135454|NCT02537522|78922541|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
44135455|NCT02537522|78922542|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
44135456|NCT02537522|78922539|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
44135457|NCT02537522|78922540|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
44135458|NCT02537522|78922541|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
44135459|NCT02537522|78922542|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
44135460|NCT02536976|78922550|FG000|Overall Study|Physician Decision|0|||
44135461|NCT02536976|78922551|FG001|Overall Study|Physician Decision|1|||
44135462|NCT02672553|78922561|FG000|Overall Study|Death|3|||
44135463|NCT02672553|78922562|FG001|Overall Study|Death|5|||
44135464|NCT02672553|78922561|FG000|Overall Study|Valve Explant|1|||
44135465|NCT02672553|78922562|FG001|Overall Study|Valve Explant|0|||
44135466|NCT02672553|78922561|FG000|Overall Study|Conversion to Commercial Valve|3|||
44135467|NCT02672553|78922562|FG001|Overall Study|Conversion to Commercial Valve|0|||
44135468|NCT02672553|78922561|FG000|Overall Study|Withdrawal by Subject|3|||
44135469|NCT02672553|78922562|FG001|Overall Study|Withdrawal by Subject|3|||
44135470|NCT02672553|78922561|FG000|Overall Study|Intraoperative screen failure|2|||
44135471|NCT02672553|78922562|FG001|Overall Study|Intraoperative screen failure|0|||
44135472|NCT01373229|78922569|FG000|Overall Study|Death|3|||
44135473|NCT01373229|78922569|FG000|Overall Study|Physician Decision|3|||
44135474|NCT02671461|78922576|FG000|Treatment|Adverse Event|0|||
44135475|NCT02671461|78922577|FG001|Treatment|Adverse Event|0|||
44135476|NCT02671461|78922578|FG002|Treatment|Adverse Event|1|||
44135477|NCT02671461|78922576|FG000|Treatment|Administrative Reason by Sponsor|1|||
44135478|NCT02671461|78922577|FG001|Treatment|Administrative Reason by Sponsor|3|||
44135479|NCT02671461|78922578|FG002|Treatment|Administrative Reason by Sponsor|4|||
44135480|NCT02671461|78922576|FG000|Treatment|Randomized, not treated|1|||
44135481|NCT02671461|78922577|FG001|Treatment|Randomized, not treated|0|||
44135482|NCT02671461|78922578|FG002|Treatment|Randomized, not treated|0|||
44135483|NCT02671461|78922576|FG000|Follow-up|Withdrawal by Subject|1|||
44135484|NCT02671461|78922577|FG001|Follow-up|Withdrawal by Subject|0|||
44135485|NCT02671461|78922578|FG002|Follow-up|Withdrawal by Subject|0|||
44135486|NCT02671461|78922576|FG000|Follow-up|Lost to Follow-up|0|||
44135487|NCT02671461|78922577|FG001|Follow-up|Lost to Follow-up|0|||
44243708|NCT01690520|79073373|FG000|Overall Study|Lost to Follow-up|2|||
44135488|NCT02671461|78922578|FG002|Follow-up|Lost to Follow-up|1|||
44243709|NCT01690520|79073374|FG001|Overall Study|Lost to Follow-up|3|||
44243710|NCT01690520|79073373|FG000|Overall Study|Withdrawal by Subject|2|||
44135489|NCT02671461|78922576|FG000|Follow-up|Administrative Reason by Sponsor|0|||
44135490|NCT02671461|78922577|FG001|Follow-up|Administrative Reason by Sponsor|1|||
44135491|NCT02671461|78922578|FG002|Follow-up|Administrative Reason by Sponsor|0|||
44135492|NCT02535416|78922595|FG000|Overall Study|Family bereavement overseas|1|||
44135493|NCT02535416|78922596|FG001|Overall Study|Family bereavement overseas|0|||
44135494|NCT02535416|78922597|FG002|Overall Study|Family bereavement overseas|0|||
44135495|NCT02535416|78922598|FG003|Overall Study|Family bereavement overseas|0|||
44135496|NCT02535416|78922599|FG004|Overall Study|Family bereavement overseas|0|||
44135497|NCT02535416|78922600|FG005|Overall Study|Family bereavement overseas|0|||
44135498|NCT02535416|78922601|FG006|Overall Study|Family bereavement overseas|0|||
44135499|NCT02535416|78922602|FG007|Overall Study|Family bereavement overseas|0|||
44135500|NCT02535416|78922603|FG008|Overall Study|Family bereavement overseas|0|||
44135501|NCT02670915|78922653|FG000|Overall Study|Withdrawal by Subject|0|||
44380287|NCT00759109|79386143|FG001|Overall Study|Adverse Event|12|||
44380288|NCT00759109|79386142|FG000|Overall Study|Inability to comply|1|||
44380289|NCT00759109|79386143|FG001|Overall Study|Inability to comply|1|||
44380290|NCT00759109|79386142|FG000|Overall Study|Withdrawal by Subject|9|||
44380291|NCT00759109|79386143|FG001|Overall Study|Withdrawal by Subject|5|||
44380292|NCT00759109|79386142|FG000|Overall Study|Death|4|||
44380293|NCT00759109|79386143|FG001|Overall Study|Death|3|||
44380294|NCT00759109|79386142|FG000|Overall Study|Lost to Follow-up|4|||
44380295|NCT00759109|79386143|FG001|Overall Study|Lost to Follow-up|6|||
44135502|NCT02670915|78922654|FG001|Overall Study|Withdrawal by Subject|1|||
44135503|NCT02670915|78922655|FG002|Overall Study|Withdrawal by Subject|4|||
44135504|NCT02670915|78922653|FG000|Overall Study|Withdrawal by parent/guardian|4|||
44135505|NCT02670915|78922654|FG001|Overall Study|Withdrawal by parent/guardian|4|||
44135506|NCT02670915|78922655|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44135507|NCT02670915|78922653|FG000|Overall Study|Unclassified|0|||
44135508|NCT02670915|78922654|FG001|Overall Study|Unclassified|3|||
44135509|NCT02670915|78922655|FG002|Overall Study|Unclassified|0|||
44135510|NCT02545868|78922666|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
44135511|NCT02545868|78922667|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
44135512|NCT02545868|78922668|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
44135513|NCT02764151|78922685|FG000|Overall Study|Subject refused further follow-up|0|||
44135514|NCT02764151|78922686|FG001|Overall Study|Subject refused further follow-up|0|||
44135515|NCT02764151|78922687|FG002|Overall Study|Subject refused further follow-up|0|||
44135516|NCT02764151|78922688|FG003|Overall Study|Subject refused further follow-up|1|||
44135517|NCT02764151|78922685|FG000|Overall Study|Other|0|||
44135518|NCT02764151|78922686|FG001|Overall Study|Other|0|||
44135519|NCT02764151|78922687|FG002|Overall Study|Other|0|||
44135520|NCT02764151|78922688|FG003|Overall Study|Other|2|||
44135521|NCT02545322|78922698|FG000|Overall Study|Withdrawal by Subject|3|||
44135522|NCT02763215|78922702|FG000|Overall Study|Participants withdrew from study|3|||
44135523|NCT02763215|78922702|FG000|Overall Study|Missed visit|1|||
44135524|NCT02763215|78922702|FG000|Overall Study|Visit outside visit-window|1|||
44135525|NCT02763215|78922702|FG000|Overall Study|Death|1|||
44135526|NCT02763215|78922702|FG000|Overall Study|Lost to Follow-up|1|||
44135527|NCT02770547|78922721|FG000|Overall Study|Patient non-compliant|1|||
44135528|NCT02770547|78922722|FG001|Overall Study|Patient non-compliant|0|||
44135529|NCT02770547|78922721|FG000|Overall Study|Adverse Event|0|||
44135530|NCT02770547|78922722|FG001|Overall Study|Adverse Event|1|||
44135531|NCT01661972|78922730|FG000|Overall Study|Adverse Event|1|||
44135532|NCT01661972|78922731|FG001|Overall Study|Adverse Event|2|||
44135533|NCT01661972|78922730|FG000|Overall Study|Death during Treatment period|1|||
44135534|NCT01661972|78922731|FG001|Overall Study|Death during Treatment period|1|||
44135535|NCT01661972|78922730|FG000|Overall Study|Withdrawal by Subject|0|||
44135536|NCT01661972|78922731|FG001|Overall Study|Withdrawal by Subject|1|||
44135537|NCT00888355|78922743|FG000|Overall Study|Adverse Event|10|||
44135538|NCT00888355|78922744|FG001|Overall Study|Adverse Event|0|||
44135539|NCT00888355|78922745|FG002|Overall Study|Adverse Event|3|||
44135540|NCT00888355|78922746|FG003|Overall Study|Adverse Event|3|||
44135541|NCT00888355|78922743|FG000|Overall Study|Lack of Efficacy|9|||
44135542|NCT00888355|78922744|FG001|Overall Study|Lack of Efficacy|2|||
44135543|NCT00888355|78922745|FG002|Overall Study|Lack of Efficacy|5|||
44135544|NCT00888355|78922746|FG003|Overall Study|Lack of Efficacy|2|||
44135545|NCT00888355|78922743|FG000|Overall Study|Lost to Follow-up|0|||
44135546|NCT00888355|78922744|FG001|Overall Study|Lost to Follow-up|2|||
44135547|NCT00888355|78922745|FG002|Overall Study|Lost to Follow-up|2|||
44135548|NCT00888355|78922746|FG003|Overall Study|Lost to Follow-up|0|||
44135549|NCT00888355|78922743|FG000|Overall Study|Protocol Violation|3|||
44135550|NCT00888355|78922744|FG001|Overall Study|Protocol Violation|2|||
44135551|NCT00888355|78922745|FG002|Overall Study|Protocol Violation|1|||
44135552|NCT00888355|78922746|FG003|Overall Study|Protocol Violation|2|||
44135553|NCT00888355|78922743|FG000|Overall Study|Withdrawal by Subject|0|||
44135554|NCT00888355|78922744|FG001|Overall Study|Withdrawal by Subject|3|||
44135555|NCT00888355|78922745|FG002|Overall Study|Withdrawal by Subject|1|||
44135556|NCT00888355|78922746|FG003|Overall Study|Withdrawal by Subject|3|||
44380296|NCT00759109|79386142|FG000|Overall Study|Started new therapy|2|||
44135557|NCT00794677|78922754|FG000|First Intervention|Withdrawal by Subject|2|||
44135558|NCT00794677|78922755|FG001|First Intervention|Withdrawal by Subject|0|||
44135559|NCT02770391|78922759|FG000|Overall Study|Lost to Follow-up|2|||
44135560|NCT02770391|78922759|FG000|Overall Study|Withdrawal by Subject|1|||
44135561|NCT02770391|78922759|FG000|Overall Study|Surgery delayed unevaluable|2|||
44135562|NCT02770391|78922759|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
44380297|NCT00759109|79386143|FG001|Overall Study|Started new therapy|6|||
44380298|NCT00759109|79386142|FG000|Overall Study|HCV RNA negative|1|||
44135563|NCT02536508|78922766|FG000|Overall Study|Withdrawal by Subject|18|||
44135564|NCT02536508|78922767|FG001|Overall Study|Withdrawal by Subject|13|||
44135565|NCT02536508|78922768|FG002|Overall Study|Withdrawal by Subject|7|||
44135566|NCT02536508|78922766|FG000|Overall Study|Adverse Event|14|||
44135567|NCT02536508|78922767|FG001|Overall Study|Adverse Event|13|||
44135568|NCT02536508|78922768|FG002|Overall Study|Adverse Event|6|||
44135569|NCT02536508|78922766|FG000|Overall Study|Lost to Follow-up|12|||
44135570|NCT02536508|78922767|FG001|Overall Study|Lost to Follow-up|4|||
44135571|NCT02536508|78922768|FG002|Overall Study|Lost to Follow-up|0|||
44135572|NCT02536508|78922766|FG000|Overall Study|Lack of Efficacy|3|||
44135573|NCT02536508|78922767|FG001|Overall Study|Lack of Efficacy|5|||
44135574|NCT02536508|78922768|FG002|Overall Study|Lack of Efficacy|4|||
44135575|NCT02536508|78922766|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
44135576|NCT02536508|78922767|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
44135577|NCT02536508|78922768|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
44135578|NCT02536508|78922766|FG000|Overall Study|Physician Decision|0|||
44135579|NCT02536508|78922767|FG001|Overall Study|Physician Decision|4|||
44135580|NCT02536508|78922768|FG002|Overall Study|Physician Decision|2|||
44135581|NCT02536508|78922766|FG000|Overall Study|Major Protocol Deviation|2|||
44135582|NCT02536508|78922767|FG001|Overall Study|Major Protocol Deviation|2|||
44135583|NCT02536508|78922768|FG002|Overall Study|Major Protocol Deviation|2|||
44135584|NCT02536508|78922766|FG000|Overall Study|Administrative Reasons|0|||
44135585|NCT02536508|78922767|FG001|Overall Study|Administrative Reasons|1|||
44135586|NCT02536508|78922768|FG002|Overall Study|Administrative Reasons|0|||
44135587|NCT00103259|78922785|FG000|Overall Study|Death|3|||
44135588|NCT00103259|78922786|FG001|Overall Study|Death|2|||
44135589|NCT00103259|78922785|FG000|Overall Study|Withdrawal by Subject|2|||
44135590|NCT00103259|78922786|FG001|Overall Study|Withdrawal by Subject|3|||
44135591|NCT00103259|78922785|FG000|Overall Study|alternative therapy|1|||
44135592|NCT00103259|78922786|FG001|Overall Study|alternative therapy|0|||
44135593|NCT00103259|78922785|FG000|Overall Study|other (reasons were not specified)|2|||
44135594|NCT00103259|78922786|FG001|Overall Study|other (reasons were not specified)|1|||
44135595|NCT00103259|78922785|FG000|Overall Study|ineligible/no protocol therapy|4|||
44135596|NCT00103259|78922786|FG001|Overall Study|ineligible/no protocol therapy|6|||
44135597|NCT02544152|78922796|FG000|Overall Study|Adverse Event|0|||
44135598|NCT02544152|78922797|FG001|Overall Study|Adverse Event|4|||
44135599|NCT02544152|78922796|FG000|Overall Study|Withdrawal by Subject|0|||
44135600|NCT02544152|78922797|FG001|Overall Study|Withdrawal by Subject|3|||
44135601|NCT02544152|78922796|FG000|Overall Study|Other|1|||
44135602|NCT02544152|78922797|FG001|Overall Study|Other|0|||
44135603|NCT02534324|78922805|FG000|Overall Study|Protocol Violation|4|||
44135604|NCT02534324|78922806|FG001|Overall Study|Protocol Violation|1|||
44135605|NCT02534324|78922805|FG000|Overall Study|Lost to Follow-up|20|||
44135606|NCT02534324|78922806|FG001|Overall Study|Lost to Follow-up|7|||
44135607|NCT02534324|78922805|FG000|Overall Study|Adverse Event|1|||
44135608|NCT02534324|78922806|FG001|Overall Study|Adverse Event|0|||
44135609|NCT02761733|78922816|FG000|Overall Study|Death|3|||
44135610|NCT02761733|78922817|FG001|Overall Study|Death|5|||
44135611|NCT02761733|78922818|FG002|Overall Study|Death|1|||
44135612|NCT02761733|78922819|FG003|Overall Study|Death|1|||
44135613|NCT02761733|78922816|FG000|Overall Study|Lost to Follow-up|6|||
44135614|NCT02761733|78922817|FG001|Overall Study|Lost to Follow-up|7|||
44135615|NCT02761733|78922818|FG002|Overall Study|Lost to Follow-up|0|||
44135616|NCT02761733|78922819|FG003|Overall Study|Lost to Follow-up|3|||
44135617|NCT02761733|78922816|FG000|Overall Study|Physician Decision|4|||
44135618|NCT02761733|78922817|FG001|Overall Study|Physician Decision|0|||
44135619|NCT02761733|78922818|FG002|Overall Study|Physician Decision|0|||
44135620|NCT02761733|78922819|FG003|Overall Study|Physician Decision|0|||
44135621|NCT02761733|78922816|FG000|Overall Study|Withdrawal by Subject|2|||
44135622|NCT02761733|78922817|FG001|Overall Study|Withdrawal by Subject|0|||
44135623|NCT02761733|78922818|FG002|Overall Study|Withdrawal by Subject|0|||
44135624|NCT02761733|78922819|FG003|Overall Study|Withdrawal by Subject|0|||
44135625|NCT02761733|78922816|FG000|Overall Study|Discharged from Study Site|10|||
44135626|NCT02761733|78922817|FG001|Overall Study|Discharged from Study Site|9|||
44135627|NCT02761733|78922818|FG002|Overall Study|Discharged from Study Site|25|||
44135628|NCT02761733|78922819|FG003|Overall Study|Discharged from Study Site|11|||
44135629|NCT02761733|78922816|FG000|Overall Study|Cognitive Impairment|5|||
44135630|NCT02761733|78922817|FG001|Overall Study|Cognitive Impairment|0|||
44135631|NCT02761733|78922818|FG002|Overall Study|Cognitive Impairment|1|||
44135632|NCT02761733|78922819|FG003|Overall Study|Cognitive Impairment|0|||
44135633|NCT03715465|78922831|FG000|Overall Study|Withdrawal by Subject|1|||
44135634|NCT03715465|78922832|FG001|Overall Study|Withdrawal by Subject|2|||
44135635|NCT00840073|78922840|FG000|Second Intervention|Missed 72 hour blood draw|1|||
44135636|NCT00840073|78922841|FG001|Second Intervention|Missed 72 hour blood draw|1|||
44135637|NCT00838279|78922847|FG000|Washout|Protocol Violation|1|||
44135638|NCT00838279|78922848|FG001|Washout|Protocol Violation|0|||
44135639|NCT00838279|78922847|FG000|Washout|Withdrawal by Subject|0|||
44135640|NCT00838279|78922848|FG001|Washout|Withdrawal by Subject|1|||
44135641|NCT02759939|78922856|FG000|Overall Study|Missing data on first outcome assessed|11|||
44135642|NCT02759939|78922857|FG001|Overall Study|Missing data on first outcome assessed|2|||
44135643|NCT02759939|78922858|FG002|Overall Study|Missing data on first outcome assessed|5|||
44135644|NCT02759939|78922859|FG003|Overall Study|Missing data on first outcome assessed|2|||
44135645|NCT02759939|78922856|FG000|Overall Study|Ineligible for T2 and T3|310|||
44135646|NCT02759939|78922857|FG001|Overall Study|Ineligible for T2 and T3|179|||
44135647|NCT02759939|78922858|FG002|Overall Study|Ineligible for T2 and T3|366|||
44135648|NCT02759939|78922859|FG003|Overall Study|Ineligible for T2 and T3|391|||
44135649|NCT02759939|78922856|FG000|Overall Study|Lost to Follow-up|735|||
44135650|NCT02759939|78922857|FG001|Overall Study|Lost to Follow-up|791|||
44135651|NCT02759939|78922858|FG002|Overall Study|Lost to Follow-up|783|||
44135652|NCT02759939|78922859|FG003|Overall Study|Lost to Follow-up|650|||
44135653|NCT00835705|78922878|FG000|First Intervention|Difficulty with vein|1|||
44135654|NCT00835705|78922879|FG001|First Intervention|Difficulty with vein|0|||
44135655|NCT00835705|78922878|FG000|Second Intervention|Difficulty with vein|1|||
44135656|NCT00835705|78922879|FG001|Second Intervention|Difficulty with vein|0|||
44135657|NCT02759471|78922883|FG000|Overall Study|discomfort|2|||
44135658|NCT00835549|78922891|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
44135659|NCT00835549|78922892|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44135660|NCT03945825|78922902|FG000|Overall Study|Enrolled but treatment not administered|0|||
44135661|NCT03945825|78922903|FG001|Overall Study|Enrolled but treatment not administered|0|||
44135662|NCT03945825|78922904|FG002|Overall Study|Enrolled but treatment not administered|0|||
44135663|NCT03945825|78922905|FG003|Overall Study|Enrolled but treatment not administered|0|||
44135664|NCT03945825|78922906|FG004|Overall Study|Enrolled but treatment not administered|1|||
44135665|NCT03945825|78922907|FG005|Overall Study|Enrolled but treatment not administered|0|||
44135666|NCT03945825|78922902|FG000|Overall Study|Lost to Follow-up|1|||
44135667|NCT03945825|78922903|FG001|Overall Study|Lost to Follow-up|5|||
44135668|NCT03945825|78922904|FG002|Overall Study|Lost to Follow-up|0|||
44135669|NCT03945825|78922905|FG003|Overall Study|Lost to Follow-up|1|||
44135670|NCT03945825|78922906|FG004|Overall Study|Lost to Follow-up|2|||
44135671|NCT03945825|78922907|FG005|Overall Study|Lost to Follow-up|2|||
44135672|NCT03945825|78922902|FG000|Overall Study|Withdrawal by Subject|1|||
44135673|NCT03945825|78922903|FG001|Overall Study|Withdrawal by Subject|0|||
44135674|NCT03945825|78922904|FG002|Overall Study|Withdrawal by Subject|1|||
44135675|NCT03945825|78922905|FG003|Overall Study|Withdrawal by Subject|1|||
44135676|NCT03945825|78922906|FG004|Overall Study|Withdrawal by Subject|0|||
44135677|NCT03945825|78922907|FG005|Overall Study|Withdrawal by Subject|1|||
44135678|NCT02759315|78922935|FG000|Overall Study|Adverse Event|0|||
44135679|NCT02759315|78922936|FG001|Overall Study|Adverse Event|0|||
44135680|NCT02759315|78922937|FG002|Overall Study|Adverse Event|0|||
44135681|NCT02759315|78922938|FG003|Overall Study|Adverse Event|1|||
44135682|NCT02759315|78922939|FG004|Overall Study|Adverse Event|0|||
44135683|NCT02759315|78922935|FG000|Overall Study|Death|0|||
44135684|NCT02759315|78922936|FG001|Overall Study|Death|0|||
44135685|NCT02759315|78922937|FG002|Overall Study|Death|1|||
44135686|NCT02759315|78922938|FG003|Overall Study|Death|0|||
44135687|NCT02759315|78922939|FG004|Overall Study|Death|0|||
44135688|NCT02759315|78922935|FG000|Overall Study|Lost to Follow-up|2|||
44135689|NCT02759315|78922936|FG001|Overall Study|Lost to Follow-up|0|||
44135690|NCT02759315|78922937|FG002|Overall Study|Lost to Follow-up|4|||
44135691|NCT02759315|78922938|FG003|Overall Study|Lost to Follow-up|0|||
44135692|NCT02759315|78922939|FG004|Overall Study|Lost to Follow-up|0|||
44135693|NCT02759315|78922935|FG000|Overall Study|Protocol Violation|0|||
44135694|NCT02759315|78922936|FG001|Overall Study|Protocol Violation|1|||
44135695|NCT02759315|78922937|FG002|Overall Study|Protocol Violation|0|||
44135696|NCT02759315|78922938|FG003|Overall Study|Protocol Violation|0|||
44135697|NCT02759315|78922939|FG004|Overall Study|Protocol Violation|0|||
44135698|NCT02759315|78922935|FG000|Overall Study|Study terminated prior to completion|2|||
44135699|NCT02759315|78922936|FG001|Overall Study|Study terminated prior to completion|0|||
44135700|NCT02759315|78922937|FG002|Overall Study|Study terminated prior to completion|5|||
44135701|NCT02759315|78922938|FG003|Overall Study|Study terminated prior to completion|0|||
44135702|NCT02759315|78922939|FG004|Overall Study|Study terminated prior to completion|1|||
44135703|NCT00835081|78922955|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44135704|NCT00835081|78922956|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44135705|NCT02543918|78922962|FG000|Overall Study|Never treated|0|||
44135706|NCT02543918|78922963|FG001|Overall Study|Never treated|1|||
44135707|NCT02543918|78922962|FG000|Overall Study|Lost to Follow-up|1|||
44135708|NCT02543918|78922963|FG001|Overall Study|Lost to Follow-up|1|||
44135709|NCT02543918|78922962|FG000|Overall Study|Withdrawal by Subject|1|||
44135710|NCT02543918|78922963|FG001|Overall Study|Withdrawal by Subject|1|||
44135711|NCT02543918|78922962|FG000|Overall Study|Adverse Event|1|||
44135712|NCT02543918|78922963|FG001|Overall Study|Adverse Event|1|||
44135713|NCT01372995|78922972|FG000|Overall Study|Spouse withdrew participant from study|0|||
44135714|NCT01372995|78922973|FG001|Overall Study|Spouse withdrew participant from study|1|||
44135715|NCT01372995|78922974|FG002|Overall Study|Spouse withdrew participant from study|0|||
44135716|NCT01372995|78922972|FG000|Overall Study|Physician Decision|0|||
44135717|NCT01372995|78922973|FG001|Overall Study|Physician Decision|0|||
44135718|NCT01372995|78922974|FG002|Overall Study|Physician Decision|1|||
44135719|NCT02757521|78922984|FG000|Overall Study|Adverse Event|1|||
44135720|NCT02757521|78922985|FG001|Overall Study|Adverse Event|0|||
44135721|NCT00834613|78922993|FG000|First Intervention|Protocol Violation|1|||
44135722|NCT00834613|78922994|FG001|First Intervention|Protocol Violation|0|||
44135723|NCT00834067|78923011|FG000|Washout of 21 Days|Protocol Violation|0|||
44135724|NCT00834067|78923012|FG001|Washout of 21 Days|Protocol Violation|1|||
44135725|NCT02758613|78923020|FG000|Treatment|Physician and Sponsor Decision|1|||
44135726|NCT02758613|78923021|FG001|Treatment|Physician and Sponsor Decision|0|||
44135727|NCT02758613|78923022|FG002|Treatment|Physician and Sponsor Decision|0|||
44135728|NCT02758613|78923023|FG003|Treatment|Physician and Sponsor Decision|0|||
44135729|NCT02758613|78923020|FG000|Treatment|Withdrawal by Subject|1|||
44135730|NCT02758613|78923021|FG001|Treatment|Withdrawal by Subject|0|||
44135731|NCT02758613|78923022|FG002|Treatment|Withdrawal by Subject|1|||
44135732|NCT02758613|78923023|FG003|Treatment|Withdrawal by Subject|0|||
44135733|NCT02758301|78923038|FG000|Overall Study|Death|12|||
44135734|NCT02758301|78923039|FG001|Overall Study|Death|0|||
44135735|NCT02758301|78923038|FG000|Overall Study|Physician Decision|10|||
44135736|NCT02758301|78923039|FG001|Overall Study|Physician Decision|1|||
44135737|NCT02758301|78923038|FG000|Overall Study|Withdrawal by Subject|5|||
44135738|NCT02758301|78923039|FG001|Overall Study|Withdrawal by Subject|6|||
44135739|NCT02758301|78923038|FG000|Overall Study|Lost to Follow-up|7|||
44135740|NCT02758301|78923039|FG001|Overall Study|Lost to Follow-up|0|||
44135741|NCT02758301|78923038|FG000|Overall Study|Protocol Violation|0|||
44135742|NCT02758301|78923039|FG001|Overall Study|Protocol Violation|1|||
44135743|NCT02669667|78923059|FG000|Overall Study|Lost to Follow-up|0|||
44135744|NCT02669667|78923060|FG001|Overall Study|Lost to Follow-up|0|||
44135745|NCT02669667|78923061|FG002|Overall Study|Lost to Follow-up|0|||
44135746|NCT02669667|78923062|FG003|Overall Study|Lost to Follow-up|0|||
44135747|NCT02669667|78923063|FG004|Overall Study|Lost to Follow-up|0|||
44135748|NCT02669667|78923064|FG005|Overall Study|Lost to Follow-up|1|||
44135749|NCT02669667|78923065|FG006|Overall Study|Lost to Follow-up|0|||
44243711|NCT01690520|79073374|FG001|Overall Study|Withdrawal by Subject|0|||
44243712|NCT01690520|79073373|FG000|Overall Study|Relapse|0|||
44380299|NCT00759109|79386143|FG001|Overall Study|HCV RNA negative|0|||
44380300|NCT00759109|79386142|FG000|Overall Study|Participant moved to a different city|0|||
44380301|NCT00759109|79386143|FG001|Overall Study|Participant moved to a different city|1|||
44380302|NCT00759109|79386142|FG000|Overall Study|Participant had a liver transplant|0|||
44513219|NCT03129100|79519004|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513220|NCT03129100|79519005|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513221|NCT03129100|79519006|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135750|NCT02669433|78923090|FG000|Overall Study|Protocol Violation|0|||
44135751|NCT02669433|78923091|FG001|Overall Study|Protocol Violation|4|||
44135752|NCT02669433|78923092|FG002|Overall Study|Protocol Violation|1|||
44135753|NCT02669433|78923090|FG000|Overall Study|Disease Progression|1|||
44135754|NCT02669433|78923091|FG001|Overall Study|Disease Progression|0|||
44135755|NCT02669433|78923092|FG002|Overall Study|Disease Progression|0|||
44135756|NCT02669433|78923090|FG000|Overall Study|Physician Decision|1|||
44135757|NCT02669433|78923091|FG001|Overall Study|Physician Decision|1|||
44135758|NCT02669433|78923092|FG002|Overall Study|Physician Decision|0|||
44135759|NCT02669433|78923090|FG000|Overall Study|Adverse Event|6|||
44135760|NCT02669433|78923091|FG001|Overall Study|Adverse Event|7|||
44243713|NCT01690520|79073374|FG001|Overall Study|Relapse|1|||
44135761|NCT02669433|78923092|FG002|Overall Study|Adverse Event|10|||
44135762|NCT02669433|78923090|FG000|Overall Study|Sponsor Termination|1|||
44135763|NCT02669433|78923091|FG001|Overall Study|Sponsor Termination|0|||
44243714|NCT01690520|79073373|FG000|Overall Study|Other|0|||
44135764|NCT02669433|78923092|FG002|Overall Study|Sponsor Termination|1|||
44380303|NCT00759109|79386143|FG001|Overall Study|Participant had a liver transplant|1|||
44135765|NCT02669433|78923090|FG000|Overall Study|Withdrawal by Subject|5|||
44135766|NCT02669433|78923091|FG001|Overall Study|Withdrawal by Subject|1|||
44243715|NCT01690520|79073374|FG001|Overall Study|Other|1|||
44380304|NCT00759109|79386142|FG000|Overall Study|Lost during study|1|||
44380305|NCT00759109|79386143|FG001|Overall Study|Lost during study|0|||
44513222|NCT03129100|79519007|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513223|NCT03129100|79519008|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135767|NCT02669433|78923092|FG002|Overall Study|Withdrawal by Subject|0|||
44135768|NCT02669433|78923090|FG000|Overall Study|Withdrawal by Caregiver|1|||
44135769|NCT02669433|78923091|FG001|Overall Study|Withdrawal by Caregiver|0|||
44135770|NCT02669433|78923092|FG002|Overall Study|Withdrawal by Caregiver|2|||
44135771|NCT02669433|78923090|FG000|Overall Study|Death|0|||
44513224|NCT03129100|79519009|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513225|NCT03129100|79519010|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135772|NCT02669433|78923091|FG001|Overall Study|Death|1|||
44135773|NCT02669433|78923092|FG002|Overall Study|Death|1|||
44135774|NCT02756819|78923100|FG000|Overall Study|Lost for observation|23|||
44135775|NCT02756819|78923100|FG000|Overall Study|Patient's unwillingness|16|||
44135776|NCT02756819|78923100|FG000|Overall Study|Insufficient efficacy|2|||
44135777|NCT02756819|78923100|FG000|Overall Study|Adverse Event|2|||
44135778|NCT02756819|78923100|FG000|Overall Study|Reason not Specified|9|||
44135779|NCT00829309|78923106|FG000|Washout: 7 Days|Protocol Violation|1|||
44135780|NCT00829309|78923107|FG001|Washout: 7 Days|Protocol Violation|0|||
44135781|NCT02669121|78923113|FG000|Overall Study|Adverse Event|4|||
44135782|NCT02669121|78923114|FG001|Overall Study|Adverse Event|5|||
44135783|NCT02669121|78923113|FG000|Overall Study|Lost to Follow-up|15|||
44135784|NCT02669121|78923114|FG001|Overall Study|Lost to Follow-up|27|||
44135785|NCT02669121|78923113|FG000|Overall Study|Withdrawal by Subject|132|||
44135786|NCT02669121|78923114|FG001|Overall Study|Withdrawal by Subject|140|||
44135787|NCT02669121|78923113|FG000|Overall Study|Pregnancy|0|||
44135788|NCT02669121|78923114|FG001|Overall Study|Pregnancy|1|||
44135789|NCT02669121|78923113|FG000|Overall Study|Discharged from US Military Active Service|117|||
44135790|NCT02669121|78923114|FG001|Overall Study|Discharged from US Military Active Service|91|||
44135791|NCT02669121|78923113|FG000|Overall Study|Reason not Specified|22|||
44135792|NCT02669121|78923114|FG001|Overall Study|Reason not Specified|18|||
44135793|NCT02743117|78923122|FG000|Overall Study|Lost to Follow-up|0|||
44135794|NCT02743117|78923123|FG001|Overall Study|Lost to Follow-up|1|||
44135795|NCT02743117|78923122|FG000|Overall Study|Other|1|||
44135796|NCT02743117|78923123|FG001|Overall Study|Other|0|||
44135797|NCT02669043|78923138|FG000|Overall Study|Didn't meet I/E criteria|4|||
44135798|NCT00805129|78923142|FG000|Overall Study|Not treated|1|||
44135799|NCT02668185|78923146|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
44135800|NCT02668185|78923147|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
44135801|NCT02668185|78923146|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
44135802|NCT02668185|78923147|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
44135803|NCT02668185|78923146|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
44135804|NCT02668185|78923147|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
44135805|NCT02668185|78923146|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
44135806|NCT02668185|78923147|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
44135807|NCT02742181|78923158|FG000|Overall Study|Physician Decision|1|||
44135808|NCT02742181|78923159|FG001|Overall Study|Physician Decision|0|||
44513226|NCT03129100|79519011|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513227|NCT03129100|79519012|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513228|NCT03129100|79519013|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513229|NCT03129100|79519014|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513230|NCT03129100|79519015|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513231|NCT03129100|79519016|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513232|NCT03129100|79519017|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135809|NCT02742103|78923167|FG000|Overall Study|Protocol Violation|1|||
44135810|NCT02742103|78923168|FG001|Overall Study|Protocol Violation|0|||
44135811|NCT02742103|78923167|FG000|Overall Study|Death|2|||
44135812|NCT02742103|78923168|FG001|Overall Study|Death|2|||
44135813|NCT02742103|78923167|FG000|Overall Study|Adverse Event|1|||
44135814|NCT02742103|78923168|FG001|Overall Study|Adverse Event|0|||
44135815|NCT02742103|78923167|FG000|Overall Study|Moved to another town|0|||
44135816|NCT02742103|78923168|FG001|Overall Study|Moved to another town|1|||
44513233|NCT03129100|79519018|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135817|NCT02742103|78923167|FG000|Overall Study|Withdrawal by Subject|5|||
44135818|NCT02742103|78923168|FG001|Overall Study|Withdrawal by Subject|2|||
44135819|NCT02741713|78923176|FG000|Overall Study|Surgery type changed intra-operatively|2|||
44135820|NCT02741713|78923177|FG001|Overall Study|Surgery type changed intra-operatively|1|||
44135821|NCT02663271|78923184|FG000|Overall Study|Withdrawal by Subject|5|||
44135822|NCT02663271|78923184|FG000|Overall Study|Lack of Efficacy|1|||
44135823|NCT02742649|78923191|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
44135824|NCT02742649|78923192|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
44135825|NCT02742649|78923193|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
44135826|NCT02742649|78923194|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
44135827|NCT02742649|78923195|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
44135828|NCT02742649|78923191|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44135829|NCT02742649|78923192|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44135830|NCT02742649|78923193|FG002|Double-Blind Treatment Period|Adverse Event|0|||
44135831|NCT02742649|78923194|FG003|Double-Blind Treatment Period|Adverse Event|0|||
44135832|NCT02742649|78923195|FG004|Double-Blind Treatment Period|Adverse Event|0|||
44135833|NCT02742649|78923191|FG000|Open-Label Period|Lost to Follow-up|0|||
44135834|NCT02742649|78923192|FG001|Open-Label Period|Lost to Follow-up|0|||
44135835|NCT02742649|78923193|FG002|Open-Label Period|Lost to Follow-up|0|||
44135836|NCT02742649|78923194|FG003|Open-Label Period|Lost to Follow-up|0|||
44135837|NCT02742649|78923195|FG004|Open-Label Period|Lost to Follow-up|1|||
44135838|NCT02665689|78923208|FG000|Overall Study|Adverse Event|1|||
44135839|NCT02665689|78923209|FG001|Overall Study|Adverse Event|0|||
44135840|NCT02665689|78923208|FG000|Overall Study|Trial termination|1|||
44135841|NCT02665689|78923209|FG001|Overall Study|Trial termination|1|||
44135842|NCT02665689|78923208|FG000|Overall Study|Lost to Follow-up|0|||
44135843|NCT02665689|78923209|FG001|Overall Study|Lost to Follow-up|1|||
44135844|NCT02665455|78923215|FG000|Overall Study|Withdrawal by Subject|6|||
44135845|NCT02665455|78923215|FG000|Overall Study|Lost to Follow-up|1|||
44135846|NCT02665455|78923215|FG000|Overall Study|Adverse Event|1|||
44135847|NCT02665455|78923215|FG000|Overall Study|Protocol Violation|1|||
44135848|NCT02755805|78923221|FG000|Overall Study|Lost to Follow-up|1|||
44135849|NCT02755805|78923222|FG001|Overall Study|Lost to Follow-up|2|||
44135850|NCT02755805|78923221|FG000|Overall Study|Refused assessments|1|||
44135851|NCT02755805|78923222|FG001|Overall Study|Refused assessments|0|||
44135852|NCT02755805|78923221|FG000|Overall Study|Withdrawal by Subject|0|||
44135853|NCT02755805|78923222|FG001|Overall Study|Withdrawal by Subject|2|||
44135854|NCT02755649|78923231|FG000|Overall Study|Transitioned into OLE study|99|||
44135855|NCT02755649|78923232|FG001|Overall Study|Transitioned into OLE study|98|||
44135856|NCT02755649|78923233|FG002|Overall Study|Transitioned into OLE study|100|||
44135857|NCT02755649|78923231|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
44135858|NCT02755649|78923232|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
44135859|NCT02755649|78923233|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
44135860|NCT02755649|78923231|FG000|Overall Study|Physician Decision|0|||
44135861|NCT02755649|78923232|FG001|Overall Study|Physician Decision|0|||
44135862|NCT02755649|78923233|FG002|Overall Study|Physician Decision|2|||
44135863|NCT02755649|78923231|FG000|Overall Study|Withdrawal by Subject|0|||
44135864|NCT02755649|78923232|FG001|Overall Study|Withdrawal by Subject|1|||
44135865|NCT02755649|78923233|FG002|Overall Study|Withdrawal by Subject|0|||
44135866|NCT02755649|78923231|FG000|Overall Study|Undecided|1|||
44135867|NCT02755649|78923232|FG001|Overall Study|Undecided|0|||
44135868|NCT02755649|78923233|FG002|Overall Study|Undecided|0|||
44135869|NCT00151411|78923243|FG000|Overall Study|Lost to Follow-up|15|||
44135870|NCT00151411|78923244|FG001|Overall Study|Lost to Follow-up|19|||
44135871|NCT00151411|78923243|FG000|Overall Study|Withdrawal by Subject|12|||
44135872|NCT00151411|78923244|FG001|Overall Study|Withdrawal by Subject|20|||
44135873|NCT00151411|78923243|FG000|Overall Study|Adverse Event|6|||
44135874|NCT00151411|78923244|FG001|Overall Study|Adverse Event|0|||
44135875|NCT00151411|78923243|FG000|Overall Study|Pregnancy|0|||
44135876|NCT00151411|78923244|FG001|Overall Study|Pregnancy|4|||
44380306|NCT00759031|79386151|FG000|First Intervention (1 Day)|Physician Decision|1|||
44380307|NCT00759031|79386152|FG001|First Intervention (1 Day)|Physician Decision|0|||
44135877|NCT02662569|78923254|FG000|Overall Study|Withdrawal by Subject|6|||
44135878|NCT02662569|78923255|FG001|Overall Study|Withdrawal by Subject|1|||
44135879|NCT02662569|78923256|FG002|Overall Study|Withdrawal by Subject|6|||
44135880|NCT02662569|78923257|FG003|Overall Study|Withdrawal by Subject|4|||
44135881|NCT02662569|78923254|FG000|Overall Study|Lost to Follow-up|1|||
44135882|NCT02662569|78923255|FG001|Overall Study|Lost to Follow-up|0|||
44135883|NCT02662569|78923256|FG002|Overall Study|Lost to Follow-up|0|||
44135884|NCT02662569|78923257|FG003|Overall Study|Lost to Follow-up|0|||
44276600|NCT04791319|79237616|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44276601|NCT04791319|79237617|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44276602|NCT04791319|79237618|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44380308|NCT00759031|79386151|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
44513234|NCT03129100|79519019|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513235|NCT03129100|79519020|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513236|NCT03129100|79519021|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
44135885|NCT02741635|78923267|FG000|Overall Study|Withdrawal by Subject|1|||
44135886|NCT02753075|78923275|FG000|Overall Study|Adverse Event|2|||
44135887|NCT02753075|78923276|FG001|Overall Study|Adverse Event|1|||
44135888|NCT02753075|78923277|FG002|Overall Study|Adverse Event|0|||
44135889|NCT02753075|78923275|FG000|Overall Study|Lost to Follow-up|2|||
44135890|NCT02753075|78923276|FG001|Overall Study|Lost to Follow-up|0|||
44135891|NCT02753075|78923277|FG002|Overall Study|Lost to Follow-up|0|||
44135892|NCT02753075|78923275|FG000|Overall Study|Withdrawal of Consent|1|||
44135893|NCT02753075|78923276|FG001|Overall Study|Withdrawal of Consent|1|||
44135894|NCT02753075|78923277|FG002|Overall Study|Withdrawal of Consent|3|||
44135895|NCT02753075|78923275|FG000|Overall Study|Physician Decision|3|||
44135896|NCT02753075|78923276|FG001|Overall Study|Physician Decision|1|||
44135897|NCT02753075|78923277|FG002|Overall Study|Physician Decision|0|||
44135898|NCT02332720|78923309|FG000|Part A and Part B|Lost to Follow-up|1|||
44135899|NCT02332720|78923310|FG001|Part A and Part B|Lost to Follow-up|0|||
44135900|NCT02332720|78923311|FG002|Part A and Part B|Lost to Follow-up|0|||
44135901|NCT02332720|78923312|FG003|Part A and Part B|Lost to Follow-up|0|||
44135902|NCT02332720|78923313|FG004|Part A and Part B|Lost to Follow-up|0|||
44135903|NCT02332720|78923314|FG005|Part A and Part B|Lost to Follow-up|2|||
44135904|NCT02332720|78923315|FG006|Part A and Part B|Lost to Follow-up|1|||
44135905|NCT02332720|78923316|FG007|Part A and Part B|Lost to Follow-up|1|||
44135906|NCT02332720|78923317|FG008|Part A and Part B|Lost to Follow-up|0|||
44135907|NCT02332720|78923318|FG009|Part A and Part B|Lost to Follow-up|0|||
44135908|NCT02332720|78923319|FG010|Part A and Part B|Lost to Follow-up|0|||
44135909|NCT02332720|78923320|FG011|Part A and Part B|Lost to Follow-up|0|||
44135910|NCT02332720|78923321|FG012|Part A and Part B|Lost to Follow-up|0|||
44135911|NCT02332720|78923322|FG013|Part A and Part B|Lost to Follow-up|0|||
44135912|NCT02332720|78923323|FG014|Part A and Part B|Lost to Follow-up|0|||
44135913|NCT02332720|78923324|FG015|Part A and Part B|Lost to Follow-up|1|||
44135914|NCT02332720|78923325|FG016|Part A and Part B|Lost to Follow-up|0|||
44135915|NCT02332720|78923326|FG017|Part A and Part B|Lost to Follow-up|0|||
44135916|NCT02332720|78923327|FG018|Part A and Part B|Lost to Follow-up|0|||
44135917|NCT02332720|78923328|FG019|Part A and Part B|Lost to Follow-up|0|||
44135918|NCT02332720|78923329|FG020|Part A and Part B|Lost to Follow-up|0|||
44135919|NCT02332720|78923330|FG021|Part A and Part B|Lost to Follow-up|0|||
44135920|NCT02332720|78923331|FG022|Part A and Part B|Lost to Follow-up|0|||
44135921|NCT02332720|78923309|FG000|Part A and Part B|Adverse Event|0|||
44135922|NCT02332720|78923310|FG001|Part A and Part B|Adverse Event|0|||
44135923|NCT02332720|78923311|FG002|Part A and Part B|Adverse Event|0|||
44513237|NCT03129100|79519022|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513238|NCT03129100|79519023|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513239|NCT03129100|79519024|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513240|NCT03129100|79519025|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
44513241|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513242|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513243|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
44135924|NCT02332720|78923312|FG003|Part A and Part B|Adverse Event|0|||
44135925|NCT02332720|78923313|FG004|Part A and Part B|Adverse Event|0|||
44135926|NCT02332720|78923314|FG005|Part A and Part B|Adverse Event|0|||
44135927|NCT02332720|78923315|FG006|Part A and Part B|Adverse Event|0|||
44135928|NCT02332720|78923316|FG007|Part A and Part B|Adverse Event|0|||
44135929|NCT02332720|78923317|FG008|Part A and Part B|Adverse Event|0|||
44135930|NCT02332720|78923318|FG009|Part A and Part B|Adverse Event|0|||
44135931|NCT02332720|78923319|FG010|Part A and Part B|Adverse Event|0|||
44135932|NCT02332720|78923320|FG011|Part A and Part B|Adverse Event|0|||
44135933|NCT02332720|78923321|FG012|Part A and Part B|Adverse Event|0|||
44135934|NCT02332720|78923322|FG013|Part A and Part B|Adverse Event|0|||
44135935|NCT02332720|78923323|FG014|Part A and Part B|Adverse Event|0|||
44135936|NCT02332720|78923324|FG015|Part A and Part B|Adverse Event|0|||
44135937|NCT02332720|78923325|FG016|Part A and Part B|Adverse Event|0|||
44135938|NCT02332720|78923326|FG017|Part A and Part B|Adverse Event|1|||
44135939|NCT02332720|78923327|FG018|Part A and Part B|Adverse Event|0|||
44135940|NCT02332720|78923328|FG019|Part A and Part B|Adverse Event|0|||
44135941|NCT02332720|78923329|FG020|Part A and Part B|Adverse Event|0|||
44135942|NCT02332720|78923330|FG021|Part A and Part B|Adverse Event|0|||
44135943|NCT02332720|78923331|FG022|Part A and Part B|Adverse Event|0|||
44135944|NCT02332720|78923309|FG000|Part A and Part B|Physician Decision|0|||
44135945|NCT02332720|78923310|FG001|Part A and Part B|Physician Decision|0|||
44135946|NCT02332720|78923311|FG002|Part A and Part B|Physician Decision|0|||
44135947|NCT02332720|78923312|FG003|Part A and Part B|Physician Decision|0|||
44135948|NCT02332720|78923313|FG004|Part A and Part B|Physician Decision|0|||
44135949|NCT02332720|78923314|FG005|Part A and Part B|Physician Decision|0|||
44135950|NCT02332720|78923315|FG006|Part A and Part B|Physician Decision|0|||
44135951|NCT02332720|78923316|FG007|Part A and Part B|Physician Decision|0|||
44135952|NCT02332720|78923317|FG008|Part A and Part B|Physician Decision|0|||
44135953|NCT02332720|78923318|FG009|Part A and Part B|Physician Decision|0|||
44135954|NCT02332720|78923319|FG010|Part A and Part B|Physician Decision|0|||
44135955|NCT02332720|78923320|FG011|Part A and Part B|Physician Decision|0|||
44135956|NCT02332720|78923321|FG012|Part A and Part B|Physician Decision|0|||
44135957|NCT02332720|78923322|FG013|Part A and Part B|Physician Decision|0|||
44135958|NCT02332720|78923323|FG014|Part A and Part B|Physician Decision|0|||
44135959|NCT02332720|78923324|FG015|Part A and Part B|Physician Decision|0|||
44135960|NCT02332720|78923325|FG016|Part A and Part B|Physician Decision|0|||
44135961|NCT02332720|78923326|FG017|Part A and Part B|Physician Decision|0|||
44135962|NCT02332720|78923327|FG018|Part A and Part B|Physician Decision|1|||
44135963|NCT02332720|78923328|FG019|Part A and Part B|Physician Decision|0|||
44135964|NCT02332720|78923329|FG020|Part A and Part B|Physician Decision|0|||
44135965|NCT02332720|78923330|FG021|Part A and Part B|Physician Decision|0|||
44135966|NCT02332720|78923331|FG022|Part A and Part B|Physician Decision|0|||
44135967|NCT02332720|78923309|FG000|Part A and Part B|Withdrawal by Subject|0|||
44135968|NCT02332720|78923310|FG001|Part A and Part B|Withdrawal by Subject|0|||
44135969|NCT02332720|78923311|FG002|Part A and Part B|Withdrawal by Subject|0|||
44135970|NCT02332720|78923312|FG003|Part A and Part B|Withdrawal by Subject|0|||
44135971|NCT02332720|78923313|FG004|Part A and Part B|Withdrawal by Subject|0|||
44135972|NCT02332720|78923314|FG005|Part A and Part B|Withdrawal by Subject|1|||
44135973|NCT02332720|78923315|FG006|Part A and Part B|Withdrawal by Subject|0|||
44135974|NCT02332720|78923316|FG007|Part A and Part B|Withdrawal by Subject|0|||
44135975|NCT02332720|78923317|FG008|Part A and Part B|Withdrawal by Subject|0|||
44135976|NCT02332720|78923318|FG009|Part A and Part B|Withdrawal by Subject|0|||
44135977|NCT02332720|78923319|FG010|Part A and Part B|Withdrawal by Subject|0|||
44135978|NCT02332720|78923320|FG011|Part A and Part B|Withdrawal by Subject|0|||
44135979|NCT02332720|78923321|FG012|Part A and Part B|Withdrawal by Subject|0|||
44135980|NCT02332720|78923322|FG013|Part A and Part B|Withdrawal by Subject|0|||
44135981|NCT02332720|78923323|FG014|Part A and Part B|Withdrawal by Subject|0|||
44135982|NCT02332720|78923324|FG015|Part A and Part B|Withdrawal by Subject|0|||
44135983|NCT02332720|78923325|FG016|Part A and Part B|Withdrawal by Subject|0|||
44135984|NCT02332720|78923326|FG017|Part A and Part B|Withdrawal by Subject|0|||
44135985|NCT02332720|78923327|FG018|Part A and Part B|Withdrawal by Subject|0|||
44135986|NCT02332720|78923328|FG019|Part A and Part B|Withdrawal by Subject|1|||
44135987|NCT02332720|78923329|FG020|Part A and Part B|Withdrawal by Subject|0|||
44135988|NCT02332720|78923330|FG021|Part A and Part B|Withdrawal by Subject|0|||
44135989|NCT02332720|78923331|FG022|Part A and Part B|Withdrawal by Subject|0|||
44135990|NCT02331394|78923403|FG000|Overall Study|Disease progression|1|||
44135991|NCT01645930|78923414|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
44135992|NCT01645930|78923414|FG000|Overall Study|Progressive Disease|12|||
44243716|NCT01690520|79073373|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
44243717|NCT01690520|79073374|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
44243718|NCT01563536|79073395|FG000|Overall Study|Withdrawal by Subject|0|||
44243719|NCT01563536|79073396|FG001|Overall Study|Withdrawal by Subject|2|||
44243720|NCT01563536|79073395|FG000|Overall Study|Lost to Follow-up|1|||
44243721|NCT01563536|79073396|FG001|Overall Study|Lost to Follow-up|0|||
44135993|NCT01645930|78923414|FG000|Overall Study|Adverse Event|4|||
44135994|NCT01645930|78923414|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
44135995|NCT01645930|78923414|FG000|Overall Study|Withdrawal by Participant|2|||
44135996|NCT01645930|78923414|FG000|Overall Study|Reason not Defined|1|||
44135997|NCT02299336|78923418|FG000|Overall Study|Withdrawal by Subject|11|||
44135998|NCT02299336|78923418|FG000|Overall Study|Adverse Event|1|||
44135999|NCT02299336|78923418|FG000|Overall Study|Death|1|||
44136000|NCT02299336|78923418|FG000|Overall Study|Lost to Follow-up|1|||
44136001|NCT02664441|78923424|FG000|Randomization|Withdrawal by Subject|0|||
44136002|NCT02664441|78923425|FG001|Randomization|Withdrawal by Subject|1|||
44136003|NCT02664441|78923424|FG000|36-week Randomized Trial|Adverse Event|2|||
44136004|NCT02664441|78923425|FG001|36-week Randomized Trial|Adverse Event|0|||
44136005|NCT02664441|78923424|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
44136006|NCT02664441|78923425|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
44136007|NCT02664441|78923424|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
44136008|NCT02664441|78923425|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
44136009|NCT02664441|78923424|FG000|18-week Open Label Extension|Adverse Event|1|||
44136010|NCT02664441|78923425|FG001|18-week Open Label Extension|Adverse Event|0|||
44136011|NCT02664441|78923424|FG000|18-week Open Label Extension|Physician Decision|1|||
44136012|NCT02664441|78923425|FG001|18-week Open Label Extension|Physician Decision|0|||
44136013|NCT02664441|78923424|FG000|18-week Open Label Extension|Death|1|||
44136014|NCT02664441|78923425|FG001|18-week Open Label Extension|Death|0|||
44136015|NCT02664441|78923424|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
44136016|NCT02664441|78923425|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
44136017|NCT02298946|78923434|FG000|Overall Study|Did not receive treatment|2|||
44136018|NCT02298946|78923435|FG001|Overall Study|Did not receive treatment|0|||
44136019|NCT02298946|78923434|FG000|Overall Study|Unevaluable|2|||
44136020|NCT02298946|78923435|FG001|Overall Study|Unevaluable|1|||
44136021|NCT02328040|78923442|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
44136022|NCT02328040|78923443|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
44136023|NCT01647958|78923451|FG000|Initial Study|Lost to Follow-up|2|||
44136024|NCT01647958|78923452|FG001|Initial Study|Lost to Follow-up|3|||
44136025|NCT01647958|78923451|FG000|Continuation Phase|treatment received during Overall Study|39|||
44136026|NCT01647958|78923452|FG001|Continuation Phase|treatment received during Overall Study|0|||
44136027|NCT01647958|78923451|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
44136028|NCT01647958|78923452|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
44136029|NCT02298868|78923467|FG000|Overall Study|Adverse Event|1|||
44136030|NCT02298868|78923467|FG000|Overall Study|Death|1|||
44136031|NCT02298868|78923467|FG000|Overall Study|Patient underwent transplant|1|||
44136032|NCT02327260|78923474|FG000|Overall Study|Lost to Follow-up|2|||
44136033|NCT02327260|78923475|FG001|Overall Study|Lost to Follow-up|3|||
44136034|NCT02327260|78923476|FG002|Overall Study|Lost to Follow-up|2|||
44136035|NCT02327260|78923474|FG000|Overall Study|invalid phone number|1|||
44136036|NCT02327260|78923475|FG001|Overall Study|invalid phone number|1|||
44136037|NCT02327260|78923476|FG002|Overall Study|invalid phone number|0|||
44136038|NCT02327260|78923474|FG000|Overall Study|non-adherence to protocol|2|||
44136039|NCT02327260|78923475|FG001|Overall Study|non-adherence to protocol|0|||
44136040|NCT02327260|78923476|FG002|Overall Study|non-adherence to protocol|0|||
44136041|NCT02327260|78923474|FG000|Overall Study|cognitive concerns|1|||
44136042|NCT02327260|78923475|FG001|Overall Study|cognitive concerns|0|||
44136043|NCT02327260|78923476|FG002|Overall Study|cognitive concerns|0|||
44136044|NCT02296840|78923487|FG000|Overall Study|Adverse Event|1|||
44136045|NCT02296840|78923488|FG001|Overall Study|Adverse Event|1|||
44136046|NCT02296840|78923487|FG000|Overall Study|Protocol Violation|2|||
44136047|NCT02296840|78923488|FG001|Overall Study|Protocol Violation|1|||
44136048|NCT02296840|78923487|FG000|Overall Study|Lost to Follow-up|6|||
44136049|NCT02296840|78923488|FG001|Overall Study|Lost to Follow-up|17|||
44136050|NCT02663895|78923497|FG000|Overall Study|Adverse Event|3|||
44136051|NCT02663895|78923497|FG000|Overall Study|Physician Decision|2|||
44136052|NCT02663895|78923497|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
44136053|NCT02663895|78923497|FG000|Overall Study|Withdrawal by Subject|1|||
44136054|NCT02663817|78923502|FG000|Overall Study|Screen failure|2|||
44136055|NCT01372605|78923510|FG000|Overall Study|Death|1|||
44136056|NCT01372605|78923511|FG001|Overall Study|Death|2|||
44136057|NCT01372605|78923510|FG000|Overall Study|Lost to Follow-up|2|||
44136058|NCT01372605|78923511|FG001|Overall Study|Lost to Follow-up|1|||
44136059|NCT01372605|78923510|FG000|Overall Study|Withdrawal by Subject|4|||
44136060|NCT01372605|78923511|FG001|Overall Study|Withdrawal by Subject|7|||
44243722|NCT01690130|79073404|FG000|Overall Study|Subject have cancelled visit.|1|||
44243723|NCT01690130|79073405|FG001|Overall Study|Subject have cancelled visit.|0|||
44136061|NCT01372605|78923510|FG000|Overall Study|Moved|3|||
44136062|NCT01372605|78923511|FG001|Overall Study|Moved|0|||
44136063|NCT01372605|78923510|FG000|Overall Study|Changed medical home|2|||
44243724|NCT01690052|79073411|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
44136064|NCT01372605|78923511|FG001|Overall Study|Changed medical home|0|||
44136065|NCT02751983|78923519|FG000|Treatment|Stopped ACT, but Remained in study|2|||
44243725|NCT01690052|79073412|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
44136066|NCT02751983|78923520|FG001|Treatment|Stopped ACT, but Remained in study|0|||
44136067|NCT02751983|78923519|FG000|Treatment|Discharged prior to beginning ACT|2|||
44136068|NCT02751983|78923520|FG001|Treatment|Discharged prior to beginning ACT|0|||
44136069|NCT02751983|78923519|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
44136070|NCT02751983|78923520|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
44136071|NCT02751983|78923519|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
44136072|NCT02751983|78923520|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
44136073|NCT02751983|78923519|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
44136074|NCT02751983|78923520|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
44136075|NCT00232141|78923540|FG000|Overall Study|Adverse Event|9|||
44136076|NCT00232141|78923541|FG001|Overall Study|Adverse Event|4|||
44136077|NCT00232141|78923540|FG000|Overall Study|Lack of Efficacy|0|||
44136078|NCT00232141|78923541|FG001|Overall Study|Lack of Efficacy|3|||
44136079|NCT00232141|78923540|FG000|Overall Study|Lost to Follow-up|9|||
44136080|NCT00232141|78923541|FG001|Overall Study|Lost to Follow-up|6|||
44136081|NCT00232141|78923540|FG000|Overall Study|Other|8|||
44136082|NCT00232141|78923541|FG001|Overall Study|Other|10|||
44136083|NCT00232141|78923540|FG000|Overall Study|Withdrawal by Subject|5|||
44136084|NCT00232141|78923541|FG001|Overall Study|Withdrawal by Subject|3|||
44136085|NCT02741245|78923570|FG000|Overall Study|Adverse Event|0|||
44136086|NCT02741245|78923571|FG001|Overall Study|Adverse Event|0|||
44136087|NCT02741245|78923572|FG002|Overall Study|Adverse Event|0|||
44136088|NCT02741245|78923573|FG003|Overall Study|Adverse Event|2|||
44136089|NCT02741245|78923574|FG004|Overall Study|Adverse Event|2|||
44136090|NCT02741245|78923570|FG000|Overall Study|Protocol Violation|0|||
44136091|NCT02741245|78923571|FG001|Overall Study|Protocol Violation|1|||
44136092|NCT02741245|78923572|FG002|Overall Study|Protocol Violation|0|||
44136093|NCT02741245|78923573|FG003|Overall Study|Protocol Violation|1|||
44136094|NCT02741245|78923574|FG004|Overall Study|Protocol Violation|0|||
44136095|NCT02741245|78923570|FG000|Overall Study|Withdrawal by Subject|0|||
44136096|NCT02741245|78923571|FG001|Overall Study|Withdrawal by Subject|0|||
44136097|NCT02741245|78923572|FG002|Overall Study|Withdrawal by Subject|0|||
44136098|NCT02741245|78923573|FG003|Overall Study|Withdrawal by Subject|1|||
44136099|NCT02741245|78923574|FG004|Overall Study|Withdrawal by Subject|0|||
44136100|NCT02751827|78923600|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
44136101|NCT02751827|78923601|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
44136102|NCT02751827|78923602|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
44136103|NCT04896593|78923610|FG000|Overall Study|Withdrawal by Subject|2|||
44136104|NCT04896593|78923610|FG000|Overall Study|Lost to Follow-up|1|||
44136105|NCT04896593|78923610|FG000|Overall Study|Did not complete onboarding|2|||
44136106|NCT04601272|78923617|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
44136107|NCT04601272|78923618|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
44136108|NCT04601272|78923619|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
44136109|NCT03965091|78923630|FG000|Overall Study|Adverse Event|0|||
44136110|NCT03965091|78923631|FG001|Overall Study|Adverse Event|2|||
44136111|NCT03965091|78923632|FG002|Overall Study|Adverse Event|3|||
44136112|NCT03965091|78923630|FG000|Overall Study|Withdrawal by Subject|11|||
44136113|NCT03965091|78923631|FG001|Overall Study|Withdrawal by Subject|3|||
44136114|NCT03965091|78923632|FG002|Overall Study|Withdrawal by Subject|5|||
44136115|NCT03965091|78923630|FG000|Overall Study|Non-compliance with study drug|0|||
44136116|NCT03965091|78923631|FG001|Overall Study|Non-compliance with study drug|0|||
44136117|NCT03965091|78923632|FG002|Overall Study|Non-compliance with study drug|1|||
44380309|NCT00759031|79386152|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
44380310|NCT00759031|79386151|FG000|First Intervention (1 Day)|Screening failure|1|||
44136118|NCT03965091|78923630|FG000|Overall Study|Lost to Follow-up|1|||
44380311|NCT00759031|79386152|FG001|First Intervention (1 Day)|Screening failure|0|||
44136119|NCT03965091|78923631|FG001|Overall Study|Lost to Follow-up|1|||
44380312|NCT00758485|79386160|FG000|Overall Study|Lost to Follow-up|0|||
44136120|NCT03965091|78923632|FG002|Overall Study|Lost to Follow-up|1|||
44136121|NCT03965091|78923630|FG000|Overall Study|Lack of Efficacy|2|||
44136122|NCT03965091|78923631|FG001|Overall Study|Lack of Efficacy|0|||
44136123|NCT03965091|78923632|FG002|Overall Study|Lack of Efficacy|0|||
44136124|NCT03965091|78923630|FG000|Overall Study|Other than specified|9|||
44136125|NCT03965091|78923631|FG001|Overall Study|Other than specified|11|||
44136126|NCT03965091|78923632|FG002|Overall Study|Other than specified|8|||
44136127|NCT03359096|78923659|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
44136128|NCT03359096|78923660|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
44136129|NCT03359096|78923659|FG000|First Intervention (4 Weeks)|Death|1|||
44136130|NCT03359096|78923660|FG001|First Intervention (4 Weeks)|Death|0|||
44136131|NCT03359096|78923659|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
44136132|NCT03359096|78923660|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
44136133|NCT03019588|78923677|FG000|Overall Study|Death|44|||
44136134|NCT03019588|78923678|FG001|Overall Study|Death|46|||
44136135|NCT03019588|78923677|FG000|Overall Study|Study terminated by Sponsor|3|||
44136136|NCT03019588|78923678|FG001|Overall Study|Study terminated by Sponsor|1|||
44136137|NCT02455557|78923706|FG000|Overall Study|Withdrawal by Subject|2|||
44136138|NCT02270450|78923714|FG000|Overall Study|Refusal unrelated to adverse event|3|||
44136139|NCT02270450|78923715|FG001|Overall Study|Refusal unrelated to adverse event|1|||
44136140|NCT02270450|78923716|FG002|Overall Study|Refusal unrelated to adverse event|5|||
44136141|NCT02270450|78923717|FG003|Overall Study|Refusal unrelated to adverse event|14|||
44136142|NCT02270450|78923714|FG000|Overall Study|Progression/relapse|1|||
44136143|NCT02270450|78923715|FG001|Overall Study|Progression/relapse|2|||
44136144|NCT02270450|78923716|FG002|Overall Study|Progression/relapse|4|||
44136145|NCT02270450|78923717|FG003|Overall Study|Progression/relapse|9|||
44136146|NCT02270450|78923714|FG000|Overall Study|Death|19|||
44136147|NCT02270450|78923715|FG001|Overall Study|Death|19|||
44136148|NCT02270450|78923716|FG002|Overall Study|Death|31|||
44136149|NCT02270450|78923717|FG003|Overall Study|Death|59|||
44136150|NCT01565499|78923738|FG000|Overall Study|Physician Decision|1|||
44136151|NCT01565499|78923738|FG000|Overall Study|Adverse Event|5|||
44136152|NCT01565499|78923738|FG000|Overall Study|Withdrawal by Subject|2|||
44136153|NCT01036087|78923742|FG000|Overall Study|Adverse Event|2|||
44136154|NCT01036087|78923742|FG000|Overall Study|Lack of Efficacy|1|||
44136155|NCT00572156|78923759|FG000|Overall Study|Adverse Event|3|||
44136156|NCT00572156|78923760|FG001|Overall Study|Adverse Event|1|||
44136157|NCT00572156|78923761|FG002|Overall Study|Adverse Event|5|||
44136158|NCT00572156|78923762|FG003|Overall Study|Adverse Event|1|||
44136159|NCT00572156|78923759|FG000|Overall Study|Lost to Follow-up|1|||
44136160|NCT00572156|78923760|FG001|Overall Study|Lost to Follow-up|1|||
44136161|NCT00572156|78923761|FG002|Overall Study|Lost to Follow-up|1|||
44136162|NCT00572156|78923762|FG003|Overall Study|Lost to Follow-up|0|||
44136163|NCT00572156|78923759|FG000|Overall Study|Protocol Violation|1|||
44136164|NCT00572156|78923760|FG001|Overall Study|Protocol Violation|2|||
44136165|NCT00572156|78923761|FG002|Overall Study|Protocol Violation|0|||
44136166|NCT00572156|78923762|FG003|Overall Study|Protocol Violation|2|||
44136167|NCT00572156|78923759|FG000|Overall Study|Patient/Parent Decision|1|||
44136168|NCT00572156|78923760|FG001|Overall Study|Patient/Parent Decision|6|||
44136169|NCT00572156|78923761|FG002|Overall Study|Patient/Parent Decision|4|||
44136170|NCT00572156|78923762|FG003|Overall Study|Patient/Parent Decision|3|||
44136171|NCT00572156|78923759|FG000|Overall Study|Sponsor Decision|20|||
44136172|NCT00572156|78923760|FG001|Overall Study|Sponsor Decision|16|||
44136173|NCT00572156|78923761|FG002|Overall Study|Sponsor Decision|17|||
44136174|NCT00572156|78923762|FG003|Overall Study|Sponsor Decision|19|||
44136175|NCT00447772|78923772|FG000|Overall Study|Lack of Efficacy|3|||
44136176|NCT00447772|78923772|FG000|Overall Study|Insufficient compliance|6|||
44136177|NCT00447772|78923772|FG000|Overall Study|Discontinuation of drug therapy|1|||
44136178|NCT00447772|78923772|FG000|Overall Study|Lost to Follow-up|9|||
44136179|NCT00447772|78923772|FG000|Overall Study|Withdrawal by Subject|1|||
44136180|NCT00447772|78923772|FG000|Overall Study|Unable to attend all study visits|2|||
44136181|NCT00447772|78923772|FG000|Overall Study|Adverse Event|1|||
44136182|NCT00447772|78923772|FG000|Overall Study|Patient relocated|1|||
44136183|NCT00447772|78923772|FG000|Overall Study|Incomplete documentation at visit 1|1|||
44136184|NCT00447772|78923772|FG000|Overall Study|Chemotherapy for lung cancer|1|||
44136185|NCT00447772|78923772|FG000|Overall Study|Premature re-injection required|1|||
44136186|NCT02296138|78923781|FG000|Overall Study|Adverse Event|348|||
44136187|NCT02296138|78923782|FG001|Overall Study|Adverse Event|259|||
44136188|NCT02296138|78923781|FG000|Overall Study|Lack of Efficacy|59|||
44136189|NCT02296138|78923782|FG001|Overall Study|Lack of Efficacy|37|||
44380313|NCT00758485|79386161|FG001|Overall Study|Lost to Follow-up|1|||
44136190|NCT02296138|78923781|FG000|Overall Study|Protocol Violation|35|||
44136191|NCT02296138|78923782|FG001|Overall Study|Protocol Violation|36|||
44136192|NCT02296138|78923781|FG000|Overall Study|Lost to Follow-up|9|||
44136193|NCT02296138|78923782|FG001|Overall Study|Lost to Follow-up|12|||
44136194|NCT02296138|78923781|FG000|Overall Study|Withdrawal by Subject|184|||
44136195|NCT02296138|78923782|FG001|Overall Study|Withdrawal by Subject|131|||
44136196|NCT02296138|78923781|FG000|Overall Study|Not Treated|1|||
44136197|NCT02296138|78923782|FG001|Overall Study|Not Treated|1|||
44136198|NCT02296138|78923781|FG000|Overall Study|Patients with data irregularities|10|||
44136199|NCT02296138|78923782|FG001|Overall Study|Patients with data irregularities|11|||
44136200|NCT02296138|78923781|FG000|Overall Study|Other than specified|15|||
44136201|NCT02296138|78923782|FG001|Overall Study|Other than specified|13|||
44136202|NCT01306942|78923791|FG000|Phase I|Adverse Event|2|||
44136203|NCT01306942|78923792|FG001|Phase I|Adverse Event|2|||
44136204|NCT01306942|78923793|FG002|Phase I|Adverse Event|0|||
44136205|NCT01306942|78923794|FG003|Phase I|Adverse Event|0|||
44136206|NCT01306942|78923791|FG000|Phase I|Physician Decision|3|||
44136207|NCT01306942|78923792|FG001|Phase I|Physician Decision|1|||
44136208|NCT01306942|78923793|FG002|Phase I|Physician Decision|0|||
44136209|NCT01306942|78923794|FG003|Phase I|Physician Decision|0|||
44136210|NCT01306942|78923791|FG000|Phase II|Adverse Event|0|||
44136211|NCT01306942|78923792|FG001|Phase II|Adverse Event|0|||
44136212|NCT01306942|78923793|FG002|Phase II|Adverse Event|0|||
44136213|NCT01306942|78923794|FG003|Phase II|Adverse Event|6|||
44136214|NCT01306942|78923791|FG000|Phase II|Physician Decision|2|||
44136215|NCT01306942|78923792|FG001|Phase II|Physician Decision|0|||
44136216|NCT01306942|78923793|FG002|Phase II|Physician Decision|0|||
44136217|NCT01306942|78923794|FG003|Phase II|Physician Decision|5|||
44136218|NCT01306942|78923791|FG000|Phase II|Withdrawal by Subject|0|||
44136219|NCT01306942|78923792|FG001|Phase II|Withdrawal by Subject|0|||
44136220|NCT01306942|78923793|FG002|Phase II|Withdrawal by Subject|0|||
44136221|NCT01306942|78923794|FG003|Phase II|Withdrawal by Subject|2|||
44136222|NCT01306942|78923791|FG000|Phase II|Death|0|||
44136223|NCT01306942|78923792|FG001|Phase II|Death|0|||
44136224|NCT01306942|78923793|FG002|Phase II|Death|0|||
44136225|NCT01306942|78923794|FG003|Phase II|Death|1|||
44136226|NCT01306942|78923791|FG000|Phase II|Not finished treatment|0|||
44136227|NCT01306942|78923792|FG001|Phase II|Not finished treatment|0|||
44136228|NCT01306942|78923793|FG002|Phase II|Not finished treatment|0|||
44136229|NCT01306942|78923794|FG003|Phase II|Not finished treatment|1|||
44136230|NCT01306942|78923791|FG000|Phase II|Protocol Violation|0|||
44136231|NCT01306942|78923792|FG001|Phase II|Protocol Violation|0|||
44136232|NCT01306942|78923793|FG002|Phase II|Protocol Violation|0|||
44136233|NCT01306942|78923794|FG003|Phase II|Protocol Violation|1|||
44136234|NCT02324842|78923809|FG000|Overall Study|Lost to Follow-up|1|||
44136235|NCT02324842|78923810|FG001|Overall Study|Lost to Follow-up|1|||
44136236|NCT02324842|78923811|FG002|Overall Study|Lost to Follow-up|2|||
44136237|NCT02295280|78923821|FG000|Overall Study|Adverse Event|0|||
44136238|NCT02295280|78923822|FG001|Overall Study|Adverse Event|1|||
44136239|NCT05263505|78923830|FG000|Overall Study|Adverse Event|0|||
44136240|NCT05263505|78923831|FG001|Overall Study|Adverse Event|1|||
44136241|NCT02294734|78923839|FG000|Overall Study|Adverse Event|5|||
44136242|NCT02294734|78923840|FG001|Overall Study|Adverse Event|5|||
44136243|NCT02294734|78923839|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
44136244|NCT02294734|78923840|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
44136245|NCT02294734|78923839|FG000|Overall Study|Lost to Follow-up|2|||
44136246|NCT02294734|78923840|FG001|Overall Study|Lost to Follow-up|0|||
44136247|NCT02294734|78923839|FG000|Overall Study|Physician Decision|2|||
44136248|NCT02294734|78923840|FG001|Overall Study|Physician Decision|1|||
44136249|NCT02294734|78923839|FG000|Overall Study|Withdrawal by Subject|4|||
44136250|NCT02294734|78923840|FG001|Overall Study|Withdrawal by Subject|2|||
44136251|NCT02323204|78923861|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
44136252|NCT02323204|78923862|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
44136253|NCT02323204|78923863|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
44136254|NCT02323204|78923864|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
44136255|NCT02323204|78923861|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
44136256|NCT02323204|78923862|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
44136257|NCT02323204|78923863|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
44136258|NCT02323204|78923864|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
44243726|NCT01689974|79073439|FG000|Overall Study|Termination of Study|5|||
44243727|NCT01689974|79073440|FG001|Overall Study|Termination of Study|5|||
44243728|NCT01587014|79073446|FG000|Overall Study|Death|2|||
44243729|NCT01458535|79073550|FG000|Overall Study|Other|0|||
44136259|NCT02323204|78923861|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
44136260|NCT02323204|78923862|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
44136261|NCT02323204|78923863|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
44136262|NCT02323204|78923864|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
44136263|NCT02323204|78923861|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
44136264|NCT02323204|78923862|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
44136265|NCT02323204|78923863|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
44136266|NCT02323204|78923864|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
44136267|NCT02323204|78923861|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
44136268|NCT02323204|78923862|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
44136269|NCT02323204|78923863|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
44136270|NCT02323204|78923864|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
44136271|NCT02323204|78923861|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
44136272|NCT02323204|78923862|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
44136273|NCT02323204|78923863|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
44136274|NCT02323204|78923864|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
44136275|NCT02323204|78923861|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
44136276|NCT02323204|78923862|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
44136277|NCT02323204|78923863|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
44136278|NCT02323204|78923864|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
44136279|NCT02323204|78923861|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
44136280|NCT02323204|78923862|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
44136281|NCT02323204|78923863|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
44136282|NCT02323204|78923864|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
44136283|NCT02323204|78923861|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
44136284|NCT02323204|78923862|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
44136285|NCT02323204|78923863|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
44136286|NCT02323204|78923864|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
44136287|NCT02322892|78923876|FG000|Overall Study|Surgery cancelled|1|||
44136288|NCT02322892|78923877|FG001|Overall Study|Surgery cancelled|2|||
44136289|NCT02322892|78923876|FG000|Overall Study|Met exclusion criteria|0|||
44136290|NCT02322892|78923877|FG001|Overall Study|Met exclusion criteria|1|||
44136291|NCT02322892|78923876|FG000|Overall Study|Protocol Violation|1|||
44136292|NCT02322892|78923877|FG001|Overall Study|Protocol Violation|0|||
44136293|NCT03916081|78923886|FG000|Overall Study|Adverse Event|1|||
44136294|NCT03916081|78923887|FG001|Overall Study|Adverse Event|0|||
44136295|NCT03916081|78923888|FG002|Overall Study|Adverse Event|0|||
44136296|NCT03916081|78923886|FG000|Overall Study|Physician Decision|0|||
44136297|NCT03916081|78923887|FG001|Overall Study|Physician Decision|0|||
44136298|NCT03916081|78923888|FG002|Overall Study|Physician Decision|1|||
44136299|NCT03916081|78923886|FG000|Overall Study|Lost to Follow-up|0|||
44136300|NCT03916081|78923887|FG001|Overall Study|Lost to Follow-up|1|||
44136301|NCT03916081|78923888|FG002|Overall Study|Lost to Follow-up|0|||
44136302|NCT03916081|78923886|FG000|Overall Study|Withdrawal by Subject|3|||
44136303|NCT03916081|78923887|FG001|Overall Study|Withdrawal by Subject|0|||
44136304|NCT03916081|78923888|FG002|Overall Study|Withdrawal by Subject|1|||
44136305|NCT03916081|78923886|FG000|Overall Study|Worsening of AD|0|||
44136306|NCT03916081|78923887|FG001|Overall Study|Worsening of AD|0|||
44136307|NCT03916081|78923888|FG002|Overall Study|Worsening of AD|1|||
44136308|NCT03116113|78923905|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136309|NCT03116113|78923906|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136310|NCT03116113|78923907|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136311|NCT03116113|78923908|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136312|NCT03116113|78923909|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136313|NCT03116113|78923910|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136314|NCT03116113|78923911|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
44136315|NCT03116113|78923912|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
44136316|NCT03116113|78923913|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
44136317|NCT02739997|78923938|FG000|Overall Study|Death|1|||
44243730|NCT01458535|79073551|FG001|Overall Study|Other|0|||
44243731|NCT01458535|79073552|FG002|Overall Study|Other|0|||
44243732|NCT01458535|79073553|FG003|Overall Study|Other|0|||
44243733|NCT01458535|79073554|FG004|Overall Study|Other|1|||
44243734|NCT01458535|79073555|FG005|Overall Study|Other|1|||
44243735|NCT01458535|79073550|FG000|Overall Study|Withdrawal by Subject|0|||
44243736|NCT01458535|79073551|FG001|Overall Study|Withdrawal by Subject|0|||
44243737|NCT01458535|79073552|FG002|Overall Study|Withdrawal by Subject|2|||
44243738|NCT01458535|79073553|FG003|Overall Study|Withdrawal by Subject|0|||
44243739|NCT01458535|79073554|FG004|Overall Study|Withdrawal by Subject|1|||
44243740|NCT01458535|79073555|FG005|Overall Study|Withdrawal by Subject|1|||
44243741|NCT01458535|79073550|FG000|Overall Study|Lost to Follow-up|0|||
44243742|NCT01458535|79073551|FG001|Overall Study|Lost to Follow-up|2|||
44243743|NCT01458535|79073552|FG002|Overall Study|Lost to Follow-up|0|||
44243744|NCT01458535|79073553|FG003|Overall Study|Lost to Follow-up|3|||
44243745|NCT01458535|79073554|FG004|Overall Study|Lost to Follow-up|2|||
44136318|NCT02739997|78923938|FG000|Overall Study|Withdrawal by Subject|1|||
44136319|NCT02221037|78923946|FG000|Overall Study|Physician Decision|0|||
44136320|NCT02221037|78923947|FG001|Overall Study|Physician Decision|0|||
44136321|NCT02221037|78923948|FG002|Overall Study|Physician Decision|1|||
44243746|NCT01458535|79073555|FG005|Overall Study|Lost to Follow-up|2|||
44243747|NCT01458535|79073550|FG000|Overall Study|Adverse Event|0|||
44243748|NCT01458535|79073551|FG001|Overall Study|Adverse Event|0|||
44243749|NCT01458535|79073552|FG002|Overall Study|Adverse Event|0|||
44136322|NCT02221037|78923949|FG003|Overall Study|Physician Decision|0|||
44136323|NCT02704429|78923965|FG000|Part A: 24 Weeks|Adverse Event|3|||
44136324|NCT02704429|78923966|FG001|Part A: 24 Weeks|Adverse Event|0|||
44136325|NCT02704429|78923965|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
44136326|NCT02704429|78923966|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
44136327|NCT02751359|78923973|FG000|Overall Study|Lost to Follow-up|1|||
44136328|NCT02750813|78923992|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
44136329|NCT02750813|78923993|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
44136330|NCT02750813|78923992|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
44136331|NCT02750813|78923993|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
44136332|NCT00503035|78924009|FG000|Overall Study|Lost to Follow-up|2|||
44136333|NCT00503035|78924009|FG000|Overall Study|Physician Decision|3|||
44136334|NCT00503035|78924009|FG000|Overall Study|Ineligible|15|||
44136335|NCT03137381|78924018|FG000|Overall Study|Adverse Event|3|||
44136336|NCT03137381|78924019|FG001|Overall Study|Adverse Event|0|||
44136337|NCT03137381|78924020|FG002|Overall Study|Adverse Event|2|||
44136338|NCT03137381|78924021|FG003|Overall Study|Adverse Event|0|||
44136339|NCT03137381|78924018|FG000|Overall Study|Lost to Follow-up|2|||
44136340|NCT03137381|78924019|FG001|Overall Study|Lost to Follow-up|1|||
44136341|NCT03137381|78924020|FG002|Overall Study|Lost to Follow-up|1|||
44136342|NCT03137381|78924021|FG003|Overall Study|Lost to Follow-up|0|||
44136343|NCT03137381|78924018|FG000|Overall Study|Protocol deviation|1|||
44136344|NCT03137381|78924019|FG001|Overall Study|Protocol deviation|1|||
44136345|NCT03137381|78924020|FG002|Overall Study|Protocol deviation|0|||
44136346|NCT03137381|78924021|FG003|Overall Study|Protocol deviation|1|||
44136347|NCT03137381|78924018|FG000|Overall Study|Withdrawal by Investigator|0|||
44136348|NCT03137381|78924019|FG001|Overall Study|Withdrawal by Investigator|1|||
44136349|NCT03137381|78924020|FG002|Overall Study|Withdrawal by Investigator|1|||
44136350|NCT03137381|78924021|FG003|Overall Study|Withdrawal by Investigator|0|||
44136351|NCT03137381|78924018|FG000|Overall Study|Withdrawal by Subject|3|||
44136352|NCT03137381|78924019|FG001|Overall Study|Withdrawal by Subject|4|||
44136353|NCT03137381|78924020|FG002|Overall Study|Withdrawal by Subject|3|||
44136354|NCT03137381|78924021|FG003|Overall Study|Withdrawal by Subject|0|||
44136355|NCT03137381|78924018|FG000|Overall Study|Pregnancy|0|||
44136356|NCT03137381|78924019|FG001|Overall Study|Pregnancy|0|||
44136357|NCT03137381|78924020|FG002|Overall Study|Pregnancy|1|||
44136358|NCT03137381|78924021|FG003|Overall Study|Pregnancy|0|||
44136359|NCT03926117|78924035|FG000|Overall Study|Unclassified|1|||
44136360|NCT03926117|78924036|FG001|Overall Study|Unclassified|4|||
44136361|NCT03926117|78924037|FG002|Overall Study|Unclassified|1|||
44136362|NCT03926117|78924038|FG003|Overall Study|Unclassified|4|||
44136363|NCT03926117|78924035|FG000|Overall Study|Withdrawal by Subject|3|||
44136364|NCT03926117|78924036|FG001|Overall Study|Withdrawal by Subject|0|||
44136365|NCT03926117|78924037|FG002|Overall Study|Withdrawal by Subject|1|||
44136366|NCT03926117|78924038|FG003|Overall Study|Withdrawal by Subject|1|||
44136367|NCT03926117|78924035|FG000|Overall Study|Lost to Follow-up|0|||
44136368|NCT03926117|78924036|FG001|Overall Study|Lost to Follow-up|2|||
44136369|NCT03926117|78924037|FG002|Overall Study|Lost to Follow-up|1|||
44136370|NCT03926117|78924038|FG003|Overall Study|Lost to Follow-up|0|||
44136371|NCT03926117|78924035|FG000|Overall Study|Adverse Event|1|||
44136372|NCT03926117|78924036|FG001|Overall Study|Adverse Event|2|||
44136373|NCT03926117|78924037|FG002|Overall Study|Adverse Event|3|||
44136374|NCT03926117|78924038|FG003|Overall Study|Adverse Event|1|||
44136375|NCT03926117|78924035|FG000|Overall Study|Randomized but not treated|1|||
44136376|NCT03926117|78924036|FG001|Overall Study|Randomized but not treated|1|||
44380314|NCT00758485|79386160|FG000|Overall Study|Not Treated|1|||
44380315|NCT00758485|79386161|FG001|Overall Study|Not Treated|2|||
44380316|NCT00757783|79386170|FG000|Overall Study|Adverse Event|0|||
44380317|NCT00757783|79386171|FG001|Overall Study|Adverse Event|2|||
44380318|NCT00757783|79386170|FG000|Overall Study|Lost to Follow-up|1|||
44380319|NCT00757783|79386171|FG001|Overall Study|Lost to Follow-up|1|||
44380320|NCT00757783|79386170|FG000|Overall Study|Protocol Violation|1|||
44243750|NCT01458535|79073553|FG003|Overall Study|Adverse Event|1|||
44243751|NCT01458535|79073554|FG004|Overall Study|Adverse Event|0|||
44243752|NCT01458535|79073555|FG005|Overall Study|Adverse Event|0|||
44243753|NCT01464827|79073583|FG000|Overall Study|Adverse Event|0|||
44243754|NCT01464827|79073584|FG001|Overall Study|Adverse Event|0|||
44380321|NCT00757783|79386171|FG001|Overall Study|Protocol Violation|0|||
44380322|NCT00757783|79386170|FG000|Overall Study|Withdrawal by Subject|2|||
44380323|NCT00757783|79386171|FG001|Overall Study|Withdrawal by Subject|1|||
44380324|NCT00757783|79386170|FG000|Overall Study|Other|1|||
44136377|NCT03926117|78924037|FG002|Overall Study|Randomized but not treated|0|||
44136378|NCT03926117|78924038|FG003|Overall Study|Randomized but not treated|1|||
44136379|NCT02750501|78924065|FG000|Overall Study|Adverse Event|4|||
44243755|NCT01464827|79073585|FG002|Overall Study|Adverse Event|0|||
44380325|NCT00757783|79386171|FG001|Overall Study|Other|2|||
44380326|NCT00757705|79386177|FG000|Overall Study|Adverse Event|19|||
44136380|NCT02750501|78924065|FG000|Overall Study|Physician Decision|1|||
44136381|NCT02750501|78924065|FG000|Overall Study|Protocol Violation|1|||
44136382|NCT02750501|78924065|FG000|Overall Study|G-tube came out|1|||
44136383|NCT02750501|78924065|FG000|Overall Study|Non-compliant use of PERT|1|||
44136384|NCT01337297|78924088|FG000|Overall Study|They entered to single anodal tDCS|4|||
44136385|NCT01337297|78924089|FG001|Overall Study|They entered to single anodal tDCS|3|||
44136386|NCT01337297|78924088|FG000|Overall Study|Lost to Follow-up|1|||
44136387|NCT01337297|78924089|FG001|Overall Study|Lost to Follow-up|3|||
44136388|NCT02302963|78924097|FG000|Overall Study|Withdrawal by Subject|2|||
44136389|NCT02302963|78924098|FG001|Overall Study|Withdrawal by Subject|1|||
44136390|NCT02302963|78924097|FG000|Overall Study|Steroid injection|0|||
44136391|NCT02302963|78924098|FG001|Overall Study|Steroid injection|1|||
44136392|NCT02302963|78924097|FG000|Overall Study|Physician Decision|1|||
44136393|NCT02302963|78924098|FG001|Overall Study|Physician Decision|0|||
44136394|NCT03507439|78924119|FG000|Overall Study|Other|2|||
44136395|NCT03507439|78924120|FG001|Overall Study|Other|1|||
44136396|NCT03507439|78924119|FG000|Overall Study|Withdrawal by Subject|1|||
44136397|NCT03507439|78924120|FG001|Overall Study|Withdrawal by Subject|0|||
44136398|NCT03507439|78924119|FG000|Overall Study|Death|1|||
44136399|NCT03507439|78924120|FG001|Overall Study|Death|1|||
44136400|NCT03507127|78924128|FG000|Overall Study|Withdrawal by Subject|1|||
44136401|NCT03507127|78924129|FG001|Overall Study|Withdrawal by Subject|0|||
44136402|NCT03507127|78924128|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
44136403|NCT03507127|78924129|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
44136404|NCT02322190|78924152|FG000|Overall Study|Death on study|1|||
44136405|NCT02322190|78924153|FG001|Overall Study|Death on study|0|||
44136406|NCT02321800|78924169|FG000|Overall Study|Withdrawal by Subject|3|||
44136407|NCT02321800|78924170|FG001|Overall Study|Withdrawal by Subject|3|||
44136408|NCT02321800|78924169|FG000|Overall Study|Death|1|||
44136409|NCT02321800|78924170|FG001|Overall Study|Death|0|||
44136410|NCT02321800|78924169|FG000|Overall Study|Protocol Violation|1|||
44136411|NCT02321800|78924170|FG001|Overall Study|Protocol Violation|0|||
44136412|NCT02321800|78924169|FG000|Overall Study|Lost to Follow-up|10|||
44136413|NCT02321800|78924170|FG001|Overall Study|Lost to Follow-up|4|||
44136414|NCT02321800|78924169|FG000|Overall Study|Adverse Event|2|||
44136415|NCT02321800|78924170|FG001|Overall Study|Adverse Event|3|||
44136416|NCT02321800|78924169|FG000|Overall Study|Other, Miscellaneous|3|||
44136417|NCT02321800|78924170|FG001|Overall Study|Other, Miscellaneous|1|||
44136418|NCT02292784|78924216|FG000|Overall Study|Lost to Follow-up|1|||
44136419|NCT02292784|78924217|FG001|Overall Study|Lost to Follow-up|17|||
44136420|NCT02292784|78924218|FG002|Overall Study|Lost to Follow-up|18|||
44136421|NCT02292784|78924216|FG000|Overall Study|Withdrawal by Subject|0|||
44136422|NCT02292784|78924217|FG001|Overall Study|Withdrawal by Subject|3|||
44136423|NCT02292784|78924218|FG002|Overall Study|Withdrawal by Subject|3|||
44136424|NCT02320396|78924228|FG000|Overall Study|Adverse Event|2|||
44136425|NCT02320396|78924229|FG001|Overall Study|Adverse Event|2|||
44136426|NCT02320396|78924228|FG000|Overall Study|Pregnancy|0|||
44136427|NCT02320396|78924229|FG001|Overall Study|Pregnancy|1|||
44136428|NCT02320396|78924228|FG000|Overall Study|Protocol Violation|0|||
44136429|NCT02320396|78924229|FG001|Overall Study|Protocol Violation|1|||
44136430|NCT02320396|78924228|FG000|Overall Study|Withdrawal by Subject|2|||
44136431|NCT02320396|78924229|FG001|Overall Study|Withdrawal by Subject|0|||
44136432|NCT02292238|78924237|FG000|Overall Study|Protocol Violation|1|||
44136433|NCT02292238|78924238|FG001|Overall Study|Protocol Violation|2|||
44136434|NCT02292238|78924237|FG000|Overall Study|Withdrawal by Subject|2|||
44136435|NCT02292238|78924238|FG001|Overall Study|Withdrawal by Subject|1|||
44136436|NCT02292238|78924237|FG000|Overall Study|Lost to Follow-up|1|||
44136437|NCT02292238|78924238|FG001|Overall Study|Lost to Follow-up|0|||
44136438|NCT02292238|78924237|FG000|Overall Study|Physician Decision|0|||
44136439|NCT02292238|78924238|FG001|Overall Study|Physician Decision|1|||
44136440|NCT02234843|78924275|FG000|Overall Study|Death|1|||
44136441|NCT02234843|78924276|FG001|Overall Study|Death|0|||
44136442|NCT02234843|78924277|FG002|Overall Study|Death|0|||
44136443|NCT02234843|78924278|FG003|Overall Study|Death|0|||
44136444|NCT02234843|78924279|FG004|Overall Study|Death|0|||
44136445|NCT02234843|78924280|FG005|Overall Study|Death|0|||
44136446|NCT02234843|78924281|FG006|Overall Study|Death|0|||
44136447|NCT02234843|78924282|FG007|Overall Study|Death|0|||
44136448|NCT02234843|78924283|FG008|Overall Study|Death|0|||
44136449|NCT02234843|78924284|FG009|Overall Study|Death|0|||
44136450|NCT02234843|78924275|FG000|Overall Study|Protocol Violation|1|||
44136451|NCT02234843|78924276|FG001|Overall Study|Protocol Violation|0|||
44136452|NCT02234843|78924277|FG002|Overall Study|Protocol Violation|1|||
44136453|NCT02234843|78924278|FG003|Overall Study|Protocol Violation|0|||
44136454|NCT02234843|78924279|FG004|Overall Study|Protocol Violation|0|||
44136455|NCT02234843|78924280|FG005|Overall Study|Protocol Violation|0|||
44136456|NCT02234843|78924281|FG006|Overall Study|Protocol Violation|0|||
44136457|NCT02234843|78924282|FG007|Overall Study|Protocol Violation|0|||
44136458|NCT02234843|78924283|FG008|Overall Study|Protocol Violation|0|||
44136459|NCT02234843|78924284|FG009|Overall Study|Protocol Violation|0|||
44136460|NCT02234843|78924275|FG000|Overall Study|Efficacy outcome reached|2|||
44136461|NCT02234843|78924276|FG001|Overall Study|Efficacy outcome reached|0|||
44136462|NCT02234843|78924277|FG002|Overall Study|Efficacy outcome reached|0|||
44136463|NCT02234843|78924278|FG003|Overall Study|Efficacy outcome reached|0|||
44136464|NCT02234843|78924279|FG004|Overall Study|Efficacy outcome reached|0|||
44136465|NCT02234843|78924280|FG005|Overall Study|Efficacy outcome reached|2|||
44136466|NCT02234843|78924281|FG006|Overall Study|Efficacy outcome reached|0|||
44136467|NCT02234843|78924282|FG007|Overall Study|Efficacy outcome reached|0|||
44136468|NCT02234843|78924283|FG008|Overall Study|Efficacy outcome reached|0|||
44136469|NCT02234843|78924284|FG009|Overall Study|Efficacy outcome reached|0|||
44136470|NCT02234843|78924275|FG000|Overall Study|Patient convenience|2|||
44136471|NCT02234843|78924276|FG001|Overall Study|Patient convenience|0|||
44136472|NCT02234843|78924277|FG002|Overall Study|Patient convenience|0|||
44136473|NCT02234843|78924278|FG003|Overall Study|Patient convenience|0|||
44136474|NCT02234843|78924279|FG004|Overall Study|Patient convenience|0|||
44136475|NCT02234843|78924280|FG005|Overall Study|Patient convenience|1|||
44136476|NCT02234843|78924281|FG006|Overall Study|Patient convenience|0|||
44136477|NCT02234843|78924282|FG007|Overall Study|Patient convenience|0|||
44136478|NCT02234843|78924283|FG008|Overall Study|Patient convenience|0|||
44136479|NCT02234843|78924284|FG009|Overall Study|Patient convenience|0|||
44136480|NCT02234843|78924275|FG000|Overall Study|Withdrawal by Subject|5|||
44136481|NCT02234843|78924276|FG001|Overall Study|Withdrawal by Subject|1|||
44136482|NCT02234843|78924277|FG002|Overall Study|Withdrawal by Subject|1|||
44136483|NCT02234843|78924278|FG003|Overall Study|Withdrawal by Subject|0|||
44136484|NCT02234843|78924279|FG004|Overall Study|Withdrawal by Subject|0|||
44136485|NCT02234843|78924280|FG005|Overall Study|Withdrawal by Subject|7|||
44136486|NCT02234843|78924281|FG006|Overall Study|Withdrawal by Subject|0|||
44136487|NCT02234843|78924282|FG007|Overall Study|Withdrawal by Subject|0|||
44136488|NCT02234843|78924283|FG008|Overall Study|Withdrawal by Subject|0|||
44136489|NCT02234843|78924284|FG009|Overall Study|Withdrawal by Subject|0|||
44136490|NCT02234843|78924275|FG000|Overall Study|Recovery|1|||
44136491|NCT02234843|78924276|FG001|Overall Study|Recovery|0|||
44136492|NCT02234843|78924277|FG002|Overall Study|Recovery|0|||
44136493|NCT02234843|78924278|FG003|Overall Study|Recovery|0|||
44136494|NCT02234843|78924279|FG004|Overall Study|Recovery|0|||
44136495|NCT02234843|78924280|FG005|Overall Study|Recovery|0|||
44136496|NCT02234843|78924281|FG006|Overall Study|Recovery|0|||
44136497|NCT02234843|78924282|FG007|Overall Study|Recovery|0|||
44136498|NCT02234843|78924283|FG008|Overall Study|Recovery|0|||
44136499|NCT02234843|78924284|FG009|Overall Study|Recovery|0|||
44136500|NCT02234843|78924275|FG000|Overall Study|Other|0|||
44136501|NCT02234843|78924276|FG001|Overall Study|Other|2|||
44513244|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
44513245|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513246|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
44513247|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513248|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513249|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513250|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513251|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513252|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513253|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513254|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513255|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513256|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513257|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513258|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44136502|NCT02234843|78924277|FG002|Overall Study|Other|0|||
44136503|NCT02234843|78924278|FG003|Overall Study|Other|1|||
44136504|NCT02234843|78924279|FG004|Overall Study|Other|0|||
44136505|NCT02234843|78924280|FG005|Overall Study|Other|1|||
44136506|NCT02234843|78924281|FG006|Overall Study|Other|0|||
44136507|NCT02234843|78924282|FG007|Overall Study|Other|1|||
44136508|NCT02234843|78924283|FG008|Overall Study|Other|0|||
44136509|NCT02234843|78924284|FG009|Overall Study|Other|0|||
44380327|NCT00757705|79386177|FG000|Overall Study|Lost to Follow-up|16|||
44136510|NCT02234843|78924275|FG000|Overall Study|Physician Decision|4|||
44136511|NCT02234843|78924276|FG001|Overall Study|Physician Decision|1|||
44136512|NCT02234843|78924277|FG002|Overall Study|Physician Decision|0|||
44136513|NCT02234843|78924278|FG003|Overall Study|Physician Decision|1|||
44136514|NCT02234843|78924279|FG004|Overall Study|Physician Decision|0|||
44380328|NCT00757705|79386177|FG000|Overall Study|Withdrawal by Subject|25|||
44136515|NCT02234843|78924280|FG005|Overall Study|Physician Decision|0|||
44136516|NCT02234843|78924281|FG006|Overall Study|Physician Decision|0|||
44136517|NCT02234843|78924282|FG007|Overall Study|Physician Decision|1|||
44136518|NCT02234843|78924283|FG008|Overall Study|Physician Decision|0|||
44136519|NCT02234843|78924284|FG009|Overall Study|Physician Decision|0|||
44136520|NCT02234843|78924275|FG000|Overall Study|Adverse Event|5|||
44136521|NCT02234843|78924276|FG001|Overall Study|Adverse Event|1|||
44136522|NCT02234843|78924277|FG002|Overall Study|Adverse Event|1|||
44136523|NCT02234843|78924278|FG003|Overall Study|Adverse Event|3|||
44136524|NCT02234843|78924279|FG004|Overall Study|Adverse Event|2|||
44136525|NCT02234843|78924280|FG005|Overall Study|Adverse Event|1|||
44136526|NCT02234843|78924281|FG006|Overall Study|Adverse Event|0|||
44136527|NCT02234843|78924282|FG007|Overall Study|Adverse Event|0|||
44136528|NCT02234843|78924283|FG008|Overall Study|Adverse Event|1|||
44136529|NCT02234843|78924284|FG009|Overall Study|Adverse Event|0|||
44136530|NCT02234843|78924275|FG000|Overall Study|Non-compliance with study drug|1|||
44136531|NCT02234843|78924276|FG001|Overall Study|Non-compliance with study drug|0|||
44136532|NCT02234843|78924277|FG002|Overall Study|Non-compliance with study drug|0|||
44136533|NCT02234843|78924278|FG003|Overall Study|Non-compliance with study drug|0|||
44136534|NCT02234843|78924279|FG004|Overall Study|Non-compliance with study drug|0|||
44136535|NCT02234843|78924280|FG005|Overall Study|Non-compliance with study drug|1|||
44136536|NCT02234843|78924281|FG006|Overall Study|Non-compliance with study drug|1|||
44136537|NCT02234843|78924282|FG007|Overall Study|Non-compliance with study drug|0|||
44136538|NCT02234843|78924283|FG008|Overall Study|Non-compliance with study drug|0|||
44136539|NCT02234843|78924284|FG009|Overall Study|Non-compliance with study drug|0|||
44136540|NCT02234843|78924275|FG000|Overall Study|Lost to Follow-up|0|||
44136541|NCT02234843|78924276|FG001|Overall Study|Lost to Follow-up|1|||
44136542|NCT02234843|78924277|FG002|Overall Study|Lost to Follow-up|0|||
44136543|NCT02234843|78924278|FG003|Overall Study|Lost to Follow-up|0|||
44136544|NCT02234843|78924279|FG004|Overall Study|Lost to Follow-up|0|||
44136545|NCT02234843|78924280|FG005|Overall Study|Lost to Follow-up|0|||
44136546|NCT02234843|78924281|FG006|Overall Study|Lost to Follow-up|1|||
44136547|NCT02234843|78924282|FG007|Overall Study|Lost to Follow-up|0|||
44136548|NCT02234843|78924283|FG008|Overall Study|Lost to Follow-up|0|||
44136549|NCT02234843|78924284|FG009|Overall Study|Lost to Follow-up|0|||
44136550|NCT02740231|78924321|FG000|Overall Study|Withdrawal by Subject|1|||
44136551|NCT02740231|78924322|FG001|Overall Study|Withdrawal by Subject|1|||
44136552|NCT02740231|78924323|FG002|Overall Study|Withdrawal by Subject|1|||
44136553|NCT02740231|78924324|FG003|Overall Study|Withdrawal by Subject|0|||
44136554|NCT02740231|78924321|FG000|Overall Study|Lack of Efficacy|0|||
44136555|NCT02740231|78924322|FG001|Overall Study|Lack of Efficacy|1|||
44136556|NCT02740231|78924323|FG002|Overall Study|Lack of Efficacy|0|||
44136557|NCT02740231|78924324|FG003|Overall Study|Lack of Efficacy|4|||
44136558|NCT02740231|78924321|FG000|Overall Study|Lost to Follow-up|1|||
44136559|NCT02740231|78924322|FG001|Overall Study|Lost to Follow-up|3|||
44136560|NCT02740231|78924323|FG002|Overall Study|Lost to Follow-up|0|||
44136561|NCT02740231|78924324|FG003|Overall Study|Lost to Follow-up|3|||
44136562|NCT02740231|78924321|FG000|Overall Study|Adverse Event|0|||
44136563|NCT02740231|78924322|FG001|Overall Study|Adverse Event|1|||
44136564|NCT02740231|78924323|FG002|Overall Study|Adverse Event|0|||
44136565|NCT02740231|78924324|FG003|Overall Study|Adverse Event|1|||
44136566|NCT02750345|78924334|FG000|Intervention 1|Adverse Event|0|||
44136567|NCT02750345|78924335|FG001|Intervention 1|Adverse Event|0|||
44136568|NCT02750345|78924336|FG002|Intervention 1|Adverse Event|0|||
44136569|NCT02750345|78924337|FG003|Intervention 1|Adverse Event|0|||
44136570|NCT02750345|78924338|FG004|Intervention 1|Adverse Event|1|||
44136571|NCT02750345|78924339|FG005|Intervention 1|Adverse Event|0|||
44243756|NCT01464827|79073586|FG003|Overall Study|Adverse Event|0|||
44243757|NCT01464827|79073587|FG004|Overall Study|Adverse Event|0|||
44243758|NCT01464827|79073588|FG005|Overall Study|Adverse Event|0|||
44243759|NCT01464827|79073589|FG006|Overall Study|Adverse Event|0|||
44243760|NCT01464827|79073590|FG007|Overall Study|Adverse Event|0|||
44243761|NCT01464827|79073591|FG008|Overall Study|Adverse Event|0|||
44243762|NCT01464827|79073592|FG009|Overall Study|Adverse Event|0|||
44243763|NCT01464827|79073593|FG010|Overall Study|Adverse Event|0|||
44243764|NCT01464827|79073594|FG011|Overall Study|Adverse Event|0|||
44243765|NCT01464827|79073595|FG012|Overall Study|Adverse Event|1|||
44243766|NCT01464827|79073596|FG013|Overall Study|Adverse Event|0|||
44136572|NCT02640625|78924349|FG000|Overall Study|Adverse Event|1|||
44136573|NCT01329263|78924356|FG000|Overall Study|Lost to Follow-up|4|||
44136574|NCT01329263|78924357|FG001|Overall Study|Lost to Follow-up|21|||
44136575|NCT01329263|78924356|FG000|Overall Study|Withdrawal by Subject|1|||
44136576|NCT01329263|78924357|FG001|Overall Study|Withdrawal by Subject|2|||
44243767|NCT01464827|79073583|FG000|Overall Study|Withdrawal by Subject|1|||
44243768|NCT01464827|79073584|FG001|Overall Study|Withdrawal by Subject|0|||
44243769|NCT01464827|79073585|FG002|Overall Study|Withdrawal by Subject|0|||
44243770|NCT01464827|79073586|FG003|Overall Study|Withdrawal by Subject|0|||
44380329|NCT00757705|79386177|FG000|Overall Study|Insufficient Response|26|||
44136577|NCT02474329|78924365|FG000|Overall Study|Withdraw or did not contribute data.|13|||
44143857|NCT00462943|78933156|FG002|Overall Study|Failure to achieve a response|1|||
44143858|NCT00462943|78933154|FG000|Overall Study|Adverse Event|6|||
44143859|NCT00462943|78933155|FG001|Overall Study|Adverse Event|4|||
44143860|NCT00462943|78933156|FG002|Overall Study|Adverse Event|1|||
44136578|NCT01388491|78924372|FG000|Overall Study|Adverse Event|10|||
44136579|NCT01388491|78924373|FG001|Overall Study|Adverse Event|9|||
44136580|NCT01388491|78924372|FG000|Overall Study|Sponsor Request|9|||
44136581|NCT01388491|78924373|FG001|Overall Study|Sponsor Request|7|||
44136582|NCT01388491|78924372|FG000|Overall Study|Withdrawal by Subject|6|||
44136583|NCT01388491|78924373|FG001|Overall Study|Withdrawal by Subject|10|||
44136584|NCT01388491|78924372|FG000|Overall Study|Lost to Follow-up|4|||
44136585|NCT01388491|78924373|FG001|Overall Study|Lost to Follow-up|3|||
44136586|NCT01388491|78924372|FG000|Overall Study|Protocol Violation|2|||
44136587|NCT01388491|78924373|FG001|Overall Study|Protocol Violation|0|||
44136588|NCT01388491|78924372|FG000|Overall Study|Noncompliance|2|||
44136589|NCT01388491|78924373|FG001|Overall Study|Noncompliance|0|||
44136590|NCT01388491|78924372|FG000|Overall Study|Pregnancy|1|||
44136591|NCT01388491|78924373|FG001|Overall Study|Pregnancy|0|||
44136592|NCT02749799|78924379|FG000|Overall Study|Adverse Event|2|||
44136593|NCT02749799|78924379|FG000|Overall Study|Lost to Follow-up|4|||
44136594|NCT02749799|78924379|FG000|Overall Study|Protocol Violation|1|||
44136595|NCT02749799|78924379|FG000|Overall Study|Withdrawal by Subject|1|||
44136596|NCT03253393|78924386|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
44136597|NCT03253393|78924387|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
44136598|NCT03253393|78924388|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
44136599|NCT03128671|78924404|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
44136600|NCT03128671|78924405|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
44136601|NCT03128671|78924404|FG000|Allocation|Death|1|||
44136602|NCT03128671|78924405|FG001|Allocation|Death|0|||
44136603|NCT03128671|78924404|FG000|Allocation|Withdrawal by Subject|4|||
44136604|NCT03128671|78924405|FG001|Allocation|Withdrawal by Subject|0|||
44136605|NCT03128671|78924404|FG000|Intervention|Withdrawal by Subject|11|||
44136606|NCT03128671|78924405|FG001|Intervention|Withdrawal by Subject|10|||
44136607|NCT03128671|78924404|FG000|Intervention|Palliative/hospice care initiated|9|||
44136608|NCT03128671|78924405|FG001|Intervention|Palliative/hospice care initiated|10|||
44136609|NCT03128671|78924404|FG000|Intervention|Death|13|||
44136610|NCT03128671|78924405|FG001|Intervention|Death|11|||
44136611|NCT03128671|78924404|FG000|Intervention|Interrupted by hurricane|1|||
44136612|NCT03128671|78924405|FG001|Intervention|Interrupted by hurricane|0|||
44136613|NCT03128671|78924404|FG000|Intervention|Physician Decision|2|||
44136614|NCT03128671|78924405|FG001|Intervention|Physician Decision|3|||
44136615|NCT02925338|78924416|FG000|Overall Study|Death|0|||
44136616|NCT02925338|78924417|FG001|Overall Study|Death|2|||
44136617|NCT02925338|78924418|FG002|Overall Study|Death|1|||
44136618|NCT02925338|78924419|FG003|Overall Study|Death|0|||
44136619|NCT02925338|78924420|FG004|Overall Study|Death|0|||
44136620|NCT02925338|78924416|FG000|Overall Study|Lost to Follow-up|30|||
44136621|NCT02925338|78924417|FG001|Overall Study|Lost to Follow-up|10|||
44136622|NCT02925338|78924418|FG002|Overall Study|Lost to Follow-up|1|||
44136623|NCT02925338|78924419|FG003|Overall Study|Lost to Follow-up|16|||
44136624|NCT02925338|78924420|FG004|Overall Study|Lost to Follow-up|3|||
44136625|NCT02925338|78924416|FG000|Overall Study|Withdrawal by Subject|3|||
44136626|NCT02925338|78924417|FG001|Overall Study|Withdrawal by Subject|0|||
44136627|NCT02925338|78924418|FG002|Overall Study|Withdrawal by Subject|3|||
44136628|NCT02925338|78924419|FG003|Overall Study|Withdrawal by Subject|2|||
44136629|NCT02925338|78924420|FG004|Overall Study|Withdrawal by Subject|2|||
44136630|NCT02925338|78924416|FG000|Overall Study|Missing|38|||
44136631|NCT02925338|78924417|FG001|Overall Study|Missing|27|||
44136632|NCT02925338|78924418|FG002|Overall Study|Missing|0|||
44136633|NCT02925338|78924419|FG003|Overall Study|Missing|3|||
44136634|NCT02925338|78924420|FG004|Overall Study|Missing|2|||
44136635|NCT02925338|78924416|FG000|Overall Study|Participant's Decision|11|||
44136636|NCT02925338|78924417|FG001|Overall Study|Participant's Decision|7|||
44136637|NCT02925338|78924418|FG002|Overall Study|Participant's Decision|3|||
44243771|NCT01464827|79073587|FG004|Overall Study|Withdrawal by Subject|1|||
44243772|NCT01464827|79073588|FG005|Overall Study|Withdrawal by Subject|0|||
44243773|NCT01464827|79073589|FG006|Overall Study|Withdrawal by Subject|0|||
44136638|NCT02925338|78924419|FG003|Overall Study|Participant's Decision|8|||
44136639|NCT02925338|78924420|FG004|Overall Study|Participant's Decision|1|||
44136640|NCT02925338|78924416|FG000|Overall Study|Treatment Discontinuation|144|||
44136641|NCT02925338|78924417|FG001|Overall Study|Treatment Discontinuation|65|||
44136642|NCT02925338|78924418|FG002|Overall Study|Treatment Discontinuation|56|||
44136643|NCT02925338|78924419|FG003|Overall Study|Treatment Discontinuation|131|||
44136644|NCT02925338|78924420|FG004|Overall Study|Treatment Discontinuation|22|||
44136645|NCT02543528|78924438|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
44136646|NCT02543528|78924439|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
44136647|NCT02543528|78924440|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
44243774|NCT01464827|79073590|FG007|Overall Study|Withdrawal by Subject|1|||
44380330|NCT00757705|79386177|FG000|Overall Study|Ineligible to continue|8|||
44136648|NCT02543528|78924441|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
44143861|NCT00462943|78933154|FG000|Overall Study|Protocol Violation|1|||
44136649|NCT02543528|78924442|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
44136650|NCT02543528|78924438|FG000|Adaptation Period|Lens Handling Difficultes|0|||
44136651|NCT02543528|78924439|FG001|Adaptation Period|Lens Handling Difficultes|0|||
44136652|NCT02543528|78924440|FG002|Adaptation Period|Lens Handling Difficultes|0|||
44136653|NCT02543528|78924441|FG003|Adaptation Period|Lens Handling Difficultes|0|||
44136654|NCT02543528|78924442|FG004|Adaptation Period|Lens Handling Difficultes|8|||
44136655|NCT02543528|78924438|FG000|Adaptation Period|Lost to Follow-up|0|||
44136656|NCT02543528|78924439|FG001|Adaptation Period|Lost to Follow-up|0|||
44136657|NCT02543528|78924440|FG002|Adaptation Period|Lost to Follow-up|0|||
44136658|NCT02543528|78924441|FG003|Adaptation Period|Lost to Follow-up|0|||
44136659|NCT02543528|78924442|FG004|Adaptation Period|Lost to Follow-up|14|||
44136660|NCT02543528|78924438|FG000|Adaptation Period|Adverse Event|0|||
44136661|NCT02543528|78924439|FG001|Adaptation Period|Adverse Event|0|||
44136662|NCT02543528|78924440|FG002|Adaptation Period|Adverse Event|0|||
44136663|NCT02543528|78924441|FG003|Adaptation Period|Adverse Event|0|||
44136664|NCT02543528|78924442|FG004|Adaptation Period|Adverse Event|2|||
44136665|NCT02543528|78924438|FG000|Extended Wear Period|Adverse Event|17|||
44136666|NCT02543528|78924439|FG001|Extended Wear Period|Adverse Event|11|||
44136667|NCT02543528|78924440|FG002|Extended Wear Period|Adverse Event|16|||
44136668|NCT02543528|78924441|FG003|Extended Wear Period|Adverse Event|3|||
44136669|NCT02543528|78924442|FG004|Extended Wear Period|Adverse Event|0|||
44136670|NCT02543528|78924438|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
44136671|NCT02543528|78924439|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
44136672|NCT02543528|78924440|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
44136673|NCT02543528|78924441|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
44136674|NCT02543528|78924442|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
44136675|NCT02543528|78924438|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
44136676|NCT02543528|78924439|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
44136677|NCT02543528|78924440|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
44136678|NCT02543528|78924441|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
44136679|NCT02543528|78924442|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
44136680|NCT02543528|78924438|FG000|Extended Wear Period|Lost to Follow-up|0|||
44136681|NCT02543528|78924439|FG001|Extended Wear Period|Lost to Follow-up|1|||
44136682|NCT02543528|78924440|FG002|Extended Wear Period|Lost to Follow-up|2|||
44136683|NCT02543528|78924441|FG003|Extended Wear Period|Lost to Follow-up|1|||
44136684|NCT02543528|78924442|FG004|Extended Wear Period|Lost to Follow-up|0|||
44136685|NCT02543528|78924438|FG000|Extended Wear Period|Withdrawal by Subject|10|||
44136686|NCT02543528|78924439|FG001|Extended Wear Period|Withdrawal by Subject|9|||
44136687|NCT02543528|78924440|FG002|Extended Wear Period|Withdrawal by Subject|4|||
44136688|NCT02543528|78924441|FG003|Extended Wear Period|Withdrawal by Subject|5|||
44136689|NCT02543528|78924442|FG004|Extended Wear Period|Withdrawal by Subject|0|||
44136690|NCT00156533|78924460|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
44136691|NCT00156533|78924461|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
44136692|NCT00156533|78924462|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
44136693|NCT00156533|78924463|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
44136694|NCT00156533|78924460|FG000|Overall Study|Withdrawal by Subject|1|||
44136695|NCT00156533|78924461|FG001|Overall Study|Withdrawal by Subject|0|||
44136696|NCT00156533|78924462|FG002|Overall Study|Withdrawal by Subject|0|||
44136697|NCT00156533|78924463|FG003|Overall Study|Withdrawal by Subject|1|||
44136698|NCT00156533|78924460|FG000|Overall Study|Failed Screening|1|||
44136699|NCT00156533|78924461|FG001|Overall Study|Failed Screening|0|||
44136700|NCT00156533|78924462|FG002|Overall Study|Failed Screening|1|||
44136701|NCT00156533|78924463|FG003|Overall Study|Failed Screening|1|||
44136702|NCT01660022|78924481|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
44136703|NCT01660022|78924482|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
44136704|NCT01660022|78924483|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
44243775|NCT01464827|79073591|FG008|Overall Study|Withdrawal by Subject|0|||
44243776|NCT01464827|79073592|FG009|Overall Study|Withdrawal by Subject|0|||
44513259|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513260|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513261|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513262|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513263|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44243777|NCT01464827|79073593|FG010|Overall Study|Withdrawal by Subject|0|||
44513264|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44136705|NCT01660022|78924484|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
44136706|NCT01660022|78924485|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
44136707|NCT01660022|78924486|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
44136708|NCT01660022|78924481|FG000|First Sequence (7 Days)|Adverse Event|0|||
44136709|NCT01660022|78924482|FG001|First Sequence (7 Days)|Adverse Event|0|||
44136710|NCT01660022|78924483|FG002|First Sequence (7 Days)|Adverse Event|0|||
44136711|NCT01660022|78924484|FG003|First Sequence (7 Days)|Adverse Event|0|||
44513265|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513266|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
44513267|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Death|0|||
44513268|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Death|0|||
44513269|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Death|1|||
44513270|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Death|0|||
44513271|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Death|0|||
44513272|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Death|0|||
44136712|NCT01660022|78924485|FG004|First Sequence (7 Days)|Adverse Event|1|||
44136713|NCT01660022|78924486|FG005|First Sequence (7 Days)|Adverse Event|3|||
44136714|NCT01660022|78924481|FG000|First Sequence (7 Days)|Protocol Violation|0|||
44136715|NCT01660022|78924482|FG001|First Sequence (7 Days)|Protocol Violation|0|||
44136716|NCT01660022|78924483|FG002|First Sequence (7 Days)|Protocol Violation|0|||
44136717|NCT01660022|78924484|FG003|First Sequence (7 Days)|Protocol Violation|0|||
44136718|NCT01660022|78924485|FG004|First Sequence (7 Days)|Protocol Violation|0|||
44136719|NCT01660022|78924486|FG005|First Sequence (7 Days)|Protocol Violation|1|||
44136720|NCT00156065|78924515|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
44136721|NCT00156065|78924516|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
44136722|NCT00156065|78924517|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
44136723|NCT00156065|78924515|FG000|Overall Study|Adverse Event|8|||
44136724|NCT00156065|78924516|FG001|Overall Study|Adverse Event|11|||
44136725|NCT00156065|78924517|FG002|Overall Study|Adverse Event|4|||
44136726|NCT00156065|78924515|FG000|Overall Study|Lack of Efficacy|2|||
44136727|NCT00156065|78924516|FG001|Overall Study|Lack of Efficacy|9|||
44136728|NCT00156065|78924517|FG002|Overall Study|Lack of Efficacy|3|||
44136729|NCT00156065|78924515|FG000|Overall Study|Withdrawal by Subject|13|||
44136730|NCT00156065|78924516|FG001|Overall Study|Withdrawal by Subject|26|||
44136731|NCT00156065|78924517|FG002|Overall Study|Withdrawal by Subject|16|||
44136732|NCT00156065|78924515|FG000|Overall Study|Lost to Follow-up|5|||
44136733|NCT00156065|78924516|FG001|Overall Study|Lost to Follow-up|7|||
44136734|NCT00156065|78924517|FG002|Overall Study|Lost to Follow-up|1|||
44136735|NCT00156065|78924515|FG000|Overall Study|Other|2|||
44136736|NCT00156065|78924516|FG001|Overall Study|Other|9|||
44136737|NCT00156065|78924517|FG002|Overall Study|Other|3|||
44136738|NCT01554956|78924528|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
44136739|NCT01554956|78924529|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
44136740|NCT01554956|78924530|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
44136741|NCT01554956|78924528|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
44136742|NCT01554956|78924529|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
44136743|NCT01554956|78924530|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
44136744|NCT01554956|78924528|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
44136745|NCT01554956|78924529|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
44136746|NCT01554956|78924530|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
44136747|NCT02138786|78924551|FG000|Overall Study|Adverse Event|0|||
44136748|NCT02138786|78924552|FG001|Overall Study|Adverse Event|2|||
44136749|NCT02138786|78924553|FG002|Overall Study|Adverse Event|1|||
44136750|NCT02138786|78924551|FG000|Overall Study|Death|1|||
44136751|NCT02138786|78924552|FG001|Overall Study|Death|7|||
44136752|NCT02138786|78924553|FG002|Overall Study|Death|2|||
44136753|NCT02138786|78924551|FG000|Overall Study|Disease Progression|1|||
44136754|NCT02138786|78924552|FG001|Overall Study|Disease Progression|1|||
44136755|NCT02138786|78924553|FG002|Overall Study|Disease Progression|3|||
44136756|NCT02138786|78924551|FG000|Overall Study|Withdrawal by Subject|1|||
44136757|NCT02138786|78924552|FG001|Overall Study|Withdrawal by Subject|2|||
44136758|NCT02138786|78924553|FG002|Overall Study|Withdrawal by Subject|0|||
44136759|NCT02138786|78924551|FG000|Overall Study|Patient's Wish|0|||
44136760|NCT02138786|78924552|FG001|Overall Study|Patient's Wish|2|||
44136761|NCT02138786|78924553|FG002|Overall Study|Patient's Wish|0|||
44136762|NCT02138786|78924551|FG000|Overall Study|Sponsor Terminated Study|0|||
44136763|NCT02138786|78924552|FG001|Overall Study|Sponsor Terminated Study|1|||
44136764|NCT02138786|78924553|FG002|Overall Study|Sponsor Terminated Study|1|||
44136765|NCT02138786|78924551|FG000|Overall Study|Non-Compliance|0|||
44136766|NCT02138786|78924552|FG001|Overall Study|Non-Compliance|0|||
44136767|NCT02138786|78924553|FG002|Overall Study|Non-Compliance|1|||
44136768|NCT02529488|78924559|FG000|Overall Study|Adverse Event|1|||
44136769|NCT02529488|78924559|FG000|Overall Study|Death|3|||
44136770|NCT01329419|78924567|FG000|Overall Study|Protocol Violation|235|||
44243778|NCT01464827|79073594|FG011|Overall Study|Withdrawal by Subject|0|||
44380331|NCT00757705|79386177|FG000|Overall Study|Non-compliant|9|||
44136771|NCT01329341|78924572|FG000|Overall Study|Withdrawal by Subject|44|||
44143862|NCT00462943|78933155|FG001|Overall Study|Protocol Violation|0|||
44380332|NCT00757705|79386177|FG000|Overall Study|Other|18|||
44380333|NCT00757627|79386181|FG000|Overall Study|Adverse Event|15|||
44513273|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Death|0|||
44136772|NCT02532764|78924586|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136773|NCT02532764|78924587|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136774|NCT02532764|78924588|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136775|NCT02532764|78924589|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136776|NCT02532764|78924590|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136777|NCT02532764|78924591|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136778|NCT02532764|78924592|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
44136779|NCT02532764|78924593|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
44136780|NCT02532764|78924594|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
44136781|NCT02532764|78924595|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
44136782|NCT02528942|78924622|FG000|Overall Study|Did not meet imaging criteria|9|||
44513274|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Death|0|||
44513275|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Death|0|||
44513276|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Death|0|||
44513277|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Death|0|||
44513278|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Death|0|||
44513279|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Death|0|||
44513280|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Death|0|||
44513281|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Death|0|||
44513282|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Death|0|||
44513283|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Death|0|||
44513284|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Death|0|||
44513285|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Death|0|||
44513286|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Death|0|||
44513287|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Death|0|||
44513288|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Death|0|||
44513289|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Death|0|||
44513290|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Death|0|||
44513291|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Death|0|||
44513292|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Death|0|||
44513293|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513294|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513295|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
44513296|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
44513297|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
44513298|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
44513299|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
44513300|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513301|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513302|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513303|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513304|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513305|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513306|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513307|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513308|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513309|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513310|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513311|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513312|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513313|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513314|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513315|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513316|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513317|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513318|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
44513319|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513320|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513321|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
44513322|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44243779|NCT01464827|79073595|FG012|Overall Study|Withdrawal by Subject|0|||
44243780|NCT01464827|79073596|FG013|Overall Study|Withdrawal by Subject|0|||
44243781|NCT01464827|79073583|FG000|Overall Study|Lost to Follow-up|0|||
44136783|NCT02528942|78924622|FG000|Overall Study|Lost to Follow-up|25|||
44243782|NCT01464827|79073584|FG001|Overall Study|Lost to Follow-up|2|||
44136784|NCT02527148|78924628|FG000|Overall Study|Did not receive study intervention|1|||
44513323|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513324|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513325|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513326|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44136785|NCT02527148|78924629|FG001|Overall Study|Did not receive study intervention|0|||
44136786|NCT02291614|78924648|FG000|Overall Study|Lost to Follow-up|0|||
44136787|NCT02291614|78924649|FG001|Overall Study|Lost to Follow-up|0|||
44136788|NCT02291614|78924650|FG002|Overall Study|Lost to Follow-up|0|||
44136789|NCT02291614|78924651|FG003|Overall Study|Lost to Follow-up|0|||
44136790|NCT02291614|78924652|FG004|Overall Study|Lost to Follow-up|0|||
44136791|NCT02291614|78924653|FG005|Overall Study|Lost to Follow-up|0|||
44136792|NCT02291614|78924654|FG006|Overall Study|Lost to Follow-up|0|||
44136793|NCT02291614|78924655|FG007|Overall Study|Lost to Follow-up|1|||
44136794|NCT02291614|78924656|FG008|Overall Study|Lost to Follow-up|0|||
44136795|NCT02291614|78924657|FG009|Overall Study|Lost to Follow-up|0|||
44136796|NCT02291614|78924658|FG010|Overall Study|Lost to Follow-up|0|||
44136797|NCT02291614|78924648|FG000|Overall Study|Withdrawal by Subject|0|||
44136798|NCT02291614|78924649|FG001|Overall Study|Withdrawal by Subject|1|||
44136799|NCT02291614|78924650|FG002|Overall Study|Withdrawal by Subject|0|||
44136800|NCT02291614|78924651|FG003|Overall Study|Withdrawal by Subject|0|||
44136801|NCT02291614|78924652|FG004|Overall Study|Withdrawal by Subject|0|||
44136802|NCT02291614|78924653|FG005|Overall Study|Withdrawal by Subject|0|||
44136803|NCT02291614|78924654|FG006|Overall Study|Withdrawal by Subject|0|||
44136804|NCT02291614|78924655|FG007|Overall Study|Withdrawal by Subject|0|||
44136805|NCT02291614|78924656|FG008|Overall Study|Withdrawal by Subject|0|||
44136806|NCT02291614|78924657|FG009|Overall Study|Withdrawal by Subject|2|||
44136807|NCT02291614|78924658|FG010|Overall Study|Withdrawal by Subject|2|||
44136808|NCT02291614|78924648|FG000|Overall Study|Decision by sponsor|0|||
44136809|NCT02291614|78924649|FG001|Overall Study|Decision by sponsor|0|||
44136810|NCT02291614|78924650|FG002|Overall Study|Decision by sponsor|0|||
44136811|NCT02291614|78924651|FG003|Overall Study|Decision by sponsor|1|||
44136812|NCT02291614|78924652|FG004|Overall Study|Decision by sponsor|0|||
44136813|NCT02291614|78924653|FG005|Overall Study|Decision by sponsor|0|||
44136814|NCT02291614|78924654|FG006|Overall Study|Decision by sponsor|0|||
44136815|NCT02291614|78924655|FG007|Overall Study|Decision by sponsor|0|||
44136816|NCT02291614|78924656|FG008|Overall Study|Decision by sponsor|0|||
44136817|NCT02291614|78924657|FG009|Overall Study|Decision by sponsor|0|||
44136818|NCT02291614|78924658|FG010|Overall Study|Decision by sponsor|0|||
44136819|NCT02291614|78924648|FG000|Overall Study|Death|0|||
44136820|NCT02291614|78924649|FG001|Overall Study|Death|0|||
44136821|NCT02291614|78924650|FG002|Overall Study|Death|1|||
44513327|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513328|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513329|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513330|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513331|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513332|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513333|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513334|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513335|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44380334|NCT00757627|79386181|FG000|Overall Study|Lack of Efficacy|10|||
44136822|NCT02291614|78924651|FG003|Overall Study|Death|0|||
44136823|NCT02291614|78924652|FG004|Overall Study|Death|1|||
44380335|NCT00757627|79386181|FG000|Overall Study|Lost to Follow-up|28|||
44380336|NCT00757627|79386181|FG000|Overall Study|Withdrawal by Subject|27|||
44380337|NCT00757627|79386181|FG000|Overall Study|Other|1|||
44380338|NCT01023308|79386192|FG000|Overall Study|Abnormal test proceedure results|3|||
44513336|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513337|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44136824|NCT02291614|78924653|FG005|Overall Study|Death|1|||
44380339|NCT01023308|79386193|FG001|Overall Study|Abnormal test proceedure results|8|||
44513338|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513339|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44136825|NCT02291614|78924654|FG006|Overall Study|Death|1|||
44136826|NCT02291614|78924655|FG007|Overall Study|Death|0|||
44136827|NCT02291614|78924656|FG008|Overall Study|Death|0|||
44136828|NCT02291614|78924657|FG009|Overall Study|Death|0|||
44136829|NCT02291614|78924658|FG010|Overall Study|Death|0|||
44380340|NCT01023308|79386192|FG000|Overall Study|Administrative problems|2|||
44136830|NCT02526524|78924694|FG000|Overall Study|Withdrawal by Subject|3|||
44136831|NCT02526524|78924695|FG001|Overall Study|Withdrawal by Subject|3|||
44136832|NCT02526524|78924696|FG002|Overall Study|Withdrawal by Subject|6|||
44136833|NCT02526524|78924697|FG003|Overall Study|Withdrawal by Subject|1|||
44136834|NCT02526524|78924698|FG004|Overall Study|Withdrawal by Subject|9|||
44136835|NCT02526524|78924699|FG005|Overall Study|Withdrawal by Subject|5|||
44136836|NCT02526524|78924694|FG000|Overall Study|Adverse Event|3|||
44136837|NCT02526524|78924695|FG001|Overall Study|Adverse Event|2|||
44136838|NCT02526524|78924696|FG002|Overall Study|Adverse Event|4|||
44136839|NCT02526524|78924697|FG003|Overall Study|Adverse Event|2|||
44136840|NCT02526524|78924698|FG004|Overall Study|Adverse Event|6|||
44136841|NCT02526524|78924699|FG005|Overall Study|Adverse Event|8|||
44136842|NCT02526524|78924694|FG000|Overall Study|Lost to Follow-up|2|||
44136843|NCT02526524|78924695|FG001|Overall Study|Lost to Follow-up|3|||
44136844|NCT02526524|78924696|FG002|Overall Study|Lost to Follow-up|8|||
44136845|NCT02526524|78924697|FG003|Overall Study|Lost to Follow-up|1|||
44136846|NCT02526524|78924698|FG004|Overall Study|Lost to Follow-up|2|||
44136847|NCT02526524|78924699|FG005|Overall Study|Lost to Follow-up|5|||
44136848|NCT02526524|78924694|FG000|Overall Study|Protocol Violation|3|||
44136849|NCT02526524|78924695|FG001|Overall Study|Protocol Violation|1|||
44136850|NCT02526524|78924696|FG002|Overall Study|Protocol Violation|5|||
44136851|NCT02526524|78924697|FG003|Overall Study|Protocol Violation|3|||
44136852|NCT02526524|78924698|FG004|Overall Study|Protocol Violation|4|||
44136853|NCT02526524|78924699|FG005|Overall Study|Protocol Violation|3|||
44136854|NCT02526524|78924694|FG000|Overall Study|Loss of Glucose Control|0|||
44136855|NCT02526524|78924695|FG001|Overall Study|Loss of Glucose Control|0|||
44136856|NCT02526524|78924696|FG002|Overall Study|Loss of Glucose Control|3|||
44136857|NCT02526524|78924697|FG003|Overall Study|Loss of Glucose Control|0|||
44136858|NCT02526524|78924698|FG004|Overall Study|Loss of Glucose Control|2|||
44136859|NCT02526524|78924699|FG005|Overall Study|Loss of Glucose Control|0|||
44136860|NCT02526524|78924694|FG000|Overall Study|Physician Decision|0|||
44136861|NCT02526524|78924695|FG001|Overall Study|Physician Decision|0|||
44136862|NCT02526524|78924696|FG002|Overall Study|Physician Decision|0|||
44136863|NCT02526524|78924697|FG003|Overall Study|Physician Decision|0|||
44136864|NCT02526524|78924698|FG004|Overall Study|Physician Decision|1|||
44136865|NCT02526524|78924699|FG005|Overall Study|Physician Decision|0|||
44136866|NCT02526524|78924694|FG000|Overall Study|Sponsor Decision|1|||
44136867|NCT02526524|78924695|FG001|Overall Study|Sponsor Decision|0|||
44136868|NCT02526524|78924696|FG002|Overall Study|Sponsor Decision|0|||
44136869|NCT02526524|78924697|FG003|Overall Study|Sponsor Decision|0|||
44136870|NCT02526524|78924698|FG004|Overall Study|Sponsor Decision|0|||
44136871|NCT02526524|78924699|FG005|Overall Study|Sponsor Decision|0|||
44136872|NCT02526290|78924713|FG000|Overall Study|Adverse Event|3|||
44136873|NCT02526290|78924713|FG000|Overall Study|Withdrawal by Subject|4|||
44513340|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513341|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513342|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513343|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513344|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
44513345|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513346|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513347|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
44513348|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513349|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513350|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513351|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513352|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513353|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513354|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513355|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513356|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513357|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513358|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44136874|NCT02526290|78924713|FG000|Overall Study|Physician Decision|1|||
44136875|NCT02319148|78924720|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
44136876|NCT02319148|78924721|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
44136877|NCT02319148|78924722|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
44136878|NCT02319148|78924723|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
44136879|NCT02319148|78924720|FG000|Second Intervention Period|No longer willing to participate|0|||
44136880|NCT02319148|78924721|FG001|Second Intervention Period|No longer willing to participate|1|||
44380341|NCT01023308|79386193|FG001|Overall Study|Administrative problems|1|||
44136881|NCT02319148|78924722|FG002|Second Intervention Period|No longer willing to participate|0|||
44136882|NCT02319148|78924723|FG003|Second Intervention Period|No longer willing to participate|0|||
44380342|NCT01023308|79386192|FG000|Overall Study|Adverse Event|130|||
44380343|NCT01023308|79386193|FG001|Overall Study|Adverse Event|66|||
44136883|NCT02319148|78924720|FG000|Second Intervention Period|Other|0|||
44136884|NCT02319148|78924721|FG001|Second Intervention Period|Other|0|||
44136885|NCT02319148|78924722|FG002|Second Intervention Period|Other|0|||
44136886|NCT02319148|78924723|FG003|Second Intervention Period|Other|1|||
44136887|NCT02526212|78924744|FG000|Overall Study|Incarceration|1|||
44136888|NCT02526212|78924745|FG001|Overall Study|Incarceration|0|||
44136889|NCT02526212|78924744|FG000|Overall Study|Lost to Follow-up|1|||
44136890|NCT02526212|78924745|FG001|Overall Study|Lost to Follow-up|0|||
44136891|NCT02526212|78924744|FG000|Overall Study|Death|0|||
44136892|NCT02526212|78924745|FG001|Overall Study|Death|1|||
44136893|NCT02532374|78924751|FG000|Overall Study|Withdrawal by Subject|1|||
44136894|NCT02532374|78924751|FG000|Overall Study|Physician Decision|1|||
44136895|NCT02525744|78924763|FG000|Period 1|Physician Decision|0|||
44136896|NCT02525744|78924764|FG001|Period 1|Physician Decision|0|||
44136897|NCT02525744|78924765|FG002|Period 1|Physician Decision|1|||
44136898|NCT02525744|78924766|FG003|Period 1|Physician Decision|0|||
44136899|NCT02525744|78924763|FG000|Period 3|Adverse Event|0|||
44136900|NCT02525744|78924764|FG001|Period 3|Adverse Event|1|||
44136901|NCT02525744|78924765|FG002|Period 3|Adverse Event|0|||
44136902|NCT02525744|78924766|FG003|Period 3|Adverse Event|0|||
44136903|NCT02525744|78924763|FG000|Period 4|Withdrawal by Subject|1|||
44136904|NCT02525744|78924764|FG001|Period 4|Withdrawal by Subject|0|||
44136905|NCT02525744|78924765|FG002|Period 4|Withdrawal by Subject|0|||
44136906|NCT02525744|78924766|FG003|Period 4|Withdrawal by Subject|0|||
44136907|NCT02525744|78924763|FG000|Period 5|Physician Decision|1|||
44136908|NCT02525744|78924764|FG001|Period 5|Physician Decision|0|||
44136909|NCT02525744|78924765|FG002|Period 5|Physician Decision|0|||
44136910|NCT02525744|78924766|FG003|Period 5|Physician Decision|0|||
44136911|NCT00152477|78924779|FG000|Chemotherapy Period|Adverse Event|9|||
44136912|NCT00152477|78924780|FG001|Chemotherapy Period|Adverse Event|4|||
44136913|NCT00152477|78924781|FG002|Chemotherapy Period|Adverse Event|5|||
44136914|NCT00152477|78924779|FG000|Chemotherapy Period|Death|1|||
44136915|NCT00152477|78924780|FG001|Chemotherapy Period|Death|3|||
44136916|NCT00152477|78924781|FG002|Chemotherapy Period|Death|3|||
44136917|NCT00152477|78924779|FG000|Chemotherapy Period|Lack of Efficacy|4|||
44136918|NCT00152477|78924780|FG001|Chemotherapy Period|Lack of Efficacy|5|||
44136919|NCT00152477|78924781|FG002|Chemotherapy Period|Lack of Efficacy|6|||
44136920|NCT00152477|78924779|FG000|Chemotherapy Period|Lost to Follow-up|1|||
44136921|NCT00152477|78924780|FG001|Chemotherapy Period|Lost to Follow-up|0|||
44136922|NCT00152477|78924781|FG002|Chemotherapy Period|Lost to Follow-up|1|||
44136923|NCT00152477|78924779|FG000|Chemotherapy Period|Protocol Violation|1|||
44136924|NCT00152477|78924780|FG001|Chemotherapy Period|Protocol Violation|1|||
44136925|NCT00152477|78924781|FG002|Chemotherapy Period|Protocol Violation|0|||
44136926|NCT00152477|78924779|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
44136927|NCT00152477|78924780|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
44136928|NCT00152477|78924781|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
44136929|NCT00152477|78924779|FG000|Chemotherapy Period|Progression of Disease|6|||
44513359|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513360|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513361|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513362|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513363|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513364|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513365|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513366|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513367|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513368|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513369|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513370|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
44513371|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513372|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513373|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
44513374|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44136930|NCT00152477|78924780|FG001|Chemotherapy Period|Progression of Disease|8|||
44136931|NCT00152477|78924781|FG002|Chemotherapy Period|Progression of Disease|4|||
44136932|NCT00152477|78924779|FG000|Chemotherapy Period|Investigator decision|0|||
44136933|NCT00152477|78924780|FG001|Chemotherapy Period|Investigator decision|0|||
44136934|NCT00152477|78924781|FG002|Chemotherapy Period|Investigator decision|1|||
44136935|NCT00152477|78924779|FG000|Chemotherapy Period|Patient condition worsened|1|||
44136936|NCT00152477|78924780|FG001|Chemotherapy Period|Patient condition worsened|0|||
44136937|NCT00152477|78924781|FG002|Chemotherapy Period|Patient condition worsened|0|||
44136938|NCT00152477|78924779|FG000|Monotherapy Period|Adverse Event|1|||
44136939|NCT00152477|78924780|FG001|Monotherapy Period|Adverse Event|0|||
44136940|NCT00152477|78924781|FG002|Monotherapy Period|Adverse Event|5|||
44136941|NCT00152477|78924779|FG000|Monotherapy Period|Death|2|||
44136942|NCT00152477|78924780|FG001|Monotherapy Period|Death|0|||
44136943|NCT00152477|78924781|FG002|Monotherapy Period|Death|1|||
44136944|NCT00152477|78924779|FG000|Monotherapy Period|Lack of Efficacy|7|||
44136945|NCT00152477|78924780|FG001|Monotherapy Period|Lack of Efficacy|16|||
44136946|NCT00152477|78924781|FG002|Monotherapy Period|Lack of Efficacy|10|||
44136947|NCT00152477|78924779|FG000|Monotherapy Period|Protocol Violation|0|||
44136948|NCT00152477|78924780|FG001|Monotherapy Period|Protocol Violation|1|||
44136949|NCT00152477|78924781|FG002|Monotherapy Period|Protocol Violation|0|||
44136950|NCT00152477|78924779|FG000|Monotherapy Period|Withdrawal by Subject|0|||
44136951|NCT00152477|78924780|FG001|Monotherapy Period|Withdrawal by Subject|0|||
44136952|NCT00152477|78924781|FG002|Monotherapy Period|Withdrawal by Subject|4|||
44136953|NCT00152477|78924779|FG000|Monotherapy Period|Progression of Disease|5|||
44136954|NCT00152477|78924780|FG001|Monotherapy Period|Progression of Disease|11|||
44136955|NCT00152477|78924781|FG002|Monotherapy Period|Progression of Disease|12|||
44136956|NCT00152477|78924779|FG000|Monotherapy Period|Patient decision|0|||
44136957|NCT00152477|78924780|FG001|Monotherapy Period|Patient decision|1|||
44136958|NCT00152477|78924781|FG002|Monotherapy Period|Patient decision|1|||
44136959|NCT00152477|78924779|FG000|Monotherapy Period|Study personel decision|0|||
44136960|NCT00152477|78924780|FG001|Monotherapy Period|Study personel decision|0|||
44136961|NCT00152477|78924781|FG002|Monotherapy Period|Study personel decision|1|||
44136962|NCT00153179|78924794|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
44136963|NCT00153179|78924795|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
44136964|NCT00153179|78924796|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
44136965|NCT00153179|78924797|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
44136966|NCT02743949|78924808|FG000|Overall Study|Adverse Event|0|||
44136967|NCT02743949|78924809|FG001|Overall Study|Adverse Event|0|||
44136968|NCT02743949|78924810|FG002|Overall Study|Adverse Event|2|||
44136969|NCT02743949|78924808|FG000|Overall Study|Significant Protocol Deviation|2|||
44136970|NCT02743949|78924809|FG001|Overall Study|Significant Protocol Deviation|0|||
44136971|NCT02743949|78924810|FG002|Overall Study|Significant Protocol Deviation|1|||
44136972|NCT02743949|78924808|FG000|Overall Study|Voluntary Withdrawal|2|||
44136973|NCT02743949|78924809|FG001|Overall Study|Voluntary Withdrawal|1|||
44136974|NCT02743949|78924810|FG002|Overall Study|Voluntary Withdrawal|0|||
44136975|NCT02531438|78924820|FG000|Overall Study|Adverse Event|7|||
44136976|NCT02531438|78924821|FG001|Overall Study|Adverse Event|9|||
44136977|NCT02531438|78924820|FG000|Overall Study|Lost to Follow-up|0|||
44136978|NCT02531438|78924821|FG001|Overall Study|Lost to Follow-up|3|||
44136979|NCT02531438|78924820|FG000|Overall Study|Withdrawal by Subject|7|||
44136980|NCT02531438|78924821|FG001|Overall Study|Withdrawal by Subject|8|||
44136981|NCT02531438|78924820|FG000|Overall Study|Physician Decision|0|||
44136982|NCT02531438|78924821|FG001|Overall Study|Physician Decision|1|||
44136983|NCT02531438|78924820|FG000|Overall Study|Death|6|||
44136984|NCT02531438|78924821|FG001|Overall Study|Death|3|||
44136985|NCT02531438|78924820|FG000|Overall Study|Randomized, but Not Treated|4|||
44136986|NCT02531438|78924821|FG001|Overall Study|Randomized, but Not Treated|0|||
44136987|NCT02531438|78924820|FG000|Overall Study|Missed EOT/PTE Visit|5|||
44136988|NCT02531438|78924821|FG001|Overall Study|Missed EOT/PTE Visit|2|||
44136989|NCT02531438|78924820|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
44136990|NCT02531438|78924821|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
44136991|NCT02289898|78924830|FG000|Overall Study|Death|5|||
44136992|NCT02289898|78924831|FG001|Overall Study|Death|4|||
44136993|NCT02289898|78924832|FG002|Overall Study|Death|3|||
44136994|NCT02289898|78924830|FG000|Overall Study|Physician Decision|2|||
44136995|NCT02289898|78924831|FG001|Overall Study|Physician Decision|5|||
44136996|NCT02289898|78924832|FG002|Overall Study|Physician Decision|2|||
44136997|NCT02289898|78924830|FG000|Overall Study|Withdrawal by Subject|0|||
44136998|NCT02289898|78924831|FG001|Overall Study|Withdrawal by Subject|4|||
44136999|NCT02289898|78924832|FG002|Overall Study|Withdrawal by Subject|1|||
44243783|NCT01464827|79073585|FG002|Overall Study|Lost to Follow-up|0|||
44243784|NCT01464827|79073586|FG003|Overall Study|Lost to Follow-up|2|||
44243785|NCT01464827|79073587|FG004|Overall Study|Lost to Follow-up|3|||
44137000|NCT02289898|78924830|FG000|Overall Study|Adverse Event|3|||
44137001|NCT02289898|78924831|FG001|Overall Study|Adverse Event|5|||
44137002|NCT02289898|78924832|FG002|Overall Study|Adverse Event|5|||
44137003|NCT02289898|78924830|FG000|Overall Study|Disease progression|34|||
44137004|NCT02289898|78924831|FG001|Overall Study|Disease progression|28|||
44137005|NCT02289898|78924832|FG002|Overall Study|Disease progression|34|||
44137006|NCT02289898|78924830|FG000|Overall Study|Use of another anticancer therapy|0|||
44137007|NCT02289898|78924831|FG001|Overall Study|Use of another anticancer therapy|0|||
44243786|NCT01464827|79073588|FG005|Overall Study|Lost to Follow-up|1|||
44137008|NCT02289898|78924832|FG002|Overall Study|Use of another anticancer therapy|1|||
44137009|NCT02289898|78924830|FG000|Overall Study|Other|8|||
44137010|NCT02289898|78924831|FG001|Overall Study|Other|7|||
44137011|NCT02289898|78924832|FG002|Overall Study|Other|10|||
44137012|NCT01660412|78924839|FG000|Overall Study|Protocol Violation|0|||
44137013|NCT01660412|78924840|FG001|Overall Study|Protocol Violation|3|||
44137014|NCT01659554|78924846|FG000|Overall Study|Study Termination|4|||
44137015|NCT01659320|78924850|FG000|Overall Study|Withdrawal by Subject|2|||
44137016|NCT01659320|78924850|FG000|Overall Study|Physician Decision|1|||
44137017|NCT01660334|78924854|FG000|Overall Study|Lost to Follow-up|1|||
44137018|NCT01660256|78924861|FG000|Overall Study|Adverse Event|4|||
44137019|NCT01660256|78924862|FG001|Overall Study|Adverse Event|0|||
44137020|NCT01660256|78924863|FG002|Overall Study|Adverse Event|2|||
44137021|NCT01660256|78924861|FG000|Overall Study|Withdrawal by Subject|1|||
44137022|NCT01660256|78924862|FG001|Overall Study|Withdrawal by Subject|0|||
44137023|NCT01660256|78924863|FG002|Overall Study|Withdrawal by Subject|2|||
44137024|NCT02034123|78924889|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137025|NCT02034123|78924890|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137026|NCT02034123|78924891|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137027|NCT02034123|78924892|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137028|NCT02034123|78924893|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
44137029|NCT02034123|78924894|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137030|NCT02034123|78924895|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137031|NCT02034123|78924896|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
44137032|NCT02034123|78924897|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
44137033|NCT02034123|78924898|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137034|NCT02034123|78924899|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137035|NCT02034123|78924900|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137036|NCT02034123|78924901|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137037|NCT02034123|78924902|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137038|NCT02034123|78924903|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137039|NCT02034123|78924904|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137040|NCT02034123|78924905|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137041|NCT02034123|78924906|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
44137042|NCT02034123|78924889|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137043|NCT02034123|78924890|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137044|NCT02034123|78924891|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137045|NCT02034123|78924892|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
44137046|NCT02034123|78924893|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137047|NCT02034123|78924894|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137048|NCT02034123|78924895|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137049|NCT02034123|78924896|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137050|NCT02034123|78924897|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137051|NCT02034123|78924898|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137052|NCT02034123|78924899|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137053|NCT02034123|78924900|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137054|NCT02034123|78924901|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137055|NCT02034123|78924902|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137056|NCT02034123|78924903|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137057|NCT02034123|78924904|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137058|NCT02034123|78924905|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137059|NCT02034123|78924906|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
44137060|NCT02034123|78924889|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137061|NCT02034123|78924890|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137062|NCT02034123|78924891|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137063|NCT02034123|78924892|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137064|NCT02034123|78924893|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137065|NCT02034123|78924894|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137066|NCT02034123|78924895|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137067|NCT02034123|78924896|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137068|NCT02034123|78924897|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
44137069|NCT02034123|78924898|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137070|NCT02034123|78924899|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137071|NCT02034123|78924900|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137072|NCT02034123|78924901|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137073|NCT02034123|78924902|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137074|NCT02034123|78924903|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137075|NCT02034123|78924904|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137076|NCT02034123|78924905|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137077|NCT02034123|78924906|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
44137078|NCT02034123|78924889|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44143863|NCT00462943|78933156|FG002|Overall Study|Protocol Violation|0|||
44137079|NCT02034123|78924890|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137080|NCT02034123|78924891|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137081|NCT02034123|78924892|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
44137082|NCT02034123|78924893|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
44137083|NCT02034123|78924894|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137084|NCT02034123|78924895|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137085|NCT02034123|78924896|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137086|NCT02034123|78924897|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137087|NCT02034123|78924898|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137088|NCT02034123|78924899|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137089|NCT02034123|78924900|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137090|NCT02034123|78924901|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137091|NCT02034123|78924902|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137092|NCT02034123|78924903|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137093|NCT02034123|78924904|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137094|NCT02034123|78924905|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137095|NCT02034123|78924906|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
44137096|NCT02318602|78924952|FG000|Overall Study|Adverse Event|0|||
44137097|NCT02318602|78924953|FG001|Overall Study|Adverse Event|1|||
44137098|NCT02318602|78924954|FG002|Overall Study|Adverse Event|1|||
44380344|NCT01023308|79386192|FG000|Overall Study|Death|21|||
44380345|NCT01023308|79386193|FG001|Overall Study|Death|17|||
44380346|NCT01023308|79386192|FG000|Overall Study|Disease progression|82|||
44380347|NCT01023308|79386193|FG001|Overall Study|Disease progression|153|||
44137099|NCT02318602|78924952|FG000|Overall Study|Withdrawal by Subject|0|||
44137100|NCT02318602|78924953|FG001|Overall Study|Withdrawal by Subject|3|||
44137101|NCT02318602|78924954|FG002|Overall Study|Withdrawal by Subject|0|||
44137102|NCT02318602|78924952|FG000|Overall Study|Death|1|||
44137103|NCT02318602|78924953|FG001|Overall Study|Death|0|||
44137104|NCT02318602|78924954|FG002|Overall Study|Death|0|||
44137105|NCT02318602|78924952|FG000|Overall Study|Guardian decision to withdraw|0|||
44137106|NCT02318602|78924953|FG001|Overall Study|Guardian decision to withdraw|0|||
44243787|NCT01464827|79073589|FG006|Overall Study|Lost to Follow-up|2|||
44243788|NCT01464827|79073590|FG007|Overall Study|Lost to Follow-up|2|||
44243789|NCT01464827|79073591|FG008|Overall Study|Lost to Follow-up|0|||
44243790|NCT01464827|79073592|FG009|Overall Study|Lost to Follow-up|0|||
44137107|NCT02318602|78924954|FG002|Overall Study|Guardian decision to withdraw|1|||
44137108|NCT02318368|78924970|FG000|Overall Study|Withdrawal by Subject|2|||
44137109|NCT02318368|78924971|FG001|Overall Study|Withdrawal by Subject|0|||
44243791|NCT01464827|79073593|FG010|Overall Study|Lost to Follow-up|0|||
44137110|NCT02318368|78924970|FG000|Overall Study|Study terminated by the sponsor|5|||
44137111|NCT02318368|78924971|FG001|Overall Study|Study terminated by the sponsor|2|||
44137112|NCT02318368|78924970|FG000|Overall Study|Death|0|||
44137113|NCT02318368|78924971|FG001|Overall Study|Death|1|||
44137114|NCT02318134|78924979|FG000|Overall Study|Withdrawal by Subject|2|||
44137115|NCT02318134|78924980|FG001|Overall Study|Withdrawal by Subject|1|||
44137116|NCT02317510|78924990|FG000|Overall Study|Adverse Event|0|||
44137117|NCT02317510|78924991|FG001|Overall Study|Adverse Event|1|||
44137118|NCT02317432|78925002|FG000|Overall Study|Death|4|||
44137119|NCT02317432|78925003|FG001|Overall Study|Death|1|||
44137120|NCT02317432|78925002|FG000|Overall Study|Lost to Follow-up|0|||
44137121|NCT02317432|78925003|FG001|Overall Study|Lost to Follow-up|5|||
44137122|NCT02317432|78925002|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
44137123|NCT02317432|78925003|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
44137124|NCT02289820|78925016|FG000|Overall Study|Withdrawal by Subject|2|||
44137125|NCT02289820|78925017|FG001|Overall Study|Withdrawal by Subject|1|||
44137126|NCT02289820|78925018|FG002|Overall Study|Withdrawal by Subject|2|||
44137127|NCT02289820|78925019|FG003|Overall Study|Withdrawal by Subject|1|||
44137128|NCT02289820|78925020|FG004|Overall Study|Withdrawal by Subject|0|||
44137129|NCT02289820|78925021|FG005|Overall Study|Withdrawal by Subject|0|||
44137130|NCT02289820|78925022|FG006|Overall Study|Withdrawal by Subject|1|||
44137131|NCT02289820|78925016|FG000|Overall Study|Death|0|||
44137132|NCT02289820|78925017|FG001|Overall Study|Death|0|||
44137133|NCT02289820|78925018|FG002|Overall Study|Death|1|||
44137134|NCT02289820|78925019|FG003|Overall Study|Death|0|||
44137135|NCT02289820|78925020|FG004|Overall Study|Death|0|||
44137136|NCT02289820|78925021|FG005|Overall Study|Death|0|||
44137137|NCT02289820|78925022|FG006|Overall Study|Death|0|||
44137138|NCT02289820|78925016|FG000|Overall Study|Lost to Follow-up|0|||
44380348|NCT01023308|79386192|FG000|Overall Study|New Cancer therapy|4|||
44380349|NCT01023308|79386193|FG001|Overall Study|New Cancer therapy|7|||
44380350|NCT01023308|79386192|FG000|Overall Study|Protocol Violation|3|||
44380351|NCT01023308|79386193|FG001|Overall Study|Protocol Violation|4|||
44380352|NCT01023308|79386192|FG000|Overall Study|Untreated|5|||
44380353|NCT01023308|79386193|FG001|Overall Study|Untreated|5|||
44380354|NCT01023308|79386192|FG000|Overall Study|Lost to Follow-up|1|||
44137139|NCT02289820|78925017|FG001|Overall Study|Lost to Follow-up|0|||
44137140|NCT02289820|78925018|FG002|Overall Study|Lost to Follow-up|3|||
44137141|NCT02289820|78925019|FG003|Overall Study|Lost to Follow-up|1|||
44137142|NCT02289820|78925020|FG004|Overall Study|Lost to Follow-up|0|||
44137143|NCT02289820|78925021|FG005|Overall Study|Lost to Follow-up|1|||
44137144|NCT02289820|78925022|FG006|Overall Study|Lost to Follow-up|1|||
44137145|NCT02289820|78925016|FG000|Overall Study|withdrawal of consent|0|||
44137146|NCT02289820|78925017|FG001|Overall Study|withdrawal of consent|1|||
44137147|NCT02289820|78925018|FG002|Overall Study|withdrawal of consent|0|||
44137148|NCT02289820|78925019|FG003|Overall Study|withdrawal of consent|0|||
44137149|NCT02289820|78925020|FG004|Overall Study|withdrawal of consent|0|||
44137150|NCT02289820|78925021|FG005|Overall Study|withdrawal of consent|0|||
44137151|NCT02289820|78925022|FG006|Overall Study|withdrawal of consent|0|||
44137152|NCT02289742|78925044|FG000|First Wear Period|Adverse event prior to treatment|0|||
44137153|NCT02289742|78925045|FG001|First Wear Period|Adverse event prior to treatment|1|||
44137154|NCT02289742|78925046|FG002|First Wear Period|Adverse event prior to treatment|0|||
44137155|NCT02289742|78925047|FG003|First Wear Period|Adverse event prior to treatment|0|||
44137156|NCT02289742|78925044|FG000|First Wear Period|Adverse Event|0|||
44137157|NCT02289742|78925045|FG001|First Wear Period|Adverse Event|0|||
44137158|NCT02289742|78925046|FG002|First Wear Period|Adverse Event|1|||
44137159|NCT02289742|78925047|FG003|First Wear Period|Adverse Event|0|||
44137160|NCT02289742|78925044|FG000|First Wear Period|Other prior to treatment|0|||
44137161|NCT02289742|78925045|FG001|First Wear Period|Other prior to treatment|0|||
44137162|NCT02289742|78925046|FG002|First Wear Period|Other prior to treatment|0|||
44137163|NCT02289742|78925047|FG003|First Wear Period|Other prior to treatment|1|||
44137164|NCT02289742|78925044|FG000|Third Wear Period|Adverse Event|0|||
44137165|NCT02289742|78925045|FG001|Third Wear Period|Adverse Event|1|||
44137166|NCT02289742|78925046|FG002|Third Wear Period|Adverse Event|0|||
44137167|NCT02289742|78925047|FG003|Third Wear Period|Adverse Event|0|||
44243792|NCT01464827|79073594|FG011|Overall Study|Lost to Follow-up|1|||
44137168|NCT02289742|78925044|FG000|Third Wear Period|Reason not given|0|||
44137169|NCT02289742|78925045|FG001|Third Wear Period|Reason not given|0|||
44137170|NCT02289742|78925046|FG002|Third Wear Period|Reason not given|0|||
44137171|NCT02289742|78925047|FG003|Third Wear Period|Reason not given|1|||
44137172|NCT02289352|78925064|FG000|Overall Study|Withdrawal by Subject|1|||
44137173|NCT02289352|78925065|FG001|Overall Study|Withdrawal by Subject|1|||
44137174|NCT02289352|78925066|FG002|Overall Study|Withdrawal by Subject|0|||
44137175|NCT02315560|78925075|FG000|Overall Study|noncompliance by subjects|3|||
44243793|NCT01464827|79073595|FG012|Overall Study|Lost to Follow-up|0|||
44380355|NCT01023308|79386193|FG001|Overall Study|Lost to Follow-up|0|||
44380356|NCT01023308|79386192|FG000|Overall Study|Withdrawal by Subject|34|||
44137176|NCT02522624|78925081|FG000|Overall Study|Technical failure|1|||
44137177|NCT02522624|78925082|FG001|Overall Study|Technical failure|0|||
44137178|NCT02287402|78925088|FG000|Treatment Period|Adverse Event|17|||
44137179|NCT02287402|78925088|FG000|Treatment Period|Voluntary Withdrawal|10|||
44137180|NCT02287402|78925088|FG000|Follow-up|Lost to Follow-up|1|||
44137181|NCT02287402|78925088|FG000|Follow-up|Voluntary Withdrawal|2|||
44137182|NCT02314780|78925095|FG000|Overall Study|organizational reasons|0|||
44137183|NCT02314780|78925096|FG001|Overall Study|organizational reasons|2|||
44137184|NCT02314780|78925097|FG002|Overall Study|organizational reasons|0|||
44137185|NCT02314780|78925095|FG000|Overall Study|Adverse Event|0|||
44137186|NCT02314780|78925096|FG001|Overall Study|Adverse Event|1|||
44137187|NCT02314780|78925097|FG002|Overall Study|Adverse Event|0|||
44137188|NCT02288182|78925107|FG000|Overall Study|Adverse Event|0|||
44137189|NCT02288182|78925108|FG001|Overall Study|Adverse Event|1|||
44137190|NCT02288182|78925107|FG000|Overall Study|Lost to Follow-up|0|||
44137191|NCT02288182|78925108|FG001|Overall Study|Lost to Follow-up|1|||
44137192|NCT02286466|78925118|FG000|Overall Study|Death|1|||
44137193|NCT02286466|78925119|FG001|Overall Study|Death|3|||
44137194|NCT02286466|78925118|FG000|Overall Study|Withdrawal by Subject|5|||
44137195|NCT02286466|78925119|FG001|Overall Study|Withdrawal by Subject|2|||
44137196|NCT02286466|78925118|FG000|Overall Study|Lost to Follow-up|1|||
44137197|NCT02286466|78925119|FG001|Overall Study|Lost to Follow-up|4|||
44137198|NCT02286466|78925118|FG000|Overall Study|Declined Clinician Assessment|0|||
44137199|NCT02286466|78925119|FG001|Overall Study|Declined Clinician Assessment|1|||
44137200|NCT02313766|78925128|FG000|Overall Study|surgery cancelled|1|||
44137201|NCT02313766|78925129|FG001|Overall Study|surgery cancelled|0|||
44137202|NCT02313766|78925130|FG002|Overall Study|surgery cancelled|0|||
44137203|NCT02313766|78925128|FG000|Overall Study|Lost to Follow-up|0|||
44137204|NCT02313766|78925129|FG001|Overall Study|Lost to Follow-up|2|||
44137205|NCT02313766|78925130|FG002|Overall Study|Lost to Follow-up|0|||
44137206|NCT02313766|78925128|FG000|Overall Study|Adverse Event|0|||
44137207|NCT02313766|78925129|FG001|Overall Study|Adverse Event|1|||
44137208|NCT02313766|78925130|FG002|Overall Study|Adverse Event|0|||
44137209|NCT01646398|78925140|FG000|Overall Study|Withdrawal by Subject|1|||
44137210|NCT01646398|78925141|FG001|Overall Study|Withdrawal by Subject|0|||
44137211|NCT01646320|78925149|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
44137212|NCT01646320|78925150|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
44137213|NCT01646320|78925149|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
44137214|NCT01646320|78925150|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
44137215|NCT01646320|78925149|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
44137216|NCT01646320|78925150|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
44137217|NCT01646320|78925149|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
44137218|NCT01646320|78925150|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
44137219|NCT01646320|78925149|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
44137220|NCT01646320|78925150|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
44137221|NCT01646320|78925149|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
44137222|NCT01646320|78925150|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
44137223|NCT01646320|78925149|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
44137224|NCT01646320|78925150|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
44137225|NCT01646320|78925149|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
44137226|NCT01646320|78925150|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
44137227|NCT01646320|78925149|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
44137228|NCT01646320|78925150|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
44137229|NCT01646320|78925149|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
44137230|NCT01646320|78925150|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
44137231|NCT01646320|78925149|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
44137232|NCT01646320|78925150|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
44243794|NCT01464827|79073596|FG013|Overall Study|Lost to Follow-up|1|||
44243795|NCT01464827|79073583|FG000|Overall Study|Other|2|||
44137233|NCT01658150|78925156|FG000|Overall Study|Withdrawal by Subject|1|||
44137234|NCT02285998|78925163|FG000|Overall Study|Adverse Event|9|||
44137235|NCT02285998|78925164|FG001|Overall Study|Adverse Event|8|||
44137236|NCT02285998|78925163|FG000|Overall Study|Physician Decision|1|||
44513375|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513376|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44137237|NCT02285998|78925164|FG001|Overall Study|Physician Decision|2|||
44513377|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513378|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44137238|NCT02285998|78925163|FG000|Overall Study|Lost to Follow-up|176|||
44137239|NCT02285998|78925164|FG001|Overall Study|Lost to Follow-up|172|||
44137240|NCT02285998|78925163|FG000|Overall Study|Withdrawal by Subject|53|||
44137241|NCT02285998|78925164|FG001|Overall Study|Withdrawal by Subject|61|||
44137242|NCT02285998|78925163|FG000|Overall Study|Other Reasons|7|||
44137243|NCT02285998|78925164|FG001|Overall Study|Other Reasons|10|||
44137244|NCT01658072|78925172|FG000|Overall Study|Protocol Violation|4|||
44137245|NCT01658072|78925173|FG001|Overall Study|Protocol Violation|2|||
44137246|NCT02285920|78925183|FG000|Overall Study|Kidney transplantation|2|||
44137247|NCT02285920|78925184|FG001|Overall Study|Kidney transplantation|2|||
44137248|NCT02285920|78925185|FG002|Overall Study|Kidney transplantation|2|||
44137249|NCT02285920|78925186|FG003|Overall Study|Kidney transplantation|0|||
44137250|NCT02285920|78925183|FG000|Overall Study|Change to peritoneal dialysis|0|||
44137251|NCT02285920|78925184|FG001|Overall Study|Change to peritoneal dialysis|0|||
44137252|NCT02285920|78925185|FG002|Overall Study|Change to peritoneal dialysis|1|||
44137253|NCT02285920|78925186|FG003|Overall Study|Change to peritoneal dialysis|0|||
44137254|NCT02285920|78925183|FG000|Overall Study|Transfer to non-participating unit|0|||
44137255|NCT02285920|78925184|FG001|Overall Study|Transfer to non-participating unit|1|||
44137256|NCT02285920|78925185|FG002|Overall Study|Transfer to non-participating unit|0|||
44137257|NCT02285920|78925186|FG003|Overall Study|Transfer to non-participating unit|0|||
44137258|NCT02285920|78925183|FG000|Overall Study|Dialysis discontinuation|0|||
44137259|NCT02285920|78925184|FG001|Overall Study|Dialysis discontinuation|1|||
44137260|NCT02285920|78925185|FG002|Overall Study|Dialysis discontinuation|0|||
44137261|NCT02285920|78925186|FG003|Overall Study|Dialysis discontinuation|0|||
44137262|NCT02285920|78925183|FG000|Overall Study|Death|2|||
44137263|NCT02285920|78925184|FG001|Overall Study|Death|0|||
44137264|NCT02285920|78925185|FG002|Overall Study|Death|2|||
44137265|NCT02285920|78925186|FG003|Overall Study|Death|1|||
44137266|NCT02035137|78925199|FG000|Overall Study|Physician Decision|0|||
44137267|NCT02035137|78925200|FG001|Overall Study|Physician Decision|0|||
44137268|NCT02035137|78925201|FG002|Overall Study|Physician Decision|1|||
44137269|NCT02035137|78925199|FG000|Overall Study|Withdrawal by Subject|0|||
44137270|NCT02035137|78925200|FG001|Overall Study|Withdrawal by Subject|1|||
44137271|NCT02035137|78925201|FG002|Overall Study|Withdrawal by Subject|2|||
44137272|NCT02035137|78925199|FG000|Overall Study|Ineligible|0|||
44137273|NCT02035137|78925200|FG001|Overall Study|Ineligible|1|||
44137274|NCT02035137|78925201|FG002|Overall Study|Ineligible|2|||
44137275|NCT02035137|78925199|FG000|Overall Study|Disease progression prior to treatment start|2|||
44137276|NCT02035137|78925200|FG001|Overall Study|Disease progression prior to treatment start|0|||
44137277|NCT02035137|78925201|FG002|Overall Study|Disease progression prior to treatment start|0|||
44137278|NCT02522780|78925211|FG000|Overall Study|Consent withdrawn by subject|5|||
44137279|NCT02522780|78925212|FG001|Overall Study|Consent withdrawn by subject|7|||
44137280|NCT02522780|78925211|FG000|Overall Study|Protocol deviation|1|||
44137281|NCT02522780|78925212|FG001|Overall Study|Protocol deviation|3|||
44137282|NCT02522780|78925211|FG000|Overall Study|Subject refused endoscopic procedure|0|||
44137283|NCT02522780|78925212|FG001|Overall Study|Subject refused endoscopic procedure|1|||
44137284|NCT02522780|78925211|FG000|Overall Study|Adverse event, non-fatal|11|||
44137285|NCT02522780|78925212|FG001|Overall Study|Adverse event, non-fatal|16|||
44137286|NCT02285062|78925232|FG000|Pre-Treatment Period|Protocol Violation|0|||
44137287|NCT02285062|78925233|FG001|Pre-Treatment Period|Protocol Violation|2|||
44137288|NCT02285062|78925232|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
44137289|NCT02285062|78925233|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
44137290|NCT01352741|78925239|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
44137291|NCT01352741|78925240|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
44137292|NCT01352741|78925239|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
44137293|NCT01352741|78925240|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
44137294|NCT01352741|78925239|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
44137295|NCT01352741|78925240|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
44137296|NCT01352741|78925239|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
44137297|NCT01352741|78925240|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
44137298|NCT01352741|78925239|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
44243796|NCT01464827|79073584|FG001|Overall Study|Other|3|||
44513379|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513380|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44137299|NCT01352741|78925240|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
44137300|NCT01352741|78925239|FG000|Open-label Tapentadol Titration Period|Other|4|||
44137301|NCT01352741|78925240|FG001|Open-label Tapentadol Titration Period|Other|0|||
44137302|NCT01352741|78925239|FG000|Double-blind Comparative Period|Protocol Violation|2|||
44137303|NCT01352741|78925240|FG001|Double-blind Comparative Period|Protocol Violation|0|||
44137304|NCT01352741|78925239|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
44243797|NCT01464827|79073585|FG002|Overall Study|Other|0|||
44243798|NCT01464827|79073586|FG003|Overall Study|Other|2|||
44137305|NCT01352741|78925240|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
44137306|NCT01352741|78925239|FG000|Double-blind Comparative Period|Adverse Event|16|||
44137307|NCT01352741|78925240|FG001|Double-blind Comparative Period|Adverse Event|17|||
44137308|NCT01352741|78925239|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
44513381|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44137309|NCT01352741|78925240|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
44137310|NCT01352741|78925239|FG000|Double-blind Comparative Period|Death|0|||
44137311|NCT01352741|78925240|FG001|Double-blind Comparative Period|Death|1|||
44137312|NCT01352741|78925239|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
44137313|NCT01352741|78925240|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
44137314|NCT01352741|78925239|FG000|Double-blind Comparative Period|Other|1|||
44137315|NCT01352741|78925240|FG001|Double-blind Comparative Period|Other|2|||
44137316|NCT01352741|78925239|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
44137317|NCT01352741|78925240|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
44137318|NCT01352741|78925239|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
44137319|NCT01352741|78925240|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
44137320|NCT01352741|78925239|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
44137321|NCT01352741|78925240|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
44137322|NCT01352741|78925239|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
44137323|NCT01352741|78925240|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
44137324|NCT01657292|78925260|FG000|Overall Study|Adverse Event|6|||
44137325|NCT01657292|78925260|FG000|Overall Study|Withdrawal by Subject|2|||
44137326|NCT01657292|78925260|FG000|Overall Study|Violation of eligibility criteria|1|||
44137327|NCT01657292|78925260|FG000|Overall Study|Change of therapy|1|||
44137328|NCT00905567|78925276|FG000|Washout|Withdrawal by Subject|0|||
44137329|NCT00905567|78925277|FG001|Washout|Withdrawal by Subject|1|||
44137330|NCT02282020|78925283|FG000|Overall Study|Objective Disease Progression|128|||
44137331|NCT02282020|78925284|FG001|Overall Study|Objective Disease Progression|30|||
44137332|NCT02282020|78925283|FG000|Overall Study|Adverse Event|18|||
44137333|NCT02282020|78925284|FG001|Overall Study|Adverse Event|15|||
44137334|NCT02282020|78925283|FG000|Overall Study|Withdrawal by Subject|7|||
44137335|NCT02282020|78925284|FG001|Overall Study|Withdrawal by Subject|10|||
44137336|NCT02282020|78925283|FG000|Overall Study|Miscellaneous|5|||
44137337|NCT02282020|78925284|FG001|Overall Study|Miscellaneous|19|||
44137338|NCT02282020|78925283|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
44137339|NCT02282020|78925284|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
44137340|NCT02282020|78925283|FG000|Overall Study|Developed Discontinuation Criteria|0|||
44137341|NCT02282020|78925284|FG001|Overall Study|Developed Discontinuation Criteria|2|||
44137342|NCT02282020|78925283|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
44137343|NCT02282020|78925284|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
44137344|NCT02281552|78925300|FG000|Overall Study|Medication error|1|||
44137345|NCT02281552|78925301|FG001|Overall Study|Medication error|0|||
44137346|NCT02281552|78925300|FG000|Overall Study|Insufficient clinical response|0|||
44137347|NCT02281552|78925301|FG001|Overall Study|Insufficient clinical response|1|||
44137348|NCT02281552|78925300|FG000|Overall Study|Adverse Event|3|||
44137349|NCT02281552|78925301|FG001|Overall Study|Adverse Event|9|||
44137350|NCT00890591|78925307|FG000|Overall Study|Lack of Efficacy|20|||
44137351|NCT02284906|78925316|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44137352|NCT02284906|78925317|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
44137353|NCT02284906|78925318|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44137354|NCT02284906|78925316|FG000|Overall Study|Major Protocol Deviation|0|||
44137355|NCT02284906|78925317|FG001|Overall Study|Major Protocol Deviation|1|||
44137356|NCT02284906|78925318|FG002|Overall Study|Major Protocol Deviation|0|||
44137357|NCT02284906|78925316|FG000|Overall Study|Voluntary Withdrawal|2|||
44137358|NCT02284906|78925317|FG001|Overall Study|Voluntary Withdrawal|4|||
44137359|NCT02284906|78925318|FG002|Overall Study|Voluntary Withdrawal|5|||
44137360|NCT02284906|78925316|FG000|Overall Study|Study Termination|0|||
44137361|NCT02284906|78925317|FG001|Overall Study|Study Termination|11|||
44137362|NCT02284906|78925318|FG002|Overall Study|Study Termination|14|||
44137363|NCT02284906|78925316|FG000|Overall Study|Reason not Specified|1|||
44137364|NCT02284906|78925317|FG001|Overall Study|Reason not Specified|1|||
44137365|NCT02284906|78925318|FG002|Overall Study|Reason not Specified|0|||
44137366|NCT02879305|78925328|FG000|Overall Study|Investigator Site Closed|55|||
44137367|NCT02879305|78925329|FG001|Overall Study|Investigator Site Closed|57|||
44137368|NCT02879305|78925328|FG000|Overall Study|Withdrawal by Subject|44|||
44137369|NCT02879305|78925329|FG001|Overall Study|Withdrawal by Subject|42|||
44137370|NCT02879305|78925328|FG000|Overall Study|Lost to Follow-up|17|||
44137371|NCT02879305|78925329|FG001|Overall Study|Lost to Follow-up|12|||
44137372|NCT02879305|78925328|FG000|Overall Study|Other|1|||
44137373|NCT02879305|78925329|FG001|Overall Study|Other|0|||
44137374|NCT02281318|78925337|FG000|Overall Study|Adverse Event|2|||
44137375|NCT02281318|78925338|FG001|Overall Study|Adverse Event|2|||
44137376|NCT02281318|78925337|FG000|Overall Study|Lack of Efficacy|2|||
44137377|NCT02281318|78925338|FG001|Overall Study|Lack of Efficacy|0|||
44137378|NCT02281318|78925337|FG000|Overall Study|Lost to Follow-up|2|||
44137379|NCT02281318|78925338|FG001|Overall Study|Lost to Follow-up|1|||
44137380|NCT02281318|78925337|FG000|Overall Study|Physician Decision|2|||
44137381|NCT02281318|78925338|FG001|Overall Study|Physician Decision|0|||
44137382|NCT02281318|78925337|FG000|Overall Study|Withdrawal by Subject|6|||
44137383|NCT02281318|78925338|FG001|Overall Study|Withdrawal by Subject|2|||
44137384|NCT01657760|78925346|FG000|Overall Study|Withdrawal by Subject|0|||
44137385|NCT01657760|78925347|FG001|Overall Study|Withdrawal by Subject|0|||
44137386|NCT01657760|78925348|FG002|Overall Study|Withdrawal by Subject|0|||
44137387|NCT01657760|78925349|FG003|Overall Study|Withdrawal by Subject|1|||
44137388|NCT01657760|78925346|FG000|Overall Study|Physician Decision|1|||
44137389|NCT01657760|78925347|FG001|Overall Study|Physician Decision|1|||
44137390|NCT01657760|78925348|FG002|Overall Study|Physician Decision|1|||
44137391|NCT01657760|78925349|FG003|Overall Study|Physician Decision|2|||
44137392|NCT02280304|78925376|FG000|Overall Study|Lost to Follow-up|7|||
44137393|NCT02280304|78925377|FG001|Overall Study|Lost to Follow-up|8|||
44137394|NCT02283658|78925397|FG000|Overall Study|Withdrawal by Subject|1|||
44137395|NCT02279524|78925424|FG000|Overall Study|Withdrawal by Subject|3|||
44137396|NCT02279524|78925425|FG001|Overall Study|Withdrawal by Subject|6|||
44137397|NCT02279524|78925426|FG002|Overall Study|Withdrawal by Subject|3|||
44137398|NCT02279524|78925424|FG000|Overall Study|Adverse Event|4|||
44137399|NCT02279524|78925425|FG001|Overall Study|Adverse Event|3|||
44137400|NCT02279524|78925426|FG002|Overall Study|Adverse Event|2|||
44137401|NCT02279524|78925424|FG000|Overall Study|Lost to Follow-up|1|||
44137402|NCT02279524|78925425|FG001|Overall Study|Lost to Follow-up|1|||
44137403|NCT02279524|78925426|FG002|Overall Study|Lost to Follow-up|0|||
44137404|NCT02279524|78925424|FG000|Overall Study|Disallowed medication|1|||
44137405|NCT02279524|78925425|FG001|Overall Study|Disallowed medication|1|||
44137406|NCT02279524|78925426|FG002|Overall Study|Disallowed medication|2|||
44137407|NCT02279524|78925424|FG000|Overall Study|Bariatric surgery|1|||
44137408|NCT02279524|78925425|FG001|Overall Study|Bariatric surgery|0|||
44137409|NCT02279524|78925426|FG002|Overall Study|Bariatric surgery|0|||
44137410|NCT02283268|78925434|FG000|Overall Study|Withdrawal by Subject|1|||
44137411|NCT00857285|78925448|FG000|Overall Study|Adverse Event|4|||
44137412|NCT00857285|78925449|FG001|Overall Study|Adverse Event|2|||
44137413|NCT00857285|78925448|FG000|Overall Study|Lack of Efficacy|0|||
44137414|NCT00857285|78925449|FG001|Overall Study|Lack of Efficacy|2|||
44137415|NCT00857285|78925448|FG000|Overall Study|Protocol Violation|3|||
44137416|NCT00857285|78925449|FG001|Overall Study|Protocol Violation|1|||
44137417|NCT00857285|78925448|FG000|Overall Study|Withdrawal by Subject|4|||
44137418|NCT00857285|78925449|FG001|Overall Study|Withdrawal by Subject|0|||
44137419|NCT00857285|78925448|FG000|Overall Study|Randomization criteria not met|1|||
44137420|NCT00857285|78925449|FG001|Overall Study|Randomization criteria not met|1|||
44137421|NCT02278354|78925455|FG000|Overall Study|Lost to Follow-up|2|||
44137422|NCT02278354|78925456|FG001|Overall Study|Lost to Follow-up|2|||
44137423|NCT02278354|78925455|FG000|Overall Study|Withdrawal by Subject|0|||
44137424|NCT02278354|78925456|FG001|Overall Study|Withdrawal by Subject|1|||
44137425|NCT02278354|78925455|FG000|Overall Study|<10 professional fights|2|||
44137426|NCT02278354|78925456|FG001|Overall Study|<10 professional fights|0|||
44137427|NCT01657370|78925475|FG000|Overall Study|Withdrawal by Subject|0|||
44137428|NCT01657370|78925476|FG001|Overall Study|Withdrawal by Subject|0|||
44137429|NCT01657370|78925477|FG002|Overall Study|Withdrawal by Subject|1|||
44137430|NCT01657370|78925478|FG003|Overall Study|Withdrawal by Subject|0|||
44137431|NCT01657370|78925479|FG004|Overall Study|Withdrawal by Subject|0|||
44137432|NCT01657370|78925480|FG005|Overall Study|Withdrawal by Subject|1|||
44137433|NCT01657370|78925475|FG000|Overall Study|Physician Decision|2|||
44137434|NCT01657370|78925476|FG001|Overall Study|Physician Decision|3|||
44137435|NCT01657370|78925477|FG002|Overall Study|Physician Decision|1|||
44137436|NCT01657370|78925478|FG003|Overall Study|Physician Decision|2|||
44137437|NCT01657370|78925479|FG004|Overall Study|Physician Decision|5|||
44137438|NCT01657370|78925480|FG005|Overall Study|Physician Decision|0|||
44137439|NCT01657370|78925475|FG000|Overall Study|Lack of Qualifying Event|1|||
44137440|NCT01657370|78925476|FG001|Overall Study|Lack of Qualifying Event|0|||
44137441|NCT01657370|78925477|FG002|Overall Study|Lack of Qualifying Event|3|||
44137442|NCT01657370|78925478|FG003|Overall Study|Lack of Qualifying Event|2|||
44137443|NCT01657370|78925479|FG004|Overall Study|Lack of Qualifying Event|1|||
44137444|NCT01657370|78925480|FG005|Overall Study|Lack of Qualifying Event|2|||
44137445|NCT01657370|78925475|FG000|Overall Study|Adverse Event|0|||
44137446|NCT01657370|78925476|FG001|Overall Study|Adverse Event|0|||
44137447|NCT01657370|78925477|FG002|Overall Study|Adverse Event|0|||
44137448|NCT01657370|78925478|FG003|Overall Study|Adverse Event|0|||
44137449|NCT01657370|78925479|FG004|Overall Study|Adverse Event|1|||
44137450|NCT01657370|78925480|FG005|Overall Study|Adverse Event|0|||
44137451|NCT01657370|78925475|FG000|Overall Study|Protocol Violation|1|||
44137452|NCT01657370|78925476|FG001|Overall Study|Protocol Violation|1|||
44243799|NCT01464827|79073587|FG004|Overall Study|Other|3|||
44243800|NCT01464827|79073588|FG005|Overall Study|Other|0|||
44243801|NCT01464827|79073589|FG006|Overall Study|Other|1|||
44137453|NCT01657370|78925477|FG002|Overall Study|Protocol Violation|1|||
44137454|NCT01657370|78925478|FG003|Overall Study|Protocol Violation|1|||
44243802|NCT01464827|79073590|FG007|Overall Study|Other|0|||
44137455|NCT01657370|78925479|FG004|Overall Study|Protocol Violation|0|||
44137456|NCT01657370|78925480|FG005|Overall Study|Protocol Violation|0|||
44137457|NCT01657370|78925475|FG000|Overall Study|Lost to Follow-up|2|||
44243803|NCT01464827|79073591|FG008|Overall Study|Other|3|||
44137458|NCT01657370|78925476|FG001|Overall Study|Lost to Follow-up|0|||
44137459|NCT01657370|78925477|FG002|Overall Study|Lost to Follow-up|1|||
44137460|NCT01657370|78925478|FG003|Overall Study|Lost to Follow-up|0|||
44137461|NCT01657370|78925479|FG004|Overall Study|Lost to Follow-up|0|||
44137462|NCT01657370|78925480|FG005|Overall Study|Lost to Follow-up|1|||
44137463|NCT00849797|78925522|FG000|First Intervention|bad veins|1|||
44137464|NCT00849797|78925523|FG001|First Intervention|bad veins|0|||
44137465|NCT00849797|78925522|FG000|First Intervention|Adverse Event|0|||
44137466|NCT00849797|78925523|FG001|First Intervention|Adverse Event|1|||
44137467|NCT00849797|78925522|FG000|Washout: One Week|Withdrawal by Subject|0|||
44137468|NCT00849797|78925523|FG001|Washout: One Week|Withdrawal by Subject|2|||
44137469|NCT00840203|78925553|FG000|First Intervention|Protocol Violation|1|||
44137470|NCT00840203|78925554|FG001|First Intervention|Protocol Violation|1|||
44137471|NCT00840203|78925553|FG000|Washout|Protocol Violation|1|||
44137472|NCT00840203|78925554|FG001|Washout|Protocol Violation|0|||
44137473|NCT00835991|78925560|FG000|First Intervention|Adverse Event|0|||
44137474|NCT00835991|78925561|FG001|First Intervention|Adverse Event|1|||
44137475|NCT00835991|78925560|FG000|Washout|Protocol Violation|0|||
44137476|NCT00835991|78925561|FG001|Washout|Protocol Violation|2|||
44137477|NCT00835991|78925560|FG000|Washout|Withdrawal by Subject|3|||
44137478|NCT00835991|78925561|FG001|Washout|Withdrawal by Subject|1|||
44137479|NCT02276872|78925568|FG000|Overall Study|Adverse Event|1|||
44137480|NCT02276872|78925569|FG001|Overall Study|Adverse Event|0|||
44137481|NCT02276872|78925570|FG002|Overall Study|Adverse Event|0|||
44137482|NCT00835367|78925585|FG000|Washout|Adverse Event|2|||
44137483|NCT00835367|78925586|FG001|Washout|Adverse Event|0|||
44137484|NCT00835367|78925585|FG000|Washout|Withdrawal by Subject|1|||
44137485|NCT00835367|78925586|FG001|Washout|Withdrawal by Subject|0|||
44137486|NCT00835367|78925585|FG000|Second Intervention|Adverse Event|1|||
44137487|NCT00835367|78925586|FG001|Second Intervention|Adverse Event|1|||
44137488|NCT02276560|78925593|FG000|Overall Study|Adverse Event|1|||
44137489|NCT02276560|78925594|FG001|Overall Study|Adverse Event|0|||
44137490|NCT02276560|78925595|FG002|Overall Study|Adverse Event|0|||
44137491|NCT02276482|78925605|FG000|Overall Study|Adverse Event|1|||
44137492|NCT02276482|78925606|FG001|Overall Study|Adverse Event|0|||
44137493|NCT02276482|78925605|FG000|Overall Study|Withdrawal by Subject|1|||
44137494|NCT02276482|78925606|FG001|Overall Study|Withdrawal by Subject|0|||
44137495|NCT02276482|78925605|FG000|Overall Study|Gram-negative infection|1|||
44137496|NCT02276482|78925606|FG001|Overall Study|Gram-negative infection|0|||
44137497|NCT02276482|78925605|FG000|Overall Study|Reason not specified|0|||
44137498|NCT02276482|78925606|FG001|Overall Study|Reason not specified|1|||
44137499|NCT00835211|78925624|FG000|First Intervention|Withdrawal by Subject|0|||
44137500|NCT00835211|78925625|FG001|First Intervention|Withdrawal by Subject|1|||
44137501|NCT00835211|78925624|FG000|Washout: 7 Days|Adverse Event|2|||
44137502|NCT00835211|78925625|FG001|Washout: 7 Days|Adverse Event|1|||
44137503|NCT00835211|78925624|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
44137504|NCT00835211|78925625|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
44137505|NCT00834743|78925638|FG000|Second Intervention|Withdrawal by Subject|1|||
44137506|NCT00834743|78925639|FG001|Second Intervention|Withdrawal by Subject|0|||
44137507|NCT00834587|78925645|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
44137508|NCT00834587|78925646|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
44137509|NCT00834431|78925652|FG000|First Intervention|Adverse Event|0|||
44137510|NCT00834431|78925653|FG001|First Intervention|Adverse Event|1|||
44243804|NCT01464827|79073592|FG009|Overall Study|Other|1|||
44137511|NCT00834431|78925652|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
44137512|NCT00834431|78925653|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
44137513|NCT00830219|78925673|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44137514|NCT00830219|78925674|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
44137515|NCT02274766|78925680|FG000|Overall Study|Withdrawal by Subject|3|||
44137516|NCT02274766|78925681|FG001|Overall Study|Withdrawal by Subject|6|||
44137517|NCT02274766|78925680|FG000|Overall Study|Did Not Receive Study Drug|1|||
44137518|NCT02274766|78925681|FG001|Overall Study|Did Not Receive Study Drug|1|||
44137519|NCT02274766|78925680|FG000|Overall Study|Subject Unwilling to Proceed|0|||
44137520|NCT02274766|78925681|FG001|Overall Study|Subject Unwilling to Proceed|1|||
44137521|NCT02274766|78925680|FG000|Overall Study|Adverse Event|0|||
44137522|NCT02274766|78925681|FG001|Overall Study|Adverse Event|1|||
44137523|NCT00829673|78925689|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44137524|NCT00829673|78925690|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44137525|NCT02370238|78925696|FG000|Overall Study|Death|42|||
44137526|NCT02370238|78925697|FG001|Overall Study|Death|35|||
44137527|NCT02370238|78925696|FG000|Overall Study|Lost to Follow-up|1|||
44137528|NCT02370238|78925697|FG001|Overall Study|Lost to Follow-up|3|||
44137529|NCT02370238|78925696|FG000|Overall Study|Withdrawal by Subject|2|||
44137530|NCT02370238|78925697|FG001|Overall Study|Withdrawal by Subject|6|||
44137531|NCT02370238|78925696|FG000|Overall Study|Other|2|||
44137532|NCT02370238|78925697|FG001|Overall Study|Other|1|||
44137533|NCT02370160|78925707|FG000|Overall Study|Death|3|||
44513382|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513383|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513384|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44137534|NCT02370160|78925708|FG001|Overall Study|Death|4|||
44137535|NCT02370160|78925709|FG002|Overall Study|Death|1|||
44137536|NCT02273908|78925724|FG000|Overall Study|Adverse Event|16|||
44137537|NCT02273908|78925725|FG001|Overall Study|Adverse Event|0|||
44243805|NCT01464827|79073593|FG010|Overall Study|Other|2|||
44243806|NCT01464827|79073594|FG011|Overall Study|Other|0|||
44243807|NCT01464827|79073595|FG012|Overall Study|Other|1|||
44243808|NCT01464827|79073596|FG013|Overall Study|Other|0|||
44513385|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513386|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513387|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513388|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44137538|NCT02273908|78925724|FG000|Overall Study|Lost to Follow-up|10|||
44137539|NCT02273908|78925725|FG001|Overall Study|Lost to Follow-up|1|||
44137540|NCT02273908|78925724|FG000|Overall Study|Did not meet entrance criteria|3|||
44137541|NCT02273908|78925725|FG001|Overall Study|Did not meet entrance criteria|2|||
44137542|NCT02273908|78925724|FG000|Overall Study|Withdrawal by Subject|4|||
44137543|NCT02273908|78925725|FG001|Overall Study|Withdrawal by Subject|2|||
44137544|NCT02273752|78925735|FG000|Overall Study|Trial was terminated early|2|||
44137545|NCT05180630|78925739|FG000|First Intervention|Physician Decision|0|||
44243809|NCT01464827|79073583|FG000|Overall Study|Not Treated|0|||
44137546|NCT05180630|78925740|FG001|First Intervention|Physician Decision|0|||
44137547|NCT05180630|78925741|FG002|First Intervention|Physician Decision|3|||
44137548|NCT02273596|78925750|FG000|24-Week Treatment Period|Adverse Event|3|||
44243810|NCT01464827|79073584|FG001|Overall Study|Not Treated|2|||
44243811|NCT01464827|79073585|FG002|Overall Study|Not Treated|0|||
44243812|NCT01464827|79073586|FG003|Overall Study|Not Treated|0|||
44243813|NCT01464827|79073587|FG004|Overall Study|Not Treated|1|||
44243814|NCT01464827|79073588|FG005|Overall Study|Not Treated|0|||
44137549|NCT02273596|78925750|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
44137550|NCT02273596|78925750|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
44137551|NCT02273596|78925750|FG000|24-Week Treatment Period|Physician Decision|1|||
44137552|NCT02273596|78925750|FG000|24-Week Treatment Period|Protocol Deviation|1|||
44137553|NCT02273596|78925750|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
44137554|NCT02273596|78925750|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
44137555|NCT02273596|78925750|FG000|Extension Period|Lost to Follow-up|1|||
44137556|NCT02273596|78925750|FG000|Extension Period|Protocol Deviation|1|||
44137557|NCT01656200|78925760|FG000|Overall Study|Withdrawal by Subject|1|||
44137558|NCT02369848|78925764|FG000|Overall Study|Death|1|||
44137559|NCT02369848|78925764|FG000|Overall Study|Withdrawal by Subject|2|||
44137560|NCT02369848|78925764|FG000|Overall Study|Lost to Follow-up|1|||
44137561|NCT02368210|78925770|FG000|Overall Study|Withdrawal by Subject|1|||
44137562|NCT02368210|78925771|FG001|Overall Study|Withdrawal by Subject|0|||
44137563|NCT02368210|78925770|FG000|Overall Study|Adverse Event|0|||
44137564|NCT02368210|78925771|FG001|Overall Study|Adverse Event|1|||
44137565|NCT02273050|78925780|FG000|Overall Study|Adverse Event|4|||
44137566|NCT02273050|78925781|FG001|Overall Study|Adverse Event|3|||
44137567|NCT02273050|78925782|FG002|Overall Study|Adverse Event|3|||
44137568|NCT02273050|78925780|FG000|Overall Study|Death|0|||
44137569|NCT02273050|78925781|FG001|Overall Study|Death|0|||
44137570|NCT02273050|78925782|FG002|Overall Study|Death|1|||
44137571|NCT02273050|78925780|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
44137572|NCT02273050|78925781|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
44137573|NCT02273050|78925782|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
44137574|NCT02273050|78925780|FG000|Overall Study|Lack of Efficacy|0|||
44137575|NCT02273050|78925781|FG001|Overall Study|Lack of Efficacy|1|||
44137576|NCT02273050|78925782|FG002|Overall Study|Lack of Efficacy|1|||
44137577|NCT02273050|78925780|FG000|Overall Study|Withdrawal by Subject|17|||
44137578|NCT02273050|78925781|FG001|Overall Study|Withdrawal by Subject|14|||
44137579|NCT02273050|78925782|FG002|Overall Study|Withdrawal by Subject|16|||
44137580|NCT02273050|78925780|FG000|Overall Study|Lost to Follow-up|0|||
44137581|NCT02273050|78925781|FG001|Overall Study|Lost to Follow-up|2|||
44137582|NCT02273050|78925782|FG002|Overall Study|Lost to Follow-up|3|||
44137583|NCT02273050|78925780|FG000|Overall Study|Protocol Violation|3|||
44137584|NCT02273050|78925781|FG001|Overall Study|Protocol Violation|1|||
44137585|NCT02273050|78925782|FG002|Overall Study|Protocol Violation|4|||
44137586|NCT02272816|78925790|FG000|Overall Study|Adverse Event|1|||
44137587|NCT02271880|78925796|FG000|Overall Study|Premature discontinuation of study|3|||
44137588|NCT02271880|78925797|FG001|Overall Study|Premature discontinuation of study|4|||
44137589|NCT02367352|78925805|FG000|Overall Study|Progressive disease|7|||
44137590|NCT02367352|78925806|FG001|Overall Study|Progressive disease|0|||
44137591|NCT02367352|78925807|FG002|Overall Study|Progressive disease|0|||
44137592|NCT02367352|78925805|FG000|Overall Study|Participant Received Alternative Therapy|1|||
44137593|NCT02367352|78925806|FG001|Overall Study|Participant Received Alternative Therapy|0|||
44137594|NCT02367352|78925807|FG002|Overall Study|Participant Received Alternative Therapy|0|||
44137595|NCT02367352|78925805|FG000|Overall Study|Adverse Event|1|||
44137596|NCT02367352|78925806|FG001|Overall Study|Adverse Event|0|||
44137597|NCT02367352|78925807|FG002|Overall Study|Adverse Event|0|||
44137598|NCT02365636|78925816|FG000|Overall Study|Adverse Event|3|||
44137599|NCT02365636|78925817|FG001|Overall Study|Adverse Event|3|||
44137600|NCT02365636|78925818|FG002|Overall Study|Adverse Event|2|||
44137601|NCT02365636|78925816|FG000|Overall Study|Protocol Violation|1|||
44137602|NCT02365636|78925817|FG001|Overall Study|Protocol Violation|4|||
44137603|NCT02365636|78925818|FG002|Overall Study|Protocol Violation|0|||
44137604|NCT02365636|78925816|FG000|Overall Study|Lost to Follow-up|0|||
44137605|NCT02365636|78925817|FG001|Overall Study|Lost to Follow-up|0|||
44137606|NCT02365636|78925818|FG002|Overall Study|Lost to Follow-up|1|||
44137607|NCT02365636|78925816|FG000|Overall Study|Other|2|||
44137608|NCT02365636|78925817|FG001|Overall Study|Other|0|||
44137609|NCT02365636|78925818|FG002|Overall Study|Other|0|||
44137610|NCT01655498|78925826|FG000|Overall Study|Unrelated health issue|2|||
44137611|NCT01655498|78925826|FG000|Overall Study|Protocol Violation|2|||
44137612|NCT01655498|78925826|FG000|Overall Study|Withdrawal by Subject|1|||
44137613|NCT02270944|78925835|FG000|Overall Study|Lost to Follow-up|9|||
44137614|NCT02270944|78925836|FG001|Overall Study|Lost to Follow-up|4|||
44137615|NCT02270944|78925835|FG000|Overall Study|Withdrawal by Subject|2|||
44137616|NCT02270944|78925836|FG001|Overall Study|Withdrawal by Subject|1|||
44137617|NCT02365558|78925843|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
44137618|NCT02365558|78925844|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
44243815|NCT01464827|79073589|FG006|Overall Study|Not Treated|1|||
44137619|NCT02365558|78925843|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
44137620|NCT02365558|78925844|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
44137621|NCT02365480|78925855|FG000|Overall Study|Withdrawal by Subject|2|||
44137622|NCT02365480|78925856|FG001|Overall Study|Withdrawal by Subject|0|||
44137623|NCT02270242|78925864|FG000|Overall Study|Withdrawal by Subject|18|||
44137624|NCT02270242|78925865|FG001|Overall Study|Withdrawal by Subject|25|||
44137625|NCT02270242|78925864|FG000|Overall Study|Lost to Follow-up|41|||
44137626|NCT02270242|78925865|FG001|Overall Study|Lost to Follow-up|27|||
44137627|NCT02270242|78925864|FG000|Overall Study|Physician Decision|0|||
44137628|NCT02270242|78925865|FG001|Overall Study|Physician Decision|1|||
44137629|NCT02364388|78925871|FG000|Overall Study|Protocol Violation|1|||
44137630|NCT02364388|78925871|FG000|Overall Study|Technical Failure|3|||
44137631|NCT02364388|78925871|FG000|Overall Study|No OA/US data|2|||
44137632|NCT02364388|78925871|FG000|Overall Study|No Biopsy|2|||
44137633|NCT02363686|78925875|FG000|Overall Study|Withdrawal by Subject|22|||
44137634|NCT02363686|78925875|FG000|Overall Study|incomplete FEES examinations|13|||
44137635|NCT02268916|78925881|FG000|Overall Study|Lost to Follow-up|1|||
44137636|NCT02268916|78925882|FG001|Overall Study|Lost to Follow-up|1|||
44137637|NCT02268916|78925881|FG000|Overall Study|Withdrawal by Subject|6|||
44137638|NCT02268916|78925882|FG001|Overall Study|Withdrawal by Subject|5|||
44137639|NCT02268916|78925881|FG000|Overall Study|Participant did not have diabetes|1|||
44137640|NCT02268916|78925882|FG001|Overall Study|Participant did not have diabetes|0|||
44137641|NCT02268916|78925881|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
44137642|NCT02268916|78925882|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
44137643|NCT02518490|78925889|FG000|Overall Study|Withdrawal by Subject|1|||
44137644|NCT02518490|78925890|FG001|Overall Study|Withdrawal by Subject|1|||
44137645|NCT01364870|78925900|FG000|Overall Study|Withdrawal by Subject|13|||
44137646|NCT01364870|78925901|FG001|Overall Study|Withdrawal by Subject|24|||
44137647|NCT01364870|78925902|FG002|Overall Study|Withdrawal by Subject|10|||
44513389|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513390|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513391|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513392|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513393|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513394|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513395|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513396|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
44513397|NCT03129100|79519000|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513398|NCT03129100|79519001|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513399|NCT03129100|79519002|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513400|NCT03129100|79519003|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513401|NCT03129100|79519004|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
44513402|NCT03129100|79519005|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
44513403|NCT03129100|79519006|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
44513404|NCT03129100|79519007|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513405|NCT03129100|79519008|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513406|NCT03129100|79519009|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513407|NCT03129100|79519010|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513408|NCT03129100|79519011|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513409|NCT03129100|79519012|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513410|NCT03129100|79519013|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513411|NCT03129100|79519014|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513412|NCT03129100|79519015|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513413|NCT03129100|79519016|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513414|NCT03129100|79519017|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513415|NCT03129100|79519018|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513416|NCT03129100|79519019|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513417|NCT03129100|79519020|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513418|NCT03129100|79519021|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513419|NCT03129100|79519022|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513420|NCT03129100|79519023|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44276603|NCT04791319|79237619|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44137648|NCT01364870|78925900|FG000|Overall Study|Adverse Event|8|||
44137649|NCT01364870|78925901|FG001|Overall Study|Adverse Event|6|||
44137650|NCT01364870|78925902|FG002|Overall Study|Adverse Event|4|||
44137651|NCT01364870|78925900|FG000|Overall Study|Protocol Violation|1|||
44137652|NCT01364870|78925901|FG001|Overall Study|Protocol Violation|0|||
44137653|NCT01364870|78925902|FG002|Overall Study|Protocol Violation|0|||
44137654|NCT02268526|78925913|FG000|Overall Study|Adverse Event|0|||
44137655|NCT02268526|78925914|FG001|Overall Study|Adverse Event|2|||
44137656|NCT02268526|78925915|FG002|Overall Study|Adverse Event|1|||
44137657|NCT02268526|78925913|FG000|Overall Study|Death|1|||
44137658|NCT02268526|78925914|FG001|Overall Study|Death|11|||
44137659|NCT02268526|78925915|FG002|Overall Study|Death|0|||
44137660|NCT02268526|78925913|FG000|Overall Study|protocol deviation|0|||
44137661|NCT02268526|78925914|FG001|Overall Study|protocol deviation|1|||
44137662|NCT02268526|78925915|FG002|Overall Study|protocol deviation|0|||
44137663|NCT02268526|78925913|FG000|Overall Study|Physician Decision|0|||
44137664|NCT02268526|78925914|FG001|Overall Study|Physician Decision|0|||
44137665|NCT02268526|78925915|FG002|Overall Study|Physician Decision|1|||
44137666|NCT02268526|78925913|FG000|Overall Study|Subject/guardian decision|0|||
44137667|NCT02268526|78925914|FG001|Overall Study|Subject/guardian decision|7|||
44137668|NCT02268526|78925915|FG002|Overall Study|Subject/guardian decision|3|||
44137669|NCT02268214|78925928|FG000|Overall Study|Subject no longer meets study criteria|0|||
44137670|NCT02268214|78925929|FG001|Overall Study|Subject no longer meets study criteria|2|||
44137671|NCT02268214|78925930|FG002|Overall Study|Subject no longer meets study criteria|0|||
44137672|NCT02268214|78925928|FG000|Overall Study|Pregnancy|2|||
44137673|NCT02268214|78925929|FG001|Overall Study|Pregnancy|2|||
44137674|NCT02268214|78925930|FG002|Overall Study|Pregnancy|1|||
44137675|NCT02268214|78925928|FG000|Overall Study|Lost to Follow-up|3|||
44137676|NCT02268214|78925929|FG001|Overall Study|Lost to Follow-up|3|||
44137677|NCT02268214|78925930|FG002|Overall Study|Lost to Follow-up|4|||
44137678|NCT02268214|78925928|FG000|Overall Study|Lack of Efficacy|1|||
44137679|NCT02268214|78925929|FG001|Overall Study|Lack of Efficacy|0|||
44137680|NCT02268214|78925930|FG002|Overall Study|Lack of Efficacy|2|||
44137681|NCT02268214|78925928|FG000|Overall Study|Adverse Event|11|||
44137682|NCT02268214|78925929|FG001|Overall Study|Adverse Event|14|||
44137683|NCT02268214|78925930|FG002|Overall Study|Adverse Event|9|||
44137684|NCT02268214|78925928|FG000|Overall Study|Withdrawal by Subject|4|||
44137685|NCT02268214|78925929|FG001|Overall Study|Withdrawal by Subject|5|||
44137686|NCT02268214|78925930|FG002|Overall Study|Withdrawal by Subject|10|||
44137687|NCT02268214|78925928|FG000|Overall Study|Subject request to discontinue treatment|10|||
44137688|NCT02268214|78925929|FG001|Overall Study|Subject request to discontinue treatment|8|||
44137689|NCT02268214|78925930|FG002|Overall Study|Subject request to discontinue treatment|6|||
44137690|NCT02268214|78925928|FG000|Overall Study|Poor/non-compliance|2|||
44137691|NCT02268214|78925929|FG001|Overall Study|Poor/non-compliance|1|||
44137692|NCT02268214|78925930|FG002|Overall Study|Poor/non-compliance|2|||
44137693|NCT02268214|78925928|FG000|Overall Study|Other reasons|7|||
44137694|NCT02268214|78925929|FG001|Overall Study|Other reasons|3|||
44137695|NCT02268214|78925930|FG002|Overall Study|Other reasons|3|||
44137696|NCT02268214|78925928|FG000|Overall Study|Not entering long-term period|2|||
44137697|NCT02268214|78925929|FG001|Overall Study|Not entering long-term period|3|||
44137698|NCT02268214|78925930|FG002|Overall Study|Not entering long-term period|5|||
44137699|NCT02521376|78925942|FG000|Overall Study|Enrolled, But Not Treated|1|||
44137700|NCT02521376|78925943|FG001|Overall Study|Enrolled, But Not Treated|0|||
44137701|NCT02521376|78925944|FG002|Overall Study|Enrolled, But Not Treated|0|||
44137702|NCT02521376|78925945|FG003|Overall Study|Enrolled, But Not Treated|0|||
44137703|NCT02268058|78925967|FG000|Overall Study|Protocol Violation|1|||
44513421|NCT03129100|79519024|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513422|NCT03129100|79519025|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
44513423|NCT03129100|79519000|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513424|NCT03129100|79519001|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513425|NCT03129100|79519002|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513426|NCT03129100|79519003|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44137704|NCT02268058|78925968|FG001|Overall Study|Protocol Violation|0|||
44137705|NCT02268058|78925969|FG002|Overall Study|Protocol Violation|0|||
44137706|NCT02268058|78925970|FG003|Overall Study|Protocol Violation|0|||
44243816|NCT01464827|79073590|FG007|Overall Study|Not Treated|0|||
44243817|NCT01464827|79073591|FG008|Overall Study|Not Treated|0|||
44513427|NCT03129100|79519004|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513428|NCT03129100|79519005|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44137707|NCT02267824|78925982|FG000|Overall Study|Pregnancy|1|||
44137708|NCT02267824|78925983|FG001|Overall Study|Pregnancy|1|||
44137709|NCT02267824|78925982|FG000|Overall Study|Lost to Follow-up|4|||
44137710|NCT02267824|78925983|FG001|Overall Study|Lost to Follow-up|0|||
44137711|NCT02267824|78925982|FG000|Overall Study|Protocol Violation|3|||
44137712|NCT02267824|78925983|FG001|Overall Study|Protocol Violation|0|||
44137713|NCT02267824|78925982|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
44137714|NCT02267824|78925983|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
44137715|NCT02267746|78925992|FG000|Overall Study|Adverse Event|0|||
44137716|NCT02267746|78925993|FG001|Overall Study|Adverse Event|2|||
44137717|NCT02267746|78925994|FG002|Overall Study|Adverse Event|1|||
44137718|NCT02267746|78925992|FG000|Overall Study|Protocol Violation|8|||
44137719|NCT02267746|78925993|FG001|Overall Study|Protocol Violation|7|||
44137720|NCT02267746|78925994|FG002|Overall Study|Protocol Violation|3|||
44137721|NCT02267746|78925992|FG000|Overall Study|Lack of Efficacy|11|||
44137722|NCT02267746|78925993|FG001|Overall Study|Lack of Efficacy|11|||
44137723|NCT02267746|78925994|FG002|Overall Study|Lack of Efficacy|15|||
44137724|NCT02267746|78925992|FG000|Overall Study|Protocol Violation|1|||
44137725|NCT02267746|78925993|FG001|Overall Study|Protocol Violation|2|||
44137726|NCT02267746|78925994|FG002|Overall Study|Protocol Violation|1|||
44137727|NCT02267746|78925992|FG000|Overall Study|Miscellaneous|1|||
44137728|NCT02267746|78925993|FG001|Overall Study|Miscellaneous|0|||
44137729|NCT02267746|78925994|FG002|Overall Study|Miscellaneous|1|||
44137730|NCT02362360|78926004|FG000|Period 1|Lack of Efficacy|1|||
44137731|NCT02362360|78926005|FG001|Period 1|Lack of Efficacy|0|||
44513429|NCT03129100|79519006|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513430|NCT03129100|79519007|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513431|NCT03129100|79519008|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513432|NCT03129100|79519009|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
44513433|NCT03129100|79519010|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513434|NCT03129100|79519011|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513435|NCT03129100|79519012|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513436|NCT03129100|79519013|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513437|NCT03129100|79519014|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513438|NCT03129100|79519015|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513439|NCT03129100|79519016|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513440|NCT03129100|79519017|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513441|NCT03129100|79519018|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513442|NCT03129100|79519019|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513443|NCT03129100|79519020|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513444|NCT03129100|79519021|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513445|NCT03129100|79519022|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513446|NCT03129100|79519023|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513447|NCT03129100|79519024|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513448|NCT03129100|79519025|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
44513449|NCT03129100|79519000|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513450|NCT03129100|79519001|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513451|NCT03129100|79519002|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513452|NCT03129100|79519003|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513453|NCT03129100|79519004|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513454|NCT03129100|79519005|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513455|NCT03129100|79519006|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513456|NCT03129100|79519007|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513457|NCT03129100|79519008|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513458|NCT03129100|79519009|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513459|NCT03129100|79519010|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513460|NCT03129100|79519011|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
44513461|NCT03129100|79519012|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513462|NCT03129100|79519013|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513463|NCT03129100|79519014|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513464|NCT03129100|79519015|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513465|NCT03129100|79519016|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513466|NCT03129100|79519017|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513467|NCT03129100|79519018|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513468|NCT03129100|79519019|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513469|NCT03129100|79519020|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513470|NCT03129100|79519021|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513471|NCT03129100|79519022|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513472|NCT03129100|79519023|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44513473|NCT03129100|79519024|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44137732|NCT02362360|78926004|FG000|Period 1|Withdrawal by Subject|2|||
44243818|NCT01464827|79073592|FG009|Overall Study|Not Treated|2|||
44243819|NCT01464827|79073593|FG010|Overall Study|Not Treated|0|||
44137733|NCT02362360|78926005|FG001|Period 1|Withdrawal by Subject|1|||
44137734|NCT02362282|78926013|FG000|Overall Study|Withdrawal by Subject|1|||
44137735|NCT02362282|78926014|FG001|Overall Study|Withdrawal by Subject|0|||
44243820|NCT01464827|79073594|FG011|Overall Study|Not Treated|1|||
44243821|NCT01464827|79073595|FG012|Overall Study|Not Treated|0|||
44137736|NCT02361580|78926022|FG000|Overall Study|Lost to Follow-up|6|||
44243822|NCT01464827|79073596|FG013|Overall Study|Not Treated|2|||
44137737|NCT02361580|78926023|FG001|Overall Study|Lost to Follow-up|3|||
44137738|NCT02520284|78926032|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
44137739|NCT02520284|78926033|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
44137740|NCT02520284|78926034|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
44137741|NCT02520284|78926032|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
44137742|NCT02520284|78926033|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
44137743|NCT02520284|78926034|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
44137744|NCT02520284|78926032|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
44137745|NCT02520284|78926033|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
44137746|NCT02520284|78926034|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
44137747|NCT02520284|78926032|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
44137748|NCT02520284|78926033|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
44137749|NCT02520284|78926034|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
44137750|NCT02520284|78926032|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
44137751|NCT02520284|78926033|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
44137752|NCT02520284|78926034|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
44137753|NCT02520284|78926032|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
44137754|NCT02520284|78926033|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
44137755|NCT02520284|78926034|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
44137756|NCT02520284|78926032|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
44137757|NCT02520284|78926033|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
44137758|NCT02520284|78926034|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
44137759|NCT02520284|78926032|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
44137760|NCT02520284|78926033|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
44137761|NCT02520284|78926034|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
44137762|NCT02520284|78926032|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
44137763|NCT02520284|78926033|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
44137764|NCT02520284|78926034|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
44137765|NCT02520284|78926032|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
44137766|NCT02520284|78926033|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
44137767|NCT02520284|78926034|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
44137768|NCT02520284|78926032|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
44137769|NCT02520284|78926033|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
44137770|NCT02520284|78926034|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
44137771|NCT02517866|78926048|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
44137772|NCT02517866|78926049|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
44137773|NCT02517866|78926050|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44137774|NCT02517866|78926048|FG000|Overall Study|Significant Protocol Deviation|4|||
44137775|NCT02517866|78926049|FG001|Overall Study|Significant Protocol Deviation|1|||
44137776|NCT02517866|78926050|FG002|Overall Study|Significant Protocol Deviation|0|||
44137777|NCT02517866|78926048|FG000|Overall Study|Lost to Follow-up|1|||
44137778|NCT02517866|78926049|FG001|Overall Study|Lost to Follow-up|0|||
44137779|NCT02517866|78926050|FG002|Overall Study|Lost to Follow-up|0|||
44137780|NCT02517866|78926048|FG000|Overall Study|Voluntary Withdrawal|2|||
44137781|NCT02517866|78926049|FG001|Overall Study|Voluntary Withdrawal|2|||
44513474|NCT03129100|79519025|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
44137782|NCT02517866|78926050|FG002|Overall Study|Voluntary Withdrawal|0|||
44137783|NCT02517866|78926048|FG000|Overall Study|Investigator Decision|2|||
44137784|NCT02517866|78926049|FG001|Overall Study|Investigator Decision|1|||
44137785|NCT02517866|78926050|FG002|Overall Study|Investigator Decision|0|||
44137786|NCT02517866|78926048|FG000|Overall Study|Reason not specified|2|||
44243823|NCT01463111|79073637|FG000|Overall Study|Withdrawal by Subject|2|||
44243824|NCT01463111|79073637|FG000|Overall Study|Lost to Follow-up|5|||
44243825|NCT01463111|79073637|FG000|Overall Study|Physician Decision|2|||
44243826|NCT01463033|79073643|FG000|Overall Study|Lost to Follow-up|4|||
44243827|NCT01463033|79073644|FG001|Overall Study|Lost to Follow-up|4|||
44243828|NCT01463033|79073643|FG000|Overall Study|Death|3|||
44243829|NCT01463033|79073644|FG001|Overall Study|Death|2|||
44243830|NCT01461707|79073653|FG000|Overall Study|Withdrawal by Subject|1|||
44243831|NCT01461707|79073654|FG001|Overall Study|Withdrawal by Subject|0|||
44243832|NCT01461551|79073663|FG000|Overall Study|Physician Decision|2|||
44243833|NCT01461551|79073664|FG001|Overall Study|Physician Decision|1|||
44276604|NCT04791319|79237620|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44276605|NCT04791319|79237621|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
44513475|NCT03129100|79519000|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513476|NCT03129100|79519001|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44137787|NCT02517866|78926049|FG001|Overall Study|Reason not specified|0|||
44243834|NCT01461551|79073665|FG002|Overall Study|Physician Decision|2|||
44243835|NCT01461005|79073673|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
44243836|NCT01460381|79073680|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
44243837|NCT01460381|79073681|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
44243838|NCT01473589|79073765|FG000|Overall Study|Adverse Event|1|||
44243839|NCT01473589|79073766|FG001|Overall Study|Adverse Event|1|||
44243840|NCT01473589|79073765|FG000|Overall Study|Death|2|||
44243841|NCT01473589|79073766|FG001|Overall Study|Death|0|||
44243842|NCT01473589|79073765|FG000|Overall Study|Lost to Follow-up|2|||
44243843|NCT01473589|79073766|FG001|Overall Study|Lost to Follow-up|2|||
44243844|NCT01473589|79073765|FG000|Overall Study|Protocol Violation|1|||
44243845|NCT01473589|79073766|FG001|Overall Study|Protocol Violation|0|||
44243846|NCT01473589|79073765|FG000|Overall Study|Withdrawal by Subject|5|||
44243847|NCT01473589|79073766|FG001|Overall Study|Withdrawal by Subject|11|||
44243848|NCT01473589|79073765|FG000|Overall Study|Physician Decision|0|||
44513477|NCT03129100|79519002|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513478|NCT03129100|79519003|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513479|NCT03129100|79519004|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513480|NCT03129100|79519005|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513481|NCT03129100|79519006|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44137788|NCT02517866|78926050|FG002|Overall Study|Reason not specified|0|||
44137789|NCT02515994|78926062|FG000|Overall Study|Protocol Violation|3|||
44137790|NCT02515994|78926063|FG001|Overall Study|Protocol Violation|5|||
44513482|NCT03129100|79519007|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44137791|NCT02515994|78926062|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
44137792|NCT02515994|78926063|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
44137793|NCT02515994|78926062|FG000|Overall Study|Adverse Event|3|||
44243849|NCT01473589|79073766|FG001|Overall Study|Physician Decision|1|||
44243850|NCT01473589|79073765|FG000|Overall Study|Entry criteria not met|0|||
44243851|NCT01473589|79073766|FG001|Overall Study|Entry criteria not met|1|||
44513483|NCT03129100|79519008|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44243852|NCT01500187|79073785|FG000|Overall Study|Lost to Follow-up|6|||
44513484|NCT03129100|79519009|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513485|NCT03129100|79519010|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44137794|NCT02515994|78926063|FG001|Overall Study|Adverse Event|1|||
44137795|NCT02515994|78926062|FG000|Overall Study|Withdrawal by Subject|2|||
44137796|NCT02515994|78926063|FG001|Overall Study|Withdrawal by Subject|0|||
44137797|NCT02516306|78926071|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
44243853|NCT01500187|79073786|FG001|Overall Study|Lost to Follow-up|0|||
44137798|NCT02516306|78926072|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
44137799|NCT02516228|78926078|FG000|Overall Study|Lost to Follow-up|1|||
44137800|NCT02516228|78926078|FG000|Overall Study|Withdrawal by Subject|1|||
44137801|NCT02516228|78926078|FG000|Overall Study|Physician Decision|1|||
44137802|NCT02519504|78926084|FG000|Overall Study|Protocol Violation|6|||
44137803|NCT02519504|78926085|FG001|Overall Study|Protocol Violation|5|||
44137804|NCT02519504|78926084|FG000|Overall Study|Ineligible for direct testing|12|||
44137805|NCT02519504|78926085|FG001|Overall Study|Ineligible for direct testing|12|||
44137806|NCT02519504|78926084|FG000|Overall Study|Did not participate in direct testing|95|||
44137807|NCT02519504|78926085|FG001|Overall Study|Did not participate in direct testing|86|||
44137808|NCT02514824|78926093|FG000|Overall Study|Withdrawal by Subject|1|||
44137809|NCT02514824|78926094|FG001|Overall Study|Withdrawal by Subject|0|||
44137810|NCT02514824|78926095|FG002|Overall Study|Withdrawal by Subject|0|||
44137811|NCT02514824|78926096|FG003|Overall Study|Withdrawal by Subject|0|||
44137812|NCT02514824|78926093|FG000|Overall Study|Dose-Limiting Toxicity|0|||
44137813|NCT02514824|78926094|FG001|Overall Study|Dose-Limiting Toxicity|1|||
44137814|NCT02514824|78926095|FG002|Overall Study|Dose-Limiting Toxicity|0|||
44137815|NCT02514824|78926096|FG003|Overall Study|Dose-Limiting Toxicity|0|||
44137816|NCT02514746|78926105|FG000|Overall Study|Chronically Ill|1|||
44137817|NCT02514746|78926106|FG001|Overall Study|Chronically Ill|2|||
44137818|NCT02514746|78926105|FG000|Overall Study|Physician Decision|4|||
44137819|NCT02514746|78926106|FG001|Overall Study|Physician Decision|2|||
44137820|NCT02514746|78926105|FG000|Overall Study|Withdrawal by Subject|12|||
44137821|NCT02514746|78926106|FG001|Overall Study|Withdrawal by Subject|10|||
44137822|NCT02514746|78926105|FG000|Overall Study|Other|5|||
44137823|NCT02514746|78926106|FG001|Overall Study|Other|1|||
44137824|NCT02483078|78926116|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
44137825|NCT02483078|78926117|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
44137826|NCT02483078|78926116|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
44137827|NCT02483078|78926117|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
44137828|NCT02483078|78926116|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
44137829|NCT02483078|78926117|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
44137830|NCT02483078|78926116|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
44137831|NCT02483078|78926117|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
44137832|NCT02483078|78926116|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
44137833|NCT02483078|78926117|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
44137834|NCT02483078|78926116|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
44137835|NCT02483078|78926117|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
44137836|NCT02452190|78926131|FG000|Overall Study|Withdrawal by Sponsor|1|||
44137837|NCT02452190|78926132|FG001|Overall Study|Withdrawal by Sponsor|3|||
44137838|NCT02452190|78926131|FG000|Overall Study|Pregnancy|1|||
44137839|NCT02452190|78926132|FG001|Overall Study|Pregnancy|0|||
44137840|NCT02452190|78926131|FG000|Overall Study|Investigator's Decision|2|||
44137841|NCT02452190|78926132|FG001|Overall Study|Investigator's Decision|0|||
44137842|NCT02452190|78926131|FG000|Overall Study|Lack of Efficacy|3|||
44137843|NCT02452190|78926132|FG001|Overall Study|Lack of Efficacy|1|||
44137844|NCT02452190|78926131|FG000|Overall Study|Lost to Follow-up|4|||
44137845|NCT02452190|78926132|FG001|Overall Study|Lost to Follow-up|3|||
44137846|NCT02452190|78926131|FG000|Overall Study|Adverse Event|2|||
44137847|NCT02452190|78926132|FG001|Overall Study|Adverse Event|5|||
44137848|NCT02452190|78926131|FG000|Overall Study|Withdrawal by Subject|20|||
44137849|NCT02452190|78926132|FG001|Overall Study|Withdrawal by Subject|11|||
44137850|NCT02452190|78926131|FG000|Overall Study|Noncompliance with study drug|1|||
44137851|NCT02452190|78926132|FG001|Overall Study|Noncompliance with study drug|0|||
44137852|NCT02452190|78926131|FG000|Overall Study|Participant traveled abroad|1|||
44137853|NCT02452190|78926132|FG001|Overall Study|Participant traveled abroad|0|||
44137854|NCT02452190|78926131|FG000|Overall Study|Death|0|||
44513486|NCT03129100|79519011|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
44513487|NCT03129100|79519012|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
44513488|NCT03129100|79519013|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
44513489|NCT03129100|79519014|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
44513490|NCT03129100|79519015|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513491|NCT03129100|79519016|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44137855|NCT02452190|78926132|FG001|Overall Study|Death|1|||
44137856|NCT02514122|78926140|FG000|Overall Study|Withdrawal by Subject|2|||
44137857|NCT02514122|78926141|FG001|Overall Study|Withdrawal by Subject|0|||
44137858|NCT00730639|78926152|FG000|Overall Study|Adverse Event|3|||
44137859|NCT00730639|78926153|FG001|Overall Study|Adverse Event|0|||
44137860|NCT00730639|78926154|FG002|Overall Study|Adverse Event|9|||
44137861|NCT00730639|78926155|FG003|Overall Study|Adverse Event|8|||
44137862|NCT00730639|78926156|FG004|Overall Study|Adverse Event|23|||
44137863|NCT00730639|78926152|FG000|Overall Study|Complete Response|0|||
44137864|NCT00730639|78926153|FG001|Overall Study|Complete Response|0|||
44137865|NCT00730639|78926154|FG002|Overall Study|Complete Response|2|||
44137866|NCT00730639|78926155|FG003|Overall Study|Complete Response|2|||
44137867|NCT00730639|78926156|FG004|Overall Study|Complete Response|1|||
44137868|NCT00730639|78926152|FG000|Overall Study|Completed Maximum Cycles|0|||
44137869|NCT00730639|78926153|FG001|Overall Study|Completed Maximum Cycles|0|||
44137870|NCT00730639|78926154|FG002|Overall Study|Completed Maximum Cycles|11|||
44137871|NCT00730639|78926155|FG003|Overall Study|Completed Maximum Cycles|3|||
44137872|NCT00730639|78926156|FG004|Overall Study|Completed Maximum Cycles|6|||
44137873|NCT00730639|78926152|FG000|Overall Study|Death|0|||
44137874|NCT00730639|78926153|FG001|Overall Study|Death|0|||
44137875|NCT00730639|78926154|FG002|Overall Study|Death|0|||
44137876|NCT00730639|78926155|FG003|Overall Study|Death|0|||
44137877|NCT00730639|78926156|FG004|Overall Study|Death|2|||
44137878|NCT00730639|78926152|FG000|Overall Study|Disease Progression|12|||
44137879|NCT00730639|78926153|FG001|Overall Study|Disease Progression|13|||
44137880|NCT00730639|78926154|FG002|Overall Study|Disease Progression|48|||
44137881|NCT00730639|78926155|FG003|Overall Study|Disease Progression|32|||
44137882|NCT00730639|78926156|FG004|Overall Study|Disease Progression|88|||
44137883|NCT00730639|78926152|FG000|Overall Study|non-specified|0|||
44137884|NCT00730639|78926153|FG001|Overall Study|non-specified|0|||
44137885|NCT00730639|78926154|FG002|Overall Study|non-specified|4|||
44137886|NCT00730639|78926155|FG003|Overall Study|non-specified|2|||
44137887|NCT00730639|78926156|FG004|Overall Study|non-specified|3|||
44137888|NCT00730639|78926152|FG000|Overall Study|Protocol Violation|0|||
44137889|NCT00730639|78926153|FG001|Overall Study|Protocol Violation|0|||
44137890|NCT00730639|78926154|FG002|Overall Study|Protocol Violation|1|||
44137891|NCT00730639|78926155|FG003|Overall Study|Protocol Violation|0|||
44137892|NCT00730639|78926156|FG004|Overall Study|Protocol Violation|0|||
44137893|NCT00730639|78926152|FG000|Overall Study|Withdrawal by Subject|0|||
44137894|NCT00730639|78926153|FG001|Overall Study|Withdrawal by Subject|0|||
44137895|NCT00730639|78926154|FG002|Overall Study|Withdrawal by Subject|6|||
44137896|NCT00730639|78926155|FG003|Overall Study|Withdrawal by Subject|3|||
44137897|NCT00730639|78926156|FG004|Overall Study|Withdrawal by Subject|4|||
44137898|NCT00730639|78926152|FG000|Overall Study|Treatment on-going|2|||
44137899|NCT00730639|78926153|FG001|Overall Study|Treatment on-going|5|||
44137900|NCT00730639|78926154|FG002|Overall Study|Treatment on-going|5|||
44137901|NCT00730639|78926155|FG003|Overall Study|Treatment on-going|4|||
44137902|NCT00730639|78926156|FG004|Overall Study|Treatment on-going|4|||
44137903|NCT02536339|78926179|FG000|Overall Study|Death|20|||
44137904|NCT02536339|78926179|FG000|Overall Study|Withdrawal by Subject|3|||
44137905|NCT02536339|78926179|FG000|Overall Study|Lost to Follow-up|2|||
44137906|NCT02536339|78926179|FG000|Overall Study|Treatment discontinued|2|||
44137907|NCT02536339|78926179|FG000|Overall Study|Physician Decision|1|||
44137908|NCT02743871|78926213|FG000|Overall Study|Lost to Follow-up|0|||
44137909|NCT02743871|78926214|FG001|Overall Study|Lost to Follow-up|0|||
44137910|NCT02743871|78926215|FG002|Overall Study|Lost to Follow-up|0|||
44137911|NCT02743871|78926216|FG003|Overall Study|Lost to Follow-up|1|||
44137912|NCT02743871|78926217|FG004|Overall Study|Lost to Follow-up|0|||
44137913|NCT02743871|78926218|FG005|Overall Study|Lost to Follow-up|0|||
44137914|NCT02743871|78926219|FG006|Overall Study|Lost to Follow-up|1|||
44137915|NCT02743871|78926220|FG007|Overall Study|Lost to Follow-up|0|||
44137916|NCT02743871|78926221|FG008|Overall Study|Lost to Follow-up|0|||
44137917|NCT02743871|78926222|FG009|Overall Study|Lost to Follow-up|0|||
44137918|NCT02743871|78926223|FG010|Overall Study|Lost to Follow-up|0|||
44137919|NCT02743871|78926224|FG011|Overall Study|Lost to Follow-up|2|||
44137920|NCT02743871|78926225|FG012|Overall Study|Lost to Follow-up|0|||
44137921|NCT02743871|78926226|FG013|Overall Study|Lost to Follow-up|0|||
44137922|NCT02743871|78926213|FG000|Overall Study|Withdrawal by Subject|0|||
44137923|NCT02743871|78926214|FG001|Overall Study|Withdrawal by Subject|0|||
44137924|NCT02743871|78926215|FG002|Overall Study|Withdrawal by Subject|0|||
44137925|NCT02743871|78926216|FG003|Overall Study|Withdrawal by Subject|0|||
44137926|NCT02743871|78926217|FG004|Overall Study|Withdrawal by Subject|0|||
44137927|NCT02743871|78926218|FG005|Overall Study|Withdrawal by Subject|0|||
44137928|NCT02743871|78926219|FG006|Overall Study|Withdrawal by Subject|0|||
44137929|NCT02743871|78926220|FG007|Overall Study|Withdrawal by Subject|0|||
44513492|NCT03129100|79519017|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513493|NCT03129100|79519018|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44137930|NCT02743871|78926221|FG008|Overall Study|Withdrawal by Subject|0|||
44137931|NCT02743871|78926222|FG009|Overall Study|Withdrawal by Subject|0|||
44137932|NCT02743871|78926223|FG010|Overall Study|Withdrawal by Subject|1|||
44137933|NCT02743871|78926224|FG011|Overall Study|Withdrawal by Subject|0|||
44137934|NCT02743871|78926225|FG012|Overall Study|Withdrawal by Subject|12|||
44137935|NCT02743871|78926226|FG013|Overall Study|Withdrawal by Subject|6|||
44137936|NCT02743871|78926213|FG000|Overall Study|Adverse Event|1|||
44137937|NCT02743871|78926214|FG001|Overall Study|Adverse Event|0|||
44137938|NCT02743871|78926215|FG002|Overall Study|Adverse Event|0|||
44137939|NCT02743871|78926216|FG003|Overall Study|Adverse Event|0|||
44243854|NCT01500031|79073804|FG000|Overall Study|Death|1|||
44137940|NCT02743871|78926217|FG004|Overall Study|Adverse Event|0|||
44137941|NCT02743871|78926218|FG005|Overall Study|Adverse Event|0|||
44137942|NCT02743871|78926219|FG006|Overall Study|Adverse Event|0|||
44137943|NCT02743871|78926220|FG007|Overall Study|Adverse Event|0|||
44137944|NCT02743871|78926221|FG008|Overall Study|Adverse Event|0|||
44137945|NCT02743871|78926222|FG009|Overall Study|Adverse Event|0|||
44137946|NCT02743871|78926223|FG010|Overall Study|Adverse Event|0|||
44137947|NCT02743871|78926224|FG011|Overall Study|Adverse Event|0|||
44137948|NCT02743871|78926225|FG012|Overall Study|Adverse Event|0|||
44137949|NCT02743871|78926226|FG013|Overall Study|Adverse Event|0|||
44137950|NCT02743871|78926213|FG000|Overall Study|Other|0|||
44137951|NCT02743871|78926214|FG001|Overall Study|Other|0|||
44137952|NCT02743871|78926215|FG002|Overall Study|Other|0|||
44137953|NCT02743871|78926216|FG003|Overall Study|Other|0|||
44137954|NCT02743871|78926217|FG004|Overall Study|Other|0|||
44137955|NCT02743871|78926218|FG005|Overall Study|Other|0|||
44137956|NCT02743871|78926219|FG006|Overall Study|Other|0|||
44137957|NCT02743871|78926220|FG007|Overall Study|Other|0|||
44137958|NCT02743871|78926221|FG008|Overall Study|Other|0|||
44137959|NCT02743871|78926222|FG009|Overall Study|Other|0|||
44137960|NCT02743871|78926223|FG010|Overall Study|Other|0|||
44137961|NCT02743871|78926224|FG011|Overall Study|Other|1|||
44137962|NCT02743871|78926225|FG012|Overall Study|Other|1|||
44137963|NCT02743871|78926226|FG013|Overall Study|Other|1|||
44137964|NCT02743871|78926213|FG000|Overall Study|Protocol Violation|0|||
44137965|NCT02743871|78926214|FG001|Overall Study|Protocol Violation|0|||
44137966|NCT02743871|78926215|FG002|Overall Study|Protocol Violation|0|||
44137967|NCT02743871|78926216|FG003|Overall Study|Protocol Violation|0|||
44137968|NCT02743871|78926217|FG004|Overall Study|Protocol Violation|0|||
44137969|NCT02743871|78926218|FG005|Overall Study|Protocol Violation|0|||
44137970|NCT02743871|78926219|FG006|Overall Study|Protocol Violation|0|||
44137971|NCT02743871|78926220|FG007|Overall Study|Protocol Violation|0|||
44137972|NCT02743871|78926221|FG008|Overall Study|Protocol Violation|0|||
44137973|NCT02743871|78926222|FG009|Overall Study|Protocol Violation|0|||
44137974|NCT02743871|78926223|FG010|Overall Study|Protocol Violation|0|||
44137975|NCT02743871|78926224|FG011|Overall Study|Protocol Violation|0|||
44137976|NCT02743871|78926225|FG012|Overall Study|Protocol Violation|2|||
44137977|NCT02743871|78926226|FG013|Overall Study|Protocol Violation|0|||
44137978|NCT01704547|78926268|FG000|Overall Study|Physician Decision|4|||
44137979|NCT01704547|78926268|FG000|Overall Study|Withdrawal by Subject|1|||
44137980|NCT00796523|78926288|FG000|Overall Study|Lost to Follow-up|9|||
44137981|NCT00796523|78926289|FG001|Overall Study|Lost to Follow-up|7|||
44137982|NCT01352585|78926304|FG000|Overall Study|Adverse Event|2|||
44137983|NCT01352585|78926305|FG001|Overall Study|Adverse Event|1|||
44137984|NCT01352585|78926304|FG000|Overall Study|Lost to Follow-up|1|||
44137985|NCT01352585|78926305|FG001|Overall Study|Lost to Follow-up|0|||
44137986|NCT01352585|78926304|FG000|Overall Study|Other|5|||
44137987|NCT01352585|78926305|FG001|Overall Study|Other|2|||
44137988|NCT01352507|78926314|FG000|Treatment Period 1|Adverse Event|3|||
44137989|NCT01352507|78926315|FG001|Treatment Period 1|Adverse Event|0|||
44137990|NCT01352507|78926314|FG000|Treatment Period 1|Lost to Follow-up|3|||
44137991|NCT01352507|78926315|FG001|Treatment Period 1|Lost to Follow-up|4|||
44137992|NCT01352507|78926314|FG000|Treatment Period 1|Withdrawal by Subject|7|||
44137993|NCT01352507|78926315|FG001|Treatment Period 1|Withdrawal by Subject|5|||
44137994|NCT01352507|78926314|FG000|Treatment Period 1|Physician Decision|1|||
44137995|NCT01352507|78926315|FG001|Treatment Period 1|Physician Decision|0|||
44137996|NCT01352507|78926314|FG000|Washout Period|Withdrawal by Subject|0|||
44137997|NCT01352507|78926315|FG001|Washout Period|Withdrawal by Subject|1|||
44137998|NCT01352507|78926314|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
44137999|NCT01352507|78926315|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
44138000|NCT01352507|78926314|FG000|Treatment Period 2|Withdrawal by Subject|4|||
44138001|NCT01352507|78926315|FG001|Treatment Period 2|Withdrawal by Subject|3|||
44138002|NCT01352507|78926314|FG000|Treatment Period 2|Lack of Efficacy|1|||
44138003|NCT01352507|78926315|FG001|Treatment Period 2|Lack of Efficacy|0|||
44138004|NCT02361346|78926336|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138005|NCT02361346|78926337|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138006|NCT02361346|78926338|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138007|NCT02361346|78926339|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
44138008|NCT02361346|78926340|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138009|NCT02361346|78926341|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138010|NCT02361346|78926342|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138011|NCT02361346|78926343|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138012|NCT02361346|78926344|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
44138013|NCT02361346|78926336|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138014|NCT02361346|78926337|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138015|NCT02361346|78926338|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138016|NCT02361346|78926339|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138017|NCT02361346|78926340|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
44138018|NCT02361346|78926341|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138019|NCT02361346|78926342|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138020|NCT02361346|78926343|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138021|NCT02361346|78926344|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
44138022|NCT02361346|78926336|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
44138023|NCT02361346|78926337|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
44138024|NCT02361346|78926338|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
44138025|NCT02361346|78926339|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
44138026|NCT02361346|78926340|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
44138027|NCT02361346|78926341|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
44138028|NCT02361346|78926342|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
44138029|NCT02361346|78926343|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
44138030|NCT02361346|78926344|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
44138031|NCT02361346|78926336|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138032|NCT02361346|78926337|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138033|NCT02361346|78926338|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138034|NCT02361346|78926339|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138035|NCT02361346|78926340|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138036|NCT02361346|78926341|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138037|NCT02361346|78926342|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138038|NCT02361346|78926343|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
44138039|NCT02361346|78926344|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
44138040|NCT02361346|78926336|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138041|NCT02361346|78926337|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138042|NCT02361346|78926338|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138043|NCT02361346|78926339|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138044|NCT02361346|78926340|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138045|NCT02361346|78926341|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138046|NCT02361346|78926342|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138047|NCT02361346|78926343|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
44138048|NCT02361346|78926344|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
44138049|NCT02361346|78926336|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138050|NCT02361346|78926337|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138051|NCT02361346|78926338|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138052|NCT02361346|78926339|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138053|NCT02361346|78926340|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138054|NCT02361346|78926341|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138055|NCT02361346|78926342|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138056|NCT02361346|78926343|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
44138057|NCT02361346|78926344|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
44138058|NCT02267278|78926386|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
44138059|NCT02267278|78926386|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
44138060|NCT02267278|78926386|FG000|Overall Study|Developed new cancer diagnoses|2|||
44138061|NCT02267278|78926386|FG000|Overall Study|prescribed prohibited medication|1|||
44138062|NCT02360098|78926392|FG000|Overall Study|Physician Decision|7|||
44138063|NCT02266888|78926403|FG000|Overall Study|Death|2|||
44138064|NCT02266888|78926404|FG001|Overall Study|Death|2|||
44138065|NCT02266888|78926405|FG002|Overall Study|Death|4|||
44138066|NCT02266888|78926406|FG003|Overall Study|Death|2|||
44138067|NCT02266888|78926403|FG000|Overall Study|Physician Decision|0|||
44138068|NCT02266888|78926404|FG001|Overall Study|Physician Decision|1|||
44138069|NCT02266888|78926405|FG002|Overall Study|Physician Decision|2|||
44138070|NCT02266888|78926406|FG003|Overall Study|Physician Decision|2|||
44138071|NCT02266888|78926403|FG000|Overall Study|Study Terminated|5|||
44138072|NCT02266888|78926404|FG001|Overall Study|Study Terminated|1|||
44138073|NCT02266888|78926405|FG002|Overall Study|Study Terminated|0|||
44138074|NCT02266888|78926406|FG003|Overall Study|Study Terminated|0|||
44138075|NCT02266888|78926403|FG000|Overall Study|No Longer Eligible|0|||
44138076|NCT02266888|78926404|FG001|Overall Study|No Longer Eligible|0|||
44138077|NCT02266888|78926405|FG002|Overall Study|No Longer Eligible|0|||
44138078|NCT02266888|78926406|FG003|Overall Study|No Longer Eligible|2|||
44138079|NCT02266888|78926403|FG000|Overall Study|Randomization Closed|0|||
44138080|NCT02266888|78926404|FG001|Overall Study|Randomization Closed|0|||
44138081|NCT02266888|78926405|FG002|Overall Study|Randomization Closed|4|||
44138082|NCT02266888|78926406|FG003|Overall Study|Randomization Closed|0|||
44138083|NCT02266888|78926403|FG000|Overall Study|Personnel unavailable at transplant|0|||
44138084|NCT02266888|78926404|FG001|Overall Study|Personnel unavailable at transplant|0|||
44138085|NCT02266888|78926405|FG002|Overall Study|Personnel unavailable at transplant|0|||
44138086|NCT02266888|78926406|FG003|Overall Study|Personnel unavailable at transplant|1|||
44138087|NCT02266888|78926403|FG000|Overall Study|Transfer of care|0|||
44138088|NCT02266888|78926404|FG001|Overall Study|Transfer of care|0|||
44138089|NCT02266888|78926405|FG002|Overall Study|Transfer of care|1|||
44138090|NCT02266888|78926406|FG003|Overall Study|Transfer of care|0|||
44138091|NCT01641952|78926414|FG000|Overall Study|Lost to Follow-up|28|||
44138092|NCT01641952|78926414|FG000|Overall Study|Adverse Event|6|||
44138093|NCT02359552|78926420|FG000|Overall Study|Lost to Follow-up|3|||
44138094|NCT02359552|78926421|FG001|Overall Study|Lost to Follow-up|4|||
44138095|NCT02743793|78926429|FG000|Overall Study|Death|1|||
44138096|NCT02743793|78926430|FG001|Overall Study|Death|1|||
44138097|NCT02743793|78926429|FG000|Overall Study|Withdrawal by Subject|0|||
44138098|NCT02743793|78926430|FG001|Overall Study|Withdrawal by Subject|1|||
44138099|NCT02743793|78926429|FG000|Overall Study|Screen Failure|4|||
44138100|NCT02743793|78926430|FG001|Overall Study|Screen Failure|0|||
44138101|NCT02743793|78926429|FG000|Overall Study|No Primary Care Physician|0|||
44138102|NCT02743793|78926430|FG001|Overall Study|No Primary Care Physician|1|||
44138103|NCT02743793|78926429|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
44138104|NCT02743793|78926430|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
44138105|NCT02743793|78926429|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
44138106|NCT02743793|78926430|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
44138107|NCT00152009|78926439|FG000|Overall Study|Adverse Event|9|||
44138108|NCT00152009|78926440|FG001|Overall Study|Adverse Event|13|||
44138109|NCT00152009|78926441|FG002|Overall Study|Adverse Event|20|||
44138110|NCT00152009|78926442|FG003|Overall Study|Adverse Event|1|||
44138111|NCT00152009|78926439|FG000|Overall Study|Protocol Violation|3|||
44138112|NCT00152009|78926440|FG001|Overall Study|Protocol Violation|0|||
44138113|NCT00152009|78926441|FG002|Overall Study|Protocol Violation|0|||
44138114|NCT00152009|78926442|FG003|Overall Study|Protocol Violation|1|||
44138115|NCT00152009|78926439|FG000|Overall Study|Withdrawal by Subject|2|||
44138116|NCT00152009|78926440|FG001|Overall Study|Withdrawal by Subject|3|||
44138117|NCT00152009|78926441|FG002|Overall Study|Withdrawal by Subject|4|||
44138118|NCT00152009|78926442|FG003|Overall Study|Withdrawal by Subject|9|||
44138119|NCT00152009|78926439|FG000|Overall Study|Lost to Follow-up|2|||
44138120|NCT00152009|78926440|FG001|Overall Study|Lost to Follow-up|4|||
44138121|NCT00152009|78926441|FG002|Overall Study|Lost to Follow-up|3|||
44138122|NCT00152009|78926442|FG003|Overall Study|Lost to Follow-up|3|||
44138123|NCT00152009|78926439|FG000|Overall Study|Lack of Efficacy|8|||
44138124|NCT00152009|78926440|FG001|Overall Study|Lack of Efficacy|6|||
44138125|NCT00152009|78926441|FG002|Overall Study|Lack of Efficacy|7|||
44138126|NCT00152009|78926442|FG003|Overall Study|Lack of Efficacy|15|||
44138127|NCT00152009|78926439|FG000|Overall Study|ECG abnormalities|2|||
44138128|NCT00152009|78926440|FG001|Overall Study|ECG abnormalities|2|||
44138129|NCT00152009|78926441|FG002|Overall Study|ECG abnormalities|2|||
44138130|NCT00152009|78926442|FG003|Overall Study|ECG abnormalities|1|||
44138131|NCT00152009|78926439|FG000|Overall Study|Sponsor's decision|3|||
44138132|NCT00152009|78926440|FG001|Overall Study|Sponsor's decision|3|||
44138133|NCT00152009|78926441|FG002|Overall Study|Sponsor's decision|1|||
44138134|NCT00152009|78926442|FG003|Overall Study|Sponsor's decision|3|||
44138135|NCT02265952|78926452|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
44138136|NCT02265952|78926453|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
44138137|NCT02265952|78926452|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
44138138|NCT02265952|78926453|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
44138139|NCT02265796|78926461|FG000|Overall Study|Death|1|||
44138140|NCT02265796|78926462|FG001|Overall Study|Death|0|||
44138141|NCT02265796|78926461|FG000|Overall Study|started on excluded medication|1|||
44138142|NCT02265796|78926462|FG001|Overall Study|started on excluded medication|0|||
44138143|NCT02265796|78926461|FG000|Overall Study|Withdrawal by Subject|1|||
44138144|NCT02265796|78926462|FG001|Overall Study|Withdrawal by Subject|1|||
44138145|NCT02357368|78926472|FG000|Overall Study|Lost to Follow-up|0|||
44138146|NCT02357368|78926473|FG001|Overall Study|Lost to Follow-up|0|||
44138147|NCT02357368|78926474|FG002|Overall Study|Lost to Follow-up|0|||
44138148|NCT02357368|78926475|FG003|Overall Study|Lost to Follow-up|1|||
44138149|NCT02357368|78926472|FG000|Overall Study|Pregnancy|3|||
44138150|NCT02357368|78926473|FG001|Overall Study|Pregnancy|2|||
44243855|NCT01500031|79073804|FG000|Overall Study|Withdrawal by Subject|4|||
44243856|NCT01473355|79073817|FG000|Overall Study|Protocol Violation|2|||
44243857|NCT01473355|79073817|FG000|Overall Study|Adverse Event|2|||
44243858|NCT01473355|79073817|FG000|Overall Study|Lost to Follow-up|2|||
44243859|NCT01472965|79073827|FG000|Overall Study|Withdrawal by Subject|1|||
44243860|NCT01472965|79073828|FG001|Overall Study|Withdrawal by Subject|0|||
44243861|NCT01457053|79073838|FG000|Overall Study|Unable to undergo selected treatment|1|||
44138151|NCT02357368|78926474|FG002|Overall Study|Pregnancy|0|||
44138152|NCT02357368|78926475|FG003|Overall Study|Pregnancy|0|||
44138153|NCT02357368|78926472|FG000|Overall Study|Withdrawal by Subject|3|||
44138154|NCT02357368|78926473|FG001|Overall Study|Withdrawal by Subject|1|||
44138155|NCT02357368|78926474|FG002|Overall Study|Withdrawal by Subject|1|||
44138156|NCT02357368|78926475|FG003|Overall Study|Withdrawal by Subject|2|||
44138157|NCT03287245|78926489|FG000|Overall Study|Study terminated by sponsor|3|||
44138158|NCT03287245|78926490|FG001|Overall Study|Study terminated by sponsor|0|||
44138159|NCT03287245|78926491|FG002|Overall Study|Study terminated by sponsor|3|||
44138160|NCT03287245|78926492|FG003|Overall Study|Study terminated by sponsor|1|||
44138161|NCT03287245|78926489|FG000|Overall Study|Adverse Event|1|||
44138162|NCT03287245|78926490|FG001|Overall Study|Adverse Event|0|||
44138163|NCT03287245|78926491|FG002|Overall Study|Adverse Event|0|||
44138164|NCT03287245|78926492|FG003|Overall Study|Adverse Event|0|||
44138165|NCT03287245|78926489|FG000|Overall Study|Withdrawal by Subject|8|||
44138166|NCT03287245|78926490|FG001|Overall Study|Withdrawal by Subject|3|||
44138167|NCT03287245|78926491|FG002|Overall Study|Withdrawal by Subject|3|||
44138168|NCT03287245|78926492|FG003|Overall Study|Withdrawal by Subject|0|||
44138169|NCT03287245|78926489|FG000|Overall Study|Physician Decision|3|||
44138170|NCT03287245|78926490|FG001|Overall Study|Physician Decision|2|||
44138171|NCT03287245|78926491|FG002|Overall Study|Physician Decision|0|||
44138172|NCT03287245|78926492|FG003|Overall Study|Physician Decision|0|||
44138173|NCT04495179|78926524|FG000|Overall Study|Lost to Follow-up|0|||
44138174|NCT04495179|78926525|FG001|Overall Study|Lost to Follow-up|1|||
44138175|NCT04495179|78926524|FG000|Overall Study|Withdrawal by Subject|2|||
44138176|NCT04495179|78926525|FG001|Overall Study|Withdrawal by Subject|4|||
44138177|NCT04495179|78926524|FG000|Overall Study|Study terminated by sponsor|0|||
44138178|NCT04495179|78926525|FG001|Overall Study|Study terminated by sponsor|18|||
44138179|NCT04495179|78926524|FG000|Overall Study|Death|0|||
44138180|NCT04495179|78926525|FG001|Overall Study|Death|4|||
44138181|NCT04495179|78926524|FG000|Overall Study|Adverse Event|0|||
44138182|NCT04495179|78926525|FG001|Overall Study|Adverse Event|1|||
44138183|NCT04201262|78926550|FG000|Overall Study|Adverse Event|1|||
44138184|NCT04201262|78926551|FG001|Overall Study|Adverse Event|2|||
44138185|NCT04201262|78926550|FG000|Overall Study|Continuing in the study|57|||
44138186|NCT04201262|78926551|FG001|Overall Study|Continuing in the study|0|||
44380357|NCT01023308|79386193|FG001|Overall Study|Withdrawal by Subject|18|||
44380358|NCT01022996|79386199|FG000|Overall Study|Adverse Event|14|||
44380359|NCT01022996|79386199|FG000|Overall Study|Withdrawal by Subject|3|||
44380360|NCT01022996|79386199|FG000|Overall Study|Lost to Follow-up|1|||
44138187|NCT04201262|78926550|FG000|Overall Study|Withdrawal by Subject|0|||
44138188|NCT04201262|78926551|FG001|Overall Study|Withdrawal by Subject|1|||
44138189|NCT03831100|78926563|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
44138190|NCT03831100|78926564|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
44138191|NCT03689244|78926583|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
44380361|NCT01022996|79386199|FG000|Overall Study|Administrative problems|6|||
44380362|NCT01022996|79386199|FG000|Overall Study|Disease Progression|32|||
44380363|NCT01022996|79386199|FG000|Overall Study|Protocol Violation|1|||
44380364|NCT00757237|79386205|FG000|Overall Study|Lost to Follow-up|0|||
44380365|NCT00757237|79386206|FG001|Overall Study|Lost to Follow-up|1|||
44380366|NCT00757237|79386205|FG000|Overall Study|Protocol Violation|0|||
44380367|NCT00757237|79386206|FG001|Overall Study|Protocol Violation|2|||
44380368|NCT00757237|79386205|FG000|Overall Study|Physician Decision|2|||
44380369|NCT00757237|79386206|FG001|Overall Study|Physician Decision|3|||
44380370|NCT00757237|79386205|FG000|Overall Study|Withdrawal by Subject|8|||
44380371|NCT00757237|79386206|FG001|Overall Study|Withdrawal by Subject|12|||
44380372|NCT00757237|79386205|FG000|Overall Study|Safety or Tolerability|3|||
44380373|NCT00757237|79386206|FG001|Overall Study|Safety or Tolerability|5|||
44380374|NCT00757237|79386205|FG000|Overall Study|Other|0|||
44380375|NCT00757237|79386206|FG001|Overall Study|Other|2|||
44380376|NCT01029392|79386214|FG000|Overall Study|Withdrawal by Subject|18|||
44513494|NCT03129100|79519019|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513495|NCT03129100|79519020|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513496|NCT03129100|79519021|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513497|NCT03129100|79519022|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513498|NCT03129100|79519023|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513499|NCT03129100|79519024|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513500|NCT03129100|79519025|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
44513501|NCT03129100|79519000|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44138192|NCT03689244|78926584|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
44138193|NCT03689244|78926585|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
44138194|NCT03689244|78926586|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
44380377|NCT01029392|79386215|FG001|Overall Study|Withdrawal by Subject|11|||
44138195|NCT03689244|78926583|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
44138196|NCT03689244|78926584|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
44138197|NCT03689244|78926585|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
44138198|NCT03689244|78926586|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
44138199|NCT03689244|78926583|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
44138200|NCT03689244|78926584|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
44138201|NCT03689244|78926585|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
44138202|NCT03689244|78926586|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
44138203|NCT03689244|78926583|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
44138204|NCT03689244|78926584|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
44138205|NCT03689244|78926585|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
44138206|NCT03689244|78926586|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
44138207|NCT03689244|78926583|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
44138208|NCT03689244|78926584|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
44138209|NCT03689244|78926585|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
44138210|NCT03689244|78926586|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
44138211|NCT03689244|78926583|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
44138212|NCT03689244|78926584|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
44138213|NCT03689244|78926585|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
44138214|NCT03689244|78926586|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
44138215|NCT03689244|78926583|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
44138216|NCT03689244|78926584|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
44138217|NCT03689244|78926585|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
44138218|NCT03689244|78926586|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
44138219|NCT03689244|78926583|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
44138220|NCT03689244|78926584|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
44138221|NCT03689244|78926585|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
44138222|NCT03689244|78926586|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
44138223|NCT03649074|78926596|FG000|Overall Study|Lost to Follow-up|2|||
44138224|NCT03649074|78926597|FG001|Overall Study|Lost to Follow-up|1|||
44138225|NCT03649074|78926596|FG000|Overall Study|Adverse Event|1|||
44138226|NCT03649074|78926597|FG001|Overall Study|Adverse Event|0|||
44138227|NCT03649074|78926596|FG000|Overall Study|Physician Decision|1|||
44138228|NCT03649074|78926597|FG001|Overall Study|Physician Decision|0|||
44138229|NCT03649074|78926596|FG000|Overall Study|Withdrawal by Subject|0|||
44138230|NCT03649074|78926597|FG001|Overall Study|Withdrawal by Subject|2|||
44138231|NCT03649074|78926596|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
44138232|NCT03649074|78926597|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
44138233|NCT03649074|78926596|FG000|Overall Study|Other|1|||
44138234|NCT03649074|78926597|FG001|Overall Study|Other|0|||
44138235|NCT02133573|78926614|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
44138236|NCT02133573|78926615|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
44138237|NCT02133573|78926614|FG000|Overall Study|Child Deaths|3|||
44138238|NCT02133573|78926615|FG001|Overall Study|Child Deaths|5|||
44138239|NCT02133573|78926614|FG000|Overall Study|Child Declined Follow Ups|2|||
44138240|NCT02133573|78926615|FG001|Overall Study|Child Declined Follow Ups|1|||
44138241|NCT02133573|78926614|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
44138242|NCT02133573|78926615|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
44138243|NCT00686595|78926650|FG000|Overall Study|Adverse Event|3|||
44138244|NCT00686595|78926650|FG000|Overall Study|Protocol Violation|1|||
44138245|NCT00686595|78926650|FG000|Overall Study|Lost to Follow-up|1|||
44138246|NCT00686595|78926650|FG000|Overall Study|Lack of Efficacy|1|||
44138247|NCT00686595|78926650|FG000|Overall Study|Poor Compliance|1|||
44243862|NCT01457053|79073839|FG001|Overall Study|Unable to undergo selected treatment|1|||
44243863|NCT01472341|79073854|FG000|Overall Study|Started insulin therapy|55|||
44138248|NCT00640159|78926654|FG000|Overall Study|Lost to Follow-up|2|||
44138249|NCT02262754|78926664|FG000|Overall Study|Adverse Event|3|||
44138250|NCT02262754|78926665|FG001|Overall Study|Adverse Event|4|||
44138251|NCT02262754|78926666|FG002|Overall Study|Adverse Event|0|||
44138252|NCT02262754|78926664|FG000|Overall Study|Lack of Efficacy|2|||
44138253|NCT02262754|78926665|FG001|Overall Study|Lack of Efficacy|0|||
44138254|NCT02262754|78926666|FG002|Overall Study|Lack of Efficacy|1|||
44138255|NCT02262754|78926664|FG000|Overall Study|Lost to Follow-up|0|||
44138256|NCT02262754|78926665|FG001|Overall Study|Lost to Follow-up|0|||
44138257|NCT02262754|78926666|FG002|Overall Study|Lost to Follow-up|1|||
44138258|NCT02262754|78926664|FG000|Overall Study|No longer meets eligibility criteria|0|||
44138259|NCT02262754|78926665|FG001|Overall Study|No longer meets eligibility criteria|1|||
44138260|NCT02262754|78926666|FG002|Overall Study|No longer meets eligibility criteria|0|||
44138261|NCT02262754|78926664|FG000|Overall Study|Study terminated by sponsor|5|||
44138262|NCT02262754|78926665|FG001|Overall Study|Study terminated by sponsor|4|||
44138263|NCT02262754|78926666|FG002|Overall Study|Study terminated by sponsor|4|||
44138264|NCT02262754|78926664|FG000|Overall Study|Protocol Violation|1|||
44138265|NCT02262754|78926665|FG001|Overall Study|Protocol Violation|0|||
44138266|NCT02262754|78926666|FG002|Overall Study|Protocol Violation|0|||
44138267|NCT02262754|78926664|FG000|Overall Study|Withdrawal by Subject|1|||
44138268|NCT02262754|78926665|FG001|Overall Study|Withdrawal by Subject|0|||
44138269|NCT02262754|78926666|FG002|Overall Study|Withdrawal by Subject|1|||
44138270|NCT02262754|78926664|FG000|Overall Study|Other|4|||
44138271|NCT02262754|78926665|FG001|Overall Study|Other|0|||
44138272|NCT02262754|78926666|FG002|Overall Study|Other|2|||
44138273|NCT02262364|78926676|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
44138274|NCT02261974|78926682|FG000|Overall Study|Withdrawal by Subject|3|||
44138275|NCT02261974|78926683|FG001|Overall Study|Withdrawal by Subject|2|||
44138276|NCT02261974|78926682|FG000|Overall Study|Pregnancy|0|||
44138277|NCT02261974|78926683|FG001|Overall Study|Pregnancy|1|||
44138278|NCT02261974|78926682|FG000|Overall Study|Missed treatment cut-off date|6|||
44138279|NCT02261974|78926683|FG001|Overall Study|Missed treatment cut-off date|3|||
44138280|NCT02261974|78926682|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
44138281|NCT02261974|78926683|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
44138282|NCT02261974|78926682|FG000|Overall Study|Lost to Follow-up|2|||
44138283|NCT02261974|78926683|FG001|Overall Study|Lost to Follow-up|0|||
44138284|NCT02261974|78926682|FG000|Overall Study|Adverse Event|1|||
44138285|NCT02261974|78926683|FG001|Overall Study|Adverse Event|0|||
44138286|NCT02356588|78926691|FG000|Overall Study|Lack of Efficacy|4|||
44138287|NCT02356588|78926692|FG001|Overall Study|Lack of Efficacy|10|||
44138288|NCT02356588|78926691|FG000|Overall Study|Adverse Event|0|||
44138289|NCT02356588|78926692|FG001|Overall Study|Adverse Event|2|||
44138290|NCT02356588|78926691|FG000|Overall Study|Withdrawal by Subject|1|||
44138291|NCT02356588|78926692|FG001|Overall Study|Withdrawal by Subject|0|||
44138292|NCT02356588|78926691|FG000|Overall Study|Protocol Violation|0|||
44138293|NCT02356588|78926692|FG001|Overall Study|Protocol Violation|1|||
44138294|NCT02355028|78926700|FG000|Overall Study|Adverse Event|2|||
44138295|NCT02355028|78926701|FG001|Overall Study|Adverse Event|0|||
44138296|NCT02355028|78926700|FG000|Overall Study|Withdrawal by Subject|1|||
44138297|NCT02355028|78926701|FG001|Overall Study|Withdrawal by Subject|1|||
44138298|NCT02355028|78926700|FG000|Overall Study|Deemed ineligible after randomization|8|||
44138299|NCT02355028|78926701|FG001|Overall Study|Deemed ineligible after randomization|4|||
44138300|NCT01643668|78926716|FG000|Overall Study|Death|1|||
44138301|NCT02260882|78926722|FG000|Overall Study|Protocol Violation|0|||
44138302|NCT02260882|78926723|FG001|Overall Study|Protocol Violation|1|||
44138303|NCT02260804|78926732|FG000|Induction Study Period|Protocol Violation|2|||
44138304|NCT02260804|78926733|FG001|Induction Study Period|Protocol Violation|0|||
44138305|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
44138306|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
44138307|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
44138308|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
44243864|NCT01472341|79073854|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
44243865|NCT01472341|79073854|FG000|Overall Study|Withdrawal by Subject|39|||
44138309|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
44138310|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
44138311|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
44138312|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
44138313|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
44138314|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
44138315|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
44138316|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
44138317|NCT02260804|78926732|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
44138318|NCT02260804|78926733|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
44138319|NCT02260804|78926732|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
44138320|NCT02260804|78926733|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
44138321|NCT02260804|78926732|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
44138322|NCT02260804|78926733|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
44138323|NCT02260804|78926732|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
44138324|NCT02260804|78926733|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
44138325|NCT02260648|78926742|FG000|Overall Study|Adverse Event|3|||
44138326|NCT02260648|78926743|FG001|Overall Study|Adverse Event|0|||
44138327|NCT02260648|78926744|FG002|Overall Study|Adverse Event|1|||
44138328|NCT02260648|78926742|FG000|Overall Study|Withdrawal by Subject|1|||
44138329|NCT02260648|78926743|FG001|Overall Study|Withdrawal by Subject|1|||
44138330|NCT02260648|78926744|FG002|Overall Study|Withdrawal by Subject|0|||
44138331|NCT02260648|78926742|FG000|Overall Study|Protocol Violation|1|||
44138332|NCT02260648|78926743|FG001|Overall Study|Protocol Violation|0|||
44138333|NCT02260648|78926744|FG002|Overall Study|Protocol Violation|0|||
44138334|NCT02260648|78926742|FG000|Overall Study|Discontinue Due to Study Termination|13|||
44138335|NCT02260648|78926743|FG001|Overall Study|Discontinue Due to Study Termination|12|||
44138336|NCT02260648|78926744|FG002|Overall Study|Discontinue Due to Study Termination|7|||
44138337|NCT02260492|78926755|FG000|Overall Study|Adverse Event|6|||
44138338|NCT02260492|78926756|FG001|Overall Study|Adverse Event|1|||
44138339|NCT02260492|78926757|FG002|Overall Study|Adverse Event|2|||
44138340|NCT02260492|78926755|FG000|Overall Study|Death|0|||
44138341|NCT02260492|78926756|FG001|Overall Study|Death|1|||
44138342|NCT02260492|78926757|FG002|Overall Study|Death|0|||
44138343|NCT02260492|78926755|FG000|Overall Study|Lost to Follow-up|12|||
44138344|NCT02260492|78926756|FG001|Overall Study|Lost to Follow-up|9|||
44138345|NCT02260492|78926757|FG002|Overall Study|Lost to Follow-up|0|||
44138346|NCT02260492|78926755|FG000|Overall Study|Physician Decision|2|||
44138347|NCT02260492|78926756|FG001|Overall Study|Physician Decision|0|||
44138348|NCT02260492|78926757|FG002|Overall Study|Physician Decision|1|||
44138349|NCT02260492|78926755|FG000|Overall Study|Withdrawal by Subject|3|||
44138350|NCT02260492|78926756|FG001|Overall Study|Withdrawal by Subject|2|||
44138351|NCT02260492|78926757|FG002|Overall Study|Withdrawal by Subject|2|||
44138352|NCT02260258|78926771|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
44138353|NCT02260258|78926772|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
44138354|NCT02260180|78926782|FG000|Overall Study|Adverse Event|2|||
44138355|NCT02260180|78926783|FG001|Overall Study|Adverse Event|0|||
44138356|NCT02260180|78926784|FG002|Overall Study|Adverse Event|1|||
44138357|NCT02353468|78926792|FG000|Overall Study|Study terminated|3|||
44138358|NCT02349412|78926798|FG000|Overall Study|Withdrawal by Subject|7|||
44138359|NCT02349412|78926799|FG001|Overall Study|Withdrawal by Subject|7|||
44138360|NCT02259400|78926807|FG000|Overall Study|Death|0|||
44138361|NCT02259400|78926808|FG001|Overall Study|Death|2|||
44138362|NCT01530997|78926814|FG000|Overall Study|Physician Decision|1|||
44138363|NCT01530997|78926814|FG000|Overall Study|Withdrawal by Subject|1|||
44138364|NCT02259088|78926827|FG000|Overall Study|Adverse Event|6|||
44138365|NCT02259088|78926828|FG001|Overall Study|Adverse Event|4|||
44138366|NCT02259088|78926827|FG000|Overall Study|Lost to Follow-up|2|||
44138367|NCT02259088|78926828|FG001|Overall Study|Lost to Follow-up|0|||
44138368|NCT02259088|78926827|FG000|Overall Study|Death|2|||
44138369|NCT02259088|78926828|FG001|Overall Study|Death|0|||
44138370|NCT02259088|78926827|FG000|Overall Study|Physician Decision|5|||
44138371|NCT02259088|78926828|FG001|Overall Study|Physician Decision|2|||
44138372|NCT02259088|78926827|FG000|Overall Study|Protocol deviation|5|||
44138373|NCT02259088|78926828|FG001|Overall Study|Protocol deviation|0|||
44243866|NCT01472341|79073854|FG000|Overall Study|Lost to Follow-up|52|||
44243867|NCT01472341|79073854|FG000|Overall Study|Laboratory parameters unavailable|25|||
44243868|NCT01472341|79073854|FG000|Overall Study|Death|9|||
44243869|NCT01472185|79073860|FG000|Overall Study|Randomized but Not Treated|0|||
44243870|NCT01472185|79073861|FG001|Overall Study|Randomized but Not Treated|1|||
44138374|NCT02259088|78926827|FG000|Overall Study|Subject/guardian decision|8|||
44243871|NCT01472185|79073860|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
44243872|NCT01472185|79073861|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
44138375|NCT02259088|78926828|FG001|Overall Study|Subject/guardian decision|8|||
44138376|NCT02880241|78926840|FG000|Overall Study|Lack of Efficacy|1|||
44138377|NCT02880241|78926841|FG001|Overall Study|Lack of Efficacy|0|||
44138378|NCT02880241|78926842|FG002|Overall Study|Lack of Efficacy|0|||
44138379|NCT02880241|78926843|FG003|Overall Study|Lack of Efficacy|0|||
44138380|NCT02880241|78926844|FG004|Overall Study|Lack of Efficacy|0|||
44138381|NCT02880241|78926845|FG005|Overall Study|Lack of Efficacy|0|||
44138382|NCT02259010|78926861|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
44138383|NCT02021773|78926870|FG000|Overall Study|Adverse Event|1|||
44138384|NCT02021773|78926871|FG001|Overall Study|Adverse Event|4|||
44138385|NCT02021773|78926872|FG002|Overall Study|Adverse Event|3|||
44138386|NCT02021773|78926870|FG000|Overall Study|Lack of Efficacy|2|||
44138387|NCT02021773|78926871|FG001|Overall Study|Lack of Efficacy|2|||
44138388|NCT02021773|78926872|FG002|Overall Study|Lack of Efficacy|2|||
44138389|NCT02021773|78926870|FG000|Overall Study|Protocol Violation|2|||
44138390|NCT02021773|78926871|FG001|Overall Study|Protocol Violation|3|||
44138391|NCT02021773|78926872|FG002|Overall Study|Protocol Violation|1|||
44138392|NCT02021773|78926870|FG000|Overall Study|Withdrawal by Subject|3|||
44138393|NCT02021773|78926871|FG001|Overall Study|Withdrawal by Subject|4|||
44138394|NCT02021773|78926872|FG002|Overall Study|Withdrawal by Subject|5|||
44138395|NCT02021773|78926870|FG000|Overall Study|Lost to Follow-up|1|||
44138396|NCT02021773|78926871|FG001|Overall Study|Lost to Follow-up|3|||
44138397|NCT02021773|78926872|FG002|Overall Study|Lost to Follow-up|0|||
44138398|NCT02021773|78926870|FG000|Overall Study|Reason not specified|3|||
44138399|NCT02021773|78926871|FG001|Overall Study|Reason not specified|0|||
44138400|NCT02021773|78926872|FG002|Overall Study|Reason not specified|0|||
44138401|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
44138402|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
44138403|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138404|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138405|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138406|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138407|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138408|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138409|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138410|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138411|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138412|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
44138413|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
44138414|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138415|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138416|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138417|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138418|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138419|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
44138420|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138421|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138422|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138423|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
44138424|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
44138425|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138426|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
44138427|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138428|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138429|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138430|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138431|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138432|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44380378|NCT01029392|79386214|FG000|Overall Study|Physician Decision|2|||
44380379|NCT01029392|79386215|FG001|Overall Study|Physician Decision|0|||
44380380|NCT00903006|79386227|FG000|Overall Study|Withdrawal by Subject|2|||
44380381|NCT00903006|79386228|FG001|Overall Study|Withdrawal by Subject|0|||
44380382|NCT00903006|79386229|FG002|Overall Study|Withdrawal by Subject|0|||
44380383|NCT00903006|79386230|FG003|Overall Study|Withdrawal by Subject|0|||
44380384|NCT00903006|79386227|FG000|Overall Study|Progressive Disease|0|||
44380385|NCT00903006|79386228|FG001|Overall Study|Progressive Disease|3|||
44138433|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138434|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138435|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138436|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
44138437|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
44138438|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
44138439|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
44138440|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
44138441|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
44138442|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
44138443|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
44138444|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
44380386|NCT00903006|79386229|FG002|Overall Study|Progressive Disease|1|||
44138445|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
44138446|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
44138447|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
44138448|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
44138449|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138450|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138451|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138452|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138453|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138454|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
44138455|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138456|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138457|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138458|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138459|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138460|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
44138461|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138462|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138463|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138464|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138465|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138466|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
44138467|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138468|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138469|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138470|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138471|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138472|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
44138473|NCT00151775|78926885|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138474|NCT00151775|78926886|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138475|NCT00151775|78926887|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138476|NCT00151775|78926888|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138477|NCT00151775|78926889|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138478|NCT00151775|78926890|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138479|NCT00151775|78926891|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
44138480|NCT00151775|78926892|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138481|NCT00151775|78926893|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138482|NCT00151775|78926894|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138483|NCT00151775|78926895|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138484|NCT00151775|78926896|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
44138485|NCT00151775|78926885|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138486|NCT00151775|78926886|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138487|NCT00151775|78926887|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138488|NCT00151775|78926888|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138489|NCT00151775|78926889|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138490|NCT00151775|78926890|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
44138491|NCT00151775|78926891|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138492|NCT00151775|78926892|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138493|NCT00151775|78926893|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138494|NCT00151775|78926894|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138495|NCT00151775|78926895|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138496|NCT00151775|78926896|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
44138497|NCT00151775|78926885|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
44138498|NCT00151775|78926886|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
44138499|NCT00151775|78926887|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
44138500|NCT00151775|78926888|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
44138501|NCT00151775|78926889|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
44138502|NCT00151775|78926890|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
44138503|NCT00151775|78926891|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
44138504|NCT00151775|78926892|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
44243873|NCT01472185|79073860|FG000|Overall Study|Hyperglycemia|5|||
44138505|NCT00151775|78926893|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
44513502|NCT03129100|79519001|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44138506|NCT00151775|78926894|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
44243874|NCT01472185|79073861|FG001|Overall Study|Hyperglycemia|2|||
44513503|NCT03129100|79519002|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44138507|NCT00151775|78926895|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
44138508|NCT00151775|78926896|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
44138509|NCT00151775|78926885|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138510|NCT00151775|78926886|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138511|NCT00151775|78926887|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138512|NCT00151775|78926888|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138513|NCT00151775|78926889|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138514|NCT00151775|78926890|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138515|NCT00151775|78926891|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
44138516|NCT00151775|78926892|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138517|NCT00151775|78926893|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138518|NCT00151775|78926894|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138519|NCT00151775|78926895|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138520|NCT00151775|78926896|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
44138521|NCT00151775|78926885|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138522|NCT00151775|78926886|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138523|NCT00151775|78926887|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
44138524|NCT00151775|78926888|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138525|NCT00151775|78926889|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138526|NCT00151775|78926890|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138527|NCT00151775|78926891|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138528|NCT00151775|78926892|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138529|NCT00151775|78926893|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138530|NCT00151775|78926894|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138531|NCT00151775|78926895|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138532|NCT00151775|78926896|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
44138533|NCT00151775|78926885|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138534|NCT00151775|78926886|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138535|NCT00151775|78926887|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
44138536|NCT00151775|78926888|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138537|NCT00151775|78926889|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138538|NCT00151775|78926890|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138539|NCT00151775|78926891|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138540|NCT00151775|78926892|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138541|NCT00151775|78926893|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138542|NCT00151775|78926894|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138543|NCT00151775|78926895|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138544|NCT00151775|78926896|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
44138545|NCT00151775|78926885|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138546|NCT00151775|78926886|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138547|NCT00151775|78926887|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138548|NCT00151775|78926888|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138549|NCT00151775|78926889|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138550|NCT00151775|78926890|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138551|NCT00151775|78926891|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138552|NCT00151775|78926892|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138553|NCT00151775|78926893|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138554|NCT00151775|78926894|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138555|NCT00151775|78926895|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
44138556|NCT00151775|78926896|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
44138557|NCT00151775|78926885|FG000|Period 4: Open Label|Increased blood pressure|0|||
44138558|NCT00151775|78926886|FG001|Period 4: Open Label|Increased blood pressure|0|||
44138559|NCT00151775|78926887|FG002|Period 4: Open Label|Increased blood pressure|0|||
44138560|NCT00151775|78926888|FG003|Period 4: Open Label|Increased blood pressure|0|||
44138561|NCT00151775|78926889|FG004|Period 4: Open Label|Increased blood pressure|1|||
44138562|NCT00151775|78926890|FG005|Period 4: Open Label|Increased blood pressure|0|||
44138563|NCT00151775|78926891|FG006|Period 4: Open Label|Increased blood pressure|0|||
44138564|NCT00151775|78926892|FG007|Period 4: Open Label|Increased blood pressure|0|||
44138565|NCT00151775|78926893|FG008|Period 4: Open Label|Increased blood pressure|0|||
44380387|NCT00903006|79386230|FG003|Overall Study|Progressive Disease|0|||
44138566|NCT00151775|78926894|FG009|Period 4: Open Label|Increased blood pressure|1|||
44243875|NCT01472185|79073860|FG000|Overall Study|Investigator's Discretion|3|||
44138567|NCT00151775|78926895|FG010|Period 4: Open Label|Increased blood pressure|0|||
44138568|NCT00151775|78926896|FG011|Period 4: Open Label|Increased blood pressure|0|||
44138569|NCT00151775|78926885|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
44138570|NCT00151775|78926886|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
44138571|NCT00151775|78926887|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
44138572|NCT00151775|78926888|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
44138573|NCT00151775|78926889|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
44138574|NCT00151775|78926890|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
44243876|NCT01472185|79073861|FG001|Overall Study|Investigator's Discretion|1|||
44243877|NCT01472185|79073860|FG000|Overall Study|Lost to Follow-up|4|||
44243878|NCT01472185|79073861|FG001|Overall Study|Lost to Follow-up|1|||
44243879|NCT01472185|79073860|FG000|Overall Study|Protocol Violation|5|||
44243880|NCT01472185|79073861|FG001|Overall Study|Protocol Violation|1|||
44138575|NCT00151775|78926891|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
44138576|NCT00151775|78926892|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
44138577|NCT00151775|78926893|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
44138578|NCT00151775|78926894|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
44138579|NCT00151775|78926895|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
44138580|NCT00151775|78926896|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
44138581|NCT00151775|78926885|FG000|Period 4: Open Label|Adverse Event|0|||
44138582|NCT00151775|78926886|FG001|Period 4: Open Label|Adverse Event|0|||
44138583|NCT00151775|78926887|FG002|Period 4: Open Label|Adverse Event|0|||
44138584|NCT00151775|78926888|FG003|Period 4: Open Label|Adverse Event|0|||
44138585|NCT00151775|78926889|FG004|Period 4: Open Label|Adverse Event|1|||
44138586|NCT00151775|78926890|FG005|Period 4: Open Label|Adverse Event|0|||
44138587|NCT00151775|78926891|FG006|Period 4: Open Label|Adverse Event|0|||
44138588|NCT00151775|78926892|FG007|Period 4: Open Label|Adverse Event|0|||
44138589|NCT00151775|78926893|FG008|Period 4: Open Label|Adverse Event|0|||
44138590|NCT00151775|78926894|FG009|Period 4: Open Label|Adverse Event|2|||
44138591|NCT00151775|78926895|FG010|Period 4: Open Label|Adverse Event|0|||
44138592|NCT00151775|78926896|FG011|Period 4: Open Label|Adverse Event|0|||
44138593|NCT00151775|78926885|FG000|Period 4: Open Label|Lost to Follow-up|0|||
44138594|NCT00151775|78926886|FG001|Period 4: Open Label|Lost to Follow-up|0|||
44138595|NCT00151775|78926887|FG002|Period 4: Open Label|Lost to Follow-up|0|||
44138596|NCT00151775|78926888|FG003|Period 4: Open Label|Lost to Follow-up|0|||
44138597|NCT00151775|78926889|FG004|Period 4: Open Label|Lost to Follow-up|17|||
44138598|NCT00151775|78926890|FG005|Period 4: Open Label|Lost to Follow-up|0|||
44138599|NCT00151775|78926891|FG006|Period 4: Open Label|Lost to Follow-up|0|||
44138600|NCT00151775|78926892|FG007|Period 4: Open Label|Lost to Follow-up|0|||
44138601|NCT00151775|78926893|FG008|Period 4: Open Label|Lost to Follow-up|0|||
44138602|NCT00151775|78926894|FG009|Period 4: Open Label|Lost to Follow-up|7|||
44138603|NCT00151775|78926895|FG010|Period 4: Open Label|Lost to Follow-up|0|||
44138604|NCT00151775|78926896|FG011|Period 4: Open Label|Lost to Follow-up|0|||
44138605|NCT00151775|78926885|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
44138606|NCT00151775|78926886|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
44138607|NCT00151775|78926887|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
44138608|NCT00151775|78926888|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
44138609|NCT00151775|78926889|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
44138610|NCT00151775|78926890|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
44138611|NCT00151775|78926891|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
44138612|NCT00151775|78926892|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
44138613|NCT00151775|78926893|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
44138614|NCT00151775|78926894|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
44138615|NCT00151775|78926895|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
44138616|NCT00151775|78926896|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
44138617|NCT00151775|78926885|FG000|Period 4: Open Label|Other|0|||
44138618|NCT00151775|78926886|FG001|Period 4: Open Label|Other|0|||
44138619|NCT00151775|78926887|FG002|Period 4: Open Label|Other|0|||
44138620|NCT00151775|78926888|FG003|Period 4: Open Label|Other|0|||
44138621|NCT00151775|78926889|FG004|Period 4: Open Label|Other|1|||
44138622|NCT00151775|78926890|FG005|Period 4: Open Label|Other|0|||
44138623|NCT00151775|78926891|FG006|Period 4: Open Label|Other|0|||
44138624|NCT00151775|78926892|FG007|Period 4: Open Label|Other|0|||
44138625|NCT00151775|78926893|FG008|Period 4: Open Label|Other|0|||
44138626|NCT00151775|78926894|FG009|Period 4: Open Label|Other|3|||
44138627|NCT00151775|78926895|FG010|Period 4: Open Label|Other|0|||
44138628|NCT00151775|78926896|FG011|Period 4: Open Label|Other|0|||
44138629|NCT00151775|78926885|FG000|Period 4: Open Label|Physician Decision|0|||
44138630|NCT00151775|78926886|FG001|Period 4: Open Label|Physician Decision|0|||
44138631|NCT00151775|78926887|FG002|Period 4: Open Label|Physician Decision|0|||
44138632|NCT00151775|78926888|FG003|Period 4: Open Label|Physician Decision|0|||
44138633|NCT00151775|78926889|FG004|Period 4: Open Label|Physician Decision|0|||
44138634|NCT00151775|78926890|FG005|Period 4: Open Label|Physician Decision|0|||
44138635|NCT00151775|78926891|FG006|Period 4: Open Label|Physician Decision|0|||
44138636|NCT00151775|78926892|FG007|Period 4: Open Label|Physician Decision|0|||
44138637|NCT00151775|78926893|FG008|Period 4: Open Label|Physician Decision|0|||
44138638|NCT00151775|78926894|FG009|Period 4: Open Label|Physician Decision|2|||
44138639|NCT00151775|78926895|FG010|Period 4: Open Label|Physician Decision|0|||
44138640|NCT00151775|78926896|FG011|Period 4: Open Label|Physician Decision|0|||
44138641|NCT00151775|78926885|FG000|Period 4: Open Label|Protocol Violation|0|||
44138642|NCT00151775|78926886|FG001|Period 4: Open Label|Protocol Violation|0|||
44138643|NCT00151775|78926887|FG002|Period 4: Open Label|Protocol Violation|0|||
44138644|NCT00151775|78926888|FG003|Period 4: Open Label|Protocol Violation|0|||
44138645|NCT00151775|78926889|FG004|Period 4: Open Label|Protocol Violation|1|||
44138646|NCT00151775|78926890|FG005|Period 4: Open Label|Protocol Violation|0|||
44138647|NCT00151775|78926891|FG006|Period 4: Open Label|Protocol Violation|0|||
44138648|NCT00151775|78926892|FG007|Period 4: Open Label|Protocol Violation|0|||
44138649|NCT00151775|78926893|FG008|Period 4: Open Label|Protocol Violation|0|||
44138650|NCT00151775|78926894|FG009|Period 4: Open Label|Protocol Violation|0|||
44138651|NCT00151775|78926895|FG010|Period 4: Open Label|Protocol Violation|0|||
44138652|NCT00151775|78926896|FG011|Period 4: Open Label|Protocol Violation|0|||
44138653|NCT02258464|78926939|FG000|Overall Study|Progressive disease (PD)|9|||
44513504|NCT03129100|79519003|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513505|NCT03129100|79519004|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513506|NCT03129100|79519005|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513507|NCT03129100|79519006|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513508|NCT03129100|79519007|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513509|NCT03129100|79519008|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513510|NCT03129100|79519009|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513511|NCT03129100|79519010|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513512|NCT03129100|79519011|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
44138654|NCT02258464|78926940|FG001|Overall Study|Progressive disease (PD)|17|||
44138655|NCT02258464|78926939|FG000|Overall Study|Study drug never administered|1|||
44138656|NCT02258464|78926940|FG001|Overall Study|Study drug never administered|1|||
44138657|NCT02258464|78926939|FG000|Overall Study|AE not related to clinical PD|1|||
44138658|NCT02258464|78926940|FG001|Overall Study|AE not related to clinical PD|3|||
44138659|NCT02258464|78926939|FG000|Overall Study|Withdrawal by Subject|5|||
44138660|NCT02258464|78926940|FG001|Overall Study|Withdrawal by Subject|4|||
44138661|NCT02258464|78926939|FG000|Overall Study|AE related to clinical PD|1|||
44380388|NCT00839332|79386243|FG000|Phase 1|Disease Progression|38|||
44138662|NCT02258464|78926940|FG001|Overall Study|AE related to clinical PD|0|||
44138663|NCT02682901|78926948|FG000|Overall Study|Adverse Event|10|||
44380389|NCT00839332|79386244|FG001|Phase 1|Disease Progression|0|||
44138664|NCT02682901|78926949|FG001|Overall Study|Adverse Event|3|||
44138665|NCT02682901|78926948|FG000|Overall Study|Lack of Efficacy|0|||
44138666|NCT02682901|78926949|FG001|Overall Study|Lack of Efficacy|1|||
44138667|NCT02258074|78926959|FG000|Overall Study|Withdrawal by Subject|1|||
44138668|NCT02258074|78926960|FG001|Overall Study|Withdrawal by Subject|0|||
44138669|NCT02258074|78926961|FG002|Overall Study|Withdrawal by Subject|0|||
44138670|NCT02258074|78926962|FG003|Overall Study|Withdrawal by Subject|0|||
44138671|NCT01643044|78926974|FG000|Overall Study|Lost to Follow-up|1|||
44138672|NCT01643044|78926975|FG001|Overall Study|Lost to Follow-up|1|||
44138673|NCT01643044|78926974|FG000|Overall Study|Miscarried baby|2|||
44138674|NCT01643044|78926975|FG001|Overall Study|Miscarried baby|2|||
44138675|NCT01643044|78926974|FG000|Overall Study|Delivered outside of hospital|1|||
44138676|NCT01643044|78926975|FG001|Overall Study|Delivered outside of hospital|2|||
44138677|NCT01642732|78926981|FG000|Overall Study|Withdrawal by Subject|1|||
44138678|NCT02257684|78926985|FG000|Overall Study|Adverse Event|2|||
44138679|NCT02257684|78926985|FG000|Overall Study|Lack of Efficacy|1|||
44138680|NCT02257684|78926985|FG000|Overall Study|Sponsor's Decision|1|||
44138681|NCT02190721|78926992|FG000|Overall Study|Patient was out of the city|0|||
44138682|NCT02190721|78926993|FG001|Overall Study|Patient was out of the city|1|||
44138683|NCT02190721|78926994|FG002|Overall Study|Patient was out of the city|0|||
44138684|NCT00581477|78927002|FG000|Overall Study|Physician Decision|2|||
44138685|NCT02348008|78927018|FG000|Overall Study|Adverse Event|2|||
44138686|NCT02348008|78927019|FG001|Overall Study|Adverse Event|3|||
44138687|NCT02348008|78927020|FG002|Overall Study|Adverse Event|3|||
44138688|NCT02348008|78927018|FG000|Overall Study|Disease Progression|1|||
44138689|NCT02348008|78927019|FG001|Overall Study|Disease Progression|5|||
44138690|NCT02348008|78927020|FG002|Overall Study|Disease Progression|16|||
44138691|NCT02348008|78927018|FG000|Overall Study|Withdrawal by Subject|0|||
44138692|NCT02348008|78927019|FG001|Overall Study|Withdrawal by Subject|1|||
44138693|NCT02348008|78927020|FG002|Overall Study|Withdrawal by Subject|0|||
44138694|NCT02348008|78927018|FG000|Overall Study|Symptomatic Deterioration|0|||
44138695|NCT02348008|78927019|FG001|Overall Study|Symptomatic Deterioration|1|||
44243881|NCT01472185|79073860|FG000|Overall Study|Subject Noncompliance|8|||
44243882|NCT01472185|79073861|FG001|Overall Study|Subject Noncompliance|15|||
44243883|NCT01472185|79073860|FG000|Overall Study|Subject Withdrew Consent|6|||
44243884|NCT01472185|79073861|FG001|Overall Study|Subject Withdrew Consent|3|||
44380390|NCT00839332|79386245|FG002|Phase 1|Disease Progression|0|||
44380391|NCT00839332|79386243|FG000|Phase 1|Adverse Event|6|||
44380392|NCT00839332|79386244|FG001|Phase 1|Adverse Event|0|||
44380393|NCT00839332|79386245|FG002|Phase 1|Adverse Event|0|||
44380394|NCT00839332|79386243|FG000|Phase 1|Withdrawal by Subject|4|||
44513513|NCT03129100|79519012|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513514|NCT03129100|79519013|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
44513515|NCT03129100|79519014|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
44513516|NCT03129100|79519015|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513517|NCT03129100|79519016|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513518|NCT03129100|79519017|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513519|NCT03129100|79519018|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513520|NCT03129100|79519019|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513521|NCT03129100|79519020|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513522|NCT03129100|79519021|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513523|NCT03129100|79519022|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513524|NCT03129100|79519023|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513525|NCT03129100|79519024|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513526|NCT03129100|79519025|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
44513527|NCT03129100|79519000|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513528|NCT03129100|79519001|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513529|NCT03129100|79519002|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513530|NCT03129100|79519003|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513531|NCT03129100|79519004|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513532|NCT03129100|79519005|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513533|NCT03129100|79519006|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44138696|NCT02348008|78927020|FG002|Overall Study|Symptomatic Deterioration|0|||
44380395|NCT00839332|79386244|FG001|Phase 1|Withdrawal by Subject|0|||
44138697|NCT04962022|78927026|FG000|Period 1|Withdrawal by Subject|1|||
44138698|NCT04962022|78927027|FG001|Period 1|Withdrawal by Subject|0|||
44138699|NCT04740905|78927044|FG000|Overall Study|Ongoing in the Study at the Primary Completion Date|272|||
44138700|NCT04740905|78927045|FG001|Overall Study|Ongoing in the Study at the Primary Completion Date|274|||
44138701|NCT04740905|78927044|FG000|Overall Study|Protocol Violation|0|||
44138702|NCT04740905|78927045|FG001|Overall Study|Protocol Violation|3|||
44138703|NCT04740905|78927044|FG000|Overall Study|Lost to Follow-up|2|||
44243885|NCT01456897|79073882|FG000|Overall Study|Adverse Event|19|||
44380396|NCT00839332|79386245|FG002|Phase 1|Withdrawal by Subject|0|||
44380397|NCT00839332|79386243|FG000|Phase 1|Physician Decision|2|||
44380398|NCT00839332|79386244|FG001|Phase 1|Physician Decision|0|||
44138704|NCT04740905|78927045|FG001|Overall Study|Lost to Follow-up|0|||
44138705|NCT04740905|78927044|FG000|Overall Study|Adverse Event|1|||
44138706|NCT04740905|78927045|FG001|Overall Study|Adverse Event|0|||
44138707|NCT04740905|78927044|FG000|Overall Study|Withdrawal by Subject|1|||
44138708|NCT04740905|78927045|FG001|Overall Study|Withdrawal by Subject|0|||
44138709|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
44138710|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
44138711|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
44138712|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
44138713|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
44138714|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
44138715|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
44138716|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
44138717|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
44138718|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
44138719|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
44138720|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
44138721|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
44138722|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
44138723|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
44138724|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
44138725|NCT04210843|78927104|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
44138726|NCT04210843|78927105|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
44138727|NCT04210843|78927104|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
44138728|NCT04210843|78927105|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
44138729|NCT04210843|78927104|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
44138730|NCT04210843|78927105|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
44380399|NCT00839332|79386245|FG002|Phase 1|Physician Decision|0|||
44380400|NCT00839332|79386243|FG000|Phase 2|Protocol Violation|0|||
44380401|NCT00839332|79386244|FG001|Phase 2|Protocol Violation|1|||
44138731|NCT04210843|78927104|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
44138732|NCT04210843|78927105|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
44138733|NCT04210843|78927104|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
44138734|NCT04210843|78927105|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
44138735|NCT04210843|78927104|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
44138736|NCT04210843|78927105|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
44138737|NCT04210843|78927104|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
44138738|NCT04210843|78927105|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
44138739|NCT04210843|78927104|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
44138740|NCT04210843|78927105|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
44138741|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
44138742|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
44138743|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
44138744|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
44138745|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
44138746|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
44138747|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
44138748|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
44138749|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
44243886|NCT01456897|79073883|FG001|Overall Study|Adverse Event|22|||
44243887|NCT01456897|79073882|FG000|Overall Study|Protocol Violation|3|||
44243888|NCT01456897|79073883|FG001|Overall Study|Protocol Violation|4|||
44243889|NCT01456897|79073882|FG000|Overall Study|Physician Decision|5|||
44243890|NCT01456897|79073883|FG001|Overall Study|Physician Decision|3|||
44243891|NCT01456897|79073882|FG000|Overall Study|Withdrawal by Subject|44|||
44243892|NCT01456897|79073883|FG001|Overall Study|Withdrawal by Subject|17|||
44243893|NCT01456897|79073882|FG000|Overall Study|Lack of Efficacy|4|||
44243894|NCT01456897|79073883|FG001|Overall Study|Lack of Efficacy|11|||
44243895|NCT01456195|79073896|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
44243896|NCT01456195|79073897|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
44243897|NCT01456195|79073898|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
44243898|NCT01456195|79073896|FG000|Overall Study|Lost to Follow-up|3|||
44243899|NCT01456195|79073897|FG001|Overall Study|Lost to Follow-up|1|||
44243900|NCT01456195|79073898|FG002|Overall Study|Lost to Follow-up|3|||
44380402|NCT00839332|79386245|FG002|Phase 2|Protocol Violation|0|||
44380403|NCT00839332|79386243|FG000|Phase 2|Disease Progression|0|||
44380404|NCT00839332|79386244|FG001|Phase 2|Disease Progression|46|||
44138750|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
44138751|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
44138752|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
44138753|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
44138754|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
44138755|NCT04210843|78927104|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
44138756|NCT04210843|78927105|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
44138757|NCT02651675|78927128|FG000|Overall Study|Death|0|||
44138758|NCT02651675|78927129|FG001|Overall Study|Death|0|||
44138759|NCT02651675|78927130|FG002|Overall Study|Death|1|||
44138760|NCT02611960|78927140|FG000|Overall Study|Adverse Event|7|||
44138761|NCT02611960|78927141|FG001|Overall Study|Adverse Event|8|||
44138762|NCT02611960|78927140|FG000|Overall Study|Death|98|||
44138763|NCT02611960|78927141|FG001|Overall Study|Death|92|||
44138764|NCT02611960|78927140|FG000|Overall Study|Withdrawal by Subject|1|||
44138765|NCT02611960|78927141|FG001|Overall Study|Withdrawal by Subject|5|||
44138766|NCT02611960|78927140|FG000|Overall Study|Sponsor Decision|11|||
44138767|NCT02611960|78927141|FG001|Overall Study|Sponsor Decision|11|||
44138768|NCT01845597|78927148|FG000|Overall Study|Death|8|||
44138769|NCT01845597|78927148|FG000|Overall Study|Lost to Follow-up|22|||
44138770|NCT00713206|78927167|FG000|Overall Study|Lost to Follow-up|4|||
44138771|NCT00713206|78927168|FG001|Overall Study|Lost to Follow-up|4|||
44138772|NCT00713206|78927167|FG000|Overall Study|Death|1|||
44138773|NCT00713206|78927168|FG001|Overall Study|Death|0|||
44138774|NCT00495131|78927176|FG000|Overall Study|Adverse Event|6|||
44138775|NCT00495131|78927177|FG001|Overall Study|Adverse Event|2|||
44138776|NCT00495131|78927176|FG000|Overall Study|Lack of Efficacy|0|||
44138777|NCT00495131|78927177|FG001|Overall Study|Lack of Efficacy|2|||
44138778|NCT00495131|78927176|FG000|Overall Study|Lost to Follow-up|0|||
44138779|NCT00495131|78927177|FG001|Overall Study|Lost to Follow-up|2|||
44138780|NCT00495131|78927176|FG000|Overall Study|Withdrawal by Subject|1|||
44138781|NCT00495131|78927177|FG001|Overall Study|Withdrawal by Subject|0|||
44138782|NCT02257372|78927183|FG000|Overall Study|Adverse Event|3|||
44138783|NCT02257372|78927184|FG001|Overall Study|Adverse Event|7|||
44138784|NCT02257372|78927183|FG000|Overall Study|Lack of Efficacy|2|||
44138785|NCT02257372|78927184|FG001|Overall Study|Lack of Efficacy|1|||
44138786|NCT02257372|78927183|FG000|Overall Study|Protocol Violation|1|||
44138787|NCT02257372|78927184|FG001|Overall Study|Protocol Violation|1|||
44138788|NCT02257372|78927183|FG000|Overall Study|Lost to Follow-up|0|||
44138789|NCT02257372|78927184|FG001|Overall Study|Lost to Follow-up|1|||
44138790|NCT02257372|78927183|FG000|Overall Study|Withdrew consent|1|||
44138791|NCT02257372|78927184|FG001|Overall Study|Withdrew consent|0|||
44138792|NCT02256982|78927192|FG000|Overall Study|Disease Progression|0|||
44138793|NCT02256982|78927193|FG001|Overall Study|Disease Progression|1|||
44138794|NCT02736721|78927199|FG000|Overall Study|Adverse Event|8|||
44138795|NCT02736721|78927199|FG000|Overall Study|Lost to Follow-up|3|||
44138796|NCT02736721|78927199|FG000|Overall Study|Other|5|||
44138797|NCT04176445|78927203|FG000|Overall Study|Adverse Event|0|||
44138798|NCT04176445|78927204|FG001|Overall Study|Adverse Event|1|||
44138799|NCT04176445|78927203|FG000|Overall Study|change plans weaning after first intervention|0|||
44138800|NCT04176445|78927204|FG001|Overall Study|change plans weaning after first intervention|1|||
44138801|NCT02738203|78927212|FG000|Overall Study|Failed IUD Insertion|2|||
44138802|NCT02738203|78927213|FG001|Overall Study|Failed IUD Insertion|2|||
44138803|NCT02738203|78927212|FG000|Overall Study|Protocol Violation|0|||
44243901|NCT01456195|79073896|FG000|Overall Study|Voluntary Withdrawal|5|||
44243902|NCT01456195|79073897|FG001|Overall Study|Voluntary Withdrawal|3|||
44243903|NCT01456195|79073898|FG002|Overall Study|Voluntary Withdrawal|7|||
44243904|NCT01456195|79073896|FG000|Overall Study|Lack of Efficacy|0|||
44243905|NCT01456195|79073897|FG001|Overall Study|Lack of Efficacy|1|||
44243906|NCT01456195|79073898|FG002|Overall Study|Lack of Efficacy|0|||
44243907|NCT01456195|79073896|FG000|Overall Study|Other Reasons|2|||
44243908|NCT01456195|79073897|FG001|Overall Study|Other Reasons|1|||
44243909|NCT01456195|79073898|FG002|Overall Study|Other Reasons|3|||
44138804|NCT02738203|78927213|FG001|Overall Study|Protocol Violation|1|||
44138805|NCT02452034|78927225|FG000|Overall Study|Adverse Event|0|||
44138806|NCT02452034|78927226|FG001|Overall Study|Adverse Event|0|||
44138807|NCT02452034|78927227|FG002|Overall Study|Adverse Event|0|||
44138808|NCT02452034|78927228|FG003|Overall Study|Adverse Event|0|||
44138809|NCT02452034|78927229|FG004|Overall Study|Adverse Event|0|||
44138810|NCT02452034|78927230|FG005|Overall Study|Adverse Event|1|||
44138811|NCT02452034|78927225|FG000|Overall Study|Death|0|||
44138812|NCT02452034|78927226|FG001|Overall Study|Death|0|||
44138813|NCT02452034|78927227|FG002|Overall Study|Death|0|||
44243910|NCT01456039|79073962|FG000|Phase 1 (First Step)|Disease Progression|1|||
44243911|NCT01456039|79073963|FG001|Phase 1 (First Step)|Disease Progression|1|||
44138814|NCT02452034|78927228|FG003|Overall Study|Death|0|||
44138815|NCT02452034|78927229|FG004|Overall Study|Death|1|||
44138816|NCT02452034|78927230|FG005|Overall Study|Death|1|||
44138817|NCT02452034|78927225|FG000|Overall Study|Physician Decision|0|||
44138818|NCT02452034|78927226|FG001|Overall Study|Physician Decision|1|||
44138819|NCT02452034|78927227|FG002|Overall Study|Physician Decision|1|||
44138820|NCT02452034|78927228|FG003|Overall Study|Physician Decision|0|||
44138821|NCT02452034|78927229|FG004|Overall Study|Physician Decision|0|||
44138822|NCT02452034|78927230|FG005|Overall Study|Physician Decision|0|||
44138823|NCT02452034|78927225|FG000|Overall Study|Protocol Violation|0|||
44138824|NCT02452034|78927226|FG001|Overall Study|Protocol Violation|0|||
44138825|NCT02452034|78927227|FG002|Overall Study|Protocol Violation|0|||
44138826|NCT02452034|78927228|FG003|Overall Study|Protocol Violation|0|||
44138827|NCT02452034|78927229|FG004|Overall Study|Protocol Violation|0|||
44138828|NCT02452034|78927230|FG005|Overall Study|Protocol Violation|1|||
44138829|NCT02452034|78927225|FG000|Overall Study|Screen Failure|1|||
44138830|NCT02452034|78927226|FG001|Overall Study|Screen Failure|0|||
44138831|NCT02452034|78927227|FG002|Overall Study|Screen Failure|0|||
44138832|NCT02452034|78927228|FG003|Overall Study|Screen Failure|1|||
44138833|NCT02452034|78927229|FG004|Overall Study|Screen Failure|0|||
44138834|NCT02452034|78927230|FG005|Overall Study|Screen Failure|0|||
44138835|NCT02452034|78927225|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
44138836|NCT02452034|78927226|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
44138837|NCT02452034|78927227|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
44138838|NCT02452034|78927228|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
44138839|NCT02452034|78927229|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
44138840|NCT02452034|78927230|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
44138841|NCT02482298|78927257|FG000|Overall Study|Withdrawal by Subject|2|||
44138842|NCT02482298|78927258|FG001|Overall Study|Withdrawal by Subject|1|||
44138843|NCT02482298|78927259|FG002|Overall Study|Withdrawal by Subject|2|||
44138844|NCT02482298|78927257|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
44138845|NCT02482298|78927258|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
44138846|NCT02482298|78927259|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
44138847|NCT02482298|78927257|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
44138848|NCT02482298|78927258|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
44138849|NCT02482298|78927259|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
44138850|NCT02482298|78927257|FG000|Overall Study|Lost to Follow-up|0|||
44138851|NCT02482298|78927258|FG001|Overall Study|Lost to Follow-up|1|||
44138852|NCT02482298|78927259|FG002|Overall Study|Lost to Follow-up|0|||
44138853|NCT00440531|78927270|FG000|Overall Study|Adverse Event|1|||
44138854|NCT00440531|78927271|FG001|Overall Study|Adverse Event|0|||
44138855|NCT00440531|78927272|FG002|Overall Study|Adverse Event|2|||
44138856|NCT00440531|78927270|FG000|Overall Study|Withdrawal by Subject|2|||
44138857|NCT00440531|78927271|FG001|Overall Study|Withdrawal by Subject|0|||
44138858|NCT00440531|78927272|FG002|Overall Study|Withdrawal by Subject|0|||
44138859|NCT00440531|78927270|FG000|Overall Study|Protocol Violation|1|||
44138860|NCT00440531|78927271|FG001|Overall Study|Protocol Violation|2|||
44138861|NCT00440531|78927272|FG002|Overall Study|Protocol Violation|0|||
44138862|NCT00440531|78927270|FG000|Overall Study|Lost to Follow-up|4|||
44138863|NCT00440531|78927271|FG001|Overall Study|Lost to Follow-up|3|||
44138864|NCT00440531|78927272|FG002|Overall Study|Lost to Follow-up|5|||
44138865|NCT00440531|78927270|FG000|Overall Study|see pre-assignment details|2|||
44138866|NCT00440531|78927271|FG001|Overall Study|see pre-assignment details|0|||
44138867|NCT00440531|78927272|FG002|Overall Study|see pre-assignment details|0|||
44138868|NCT02513732|78927278|FG000|Overall Study|Lost to Follow-up|11|||
44138869|NCT02513732|78927278|FG000|Overall Study|Death|9|||
44138870|NCT02513732|78927278|FG000|Overall Study|Changing hospital|2|||
44138871|NCT00429923|78927285|FG000|Overall Study|Adverse Event|0|||
44138872|NCT00429923|78927286|FG001|Overall Study|Adverse Event|2|||
44138873|NCT00429923|78927287|FG002|Overall Study|Adverse Event|3|||
44138874|NCT00429923|78927285|FG000|Overall Study|Lack of Efficacy|4|||
44138875|NCT00429923|78927286|FG001|Overall Study|Lack of Efficacy|1|||
44138876|NCT00429923|78927287|FG002|Overall Study|Lack of Efficacy|33|||
44138877|NCT00429923|78927285|FG000|Overall Study|Lost to Follow-up|0|||
44138878|NCT00429923|78927286|FG001|Overall Study|Lost to Follow-up|0|||
44138879|NCT00429923|78927287|FG002|Overall Study|Lost to Follow-up|2|||
44138880|NCT00429923|78927285|FG000|Overall Study|Withdrew Consent|1|||
44138881|NCT00429923|78927286|FG001|Overall Study|Withdrew Consent|0|||
44138882|NCT00429923|78927287|FG002|Overall Study|Withdrew Consent|1|||
44138883|NCT00429923|78927285|FG000|Overall Study|Early Termination|0|||
44138884|NCT00429923|78927286|FG001|Overall Study|Early Termination|1|||
44138885|NCT00429923|78927287|FG002|Overall Study|Early Termination|0|||
44138886|NCT02256436|78927294|FG000|Overall Study|Adverse Event|9|||
44138887|NCT02256436|78927295|FG001|Overall Study|Adverse Event|14|||
44138888|NCT02256436|78927294|FG000|Overall Study|Death|216|||
44138889|NCT02256436|78927295|FG001|Overall Study|Death|208|||
44138890|NCT02256436|78927294|FG000|Overall Study|Lost to Follow-up|1|||
44138891|NCT02256436|78927295|FG001|Overall Study|Lost to Follow-up|2|||
44138892|NCT02256436|78927294|FG000|Overall Study|Physician Decision|1|||
44138893|NCT02256436|78927295|FG001|Overall Study|Physician Decision|0|||
44138894|NCT02256436|78927294|FG000|Overall Study|Protocol Violation|0|||
44138895|NCT02256436|78927295|FG001|Overall Study|Protocol Violation|1|||
44138896|NCT02256436|78927294|FG000|Overall Study|Withdrawal by Subject|26|||
44138897|NCT02256436|78927295|FG001|Overall Study|Withdrawal by Subject|10|||
44138898|NCT02256436|78927294|FG000|Overall Study|Transferred to Extension Study|11|||
44138899|NCT02256436|78927295|FG001|Overall Study|Transferred to Extension Study|23|||
44138900|NCT02256436|78927294|FG000|Overall Study|Did Not Continue on Extension Study|8|||
44138901|NCT02256436|78927295|FG001|Overall Study|Did Not Continue on Extension Study|12|||
44138902|NCT00326183|78927304|FG000|Overall Study|Lost to Follow-up|104|||
44138903|NCT00326183|78927305|FG001|Overall Study|Lost to Follow-up|56|||
44138904|NCT00326183|78927304|FG000|Overall Study|Protocol Violation|6|||
44138905|NCT00326183|78927305|FG001|Overall Study|Protocol Violation|3|||
44138906|NCT00326183|78927304|FG000|Overall Study|Withdrawal by Subject|35|||
44138907|NCT00326183|78927305|FG001|Overall Study|Withdrawal by Subject|7|||
44138908|NCT00326183|78927304|FG000|Overall Study|Subject Moved|7|||
44138909|NCT00326183|78927305|FG001|Overall Study|Subject Moved|4|||
44138910|NCT00326183|78927304|FG000|Overall Study|Other|47|||
44138911|NCT00326183|78927305|FG001|Overall Study|Other|13|||
44138912|NCT00326183|78927304|FG000|Overall Study|Adverse Event|1|||
44138913|NCT00326183|78927305|FG001|Overall Study|Adverse Event|0|||
44138914|NCT02481050|78927309|FG000|Overall Study|Adverse Event|1|||
44138915|NCT02481050|78927309|FG000|Overall Study|Disease Progression|47|||
44138916|NCT02481050|78927309|FG000|Overall Study|Withdrawal by Subject|7|||
44138917|NCT02481050|78927309|FG000|Overall Study|Other|3|||
44138918|NCT02511782|78927316|FG000|Overall Study|Withdrawal by Subject|1|||
44138919|NCT02511782|78927317|FG001|Overall Study|Withdrawal by Subject|0|||
44513534|NCT03129100|79519007|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513535|NCT03129100|79519008|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44138920|NCT02511782|78927318|FG002|Overall Study|Withdrawal by Subject|0|||
44138921|NCT02480114|78927328|FG000|Overall Study|Not completing surveys|3|||
44138922|NCT02480114|78927329|FG001|Overall Study|Not completing surveys|2|||
44138923|NCT02480114|78927328|FG000|Overall Study|Withdrawal by Subject|2|||
44138924|NCT02480114|78927329|FG001|Overall Study|Withdrawal by Subject|4|||
44138925|NCT02480114|78927328|FG000|Overall Study|Disease progression|3|||
44138926|NCT02480114|78927329|FG001|Overall Study|Disease progression|0|||
44138927|NCT02480114|78927328|FG000|Overall Study|Improper completion of survey|1|||
44138928|NCT02480114|78927329|FG001|Overall Study|Improper completion of survey|1|||
44138929|NCT02480114|78927328|FG000|Overall Study|Not eligible|0|||
44138930|NCT02480114|78927329|FG001|Overall Study|Not eligible|1|||
44138931|NCT02479880|78927337|FG000|Overall Study|Study Terminated by Sponsor|13|||
44138932|NCT02479880|78927338|FG001|Overall Study|Study Terminated by Sponsor|12|||
44138933|NCT02479880|78927337|FG000|Overall Study|Pregnancy|0|||
44138934|NCT02479880|78927338|FG001|Overall Study|Pregnancy|1|||
44138935|NCT02479802|78927344|FG000|Overall Study|Lost to Follow-up|1|||
44138936|NCT02479802|78927344|FG000|Overall Study|Adverse Event|1|||
44138937|NCT02479412|78927357|FG000|Overall Study|Adverse Event|0|||
44138938|NCT02479412|78927358|FG001|Overall Study|Adverse Event|0|||
44138939|NCT02479412|78927359|FG002|Overall Study|Adverse Event|1|||
44138940|NCT02479412|78927360|FG003|Overall Study|Adverse Event|0|||
44138941|NCT02479412|78927361|FG004|Overall Study|Adverse Event|0|||
44138942|NCT02479412|78927362|FG005|Overall Study|Adverse Event|0|||
44138943|NCT02479412|78927363|FG006|Overall Study|Adverse Event|0|||
44138944|NCT02479412|78927364|FG007|Overall Study|Adverse Event|0|||
44138945|NCT02479412|78927365|FG008|Overall Study|Adverse Event|0|||
44138946|NCT02479412|78927357|FG000|Overall Study|Study-specific withdrawal criteria|0|||
44138947|NCT02479412|78927358|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44138948|NCT02479412|78927359|FG002|Overall Study|Study-specific withdrawal criteria|1|||
44138949|NCT02479412|78927360|FG003|Overall Study|Study-specific withdrawal criteria|1|||
44138950|NCT02479412|78927361|FG004|Overall Study|Study-specific withdrawal criteria|0|||
44138951|NCT02479412|78927362|FG005|Overall Study|Study-specific withdrawal criteria|0|||
44138952|NCT02479412|78927363|FG006|Overall Study|Study-specific withdrawal criteria|0|||
44138953|NCT02479412|78927364|FG007|Overall Study|Study-specific withdrawal criteria|1|||
44138954|NCT02479412|78927365|FG008|Overall Study|Study-specific withdrawal criteria|1|||
44138955|NCT02479412|78927357|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
44138956|NCT02479412|78927358|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
44138957|NCT02479412|78927359|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
44138958|NCT02479412|78927360|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
44138959|NCT02479412|78927361|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
44138960|NCT02479412|78927362|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
44138961|NCT02479412|78927363|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
44138962|NCT02479412|78927364|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
44138963|NCT02479412|78927365|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
44138964|NCT00224003|78927381|FG000|Overall Study|Adverse Event|1|||
44138965|NCT00224003|78927381|FG000|Overall Study|Protocol Violation|2|||
44138966|NCT00224003|78927381|FG000|Overall Study|Withdrawal by Subject|1|||
44138967|NCT00224003|78927381|FG000|Overall Study|unk|3|||
44138968|NCT02450552|78927387|FG000|Overall Study|Withdrawal by Subject|4|||
44138969|NCT02450552|78927388|FG001|Overall Study|Withdrawal by Subject|0|||
44138970|NCT02450552|78927389|FG002|Overall Study|Withdrawal by Subject|4|||
44138971|NCT02450552|78927387|FG000|Overall Study|Physician Decision|1|||
44138972|NCT02450552|78927388|FG001|Overall Study|Physician Decision|0|||
44138973|NCT02450552|78927389|FG002|Overall Study|Physician Decision|1|||
44138974|NCT02508428|78927399|FG000|Overall Study|Death|32|||
44138975|NCT02508428|78927400|FG001|Overall Study|Death|33|||
44138976|NCT02508428|78927399|FG000|Overall Study|Liner revised|3|||
44138977|NCT02508428|78927400|FG001|Overall Study|Liner revised|19|||
44138978|NCT02508428|78927399|FG000|Overall Study|Incomplete follow-up|17|||
44138979|NCT02508428|78927400|FG001|Overall Study|Incomplete follow-up|15|||
44138980|NCT02448680|78927408|FG000|Overall Study|Physician Decision|1|||
44138981|NCT02448680|78927409|FG001|Overall Study|Physician Decision|1|||
44138982|NCT02448680|78927408|FG000|Overall Study|Withdrawal by Subject|0|||
44138983|NCT02448680|78927409|FG001|Overall Study|Withdrawal by Subject|2|||
44138984|NCT02448446|78927419|FG000|Overall Study|Withdrawal by Subject|1|||
44138985|NCT02448446|78927420|FG001|Overall Study|Withdrawal by Subject|0|||
44138986|NCT02447744|78927428|FG000|Overall Study|Withdrawal by Subject|3|||
44138987|NCT02447744|78927429|FG001|Overall Study|Withdrawal by Subject|1|||
44138988|NCT02447744|78927428|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
44138989|NCT02447744|78927429|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
44138990|NCT02478632|78927437|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
44138991|NCT02478632|78927438|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
44138992|NCT02478632|78927437|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
44138993|NCT02478632|78927438|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
44138994|NCT02478632|78927437|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
44138995|NCT02478632|78927438|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
44138996|NCT02478398|78927449|FG000|Overall Study|Adverse Event|20|||
44138997|NCT02478398|78927450|FG001|Overall Study|Adverse Event|5|||
44138998|NCT02478398|78927449|FG000|Overall Study|Lost to Follow-up|5|||
44138999|NCT02478398|78927450|FG001|Overall Study|Lost to Follow-up|4|||
44139000|NCT02478398|78927449|FG000|Overall Study|Non-Compliance With Study Drug|5|||
44139001|NCT02478398|78927450|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44139002|NCT02478398|78927449|FG000|Overall Study|Protocol Violation|3|||
44139003|NCT02478398|78927450|FG001|Overall Study|Protocol Violation|1|||
44139004|NCT02478398|78927449|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
44139005|NCT02478398|78927450|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
44139006|NCT02478398|78927449|FG000|Overall Study|Withdrawal By Participant|10|||
44139007|NCT02478398|78927450|FG001|Overall Study|Withdrawal By Participant|4|||
44139008|NCT02478164|78927457|FG000|Overall Study|Lack of Efficacy|13|||
44139009|NCT02478164|78927457|FG000|Overall Study|Adverse Event|1|||
44139010|NCT02478164|78927457|FG000|Overall Study|Withdrawal by Subject|1|||
44139011|NCT02476994|78927463|FG000|Overall Study|Based on feedback from FDA|1|||
44139012|NCT02476994|78927464|FG001|Overall Study|Based on feedback from FDA|0|||
44139013|NCT02508194|78927472|FG000|Overall Study|Death|5|||
44139014|NCT02508194|78927473|FG001|Overall Study|Death|3|||
44139015|NCT02508194|78927472|FG000|Overall Study|Lost to Follow-up|25|||
44139016|NCT02508194|78927473|FG001|Overall Study|Lost to Follow-up|18|||
44139017|NCT02508194|78927472|FG000|Overall Study|Withdrawal by Subject|20|||
44139018|NCT02508194|78927473|FG001|Overall Study|Withdrawal by Subject|18|||
44139019|NCT02508194|78927472|FG000|Overall Study|Error in Randomization|1|||
44139020|NCT02508194|78927473|FG001|Overall Study|Error in Randomization|3|||
44139021|NCT02508194|78927472|FG000|Overall Study|Principal Investigator Decision|1|||
44139022|NCT02508194|78927473|FG001|Overall Study|Principal Investigator Decision|2|||
44139023|NCT02508116|78927481|FG000|Overall Study|Lost to Follow-up|2|||
44139024|NCT02508116|78927482|FG001|Overall Study|Lost to Follow-up|3|||
44139025|NCT02508116|78927481|FG000|Overall Study|Withdrawal by Subject|3|||
44139026|NCT02508116|78927482|FG001|Overall Study|Withdrawal by Subject|2|||
44139027|NCT02508116|78927481|FG000|Overall Study|Protocol Violation|1|||
44139028|NCT02508116|78927482|FG001|Overall Study|Protocol Violation|2|||
44380405|NCT00839332|79386245|FG002|Phase 2|Disease Progression|21|||
44513536|NCT03129100|79519009|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44139029|NCT02508116|78927481|FG000|Overall Study|Physician Decision|2|||
44139030|NCT02508116|78927482|FG001|Overall Study|Physician Decision|0|||
44139031|NCT01653782|78927491|FG000|Overall Study|Withdrawal by Subject|9|||
44139032|NCT01653782|78927492|FG001|Overall Study|Withdrawal by Subject|15|||
44139033|NCT01653782|78927493|FG002|Overall Study|Withdrawal by Subject|4|||
44139034|NCT01653782|78927491|FG000|Overall Study|Lost to Follow-up|7|||
44139035|NCT01653782|78927492|FG001|Overall Study|Lost to Follow-up|3|||
44139036|NCT01653782|78927493|FG002|Overall Study|Lost to Follow-up|2|||
44139037|NCT02318329|78927511|FG000|Overall Study|Progressive Disease|2|||
44139038|NCT02318329|78927512|FG001|Overall Study|Progressive Disease|3|||
44139039|NCT02318329|78927513|FG002|Overall Study|Progressive Disease|2|||
44139040|NCT02318329|78927514|FG003|Overall Study|Progressive Disease|3|||
44139041|NCT02318329|78927515|FG004|Overall Study|Progressive Disease|3|||
44139042|NCT02318329|78927516|FG005|Overall Study|Progressive Disease|3|||
44139043|NCT02318329|78927517|FG006|Overall Study|Progressive Disease|1|||
44513537|NCT03129100|79519010|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513538|NCT03129100|79519011|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513539|NCT03129100|79519012|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513540|NCT03129100|79519013|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513541|NCT03129100|79519014|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513542|NCT03129100|79519015|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
44513543|NCT03129100|79519016|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513544|NCT03129100|79519017|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513545|NCT03129100|79519018|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513546|NCT03129100|79519019|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513547|NCT03129100|79519020|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513548|NCT03129100|79519021|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513549|NCT03129100|79519022|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513550|NCT03129100|79519023|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513551|NCT03129100|79519024|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513552|NCT03129100|79519025|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
44513553|NCT03129100|79519000|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513554|NCT03129100|79519001|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513555|NCT03129100|79519002|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513556|NCT03129100|79519003|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513557|NCT03129100|79519004|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513558|NCT03129100|79519005|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44139044|NCT02318329|78927518|FG007|Overall Study|Progressive Disease|1|||
44139045|NCT02318329|78927519|FG008|Overall Study|Progressive Disease|5|||
44139046|NCT02318329|78927520|FG009|Overall Study|Progressive Disease|39|||
44139047|NCT02318329|78927511|FG000|Overall Study|Death|0|||
44139048|NCT02318329|78927512|FG001|Overall Study|Death|0|||
44139049|NCT02318329|78927513|FG002|Overall Study|Death|0|||
44139050|NCT02318329|78927514|FG003|Overall Study|Death|0|||
44139051|NCT02318329|78927515|FG004|Overall Study|Death|0|||
44139052|NCT02318329|78927516|FG005|Overall Study|Death|0|||
44139053|NCT02318329|78927517|FG006|Overall Study|Death|0|||
44139054|NCT02318329|78927518|FG007|Overall Study|Death|0|||
44139055|NCT02318329|78927519|FG008|Overall Study|Death|0|||
44139056|NCT02318329|78927520|FG009|Overall Study|Death|5|||
44139057|NCT02318329|78927511|FG000|Overall Study|Lost to Follow-up|0|||
44139058|NCT02318329|78927512|FG001|Overall Study|Lost to Follow-up|0|||
44139059|NCT02318329|78927513|FG002|Overall Study|Lost to Follow-up|0|||
44139060|NCT02318329|78927514|FG003|Overall Study|Lost to Follow-up|0|||
44139061|NCT02318329|78927515|FG004|Overall Study|Lost to Follow-up|0|||
44139062|NCT02318329|78927516|FG005|Overall Study|Lost to Follow-up|0|||
44139063|NCT02318329|78927517|FG006|Overall Study|Lost to Follow-up|0|||
44139064|NCT02318329|78927518|FG007|Overall Study|Lost to Follow-up|0|||
44139065|NCT02318329|78927519|FG008|Overall Study|Lost to Follow-up|0|||
44139066|NCT02318329|78927520|FG009|Overall Study|Lost to Follow-up|1|||
44139067|NCT02318329|78927511|FG000|Overall Study|Withdrawal by Subject|0|||
44139068|NCT02318329|78927512|FG001|Overall Study|Withdrawal by Subject|0|||
44139069|NCT02318329|78927513|FG002|Overall Study|Withdrawal by Subject|0|||
44139070|NCT02318329|78927514|FG003|Overall Study|Withdrawal by Subject|0|||
44139071|NCT02318329|78927515|FG004|Overall Study|Withdrawal by Subject|0|||
44139072|NCT02318329|78927516|FG005|Overall Study|Withdrawal by Subject|0|||
44139073|NCT02318329|78927517|FG006|Overall Study|Withdrawal by Subject|0|||
44139074|NCT02318329|78927518|FG007|Overall Study|Withdrawal by Subject|0|||
44139075|NCT02318329|78927519|FG008|Overall Study|Withdrawal by Subject|0|||
44139076|NCT02318329|78927520|FG009|Overall Study|Withdrawal by Subject|6|||
44139077|NCT02318329|78927511|FG000|Overall Study|Other|1|||
44139078|NCT02318329|78927512|FG001|Overall Study|Other|1|||
44139079|NCT02318329|78927513|FG002|Overall Study|Other|1|||
44139080|NCT02318329|78927514|FG003|Overall Study|Other|0|||
44139081|NCT02318329|78927515|FG004|Overall Study|Other|0|||
44139082|NCT02318329|78927516|FG005|Overall Study|Other|0|||
44139083|NCT02318329|78927517|FG006|Overall Study|Other|0|||
44139084|NCT02318329|78927518|FG007|Overall Study|Other|0|||
44139085|NCT02318329|78927519|FG008|Overall Study|Other|1|||
44139086|NCT02318329|78927520|FG009|Overall Study|Other|1|||
44139087|NCT02255656|78927561|FG000|Overall Study|Adverse Event|11|||
44139088|NCT02255656|78927561|FG000|Overall Study|Poor compliance to protocol|3|||
44139089|NCT02255656|78927561|FG000|Overall Study|Lost to Follow-up|30|||
44139090|NCT02255656|78927561|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
44139091|NCT02255656|78927561|FG000|Overall Study|Other|126|||
44139092|NCT02255500|78927574|FG000|Overall Study|Withdrawal by Subject|1|||
44139093|NCT02255500|78927575|FG001|Overall Study|Withdrawal by Subject|0|||
44139094|NCT02505542|78927581|FG000|Part A: Open-Label Period|Adverse Event|31|||
44139095|NCT02505542|78927582|FG001|Part A: Open-Label Period|Adverse Event|0|||
44139096|NCT02505542|78927583|FG002|Part A: Open-Label Period|Adverse Event|0|||
44139097|NCT02505542|78927584|FG003|Part A: Open-Label Period|Adverse Event|0|||
44139098|NCT02505542|78927581|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
44139099|NCT02505542|78927582|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
44139100|NCT02505542|78927583|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
44139101|NCT02505542|78927584|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
44139102|NCT02505542|78927581|FG000|Part A: Open-Label Period|Protocol Violation|1|||
44243912|NCT01456039|79073964|FG002|Phase 1 (First Step)|Disease Progression|0|||
44139103|NCT02505542|78927582|FG001|Part A: Open-Label Period|Protocol Violation|0|||
44139104|NCT02505542|78927583|FG002|Part A: Open-Label Period|Protocol Violation|0|||
44139105|NCT02505542|78927584|FG003|Part A: Open-Label Period|Protocol Violation|0|||
44139106|NCT02505542|78927581|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
44139107|NCT02505542|78927582|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
44139108|NCT02505542|78927583|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
44139109|NCT02505542|78927584|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
44139110|NCT02505542|78927581|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
44139111|NCT02505542|78927582|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
44139112|NCT02505542|78927583|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
44139113|NCT02505542|78927584|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
44139114|NCT02505542|78927581|FG000|Part A: Open-Label Period|New medical history available|1|||
44139115|NCT02505542|78927582|FG001|Part A: Open-Label Period|New medical history available|0|||
44139116|NCT02505542|78927583|FG002|Part A: Open-Label Period|New medical history available|0|||
44139117|NCT02505542|78927584|FG003|Part A: Open-Label Period|New medical history available|0|||
44139118|NCT02505542|78927581|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
44139119|NCT02505542|78927582|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
44139120|NCT02505542|78927583|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
44139121|NCT02505542|78927584|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
44139122|NCT02505542|78927581|FG000|Part A: Open-Label Period|Pregnancy|2|||
44139123|NCT02505542|78927582|FG001|Part A: Open-Label Period|Pregnancy|0|||
44139124|NCT02505542|78927583|FG002|Part A: Open-Label Period|Pregnancy|0|||
44139125|NCT02505542|78927584|FG003|Part A: Open-Label Period|Pregnancy|0|||
44139126|NCT02505542|78927581|FG000|Part A: Open-Label Period|Sponsor directive|1|||
44139127|NCT02505542|78927582|FG001|Part A: Open-Label Period|Sponsor directive|0|||
44139128|NCT02505542|78927583|FG002|Part A: Open-Label Period|Sponsor directive|0|||
44139129|NCT02505542|78927584|FG003|Part A: Open-Label Period|Sponsor directive|0|||
44139130|NCT02505542|78927581|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
44139131|NCT02505542|78927582|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
44139132|NCT02505542|78927583|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
44139133|NCT02505542|78927584|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
44139134|NCT02505542|78927581|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
44139135|NCT02505542|78927582|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
44139136|NCT02505542|78927583|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
44139137|NCT02505542|78927584|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
44139138|NCT02505542|78927581|FG000|Part A: Open-Label Period|Non-compliance|1|||
44139139|NCT02505542|78927582|FG001|Part A: Open-Label Period|Non-compliance|0|||
44139140|NCT02505542|78927583|FG002|Part A: Open-Label Period|Non-compliance|0|||
44139141|NCT02505542|78927584|FG003|Part A: Open-Label Period|Non-compliance|0|||
44139142|NCT02505542|78927581|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
44139143|NCT02505542|78927582|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
44139144|NCT02505542|78927583|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
44139145|NCT02505542|78927584|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
44139146|NCT02505542|78927581|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
44139147|NCT02505542|78927582|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
44139148|NCT02505542|78927583|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
44139149|NCT02505542|78927584|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
44139150|NCT02505542|78927581|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
44139151|NCT02505542|78927582|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
44139152|NCT02505542|78927583|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
44139153|NCT02505542|78927584|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
44139154|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Adverse Event|0|||
44139155|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Adverse Event|0|||
44139156|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Adverse Event|1|||
44139157|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Adverse Event|3|||
44139158|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
44139159|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
44139160|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
44139161|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
44139162|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
44139163|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
44139164|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
44139165|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
44139166|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
44513559|NCT03129100|79519006|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513560|NCT03129100|79519007|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513561|NCT03129100|79519008|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513562|NCT03129100|79519009|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513563|NCT03129100|79519010|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513564|NCT03129100|79519011|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513565|NCT03129100|79519012|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
44513566|NCT03129100|79519013|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513567|NCT03129100|79519014|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
44513568|NCT03129100|79519015|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
44513569|NCT03129100|79519016|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44139167|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
44139168|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
44139169|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
44139170|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
44139171|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
44139172|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
44139173|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
44139174|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
44139175|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
44139176|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
44139177|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
44139178|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
44139179|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
44139180|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
44139181|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
44139182|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Miscalculation|0|||
44139183|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Miscalculation|1|||
44139184|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Miscalculation|0|||
44139185|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Miscalculation|0|||
44139186|NCT02505542|78927581|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
44139187|NCT02505542|78927582|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
44139188|NCT02505542|78927583|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
44139189|NCT02505542|78927584|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
44139190|NCT02475980|78927633|FG000|Overall Study|Lost to Follow-up|4|||
44139191|NCT02475980|78927633|FG000|Overall Study|Withdrawal by Subject|1|||
44139192|NCT02447432|78927639|FG000|Epoch 001|Adverse Event|1|||
44139193|NCT02447432|78927640|FG001|Epoch 001|Adverse Event|1|||
44139194|NCT02447432|78927639|FG000|Epoch 001|Withdrawal by Subject|0|||
44139195|NCT02447432|78927640|FG001|Epoch 001|Withdrawal by Subject|4|||
44139196|NCT02447432|78927639|FG000|Epoch 001|Migrated/moved from study area|3|||
44139197|NCT02447432|78927640|FG001|Epoch 001|Migrated/moved from study area|5|||
44139198|NCT02447432|78927639|FG000|Epoch 001|Lost to Follow-up|1|||
44139199|NCT02447432|78927640|FG001|Epoch 001|Lost to Follow-up|3|||
44139200|NCT02446886|78927648|FG000|Overall Study|Adverse Event|1|||
44139201|NCT02446886|78927649|FG001|Overall Study|Adverse Event|3|||
44139202|NCT02446886|78927648|FG000|Overall Study|Withdrawal by Subject|1|||
44139203|NCT02446886|78927649|FG001|Overall Study|Withdrawal by Subject|1|||
44139204|NCT03448939|78927667|FG000|Overall Study|Adverse Event|5|||
44139205|NCT03448939|78927668|FG001|Overall Study|Adverse Event|1|||
44139206|NCT03448939|78927667|FG000|Overall Study|Lost to Follow-up|6|||
44139207|NCT03448939|78927668|FG001|Overall Study|Lost to Follow-up|6|||
44139208|NCT03448939|78927667|FG000|Overall Study|Pregnancy|1|||
44139209|NCT03448939|78927668|FG001|Overall Study|Pregnancy|1|||
44139210|NCT03448939|78927667|FG000|Overall Study|Withdrawal by Subject|9|||
44139211|NCT03448939|78927668|FG001|Overall Study|Withdrawal by Subject|3|||
44139212|NCT02504294|78927686|FG000|Overall Study|Adverse Event|15|||
44139213|NCT02504294|78927687|FG001|Overall Study|Adverse Event|12|||
44139214|NCT02504294|78927686|FG000|Overall Study|Withdrawal by Subject|7|||
44139215|NCT02504294|78927687|FG001|Overall Study|Withdrawal by Subject|1|||
44139216|NCT02504294|78927686|FG000|Overall Study|Protocol Violation|27|||
44139217|NCT02504294|78927687|FG001|Overall Study|Protocol Violation|26|||
44139218|NCT02504294|78927686|FG000|Overall Study|Physician Decision|1|||
44139219|NCT02504294|78927687|FG001|Overall Study|Physician Decision|2|||
44139220|NCT02504294|78927686|FG000|Overall Study|Lost to Follow-up|6|||
44139221|NCT02504294|78927687|FG001|Overall Study|Lost to Follow-up|7|||
44139222|NCT02446418|78927695|FG000|Overall Study|Adverse Event|4|||
44139223|NCT02446418|78927696|FG001|Overall Study|Adverse Event|8|||
44139224|NCT02446418|78927695|FG000|Overall Study|Physician Decision|5|||
44139225|NCT02446418|78927696|FG001|Overall Study|Physician Decision|1|||
44139226|NCT02446418|78927695|FG000|Overall Study|Withdrawal by Subject|3|||
44139227|NCT02446418|78927696|FG001|Overall Study|Withdrawal by Subject|3|||
44139228|NCT02446418|78927695|FG000|Overall Study|Lost to Follow-up|2|||
44139229|NCT02446418|78927696|FG001|Overall Study|Lost to Follow-up|2|||
44139230|NCT02446418|78927695|FG000|Overall Study|Protocol Violation|1|||
44139231|NCT02446418|78927696|FG001|Overall Study|Protocol Violation|2|||
44139232|NCT02446418|78927695|FG000|Overall Study|Lack of Efficacy|2|||
44139233|NCT02446418|78927696|FG001|Overall Study|Lack of Efficacy|0|||
44139234|NCT02446418|78927695|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
44139235|NCT02446418|78927696|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
44139236|NCT02445794|78927706|FG000|Overall Study|Adverse Event|0|||
44139237|NCT02445794|78927707|FG001|Overall Study|Adverse Event|0|||
44139238|NCT02445794|78927708|FG002|Overall Study|Adverse Event|2|||
44139239|NCT02445794|78927709|FG003|Overall Study|Adverse Event|0|||
44139240|NCT02475278|78927724|FG000|Overall Study|Lost to Follow-up|1|||
44139241|NCT02475278|78927724|FG000|Overall Study|Reason Not Specified|1|||
44139242|NCT02254486|78927730|FG000|Overall Study|Adverse Event|1|||
44139243|NCT02254486|78927731|FG001|Overall Study|Adverse Event|1|||
44139244|NCT02254486|78927730|FG000|Overall Study|Lack of Efficacy|1|||
44139245|NCT02254486|78927731|FG001|Overall Study|Lack of Efficacy|0|||
44139246|NCT02254486|78927730|FG000|Overall Study|Lost to Follow-up|2|||
44243913|NCT01456039|79073962|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
44380406|NCT00839332|79386243|FG000|Phase 2|Adverse Event|0|||
44139247|NCT02254486|78927731|FG001|Overall Study|Lost to Follow-up|4|||
44139248|NCT02254486|78927730|FG000|Overall Study|Protocol Violation|1|||
44139249|NCT02254486|78927731|FG001|Overall Study|Protocol Violation|2|||
44139250|NCT02254486|78927730|FG000|Overall Study|Withdrawal by Subject|17|||
44139251|NCT02254486|78927731|FG001|Overall Study|Withdrawal by Subject|15|||
44139252|NCT02254486|78927730|FG000|Overall Study|GFR<60mL/min|16|||
44139253|NCT02254486|78927731|FG001|Overall Study|GFR<60mL/min|21|||
44139254|NCT02254486|78927730|FG000|Overall Study|Various|12|||
44139255|NCT02254486|78927731|FG001|Overall Study|Various|12|||
44139256|NCT01641640|78927737|FG000|Overall Study|Enrolled but not treated|1|||
44139257|NCT01641640|78927737|FG000|Overall Study|Efficacy failure|29|||
44139258|NCT01641640|78927737|FG000|Overall Study|Lost to Follow-up|3|||
44139259|NCT01641640|78927737|FG000|Overall Study|Withdrawal by Subject|2|||
44139260|NCT01641640|78927737|FG000|Overall Study|Adverse Event|1|||
44139261|NCT01639144|78927743|FG000|Overall Study|Withdrawal by Subject|4|||
44139262|NCT01639144|78927744|FG001|Overall Study|Withdrawal by Subject|2|||
44139263|NCT01639144|78927743|FG000|Overall Study|Physician Decision|2|||
44139264|NCT01639144|78927744|FG001|Overall Study|Physician Decision|0|||
44139265|NCT01639144|78927743|FG000|Overall Study|Met postoperative exclusion criteria|4|||
44139266|NCT01639144|78927744|FG001|Overall Study|Met postoperative exclusion criteria|3|||
44139267|NCT01601626|78927753|FG000|Overall Study|Death|1|||
44139268|NCT01601626|78927754|FG001|Overall Study|Death|1|||
44139269|NCT01601626|78927755|FG002|Overall Study|Death|1|||
44139270|NCT01601626|78927753|FG000|Overall Study|Lost to Follow-up|1|||
44139271|NCT01601626|78927754|FG001|Overall Study|Lost to Follow-up|2|||
44139272|NCT01601626|78927755|FG002|Overall Study|Lost to Follow-up|0|||
44139273|NCT01601626|78927753|FG000|Overall Study|Unable to Get to Clinic|0|||
44139274|NCT01601626|78927754|FG001|Overall Study|Unable to Get to Clinic|1|||
44139275|NCT01601626|78927755|FG002|Overall Study|Unable to Get to Clinic|0|||
44139276|NCT01601626|78927753|FG000|Overall Study|Withdrawal by Subject|0|||
44139277|NCT01601626|78927754|FG001|Overall Study|Withdrawal by Subject|1|||
44139278|NCT01601626|78927755|FG002|Overall Study|Withdrawal by Subject|1|||
44139279|NCT01601626|78927753|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
44139280|NCT01601626|78927754|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
44139281|NCT01601626|78927755|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
44139282|NCT02737501|78927765|FG000|Randomized Phase|Died|41|||
44139283|NCT02737501|78927766|FG001|Randomized Phase|Died|29|||
44139284|NCT02737501|78927767|FG002|Randomized Phase|Died|0|||
44139285|NCT02737501|78927765|FG000|Randomized Phase|Withdrawal by Subject|16|||
44139286|NCT02737501|78927766|FG001|Randomized Phase|Withdrawal by Subject|6|||
44139287|NCT02737501|78927767|FG002|Randomized Phase|Withdrawal by Subject|0|||
44139288|NCT02737501|78927765|FG000|Randomized Phase|Lost to Follow-up|0|||
44139289|NCT02737501|78927766|FG001|Randomized Phase|Lost to Follow-up|1|||
44139290|NCT02737501|78927767|FG002|Randomized Phase|Lost to Follow-up|0|||
44139291|NCT02737501|78927765|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
44139292|NCT02737501|78927766|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
44139293|NCT02737501|78927767|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
44139294|NCT02737501|78927765|FG000|Randomized Phase|Reason not Specified|1|||
44139295|NCT02737501|78927766|FG001|Randomized Phase|Reason not Specified|1|||
44139296|NCT02737501|78927767|FG002|Randomized Phase|Reason not Specified|0|||
44139297|NCT02737501|78927765|FG000|Randomized Phase|Never Treated|1|||
44139298|NCT02737501|78927766|FG001|Randomized Phase|Never Treated|1|||
44139299|NCT02737501|78927767|FG002|Randomized Phase|Never Treated|0|||
44139300|NCT02737501|78927765|FG000|Crossover Phase|Died|0|||
44139301|NCT02737501|78927766|FG001|Crossover Phase|Died|0|||
44139302|NCT02737501|78927767|FG002|Crossover Phase|Died|22|||
44139303|NCT02737501|78927765|FG000|Crossover Phase|Withdrew Consent|0|||
44139304|NCT02737501|78927766|FG001|Crossover Phase|Withdrew Consent|0|||
44139305|NCT02737501|78927767|FG002|Crossover Phase|Withdrew Consent|9|||
44139306|NCT02737501|78927765|FG000|Crossover Phase|Physician Decision|0|||
44139307|NCT02737501|78927766|FG001|Crossover Phase|Physician Decision|0|||
44380407|NCT00839332|79386244|FG001|Phase 2|Adverse Event|8|||
44380408|NCT00839332|79386245|FG002|Phase 2|Adverse Event|6|||
44380409|NCT00839332|79386243|FG000|Phase 2|Death|0|||
44139308|NCT02737501|78927767|FG002|Crossover Phase|Physician Decision|1|||
44139309|NCT02737501|78927765|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
44139310|NCT02737501|78927766|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
44139311|NCT02737501|78927767|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
44139312|NCT01640314|78927777|FG000|Overall Study|Protocol Violation|0|||
44139313|NCT01640314|78927778|FG001|Overall Study|Protocol Violation|1|||
44139314|NCT02740049|78927860|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
44139315|NCT01601704|78927866|FG000|Overall Study|Randomized but not dispensed study med|1|||
44139316|NCT01601704|78927867|FG001|Overall Study|Randomized but not dispensed study med|4|||
44139317|NCT01601470|78927873|FG000|Period 2 - LCZ696|Physician Decision|1|||
44380410|NCT00839332|79386244|FG001|Phase 2|Death|4|||
44380411|NCT00839332|79386245|FG002|Phase 2|Death|2|||
44380412|NCT00839332|79386243|FG000|Phase 2|Withdrawal by Subject|0|||
44139318|NCT03248375|78927897|FG000|Overall Study|Lost to Follow-up|5|||
44139319|NCT01637272|78927901|FG000|Overall Study|Adverse Event|6|||
44380413|NCT00839332|79386244|FG001|Phase 2|Withdrawal by Subject|5|||
44380414|NCT00839332|79386245|FG002|Phase 2|Withdrawal by Subject|8|||
44380415|NCT00839332|79386243|FG000|Phase 2|Physician Decision|0|||
44139320|NCT01637272|78927901|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44380416|NCT00839332|79386244|FG001|Phase 2|Physician Decision|4|||
44380417|NCT00839332|79386245|FG002|Phase 2|Physician Decision|1|||
44380418|NCT00839332|79386243|FG000|Phase 2|Lost to Follow-up|0|||
44139321|NCT01637272|78927901|FG000|Overall Study|Withdrawal by Subject|3|||
44139322|NCT01637272|78927901|FG000|Overall Study|Lost to Follow-up|2|||
44139323|NCT01637272|78927901|FG000|Overall Study|completed core, did not enter ext. phase|4|||
44139324|NCT01637272|78927901|FG000|Overall Study|Administrative problems|1|||
44139325|NCT01637272|78927901|FG000|Overall Study|Protocol Violation|2|||
44139326|NCT01636960|78927920|FG000|Induction Phase|Adverse Event|2|||
44139327|NCT01636960|78927920|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
44139328|NCT01636960|78927920|FG000|Maintenance Phase|Adverse Event|3|||
44139329|NCT01636960|78927920|FG000|Maintenance Phase|Progressive disease|1|||
44139330|NCT01636258|78927926|FG000|Overall Study|Lost to Follow-up|1|||
44139331|NCT01636258|78927927|FG001|Overall Study|Lost to Follow-up|0|||
44139332|NCT02504216|78927936|FG000|Overall Study|Lost to Follow-up|3|||
44139333|NCT02504216|78927937|FG001|Overall Study|Lost to Follow-up|3|||
44139334|NCT02504216|78927936|FG000|Overall Study|Withdrawal by Subject|8|||
44139335|NCT02504216|78927937|FG001|Overall Study|Withdrawal by Subject|12|||
44139336|NCT04354870|78927945|FG000|Overall Study|Lost to Follow-up|32|||
44139337|NCT04354870|78927946|FG001|Overall Study|Lost to Follow-up|12|||
44139338|NCT04354870|78927945|FG000|Overall Study|Withdrawal by Subject|10|||
44139339|NCT04354870|78927946|FG001|Overall Study|Withdrawal by Subject|16|||
44139340|NCT04354870|78927945|FG000|Overall Study|Did not complete all study visits|6|||
44139341|NCT04354870|78927946|FG001|Overall Study|Did not complete all study visits|5|||
44139342|NCT02473952|78927954|FG000|Overall Study|Adverse Event|2|||
44139343|NCT02473952|78927955|FG001|Overall Study|Adverse Event|2|||
44139344|NCT02473952|78927954|FG000|Overall Study|Withdrawal by Subject|0|||
44139345|NCT02473952|78927955|FG001|Overall Study|Withdrawal by Subject|6|||
44139346|NCT02473640|78927961|FG000|Treatment Period 1|Adverse Event|1|||
44139347|NCT01637584|78927970|FG000|Overall Study|Withdrawal by Subject|1|||
44139348|NCT01637584|78927971|FG001|Overall Study|Withdrawal by Subject|3|||
44139349|NCT03883906|78927978|FG000|Overall Study|Withdrawal by Subject|2|||
44139350|NCT03883906|78927978|FG000|Overall Study|Physician Decision|5|||
44139351|NCT02503202|78927987|FG000|Base Study: Up to Month 6|Death|1|||
44139352|NCT02503202|78927988|FG001|Base Study: Up to Month 6|Death|1|||
44139353|NCT02503202|78927989|FG002|Base Study: Up to Month 6|Death|0|||
44139354|NCT02503202|78927990|FG003|Base Study: Up to Month 6|Death|0|||
44139355|NCT02503202|78927991|FG004|Base Study: Up to Month 6|Death|0|||
44139356|NCT02503202|78927987|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
44139357|NCT02503202|78927988|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
44139358|NCT02503202|78927989|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
44139359|NCT02503202|78927990|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
44139360|NCT02503202|78927991|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
44139361|NCT02503202|78927987|FG000|Base Study: Up to Month 6|Physician Decision|0|||
44139362|NCT02503202|78927988|FG001|Base Study: Up to Month 6|Physician Decision|0|||
44139363|NCT02503202|78927989|FG002|Base Study: Up to Month 6|Physician Decision|0|||
44139364|NCT02503202|78927990|FG003|Base Study: Up to Month 6|Physician Decision|0|||
44139365|NCT02503202|78927991|FG004|Base Study: Up to Month 6|Physician Decision|1|||
44139366|NCT02503202|78927987|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
44139367|NCT02503202|78927988|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
44139368|NCT02503202|78927989|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
44139369|NCT02503202|78927990|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
44139370|NCT02503202|78927991|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
44139371|NCT02503202|78927987|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
44139372|NCT02503202|78927988|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
44139373|NCT02503202|78927989|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
44139374|NCT02503202|78927990|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
44139375|NCT02503202|78927991|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
44139376|NCT02503202|78927987|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
44139377|NCT02503202|78927988|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
44139378|NCT02503202|78927989|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
44139379|NCT02503202|78927990|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
44139380|NCT02503202|78927991|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
44139381|NCT02503202|78927987|FG000|Extension: Month 6 to 24|Death|1|||
44139382|NCT02503202|78927988|FG001|Extension: Month 6 to 24|Death|0|||
44139383|NCT02503202|78927989|FG002|Extension: Month 6 to 24|Death|0|||
44139384|NCT02503202|78927990|FG003|Extension: Month 6 to 24|Death|0|||
44243914|NCT01456039|79073963|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
44139385|NCT02503202|78927991|FG004|Extension: Month 6 to 24|Death|0|||
44139386|NCT02503202|78927987|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
44139387|NCT02503202|78927988|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
44139388|NCT02503202|78927989|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
44139389|NCT02503202|78927990|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
44139390|NCT02503202|78927991|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
44139391|NCT02503202|78927987|FG000|Extension: Month 6 to 24|Physician Decision|1|||
44243915|NCT01456039|79073964|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
44243916|NCT01456039|79073962|FG000|Phase 1 (First Step)|Adverse Event|0|||
44139392|NCT02503202|78927988|FG001|Extension: Month 6 to 24|Physician Decision|0|||
44139393|NCT02503202|78927989|FG002|Extension: Month 6 to 24|Physician Decision|1|||
44139394|NCT02503202|78927990|FG003|Extension: Month 6 to 24|Physician Decision|3|||
44139395|NCT02503202|78927991|FG004|Extension: Month 6 to 24|Physician Decision|0|||
44139396|NCT02503202|78927987|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
44139397|NCT02503202|78927988|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
44139398|NCT02503202|78927989|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
44139399|NCT02503202|78927990|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
44139400|NCT02503202|78927991|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
44139401|NCT02502734|78928003|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
44139402|NCT02502734|78928004|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
44139403|NCT02502734|78928003|FG000|Washout Period|Adverse Event|1|||
44139404|NCT02502734|78928004|FG001|Washout Period|Adverse Event|0|||
44139405|NCT02473250|78928012|FG000|Overall Study|Lost to Follow-up|10|||
44139406|NCT02473250|78928012|FG000|Overall Study|Physician Decision|5|||
44139407|NCT02473250|78928012|FG000|Overall Study|Did not tolerate medication washout|3|||
44513570|NCT03129100|79519017|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513571|NCT03129100|79519018|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513572|NCT03129100|79519019|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513573|NCT03129100|79519020|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513574|NCT03129100|79519021|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44139408|NCT02473250|78928012|FG000|Overall Study|Antidepressant effect of divalproex|2|||
44139409|NCT02706730|78928017|FG000|Overall Study|Adverse Event|3|||
44513575|NCT03129100|79519022|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513576|NCT03129100|79519023|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513577|NCT03129100|79519024|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513578|NCT03129100|79519025|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
44513579|NCT03129100|79519000|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513580|NCT03129100|79519001|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513581|NCT03129100|79519002|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513582|NCT03129100|79519003|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513583|NCT03129100|79519004|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513584|NCT03129100|79519005|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513585|NCT03129100|79519006|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513586|NCT03129100|79519007|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513587|NCT03129100|79519008|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513588|NCT03129100|79519009|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513589|NCT03129100|79519010|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513590|NCT03129100|79519011|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513591|NCT03129100|79519012|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513592|NCT03129100|79519013|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513593|NCT03129100|79519014|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513594|NCT03129100|79519015|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513595|NCT03129100|79519016|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513596|NCT03129100|79519017|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
44513597|NCT03129100|79519018|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513598|NCT03129100|79519019|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
44513599|NCT03129100|79519020|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513600|NCT03129100|79519021|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513601|NCT03129100|79519022|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44139410|NCT02706730|78928017|FG000|Overall Study|Lack of Efficacy|5|||
44139411|NCT02706730|78928017|FG000|Overall Study|Withdrawal by Subject|11|||
44139412|NCT02706730|78928017|FG000|Overall Study|Study Terminated by Sponsor|11|||
44139413|NCT02706730|78928017|FG000|Overall Study|Subject chose not to receive injection|3|||
44139414|NCT02443688|78928024|FG000|Overall Study|Adverse Event|2|||
44139415|NCT02443688|78928025|FG001|Overall Study|Adverse Event|3|||
44139416|NCT02443688|78928026|FG002|Overall Study|Adverse Event|2|||
44139417|NCT02443688|78928024|FG000|Overall Study|Lost to Follow-up|1|||
44139418|NCT02443688|78928025|FG001|Overall Study|Lost to Follow-up|0|||
44139419|NCT02443688|78928026|FG002|Overall Study|Lost to Follow-up|0|||
44139420|NCT02443688|78928024|FG000|Overall Study|Physician Decision|3|||
44139421|NCT02443688|78928025|FG001|Overall Study|Physician Decision|0|||
44139422|NCT02443688|78928026|FG002|Overall Study|Physician Decision|1|||
44139423|NCT02443688|78928024|FG000|Overall Study|Pregnancy|0|||
44139424|NCT02443688|78928025|FG001|Overall Study|Pregnancy|0|||
44139425|NCT02443688|78928026|FG002|Overall Study|Pregnancy|1|||
44139426|NCT02443688|78928024|FG000|Overall Study|Withdrawal by Subject|3|||
44139427|NCT02443688|78928025|FG001|Overall Study|Withdrawal by Subject|3|||
44139428|NCT02443688|78928026|FG002|Overall Study|Withdrawal by Subject|4|||
44139429|NCT02443688|78928024|FG000|Overall Study|Non-compliance with study drug|1|||
44139430|NCT02443688|78928025|FG001|Overall Study|Non-compliance with study drug|2|||
44139431|NCT02443688|78928026|FG002|Overall Study|Non-compliance with study drug|4|||
44139432|NCT02443688|78928024|FG000|Overall Study|Sponsor Request|2|||
44139433|NCT02443688|78928025|FG001|Overall Study|Sponsor Request|1|||
44139434|NCT02443688|78928026|FG002|Overall Study|Sponsor Request|0|||
44139435|NCT02443298|78928040|FG000|Overall Study|Adverse Event|3|||
44139436|NCT02443298|78928041|FG001|Overall Study|Adverse Event|3|||
44139437|NCT02443298|78928040|FG000|Overall Study|Withdrawal by Subject|1|||
44139438|NCT02443298|78928041|FG001|Overall Study|Withdrawal by Subject|2|||
44139439|NCT02500706|78928050|FG000|Overall Study|Adverse Event|0|||
44139440|NCT02500706|78928051|FG001|Overall Study|Adverse Event|0|||
44139441|NCT02500706|78928052|FG002|Overall Study|Adverse Event|1|||
44139442|NCT02500706|78928050|FG000|Overall Study|Lost to Follow-up|0|||
44139443|NCT02500706|78928051|FG001|Overall Study|Lost to Follow-up|1|||
44139444|NCT02500706|78928052|FG002|Overall Study|Lost to Follow-up|1|||
44139445|NCT02500706|78928050|FG000|Overall Study|Withdrawal by Subject|4|||
44139446|NCT02500706|78928051|FG001|Overall Study|Withdrawal by Subject|6|||
44139447|NCT02500706|78928052|FG002|Overall Study|Withdrawal by Subject|4|||
44139448|NCT02500706|78928050|FG000|Overall Study|Unclassified|0|||
44139449|NCT02500706|78928051|FG001|Overall Study|Unclassified|0|||
44139450|NCT02500706|78928052|FG002|Overall Study|Unclassified|1|||
44139451|NCT02442830|78928062|FG000|Overall Study|Technical Failure|0|||
44139452|NCT02442830|78928063|FG001|Overall Study|Technical Failure|1|||
44139453|NCT02471612|78928070|FG000|Overall Study|Lost to Follow-up|2|||
44139454|NCT02500550|78928087|FG000|Overall Study|Death|7|||
44139455|NCT02499770|78928093|FG000|Overall Study|Death|17|||
44139456|NCT02499770|78928094|FG001|Overall Study|Death|56|||
44139457|NCT02499770|78928093|FG000|Overall Study|Study completion|1|||
44139458|NCT02499770|78928094|FG001|Overall Study|Study completion|10|||
44139459|NCT02499770|78928093|FG000|Overall Study|Withdrawal by Subject|0|||
44139460|NCT02499770|78928094|FG001|Overall Study|Withdrawal by Subject|7|||
44139461|NCT02499770|78928093|FG000|Overall Study|Lost to Follow-up|0|||
44139462|NCT02499770|78928094|FG001|Overall Study|Lost to Follow-up|2|||
44139463|NCT02499770|78928093|FG000|Overall Study|Subject declined further treatment|1|||
44139464|NCT02499770|78928094|FG001|Overall Study|Subject declined further treatment|0|||
44139465|NCT02499770|78928093|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
44139466|NCT02499770|78928094|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
44139467|NCT02499770|78928093|FG000|Overall Study|Randomized but not enrolled|0|||
44139468|NCT02499770|78928094|FG001|Overall Study|Randomized but not enrolled|1|||
44139469|NCT02442284|78928106|FG000|Overall Study|Adverse Event|1|||
44139470|NCT02442284|78928106|FG000|Overall Study|Withdrew Consent|2|||
44139471|NCT02442284|78928106|FG000|Overall Study|Lost to Follow-up|3|||
44139472|NCT02442284|78928106|FG000|Overall Study|Other|1|||
44139473|NCT02442206|78928116|FG000|Period 1|Adverse Event|1|||
44380419|NCT00839332|79386244|FG001|Phase 2|Lost to Follow-up|0|||
44380420|NCT00839332|79386245|FG002|Phase 2|Lost to Follow-up|1|||
44139474|NCT02442206|78928117|FG001|Period 1|Adverse Event|1|||
44139475|NCT02442206|78928116|FG000|Period 1|withdrew consent|0|||
44139476|NCT02442206|78928117|FG001|Period 1|withdrew consent|1|||
44139477|NCT02442206|78928116|FG000|Period 1|COPD exacerbation|0|||
44139478|NCT02442206|78928117|FG001|Period 1|COPD exacerbation|1|||
44139479|NCT02442206|78928116|FG000|Period 2|Adverse Event|1|||
44139480|NCT02442206|78928117|FG001|Period 2|Adverse Event|0|||
44139481|NCT02499146|78928124|FG000|Overall Study|Lost to Follow-up|1|||
44139482|NCT02499146|78928124|FG000|Overall Study|Withdrawal by Subject|1|||
44139483|NCT02499146|78928124|FG000|Overall Study|Other|2|||
44276606|NCT04791319|79237611|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
44139484|NCT02499146|78928124|FG000|Overall Study|Ongoing at date of cut-off|9|||
44139485|NCT02499146|78928124|FG000|Overall Study|Began other treatment/therapy|13|||
44139486|NCT03544138|78928128|FG000|Overall Study|Lost to Follow-up|29|||
44139487|NCT01634854|78928134|FG000|Overall Study|Cesarean delivery|2|||
44139488|NCT01634854|78928135|FG001|Overall Study|Cesarean delivery|7|||
44380421|NCT00902850|79386256|FG000|Overall Study|Physician Decision|2|||
44139489|NCT02469896|78928143|FG000|Overall Study|Withdrawal by Subject|2|||
44139490|NCT02469896|78928144|FG001|Overall Study|Withdrawal by Subject|0|||
44139491|NCT02441114|78928154|FG000|Washout2|Withdrawal by Subject|4|||
44139492|NCT02498678|78928160|FG000|Overall Study|interference from the surgical team|0|||
44139493|NCT02498678|78928161|FG001|Overall Study|interference from the surgical team|2|||
44139494|NCT02441036|78928172|FG000|Overall Study|No tissue resected|0|||
44139495|NCT02441036|78928173|FG001|Overall Study|No tissue resected|1|||
44139496|NCT02441036|78928174|FG002|Overall Study|No tissue resected|0|||
44139497|NCT02441036|78928175|FG003|Overall Study|No tissue resected|1|||
44139498|NCT02441036|78928176|FG004|Overall Study|No tissue resected|0|||
44139499|NCT02498444|78928191|FG000|Overall Study|Withdrawal by Subject|3|||
44139500|NCT02498444|78928192|FG001|Overall Study|Withdrawal by Subject|0|||
44139501|NCT02498444|78928191|FG000|Overall Study|Physician Decision|1|||
44139502|NCT02498444|78928192|FG001|Overall Study|Physician Decision|0|||
44139503|NCT02497976|78928200|FG000|Overall Study|Withdrawal by Subject|2|||
44139504|NCT02497976|78928201|FG001|Overall Study|Withdrawal by Subject|0|||
44139505|NCT02497976|78928200|FG000|Overall Study|Moved out of area|0|||
44139506|NCT02497976|78928201|FG001|Overall Study|Moved out of area|1|||
44139507|NCT03347188|78928209|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
44139508|NCT03347188|78928210|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
44139509|NCT03347188|78928209|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
44139510|NCT03347188|78928210|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
44139511|NCT03347188|78928209|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
44139512|NCT03347188|78928210|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
44139513|NCT03347188|78928209|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
44139514|NCT03347188|78928210|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
44139515|NCT03347188|78928209|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
44139516|NCT03347188|78928210|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
44139517|NCT03347188|78928209|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
44139518|NCT03347188|78928210|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
44139519|NCT03347188|78928209|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
44139520|NCT03347188|78928210|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
44139521|NCT03347188|78928209|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
44139522|NCT03347188|78928210|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
44139523|NCT02440568|78928220|FG000|Overall Study|Death|1|||
44139524|NCT02440568|78928221|FG001|Overall Study|Death|3|||
44139525|NCT02440568|78928222|FG002|Overall Study|Death|4|||
44139526|NCT02440568|78928223|FG003|Overall Study|Death|2|||
44139527|NCT02440568|78928220|FG000|Overall Study|Lack of Efficacy|2|||
44139528|NCT02440568|78928221|FG001|Overall Study|Lack of Efficacy|0|||
44139529|NCT02440568|78928222|FG002|Overall Study|Lack of Efficacy|1|||
44139530|NCT02440568|78928223|FG003|Overall Study|Lack of Efficacy|0|||
44139531|NCT02440568|78928220|FG000|Overall Study|Lost to Follow-up|1|||
44139532|NCT02440568|78928221|FG001|Overall Study|Lost to Follow-up|0|||
44139533|NCT02440568|78928222|FG002|Overall Study|Lost to Follow-up|0|||
44139534|NCT02440568|78928223|FG003|Overall Study|Lost to Follow-up|0|||
44139535|NCT03090191|78928236|FG000|Overall Study|Adverse Event|90|||
44139536|NCT03090191|78928237|FG001|Overall Study|Adverse Event|72|||
44139537|NCT03090191|78928236|FG000|Overall Study|Death|365|||
44139538|NCT03090191|78928237|FG001|Overall Study|Death|358|||
44139539|NCT03090191|78928236|FG000|Overall Study|Lost to Follow-up|382|||
44139540|NCT03090191|78928237|FG001|Overall Study|Lost to Follow-up|394|||
44139541|NCT03090191|78928236|FG000|Overall Study|Physician Decision|77|||
44139542|NCT03090191|78928237|FG001|Overall Study|Physician Decision|66|||
44139543|NCT03090191|78928236|FG000|Overall Study|Protocol Violation|43|||
44139544|NCT03090191|78928237|FG001|Overall Study|Protocol Violation|52|||
44139545|NCT03090191|78928236|FG000|Overall Study|Withdrawal by Subject|2160|||
44139546|NCT03090191|78928237|FG001|Overall Study|Withdrawal by Subject|2133|||
44139547|NCT03090191|78928236|FG000|Overall Study|Site terminated|7|||
44139548|NCT03090191|78928237|FG001|Overall Study|Site terminated|8|||
44380422|NCT00902850|79386257|FG001|Overall Study|Physician Decision|2|||
44513602|NCT03129100|79519023|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513603|NCT03129100|79519024|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513604|NCT03129100|79519025|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
44513605|NCT03129100|79519000|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513606|NCT03129100|79519001|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139549|NCT03090191|78928236|FG000|Overall Study|Other|66|||
44139550|NCT03090191|78928237|FG001|Overall Study|Other|60|||
44139551|NCT03090191|78928236|FG000|Overall Study|Withdrawn before any study vaccination|43|||
44139552|NCT03090191|78928237|FG001|Overall Study|Withdrawn before any study vaccination|52|||
44139553|NCT02439320|78928259|FG000|Overall Study|Adverse Event|0|||
44139554|NCT02439320|78928260|FG001|Overall Study|Adverse Event|2|||
44139555|NCT02439320|78928261|FG002|Overall Study|Adverse Event|0|||
44139556|NCT02439320|78928259|FG000|Overall Study|Lost to Follow-up|37|||
44380423|NCT00902538|79386266|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
44139557|NCT02439320|78928260|FG001|Overall Study|Lost to Follow-up|34|||
44139558|NCT02439320|78928261|FG002|Overall Study|Lost to Follow-up|42|||
44139559|NCT02439320|78928259|FG000|Overall Study|Death|0|||
44139560|NCT02439320|78928260|FG001|Overall Study|Death|1|||
44139561|NCT02439320|78928261|FG002|Overall Study|Death|0|||
44139562|NCT02439320|78928259|FG000|Overall Study|Noncompliance with Protocol|10|||
44139563|NCT02439320|78928260|FG001|Overall Study|Noncompliance with Protocol|11|||
44139564|NCT02439320|78928261|FG002|Overall Study|Noncompliance with Protocol|7|||
44139565|NCT02439320|78928259|FG000|Overall Study|Pregnancy|0|||
44139566|NCT02439320|78928260|FG001|Overall Study|Pregnancy|1|||
44139567|NCT02439320|78928261|FG002|Overall Study|Pregnancy|1|||
44139568|NCT02439320|78928259|FG000|Overall Study|Withdrawal by Subject|12|||
44139569|NCT02439320|78928260|FG001|Overall Study|Withdrawal by Subject|16|||
44139570|NCT02439320|78928261|FG002|Overall Study|Withdrawal by Subject|14|||
44139571|NCT02439320|78928259|FG000|Overall Study|Physician Decision|2|||
44139572|NCT02439320|78928260|FG001|Overall Study|Physician Decision|1|||
44139573|NCT02439320|78928261|FG002|Overall Study|Physician Decision|0|||
44139574|NCT02439320|78928259|FG000|Overall Study|Sponsor Request|0|||
44139575|NCT02439320|78928260|FG001|Overall Study|Sponsor Request|2|||
44139576|NCT02439320|78928261|FG002|Overall Study|Sponsor Request|1|||
44139577|NCT02439320|78928259|FG000|Overall Study|Randomization Failure|35|||
44139578|NCT02439320|78928260|FG001|Overall Study|Randomization Failure|46|||
44139579|NCT02439320|78928261|FG002|Overall Study|Randomization Failure|34|||
44139580|NCT02469038|78928277|FG000|Overall Study|Physician Decision|4|||
44139581|NCT02469038|78928278|FG001|Overall Study|Physician Decision|5|||
44139582|NCT02468648|78928284|FG000|Overall Study|Death|1|||
44139583|NCT02468414|78928290|FG000|Overall Study|Early Study Termination by Sponsor|1|||
44139584|NCT02468414|78928291|FG001|Overall Study|Early Study Termination by Sponsor|0|||
44139585|NCT02468414|78928290|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
44139586|NCT02468414|78928291|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
44139587|NCT02468414|78928290|FG000|Overall Study|Screen Failure|1|||
44139588|NCT02468414|78928291|FG001|Overall Study|Screen Failure|0|||
44139589|NCT02466386|78928297|FG000|Overall Study|Adverse Event|5|||
44139590|NCT02466386|78928297|FG000|Overall Study|Protocol Violation|2|||
44139591|NCT02466386|78928297|FG000|Overall Study|Withdrawal by Subject|14|||
44139592|NCT02466386|78928297|FG000|Overall Study|Lost to Follow-up|5|||
44139593|NCT02466386|78928297|FG000|Overall Study|Lack of Efficacy|8|||
44139594|NCT02466386|78928297|FG000|Overall Study|Other|10|||
44139595|NCT01633060|78928303|FG000|Randomization Phase|Protocol deviation|1|||
44139596|NCT01633060|78928304|FG001|Randomization Phase|Protocol deviation|2|||
44139597|NCT01633060|78928303|FG000|Randomization Phase|Technical problem|0|||
44139598|NCT01633060|78928304|FG001|Randomization Phase|Technical problem|1|||
44139599|NCT01633060|78928303|FG000|Treatment Phase|Adverse Event|24|||
44139600|NCT01633060|78928304|FG001|Treatment Phase|Adverse Event|3|||
44139601|NCT01633060|78928303|FG000|Treatment Phase|Lost to Follow-up|1|||
44139602|NCT01633060|78928304|FG001|Treatment Phase|Lost to Follow-up|0|||
44139603|NCT01633060|78928303|FG000|Treatment Phase|Physician Decision|16|||
44139604|NCT01633060|78928304|FG001|Treatment Phase|Physician Decision|7|||
44139605|NCT01633060|78928303|FG000|Treatment Phase|Progressive Disease|210|||
44139606|NCT01633060|78928304|FG001|Treatment Phase|Progressive Disease|120|||
44139607|NCT01633060|78928303|FG000|Treatment Phase|Protocol Deviation|1|||
44139608|NCT01633060|78928304|FG001|Treatment Phase|Protocol Deviation|0|||
44139609|NCT01633060|78928303|FG000|Treatment Phase|Study Terminated by sponsor|7|||
44139610|NCT01633060|78928304|FG001|Treatment Phase|Study Terminated by sponsor|3|||
44139611|NCT01633060|78928303|FG000|Treatment Phase|Subject/guardian decision|25|||
44139612|NCT01633060|78928304|FG001|Treatment Phase|Subject/guardian decision|4|||
44139613|NCT01633060|78928303|FG000|Treatment Phase|Death|4|||
44243917|NCT01456039|79073963|FG001|Phase 1 (First Step)|Adverse Event|3|||
44243918|NCT01456039|79073964|FG002|Phase 1 (First Step)|Adverse Event|0|||
44513607|NCT03129100|79519002|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513608|NCT03129100|79519003|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513609|NCT03129100|79519004|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513610|NCT03129100|79519005|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513611|NCT03129100|79519006|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513612|NCT03129100|79519007|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513613|NCT03129100|79519008|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44243919|NCT01456039|79073962|FG000|Phase 1 (First Step)|Other|0|||
44139614|NCT01633060|78928304|FG001|Treatment Phase|Death|3|||
44139615|NCT01633060|78928303|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
44243920|NCT01456039|79073963|FG001|Phase 1 (First Step)|Other|1|||
44139616|NCT01633060|78928304|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44139617|NCT01633060|78928303|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
44139618|NCT01633060|78928304|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
44513614|NCT03129100|79519009|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139619|NCT01633060|78928303|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
44139620|NCT01633060|78928304|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
44139621|NCT01633060|78928303|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
44139622|NCT01633060|78928304|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
44139623|NCT01633060|78928303|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
44139624|NCT01633060|78928304|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
44139625|NCT01633060|78928303|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
44139626|NCT01633060|78928304|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
44139627|NCT01632904|78928313|FG000|Overall Study|Adverse Event|4|||
44139628|NCT01632904|78928314|FG001|Overall Study|Adverse Event|1|||
44139629|NCT01632904|78928313|FG000|Overall Study|Physician Decision|0|||
44139630|NCT01632904|78928314|FG001|Overall Study|Physician Decision|1|||
44139631|NCT01632904|78928313|FG000|Overall Study|Subject decision|3|||
44139632|NCT01632904|78928314|FG001|Overall Study|Subject decision|2|||
44139633|NCT01632904|78928313|FG000|Overall Study|Disease Progression|0|||
44139634|NCT01632904|78928314|FG001|Overall Study|Disease Progression|1|||
44139635|NCT01632904|78928313|FG000|Overall Study|Reason for discontinuation not available|0|||
44139636|NCT01632904|78928314|FG001|Overall Study|Reason for discontinuation not available|1|||
44139637|NCT03834779|78928322|FG000|Overall Study|Death|1|||
44139638|NCT03834779|78928323|FG001|Overall Study|Death|2|||
44139639|NCT03834779|78928322|FG000|Overall Study|Lost to Follow-up|6|||
44139640|NCT03834779|78928323|FG001|Overall Study|Lost to Follow-up|4|||
44139641|NCT03726437|78928332|FG000|Overall Study|Lost to Follow-up|85|||
44139642|NCT03726437|78928333|FG001|Overall Study|Lost to Follow-up|76|||
44139643|NCT02465528|78928343|FG000|Overall Study|Progressive disease|0|||
44139644|NCT02465528|78928344|FG001|Overall Study|Progressive disease|2|||
44139645|NCT02465528|78928345|FG002|Overall Study|Progressive disease|9|||
44139646|NCT02465528|78928346|FG003|Overall Study|Progressive disease|4|||
44139647|NCT02465528|78928343|FG000|Overall Study|Study terminated by sponsor|1|||
44139648|NCT02465528|78928344|FG001|Overall Study|Study terminated by sponsor|2|||
44139649|NCT02465528|78928345|FG002|Overall Study|Study terminated by sponsor|0|||
44139650|NCT02465528|78928346|FG003|Overall Study|Study terminated by sponsor|0|||
44139651|NCT02465528|78928343|FG000|Overall Study|Withdrawal by Subject|0|||
44139652|NCT02465528|78928344|FG001|Overall Study|Withdrawal by Subject|0|||
44139653|NCT02465528|78928345|FG002|Overall Study|Withdrawal by Subject|2|||
44139654|NCT02465528|78928346|FG003|Overall Study|Withdrawal by Subject|0|||
44139655|NCT02465528|78928343|FG000|Overall Study|Adverse Event|0|||
44139656|NCT02465528|78928344|FG001|Overall Study|Adverse Event|0|||
44139657|NCT02465528|78928345|FG002|Overall Study|Adverse Event|0|||
44139658|NCT02465528|78928346|FG003|Overall Study|Adverse Event|1|||
44139659|NCT02465528|78928343|FG000|Overall Study|Physician Decision|0|||
44139660|NCT02465528|78928344|FG001|Overall Study|Physician Decision|0|||
44139661|NCT02465528|78928345|FG002|Overall Study|Physician Decision|1|||
44139662|NCT02465528|78928346|FG003|Overall Study|Physician Decision|0|||
44139663|NCT02438384|78928361|FG000|Overall Study|Lost to Follow-up|8|||
44139664|NCT02438384|78928362|FG001|Overall Study|Lost to Follow-up|6|||
44139665|NCT02438384|78928363|FG002|Overall Study|Lost to Follow-up|4|||
44139666|NCT02463032|78928373|FG000|Overall Study|Lack of Efficacy|61|||
44139667|NCT02463032|78928374|FG001|Overall Study|Lack of Efficacy|50|||
44139668|NCT02463032|78928373|FG000|Overall Study|Death|8|||
44139669|NCT02463032|78928374|FG001|Overall Study|Death|8|||
44139670|NCT02463032|78928373|FG000|Overall Study|Adverse Event|2|||
44139671|NCT02463032|78928374|FG001|Overall Study|Adverse Event|6|||
44139672|NCT02496884|78928384|FG000|Overall Study|Counted twice as enrolled|2|||
44139673|NCT02496884|78928385|FG001|Overall Study|Counted twice as enrolled|0|||
44139674|NCT02496884|78928386|FG002|Overall Study|Counted twice as enrolled|0|||
44139675|NCT02496884|78928387|FG003|Overall Study|Counted twice as enrolled|0|||
44139676|NCT02496884|78928384|FG000|Overall Study|Withdrawal by Subject|0|||
44139677|NCT02496884|78928385|FG001|Overall Study|Withdrawal by Subject|3|||
44139678|NCT02496884|78928386|FG002|Overall Study|Withdrawal by Subject|0|||
44139679|NCT02496884|78928387|FG003|Overall Study|Withdrawal by Subject|0|||
44139680|NCT02462876|78928397|FG000|Overall Study|Death|3|||
44139681|NCT02462876|78928397|FG000|Overall Study|Lost to Follow-up|7|||
44139682|NCT02462876|78928397|FG000|Overall Study|Surgical Bypass|9|||
44139683|NCT02462876|78928397|FG000|Overall Study|Amputation Above the Metatarsals|1|||
44276607|NCT04791319|79237612|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44139684|NCT02462876|78928397|FG000|Overall Study|36 months follow-up visit missed|1|||
44139685|NCT02462876|78928397|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
44139686|NCT02462876|78928397|FG000|Overall Study|Patient did not come back to the vascular department|1|||
44139687|NCT02462876|78928397|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
44139688|NCT02462876|78928397|FG000|Overall Study|Patient refused to come back|1|||
44139689|NCT02462876|78928397|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
44139690|NCT02462876|78928397|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
44139691|NCT03386721|78928416|FG000|Overall Study|Death|12|||
44139692|NCT03386721|78928417|FG001|Overall Study|Death|21|||
44139693|NCT03386721|78928418|FG002|Overall Study|Death|2|||
44139694|NCT03386721|78928419|FG003|Overall Study|Death|5|||
44139695|NCT03386721|78928420|FG004|Overall Study|Death|1|||
44139696|NCT03386721|78928421|FG005|Overall Study|Death|12|||
44139697|NCT03386721|78928422|FG006|Overall Study|Death|1|||
44139698|NCT03386721|78928423|FG007|Overall Study|Death|1|||
44139699|NCT03386721|78928424|FG008|Overall Study|Death|12|||
44139700|NCT03386721|78928425|FG009|Overall Study|Death|20|||
44139701|NCT03386721|78928426|FG010|Overall Study|Death|21|||
44139702|NCT03386721|78928427|FG011|Overall Study|Death|21|||
44139703|NCT03386721|78928428|FG012|Overall Study|Death|14|||
44139704|NCT03386721|78928429|FG013|Overall Study|Death|2|||
44139705|NCT03386721|78928430|FG014|Overall Study|Death|1|||
44139706|NCT03386721|78928416|FG000|Overall Study|Lost to Follow-up|1|||
44139707|NCT03386721|78928417|FG001|Overall Study|Lost to Follow-up|3|||
44139708|NCT03386721|78928418|FG002|Overall Study|Lost to Follow-up|0|||
44139709|NCT03386721|78928419|FG003|Overall Study|Lost to Follow-up|0|||
44139710|NCT03386721|78928420|FG004|Overall Study|Lost to Follow-up|0|||
44139711|NCT03386721|78928421|FG005|Overall Study|Lost to Follow-up|2|||
44139712|NCT03386721|78928422|FG006|Overall Study|Lost to Follow-up|1|||
44139713|NCT03386721|78928423|FG007|Overall Study|Lost to Follow-up|0|||
44139714|NCT03386721|78928424|FG008|Overall Study|Lost to Follow-up|1|||
44139715|NCT03386721|78928425|FG009|Overall Study|Lost to Follow-up|2|||
44139716|NCT03386721|78928426|FG010|Overall Study|Lost to Follow-up|1|||
44139717|NCT03386721|78928427|FG011|Overall Study|Lost to Follow-up|0|||
44139718|NCT03386721|78928428|FG012|Overall Study|Lost to Follow-up|0|||
44139719|NCT03386721|78928429|FG013|Overall Study|Lost to Follow-up|0|||
44139720|NCT03386721|78928430|FG014|Overall Study|Lost to Follow-up|0|||
44139721|NCT03386721|78928416|FG000|Overall Study|Reason not specified|3|||
44139722|NCT03386721|78928417|FG001|Overall Study|Reason not specified|0|||
44139723|NCT03386721|78928418|FG002|Overall Study|Reason not specified|0|||
44139724|NCT03386721|78928419|FG003|Overall Study|Reason not specified|0|||
44139725|NCT03386721|78928420|FG004|Overall Study|Reason not specified|0|||
44139726|NCT03386721|78928421|FG005|Overall Study|Reason not specified|3|||
44139727|NCT03386721|78928422|FG006|Overall Study|Reason not specified|1|||
44139728|NCT03386721|78928423|FG007|Overall Study|Reason not specified|0|||
44139729|NCT03386721|78928424|FG008|Overall Study|Reason not specified|0|||
44139730|NCT03386721|78928425|FG009|Overall Study|Reason not specified|1|||
44139731|NCT03386721|78928426|FG010|Overall Study|Reason not specified|2|||
44139732|NCT03386721|78928427|FG011|Overall Study|Reason not specified|6|||
44139733|NCT03386721|78928428|FG012|Overall Study|Reason not specified|1|||
44139734|NCT03386721|78928429|FG013|Overall Study|Reason not specified|0|||
44139735|NCT03386721|78928430|FG014|Overall Study|Reason not specified|0|||
44139736|NCT03386721|78928416|FG000|Overall Study|Progressive Disease|0|||
44139737|NCT03386721|78928417|FG001|Overall Study|Progressive Disease|0|||
44139738|NCT03386721|78928418|FG002|Overall Study|Progressive Disease|1|||
44139739|NCT03386721|78928419|FG003|Overall Study|Progressive Disease|0|||
44139740|NCT03386721|78928420|FG004|Overall Study|Progressive Disease|0|||
44139741|NCT03386721|78928421|FG005|Overall Study|Progressive Disease|1|||
44139742|NCT03386721|78928422|FG006|Overall Study|Progressive Disease|0|||
44139743|NCT03386721|78928423|FG007|Overall Study|Progressive Disease|0|||
44513615|NCT03129100|79519010|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513616|NCT03129100|79519011|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513617|NCT03129100|79519012|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513618|NCT03129100|79519013|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139744|NCT03386721|78928424|FG008|Overall Study|Progressive Disease|2|||
44139745|NCT03386721|78928425|FG009|Overall Study|Progressive Disease|1|||
44139746|NCT03386721|78928426|FG010|Overall Study|Progressive Disease|1|||
44139747|NCT03386721|78928427|FG011|Overall Study|Progressive Disease|0|||
44513619|NCT03129100|79519014|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513620|NCT03129100|79519015|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139748|NCT03386721|78928428|FG012|Overall Study|Progressive Disease|1|||
44139749|NCT03386721|78928429|FG013|Overall Study|Progressive Disease|0|||
44139750|NCT03386721|78928430|FG014|Overall Study|Progressive Disease|0|||
44139751|NCT03386721|78928416|FG000|Overall Study|Site Terminated by Sponsor|5|||
44139752|NCT03386721|78928417|FG001|Overall Study|Site Terminated by Sponsor|5|||
44139753|NCT03386721|78928418|FG002|Overall Study|Site Terminated by Sponsor|0|||
44139754|NCT03386721|78928419|FG003|Overall Study|Site Terminated by Sponsor|0|||
44139755|NCT03386721|78928420|FG004|Overall Study|Site Terminated by Sponsor|1|||
44139756|NCT03386721|78928421|FG005|Overall Study|Site Terminated by Sponsor|3|||
44139757|NCT03386721|78928422|FG006|Overall Study|Site Terminated by Sponsor|0|||
44139758|NCT03386721|78928423|FG007|Overall Study|Site Terminated by Sponsor|1|||
44139759|NCT03386721|78928424|FG008|Overall Study|Site Terminated by Sponsor|4|||
44139760|NCT03386721|78928425|FG009|Overall Study|Site Terminated by Sponsor|5|||
44139761|NCT03386721|78928426|FG010|Overall Study|Site Terminated by Sponsor|3|||
44513621|NCT03129100|79519016|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139762|NCT03386721|78928427|FG011|Overall Study|Site Terminated by Sponsor|11|||
44139763|NCT03386721|78928428|FG012|Overall Study|Site Terminated by Sponsor|6|||
44139764|NCT03386721|78928429|FG013|Overall Study|Site Terminated by Sponsor|0|||
44139765|NCT03386721|78928430|FG014|Overall Study|Site Terminated by Sponsor|0|||
44139766|NCT03386721|78928416|FG000|Overall Study|Symptomatic Deterioration|0|||
44139767|NCT03386721|78928417|FG001|Overall Study|Symptomatic Deterioration|0|||
44139768|NCT03386721|78928418|FG002|Overall Study|Symptomatic Deterioration|0|||
44139769|NCT03386721|78928419|FG003|Overall Study|Symptomatic Deterioration|0|||
44139770|NCT03386721|78928420|FG004|Overall Study|Symptomatic Deterioration|0|||
44139771|NCT03386721|78928421|FG005|Overall Study|Symptomatic Deterioration|0|||
44139772|NCT03386721|78928422|FG006|Overall Study|Symptomatic Deterioration|0|||
44139773|NCT03386721|78928423|FG007|Overall Study|Symptomatic Deterioration|0|||
44139774|NCT03386721|78928424|FG008|Overall Study|Symptomatic Deterioration|1|||
44139775|NCT03386721|78928425|FG009|Overall Study|Symptomatic Deterioration|0|||
44139776|NCT03386721|78928426|FG010|Overall Study|Symptomatic Deterioration|0|||
44139777|NCT03386721|78928427|FG011|Overall Study|Symptomatic Deterioration|1|||
44139778|NCT03386721|78928428|FG012|Overall Study|Symptomatic Deterioration|0|||
44139779|NCT03386721|78928429|FG013|Overall Study|Symptomatic Deterioration|0|||
44139780|NCT03386721|78928430|FG014|Overall Study|Symptomatic Deterioration|0|||
44139781|NCT03386721|78928416|FG000|Overall Study|Withdrawal by Subject|1|||
44139782|NCT03386721|78928417|FG001|Overall Study|Withdrawal by Subject|2|||
44139783|NCT03386721|78928418|FG002|Overall Study|Withdrawal by Subject|0|||
44139784|NCT03386721|78928419|FG003|Overall Study|Withdrawal by Subject|0|||
44139785|NCT03386721|78928420|FG004|Overall Study|Withdrawal by Subject|0|||
44139786|NCT03386721|78928421|FG005|Overall Study|Withdrawal by Subject|0|||
44139787|NCT03386721|78928422|FG006|Overall Study|Withdrawal by Subject|0|||
44139788|NCT03386721|78928423|FG007|Overall Study|Withdrawal by Subject|0|||
44139789|NCT03386721|78928424|FG008|Overall Study|Withdrawal by Subject|2|||
44139790|NCT03386721|78928425|FG009|Overall Study|Withdrawal by Subject|1|||
44139791|NCT03386721|78928426|FG010|Overall Study|Withdrawal by Subject|3|||
44139792|NCT03386721|78928427|FG011|Overall Study|Withdrawal by Subject|2|||
44139793|NCT03386721|78928428|FG012|Overall Study|Withdrawal by Subject|3|||
44139794|NCT03386721|78928429|FG013|Overall Study|Withdrawal by Subject|0|||
44139795|NCT03386721|78928430|FG014|Overall Study|Withdrawal by Subject|0|||
44139796|NCT02462720|78928462|FG000|Part 2|Withdrawal by Subject|1|||
44139797|NCT02462720|78928463|FG001|Part 2|Withdrawal by Subject|0|||
44139798|NCT02462720|78928462|FG000|Part 2|Protocol Violation|0|||
44139799|NCT02462720|78928463|FG001|Part 2|Protocol Violation|1|||
44139800|NCT02246218|78928473|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44139801|NCT02246218|78928474|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44139802|NCT02246218|78928473|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
44139803|NCT02246218|78928474|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
44139804|NCT02246218|78928473|FG000|Overall Study|Adverse Event|1|||
44139805|NCT02246218|78928474|FG001|Overall Study|Adverse Event|1|||
44139806|NCT02246218|78928473|FG000|Overall Study|Lost to Follow-up|1|||
44139807|NCT02246218|78928474|FG001|Overall Study|Lost to Follow-up|0|||
44139808|NCT02244580|78928480|FG000|Overall Study|No cancer tissues available|241|||
44139809|NCT02244424|78928490|FG000|Overall Study|Lost to Follow-up|20|||
44139810|NCT02244424|78928491|FG001|Overall Study|Lost to Follow-up|10|||
44139811|NCT00159783|78928500|FG000|Overall Study|Adverse Event|5|||
44139812|NCT00159783|78928501|FG001|Overall Study|Adverse Event|7|||
44139813|NCT00159783|78928502|FG002|Overall Study|Adverse Event|9|||
44139814|NCT00159783|78928500|FG000|Overall Study|Lack of Efficacy|1|||
44139815|NCT00159783|78928501|FG001|Overall Study|Lack of Efficacy|2|||
44139816|NCT00159783|78928502|FG002|Overall Study|Lack of Efficacy|3|||
44139817|NCT00159783|78928500|FG000|Overall Study|Withdrawal by Subject|7|||
44139818|NCT00159783|78928501|FG001|Overall Study|Withdrawal by Subject|11|||
44139819|NCT00159783|78928502|FG002|Overall Study|Withdrawal by Subject|12|||
44139820|NCT00159783|78928500|FG000|Overall Study|Lost to Follow-up|6|||
44139821|NCT00159783|78928501|FG001|Overall Study|Lost to Follow-up|5|||
44139822|NCT00159783|78928502|FG002|Overall Study|Lost to Follow-up|11|||
44139823|NCT00159783|78928500|FG000|Overall Study|Other|0|||
44139824|NCT00159783|78928501|FG001|Overall Study|Other|2|||
44139825|NCT00159783|78928502|FG002|Overall Study|Other|4|||
44139826|NCT00646204|78928513|FG000|Overall Study|Adverse Event|3|||
44139827|NCT00646204|78928514|FG001|Overall Study|Adverse Event|0|||
44139828|NCT00646204|78928513|FG000|Overall Study|Withdrawal by Subject|1|||
44139829|NCT00646204|78928514|FG001|Overall Study|Withdrawal by Subject|0|||
44139830|NCT02936323|78928531|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
44139831|NCT02936323|78928532|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
44139832|NCT02936323|78928533|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
44139833|NCT02936323|78928534|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
44139834|NCT02936323|78928535|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
44139835|NCT02936323|78928536|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
44139836|NCT02936323|78928537|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
44139837|NCT02936323|78928538|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
44139838|NCT02936323|78928539|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
44139839|NCT02936323|78928540|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
44139840|NCT02936323|78928531|FG000|Phase 1 Dose Escalation|Death|2|||
44139841|NCT02936323|78928532|FG001|Phase 1 Dose Escalation|Death|1|||
44139842|NCT02936323|78928533|FG002|Phase 1 Dose Escalation|Death|3|||
44139843|NCT02936323|78928534|FG003|Phase 1 Dose Escalation|Death|1|||
44139844|NCT02936323|78928535|FG004|Phase 1 Dose Escalation|Death|2|||
44139845|NCT02936323|78928536|FG005|Phase 1 Dose Escalation|Death|3|||
44139846|NCT02936323|78928537|FG006|Phase 1 Dose Escalation|Death|3|||
44139847|NCT02936323|78928538|FG007|Phase 1 Dose Escalation|Death|0|||
44139848|NCT02936323|78928539|FG008|Phase 1 Dose Escalation|Death|0|||
44139849|NCT02936323|78928540|FG009|Phase 1 Dose Escalation|Death|0|||
44139850|NCT02936323|78928531|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139851|NCT02936323|78928532|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139852|NCT02936323|78928533|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139853|NCT02936323|78928534|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139854|NCT02936323|78928535|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139855|NCT02936323|78928536|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
44139856|NCT02936323|78928537|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139857|NCT02936323|78928538|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139858|NCT02936323|78928539|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139859|NCT02936323|78928540|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
44139860|NCT02936323|78928531|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139861|NCT02936323|78928532|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139862|NCT02936323|78928533|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139863|NCT02936323|78928534|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139864|NCT02936323|78928535|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139865|NCT02936323|78928536|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139866|NCT02936323|78928537|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
44139867|NCT02936323|78928538|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
44139868|NCT02936323|78928539|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
44139869|NCT02936323|78928540|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
44139870|NCT02936323|78928531|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
44139871|NCT02936323|78928532|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
44139872|NCT02936323|78928533|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
44139873|NCT02936323|78928534|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
44139874|NCT02936323|78928535|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
44139875|NCT02936323|78928536|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
44139876|NCT02936323|78928537|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
44139877|NCT02936323|78928538|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
44139878|NCT02936323|78928539|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
44139879|NCT02936323|78928540|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
44139880|NCT02936323|78928531|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139881|NCT02936323|78928532|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139882|NCT02936323|78928533|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139883|NCT02936323|78928534|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139884|NCT02936323|78928535|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139885|NCT02936323|78928536|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139886|NCT02936323|78928537|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139887|NCT02936323|78928538|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
44139888|NCT02936323|78928539|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
44139889|NCT02936323|78928540|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
44139890|NCT02936323|78928531|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44139891|NCT02936323|78928532|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44243921|NCT01456039|79073964|FG002|Phase 1 (First Step)|Other|0|||
44243922|NCT01456039|79073962|FG000|Phase 2 (Second Step)|Disease Progression|0|||
44243923|NCT01456039|79073963|FG001|Phase 2 (Second Step)|Disease Progression|0|||
44243924|NCT01456039|79073964|FG002|Phase 2 (Second Step)|Disease Progression|17|||
44513622|NCT03129100|79519017|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139892|NCT02936323|78928533|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44139893|NCT02936323|78928534|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44139894|NCT02936323|78928535|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44139895|NCT02936323|78928536|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44513623|NCT03129100|79519018|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44139896|NCT02936323|78928537|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44139897|NCT02936323|78928538|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44139898|NCT02936323|78928539|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
44243925|NCT01456039|79073962|FG000|Phase 2 (Second Step)|Adverse Event|0|||
44243926|NCT01456039|79073963|FG001|Phase 2 (Second Step)|Adverse Event|0|||
44243927|NCT01456039|79073964|FG002|Phase 2 (Second Step)|Adverse Event|10|||
44139899|NCT02936323|78928540|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
44139900|NCT02936323|78928531|FG000|Phase 2a Dose Expansion|Death|0|||
44139901|NCT02936323|78928532|FG001|Phase 2a Dose Expansion|Death|0|||
44139902|NCT02936323|78928533|FG002|Phase 2a Dose Expansion|Death|0|||
44139903|NCT02936323|78928534|FG003|Phase 2a Dose Expansion|Death|0|||
44139904|NCT02936323|78928535|FG004|Phase 2a Dose Expansion|Death|0|||
44139905|NCT02936323|78928536|FG005|Phase 2a Dose Expansion|Death|0|||
44139906|NCT02936323|78928537|FG006|Phase 2a Dose Expansion|Death|0|||
44139907|NCT02936323|78928538|FG007|Phase 2a Dose Expansion|Death|4|||
44139908|NCT02936323|78928539|FG008|Phase 2a Dose Expansion|Death|8|||
44139909|NCT02936323|78928540|FG009|Phase 2a Dose Expansion|Death|10|||
44139910|NCT02243176|78928574|FG000|Overall Study|Other reason|1|||
44139911|NCT02243176|78928575|FG001|Overall Study|Other reason|2|||
44139912|NCT02243176|78928574|FG000|Overall Study|protocol specified withdrawal critera|1|||
44139913|NCT02243176|78928575|FG001|Overall Study|protocol specified withdrawal critera|3|||
44139914|NCT02243176|78928574|FG000|Overall Study|Protocol Violation|2|||
44139915|NCT02243176|78928575|FG001|Overall Study|Protocol Violation|1|||
44139916|NCT02243176|78928574|FG000|Overall Study|Withdrawal by Subject|8|||
44139917|NCT02243176|78928575|FG001|Overall Study|Withdrawal by Subject|7|||
44139918|NCT02243176|78928574|FG000|Overall Study|Adverse Event|2|||
44139919|NCT02243176|78928575|FG001|Overall Study|Adverse Event|2|||
44139920|NCT00002663|78928586|FG000|Overall Study|Death|4|||
44139921|NCT00002663|78928587|FG001|Overall Study|Death|1|||
44139922|NCT00002663|78928588|FG002|Overall Study|Death|1|||
44139923|NCT00002663|78928589|FG003|Overall Study|Death|0|||
44139924|NCT00002663|78928590|FG004|Overall Study|Death|0|||
44139925|NCT00002663|78928591|FG005|Overall Study|Death|13|||
44139926|NCT00002663|78928592|FG006|Overall Study|Death|0|||
44139927|NCT00002663|78928593|FG007|Overall Study|Death|1|||
44139928|NCT00002663|78928594|FG008|Overall Study|Death|1|||
44139929|NCT00002663|78928595|FG009|Overall Study|Death|1|||
44139930|NCT00002663|78928586|FG000|Overall Study|Lost to Follow-up|3|||
44139931|NCT00002663|78928587|FG001|Overall Study|Lost to Follow-up|0|||
44139932|NCT00002663|78928588|FG002|Overall Study|Lost to Follow-up|0|||
44139933|NCT00002663|78928589|FG003|Overall Study|Lost to Follow-up|1|||
44139934|NCT00002663|78928590|FG004|Overall Study|Lost to Follow-up|0|||
44139935|NCT00002663|78928591|FG005|Overall Study|Lost to Follow-up|1|||
44139936|NCT00002663|78928592|FG006|Overall Study|Lost to Follow-up|0|||
44139937|NCT00002663|78928593|FG007|Overall Study|Lost to Follow-up|0|||
44139938|NCT00002663|78928594|FG008|Overall Study|Lost to Follow-up|0|||
44139939|NCT00002663|78928595|FG009|Overall Study|Lost to Follow-up|0|||
44139940|NCT00002663|78928586|FG000|Overall Study|Other|0|||
44139941|NCT00002663|78928587|FG001|Overall Study|Other|1|||
44139942|NCT00002663|78928588|FG002|Overall Study|Other|0|||
44139943|NCT00002663|78928589|FG003|Overall Study|Other|0|||
44139944|NCT00002663|78928590|FG004|Overall Study|Other|0|||
44139945|NCT00002663|78928591|FG005|Overall Study|Other|1|||
44139946|NCT00002663|78928592|FG006|Overall Study|Other|1|||
44139947|NCT00002663|78928593|FG007|Overall Study|Other|0|||
44139948|NCT00002663|78928594|FG008|Overall Study|Other|0|||
44139949|NCT00002663|78928595|FG009|Overall Study|Other|0|||
44139950|NCT00002663|78928586|FG000|Overall Study|Physician Decision|0|||
44139951|NCT00002663|78928587|FG001|Overall Study|Physician Decision|0|||
44139952|NCT00002663|78928588|FG002|Overall Study|Physician Decision|0|||
44139953|NCT00002663|78928589|FG003|Overall Study|Physician Decision|0|||
44139954|NCT00002663|78928590|FG004|Overall Study|Physician Decision|1|||
44139955|NCT00002663|78928591|FG005|Overall Study|Physician Decision|0|||
44139956|NCT00002663|78928592|FG006|Overall Study|Physician Decision|0|||
44139957|NCT00002663|78928593|FG007|Overall Study|Physician Decision|0|||
44139958|NCT00002663|78928594|FG008|Overall Study|Physician Decision|1|||
44139959|NCT00002663|78928595|FG009|Overall Study|Physician Decision|1|||
44139960|NCT00002663|78928586|FG000|Overall Study|Adverse Event|0|||
44139961|NCT00002663|78928587|FG001|Overall Study|Adverse Event|0|||
44139962|NCT00002663|78928588|FG002|Overall Study|Adverse Event|0|||
44139963|NCT00002663|78928589|FG003|Overall Study|Adverse Event|1|||
44243928|NCT01456039|79073962|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
44243929|NCT01456039|79073963|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
44139964|NCT00002663|78928590|FG004|Overall Study|Adverse Event|0|||
44139965|NCT00002663|78928591|FG005|Overall Study|Adverse Event|0|||
44139966|NCT00002663|78928592|FG006|Overall Study|Adverse Event|0|||
44139967|NCT00002663|78928593|FG007|Overall Study|Adverse Event|1|||
44139968|NCT00002663|78928594|FG008|Overall Study|Adverse Event|0|||
44139969|NCT00002663|78928595|FG009|Overall Study|Adverse Event|0|||
44139970|NCT02240680|78928606|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
44139971|NCT02240680|78928607|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
44139972|NCT02240680|78928608|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
44139973|NCT02240680|78928609|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
44139974|NCT02240680|78928606|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
44139975|NCT02240680|78928607|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
44139976|NCT02240680|78928608|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
44139977|NCT02240680|78928609|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
44139978|NCT02240680|78928606|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
44139979|NCT02240680|78928607|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
44139980|NCT02240680|78928608|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
44139981|NCT02240680|78928609|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
44139982|NCT02240680|78928606|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
44139983|NCT02240680|78928607|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
44139984|NCT02240680|78928608|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
44139985|NCT02240680|78928609|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
44139986|NCT02240680|78928606|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
44139987|NCT02240680|78928607|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
44139988|NCT02240680|78928608|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
44139989|NCT02240680|78928609|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
44139990|NCT02240680|78928606|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
44139991|NCT02240680|78928607|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
44139992|NCT02240680|78928608|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
44139993|NCT02240680|78928609|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
44139994|NCT02240680|78928606|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
44139995|NCT02240680|78928607|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
44139996|NCT02240680|78928608|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
44139997|NCT02240680|78928609|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
44139998|NCT02240680|78928606|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
44139999|NCT02240680|78928607|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
44140000|NCT02240680|78928608|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
44140001|NCT02240680|78928609|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
44140002|NCT02240368|78928620|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
44140003|NCT02240368|78928621|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
44140004|NCT02240368|78928622|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
44513624|NCT03129100|79519019|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513625|NCT03129100|79519020|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
44513626|NCT03129100|79519021|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513627|NCT03129100|79519022|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513628|NCT03129100|79519023|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513629|NCT03129100|79519024|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44513630|NCT03129100|79519025|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
44243930|NCT01456039|79073964|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
44513631|NCT03129100|79519000|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
44513632|NCT03129100|79519001|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
44513633|NCT03129100|79519002|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
44513634|NCT03129100|79519003|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
44513635|NCT03129100|79519004|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
44140005|NCT02240368|78928620|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
44140006|NCT02240368|78928621|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
44140007|NCT02240368|78928622|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
44243931|NCT01456039|79073962|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
44513636|NCT03129100|79519005|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
44513637|NCT03129100|79519006|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
44513638|NCT03129100|79519007|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
44513639|NCT03129100|79519008|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
44513640|NCT03129100|79519009|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
44513641|NCT03129100|79519010|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
44513642|NCT03129100|79519011|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
44513643|NCT03129100|79519012|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
44513644|NCT03129100|79519013|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
44513645|NCT03129100|79519014|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
44513646|NCT03129100|79519015|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
44513647|NCT03129100|79519016|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
44513648|NCT03129100|79519017|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
44513649|NCT03129100|79519018|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
44513650|NCT03129100|79519019|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
44513651|NCT03129100|79519020|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
44513652|NCT03129100|79519021|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
44380424|NCT00902538|79386267|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
44380425|NCT00902538|79386268|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
44380426|NCT00902538|79386269|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
44380427|NCT00902538|79386270|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
44380428|NCT00902538|79386271|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
44513653|NCT03129100|79519022|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
44513654|NCT03129100|79519023|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
44513655|NCT03129100|79519024|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
44513656|NCT03129100|79519025|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
44513657|NCT03129100|79519000|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513658|NCT03129100|79519001|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513659|NCT03129100|79519002|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44140008|NCT02239978|78928632|FG000|Overall Study|Withdrawal by Subject|2|||
44140009|NCT02239978|78928633|FG001|Overall Study|Withdrawal by Subject|0|||
44140010|NCT02239510|78928643|FG000|Overall Study|Lost to Follow-up|2|||
44140011|NCT02239510|78928644|FG001|Overall Study|Lost to Follow-up|1|||
44140012|NCT02462486|78928653|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
44140013|NCT02462486|78928654|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
44140014|NCT02462486|78928655|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
44140015|NCT02462486|78928653|FG000|Overall Study|Adverse Event|53|||
44140016|NCT02462486|78928654|FG001|Overall Study|Adverse Event|48|||
44140017|NCT02462486|78928655|FG002|Overall Study|Adverse Event|21|||
44140018|NCT02462486|78928653|FG000|Overall Study|Lack of Efficacy|6|||
44140019|NCT02462486|78928654|FG001|Overall Study|Lack of Efficacy|12|||
44140020|NCT02462486|78928655|FG002|Overall Study|Lack of Efficacy|3|||
44140021|NCT02462486|78928653|FG000|Overall Study|Lost to Follow-up|3|||
44140022|NCT02462486|78928654|FG001|Overall Study|Lost to Follow-up|4|||
44140023|NCT02462486|78928655|FG002|Overall Study|Lost to Follow-up|2|||
44140024|NCT02462486|78928653|FG000|Overall Study|Withdrawal by Subject|25|||
44140025|NCT02462486|78928654|FG001|Overall Study|Withdrawal by Subject|22|||
44140026|NCT02462486|78928655|FG002|Overall Study|Withdrawal by Subject|19|||
44140027|NCT02462486|78928653|FG000|Overall Study|Protocol Violation|3|||
44140028|NCT02462486|78928654|FG001|Overall Study|Protocol Violation|1|||
44140029|NCT02462486|78928655|FG002|Overall Study|Protocol Violation|1|||
44140030|NCT02462486|78928653|FG000|Overall Study|Reason not Specified|3|||
44140031|NCT02462486|78928654|FG001|Overall Study|Reason not Specified|4|||
44140032|NCT02462486|78928655|FG002|Overall Study|Reason not Specified|3|||
44140033|NCT02495948|78928663|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
44140034|NCT02495948|78928664|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
44140035|NCT02495948|78928663|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
44140036|NCT02495948|78928664|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
44140037|NCT02461628|78928673|FG000|Overall Study|Refused to complete survey|4|||
44140038|NCT02461628|78928674|FG001|Overall Study|Refused to complete survey|7|||
44140039|NCT02461160|78928693|FG000|Overall Study|Lost to Follow-up|0|||
44140040|NCT02461160|78928694|FG001|Overall Study|Lost to Follow-up|0|||
44140041|NCT02461160|78928695|FG002|Overall Study|Lost to Follow-up|0|||
44140042|NCT02461160|78928696|FG003|Overall Study|Lost to Follow-up|0|||
44140043|NCT02461160|78928697|FG004|Overall Study|Lost to Follow-up|0|||
44140044|NCT02461160|78928698|FG005|Overall Study|Lost to Follow-up|0|||
44140045|NCT02461160|78928699|FG006|Overall Study|Lost to Follow-up|0|||
44140046|NCT02461160|78928700|FG007|Overall Study|Lost to Follow-up|1|||
44140047|NCT02461160|78928701|FG008|Overall Study|Lost to Follow-up|0|||
44140048|NCT02461160|78928702|FG009|Overall Study|Lost to Follow-up|0|||
44140049|NCT02461160|78928703|FG010|Overall Study|Lost to Follow-up|0|||
44140050|NCT02461160|78928704|FG011|Overall Study|Lost to Follow-up|0|||
44140051|NCT02461160|78928705|FG012|Overall Study|Lost to Follow-up|0|||
44140052|NCT01653704|78928756|FG000|Overall Study|Technical failure during recording|1|||
44140053|NCT01653704|78928757|FG001|Overall Study|Technical failure during recording|1|||
44140054|NCT01653704|78928756|FG000|Overall Study|Performance not reflective of training|1|||
44140055|NCT01653704|78928757|FG001|Overall Study|Performance not reflective of training|0|||
44140056|NCT02495168|78928766|FG000|Overall Study|Other than Specified|18|||
44140057|NCT02495168|78928767|FG001|Overall Study|Other than Specified|22|||
44140058|NCT02495168|78928768|FG002|Overall Study|Other than Specified|5|||
44140059|NCT02495168|78928766|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
44140060|NCT02495168|78928767|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
44140061|NCT02495168|78928768|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
44140062|NCT02495168|78928766|FG000|Overall Study|Physician Decision|1|||
44140063|NCT02495168|78928767|FG001|Overall Study|Physician Decision|1|||
44140064|NCT02495168|78928768|FG002|Overall Study|Physician Decision|0|||
44140065|NCT02495168|78928766|FG000|Overall Study|Lost to Follow-up|10|||
44243932|NCT01456039|79073963|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
44243933|NCT01456039|79073964|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
44243934|NCT01456039|79073962|FG000|Phase 2 (Second Step)|Other|0|||
44243935|NCT01456039|79073963|FG001|Phase 2 (Second Step)|Other|0|||
44140066|NCT02495168|78928767|FG001|Overall Study|Lost to Follow-up|6|||
44140067|NCT02495168|78928768|FG002|Overall Study|Lost to Follow-up|1|||
44140068|NCT02495168|78928766|FG000|Overall Study|Withdrawal by Subject|1|||
44140069|NCT02495168|78928767|FG001|Overall Study|Withdrawal by Subject|4|||
44140070|NCT02495168|78928768|FG002|Overall Study|Withdrawal by Subject|2|||
44140071|NCT02495168|78928766|FG000|Overall Study|Protocol Violation|0|||
44140072|NCT02495168|78928767|FG001|Overall Study|Protocol Violation|10|||
44140073|NCT02495168|78928768|FG002|Overall Study|Protocol Violation|1|||
44140074|NCT02495168|78928766|FG000|Overall Study|Adverse Event|4|||
44140075|NCT02495168|78928767|FG001|Overall Study|Adverse Event|8|||
44140076|NCT02495168|78928768|FG002|Overall Study|Adverse Event|3|||
44140077|NCT02495168|78928766|FG000|Overall Study|Lack of Efficacy|0|||
44140078|NCT02495168|78928767|FG001|Overall Study|Lack of Efficacy|0|||
44140079|NCT02495168|78928768|FG002|Overall Study|Lack of Efficacy|3|||
44140080|NCT02494778|78928776|FG000|Overall Study|Death|3|||
44140081|NCT02494778|78928776|FG000|Overall Study|Other|173|||
44140082|NCT02494778|78928776|FG000|Overall Study|Lack of Efficacy|4|||
44140083|NCT02494778|78928776|FG000|Overall Study|Adverse Event|18|||
44140084|NCT02494778|78928776|FG000|Overall Study|Withdrawal by Subject|20|||
44140085|NCT02494778|78928776|FG000|Overall Study|Lost to Follow-up|2|||
44140086|NCT02494778|78928776|FG000|Overall Study|Noncompliant with study drug admin.|1|||
44140087|NCT02493764|78928782|FG000|Overall Study|Adverse Event|2|||
44140088|NCT02493764|78928783|FG001|Overall Study|Adverse Event|2|||
44140089|NCT02493764|78928782|FG000|Overall Study|Death|44|||
44140090|NCT02493764|78928783|FG001|Overall Study|Death|58|||
44140091|NCT02493764|78928782|FG000|Overall Study|Lost to Follow-up|2|||
44140092|NCT02493764|78928783|FG001|Overall Study|Lost to Follow-up|1|||
44140093|NCT02493764|78928782|FG000|Overall Study|Protocol Violation|6|||
44140094|NCT02493764|78928783|FG001|Overall Study|Protocol Violation|7|||
44140095|NCT02493764|78928782|FG000|Overall Study|Physician Decision|1|||
44140096|NCT02493764|78928783|FG001|Overall Study|Physician Decision|1|||
44140097|NCT02493764|78928782|FG000|Overall Study|Participant moved|17|||
44140098|NCT02493764|78928783|FG001|Overall Study|Participant moved|5|||
44140099|NCT02493764|78928782|FG000|Overall Study|Withdrawal parent/guardian|0|||
44140100|NCT02493764|78928783|FG001|Overall Study|Withdrawal parent/guardian|1|||
44140101|NCT02493764|78928782|FG000|Overall Study|Withdrawal by Subject|11|||
44140102|NCT02493764|78928783|FG001|Overall Study|Withdrawal by Subject|7|||
44140103|NCT02460380|78928791|FG000|Overall Study|Withdrawal by Subject|10|||
44140104|NCT02460380|78928792|FG001|Overall Study|Withdrawal by Subject|5|||
44140105|NCT02493062|78928799|FG000|Overall Study|Physician Decision|12|||
44140106|NCT02492984|78928805|FG000|Overall Study|Adverse Event|1|||
44140107|NCT02492984|78928806|FG001|Overall Study|Adverse Event|0|||
44140108|NCT02492984|78928805|FG000|Overall Study|Protocol Violation|1|||
44140109|NCT02492984|78928806|FG001|Overall Study|Protocol Violation|0|||
44140110|NCT02492984|78928805|FG000|Overall Study|Withdrawal by Subject|1|||
44140111|NCT02492984|78928806|FG001|Overall Study|Withdrawal by Subject|0|||
44140112|NCT01680159|78928819|FG000|Screening Period|Not meet criteria for dose-up period|7|||
44140113|NCT01680159|78928819|FG000|Increased Dose Period|Adverse Event|6|||
44140114|NCT01680159|78928819|FG000|Increased Dose Period|Withdrawal by Subject|2|||
44140115|NCT02491892|78928841|FG000|Overall Study|Adverse Event|1|||
44380429|NCT00902538|79386266|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
44140116|NCT02491892|78928842|FG001|Overall Study|Adverse Event|1|||
44140117|NCT02491892|78928841|FG000|Overall Study|Death|1|||
44140118|NCT02491892|78928842|FG001|Overall Study|Death|1|||
44140119|NCT02491892|78928841|FG000|Overall Study|Lack of Efficacy|37|||
44140120|NCT02491892|78928842|FG001|Overall Study|Lack of Efficacy|36|||
44140121|NCT02491892|78928841|FG000|Overall Study|Refused Treatment|1|||
44140122|NCT02491892|78928842|FG001|Overall Study|Refused Treatment|0|||
44140123|NCT02491892|78928841|FG000|Overall Study|Lost to Follow-up|1|||
44140124|NCT02491892|78928842|FG001|Overall Study|Lost to Follow-up|0|||
44140125|NCT04931888|78928852|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
44140126|NCT04931888|78928853|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
44140127|NCT04931888|78928854|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
44140128|NCT04931888|78928855|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
44140129|NCT02436356|78928884|FG000|Overall Study|Excluded by MRI Screening|0|||
44140130|NCT02436356|78928885|FG001|Overall Study|Excluded by MRI Screening|0|||
44140131|NCT02436356|78928886|FG002|Overall Study|Excluded by MRI Screening|2|||
44140132|NCT02436356|78928884|FG000|Overall Study|Lost to Follow-up|0|||
44140133|NCT02436356|78928885|FG001|Overall Study|Lost to Follow-up|1|||
44140134|NCT02436356|78928886|FG002|Overall Study|Lost to Follow-up|0|||
44140135|NCT02436356|78928884|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
44140136|NCT02436356|78928885|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
44140137|NCT02436356|78928886|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
44140138|NCT02436356|78928884|FG000|Overall Study|Excluded due to other medical conditions|3|||
44140139|NCT02436356|78928885|FG001|Overall Study|Excluded due to other medical conditions|0|||
44140140|NCT02436356|78928886|FG002|Overall Study|Excluded due to other medical conditions|0|||
44140141|NCT02436356|78928884|FG000|Overall Study|Withdrawal by Subject|1|||
44140142|NCT02436356|78928885|FG001|Overall Study|Withdrawal by Subject|0|||
44140143|NCT02436356|78928886|FG002|Overall Study|Withdrawal by Subject|0|||
44140144|NCT02436200|78928899|FG000|Overall Study|Significant outlier|1|||
44140145|NCT01679613|78928903|FG000|Overall Study|other than stated above|0|||
44140146|NCT01679613|78928904|FG001|Overall Study|other than stated above|1|||
44140147|NCT01679613|78928905|FG002|Overall Study|other than stated above|2|||
44140148|NCT01679613|78928906|FG003|Overall Study|other than stated above|2|||
44140149|NCT02489630|78928915|FG000|Overall Study|Oversedation|1|||
44140150|NCT02489630|78928916|FG001|Overall Study|Oversedation|1|||
44140151|NCT02489630|78928915|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
44140152|NCT02489630|78928916|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
44140153|NCT02739347|78928924|FG000|Overall Study|Adverse Event|3|||
44140154|NCT02739347|78928925|FG001|Overall Study|Adverse Event|0|||
44140155|NCT02739347|78928924|FG000|Overall Study|Protocol Violation|0|||
44140156|NCT02739347|78928925|FG001|Overall Study|Protocol Violation|1|||
44140157|NCT02739347|78928924|FG000|Overall Study|Lost to Follow-up|0|||
44140158|NCT02739347|78928925|FG001|Overall Study|Lost to Follow-up|2|||
44140159|NCT02435966|78928934|FG000|Overall Study|Withdrawal by Subject|0|||
44140160|NCT02435966|78928935|FG001|Overall Study|Withdrawal by Subject|1|||
44140161|NCT02435966|78928936|FG002|Overall Study|Withdrawal by Subject|0|||
44140162|NCT01679301|78928944|FG000|Screening Period|screen failure|3|||
44140163|NCT01679301|78928945|FG001|Screening Period|screen failure|0|||
44140164|NCT01679301|78928946|FG002|Screening Period|screen failure|0|||
44140165|NCT01678911|78928952|FG000|Second Intervention|Lost to Follow-up|2|||
44140166|NCT01678911|78928953|FG001|Second Intervention|Lost to Follow-up|0|||
44140167|NCT02487446|78928959|FG000|Period 1|Physician Decision|0|||
44140168|NCT02487446|78928960|FG001|Period 1|Physician Decision|1|||
44140169|NCT02487446|78928959|FG000|Period 1|Lack of Efficacy|1|||
44140170|NCT02487446|78928960|FG001|Period 1|Lack of Efficacy|0|||
44140171|NCT02487446|78928959|FG000|Period 1|Protocol deviation|3|||
44140172|NCT02487446|78928960|FG001|Period 1|Protocol deviation|2|||
44140173|NCT02487446|78928959|FG000|Period 1|Lost to Follow-up|2|||
44140174|NCT02487446|78928960|FG001|Period 1|Lost to Follow-up|0|||
44140175|NCT02487446|78928959|FG000|Period 1|Withdrawal by Subject|2|||
44140176|NCT02487446|78928960|FG001|Period 1|Withdrawal by Subject|0|||
44140177|NCT02487446|78928959|FG000|Period 1|Adverse Event|5|||
44140178|NCT02487446|78928960|FG001|Period 1|Adverse Event|5|||
44140179|NCT02487446|78928959|FG000|Washout|Lost to Follow-up|0|||
44140180|NCT02487446|78928960|FG001|Washout|Lost to Follow-up|2|||
44140181|NCT02487446|78928959|FG000|Washout|Withdrawal by Subject|1|||
44243936|NCT01456039|79073964|FG002|Phase 2 (Second Step)|Other|1|||
44243937|NCT01455415|79073982|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
44140182|NCT02487446|78928960|FG001|Washout|Withdrawal by Subject|4|||
44140183|NCT02487446|78928959|FG000|Washout|Adverse Event|2|||
44140184|NCT02487446|78928960|FG001|Washout|Adverse Event|2|||
44140185|NCT02487446|78928959|FG000|Period 2|Protocol deviation|0|||
44140186|NCT02487446|78928960|FG001|Period 2|Protocol deviation|1|||
44140187|NCT02487446|78928959|FG000|Period 2|Lost to Follow-up|1|||
44140188|NCT02487446|78928960|FG001|Period 2|Lost to Follow-up|1|||
44140189|NCT02487446|78928959|FG000|Period 2|Withdrawal by Subject|1|||
44140190|NCT02487446|78928960|FG001|Period 2|Withdrawal by Subject|1|||
44140191|NCT02487446|78928959|FG000|Period 2|Adverse Event|6|||
44140192|NCT02487446|78928960|FG001|Period 2|Adverse Event|2|||
44140193|NCT02739269|78928969|FG000|Overall Study|Protocol Violation|5|||
44140194|NCT02739269|78928970|FG001|Overall Study|Protocol Violation|0|||
44140195|NCT02739269|78928969|FG000|Overall Study|Cycle cancellation|2|||
44243938|NCT01455415|79073983|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
44513660|NCT03129100|79519003|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513661|NCT03129100|79519004|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513662|NCT03129100|79519005|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513663|NCT03129100|79519006|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513664|NCT03129100|79519007|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513665|NCT03129100|79519008|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513666|NCT03129100|79519009|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513667|NCT03129100|79519010|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513668|NCT03129100|79519011|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513669|NCT03129100|79519012|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513670|NCT03129100|79519013|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513671|NCT03129100|79519014|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513672|NCT03129100|79519015|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513673|NCT03129100|79519016|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513674|NCT03129100|79519017|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513675|NCT03129100|79519018|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513676|NCT03129100|79519019|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513677|NCT03129100|79519020|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
44513678|NCT03129100|79519021|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513679|NCT03129100|79519022|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513680|NCT03129100|79519023|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513681|NCT03129100|79519024|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513682|NCT03129100|79519025|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
44513683|NCT03129100|79519000|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
44513684|NCT03129100|79519001|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
44513685|NCT03129100|79519002|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
44513686|NCT03129100|79519003|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
44513687|NCT03129100|79519004|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
44513688|NCT03129100|79519005|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
44513689|NCT03129100|79519006|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
44513690|NCT03129100|79519007|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
44513691|NCT03129100|79519008|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
44513692|NCT03129100|79519009|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
44513693|NCT03129100|79519010|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
44513694|NCT03129100|79519011|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
44513695|NCT03129100|79519012|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
44513696|NCT03129100|79519013|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
44513697|NCT03129100|79519014|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
44513698|NCT03129100|79519015|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
44513699|NCT03129100|79519016|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
44513700|NCT03129100|79519017|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
44513701|NCT03129100|79519018|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
44513702|NCT03129100|79519019|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
44513703|NCT03129100|79519020|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
44513704|NCT03129100|79519021|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
44513705|NCT03129100|79519022|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
44513706|NCT03129100|79519023|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
44513707|NCT03129100|79519024|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
44513708|NCT03129100|79519025|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
44513709|NCT03129100|79519000|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513710|NCT03129100|79519001|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513711|NCT03129100|79519002|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44243939|NCT01455415|79073982|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
44243940|NCT01455415|79073983|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
44243941|NCT01455415|79073982|FG000|Period 1|Drug Error not Associated to AE|0|||
44243942|NCT01455415|79073983|FG001|Period 1|Drug Error not Associated to AE|1|||
44243943|NCT01455415|79073982|FG000|Period 1|AE Not Related to Study Drug|2|||
44243944|NCT01455415|79073983|FG001|Period 1|AE Not Related to Study Drug|6|||
44243945|NCT01455415|79073982|FG000|Period 1|Withdrawal by Subject|4|||
44243946|NCT01455415|79073983|FG001|Period 1|Withdrawal by Subject|5|||
44243947|NCT01455415|79073982|FG000|Period 1|Unspecified Reason|1|||
44243948|NCT01455415|79073983|FG001|Period 1|Unspecified Reason|1|||
44243949|NCT01455415|79073982|FG000|Period 1|Protocol Violation|0|||
44243950|NCT01455415|79073983|FG001|Period 1|Protocol Violation|2|||
44243951|NCT01455415|79073982|FG000|Washout|AE Related to Study Drug|2|||
44243952|NCT01455415|79073983|FG001|Washout|AE Related to Study Drug|0|||
44243953|NCT01455415|79073982|FG000|Washout|Lost to Follow-up|1|||
44243954|NCT01455415|79073983|FG001|Washout|Lost to Follow-up|0|||
44243955|NCT01455415|79073982|FG000|Washout|Drug Error not Associated to AE|2|||
44243956|NCT01455415|79073983|FG001|Washout|Drug Error not Associated to AE|1|||
44243957|NCT01455415|79073982|FG000|Washout|AE Not Related to Study Drug|2|||
44243958|NCT01455415|79073983|FG001|Washout|AE Not Related to Study Drug|3|||
44243959|NCT01455415|79073982|FG000|Washout|Unspecified Reason|1|||
44243960|NCT01455415|79073983|FG001|Washout|Unspecified Reason|2|||
44243961|NCT01455415|79073982|FG000|Washout|Protocol Violation|0|||
44243962|NCT01455415|79073983|FG001|Washout|Protocol Violation|1|||
44140196|NCT02739269|78928970|FG001|Overall Study|Cycle cancellation|2|||
44140197|NCT02739269|78928969|FG000|Overall Study|Withdrawal by Subject|0|||
44140198|NCT02739269|78928970|FG001|Overall Study|Withdrawal by Subject|2|||
44140199|NCT03318523|78928980|FG000|PC Period: Up to Year 1|Adverse Event|1|||
44140200|NCT03318523|78928981|FG001|PC Period: Up to Year 1|Adverse Event|0|||
44140201|NCT03318523|78928982|FG002|PC Period: Up to Year 1|Adverse Event|2|||
44140202|NCT03318523|78928983|FG003|PC Period: Up to Year 1|Adverse Event|0|||
44140203|NCT03318523|78928984|FG004|PC Period: Up to Year 1|Adverse Event|0|||
44140204|NCT03318523|78928985|FG005|PC Period: Up to Year 1|Adverse Event|0|||
44140205|NCT03318523|78928986|FG006|PC Period: Up to Year 1|Adverse Event|0|||
44140206|NCT03318523|78928987|FG007|PC Period: Up to Year 1|Adverse Event|0|||
44140207|NCT03318523|78928988|FG008|PC Period: Up to Year 1|Adverse Event|0|||
44140208|NCT03318523|78928989|FG009|PC Period: Up to Year 1|Adverse Event|0|||
44140209|NCT03318523|78928980|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
44140210|NCT03318523|78928981|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
44140211|NCT03318523|78928982|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140212|NCT03318523|78928983|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
44140213|NCT03318523|78928984|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140214|NCT03318523|78928985|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140215|NCT03318523|78928986|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140216|NCT03318523|78928987|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140217|NCT03318523|78928988|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140218|NCT03318523|78928989|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
44140219|NCT03318523|78928980|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140220|NCT03318523|78928981|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140221|NCT03318523|78928982|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140222|NCT03318523|78928983|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140223|NCT03318523|78928984|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
44140224|NCT03318523|78928985|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140225|NCT03318523|78928986|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140226|NCT03318523|78928987|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
44140227|NCT03318523|78928988|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
44140228|NCT03318523|78928989|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
44140229|NCT03318523|78928980|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
44140230|NCT03318523|78928981|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
44140231|NCT03318523|78928982|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
44140232|NCT03318523|78928983|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
44140233|NCT03318523|78928984|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
44140234|NCT03318523|78928985|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
44243963|NCT01455415|79073982|FG000|Period 2|AE Related to Study Drug|1|||
44243964|NCT01455415|79073983|FG001|Period 2|AE Related to Study Drug|2|||
44243965|NCT01455415|79073982|FG000|Period 2|Lost to Follow-up|2|||
44243966|NCT01455415|79073983|FG001|Period 2|Lost to Follow-up|1|||
44243967|NCT01455415|79073982|FG000|Period 2|AE Not Related to Study Drug|2|||
44243968|NCT01455415|79073983|FG001|Period 2|AE Not Related to Study Drug|1|||
44243969|NCT01455415|79073982|FG000|Period 2|Lack of Efficacy|2|||
44243970|NCT01455415|79073983|FG001|Period 2|Lack of Efficacy|0|||
44243971|NCT01455415|79073982|FG000|Period 2|Withdrawal by Subject|2|||
44243972|NCT01455415|79073983|FG001|Period 2|Withdrawal by Subject|3|||
44243973|NCT01455415|79073982|FG000|Period 2|Unspecified Reason|2|||
44243974|NCT01455415|79073983|FG001|Period 2|Unspecified Reason|3|||
44243975|NCT01455415|79073982|FG000|Period 2|Protocol Violation|2|||
44243976|NCT01455415|79073983|FG001|Period 2|Protocol Violation|0|||
44243977|NCT01455415|79073982|FG000|Follow-up|AE Related to Study Drug|0|||
44243978|NCT01455415|79073983|FG001|Follow-up|AE Related to Study Drug|1|||
44243979|NCT01455415|79073982|FG000|Follow-up|Lack of Efficacy|0|||
44243980|NCT01455415|79073983|FG001|Follow-up|Lack of Efficacy|1|||
44243981|NCT01455415|79073982|FG000|Follow-up|Withdrawal by Subject|2|||
44243982|NCT01455415|79073983|FG001|Follow-up|Withdrawal by Subject|0|||
44243983|NCT01455415|79073982|FG000|Follow-up|Unspecified Reason|1|||
44243984|NCT01455415|79073983|FG001|Follow-up|Unspecified Reason|0|||
44243985|NCT01471171|79073989|FG000|Treatment Period 1|Adverse Event|4|||
44243986|NCT01471171|79073990|FG001|Treatment Period 1|Adverse Event|1|||
44243987|NCT01471171|79073989|FG000|Treatment Period 2|Adverse Event|1|||
44243988|NCT01471171|79073990|FG001|Treatment Period 2|Adverse Event|0|||
44140235|NCT03318523|78928986|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
44140236|NCT03318523|78928987|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
44140237|NCT03318523|78928988|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
44243989|NCT01471093|79073998|FG000|Overall Study|Adverse Event|1|||
44243990|NCT01471093|79073999|FG001|Overall Study|Adverse Event|0|||
44140238|NCT03318523|78928989|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
44140239|NCT03318523|78928980|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140240|NCT03318523|78928981|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140241|NCT03318523|78928982|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140242|NCT03318523|78928983|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140243|NCT03318523|78928984|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140244|NCT03318523|78928985|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
44140245|NCT03318523|78928986|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140246|NCT03318523|78928987|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140247|NCT03318523|78928988|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140248|NCT03318523|78928989|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
44140249|NCT03318523|78928980|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140250|NCT03318523|78928981|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140251|NCT03318523|78928982|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140252|NCT03318523|78928983|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140253|NCT03318523|78928984|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140254|NCT03318523|78928985|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140255|NCT03318523|78928986|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140256|NCT03318523|78928987|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140257|NCT03318523|78928988|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
44140258|NCT03318523|78928989|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
44140259|NCT03318523|78928980|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
44140260|NCT03318523|78928981|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
44140261|NCT03318523|78928982|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
44140262|NCT03318523|78928983|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
44140263|NCT03318523|78928984|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
44140264|NCT03318523|78928985|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
44140265|NCT03318523|78928986|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
44140266|NCT03318523|78928987|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
44140267|NCT03318523|78928988|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
44140268|NCT03318523|78928989|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
44140269|NCT03318523|78928980|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140270|NCT03318523|78928981|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140271|NCT03318523|78928982|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140272|NCT03318523|78928983|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140273|NCT03318523|78928984|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
44140274|NCT03318523|78928985|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140275|NCT03318523|78928986|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140276|NCT03318523|78928987|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
44140277|NCT03318523|78928988|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
44140278|NCT03318523|78928989|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
44140279|NCT01678209|78929016|FG000|Overall Study|could not scan twice|1|||
44140280|NCT01678209|78929017|FG001|Overall Study|could not scan twice|1|||
44140281|NCT01678209|78929018|FG002|Overall Study|could not scan twice|1|||
44140282|NCT01678209|78929016|FG000|Overall Study|scheduling conflicts|0|||
44140283|NCT01678209|78929017|FG001|Overall Study|scheduling conflicts|0|||
44140284|NCT01678209|78929018|FG002|Overall Study|scheduling conflicts|1|||
44140285|NCT01678209|78929016|FG000|Overall Study|screen fail|16|||
44140286|NCT01678209|78929017|FG001|Overall Study|screen fail|17|||
44140287|NCT01678209|78929018|FG002|Overall Study|screen fail|16|||
44243991|NCT01471093|79074000|FG002|Overall Study|Adverse Event|0|||
44513712|NCT03129100|79519003|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513713|NCT03129100|79519004|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513714|NCT03129100|79519005|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513715|NCT03129100|79519006|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513716|NCT03129100|79519007|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513717|NCT03129100|79519008|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513718|NCT03129100|79519009|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513719|NCT03129100|79519010|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513720|NCT03129100|79519011|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513721|NCT03129100|79519012|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513722|NCT03129100|79519013|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44140288|NCT02239120|78929028|FG000|Overall Study|Death|56|||
44140289|NCT02239120|78929029|FG001|Overall Study|Death|58|||
44140290|NCT02239120|78929028|FG000|Overall Study|Lost to Follow-up|19|||
44140291|NCT02239120|78929029|FG001|Overall Study|Lost to Follow-up|14|||
44140292|NCT01603407|78929038|FG000|Overall Study|Adverse Event|1|||
44140293|NCT01603407|78929039|FG001|Overall Study|Adverse Event|1|||
44140294|NCT01603407|78929040|FG002|Overall Study|Adverse Event|1|||
44140295|NCT01603407|78929038|FG000|Overall Study|Protocol Violation|2|||
44140296|NCT01603407|78929039|FG001|Overall Study|Protocol Violation|2|||
44140297|NCT01603407|78929040|FG002|Overall Study|Protocol Violation|0|||
44140298|NCT01603407|78929038|FG000|Overall Study|Withdrawal by Subject|8|||
44140299|NCT01603407|78929039|FG001|Overall Study|Withdrawal by Subject|5|||
44140300|NCT01603407|78929040|FG002|Overall Study|Withdrawal by Subject|7|||
44140301|NCT01603407|78929038|FG000|Overall Study|Lost to Follow-up|0|||
44140302|NCT01603407|78929039|FG001|Overall Study|Lost to Follow-up|3|||
44140303|NCT01603407|78929040|FG002|Overall Study|Lost to Follow-up|2|||
44140304|NCT02235454|78929070|FG000|Overall Study|Withdrawal by Subject|2|||
44140305|NCT02235298|78929076|FG000|Overall Study|Lost to Follow-up|6|||
44140306|NCT02235298|78929077|FG001|Overall Study|Lost to Follow-up|5|||
44140307|NCT02235298|78929076|FG000|Overall Study|Adverse Event|2|||
44140308|NCT02235298|78929077|FG001|Overall Study|Adverse Event|2|||
44140309|NCT02235298|78929076|FG000|Overall Study|Withdrawal by Subject|0|||
44140310|NCT02235298|78929077|FG001|Overall Study|Withdrawal by Subject|1|||
44140311|NCT02234596|78929083|FG000|Overall Study|Participant not treated|2|||
44140312|NCT02234362|78929087|FG000|Overall Study|Not eligible after first screening visit|17|||
44140313|NCT02234362|78929087|FG000|Overall Study|Lost to Follow-up|6|||
44140314|NCT02234362|78929087|FG000|Overall Study|Withdrawal by Subject|3|||
44140315|NCT02234284|78929093|FG000|Overall Study|Death|4|||
44140316|NCT02234284|78929094|FG001|Overall Study|Death|2|||
44140317|NCT02234284|78929093|FG000|Overall Study|Withdrawal by Subject|1|||
44140318|NCT02234284|78929094|FG001|Overall Study|Withdrawal by Subject|0|||
44140319|NCT02234284|78929093|FG000|Overall Study|Lost to Follow-up|20|||
44140320|NCT02234284|78929094|FG001|Overall Study|Lost to Follow-up|7|||
44140321|NCT02232880|78929104|FG000|Overall Study|study stopped prior to randomization|1|||
44140322|NCT02896855|78929110|FG000|Overall Study|Death|50|||
44140323|NCT02896855|78929111|FG001|Overall Study|Death|40|||
44140324|NCT02896855|78929110|FG000|Overall Study|Lost to Follow-up|15|||
44140325|NCT02896855|78929111|FG001|Overall Study|Lost to Follow-up|9|||
44140326|NCT02896855|78929110|FG000|Overall Study|Withdrawal by Subject|7|||
44140327|NCT02896855|78929111|FG001|Overall Study|Withdrawal by Subject|4|||
44140328|NCT02232802|78929122|FG000|Period 1|Sponsor request|1|||
44140329|NCT02232802|78929123|FG001|Period 1|Sponsor request|0|||
44140330|NCT02232802|78929122|FG000|Period 1|Adverse Event|1|||
44140331|NCT02232802|78929123|FG001|Period 1|Adverse Event|1|||
44140332|NCT02434328|78929131|FG000|Overall Study|Adverse Event|9|||
44140333|NCT02434328|78929132|FG001|Overall Study|Adverse Event|4|||
44140334|NCT02434328|78929131|FG000|Overall Study|Lack of Efficacy|0|||
44140335|NCT02434328|78929132|FG001|Overall Study|Lack of Efficacy|2|||
44140336|NCT02434328|78929131|FG000|Overall Study|Physician Decision|0|||
44140337|NCT02434328|78929132|FG001|Overall Study|Physician Decision|1|||
44140338|NCT02434328|78929131|FG000|Overall Study|Withdrawal by Subject|12|||
44140339|NCT02434328|78929132|FG001|Overall Study|Withdrawal by Subject|21|||
44140340|NCT02434328|78929131|FG000|Overall Study|Death|4|||
44140341|NCT02434328|78929132|FG001|Overall Study|Death|7|||
44140342|NCT02434328|78929131|FG000|Overall Study|Lost to Follow-up|1|||
44140343|NCT02434328|78929132|FG001|Overall Study|Lost to Follow-up|6|||
44140344|NCT02434328|78929131|FG000|Overall Study|Other|4|||
44140345|NCT02434328|78929132|FG001|Overall Study|Other|1|||
44243992|NCT01471093|79074001|FG003|Overall Study|Adverse Event|0|||
44243993|NCT01471015|79074010|FG000|Overall Study|Death|0|||
44243994|NCT01471015|79074011|FG001|Overall Study|Death|1|||
44243995|NCT01471015|79074012|FG002|Overall Study|Death|1|||
44243996|NCT01497067|79074020|FG000|Overall Study|Lost to Follow-up|56|||
44243997|NCT01497067|79074020|FG000|Overall Study|Adverse Event|3|||
44243998|NCT01497067|79074020|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
44243999|NCT01497067|79074020|FG000|Overall Study|Other|13|||
44140346|NCT02660229|78929141|FG000|Overall Study|Adverse Event|2|||
44140347|NCT02660229|78929142|FG001|Overall Study|Adverse Event|0|||
44140348|NCT02660229|78929141|FG000|Overall Study|Withdrawal by Subject|0|||
44140349|NCT02660229|78929142|FG001|Overall Study|Withdrawal by Subject|1|||
44140350|NCT02232178|78929151|FG000|Overall Study|Lost to Follow-up|0|||
44140351|NCT02232178|78929152|FG001|Overall Study|Lost to Follow-up|1|||
44140352|NCT02232178|78929153|FG002|Overall Study|Lost to Follow-up|0|||
44140353|NCT02232178|78929151|FG000|Overall Study|ineligibility|0|||
44140354|NCT02232178|78929152|FG001|Overall Study|ineligibility|0|||
44140355|NCT02232178|78929153|FG002|Overall Study|ineligibility|1|||
44140356|NCT02232178|78929151|FG000|Overall Study|surgical complication|1|||
44140357|NCT02232178|78929152|FG001|Overall Study|surgical complication|0|||
44140358|NCT02232178|78929153|FG002|Overall Study|surgical complication|0|||
44140359|NCT01678131|78929164|FG000|Overall Study|Adverse Event|0|||
44140360|NCT01678131|78929165|FG001|Overall Study|Adverse Event|1|||
44140361|NCT01678131|78929166|FG002|Overall Study|Adverse Event|0|||
44140362|NCT01678131|78929164|FG000|Overall Study|Withdrawal by Subject|0|||
44140363|NCT01678131|78929165|FG001|Overall Study|Withdrawal by Subject|0|||
44140364|NCT01678131|78929166|FG002|Overall Study|Withdrawal by Subject|2|||
44140365|NCT02231164|78929176|FG000|Overall Study|Adverse Event|1|||
44140366|NCT02231164|78929177|FG001|Overall Study|Adverse Event|1|||
44140367|NCT02231164|78929176|FG000|Overall Study|Lack of Efficacy|4|||
44140368|NCT02231164|78929177|FG001|Overall Study|Lack of Efficacy|3|||
44140369|NCT02231164|78929176|FG000|Overall Study|Withdrawal by Subject|1|||
44140370|NCT02231164|78929177|FG001|Overall Study|Withdrawal by Subject|2|||
44140371|NCT02457182|78929185|FG000|Overall Study|Lost to Follow-up|1|||
44140372|NCT02457182|78929186|FG001|Overall Study|Lost to Follow-up|0|||
44140373|NCT02230384|78929194|FG000|Phase 1|Lost to Follow-up|1|||
44140374|NCT02230384|78929195|FG001|Phase 1|Lost to Follow-up|0|||
44140375|NCT02230384|78929194|FG000|Phase 1|Physician Decision|0|||
44140376|NCT02230384|78929195|FG001|Phase 1|Physician Decision|1|||
44140377|NCT02230384|78929194|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
44140378|NCT02230384|78929195|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
44140379|NCT02230384|78929194|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
44140380|NCT02230384|78929195|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
44140381|NCT02230384|78929194|FG000|Phase 2 - Switch|Adverse Event|2|||
44140382|NCT02230384|78929195|FG001|Phase 2 - Switch|Adverse Event|0|||
44140383|NCT02738801|78929211|FG000|Overall Study|Adverse Event|1|||
44140384|NCT02738801|78929212|FG001|Overall Study|Adverse Event|1|||
44140385|NCT02738801|78929211|FG000|Overall Study|Withdrawal by Subject|0|||
44140386|NCT02738801|78929212|FG001|Overall Study|Withdrawal by Subject|1|||
44140387|NCT02230306|78929228|FG000|Overall Study|Did not receive study treatment|1|||
44140388|NCT01680861|78929234|FG000|Early Post-transplant Period|Protocol Violation|1|||
44140389|NCT01680861|78929235|FG001|Early Post-transplant Period|Protocol Violation|1|||
44140390|NCT02229214|78929245|FG000|Overall Study|Adverse Event|2|||
44140391|NCT02229214|78929246|FG001|Overall Study|Adverse Event|0|||
44140392|NCT02229214|78929245|FG000|Overall Study|Withdrawal by Subject|4|||
44140393|NCT02229214|78929246|FG001|Overall Study|Withdrawal by Subject|0|||
44140394|NCT02228980|78929258|FG000|Overall Study|Adverse Event|14|||
44140395|NCT02228980|78929259|FG001|Overall Study|Adverse Event|0|||
44140396|NCT02228980|78929260|FG002|Overall Study|Adverse Event|0|||
44140397|NCT02228980|78929261|FG003|Overall Study|Adverse Event|0|||
44140398|NCT02228980|78929258|FG000|Overall Study|Protocol Violation|7|||
44140399|NCT02228980|78929259|FG001|Overall Study|Protocol Violation|0|||
44140400|NCT02228980|78929260|FG002|Overall Study|Protocol Violation|0|||
44140401|NCT02228980|78929261|FG003|Overall Study|Protocol Violation|0|||
44140402|NCT02228980|78929258|FG000|Overall Study|Withdrawal by Subject|3|||
44140403|NCT02228980|78929259|FG001|Overall Study|Withdrawal by Subject|3|||
44140404|NCT02228980|78929260|FG002|Overall Study|Withdrawal by Subject|2|||
44140405|NCT02228980|78929261|FG003|Overall Study|Withdrawal by Subject|3|||
44140406|NCT02228590|78929275|FG000|Overall Study|Withdrawal by Subject|1|||
44140407|NCT02227108|78929280|FG000|Overall Study|Did not receive treatment|2|||
44140408|NCT02227108|78929280|FG000|Overall Study|Other|3|||
44140409|NCT02227108|78929280|FG000|Overall Study|Progressive disease|17|||
44140410|NCT02227108|78929280|FG000|Overall Study|Initiation of alternative therapy|2|||
44140411|NCT02227108|78929280|FG000|Overall Study|Investigator discretion|1|||
44140412|NCT02227108|78929280|FG000|Overall Study|Adverse Event|6|||
44140413|NCT03564145|78929284|FG000|Overall Study|Adverse Event|4|||
44140414|NCT03564145|78929284|FG000|Overall Study|Lost to Follow-up|21|||
44140415|NCT03564145|78929284|FG000|Overall Study|Protocol Violation|2|||
44140416|NCT03564145|78929284|FG000|Overall Study|Withdrawal by Subject|48|||
44140417|NCT03564145|78929284|FG000|Overall Study|Study Terminated by Sponsor|146|||
44140418|NCT03564145|78929284|FG000|Overall Study|Physician Decision|1|||
44140419|NCT03564145|78929284|FG000|Overall Study|Other Than Specified|1|||
44140420|NCT03564145|78929284|FG000|Overall Study|Pregnancy|1|||
44140421|NCT02226562|78929290|FG000|Overall Study|Lost to Follow-up|0|||
44140422|NCT02226562|78929291|FG001|Overall Study|Lost to Follow-up|1|||
44140423|NCT02456636|78929325|FG000|Overall Study|Death|0|||
44140424|NCT02456636|78929326|FG001|Overall Study|Death|3|||
44140425|NCT02456636|78929327|FG002|Overall Study|Death|0|||
44140426|NCT02456636|78929325|FG000|Overall Study|Pregnancy|1|||
44140427|NCT02456636|78929326|FG001|Overall Study|Pregnancy|3|||
44140428|NCT02456636|78929327|FG002|Overall Study|Pregnancy|5|||
44140429|NCT02456636|78929325|FG000|Overall Study|Physician Decision|4|||
44140430|NCT02456636|78929326|FG001|Overall Study|Physician Decision|5|||
44140431|NCT02456636|78929327|FG002|Overall Study|Physician Decision|4|||
44140432|NCT02456636|78929325|FG000|Overall Study|Withdrawal by Subject|13|||
44140433|NCT02456636|78929326|FG001|Overall Study|Withdrawal by Subject|14|||
44140434|NCT02456636|78929327|FG002|Overall Study|Withdrawal by Subject|16|||
44140435|NCT02456636|78929325|FG000|Overall Study|Lost to Follow-up|50|||
44140436|NCT02456636|78929326|FG001|Overall Study|Lost to Follow-up|44|||
44140437|NCT02456636|78929327|FG002|Overall Study|Lost to Follow-up|50|||
44140438|NCT02226172|78929335|FG000|Overall Study|Participant refused further follow-up|4|||
44140439|NCT02226172|78929335|FG000|Overall Study|Other|5|||
44140440|NCT02226172|78929335|FG000|Overall Study|Death|1|||
44140441|NCT02226172|78929335|FG000|Overall Study|Study terminated by sponsor|1|||
44140442|NCT02226172|78929335|FG000|Overall Study|Adverse Event|6|||
44140443|NCT01676961|78929339|FG000|Overall Study|Death|3|||
44140444|NCT01676961|78929339|FG000|Overall Study|Lost to Follow-up|1|||
44140445|NCT01676961|78929339|FG000|Overall Study|Withdrawal by Subject|1|||
44140446|NCT01676727|78929361|FG000|Overall Study|Death|18|||
44140447|NCT01676727|78929361|FG000|Overall Study|Withdrawal by Subject|6|||
44140448|NCT01676727|78929361|FG000|Overall Study|Screening failure|5|||
44140449|NCT01676727|78929361|FG000|Overall Study|Not willing to attend 1-year visit|2|||
44140450|NCT01676727|78929361|FG000|Overall Study|Valve explanted|1|||
44140451|NCT02738879|78929368|FG000|Overall Study|Adverse Event|1|||
44140452|NCT02738879|78929369|FG001|Overall Study|Adverse Event|1|||
44140453|NCT02738879|78929368|FG000|Overall Study|Death|0|||
44140454|NCT02738879|78929369|FG001|Overall Study|Death|2|||
44140455|NCT02738879|78929368|FG000|Overall Study|Lost to Follow-up|1|||
44140456|NCT02738879|78929369|FG001|Overall Study|Lost to Follow-up|5|||
44140457|NCT02738879|78929368|FG000|Overall Study|Protocol Violation|1|||
44140458|NCT02738879|78929369|FG001|Overall Study|Protocol Violation|3|||
44140459|NCT02738879|78929368|FG000|Overall Study|Physician Decision|3|||
44140460|NCT02738879|78929369|FG001|Overall Study|Physician Decision|4|||
44140461|NCT02738879|78929368|FG000|Overall Study|Pregnancy|0|||
44140462|NCT02738879|78929369|FG001|Overall Study|Pregnancy|1|||
44140463|NCT02738879|78929368|FG000|Overall Study|Screen Failure|1|||
44140464|NCT02738879|78929369|FG001|Overall Study|Screen Failure|2|||
44140465|NCT02738879|78929368|FG000|Overall Study|Site Discontinued Study Participation|1|||
44140466|NCT02738879|78929369|FG001|Overall Study|Site Discontinued Study Participation|0|||
44140467|NCT02738879|78929368|FG000|Overall Study|Withdrawal by Subject|5|||
44140468|NCT02738879|78929369|FG001|Overall Study|Withdrawal by Subject|7|||
44140469|NCT03502811|78929375|FG000|Overall Study|Death|157|||
44140470|NCT03502811|78929375|FG000|Overall Study|Withdrawal by Subject|105|||
44140471|NCT03502811|78929375|FG000|Overall Study|Lost to Follow-up|26|||
44140472|NCT03502811|78929375|FG000|Overall Study|No Visits (Missed)|31|||
44140473|NCT00515671|78929387|FG000|Overall Study|Lost to Follow-up|13|||
44140474|NCT00515671|78929388|FG001|Overall Study|Lost to Follow-up|10|||
44140475|NCT00515671|78929387|FG000|Overall Study|Withdrawal by Subject|3|||
44140476|NCT00515671|78929388|FG001|Overall Study|Withdrawal by Subject|5|||
44140477|NCT00515671|78929387|FG000|Overall Study|incarcerated|1|||
44140478|NCT00515671|78929388|FG001|Overall Study|incarcerated|2|||
44140479|NCT01677195|78929397|FG000|Overall Study|Lost to Follow-up|14|||
44140480|NCT01677195|78929398|FG001|Overall Study|Lost to Follow-up|22|||
44140481|NCT01677195|78929399|FG002|Overall Study|Lost to Follow-up|22|||
44140482|NCT01677195|78929397|FG000|Overall Study|Withdrawal by Subject|1|||
44140483|NCT01677195|78929398|FG001|Overall Study|Withdrawal by Subject|0|||
44140484|NCT01677195|78929399|FG002|Overall Study|Withdrawal by Subject|1|||
44140485|NCT01677195|78929397|FG000|Overall Study|Adverse Event|6|||
44140486|NCT01677195|78929398|FG001|Overall Study|Adverse Event|4|||
44140487|NCT01677195|78929399|FG002|Overall Study|Adverse Event|1|||
44140488|NCT01677195|78929397|FG000|Overall Study|Physician Decision|1|||
44140489|NCT01677195|78929398|FG001|Overall Study|Physician Decision|2|||
44140490|NCT01677195|78929399|FG002|Overall Study|Physician Decision|2|||
44140491|NCT01677195|78929397|FG000|Overall Study|Pregnancy|0|||
44140492|NCT01677195|78929398|FG001|Overall Study|Pregnancy|1|||
44140493|NCT01677195|78929399|FG002|Overall Study|Pregnancy|0|||
44140494|NCT01677195|78929397|FG000|Overall Study|Protocol Violation|7|||
44140495|NCT01677195|78929398|FG001|Overall Study|Protocol Violation|3|||
44140496|NCT01677195|78929399|FG002|Overall Study|Protocol Violation|4|||
44140497|NCT00928447|78929411|FG000|Overall Study|Withdrawal by Subject|1|||
44140498|NCT00928447|78929411|FG000|Overall Study|Investigator's decision|1|||
44140499|NCT02224846|78929417|FG000|Period 1 (Month 3)|Adverse Event|2|||
44140500|NCT02224846|78929418|FG001|Period 1 (Month 3)|Adverse Event|1|||
44140501|NCT02224846|78929417|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
44140502|NCT02224846|78929418|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
44140503|NCT02224846|78929417|FG000|Period 1 (Month 3)|Protocol Violation|4|||
44276608|NCT04791319|79237613|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
44276609|NCT04791319|79237614|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
44140504|NCT02224846|78929418|FG001|Period 1 (Month 3)|Protocol Violation|8|||
44140505|NCT02224846|78929417|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
44140506|NCT02224846|78929418|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
44140507|NCT02224846|78929417|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
44140508|NCT02224846|78929418|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
44140509|NCT02224846|78929417|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
44140510|NCT02224846|78929418|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
44140511|NCT02224846|78929417|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
44140512|NCT02224846|78929418|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
44140513|NCT02224846|78929417|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
44140514|NCT02224846|78929418|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
44140515|NCT02224846|78929417|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
44140516|NCT02224846|78929418|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
44140517|NCT02224846|78929417|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
44140518|NCT02224846|78929418|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
44140519|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
44140520|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
44140521|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
44140522|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
44140523|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
44140524|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
44140525|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
44140526|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
44140527|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
44140528|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
44140529|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
44140530|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
44140531|NCT02224846|78929417|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
44140532|NCT02224846|78929418|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
44140533|NCT01632280|78929426|FG000|Overall Study|Withdrawal by Subject|1|||
44140534|NCT01632280|78929427|FG001|Overall Study|Withdrawal by Subject|0|||
44140535|NCT02224690|78929435|FG000|Overall Study|Adverse Event|8|||
44140536|NCT02224690|78929436|FG001|Overall Study|Adverse Event|1|||
44513723|NCT03129100|79519014|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513724|NCT03129100|79519015|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513725|NCT03129100|79519016|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513726|NCT03129100|79519017|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513727|NCT03129100|79519018|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513728|NCT03129100|79519019|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513729|NCT03129100|79519020|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513730|NCT03129100|79519021|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513731|NCT03129100|79519022|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513732|NCT03129100|79519023|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
44513733|NCT03129100|79519024|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
44513734|NCT03129100|79519025|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
44513735|NCT03129100|79519000|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513736|NCT03129100|79519001|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513737|NCT03129100|79519002|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513738|NCT03129100|79519003|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513739|NCT03129100|79519004|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513740|NCT03129100|79519005|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513741|NCT03129100|79519006|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513742|NCT03129100|79519007|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513743|NCT03129100|79519008|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513744|NCT03129100|79519009|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44140537|NCT02224690|78929435|FG000|Overall Study|Met Withdrawal Criteria|4|||
44140538|NCT02224690|78929436|FG001|Overall Study|Met Withdrawal Criteria|0|||
44140539|NCT02224690|78929435|FG000|Overall Study|Use of G-tube|1|||
44513745|NCT03129100|79519010|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44140540|NCT02224690|78929436|FG001|Overall Study|Use of G-tube|0|||
44140541|NCT02224690|78929435|FG000|Overall Study|Did not meet eligibility criteria|1|||
44140542|NCT02224690|78929436|FG001|Overall Study|Did not meet eligibility criteria|0|||
44140543|NCT01634152|78929445|FG000|Overall Study|Adverse Event|2|||
44140544|NCT01634152|78929446|FG001|Overall Study|Adverse Event|0|||
44140545|NCT01634152|78929447|FG002|Overall Study|Adverse Event|2|||
44140546|NCT01634152|78929445|FG000|Overall Study|Consent withdrawn not due to AE|1|||
44140547|NCT01634152|78929446|FG001|Overall Study|Consent withdrawn not due to AE|0|||
44140548|NCT01634152|78929447|FG002|Overall Study|Consent withdrawn not due to AE|1|||
44140549|NCT01634152|78929445|FG000|Overall Study|Not treated|0|||
44140550|NCT01634152|78929446|FG001|Overall Study|Not treated|1|||
44140551|NCT01634152|78929447|FG002|Overall Study|Not treated|0|||
44140552|NCT01634152|78929445|FG000|Overall Study|Other reason not defined above|1|||
44513746|NCT03129100|79519011|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44140553|NCT01634152|78929446|FG001|Overall Study|Other reason not defined above|0|||
44244000|NCT01470469|79074050|FG000|Overall Study|Withdrawal by Subject|4|||
44513747|NCT03129100|79519012|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513748|NCT03129100|79519013|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513749|NCT03129100|79519014|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513750|NCT03129100|79519015|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513751|NCT03129100|79519016|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513752|NCT03129100|79519017|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513753|NCT03129100|79519018|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513754|NCT03129100|79519019|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513755|NCT03129100|79519020|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513756|NCT03129100|79519021|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513757|NCT03129100|79519022|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
44513758|NCT03129100|79519023|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
44513759|NCT03129100|79519024|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
44513760|NCT03129100|79519025|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
44513761|NCT03129100|79519000|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44244001|NCT01470469|79074051|FG001|Overall Study|Withdrawal by Subject|6|||
44244002|NCT01470469|79074050|FG000|Overall Study|Lack of Efficacy|1|||
44513762|NCT03129100|79519001|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44140554|NCT01634152|78929447|FG002|Overall Study|Other reason not defined above|1|||
44140555|NCT03862807|78929455|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
44140556|NCT04906499|78929459|FG000|Overall Study|Lack of time|1|||
44140557|NCT04757649|78929463|FG000|Overall Study|Withdrawal by Subject|1|||
44140558|NCT04757649|78929463|FG000|Overall Study|Adverse Event|1|||
44140559|NCT04393779|78929467|FG000|Overall Study|Death|1|||
44140560|NCT04393779|78929467|FG000|Overall Study|Device reintervention or explant|4|||
44140561|NCT03718884|78929471|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
44140562|NCT03718884|78929472|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
44140563|NCT03718884|78929471|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
44140564|NCT03718884|78929472|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
44140565|NCT03509467|78929495|FG000|Overall Study|Withdrawal by Subject|5|||
44140566|NCT03509467|78929496|FG001|Overall Study|Withdrawal by Subject|1|||
44140567|NCT03509467|78929497|FG002|Overall Study|Withdrawal by Subject|6|||
44140568|NCT03509467|78929498|FG003|Overall Study|Withdrawal by Subject|7|||
44140569|NCT03509467|78929499|FG004|Overall Study|Withdrawal by Subject|10|||
44140570|NCT03509467|78929500|FG005|Overall Study|Withdrawal by Subject|10|||
44140571|NCT03509467|78929501|FG006|Overall Study|Withdrawal by Subject|10|||
44140572|NCT03509467|78929502|FG007|Overall Study|Withdrawal by Subject|10|||
44140573|NCT03509467|78929495|FG000|Overall Study|Death|0|||
44140574|NCT03509467|78929496|FG001|Overall Study|Death|0|||
44140575|NCT03509467|78929497|FG002|Overall Study|Death|2|||
44140576|NCT03509467|78929498|FG003|Overall Study|Death|2|||
44140577|NCT03509467|78929499|FG004|Overall Study|Death|1|||
44140578|NCT03509467|78929500|FG005|Overall Study|Death|0|||
44140579|NCT03509467|78929501|FG006|Overall Study|Death|1|||
44140580|NCT03509467|78929502|FG007|Overall Study|Death|0|||
44140581|NCT03509467|78929495|FG000|Overall Study|Proxy Withdrawal|0|||
44140582|NCT03509467|78929496|FG001|Overall Study|Proxy Withdrawal|0|||
44140583|NCT03509467|78929497|FG002|Overall Study|Proxy Withdrawal|0|||
44140584|NCT03509467|78929498|FG003|Overall Study|Proxy Withdrawal|0|||
44140585|NCT03509467|78929499|FG004|Overall Study|Proxy Withdrawal|0|||
44140586|NCT03509467|78929500|FG005|Overall Study|Proxy Withdrawal|0|||
44140587|NCT03509467|78929501|FG006|Overall Study|Proxy Withdrawal|0|||
44140588|NCT03509467|78929502|FG007|Overall Study|Proxy Withdrawal|1|||
44140589|NCT03406156|78929526|FG000|Overall Study|Death|6|||
44140590|NCT03406156|78929527|FG001|Overall Study|Death|2|||
44140591|NCT03406156|78929526|FG000|Overall Study|Withdrawal by Subject|0|||
44140592|NCT03406156|78929527|FG001|Overall Study|Withdrawal by Subject|2|||
44244003|NCT01470469|79074051|FG001|Overall Study|Lack of Efficacy|7|||
44513763|NCT03129100|79519002|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513764|NCT03129100|79519003|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513765|NCT03129100|79519004|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513766|NCT03129100|79519005|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513767|NCT03129100|79519006|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513768|NCT03129100|79519007|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513769|NCT03129100|79519008|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513770|NCT03129100|79519009|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44140593|NCT03406156|78929526|FG000|Overall Study|COVID-19 infection|1|||
44244004|NCT01470469|79074050|FG000|Overall Study|Adverse Event|0|||
44140594|NCT03406156|78929527|FG001|Overall Study|COVID-19 infection|0|||
44140595|NCT03406156|78929526|FG000|Overall Study|Non-compliance with study procedures|0|||
44140596|NCT03406156|78929527|FG001|Overall Study|Non-compliance with study procedures|1|||
44140597|NCT03406156|78929526|FG000|Overall Study|Other, not specified|0|||
44140598|NCT03406156|78929527|FG001|Overall Study|Other, not specified|1|||
44140599|NCT03021954|78929537|FG000|Overall Study|Lost to Follow-up|10|||
44140600|NCT03021954|78929538|FG001|Overall Study|Lost to Follow-up|43|||
44140601|NCT03021954|78929537|FG000|Overall Study|Subjects had avulsion trauma|4|||
44513771|NCT03129100|79519010|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513772|NCT03129100|79519011|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513773|NCT03129100|79519012|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513774|NCT03129100|79519013|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513775|NCT03129100|79519014|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513776|NCT03129100|79519015|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513777|NCT03129100|79519016|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513778|NCT03129100|79519017|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513779|NCT03129100|79519018|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513780|NCT03129100|79519019|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44140602|NCT03021954|78929538|FG001|Overall Study|Subjects had avulsion trauma|1|||
44140603|NCT02994927|78929548|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44140604|NCT02994927|78929549|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44140605|NCT02994927|78929548|FG000|Overall Study|Did not meet eligibility criteria|0|||
44140606|NCT02994927|78929549|FG001|Overall Study|Did not meet eligibility criteria|1|||
44513781|NCT03129100|79519020|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513782|NCT03129100|79519021|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513783|NCT03129100|79519022|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513784|NCT03129100|79519023|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513785|NCT03129100|79519024|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
44513786|NCT03129100|79519025|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
44513787|NCT03129100|79519000|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513788|NCT03129100|79519001|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513789|NCT03129100|79519002|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513790|NCT03129100|79519003|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513791|NCT03129100|79519004|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513792|NCT03129100|79519005|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513793|NCT03129100|79519006|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513794|NCT03129100|79519007|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513795|NCT03129100|79519008|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513796|NCT03129100|79519009|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513797|NCT03129100|79519010|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513798|NCT03129100|79519011|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513799|NCT03129100|79519012|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513800|NCT03129100|79519013|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513801|NCT03129100|79519014|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513802|NCT03129100|79519015|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513803|NCT03129100|79519016|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513804|NCT03129100|79519017|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513805|NCT03129100|79519018|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513806|NCT03129100|79519019|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513807|NCT03129100|79519020|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513808|NCT03129100|79519021|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513809|NCT03129100|79519022|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513810|NCT03129100|79519023|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513811|NCT03129100|79519024|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
44513812|NCT03129100|79519025|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
44513813|NCT03129100|79519000|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
44513814|NCT03129100|79519001|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
44513815|NCT03129100|79519002|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
44513816|NCT03129100|79519003|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
44513817|NCT03129100|79519004|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
44513818|NCT03129100|79519005|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
44513819|NCT03129100|79519006|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
44513820|NCT03129100|79519007|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
44513821|NCT03129100|79519008|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
44513822|NCT03129100|79519009|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
44513823|NCT03129100|79519010|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
44513824|NCT03129100|79519011|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
44513825|NCT03129100|79519012|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
44513826|NCT03129100|79519013|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
44513827|NCT03129100|79519014|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
44276610|NCT04791319|79237615|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44276611|NCT04791319|79237616|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44276612|NCT04791319|79237617|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44513828|NCT03129100|79519015|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
44513829|NCT03129100|79519016|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
44513830|NCT03129100|79519017|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
44513831|NCT03129100|79519018|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
44513832|NCT03129100|79519019|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
44513833|NCT03129100|79519020|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
44513834|NCT03129100|79519021|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
44513835|NCT03129100|79519022|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
44513836|NCT03129100|79519023|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
44513837|NCT03129100|79519024|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
44513838|NCT03129100|79519025|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
44513839|NCT03101020|79519064|FG000|Overall Study|Lack of time to participate|1|||
44513840|NCT03101020|79519065|FG001|Overall Study|Lack of time to participate|0|||
44513841|NCT03101020|79519064|FG000|Overall Study|Ran over by a car|0|||
44513842|NCT03101020|79519065|FG001|Overall Study|Ran over by a car|1|||
44513843|NCT03101020|79519064|FG000|Overall Study|Withdrawal by Subject|0|||
44513844|NCT03101020|79519065|FG001|Overall Study|Withdrawal by Subject|2|||
44513845|NCT03100942|79519075|FG000|Randomized Treatment Period|Withdrew Consent|4|||
44513846|NCT03100942|79519076|FG001|Randomized Treatment Period|Withdrew Consent|5|||
44513847|NCT03100942|79519077|FG002|Randomized Treatment Period|Withdrew Consent|3|||
44513848|NCT03100942|79519078|FG003|Randomized Treatment Period|Withdrew Consent|3|||
44513849|NCT03100942|79519079|FG004|Randomized Treatment Period|Withdrew Consent|0|||
44513850|NCT03100942|79519080|FG005|Randomized Treatment Period|Withdrew Consent|0|||
44513851|NCT03100942|79519081|FG006|Randomized Treatment Period|Withdrew Consent|0|||
44513852|NCT03100942|79519075|FG000|Randomized Treatment Period|Adverse Event|5|||
44513853|NCT03100942|79519076|FG001|Randomized Treatment Period|Adverse Event|2|||
44513854|NCT03100942|79519077|FG002|Randomized Treatment Period|Adverse Event|1|||
44513855|NCT03100942|79519078|FG003|Randomized Treatment Period|Adverse Event|0|||
44513856|NCT03100942|79519079|FG004|Randomized Treatment Period|Adverse Event|0|||
44513857|NCT03100942|79519080|FG005|Randomized Treatment Period|Adverse Event|0|||
44513858|NCT03100942|79519081|FG006|Randomized Treatment Period|Adverse Event|0|||
44513859|NCT03100942|79519075|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
44140607|NCT02994927|78929548|FG000|Overall Study|Physician Decision|4|||
44140608|NCT02994927|78929549|FG001|Overall Study|Physician Decision|3|||
44140609|NCT02994927|78929548|FG000|Overall Study|Death|4|||
44140610|NCT02994927|78929549|FG001|Overall Study|Death|2|||
44140611|NCT02994927|78929548|FG000|Overall Study|Adverse Event|2|||
44140612|NCT02994927|78929549|FG001|Overall Study|Adverse Event|1|||
44140613|NCT02994927|78929548|FG000|Overall Study|Withdrawal by Subject|3|||
44140614|NCT02994927|78929549|FG001|Overall Study|Withdrawal by Subject|6|||
44140615|NCT02994927|78929548|FG000|Overall Study|Lost to Follow-up|2|||
44140616|NCT02994927|78929549|FG001|Overall Study|Lost to Follow-up|1|||
44140617|NCT02718716|78929560|FG000|Overall Study|Lack of Efficacy|1|||
44140618|NCT02718716|78929561|FG001|Overall Study|Lack of Efficacy|0|||
44244005|NCT01470469|79074051|FG001|Overall Study|Adverse Event|7|||
44244006|NCT01470469|79074050|FG000|Overall Study|Lost to Follow-up|2|||
44513860|NCT03100942|79519076|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
44513861|NCT03100942|79519077|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
44513862|NCT03100942|79519078|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
44513863|NCT03100942|79519079|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
44380430|NCT00902538|79386267|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
44513864|NCT03100942|79519080|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
44513865|NCT03100942|79519081|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
44513866|NCT03100942|79519075|FG000|Randomized Treatment Period|Protocol Violation|0|||
44513867|NCT03100942|79519076|FG001|Randomized Treatment Period|Protocol Violation|1|||
44140619|NCT02718716|78929562|FG002|Overall Study|Lack of Efficacy|0|||
44140620|NCT02718716|78929563|FG003|Overall Study|Lack of Efficacy|0|||
44140621|NCT02718716|78929564|FG004|Overall Study|Lack of Efficacy|0|||
44140622|NCT02032823|78929587|FG000|Overall Study|Death|75|||
44140623|NCT02032823|78929588|FG001|Overall Study|Death|109|||
44140624|NCT02032823|78929587|FG000|Overall Study|Lost to Follow-up|18|||
44140625|NCT02032823|78929588|FG001|Overall Study|Lost to Follow-up|17|||
44140626|NCT02032823|78929587|FG000|Overall Study|Withdrawal by Subject|70|||
44140627|NCT02032823|78929588|FG001|Overall Study|Withdrawal by Subject|53|||
44140628|NCT02032823|78929587|FG000|Overall Study|Ongoing study at data cut-off|755|||
44140629|NCT02032823|78929588|FG001|Overall Study|Ongoing study at data cut-off|731|||
44140630|NCT02032823|78929587|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
44140631|NCT02032823|78929588|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
44140632|NCT01267955|78929594|FG000|Stage 1 (6 Months)|Death|3|||
44140633|NCT01267955|78929594|FG000|Stage 2 (6 Months)|Death|5|||
44140634|NCT01267955|78929594|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
44140635|NCT00890045|78929600|FG000|Overall Study|Death|0|||
44140636|NCT00890045|78929601|FG001|Overall Study|Death|1|||
44140637|NCT00890045|78929600|FG000|Overall Study|Did not receive HeRO Graft|0|||
44140638|NCT00890045|78929601|FG001|Overall Study|Did not receive HeRO Graft|2|||
44140639|NCT00890045|78929600|FG000|Overall Study|Lost to Follow-up|5|||
44140640|NCT00890045|78929601|FG001|Overall Study|Lost to Follow-up|7|||
44140641|NCT00598481|78929614|FG000|Treatment|Physician Decision|1|||
44140642|NCT01378429|78929641|FG000|Overall Study|Noncompliance with study drug|1|||
44140643|NCT01378429|78929642|FG001|Overall Study|Noncompliance with study drug|0|||
44140644|NCT01599754|78929653|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
44140645|NCT01599754|78929654|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
44140646|NCT01599754|78929653|FG000|Overall Study|Participant noncompliance|4|||
44140647|NCT01599754|78929654|FG001|Overall Study|Participant noncompliance|4|||
44140648|NCT01599754|78929653|FG000|Overall Study|Lost to Follow-up|13|||
44140649|NCT01599754|78929654|FG001|Overall Study|Lost to Follow-up|6|||
44140650|NCT01599754|78929653|FG000|Overall Study|Death|31|||
44140651|NCT01599754|78929654|FG001|Overall Study|Death|33|||
44140652|NCT01599754|78929653|FG000|Overall Study|Adverse Event|3|||
44140653|NCT01599754|78929654|FG001|Overall Study|Adverse Event|2|||
44140654|NCT01599754|78929653|FG000|Overall Study|Investigator decision|1|||
44140655|NCT01599754|78929654|FG001|Overall Study|Investigator decision|3|||
44140656|NCT01599754|78929653|FG000|Overall Study|Withdrawal by Subject|24|||
44140657|NCT01599754|78929654|FG001|Overall Study|Withdrawal by Subject|25|||
44140658|NCT01599754|78929653|FG000|Overall Study|Study terminated by sponsor|282|||
44140659|NCT01599754|78929654|FG001|Overall Study|Study terminated by sponsor|285|||
44140660|NCT02223754|78929662|FG000|Period 1|Adverse Event|1|||
44140661|NCT02223754|78929663|FG001|Period 1|Adverse Event|0|||
44140662|NCT02223754|78929662|FG000|Period 1|Lost to Follow-up|0|||
44140663|NCT02223754|78929663|FG001|Period 1|Lost to Follow-up|1|||
44140664|NCT02223754|78929662|FG000|Period 1|Protocol Violation|2|||
44140665|NCT02223754|78929663|FG001|Period 1|Protocol Violation|4|||
44140666|NCT02223754|78929662|FG000|Period 1|Withdrawal by Subject|0|||
44140667|NCT02223754|78929663|FG001|Period 1|Withdrawal by Subject|4|||
44140668|NCT02223754|78929662|FG000|Period 1|Test Article No Longer Available|1|||
44140669|NCT02223754|78929663|FG001|Period 1|Test Article No Longer Available|5|||
44140670|NCT02223754|78929662|FG000|Period 1|Unsatisfactory Visual Response|0|||
44140671|NCT02223754|78929663|FG001|Period 1|Unsatisfactory Visual Response|1|||
44140672|NCT02223754|78929662|FG000|Period 2|Adverse Event|0|||
44140673|NCT02223754|78929663|FG001|Period 2|Adverse Event|1|||
44140674|NCT02223754|78929662|FG000|Period 2|Protocol Violation|1|||
44140675|NCT02223754|78929663|FG001|Period 2|Protocol Violation|0|||
44140676|NCT02223754|78929662|FG000|Period 2|Lens Discomfort|1|||
44140677|NCT02223754|78929663|FG001|Period 2|Lens Discomfort|1|||
44140678|NCT02223754|78929662|FG000|Period 2|Lost to Follow-up|1|||
44140679|NCT02223754|78929663|FG001|Period 2|Lost to Follow-up|0|||
44140680|NCT02223754|78929662|FG000|Period 2|Test Article No Longer Available|0|||
44140681|NCT02223754|78929663|FG001|Period 2|Test Article No Longer Available|1|||
44244007|NCT01470469|79074051|FG001|Overall Study|Lost to Follow-up|2|||
44244008|NCT01470469|79074050|FG000|Overall Study|Protocol Violation|1|||
44244009|NCT01470469|79074051|FG001|Overall Study|Protocol Violation|1|||
44244010|NCT01470469|79074050|FG000|Overall Study|Other|2|||
44244011|NCT01470469|79074051|FG001|Overall Study|Other|1|||
44140682|NCT02223364|78929673|FG000|Overall Study|Protocol Violation|3|||
44140683|NCT02223364|78929674|FG001|Overall Study|Protocol Violation|0|||
44140684|NCT02223364|78929675|FG002|Overall Study|Protocol Violation|3|||
44140685|NCT02223364|78929673|FG000|Overall Study|subject expired before surgery|1|||
44244012|NCT01470001|79074059|FG000|Overall Study|Lost to Follow-up|1|||
44513868|NCT03100942|79519077|FG002|Randomized Treatment Period|Protocol Violation|1|||
44140686|NCT02223364|78929674|FG001|Overall Study|subject expired before surgery|0|||
44140687|NCT02223364|78929675|FG002|Overall Study|subject expired before surgery|0|||
44140688|NCT02223364|78929673|FG000|Overall Study|Physician Decision|1|||
44140689|NCT02223364|78929674|FG001|Overall Study|Physician Decision|0|||
44140690|NCT02223364|78929675|FG002|Overall Study|Physician Decision|0|||
44140691|NCT01378975|78929685|FG000|Overall Study|Death|77|||
44140692|NCT01378975|78929686|FG001|Overall Study|Death|46|||
44140693|NCT01378975|78929685|FG000|Overall Study|Investigator Request|1|||
44140694|NCT01378975|78929686|FG001|Overall Study|Investigator Request|0|||
44140695|NCT01378975|78929685|FG000|Overall Study|Lost to Follow-up|4|||
44140696|NCT01378975|78929686|FG001|Overall Study|Lost to Follow-up|1|||
44140697|NCT01378975|78929685|FG000|Overall Study|Withdrew Consent|4|||
44140698|NCT01378975|78929686|FG001|Overall Study|Withdrew Consent|3|||
44140699|NCT02222896|78929693|FG000|Abdomen|Did not qualify|34|||
44140700|NCT02222896|78929694|FG001|Abdomen|Did not qualify|10|||
44140701|NCT02222896|78929695|FG002|Abdomen|Did not qualify|32|||
44140702|NCT02222896|78929693|FG000|Groin|Did not qualify|43|||
44140703|NCT02222896|78929694|FG001|Groin|Did not qualify|9|||
44140704|NCT02222896|78929695|FG002|Groin|Did not qualify|40|||
44140705|NCT02222818|78929708|FG000|Period 1|Eligibility criteria not met|0|||
44140706|NCT02222818|78929709|FG001|Period 1|Eligibility criteria not met|3|||
44140707|NCT01378195|78929716|FG000|Overall Study|Lost to Follow-up|29|||
44140708|NCT01378195|78929717|FG001|Overall Study|Lost to Follow-up|18|||
44140709|NCT01378117|78929726|FG000|Overall Study|withdrawal|2|||
44140710|NCT01378117|78929727|FG001|Overall Study|withdrawal|1|||
44140711|NCT01378117|78929728|FG002|Overall Study|withdrawal|2|||
44140712|NCT01378117|78929726|FG000|Overall Study|discharged before med given|2|||
44140713|NCT01378117|78929727|FG001|Overall Study|discharged before med given|0|||
44140714|NCT01378117|78929728|FG002|Overall Study|discharged before med given|1|||
44140715|NCT04254809|78929763|FG000|Overall Study|Lost to Follow-up|5|||
44140716|NCT04254809|78929764|FG001|Overall Study|Lost to Follow-up|10|||
44140717|NCT02736409|78929774|FG000|Overall Study|Withdrawal by Subject|4|||
44140718|NCT02736409|78929775|FG001|Overall Study|Withdrawal by Subject|2|||
44140719|NCT02736409|78929776|FG002|Overall Study|Withdrawal by Subject|17|||
44140720|NCT02736409|78929777|FG003|Overall Study|Withdrawal by Subject|3|||
44140721|NCT02736409|78929774|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44140722|NCT02736409|78929775|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44140723|NCT02736409|78929776|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44380431|NCT00902538|79386268|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
44380432|NCT00902538|79386269|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
44380433|NCT00902538|79386270|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
44380434|NCT00902538|79386271|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
44380435|NCT00902538|79386266|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
44380436|NCT00902538|79386267|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
44380437|NCT00902538|79386268|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
44380438|NCT00902538|79386269|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
44380439|NCT00902538|79386270|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
44380440|NCT00902538|79386271|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
44380441|NCT00902538|79386266|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
44380442|NCT00902538|79386267|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
44380443|NCT00902538|79386268|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
44380444|NCT00902538|79386269|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
44380445|NCT00902538|79386270|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
44380446|NCT00902538|79386271|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
44380447|NCT00902538|79386266|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
44380448|NCT00902538|79386267|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
44380449|NCT00902538|79386268|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
44380450|NCT00902538|79386269|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
44380451|NCT00902538|79386270|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
44380452|NCT00902538|79386271|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
44380453|NCT00902538|79386266|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
44380454|NCT00902538|79386267|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
44380455|NCT00902538|79386268|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
44380456|NCT00902538|79386269|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
44140724|NCT02736409|78929777|FG003|Overall Study|Non-Compliance with Study Drug|1|||
44140725|NCT02736409|78929774|FG000|Overall Study|Adverse Event|0|||
44140726|NCT02736409|78929775|FG001|Overall Study|Adverse Event|1|||
44140727|NCT02736409|78929776|FG002|Overall Study|Adverse Event|5|||
44140728|NCT02736409|78929777|FG003|Overall Study|Adverse Event|4|||
44380457|NCT00902538|79386270|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
44140729|NCT02736409|78929774|FG000|Overall Study|Other|0|||
44140730|NCT02736409|78929775|FG001|Overall Study|Other|0|||
44140731|NCT02736409|78929776|FG002|Overall Study|Other|1|||
44140732|NCT02736409|78929777|FG003|Overall Study|Other|1|||
44140733|NCT02736409|78929774|FG000|Overall Study|Pregnancy|0|||
44140734|NCT02736409|78929775|FG001|Overall Study|Pregnancy|0|||
44140735|NCT02736409|78929776|FG002|Overall Study|Pregnancy|1|||
44140736|NCT02736409|78929777|FG003|Overall Study|Pregnancy|0|||
44140737|NCT02736409|78929774|FG000|Overall Study|Lost to Follow-up|0|||
44140738|NCT02736409|78929775|FG001|Overall Study|Lost to Follow-up|0|||
44140739|NCT02736409|78929776|FG002|Overall Study|Lost to Follow-up|2|||
44140740|NCT02736409|78929777|FG003|Overall Study|Lost to Follow-up|1|||
44140741|NCT02736409|78929774|FG000|Overall Study|Physician Decision|0|||
44140742|NCT02736409|78929775|FG001|Overall Study|Physician Decision|0|||
44140743|NCT02736409|78929776|FG002|Overall Study|Physician Decision|0|||
44140744|NCT02736409|78929777|FG003|Overall Study|Physician Decision|2|||
44140745|NCT03099707|78929790|FG000|Overall Study|Withdrawal by Subject|0|||
44140746|NCT03099707|78929791|FG001|Overall Study|Withdrawal by Subject|3|||
44140747|NCT03099707|78929790|FG000|Overall Study|Lost to Follow-up|0|||
44140748|NCT03099707|78929791|FG001|Overall Study|Lost to Follow-up|1|||
44140749|NCT02906033|78929799|FG000|Baseline|Protocol Violation|37|||
44140750|NCT02906033|78929800|FG001|Baseline|Protocol Violation|33|||
44140751|NCT02906033|78929799|FG000|Follow-up|Lost to Follow-up|46|||
44140752|NCT02906033|78929800|FG001|Follow-up|Lost to Follow-up|62|||
44140753|NCT02221882|78929812|FG000|Overall Study|Withdrawal by Subject|0|||
44140754|NCT02221882|78929813|FG001|Overall Study|Withdrawal by Subject|0|||
44140755|NCT02221882|78929814|FG002|Overall Study|Withdrawal by Subject|4|||
44140756|NCT02221882|78929815|FG003|Overall Study|Withdrawal by Subject|2|||
44140757|NCT02221882|78929816|FG004|Overall Study|Withdrawal by Subject|2|||
44140758|NCT02221882|78929817|FG005|Overall Study|Withdrawal by Subject|2|||
44140759|NCT02221882|78929812|FG000|Overall Study|Death|0|||
44140760|NCT02221882|78929813|FG001|Overall Study|Death|1|||
44140761|NCT02221882|78929814|FG002|Overall Study|Death|0|||
44140762|NCT02221882|78929815|FG003|Overall Study|Death|0|||
44140763|NCT02221882|78929816|FG004|Overall Study|Death|0|||
44140764|NCT02221882|78929817|FG005|Overall Study|Death|0|||
44140765|NCT02837783|78929838|FG000|Overall Study|Adverse Event|1|||
44140766|NCT02837783|78929839|FG001|Overall Study|Adverse Event|0|||
44140767|NCT02837783|78929838|FG000|Overall Study|Other, Not Specified|1|||
44140768|NCT02837783|78929839|FG001|Overall Study|Other, Not Specified|2|||
44140769|NCT02221648|78929847|FG000|Overall Study|Withdrawal by Subject|3|||
44140770|NCT02221648|78929848|FG001|Overall Study|Withdrawal by Subject|3|||
44140771|NCT02220712|78929858|FG000|Overall Study|Adverse Event|1|||
44140772|NCT02220712|78929858|FG000|Overall Study|Withdrawal by Subject|2|||
44140773|NCT02220712|78929858|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
44140774|NCT02219932|78929868|FG000|Overall Study|Other|5|||
44140775|NCT02219932|78929869|FG001|Overall Study|Other|11|||
44140776|NCT02219932|78929868|FG000|Overall Study|Death|1|||
44140777|NCT02219932|78929869|FG001|Overall Study|Death|1|||
44140778|NCT02219932|78929868|FG000|Overall Study|Investigator Decision|0|||
44140779|NCT02219932|78929869|FG001|Overall Study|Investigator Decision|1|||
44140780|NCT02219932|78929868|FG000|Overall Study|Consent Withdrawn|11|||
44140781|NCT02219932|78929869|FG001|Overall Study|Consent Withdrawn|7|||
44140782|NCT02219932|78929868|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
44140783|NCT02219932|78929869|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
44140784|NCT02219932|78929868|FG000|Overall Study|Protocol Violation|10|||
44140785|NCT02219932|78929869|FG001|Overall Study|Protocol Violation|6|||
44140786|NCT02219932|78929868|FG000|Overall Study|Pregnancy|1|||
44140787|NCT02219932|78929869|FG001|Overall Study|Pregnancy|0|||
44140788|NCT02219932|78929868|FG000|Overall Study|Lost to Follow-up|4|||
44140789|NCT02219932|78929869|FG001|Overall Study|Lost to Follow-up|2|||
44140790|NCT02219932|78929868|FG000|Overall Study|Adverse Event|23|||
44140791|NCT02219932|78929869|FG001|Overall Study|Adverse Event|21|||
44140792|NCT02219464|78929881|FG000|Overall Study|Withdrawal by Subject|1|||
44140793|NCT02219464|78929882|FG001|Overall Study|Withdrawal by Subject|0|||
44140794|NCT02219464|78929881|FG000|Overall Study|case cancelled|1|||
44140795|NCT02219464|78929882|FG001|Overall Study|case cancelled|0|||
44140796|NCT02219464|78929881|FG000|Overall Study|catheter malfunction|1|||
44140797|NCT02219464|78929882|FG001|Overall Study|catheter malfunction|0|||
44140798|NCT02219308|78929890|FG000|Overall Study|Withdrawal by Subject|1|||
44140799|NCT02219308|78929891|FG001|Overall Study|Withdrawal by Subject|2|||
44380458|NCT00902538|79386271|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
44380459|NCT00902538|79386266|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
44380460|NCT00902538|79386267|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
44380461|NCT00902538|79386268|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
44380462|NCT00902538|79386269|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
44380463|NCT00902538|79386270|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
44380464|NCT00902538|79386271|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
44140800|NCT02218372|78929899|FG000|Overall Study|Adverse Event|1|||
44140801|NCT02218372|78929900|FG001|Overall Study|Adverse Event|1|||
44140802|NCT02218372|78929899|FG000|Overall Study|Miscellaneous|2|||
44140803|NCT02218372|78929900|FG001|Overall Study|Miscellaneous|1|||
44140804|NCT02218372|78929899|FG000|Overall Study|Randomized but did not receive treatment|2|||
44140805|NCT02218372|78929900|FG001|Overall Study|Randomized but did not receive treatment|3|||
44140806|NCT02218372|78929899|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44140807|NCT02218372|78929900|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44140808|NCT02218216|78929913|FG000|Overall Study|Study terminated before completed|6|||
44140809|NCT02218216|78929914|FG001|Overall Study|Study terminated before completed|0|||
44140810|NCT02218216|78929915|FG002|Overall Study|Study terminated before completed|0|||
44140811|NCT02217982|78929925|FG000|Overall Study|Trial discontinued|1|||
44140812|NCT02217982|78929926|FG001|Overall Study|Trial discontinued|0|||
44140813|NCT02217982|78929925|FG000|Overall Study|Adverse Event|0|||
44513869|NCT03100942|79519078|FG003|Randomized Treatment Period|Protocol Violation|1|||
44513870|NCT03100942|79519079|FG004|Randomized Treatment Period|Protocol Violation|0|||
44513871|NCT03100942|79519080|FG005|Randomized Treatment Period|Protocol Violation|0|||
44513872|NCT03100942|79519081|FG006|Randomized Treatment Period|Protocol Violation|0|||
44513873|NCT03100942|79519075|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
44513874|NCT03100942|79519076|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
44513875|NCT03100942|79519077|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
44513876|NCT03100942|79519078|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
44513877|NCT03100942|79519079|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
44140814|NCT02217982|78929926|FG001|Overall Study|Adverse Event|1|||
44140815|NCT02254408|78929934|FG000|Overall Study|Randomized But Not Treated|1|||
44140816|NCT02254408|78929935|FG001|Overall Study|Randomized But Not Treated|3|||
44140817|NCT02254408|78929934|FG000|Overall Study|Adverse Event|1|||
44140818|NCT02254408|78929935|FG001|Overall Study|Adverse Event|0|||
44140819|NCT02254408|78929934|FG000|Overall Study|Death|2|||
44140820|NCT02254408|78929935|FG001|Overall Study|Death|3|||
44140821|NCT02254408|78929934|FG000|Overall Study|Investigator's Discretion|0|||
44140822|NCT02254408|78929935|FG001|Overall Study|Investigator's Discretion|1|||
44140823|NCT02254408|78929934|FG000|Overall Study|Withdrawal by Subject|3|||
44140824|NCT02254408|78929935|FG001|Overall Study|Withdrawal by Subject|3|||
44140825|NCT02254408|78929934|FG000|Overall Study|Lost to Follow-up|1|||
44140826|NCT02254408|78929935|FG001|Overall Study|Lost to Follow-up|0|||
44140827|NCT02207608|78929943|FG000|Overall Study|Adverse Event|1|||
44140828|NCT02207608|78929944|FG001|Overall Study|Adverse Event|0|||
44140829|NCT03530995|78929952|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
44140830|NCT03530995|78929953|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
44140831|NCT03530995|78929952|FG000|Part 1 Period 3|Protocol Violation|1|||
44140832|NCT03530995|78929953|FG001|Part 1 Period 3|Protocol Violation|0|||
44140833|NCT03530995|78929952|FG000|Part 1 Period 4|Physician Decision|1|||
44140834|NCT03530995|78929953|FG001|Part 1 Period 4|Physician Decision|0|||
44140835|NCT03530995|78929952|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
44140836|NCT03530995|78929953|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
44140837|NCT02217436|78929977|FG000|Overall Study|Protocol Violation|1|||
44140838|NCT02217436|78929978|FG001|Overall Study|Protocol Violation|1|||
44140839|NCT02217436|78929977|FG000|Overall Study|Incomplete data|0|||
44140840|NCT02217436|78929978|FG001|Overall Study|Incomplete data|1|||
44140841|NCT02207530|78929984|FG000|Overall Study|Worsening condition under investigation|78|||
44140842|NCT02207530|78929984|FG000|Overall Study|Patient decision to stop study treatment|5|||
44140843|NCT02207530|78929984|FG000|Overall Study|Adverse Event|8|||
44140844|NCT02207374|78929991|FG000|Overall Study|Withdrawal by Subject|5|||
44140845|NCT02207374|78929992|FG001|Overall Study|Withdrawal by Subject|9|||
44140846|NCT02207374|78929993|FG002|Overall Study|Withdrawal by Subject|4|||
44140847|NCT02207374|78929991|FG000|Overall Study|Death|1|||
44140848|NCT02207374|78929992|FG001|Overall Study|Death|0|||
44140849|NCT02207374|78929993|FG002|Overall Study|Death|1|||
44140850|NCT02207374|78929991|FG000|Overall Study|Missing follow-up information|0|||
44140851|NCT02207374|78929992|FG001|Overall Study|Missing follow-up information|1|||
44140852|NCT02207374|78929993|FG002|Overall Study|Missing follow-up information|1|||
44140853|NCT02217280|78930001|FG000|Overall Study|Withdrawal by Subject|2|||
44140854|NCT02217280|78930001|FG000|Overall Study|Post-consent sceen fail|2|||
44140855|NCT02786537|78930012|FG000|As Randomized|Adverse Event|0|||
44140856|NCT02786537|78930013|FG001|As Randomized|Adverse Event|11|||
44140857|NCT02786537|78930014|FG002|As Randomized|Adverse Event|0|||
44140858|NCT02786537|78930015|FG003|As Randomized|Adverse Event|4|||
44140859|NCT02786537|78930016|FG004|As Randomized|Adverse Event|6|||
44140860|NCT02786537|78930017|FG005|As Randomized|Adverse Event|2|||
44140861|NCT02786537|78930012|FG000|As Randomized|Lack of Efficacy|0|||
44140862|NCT02786537|78930013|FG001|As Randomized|Lack of Efficacy|0|||
44140863|NCT02786537|78930014|FG002|As Randomized|Lack of Efficacy|0|||
44140864|NCT02786537|78930015|FG003|As Randomized|Lack of Efficacy|1|||
44140865|NCT02786537|78930016|FG004|As Randomized|Lack of Efficacy|0|||
44140866|NCT02786537|78930017|FG005|As Randomized|Lack of Efficacy|0|||
44140867|NCT02786537|78930012|FG000|As Randomized|Withdrawal by Subject|1|||
44276613|NCT04791319|79237618|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44276614|NCT04791319|79237619|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44276615|NCT04791319|79237620|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44276616|NCT04791319|79237621|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
44276617|NCT04791319|79237611|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
44276618|NCT04791319|79237612|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
44276619|NCT04791319|79237613|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
44276620|NCT04791319|79237614|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
44276621|NCT04791319|79237615|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44276622|NCT04791319|79237616|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44276623|NCT04791319|79237617|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44276624|NCT04791319|79237618|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44140868|NCT02786537|78930013|FG001|As Randomized|Withdrawal by Subject|2|||
44140869|NCT02786537|78930014|FG002|As Randomized|Withdrawal by Subject|0|||
44513878|NCT03100942|79519080|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
44140870|NCT02786537|78930015|FG003|As Randomized|Withdrawal by Subject|1|||
44140871|NCT02786537|78930016|FG004|As Randomized|Withdrawal by Subject|1|||
44140872|NCT02786537|78930017|FG005|As Randomized|Withdrawal by Subject|0|||
44140873|NCT02786537|78930012|FG000|As Randomized|Death|0|||
44140874|NCT02786537|78930013|FG001|As Randomized|Death|2|||
44513879|NCT03100942|79519081|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
44140875|NCT02786537|78930014|FG002|As Randomized|Death|0|||
44140876|NCT02786537|78930015|FG003|As Randomized|Death|3|||
44140877|NCT02786537|78930016|FG004|As Randomized|Death|1|||
44140878|NCT02786537|78930017|FG005|As Randomized|Death|0|||
44140879|NCT02786537|78930012|FG000|As Randomized|Non-compliance with study drug|1|||
44140880|NCT02786537|78930013|FG001|As Randomized|Non-compliance with study drug|11|||
44140881|NCT02786537|78930014|FG002|As Randomized|Non-compliance with study drug|0|||
44140882|NCT02786537|78930015|FG003|As Randomized|Non-compliance with study drug|1|||
44140883|NCT02786537|78930016|FG004|As Randomized|Non-compliance with study drug|0|||
44140884|NCT02786537|78930017|FG005|As Randomized|Non-compliance with study drug|1|||
44140885|NCT02786537|78930012|FG000|As Randomized|Lost to treatment follow-up|4|||
44140886|NCT02786537|78930013|FG001|As Randomized|Lost to treatment follow-up|32|||
44140887|NCT02786537|78930014|FG002|As Randomized|Lost to treatment follow-up|0|||
44140888|NCT02786537|78930015|FG003|As Randomized|Lost to treatment follow-up|24|||
44140889|NCT02786537|78930016|FG004|As Randomized|Lost to treatment follow-up|4|||
44140890|NCT02786537|78930017|FG005|As Randomized|Lost to treatment follow-up|4|||
44140891|NCT02786537|78930012|FG000|As Randomized|Incarceration|0|||
44140892|NCT02786537|78930013|FG001|As Randomized|Incarceration|1|||
44140893|NCT02786537|78930014|FG002|As Randomized|Incarceration|0|||
44140894|NCT02786537|78930015|FG003|As Randomized|Incarceration|0|||
44140895|NCT02786537|78930016|FG004|As Randomized|Incarceration|0|||
44140896|NCT02786537|78930017|FG005|As Randomized|Incarceration|0|||
44140897|NCT02786537|78930012|FG000|As Randomized|Opiate Dependency Relapse|0|||
44140898|NCT02786537|78930013|FG001|As Randomized|Opiate Dependency Relapse|1|||
44140899|NCT02786537|78930014|FG002|As Randomized|Opiate Dependency Relapse|0|||
44140900|NCT02786537|78930015|FG003|As Randomized|Opiate Dependency Relapse|0|||
44140901|NCT02786537|78930016|FG004|As Randomized|Opiate Dependency Relapse|0|||
44140902|NCT02786537|78930017|FG005|As Randomized|Opiate Dependency Relapse|0|||
44140903|NCT02786537|78930012|FG000|As Randomized|HCV drugs stolen from pt|0|||
44140904|NCT02786537|78930013|FG001|As Randomized|HCV drugs stolen from pt|1|||
44140905|NCT02786537|78930014|FG002|As Randomized|HCV drugs stolen from pt|0|||
44140906|NCT02786537|78930015|FG003|As Randomized|HCV drugs stolen from pt|0|||
44140907|NCT02786537|78930016|FG004|As Randomized|HCV drugs stolen from pt|0|||
44140908|NCT02786537|78930017|FG005|As Randomized|HCV drugs stolen from pt|0|||
44140909|NCT02786537|78930012|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
44140910|NCT02786537|78930013|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
44140911|NCT02786537|78930014|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
44140912|NCT02786537|78930015|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
44140913|NCT02786537|78930016|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
44140914|NCT02786537|78930017|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
44140915|NCT02786537|78930012|FG000|As Randomized|Subject lost insurance|0|||
44140916|NCT02786537|78930013|FG001|As Randomized|Subject lost insurance|0|||
44140917|NCT02786537|78930014|FG002|As Randomized|Subject lost insurance|0|||
44140918|NCT02786537|78930015|FG003|As Randomized|Subject lost insurance|1|||
44140919|NCT02786537|78930016|FG004|As Randomized|Subject lost insurance|0|||
44140920|NCT02786537|78930017|FG005|As Randomized|Subject lost insurance|0|||
44140921|NCT02786537|78930012|FG000|As Treated|Adverse Event|0|||
44140922|NCT02786537|78930013|FG001|As Treated|Adverse Event|11|||
44140923|NCT02786537|78930014|FG002|As Treated|Adverse Event|0|||
44140924|NCT02786537|78930015|FG003|As Treated|Adverse Event|4|||
44140925|NCT02786537|78930016|FG004|As Treated|Adverse Event|6|||
44140926|NCT02786537|78930017|FG005|As Treated|Adverse Event|2|||
44140927|NCT02786537|78930012|FG000|As Treated|Death|0|||
44140928|NCT02786537|78930013|FG001|As Treated|Death|2|||
44140929|NCT02786537|78930014|FG002|As Treated|Death|0|||
44140930|NCT02786537|78930015|FG003|As Treated|Death|3|||
44140931|NCT02786537|78930016|FG004|As Treated|Death|1|||
44140932|NCT02786537|78930017|FG005|As Treated|Death|0|||
44140933|NCT02786537|78930012|FG000|As Treated|Lack of Efficacy|0|||
44140934|NCT02786537|78930013|FG001|As Treated|Lack of Efficacy|0|||
44140935|NCT02786537|78930014|FG002|As Treated|Lack of Efficacy|0|||
44140936|NCT02786537|78930015|FG003|As Treated|Lack of Efficacy|1|||
44140937|NCT02786537|78930016|FG004|As Treated|Lack of Efficacy|0|||
44140938|NCT02786537|78930017|FG005|As Treated|Lack of Efficacy|0|||
44140939|NCT02786537|78930012|FG000|As Treated|Lost to Follow-up|4|||
44140940|NCT02786537|78930013|FG001|As Treated|Lost to Follow-up|32|||
44140941|NCT02786537|78930014|FG002|As Treated|Lost to Follow-up|0|||
44140942|NCT02786537|78930015|FG003|As Treated|Lost to Follow-up|25|||
44140943|NCT02786537|78930016|FG004|As Treated|Lost to Follow-up|4|||
44140944|NCT02786537|78930017|FG005|As Treated|Lost to Follow-up|4|||
44140945|NCT02786537|78930012|FG000|As Treated|Non-compliance with study drug|1|||
44140946|NCT02786537|78930013|FG001|As Treated|Non-compliance with study drug|11|||
44140947|NCT02786537|78930014|FG002|As Treated|Non-compliance with study drug|0|||
44140948|NCT02786537|78930015|FG003|As Treated|Non-compliance with study drug|1|||
44140949|NCT02786537|78930016|FG004|As Treated|Non-compliance with study drug|0|||
44140950|NCT02786537|78930017|FG005|As Treated|Non-compliance with study drug|1|||
44140951|NCT02786537|78930012|FG000|As Treated|Lost insurance|0|||
44140952|NCT02786537|78930013|FG001|As Treated|Lost insurance|0|||
44140953|NCT02786537|78930014|FG002|As Treated|Lost insurance|0|||
44140954|NCT02786537|78930015|FG003|As Treated|Lost insurance|1|||
44140955|NCT02786537|78930016|FG004|As Treated|Lost insurance|0|||
44140956|NCT02786537|78930017|FG005|As Treated|Lost insurance|0|||
44140957|NCT02786537|78930012|FG000|As Treated|Withdrawal by Subject|1|||
44140958|NCT02786537|78930013|FG001|As Treated|Withdrawal by Subject|2|||
44140959|NCT02786537|78930014|FG002|As Treated|Withdrawal by Subject|0|||
44140960|NCT02786537|78930015|FG003|As Treated|Withdrawal by Subject|0|||
44140961|NCT02786537|78930016|FG004|As Treated|Withdrawal by Subject|1|||
44140962|NCT02786537|78930017|FG005|As Treated|Withdrawal by Subject|0|||
44140963|NCT02786537|78930012|FG000|As Treated|Incarceration|0|||
44140964|NCT02786537|78930013|FG001|As Treated|Incarceration|1|||
44140965|NCT02786537|78930014|FG002|As Treated|Incarceration|0|||
44140966|NCT02786537|78930015|FG003|As Treated|Incarceration|0|||
44140967|NCT02786537|78930016|FG004|As Treated|Incarceration|0|||
44140968|NCT02786537|78930017|FG005|As Treated|Incarceration|0|||
44140969|NCT02786537|78930012|FG000|As Treated|Opiate dependency relapse|0|||
44140970|NCT02786537|78930013|FG001|As Treated|Opiate dependency relapse|1|||
44140971|NCT02786537|78930014|FG002|As Treated|Opiate dependency relapse|0|||
44140972|NCT02786537|78930015|FG003|As Treated|Opiate dependency relapse|0|||
44140973|NCT02786537|78930016|FG004|As Treated|Opiate dependency relapse|0|||
44140974|NCT02786537|78930017|FG005|As Treated|Opiate dependency relapse|0|||
44140975|NCT02786537|78930012|FG000|As Treated|Drugs stolen from patient|0|||
44140976|NCT02786537|78930013|FG001|As Treated|Drugs stolen from patient|1|||
44140977|NCT02786537|78930014|FG002|As Treated|Drugs stolen from patient|0|||
44140978|NCT02786537|78930015|FG003|As Treated|Drugs stolen from patient|0|||
44140979|NCT02786537|78930016|FG004|As Treated|Drugs stolen from patient|0|||
44140980|NCT02786537|78930017|FG005|As Treated|Drugs stolen from patient|0|||
44140981|NCT02786537|78930012|FG000|As Treated|Advised to stop tx after loss of meds|0|||
44140982|NCT02786537|78930013|FG001|As Treated|Advised to stop tx after loss of meds|1|||
44140983|NCT02786537|78930014|FG002|As Treated|Advised to stop tx after loss of meds|0|||
44140984|NCT02786537|78930015|FG003|As Treated|Advised to stop tx after loss of meds|0|||
44140985|NCT02786537|78930016|FG004|As Treated|Advised to stop tx after loss of meds|0|||
44140986|NCT02786537|78930017|FG005|As Treated|Advised to stop tx after loss of meds|0|||
44140987|NCT02216812|78930125|FG000|Overall Study|Lost to Follow-up|10|||
44140988|NCT02216812|78930126|FG001|Overall Study|Lost to Follow-up|5|||
44140989|NCT02252536|78930134|FG000|Overall Study|Lost to Follow-up|5|||
44140990|NCT02252536|78930135|FG001|Overall Study|Lost to Follow-up|3|||
44140991|NCT02206828|78930141|FG000|Overall Study|Lost to Follow-up|7|||
44140992|NCT01209767|78930168|FG000|Overall Study|Withdrawal by Subject|1|||
44140993|NCT01209767|78930168|FG000|Overall Study|Lost to Follow-up|3|||
44140994|NCT02252146|78930176|FG000|Overall Study|Lack of Efficacy|4|||
44140995|NCT02252146|78930176|FG000|Overall Study|Entered hospice care|1|||
44140996|NCT02252146|78930176|FG000|Overall Study|Inability to travel to study site|1|||
44140997|NCT02251990|78930182|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
44140998|NCT02251990|78930183|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
44140999|NCT02251990|78930182|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
44141000|NCT02251990|78930183|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
44141001|NCT02251990|78930182|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
44141002|NCT02251990|78930183|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
44141003|NCT02251990|78930182|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
44141004|NCT02251990|78930183|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
44141005|NCT02251990|78930182|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
44141006|NCT02251990|78930183|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
44141007|NCT02251990|78930182|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
44141008|NCT02251990|78930183|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
44141009|NCT02251912|78930192|FG000|Overall Study|Withdrawal by Subject|2|||
44141010|NCT02251912|78930193|FG001|Overall Study|Withdrawal by Subject|3|||
44141011|NCT02251912|78930192|FG000|Overall Study|Adverse Event|0|||
44141012|NCT02251912|78930193|FG001|Overall Study|Adverse Event|2|||
44141013|NCT02206048|78930208|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
44141014|NCT02205814|78930220|FG000|Overall Study|Lost to Follow-up|0|||
44141015|NCT02205814|78930221|FG001|Overall Study|Lost to Follow-up|0|||
44141016|NCT02205814|78930222|FG002|Overall Study|Lost to Follow-up|0|||
44141017|NCT02205814|78930223|FG003|Overall Study|Lost to Follow-up|1|||
44141018|NCT02205814|78930220|FG000|Overall Study|Lack of Efficacy|1|||
44141019|NCT02205814|78930221|FG001|Overall Study|Lack of Efficacy|0|||
44141020|NCT02205814|78930222|FG002|Overall Study|Lack of Efficacy|1|||
44141021|NCT02205814|78930223|FG003|Overall Study|Lack of Efficacy|1|||
44141022|NCT02205814|78930220|FG000|Overall Study|Physician Decision|0|||
44141023|NCT02205814|78930221|FG001|Overall Study|Physician Decision|0|||
44141024|NCT02205814|78930222|FG002|Overall Study|Physician Decision|1|||
44141025|NCT02205814|78930223|FG003|Overall Study|Physician Decision|0|||
44141026|NCT02205814|78930220|FG000|Overall Study|Protocol Violation|1|||
44141027|NCT02205814|78930221|FG001|Overall Study|Protocol Violation|0|||
44141028|NCT02205814|78930222|FG002|Overall Study|Protocol Violation|0|||
44141029|NCT02205814|78930223|FG003|Overall Study|Protocol Violation|1|||
44141030|NCT02205814|78930220|FG000|Overall Study|Withdrawal by Subject|0|||
44141031|NCT02205814|78930221|FG001|Overall Study|Withdrawal by Subject|1|||
44141032|NCT02205814|78930222|FG002|Overall Study|Withdrawal by Subject|2|||
44141033|NCT02205814|78930223|FG003|Overall Study|Withdrawal by Subject|1|||
44141034|NCT02205814|78930220|FG000|Overall Study|not compliant with study procedures|0|||
44141035|NCT02205814|78930221|FG001|Overall Study|not compliant with study procedures|0|||
44141036|NCT02205814|78930222|FG002|Overall Study|not compliant with study procedures|1|||
44141037|NCT02205814|78930223|FG003|Overall Study|not compliant with study procedures|0|||
44141038|NCT02662985|78930235|FG000|Treatment Period 1|Adverse Event|0|||
44141039|NCT02662985|78930236|FG001|Treatment Period 1|Adverse Event|2|||
44141040|NCT02662985|78930235|FG000|Treatment Period 1|Protocol Violation|0|||
44141041|NCT02662985|78930236|FG001|Treatment Period 1|Protocol Violation|1|||
44141042|NCT02662985|78930235|FG000|Treatment Period 1|Physician Decision|1|||
44141043|NCT02662985|78930236|FG001|Treatment Period 1|Physician Decision|0|||
44141044|NCT02662985|78930235|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44141045|NCT02662985|78930236|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44141046|NCT02662985|78930235|FG000|Treatment Period 2|Lack of Efficacy|0|||
44141047|NCT02662985|78930236|FG001|Treatment Period 2|Lack of Efficacy|1|||
44141048|NCT02662985|78930235|FG000|Treatment Period 2|Lost to Follow-up|1|||
44141049|NCT02662985|78930236|FG001|Treatment Period 2|Lost to Follow-up|0|||
44141050|NCT02662985|78930235|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
44141051|NCT02662985|78930236|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
44141052|NCT02662985|78930235|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
44141053|NCT02662985|78930236|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
44141054|NCT02662985|78930235|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
44141055|NCT02662985|78930236|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
44141056|NCT02662985|78930235|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
44141057|NCT02662985|78930236|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
44141058|NCT02662985|78930235|FG000|Treatment Period 3 (Extension Period)|Death|0|||
44141059|NCT02662985|78930236|FG001|Treatment Period 3 (Extension Period)|Death|1|||
44141060|NCT01631812|78930242|FG000|Overall Study|Adverse Event|25|||
44141061|NCT01631812|78930242|FG000|Overall Study|Lack of Efficacy|5|||
44141062|NCT01631812|78930242|FG000|Overall Study|Withdrawal by Subject|4|||
44141063|NCT01631812|78930242|FG000|Overall Study|Physician Decision|3|||
44141064|NCT02323295|78930248|FG000|Overall Study|Adverse Event|0|||
44141065|NCT02323295|78930249|FG001|Overall Study|Adverse Event|1|||
44141066|NCT02323295|78930248|FG000|Overall Study|Withdrawal by Subject|0|||
44141067|NCT02323295|78930249|FG001|Overall Study|Withdrawal by Subject|1|||
44141068|NCT02323295|78930248|FG000|Overall Study|Patient did not have surgery as planned.|0|||
44141069|NCT02323295|78930249|FG001|Overall Study|Patient did not have surgery as planned.|1|||
44141070|NCT02215954|78930258|FG000|Overall Study|Adverse Event|0|||
44141071|NCT02215954|78930259|FG001|Overall Study|Adverse Event|0|||
44141072|NCT02215954|78930260|FG002|Overall Study|Adverse Event|1|||
44141073|NCT02215954|78930258|FG000|Overall Study|Withdrawal by Subject|0|||
44141074|NCT02215954|78930259|FG001|Overall Study|Withdrawal by Subject|0|||
44141075|NCT02215954|78930260|FG002|Overall Study|Withdrawal by Subject|2|||
44141076|NCT02215954|78930258|FG000|Overall Study|Not exposed|1|||
44141077|NCT02215954|78930259|FG001|Overall Study|Not exposed|1|||
44141078|NCT02215954|78930260|FG002|Overall Study|Not exposed|3|||
44141079|NCT01941719|78930271|FG000|Overall Study|Lost to Follow-up|20|||
44141080|NCT01941719|78930272|FG001|Overall Study|Lost to Follow-up|19|||
44141081|NCT02215252|78930282|FG000|Overall Study|Adverse Event|1|||
44141082|NCT02215252|78930283|FG001|Overall Study|Adverse Event|5|||
44244013|NCT01470001|79074060|FG001|Overall Study|Lost to Follow-up|1|||
44244014|NCT01470001|79074059|FG000|Overall Study|Physician Decision|2|||
44141083|NCT02215252|78930284|FG002|Overall Study|Adverse Event|2|||
44141084|NCT02215252|78930282|FG000|Overall Study|Lost to Follow-up|0|||
44141085|NCT02215252|78930283|FG001|Overall Study|Lost to Follow-up|0|||
44244015|NCT01470001|79074060|FG001|Overall Study|Physician Decision|0|||
44244016|NCT01470001|79074059|FG000|Overall Study|Withdrawal by Subject|2|||
44141086|NCT02215252|78930284|FG002|Overall Study|Lost to Follow-up|1|||
44141087|NCT02215252|78930282|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
44141088|NCT02215252|78930283|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
44141089|NCT02215252|78930284|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
44141090|NCT02215252|78930282|FG000|Overall Study|Protocol Violation|0|||
44141091|NCT02215252|78930283|FG001|Overall Study|Protocol Violation|1|||
44141092|NCT02215252|78930284|FG002|Overall Study|Protocol Violation|0|||
44141093|NCT02215252|78930282|FG000|Overall Study|Withdrawal by Subject|1|||
44141094|NCT02215252|78930283|FG001|Overall Study|Withdrawal by Subject|0|||
44141095|NCT02215252|78930284|FG002|Overall Study|Withdrawal by Subject|0|||
44141096|NCT02215252|78930282|FG000|Overall Study|Other|0|||
44141097|NCT02215252|78930283|FG001|Overall Study|Other|1|||
44141098|NCT02215252|78930284|FG002|Overall Study|Other|1|||
44141099|NCT02204410|78930296|FG000|Overall Study|Lost to Follow-up|5|||
44141100|NCT02204410|78930296|FG000|Overall Study|Physician Decision|2|||
44141101|NCT02204410|78930296|FG000|Overall Study|Protocol Violation|1|||
44141102|NCT02204410|78930296|FG000|Overall Study|Withdrawal by Subject|3|||
44141103|NCT02250274|78930302|FG000|Overall Study|Insufficient blood draw amount|7|||
44141104|NCT02250274|78930303|FG001|Overall Study|Insufficient blood draw amount|6|||
44141105|NCT02213380|78930317|FG000|Underwent Randomization|Withdrawal by Subject|2|||
44141106|NCT02213380|78930318|FG001|Underwent Randomization|Withdrawal by Subject|0|||
44141107|NCT02213380|78930317|FG000|Underwent Randomization|Not treated|3|||
44141108|NCT02213380|78930318|FG001|Underwent Randomization|Not treated|3|||
44141109|NCT02213380|78930317|FG000|Per-protocol Analysis|Protocol Violation|32|||
44141110|NCT02213380|78930318|FG001|Per-protocol Analysis|Protocol Violation|36|||
44141111|NCT02202850|78930326|FG000|Overall Study|Other|2|||
44141112|NCT02202850|78930327|FG001|Overall Study|Other|2|||
44141113|NCT02202850|78930326|FG000|Overall Study|Enbrel treatment discontinued|15|||
44141114|NCT02202850|78930327|FG001|Overall Study|Enbrel treatment discontinued|3|||
44141115|NCT02202850|78930326|FG000|Overall Study|Lost to Follow-up|7|||
44141116|NCT02202850|78930327|FG001|Overall Study|Lost to Follow-up|1|||
44141117|NCT02212678|78930333|FG000|Overall Study|Adverse Event|1|||
44141118|NCT03104075|78930339|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
44141119|NCT03104075|78930340|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
44141120|NCT03038087|78930347|FG000|Overall Study|lost data|1|||
44141121|NCT02249182|78930358|FG000|Treatment Phase|Lost to Follow-up|4|||
44141122|NCT02249182|78930359|FG001|Treatment Phase|Lost to Follow-up|0|||
44141123|NCT02249182|78930360|FG002|Treatment Phase|Lost to Follow-up|0|||
44141124|NCT02249182|78930361|FG003|Treatment Phase|Lost to Follow-up|0|||
44141125|NCT02249182|78930362|FG004|Treatment Phase|Lost to Follow-up|0|||
44141126|NCT03641339|78930393|FG000|Overall Study|Physician Decision|1|||
44141127|NCT03641339|78930394|FG001|Overall Study|Physician Decision|0|||
44141128|NCT03641339|78930395|FG002|Overall Study|Physician Decision|0|||
44141129|NCT03641339|78930396|FG003|Overall Study|Physician Decision|0|||
44141130|NCT03641339|78930397|FG004|Overall Study|Physician Decision|0|||
44141131|NCT03641339|78930398|FG005|Overall Study|Physician Decision|0|||
44141132|NCT03641339|78930393|FG000|Overall Study|Withdrawal by Subject|0|||
44141133|NCT03641339|78930394|FG001|Overall Study|Withdrawal by Subject|2|||
44141134|NCT03641339|78930395|FG002|Overall Study|Withdrawal by Subject|0|||
44141135|NCT03641339|78930396|FG003|Overall Study|Withdrawal by Subject|2|||
44141136|NCT03641339|78930397|FG004|Overall Study|Withdrawal by Subject|0|||
44141137|NCT03641339|78930398|FG005|Overall Study|Withdrawal by Subject|1|||
44141138|NCT02248480|78930414|FG000|Overall Study|Lack of Efficacy|4|||
44141139|NCT02248480|78930415|FG001|Overall Study|Lack of Efficacy|6|||
44141140|NCT02248480|78930414|FG000|Overall Study|Adverse Event|11|||
44141141|NCT02248480|78930415|FG001|Overall Study|Adverse Event|2|||
44276625|NCT04791319|79237619|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44276626|NCT04791319|79237620|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44276627|NCT04791319|79237621|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
44276628|NCT04791319|79237611|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
44276629|NCT04791319|79237612|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
44276630|NCT04791319|79237613|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
44380465|NCT00902538|79386266|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
44380466|NCT00902538|79386267|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
44380467|NCT00902538|79386268|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
44513880|NCT03100942|79519075|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
44513881|NCT03100942|79519076|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
44141142|NCT02248480|78930414|FG000|Overall Study|Withdrawal by Subject|2|||
44141143|NCT02248480|78930415|FG001|Overall Study|Withdrawal by Subject|4|||
44141144|NCT02248480|78930414|FG000|Overall Study|Entry Criteria Not Met|0|||
44141145|NCT02248480|78930415|FG001|Overall Study|Entry Criteria Not Met|1|||
44141146|NCT02248480|78930414|FG000|Overall Study|Other:Physician Decision|0|||
44141147|NCT02248480|78930415|FG001|Overall Study|Other:Physician Decision|1|||
44141148|NCT01653158|78930422|FG000|Overall Study|Death|0|||
44141149|NCT01653158|78930423|FG001|Overall Study|Death|0|||
44141150|NCT01653158|78930424|FG002|Overall Study|Death|0|||
44141151|NCT01653158|78930425|FG003|Overall Study|Death|1|||
44141152|NCT01653158|78930426|FG004|Overall Study|Death|0|||
44141153|NCT01653158|78930427|FG005|Overall Study|Death|0|||
44141154|NCT01653158|78930428|FG006|Overall Study|Death|0|||
44141155|NCT01653158|78930429|FG007|Overall Study|Death|2|||
44141156|NCT01653158|78930422|FG000|Overall Study|Adverse Event|0|||
44141157|NCT01653158|78930423|FG001|Overall Study|Adverse Event|0|||
44141158|NCT01653158|78930424|FG002|Overall Study|Adverse Event|0|||
44141159|NCT01653158|78930425|FG003|Overall Study|Adverse Event|1|||
44141160|NCT01653158|78930426|FG004|Overall Study|Adverse Event|0|||
44141161|NCT01653158|78930427|FG005|Overall Study|Adverse Event|0|||
44141162|NCT01653158|78930428|FG006|Overall Study|Adverse Event|0|||
44141163|NCT01653158|78930429|FG007|Overall Study|Adverse Event|3|||
44141164|NCT01653158|78930422|FG000|Overall Study|Other|0|||
44141165|NCT01653158|78930423|FG001|Overall Study|Other|0|||
44141166|NCT01653158|78930424|FG002|Overall Study|Other|0|||
44141167|NCT01653158|78930425|FG003|Overall Study|Other|0|||
44141168|NCT01653158|78930426|FG004|Overall Study|Other|0|||
44141169|NCT01653158|78930427|FG005|Overall Study|Other|0|||
44141170|NCT01653158|78930428|FG006|Overall Study|Other|0|||
44141171|NCT01653158|78930429|FG007|Overall Study|Other|1|||
44141172|NCT01653158|78930422|FG000|Overall Study|Progressive disease|0|||
44141173|NCT01653158|78930423|FG001|Overall Study|Progressive disease|0|||
44141174|NCT01653158|78930424|FG002|Overall Study|Progressive disease|0|||
44141175|NCT01653158|78930425|FG003|Overall Study|Progressive disease|0|||
44141176|NCT01653158|78930426|FG004|Overall Study|Progressive disease|1|||
44141177|NCT01653158|78930427|FG005|Overall Study|Progressive disease|1|||
44141178|NCT01653158|78930428|FG006|Overall Study|Progressive disease|2|||
44141179|NCT01653158|78930429|FG007|Overall Study|Progressive disease|9|||
44141180|NCT01653158|78930422|FG000|Overall Study|Withdrawal by Subject|1|||
44141181|NCT01653158|78930423|FG001|Overall Study|Withdrawal by Subject|0|||
44141182|NCT01653158|78930424|FG002|Overall Study|Withdrawal by Subject|0|||
44141183|NCT01653158|78930425|FG003|Overall Study|Withdrawal by Subject|0|||
44141184|NCT01653158|78930426|FG004|Overall Study|Withdrawal by Subject|0|||
44141185|NCT01653158|78930427|FG005|Overall Study|Withdrawal by Subject|0|||
44141186|NCT01653158|78930428|FG006|Overall Study|Withdrawal by Subject|0|||
44141187|NCT01653158|78930429|FG007|Overall Study|Withdrawal by Subject|0|||
44141188|NCT02247466|78930454|FG000|Overall Study|Procedure changed to open surgery|0|||
44141189|NCT02247466|78930455|FG001|Overall Study|Procedure changed to open surgery|3|||
44141190|NCT03317795|78930463|FG000|Overall Study|IUD Expulsion|1|||
44141191|NCT03317795|78930464|FG001|Overall Study|IUD Expulsion|0|||
44141192|NCT03317795|78930463|FG000|Overall Study|Lost to Follow-up|1|||
44141193|NCT03317795|78930464|FG001|Overall Study|Lost to Follow-up|3|||
44141194|NCT03317795|78930463|FG000|Overall Study|Treatment change|0|||
44141195|NCT03317795|78930464|FG001|Overall Study|Treatment change|3|||
44141196|NCT03317795|78930463|FG000|Overall Study|Intolerance of medication|0|||
44141197|NCT03317795|78930464|FG001|Overall Study|Intolerance of medication|1|||
44141198|NCT02202616|78930470|FG000|Overall Study|Screen failed|24|||
44141199|NCT02202616|78930470|FG000|Overall Study|Adverse Event|32|||
44244017|NCT01470001|79074060|FG001|Overall Study|Withdrawal by Subject|1|||
44244018|NCT01469377|79074069|FG000|Overall Study|Protocol Deviation|7|||
44244019|NCT01469377|79074070|FG001|Overall Study|Protocol Deviation|10|||
44244020|NCT01469377|79074071|FG002|Overall Study|Protocol Deviation|10|||
44244021|NCT01469377|79074069|FG000|Overall Study|Lost to Follow-up|3|||
44244022|NCT01469377|79074070|FG001|Overall Study|Lost to Follow-up|2|||
44244023|NCT01469377|79074071|FG002|Overall Study|Lost to Follow-up|5|||
44244024|NCT01469377|79074069|FG000|Overall Study|Withdrawal of Consent|12|||
44380468|NCT00902538|79386269|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
44380469|NCT00902538|79386270|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
44141200|NCT02202616|78930470|FG000|Overall Study|Protocol deviation|18|||
44141201|NCT02202616|78930470|FG000|Overall Study|Patient withdrew consent|12|||
44141202|NCT02202616|78930470|FG000|Overall Study|Lost to Follow-up|6|||
44141203|NCT02202616|78930470|FG000|Overall Study|Administrative problems|6|||
44141204|NCT02202616|78930470|FG000|Overall Study|Abnormal test procedure result|1|||
44141205|NCT02202616|78930470|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44141206|NCT02455388|78930477|FG000|Overall Study|Protocol Violation|1|||
44141207|NCT02455388|78930478|FG001|Overall Study|Protocol Violation|0|||
44141208|NCT02455388|78930479|FG002|Overall Study|Protocol Violation|4|||
44141209|NCT02455388|78930477|FG000|Overall Study|Withdrawal by Subject|0|||
44141210|NCT02455388|78930478|FG001|Overall Study|Withdrawal by Subject|0|||
44141211|NCT02455388|78930479|FG002|Overall Study|Withdrawal by Subject|7|||
44141212|NCT02455076|78930492|FG000|Inpatient|Withdrawal by Subject|1|||
44141213|NCT02455076|78930493|FG001|Inpatient|Withdrawal by Subject|0|||
44244025|NCT01469377|79074070|FG001|Overall Study|Withdrawal of Consent|14|||
44141214|NCT02455076|78930494|FG002|Inpatient|Withdrawal by Subject|0|||
44141215|NCT02455076|78930495|FG003|Inpatient|Withdrawal by Subject|0|||
44141216|NCT02455076|78930496|FG004|Inpatient|Withdrawal by Subject|0|||
44141217|NCT02455076|78930492|FG000|Inpatient|Discharged <24 h after admission|0|||
44141218|NCT02455076|78930493|FG001|Inpatient|Discharged <24 h after admission|1|||
44141219|NCT02455076|78930494|FG002|Inpatient|Discharged <24 h after admission|0|||
44141220|NCT02455076|78930495|FG003|Inpatient|Discharged <24 h after admission|0|||
44141221|NCT02455076|78930496|FG004|Inpatient|Discharged <24 h after admission|0|||
44141222|NCT02455076|78930492|FG000|Inpatient|Adverse Event|3|||
44141223|NCT02455076|78930493|FG001|Inpatient|Adverse Event|0|||
44141224|NCT02455076|78930494|FG002|Inpatient|Adverse Event|0|||
44141225|NCT02455076|78930495|FG003|Inpatient|Adverse Event|0|||
44141226|NCT02455076|78930496|FG004|Inpatient|Adverse Event|0|||
44141227|NCT02455076|78930492|FG000|Outpatient|Adverse Event|0|||
44141228|NCT02455076|78930493|FG001|Outpatient|Adverse Event|0|||
44141229|NCT02455076|78930494|FG002|Outpatient|Adverse Event|0|||
44141230|NCT02455076|78930495|FG003|Outpatient|Adverse Event|5|||
44141231|NCT02455076|78930496|FG004|Outpatient|Adverse Event|0|||
44141232|NCT02455076|78930492|FG000|Outpatient|Lost to Follow-up|0|||
44141233|NCT02455076|78930493|FG001|Outpatient|Lost to Follow-up|0|||
44141234|NCT02455076|78930494|FG002|Outpatient|Lost to Follow-up|0|||
44141235|NCT02455076|78930495|FG003|Outpatient|Lost to Follow-up|1|||
44141236|NCT02455076|78930496|FG004|Outpatient|Lost to Follow-up|12|||
44141237|NCT02433080|78930510|FG000|Overall Study|Lost to Follow-up|1|||
44141238|NCT02433080|78930511|FG001|Overall Study|Lost to Follow-up|2|||
44141239|NCT02433080|78930510|FG000|Overall Study|Withdrawal by Subject|0|||
44141240|NCT02433080|78930511|FG001|Overall Study|Withdrawal by Subject|2|||
44141241|NCT03092219|78930520|FG000|Overall Study|Protocol Violation|7|||
44141242|NCT03092219|78930521|FG001|Overall Study|Protocol Violation|4|||
44141243|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Death|3|||
44141244|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Death|2|||
44141245|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Death|4|||
44141246|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Death|3|||
44141247|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Death|0|||
44141248|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Death|0|||
44141249|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
44141250|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
44141251|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
44141252|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
44141253|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
44141254|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
44141255|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
44141256|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
44141257|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
44141258|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
44141259|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
44141260|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
44141261|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
44141262|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
44141263|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
44141264|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
44141265|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
44141266|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
44141267|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
44141268|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
44141269|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
44141270|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
44141271|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
44141272|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
44141273|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
44141274|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
44141275|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
44141276|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
44141277|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
44141278|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
44141279|NCT02432846|78930536|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
44141280|NCT02432846|78930537|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
44141281|NCT02432846|78930538|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
44141282|NCT02432846|78930539|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
44141283|NCT02432846|78930540|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
44141284|NCT02432846|78930541|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
44141285|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
44141286|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
44141287|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
44141288|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
44141289|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
44141290|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
44141291|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
44141292|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
44141293|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
44141294|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
44141295|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
44141296|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
44141297|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
44141298|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
44141299|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
44141300|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
44141301|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
44141302|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
44141303|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
44141304|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
44141305|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
44141306|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
44141307|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
44141308|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
44141309|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
44141310|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
44141311|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
44141312|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
44141313|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
44141314|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
44141315|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
44141316|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
44141317|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
44141318|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
44141319|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
44141320|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
44141321|NCT02432846|78930536|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
44141322|NCT02432846|78930537|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
44141323|NCT02432846|78930538|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
44141324|NCT02432846|78930539|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
44141325|NCT02432846|78930540|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
44141326|NCT02432846|78930541|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
44141327|NCT02432144|78930554|FG000|Overall Study|Participant Non-Compliance|1|||
44141328|NCT02246998|78930562|FG000|Overall Study|Adverse Event|0|||
44141329|NCT02246998|78930563|FG001|Overall Study|Adverse Event|1|||
44141330|NCT02246998|78930564|FG002|Overall Study|Adverse Event|1|||
44141331|NCT02246998|78930565|FG003|Overall Study|Adverse Event|0|||
44141332|NCT02246998|78930562|FG000|Overall Study|Lost to Follow-up|1|||
44141333|NCT02246998|78930563|FG001|Overall Study|Lost to Follow-up|0|||
44141334|NCT02246998|78930564|FG002|Overall Study|Lost to Follow-up|0|||
44141335|NCT02246998|78930565|FG003|Overall Study|Lost to Follow-up|1|||
44141336|NCT02246998|78930562|FG000|Overall Study|Randomized but Never Dosed|1|||
44141337|NCT02246998|78930563|FG001|Overall Study|Randomized but Never Dosed|2|||
44141338|NCT02246998|78930564|FG002|Overall Study|Randomized but Never Dosed|2|||
44141339|NCT02246998|78930565|FG003|Overall Study|Randomized but Never Dosed|1|||
44141340|NCT02486588|78930584|FG000|Overall Study|Randomized in error- ineligible|738|||
44141341|NCT02486588|78930585|FG001|Overall Study|Randomized in error- ineligible|750|||
44141342|NCT02486588|78930586|FG002|Overall Study|Randomized in error- ineligible|755|||
44141343|NCT02486588|78930587|FG003|Overall Study|Randomized in error- ineligible|738|||
44141344|NCT02486588|78930588|FG004|Overall Study|Randomized in error- ineligible|746|||
44141345|NCT02486588|78930589|FG005|Overall Study|Randomized in error- ineligible|746|||
44141346|NCT00805961|78930608|FG000|Modality Therapy|Withdrawal by Subject|1|||
44141347|NCT00805961|78930608|FG000|Modality Therapy|Adverse Event|1|||
44141348|NCT00805961|78930608|FG000|Modality Therapy|Disease Progression|2|||
44141349|NCT00805961|78930608|FG000|Treatment-Free Interval|Adverse Event|3|||
44380470|NCT00902538|79386271|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
44513882|NCT03100942|79519077|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
44513883|NCT03100942|79519078|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
44513884|NCT03100942|79519079|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
44141350|NCT00805961|78930608|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
44141351|NCT00805961|78930608|FG000|Treatment-Free Interval|Physician Decision|1|||
44141352|NCT00805961|78930608|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
44141353|NCT00805961|78930608|FG000|Maintenance Treatment|Lack of Efficacy|13|||
44141354|NCT00805961|78930608|FG000|Maintenance Treatment|Intercurrent Illness|7|||
44141355|NCT00805961|78930608|FG000|Maintenance Treatment|Adverse Event|6|||
44141356|NCT00805961|78930608|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
44141357|NCT00805961|78930608|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
44141358|NCT00805961|78930608|FG000|Maintenance Treatment|Withdrawn Consent|1|||
44141359|NCT02202538|78930612|FG000|Overall Study|Withdrawal by Subject|5|||
44141360|NCT02202538|78930612|FG000|Overall Study|Did not meet all inclusion criteria|2|||
44141361|NCT02202538|78930612|FG000|Overall Study|Investigator Decision|1|||
44141362|NCT02454608|78930619|FG000|Double-Blind Period|Lack of Efficacy|0|||
44141363|NCT02454608|78930620|FG001|Double-Blind Period|Lack of Efficacy|2|||
44141364|NCT02454608|78930621|FG002|Double-Blind Period|Lack of Efficacy|0|||
44141365|NCT02454608|78930619|FG000|Open Label Period|Lost to Follow-up|0|||
44141366|NCT02454608|78930620|FG001|Open Label Period|Lost to Follow-up|0|||
44141367|NCT02454608|78930621|FG002|Open Label Period|Lost to Follow-up|11|||
44141368|NCT02454608|78930619|FG000|Open Label Period|Withdrawal by Subject|0|||
44141369|NCT02454608|78930620|FG001|Open Label Period|Withdrawal by Subject|0|||
44141370|NCT02454608|78930621|FG002|Open Label Period|Withdrawal by Subject|8|||
44141371|NCT02246764|78930632|FG000|Overall Study|Adverse Event|15|||
44141372|NCT02246764|78930633|FG001|Overall Study|Adverse Event|29|||
44141373|NCT02246764|78930634|FG002|Overall Study|Adverse Event|1|||
44141374|NCT02246764|78930632|FG000|Overall Study|Withdrawal by Subject|0|||
44141375|NCT02246764|78930633|FG001|Overall Study|Withdrawal by Subject|0|||
44141376|NCT02246764|78930634|FG002|Overall Study|Withdrawal by Subject|1|||
44141377|NCT02246764|78930632|FG000|Overall Study|Disallowed Concomitant Medication|1|||
44141378|NCT02246764|78930633|FG001|Overall Study|Disallowed Concomitant Medication|0|||
44141379|NCT02246764|78930634|FG002|Overall Study|Disallowed Concomitant Medication|0|||
44141380|NCT02246764|78930632|FG000|Overall Study|Physician Decision|0|||
44141381|NCT02246764|78930633|FG001|Overall Study|Physician Decision|2|||
44141382|NCT02246764|78930634|FG002|Overall Study|Physician Decision|1|||
44141383|NCT02246764|78930632|FG000|Overall Study|Protocol Violation|2|||
44141384|NCT02246764|78930633|FG001|Overall Study|Protocol Violation|1|||
44141385|NCT02246764|78930634|FG002|Overall Study|Protocol Violation|1|||
44141386|NCT02454530|78930644|FG000|Overall Study|Other|8|||
44141387|NCT02454530|78930645|FG001|Overall Study|Other|13|||
44141388|NCT02454530|78930644|FG000|Overall Study|Missing information|56|||
44141389|NCT02454530|78930645|FG001|Overall Study|Missing information|69|||
44141390|NCT02454530|78930644|FG000|Overall Study|Death|2|||
44141391|NCT02454530|78930645|FG001|Overall Study|Death|41|||
44141392|NCT02454530|78930644|FG000|Overall Study|Lost to Follow-up|4|||
44141393|NCT02454530|78930645|FG001|Overall Study|Lost to Follow-up|4|||
44141394|NCT02431676|78930655|FG000|Overall Study|no lab obtained|0|||
44141395|NCT02431676|78930656|FG001|Overall Study|no lab obtained|1|||
44141396|NCT02431676|78930657|FG002|Overall Study|no lab obtained|2|||
44141397|NCT01654250|78930667|FG000|Overall Study|Lost to Follow-up|1|||
44141398|NCT01654250|78930668|FG001|Overall Study|Lost to Follow-up|0|||
44141399|NCT01652690|78930677|FG000|Overall Study|Withdrawal by Subject|16|||
44141400|NCT01652690|78930678|FG001|Overall Study|Withdrawal by Subject|4|||
44141401|NCT01652690|78930677|FG000|Overall Study|Other|8|||
44141402|NCT01652690|78930678|FG001|Overall Study|Other|9|||
44141403|NCT01652690|78930677|FG000|Overall Study|Lost to Follow-up|6|||
44141404|NCT01652690|78930678|FG001|Overall Study|Lost to Follow-up|6|||
44141405|NCT01652690|78930677|FG000|Overall Study|Death|5|||
44141406|NCT01652690|78930678|FG001|Overall Study|Death|2|||
44141407|NCT02429258|78930686|FG000|Overall Study|Withdrawal by Subject|2|||
44141408|NCT02429258|78930687|FG001|Overall Study|Withdrawal by Subject|0|||
44141409|NCT02429258|78930686|FG000|Overall Study|Protocol Violation|0|||
44141410|NCT02429258|78930687|FG001|Overall Study|Protocol Violation|1|||
44141411|NCT02201524|78930697|FG000|Overall Study|Adverse Event|0|||
44141412|NCT02201524|78930698|FG001|Overall Study|Adverse Event|2|||
44141413|NCT02201524|78930699|FG002|Overall Study|Adverse Event|1|||
44141414|NCT02201524|78930700|FG003|Overall Study|Adverse Event|0|||
44141415|NCT02201524|78930697|FG000|Overall Study|Insufficient clinical response|1|||
44141416|NCT02201524|78930698|FG001|Overall Study|Insufficient clinical response|0|||
44380471|NCT00902538|79386266|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
44380472|NCT00902538|79386267|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
44141417|NCT02201524|78930699|FG002|Overall Study|Insufficient clinical response|0|||
44141418|NCT02201524|78930700|FG003|Overall Study|Insufficient clinical response|0|||
44141419|NCT02201524|78930697|FG000|Overall Study|Lost to Follow-up|0|||
44141420|NCT02201524|78930698|FG001|Overall Study|Lost to Follow-up|0|||
44141421|NCT02201524|78930699|FG002|Overall Study|Lost to Follow-up|2|||
44141422|NCT02201524|78930700|FG003|Overall Study|Lost to Follow-up|0|||
44141423|NCT02201524|78930697|FG000|Overall Study|No longer meets eligibility criteria|0|||
44380473|NCT00902538|79386268|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
44141424|NCT02201524|78930698|FG001|Overall Study|No longer meets eligibility criteria|0|||
44141425|NCT02201524|78930699|FG002|Overall Study|No longer meets eligibility criteria|0|||
44141426|NCT02201524|78930700|FG003|Overall Study|No longer meets eligibility criteria|2|||
44141427|NCT02201524|78930697|FG000|Overall Study|Protocol Violation|0|||
44141428|NCT02201524|78930698|FG001|Overall Study|Protocol Violation|0|||
44141429|NCT02201524|78930699|FG002|Overall Study|Protocol Violation|0|||
44141430|NCT02201524|78930700|FG003|Overall Study|Protocol Violation|1|||
44141431|NCT02201524|78930697|FG000|Overall Study|Withdrawal by Subject|0|||
44141432|NCT02201524|78930698|FG001|Overall Study|Withdrawal by Subject|0|||
44141433|NCT02201524|78930699|FG002|Overall Study|Withdrawal by Subject|1|||
44141434|NCT02201524|78930700|FG003|Overall Study|Withdrawal by Subject|1|||
44141435|NCT02201524|78930697|FG000|Overall Study|Other|1|||
44141436|NCT02201524|78930698|FG001|Overall Study|Other|1|||
44141437|NCT02201524|78930699|FG002|Overall Study|Other|0|||
44141438|NCT02201524|78930700|FG003|Overall Study|Other|0|||
44141439|NCT02453048|78930715|FG000|Overall Study|Only part of initial 6 mo. study|0|||
44141440|NCT02453048|78930716|FG001|Overall Study|Only part of initial 6 mo. study|0|||
44141441|NCT02453048|78930717|FG002|Overall Study|Only part of initial 6 mo. study|0|||
44244026|NCT01469377|79074071|FG002|Overall Study|Withdrawal of Consent|15|||
44276631|NCT04791319|79237614|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
44276632|NCT04791319|79237615|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276633|NCT04791319|79237616|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276634|NCT04791319|79237617|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276635|NCT04791319|79237618|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276636|NCT04791319|79237619|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276637|NCT04791319|79237620|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276638|NCT04791319|79237621|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
44276639|NCT04791319|79237611|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276640|NCT04791319|79237612|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276641|NCT04791319|79237613|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276642|NCT04791319|79237614|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
44276643|NCT04791319|79237615|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276644|NCT04791319|79237616|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276645|NCT04791319|79237617|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276646|NCT04791319|79237618|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276647|NCT04791319|79237619|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276648|NCT04791319|79237620|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276649|NCT04791319|79237621|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
44276650|NCT04791319|79237611|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276651|NCT04791319|79237612|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276652|NCT04791319|79237613|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276653|NCT04791319|79237614|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276654|NCT04791319|79237615|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
44276655|NCT04791319|79237616|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
44276656|NCT04791319|79237617|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
44276657|NCT04791319|79237618|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276658|NCT04791319|79237619|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276659|NCT04791319|79237620|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
44276660|NCT04791319|79237621|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
44276661|NCT04791319|79237611|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276662|NCT04791319|79237612|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44244027|NCT01469377|79074069|FG000|Overall Study|Adverse Event|8|||
44244028|NCT01469377|79074070|FG001|Overall Study|Adverse Event|18|||
44244029|NCT01469377|79074071|FG002|Overall Study|Adverse Event|36|||
44244030|NCT01469377|79074069|FG000|Overall Study|Insufficient Therapeutic Response|3|||
44244031|NCT01469377|79074070|FG001|Overall Study|Insufficient Therapeutic Response|4|||
44244032|NCT01469377|79074071|FG002|Overall Study|Insufficient Therapeutic Response|0|||
44244033|NCT01469377|79074069|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44244034|NCT01469377|79074070|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44244035|NCT01469377|79074071|FG002|Overall Study|Other Miscellaneous Reasons|0|||
44244036|NCT01469221|79074081|FG000|Double Blind Phase|Protocol Violation|1|||
44244037|NCT01469221|79074082|FG001|Double Blind Phase|Protocol Violation|0|||
44244038|NCT01469221|79074083|FG002|Double Blind Phase|Protocol Violation|0|||
44244039|NCT01469221|79074081|FG000|Double Blind Phase|Physician Decision|1|||
44244040|NCT01469221|79074082|FG001|Double Blind Phase|Physician Decision|1|||
44141442|NCT02453048|78930718|FG003|Overall Study|Only part of initial 6 mo. study|0|||
44141443|NCT02453048|78930719|FG004|Overall Study|Only part of initial 6 mo. study|6|||
44141444|NCT02453048|78930715|FG000|Overall Study|Lost to Follow-up|0|||
44141445|NCT02453048|78930716|FG001|Overall Study|Lost to Follow-up|1|||
44141446|NCT02453048|78930717|FG002|Overall Study|Lost to Follow-up|2|||
44141447|NCT02453048|78930718|FG003|Overall Study|Lost to Follow-up|0|||
44141448|NCT02453048|78930719|FG004|Overall Study|Lost to Follow-up|0|||
44141449|NCT02137252|78930733|FG000|Overall Study|trial terminated early|2|||
44141450|NCT02137252|78930734|FG001|Overall Study|trial terminated early|1|||
44141451|NCT02201290|78930740|FG000|Overall Study|Withdrawal by Subject|2|||
44141452|NCT02201290|78930740|FG000|Overall Study|Lack of Efficacy|2|||
44141453|NCT02201290|78930740|FG000|Overall Study|Adverse Event|1|||
44380474|NCT00902538|79386269|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
44141454|NCT02200510|78930746|FG000|Overall Study|Death|1|||
44141455|NCT02200510|78930747|FG001|Overall Study|Death|1|||
44141456|NCT02200510|78930746|FG000|Overall Study|Protocol Violation|0|||
44141457|NCT02200510|78930747|FG001|Overall Study|Protocol Violation|1|||
44141458|NCT02200510|78930746|FG000|Overall Study|Lost to Follow-up|7|||
44141459|NCT02200510|78930747|FG001|Overall Study|Lost to Follow-up|1|||
44141460|NCT02200510|78930746|FG000|Overall Study|potential COI - joined study team|1|||
44141461|NCT02200510|78930747|FG001|Overall Study|potential COI - joined study team|0|||
44141462|NCT02452892|78930757|FG000|Week 1 Initial Randommization|Adverse Event|1|||
44141463|NCT02452892|78930758|FG001|Week 1 Initial Randommization|Adverse Event|0|||
44141464|NCT02452892|78930759|FG002|Week 1 Initial Randommization|Adverse Event|0|||
44141465|NCT02452892|78930760|FG003|Week 1 Initial Randommization|Adverse Event|0|||
44141466|NCT02452892|78930757|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
44141467|NCT02452892|78930758|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
44141468|NCT02452892|78930759|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
44141469|NCT02452892|78930760|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
44141470|NCT02452892|78930757|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
44141471|NCT02452892|78930758|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
44141472|NCT02452892|78930759|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
44141473|NCT02452892|78930760|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
44141474|NCT02452892|78930757|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
44141475|NCT02452892|78930758|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
44141476|NCT02452892|78930759|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
44141477|NCT02452892|78930760|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
44141478|NCT02452892|78930757|FG000|Follow-up|Withdrawal by Subject|0|||
44141479|NCT02452892|78930758|FG001|Follow-up|Withdrawal by Subject|0|||
44141480|NCT02452892|78930759|FG002|Follow-up|Withdrawal by Subject|0|||
44141481|NCT02452892|78930760|FG003|Follow-up|Withdrawal by Subject|1|||
44141482|NCT02452892|78930757|FG000|Follow-up|Subject left town on Day 42|1|||
44141483|NCT02452892|78930758|FG001|Follow-up|Subject left town on Day 42|0|||
44141484|NCT02452892|78930759|FG002|Follow-up|Subject left town on Day 42|0|||
44141485|NCT02452892|78930760|FG003|Follow-up|Subject left town on Day 42|0|||
44141486|NCT02135848|78930775|FG000|Overall Study|Adverse Event|2|||
44141487|NCT02135848|78930776|FG001|Overall Study|Adverse Event|0|||
44141488|NCT02135848|78930775|FG000|Overall Study|Withdrawal by Subject|1|||
44141489|NCT02135848|78930776|FG001|Overall Study|Withdrawal by Subject|1|||
44141490|NCT02738333|78930796|FG000|Overall Study|Death|1|||
44141491|NCT02738333|78930797|FG001|Overall Study|Death|0|||
44141492|NCT02738333|78930798|FG002|Overall Study|Death|0|||
44141493|NCT02738333|78930796|FG000|Overall Study|Lost to Follow-up|1|||
44141494|NCT02738333|78930797|FG001|Overall Study|Lost to Follow-up|0|||
44141495|NCT02738333|78930798|FG002|Overall Study|Lost to Follow-up|0|||
44141496|NCT02135692|78930806|FG000|Overall Study|Adverse Event|3|||
44141497|NCT02135692|78930806|FG000|Overall Study|Lack of Efficacy|2|||
44141498|NCT02135692|78930806|FG000|Overall Study|Protocol Violation|2|||
44141499|NCT02135692|78930806|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
44141500|NCT02135692|78930806|FG000|Overall Study|Product commercially available|159|||
44141501|NCT02135692|78930806|FG000|Overall Study|Study closed/terminated|153|||
44141502|NCT02135692|78930806|FG000|Overall Study|Lost to Follow-up|4|||
44141503|NCT02135692|78930806|FG000|Overall Study|Withdrawal by Subject|15|||
44141504|NCT02429414|78930812|FG000|Overall Study|Physician Decision|0|||
44141505|NCT02429414|78930813|FG001|Overall Study|Physician Decision|1|||
44141506|NCT02135614|78930821|FG000|Overall Study|Randomized but Not Treated|2|||
44141507|NCT02135614|78930822|FG001|Overall Study|Randomized but Not Treated|1|||
44141508|NCT02135614|78930821|FG000|Overall Study|Adverse Event|0|||
44141509|NCT02135614|78930822|FG001|Overall Study|Adverse Event|1|||
44141510|NCT02135614|78930821|FG000|Overall Study|Death|1|||
44141511|NCT02135614|78930822|FG001|Overall Study|Death|0|||
44141512|NCT02135614|78930821|FG000|Overall Study|Investigator's Discretion|0|||
44141513|NCT02135614|78930822|FG001|Overall Study|Investigator's Discretion|1|||
44141514|NCT02135614|78930821|FG000|Overall Study|Withdrew Consent|2|||
44141515|NCT02135614|78930822|FG001|Overall Study|Withdrew Consent|2|||
44141516|NCT02135614|78930821|FG000|Overall Study|Lost to Follow-up|3|||
44141517|NCT02135614|78930822|FG001|Overall Study|Lost to Follow-up|0|||
44141518|NCT02168842|78930830|FG000|Overall Study|Withdrawal by Subject|5|||
44141519|NCT02168842|78930831|FG001|Overall Study|Withdrawal by Subject|3|||
44141520|NCT02168842|78930830|FG000|Overall Study|Lost to Follow-up|0|||
44141521|NCT02168842|78930831|FG001|Overall Study|Lost to Follow-up|2|||
44141522|NCT02168842|78930830|FG000|Overall Study|Death|2|||
44141523|NCT02168842|78930831|FG001|Overall Study|Death|1|||
44141524|NCT02168842|78930830|FG000|Overall Study|Physician Decision|1|||
44141525|NCT02168842|78930831|FG001|Overall Study|Physician Decision|2|||
44141526|NCT02200042|78930841|FG000|Overall Study|Withdrawal by Subject|0|||
44141527|NCT02200042|78930842|FG001|Overall Study|Withdrawal by Subject|1|||
44141528|NCT02199028|78930850|FG000|Week 1|Adverse Event|1|||
44380475|NCT00902538|79386270|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
44380476|NCT00902538|79386271|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
44380477|NCT00902538|79386266|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
44380478|NCT00902538|79386267|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
44380479|NCT00902538|79386268|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
44141529|NCT02199028|78930851|FG001|Week 1|Adverse Event|0|||
44141530|NCT02199028|78930850|FG000|Week 3|Adverse Event|1|||
44141531|NCT02199028|78930851|FG001|Week 3|Adverse Event|0|||
44141532|NCT03347123|78930860|FG000|Overall Study|Death|1|||
44141533|NCT03347123|78930861|FG001|Overall Study|Death|2|||
44141534|NCT03347123|78930862|FG002|Overall Study|Death|0|||
44141535|NCT03347123|78930863|FG003|Overall Study|Death|0|||
44141536|NCT03347123|78930864|FG004|Overall Study|Death|0|||
44141537|NCT03347123|78930865|FG005|Overall Study|Death|0|||
44141538|NCT03347123|78930866|FG006|Overall Study|Death|0|||
44380480|NCT00902538|79386269|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
44380481|NCT00902538|79386270|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
44380482|NCT00902538|79386271|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
44380483|NCT00902538|79386266|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
44380484|NCT00902538|79386267|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
44380485|NCT00902538|79386268|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
44380486|NCT00902538|79386269|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
44380487|NCT00902538|79386270|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
44380488|NCT00902538|79386271|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
44380489|NCT00902538|79386266|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
44141539|NCT03347123|78930860|FG000|Overall Study|Withdrawal by Subject|1|||
44141540|NCT03347123|78930861|FG001|Overall Study|Withdrawal by Subject|0|||
44141541|NCT03347123|78930862|FG002|Overall Study|Withdrawal by Subject|0|||
44141542|NCT03347123|78930863|FG003|Overall Study|Withdrawal by Subject|0|||
44141543|NCT03347123|78930864|FG004|Overall Study|Withdrawal by Subject|0|||
44141544|NCT03347123|78930865|FG005|Overall Study|Withdrawal by Subject|0|||
44141545|NCT03347123|78930866|FG006|Overall Study|Withdrawal by Subject|0|||
44141546|NCT03347123|78930860|FG000|Overall Study|Reason not Specified|3|||
44141547|NCT03347123|78930861|FG001|Overall Study|Reason not Specified|4|||
44141548|NCT03347123|78930862|FG002|Overall Study|Reason not Specified|0|||
44141549|NCT03347123|78930863|FG003|Overall Study|Reason not Specified|0|||
44141550|NCT03347123|78930864|FG004|Overall Study|Reason not Specified|0|||
44141551|NCT03347123|78930865|FG005|Overall Study|Reason not Specified|0|||
44380490|NCT00902538|79386267|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
44380491|NCT00902538|79386268|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
44380492|NCT00902538|79386269|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
44380493|NCT00902538|79386270|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
44380494|NCT00902538|79386271|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
44380495|NCT00902538|79386266|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
44380496|NCT00902538|79386267|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
44380497|NCT00902538|79386268|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
44380498|NCT00902538|79386269|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
44380499|NCT00902538|79386270|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
44380500|NCT00902538|79386271|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
44380501|NCT00902538|79386266|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
44513885|NCT03100942|79519080|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
44141552|NCT03347123|78930866|FG006|Overall Study|Reason not Specified|0|||
44141553|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
44141554|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
44141555|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
44141556|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
44141557|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
44141558|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
44141559|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
44141560|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
44380502|NCT00902538|79386267|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
44380503|NCT00902538|79386268|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
44380504|NCT00902538|79386269|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
44380505|NCT00902538|79386270|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
44380506|NCT00902538|79386271|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
44380507|NCT00902538|79386266|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
44380508|NCT00902538|79386267|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
44380509|NCT00902538|79386268|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
44380510|NCT00902538|79386269|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
44380511|NCT00902538|79386270|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
44380512|NCT00902538|79386271|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
44380513|NCT00902538|79386266|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
44380514|NCT00902538|79386267|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
44380515|NCT00902538|79386268|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
44380516|NCT00902538|79386269|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
44380517|NCT00902538|79386270|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
44380518|NCT00902538|79386271|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
44380519|NCT00902538|79386266|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
44380520|NCT00902538|79386267|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
44380521|NCT00902538|79386268|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
44380522|NCT00902538|79386269|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
44380523|NCT00902538|79386270|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
44380524|NCT00902538|79386271|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
44380525|NCT01036022|79386293|FG000|Overall Study|Adverse Event|1|||
44380526|NCT01036022|79386294|FG001|Overall Study|Adverse Event|3|||
44380527|NCT01036022|79386295|FG002|Overall Study|Adverse Event|2|||
44380528|NCT01036022|79386296|FG003|Overall Study|Adverse Event|1|||
44380529|NCT01036022|79386297|FG004|Overall Study|Adverse Event|0|||
44380530|NCT01036022|79386298|FG005|Overall Study|Adverse Event|2|||
44380531|NCT01036022|79386293|FG000|Overall Study|Lack of Efficacy|1|||
44380532|NCT01036022|79386294|FG001|Overall Study|Lack of Efficacy|1|||
44380533|NCT01036022|79386295|FG002|Overall Study|Lack of Efficacy|1|||
44380534|NCT01036022|79386296|FG003|Overall Study|Lack of Efficacy|0|||
44380535|NCT01036022|79386297|FG004|Overall Study|Lack of Efficacy|1|||
44380536|NCT01036022|79386298|FG005|Overall Study|Lack of Efficacy|1|||
44380537|NCT01036022|79386293|FG000|Overall Study|Physician Decision|0|||
44380538|NCT01036022|79386294|FG001|Overall Study|Physician Decision|0|||
44244041|NCT01469221|79074083|FG002|Double Blind Phase|Physician Decision|0|||
44244042|NCT01469221|79074081|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
44380539|NCT01036022|79386295|FG002|Overall Study|Physician Decision|1|||
44380540|NCT01036022|79386296|FG003|Overall Study|Physician Decision|0|||
44380541|NCT01036022|79386297|FG004|Overall Study|Physician Decision|0|||
44380542|NCT01036022|79386298|FG005|Overall Study|Physician Decision|0|||
44380543|NCT01036022|79386293|FG000|Overall Study|Withdrawal by Subject|0|||
44244043|NCT01469221|79074082|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
44380544|NCT01036022|79386294|FG001|Overall Study|Withdrawal by Subject|0|||
44380545|NCT01036022|79386295|FG002|Overall Study|Withdrawal by Subject|0|||
44380546|NCT01036022|79386296|FG003|Overall Study|Withdrawal by Subject|1|||
44380547|NCT01036022|79386297|FG004|Overall Study|Withdrawal by Subject|2|||
44380548|NCT01036022|79386298|FG005|Overall Study|Withdrawal by Subject|0|||
44380549|NCT00752557|79386323|FG000|Overall Study|Withdrawal by Subject|4|||
44380550|NCT00752557|79386324|FG001|Overall Study|Withdrawal by Subject|3|||
44380551|NCT00752557|79386325|FG002|Overall Study|Withdrawal by Subject|3|||
44380552|NCT00752557|79386323|FG000|Overall Study|Unspecified resaons|0|||
44380553|NCT00752557|79386324|FG001|Overall Study|Unspecified resaons|2|||
44380554|NCT00752557|79386325|FG002|Overall Study|Unspecified resaons|2|||
44380555|NCT00752557|79386323|FG000|Overall Study|Lost to Follow-up|1|||
44380556|NCT00752557|79386324|FG001|Overall Study|Lost to Follow-up|0|||
44380557|NCT00752557|79386325|FG002|Overall Study|Lost to Follow-up|1|||
44380558|NCT00747643|79386337|FG000|Overall Study|Withdrawal by Subject|36|||
44380559|NCT00747643|79386338|FG001|Overall Study|Withdrawal by Subject|27|||
44380560|NCT01022762|79386346|FG000|Overall Study|Adverse Event|3|||
44380561|NCT01022762|79386347|FG001|Overall Study|Adverse Event|1|||
44380562|NCT01022762|79386346|FG000|Overall Study|Lack of Efficacy|0|||
44380563|NCT01022762|79386347|FG001|Overall Study|Lack of Efficacy|1|||
44380564|NCT01022762|79386346|FG000|Overall Study|Protocol Violation|7|||
44380565|NCT01022762|79386347|FG001|Overall Study|Protocol Violation|6|||
44380566|NCT01022762|79386346|FG000|Overall Study|Unclassified|12|||
44380567|NCT01022762|79386347|FG001|Overall Study|Unclassified|20|||
44380568|NCT01028378|79386353|FG000|Overall Study|Lost to Follow-up|12|||
44380569|NCT01028378|79386353|FG000|Overall Study|Withdrawal by Subject|1|||
44380570|NCT01028378|79386353|FG000|Overall Study|Adminstrative Reasons|4|||
44380571|NCT00747565|79386359|FG000|Overall Study|Withdrawal by Subject|10|||
44141561|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
44141562|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
44141563|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
44141564|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
44141565|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
44141566|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
44141567|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
44141568|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
44141569|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
44141570|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
44141571|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
44141572|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
44141573|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
44141574|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
44141575|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
44141576|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
44141577|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
44380572|NCT00747565|79386360|FG001|Overall Study|Withdrawal by Subject|6|||
44380573|NCT00747565|79386359|FG000|Overall Study|Lost to Follow-up|4|||
44380574|NCT00747565|79386360|FG001|Overall Study|Lost to Follow-up|1|||
44380575|NCT01028300|79386366|FG000|Overall Study|Study Terminated|4|||
44380576|NCT00752089|79386370|FG000|Overall Study|Adverse Event|1|||
44380577|NCT00752089|79386370|FG000|Overall Study|Protocol Deviation|2|||
44380578|NCT00752089|79386370|FG000|Overall Study|Could not attend visit 9|1|||
44380579|NCT00752089|79386370|FG000|Overall Study|Not capable of wearing partial denture|1|||
44380580|NCT00752089|79386370|FG000|Overall Study|Cannot continue the study|1|||
44380581|NCT00751933|79386381|FG000|Overall Study|Withdrawal by Subject|0|||
44380582|NCT00751933|79386382|FG001|Overall Study|Withdrawal by Subject|1|||
44380583|NCT00751933|79386383|FG002|Overall Study|Withdrawal by Subject|0|||
44380584|NCT00751933|79386384|FG003|Overall Study|Withdrawal by Subject|0|||
44380585|NCT00751933|79386381|FG000|Overall Study|Physician Decision|0|||
44141578|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
44244044|NCT01469221|79074083|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
44244045|NCT01453855|79074092|FG000|Overall Study|Adverse Event|3|||
44380586|NCT00751933|79386382|FG001|Overall Study|Physician Decision|0|||
44380587|NCT00751933|79386383|FG002|Overall Study|Physician Decision|1|||
44380588|NCT00751933|79386384|FG003|Overall Study|Physician Decision|1|||
44380589|NCT00751621|79386388|FG000|Overall Study|Adverse Event|1|||
44380590|NCT00751621|79386388|FG000|Overall Study|Withdrawal by Subject|1|||
44380591|NCT00751621|79386388|FG000|Overall Study|Subject moved to another country|1|||
44380592|NCT00751621|79386388|FG000|Overall Study|Poor adherence to asthma treatment|1|||
44244046|NCT01453855|79074093|FG001|Overall Study|Adverse Event|4|||
44244047|NCT01453855|79074092|FG000|Overall Study|Lost to Follow-up|2|||
44380593|NCT01028222|79386396|FG000|Overall Study|Protocol deviation|1|||
44380594|NCT01028222|79386397|FG001|Overall Study|Protocol deviation|0|||
44380595|NCT01028222|79386396|FG000|Overall Study|Disease progression|33|||
44380596|NCT01028222|79386397|FG001|Overall Study|Disease progression|9|||
44513886|NCT03100942|79519081|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
44380597|NCT01028222|79386396|FG000|Overall Study|Administrative problems|1|||
44380598|NCT01028222|79386397|FG001|Overall Study|Administrative problems|1|||
44380599|NCT01028222|79386396|FG000|Overall Study|Lost to Follow-up|0|||
44380600|NCT01028222|79386397|FG001|Overall Study|Lost to Follow-up|1|||
44380601|NCT01028222|79386396|FG000|Overall Study|Withdrawal by Subject|1|||
44141579|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
44141580|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
44141581|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
44380602|NCT01028222|79386397|FG001|Overall Study|Withdrawal by Subject|0|||
44380603|NCT01028222|79386396|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
44380604|NCT01028222|79386397|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
44380605|NCT01028222|79386396|FG000|Overall Study|Adverse Event|2|||
44380606|NCT01028222|79386397|FG001|Overall Study|Adverse Event|0|||
44380607|NCT00586495|79386404|FG000|Treatment Period|Adverse Event|11|||
44380608|NCT00586495|79386404|FG000|Treatment Period|Death|1|||
44380609|NCT00586495|79386404|FG000|Treatment Period|Protocol Violation|1|||
44380610|NCT00586495|79386404|FG000|Treatment Period|Withdrawal by Subject|1|||
44380611|NCT00586495|79386404|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
44380612|NCT00586495|79386404|FG000|Treatment Period|Switch to commercial drug|10|||
44380613|NCT00586495|79386404|FG000|Follow-up|Death|40|||
44380614|NCT00586495|79386404|FG000|Follow-up|Lost to Follow-up|1|||
44380615|NCT00586495|79386404|FG000|Follow-up|Withdrawal by Subject|4|||
44380616|NCT00586495|79386404|FG000|Follow-up|Protocol driven decision point|37|||
44380617|NCT00586495|79386404|FG000|Follow-up|Switch to commercial drug|10|||
44380618|NCT01027754|79386410|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
44380619|NCT01027754|79386411|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
44380620|NCT01027754|79386410|FG000|Overall Study|Withdrawal by Subject|0|||
44380621|NCT01027754|79386411|FG001|Overall Study|Withdrawal by Subject|5|||
44380622|NCT01034540|79386423|FG000|Overall Study|Adverse Event|0|||
44380623|NCT01034540|79386424|FG001|Overall Study|Adverse Event|1|||
44380624|NCT00774930|79386434|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
44380625|NCT00774930|79386435|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
44380626|NCT00774930|79386434|FG000|DB Phase|Adverse Event|1|||
44380627|NCT00774930|79386435|FG001|DB Phase|Adverse Event|2|||
44380628|NCT00774930|79386434|FG000|DB Phase|Subject Decision|1|||
44380629|NCT00774930|79386435|FG001|DB Phase|Subject Decision|5|||
44380630|NCT00774930|79386434|FG000|DB Phase|Sponsor Decision|0|||
44380631|NCT00774930|79386435|FG001|DB Phase|Sponsor Decision|1|||
44380632|NCT00774930|79386434|FG000|DB Phase|Disease Progression|1|||
44380633|NCT00774930|79386435|FG001|DB Phase|Disease Progression|1|||
44380634|NCT00774930|79386434|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
44380635|NCT00774930|79386435|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
44380636|NCT00774930|79386434|FG000|IOL Phase|Adverse Event|1|||
44380637|NCT00774930|79386435|FG001|IOL Phase|Adverse Event|1|||
44380638|NCT00774930|79386434|FG000|IOL Phase|Subject Decision|4|||
44380639|NCT00774930|79386435|FG001|IOL Phase|Subject Decision|3|||
44380640|NCT00774930|79386434|FG000|IOL Phase|Physician Decision|3|||
44380641|NCT00774930|79386435|FG001|IOL Phase|Physician Decision|2|||
44380642|NCT00774930|79386434|FG000|IOL Phase|Sponsor Decision|1|||
44380643|NCT00774930|79386435|FG001|IOL Phase|Sponsor Decision|0|||
44380644|NCT00774930|79386434|FG000|IOL Phase|Disease Progression|2|||
44380645|NCT00774930|79386435|FG001|IOL Phase|Disease Progression|1|||
44380646|NCT00774930|79386434|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
44380647|NCT00774930|79386435|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
44380648|NCT00774930|79386434|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
44380649|NCT00774930|79386435|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
44380650|NCT00774930|79386434|FG000|IOL Phase|Other|1|||
44380651|NCT00774930|79386435|FG001|IOL Phase|Other|0|||
44380652|NCT00774930|79386434|FG000|IOL Phase|Brain radiation|0|||
44380653|NCT00774930|79386435|FG001|IOL Phase|Brain radiation|1|||
44380654|NCT00774930|79386434|FG000|LTOLE Phase|Adverse Event|7|||
44380655|NCT00774930|79386435|FG001|LTOLE Phase|Adverse Event|3|||
44380656|NCT00774930|79386434|FG000|LTOLE Phase|Subject decision|0|||
44380657|NCT00774930|79386435|FG001|LTOLE Phase|Subject decision|5|||
44380658|NCT00774930|79386434|FG000|LTOLE Phase|Physician Decision|4|||
44380659|NCT00774930|79386435|FG001|LTOLE Phase|Physician Decision|1|||
44380660|NCT00774930|79386434|FG000|LTOLE Phase|Sponsor decision|2|||
44380661|NCT00774930|79386435|FG001|LTOLE Phase|Sponsor decision|1|||
44380662|NCT00774930|79386434|FG000|LTOLE Phase|Disease Progression|2|||
44380663|NCT00774930|79386435|FG001|LTOLE Phase|Disease Progression|5|||
44380664|NCT00774930|79386434|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
44380665|NCT00774930|79386435|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
44380666|NCT00774930|79386434|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
44380667|NCT00774930|79386435|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
44380668|NCT01027364|79386456|FG000|Overall Study|Adverse Event|1|||
44380669|NCT01027364|79386457|FG001|Overall Study|Adverse Event|0|||
44380670|NCT01027364|79386458|FG002|Overall Study|Adverse Event|1|||
44380671|NCT01027364|79386459|FG003|Overall Study|Adverse Event|0|||
44380672|NCT01027364|79386456|FG000|Overall Study|Lost to Follow-up|1|||
44380673|NCT01027364|79386457|FG001|Overall Study|Lost to Follow-up|0|||
44380674|NCT01027364|79386458|FG002|Overall Study|Lost to Follow-up|0|||
44380675|NCT01027364|79386459|FG003|Overall Study|Lost to Follow-up|0|||
44380676|NCT01027364|79386456|FG000|Overall Study|Protocol Violation|1|||
44380677|NCT01027364|79386457|FG001|Overall Study|Protocol Violation|0|||
44380678|NCT01027364|79386458|FG002|Overall Study|Protocol Violation|0|||
44380679|NCT01027364|79386459|FG003|Overall Study|Protocol Violation|1|||
44380680|NCT01027364|79386456|FG000|Overall Study|Withdrawal by Subject|1|||
44380681|NCT01027364|79386457|FG001|Overall Study|Withdrawal by Subject|2|||
44380682|NCT01027364|79386458|FG002|Overall Study|Withdrawal by Subject|0|||
44380683|NCT01027364|79386459|FG003|Overall Study|Withdrawal by Subject|0|||
44380684|NCT01027286|79386487|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
44380685|NCT01027286|79386488|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
44380686|NCT01027286|79386487|FG000|Overall Study|Lost to Follow-up|0|||
44380687|NCT01027286|79386488|FG001|Overall Study|Lost to Follow-up|1|||
44513887|NCT03100942|79519075|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
44513888|NCT03100942|79519076|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
44513889|NCT03100942|79519077|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
44141582|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
44141583|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
44141584|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
44141585|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
44141586|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
44141587|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
44141588|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
44141589|NCT02198794|78930877|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
44141590|NCT02198794|78930878|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
44141591|NCT02198794|78930879|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
44141592|NCT02198794|78930880|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
44141593|NCT02198794|78930877|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
44141594|NCT02198794|78930878|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
44141595|NCT02198794|78930879|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
44141596|NCT02198794|78930880|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
44141597|NCT02198794|78930877|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
44141598|NCT02198794|78930878|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
44141599|NCT02198794|78930879|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
44141600|NCT02198794|78930880|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
44141601|NCT02198794|78930877|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
44141602|NCT02198794|78930878|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
44141603|NCT02198794|78930879|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
44141604|NCT02198794|78930880|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
44244048|NCT01453855|79074093|FG001|Overall Study|Lost to Follow-up|1|||
44244049|NCT01453855|79074092|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
44513890|NCT03100942|79519078|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
44513891|NCT03100942|79519079|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
44513892|NCT03100942|79519080|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
44513893|NCT03100942|79519081|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
44513894|NCT03099694|79519096|FG000|Overall Study|Withdrawal by Subject|11|||
44513895|NCT03099694|79519097|FG001|Overall Study|Withdrawal by Subject|13|||
44513896|NCT03099694|79519096|FG000|Overall Study|Lost to Follow-up|9|||
44513897|NCT03099694|79519097|FG001|Overall Study|Lost to Follow-up|5|||
44513898|NCT03099538|79519104|FG000|Overall Study|Lack of Efficacy|3|||
44513899|NCT03099304|79519113|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
44513900|NCT03099304|79519114|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
44141605|NCT02198794|78930877|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
44141606|NCT02198794|78930878|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
44141607|NCT02198794|78930879|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
44141608|NCT02198794|78930880|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
44141609|NCT02198794|78930877|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
44244050|NCT01453855|79074093|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
44244051|NCT01453855|79074092|FG000|Overall Study|Noncompliance|1|||
44244052|NCT01453855|79074093|FG001|Overall Study|Noncompliance|0|||
44380688|NCT01026974|79386498|FG000|Overall Study|Withdrawal by Subject|0|||
44380689|NCT01026974|79386499|FG001|Overall Study|Withdrawal by Subject|1|||
44380690|NCT01026974|79386500|FG002|Overall Study|Withdrawal by Subject|7|||
44513901|NCT03099304|79519115|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
44380691|NCT01026974|79386501|FG003|Overall Study|Withdrawal by Subject|2|||
44513902|NCT03099304|79519116|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
44513903|NCT03099304|79519117|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
44141610|NCT02198794|78930878|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
44141611|NCT02198794|78930879|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
44141612|NCT02198794|78930880|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
44141613|NCT02133664|78930891|FG000|Overall Study|Lost to Follow-up|2|||
44141614|NCT02133664|78930892|FG001|Overall Study|Lost to Follow-up|1|||
44141615|NCT02133664|78930891|FG000|Overall Study|Adverse Event|3|||
44141616|NCT02133664|78930892|FG001|Overall Study|Adverse Event|6|||
44141617|NCT02133508|78930898|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
44141618|NCT02133508|78930898|FG000|Overall Study|Death|12|||
44141619|NCT02133508|78930898|FG000|Overall Study|Lost to Follow-up|2|||
44141620|NCT02133352|78930902|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
44141621|NCT02167594|78930909|FG000|Overall Study|Withdrawal by Subject|2|||
44141622|NCT02167594|78930910|FG001|Overall Study|Withdrawal by Subject|0|||
44141623|NCT02167594|78930911|FG002|Overall Study|Withdrawal by Subject|0|||
44141624|NCT02167594|78930909|FG000|Overall Study|Death|0|||
44141625|NCT02167594|78930910|FG001|Overall Study|Death|1|||
44380692|NCT01026974|79386498|FG000|Overall Study|Lost to Follow-up|1|||
44380693|NCT01026974|79386499|FG001|Overall Study|Lost to Follow-up|1|||
44380694|NCT01026974|79386500|FG002|Overall Study|Lost to Follow-up|4|||
44141626|NCT02167594|78930911|FG002|Overall Study|Death|0|||
44141627|NCT02555657|78930922|FG000|Overall Study|Death|274|||
44141628|NCT02555657|78930923|FG001|Overall Study|Death|262|||
44141629|NCT02555657|78930922|FG000|Overall Study|Physician Decision|0|||
44141630|NCT02555657|78930923|FG001|Overall Study|Physician Decision|1|||
44141631|NCT02555657|78930922|FG000|Overall Study|Sponsor Decision|27|||
44141632|NCT02555657|78930923|FG001|Overall Study|Sponsor Decision|15|||
44141633|NCT02555657|78930922|FG000|Overall Study|Withdrawal by Subject|11|||
44141634|NCT02555657|78930923|FG001|Overall Study|Withdrawal by Subject|32|||
44244053|NCT01453855|79074092|FG000|Overall Study|Inadequate Control of IOP|1|||
44244054|NCT01453855|79074093|FG001|Overall Study|Inadequate Control of IOP|5|||
44244055|NCT01453855|79074092|FG000|Overall Study|Other|0|||
44244056|NCT01453855|79074093|FG001|Overall Study|Other|1|||
44244057|NCT01469065|79074104|FG000|Overall Study|Lack of Efficacy|0|||
44244058|NCT01469065|79074105|FG001|Overall Study|Lack of Efficacy|0|||
44380695|NCT01026974|79386501|FG003|Overall Study|Lost to Follow-up|0|||
44380696|NCT01026974|79386498|FG000|Overall Study|Adverse Event|0|||
44380697|NCT01026974|79386499|FG001|Overall Study|Adverse Event|0|||
44513904|NCT03099304|79519118|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
44513905|NCT03099304|79519113|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
44513906|NCT03099304|79519114|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
44513907|NCT03099304|79519115|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
44513908|NCT03099304|79519116|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
44513909|NCT03099304|79519117|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
44513910|NCT03099304|79519118|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
44513911|NCT03099304|79519113|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
44513912|NCT03099304|79519114|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
44513913|NCT03099304|79519115|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
44141635|NCT02195518|78930955|FG000|Overall Study|Adverse Event|1|||
44141636|NCT02195518|78930955|FG000|Overall Study|Protocol Violation|4|||
44141637|NCT02195518|78930955|FG000|Overall Study|Pregnancy|2|||
44141638|NCT02195518|78930955|FG000|Overall Study|Withdrawal by Subject|1|||
44141639|NCT02195518|78930955|FG000|Overall Study|Lost to Follow-up|1|||
44141640|NCT02133742|78930985|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
44141641|NCT02133742|78930985|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
44141642|NCT02133742|78930985|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
44141643|NCT02133742|78930985|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
44244059|NCT01469065|79074106|FG002|Overall Study|Lack of Efficacy|0|||
44244060|NCT01469065|79074107|FG003|Overall Study|Lack of Efficacy|0|||
44380698|NCT01026974|79386500|FG002|Overall Study|Adverse Event|0|||
44513914|NCT03099304|79519116|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
44141644|NCT02133742|78930985|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
44141645|NCT03032705|78930993|FG000|Overall Study|Lost to Follow-up|16|||
44141646|NCT03032705|78930994|FG001|Overall Study|Lost to Follow-up|17|||
44380699|NCT01026974|79386501|FG003|Overall Study|Adverse Event|1|||
44141647|NCT03032705|78930993|FG000|Overall Study|did not quality|6|||
44380700|NCT01026974|79386498|FG000|Overall Study|Inappropriate enrollment|0|||
44380701|NCT01026974|79386499|FG001|Overall Study|Inappropriate enrollment|0|||
44141648|NCT03032705|78930994|FG001|Overall Study|did not quality|6|||
44141649|NCT04476251|78931000|FG000|Overall Study|Not treated|1|||
44141650|NCT03795233|78931006|FG000|Overall Study|Withdrawal by Subject|2|||
44141651|NCT03795233|78931007|FG001|Overall Study|Withdrawal by Subject|1|||
44141652|NCT03795233|78931006|FG000|Overall Study|Lost to Follow-up|1|||
44141653|NCT03795233|78931007|FG001|Overall Study|Lost to Follow-up|0|||
44141654|NCT03795233|78931006|FG000|Overall Study|Death|1|||
44141655|NCT03795233|78931007|FG001|Overall Study|Death|0|||
44141656|NCT03564119|78931015|FG000|Overall Study|Adverse Event|4|||
44141657|NCT03564119|78931016|FG001|Overall Study|Adverse Event|0|||
44141658|NCT03564119|78931015|FG000|Overall Study|Lost to Follow-up|1|||
44141659|NCT03564119|78931016|FG001|Overall Study|Lost to Follow-up|4|||
44141660|NCT03564119|78931015|FG000|Overall Study|Protocol Violation|1|||
44141661|NCT03564119|78931016|FG001|Overall Study|Protocol Violation|0|||
44141662|NCT03564119|78931015|FG000|Overall Study|Withdrawal by Subject|9|||
44141663|NCT03564119|78931016|FG001|Overall Study|Withdrawal by Subject|4|||
44141664|NCT03564119|78931015|FG000|Overall Study|Other Than Specified|0|||
44141665|NCT03564119|78931016|FG001|Overall Study|Other Than Specified|1|||
44141666|NCT04531241|78931022|FG000|Period 1|Withdrawal by Subject|2|||
44141667|NCT04531241|78931023|FG001|Period 1|Withdrawal by Subject|0|||
44141668|NCT04531241|78931022|FG000|Period 1|Dispesed incorrect lens power|1|||
44380702|NCT01026974|79386500|FG002|Overall Study|Inappropriate enrollment|1|||
44380703|NCT01026974|79386501|FG003|Overall Study|Inappropriate enrollment|0|||
44380704|NCT00897390|79386516|FG000|Overall Study|Adverse Event|2|||
44380705|NCT00897390|79386516|FG000|Overall Study|No Longer Met Study Criteria|1|||
44380706|NCT00897390|79386516|FG000|Overall Study|Personal Reasons|1|||
44380707|NCT00897390|79386516|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
44380708|NCT01034462|79386529|FG000|Overall Study|Adverse Event|7|||
44380709|NCT01034462|79386530|FG001|Overall Study|Adverse Event|17|||
44380710|NCT01034462|79386529|FG000|Overall Study|Lack of Efficacy|4|||
44380711|NCT01034462|79386530|FG001|Overall Study|Lack of Efficacy|4|||
44380712|NCT01034462|79386529|FG000|Overall Study|Protocol Violation|10|||
44380713|NCT01034462|79386530|FG001|Overall Study|Protocol Violation|7|||
44141669|NCT04531241|78931023|FG001|Period 1|Dispesed incorrect lens power|0|||
44141670|NCT04531241|78931022|FG000|Period 1|Protocol Violation|1|||
44141671|NCT04531241|78931023|FG001|Period 1|Protocol Violation|0|||
44141672|NCT04531241|78931022|FG000|Period 1|No longer eligible|0|||
44141673|NCT04531241|78931023|FG001|Period 1|No longer eligible|1|||
44380714|NCT01034462|79386529|FG000|Overall Study|Withdrawal by Subject|9|||
44380715|NCT01034462|79386530|FG001|Overall Study|Withdrawal by Subject|8|||
44380716|NCT01034462|79386529|FG000|Overall Study|Lost to Follow-up|14|||
44380717|NCT01034462|79386530|FG001|Overall Study|Lost to Follow-up|16|||
44380718|NCT01034462|79386529|FG000|Overall Study|Other reasons|1|||
44380719|NCT01034462|79386530|FG001|Overall Study|Other reasons|2|||
44380720|NCT01033448|79386538|FG000|Overall Study|Withdrawal by Subject|4|||
44380721|NCT01033448|79386538|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
44380722|NCT01033448|79386538|FG000|Overall Study|Lost to Follow-up|3|||
44380723|NCT01033448|79386538|FG000|Overall Study|Withdrew due to other reasons|3|||
44380724|NCT01033448|79386538|FG000|Overall Study|Unknown disposition|1|||
44513915|NCT03099304|79519117|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
44141674|NCT04531241|78931022|FG000|Period 1|Lens Discomfort|0|||
44141675|NCT04531241|78931023|FG001|Period 1|Lens Discomfort|1|||
44244061|NCT01469065|79074108|FG004|Overall Study|Lack of Efficacy|1|||
44244062|NCT01469065|79074104|FG000|Overall Study|Other|0|||
44244063|NCT01469065|79074105|FG001|Overall Study|Other|1|||
44244064|NCT01469065|79074106|FG002|Overall Study|Other|0|||
44244065|NCT01469065|79074107|FG003|Overall Study|Other|0|||
44244066|NCT01469065|79074108|FG004|Overall Study|Other|0|||
44244067|NCT01586624|79074132|FG000|Overall Study|Adverse Event|3|||
44244068|NCT01586624|79074133|FG001|Overall Study|Adverse Event|0|||
44244069|NCT01586624|79074134|FG002|Overall Study|Adverse Event|2|||
44380725|NCT00746941|79386548|FG000|Overall Study|Death|2|||
44380726|NCT00746941|79386549|FG001|Overall Study|Death|0|||
44141676|NCT04531241|78931022|FG000|Period 2|Covid-19 Related|1|||
44141677|NCT04531241|78931023|FG001|Period 2|Covid-19 Related|1|||
44141678|NCT03181529|78931031|FG000|Overall Study|Withdrawal by Subject|1|||
44141679|NCT03181529|78931032|FG001|Overall Study|Withdrawal by Subject|1|||
44141680|NCT03181529|78931031|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
44141681|NCT03181529|78931032|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
44141682|NCT03470441|78931046|FG000|Overall Study|Death|0|||
44141683|NCT03470441|78931047|FG001|Overall Study|Death|1|||
44380727|NCT00746941|79386550|FG002|Overall Study|Death|0|||
44380728|NCT00746941|79386551|FG003|Overall Study|Death|6|||
44380729|NCT00746941|79386548|FG000|Overall Study|Physician Decision|0|||
44380730|NCT00746941|79386549|FG001|Overall Study|Physician Decision|0|||
44380731|NCT00746941|79386550|FG002|Overall Study|Physician Decision|2|||
44380732|NCT00746941|79386551|FG003|Overall Study|Physician Decision|0|||
44244070|NCT01586624|79074135|FG003|Overall Study|Adverse Event|1|||
44244071|NCT01586624|79074136|FG004|Overall Study|Adverse Event|3|||
44513916|NCT03099304|79519118|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
44513917|NCT03099304|79519113|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
44513918|NCT03099304|79519114|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
44513919|NCT03099304|79519115|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
44380733|NCT00746941|79386548|FG000|Overall Study|Withdrawal by Subject|3|||
44380734|NCT00746941|79386549|FG001|Overall Study|Withdrawal by Subject|0|||
44380735|NCT00746941|79386550|FG002|Overall Study|Withdrawal by Subject|0|||
44380736|NCT00746941|79386551|FG003|Overall Study|Withdrawal by Subject|2|||
44380737|NCT00746941|79386548|FG000|Overall Study|Other, reason not provided|2|||
44380738|NCT00746941|79386549|FG001|Overall Study|Other, reason not provided|4|||
44380739|NCT00746941|79386550|FG002|Overall Study|Other, reason not provided|0|||
44276663|NCT04791319|79237613|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276664|NCT04791319|79237614|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276665|NCT04791319|79237615|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276666|NCT04791319|79237616|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276667|NCT04791319|79237617|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276668|NCT04791319|79237618|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276669|NCT04791319|79237619|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276670|NCT04791319|79237620|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
44380740|NCT00746941|79386551|FG003|Overall Study|Other, reason not provided|4|||
44380741|NCT00746941|79386548|FG000|Overall Study|Adverse Event|0|||
44380742|NCT00746941|79386549|FG001|Overall Study|Adverse Event|0|||
44380743|NCT00746941|79386550|FG002|Overall Study|Adverse Event|0|||
44380744|NCT00746941|79386551|FG003|Overall Study|Adverse Event|1|||
44513920|NCT03099304|79519116|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
44513921|NCT03099304|79519117|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
44513922|NCT03099304|79519118|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
44513923|NCT03099304|79519113|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
44513924|NCT03099304|79519114|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
44513925|NCT03099304|79519115|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
44244072|NCT01586624|79074137|FG005|Overall Study|Adverse Event|3|||
44244073|NCT01586624|79074138|FG006|Overall Study|Adverse Event|2|||
44513926|NCT03099304|79519116|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
44513927|NCT03099304|79519117|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
44513928|NCT03099304|79519118|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
44513929|NCT03099304|79519113|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
44513930|NCT03099304|79519114|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
44513931|NCT03099304|79519115|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
44244074|NCT01586624|79074139|FG007|Overall Study|Adverse Event|3|||
44244075|NCT01586624|79074132|FG000|Overall Study|Physician Decision|0|||
44244076|NCT01586624|79074133|FG001|Overall Study|Physician Decision|1|||
44244077|NCT01586624|79074134|FG002|Overall Study|Physician Decision|1|||
44244078|NCT01586624|79074135|FG003|Overall Study|Physician Decision|0|||
44380745|NCT00746785|79386563|FG000|Overall Study|Lost to Follow-up|29|||
44513932|NCT03099304|79519116|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
44513933|NCT03099304|79519117|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
44244079|NCT01586624|79074136|FG004|Overall Study|Physician Decision|2|||
44244080|NCT01586624|79074137|FG005|Overall Study|Physician Decision|0|||
44244081|NCT01586624|79074138|FG006|Overall Study|Physician Decision|1|||
44380746|NCT00746785|79386564|FG001|Overall Study|Lost to Follow-up|25|||
44380747|NCT00746785|79386565|FG002|Overall Study|Lost to Follow-up|27|||
44380748|NCT00750919|79386573|FG000|Overall Study|Adverse Event|9|||
44380749|NCT00750919|79386573|FG000|Overall Study|Withdrawal by Subject|1|||
44141684|NCT03470441|78931048|FG002|Overall Study|Death|1|||
44141685|NCT03470441|78931049|FG003|Overall Study|Death|0|||
44141686|NCT03470441|78931046|FG000|Overall Study|Adverse Event|0|||
44141687|NCT03470441|78931047|FG001|Overall Study|Adverse Event|0|||
44141688|NCT03470441|78931048|FG002|Overall Study|Adverse Event|0|||
44141689|NCT03470441|78931049|FG003|Overall Study|Adverse Event|1|||
44141690|NCT03470441|78931046|FG000|Overall Study|Withdrawal by Subject|1|||
44141691|NCT03470441|78931047|FG001|Overall Study|Withdrawal by Subject|4|||
44141692|NCT03470441|78931048|FG002|Overall Study|Withdrawal by Subject|1|||
44141693|NCT03470441|78931049|FG003|Overall Study|Withdrawal by Subject|3|||
44141694|NCT03361865|78931061|FG000|Overall Study|Death|17|||
44141695|NCT03361865|78931062|FG001|Overall Study|Death|18|||
44141696|NCT03361865|78931061|FG000|Overall Study|Physician Decision|1|||
44380750|NCT00750919|79386573|FG000|Overall Study|Lack of Efficacy|8|||
44380751|NCT00750919|79386573|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
44380752|NCT00750919|79386573|FG000|Overall Study|Other|36|||
44380753|NCT00746551|79386579|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
44380754|NCT00746551|79386580|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
44380755|NCT00746551|79386579|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
44380756|NCT00746551|79386580|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
44380757|NCT00746551|79386579|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
44380758|NCT00746551|79386580|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
44380759|NCT00753649|79386588|FG000|Overall Study|Migrated/moved from study area|1|||
44380760|NCT00753649|79386589|FG001|Overall Study|Migrated/moved from study area|0|||
44380761|NCT00753649|79386588|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
44380762|NCT00753649|79386589|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
44380763|NCT00753649|79386588|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
44380764|NCT00753649|79386589|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
44380765|NCT00753649|79386588|FG000|Overall Study|Protocol Violation|2|||
44380766|NCT00753649|79386589|FG001|Overall Study|Protocol Violation|0|||
44380767|NCT00750139|79386599|FG000|Overall Study|Adverse Event|1|||
44380768|NCT00750139|79386600|FG001|Overall Study|Adverse Event|2|||
44380769|NCT00750139|79386601|FG002|Overall Study|Adverse Event|0|||
44380770|NCT00750139|79386602|FG003|Overall Study|Adverse Event|1|||
44141697|NCT03361865|78931062|FG001|Overall Study|Physician Decision|9|||
44141698|NCT03361865|78931061|FG000|Overall Study|Withdrawal by Subject|1|||
44141699|NCT03361865|78931062|FG001|Overall Study|Withdrawal by Subject|0|||
44141700|NCT02149121|78931076|FG000|Main Study Period|Lack of Efficacy|2|||
44141701|NCT02149121|78931077|FG001|Main Study Period|Lack of Efficacy|2|||
44141702|NCT02149121|78931078|FG002|Main Study Period|Lack of Efficacy|1|||
44141703|NCT02149121|78931079|FG003|Main Study Period|Lack of Efficacy|0|||
44141704|NCT02149121|78931080|FG004|Main Study Period|Lack of Efficacy|0|||
44244082|NCT01586624|79074139|FG007|Overall Study|Physician Decision|1|||
44244083|NCT01586624|79074132|FG000|Overall Study|Withdrawal by Subject|0|||
44244084|NCT01586624|79074133|FG001|Overall Study|Withdrawal by Subject|0|||
44244085|NCT01586624|79074134|FG002|Overall Study|Withdrawal by Subject|0|||
44244086|NCT01586624|79074135|FG003|Overall Study|Withdrawal by Subject|1|||
44244087|NCT01586624|79074136|FG004|Overall Study|Withdrawal by Subject|0|||
44244088|NCT01586624|79074137|FG005|Overall Study|Withdrawal by Subject|0|||
44276671|NCT04791319|79237621|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
44276672|NCT04791319|79237611|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
44276673|NCT04791319|79237612|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
44276674|NCT04791319|79237613|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
44276675|NCT04791319|79237614|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
44276676|NCT04791319|79237615|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
44276677|NCT04791319|79237616|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
44276678|NCT04791319|79237617|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
44276679|NCT04791319|79237618|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
44276680|NCT04791319|79237619|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
44276681|NCT04791319|79237620|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
44380771|NCT00750139|79386599|FG000|Overall Study|Lost to Follow-up|17|||
44380772|NCT00750139|79386600|FG001|Overall Study|Lost to Follow-up|12|||
44141705|NCT02149121|78931081|FG005|Main Study Period|Lack of Efficacy|0|||
44513934|NCT03099304|79519118|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
44141706|NCT02149121|78931082|FG006|Main Study Period|Lack of Efficacy|0|||
44141707|NCT02149121|78931076|FG000|Main Study Period|Withdrawal by Subject|9|||
44141708|NCT02149121|78931077|FG001|Main Study Period|Withdrawal by Subject|5|||
44141709|NCT02149121|78931078|FG002|Main Study Period|Withdrawal by Subject|1|||
44244089|NCT01586624|79074138|FG006|Overall Study|Withdrawal by Subject|0|||
44141710|NCT02149121|78931079|FG003|Main Study Period|Withdrawal by Subject|0|||
44141711|NCT02149121|78931080|FG004|Main Study Period|Withdrawal by Subject|0|||
44141712|NCT02149121|78931081|FG005|Main Study Period|Withdrawal by Subject|0|||
44141713|NCT02149121|78931082|FG006|Main Study Period|Withdrawal by Subject|0|||
44141714|NCT02149121|78931076|FG000|Main Study Period|Adverse Event|2|||
44141715|NCT02149121|78931077|FG001|Main Study Period|Adverse Event|5|||
44141716|NCT02149121|78931078|FG002|Main Study Period|Adverse Event|1|||
44141717|NCT02149121|78931079|FG003|Main Study Period|Adverse Event|0|||
44141718|NCT02149121|78931080|FG004|Main Study Period|Adverse Event|0|||
44141719|NCT02149121|78931081|FG005|Main Study Period|Adverse Event|0|||
44141720|NCT02149121|78931082|FG006|Main Study Period|Adverse Event|0|||
44141721|NCT02149121|78931076|FG000|Main Study Period|Protocol Violation|2|||
44141722|NCT02149121|78931077|FG001|Main Study Period|Protocol Violation|0|||
44141723|NCT02149121|78931078|FG002|Main Study Period|Protocol Violation|0|||
44141724|NCT02149121|78931079|FG003|Main Study Period|Protocol Violation|0|||
44276682|NCT04791319|79237621|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
44276683|NCT04791319|79237611|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
44513935|NCT03099304|79519113|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
44513936|NCT03099304|79519114|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
44513937|NCT03099304|79519115|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
44513938|NCT03099304|79519116|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
44513939|NCT03099304|79519117|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
44513940|NCT03099304|79519118|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
44513941|NCT03099304|79519113|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
44513942|NCT03099304|79519114|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
44513943|NCT03099304|79519115|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
44513944|NCT03099304|79519116|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
44513945|NCT03099304|79519117|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
44513946|NCT03099304|79519118|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
44513947|NCT03099304|79519113|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
44513948|NCT03099304|79519114|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
44513949|NCT03099304|79519115|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
44276684|NCT04791319|79237612|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
44513950|NCT03099304|79519116|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
44513951|NCT03099304|79519117|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
44513952|NCT03099304|79519118|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
44513953|NCT03099304|79519113|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
44513954|NCT03099304|79519114|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
44380773|NCT00750139|79386601|FG002|Overall Study|Lost to Follow-up|15|||
44380774|NCT00750139|79386602|FG003|Overall Study|Lost to Follow-up|6|||
44380775|NCT00750139|79386599|FG000|Overall Study|Withdrawal by Subject|3|||
44380776|NCT00750139|79386600|FG001|Overall Study|Withdrawal by Subject|2|||
44380777|NCT00750139|79386601|FG002|Overall Study|Withdrawal by Subject|6|||
44513955|NCT03099304|79519115|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
44276685|NCT04791319|79237613|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
44513956|NCT03099304|79519116|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
44513957|NCT03099304|79519117|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
44513958|NCT03099304|79519118|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
44141725|NCT02149121|78931080|FG004|Main Study Period|Protocol Violation|0|||
44276686|NCT04791319|79237614|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
44276687|NCT04791319|79237615|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
44276688|NCT04791319|79237616|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
44276689|NCT04791319|79237617|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
44276690|NCT04791319|79237618|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
44276691|NCT04791319|79237619|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
44276692|NCT04791319|79237620|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
44276693|NCT04791319|79237621|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
44276694|NCT03472495|79237678|FG000|Overall Study|Treatment no longer indicated|1|||
44276695|NCT03472495|79237679|FG001|Overall Study|Treatment no longer indicated|2|||
44276696|NCT03472495|79237678|FG000|Overall Study|Physician Decision|0|||
44276697|NCT03472495|79237679|FG001|Overall Study|Physician Decision|2|||
44276698|NCT03234907|79237687|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
44380778|NCT00750139|79386602|FG003|Overall Study|Withdrawal by Subject|2|||
44513959|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
44513960|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
44513961|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
44141726|NCT02149121|78931081|FG005|Main Study Period|Protocol Violation|0|||
44141727|NCT02149121|78931082|FG006|Main Study Period|Protocol Violation|0|||
44380779|NCT00750139|79386599|FG000|Overall Study|Physician Decision|1|||
44380780|NCT00750139|79386600|FG001|Overall Study|Physician Decision|1|||
44380781|NCT00750139|79386601|FG002|Overall Study|Physician Decision|0|||
44380782|NCT00750139|79386602|FG003|Overall Study|Physician Decision|0|||
44380783|NCT00750139|79386599|FG000|Overall Study|Non-compliance|1|||
44380784|NCT00750139|79386600|FG001|Overall Study|Non-compliance|0|||
44380785|NCT00750139|79386601|FG002|Overall Study|Non-compliance|1|||
44380786|NCT00750139|79386602|FG003|Overall Study|Non-compliance|3|||
44380787|NCT00750139|79386599|FG000|Overall Study|Termination by sponsor|4|||
44380788|NCT00750139|79386600|FG001|Overall Study|Termination by sponsor|0|||
44380789|NCT00750139|79386601|FG002|Overall Study|Termination by sponsor|0|||
44380790|NCT00750139|79386602|FG003|Overall Study|Termination by sponsor|1|||
44380791|NCT00750139|79386599|FG000|Overall Study|Non-specific|62|||
44380792|NCT00750139|79386600|FG001|Overall Study|Non-specific|42|||
44380793|NCT00750139|79386601|FG002|Overall Study|Non-specific|79|||
44380794|NCT00750139|79386602|FG003|Overall Study|Non-specific|33|||
44380795|NCT00750061|79386616|FG000|Overall Study|Adverse Event|2|||
44380796|NCT00750061|79386617|FG001|Overall Study|Adverse Event|0|||
44380797|NCT00750061|79386616|FG000|Overall Study|Withdrawal by Subject|0|||
44380798|NCT00750061|79386617|FG001|Overall Study|Withdrawal by Subject|1|||
44380799|NCT00750061|79386616|FG000|Overall Study|Physician Decision|0|||
44380800|NCT00750061|79386617|FG001|Overall Study|Physician Decision|1|||
44380801|NCT00744757|79386623|FG000|Overall Study|Objective disease progression|7|||
44380802|NCT00744757|79386623|FG000|Overall Study|Physician Decision|5|||
44380803|NCT00744757|79386623|FG000|Overall Study|Withdrawal by Subject|1|||
44380804|NCT00744757|79386623|FG000|Overall Study|Death|6|||
44380805|NCT00744757|79386623|FG000|Overall Study|Adverse Event|2|||
44380806|NCT00745849|79386627|FG000|First Intervention|Withdrawal by Subject|0|||
44380807|NCT00745849|79386628|FG001|First Intervention|Withdrawal by Subject|1|||
44380808|NCT00745849|79386627|FG000|First Intervention|Lost to Follow-up|1|||
44380809|NCT00745849|79386628|FG001|First Intervention|Lost to Follow-up|1|||
44380810|NCT00745849|79386627|FG000|Second Intervention|Lost to Follow-up|2|||
44380811|NCT00745849|79386628|FG001|Second Intervention|Lost to Follow-up|1|||
44380812|NCT00749203|79386645|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
44380813|NCT00749203|79386646|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
44380814|NCT00749203|79386645|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
44380815|NCT00749203|79386646|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
44380816|NCT00749203|79386645|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
44380817|NCT00749203|79386646|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
44380818|NCT00749203|79386645|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
44380819|NCT00749203|79386646|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
44380820|NCT00749203|79386645|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
44380821|NCT00749203|79386646|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
44380822|NCT00749203|79386645|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
44380823|NCT00749203|79386646|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
44380824|NCT00748969|79386654|FG000|Overall Study|Withdrawal by Subject|1|||
44380825|NCT00748969|79386655|FG001|Overall Study|Withdrawal by Subject|0|||
44380826|NCT00748969|79386654|FG000|Overall Study|Withdrawal by Subject|0|||
44380827|NCT00748969|79386655|FG001|Overall Study|Withdrawal by Subject|1|||
44380828|NCT00745615|79386665|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
44380829|NCT00745615|79386666|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
44380830|NCT00745615|79386667|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
44380831|NCT00745615|79386668|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
44380832|NCT00745615|79386669|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
44380833|NCT00745615|79386670|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
44380834|NCT00745615|79386665|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
44513962|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
44513963|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
44513964|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
44513965|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
44513966|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
44513967|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
44513968|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
44380835|NCT00745615|79386666|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
44380836|NCT00745615|79386667|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
44513969|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
44380837|NCT00745615|79386668|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
44380838|NCT00745615|79386669|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
44513970|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
44380839|NCT00745615|79386670|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
44380840|NCT00745615|79386665|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
44380841|NCT00745615|79386666|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
44380842|NCT00745615|79386667|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
44380843|NCT00745615|79386668|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
44380844|NCT00745615|79386669|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
44380845|NCT00745615|79386670|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
44380846|NCT00745615|79386665|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
44380847|NCT00745615|79386666|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
44380848|NCT00745615|79386667|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
44380849|NCT00745615|79386668|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
44380850|NCT00745615|79386669|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
44380851|NCT00745615|79386670|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
44380852|NCT00745615|79386665|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
44380853|NCT00745615|79386666|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
44380854|NCT00745615|79386667|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
44380855|NCT00745615|79386668|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
44380856|NCT00745615|79386669|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
44380857|NCT00745615|79386670|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
44380858|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
44380859|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
44380860|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
44380861|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
44380862|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
44380863|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
44380864|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
44380865|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
44380866|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
44380867|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
44380868|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
44380869|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
44380870|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
44380871|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
44380872|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
44380873|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
44380874|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
44380875|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
44380876|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
44380877|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
44380878|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
44380879|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
44380880|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
44380881|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
44513971|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
44513972|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
44276699|NCT03234907|79237688|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
44276700|NCT03234907|79237689|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
44276701|NCT03234907|79237690|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
44276702|NCT03234907|79237691|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
44276703|NCT03234907|79237692|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
44276704|NCT03234907|79237687|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
44276705|NCT03234907|79237688|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
44276706|NCT03234907|79237689|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
44276707|NCT03234907|79237690|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
44276708|NCT03234907|79237691|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
44276709|NCT03234907|79237692|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
44276710|NCT03234907|79237687|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
44276711|NCT03234907|79237688|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
44276712|NCT03234907|79237689|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
44276713|NCT03234907|79237690|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
44276714|NCT03234907|79237691|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
44276715|NCT03234907|79237692|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
44276716|NCT03234907|79237687|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
44276717|NCT03234907|79237688|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
44276718|NCT03234907|79237689|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
44380882|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
44380883|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
44380884|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
44380885|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
44380886|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
44380887|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
44380888|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
44380889|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
44380890|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
44380891|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
44380892|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
44380893|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
44380894|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
44380895|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
44380896|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
44380897|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
44380898|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
44380899|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
44380900|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
44380901|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
44380902|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
44380903|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
44380904|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
44380905|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
44380906|NCT00745615|79386665|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
44380907|NCT00745615|79386666|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
44380908|NCT00745615|79386667|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
44380909|NCT00745615|79386668|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
44380910|NCT00745615|79386669|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
44380911|NCT00745615|79386670|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
44380912|NCT00744523|79386693|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
44380913|NCT00744523|79386694|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
44380914|NCT00744991|79386702|FG000|Overall Study|Progressive Disease|11|||
44380915|NCT00744991|79386702|FG000|Overall Study|Withdrawal by Subject|8|||
44380916|NCT00744991|79386702|FG000|Overall Study|Physician Decision|3|||
44380917|NCT00744991|79386702|FG000|Overall Study|Adverse Event|2|||
44380918|NCT00744991|79386702|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
44380919|NCT00839254|79386726|FG000|Overall Study|Protocol Violation|0|||
44380920|NCT00839254|79386727|FG001|Overall Study|Protocol Violation|1|||
44380921|NCT00839254|79386728|FG002|Overall Study|Protocol Violation|1|||
44380922|NCT00839254|79386729|FG003|Overall Study|Protocol Violation|1|||
44380923|NCT00839254|79386730|FG004|Overall Study|Protocol Violation|0|||
44380924|NCT00839254|79386731|FG005|Overall Study|Protocol Violation|0|||
44380925|NCT00839254|79386732|FG006|Overall Study|Protocol Violation|1|||
44380926|NCT00839254|79386733|FG007|Overall Study|Protocol Violation|2|||
44380927|NCT00839254|79386726|FG000|Overall Study|Physician Decision|0|||
44380928|NCT00839254|79386727|FG001|Overall Study|Physician Decision|1|||
44380929|NCT00839254|79386728|FG002|Overall Study|Physician Decision|0|||
44380930|NCT00839254|79386729|FG003|Overall Study|Physician Decision|0|||
44380931|NCT00839254|79386730|FG004|Overall Study|Physician Decision|0|||
44380932|NCT00839254|79386731|FG005|Overall Study|Physician Decision|0|||
44380933|NCT00839254|79386732|FG006|Overall Study|Physician Decision|0|||
44380934|NCT00839254|79386733|FG007|Overall Study|Physician Decision|1|||
44380935|NCT00839254|79386726|FG000|Overall Study|Wrong treatment number allocation|0|||
44380936|NCT00839254|79386727|FG001|Overall Study|Wrong treatment number allocation|1|||
44380937|NCT00839254|79386728|FG002|Overall Study|Wrong treatment number allocation|0|||
44380938|NCT00839254|79386729|FG003|Overall Study|Wrong treatment number allocation|0|||
44380939|NCT00839254|79386730|FG004|Overall Study|Wrong treatment number allocation|0|||
44380940|NCT00839254|79386731|FG005|Overall Study|Wrong treatment number allocation|1|||
44380941|NCT00839254|79386732|FG006|Overall Study|Wrong treatment number allocation|0|||
44380942|NCT00839254|79386733|FG007|Overall Study|Wrong treatment number allocation|0|||
44380943|NCT00839254|79386726|FG000|Overall Study|Adverse Event|12|||
44380944|NCT00839254|79386727|FG001|Overall Study|Adverse Event|6|||
44380945|NCT00839254|79386728|FG002|Overall Study|Adverse Event|3|||
44380946|NCT00839254|79386729|FG003|Overall Study|Adverse Event|5|||
44380947|NCT00839254|79386730|FG004|Overall Study|Adverse Event|2|||
44380948|NCT00839254|79386731|FG005|Overall Study|Adverse Event|1|||
44380949|NCT00839254|79386732|FG006|Overall Study|Adverse Event|0|||
44380950|NCT00839254|79386733|FG007|Overall Study|Adverse Event|1|||
44380951|NCT00839254|79386726|FG000|Overall Study|Withdrawal by Subject|87|||
44380952|NCT00839254|79386727|FG001|Overall Study|Withdrawal by Subject|53|||
44380953|NCT00839254|79386728|FG002|Overall Study|Withdrawal by Subject|54|||
44380954|NCT00839254|79386729|FG003|Overall Study|Withdrawal by Subject|32|||
44380955|NCT00839254|79386730|FG004|Overall Study|Withdrawal by Subject|27|||
44380956|NCT00839254|79386731|FG005|Overall Study|Withdrawal by Subject|15|||
44380957|NCT00839254|79386732|FG006|Overall Study|Withdrawal by Subject|22|||
44380958|NCT00839254|79386733|FG007|Overall Study|Withdrawal by Subject|9|||
44380959|NCT00839254|79386726|FG000|Overall Study|Wrong group allocation|0|||
44380960|NCT00839254|79386727|FG001|Overall Study|Wrong group allocation|0|||
44380961|NCT00839254|79386728|FG002|Overall Study|Wrong group allocation|0|||
44380962|NCT00839254|79386729|FG003|Overall Study|Wrong group allocation|0|||
44380963|NCT00839254|79386730|FG004|Overall Study|Wrong group allocation|0|||
44380964|NCT00839254|79386731|FG005|Overall Study|Wrong group allocation|0|||
44141728|NCT02149121|78931076|FG000|Main Study Period|Lost to Follow-up|2|||
44141729|NCT02149121|78931077|FG001|Main Study Period|Lost to Follow-up|1|||
44141730|NCT02149121|78931078|FG002|Main Study Period|Lost to Follow-up|0|||
44141731|NCT02149121|78931079|FG003|Main Study Period|Lost to Follow-up|0|||
44141732|NCT02149121|78931080|FG004|Main Study Period|Lost to Follow-up|0|||
44141733|NCT02149121|78931081|FG005|Main Study Period|Lost to Follow-up|0|||
44141734|NCT02149121|78931082|FG006|Main Study Period|Lost to Follow-up|0|||
44141735|NCT02149121|78931076|FG000|Main Study Period|Death|1|||
44141736|NCT02149121|78931077|FG001|Main Study Period|Death|0|||
44141737|NCT02149121|78931078|FG002|Main Study Period|Death|0|||
44141738|NCT02149121|78931079|FG003|Main Study Period|Death|0|||
44141739|NCT02149121|78931080|FG004|Main Study Period|Death|0|||
44141740|NCT02149121|78931081|FG005|Main Study Period|Death|0|||
44141741|NCT02149121|78931082|FG006|Main Study Period|Death|0|||
44141742|NCT02149121|78931076|FG000|Main Study Period|Physician Decision|1|||
44141743|NCT02149121|78931077|FG001|Main Study Period|Physician Decision|0|||
44141744|NCT02149121|78931078|FG002|Main Study Period|Physician Decision|0|||
44141745|NCT02149121|78931079|FG003|Main Study Period|Physician Decision|0|||
44141746|NCT02149121|78931080|FG004|Main Study Period|Physician Decision|0|||
44141747|NCT02149121|78931081|FG005|Main Study Period|Physician Decision|0|||
44141748|NCT02149121|78931082|FG006|Main Study Period|Physician Decision|0|||
44141749|NCT02149121|78931076|FG000|Main Study Period|Developed any malignancy|0|||
44141750|NCT02149121|78931077|FG001|Main Study Period|Developed any malignancy|1|||
44141751|NCT02149121|78931078|FG002|Main Study Period|Developed any malignancy|1|||
44141752|NCT02149121|78931079|FG003|Main Study Period|Developed any malignancy|0|||
44141753|NCT02149121|78931080|FG004|Main Study Period|Developed any malignancy|0|||
44141754|NCT02149121|78931081|FG005|Main Study Period|Developed any malignancy|0|||
44141755|NCT02149121|78931082|FG006|Main Study Period|Developed any malignancy|0|||
44141756|NCT02149121|78931076|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
44141757|NCT02149121|78931077|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
44141758|NCT02149121|78931078|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
44141759|NCT02149121|78931079|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
44141760|NCT02149121|78931080|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
44141761|NCT02149121|78931081|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
44141762|NCT02149121|78931082|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
44141763|NCT02149121|78931076|FG000|Main Study Period|Disease progression|0|||
44141764|NCT02149121|78931077|FG001|Main Study Period|Disease progression|1|||
44141765|NCT02149121|78931078|FG002|Main Study Period|Disease progression|0|||
44141766|NCT02149121|78931079|FG003|Main Study Period|Disease progression|0|||
44141767|NCT02149121|78931080|FG004|Main Study Period|Disease progression|0|||
44141768|NCT02149121|78931081|FG005|Main Study Period|Disease progression|0|||
44141769|NCT02149121|78931082|FG006|Main Study Period|Disease progression|0|||
44141770|NCT02149121|78931076|FG000|Extension Study Period|Withdrawal by Subject|0|||
44244090|NCT01586624|79074139|FG007|Overall Study|Withdrawal by Subject|0|||
44244091|NCT01586624|79074132|FG000|Overall Study|Evidence of disease progression|1|||
44244092|NCT01586624|79074133|FG001|Overall Study|Evidence of disease progression|3|||
44244093|NCT01586624|79074134|FG002|Overall Study|Evidence of disease progression|2|||
44244094|NCT01586624|79074135|FG003|Overall Study|Evidence of disease progression|5|||
44244095|NCT01586624|79074136|FG004|Overall Study|Evidence of disease progression|3|||
44244096|NCT01586624|79074137|FG005|Overall Study|Evidence of disease progression|5|||
44244097|NCT01586624|79074138|FG006|Overall Study|Evidence of disease progression|4|||
44244098|NCT01586624|79074139|FG007|Overall Study|Evidence of disease progression|6|||
44244099|NCT01586624|79074132|FG000|Overall Study|Screen failure (no treatment received)|0|||
44380965|NCT00839254|79386732|FG006|Overall Study|Wrong group allocation|1|||
44244100|NCT01586624|79074133|FG001|Overall Study|Screen failure (no treatment received)|0|||
44380966|NCT00839254|79386733|FG007|Overall Study|Wrong group allocation|0|||
44513973|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
44513974|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
44141771|NCT02149121|78931077|FG001|Extension Study Period|Withdrawal by Subject|0|||
44141772|NCT02149121|78931078|FG002|Extension Study Period|Withdrawal by Subject|0|||
44141773|NCT02149121|78931079|FG003|Extension Study Period|Withdrawal by Subject|1|||
44141774|NCT02149121|78931080|FG004|Extension Study Period|Withdrawal by Subject|0|||
44141775|NCT02149121|78931081|FG005|Extension Study Period|Withdrawal by Subject|2|||
44141776|NCT02149121|78931082|FG006|Extension Study Period|Withdrawal by Subject|0|||
44141777|NCT01865617|78931134|FG000|Overall Study|Death|27|||
44141778|NCT01865617|78931135|FG001|Overall Study|Death|3|||
44141779|NCT01865617|78931136|FG002|Overall Study|Death|1|||
44141780|NCT01865617|78931137|FG003|Overall Study|Death|1|||
44141781|NCT01865617|78931138|FG004|Overall Study|Death|5|||
44141782|NCT01865617|78931139|FG005|Overall Study|Death|1|||
44141783|NCT01865617|78931140|FG006|Overall Study|Death|11|||
44141784|NCT01865617|78931141|FG007|Overall Study|Death|1|||
44141785|NCT01865617|78931142|FG008|Overall Study|Death|11|||
44141786|NCT01865617|78931143|FG009|Overall Study|Death|3|||
44141787|NCT01865617|78931144|FG010|Overall Study|Death|32|||
44141788|NCT01865617|78931145|FG011|Overall Study|Death|6|||
44141789|NCT01865617|78931146|FG012|Overall Study|Death|13|||
44141790|NCT01865617|78931134|FG000|Overall Study|Lost to Follow-up|2|||
44141791|NCT01865617|78931135|FG001|Overall Study|Lost to Follow-up|0|||
44141792|NCT01865617|78931136|FG002|Overall Study|Lost to Follow-up|0|||
44141793|NCT01865617|78931137|FG003|Overall Study|Lost to Follow-up|0|||
44141794|NCT01865617|78931138|FG004|Overall Study|Lost to Follow-up|0|||
44141795|NCT01865617|78931139|FG005|Overall Study|Lost to Follow-up|0|||
44141796|NCT01865617|78931140|FG006|Overall Study|Lost to Follow-up|0|||
44141797|NCT01865617|78931141|FG007|Overall Study|Lost to Follow-up|0|||
44141798|NCT01865617|78931142|FG008|Overall Study|Lost to Follow-up|0|||
44141799|NCT01865617|78931143|FG009|Overall Study|Lost to Follow-up|0|||
44141800|NCT01865617|78931144|FG010|Overall Study|Lost to Follow-up|0|||
44141801|NCT01865617|78931145|FG011|Overall Study|Lost to Follow-up|0|||
44141802|NCT01865617|78931146|FG012|Overall Study|Lost to Follow-up|0|||
44141803|NCT01865617|78931134|FG000|Overall Study|Withdrawal by Subject|1|||
44141804|NCT01865617|78931135|FG001|Overall Study|Withdrawal by Subject|0|||
44141805|NCT01865617|78931136|FG002|Overall Study|Withdrawal by Subject|0|||
44141806|NCT01865617|78931137|FG003|Overall Study|Withdrawal by Subject|0|||
44141807|NCT01865617|78931138|FG004|Overall Study|Withdrawal by Subject|0|||
44141808|NCT01865617|78931139|FG005|Overall Study|Withdrawal by Subject|0|||
44141809|NCT01865617|78931140|FG006|Overall Study|Withdrawal by Subject|0|||
44141810|NCT01865617|78931141|FG007|Overall Study|Withdrawal by Subject|0|||
44141811|NCT01865617|78931142|FG008|Overall Study|Withdrawal by Subject|0|||
44141812|NCT01865617|78931143|FG009|Overall Study|Withdrawal by Subject|0|||
44141813|NCT01865617|78931144|FG010|Overall Study|Withdrawal by Subject|0|||
44141814|NCT01865617|78931145|FG011|Overall Study|Withdrawal by Subject|0|||
44141815|NCT01865617|78931146|FG012|Overall Study|Withdrawal by Subject|0|||
44141816|NCT01865617|78931134|FG000|Overall Study|Patient proceeded to new therapy|0|||
44141817|NCT01865617|78931135|FG001|Overall Study|Patient proceeded to new therapy|0|||
44141818|NCT01865617|78931136|FG002|Overall Study|Patient proceeded to new therapy|0|||
44141819|NCT01865617|78931137|FG003|Overall Study|Patient proceeded to new therapy|0|||
44141820|NCT01865617|78931138|FG004|Overall Study|Patient proceeded to new therapy|2|||
44141821|NCT01865617|78931139|FG005|Overall Study|Patient proceeded to new therapy|0|||
44141822|NCT01865617|78931140|FG006|Overall Study|Patient proceeded to new therapy|0|||
44141823|NCT01865617|78931141|FG007|Overall Study|Patient proceeded to new therapy|0|||
44141824|NCT01865617|78931142|FG008|Overall Study|Patient proceeded to new therapy|0|||
44141825|NCT01865617|78931143|FG009|Overall Study|Patient proceeded to new therapy|0|||
44141826|NCT01865617|78931144|FG010|Overall Study|Patient proceeded to new therapy|0|||
44380967|NCT00839254|79386726|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
44380968|NCT00839254|79386727|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
44380969|NCT00839254|79386728|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
44380970|NCT00839254|79386729|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
44380971|NCT00839254|79386730|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
44380972|NCT00839254|79386731|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
44380973|NCT00839254|79386732|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
44380974|NCT00839254|79386733|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
44380975|NCT00839254|79386726|FG000|Overall Study|Withdrawn due to non-compliance|2|||
44380976|NCT00839254|79386727|FG001|Overall Study|Withdrawn due to non-compliance|0|||
44380977|NCT00839254|79386728|FG002|Overall Study|Withdrawn due to non-compliance|0|||
44380978|NCT00839254|79386729|FG003|Overall Study|Withdrawn due to non-compliance|0|||
44141827|NCT01865617|78931145|FG011|Overall Study|Patient proceeded to new therapy|0|||
44141828|NCT01865617|78931146|FG012|Overall Study|Patient proceeded to new therapy|0|||
44141829|NCT01865617|78931134|FG000|Overall Study|Other|0|||
44380979|NCT00839254|79386730|FG004|Overall Study|Withdrawn due to non-compliance|0|||
44380980|NCT00839254|79386731|FG005|Overall Study|Withdrawn due to non-compliance|0|||
44141830|NCT01865617|78931135|FG001|Overall Study|Other|0|||
44141831|NCT01865617|78931136|FG002|Overall Study|Other|0|||
44141832|NCT01865617|78931137|FG003|Overall Study|Other|0|||
44141833|NCT01865617|78931138|FG004|Overall Study|Other|0|||
44141834|NCT01865617|78931139|FG005|Overall Study|Other|0|||
44141835|NCT01865617|78931140|FG006|Overall Study|Other|1|||
44141836|NCT01865617|78931141|FG007|Overall Study|Other|0|||
44141837|NCT01865617|78931142|FG008|Overall Study|Other|0|||
44141838|NCT01865617|78931143|FG009|Overall Study|Other|0|||
44380981|NCT00839254|79386732|FG006|Overall Study|Withdrawn due to non-compliance|0|||
44380982|NCT00839254|79386733|FG007|Overall Study|Withdrawn due to non-compliance|0|||
44380983|NCT00839254|79386726|FG000|Overall Study|Lost to Follow-up|51|||
44380984|NCT00839254|79386727|FG001|Overall Study|Lost to Follow-up|30|||
44380985|NCT00839254|79386728|FG002|Overall Study|Lost to Follow-up|32|||
44380986|NCT00839254|79386729|FG003|Overall Study|Lost to Follow-up|24|||
44380987|NCT00839254|79386730|FG004|Overall Study|Lost to Follow-up|8|||
44380988|NCT00839254|79386731|FG005|Overall Study|Lost to Follow-up|8|||
44380989|NCT00839254|79386732|FG006|Overall Study|Lost to Follow-up|4|||
44380990|NCT00839254|79386733|FG007|Overall Study|Lost to Follow-up|2|||
44380991|NCT00586339|79386785|FG000|Overall Study|Withdrawal by Subject|1|||
44380992|NCT00586339|79386786|FG001|Overall Study|Withdrawal by Subject|3|||
44380993|NCT00586339|79386787|FG002|Overall Study|Withdrawal by Subject|1|||
44380994|NCT00586339|79386785|FG000|Overall Study|Migrated/moved from study area|3|||
44380995|NCT00586339|79386786|FG001|Overall Study|Migrated/moved from study area|2|||
44380996|NCT00586339|79386787|FG002|Overall Study|Migrated/moved from study area|4|||
44380997|NCT00586339|79386785|FG000|Overall Study|Lost to Follow-up|3|||
44380998|NCT00586339|79386786|FG001|Overall Study|Lost to Follow-up|2|||
44380999|NCT00586339|79386787|FG002|Overall Study|Lost to Follow-up|1|||
44381000|NCT00812968|79386795|FG000|Overall Study|Relapse after erythroid response|6|||
44381001|NCT00812968|79386795|FG000|Overall Study|Disease progression|1|||
44381002|NCT00812968|79386795|FG000|Overall Study|No further treatment required|1|||
44381003|NCT00812968|79386795|FG000|Overall Study|Study closed due to marketing approval|3|||
44381004|NCT00839098|79386804|FG000|Overall Study|Withdrawal by Subject|2|||
44381005|NCT00839098|79386805|FG001|Overall Study|Withdrawal by Subject|1|||
44381006|NCT00839098|79386806|FG002|Overall Study|Withdrawal by Subject|7|||
44381007|NCT00813748|79386816|FG000|Skin Test Substudy|Physician Decision|0|||
44381008|NCT00813748|79386817|FG001|Skin Test Substudy|Physician Decision|1|||
44381009|NCT00813592|79386825|FG000|Overall Study|Disease assessment was not completed per|2|||
44381010|NCT05067647|79386830|FG000|Overall Study|Lost to Follow-up|1|||
44381011|NCT04795323|79386836|FG000|Overall Study|Did not interact with TARA|1|||
44381012|NCT04795323|79386837|FG001|Overall Study|Did not interact with TARA|0|||
44381013|NCT04732871|79386855|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
44381014|NCT04732871|79386856|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
44381015|NCT04732871|79386857|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
44381016|NCT04732871|79386855|FG000|Overall Study|Lost to Follow-up|7|||
44381017|NCT04732871|79386856|FG001|Overall Study|Lost to Follow-up|4|||
44141839|NCT01865617|78931144|FG010|Overall Study|Other|0|||
44141840|NCT01865617|78931145|FG011|Overall Study|Other|0|||
44141841|NCT01865617|78931146|FG012|Overall Study|Other|0|||
44141842|NCT02458313|78931179|FG000|Overall Study|Withdrawal by Subject|6|||
44141843|NCT02458313|78931180|FG001|Overall Study|Withdrawal by Subject|8|||
44244101|NCT01586624|79074134|FG002|Overall Study|Screen failure (no treatment received)|0|||
44244102|NCT01586624|79074135|FG003|Overall Study|Screen failure (no treatment received)|0|||
44381018|NCT04732871|79386857|FG002|Overall Study|Lost to Follow-up|3|||
44381019|NCT04732871|79386855|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
44381020|NCT04732871|79386856|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
44381021|NCT04732871|79386857|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
44381022|NCT04732871|79386855|FG000|Overall Study|Migrated / moved from the study area|5|||
44381023|NCT04732871|79386856|FG001|Overall Study|Migrated / moved from the study area|0|||
44381024|NCT04732871|79386857|FG002|Overall Study|Migrated / moved from the study area|0|||
44381025|NCT04732871|79386855|FG000|Overall Study|Other|1|||
44381026|NCT04732871|79386856|FG001|Overall Study|Other|0|||
44381027|NCT04732871|79386857|FG002|Overall Study|Other|1|||
44381028|NCT04732871|79386855|FG000|Overall Study|Ongoing|6|||
44381029|NCT04732871|79386856|FG001|Overall Study|Ongoing|0|||
44381030|NCT04732871|79386857|FG002|Overall Study|Ongoing|1|||
44381031|NCT04732871|79386855|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
44381032|NCT04732871|79386856|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
44381033|NCT04732871|79386857|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
44381034|NCT04497389|79386883|FG000|Overall Study|Withdrawal by Subject|1|||
44381035|NCT04497389|79386884|FG001|Overall Study|Withdrawal by Subject|0|||
44381036|NCT04425629|79386952|FG000|Overall Study|Adverse Event|0|||
44381037|NCT04425629|79386953|FG001|Overall Study|Adverse Event|0|||
44381038|NCT04425629|79386954|FG002|Overall Study|Adverse Event|0|||
44381039|NCT04425629|79386955|FG003|Overall Study|Adverse Event|0|||
44381040|NCT04425629|79386956|FG004|Overall Study|Adverse Event|1|||
44141844|NCT02458313|78931179|FG000|Overall Study|Excluded for motion during MRI|1|||
44381041|NCT04425629|79386957|FG005|Overall Study|Adverse Event|0|||
44381042|NCT04425629|79386958|FG006|Overall Study|Adverse Event|0|||
44381043|NCT04425629|79386959|FG007|Overall Study|Adverse Event|0|||
44381044|NCT04425629|79386960|FG008|Overall Study|Adverse Event|0|||
44381045|NCT04425629|79386961|FG009|Overall Study|Adverse Event|3|||
44381046|NCT04425629|79386962|FG010|Overall Study|Adverse Event|2|||
44141845|NCT02458313|78931180|FG001|Overall Study|Excluded for motion during MRI|2|||
44381047|NCT04425629|79386963|FG011|Overall Study|Adverse Event|1|||
44381048|NCT04425629|79386964|FG012|Overall Study|Adverse Event|1|||
44381049|NCT04425629|79386965|FG013|Overall Study|Adverse Event|0|||
44381050|NCT04425629|79386966|FG014|Overall Study|Adverse Event|0|||
44381051|NCT04425629|79386967|FG015|Overall Study|Adverse Event|0|||
44381052|NCT04425629|79386968|FG016|Overall Study|Adverse Event|0|||
44381053|NCT04425629|79386969|FG017|Overall Study|Adverse Event|0|||
44381054|NCT04425629|79386970|FG018|Overall Study|Adverse Event|0|||
44381055|NCT04425629|79386952|FG000|Overall Study|Lost to Follow-up|1|||
44381056|NCT04425629|79386953|FG001|Overall Study|Lost to Follow-up|3|||
44381057|NCT04425629|79386954|FG002|Overall Study|Lost to Follow-up|1|||
44381058|NCT04425629|79386955|FG003|Overall Study|Lost to Follow-up|7|||
44381059|NCT04425629|79386956|FG004|Overall Study|Lost to Follow-up|1|||
44381060|NCT04425629|79386957|FG005|Overall Study|Lost to Follow-up|2|||
44381061|NCT04425629|79386958|FG006|Overall Study|Lost to Follow-up|1|||
44381062|NCT04425629|79386959|FG007|Overall Study|Lost to Follow-up|0|||
44381063|NCT04425629|79386960|FG008|Overall Study|Lost to Follow-up|1|||
44381064|NCT04425629|79386961|FG009|Overall Study|Lost to Follow-up|64|||
44381065|NCT04425629|79386962|FG010|Overall Study|Lost to Follow-up|70|||
44381066|NCT04425629|79386963|FG011|Overall Study|Lost to Follow-up|98|||
44381067|NCT04425629|79386964|FG012|Overall Study|Lost to Follow-up|30|||
44381068|NCT04425629|79386965|FG013|Overall Study|Lost to Follow-up|0|||
44381069|NCT04425629|79386966|FG014|Overall Study|Lost to Follow-up|5|||
44381070|NCT04425629|79386967|FG015|Overall Study|Lost to Follow-up|4|||
44381071|NCT04425629|79386968|FG016|Overall Study|Lost to Follow-up|0|||
44381072|NCT04425629|79386969|FG017|Overall Study|Lost to Follow-up|3|||
44141846|NCT01328431|78931197|FG000|Baseline|Protocol Violation|0|||
44141847|NCT01328431|78931198|FG001|Baseline|Protocol Violation|2|||
44381073|NCT04425629|79386970|FG018|Overall Study|Lost to Follow-up|1|||
44381074|NCT04425629|79386952|FG000|Overall Study|Subject Decision|0|||
44381075|NCT04425629|79386953|FG001|Overall Study|Subject Decision|2|||
44381076|NCT04425629|79386954|FG002|Overall Study|Subject Decision|1|||
44381077|NCT04425629|79386955|FG003|Overall Study|Subject Decision|3|||
44381078|NCT04425629|79386956|FG004|Overall Study|Subject Decision|6|||
44381079|NCT04425629|79386957|FG005|Overall Study|Subject Decision|6|||
44381080|NCT04425629|79386958|FG006|Overall Study|Subject Decision|3|||
44381081|NCT04425629|79386959|FG007|Overall Study|Subject Decision|3|||
44381082|NCT04425629|79386960|FG008|Overall Study|Subject Decision|1|||
44141848|NCT01328431|78931197|FG000|1 Month (1M)|Lost to Follow-up|55|||
44141849|NCT01328431|78931198|FG001|1 Month (1M)|Lost to Follow-up|58|||
44141850|NCT01328431|78931197|FG000|3 Month (3M)|Death|2|||
44141851|NCT01328431|78931198|FG001|3 Month (3M)|Death|2|||
44141852|NCT01328431|78931197|FG000|3 Month (3M)|Lost to Follow-up|75|||
44141853|NCT01328431|78931198|FG001|3 Month (3M)|Lost to Follow-up|70|||
44381083|NCT04425629|79386961|FG009|Overall Study|Subject Decision|70|||
44381084|NCT04425629|79386962|FG010|Overall Study|Subject Decision|95|||
44381085|NCT04425629|79386963|FG011|Overall Study|Subject Decision|124|||
44381086|NCT04425629|79386964|FG012|Overall Study|Subject Decision|25|||
44141854|NCT01328431|78931197|FG000|12 Month (12M)|Death|2|||
44141855|NCT01328431|78931198|FG001|12 Month (12M)|Death|6|||
44141856|NCT01328431|78931197|FG000|12 Month (12M)|Lost to Follow-up|82|||
44141857|NCT01328431|78931198|FG001|12 Month (12M)|Lost to Follow-up|91|||
44141858|NCT00893789|78931208|FG000|Overall Study|Withdrawal by Subject|3|||
44141859|NCT00893789|78931209|FG001|Overall Study|Withdrawal by Subject|1|||
44141860|NCT00893789|78931210|FG002|Overall Study|Withdrawal by Subject|3|||
44141861|NCT00893789|78931211|FG003|Overall Study|Withdrawal by Subject|1|||
44141862|NCT00893789|78931208|FG000|Overall Study|Noncompliance With Study Drug|1|||
44141863|NCT00893789|78931209|FG001|Overall Study|Noncompliance With Study Drug|0|||
44141864|NCT00893789|78931210|FG002|Overall Study|Noncompliance With Study Drug|1|||
44141865|NCT00893789|78931211|FG003|Overall Study|Noncompliance With Study Drug|2|||
44141866|NCT00893789|78931208|FG000|Overall Study|Noncompliance With Study Procedures|1|||
44141867|NCT00893789|78931209|FG001|Overall Study|Noncompliance With Study Procedures|0|||
44381087|NCT04425629|79386965|FG013|Overall Study|Subject Decision|0|||
44381088|NCT04425629|79386966|FG014|Overall Study|Subject Decision|1|||
44381089|NCT04425629|79386967|FG015|Overall Study|Subject Decision|4|||
44381090|NCT04425629|79386968|FG016|Overall Study|Subject Decision|1|||
44381091|NCT04425629|79386969|FG017|Overall Study|Subject Decision|0|||
44381092|NCT04425629|79386970|FG018|Overall Study|Subject Decision|2|||
44381093|NCT04425629|79386952|FG000|Overall Study|Death|0|||
44381094|NCT04425629|79386953|FG001|Overall Study|Death|0|||
44381095|NCT04425629|79386954|FG002|Overall Study|Death|0|||
44381096|NCT04425629|79386955|FG003|Overall Study|Death|0|||
44381097|NCT04425629|79386956|FG004|Overall Study|Death|0|||
44381098|NCT04425629|79386957|FG005|Overall Study|Death|0|||
44381099|NCT04425629|79386958|FG006|Overall Study|Death|0|||
44381100|NCT04425629|79386959|FG007|Overall Study|Death|0|||
44381101|NCT04425629|79386960|FG008|Overall Study|Death|0|||
44381102|NCT04425629|79386961|FG009|Overall Study|Death|11|||
44381103|NCT04425629|79386962|FG010|Overall Study|Death|2|||
44381104|NCT04425629|79386963|FG011|Overall Study|Death|4|||
44381105|NCT04425629|79386964|FG012|Overall Study|Death|0|||
44381106|NCT04425629|79386965|FG013|Overall Study|Death|0|||
44381107|NCT04425629|79386966|FG014|Overall Study|Death|0|||
44381108|NCT04425629|79386967|FG015|Overall Study|Death|0|||
44381109|NCT04425629|79386968|FG016|Overall Study|Death|0|||
44381110|NCT04425629|79386969|FG017|Overall Study|Death|0|||
44381111|NCT04425629|79386970|FG018|Overall Study|Death|0|||
44381112|NCT04425629|79386952|FG000|Overall Study|Sponsor Request|0|||
44381113|NCT04425629|79386953|FG001|Overall Study|Sponsor Request|0|||
44381114|NCT04425629|79386954|FG002|Overall Study|Sponsor Request|0|||
44381115|NCT04425629|79386955|FG003|Overall Study|Sponsor Request|2|||
44381116|NCT04425629|79386956|FG004|Overall Study|Sponsor Request|2|||
44381117|NCT04425629|79386957|FG005|Overall Study|Sponsor Request|2|||
44381118|NCT04425629|79386958|FG006|Overall Study|Sponsor Request|1|||
44381119|NCT04425629|79386959|FG007|Overall Study|Sponsor Request|0|||
44381120|NCT04425629|79386960|FG008|Overall Study|Sponsor Request|0|||
44381121|NCT04425629|79386961|FG009|Overall Study|Sponsor Request|9|||
44381122|NCT04425629|79386962|FG010|Overall Study|Sponsor Request|9|||
44381123|NCT04425629|79386963|FG011|Overall Study|Sponsor Request|10|||
44381124|NCT04425629|79386964|FG012|Overall Study|Sponsor Request|8|||
44381125|NCT04425629|79386965|FG013|Overall Study|Sponsor Request|0|||
44381126|NCT04425629|79386966|FG014|Overall Study|Sponsor Request|0|||
44381127|NCT04425629|79386967|FG015|Overall Study|Sponsor Request|1|||
44381128|NCT04425629|79386968|FG016|Overall Study|Sponsor Request|0|||
44381129|NCT04425629|79386969|FG017|Overall Study|Sponsor Request|0|||
44381130|NCT04425629|79386970|FG018|Overall Study|Sponsor Request|0|||
44381131|NCT04425629|79386952|FG000|Overall Study|Physician Decision|0|||
44381132|NCT04425629|79386953|FG001|Overall Study|Physician Decision|0|||
44381133|NCT04425629|79386954|FG002|Overall Study|Physician Decision|0|||
44381134|NCT04425629|79386955|FG003|Overall Study|Physician Decision|0|||
44381135|NCT04425629|79386956|FG004|Overall Study|Physician Decision|0|||
44381136|NCT04425629|79386957|FG005|Overall Study|Physician Decision|0|||
44381137|NCT04425629|79386958|FG006|Overall Study|Physician Decision|0|||
44381138|NCT04425629|79386959|FG007|Overall Study|Physician Decision|0|||
44381139|NCT04425629|79386960|FG008|Overall Study|Physician Decision|0|||
44381140|NCT04425629|79386961|FG009|Overall Study|Physician Decision|4|||
44381141|NCT04425629|79386962|FG010|Overall Study|Physician Decision|3|||
44381142|NCT04425629|79386963|FG011|Overall Study|Physician Decision|5|||
44381143|NCT04425629|79386964|FG012|Overall Study|Physician Decision|1|||
44381144|NCT04425629|79386965|FG013|Overall Study|Physician Decision|0|||
44381145|NCT04425629|79386966|FG014|Overall Study|Physician Decision|0|||
44381146|NCT04425629|79386967|FG015|Overall Study|Physician Decision|1|||
44381147|NCT04425629|79386968|FG016|Overall Study|Physician Decision|0|||
44381148|NCT04425629|79386969|FG017|Overall Study|Physician Decision|0|||
44381149|NCT04425629|79386970|FG018|Overall Study|Physician Decision|0|||
44381150|NCT04425629|79386952|FG000|Overall Study|Lack of Efficacy|0|||
44381151|NCT04425629|79386953|FG001|Overall Study|Lack of Efficacy|0|||
44381152|NCT04425629|79386954|FG002|Overall Study|Lack of Efficacy|0|||
44381153|NCT04425629|79386955|FG003|Overall Study|Lack of Efficacy|0|||
44381154|NCT04425629|79386956|FG004|Overall Study|Lack of Efficacy|0|||
44381155|NCT04425629|79386957|FG005|Overall Study|Lack of Efficacy|0|||
44381156|NCT04425629|79386958|FG006|Overall Study|Lack of Efficacy|0|||
44381157|NCT04425629|79386959|FG007|Overall Study|Lack of Efficacy|0|||
44381158|NCT04425629|79386960|FG008|Overall Study|Lack of Efficacy|0|||
44381159|NCT04425629|79386961|FG009|Overall Study|Lack of Efficacy|0|||
44381160|NCT04425629|79386962|FG010|Overall Study|Lack of Efficacy|1|||
44381161|NCT04425629|79386963|FG011|Overall Study|Lack of Efficacy|0|||
44381162|NCT04425629|79386964|FG012|Overall Study|Lack of Efficacy|0|||
44381163|NCT04425629|79386965|FG013|Overall Study|Lack of Efficacy|0|||
44381164|NCT04425629|79386966|FG014|Overall Study|Lack of Efficacy|0|||
44381165|NCT04425629|79386967|FG015|Overall Study|Lack of Efficacy|0|||
44381166|NCT04425629|79386968|FG016|Overall Study|Lack of Efficacy|0|||
44381167|NCT04425629|79386969|FG017|Overall Study|Lack of Efficacy|0|||
44381168|NCT04425629|79386970|FG018|Overall Study|Lack of Efficacy|0|||
44381169|NCT04417218|79387120|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
44381170|NCT04417218|79387121|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
44381171|NCT04134767|79387129|FG000|Overall Study|Death|0|||
44381172|NCT04134767|79387130|FG001|Overall Study|Death|1|||
44381173|NCT04134767|79387129|FG000|Overall Study|Removed for harassing staff|0|||
44381174|NCT04134767|79387130|FG001|Overall Study|Removed for harassing staff|1|||
44381175|NCT04134767|79387129|FG000|Overall Study|Lost to Follow-up|44|||
44381176|NCT04134767|79387130|FG001|Overall Study|Lost to Follow-up|40|||
44381177|NCT04024462|79387160|FG000|Overall Study|Withdrawal by Subject|6|||
44381178|NCT04024462|79387161|FG001|Overall Study|Withdrawal by Subject|7|||
44381179|NCT04024462|79387160|FG000|Overall Study|Progressive Disease|0|||
44381180|NCT04024462|79387161|FG001|Overall Study|Progressive Disease|1|||
44381181|NCT04024462|79387160|FG000|Overall Study|Adverse Event|0|||
44381182|NCT04024462|79387161|FG001|Overall Study|Adverse Event|1|||
44381183|NCT04024462|79387160|FG000|Overall Study|Death|0|||
44381184|NCT04024462|79387161|FG001|Overall Study|Death|1|||
44381185|NCT04024462|79387160|FG000|Overall Study|Lost to Follow-up|1|||
44381186|NCT04024462|79387161|FG001|Overall Study|Lost to Follow-up|0|||
44381187|NCT04024462|79387160|FG000|Overall Study|Ongoing in the Study|94|||
44381188|NCT04024462|79387161|FG001|Overall Study|Ongoing in the Study|89|||
44381189|NCT03960580|79387170|FG000|Overall Study|Adverse Event|2|||
44381190|NCT03960580|79387171|FG001|Overall Study|Adverse Event|1|||
44381191|NCT03960580|79387172|FG002|Overall Study|Adverse Event|1|||
44381192|NCT03960580|79387170|FG000|Overall Study|Lost to Follow-up|1|||
44381193|NCT03960580|79387171|FG001|Overall Study|Lost to Follow-up|0|||
44381194|NCT03960580|79387172|FG002|Overall Study|Lost to Follow-up|0|||
44141868|NCT00893789|78931210|FG002|Overall Study|Noncompliance With Study Procedures|0|||
44141869|NCT00893789|78931211|FG003|Overall Study|Noncompliance With Study Procedures|0|||
44141870|NCT00893789|78931208|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
44141871|NCT00893789|78931209|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
44141872|NCT00893789|78931210|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
44141873|NCT00893789|78931211|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
44141874|NCT00893789|78931208|FG000|Overall Study|Adverse Event|0|||
44141875|NCT00893789|78931209|FG001|Overall Study|Adverse Event|2|||
44141876|NCT00893789|78931210|FG002|Overall Study|Adverse Event|1|||
44141877|NCT00893789|78931211|FG003|Overall Study|Adverse Event|5|||
44141878|NCT00893789|78931208|FG000|Overall Study|Protocol Violation|0|||
44141879|NCT00893789|78931209|FG001|Overall Study|Protocol Violation|1|||
44141880|NCT00893789|78931210|FG002|Overall Study|Protocol Violation|1|||
44141881|NCT00893789|78931211|FG003|Overall Study|Protocol Violation|4|||
44141882|NCT00893789|78931208|FG000|Overall Study|Lost to Follow-up|0|||
44141883|NCT00893789|78931209|FG001|Overall Study|Lost to Follow-up|0|||
44141884|NCT00893789|78931210|FG002|Overall Study|Lost to Follow-up|0|||
44141885|NCT00893789|78931211|FG003|Overall Study|Lost to Follow-up|1|||
44141886|NCT02164864|78931224|FG000|Overall Study|Trial disease worsening|7|||
44141887|NCT02164864|78931225|FG001|Overall Study|Trial disease worsening|5|||
44141888|NCT02164864|78931226|FG002|Overall Study|Trial disease worsening|1|||
44141889|NCT02164864|78931224|FG000|Overall Study|Other pre-existing disease worsening|6|||
44141890|NCT02164864|78931225|FG001|Overall Study|Other pre-existing disease worsening|4|||
44141891|NCT02164864|78931226|FG002|Overall Study|Other pre-existing disease worsening|9|||
44141892|NCT02164864|78931224|FG000|Overall Study|Other Adverse Event (AE)|52|||
44141893|NCT02164864|78931225|FG001|Overall Study|Other Adverse Event (AE)|32|||
44141894|NCT02164864|78931226|FG002|Overall Study|Other Adverse Event (AE)|49|||
44244103|NCT01586624|79074136|FG004|Overall Study|Screen failure (no treatment received)|0|||
44244104|NCT01586624|79074137|FG005|Overall Study|Screen failure (no treatment received)|0|||
44141895|NCT02164864|78931224|FG000|Overall Study|Protocol Violation|2|||
44141896|NCT02164864|78931225|FG001|Overall Study|Protocol Violation|4|||
44141897|NCT02164864|78931226|FG002|Overall Study|Protocol Violation|1|||
44141898|NCT02164864|78931224|FG000|Overall Study|Lost to Follow-up|4|||
44141899|NCT02164864|78931225|FG001|Overall Study|Lost to Follow-up|3|||
44141900|NCT02164864|78931226|FG002|Overall Study|Lost to Follow-up|2|||
44381195|NCT03960580|79387170|FG000|Overall Study|Lack of Efficacy|2|||
44381196|NCT03960580|79387171|FG001|Overall Study|Lack of Efficacy|1|||
44381197|NCT03960580|79387172|FG002|Overall Study|Lack of Efficacy|0|||
44381198|NCT03960580|79387170|FG000|Overall Study|Protocol Violation|0|||
44381199|NCT03960580|79387171|FG001|Overall Study|Protocol Violation|0|||
44381200|NCT03960580|79387172|FG002|Overall Study|Protocol Violation|1|||
44381201|NCT03960580|79387170|FG000|Overall Study|Withdrawal by Subject|1|||
44381202|NCT03960580|79387171|FG001|Overall Study|Withdrawal by Subject|1|||
44381203|NCT03960580|79387172|FG002|Overall Study|Withdrawal by Subject|1|||
44141901|NCT02164864|78931224|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
44141902|NCT02164864|78931225|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
44141903|NCT02164864|78931226|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
44141904|NCT02164864|78931224|FG000|Overall Study|Other than stated|3|||
44141905|NCT02164864|78931225|FG001|Overall Study|Other than stated|4|||
44141906|NCT02164864|78931226|FG002|Overall Study|Other than stated|14|||
44141907|NCT02419807|78931237|FG000|Overall Study|Withdrawal by Subject|4|||
44141908|NCT02419807|78931237|FG000|Overall Study|Physician Decision|1|||
44141909|NCT02419807|78931237|FG000|Overall Study|Protocol Violation|5|||
44141910|NCT03857867|78931241|FG000|Overall Study|Physician Decision|1|||
44141911|NCT01628926|78931249|FG000|Overall Study|Adverse Event|13|||
44141912|NCT01628926|78931250|FG001|Overall Study|Adverse Event|11|||
44141913|NCT01628926|78931251|FG002|Overall Study|Adverse Event|9|||
44141914|NCT01628926|78931249|FG000|Overall Study|Lack of Efficacy|2|||
44141915|NCT01628926|78931250|FG001|Overall Study|Lack of Efficacy|1|||
44141916|NCT01628926|78931251|FG002|Overall Study|Lack of Efficacy|5|||
44141917|NCT01628926|78931249|FG000|Overall Study|Withdrawal by Subject|6|||
44141918|NCT01628926|78931250|FG001|Overall Study|Withdrawal by Subject|4|||
44141919|NCT01628926|78931251|FG002|Overall Study|Withdrawal by Subject|2|||
44141920|NCT01628926|78931249|FG000|Overall Study|Protocol Violation|0|||
44141921|NCT01628926|78931250|FG001|Overall Study|Protocol Violation|1|||
44141922|NCT01628926|78931251|FG002|Overall Study|Protocol Violation|0|||
44141923|NCT01628926|78931249|FG000|Overall Study|Discontinuation criteria|3|||
44141924|NCT01628926|78931250|FG001|Overall Study|Discontinuation criteria|4|||
44141925|NCT01628926|78931251|FG002|Overall Study|Discontinuation criteria|0|||
44141926|NCT01628926|78931249|FG000|Overall Study|Physician Decision|2|||
44141927|NCT01628926|78931250|FG001|Overall Study|Physician Decision|2|||
44141928|NCT01628926|78931251|FG002|Overall Study|Physician Decision|1|||
44141929|NCT01628848|78931262|FG000|Overall Study|Adverse Event|9|||
44141930|NCT01628848|78931263|FG001|Overall Study|Adverse Event|7|||
44141931|NCT01628848|78931262|FG000|Overall Study|Lack of Efficacy|0|||
44141932|NCT01628848|78931263|FG001|Overall Study|Lack of Efficacy|4|||
44141933|NCT01628848|78931262|FG000|Overall Study|Withdrawal by Subject|0|||
44141934|NCT01628848|78931263|FG001|Overall Study|Withdrawal by Subject|2|||
44141935|NCT01628848|78931262|FG000|Overall Study|Physician Decision|3|||
44141936|NCT01628848|78931263|FG001|Overall Study|Physician Decision|1|||
44141937|NCT02164318|78931273|FG000|Overall Study|Withdrawal by Subject|0|||
44141938|NCT02164318|78931274|FG001|Overall Study|Withdrawal by Subject|1|||
44141939|NCT02164318|78931275|FG002|Overall Study|Withdrawal by Subject|0|||
44141940|NCT02164318|78931276|FG003|Overall Study|Withdrawal by Subject|1|||
44141941|NCT03436199|78931289|FG000|Overall Study|Adverse Event|15|||
44141942|NCT03436199|78931290|FG001|Overall Study|Adverse Event|40|||
44141943|NCT03436199|78931291|FG002|Overall Study|Adverse Event|7|||
44141944|NCT03436199|78931289|FG000|Overall Study|Withdrawal by Subject|4|||
44141945|NCT03436199|78931290|FG001|Overall Study|Withdrawal by Subject|10|||
44141946|NCT03436199|78931291|FG002|Overall Study|Withdrawal by Subject|3|||
44141947|NCT03436199|78931289|FG000|Overall Study|Lost to Follow-up|1|||
44141948|NCT03436199|78931290|FG001|Overall Study|Lost to Follow-up|0|||
44141949|NCT03436199|78931291|FG002|Overall Study|Lost to Follow-up|2|||
44141950|NCT03436199|78931289|FG000|Overall Study|Protocol Violation|1|||
44141951|NCT03436199|78931290|FG001|Overall Study|Protocol Violation|1|||
44141952|NCT03436199|78931291|FG002|Overall Study|Protocol Violation|0|||
44141953|NCT03436199|78931289|FG000|Overall Study|Physician Decision|0|||
44141954|NCT03436199|78931290|FG001|Overall Study|Physician Decision|1|||
44141955|NCT03436199|78931291|FG002|Overall Study|Physician Decision|0|||
44141956|NCT03436199|78931289|FG000|Overall Study|Could not return to clinic|1|||
44141957|NCT03436199|78931290|FG001|Overall Study|Could not return to clinic|0|||
44141958|NCT03436199|78931291|FG002|Overall Study|Could not return to clinic|0|||
44141959|NCT03436199|78931289|FG000|Overall Study|Withdrawn per physician|0|||
44244105|NCT01586624|79074138|FG006|Overall Study|Screen failure (no treatment received)|1|||
44244106|NCT01586624|79074139|FG007|Overall Study|Screen failure (no treatment received)|0|||
44244107|NCT01586156|79074161|FG000|Overall Study|Pregnancy|0|||
44244108|NCT01586156|79074162|FG001|Overall Study|Pregnancy|1|||
44141960|NCT03436199|78931290|FG001|Overall Study|Withdrawn per physician|1|||
44141961|NCT03436199|78931291|FG002|Overall Study|Withdrawn per physician|0|||
44141962|NCT02131636|78931301|FG000|Overall Study|Personal Reasons|4|||
44141963|NCT02131636|78931302|FG001|Overall Study|Personal Reasons|4|||
44141964|NCT02131636|78931301|FG000|Overall Study|Lost to Follow-up|4|||
44141965|NCT02131636|78931302|FG001|Overall Study|Lost to Follow-up|0|||
44141966|NCT02131636|78931301|FG000|Overall Study|Adverse Event|4|||
44244109|NCT01586156|79074163|FG002|Overall Study|Pregnancy|0|||
44141967|NCT02131636|78931302|FG001|Overall Study|Adverse Event|1|||
44141968|NCT02131324|78931310|FG000|Overall Study|Withdrawal by Subject|1|||
44141969|NCT02131324|78931311|FG001|Overall Study|Withdrawal by Subject|2|||
44141970|NCT02131324|78931310|FG000|Overall Study|Lost to Follow-up|1|||
44141971|NCT02131324|78931311|FG001|Overall Study|Lost to Follow-up|1|||
44141972|NCT02734693|78931320|FG000|Overall Study|Adverse Event|1|||
44244110|NCT01459913|79074175|FG000|Overall Study|Adverse Event|0|||
44244111|NCT01459913|79074176|FG001|Overall Study|Adverse Event|0|||
44141973|NCT02734693|78931321|FG001|Overall Study|Adverse Event|3|||
44141974|NCT02734693|78931322|FG002|Overall Study|Adverse Event|3|||
44141975|NCT02734693|78931320|FG000|Overall Study|Lack of Efficacy|1|||
44141976|NCT02734693|78931321|FG001|Overall Study|Lack of Efficacy|0|||
44141977|NCT02734693|78931322|FG002|Overall Study|Lack of Efficacy|0|||
44141978|NCT02734693|78931320|FG000|Overall Study|Lost to Follow-up|2|||
44141979|NCT02734693|78931321|FG001|Overall Study|Lost to Follow-up|0|||
44141980|NCT02734693|78931322|FG002|Overall Study|Lost to Follow-up|0|||
44141981|NCT02734693|78931320|FG000|Overall Study|Protocol Violation|1|||
44141982|NCT02734693|78931321|FG001|Overall Study|Protocol Violation|0|||
44141983|NCT02734693|78931322|FG002|Overall Study|Protocol Violation|0|||
44141984|NCT02734693|78931320|FG000|Overall Study|Withdrawal by Subject|1|||
44141985|NCT02734693|78931321|FG001|Overall Study|Withdrawal by Subject|0|||
44141986|NCT02734693|78931322|FG002|Overall Study|Withdrawal by Subject|0|||
44141987|NCT02193880|78931330|FG000|Overall Study|patients did not collect enough HPC|3|||
44141988|NCT01378325|78931336|FG000|Overall Study|Protocol Violation|0|||
44141989|NCT01378325|78931337|FG001|Overall Study|Protocol Violation|1|||
44141990|NCT01093573|78931346|FG000|Overall Study|Physician Decision|0|||
44141991|NCT01093573|78931347|FG001|Overall Study|Physician Decision|0|||
44141992|NCT01093573|78931348|FG002|Overall Study|Physician Decision|1|||
44141993|NCT01093573|78931346|FG000|Overall Study|Insurance Denied|0|||
44141994|NCT01093573|78931347|FG001|Overall Study|Insurance Denied|0|||
44141995|NCT01093573|78931348|FG002|Overall Study|Insurance Denied|1|||
44141996|NCT02733367|78931376|FG000|Overall Study|Withdrawal by Subject|6|||
44141997|NCT03688555|78931383|FG000|Treatment Period|Adverse Event|0|||
44141998|NCT03688555|78931384|FG001|Treatment Period|Adverse Event|0|||
44141999|NCT03688555|78931385|FG002|Treatment Period|Adverse Event|1|||
44142000|NCT01328951|78931427|FG000|Overall Study|Disease Progression|17|||
44142001|NCT01328951|78931428|FG001|Overall Study|Disease Progression|14|||
44142002|NCT01328951|78931427|FG000|Overall Study|Adverse Event|2|||
44142003|NCT01328951|78931428|FG001|Overall Study|Adverse Event|0|||
44142004|NCT01328951|78931427|FG000|Overall Study|Death|243|||
44142005|NCT01328951|78931428|FG001|Overall Study|Death|258|||
44142006|NCT01328951|78931427|FG000|Overall Study|Lost to Follow-up|6|||
44142007|NCT01328951|78931428|FG001|Overall Study|Lost to Follow-up|7|||
44142008|NCT01328951|78931427|FG000|Overall Study|Withdrawal by Subject|6|||
44142009|NCT01328951|78931428|FG001|Overall Study|Withdrawal by Subject|6|||
44142010|NCT01328951|78931427|FG000|Overall Study|Study Closed by the Sponsor|36|||
44142011|NCT01328951|78931428|FG001|Overall Study|Study Closed by the Sponsor|31|||
44142012|NCT01328951|78931427|FG000|Overall Study|Other|11|||
44142013|NCT01328951|78931428|FG001|Overall Study|Other|6|||
44142014|NCT02611817|78931441|FG000|Open-label Induction Phase|Reason not Specified|9|||
44142015|NCT02611817|78931442|FG001|Open-label Induction Phase|Reason not Specified|0|||
44142016|NCT02611817|78931443|FG002|Open-label Induction Phase|Reason not Specified|0|||
44142017|NCT02611817|78931441|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
44142018|NCT02611817|78931442|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
44142019|NCT02611817|78931443|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
44142020|NCT02611817|78931441|FG000|Open-label Induction Phase|Pregnancy|1|||
44142021|NCT02611817|78931442|FG001|Open-label Induction Phase|Pregnancy|0|||
44142022|NCT02611817|78931443|FG002|Open-label Induction Phase|Pregnancy|0|||
44142023|NCT02611817|78931441|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
44142024|NCT02611817|78931442|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
44142025|NCT02611817|78931443|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
44142026|NCT02611817|78931441|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
44142027|NCT02611817|78931442|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
44142028|NCT02611817|78931443|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
44142029|NCT02611817|78931441|FG000|Open-label Induction Phase|Protocol Violation|5|||
44142030|NCT02611817|78931442|FG001|Open-label Induction Phase|Protocol Violation|0|||
44244112|NCT01459913|79074177|FG002|Overall Study|Adverse Event|0|||
44244113|NCT01459913|79074178|FG003|Overall Study|Adverse Event|3|||
44142031|NCT02611817|78931443|FG002|Open-label Induction Phase|Protocol Violation|0|||
44142032|NCT02611817|78931441|FG000|Open-label Induction Phase|Adverse Event|16|||
44142033|NCT02611817|78931442|FG001|Open-label Induction Phase|Adverse Event|0|||
44142034|NCT02611817|78931443|FG002|Open-label Induction Phase|Adverse Event|0|||
44142035|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
44142036|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
44142037|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
44142038|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
44142039|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
44142040|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
44142041|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
44513975|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
44142042|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
44142043|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
44142044|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
44142045|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
44142046|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
44142047|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
44142048|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
44142049|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
44142050|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
44142051|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
44142052|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
44142053|NCT02611817|78931441|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
44142054|NCT02611817|78931442|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
44142055|NCT02611817|78931443|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
44142056|NCT02735915|78931450|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
44142057|NCT02735915|78931450|FG000|Overall Study|Withdrawal following SAE|2|||
44513976|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
44513977|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
44513978|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
44513979|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
44513980|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
44513981|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
44513982|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
44513983|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
44513984|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
44513985|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
44513986|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
44513987|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
44513988|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
44513989|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
44513990|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
44513991|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
44513992|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
44513993|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
44513994|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
44513995|NCT03099304|79519113|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
44513996|NCT03099304|79519114|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
44513997|NCT03099304|79519115|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
44513998|NCT03099304|79519116|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
44513999|NCT03099304|79519117|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
44514000|NCT03099304|79519118|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
44514001|NCT03097588|79519145|FG000|Overall Study|Adverse Event|1|||
44514002|NCT01631214|79519151|FG000|Overall Study|Withdrawal by Subject|276|||
44514003|NCT01631214|79519152|FG001|Overall Study|Withdrawal by Subject|290|||
44514004|NCT01631214|79519151|FG000|Overall Study|Death|113|||
44514005|NCT01631214|79519152|FG001|Overall Study|Death|106|||
44514006|NCT01631214|79519151|FG000|Overall Study|Lost to Follow-up|54|||
44514007|NCT01631214|79519152|FG001|Overall Study|Lost to Follow-up|40|||
44514008|NCT01631214|79519151|FG000|Overall Study|Adverse Event|45|||
44514009|NCT01631214|79519152|FG001|Overall Study|Adverse Event|45|||
44514010|NCT01631214|79519151|FG000|Overall Study|Other|22|||
44514011|NCT01631214|79519152|FG001|Overall Study|Other|19|||
44514012|NCT01631214|79519151|FG000|Overall Study|Noncompliance|16|||
44514013|NCT01631214|79519152|FG001|Overall Study|Noncompliance|15|||
44514014|NCT01631214|79519151|FG000|Overall Study|Requirement for Alternative Therapy|8|||
44514015|NCT01631214|79519152|FG001|Overall Study|Requirement for Alternative Therapy|3|||
44514016|NCT01631214|79519151|FG000|Overall Study|Protocol Deviation|4|||
44514017|NCT01631214|79519152|FG001|Overall Study|Protocol Deviation|3|||
44514018|NCT01631214|79519151|FG000|Overall Study|Ineligibility determined|5|||
44514019|NCT01631214|79519152|FG001|Overall Study|Ineligibility determined|2|||
44514020|NCT01631214|79519151|FG000|Overall Study|Administrative Decision|1|||
44514021|NCT01631214|79519152|FG001|Overall Study|Administrative Decision|0|||
44514022|NCT03093454|79519162|FG000|Overall Study|Withdrawal by Subject|1|||
44514023|NCT03093454|79519163|FG001|Overall Study|Withdrawal by Subject|1|||
44514024|NCT03093454|79519162|FG000|Overall Study|Scheduling conflict|3|||
44514025|NCT03093454|79519163|FG001|Overall Study|Scheduling conflict|1|||
44514026|NCT03093454|79519162|FG000|Overall Study|Physician Decision|2|||
44142058|NCT02735915|78931450|FG000|Overall Study|Withdrawal by Subject|1|||
44514027|NCT03093454|79519163|FG001|Overall Study|Physician Decision|1|||
44514028|NCT00468130|79519184|FG000|Overall Study|Adverse Event|2|||
44142059|NCT02557139|78931459|FG000|Overall Study|Significant liver elevation|1|||
44142060|NCT02557139|78931460|FG001|Overall Study|Significant liver elevation|0|||
44142061|NCT02557139|78931461|FG002|Overall Study|Significant liver elevation|1|||
44142062|NCT02557139|78931459|FG000|Overall Study|Withdrawal by Subject|1|||
44142063|NCT02557139|78931460|FG001|Overall Study|Withdrawal by Subject|0|||
44142064|NCT02557139|78931461|FG002|Overall Study|Withdrawal by Subject|0|||
44381204|NCT03960580|79387170|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
44142065|NCT02557139|78931459|FG000|Overall Study|Illness of prohibited medication|0|||
44142066|NCT02557139|78931460|FG001|Overall Study|Illness of prohibited medication|0|||
44142067|NCT02557139|78931461|FG002|Overall Study|Illness of prohibited medication|1|||
44142068|NCT01328717|78931478|FG000|Overall Study|Adverse Event|1|||
44142069|NCT01677741|78931490|FG000|Overall Study|Death|0|||
44142070|NCT01677741|78931491|FG001|Overall Study|Death|0|||
44142071|NCT01677741|78931492|FG002|Overall Study|Death|0|||
44142072|NCT01677741|78931493|FG003|Overall Study|Death|1|||
44142073|NCT01677741|78931494|FG004|Overall Study|Death|0|||
44142074|NCT01677741|78931495|FG005|Overall Study|Death|1|||
44142075|NCT01677741|78931496|FG006|Overall Study|Death|0|||
44142076|NCT01677741|78931497|FG007|Overall Study|Death|0|||
44142077|NCT01677741|78931490|FG000|Overall Study|Withdrawal by Subject|2|||
44142078|NCT01677741|78931491|FG001|Overall Study|Withdrawal by Subject|7|||
44142079|NCT01677741|78931492|FG002|Overall Study|Withdrawal by Subject|5|||
44142080|NCT01677741|78931493|FG003|Overall Study|Withdrawal by Subject|4|||
44142081|NCT01677741|78931494|FG004|Overall Study|Withdrawal by Subject|11|||
44142082|NCT01677741|78931495|FG005|Overall Study|Withdrawal by Subject|20|||
44142083|NCT01677741|78931496|FG006|Overall Study|Withdrawal by Subject|4|||
44142084|NCT01677741|78931497|FG007|Overall Study|Withdrawal by Subject|2|||
44142085|NCT01677741|78931490|FG000|Overall Study|Enrolled in a rollover study|0|||
44142086|NCT01677741|78931491|FG001|Overall Study|Enrolled in a rollover study|3|||
44142087|NCT01677741|78931492|FG002|Overall Study|Enrolled in a rollover study|2|||
44142088|NCT01677741|78931493|FG003|Overall Study|Enrolled in a rollover study|1|||
44142089|NCT01677741|78931494|FG004|Overall Study|Enrolled in a rollover study|6|||
44142090|NCT01677741|78931495|FG005|Overall Study|Enrolled in a rollover study|6|||
44142091|NCT01677741|78931496|FG006|Overall Study|Enrolled in a rollover study|7|||
44142092|NCT01677741|78931497|FG007|Overall Study|Enrolled in a rollover study|0|||
44142093|NCT01677741|78931490|FG000|Overall Study|Progressive disease|1|||
44142094|NCT01677741|78931491|FG001|Overall Study|Progressive disease|0|||
44142095|NCT01677741|78931492|FG002|Overall Study|Progressive disease|1|||
44142096|NCT01677741|78931493|FG003|Overall Study|Progressive disease|0|||
44142097|NCT01677741|78931494|FG004|Overall Study|Progressive disease|0|||
44142098|NCT01677741|78931495|FG005|Overall Study|Progressive disease|1|||
44142099|NCT01677741|78931496|FG006|Overall Study|Progressive disease|0|||
44142100|NCT01677741|78931497|FG007|Overall Study|Progressive disease|0|||
44142101|NCT01677507|78931549|FG000|Initial Assignment|Adverse Event|0|||
44142102|NCT01677507|78931550|FG001|Initial Assignment|Adverse Event|1|||
44142103|NCT01677507|78931549|FG000|Initial Assignment|Protocol Violation|0|||
44142104|NCT01677507|78931550|FG001|Initial Assignment|Protocol Violation|1|||
44142105|NCT01677507|78931549|FG000|Second Assigment|Withdrawal by Subject|2|||
44142106|NCT01677507|78931550|FG001|Second Assigment|Withdrawal by Subject|2|||
44142107|NCT01677507|78931549|FG000|Second Assigment|Adverse Event|1|||
44142108|NCT01677507|78931550|FG001|Second Assigment|Adverse Event|3|||
44142109|NCT02732951|78931569|FG000|Overall Study|Other than listed|1|||
44142110|NCT02732951|78931570|FG001|Overall Study|Other than listed|0|||
44142111|NCT02732951|78931569|FG000|Overall Study|Lost to Follow-up|0|||
44142112|NCT02732951|78931570|FG001|Overall Study|Lost to Follow-up|1|||
44142113|NCT02732951|78931569|FG000|Overall Study|Adverse Event|4|||
44142114|NCT02732951|78931570|FG001|Overall Study|Adverse Event|4|||
44142115|NCT02732951|78931569|FG000|Overall Study|Protocol Violation|0|||
44142116|NCT02732951|78931570|FG001|Overall Study|Protocol Violation|1|||
44142117|NCT01377233|78931581|FG000|Open-label|Adverse Event|1|||
44142118|NCT01377233|78931582|FG001|Open-label|Adverse Event|0|||
44142119|NCT01377233|78931583|FG002|Open-label|Adverse Event|0|||
44381205|NCT03960580|79387171|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
44514029|NCT00468130|79519185|FG001|Overall Study|Adverse Event|1|||
44142120|NCT01377233|78931584|FG003|Open-label|Adverse Event|0|||
44142121|NCT01377233|78931585|FG004|Open-label|Adverse Event|0|||
44142122|NCT01377233|78931581|FG000|Open-label|Withdrawal by Subject|3|||
44142123|NCT01377233|78931582|FG001|Open-label|Withdrawal by Subject|0|||
44142124|NCT01377233|78931583|FG002|Open-label|Withdrawal by Subject|0|||
44142125|NCT01377233|78931584|FG003|Open-label|Withdrawal by Subject|0|||
44142126|NCT01377233|78931585|FG004|Open-label|Withdrawal by Subject|0|||
44514030|NCT00468130|79519184|FG000|Overall Study|Withdrawal by Subject|0|||
44142127|NCT01377233|78931581|FG000|Double-blind|Adverse Event|0|||
44142128|NCT01377233|78931582|FG001|Double-blind|Adverse Event|1|||
44142129|NCT01377233|78931583|FG002|Double-blind|Adverse Event|2|||
44142130|NCT01377233|78931584|FG003|Double-blind|Adverse Event|2|||
44142131|NCT01377233|78931585|FG004|Double-blind|Adverse Event|0|||
44142132|NCT01377233|78931581|FG000|Double-blind|Protocol Violation|0|||
44142133|NCT01377233|78931582|FG001|Double-blind|Protocol Violation|0|||
44142134|NCT01377233|78931583|FG002|Double-blind|Protocol Violation|0|||
44142135|NCT01377233|78931584|FG003|Double-blind|Protocol Violation|0|||
44142136|NCT01377233|78931585|FG004|Double-blind|Protocol Violation|1|||
44142137|NCT01377233|78931581|FG000|Double-blind|Withdrawal by Subject|0|||
44142138|NCT01377233|78931582|FG001|Double-blind|Withdrawal by Subject|0|||
44142139|NCT01377233|78931583|FG002|Double-blind|Withdrawal by Subject|0|||
44142140|NCT01377233|78931584|FG003|Double-blind|Withdrawal by Subject|1|||
44142141|NCT01377233|78931585|FG004|Double-blind|Withdrawal by Subject|0|||
44142142|NCT01377233|78931581|FG000|Double-blind|Administrative or other|0|||
44142143|NCT01377233|78931582|FG001|Double-blind|Administrative or other|0|||
44142144|NCT01377233|78931583|FG002|Double-blind|Administrative or other|0|||
44142145|NCT01377233|78931584|FG003|Double-blind|Administrative or other|1|||
44142146|NCT01377233|78931585|FG004|Double-blind|Administrative or other|1|||
44142147|NCT03248531|78931604|FG000|Overall Study|Adverse Event|0|||
44142148|NCT03248531|78931605|FG001|Overall Study|Adverse Event|0|||
44142149|NCT03248531|78931606|FG002|Overall Study|Adverse Event|1|||
44142150|NCT03248531|78931604|FG000|Overall Study|Lost to Follow-up|1|||
44142151|NCT03248531|78931605|FG001|Overall Study|Lost to Follow-up|0|||
44142152|NCT03248531|78931606|FG002|Overall Study|Lost to Follow-up|5|||
44142153|NCT03248531|78931604|FG000|Overall Study|Withdrawal by Subject|3|||
44142154|NCT03248531|78931605|FG001|Overall Study|Withdrawal by Subject|3|||
44142155|NCT03248531|78931606|FG002|Overall Study|Withdrawal by Subject|2|||
44142156|NCT03248531|78931604|FG000|Overall Study|Sponsor Request|0|||
44142157|NCT03248531|78931605|FG001|Overall Study|Sponsor Request|2|||
44142158|NCT03248531|78931606|FG002|Overall Study|Sponsor Request|0|||
44142159|NCT02656329|78931623|FG000|Overall Study|Lost to Follow-up|2|||
44142160|NCT02656329|78931624|FG001|Overall Study|Lost to Follow-up|3|||
44514031|NCT00468130|79519185|FG001|Overall Study|Withdrawal by Subject|1|||
44514032|NCT00911820|79519195|FG000|Overall Study|RECIST progression|12|||
44514033|NCT00911820|79519196|FG001|Overall Study|RECIST progression|8|||
44514034|NCT00911820|79519195|FG000|Overall Study|Adverse Event|8|||
44142161|NCT02656329|78931623|FG000|Overall Study|Withdrawal by Subject|7|||
44514035|NCT00911820|79519196|FG001|Overall Study|Adverse Event|8|||
44514036|NCT00911820|79519195|FG000|Overall Study|Clinical Progression|7|||
44514037|NCT00911820|79519196|FG001|Overall Study|Clinical Progression|5|||
44514038|NCT00911820|79519195|FG000|Overall Study|Physician Decision|5|||
44514039|NCT00911820|79519196|FG001|Overall Study|Physician Decision|9|||
44514040|NCT00911820|79519195|FG000|Overall Study|Decline in Performance Status|4|||
44514041|NCT00911820|79519196|FG001|Overall Study|Decline in Performance Status|2|||
44514042|NCT00911820|79519195|FG000|Overall Study|Withdrawal by Subject|3|||
44514043|NCT00911820|79519196|FG001|Overall Study|Withdrawal by Subject|4|||
44514044|NCT00911820|79519195|FG000|Overall Study|Death|1|||
44142162|NCT02656329|78931624|FG001|Overall Study|Withdrawal by Subject|6|||
44142163|NCT02656329|78931623|FG000|Overall Study|Study termination by Sponsor|150|||
44142164|NCT02656329|78931624|FG001|Overall Study|Study termination by Sponsor|142|||
44142165|NCT02656329|78931623|FG000|Overall Study|Other than specified above|5|||
44142166|NCT02656329|78931624|FG001|Overall Study|Other than specified above|6|||
44142167|NCT02712905|78931649|FG000|Monotherapy|Death|2|||
44142168|NCT02712905|78931650|FG001|Monotherapy|Death|5|||
44142169|NCT02712905|78931651|FG002|Monotherapy|Death|0|||
44142170|NCT02712905|78931652|FG003|Monotherapy|Death|3|||
44142171|NCT02712905|78931653|FG004|Monotherapy|Death|15|||
44142172|NCT02712905|78931654|FG005|Monotherapy|Death|1|||
44142173|NCT02712905|78931655|FG006|Monotherapy|Death|3|||
44142174|NCT02712905|78931656|FG007|Monotherapy|Death|3|||
44142175|NCT02712905|78931657|FG008|Monotherapy|Death|0|||
44142176|NCT02712905|78931658|FG009|Monotherapy|Death|27|||
44142177|NCT02712905|78931659|FG010|Monotherapy|Death|2|||
44142178|NCT02712905|78931660|FG011|Monotherapy|Death|5|||
44142179|NCT02712905|78931661|FG012|Monotherapy|Death|0|||
44142180|NCT02712905|78931662|FG013|Monotherapy|Death|0|||
44244114|NCT01459913|79074175|FG000|Overall Study|Withdrawal by Subject|4|||
44244115|NCT01459913|79074176|FG001|Overall Study|Withdrawal by Subject|0|||
44244116|NCT01459913|79074177|FG002|Overall Study|Withdrawal by Subject|0|||
44244117|NCT01459913|79074178|FG003|Overall Study|Withdrawal by Subject|5|||
44514045|NCT00911820|79519196|FG001|Overall Study|Death|2|||
44514046|NCT00911820|79519195|FG000|Overall Study|Pursue surgery|1|||
44514047|NCT00911820|79519196|FG001|Overall Study|Pursue surgery|1|||
44514048|NCT00911820|79519195|FG000|Overall Study|Pursue Radiation|1|||
44244118|NCT01459913|79074175|FG000|Overall Study|Lost to Follow-up|7|||
44244119|NCT01459913|79074176|FG001|Overall Study|Lost to Follow-up|4|||
44244120|NCT01459913|79074177|FG002|Overall Study|Lost to Follow-up|1|||
44244121|NCT01459913|79074178|FG003|Overall Study|Lost to Follow-up|8|||
44244122|NCT01459913|79074175|FG000|Overall Study|Death|0|||
44244123|NCT01459913|79074176|FG001|Overall Study|Death|0|||
44244124|NCT01459913|79074177|FG002|Overall Study|Death|0|||
44244125|NCT01459913|79074178|FG003|Overall Study|Death|1|||
44244126|NCT01459913|79074175|FG000|Overall Study|Non- Compliance|0|||
44244127|NCT01459913|79074176|FG001|Overall Study|Non- Compliance|0|||
44244128|NCT01459913|79074177|FG002|Overall Study|Non- Compliance|0|||
44244129|NCT01459913|79074178|FG003|Overall Study|Non- Compliance|3|||
44244130|NCT01459913|79074175|FG000|Overall Study|Physician Decision|0|||
44244131|NCT01459913|79074176|FG001|Overall Study|Physician Decision|1|||
44244132|NCT01459913|79074177|FG002|Overall Study|Physician Decision|0|||
44244133|NCT01459913|79074178|FG003|Overall Study|Physician Decision|0|||
44244134|NCT01459913|79074175|FG000|Overall Study|Study Terminated by Sponsor|30|||
44514049|NCT00911820|79519196|FG001|Overall Study|Pursue Radiation|0|||
44514050|NCT00911820|79519195|FG000|Overall Study|Still on Therapy|2|||
44514051|NCT00911820|79519196|FG001|Overall Study|Still on Therapy|2|||
44142181|NCT02712905|78931663|FG014|Monotherapy|Death|0|||
44142182|NCT02712905|78931664|FG015|Monotherapy|Death|0|||
44142183|NCT02712905|78931665|FG016|Monotherapy|Death|0|||
44244135|NCT01459913|79074176|FG001|Overall Study|Study Terminated by Sponsor|15|||
44244136|NCT01459913|79074177|FG002|Overall Study|Study Terminated by Sponsor|9|||
44244137|NCT01459913|79074178|FG003|Overall Study|Study Terminated by Sponsor|11|||
44244138|NCT01459913|79074175|FG000|Overall Study|Other|0|||
44244139|NCT01459913|79074176|FG001|Overall Study|Other|0|||
44244140|NCT01459913|79074177|FG002|Overall Study|Other|3|||
44244141|NCT01459913|79074178|FG003|Overall Study|Other|1|||
44514052|NCT00911820|79519195|FG000|Overall Study|Pathology Not Confirmed|1|||
44514053|NCT00911820|79519196|FG001|Overall Study|Pathology Not Confirmed|0|||
44514054|NCT00911820|79519195|FG000|Overall Study|Withdraw before Receive Treatment|0|||
44142184|NCT02712905|78931666|FG017|Monotherapy|Death|0|||
44142185|NCT02712905|78931649|FG000|Monotherapy|Lost to Follow-up|0|||
44244142|NCT01459913|79074175|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
44244143|NCT01459913|79074176|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
44244144|NCT01459913|79074177|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
44244145|NCT01459913|79074178|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
44142186|NCT02712905|78931650|FG001|Monotherapy|Lost to Follow-up|1|||
44244146|NCT01458587|79074192|FG000|Overall Study|Withdrawal by Subject|1|||
44514055|NCT00911820|79519196|FG001|Overall Study|Withdraw before Receive Treatment|2|||
44142187|NCT02712905|78931651|FG002|Monotherapy|Lost to Follow-up|0|||
44142188|NCT02712905|78931652|FG003|Monotherapy|Lost to Follow-up|1|||
44142189|NCT02712905|78931653|FG004|Monotherapy|Lost to Follow-up|0|||
44142190|NCT02712905|78931654|FG005|Monotherapy|Lost to Follow-up|0|||
44142191|NCT02712905|78931655|FG006|Monotherapy|Lost to Follow-up|0|||
44142192|NCT02712905|78931656|FG007|Monotherapy|Lost to Follow-up|0|||
44244147|NCT01458587|79074193|FG001|Overall Study|Withdrawal by Subject|0|||
44142193|NCT02712905|78931657|FG008|Monotherapy|Lost to Follow-up|0|||
44142194|NCT02712905|78931658|FG009|Monotherapy|Lost to Follow-up|2|||
44142195|NCT02712905|78931659|FG010|Monotherapy|Lost to Follow-up|0|||
44142196|NCT02712905|78931660|FG011|Monotherapy|Lost to Follow-up|0|||
44142197|NCT02712905|78931661|FG012|Monotherapy|Lost to Follow-up|0|||
44142198|NCT02712905|78931662|FG013|Monotherapy|Lost to Follow-up|0|||
44142199|NCT02712905|78931663|FG014|Monotherapy|Lost to Follow-up|0|||
44142200|NCT02712905|78931664|FG015|Monotherapy|Lost to Follow-up|0|||
44142201|NCT02712905|78931665|FG016|Monotherapy|Lost to Follow-up|0|||
44142202|NCT02712905|78931666|FG017|Monotherapy|Lost to Follow-up|0|||
44142203|NCT02712905|78931649|FG000|Monotherapy|Physician Decision|1|||
44142204|NCT02712905|78931650|FG001|Monotherapy|Physician Decision|0|||
44142205|NCT02712905|78931651|FG002|Monotherapy|Physician Decision|0|||
44142206|NCT02712905|78931652|FG003|Monotherapy|Physician Decision|1|||
44142207|NCT02712905|78931653|FG004|Monotherapy|Physician Decision|0|||
44142208|NCT02712905|78931654|FG005|Monotherapy|Physician Decision|0|||
44142209|NCT02712905|78931655|FG006|Monotherapy|Physician Decision|0|||
44142210|NCT02712905|78931656|FG007|Monotherapy|Physician Decision|0|||
44142211|NCT02712905|78931657|FG008|Monotherapy|Physician Decision|0|||
44244148|NCT01458275|79074204|FG000|Overall Study|Adverse Event|3|||
44244149|NCT01458275|79074205|FG001|Overall Study|Adverse Event|4|||
44244150|NCT01458275|79074206|FG002|Overall Study|Adverse Event|1|||
44244151|NCT01458275|79074204|FG000|Overall Study|Lost to Follow-up|3|||
44244152|NCT01458275|79074205|FG001|Overall Study|Lost to Follow-up|2|||
44244153|NCT01458275|79074206|FG002|Overall Study|Lost to Follow-up|5|||
44244154|NCT01458275|79074204|FG000|Overall Study|Protocol Violation|5|||
44244155|NCT01458275|79074205|FG001|Overall Study|Protocol Violation|5|||
44244156|NCT01458275|79074206|FG002|Overall Study|Protocol Violation|2|||
44244157|NCT01458275|79074204|FG000|Overall Study|Withdrawal by Subject|3|||
44244158|NCT01458275|79074205|FG001|Overall Study|Withdrawal by Subject|2|||
44244159|NCT01458275|79074206|FG002|Overall Study|Withdrawal by Subject|1|||
44244160|NCT01458119|79074216|FG000|Overall Study|Physician Decision|4|||
44244161|NCT01458119|79074216|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
44244162|NCT01458119|79074216|FG000|Overall Study|Pregnancy|1|||
44244163|NCT01458119|79074216|FG000|Overall Study|Death|2|||
44244164|NCT01458119|79074216|FG000|Overall Study|Adverse Event|1|||
44244165|NCT01458119|79074216|FG000|Overall Study|Consent Withdrawn by Participant|8|||
44244166|NCT01458119|79074216|FG000|Overall Study|Non-compliance With Study Drug|3|||
44244167|NCT01688726|79074231|FG000|Overall Study|Adverse Event|1|||
44244168|NCT01688726|79074232|FG001|Overall Study|Adverse Event|0|||
44244169|NCT01688726|79074231|FG000|Overall Study|Relocated abroad|0|||
44244170|NCT01688726|79074232|FG001|Overall Study|Relocated abroad|1|||
44244171|NCT01585766|79074248|FG000|Overall Study|Withdrawal by Subject|0|||
44244172|NCT01585766|79074249|FG001|Overall Study|Withdrawal by Subject|1|||
44244173|NCT01585766|79074250|FG002|Overall Study|Withdrawal by Subject|1|||
44244174|NCT01585766|79074251|FG003|Overall Study|Withdrawal by Subject|0|||
44244175|NCT01585766|79074252|FG004|Overall Study|Withdrawal by Subject|0|||
44244176|NCT01585766|79074253|FG005|Overall Study|Withdrawal by Subject|0|||
44142212|NCT02712905|78931658|FG009|Monotherapy|Physician Decision|1|||
44142213|NCT02712905|78931659|FG010|Monotherapy|Physician Decision|0|||
44142214|NCT02712905|78931660|FG011|Monotherapy|Physician Decision|0|||
44142215|NCT02712905|78931661|FG012|Monotherapy|Physician Decision|0|||
44142216|NCT02712905|78931662|FG013|Monotherapy|Physician Decision|0|||
44142217|NCT02712905|78931663|FG014|Monotherapy|Physician Decision|0|||
44142218|NCT02712905|78931664|FG015|Monotherapy|Physician Decision|0|||
44142219|NCT02712905|78931665|FG016|Monotherapy|Physician Decision|0|||
44142220|NCT02712905|78931666|FG017|Monotherapy|Physician Decision|0|||
44244177|NCT01585766|79074248|FG000|Overall Study|Death|0|||
44244178|NCT01585766|79074249|FG001|Overall Study|Death|1|||
44244179|NCT01585766|79074250|FG002|Overall Study|Death|0|||
44244180|NCT01585766|79074251|FG003|Overall Study|Death|0|||
44244181|NCT01585766|79074252|FG004|Overall Study|Death|0|||
44142221|NCT02712905|78931649|FG000|Monotherapy|Study Terminated by Sponsor|0|||
44244182|NCT01585766|79074253|FG005|Overall Study|Death|0|||
44244183|NCT01585766|79074248|FG000|Overall Study|Physician Decision|0|||
44244184|NCT01585766|79074249|FG001|Overall Study|Physician Decision|0|||
44244185|NCT01585766|79074250|FG002|Overall Study|Physician Decision|1|||
44244186|NCT01585766|79074251|FG003|Overall Study|Physician Decision|0|||
44244187|NCT01585766|79074252|FG004|Overall Study|Physician Decision|0|||
44244188|NCT01585766|79074253|FG005|Overall Study|Physician Decision|0|||
44244189|NCT01562444|79074277|FG000|Overall Study|Did not meet entry criteria|2|||
44244190|NCT01562444|79074278|FG001|Overall Study|Did not meet entry criteria|0|||
44142222|NCT02712905|78931650|FG001|Monotherapy|Study Terminated by Sponsor|0|||
44142223|NCT02712905|78931651|FG002|Monotherapy|Study Terminated by Sponsor|0|||
44142224|NCT02712905|78931652|FG003|Monotherapy|Study Terminated by Sponsor|0|||
44142225|NCT02712905|78931653|FG004|Monotherapy|Study Terminated by Sponsor|1|||
44142226|NCT02712905|78931654|FG005|Monotherapy|Study Terminated by Sponsor|0|||
44142227|NCT02712905|78931655|FG006|Monotherapy|Study Terminated by Sponsor|0|||
44142228|NCT02712905|78931656|FG007|Monotherapy|Study Terminated by Sponsor|0|||
44142229|NCT02712905|78931657|FG008|Monotherapy|Study Terminated by Sponsor|0|||
44142230|NCT02712905|78931658|FG009|Monotherapy|Study Terminated by Sponsor|2|||
44142231|NCT02712905|78931659|FG010|Monotherapy|Study Terminated by Sponsor|0|||
44142232|NCT02712905|78931660|FG011|Monotherapy|Study Terminated by Sponsor|0|||
44142233|NCT02712905|78931661|FG012|Monotherapy|Study Terminated by Sponsor|0|||
44142234|NCT02712905|78931662|FG013|Monotherapy|Study Terminated by Sponsor|0|||
44142235|NCT02712905|78931663|FG014|Monotherapy|Study Terminated by Sponsor|0|||
44142236|NCT02712905|78931664|FG015|Monotherapy|Study Terminated by Sponsor|0|||
44142237|NCT02712905|78931665|FG016|Monotherapy|Study Terminated by Sponsor|0|||
44142238|NCT02712905|78931666|FG017|Monotherapy|Study Terminated by Sponsor|0|||
44142239|NCT02712905|78931649|FG000|Monotherapy|Withdrawal by Subject|0|||
44142240|NCT02712905|78931650|FG001|Monotherapy|Withdrawal by Subject|0|||
44142241|NCT02712905|78931651|FG002|Monotherapy|Withdrawal by Subject|1|||
44142242|NCT02712905|78931652|FG003|Monotherapy|Withdrawal by Subject|0|||
44142243|NCT02712905|78931653|FG004|Monotherapy|Withdrawal by Subject|2|||
44142244|NCT02712905|78931654|FG005|Monotherapy|Withdrawal by Subject|0|||
44142245|NCT02712905|78931655|FG006|Monotherapy|Withdrawal by Subject|0|||
44142246|NCT02712905|78931656|FG007|Monotherapy|Withdrawal by Subject|0|||
44142247|NCT02712905|78931657|FG008|Monotherapy|Withdrawal by Subject|0|||
44142248|NCT02712905|78931658|FG009|Monotherapy|Withdrawal by Subject|4|||
44142249|NCT02712905|78931659|FG010|Monotherapy|Withdrawal by Subject|1|||
44142250|NCT02712905|78931660|FG011|Monotherapy|Withdrawal by Subject|2|||
44142251|NCT02712905|78931661|FG012|Monotherapy|Withdrawal by Subject|0|||
44142252|NCT02712905|78931662|FG013|Monotherapy|Withdrawal by Subject|0|||
44142253|NCT02712905|78931663|FG014|Monotherapy|Withdrawal by Subject|0|||
44142254|NCT02712905|78931664|FG015|Monotherapy|Withdrawal by Subject|0|||
44142255|NCT02712905|78931665|FG016|Monotherapy|Withdrawal by Subject|0|||
44142256|NCT02712905|78931666|FG017|Monotherapy|Withdrawal by Subject|0|||
44142257|NCT02712905|78931649|FG000|Monotherapy|Started New Cancer Drug|0|||
44142258|NCT02712905|78931650|FG001|Monotherapy|Started New Cancer Drug|0|||
44142259|NCT02712905|78931651|FG002|Monotherapy|Started New Cancer Drug|0|||
44142260|NCT02712905|78931652|FG003|Monotherapy|Started New Cancer Drug|0|||
44142261|NCT02712905|78931653|FG004|Monotherapy|Started New Cancer Drug|0|||
44142262|NCT02712905|78931654|FG005|Monotherapy|Started New Cancer Drug|1|||
44142263|NCT02712905|78931655|FG006|Monotherapy|Started New Cancer Drug|0|||
44142264|NCT02712905|78931656|FG007|Monotherapy|Started New Cancer Drug|0|||
44514056|NCT00246324|79519211|FG000|Overall Study|Withdrawal by Subject|1|||
44142265|NCT02712905|78931657|FG008|Monotherapy|Started New Cancer Drug|0|||
44142266|NCT02712905|78931658|FG009|Monotherapy|Started New Cancer Drug|0|||
44142267|NCT02712905|78931659|FG010|Monotherapy|Started New Cancer Drug|0|||
44142268|NCT02712905|78931660|FG011|Monotherapy|Started New Cancer Drug|0|||
44142269|NCT02712905|78931661|FG012|Monotherapy|Started New Cancer Drug|0|||
44142270|NCT02712905|78931662|FG013|Monotherapy|Started New Cancer Drug|0|||
44514057|NCT04234984|79519217|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
44514058|NCT04234984|79519217|FG000|Follow-up at the Second Time Point|Death|1|||
44514059|NCT04234984|79519217|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
44514060|NCT03922750|79519231|FG000|Overall Study|Unclassified|0|||
44514061|NCT03922750|79519232|FG001|Overall Study|Unclassified|0|||
44514062|NCT03922750|79519233|FG002|Overall Study|Unclassified|1|||
44514063|NCT03922750|79519231|FG000|Overall Study|Adverse Event|0|||
44514064|NCT03922750|79519232|FG001|Overall Study|Adverse Event|1|||
44514065|NCT03922750|79519233|FG002|Overall Study|Adverse Event|0|||
44514066|NCT04634253|79519255|FG000|Overall Study|Adverse Event|1|||
44514067|NCT04634253|79519256|FG001|Overall Study|Adverse Event|1|||
44514068|NCT04634253|79519257|FG002|Overall Study|Adverse Event|0|||
44514069|NCT04634253|79519255|FG000|Overall Study|Physician Decision|0|||
44514070|NCT04634253|79519256|FG001|Overall Study|Physician Decision|1|||
44514071|NCT04634253|79519257|FG002|Overall Study|Physician Decision|0|||
44142271|NCT02712905|78931663|FG014|Monotherapy|Started New Cancer Drug|0|||
44142272|NCT02712905|78931664|FG015|Monotherapy|Started New Cancer Drug|0|||
44142273|NCT02712905|78931665|FG016|Monotherapy|Started New Cancer Drug|0|||
44142274|NCT02712905|78931666|FG017|Monotherapy|Started New Cancer Drug|0|||
44142275|NCT02712905|78931649|FG000|Monotherapy|Adverse Event|0|||
44142276|NCT02712905|78931650|FG001|Monotherapy|Adverse Event|0|||
44142277|NCT02712905|78931651|FG002|Monotherapy|Adverse Event|0|||
44142278|NCT02712905|78931652|FG003|Monotherapy|Adverse Event|0|||
44142279|NCT02712905|78931653|FG004|Monotherapy|Adverse Event|0|||
44142280|NCT02712905|78931654|FG005|Monotherapy|Adverse Event|0|||
44142281|NCT02712905|78931655|FG006|Monotherapy|Adverse Event|0|||
44142282|NCT02712905|78931656|FG007|Monotherapy|Adverse Event|0|||
44142283|NCT02712905|78931657|FG008|Monotherapy|Adverse Event|1|||
44142284|NCT02712905|78931658|FG009|Monotherapy|Adverse Event|0|||
44142285|NCT02712905|78931659|FG010|Monotherapy|Adverse Event|0|||
44142286|NCT02712905|78931660|FG011|Monotherapy|Adverse Event|0|||
44142287|NCT02712905|78931661|FG012|Monotherapy|Adverse Event|0|||
44142288|NCT02712905|78931662|FG013|Monotherapy|Adverse Event|0|||
44142289|NCT02712905|78931663|FG014|Monotherapy|Adverse Event|0|||
44142290|NCT02712905|78931664|FG015|Monotherapy|Adverse Event|0|||
44142291|NCT02712905|78931665|FG016|Monotherapy|Adverse Event|0|||
44142292|NCT02712905|78931666|FG017|Monotherapy|Adverse Event|0|||
44142293|NCT02712905|78931649|FG000|Combination Therapy|Death|0|||
44142294|NCT02712905|78931650|FG001|Combination Therapy|Death|0|||
44142295|NCT02712905|78931651|FG002|Combination Therapy|Death|0|||
44142296|NCT02712905|78931652|FG003|Combination Therapy|Death|0|||
44142297|NCT02712905|78931653|FG004|Combination Therapy|Death|0|||
44142298|NCT02712905|78931654|FG005|Combination Therapy|Death|0|||
44142299|NCT02712905|78931655|FG006|Combination Therapy|Death|0|||
44142300|NCT02712905|78931656|FG007|Combination Therapy|Death|0|||
44142301|NCT02712905|78931657|FG008|Combination Therapy|Death|0|||
44142302|NCT02712905|78931658|FG009|Combination Therapy|Death|0|||
44142303|NCT02712905|78931659|FG010|Combination Therapy|Death|0|||
44142304|NCT02712905|78931660|FG011|Combination Therapy|Death|0|||
44142305|NCT02712905|78931661|FG012|Combination Therapy|Death|5|||
44142306|NCT02712905|78931662|FG013|Combination Therapy|Death|6|||
44142307|NCT02712905|78931663|FG014|Combination Therapy|Death|1|||
44142308|NCT02712905|78931664|FG015|Combination Therapy|Death|3|||
44142309|NCT02712905|78931665|FG016|Combination Therapy|Death|1|||
44142310|NCT02712905|78931666|FG017|Combination Therapy|Death|3|||
44142311|NCT02712905|78931649|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
44142312|NCT02712905|78931650|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
44142313|NCT02712905|78931651|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
44142314|NCT02712905|78931652|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
44142315|NCT02712905|78931653|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
44142316|NCT02712905|78931654|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
44142317|NCT02712905|78931655|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
44142318|NCT02712905|78931656|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
44142319|NCT02712905|78931657|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
44142320|NCT02712905|78931658|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
44142321|NCT02712905|78931659|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
44142322|NCT02712905|78931660|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
44142323|NCT02712905|78931661|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
44142324|NCT02712905|78931662|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
44142325|NCT02712905|78931663|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
44142326|NCT02712905|78931664|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
44142327|NCT02712905|78931665|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
44142328|NCT02712905|78931666|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
44142329|NCT02712905|78931649|FG000|Combination Therapy|Withdrawal by Subject|0|||
44142330|NCT02712905|78931650|FG001|Combination Therapy|Withdrawal by Subject|0|||
44142331|NCT02712905|78931651|FG002|Combination Therapy|Withdrawal by Subject|0|||
44142332|NCT02712905|78931652|FG003|Combination Therapy|Withdrawal by Subject|0|||
44142333|NCT02712905|78931653|FG004|Combination Therapy|Withdrawal by Subject|0|||
44142334|NCT02712905|78931654|FG005|Combination Therapy|Withdrawal by Subject|0|||
44142335|NCT02712905|78931655|FG006|Combination Therapy|Withdrawal by Subject|0|||
44142336|NCT02712905|78931656|FG007|Combination Therapy|Withdrawal by Subject|0|||
44142337|NCT02712905|78931657|FG008|Combination Therapy|Withdrawal by Subject|0|||
44142338|NCT02712905|78931658|FG009|Combination Therapy|Withdrawal by Subject|0|||
44142339|NCT02712905|78931659|FG010|Combination Therapy|Withdrawal by Subject|0|||
44142340|NCT02712905|78931660|FG011|Combination Therapy|Withdrawal by Subject|0|||
44142341|NCT02712905|78931661|FG012|Combination Therapy|Withdrawal by Subject|0|||
44142342|NCT02712905|78931662|FG013|Combination Therapy|Withdrawal by Subject|0|||
44142343|NCT02712905|78931663|FG014|Combination Therapy|Withdrawal by Subject|0|||
44142344|NCT02712905|78931664|FG015|Combination Therapy|Withdrawal by Subject|1|||
44142345|NCT02712905|78931665|FG016|Combination Therapy|Withdrawal by Subject|0|||
44142346|NCT02712905|78931666|FG017|Combination Therapy|Withdrawal by Subject|2|||
44142347|NCT02712905|78931649|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142348|NCT02712905|78931650|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142349|NCT02712905|78931651|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142350|NCT02712905|78931652|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142351|NCT02712905|78931653|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142352|NCT02712905|78931654|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142353|NCT02712905|78931655|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142354|NCT02712905|78931656|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142355|NCT02712905|78931657|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142356|NCT02712905|78931658|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142357|NCT02712905|78931659|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142358|NCT02712905|78931660|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142359|NCT02712905|78931661|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142360|NCT02712905|78931662|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142361|NCT02712905|78931663|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142362|NCT02712905|78931664|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
44142363|NCT02712905|78931665|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142364|NCT02712905|78931666|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
44142365|NCT03776357|78931704|FG000|Overall Study|Lost to Follow-up|3|||
44142366|NCT04520997|78931710|FG000|Overall Study|Lost to Follow-up|1|||
44142367|NCT04520997|78931711|FG001|Overall Study|Lost to Follow-up|1|||
44142368|NCT04520997|78931710|FG000|Overall Study|Withdrawal by Subject|1|||
44142369|NCT04520997|78931711|FG001|Overall Study|Withdrawal by Subject|0|||
44142370|NCT04520997|78931710|FG000|Overall Study|Not Treated|0|||
44142371|NCT04520997|78931711|FG001|Overall Study|Not Treated|1|||
44142372|NCT02734433|78931722|FG000|Overall Study|Disease progression|1|||
44142373|NCT02734433|78931723|FG001|Overall Study|Disease progression|5|||
44142374|NCT02734433|78931722|FG000|Overall Study|Clinical progression|0|||
44142375|NCT02734433|78931723|FG001|Overall Study|Clinical progression|1|||
44142376|NCT02734433|78931722|FG000|Overall Study|Withdrawal by Subject|1|||
44142377|NCT02734433|78931723|FG001|Overall Study|Withdrawal by Subject|2|||
44142378|NCT02452424|78931749|FG000|Overall Study|Death|2|||
44142379|NCT02452424|78931750|FG001|Overall Study|Death|2|||
44142380|NCT02452424|78931751|FG002|Overall Study|Death|2|||
44142381|NCT02452424|78931752|FG003|Overall Study|Death|6|||
44142382|NCT02452424|78931753|FG004|Overall Study|Death|2|||
44142383|NCT02452424|78931754|FG005|Overall Study|Death|0|||
44142384|NCT02452424|78931755|FG006|Overall Study|Death|5|||
44142385|NCT02452424|78931756|FG007|Overall Study|Death|1|||
44142386|NCT02452424|78931757|FG008|Overall Study|Death|3|||
44142387|NCT02452424|78931758|FG009|Overall Study|Death|1|||
44142388|NCT02452424|78931759|FG010|Overall Study|Death|0|||
44142389|NCT02452424|78931749|FG000|Overall Study|Lost to Follow-up|0|||
44244191|NCT01562444|79074279|FG002|Overall Study|Did not meet entry criteria|3|||
44381206|NCT03960580|79387172|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
44381207|NCT03803202|79387189|FG000|Overall Study|Other|0|||
44381208|NCT03803202|79387190|FG001|Overall Study|Other|1|||
44381209|NCT03803202|79387191|FG002|Overall Study|Other|0|||
44381210|NCT03803202|79387192|FG003|Overall Study|Other|0|||
44381211|NCT03803202|79387193|FG004|Overall Study|Other|0|||
44381212|NCT03803202|79387194|FG005|Overall Study|Other|0|||
44381213|NCT03803202|79387195|FG006|Overall Study|Other|0|||
44381214|NCT03803202|79387196|FG007|Overall Study|Other|0|||
44381215|NCT03803202|79387197|FG008|Overall Study|Other|0|||
44381216|NCT03803202|79387189|FG000|Overall Study|Death|0|||
44381217|NCT03803202|79387190|FG001|Overall Study|Death|0|||
44381218|NCT03803202|79387191|FG002|Overall Study|Death|0|||
44381219|NCT03803202|79387192|FG003|Overall Study|Death|0|||
44381220|NCT03803202|79387193|FG004|Overall Study|Death|0|||
44381221|NCT03803202|79387194|FG005|Overall Study|Death|1|||
44381222|NCT03803202|79387195|FG006|Overall Study|Death|0|||
44381223|NCT03803202|79387196|FG007|Overall Study|Death|0|||
44244192|NCT01562444|79074277|FG000|Overall Study|Did not comply with blood draw schedule|1|||
44381224|NCT03803202|79387197|FG008|Overall Study|Death|0|||
44381225|NCT03803202|79387189|FG000|Overall Study|Withdrawal by Subject|0|||
44381226|NCT03803202|79387190|FG001|Overall Study|Withdrawal by Subject|0|||
44381227|NCT03803202|79387191|FG002|Overall Study|Withdrawal by Subject|1|||
44381228|NCT03803202|79387192|FG003|Overall Study|Withdrawal by Subject|0|||
44514072|NCT04634253|79519255|FG000|Overall Study|Withdrawal by Subject|1|||
44514073|NCT04634253|79519256|FG001|Overall Study|Withdrawal by Subject|0|||
44381229|NCT03803202|79387193|FG004|Overall Study|Withdrawal by Subject|0|||
44381230|NCT03803202|79387194|FG005|Overall Study|Withdrawal by Subject|0|||
44381231|NCT03803202|79387195|FG006|Overall Study|Withdrawal by Subject|0|||
44381232|NCT03803202|79387196|FG007|Overall Study|Withdrawal by Subject|1|||
44381233|NCT03803202|79387197|FG008|Overall Study|Withdrawal by Subject|0|||
44381234|NCT03803202|79387189|FG000|Overall Study|Lost to Follow-up|0|||
44381235|NCT03803202|79387190|FG001|Overall Study|Lost to Follow-up|0|||
44381236|NCT03803202|79387191|FG002|Overall Study|Lost to Follow-up|0|||
44381237|NCT03803202|79387192|FG003|Overall Study|Lost to Follow-up|1|||
44244193|NCT01562444|79074278|FG001|Overall Study|Did not comply with blood draw schedule|0|||
44244194|NCT01562444|79074279|FG002|Overall Study|Did not comply with blood draw schedule|1|||
44244195|NCT01562444|79074277|FG000|Overall Study|Unavailable serological results|0|||
44142390|NCT02452424|78931750|FG001|Overall Study|Lost to Follow-up|1|||
44142391|NCT02452424|78931751|FG002|Overall Study|Lost to Follow-up|1|||
44142392|NCT02452424|78931752|FG003|Overall Study|Lost to Follow-up|0|||
44142393|NCT02452424|78931753|FG004|Overall Study|Lost to Follow-up|0|||
44142394|NCT02452424|78931754|FG005|Overall Study|Lost to Follow-up|0|||
44142395|NCT02452424|78931755|FG006|Overall Study|Lost to Follow-up|0|||
44142396|NCT02452424|78931756|FG007|Overall Study|Lost to Follow-up|0|||
44142397|NCT02452424|78931757|FG008|Overall Study|Lost to Follow-up|0|||
44142398|NCT02452424|78931758|FG009|Overall Study|Lost to Follow-up|0|||
44142399|NCT02452424|78931759|FG010|Overall Study|Lost to Follow-up|0|||
44142400|NCT02452424|78931749|FG000|Overall Study|Withdrawal by Subject|0|||
44142401|NCT02452424|78931750|FG001|Overall Study|Withdrawal by Subject|0|||
44142402|NCT02452424|78931751|FG002|Overall Study|Withdrawal by Subject|3|||
44142403|NCT02452424|78931752|FG003|Overall Study|Withdrawal by Subject|2|||
44142404|NCT02452424|78931753|FG004|Overall Study|Withdrawal by Subject|0|||
44142405|NCT02452424|78931754|FG005|Overall Study|Withdrawal by Subject|0|||
44142406|NCT02452424|78931755|FG006|Overall Study|Withdrawal by Subject|1|||
44142407|NCT02452424|78931756|FG007|Overall Study|Withdrawal by Subject|0|||
44142408|NCT02452424|78931757|FG008|Overall Study|Withdrawal by Subject|1|||
44142409|NCT02452424|78931758|FG009|Overall Study|Withdrawal by Subject|1|||
44142410|NCT02452424|78931759|FG010|Overall Study|Withdrawal by Subject|0|||
44142411|NCT02452424|78931749|FG000|Overall Study|Other|0|||
44142412|NCT02452424|78931750|FG001|Overall Study|Other|0|||
44142413|NCT02452424|78931751|FG002|Overall Study|Other|1|||
44142414|NCT02452424|78931752|FG003|Overall Study|Other|0|||
44142415|NCT02452424|78931753|FG004|Overall Study|Other|0|||
44142416|NCT02452424|78931754|FG005|Overall Study|Other|1|||
44142417|NCT02452424|78931755|FG006|Overall Study|Other|4|||
44142418|NCT02452424|78931756|FG007|Overall Study|Other|3|||
44142419|NCT02452424|78931757|FG008|Overall Study|Other|0|||
44142420|NCT02452424|78931758|FG009|Overall Study|Other|0|||
44142421|NCT02452424|78931759|FG010|Overall Study|Other|1|||
44142422|NCT02452424|78931749|FG000|Overall Study|Progressive disease (per RECIST)|0|||
44142423|NCT02452424|78931750|FG001|Overall Study|Progressive disease (per RECIST)|0|||
44142424|NCT02452424|78931751|FG002|Overall Study|Progressive disease (per RECIST)|0|||
44244196|NCT01562444|79074278|FG001|Overall Study|Unavailable serological results|2|||
44244197|NCT01562444|79074279|FG002|Overall Study|Unavailable serological results|2|||
44244198|NCT01562444|79074277|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
44244199|NCT01562444|79074278|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
44244200|NCT01562444|79074279|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
44244201|NCT01562444|79074277|FG000|Overall Study|Protocol forbidden medication|1|||
44244202|NCT01562444|79074278|FG001|Overall Study|Protocol forbidden medication|0|||
44244203|NCT01562444|79074279|FG002|Overall Study|Protocol forbidden medication|0|||
44276719|NCT03234907|79237690|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
44244204|NCT01457339|79074289|FG000|Period 3 (100 mg)|Adverse Event|0|||
44244205|NCT01457339|79074290|FG001|Period 3 (100 mg)|Adverse Event|1|||
44381238|NCT03803202|79387193|FG004|Overall Study|Lost to Follow-up|1|||
44142425|NCT02452424|78931752|FG003|Overall Study|Progressive disease (per RECIST)|0|||
44142426|NCT02452424|78931753|FG004|Overall Study|Progressive disease (per RECIST)|0|||
44142427|NCT02452424|78931754|FG005|Overall Study|Progressive disease (per RECIST)|0|||
44142428|NCT02452424|78931755|FG006|Overall Study|Progressive disease (per RECIST)|0|||
44142429|NCT02452424|78931756|FG007|Overall Study|Progressive disease (per RECIST)|0|||
44142430|NCT02452424|78931757|FG008|Overall Study|Progressive disease (per RECIST)|2|||
44142431|NCT02452424|78931758|FG009|Overall Study|Progressive disease (per RECIST)|0|||
44142432|NCT02452424|78931759|FG010|Overall Study|Progressive disease (per RECIST)|0|||
44244206|NCT01457339|79074289|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
44381239|NCT03803202|79387194|FG005|Overall Study|Lost to Follow-up|0|||
44381240|NCT03803202|79387195|FG006|Overall Study|Lost to Follow-up|1|||
44142433|NCT02452424|78931749|FG000|Overall Study|Adverse Event|0|||
44142434|NCT02452424|78931750|FG001|Overall Study|Adverse Event|0|||
44142435|NCT02452424|78931751|FG002|Overall Study|Adverse Event|0|||
44142436|NCT02452424|78931752|FG003|Overall Study|Adverse Event|0|||
44142437|NCT02452424|78931753|FG004|Overall Study|Adverse Event|0|||
44142438|NCT02452424|78931754|FG005|Overall Study|Adverse Event|0|||
44142439|NCT02452424|78931755|FG006|Overall Study|Adverse Event|0|||
44142440|NCT02452424|78931756|FG007|Overall Study|Adverse Event|0|||
44142441|NCT02452424|78931757|FG008|Overall Study|Adverse Event|0|||
44142442|NCT02452424|78931758|FG009|Overall Study|Adverse Event|0|||
44142443|NCT02452424|78931759|FG010|Overall Study|Adverse Event|1|||
44142444|NCT02419508|78931787|FG000|Overall Study|Adverse Event|9|||
44142445|NCT02419508|78931788|FG001|Overall Study|Adverse Event|3|||
44142446|NCT02419508|78931787|FG000|Overall Study|Withdrawal by Subject|1|||
44142447|NCT02419508|78931788|FG001|Overall Study|Withdrawal by Subject|0|||
44142448|NCT02419508|78931787|FG000|Overall Study|Other - Reason not specified|0|||
44142449|NCT02419508|78931788|FG001|Overall Study|Other - Reason not specified|1|||
44142450|NCT01328249|78931796|FG000|Overall Study|Adverse Event|3|||
44142451|NCT01328249|78931797|FG001|Overall Study|Adverse Event|0|||
44142452|NCT01328249|78931796|FG000|Overall Study|Disease progression|1|||
44142453|NCT01328249|78931797|FG001|Overall Study|Disease progression|0|||
44142454|NCT01328249|78931796|FG000|Overall Study|Withdrawal by Subject|1|||
44142455|NCT01328249|78931797|FG001|Overall Study|Withdrawal by Subject|1|||
44142456|NCT01328249|78931796|FG000|Overall Study|Moved before end of treatment visit|1|||
44142457|NCT01328249|78931797|FG001|Overall Study|Moved before end of treatment visit|0|||
44142458|NCT01328249|78931796|FG000|Overall Study|Subject choice|1|||
44142459|NCT01328249|78931797|FG001|Overall Study|Subject choice|1|||
44142460|NCT01328249|78931796|FG000|Overall Study|Protocol Violation|0|||
44142461|NCT01328249|78931797|FG001|Overall Study|Protocol Violation|1|||
44142462|NCT01651052|78931805|FG000|Overall Study|Death|21|||
44142463|NCT01651052|78931805|FG000|Overall Study|Explant|1|||
44142464|NCT01651052|78931805|FG000|Overall Study|Withdrawal by Subject|1|||
44142465|NCT01651052|78931805|FG000|Overall Study|Lost to Follow-up|3|||
44142466|NCT02388074|78931809|FG000|Overall Study|Lost in Transit|2|||
44142467|NCT02388074|78931809|FG000|Overall Study|Sample Not Returned|1|||
44142468|NCT01602549|78931815|FG000|Overall Study|Protocol Violation|0|||
44142469|NCT01602549|78931816|FG001|Overall Study|Protocol Violation|1|||
44142470|NCT01602549|78931815|FG000|Overall Study|Withdrawal by Subject|1|||
44142471|NCT01602549|78931816|FG001|Overall Study|Withdrawal by Subject|0|||
44142472|NCT02427464|78931826|FG000|Overall Study|Adverse Event|6|||
44142473|NCT02427464|78931827|FG001|Overall Study|Adverse Event|1|||
44142474|NCT02427464|78931826|FG000|Overall Study|Lost to Follow-up|16|||
44142475|NCT02427464|78931827|FG001|Overall Study|Lost to Follow-up|5|||
44142476|NCT02427464|78931826|FG000|Overall Study|Physician Decision|2|||
44142477|NCT02427464|78931827|FG001|Overall Study|Physician Decision|0|||
44142478|NCT02427464|78931826|FG000|Overall Study|Withdrawal by Subject|10|||
44142479|NCT02427464|78931827|FG001|Overall Study|Withdrawal by Subject|8|||
44142480|NCT02427464|78931826|FG000|Overall Study|Noncompliance|16|||
44142481|NCT02427464|78931827|FG001|Overall Study|Noncompliance|10|||
44142482|NCT02426918|78931836|FG000|Overall Study|Adverse Event|2|||
44142483|NCT02426918|78931837|FG001|Overall Study|Adverse Event|2|||
44142484|NCT02426918|78931838|FG002|Overall Study|Adverse Event|0|||
44142485|NCT02426918|78931836|FG000|Overall Study|Physician Decision|1|||
44142486|NCT02426918|78931837|FG001|Overall Study|Physician Decision|1|||
44142487|NCT02426918|78931838|FG002|Overall Study|Physician Decision|1|||
44142488|NCT02426918|78931836|FG000|Overall Study|Withdrawal by Subject|5|||
44142489|NCT02426918|78931837|FG001|Overall Study|Withdrawal by Subject|5|||
44142490|NCT02426918|78931838|FG002|Overall Study|Withdrawal by Subject|4|||
44142491|NCT02426918|78931836|FG000|Overall Study|Other|9|||
44142492|NCT02426918|78931837|FG001|Overall Study|Other|11|||
44142493|NCT02426918|78931838|FG002|Overall Study|Other|9|||
44142494|NCT02387840|78931852|FG000|Overall Study|Death|0|||
44142495|NCT02387840|78931853|FG001|Overall Study|Death|0|||
44142496|NCT02387840|78931854|FG002|Overall Study|Death|0|||
44142497|NCT02387840|78931855|FG003|Overall Study|Death|0|||
44142498|NCT02387840|78931856|FG004|Overall Study|Death|0|||
44142499|NCT02387840|78931857|FG005|Overall Study|Death|1|||
44142500|NCT02387762|78931879|FG000|Overall Study|Withdrawal by Subject|1|||
44142501|NCT02387762|78931880|FG001|Overall Study|Withdrawal by Subject|0|||
44142502|NCT02418182|78931888|FG000|Overall Study|Unable to re-consent|18|||
44142503|NCT02418182|78931889|FG001|Overall Study|Unable to re-consent|15|||
44142504|NCT02418182|78931888|FG000|Overall Study|Lost to Follow-up|0|||
44142505|NCT02418182|78931889|FG001|Overall Study|Lost to Follow-up|2|||
44142506|NCT02387372|78931910|FG000|Overall Study|Not Treated|1|||
44142507|NCT02387372|78931911|FG001|Overall Study|Not Treated|0|||
44142508|NCT02426138|78931927|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
44142509|NCT02426138|78931928|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
44142510|NCT02426684|78931941|FG000|Overall Study|Physician Decision|1|||
44142511|NCT02656173|78931947|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
44142512|NCT02656173|78931948|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
44142513|NCT02656173|78931947|FG000|Overall Study|Adverse Event|7|||
44142514|NCT02656173|78931948|FG001|Overall Study|Adverse Event|5|||
44142515|NCT02656173|78931947|FG000|Overall Study|Withdrawal by Subject|1|||
44142516|NCT02656173|78931948|FG001|Overall Study|Withdrawal by Subject|3|||
44142517|NCT02656173|78931947|FG000|Overall Study|Protocol Violation|0|||
44142518|NCT02656173|78931948|FG001|Overall Study|Protocol Violation|1|||
44142519|NCT02656173|78931947|FG000|Overall Study|Miscellaneous|2|||
44142520|NCT02656173|78931948|FG001|Overall Study|Miscellaneous|0|||
44142521|NCT02656017|78931958|FG000|Overall Study|Study burden|3|||
44142522|NCT02656017|78931959|FG001|Overall Study|Study burden|3|||
44142523|NCT02656017|78931958|FG000|Overall Study|Adverse Event|2|||
44142524|NCT02656017|78931959|FG001|Overall Study|Adverse Event|1|||
44142525|NCT02656017|78931958|FG000|Overall Study|Unable/unwilling to take study medication|2|||
44142526|NCT02656017|78931959|FG001|Overall Study|Unable/unwilling to take study medication|1|||
44142527|NCT02656017|78931958|FG000|Overall Study|Began Tolvaptan|1|||
44142528|NCT02656017|78931959|FG001|Overall Study|Began Tolvaptan|1|||
44142529|NCT02656017|78931958|FG000|Overall Study|Withdrawal by Subject|1|||
44142530|NCT02656017|78931959|FG001|Overall Study|Withdrawal by Subject|0|||
44142531|NCT02657343|78931971|FG000|Overall Study|Death|0|||
44142532|NCT02657343|78931972|FG001|Overall Study|Death|2|||
44142533|NCT02657343|78931973|FG002|Overall Study|Death|0|||
44142534|NCT02657343|78931974|FG003|Overall Study|Death|0|||
44142535|NCT02657343|78931975|FG004|Overall Study|Death|0|||
44142536|NCT02657343|78931976|FG005|Overall Study|Death|0|||
44142537|NCT02657343|78931971|FG000|Overall Study|Patient went to hospice|1|||
44142538|NCT02657343|78931972|FG001|Overall Study|Patient went to hospice|0|||
44142539|NCT02657343|78931973|FG002|Overall Study|Patient went to hospice|0|||
44142540|NCT02657343|78931974|FG003|Overall Study|Patient went to hospice|0|||
44142541|NCT02657343|78931975|FG004|Overall Study|Patient went to hospice|0|||
44142542|NCT02657343|78931976|FG005|Overall Study|Patient went to hospice|0|||
44142543|NCT02657343|78931971|FG000|Overall Study|Withdrawal by Subject|0|||
44142544|NCT02657343|78931972|FG001|Overall Study|Withdrawal by Subject|0|||
44142545|NCT02657343|78931973|FG002|Overall Study|Withdrawal by Subject|0|||
44142546|NCT02657343|78931974|FG003|Overall Study|Withdrawal by Subject|0|||
44142547|NCT02657343|78931975|FG004|Overall Study|Withdrawal by Subject|1|||
44142548|NCT02657343|78931976|FG005|Overall Study|Withdrawal by Subject|0|||
44142549|NCT02655237|78931992|FG000|Overall Study|Adverse Event|10|||
44142550|NCT02655237|78931993|FG001|Overall Study|Adverse Event|7|||
44142551|NCT02655237|78931992|FG000|Overall Study|Protocol Deviation|2|||
44142552|NCT02655237|78931993|FG001|Overall Study|Protocol Deviation|0|||
44142553|NCT02655237|78931992|FG000|Overall Study|Withdrawal by Participant|1|||
44142554|NCT02655237|78931993|FG001|Overall Study|Withdrawal by Participant|2|||
44142555|NCT02655237|78931992|FG000|Overall Study|Lack of Efficacy|0|||
44142556|NCT02655237|78931993|FG001|Overall Study|Lack of Efficacy|1|||
44142557|NCT02655237|78931992|FG000|Overall Study|Recovery Leading to Surgery|2|||
44142558|NCT02655237|78931993|FG001|Overall Study|Recovery Leading to Surgery|1|||
44142559|NCT02655237|78931992|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
44142560|NCT02655237|78931993|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
44142561|NCT02655237|78931992|FG000|Overall Study|Randomized but Not Treated|1|||
44142562|NCT02655237|78931993|FG001|Overall Study|Randomized but Not Treated|0|||
44142563|NCT02657031|78932001|FG000|Overall Study|Adverse Event|1|||
44142564|NCT02657031|78932002|FG001|Overall Study|Adverse Event|2|||
44142565|NCT04375397|78932030|FG000|Overall Study|Death|1|||
44142566|NCT04375397|78932031|FG001|Overall Study|Death|1|||
44142567|NCT04375397|78932030|FG000|Overall Study|Withdrew consent|2|||
44142568|NCT04375397|78932031|FG001|Overall Study|Withdrew consent|0|||
44142569|NCT04375397|78932030|FG000|Overall Study|Lost to Follow-up|6|||
44142570|NCT04375397|78932031|FG001|Overall Study|Lost to Follow-up|4|||
44142571|NCT04375397|78932030|FG000|Overall Study|Other, not specified|0|||
44142572|NCT04375397|78932031|FG001|Overall Study|Other, not specified|1|||
44142573|NCT02387216|78932039|FG000|Overall Study|Progressive disease|2|||
44142574|NCT02387216|78932040|FG001|Overall Study|Progressive disease|0|||
44142575|NCT02387216|78932039|FG000|Overall Study|Withdrawal by Subject|3|||
44142576|NCT02387216|78932040|FG001|Overall Study|Withdrawal by Subject|5|||
44142577|NCT02387216|78932039|FG000|Overall Study|Physician Decision|2|||
44142578|NCT02387216|78932040|FG001|Overall Study|Physician Decision|0|||
44142579|NCT02387216|78932039|FG000|Overall Study|Sponsor Decision|28|||
44142580|NCT02387216|78932040|FG001|Overall Study|Sponsor Decision|12|||
44142581|NCT02387216|78932039|FG000|Overall Study|Death|60|||
44514074|NCT04634253|79519257|FG002|Overall Study|Withdrawal by Subject|3|||
44514075|NCT04209634|79519324|FG000|Overall Study|Ongoing|10|||
44514076|NCT03915951|79519330|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
44514077|NCT03915951|79519331|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
44142582|NCT02387216|78932040|FG001|Overall Study|Death|23|||
44514078|NCT03915951|79519330|FG000|Overall Study|Adverse Event|12|||
44142583|NCT02387216|78932039|FG000|Overall Study|Other|5|||
44142584|NCT02387216|78932040|FG001|Overall Study|Other|4|||
44142585|NCT02387216|78932039|FG000|Overall Study|Lost to Follow-up|0|||
44142586|NCT02387216|78932040|FG001|Overall Study|Lost to Follow-up|3|||
44142587|NCT02417246|78932048|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
44142588|NCT02417246|78932049|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
44142589|NCT02417246|78932048|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
44142590|NCT02417246|78932049|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
44142591|NCT02417246|78932048|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
44142592|NCT02417246|78932049|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
44142593|NCT02417246|78932048|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
44142594|NCT02417246|78932049|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
44142595|NCT02424734|78932060|FG000|Overall Study|Treatment stopped to be discharged home|2|||
44142596|NCT02424734|78932061|FG001|Overall Study|Treatment stopped to be discharged home|2|||
44142597|NCT02424734|78932062|FG002|Overall Study|Treatment stopped to be discharged home|0|||
44142598|NCT02424578|78932073|FG000|Overall Study|Withdrawal by Subject|0|||
44142599|NCT02424578|78932074|FG001|Overall Study|Withdrawal by Subject|1|||
44142600|NCT02416934|78932082|FG000|Overall Study|given steroids|1|||
44142601|NCT02416934|78932083|FG001|Overall Study|given steroids|2|||
44142602|NCT02416934|78932082|FG000|Overall Study|Lost to Follow-up|0|||
44142603|NCT02416934|78932083|FG001|Overall Study|Lost to Follow-up|2|||
44142604|NCT02416934|78932082|FG000|Overall Study|Withdrawal by Subject|1|||
44142605|NCT02416934|78932083|FG001|Overall Study|Withdrawal by Subject|0|||
44142606|NCT02416934|78932082|FG000|Overall Study|recruited during continuing renewal proc|0|||
44142607|NCT02416934|78932083|FG001|Overall Study|recruited during continuing renewal proc|1|||
44142608|NCT02416934|78932082|FG000|Overall Study|Protocol Violation|0|||
44142609|NCT02416934|78932083|FG001|Overall Study|Protocol Violation|1|||
44142610|NCT02416934|78932082|FG000|Overall Study|surgery started late|0|||
44142611|NCT02416934|78932083|FG001|Overall Study|surgery started late|1|||
44142612|NCT02416934|78932082|FG000|Overall Study|re-operation|1|||
44142613|NCT02416934|78932083|FG001|Overall Study|re-operation|0|||
44142614|NCT02819635|78932103|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
44142615|NCT02819635|78932104|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
44142616|NCT02819635|78932105|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
44142617|NCT02819635|78932106|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
44142618|NCT02819635|78932107|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
44142619|NCT02819635|78932108|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
44142620|NCT02819635|78932109|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
44142621|NCT02819635|78932110|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
44142622|NCT02819635|78932111|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
44142623|NCT02819635|78932112|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
44142624|NCT02819635|78932113|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
44142625|NCT02819635|78932114|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
44142626|NCT02819635|78932103|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142627|NCT02819635|78932104|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142628|NCT02819635|78932105|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142629|NCT02819635|78932106|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142630|NCT02819635|78932107|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
44142631|NCT02819635|78932108|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
44142632|NCT02819635|78932109|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
44142633|NCT02819635|78932110|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142634|NCT02819635|78932111|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142635|NCT02819635|78932112|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142636|NCT02819635|78932113|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142637|NCT02819635|78932114|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
44142638|NCT02819635|78932103|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142639|NCT02819635|78932104|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142640|NCT02819635|78932105|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142641|NCT02819635|78932106|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142642|NCT02819635|78932107|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142643|NCT02819635|78932108|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
44142644|NCT02819635|78932109|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
44142645|NCT02819635|78932110|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142646|NCT02819635|78932111|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142647|NCT02819635|78932112|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142648|NCT02819635|78932113|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142649|NCT02819635|78932114|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
44142650|NCT02819635|78932103|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142651|NCT02819635|78932104|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44244207|NCT01457339|79074290|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
44244208|NCT01457339|79074289|FG000|Period 6 (250 mg)|Family Emergency|1|||
44514079|NCT03915951|79519331|FG001|Overall Study|Adverse Event|6|||
44142652|NCT02819635|78932105|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142653|NCT02819635|78932106|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142654|NCT02819635|78932107|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142655|NCT02819635|78932108|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142656|NCT02819635|78932109|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
44142657|NCT02819635|78932110|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142658|NCT02819635|78932111|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142659|NCT02819635|78932112|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142660|NCT02819635|78932113|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142661|NCT02819635|78932114|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
44142662|NCT02819635|78932103|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
44142663|NCT02819635|78932104|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
44142664|NCT02819635|78932105|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
44142665|NCT02819635|78932106|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
44142666|NCT02819635|78932107|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
44142667|NCT02819635|78932108|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
44142668|NCT02819635|78932109|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
44142669|NCT02819635|78932110|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
44142670|NCT02819635|78932111|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
44142671|NCT02819635|78932112|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
44142672|NCT02819635|78932113|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
44142673|NCT02819635|78932114|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
44142674|NCT02819635|78932103|FG000|Substudy 2, Part 2|Adverse Event|0|||
44142675|NCT02819635|78932104|FG001|Substudy 2, Part 2|Adverse Event|0|||
44142676|NCT02819635|78932105|FG002|Substudy 2, Part 2|Adverse Event|0|||
44142677|NCT02819635|78932106|FG003|Substudy 2, Part 2|Adverse Event|0|||
44142678|NCT02819635|78932107|FG004|Substudy 2, Part 2|Adverse Event|0|||
44142679|NCT02819635|78932108|FG005|Substudy 2, Part 2|Adverse Event|4|||
44142680|NCT02819635|78932109|FG006|Substudy 2, Part 2|Adverse Event|0|||
44142681|NCT02819635|78932110|FG007|Substudy 2, Part 2|Adverse Event|0|||
44142682|NCT02819635|78932111|FG008|Substudy 2, Part 2|Adverse Event|0|||
44142683|NCT02819635|78932112|FG009|Substudy 2, Part 2|Adverse Event|0|||
44142684|NCT02819635|78932113|FG010|Substudy 2, Part 2|Adverse Event|0|||
44142685|NCT02819635|78932114|FG011|Substudy 2, Part 2|Adverse Event|0|||
44142686|NCT02819635|78932103|FG000|Substudy 2, Part 2|Withdrew consent|0|||
44142687|NCT02819635|78932104|FG001|Substudy 2, Part 2|Withdrew consent|0|||
44142688|NCT02819635|78932105|FG002|Substudy 2, Part 2|Withdrew consent|0|||
44142689|NCT02819635|78932106|FG003|Substudy 2, Part 2|Withdrew consent|0|||
44142690|NCT02819635|78932107|FG004|Substudy 2, Part 2|Withdrew consent|0|||
44142691|NCT02819635|78932108|FG005|Substudy 2, Part 2|Withdrew consent|3|||
44142692|NCT02819635|78932109|FG006|Substudy 2, Part 2|Withdrew consent|1|||
44142693|NCT02819635|78932110|FG007|Substudy 2, Part 2|Withdrew consent|0|||
44142694|NCT02819635|78932111|FG008|Substudy 2, Part 2|Withdrew consent|0|||
44142695|NCT02819635|78932112|FG009|Substudy 2, Part 2|Withdrew consent|0|||
44142696|NCT02819635|78932113|FG010|Substudy 2, Part 2|Withdrew consent|0|||
44142697|NCT02819635|78932114|FG011|Substudy 2, Part 2|Withdrew consent|0|||
44142698|NCT02819635|78932103|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
44142699|NCT02819635|78932104|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
44142700|NCT02819635|78932105|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
44142701|NCT02819635|78932106|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
44142702|NCT02819635|78932107|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
44142703|NCT02819635|78932108|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
44142704|NCT02819635|78932109|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
44142705|NCT02819635|78932110|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
44381241|NCT03803202|79387196|FG007|Overall Study|Lost to Follow-up|0|||
44514080|NCT03915951|79519330|FG000|Overall Study|Disease progression (radiological)|17|||
44514081|NCT03915951|79519331|FG001|Overall Study|Disease progression (radiological)|15|||
44514082|NCT03915951|79519330|FG000|Overall Study|Disease progression (clinical)|4|||
44142706|NCT02819635|78932111|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
44142707|NCT02819635|78932112|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
44142708|NCT02819635|78932113|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
44142709|NCT02819635|78932114|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
44142710|NCT02819635|78932103|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142711|NCT02819635|78932104|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142712|NCT02819635|78932105|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142713|NCT02819635|78932106|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142714|NCT02819635|78932107|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142715|NCT02819635|78932108|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142716|NCT02819635|78932109|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
44381242|NCT03803202|79387197|FG008|Overall Study|Lost to Follow-up|0|||
44142717|NCT02819635|78932110|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142718|NCT02819635|78932111|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142719|NCT02819635|78932112|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142720|NCT02819635|78932113|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142721|NCT02819635|78932114|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
44142722|NCT02819635|78932103|FG000|Substudy 2, Part 2|Other, not specified|0|||
44142723|NCT02819635|78932104|FG001|Substudy 2, Part 2|Other, not specified|0|||
44142724|NCT02819635|78932105|FG002|Substudy 2, Part 2|Other, not specified|0|||
44142725|NCT02819635|78932106|FG003|Substudy 2, Part 2|Other, not specified|0|||
44142726|NCT02819635|78932107|FG004|Substudy 2, Part 2|Other, not specified|0|||
44142727|NCT02819635|78932108|FG005|Substudy 2, Part 2|Other, not specified|4|||
44142728|NCT02819635|78932109|FG006|Substudy 2, Part 2|Other, not specified|8|||
44142729|NCT02819635|78932110|FG007|Substudy 2, Part 2|Other, not specified|0|||
44142730|NCT02819635|78932111|FG008|Substudy 2, Part 2|Other, not specified|0|||
44142731|NCT02819635|78932112|FG009|Substudy 2, Part 2|Other, not specified|0|||
44142732|NCT02819635|78932113|FG010|Substudy 2, Part 2|Other, not specified|0|||
44142733|NCT02819635|78932114|FG011|Substudy 2, Part 2|Other, not specified|0|||
44142734|NCT02819635|78932103|FG000|Substudy 3|Adverse Event|0|||
44142735|NCT02819635|78932104|FG001|Substudy 3|Adverse Event|0|||
44142736|NCT02819635|78932105|FG002|Substudy 3|Adverse Event|0|||
44142737|NCT02819635|78932106|FG003|Substudy 3|Adverse Event|0|||
44142738|NCT02819635|78932107|FG004|Substudy 3|Adverse Event|0|||
44142739|NCT02819635|78932108|FG005|Substudy 3|Adverse Event|0|||
44142740|NCT02819635|78932109|FG006|Substudy 3|Adverse Event|0|||
44142741|NCT02819635|78932110|FG007|Substudy 3|Adverse Event|0|||
44142742|NCT02819635|78932111|FG008|Substudy 3|Adverse Event|32|||
44142743|NCT02819635|78932112|FG009|Substudy 3|Adverse Event|3|||
44142744|NCT02819635|78932113|FG010|Substudy 3|Adverse Event|12|||
44142745|NCT02819635|78932114|FG011|Substudy 3|Adverse Event|18|||
44142746|NCT02819635|78932103|FG000|Substudy 3|Withdrew consent|0|||
44142747|NCT02819635|78932104|FG001|Substudy 3|Withdrew consent|0|||
44142748|NCT02819635|78932105|FG002|Substudy 3|Withdrew consent|0|||
44142749|NCT02819635|78932106|FG003|Substudy 3|Withdrew consent|0|||
44142750|NCT02819635|78932107|FG004|Substudy 3|Withdrew consent|0|||
44142751|NCT02819635|78932108|FG005|Substudy 3|Withdrew consent|0|||
44142752|NCT02819635|78932109|FG006|Substudy 3|Withdrew consent|0|||
44142753|NCT02819635|78932110|FG007|Substudy 3|Withdrew consent|0|||
44142754|NCT02819635|78932111|FG008|Substudy 3|Withdrew consent|11|||
44142755|NCT02819635|78932112|FG009|Substudy 3|Withdrew consent|1|||
44142756|NCT02819635|78932113|FG010|Substudy 3|Withdrew consent|4|||
44142757|NCT02819635|78932114|FG011|Substudy 3|Withdrew consent|9|||
44142758|NCT02819635|78932103|FG000|Substudy 3|Lost to Follow-up|0|||
44142759|NCT02819635|78932104|FG001|Substudy 3|Lost to Follow-up|0|||
44142760|NCT02819635|78932105|FG002|Substudy 3|Lost to Follow-up|0|||
44142761|NCT02819635|78932106|FG003|Substudy 3|Lost to Follow-up|0|||
44142762|NCT02819635|78932107|FG004|Substudy 3|Lost to Follow-up|0|||
44142763|NCT02819635|78932108|FG005|Substudy 3|Lost to Follow-up|0|||
44142764|NCT02819635|78932109|FG006|Substudy 3|Lost to Follow-up|0|||
44142765|NCT02819635|78932110|FG007|Substudy 3|Lost to Follow-up|0|||
44142766|NCT02819635|78932111|FG008|Substudy 3|Lost to Follow-up|1|||
44142767|NCT02819635|78932112|FG009|Substudy 3|Lost to Follow-up|0|||
44142768|NCT02819635|78932113|FG010|Substudy 3|Lost to Follow-up|1|||
44244209|NCT01457339|79074290|FG001|Period 6 (250 mg)|Family Emergency|0|||
44244210|NCT01457339|79074289|FG000|Period 6 (250 mg)|Personal appointment|0|||
44244211|NCT01457339|79074290|FG001|Period 6 (250 mg)|Personal appointment|1|||
44142769|NCT02819635|78932114|FG011|Substudy 3|Lost to Follow-up|1|||
44142770|NCT02819635|78932103|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142771|NCT02819635|78932104|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142772|NCT02819635|78932105|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142773|NCT02819635|78932106|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142774|NCT02819635|78932107|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142775|NCT02819635|78932108|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142776|NCT02819635|78932109|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142777|NCT02819635|78932110|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142778|NCT02819635|78932111|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142779|NCT02819635|78932112|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142780|NCT02819635|78932113|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
44142781|NCT02819635|78932114|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
44142782|NCT02819635|78932103|FG000|Substudy 3|Other, not specified|0|||
44142783|NCT02819635|78932104|FG001|Substudy 3|Other, not specified|0|||
44381243|NCT03782727|79387231|FG000|Overall Study|Lost to Follow-up|32|||
44142784|NCT02819635|78932105|FG002|Substudy 3|Other, not specified|0|||
44142785|NCT02819635|78932106|FG003|Substudy 3|Other, not specified|0|||
44142786|NCT02819635|78932107|FG004|Substudy 3|Other, not specified|0|||
44142787|NCT02819635|78932108|FG005|Substudy 3|Other, not specified|0|||
44142788|NCT02819635|78932109|FG006|Substudy 3|Other, not specified|0|||
44142789|NCT02819635|78932110|FG007|Substudy 3|Other, not specified|0|||
44142790|NCT02819635|78932111|FG008|Substudy 3|Other, not specified|202|||
44142791|NCT02819635|78932112|FG009|Substudy 3|Other, not specified|5|||
44142792|NCT02819635|78932113|FG010|Substudy 3|Other, not specified|89|||
44142793|NCT02819635|78932114|FG011|Substudy 3|Other, not specified|39|||
44142794|NCT02424344|78932149|FG000|Overall Study|Lack of Efficacy|0|||
44142795|NCT02424344|78932150|FG001|Overall Study|Lack of Efficacy|1|||
44142796|NCT02424344|78932149|FG000|Overall Study|Withdrawal by Subject|2|||
44142797|NCT02424344|78932150|FG001|Overall Study|Withdrawal by Subject|1|||
44142798|NCT02424344|78932149|FG000|Overall Study|Lost to Follow-up|1|||
44142799|NCT02424344|78932150|FG001|Overall Study|Lost to Follow-up|0|||
44142800|NCT02424344|78932149|FG000|Overall Study|Adverse Event|4|||
44142801|NCT02424344|78932150|FG001|Overall Study|Adverse Event|8|||
44142802|NCT02423798|78932156|FG000|Overall Study|Withdrawal by Subject|3|||
44142803|NCT02383940|78932179|FG000|Overall Study|Adverse Event|1|||
44142804|NCT02383940|78932180|FG001|Overall Study|Adverse Event|0|||
44142805|NCT02383940|78932179|FG000|Overall Study|Lost to Follow-up|2|||
44142806|NCT02383940|78932180|FG001|Overall Study|Lost to Follow-up|2|||
44142807|NCT02383940|78932179|FG000|Overall Study|Physician Decision|2|||
44142808|NCT02383940|78932180|FG001|Overall Study|Physician Decision|0|||
44142809|NCT02383940|78932179|FG000|Overall Study|Withdrawal by Subject|1|||
44142810|NCT02383940|78932180|FG001|Overall Study|Withdrawal by Subject|1|||
44142811|NCT02383940|78932179|FG000|Overall Study|Randomized but not treated|2|||
44142812|NCT02383940|78932180|FG001|Overall Study|Randomized but not treated|0|||
44142813|NCT02383940|78932179|FG000|Overall Study|Other than specified above|1|||
44142814|NCT02383940|78932180|FG001|Overall Study|Other than specified above|0|||
44142815|NCT02383862|78932188|FG000|3 Month Follow up|Lost to Follow-up|23|||
44142816|NCT02383862|78932189|FG001|3 Month Follow up|Lost to Follow-up|21|||
44142817|NCT02383472|78932204|FG000|Overall Study|Withdrawal by Subject|1|||
44142818|NCT02383472|78932205|FG001|Overall Study|Withdrawal by Subject|1|||
44142819|NCT02234323|78932213|FG000|All Enrolled|Not Treated: Completed study in database|2|||
44142820|NCT02234323|78932213|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
44142821|NCT02234323|78932213|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
44142822|NCT02234323|78932213|FG000|All Treated|Death|1|||
44142823|NCT02234323|78932213|FG000|All Treated|Physician Decision|5|||
44142824|NCT02234323|78932213|FG000|All Treated|Lack of Efficacy|3|||
44142825|NCT02234323|78932213|FG000|All Treated|Exceeded lab value limit|2|||
44142826|NCT02234323|78932213|FG000|All Treated|Other|7|||
44142827|NCT02414828|78932223|FG000|Overall Study|Lost to Follow-up|0|||
44142828|NCT02414828|78932224|FG001|Overall Study|Lost to Follow-up|1|||
44142829|NCT02414828|78932225|FG002|Overall Study|Lost to Follow-up|1|||
44142830|NCT02414828|78932226|FG003|Overall Study|Lost to Follow-up|2|||
44142831|NCT02413346|78932239|FG000|Overall Study|Adverse Event|6|||
44142832|NCT02413346|78932240|FG001|Overall Study|Adverse Event|6|||
44142833|NCT02413346|78932239|FG000|Overall Study|Withdrawal by Subject|30|||
44142834|NCT02413346|78932240|FG001|Overall Study|Withdrawal by Subject|40|||
44244212|NCT01456949|79074313|FG000|Enrollment|PI death- incomplete data|6|||
44244213|NCT01456949|79074313|FG000|Enrollment|Death|1|||
44244214|NCT01456949|79074313|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
44244215|NCT01456949|79074313|FG000|Enrollment|Physician Decision|10|||
44381244|NCT03737812|79387238|FG000|Overall Study|Withdrawal by Subject|1|||
44381245|NCT03737812|79387239|FG001|Overall Study|Withdrawal by Subject|2|||
44142835|NCT02413346|78932239|FG000|Overall Study|Lost to Follow-up|17|||
44142836|NCT02413346|78932240|FG001|Overall Study|Lost to Follow-up|21|||
44142837|NCT02413346|78932239|FG000|Overall Study|Protocol Violation|2|||
44142838|NCT02413346|78932240|FG001|Overall Study|Protocol Violation|0|||
44142839|NCT02413346|78932239|FG000|Overall Study|Other Miscellaneous Reasons|4|||
44142840|NCT02413346|78932240|FG001|Overall Study|Other Miscellaneous Reasons|3|||
44142841|NCT03390101|78932253|FG000|Weeks 0-12|Withdrawal by Subject|0|||
44142842|NCT03390101|78932254|FG001|Weeks 0-12|Withdrawal by Subject|1|||
44142843|NCT03390101|78932255|FG002|Weeks 0-12|Withdrawal by Subject|1|||
44142844|NCT03390101|78932253|FG000|Weeks 0-12|Lost to Follow-up|0|||
44142845|NCT03390101|78932254|FG001|Weeks 0-12|Lost to Follow-up|1|||
44142846|NCT03390101|78932255|FG002|Weeks 0-12|Lost to Follow-up|0|||
44142847|NCT03390101|78932253|FG000|Weeks 12-54|Withdrawal by Subject|0|||
44142848|NCT03390101|78932254|FG001|Weeks 12-54|Withdrawal by Subject|3|||
44142849|NCT03390101|78932255|FG002|Weeks 12-54|Withdrawal by Subject|1|||
44142850|NCT03390101|78932253|FG000|Weeks 12-54|Pregnancy|1|||
44142851|NCT03390101|78932254|FG001|Weeks 12-54|Pregnancy|0|||
44142852|NCT03390101|78932255|FG002|Weeks 12-54|Pregnancy|0|||
44142853|NCT03390101|78932253|FG000|Weeks 12-54|Adverse Event|2|||
44244216|NCT01456949|79074313|FG000|Enrollment|Withdrawal by Subject|7|||
44142854|NCT03390101|78932254|FG001|Weeks 12-54|Adverse Event|1|||
44142855|NCT03390101|78932255|FG002|Weeks 12-54|Adverse Event|1|||
44142856|NCT02732639|78932263|FG000|Overall Study|Lost to Follow-up|1|||
44142857|NCT02732561|78932269|FG000|Overall Study|Lost to Follow-up|1|||
44142858|NCT02732561|78932270|FG001|Overall Study|Lost to Follow-up|1|||
44142859|NCT02732561|78932269|FG000|Overall Study|Withdrawal by Subject|1|||
44142860|NCT02732561|78932270|FG001|Overall Study|Withdrawal by Subject|0|||
44142861|NCT02412878|78932278|FG000|Overall Study|Withdrawal by Subject|19|||
44142862|NCT02412878|78932279|FG001|Overall Study|Withdrawal by Subject|10|||
44142863|NCT02412878|78932278|FG000|Overall Study|Lost to Follow-up|2|||
44142864|NCT02412878|78932279|FG001|Overall Study|Lost to Follow-up|3|||
44142865|NCT02380742|78932287|FG000|Overall Study|Withdrawal by Subject|1|||
44142866|NCT02380742|78932288|FG001|Overall Study|Withdrawal by Subject|0|||
44142867|NCT02922725|78932297|FG000|Overall Study|Withdrawal by Subject|1|||
44142868|NCT02922725|78932298|FG001|Overall Study|Withdrawal by Subject|0|||
44142869|NCT02922725|78932299|FG002|Overall Study|Withdrawal by Subject|0|||
44142870|NCT02805257|78932308|FG000|Overall Study|Lost to Follow-up|7|||
44142871|NCT02805257|78932309|FG001|Overall Study|Lost to Follow-up|6|||
44142872|NCT02805257|78932308|FG000|Overall Study|Death|0|||
44142873|NCT02805257|78932309|FG001|Overall Study|Death|1|||
44142874|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
44142875|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
44142876|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
44142877|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
44142878|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
44142879|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
44142880|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
44142881|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
44142882|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
44142883|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
44142884|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
44142885|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
44142886|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
44142887|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
44142888|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
44142889|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
44276720|NCT03234907|79237691|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
44276721|NCT03234907|79237692|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
44276722|NCT03234907|79237687|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
44276723|NCT03234907|79237688|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
44276724|NCT03234907|79237689|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
44276725|NCT03234907|79237690|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
44276726|NCT03234907|79237691|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
44276727|NCT03234907|79237692|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
44514083|NCT03915951|79519331|FG001|Overall Study|Disease progression (clinical)|1|||
44514084|NCT03915951|79519330|FG000|Overall Study|Patient decision|0|||
44142890|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
44142891|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
44142892|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
44142893|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
44142894|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
44142895|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
44142896|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
44142897|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
44142898|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
44142899|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
44142900|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
44142901|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
44142902|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
44142903|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
44142904|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
44142905|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
44142906|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
44142907|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
44142908|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
44142909|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
44142910|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
44142911|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
44142912|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
44142913|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
44142914|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
44142915|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
44142916|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
44514085|NCT03915951|79519331|FG001|Overall Study|Patient decision|4|||
44142917|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
44142918|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
44142919|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
44142920|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
44142921|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
44381246|NCT03737812|79387240|FG002|Overall Study|Withdrawal by Subject|1|||
44381247|NCT03737812|79387238|FG000|Overall Study|Sponsor Discontinued the Study|4|||
44381248|NCT03737812|79387239|FG001|Overall Study|Sponsor Discontinued the Study|3|||
44381249|NCT03737812|79387240|FG002|Overall Study|Sponsor Discontinued the Study|2|||
44381250|NCT03737812|79387238|FG000|Overall Study|Adverse Event|0|||
44381251|NCT03737812|79387239|FG001|Overall Study|Adverse Event|1|||
44381252|NCT03737812|79387240|FG002|Overall Study|Adverse Event|0|||
44381253|NCT03737812|79387238|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
44381254|NCT03737812|79387239|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
44381255|NCT03737812|79387240|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
44381256|NCT03635424|79387248|FG000|Overall Study|Adverse Event|1|||
44381257|NCT03635424|79387248|FG000|Overall Study|Death|1|||
44381258|NCT03635424|79387248|FG000|Overall Study|Device not implanted|1|||
44381259|NCT03565367|79387254|FG000|Overall Study|No scan due to technical issues|4|||
44142922|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
44142923|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
44142924|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
44142925|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
44142926|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
44142927|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
44142928|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
44142929|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
44142930|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
44142931|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
44142932|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
44142933|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
44142934|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
44142935|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
44142936|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
44142937|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
44142938|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
44142939|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
44142940|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
44142941|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
44142942|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
44142943|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
44142944|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
44142945|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
44142946|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
44142947|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
44142948|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
44142949|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
44142950|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
44142951|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
44142952|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
44142953|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
44142954|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
44142955|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
44142956|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
44142957|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
44142958|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
44142959|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
44142960|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
44142961|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
44142962|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
44142963|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
44142964|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
44142965|NCT01791595|78932322|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
44142966|NCT01791595|78932323|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
44142967|NCT01791595|78932324|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
44381260|NCT03565367|79387255|FG001|Overall Study|No scan due to technical issues|0|||
44381261|NCT03443687|79387263|FG000|Overall Study|Lost to Follow-up|3|||
44381262|NCT03443687|79387264|FG001|Overall Study|Lost to Follow-up|5|||
44142968|NCT01791595|78932325|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
44142969|NCT01791595|78932326|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
44142970|NCT01791595|78932327|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
44142971|NCT01791595|78932328|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
44142972|NCT01791595|78932322|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
44142973|NCT01791595|78932323|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
44142974|NCT01791595|78932324|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
44142975|NCT01791595|78932325|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
44142976|NCT01791595|78932326|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
44142977|NCT01791595|78932327|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
44142978|NCT01791595|78932328|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
44142979|NCT01791595|78932322|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
44142980|NCT01791595|78932323|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
44142981|NCT01791595|78932324|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
44142982|NCT01791595|78932325|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
44142983|NCT01791595|78932326|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
44142984|NCT01791595|78932327|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
44142985|NCT01791595|78932328|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
44142986|NCT01791595|78932322|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
44142987|NCT01791595|78932323|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
44142988|NCT01791595|78932324|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
44142989|NCT01791595|78932325|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
44142990|NCT01791595|78932326|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
44142991|NCT01791595|78932327|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
44142992|NCT01791595|78932328|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
44142993|NCT01791595|78932322|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
44142994|NCT01791595|78932323|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
44142995|NCT01791595|78932324|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
44142996|NCT01791595|78932325|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
44142997|NCT01791595|78932326|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
44142998|NCT01791595|78932327|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
44142999|NCT01791595|78932328|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
44143000|NCT01559363|78932381|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
44143001|NCT01559363|78932382|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
44143002|NCT01559363|78932383|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
44143003|NCT01559363|78932384|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
44143004|NCT01559363|78932385|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
44143005|NCT01559363|78932386|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
44143006|NCT01559363|78932381|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
44143007|NCT01559363|78932382|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
44143008|NCT01559363|78932383|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
44143009|NCT01559363|78932384|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
44143010|NCT01559363|78932385|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
44143011|NCT01559363|78932386|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
44143012|NCT01559363|78932381|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
44143013|NCT01559363|78932382|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
44143014|NCT01559363|78932383|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
44143015|NCT01559363|78932384|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
44143016|NCT01559363|78932385|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
44143017|NCT01559363|78932386|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
44143018|NCT01559363|78932381|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
44143019|NCT01559363|78932382|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
44143020|NCT01559363|78932383|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
44143021|NCT01559363|78932384|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
44143022|NCT01559363|78932385|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
44143023|NCT01559363|78932386|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
44244217|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
44244218|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
44143024|NCT01559363|78932381|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
44143025|NCT01559363|78932382|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
44143026|NCT01559363|78932383|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
44143027|NCT01559363|78932384|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
44143028|NCT01559363|78932385|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
44244219|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
44514086|NCT03915951|79519330|FG000|Overall Study|Investigator decision|0|||
44514087|NCT03915951|79519331|FG001|Overall Study|Investigator decision|1|||
44143029|NCT01559363|78932386|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
44143030|NCT01559363|78932381|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
44143031|NCT01559363|78932382|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
44143032|NCT01559363|78932383|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
44143033|NCT01559363|78932384|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
44143034|NCT01559363|78932385|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
44143035|NCT01559363|78932386|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
44143036|NCT01559363|78932381|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
44143037|NCT01559363|78932382|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
44143038|NCT01559363|78932383|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
44143039|NCT01559363|78932384|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
44143040|NCT01559363|78932385|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
44143041|NCT01559363|78932386|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
44143042|NCT02732327|78932408|FG000|Overall Study|Protocol Violation|0|||
44143043|NCT02732327|78932409|FG001|Overall Study|Protocol Violation|1|||
44143044|NCT03179605|78932415|FG000|Overall Study|Withdrawal by Subject|1|||
44244220|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
44244221|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
44244222|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
44244223|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
44244224|NCT01456949|79074313|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
44244225|NCT01456169|79074320|FG000|Overall Study|Adverse Event|1|||
44244226|NCT01456169|79074321|FG001|Overall Study|Adverse Event|2|||
44244227|NCT01456169|79074322|FG002|Overall Study|Adverse Event|7|||
44244228|NCT01456169|79074320|FG000|Overall Study|Major Protocol Deviation|3|||
44244229|NCT01456169|79074321|FG001|Overall Study|Major Protocol Deviation|2|||
44244230|NCT01456169|79074322|FG002|Overall Study|Major Protocol Deviation|3|||
44244231|NCT01456169|79074320|FG000|Overall Study|Voluntary Withdrawal|3|||
44244232|NCT01456169|79074321|FG001|Overall Study|Voluntary Withdrawal|0|||
44244233|NCT01456169|79074322|FG002|Overall Study|Voluntary Withdrawal|2|||
44244234|NCT01456169|79074320|FG000|Overall Study|Lack of Efficacy|2|||
44244235|NCT01456169|79074321|FG001|Overall Study|Lack of Efficacy|0|||
44244236|NCT01456169|79074322|FG002|Overall Study|Lack of Efficacy|0|||
44514088|NCT03915951|79519330|FG000|Overall Study|Consent withdrawn|1|||
44143045|NCT02412722|78932425|FG000|Overall Study|Adverse Event|0|||
44143046|NCT02412722|78932426|FG001|Overall Study|Adverse Event|2|||
44143047|NCT02412722|78932427|FG002|Overall Study|Adverse Event|0|||
44143048|NCT02412722|78932428|FG003|Overall Study|Adverse Event|3|||
44143049|NCT02412722|78932429|FG004|Overall Study|Adverse Event|0|||
44143050|NCT02412722|78932430|FG005|Overall Study|Adverse Event|3|||
44143051|NCT02412722|78932425|FG000|Overall Study|Progressive Disease|6|||
44143052|NCT02412722|78932426|FG001|Overall Study|Progressive Disease|4|||
44143053|NCT02412722|78932427|FG002|Overall Study|Progressive Disease|4|||
44143054|NCT02412722|78932428|FG003|Overall Study|Progressive Disease|9|||
44143055|NCT02412722|78932429|FG004|Overall Study|Progressive Disease|3|||
44143056|NCT02412722|78932430|FG005|Overall Study|Progressive Disease|3|||
44143057|NCT02412722|78932425|FG000|Overall Study|Withdrawal by Subject|2|||
44143058|NCT02412722|78932426|FG001|Overall Study|Withdrawal by Subject|0|||
44143059|NCT02412722|78932427|FG002|Overall Study|Withdrawal by Subject|1|||
44143060|NCT02412722|78932428|FG003|Overall Study|Withdrawal by Subject|2|||
44143061|NCT02412722|78932429|FG004|Overall Study|Withdrawal by Subject|1|||
44143062|NCT02412722|78932430|FG005|Overall Study|Withdrawal by Subject|1|||
44244237|NCT01456169|79074320|FG000|Overall Study|Other|1|||
44244238|NCT01456169|79074321|FG001|Overall Study|Other|1|||
44514089|NCT03915951|79519331|FG001|Overall Study|Consent withdrawn|1|||
44514090|NCT03915951|79519330|FG000|Overall Study|Death|0|||
44514091|NCT03915951|79519331|FG001|Overall Study|Death|3|||
44514092|NCT03725982|79519369|FG000|First Intervention|Withdrawal by Subject|0|||
44514093|NCT03725982|79519370|FG001|First Intervention|Withdrawal by Subject|1|||
44514094|NCT03725982|79519369|FG000|First Intervention|Physician Decision|1|||
44514095|NCT03725982|79519370|FG001|First Intervention|Physician Decision|1|||
44514096|NCT03354273|79519436|FG000|Overall Study|Adverse Event|5|||
44514097|NCT03354273|79519436|FG000|Overall Study|Screen Failure|21|||
44514098|NCT03354273|79519436|FG000|Overall Study|Withdrawal by Subject|34|||
44514099|NCT03354273|79519436|FG000|Overall Study|Technical Problems|30|||
44514100|NCT03354273|79519436|FG000|Overall Study|Lost to Follow-up|4|||
44514101|NCT03354273|79519436|FG000|Overall Study|Investigator Decision|3|||
44514102|NCT03354273|79519436|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
44514103|NCT03354273|79519436|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
44514104|NCT03354273|79519436|FG000|Overall Study|COVID-19 Restrictions|9|||
44244239|NCT01456169|79074322|FG002|Overall Study|Other|0|||
44244240|NCT01454531|79074331|FG000|Overall Study|Adverse Event|14|||
44143063|NCT02412722|78932425|FG000|Overall Study|Lost to Follow-up|0|||
44143064|NCT02412722|78932426|FG001|Overall Study|Lost to Follow-up|0|||
44143065|NCT02412722|78932427|FG002|Overall Study|Lost to Follow-up|0|||
44143066|NCT02412722|78932428|FG003|Overall Study|Lost to Follow-up|0|||
44143067|NCT02412722|78932429|FG004|Overall Study|Lost to Follow-up|1|||
44143068|NCT02412722|78932430|FG005|Overall Study|Lost to Follow-up|0|||
44143069|NCT02412722|78932425|FG000|Overall Study|Received drug in run-in and discontinued|0|||
44143070|NCT02412722|78932426|FG001|Overall Study|Received drug in run-in and discontinued|2|||
44143071|NCT02412722|78932427|FG002|Overall Study|Received drug in run-in and discontinued|0|||
44143072|NCT02412722|78932428|FG003|Overall Study|Received drug in run-in and discontinued|0|||
44143073|NCT02412722|78932429|FG004|Overall Study|Received drug in run-in and discontinued|0|||
44143074|NCT02412722|78932430|FG005|Overall Study|Received drug in run-in and discontinued|0|||
44143075|NCT02412722|78932425|FG000|Overall Study|Reason not Specified|3|||
44143076|NCT02412722|78932426|FG001|Overall Study|Reason not Specified|0|||
44143077|NCT02412722|78932427|FG002|Overall Study|Reason not Specified|2|||
44143078|NCT02412722|78932428|FG003|Overall Study|Reason not Specified|1|||
44143079|NCT02412722|78932429|FG004|Overall Study|Reason not Specified|2|||
44143080|NCT02412722|78932430|FG005|Overall Study|Reason not Specified|6|||
44143081|NCT03074695|78932466|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
44143082|NCT03074695|78932467|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
44514105|NCT03354273|79519436|FG000|Overall Study|Other|5|||
44276728|NCT03234907|79237687|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
44276729|NCT03234907|79237688|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
44143083|NCT03074695|78932466|FG000|Overall Study|Research staff not available|1|||
44143084|NCT03074695|78932467|FG001|Overall Study|Research staff not available|2|||
44143085|NCT03074695|78932466|FG000|Overall Study|Did not receive neuraxial block|2|||
44514106|NCT02759185|79519460|FG000|Stage 1|Adverse Event|0|||
44514107|NCT02759185|79519461|FG001|Stage 1|Adverse Event|1|||
44514108|NCT02759185|79519462|FG002|Stage 1|Adverse Event|3|||
44514109|NCT02759185|79519463|FG003|Stage 1|Adverse Event|0|||
44514110|NCT02759185|79519464|FG004|Stage 1|Adverse Event|0|||
44514111|NCT02759185|79519465|FG005|Stage 1|Adverse Event|0|||
44514112|NCT02759185|79519466|FG006|Stage 1|Adverse Event|0|||
44514113|NCT02759185|79519460|FG000|Stage 1|Withdrawal by Subject|1|||
44514114|NCT02759185|79519461|FG001|Stage 1|Withdrawal by Subject|0|||
44514115|NCT02759185|79519462|FG002|Stage 1|Withdrawal by Subject|0|||
44143086|NCT03074695|78932467|FG001|Overall Study|Did not receive neuraxial block|2|||
44143087|NCT03469999|78932473|FG000|Overall Study|Lost to Follow-up|2|||
44143088|NCT02379728|78932480|FG000|Overall Study|Lost to Follow-up|1|||
44143089|NCT02379728|78932481|FG001|Overall Study|Lost to Follow-up|0|||
44143090|NCT02379728|78932482|FG002|Overall Study|Lost to Follow-up|3|||
44143091|NCT02379728|78932483|FG003|Overall Study|Lost to Follow-up|0|||
44143092|NCT02379728|78932480|FG000|Overall Study|Withdrawal by Subject|5|||
44143093|NCT02379728|78932481|FG001|Overall Study|Withdrawal by Subject|0|||
44143094|NCT02379728|78932482|FG002|Overall Study|Withdrawal by Subject|5|||
44143095|NCT02379728|78932483|FG003|Overall Study|Withdrawal by Subject|3|||
44143096|NCT02379728|78932480|FG000|Overall Study|Protocol Violation|0|||
44143097|NCT02379728|78932481|FG001|Overall Study|Protocol Violation|0|||
44143098|NCT02379728|78932482|FG002|Overall Study|Protocol Violation|2|||
44143099|NCT02379728|78932483|FG003|Overall Study|Protocol Violation|0|||
44143100|NCT03463993|78932494|FG000|Overall Study|Lost to Follow-up|7|||
44143101|NCT03463993|78932495|FG001|Overall Study|Lost to Follow-up|8|||
44143102|NCT03463993|78932494|FG000|Overall Study|Withdrawal by Subject|2|||
44143103|NCT03463993|78932495|FG001|Overall Study|Withdrawal by Subject|0|||
44143104|NCT03463993|78932494|FG000|Overall Study|Protocol Violation|4|||
44143105|NCT03463993|78932495|FG001|Overall Study|Protocol Violation|1|||
44143106|NCT03463993|78932494|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
44143107|NCT03463993|78932495|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
44143108|NCT03463993|78932494|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
44143109|NCT03463993|78932495|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
44143110|NCT02412488|78932510|FG000|Overall Study|Lost to Follow-up|10|||
44143111|NCT02412488|78932510|FG000|Overall Study|Withdrawal by Subject|5|||
44143112|NCT02412488|78932510|FG000|Overall Study|Physician Decision|1|||
44143113|NCT02412488|78932510|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
44143114|NCT02412488|78932510|FG000|Overall Study|Reveal LINQ explant|1|||
44143115|NCT02378480|78932516|FG000|Overall Study|Physician Decision|1|||
44143116|NCT02378480|78932517|FG001|Overall Study|Physician Decision|1|||
44143117|NCT02378480|78932516|FG000|Overall Study|Death|1|||
44143118|NCT02378480|78932517|FG001|Overall Study|Death|2|||
44143119|NCT02378480|78932516|FG000|Overall Study|Randomized, but Not Treated|6|||
44244241|NCT01454531|79074331|FG000|Overall Study|Withdrawal by Subject|5|||
44244242|NCT01454531|79074331|FG000|Overall Study|Lost to Follow-up|1|||
44244243|NCT01454531|79074331|FG000|Overall Study|Physician Decision|1|||
44244244|NCT01454531|79074331|FG000|Overall Study|Delay in IMP administration|1|||
44244245|NCT01454531|79074331|FG000|Overall Study|Other|1|||
44244246|NCT01454063|79074337|FG000|Randomized|Adverse Event|1|||
44244247|NCT01454063|79074338|FG001|Randomized|Adverse Event|1|||
44244248|NCT01454063|79074337|FG000|Randomized|Protocol Violation|0|||
44244249|NCT01454063|79074338|FG001|Randomized|Protocol Violation|1|||
44244250|NCT01453595|79074347|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
44244251|NCT01453595|79074348|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44244252|NCT01453595|79074349|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
44244253|NCT01453439|79074357|FG000|Treatment Phase|Withdrawal by Subject|13|||
44244254|NCT01453439|79074358|FG001|Treatment Phase|Withdrawal by Subject|10|||
44244255|NCT01453439|79074357|FG000|Treatment Phase|Suicidal Ideation|2|||
44381263|NCT03443687|79387263|FG000|Overall Study|Withdrawal by Subject|1|||
44381264|NCT03443687|79387264|FG001|Overall Study|Withdrawal by Subject|0|||
44381265|NCT03443687|79387263|FG000|Overall Study|Discontinued intervention|1|||
44143120|NCT02378480|78932517|FG001|Overall Study|Randomized, but Not Treated|4|||
44143121|NCT02378480|78932516|FG000|Overall Study|Adverse Event|0|||
44143122|NCT02378480|78932517|FG001|Overall Study|Adverse Event|1|||
44143123|NCT02378480|78932516|FG000|Overall Study|Missed EOT/PTE Visit|1|||
44143124|NCT02378480|78932517|FG001|Overall Study|Missed EOT/PTE Visit|2|||
44244256|NCT01453439|79074358|FG001|Treatment Phase|Suicidal Ideation|0|||
44244257|NCT01453439|79074357|FG000|Treatment Phase|Need for higher level of care|1|||
44244258|NCT01453439|79074358|FG001|Treatment Phase|Need for higher level of care|1|||
44381266|NCT03443687|79387264|FG001|Overall Study|Discontinued intervention|1|||
44381267|NCT03384654|79387274|FG000|Overall Study|Withdrawal by Subject|0|||
44143125|NCT02378480|78932516|FG000|Overall Study|Withdrawal by Subject|9|||
44143126|NCT02378480|78932517|FG001|Overall Study|Withdrawal by Subject|4|||
44143127|NCT02378480|78932516|FG000|Overall Study|Lost to Follow-up|10|||
44143128|NCT02378480|78932517|FG001|Overall Study|Lost to Follow-up|18|||
44143129|NCT02411396|78932523|FG000|Overall Study|Lost to Follow-up|31|||
44143130|NCT02411396|78932523|FG000|Overall Study|Death|10|||
44143131|NCT02345252|78932544|FG000|Double-Blind Phase|Adverse Event|2|||
44143132|NCT02345252|78932545|FG001|Double-Blind Phase|Adverse Event|3|||
44143133|NCT02345252|78932544|FG000|Double-Blind Phase|Death|1|||
44143134|NCT02345252|78932545|FG001|Double-Blind Phase|Death|2|||
44143135|NCT02345252|78932544|FG000|Double-Blind Phase|Lack of Efficacy|1|||
44143136|NCT02345252|78932545|FG001|Double-Blind Phase|Lack of Efficacy|0|||
44143137|NCT02345252|78932544|FG000|Double-Blind Phase|Investigator's Discretion|4|||
44143138|NCT02345252|78932545|FG001|Double-Blind Phase|Investigator's Discretion|6|||
44143139|NCT02345252|78932544|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
44143140|NCT02345252|78932545|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
44143141|NCT02345252|78932544|FG000|Double-Blind Phase|Protocol Violation|2|||
44143142|NCT02345252|78932545|FG001|Double-Blind Phase|Protocol Violation|1|||
44143143|NCT02345252|78932544|FG000|Double-Blind Phase|Withdrew Consent|21|||
44143144|NCT02345252|78932545|FG001|Double-Blind Phase|Withdrew Consent|23|||
44143145|NCT02345252|78932544|FG000|Double-Blind Phase|Lost to Follow-up|8|||
44143146|NCT02345252|78932545|FG001|Double-Blind Phase|Lost to Follow-up|10|||
44143147|NCT02345252|78932544|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
44143148|NCT02345252|78932545|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
44143149|NCT01239797|78932555|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
44143150|NCT01239797|78932556|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
44143151|NCT01239797|78932555|FG000|Randomized Participants|Participant withdrew consent|1|||
44143152|NCT01239797|78932556|FG001|Randomized Participants|Participant withdrew consent|7|||
44143153|NCT01239797|78932555|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
44143154|NCT01239797|78932556|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
44143155|NCT01239797|78932555|FG000|Treated Participants|Disease progression|185|||
44143156|NCT01239797|78932556|FG001|Treated Participants|Disease progression|185|||
44143157|NCT01239797|78932555|FG000|Treated Participants|Study drug toxicity|39|||
44143158|NCT01239797|78932556|FG001|Treated Participants|Study drug toxicity|45|||
44143159|NCT01239797|78932555|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
44143160|NCT01239797|78932556|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
44143161|NCT01239797|78932555|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
44143162|NCT01239797|78932556|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
44143163|NCT01239797|78932555|FG000|Treated Participants|Administrative reason by sponsor|13|||
44143164|NCT01239797|78932556|FG001|Treated Participants|Administrative reason by sponsor|4|||
44381268|NCT03384654|79387275|FG001|Overall Study|Withdrawal by Subject|0|||
44381269|NCT03384654|79387276|FG002|Overall Study|Withdrawal by Subject|1|||
44381270|NCT03384654|79387277|FG003|Overall Study|Withdrawal by Subject|0|||
44381271|NCT03085485|79387305|FG000|Overall Study|Death|1|||
44244259|NCT01453439|79074357|FG000|Treatment Phase|Therapist conflict of interest|1|||
44244260|NCT01453439|79074358|FG001|Treatment Phase|Therapist conflict of interest|0|||
44244261|NCT01453439|79074357|FG000|Follow-up|Withdrawal by Subject|0|||
44143165|NCT01239797|78932555|FG000|Treated Participants|Other reasons|14|||
44143166|NCT01239797|78932556|FG001|Treated Participants|Other reasons|14|||
44143167|NCT01239797|78932555|FG000|Treated Participants|Participant withdrew consent|6|||
44244262|NCT01453439|79074358|FG001|Follow-up|Withdrawal by Subject|1|||
44143168|NCT01239797|78932556|FG001|Treated Participants|Participant withdrew consent|11|||
44143169|NCT01239797|78932555|FG000|Treated Participants|Death|1|||
44143170|NCT01239797|78932556|FG001|Treated Participants|Death|1|||
44143171|NCT01239797|78932555|FG000|Treated Participants|Participant no longer meets study criteria|1|||
44143172|NCT01239797|78932556|FG001|Treated Participants|Participant no longer meets study criteria|1|||
44143173|NCT01239797|78932555|FG000|Treated Participants|Poor/non-compliance|0|||
44143174|NCT01239797|78932556|FG001|Treated Participants|Poor/non-compliance|1|||
44143175|NCT01092143|78932567|FG000|Overall Study|Adverse Event|10|||
44143176|NCT01092143|78932568|FG001|Overall Study|Adverse Event|5|||
44143177|NCT01092143|78932569|FG002|Overall Study|Adverse Event|1|||
44143178|NCT01092143|78932570|FG003|Overall Study|Adverse Event|4|||
44143179|NCT01092143|78932571|FG004|Overall Study|Adverse Event|3|||
44143180|NCT01092143|78932567|FG000|Overall Study|Lost to Follow-up|1|||
44143181|NCT01092143|78932568|FG001|Overall Study|Lost to Follow-up|0|||
44143182|NCT01092143|78932569|FG002|Overall Study|Lost to Follow-up|1|||
44143183|NCT01092143|78932570|FG003|Overall Study|Lost to Follow-up|0|||
44143184|NCT01092143|78932571|FG004|Overall Study|Lost to Follow-up|0|||
44143185|NCT01092143|78932567|FG000|Overall Study|Consent withdrawn|2|||
44143186|NCT01092143|78932568|FG001|Overall Study|Consent withdrawn|1|||
44143187|NCT01092143|78932569|FG002|Overall Study|Consent withdrawn|0|||
44143188|NCT01092143|78932570|FG003|Overall Study|Consent withdrawn|1|||
44143189|NCT01092143|78932571|FG004|Overall Study|Consent withdrawn|3|||
44143190|NCT01092143|78932567|FG000|Overall Study|Not treated|0|||
44143191|NCT01092143|78932568|FG001|Overall Study|Not treated|0|||
44143192|NCT01092143|78932569|FG002|Overall Study|Not treated|1|||
44143193|NCT01092143|78932570|FG003|Overall Study|Not treated|0|||
44143194|NCT01092143|78932571|FG004|Overall Study|Not treated|0|||
44143195|NCT01092143|78932567|FG000|Overall Study|did not reversibility criteria|0|||
44143196|NCT01092143|78932568|FG001|Overall Study|did not reversibility criteria|0|||
44143197|NCT01092143|78932569|FG002|Overall Study|did not reversibility criteria|1|||
44143198|NCT01092143|78932570|FG003|Overall Study|did not reversibility criteria|0|||
44143199|NCT01092143|78932571|FG004|Overall Study|did not reversibility criteria|0|||
44143200|NCT01092143|78932567|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
44143201|NCT01092143|78932568|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
44143202|NCT01092143|78932569|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
44143203|NCT01092143|78932570|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
44143204|NCT01092143|78932571|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
44143205|NCT01092143|78932567|FG000|Overall Study|Ineligible patient|1|||
44143206|NCT01092143|78932568|FG001|Overall Study|Ineligible patient|0|||
44143207|NCT01092143|78932569|FG002|Overall Study|Ineligible patient|0|||
44143208|NCT01092143|78932570|FG003|Overall Study|Ineligible patient|0|||
44143209|NCT01092143|78932571|FG004|Overall Study|Ineligible patient|0|||
44143210|NCT01092143|78932567|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
44143211|NCT01092143|78932568|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
44143212|NCT01092143|78932569|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
44143213|NCT01092143|78932570|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
44143214|NCT01092143|78932571|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
44143215|NCT01092143|78932567|FG000|Overall Study|Patient travel|0|||
44143216|NCT01092143|78932568|FG001|Overall Study|Patient travel|0|||
44143217|NCT01092143|78932569|FG002|Overall Study|Patient travel|0|||
44143218|NCT01092143|78932570|FG003|Overall Study|Patient travel|0|||
44143219|NCT01092143|78932571|FG004|Overall Study|Patient travel|1|||
44143220|NCT01092143|78932567|FG000|Overall Study|Non compliance with study medication|0|||
44143221|NCT01092143|78932568|FG001|Overall Study|Non compliance with study medication|0|||
44143222|NCT01092143|78932569|FG002|Overall Study|Non compliance with study medication|0|||
44143223|NCT01092143|78932570|FG003|Overall Study|Non compliance with study medication|0|||
44143224|NCT01092143|78932571|FG004|Overall Study|Non compliance with study medication|1|||
44143225|NCT01092143|78932567|FG000|Overall Study|Randomized by mistake|0|||
44143226|NCT01092143|78932568|FG001|Overall Study|Randomized by mistake|0|||
44143227|NCT01092143|78932569|FG002|Overall Study|Randomized by mistake|0|||
44143228|NCT01092143|78932570|FG003|Overall Study|Randomized by mistake|1|||
44143229|NCT01092143|78932571|FG004|Overall Study|Randomized by mistake|0|||
44143230|NCT01092143|78932567|FG000|Overall Study|Pregnancy|0|||
44143231|NCT01092143|78932568|FG001|Overall Study|Pregnancy|0|||
44143232|NCT01092143|78932569|FG002|Overall Study|Pregnancy|0|||
44143233|NCT01092143|78932570|FG003|Overall Study|Pregnancy|1|||
44143234|NCT01092143|78932571|FG004|Overall Study|Pregnancy|0|||
44143235|NCT02377466|78932585|FG000|Overall Study|Other: Randomized and not treated|0|||
44143236|NCT02377466|78932586|FG001|Overall Study|Other: Randomized and not treated|2|||
44381272|NCT03085485|79387306|FG001|Overall Study|Death|0|||
44143237|NCT00950989|78932603|FG000|Overall Study|Death|0|||
44143238|NCT00950989|78932604|FG001|Overall Study|Death|0|||
44143239|NCT00950989|78932605|FG002|Overall Study|Death|1|||
44143240|NCT00950989|78932606|FG003|Overall Study|Death|0|||
44143241|NCT00950989|78932603|FG000|Overall Study|Administrative Decision|0|||
44143242|NCT00950989|78932604|FG001|Overall Study|Administrative Decision|1|||
44143243|NCT00950989|78932605|FG002|Overall Study|Administrative Decision|0|||
44143244|NCT00950989|78932606|FG003|Overall Study|Administrative Decision|0|||
44143245|NCT00950989|78932603|FG000|Overall Study|Disease Progression|0|||
44143246|NCT00950989|78932604|FG001|Overall Study|Disease Progression|0|||
44143247|NCT00950989|78932605|FG002|Overall Study|Disease Progression|1|||
44143248|NCT00950989|78932606|FG003|Overall Study|Disease Progression|0|||
44143249|NCT00950989|78932603|FG000|Overall Study|Withdrawal by Subject|2|||
44143250|NCT00950989|78932604|FG001|Overall Study|Withdrawal by Subject|1|||
44143251|NCT00950989|78932605|FG002|Overall Study|Withdrawal by Subject|0|||
44143252|NCT00950989|78932606|FG003|Overall Study|Withdrawal by Subject|0|||
44143253|NCT00950989|78932603|FG000|Overall Study|Adverse Event|2|||
44143254|NCT00950989|78932604|FG001|Overall Study|Adverse Event|1|||
44143255|NCT00950989|78932605|FG002|Overall Study|Adverse Event|1|||
44143256|NCT00950989|78932606|FG003|Overall Study|Adverse Event|0|||
44244263|NCT01453439|79074357|FG000|Follow-up|Lost to Follow-up|5|||
44244264|NCT01453439|79074358|FG001|Follow-up|Lost to Follow-up|10|||
44244265|NCT01453361|79074364|FG000|Overall Study|Disease Progression|6|||
44244266|NCT01453361|79074364|FG000|Overall Study|Screen-Failures|10|||
44244267|NCT01585298|79074368|FG000|Overall Study|Study completion was not documented.|1|||
44244268|NCT01585298|79074368|FG000|Overall Study|Protocol deviation|1|||
44244269|NCT01585298|79074368|FG000|Overall Study|Administrative problems|4|||
44244270|NCT01585298|79074368|FG000|Overall Study|Lost to Follow-up|2|||
44244271|NCT01585298|79074368|FG000|Overall Study|Withdrawal by Subject|4|||
44244272|NCT01585298|79074368|FG000|Overall Study|Abnormal test procedure results|1|||
44244273|NCT01585298|79074368|FG000|Overall Study|Adverse Event|24|||
44244274|NCT01453205|79074375|FG000|Overall Study|Lost to Follow-up|3|||
44244275|NCT01453205|79074376|FG001|Overall Study|Lost to Follow-up|0|||
44244276|NCT01453205|79074377|FG002|Overall Study|Lost to Follow-up|1|||
44244277|NCT01453205|79074375|FG000|Overall Study|Withdrawal by Subject|8|||
44244278|NCT01453205|79074376|FG001|Overall Study|Withdrawal by Subject|3|||
44244279|NCT01453205|79074377|FG002|Overall Study|Withdrawal by Subject|0|||
44244280|NCT01453205|79074375|FG000|Overall Study|Death|24|||
44244281|NCT01453205|79074376|FG001|Overall Study|Death|22|||
44244282|NCT01453205|79074377|FG002|Overall Study|Death|18|||
44244283|NCT01453205|79074375|FG000|Overall Study|Other|45|||
44244284|NCT01453205|79074376|FG001|Overall Study|Other|27|||
44244285|NCT01453205|79074377|FG002|Overall Study|Other|35|||
44244286|NCT01453049|79074390|FG000|Overall Study|Protocol Violation|2|||
44244287|NCT01453049|79074391|FG001|Overall Study|Protocol Violation|5|||
44244288|NCT01453049|79074390|FG000|Overall Study|Lost to Follow-up|2|||
44143257|NCT00593567|78932621|FG000|Overall Study|Adverse Event|2|||
44244289|NCT01453049|79074391|FG001|Overall Study|Lost to Follow-up|1|||
44244290|NCT01453049|79074390|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
44244291|NCT01453049|79074391|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
44244292|NCT01453049|79074390|FG000|Overall Study|Withdrawal by Subject|1|||
44244293|NCT01453049|79074391|FG001|Overall Study|Withdrawal by Subject|0|||
44244294|NCT01453049|79074390|FG000|Overall Study|Randomized in Error|1|||
44381273|NCT03085485|79387305|FG000|Overall Study|Lost to Follow-up|1|||
44143258|NCT00593567|78932622|FG001|Overall Study|Adverse Event|0|||
44143259|NCT00593567|78932621|FG000|Overall Study|Physician Decision|2|||
44143260|NCT00593567|78932622|FG001|Overall Study|Physician Decision|0|||
44143261|NCT00593567|78932621|FG000|Overall Study|Protocol Violation|13|||
44244295|NCT01453049|79074391|FG001|Overall Study|Randomized in Error|0|||
44244296|NCT01452347|79074399|FG000|Overall Study|Adverse Event|2|||
44244297|NCT01452347|79074400|FG001|Overall Study|Adverse Event|1|||
44244298|NCT01452347|79074399|FG000|Overall Study|Non compliance protocol|2|||
44244299|NCT01452347|79074400|FG001|Overall Study|Non compliance protocol|0|||
44244300|NCT01452347|79074399|FG000|Overall Study|Lost to Follow-up|2|||
44244301|NCT01452347|79074400|FG001|Overall Study|Lost to Follow-up|0|||
44244302|NCT01452347|79074399|FG000|Overall Study|Withdrawal by Subject|3|||
44244303|NCT01452347|79074400|FG001|Overall Study|Withdrawal by Subject|3|||
44143262|NCT00593567|78932622|FG001|Overall Study|Protocol Violation|7|||
44143263|NCT00593567|78932621|FG000|Overall Study|Lack of Efficacy|2|||
44143264|NCT00593567|78932622|FG001|Overall Study|Lack of Efficacy|1|||
44143265|NCT00593567|78932621|FG000|Overall Study|Withdrawal by Subject|1|||
44143266|NCT00593567|78932622|FG001|Overall Study|Withdrawal by Subject|2|||
44143267|NCT02411084|78932630|FG000|Overall Study|Lack of Efficacy|6|||
44143268|NCT02411084|78932631|FG001|Overall Study|Lack of Efficacy|3|||
44143269|NCT02411084|78932630|FG000|Overall Study|Death|5|||
44143270|NCT02411084|78932631|FG001|Overall Study|Death|4|||
44143271|NCT02411084|78932630|FG000|Overall Study|Adverse Event|2|||
44143272|NCT02411084|78932631|FG001|Overall Study|Adverse Event|1|||
44143273|NCT02411084|78932630|FG000|Overall Study|Other reasons|0|||
44143274|NCT02411084|78932631|FG001|Overall Study|Other reasons|5|||
44143275|NCT01602315|78932644|FG000|Overall Study|Protocol Violation|0|||
44143276|NCT01602315|78932645|FG001|Overall Study|Protocol Violation|0|||
44143277|NCT01602315|78932646|FG002|Overall Study|Protocol Violation|0|||
44143278|NCT01602315|78932647|FG003|Overall Study|Protocol Violation|0|||
44143279|NCT01602315|78932648|FG004|Overall Study|Protocol Violation|0|||
44143280|NCT01602315|78932649|FG005|Overall Study|Protocol Violation|1|||
44143281|NCT01602315|78932650|FG006|Overall Study|Protocol Violation|0|||
44143282|NCT01602315|78932644|FG000|Overall Study|Physician Decision|2|||
44143283|NCT01602315|78932645|FG001|Overall Study|Physician Decision|0|||
44143284|NCT01602315|78932646|FG002|Overall Study|Physician Decision|0|||
44143285|NCT01602315|78932647|FG003|Overall Study|Physician Decision|0|||
44143286|NCT01602315|78932648|FG004|Overall Study|Physician Decision|2|||
44143287|NCT01602315|78932649|FG005|Overall Study|Physician Decision|1|||
44143288|NCT01602315|78932650|FG006|Overall Study|Physician Decision|1|||
44143289|NCT01602315|78932644|FG000|Overall Study|Disease progression|6|||
44143290|NCT01602315|78932645|FG001|Overall Study|Disease progression|3|||
44143291|NCT01602315|78932646|FG002|Overall Study|Disease progression|10|||
44143292|NCT01602315|78932647|FG003|Overall Study|Disease progression|1|||
44143293|NCT01602315|78932648|FG004|Overall Study|Disease progression|41|||
44143294|NCT01602315|78932649|FG005|Overall Study|Disease progression|12|||
44143295|NCT01602315|78932650|FG006|Overall Study|Disease progression|15|||
44143296|NCT01602315|78932644|FG000|Overall Study|Death|1|||
44143297|NCT01602315|78932645|FG001|Overall Study|Death|1|||
44143298|NCT01602315|78932646|FG002|Overall Study|Death|1|||
44143299|NCT01602315|78932647|FG003|Overall Study|Death|1|||
44143300|NCT01602315|78932648|FG004|Overall Study|Death|7|||
44143301|NCT01602315|78932649|FG005|Overall Study|Death|2|||
44143302|NCT01602315|78932650|FG006|Overall Study|Death|2|||
44143303|NCT01602315|78932644|FG000|Overall Study|Withdrawal by Subject|2|||
44143304|NCT01602315|78932645|FG001|Overall Study|Withdrawal by Subject|0|||
44143305|NCT01602315|78932646|FG002|Overall Study|Withdrawal by Subject|2|||
44143306|NCT01602315|78932647|FG003|Overall Study|Withdrawal by Subject|0|||
44143307|NCT01602315|78932648|FG004|Overall Study|Withdrawal by Subject|6|||
44244304|NCT01452347|79074399|FG000|Overall Study|Not treated|6|||
44244305|NCT01452347|79074400|FG001|Overall Study|Not treated|3|||
44244306|NCT01452347|79074399|FG000|Overall Study|Other reason not defined above|2|||
44244307|NCT01452347|79074400|FG001|Overall Study|Other reason not defined above|0|||
44244308|NCT01451723|79074410|FG000|Overall Study|study halted|6|||
44244309|NCT01451723|79074411|FG001|Overall Study|study halted|5|||
44244310|NCT01451645|79074419|FG000|Overall Study|Protocol Violation|1|||
44244311|NCT01451645|79074420|FG001|Overall Study|Protocol Violation|0|||
44244312|NCT01451645|79074419|FG000|Overall Study|Adverse Event|0|||
44244313|NCT01451645|79074420|FG001|Overall Study|Adverse Event|3|||
44244314|NCT01451645|79074419|FG000|Overall Study|Withdrawal by Subject|4|||
44244315|NCT01451645|79074420|FG001|Overall Study|Withdrawal by Subject|2|||
44244316|NCT01451645|79074419|FG000|Overall Study|Lost to Follow-up|4|||
44244317|NCT01451645|79074420|FG001|Overall Study|Lost to Follow-up|3|||
44244318|NCT01450943|79074429|FG000|Overall Study|Screen failure, loss to follow-up|2|||
44244319|NCT01450943|79074430|FG001|Overall Study|Screen failure, loss to follow-up|7|||
44244320|NCT01450943|79074431|FG002|Overall Study|Screen failure, loss to follow-up|6|||
44244321|NCT01450631|79074445|FG000|Overall Study|Lost to Follow-up|2|||
44381274|NCT03085485|79387306|FG001|Overall Study|Lost to Follow-up|0|||
44381275|NCT03043872|79387324|FG000|Overall Study|Withdrawal by Subject|6|||
44143308|NCT01602315|78932649|FG005|Overall Study|Withdrawal by Subject|0|||
44143309|NCT01602315|78932650|FG006|Overall Study|Withdrawal by Subject|1|||
44143310|NCT01602315|78932644|FG000|Overall Study|Adverse Event|5|||
44143311|NCT01602315|78932645|FG001|Overall Study|Adverse Event|1|||
44143312|NCT01602315|78932646|FG002|Overall Study|Adverse Event|5|||
44143313|NCT01602315|78932647|FG003|Overall Study|Adverse Event|4|||
44143314|NCT01602315|78932648|FG004|Overall Study|Adverse Event|15|||
44244322|NCT01450631|79074446|FG001|Overall Study|Lost to Follow-up|4|||
44244323|NCT01450631|79074445|FG000|Overall Study|Withdrawal by Subject|1|||
44244324|NCT01450631|79074446|FG001|Overall Study|Withdrawal by Subject|0|||
44244325|NCT01450007|79074455|FG000|Overall Study|Late exclusion before treatment|2|||
44381276|NCT03043872|79387325|FG001|Overall Study|Withdrawal by Subject|6|||
44143315|NCT01602315|78932649|FG005|Overall Study|Adverse Event|3|||
44143316|NCT01602315|78932650|FG006|Overall Study|Adverse Event|9|||
44143317|NCT01602315|78932644|FG000|Overall Study|Subject/guardian decision|0|||
44244326|NCT01450007|79074456|FG001|Overall Study|Late exclusion before treatment|3|||
44244327|NCT01450007|79074457|FG002|Overall Study|Late exclusion before treatment|2|||
44244328|NCT01450007|79074455|FG000|Overall Study|Protocol Violation|0|||
44244329|NCT01450007|79074456|FG001|Overall Study|Protocol Violation|1|||
44244330|NCT01450007|79074457|FG002|Overall Study|Protocol Violation|1|||
44244331|NCT01450007|79074455|FG000|Overall Study|Adverse Event|0|||
44244332|NCT01450007|79074456|FG001|Overall Study|Adverse Event|1|||
44244333|NCT01450007|79074457|FG002|Overall Study|Adverse Event|0|||
44244334|NCT01496365|79074472|FG000|Overall Study|Adverse Event|2|||
44244335|NCT01496365|79074473|FG001|Overall Study|Adverse Event|3|||
44244336|NCT01496365|79074474|FG002|Overall Study|Adverse Event|3|||
44244337|NCT01496365|79074475|FG003|Overall Study|Adverse Event|2|||
44244338|NCT01496365|79074476|FG004|Overall Study|Adverse Event|5|||
44244339|NCT01496365|79074477|FG005|Overall Study|Adverse Event|6|||
44244340|NCT01496365|79074478|FG006|Overall Study|Adverse Event|4|||
44244341|NCT01496365|79074472|FG000|Overall Study|Withdrawal by Subject|6|||
44244342|NCT01496365|79074473|FG001|Overall Study|Withdrawal by Subject|6|||
44244343|NCT01496365|79074474|FG002|Overall Study|Withdrawal by Subject|0|||
44244344|NCT01496365|79074475|FG003|Overall Study|Withdrawal by Subject|1|||
44244345|NCT01496365|79074476|FG004|Overall Study|Withdrawal by Subject|3|||
44244346|NCT01496365|79074477|FG005|Overall Study|Withdrawal by Subject|2|||
44244347|NCT01496365|79074478|FG006|Overall Study|Withdrawal by Subject|1|||
44244348|NCT01496365|79074472|FG000|Overall Study|Protocol Violation|2|||
44244349|NCT01496365|79074473|FG001|Overall Study|Protocol Violation|1|||
44244350|NCT01496365|79074474|FG002|Overall Study|Protocol Violation|1|||
44244351|NCT01496365|79074475|FG003|Overall Study|Protocol Violation|0|||
44244352|NCT01496365|79074476|FG004|Overall Study|Protocol Violation|0|||
44244353|NCT01496365|79074477|FG005|Overall Study|Protocol Violation|1|||
44244354|NCT01496365|79074478|FG006|Overall Study|Protocol Violation|0|||
44244355|NCT01496365|79074472|FG000|Overall Study|Lack of Efficacy|1|||
44244356|NCT01496365|79074473|FG001|Overall Study|Lack of Efficacy|0|||
44244357|NCT01496365|79074474|FG002|Overall Study|Lack of Efficacy|0|||
44244358|NCT01496365|79074475|FG003|Overall Study|Lack of Efficacy|0|||
44244359|NCT01496365|79074476|FG004|Overall Study|Lack of Efficacy|0|||
44244360|NCT01496365|79074477|FG005|Overall Study|Lack of Efficacy|1|||
44244361|NCT01496365|79074478|FG006|Overall Study|Lack of Efficacy|0|||
44244362|NCT01496365|79074472|FG000|Overall Study|Lost to Follow-up|0|||
44244363|NCT01496365|79074473|FG001|Overall Study|Lost to Follow-up|1|||
44244364|NCT01496365|79074474|FG002|Overall Study|Lost to Follow-up|0|||
44244365|NCT01496365|79074475|FG003|Overall Study|Lost to Follow-up|0|||
44244366|NCT01496365|79074476|FG004|Overall Study|Lost to Follow-up|2|||
44244367|NCT01496365|79074477|FG005|Overall Study|Lost to Follow-up|0|||
44244368|NCT01496365|79074478|FG006|Overall Study|Lost to Follow-up|0|||
44244369|NCT01496365|79074472|FG000|Overall Study|Other|4|||
44244370|NCT01496365|79074473|FG001|Overall Study|Other|4|||
44244371|NCT01496365|79074474|FG002|Overall Study|Other|2|||
44244372|NCT01496365|79074475|FG003|Overall Study|Other|1|||
44244373|NCT01496365|79074476|FG004|Overall Study|Other|3|||
44244374|NCT01496365|79074477|FG005|Overall Study|Other|0|||
44244375|NCT01496365|79074478|FG006|Overall Study|Other|1|||
44244376|NCT01496287|79074494|FG000|Overall Study|Lost to Follow-up|1|||
44244377|NCT01496287|79074494|FG000|Overall Study|Incomplete anesthesia|5|||
44381277|NCT03043872|79387326|FG002|Overall Study|Withdrawal by Subject|15|||
44143318|NCT01602315|78932645|FG001|Overall Study|Subject/guardian decision|0|||
44244378|NCT01495975|79074501|FG000|Overall Study|Lost to Follow-up|1|||
44244379|NCT01495975|79074502|FG001|Overall Study|Lost to Follow-up|0|||
44244380|NCT01468987|79074510|FG000|Overall Study|Adverse Event|12|||
44244381|NCT01468987|79074511|FG001|Overall Study|Adverse Event|9|||
44244382|NCT01468987|79074510|FG000|Overall Study|Death|4|||
44244383|NCT01468987|79074511|FG001|Overall Study|Death|1|||
44244384|NCT01468987|79074510|FG000|Overall Study|Lost to Follow-up|10|||
44244385|NCT01468987|79074511|FG001|Overall Study|Lost to Follow-up|5|||
44244386|NCT01468987|79074510|FG000|Overall Study|Protocol Violation|8|||
44244387|NCT01468987|79074511|FG001|Overall Study|Protocol Violation|2|||
44244388|NCT01468987|79074510|FG000|Overall Study|Withdrawal by Subject|28|||
44244389|NCT01468987|79074511|FG001|Overall Study|Withdrawal by Subject|28|||
44244390|NCT01468987|79074510|FG000|Overall Study|Physician Decision|8|||
44244391|NCT01468987|79074511|FG001|Overall Study|Physician Decision|15|||
44514116|NCT02759185|79519463|FG003|Stage 1|Withdrawal by Subject|0|||
44244392|NCT01468987|79074510|FG000|Overall Study|Sponsor Decision|1|||
44244393|NCT01468987|79074511|FG001|Overall Study|Sponsor Decision|0|||
44244394|NCT01687712|79074521|FG000|Cycle 1|Not Biochemically Pregnant|386|||
44244395|NCT01687712|79074522|FG001|Cycle 1|Not Biochemically Pregnant|348|||
44244396|NCT01687712|79074521|FG000|Cycle 1|Early Pregnancy Loss|43|||
44244397|NCT01687712|79074522|FG001|Cycle 1|Early Pregnancy Loss|60|||
44244398|NCT01687712|79074521|FG000|Cycle 1|Ectopic Pregnancy|5|||
44244399|NCT01687712|79074522|FG001|Cycle 1|Ectopic Pregnancy|5|||
44244400|NCT01687712|79074521|FG000|Cycle 1|Heterotropic Pregnancy|1|||
44244401|NCT01687712|79074522|FG001|Cycle 1|Heterotropic Pregnancy|0|||
44244402|NCT01687712|79074521|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
44381278|NCT03043872|79387324|FG000|Overall Study|Lost to Follow-up|2|||
44244403|NCT01687712|79074522|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
44244404|NCT01687712|79074521|FG000|Cycle 1|Abortion|3|||
44244405|NCT01687712|79074522|FG001|Cycle 1|Abortion|0|||
44244406|NCT01687712|79074521|FG000|Cycle 1|Intrauterine Fetal Death|0|||
44244407|NCT01687712|79074522|FG001|Cycle 1|Intrauterine Fetal Death|1|||
44244408|NCT01687712|79074521|FG000|Cycle 1|Lost to Follow-up|1|||
44244409|NCT01687712|79074522|FG001|Cycle 1|Lost to Follow-up|1|||
44244410|NCT01687712|79074521|FG000|Cycle 2|Not Biochemically Pregnant|74|||
44244411|NCT01687712|79074522|FG001|Cycle 2|Not Biochemically Pregnant|77|||
44244412|NCT01687712|79074521|FG000|Cycle 2|Early Pregnancy Loss|18|||
44244413|NCT01687712|79074522|FG001|Cycle 2|Early Pregnancy Loss|16|||
44244414|NCT01687712|79074521|FG000|Cycle 2|Ectopic Pregnancy|0|||
44244415|NCT01687712|79074522|FG001|Cycle 2|Ectopic Pregnancy|1|||
44244416|NCT01687712|79074521|FG000|Cycle 2|Still Birth|1|||
44244417|NCT01687712|79074522|FG001|Cycle 2|Still Birth|0|||
44244418|NCT01687712|79074521|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
44244419|NCT01687712|79074522|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
44244420|NCT01687712|79074521|FG000|Cycle 3|Not Biochemically Pregnant|21|||
44244421|NCT01687712|79074522|FG001|Cycle 3|Not Biochemically Pregnant|22|||
44244422|NCT01687712|79074521|FG000|Cycle 3|Early Pregnancy Loss|1|||
44244423|NCT01687712|79074522|FG001|Cycle 3|Early Pregnancy Loss|2|||
44244424|NCT01687712|79074521|FG000|Cycle 3|Ectopic Pregnancy|1|||
44244425|NCT01687712|79074522|FG001|Cycle 3|Ectopic Pregnancy|0|||
44244426|NCT01687712|79074521|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
44244427|NCT01687712|79074522|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
44244428|NCT01603628|79074535|FG000|Overall Study|Personal Reasons|1|||
44244429|NCT01603628|79074536|FG001|Overall Study|Personal Reasons|1|||
44244430|NCT01603628|79074537|FG002|Overall Study|Personal Reasons|2|||
44244431|NCT01603628|79074535|FG000|Overall Study|Protocol Violation|1|||
44244432|NCT01603628|79074536|FG001|Overall Study|Protocol Violation|1|||
44244433|NCT01603628|79074537|FG002|Overall Study|Protocol Violation|0|||
44244434|NCT01603628|79074535|FG000|Overall Study|Lost to Follow-up|0|||
44244435|NCT01603628|79074536|FG001|Overall Study|Lost to Follow-up|1|||
44244436|NCT01603628|79074537|FG002|Overall Study|Lost to Follow-up|0|||
44244437|NCT01603628|79074535|FG000|Overall Study|Other Miscellaneous Reason|1|||
44244438|NCT01603628|79074536|FG001|Overall Study|Other Miscellaneous Reason|0|||
44244439|NCT01603628|79074537|FG002|Overall Study|Other Miscellaneous Reason|0|||
44244440|NCT01453153|79074548|FG000|Overall Study|Physician Decision|0|||
44244441|NCT01453153|79074549|FG001|Overall Study|Physician Decision|0|||
44244442|NCT01453153|79074550|FG002|Overall Study|Physician Decision|1|||
44244443|NCT01453153|79074548|FG000|Overall Study|Progressive Disease|3|||
44244444|NCT01453153|79074549|FG001|Overall Study|Progressive Disease|2|||
44244445|NCT01453153|79074550|FG002|Overall Study|Progressive Disease|16|||
44244446|NCT01453153|79074548|FG000|Overall Study|Withdrawal by Subject|0|||
44244447|NCT01453153|79074549|FG001|Overall Study|Withdrawal by Subject|1|||
44244448|NCT01453153|79074550|FG002|Overall Study|Withdrawal by Subject|2|||
44244449|NCT01453153|79074548|FG000|Overall Study|Adverse Event|1|||
44244450|NCT01453153|79074549|FG001|Overall Study|Adverse Event|1|||
44244451|NCT01453153|79074550|FG002|Overall Study|Adverse Event|1|||
44244452|NCT01584440|79074564|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
44244453|NCT01584440|79074565|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
44244454|NCT01584440|79074566|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
44244455|NCT01584440|79074567|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
44244456|NCT01584440|79074568|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
44244457|NCT01584440|79074564|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
44244458|NCT01584440|79074565|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
44244459|NCT01584440|79074566|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
44244460|NCT01584440|79074567|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
44244461|NCT01584440|79074568|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
44276730|NCT03234907|79237689|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
44276731|NCT03234907|79237690|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
44276732|NCT03234907|79237691|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
44244462|NCT01584440|79074564|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
44244463|NCT01584440|79074565|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
44244464|NCT01584440|79074566|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
44276733|NCT03234907|79237692|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
44381279|NCT03043872|79387325|FG001|Overall Study|Lost to Follow-up|1|||
44244465|NCT01584440|79074567|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
44244466|NCT01584440|79074568|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
44244467|NCT01584440|79074564|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
44244468|NCT01584440|79074565|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
44244469|NCT01584440|79074566|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
44244470|NCT01584440|79074567|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
44244471|NCT01584440|79074568|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
44244472|NCT01584440|79074564|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
44244473|NCT01584440|79074565|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
44244474|NCT01584440|79074566|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
44244475|NCT01584440|79074567|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
44244476|NCT01584440|79074568|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
44244477|NCT01584440|79074564|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
44244478|NCT01584440|79074565|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
44244479|NCT01584440|79074566|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
44244480|NCT01584440|79074567|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
44244481|NCT01584440|79074568|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
44244482|NCT01584440|79074564|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
44244483|NCT01584440|79074565|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
44244484|NCT01584440|79074566|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
44244485|NCT01584440|79074567|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
44244486|NCT01584440|79074568|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
44244487|NCT01584440|79074564|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
44244488|NCT01584440|79074565|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
44244489|NCT01584440|79074566|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
44244490|NCT01584440|79074567|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
44244491|NCT01584440|79074568|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
44244492|NCT01584440|79074564|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
44244493|NCT01584440|79074565|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
44244494|NCT01584440|79074566|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
44244495|NCT01584440|79074567|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
44244496|NCT01584440|79074568|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
44244497|NCT01687478|79074583|FG000|Overall Study|Adverse Event|3|||
44244498|NCT01687478|79074584|FG001|Overall Study|Adverse Event|10|||
44244499|NCT01687478|79074583|FG000|Overall Study|Lost to Follow-up|1|||
44244500|NCT01687478|79074584|FG001|Overall Study|Lost to Follow-up|3|||
44244501|NCT01687478|79074583|FG000|Overall Study|Protocol Violation|0|||
44244502|NCT01687478|79074584|FG001|Overall Study|Protocol Violation|2|||
44244503|NCT01687478|79074583|FG000|Overall Study|Withdrawal by Subject|21|||
44244504|NCT01687478|79074584|FG001|Overall Study|Withdrawal by Subject|19|||
44244505|NCT01687478|79074583|FG000|Overall Study|Physician Decision|1|||
44244506|NCT01687478|79074584|FG001|Overall Study|Physician Decision|3|||
44244507|NCT01687478|79074583|FG000|Overall Study|Entry Criteria Not Met|6|||
44244508|NCT01687478|79074584|FG001|Overall Study|Entry Criteria Not Met|2|||
44244509|NCT01468909|79074592|FG000|Overall Study|Never Treated|2|||
44244510|NCT01468909|79074593|FG001|Overall Study|Never Treated|2|||
44244511|NCT01468597|79074599|FG000|Overall Study|Found ineligible|17|||
44244512|NCT01468597|79074599|FG000|Overall Study|concomitant valves|12|||
44244513|NCT01468597|79074599|FG000|Overall Study|off-pump CABG|1|||
44244514|NCT01468597|79074599|FG000|Overall Study|no platelet function data|5|||
44244515|NCT01687166|79074607|FG000|Overall Study|Attempt subject|2|||
44244516|NCT01687166|79074608|FG001|Overall Study|Attempt subject|3|||
44244517|NCT01687166|79074609|FG002|Overall Study|Attempt subject|2|||
44244518|NCT01687166|79074610|FG003|Overall Study|Attempt subject|0|||
44244519|NCT01687166|79074607|FG000|Overall Study|Did not meet eligibility criteria|4|||
44244520|NCT01687166|79074608|FG001|Overall Study|Did not meet eligibility criteria|6|||
44244521|NCT01687166|79074609|FG002|Overall Study|Did not meet eligibility criteria|1|||
44244522|NCT01687166|79074610|FG003|Overall Study|Did not meet eligibility criteria|1|||
44244523|NCT01687166|79074607|FG000|Overall Study|Adverse Event|2|||
44244524|NCT01687166|79074608|FG001|Overall Study|Adverse Event|1|||
44244525|NCT01687166|79074609|FG002|Overall Study|Adverse Event|0|||
44244526|NCT01687166|79074610|FG003|Overall Study|Adverse Event|0|||
44244527|NCT01687166|79074607|FG000|Overall Study|Physician Decision|3|||
44244528|NCT01687166|79074608|FG001|Overall Study|Physician Decision|2|||
44244529|NCT01687166|79074609|FG002|Overall Study|Physician Decision|1|||
44244530|NCT01687166|79074610|FG003|Overall Study|Physician Decision|0|||
44244531|NCT01687166|79074607|FG000|Overall Study|Withdrawal by Subject|11|||
44244532|NCT01687166|79074608|FG001|Overall Study|Withdrawal by Subject|4|||
44244533|NCT01687166|79074609|FG002|Overall Study|Withdrawal by Subject|3|||
44244534|NCT01687166|79074610|FG003|Overall Study|Withdrawal by Subject|0|||
44244535|NCT01687166|79074607|FG000|Overall Study|Lost to Follow-up|2|||
44244536|NCT01687166|79074608|FG001|Overall Study|Lost to Follow-up|5|||
44244537|NCT01687166|79074609|FG002|Overall Study|Lost to Follow-up|1|||
44244538|NCT01687166|79074610|FG003|Overall Study|Lost to Follow-up|0|||
44244539|NCT01687166|79074607|FG000|Overall Study|Equipment/Device Availability|0|||
44244540|NCT01687166|79074608|FG001|Overall Study|Equipment/Device Availability|1|||
44244541|NCT01687166|79074609|FG002|Overall Study|Equipment/Device Availability|0|||
44244542|NCT01687166|79074610|FG003|Overall Study|Equipment/Device Availability|0|||
44244543|NCT01687166|79074607|FG000|Overall Study|Death|1|||
44244544|NCT01687166|79074608|FG001|Overall Study|Death|1|||
44244545|NCT01687166|79074609|FG002|Overall Study|Death|0|||
44244546|NCT01687166|79074610|FG003|Overall Study|Death|0|||
44244547|NCT01687166|79074607|FG000|Overall Study|Protocol Violation|1|||
44244548|NCT01687166|79074608|FG001|Overall Study|Protocol Violation|1|||
44244549|NCT01687166|79074609|FG002|Overall Study|Protocol Violation|1|||
44244550|NCT01687166|79074610|FG003|Overall Study|Protocol Violation|0|||
44244551|NCT01687166|79074607|FG000|Overall Study|Subject moved out of state|0|||
44381280|NCT03043872|79387326|FG002|Overall Study|Lost to Follow-up|1|||
44244552|NCT01687166|79074608|FG001|Overall Study|Subject moved out of state|1|||
44244553|NCT01687166|79074609|FG002|Overall Study|Subject moved out of state|0|||
44244554|NCT01687166|79074610|FG003|Overall Study|Subject moved out of state|0|||
44244555|NCT01687166|79074607|FG000|Overall Study|Patient unable to be compliant|1|||
44244556|NCT01687166|79074608|FG001|Overall Study|Patient unable to be compliant|0|||
44244557|NCT01687166|79074609|FG002|Overall Study|Patient unable to be compliant|0|||
44244558|NCT01687166|79074610|FG003|Overall Study|Patient unable to be compliant|0|||
44244559|NCT01687166|79074607|FG000|Overall Study|Physician choice to use different device|1|||
44244560|NCT01687166|79074608|FG001|Overall Study|Physician choice to use different device|2|||
44244561|NCT01687166|79074609|FG002|Overall Study|Physician choice to use different device|4|||
44244562|NCT01687166|79074610|FG003|Overall Study|Physician choice to use different device|0|||
44244563|NCT01687166|79074607|FG000|Overall Study|Insurance|0|||
44244564|NCT01687166|79074608|FG001|Overall Study|Insurance|0|||
44244565|NCT01687166|79074609|FG002|Overall Study|Insurance|1|||
44244566|NCT01687166|79074610|FG003|Overall Study|Insurance|1|||
44244567|NCT01561976|79074624|FG000|Period 1|Adverse Event|0|||
44244568|NCT01561976|79074625|FG001|Period 1|Adverse Event|0|||
44244569|NCT01561976|79074626|FG002|Period 1|Adverse Event|1|||
44244570|NCT01561976|79074627|FG003|Period 1|Adverse Event|0|||
44244571|NCT01561976|79074628|FG004|Period 1|Adverse Event|0|||
44244572|NCT01561976|79074629|FG005|Period 1|Adverse Event|0|||
44244573|NCT01561976|79074624|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
44244574|NCT01561976|79074625|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
44244575|NCT01561976|79074626|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
44244576|NCT01561976|79074627|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
44244577|NCT01561976|79074628|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
44244578|NCT01561976|79074629|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
44244579|NCT01561976|79074624|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44244580|NCT01561976|79074625|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44244581|NCT01561976|79074626|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44244582|NCT01561976|79074627|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44244583|NCT01561976|79074628|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44244584|NCT01561976|79074629|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
44244585|NCT01561976|79074624|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
44244586|NCT01561976|79074625|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
44244587|NCT01561976|79074626|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
44244588|NCT01561976|79074627|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
44244589|NCT01561976|79074628|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
44244590|NCT01561976|79074629|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
44244591|NCT01686932|79074639|FG000|Period 1|Adverse Event|1|||
44244592|NCT01686932|79074640|FG001|Period 1|Adverse Event|1|||
44244593|NCT01468207|79074648|FG000|Treatment Period 1|Adverse Event|1|||
44244594|NCT01468207|79074649|FG001|Treatment Period 1|Adverse Event|0|||
44244595|NCT01468207|79074650|FG002|Treatment Period 1|Adverse Event|0|||
44244596|NCT01468207|79074651|FG003|Treatment Period 1|Adverse Event|0|||
44244597|NCT01468207|79074652|FG004|Treatment Period 1|Adverse Event|0|||
44244598|NCT01468207|79074653|FG005|Treatment Period 1|Adverse Event|0|||
44244599|NCT01468207|79074648|FG000|Treatment Period 1|Protocol Violation|1|||
44244600|NCT01468207|79074649|FG001|Treatment Period 1|Protocol Violation|1|||
44244601|NCT01468207|79074650|FG002|Treatment Period 1|Protocol Violation|0|||
44143319|NCT01602315|78932646|FG002|Overall Study|Subject/guardian decision|0|||
44244602|NCT01468207|79074651|FG003|Treatment Period 1|Protocol Violation|0|||
44244603|NCT01468207|79074652|FG004|Treatment Period 1|Protocol Violation|0|||
44244604|NCT01468207|79074653|FG005|Treatment Period 1|Protocol Violation|0|||
44244605|NCT01468207|79074648|FG000|Treatment Period 1|Withdrawal by Subject|5|||
44244606|NCT01468207|79074649|FG001|Treatment Period 1|Withdrawal by Subject|4|||
44244607|NCT01468207|79074650|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44244608|NCT01468207|79074651|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44244609|NCT01468207|79074652|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44244610|NCT01468207|79074653|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44244611|NCT01468207|79074648|FG000|Treatment Period 1|Lost to Follow-up|2|||
44244612|NCT01468207|79074649|FG001|Treatment Period 1|Lost to Follow-up|1|||
44244613|NCT01468207|79074650|FG002|Treatment Period 1|Lost to Follow-up|0|||
44244614|NCT01468207|79074651|FG003|Treatment Period 1|Lost to Follow-up|0|||
44244615|NCT01468207|79074652|FG004|Treatment Period 1|Lost to Follow-up|0|||
44244616|NCT01468207|79074653|FG005|Treatment Period 1|Lost to Follow-up|0|||
44244617|NCT01468207|79074648|FG000|Treatment Period 1|Other|0|||
44244618|NCT01468207|79074649|FG001|Treatment Period 1|Other|2|||
44244619|NCT01468207|79074650|FG002|Treatment Period 1|Other|0|||
44244620|NCT01468207|79074651|FG003|Treatment Period 1|Other|0|||
44244621|NCT01468207|79074652|FG004|Treatment Period 1|Other|0|||
44244622|NCT01468207|79074653|FG005|Treatment Period 1|Other|0|||
44244623|NCT01468207|79074648|FG000|Treatment Period 2|Adverse Event|0|||
44244624|NCT01468207|79074649|FG001|Treatment Period 2|Adverse Event|0|||
44244625|NCT01468207|79074650|FG002|Treatment Period 2|Adverse Event|6|||
44244626|NCT01468207|79074651|FG003|Treatment Period 2|Adverse Event|1|||
44244627|NCT01468207|79074652|FG004|Treatment Period 2|Adverse Event|2|||
44244628|NCT01468207|79074653|FG005|Treatment Period 2|Adverse Event|1|||
44244629|NCT01468207|79074648|FG000|Treatment Period 2|Lack of Efficacy|0|||
44244630|NCT01468207|79074649|FG001|Treatment Period 2|Lack of Efficacy|0|||
44244631|NCT01468207|79074650|FG002|Treatment Period 2|Lack of Efficacy|1|||
44244632|NCT01468207|79074651|FG003|Treatment Period 2|Lack of Efficacy|1|||
44244633|NCT01468207|79074652|FG004|Treatment Period 2|Lack of Efficacy|0|||
44244634|NCT01468207|79074653|FG005|Treatment Period 2|Lack of Efficacy|2|||
44244635|NCT01468207|79074648|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44244636|NCT01468207|79074649|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44244637|NCT01468207|79074650|FG002|Treatment Period 2|Withdrawal by Subject|5|||
44244638|NCT01468207|79074651|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44244639|NCT01468207|79074652|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44244640|NCT01468207|79074653|FG005|Treatment Period 2|Withdrawal by Subject|2|||
44244641|NCT01468207|79074648|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
44244642|NCT01468207|79074649|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
44244643|NCT01468207|79074650|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
44244644|NCT01468207|79074651|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
44244645|NCT01468207|79074652|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
44244646|NCT01468207|79074653|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
44244647|NCT01468207|79074648|FG000|Treatment Period 2|Lost to Follow-up|0|||
44244648|NCT01468207|79074649|FG001|Treatment Period 2|Lost to Follow-up|0|||
44244649|NCT01468207|79074650|FG002|Treatment Period 2|Lost to Follow-up|5|||
44244650|NCT01468207|79074651|FG003|Treatment Period 2|Lost to Follow-up|1|||
44244651|NCT01468207|79074652|FG004|Treatment Period 2|Lost to Follow-up|0|||
44244652|NCT01468207|79074653|FG005|Treatment Period 2|Lost to Follow-up|0|||
44244653|NCT01468207|79074648|FG000|Treatment Period 2|Other|0|||
44244654|NCT01468207|79074649|FG001|Treatment Period 2|Other|0|||
44244655|NCT01468207|79074650|FG002|Treatment Period 2|Other|5|||
44244656|NCT01468207|79074651|FG003|Treatment Period 2|Other|1|||
44244657|NCT01468207|79074652|FG004|Treatment Period 2|Other|1|||
44244658|NCT01468207|79074653|FG005|Treatment Period 2|Other|2|||
44244659|NCT01494649|79074673|FG000|Overall Study|Lost to Follow-up|0|||
44244660|NCT01494649|79074674|FG001|Overall Study|Lost to Follow-up|1|||
44244661|NCT01686152|79074685|FG000|Overall Study|Withdrawal by Subject|11|||
44244662|NCT01686152|79074686|FG001|Overall Study|Withdrawal by Subject|11|||
44244663|NCT01686152|79074687|FG002|Overall Study|Withdrawal by Subject|3|||
44244664|NCT01686152|79074685|FG000|Overall Study|Drug Code Unblinded|0|||
44244665|NCT01686152|79074686|FG001|Overall Study|Drug Code Unblinded|1|||
44244666|NCT01686152|79074687|FG002|Overall Study|Drug Code Unblinded|0|||
44244667|NCT01686152|79074685|FG000|Overall Study|Protocol Violation|6|||
44244668|NCT01686152|79074686|FG001|Overall Study|Protocol Violation|1|||
44244669|NCT01686152|79074687|FG002|Overall Study|Protocol Violation|0|||
44244670|NCT01686152|79074685|FG000|Overall Study|Adverse Event|12|||
44244671|NCT01686152|79074686|FG001|Overall Study|Adverse Event|11|||
44244672|NCT01686152|79074687|FG002|Overall Study|Adverse Event|0|||
44244673|NCT01686152|79074685|FG000|Overall Study|Lack of Efficacy|0|||
44244674|NCT01686152|79074686|FG001|Overall Study|Lack of Efficacy|0|||
44244675|NCT01686152|79074687|FG002|Overall Study|Lack of Efficacy|1|||
44244676|NCT01686152|79074685|FG000|Overall Study|IP Non-compliance|5|||
44244677|NCT01686152|79074686|FG001|Overall Study|IP Non-compliance|5|||
44244678|NCT01686152|79074687|FG002|Overall Study|IP Non-compliance|0|||
44244679|NCT01686152|79074685|FG000|Overall Study|Lost to Follow-up|7|||
44381281|NCT03043872|79387324|FG000|Overall Study|Death|270|||
44244680|NCT01686152|79074686|FG001|Overall Study|Lost to Follow-up|6|||
44244681|NCT01686152|79074687|FG002|Overall Study|Lost to Follow-up|5|||
44244682|NCT01452919|79074695|FG000|Open-Label Treatment|Adverse Event|5|||
44244683|NCT01452919|79074696|FG001|Open-Label Treatment|Adverse Event|0|||
44244684|NCT01452919|79074697|FG002|Open-Label Treatment|Adverse Event|0|||
44244685|NCT01452919|79074695|FG000|Open-Label Treatment|Lost to Follow-up|4|||
44244686|NCT01452919|79074696|FG001|Open-Label Treatment|Lost to Follow-up|0|||
44244687|NCT01452919|79074697|FG002|Open-Label Treatment|Lost to Follow-up|0|||
44244688|NCT01452919|79074695|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
44244689|NCT01452919|79074696|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
44244690|NCT01452919|79074697|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
44244691|NCT01452919|79074695|FG000|Open-Label Treatment|Protocol Violation|4|||
44244692|NCT01452919|79074696|FG001|Open-Label Treatment|Protocol Violation|0|||
44244693|NCT01452919|79074697|FG002|Open-Label Treatment|Protocol Violation|0|||
44244694|NCT01452919|79074695|FG000|Open-Label Treatment|Sponsor Decision|1|||
44244695|NCT01452919|79074696|FG001|Open-Label Treatment|Sponsor Decision|0|||
44244696|NCT01452919|79074697|FG002|Open-Label Treatment|Sponsor Decision|0|||
44244697|NCT01452919|79074695|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
44244698|NCT01452919|79074696|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
44244699|NCT01452919|79074697|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
44244700|NCT01452919|79074695|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
44381282|NCT03043872|79387325|FG001|Overall Study|Death|269|||
44244701|NCT01452919|79074696|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
44244702|NCT01452919|79074697|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
44244703|NCT01452919|79074695|FG000|Randomization Treatment|Adverse Event|0|||
44244704|NCT01452919|79074696|FG001|Randomization Treatment|Adverse Event|0|||
44244705|NCT01452919|79074697|FG002|Randomization Treatment|Adverse Event|2|||
44244706|NCT01452919|79074695|FG000|Randomization Treatment|Sponsor Decision|0|||
44244707|NCT01452919|79074696|FG001|Randomization Treatment|Sponsor Decision|1|||
44244708|NCT01452919|79074697|FG002|Randomization Treatment|Sponsor Decision|0|||
44244709|NCT01452919|79074695|FG000|Randomization Treatment|Withdrawal by Subject|0|||
44244710|NCT01452919|79074696|FG001|Randomization Treatment|Withdrawal by Subject|1|||
44244711|NCT01452919|79074697|FG002|Randomization Treatment|Withdrawal by Subject|0|||
44244712|NCT01452919|79074695|FG000|Randomization Treatment|Subject is moving or has moved|0|||
44244713|NCT01452919|79074696|FG001|Randomization Treatment|Subject is moving or has moved|1|||
44244714|NCT01452919|79074697|FG002|Randomization Treatment|Subject is moving or has moved|0|||
44244715|NCT01582178|79074709|FG000|Overall Study|Physician Decision|6|||
44244716|NCT01582178|79074710|FG001|Overall Study|Physician Decision|5|||
44244717|NCT01561898|79074720|FG000|Overall Study|Withdrawal by Subject|0|||
44244718|NCT01561898|79074721|FG001|Overall Study|Withdrawal by Subject|8|||
44244719|NCT01561898|79074722|FG002|Overall Study|Withdrawal by Subject|12|||
44244720|NCT01561898|79074723|FG003|Overall Study|Withdrawal by Subject|5|||
44244721|NCT01561898|79074720|FG000|Overall Study|Lack of Efficacy|0|||
44244722|NCT01561898|79074721|FG001|Overall Study|Lack of Efficacy|8|||
44244723|NCT01561898|79074722|FG002|Overall Study|Lack of Efficacy|10|||
44244724|NCT01561898|79074723|FG003|Overall Study|Lack of Efficacy|5|||
44244725|NCT01561898|79074720|FG000|Overall Study|Worsening of complications|0|||
44244726|NCT01561898|79074721|FG001|Overall Study|Worsening of complications|1|||
44244727|NCT01561898|79074722|FG002|Overall Study|Worsening of complications|0|||
44244728|NCT01561898|79074723|FG003|Overall Study|Worsening of complications|0|||
44244729|NCT01561898|79074720|FG000|Overall Study|Lost to Follow-up|0|||
44244730|NCT01561898|79074721|FG001|Overall Study|Lost to Follow-up|0|||
44244731|NCT01561898|79074722|FG002|Overall Study|Lost to Follow-up|1|||
44244732|NCT01561898|79074723|FG003|Overall Study|Lost to Follow-up|0|||
44244733|NCT01561898|79074720|FG000|Overall Study|Adverse Event|1|||
44244734|NCT01561898|79074721|FG001|Overall Study|Adverse Event|19|||
44244735|NCT01561898|79074722|FG002|Overall Study|Adverse Event|14|||
44244736|NCT01561898|79074723|FG003|Overall Study|Adverse Event|9|||
44244737|NCT01561898|79074720|FG000|Overall Study|Physician Decision|1|||
44244738|NCT01561898|79074721|FG001|Overall Study|Physician Decision|5|||
44244739|NCT01561898|79074722|FG002|Overall Study|Physician Decision|7|||
44244740|NCT01561898|79074723|FG003|Overall Study|Physician Decision|1|||
44244741|NCT01685840|79074733|FG000|Overall Study|Death|77|||
44244742|NCT01685840|79074734|FG001|Overall Study|Death|66|||
44244743|NCT01685840|79074733|FG000|Overall Study|Lost to Follow-up|27|||
44143320|NCT01602315|78932647|FG003|Overall Study|Subject/guardian decision|0|||
44244744|NCT01685840|79074734|FG001|Overall Study|Lost to Follow-up|25|||
44244745|NCT01685840|79074733|FG000|Overall Study|Physician Decision|3|||
44244746|NCT01685840|79074734|FG001|Overall Study|Physician Decision|7|||
44244747|NCT01685840|79074733|FG000|Overall Study|Withdrawal by Subject|14|||
44244748|NCT01685840|79074734|FG001|Overall Study|Withdrawal by Subject|17|||
44244749|NCT01685840|79074733|FG000|Overall Study|Futility|197|||
44244750|NCT01685840|79074734|FG001|Overall Study|Futility|200|||
44244751|NCT01685840|79074733|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
44244752|NCT01685840|79074734|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
44244753|NCT01452529|79074744|FG000|Run-in Period|Adverse Event|96|||
44514117|NCT02759185|79519464|FG004|Stage 1|Withdrawal by Subject|0|||
44514118|NCT02759185|79519465|FG005|Stage 1|Withdrawal by Subject|0|||
44514119|NCT02759185|79519466|FG006|Stage 1|Withdrawal by Subject|0|||
44514120|NCT02759185|79519460|FG000|Stage 2|Adverse Event|0|||
44514121|NCT02759185|79519461|FG001|Stage 2|Adverse Event|0|||
44514122|NCT02759185|79519462|FG002|Stage 2|Adverse Event|0|||
44514123|NCT02759185|79519463|FG003|Stage 2|Adverse Event|0|||
44514124|NCT02759185|79519464|FG004|Stage 2|Adverse Event|1|||
44514125|NCT02759185|79519465|FG005|Stage 2|Adverse Event|2|||
44514126|NCT02759185|79519466|FG006|Stage 2|Adverse Event|0|||
44514127|NCT02759185|79519460|FG000|Stage 2|Withdrawal by Subject|0|||
44514128|NCT02759185|79519461|FG001|Stage 2|Withdrawal by Subject|0|||
44514129|NCT02759185|79519462|FG002|Stage 2|Withdrawal by Subject|0|||
44514130|NCT02759185|79519463|FG003|Stage 2|Withdrawal by Subject|0|||
44514131|NCT02759185|79519464|FG004|Stage 2|Withdrawal by Subject|1|||
44514132|NCT02759185|79519465|FG005|Stage 2|Withdrawal by Subject|1|||
44514133|NCT02759185|79519466|FG006|Stage 2|Withdrawal by Subject|1|||
44514134|NCT01844518|79519499|FG000|Overall Study|Adverse Event|7|||
44244754|NCT01452529|79074745|FG001|Run-in Period|Adverse Event|0|||
44244755|NCT01452529|79074746|FG002|Run-in Period|Adverse Event|0|||
44244756|NCT01452529|79074744|FG000|Run-in Period|Withdrawal by Subject|49|||
44244757|NCT01452529|79074745|FG001|Run-in Period|Withdrawal by Subject|0|||
44244758|NCT01452529|79074746|FG002|Run-in Period|Withdrawal by Subject|0|||
44244759|NCT01452529|79074744|FG000|Run-in Period|Lost to Follow-up|19|||
44244760|NCT01452529|79074745|FG001|Run-in Period|Lost to Follow-up|0|||
44244761|NCT01452529|79074746|FG002|Run-in Period|Lost to Follow-up|0|||
44244762|NCT01452529|79074744|FG000|Run-in Period|Lack of Efficacy|46|||
44244763|NCT01452529|79074745|FG001|Run-in Period|Lack of Efficacy|0|||
44244764|NCT01452529|79074746|FG002|Run-in Period|Lack of Efficacy|0|||
44244765|NCT01452529|79074744|FG000|Run-in Period|Confirmed or suspected diversion|23|||
44244766|NCT01452529|79074745|FG001|Run-in Period|Confirmed or suspected diversion|0|||
44244767|NCT01452529|79074746|FG002|Run-in Period|Confirmed or suspected diversion|0|||
44244768|NCT01452529|79074744|FG000|Run-in Period|Administrative|21|||
44244769|NCT01452529|79074745|FG001|Run-in Period|Administrative|0|||
44244770|NCT01452529|79074746|FG002|Run-in Period|Administrative|0|||
44244771|NCT01452529|79074744|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
44244772|NCT01452529|79074745|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
44244773|NCT01452529|79074746|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
44244774|NCT01452529|79074744|FG000|Double-blind (DB) Period|Adverse Event|0|||
44244775|NCT01452529|79074745|FG001|Double-blind (DB) Period|Adverse Event|18|||
44244776|NCT01452529|79074746|FG002|Double-blind (DB) Period|Adverse Event|11|||
44244777|NCT01452529|79074744|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
44244778|NCT01452529|79074745|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
44244779|NCT01452529|79074746|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
44244780|NCT01452529|79074744|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
44244781|NCT01452529|79074745|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
44244782|NCT01452529|79074746|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
44244783|NCT01452529|79074744|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
44244784|NCT01452529|79074745|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
44244785|NCT01452529|79074746|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
44244786|NCT01452529|79074744|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
44244787|NCT01452529|79074745|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
44244788|NCT01452529|79074746|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
44244789|NCT01452529|79074744|FG000|Double-blind (DB) Period|Administrative|0|||
44244790|NCT01452529|79074745|FG001|Double-blind (DB) Period|Administrative|11|||
44244791|NCT01452529|79074746|FG002|Double-blind (DB) Period|Administrative|7|||
44244792|NCT01685606|79074753|FG000|Overall Study|Withdrawal by Subject|1|||
44244793|NCT01685372|79074759|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
44244794|NCT01685372|79074760|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
44244795|NCT01685216|79074766|FG000|Overall Study|Did not receive study drug|1|||
44244796|NCT01685138|79074770|FG000|Overall Study|Lost to Follow-up|1|||
44244797|NCT01685138|79074770|FG000|Overall Study|Protocol Violation|1|||
44244798|NCT01685138|79074770|FG000|Overall Study|No longer requires treatment|1|||
44244799|NCT01685138|79074770|FG000|Overall Study|Subject/guardian decision|2|||
44244800|NCT01685138|79074770|FG000|Overall Study|Physician Decision|6|||
44244801|NCT01685138|79074770|FG000|Overall Study|Death|10|||
44244802|NCT01685138|79074770|FG000|Overall Study|Adverse Event|18|||
44244803|NCT01685138|79074770|FG000|Overall Study|Progressive disease|53|||
44244804|NCT01685060|79074774|FG000|Overall Study|Rollover patients|16|||
44244805|NCT01685060|79074774|FG000|Overall Study|Adverse Event|12|||
44244806|NCT01685060|79074774|FG000|Overall Study|Progressive disease|69|||
44244807|NCT01685060|79074774|FG000|Overall Study|Physician Decision|14|||
44244808|NCT01685060|79074774|FG000|Overall Study|Subject/guardian decision|20|||
44244809|NCT01685060|79074774|FG000|Overall Study|Lost to Follow-up|1|||
44244810|NCT01685060|79074774|FG000|Overall Study|Death|8|||
44143321|NCT01602315|78932648|FG004|Overall Study|Subject/guardian decision|0|||
44143322|NCT01602315|78932649|FG005|Overall Study|Subject/guardian decision|0|||
44143323|NCT01602315|78932650|FG006|Overall Study|Subject/guardian decision|1|||
44244811|NCT01582100|79074778|FG000|Overall Study|Adverse Event|1|||
44244812|NCT01582100|79074778|FG000|Overall Study|Withdrawal by Subject|1|||
44244813|NCT01579916|79074784|FG000|Overall Study|Lost to Follow-up|6|||
44244814|NCT01579916|79074785|FG001|Overall Study|Lost to Follow-up|1|||
44244815|NCT01579916|79074784|FG000|Overall Study|Withdrawal by Subject|1|||
44514135|NCT01844518|79519500|FG001|Overall Study|Adverse Event|1|||
44244816|NCT01579916|79074785|FG001|Overall Study|Withdrawal by Subject|1|||
44244817|NCT01579916|79074784|FG000|Overall Study|Death|1|||
44244818|NCT01579916|79074785|FG001|Overall Study|Death|0|||
44244819|NCT01684202|79074795|FG000|Dose-escalation Period|Adverse Event|0|||
44244820|NCT01684202|79074796|FG001|Dose-escalation Period|Adverse Event|1|||
44244821|NCT01684202|79074797|FG002|Dose-escalation Period|Adverse Event|0|||
44244822|NCT01684202|79074798|FG003|Dose-escalation Period|Adverse Event|0|||
44244823|NCT01684202|79074795|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
44143324|NCT01602315|78932644|FG000|Overall Study|Cross-over patients to combo treatment|0|||
44244824|NCT01684202|79074796|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
44244825|NCT01684202|79074797|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
44244826|NCT01684202|79074798|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
44244827|NCT01684202|79074795|FG000|Maintenance Period|Adverse Event|1|||
44244828|NCT01684202|79074796|FG001|Maintenance Period|Adverse Event|1|||
44244829|NCT01684202|79074797|FG002|Maintenance Period|Adverse Event|1|||
44244830|NCT01684202|79074798|FG003|Maintenance Period|Adverse Event|1|||
44244831|NCT01684202|79074795|FG000|Maintenance Period|Physician Decision|0|||
44244832|NCT01684202|79074796|FG001|Maintenance Period|Physician Decision|1|||
44244833|NCT01684202|79074797|FG002|Maintenance Period|Physician Decision|0|||
44244834|NCT01684202|79074798|FG003|Maintenance Period|Physician Decision|0|||
44244835|NCT01684202|79074795|FG000|Maintenance Period|Withdrawal by Subject|0|||
44244836|NCT01684202|79074796|FG001|Maintenance Period|Withdrawal by Subject|1|||
44244837|NCT01684202|79074797|FG002|Maintenance Period|Withdrawal by Subject|0|||
44244838|NCT01684202|79074798|FG003|Maintenance Period|Withdrawal by Subject|0|||
44244839|NCT01684046|79074808|FG000|Period 1, First 30 Days|Adverse Event|0|||
44244840|NCT01684046|79074809|FG001|Period 1, First 30 Days|Adverse Event|2|||
44244841|NCT01559090|79074818|FG000|Stage I|Withdrawal by Subject|2|||
44244842|NCT01559090|79074819|FG001|Stage I|Withdrawal by Subject|2|||
44244843|NCT01559090|79074820|FG002|Stage I|Withdrawal by Subject|3|||
44244844|NCT01559090|79074818|FG000|Stage II|Withdrawal by Subject|1|||
44244845|NCT01559090|79074819|FG001|Stage II|Withdrawal by Subject|0|||
44244846|NCT01559090|79074820|FG002|Stage II|Withdrawal by Subject|0|||
44244847|NCT01683266|79074830|FG000|Overall Study|Adverse Event|5|||
44244848|NCT01683266|79074831|FG001|Overall Study|Adverse Event|4|||
44244849|NCT01683266|79074830|FG000|Overall Study|Lack of Efficacy|5|||
44244850|NCT01683266|79074831|FG001|Overall Study|Lack of Efficacy|2|||
44244851|NCT01683266|79074830|FG000|Overall Study|Protocol Violation|13|||
44244852|NCT01683266|79074831|FG001|Overall Study|Protocol Violation|6|||
44244853|NCT01683266|79074830|FG000|Overall Study|Personal Reason|17|||
44244854|NCT01683266|79074831|FG001|Overall Study|Personal Reason|25|||
44244855|NCT01683266|79074830|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
44244856|NCT01683266|79074831|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
44244857|NCT01683266|79074830|FG000|Overall Study|Lost to Follow-up|5|||
44244858|NCT01683266|79074831|FG001|Overall Study|Lost to Follow-up|0|||
44244859|NCT01683266|79074830|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
44244860|NCT01683266|79074831|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
44244861|NCT01683266|79074830|FG000|Overall Study|Nonserious Hypoglycemia|0|||
44244862|NCT01683266|79074831|FG001|Overall Study|Nonserious Hypoglycemia|3|||
44244863|NCT01683266|79074830|FG000|Overall Study|Perceived Lack of Efficacy|1|||
44244864|NCT01683266|79074831|FG001|Overall Study|Perceived Lack of Efficacy|1|||
44244865|NCT01683266|79074830|FG000|Overall Study|Possibly Hypoglycemia|1|||
44244866|NCT01683266|79074831|FG001|Overall Study|Possibly Hypoglycemia|0|||
44244867|NCT01683266|79074830|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
44244868|NCT01683266|79074831|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
44244869|NCT01467661|79074837|FG000|Overall Study|Adverse Event|16|||
44244870|NCT01467661|79074837|FG000|Overall Study|Withdrawal by Subject|1|||
44244871|NCT01467661|79074837|FG000|Overall Study|Lack of Efficacy|3|||
44244872|NCT01467661|79074837|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
44244873|NCT01577186|79074843|FG000|Overall Study|Adverse Event|23|||
44381283|NCT03043872|79387326|FG002|Overall Study|Death|296|||
44381284|NCT02928224|79387348|FG000|Overall Study|Lost to Follow-up|1|||
44381285|NCT02928224|79387349|FG001|Overall Study|Lost to Follow-up|1|||
44381286|NCT02928224|79387350|FG002|Overall Study|Lost to Follow-up|3|||
44381287|NCT02928224|79387351|FG003|Overall Study|Lost to Follow-up|0|||
44244874|NCT01577186|79074843|FG000|Overall Study|Death|1|||
44244875|NCT01577186|79074843|FG000|Overall Study|Lost to Follow-up|28|||
44244876|NCT01577186|79074843|FG000|Overall Study|Withdrawal by Subject|35|||
44244877|NCT01577186|79074843|FG000|Overall Study|Insufficient Response|18|||
44244878|NCT01577186|79074843|FG000|Overall Study|Ineligible to Continue|15|||
44244879|NCT01577186|79074843|FG000|Overall Study|Non-Compliant|8|||
44244880|NCT01577186|79074843|FG000|Overall Study|Other|2|||
44244881|NCT01559012|79074849|FG000|Overall Study|Withdrawal by Subject|0|||
44244882|NCT01559012|79074850|FG001|Overall Study|Withdrawal by Subject|1|||
44244883|NCT01451827|79074875|FG000|Overall Study|Adverse Event|2|||
44244884|NCT01451827|79074876|FG001|Overall Study|Adverse Event|0|||
44244885|NCT01451827|79074877|FG002|Overall Study|Adverse Event|1|||
44381288|NCT02928224|79387348|FG000|Overall Study|Death|30|||
44381289|NCT02928224|79387349|FG001|Overall Study|Death|209|||
44244886|NCT01451827|79074878|FG003|Overall Study|Adverse Event|1|||
44244887|NCT01451827|79074875|FG000|Overall Study|Protocol deviation|1|||
44244888|NCT01451827|79074876|FG001|Overall Study|Protocol deviation|0|||
44244889|NCT01451827|79074877|FG002|Overall Study|Protocol deviation|0|||
44244890|NCT01451827|79074878|FG003|Overall Study|Protocol deviation|0|||
44244891|NCT01451827|79074875|FG000|Overall Study|Lost to Follow-up|0|||
44381290|NCT02928224|79387350|FG002|Overall Study|Death|193|||
44381291|NCT02928224|79387351|FG003|Overall Study|Death|198|||
44381292|NCT02928224|79387348|FG000|Overall Study|Withdrawal by Subject|0|||
44244892|NCT01451827|79074876|FG001|Overall Study|Lost to Follow-up|3|||
44244893|NCT01451827|79074877|FG002|Overall Study|Lost to Follow-up|0|||
44244894|NCT01451827|79074878|FG003|Overall Study|Lost to Follow-up|2|||
44244895|NCT01451827|79074875|FG000|Overall Study|Participant met withdrawal criteria|0|||
44244896|NCT01451827|79074876|FG001|Overall Study|Participant met withdrawal criteria|2|||
44244897|NCT01451827|79074877|FG002|Overall Study|Participant met withdrawal criteria|0|||
44244898|NCT01451827|79074878|FG003|Overall Study|Participant met withdrawal criteria|0|||
44244899|NCT01451827|79074875|FG000|Overall Study|Withdrawal by Subject|0|||
44244900|NCT01451827|79074876|FG001|Overall Study|Withdrawal by Subject|0|||
44244901|NCT01451827|79074877|FG002|Overall Study|Withdrawal by Subject|1|||
44244902|NCT01451827|79074878|FG003|Overall Study|Withdrawal by Subject|1|||
44244903|NCT01557920|79074888|FG000|Overall Study|Withdrawal by Subject|2|||
44244904|NCT01557920|79074889|FG001|Overall Study|Withdrawal by Subject|3|||
44244905|NCT01557920|79074888|FG000|Overall Study|Lack of Efficacy|1|||
44244906|NCT01557920|79074889|FG001|Overall Study|Lack of Efficacy|0|||
44244907|NCT01688882|79074924|FG000|Overall Study|Adverse Event|1|||
44244908|NCT01688882|79074925|FG001|Overall Study|Adverse Event|0|||
44244909|NCT01688882|79074924|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44244910|NCT01688882|79074925|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44244911|NCT01688882|79074924|FG000|Overall Study|Administrative problems|1|||
44244912|NCT01688882|79074925|FG001|Overall Study|Administrative problems|0|||
44244913|NCT01467583|79074938|FG000|Overall Study|Death|1|||
44244914|NCT01467583|79074939|FG001|Overall Study|Death|1|||
44244915|NCT01467583|79074940|FG002|Overall Study|Death|0|||
44244916|NCT01467583|79074938|FG000|Overall Study|Withdrawal by Subject|1|||
44244917|NCT01467583|79074939|FG001|Overall Study|Withdrawal by Subject|0|||
44244918|NCT01467583|79074940|FG002|Overall Study|Withdrawal by Subject|0|||
44244919|NCT01467583|79074938|FG000|Overall Study|Protocol Violation|0|||
44244920|NCT01467583|79074939|FG001|Overall Study|Protocol Violation|0|||
44244921|NCT01467583|79074940|FG002|Overall Study|Protocol Violation|2|||
44244922|NCT01576718|79074957|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
44244923|NCT01576718|79074958|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44244924|NCT01576718|79074959|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44244925|NCT01576718|79074960|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44244926|NCT01576718|79074961|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44244927|NCT01576718|79074962|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44244928|NCT01576718|79074963|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
44244929|NCT01576718|79074957|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
44244930|NCT01576718|79074958|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44244931|NCT01576718|79074959|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44244932|NCT01576718|79074960|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44244933|NCT01576718|79074961|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44244934|NCT01576718|79074962|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44244935|NCT01576718|79074963|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
44244936|NCT01576718|79074957|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
44244937|NCT01576718|79074958|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44244938|NCT01576718|79074959|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44244939|NCT01576718|79074960|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44244940|NCT01576718|79074961|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44244941|NCT01576718|79074962|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44244942|NCT01576718|79074963|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
44244943|NCT01576718|79074957|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
44244944|NCT01576718|79074958|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44244945|NCT01576718|79074959|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44244946|NCT01576718|79074960|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44244947|NCT01576718|79074961|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44244948|NCT01576718|79074962|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44244949|NCT01576718|79074963|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
44244950|NCT01576718|79074957|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
44244951|NCT01576718|79074958|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44244952|NCT01576718|79074959|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44244953|NCT01576718|79074960|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44244954|NCT01576718|79074961|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44244955|NCT01576718|79074962|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44244956|NCT01576718|79074963|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
44244957|NCT01576718|79074957|FG000|Treatment Period|Adverse Event|0|||
44244958|NCT01576718|79074958|FG001|Treatment Period|Adverse Event|1|||
44244959|NCT01576718|79074959|FG002|Treatment Period|Adverse Event|1|||
44244960|NCT01576718|79074960|FG003|Treatment Period|Adverse Event|1|||
44244961|NCT01576718|79074961|FG004|Treatment Period|Adverse Event|1|||
44244962|NCT01576718|79074962|FG005|Treatment Period|Adverse Event|1|||
44244963|NCT01576718|79074963|FG006|Treatment Period|Adverse Event|0|||
44244964|NCT01576718|79074957|FG000|Treatment Period|Withdrawal by Subject|0|||
44244965|NCT01576718|79074958|FG001|Treatment Period|Withdrawal by Subject|1|||
44244966|NCT01576718|79074959|FG002|Treatment Period|Withdrawal by Subject|1|||
44244967|NCT01576718|79074960|FG003|Treatment Period|Withdrawal by Subject|0|||
44244968|NCT01576718|79074961|FG004|Treatment Period|Withdrawal by Subject|2|||
44244969|NCT01576718|79074962|FG005|Treatment Period|Withdrawal by Subject|4|||
44244970|NCT01576718|79074963|FG006|Treatment Period|Withdrawal by Subject|2|||
44244971|NCT01576718|79074957|FG000|Treatment Period|Physician Decision|0|||
44244972|NCT01576718|79074958|FG001|Treatment Period|Physician Decision|1|||
44244973|NCT01576718|79074959|FG002|Treatment Period|Physician Decision|1|||
44244974|NCT01576718|79074960|FG003|Treatment Period|Physician Decision|1|||
44244975|NCT01576718|79074961|FG004|Treatment Period|Physician Decision|1|||
44244976|NCT01576718|79074962|FG005|Treatment Period|Physician Decision|0|||
44244977|NCT01576718|79074963|FG006|Treatment Period|Physician Decision|0|||
44244978|NCT01576718|79074957|FG000|Treatment Period|Protocol Violation|0|||
44244979|NCT01576718|79074958|FG001|Treatment Period|Protocol Violation|5|||
44244980|NCT01576718|79074959|FG002|Treatment Period|Protocol Violation|4|||
44244981|NCT01576718|79074960|FG003|Treatment Period|Protocol Violation|10|||
44244982|NCT01576718|79074961|FG004|Treatment Period|Protocol Violation|6|||
44244983|NCT01576718|79074962|FG005|Treatment Period|Protocol Violation|8|||
44244984|NCT01576718|79074963|FG006|Treatment Period|Protocol Violation|12|||
44244985|NCT01576718|79074957|FG000|Treatment Period|Sponsor request|0|||
44244986|NCT01576718|79074958|FG001|Treatment Period|Sponsor request|1|||
44244987|NCT01576718|79074959|FG002|Treatment Period|Sponsor request|0|||
44244988|NCT01576718|79074960|FG003|Treatment Period|Sponsor request|0|||
44244989|NCT01576718|79074961|FG004|Treatment Period|Sponsor request|0|||
44244990|NCT01576718|79074962|FG005|Treatment Period|Sponsor request|1|||
44244991|NCT01576718|79074963|FG006|Treatment Period|Sponsor request|0|||
44143325|NCT01602315|78932645|FG001|Overall Study|Cross-over patients to combo treatment|0|||
44143326|NCT01602315|78932646|FG002|Overall Study|Cross-over patients to combo treatment|0|||
44244992|NCT01576718|79074957|FG000|Treatment Period|Met stopping criteria|0|||
44244993|NCT01576718|79074958|FG001|Treatment Period|Met stopping criteria|16|||
44244994|NCT01576718|79074959|FG002|Treatment Period|Met stopping criteria|13|||
44244995|NCT01576718|79074960|FG003|Treatment Period|Met stopping criteria|19|||
44514136|NCT01844518|79519499|FG000|Overall Study|Lack of Efficacy|17|||
44514137|NCT01844518|79519500|FG001|Overall Study|Lack of Efficacy|5|||
44514138|NCT01844518|79519499|FG000|Overall Study|Participant's request to discontinue|4|||
44514139|NCT01844518|79519500|FG001|Overall Study|Participant's request to discontinue|1|||
44514140|NCT01844518|79519499|FG000|Overall Study|Poor/Non-compliance|1|||
44514141|NCT01844518|79519500|FG001|Overall Study|Poor/Non-compliance|0|||
44514142|NCT01844518|79519499|FG000|Overall Study|No Longer Met Study Criteria|2|||
44244996|NCT01576718|79074961|FG004|Treatment Period|Met stopping criteria|16|||
44244997|NCT01576718|79074962|FG005|Treatment Period|Met stopping criteria|33|||
44514143|NCT01844518|79519500|FG001|Overall Study|No Longer Met Study Criteria|0|||
44514144|NCT01844518|79519499|FG000|Overall Study|Withdrawal by Subject|9|||
44244998|NCT01576718|79074963|FG006|Treatment Period|Met stopping criteria|15|||
44244999|NCT01576718|79074957|FG000|Treatment Period|Lost to Follow-up|0|||
44514145|NCT01844518|79519500|FG001|Overall Study|Withdrawal by Subject|0|||
44245000|NCT01576718|79074958|FG001|Treatment Period|Lost to Follow-up|0|||
44245001|NCT01576718|79074959|FG002|Treatment Period|Lost to Follow-up|0|||
44245002|NCT01576718|79074960|FG003|Treatment Period|Lost to Follow-up|0|||
44245003|NCT01576718|79074961|FG004|Treatment Period|Lost to Follow-up|1|||
44245004|NCT01576718|79074962|FG005|Treatment Period|Lost to Follow-up|0|||
44245005|NCT01576718|79074963|FG006|Treatment Period|Lost to Follow-up|0|||
44245006|NCT01576718|79074957|FG000|Treatment Period|Noncompliance to study medication|0|||
44245007|NCT01576718|79074958|FG001|Treatment Period|Noncompliance to study medication|0|||
44245008|NCT01576718|79074959|FG002|Treatment Period|Noncompliance to study medication|0|||
44245009|NCT01576718|79074960|FG003|Treatment Period|Noncompliance to study medication|0|||
44245010|NCT01576718|79074961|FG004|Treatment Period|Noncompliance to study medication|0|||
44245011|NCT01576718|79074962|FG005|Treatment Period|Noncompliance to study medication|1|||
44245012|NCT01576718|79074963|FG006|Treatment Period|Noncompliance to study medication|1|||
44245013|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
44245014|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
44245015|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
44245016|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
44245017|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
44245018|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
44245019|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
44245020|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
44245021|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
44245022|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
44245023|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
44245024|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
44245025|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
44245026|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
44245027|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
44245028|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
44245029|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
44245030|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
44245031|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Early termination|0|||
44245032|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Early termination|0|||
44245033|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Early termination|34|||
44245034|NCT01493557|79074980|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
44245035|NCT01493557|79074981|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
44245036|NCT01493557|79074982|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
44245037|NCT01493557|79074980|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
44245038|NCT01493557|79074981|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
44245039|NCT01493557|79074982|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
44245040|NCT01493557|79074980|FG000|Randomized to Management Strategies|Other adverse event|8|||
44245041|NCT01493557|79074981|FG001|Randomized to Management Strategies|Other adverse event|5|||
44245042|NCT01493557|79074982|FG002|Randomized to Management Strategies|Other adverse event|0|||
44245043|NCT01493557|79074980|FG000|Randomized to Management Strategies|Protocol Violation|3|||
44245044|NCT01493557|79074981|FG001|Randomized to Management Strategies|Protocol Violation|0|||
44245045|NCT01493557|79074982|FG002|Randomized to Management Strategies|Protocol Violation|0|||
44245046|NCT01493557|79074980|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
44245047|NCT01493557|79074981|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
44245048|NCT01493557|79074982|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
44245049|NCT01493557|79074980|FG000|Randomized to Management Strategies|Other than stated above|1|||
44245050|NCT01493557|79074981|FG001|Randomized to Management Strategies|Other than stated above|3|||
44245051|NCT01493557|79074982|FG002|Randomized to Management Strategies|Other than stated above|0|||
44245052|NCT01493557|79074980|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
44245053|NCT01493557|79074981|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
44245054|NCT01493557|79074982|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
44245055|NCT01493557|79074980|FG000|Adding the Second Strategy|Other adverse event|1|||
44245056|NCT01493557|79074981|FG001|Adding the Second Strategy|Other adverse event|2|||
44245057|NCT01493557|79074982|FG002|Adding the Second Strategy|Other adverse event|0|||
44245058|NCT01493557|79074980|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
44381293|NCT02928224|79387349|FG001|Overall Study|Withdrawal by Subject|3|||
44245059|NCT01493557|79074981|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
44245060|NCT01493557|79074982|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
44245061|NCT01451749|79074991|FG000|Overall Study|Protocol Violation|14|||
44245062|NCT01451749|79074992|FG001|Overall Study|Protocol Violation|7|||
44245063|NCT01451749|79074991|FG000|Overall Study|Lost to Follow-up|15|||
44245064|NCT01451749|79074992|FG001|Overall Study|Lost to Follow-up|5|||
44245065|NCT01451749|79074991|FG000|Overall Study|Meet the exclusion criteria,and|1|||
44245066|NCT01451749|79074992|FG001|Overall Study|Meet the exclusion criteria,and|1|||
44245067|NCT01451749|79074991|FG000|Overall Study|Adverse Event|2|||
44245068|NCT01451749|79074992|FG001|Overall Study|Adverse Event|0|||
44245069|NCT01451749|79074991|FG000|Overall Study|Withdrawal by Subject|0|||
44245070|NCT01451749|79074992|FG001|Overall Study|Withdrawal by Subject|1|||
44245071|NCT01576484|79075002|FG000|Overall Study|Adverse Event|1|||
44245072|NCT01576484|79075003|FG001|Overall Study|Adverse Event|1|||
44245073|NCT01576484|79075002|FG000|Overall Study|Protocol Violation|0|||
44245074|NCT01576484|79075003|FG001|Overall Study|Protocol Violation|2|||
44245075|NCT01576484|79075002|FG000|Overall Study|Sponsor Decision|2|||
44245076|NCT01576484|79075003|FG001|Overall Study|Sponsor Decision|8|||
44245077|NCT01576484|79075002|FG000|Overall Study|Withdrawal by Subject|0|||
44245078|NCT01576484|79075003|FG001|Overall Study|Withdrawal by Subject|3|||
44245079|NCT01576484|79075002|FG000|Overall Study|Other|2|||
44245080|NCT01576484|79075003|FG001|Overall Study|Other|5|||
44245081|NCT01467505|79075013|FG000|Overall Study|Adverse Event|1|||
44245082|NCT01467505|79075014|FG001|Overall Study|Adverse Event|0|||
44245083|NCT01467505|79075013|FG000|Overall Study|Withdrawal by Subject|4|||
44245084|NCT01467505|79075014|FG001|Overall Study|Withdrawal by Subject|0|||
44245085|NCT01467505|79075013|FG000|Overall Study|Study Terminated by Sponsor|28|||
44245086|NCT01467505|79075014|FG001|Overall Study|Study Terminated by Sponsor|3|||
44245087|NCT01467271|79075020|FG000|Overall Study|Death|84|||
44245088|NCT01467271|79075020|FG000|Overall Study|Lost to Follow-up|83|||
44245089|NCT01467271|79075020|FG000|Overall Study|Retraction of patient's consent|21|||
44245090|NCT01467271|79075020|FG000|Overall Study|Other reason|14|||
44245091|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Adverse Event|5|||
44245092|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Adverse Event|13|||
44245093|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Adverse Event|0|||
44245094|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
44245095|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
44245096|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
44245097|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
44245098|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
44245099|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
44245100|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
44245101|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
44245102|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
44245103|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
44245104|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
44245105|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
44245106|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
44245107|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
44245108|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
44245109|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Physician Decision|2|||
44245110|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Physician Decision|3|||
44245111|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Physician Decision|0|||
44245112|NCT01449929|79075026|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
44245113|NCT01449929|79075027|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
44245114|NCT01449929|79075028|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
44245115|NCT01449929|79075026|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
44245116|NCT01449929|79075027|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
44245117|NCT01449929|79075028|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
44245118|NCT01449929|79075026|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
44245119|NCT01449929|79075027|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
44245120|NCT01449929|79075028|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
44245121|NCT01449929|79075026|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
44245122|NCT01449929|79075027|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
44245123|NCT01449929|79075028|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
44245124|NCT01449539|79075038|FG000|Overall Study|Withdrawal by Subject|3|||
44245125|NCT01449539|79075038|FG000|Overall Study|Toxicity not study related|1|||
44245126|NCT01451515|79075045|FG000|Overall Study|Death|0|||
44245127|NCT01451515|79075046|FG001|Overall Study|Death|1|||
44276734|NCT03234907|79237687|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
44245128|NCT01451515|79075047|FG002|Overall Study|Death|0|||
44245129|NCT01451515|79075045|FG000|Overall Study|Withdrawal by Subject|0|||
44245130|NCT01451515|79075046|FG001|Overall Study|Withdrawal by Subject|1|||
44245131|NCT01451515|79075047|FG002|Overall Study|Withdrawal by Subject|0|||
44245132|NCT01451515|79075045|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
44245133|NCT01451515|79075046|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
44245134|NCT01451515|79075047|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
44245135|NCT01451515|79075045|FG000|Overall Study|Relapse (except CNS)|1|||
44245136|NCT01451515|79075046|FG001|Overall Study|Relapse (except CNS)|1|||
44245137|NCT01451515|79075047|FG002|Overall Study|Relapse (except CNS)|0|||
44245138|NCT01466881|79075058|FG000|Overall Study|Ineligible|5|||
44245139|NCT01466881|79075058|FG000|Overall Study|Adverse Event|6|||
44245140|NCT01466881|79075058|FG000|Overall Study|Progression/relapse|20|||
44245141|NCT01466881|79075058|FG000|Overall Study|Death|4|||
44245142|NCT01466881|79075058|FG000|Overall Study|Other reason not protocol specified|5|||
44245143|NCT01576406|79075070|FG000|Overall Study|Lost to Follow-up|1|||
44245144|NCT01576406|79075071|FG001|Overall Study|Lost to Follow-up|2|||
44245145|NCT01576406|79075072|FG002|Overall Study|Lost to Follow-up|0|||
44245146|NCT01576406|79075073|FG003|Overall Study|Lost to Follow-up|0|||
44245147|NCT01576406|79075074|FG004|Overall Study|Lost to Follow-up|0|||
44245148|NCT01576406|79075075|FG005|Overall Study|Lost to Follow-up|0|||
44245149|NCT01576406|79075070|FG000|Overall Study|Death|3|||
44245150|NCT01576406|79075071|FG001|Overall Study|Death|4|||
44245151|NCT01576406|79075072|FG002|Overall Study|Death|8|||
44245152|NCT01576406|79075073|FG003|Overall Study|Death|5|||
44245153|NCT01576406|79075074|FG004|Overall Study|Death|7|||
44245154|NCT01576406|79075075|FG005|Overall Study|Death|9|||
44245155|NCT01576406|79075070|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
44245156|NCT01576406|79075071|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
44245157|NCT01576406|79075072|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
44245158|NCT01576406|79075073|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
44245159|NCT01576406|79075074|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
44245160|NCT01576406|79075075|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
44245161|NCT01576406|79075070|FG000|Overall Study|Withdrawal the consent|2|||
44245162|NCT01576406|79075071|FG001|Overall Study|Withdrawal the consent|2|||
44245163|NCT01576406|79075072|FG002|Overall Study|Withdrawal the consent|5|||
44245164|NCT01576406|79075073|FG003|Overall Study|Withdrawal the consent|1|||
44245165|NCT01576406|79075074|FG004|Overall Study|Withdrawal the consent|1|||
44245166|NCT01576406|79075075|FG005|Overall Study|Withdrawal the consent|3|||
44245167|NCT01576406|79075070|FG000|Overall Study|Other|0|||
44245168|NCT01576406|79075071|FG001|Overall Study|Other|0|||
44245169|NCT01576406|79075072|FG002|Overall Study|Other|2|||
44245170|NCT01576406|79075073|FG003|Overall Study|Other|2|||
44245171|NCT01576406|79075074|FG004|Overall Study|Other|0|||
44245172|NCT01576406|79075075|FG005|Overall Study|Other|0|||
44245173|NCT01576172|79075091|FG000|Overall Study|Ineligible|2|||
44245174|NCT01576172|79075092|FG001|Overall Study|Ineligible|1|||
44245175|NCT01576172|79075091|FG000|Overall Study|Withdrawal by Subject|2|||
44245176|NCT01576172|79075092|FG001|Overall Study|Withdrawal by Subject|0|||
44245177|NCT01576172|79075091|FG000|Overall Study|Insurance issue|1|||
44245178|NCT01576172|79075092|FG001|Overall Study|Insurance issue|0|||
44245179|NCT01542788|79075102|FG000|Overall Study|Randomized but Not Treated|2|||
44245180|NCT01542788|79075103|FG001|Overall Study|Randomized but Not Treated|0|||
44245181|NCT01542788|79075102|FG000|Overall Study|Lack of Efficacy|41|||
44245182|NCT01542788|79075103|FG001|Overall Study|Lack of Efficacy|71|||
44245183|NCT01542788|79075102|FG000|Overall Study|Lost to Follow-up|5|||
44245184|NCT01542788|79075103|FG001|Overall Study|Lost to Follow-up|0|||
44245185|NCT01542788|79075102|FG000|Overall Study|Death|3|||
44245186|NCT01542788|79075103|FG001|Overall Study|Death|0|||
44245187|NCT01542788|79075102|FG000|Overall Study|Protocol Violation|2|||
44245188|NCT01542788|79075103|FG001|Overall Study|Protocol Violation|0|||
44245189|NCT01542788|79075102|FG000|Overall Study|Physician Decision|1|||
44245190|NCT01542788|79075103|FG001|Overall Study|Physician Decision|0|||
44245191|NCT01542788|79075102|FG000|Overall Study|Withdrawal by Subject|1|||
44245192|NCT01542788|79075103|FG001|Overall Study|Withdrawal by Subject|0|||
44245193|NCT01542632|79075115|FG000|Overall Study|Withdrawal of Consent|0|||
44245194|NCT01542632|79075116|FG001|Overall Study|Withdrawal of Consent|0|||
44245195|NCT01542632|79075117|FG002|Overall Study|Withdrawal of Consent|0|||
44245196|NCT01542632|79075118|FG003|Overall Study|Withdrawal of Consent|2|||
44245197|NCT01542632|79075119|FG004|Overall Study|Withdrawal of Consent|3|||
44245198|NCT01542632|79075120|FG005|Overall Study|Withdrawal of Consent|0|||
44245199|NCT01542632|79075115|FG000|Overall Study|Adverse Event|0|||
44245200|NCT01542632|79075116|FG001|Overall Study|Adverse Event|0|||
44245201|NCT01542632|79075117|FG002|Overall Study|Adverse Event|1|||
44245202|NCT01542632|79075118|FG003|Overall Study|Adverse Event|0|||
44245203|NCT01542632|79075119|FG004|Overall Study|Adverse Event|0|||
44245204|NCT01542632|79075120|FG005|Overall Study|Adverse Event|0|||
44245205|NCT01542632|79075115|FG000|Overall Study|Lost to Follow-up|0|||
44245206|NCT01542632|79075116|FG001|Overall Study|Lost to Follow-up|1|||
44245207|NCT01542632|79075117|FG002|Overall Study|Lost to Follow-up|0|||
44245208|NCT01542632|79075118|FG003|Overall Study|Lost to Follow-up|0|||
44245209|NCT01542632|79075119|FG004|Overall Study|Lost to Follow-up|0|||
44245210|NCT01542632|79075120|FG005|Overall Study|Lost to Follow-up|0|||
44245211|NCT01542632|79075115|FG000|Overall Study|Sponsor/Investigator Decision|0|||
44245212|NCT01542632|79075116|FG001|Overall Study|Sponsor/Investigator Decision|0|||
44245213|NCT01542632|79075117|FG002|Overall Study|Sponsor/Investigator Decision|0|||
44245214|NCT01542632|79075118|FG003|Overall Study|Sponsor/Investigator Decision|0|||
44245215|NCT01542632|79075119|FG004|Overall Study|Sponsor/Investigator Decision|1|||
44245216|NCT01542632|79075120|FG005|Overall Study|Sponsor/Investigator Decision|0|||
44245217|NCT01557842|79075141|FG000|Overall Study|Lost to Follow-up|0|||
44245218|NCT01557842|79075142|FG001|Overall Study|Lost to Follow-up|1|||
44245219|NCT01557842|79075141|FG000|Overall Study|Death|1|||
44245220|NCT01557842|79075142|FG001|Overall Study|Death|0|||
44245221|NCT01557842|79075141|FG000|Overall Study|Lack of Efficacy|0|||
44245222|NCT01557842|79075142|FG001|Overall Study|Lack of Efficacy|1|||
44245223|NCT01557842|79075141|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
44245224|NCT01557842|79075142|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
44245225|NCT01557842|79075141|FG000|Overall Study|Study Terminated by Sponsor|3|||
44245226|NCT01557842|79075142|FG001|Overall Study|Study Terminated by Sponsor|4|||
44245227|NCT01557842|79075141|FG000|Overall Study|Not Ablated|2|||
44245228|NCT01557842|79075142|FG001|Overall Study|Not Ablated|0|||
44245229|NCT01541930|79075148|FG000|Overall Study|Withdrawal by Subject|1|||
44245230|NCT01576016|79075165|FG000|Lead Safety|Death|132|||
44245231|NCT01576016|79075166|FG001|Lead Safety|Death|0|||
44245232|NCT01576016|79075165|FG000|Lead Safety|Withdrawal by Subject|81|||
44245233|NCT01576016|79075166|FG001|Lead Safety|Withdrawal by Subject|0|||
44245234|NCT01576016|79075165|FG000|Lead Safety|System Explanted without Replacement|24|||
44245235|NCT01576016|79075166|FG001|Lead Safety|System Explanted without Replacement|0|||
44245236|NCT01576016|79075165|FG000|Lead Safety|Physician Decision|14|||
44245237|NCT01576016|79075166|FG001|Lead Safety|Physician Decision|0|||
44245238|NCT01576016|79075165|FG000|Lead Safety|Lost to Follow-up|13|||
44245239|NCT01576016|79075166|FG001|Lead Safety|Lost to Follow-up|0|||
44245240|NCT01576016|79075165|FG000|Lead Safety|Unsuccessful implant|2|||
44245241|NCT01576016|79075166|FG001|Lead Safety|Unsuccessful implant|0|||
44245242|NCT01576016|79075165|FG000|Lead Safety|Sponsor request|1|||
44245243|NCT01576016|79075166|FG001|Lead Safety|Sponsor request|0|||
44245244|NCT01576016|79075165|FG000|Lead Safety|Device replaced with CRT-D|1|||
44245245|NCT01576016|79075166|FG001|Lead Safety|Device replaced with CRT-D|0|||
44245246|NCT01576016|79075165|FG000|Lead Safety|Patient on Palliative Care|1|||
44245247|NCT01576016|79075166|FG001|Lead Safety|Patient on Palliative Care|0|||
44245248|NCT01576016|79075165|FG000|Lead Safety|Patient noncompliance|1|||
44245249|NCT01576016|79075166|FG001|Lead Safety|Patient noncompliance|0|||
44245250|NCT01576016|79075165|FG000|Lead Safety|Too far from study site|1|||
44245251|NCT01576016|79075166|FG001|Lead Safety|Too far from study site|0|||
44245252|NCT01576016|79075165|FG000|Lead Safety|System deactivated|1|||
44245253|NCT01576016|79075166|FG001|Lead Safety|System deactivated|0|||
44245254|NCT01576016|79075165|FG000|Lead Safety|Patient no longer followed by study PI|1|||
44245255|NCT01576016|79075166|FG001|Lead Safety|Patient no longer followed by study PI|0|||
44245256|NCT01576016|79075165|FG000|MRI Safety|Withdrawal by Subject|0|||
44245257|NCT01576016|79075166|FG001|MRI Safety|Withdrawal by Subject|10|||
44245258|NCT01576016|79075165|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
44245259|NCT01576016|79075166|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
44245260|NCT01576016|79075165|FG000|MRI Safety|Has not yet completed MRI scan|0|||
44245261|NCT01576016|79075166|FG001|MRI Safety|Has not yet completed MRI scan|56|||
44245262|NCT01576016|79075165|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
44245263|NCT01576016|79075166|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
44245264|NCT01540838|79075176|FG000|Overall Study|Open nasogastric tube|9|||
44245265|NCT01540838|79075177|FG001|Overall Study|Open nasogastric tube|7|||
44245266|NCT01540838|79075176|FG000|Overall Study|Treatment doses missing|8|||
44245267|NCT01540838|79075177|FG001|Overall Study|Treatment doses missing|12|||
44245268|NCT01540838|79075176|FG000|Overall Study|Additional antibiotic treatment|1|||
44245269|NCT01540838|79075177|FG001|Overall Study|Additional antibiotic treatment|2|||
44245270|NCT01540838|79075176|FG000|Overall Study|Died before treatment initiation|1|||
44245271|NCT01540838|79075177|FG001|Overall Study|Died before treatment initiation|1|||
44245272|NCT01540838|79075176|FG000|Overall Study|Not BM. Other treatment|3|||
44245273|NCT01540838|79075177|FG001|Overall Study|Not BM. Other treatment|1|||
44245274|NCT01451437|79075192|FG000|Overall Study|Adverse Event|0|||
44245275|NCT01451437|79075193|FG001|Overall Study|Adverse Event|0|||
44245276|NCT01451437|79075194|FG002|Overall Study|Adverse Event|0|||
44245277|NCT01451437|79075195|FG003|Overall Study|Adverse Event|0|||
44245278|NCT01451437|79075196|FG004|Overall Study|Adverse Event|0|||
44245279|NCT01451437|79075197|FG005|Overall Study|Adverse Event|1|||
44245280|NCT01451437|79075198|FG006|Overall Study|Adverse Event|1|||
44245281|NCT01451437|79075199|FG007|Overall Study|Adverse Event|2|||
44245282|NCT01451437|79075200|FG008|Overall Study|Adverse Event|1|||
44245283|NCT01451437|79075192|FG000|Overall Study|Physician Decision|1|||
44245284|NCT01451437|79075193|FG001|Overall Study|Physician Decision|1|||
44245285|NCT01451437|79075194|FG002|Overall Study|Physician Decision|2|||
44245286|NCT01451437|79075195|FG003|Overall Study|Physician Decision|0|||
44245287|NCT01451437|79075196|FG004|Overall Study|Physician Decision|0|||
44245288|NCT01451437|79075197|FG005|Overall Study|Physician Decision|0|||
44245289|NCT01451437|79075198|FG006|Overall Study|Physician Decision|0|||
44245290|NCT01451437|79075199|FG007|Overall Study|Physician Decision|0|||
44245291|NCT01451437|79075200|FG008|Overall Study|Physician Decision|0|||
44245292|NCT01451437|79075192|FG000|Overall Study|Disease Progression|0|||
44245293|NCT01451437|79075193|FG001|Overall Study|Disease Progression|0|||
44245294|NCT01451437|79075194|FG002|Overall Study|Disease Progression|1|||
44245295|NCT01451437|79075195|FG003|Overall Study|Disease Progression|1|||
44245296|NCT01451437|79075196|FG004|Overall Study|Disease Progression|3|||
44245297|NCT01451437|79075197|FG005|Overall Study|Disease Progression|2|||
44245298|NCT01451437|79075198|FG006|Overall Study|Disease Progression|3|||
44245299|NCT01451437|79075199|FG007|Overall Study|Disease Progression|1|||
44245300|NCT01451437|79075200|FG008|Overall Study|Disease Progression|3|||
44245301|NCT01451437|79075192|FG000|Overall Study|Protocol Violation|0|||
44245302|NCT01451437|79075193|FG001|Overall Study|Protocol Violation|0|||
44245303|NCT01451437|79075194|FG002|Overall Study|Protocol Violation|0|||
44245304|NCT01451437|79075195|FG003|Overall Study|Protocol Violation|0|||
44245305|NCT01451437|79075196|FG004|Overall Study|Protocol Violation|0|||
44245306|NCT01451437|79075197|FG005|Overall Study|Protocol Violation|0|||
44245307|NCT01451437|79075198|FG006|Overall Study|Protocol Violation|1|||
44245308|NCT01451437|79075199|FG007|Overall Study|Protocol Violation|0|||
44245309|NCT01451437|79075200|FG008|Overall Study|Protocol Violation|0|||
44514146|NCT01844518|79519499|FG000|Overall Study|Pregnancy|1|||
44514147|NCT01844518|79519500|FG001|Overall Study|Pregnancy|0|||
44143327|NCT01602315|78932647|FG003|Overall Study|Cross-over patients to combo treatment|0|||
44143328|NCT01602315|78932648|FG004|Overall Study|Cross-over patients to combo treatment|0|||
44143329|NCT01602315|78932649|FG005|Overall Study|Cross-over patients to combo treatment|16|||
44143330|NCT01602315|78932650|FG006|Overall Study|Cross-over patients to combo treatment|0|||
44143331|NCT02344004|78932697|FG000|Overall Study|Adverse Event|11|||
44143332|NCT02344004|78932698|FG001|Overall Study|Adverse Event|1|||
44143333|NCT02344004|78932697|FG000|Overall Study|Death|9|||
44143334|NCT02344004|78932698|FG001|Overall Study|Death|7|||
44143335|NCT02344004|78932697|FG000|Overall Study|Physician Decision|4|||
44143336|NCT02344004|78932698|FG001|Overall Study|Physician Decision|1|||
44143337|NCT02344004|78932697|FG000|Overall Study|Withdrawal by Subject|22|||
44143338|NCT02344004|78932698|FG001|Overall Study|Withdrawal by Subject|5|||
44143339|NCT02344004|78932697|FG000|Overall Study|Rescue Medication|2|||
44143340|NCT02344004|78932698|FG001|Overall Study|Rescue Medication|0|||
44143341|NCT02344004|78932697|FG000|Overall Study|Other Not Specified|12|||
44143342|NCT02344004|78932698|FG001|Overall Study|Other Not Specified|0|||
44143343|NCT02344004|78932697|FG000|Overall Study|Protocol Violation|1|||
44143344|NCT02344004|78932698|FG001|Overall Study|Protocol Violation|0|||
44143345|NCT01328093|78932707|FG000|Double-Blind Phase|Adverse Event|78|||
44143346|NCT01328093|78932708|FG001|Double-Blind Phase|Adverse Event|15|||
44143347|NCT01328093|78932707|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
44143348|NCT01328093|78932708|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
44143349|NCT01328093|78932707|FG000|Double-Blind Phase|Lost to Follow-up|39|||
44143350|NCT01328093|78932708|FG001|Double-Blind Phase|Lost to Follow-up|14|||
44143351|NCT01328093|78932707|FG000|Double-Blind Phase|Protocol Violation|30|||
44143352|NCT01328093|78932708|FG001|Double-Blind Phase|Protocol Violation|10|||
44245310|NCT01451437|79075192|FG000|Overall Study|Withdrawal by Subject|0|||
44245311|NCT01451437|79075193|FG001|Overall Study|Withdrawal by Subject|0|||
44245312|NCT01451437|79075194|FG002|Overall Study|Withdrawal by Subject|0|||
44514148|NCT01039584|79519569|FG000|Overall Study|Withdrawal by Subject|4|||
44514149|NCT01039584|79519570|FG001|Overall Study|Withdrawal by Subject|2|||
44245313|NCT01451437|79075195|FG003|Overall Study|Withdrawal by Subject|0|||
44514150|NCT01039584|79519571|FG002|Overall Study|Withdrawal by Subject|1|||
44514151|NCT01039584|79519569|FG000|Overall Study|Protocol Violation|10|||
44514152|NCT01039584|79519570|FG001|Overall Study|Protocol Violation|4|||
44514153|NCT01039584|79519571|FG002|Overall Study|Protocol Violation|6|||
44143353|NCT01328093|78932707|FG000|Double-Blind Phase|Lack of Efficacy|55|||
44143354|NCT01328093|78932708|FG001|Double-Blind Phase|Lack of Efficacy|13|||
44143355|NCT01328093|78932707|FG000|Double-Blind Phase|Sponsor Decision|17|||
44143356|NCT01328093|78932708|FG001|Double-Blind Phase|Sponsor Decision|3|||
44245314|NCT01451437|79075196|FG004|Overall Study|Withdrawal by Subject|1|||
44245315|NCT01451437|79075197|FG005|Overall Study|Withdrawal by Subject|0|||
44245316|NCT01451437|79075198|FG006|Overall Study|Withdrawal by Subject|1|||
44245317|NCT01451437|79075199|FG007|Overall Study|Withdrawal by Subject|0|||
44245318|NCT01451437|79075200|FG008|Overall Study|Withdrawal by Subject|0|||
44245319|NCT01451203|79075231|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
44514154|NCT01039584|79519569|FG000|Overall Study|Lost to Follow-up|5|||
44245320|NCT01451203|79075232|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
44245321|NCT01451203|79075231|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
44245322|NCT01451203|79075232|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
44245323|NCT01451203|79075231|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
44245324|NCT01451203|79075232|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
44245325|NCT01451203|79075231|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
44245326|NCT01451203|79075232|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
44245327|NCT01451203|79075231|FG000|Double-blind Treatment Period|Adverse Event|6|||
44245328|NCT01451203|79075232|FG001|Double-blind Treatment Period|Adverse Event|9|||
44245329|NCT01451203|79075231|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
44245330|NCT01451203|79075232|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
44245331|NCT01451203|79075231|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
44245332|NCT01451203|79075232|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
44245333|NCT01451203|79075231|FG000|Double-blind Treatment Period|Investigator decision|2|||
44245334|NCT01451203|79075232|FG001|Double-blind Treatment Period|Investigator decision|0|||
44245335|NCT01451203|79075231|FG000|Post-treatment Period|Consent withdrawn|2|||
44245336|NCT01451203|79075232|FG001|Post-treatment Period|Consent withdrawn|4|||
44245337|NCT01451203|79075231|FG000|Post-treatment Period|Lack of Efficacy|12|||
44245338|NCT01451203|79075232|FG001|Post-treatment Period|Lack of Efficacy|28|||
44245339|NCT01451203|79075231|FG000|Post-treatment Period|Adverse Event|0|||
44245340|NCT01451203|79075232|FG001|Post-treatment Period|Adverse Event|1|||
44245341|NCT01451203|79075231|FG000|Post-treatment Period|Investigator decision|0|||
44245342|NCT01451203|79075232|FG001|Post-treatment Period|Investigator decision|1|||
44245343|NCT01556438|79075240|FG000|Overall Study|Adverse Event|4|||
44245344|NCT01556438|79075241|FG001|Overall Study|Adverse Event|2|||
44245345|NCT01556438|79075240|FG000|Overall Study|Sponsor Decision|0|||
44245346|NCT01556438|79075241|FG001|Overall Study|Sponsor Decision|2|||
44245347|NCT01556438|79075240|FG000|Overall Study|Progressive Disease|0|||
44245348|NCT01556438|79075241|FG001|Overall Study|Progressive Disease|6|||
44245349|NCT01556438|79075240|FG000|Overall Study|Death|0|||
44245350|NCT01556438|79075241|FG001|Overall Study|Death|1|||
44245351|NCT01554176|79075267|FG000|Treatment Phase|Protocol Violation|1|||
44245352|NCT01554176|79075268|FG001|Treatment Phase|Protocol Violation|2|||
44245353|NCT01554176|79075269|FG002|Treatment Phase|Protocol Violation|0|||
44245354|NCT01554176|79075270|FG003|Treatment Phase|Protocol Violation|0|||
44245355|NCT01554176|79075271|FG004|Treatment Phase|Protocol Violation|0|||
44245356|NCT01554176|79075267|FG000|Treatment Phase|Physician Decision|1|||
44245357|NCT01554176|79075268|FG001|Treatment Phase|Physician Decision|1|||
44245358|NCT01554176|79075269|FG002|Treatment Phase|Physician Decision|0|||
44245359|NCT01554176|79075270|FG003|Treatment Phase|Physician Decision|0|||
44245360|NCT01554176|79075271|FG004|Treatment Phase|Physician Decision|0|||
44245361|NCT01554176|79075267|FG000|Treatment Phase|Lack of Efficacy|0|||
44245362|NCT01554176|79075268|FG001|Treatment Phase|Lack of Efficacy|1|||
44245363|NCT01554176|79075269|FG002|Treatment Phase|Lack of Efficacy|0|||
44245364|NCT01554176|79075270|FG003|Treatment Phase|Lack of Efficacy|0|||
44245365|NCT01554176|79075271|FG004|Treatment Phase|Lack of Efficacy|0|||
44245366|NCT01554176|79075267|FG000|Treatment Phase|Adverse event, non-fatal|1|||
44245367|NCT01554176|79075268|FG001|Treatment Phase|Adverse event, non-fatal|1|||
44245368|NCT01554176|79075269|FG002|Treatment Phase|Adverse event, non-fatal|0|||
44245369|NCT01554176|79075270|FG003|Treatment Phase|Adverse event, non-fatal|0|||
44245370|NCT01554176|79075271|FG004|Treatment Phase|Adverse event, non-fatal|0|||
44245371|NCT01554176|79075267|FG000|Treatment Phase|Non-compliance with study drug|1|||
44245372|NCT01554176|79075268|FG001|Treatment Phase|Non-compliance with study drug|0|||
44245373|NCT01554176|79075269|FG002|Treatment Phase|Non-compliance with study drug|0|||
44245374|NCT01554176|79075270|FG003|Treatment Phase|Non-compliance with study drug|0|||
44245375|NCT01554176|79075271|FG004|Treatment Phase|Non-compliance with study drug|0|||
44245376|NCT01554176|79075267|FG000|Treatment Phase|Withdrawal by Subject|1|||
44245377|NCT01554176|79075268|FG001|Treatment Phase|Withdrawal by Subject|0|||
44514155|NCT01039584|79519570|FG001|Overall Study|Lost to Follow-up|3|||
44514156|NCT01039584|79519571|FG002|Overall Study|Lost to Follow-up|4|||
44514157|NCT01039584|79519569|FG000|Overall Study|Negative Baseline culture for Candida|59|||
44514158|NCT01039584|79519570|FG001|Overall Study|Negative Baseline culture for Candida|59|||
44514159|NCT01039584|79519571|FG002|Overall Study|Negative Baseline culture for Candida|24|||
44514160|NCT01039584|79519569|FG000|Overall Study|Lack of Efficacy|7|||
44514161|NCT01039584|79519570|FG001|Overall Study|Lack of Efficacy|6|||
44514162|NCT01039584|79519571|FG002|Overall Study|Lack of Efficacy|10|||
44245378|NCT01554176|79075269|FG002|Treatment Phase|Withdrawal by Subject|0|||
44245379|NCT01554176|79075270|FG003|Treatment Phase|Withdrawal by Subject|0|||
44245380|NCT01554176|79075271|FG004|Treatment Phase|Withdrawal by Subject|0|||
44514163|NCT01039584|79519569|FG000|Overall Study|other|1|||
44143357|NCT01328093|78932707|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
44514164|NCT01039584|79519570|FG001|Overall Study|other|3|||
44514165|NCT01039584|79519571|FG002|Overall Study|other|1|||
44514166|NCT01039584|79519569|FG000|Overall Study|Pap smear with significant pathology|10|||
44245381|NCT01554176|79075267|FG000|Treatment Phase|Lost to Follow-up|3|||
44245382|NCT01554176|79075268|FG001|Treatment Phase|Lost to Follow-up|0|||
44245383|NCT01554176|79075269|FG002|Treatment Phase|Lost to Follow-up|0|||
44245384|NCT01554176|79075270|FG003|Treatment Phase|Lost to Follow-up|0|||
44245385|NCT01554176|79075271|FG004|Treatment Phase|Lost to Follow-up|0|||
44245386|NCT01554176|79075267|FG000|Run-out Phase|Protocol Violation|0|||
44245387|NCT01554176|79075268|FG001|Run-out Phase|Protocol Violation|0|||
44245388|NCT01554176|79075269|FG002|Run-out Phase|Protocol Violation|0|||
44245389|NCT01554176|79075270|FG003|Run-out Phase|Protocol Violation|1|||
44245390|NCT01554176|79075271|FG004|Run-out Phase|Protocol Violation|0|||
44245391|NCT01466491|79075287|FG000|Overall Study|Protocol Violation|0|||
44245392|NCT01466491|79075288|FG001|Overall Study|Protocol Violation|3|||
44245393|NCT01466491|79075289|FG002|Overall Study|Protocol Violation|2|||
44245394|NCT01466491|79075290|FG003|Overall Study|Protocol Violation|0|||
44245395|NCT01466491|79075287|FG000|Overall Study|Missing Data|0|||
44245396|NCT01466491|79075288|FG001|Overall Study|Missing Data|0|||
44245397|NCT01466491|79075289|FG002|Overall Study|Missing Data|1|||
44245398|NCT01466491|79075290|FG003|Overall Study|Missing Data|0|||
44245399|NCT01466179|79075300|FG000|Overall Study|Ongoing in core study|2|||
44245400|NCT01466179|79075300|FG000|Overall Study|Physician Decision|46|||
44245401|NCT01466179|79075300|FG000|Overall Study|Progressive disease|43|||
44245402|NCT01466179|79075300|FG000|Overall Study|Adverse Event|32|||
44245403|NCT01466179|79075300|FG000|Overall Study|Disease relapse|23|||
44245404|NCT01466179|79075300|FG000|Overall Study|Lack of Efficacy|14|||
44245405|NCT01466179|79075300|FG000|Overall Study|Death|7|||
44245406|NCT01466179|79075300|FG000|Overall Study|Withdrawal by Subject|7|||
44245407|NCT01466179|79075300|FG000|Overall Study|Protocol Violation|2|||
44245408|NCT01466179|79075300|FG000|Overall Study|Other|3|||
44245409|NCT01493089|79075309|FG000|Overall Study|Protocol Violation|2|||
44245410|NCT01493089|79075310|FG001|Overall Study|Protocol Violation|2|||
44245411|NCT01493089|79075309|FG000|Overall Study|Withdrawal by Subject|1|||
44245412|NCT01493089|79075310|FG001|Overall Study|Withdrawal by Subject|0|||
44245413|NCT01493089|79075309|FG000|Overall Study|Physician Decision|0|||
44245414|NCT01493089|79075310|FG001|Overall Study|Physician Decision|1|||
44245415|NCT01450813|79075322|FG000|Overall Study|Physician Decision|1|||
44245416|NCT01450813|79075323|FG001|Overall Study|Physician Decision|1|||
44245417|NCT01450813|79075324|FG002|Overall Study|Physician Decision|0|||
44245418|NCT01450813|79075325|FG003|Overall Study|Physician Decision|3|||
44245419|NCT01539512|79075339|FG000|Overall Study|Adverse Event|9|||
44245420|NCT01539512|79075340|FG001|Overall Study|Adverse Event|7|||
44245421|NCT01539512|79075339|FG000|Overall Study|Physician Decision|1|||
44245422|NCT01539512|79075340|FG001|Overall Study|Physician Decision|1|||
44276735|NCT03234907|79237688|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
44514167|NCT01039584|79519570|FG001|Overall Study|Pap smear with significant pathology|10|||
44514168|NCT01039584|79519571|FG002|Overall Study|Pap smear with significant pathology|3|||
44514169|NCT01039584|79519569|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
44514170|NCT01039584|79519570|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
44514171|NCT01039584|79519571|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
44514172|NCT00920387|79519581|FG000|Stage 1|Adverse Event|1|||
44514173|NCT00920387|79519582|FG001|Stage 1|Adverse Event|0|||
44514174|NCT00920387|79519583|FG002|Stage 1|Adverse Event|0|||
44514175|NCT00679783|79519608|FG000|Overall Study|Adverse Event|0|||
44514176|NCT00679783|79519609|FG001|Overall Study|Adverse Event|0|||
44143358|NCT01328093|78932708|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
44143359|NCT01328093|78932707|FG000|Double-Blind Phase|Scheduling conflict|8|||
44514177|NCT00679783|79519610|FG002|Overall Study|Adverse Event|0|||
44245423|NCT01539512|79075339|FG000|Overall Study|Withdrawal by Subject|12|||
44245424|NCT01539512|79075340|FG001|Overall Study|Withdrawal by Subject|5|||
44245425|NCT01539512|79075339|FG000|Overall Study|Richter's Transformation|1|||
44245426|NCT01539512|79075340|FG001|Overall Study|Richter's Transformation|0|||
44245427|NCT01449955|79075348|FG000|Overall Study|Withdrawal by Subject|1|||
44514178|NCT00679783|79519611|FG003|Overall Study|Adverse Event|3|||
44245428|NCT01449955|79075349|FG001|Overall Study|Withdrawal by Subject|2|||
44245429|NCT01574612|79075362|FG000|Overall Study|Adverse Event|3|||
44245430|NCT01574612|79075362|FG000|Overall Study|non compliant with drug|2|||
44245431|NCT01574612|79075362|FG000|Overall Study|Withdrawal by Subject|1|||
44245432|NCT01574612|79075362|FG000|Overall Study|Lost to Follow-up|2|||
44245433|NCT01573910|79075368|FG000|Overall Study|Adverse Event|4|||
44245434|NCT01573910|79075369|FG001|Overall Study|Adverse Event|4|||
44245435|NCT01573910|79075368|FG000|Overall Study|Lost to Follow-up|2|||
44245436|NCT01573910|79075369|FG001|Overall Study|Lost to Follow-up|1|||
44245437|NCT01573910|79075368|FG000|Overall Study|Withdrawal by Subject|0|||
44245438|NCT01573910|79075369|FG001|Overall Study|Withdrawal by Subject|1|||
44245439|NCT01573910|79075368|FG000|Overall Study|Protocol Violation|3|||
44245440|NCT01573910|79075369|FG001|Overall Study|Protocol Violation|0|||
44245441|NCT01573910|79075368|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
44245442|NCT01573910|79075369|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
44245443|NCT01491919|79075378|FG000|Overall Study|Insufficient PK sampling|1|||
44245444|NCT01491919|79075379|FG001|Overall Study|Insufficient PK sampling|2|||
44245445|NCT01491919|79075380|FG002|Overall Study|Insufficient PK sampling|1|||
44245446|NCT01573442|79075392|FG000|Overall Study|Cancels|9|||
44245447|NCT01573442|79075393|FG001|Overall Study|Cancels|10|||
44245448|NCT01491841|79075462|FG000|Overall Study|Screen Failure|10|||
44245449|NCT01491841|79075462|FG000|Overall Study|Withdrawal by Subject|1|||
44245450|NCT01553318|79075481|FG000|Overall Study|Protocol Violation|3|||
44245451|NCT01553318|79075482|FG001|Overall Study|Protocol Violation|2|||
44245452|NCT01572740|79075501|FG000|Overall Study|Adverse Event|1|||
44245453|NCT01572740|79075502|FG001|Overall Study|Adverse Event|1|||
44245454|NCT01572740|79075501|FG000|Overall Study|Withdrawal by Subject|1|||
44245455|NCT01572740|79075502|FG001|Overall Study|Withdrawal by Subject|1|||
44245456|NCT01572740|79075501|FG000|Overall Study|unclassified|4|||
44245457|NCT01572740|79075502|FG001|Overall Study|unclassified|3|||
44245458|NCT01491607|79075512|FG000|Overall Study|Lost to Follow-up|7|||
44245459|NCT01491607|79075512|FG000|Overall Study|Withdrawal by Subject|3|||
44245460|NCT01449721|79075595|FG000|Overall Study|Physician Decision|0|||
44245461|NCT01449721|79075596|FG001|Overall Study|Physician Decision|1|||
44245462|NCT01449721|79075595|FG000|Overall Study|Physician Decision|0|||
44245463|NCT01449721|79075596|FG001|Overall Study|Physician Decision|1|||
44245464|NCT01553084|79075605|FG000|Overall Study|Withdrawal by Subject|15|||
44245465|NCT01553084|79075606|FG001|Overall Study|Withdrawal by Subject|13|||
44276736|NCT03234907|79237689|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
44514179|NCT00679783|79519612|FG004|Overall Study|Adverse Event|0|||
44514180|NCT00679783|79519613|FG005|Overall Study|Adverse Event|0|||
44514181|NCT00679783|79519614|FG006|Overall Study|Adverse Event|1|||
44514182|NCT00679783|79519608|FG000|Overall Study|Lack of Efficacy|0|||
44514183|NCT00679783|79519609|FG001|Overall Study|Lack of Efficacy|1|||
44514184|NCT00679783|79519610|FG002|Overall Study|Lack of Efficacy|0|||
44514185|NCT00679783|79519611|FG003|Overall Study|Lack of Efficacy|2|||
44514186|NCT00679783|79519612|FG004|Overall Study|Lack of Efficacy|0|||
44514187|NCT00679783|79519613|FG005|Overall Study|Lack of Efficacy|0|||
44514188|NCT00679783|79519614|FG006|Overall Study|Lack of Efficacy|0|||
44143360|NCT01328093|78932708|FG001|Double-Blind Phase|Scheduling conflict|3|||
44143361|NCT01328093|78932707|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
44245466|NCT01553084|79075607|FG002|Overall Study|Withdrawal by Subject|35|||
44245467|NCT01536860|79075617|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
44245468|NCT01536860|79075618|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
44245469|NCT01536860|79075619|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
44245470|NCT01552928|79075631|FG000|Period 3|Adverse Event|0|||
44245471|NCT01552928|79075632|FG001|Period 3|Adverse Event|0|||
44245472|NCT01552928|79075633|FG002|Period 3|Adverse Event|1|||
44514189|NCT00679783|79519608|FG000|Overall Study|Withdrawal by Subject|0|||
44514190|NCT00679783|79519609|FG001|Overall Study|Withdrawal by Subject|0|||
44245473|NCT01552928|79075634|FG003|Period 3|Adverse Event|0|||
44245474|NCT01448707|79075653|FG000|Overall Study|Adverse Event|3|||
44245475|NCT01448707|79075654|FG001|Overall Study|Adverse Event|1|||
44245476|NCT01448707|79075653|FG000|Overall Study|Lost to Follow-up|2|||
44245477|NCT01448707|79075654|FG001|Overall Study|Lost to Follow-up|6|||
44245478|NCT01448707|79075653|FG000|Overall Study|Withdrawal by Subject|6|||
44245479|NCT01448707|79075654|FG001|Overall Study|Withdrawal by Subject|7|||
44245480|NCT01448707|79075653|FG000|Overall Study|Other|7|||
44245481|NCT01448707|79075654|FG001|Overall Study|Other|4|||
44245482|NCT01536704|79075660|FG000|Washout Period 1|Withdrawal by Subject|1|||
44245483|NCT01536704|79075661|FG001|Washout Period 1|Withdrawal by Subject|2|||
44245484|NCT01536704|79075662|FG002|Washout Period 1|Withdrawal by Subject|0|||
44245485|NCT01536704|79075663|FG003|Washout Period 1|Withdrawal by Subject|0|||
44245486|NCT01536704|79075660|FG000|Washout Period 2|Adverse Event|1|||
44245487|NCT01536704|79075661|FG001|Washout Period 2|Adverse Event|0|||
44245488|NCT01536704|79075662|FG002|Washout Period 2|Adverse Event|0|||
44245489|NCT01536704|79075663|FG003|Washout Period 2|Adverse Event|0|||
44245490|NCT01536704|79075660|FG000|Washout Period 2|Withdrawal by Subject|0|||
44245491|NCT01536704|79075661|FG001|Washout Period 2|Withdrawal by Subject|0|||
44245492|NCT01536704|79075662|FG002|Washout Period 2|Withdrawal by Subject|0|||
44245493|NCT01536704|79075663|FG003|Washout Period 2|Withdrawal by Subject|1|||
44245494|NCT01536704|79075660|FG000|Period 3|Adverse Event|0|||
44245495|NCT01536704|79075661|FG001|Period 3|Adverse Event|0|||
44245496|NCT01536704|79075662|FG002|Period 3|Adverse Event|0|||
44245497|NCT01536704|79075663|FG003|Period 3|Adverse Event|1|||
44245498|NCT01536704|79075660|FG000|Washout Period 3|Adverse Event|0|||
44245499|NCT01536704|79075661|FG001|Washout Period 3|Adverse Event|0|||
44245500|NCT01536704|79075662|FG002|Washout Period 3|Adverse Event|1|||
44245501|NCT01536704|79075663|FG003|Washout Period 3|Adverse Event|0|||
44245502|NCT01552772|79075677|FG000|Overall Study|Lost to Follow-up|2|||
44245503|NCT01552772|79075677|FG000|Overall Study|Adverse Event|1|||
44245504|NCT01552772|79075677|FG000|Overall Study|Protocol Deviation|1|||
44245505|NCT01552694|79075684|FG000|Overall Study|Lost to Follow-up|0|||
44245506|NCT01552694|79075685|FG001|Overall Study|Lost to Follow-up|1|||
44245507|NCT01552694|79075684|FG000|Overall Study|Protocol Violation|0|||
44245508|NCT01552694|79075685|FG001|Overall Study|Protocol Violation|1|||
44245509|NCT01464931|79075693|FG000|Overall Study|Withdrawal by Subject|1|||
44245510|NCT01464931|79075694|FG001|Overall Study|Withdrawal by Subject|0|||
44245511|NCT01536392|79075719|FG000|Overall Study|Adverse Event|2|||
44245512|NCT01536392|79075720|FG001|Overall Study|Adverse Event|2|||
44245513|NCT01536392|79075719|FG000|Overall Study|Physician Decision|2|||
44245514|NCT01536392|79075720|FG001|Overall Study|Physician Decision|3|||
44245515|NCT01536392|79075719|FG000|Overall Study|Withdrawal by Subject|3|||
44245516|NCT01536392|79075720|FG001|Overall Study|Withdrawal by Subject|6|||
44245517|NCT01536392|79075719|FG000|Overall Study|Non Compliance|3|||
44245518|NCT01536392|79075720|FG001|Overall Study|Non Compliance|4|||
44245519|NCT01536392|79075719|FG000|Overall Study|Completed therapy early|3|||
44245520|NCT01536392|79075720|FG001|Overall Study|Completed therapy early|0|||
44245521|NCT01464619|79075728|FG000|Overall Study|Lost to Follow-up|3|||
44245522|NCT01464619|79075729|FG001|Overall Study|Lost to Follow-up|4|||
44245523|NCT01490125|79075795|FG000|Period I|Adverse Event|4|||
44245524|NCT01490125|79075796|FG001|Period I|Adverse Event|1|||
44245525|NCT01490125|79075797|FG002|Period I|Adverse Event|1|||
44245526|NCT01490125|79075798|FG003|Period I|Adverse Event|3|||
44245527|NCT01490125|79075799|FG004|Period I|Adverse Event|2|||
44245528|NCT01490125|79075800|FG005|Period I|Adverse Event|4|||
44245529|NCT01490125|79075795|FG000|Period I|Protocol Violation|1|||
44245530|NCT01490125|79075796|FG001|Period I|Protocol Violation|1|||
44245531|NCT01490125|79075797|FG002|Period I|Protocol Violation|1|||
44245532|NCT01490125|79075798|FG003|Period I|Protocol Violation|1|||
44245533|NCT01490125|79075799|FG004|Period I|Protocol Violation|0|||
44245534|NCT01490125|79075800|FG005|Period I|Protocol Violation|0|||
44245535|NCT01490125|79075795|FG000|Period I|Withdrawal by Subject|1|||
44245536|NCT01490125|79075796|FG001|Period I|Withdrawal by Subject|3|||
44245537|NCT01490125|79075797|FG002|Period I|Withdrawal by Subject|2|||
44245538|NCT01490125|79075798|FG003|Period I|Withdrawal by Subject|1|||
44245539|NCT01490125|79075799|FG004|Period I|Withdrawal by Subject|2|||
44245540|NCT01490125|79075800|FG005|Period I|Withdrawal by Subject|1|||
44245541|NCT01490125|79075795|FG000|Period II|Adverse Event|2|||
44245542|NCT01490125|79075796|FG001|Period II|Adverse Event|3|||
44245543|NCT01490125|79075797|FG002|Period II|Adverse Event|2|||
44245544|NCT01490125|79075798|FG003|Period II|Adverse Event|2|||
44245545|NCT01490125|79075799|FG004|Period II|Adverse Event|4|||
44245546|NCT01490125|79075800|FG005|Period II|Adverse Event|2|||
44245547|NCT01490125|79075795|FG000|Period II|Protocol Violation|0|||
44245548|NCT01490125|79075796|FG001|Period II|Protocol Violation|0|||
44245549|NCT01490125|79075797|FG002|Period II|Protocol Violation|1|||
44245550|NCT01490125|79075798|FG003|Period II|Protocol Violation|1|||
44245551|NCT01490125|79075799|FG004|Period II|Protocol Violation|0|||
44245552|NCT01490125|79075800|FG005|Period II|Protocol Violation|0|||
44245553|NCT01490125|79075795|FG000|Period II|Lost to Follow-up|0|||
44245554|NCT01490125|79075796|FG001|Period II|Lost to Follow-up|1|||
44245555|NCT01490125|79075797|FG002|Period II|Lost to Follow-up|0|||
44245556|NCT01490125|79075798|FG003|Period II|Lost to Follow-up|0|||
44245557|NCT01490125|79075799|FG004|Period II|Lost to Follow-up|0|||
44514191|NCT00679783|79519610|FG002|Overall Study|Withdrawal by Subject|1|||
44514192|NCT00679783|79519611|FG003|Overall Study|Withdrawal by Subject|1|||
44514193|NCT00679783|79519612|FG004|Overall Study|Withdrawal by Subject|0|||
44143362|NCT01328093|78932708|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
44143363|NCT01328093|78932707|FG000|Double-Blind Phase|Death|1|||
44143364|NCT01328093|78932708|FG001|Double-Blind Phase|Death|0|||
44143365|NCT01328093|78932707|FG000|Open-Label Phase|Sponsor Decision|98|||
44143366|NCT01328093|78932708|FG001|Open-Label Phase|Sponsor Decision|34|||
44143367|NCT01328093|78932707|FG000|Open-Label Phase|Protocol Violation|8|||
44143368|NCT01328093|78932708|FG001|Open-Label Phase|Protocol Violation|3|||
44143369|NCT01328093|78932707|FG000|Open-Label Phase|Lost to Follow-up|10|||
44143370|NCT01328093|78932708|FG001|Open-Label Phase|Lost to Follow-up|1|||
44143371|NCT01328093|78932707|FG000|Open-Label Phase|Adverse Event|10|||
44143372|NCT01328093|78932708|FG001|Open-Label Phase|Adverse Event|4|||
44143373|NCT01328093|78932707|FG000|Open-Label Phase|Lack of Efficacy|5|||
44514194|NCT00679783|79519613|FG005|Overall Study|Withdrawal by Subject|0|||
44514195|NCT00679783|79519614|FG006|Overall Study|Withdrawal by Subject|0|||
44514196|NCT00679783|79519608|FG000|Overall Study|Not Captured|0|||
44514197|NCT00679783|79519609|FG001|Overall Study|Not Captured|0|||
44514198|NCT00679783|79519610|FG002|Overall Study|Not Captured|0|||
44514199|NCT00679783|79519611|FG003|Overall Study|Not Captured|5|||
44514200|NCT00679783|79519612|FG004|Overall Study|Not Captured|0|||
44514201|NCT00679783|79519613|FG005|Overall Study|Not Captured|0|||
44514202|NCT00679783|79519614|FG006|Overall Study|Not Captured|0|||
44514203|NCT00679783|79519608|FG000|Overall Study|Ongoing at data cut-off|2|||
44514204|NCT00679783|79519609|FG001|Overall Study|Ongoing at data cut-off|2|||
44514205|NCT00679783|79519610|FG002|Overall Study|Ongoing at data cut-off|0|||
44514206|NCT00679783|79519611|FG003|Overall Study|Ongoing at data cut-off|9|||
44514207|NCT00679783|79519612|FG004|Overall Study|Ongoing at data cut-off|1|||
44514208|NCT00679783|79519613|FG005|Overall Study|Ongoing at data cut-off|0|||
44514209|NCT00679783|79519614|FG006|Overall Study|Ongoing at data cut-off|0|||
44514210|NCT03896490|79519636|FG000|Overall Study|Withdrawal by Subject|1|||
44514211|NCT03896490|79519637|FG001|Overall Study|Withdrawal by Subject|1|||
44514212|NCT03617172|79519645|FG000|Overall Study|Lost to Follow-up|1|||
44514213|NCT03617172|79519646|FG001|Overall Study|Lost to Follow-up|0|||
44514214|NCT03760146|79519658|FG000|Overall Study|Adverse Event|11|||
44514215|NCT03760146|79519659|FG001|Overall Study|Adverse Event|8|||
44514216|NCT03760146|79519660|FG002|Overall Study|Adverse Event|0|||
44514217|NCT03760146|79519661|FG003|Overall Study|Adverse Event|0|||
44514218|NCT03760146|79519662|FG004|Overall Study|Adverse Event|0|||
44514219|NCT03760146|79519663|FG005|Overall Study|Adverse Event|0|||
44514220|NCT03760146|79519658|FG000|Overall Study|Death|1|||
44514221|NCT03760146|79519659|FG001|Overall Study|Death|0|||
44514222|NCT03760146|79519660|FG002|Overall Study|Death|0|||
44514223|NCT03760146|79519661|FG003|Overall Study|Death|0|||
44514224|NCT03760146|79519662|FG004|Overall Study|Death|0|||
44514225|NCT03760146|79519663|FG005|Overall Study|Death|0|||
44514226|NCT03760146|79519658|FG000|Overall Study|Lost to Follow-up|41|||
44514227|NCT03760146|79519659|FG001|Overall Study|Lost to Follow-up|28|||
44514228|NCT03760146|79519660|FG002|Overall Study|Lost to Follow-up|9|||
44514229|NCT03760146|79519661|FG003|Overall Study|Lost to Follow-up|2|||
44514230|NCT03760146|79519662|FG004|Overall Study|Lost to Follow-up|14|||
44514231|NCT03760146|79519663|FG005|Overall Study|Lost to Follow-up|8|||
44143374|NCT01328093|78932708|FG001|Open-Label Phase|Lack of Efficacy|6|||
44143375|NCT01328093|78932707|FG000|Open-Label Phase|Withdrawal by Subject|4|||
44143376|NCT01328093|78932708|FG001|Open-Label Phase|Withdrawal by Subject|1|||
44143377|NCT01328093|78932707|FG000|Open-Label Phase|Scheduling conflict|2|||
44514232|NCT03760146|79519658|FG000|Overall Study|No longer met eligibility criteria|3|||
44143378|NCT01328093|78932708|FG001|Open-Label Phase|Scheduling conflict|1|||
44143379|NCT01328093|78932707|FG000|Open-Label Phase|Subject is moving or has moved|2|||
44514233|NCT03760146|79519659|FG001|Overall Study|No longer met eligibility criteria|9|||
44514234|NCT03760146|79519660|FG002|Overall Study|No longer met eligibility criteria|0|||
44514235|NCT03760146|79519661|FG003|Overall Study|No longer met eligibility criteria|0|||
44514236|NCT03760146|79519662|FG004|Overall Study|No longer met eligibility criteria|1|||
44514237|NCT03760146|79519663|FG005|Overall Study|No longer met eligibility criteria|0|||
44514238|NCT03760146|79519658|FG000|Overall Study|Protocol Violation|21|||
44514239|NCT03760146|79519659|FG001|Overall Study|Protocol Violation|13|||
44514240|NCT03760146|79519660|FG002|Overall Study|Protocol Violation|1|||
44514241|NCT03760146|79519661|FG003|Overall Study|Protocol Violation|0|||
44143380|NCT01328093|78932708|FG001|Open-Label Phase|Subject is moving or has moved|0|||
44143381|NCT01328093|78932707|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
44245558|NCT01490125|79075800|FG005|Period II|Lost to Follow-up|0|||
44514242|NCT03760146|79519662|FG004|Overall Study|Protocol Violation|1|||
44514243|NCT03760146|79519663|FG005|Overall Study|Protocol Violation|0|||
44245559|NCT01490125|79075795|FG000|Period II|Withdrawal by Subject|1|||
44245560|NCT01490125|79075796|FG001|Period II|Withdrawal by Subject|0|||
44245561|NCT01490125|79075797|FG002|Period II|Withdrawal by Subject|0|||
44245562|NCT01490125|79075798|FG003|Period II|Withdrawal by Subject|0|||
44245563|NCT01490125|79075799|FG004|Period II|Withdrawal by Subject|0|||
44245564|NCT01490125|79075800|FG005|Period II|Withdrawal by Subject|0|||
44245565|NCT01490125|79075795|FG000|Period III|Adverse Event|3|||
44245566|NCT01490125|79075796|FG001|Period III|Adverse Event|1|||
44245567|NCT01490125|79075797|FG002|Period III|Adverse Event|0|||
44245568|NCT01490125|79075798|FG003|Period III|Adverse Event|1|||
44245569|NCT01490125|79075799|FG004|Period III|Adverse Event|0|||
44245570|NCT01490125|79075800|FG005|Period III|Adverse Event|0|||
44245571|NCT01490125|79075795|FG000|Period III|Death|0|||
44245572|NCT01490125|79075796|FG001|Period III|Death|0|||
44245573|NCT01490125|79075797|FG002|Period III|Death|0|||
44245574|NCT01490125|79075798|FG003|Period III|Death|1|||
44245575|NCT01490125|79075799|FG004|Period III|Death|0|||
44245576|NCT01490125|79075800|FG005|Period III|Death|0|||
44245577|NCT01490125|79075795|FG000|Period III|Lack of Efficacy|0|||
44514244|NCT03760146|79519658|FG000|Overall Study|Withdrawal by Subject|19|||
44514245|NCT03760146|79519659|FG001|Overall Study|Withdrawal by Subject|20|||
44514246|NCT03760146|79519660|FG002|Overall Study|Withdrawal by Subject|1|||
44514247|NCT03760146|79519661|FG003|Overall Study|Withdrawal by Subject|0|||
44514248|NCT03760146|79519662|FG004|Overall Study|Withdrawal by Subject|1|||
44514249|NCT03760146|79519663|FG005|Overall Study|Withdrawal by Subject|0|||
44514250|NCT03877068|79519683|FG000|Overall Study|Physician Decision|9|||
44514251|NCT03877068|79519684|FG001|Overall Study|Physician Decision|3|||
44514252|NCT03760068|79519694|FG000|Overall Study|Withdrawal by Subject|7|||
44514253|NCT03760068|79519695|FG001|Overall Study|Withdrawal by Subject|8|||
44514254|NCT03760068|79519694|FG000|Overall Study|Adverse Event|1|||
44514255|NCT03760068|79519695|FG001|Overall Study|Adverse Event|2|||
44514256|NCT03760068|79519694|FG000|Overall Study|Administrative Decision by Sponsor|0|||
44514257|NCT03760068|79519695|FG001|Overall Study|Administrative Decision by Sponsor|2|||
44514258|NCT03760068|79519694|FG000|Overall Study|Physician Decision|1|||
44514259|NCT03760068|79519695|FG001|Overall Study|Physician Decision|2|||
44245578|NCT01490125|79075796|FG001|Period III|Lack of Efficacy|0|||
44245579|NCT01490125|79075797|FG002|Period III|Lack of Efficacy|0|||
44245580|NCT01490125|79075798|FG003|Period III|Lack of Efficacy|0|||
44514260|NCT03760068|79519694|FG000|Overall Study|Lost to Follow-up|4|||
44245581|NCT01490125|79075799|FG004|Period III|Lack of Efficacy|1|||
44245582|NCT01490125|79075800|FG005|Period III|Lack of Efficacy|0|||
44245583|NCT01446913|79075811|FG000|Overall Study|Significant illness|1|||
44245584|NCT01446913|79075812|FG001|Overall Study|Significant illness|1|||
44245585|NCT01446913|79075813|FG002|Overall Study|Significant illness|1|||
44245586|NCT01446913|79075811|FG000|Overall Study|Withdrawal by Subject|5|||
44245587|NCT01446913|79075812|FG001|Overall Study|Withdrawal by Subject|3|||
44514261|NCT03760068|79519695|FG001|Overall Study|Lost to Follow-up|9|||
44514262|NCT03760068|79519694|FG000|Overall Study|Subject Moved Out of State|1|||
44514263|NCT03760068|79519695|FG001|Overall Study|Subject Moved Out of State|0|||
44514264|NCT03759600|79519702|FG000|Overall Study|Adverse Event|2|||
44245588|NCT01446913|79075813|FG002|Overall Study|Withdrawal by Subject|5|||
44245589|NCT01446913|79075811|FG000|Overall Study|Physician Decision|0|||
44245590|NCT01446913|79075812|FG001|Overall Study|Physician Decision|0|||
44245591|NCT01446913|79075813|FG002|Overall Study|Physician Decision|2|||
44245592|NCT01446913|79075811|FG000|Overall Study|Lost to Follow-up|3|||
44245593|NCT01446913|79075812|FG001|Overall Study|Lost to Follow-up|5|||
44245594|NCT01446913|79075813|FG002|Overall Study|Lost to Follow-up|3|||
44245595|NCT01420549|79075844|FG000|Overall Study|Adverse Event|1|||
44245596|NCT01420549|79075845|FG001|Overall Study|Adverse Event|1|||
44245597|NCT01420549|79075844|FG000|Overall Study|Lost to Follow-up|2|||
44245598|NCT01420549|79075845|FG001|Overall Study|Lost to Follow-up|2|||
44245599|NCT01420549|79075844|FG000|Overall Study|Protocol Violation|0|||
44245600|NCT01420549|79075845|FG001|Overall Study|Protocol Violation|1|||
44245601|NCT01420549|79075844|FG000|Overall Study|Non-adherence to medication|4|||
44245602|NCT01420549|79075845|FG001|Overall Study|Non-adherence to medication|1|||
44245603|NCT01440595|79075866|FG000|Overall Study|Lost to Follow-up|0|||
44245604|NCT01440595|79075867|FG001|Overall Study|Lost to Follow-up|1|||
44245605|NCT01440595|79075868|FG002|Overall Study|Lost to Follow-up|0|||
44245606|NCT01440595|79075866|FG000|Overall Study|Study terminated by sponsor.|1|||
44245607|NCT01440595|79075867|FG001|Overall Study|Study terminated by sponsor.|2|||
44245608|NCT01440595|79075868|FG002|Overall Study|Study terminated by sponsor.|1|||
44245609|NCT01440517|79075874|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
44245610|NCT01440283|79075878|FG000|Overall Study|Death|3|||
44245611|NCT01440283|79075878|FG000|Overall Study|Withdrawal by Subject|4|||
44245612|NCT01440283|79075878|FG000|Overall Study|Physician Decision|3|||
44245613|NCT01440049|79075888|FG000|Overall Study|Adverse Event|5|||
44245614|NCT01439971|79075949|FG000|Overall Study|Required number in cohort dosed|0|||
44245615|NCT01439971|79075950|FG001|Overall Study|Required number in cohort dosed|1|||
44245616|NCT01439971|79075951|FG002|Overall Study|Required number in cohort dosed|2|||
44245617|NCT01439971|79075952|FG003|Overall Study|Required number in cohort dosed|0|||
44245618|NCT01439971|79075953|FG004|Overall Study|Required number in cohort dosed|1|||
44245619|NCT01447927|79076016|FG000|Overall Study|Adverse Event|4|||
44245620|NCT01447927|79076017|FG001|Overall Study|Adverse Event|3|||
44245621|NCT01447927|79076016|FG000|Overall Study|Withdrawal by Subject|1|||
44245622|NCT01447927|79076017|FG001|Overall Study|Withdrawal by Subject|0|||
44245623|NCT01551758|79076039|FG000|Overall Study|Adverse Event|29|||
44245624|NCT01551758|79076040|FG001|Overall Study|Adverse Event|43|||
44245625|NCT01551758|79076039|FG000|Overall Study|Lack of Efficacy|0|||
44245626|NCT01551758|79076040|FG001|Overall Study|Lack of Efficacy|1|||
44245627|NCT01551758|79076039|FG000|Overall Study|Protocol Violation|5|||
44245628|NCT01551758|79076040|FG001|Overall Study|Protocol Violation|6|||
44245629|NCT01551758|79076039|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
44245630|NCT01551758|79076040|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
44245631|NCT01551758|79076039|FG000|Overall Study|Lost to Follow-up|29|||
44245632|NCT01551758|79076040|FG001|Overall Study|Lost to Follow-up|25|||
44245633|NCT01551758|79076039|FG000|Overall Study|Physician Decision|9|||
44245634|NCT01551758|79076040|FG001|Overall Study|Physician Decision|3|||
44245635|NCT01551758|79076039|FG000|Overall Study|Withdrawal by Subject|14|||
44245636|NCT01551758|79076040|FG001|Overall Study|Withdrawal by Subject|17|||
44245637|NCT01449461|79076243|FG000|Overall Study|Adverse Event|0|||
44245638|NCT01449461|79076244|FG001|Overall Study|Adverse Event|3|||
44245639|NCT01449461|79076245|FG002|Overall Study|Adverse Event|2|||
44245640|NCT01449461|79076246|FG003|Overall Study|Adverse Event|3|||
44245641|NCT01449461|79076247|FG004|Overall Study|Adverse Event|4|||
44245642|NCT01449461|79076248|FG005|Overall Study|Adverse Event|4|||
44245643|NCT01449461|79076243|FG000|Overall Study|Death|0|||
44245644|NCT01449461|79076244|FG001|Overall Study|Death|2|||
44514265|NCT03759600|79519702|FG000|Overall Study|Progressive Disease|15|||
44514266|NCT03759600|79519702|FG000|Overall Study|Site Terminated by Sponsor|3|||
44245645|NCT01449461|79076245|FG002|Overall Study|Death|0|||
44245646|NCT01449461|79076246|FG003|Overall Study|Death|0|||
44245647|NCT01449461|79076247|FG004|Overall Study|Death|7|||
44245648|NCT01449461|79076248|FG005|Overall Study|Death|1|||
44245649|NCT01449461|79076243|FG000|Overall Study|Physician Decision|0|||
44245650|NCT01449461|79076244|FG001|Overall Study|Physician Decision|1|||
44514267|NCT04724733|79519709|FG000|Overall Study|Lost to Follow-up|1|||
44514268|NCT04724733|79519710|FG001|Overall Study|Lost to Follow-up|1|||
44245651|NCT01449461|79076245|FG002|Overall Study|Physician Decision|0|||
44245652|NCT01449461|79076246|FG003|Overall Study|Physician Decision|4|||
44514269|NCT04724733|79519711|FG002|Overall Study|Lost to Follow-up|1|||
44245653|NCT01449461|79076247|FG004|Overall Study|Physician Decision|1|||
44245654|NCT01449461|79076248|FG005|Overall Study|Physician Decision|0|||
44514270|NCT04635839|79519721|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
44514271|NCT04635839|79519722|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
44514272|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
44245655|NCT01449461|79076243|FG000|Overall Study|Documented Progressive Disease|4|||
44245656|NCT01449461|79076244|FG001|Overall Study|Documented Progressive Disease|7|||
44245657|NCT01449461|79076245|FG002|Overall Study|Documented Progressive Disease|14|||
44245658|NCT01449461|79076246|FG003|Overall Study|Documented Progressive Disease|15|||
44245659|NCT01449461|79076247|FG004|Overall Study|Documented Progressive Disease|24|||
44245660|NCT01449461|79076248|FG005|Overall Study|Documented Progressive Disease|5|||
44245661|NCT01449461|79076243|FG000|Overall Study|Clinical Progressive Disease|2|||
44245662|NCT01449461|79076244|FG001|Overall Study|Clinical Progressive Disease|2|||
44245663|NCT01449461|79076245|FG002|Overall Study|Clinical Progressive Disease|0|||
44245664|NCT01449461|79076246|FG003|Overall Study|Clinical Progressive Disease|3|||
44245665|NCT01449461|79076247|FG004|Overall Study|Clinical Progressive Disease|4|||
44381294|NCT02928224|79387350|FG002|Overall Study|Withdrawal by Subject|7|||
44514273|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
44514274|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
44514275|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
44514276|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
44514277|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
44514278|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
44514279|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
44143382|NCT01328093|78932708|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
44143383|NCT02654145|78932715|FG000|Overall Study|Lack of Efficacy|1|||
44143384|NCT02654145|78932715|FG000|Overall Study|Protocol Violation|1|||
44143385|NCT02654145|78932715|FG000|Overall Study|Withdrawal by Subject|5|||
44143386|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
44143387|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
44143388|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
44143389|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
44143390|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
44143391|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
44143392|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
44143393|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
44143394|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
44143395|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
44143396|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
44143397|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
44143398|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
44143399|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
44143400|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
44143401|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
44143402|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
44143403|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
44143404|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
44143405|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
44143406|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
44143407|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
44143408|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
44143409|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
44143410|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
44143411|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
44143412|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
44143413|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
44245666|NCT01449461|79076248|FG005|Overall Study|Clinical Progressive Disease|2|||
44514280|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
44143414|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
44143415|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
44245667|NCT01449461|79076243|FG000|Overall Study|Protocol Violation|0|||
44245668|NCT01449461|79076244|FG001|Overall Study|Protocol Violation|0|||
44245669|NCT01449461|79076245|FG002|Overall Study|Protocol Violation|0|||
44245670|NCT01449461|79076246|FG003|Overall Study|Protocol Violation|1|||
44245671|NCT01449461|79076247|FG004|Overall Study|Protocol Violation|0|||
44245672|NCT01449461|79076248|FG005|Overall Study|Protocol Violation|0|||
44245673|NCT01449461|79076243|FG000|Overall Study|Site Terminated by Sponsor|0|||
44245674|NCT01449461|79076244|FG001|Overall Study|Site Terminated by Sponsor|1|||
44514281|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
44514282|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
44514283|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
44514284|NCT04493502|79519730|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
44245675|NCT01449461|79076245|FG002|Overall Study|Site Terminated by Sponsor|2|||
44245676|NCT01449461|79076246|FG003|Overall Study|Site Terminated by Sponsor|3|||
44245677|NCT01449461|79076247|FG004|Overall Study|Site Terminated by Sponsor|4|||
44245678|NCT01449461|79076248|FG005|Overall Study|Site Terminated by Sponsor|1|||
44245679|NCT01449461|79076243|FG000|Overall Study|Withdrawal by Subject|0|||
44245680|NCT01449461|79076244|FG001|Overall Study|Withdrawal by Subject|1|||
44245681|NCT01449461|79076245|FG002|Overall Study|Withdrawal by Subject|0|||
44245682|NCT01449461|79076246|FG003|Overall Study|Withdrawal by Subject|0|||
44245683|NCT01449461|79076247|FG004|Overall Study|Withdrawal by Subject|2|||
44245684|NCT01449461|79076248|FG005|Overall Study|Withdrawal by Subject|1|||
44245685|NCT01449461|79076243|FG000|Overall Study|Reason not Specified|0|||
44245686|NCT01449461|79076244|FG001|Overall Study|Reason not Specified|1|||
44245687|NCT01449461|79076245|FG002|Overall Study|Reason not Specified|0|||
44245688|NCT01449461|79076246|FG003|Overall Study|Reason not Specified|3|||
44245689|NCT01449461|79076247|FG004|Overall Study|Reason not Specified|2|||
44245690|NCT01449461|79076248|FG005|Overall Study|Reason not Specified|1|||
44245691|NCT01572038|79076284|FG000|Overall Study|Death|648|||
44245692|NCT01572038|79076284|FG000|Overall Study|Withdrawal by Subject|204|||
44245693|NCT01572038|79076284|FG000|Overall Study|Lost to Follow-up|81|||
44245694|NCT01572038|79076284|FG000|Overall Study|Physician Decision|20|||
44245695|NCT01572038|79076284|FG000|Overall Study|Patient Decision|14|||
44245696|NCT01572038|79076284|FG000|Overall Study|Progressive Disease|8|||
44245697|NCT01572038|79076284|FG000|Overall Study|Site Closed Before Completing Form|6|||
44245698|NCT01572038|79076284|FG000|Overall Study|Enrolled into Another Trial|3|||
44245699|NCT01572038|79076284|FG000|Overall Study|Participated in Another Trial|3|||
44245700|NCT01572038|79076284|FG000|Overall Study|Termination by Sponsor|2|||
44245701|NCT01572038|79076284|FG000|Overall Study|Patient Deterioration|1|||
44245702|NCT01572038|79076284|FG000|Overall Study|Sponsor Decision|1|||
44245703|NCT01448213|79076312|FG000|Overall Study|Lost to Follow-up|12|||
44245704|NCT01448213|79076313|FG001|Overall Study|Lost to Follow-up|10|||
44245705|NCT01448213|79076312|FG000|Overall Study|Adverse Event|4|||
44245706|NCT01448213|79076313|FG001|Overall Study|Adverse Event|10|||
44245707|NCT01448213|79076312|FG000|Overall Study|Protocol Violation|1|||
44245708|NCT01448213|79076313|FG001|Overall Study|Protocol Violation|2|||
44245709|NCT01448057|79076330|FG000|Overall Study|Protocol Violation|3|||
44245710|NCT01448057|79076331|FG001|Overall Study|Protocol Violation|2|||
44245711|NCT01448057|79076330|FG000|Overall Study|Lost to Follow-up|3|||
44245712|NCT01448057|79076331|FG001|Overall Study|Lost to Follow-up|0|||
44245713|NCT01448057|79076330|FG000|Overall Study|Adverse Event|0|||
44245714|NCT01448057|79076331|FG001|Overall Study|Adverse Event|2|||
44245715|NCT01448057|79076330|FG000|Overall Study|Withdrawal by Subject|2|||
44245716|NCT01448057|79076331|FG001|Overall Study|Withdrawal by Subject|0|||
44245717|NCT01447433|79076339|FG000|Overall Study|Lost to Follow-up|0|||
44245718|NCT01447433|79076340|FG001|Overall Study|Lost to Follow-up|2|||
44245719|NCT01447433|79076339|FG000|Overall Study|Withdrawal by Subject|3|||
44245720|NCT01447433|79076340|FG001|Overall Study|Withdrawal by Subject|3|||
44245721|NCT01447433|79076339|FG000|Overall Study|Protocol Violation|1|||
44245722|NCT01447433|79076340|FG001|Overall Study|Protocol Violation|1|||
44245723|NCT01446965|79076348|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
44245724|NCT01446965|79076349|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
44245725|NCT01446965|79076348|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
44245726|NCT01446965|79076349|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
44245727|NCT01446809|79076357|FG000|Overall Study|Adverse Event|0|||
44245728|NCT01446809|79076358|FG001|Overall Study|Adverse Event|0|||
44245729|NCT01446809|79076359|FG002|Overall Study|Adverse Event|1|||
44245730|NCT01446809|79076357|FG000|Overall Study|Failure to complete study procedures|0|||
44514285|NCT04493502|79519731|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
44245731|NCT01446809|79076358|FG001|Overall Study|Failure to complete study procedures|0|||
44245732|NCT01446809|79076359|FG002|Overall Study|Failure to complete study procedures|1|||
44514286|NCT04493502|79519730|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
44245733|NCT01446419|79076370|FG000|Overall Study|Death|1|||
44245734|NCT01446419|79076371|FG001|Overall Study|Death|0|||
44245735|NCT01446419|79076370|FG000|Overall Study|Withdrawal by Subject|1|||
44245736|NCT01446419|79076371|FG001|Overall Study|Withdrawal by Subject|1|||
44245737|NCT01446419|79076370|FG000|Overall Study|Terminated per protocol|3|||
44245738|NCT01446419|79076371|FG001|Overall Study|Terminated per protocol|0|||
44245739|NCT01445951|79076380|FG000|Overall Study|Adverse Event|16|||
44245740|NCT01445951|79076381|FG001|Overall Study|Adverse Event|9|||
44245741|NCT01445951|79076382|FG002|Overall Study|Adverse Event|0|||
44245742|NCT01445951|79076380|FG000|Overall Study|Protocol Violation|2|||
44245743|NCT01445951|79076381|FG001|Overall Study|Protocol Violation|2|||
44245744|NCT01445951|79076382|FG002|Overall Study|Protocol Violation|2|||
44245745|NCT01445951|79076380|FG000|Overall Study|Withdrawal by Subject|21|||
44245746|NCT01445951|79076381|FG001|Overall Study|Withdrawal by Subject|16|||
44245747|NCT01445951|79076382|FG002|Overall Study|Withdrawal by Subject|8|||
44245748|NCT01445951|79076380|FG000|Overall Study|Physician Decision|3|||
44245749|NCT01445951|79076381|FG001|Overall Study|Physician Decision|1|||
44245750|NCT01445951|79076382|FG002|Overall Study|Physician Decision|0|||
44245751|NCT01445951|79076380|FG000|Overall Study|Lost to Follow-up|1|||
44245752|NCT01445951|79076381|FG001|Overall Study|Lost to Follow-up|2|||
44245753|NCT01445951|79076382|FG002|Overall Study|Lost to Follow-up|4|||
44245754|NCT01445951|79076380|FG000|Overall Study|Pregnancy|0|||
44245755|NCT01445951|79076381|FG001|Overall Study|Pregnancy|1|||
44245756|NCT01445951|79076382|FG002|Overall Study|Pregnancy|4|||
44245757|NCT01445951|79076380|FG000|Overall Study|Death|0|||
44245758|NCT01445951|79076381|FG001|Overall Study|Death|0|||
44245759|NCT01445951|79076382|FG002|Overall Study|Death|1|||
44245760|NCT01445951|79076380|FG000|Overall Study|Non-compliance with study drug|1|||
44245761|NCT01445951|79076381|FG001|Overall Study|Non-compliance with study drug|2|||
44245762|NCT01445951|79076382|FG002|Overall Study|Non-compliance with study drug|0|||
44245763|NCT01445951|79076380|FG000|Overall Study|Non-compliance with protocol|0|||
44245764|NCT01445951|79076381|FG001|Overall Study|Non-compliance with protocol|1|||
44245765|NCT01445951|79076382|FG002|Overall Study|Non-compliance with protocol|0|||
44245766|NCT01445951|79076380|FG000|Overall Study|Sponsor decision - subject travel|0|||
44245767|NCT01445951|79076381|FG001|Overall Study|Sponsor decision - subject travel|1|||
44245768|NCT01445951|79076382|FG002|Overall Study|Sponsor decision - subject travel|0|||
44245769|NCT01445951|79076380|FG000|Overall Study|Cough|0|||
44245770|NCT01445951|79076381|FG001|Overall Study|Cough|1|||
44245771|NCT01445951|79076382|FG002|Overall Study|Cough|0|||
44245772|NCT01444781|79076397|FG000|Overall Study|Lost to Follow-up|0|||
44245773|NCT01444781|79076398|FG001|Overall Study|Lost to Follow-up|3|||
44245774|NCT01444781|79076399|FG002|Overall Study|Lost to Follow-up|1|||
44245775|NCT01444781|79076397|FG000|Overall Study|Withdrawal by Subject|3|||
44245776|NCT01444781|79076398|FG001|Overall Study|Withdrawal by Subject|1|||
44245777|NCT01444781|79076399|FG002|Overall Study|Withdrawal by Subject|2|||
44276737|NCT03234907|79237690|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
44276738|NCT03234907|79237691|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
44276739|NCT03234907|79237692|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
44276740|NCT03818581|79237706|FG000|Overall Study|Adverse Event|1|||
44381295|NCT02928224|79387351|FG003|Overall Study|Withdrawal by Subject|20|||
44514287|NCT04493502|79519731|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
44514288|NCT04493502|79519730|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
44514289|NCT04493502|79519731|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
44514290|NCT04493502|79519730|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
44514291|NCT04493502|79519731|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
44514292|NCT04493502|79519730|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
44514293|NCT04493502|79519731|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
44514294|NCT04493502|79519730|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
44514295|NCT04493502|79519731|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
44514296|NCT04493502|79519730|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
44514297|NCT04493502|79519731|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
44514298|NCT04147858|79519742|FG000|Overall Study|Adverse Event|6|||
44514299|NCT04147858|79519743|FG001|Overall Study|Adverse Event|6|||
44514300|NCT04147858|79519744|FG002|Overall Study|Adverse Event|6|||
44514301|NCT04147858|79519742|FG000|Overall Study|Lack of Efficacy|3|||
44514302|NCT04147858|79519743|FG001|Overall Study|Lack of Efficacy|3|||
44514303|NCT04147858|79519744|FG002|Overall Study|Lack of Efficacy|1|||
44514304|NCT04147858|79519742|FG000|Overall Study|Lost to Follow-up|1|||
44245778|NCT01444391|79076414|FG000|Overall Study|Death|1|||
44245779|NCT01443923|79076420|FG000|Overall Study|Adverse Event|1|||
44245780|NCT01443923|79076421|FG001|Overall Study|Adverse Event|0|||
44245781|NCT01551212|79076433|FG000|Overall Study|Graft loss/Retransplantation|0|||
44245782|NCT01551212|79076434|FG001|Overall Study|Graft loss/Retransplantation|1|||
44245783|NCT01551212|79076433|FG000|Overall Study|Administrative problems|1|||
44245784|NCT01551212|79076434|FG001|Overall Study|Administrative problems|2|||
44245785|NCT01551212|79076433|FG000|Overall Study|Lost to Follow-up|0|||
44245786|NCT01551212|79076434|FG001|Overall Study|Lost to Follow-up|1|||
44245787|NCT01551212|79076433|FG000|Overall Study|Protocol Violation|0|||
44245788|NCT01551212|79076434|FG001|Overall Study|Protocol Violation|1|||
44245789|NCT01551212|79076433|FG000|Overall Study|Withdrawal by Subject|0|||
44245790|NCT01551212|79076434|FG001|Overall Study|Withdrawal by Subject|7|||
44245791|NCT01551212|79076433|FG000|Overall Study|Death|2|||
44245792|NCT01551212|79076434|FG001|Overall Study|Death|4|||
44245793|NCT01551212|79076433|FG000|Overall Study|Never Received Study Treatment|2|||
44245794|NCT01551212|79076434|FG001|Overall Study|Never Received Study Treatment|4|||
44245795|NCT01550744|79076494|FG000|Open-Label|Lost to Follow-up|7|||
44245796|NCT01550744|79076495|FG001|Open-Label|Lost to Follow-up|0|||
44245797|NCT01550744|79076496|FG002|Open-Label|Lost to Follow-up|0|||
44245798|NCT01550744|79076494|FG000|Open-Label|Withdrawal by Subject|13|||
44245799|NCT01550744|79076495|FG001|Open-Label|Withdrawal by Subject|0|||
44245800|NCT01550744|79076496|FG002|Open-Label|Withdrawal by Subject|0|||
44245801|NCT01550744|79076494|FG000|Open-Label|Adverse Event|11|||
44245802|NCT01550744|79076495|FG001|Open-Label|Adverse Event|0|||
44245803|NCT01550744|79076496|FG002|Open-Label|Adverse Event|0|||
44245804|NCT01550744|79076494|FG000|Open-Label|Lack of Efficacy|4|||
44245805|NCT01550744|79076495|FG001|Open-Label|Lack of Efficacy|0|||
44245806|NCT01550744|79076496|FG002|Open-Label|Lack of Efficacy|0|||
44245807|NCT01550744|79076494|FG000|Open-Label|Protocol Violation|4|||
44245808|NCT01550744|79076495|FG001|Open-Label|Protocol Violation|0|||
44245809|NCT01550744|79076496|FG002|Open-Label|Protocol Violation|0|||
44245810|NCT01550744|79076494|FG000|Open-Label|Not all 3 study drug injections received|2|||
44245811|NCT01550744|79076495|FG001|Open-Label|Not all 3 study drug injections received|0|||
44245812|NCT01550744|79076496|FG002|Open-Label|Not all 3 study drug injections received|0|||
44245813|NCT01550744|79076494|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
44245814|NCT01550744|79076495|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
44245815|NCT01550744|79076496|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
44245816|NCT01550744|79076494|FG000|Open-Label|Other|1|||
44245817|NCT01550744|79076495|FG001|Open-Label|Other|0|||
44245818|NCT01550744|79076496|FG002|Open-Label|Other|0|||
44245819|NCT01550744|79076494|FG000|Double-Blind|Lost to Follow-up|0|||
44245820|NCT01550744|79076495|FG001|Double-Blind|Lost to Follow-up|6|||
44245821|NCT01550744|79076496|FG002|Double-Blind|Lost to Follow-up|12|||
44245822|NCT01550744|79076494|FG000|Double-Blind|Withdrawal by Subject|0|||
44245823|NCT01550744|79076495|FG001|Double-Blind|Withdrawal by Subject|2|||
44245824|NCT01550744|79076496|FG002|Double-Blind|Withdrawal by Subject|15|||
44245825|NCT01550744|79076494|FG000|Double-Blind|Adverse Event|0|||
44245826|NCT01550744|79076495|FG001|Double-Blind|Adverse Event|4|||
44245827|NCT01550744|79076496|FG002|Double-Blind|Adverse Event|15|||
44245828|NCT01550744|79076494|FG000|Double-Blind|Death|0|||
44245829|NCT01550744|79076495|FG001|Double-Blind|Death|1|||
44245830|NCT01550744|79076496|FG002|Double-Blind|Death|0|||
44245831|NCT01550744|79076494|FG000|Double-Blind|Lack of Efficacy|0|||
44245832|NCT01550744|79076495|FG001|Double-Blind|Lack of Efficacy|2|||
44245833|NCT01550744|79076496|FG002|Double-Blind|Lack of Efficacy|8|||
44245834|NCT01550744|79076494|FG000|Double-Blind|Protocol Violation|0|||
44381296|NCT02928224|79387348|FG000|Overall Study|Study participation terminated by sponsor|3|||
44381297|NCT02928224|79387349|FG001|Overall Study|Study participation terminated by sponsor|8|||
44381298|NCT02928224|79387350|FG002|Overall Study|Study participation terminated by sponsor|12|||
44514305|NCT04147858|79519743|FG001|Overall Study|Lost to Follow-up|6|||
44514306|NCT04147858|79519744|FG002|Overall Study|Lost to Follow-up|2|||
44245835|NCT01550744|79076495|FG001|Double-Blind|Protocol Violation|0|||
44245836|NCT01550744|79076496|FG002|Double-Blind|Protocol Violation|4|||
44245837|NCT01550744|79076494|FG000|Double-Blind|Pregnancy|0|||
44245838|NCT01550744|79076495|FG001|Double-Blind|Pregnancy|0|||
44245839|NCT01550744|79076496|FG002|Double-Blind|Pregnancy|3|||
44245840|NCT01550744|79076494|FG000|Double-Blind|Other|0|||
44245841|NCT01550744|79076495|FG001|Double-Blind|Other|2|||
44245842|NCT01550744|79076496|FG002|Double-Blind|Other|10|||
44245843|NCT01549964|79076557|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
44381299|NCT02928224|79387351|FG003|Overall Study|Study participation terminated by sponsor|3|||
44514307|NCT04147858|79519742|FG000|Overall Study|Withdrawal by Subject|3|||
44514308|NCT04147858|79519743|FG001|Overall Study|Withdrawal by Subject|4|||
44514309|NCT04147858|79519744|FG002|Overall Study|Withdrawal by Subject|10|||
44514310|NCT04147858|79519742|FG000|Overall Study|Subject Noncompliance, Other|4|||
44514311|NCT04147858|79519743|FG001|Overall Study|Subject Noncompliance, Other|3|||
44245844|NCT01549964|79076558|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
44245845|NCT01549964|79076559|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
44245846|NCT01549964|79076560|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
44245847|NCT01549964|79076557|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
44245848|NCT01549964|79076558|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
44245849|NCT01549964|79076559|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
44245850|NCT01549964|79076560|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
44245851|NCT01549964|79076557|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
44245852|NCT01549964|79076558|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
44245853|NCT01549964|79076559|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
44245854|NCT01549964|79076560|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
44245855|NCT01549964|79076557|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
44245856|NCT01549964|79076558|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
44245857|NCT01549964|79076559|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
44245858|NCT01549964|79076560|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
44245859|NCT01549964|79076557|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
44245860|NCT01549964|79076558|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
44245861|NCT01549964|79076559|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
44245862|NCT01549964|79076560|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
44245863|NCT01549964|79076557|FG000|24-Week Treatment Period|Other|1|||
44245864|NCT01549964|79076558|FG001|24-Week Treatment Period|Other|0|||
44245865|NCT01549964|79076559|FG002|24-Week Treatment Period|Other|1|||
44245866|NCT01549964|79076560|FG003|24-Week Treatment Period|Other|0|||
44245867|NCT01549964|79076557|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
44245868|NCT01549964|79076558|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
44245869|NCT01549964|79076559|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
44245870|NCT01549964|79076560|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
44245871|NCT01549964|79076557|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
44245872|NCT01549964|79076558|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
44245873|NCT01549964|79076559|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
44245874|NCT01549964|79076560|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
44245875|NCT01549964|79076557|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
44245876|NCT01549964|79076558|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
44245877|NCT01549964|79076559|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
44245878|NCT01549964|79076560|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
44245879|NCT01549964|79076557|FG000|80-Week Extension Period|Pregnancy|0|||
44245880|NCT01549964|79076558|FG001|80-Week Extension Period|Pregnancy|0|||
44245881|NCT01549964|79076559|FG002|80-Week Extension Period|Pregnancy|1|||
44245882|NCT01549964|79076560|FG003|80-Week Extension Period|Pregnancy|0|||
44245883|NCT01549964|79076557|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
44245884|NCT01549964|79076558|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
44245885|NCT01549964|79076559|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
44245886|NCT01549964|79076560|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
44245887|NCT01549964|79076557|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
44245888|NCT01549964|79076558|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
44245889|NCT01549964|79076559|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
44245890|NCT01549964|79076560|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
44245891|NCT01549964|79076557|FG000|80-Week Extension Period|Lost to Follow-up|1|||
44245892|NCT01549964|79076558|FG001|80-Week Extension Period|Lost to Follow-up|0|||
44245893|NCT01549964|79076559|FG002|80-Week Extension Period|Lost to Follow-up|2|||
44245894|NCT01549964|79076560|FG003|80-Week Extension Period|Lost to Follow-up|1|||
44245895|NCT01549964|79076557|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
44245896|NCT01549964|79076558|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
44245897|NCT01549964|79076559|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
44245898|NCT01549964|79076560|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
44245899|NCT01570244|79076642|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
44245900|NCT01535222|79076677|FG000|Overall Study|Inclusion/exclusion|0|||
44245901|NCT01535222|79076678|FG001|Overall Study|Inclusion/exclusion|0|||
44245902|NCT01535222|79076679|FG002|Overall Study|Inclusion/exclusion|1|||
44245903|NCT01535222|79076680|FG003|Overall Study|Inclusion/exclusion|0|||
44245904|NCT01535222|79076681|FG004|Overall Study|Inclusion/exclusion|0|||
44245905|NCT01535222|79076682|FG005|Overall Study|Inclusion/exclusion|0|||
44245906|NCT01549886|79076698|FG000|Overall Study|Sponsor's decision|2|||
44245907|NCT01549886|79076699|FG001|Overall Study|Sponsor's decision|3|||
44245908|NCT01443845|79076728|FG000|Overall Study|Protocol Violation|43|||
44245909|NCT01443845|79076729|FG001|Overall Study|Protocol Violation|45|||
44245910|NCT01443845|79076728|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
44245911|NCT01443845|79076729|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
44276741|NCT03818581|79237707|FG001|Overall Study|Adverse Event|0|||
44276742|NCT03818581|79237708|FG002|Overall Study|Adverse Event|0|||
44276743|NCT03818581|79237709|FG003|Overall Study|Adverse Event|0|||
44276744|NCT03818581|79237710|FG004|Overall Study|Adverse Event|0|||
44276745|NCT03818581|79237706|FG000|Overall Study|Covid-19|2|||
44276746|NCT03818581|79237707|FG001|Overall Study|Covid-19|0|||
44245912|NCT01443845|79076728|FG000|Overall Study|Deterioration in pulmonary function|1|||
44276747|NCT03818581|79237708|FG002|Overall Study|Covid-19|0|||
44245913|NCT01443845|79076729|FG001|Overall Study|Deterioration in pulmonary function|4|||
44245914|NCT01443845|79076728|FG000|Overall Study|Lack of Efficacy|10|||
44245915|NCT01443845|79076729|FG001|Overall Study|Lack of Efficacy|5|||
44245916|NCT01443845|79076728|FG000|Overall Study|Adverse Event|64|||
44245917|NCT01443845|79076729|FG001|Overall Study|Adverse Event|138|||
44245918|NCT01443845|79076728|FG000|Overall Study|Withdrawal by Subject|63|||
44245919|NCT01443845|79076729|FG001|Overall Study|Withdrawal by Subject|67|||
44245920|NCT01443845|79076728|FG000|Overall Study|Military Conflict - Site Terminated|20|||
44245921|NCT01443845|79076729|FG001|Overall Study|Military Conflict - Site Terminated|21|||
44245922|NCT01443845|79076728|FG000|Overall Study|Lost to Follow-up|9|||
44245923|NCT01443845|79076729|FG001|Overall Study|Lost to Follow-up|13|||
44245924|NCT01549652|79076738|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
44245925|NCT01549652|79076739|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
44245926|NCT01549652|79076740|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
44245927|NCT01549652|79076741|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
44245928|NCT01549652|79076738|FG000|Overall Study|Study Drug Titration Failure|5|||
44245929|NCT01549652|79076739|FG001|Overall Study|Study Drug Titration Failure|6|||
44245930|NCT01549652|79076740|FG002|Overall Study|Study Drug Titration Failure|0|||
44245931|NCT01549652|79076741|FG003|Overall Study|Study Drug Titration Failure|0|||
44245932|NCT01549652|79076738|FG000|Overall Study|Withdrawal Effect|0|||
44245933|NCT01549652|79076739|FG001|Overall Study|Withdrawal Effect|2|||
44245934|NCT01549652|79076740|FG002|Overall Study|Withdrawal Effect|0|||
44245935|NCT01549652|79076741|FG003|Overall Study|Withdrawal Effect|0|||
44245936|NCT01549652|79076738|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
44245937|NCT01549652|79076739|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
44245938|NCT01549652|79076740|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
44245939|NCT01549652|79076741|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
44245940|NCT01549652|79076738|FG000|Overall Study|Problem with Infusion|1|||
44245941|NCT01549652|79076739|FG001|Overall Study|Problem with Infusion|0|||
44245942|NCT01549652|79076740|FG002|Overall Study|Problem with Infusion|0|||
44245943|NCT01549652|79076741|FG003|Overall Study|Problem with Infusion|0|||
44245944|NCT01549652|79076738|FG000|Overall Study|Titration Non-Compliance|1|||
44245945|NCT01549652|79076739|FG001|Overall Study|Titration Non-Compliance|3|||
44245946|NCT01549652|79076740|FG002|Overall Study|Titration Non-Compliance|4|||
44245947|NCT01549652|79076741|FG003|Overall Study|Titration Non-Compliance|5|||
44245948|NCT01549652|79076738|FG000|Overall Study|Titration Side Effects|0|||
44245949|NCT01549652|79076739|FG001|Overall Study|Titration Side Effects|0|||
44245950|NCT01549652|79076740|FG002|Overall Study|Titration Side Effects|6|||
44245951|NCT01549652|79076741|FG003|Overall Study|Titration Side Effects|3|||
44245952|NCT01549652|79076738|FG000|Overall Study|Withdrawal by Subject|0|||
44245953|NCT01549652|79076739|FG001|Overall Study|Withdrawal by Subject|0|||
44245954|NCT01549652|79076740|FG002|Overall Study|Withdrawal by Subject|5|||
44245955|NCT01549652|79076741|FG003|Overall Study|Withdrawal by Subject|3|||
44245956|NCT01569464|79076749|FG000|Overall Study|Adverse Event|4|||
44245957|NCT01569464|79076750|FG001|Overall Study|Adverse Event|0|||
44245958|NCT01569464|79076749|FG000|Overall Study|Lack of Efficacy|1|||
44245959|NCT01569464|79076750|FG001|Overall Study|Lack of Efficacy|0|||
44245960|NCT01569464|79076749|FG000|Overall Study|Protocol Violation|1|||
44245961|NCT01569464|79076750|FG001|Overall Study|Protocol Violation|0|||
44245962|NCT01569464|79076749|FG000|Overall Study|Lost to Follow-up|2|||
44245963|NCT01569464|79076750|FG001|Overall Study|Lost to Follow-up|3|||
44245964|NCT01569464|79076749|FG000|Overall Study|Withdrawal by Subject|1|||
44245965|NCT01569464|79076750|FG001|Overall Study|Withdrawal by Subject|1|||
44245966|NCT01569464|79076749|FG000|Overall Study|Other|1|||
44245967|NCT01569464|79076750|FG001|Overall Study|Other|1|||
44245968|NCT01534676|79076760|FG000|Overall Study|Study closed due to poor enrollment|2|||
44245969|NCT01534676|79076761|FG001|Overall Study|Study closed due to poor enrollment|1|||
44245970|NCT01442675|79076767|FG000|Overall Study|Protocol Violation|6|||
44245971|NCT01442675|79076767|FG000|Overall Study|Lost to Follow-up|2|||
44245972|NCT01442675|79076767|FG000|Overall Study|Withdrawal by Subject|4|||
44245973|NCT01534520|79076774|FG000|Overall Study|Adverse Event|0|||
44245974|NCT01534520|79076775|FG001|Overall Study|Adverse Event|1|||
44245975|NCT01534208|79076805|FG000|Overall Study|Lost to Follow-up|19|||
44245976|NCT01534208|79076806|FG001|Overall Study|Lost to Follow-up|14|||
44245977|NCT01534208|79076805|FG000|Overall Study|Withdrawal by Subject|6|||
44245978|NCT01534208|79076806|FG001|Overall Study|Withdrawal by Subject|20|||
44245979|NCT01534208|79076805|FG000|Overall Study|Adverse Event|15|||
44245980|NCT01534208|79076806|FG001|Overall Study|Adverse Event|8|||
44245981|NCT01534208|79076805|FG000|Overall Study|Physician Decision|2|||
44245982|NCT01534208|79076806|FG001|Overall Study|Physician Decision|0|||
44245983|NCT01534208|79076805|FG000|Overall Study|Lack of Efficacy|0|||
44245984|NCT01534208|79076806|FG001|Overall Study|Lack of Efficacy|3|||
44245985|NCT01534208|79076805|FG000|Overall Study|Protocol Violation|2|||
44245986|NCT01534208|79076806|FG001|Overall Study|Protocol Violation|2|||
44245987|NCT01534208|79076805|FG000|Overall Study|Sponsor decision|4|||
44245988|NCT01534208|79076806|FG001|Overall Study|Sponsor decision|1|||
44245989|NCT01534208|79076805|FG000|Overall Study|Subject relocation|2|||
44245990|NCT01534208|79076806|FG001|Overall Study|Subject relocation|0|||
44245991|NCT01534208|79076805|FG000|Overall Study|Lab assessment|2|||
44245992|NCT01534208|79076806|FG001|Overall Study|Lab assessment|1|||
44245993|NCT01534208|79076805|FG000|Overall Study|Eligibility error|3|||
44245994|NCT01534208|79076806|FG001|Overall Study|Eligibility error|0|||
44245995|NCT01534208|79076805|FG000|Overall Study|PCP decision|1|||
44245996|NCT01534208|79076806|FG001|Overall Study|PCP decision|0|||
44245997|NCT01534208|79076805|FG000|Overall Study|Needed prohibited meds|1|||
44245998|NCT01534208|79076806|FG001|Overall Study|Needed prohibited meds|0|||
44245999|NCT01548638|79076812|FG000|Overall Study|Protocol Violation|3|||
44246000|NCT01548638|79076812|FG000|Overall Study|Withdrawal by Subject|1|||
44246001|NCT01533428|79076836|FG000|Overall Study|Adverse Event|0|||
44246002|NCT01533428|79076837|FG001|Overall Study|Adverse Event|1|||
44246003|NCT01533428|79076836|FG000|Overall Study|Lost to Follow-up|2|||
44246004|NCT01533428|79076837|FG001|Overall Study|Lost to Follow-up|1|||
44246005|NCT01533428|79076836|FG000|Overall Study|Withdrawal by Subject|7|||
44246006|NCT01533428|79076837|FG001|Overall Study|Withdrawal by Subject|6|||
44246007|NCT01517984|79076846|FG000|Overall Study|Lost to Follow-up|0|||
44246008|NCT01517984|79076847|FG001|Overall Study|Lost to Follow-up|1|||
44246009|NCT01517984|79076848|FG002|Overall Study|Lost to Follow-up|0|||
44246010|NCT01517984|79076849|FG003|Overall Study|Lost to Follow-up|0|||
44246011|NCT01517984|79076846|FG000|Overall Study|Withdrawal by Subject|1|||
44246012|NCT01517984|79076847|FG001|Overall Study|Withdrawal by Subject|8|||
44246013|NCT01517984|79076848|FG002|Overall Study|Withdrawal by Subject|4|||
44246014|NCT01517984|79076849|FG003|Overall Study|Withdrawal by Subject|1|||
44246015|NCT01517984|79076846|FG000|Overall Study|Screen Failure|4|||
44246016|NCT01517984|79076847|FG001|Overall Study|Screen Failure|0|||
44246017|NCT01517984|79076848|FG002|Overall Study|Screen Failure|0|||
44246018|NCT01517984|79076849|FG003|Overall Study|Screen Failure|0|||
44246019|NCT01517984|79076846|FG000|Overall Study|Ineligible for randomization|0|||
44246020|NCT01517984|79076847|FG001|Overall Study|Ineligible for randomization|14|||
44246021|NCT01517984|79076848|FG002|Overall Study|Ineligible for randomization|0|||
44246022|NCT01517984|79076849|FG003|Overall Study|Ineligible for randomization|0|||
44246023|NCT01517750|79076877|FG000|Overall Study|Lost to Follow-up|1|||
44246024|NCT01517750|79076878|FG001|Overall Study|Lost to Follow-up|2|||
44246025|NCT01517750|79076879|FG002|Overall Study|Lost to Follow-up|4|||
44246026|NCT01517750|79076880|FG003|Overall Study|Lost to Follow-up|1|||
44246027|NCT01548404|79076905|FG000|Overall Study|Adverse Event|3|||
44246028|NCT01548404|79076906|FG001|Overall Study|Adverse Event|1|||
44246029|NCT01548404|79076905|FG000|Overall Study|Physician Decision|2|||
44246030|NCT01548404|79076906|FG001|Overall Study|Physician Decision|1|||
44246031|NCT01548404|79076905|FG000|Overall Study|Inadequate response to study treatment|23|||
44246032|NCT01548404|79076906|FG001|Overall Study|Inadequate response to study treatment|7|||
44246033|NCT01548404|79076905|FG000|Overall Study|Lost to Follow-up|2|||
44246034|NCT01548404|79076906|FG001|Overall Study|Lost to Follow-up|0|||
44246035|NCT01548404|79076905|FG000|Overall Study|Withdrawal by Subject|0|||
44246036|NCT01548404|79076906|FG001|Overall Study|Withdrawal by Subject|3|||
44246037|NCT01548404|79076905|FG000|Overall Study|Other than specified above|0|||
44246038|NCT01548404|79076906|FG001|Overall Study|Other than specified above|2|||
44246039|NCT01547780|79076920|FG000|Baseline PET Scan|Physician Decision|1|||
44246040|NCT01547780|79076921|FG001|Baseline PET Scan|Physician Decision|0|||
44246041|NCT01547780|79076922|FG002|Baseline PET Scan|Physician Decision|1|||
44246042|NCT01547780|79076923|FG003|Baseline PET Scan|Physician Decision|0|||
44246043|NCT01547780|79076920|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
44246044|NCT01547780|79076921|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
44246045|NCT01547780|79076922|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
44246046|NCT01547780|79076923|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
44246047|NCT01547390|79076945|FG000|Overall Study|Withdrawal by Subject|10|||
44246048|NCT01547390|79076946|FG001|Overall Study|Withdrawal by Subject|7|||
44246049|NCT01547390|79076945|FG000|Overall Study|termination of pregnancy|0|||
44246050|NCT01547390|79076946|FG001|Overall Study|termination of pregnancy|1|||
44381300|NCT02928224|79387348|FG000|Overall Study|Other|3|||
44381301|NCT02928224|79387349|FG001|Overall Study|Other|3|||
44381302|NCT02928224|79387350|FG002|Overall Study|Other|5|||
44276748|NCT03818581|79237709|FG003|Overall Study|Covid-19|0|||
44514312|NCT04147858|79519744|FG002|Overall Study|Subject Noncompliance, Other|1|||
44514313|NCT04146896|79519754|FG000|Overall Study|Adverse Event|5|||
44514314|NCT04146896|79519755|FG001|Overall Study|Adverse Event|8|||
44514315|NCT04146896|79519754|FG000|Overall Study|Lack of Efficacy|3|||
44514316|NCT04146896|79519755|FG001|Overall Study|Lack of Efficacy|2|||
44246051|NCT01547390|79076945|FG000|Overall Study|Lost to Follow-up|0|||
44246052|NCT01547390|79076946|FG001|Overall Study|Lost to Follow-up|2|||
44246053|NCT01547390|79076945|FG000|Overall Study|Adverse Event|3|||
44246054|NCT01547390|79076946|FG001|Overall Study|Adverse Event|0|||
44246055|NCT01546922|79076952|FG000|First Period of 10 Weeks|Protocol Violation|3|||
44276749|NCT03818581|79237710|FG004|Overall Study|Covid-19|1|||
44514317|NCT04146896|79519754|FG000|Overall Study|Lost to Follow-up|0|||
44246056|NCT01546922|79076953|FG001|First Period of 10 Weeks|Protocol Violation|1|||
44246057|NCT01546922|79076952|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
44381303|NCT02928224|79387351|FG003|Overall Study|Other|0|||
44514318|NCT04146896|79519755|FG001|Overall Study|Lost to Follow-up|1|||
44246058|NCT01546922|79076953|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
44246059|NCT01546922|79076952|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
44246060|NCT01546922|79076953|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
44246061|NCT01546922|79076952|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
44246062|NCT01546922|79076953|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
44246063|NCT01546922|79076952|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
44246064|NCT01546922|79076953|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
44246065|NCT01532648|79076970|FG000|Overall Study|Lost to Follow-up|3|||
44246066|NCT01532648|79076971|FG001|Overall Study|Lost to Follow-up|4|||
44246067|NCT01532648|79076970|FG000|Overall Study|Lack of Efficacy|4|||
44246068|NCT01532648|79076971|FG001|Overall Study|Lack of Efficacy|1|||
44246069|NCT01532648|79076970|FG000|Overall Study|Protocol Violation|1|||
44246070|NCT01532648|79076971|FG001|Overall Study|Protocol Violation|1|||
44246071|NCT01532648|79076970|FG000|Overall Study|Adverse Event|12|||
44246072|NCT01532648|79076971|FG001|Overall Study|Adverse Event|9|||
44246073|NCT01532648|79076970|FG000|Overall Study|Withdrawal by Subject|16|||
44246074|NCT01532648|79076971|FG001|Overall Study|Withdrawal by Subject|2|||
44246075|NCT01532570|79077001|FG000|Overall Study|Lack of Efficacy|1|||
44246076|NCT01532570|79077002|FG001|Overall Study|Lack of Efficacy|0|||
44246077|NCT01532570|79077003|FG002|Overall Study|Lack of Efficacy|0|||
44246078|NCT01532570|79077004|FG003|Overall Study|Lack of Efficacy|0|||
44246079|NCT01532570|79077001|FG000|Overall Study|Withdrawal by Subject|0|||
44246080|NCT01532570|79077002|FG001|Overall Study|Withdrawal by Subject|1|||
44246081|NCT01532570|79077003|FG002|Overall Study|Withdrawal by Subject|0|||
44246082|NCT01532570|79077004|FG003|Overall Study|Withdrawal by Subject|0|||
44246083|NCT01532414|79077037|FG000|Overall Study|Lost to Follow-up|3|||
44246084|NCT01532414|79077038|FG001|Overall Study|Lost to Follow-up|0|||
44246085|NCT01532414|79077039|FG002|Overall Study|Lost to Follow-up|1|||
44246086|NCT01532414|79077037|FG000|Overall Study|Withdrawal by Subject|3|||
44246087|NCT01532414|79077038|FG001|Overall Study|Withdrawal by Subject|0|||
44246088|NCT01532414|79077039|FG002|Overall Study|Withdrawal by Subject|0|||
44246089|NCT01532414|79077037|FG000|Overall Study|No V6 semen sample|0|||
44276750|NCT03818581|79237706|FG000|Overall Study|Withdrawal by Subject|0|||
44276751|NCT03818581|79237707|FG001|Overall Study|Withdrawal by Subject|0|||
44276752|NCT03818581|79237708|FG002|Overall Study|Withdrawal by Subject|0|||
44276753|NCT03818581|79237709|FG003|Overall Study|Withdrawal by Subject|0|||
44276754|NCT03818581|79237710|FG004|Overall Study|Withdrawal by Subject|1|||
44276755|NCT03818581|79237706|FG000|Overall Study|No longer met study criteria|1|||
44276756|NCT03818581|79237707|FG001|Overall Study|No longer met study criteria|0|||
44276757|NCT03818581|79237708|FG002|Overall Study|No longer met study criteria|0|||
44276758|NCT03818581|79237709|FG003|Overall Study|No longer met study criteria|0|||
44276759|NCT03818581|79237710|FG004|Overall Study|No longer met study criteria|2|||
44276760|NCT03736447|79237724|FG000|Overall Study|Adverse Event|5|||
44276761|NCT03736447|79237725|FG001|Overall Study|Adverse Event|1|||
44276762|NCT03736447|79237724|FG000|Overall Study|Withdrawal by Subject|5|||
44276763|NCT03736447|79237725|FG001|Overall Study|Withdrawal by Subject|1|||
44276764|NCT03736447|79237724|FG000|Overall Study|Lost to Follow-up|1|||
44276765|NCT03736447|79237725|FG001|Overall Study|Lost to Follow-up|0|||
44276766|NCT03736447|79237724|FG000|Overall Study|Physician Decision|1|||
44514319|NCT04146896|79519754|FG000|Overall Study|Non-compliance|5|||
44514320|NCT04146896|79519755|FG001|Overall Study|Non-compliance|4|||
44514321|NCT04146896|79519754|FG000|Overall Study|Withdrawal by Subject|3|||
44246090|NCT01532414|79077038|FG001|Overall Study|No V6 semen sample|1|||
44246091|NCT01532414|79077039|FG002|Overall Study|No V6 semen sample|0|||
44246092|NCT01532414|79077037|FG000|Overall Study|Adverse Event|0|||
44246093|NCT01532414|79077038|FG001|Overall Study|Adverse Event|1|||
44246094|NCT01532414|79077039|FG002|Overall Study|Adverse Event|1|||
44246095|NCT01532414|79077037|FG000|Overall Study|Unable to complete 24 hour PK|0|||
44246096|NCT01532414|79077038|FG001|Overall Study|Unable to complete 24 hour PK|0|||
44246097|NCT01532414|79077039|FG002|Overall Study|Unable to complete 24 hour PK|1|||
44276767|NCT03736447|79237725|FG001|Overall Study|Physician Decision|0|||
44246098|NCT01532414|79077037|FG000|Overall Study|Withdrawn by sponsor|1|||
44246099|NCT01532414|79077038|FG001|Overall Study|Withdrawn by sponsor|0|||
44246100|NCT01532414|79077039|FG002|Overall Study|Withdrawn by sponsor|0|||
44246101|NCT01441973|79077049|FG000|Overall Study|Disease progression|8|||
44246102|NCT01441973|79077050|FG001|Overall Study|Disease progression|6|||
44276768|NCT03736447|79237724|FG000|Overall Study|Continued commitment to study treatment|3|||
44276769|NCT03736447|79237725|FG001|Overall Study|Continued commitment to study treatment|0|||
44514322|NCT04146896|79519755|FG001|Overall Study|Withdrawal by Subject|5|||
44246103|NCT01441973|79077049|FG000|Overall Study|Adverse event unrelated to study drug|3|||
44246104|NCT01441973|79077050|FG001|Overall Study|Adverse event unrelated to study drug|2|||
44246105|NCT01441973|79077049|FG000|Overall Study|Participant request to discontinue|1|||
44276770|NCT03736447|79237724|FG000|Overall Study|Taste aversion to study product|0|||
44514323|NCT04146896|79519754|FG000|Overall Study|Randomized in error|1|||
44514324|NCT04146896|79519755|FG001|Overall Study|Randomized in error|2|||
44246106|NCT01441973|79077050|FG001|Overall Study|Participant request to discontinue|1|||
44276771|NCT03736447|79237725|FG001|Overall Study|Taste aversion to study product|1|||
44276772|NCT02132754|79237774|FG000|Overall Study|Adverse Event|0|||
44276773|NCT02132754|79237775|FG001|Overall Study|Adverse Event|0|||
44276774|NCT02132754|79237776|FG002|Overall Study|Adverse Event|0|||
44276775|NCT02132754|79237777|FG003|Overall Study|Adverse Event|0|||
44276776|NCT02132754|79237778|FG004|Overall Study|Adverse Event|0|||
44276777|NCT02132754|79237779|FG005|Overall Study|Adverse Event|0|||
44276778|NCT02132754|79237780|FG006|Overall Study|Adverse Event|0|||
44276779|NCT02132754|79237781|FG007|Overall Study|Adverse Event|0|||
44276780|NCT02132754|79237782|FG008|Overall Study|Adverse Event|0|||
44276781|NCT02132754|79237783|FG009|Overall Study|Adverse Event|0|||
44276782|NCT02132754|79237784|FG010|Overall Study|Adverse Event|0|||
44276783|NCT02132754|79237785|FG011|Overall Study|Adverse Event|0|||
44276784|NCT02132754|79237786|FG012|Overall Study|Adverse Event|0|||
44276785|NCT02132754|79237787|FG013|Overall Study|Adverse Event|0|||
44276786|NCT02132754|79237788|FG014|Overall Study|Adverse Event|0|||
44276787|NCT02132754|79237789|FG015|Overall Study|Adverse Event|0|||
44276788|NCT02132754|79237790|FG016|Overall Study|Adverse Event|0|||
44276789|NCT02132754|79237791|FG017|Overall Study|Adverse Event|1|||
44276790|NCT02132754|79237792|FG018|Overall Study|Adverse Event|0|||
44276791|NCT02132754|79237793|FG019|Overall Study|Adverse Event|0|||
44276792|NCT02132754|79237794|FG020|Overall Study|Adverse Event|0|||
44276793|NCT02132754|79237795|FG021|Overall Study|Adverse Event|0|||
44276794|NCT02132754|79237796|FG022|Overall Study|Adverse Event|0|||
44276795|NCT02132754|79237797|FG023|Overall Study|Adverse Event|0|||
44276796|NCT02132754|79237798|FG024|Overall Study|Adverse Event|0|||
44276797|NCT02132754|79237799|FG025|Overall Study|Adverse Event|1|||
44276798|NCT02132754|79237800|FG026|Overall Study|Adverse Event|1|||
44276799|NCT02132754|79237801|FG027|Overall Study|Adverse Event|0|||
44246107|NCT01441973|79077049|FG000|Overall Study|Poor compliance/noncompliance|0|||
44246108|NCT01441973|79077050|FG001|Overall Study|Poor compliance/noncompliance|1|||
44246109|NCT01441973|79077049|FG000|Overall Study|Administrative reason by sponsor|3|||
44246110|NCT01441973|79077050|FG001|Overall Study|Administrative reason by sponsor|5|||
44246111|NCT01441973|79077049|FG000|Overall Study|Participant withdrew consent|0|||
44246112|NCT01441973|79077050|FG001|Overall Study|Participant withdrew consent|1|||
44246113|NCT01575899|79077069|FG000|Overall Study|Lost to Follow-up|3|||
44246114|NCT01575899|79077070|FG001|Overall Study|Lost to Follow-up|4|||
44246115|NCT01575899|79077071|FG002|Overall Study|Lost to Follow-up|2|||
44246116|NCT01575899|79077069|FG000|Overall Study|Protocol Violation|2|||
44246117|NCT01575899|79077070|FG001|Overall Study|Protocol Violation|1|||
44246118|NCT01575899|79077071|FG002|Overall Study|Protocol Violation|0|||
44246119|NCT01440881|79077083|FG000|Overall Study|Death|0|||
44246120|NCT01440881|79077084|FG001|Overall Study|Death|1|||
44246121|NCT01575197|79077099|FG000|Overall Study|Migration out of study area|1|||
44246122|NCT01575197|79077100|FG001|Overall Study|Migration out of study area|5|||
44246123|NCT01575197|79077101|FG002|Overall Study|Migration out of study area|4|||
44246124|NCT01575197|79077099|FG000|Overall Study|SAE|0|||
44246125|NCT01575197|79077100|FG001|Overall Study|SAE|1|||
44246126|NCT01575197|79077101|FG002|Overall Study|SAE|0|||
44246127|NCT01575197|79077099|FG000|Overall Study|Lost to Follow-up|0|||
44276800|NCT02132754|79237802|FG028|Overall Study|Adverse Event|0|||
44276801|NCT02132754|79237803|FG029|Overall Study|Adverse Event|0|||
44276802|NCT02132754|79237804|FG030|Overall Study|Adverse Event|1|||
44143416|NCT01111565|78932719|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
44246128|NCT01575197|79077100|FG001|Overall Study|Lost to Follow-up|1|||
44246129|NCT01575197|79077101|FG002|Overall Study|Lost to Follow-up|0|||
44246130|NCT01575197|79077099|FG000|Overall Study|Withdrawal by Subject|0|||
44246131|NCT01575197|79077100|FG001|Overall Study|Withdrawal by Subject|1|||
44143417|NCT01111565|78932720|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
44143864|NCT00462943|78933154|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
44246132|NCT01575197|79077101|FG002|Overall Study|Withdrawal by Subject|1|||
44246133|NCT01575197|79077099|FG000|Overall Study|Protocol Violation|2|||
44276803|NCT02132754|79237805|FG031|Overall Study|Adverse Event|0|||
44514325|NCT04072887|79519767|FG000|Overall Study|Withdrawal by Subject|3|||
44514326|NCT04072887|79519768|FG001|Overall Study|Withdrawal by Subject|8|||
44276804|NCT02132754|79237806|FG032|Overall Study|Adverse Event|1|||
44276805|NCT02132754|79237807|FG033|Overall Study|Adverse Event|1|||
44276806|NCT02132754|79237774|FG000|Overall Study|Clinical Progression|0|||
44276807|NCT02132754|79237775|FG001|Overall Study|Clinical Progression|0|||
44276808|NCT02132754|79237776|FG002|Overall Study|Clinical Progression|0|||
44276809|NCT02132754|79237777|FG003|Overall Study|Clinical Progression|0|||
44514327|NCT04072887|79519769|FG002|Overall Study|Withdrawal by Subject|1|||
44514328|NCT04072887|79519770|FG003|Overall Study|Withdrawal by Subject|3|||
44246134|NCT01575197|79077100|FG001|Overall Study|Protocol Violation|1|||
44246135|NCT01575197|79077101|FG002|Overall Study|Protocol Violation|1|||
44246136|NCT01574651|79077132|FG000|Overall Study|Lost to Follow-up|2|||
44246137|NCT01574651|79077133|FG001|Overall Study|Lost to Follow-up|4|||
44276810|NCT02132754|79237778|FG004|Overall Study|Clinical Progression|0|||
44246138|NCT01574651|79077132|FG000|Overall Study|Administrative problems|0|||
44246139|NCT01574651|79077133|FG001|Overall Study|Administrative problems|1|||
44276811|NCT02132754|79237779|FG005|Overall Study|Clinical Progression|0|||
44276812|NCT02132754|79237780|FG006|Overall Study|Clinical Progression|0|||
44276813|NCT02132754|79237781|FG007|Overall Study|Clinical Progression|0|||
44276814|NCT02132754|79237782|FG008|Overall Study|Clinical Progression|0|||
44276815|NCT02132754|79237783|FG009|Overall Study|Clinical Progression|1|||
44276816|NCT02132754|79237784|FG010|Overall Study|Clinical Progression|0|||
44276817|NCT02132754|79237785|FG011|Overall Study|Clinical Progression|0|||
44276818|NCT02132754|79237786|FG012|Overall Study|Clinical Progression|0|||
44276819|NCT02132754|79237787|FG013|Overall Study|Clinical Progression|0|||
44276820|NCT02132754|79237788|FG014|Overall Study|Clinical Progression|0|||
44276821|NCT02132754|79237789|FG015|Overall Study|Clinical Progression|0|||
44276822|NCT02132754|79237790|FG016|Overall Study|Clinical Progression|1|||
44276823|NCT02132754|79237791|FG017|Overall Study|Clinical Progression|1|||
44276824|NCT02132754|79237792|FG018|Overall Study|Clinical Progression|0|||
44276825|NCT02132754|79237793|FG019|Overall Study|Clinical Progression|1|||
44276826|NCT02132754|79237794|FG020|Overall Study|Clinical Progression|0|||
44276827|NCT02132754|79237795|FG021|Overall Study|Clinical Progression|0|||
44276828|NCT02132754|79237796|FG022|Overall Study|Clinical Progression|1|||
44276829|NCT02132754|79237797|FG023|Overall Study|Clinical Progression|0|||
44276830|NCT02132754|79237798|FG024|Overall Study|Clinical Progression|1|||
44276831|NCT02132754|79237799|FG025|Overall Study|Clinical Progression|1|||
44276832|NCT02132754|79237800|FG026|Overall Study|Clinical Progression|0|||
44276833|NCT02132754|79237801|FG027|Overall Study|Clinical Progression|1|||
44276834|NCT02132754|79237802|FG028|Overall Study|Clinical Progression|1|||
44276835|NCT02132754|79237803|FG029|Overall Study|Clinical Progression|0|||
44276836|NCT02132754|79237804|FG030|Overall Study|Clinical Progression|1|||
44276837|NCT02132754|79237805|FG031|Overall Study|Clinical Progression|0|||
44276838|NCT02132754|79237806|FG032|Overall Study|Clinical Progression|0|||
44276839|NCT02132754|79237807|FG033|Overall Study|Clinical Progression|2|||
44276840|NCT02132754|79237774|FG000|Overall Study|Death|0|||
44276841|NCT02132754|79237775|FG001|Overall Study|Death|0|||
44276842|NCT02132754|79237776|FG002|Overall Study|Death|0|||
44276843|NCT02132754|79237777|FG003|Overall Study|Death|0|||
44276844|NCT02132754|79237778|FG004|Overall Study|Death|0|||
44276845|NCT02132754|79237779|FG005|Overall Study|Death|0|||
44276846|NCT02132754|79237780|FG006|Overall Study|Death|0|||
44276847|NCT02132754|79237781|FG007|Overall Study|Death|0|||
44246140|NCT01574651|79077132|FG000|Overall Study|Death|3|||
44246141|NCT01574651|79077133|FG001|Overall Study|Death|3|||
44246142|NCT01574651|79077132|FG000|Overall Study|Patient's inability to use the device|0|||
44246143|NCT01574651|79077133|FG001|Overall Study|Patient's inability to use the device|1|||
44246144|NCT01574651|79077132|FG000|Overall Study|Adverse Event|36|||
44276848|NCT02132754|79237782|FG008|Overall Study|Death|0|||
44276849|NCT02132754|79237783|FG009|Overall Study|Death|0|||
44276850|NCT02132754|79237784|FG010|Overall Study|Death|0|||
44276851|NCT02132754|79237785|FG011|Overall Study|Death|0|||
44276852|NCT02132754|79237786|FG012|Overall Study|Death|0|||
44276853|NCT02132754|79237787|FG013|Overall Study|Death|0|||
44276854|NCT02132754|79237788|FG014|Overall Study|Death|0|||
44276855|NCT02132754|79237789|FG015|Overall Study|Death|1|||
44276856|NCT02132754|79237790|FG016|Overall Study|Death|0|||
44276857|NCT02132754|79237791|FG017|Overall Study|Death|0|||
44276858|NCT02132754|79237792|FG018|Overall Study|Death|0|||
44276859|NCT02132754|79237793|FG019|Overall Study|Death|1|||
44276860|NCT02132754|79237794|FG020|Overall Study|Death|0|||
44276861|NCT02132754|79237795|FG021|Overall Study|Death|1|||
44514329|NCT04072887|79519771|FG004|Overall Study|Withdrawal by Subject|3|||
44514330|NCT04072887|79519772|FG005|Overall Study|Withdrawal by Subject|13|||
44276862|NCT02132754|79237796|FG022|Overall Study|Death|0|||
44276863|NCT02132754|79237797|FG023|Overall Study|Death|0|||
44276864|NCT02132754|79237798|FG024|Overall Study|Death|0|||
44276865|NCT02132754|79237799|FG025|Overall Study|Death|0|||
44143418|NCT01111565|78932721|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
44246145|NCT01574651|79077133|FG001|Overall Study|Adverse Event|27|||
44246146|NCT01574651|79077132|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44276866|NCT02132754|79237800|FG026|Overall Study|Death|1|||
44276867|NCT02132754|79237801|FG027|Overall Study|Death|0|||
44276868|NCT02132754|79237802|FG028|Overall Study|Death|0|||
44276869|NCT02132754|79237803|FG029|Overall Study|Death|0|||
44514331|NCT04072887|79519767|FG000|Overall Study|Adverse Event|2|||
44143419|NCT01111565|78932722|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
44276870|NCT02132754|79237804|FG030|Overall Study|Death|0|||
44276871|NCT02132754|79237805|FG031|Overall Study|Death|0|||
44276872|NCT02132754|79237806|FG032|Overall Study|Death|0|||
44276873|NCT02132754|79237807|FG033|Overall Study|Death|2|||
44276874|NCT02132754|79237774|FG000|Overall Study|Excluded Medication|0|||
44276875|NCT02132754|79237775|FG001|Overall Study|Excluded Medication|0|||
44276876|NCT02132754|79237776|FG002|Overall Study|Excluded Medication|0|||
44143420|NCT01111565|78932723|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
44143421|NCT01111565|78932719|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44246147|NCT01574651|79077133|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44246148|NCT01574651|79077132|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44246149|NCT01574651|79077133|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44246150|NCT01574651|79077132|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
44246151|NCT01574651|79077133|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44246152|NCT01574651|79077132|FG000|Overall Study|Protocol Violation|3|||
44246153|NCT01574651|79077133|FG001|Overall Study|Protocol Violation|5|||
44246154|NCT01574651|79077132|FG000|Overall Study|Withdrawal by Subject|9|||
44246155|NCT01574651|79077133|FG001|Overall Study|Withdrawal by Subject|10|||
44143422|NCT01111565|78932720|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44143423|NCT01111565|78932721|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44143424|NCT01111565|78932722|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
44143425|NCT01111565|78932723|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44143426|NCT01111565|78932719|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44143427|NCT01111565|78932720|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44143428|NCT01111565|78932721|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
44143429|NCT01111565|78932722|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44143430|NCT01111565|78932723|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44143431|NCT01111565|78932719|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
44143432|NCT01111565|78932720|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
44143433|NCT01111565|78932721|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
44143434|NCT01111565|78932722|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
44143435|NCT01111565|78932723|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
44143436|NCT01111565|78932719|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
44143437|NCT01111565|78932720|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
44143438|NCT01111565|78932721|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
44143439|NCT01111565|78932722|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
44143440|NCT01111565|78932723|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
44143441|NCT01111565|78932719|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
44246156|NCT01440803|79077145|FG000|Overall Study|Met study stopping rule|2|||
44246157|NCT01440803|79077146|FG001|Overall Study|Met study stopping rule|1|||
44246158|NCT01440803|79077145|FG000|Overall Study|Lost to Follow-up|0|||
44246159|NCT01440803|79077146|FG001|Overall Study|Lost to Follow-up|2|||
44246160|NCT01440803|79077145|FG000|Overall Study|Withdrawal by Subject|0|||
44246161|NCT01440803|79077146|FG001|Overall Study|Withdrawal by Subject|1|||
44246162|NCT01517282|79077157|FG000|Overall Study|Consent withdrawn|0|||
44276877|NCT02132754|79237777|FG003|Overall Study|Excluded Medication|0|||
44276878|NCT02132754|79237778|FG004|Overall Study|Excluded Medication|0|||
44276879|NCT02132754|79237779|FG005|Overall Study|Excluded Medication|0|||
44276880|NCT02132754|79237780|FG006|Overall Study|Excluded Medication|0|||
44276881|NCT02132754|79237781|FG007|Overall Study|Excluded Medication|0|||
44276882|NCT02132754|79237782|FG008|Overall Study|Excluded Medication|0|||
44246163|NCT01517282|79077158|FG001|Overall Study|Consent withdrawn|1|||
44246164|NCT01517282|79077159|FG002|Overall Study|Consent withdrawn|1|||
44246165|NCT01517282|79077160|FG003|Overall Study|Consent withdrawn|1|||
44246166|NCT01517282|79077157|FG000|Overall Study|Physician Decision|1|||
44246167|NCT01517282|79077158|FG001|Overall Study|Physician Decision|0|||
44246168|NCT01517282|79077159|FG002|Overall Study|Physician Decision|0|||
44246169|NCT01517282|79077160|FG003|Overall Study|Physician Decision|0|||
44276883|NCT02132754|79237783|FG009|Overall Study|Excluded Medication|0|||
44276884|NCT02132754|79237784|FG010|Overall Study|Excluded Medication|0|||
44276885|NCT02132754|79237785|FG011|Overall Study|Excluded Medication|0|||
44276886|NCT02132754|79237786|FG012|Overall Study|Excluded Medication|0|||
44276887|NCT02132754|79237787|FG013|Overall Study|Excluded Medication|0|||
44276888|NCT02132754|79237788|FG014|Overall Study|Excluded Medication|0|||
44276889|NCT02132754|79237789|FG015|Overall Study|Excluded Medication|0|||
44276890|NCT02132754|79237790|FG016|Overall Study|Excluded Medication|0|||
44276891|NCT02132754|79237791|FG017|Overall Study|Excluded Medication|0|||
44276892|NCT02132754|79237792|FG018|Overall Study|Excluded Medication|0|||
44276893|NCT02132754|79237793|FG019|Overall Study|Excluded Medication|0|||
44276894|NCT02132754|79237794|FG020|Overall Study|Excluded Medication|1|||
44276895|NCT02132754|79237795|FG021|Overall Study|Excluded Medication|0|||
44276896|NCT02132754|79237796|FG022|Overall Study|Excluded Medication|0|||
44276897|NCT02132754|79237797|FG023|Overall Study|Excluded Medication|0|||
44276898|NCT02132754|79237798|FG024|Overall Study|Excluded Medication|0|||
44276899|NCT02132754|79237799|FG025|Overall Study|Excluded Medication|0|||
44276900|NCT02132754|79237800|FG026|Overall Study|Excluded Medication|0|||
44276901|NCT02132754|79237801|FG027|Overall Study|Excluded Medication|0|||
44276902|NCT02132754|79237802|FG028|Overall Study|Excluded Medication|0|||
44276903|NCT02132754|79237803|FG029|Overall Study|Excluded Medication|0|||
44276904|NCT02132754|79237804|FG030|Overall Study|Excluded Medication|0|||
44276905|NCT02132754|79237805|FG031|Overall Study|Excluded Medication|0|||
44276906|NCT02132754|79237806|FG032|Overall Study|Excluded Medication|0|||
44276907|NCT02132754|79237807|FG033|Overall Study|Excluded Medication|1|||
44246170|NCT01440647|79077181|FG000|Overall Study|Death|2|||
44246171|NCT01440647|79077182|FG001|Overall Study|Death|3|||
44246172|NCT01516970|79077190|FG000|Overall Study|Lost to Follow-up|7|||
44246173|NCT01516970|79077191|FG001|Overall Study|Lost to Follow-up|8|||
44246174|NCT01516970|79077190|FG000|Overall Study|Adverse Event|1|||
44246175|NCT01516970|79077191|FG001|Overall Study|Adverse Event|5|||
44246176|NCT01516970|79077190|FG000|Overall Study|Withdrawal by Subject|1|||
44246177|NCT01516970|79077191|FG001|Overall Study|Withdrawal by Subject|1|||
44246178|NCT01516970|79077190|FG000|Overall Study|Other|9|||
44276908|NCT02132754|79237774|FG000|Overall Study|Physician Decision|0|||
44276909|NCT02132754|79237775|FG001|Overall Study|Physician Decision|0|||
44276910|NCT02132754|79237776|FG002|Overall Study|Physician Decision|0|||
44276911|NCT02132754|79237777|FG003|Overall Study|Physician Decision|0|||
44276912|NCT02132754|79237778|FG004|Overall Study|Physician Decision|0|||
44276913|NCT02132754|79237779|FG005|Overall Study|Physician Decision|0|||
44276914|NCT02132754|79237780|FG006|Overall Study|Physician Decision|0|||
44276915|NCT02132754|79237781|FG007|Overall Study|Physician Decision|0|||
44276916|NCT02132754|79237782|FG008|Overall Study|Physician Decision|0|||
44276917|NCT02132754|79237783|FG009|Overall Study|Physician Decision|1|||
44276918|NCT02132754|79237784|FG010|Overall Study|Physician Decision|0|||
44276919|NCT02132754|79237785|FG011|Overall Study|Physician Decision|1|||
44276920|NCT02132754|79237786|FG012|Overall Study|Physician Decision|1|||
44276921|NCT02132754|79237787|FG013|Overall Study|Physician Decision|0|||
44276922|NCT02132754|79237788|FG014|Overall Study|Physician Decision|0|||
44276923|NCT02132754|79237789|FG015|Overall Study|Physician Decision|1|||
44276924|NCT02132754|79237790|FG016|Overall Study|Physician Decision|0|||
44276925|NCT02132754|79237791|FG017|Overall Study|Physician Decision|0|||
44276926|NCT02132754|79237792|FG018|Overall Study|Physician Decision|0|||
44276927|NCT02132754|79237793|FG019|Overall Study|Physician Decision|0|||
44276928|NCT02132754|79237794|FG020|Overall Study|Physician Decision|0|||
44246179|NCT01516970|79077191|FG001|Overall Study|Other|7|||
44246180|NCT01516892|79077212|FG000|Overall Study|Adverse Event|25|||
44246181|NCT01516892|79077212|FG000|Overall Study|Lack of Efficacy|35|||
44276929|NCT02132754|79237795|FG021|Overall Study|Physician Decision|0|||
44276930|NCT02132754|79237796|FG022|Overall Study|Physician Decision|0|||
44276931|NCT02132754|79237797|FG023|Overall Study|Physician Decision|0|||
44276932|NCT02132754|79237798|FG024|Overall Study|Physician Decision|1|||
44276933|NCT02132754|79237799|FG025|Overall Study|Physician Decision|0|||
44276934|NCT02132754|79237800|FG026|Overall Study|Physician Decision|0|||
44276935|NCT02132754|79237801|FG027|Overall Study|Physician Decision|0|||
44276936|NCT02132754|79237802|FG028|Overall Study|Physician Decision|0|||
44276937|NCT02132754|79237803|FG029|Overall Study|Physician Decision|0|||
44381304|NCT02842086|79387370|FG000|Overall Study|Randomized but Never Treated|6|||
44381305|NCT02842086|79387371|FG001|Overall Study|Randomized but Never Treated|6|||
44381306|NCT02842086|79387370|FG000|Overall Study|Still in Double-Blind Phase|7|||
44381307|NCT02842086|79387371|FG001|Overall Study|Still in Double-Blind Phase|3|||
44381308|NCT02842086|79387370|FG000|Overall Study|Adverse Event|18|||
44381309|NCT02842086|79387371|FG001|Overall Study|Adverse Event|20|||
44381310|NCT02842086|79387370|FG000|Overall Study|Death|3|||
44381311|NCT02842086|79387371|FG001|Overall Study|Death|3|||
44246182|NCT01516892|79077212|FG000|Overall Study|Pregnancy|5|||
44246183|NCT01516892|79077212|FG000|Overall Study|Lost to Follow-up|82|||
44246184|NCT01516892|79077212|FG000|Overall Study|Subject Withdrew Consent|92|||
44246185|NCT01516892|79077212|FG000|Overall Study|Protocol Violation|60|||
44246186|NCT01516892|79077212|FG000|Overall Study|Other Miscellaneous Reasons|43|||
44246187|NCT01516892|79077212|FG000|Overall Study|Missing|1|||
44246188|NCT01516736|79077237|FG000|Overall Study|Withdrawal by Subject|10|||
44246189|NCT01516736|79077238|FG001|Overall Study|Withdrawal by Subject|4|||
44246190|NCT01516736|79077237|FG000|Overall Study|Adverse Event|4|||
44246191|NCT01516736|79077238|FG001|Overall Study|Adverse Event|5|||
44246192|NCT01516736|79077237|FG000|Overall Study|Death|3|||
44246193|NCT01516736|79077238|FG001|Overall Study|Death|1|||
44276938|NCT02132754|79237804|FG030|Overall Study|Physician Decision|0|||
44276939|NCT02132754|79237805|FG031|Overall Study|Physician Decision|1|||
44276940|NCT02132754|79237806|FG032|Overall Study|Physician Decision|0|||
44276941|NCT02132754|79237807|FG033|Overall Study|Physician Decision|3|||
44381312|NCT02842086|79387370|FG000|Overall Study|Investigator's Discretion|9|||
44276942|NCT02132754|79237774|FG000|Overall Study|Progressive Disease|1|||
44246194|NCT01516736|79077237|FG000|Overall Study|Physician Decision|2|||
44246195|NCT01516736|79077238|FG001|Overall Study|Physician Decision|1|||
44276943|NCT02132754|79237775|FG001|Overall Study|Progressive Disease|1|||
44276944|NCT02132754|79237776|FG002|Overall Study|Progressive Disease|1|||
44276945|NCT02132754|79237777|FG003|Overall Study|Progressive Disease|1|||
44246196|NCT01516736|79077237|FG000|Overall Study|Lack of Efficacy|1|||
44276946|NCT02132754|79237778|FG004|Overall Study|Progressive Disease|1|||
44276947|NCT02132754|79237779|FG005|Overall Study|Progressive Disease|1|||
44276948|NCT02132754|79237780|FG006|Overall Study|Progressive Disease|1|||
44276949|NCT02132754|79237781|FG007|Overall Study|Progressive Disease|1|||
44246197|NCT01516736|79077238|FG001|Overall Study|Lack of Efficacy|0|||
44246198|NCT01516736|79077237|FG000|Overall Study|Protocol Violation|0|||
44246199|NCT01516736|79077238|FG001|Overall Study|Protocol Violation|1|||
44246200|NCT01516736|79077237|FG000|Overall Study|Other (not specified)|0|||
44246201|NCT01516736|79077238|FG001|Overall Study|Other (not specified)|1|||
44246202|NCT01546688|79077250|FG000|Overall Study|Adverse Event|0|||
44246203|NCT01546688|79077251|FG001|Overall Study|Adverse Event|4|||
44246204|NCT01546688|79077250|FG000|Overall Study|Withdrawal by Subject|2|||
44246205|NCT01546688|79077251|FG001|Overall Study|Withdrawal by Subject|1|||
44246206|NCT01546688|79077250|FG000|Overall Study|Lack of Efficacy|1|||
44246207|NCT01546688|79077251|FG001|Overall Study|Lack of Efficacy|0|||
44246208|NCT01516034|79077257|FG000|Overall Study|Physician Decision|1|||
44246209|NCT01516034|79077257|FG000|Overall Study|Lack of Efficacy|7|||
44246210|NCT01440569|79077268|FG000|Main Study|Enrolled but not treated|1|||
44246211|NCT01440569|79077269|FG001|Main Study|Enrolled but not treated|0|||
44246212|NCT01440569|79077268|FG000|Main Study|Adverse Event|9|||
44246213|NCT01440569|79077269|FG001|Main Study|Adverse Event|0|||
44246214|NCT01440569|79077268|FG000|Main Study|Pregnancy|1|||
44246215|NCT01440569|79077269|FG001|Main Study|Pregnancy|0|||
44246216|NCT01440569|79077268|FG000|Main Study|Investigator's Discretion|1|||
44246217|NCT01440569|79077269|FG001|Main Study|Investigator's Discretion|1|||
44246218|NCT01440569|79077268|FG000|Main Study|Withdrew Consent|7|||
44246219|NCT01440569|79077269|FG001|Main Study|Withdrew Consent|1|||
44246220|NCT01440569|79077268|FG000|Main Study|Lost to Follow-up|13|||
44246221|NCT01440569|79077269|FG001|Main Study|Lost to Follow-up|2|||
44246222|NCT01440569|79077268|FG000|Main Study|Subject Non-Compliance|3|||
44246223|NCT01440569|79077269|FG001|Main Study|Subject Non-Compliance|0|||
44246224|NCT01440569|79077268|FG000|Main Study|Protocol Violation|1|||
44246225|NCT01440569|79077269|FG001|Main Study|Protocol Violation|0|||
44246226|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Adverse Event|3|||
44246227|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Adverse Event|0|||
44246228|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Pregnancy|1|||
44246229|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Pregnancy|0|||
44246230|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
44246231|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
44246232|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
44246233|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
44246234|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
44246235|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
44246236|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
44246237|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
44246238|NCT01440569|79077268|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
44246239|NCT01440569|79077269|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
44246240|NCT01546142|79077292|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
44246241|NCT01546142|79077293|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
44246242|NCT01546142|79077292|FG000|Overall Study|Subject Noncompliance|1|||
44246243|NCT01546142|79077293|FG001|Overall Study|Subject Noncompliance|1|||
44246244|NCT01546142|79077292|FG000|Overall Study|Adverse Event|6|||
44246245|NCT01546142|79077293|FG001|Overall Study|Adverse Event|3|||
44246246|NCT01546142|79077292|FG000|Overall Study|Lost to Follow-up|20|||
44246247|NCT01546142|79077293|FG001|Overall Study|Lost to Follow-up|15|||
44246248|NCT01546142|79077292|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
44246249|NCT01546142|79077293|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
44246250|NCT01546142|79077292|FG000|Overall Study|Subject Randomized but Not Treated|1|||
44246251|NCT01546142|79077293|FG001|Overall Study|Subject Randomized but Not Treated|0|||
44246252|NCT01440101|79077327|FG000|Overall Study|Adverse Event|2|||
44246253|NCT01440101|79077328|FG001|Overall Study|Adverse Event|0|||
44246254|NCT01440101|79077329|FG002|Overall Study|Adverse Event|0|||
44246255|NCT01440101|79077327|FG000|Overall Study|Withdrawal by Subject|0|||
44246256|NCT01440101|79077328|FG001|Overall Study|Withdrawal by Subject|3|||
44246257|NCT01440101|79077329|FG002|Overall Study|Withdrawal by Subject|1|||
44246258|NCT01440101|79077327|FG000|Overall Study|Other|0|||
44246259|NCT01440101|79077328|FG001|Overall Study|Other|1|||
44246260|NCT01440101|79077329|FG002|Overall Study|Other|0|||
44246261|NCT01530464|79077340|FG000|Washout (24h)|Withdrawal by Subject|1|||
44246262|NCT01530464|79077341|FG001|Washout (24h)|Withdrawal by Subject|0|||
44246263|NCT01530464|79077340|FG000|Washout (24h)|Withdrawal by Subject|0|||
44246264|NCT01530464|79077341|FG001|Washout (24h)|Withdrawal by Subject|1|||
44246265|NCT01439945|79077408|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
44514332|NCT04072887|79519768|FG001|Overall Study|Adverse Event|4|||
44246266|NCT01439945|79077409|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
44246267|NCT01439945|79077410|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
44246268|NCT01439945|79077411|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
44246269|NCT01439945|79077408|FG000|Double-Blind Treatment Phase|Ineligible|1|||
44246270|NCT01439945|79077409|FG001|Double-Blind Treatment Phase|Ineligible|2|||
44246271|NCT01439945|79077410|FG002|Double-Blind Treatment Phase|Ineligible|0|||
44246272|NCT01439945|79077411|FG003|Double-Blind Treatment Phase|Ineligible|1|||
44246273|NCT01420081|79077516|FG000|Overall Study|Death|1|||
44246274|NCT01420081|79077517|FG001|Overall Study|Death|0|||
44246275|NCT01420081|79077518|FG002|Overall Study|Death|8|||
44246276|NCT01420081|79077519|FG003|Overall Study|Death|0|||
44246277|NCT01420081|79077520|FG004|Overall Study|Death|7|||
44246278|NCT01420081|79077521|FG005|Overall Study|Death|12|||
44246279|NCT01420081|79077522|FG006|Overall Study|Death|0|||
44246280|NCT01420081|79077523|FG007|Overall Study|Death|1|||
44246281|NCT01420081|79077524|FG008|Overall Study|Death|1|||
44246282|NCT01420081|79077516|FG000|Overall Study|Lost to Follow-up|0|||
44246283|NCT01420081|79077517|FG001|Overall Study|Lost to Follow-up|0|||
44246284|NCT01420081|79077518|FG002|Overall Study|Lost to Follow-up|0|||
44514333|NCT04072887|79519769|FG002|Overall Study|Adverse Event|1|||
44514334|NCT04072887|79519770|FG003|Overall Study|Adverse Event|4|||
44514335|NCT04072887|79519771|FG004|Overall Study|Adverse Event|0|||
44143442|NCT01111565|78932720|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
44246285|NCT01420081|79077519|FG003|Overall Study|Lost to Follow-up|0|||
44246286|NCT01420081|79077520|FG004|Overall Study|Lost to Follow-up|1|||
44246287|NCT01420081|79077521|FG005|Overall Study|Lost to Follow-up|1|||
44246288|NCT01420081|79077522|FG006|Overall Study|Lost to Follow-up|0|||
44246289|NCT01420081|79077523|FG007|Overall Study|Lost to Follow-up|0|||
44246290|NCT01420081|79077524|FG008|Overall Study|Lost to Follow-up|0|||
44246291|NCT01420081|79077516|FG000|Overall Study|Study Terminated by Sponsor|2|||
44246292|NCT01420081|79077517|FG001|Overall Study|Study Terminated by Sponsor|1|||
44246293|NCT01420081|79077518|FG002|Overall Study|Study Terminated by Sponsor|1|||
44246294|NCT01420081|79077519|FG003|Overall Study|Study Terminated by Sponsor|3|||
44246295|NCT01420081|79077520|FG004|Overall Study|Study Terminated by Sponsor|11|||
44246296|NCT01420081|79077521|FG005|Overall Study|Study Terminated by Sponsor|7|||
44246297|NCT01420081|79077522|FG006|Overall Study|Study Terminated by Sponsor|3|||
44246298|NCT01420081|79077523|FG007|Overall Study|Study Terminated by Sponsor|2|||
44246299|NCT01420081|79077524|FG008|Overall Study|Study Terminated by Sponsor|2|||
44246300|NCT01420081|79077516|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
44246301|NCT01420081|79077517|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
44246302|NCT01420081|79077518|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
44246303|NCT01420081|79077519|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
44246304|NCT01420081|79077520|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
44246305|NCT01420081|79077521|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
44246306|NCT01420081|79077522|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
44246307|NCT01420081|79077523|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
44246308|NCT01420081|79077524|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
44246309|NCT01420081|79077516|FG000|Overall Study|Other Reasons|0|||
44246310|NCT01420081|79077517|FG001|Overall Study|Other Reasons|0|||
44246311|NCT01420081|79077518|FG002|Overall Study|Other Reasons|1|||
44246312|NCT01420081|79077519|FG003|Overall Study|Other Reasons|0|||
44246313|NCT01420081|79077520|FG004|Overall Study|Other Reasons|0|||
44246314|NCT01420081|79077521|FG005|Overall Study|Other Reasons|0|||
44246315|NCT01420081|79077522|FG006|Overall Study|Other Reasons|0|||
44246316|NCT01420081|79077523|FG007|Overall Study|Other Reasons|0|||
44246317|NCT01420081|79077524|FG008|Overall Study|Other Reasons|0|||
44246318|NCT01439867|79077542|FG000|Overall Study|Non-compliance|0|||
44246319|NCT01439867|79077543|FG001|Overall Study|Non-compliance|1|||
44246320|NCT01439867|79077542|FG000|Overall Study|Withdrawal by Subject|1|||
44246321|NCT01439867|79077543|FG001|Overall Study|Withdrawal by Subject|2|||
44246322|NCT01439867|79077542|FG000|Overall Study|Administrative Decision|4|||
44246323|NCT01439867|79077543|FG001|Overall Study|Administrative Decision|5|||
44246324|NCT01439867|79077542|FG000|Overall Study|Protocol-specified Criteria|1|||
44246325|NCT01439867|79077543|FG001|Overall Study|Protocol-specified Criteria|0|||
44246326|NCT01439711|79077560|FG000|Overall Study|Ineligible|13|||
44246327|NCT01439711|79077560|FG000|Overall Study|Cancel|3|||
44246328|NCT01439711|79077560|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
44246329|NCT01439711|79077560|FG000|Overall Study|Adverse Event|5|||
44246330|NCT01439711|79077560|FG000|Overall Study|Withdrawal by Subject|3|||
44246331|NCT01439711|79077560|FG000|Overall Study|Progression During Active Tx|3|||
44246332|NCT01439711|79077560|FG000|Overall Study|Noncompliance|3|||
44246333|NCT01439711|79077560|FG000|Overall Study|No MRI|9|||
44246334|NCT01439555|79077564|FG000|Overall Study|Protocol Violation|1|||
44246335|NCT01544582|79077584|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
44246336|NCT01544582|79077585|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
44246337|NCT01544582|79077586|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
44246338|NCT01544582|79077587|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
44246339|NCT01544582|79077584|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
44246340|NCT01544582|79077585|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
44246341|NCT01544582|79077586|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
44246342|NCT01544582|79077587|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
44246343|NCT01544582|79077584|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
44514336|NCT04072887|79519772|FG005|Overall Study|Adverse Event|1|||
44246344|NCT01544582|79077585|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
44246345|NCT01544582|79077586|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
44246346|NCT01544582|79077587|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
44246347|NCT01544582|79077584|FG000|Analysis Population|Physician Decision|0|||
44246348|NCT01544582|79077585|FG001|Analysis Population|Physician Decision|13|||
44246349|NCT01544582|79077586|FG002|Analysis Population|Physician Decision|10|||
44246350|NCT01544582|79077587|FG003|Analysis Population|Physician Decision|9|||
44246351|NCT01544582|79077584|FG000|Analysis Population|Safety Reason|0|||
44246352|NCT01544582|79077585|FG001|Analysis Population|Safety Reason|33|||
44246353|NCT01544582|79077586|FG002|Analysis Population|Safety Reason|31|||
44246354|NCT01544582|79077587|FG003|Analysis Population|Safety Reason|8|||
44246355|NCT01544582|79077584|FG000|Analysis Population|Effectiveness Reason|0|||
44246356|NCT01544582|79077585|FG001|Analysis Population|Effectiveness Reason|48|||
44246357|NCT01544582|79077586|FG002|Analysis Population|Effectiveness Reason|29|||
44246358|NCT01544582|79077587|FG003|Analysis Population|Effectiveness Reason|12|||
44246359|NCT01544582|79077584|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
44246360|NCT01544582|79077585|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
44246361|NCT01544582|79077586|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
44246362|NCT01544582|79077587|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
44246363|NCT01544582|79077584|FG000|Analysis Population|Lost to Follow-up|0|||
44246364|NCT01544582|79077585|FG001|Analysis Population|Lost to Follow-up|6|||
44246365|NCT01544582|79077586|FG002|Analysis Population|Lost to Follow-up|6|||
44246366|NCT01544582|79077587|FG003|Analysis Population|Lost to Follow-up|5|||
44246367|NCT01544582|79077584|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
44246368|NCT01544582|79077585|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
44246369|NCT01544582|79077586|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
44246370|NCT01544582|79077587|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
44246371|NCT01544582|79077584|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
44246372|NCT01544582|79077585|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
44246373|NCT01544582|79077586|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
44246374|NCT01544582|79077587|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
44246375|NCT01544582|79077584|FG000|Analysis Population|Intolerance|0|||
44246376|NCT01544582|79077585|FG001|Analysis Population|Intolerance|1|||
44246377|NCT01544582|79077586|FG002|Analysis Population|Intolerance|0|||
44246378|NCT01544582|79077587|FG003|Analysis Population|Intolerance|0|||
44246379|NCT01544582|79077584|FG000|Analysis Population|Liver Transplantation|0|||
44246380|NCT01544582|79077585|FG001|Analysis Population|Liver Transplantation|0|||
44246381|NCT01544582|79077586|FG002|Analysis Population|Liver Transplantation|1|||
44246382|NCT01544582|79077587|FG003|Analysis Population|Liver Transplantation|0|||
44246383|NCT01544582|79077584|FG000|Analysis Population|No Social Insurance|0|||
44246384|NCT01544582|79077585|FG001|Analysis Population|No Social Insurance|0|||
44246385|NCT01544582|79077586|FG002|Analysis Population|No Social Insurance|1|||
44246386|NCT01544582|79077587|FG003|Analysis Population|No Social Insurance|0|||
44246387|NCT01544582|79077584|FG000|Analysis Population|Poor Adherence|0|||
44246388|NCT01544582|79077585|FG001|Analysis Population|Poor Adherence|0|||
44246389|NCT01544582|79077586|FG002|Analysis Population|Poor Adherence|1|||
44246390|NCT01544582|79077587|FG003|Analysis Population|Poor Adherence|0|||
44246391|NCT01544582|79077584|FG000|Analysis Population|Poor Participant Compliance|0|||
44246392|NCT01544582|79077585|FG001|Analysis Population|Poor Participant Compliance|1|||
44246393|NCT01544582|79077586|FG002|Analysis Population|Poor Participant Compliance|0|||
44246394|NCT01544582|79077587|FG003|Analysis Population|Poor Participant Compliance|0|||
44246395|NCT01544582|79077584|FG000|Analysis Population|Programmed Surgery|0|||
44246396|NCT01544582|79077585|FG001|Analysis Population|Programmed Surgery|1|||
44246397|NCT01544582|79077586|FG002|Analysis Population|Programmed Surgery|0|||
44246398|NCT01544582|79077587|FG003|Analysis Population|Programmed Surgery|0|||
44246399|NCT01544582|79077584|FG000|Analysis Population|Participant in Jail|0|||
44246400|NCT01544582|79077585|FG001|Analysis Population|Participant in Jail|0|||
44246401|NCT01544582|79077586|FG002|Analysis Population|Participant in Jail|1|||
44246402|NCT01544582|79077587|FG003|Analysis Population|Participant in Jail|0|||
44276950|NCT02132754|79237782|FG008|Overall Study|Progressive Disease|1|||
44276951|NCT02132754|79237783|FG009|Overall Study|Progressive Disease|3|||
44276952|NCT02132754|79237784|FG010|Overall Study|Progressive Disease|3|||
44143443|NCT01111565|78932721|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
44246403|NCT01439165|79077615|FG000|Overall Study|Protocol Violation|3|||
44246404|NCT01439165|79077616|FG001|Overall Study|Protocol Violation|0|||
44246405|NCT01439165|79077615|FG000|Overall Study|Lost to Follow-up|11|||
44246406|NCT01439165|79077616|FG001|Overall Study|Lost to Follow-up|1|||
44246407|NCT01439165|79077615|FG000|Overall Study|Withdrawal by Subject|7|||
44246408|NCT01439165|79077616|FG001|Overall Study|Withdrawal by Subject|1|||
44246409|NCT01529606|79077630|FG000|Overall Study|Lost to Follow-up|21|||
44246410|NCT01529606|79077631|FG001|Overall Study|Lost to Follow-up|18|||
44246411|NCT01439009|79077648|FG000|Overall Study|Physician Decision|5|||
44246412|NCT01439009|79077649|FG001|Overall Study|Physician Decision|3|||
44246413|NCT01439009|79077648|FG000|Overall Study|Protocol Violation|2|||
44246414|NCT01439009|79077649|FG001|Overall Study|Protocol Violation|0|||
44246415|NCT01439009|79077648|FG000|Overall Study|Deviation of exclusion criteria|1|||
44246416|NCT01439009|79077649|FG001|Overall Study|Deviation of exclusion criteria|0|||
44246417|NCT01572389|79077668|FG000|Overall Study|Death|1|||
44246418|NCT01572389|79077669|FG001|Overall Study|Death|3|||
44246419|NCT01572389|79077668|FG000|Overall Study|Withdrawal by Subject|14|||
44246420|NCT01572389|79077669|FG001|Overall Study|Withdrawal by Subject|2|||
44246421|NCT01572389|79077668|FG000|Overall Study|Lost to Follow-up|25|||
44246422|NCT01572389|79077669|FG001|Overall Study|Lost to Follow-up|14|||
44246423|NCT01572389|79077668|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
44246424|NCT01572389|79077669|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
44246425|NCT01571453|79077681|FG000|Overall Study|Adverse Event|14|||
44246426|NCT01571453|79077682|FG001|Overall Study|Adverse Event|32|||
44246427|NCT01571453|79077681|FG000|Overall Study|Lack of Efficacy|8|||
44246428|NCT01571453|79077682|FG001|Overall Study|Lack of Efficacy|3|||
44246429|NCT01571453|79077681|FG000|Overall Study|Non-compliance|2|||
44246430|NCT01571453|79077682|FG001|Overall Study|Non-compliance|4|||
44246431|NCT01571453|79077681|FG000|Overall Study|Protocol Violation|1|||
44246432|NCT01571453|79077682|FG001|Overall Study|Protocol Violation|5|||
44246433|NCT01571453|79077681|FG000|Overall Study|Withdrawal of consent|5|||
44246434|NCT01571453|79077682|FG001|Overall Study|Withdrawal of consent|13|||
44246435|NCT01571453|79077681|FG000|Overall Study|Lost to Follow-up|4|||
44246436|NCT01571453|79077682|FG001|Overall Study|Lost to Follow-up|2|||
44246437|NCT01571453|79077681|FG000|Overall Study|Administrative or other reason(s)|4|||
44246438|NCT01571453|79077682|FG001|Overall Study|Administrative or other reason(s)|3|||
44246439|NCT01446289|79077692|FG000|Overall Study|Withdrawal by Subject|1|||
44246440|NCT01446289|79077693|FG001|Overall Study|Withdrawal by Subject|0|||
44246441|NCT01446289|79077694|FG002|Overall Study|Withdrawal by Subject|1|||
44246442|NCT01446289|79077695|FG003|Overall Study|Withdrawal by Subject|0|||
44246443|NCT01438541|79077707|FG000|Overall Study|Physician Decision|1|||
44246444|NCT01438541|79077707|FG000|Overall Study|Withdrawal by Subject|1|||
44246445|NCT01438541|79077707|FG000|Overall Study|discharge from the hospital|5|||
44246446|NCT01419769|79077711|FG000|Overall Study|Did not receive the AXIOS stent|3|||
44246447|NCT01419769|79077711|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
44246448|NCT01438307|79077717|FG000|Overall Study|Death|1|||
44246449|NCT01438307|79077718|FG001|Overall Study|Death|1|||
44246450|NCT01444651|79077726|FG000|Overall Study|Adverse Event|3|||
44246451|NCT01444651|79077727|FG001|Overall Study|Adverse Event|2|||
44246452|NCT01444651|79077726|FG000|Overall Study|Lost to Follow-up|5|||
44246453|NCT01444651|79077727|FG001|Overall Study|Lost to Follow-up|5|||
44246454|NCT01444651|79077726|FG000|Overall Study|Non-fasting|2|||
44246455|NCT01444651|79077727|FG001|Overall Study|Non-fasting|1|||
44246456|NCT01444651|79077726|FG000|Overall Study|Missing data|1|||
44246457|NCT01444651|79077727|FG001|Overall Study|Missing data|1|||
44246458|NCT01570751|79077735|FG000|Period A (16 Weeks)|Protocol Violation|1|||
44246459|NCT01570751|79077736|FG001|Period A (16 Weeks)|Protocol Violation|1|||
44246460|NCT01570751|79077735|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
44246461|NCT01570751|79077736|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
44246462|NCT01570751|79077735|FG000|Period A (16 Weeks)|Unclassified|2|||
44246463|NCT01570751|79077736|FG001|Period A (16 Weeks)|Unclassified|3|||
44246464|NCT01570751|79077735|FG000|Period B (16 Weeks)|Adverse Event|1|||
44246465|NCT01570751|79077736|FG001|Period B (16 Weeks)|Adverse Event|0|||
44246466|NCT01570751|79077735|FG000|Period B (16 Weeks)|Protocol Violation|0|||
44246467|NCT01570751|79077736|FG001|Period B (16 Weeks)|Protocol Violation|1|||
44246468|NCT01419535|79077746|FG000|Overall Study|could not maintain iv line|1|||
44246469|NCT01419535|79077747|FG001|Overall Study|could not maintain iv line|1|||
44246470|NCT01419535|79077746|FG000|Overall Study|Withdrawal by Subject|0|||
44246471|NCT01419535|79077747|FG001|Overall Study|Withdrawal by Subject|1|||
44246472|NCT01438151|79077753|FG000|Overall Study|study terminated|8|||
44246473|NCT01418365|79077779|FG000|First Intervention|Withdrawal by Subject|0|||
44246474|NCT01418365|79077780|FG001|First Intervention|Withdrawal by Subject|1|||
44246475|NCT01418365|79077779|FG000|First Intervention|Non-compliance|1|||
44246476|NCT01418365|79077780|FG001|First Intervention|Non-compliance|0|||
44246477|NCT01418365|79077779|FG000|Second Intervention|Withdrawal by Subject|0|||
44514337|NCT04072887|79519767|FG000|Overall Study|Physician Decision|2|||
44246478|NCT01418365|79077780|FG001|Second Intervention|Withdrawal by Subject|1|||
44246479|NCT01437995|79077815|FG000|Overall Study|Lost to Follow-up|11|||
44514338|NCT04072887|79519768|FG001|Overall Study|Physician Decision|0|||
44514339|NCT04072887|79519769|FG002|Overall Study|Physician Decision|0|||
44246480|NCT01437995|79077816|FG001|Overall Study|Lost to Follow-up|18|||
44246481|NCT01437995|79077817|FG002|Overall Study|Lost to Follow-up|20|||
44514340|NCT04072887|79519770|FG003|Overall Study|Physician Decision|0|||
44514341|NCT04072887|79519771|FG004|Overall Study|Physician Decision|0|||
44246482|NCT01439347|79077866|FG000|Overall Study|Death|10|||
44246483|NCT01439347|79077867|FG001|Overall Study|Death|9|||
44246484|NCT01439347|79077866|FG000|Overall Study|Withdrawal by Subject|0|||
44246485|NCT01439347|79077867|FG001|Overall Study|Withdrawal by Subject|1|||
44246486|NCT01439347|79077866|FG000|Overall Study|Physician Decision|1|||
44246487|NCT01439347|79077867|FG001|Overall Study|Physician Decision|0|||
44246488|NCT01439347|79077866|FG000|Overall Study|Sponsor Terminated Study|2|||
44246489|NCT01439347|79077867|FG001|Overall Study|Sponsor Terminated Study|3|||
44246490|NCT01438957|79077914|FG000|Overall Study|Physician Decision|1|||
44246491|NCT01438957|79077915|FG001|Overall Study|Physician Decision|1|||
44246492|NCT01438957|79077916|FG002|Overall Study|Physician Decision|0|||
44246493|NCT01438957|79077917|FG003|Overall Study|Physician Decision|1|||
44246494|NCT01438957|79077918|FG004|Overall Study|Physician Decision|0|||
44246495|NCT01444417|79077967|FG000|Overall Study|Ineligibility Determined|0|||
44246496|NCT01444417|79077968|FG001|Overall Study|Ineligibility Determined|1|||
44246497|NCT01444417|79077967|FG000|Overall Study|Withdrawal by Subject|2|||
44514342|NCT04072887|79519772|FG005|Overall Study|Physician Decision|1|||
44514343|NCT04072887|79519767|FG000|Overall Study|Lost to Follow-up|1|||
44514344|NCT04072887|79519768|FG001|Overall Study|Lost to Follow-up|3|||
44514345|NCT04072887|79519769|FG002|Overall Study|Lost to Follow-up|0|||
44514346|NCT04072887|79519770|FG003|Overall Study|Lost to Follow-up|0|||
44514347|NCT04072887|79519771|FG004|Overall Study|Lost to Follow-up|0|||
44514348|NCT04072887|79519772|FG005|Overall Study|Lost to Follow-up|0|||
44514349|NCT04072887|79519767|FG000|Overall Study|Death|0|||
44514350|NCT04072887|79519768|FG001|Overall Study|Death|2|||
44514351|NCT04072887|79519769|FG002|Overall Study|Death|0|||
44514352|NCT04072887|79519770|FG003|Overall Study|Death|2|||
44514353|NCT04072887|79519771|FG004|Overall Study|Death|3|||
44514354|NCT04072887|79519772|FG005|Overall Study|Death|0|||
44514355|NCT03516812|79519865|FG000|Overall Study|Adverse Event|4|||
44514356|NCT03516812|79519865|FG000|Overall Study|Lack of Efficacy|2|||
44514357|NCT03440047|79519869|FG000|Overall Study|Withdrawal by Subject|2|||
44514358|NCT03122119|79519900|FG000|Overall Study|Did not meet eligibility critria|1|||
44514359|NCT02613169|79519906|FG000|Overall Study|Withdrawal by Subject|4|||
44143444|NCT01111565|78932722|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
44143445|NCT01111565|78932723|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
44143446|NCT02343458|78932737|FG000|Overall Study|Adverse Event|15|||
44143447|NCT02343458|78932738|FG001|Overall Study|Adverse Event|14|||
44143448|NCT02343458|78932739|FG002|Overall Study|Adverse Event|15|||
44143449|NCT02343458|78932740|FG003|Overall Study|Adverse Event|3|||
44143450|NCT02343458|78932737|FG000|Overall Study|Lack of Efficacy|3|||
44143451|NCT02343458|78932738|FG001|Overall Study|Lack of Efficacy|8|||
44143452|NCT02343458|78932739|FG002|Overall Study|Lack of Efficacy|4|||
44143453|NCT02343458|78932740|FG003|Overall Study|Lack of Efficacy|8|||
44246498|NCT01444417|79077968|FG001|Overall Study|Withdrawal by Subject|0|||
44246499|NCT01444027|79077995|FG000|Overall Study|Withdrawal by Subject|4|||
44246500|NCT01444027|79077996|FG001|Overall Study|Withdrawal by Subject|10|||
44246501|NCT01444027|79077997|FG002|Overall Study|Withdrawal by Subject|24|||
44246502|NCT01444027|79077995|FG000|Overall Study|Lost to Follow-up|26|||
44246503|NCT01444027|79077996|FG001|Overall Study|Lost to Follow-up|20|||
44246504|NCT01444027|79077997|FG002|Overall Study|Lost to Follow-up|14|||
44246505|NCT01438489|79078039|FG000|Overall Study|Lost to Follow-up|4|||
44246506|NCT01438489|79078040|FG001|Overall Study|Lost to Follow-up|2|||
44143454|NCT02343458|78932737|FG000|Overall Study|Withdrawal by Subject|18|||
44381313|NCT02842086|79387371|FG001|Overall Study|Investigator's Discretion|13|||
44381314|NCT02842086|79387370|FG000|Overall Study|Non-Compliance with Study Drug|9|||
44514360|NCT02613169|79519907|FG001|Overall Study|Withdrawal by Subject|1|||
44246507|NCT01438489|79078041|FG002|Overall Study|Lost to Follow-up|2|||
44246508|NCT01438489|79078039|FG000|Overall Study|Withdrawal by Subject|11|||
44246509|NCT01438489|79078040|FG001|Overall Study|Withdrawal by Subject|3|||
44246510|NCT01438489|79078041|FG002|Overall Study|Withdrawal by Subject|8|||
44514361|NCT02613169|79519906|FG000|Overall Study|Lost to Follow-up|0|||
44246511|NCT01438489|79078039|FG000|Overall Study|Death|0|||
44246512|NCT01438489|79078040|FG001|Overall Study|Death|0|||
44246513|NCT01438489|79078041|FG002|Overall Study|Death|1|||
44381315|NCT02842086|79387371|FG001|Overall Study|Non-Compliance with Study Drug|8|||
44514362|NCT02613169|79519907|FG001|Overall Study|Lost to Follow-up|5|||
44514363|NCT02613169|79519906|FG000|Overall Study|HIV|0|||
44514364|NCT02613169|79519907|FG001|Overall Study|HIV|2|||
44246514|NCT01438489|79078039|FG000|Overall Study|Sponsor decision|4|||
44246515|NCT01438489|79078040|FG001|Overall Study|Sponsor decision|1|||
44246516|NCT01438489|79078041|FG002|Overall Study|Sponsor decision|4|||
44246517|NCT01438489|79078039|FG000|Overall Study|Subject choice/Subject moved|2|||
44246518|NCT01438489|79078040|FG001|Overall Study|Subject choice/Subject moved|1|||
44246519|NCT01438489|79078041|FG002|Overall Study|Subject choice/Subject moved|1|||
44246520|NCT01438489|79078039|FG000|Overall Study|Investigator decision|0|||
44246521|NCT01438489|79078040|FG001|Overall Study|Investigator decision|1|||
44246522|NCT01438489|79078041|FG002|Overall Study|Investigator decision|0|||
44246523|NCT01438489|79078039|FG000|Overall Study|AE/SAEs|2|||
44246524|NCT01438489|79078040|FG001|Overall Study|AE/SAEs|1|||
44246525|NCT01438489|79078041|FG002|Overall Study|AE/SAEs|1|||
44246526|NCT01438489|79078039|FG000|Overall Study|Received prohibited medication|1|||
44246527|NCT01438489|79078040|FG001|Overall Study|Received prohibited medication|0|||
44246528|NCT01438489|79078041|FG002|Overall Study|Received prohibited medication|0|||
44246529|NCT01438489|79078039|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
44246530|NCT01438489|79078040|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
44246531|NCT01438489|79078041|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
44246532|NCT01438489|79078039|FG000|Overall Study|Inadequate venous access|0|||
44246533|NCT01438489|79078040|FG001|Overall Study|Inadequate venous access|2|||
44246534|NCT01438489|79078041|FG002|Overall Study|Inadequate venous access|0|||
44246535|NCT01418209|79078067|FG000|Overall Study|Withdrawal by Subject|1|||
44246536|NCT01418209|79078068|FG001|Overall Study|Withdrawal by Subject|0|||
44246537|NCT01418209|79078069|FG002|Overall Study|Withdrawal by Subject|1|||
44246538|NCT01418209|79078067|FG000|Overall Study|Did not provide hot flash diary data|1|||
44246539|NCT01418209|79078068|FG001|Overall Study|Did not provide hot flash diary data|3|||
44246540|NCT01418209|79078069|FG002|Overall Study|Did not provide hot flash diary data|3|||
44246541|NCT01570361|79078088|FG000|Overall Study|Subject discontinued|1|||
44246542|NCT01570361|79078089|FG001|Overall Study|Subject discontinued|2|||
44246543|NCT01570361|79078088|FG000|Overall Study|Sponsor closing the study|51|||
44246544|NCT01570361|79078089|FG001|Overall Study|Sponsor closing the study|50|||
44246545|NCT01570361|79078088|FG000|Overall Study|Subject excluded|5|||
44246546|NCT01570361|79078089|FG001|Overall Study|Subject excluded|3|||
44246547|NCT01570361|79078088|FG000|Overall Study|Subject withdrew consent|14|||
44246548|NCT01570361|79078089|FG001|Overall Study|Subject withdrew consent|9|||
44246549|NCT01570361|79078088|FG000|Overall Study|Adverse Event|2|||
44246550|NCT01570361|79078089|FG001|Overall Study|Adverse Event|1|||
44246551|NCT01570361|79078088|FG000|Overall Study|Lost to Follow-up|4|||
44246552|NCT01570361|79078089|FG001|Overall Study|Lost to Follow-up|4|||
44246553|NCT01570361|79078088|FG000|Overall Study|Death|5|||
44246554|NCT01570361|79078089|FG001|Overall Study|Death|4|||
44246555|NCT01570361|79078088|FG000|Overall Study|Other|0|||
44246556|NCT01570361|79078089|FG001|Overall Study|Other|2|||
44246557|NCT01417195|79078100|FG000|Overall Study|Stimulation failure|1|||
44246558|NCT01417195|79078101|FG001|Overall Study|Stimulation failure|0|||
44246559|NCT01417195|79078100|FG000|Overall Study|No embryos for transfer|0|||
44246560|NCT01417195|79078101|FG001|Overall Study|No embryos for transfer|1|||
44246561|NCT01417195|79078100|FG000|Overall Study|No transfer due to risk of OHSS|1|||
44246562|NCT01417195|79078101|FG001|Overall Study|No transfer due to risk of OHSS|0|||
44246563|NCT01417195|79078100|FG000|Overall Study|No transfer due to elevated progesterone|1|||
44246564|NCT01417195|79078101|FG001|Overall Study|No transfer due to elevated progesterone|0|||
44246565|NCT01443403|79078134|FG000|Overall Study|Adverse Event|1|||
44246566|NCT01443403|79078135|FG001|Overall Study|Adverse Event|1|||
44246567|NCT01443403|79078136|FG002|Overall Study|Adverse Event|4|||
44246568|NCT01443403|79078137|FG003|Overall Study|Adverse Event|5|||
44246569|NCT01443403|79078134|FG000|Overall Study|Withdrawal by Subject|0|||
44246570|NCT01443403|79078135|FG001|Overall Study|Withdrawal by Subject|1|||
44246571|NCT01443403|79078136|FG002|Overall Study|Withdrawal by Subject|2|||
44246572|NCT01443403|79078137|FG003|Overall Study|Withdrawal by Subject|1|||
44246573|NCT01443403|79078134|FG000|Overall Study|Lost to Follow-up|0|||
44246574|NCT01443403|79078135|FG001|Overall Study|Lost to Follow-up|0|||
44246575|NCT01443403|79078136|FG002|Overall Study|Lost to Follow-up|0|||
44246576|NCT01443403|79078137|FG003|Overall Study|Lost to Follow-up|1|||
44246577|NCT01443403|79078134|FG000|Overall Study|Protocol Violation|2|||
44246578|NCT01443403|79078135|FG001|Overall Study|Protocol Violation|1|||
44246579|NCT01443403|79078136|FG002|Overall Study|Protocol Violation|1|||
44246580|NCT01443403|79078137|FG003|Overall Study|Protocol Violation|1|||
44246581|NCT01443403|79078134|FG000|Overall Study|Use of Prohibited Treatment|2|||
44246582|NCT01443403|79078135|FG001|Overall Study|Use of Prohibited Treatment|3|||
44246583|NCT01443403|79078136|FG002|Overall Study|Use of Prohibited Treatment|0|||
44246584|NCT01443403|79078137|FG003|Overall Study|Use of Prohibited Treatment|0|||
44246585|NCT01443403|79078134|FG000|Overall Study|Other - Miscellaneous|1|||
44246586|NCT01443403|79078135|FG001|Overall Study|Other - Miscellaneous|0|||
44143455|NCT02343458|78932738|FG001|Overall Study|Withdrawal by Subject|17|||
44246587|NCT01443403|79078136|FG002|Overall Study|Other - Miscellaneous|0|||
44246588|NCT01443403|79078137|FG003|Overall Study|Other - Miscellaneous|1|||
44246589|NCT01438177|79078150|FG000|Overall Study|Withdrawal by Subject|1|||
44246590|NCT01438177|79078150|FG000|Overall Study|Initiation of new therapy|1|||
44246591|NCT01442779|79078154|FG000|Overall Study|Withdrawal by Subject|3|||
44246592|NCT01442779|79078154|FG000|Overall Study|Death|3|||
44246593|NCT01442779|79078154|FG000|Overall Study|Non-compliance|1|||
44246594|NCT01416805|79078160|FG000|Overall Study|Lost to Follow-up|4|||
44246595|NCT01416805|79078161|FG001|Overall Study|Lost to Follow-up|4|||
44246596|NCT01437943|79078169|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
44246597|NCT01437943|79078170|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
44246598|NCT01437943|79078169|FG000|Overall Study|Subject expressed pregnancy plans|1|||
44246599|NCT01437943|79078170|FG001|Overall Study|Subject expressed pregnancy plans|0|||
44246600|NCT01437943|79078169|FG000|Overall Study|Adverse Event|2|||
44246601|NCT01437943|79078170|FG001|Overall Study|Adverse Event|0|||
44246602|NCT01570283|79078179|FG000|Cohort 1: Dose Level 1|Death|0|||
44246603|NCT01570283|79078180|FG001|Cohort 1: Dose Level 1|Death|1|||
44246604|NCT01570283|79078181|FG002|Cohort 1: Dose Level 1|Death|0|||
44246605|NCT01570283|79078182|FG003|Cohort 1: Dose Level 1|Death|0|||
44246606|NCT01570283|79078183|FG004|Cohort 1: Dose Level 1|Death|0|||
44246607|NCT01570283|79078184|FG005|Cohort 1: Dose Level 1|Death|0|||
44246608|NCT01570283|79078179|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
44246609|NCT01570283|79078180|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
44246610|NCT01570283|79078181|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
44246611|NCT01570283|79078182|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
44246612|NCT01570283|79078183|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
44246613|NCT01570283|79078184|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
44246614|NCT01570283|79078179|FG000|Cohort 2: Dose Level 2|Death|0|||
44246615|NCT01570283|79078180|FG001|Cohort 2: Dose Level 2|Death|0|||
44246616|NCT01570283|79078181|FG002|Cohort 2: Dose Level 2|Death|1|||
44246617|NCT01570283|79078182|FG003|Cohort 2: Dose Level 2|Death|0|||
44246618|NCT01570283|79078183|FG004|Cohort 2: Dose Level 2|Death|0|||
44246619|NCT01570283|79078184|FG005|Cohort 2: Dose Level 2|Death|0|||
44246620|NCT01570283|79078179|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
44246621|NCT01570283|79078180|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
44246622|NCT01570283|79078181|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
44246623|NCT01570283|79078182|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
44246624|NCT01570283|79078183|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
44246625|NCT01570283|79078184|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
44246626|NCT01570283|79078179|FG000|Cohort 3: Dose Level 3|Death|0|||
44246627|NCT01570283|79078180|FG001|Cohort 3: Dose Level 3|Death|0|||
44246628|NCT01570283|79078181|FG002|Cohort 3: Dose Level 3|Death|0|||
44246629|NCT01570283|79078182|FG003|Cohort 3: Dose Level 3|Death|0|||
44246630|NCT01570283|79078183|FG004|Cohort 3: Dose Level 3|Death|0|||
44246631|NCT01570283|79078184|FG005|Cohort 3: Dose Level 3|Death|1|||
44246632|NCT01570283|79078179|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
44246633|NCT01570283|79078180|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
44246634|NCT01570283|79078181|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
44246635|NCT01570283|79078182|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
44246636|NCT01570283|79078183|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
44246637|NCT01570283|79078184|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
44246638|NCT01436357|79078200|FG000|Overall Study|Death|5|||
44246639|NCT01436357|79078201|FG001|Overall Study|Death|1|||
44246640|NCT01436357|79078200|FG000|Overall Study|Enrolled but not vaccinated|1|||
44246641|NCT01436357|79078201|FG001|Overall Study|Enrolled but not vaccinated|1|||
44246642|NCT01436357|79078200|FG000|Overall Study|Incarceration|18|||
44246643|NCT01436357|79078201|FG001|Overall Study|Incarceration|20|||
44246644|NCT01436357|79078200|FG000|Overall Study|Lost to Follow-up|67|||
44246645|NCT01436357|79078201|FG001|Overall Study|Lost to Follow-up|61|||
44246646|NCT01436357|79078200|FG000|Overall Study|Protocol Violation|1|||
44246647|NCT01436357|79078201|FG001|Overall Study|Protocol Violation|0|||
44246648|NCT01436357|79078200|FG000|Overall Study|Withdrawal by Subject|26|||
44381316|NCT02842086|79387370|FG000|Overall Study|Protocol Violation|8|||
44381317|NCT02842086|79387371|FG001|Overall Study|Protocol Violation|4|||
44381318|NCT02842086|79387370|FG000|Overall Study|Withdrew Consent|205|||
44246649|NCT01436357|79078201|FG001|Overall Study|Withdrawal by Subject|38|||
44246650|NCT01436357|79078200|FG000|Overall Study|Physician Decision|3|||
44246651|NCT01436357|79078201|FG001|Overall Study|Physician Decision|4|||
44246652|NCT01436357|79078200|FG000|Overall Study|Moved out of area|1|||
44381319|NCT02842086|79387371|FG001|Overall Study|Withdrew Consent|194|||
44246653|NCT01436357|79078201|FG001|Overall Study|Moved out of area|2|||
44246654|NCT01436357|79078200|FG000|Overall Study|Subject in rehab|0|||
44246655|NCT01436357|79078201|FG001|Overall Study|Subject in rehab|1|||
44246656|NCT01436201|79078207|FG000|Overall Study|Adverse Event|2|||
44246657|NCT01436201|79078207|FG000|Overall Study|Withdrawal by Subject|1|||
44246658|NCT01436201|79078207|FG000|Overall Study|Protocol Violation|1|||
44381320|NCT02842086|79387370|FG000|Overall Study|Lost to Follow-up|274|||
44381321|NCT02842086|79387371|FG001|Overall Study|Lost to Follow-up|236|||
44246659|NCT01437397|79078218|FG000|Overall Study|Lost to Follow-up|9|||
44246660|NCT01437397|79078219|FG001|Overall Study|Lost to Follow-up|4|||
44246661|NCT01437397|79078220|FG002|Overall Study|Lost to Follow-up|2|||
44246662|NCT01437397|79078221|FG003|Overall Study|Lost to Follow-up|4|||
44246663|NCT01437397|79078222|FG004|Overall Study|Lost to Follow-up|5|||
44246664|NCT01437397|79078218|FG000|Overall Study|Withdrawal by Subject|11|||
44246665|NCT01437397|79078219|FG001|Overall Study|Withdrawal by Subject|12|||
44246666|NCT01437397|79078220|FG002|Overall Study|Withdrawal by Subject|24|||
44246667|NCT01437397|79078221|FG003|Overall Study|Withdrawal by Subject|11|||
44246668|NCT01437397|79078222|FG004|Overall Study|Withdrawal by Subject|22|||
44246669|NCT01437397|79078218|FG000|Overall Study|Protocol Violation|10|||
44246670|NCT01437397|79078219|FG001|Overall Study|Protocol Violation|12|||
44246671|NCT01437397|79078220|FG002|Overall Study|Protocol Violation|13|||
44246672|NCT01437397|79078221|FG003|Overall Study|Protocol Violation|21|||
44246673|NCT01437397|79078222|FG004|Overall Study|Protocol Violation|19|||
44246674|NCT01437397|79078218|FG000|Overall Study|Lack of Efficacy|5|||
44246675|NCT01437397|79078219|FG001|Overall Study|Lack of Efficacy|4|||
44246676|NCT01437397|79078220|FG002|Overall Study|Lack of Efficacy|8|||
44246677|NCT01437397|79078221|FG003|Overall Study|Lack of Efficacy|10|||
44246678|NCT01437397|79078222|FG004|Overall Study|Lack of Efficacy|20|||
44246679|NCT01437397|79078218|FG000|Overall Study|Adverse Event|21|||
44246680|NCT01437397|79078219|FG001|Overall Study|Adverse Event|22|||
44246681|NCT01437397|79078220|FG002|Overall Study|Adverse Event|16|||
44246682|NCT01437397|79078221|FG003|Overall Study|Adverse Event|14|||
44246683|NCT01437397|79078222|FG004|Overall Study|Adverse Event|21|||
44246684|NCT01437397|79078218|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
44246685|NCT01437397|79078219|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
44246686|NCT01437397|79078220|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
44246687|NCT01437397|79078221|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
44246688|NCT01437397|79078222|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
44246689|NCT01437319|79078234|FG000|Phase I|Lost to Follow-up|2|||
44246690|NCT01437319|79078235|FG001|Phase I|Lost to Follow-up|0|||
44246691|NCT01437319|79078236|FG002|Phase I|Lost to Follow-up|0|||
44246692|NCT01437319|79078234|FG000|Phase I|Protocol Violation|1|||
44246693|NCT01437319|79078235|FG001|Phase I|Protocol Violation|0|||
44246694|NCT01437319|79078236|FG002|Phase I|Protocol Violation|0|||
44246695|NCT01437319|79078234|FG000|Phase I|Study related symptoms/complaints|27|||
44246696|NCT01437319|79078235|FG001|Phase I|Study related symptoms/complaints|0|||
44246697|NCT01437319|79078236|FG002|Phase I|Study related symptoms/complaints|0|||
44246698|NCT01437319|79078234|FG000|Phase I|Withdrawal by Subject|25|||
44246699|NCT01437319|79078235|FG001|Phase I|Withdrawal by Subject|0|||
44246700|NCT01437319|79078236|FG002|Phase I|Withdrawal by Subject|0|||
44246701|NCT01437319|79078234|FG000|Phase II|Withdrawal by Subject|0|||
44246702|NCT01437319|79078235|FG001|Phase II|Withdrawal by Subject|8|||
44246703|NCT01437319|79078236|FG002|Phase II|Withdrawal by Subject|16|||
44246704|NCT01437319|79078234|FG000|Phase II|Lost to Follow-up|0|||
44246705|NCT01437319|79078235|FG001|Phase II|Lost to Follow-up|7|||
44246706|NCT01437319|79078236|FG002|Phase II|Lost to Follow-up|2|||
44246707|NCT01437319|79078234|FG000|Phase II|Study related symptoms/complaints|0|||
44246708|NCT01437319|79078235|FG001|Phase II|Study related symptoms/complaints|28|||
44246709|NCT01437319|79078236|FG002|Phase II|Study related symptoms/complaints|19|||
44246710|NCT01437319|79078234|FG000|Phase II|Protocol Violation|0|||
44246711|NCT01437319|79078235|FG001|Phase II|Protocol Violation|1|||
44246712|NCT01437319|79078236|FG002|Phase II|Protocol Violation|0|||
44246713|NCT01416571|79078245|FG000|Overall Study|Lost to Follow-up|2|||
44246714|NCT01442155|79078266|FG000|Overall Study|Complete remission|35|||
44246715|NCT01442155|79078266|FG000|Overall Study|Recurrence|26|||
44143456|NCT02343458|78932739|FG002|Overall Study|Withdrawal by Subject|23|||
44143457|NCT02343458|78932740|FG003|Overall Study|Withdrawal by Subject|14|||
44143458|NCT02343458|78932737|FG000|Overall Study|Physician Decision|1|||
44143459|NCT02343458|78932738|FG001|Overall Study|Physician Decision|4|||
44143460|NCT02343458|78932739|FG002|Overall Study|Physician Decision|2|||
44143461|NCT02343458|78932740|FG003|Overall Study|Physician Decision|2|||
44246716|NCT01442155|79078266|FG000|Overall Study|Adverse Event|2|||
44246717|NCT01442155|79078266|FG000|Overall Study|Lost to Follow-up|2|||
44246718|NCT01416181|79078272|FG000|Part 1|Other|10|||
44246719|NCT01416181|79078273|FG001|Part 1|Other|24|||
44246720|NCT01416181|79078272|FG000|Part 1|Death|0|||
44246721|NCT01416181|79078273|FG001|Part 1|Death|1|||
44381322|NCT02842086|79387370|FG000|Overall Study|HIV-1 Infection|5|||
44246722|NCT01416181|79078272|FG000|Part 1|Investigator Decision|7|||
44246723|NCT01416181|79078273|FG001|Part 1|Investigator Decision|6|||
44246724|NCT01416181|79078272|FG000|Part 1|Withdrawal by Subject|74|||
44246725|NCT01416181|79078273|FG001|Part 1|Withdrawal by Subject|48|||
44276953|NCT02132754|79237785|FG011|Overall Study|Progressive Disease|2|||
44143462|NCT02343458|78932737|FG000|Overall Study|Lost to Follow-up|5|||
44246726|NCT01416181|79078272|FG000|Part 1|Lack of Efficacy|16|||
44246727|NCT01416181|79078273|FG001|Part 1|Lack of Efficacy|8|||
44246728|NCT01416181|79078272|FG000|Part 1|Lost to Follow-up|1|||
44246729|NCT01416181|79078273|FG001|Part 1|Lost to Follow-up|1|||
44246730|NCT01416181|79078272|FG000|Part 1|Adverse Event|15|||
44246731|NCT01416181|79078273|FG001|Part 1|Adverse Event|18|||
44246732|NCT01416181|79078272|FG000|Part 1|Ongoing in Follow-Up|14|||
44246733|NCT01416181|79078273|FG001|Part 1|Ongoing in Follow-Up|8|||
44246734|NCT01416181|79078272|FG000|Part 2|Adverse Event|11|||
44246735|NCT01416181|79078273|FG001|Part 2|Adverse Event|4|||
44246736|NCT01416181|79078272|FG000|Part 2|Other|234|||
44246737|NCT01416181|79078273|FG001|Part 2|Other|267|||
44246738|NCT01416181|79078272|FG000|Part 2|Investigator Decision|6|||
44246739|NCT01416181|79078273|FG001|Part 2|Investigator Decision|7|||
44246740|NCT01416181|79078272|FG000|Part 2|Withdrawal by Subject|14|||
44246741|NCT01416181|79078273|FG001|Part 2|Withdrawal by Subject|5|||
44246742|NCT01416181|79078272|FG000|Part 2|Lack of Efficacy|4|||
44246743|NCT01416181|79078273|FG001|Part 2|Lack of Efficacy|1|||
44246744|NCT01416181|79078272|FG000|Part 2|Lost to Follow-up|2|||
44246745|NCT01416181|79078273|FG001|Part 2|Lost to Follow-up|2|||
44246746|NCT01441765|79078281|FG000|Overall Study|Death|1|||
44246747|NCT01441765|79078282|FG001|Overall Study|Death|0|||
44246748|NCT01419665|79078290|FG000|Combination Treatment|Adverse Event|7|||
44246749|NCT01419665|79078291|FG001|Combination Treatment|Adverse Event|10|||
44246750|NCT01419665|79078290|FG000|Combination Treatment|Physician Decision|5|||
44246751|NCT01419665|79078291|FG001|Combination Treatment|Physician Decision|8|||
44246752|NCT01419665|79078290|FG000|Combination Treatment|Protocol Violation|6|||
44246753|NCT01419665|79078291|FG001|Combination Treatment|Protocol Violation|2|||
44246754|NCT01419665|79078290|FG000|Combination Treatment|disease progression|10|||
44246755|NCT01419665|79078291|FG001|Combination Treatment|disease progression|9|||
44246756|NCT01419665|79078290|FG000|Combination Treatment|Death|5|||
44246757|NCT01419665|79078291|FG001|Combination Treatment|Death|7|||
44246758|NCT01419665|79078290|FG000|Combination Treatment|administrative problems|0|||
44246759|NCT01419665|79078291|FG001|Combination Treatment|administrative problems|1|||
44246760|NCT01419665|79078290|FG000|Combination Treatment|Withdrawal by Subject|5|||
44246761|NCT01419665|79078291|FG001|Combination Treatment|Withdrawal by Subject|4|||
44246762|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
44246763|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
44246764|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
44246765|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
44246766|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
44246767|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
44246768|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
44246769|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
44246770|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
44246771|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
44246772|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
44246773|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
44246774|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|Death|1|||
44246775|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|Death|2|||
44246776|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
44246777|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
44246778|NCT01419665|79078290|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
44246779|NCT01419665|79078291|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
44246780|NCT01419665|79078290|FG000|Open Label Phase|Death|1|||
44246781|NCT01419665|79078291|FG001|Open Label Phase|Death|0|||
44246782|NCT01419665|79078290|FG000|Open Label Phase|disease progression|0|||
44246783|NCT01419665|79078291|FG001|Open Label Phase|disease progression|1|||
44514365|NCT02613169|79519906|FG000|Overall Study|No TB infection endpoint|14|||
44514366|NCT02613169|79519907|FG001|Overall Study|No TB infection endpoint|9|||
44514367|NCT01974765|79519913|FG000|Overall Study|Withdrawal by Subject|1|||
44514368|NCT01974765|79519913|FG000|Overall Study|Death|1|||
44514369|NCT01974765|79519913|FG000|Overall Study|Adverse Event|2|||
44514370|NCT01725217|79519920|FG000|Overall Study|Withdrawal by Subject|1|||
44514371|NCT01725217|79519921|FG001|Overall Study|Withdrawal by Subject|0|||
44246784|NCT01436305|79078302|FG000|Overall Study|Death|1|||
44246785|NCT01436305|79078303|FG001|Overall Study|Death|0|||
44246786|NCT01436305|79078304|FG002|Overall Study|Death|0|||
44246787|NCT01436305|79078302|FG000|Overall Study|Lost to Follow-up|0|||
44246788|NCT01436305|79078303|FG001|Overall Study|Lost to Follow-up|1|||
44246789|NCT01436305|79078304|FG002|Overall Study|Lost to Follow-up|0|||
44246790|NCT01436305|79078302|FG000|Overall Study|Withdrawal by Subject|1|||
44246791|NCT01436305|79078303|FG001|Overall Study|Withdrawal by Subject|3|||
44246792|NCT01436305|79078304|FG002|Overall Study|Withdrawal by Subject|0|||
44246793|NCT01436149|79078314|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
44276954|NCT02132754|79237786|FG012|Overall Study|Progressive Disease|2|||
44514372|NCT01725217|79519922|FG002|Overall Study|Withdrawal by Subject|0|||
44246794|NCT01436149|79078315|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
44246795|NCT01436149|79078316|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
44246796|NCT01436149|79078314|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
44246797|NCT01436149|79078315|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246798|NCT01436149|79078316|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246799|NCT01436149|79078314|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
44246800|NCT01436149|79078315|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246801|NCT01436149|79078316|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246802|NCT01436149|79078314|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
44246803|NCT01436149|79078315|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246804|NCT01436149|79078316|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246805|NCT01436149|79078314|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
44246806|NCT01436149|79078315|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
44246807|NCT01436149|79078316|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
44246808|NCT01436149|79078314|FG000|Antidepressant Lead-in Phase|Other|119|||
44246809|NCT01436149|79078315|FG001|Antidepressant Lead-in Phase|Other|0|||
44246810|NCT01436149|79078316|FG002|Antidepressant Lead-in Phase|Other|0|||
44246811|NCT01436149|79078314|FG000|Randomized Phase|Adverse Event|9|||
44246812|NCT01436149|79078315|FG001|Randomized Phase|Adverse Event|10|||
44246813|NCT01436149|79078316|FG002|Randomized Phase|Adverse Event|11|||
44246814|NCT01436149|79078314|FG000|Randomized Phase|Protocol Violation|4|||
44246815|NCT01436149|79078315|FG001|Randomized Phase|Protocol Violation|5|||
44246816|NCT01436149|79078316|FG002|Randomized Phase|Protocol Violation|0|||
44246817|NCT01436149|79078314|FG000|Randomized Phase|Withdrawal by Subject|16|||
44246818|NCT01436149|79078315|FG001|Randomized Phase|Withdrawal by Subject|10|||
44246819|NCT01436149|79078316|FG002|Randomized Phase|Withdrawal by Subject|10|||
44246820|NCT01436149|79078314|FG000|Randomized Phase|Lost to Follow-up|34|||
44246821|NCT01436149|79078315|FG001|Randomized Phase|Lost to Follow-up|5|||
44246822|NCT01436149|79078316|FG002|Randomized Phase|Lost to Follow-up|6|||
44246823|NCT01436149|79078314|FG000|Randomized Phase|Lack of Efficacy|0|||
44246824|NCT01436149|79078315|FG001|Randomized Phase|Lack of Efficacy|0|||
44246825|NCT01436149|79078316|FG002|Randomized Phase|Lack of Efficacy|1|||
44246826|NCT01436149|79078314|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
44246827|NCT01436149|79078315|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
44246828|NCT01436149|79078316|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
44246829|NCT01436149|79078314|FG000|Randomized Phase|Other|12|||
44246830|NCT01436149|79078315|FG001|Randomized Phase|Other|5|||
44246831|NCT01436149|79078316|FG002|Randomized Phase|Other|11|||
44246832|NCT01415401|79078322|FG000|Overall Study|Adverse Event|5|||
44246833|NCT01415401|79078322|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
44246834|NCT01415401|79078322|FG000|Overall Study|Terminated by Sponsor|1|||
44246835|NCT01414855|79078326|FG000|Overall Study|Death|17|||
44246836|NCT01414855|79078326|FG000|Overall Study|Lost to Follow-up|5|||
44246837|NCT01414855|79078326|FG000|Overall Study|Withdrawal by Subject|7|||
44246838|NCT01527500|79078334|FG000|Part A|Administrative|11|||
44246839|NCT01527500|79078335|FG001|Part A|Administrative|7|||
44246840|NCT01527500|79078334|FG000|Part A|Adverse Event|4|||
44246841|NCT01527500|79078335|FG001|Part A|Adverse Event|2|||
44246842|NCT01527500|79078334|FG000|Part A|Death|4|||
44246843|NCT01527500|79078335|FG001|Part A|Death|1|||
44246844|NCT01527500|79078334|FG000|Part A|Lost to Follow-up|0|||
44246845|NCT01527500|79078335|FG001|Part A|Lost to Follow-up|1|||
44246846|NCT01527500|79078334|FG000|Part A|Protocol Deviation|9|||
44246847|NCT01527500|79078335|FG001|Part A|Protocol Deviation|2|||
44246848|NCT01527500|79078334|FG000|Part A|Withdrawal by Subject|2|||
44246849|NCT01527500|79078335|FG001|Part A|Withdrawal by Subject|0|||
44246850|NCT01527500|79078334|FG000|Part B|Adverse Event|1|||
44246851|NCT01527500|79078335|FG001|Part B|Adverse Event|0|||
44246852|NCT01527110|79078360|FG000|Overall Study|Adverse Event|1|||
44246853|NCT01441063|79078364|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
44246854|NCT01441063|79078364|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
44246855|NCT01436071|79078373|FG000|Overall Study|Adverse Event|1|||
44246856|NCT01436071|79078374|FG001|Overall Study|Adverse Event|0|||
44246857|NCT01436071|79078373|FG000|Overall Study|Lack of Efficacy|16|||
44246858|NCT01436071|79078374|FG001|Overall Study|Lack of Efficacy|7|||
44246859|NCT01436071|79078373|FG000|Overall Study|Protocol Violation|0|||
44246860|NCT01436071|79078374|FG001|Overall Study|Protocol Violation|1|||
44246861|NCT01436071|79078373|FG000|Overall Study|Lost to Follow-up|3|||
44246862|NCT01436071|79078374|FG001|Overall Study|Lost to Follow-up|1|||
44246863|NCT01436071|79078373|FG000|Overall Study|Physician Decision|1|||
44246864|NCT01436071|79078374|FG001|Overall Study|Physician Decision|0|||
44246865|NCT01436071|79078373|FG000|Overall Study|Withdrawal by Subject|2|||
44246866|NCT01436071|79078374|FG001|Overall Study|Withdrawal by Subject|2|||
44246867|NCT01436071|79078373|FG000|Overall Study|Did Not Receive Trial Medication|3|||
44246868|NCT01436071|79078374|FG001|Overall Study|Did Not Receive Trial Medication|3|||
44246869|NCT01514240|79078382|FG000|Overall Study|Adverse Event|4|||
44246870|NCT01514240|79078383|FG001|Overall Study|Adverse Event|4|||
44246871|NCT01514240|79078382|FG000|Overall Study|Subject Decision|2|||
44246872|NCT01514240|79078383|FG001|Overall Study|Subject Decision|7|||
44246873|NCT01435759|79078394|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
44246874|NCT01435759|79078395|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
44246875|NCT01435759|79078396|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
44246876|NCT01435759|79078397|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
44246877|NCT01435759|79078398|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
44246878|NCT01435759|79078399|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
44246879|NCT01435759|79078394|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
44246880|NCT01435759|79078395|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246881|NCT01435759|79078396|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246882|NCT01435759|79078397|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246883|NCT01435759|79078398|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246884|NCT01435759|79078399|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
44246885|NCT01435759|79078394|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
44246886|NCT01435759|79078395|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246887|NCT01435759|79078396|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246888|NCT01435759|79078397|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246889|NCT01435759|79078398|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246890|NCT01435759|79078399|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
44246891|NCT01435759|79078394|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
44246892|NCT01435759|79078395|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246893|NCT01435759|79078396|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246894|NCT01435759|79078397|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246895|NCT01435759|79078398|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246896|NCT01435759|79078399|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
44246897|NCT01435759|79078394|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
44246898|NCT01435759|79078395|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246899|NCT01435759|79078396|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246900|NCT01435759|79078397|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246901|NCT01435759|79078398|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246902|NCT01435759|79078399|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246903|NCT01435759|79078394|FG000|Antidepressant Lead-in Phase|Other|119|||
44246904|NCT01435759|79078395|FG001|Antidepressant Lead-in Phase|Other|0|||
44246905|NCT01435759|79078396|FG002|Antidepressant Lead-in Phase|Other|0|||
44246906|NCT01435759|79078397|FG003|Antidepressant Lead-in Phase|Other|0|||
44246907|NCT01435759|79078398|FG004|Antidepressant Lead-in Phase|Other|0|||
44246908|NCT01435759|79078399|FG005|Antidepressant Lead-in Phase|Other|0|||
44246909|NCT01435759|79078394|FG000|Double-blind Phase|Adverse Event|7|||
44246910|NCT01435759|79078395|FG001|Double-blind Phase|Adverse Event|0|||
44246911|NCT01435759|79078396|FG002|Double-blind Phase|Adverse Event|1|||
44246912|NCT01435759|79078397|FG003|Double-blind Phase|Adverse Event|1|||
44246913|NCT01435759|79078398|FG004|Double-blind Phase|Adverse Event|1|||
44246914|NCT01435759|79078399|FG005|Double-blind Phase|Adverse Event|3|||
44246915|NCT01435759|79078394|FG000|Double-blind Phase|Protocol Violation|2|||
44246916|NCT01435759|79078395|FG001|Double-blind Phase|Protocol Violation|0|||
44246917|NCT01435759|79078396|FG002|Double-blind Phase|Protocol Violation|1|||
44246918|NCT01435759|79078397|FG003|Double-blind Phase|Protocol Violation|2|||
44246919|NCT01435759|79078398|FG004|Double-blind Phase|Protocol Violation|0|||
44246920|NCT01435759|79078399|FG005|Double-blind Phase|Protocol Violation|1|||
44246921|NCT01435759|79078394|FG000|Double-blind Phase|Withdrawal by Subject|17|||
44246922|NCT01435759|79078395|FG001|Double-blind Phase|Withdrawal by Subject|4|||
44246923|NCT01435759|79078396|FG002|Double-blind Phase|Withdrawal by Subject|3|||
44246924|NCT01435759|79078397|FG003|Double-blind Phase|Withdrawal by Subject|4|||
44246925|NCT01435759|79078398|FG004|Double-blind Phase|Withdrawal by Subject|2|||
44246926|NCT01435759|79078399|FG005|Double-blind Phase|Withdrawal by Subject|2|||
44246927|NCT01435759|79078394|FG000|Double-blind Phase|Lost to Follow-up|31|||
44246928|NCT01435759|79078395|FG001|Double-blind Phase|Lost to Follow-up|1|||
44246929|NCT01435759|79078396|FG002|Double-blind Phase|Lost to Follow-up|2|||
44246930|NCT01435759|79078397|FG003|Double-blind Phase|Lost to Follow-up|0|||
44381323|NCT02842086|79387371|FG001|Overall Study|HIV-1 Infection|6|||
44381324|NCT02788474|79387379|FG000|Double Blind Treatment Period|Not treated|1|||
44381325|NCT02788474|79387380|FG001|Double Blind Treatment Period|Not treated|0|||
44514373|NCT01344057|79519948|FG000|Overall Study|Premature Withdrawal|1|||
44514374|NCT00886782|79519955|FG000|Overall Study|Disease progression|3|||
44246931|NCT01435759|79078398|FG004|Double-blind Phase|Lost to Follow-up|3|||
44246932|NCT01435759|79078399|FG005|Double-blind Phase|Lost to Follow-up|3|||
44246933|NCT01435759|79078394|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
44276955|NCT02132754|79237787|FG013|Overall Study|Progressive Disease|3|||
44276956|NCT02132754|79237788|FG014|Overall Study|Progressive Disease|2|||
44276957|NCT02132754|79237789|FG015|Overall Study|Progressive Disease|1|||
44276958|NCT02132754|79237790|FG016|Overall Study|Progressive Disease|2|||
44514375|NCT00886782|79519956|FG001|Overall Study|Disease progression|3|||
44246934|NCT01435759|79078395|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246935|NCT01435759|79078396|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246936|NCT01435759|79078397|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246937|NCT01435759|79078398|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
44246938|NCT01435759|79078399|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
44246939|NCT01435759|79078394|FG000|Double-blind Phase|Other|8|||
44246940|NCT01435759|79078395|FG001|Double-blind Phase|Other|2|||
44246941|NCT01435759|79078396|FG002|Double-blind Phase|Other|0|||
44246942|NCT01435759|79078397|FG003|Double-blind Phase|Other|2|||
44246943|NCT01435759|79078398|FG004|Double-blind Phase|Other|0|||
44246944|NCT01435759|79078399|FG005|Double-blind Phase|Other|0|||
44246945|NCT01393405|79078411|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
44246946|NCT01393405|79078412|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
44246947|NCT01393405|79078413|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
44246948|NCT01393405|79078411|FG000|Induction Period (week1-16)|Adverse Event|16|||
44246949|NCT01393405|79078412|FG001|Induction Period (week1-16)|Adverse Event|0|||
44246950|NCT01393405|79078413|FG002|Induction Period (week1-16)|Adverse Event|0|||
44246951|NCT01393405|79078411|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
44246952|NCT01393405|79078412|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
44246953|NCT01393405|79078413|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
44246954|NCT01393405|79078411|FG000|Maintenance Period Week|Lack of Efficacy|0|||
44246955|NCT01393405|79078412|FG001|Maintenance Period Week|Lack of Efficacy|22|||
44246956|NCT01393405|79078413|FG002|Maintenance Period Week|Lack of Efficacy|22|||
44246957|NCT01393405|79078411|FG000|Maintenance Period Week|Adverse Event|0|||
44246958|NCT01393405|79078412|FG001|Maintenance Period Week|Adverse Event|5|||
44246959|NCT01393405|79078413|FG002|Maintenance Period Week|Adverse Event|2|||
44246960|NCT01393405|79078411|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
44246961|NCT01393405|79078412|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
44246962|NCT01393405|79078413|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
44246963|NCT01393405|79078411|FG000|Maintenance Period Week|Lost to Follow-up|0|||
44246964|NCT01393405|79078412|FG001|Maintenance Period Week|Lost to Follow-up|1|||
44246965|NCT01393405|79078413|FG002|Maintenance Period Week|Lost to Follow-up|0|||
44246966|NCT01419197|79078425|FG000|Overall Study|Death|247|||
44246967|NCT01419197|79078426|FG001|Overall Study|Death|122|||
44246968|NCT01419197|79078425|FG000|Overall Study|Physician Decision|4|||
44246969|NCT01419197|79078426|FG001|Overall Study|Physician Decision|4|||
44246970|NCT01419197|79078425|FG000|Overall Study|Non-compliance|3|||
44246971|NCT01419197|79078426|FG001|Overall Study|Non-compliance|1|||
44246972|NCT01419197|79078425|FG000|Overall Study|Withdrawal by Subject|33|||
44246973|NCT01419197|79078426|FG001|Overall Study|Withdrawal by Subject|32|||
44246974|NCT01419197|79078425|FG000|Overall Study|Study Completed by Sponsor|103|||
44246975|NCT01419197|79078426|FG001|Overall Study|Study Completed by Sponsor|34|||
44246976|NCT01419197|79078425|FG000|Overall Study|Reason Not Specified|0|||
44246977|NCT01419197|79078426|FG001|Overall Study|Reason Not Specified|1|||
44246978|NCT01419197|79078425|FG000|Overall Study|Lost to Follow-up|14|||
44246979|NCT01419197|79078426|FG001|Overall Study|Lost to Follow-up|4|||
44246980|NCT01414075|79078437|FG000|Overall Study|Adverse Event|1|||
44246981|NCT01414075|79078438|FG001|Overall Study|Adverse Event|0|||
44246982|NCT01414075|79078439|FG002|Overall Study|Adverse Event|1|||
44246983|NCT01414075|79078440|FG003|Overall Study|Adverse Event|0|||
44246984|NCT01414075|79078437|FG000|Overall Study|Death|1|||
44246985|NCT01414075|79078438|FG001|Overall Study|Death|0|||
44246986|NCT01414075|79078439|FG002|Overall Study|Death|0|||
44246987|NCT01414075|79078440|FG003|Overall Study|Death|1|||
44246988|NCT01414075|79078437|FG000|Overall Study|Withdrawal by Subject|0|||
44246989|NCT01414075|79078438|FG001|Overall Study|Withdrawal by Subject|0|||
44246990|NCT01414075|79078439|FG002|Overall Study|Withdrawal by Subject|0|||
44246991|NCT01414075|79078440|FG003|Overall Study|Withdrawal by Subject|1|||
44246992|NCT01414075|79078437|FG000|Overall Study|Other than specified|1|||
44246993|NCT01414075|79078438|FG001|Overall Study|Other than specified|0|||
44246994|NCT01414075|79078439|FG002|Overall Study|Other than specified|1|||
44246995|NCT01414075|79078440|FG003|Overall Study|Other than specified|0|||
44246996|NCT01434823|79078452|FG000|Overall Study|Incomplete data in medical record|4|||
44246997|NCT01434823|79078453|FG001|Overall Study|Incomplete data in medical record|7|||
44246998|NCT01513460|79078463|FG000|Overall Study|Death|0|||
44246999|NCT01513460|79078464|FG001|Overall Study|Death|0|||
44247000|NCT01513460|79078465|FG002|Overall Study|Death|1|||
44247001|NCT01513460|79078463|FG000|Overall Study|Lost to Follow-up|0|||
44247002|NCT01513460|79078464|FG001|Overall Study|Lost to Follow-up|0|||
44143463|NCT02343458|78932738|FG001|Overall Study|Lost to Follow-up|5|||
44247003|NCT01513460|79078465|FG002|Overall Study|Lost to Follow-up|2|||
44247004|NCT01513460|79078463|FG000|Overall Study|Abnormal laboratory value|1|||
44247005|NCT01513460|79078464|FG001|Overall Study|Abnormal laboratory value|0|||
44247006|NCT01513460|79078465|FG002|Overall Study|Abnormal laboratory value|1|||
44247007|NCT01513460|79078463|FG000|Overall Study|Lack of Efficacy|1|||
44247008|NCT01513460|79078464|FG001|Overall Study|Lack of Efficacy|2|||
44247009|NCT01513460|79078465|FG002|Overall Study|Lack of Efficacy|5|||
44247010|NCT01513460|79078463|FG000|Overall Study|Protocol deviations|3|||
44247011|NCT01513460|79078464|FG001|Overall Study|Protocol deviations|4|||
44247012|NCT01513460|79078465|FG002|Overall Study|Protocol deviations|3|||
44247013|NCT01513460|79078463|FG000|Overall Study|Withdrawal by Subject|7|||
44247014|NCT01513460|79078464|FG001|Overall Study|Withdrawal by Subject|8|||
44247015|NCT01513460|79078465|FG002|Overall Study|Withdrawal by Subject|21|||
44247016|NCT01513460|79078463|FG000|Overall Study|Adverse Event|16|||
44247017|NCT01513460|79078464|FG001|Overall Study|Adverse Event|18|||
44247018|NCT01513460|79078465|FG002|Overall Study|Adverse Event|23|||
44247019|NCT01513460|79078463|FG000|Overall Study|Abnormal test procedure|1|||
44247020|NCT01513460|79078464|FG001|Overall Study|Abnormal test procedure|0|||
44247021|NCT01513460|79078465|FG002|Overall Study|Abnormal test procedure|0|||
44247022|NCT01392547|79078475|FG000|Overall Study|Adverse Event|2|||
44247023|NCT01392547|79078475|FG000|Overall Study|Non-compliance|2|||
44247024|NCT01392547|79078475|FG000|Overall Study|Withdrawal criteria|3|||
44247025|NCT01392547|79078475|FG000|Overall Study|Unclassified|1|||
44247026|NCT01435655|79078481|FG000|Overall Study|Death|2|||
44247027|NCT01435655|79078481|FG000|Overall Study|Other|1|||
44247028|NCT01434667|79078487|FG000|Overall Study|Lost to Follow-up|5|||
44247029|NCT01434667|79078488|FG001|Overall Study|Lost to Follow-up|10|||
44247030|NCT01513148|79078496|FG000|Overall Study|Protocol Violation|2|||
44247031|NCT01513148|79078497|FG001|Overall Study|Protocol Violation|2|||
44247032|NCT01418339|79078545|FG000|Overall Study|Adverse Event|5|||
44247033|NCT01418339|79078546|FG001|Overall Study|Adverse Event|2|||
44247034|NCT01418339|79078545|FG000|Overall Study|Subject Withdrew Consent|1|||
44247035|NCT01418339|79078546|FG001|Overall Study|Subject Withdrew Consent|2|||
44247036|NCT01418339|79078545|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
44247037|NCT01418339|79078546|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
44247038|NCT01512368|79078552|FG000|Overall Study|Protocol Violation|3|||
44247039|NCT01412983|79078556|FG000|1st Period|Ineligible|0|||
44247040|NCT01412983|79078557|FG001|1st Period|Ineligible|1|||
44247041|NCT01412983|79078556|FG000|1st Period|Positive slit lamp finding|0|||
44247042|NCT01412983|79078557|FG001|1st Period|Positive slit lamp finding|1|||
44247043|NCT01412983|79078556|FG000|1st Period|Unacceptable lens movement|0|||
44247044|NCT01412983|79078557|FG001|1st Period|Unacceptable lens movement|1|||
44247045|NCT01412983|79078556|FG000|1st Period|Inability to maintain wear|0|||
44247046|NCT01412983|79078557|FG001|1st Period|Inability to maintain wear|1|||
44247047|NCT01417481|79078566|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
44247048|NCT01417481|79078567|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
44247049|NCT01392469|79078573|FG000|Overall Study|Adverse Event|2|||
44247050|NCT01392469|79078573|FG000|Overall Study|Withdrawal by Subject|1|||
44247051|NCT01392469|79078573|FG000|Overall Study|Protocol Violation|1|||
44247052|NCT01435577|79078590|FG000|Overall Study|Adverse Event|10|||
44247053|NCT01435577|79078591|FG001|Overall Study|Adverse Event|0|||
44247054|NCT01435577|79078590|FG000|Overall Study|Lack of Efficacy|7|||
44247055|NCT01435577|79078591|FG001|Overall Study|Lack of Efficacy|51|||
44247056|NCT01435577|79078590|FG000|Overall Study|Alternative treatment started|0|||
44247057|NCT01435577|79078591|FG001|Overall Study|Alternative treatment started|1|||
44247058|NCT01411891|79078603|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
44247059|NCT01411891|79078604|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
44247060|NCT01416389|79078612|FG000|Overall Study|Lost to Follow-up|1|||
44247061|NCT01416389|79078613|FG001|Overall Study|Lost to Follow-up|0|||
44247062|NCT01416389|79078612|FG000|Overall Study|Started New Therapy|2|||
44247063|NCT01416389|79078613|FG001|Overall Study|Started New Therapy|0|||
44247064|NCT01544348|79078629|FG000|Overall Study|Lost to Follow-up|1|||
44247065|NCT01544348|79078630|FG001|Overall Study|Lost to Follow-up|0|||
44247066|NCT01544348|79078631|FG002|Overall Study|Lost to Follow-up|0|||
44247067|NCT01544348|79078632|FG003|Overall Study|Lost to Follow-up|0|||
44247068|NCT01544348|79078633|FG004|Overall Study|Lost to Follow-up|0|||
44247069|NCT01544348|79078634|FG005|Overall Study|Lost to Follow-up|0|||
44247070|NCT01544348|79078635|FG006|Overall Study|Lost to Follow-up|1|||
44247071|NCT01544348|79078636|FG007|Overall Study|Lost to Follow-up|0|||
44247072|NCT01544348|79078629|FG000|Overall Study|Withdrawal by Subject|1|||
44247073|NCT01544348|79078630|FG001|Overall Study|Withdrawal by Subject|0|||
44247074|NCT01544348|79078631|FG002|Overall Study|Withdrawal by Subject|0|||
44247075|NCT01544348|79078632|FG003|Overall Study|Withdrawal by Subject|0|||
44247076|NCT01544348|79078633|FG004|Overall Study|Withdrawal by Subject|1|||
44247077|NCT01544348|79078634|FG005|Overall Study|Withdrawal by Subject|2|||
44247078|NCT01544348|79078635|FG006|Overall Study|Withdrawal by Subject|1|||
44247079|NCT01544348|79078636|FG007|Overall Study|Withdrawal by Subject|0|||
44247080|NCT01544348|79078629|FG000|Overall Study|Physician Decision|0|||
44247081|NCT01544348|79078630|FG001|Overall Study|Physician Decision|0|||
44247082|NCT01544348|79078631|FG002|Overall Study|Physician Decision|0|||
44247083|NCT01544348|79078632|FG003|Overall Study|Physician Decision|0|||
44247084|NCT01544348|79078633|FG004|Overall Study|Physician Decision|0|||
44247085|NCT01544348|79078634|FG005|Overall Study|Physician Decision|1|||
44247086|NCT01544348|79078635|FG006|Overall Study|Physician Decision|0|||
44247087|NCT01544348|79078636|FG007|Overall Study|Physician Decision|0|||
44247088|NCT01416155|79078661|FG000|Overall Study|Adverse Event|8|||
44247089|NCT01416155|79078661|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
44247090|NCT01416155|79078661|FG000|Overall Study|Withdrawal by Subject|33|||
44247091|NCT01416155|79078661|FG000|Overall Study|Investigator decision|8|||
44247092|NCT01416155|79078661|FG000|Overall Study|Other|7|||
44247093|NCT01415921|79078667|FG000|Overall Study|Adverse Event|0|||
44247094|NCT01415921|79078668|FG001|Overall Study|Adverse Event|1|||
44247095|NCT01415921|79078667|FG000|Overall Study|Physician Decision|1|||
44247096|NCT01415921|79078668|FG001|Overall Study|Physician Decision|1|||
44247097|NCT01415921|79078667|FG000|Overall Study|Withdrawal by Subject|0|||
44247098|NCT01415921|79078668|FG001|Overall Study|Withdrawal by Subject|1|||
44247099|NCT01415921|79078667|FG000|Overall Study|Other|2|||
44247100|NCT01415921|79078668|FG001|Overall Study|Other|0|||
44247101|NCT01415531|79078676|FG000|Overall Study|Adverse Event|7|||
44247102|NCT01415531|79078677|FG001|Overall Study|Adverse Event|10|||
44247103|NCT01415531|79078676|FG000|Overall Study|Lack of Efficacy|3|||
44247104|NCT01415531|79078677|FG001|Overall Study|Lack of Efficacy|2|||
44247105|NCT01415531|79078676|FG000|Overall Study|Protocol Violation|0|||
44247106|NCT01415531|79078677|FG001|Overall Study|Protocol Violation|1|||
44247107|NCT01415531|79078676|FG000|Overall Study|Withdrawal by Subject|5|||
44247108|NCT01415531|79078677|FG001|Overall Study|Withdrawal by Subject|4|||
44247109|NCT01415531|79078676|FG000|Overall Study|Lost to Follow-up|6|||
44247110|NCT01415531|79078677|FG001|Overall Study|Lost to Follow-up|14|||
44247111|NCT01415531|79078676|FG000|Overall Study|Lack of Compliance|1|||
44247112|NCT01415531|79078677|FG001|Overall Study|Lack of Compliance|4|||
44247113|NCT01415531|79078676|FG000|Overall Study|Other Reasons|3|||
44247114|NCT01415531|79078677|FG001|Overall Study|Other Reasons|2|||
44247115|NCT01544114|79078686|FG000|Overall Study|Withdrawal by Subject|0|||
44247116|NCT01544114|79078687|FG001|Overall Study|Withdrawal by Subject|0|||
44247117|NCT01544114|79078688|FG002|Overall Study|Withdrawal by Subject|3|||
44247118|NCT01544114|79078686|FG000|Overall Study|Lost to Follow-up|0|||
44247119|NCT01544114|79078687|FG001|Overall Study|Lost to Follow-up|2|||
44247120|NCT01544114|79078688|FG002|Overall Study|Lost to Follow-up|0|||
44247121|NCT01544114|79078686|FG000|Overall Study|Adverse Event|1|||
44247122|NCT01544114|79078687|FG001|Overall Study|Adverse Event|1|||
44247123|NCT01544114|79078688|FG002|Overall Study|Adverse Event|2|||
44143464|NCT02343458|78932739|FG002|Overall Study|Lost to Follow-up|3|||
44143465|NCT02343458|78932740|FG003|Overall Study|Lost to Follow-up|1|||
44143466|NCT02343458|78932737|FG000|Overall Study|Protocol Violation|2|||
44143467|NCT02343458|78932738|FG001|Overall Study|Protocol Violation|5|||
44143468|NCT02343458|78932739|FG002|Overall Study|Protocol Violation|2|||
44143469|NCT02343458|78932740|FG003|Overall Study|Protocol Violation|2|||
44143470|NCT02343458|78932737|FG000|Overall Study|Protocol Specified Criteria|17|||
44143471|NCT02343458|78932738|FG001|Overall Study|Protocol Specified Criteria|13|||
44143472|NCT02343458|78932739|FG002|Overall Study|Protocol Specified Criteria|14|||
44143473|NCT02343458|78932740|FG003|Overall Study|Protocol Specified Criteria|8|||
44143474|NCT01328041|78932763|FG000|Overall Study|Adverse Event|7|||
44143475|NCT01328041|78932763|FG000|Overall Study|Lack of Efficacy|27|||
44143476|NCT01328041|78932763|FG000|Overall Study|Protocol Violation|7|||
44143477|NCT01328041|78932763|FG000|Overall Study|Lost to Follow-up|7|||
44143478|NCT01328041|78932763|FG000|Overall Study|Physician Decision|2|||
44247124|NCT01544114|79078686|FG000|Overall Study|Protocol Violation|0|||
44247125|NCT01544114|79078687|FG001|Overall Study|Protocol Violation|1|||
44247126|NCT01544114|79078688|FG002|Overall Study|Protocol Violation|0|||
44247127|NCT01435265|79078700|FG000|Overall Study|Lost to Follow-up|0|||
44514376|NCT00886782|79519957|FG002|Overall Study|Disease progression|3|||
44514377|NCT00886782|79519955|FG000|Overall Study|Study drug toxicity|0|||
44247128|NCT01435265|79078701|FG001|Overall Study|Lost to Follow-up|1|||
44247129|NCT01433263|79078709|FG000|Overall Study|Adverse Event|3|||
44247130|NCT01433263|79078710|FG001|Overall Study|Adverse Event|1|||
44247131|NCT01433263|79078709|FG000|Overall Study|Death|5|||
44381326|NCT02788474|79387379|FG000|Double Blind Treatment Period|Patient's refusal|3|||
44514378|NCT00886782|79519956|FG001|Overall Study|Study drug toxicity|0|||
44514379|NCT00886782|79519957|FG002|Overall Study|Study drug toxicity|1|||
44247132|NCT01433263|79078710|FG001|Overall Study|Death|3|||
44247133|NCT01433263|79078709|FG000|Overall Study|Lost to Follow-up|0|||
44514380|NCT00886782|79519955|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
44247134|NCT01433263|79078710|FG001|Overall Study|Lost to Follow-up|1|||
44247135|NCT01433263|79078709|FG000|Overall Study|Protocol Deviation|1|||
44247136|NCT01433263|79078710|FG001|Overall Study|Protocol Deviation|0|||
44247137|NCT01433263|79078709|FG000|Overall Study|Withdrawal by Subject|10|||
44247138|NCT01433263|79078710|FG001|Overall Study|Withdrawal by Subject|7|||
44247139|NCT01432951|79078719|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
44381327|NCT02788474|79387380|FG001|Double Blind Treatment Period|Patient's refusal|0|||
44143479|NCT01328041|78932763|FG000|Overall Study|Withdrawal by Subject|7|||
44143480|NCT02410772|78932770|FG000|Overall Study|Death|3|||
44247140|NCT01432327|79078728|FG000|Posttest 3 Months|depression|3|||
44247141|NCT01432327|79078729|FG001|Posttest 3 Months|depression|0|||
44247142|NCT01432327|79078730|FG002|Posttest 3 Months|depression|0|||
44247143|NCT01432327|79078731|FG003|Posttest 3 Months|depression|0|||
44247144|NCT01432327|79078728|FG000|Posttest 3 Months|Lost to Follow-up|1|||
44247145|NCT01432327|79078729|FG001|Posttest 3 Months|Lost to Follow-up|0|||
44247146|NCT01432327|79078730|FG002|Posttest 3 Months|Lost to Follow-up|2|||
44247147|NCT01432327|79078731|FG003|Posttest 3 Months|Lost to Follow-up|1|||
44247148|NCT01432327|79078728|FG000|Posttest 3 Months|Allergic reaction|0|||
44247149|NCT01432327|79078729|FG001|Posttest 3 Months|Allergic reaction|2|||
44247150|NCT01432327|79078730|FG002|Posttest 3 Months|Allergic reaction|0|||
44247151|NCT01432327|79078731|FG003|Posttest 3 Months|Allergic reaction|0|||
44247152|NCT01432327|79078728|FG000|Posttest 6 Months|Lost to Follow-up|0|||
44247153|NCT01432327|79078729|FG001|Posttest 6 Months|Lost to Follow-up|0|||
44247154|NCT01432327|79078730|FG002|Posttest 6 Months|Lost to Follow-up|3|||
44247155|NCT01432327|79078731|FG003|Posttest 6 Months|Lost to Follow-up|2|||
44247156|NCT01432327|79078728|FG000|Posttest 6 Months|Allergic reaction|0|||
44247157|NCT01432327|79078729|FG001|Posttest 6 Months|Allergic reaction|0|||
44247158|NCT01432327|79078730|FG002|Posttest 6 Months|Allergic reaction|1|||
44247159|NCT01432327|79078731|FG003|Posttest 6 Months|Allergic reaction|0|||
44514381|NCT00886782|79519956|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
44514382|NCT00886782|79519957|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
44514383|NCT00583024|79519965|FG000|Overall Study|Lost to Follow-up|4|||
44514384|NCT03435640|79519980|FG000|Overall Study|Withdrawal by Subject|0|||
44514385|NCT03435640|79519981|FG001|Overall Study|Withdrawal by Subject|1|||
44514386|NCT03435640|79519982|FG002|Overall Study|Withdrawal by Subject|0|||
44247160|NCT01432327|79078728|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
44247161|NCT01432327|79078729|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
44247162|NCT01432327|79078730|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
44247163|NCT01432327|79078731|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
44247164|NCT01432327|79078728|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
44247165|NCT01432327|79078729|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
44247166|NCT01432327|79078730|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
44247167|NCT01432327|79078731|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
44247168|NCT01432327|79078728|FG000|Posttest 1 Year|Lost to Follow-up|0|||
44247169|NCT01432327|79078729|FG001|Posttest 1 Year|Lost to Follow-up|0|||
44247170|NCT01432327|79078730|FG002|Posttest 1 Year|Lost to Follow-up|4|||
44247171|NCT01432327|79078731|FG003|Posttest 1 Year|Lost to Follow-up|2|||
44247172|NCT01432327|79078728|FG000|Posttest 1 Year|Allergic reaction|0|||
44247173|NCT01432327|79078729|FG001|Posttest 1 Year|Allergic reaction|0|||
44247174|NCT01432327|79078730|FG002|Posttest 1 Year|Allergic reaction|1|||
44247175|NCT01432327|79078731|FG003|Posttest 1 Year|Allergic reaction|1|||
44247176|NCT01410799|79078741|FG000|Overall Study|PI decision|13|||
44247177|NCT01432171|79078747|FG000|Overall Study|Death|1|||
44247178|NCT01432171|79078748|FG001|Overall Study|Death|2|||
44247179|NCT01432171|79078747|FG000|Overall Study|Lost to Follow-up|6|||
44247180|NCT01432171|79078748|FG001|Overall Study|Lost to Follow-up|5|||
44247181|NCT01432171|79078747|FG000|Overall Study|Withdrawal by Subject|3|||
44247182|NCT01432171|79078748|FG001|Overall Study|Withdrawal by Subject|1|||
44247183|NCT01432171|79078747|FG000|Overall Study|Noncompliance|2|||
44247184|NCT01432171|79078748|FG001|Overall Study|Noncompliance|3|||
44247185|NCT01432171|79078747|FG000|Overall Study|Insurance denial trial coverage|1|||
44247186|NCT01432171|79078748|FG001|Overall Study|Insurance denial trial coverage|0|||
44247187|NCT01432171|79078747|FG000|Overall Study|Patient moved to palliative care|1|||
44247188|NCT01432171|79078748|FG001|Overall Study|Patient moved to palliative care|0|||
44247189|NCT01435031|79078758|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
44247190|NCT01435031|79078758|FG000|ITT at 1 Month|Death|1|||
44247191|NCT01435031|79078758|FG000|ITT at 1 Month|Lost to Follow-up|4|||
44247192|NCT01435031|79078758|FG000|ITT at 6 Months|Death|2|||
44247193|NCT01435031|79078758|FG000|ITT at 6 Months|Lost to Follow-up|3|||
44514387|NCT03435640|79519983|FG003|Overall Study|Withdrawal by Subject|2|||
44514388|NCT03435640|79519984|FG004|Overall Study|Withdrawal by Subject|0|||
44514389|NCT03435640|79519985|FG005|Overall Study|Withdrawal by Subject|0|||
44247194|NCT01435031|79078758|FG000|ITT at 1 Year|Death|1|||
44247195|NCT01435031|79078758|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
44247196|NCT01435031|79078758|FG000|ITT at 1 Year|Lost to Follow-up|6|||
44247197|NCT01435031|79078758|FG000|ITT at 2 Years|Death|7|||
44247198|NCT01435031|79078758|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
44247199|NCT01435031|79078758|FG000|ITT at 2 Years|Lost to Follow-up|4|||
44247200|NCT01435031|79078758|FG000|ITT at 3 Years|Death|5|||
44247201|NCT01435031|79078758|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
44247202|NCT01435031|79078758|FG000|ITT at 3 Years|Lost to Follow-up|4|||
44514390|NCT03435640|79519986|FG006|Overall Study|Withdrawal by Subject|3|||
44247203|NCT01435031|79078758|FG000|ITT at 4 Years|Death|4|||
44247204|NCT01435031|79078758|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
44247205|NCT01435031|79078758|FG000|ITT at 4 Years|Lost to Follow-up|1|||
44247206|NCT01433549|79078762|FG000|Phase 2: Second Study Product|Adverse Event|0|||
44247207|NCT01433549|79078763|FG001|Phase 2: Second Study Product|Adverse Event|1|||
44247208|NCT01414205|79078771|FG000|Overall Study|Death|5|||
44247209|NCT01414205|79078772|FG001|Overall Study|Death|1|||
44247210|NCT01414205|79078771|FG000|Overall Study|Lost to Follow-up|1|||
44247211|NCT01414205|79078772|FG001|Overall Study|Lost to Follow-up|4|||
44247212|NCT01414205|79078771|FG000|Overall Study|Physician Decision|0|||
44247213|NCT01414205|79078772|FG001|Overall Study|Physician Decision|1|||
44247214|NCT01414205|79078771|FG000|Overall Study|Randomized but not Treated|1|||
44247215|NCT01414205|79078772|FG001|Overall Study|Randomized but not Treated|1|||
44247216|NCT01433471|79078780|FG000|Overall Study|Withdrawal by Subject|0|||
44247217|NCT01433471|79078781|FG001|Overall Study|Withdrawal by Subject|1|||
44247218|NCT01433159|79078791|FG000|Overall Study|Adverse Event|1|||
44247219|NCT01433159|79078792|FG001|Overall Study|Adverse Event|0|||
44247220|NCT01433159|79078791|FG000|Overall Study|Physician Decision|1|||
44247221|NCT01433159|79078792|FG001|Overall Study|Physician Decision|0|||
44247222|NCT01433159|79078791|FG000|Overall Study|Protocol Violation|0|||
44247223|NCT01433159|79078792|FG001|Overall Study|Protocol Violation|1|||
44247224|NCT01413503|79078807|FG000|Overall Study|Lost to Follow-up|1|||
44247225|NCT01413191|79078811|FG000|Overall Study|Lost to Follow-up|5|||
44247226|NCT01413191|79078811|FG000|Overall Study|Disease Progression|5|||
44247227|NCT01413191|79078811|FG000|Overall Study|Death|1|||
44247228|NCT01412957|79078817|FG000|Overall Study|Withdrawal by Subject|6|||
44247229|NCT01412957|79078818|FG001|Overall Study|Withdrawal by Subject|22|||
44247230|NCT01412957|79078817|FG000|Overall Study|Lost to Follow-up|7|||
44247231|NCT01412957|79078818|FG001|Overall Study|Lost to Follow-up|2|||
44247232|NCT01412957|79078817|FG000|Overall Study|Death|136|||
44247233|NCT01412957|79078818|FG001|Overall Study|Death|133|||
44247234|NCT01432457|79078831|FG000|Overall Study|Adverse Event|7|||
44247235|NCT01432457|79078832|FG001|Overall Study|Adverse Event|10|||
44247236|NCT01432457|79078833|FG002|Overall Study|Adverse Event|16|||
44247237|NCT01432457|79078831|FG000|Overall Study|Lack of Efficacy|2|||
44247238|NCT01432457|79078832|FG001|Overall Study|Lack of Efficacy|1|||
44247239|NCT01432457|79078833|FG002|Overall Study|Lack of Efficacy|1|||
44247240|NCT01432457|79078831|FG000|Overall Study|Lost to Follow-up|11|||
44247241|NCT01432457|79078832|FG001|Overall Study|Lost to Follow-up|15|||
44247242|NCT01432457|79078833|FG002|Overall Study|Lost to Follow-up|20|||
44247243|NCT01432457|79078831|FG000|Overall Study|Protocol Violation|3|||
44247244|NCT01432457|79078832|FG001|Overall Study|Protocol Violation|2|||
44247245|NCT01432457|79078833|FG002|Overall Study|Protocol Violation|6|||
44247246|NCT01432457|79078831|FG000|Overall Study|Withdrawal by Subject|6|||
44247247|NCT01432457|79078832|FG001|Overall Study|Withdrawal by Subject|11|||
44247248|NCT01432457|79078833|FG002|Overall Study|Withdrawal by Subject|9|||
44247249|NCT01432457|79078831|FG000|Overall Study|Reasons not defined|2|||
44247250|NCT01432457|79078832|FG001|Overall Study|Reasons not defined|3|||
44247251|NCT01432457|79078833|FG002|Overall Study|Reasons not defined|4|||
44247252|NCT01432457|79078831|FG000|Overall Study|Did not take study drug|6|||
44247253|NCT01432457|79078832|FG001|Overall Study|Did not take study drug|6|||
44247254|NCT01432457|79078833|FG002|Overall Study|Did not take study drug|3|||
44247255|NCT01390441|79078855|FG000|Treatment Period|Protocol Violation|0|||
44247256|NCT01390441|79078856|FG001|Treatment Period|Protocol Violation|1|||
44247257|NCT01390441|79078857|FG002|Treatment Period|Protocol Violation|0|||
44247258|NCT01390441|79078858|FG003|Treatment Period|Protocol Violation|0|||
44247259|NCT01390441|79078859|FG004|Treatment Period|Protocol Violation|0|||
44247260|NCT01390441|79078855|FG000|Treatment Period|Physician Decision|0|||
44247261|NCT01390441|79078856|FG001|Treatment Period|Physician Decision|0|||
44247262|NCT01390441|79078857|FG002|Treatment Period|Physician Decision|0|||
44247263|NCT01390441|79078858|FG003|Treatment Period|Physician Decision|1|||
44247264|NCT01390441|79078859|FG004|Treatment Period|Physician Decision|0|||
44247265|NCT01390441|79078855|FG000|Treatment Period|Lack of Efficacy|0|||
44247266|NCT01390441|79078856|FG001|Treatment Period|Lack of Efficacy|0|||
44247267|NCT01390441|79078857|FG002|Treatment Period|Lack of Efficacy|0|||
44247268|NCT01390441|79078858|FG003|Treatment Period|Lack of Efficacy|0|||
44247269|NCT01390441|79078859|FG004|Treatment Period|Lack of Efficacy|1|||
44247270|NCT01390441|79078855|FG000|Treatment Period|Unknown due to early stopping of study|0|||
44247271|NCT01390441|79078856|FG001|Treatment Period|Unknown due to early stopping of study|0|||
44247272|NCT01390441|79078857|FG002|Treatment Period|Unknown due to early stopping of study|8|||
44514391|NCT03435640|79519987|FG007|Overall Study|Withdrawal by Subject|0|||
44247273|NCT01390441|79078858|FG003|Treatment Period|Unknown due to early stopping of study|11|||
44247274|NCT01390441|79078859|FG004|Treatment Period|Unknown due to early stopping of study|7|||
44247275|NCT01390441|79078855|FG000|Treatment Period|Adverse Event|0|||
44247276|NCT01390441|79078856|FG001|Treatment Period|Adverse Event|0|||
44247277|NCT01390441|79078857|FG002|Treatment Period|Adverse Event|1|||
44247278|NCT01390441|79078858|FG003|Treatment Period|Adverse Event|1|||
44247279|NCT01390441|79078859|FG004|Treatment Period|Adverse Event|2|||
44514392|NCT03435640|79519988|FG008|Overall Study|Withdrawal by Subject|0|||
44514393|NCT03435640|79519989|FG009|Overall Study|Withdrawal by Subject|2|||
44247280|NCT01390441|79078855|FG000|Treatment Period|Withdrawal by Subject|0|||
44247281|NCT01390441|79078856|FG001|Treatment Period|Withdrawal by Subject|0|||
44247282|NCT01390441|79078857|FG002|Treatment Period|Withdrawal by Subject|1|||
44247283|NCT01390441|79078858|FG003|Treatment Period|Withdrawal by Subject|0|||
44247284|NCT01390441|79078859|FG004|Treatment Period|Withdrawal by Subject|1|||
44247285|NCT01390441|79078855|FG000|Treatment Period|Lost to Follow-up|1|||
44247286|NCT01390441|79078856|FG001|Treatment Period|Lost to Follow-up|0|||
44247287|NCT01390441|79078857|FG002|Treatment Period|Lost to Follow-up|0|||
44247288|NCT01390441|79078858|FG003|Treatment Period|Lost to Follow-up|0|||
44247289|NCT01390441|79078859|FG004|Treatment Period|Lost to Follow-up|0|||
44247290|NCT01390441|79078855|FG000|Extension Period|Protocol Violation|3|||
44247291|NCT01390441|79078856|FG001|Extension Period|Protocol Violation|1|||
44247292|NCT01390441|79078857|FG002|Extension Period|Protocol Violation|0|||
44247293|NCT01390441|79078858|FG003|Extension Period|Protocol Violation|1|||
44247294|NCT01390441|79078859|FG004|Extension Period|Protocol Violation|0|||
44247295|NCT01412879|79078908|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
44247296|NCT01412879|79078909|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
44247297|NCT01412879|79078910|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
44247298|NCT01412879|79078908|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
44247299|NCT01412879|79078909|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
44247300|NCT01412879|79078910|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
44247301|NCT01412879|79078908|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
44247302|NCT01412879|79078909|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
44247303|NCT01412879|79078910|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
44247304|NCT01412879|79078908|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
44247305|NCT01412879|79078909|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
44247306|NCT01412879|79078910|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
44247307|NCT01412879|79078908|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
44247308|NCT01412879|79078909|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
44247309|NCT01412879|79078910|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
44247310|NCT01431079|79078922|FG000|Overall Study|Lost to Follow-up|35|||
44247311|NCT01431079|79078923|FG001|Overall Study|Lost to Follow-up|39|||
44247312|NCT01430611|79078955|FG000|Overall Study|Adverse Event|0|||
44247313|NCT01430611|79078956|FG001|Overall Study|Adverse Event|1|||
44247314|NCT01430611|79078955|FG000|Overall Study|Protocol Violation|1|||
44247315|NCT01430611|79078956|FG001|Overall Study|Protocol Violation|0|||
44247316|NCT01430611|79078955|FG000|Overall Study|Lost to Follow-up|1|||
44247317|NCT01430611|79078956|FG001|Overall Study|Lost to Follow-up|0|||
44247318|NCT01430611|79078955|FG000|Overall Study|Withdrawal by Subject|15|||
44247319|NCT01430611|79078956|FG001|Overall Study|Withdrawal by Subject|14|||
44247320|NCT01409707|79078965|FG000|Overall Study|Withdrawal by Subject|5|||
44247321|NCT01409707|79078966|FG001|Overall Study|Withdrawal by Subject|17|||
44247322|NCT01409707|79078967|FG002|Overall Study|Withdrawal by Subject|16|||
44247323|NCT01389973|79078974|FG000|Overall Study|Lost to Follow-up|1|||
44247324|NCT01389973|79078974|FG000|Overall Study|Trial Stopped by Sponsor|9|||
44247325|NCT01389973|79078974|FG000|Overall Study|Other|10|||
44247326|NCT01389817|79078994|FG000|Overall Study|Physician Decision|1|||
44247327|NCT01389817|79078995|FG001|Overall Study|Physician Decision|0|||
44247328|NCT01389817|79078994|FG000|Overall Study|Lost to Follow-up|1|||
44247329|NCT01389817|79078995|FG001|Overall Study|Lost to Follow-up|0|||
44247330|NCT01389817|79078994|FG000|Overall Study|Withdrawal by Subject|2|||
44247331|NCT01389817|79078995|FG001|Overall Study|Withdrawal by Subject|0|||
44247332|NCT01430455|79079010|FG000|Overall Study|Withdrawal by Subject|1|||
44247333|NCT01430455|79079010|FG000|Overall Study|Switched to follow-up phase|1|||
44247334|NCT01429441|79079038|FG000|Overall Study|Adverse Event|5|||
44247335|NCT01429441|79079039|FG001|Overall Study|Adverse Event|1|||
44247336|NCT01429441|79079038|FG000|Overall Study|Death|0|||
44247337|NCT01429441|79079039|FG001|Overall Study|Death|2|||
44247338|NCT01429441|79079038|FG000|Overall Study|Lost to Follow-up|5|||
44247339|NCT01429441|79079039|FG001|Overall Study|Lost to Follow-up|2|||
44276959|NCT02132754|79237791|FG017|Overall Study|Progressive Disease|1|||
44276960|NCT02132754|79237792|FG018|Overall Study|Progressive Disease|3|||
44247340|NCT01429441|79079038|FG000|Overall Study|Physician Decision|1|||
44247341|NCT01429441|79079039|FG001|Overall Study|Physician Decision|0|||
44247342|NCT01429441|79079038|FG000|Overall Study|Withdrawal by Subject|27|||
44247343|NCT01429441|79079039|FG001|Overall Study|Withdrawal by Subject|18|||
44247344|NCT01429285|79079074|FG000|Overall Study|Protocol Violation|9|||
44247345|NCT01429285|79079075|FG001|Overall Study|Protocol Violation|4|||
44247346|NCT01429285|79079074|FG000|Overall Study|Missing Data|5|||
44247347|NCT01429285|79079075|FG001|Overall Study|Missing Data|3|||
44247348|NCT01429285|79079074|FG000|Overall Study|Erroneously Enrolled Twice|8|||
44247349|NCT01429285|79079075|FG001|Overall Study|Erroneously Enrolled Twice|2|||
44514394|NCT03435640|79519990|FG010|Overall Study|Withdrawal by Subject|3|||
44514395|NCT03435640|79519980|FG000|Overall Study|Lost to Follow-up|0|||
44247350|NCT01429051|79079152|FG000|Titration Phase|Death|1|||
44247351|NCT01429051|79079152|FG000|Titration Phase|Withdrawal by Subject|7|||
44247352|NCT01429051|79079152|FG000|Titration Phase|Physician Decision|1|||
44247353|NCT01429051|79079152|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
44247354|NCT01429051|79079152|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
44247355|NCT01429051|79079152|FG000|Efficacy Phase|Adverse Event|1|||
44247356|NCT01429051|79079152|FG000|Efficacy Phase|Death|1|||
44247357|NCT01429051|79079152|FG000|Tolerability Phase|Death|5|||
44247358|NCT01429051|79079152|FG000|Tolerability Phase|Adverse Event|2|||
44247359|NCT01429051|79079152|FG000|Tolerability Phase|Withdrawal by Subject|5|||
44247360|NCT01429051|79079152|FG000|Tolerability Phase|Physician Decision|1|||
44247361|NCT01429051|79079152|FG000|Tolerability Phase|Other|2|||
44247362|NCT01428661|79079185|FG000|Double-Masked Phase|Protocol Violation|9|||
44247363|NCT01428661|79079186|FG001|Double-Masked Phase|Protocol Violation|4|||
44247364|NCT01428661|79079187|FG002|Double-Masked Phase|Protocol Violation|0|||
44247365|NCT01428661|79079185|FG000|Double-Masked Phase|Adverse Event|13|||
44247366|NCT01428661|79079186|FG001|Double-Masked Phase|Adverse Event|4|||
44247367|NCT01428661|79079187|FG002|Double-Masked Phase|Adverse Event|0|||
44247368|NCT01428661|79079185|FG000|Double-Masked Phase|Lost to Follow-up|14|||
44247369|NCT01428661|79079186|FG001|Double-Masked Phase|Lost to Follow-up|14|||
44247370|NCT01428661|79079187|FG002|Double-Masked Phase|Lost to Follow-up|0|||
44247371|NCT01428661|79079185|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
44247372|NCT01428661|79079186|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
44247373|NCT01428661|79079187|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
44247374|NCT01428661|79079185|FG000|Double-Masked Phase|Lack of Efficacy|2|||
44247375|NCT01428661|79079186|FG001|Double-Masked Phase|Lack of Efficacy|1|||
44247376|NCT01428661|79079187|FG002|Double-Masked Phase|Lack of Efficacy|0|||
44247377|NCT01428661|79079185|FG000|Double-Masked Phase|*Various|1|||
44247378|NCT01428661|79079186|FG001|Double-Masked Phase|*Various|6|||
44247379|NCT01428661|79079187|FG002|Double-Masked Phase|*Various|0|||
44276961|NCT02132754|79237793|FG019|Overall Study|Progressive Disease|1|||
44276962|NCT02132754|79237794|FG020|Overall Study|Progressive Disease|1|||
44276963|NCT02132754|79237795|FG021|Overall Study|Progressive Disease|3|||
44276964|NCT02132754|79237796|FG022|Overall Study|Progressive Disease|2|||
44276965|NCT02132754|79237797|FG023|Overall Study|Progressive Disease|3|||
44276966|NCT02132754|79237798|FG024|Overall Study|Progressive Disease|0|||
44381328|NCT02788474|79387379|FG000|Double Blind Treatment Period|Adverse Event|6|||
44381329|NCT02788474|79387380|FG001|Double Blind Treatment Period|Adverse Event|4|||
44381330|NCT02788474|79387379|FG000|Open Label Treatment Period|Adverse Event|29|||
44381331|NCT02788474|79387380|FG001|Open Label Treatment Period|Adverse Event|9|||
44381332|NCT02788474|79387379|FG000|Open Label Treatment Period|Other than reason specified|1|||
44381333|NCT02788474|79387380|FG001|Open Label Treatment Period|Other than reason specified|0|||
44381334|NCT02788474|79387379|FG000|Open Label Treatment Period|Patient's refusal|1|||
44381335|NCT02788474|79387380|FG001|Open Label Treatment Period|Patient's refusal|3|||
44381336|NCT02788474|79387379|FG000|Open Label Treatment Period|Non-compliance|1|||
44381337|NCT02788474|79387380|FG001|Open Label Treatment Period|Non-compliance|0|||
44381338|NCT02631746|79387387|FG000|Overall Study|Lack of Efficacy|3|||
44381339|NCT02166463|79387404|FG000|Overall Study|Lost to Follow-up|0|||
44381340|NCT02166463|79387405|FG001|Overall Study|Lost to Follow-up|1|||
44143481|NCT02410772|78932771|FG001|Overall Study|Death|4|||
44276967|NCT02132754|79237799|FG025|Overall Study|Progressive Disease|1|||
44276968|NCT02132754|79237800|FG026|Overall Study|Progressive Disease|2|||
44276969|NCT02132754|79237801|FG027|Overall Study|Progressive Disease|1|||
44276970|NCT02132754|79237802|FG028|Overall Study|Progressive Disease|2|||
44276971|NCT02132754|79237803|FG029|Overall Study|Progressive Disease|3|||
44276972|NCT02132754|79237804|FG030|Overall Study|Progressive Disease|1|||
44276973|NCT02132754|79237805|FG031|Overall Study|Progressive Disease|1|||
44276974|NCT02132754|79237806|FG032|Overall Study|Progressive Disease|3|||
44247380|NCT01428661|79079185|FG000|Open Label Extension|Protocol Violation|0|||
44247381|NCT01428661|79079186|FG001|Open Label Extension|Protocol Violation|0|||
44247382|NCT01428661|79079187|FG002|Open Label Extension|Protocol Violation|9|||
44247383|NCT01428661|79079185|FG000|Open Label Extension|Adverse Event|0|||
44247384|NCT01428661|79079186|FG001|Open Label Extension|Adverse Event|0|||
44247385|NCT01428661|79079187|FG002|Open Label Extension|Adverse Event|15|||
44247386|NCT01428661|79079185|FG000|Open Label Extension|Lost to Follow-up|0|||
44247387|NCT01428661|79079186|FG001|Open Label Extension|Lost to Follow-up|0|||
44247388|NCT01428661|79079187|FG002|Open Label Extension|Lost to Follow-up|38|||
44381341|NCT02166463|79387404|FG000|Overall Study|Physician Decision|10|||
44381342|NCT02166463|79387405|FG001|Overall Study|Physician Decision|10|||
44276975|NCT02132754|79237807|FG033|Overall Study|Progressive Disease|6|||
44276976|NCT02132754|79237774|FG000|Overall Study|Screen Failure|0|||
44276977|NCT02132754|79237775|FG001|Overall Study|Screen Failure|0|||
44381343|NCT02166463|79387404|FG000|Overall Study|Ineligible|11|||
44143482|NCT02410772|78932772|FG002|Overall Study|Death|8|||
44381344|NCT02166463|79387405|FG001|Overall Study|Ineligible|2|||
44381345|NCT02166463|79387404|FG000|Overall Study|Progressive Disease|9|||
44381346|NCT02166463|79387405|FG001|Overall Study|Progressive Disease|6|||
44381347|NCT02166463|79387404|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
44381348|NCT02166463|79387405|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
44381349|NCT02166463|79387404|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
44381350|NCT02166463|79387405|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
44381351|NCT02166463|79387404|FG000|Overall Study|Refusal of further protocol therapy|5|||
44381352|NCT02166463|79387405|FG001|Overall Study|Refusal of further protocol therapy|6|||
44381353|NCT02101034|79387416|FG000|Overall Study|Enrolled but did not start treatment|0|||
44381354|NCT02101034|79387417|FG001|Overall Study|Enrolled but did not start treatment|0|||
44381355|NCT02101034|79387418|FG002|Overall Study|Enrolled but did not start treatment|1|||
44381356|NCT02101034|79387419|FG003|Overall Study|Enrolled but did not start treatment|0|||
44381357|NCT02101034|79387420|FG004|Overall Study|Enrolled but did not start treatment|0|||
44381358|NCT02000622|79387443|FG000|Overall Study|Withdrawal by Subject|5|||
44381359|NCT02000622|79387444|FG001|Overall Study|Withdrawal by Subject|7|||
44381360|NCT02000622|79387443|FG000|Overall Study|Lost to Follow-up|4|||
44381361|NCT02000622|79387444|FG001|Overall Study|Lost to Follow-up|0|||
44381362|NCT02000622|79387443|FG000|Overall Study|Death|159|||
44381363|NCT02000622|79387444|FG001|Overall Study|Death|73|||
44381364|NCT02000622|79387443|FG000|Overall Study|Withdrawn due to site closure|1|||
44381365|NCT02000622|79387444|FG001|Overall Study|Withdrawn due to site closure|0|||
44381366|NCT00798135|79387459|FG000|Overall Study|Disease progression, relapse|11|||
44381367|NCT00798135|79387459|FG000|Overall Study|Disease progression, refractory|1|||
44381368|NCT00798135|79387459|FG000|Overall Study|Physician Decision|1|||
44381369|NCT00813358|79387482|FG000|Overall Study|Death|32|||
44381370|NCT00813358|79387482|FG000|Overall Study|Lost to Follow-up|12|||
44381371|NCT00813358|79387482|FG000|Overall Study|other endpoints|5|||
44381372|NCT00813358|79387482|FG000|Overall Study|Withdrawal by Subject|20|||
44381373|NCT00812812|79387488|FG000|Overall Study|Adverse Event|2|||
44381374|NCT00812812|79387489|FG001|Overall Study|Adverse Event|1|||
44381375|NCT00812812|79387488|FG000|Overall Study|Lack of Efficacy|1|||
44381376|NCT00812812|79387489|FG001|Overall Study|Lack of Efficacy|0|||
44381377|NCT00812812|79387488|FG000|Overall Study|Lost to Follow-up|0|||
44381378|NCT00812812|79387489|FG001|Overall Study|Lost to Follow-up|1|||
44381379|NCT00812812|79387488|FG000|Overall Study|Withdrawal by Subject|0|||
44381380|NCT00812812|79387489|FG001|Overall Study|Withdrawal by Subject|2|||
44381381|NCT00810082|79387499|FG000|Overall Study|Lost to Follow-up|0|||
44381382|NCT00810082|79387500|FG001|Overall Study|Lost to Follow-up|4|||
44381383|NCT00748189|79387508|FG000|Overall Study|Death|99|||
44381384|NCT00748189|79387509|FG001|Overall Study|Death|84|||
44381385|NCT00748189|79387508|FG000|Overall Study|Withdrawal by Subject|23|||
44381386|NCT00748189|79387509|FG001|Overall Study|Withdrawal by Subject|29|||
44381387|NCT00748189|79387508|FG000|Overall Study|Physician Decision|16|||
44381388|NCT00748189|79387509|FG001|Overall Study|Physician Decision|5|||
44381389|NCT00748189|79387508|FG000|Overall Study|Lost to Follow-up|8|||
44381390|NCT00748189|79387509|FG001|Overall Study|Lost to Follow-up|15|||
44381391|NCT00748189|79387508|FG000|Overall Study|Study terminated by Sponsor|70|||
44381392|NCT00748189|79387509|FG001|Overall Study|Study terminated by Sponsor|79|||
44381393|NCT00744055|79387522|FG000|Overall Study|Withdrawal by Subject|6|||
44381394|NCT00744055|79387523|FG001|Overall Study|Withdrawal by Subject|9|||
44381395|NCT00744055|79387522|FG000|Overall Study|Lack of Efficacy|0|||
44381396|NCT00744055|79387523|FG001|Overall Study|Lack of Efficacy|1|||
44381397|NCT00744055|79387522|FG000|Overall Study|Physician Decision|0|||
44381398|NCT00744055|79387523|FG001|Overall Study|Physician Decision|2|||
44143483|NCT02410772|78932770|FG000|Overall Study|Lost to Follow-up|31|||
44247389|NCT01428661|79079185|FG000|Open Label Extension|Withdrawal by Subject|0|||
44247390|NCT01428661|79079186|FG001|Open Label Extension|Withdrawal by Subject|0|||
44247391|NCT01428661|79079187|FG002|Open Label Extension|Withdrawal by Subject|49|||
44247392|NCT01428661|79079185|FG000|Open Label Extension|Lack of Efficacy|0|||
44247393|NCT01428661|79079186|FG001|Open Label Extension|Lack of Efficacy|0|||
44247394|NCT01428661|79079187|FG002|Open Label Extension|Lack of Efficacy|24|||
44247395|NCT01428661|79079185|FG000|Open Label Extension|**Various|0|||
44247396|NCT01428661|79079186|FG001|Open Label Extension|**Various|0|||
44381399|NCT00744055|79387522|FG000|Overall Study|Protocol Violation|1|||
44381400|NCT00744055|79387523|FG001|Overall Study|Protocol Violation|1|||
44381401|NCT00744055|79387522|FG000|Overall Study|Lost to Follow-up|0|||
44381402|NCT00744055|79387523|FG001|Overall Study|Lost to Follow-up|1|||
44143484|NCT02410772|78932771|FG001|Overall Study|Lost to Follow-up|23|||
44247397|NCT01428661|79079187|FG002|Open Label Extension|**Various|185|||
44381403|NCT00748033|79387531|FG000|Overall Study|Adverse Event|0|||
44381404|NCT00748033|79387532|FG001|Overall Study|Adverse Event|1|||
44381405|NCT00735553|79387549|FG000|Overall Study|Study prematurely terminated|77|||
44381406|NCT00740779|79387560|FG000|Overall Study|Adverse Event|4|||
44143485|NCT02410772|78932772|FG002|Overall Study|Lost to Follow-up|22|||
44247398|NCT01428583|79079195|FG000|Overall Study|Adverse Event|75|||
44514396|NCT03435640|79519981|FG001|Overall Study|Lost to Follow-up|0|||
44514397|NCT03435640|79519982|FG002|Overall Study|Lost to Follow-up|1|||
44143486|NCT02410772|78932770|FG000|Overall Study|Pregnancy|8|||
44143487|NCT02410772|78932771|FG001|Overall Study|Pregnancy|4|||
44143488|NCT02410772|78932772|FG002|Overall Study|Pregnancy|5|||
44143489|NCT02410772|78932770|FG000|Overall Study|Protocol Violation|8|||
44143490|NCT02410772|78932771|FG001|Overall Study|Protocol Violation|8|||
44514398|NCT03435640|79519983|FG003|Overall Study|Lost to Follow-up|0|||
44143491|NCT02410772|78932772|FG002|Overall Study|Protocol Violation|4|||
44143492|NCT02410772|78932770|FG000|Overall Study|Baseline Drug Resistance|49|||
44143493|NCT02410772|78932771|FG001|Overall Study|Baseline Drug Resistance|40|||
44143494|NCT02410772|78932772|FG002|Overall Study|Baseline Drug Resistance|51|||
44143495|NCT02410772|78932770|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
44143496|NCT02410772|78932771|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
44143497|NCT02410772|78932772|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
44143498|NCT02410772|78932770|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
44143499|NCT02410772|78932771|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
44143500|NCT02410772|78932772|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
44514399|NCT03435640|79519984|FG004|Overall Study|Lost to Follow-up|0|||
44514400|NCT03435640|79519985|FG005|Overall Study|Lost to Follow-up|0|||
44143501|NCT01648790|78932789|FG000|Treatment 3|Withdrawal by Subject|0|||
44247399|NCT01428583|79079195|FG000|Overall Study|Withdrawal by Subject|51|||
44247400|NCT01428583|79079195|FG000|Overall Study|Lack of Efficacy|37|||
44247401|NCT01428583|79079195|FG000|Overall Study|Lost to Follow-up|17|||
44514401|NCT03435640|79519986|FG006|Overall Study|Lost to Follow-up|0|||
44514402|NCT03435640|79519987|FG007|Overall Study|Lost to Follow-up|0|||
44514403|NCT03435640|79519988|FG008|Overall Study|Lost to Follow-up|0|||
44514404|NCT03435640|79519989|FG009|Overall Study|Lost to Follow-up|0|||
44514405|NCT03435640|79519990|FG010|Overall Study|Lost to Follow-up|0|||
44514406|NCT00655876|79520018|FG000|Overall Study|Protocol Violation|9|||
44514407|NCT00655876|79520019|FG001|Overall Study|Protocol Violation|7|||
44514408|NCT03092752|79520025|FG000|Overall Study|Aged <40 years|14209|||
44514409|NCT03092752|79520025|FG000|Overall Study|At least one claim with T2DM|61299|||
44514410|NCT03092752|79520025|FG000|Overall Study|Having no claim of study drugs|29282|||
44514411|NCT03092752|79520025|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
44514412|NCT03092752|79520025|FG000|Overall Study|<6 month history|245900|||
44514413|NCT03750552|79520048|FG000|Overall Study|Adverse Event|5|||
44514414|NCT03750552|79520049|FG001|Overall Study|Adverse Event|1|||
44514415|NCT03750552|79520048|FG000|Overall Study|Withdrawal by Subject|1|||
44514416|NCT03750552|79520049|FG001|Overall Study|Withdrawal by Subject|1|||
44143502|NCT01648790|78932790|FG001|Treatment 3|Withdrawal by Subject|0|||
44514417|NCT03750552|79520048|FG000|Overall Study|Other|2|||
44514418|NCT03750552|79520049|FG001|Overall Study|Other|0|||
44514419|NCT03750240|79520056|FG000|Overall Study|Technical Difficulties|2|||
44514420|NCT03091738|79520060|FG000|Overall Study|Adverse Event|1|||
44514421|NCT03091738|79520060|FG000|Overall Study|Lost to Follow-up|1|||
44143503|NCT01648790|78932791|FG002|Treatment 3|Withdrawal by Subject|0|||
44247402|NCT01428583|79079195|FG000|Overall Study|Death|1|||
44247403|NCT01428583|79079195|FG000|Overall Study|Pregnancy|1|||
44247404|NCT01428583|79079195|FG000|Overall Study|Protocol Violation|1|||
44247405|NCT01428583|79079195|FG000|Overall Study|Physician Decision|12|||
44514422|NCT03193216|79520066|FG000|Overall Study|Lost to Follow-up|1|||
44514423|NCT03193216|79520067|FG001|Overall Study|Lost to Follow-up|0|||
44247406|NCT01428583|79079195|FG000|Overall Study|Non-compliant|25|||
44514424|NCT03193216|79520066|FG000|Overall Study|Withdrawal by Subject|5|||
44514425|NCT03193216|79520067|FG001|Overall Study|Withdrawal by Subject|0|||
44514426|NCT03193216|79520066|FG000|Overall Study|Physician Decision|4|||
44514427|NCT03193216|79520067|FG001|Overall Study|Physician Decision|0|||
44514428|NCT03091348|79520075|FG000|Overall Study|Lost to Follow-up|2|||
44514429|NCT03091348|79520076|FG001|Overall Study|Lost to Follow-up|1|||
44247407|NCT01428583|79079195|FG000|Overall Study|Confirmed positive urine drug test|8|||
44247408|NCT01428583|79079195|FG000|Overall Study|Sponsor's request|3|||
44247409|NCT01428583|79079195|FG000|Overall Study|Other|6|||
44247410|NCT01428193|79079212|FG000|Overall Study|Physician Decision|1|||
44247411|NCT01428193|79079212|FG000|Overall Study|Elevated screening liver enzymes|1|||
44247412|NCT01428115|79079216|FG000|Overall Study|Lack of Efficacy|3|||
44247413|NCT01428115|79079216|FG000|Overall Study|Lost to Follow-up|10|||
44247414|NCT01428115|79079216|FG000|Overall Study|Pregnancy|1|||
44247415|NCT01428115|79079216|FG000|Overall Study|Protocol Violation|3|||
44247416|NCT01428115|79079216|FG000|Overall Study|Withdrawal by Subject|4|||
44247417|NCT01427803|79079223|FG000|Overall Study|Lost to Follow-up|32|||
44247418|NCT01427803|79079224|FG001|Overall Study|Lost to Follow-up|26|||
44247419|NCT01427803|79079223|FG000|Overall Study|Withdrawal by Subject|20|||
44247420|NCT01427803|79079224|FG001|Overall Study|Withdrawal by Subject|0|||
44247421|NCT01427803|79079223|FG000|Overall Study|Unable to complete full treatment period|6|||
44247422|NCT01427803|79079224|FG001|Overall Study|Unable to complete full treatment period|0|||
44247423|NCT01427803|79079223|FG000|Overall Study|Protocol Violation|1|||
44247424|NCT01427803|79079224|FG001|Overall Study|Protocol Violation|0|||
44247425|NCT01427803|79079223|FG000|Overall Study|Physician Decision|3|||
44247426|NCT01427803|79079224|FG001|Overall Study|Physician Decision|0|||
44247427|NCT01427803|79079223|FG000|Overall Study|did not take product|1|||
44247428|NCT01427803|79079224|FG001|Overall Study|did not take product|0|||
44247429|NCT01408537|79079228|FG000|Overall Study|Withdrawal by Subject|2|||
44247430|NCT01408537|79079228|FG000|Overall Study|Protocol Violation|3|||
44247431|NCT01408537|79079228|FG000|Overall Study|Lost to Follow-up|3|||
44247432|NCT01408459|79079261|FG000|Overall Study|Withdrawal by Subject|1|||
44247433|NCT01408459|79079262|FG001|Overall Study|Withdrawal by Subject|1|||
44247434|NCT01408303|79079281|FG000|Overall Study|Adverse Event|3|||
44247435|NCT01408303|79079282|FG001|Overall Study|Adverse Event|7|||
44247436|NCT01408303|79079283|FG002|Overall Study|Adverse Event|2|||
44247437|NCT01408303|79079281|FG000|Overall Study|Lost to Follow-up|0|||
44247438|NCT01408303|79079282|FG001|Overall Study|Lost to Follow-up|1|||
44247439|NCT01408303|79079283|FG002|Overall Study|Lost to Follow-up|2|||
44247440|NCT01408303|79079281|FG000|Overall Study|Withdrawal by Subject|2|||
44247441|NCT01408303|79079282|FG001|Overall Study|Withdrawal by Subject|3|||
44247442|NCT01408303|79079283|FG002|Overall Study|Withdrawal by Subject|1|||
44247443|NCT01408303|79079281|FG000|Overall Study|Protocol Violation|0|||
44247444|NCT01408303|79079282|FG001|Overall Study|Protocol Violation|1|||
44247445|NCT01408303|79079283|FG002|Overall Study|Protocol Violation|0|||
44247446|NCT01408303|79079281|FG000|Overall Study|Noncompliance|1|||
44247447|NCT01408303|79079282|FG001|Overall Study|Noncompliance|0|||
44247448|NCT01408303|79079283|FG002|Overall Study|Noncompliance|1|||
44247449|NCT01408147|79079304|FG000|Overall Study|Withdrawal by Subject|0|||
44247450|NCT01408147|79079305|FG001|Overall Study|Withdrawal by Subject|1|||
44247451|NCT01407367|79079313|FG000|Overall Study|Death|24|||
44247452|NCT01407367|79079314|FG001|Overall Study|Death|32|||
44247453|NCT01407367|79079313|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
44247454|NCT01407367|79079314|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
44247455|NCT01407367|79079313|FG000|Overall Study|Withdrawal by Subject|4|||
44247456|NCT01407367|79079314|FG001|Overall Study|Withdrawal by Subject|15|||
44247457|NCT01407367|79079313|FG000|Overall Study|Lost to Follow-up|0|||
44247458|NCT01407367|79079314|FG001|Overall Study|Lost to Follow-up|2|||
44247459|NCT01405027|79079350|FG000|Overall Study|Withdrawn consent|3|||
44247460|NCT01405027|79079351|FG001|Overall Study|Withdrawn consent|0|||
44247461|NCT01405027|79079350|FG000|Overall Study|Lost to Follow-up|16|||
44247462|NCT01405027|79079351|FG001|Overall Study|Lost to Follow-up|24|||
44514430|NCT03751098|79520083|FG000|Overall Study|Withdrawal by Subject|0|||
44514431|NCT03751098|79520084|FG001|Overall Study|Withdrawal by Subject|1|||
44514432|NCT03751020|79520095|FG000|Overall Study|Withdrawal by Subject|2|||
44514433|NCT03751020|79520096|FG001|Overall Study|Withdrawal by Subject|0|||
44514434|NCT03751020|79520097|FG002|Overall Study|Withdrawal by Subject|0|||
44514435|NCT03751020|79520095|FG000|Overall Study|Lost to Follow-up|7|||
44514436|NCT03751020|79520096|FG001|Overall Study|Lost to Follow-up|4|||
44514437|NCT03751020|79520097|FG002|Overall Study|Lost to Follow-up|10|||
44514438|NCT03090100|79520107|FG000|Overall Study|Adverse Event|9|||
44514439|NCT03090100|79520108|FG001|Overall Study|Adverse Event|11|||
44514440|NCT03090100|79520107|FG000|Overall Study|Pregnancy|1|||
44514441|NCT03090100|79520108|FG001|Overall Study|Pregnancy|1|||
44514442|NCT03090100|79520107|FG000|Overall Study|Lack of Efficacy|2|||
44247463|NCT01405027|79079350|FG000|Overall Study|Investigator judgement|0|||
44247464|NCT01405027|79079351|FG001|Overall Study|Investigator judgement|2|||
44247465|NCT01405027|79079350|FG000|Overall Study|Death|1|||
44247466|NCT01405027|79079351|FG001|Overall Study|Death|0|||
44247467|NCT01405027|79079350|FG000|Overall Study|Other or Unknown|12|||
44247468|NCT01405027|79079351|FG001|Overall Study|Other or Unknown|25|||
44247469|NCT01412801|79079372|FG000|Overall Study|Death|0|||
44247470|NCT01412801|79079373|FG001|Overall Study|Death|1|||
44247471|NCT01412801|79079374|FG002|Overall Study|Death|0|||
44514443|NCT03090100|79520108|FG001|Overall Study|Lack of Efficacy|7|||
44247472|NCT01412801|79079375|FG003|Overall Study|Death|4|||
44247473|NCT01412801|79079376|FG004|Overall Study|Death|2|||
44247474|NCT01412801|79079377|FG005|Overall Study|Death|2|||
44247475|NCT01412801|79079372|FG000|Overall Study|Lost to Follow-up|1|||
44247476|NCT01412801|79079373|FG001|Overall Study|Lost to Follow-up|2|||
44247477|NCT01412801|79079374|FG002|Overall Study|Lost to Follow-up|4|||
44247478|NCT01412801|79079375|FG003|Overall Study|Lost to Follow-up|0|||
44247479|NCT01412801|79079376|FG004|Overall Study|Lost to Follow-up|1|||
44247480|NCT01412801|79079377|FG005|Overall Study|Lost to Follow-up|1|||
44247481|NCT01412801|79079372|FG000|Overall Study|Withdrawal by Subject|3|||
44247482|NCT01412801|79079373|FG001|Overall Study|Withdrawal by Subject|2|||
44247483|NCT01412801|79079374|FG002|Overall Study|Withdrawal by Subject|1|||
44247484|NCT01412801|79079375|FG003|Overall Study|Withdrawal by Subject|0|||
44247485|NCT01412801|79079376|FG004|Overall Study|Withdrawal by Subject|0|||
44247486|NCT01412801|79079377|FG005|Overall Study|Withdrawal by Subject|0|||
44247487|NCT01412801|79079372|FG000|Overall Study|Relocated to another area|0|||
44247488|NCT01412801|79079373|FG001|Overall Study|Relocated to another area|0|||
44247489|NCT01412801|79079374|FG002|Overall Study|Relocated to another area|2|||
44247490|NCT01412801|79079375|FG003|Overall Study|Relocated to another area|0|||
44247491|NCT01412801|79079376|FG004|Overall Study|Relocated to another area|0|||
44247492|NCT01412801|79079377|FG005|Overall Study|Relocated to another area|0|||
44247493|NCT01525628|79079425|FG000|Overall Study|Adverse Event|1|||
44247494|NCT01525628|79079426|FG001|Overall Study|Adverse Event|1|||
44247495|NCT01525628|79079427|FG002|Overall Study|Adverse Event|2|||
44247496|NCT01525628|79079428|FG003|Overall Study|Adverse Event|0|||
44247497|NCT01525628|79079429|FG004|Overall Study|Adverse Event|1|||
44247498|NCT01525628|79079425|FG000|Overall Study|Lack of Efficacy|0|||
44247499|NCT01525628|79079426|FG001|Overall Study|Lack of Efficacy|2|||
44247500|NCT01525628|79079427|FG002|Overall Study|Lack of Efficacy|2|||
44247501|NCT01525628|79079428|FG003|Overall Study|Lack of Efficacy|1|||
44247502|NCT01525628|79079429|FG004|Overall Study|Lack of Efficacy|2|||
44247503|NCT01525628|79079425|FG000|Overall Study|Protocol Violation|0|||
44247504|NCT01525628|79079426|FG001|Overall Study|Protocol Violation|0|||
44276978|NCT02132754|79237776|FG002|Overall Study|Screen Failure|0|||
44276979|NCT02132754|79237777|FG003|Overall Study|Screen Failure|0|||
44276980|NCT02132754|79237778|FG004|Overall Study|Screen Failure|0|||
44143504|NCT01648790|78932792|FG003|Treatment 3|Withdrawal by Subject|1|||
44143505|NCT01648790|78932793|FG004|Treatment 3|Withdrawal by Subject|0|||
44143506|NCT01936857|78932816|FG000|Overall Study|Sent to prison or 06 center|11|||
44143507|NCT01936857|78932817|FG001|Overall Study|Sent to prison or 06 center|12|||
44247505|NCT01525628|79079427|FG002|Overall Study|Protocol Violation|1|||
44276981|NCT02132754|79237779|FG005|Overall Study|Screen Failure|0|||
44514444|NCT03090100|79520107|FG000|Overall Study|Lost to Follow-up|2|||
44514445|NCT03090100|79520108|FG001|Overall Study|Lost to Follow-up|2|||
44514446|NCT03090100|79520107|FG000|Overall Study|Withdrawal by Subject|7|||
44514447|NCT03090100|79520108|FG001|Overall Study|Withdrawal by Subject|19|||
44514448|NCT03090100|79520107|FG000|Overall Study|Protocol Violation|2|||
44514449|NCT03090100|79520108|FG001|Overall Study|Protocol Violation|6|||
44514450|NCT03090100|79520107|FG000|Overall Study|Non-compliance|2|||
44514451|NCT03090100|79520108|FG001|Overall Study|Non-compliance|0|||
44514452|NCT03090100|79520107|FG000|Overall Study|Other|2|||
44514453|NCT03090100|79520108|FG001|Overall Study|Other|2|||
44514454|NCT03089944|79520114|FG000|Overall Study|Lost to Follow-up|8|||
44514455|NCT03089944|79520114|FG000|Overall Study|Withdrew Consent|2|||
44514456|NCT03089944|79520114|FG000|Overall Study|Adverse Event|1|||
44514457|NCT03089944|79520114|FG000|Overall Study|Other|1|||
44514458|NCT03739866|79520137|FG000|Overall Study|Lost to Follow-up|0|||
44514459|NCT03739866|79520138|FG001|Overall Study|Lost to Follow-up|0|||
44514460|NCT03739866|79520139|FG002|Overall Study|Lost to Follow-up|0|||
44514461|NCT03739866|79520140|FG003|Overall Study|Lost to Follow-up|1|||
44514462|NCT03739866|79520141|FG004|Overall Study|Lost to Follow-up|0|||
44514463|NCT03739866|79520142|FG005|Overall Study|Lost to Follow-up|0|||
44514464|NCT03739866|79520143|FG006|Overall Study|Lost to Follow-up|0|||
44514465|NCT03739866|79520144|FG007|Overall Study|Lost to Follow-up|0|||
44514466|NCT03739866|79520137|FG000|Overall Study|Enrolled but not treated|0|||
44514467|NCT03739866|79520138|FG001|Overall Study|Enrolled but not treated|0|||
44514468|NCT03739866|79520139|FG002|Overall Study|Enrolled but not treated|1|||
44514469|NCT03739866|79520140|FG003|Overall Study|Enrolled but not treated|0|||
44514470|NCT03739866|79520141|FG004|Overall Study|Enrolled but not treated|1|||
44143508|NCT01936857|78932816|FG000|Overall Study|Lost to Follow-up|10|||
44276982|NCT02132754|79237780|FG006|Overall Study|Screen Failure|0|||
44514471|NCT03739866|79520142|FG005|Overall Study|Enrolled but not treated|0|||
44514472|NCT03739866|79520143|FG006|Overall Study|Enrolled but not treated|0|||
44143509|NCT01936857|78932817|FG001|Overall Study|Lost to Follow-up|7|||
44514473|NCT03739866|79520144|FG007|Overall Study|Enrolled but not treated|0|||
44514474|NCT03739242|79520168|FG000|Overall Study|Withdrawal by Subject|1|||
44514475|NCT03739242|79520169|FG001|Overall Study|Withdrawal by Subject|1|||
44247506|NCT01525628|79079428|FG003|Overall Study|Protocol Violation|0|||
44247507|NCT01525628|79079429|FG004|Overall Study|Protocol Violation|0|||
44514476|NCT03739242|79520168|FG000|Overall Study|Protocol Violation|0|||
44381407|NCT00740779|79387561|FG001|Overall Study|Adverse Event|6|||
44381408|NCT00740779|79387562|FG002|Overall Study|Adverse Event|3|||
44381409|NCT00740779|79387560|FG000|Overall Study|Protocol Violation|1|||
44381410|NCT00740779|79387561|FG001|Overall Study|Protocol Violation|1|||
44381411|NCT00740779|79387562|FG002|Overall Study|Protocol Violation|1|||
44381412|NCT00740779|79387560|FG000|Overall Study|Lack of Efficacy|0|||
44381413|NCT00740779|79387561|FG001|Overall Study|Lack of Efficacy|0|||
44247508|NCT01525628|79079425|FG000|Overall Study|Lost to Follow-up|1|||
44247509|NCT01525628|79079426|FG001|Overall Study|Lost to Follow-up|1|||
44247510|NCT01525628|79079427|FG002|Overall Study|Lost to Follow-up|0|||
44247511|NCT01525628|79079428|FG003|Overall Study|Lost to Follow-up|0|||
44247512|NCT01525628|79079429|FG004|Overall Study|Lost to Follow-up|0|||
44247513|NCT01525628|79079425|FG000|Overall Study|Withdrawal by Subject|0|||
44247514|NCT01525628|79079426|FG001|Overall Study|Withdrawal by Subject|1|||
44247515|NCT01525628|79079427|FG002|Overall Study|Withdrawal by Subject|0|||
44247516|NCT01525628|79079428|FG003|Overall Study|Withdrawal by Subject|0|||
44247517|NCT01525628|79079429|FG004|Overall Study|Withdrawal by Subject|0|||
44247518|NCT01525628|79079425|FG000|Overall Study|Other reason not defined above|0|||
44247519|NCT01525628|79079426|FG001|Overall Study|Other reason not defined above|0|||
44247520|NCT01525628|79079427|FG002|Overall Study|Other reason not defined above|0|||
44247521|NCT01525628|79079428|FG003|Overall Study|Other reason not defined above|3|||
44247522|NCT01525628|79079429|FG004|Overall Study|Other reason not defined above|0|||
44247523|NCT01412021|79079443|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
44247524|NCT01412021|79079443|FG000|Overall Study|Treatment Prior to Approval|3|||
44514477|NCT03739242|79520169|FG001|Overall Study|Protocol Violation|1|||
44514478|NCT02849626|79520226|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
44514479|NCT02849626|79520227|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
44514480|NCT02849626|79520228|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
44514481|NCT02849626|79520229|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
44514482|NCT02849626|79520226|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
44514483|NCT02849626|79520227|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
44514484|NCT02849626|79520228|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
44514485|NCT02849626|79520229|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
44514486|NCT02849626|79520226|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
44514487|NCT02849626|79520227|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
44514488|NCT02849626|79520228|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
44514489|NCT02849626|79520229|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
44514490|NCT02849626|79520226|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
44514491|NCT02849626|79520227|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
44514492|NCT02849626|79520228|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
44514493|NCT02849626|79520229|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
44143510|NCT01936857|78932816|FG000|Overall Study|Death|7|||
44247525|NCT01412021|79079443|FG000|Overall Study|Transferred to Other Hospital|9|||
44247526|NCT01426789|79079449|FG000|Part 1|Protocol deviation|0|||
44247527|NCT01426789|79079450|FG001|Part 1|Protocol deviation|1|||
44247528|NCT01426789|79079451|FG002|Part 1|Protocol deviation|0|||
44247529|NCT01426789|79079452|FG003|Part 1|Protocol deviation|0|||
44276983|NCT02132754|79237781|FG007|Overall Study|Screen Failure|0|||
44276984|NCT02132754|79237782|FG008|Overall Study|Screen Failure|0|||
44276985|NCT02132754|79237783|FG009|Overall Study|Screen Failure|0|||
44276986|NCT02132754|79237784|FG010|Overall Study|Screen Failure|0|||
44276987|NCT02132754|79237785|FG011|Overall Study|Screen Failure|0|||
44276988|NCT02132754|79237786|FG012|Overall Study|Screen Failure|0|||
44276989|NCT02132754|79237787|FG013|Overall Study|Screen Failure|0|||
44276990|NCT02132754|79237788|FG014|Overall Study|Screen Failure|0|||
44276991|NCT02132754|79237789|FG015|Overall Study|Screen Failure|0|||
44276992|NCT02132754|79237790|FG016|Overall Study|Screen Failure|0|||
44276993|NCT02132754|79237791|FG017|Overall Study|Screen Failure|0|||
44276994|NCT02132754|79237792|FG018|Overall Study|Screen Failure|0|||
44381414|NCT00740779|79387562|FG002|Overall Study|Lack of Efficacy|2|||
44381415|NCT00740779|79387560|FG000|Overall Study|Withdrawal by Subject|2|||
44381416|NCT00740779|79387561|FG001|Overall Study|Withdrawal by Subject|4|||
44381417|NCT00740779|79387562|FG002|Overall Study|Withdrawal by Subject|2|||
44381418|NCT00740779|79387560|FG000|Overall Study|Lost to Follow-up|2|||
44381419|NCT00740779|79387561|FG001|Overall Study|Lost to Follow-up|3|||
44381420|NCT00740779|79387562|FG002|Overall Study|Lost to Follow-up|5|||
44381421|NCT00735475|79387572|FG000|Overall Study|Adverse Event|0|||
44381422|NCT00735475|79387573|FG001|Overall Study|Adverse Event|1|||
44381423|NCT00735475|79387572|FG000|Overall Study|Death|1|||
44381424|NCT00735475|79387573|FG001|Overall Study|Death|1|||
44514494|NCT02849626|79520226|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
44514495|NCT02849626|79520227|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
44143511|NCT01936857|78932817|FG001|Overall Study|Death|3|||
44247530|NCT01426789|79079453|FG004|Part 1|Protocol deviation|0|||
44247531|NCT01426789|79079454|FG005|Part 1|Protocol deviation|0|||
44276995|NCT02132754|79237793|FG019|Overall Study|Screen Failure|1|||
44276996|NCT02132754|79237794|FG020|Overall Study|Screen Failure|0|||
44247532|NCT01426789|79079449|FG000|Part 1|Lost to Follow-up|1|||
44247533|NCT01426789|79079450|FG001|Part 1|Lost to Follow-up|2|||
44247534|NCT01426789|79079451|FG002|Part 1|Lost to Follow-up|0|||
44247535|NCT01426789|79079452|FG003|Part 1|Lost to Follow-up|0|||
44247536|NCT01426789|79079453|FG004|Part 1|Lost to Follow-up|0|||
44247537|NCT01426789|79079454|FG005|Part 1|Lost to Follow-up|0|||
44247538|NCT01426789|79079449|FG000|Part 1|Lack of Efficacy|2|||
44247539|NCT01426789|79079450|FG001|Part 1|Lack of Efficacy|1|||
44247540|NCT01426789|79079451|FG002|Part 1|Lack of Efficacy|0|||
44247541|NCT01426789|79079452|FG003|Part 1|Lack of Efficacy|0|||
44247542|NCT01426789|79079453|FG004|Part 1|Lack of Efficacy|0|||
44247543|NCT01426789|79079454|FG005|Part 1|Lack of Efficacy|0|||
44247544|NCT01426789|79079449|FG000|Part 1|Adverse Event|3|||
44247545|NCT01426789|79079450|FG001|Part 1|Adverse Event|0|||
44247546|NCT01426789|79079451|FG002|Part 1|Adverse Event|0|||
44247547|NCT01426789|79079452|FG003|Part 1|Adverse Event|0|||
44247548|NCT01426789|79079453|FG004|Part 1|Adverse Event|0|||
44247549|NCT01426789|79079454|FG005|Part 1|Adverse Event|0|||
44247550|NCT01426789|79079449|FG000|Part 2|Protocol deviation|0|||
44247551|NCT01426789|79079450|FG001|Part 2|Protocol deviation|0|||
44247552|NCT01426789|79079451|FG002|Part 2|Protocol deviation|1|||
44247553|NCT01426789|79079452|FG003|Part 2|Protocol deviation|0|||
44247554|NCT01426789|79079453|FG004|Part 2|Protocol deviation|0|||
44247555|NCT01426789|79079454|FG005|Part 2|Protocol deviation|0|||
44247556|NCT01426789|79079449|FG000|Part 2|Death|0|||
44247557|NCT01426789|79079450|FG001|Part 2|Death|0|||
44247558|NCT01426789|79079451|FG002|Part 2|Death|1|||
44247559|NCT01426789|79079452|FG003|Part 2|Death|0|||
44247560|NCT01426789|79079453|FG004|Part 2|Death|1|||
44247561|NCT01426789|79079454|FG005|Part 2|Death|0|||
44247562|NCT01426789|79079449|FG000|Part 2|Administrative problems|0|||
44247563|NCT01426789|79079450|FG001|Part 2|Administrative problems|0|||
44247564|NCT01426789|79079451|FG002|Part 2|Administrative problems|2|||
44247565|NCT01426789|79079452|FG003|Part 2|Administrative problems|0|||
44247566|NCT01426789|79079453|FG004|Part 2|Administrative problems|1|||
44247567|NCT01426789|79079454|FG005|Part 2|Administrative problems|0|||
44247568|NCT01426789|79079449|FG000|Part 2|Lost to Follow-up|0|||
44247569|NCT01426789|79079450|FG001|Part 2|Lost to Follow-up|0|||
44247570|NCT01426789|79079451|FG002|Part 2|Lost to Follow-up|4|||
44247571|NCT01426789|79079452|FG003|Part 2|Lost to Follow-up|0|||
44247572|NCT01426789|79079453|FG004|Part 2|Lost to Follow-up|1|||
44247573|NCT01426789|79079454|FG005|Part 2|Lost to Follow-up|0|||
44247574|NCT01426789|79079449|FG000|Part 2|Withdrawal by Subject|0|||
44247575|NCT01426789|79079450|FG001|Part 2|Withdrawal by Subject|0|||
44247576|NCT01426789|79079451|FG002|Part 2|Withdrawal by Subject|0|||
44247577|NCT01426789|79079452|FG003|Part 2|Withdrawal by Subject|1|||
44247578|NCT01426789|79079453|FG004|Part 2|Withdrawal by Subject|2|||
44247579|NCT01426789|79079454|FG005|Part 2|Withdrawal by Subject|0|||
44247580|NCT01426789|79079449|FG000|Part 2|Lack of Efficacy|0|||
44247581|NCT01426789|79079450|FG001|Part 2|Lack of Efficacy|0|||
44247582|NCT01426789|79079451|FG002|Part 2|Lack of Efficacy|5|||
44247583|NCT01426789|79079452|FG003|Part 2|Lack of Efficacy|0|||
44247584|NCT01426789|79079453|FG004|Part 2|Lack of Efficacy|2|||
44247585|NCT01426789|79079454|FG005|Part 2|Lack of Efficacy|0|||
44247586|NCT01426789|79079449|FG000|Part 2|Adverse Event|0|||
44247587|NCT01426789|79079450|FG001|Part 2|Adverse Event|0|||
44247588|NCT01426789|79079451|FG002|Part 2|Adverse Event|2|||
44514496|NCT02849626|79520228|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
44514497|NCT02849626|79520229|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
44247589|NCT01426789|79079452|FG003|Part 2|Adverse Event|0|||
44247590|NCT01426789|79079453|FG004|Part 2|Adverse Event|1|||
44247591|NCT01426789|79079454|FG005|Part 2|Adverse Event|0|||
44514498|NCT02849626|79520226|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
44247592|NCT01426009|79079475|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
44247593|NCT01426009|79079475|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
44247594|NCT01426009|79079475|FG000|Washout 1|Withdrawal by Subject|1|||
44247595|NCT01426009|79079475|FG000|Washout 1|Personal Reasons|1|||
44247596|NCT01426009|79079475|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
44247597|NCT01426009|79079475|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
44247598|NCT01426009|79079475|FG000|Washout 2|electrive surgery|1|||
44381425|NCT00735475|79387572|FG000|Overall Study|Lost to Follow-up|3|||
44514499|NCT02849626|79520227|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
44247599|NCT01426009|79079475|FG000|Washout 3|personal reasons|1|||
44247600|NCT01426009|79079475|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
44247601|NCT01426009|79079475|FG000|Washout 4|Lost to Follow-up|1|||
44247602|NCT01411319|79079504|FG000|Overall Study|Lost to Follow-up|1|||
44247603|NCT01543958|79079508|FG000|Overall Study|Loss to follow-up|3|||
44247604|NCT01543958|79079508|FG000|Overall Study|ART initiation|1|||
44247605|NCT01411085|79079512|FG000|Overall Study|Physician Decision|1|||
44247606|NCT01411085|79079512|FG000|Overall Study|Protocol Violation|1|||
44247607|NCT01411085|79079512|FG000|Overall Study|Adverse Event|1|||
44247608|NCT01543490|79079518|FG000|Overall Study|Adverse Event|4|||
44247609|NCT01543490|79079519|FG001|Overall Study|Adverse Event|0|||
44247610|NCT01543490|79079518|FG000|Overall Study|Physician Decision|1|||
44247611|NCT01543490|79079519|FG001|Overall Study|Physician Decision|0|||
44247612|NCT01543490|79079518|FG000|Overall Study|Lack of Efficacy|3|||
44247613|NCT01543490|79079519|FG001|Overall Study|Lack of Efficacy|3|||
44247614|NCT01543490|79079518|FG000|Overall Study|Lost to Follow-up|5|||
44247615|NCT01543490|79079519|FG001|Overall Study|Lost to Follow-up|0|||
44247616|NCT01543490|79079518|FG000|Overall Study|Withdrawal by Subject|2|||
44247617|NCT01543490|79079519|FG001|Overall Study|Withdrawal by Subject|0|||
44247618|NCT01543490|79079518|FG000|Overall Study|Other-Various Administrative Reasons|1|||
44247619|NCT01543490|79079519|FG001|Overall Study|Other-Various Administrative Reasons|2|||
44247620|NCT01404949|79079525|FG000|Overall Study|Not Treated|1|||
44247621|NCT01431521|79079533|FG000|Overall Study|Withdrawal by Subject|0|||
44247622|NCT01431521|79079534|FG001|Overall Study|Withdrawal by Subject|0|||
44247623|NCT01431521|79079535|FG002|Overall Study|Withdrawal by Subject|1|||
44247624|NCT01431521|79079536|FG003|Overall Study|Withdrawal by Subject|0|||
44247625|NCT01404325|79079612|FG000|Overall Study|Lost to Follow-up|1|||
44247626|NCT01404325|79079613|FG001|Overall Study|Lost to Follow-up|0|||
44247627|NCT01404325|79079612|FG000|Overall Study|Death|2|||
44247628|NCT01404325|79079613|FG001|Overall Study|Death|0|||
44247629|NCT01404325|79079612|FG000|Overall Study|Graft loss/Retransplantation|1|||
44247630|NCT01404325|79079613|FG001|Overall Study|Graft loss/Retransplantation|0|||
44247631|NCT01404325|79079612|FG000|Overall Study|non-specified reason|0|||
44247632|NCT01404325|79079613|FG001|Overall Study|non-specified reason|2|||
44247633|NCT01425463|79079634|FG000|Overall Study|Adverse Event|5|||
44247634|NCT01425463|79079635|FG001|Overall Study|Adverse Event|7|||
44247635|NCT01425463|79079634|FG000|Overall Study|Lack of Efficacy|1|||
44247636|NCT01425463|79079635|FG001|Overall Study|Lack of Efficacy|1|||
44247637|NCT01425463|79079634|FG000|Overall Study|Protocol Violation|2|||
44247638|NCT01425463|79079635|FG001|Overall Study|Protocol Violation|2|||
44247639|NCT01425463|79079634|FG000|Overall Study|Lost to Follow-up|5|||
44247640|NCT01425463|79079635|FG001|Overall Study|Lost to Follow-up|2|||
44247641|NCT01425463|79079634|FG000|Overall Study|Withdrawal by Subject|7|||
44247642|NCT01425463|79079635|FG001|Overall Study|Withdrawal by Subject|5|||
44247643|NCT01425463|79079634|FG000|Overall Study|Unknown Reason|4|||
44247644|NCT01425463|79079635|FG001|Overall Study|Unknown Reason|7|||
44247645|NCT04655586|79079657|FG000|Overall Study|Physician Decision|1|||
44247646|NCT04655586|79079658|FG001|Overall Study|Physician Decision|3|||
44247647|NCT04655586|79079659|FG002|Overall Study|Physician Decision|4|||
44247648|NCT04655586|79079657|FG000|Overall Study|Withdrawal by Subject|1|||
44247649|NCT04655586|79079658|FG001|Overall Study|Withdrawal by Subject|3|||
44247650|NCT04655586|79079659|FG002|Overall Study|Withdrawal by Subject|1|||
44247651|NCT01388647|79079682|FG000|Overall Study|Adverse Event|1|||
44247652|NCT01388647|79079683|FG001|Overall Study|Adverse Event|2|||
44247653|NCT01402063|79079758|FG000|Overall Study|Withdrawal by Subject|3|||
44247654|NCT01402063|79079759|FG001|Overall Study|Withdrawal by Subject|3|||
44247655|NCT01796301|79079767|FG000|Overall Study|Withdrawal by Subject|15|||
44247656|NCT01796301|79079768|FG001|Overall Study|Withdrawal by Subject|15|||
44247657|NCT01796301|79079767|FG000|Overall Study|Lost to Follow-up|3|||
44247658|NCT01796301|79079768|FG001|Overall Study|Lost to Follow-up|3|||
44247659|NCT01796301|79079767|FG000|Overall Study|Death|0|||
44247660|NCT01796301|79079768|FG001|Overall Study|Death|1|||
44247661|NCT01796301|79079767|FG000|Overall Study|Decision by Sponsor|0|||
44247662|NCT01796301|79079768|FG001|Overall Study|Decision by Sponsor|1|||
44247663|NCT01388335|79079787|FG000|Period 1|Progressive Disease|1|||
44514500|NCT02849626|79520228|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
44514501|NCT02849626|79520229|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
44514502|NCT02849626|79520226|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
44514503|NCT02849626|79520227|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
44247664|NCT01388335|79079787|FG000|Period 2|Progressive Disease|2|||
44247665|NCT01388335|79079787|FG000|Period 2|Sponsor Decision|1|||
44247666|NCT01388335|79079787|FG000|Safety Extension|Progressive Disease|7|||
44247667|NCT01401361|79079834|FG000|Overall Study|Withdrawal by Subject|16|||
44247668|NCT01401361|79079834|FG000|Overall Study|Lack of Efficacy|6|||
44247669|NCT01401361|79079834|FG000|Overall Study|Physician Decision|1|||
44247670|NCT01401361|79079834|FG000|Overall Study|Lost to Follow-up|3|||
44514504|NCT02849626|79520228|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
44247671|NCT01401361|79079834|FG000|Overall Study|Subject/family decision post procedure|2|||
44276997|NCT02132754|79237795|FG021|Overall Study|Screen Failure|1|||
44143512|NCT01936857|78932816|FG000|Overall Study|Moved|2|||
44143513|NCT01936857|78932817|FG001|Overall Study|Moved|1|||
44247672|NCT01401283|79079840|FG000|Overall Study|surgery cancelled|5|||
44247673|NCT01401283|79079841|FG001|Overall Study|surgery cancelled|8|||
44247674|NCT01401283|79079840|FG000|Overall Study|preoperative arrhythmia|5|||
44276998|NCT02132754|79237796|FG022|Overall Study|Screen Failure|0|||
44247675|NCT01401283|79079841|FG001|Overall Study|preoperative arrhythmia|0|||
44247676|NCT01401283|79079840|FG000|Overall Study|no central venous access|0|||
44247677|NCT01401283|79079841|FG001|Overall Study|no central venous access|1|||
44514505|NCT02849626|79520229|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
44514506|NCT02849626|79520226|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
44514507|NCT02849626|79520227|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
44247678|NCT01401283|79079840|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
44247679|NCT01401283|79079841|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
44247680|NCT01422889|79079864|FG000|Overall Study|No Data Entered for Study Stent|9|||
44247681|NCT01400971|79079868|FG000|Overall Study|Death|82|||
44247682|NCT01400971|79079868|FG000|Overall Study|Lost to Follow-up|196|||
44247683|NCT01400971|79079868|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
44247684|NCT01400971|79079868|FG000|Overall Study|Physician Decision|57|||
44247685|NCT01400971|79079868|FG000|Overall Study|Withdrawal by Subject|158|||
44247686|NCT01400971|79079868|FG000|Overall Study|Other|422|||
44247687|NCT01387789|79079872|FG000|Overall Study|Adverse Event|5|||
44247688|NCT01387789|79079872|FG000|Overall Study|Lack of Efficacy|2|||
44247689|NCT01387789|79079872|FG000|Overall Study|Lost to Follow-up|1|||
44247690|NCT01400893|79079883|FG000|Overall Study|Death|27|||
44247691|NCT01400893|79079884|FG001|Overall Study|Death|21|||
44247692|NCT01400893|79079883|FG000|Overall Study|Lost to Follow-up|0|||
44247693|NCT01400893|79079884|FG001|Overall Study|Lost to Follow-up|6|||
44247694|NCT01400815|79079924|FG000|Overall Study|Adverse Event|3|||
44247695|NCT01400815|79079925|FG001|Overall Study|Adverse Event|0|||
44247696|NCT01400815|79079924|FG000|Overall Study|Death|0|||
44247697|NCT01400815|79079925|FG001|Overall Study|Death|1|||
44247698|NCT01400815|79079924|FG000|Overall Study|Lost to Follow-up|18|||
44247699|NCT01400815|79079925|FG001|Overall Study|Lost to Follow-up|11|||
44247700|NCT01400815|79079924|FG000|Overall Study|Protocol Violation|0|||
44247701|NCT01400815|79079925|FG001|Overall Study|Protocol Violation|1|||
44247702|NCT01400815|79079924|FG000|Overall Study|Physician Decision|1|||
44247703|NCT01400815|79079925|FG001|Overall Study|Physician Decision|0|||
44247704|NCT01400815|79079924|FG000|Overall Study|Withdrawal by Subject|15|||
44247705|NCT01400815|79079925|FG001|Overall Study|Withdrawal by Subject|8|||
44247706|NCT01400815|79079924|FG000|Overall Study|Subject in jail|1|||
44247707|NCT01400815|79079925|FG001|Overall Study|Subject in jail|0|||
44247708|NCT01400503|79079979|FG000|Overall Study|Withdrawal by Subject|1|||
44247709|NCT01400503|79079979|FG000|Overall Study|Study Terminated by Sponsor|58|||
44247710|NCT01400503|79079979|FG000|Overall Study|Other|1|||
44247711|NCT01400425|79079995|FG000|Overall Study|Withdrawal by Subject|10|||
44247712|NCT01421719|79080001|FG000|Overall Study|Withdrawal by Subject|4|||
44247713|NCT01421641|79080008|FG000|Overall Study|Protocol Violation|2|||
44247714|NCT01421641|79080009|FG001|Overall Study|Protocol Violation|2|||
44247715|NCT01385995|79080017|FG000|Period 1, 2 Months|Physician Decision|1|||
44247716|NCT01385995|79080018|FG001|Period 1, 2 Months|Physician Decision|0|||
44247717|NCT01421017|79080029|FG000|Overall Study|Withdrawal by Subject|2|||
44247718|NCT01421017|79080030|FG001|Overall Study|Withdrawal by Subject|0|||
44247719|NCT01421017|79080031|FG002|Overall Study|Withdrawal by Subject|0|||
44247720|NCT01421017|79080029|FG000|Overall Study|POD|0|||
44247721|NCT01421017|79080030|FG001|Overall Study|POD|6|||
44247722|NCT01421017|79080031|FG002|Overall Study|POD|3|||
44247723|NCT01420627|79080078|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
44247724|NCT01400113|79080088|FG000|Overall Study|Withdrawal by Subject|1|||
44247725|NCT01400113|79080089|FG001|Overall Study|Withdrawal by Subject|1|||
44247726|NCT01399723|79080097|FG000|Overall Study|Lost to Follow-up|0|||
44247727|NCT01399723|79080098|FG001|Overall Study|Lost to Follow-up|1|||
44247728|NCT01385371|79080107|FG000|Overall Study|Adverse Event|54|||
44514508|NCT02849626|79520228|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
44514509|NCT02849626|79520229|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
44514510|NCT02849626|79520226|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
44514511|NCT02849626|79520227|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
44514512|NCT02849626|79520228|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
44514513|NCT02849626|79520229|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
44514514|NCT02849626|79520226|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
44514515|NCT02849626|79520227|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
44514516|NCT02849626|79520228|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
44514517|NCT02849626|79520229|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
44514518|NCT02849626|79520226|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
44514519|NCT02849626|79520227|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
44143514|NCT01936857|78932816|FG000|Overall Study|Withdrawal by Subject|1|||
44143515|NCT01936857|78932817|FG001|Overall Study|Withdrawal by Subject|0|||
44143516|NCT01936857|78932816|FG000|Overall Study|Side effect of medication|1|||
44247729|NCT01385371|79080108|FG001|Overall Study|Adverse Event|19|||
44247730|NCT01385371|79080107|FG000|Overall Study|Lost to Follow-up|16|||
44247731|NCT01385371|79080108|FG001|Overall Study|Lost to Follow-up|16|||
44247732|NCT01385371|79080107|FG000|Overall Study|Withdrawal by Subject|52|||
44514520|NCT02849626|79520228|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
44247733|NCT01385371|79080108|FG001|Overall Study|Withdrawal by Subject|39|||
44247734|NCT01385371|79080107|FG000|Overall Study|Protocol Violation|25|||
44247735|NCT01385371|79080108|FG001|Overall Study|Protocol Violation|21|||
44247736|NCT01385371|79080107|FG000|Overall Study|Administrative|2|||
44247737|NCT01385371|79080108|FG001|Overall Study|Administrative|2|||
44247738|NCT01399099|79080114|FG000|Overall Study|Lost to Follow-up|11|||
44247739|NCT01399099|79080114|FG000|Overall Study|Physician Decision|1|||
44247740|NCT01399099|79080114|FG000|Overall Study|Protocol Violation|1|||
44247741|NCT01399099|79080114|FG000|Overall Study|Skin Irritation|13|||
44247742|NCT01399099|79080114|FG000|Overall Study|Infection|1|||
44247743|NCT01399099|79080114|FG000|Overall Study|Miscellaneous|4|||
44247744|NCT01398787|79080119|FG000|Overall Study|Adverse Event|1|||
44247745|NCT01383499|79080125|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
44247746|NCT01383499|79080126|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44247747|NCT01383499|79080127|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44247748|NCT01383499|79080128|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44247749|NCT01397461|79080144|FG000|Overall Study|Withdrawal by Subject|2|||
44247750|NCT01397461|79080145|FG001|Overall Study|Withdrawal by Subject|1|||
44247751|NCT01397461|79080146|FG002|Overall Study|Withdrawal by Subject|0|||
44247752|NCT01397461|79080144|FG000|Overall Study|Lost to Follow-up|0|||
44247753|NCT01397461|79080145|FG001|Overall Study|Lost to Follow-up|2|||
44247754|NCT01397461|79080146|FG002|Overall Study|Lost to Follow-up|1|||
44247755|NCT01397461|79080144|FG000|Overall Study|Lack of Efficacy|0|||
44247756|NCT01397461|79080145|FG001|Overall Study|Lack of Efficacy|3|||
44247757|NCT01397461|79080146|FG002|Overall Study|Lack of Efficacy|0|||
44247758|NCT01397461|79080144|FG000|Overall Study|Not treated|0|||
44247759|NCT01397461|79080145|FG001|Overall Study|Not treated|0|||
44247760|NCT01397461|79080146|FG002|Overall Study|Not treated|1|||
44247761|NCT01382251|79080156|FG000|Overall Study|Surgeries cancelled or delayed|16|||
44247762|NCT01382251|79080157|FG001|Overall Study|Surgeries cancelled or delayed|16|||
44247763|NCT01382251|79080156|FG000|Overall Study|Lost to Follow-up|4|||
44247764|NCT01382251|79080157|FG001|Overall Study|Lost to Follow-up|4|||
44247765|NCT01382251|79080156|FG000|Overall Study|Contacted after study closed|1|||
44247766|NCT01382251|79080157|FG001|Overall Study|Contacted after study closed|1|||
44247767|NCT01396525|79080162|FG000|Overall Study|Withdrawal by Subject|8|||
44247768|NCT01396525|79080162|FG000|Overall Study|Death|14|||
44247769|NCT01396525|79080162|FG000|Overall Study|Lost to Follow-up|4|||
44247770|NCT02849652|79080174|FG000|Overall Study|Lost to Follow-up|104|||
44247771|NCT02849652|79080175|FG001|Overall Study|Lost to Follow-up|35|||
44247772|NCT02849652|79080176|FG002|Overall Study|Lost to Follow-up|116|||
44247773|NCT02849652|79080177|FG003|Overall Study|Lost to Follow-up|22|||
44247774|NCT02849652|79080174|FG000|Overall Study|Withdrawal by Subject|10|||
44247775|NCT02849652|79080175|FG001|Overall Study|Withdrawal by Subject|2|||
44247776|NCT02849652|79080176|FG002|Overall Study|Withdrawal by Subject|8|||
44247777|NCT02849652|79080177|FG003|Overall Study|Withdrawal by Subject|4|||
44247778|NCT01396447|79080189|FG000|Overall Study|Did Not Receive Treatment|3|||
44247779|NCT01396447|79080190|FG001|Overall Study|Did Not Receive Treatment|2|||
44247780|NCT01396447|79080191|FG002|Overall Study|Did Not Receive Treatment|1|||
44247781|NCT01396447|79080192|FG003|Overall Study|Did Not Receive Treatment|0|||
44247782|NCT01396447|79080189|FG000|Overall Study|Adverse Event|15|||
44247783|NCT01396447|79080190|FG001|Overall Study|Adverse Event|12|||
44247784|NCT01396447|79080191|FG002|Overall Study|Adverse Event|12|||
44247785|NCT01396447|79080192|FG003|Overall Study|Adverse Event|17|||
44247786|NCT01396447|79080189|FG000|Overall Study|Insufficient Therapeutic Response|5|||
44247787|NCT01396447|79080190|FG001|Overall Study|Insufficient Therapeutic Response|5|||
44247788|NCT01396447|79080191|FG002|Overall Study|Insufficient Therapeutic Response|2|||
44247789|NCT01396447|79080192|FG003|Overall Study|Insufficient Therapeutic Response|4|||
44247790|NCT01396447|79080189|FG000|Overall Study|Protocol Violation|5|||
44247791|NCT01396447|79080190|FG001|Overall Study|Protocol Violation|2|||
44247792|NCT01396447|79080191|FG002|Overall Study|Protocol Violation|3|||
44247793|NCT01396447|79080192|FG003|Overall Study|Protocol Violation|7|||
44381426|NCT00735475|79387573|FG001|Overall Study|Lost to Follow-up|3|||
44381427|NCT00735475|79387572|FG000|Overall Study|Physician Decision|0|||
44381428|NCT00735475|79387573|FG001|Overall Study|Physician Decision|1|||
44381429|NCT00735475|79387572|FG000|Overall Study|Withdrawal by Subject|4|||
44143517|NCT01936857|78932817|FG001|Overall Study|Side effect of medication|0|||
44247794|NCT01396447|79080189|FG000|Overall Study|Withdrawal of Consent|11|||
44247795|NCT01396447|79080190|FG001|Overall Study|Withdrawal of Consent|9|||
44247796|NCT01396447|79080191|FG002|Overall Study|Withdrawal of Consent|4|||
44247797|NCT01396447|79080192|FG003|Overall Study|Withdrawal of Consent|15|||
44247798|NCT01396447|79080189|FG000|Overall Study|Lost to Follow-up|4|||
44247799|NCT01396447|79080190|FG001|Overall Study|Lost to Follow-up|8|||
44247800|NCT01396447|79080191|FG002|Overall Study|Lost to Follow-up|7|||
44247801|NCT01396447|79080192|FG003|Overall Study|Lost to Follow-up|9|||
44247802|NCT01396447|79080189|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44247803|NCT01396447|79080190|FG001|Overall Study|Other Miscellaneous Reasons|2|||
44247804|NCT01396447|79080191|FG002|Overall Study|Other Miscellaneous Reasons|1|||
44247805|NCT01396447|79080192|FG003|Overall Study|Other Miscellaneous Reasons|0|||
44143518|NCT01936857|78932816|FG000|Overall Study|Other|2|||
44247806|NCT01678560|79080265|FG000|Overall Study|Physician Decision|4|||
44247807|NCT01678560|79080266|FG001|Overall Study|Physician Decision|4|||
44247808|NCT01678560|79080265|FG000|Overall Study|Death|0|||
44247809|NCT01678560|79080266|FG001|Overall Study|Death|1|||
44247810|NCT01678560|79080265|FG000|Overall Study|Withdrawal by Subject|0|||
44247811|NCT01678560|79080266|FG001|Overall Study|Withdrawal by Subject|1|||
44247812|NCT01381549|79080305|FG000|Overall Study|Ineligible: No organisms isolated|0|||
44247813|NCT01381549|79080306|FG001|Overall Study|Ineligible: No organisms isolated|0|||
44247814|NCT01381549|79080307|FG002|Overall Study|Ineligible: No organisms isolated|1|||
44247815|NCT00159432|79080316|FG000|Overall Study|Adverse Event|1|||
44247816|NCT00159432|79080316|FG000|Overall Study|Death|1|||
44247817|NCT00159432|79080316|FG000|Overall Study|Lack of Efficacy|8|||
44247818|NCT01396057|79080322|FG000|Overall Study|Adverse Event|2|||
44247819|NCT01396057|79080323|FG001|Overall Study|Adverse Event|6|||
44247820|NCT01396057|79080322|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44247821|NCT01396057|79080323|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
44247822|NCT01396057|79080322|FG000|Overall Study|Protocol deviation|4|||
44247823|NCT01396057|79080323|FG001|Overall Study|Protocol deviation|4|||
44247824|NCT01396057|79080322|FG000|Overall Study|Consent withdrawn|3|||
44247825|NCT01396057|79080323|FG001|Overall Study|Consent withdrawn|2|||
44247826|NCT01380769|79080340|FG000|Overall Study|Withdrawal by Subject|7|||
44247827|NCT01380769|79080341|FG001|Overall Study|Withdrawal by Subject|11|||
44247828|NCT01380769|79080340|FG000|Overall Study|Physician Decision|1|||
44276999|NCT02132754|79237797|FG023|Overall Study|Screen Failure|0|||
44277000|NCT02132754|79237798|FG024|Overall Study|Screen Failure|0|||
44277001|NCT02132754|79237799|FG025|Overall Study|Screen Failure|0|||
44277002|NCT02132754|79237800|FG026|Overall Study|Screen Failure|0|||
44277003|NCT02132754|79237801|FG027|Overall Study|Screen Failure|0|||
44277004|NCT02132754|79237802|FG028|Overall Study|Screen Failure|0|||
44277005|NCT02132754|79237803|FG029|Overall Study|Screen Failure|0|||
44277006|NCT02132754|79237804|FG030|Overall Study|Screen Failure|0|||
44277007|NCT02132754|79237805|FG031|Overall Study|Screen Failure|0|||
44277008|NCT02132754|79237806|FG032|Overall Study|Screen Failure|0|||
44277009|NCT02132754|79237807|FG033|Overall Study|Screen Failure|0|||
44277010|NCT02132754|79237774|FG000|Overall Study|Transferred to Extension Study|0|||
44277011|NCT02132754|79237775|FG001|Overall Study|Transferred to Extension Study|0|||
44277012|NCT02132754|79237776|FG002|Overall Study|Transferred to Extension Study|0|||
44277013|NCT02132754|79237777|FG003|Overall Study|Transferred to Extension Study|0|||
44277014|NCT02132754|79237778|FG004|Overall Study|Transferred to Extension Study|0|||
44277015|NCT02132754|79237779|FG005|Overall Study|Transferred to Extension Study|0|||
44277016|NCT02132754|79237780|FG006|Overall Study|Transferred to Extension Study|0|||
44277017|NCT02132754|79237781|FG007|Overall Study|Transferred to Extension Study|0|||
44277018|NCT02132754|79237782|FG008|Overall Study|Transferred to Extension Study|0|||
44277019|NCT02132754|79237783|FG009|Overall Study|Transferred to Extension Study|0|||
44277020|NCT02132754|79237784|FG010|Overall Study|Transferred to Extension Study|0|||
44277021|NCT02132754|79237785|FG011|Overall Study|Transferred to Extension Study|0|||
44247829|NCT01380769|79080341|FG001|Overall Study|Physician Decision|1|||
44247830|NCT01380769|79080340|FG000|Overall Study|Adverse Event|1|||
44247831|NCT01380769|79080341|FG001|Overall Study|Adverse Event|1|||
44247832|NCT01380769|79080340|FG000|Overall Study|Protocol Violation|0|||
44277022|NCT02132754|79237786|FG012|Overall Study|Transferred to Extension Study|0|||
44277023|NCT02132754|79237787|FG013|Overall Study|Transferred to Extension Study|0|||
44277024|NCT02132754|79237788|FG014|Overall Study|Transferred to Extension Study|0|||
44247833|NCT01380769|79080341|FG001|Overall Study|Protocol Violation|1|||
44247834|NCT01395901|79080349|FG000|Overall Study|Lost to Follow-up|4|||
44247835|NCT01395901|79080350|FG001|Overall Study|Lost to Follow-up|0|||
44247836|NCT01395901|79080349|FG000|Overall Study|Randomized but not received study drug|5|||
44247837|NCT01395901|79080350|FG001|Overall Study|Randomized but not received study drug|4|||
44247838|NCT01395901|79080349|FG000|Overall Study|Adverse Event|0|||
44247839|NCT01395901|79080350|FG001|Overall Study|Adverse Event|1|||
44247840|NCT01395901|79080349|FG000|Overall Study|Withdrawal of consent|1|||
44277025|NCT02132754|79237789|FG015|Overall Study|Transferred to Extension Study|0|||
44247841|NCT01395901|79080350|FG001|Overall Study|Withdrawal of consent|0|||
44247842|NCT01395823|79080358|FG000|Overall Study|Death|4|||
44247843|NCT01395823|79080359|FG001|Overall Study|Death|4|||
44247844|NCT01395823|79080358|FG000|Overall Study|Physician Decision|3|||
44247845|NCT01395823|79080359|FG001|Overall Study|Physician Decision|1|||
44247846|NCT01395823|79080358|FG000|Overall Study|Lost to Follow-up|1|||
44277026|NCT02132754|79237790|FG016|Overall Study|Transferred to Extension Study|0|||
44277027|NCT02132754|79237791|FG017|Overall Study|Transferred to Extension Study|0|||
44143519|NCT01936857|78932817|FG001|Overall Study|Other|2|||
44247847|NCT01395823|79080359|FG001|Overall Study|Lost to Follow-up|0|||
44247848|NCT01395823|79080358|FG000|Overall Study|Transplant|1|||
44277028|NCT02132754|79237792|FG018|Overall Study|Transferred to Extension Study|0|||
44277029|NCT02132754|79237793|FG019|Overall Study|Transferred to Extension Study|0|||
44277030|NCT02132754|79237794|FG020|Overall Study|Transferred to Extension Study|0|||
44247849|NCT01395823|79080359|FG001|Overall Study|Transplant|0|||
44247850|NCT01395823|79080358|FG000|Overall Study|GI symptoms|1|||
44247851|NCT01395823|79080359|FG001|Overall Study|GI symptoms|0|||
44247852|NCT01395823|79080358|FG000|Overall Study|Withdrawal by Subject|5|||
44247853|NCT01395823|79080359|FG001|Overall Study|Withdrawal by Subject|4|||
44247854|NCT00158184|79080367|FG000|Overall Study|personal issues|3|||
44247855|NCT00158184|79080368|FG001|Overall Study|personal issues|1|||
44247856|NCT00158184|79080367|FG000|Overall Study|failed for follow unit/study rules|2|||
44247857|NCT00158184|79080368|FG001|Overall Study|failed for follow unit/study rules|0|||
44247858|NCT00158184|79080367|FG000|Overall Study|Adverse Event|1|||
44247859|NCT00158184|79080368|FG001|Overall Study|Adverse Event|1|||
44247860|NCT01380691|79080376|FG000|Washout (7 Days)|Protocol Violation|0|||
44247861|NCT01380691|79080377|FG001|Washout (7 Days)|Protocol Violation|0|||
44247862|NCT01380691|79080378|FG002|Washout (7 Days)|Protocol Violation|0|||
44247863|NCT01380691|79080379|FG003|Washout (7 Days)|Protocol Violation|1|||
44247864|NCT01380691|79080376|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
44247865|NCT01380691|79080377|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
44247866|NCT01380691|79080378|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
44247867|NCT01380691|79080379|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
44247868|NCT01380535|79080405|FG000|Overall Study|Adverse Event|3|||
44247869|NCT01380535|79080406|FG001|Overall Study|Adverse Event|3|||
44247870|NCT01380535|79080405|FG000|Overall Study|Death|3|||
44247871|NCT01380535|79080406|FG001|Overall Study|Death|0|||
44247872|NCT01380535|79080405|FG000|Overall Study|Study site closed|0|||
44247873|NCT01380535|79080406|FG001|Overall Study|Study site closed|5|||
44247874|NCT01380535|79080405|FG000|Overall Study|Withdrawal by Subject|1|||
44247875|NCT01380535|79080406|FG001|Overall Study|Withdrawal by Subject|2|||
44247876|NCT01380535|79080405|FG000|Overall Study|Protocol Violation|0|||
44247877|NCT01380535|79080406|FG001|Overall Study|Protocol Violation|2|||
44247878|NCT01380535|79080405|FG000|Overall Study|Lack of Efficacy|0|||
44247879|NCT01380535|79080406|FG001|Overall Study|Lack of Efficacy|3|||
44247880|NCT01380379|79080416|FG000|Overall Study|Pregnancy|1|||
44247881|NCT01380145|79080420|FG000|Overall Study|Progressive disease|4|||
44247882|NCT03420222|79080446|FG000|Overall Study|Withdrawal by Subject|5|||
44247883|NCT03420222|79080447|FG001|Overall Study|Withdrawal by Subject|0|||
44247884|NCT03420222|79080446|FG000|Overall Study|Physician Decision|0|||
44247885|NCT03420222|79080447|FG001|Overall Study|Physician Decision|1|||
44247886|NCT01394185|79080453|FG000|Overall Study|Withdrawal by Subject|2|||
44247887|NCT01394185|79080454|FG001|Overall Study|Withdrawal by Subject|0|||
44247888|NCT01394185|79080455|FG002|Overall Study|Withdrawal by Subject|0|||
44247889|NCT01394185|79080456|FG003|Overall Study|Withdrawal by Subject|0|||
44247890|NCT01394185|79080457|FG004|Overall Study|Withdrawal by Subject|1|||
44247891|NCT01394185|79080458|FG005|Overall Study|Withdrawal by Subject|0|||
44247892|NCT01394185|79080453|FG000|Overall Study|Change in protocol|3|||
44247893|NCT01394185|79080454|FG001|Overall Study|Change in protocol|0|||
44247894|NCT01394185|79080455|FG002|Overall Study|Change in protocol|0|||
44247895|NCT01394185|79080456|FG003|Overall Study|Change in protocol|0|||
44247896|NCT01394185|79080457|FG004|Overall Study|Change in protocol|3|||
44247897|NCT01394185|79080458|FG005|Overall Study|Change in protocol|0|||
44247898|NCT01394185|79080453|FG000|Overall Study|Protocol Violation|1|||
44247899|NCT01394185|79080454|FG001|Overall Study|Protocol Violation|0|||
44247900|NCT01394185|79080455|FG002|Overall Study|Protocol Violation|0|||
44247901|NCT01394185|79080456|FG003|Overall Study|Protocol Violation|1|||
44247902|NCT01394185|79080457|FG004|Overall Study|Protocol Violation|0|||
44247903|NCT01394185|79080458|FG005|Overall Study|Protocol Violation|1|||
44247904|NCT01677936|79080491|FG000|Overall Study|Lost to Follow-up|4|||
44247905|NCT01677936|79080492|FG001|Overall Study|Lost to Follow-up|1|||
44247906|NCT01677936|79080491|FG000|Overall Study|Protocol Violation|3|||
44247907|NCT01677936|79080492|FG001|Overall Study|Protocol Violation|0|||
44247908|NCT01677936|79080491|FG000|Overall Study|Adverse Event|1|||
44247909|NCT01677936|79080492|FG001|Overall Study|Adverse Event|0|||
44247910|NCT01677936|79080491|FG000|Overall Study|Lost to Follow-up|1|||
44247911|NCT01677936|79080492|FG001|Overall Study|Lost to Follow-up|0|||
44247912|NCT01677936|79080491|FG000|Overall Study|Protocol Violation|0|||
44143520|NCT01602224|78932826|FG000|Overall Study|Adverse Event|0|||
44247913|NCT01677936|79080492|FG001|Overall Study|Protocol Violation|4|||
44247914|NCT01525550|79080523|FG000|Overall Study|Lost to Follow-up|8|||
44247915|NCT01525550|79080524|FG001|Overall Study|Lost to Follow-up|2|||
44247916|NCT01525550|79080523|FG000|Overall Study|Death|19|||
44247917|NCT01525550|79080524|FG001|Overall Study|Death|28|||
44247918|NCT01525550|79080523|FG000|Overall Study|Other|0|||
44247919|NCT01525550|79080524|FG001|Overall Study|Other|4|||
44247920|NCT01525550|79080523|FG000|Overall Study|Sponsor's Decision|30|||
44247921|NCT01525550|79080524|FG001|Overall Study|Sponsor's Decision|11|||
44247922|NCT01525550|79080523|FG000|Overall Study|Withdrawal by Subject|4|||
44247923|NCT01525550|79080524|FG001|Overall Study|Withdrawal by Subject|0|||
44247924|NCT00211237|79080545|FG000|Baseline|Withdrew|1|||
44247925|NCT00211237|79080546|FG001|Baseline|Withdrew|3|||
44247926|NCT00211237|79080547|FG002|Baseline|Withdrew|0|||
44247927|NCT00211237|79080545|FG000|Baseline|Refused random assignment|1|||
44247928|NCT00211237|79080546|FG001|Baseline|Refused random assignment|0|||
44247929|NCT00211237|79080547|FG002|Baseline|Refused random assignment|0|||
44247930|NCT00211237|79080545|FG000|1 Month|Death|2|||
44247931|NCT00211237|79080546|FG001|1 Month|Death|1|||
44247932|NCT00211237|79080547|FG002|1 Month|Death|0|||
44247933|NCT00211237|79080545|FG000|1 Month|Lost to Follow-up|0|||
44247934|NCT00211237|79080546|FG001|1 Month|Lost to Follow-up|2|||
44247935|NCT00211237|79080547|FG002|1 Month|Lost to Follow-up|0|||
44247936|NCT00211237|79080545|FG000|1 Month|Withdrew|0|||
44247937|NCT00211237|79080546|FG001|1 Month|Withdrew|4|||
44247938|NCT00211237|79080547|FG002|1 Month|Withdrew|0|||
44247939|NCT00211237|79080545|FG000|1 Month|Additional surgery needed|1|||
44247940|NCT00211237|79080546|FG001|1 Month|Additional surgery needed|0|||
44247941|NCT00211237|79080547|FG002|1 Month|Additional surgery needed|0|||
44247942|NCT00211237|79080545|FG000|1 Month|Non-medical problem|0|||
44247943|NCT00211237|79080546|FG001|1 Month|Non-medical problem|2|||
44247944|NCT00211237|79080547|FG002|1 Month|Non-medical problem|0|||
44247945|NCT00211237|79080545|FG000|3 Months|Death|7|||
44247946|NCT00211237|79080546|FG001|3 Months|Death|3|||
44247947|NCT00211237|79080547|FG002|3 Months|Death|0|||
44247948|NCT00211237|79080545|FG000|3 Months|Could not comply with protocol|1|||
44247949|NCT00211237|79080546|FG001|3 Months|Could not comply with protocol|0|||
44247950|NCT00211237|79080547|FG002|3 Months|Could not comply with protocol|0|||
44247951|NCT00211237|79080545|FG000|3 Months|Withdrew|0|||
44247952|NCT00211237|79080546|FG001|3 Months|Withdrew|1|||
44247953|NCT00211237|79080547|FG002|3 Months|Withdrew|0|||
44247954|NCT00211237|79080545|FG000|3 Months|Non-medical problem|0|||
44247955|NCT00211237|79080546|FG001|3 Months|Non-medical problem|0|||
44247956|NCT00211237|79080547|FG002|3 Months|Non-medical problem|1|||
44247957|NCT00211237|79080545|FG000|6 Months|Death|6|||
44247958|NCT00211237|79080546|FG001|6 Months|Death|0|||
44247959|NCT00211237|79080547|FG002|6 Months|Death|3|||
44247960|NCT00211237|79080545|FG000|6 Months|Lost to Follow-up|2|||
44247961|NCT00211237|79080546|FG001|6 Months|Lost to Follow-up|0|||
44247962|NCT00211237|79080547|FG002|6 Months|Lost to Follow-up|0|||
44247963|NCT00211237|79080545|FG000|6 Months|Could not comply with protocol|0|||
44247964|NCT00211237|79080546|FG001|6 Months|Could not comply with protocol|2|||
44247965|NCT00211237|79080547|FG002|6 Months|Could not comply with protocol|0|||
44247966|NCT00211237|79080545|FG000|12 Months|Death|8|||
44247967|NCT00211237|79080546|FG001|12 Months|Death|2|||
44247968|NCT00211237|79080547|FG002|12 Months|Death|3|||
44247969|NCT00211237|79080545|FG000|12 Months|Lost to Follow-up|1|||
44247970|NCT00211237|79080546|FG001|12 Months|Lost to Follow-up|0|||
44247971|NCT00211237|79080547|FG002|12 Months|Lost to Follow-up|1|||
44247972|NCT00211237|79080545|FG000|12 Months|Withdrew|0|||
44247973|NCT00211237|79080546|FG001|12 Months|Withdrew|0|||
44247974|NCT00211237|79080547|FG002|12 Months|Withdrew|1|||
44247975|NCT00211237|79080545|FG000|12 Months|unrelated medical problem|0|||
44247976|NCT00211237|79080546|FG001|12 Months|unrelated medical problem|0|||
44247977|NCT00211237|79080547|FG002|12 Months|unrelated medical problem|1|||
44247978|NCT01489358|79080567|FG000|Overall Study|Lost to Follow-up|0|||
44247979|NCT01489358|79080568|FG001|Overall Study|Lost to Follow-up|0|||
44247980|NCT01489358|79080569|FG002|Overall Study|Lost to Follow-up|2|||
44247981|NCT01525238|79080580|FG000|Overall Study|Withdrawal by Subject|1|||
44247982|NCT01525238|79080581|FG001|Overall Study|Withdrawal by Subject|0|||
44247983|NCT01525238|79080582|FG002|Overall Study|Withdrawal by Subject|0|||
44247984|NCT01488578|79080603|FG000|Overall Study|Protocol Violation|1836|||
44247985|NCT01524770|79080644|FG000|First Intervention|Withdrawal by Subject|1|||
44247986|NCT01524770|79080645|FG001|First Intervention|Withdrawal by Subject|0|||
44247987|NCT01524770|79080644|FG000|First Intervention|Adverse Event|1|||
44247988|NCT01524770|79080645|FG001|First Intervention|Adverse Event|1|||
44247989|NCT01524770|79080644|FG000|First Intervention|Protocol Violation|1|||
44247990|NCT01524770|79080645|FG001|First Intervention|Protocol Violation|0|||
44514521|NCT02849626|79520229|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
44514522|NCT03735498|79520247|FG000|Overall Study|Withdrawal by Subject|5|||
44514523|NCT03735498|79520247|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
44247991|NCT05166876|79080669|FG000|Overall Study|Withdrawal by Subject|1|||
44247992|NCT05166876|79080670|FG001|Overall Study|Withdrawal by Subject|0|||
44514524|NCT02659540|79520253|FG000|Overall Study|Adverse Event|3|||
44247993|NCT05166876|79080671|FG002|Overall Study|Withdrawal by Subject|0|||
44247994|NCT05065619|79080685|FG000|Up to Day 42|Lost to Follow-up|1|||
44247995|NCT05065619|79080686|FG001|Up to Day 42|Lost to Follow-up|0|||
44247996|NCT05065619|79080685|FG000|Up to Day 42|Withdrawal by Subject|1|||
44247997|NCT05065619|79080686|FG001|Up to Day 42|Withdrawal by Subject|0|||
44247998|NCT05065619|79080685|FG000|After Day 43|Lost to Follow-up|1|||
44247999|NCT05065619|79080686|FG001|After Day 43|Lost to Follow-up|0|||
44248000|NCT05065619|79080685|FG000|After Day 43|Physician Decision|3|||
44248001|NCT05065619|79080686|FG001|After Day 43|Physician Decision|0|||
44248002|NCT05065619|79080685|FG000|After Day 43|Withdrawal by Subject|1|||
44248003|NCT05065619|79080686|FG001|After Day 43|Withdrawal by Subject|2|||
44248004|NCT05065619|79080685|FG000|After Day 43|Public vaccination|6|||
44248005|NCT05065619|79080686|FG001|After Day 43|Public vaccination|8|||
44248006|NCT05065619|79080685|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
44248007|NCT05065619|79080686|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
44248008|NCT05065619|79080685|FG000|After Day 43|Study Terminated by Sponsor|88|||
44248009|NCT05065619|79080686|FG001|After Day 43|Study Terminated by Sponsor|16|||
44248010|NCT04581200|79080712|FG000|Overall Study|Lost to Follow-up|6|||
44248011|NCT04581200|79080713|FG001|Overall Study|Lost to Follow-up|5|||
44248020|NCT04481243|79080734|FG000|Overall Study|Withdrawal by Subject|4|||
44248021|NCT04468230|79080738|FG000|Overall Study|Adverse Event|2|||
44248022|NCT04439175|79080755|FG000|Overall Study|Never started treatment|4|||
44248023|NCT04439175|79080755|FG000|Overall Study|Ineligible|5|||
44248024|NCT04439175|79080755|FG000|Overall Study|Adverse Event|6|||
44248025|NCT04439175|79080755|FG000|Overall Study|Death|4|||
44248026|NCT04439175|79080755|FG000|Overall Study|Disease progression|44|||
44248027|NCT04439175|79080755|FG000|Overall Study|Withdrawal by Subject|4|||
44248028|NCT04439175|79080755|FG000|Overall Study|Alternative Therapy|1|||
44248029|NCT04439175|79080755|FG000|Overall Study|Other|2|||
44248030|NCT04439136|79080759|FG000|Overall Study|Ineligible|1|||
44248031|NCT04439136|79080759|FG000|Overall Study|Never Started Treatment|2|||
44248032|NCT04439136|79080759|FG000|Overall Study|Adverse Event|4|||
44248033|NCT04439136|79080759|FG000|Overall Study|Death|3|||
44248034|NCT04439136|79080759|FG000|Overall Study|Disease Progression|27|||
44248035|NCT04439136|79080759|FG000|Overall Study|Alternative Therapy|1|||
44248036|NCT04439136|79080759|FG000|Overall Study|Increased Tumor Burden|1|||
44248037|NCT04439136|79080759|FG000|Overall Study|Symptomatic Detrioration|1|||
44248038|NCT04204902|79080792|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
44248039|NCT04204902|79080793|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
44248040|NCT04166383|79080799|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
44248041|NCT04166383|79080799|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
44248042|NCT04166383|79080799|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
44248043|NCT04163458|79080820|FG000|Overall Study|Protocol Deviation|7|||
44248044|NCT04163458|79080821|FG001|Overall Study|Protocol Deviation|13|||
44248045|NCT04163458|79080820|FG000|Overall Study|Adverse Event|5|||
44248046|NCT04163458|79080821|FG001|Overall Study|Adverse Event|8|||
44248047|NCT04163458|79080820|FG000|Overall Study|Due to COVID-19 pandemic|4|||
44248048|NCT04163458|79080821|FG001|Overall Study|Due to COVID-19 pandemic|2|||
44248049|NCT04163458|79080820|FG000|Overall Study|Participant withdrew consent|2|||
44248050|NCT04163458|79080821|FG001|Overall Study|Participant withdrew consent|3|||
44248051|NCT04163458|79080820|FG000|Overall Study|Randomization failure|2|||
44248052|NCT04163458|79080821|FG001|Overall Study|Randomization failure|2|||
44248053|NCT04163458|79080820|FG000|Overall Study|Other|4|||
44248054|NCT04163458|79080821|FG001|Overall Study|Other|2|||
44248055|NCT03783442|79080874|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
44248056|NCT03783442|79080875|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
44248057|NCT03783442|79080874|FG000|Overall Study|Death|196|||
44248058|NCT03783442|79080875|FG001|Overall Study|Death|226|||
44248059|NCT03783442|79080874|FG000|Overall Study|Withdrawal by Subject|14|||
44248060|NCT03783442|79080875|FG001|Overall Study|Withdrawal by Subject|17|||
44248061|NCT03783442|79080874|FG000|Overall Study|Lost to Follow-up|2|||
44248062|NCT03783442|79080875|FG001|Overall Study|Lost to Follow-up|3|||
44248063|NCT03734016|79080883|FG000|Overall Study|Participants Remaining in the Study|260|||
44248064|NCT03734016|79080884|FG001|Overall Study|Participants Remaining in the Study|240|||
44248065|NCT03734016|79080883|FG000|Overall Study|Death|48|||
44514525|NCT02659540|79520254|FG001|Overall Study|Adverse Event|2|||
44514526|NCT02659540|79520253|FG000|Overall Study|Death|1|||
44514527|NCT02659540|79520254|FG001|Overall Study|Death|0|||
44248066|NCT03734016|79080884|FG001|Overall Study|Death|60|||
44248067|NCT03734016|79080883|FG000|Overall Study|Withdrawal by Subject|14|||
44248068|NCT03734016|79080884|FG001|Overall Study|Withdrawal by Subject|16|||
44248069|NCT03734016|79080883|FG000|Overall Study|Physician Decision|0|||
44248070|NCT03734016|79080884|FG001|Overall Study|Physician Decision|7|||
44248071|NCT03734016|79080883|FG000|Overall Study|Lost to Follow-up|3|||
44514528|NCT02659540|79520253|FG000|Overall Study|Progressive disease|2|||
44248072|NCT03734016|79080884|FG001|Overall Study|Lost to Follow-up|1|||
44248073|NCT03734016|79080883|FG000|Overall Study|Adverse Event|2|||
44248074|NCT03734016|79080884|FG001|Overall Study|Adverse Event|1|||
44143521|NCT01602224|78932827|FG001|Overall Study|Adverse Event|1|||
44248075|NCT03693300|79080893|FG000|Overall Study|Patients ongoing study|43|||
44514529|NCT02659540|79520254|FG001|Overall Study|Progressive disease|6|||
44514530|NCT01097746|79520260|FG000|Overall Study|Adverse Event|4|||
44248076|NCT03693300|79080894|FG001|Overall Study|Patients ongoing study|1|||
44248077|NCT03671564|79080905|FG000|Overall Study|Progressive Disease|3|||
44248078|NCT03671564|79080906|FG001|Overall Study|Progressive Disease|5|||
44248079|NCT03671564|79080907|FG002|Overall Study|Progressive Disease|3|||
44248080|NCT03671564|79080905|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
44248081|NCT03671564|79080906|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
44248082|NCT03671564|79080907|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
44248083|NCT03671564|79080905|FG000|Overall Study|Withdrawal by Subject|1|||
44248084|NCT03671564|79080906|FG001|Overall Study|Withdrawal by Subject|1|||
44248085|NCT03671564|79080907|FG002|Overall Study|Withdrawal by Subject|0|||
44248086|NCT03632720|79080927|FG000|Overall Study|Adverse Event|2|||
44248087|NCT03632720|79080928|FG001|Overall Study|Adverse Event|0|||
44248088|NCT03632720|79080929|FG002|Overall Study|Adverse Event|0|||
44248089|NCT03632720|79080927|FG000|Overall Study|Lost to Follow-up|0|||
44248090|NCT03632720|79080928|FG001|Overall Study|Lost to Follow-up|1|||
44248091|NCT03632720|79080929|FG002|Overall Study|Lost to Follow-up|0|||
44248092|NCT03632720|79080927|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
44248093|NCT03632720|79080928|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
44248094|NCT03632720|79080929|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
44248095|NCT03632720|79080927|FG000|Overall Study|Screen failure|0|||
44248096|NCT03632720|79080928|FG001|Overall Study|Screen failure|1|||
44248097|NCT03632720|79080929|FG002|Overall Study|Screen failure|0|||
44248098|NCT03606512|79080941|FG000|Overall Study|Lost to Follow-up|0|||
44248099|NCT03606512|79080942|FG001|Overall Study|Lost to Follow-up|1|||
44248100|NCT03606512|79080941|FG000|Overall Study|'moved from study area|0|||
44248101|NCT03606512|79080942|FG001|Overall Study|'moved from study area|1|||
44248102|NCT03398200|79080965|FG000|Overall Study|Withdrawal by Subject|0|||
44248103|NCT03398200|79080966|FG001|Overall Study|Withdrawal by Subject|1|||
44248104|NCT03323099|79080992|FG000|Overall Study|Withdrawal by Subject|6|||
44248105|NCT03323099|79080993|FG001|Overall Study|Withdrawal by Subject|12|||
44248106|NCT03323099|79080992|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
44248107|NCT03323099|79080993|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
44248108|NCT03323034|79081004|FG000|Overall Study|Lack of Efficacy|5|||
44248109|NCT03323034|79081005|FG001|Overall Study|Lack of Efficacy|5|||
44248110|NCT03323034|79081006|FG002|Overall Study|Lack of Efficacy|6|||
44248111|NCT03323034|79081007|FG003|Overall Study|Lack of Efficacy|5|||
44248112|NCT03323034|79081008|FG004|Overall Study|Lack of Efficacy|5|||
44248113|NCT03323034|79081004|FG000|Overall Study|Physician Decision|0|||
44248114|NCT03323034|79081005|FG001|Overall Study|Physician Decision|0|||
44248115|NCT03323034|79081006|FG002|Overall Study|Physician Decision|0|||
44248116|NCT03323034|79081007|FG003|Overall Study|Physician Decision|0|||
44248117|NCT03323034|79081008|FG004|Overall Study|Physician Decision|1|||
44248118|NCT03323034|79081004|FG000|Overall Study|Withdrawal by Subject|1|||
44248119|NCT03323034|79081005|FG001|Overall Study|Withdrawal by Subject|1|||
44248120|NCT03323034|79081006|FG002|Overall Study|Withdrawal by Subject|0|||
44248121|NCT03323034|79081007|FG003|Overall Study|Withdrawal by Subject|1|||
44248122|NCT03323034|79081008|FG004|Overall Study|Withdrawal by Subject|0|||
44248123|NCT03307252|79081032|FG000|Part 2, Period 1|Treatment not received|0|||
44248124|NCT03307252|79081033|FG001|Part 2, Period 1|Treatment not received|0|||
44248125|NCT03307252|79081034|FG002|Part 2, Period 1|Treatment not received|0|||
44248126|NCT03307252|79081035|FG003|Part 2, Period 1|Treatment not received|0|||
44248127|NCT03307252|79081036|FG004|Part 2, Period 1|Treatment not received|0|||
44248128|NCT03307252|79081037|FG005|Part 2, Period 1|Treatment not received|1|||
44248129|NCT03307252|79081038|FG006|Part 2, Period 1|Treatment not received|0|||
44248130|NCT03307252|79081039|FG007|Part 2, Period 1|Treatment not received|0|||
44248131|NCT03307252|79081040|FG008|Part 2, Period 1|Treatment not received|0|||
44248132|NCT03307252|79081041|FG009|Part 2, Period 1|Treatment not received|0|||
44248133|NCT03307252|79081042|FG010|Part 2, Period 1|Treatment not received|0|||
44248134|NCT03307252|79081032|FG000|Part 2, Period 3|Other than listed|0|||
44248135|NCT03307252|79081033|FG001|Part 2, Period 3|Other than listed|0|||
44248136|NCT03307252|79081034|FG002|Part 2, Period 3|Other than listed|0|||
44248137|NCT03307252|79081035|FG003|Part 2, Period 3|Other than listed|0|||
44248138|NCT03307252|79081036|FG004|Part 2, Period 3|Other than listed|1|||
44248139|NCT03307252|79081037|FG005|Part 2, Period 3|Other than listed|0|||
44248140|NCT03307252|79081038|FG006|Part 2, Period 3|Other than listed|0|||
44381430|NCT00735475|79387573|FG001|Overall Study|Withdrawal by Subject|5|||
44514531|NCT01097746|79520260|FG000|Overall Study|taken off study before any treatment given|1|||
44143522|NCT01602224|78932828|FG002|Overall Study|Adverse Event|0|||
44248141|NCT03307252|79081039|FG007|Part 2, Period 3|Other than listed|0|||
44248142|NCT03307252|79081040|FG008|Part 2, Period 3|Other than listed|0|||
44248143|NCT03307252|79081041|FG009|Part 2, Period 3|Other than listed|0|||
44248144|NCT03307252|79081042|FG010|Part 2, Period 3|Other than listed|0|||
44248145|NCT03307252|79081032|FG000|Part 2, Period 4|Other than listed|0|||
44248146|NCT03307252|79081033|FG001|Part 2, Period 4|Other than listed|0|||
44248147|NCT03307252|79081034|FG002|Part 2, Period 4|Other than listed|0|||
44248148|NCT03307252|79081035|FG003|Part 2, Period 4|Other than listed|0|||
44248149|NCT03307252|79081036|FG004|Part 2, Period 4|Other than listed|0|||
44248150|NCT03307252|79081037|FG005|Part 2, Period 4|Other than listed|0|||
44248151|NCT03307252|79081038|FG006|Part 2, Period 4|Other than listed|1|||
44248152|NCT03307252|79081039|FG007|Part 2, Period 4|Other than listed|0|||
44248153|NCT03307252|79081040|FG008|Part 2, Period 4|Other than listed|0|||
44248154|NCT03307252|79081041|FG009|Part 2, Period 4|Other than listed|0|||
44248155|NCT03307252|79081042|FG010|Part 2, Period 4|Other than listed|0|||
44248156|NCT03307252|79081032|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248157|NCT03307252|79081033|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248158|NCT03307252|79081034|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248159|NCT03307252|79081035|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248160|NCT03307252|79081036|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248161|NCT03307252|79081037|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248162|NCT03307252|79081038|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248163|NCT03307252|79081039|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248164|NCT03307252|79081040|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248165|NCT03307252|79081041|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
44248166|NCT03307252|79081042|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
44248167|NCT03286504|79081060|FG000|Overall Study|Lost to Follow-up|19|||
44248168|NCT03286504|79081061|FG001|Overall Study|Lost to Follow-up|16|||
44248169|NCT03191786|79081078|FG000|Overall Study|Death|236|||
44248170|NCT03191786|79081079|FG001|Overall Study|Death|127|||
44248171|NCT03191786|79081078|FG000|Overall Study|Lost to Follow-up|9|||
44248172|NCT03191786|79081079|FG001|Overall Study|Lost to Follow-up|3|||
44248173|NCT03191786|79081078|FG000|Overall Study|Physician Decision|1|||
44248174|NCT03191786|79081079|FG001|Overall Study|Physician Decision|0|||
44248175|NCT03191786|79081078|FG000|Overall Study|Study Terminated By Sponsor|15|||
44248176|NCT03191786|79081079|FG001|Overall Study|Study Terminated By Sponsor|5|||
44248177|NCT03191786|79081078|FG000|Overall Study|Withdrawal by Subject|26|||
44248178|NCT03191786|79081079|FG001|Overall Study|Withdrawal by Subject|16|||
44248179|NCT03138733|79081087|FG000|Overall Study|Death|17|||
44248180|NCT03138733|79081088|FG001|Overall Study|Death|18|||
44248181|NCT03138733|79081087|FG000|Overall Study|Withdrawal by Subject|11|||
44248182|NCT03138733|79081088|FG001|Overall Study|Withdrawal by Subject|6|||
44248183|NCT03138733|79081087|FG000|Overall Study|Lost to Follow-up|3|||
44248184|NCT03138733|79081088|FG001|Overall Study|Lost to Follow-up|2|||
44248185|NCT03138733|79081087|FG000|Overall Study|Adverse Event|1|||
44248186|NCT03138733|79081088|FG001|Overall Study|Adverse Event|0|||
44248187|NCT03138733|79081087|FG000|Overall Study|Protocol Violation|1|||
44248188|NCT03138733|79081088|FG001|Overall Study|Protocol Violation|3|||
44248189|NCT03138733|79081087|FG000|Overall Study|Administrative or logistical reason|1|||
44248190|NCT03138733|79081088|FG001|Overall Study|Administrative or logistical reason|0|||
44248191|NCT03138733|79081087|FG000|Overall Study|The patient was transferred to another hospital|1|||
44248192|NCT03138733|79081088|FG001|Overall Study|The patient was transferred to another hospital|0|||
44248193|NCT03057054|79081096|FG000|Overall Study|Death|4|||
44248194|NCT03057054|79081097|FG001|Overall Study|Death|4|||
44248195|NCT03057054|79081096|FG000|Overall Study|Withdrawal by Subject|6|||
44248196|NCT03057054|79081097|FG001|Overall Study|Withdrawal by Subject|3|||
44248197|NCT03057054|79081096|FG000|Overall Study|Ineligible|1|||
44248198|NCT03057054|79081097|FG001|Overall Study|Ineligible|1|||
44514532|NCT03733470|79520290|FG000|Overall Study|PI Decision|1|||
44514533|NCT03733470|79520291|FG001|Overall Study|PI Decision|1|||
44514534|NCT03732534|79520297|FG000|Overall Study|Study terminated by Sponsor|6|||
44514535|NCT03087058|79520303|FG000|Overall Study|Withdrawal by Subject|2|||
44514536|NCT03087058|79520304|FG001|Overall Study|Withdrawal by Subject|0|||
44248199|NCT02854527|79081174|FG000|Overall Study|Adverse Event|0|||
44248200|NCT02854527|79081175|FG001|Overall Study|Adverse Event|0|||
44248201|NCT02854527|79081176|FG002|Overall Study|Adverse Event|0|||
44248202|NCT02854527|79081177|FG003|Overall Study|Adverse Event|0|||
44248203|NCT02854527|79081178|FG004|Overall Study|Adverse Event|1|||
44248204|NCT02854527|79081179|FG005|Overall Study|Adverse Event|0|||
44248205|NCT02854527|79081180|FG006|Overall Study|Adverse Event|0|||
44248206|NCT02854527|79081181|FG007|Overall Study|Adverse Event|0|||
44248207|NCT02854527|79081182|FG008|Overall Study|Adverse Event|0|||
44248208|NCT02854527|79081183|FG009|Overall Study|Adverse Event|0|||
44381431|NCT01026818|79387582|FG000|Screening Period|Entry Criteria Not Met|105|||
44514537|NCT03087058|79520305|FG002|Overall Study|Withdrawal by Subject|0|||
44248209|NCT02854527|79081174|FG000|Overall Study|Lost to Follow-up|0|||
44248210|NCT02854527|79081175|FG001|Overall Study|Lost to Follow-up|0|||
44248211|NCT02854527|79081176|FG002|Overall Study|Lost to Follow-up|0|||
44248212|NCT02854527|79081177|FG003|Overall Study|Lost to Follow-up|1|||
44381432|NCT01026818|79387583|FG001|Screening Period|Entry Criteria Not Met|0|||
44514538|NCT03726996|79520312|FG000|Overall Study|Parent's decision|2|||
44514539|NCT03726996|79520312|FG000|Overall Study|Study early termination|2|||
44248213|NCT02854527|79081178|FG004|Overall Study|Lost to Follow-up|0|||
44248214|NCT02854527|79081179|FG005|Overall Study|Lost to Follow-up|0|||
44248215|NCT02854527|79081180|FG006|Overall Study|Lost to Follow-up|0|||
44248216|NCT02854527|79081181|FG007|Overall Study|Lost to Follow-up|0|||
44248217|NCT02854527|79081182|FG008|Overall Study|Lost to Follow-up|0|||
44248218|NCT02854527|79081183|FG009|Overall Study|Lost to Follow-up|0|||
44248219|NCT02772081|79081197|FG000|Overall Study|Physician Decision|1|||
44248220|NCT02772081|79081198|FG001|Overall Study|Physician Decision|1|||
44248221|NCT02772081|79081197|FG000|Overall Study|Death|1|||
44248222|NCT02772081|79081198|FG001|Overall Study|Death|1|||
44248223|NCT02639559|79081206|FG000|Overall Study|Mobilization failure|0|||
44248224|NCT02639559|79081207|FG001|Overall Study|Mobilization failure|3|||
44248225|NCT02639559|79081206|FG000|Overall Study|Issues with vascular acess|1|||
44248226|NCT02639559|79081207|FG001|Overall Study|Issues with vascular acess|0|||
44248227|NCT02581891|79081215|FG000|Overall Study|Adverse Event|4|||
44248228|NCT02581891|79081216|FG001|Overall Study|Adverse Event|6|||
44248229|NCT02581891|79081215|FG000|Overall Study|Death|3|||
44248230|NCT02581891|79081216|FG001|Overall Study|Death|4|||
44248231|NCT02581891|79081215|FG000|Overall Study|Lost to Follow-up|1|||
44248232|NCT02581891|79081216|FG001|Overall Study|Lost to Follow-up|2|||
44248233|NCT02581891|79081215|FG000|Overall Study|Physician Decision|0|||
44248234|NCT02581891|79081216|FG001|Overall Study|Physician Decision|1|||
44248235|NCT02581891|79081215|FG000|Overall Study|Withdrawal by Subject|4|||
44248236|NCT02581891|79081216|FG001|Overall Study|Withdrawal by Subject|5|||
44248237|NCT02581891|79081215|FG000|Overall Study|Other Reasons|3|||
44248238|NCT02581891|79081216|FG001|Overall Study|Other Reasons|1|||
44248239|NCT02581891|79081215|FG000|Overall Study|Discontinued during followup|1|||
44248240|NCT02581891|79081216|FG001|Overall Study|Discontinued during followup|0|||
44248241|NCT02576535|79081223|FG000|Overall Study|Withdrawal by Subject|2|||
44248242|NCT02574845|79081233|FG000|Overall Study|Consent withdrawn further participation|0|||
44248243|NCT02574845|79081234|FG001|Overall Study|Consent withdrawn further participation|0|||
44248244|NCT02574845|79081235|FG002|Overall Study|Consent withdrawn further participation|0|||
44248245|NCT02574845|79081236|FG003|Overall Study|Consent withdrawn further participation|0|||
44248246|NCT02574845|79081237|FG004|Overall Study|Consent withdrawn further participation|1|||
44248247|NCT02574845|79081238|FG005|Overall Study|Consent withdrawn further participation|0|||
44248248|NCT02574845|79081233|FG000|Overall Study|Adverse Event|0|||
44248249|NCT02574845|79081234|FG001|Overall Study|Adverse Event|1|||
44248250|NCT02574845|79081235|FG002|Overall Study|Adverse Event|0|||
44248251|NCT02574845|79081236|FG003|Overall Study|Adverse Event|0|||
44248252|NCT02574845|79081237|FG004|Overall Study|Adverse Event|0|||
44248253|NCT02574845|79081238|FG005|Overall Study|Adverse Event|1|||
44248254|NCT01946139|79081310|FG000|Overall Study|Withdrawal by Subject|8|||
44248255|NCT01946139|79081310|FG000|Overall Study|ineligible|8|||
44248256|NCT01946139|79081310|FG000|Overall Study|Specimens not available|4|||
44248257|NCT01685008|79081318|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
44248258|NCT01685008|79081319|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
44248259|NCT01685008|79081320|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
44248260|NCT01685008|79081321|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
44248261|NCT01685008|79081318|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
44248262|NCT01685008|79081319|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
44248263|NCT01685008|79081320|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
44248264|NCT01685008|79081321|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
44143523|NCT01602224|78932826|FG000|Overall Study|Investigator Decison|1|||
44248265|NCT01685008|79081318|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
44248266|NCT01685008|79081319|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
44248267|NCT01685008|79081320|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
44248268|NCT01685008|79081321|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
44248269|NCT01685008|79081318|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
44248270|NCT01685008|79081319|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
44248271|NCT01685008|79081320|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
44248272|NCT01685008|79081321|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
44248273|NCT01685008|79081318|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
44143524|NCT01602224|78932827|FG001|Overall Study|Investigator Decison|0|||
44248274|NCT01685008|79081319|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
44248275|NCT01685008|79081320|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
44248276|NCT01685008|79081321|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
44248277|NCT01556490|79081350|FG000|Randomized Patients Summary|Protocol Violation|22|||
44248278|NCT01556490|79081351|FG001|Randomized Patients Summary|Protocol Violation|23|||
44248279|NCT01556490|79081350|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
44248280|NCT01556490|79081351|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
44248281|NCT01133990|79081370|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
44248282|NCT01133990|79081371|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44514540|NCT03882970|79520320|FG000|Overall Study|Adverse Event|5|||
44514541|NCT03882970|79520321|FG001|Overall Study|Adverse Event|7|||
44248283|NCT01133990|79081372|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44248284|NCT01133990|79081373|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44248285|NCT01133990|79081374|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44248286|NCT01133990|79081375|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44248287|NCT01133990|79081370|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
44248288|NCT01133990|79081371|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
44248289|NCT01133990|79081372|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
44248290|NCT01133990|79081373|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
44248291|NCT01133990|79081374|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
44248292|NCT01133990|79081375|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
44248293|NCT01133990|79081370|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
44248294|NCT01133990|79081371|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44248295|NCT01133990|79081372|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44248296|NCT01133990|79081373|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44248297|NCT01133990|79081374|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44248298|NCT01133990|79081375|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44248299|NCT01133990|79081370|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
44248300|NCT01133990|79081371|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
44248301|NCT01133990|79081372|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
44248302|NCT01133990|79081373|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
44248303|NCT01133990|79081374|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
44248304|NCT01133990|79081375|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
44248305|NCT00910429|79081384|FG000|Overall Study|Death|18|||
44248306|NCT00910429|79081385|FG001|Overall Study|Death|12|||
44248307|NCT00910429|79081384|FG000|Overall Study|Withdrawal by Subject|3|||
44248308|NCT00910429|79081385|FG001|Overall Study|Withdrawal by Subject|2|||
44248309|NCT00910429|79081384|FG000|Overall Study|Protocol Violation|1|||
44248310|NCT00910429|79081385|FG001|Overall Study|Protocol Violation|0|||
44248311|NCT00910429|79081384|FG000|Overall Study|Lost to Follow-up|2|||
44248312|NCT00910429|79081385|FG001|Overall Study|Lost to Follow-up|1|||
44248313|NCT00910429|79081384|FG000|Overall Study|Adverse Event|10|||
44248314|NCT00910429|79081385|FG001|Overall Study|Adverse Event|5|||
44248315|NCT00910429|79081384|FG000|Overall Study|Drug non-compliance|1|||
44248316|NCT00910429|79081385|FG001|Overall Study|Drug non-compliance|0|||
44248317|NCT00910429|79081384|FG000|Overall Study|Lack of Efficacy|4|||
44248318|NCT00910429|79081385|FG001|Overall Study|Lack of Efficacy|1|||
44248319|NCT00863681|79081394|FG000|Overall Study|Other|2|||
44248320|NCT00863681|79081395|FG001|Overall Study|Other|0|||
44248321|NCT00863681|79081396|FG002|Overall Study|Other|0|||
44248322|NCT00863681|79081394|FG000|Overall Study|Missing|1|||
44248323|NCT00863681|79081395|FG001|Overall Study|Missing|0|||
44248324|NCT00863681|79081396|FG002|Overall Study|Missing|0|||
44248325|NCT00863681|79081394|FG000|Overall Study|Death|40|||
44248326|NCT00863681|79081395|FG001|Overall Study|Death|23|||
44248327|NCT00863681|79081396|FG002|Overall Study|Death|6|||
44248328|NCT00863681|79081394|FG000|Overall Study|Withdrawal by Subject|12|||
44248329|NCT00863681|79081395|FG001|Overall Study|Withdrawal by Subject|5|||
44248330|NCT00863681|79081396|FG002|Overall Study|Withdrawal by Subject|2|||
44248331|NCT00863681|79081394|FG000|Overall Study|Protocol Violation|2|||
44248332|NCT00863681|79081395|FG001|Overall Study|Protocol Violation|0|||
44248333|NCT00863681|79081396|FG002|Overall Study|Protocol Violation|0|||
44248334|NCT00863681|79081394|FG000|Overall Study|Lost to Follow-up|3|||
44248335|NCT00863681|79081395|FG001|Overall Study|Lost to Follow-up|0|||
44248336|NCT00863681|79081396|FG002|Overall Study|Lost to Follow-up|3|||
44248337|NCT00863681|79081394|FG000|Overall Study|Adverse Event|28|||
44248338|NCT00863681|79081395|FG001|Overall Study|Adverse Event|10|||
44248339|NCT00863681|79081396|FG002|Overall Study|Adverse Event|6|||
44248340|NCT00863681|79081394|FG000|Overall Study|Lack of Efficacy|2|||
44248341|NCT00863681|79081395|FG001|Overall Study|Lack of Efficacy|2|||
44248342|NCT00863681|79081396|FG002|Overall Study|Lack of Efficacy|1|||
44248343|NCT00863681|79081394|FG000|Overall Study|Non-compliance with study drug|1|||
44248344|NCT00863681|79081395|FG001|Overall Study|Non-compliance with study drug|3|||
44381433|NCT01026818|79387584|FG002|Screening Period|Entry Criteria Not Met|0|||
44248345|NCT00863681|79081396|FG002|Overall Study|Non-compliance with study drug|0|||
44248346|NCT00846742|79081404|FG000|Overall Study|Withdrawal by Subject|1|||
44248347|NCT00734149|79081409|FG000|Overall Study|Withdrawal by Subject|1|||
44248348|NCT00587431|79081417|FG000|Overall Study|Adverse Event|1|||
44248349|NCT00587431|79081418|FG001|Overall Study|Adverse Event|0|||
44248350|NCT00587431|79081417|FG000|Overall Study|Withdrawal by Subject|0|||
44248351|NCT00587431|79081418|FG001|Overall Study|Withdrawal by Subject|1|||
44248352|NCT00097786|79081440|FG000|Overall Study|lost to follow-up for all-cause death|296|||
44248353|NCT00097786|79081441|FG001|Overall Study|lost to follow-up for all-cause death|292|||
44248354|NCT00097786|79081442|FG002|Overall Study|lost to follow-up for all-cause death|313|||
44248355|NCT00097786|79081443|FG003|Overall Study|lost to follow-up for all-cause death|310|||
44381434|NCT01026818|79387585|FG003|Screening Period|Entry Criteria Not Met|0|||
44248356|NCT01524692|79081453|FG000|Overall Study|Withdrawal by Subject|3|||
44248357|NCT01431287|79081472|FG000|Overall Study|not treated|0|||
44248358|NCT01431287|79081473|FG001|Overall Study|not treated|0|||
44248359|NCT01431287|79081474|FG002|Overall Study|not treated|1|||
44248360|NCT01431287|79081475|FG003|Overall Study|not treated|0|||
44248361|NCT01431287|79081476|FG004|Overall Study|not treated|0|||
44248362|NCT01431287|79081472|FG000|Overall Study|Adverse Event|59|||
44248363|NCT01431287|79081473|FG001|Overall Study|Adverse Event|57|||
44248364|NCT01431287|79081474|FG002|Overall Study|Adverse Event|53|||
44248365|NCT01431287|79081475|FG003|Overall Study|Adverse Event|33|||
44248366|NCT01431287|79081476|FG004|Overall Study|Adverse Event|41|||
44248367|NCT01431287|79081472|FG000|Overall Study|Non compliant with protocol|6|||
44248368|NCT01431287|79081473|FG001|Overall Study|Non compliant with protocol|6|||
44248369|NCT01431287|79081474|FG002|Overall Study|Non compliant with protocol|5|||
44248370|NCT01431287|79081475|FG003|Overall Study|Non compliant with protocol|6|||
44248371|NCT01431287|79081476|FG004|Overall Study|Non compliant with protocol|5|||
44248372|NCT01431287|79081472|FG000|Overall Study|Lost to Follow-up|0|||
44248373|NCT01431287|79081473|FG001|Overall Study|Lost to Follow-up|3|||
44248374|NCT01431287|79081474|FG002|Overall Study|Lost to Follow-up|2|||
44248375|NCT01431287|79081475|FG003|Overall Study|Lost to Follow-up|3|||
44248376|NCT01431287|79081476|FG004|Overall Study|Lost to Follow-up|1|||
44248377|NCT01431287|79081472|FG000|Overall Study|Consent withdrawn not due to AE|29|||
44248378|NCT01431287|79081473|FG001|Overall Study|Consent withdrawn not due to AE|30|||
44248379|NCT01431287|79081474|FG002|Overall Study|Consent withdrawn not due to AE|34|||
44248380|NCT01431287|79081475|FG003|Overall Study|Consent withdrawn not due to AE|19|||
44248381|NCT01431287|79081476|FG004|Overall Study|Consent withdrawn not due to AE|29|||
44248382|NCT01431287|79081472|FG000|Overall Study|not stated above|4|||
44248383|NCT01431287|79081473|FG001|Overall Study|not stated above|2|||
44248384|NCT01431287|79081474|FG002|Overall Study|not stated above|2|||
44248385|NCT01431287|79081475|FG003|Overall Study|not stated above|2|||
44248386|NCT01431287|79081476|FG004|Overall Study|not stated above|1|||
44248387|NCT01274715|79081522|FG000|Overall Study|Lost to Follow-up|1|||
44248388|NCT01274715|79081522|FG000|Overall Study|After consent, met exclusion criteria.|1|||
44248389|NCT01274715|79081522|FG000|Overall Study|After consent, met exclusion criteria.|1|||
44248390|NCT01274715|79081522|FG000|Overall Study|After consent, met exclusion criteria.|1|||
44248391|NCT01410227|79081526|FG000|Overall Study|Adverse Event|1|||
44248392|NCT01410227|79081527|FG001|Overall Study|Adverse Event|0|||
44248393|NCT01410227|79081528|FG002|Overall Study|Adverse Event|0|||
44248394|NCT01410227|79081529|FG003|Overall Study|Adverse Event|0|||
44248395|NCT01410227|79081526|FG000|Overall Study|Withdrawal by Subject|3|||
44248396|NCT01410227|79081527|FG001|Overall Study|Withdrawal by Subject|0|||
44248397|NCT01410227|79081528|FG002|Overall Study|Withdrawal by Subject|1|||
44248398|NCT01410227|79081529|FG003|Overall Study|Withdrawal by Subject|0|||
44248399|NCT01410227|79081526|FG000|Overall Study|Pregnancy|0|||
44248400|NCT01410227|79081527|FG001|Overall Study|Pregnancy|0|||
44248401|NCT01410227|79081528|FG002|Overall Study|Pregnancy|0|||
44248402|NCT01410227|79081529|FG003|Overall Study|Pregnancy|1|||
44248403|NCT01410227|79081526|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
44248404|NCT01410227|79081527|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
44248405|NCT01410227|79081528|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
44248406|NCT01410227|79081529|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
44248407|NCT01274559|79081541|FG000|Overall Study|Adverse Event|57|||
44248408|NCT01274559|79081542|FG001|Overall Study|Adverse Event|13|||
44248409|NCT01274559|79081541|FG000|Overall Study|Death|1|||
44248410|NCT01274559|79081542|FG001|Overall Study|Death|1|||
44248411|NCT01274559|79081541|FG000|Overall Study|Lost to Follow-up|3|||
44143525|NCT01602224|78932828|FG002|Overall Study|Investigator Decison|0|||
44143526|NCT01602224|78932826|FG000|Overall Study|Lost to Follow-up|0|||
44248412|NCT01274559|79081542|FG001|Overall Study|Lost to Follow-up|3|||
44248413|NCT01274559|79081541|FG000|Overall Study|Non-compliance with Study Drug|2|||
44248414|NCT01274559|79081542|FG001|Overall Study|Non-compliance with Study Drug|4|||
44248415|NCT01274559|79081541|FG000|Overall Study|Physician Decision|2|||
44248416|NCT01274559|79081542|FG001|Overall Study|Physician Decision|1|||
44248417|NCT01274559|79081541|FG000|Overall Study|Protocol Violation|28|||
44248418|NCT01274559|79081542|FG001|Overall Study|Protocol Violation|23|||
44248419|NCT01274559|79081541|FG000|Overall Study|Study Terminated by Sponsor|79|||
44143527|NCT01602224|78932827|FG001|Overall Study|Lost to Follow-up|0|||
44248420|NCT01274559|79081542|FG001|Overall Study|Study Terminated by Sponsor|87|||
44248421|NCT01274559|79081541|FG000|Overall Study|Withdrawal by Subject|25|||
44248422|NCT01274559|79081542|FG001|Overall Study|Withdrawal by Subject|13|||
44248423|NCT01409993|79081550|FG000|Overall Study|Adverse Event|4|||
44248424|NCT01409993|79081551|FG001|Overall Study|Adverse Event|4|||
44248425|NCT01409993|79081552|FG002|Overall Study|Adverse Event|3|||
44248426|NCT01409993|79081553|FG003|Overall Study|Adverse Event|1|||
44248427|NCT01409993|79081550|FG000|Overall Study|Withdrawal by Subject|0|||
44143528|NCT01602224|78932828|FG002|Overall Study|Lost to Follow-up|1|||
44248428|NCT01409993|79081551|FG001|Overall Study|Withdrawal by Subject|0|||
44248429|NCT01409993|79081552|FG002|Overall Study|Withdrawal by Subject|0|||
44248430|NCT01409993|79081553|FG003|Overall Study|Withdrawal by Subject|4|||
44248431|NCT01409993|79081550|FG000|Overall Study|Lost to Follow-up|0|||
44248432|NCT01409993|79081551|FG001|Overall Study|Lost to Follow-up|1|||
44248433|NCT01409993|79081552|FG002|Overall Study|Lost to Follow-up|0|||
44248434|NCT01409993|79081553|FG003|Overall Study|Lost to Follow-up|0|||
44248435|NCT01273623|79081567|FG000|Overall Study|did not meet IVUS criteria|29|||
44248436|NCT01409915|79081575|FG000|Overall Study|Adverse Event|0|||
44248437|NCT01409915|79081576|FG001|Overall Study|Adverse Event|2|||
44248438|NCT01409915|79081575|FG000|Overall Study|Withdrawal by Subject|0|||
44248439|NCT01409915|79081576|FG001|Overall Study|Withdrawal by Subject|1|||
44248440|NCT01409915|79081575|FG000|Overall Study|Protocol Violation|1|||
44248441|NCT01409915|79081576|FG001|Overall Study|Protocol Violation|0|||
44248442|NCT01272921|79081584|FG000|Overall Study|Protocol Violation|2|||
44248443|NCT01272921|79081585|FG001|Overall Study|Protocol Violation|1|||
44248444|NCT01409837|79081595|FG000|Overall Study|Withdrawal by Subject|2|||
44248445|NCT01409837|79081596|FG001|Overall Study|Withdrawal by Subject|1|||
44248446|NCT01409837|79081595|FG000|Overall Study|Lost to Follow-up|1|||
44248447|NCT01409837|79081596|FG001|Overall Study|Lost to Follow-up|0|||
44248448|NCT01409837|79081595|FG000|Overall Study|Physician Decision|0|||
44248449|NCT01409837|79081596|FG001|Overall Study|Physician Decision|1|||
44248450|NCT01430585|79081615|FG000|Overall Study|Death|1|||
44248451|NCT01430585|79081615|FG000|Overall Study|Objective Progression or Relapse|3|||
44248452|NCT01430585|79081615|FG000|Overall Study|Study Terminated by Sponsor|3|||
44248453|NCT01430585|79081615|FG000|Overall Study|Other|7|||
44248454|NCT01408901|79081638|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
44248455|NCT01408901|79081639|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
44248456|NCT01408901|79081640|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
44248457|NCT01408901|79081641|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
44248458|NCT01408901|79081638|FG000|6-Week Follow-Up|Death|1|||
44248459|NCT01408901|79081639|FG001|6-Week Follow-Up|Death|0|||
44248460|NCT01408901|79081640|FG002|6-Week Follow-Up|Death|0|||
44248461|NCT01408901|79081641|FG003|6-Week Follow-Up|Death|0|||
44248462|NCT01408901|79081638|FG000|6-Week Follow-Up|Cancelled visit|0|||
44248463|NCT01408901|79081639|FG001|6-Week Follow-Up|Cancelled visit|1|||
44248464|NCT01408901|79081640|FG002|6-Week Follow-Up|Cancelled visit|0|||
44248465|NCT01408901|79081641|FG003|6-Week Follow-Up|Cancelled visit|2|||
44248466|NCT01408901|79081638|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
44248467|NCT01408901|79081639|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
44248468|NCT01408901|79081640|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
44248469|NCT01408901|79081641|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
44248470|NCT01408901|79081638|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
44248471|NCT01408901|79081639|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
44248472|NCT01408901|79081640|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
44248473|NCT01408901|79081641|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
44248474|NCT01408901|79081638|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
44248475|NCT01408901|79081639|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
44248476|NCT01408901|79081640|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
44248477|NCT01408901|79081641|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
44248478|NCT01408901|79081638|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
44248479|NCT01408901|79081639|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
44248480|NCT01408901|79081640|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
44248481|NCT01408901|79081641|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
44248482|NCT01408901|79081638|FG000|26-Week Follow-Up|Death|0|||
44248483|NCT01408901|79081639|FG001|26-Week Follow-Up|Death|1|||
44248484|NCT01408901|79081640|FG002|26-Week Follow-Up|Death|0|||
44248485|NCT01408901|79081641|FG003|26-Week Follow-Up|Death|0|||
44248486|NCT01428713|79081657|FG000|Overall Study|Non-compliance|2|||
44248487|NCT01428713|79081658|FG001|Overall Study|Non-compliance|2|||
44248488|NCT01428713|79081657|FG000|Overall Study|Withdrawal by Subject|1|||
44248489|NCT01428713|79081658|FG001|Overall Study|Withdrawal by Subject|1|||
44248490|NCT01428713|79081657|FG000|Overall Study|Adverse Event|0|||
44248491|NCT01428713|79081658|FG001|Overall Study|Adverse Event|2|||
44248492|NCT01408277|79081666|FG000|Overall Study|Adverse Event|3|||
44381435|NCT01026818|79387582|FG000|Screening Period|Withdrawal by Subject|49|||
44514542|NCT03882970|79520322|FG002|Overall Study|Adverse Event|3|||
44248493|NCT01408277|79081667|FG001|Overall Study|Adverse Event|4|||
44248494|NCT01408277|79081666|FG000|Overall Study|Lost to Follow-up|1|||
44248495|NCT01408277|79081667|FG001|Overall Study|Lost to Follow-up|0|||
44248496|NCT01408277|79081666|FG000|Overall Study|Withdrawal by Subject|2|||
44248497|NCT01408277|79081667|FG001|Overall Study|Withdrawal by Subject|0|||
44248498|NCT01408277|79081666|FG000|Overall Study|Protocol Violation|2|||
44248499|NCT01408277|79081667|FG001|Overall Study|Protocol Violation|0|||
44248500|NCT01408043|79081673|FG000|Overall Study|unable to collect cells|1|||
44248501|NCT01524224|79081685|FG000|Overall Study|Progressive Disease|1|||
44248502|NCT01524224|79081686|FG001|Overall Study|Progressive Disease|0|||
44248503|NCT01524224|79081687|FG002|Overall Study|Progressive Disease|2|||
44248504|NCT01524224|79081688|FG003|Overall Study|Progressive Disease|1|||
44248505|NCT01524224|79081689|FG004|Overall Study|Progressive Disease|2|||
44248506|NCT01524224|79081690|FG005|Overall Study|Progressive Disease|1|||
44248507|NCT01524224|79081691|FG006|Overall Study|Progressive Disease|1|||
44248508|NCT01524224|79081692|FG007|Overall Study|Progressive Disease|5|||
44248509|NCT01524224|79081685|FG000|Overall Study|Withdrawal by Subject|2|||
44248510|NCT01524224|79081686|FG001|Overall Study|Withdrawal by Subject|0|||
44248511|NCT01524224|79081687|FG002|Overall Study|Withdrawal by Subject|0|||
44248512|NCT01524224|79081688|FG003|Overall Study|Withdrawal by Subject|0|||
44248513|NCT01524224|79081689|FG004|Overall Study|Withdrawal by Subject|0|||
44248514|NCT01524224|79081690|FG005|Overall Study|Withdrawal by Subject|0|||
44248515|NCT01524224|79081691|FG006|Overall Study|Withdrawal by Subject|2|||
44248516|NCT01524224|79081692|FG007|Overall Study|Withdrawal by Subject|0|||
44248517|NCT01524224|79081685|FG000|Overall Study|Adverse Event|0|||
44248518|NCT01524224|79081686|FG001|Overall Study|Adverse Event|1|||
44248519|NCT01524224|79081687|FG002|Overall Study|Adverse Event|0|||
44248520|NCT01524224|79081688|FG003|Overall Study|Adverse Event|0|||
44248521|NCT01524224|79081689|FG004|Overall Study|Adverse Event|0|||
44248522|NCT01524224|79081690|FG005|Overall Study|Adverse Event|1|||
44248523|NCT01524224|79081691|FG006|Overall Study|Adverse Event|0|||
44248524|NCT01524224|79081692|FG007|Overall Study|Adverse Event|0|||
44248525|NCT01524224|79081685|FG000|Overall Study|Physician Decision|0|||
44248526|NCT01524224|79081686|FG001|Overall Study|Physician Decision|0|||
44248527|NCT01524224|79081687|FG002|Overall Study|Physician Decision|0|||
44248528|NCT01524224|79081688|FG003|Overall Study|Physician Decision|1|||
44248529|NCT01524224|79081689|FG004|Overall Study|Physician Decision|1|||
44248530|NCT01524224|79081690|FG005|Overall Study|Physician Decision|0|||
44248531|NCT01524224|79081691|FG006|Overall Study|Physician Decision|0|||
44248532|NCT01524224|79081692|FG007|Overall Study|Physician Decision|1|||
44248533|NCT01524224|79081685|FG000|Overall Study|Sponsor Decision|0|||
44248534|NCT01524224|79081686|FG001|Overall Study|Sponsor Decision|0|||
44248535|NCT01524224|79081687|FG002|Overall Study|Sponsor Decision|0|||
44248536|NCT01524224|79081688|FG003|Overall Study|Sponsor Decision|0|||
44248537|NCT01524224|79081689|FG004|Overall Study|Sponsor Decision|1|||
44248538|NCT01524224|79081690|FG005|Overall Study|Sponsor Decision|0|||
44248539|NCT01524224|79081691|FG006|Overall Study|Sponsor Decision|0|||
44248540|NCT01524224|79081692|FG007|Overall Study|Sponsor Decision|0|||
44248541|NCT00219349|79081710|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
44248542|NCT00219349|79081710|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
44248543|NCT00219349|79081710|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
44248544|NCT00219349|79081710|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
44248545|NCT01523756|79081714|FG000|Baseline Period|Adverse Event|0|||
44248546|NCT01523756|79081715|FG001|Baseline Period|Adverse Event|1|||
44248547|NCT01523756|79081714|FG000|Test Period 1|Adverse Event|1|||
44248548|NCT01523756|79081715|FG001|Test Period 1|Adverse Event|0|||
44248549|NCT01523756|79081714|FG000|Test Period 2|Withdrawal by Subject|0|||
44248550|NCT01523756|79081715|FG001|Test Period 2|Withdrawal by Subject|1|||
44248551|NCT00218257|79081723|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
44248552|NCT00218257|79081724|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
44248553|NCT01523366|79081735|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44248554|NCT01523366|79081736|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44248555|NCT01523366|79081735|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
44248556|NCT01523366|79081736|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
44248557|NCT01427933|79081746|FG000|Overall Study|Withdrawal by Subject|5|||
44248558|NCT01427933|79081747|FG001|Overall Study|Withdrawal by Subject|8|||
44248559|NCT01427933|79081746|FG000|Overall Study|Lost to Follow-up|1|||
44248560|NCT01427933|79081747|FG001|Overall Study|Lost to Follow-up|5|||
44248561|NCT01427933|79081746|FG000|Overall Study|Other|1|||
44248562|NCT01427933|79081747|FG001|Overall Study|Other|0|||
44248563|NCT01427933|79081746|FG000|Overall Study|Investigator's Decision|1|||
44248564|NCT01427933|79081747|FG001|Overall Study|Investigator's Decision|0|||
44514543|NCT03882970|79520323|FG003|Overall Study|Adverse Event|1|||
44514544|NCT03882970|79520320|FG000|Overall Study|Death|1|||
44514545|NCT03882970|79520321|FG001|Overall Study|Death|2|||
44248565|NCT00217087|79081756|FG000|Overall Study|decided to have esophagectomy|1|||
44248566|NCT00217087|79081757|FG001|Overall Study|decided to have esophagectomy|2|||
44248567|NCT00217087|79081756|FG000|Overall Study|completed less than 12 months return|10|||
44514546|NCT03882970|79520322|FG002|Overall Study|Death|1|||
44514547|NCT03882970|79520323|FG003|Overall Study|Death|1|||
44248568|NCT00217087|79081757|FG001|Overall Study|completed less than 12 months return|18|||
44248569|NCT01406873|79081771|FG000|Overall Study|Withdrawal by Subject|1|||
44248570|NCT01406873|79081772|FG001|Overall Study|Withdrawal by Subject|1|||
44248571|NCT01406795|79081788|FG000|Overall Study|Withdrawal by Subject|1|||
44248572|NCT01406717|79081794|FG000|Overall Study|Subject non-compliance|4|||
44248573|NCT01406717|79081795|FG001|Overall Study|Subject non-compliance|3|||
44248574|NCT01406717|79081794|FG000|Overall Study|Protocol Violation|5|||
44248575|NCT01406717|79081795|FG001|Overall Study|Protocol Violation|1|||
44248576|NCT01406717|79081794|FG000|Overall Study|Lost to Follow-up|14|||
44514548|NCT03882970|79520320|FG000|Overall Study|Lost to Follow-up|8|||
44248577|NCT01406717|79081795|FG001|Overall Study|Lost to Follow-up|8|||
44248578|NCT01406717|79081794|FG000|Overall Study|Withdrawal by Subject|19|||
44248579|NCT01406717|79081795|FG001|Overall Study|Withdrawal by Subject|15|||
44248580|NCT01406717|79081794|FG000|Overall Study|Adverse Event|1|||
44248581|NCT01406717|79081795|FG001|Overall Study|Adverse Event|2|||
44248582|NCT01406717|79081794|FG000|Overall Study|Lack of Efficacy|0|||
44248583|NCT01406717|79081795|FG001|Overall Study|Lack of Efficacy|1|||
44248584|NCT01406717|79081794|FG000|Overall Study|Non-completion of visit activity|0|||
44248585|NCT01406717|79081795|FG001|Overall Study|Non-completion of visit activity|1|||
44248586|NCT01406015|79081813|FG000|Overall Study|Withdrawal by Subject|3|||
44248587|NCT01406015|79081814|FG001|Overall Study|Withdrawal by Subject|3|||
44248588|NCT00215683|79081823|FG000|Overall Study|Adverse Event|15|||
44248589|NCT00215683|79081824|FG001|Overall Study|Adverse Event|16|||
44248590|NCT00215683|79081825|FG002|Overall Study|Adverse Event|15|||
44514549|NCT03882970|79520321|FG001|Overall Study|Lost to Follow-up|9|||
44514550|NCT03882970|79520322|FG002|Overall Study|Lost to Follow-up|5|||
44248591|NCT00215683|79081823|FG000|Overall Study|Lack of Efficacy|5|||
44248592|NCT00215683|79081824|FG001|Overall Study|Lack of Efficacy|1|||
44248593|NCT00215683|79081825|FG002|Overall Study|Lack of Efficacy|2|||
44248594|NCT00215683|79081823|FG000|Overall Study|Lost to Follow-up|0|||
44248595|NCT00215683|79081824|FG001|Overall Study|Lost to Follow-up|2|||
44248596|NCT00215683|79081825|FG002|Overall Study|Lost to Follow-up|1|||
44248597|NCT00215683|79081823|FG000|Overall Study|Withdrawal by Subject|9|||
44248598|NCT00215683|79081824|FG001|Overall Study|Withdrawal by Subject|4|||
44514551|NCT03882970|79520323|FG003|Overall Study|Lost to Follow-up|5|||
44514552|NCT03882970|79520320|FG000|Overall Study|Physician Decision|0|||
44514553|NCT03882970|79520321|FG001|Overall Study|Physician Decision|2|||
44514554|NCT03882970|79520322|FG002|Overall Study|Physician Decision|2|||
44514555|NCT03882970|79520323|FG003|Overall Study|Physician Decision|2|||
44514556|NCT03882970|79520320|FG000|Overall Study|Protocol Violation|2|||
44514557|NCT03882970|79520321|FG001|Overall Study|Protocol Violation|0|||
44514558|NCT03882970|79520322|FG002|Overall Study|Protocol Violation|0|||
44514559|NCT03882970|79520323|FG003|Overall Study|Protocol Violation|0|||
44514560|NCT03882970|79520320|FG000|Overall Study|Withdrawal by Subject|8|||
44514561|NCT03882970|79520321|FG001|Overall Study|Withdrawal by Subject|17|||
44514562|NCT03882970|79520322|FG002|Overall Study|Withdrawal by Subject|7|||
44514563|NCT03882970|79520323|FG003|Overall Study|Withdrawal by Subject|22|||
44514564|NCT03882970|79520320|FG000|Overall Study|Personal Reason|2|||
44514565|NCT03882970|79520321|FG001|Overall Study|Personal Reason|3|||
44514566|NCT03882970|79520322|FG002|Overall Study|Personal Reason|1|||
44514567|NCT03882970|79520323|FG003|Overall Study|Personal Reason|3|||
44514568|NCT03730480|79520337|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
44514569|NCT03668808|79520342|FG000|First Intervention|Withdrawal by Subject|2|||
44514570|NCT03668808|79520343|FG001|First Intervention|Withdrawal by Subject|2|||
44514571|NCT02982954|79520355|FG000|Overall Study|Death|55|||
44514572|NCT02982954|79520356|FG001|Overall Study|Death|29|||
44514573|NCT02982954|79520357|FG002|Overall Study|Death|15|||
44514574|NCT02982954|79520358|FG003|Overall Study|Death|20|||
44514575|NCT02982954|79520355|FG000|Overall Study|Lost to Follow-up|2|||
44514576|NCT02982954|79520356|FG001|Overall Study|Lost to Follow-up|1|||
44514577|NCT02982954|79520357|FG002|Overall Study|Lost to Follow-up|0|||
44514578|NCT02982954|79520358|FG003|Overall Study|Lost to Follow-up|0|||
44514579|NCT02982954|79520355|FG000|Overall Study|Participant withdrew consent|7|||
44248599|NCT00215683|79081825|FG002|Overall Study|Withdrawal by Subject|13|||
44248600|NCT00215683|79081823|FG000|Overall Study|Physician Decision|0|||
44248601|NCT00215683|79081824|FG001|Overall Study|Physician Decision|0|||
44248602|NCT00215683|79081825|FG002|Overall Study|Physician Decision|1|||
44248603|NCT00215683|79081823|FG000|Overall Study|Difficult to attend visits|0|||
44248604|NCT00215683|79081824|FG001|Overall Study|Difficult to attend visits|1|||
44248605|NCT00215683|79081825|FG002|Overall Study|Difficult to attend visits|0|||
44248606|NCT00215683|79081823|FG000|Overall Study|No study drug available|0|||
44514580|NCT02982954|79520356|FG001|Overall Study|Participant withdrew consent|5|||
44514581|NCT02982954|79520357|FG002|Overall Study|Participant withdrew consent|1|||
44248607|NCT00215683|79081824|FG001|Overall Study|No study drug available|1|||
44248608|NCT00215683|79081825|FG002|Overall Study|No study drug available|0|||
44514582|NCT02982954|79520358|FG003|Overall Study|Participant withdrew consent|1|||
44514583|NCT02982954|79520355|FG000|Overall Study|Other reasons|42|||
44514584|NCT02982954|79520356|FG001|Overall Study|Other reasons|17|||
44143529|NCT01602224|78932826|FG000|Overall Study|Protocol Violation|0|||
44248609|NCT00215683|79081823|FG000|Overall Study|Intermittent therapy required|0|||
44514585|NCT02982954|79520357|FG002|Overall Study|Other reasons|12|||
44514586|NCT02982954|79520358|FG003|Overall Study|Other reasons|3|||
44514587|NCT02982954|79520355|FG000|Overall Study|Premature site closure|0|||
44514588|NCT02982954|79520356|FG001|Overall Study|Premature site closure|0|||
44514589|NCT02982954|79520357|FG002|Overall Study|Premature site closure|0|||
44248610|NCT00215683|79081824|FG001|Overall Study|Intermittent therapy required|1|||
44248611|NCT00215683|79081825|FG002|Overall Study|Intermittent therapy required|0|||
44248612|NCT00215137|79081833|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
44248613|NCT00215137|79081834|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
44248614|NCT00215137|79081835|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
44248615|NCT00215137|79081833|FG000|Randomization Period|Lost to Follow-up|0|||
44248616|NCT00215137|79081834|FG001|Randomization Period|Lost to Follow-up|1|||
44248617|NCT00215137|79081835|FG002|Randomization Period|Lost to Follow-up|0|||
44248618|NCT00215137|79081833|FG000|Randomization Period|Withdrawal by Subject|0|||
44248619|NCT00215137|79081834|FG001|Randomization Period|Withdrawal by Subject|1|||
44248620|NCT00215137|79081835|FG002|Randomization Period|Withdrawal by Subject|0|||
44248621|NCT00214201|79081845|FG000|Overall Study|Withdrawal by Subject|2|||
44248622|NCT00214201|79081846|FG001|Overall Study|Withdrawal by Subject|0|||
44248623|NCT00214201|79081845|FG000|Overall Study|Death|0|||
44248624|NCT00214201|79081846|FG001|Overall Study|Death|2|||
44248625|NCT01486784|79081859|FG000|Overall Study|Withdrawal by Subject|0|||
44248626|NCT01486784|79081860|FG001|Overall Study|Withdrawal by Subject|0|||
44248627|NCT01486784|79081861|FG002|Overall Study|Withdrawal by Subject|1|||
44248628|NCT01486784|79081862|FG003|Overall Study|Withdrawal by Subject|0|||
44248629|NCT01486784|79081863|FG004|Overall Study|Withdrawal by Subject|1|||
44248630|NCT01486784|79081864|FG005|Overall Study|Withdrawal by Subject|2|||
44248631|NCT01486784|79081859|FG000|Overall Study|Subject did not meet entry criteria|0|||
44248632|NCT01486784|79081860|FG001|Overall Study|Subject did not meet entry criteria|0|||
44248633|NCT01486784|79081861|FG002|Overall Study|Subject did not meet entry criteria|0|||
44248634|NCT01486784|79081862|FG003|Overall Study|Subject did not meet entry criteria|0|||
44248635|NCT01486784|79081863|FG004|Overall Study|Subject did not meet entry criteria|1|||
44248636|NCT01486784|79081864|FG005|Overall Study|Subject did not meet entry criteria|0|||
44248637|NCT01486784|79081859|FG000|Overall Study|Death|0|||
44248638|NCT01486784|79081860|FG001|Overall Study|Death|0|||
44248639|NCT01486784|79081861|FG002|Overall Study|Death|0|||
44248640|NCT01486784|79081862|FG003|Overall Study|Death|0|||
44248641|NCT01486784|79081863|FG004|Overall Study|Death|0|||
44248642|NCT01486784|79081864|FG005|Overall Study|Death|1|||
44248643|NCT01521884|79081878|FG000|Overall Study|Non Responders|10|||
44248644|NCT01521884|79081878|FG000|Overall Study|Adverse Event|5|||
44248645|NCT01521884|79081878|FG000|Overall Study|Pregnancy|1|||
44248646|NCT01521884|79081878|FG000|Overall Study|Withdrawal by Subject|1|||
44248647|NCT01521884|79081878|FG000|Overall Study|Physician Decision|2|||
44248648|NCT01521884|79081878|FG000|Overall Study|Protocol Violation|3|||
44248649|NCT01521884|79081878|FG000|Overall Study|Participant non-eligible|1|||
44248650|NCT01521884|79081878|FG000|Overall Study|Lost to Follow-up|4|||
44248651|NCT01677858|79081887|FG000|Overall Study|Adverse Event|0|||
44248652|NCT01677858|79081888|FG001|Overall Study|Adverse Event|0|||
44248653|NCT01677858|79081889|FG002|Overall Study|Adverse Event|2|||
44248654|NCT01677858|79081890|FG003|Overall Study|Adverse Event|3|||
44248655|NCT01677858|79081891|FG004|Overall Study|Adverse Event|13|||
44248656|NCT01677858|79081887|FG000|Overall Study|Death|0|||
44248657|NCT01677858|79081888|FG001|Overall Study|Death|0|||
44248658|NCT01677858|79081889|FG002|Overall Study|Death|0|||
44248659|NCT01677858|79081890|FG003|Overall Study|Death|0|||
44248660|NCT01677858|79081891|FG004|Overall Study|Death|1|||
44248661|NCT01677858|79081887|FG000|Overall Study|Physician Decision|1|||
44248662|NCT01677858|79081888|FG001|Overall Study|Physician Decision|0|||
44248663|NCT01677858|79081889|FG002|Overall Study|Physician Decision|2|||
44248664|NCT01677858|79081890|FG003|Overall Study|Physician Decision|0|||
44248665|NCT01677858|79081891|FG004|Overall Study|Physician Decision|12|||
44248666|NCT01677858|79081887|FG000|Overall Study|Progressive Disease|2|||
44248667|NCT01677858|79081888|FG001|Overall Study|Progressive Disease|1|||
44248668|NCT01677858|79081889|FG002|Overall Study|Progressive Disease|9|||
44248669|NCT01677858|79081890|FG003|Overall Study|Progressive Disease|3|||
44248670|NCT01677858|79081891|FG004|Overall Study|Progressive Disease|43|||
44248671|NCT01677858|79081887|FG000|Overall Study|Withdrawal by Subject|0|||
44248672|NCT01677858|79081888|FG001|Overall Study|Withdrawal by Subject|1|||
44248673|NCT01677858|79081889|FG002|Overall Study|Withdrawal by Subject|1|||
44248674|NCT01677858|79081890|FG003|Overall Study|Withdrawal by Subject|0|||
44248675|NCT01677858|79081891|FG004|Overall Study|Withdrawal by Subject|15|||
44248676|NCT01677858|79081887|FG000|Overall Study|Lost to Follow-up|0|||
44248677|NCT01677858|79081888|FG001|Overall Study|Lost to Follow-up|0|||
44248678|NCT01677858|79081889|FG002|Overall Study|Lost to Follow-up|0|||
44248679|NCT01677858|79081890|FG003|Overall Study|Lost to Follow-up|0|||
44248680|NCT01677858|79081891|FG004|Overall Study|Lost to Follow-up|1|||
44248681|NCT01486316|79081911|FG000|Overall Study|Device explanted with/without re-implant|3|||
44248682|NCT01486316|79081912|FG001|Overall Study|Device explanted with/without re-implant|2|||
44248683|NCT01486316|79081913|FG002|Overall Study|Device explanted with/without re-implant|0|||
44248684|NCT01486316|79081914|FG003|Overall Study|Device explanted with/without re-implant|2|||
44248685|NCT01486316|79081911|FG000|Overall Study|Not meeting eligibility criteria|0|||
44248686|NCT01486316|79081912|FG001|Overall Study|Not meeting eligibility criteria|0|||
44248687|NCT01486316|79081913|FG002|Overall Study|Not meeting eligibility criteria|1|||
44248688|NCT01486316|79081914|FG003|Overall Study|Not meeting eligibility criteria|0|||
44248689|NCT01486316|79081911|FG000|Overall Study|Withdrawal by Subject|1|||
44248690|NCT01486316|79081912|FG001|Overall Study|Withdrawal by Subject|0|||
44248691|NCT01486316|79081913|FG002|Overall Study|Withdrawal by Subject|3|||
44248692|NCT01486316|79081914|FG003|Overall Study|Withdrawal by Subject|0|||
44248693|NCT01486316|79081911|FG000|Overall Study|Physician Decision|0|||
44248694|NCT01486316|79081912|FG001|Overall Study|Physician Decision|0|||
44248695|NCT01486316|79081913|FG002|Overall Study|Physician Decision|1|||
44248696|NCT01486316|79081914|FG003|Overall Study|Physician Decision|0|||
44248697|NCT01486316|79081911|FG000|Overall Study|Death|0|||
44248698|NCT01486316|79081912|FG001|Overall Study|Death|1|||
44248699|NCT01486316|79081913|FG002|Overall Study|Death|0|||
44248700|NCT01486316|79081914|FG003|Overall Study|Death|0|||
44248701|NCT01486238|79081925|FG000|Overall Study|Death|0|||
44248702|NCT01486238|79081926|FG001|Overall Study|Death|2|||
44248703|NCT01486238|79081925|FG000|Overall Study|Withdrawal by Subject|2|||
44248704|NCT01486238|79081926|FG001|Overall Study|Withdrawal by Subject|1|||
44248705|NCT01486238|79081925|FG000|Overall Study|Lost to Follow-up|0|||
44248706|NCT01486238|79081926|FG001|Overall Study|Lost to Follow-up|3|||
44248707|NCT01602744|79081934|FG000|Overall Study|Death|17|||
44248708|NCT01602744|79081935|FG001|Overall Study|Death|15|||
44248709|NCT01602744|79081934|FG000|Overall Study|Lost to Follow-up|13|||
44248710|NCT01602744|79081935|FG001|Overall Study|Lost to Follow-up|8|||
44248711|NCT03598777|79081946|FG000|Overall Study|Study Terminated by Sponsor|3|||
44248712|NCT03598777|79081947|FG001|Overall Study|Study Terminated by Sponsor|0|||
44248713|NCT03598777|79081948|FG002|Overall Study|Study Terminated by Sponsor|0|||
44248714|NCT03598777|79081949|FG003|Overall Study|Study Terminated by Sponsor|0|||
44248715|NCT03598777|79081950|FG004|Overall Study|Study Terminated by Sponsor|15|||
44248716|NCT03598777|79081946|FG000|Overall Study|Withdrawal by Subject|1|||
44248717|NCT03598777|79081947|FG001|Overall Study|Withdrawal by Subject|1|||
44248718|NCT03598777|79081948|FG002|Overall Study|Withdrawal by Subject|0|||
44248719|NCT03598777|79081949|FG003|Overall Study|Withdrawal by Subject|0|||
44248720|NCT03598777|79081950|FG004|Overall Study|Withdrawal by Subject|0|||
44248721|NCT03598777|79081946|FG000|Overall Study|Adverse Event|1|||
44248722|NCT03598777|79081947|FG001|Overall Study|Adverse Event|0|||
44248723|NCT03598777|79081948|FG002|Overall Study|Adverse Event|0|||
44248724|NCT03598777|79081949|FG003|Overall Study|Adverse Event|0|||
44248725|NCT03598777|79081950|FG004|Overall Study|Adverse Event|0|||
44248726|NCT03598777|79081946|FG000|Overall Study|Lost to Follow-up|1|||
44248727|NCT03598777|79081947|FG001|Overall Study|Lost to Follow-up|0|||
44248728|NCT03598777|79081948|FG002|Overall Study|Lost to Follow-up|0|||
44248729|NCT03598777|79081949|FG003|Overall Study|Lost to Follow-up|0|||
44248730|NCT03598777|79081950|FG004|Overall Study|Lost to Follow-up|0|||
44248731|NCT04348591|79082005|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
44248732|NCT04348591|79082006|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
44248733|NCT04348591|79082005|FG000|Imaging Session (120 Min)|Physician Decision|0|||
44248734|NCT04348591|79082006|FG001|Imaging Session (120 Min)|Physician Decision|1|||
44248735|NCT04348591|79082005|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
44248736|NCT04348591|79082006|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
44248737|NCT04046250|79082025|FG000|Overall Study|Death|0|||
44248738|NCT04046250|79082026|FG001|Overall Study|Death|1|||
44248739|NCT04046250|79082025|FG000|Overall Study|Withdrawal by Subject|3|||
44248740|NCT04046250|79082026|FG001|Overall Study|Withdrawal by Subject|3|||
44248741|NCT03841526|79082034|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
44248742|NCT03841526|79082035|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
44248743|NCT03841526|79082036|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
44248744|NCT03841526|79082037|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
44248745|NCT03841526|79082038|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
44248746|NCT03841526|79082039|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
44248747|NCT03841526|79082034|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
44248748|NCT03841526|79082035|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
44248749|NCT03841526|79082036|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
44248750|NCT03841526|79082037|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
44248751|NCT03841526|79082038|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
44248752|NCT03841526|79082039|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
44248753|NCT03841526|79082034|FG000|Outpatient Phase Treatment|Physician Decision|0|||
44248754|NCT03841526|79082035|FG001|Outpatient Phase Treatment|Physician Decision|1|||
44248755|NCT03841526|79082036|FG002|Outpatient Phase Treatment|Physician Decision|0|||
44248756|NCT03841526|79082037|FG003|Outpatient Phase Treatment|Physician Decision|0|||
44248757|NCT03841526|79082038|FG004|Outpatient Phase Treatment|Physician Decision|0|||
44248758|NCT03841526|79082039|FG005|Outpatient Phase Treatment|Physician Decision|0|||
44248759|NCT03841526|79082034|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
44248760|NCT03841526|79082035|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
44248761|NCT03841526|79082036|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
44248762|NCT03841526|79082037|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
44248763|NCT03841526|79082038|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
44248764|NCT03841526|79082039|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
44248765|NCT03834506|79082062|FG000|Overall Study|Death|268|||
44248766|NCT03834506|79082063|FG001|Overall Study|Death|285|||
44248767|NCT03834506|79082062|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44248768|NCT03834506|79082063|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44248769|NCT03834506|79082062|FG000|Overall Study|Withdrawal by Subject|12|||
44248770|NCT03834506|79082063|FG001|Overall Study|Withdrawal by Subject|8|||
44248771|NCT03834506|79082062|FG000|Overall Study|Participants ongoing in the study|234|||
44248772|NCT03834506|79082063|FG001|Overall Study|Participants ongoing in the study|221|||
44248773|NCT03535740|79082069|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
44248774|NCT03535740|79082069|FG000|Overall Study|Death|34|||
44248775|NCT03535740|79082069|FG000|Overall Study|Lost to Follow-up|1|||
44248776|NCT03535740|79082069|FG000|Overall Study|Withdrawal by Subject|13|||
44248777|NCT03351049|79082080|FG000|Overall Study|Withdrawal|26|||
44248778|NCT03351049|79082081|FG001|Overall Study|Withdrawal|22|||
44248779|NCT03288506|79082102|FG000|Overall Study|Withdrawal by Subject|52|||
44248780|NCT03180684|79082110|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
44248781|NCT03180684|79082111|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
44248782|NCT03180684|79082110|FG000|Overall Study|Physician Decision|1|||
44248783|NCT03180684|79082111|FG001|Overall Study|Physician Decision|0|||
44248784|NCT03180684|79082110|FG000|Overall Study|Lost to Follow-up|1|||
44248785|NCT03180684|79082111|FG001|Overall Study|Lost to Follow-up|0|||
44248786|NCT03180684|79082110|FG000|Overall Study|Progressive Disease|1|||
44248787|NCT03180684|79082111|FG001|Overall Study|Progressive Disease|0|||
44248788|NCT02515227|79082159|FG000|Overall Study|Adverse Event|0|||
44248789|NCT02515227|79082160|FG001|Overall Study|Adverse Event|2|||
44248790|NCT02515227|79082159|FG000|Overall Study|Progressive disease|2|||
44248791|NCT02515227|79082160|FG001|Overall Study|Progressive disease|9|||
44248792|NCT02369458|79082170|FG000|Overall Study|Determined to be not eligible|1|||
44248793|NCT02369458|79082171|FG001|Overall Study|Determined to be not eligible|0|||
44248794|NCT00070499|79082215|FG000|Overall Study|Adverse Event|6|||
44248795|NCT00070499|79082216|FG001|Overall Study|Adverse Event|6|||
44248796|NCT00070499|79082217|FG002|Overall Study|Adverse Event|19|||
44248797|NCT00070499|79082218|FG003|Overall Study|Adverse Event|15|||
44248798|NCT00070499|79082215|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
44248799|NCT00070499|79082216|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
44248800|NCT00070499|79082217|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
44248801|NCT00070499|79082218|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
44248802|NCT00070499|79082215|FG000|Overall Study|Progression/relapse|4|||
44248803|NCT00070499|79082216|FG001|Overall Study|Progression/relapse|2|||
44248804|NCT00070499|79082217|FG002|Overall Study|Progression/relapse|1|||
44248805|NCT00070499|79082218|FG003|Overall Study|Progression/relapse|4|||
44248806|NCT00070499|79082215|FG000|Overall Study|Death|1|||
44248807|NCT00070499|79082216|FG001|Overall Study|Death|1|||
44248808|NCT00070499|79082217|FG002|Overall Study|Death|1|||
44248809|NCT00070499|79082218|FG003|Overall Study|Death|2|||
44248810|NCT00070499|79082215|FG000|Overall Study|Other - not protocol specified|7|||
44248811|NCT00070499|79082216|FG001|Overall Study|Other - not protocol specified|3|||
44248812|NCT00070499|79082217|FG002|Overall Study|Other - not protocol specified|12|||
44248813|NCT00070499|79082218|FG003|Overall Study|Other - not protocol specified|20|||
44248814|NCT00070499|79082215|FG000|Overall Study|Still on protocol treatment|10|||
44248815|NCT00070499|79082216|FG001|Overall Study|Still on protocol treatment|4|||
44248816|NCT00070499|79082217|FG002|Overall Study|Still on protocol treatment|79|||
44248817|NCT00070499|79082218|FG003|Overall Study|Still on protocol treatment|57|||
44248818|NCT00070499|79082215|FG000|Overall Study|Did not start treatment|1|||
44248819|NCT00070499|79082216|FG001|Overall Study|Did not start treatment|0|||
44248820|NCT00070499|79082217|FG002|Overall Study|Did not start treatment|0|||
44248821|NCT00070499|79082218|FG003|Overall Study|Did not start treatment|2|||
44248822|NCT00070499|79082215|FG000|Overall Study|Not eligible|2|||
44248823|NCT00070499|79082216|FG001|Overall Study|Not eligible|5|||
44248824|NCT00070499|79082217|FG002|Overall Study|Not eligible|3|||
44248825|NCT00070499|79082218|FG003|Overall Study|Not eligible|2|||
44248826|NCT00066573|79082238|FG000|Overall Study|Did not received protocol treatment|28|||
44248827|NCT00066573|79082239|FG001|Overall Study|Did not received protocol treatment|28|||
44248828|NCT03594955|79082245|FG000|Overall Study|Adverse Event|1|||
44248829|NCT03594955|79082245|FG000|Overall Study|Progressive disease|5|||
44143530|NCT01602224|78932827|FG001|Overall Study|Protocol Violation|1|||
44143531|NCT01602224|78932828|FG002|Overall Study|Protocol Violation|0|||
44248830|NCT03594955|79082245|FG000|Overall Study|Sponsor's decision|1|||
44248831|NCT01677624|79082273|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
44143532|NCT01602224|78932826|FG000|Overall Study|Sponsor Decision|2|||
44248832|NCT01272219|79082294|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
44248833|NCT01272219|79082295|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
44248834|NCT01272219|79082296|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
44248835|NCT01272219|79082297|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
44248836|NCT01272219|79082298|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
44248837|NCT01272219|79082299|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
44248838|NCT01272219|79082294|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
44248839|NCT01272219|79082295|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
44248840|NCT01272219|79082296|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
44248841|NCT01272219|79082297|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
44514590|NCT02982954|79520358|FG003|Overall Study|Premature site closure|1|||
44514591|NCT03724968|79520370|FG000|Overall Study|Insurance issues|0|||
44514592|NCT03724968|79520371|FG001|Overall Study|Insurance issues|1|||
44381436|NCT01026818|79387583|FG001|Screening Period|Withdrawal by Subject|0|||
44381437|NCT01026818|79387584|FG002|Screening Period|Withdrawal by Subject|0|||
44381438|NCT01026818|79387585|FG003|Screening Period|Withdrawal by Subject|0|||
44381439|NCT01026818|79387582|FG000|Screening Period|Protocol Deviation|3|||
44381440|NCT01026818|79387583|FG001|Screening Period|Protocol Deviation|0|||
44381441|NCT01026818|79387584|FG002|Screening Period|Protocol Deviation|0|||
44514593|NCT03724968|79520370|FG000|Overall Study|Study closed|0|||
44143533|NCT01602224|78932827|FG001|Overall Study|Sponsor Decision|3|||
44143534|NCT01602224|78932828|FG002|Overall Study|Sponsor Decision|2|||
44248842|NCT01272219|79082298|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
44514594|NCT03724968|79520371|FG001|Overall Study|Study closed|1|||
44514595|NCT03724812|79520377|FG000|Overall Study|Missed Visit|1|||
44514596|NCT03724812|79520377|FG000|Overall Study|Death|2|||
44514597|NCT03724812|79520377|FG000|Overall Study|Withdrawal by Subject|1|||
44514598|NCT03722784|79520384|FG000|Overall Study|Withdrawal by Subject|1|||
44514599|NCT03722784|79520385|FG001|Overall Study|Withdrawal by Subject|0|||
44514600|NCT03722784|79520384|FG000|Overall Study|Physician Decision|1|||
44514601|NCT03722784|79520385|FG001|Overall Study|Physician Decision|1|||
44248843|NCT01272219|79082299|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
44248844|NCT01272219|79082294|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
44248845|NCT01272219|79082295|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
44248846|NCT01272219|79082296|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
44248847|NCT01272219|79082297|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
44248848|NCT01272219|79082298|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
44248849|NCT01272219|79082299|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
44248850|NCT01272219|79082294|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
44248851|NCT01272219|79082295|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
44248852|NCT01272219|79082296|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
44248853|NCT01272219|79082297|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
44248854|NCT01272219|79082298|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
44248855|NCT01272219|79082299|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
44248856|NCT01272219|79082294|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
44248857|NCT01272219|79082295|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
44248858|NCT01272219|79082296|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
44248859|NCT01272219|79082297|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
44248860|NCT01272219|79082298|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
44248861|NCT01272219|79082299|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
44248862|NCT01272219|79082294|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
44248863|NCT01272219|79082295|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
44248864|NCT01272219|79082296|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
44248865|NCT01272219|79082297|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
44248866|NCT01272219|79082298|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
44248867|NCT01272219|79082299|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
44248868|NCT01272219|79082294|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
44248869|NCT01272219|79082295|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
44248870|NCT01272219|79082296|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
44248871|NCT01272219|79082297|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
44248872|NCT01272219|79082298|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
44248873|NCT01272219|79082299|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
44248874|NCT01272219|79082294|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
44248875|NCT01272219|79082295|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
44248876|NCT01272219|79082296|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
44277031|NCT02132754|79237795|FG021|Overall Study|Transferred to Extension Study|0|||
44277032|NCT02132754|79237796|FG022|Overall Study|Transferred to Extension Study|0|||
44514602|NCT03722784|79520384|FG000|Overall Study|Protocol Violation|0|||
44143535|NCT01602224|78932826|FG000|Overall Study|Withdrawal by Subject|5|||
44277033|NCT02132754|79237797|FG023|Overall Study|Transferred to Extension Study|0|||
44143536|NCT01602224|78932827|FG001|Overall Study|Withdrawal by Subject|3|||
44143537|NCT01602224|78932828|FG002|Overall Study|Withdrawal by Subject|3|||
44277034|NCT02132754|79237798|FG024|Overall Study|Transferred to Extension Study|0|||
44381442|NCT01026818|79387585|FG003|Screening Period|Protocol Deviation|0|||
44381443|NCT01026818|79387582|FG000|Screening Period|Adverse Event|2|||
44381444|NCT01026818|79387583|FG001|Screening Period|Adverse Event|0|||
44514603|NCT03722784|79520385|FG001|Overall Study|Protocol Violation|1|||
44514604|NCT03722238|79520394|FG000|Overall Study|Protocol Violation|1|||
44514605|NCT03722238|79520395|FG001|Overall Study|Protocol Violation|0|||
44248877|NCT01272219|79082297|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
44248878|NCT01272219|79082298|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
44248879|NCT01272219|79082299|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
44248880|NCT01272219|79082294|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
44248881|NCT01272219|79082295|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
44248882|NCT01272219|79082296|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
44248883|NCT01272219|79082297|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
44248884|NCT01272219|79082298|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
44248885|NCT01272219|79082299|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
44248886|NCT01272219|79082294|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
44248887|NCT01272219|79082295|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
44248888|NCT01272219|79082296|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
44248889|NCT01272219|79082297|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
44248890|NCT01272219|79082298|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
44248891|NCT01272219|79082299|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
44248892|NCT01272219|79082294|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
44248893|NCT01272219|79082295|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
44248894|NCT01272219|79082296|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
44248895|NCT01272219|79082297|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
44248896|NCT01272219|79082298|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
44248897|NCT01272219|79082299|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
44248898|NCT01272219|79082294|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
44248899|NCT01272219|79082295|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
44248900|NCT01272219|79082296|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
44248901|NCT01272219|79082297|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
44248902|NCT01272219|79082298|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
44248903|NCT01272219|79082299|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
44248904|NCT01272219|79082294|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
44248905|NCT01272219|79082295|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
44248906|NCT01272219|79082296|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
44248907|NCT01272219|79082297|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
44248908|NCT01272219|79082298|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
44248909|NCT01272219|79082299|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
44248910|NCT01272219|79082294|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
44248911|NCT01272219|79082295|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
44248912|NCT01272219|79082296|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
44248913|NCT01272219|79082297|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
44248914|NCT01272219|79082298|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
44248915|NCT01272219|79082299|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
44248916|NCT01272219|79082294|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
44248917|NCT01272219|79082295|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
44248918|NCT01272219|79082296|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
44248919|NCT01272219|79082297|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
44248920|NCT01272219|79082298|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
44248921|NCT01272219|79082299|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
44248922|NCT01272219|79082294|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
44248923|NCT01272219|79082295|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
44248924|NCT01272219|79082296|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
44248925|NCT01272219|79082297|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
44248926|NCT01272219|79082298|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
44248927|NCT01272219|79082299|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
44248928|NCT01510028|79082316|FG000|Overall Study|Lack of Efficacy|1|||
44248929|NCT01510028|79082317|FG001|Overall Study|Lack of Efficacy|0|||
44248930|NCT01510028|79082318|FG002|Overall Study|Lack of Efficacy|0|||
44248931|NCT01510028|79082319|FG003|Overall Study|Lack of Efficacy|0|||
44381445|NCT01026818|79387584|FG002|Screening Period|Adverse Event|0|||
44381446|NCT01026818|79387585|FG003|Screening Period|Adverse Event|0|||
44248932|NCT01521494|79082340|FG000|Overall Study|Adverse Event|1|||
44248933|NCT01521494|79082341|FG001|Overall Study|Adverse Event|2|||
44248934|NCT01521494|79082342|FG002|Overall Study|Adverse Event|9|||
44248935|NCT01521494|79082343|FG003|Overall Study|Adverse Event|6|||
44248936|NCT01521494|79082344|FG004|Overall Study|Adverse Event|2|||
44248937|NCT01521494|79082340|FG000|Overall Study|Lack of Efficacy|0|||
44248938|NCT01521494|79082341|FG001|Overall Study|Lack of Efficacy|0|||
44248939|NCT01521494|79082342|FG002|Overall Study|Lack of Efficacy|0|||
44248940|NCT01521494|79082343|FG003|Overall Study|Lack of Efficacy|0|||
44248941|NCT01521494|79082344|FG004|Overall Study|Lack of Efficacy|2|||
44248942|NCT01521494|79082340|FG000|Overall Study|Withdrawal by Subject|1|||
44248943|NCT01521494|79082341|FG001|Overall Study|Withdrawal by Subject|1|||
44248944|NCT01521494|79082342|FG002|Overall Study|Withdrawal by Subject|0|||
44248945|NCT01521494|79082343|FG003|Overall Study|Withdrawal by Subject|2|||
44248946|NCT01521494|79082344|FG004|Overall Study|Withdrawal by Subject|0|||
44248947|NCT01521494|79082340|FG000|Overall Study|Decrease in serum phosphate|0|||
44248948|NCT01521494|79082341|FG001|Overall Study|Decrease in serum phosphate|2|||
44248949|NCT01521494|79082342|FG002|Overall Study|Decrease in serum phosphate|3|||
44248950|NCT01521494|79082343|FG003|Overall Study|Decrease in serum phosphate|12|||
44248951|NCT01521494|79082344|FG004|Overall Study|Decrease in serum phosphate|0|||
44248952|NCT01521494|79082340|FG000|Overall Study|Decrease in serum calcium|0|||
44248953|NCT01521494|79082341|FG001|Overall Study|Decrease in serum calcium|0|||
44248954|NCT01521494|79082342|FG002|Overall Study|Decrease in serum calcium|0|||
44248955|NCT01521494|79082343|FG003|Overall Study|Decrease in serum calcium|1|||
44248956|NCT01521494|79082344|FG004|Overall Study|Decrease in serum calcium|1|||
44248957|NCT01521494|79082340|FG000|Overall Study|Physician Decision|0|||
44248958|NCT01521494|79082341|FG001|Overall Study|Physician Decision|0|||
44248959|NCT01521494|79082342|FG002|Overall Study|Physician Decision|0|||
44248960|NCT01521494|79082343|FG003|Overall Study|Physician Decision|0|||
44248961|NCT01521494|79082344|FG004|Overall Study|Physician Decision|2|||
44248962|NCT01270971|79082358|FG000|Overall Study|Withdrawal by Subject|24|||
44248963|NCT01270971|79082359|FG001|Overall Study|Withdrawal by Subject|11|||
44248964|NCT01270971|79082358|FG000|Overall Study|Lost to Follow-up|18|||
44248965|NCT01270971|79082359|FG001|Overall Study|Lost to Follow-up|5|||
44248966|NCT01270971|79082358|FG000|Overall Study|Adverse Event|1|||
44248967|NCT01270971|79082359|FG001|Overall Study|Adverse Event|2|||
44248968|NCT01270971|79082358|FG000|Overall Study|Non compliance|2|||
44248969|NCT01270971|79082359|FG001|Overall Study|Non compliance|2|||
44248970|NCT01270971|79082358|FG000|Overall Study|Non-specific|7|||
44248971|NCT01270971|79082359|FG001|Overall Study|Non-specific|3|||
44248972|NCT01270503|79082386|FG000|Overall Study|Lost to Follow-up|1|||
44248973|NCT01277211|79082403|FG000|Overall Study|Adverse Event|60|||
44248974|NCT01277211|79082404|FG001|Overall Study|Adverse Event|22|||
44248975|NCT01277211|79082403|FG000|Overall Study|Pregnancy|9|||
44248976|NCT01277211|79082404|FG001|Overall Study|Pregnancy|4|||
44248977|NCT01277211|79082403|FG000|Overall Study|Lost to Follow-up|14|||
44248978|NCT01277211|79082404|FG001|Overall Study|Lost to Follow-up|9|||
44248979|NCT01277211|79082403|FG000|Overall Study|Did not wish to continue|17|||
44248980|NCT01277211|79082404|FG001|Overall Study|Did not wish to continue|0|||
44248981|NCT01277211|79082403|FG000|Overall Study|Withdrew Consent|9|||
44248982|NCT01277211|79082404|FG001|Overall Study|Withdrew Consent|9|||
44248983|NCT01277211|79082403|FG000|Overall Study|Non-compliance with protocol|13|||
44248984|NCT01277211|79082404|FG001|Overall Study|Non-compliance with protocol|4|||
44248985|NCT01277211|79082403|FG000|Overall Study|Did not meet protocol eligibility|1|||
44248986|NCT01277211|79082404|FG001|Overall Study|Did not meet protocol eligibility|0|||
44248987|NCT01277211|79082403|FG000|Overall Study|Administrative|3|||
44248988|NCT01277211|79082404|FG001|Overall Study|Administrative|0|||
44248989|NCT01277211|79082403|FG000|Overall Study|Pregnancy wish|0|||
44248990|NCT01277211|79082404|FG001|Overall Study|Pregnancy wish|2|||
44248991|NCT01277211|79082403|FG000|Overall Study|Discontinued prior to treatment|24|||
44248992|NCT01277211|79082404|FG001|Overall Study|Discontinued prior to treatment|13|||
44248993|NCT01676220|79082412|FG000|Overall Study|Randomized But Not Treated|4|||
44248994|NCT01676220|79082413|FG001|Overall Study|Randomized But Not Treated|1|||
44277035|NCT02132754|79237799|FG025|Overall Study|Transferred to Extension Study|0|||
44277036|NCT02132754|79237800|FG026|Overall Study|Transferred to Extension Study|0|||
44248995|NCT01676220|79082412|FG000|Overall Study|Adverse Event|10|||
44248996|NCT01676220|79082413|FG001|Overall Study|Adverse Event|8|||
44248997|NCT01676220|79082412|FG000|Overall Study|Lack of Efficacy|2|||
44248998|NCT01676220|79082413|FG001|Overall Study|Lack of Efficacy|5|||
44277037|NCT02132754|79237801|FG027|Overall Study|Transferred to Extension Study|0|||
44143538|NCT04498247|78932846|FG000|Overall Study|Lost to Follow-up|0|||
44248999|NCT01676220|79082412|FG000|Overall Study|Protocol Violation|11|||
44249000|NCT01676220|79082413|FG001|Overall Study|Protocol Violation|12|||
44277038|NCT02132754|79237802|FG028|Overall Study|Transferred to Extension Study|0|||
44249001|NCT01676220|79082412|FG000|Overall Study|Received Rescue Therapy|14|||
44249002|NCT01676220|79082413|FG001|Overall Study|Received Rescue Therapy|22|||
44249003|NCT01676220|79082412|FG000|Overall Study|Personal Reason|34|||
44249004|NCT01676220|79082413|FG001|Overall Study|Personal Reason|45|||
44249005|NCT01676220|79082412|FG000|Overall Study|Lost to Follow-up|11|||
44249006|NCT01676220|79082413|FG001|Overall Study|Lost to Follow-up|18|||
44249007|NCT01676220|79082412|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
44249008|NCT01676220|79082413|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
44249009|NCT01676220|79082412|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
44249010|NCT01676220|79082413|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
44249011|NCT01676220|79082412|FG000|Overall Study|Perceived Lack of Efficacy|3|||
44249012|NCT01676220|79082413|FG001|Overall Study|Perceived Lack of Efficacy|1|||
44249013|NCT01676220|79082412|FG000|Overall Study|Non Serious Hypoglycemia|2|||
44249014|NCT01676220|79082413|FG001|Overall Study|Non Serious Hypoglycemia|0|||
44249015|NCT01676220|79082412|FG000|Overall Study|No More Need of Insulin|1|||
44249016|NCT01676220|79082413|FG001|Overall Study|No More Need of Insulin|0|||
44249017|NCT04007094|79082439|FG000|Overall Study|Lost to Follow-up|1|||
44249018|NCT04007094|79082440|FG001|Overall Study|Lost to Follow-up|1|||
44249019|NCT01485614|79082461|FG000|Randomization|Not Treated|1|||
44249020|NCT01485614|79082462|FG001|Randomization|Not Treated|0|||
44249021|NCT01485614|79082463|FG002|Randomization|Not Treated|0|||
44249022|NCT01485614|79082464|FG003|Randomization|Not Treated|0|||
44249023|NCT01485614|79082461|FG000|Weeks 0-20|Lost to Follow-up|2|||
44249024|NCT01485614|79082462|FG001|Weeks 0-20|Lost to Follow-up|0|||
44249025|NCT01485614|79082463|FG002|Weeks 0-20|Lost to Follow-up|0|||
44249026|NCT01485614|79082464|FG003|Weeks 0-20|Lost to Follow-up|0|||
44277039|NCT02132754|79237803|FG029|Overall Study|Transferred to Extension Study|0|||
44277040|NCT02132754|79237804|FG030|Overall Study|Transferred to Extension Study|0|||
44277041|NCT02132754|79237805|FG031|Overall Study|Transferred to Extension Study|0|||
44277042|NCT02132754|79237806|FG032|Overall Study|Transferred to Extension Study|0|||
44277043|NCT02132754|79237807|FG033|Overall Study|Transferred to Extension Study|6|||
44277044|NCT02132754|79237774|FG000|Overall Study|Withdrawal by Subject|0|||
44277045|NCT02132754|79237775|FG001|Overall Study|Withdrawal by Subject|0|||
44277046|NCT02132754|79237776|FG002|Overall Study|Withdrawal by Subject|0|||
44277047|NCT02132754|79237777|FG003|Overall Study|Withdrawal by Subject|0|||
44277048|NCT02132754|79237778|FG004|Overall Study|Withdrawal by Subject|0|||
44277049|NCT02132754|79237779|FG005|Overall Study|Withdrawal by Subject|0|||
44277050|NCT02132754|79237780|FG006|Overall Study|Withdrawal by Subject|0|||
44277051|NCT02132754|79237781|FG007|Overall Study|Withdrawal by Subject|0|||
44381447|NCT01026818|79387582|FG000|Screening Period|Physician Decision|1|||
44249027|NCT01485614|79082461|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
44249028|NCT01485614|79082462|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
44249029|NCT01485614|79082463|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
44249030|NCT01485614|79082464|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
44249031|NCT01485614|79082461|FG000|Weeks 0-20|Withdrawal by Subject|3|||
44381448|NCT01026818|79387583|FG001|Screening Period|Physician Decision|0|||
44277052|NCT02132754|79237782|FG008|Overall Study|Withdrawal by Subject|0|||
44249032|NCT01485614|79082462|FG001|Weeks 0-20|Withdrawal by Subject|2|||
44249033|NCT01485614|79082463|FG002|Weeks 0-20|Withdrawal by Subject|1|||
44249034|NCT01485614|79082464|FG003|Weeks 0-20|Withdrawal by Subject|0|||
44249035|NCT01485614|79082461|FG000|Weeks 20-54|Lost to Follow-up|4|||
44249036|NCT01485614|79082462|FG001|Weeks 20-54|Lost to Follow-up|3|||
44249037|NCT01485614|79082463|FG002|Weeks 20-54|Lost to Follow-up|1|||
44249038|NCT01485614|79082464|FG003|Weeks 20-54|Lost to Follow-up|0|||
44249039|NCT01485614|79082461|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
44249040|NCT01485614|79082462|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
44249041|NCT01485614|79082463|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
44249042|NCT01485614|79082464|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
44249043|NCT01485614|79082461|FG000|Weeks 20-54|Withdrawal by Subject|5|||
44249044|NCT01485614|79082462|FG001|Weeks 20-54|Withdrawal by Subject|3|||
44249045|NCT01485614|79082463|FG002|Weeks 20-54|Withdrawal by Subject|0|||
44249046|NCT01485614|79082464|FG003|Weeks 20-54|Withdrawal by Subject|0|||
44249047|NCT01485536|79082514|FG000|Overall Study|Withdrawal by Subject|3|||
44249048|NCT01485536|79082514|FG000|Overall Study|Adverse Event|1|||
44249049|NCT02658630|79082518|FG000|Overall Study|Withdrawal by Subject|4|||
44249050|NCT01484912|79082524|FG000|Overall Study|Withdrawal by Subject|1|||
44249051|NCT01484912|79082525|FG001|Overall Study|Withdrawal by Subject|0|||
44249052|NCT01484912|79082524|FG000|Overall Study|Physician Decision|0|||
44249053|NCT01484912|79082525|FG001|Overall Study|Physician Decision|1|||
44249054|NCT01520870|79082531|FG000|Overall Study|Withdrawal by Subject|2|||
44249055|NCT01520714|79082537|FG000|Overall Study|Protocol Violation|0|||
44249056|NCT01520714|79082538|FG001|Overall Study|Protocol Violation|3|||
44249057|NCT01520714|79082537|FG000|Overall Study|Adverse Event|0|||
44249058|NCT01520714|79082538|FG001|Overall Study|Adverse Event|2|||
44249059|NCT01520714|79082537|FG000|Overall Study|Lack of Efficacy|0|||
44249060|NCT01520714|79082538|FG001|Overall Study|Lack of Efficacy|1|||
44249061|NCT02659098|79082557|FG000|Overall Study|Withdrawal by Subject|7|||
44249062|NCT01508936|79082568|FG000|Overall Study|Adverse Event|11|||
44249063|NCT01508936|79082569|FG001|Overall Study|Adverse Event|32|||
44249064|NCT01508936|79082568|FG000|Overall Study|Lack of Efficacy|0|||
44249065|NCT01508936|79082569|FG001|Overall Study|Lack of Efficacy|1|||
44249066|NCT01508936|79082568|FG000|Overall Study|Withdrawal by Subject|4|||
44249067|NCT01508936|79082569|FG001|Overall Study|Withdrawal by Subject|18|||
44249068|NCT01508936|79082568|FG000|Overall Study|Protocol Violation|2|||
44249069|NCT01508936|79082569|FG001|Overall Study|Protocol Violation|3|||
44249070|NCT01508936|79082568|FG000|Overall Study|Lost to Follow-up|2|||
44249071|NCT01508936|79082569|FG001|Overall Study|Lost to Follow-up|9|||
44249072|NCT01508936|79082568|FG000|Overall Study|Other|0|||
44249073|NCT01508936|79082569|FG001|Overall Study|Other|5|||
44143539|NCT04498247|78932847|FG001|Overall Study|Lost to Follow-up|0|||
44143540|NCT04498247|78932848|FG002|Overall Study|Lost to Follow-up|0|||
44143541|NCT04498247|78932849|FG003|Overall Study|Lost to Follow-up|1|||
44143542|NCT04498247|78932850|FG004|Overall Study|Lost to Follow-up|0|||
44143543|NCT04498247|78932851|FG005|Overall Study|Lost to Follow-up|0|||
44143544|NCT04498247|78932852|FG006|Overall Study|Lost to Follow-up|0|||
44143545|NCT04498247|78932853|FG007|Overall Study|Lost to Follow-up|0|||
44143546|NCT04498247|78932846|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
44143547|NCT04498247|78932847|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
44143548|NCT04498247|78932848|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
44143549|NCT04498247|78932849|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
44143550|NCT04498247|78932850|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
44249074|NCT01508936|79082568|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
44249075|NCT01508936|79082569|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
44249076|NCT01508702|79082590|FG000|Overall Study|Adverse Event|7|||
44249077|NCT01508702|79082591|FG001|Overall Study|Adverse Event|3|||
44249078|NCT01508702|79082590|FG000|Overall Study|Gout flare|2|||
44249079|NCT01508702|79082591|FG001|Overall Study|Gout flare|0|||
44249080|NCT01508702|79082590|FG000|Overall Study|Protocol Violation|2|||
44249081|NCT01508702|79082591|FG001|Overall Study|Protocol Violation|1|||
44143551|NCT04498247|78932851|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
44143552|NCT04498247|78932852|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
44143553|NCT04498247|78932853|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
44143554|NCT04498247|78932846|FG000|Overall Study|Withdrawal by Subject|0|||
44143555|NCT04498247|78932847|FG001|Overall Study|Withdrawal by Subject|8|||
44143556|NCT04498247|78932848|FG002|Overall Study|Withdrawal by Subject|0|||
44143557|NCT04498247|78932849|FG003|Overall Study|Withdrawal by Subject|7|||
44143558|NCT04498247|78932850|FG004|Overall Study|Withdrawal by Subject|0|||
44143559|NCT04498247|78932851|FG005|Overall Study|Withdrawal by Subject|0|||
44143560|NCT04498247|78932852|FG006|Overall Study|Withdrawal by Subject|1|||
44143561|NCT04498247|78932853|FG007|Overall Study|Withdrawal by Subject|0|||
44143562|NCT04498247|78932846|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
44143563|NCT04498247|78932847|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
44143564|NCT04498247|78932848|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
44514606|NCT03722238|79520394|FG000|Overall Study|Physician Decision|1|||
44514607|NCT03722238|79520395|FG001|Overall Study|Physician Decision|0|||
44249082|NCT01508702|79082590|FG000|Overall Study|Lost to Follow-up|1|||
44249083|NCT01508702|79082591|FG001|Overall Study|Lost to Follow-up|2|||
44249084|NCT01508702|79082590|FG000|Overall Study|Withdrawal by Subject|11|||
44249085|NCT01508702|79082591|FG001|Overall Study|Withdrawal by Subject|7|||
44249086|NCT01484834|79082605|FG000|Overall Study|Lost to Follow-up|5|||
44249087|NCT01484834|79082606|FG001|Overall Study|Lost to Follow-up|8|||
44249088|NCT01484834|79082607|FG002|Overall Study|Lost to Follow-up|1|||
44249089|NCT01484834|79082608|FG003|Overall Study|Lost to Follow-up|4|||
44249090|NCT01484132|79082618|FG000|Overall Study|Lost to Follow-up|8|||
44249091|NCT01484132|79082618|FG000|Overall Study|Difficulty with time commitment|2|||
44249092|NCT01484132|79082618|FG000|Overall Study|Ineligible|1|||
44249093|NCT01484132|79082618|FG000|Overall Study|No pre-treatment urine sample collected|1|||
44249094|NCT01484132|79082618|FG000|Overall Study|No post-treatment urine sample collected|10|||
44249095|NCT01276041|79082622|FG000|Overall Study|Adverse Event|2|||
44249096|NCT01276041|79082622|FG000|Overall Study|Protocol Violation|1|||
44249097|NCT01275339|79082630|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
44143565|NCT04498247|78932849|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
44143566|NCT04498247|78932850|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
44143567|NCT04498247|78932851|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
44249098|NCT01275339|79082631|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
44249099|NCT01275339|79082632|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
44249100|NCT01275339|79082633|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
44381449|NCT01026818|79387584|FG002|Screening Period|Physician Decision|0|||
44381450|NCT01026818|79387585|FG003|Screening Period|Physician Decision|0|||
44514608|NCT03722238|79520394|FG000|Overall Study|Death|1|||
44514609|NCT03722238|79520395|FG001|Overall Study|Death|0|||
44514610|NCT03722238|79520394|FG000|Overall Study|Lost to Follow-up|6|||
44514611|NCT03722238|79520395|FG001|Overall Study|Lost to Follow-up|0|||
44514612|NCT03722238|79520394|FG000|Overall Study|Partial missing data|44|||
44514613|NCT03722238|79520395|FG001|Overall Study|Partial missing data|1|||
44514614|NCT03722238|79520394|FG000|Overall Study|Withdrawal by Subject|2|||
44514615|NCT03722238|79520395|FG001|Overall Study|Withdrawal by Subject|0|||
44143568|NCT04498247|78932852|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
44249101|NCT01275339|79082630|FG000|Overall Study|Withdrawal by Subject|0|||
44249102|NCT01275339|79082631|FG001|Overall Study|Withdrawal by Subject|0|||
44381451|NCT01026818|79387582|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
44514616|NCT03722238|79520394|FG000|Overall Study|Other|4|||
44514617|NCT03722238|79520395|FG001|Overall Study|Other|0|||
44249103|NCT01275339|79082632|FG002|Overall Study|Withdrawal by Subject|1|||
44249104|NCT01275339|79082633|FG003|Overall Study|Withdrawal by Subject|0|||
44249105|NCT01520402|79082643|FG000|Overall Study|Withdrawal by Subject|2|||
44249106|NCT01520402|79082643|FG000|Overall Study|Physician Decision|3|||
44249107|NCT01520324|79082658|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
44249108|NCT01519934|79082662|FG000|Overall Study|Lost to Follow-up|3|||
44249109|NCT01484054|79082666|FG000|Period 1|Withdrawal by Subject|0|||
44249110|NCT01484054|79082667|FG001|Period 1|Withdrawal by Subject|1|||
44249111|NCT01507298|79082685|FG000|Overall Study|Protocol Violation|0|||
44249112|NCT01507298|79082686|FG001|Overall Study|Protocol Violation|6|||
44249113|NCT01483118|79082695|FG000|Overall Study|Lost to Follow-up|12|||
44249114|NCT01483118|79082696|FG001|Overall Study|Lost to Follow-up|16|||
44249115|NCT01506908|79082706|FG000|Overall Study|Adverse Event|1|||
44249116|NCT01506908|79082707|FG001|Overall Study|Adverse Event|0|||
44249117|NCT01519778|79082715|FG000|Overall Study|Withdrawal by Subject|3|||
44249118|NCT01519778|79082715|FG000|Overall Study|Lost to Follow-up|10|||
44249119|NCT01519778|79082715|FG000|Overall Study|Physician Decision|1|||
44249120|NCT01519700|79082723|FG000|Overall Study|Death|1|||
44249121|NCT01519700|79082724|FG001|Overall Study|Death|0|||
44249122|NCT01519700|79082725|FG002|Overall Study|Death|0|||
44249123|NCT01519700|79082726|FG003|Overall Study|Death|0|||
44249124|NCT01519700|79082723|FG000|Overall Study|Lost to Follow-up|0|||
44249125|NCT01519700|79082724|FG001|Overall Study|Lost to Follow-up|0|||
44249126|NCT01519700|79082725|FG002|Overall Study|Lost to Follow-up|1|||
44249127|NCT01519700|79082726|FG003|Overall Study|Lost to Follow-up|1|||
44249128|NCT01519700|79082723|FG000|Overall Study|Physician Decision|1|||
44249129|NCT01519700|79082724|FG001|Overall Study|Physician Decision|1|||
44249130|NCT01519700|79082725|FG002|Overall Study|Physician Decision|3|||
44249131|NCT01519700|79082726|FG003|Overall Study|Physician Decision|0|||
44249132|NCT01519700|79082723|FG000|Overall Study|Withdrawal by Subject|5|||
44249133|NCT01519700|79082724|FG001|Overall Study|Withdrawal by Subject|3|||
44249134|NCT01519700|79082725|FG002|Overall Study|Withdrawal by Subject|3|||
44514618|NCT03722238|79520394|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
44514619|NCT03722238|79520395|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
44514620|NCT03722238|79520394|FG000|Overall Study|Did not meet risk classification group criteria|90|||
44249135|NCT01519700|79082726|FG003|Overall Study|Withdrawal by Subject|2|||
44249136|NCT01519700|79082723|FG000|Overall Study|Other Reason|2|||
44249137|NCT01519700|79082724|FG001|Overall Study|Other Reason|2|||
44249138|NCT01519700|79082725|FG002|Overall Study|Other Reason|0|||
44249139|NCT01519700|79082726|FG003|Overall Study|Other Reason|4|||
44249140|NCT02656680|79082744|FG000|Overall Study|Lost to Follow-up|0|||
44249141|NCT02656680|79082745|FG001|Overall Study|Lost to Follow-up|1|||
44249142|NCT02658084|79082781|FG000|Overall Study|Withdrawal by Subject|1|||
44249143|NCT02658084|79082782|FG001|Overall Study|Withdrawal by Subject|0|||
44249144|NCT02658084|79082781|FG000|Overall Study|Study Termination|1|||
44249145|NCT02658084|79082782|FG001|Overall Study|Study Termination|0|||
44249146|NCT01482962|79082798|FG000|Overall Study|Progressive Disease|65|||
44249147|NCT01482962|79082799|FG001|Overall Study|Progressive Disease|53|||
44249148|NCT01482962|79082798|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
44249149|NCT01482962|79082799|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
44249150|NCT01482962|79082798|FG000|Overall Study|Adverse Event|18|||
44249151|NCT01482962|79082799|FG001|Overall Study|Adverse Event|22|||
44249152|NCT01482962|79082798|FG000|Overall Study|Withdrawal by Participant|8|||
44249153|NCT01482962|79082799|FG001|Overall Study|Withdrawal by Participant|13|||
44249154|NCT01482962|79082798|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
44249155|NCT01482962|79082799|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
44249156|NCT01482962|79082798|FG000|Overall Study|Other Reason|1|||
44249157|NCT01482962|79082799|FG001|Overall Study|Other Reason|5|||
44249158|NCT01482962|79082798|FG000|Overall Study|Study Terminated by Sponsor|5|||
44249159|NCT01482962|79082799|FG001|Overall Study|Study Terminated by Sponsor|2|||
44249160|NCT01482962|79082798|FG000|Overall Study|Did not Receive Study Drug|1|||
44249161|NCT01482962|79082799|FG001|Overall Study|Did not Receive Study Drug|6|||
44249162|NCT02655666|79082807|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
44381452|NCT01026818|79387583|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
44249163|NCT01506596|79082811|FG000|Overall Study|ineligible pathology|1|||
44249164|NCT01482884|79082830|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
44249165|NCT01482884|79082831|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
44249166|NCT01482884|79082830|FG000|Overall Study|Protocol Violation|1|||
44249167|NCT01482884|79082831|FG001|Overall Study|Protocol Violation|0|||
44249168|NCT01482884|79082830|FG000|Overall Study|Lost to Follow-up|2|||
44249169|NCT01482884|79082831|FG001|Overall Study|Lost to Follow-up|2|||
44249170|NCT01482884|79082830|FG000|Overall Study|Lack of Efficacy|0|||
44249171|NCT01482884|79082831|FG001|Overall Study|Lack of Efficacy|1|||
44249172|NCT01482884|79082830|FG000|Overall Study|Adverse Event|2|||
44249173|NCT01482884|79082831|FG001|Overall Study|Adverse Event|1|||
44249174|NCT01482884|79082830|FG000|Overall Study|Withdrawal by Subject|8|||
44249175|NCT01482884|79082831|FG001|Overall Study|Withdrawal by Subject|13|||
44249176|NCT01518374|79082837|FG000|Overall Study|Withdrawal by Subject|2|||
44249177|NCT01518374|79082837|FG000|Overall Study|Protocol Violation|3|||
44249178|NCT01518374|79082837|FG000|Overall Study|Lost to Follow-up|2|||
44249179|NCT01481324|79082844|FG000|Overall Study|Missing Data|0|||
44249180|NCT01481324|79082845|FG001|Overall Study|Missing Data|2|||
44249181|NCT01481324|79082846|FG002|Overall Study|Missing Data|2|||
44249182|NCT04591626|79082856|FG000|Overall Study|Adverse Event|4|||
44249183|NCT04591626|79082857|FG001|Overall Study|Adverse Event|0|||
44249184|NCT04591626|79082856|FG000|Overall Study|Withdrawal by Subject|5|||
44249185|NCT04591626|79082857|FG001|Overall Study|Withdrawal by Subject|3|||
44249186|NCT04591626|79082856|FG000|Overall Study|Physician Decision|0|||
44249187|NCT04591626|79082857|FG001|Overall Study|Physician Decision|1|||
44249188|NCT04591626|79082856|FG000|Overall Study|Death|0|||
44249189|NCT04591626|79082857|FG001|Overall Study|Death|1|||
44249190|NCT04591626|79082856|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44249191|NCT04591626|79082857|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44249192|NCT03583333|79082865|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
44249193|NCT03583333|79082866|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
44249194|NCT03583333|79082865|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
44249195|NCT03583333|79082866|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
44249196|NCT03583333|79082865|FG000|Overall Study|Withdrawal by Subject|9|||
44249197|NCT03583333|79082866|FG001|Overall Study|Withdrawal by Subject|5|||
44249198|NCT03583333|79082865|FG000|Overall Study|Physician Decision|3|||
44249199|NCT03583333|79082866|FG001|Overall Study|Physician Decision|2|||
44249200|NCT03583333|79082865|FG000|Overall Study|Death|12|||
44249201|NCT03583333|79082866|FG001|Overall Study|Death|7|||
44249202|NCT01602510|79082872|FG000|Open Label Phase|Adverse Event|46|||
44249203|NCT01602510|79082873|FG001|Open Label Phase|Adverse Event|0|||
44249204|NCT01602510|79082874|FG002|Open Label Phase|Adverse Event|0|||
44249205|NCT01602510|79082872|FG000|Open Label Phase|Lack of Efficacy|22|||
44249206|NCT01602510|79082873|FG001|Open Label Phase|Lack of Efficacy|0|||
44249207|NCT01602510|79082874|FG002|Open Label Phase|Lack of Efficacy|0|||
44249208|NCT01602510|79082872|FG000|Open Label Phase|Protocol Violation|15|||
44249209|NCT01602510|79082873|FG001|Open Label Phase|Protocol Violation|0|||
44249210|NCT01602510|79082874|FG002|Open Label Phase|Protocol Violation|0|||
44249211|NCT01602510|79082872|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
44249212|NCT01602510|79082873|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
44249213|NCT01602510|79082874|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
44249214|NCT01602510|79082872|FG000|Open Label Phase|Lost to Follow-up|22|||
44249215|NCT01602510|79082873|FG001|Open Label Phase|Lost to Follow-up|0|||
44249216|NCT01602510|79082874|FG002|Open Label Phase|Lost to Follow-up|0|||
44249217|NCT01602510|79082872|FG000|Open Label Phase|Physician Decision|19|||
44249218|NCT01602510|79082873|FG001|Open Label Phase|Physician Decision|0|||
44249219|NCT01602510|79082874|FG002|Open Label Phase|Physician Decision|0|||
44249220|NCT01602510|79082872|FG000|Open Label Phase|Withdrawal by Subject|57|||
44249221|NCT01602510|79082873|FG001|Open Label Phase|Withdrawal by Subject|0|||
44249222|NCT01602510|79082874|FG002|Open Label Phase|Withdrawal by Subject|0|||
44249223|NCT01602510|79082872|FG000|Randomized Phase|Adverse Event|0|||
44249224|NCT01602510|79082873|FG001|Randomized Phase|Adverse Event|2|||
44249225|NCT01602510|79082874|FG002|Randomized Phase|Adverse Event|6|||
44249226|NCT01602510|79082872|FG000|Randomized Phase|Lack of Efficacy|0|||
44249227|NCT01602510|79082873|FG001|Randomized Phase|Lack of Efficacy|4|||
44249228|NCT01602510|79082874|FG002|Randomized Phase|Lack of Efficacy|4|||
44249229|NCT01602510|79082872|FG000|Randomized Phase|Protocol Violation|0|||
44249230|NCT01602510|79082873|FG001|Randomized Phase|Protocol Violation|3|||
44249231|NCT01602510|79082874|FG002|Randomized Phase|Protocol Violation|3|||
44249232|NCT01602510|79082872|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
44249233|NCT01602510|79082873|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
44249234|NCT01602510|79082874|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
44249235|NCT01602510|79082872|FG000|Randomized Phase|Lost to Follow-up|0|||
44249236|NCT01602510|79082873|FG001|Randomized Phase|Lost to Follow-up|1|||
44249237|NCT01602510|79082874|FG002|Randomized Phase|Lost to Follow-up|3|||
44143569|NCT04498247|78932853|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
44143570|NCT03887117|78932881|FG000|Overall Study|Discontinued prematurely|0|||
44143571|NCT03887117|78932882|FG001|Overall Study|Discontinued prematurely|1|||
44249238|NCT01602510|79082872|FG000|Randomized Phase|Physician Decision|0|||
44249239|NCT01602510|79082873|FG001|Randomized Phase|Physician Decision|0|||
44249240|NCT01602510|79082874|FG002|Randomized Phase|Physician Decision|2|||
44249241|NCT01602510|79082872|FG000|Randomized Phase|Withdrawal by Subject|0|||
44249242|NCT01602510|79082873|FG001|Randomized Phase|Withdrawal by Subject|6|||
44249243|NCT01602510|79082874|FG002|Randomized Phase|Withdrawal by Subject|7|||
44249244|NCT01675596|79082889|FG000|Overall Study|Death|6|||
44249245|NCT01675596|79082889|FG000|Overall Study|Exit with other reason|1|||
44249246|NCT01675596|79082889|FG000|Overall Study|Missed Visit|1|||
44249247|NCT02653326|79082899|FG000|Overall Study|Lost to Follow-up|10|||
44249248|NCT02653326|79082900|FG001|Overall Study|Lost to Follow-up|7|||
44249249|NCT02653170|79082909|FG000|Overall Study|Withdrawal by Subject|3|||
44249250|NCT02653170|79082910|FG001|Overall Study|Withdrawal by Subject|8|||
44249251|NCT02653170|79082911|FG002|Overall Study|Withdrawal by Subject|3|||
44249252|NCT02653170|79082909|FG000|Overall Study|withdrawn by study team|2|||
44249253|NCT02653170|79082910|FG001|Overall Study|withdrawn by study team|4|||
44249254|NCT02653170|79082911|FG002|Overall Study|withdrawn by study team|5|||
44249255|NCT02653170|79082909|FG000|Overall Study|Lost to Follow-up|12|||
44249256|NCT02653170|79082910|FG001|Overall Study|Lost to Follow-up|4|||
44249257|NCT02653170|79082911|FG002|Overall Study|Lost to Follow-up|10|||
44249258|NCT01463696|79082931|FG000|Overall Study|Adverse Event|0|||
44249259|NCT01463696|79082932|FG001|Overall Study|Adverse Event|1|||
44249260|NCT01463696|79082933|FG002|Overall Study|Adverse Event|0|||
44249261|NCT01463696|79082934|FG003|Overall Study|Adverse Event|2|||
44249262|NCT01463696|79082935|FG004|Overall Study|Adverse Event|0|||
44249263|NCT01463696|79082936|FG005|Overall Study|Adverse Event|1|||
44249264|NCT01463696|79082937|FG006|Overall Study|Adverse Event|3|||
44249265|NCT01463696|79082938|FG007|Overall Study|Adverse Event|2|||
44249266|NCT01463696|79082931|FG000|Overall Study|Lost to Follow-up|0|||
44249267|NCT01463696|79082932|FG001|Overall Study|Lost to Follow-up|0|||
44249268|NCT01463696|79082933|FG002|Overall Study|Lost to Follow-up|1|||
44249269|NCT01463696|79082934|FG003|Overall Study|Lost to Follow-up|0|||
44249270|NCT01463696|79082935|FG004|Overall Study|Lost to Follow-up|0|||
44249271|NCT01463696|79082936|FG005|Overall Study|Lost to Follow-up|0|||
44249272|NCT01463696|79082937|FG006|Overall Study|Lost to Follow-up|0|||
44249273|NCT01463696|79082938|FG007|Overall Study|Lost to Follow-up|0|||
44249274|NCT01463696|79082931|FG000|Overall Study|Progressive Disease|0|||
44249275|NCT01463696|79082932|FG001|Overall Study|Progressive Disease|1|||
44249276|NCT01463696|79082933|FG002|Overall Study|Progressive Disease|0|||
44249277|NCT01463696|79082934|FG003|Overall Study|Progressive Disease|1|||
44249278|NCT01463696|79082935|FG004|Overall Study|Progressive Disease|0|||
44249279|NCT01463696|79082936|FG005|Overall Study|Progressive Disease|1|||
44249280|NCT01463696|79082937|FG006|Overall Study|Progressive Disease|4|||
44249281|NCT01463696|79082938|FG007|Overall Study|Progressive Disease|2|||
44249282|NCT01463696|79082931|FG000|Overall Study|Withdrawal by Subject|0|||
44249283|NCT01463696|79082932|FG001|Overall Study|Withdrawal by Subject|0|||
44249284|NCT01463696|79082933|FG002|Overall Study|Withdrawal by Subject|0|||
44249285|NCT01463696|79082934|FG003|Overall Study|Withdrawal by Subject|1|||
44249286|NCT01463696|79082935|FG004|Overall Study|Withdrawal by Subject|1|||
44249287|NCT01463696|79082936|FG005|Overall Study|Withdrawal by Subject|1|||
44249288|NCT01463696|79082937|FG006|Overall Study|Withdrawal by Subject|2|||
44249289|NCT01463696|79082938|FG007|Overall Study|Withdrawal by Subject|0|||
44249290|NCT01463696|79082931|FG000|Overall Study|Not Treated|0|||
44249291|NCT01463696|79082932|FG001|Overall Study|Not Treated|0|||
44249292|NCT01463696|79082933|FG002|Overall Study|Not Treated|0|||
44249293|NCT01463696|79082934|FG003|Overall Study|Not Treated|0|||
44249294|NCT01463696|79082935|FG004|Overall Study|Not Treated|0|||
44249295|NCT01463696|79082936|FG005|Overall Study|Not Treated|0|||
44514621|NCT03722238|79520395|FG001|Overall Study|Did not meet risk classification group criteria|0|||
44514622|NCT03722238|79520394|FG000|Overall Study|Did not sign consent|17|||
44514623|NCT03722238|79520395|FG001|Overall Study|Did not sign consent|0|||
44514624|NCT03722238|79520394|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
44514625|NCT03722238|79520395|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
44514626|NCT03722238|79520394|FG000|Overall Study|Not willing to purchase study medication|142|||
44514627|NCT03722238|79520395|FG001|Overall Study|Not willing to purchase study medication|0|||
44514628|NCT03722238|79520394|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
44514629|NCT03722238|79520395|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
44514630|NCT02927080|79520411|FG000|Overall Study|Withdrawal by Subject|0|||
44514631|NCT02927080|79520412|FG001|Overall Study|Withdrawal by Subject|0|||
44514632|NCT02927080|79520413|FG002|Overall Study|Withdrawal by Subject|0|||
44514633|NCT02927080|79520414|FG003|Overall Study|Withdrawal by Subject|0|||
44514634|NCT02927080|79520415|FG004|Overall Study|Withdrawal by Subject|1|||
44514635|NCT02927080|79520416|FG005|Overall Study|Withdrawal by Subject|0|||
44514636|NCT02927080|79520417|FG006|Overall Study|Withdrawal by Subject|1|||
44514637|NCT02927080|79520418|FG007|Overall Study|Withdrawal by Subject|1|||
44514638|NCT02927080|79520419|FG008|Overall Study|Withdrawal by Subject|0|||
44514639|NCT02927080|79520420|FG009|Overall Study|Withdrawal by Subject|2|||
44514640|NCT02927080|79520411|FG000|Overall Study|Willingness to comply with protocol|0|||
44514641|NCT02927080|79520412|FG001|Overall Study|Willingness to comply with protocol|0|||
44249296|NCT01463696|79082937|FG006|Overall Study|Not Treated|1|||
44249297|NCT01463696|79082938|FG007|Overall Study|Not Treated|0|||
44249298|NCT02653482|79082962|FG000|Overall Study|Death|1|||
44249299|NCT02653482|79082963|FG001|Overall Study|Death|1|||
44249300|NCT01362348|79082969|FG000|Overall Study|Protocol-defined stopping criteria|9|||
44249301|NCT01362348|79082969|FG000|Overall Study|Study closed/terminated|5|||
44249302|NCT01675128|79083039|FG000|Overall Study|Disease progression on study|1|||
44249303|NCT01675128|79083040|FG001|Overall Study|Disease progression on study|1|||
44514642|NCT02927080|79520413|FG002|Overall Study|Willingness to comply with protocol|0|||
44514643|NCT02927080|79520414|FG003|Overall Study|Willingness to comply with protocol|0|||
44514644|NCT02927080|79520415|FG004|Overall Study|Willingness to comply with protocol|0|||
44514645|NCT02927080|79520416|FG005|Overall Study|Willingness to comply with protocol|0|||
44514646|NCT02927080|79520417|FG006|Overall Study|Willingness to comply with protocol|0|||
44514647|NCT02927080|79520418|FG007|Overall Study|Willingness to comply with protocol|0|||
44514648|NCT02927080|79520419|FG008|Overall Study|Willingness to comply with protocol|0|||
44514649|NCT02927080|79520420|FG009|Overall Study|Willingness to comply with protocol|1|||
44514650|NCT02927080|79520411|FG000|Overall Study|Study terminated by Sponsor|0|||
44514651|NCT02927080|79520412|FG001|Overall Study|Study terminated by Sponsor|0|||
44514652|NCT02927080|79520413|FG002|Overall Study|Study terminated by Sponsor|0|||
44143572|NCT03887117|78932883|FG002|Overall Study|Discontinued prematurely|1|||
44249304|NCT01675128|79083041|FG002|Overall Study|Disease progression on study|1|||
44249305|NCT01675128|79083039|FG000|Overall Study|Refused further treatment|1|||
44249306|NCT01675128|79083040|FG001|Overall Study|Refused further treatment|0|||
44249307|NCT01675128|79083041|FG002|Overall Study|Refused further treatment|0|||
44249308|NCT01675128|79083039|FG000|Overall Study|Pulmonary complication; off study|0|||
44249309|NCT01675128|79083040|FG001|Overall Study|Pulmonary complication; off study|1|||
44249310|NCT01675128|79083041|FG002|Overall Study|Pulmonary complication; off study|0|||
44249311|NCT01427309|79083087|FG000|Overall Study|Lost to Follow-up|130|||
44249312|NCT01427309|79083088|FG001|Overall Study|Lost to Follow-up|145|||
44249313|NCT01427309|79083089|FG002|Overall Study|Lost to Follow-up|122|||
44249314|NCT01427309|79083090|FG003|Overall Study|Lost to Follow-up|135|||
44249315|NCT01427309|79083087|FG000|Overall Study|Protocol Violation|42|||
44249316|NCT01427309|79083088|FG001|Overall Study|Protocol Violation|69|||
44249317|NCT01427309|79083089|FG002|Overall Study|Protocol Violation|125|||
44249318|NCT01427309|79083090|FG003|Overall Study|Protocol Violation|124|||
44249319|NCT01427309|79083087|FG000|Overall Study|Adverse Event|0|||
44249320|NCT01427309|79083088|FG001|Overall Study|Adverse Event|0|||
44249321|NCT01427309|79083089|FG002|Overall Study|Adverse Event|3|||
44249322|NCT01427309|79083090|FG003|Overall Study|Adverse Event|1|||
44249323|NCT01427309|79083087|FG000|Overall Study|Serious adverse event|52|||
44249324|NCT01427309|79083088|FG001|Overall Study|Serious adverse event|45|||
44249325|NCT01427309|79083089|FG002|Overall Study|Serious adverse event|50|||
44249326|NCT01427309|79083090|FG003|Overall Study|Serious adverse event|61|||
44249327|NCT01427309|79083087|FG000|Overall Study|Withdrawal by Subject|148|||
44249328|NCT01427309|79083088|FG001|Overall Study|Withdrawal by Subject|148|||
44249329|NCT01427309|79083089|FG002|Overall Study|Withdrawal by Subject|61|||
44249330|NCT01427309|79083090|FG003|Overall Study|Withdrawal by Subject|55|||
44249331|NCT01426373|79083100|FG000|Overall Study|Adverse Event|6|||
44249332|NCT01426373|79083100|FG000|Overall Study|Lost to Follow-up|14|||
44249333|NCT01426373|79083100|FG000|Overall Study|Participant Convenience|10|||
44249334|NCT01426373|79083100|FG000|Overall Study|Miscellaneous Reasons|4|||
44249335|NCT01426217|79083108|FG000|Overall Study|lost sample|8|||
44249336|NCT01426217|79083109|FG001|Overall Study|lost sample|14|||
44249337|NCT01425749|79083117|FG000|Overall Study|progression of melanoma|0|||
44249338|NCT01425749|79083118|FG001|Overall Study|progression of melanoma|1|||
44277053|NCT02132754|79237783|FG009|Overall Study|Withdrawal by Subject|1|||
44277054|NCT02132754|79237784|FG010|Overall Study|Withdrawal by Subject|0|||
44277055|NCT02132754|79237785|FG011|Overall Study|Withdrawal by Subject|0|||
44277056|NCT02132754|79237786|FG012|Overall Study|Withdrawal by Subject|1|||
44277057|NCT02132754|79237787|FG013|Overall Study|Withdrawal by Subject|0|||
44277058|NCT02132754|79237788|FG014|Overall Study|Withdrawal by Subject|1|||
44277059|NCT02132754|79237789|FG015|Overall Study|Withdrawal by Subject|2|||
44277060|NCT02132754|79237790|FG016|Overall Study|Withdrawal by Subject|1|||
44277061|NCT02132754|79237791|FG017|Overall Study|Withdrawal by Subject|0|||
44277062|NCT02132754|79237792|FG018|Overall Study|Withdrawal by Subject|0|||
44277063|NCT02132754|79237793|FG019|Overall Study|Withdrawal by Subject|0|||
44277064|NCT02132754|79237794|FG020|Overall Study|Withdrawal by Subject|1|||
44277065|NCT02132754|79237795|FG021|Overall Study|Withdrawal by Subject|0|||
44277066|NCT02132754|79237796|FG022|Overall Study|Withdrawal by Subject|0|||
44277067|NCT02132754|79237797|FG023|Overall Study|Withdrawal by Subject|0|||
44514653|NCT02927080|79520414|FG003|Overall Study|Study terminated by Sponsor|0|||
44514654|NCT02927080|79520415|FG004|Overall Study|Study terminated by Sponsor|0|||
44249339|NCT01403987|79083134|FG000|Overall Study|Residents forgot their secret PIN|18|||
44249340|NCT01403987|79083135|FG001|Overall Study|Residents forgot their secret PIN|17|||
44249341|NCT01403987|79083136|FG002|Overall Study|Residents forgot their secret PIN|18|||
44249342|NCT01425359|79083146|FG000|Overall Study|Randomized but Not Treated|2|||
44249343|NCT01425359|79083147|FG001|Overall Study|Randomized but Not Treated|3|||
44277068|NCT02132754|79237798|FG024|Overall Study|Withdrawal by Subject|1|||
44277069|NCT02132754|79237799|FG025|Overall Study|Withdrawal by Subject|0|||
44277070|NCT02132754|79237800|FG026|Overall Study|Withdrawal by Subject|0|||
44514655|NCT02927080|79520416|FG005|Overall Study|Study terminated by Sponsor|0|||
44249344|NCT01425359|79083146|FG000|Overall Study|Adverse Event|9|||
44249345|NCT01425359|79083147|FG001|Overall Study|Adverse Event|8|||
44249346|NCT01425359|79083146|FG000|Overall Study|Revascularization|0|||
44249347|NCT01425359|79083147|FG001|Overall Study|Revascularization|1|||
44249348|NCT01425359|79083146|FG000|Overall Study|Death|0|||
44249349|NCT01425359|79083147|FG001|Overall Study|Death|1|||
44249350|NCT01425359|79083146|FG000|Overall Study|Unsatisfactory Response|1|||
44249351|NCT01425359|79083147|FG001|Overall Study|Unsatisfactory Response|0|||
44249352|NCT01425359|79083146|FG000|Overall Study|Protocol Violation|1|||
44249353|NCT01425359|79083147|FG001|Overall Study|Protocol Violation|2|||
44249354|NCT01425359|79083146|FG000|Overall Study|Subject Withdrew Consent|1|||
44249355|NCT01425359|79083147|FG001|Overall Study|Subject Withdrew Consent|2|||
44249356|NCT01425359|79083146|FG000|Overall Study|Investigator's Discretion|2|||
44277071|NCT02132754|79237801|FG027|Overall Study|Withdrawal by Subject|1|||
44277072|NCT02132754|79237802|FG028|Overall Study|Withdrawal by Subject|0|||
44277073|NCT02132754|79237803|FG029|Overall Study|Withdrawal by Subject|0|||
44249357|NCT01425359|79083147|FG001|Overall Study|Investigator's Discretion|0|||
44249358|NCT01425359|79083146|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
44277074|NCT02132754|79237804|FG030|Overall Study|Withdrawal by Subject|0|||
44277075|NCT02132754|79237805|FG031|Overall Study|Withdrawal by Subject|1|||
44277076|NCT02132754|79237806|FG032|Overall Study|Withdrawal by Subject|0|||
44277077|NCT02132754|79237807|FG033|Overall Study|Withdrawal by Subject|2|||
44277078|NCT02151786|79237917|FG000|Overall Study|Unavailability of Case Report Form|26|||
44277079|NCT02151786|79237917|FG000|Overall Study|Outside the Contract Period|1|||
44277080|NCT02151786|79237917|FG000|Overall Study|Randomized, not Treated|1|||
44277081|NCT02151786|79237917|FG000|Overall Study|Unavailability of Information|8|||
44277082|NCT02132130|79237925|FG000|Overall Study|Lost to Follow-up|0|||
44277083|NCT02132130|79237926|FG001|Overall Study|Lost to Follow-up|2|||
44277084|NCT02132130|79237927|FG002|Overall Study|Lost to Follow-up|0|||
44277085|NCT02132130|79237928|FG003|Overall Study|Lost to Follow-up|0|||
44277086|NCT02132130|79237925|FG000|Overall Study|Withdrawal by Subject|0|||
44277087|NCT02132130|79237926|FG001|Overall Study|Withdrawal by Subject|0|||
44277088|NCT02132130|79237927|FG002|Overall Study|Withdrawal by Subject|0|||
44277089|NCT02132130|79237928|FG003|Overall Study|Withdrawal by Subject|1|||
44277090|NCT02131662|79237947|FG000|Overall Study|Protocol Violation|1|||
44277091|NCT02131662|79237948|FG001|Overall Study|Protocol Violation|0|||
44277092|NCT02131662|79237949|FG002|Overall Study|Protocol Violation|0|||
44277093|NCT02131662|79237950|FG003|Overall Study|Protocol Violation|0|||
44277094|NCT02131662|79237951|FG004|Overall Study|Protocol Violation|0|||
44277095|NCT02131662|79237947|FG000|Overall Study|Other|2|||
44277096|NCT02131662|79237948|FG001|Overall Study|Other|4|||
44277097|NCT02131662|79237949|FG002|Overall Study|Other|3|||
44277098|NCT02131662|79237950|FG003|Overall Study|Other|3|||
44277099|NCT02131662|79237951|FG004|Overall Study|Other|4|||
44277100|NCT02131662|79237947|FG000|Overall Study|Adverse Event|0|||
44277101|NCT02131662|79237948|FG001|Overall Study|Adverse Event|1|||
44277102|NCT02131662|79237949|FG002|Overall Study|Adverse Event|1|||
44277103|NCT02131662|79237950|FG003|Overall Study|Adverse Event|1|||
44277104|NCT02131662|79237951|FG004|Overall Study|Adverse Event|3|||
44277105|NCT02131662|79237947|FG000|Overall Study|Pregnancy|0|||
44277106|NCT02131662|79237948|FG001|Overall Study|Pregnancy|1|||
44277107|NCT02131662|79237949|FG002|Overall Study|Pregnancy|0|||
44277108|NCT02131662|79237950|FG003|Overall Study|Pregnancy|1|||
44277109|NCT02131662|79237951|FG004|Overall Study|Pregnancy|0|||
44277110|NCT02131662|79237947|FG000|Overall Study|Wish for pregnancy|0|||
44514656|NCT02927080|79520417|FG006|Overall Study|Study terminated by Sponsor|6|||
44514657|NCT02927080|79520418|FG007|Overall Study|Study terminated by Sponsor|7|||
44249359|NCT01425359|79083147|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
44249360|NCT01403051|79083167|FG000|Overall Study|Protocol Violation|2|||
44249361|NCT01403051|79083168|FG001|Overall Study|Protocol Violation|0|||
44249362|NCT01403051|79083167|FG000|Overall Study|Death|1|||
44514658|NCT02927080|79520419|FG008|Overall Study|Study terminated by Sponsor|2|||
44514659|NCT02927080|79520420|FG009|Overall Study|Study terminated by Sponsor|3|||
44249363|NCT01403051|79083168|FG001|Overall Study|Death|0|||
44277111|NCT02131662|79237948|FG001|Overall Study|Wish for pregnancy|0|||
44277112|NCT02131662|79237949|FG002|Overall Study|Wish for pregnancy|0|||
44277113|NCT02131662|79237950|FG003|Overall Study|Wish for pregnancy|0|||
44277114|NCT02131662|79237951|FG004|Overall Study|Wish for pregnancy|1|||
44277115|NCT02131662|79237947|FG000|Overall Study|Lack of Efficacy|1|||
44277116|NCT02131662|79237948|FG001|Overall Study|Lack of Efficacy|0|||
44277117|NCT02131662|79237949|FG002|Overall Study|Lack of Efficacy|0|||
44277118|NCT02131662|79237950|FG003|Overall Study|Lack of Efficacy|0|||
44277119|NCT02131662|79237951|FG004|Overall Study|Lack of Efficacy|1|||
44277120|NCT02131662|79237947|FG000|Overall Study|Withdrawal by Subject|1|||
44277121|NCT02131662|79237948|FG001|Overall Study|Withdrawal by Subject|5|||
44249364|NCT01403051|79083167|FG000|Overall Study|Withdrawal by Subject|2|||
44249365|NCT01403051|79083168|FG001|Overall Study|Withdrawal by Subject|1|||
44277122|NCT02131662|79237949|FG002|Overall Study|Withdrawal by Subject|1|||
44277123|NCT02131662|79237950|FG003|Overall Study|Withdrawal by Subject|5|||
44277124|NCT02131662|79237951|FG004|Overall Study|Withdrawal by Subject|6|||
44277125|NCT02131662|79237947|FG000|Overall Study|Lost to Follow-up|1|||
44277126|NCT02131662|79237948|FG001|Overall Study|Lost to Follow-up|3|||
44277127|NCT02131662|79237949|FG002|Overall Study|Lost to Follow-up|0|||
44277128|NCT02131662|79237950|FG003|Overall Study|Lost to Follow-up|9|||
44277129|NCT02131662|79237951|FG004|Overall Study|Lost to Follow-up|0|||
44277130|NCT02131662|79237947|FG000|Overall Study|Not treated|2|||
44277131|NCT02131662|79237948|FG001|Overall Study|Not treated|0|||
44277132|NCT02131662|79237949|FG002|Overall Study|Not treated|2|||
44277133|NCT02131662|79237950|FG003|Overall Study|Not treated|2|||
44277134|NCT02131662|79237951|FG004|Overall Study|Not treated|3|||
44277135|NCT02106156|79237970|FG000|Overall Study|Patient Died|19|||
44277136|NCT02106156|79237971|FG001|Overall Study|Patient Died|0|||
44277137|NCT02106156|79237972|FG002|Overall Study|Patient Died|0|||
44277138|NCT02106156|79237970|FG000|Overall Study|Lack of Tolerability|305|||
44277139|NCT02106156|79237971|FG001|Overall Study|Lack of Tolerability|3|||
44277140|NCT02106156|79237972|FG002|Overall Study|Lack of Tolerability|0|||
44277141|NCT02106156|79237970|FG000|Overall Study|Lack of Virological Response|1044|||
44277142|NCT02106156|79237971|FG001|Overall Study|Lack of Virological Response|8|||
44277143|NCT02106156|79237972|FG002|Overall Study|Lack of Virological Response|0|||
44277144|NCT02106156|79237970|FG000|Overall Study|Concomitant Disease|74|||
44277145|NCT02106156|79237971|FG001|Overall Study|Concomitant Disease|2|||
44277146|NCT02106156|79237972|FG002|Overall Study|Concomitant Disease|0|||
44277147|NCT02106156|79237970|FG000|Overall Study|Lack of Compliance|211|||
44277148|NCT02106156|79237971|FG001|Overall Study|Lack of Compliance|7|||
44277149|NCT02106156|79237972|FG002|Overall Study|Lack of Compliance|0|||
44277150|NCT02106156|79237970|FG000|Overall Study|Patients Request|307|||
44277151|NCT02106156|79237971|FG001|Overall Study|Patients Request|9|||
44277152|NCT02106156|79237972|FG002|Overall Study|Patients Request|0|||
44277153|NCT02106156|79237970|FG000|Overall Study|Lost to Follow-up|451|||
44277154|NCT02106156|79237971|FG001|Overall Study|Lost to Follow-up|8|||
44277155|NCT02106156|79237972|FG002|Overall Study|Lost to Follow-up|0|||
44277156|NCT02106156|79237970|FG000|Overall Study|Unplanned Event|82|||
44277157|NCT02106156|79237971|FG001|Overall Study|Unplanned Event|2|||
44277158|NCT02106156|79237972|FG002|Overall Study|Unplanned Event|0|||
44277159|NCT02106156|79237970|FG000|Overall Study|Change of Laboratory Parameter|10|||
44277160|NCT02106156|79237971|FG001|Overall Study|Change of Laboratory Parameter|0|||
44277161|NCT02106156|79237972|FG002|Overall Study|Change of Laboratory Parameter|0|||
44277162|NCT02106156|79237970|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
44277163|NCT02106156|79237971|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
44277164|NCT02106156|79237972|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
44277165|NCT02106156|79237970|FG000|Overall Study|Relocation/Change of Physician|40|||
44277166|NCT02106156|79237971|FG001|Overall Study|Relocation/Change of Physician|1|||
44277167|NCT02106156|79237972|FG002|Overall Study|Relocation/Change of Physician|0|||
44277168|NCT01598610|79237998|FG000|Overall Study|Adverse Event|1|||
44277169|NCT01625988|79238004|FG000|Overall Study|Lost to Follow-up|5|||
44277170|NCT01625988|79238005|FG001|Overall Study|Lost to Follow-up|6|||
44277171|NCT01625988|79238004|FG000|Overall Study|Withdrawal by Subject|8|||
44277172|NCT01625988|79238005|FG001|Overall Study|Withdrawal by Subject|3|||
44277173|NCT01625988|79238004|FG000|Overall Study|Adverse Event|0|||
44277174|NCT01625988|79238005|FG001|Overall Study|Adverse Event|1|||
44277175|NCT01625988|79238004|FG000|Overall Study|Lack of Efficacy|0|||
44277176|NCT01625988|79238005|FG001|Overall Study|Lack of Efficacy|1|||
44277177|NCT01625988|79238004|FG000|Overall Study|Randomized Inappropriately|1|||
44277178|NCT01625988|79238005|FG001|Overall Study|Randomized Inappropriately|0|||
44277179|NCT01625988|79238004|FG000|Overall Study|Protocol Violation|0|||
44277180|NCT01625988|79238005|FG001|Overall Study|Protocol Violation|2|||
44277181|NCT02131272|79238016|FG000|Overall Study|Withdrawal by parent|0|||
44277182|NCT02131272|79238017|FG001|Overall Study|Withdrawal by parent|1|||
44514660|NCT02927080|79520411|FG000|Overall Study|Adverse Event|0|||
44514661|NCT02927080|79520412|FG001|Overall Study|Adverse Event|1|||
44514662|NCT02927080|79520413|FG002|Overall Study|Adverse Event|0|||
44514663|NCT02927080|79520414|FG003|Overall Study|Adverse Event|0|||
44514664|NCT02927080|79520415|FG004|Overall Study|Adverse Event|0|||
44514665|NCT02927080|79520416|FG005|Overall Study|Adverse Event|0|||
44514666|NCT02927080|79520417|FG006|Overall Study|Adverse Event|0|||
44277183|NCT02131272|79238016|FG000|Overall Study|Withdrawal by Subject|0|||
44277184|NCT02131272|79238017|FG001|Overall Study|Withdrawal by Subject|1|||
44514667|NCT02927080|79520418|FG007|Overall Study|Adverse Event|1|||
44277185|NCT02131272|79238016|FG000|Overall Study|Withdrawal Criteria|1|||
44277186|NCT02131272|79238017|FG001|Overall Study|Withdrawal Criteria|0|||
44277187|NCT02130882|79238025|FG000|Overall Study|Withdrawal by Subject|0|||
44277188|NCT02130882|79238026|FG001|Overall Study|Withdrawal by Subject|1|||
44277189|NCT02130570|79238034|FG000|Overall Study|Death|3|||
44277190|NCT02130570|79238035|FG001|Overall Study|Death|5|||
44277191|NCT02130570|79238034|FG000|Overall Study|Withdrawal by Subject|6|||
44277192|NCT02130570|79238035|FG001|Overall Study|Withdrawal by Subject|3|||
44277193|NCT02130570|79238034|FG000|Overall Study|Part of practice that discontinued study|0|||
44277194|NCT02130570|79238035|FG001|Overall Study|Part of practice that discontinued study|5|||
44277195|NCT02149836|79238042|FG000|Overall Study|Withdrawal by Subject|1|||
44277196|NCT02130024|79238048|FG000|Overall Study|Adverse Event|10|||
44277197|NCT02130024|79238049|FG001|Overall Study|Adverse Event|11|||
44277198|NCT02130024|79238048|FG000|Overall Study|Death|2|||
44277199|NCT02130024|79238049|FG001|Overall Study|Death|2|||
44277200|NCT02130024|79238048|FG000|Overall Study|Lost to Follow-up|1|||
44277201|NCT02130024|79238049|FG001|Overall Study|Lost to Follow-up|1|||
44277202|NCT02130024|79238048|FG000|Overall Study|Physician Decision|1|||
44277203|NCT02130024|79238049|FG001|Overall Study|Physician Decision|3|||
44277204|NCT02130024|79238048|FG000|Overall Study|Protocol Deviation|4|||
44277205|NCT02130024|79238049|FG001|Overall Study|Protocol Deviation|0|||
44277206|NCT02130024|79238048|FG000|Overall Study|Site Administration Problems|1|||
44277207|NCT02130024|79238049|FG001|Overall Study|Site Administration Problems|0|||
44277208|NCT02130024|79238048|FG000|Overall Study|Subject Withdrew Consent|6|||
44277209|NCT02130024|79238049|FG001|Overall Study|Subject Withdrew Consent|14|||
44277210|NCT02105688|79238057|FG000|Part A: Double-Blind|Adverse Event|1|||
44277211|NCT02105688|79238058|FG001|Part A: Double-Blind|Adverse Event|0|||
44277212|NCT02105688|79238057|FG000|Part A: Double-Blind|Death|0|||
44277213|NCT02105688|79238058|FG001|Part A: Double-Blind|Death|1|||
44277214|NCT02105688|79238057|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
44277215|NCT02105688|79238058|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
44277216|NCT02105688|79238057|FG000|Part A: Double-Blind|Physician Decision|0|||
44277217|NCT02105688|79238058|FG001|Part A: Double-Blind|Physician Decision|1|||
44277218|NCT02105688|79238057|FG000|Part A: Double-Blind|Status Unknown|0|||
44277219|NCT02105688|79238058|FG001|Part A: Double-Blind|Status Unknown|2|||
44277220|NCT02105688|79238057|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
44277221|NCT02105688|79238058|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
44277222|NCT02105688|79238057|FG000|Part B: Observational Follow-up|Death|2|||
44277223|NCT02105688|79238058|FG001|Part B: Observational Follow-up|Death|1|||
44277224|NCT02105688|79238057|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
44277225|NCT02105688|79238058|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
44277226|NCT02105688|79238057|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
44277227|NCT02105688|79238058|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
44277228|NCT02105688|79238057|FG000|Part B: Observational Follow-up|Physician Decision|3|||
44277229|NCT02105688|79238058|FG001|Part B: Observational Follow-up|Physician Decision|1|||
44277230|NCT02105454|79238065|FG000|Overall Study|Withdrawal by Subject|1|||
44277231|NCT01625910|79238071|FG000|Overall Study|Lost to Follow-up|3|||
44277232|NCT01625910|79238072|FG001|Overall Study|Lost to Follow-up|4|||
44277233|NCT02104752|79238082|FG000|Overall Study|Withdrawal by Subject|1|||
44277234|NCT02104752|79238083|FG001|Overall Study|Withdrawal by Subject|0|||
44277235|NCT02104752|79238082|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
44277236|NCT02104752|79238083|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
44277237|NCT02102724|79238091|FG000|Overall Study|Lost to Follow-up|1|||
44277238|NCT02102724|79238092|FG001|Overall Study|Lost to Follow-up|0|||
44277239|NCT02102724|79238091|FG000|Overall Study|surgery for brain aneurysm|1|||
44277240|NCT02102724|79238092|FG001|Overall Study|surgery for brain aneurysm|1|||
44277241|NCT02102490|79238098|FG000|Overall Study|Death|6|||
44277242|NCT02102490|79238098|FG000|Overall Study|Lost to Follow-up|1|||
44277243|NCT02101554|79238105|FG000|Overall Study|Protocol Violation|0|||
44277244|NCT02101554|79238106|FG001|Overall Study|Protocol Violation|1|||
44277245|NCT02101554|79238107|FG002|Overall Study|Protocol Violation|0|||
44277246|NCT02101554|79238105|FG000|Overall Study|Insufficient Clinical Response|0|||
44249366|NCT01403051|79083167|FG000|Overall Study|Lost to Follow-up|5|||
44249367|NCT01403051|79083168|FG001|Overall Study|Lost to Follow-up|5|||
44249368|NCT04115748|79083183|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
44249369|NCT04115748|79083184|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
44249370|NCT04115748|79083185|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
44249371|NCT04115748|79083186|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
44249372|NCT04115748|79083187|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
44249373|NCT04115748|79083188|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
44249374|NCT04115748|79083189|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
44249375|NCT04115748|79083190|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
44249376|NCT04115748|79083191|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
44249377|NCT04115748|79083192|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
44277247|NCT02101554|79238106|FG001|Overall Study|Insufficient Clinical Response|2|||
44277248|NCT02101554|79238107|FG002|Overall Study|Insufficient Clinical Response|0|||
44277249|NCT02101554|79238105|FG000|Overall Study|Adverse Event|2|||
44277250|NCT02101554|79238106|FG001|Overall Study|Adverse Event|1|||
44277251|NCT02101554|79238107|FG002|Overall Study|Adverse Event|1|||
44277252|NCT02101554|79238105|FG000|Overall Study|Lost to Follow-up|0|||
44277253|NCT02101554|79238106|FG001|Overall Study|Lost to Follow-up|1|||
44277254|NCT02101554|79238107|FG002|Overall Study|Lost to Follow-up|0|||
44277255|NCT02101554|79238105|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
44277256|NCT02101554|79238106|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
44514668|NCT02927080|79520419|FG008|Overall Study|Adverse Event|0|||
44277257|NCT02101554|79238107|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
44277258|NCT02128932|79238118|FG000|Overall Study|Withdrawal by Subject|11|||
44277259|NCT02128932|79238119|FG001|Overall Study|Withdrawal by Subject|7|||
44277260|NCT02128932|79238120|FG002|Overall Study|Withdrawal by Subject|8|||
44277261|NCT02128932|79238118|FG000|Overall Study|Death|2|||
44277262|NCT02128932|79238119|FG001|Overall Study|Death|0|||
44277263|NCT02128932|79238120|FG002|Overall Study|Death|2|||
44277264|NCT02128932|79238118|FG000|Overall Study|Lost to Follow-up|2|||
44277265|NCT02128932|79238119|FG001|Overall Study|Lost to Follow-up|1|||
44277266|NCT02128932|79238120|FG002|Overall Study|Lost to Follow-up|1|||
44277267|NCT02128932|79238118|FG000|Overall Study|No reason for withdrawal|12|||
44277268|NCT02128932|79238119|FG001|Overall Study|No reason for withdrawal|11|||
44277269|NCT02128932|79238120|FG002|Overall Study|No reason for withdrawal|7|||
44277270|NCT02128542|79238130|FG000|Overall Study|Lost to Follow-up|3|||
44277271|NCT02128542|79238131|FG001|Overall Study|Lost to Follow-up|0|||
44277272|NCT02128542|79238130|FG000|Overall Study|Withdrew Consent|1|||
44277273|NCT02128542|79238131|FG001|Overall Study|Withdrew Consent|0|||
44277274|NCT02127372|79238141|FG000|Overall Study|Withdrawal by Subject|1|||
44277275|NCT02127372|79238142|FG001|Overall Study|Withdrawal by Subject|0|||
44277276|NCT02126826|79238156|FG000|Overall Study|Withdrawal by Subject|0|||
44277277|NCT02126826|79238157|FG001|Overall Study|Withdrawal by Subject|0|||
44277278|NCT02126826|79238158|FG002|Overall Study|Withdrawal by Subject|0|||
44277279|NCT02126826|79238159|FG003|Overall Study|Withdrawal by Subject|1|||
44277280|NCT02126826|79238160|FG004|Overall Study|Withdrawal by Subject|0|||
44277281|NCT02126826|79238161|FG005|Overall Study|Withdrawal by Subject|0|||
44277282|NCT02126826|79238162|FG006|Overall Study|Withdrawal by Subject|0|||
44277283|NCT02126670|79238187|FG000|Overall Study|Withdrawal by Subject|1|||
44277284|NCT02126670|79238188|FG001|Overall Study|Withdrawal by Subject|0|||
44277285|NCT02126670|79238189|FG002|Overall Study|Withdrawal by Subject|0|||
44277286|NCT02126670|79238190|FG003|Overall Study|Withdrawal by Subject|1|||
44277287|NCT02125734|79238202|FG000|Period 2|Adverse Event|0|||
44277288|NCT02125734|79238203|FG001|Period 2|Adverse Event|1|||
44277289|NCT02124798|79238209|FG000|Overall Study|Adverse Event|3|||
44277290|NCT02124798|79238209|FG000|Overall Study|Lost to Follow-up|1|||
44277291|NCT02146326|79238217|FG000|Overall Study|Lost to Follow-up|3|||
44277292|NCT02146326|79238218|FG001|Overall Study|Lost to Follow-up|3|||
44277293|NCT02146326|79238219|FG002|Overall Study|Lost to Follow-up|11|||
44277294|NCT02146326|79238220|FG003|Overall Study|Lost to Follow-up|19|||
44277295|NCT02146326|79238217|FG000|Overall Study|Withdrawal by Subject|2|||
44277296|NCT02146326|79238218|FG001|Overall Study|Withdrawal by Subject|1|||
44277297|NCT02146326|79238219|FG002|Overall Study|Withdrawal by Subject|15|||
44277298|NCT02146326|79238220|FG003|Overall Study|Withdrawal by Subject|11|||
44277299|NCT02146326|79238217|FG000|Overall Study|Separated from mental health center|23|||
44277300|NCT02146326|79238218|FG001|Overall Study|Separated from mental health center|33|||
44277301|NCT02146326|79238219|FG002|Overall Study|Separated from mental health center|0|||
44143573|NCT03887117|78932884|FG003|Overall Study|Discontinued prematurely|2|||
44249378|NCT04115748|79083183|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249379|NCT04115748|79083184|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249380|NCT04115748|79083185|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249381|NCT04115748|79083186|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
44249382|NCT04115748|79083187|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249383|NCT04115748|79083188|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249384|NCT04115748|79083189|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249385|NCT04115748|79083190|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249386|NCT04115748|79083191|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249387|NCT04115748|79083192|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
44249388|NCT04115748|79083183|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
44249389|NCT04115748|79083184|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
44249390|NCT04115748|79083185|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
44249391|NCT04115748|79083186|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
44249392|NCT04115748|79083187|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
44277302|NCT02146326|79238220|FG003|Overall Study|Separated from mental health center|0|||
44277303|NCT02146326|79238217|FG000|Overall Study|Incarcerated|0|||
44514669|NCT02927080|79520420|FG009|Overall Study|Adverse Event|1|||
44514670|NCT02927080|79520411|FG000|Overall Study|Other|0|||
44277304|NCT02146326|79238218|FG001|Overall Study|Incarcerated|0|||
44277305|NCT02146326|79238219|FG002|Overall Study|Incarcerated|3|||
44277306|NCT02146326|79238220|FG003|Overall Study|Incarcerated|8|||
44277307|NCT02146326|79238217|FG000|Overall Study|Death|0|||
44277308|NCT02146326|79238218|FG001|Overall Study|Death|0|||
44277309|NCT02146326|79238219|FG002|Overall Study|Death|4|||
44277310|NCT02146326|79238220|FG003|Overall Study|Death|4|||
44277311|NCT02146326|79238217|FG000|Overall Study|Unable to complete interview|0|||
44277312|NCT02146326|79238218|FG001|Overall Study|Unable to complete interview|0|||
44277313|NCT02146326|79238219|FG002|Overall Study|Unable to complete interview|10|||
44514671|NCT02927080|79520412|FG001|Overall Study|Other|0|||
44277314|NCT02146326|79238220|FG003|Overall Study|Unable to complete interview|6|||
44277315|NCT02146248|79238236|FG000|Overall Study|Withdrawal by Subject|2|||
44277316|NCT02145468|79238246|FG000|Overall Study|Withdrawal by Subject|5|||
44277317|NCT02145468|79238247|FG001|Overall Study|Withdrawal by Subject|8|||
44277318|NCT02124564|79238253|FG000|Treatment Period|Adverse Event|2|||
44277319|NCT02124564|79238253|FG000|Treatment Period|Lack of Efficacy|3|||
44277320|NCT02124564|79238253|FG000|Treatment Period|Withdrawal by Subject|2|||
44277321|NCT02145390|79238258|FG000|Overall Study|Withdrawal by Subject|1|||
44277322|NCT02100696|79238268|FG000|Induction Phase|Adverse Event|0|||
44277323|NCT02100696|79238269|FG001|Induction Phase|Adverse Event|0|||
44277324|NCT02100696|79238270|FG002|Induction Phase|Adverse Event|1|||
44277325|NCT02100696|79238271|FG003|Induction Phase|Adverse Event|0|||
44277326|NCT02100696|79238272|FG004|Induction Phase|Adverse Event|0|||
44277327|NCT02100696|79238273|FG005|Induction Phase|Adverse Event|0|||
44249393|NCT04115748|79083188|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
44249394|NCT04115748|79083189|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
44249395|NCT04115748|79083190|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
44249396|NCT04115748|79083191|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
44249397|NCT04115748|79083192|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
44249398|NCT04115748|79083183|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44277328|NCT02100696|79238268|FG000|Induction Phase|Lost to Follow-up|1|||
44277329|NCT02100696|79238269|FG001|Induction Phase|Lost to Follow-up|0|||
44381453|NCT01026818|79387584|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
44381454|NCT01026818|79387585|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
44381455|NCT01026818|79387582|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
44381456|NCT01026818|79387583|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
44381457|NCT01026818|79387584|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
44381458|NCT01026818|79387585|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
44381459|NCT01026818|79387582|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
44381460|NCT01026818|79387583|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
44381461|NCT01026818|79387584|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
44381462|NCT01026818|79387585|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
44381463|NCT01026818|79387582|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
44381464|NCT01026818|79387583|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
44381465|NCT01026818|79387584|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
44381466|NCT01026818|79387585|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
44381467|NCT01026818|79387582|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
44381468|NCT01026818|79387583|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
44381469|NCT01026818|79387584|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
44381470|NCT01026818|79387585|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
44381471|NCT01026818|79387582|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
44381472|NCT01026818|79387583|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
44381473|NCT01026818|79387584|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
44381474|NCT01026818|79387585|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
44381475|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
44381476|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
44381477|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
44514672|NCT02927080|79520413|FG002|Overall Study|Other|0|||
44277330|NCT02100696|79238270|FG002|Induction Phase|Lost to Follow-up|1|||
44277331|NCT02100696|79238271|FG003|Induction Phase|Lost to Follow-up|0|||
44277332|NCT02100696|79238272|FG004|Induction Phase|Lost to Follow-up|0|||
44277333|NCT02100696|79238273|FG005|Induction Phase|Lost to Follow-up|0|||
44277334|NCT02100696|79238268|FG000|Induction Phase|Protocol Violation|0|||
44277335|NCT02100696|79238269|FG001|Induction Phase|Protocol Violation|1|||
44277336|NCT02100696|79238270|FG002|Induction Phase|Protocol Violation|1|||
44277337|NCT02100696|79238271|FG003|Induction Phase|Protocol Violation|0|||
44277338|NCT02100696|79238272|FG004|Induction Phase|Protocol Violation|0|||
44277339|NCT02100696|79238273|FG005|Induction Phase|Protocol Violation|0|||
44277340|NCT02100696|79238268|FG000|Induction Phase|Withdrawal by Subject|8|||
44249399|NCT04115748|79083184|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44249400|NCT04115748|79083185|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44249401|NCT04115748|79083186|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44249402|NCT04115748|79083187|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44277341|NCT02100696|79238269|FG001|Induction Phase|Withdrawal by Subject|2|||
44277342|NCT02100696|79238270|FG002|Induction Phase|Withdrawal by Subject|13|||
44277343|NCT02100696|79238271|FG003|Induction Phase|Withdrawal by Subject|0|||
44514673|NCT02927080|79520414|FG003|Overall Study|Other|0|||
44514674|NCT02927080|79520415|FG004|Overall Study|Other|0|||
44514675|NCT02927080|79520416|FG005|Overall Study|Other|0|||
44514676|NCT02927080|79520417|FG006|Overall Study|Other|1|||
44277344|NCT02100696|79238272|FG004|Induction Phase|Withdrawal by Subject|0|||
44277345|NCT02100696|79238273|FG005|Induction Phase|Withdrawal by Subject|0|||
44514677|NCT02927080|79520418|FG007|Overall Study|Other|0|||
44514678|NCT02927080|79520419|FG008|Overall Study|Other|1|||
44514679|NCT02927080|79520420|FG009|Overall Study|Other|0|||
44514680|NCT02374476|79520467|FG000|VT Induced Ablation|Screening Failures|36|||
44514681|NCT02374476|79520468|FG001|VT Induced Ablation|Screening Failures|0|||
44514682|NCT02374476|79520469|FG002|VT Induced Ablation|Screening Failures|0|||
44514683|NCT02374476|79520467|FG000|Arm Assignment|Withdrawal by Subject|0|||
44514684|NCT02374476|79520468|FG001|Arm Assignment|Withdrawal by Subject|0|||
44514685|NCT02374476|79520469|FG002|Arm Assignment|Withdrawal by Subject|1|||
44514686|NCT02918292|79520476|FG000|Study Enrollment Prior to Transplant|Death|1|||
44514687|NCT02918292|79520476|FG000|Study Follow up After Transplant|Death|6|||
44514688|NCT03720210|79520480|FG000|Overall Study|Lost to Follow-up|1|||
44514689|NCT03719586|79520488|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
44514690|NCT03719586|79520489|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
44514691|NCT03719586|79520490|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
44514692|NCT03719586|79520491|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
44514693|NCT03353350|79520517|FG000|30-week Core Treatment Period|Protocol Violation|1|||
44514694|NCT03353350|79520518|FG001|30-week Core Treatment Period|Protocol Violation|1|||
44514695|NCT03353350|79520519|FG002|30-week Core Treatment Period|Protocol Violation|1|||
44514696|NCT03353350|79520520|FG003|30-week Core Treatment Period|Protocol Violation|0|||
44514697|NCT03353350|79520517|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
44514698|NCT03353350|79520518|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
44514699|NCT03353350|79520519|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
44514700|NCT03353350|79520520|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
44514701|NCT03353350|79520517|FG000|30-week Core Treatment Period|Adverse Event|0|||
44514702|NCT03353350|79520518|FG001|30-week Core Treatment Period|Adverse Event|4|||
44514703|NCT03353350|79520519|FG002|30-week Core Treatment Period|Adverse Event|2|||
44514704|NCT03353350|79520520|FG003|30-week Core Treatment Period|Adverse Event|3|||
44514705|NCT03353350|79520517|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
44514706|NCT03353350|79520518|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
44514707|NCT03353350|79520519|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
44514708|NCT03353350|79520520|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
44514709|NCT03353350|79520517|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
44514710|NCT03353350|79520518|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
44514711|NCT03353350|79520519|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
44514712|NCT03353350|79520520|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
44514713|NCT03353350|79520517|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
44514714|NCT03353350|79520518|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
44514715|NCT03353350|79520519|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
44514716|NCT03353350|79520520|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
44514717|NCT03353350|79520517|FG000|26-week Treatment Extension Period|Adverse Event|1|||
44514718|NCT03353350|79520518|FG001|26-week Treatment Extension Period|Adverse Event|0|||
44514719|NCT03353350|79520519|FG002|26-week Treatment Extension Period|Adverse Event|0|||
44514720|NCT03353350|79520520|FG003|26-week Treatment Extension Period|Adverse Event|1|||
44143574|NCT04038385|78932905|FG000|Overall Study|Completed baseline assessment only|7|||
44143575|NCT04038385|78932906|FG001|Overall Study|Completed baseline assessment only|4|||
44143576|NCT04038385|78932905|FG000|Overall Study|Moved out of area|4|||
44514721|NCT03353350|79520517|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
44514722|NCT03353350|79520518|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
44514723|NCT03353350|79520519|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
44514724|NCT03353350|79520520|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
44514725|NCT03032068|79520534|FG000|Overall Study|Adverse Event|1|||
44514726|NCT02674516|79520554|FG000|Overall Study|Lost to Follow-up|3|||
44514727|NCT02674516|79520555|FG001|Overall Study|Lost to Follow-up|0|||
44514728|NCT02674516|79520554|FG000|Overall Study|Protocol Violation|0|||
44143577|NCT04038385|78932906|FG001|Overall Study|Moved out of area|2|||
44514729|NCT02674516|79520555|FG001|Overall Study|Protocol Violation|4|||
44514730|NCT02674516|79520554|FG000|Overall Study|Knowledge of study hypothesis|1|||
44514731|NCT02674516|79520555|FG001|Overall Study|Knowledge of study hypothesis|0|||
44514732|NCT02463448|79520561|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
44249403|NCT04115748|79083188|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44249404|NCT04115748|79083189|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44514733|NCT02463448|79520561|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
44249405|NCT04115748|79083190|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44277346|NCT02100696|79238268|FG000|Induction Phase|Physician Decision|1|||
44277347|NCT02100696|79238269|FG001|Induction Phase|Physician Decision|0|||
44277348|NCT02100696|79238270|FG002|Induction Phase|Physician Decision|2|||
44277349|NCT02100696|79238271|FG003|Induction Phase|Physician Decision|0|||
44277350|NCT02100696|79238272|FG004|Induction Phase|Physician Decision|0|||
44277351|NCT02100696|79238273|FG005|Induction Phase|Physician Decision|0|||
44277352|NCT02100696|79238268|FG000|Induction Phase|Multiple Reasons|5|||
44277353|NCT02100696|79238269|FG001|Induction Phase|Multiple Reasons|2|||
44277354|NCT02100696|79238270|FG002|Induction Phase|Multiple Reasons|8|||
44277355|NCT02100696|79238271|FG003|Induction Phase|Multiple Reasons|0|||
44277356|NCT02100696|79238272|FG004|Induction Phase|Multiple Reasons|0|||
44277357|NCT02100696|79238273|FG005|Induction Phase|Multiple Reasons|0|||
44277358|NCT02100696|79238268|FG000|Maintenance Phase|Adverse Event|0|||
44277359|NCT02100696|79238269|FG001|Maintenance Phase|Adverse Event|0|||
44277360|NCT02100696|79238270|FG002|Maintenance Phase|Adverse Event|0|||
44277361|NCT02100696|79238271|FG003|Maintenance Phase|Adverse Event|0|||
44277362|NCT02100696|79238272|FG004|Maintenance Phase|Adverse Event|0|||
44277363|NCT02100696|79238273|FG005|Maintenance Phase|Adverse Event|2|||
44277364|NCT02100696|79238268|FG000|Maintenance Phase|Lost to Follow-up|0|||
44277365|NCT02100696|79238269|FG001|Maintenance Phase|Lost to Follow-up|0|||
44277366|NCT02100696|79238270|FG002|Maintenance Phase|Lost to Follow-up|0|||
44277367|NCT02100696|79238271|FG003|Maintenance Phase|Lost to Follow-up|0|||
44277368|NCT02100696|79238272|FG004|Maintenance Phase|Lost to Follow-up|1|||
44277369|NCT02100696|79238273|FG005|Maintenance Phase|Lost to Follow-up|0|||
44277370|NCT02100696|79238268|FG000|Maintenance Phase|Protocol Violation|0|||
44277371|NCT02100696|79238269|FG001|Maintenance Phase|Protocol Violation|0|||
44277372|NCT02100696|79238270|FG002|Maintenance Phase|Protocol Violation|0|||
44277373|NCT02100696|79238271|FG003|Maintenance Phase|Protocol Violation|0|||
44277374|NCT02100696|79238272|FG004|Maintenance Phase|Protocol Violation|1|||
44277375|NCT02100696|79238273|FG005|Maintenance Phase|Protocol Violation|0|||
44277376|NCT02100696|79238268|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44277377|NCT02100696|79238269|FG001|Maintenance Phase|Withdrawal by Subject|0|||
44277378|NCT02100696|79238270|FG002|Maintenance Phase|Withdrawal by Subject|0|||
44277379|NCT02100696|79238271|FG003|Maintenance Phase|Withdrawal by Subject|1|||
44277380|NCT02100696|79238272|FG004|Maintenance Phase|Withdrawal by Subject|4|||
44277381|NCT02100696|79238273|FG005|Maintenance Phase|Withdrawal by Subject|2|||
44277382|NCT02100696|79238268|FG000|Maintenance Phase|Physician Decision|0|||
44277383|NCT02100696|79238269|FG001|Maintenance Phase|Physician Decision|0|||
44277384|NCT02100696|79238270|FG002|Maintenance Phase|Physician Decision|0|||
44277385|NCT02100696|79238271|FG003|Maintenance Phase|Physician Decision|0|||
44277386|NCT02100696|79238272|FG004|Maintenance Phase|Physician Decision|1|||
44277387|NCT02100696|79238273|FG005|Maintenance Phase|Physician Decision|0|||
44277388|NCT02100696|79238268|FG000|Maintenance Phase|Multiple Reasons|0|||
44277389|NCT02100696|79238269|FG001|Maintenance Phase|Multiple Reasons|0|||
44277390|NCT02100696|79238270|FG002|Maintenance Phase|Multiple Reasons|0|||
44277391|NCT02100696|79238271|FG003|Maintenance Phase|Multiple Reasons|0|||
44277392|NCT02100696|79238272|FG004|Maintenance Phase|Multiple Reasons|2|||
44277393|NCT02100696|79238273|FG005|Maintenance Phase|Multiple Reasons|1|||
44277394|NCT02145156|79238297|FG000|Overall Study|No match to vaccination records|60|||
44277395|NCT02145156|79238298|FG001|Overall Study|No match to vaccination records|52|||
44277396|NCT02145156|79238299|FG002|Overall Study|No match to vaccination records|41|||
44277397|NCT02123472|79238307|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
44277398|NCT02123472|79238308|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
44277399|NCT02145078|79238314|FG000|Overall Study|Death|1|||
44277400|NCT02145078|79238314|FG000|Overall Study|Reason not given|3|||
44277401|NCT02144610|79238320|FG000|Overall Study|Physician Decision|1|||
44277402|NCT02144610|79238321|FG001|Overall Study|Physician Decision|0|||
44277403|NCT02144610|79238320|FG000|Overall Study|Withdrawal by Subject|1|||
44277404|NCT02144610|79238321|FG001|Overall Study|Withdrawal by Subject|5|||
44277405|NCT02144610|79238320|FG000|Overall Study|Death|2|||
44277406|NCT02144610|79238321|FG001|Overall Study|Death|2|||
44277407|NCT02144610|79238320|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
44277408|NCT02144610|79238321|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
44277409|NCT02144610|79238320|FG000|Overall Study|Other|0|||
44277410|NCT02144610|79238321|FG001|Overall Study|Other|1|||
44277812|NCT02092350|79238806|FG000|Overall Study|Withdrawal by Subject|2|||
44277813|NCT02092350|79238807|FG001|Overall Study|Withdrawal by Subject|2|||
44277814|NCT02117544|79238815|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
44277815|NCT02117544|79238816|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
44277816|NCT02138136|79238823|FG000|Overall Study|Protocol Violation|4|||
44514734|NCT02463448|79520561|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
44514735|NCT02463448|79520561|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
44277817|NCT02138136|79238823|FG000|Overall Study|Physician Decision|7|||
44277818|NCT02138136|79238823|FG000|Overall Study|Lack of Efficacy|35|||
44277819|NCT02138136|79238823|FG000|Overall Study|Pregnancy|2|||
44514736|NCT03794544|79520569|FG000|Overall Study|Withdrawal by Subject|1|||
44277820|NCT02138136|79238823|FG000|Overall Study|Adverse Event|18|||
44277411|NCT02100228|79238329|FG000|Overall Study|Other|19|||
44277412|NCT02100228|79238330|FG001|Overall Study|Other|19|||
44277413|NCT02100228|79238329|FG000|Overall Study|Administrative reason|0|||
44277414|NCT02100228|79238330|FG001|Overall Study|Administrative reason|1|||
44277415|NCT02100228|79238329|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
44277416|NCT02100228|79238330|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
44277417|NCT02100228|79238329|FG000|Overall Study|Non-compliance|0|||
44277418|NCT02100228|79238330|FG001|Overall Study|Non-compliance|3|||
44277419|NCT02100228|79238329|FG000|Overall Study|Lost to Follow-up|0|||
44277420|NCT02100228|79238330|FG001|Overall Study|Lost to Follow-up|1|||
44277421|NCT02100228|79238329|FG000|Overall Study|Withdrawal by Subject|27|||
44277422|NCT02100228|79238330|FG001|Overall Study|Withdrawal by Subject|37|||
44277423|NCT02100228|79238329|FG000|Overall Study|Adverse Event|16|||
44277424|NCT02100228|79238330|FG001|Overall Study|Adverse Event|12|||
44277425|NCT02100228|79238329|FG000|Overall Study|Death|1|||
44277426|NCT02100228|79238330|FG001|Overall Study|Death|1|||
44277427|NCT02099838|79238338|FG000|Overall Study|Death|1|||
44277428|NCT02099838|79238339|FG001|Overall Study|Death|0|||
44277429|NCT02099838|79238338|FG000|Overall Study|Lost to Follow-up|3|||
44277430|NCT02099838|79238339|FG001|Overall Study|Lost to Follow-up|1|||
44277431|NCT02099838|79238338|FG000|Overall Study|Withdrawal by Subject|0|||
44277432|NCT02099838|79238339|FG001|Overall Study|Withdrawal by Subject|1|||
44277433|NCT02144220|79238345|FG000|Overall Study|technology incompatibility|9|||
44277434|NCT02144220|79238345|FG000|Overall Study|Lack of Efficacy|4|||
44143578|NCT04038385|78932905|FG000|Overall Study|Discontinued study involvement|6|||
44143579|NCT04038385|78932906|FG001|Overall Study|Discontinued study involvement|1|||
44143580|NCT00783263|78932916|FG000|Overall Study|Adverse Event|3|||
44143581|NCT00783263|78932917|FG001|Overall Study|Adverse Event|0|||
44143582|NCT00783263|78932918|FG002|Overall Study|Adverse Event|2|||
44277435|NCT02144220|79238345|FG000|Overall Study|Physician Decision|3|||
44277436|NCT02144220|79238345|FG000|Overall Study|Withdrawal by Subject|2|||
44277437|NCT02144220|79238345|FG000|Overall Study|Protocol Violation|1|||
44277438|NCT02099682|79238349|FG000|Overall Study|Data Not Available|51|||
44277439|NCT02099682|79238349|FG000|Overall Study|Lost to Follow-up|31|||
44277440|NCT02099682|79238349|FG000|Overall Study|Other|29|||
44277441|NCT02142894|79238353|FG000|Overall Study|Protocol Violation|8|||
44277442|NCT02098746|79238357|FG000|Overall Study|Changes of Investigator|2|||
44277443|NCT02098746|79238357|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44277444|NCT02098746|79238357|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
44277445|NCT02098746|79238357|FG000|Overall Study|Data Not Available After Treatment|1|||
44277446|NCT02122770|79238365|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
44277447|NCT02122770|79238366|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
44277448|NCT02122770|79238367|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
44277449|NCT02122770|79238368|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
44277450|NCT02122770|79238369|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
44277451|NCT02122770|79238370|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
44143583|NCT00783263|78932919|FG003|Overall Study|Adverse Event|1|||
44143584|NCT00783263|78932916|FG000|Overall Study|Lost to Follow-up|1|||
44143585|NCT00783263|78932917|FG001|Overall Study|Lost to Follow-up|1|||
44143586|NCT00783263|78932918|FG002|Overall Study|Lost to Follow-up|0|||
44143587|NCT00783263|78932919|FG003|Overall Study|Lost to Follow-up|0|||
44143588|NCT00783263|78932916|FG000|Overall Study|Withdrawal by Subject|0|||
44143589|NCT00783263|78932917|FG001|Overall Study|Withdrawal by Subject|1|||
44143590|NCT00783263|78932918|FG002|Overall Study|Withdrawal by Subject|1|||
44143591|NCT00783263|78932919|FG003|Overall Study|Withdrawal by Subject|2|||
44143592|NCT03987919|78932946|FG000|Overall Study|Adverse Event|1|||
44143593|NCT03987919|78932947|FG001|Overall Study|Adverse Event|4|||
44249406|NCT04115748|79083191|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
44249407|NCT04115748|79083192|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
44249408|NCT02652624|79083249|FG000|Randomized Phase|Pregnancy|3|||
44249409|NCT02652624|79083250|FG001|Randomized Phase|Pregnancy|1|||
44249410|NCT02652624|79083249|FG000|Randomized Phase|Investigator's Discretion|0|||
44249411|NCT02652624|79083250|FG001|Randomized Phase|Investigator's Discretion|2|||
44249412|NCT02652624|79083249|FG000|Randomized Phase|Death|0|||
44249413|NCT02652624|79083250|FG001|Randomized Phase|Death|1|||
44249414|NCT02652624|79083249|FG000|Randomized Phase|Lost to Follow-up|0|||
44249415|NCT02652624|79083250|FG001|Randomized Phase|Lost to Follow-up|1|||
44249416|NCT02652624|79083249|FG000|Extension Phase|Lost to Follow-up|3|||
44249417|NCT02652624|79083250|FG001|Extension Phase|Lost to Follow-up|1|||
44249418|NCT02652624|79083249|FG000|Extension Phase|Pregnancy|1|||
44277452|NCT02122770|79238365|FG000|Part A: Drug-drug Interaction 2|Other|0|||
44277453|NCT02122770|79238366|FG001|Part A: Drug-drug Interaction 2|Other|0|||
44277454|NCT02122770|79238367|FG002|Part A: Drug-drug Interaction 2|Other|1|||
44277455|NCT02122770|79238368|FG003|Part A: Drug-drug Interaction 2|Other|0|||
44143594|NCT03987919|78932948|FG002|Overall Study|Adverse Event|1|||
44277456|NCT02122770|79238369|FG004|Part A: Drug-drug Interaction 2|Other|0|||
44277457|NCT02122770|79238370|FG005|Part A: Drug-drug Interaction 2|Other|0|||
44277458|NCT02122770|79238365|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
44277459|NCT02122770|79238366|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
44277460|NCT02122770|79238367|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
44277461|NCT02122770|79238368|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
44277462|NCT02122770|79238369|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
44277463|NCT02122770|79238370|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
44277464|NCT02122770|79238365|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
44277465|NCT02122770|79238366|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
44277466|NCT02122770|79238367|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
44277467|NCT02122770|79238368|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
44277468|NCT02122770|79238369|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
44277469|NCT02122770|79238370|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
44277470|NCT02122770|79238365|FG000|Part B: Standard of Care|Adverse Event|0|||
44277471|NCT02122770|79238366|FG001|Part B: Standard of Care|Adverse Event|0|||
44277472|NCT02122770|79238367|FG002|Part B: Standard of Care|Adverse Event|0|||
44277473|NCT02122770|79238368|FG003|Part B: Standard of Care|Adverse Event|0|||
44277474|NCT02122770|79238369|FG004|Part B: Standard of Care|Adverse Event|4|||
44277475|NCT02122770|79238370|FG005|Part B: Standard of Care|Adverse Event|1|||
44277476|NCT02122770|79238365|FG000|Part B: Standard of Care|Other|0|||
44277477|NCT02122770|79238366|FG001|Part B: Standard of Care|Other|0|||
44277478|NCT02122770|79238367|FG002|Part B: Standard of Care|Other|0|||
44277479|NCT02122770|79238368|FG003|Part B: Standard of Care|Other|0|||
44277480|NCT02122770|79238369|FG004|Part B: Standard of Care|Other|0|||
44277481|NCT02122770|79238370|FG005|Part B: Standard of Care|Other|2|||
44277482|NCT02122770|79238365|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
44277483|NCT02122770|79238366|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
44277484|NCT02122770|79238367|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
44277485|NCT02122770|79238368|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
44277486|NCT02122770|79238369|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
44277487|NCT02122770|79238370|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
44277488|NCT02122770|79238365|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
44277489|NCT02122770|79238366|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
44277490|NCT02122770|79238367|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
44277491|NCT02122770|79238368|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
44277492|NCT02122770|79238369|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
44277493|NCT02122770|79238370|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
44277494|NCT02122770|79238365|FG000|Part B: Standard of Care|Progressive Disease|0|||
44277495|NCT02122770|79238366|FG001|Part B: Standard of Care|Progressive Disease|0|||
44277496|NCT02122770|79238367|FG002|Part B: Standard of Care|Progressive Disease|0|||
44277497|NCT02122770|79238368|FG003|Part B: Standard of Care|Progressive Disease|0|||
44277498|NCT02122770|79238369|FG004|Part B: Standard of Care|Progressive Disease|10|||
44277499|NCT02122770|79238370|FG005|Part B: Standard of Care|Progressive Disease|8|||
44277500|NCT02122380|79238395|FG000|First Intervention (30 Days)|Adverse Event|1|||
44277501|NCT02122380|79238396|FG001|First Intervention (30 Days)|Adverse Event|0|||
44277502|NCT02122380|79238395|FG000|First Intervention (30 Days)|Physician Decision|0|||
44277503|NCT02122380|79238396|FG001|First Intervention (30 Days)|Physician Decision|1|||
44143595|NCT03987919|78932949|FG003|Overall Study|Adverse Event|3|||
44143596|NCT03987919|78932946|FG000|Overall Study|Death|4|||
44143597|NCT03987919|78932947|FG001|Overall Study|Death|4|||
44143598|NCT03987919|78932948|FG002|Overall Study|Death|4|||
44143599|NCT03987919|78932949|FG003|Overall Study|Death|1|||
44249419|NCT02652624|79083250|FG001|Extension Phase|Pregnancy|1|||
44143600|NCT03987919|78932946|FG000|Overall Study|Lost to Follow-up|5|||
44249420|NCT02652624|79083249|FG000|Extension Phase|Adverse Event|0|||
44249421|NCT02652624|79083250|FG001|Extension Phase|Adverse Event|1|||
44249422|NCT02652624|79083249|FG000|Extension Phase|Withdrew Consent|0|||
44249423|NCT02652624|79083250|FG001|Extension Phase|Withdrew Consent|1|||
44249424|NCT00249795|79083260|FG000|Overall Study|Not treated|16|||
44249425|NCT00249795|79083261|FG001|Overall Study|Not treated|14|||
44249426|NCT00249795|79083260|FG000|Overall Study|Symptomatic hypotension|127|||
44249427|NCT00249795|79083261|FG001|Overall Study|Symptomatic hypotension|64|||
44249428|NCT00249795|79083260|FG000|Overall Study|Other Serious Adverse Event|84|||
44249429|NCT00249795|79083261|FG001|Overall Study|Other Serious Adverse Event|93|||
44249430|NCT00249795|79083260|FG000|Overall Study|Qualifying condition not present|26|||
44249431|NCT00249795|79083261|FG001|Overall Study|Qualifying condition not present|29|||
44249432|NCT00249795|79083260|FG000|Overall Study|Withdrawal by Subject|678|||
44249433|NCT00249795|79083261|FG001|Overall Study|Withdrawal by Subject|742|||
44249434|NCT00249795|79083260|FG000|Overall Study|Thromboembolic / outcome event|39|||
44249435|NCT00249795|79083261|FG001|Overall Study|Thromboembolic / outcome event|45|||
44249436|NCT00249795|79083260|FG000|Overall Study|Oral anticoagulant required|2|||
44249437|NCT00249795|79083261|FG001|Overall Study|Oral anticoagulant required|0|||
44143601|NCT03987919|78932947|FG001|Overall Study|Lost to Follow-up|6|||
44143602|NCT03987919|78932948|FG002|Overall Study|Lost to Follow-up|8|||
44277504|NCT02122380|79238395|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
44277505|NCT02122380|79238396|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
44277506|NCT02122380|79238395|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
44277507|NCT02122380|79238396|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
44277508|NCT02122380|79238395|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
44277509|NCT02122380|79238396|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
44277510|NCT02122146|79238411|FG000|Part 1: Dose Escalation|Death|0|||
44277511|NCT02122146|79238412|FG001|Part 1: Dose Escalation|Death|1|||
44277512|NCT02122146|79238413|FG002|Part 1: Dose Escalation|Death|1|||
44277513|NCT02122146|79238414|FG003|Part 1: Dose Escalation|Death|0|||
44277514|NCT02122146|79238415|FG004|Part 1: Dose Escalation|Death|0|||
44277515|NCT02122146|79238416|FG005|Part 1: Dose Escalation|Death|0|||
44277516|NCT02122146|79238417|FG006|Part 1: Dose Escalation|Death|0|||
44277517|NCT02122146|79238418|FG007|Part 1: Dose Escalation|Death|0|||
44277518|NCT02122146|79238411|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
44277519|NCT02122146|79238412|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
44277520|NCT02122146|79238413|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
44277521|NCT02122146|79238414|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
44277522|NCT02122146|79238415|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
44277523|NCT02122146|79238416|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
44277524|NCT02122146|79238417|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
44277525|NCT02122146|79238418|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
44277526|NCT02122146|79238411|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277527|NCT02122146|79238412|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277528|NCT02122146|79238413|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277529|NCT02122146|79238414|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
44381478|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
44381479|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
44381480|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
44381481|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
44143603|NCT03987919|78932949|FG003|Overall Study|Lost to Follow-up|12|||
44143604|NCT03987919|78932946|FG000|Overall Study|Physician Decision|0|||
44381482|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
44381483|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
44381484|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
44143605|NCT03987919|78932947|FG001|Overall Study|Physician Decision|2|||
44143606|NCT03987919|78932948|FG002|Overall Study|Physician Decision|0|||
44381485|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
44381486|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
44381487|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
44381488|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
44381489|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
44143607|NCT03987919|78932949|FG003|Overall Study|Physician Decision|4|||
44249438|NCT00249795|79083260|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
44249439|NCT00249795|79083261|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
44249440|NCT00249795|79083260|FG000|Overall Study|Non-compliance|71|||
44249441|NCT00249795|79083261|FG001|Overall Study|Non-compliance|69|||
44249442|NCT00249795|79083260|FG000|Overall Study|Study drug intolerance|3|||
44249443|NCT00249795|79083261|FG001|Overall Study|Study drug intolerance|3|||
44249444|NCT00249795|79083260|FG000|Overall Study|Other adverse events (non-serious)|188|||
44249445|NCT00249795|79083261|FG001|Overall Study|Other adverse events (non-serious)|159|||
44249446|NCT00249795|79083260|FG000|Overall Study|Physician withdrew consent|71|||
44249447|NCT00249795|79083261|FG001|Overall Study|Physician withdrew consent|63|||
44249448|NCT00249795|79083260|FG000|Overall Study|Surgery / procedure|4|||
44249449|NCT00249795|79083261|FG001|Overall Study|Surgery / procedure|5|||
44249450|NCT00249795|79083260|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
44249451|NCT00249795|79083261|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
44277530|NCT02122146|79238415|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277531|NCT02122146|79238416|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277532|NCT02122146|79238417|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277533|NCT02122146|79238418|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
44277534|NCT02122146|79238411|FG000|Part 1: Dose Escalation|Other|1|||
44381490|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
44381491|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
44277535|NCT02122146|79238412|FG001|Part 1: Dose Escalation|Other|0|||
44143608|NCT03987919|78932946|FG000|Overall Study|Pregnancy|1|||
44249452|NCT00249795|79083260|FG000|Overall Study|Lightheadedness / dizziness|15|||
44277536|NCT02122146|79238413|FG002|Part 1: Dose Escalation|Other|0|||
44277537|NCT02122146|79238414|FG003|Part 1: Dose Escalation|Other|0|||
44277538|NCT02122146|79238415|FG004|Part 1: Dose Escalation|Other|0|||
44249453|NCT00249795|79083261|FG001|Overall Study|Lightheadedness / dizziness|11|||
44277539|NCT02122146|79238416|FG005|Part 1: Dose Escalation|Other|1|||
44277540|NCT02122146|79238417|FG006|Part 1: Dose Escalation|Other|1|||
44277541|NCT02122146|79238418|FG007|Part 1: Dose Escalation|Other|2|||
44277542|NCT02121834|79238444|FG000|Overall Study|Protocol Violation|0|||
44514737|NCT03794544|79520570|FG001|Overall Study|Withdrawal by Subject|1|||
44514738|NCT03794544|79520571|FG002|Overall Study|Withdrawal by Subject|0|||
44514739|NCT03794544|79520572|FG003|Overall Study|Withdrawal by Subject|0|||
44143609|NCT03987919|78932947|FG001|Overall Study|Pregnancy|0|||
44143610|NCT03987919|78932948|FG002|Overall Study|Pregnancy|1|||
44143611|NCT03987919|78932949|FG003|Overall Study|Pregnancy|1|||
44143612|NCT03987919|78932946|FG000|Overall Study|Protocol Violation|0|||
44143613|NCT03987919|78932947|FG001|Overall Study|Protocol Violation|1|||
44143614|NCT03987919|78932948|FG002|Overall Study|Protocol Violation|0|||
44143615|NCT03987919|78932949|FG003|Overall Study|Protocol Violation|0|||
44143616|NCT03987919|78932946|FG000|Overall Study|Site terminated by Sponsor|0|||
44143617|NCT03987919|78932947|FG001|Overall Study|Site terminated by Sponsor|0|||
44249454|NCT00249795|79083260|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
44249455|NCT00249795|79083261|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
44249456|NCT00249795|79083260|FG000|Overall Study|Other contraindicated medication|1|||
44249457|NCT00249795|79083261|FG001|Overall Study|Other contraindicated medication|1|||
44249458|NCT00249795|79083260|FG000|Overall Study|Event related to cardiac condition|17|||
44249459|NCT00249795|79083261|FG001|Overall Study|Event related to cardiac condition|16|||
44277543|NCT02121834|79238445|FG001|Overall Study|Protocol Violation|1|||
44277544|NCT02121834|79238446|FG002|Overall Study|Protocol Violation|0|||
44277545|NCT02121834|79238447|FG003|Overall Study|Protocol Violation|0|||
44277546|NCT02121834|79238448|FG004|Overall Study|Protocol Violation|0|||
44277547|NCT02121834|79238449|FG005|Overall Study|Protocol Violation|0|||
44249460|NCT00249795|79083260|FG000|Overall Study|Patient not wish to continue after May08|4|||
44249461|NCT00249795|79083261|FG001|Overall Study|Patient not wish to continue after May08|6|||
44249462|NCT00249795|79083260|FG000|Overall Study|Site not agree to continue after May08|1|||
44249463|NCT00249795|79083261|FG001|Overall Study|Site not agree to continue after May08|1|||
44249464|NCT00249795|79083260|FG000|Overall Study|Lost to Follow-up|0|||
44249465|NCT00249795|79083261|FG001|Overall Study|Lost to Follow-up|2|||
44249466|NCT00249795|79083260|FG000|Overall Study|Missing|0|||
44249467|NCT00249795|79083261|FG001|Overall Study|Missing|1|||
44249468|NCT02651220|79083270|FG000|Overall Study|Adverse Event|1|||
44249469|NCT02651220|79083271|FG001|Overall Study|Adverse Event|5|||
44277548|NCT02121834|79238450|FG006|Overall Study|Protocol Violation|0|||
44277549|NCT02121834|79238444|FG000|Overall Study|Withdrawal by Subject|0|||
44277550|NCT02121834|79238445|FG001|Overall Study|Withdrawal by Subject|1|||
44277551|NCT02121834|79238446|FG002|Overall Study|Withdrawal by Subject|1|||
44277552|NCT02121834|79238447|FG003|Overall Study|Withdrawal by Subject|0|||
44277553|NCT02121834|79238448|FG004|Overall Study|Withdrawal by Subject|0|||
44277554|NCT02121834|79238449|FG005|Overall Study|Withdrawal by Subject|0|||
44277555|NCT02121834|79238450|FG006|Overall Study|Withdrawal by Subject|0|||
44277556|NCT02121834|79238444|FG000|Overall Study|Lost to Follow-up|0|||
44277557|NCT02121834|79238445|FG001|Overall Study|Lost to Follow-up|0|||
44277558|NCT02121834|79238446|FG002|Overall Study|Lost to Follow-up|1|||
44277559|NCT02121834|79238447|FG003|Overall Study|Lost to Follow-up|0|||
44277560|NCT02121834|79238448|FG004|Overall Study|Lost to Follow-up|0|||
44277561|NCT02121834|79238449|FG005|Overall Study|Lost to Follow-up|0|||
44277562|NCT02121834|79238450|FG006|Overall Study|Lost to Follow-up|0|||
44277563|NCT02121756|79238478|FG000|Overall Study|Adverse Event|3|||
44277564|NCT02121756|79238479|FG001|Overall Study|Adverse Event|0|||
44277565|NCT02121756|79238478|FG000|Overall Study|Protocol Violation|1|||
44277566|NCT02121756|79238479|FG001|Overall Study|Protocol Violation|1|||
44277567|NCT02121756|79238478|FG000|Overall Study|Physician Decision|2|||
44277568|NCT02121756|79238479|FG001|Overall Study|Physician Decision|1|||
44277569|NCT02142504|79238491|FG000|Overall Study|Protocol Violation|2|||
44277570|NCT02142504|79238492|FG001|Overall Study|Protocol Violation|1|||
44277571|NCT02142504|79238493|FG002|Overall Study|Protocol Violation|2|||
44277572|NCT02142504|79238491|FG000|Overall Study|Adverse Event|2|||
44277573|NCT02142504|79238492|FG001|Overall Study|Adverse Event|3|||
44514740|NCT03794544|79520569|FG000|Overall Study|Death|0|||
44514741|NCT03794544|79520570|FG001|Overall Study|Death|0|||
44143618|NCT03987919|78932948|FG002|Overall Study|Site terminated by Sponsor|0|||
44143619|NCT03987919|78932949|FG003|Overall Study|Site terminated by Sponsor|1|||
44277574|NCT02142504|79238493|FG002|Overall Study|Adverse Event|4|||
44514742|NCT03794544|79520571|FG002|Overall Study|Death|0|||
44143620|NCT03987919|78932946|FG000|Overall Study|Withdrawal by Subject|7|||
44249470|NCT02651220|79083272|FG002|Overall Study|Adverse Event|1|||
44249471|NCT02651220|79083270|FG000|Overall Study|Lost to Follow-up|8|||
44277575|NCT02142504|79238491|FG000|Overall Study|Lost to Follow-up|12|||
44277576|NCT02142504|79238492|FG001|Overall Study|Lost to Follow-up|19|||
44277577|NCT02142504|79238493|FG002|Overall Study|Lost to Follow-up|17|||
44277578|NCT02142504|79238491|FG000|Overall Study|Withdrawal by Subject|7|||
44277579|NCT02142504|79238492|FG001|Overall Study|Withdrawal by Subject|9|||
44514743|NCT03794544|79520572|FG003|Overall Study|Death|1|||
44249472|NCT02651220|79083271|FG001|Overall Study|Lost to Follow-up|14|||
44277580|NCT02142504|79238493|FG002|Overall Study|Withdrawal by Subject|11|||
44277581|NCT02142504|79238491|FG000|Overall Study|Pregnancy|4|||
44277582|NCT02142504|79238492|FG001|Overall Study|Pregnancy|4|||
44277583|NCT02142504|79238493|FG002|Overall Study|Pregnancy|2|||
44277584|NCT02142504|79238491|FG000|Overall Study|Physician Decision|0|||
44277585|NCT02142504|79238492|FG001|Overall Study|Physician Decision|1|||
44277586|NCT02142504|79238493|FG002|Overall Study|Physician Decision|3|||
44277587|NCT02142504|79238491|FG000|Overall Study|Reason Not Specified|4|||
44277588|NCT02142504|79238492|FG001|Overall Study|Reason Not Specified|5|||
44277589|NCT02142504|79238493|FG002|Overall Study|Reason Not Specified|4|||
44277590|NCT02121522|79238501|FG000|Overall Study|Adverse Event|1|||
44277591|NCT02121210|79238507|FG000|Overall Study|Adverse Event|5|||
44277592|NCT02121210|79238508|FG001|Overall Study|Adverse Event|7|||
44277593|NCT02121210|79238507|FG000|Overall Study|Lack of Efficacy|2|||
44277594|NCT02121210|79238508|FG001|Overall Study|Lack of Efficacy|0|||
44249473|NCT02651220|79083272|FG002|Overall Study|Lost to Follow-up|14|||
44249474|NCT02651220|79083270|FG000|Overall Study|Non-Compliance with Study Drug|4|||
44249475|NCT02651220|79083271|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44249476|NCT02651220|79083272|FG002|Overall Study|Non-Compliance with Study Drug|1|||
44249477|NCT02651220|79083270|FG000|Overall Study|Pregnancy|1|||
44249478|NCT02651220|79083271|FG001|Overall Study|Pregnancy|0|||
44249479|NCT02651220|79083272|FG002|Overall Study|Pregnancy|1|||
44249480|NCT02651220|79083270|FG000|Overall Study|Protocol Violation|0|||
44249481|NCT02651220|79083271|FG001|Overall Study|Protocol Violation|0|||
44249482|NCT02651220|79083272|FG002|Overall Study|Protocol Violation|1|||
44249483|NCT02651220|79083270|FG000|Overall Study|Withdrawal by Subject|5|||
44249484|NCT02651220|79083271|FG001|Overall Study|Withdrawal by Subject|6|||
44249485|NCT02651220|79083272|FG002|Overall Study|Withdrawal by Subject|8|||
44249486|NCT02651220|79083270|FG000|Overall Study|Miscellaneous|4|||
44249487|NCT02651220|79083271|FG001|Overall Study|Miscellaneous|1|||
44249488|NCT02651220|79083272|FG002|Overall Study|Miscellaneous|2|||
44249489|NCT02651220|79083270|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44249490|NCT02651220|79083271|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
44249491|NCT02651220|79083272|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
44249492|NCT00247611|79083320|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
44249493|NCT00247611|79083321|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
44249494|NCT00247611|79083320|FG000|Baselined|Completed baseline only|9|||
44249495|NCT00247611|79083321|FG001|Baselined|Completed baseline only|8|||
44249496|NCT00246753|79083344|FG000|Overall Study|Withdrawal by Subject|2|||
44249497|NCT00246753|79083344|FG000|Overall Study|Physician Decision|2|||
44249498|NCT00246753|79083344|FG000|Overall Study|Adverse Event|2|||
44249499|NCT00246753|79083344|FG000|Overall Study|Unacceptable toxicity|2|||
44277595|NCT02121210|79238507|FG000|Overall Study|Other than specified above|0|||
44277596|NCT02121210|79238508|FG001|Overall Study|Other than specified above|2|||
44277597|NCT02141490|79238517|FG000|Overall Study|Screening failures|4|||
44277598|NCT02141490|79238518|FG001|Overall Study|Screening failures|0|||
44277599|NCT02141490|79238519|FG002|Overall Study|Screening failures|0|||
44277600|NCT02097108|79238529|FG000|Overall Study|Adverse Event|1|||
44277601|NCT02097108|79238529|FG000|Overall Study|patient was abroad for 6 months|1|||
44277602|NCT02097030|79238535|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
44277603|NCT02097030|79238536|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
44277604|NCT02097030|79238535|FG000|First Intervention (3 Days)|Visual Acuity|0|||
44277605|NCT02097030|79238536|FG001|First Intervention (3 Days)|Visual Acuity|1|||
44277606|NCT02096952|79238546|FG000|Overall Study|Adverse Event|1|||
44277607|NCT02120898|79238553|FG000|Overall Study|Withdrawal by Subject|4|||
44277608|NCT02120898|79238554|FG001|Overall Study|Withdrawal by Subject|2|||
44277609|NCT02120898|79238555|FG002|Overall Study|Withdrawal by Subject|2|||
44277610|NCT02120898|79238553|FG000|Overall Study|Non-compliance with study drug|3|||
44277611|NCT02120898|79238554|FG001|Overall Study|Non-compliance with study drug|0|||
44514744|NCT03794544|79520569|FG000|Overall Study|Lost to Follow-up|0|||
44514745|NCT03794544|79520570|FG001|Overall Study|Lost to Follow-up|1|||
44277612|NCT02120898|79238555|FG002|Overall Study|Non-compliance with study drug|0|||
44277613|NCT02120898|79238553|FG000|Overall Study|Adverse Event|1|||
44277614|NCT02120898|79238554|FG001|Overall Study|Adverse Event|2|||
44277615|NCT02120898|79238555|FG002|Overall Study|Adverse Event|1|||
44277616|NCT02120898|79238553|FG000|Overall Study|Protocol Violation|1|||
44249500|NCT00246129|79083361|FG000|Overall Study|Lost to Follow-up|1|||
44249501|NCT00246129|79083362|FG001|Overall Study|Lost to Follow-up|0|||
44249502|NCT00246129|79083361|FG000|Overall Study|Death|2|||
44249503|NCT00246129|79083362|FG001|Overall Study|Death|1|||
44277617|NCT02120898|79238554|FG001|Overall Study|Protocol Violation|2|||
44277618|NCT02120898|79238555|FG002|Overall Study|Protocol Violation|0|||
44277619|NCT02120898|79238553|FG000|Overall Study|Lost to Follow-up|0|||
44277620|NCT02120898|79238554|FG001|Overall Study|Lost to Follow-up|0|||
44277621|NCT02120898|79238555|FG002|Overall Study|Lost to Follow-up|1|||
44249504|NCT00246129|79083361|FG000|Overall Study|suffered primary non-function|1|||
44249505|NCT00246129|79083362|FG001|Overall Study|suffered primary non-function|0|||
44249506|NCT00246129|79083361|FG000|Overall Study|grafts failed|3|||
44277622|NCT02120664|79238568|FG000|Overall Study|Withdrawal by Subject|0|||
44277623|NCT02120664|79238569|FG001|Overall Study|Withdrawal by Subject|0|||
44277624|NCT02120664|79238570|FG002|Overall Study|Withdrawal by Subject|0|||
44277625|NCT02120664|79238571|FG003|Overall Study|Withdrawal by Subject|1|||
44277626|NCT02120664|79238572|FG004|Overall Study|Withdrawal by Subject|0|||
44277627|NCT01627860|79238587|FG000|Overall Study|Adverse Event|9|||
44277628|NCT01627860|79238588|FG001|Overall Study|Adverse Event|4|||
44277629|NCT01627860|79238587|FG000|Overall Study|Withdrawal by Subject|2|||
44277630|NCT01627860|79238588|FG001|Overall Study|Withdrawal by Subject|1|||
44277631|NCT01627860|79238587|FG000|Overall Study|Seizure frequency doubled|0|||
44277632|NCT01627860|79238588|FG001|Overall Study|Seizure frequency doubled|1|||
44277633|NCT01627860|79238587|FG000|Overall Study|Protocol Violation|1|||
44277634|NCT01627860|79238588|FG001|Overall Study|Protocol Violation|0|||
44277635|NCT01627782|79238598|FG000|Overall Study|Adverse Event|1|||
44277636|NCT01627782|79238599|FG001|Overall Study|Adverse Event|2|||
44277637|NCT01627782|79238600|FG002|Overall Study|Adverse Event|0|||
44277638|NCT01627782|79238601|FG003|Overall Study|Adverse Event|1|||
44277639|NCT01627782|79238598|FG000|Overall Study|Lack of Efficacy|11|||
44277640|NCT01627782|79238599|FG001|Overall Study|Lack of Efficacy|1|||
44277641|NCT01627782|79238600|FG002|Overall Study|Lack of Efficacy|15|||
44277642|NCT01627782|79238601|FG003|Overall Study|Lack of Efficacy|2|||
44277643|NCT01627782|79238598|FG000|Overall Study|Protocol Violation|1|||
44249507|NCT00246129|79083362|FG001|Overall Study|grafts failed|1|||
44249508|NCT03182868|79083385|FG000|Overall Study|Protocol Violation|3|||
44249509|NCT03182868|79083386|FG001|Overall Study|Protocol Violation|0|||
44249510|NCT03182868|79083387|FG002|Overall Study|Protocol Violation|4|||
44249511|NCT03182868|79083388|FG003|Overall Study|Protocol Violation|1|||
44249512|NCT03182868|79083389|FG004|Overall Study|Protocol Violation|8|||
44249513|NCT00245583|79083413|FG000|Overall Study|Lost to Follow-up|1|||
44249514|NCT00245583|79083414|FG001|Overall Study|Lost to Follow-up|5|||
44249515|NCT00245583|79083413|FG000|Overall Study|Adverse Event|2|||
44249516|NCT00245583|79083414|FG001|Overall Study|Adverse Event|1|||
44249517|NCT00245583|79083413|FG000|Overall Study|Lack of Efficacy|1|||
44249518|NCT00245583|79083414|FG001|Overall Study|Lack of Efficacy|0|||
44249519|NCT00245583|79083413|FG000|Overall Study|Withdrawal by Subject|2|||
44249520|NCT00245583|79083414|FG001|Overall Study|Withdrawal by Subject|3|||
44249521|NCT02652156|79083423|FG000|Overall Study|Physician Decision|1|||
44249522|NCT02652156|79083424|FG001|Overall Study|Physician Decision|0|||
44249523|NCT02652156|79083425|FG002|Overall Study|Physician Decision|0|||
44249524|NCT01675050|79083472|FG000|Period One Treatment|Withdrawal by Subject|1|||
44277644|NCT01627782|79238599|FG001|Overall Study|Protocol Violation|0|||
44277645|NCT01627782|79238600|FG002|Overall Study|Protocol Violation|0|||
44277646|NCT01627782|79238601|FG003|Overall Study|Protocol Violation|0|||
44277647|NCT01627782|79238598|FG000|Overall Study|Withdrawal by Subject|2|||
44277648|NCT01627782|79238599|FG001|Overall Study|Withdrawal by Subject|1|||
44277649|NCT01627782|79238600|FG002|Overall Study|Withdrawal by Subject|0|||
44277650|NCT01627782|79238601|FG003|Overall Study|Withdrawal by Subject|0|||
44277651|NCT01627782|79238598|FG000|Overall Study|Other|0|||
44277652|NCT01627782|79238599|FG001|Overall Study|Other|2|||
44277653|NCT01627782|79238600|FG002|Overall Study|Other|0|||
44277654|NCT01627782|79238601|FG003|Overall Study|Other|3|||
44277655|NCT01627782|79238598|FG000|Overall Study|Randomized But Not Treated|1|||
44277656|NCT01627782|79238599|FG001|Overall Study|Randomized But Not Treated|0|||
44277657|NCT01627782|79238600|FG002|Overall Study|Randomized But Not Treated|0|||
44277658|NCT01627782|79238601|FG003|Overall Study|Randomized But Not Treated|0|||
44277659|NCT01598532|79238613|FG000|Overall Study|Lost to Follow-up|3|||
44249525|NCT01675050|79083473|FG001|Period One Treatment|Withdrawal by Subject|0|||
44277660|NCT01598532|79238613|FG000|Overall Study|Did not meet inclusion criteria|8|||
44277661|NCT02119650|79238622|FG000|Overall Study|Adverse Event|3|||
44277662|NCT02119650|79238623|FG001|Overall Study|Adverse Event|4|||
44277663|NCT02119650|79238622|FG000|Overall Study|Subject decision|2|||
44277664|NCT02119650|79238623|FG001|Overall Study|Subject decision|3|||
44277665|NCT02119650|79238622|FG000|Overall Study|Disease progression|11|||
44277666|NCT02119650|79238623|FG001|Overall Study|Disease progression|14|||
44277667|NCT02119650|79238622|FG000|Overall Study|Death|5|||
44277668|NCT02119650|79238623|FG001|Overall Study|Death|1|||
44277669|NCT02119650|79238622|FG000|Overall Study|Noncompliance with study treatment|1|||
44249526|NCT00244881|79083492|FG000|Overall Study|Withdrawal by Subject|3|||
44277670|NCT02119650|79238623|FG001|Overall Study|Noncompliance with study treatment|1|||
44277671|NCT02119650|79238622|FG000|Overall Study|Study terminated by the sponsor|1|||
44249527|NCT00244725|79083523|FG000|Overall Study|Lost to Follow-up|3|||
44249528|NCT00244725|79083524|FG001|Overall Study|Lost to Follow-up|4|||
44249529|NCT00244725|79083525|FG002|Overall Study|Lost to Follow-up|9|||
44249530|NCT00244725|79083526|FG003|Overall Study|Lost to Follow-up|2|||
44277672|NCT02119650|79238623|FG001|Overall Study|Study terminated by the sponsor|0|||
44277673|NCT02119650|79238622|FG000|Overall Study|Physician Decision|0|||
44277674|NCT02119650|79238623|FG001|Overall Study|Physician Decision|2|||
44277675|NCT02119650|79238622|FG000|Overall Study|Multiple reasons for termination|2|||
44277676|NCT02119650|79238623|FG001|Overall Study|Multiple reasons for termination|1|||
44277677|NCT02119416|79238632|FG000|Overall Study|Protocol Violation|1|||
44277678|NCT02119416|79238633|FG001|Overall Study|Protocol Violation|1|||
44277679|NCT02119416|79238634|FG002|Overall Study|Protocol Violation|1|||
44277680|NCT02119416|79238632|FG000|Overall Study|wrong pubertal stage|1|||
44277681|NCT02119416|79238633|FG001|Overall Study|wrong pubertal stage|0|||
44277682|NCT02119416|79238634|FG002|Overall Study|wrong pubertal stage|1|||
44277683|NCT02140164|79238645|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
44277684|NCT02119260|79238656|FG000|Overall Study|Adverse Event|1|||
44277685|NCT02119260|79238657|FG001|Overall Study|Adverse Event|0|||
44277686|NCT02119260|79238658|FG002|Overall Study|Adverse Event|0|||
44277687|NCT02119260|79238659|FG003|Overall Study|Adverse Event|0|||
44277688|NCT02119260|79238660|FG004|Overall Study|Adverse Event|0|||
44277689|NCT02119260|79238661|FG005|Overall Study|Adverse Event|0|||
44277690|NCT02119260|79238662|FG006|Overall Study|Adverse Event|0|||
44277691|NCT02119260|79238656|FG000|Overall Study|Withdrew consent|0|||
44381492|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
44514746|NCT03794544|79520571|FG002|Overall Study|Lost to Follow-up|1|||
44514747|NCT03794544|79520572|FG003|Overall Study|Lost to Follow-up|0|||
44514748|NCT03794544|79520569|FG000|Overall Study|Other|0|||
44514749|NCT03794544|79520570|FG001|Overall Study|Other|1|||
44514750|NCT03794544|79520571|FG002|Overall Study|Other|0|||
44514751|NCT03794544|79520572|FG003|Overall Study|Other|0|||
44514752|NCT01804270|79520584|FG000|Overall Study|Withdrawal by Subject|1|||
44514753|NCT01804270|79520585|FG001|Overall Study|Withdrawal by Subject|1|||
44514754|NCT03107026|79520594|FG000|Overall Study|Adverse Event|2|||
44514755|NCT03107026|79520595|FG001|Overall Study|Adverse Event|14|||
44514756|NCT03107026|79520596|FG002|Overall Study|Adverse Event|23|||
44514757|NCT03107026|79520594|FG000|Overall Study|Lost to Follow-up|12|||
44143621|NCT03987919|78932947|FG001|Overall Study|Withdrawal by Subject|7|||
44143622|NCT03987919|78932948|FG002|Overall Study|Withdrawal by Subject|8|||
44143623|NCT03987919|78932949|FG003|Overall Study|Withdrawal by Subject|4|||
44249531|NCT00244725|79083523|FG000|Overall Study|Withdrawal by Subject|9|||
44249532|NCT00244725|79083524|FG001|Overall Study|Withdrawal by Subject|7|||
44143624|NCT03987919|78932946|FG000|Overall Study|Other - as reported by the investigator|1|||
44143625|NCT03987919|78932947|FG001|Overall Study|Other - as reported by the investigator|3|||
44143626|NCT03987919|78932948|FG002|Overall Study|Other - as reported by the investigator|2|||
44143627|NCT03987919|78932949|FG003|Overall Study|Other - as reported by the investigator|0|||
44249533|NCT00244725|79083525|FG002|Overall Study|Withdrawal by Subject|7|||
44249534|NCT00244725|79083526|FG003|Overall Study|Withdrawal by Subject|8|||
44249535|NCT00244725|79083523|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
44249536|NCT00244725|79083524|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
44249537|NCT00244725|79083525|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
44249538|NCT00244725|79083526|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
44249539|NCT00244725|79083523|FG000|Overall Study|Physician Decision|3|||
44249540|NCT00244725|79083524|FG001|Overall Study|Physician Decision|0|||
44249541|NCT00244725|79083525|FG002|Overall Study|Physician Decision|1|||
44249542|NCT00244725|79083526|FG003|Overall Study|Physician Decision|2|||
44249543|NCT00244725|79083523|FG000|Overall Study|Adverse Events|3|||
44249544|NCT00244725|79083524|FG001|Overall Study|Adverse Events|1|||
44277692|NCT02119260|79238657|FG001|Overall Study|Withdrew consent|1|||
44277693|NCT02119260|79238658|FG002|Overall Study|Withdrew consent|1|||
44277694|NCT02119260|79238659|FG003|Overall Study|Withdrew consent|0|||
44277695|NCT02119260|79238660|FG004|Overall Study|Withdrew consent|0|||
44381493|NCT01026818|79387584|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
44514758|NCT03107026|79520595|FG001|Overall Study|Lost to Follow-up|12|||
44514759|NCT03107026|79520596|FG002|Overall Study|Lost to Follow-up|13|||
44514760|NCT03107026|79520594|FG000|Overall Study|Protocol Violation|1|||
44514761|NCT03107026|79520595|FG001|Overall Study|Protocol Violation|2|||
44249545|NCT00244725|79083525|FG002|Overall Study|Adverse Events|4|||
44249546|NCT00244725|79083526|FG003|Overall Study|Adverse Events|4|||
44277696|NCT02119260|79238661|FG005|Overall Study|Withdrew consent|0|||
44277697|NCT02119260|79238662|FG006|Overall Study|Withdrew consent|0|||
44277698|NCT02119104|79238687|FG000|Overall Study|Protocol Violation|16|||
44277699|NCT02119026|79238693|FG000|1st-line Treatment|Adverse Event|9|||
44277700|NCT02119026|79238694|FG001|1st-line Treatment|Adverse Event|14|||
44277701|NCT02119026|79238693|FG000|1st-line Treatment|Physician Decision|3|||
44277702|NCT02119026|79238694|FG001|1st-line Treatment|Physician Decision|8|||
44277703|NCT02119026|79238693|FG000|1st-line Treatment|Withdrawal by Subject|4|||
44277704|NCT02119026|79238694|FG001|1st-line Treatment|Withdrawal by Subject|10|||
44277705|NCT02119026|79238693|FG000|1st-line Treatment|Patient condition or compliance|6|||
44277706|NCT02119026|79238694|FG001|1st-line Treatment|Patient condition or compliance|4|||
44277707|NCT02119026|79238693|FG000|1st-line Treatment|Surgery of metastases|2|||
44277708|NCT02119026|79238694|FG001|1st-line Treatment|Surgery of metastases|1|||
44277709|NCT02119026|79238693|FG000|1st-line Treatment|Death|2|||
44277710|NCT02119026|79238694|FG001|1st-line Treatment|Death|1|||
44277711|NCT02119026|79238693|FG000|2nd-line Treatment|Lost to Follow-up|2|||
44277712|NCT02119026|79238694|FG001|2nd-line Treatment|Lost to Follow-up|0|||
44277713|NCT02119026|79238693|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
44277714|NCT02119026|79238694|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
44277715|NCT02119026|79238693|FG000|2nd-line Treatment|Adverse Event|4|||
44277716|NCT02119026|79238694|FG001|2nd-line Treatment|Adverse Event|1|||
44277717|NCT02095158|79238700|FG000|Overall Study|Adverse Event|14|||
44277718|NCT02095158|79238700|FG000|Overall Study|Lack of Efficacy|3|||
44277719|NCT02095158|79238700|FG000|Overall Study|Pregnancy|1|||
44277720|NCT02095158|79238700|FG000|Overall Study|Lost to Follow-up|20|||
44277721|NCT02095158|79238700|FG000|Overall Study|Personal Reasons|35|||
44277722|NCT02095158|79238700|FG000|Overall Study|Protocol Violation|1|||
44277723|NCT02095158|79238700|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44277724|NCT02094612|79238706|FG000|Overall Study|Lost to Follow-up|47|||
44277725|NCT02094612|79238707|FG001|Overall Study|Lost to Follow-up|47|||
44277726|NCT02094612|79238706|FG000|Overall Study|Never started ADHD medication|32|||
44277727|NCT02094612|79238707|FG001|Overall Study|Never started ADHD medication|23|||
44277728|NCT02139306|79238715|FG000|Overall Study|Withdrawal by Subject|4|||
44277729|NCT02139306|79238716|FG001|Overall Study|Withdrawal by Subject|6|||
44277730|NCT02139306|79238715|FG000|Overall Study|Adverse Event|3|||
44277731|NCT02139306|79238716|FG001|Overall Study|Adverse Event|4|||
44277732|NCT02139306|79238715|FG000|Overall Study|Physician Decision|0|||
44277733|NCT02139306|79238716|FG001|Overall Study|Physician Decision|1|||
44277734|NCT02139306|79238715|FG000|Overall Study|Other Unspecified|2|||
44277735|NCT02139306|79238716|FG001|Overall Study|Other Unspecified|3|||
44277736|NCT02139306|79238715|FG000|Overall Study|Protocol Violation|4|||
44277737|NCT02139306|79238716|FG001|Overall Study|Protocol Violation|0|||
44249547|NCT00244725|79083523|FG000|Overall Study|Withdrwal by participant|1|||
44249548|NCT00244725|79083524|FG001|Overall Study|Withdrwal by participant|0|||
44249549|NCT00244725|79083525|FG002|Overall Study|Withdrwal by participant|0|||
44143628|NCT00535405|78932969|FG000|Overall Study|Adverse Event|6|||
44143629|NCT00535405|78932970|FG001|Overall Study|Adverse Event|8|||
44143630|NCT00535405|78932971|FG002|Overall Study|Adverse Event|3|||
44143631|NCT00535405|78932972|FG003|Overall Study|Adverse Event|8|||
44143632|NCT00535405|78932973|FG004|Overall Study|Adverse Event|6|||
44143633|NCT00535405|78932969|FG000|Overall Study|Lost to Follow-up|1|||
44143634|NCT00535405|78932970|FG001|Overall Study|Lost to Follow-up|3|||
44277738|NCT02094300|79238723|FG000|Overall Study|Death|7|||
44277739|NCT02094300|79238723|FG000|Overall Study|Lost to Follow-up|10|||
44249550|NCT00244725|79083526|FG003|Overall Study|Withdrwal by participant|1|||
44249551|NCT00244725|79083523|FG000|Overall Study|Liver function test abnormality|2|||
44249552|NCT00244725|79083524|FG001|Overall Study|Liver function test abnormality|0|||
44249553|NCT00244725|79083525|FG002|Overall Study|Liver function test abnormality|0|||
44249554|NCT00244725|79083526|FG003|Overall Study|Liver function test abnormality|1|||
44249555|NCT00244725|79083523|FG000|Overall Study|Sponsor withdrew the participant|1|||
44249556|NCT00244725|79083524|FG001|Overall Study|Sponsor withdrew the participant|0|||
44249557|NCT00244725|79083525|FG002|Overall Study|Sponsor withdrew the participant|0|||
44277740|NCT02094300|79238723|FG000|Overall Study|Still be eligible for follow-up|3|||
44277741|NCT02118792|79238729|FG000|Overall Study|Withdrawal by Subject|6|||
44277742|NCT02118792|79238730|FG001|Overall Study|Withdrawal by Subject|3|||
44277743|NCT02118792|79238729|FG000|Overall Study|Lost to Follow-up|4|||
44143635|NCT00535405|78932971|FG002|Overall Study|Lost to Follow-up|3|||
44143636|NCT00535405|78932972|FG003|Overall Study|Lost to Follow-up|2|||
44143637|NCT00535405|78932973|FG004|Overall Study|Lost to Follow-up|1|||
44143638|NCT00535405|78932969|FG000|Overall Study|Physician Decision|3|||
44277744|NCT02118792|79238730|FG001|Overall Study|Lost to Follow-up|4|||
44277745|NCT02118792|79238729|FG000|Overall Study|Adverse Event|5|||
44277746|NCT02118792|79238730|FG001|Overall Study|Adverse Event|4|||
44277747|NCT02118792|79238729|FG000|Overall Study|Withdrawal by parent/guardian|14|||
44277748|NCT02118792|79238730|FG001|Overall Study|Withdrawal by parent/guardian|20|||
44277749|NCT02118792|79238729|FG000|Overall Study|Other|1|||
44277750|NCT02118792|79238730|FG001|Overall Study|Other|6|||
44277751|NCT02118792|79238729|FG000|Overall Study|Randomised but not treated|1|||
44277752|NCT02118792|79238730|FG001|Overall Study|Randomised but not treated|0|||
44143639|NCT00535405|78932970|FG001|Overall Study|Physician Decision|2|||
44249558|NCT00244725|79083526|FG003|Overall Study|Sponsor withdrew the participant|1|||
44249559|NCT00244725|79083523|FG000|Overall Study|Mediciation Error|0|||
44249560|NCT00244725|79083524|FG001|Overall Study|Mediciation Error|1|||
44249561|NCT00244725|79083525|FG002|Overall Study|Mediciation Error|0|||
44249562|NCT00244725|79083526|FG003|Overall Study|Mediciation Error|0|||
44249563|NCT00244725|79083523|FG000|Overall Study|Rehab Refused to allow participantion|0|||
44249564|NCT00244725|79083524|FG001|Overall Study|Rehab Refused to allow participantion|1|||
44249565|NCT00244725|79083525|FG002|Overall Study|Rehab Refused to allow participantion|0|||
44249566|NCT00244725|79083526|FG003|Overall Study|Rehab Refused to allow participantion|0|||
44249567|NCT00244725|79083523|FG000|Overall Study|Headache|0|||
44249568|NCT00244725|79083524|FG001|Overall Study|Headache|1|||
44249569|NCT00244725|79083525|FG002|Overall Study|Headache|0|||
44249570|NCT00244725|79083526|FG003|Overall Study|Headache|0|||
44249571|NCT00244725|79083523|FG000|Overall Study|Received prohibited medication|0|||
44249572|NCT00244725|79083524|FG001|Overall Study|Received prohibited medication|1|||
44249573|NCT00244725|79083525|FG002|Overall Study|Received prohibited medication|0|||
44249574|NCT00244725|79083526|FG003|Overall Study|Received prohibited medication|1|||
44249575|NCT00244725|79083523|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
44249576|NCT00244725|79083524|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
44249577|NCT00244725|79083525|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
44277753|NCT02118714|79238738|FG000|Overall Study|Lost to Follow-up|2|||
44277754|NCT02118714|79238738|FG000|Overall Study|Protocol Violation|1|||
44277755|NCT02138916|79238745|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
44277756|NCT02138916|79238746|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
44277757|NCT02138916|79238747|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
44277758|NCT02138916|79238745|FG000|Overall Study|Death|14|||
44381494|NCT01026818|79387585|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
44143640|NCT00535405|78932971|FG002|Overall Study|Physician Decision|0|||
44143641|NCT00535405|78932972|FG003|Overall Study|Physician Decision|1|||
44143642|NCT00535405|78932973|FG004|Overall Study|Physician Decision|1|||
44249578|NCT00244725|79083526|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
44249579|NCT00244725|79083523|FG000|Overall Study|Administrative reason|0|||
44249580|NCT00244725|79083524|FG001|Overall Study|Administrative reason|0|||
44249581|NCT00244725|79083525|FG002|Overall Study|Administrative reason|1|||
44249582|NCT00244725|79083526|FG003|Overall Study|Administrative reason|0|||
44249583|NCT00244725|79083523|FG000|Overall Study|Vomit|0|||
44249584|NCT00244725|79083524|FG001|Overall Study|Vomit|0|||
44249585|NCT00244725|79083525|FG002|Overall Study|Vomit|1|||
44249586|NCT00244725|79083526|FG003|Overall Study|Vomit|0|||
44249587|NCT00244725|79083523|FG000|Overall Study|Failed to follow-up|0|||
44249588|NCT00244725|79083524|FG001|Overall Study|Failed to follow-up|0|||
44381495|NCT01026818|79387582|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
44143643|NCT00535405|78932969|FG000|Overall Study|Protocol Violation|2|||
44143644|NCT00535405|78932970|FG001|Overall Study|Protocol Violation|2|||
44143645|NCT00535405|78932971|FG002|Overall Study|Protocol Violation|2|||
44143646|NCT00535405|78932972|FG003|Overall Study|Protocol Violation|1|||
44514762|NCT03107026|79520596|FG002|Overall Study|Protocol Violation|0|||
44143647|NCT00535405|78932973|FG004|Overall Study|Protocol Violation|0|||
44143648|NCT00535405|78932969|FG000|Overall Study|Withdrawal by Subject|5|||
44143649|NCT00535405|78932970|FG001|Overall Study|Withdrawal by Subject|11|||
44143650|NCT00535405|78932971|FG002|Overall Study|Withdrawal by Subject|10|||
44143651|NCT00535405|78932972|FG003|Overall Study|Withdrawal by Subject|10|||
44143652|NCT00535405|78932973|FG004|Overall Study|Withdrawal by Subject|8|||
44143653|NCT00271817|78932988|FG000|Part 1|Adverse Event|68|||
44143654|NCT00271817|78932989|FG001|Part 1|Adverse Event|25|||
44143655|NCT00271817|78932990|FG002|Part 1|Adverse Event|156|||
44143656|NCT00271817|78932988|FG000|Part 1|Lost to Follow-up|6|||
44143657|NCT00271817|78932989|FG001|Part 1|Lost to Follow-up|8|||
44277759|NCT02138916|79238746|FG001|Overall Study|Death|11|||
44277760|NCT02138916|79238747|FG002|Overall Study|Death|12|||
44381496|NCT01026818|79387583|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
44514763|NCT03107026|79520594|FG000|Overall Study|Pregnancy|1|||
44514764|NCT03107026|79520595|FG001|Overall Study|Pregnancy|0|||
44143658|NCT00271817|78932990|FG002|Part 1|Lost to Follow-up|24|||
44143659|NCT00271817|78932988|FG000|Part 1|Protocol Violation|5|||
44143660|NCT00271817|78932989|FG001|Part 1|Protocol Violation|4|||
44143661|NCT00271817|78932990|FG002|Part 1|Protocol Violation|7|||
44249589|NCT00244725|79083525|FG002|Overall Study|Failed to follow-up|1|||
44249590|NCT00244725|79083526|FG003|Overall Study|Failed to follow-up|1|||
44249591|NCT02649894|79083538|FG000|Overall Study|Adverse Event|1|||
44249592|NCT02649894|79083539|FG001|Overall Study|Adverse Event|0|||
44249593|NCT02649894|79083538|FG000|Overall Study|Physician Decision|0|||
44249594|NCT02649894|79083539|FG001|Overall Study|Physician Decision|1|||
44249595|NCT02649894|79083538|FG000|Overall Study|Withdrawal by Subject|5|||
44249596|NCT02649894|79083539|FG001|Overall Study|Withdrawal by Subject|2|||
44277761|NCT02138916|79238745|FG000|Overall Study|Withdrawal by Subject|27|||
44514765|NCT03107026|79520596|FG002|Overall Study|Pregnancy|0|||
44143662|NCT00271817|78932988|FG000|Part 1|Patient Moved|3|||
44381672|NCT00733291|79387804|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
44381673|NCT00733291|79387805|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
44381674|NCT00732199|79387818|FG000|Overall Study|Withdrawal by Subject|25|||
44381675|NCT00732199|79387819|FG001|Overall Study|Withdrawal by Subject|18|||
44381676|NCT00732199|79387818|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
44381677|NCT00732199|79387819|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
44381678|NCT00807040|79387830|FG000|Overall Study|Death|24|||
44381679|NCT00807040|79387831|FG001|Overall Study|Death|29|||
44381680|NCT00807040|79387830|FG000|Overall Study|Withdrawal by Subject|8|||
44381681|NCT00807040|79387831|FG001|Overall Study|Withdrawal by Subject|6|||
44381682|NCT00807040|79387830|FG000|Overall Study|Lost to Follow-up|4|||
44381683|NCT00807040|79387831|FG001|Overall Study|Lost to Follow-up|6|||
44381684|NCT00811720|79387839|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
44381685|NCT00811720|79387840|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
44381686|NCT00811720|79387839|FG000|All Treated Patients|Adverse Event|20|||
44381687|NCT00811720|79387840|FG001|All Treated Patients|Adverse Event|62|||
44381688|NCT00811720|79387839|FG000|All Treated Patients|Lack of Efficacy|22|||
44381689|NCT00811720|79387840|FG001|All Treated Patients|Lack of Efficacy|18|||
44381690|NCT00811720|79387839|FG000|All Treated Patients|Non-compliance|0|||
44381691|NCT00811720|79387840|FG001|All Treated Patients|Non-compliance|14|||
44381692|NCT00811720|79387839|FG000|All Treated Patients|Protocol Violation|9|||
44381693|NCT00811720|79387840|FG001|All Treated Patients|Protocol Violation|16|||
44381694|NCT00811720|79387839|FG000|All Treated Patients|Withdrawal by Subject|28|||
44381695|NCT00811720|79387840|FG001|All Treated Patients|Withdrawal by Subject|34|||
44381696|NCT00811720|79387839|FG000|All Treated Patients|Lost to Follow-up|10|||
44381697|NCT00811720|79387840|FG001|All Treated Patients|Lost to Follow-up|16|||
44381698|NCT00811720|79387839|FG000|All Treated Patients|Other Reason|7|||
44381699|NCT00811720|79387840|FG001|All Treated Patients|Other Reason|4|||
44381700|NCT04202679|79387848|FG000|Overall Study|Adverse Event|2|||
44381701|NCT04202679|79387849|FG001|Overall Study|Adverse Event|0|||
44381702|NCT04202679|79387848|FG000|Overall Study|Poor compliance to protocol|1|||
44381703|NCT04202679|79387849|FG001|Overall Study|Poor compliance to protocol|0|||
44381704|NCT04202679|79387848|FG000|Overall Study|Withdrawal by Subject|23|||
44381705|NCT04202679|79387849|FG001|Overall Study|Withdrawal by Subject|6|||
44381706|NCT00811642|79387856|FG000|Overall Study|Adverse Event|3|||
44381707|NCT00811642|79387856|FG000|Overall Study|Protocol Violation|1|||
44381708|NCT00811642|79387856|FG000|Overall Study|Death|2|||
44381709|NCT00811642|79387856|FG000|Overall Study|Withdrawal by Subject|7|||
44381710|NCT00811642|79387856|FG000|Overall Study|Cumulative use of antifungal agent|2|||
44381711|NCT00809926|79387862|FG000|Overall Study|Adverse Event|18|||
44381712|NCT00809926|79387863|FG001|Overall Study|Adverse Event|10|||
44381713|NCT00809926|79387862|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
44381714|NCT00809926|79387863|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44381715|NCT00809926|79387862|FG000|Overall Study|Patient withdrew consent|8|||
44381716|NCT00809926|79387863|FG001|Overall Study|Patient withdrew consent|6|||
44381717|NCT00809926|79387862|FG000|Overall Study|Lost to Follow-up|2|||
44381718|NCT00809926|79387863|FG001|Overall Study|Lost to Follow-up|1|||
44381719|NCT00809926|79387862|FG000|Overall Study|Administrative Problems|0|||
44381720|NCT00809926|79387863|FG001|Overall Study|Administrative Problems|1|||
44381721|NCT00809926|79387862|FG000|Overall Study|Protocol deviation|0|||
44381722|NCT00809926|79387863|FG001|Overall Study|Protocol deviation|2|||
44381723|NCT00590980|79387869|FG000|Overall Study|Did not meet all inclusion criteria|10|||
44381724|NCT00590824|79387877|FG000|Overall Study|Disease could not be resected|0|||
44381725|NCT00590824|79387878|FG001|Overall Study|Disease could not be resected|2|||
44381726|NCT00590824|79387879|FG002|Overall Study|Disease could not be resected|1|||
44381727|NCT00590824|79387880|FG003|Overall Study|Disease could not be resected|0|||
44381728|NCT00590824|79387877|FG000|Overall Study|Adverse Event|0|||
44381729|NCT00590824|79387878|FG001|Overall Study|Adverse Event|0|||
44381730|NCT00590824|79387879|FG002|Overall Study|Adverse Event|0|||
44381731|NCT00590824|79387880|FG003|Overall Study|Adverse Event|1|||
44381732|NCT00590590|79387893|FG000|Overall Study|Lack of Efficacy|1|||
44277821|NCT02138136|79238823|FG000|Overall Study|Withdrawal by Subject|36|||
44277822|NCT02138136|79238823|FG000|Overall Study|Lost to Follow-up|32|||
44277823|NCT02138136|79238823|FG000|Overall Study|Withdrawn by Sponsor|5|||
44381733|NCT00590590|79387894|FG001|Overall Study|Lack of Efficacy|2|||
44381734|NCT00590590|79387895|FG002|Overall Study|Lack of Efficacy|0|||
44381735|NCT00590590|79387893|FG000|Overall Study|Adverse Event|1|||
44381736|NCT00590590|79387894|FG001|Overall Study|Adverse Event|0|||
44381737|NCT00590590|79387895|FG002|Overall Study|Adverse Event|0|||
44381738|NCT00590590|79387893|FG000|Overall Study|Protocol Violation|0|||
44381739|NCT00590590|79387894|FG001|Overall Study|Protocol Violation|0|||
44381740|NCT00590590|79387895|FG002|Overall Study|Protocol Violation|2|||
44381741|NCT00590590|79387893|FG000|Overall Study|Lost to Follow-up|4|||
44381742|NCT00590590|79387894|FG001|Overall Study|Lost to Follow-up|1|||
44381743|NCT00590590|79387895|FG002|Overall Study|Lost to Follow-up|2|||
44381744|NCT00590590|79387893|FG000|Overall Study|Withdrawal by Subject|0|||
44381745|NCT00590590|79387894|FG001|Overall Study|Withdrawal by Subject|1|||
44381746|NCT00590590|79387895|FG002|Overall Study|Withdrawal by Subject|1|||
44381747|NCT00590590|79387893|FG000|Overall Study|Did not complete due to study closure|1|||
44277824|NCT01626690|79238830|FG000|Overall Study|Protocol Violation|1|||
44277825|NCT01626690|79238831|FG001|Overall Study|Protocol Violation|0|||
44381748|NCT00590590|79387894|FG001|Overall Study|Did not complete due to study closure|1|||
44381749|NCT00590590|79387895|FG002|Overall Study|Did not complete due to study closure|1|||
44381750|NCT00590590|79387893|FG000|Overall Study|Did not complete study|0|||
44381751|NCT00590590|79387894|FG001|Overall Study|Did not complete study|1|||
44381752|NCT00590590|79387895|FG002|Overall Study|Did not complete study|0|||
44381753|NCT00809614|79387905|FG000|Overall Study|Lack of Efficacy|2|||
44381754|NCT00809614|79387906|FG001|Overall Study|Lack of Efficacy|3|||
44381755|NCT00809614|79387905|FG000|Overall Study|Withdrawal by Subject|1|||
44381756|NCT00809614|79387906|FG001|Overall Study|Withdrawal by Subject|1|||
44381757|NCT00731731|79387915|FG000|Overall Study|Protocol Violation|0|||
44249755|NCT01503164|79083958|FG001|Overall Study|Withdrawal by Subject|1|||
44249756|NCT00088465|79083964|FG000|Overall Study|Withdrawal by Subject|290|||
44249757|NCT00088465|79083964|FG000|Overall Study|Adverse Event|77|||
44249758|NCT00088465|79083964|FG000|Overall Study|Lost to Follow-up|57|||
44249759|NCT00088465|79083964|FG000|Overall Study|Physician Decision|45|||
44381758|NCT00731731|79387916|FG001|Overall Study|Protocol Violation|0|||
44381759|NCT00731731|79387917|FG002|Overall Study|Protocol Violation|1|||
44381760|NCT00731731|79387915|FG000|Overall Study|Cancel prior to treatment|0|||
44381761|NCT00731731|79387916|FG001|Overall Study|Cancel prior to treatment|0|||
44514968|NCT03711162|79520860|FG000|Overall Study|Study Terminated by Sponsor|139|||
44514969|NCT03711162|79520861|FG001|Overall Study|Study Terminated by Sponsor|152|||
44381762|NCT00731731|79387917|FG002|Overall Study|Cancel prior to treatment|2|||
44514970|NCT03711162|79520862|FG002|Overall Study|Study Terminated by Sponsor|146|||
44514971|NCT03711162|79520860|FG000|Overall Study|Withdrawal by Subject|17|||
44514972|NCT03711162|79520861|FG001|Overall Study|Withdrawal by Subject|10|||
44514973|NCT03711162|79520862|FG002|Overall Study|Withdrawal by Subject|10|||
44514974|NCT03711162|79520860|FG000|Overall Study|Miscellaneous|1|||
44514975|NCT03711162|79520861|FG001|Overall Study|Miscellaneous|2|||
44381763|NCT00806494|79387930|FG000|Overall Study|Adverse Event|29|||
44381764|NCT00806494|79387930|FG000|Overall Study|Lack of Efficacy|6|||
44381765|NCT00806494|79387930|FG000|Overall Study|Lost to Follow-up|10|||
44381766|NCT00806494|79387930|FG000|Overall Study|Other|30|||
44381767|NCT00806494|79387930|FG000|Overall Study|Withdrawal by Subject|5|||
44381768|NCT00806416|79387937|FG000|Period 1 - Part I|Adverse Event|0|||
44381769|NCT00806416|79387938|FG001|Period 1 - Part I|Adverse Event|1|||
44381770|NCT00806416|79387939|FG002|Period 1 - Part I|Adverse Event|0|||
44381771|NCT00806416|79387940|FG003|Period 1 - Part I|Adverse Event|0|||
44381772|NCT00806416|79387937|FG000|Period 1 - Part I|Lost to Follow-up|0|||
44381773|NCT00806416|79387938|FG001|Period 1 - Part I|Lost to Follow-up|2|||
44381774|NCT00806416|79387939|FG002|Period 1 - Part I|Lost to Follow-up|0|||
44381775|NCT00806416|79387940|FG003|Period 1 - Part I|Lost to Follow-up|0|||
44381776|NCT00806416|79387937|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
44381777|NCT00806416|79387938|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
44381778|NCT00806416|79387939|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
44381779|NCT00806416|79387940|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
44514976|NCT03711162|79520862|FG002|Overall Study|Miscellaneous|2|||
44514977|NCT03711162|79520860|FG000|Overall Study|Not Treated|1|||
44514978|NCT03711162|79520861|FG001|Overall Study|Not Treated|0|||
44514979|NCT03711162|79520862|FG002|Overall Study|Not Treated|1|||
44514980|NCT03711162|79520860|FG000|Overall Study|Physician Decision|0|||
44514981|NCT03711162|79520861|FG001|Overall Study|Physician Decision|2|||
44514982|NCT03711162|79520862|FG002|Overall Study|Physician Decision|0|||
44514983|NCT03711162|79520860|FG000|Overall Study|Lack of Efficacy|0|||
44381780|NCT00806416|79387937|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
44381781|NCT00806416|79387938|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
44381782|NCT00806416|79387939|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
44381783|NCT00806416|79387940|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
44381784|NCT02724969|79387950|FG000|Overall Study|Lost to Follow-up|12|||
44381785|NCT02724969|79387951|FG001|Overall Study|Lost to Follow-up|6|||
44381786|NCT02724969|79387950|FG000|Overall Study|Withdrawal by Subject|3|||
44381787|NCT02724969|79387951|FG001|Overall Study|Withdrawal by Subject|3|||
44381788|NCT02724969|79387950|FG000|Overall Study|Infant demise|0|||
44381789|NCT02724969|79387951|FG001|Overall Study|Infant demise|2|||
44381790|NCT00811252|79387960|FG000|Overall Study|Adverse Event|6|||
44381791|NCT00811252|79387961|FG001|Overall Study|Adverse Event|10|||
44381792|NCT00811252|79387962|FG002|Overall Study|Adverse Event|15|||
44381793|NCT00811252|79387960|FG000|Overall Study|Lack of Efficacy|7|||
44514984|NCT03711162|79520861|FG001|Overall Study|Lack of Efficacy|0|||
44514985|NCT03711162|79520862|FG002|Overall Study|Lack of Efficacy|2|||
44514986|NCT03711162|79520860|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
44514987|NCT03711162|79520861|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
44514988|NCT03711162|79520862|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
44514989|NCT03072160|79520878|FG000|Overall Study|Adverse Event|3|||
44514990|NCT03072160|79520879|FG001|Overall Study|Adverse Event|1|||
44514991|NCT03072160|79520878|FG000|Overall Study|Refused further treatment|6|||
44514992|NCT03072160|79520879|FG001|Overall Study|Refused further treatment|1|||
44143865|NCT00462943|78933155|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
44143866|NCT00462943|78933156|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
44143867|NCT00462943|78933154|FG000|Overall Study|Disease Progression|15|||
44143868|NCT00462943|78933155|FG001|Overall Study|Disease Progression|15|||
44143869|NCT00462943|78933156|FG002|Overall Study|Disease Progression|9|||
44143870|NCT00462943|78933154|FG000|Overall Study|Death|5|||
44381794|NCT00811252|79387961|FG001|Overall Study|Lack of Efficacy|2|||
44143871|NCT00462943|78933155|FG001|Overall Study|Death|2|||
44381795|NCT00811252|79387962|FG002|Overall Study|Lack of Efficacy|0|||
44381796|NCT00811252|79387960|FG000|Overall Study|Protocol Violation|3|||
44381797|NCT00811252|79387961|FG001|Overall Study|Protocol Violation|3|||
44381798|NCT00811252|79387962|FG002|Overall Study|Protocol Violation|2|||
44381799|NCT00811252|79387960|FG000|Overall Study|Withdrawal of Consent|1|||
44381800|NCT00811252|79387961|FG001|Overall Study|Withdrawal of Consent|2|||
44143872|NCT00462943|78933156|FG002|Overall Study|Death|7|||
44143873|NCT00462943|78933154|FG000|Overall Study|Stem Cell Transplant|1|||
44143874|NCT00462943|78933155|FG001|Overall Study|Stem Cell Transplant|1|||
44143875|NCT00462943|78933156|FG002|Overall Study|Stem Cell Transplant|0|||
44143876|NCT00462943|78933154|FG000|Overall Study|Bone Marrow Transplant|1|||
44143877|NCT00462943|78933155|FG001|Overall Study|Bone Marrow Transplant|0|||
44143878|NCT00462943|78933156|FG002|Overall Study|Bone Marrow Transplant|0|||
44143879|NCT00462943|78933154|FG000|Overall Study|Required Lymphocyte Infusion|1|||
44143880|NCT00462943|78933155|FG001|Overall Study|Required Lymphocyte Infusion|0|||
44143881|NCT00462943|78933156|FG002|Overall Study|Required Lymphocyte Infusion|0|||
44381801|NCT00811252|79387962|FG002|Overall Study|Withdrawal of Consent|2|||
44381802|NCT00811252|79387960|FG000|Overall Study|Lost to Follow-up|0|||
44381803|NCT00811252|79387961|FG001|Overall Study|Lost to Follow-up|0|||
44381804|NCT00811252|79387962|FG002|Overall Study|Lost to Follow-up|2|||
44514993|NCT03072160|79520878|FG000|Overall Study|Physician Decision|1|||
44514994|NCT03072160|79520879|FG001|Overall Study|Physician Decision|0|||
44381805|NCT00811252|79387960|FG000|Overall Study|Administrative or Other Reasons|0|||
44381806|NCT00811252|79387961|FG001|Overall Study|Administrative or Other Reasons|3|||
44381807|NCT00811252|79387962|FG002|Overall Study|Administrative or Other Reasons|2|||
44381808|NCT00736957|79387979|FG000|Overall Study|Adverse Event|43|||
44381809|NCT00736957|79387979|FG000|Overall Study|Withdrawal by Subject|49|||
44381810|NCT00736957|79387979|FG000|Overall Study|violation of eligibility criteria|2|||
44381811|NCT00736957|79387979|FG000|Overall Study|did not attend hospital appointments|1|||
44514995|NCT03072160|79520878|FG000|Overall Study|Disease progression on study|1|||
44514996|NCT03072160|79520879|FG001|Overall Study|Disease progression on study|1|||
44514997|NCT03072160|79520878|FG000|Overall Study|No contact|0|||
44514998|NCT03072160|79520879|FG001|Overall Study|No contact|1|||
44514999|NCT00407602|79520917|FG000|Overall Study|Death - unrelated to device|1|||
44381812|NCT00736957|79387979|FG000|Overall Study|not eligible for Treatment Period I|22|||
44381813|NCT00736957|79387979|FG000|Overall Study|Physician Decision|5|||
44381814|NCT00736879|79387987|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
44381815|NCT00736879|79387988|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
44381816|NCT00736879|79387989|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
44381817|NCT00736879|79387990|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
44381818|NCT00736879|79387987|FG000|Double Blind Treatment Period|Adverse Event|0|||
44381819|NCT00736879|79387988|FG001|Double Blind Treatment Period|Adverse Event|1|||
44381820|NCT00736879|79387989|FG002|Double Blind Treatment Period|Adverse Event|1|||
44381821|NCT00736879|79387990|FG003|Double Blind Treatment Period|Adverse Event|0|||
44381822|NCT00736879|79387987|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
44381823|NCT00736879|79387988|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
44381824|NCT00736879|79387989|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
44381825|NCT00736879|79387990|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
44381826|NCT00736879|79387987|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
44381827|NCT00736879|79387988|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
44381828|NCT00736879|79387989|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
44381829|NCT00736879|79387990|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
44381830|NCT00736879|79387987|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
44381831|NCT00736879|79387988|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
44381832|NCT00736879|79387989|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
44381833|NCT00736879|79387990|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
44381834|NCT00736879|79387987|FG000|Double Blind Treatment Period|No longer met criteria|0|||
44381835|NCT00736879|79387988|FG001|Double Blind Treatment Period|No longer met criteria|1|||
44381836|NCT00736879|79387989|FG002|Double Blind Treatment Period|No longer met criteria|0|||
44381837|NCT00736879|79387990|FG003|Double Blind Treatment Period|No longer met criteria|0|||
44381838|NCT00736879|79387987|FG000|Double Blind Treatment Period|non-specified|0|||
44381839|NCT00736879|79387988|FG001|Double Blind Treatment Period|non-specified|1|||
44381840|NCT00736879|79387989|FG002|Double Blind Treatment Period|non-specified|0|||
44381841|NCT00736879|79387990|FG003|Double Blind Treatment Period|non-specified|0|||
44381842|NCT00736879|79387987|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
44381843|NCT00736879|79387988|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
44381844|NCT00736879|79387989|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
44381845|NCT00736879|79387990|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
44381846|NCT00736879|79387987|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
44381847|NCT00736879|79387988|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
44381848|NCT00736879|79387989|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
44515000|NCT00407602|79520917|FG000|Overall Study|Device explanted|5|||
44515001|NCT00407602|79520917|FG000|Overall Study|Withdrawal by Subject|1|||
44515002|NCT03057496|79520924|FG000|Overall Study|Withdrawal by Subject|8|||
44515003|NCT03057496|79520924|FG000|Overall Study|Lost to Follow-up|5|||
44515004|NCT03057496|79520924|FG000|Overall Study|Did not use device during home trial|3|||
44515005|NCT03057496|79520924|FG000|Overall Study|Device failure|2|||
44515006|NCT03708744|79520934|FG000|Overall Study|Withdrawal by Subject|0|||
44515007|NCT03708744|79520935|FG001|Overall Study|Withdrawal by Subject|0|||
44515008|NCT03708744|79520936|FG002|Overall Study|Withdrawal by Subject|1|||
44515009|NCT03708744|79520937|FG003|Overall Study|Withdrawal by Subject|0|||
44515010|NCT02574286|79520951|FG000|Overall Study|Adverse Event|3|||
44515011|NCT02574286|79520951|FG000|Overall Study|Withdrawal by Subject|2|||
44515012|NCT02083354|79520959|FG000|Overall Study|Withdrawal by Subject|9|||
44515013|NCT02083354|79520959|FG000|Overall Study|Lost to Follow-up|1|||
44515014|NCT02083354|79520959|FG000|Overall Study|Adverse Event|3|||
44515015|NCT02083354|79520959|FG000|Overall Study|Disease progression|46|||
44515016|NCT02083354|79520959|FG000|Overall Study|Study closed/terminated|5|||
44515017|NCT04230486|79520963|FG000|Overall Study|Screen Failure|1|||
44515018|NCT01399918|79520969|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
44515019|NCT00112840|79520976|FG000|Overall Study|Physician Decision|1|||
44515020|NCT00112840|79520977|FG001|Overall Study|Physician Decision|0|||
44515021|NCT00112840|79520978|FG002|Overall Study|Physician Decision|0|||
44515022|NCT00112840|79520976|FG000|Overall Study|Withdrawal by Subject|1|||
44515023|NCT00112840|79520977|FG001|Overall Study|Withdrawal by Subject|0|||
44515024|NCT00112840|79520978|FG002|Overall Study|Withdrawal by Subject|1|||
44515025|NCT00112840|79520976|FG000|Overall Study|Protocol Violation|0|||
44515026|NCT00112840|79520977|FG001|Overall Study|Protocol Violation|0|||
44515027|NCT00112840|79520978|FG002|Overall Study|Protocol Violation|5|||
44143882|NCT00462943|78933154|FG000|Overall Study|Transplant - not specified|1|||
44143883|NCT00462943|78933155|FG001|Overall Study|Transplant - not specified|0|||
44515028|NCT02197572|79520991|FG000|Overall Study|Progressive Disease|28|||
44515029|NCT02197572|79520991|FG000|Overall Study|Withdrawal by Subject|9|||
44515030|NCT02197572|79520991|FG000|Overall Study|Adverse Event|3|||
44515031|NCT02197572|79520991|FG000|Overall Study|Reason Not Specified|4|||
44515032|NCT03176784|79520999|FG000|Overall Study|Lost to Follow-up|77|||
44515033|NCT03176784|79521000|FG001|Overall Study|Lost to Follow-up|79|||
44515034|NCT03176784|79521001|FG002|Overall Study|Lost to Follow-up|79|||
44515035|NCT03176784|79521002|FG003|Overall Study|Lost to Follow-up|49|||
44515036|NCT03176784|79520999|FG000|Overall Study|Withdrawal by Subject|28|||
44515037|NCT03176784|79521000|FG001|Overall Study|Withdrawal by Subject|34|||
44515038|NCT03176784|79521001|FG002|Overall Study|Withdrawal by Subject|34|||
44515039|NCT03176784|79521002|FG003|Overall Study|Withdrawal by Subject|21|||
44515040|NCT03049852|79521015|FG000|Overall Study|Lost to Follow-up|0|||
44515041|NCT03049852|79521016|FG001|Overall Study|Lost to Follow-up|1|||
44515042|NCT03049852|79521017|FG002|Overall Study|Lost to Follow-up|0|||
44515043|NCT05091528|79521029|FG000|Overall Study|Study Termination by Sponsor|0|||
44515044|NCT05091528|79521030|FG001|Overall Study|Study Termination by Sponsor|1|||
44143884|NCT00462943|78933156|FG002|Overall Study|Transplant - not specified|1|||
44143885|NCT00462943|78933154|FG000|Overall Study|Physician Decision|1|||
44515045|NCT05091528|79521031|FG002|Overall Study|Study Termination by Sponsor|0|||
44515046|NCT05091528|79521032|FG003|Overall Study|Study Termination by Sponsor|1|||
44515047|NCT01317004|79521055|FG000|Overall Study|Withdrawal by Subject|1|||
44515048|NCT01317004|79521056|FG001|Overall Study|Withdrawal by Subject|4|||
44515049|NCT01317004|79521055|FG000|Overall Study|Protocol Violation|0|||
44249760|NCT00088465|79083964|FG000|Overall Study|Sponsor Decision|37|||
44249761|NCT00088465|79083964|FG000|Overall Study|Lack of Efficacy|27|||
44249762|NCT00088465|79083964|FG000|Overall Study|Protocol Violation|17|||
44249763|NCT00088465|79083964|FG000|Overall Study|Death|11|||
44249764|NCT00088153|79083992|FG000|Overall Study|Physician Decision|3|||
44249765|NCT00088153|79083993|FG001|Overall Study|Physician Decision|3|||
44249766|NCT00088153|79083992|FG000|Overall Study|Withdrawal by Subject|10|||
44249767|NCT00088153|79083993|FG001|Overall Study|Withdrawal by Subject|10|||
44249768|NCT00088153|79083992|FG000|Overall Study|Lost to Follow-up|11|||
44381849|NCT00736879|79387990|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
44381850|NCT00806260|79388009|FG000|Period 1 (1 Day)|Adverse Event|0|||
44515050|NCT01317004|79521056|FG001|Overall Study|Protocol Violation|2|||
44515051|NCT01317004|79521055|FG000|Overall Study|Adverse Event|3|||
44515052|NCT01317004|79521056|FG001|Overall Study|Adverse Event|3|||
44515053|NCT01343056|79521066|FG000|Overall Study|Lost to Follow-up|7|||
44515054|NCT01343056|79521067|FG001|Overall Study|Lost to Follow-up|5|||
44381851|NCT00806260|79388010|FG001|Period 1 (1 Day)|Adverse Event|0|||
44381852|NCT00806260|79388011|FG002|Period 1 (1 Day)|Adverse Event|0|||
44381853|NCT00806260|79388012|FG003|Period 1 (1 Day)|Adverse Event|0|||
44515055|NCT01343056|79521068|FG002|Overall Study|Lost to Follow-up|3|||
44515056|NCT01343056|79521069|FG003|Overall Study|Lost to Follow-up|9|||
44515057|NCT01316692|79521083|FG000|Overall Study|Adverse Event|5|||
44515058|NCT01316692|79521083|FG000|Overall Study|Disease Progression|7|||
44515059|NCT01316380|79521090|FG000|Overall Study|Adverse Event|0|||
44515060|NCT01316380|79521091|FG001|Overall Study|Adverse Event|2|||
44515061|NCT01316380|79521092|FG002|Overall Study|Adverse Event|1|||
44515062|NCT01316380|79521090|FG000|Overall Study|Protocol Violation|0|||
44515063|NCT01316380|79521091|FG001|Overall Study|Protocol Violation|0|||
44381854|NCT00806260|79388013|FG004|Period 1 (1 Day)|Adverse Event|3|||
44249769|NCT00088153|79083993|FG001|Overall Study|Lost to Follow-up|12|||
44381855|NCT00806260|79388014|FG005|Period 1 (1 Day)|Adverse Event|0|||
44381856|NCT00806260|79388009|FG000|Period 2|Adverse Event|0|||
44515064|NCT01316380|79521092|FG002|Overall Study|Protocol Violation|1|||
44515065|NCT01316380|79521090|FG000|Overall Study|Withdrawal by Subject|1|||
44515066|NCT01316380|79521091|FG001|Overall Study|Withdrawal by Subject|2|||
44515067|NCT01316380|79521092|FG002|Overall Study|Withdrawal by Subject|0|||
44515068|NCT01316380|79521090|FG000|Overall Study|Other|0|||
44515069|NCT01316380|79521091|FG001|Overall Study|Other|1|||
44515070|NCT01316380|79521092|FG002|Overall Study|Other|1|||
44515071|NCT01316380|79521090|FG000|Overall Study|Not treated|1|||
44515072|NCT01316380|79521091|FG001|Overall Study|Not treated|0|||
44515073|NCT01316380|79521092|FG002|Overall Study|Not treated|0|||
44515074|NCT01316224|79521100|FG000|Overall Study|Protocol Violation|3|||
44515075|NCT01316224|79521100|FG000|Overall Study|Adverse Event|3|||
44515076|NCT01316224|79521100|FG000|Overall Study|Lack of Efficacy|1|||
44515077|NCT01316224|79521100|FG000|Overall Study|Withdrawal by Subject|1|||
44515078|NCT01316224|79521100|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
44515079|NCT01316224|79521100|FG000|Overall Study|Other|1|||
44515080|NCT04315298|79521123|FG000|Overall Study|Withdrawal by Subject|0|||
44515081|NCT04315298|79521124|FG001|Overall Study|Withdrawal by Subject|0|||
44515082|NCT04315298|79521125|FG002|Overall Study|Withdrawal by Subject|0|||
44515083|NCT04315298|79521126|FG003|Overall Study|Withdrawal by Subject|2|||
44515084|NCT04315298|79521127|FG004|Overall Study|Withdrawal by Subject|2|||
44515085|NCT04315298|79521128|FG005|Overall Study|Withdrawal by Subject|2|||
44515086|NCT04315298|79521129|FG006|Overall Study|Withdrawal by Subject|0|||
44515087|NCT04315298|79521130|FG007|Overall Study|Withdrawal by Subject|1|||
44515088|NCT04315298|79521131|FG008|Overall Study|Withdrawal by Subject|1|||
44515089|NCT04315298|79521132|FG009|Overall Study|Withdrawal by Subject|1|||
44515090|NCT04315298|79521133|FG010|Overall Study|Withdrawal by Subject|0|||
44515091|NCT04315298|79521134|FG011|Overall Study|Withdrawal by Subject|0|||
44515092|NCT04315298|79521135|FG012|Overall Study|Withdrawal by Subject|0|||
44515093|NCT04315298|79521136|FG013|Overall Study|Withdrawal by Subject|0|||
44515094|NCT04315298|79521137|FG014|Overall Study|Withdrawal by Subject|0|||
44515095|NCT04315298|79521138|FG015|Overall Study|Withdrawal by Subject|0|||
44515096|NCT04315298|79521139|FG016|Overall Study|Withdrawal by Subject|0|||
44515097|NCT04315298|79521140|FG017|Overall Study|Withdrawal by Subject|0|||
44515098|NCT04315298|79521141|FG018|Overall Study|Withdrawal by Subject|0|||
44515099|NCT04315298|79521123|FG000|Overall Study|Physician Decision|0|||
44515100|NCT04315298|79521124|FG001|Overall Study|Physician Decision|0|||
44515101|NCT04315298|79521125|FG002|Overall Study|Physician Decision|0|||
44143886|NCT00462943|78933155|FG001|Overall Study|Physician Decision|0|||
44515102|NCT04315298|79521126|FG003|Overall Study|Physician Decision|0|||
44143887|NCT00462943|78933156|FG002|Overall Study|Physician Decision|0|||
44515103|NCT04315298|79521127|FG004|Overall Study|Physician Decision|1|||
44515104|NCT04315298|79521128|FG005|Overall Study|Physician Decision|0|||
44515105|NCT04315298|79521129|FG006|Overall Study|Physician Decision|0|||
44515106|NCT04315298|79521130|FG007|Overall Study|Physician Decision|0|||
44515107|NCT04315298|79521131|FG008|Overall Study|Physician Decision|0|||
44515108|NCT04315298|79521132|FG009|Overall Study|Physician Decision|0|||
44515109|NCT04315298|79521133|FG010|Overall Study|Physician Decision|0|||
44515110|NCT04315298|79521134|FG011|Overall Study|Physician Decision|0|||
44381857|NCT00806260|79388010|FG001|Period 2|Adverse Event|0|||
44381858|NCT00806260|79388011|FG002|Period 2|Adverse Event|0|||
44381859|NCT00806260|79388012|FG003|Period 2|Adverse Event|1|||
44381860|NCT00806260|79388013|FG004|Period 2|Adverse Event|0|||
44249770|NCT01502228|79084012|FG000|Overall Study|Death|1|||
44515111|NCT04315298|79521135|FG012|Overall Study|Physician Decision|0|||
44381861|NCT00806260|79388014|FG005|Period 2|Adverse Event|0|||
44381862|NCT00806260|79388009|FG000|Period 2|Protocol Violation|1|||
44381863|NCT00806260|79388010|FG001|Period 2|Protocol Violation|0|||
44381864|NCT00806260|79388011|FG002|Period 2|Protocol Violation|1|||
44381865|NCT00806260|79388012|FG003|Period 2|Protocol Violation|0|||
44381866|NCT00806260|79388013|FG004|Period 2|Protocol Violation|0|||
44381867|NCT00806260|79388014|FG005|Period 2|Protocol Violation|0|||
44381868|NCT00806260|79388009|FG000|Period 2|Need to take concomitant medication|1|||
44381869|NCT00806260|79388010|FG001|Period 2|Need to take concomitant medication|0|||
44381870|NCT00806260|79388011|FG002|Period 2|Need to take concomitant medication|0|||
44381871|NCT00806260|79388012|FG003|Period 2|Need to take concomitant medication|0|||
44381872|NCT00806260|79388013|FG004|Period 2|Need to take concomitant medication|0|||
44381873|NCT00806260|79388014|FG005|Period 2|Need to take concomitant medication|0|||
44381874|NCT00806260|79388009|FG000|Period 2|sponsor request|0|||
44381875|NCT00806260|79388010|FG001|Period 2|sponsor request|0|||
44381876|NCT00806260|79388011|FG002|Period 2|sponsor request|1|||
44381877|NCT00806260|79388012|FG003|Period 2|sponsor request|1|||
44381878|NCT00806260|79388013|FG004|Period 2|sponsor request|0|||
44381879|NCT00806260|79388014|FG005|Period 2|sponsor request|0|||
44381880|NCT00806260|79388009|FG000|Period 3|Protocol Violation|0|||
44381881|NCT00806260|79388010|FG001|Period 3|Protocol Violation|1|||
44381882|NCT00806260|79388011|FG002|Period 3|Protocol Violation|1|||
44381883|NCT00806260|79388012|FG003|Period 3|Protocol Violation|0|||
44381884|NCT00806260|79388013|FG004|Period 3|Protocol Violation|0|||
44381885|NCT00806260|79388014|FG005|Period 3|Protocol Violation|0|||
44381886|NCT00806260|79388009|FG000|Period 3|Pregnancy|1|||
44381887|NCT00806260|79388010|FG001|Period 3|Pregnancy|0|||
44381888|NCT00806260|79388011|FG002|Period 3|Pregnancy|0|||
44381889|NCT00806260|79388012|FG003|Period 3|Pregnancy|0|||
44381890|NCT00806260|79388013|FG004|Period 3|Pregnancy|0|||
44381891|NCT00806260|79388014|FG005|Period 3|Pregnancy|0|||
44381892|NCT00742885|79388028|FG000|Overall Study|Lost to Follow-up|1|||
44381893|NCT00742885|79388029|FG001|Overall Study|Lost to Follow-up|0|||
44381894|NCT00811174|79388038|FG000|Overall Study|Protocol Violation|2|||
44381895|NCT00811174|79388038|FG000|Overall Study|Sponsors Decision|1|||
44381896|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
44381897|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
44515112|NCT04315298|79521136|FG013|Overall Study|Physician Decision|0|||
44515113|NCT04315298|79521137|FG014|Overall Study|Physician Decision|0|||
44515114|NCT04315298|79521138|FG015|Overall Study|Physician Decision|0|||
44515115|NCT04315298|79521139|FG016|Overall Study|Physician Decision|0|||
44515116|NCT04315298|79521140|FG017|Overall Study|Physician Decision|0|||
44515117|NCT04315298|79521141|FG018|Overall Study|Physician Decision|0|||
44515118|NCT04315298|79521123|FG000|Overall Study|Lost to Follow-up|5|||
44249771|NCT01502072|79084019|FG000|Overall Study|Withdrawal by Subject|1|||
44381898|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
44381899|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
44381900|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
44381901|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
44381902|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
44381903|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
44381904|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
44381905|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
44381906|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
44381907|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
44515119|NCT04315298|79521124|FG001|Overall Study|Lost to Follow-up|10|||
44381908|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
44381909|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
44381910|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
44381911|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
44381912|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
44381913|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
44381914|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
44381915|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
44381916|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
44381917|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
44381918|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
44381919|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
44381920|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
44381921|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
44381922|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
44381923|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
44381924|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
44381925|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
44515120|NCT04315298|79521125|FG002|Overall Study|Lost to Follow-up|6|||
44515121|NCT04315298|79521126|FG003|Overall Study|Lost to Follow-up|8|||
44515122|NCT04315298|79521127|FG004|Overall Study|Lost to Follow-up|12|||
44515123|NCT04315298|79521128|FG005|Overall Study|Lost to Follow-up|13|||
44515124|NCT04315298|79521129|FG006|Overall Study|Lost to Follow-up|9|||
44515125|NCT04315298|79521130|FG007|Overall Study|Lost to Follow-up|16|||
44515126|NCT04315298|79521131|FG008|Overall Study|Lost to Follow-up|14|||
44515127|NCT04315298|79521132|FG009|Overall Study|Lost to Follow-up|0|||
44143888|NCT00462943|78933154|FG000|Overall Study|Withdrawal by Subject|0|||
44143889|NCT00462943|78933155|FG001|Overall Study|Withdrawal by Subject|1|||
44143890|NCT00462943|78933156|FG002|Overall Study|Withdrawal by Subject|0|||
44381926|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
44381927|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
44381928|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
44381929|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
44381930|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
44381931|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
44381932|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
44381933|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
44381934|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
44381935|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
44515128|NCT04315298|79521133|FG010|Overall Study|Lost to Follow-up|2|||
44515129|NCT04315298|79521134|FG011|Overall Study|Lost to Follow-up|1|||
44515130|NCT04315298|79521135|FG012|Overall Study|Lost to Follow-up|0|||
44515131|NCT04315298|79521136|FG013|Overall Study|Lost to Follow-up|0|||
44515132|NCT04315298|79521137|FG014|Overall Study|Lost to Follow-up|0|||
44515133|NCT04315298|79521138|FG015|Overall Study|Lost to Follow-up|2|||
44515134|NCT04315298|79521139|FG016|Overall Study|Lost to Follow-up|0|||
44515135|NCT04315298|79521140|FG017|Overall Study|Lost to Follow-up|0|||
44515136|NCT04315298|79521141|FG018|Overall Study|Lost to Follow-up|0|||
44515137|NCT04315298|79521123|FG000|Overall Study|Death|24|||
44381936|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
44381937|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
44381938|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
44381939|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
44381940|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
44381941|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
44381942|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
44381943|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
44381944|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
44381945|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
44381946|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
44381947|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
44143891|NCT02730793|78933180|FG000|Overall Study|Physician Decision|0|||
44143892|NCT02730793|78933181|FG001|Overall Study|Physician Decision|1|||
44143893|NCT02730793|78933180|FG000|Overall Study|Withdrawal by Subject|0|||
44143894|NCT02730793|78933181|FG001|Overall Study|Withdrawal by Subject|1|||
44143895|NCT02855125|78933189|FG000|Overall Study|Withdrawal by Subject|2|||
44381948|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
44381949|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
44143896|NCT02855125|78933190|FG001|Overall Study|Withdrawal by Subject|2|||
44515138|NCT04315298|79521124|FG001|Overall Study|Death|60|||
44515139|NCT04315298|79521125|FG002|Overall Study|Death|49|||
44515140|NCT04315298|79521126|FG003|Overall Study|Death|59|||
44515141|NCT04315298|79521127|FG004|Overall Study|Death|70|||
44515142|NCT04315298|79521128|FG005|Overall Study|Death|114|||
44515143|NCT04315298|79521129|FG006|Overall Study|Death|9|||
44143897|NCT02855125|78933189|FG000|Overall Study|Clinical Disease Progression|5|||
44143898|NCT02855125|78933190|FG001|Overall Study|Clinical Disease Progression|4|||
44143899|NCT02855125|78933189|FG000|Overall Study|Radiologic Disease Progression|36|||
44143900|NCT02855125|78933190|FG001|Overall Study|Radiologic Disease Progression|39|||
44143901|NCT02855125|78933189|FG000|Overall Study|Adverse Event|11|||
44143902|NCT02855125|78933190|FG001|Overall Study|Adverse Event|7|||
44515144|NCT04315298|79521130|FG007|Overall Study|Death|12|||
44515145|NCT04315298|79521131|FG008|Overall Study|Death|21|||
44381950|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
44381951|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
44381952|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
44381953|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
44381954|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
44381955|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
44381956|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
44381957|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
44381958|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
44381959|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
44381960|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
44381961|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
44381962|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
44381963|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
44381964|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
44381965|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
44381966|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Change of location|0|||
44381967|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Change of location|0|||
44381968|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Change of location|0|||
44381969|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Change of location|1|||
44381970|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Change of location|0|||
44381971|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
44381972|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
44381973|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
44381974|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
44381975|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
44381976|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
44381977|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
44381978|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
44381979|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
44381980|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
44381981|NCT00730405|79388047|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
44381982|NCT00730405|79388048|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
44381983|NCT00730405|79388049|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
44381984|NCT00730405|79388050|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
44381985|NCT00730405|79388051|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
44381986|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
44381987|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
44381988|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
44381989|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
44515146|NCT04315298|79521132|FG009|Overall Study|Death|16|||
44515147|NCT04315298|79521133|FG010|Overall Study|Death|40|||
44515148|NCT04315298|79521134|FG011|Overall Study|Death|40|||
44515149|NCT04315298|79521135|FG012|Overall Study|Death|3|||
44515150|NCT04315298|79521136|FG013|Overall Study|Death|4|||
44515151|NCT04315298|79521137|FG014|Overall Study|Death|6|||
44515152|NCT04315298|79521138|FG015|Overall Study|Death|4|||
44515153|NCT04315298|79521139|FG016|Overall Study|Death|3|||
44515154|NCT04315298|79521140|FG017|Overall Study|Death|1|||
44515155|NCT04315298|79521141|FG018|Overall Study|Death|0|||
44515156|NCT04308668|79521210|FG000|Overall Study|Lost to Follow-up|32|||
44515157|NCT04308668|79521211|FG001|Overall Study|Lost to Follow-up|38|||
44515158|NCT04308668|79521210|FG000|Overall Study|Withdrawal by Subject|4|||
44515159|NCT04308668|79521211|FG001|Overall Study|Withdrawal by Subject|4|||
44515160|NCT04451330|79521219|FG000|Overall Study|Adverse Event|1|||
44515161|NCT04451330|79521220|FG001|Overall Study|Adverse Event|2|||
44515162|NCT04451330|79521219|FG000|Overall Study|Lost to Follow-up|5|||
44515163|NCT04451330|79521220|FG001|Overall Study|Lost to Follow-up|0|||
44515164|NCT04451330|79521219|FG000|Overall Study|Withdrawal by Subject|3|||
44515165|NCT04451330|79521220|FG001|Overall Study|Withdrawal by Subject|1|||
44515166|NCT04451330|79521219|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44515167|NCT04451330|79521220|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44515168|NCT04451330|79521219|FG000|Overall Study|Other than specified|0|||
44515169|NCT04451330|79521220|FG001|Overall Study|Other than specified|1|||
44515170|NCT02493426|79521226|FG000|Overall Study|Withdrawal by Subject|0|||
44515171|NCT02493426|79521227|FG001|Overall Study|Withdrawal by Subject|1|||
44515172|NCT04448756|79521236|FG000|Overall Study|Adverse Event|0|||
44515173|NCT04448756|79521237|FG001|Overall Study|Adverse Event|1|||
44515174|NCT04448756|79521238|FG002|Overall Study|Adverse Event|0|||
44249772|NCT01502072|79084020|FG001|Overall Study|Withdrawal by Subject|0|||
44249773|NCT01502072|79084021|FG002|Overall Study|Withdrawal by Subject|0|||
44249774|NCT01502072|79084019|FG000|Overall Study|Death|0|||
44249775|NCT01502072|79084020|FG001|Overall Study|Death|1|||
44249776|NCT01502072|79084021|FG002|Overall Study|Death|0|||
44249777|NCT01462370|79084029|FG000|Overall Study|Lack of Qualifying Event|1|||
44249778|NCT01462370|79084030|FG001|Overall Study|Lack of Qualifying Event|1|||
44249779|NCT01462370|79084029|FG000|Overall Study|Physician Decision|0|||
44249780|NCT01462370|79084030|FG001|Overall Study|Physician Decision|1|||
44249781|NCT01462370|79084029|FG000|Overall Study|Withdrawal by Subject|0|||
44249782|NCT01462370|79084030|FG001|Overall Study|Withdrawal by Subject|3|||
44249783|NCT01479764|79084038|FG000|Randomized|Adverse Event|1|||
44249784|NCT01479764|79084039|FG001|Randomized|Adverse Event|1|||
44249785|NCT01479764|79084038|FG000|Randomized|Withdrawal by Subject|1|||
44249786|NCT01479764|79084039|FG001|Randomized|Withdrawal by Subject|0|||
44249787|NCT01479764|79084038|FG000|Treated|Lost to Follow-up|0|||
44249788|NCT01479764|79084039|FG001|Treated|Lost to Follow-up|2|||
44249789|NCT01479530|79084047|FG000|Overall Study|Adverse Event|5|||
44249790|NCT01479530|79084048|FG001|Overall Study|Adverse Event|6|||
44249791|NCT01479530|79084047|FG000|Overall Study|Lack of Efficacy|0|||
44249792|NCT01479530|79084048|FG001|Overall Study|Lack of Efficacy|1|||
44249793|NCT01479530|79084047|FG000|Overall Study|Protocol Violation|2|||
44249794|NCT01479530|79084048|FG001|Overall Study|Protocol Violation|3|||
44249795|NCT01479530|79084047|FG000|Overall Study|Withdrawal of Consent|3|||
44277826|NCT01626690|79238830|FG000|Overall Study|Adverse Event|1|||
44277827|NCT01626690|79238831|FG001|Overall Study|Adverse Event|0|||
44277828|NCT01626456|79238841|FG000|Overall Study|Withdrawal by Subject|21|||
44277829|NCT01626456|79238842|FG001|Overall Study|Withdrawal by Subject|46|||
44277830|NCT01626456|79238841|FG000|Overall Study|Adverse Event|2|||
44277831|NCT01626456|79238842|FG001|Overall Study|Adverse Event|27|||
44277832|NCT01626456|79238841|FG000|Overall Study|Lost to Follow-up|2|||
44277833|NCT01626456|79238842|FG001|Overall Study|Lost to Follow-up|27|||
44277834|NCT01626456|79238841|FG000|Overall Study|Lack of Efficacy|6|||
44277835|NCT01626456|79238842|FG001|Overall Study|Lack of Efficacy|7|||
44277836|NCT01626456|79238841|FG000|Overall Study|Physician Decision|1|||
44277837|NCT01626456|79238842|FG001|Overall Study|Physician Decision|4|||
44277838|NCT01626456|79238841|FG000|Overall Study|Protocol Violation|1|||
44277839|NCT01626456|79238842|FG001|Overall Study|Protocol Violation|1|||
44277840|NCT01626456|79238841|FG000|Overall Study|Site Closure|2|||
44277841|NCT01626456|79238842|FG001|Overall Study|Site Closure|3|||
44277842|NCT01626456|79238841|FG000|Overall Study|Incarceration|0|||
44277843|NCT01626456|79238842|FG001|Overall Study|Incarceration|2|||
44277844|NCT02116608|79238860|FG000|Overall Study|Lost to Follow-up|0|||
44277845|NCT02116608|79238861|FG001|Overall Study|Lost to Follow-up|0|||
44277846|NCT02116608|79238862|FG002|Overall Study|Lost to Follow-up|1|||
44277847|NCT02116608|79238860|FG000|Overall Study|Physician Decision|0|||
44277848|NCT02116608|79238861|FG001|Overall Study|Physician Decision|1|||
44277849|NCT02116608|79238862|FG002|Overall Study|Physician Decision|0|||
44277850|NCT02116608|79238860|FG000|Overall Study|Death|0|||
44277851|NCT02116608|79238861|FG001|Overall Study|Death|1|||
44277852|NCT02116608|79238862|FG002|Overall Study|Death|0|||
44277853|NCT02092116|79238872|FG000|Overall Study|Withdrawal by Subject|0|||
44277854|NCT02092116|79238873|FG001|Overall Study|Withdrawal by Subject|3|||
44277855|NCT02092116|79238872|FG000|Overall Study|Adverse Event|0|||
44277856|NCT02092116|79238873|FG001|Overall Study|Adverse Event|1|||
44277857|NCT02091726|79238879|FG000|Overall Study|Lost to Follow-up|6|||
44277858|NCT02091414|79238883|FG000|Overall Study|Withdrawal by Subject|2|||
44277859|NCT02091414|79238883|FG000|Overall Study|Death|2|||
44277860|NCT02116530|79238889|FG000|Overall Study|Withdrawal by Subject|1|||
44277861|NCT02116530|79238890|FG001|Overall Study|Withdrawal by Subject|2|||
44277862|NCT02116530|79238889|FG000|Overall Study|Adverse Event|4|||
44277863|NCT02116530|79238890|FG001|Overall Study|Adverse Event|0|||
44277864|NCT02116530|79238889|FG000|Overall Study|Physician Decision|1|||
44277865|NCT02116530|79238890|FG001|Overall Study|Physician Decision|0|||
44277866|NCT02116530|79238889|FG000|Overall Study|Lost to Follow-up|1|||
44277867|NCT02116530|79238890|FG001|Overall Study|Lost to Follow-up|0|||
44249796|NCT01479530|79084048|FG001|Overall Study|Withdrawal of Consent|2|||
44249797|NCT01479374|79084057|FG000|Overall Study|Adverse Event|2|||
44277868|NCT02116530|79238889|FG000|Overall Study|Other Medical Problems|2|||
44249798|NCT01479374|79084058|FG001|Overall Study|Adverse Event|1|||
44249799|NCT01479374|79084059|FG002|Overall Study|Adverse Event|0|||
44249800|NCT01479374|79084057|FG000|Overall Study|Lost to Follow-up|1|||
44249801|NCT01479374|79084058|FG001|Overall Study|Lost to Follow-up|2|||
44277869|NCT02116530|79238890|FG001|Overall Study|Other Medical Problems|2|||
44277870|NCT02072226|79238898|FG000|Overall Study|Lost to Follow-up|11|||
44277871|NCT02072226|79238899|FG001|Overall Study|Lost to Follow-up|7|||
44277872|NCT02072226|79238898|FG000|Overall Study|Patient Non-compliance|2|||
44277873|NCT02072226|79238899|FG001|Overall Study|Patient Non-compliance|3|||
44277874|NCT02072226|79238898|FG000|Overall Study|Death|1|||
44277875|NCT02072226|79238899|FG001|Overall Study|Death|0|||
44381990|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
44381991|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
44381992|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
44381993|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
44381994|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
44381995|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
44381996|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
44381997|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
44381998|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
44381999|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
44382000|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
44382001|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Death|0|||
44382002|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Death|1|||
44382003|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Death|0|||
44382004|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Death|1|||
44382005|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Death|0|||
44382006|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Change of location|1|||
44382007|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Change of location|1|||
44382008|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Change of location|0|||
44382009|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Change of location|1|||
44382010|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Change of location|0|||
44382011|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
44382012|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
44382013|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
44382014|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
44382015|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
44382016|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
44382017|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
44382018|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
44382019|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
44382020|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
44382021|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
44382022|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
44382023|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
44382024|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
44382025|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
44382026|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
44382027|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
44382028|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
44382029|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
44382030|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
44382031|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
44382032|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
44382033|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
44382034|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
44382035|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
44382036|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
44277876|NCT02072226|79238898|FG000|Overall Study|Patient Withdrawal of Consent|1|||
44277877|NCT02072226|79238899|FG001|Overall Study|Patient Withdrawal of Consent|0|||
44277878|NCT02090634|79238907|FG000|Overall Study|Lost to Follow-up|0|||
44277879|NCT02090634|79238908|FG001|Overall Study|Lost to Follow-up|1|||
44277880|NCT02090634|79238907|FG000|Overall Study|Death|0|||
44277881|NCT02090634|79238908|FG001|Overall Study|Death|1|||
44382037|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
44382038|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
44382039|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
44382040|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
44382041|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
44382042|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
44382043|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
44382044|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
44382045|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
44382046|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
44277882|NCT02090634|79238907|FG000|Overall Study|Protocol Violation|3|||
44277883|NCT02090634|79238908|FG001|Overall Study|Protocol Violation|1|||
44515175|NCT04448756|79521236|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
44515176|NCT04448756|79521237|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
44515177|NCT04448756|79521238|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
44515178|NCT04448756|79521236|FG000|Overall Study|Withdrawal by Subject|0|||
44515179|NCT04448756|79521237|FG001|Overall Study|Withdrawal by Subject|3|||
44249802|NCT01479374|79084059|FG002|Overall Study|Lost to Follow-up|0|||
44249803|NCT01479374|79084057|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
44277884|NCT02090634|79238907|FG000|Overall Study|Adverse Event|2|||
44277885|NCT02090634|79238908|FG001|Overall Study|Adverse Event|0|||
44277886|NCT02114892|79238916|FG000|Overall Study|Lost to Follow-up|1|||
44277887|NCT02114892|79238917|FG001|Overall Study|Lost to Follow-up|2|||
44277888|NCT02070978|79238926|FG000|Overall Study|Adverse Event|6|||
44277889|NCT02070978|79238927|FG001|Overall Study|Adverse Event|2|||
44277890|NCT02070978|79238928|FG002|Overall Study|Adverse Event|0|||
44277891|NCT02070978|79238926|FG000|Overall Study|Lost to Follow-up|1|||
44277892|NCT02070978|79238927|FG001|Overall Study|Lost to Follow-up|3|||
44515180|NCT04448756|79521238|FG002|Overall Study|Withdrawal by Subject|1|||
44515181|NCT04448756|79521236|FG000|Overall Study|Death|2|||
44249804|NCT01479374|79084058|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
44249805|NCT01479374|79084059|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
44249806|NCT01479374|79084057|FG000|Overall Study|Other|0|||
44249807|NCT01479374|79084058|FG001|Overall Study|Other|4|||
44249808|NCT01479374|79084059|FG002|Overall Study|Other|5|||
44249809|NCT00087529|79084069|FG000|Overall Study|Death|1|||
44249810|NCT00087529|79084070|FG001|Overall Study|Death|0|||
44249811|NCT00087529|79084069|FG000|Overall Study|Adverse Event|0|||
44249812|NCT00087529|79084070|FG001|Overall Study|Adverse Event|8|||
44249813|NCT00087529|79084069|FG000|Overall Study|Pregnancy|0|||
44249814|NCT00087529|79084070|FG001|Overall Study|Pregnancy|1|||
44249815|NCT00087529|79084069|FG000|Overall Study|Lost to Follow-up|2|||
44249816|NCT00087529|79084070|FG001|Overall Study|Lost to Follow-up|3|||
44249817|NCT00087529|79084069|FG000|Overall Study|Participant Decision|14|||
44249818|NCT00087529|79084070|FG001|Overall Study|Participant Decision|37|||
44249819|NCT00087529|79084069|FG000|Overall Study|Physician Decision|4|||
44249820|NCT00087529|79084070|FG001|Overall Study|Physician Decision|8|||
44249821|NCT00087529|79084069|FG000|Overall Study|Initiation of Excluded Therapy|0|||
44249822|NCT00087529|79084070|FG001|Overall Study|Initiation of Excluded Therapy|1|||
44249823|NCT00087529|79084069|FG000|Overall Study|Participant Noncompliance|0|||
44249824|NCT00087529|79084070|FG001|Overall Study|Participant Noncompliance|1|||
44249825|NCT00087529|79084069|FG000|Overall Study|Disease Progression|5|||
44249826|NCT00087529|79084070|FG001|Overall Study|Disease Progression|4|||
44249827|NCT00087529|79084069|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
44249828|NCT00087529|79084070|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
44249829|NCT01500434|79084093|FG000|Overall Study|Death|1|||
44249830|NCT01500434|79084093|FG000|Overall Study|Withdrawal by Subject|1|||
44249831|NCT01500434|79084093|FG000|Overall Study|Missed 12-month follow-up|5|||
44249832|NCT00087139|79084100|FG000|Overall Study|Adverse Event|18|||
44249833|NCT00087139|79084101|FG001|Overall Study|Adverse Event|17|||
44249834|NCT00087139|79084102|FG002|Overall Study|Adverse Event|13|||
44249835|NCT00087139|79084100|FG000|Overall Study|Death|2|||
44249836|NCT00087139|79084101|FG001|Overall Study|Death|1|||
44249837|NCT00087139|79084102|FG002|Overall Study|Death|0|||
44249838|NCT00087139|79084100|FG000|Overall Study|Withdrawal by Subject|3|||
44249839|NCT00087139|79084101|FG001|Overall Study|Withdrawal by Subject|2|||
44249840|NCT00087139|79084102|FG002|Overall Study|Withdrawal by Subject|2|||
44249841|NCT00087139|79084100|FG000|Overall Study|Physician Decision|1|||
44249842|NCT00087139|79084101|FG001|Overall Study|Physician Decision|1|||
44249843|NCT00087139|79084102|FG002|Overall Study|Physician Decision|1|||
44249844|NCT00087139|79084100|FG000|Overall Study|Disease progression|9|||
44249845|NCT00087139|79084101|FG001|Overall Study|Disease progression|19|||
44249846|NCT00087139|79084102|FG002|Overall Study|Disease progression|12|||
44249847|NCT00087139|79084100|FG000|Overall Study|Ineligible|4|||
44249848|NCT00087139|79084101|FG001|Overall Study|Ineligible|7|||
44249849|NCT00087139|79084102|FG002|Overall Study|Ineligible|4|||
44249850|NCT00087139|79084100|FG000|Overall Study|Symptomatic deterioration|1|||
44249851|NCT00087139|79084101|FG001|Overall Study|Symptomatic deterioration|1|||
44249852|NCT00087139|79084102|FG002|Overall Study|Symptomatic deterioration|3|||
44249853|NCT00087139|79084100|FG000|Overall Study|Use of coumadin|1|||
44249854|NCT00087139|79084101|FG001|Overall Study|Use of coumadin|0|||
44515182|NCT04448756|79521237|FG001|Overall Study|Death|1|||
44515183|NCT04448756|79521238|FG002|Overall Study|Death|0|||
44249855|NCT00087139|79084102|FG002|Overall Study|Use of coumadin|0|||
44249856|NCT00087139|79084100|FG000|Overall Study|Response achieved|0|||
44249857|NCT00087139|79084101|FG001|Overall Study|Response achieved|1|||
44249858|NCT00087139|79084102|FG002|Overall Study|Response achieved|0|||
44249859|NCT00087139|79084100|FG000|Overall Study|Extradural disease|0|||
44249860|NCT00087139|79084101|FG001|Overall Study|Extradural disease|0|||
44277893|NCT02070978|79238928|FG002|Overall Study|Lost to Follow-up|4|||
44277894|NCT02070978|79238926|FG000|Overall Study|Withdrawal by Subject|3|||
44515184|NCT04274192|79521248|FG000|Overall Study|Protocol Violation|1|||
44515185|NCT04274192|79521249|FG001|Overall Study|Protocol Violation|0|||
44515186|NCT04387136|79521259|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
44515187|NCT04387136|79521260|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
44515188|NCT04252586|79521266|FG000|Overall Study|Withdrawal by parent/guardian|3|||
44515189|NCT04252586|79521266|FG000|Overall Study|Adverse Event|1|||
44515190|NCT04252586|79521266|FG000|Overall Study|Death|2|||
44515191|NCT04252586|79521266|FG000|Overall Study|Study terminated by sponsor|4|||
44515192|NCT04252586|79521266|FG000|Overall Study|Sponsor request|10|||
44515193|NCT04252586|79521266|FG000|Overall Study|Did not complete treatment period|1|||
44515194|NCT04247828|79521271|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
44515195|NCT04507776|79521275|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
44515196|NCT04386902|79521284|FG000|Overall Study|Withdrawal by Subject|5|||
44515197|NCT04386902|79521284|FG000|Overall Study|Technical problems in the recording|5|||
44515198|NCT04232540|79521290|FG000|Overall Study|Lost to Follow-up|1|||
44515199|NCT04232540|79521291|FG001|Overall Study|Lost to Follow-up|0|||
44515200|NCT04504032|79521299|FG000|Overall Study|Adverse Event|1|||
44515201|NCT04504032|79521300|FG001|Overall Study|Adverse Event|2|||
44515202|NCT04504032|79521299|FG000|Overall Study|Lost to Follow-up|6|||
44515203|NCT04504032|79521300|FG001|Overall Study|Lost to Follow-up|9|||
44515204|NCT04504032|79521299|FG000|Overall Study|Protocol Violation|2|||
44515205|NCT04504032|79521300|FG001|Overall Study|Protocol Violation|0|||
44515206|NCT04504032|79521299|FG000|Overall Study|Study terminated by sponsor|1|||
44515207|NCT04504032|79521300|FG001|Overall Study|Study terminated by sponsor|2|||
44515208|NCT04504032|79521299|FG000|Overall Study|Withdrawal by Subject|9|||
44515209|NCT04504032|79521300|FG001|Overall Study|Withdrawal by Subject|11|||
44515210|NCT04504032|79521299|FG000|Overall Study|Disease progression prior to dosing|15|||
44515211|NCT04504032|79521300|FG001|Overall Study|Disease progression prior to dosing|3|||
44515212|NCT04504032|79521299|FG000|Overall Study|Drug supply issues|1|||
44515213|NCT04504032|79521300|FG001|Overall Study|Drug supply issues|1|||
44515214|NCT04504032|79521299|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
44515215|NCT04504032|79521300|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
44515216|NCT04439240|79521306|FG000|Overall Study|Ineligible|2|||
44515217|NCT04439240|79521306|FG000|Overall Study|Never started treatment|2|||
44515218|NCT04439240|79521306|FG000|Overall Study|Adverse Event|12|||
44515219|NCT04439240|79521306|FG000|Overall Study|Death|2|||
44515220|NCT04439240|79521306|FG000|Overall Study|Disease progression|25|||
44515221|NCT04439240|79521306|FG000|Overall Study|Other diseases|2|||
44515222|NCT04439240|79521306|FG000|Overall Study|Withdrawal by Subject|3|||
44515223|NCT04439240|79521306|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
44515224|NCT04439240|79521306|FG000|Overall Study|Symptomatic decline|1|||
44515225|NCT04439240|79521306|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
44515226|NCT04439240|79521306|FG000|Overall Study|Clinical progression|1|||
44515227|NCT04605588|79521312|FG000|Overall Study|Withdrawal by Subject|1|||
44382047|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
44382048|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
44382049|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
44382050|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
44382051|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
44382052|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
44382053|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
44382054|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
44382055|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
44382056|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
44382057|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
44382058|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
44382059|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
44382060|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
44515228|NCT04605588|79521313|FG001|Overall Study|Withdrawal by Subject|0|||
44515229|NCT04885296|79521319|FG000|Period 1|Covid-19 Related|1|||
44515230|NCT04885296|79521320|FG001|Period 1|Covid-19 Related|0|||
44515231|NCT04885296|79521319|FG000|Period 1|Adverse Event|0|||
44515232|NCT04885296|79521320|FG001|Period 1|Adverse Event|1|||
44515233|NCT04885296|79521319|FG000|Period 1|Withdrawal by Subject|1|||
44515234|NCT04885296|79521320|FG001|Period 1|Withdrawal by Subject|1|||
44515235|NCT04885296|79521319|FG000|Period 1|Test Article No Longer Available|1|||
44515236|NCT04885296|79521320|FG001|Period 1|Test Article No Longer Available|0|||
44515237|NCT04885296|79521319|FG000|Period 1|Dispensed Study lens in Error|1|||
44515238|NCT04885296|79521320|FG001|Period 1|Dispensed Study lens in Error|0|||
44515239|NCT04885296|79521319|FG000|Period 1|Lost to Follow-up|1|||
44515240|NCT04885296|79521320|FG001|Period 1|Lost to Follow-up|0|||
44515241|NCT04885296|79521319|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
44515242|NCT04885296|79521320|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
44515243|NCT04602000|79521331|FG000|Overall Study|Withdrawal by Subject|3|||
44515244|NCT04602000|79521332|FG001|Overall Study|Withdrawal by Subject|6|||
44515245|NCT04602000|79521333|FG002|Overall Study|Withdrawal by Subject|3|||
44515246|NCT04602000|79521334|FG003|Overall Study|Withdrawal by Subject|27|||
44515247|NCT04602000|79521335|FG004|Overall Study|Withdrawal by Subject|39|||
44515248|NCT04602000|79521331|FG000|Overall Study|Physician Decision|1|||
44515249|NCT04602000|79521332|FG001|Overall Study|Physician Decision|0|||
44515250|NCT04602000|79521333|FG002|Overall Study|Physician Decision|0|||
44515251|NCT04602000|79521334|FG003|Overall Study|Physician Decision|2|||
44515252|NCT04602000|79521335|FG004|Overall Study|Physician Decision|2|||
44515253|NCT04602000|79521331|FG000|Overall Study|Death|0|||
44515254|NCT04602000|79521332|FG001|Overall Study|Death|1|||
44515255|NCT04602000|79521333|FG002|Overall Study|Death|0|||
44515256|NCT04602000|79521334|FG003|Overall Study|Death|1|||
44515257|NCT04602000|79521335|FG004|Overall Study|Death|2|||
44515258|NCT04602000|79521331|FG000|Overall Study|Lost to Follow-up|0|||
44382061|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Missing|0|||
44277895|NCT02070978|79238927|FG001|Overall Study|Withdrawal by Subject|5|||
44277896|NCT02070978|79238928|FG002|Overall Study|Withdrawal by Subject|3|||
44277897|NCT02070978|79238926|FG000|Overall Study|Protocol Violation|1|||
44277898|NCT02070978|79238927|FG001|Overall Study|Protocol Violation|0|||
44277899|NCT02070978|79238928|FG002|Overall Study|Protocol Violation|3|||
44277900|NCT02070978|79238926|FG000|Overall Study|Lack of Efficacy|0|||
44277901|NCT02070978|79238927|FG001|Overall Study|Lack of Efficacy|1|||
44277902|NCT02070978|79238928|FG002|Overall Study|Lack of Efficacy|0|||
44277903|NCT02070978|79238926|FG000|Overall Study|Death|0|||
44277904|NCT02070978|79238927|FG001|Overall Study|Death|0|||
44277905|NCT02070978|79238928|FG002|Overall Study|Death|2|||
44277906|NCT02070978|79238926|FG000|Overall Study|Un-specified|3|||
44277907|NCT02070978|79238927|FG001|Overall Study|Un-specified|2|||
44277908|NCT02070978|79238928|FG002|Overall Study|Un-specified|2|||
44382062|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Missing|0|||
44382063|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Missing|2|||
44382064|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Missing|0|||
44382065|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Missing|0|||
44382066|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
44382067|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
44382068|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
44382069|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
44382070|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
44382071|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
44382072|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
44382073|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
44382074|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
44382075|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
44382076|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
44382077|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
44382078|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
44515259|NCT04602000|79521332|FG001|Overall Study|Lost to Follow-up|0|||
44515260|NCT04602000|79521333|FG002|Overall Study|Lost to Follow-up|0|||
44515261|NCT04602000|79521334|FG003|Overall Study|Lost to Follow-up|3|||
44515262|NCT04602000|79521335|FG004|Overall Study|Lost to Follow-up|4|||
44515263|NCT04602000|79521331|FG000|Overall Study|Other|4|||
44515264|NCT04602000|79521332|FG001|Overall Study|Other|1|||
44277909|NCT02070978|79238926|FG000|Overall Study|Terminated by Sponsor|33|||
44277910|NCT02070978|79238927|FG001|Overall Study|Terminated by Sponsor|40|||
44277911|NCT02070978|79238928|FG002|Overall Study|Terminated by Sponsor|39|||
44277912|NCT02114268|79238942|FG000|Overall Study|Lost to Follow-up|4|||
44277913|NCT02114268|79238943|FG001|Overall Study|Lost to Follow-up|1|||
44277914|NCT02114268|79238944|FG002|Overall Study|Lost to Follow-up|1|||
44277915|NCT02114268|79238945|FG003|Overall Study|Lost to Follow-up|0|||
44515265|NCT04602000|79521333|FG002|Overall Study|Other|2|||
44277916|NCT02114268|79238946|FG004|Overall Study|Lost to Follow-up|0|||
44277917|NCT02114268|79238947|FG005|Overall Study|Lost to Follow-up|2|||
44277918|NCT02114268|79238942|FG000|Overall Study|Withdrawal by Subject|1|||
44515266|NCT04602000|79521334|FG003|Overall Study|Other|5|||
44515267|NCT04602000|79521335|FG004|Overall Study|Other|4|||
44515268|NCT04602000|79521331|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
44277919|NCT02114268|79238943|FG001|Overall Study|Withdrawal by Subject|0|||
44277920|NCT02114268|79238944|FG002|Overall Study|Withdrawal by Subject|0|||
44277921|NCT02114268|79238945|FG003|Overall Study|Withdrawal by Subject|0|||
44277922|NCT02114268|79238946|FG004|Overall Study|Withdrawal by Subject|0|||
44277923|NCT02114268|79238947|FG005|Overall Study|Withdrawal by Subject|1|||
44277924|NCT02114268|79238942|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
44515269|NCT04602000|79521332|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
44515270|NCT04602000|79521333|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
44515271|NCT04602000|79521334|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
44515272|NCT04602000|79521335|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
44515273|NCT03041116|79521351|FG000|Double-blind|Death|0|||
44515274|NCT03041116|79521352|FG001|Double-blind|Death|2|||
44515275|NCT03041116|79521351|FG000|Double-blind|Withdrawal by Subject|0|||
44515276|NCT03041116|79521352|FG001|Double-blind|Withdrawal by Subject|4|||
44515277|NCT03041116|79521351|FG000|Open-label|Death|1|||
44515278|NCT03041116|79521352|FG001|Open-label|Death|0|||
44515279|NCT03041116|79521351|FG000|Open-label|Termination of the study by Sponsor|39|||
44515280|NCT03041116|79521352|FG001|Open-label|Termination of the study by Sponsor|37|||
44515281|NCT03041116|79521351|FG000|Open-label|Withdrawal by Subject|1|||
44515282|NCT03041116|79521352|FG001|Open-label|Withdrawal by Subject|0|||
44515283|NCT04860258|79521369|FG000|Overall Study|Withdrawal by Subject|0|||
44515284|NCT04860258|79521370|FG001|Overall Study|Withdrawal by Subject|0|||
44515285|NCT04860258|79521371|FG002|Overall Study|Withdrawal by Subject|4|||
44515286|NCT04860258|79521372|FG003|Overall Study|Withdrawal by Subject|1|||
44515287|NCT04860258|79521373|FG004|Overall Study|Withdrawal by Subject|4|||
44515288|NCT04860258|79521374|FG005|Overall Study|Withdrawal by Subject|1|||
44515289|NCT04860258|79521375|FG006|Overall Study|Withdrawal by Subject|0|||
44515290|NCT03041038|79521393|FG000|Overall Study|Withdrawal by Subject|4|||
44515291|NCT03041038|79521394|FG001|Overall Study|Withdrawal by Subject|0|||
44515292|NCT03041038|79521393|FG000|Overall Study|Lost to Follow-up|1|||
44515293|NCT03041038|79521394|FG001|Overall Study|Lost to Follow-up|1|||
44515294|NCT03041038|79521393|FG000|Overall Study|Protocol Violation|1|||
44515295|NCT03041038|79521394|FG001|Overall Study|Protocol Violation|1|||
44515296|NCT04382066|79521405|FG000|Overall Study|Adverse Event|1|||
44515297|NCT04382066|79521406|FG001|Overall Study|Adverse Event|0|||
44515298|NCT04382066|79521407|FG002|Overall Study|Adverse Event|0|||
44515299|NCT04382066|79521405|FG000|Overall Study|Death|1|||
44515300|NCT04382066|79521406|FG001|Overall Study|Death|0|||
44515301|NCT04382066|79521407|FG002|Overall Study|Death|1|||
44515302|NCT04435184|79521423|FG000|Overall Study|follow-up blood draws missing|3|||
44515303|NCT04435184|79521424|FG001|Overall Study|follow-up blood draws missing|5|||
44515304|NCT03693404|79521432|FG000|Overall Study|Withdrawal by Subject|1|||
44515305|NCT03693404|79521433|FG001|Overall Study|Withdrawal by Subject|0|||
44515306|NCT03693404|79521432|FG000|Overall Study|Lost to Follow-up|0|||
44515307|NCT03693404|79521433|FG001|Overall Study|Lost to Follow-up|5|||
44382079|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
44382080|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
44382081|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
44382082|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
44382083|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
44143903|NCT02855125|78933189|FG000|Overall Study|Physician Decision|1|||
44143904|NCT02855125|78933190|FG001|Overall Study|Physician Decision|0|||
44382084|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
44382085|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
44382086|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
44382087|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
44382088|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
44382089|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
44382090|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
44382091|NCT00730405|79388047|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
44382092|NCT00730405|79388048|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
44382093|NCT00730405|79388049|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
44382094|NCT00730405|79388050|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
44382095|NCT00730405|79388051|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
44382096|NCT00736723|79388067|FG000|Overall Study|Withdrawal by Subject|4|||
44382097|NCT00736723|79388068|FG001|Overall Study|Withdrawal by Subject|3|||
44382098|NCT00736645|79388078|FG000|Overall Study|Adverse Event|0|||
44515308|NCT03693404|79521432|FG000|Overall Study|Excluded from Analysis|0|||
44515309|NCT03693404|79521433|FG001|Overall Study|Excluded from Analysis|1|||
44515310|NCT03696108|79521441|FG000|Overall Study|Physician Decision|1|||
44515311|NCT03696108|79521442|FG001|Overall Study|Physician Decision|0|||
44143905|NCT02855125|78933189|FG000|Overall Study|On Treatment|9|||
44515312|NCT03696108|79521441|FG000|Overall Study|Withdrawal by Subject|3|||
44515313|NCT03696108|79521442|FG001|Overall Study|Withdrawal by Subject|6|||
44515314|NCT04218110|79521452|FG000|Overall Study|Withdrawal by Subject|0|||
44515315|NCT04218110|79521453|FG001|Overall Study|Withdrawal by Subject|0|||
44515316|NCT04218110|79521454|FG002|Overall Study|Withdrawal by Subject|0|||
44515317|NCT04218110|79521455|FG003|Overall Study|Withdrawal by Subject|1|||
44515318|NCT04214600|79521467|FG000|Overall Study|Lost to Follow-up|9|||
44515319|NCT04214600|79521468|FG001|Overall Study|Lost to Follow-up|14|||
44515320|NCT04210310|79521477|FG000|Overall Study|Lost to Follow-up|32|||
44515321|NCT04210310|79521478|FG001|Overall Study|Lost to Follow-up|1|||
44515322|NCT04209530|79521486|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
44515323|NCT04209530|79521487|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
44515324|NCT04209530|79521486|FG000|Overall Study|Withdrawal by Subject|0|||
44143906|NCT02855125|78933190|FG001|Overall Study|On Treatment|11|||
44143907|NCT02855125|78933189|FG000|Overall Study|Randomized but not treated|0|||
44249861|NCT00087139|79084102|FG002|Overall Study|Extradural disease|1|||
44382099|NCT00736645|79388079|FG001|Overall Study|Adverse Event|2|||
44382100|NCT00736645|79388080|FG002|Overall Study|Adverse Event|0|||
44382101|NCT00736645|79388081|FG003|Overall Study|Adverse Event|0|||
44382102|NCT00736489|79388091|FG000|Period 1|Lost to Follow-up|1|||
44382103|NCT00736489|79388092|FG001|Period 1|Lost to Follow-up|0|||
44382104|NCT00736489|79388093|FG002|Period 1|Lost to Follow-up|0|||
44382105|NCT00736489|79388094|FG003|Period 1|Lost to Follow-up|0|||
44382106|NCT00736489|79388095|FG004|Period 1|Lost to Follow-up|0|||
44382107|NCT00736489|79388096|FG005|Period 1|Lost to Follow-up|0|||
44382108|NCT00736489|79388091|FG000|Period 1|Withdrawal by Subject|0|||
44382109|NCT00736489|79388092|FG001|Period 1|Withdrawal by Subject|0|||
44382110|NCT00736489|79388093|FG002|Period 1|Withdrawal by Subject|0|||
44382111|NCT00736489|79388094|FG003|Period 1|Withdrawal by Subject|0|||
44382112|NCT00736489|79388095|FG004|Period 1|Withdrawal by Subject|0|||
44382113|NCT00736489|79388096|FG005|Period 1|Withdrawal by Subject|1|||
44382114|NCT00730327|79388128|FG000|Overall Study|Lost to Follow-up|14|||
44382115|NCT00730327|79388129|FG001|Overall Study|Lost to Follow-up|16|||
44382116|NCT00730327|79388128|FG000|Overall Study|Adverse Event|8|||
44382117|NCT00730327|79388129|FG001|Overall Study|Adverse Event|1|||
44382118|NCT00730327|79388128|FG000|Overall Study|Withdrawal by Subject|3|||
44382119|NCT00730327|79388129|FG001|Overall Study|Withdrawal by Subject|13|||
44382120|NCT00730327|79388128|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
44382121|NCT00730327|79388129|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
44382122|NCT00742417|79388144|FG000|Randomized|Withdrawal by legal representative|0|||
44382123|NCT00742417|79388145|FG001|Randomized|Withdrawal by legal representative|1|||
44382124|NCT00742417|79388144|FG000|Randomized|Withdrawal by Subject|1|||
44277925|NCT02114268|79238943|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
44277926|NCT02114268|79238944|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
44382125|NCT00742417|79388145|FG001|Randomized|Withdrawal by Subject|0|||
44382126|NCT00742417|79388144|FG000|Randomized|Physician Decision|1|||
44382127|NCT00742417|79388145|FG001|Randomized|Physician Decision|0|||
44515325|NCT04209530|79521487|FG001|Overall Study|Withdrawal by Subject|1|||
44515326|NCT04349098|79521495|FG000|Overall Study|Death|16|||
44515327|NCT04349098|79521496|FG001|Overall Study|Death|8|||
44515328|NCT04349098|79521495|FG000|Overall Study|Lost to Follow-up|11|||
44515329|NCT04349098|79521496|FG001|Overall Study|Lost to Follow-up|8|||
44143908|NCT02855125|78933190|FG001|Overall Study|Randomized but not treated|1|||
44143909|NCT02730871|78933213|FG000|Overall Study|Adverse Event|6|||
44143910|NCT02730871|78933214|FG001|Overall Study|Adverse Event|0|||
44249862|NCT01500278|79084154|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
44249863|NCT01500278|79084155|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
44249864|NCT01500278|79084154|FG000|Week 0 - Week 12|Protocol Violation|10|||
44249865|NCT01500278|79084155|FG001|Week 0 - Week 12|Protocol Violation|16|||
44249866|NCT01500278|79084154|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
44249867|NCT01500278|79084155|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
44249868|NCT01500278|79084154|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
44249869|NCT01500278|79084155|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
44249870|NCT01500278|79084154|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
44249871|NCT01500278|79084155|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
44249872|NCT01500278|79084154|FG000|Week 0 - Week 12|Patient decision|1|||
44249873|NCT01500278|79084155|FG001|Week 0 - Week 12|Patient decision|0|||
44249874|NCT01500278|79084154|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
44249875|NCT01500278|79084155|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
44249876|NCT01500278|79084154|FG000|Week 0 - Week 12|Investigator decision|1|||
44277927|NCT02114268|79238945|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
44382128|NCT00742417|79388144|FG000|Intensive Period|Withdrawal by Subject|1|||
44382129|NCT00742417|79388145|FG001|Intensive Period|Withdrawal by Subject|1|||
44382130|NCT00742417|79388144|FG000|Intensive Period|Adverse Event|2|||
44249877|NCT01500278|79084155|FG001|Week 0 - Week 12|Investigator decision|0|||
44382131|NCT00742417|79388145|FG001|Intensive Period|Adverse Event|0|||
44515330|NCT04349098|79521495|FG000|Overall Study|Withdrawal by Subject|8|||
44515331|NCT04349098|79521496|FG001|Overall Study|Withdrawal by Subject|5|||
44249878|NCT01500278|79084154|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
44382132|NCT00811018|79388153|FG000|Overall Study|Additional Chronic Treatment|31|||
44382133|NCT00811018|79388153|FG000|Overall Study|Adverse Event|79|||
44382134|NCT00811018|79388153|FG000|Overall Study|Death|147|||
44382135|NCT00811018|79388153|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
44382136|NCT00811018|79388153|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
44382137|NCT00811018|79388153|FG000|Overall Study|Investigator Decision|57|||
44382138|NCT00811018|79388153|FG000|Overall Study|Lost to Follow-up|19|||
44382139|NCT00811018|79388153|FG000|Overall Study|Pregnancy|6|||
44382140|NCT00811018|79388153|FG000|Overall Study|Sponsor Decision|450|||
44382141|NCT00811018|79388153|FG000|Overall Study|Withdrawal by Subject|70|||
44382142|NCT00811018|79388153|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
44382143|NCT00811018|79388153|FG000|Overall Study|Other|26|||
44382144|NCT00730171|79388162|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
44382145|NCT00730171|79388162|FG000|Overall Study|Adverse Event|193|||
44382146|NCT00730171|79388162|FG000|Overall Study|Protocol Violation|48|||
44382147|NCT00730171|79388162|FG000|Overall Study|Withdrawal by Subject|202|||
44382148|NCT00730171|79388162|FG000|Overall Study|Lost to Follow-up|121|||
44382149|NCT00730171|79388162|FG000|Overall Study|Insufficient Therapeutic Response|141|||
44382150|NCT00730171|79388162|FG000|Overall Study|Other|61|||
44382151|NCT00730015|79388173|FG000|Overall Study|Adverse Event|11|||
44382152|NCT00730015|79388174|FG001|Overall Study|Adverse Event|10|||
44382153|NCT00730015|79388175|FG002|Overall Study|Adverse Event|8|||
44382154|NCT00730015|79388173|FG000|Overall Study|Protocol Violation|2|||
44382155|NCT00730015|79388174|FG001|Overall Study|Protocol Violation|6|||
44382156|NCT00730015|79388175|FG002|Overall Study|Protocol Violation|4|||
44382157|NCT00730015|79388173|FG000|Overall Study|Withdrawal by Subject|12|||
44382158|NCT00730015|79388174|FG001|Overall Study|Withdrawal by Subject|12|||
44382159|NCT00730015|79388175|FG002|Overall Study|Withdrawal by Subject|8|||
44382160|NCT00730015|79388173|FG000|Overall Study|Lost to Follow-up|4|||
44382161|NCT00730015|79388174|FG001|Overall Study|Lost to Follow-up|10|||
44382162|NCT00730015|79388175|FG002|Overall Study|Lost to Follow-up|3|||
44382163|NCT00730015|79388173|FG000|Overall Study|Lack of Efficacy|1|||
44382164|NCT00730015|79388174|FG001|Overall Study|Lack of Efficacy|2|||
44382165|NCT00730015|79388175|FG002|Overall Study|Lack of Efficacy|8|||
44382166|NCT00730015|79388173|FG000|Overall Study|Other Reason|1|||
44382167|NCT00730015|79388174|FG001|Overall Study|Other Reason|0|||
44382168|NCT00730015|79388175|FG002|Overall Study|Other Reason|1|||
44382169|NCT00806026|79388194|FG000|Overall Study|Death|0|||
44382170|NCT00806026|79388195|FG001|Overall Study|Death|0|||
44382171|NCT00806026|79388196|FG002|Overall Study|Death|0|||
44382172|NCT00806026|79388197|FG003|Overall Study|Death|1|||
44382173|NCT00806026|79388198|FG004|Overall Study|Death|0|||
44382174|NCT00806026|79388199|FG005|Overall Study|Death|0|||
44382175|NCT00806026|79388194|FG000|Overall Study|Did not meet entrance criteria|4|||
44382176|NCT00806026|79388195|FG001|Overall Study|Did not meet entrance criteria|1|||
44382177|NCT00806026|79388196|FG002|Overall Study|Did not meet entrance criteria|2|||
44382178|NCT00806026|79388197|FG003|Overall Study|Did not meet entrance criteria|1|||
44382179|NCT00806026|79388198|FG004|Overall Study|Did not meet entrance criteria|0|||
44382180|NCT00806026|79388199|FG005|Overall Study|Did not meet entrance criteria|0|||
44382181|NCT00806026|79388194|FG000|Overall Study|Lack of Efficacy|5|||
44382182|NCT00806026|79388195|FG001|Overall Study|Lack of Efficacy|18|||
44382183|NCT00806026|79388196|FG002|Overall Study|Lack of Efficacy|13|||
44382184|NCT00806026|79388197|FG003|Overall Study|Lack of Efficacy|4|||
44382185|NCT00806026|79388198|FG004|Overall Study|Lack of Efficacy|8|||
44382186|NCT00806026|79388199|FG005|Overall Study|Lack of Efficacy|7|||
44382187|NCT00806026|79388194|FG000|Overall Study|Lost to Follow-up|8|||
44382188|NCT00806026|79388195|FG001|Overall Study|Lost to Follow-up|15|||
44382189|NCT00806026|79388196|FG002|Overall Study|Lost to Follow-up|8|||
44382190|NCT00806026|79388197|FG003|Overall Study|Lost to Follow-up|2|||
44382191|NCT00806026|79388198|FG004|Overall Study|Lost to Follow-up|6|||
44382192|NCT00806026|79388199|FG005|Overall Study|Lost to Follow-up|6|||
44382193|NCT00806026|79388194|FG000|Overall Study|Withdrawal by Subject|14|||
44382194|NCT00806026|79388195|FG001|Overall Study|Withdrawal by Subject|17|||
44382195|NCT00806026|79388196|FG002|Overall Study|Withdrawal by Subject|9|||
44382196|NCT00806026|79388197|FG003|Overall Study|Withdrawal by Subject|2|||
44382197|NCT00806026|79388198|FG004|Overall Study|Withdrawal by Subject|5|||
44382198|NCT00806026|79388199|FG005|Overall Study|Withdrawal by Subject|3|||
44382199|NCT00806026|79388194|FG000|Overall Study|Other|3|||
44382200|NCT00806026|79388195|FG001|Overall Study|Other|6|||
44382201|NCT00806026|79388196|FG002|Overall Study|Other|8|||
44382202|NCT00806026|79388197|FG003|Overall Study|Other|2|||
44382203|NCT00806026|79388198|FG004|Overall Study|Other|0|||
44382204|NCT00806026|79388199|FG005|Overall Study|Other|4|||
44382205|NCT00806026|79388194|FG000|Overall Study|Protocol Violation|6|||
44382206|NCT00806026|79388195|FG001|Overall Study|Protocol Violation|9|||
44382207|NCT00806026|79388196|FG002|Overall Study|Protocol Violation|9|||
44382208|NCT00806026|79388197|FG003|Overall Study|Protocol Violation|0|||
44382209|NCT00806026|79388198|FG004|Overall Study|Protocol Violation|2|||
44382210|NCT00806026|79388199|FG005|Overall Study|Protocol Violation|3|||
44382211|NCT00806026|79388194|FG000|Overall Study|Adverse Event|52|||
44382212|NCT00806026|79388195|FG001|Overall Study|Adverse Event|35|||
44382213|NCT00806026|79388196|FG002|Overall Study|Adverse Event|44|||
44382214|NCT00806026|79388197|FG003|Overall Study|Adverse Event|17|||
44382215|NCT00806026|79388198|FG004|Overall Study|Adverse Event|9|||
44382216|NCT00806026|79388199|FG005|Overall Study|Adverse Event|9|||
44382217|NCT04026165|79388214|FG000|Run-in Placebo Period|Enrollment Error|13|||
44382218|NCT04026165|79388215|FG001|Run-in Placebo Period|Enrollment Error|0|||
44382219|NCT04026165|79388216|FG002|Run-in Placebo Period|Enrollment Error|0|||
44382220|NCT04026165|79388217|FG003|Run-in Placebo Period|Enrollment Error|0|||
44515332|NCT04349098|79521495|FG000|Overall Study|Other|3|||
44382221|NCT04026165|79388214|FG000|Run-in Placebo Period|Run-in Failure|4|||
44382222|NCT04026165|79388215|FG001|Run-in Placebo Period|Run-in Failure|0|||
44382223|NCT04026165|79388216|FG002|Run-in Placebo Period|Run-in Failure|0|||
44382224|NCT04026165|79388217|FG003|Run-in Placebo Period|Run-in Failure|0|||
44382225|NCT04026165|79388214|FG000|Run-in Placebo Period|Protocol Violation|2|||
44382226|NCT04026165|79388215|FG001|Run-in Placebo Period|Protocol Violation|0|||
44382227|NCT04026165|79388216|FG002|Run-in Placebo Period|Protocol Violation|0|||
44382228|NCT04026165|79388217|FG003|Run-in Placebo Period|Protocol Violation|0|||
44382229|NCT04026165|79388214|FG000|Run-in Placebo Period|Withdrew Consent|2|||
44515333|NCT04349098|79521496|FG001|Overall Study|Other|5|||
44515334|NCT04208750|79521504|FG000|Overall Study|Lost to Follow-up|16|||
44515335|NCT04208750|79521505|FG001|Overall Study|Lost to Follow-up|15|||
44515336|NCT04381988|79521513|FG000|Overall Study|The study was terminated|4|||
44515337|NCT04381988|79521514|FG001|Overall Study|The study was terminated|0|||
44277928|NCT02114268|79238946|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
44277929|NCT02114268|79238947|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
44277930|NCT02089230|79238969|FG000|Overall Study|Death|0|||
44277931|NCT02089230|79238970|FG001|Overall Study|Death|0|||
44277932|NCT02089230|79238971|FG002|Overall Study|Death|2|||
44277933|NCT02089230|79238969|FG000|Overall Study|Seeking Alternative Therapy|0|||
44277934|NCT02089230|79238970|FG001|Overall Study|Seeking Alternative Therapy|0|||
44277935|NCT02089230|79238971|FG002|Overall Study|Seeking Alternative Therapy|4|||
44277936|NCT02070744|79238983|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
44277937|NCT02070744|79238984|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
44277938|NCT02070744|79238985|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
44277939|NCT02070744|79238986|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
44515338|NCT04333498|79521522|FG000|Overall Study|Lost to Follow-up|1|||
44515339|NCT04333498|79521523|FG001|Overall Study|Lost to Follow-up|0|||
44515340|NCT04333498|79521522|FG000|Overall Study|Lost to Follow-up|0|||
44515341|NCT04333498|79521523|FG001|Overall Study|Lost to Follow-up|1|||
44277940|NCT02070744|79238987|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
44277941|NCT02070744|79238983|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
44277942|NCT02070744|79238984|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
44277943|NCT02070744|79238985|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
44277944|NCT02070744|79238986|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
44382230|NCT04026165|79388215|FG001|Run-in Placebo Period|Withdrew Consent|0|||
44382231|NCT04026165|79388216|FG002|Run-in Placebo Period|Withdrew Consent|0|||
44382232|NCT04026165|79388217|FG003|Run-in Placebo Period|Withdrew Consent|0|||
44515342|NCT03355664|79521531|FG000|Overall Study|Adverse Event|1|||
44277945|NCT02070744|79238987|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
44277946|NCT02070744|79238983|FG000|OLE Phase (48 Weeks)|Other|0|||
44382233|NCT04026165|79388214|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
44515343|NCT03355664|79521532|FG001|Overall Study|Adverse Event|2|||
44515344|NCT03355664|79521531|FG000|Overall Study|Lost to Follow-up|11|||
44515345|NCT03355664|79521532|FG001|Overall Study|Lost to Follow-up|7|||
44515346|NCT03355664|79521531|FG000|Overall Study|Protocol Violation|1|||
44277947|NCT02070744|79238984|FG001|OLE Phase (48 Weeks)|Other|0|||
44277948|NCT02070744|79238985|FG002|OLE Phase (48 Weeks)|Other|0|||
44277949|NCT02070744|79238986|FG003|OLE Phase (48 Weeks)|Other|0|||
44515347|NCT03355664|79521532|FG001|Overall Study|Protocol Violation|2|||
44515348|NCT03355664|79521531|FG000|Overall Study|Withdrawal by Subject|2|||
44515349|NCT03355664|79521532|FG001|Overall Study|Withdrawal by Subject|1|||
44515350|NCT04170686|79521540|FG000|Screening|Physician Decision|12|||
44515351|NCT04170686|79521541|FG001|Screening|Physician Decision|13|||
44515352|NCT04170686|79521540|FG000|Randomization and Treatment|Lost to Follow-up|26|||
44515353|NCT04170686|79521541|FG001|Randomization and Treatment|Lost to Follow-up|15|||
44515354|NCT03695094|79521549|FG000|Overall Study|Adverse Event|1|||
44515355|NCT03695094|79521550|FG001|Overall Study|Adverse Event|1|||
44515356|NCT03695094|79521549|FG000|Overall Study|Withdrawal by Subject|1|||
44515357|NCT03695094|79521550|FG001|Overall Study|Withdrawal by Subject|0|||
44249879|NCT01500278|79084155|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
44249880|NCT01500278|79084154|FG000|Week 0 - Week 12|Sponsor decision|1|||
44249881|NCT01500278|79084155|FG001|Week 0 - Week 12|Sponsor decision|0|||
44249882|NCT01500278|79084154|FG000|Week 0 - Week 12|Personal reason|0|||
44249883|NCT01500278|79084155|FG001|Week 0 - Week 12|Personal reason|1|||
44249884|NCT01500278|79084154|FG000|Week 0 - Week 12|Other serious disease|0|||
44249885|NCT01500278|79084155|FG001|Week 0 - Week 12|Other serious disease|1|||
44249886|NCT01500278|79084154|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
44249887|NCT01500278|79084155|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
44249888|NCT01500278|79084154|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
44249889|NCT01500278|79084155|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
44249890|NCT01500278|79084154|FG000|Week 13 - Week 104|Protocol Violation|6|||
44249891|NCT01500278|79084155|FG001|Week 13 - Week 104|Protocol Violation|6|||
44249892|NCT01500278|79084154|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
44249893|NCT01500278|79084155|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
44277950|NCT02070744|79238987|FG004|OLE Phase (48 Weeks)|Other|1|||
44382234|NCT04026165|79388215|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
44515358|NCT04497948|79521558|FG000|Overall Study|Death|2|||
44515359|NCT04495374|79521568|FG000|Overall Study|Protocol Violation|2|||
44143911|NCT03376789|78933222|FG000|Overall Study|Withdrawal by Subject|3|||
44143912|NCT03376789|78933223|FG001|Overall Study|Withdrawal by Subject|5|||
44143913|NCT03376789|78933222|FG000|Overall Study|Protocol Violation|0|||
44143914|NCT03376789|78933223|FG001|Overall Study|Protocol Violation|1|||
44143915|NCT03376789|78933222|FG000|Overall Study|Adverse Event|0|||
44143916|NCT03376789|78933223|FG001|Overall Study|Adverse Event|1|||
44143917|NCT03376789|78933222|FG000|Overall Study|Lost to Follow-up|1|||
44143918|NCT03376789|78933223|FG001|Overall Study|Lost to Follow-up|1|||
44143919|NCT03376789|78933222|FG000|Overall Study|Per sponsor due to noncompliance|1|||
44143920|NCT03376789|78933223|FG001|Overall Study|Per sponsor due to noncompliance|0|||
44143921|NCT03376789|78933222|FG000|Overall Study|Subject off study medication|0|||
44143922|NCT03376789|78933223|FG001|Overall Study|Subject off study medication|1|||
44143923|NCT04032093|78933239|FG000|Overall Study|Lost to Follow-up|7|||
44143924|NCT04032093|78933240|FG001|Overall Study|Lost to Follow-up|7|||
44143925|NCT04032093|78933241|FG002|Overall Study|Lost to Follow-up|6|||
44143926|NCT04032093|78933242|FG003|Overall Study|Lost to Follow-up|10|||
44143927|NCT04032093|78933243|FG004|Overall Study|Lost to Follow-up|13|||
44143928|NCT04032093|78933244|FG005|Overall Study|Lost to Follow-up|7|||
44143929|NCT04032093|78933245|FG006|Overall Study|Lost to Follow-up|7|||
44143930|NCT04032093|78933246|FG007|Overall Study|Lost to Follow-up|5|||
44143931|NCT04032093|78933247|FG008|Overall Study|Lost to Follow-up|9|||
44143932|NCT04032093|78933248|FG009|Overall Study|Lost to Follow-up|12|||
44143933|NCT04032093|78933239|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44143934|NCT04032093|78933240|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44143935|NCT04032093|78933241|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
44143936|NCT04032093|78933242|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
44143937|NCT04032093|78933243|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
44143938|NCT04032093|78933244|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
44143939|NCT04032093|78933245|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
44143940|NCT04032093|78933246|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
44143941|NCT04032093|78933247|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
44143942|NCT04032093|78933248|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
44143943|NCT04032093|78933239|FG000|Overall Study|Other|1|||
44143944|NCT04032093|78933240|FG001|Overall Study|Other|0|||
44143945|NCT04032093|78933241|FG002|Overall Study|Other|0|||
44143946|NCT04032093|78933242|FG003|Overall Study|Other|1|||
44143947|NCT04032093|78933243|FG004|Overall Study|Other|1|||
44143948|NCT04032093|78933244|FG005|Overall Study|Other|0|||
44143949|NCT04032093|78933245|FG006|Overall Study|Other|0|||
44143950|NCT04032093|78933246|FG007|Overall Study|Other|0|||
44143951|NCT04032093|78933247|FG008|Overall Study|Other|0|||
44143952|NCT04032093|78933248|FG009|Overall Study|Other|1|||
44143953|NCT04032093|78933239|FG000|Overall Study|Withdrawal by Subject|1|||
44143954|NCT04032093|78933240|FG001|Overall Study|Withdrawal by Subject|3|||
44143955|NCT04032093|78933241|FG002|Overall Study|Withdrawal by Subject|2|||
44249894|NCT01500278|79084154|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
44249895|NCT01500278|79084155|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
44249896|NCT01500278|79084154|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
44249897|NCT01500278|79084155|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
44249898|NCT01500278|79084154|FG000|Week 13 - Week 104|Non/bad compliance|7|||
44249899|NCT01500278|79084155|FG001|Week 13 - Week 104|Non/bad compliance|5|||
44249900|NCT01500278|79084154|FG000|Week 13 - Week 104|Recurrent infections|1|||
44249901|NCT01500278|79084155|FG001|Week 13 - Week 104|Recurrent infections|0|||
44249902|NCT01500278|79084154|FG000|Week 13 - Week 104|False positive test|1|||
44249903|NCT01500278|79084155|FG001|Week 13 - Week 104|False positive test|2|||
44249904|NCT01500278|79084154|FG000|Week 13 - Week 104|Sponsor request|4|||
44382235|NCT04026165|79388216|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
44143956|NCT04032093|78933242|FG003|Overall Study|Withdrawal by Subject|2|||
44143957|NCT04032093|78933243|FG004|Overall Study|Withdrawal by Subject|3|||
44143958|NCT04032093|78933244|FG005|Overall Study|Withdrawal by Subject|0|||
44143959|NCT04032093|78933245|FG006|Overall Study|Withdrawal by Subject|0|||
44143960|NCT04032093|78933246|FG007|Overall Study|Withdrawal by Subject|0|||
44143961|NCT04032093|78933247|FG008|Overall Study|Withdrawal by Subject|0|||
44143962|NCT04032093|78933248|FG009|Overall Study|Withdrawal by Subject|0|||
44143963|NCT04032093|78933239|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44143964|NCT04032093|78933240|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44143965|NCT04032093|78933241|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44143966|NCT04032093|78933242|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
44143967|NCT04032093|78933243|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
44143968|NCT04032093|78933244|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
44143969|NCT04032093|78933245|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
44143970|NCT04032093|78933246|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
44143971|NCT04032093|78933247|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
44249905|NCT01500278|79084155|FG001|Week 13 - Week 104|Sponsor request|0|||
44249906|NCT01500278|79084154|FG000|Week 13 - Week 104|Withdrawn in error|1|||
44143972|NCT04032093|78933248|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
44143973|NCT04032093|78933239|FG000|Overall Study|Adverse Event|0|||
44143974|NCT04032093|78933240|FG001|Overall Study|Adverse Event|0|||
44143975|NCT04032093|78933241|FG002|Overall Study|Adverse Event|0|||
44143976|NCT04032093|78933242|FG003|Overall Study|Adverse Event|0|||
44143977|NCT04032093|78933243|FG004|Overall Study|Adverse Event|0|||
44143978|NCT04032093|78933244|FG005|Overall Study|Adverse Event|0|||
44143979|NCT04032093|78933245|FG006|Overall Study|Adverse Event|0|||
44143980|NCT04032093|78933246|FG007|Overall Study|Adverse Event|0|||
44143981|NCT04032093|78933247|FG008|Overall Study|Adverse Event|0|||
44143982|NCT04032093|78933248|FG009|Overall Study|Adverse Event|1|||
44143983|NCT04032093|78933239|FG000|Overall Study|Physician Decision|0|||
44143984|NCT04032093|78933240|FG001|Overall Study|Physician Decision|0|||
44143985|NCT04032093|78933241|FG002|Overall Study|Physician Decision|0|||
44143986|NCT04032093|78933242|FG003|Overall Study|Physician Decision|0|||
44143987|NCT04032093|78933243|FG004|Overall Study|Physician Decision|0|||
44143988|NCT04032093|78933244|FG005|Overall Study|Physician Decision|1|||
44143989|NCT04032093|78933245|FG006|Overall Study|Physician Decision|0|||
44143990|NCT04032093|78933246|FG007|Overall Study|Physician Decision|0|||
44143991|NCT04032093|78933247|FG008|Overall Study|Physician Decision|0|||
44143992|NCT04032093|78933248|FG009|Overall Study|Physician Decision|0|||
44143993|NCT01675167|78933272|FG000|Open-label Titration Phase|Adverse Event|81|||
44143994|NCT01675167|78933273|FG001|Open-label Titration Phase|Adverse Event|0|||
44143995|NCT01675167|78933274|FG002|Open-label Titration Phase|Adverse Event|0|||
44143996|NCT01675167|78933272|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
44143997|NCT01675167|78933273|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
44143998|NCT01675167|78933274|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
44143999|NCT01675167|78933272|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
44144000|NCT01675167|78933273|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
44144001|NCT01675167|78933274|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
44144002|NCT01675167|78933272|FG000|Open-label Titration Phase|Protocol Violation|43|||
44144003|NCT01675167|78933273|FG001|Open-label Titration Phase|Protocol Violation|0|||
44144004|NCT01675167|78933274|FG002|Open-label Titration Phase|Protocol Violation|0|||
44144005|NCT01675167|78933272|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
44144006|NCT01675167|78933273|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
44144007|NCT01675167|78933274|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
44144008|NCT01675167|78933272|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
44144009|NCT01675167|78933273|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
44144010|NCT01675167|78933274|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
44144011|NCT01675167|78933272|FG000|Open-label Titration Phase|Other|55|||
44144012|NCT01675167|78933273|FG001|Open-label Titration Phase|Other|0|||
44144013|NCT01675167|78933274|FG002|Open-label Titration Phase|Other|0|||
44144014|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
44144015|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
44144016|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
44144017|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44144018|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
44144019|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
44144020|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Adverse Event|0|||
44515360|NCT04495374|79521569|FG001|Overall Study|Protocol Violation|1|||
44515361|NCT04794270|79521575|FG000|Period 1|Non Compliance|1|||
44515362|NCT04794270|79521576|FG001|Period 1|Non Compliance|0|||
44515363|NCT04794270|79521575|FG000|Period 1|Adverse Event|1|||
44144021|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Adverse Event|5|||
44515364|NCT04794270|79521576|FG001|Period 1|Adverse Event|0|||
44515365|NCT04794270|79521575|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
44515366|NCT04794270|79521576|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
44515367|NCT04567186|79521582|FG000|Period 1|COVID-19 related|1|||
44515368|NCT04567186|79521583|FG001|Period 1|COVID-19 related|0|||
44515369|NCT04567186|79521582|FG000|Period 1|Protocol Violation|0|||
44515370|NCT04567186|79521583|FG001|Period 1|Protocol Violation|1|||
44515371|NCT04567186|79521582|FG000|Period 1|Adverse Event|0|||
44515372|NCT04567186|79521583|FG001|Period 1|Adverse Event|2|||
44144022|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Adverse Event|13|||
44144023|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
44144024|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
44144025|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
44144026|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
44144027|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
44144028|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
44144029|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
44354871|NCT01035255|79359276|FG001|Overall Study|patient's request|13|||
44515373|NCT04567186|79521582|FG000|Period 2|COVID-19 Related|0|||
44354872|NCT01190124|79359285|FG000|Overall Study|Death|3|||
44354873|NCT01190124|79359286|FG001|Overall Study|Death|0|||
44144030|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
44144031|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
44144032|NCT01675167|78933272|FG000|Double-blind Treatment Phase|Other|0|||
44144033|NCT01675167|78933273|FG001|Double-blind Treatment Phase|Other|7|||
44144034|NCT01675167|78933274|FG002|Double-blind Treatment Phase|Other|5|||
44144035|NCT01675011|78933284|FG000|Overall Study|Trial terminated by Sponsor|3|||
44144036|NCT01675011|78933285|FG001|Overall Study|Trial terminated by Sponsor|1|||
44277951|NCT02113956|79239004|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
44515374|NCT04567186|79521583|FG001|Period 2|COVID-19 Related|1|||
44515375|NCT04567186|79521582|FG000|Period 2|Protocol Violation|0|||
44515376|NCT04567186|79521583|FG001|Period 2|Protocol Violation|1|||
44515377|NCT04567186|79521582|FG000|Period 2|Lost to Follow-up|0|||
44515378|NCT04567186|79521583|FG001|Period 2|Lost to Follow-up|1|||
44515379|NCT04567186|79521582|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
44515380|NCT04567186|79521583|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
44515381|NCT04168190|79521594|FG000|Overall Study|Lost to Follow-up|0|||
44515382|NCT04168190|79521595|FG001|Overall Study|Lost to Follow-up|1|||
44515383|NCT04168190|79521596|FG002|Overall Study|Lost to Follow-up|0|||
44515384|NCT04168190|79521597|FG003|Overall Study|Lost to Follow-up|7|||
44515385|NCT04168190|79521598|FG004|Overall Study|Lost to Follow-up|5|||
44515386|NCT04168190|79521594|FG000|Overall Study|Withdrawal by Subject|1|||
44515387|NCT04168190|79521595|FG001|Overall Study|Withdrawal by Subject|0|||
44515388|NCT04168190|79521596|FG002|Overall Study|Withdrawal by Subject|0|||
44515389|NCT04168190|79521597|FG003|Overall Study|Withdrawal by Subject|2|||
44515390|NCT04168190|79521598|FG004|Overall Study|Withdrawal by Subject|4|||
44515391|NCT04168190|79521594|FG000|Overall Study|Death|0|||
44144037|NCT04109547|78933313|FG000|Overall Study|Withdrawal by Subject|3|||
44144038|NCT04109547|78933314|FG001|Overall Study|Withdrawal by Subject|2|||
44144039|NCT04109547|78933315|FG002|Overall Study|Withdrawal by Subject|6|||
44144040|NCT04109547|78933316|FG003|Overall Study|Withdrawal by Subject|6|||
44144041|NCT04109547|78933313|FG000|Overall Study|Lost to Follow-up|0|||
44144042|NCT04109547|78933314|FG001|Overall Study|Lost to Follow-up|0|||
44144043|NCT04109547|78933315|FG002|Overall Study|Lost to Follow-up|0|||
44144044|NCT04109547|78933316|FG003|Overall Study|Lost to Follow-up|1|||
44144045|NCT04109547|78933313|FG000|Overall Study|Physician Decision|1|||
44144046|NCT04109547|78933314|FG001|Overall Study|Physician Decision|2|||
44144047|NCT04109547|78933315|FG002|Overall Study|Physician Decision|0|||
44144048|NCT04109547|78933316|FG003|Overall Study|Physician Decision|0|||
44144049|NCT02649231|78933339|FG000|Overall Study|Adverse Event|0|||
44144050|NCT02649231|78933340|FG001|Overall Study|Adverse Event|0|||
44382236|NCT04026165|79388217|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
44382237|NCT04026165|79388214|FG000|Run-in SEL Period|Run-in Failure|0|||
44382238|NCT04026165|79388215|FG001|Run-in SEL Period|Run-in Failure|26|||
44382239|NCT04026165|79388216|FG002|Run-in SEL Period|Run-in Failure|0|||
44382240|NCT04026165|79388217|FG003|Run-in SEL Period|Run-in Failure|0|||
44382241|NCT04026165|79388214|FG000|Run-in SEL Period|Withdrew Consent|0|||
44382242|NCT04026165|79388215|FG001|Run-in SEL Period|Withdrew Consent|10|||
44382243|NCT04026165|79388216|FG002|Run-in SEL Period|Withdrew Consent|0|||
44515392|NCT04168190|79521595|FG001|Overall Study|Death|0|||
44515393|NCT04168190|79521596|FG002|Overall Study|Death|0|||
44515394|NCT04168190|79521597|FG003|Overall Study|Death|1|||
44515395|NCT04168190|79521598|FG004|Overall Study|Death|0|||
44382244|NCT04026165|79388217|FG003|Run-in SEL Period|Withdrew Consent|0|||
44382245|NCT04026165|79388214|FG000|Run-in SEL Period|Enrollment Error|0|||
44382246|NCT04026165|79388215|FG001|Run-in SEL Period|Enrollment Error|4|||
44382247|NCT04026165|79388216|FG002|Run-in SEL Period|Enrollment Error|0|||
44382248|NCT04026165|79388217|FG003|Run-in SEL Period|Enrollment Error|0|||
44382249|NCT04026165|79388214|FG000|Run-in SEL Period|Protocol Violation|0|||
44382250|NCT04026165|79388215|FG001|Run-in SEL Period|Protocol Violation|3|||
44382251|NCT04026165|79388216|FG002|Run-in SEL Period|Protocol Violation|0|||
44382252|NCT04026165|79388217|FG003|Run-in SEL Period|Protocol Violation|0|||
44382253|NCT04026165|79388214|FG000|Run-in SEL Period|Investigator's Discretion|0|||
44382254|NCT04026165|79388215|FG001|Run-in SEL Period|Investigator's Discretion|2|||
44382255|NCT04026165|79388216|FG002|Run-in SEL Period|Investigator's Discretion|0|||
44382256|NCT04026165|79388217|FG003|Run-in SEL Period|Investigator's Discretion|0|||
44382257|NCT04026165|79388214|FG000|Run-in SEL Period|Death|0|||
44382258|NCT04026165|79388215|FG001|Run-in SEL Period|Death|1|||
44382259|NCT04026165|79388216|FG002|Run-in SEL Period|Death|0|||
44382260|NCT04026165|79388217|FG003|Run-in SEL Period|Death|0|||
44382261|NCT04026165|79388214|FG000|Randomized Period|Withdrew Consent|0|||
44382262|NCT04026165|79388215|FG001|Randomized Period|Withdrew Consent|0|||
44382263|NCT04026165|79388216|FG002|Randomized Period|Withdrew Consent|5|||
44382264|NCT04026165|79388217|FG003|Randomized Period|Withdrew Consent|8|||
44382265|NCT04026165|79388214|FG000|Randomized Period|Death|0|||
44382266|NCT04026165|79388215|FG001|Randomized Period|Death|0|||
44382267|NCT04026165|79388216|FG002|Randomized Period|Death|5|||
44382268|NCT04026165|79388217|FG003|Randomized Period|Death|7|||
44382269|NCT04026165|79388214|FG000|Randomized Period|Investigator's Discretion|0|||
44382270|NCT04026165|79388215|FG001|Randomized Period|Investigator's Discretion|0|||
44382271|NCT04026165|79388216|FG002|Randomized Period|Investigator's Discretion|2|||
44382272|NCT04026165|79388217|FG003|Randomized Period|Investigator's Discretion|2|||
44382273|NCT04026165|79388214|FG000|Randomized Period|Lost to Follow-up|0|||
44382274|NCT04026165|79388215|FG001|Randomized Period|Lost to Follow-up|0|||
44382275|NCT04026165|79388216|FG002|Randomized Period|Lost to Follow-up|2|||
44382276|NCT04026165|79388217|FG003|Randomized Period|Lost to Follow-up|2|||
44382277|NCT00805792|79388225|FG000|Overall Study|Death|3|||
44382278|NCT00805792|79388225|FG000|Overall Study|Lost to Follow-up|2|||
44382279|NCT00590044|79388231|FG000|Overall Study|Withdrawal by Subject|2|||
44382280|NCT00590044|79388232|FG001|Overall Study|Withdrawal by Subject|2|||
44382281|NCT00590044|79388231|FG000|Overall Study|wrong insulin arm assigned|1|||
44382282|NCT00590044|79388232|FG001|Overall Study|wrong insulin arm assigned|0|||
44382283|NCT00590044|79388231|FG000|Overall Study|Protocol Violation|1|||
44382284|NCT00590044|79388232|FG001|Overall Study|Protocol Violation|0|||
44382285|NCT00805480|79388245|FG000|Overall Study|Withdrawal by Subject|13|||
44382286|NCT00805480|79388246|FG001|Overall Study|Withdrawal by Subject|5|||
44382287|NCT00805480|79388247|FG002|Overall Study|Withdrawal by Subject|11|||
44515396|NCT04732338|79521612|FG000|Overall Study|Lost to Follow-up|3|||
44515397|NCT04732338|79521613|FG001|Overall Study|Lost to Follow-up|3|||
44515398|NCT04194008|79521619|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
44515399|NCT04194008|79521619|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
44515400|NCT04194008|79521619|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
44144051|NCT02649231|78933341|FG002|Overall Study|Adverse Event|0|||
44144052|NCT02649231|78933342|FG003|Overall Study|Adverse Event|1|||
44144053|NCT02649231|78933339|FG000|Overall Study|Lost to Follow-up|2|||
44144054|NCT02649231|78933340|FG001|Overall Study|Lost to Follow-up|1|||
44144055|NCT02649231|78933341|FG002|Overall Study|Lost to Follow-up|1|||
44144056|NCT02649231|78933342|FG003|Overall Study|Lost to Follow-up|0|||
44144057|NCT02649231|78933339|FG000|Overall Study|Withdrawal by Subject|0|||
44144058|NCT02649231|78933340|FG001|Overall Study|Withdrawal by Subject|1|||
44144059|NCT02649231|78933341|FG002|Overall Study|Withdrawal by Subject|0|||
44144060|NCT02649231|78933342|FG003|Overall Study|Withdrawal by Subject|1|||
44144061|NCT02649231|78933339|FG000|Overall Study|Protocol Violation|2|||
44144062|NCT02649231|78933340|FG001|Overall Study|Protocol Violation|1|||
44144063|NCT02649231|78933341|FG002|Overall Study|Protocol Violation|1|||
44144064|NCT02649231|78933342|FG003|Overall Study|Protocol Violation|0|||
44144065|NCT01376245|78933356|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
44144066|NCT01376245|78933357|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
44144067|NCT01376245|78933358|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
44144068|NCT01376245|78933359|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
44144069|NCT01376245|78933360|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
44144070|NCT01376245|78933356|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
44144071|NCT01376245|78933357|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
44144072|NCT01376245|78933358|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
44144073|NCT01376245|78933359|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
44144074|NCT01376245|78933360|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
44144075|NCT01376245|78933356|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
44144076|NCT01376245|78933357|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
44144077|NCT01376245|78933358|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
44144078|NCT01376245|78933359|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
44144079|NCT01376245|78933360|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
44144080|NCT01376245|78933356|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
44144081|NCT01376245|78933357|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
44144082|NCT01376245|78933358|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
44144083|NCT01376245|78933359|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
44144084|NCT01376245|78933360|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
44144085|NCT01376245|78933356|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
44144086|NCT01376245|78933357|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
44144087|NCT01376245|78933358|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
44144088|NCT01376245|78933359|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
44144089|NCT01376245|78933360|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
44144090|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
44144091|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
44144092|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
44144093|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
44144094|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
44144095|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
44144096|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
44144097|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
44144098|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
44144099|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
44144100|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
44144101|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
44382288|NCT00805480|79388248|FG003|Overall Study|Withdrawal by Subject|5|||
44382289|NCT00805480|79388245|FG000|Overall Study|Lost to Follow-up|1|||
44382290|NCT00805480|79388246|FG001|Overall Study|Lost to Follow-up|2|||
44515401|NCT04194008|79521619|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
44515402|NCT04194008|79521619|FG000|Treatment Phase With Nerivio|Missing data|4|||
44515403|NCT04194008|79521619|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
44515404|NCT04189952|79521632|FG000|Follow-up Period|Death|1|||
44515405|NCT04189952|79521632|FG000|Follow-up Period|Withdrawal by Subject|1|||
44515406|NCT04716426|79521638|FG000|Overall Study|Vaccination|1|||
44515407|NCT04716426|79521639|FG001|Overall Study|Vaccination|1|||
44515408|NCT04716426|79521638|FG000|Overall Study|Contamination|1|||
44382291|NCT00805480|79388247|FG002|Overall Study|Lost to Follow-up|0|||
44515409|NCT04716426|79521639|FG001|Overall Study|Contamination|0|||
44144102|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
44144103|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
44144104|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
44144105|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
44515410|NCT03694548|79521647|FG000|Part A Survey|Protocol Violation|3|||
44515411|NCT03694548|79521648|FG001|Part A Survey|Protocol Violation|3|||
44515412|NCT03694548|79521649|FG002|Part A Survey|Protocol Violation|0|||
44144106|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
44144107|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
44144108|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
44382292|NCT00805480|79388248|FG003|Overall Study|Lost to Follow-up|0|||
44382293|NCT00805480|79388245|FG000|Overall Study|Adverse Event|0|||
44382294|NCT00805480|79388246|FG001|Overall Study|Adverse Event|0|||
44382295|NCT00805480|79388247|FG002|Overall Study|Adverse Event|1|||
44382296|NCT00805480|79388248|FG003|Overall Study|Adverse Event|0|||
44382297|NCT00729937|79388264|FG000|Overall Study|Lost to Follow-up|49|||
44382298|NCT00729937|79388265|FG001|Overall Study|Lost to Follow-up|58|||
44382299|NCT00729937|79388266|FG002|Overall Study|Lost to Follow-up|18|||
44382300|NCT00729937|79388267|FG003|Overall Study|Lost to Follow-up|33|||
44382301|NCT00729937|79388268|FG004|Overall Study|Lost to Follow-up|18|||
44382302|NCT00729937|79388269|FG005|Overall Study|Lost to Follow-up|23|||
44382303|NCT00729937|79388264|FG000|Overall Study|Physician Decision|7|||
44382304|NCT00729937|79388265|FG001|Overall Study|Physician Decision|16|||
44382305|NCT00729937|79388266|FG002|Overall Study|Physician Decision|2|||
44382306|NCT00729937|79388267|FG003|Overall Study|Physician Decision|0|||
44382307|NCT00729937|79388268|FG004|Overall Study|Physician Decision|5|||
44515413|NCT03694548|79521647|FG000|Part B Yoga Program|Protocol Violation|0|||
44515414|NCT03694548|79521648|FG001|Part B Yoga Program|Protocol Violation|0|||
44515415|NCT03694548|79521649|FG002|Part B Yoga Program|Protocol Violation|3|||
44515416|NCT03694548|79521647|FG000|Part B Yoga Program|Did not attend intervention|0|||
44515417|NCT03694548|79521648|FG001|Part B Yoga Program|Did not attend intervention|0|||
44515418|NCT03694548|79521649|FG002|Part B Yoga Program|Did not attend intervention|8|||
44515419|NCT04166630|79521661|FG000|Overall Study|Withdrawal by Subject|0|||
44515420|NCT04166630|79521662|FG001|Overall Study|Withdrawal by Subject|1|||
44515421|NCT04164758|79521671|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
44515422|NCT04164758|79521672|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
44515423|NCT04164758|79521673|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
44515424|NCT04164758|79521671|FG000|Overall Study|Adverse Event|0|||
44515425|NCT04164758|79521672|FG001|Overall Study|Adverse Event|1|||
44515426|NCT04164758|79521673|FG002|Overall Study|Adverse Event|0|||
44515427|NCT04178720|79521683|FG000|Overall Study|Withdrawal by Subject|2|||
44515428|NCT04178720|79521684|FG001|Overall Study|Withdrawal by Subject|0|||
44515429|NCT04178720|79521683|FG000|Overall Study|Relocation|0|||
44515430|NCT04178720|79521684|FG001|Overall Study|Relocation|1|||
44515431|NCT04177862|79521695|FG000|Overall Study|Protocol Violation|2|||
44515432|NCT04177862|79521696|FG001|Overall Study|Protocol Violation|7|||
44515433|NCT04173572|79521705|FG000|Overall Study|Withdrawal by Subject|1|||
44515434|NCT04173572|79521706|FG001|Overall Study|Withdrawal by Subject|5|||
44515435|NCT04173572|79521705|FG000|Overall Study|Lost to Follow-up|3|||
44515436|NCT04173572|79521706|FG001|Overall Study|Lost to Follow-up|1|||
44515437|NCT04157738|79521714|FG000|Overall Study|Moved out of state|0|||
44515438|NCT04157738|79521715|FG001|Overall Study|Moved out of state|2|||
44515439|NCT04157738|79521714|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
44515440|NCT04157738|79521715|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
44515441|NCT04156646|79521723|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
44515442|NCT04156646|79521724|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
44515443|NCT04150250|79521735|FG000|Overall Study|Lost to Follow-up|0|||
44515444|NCT04150250|79521736|FG001|Overall Study|Lost to Follow-up|2|||
44515445|NCT04537806|79521744|FG000|Overall Study|Randomized but not treated|1|||
44382308|NCT00729937|79388269|FG005|Overall Study|Physician Decision|8|||
44382309|NCT00729937|79388264|FG000|Overall Study|Death|1|||
44515446|NCT04537806|79521745|FG001|Overall Study|Randomized but not treated|0|||
44515447|NCT04537806|79521744|FG000|Overall Study|Adverse Event|1|||
44515448|NCT04537806|79521745|FG001|Overall Study|Adverse Event|1|||
44515449|NCT04015232|79521753|FG000|Overall Study|Withdrawal by Subject|7|||
44515450|NCT04015232|79521754|FG001|Overall Study|Withdrawal by Subject|4|||
44515451|NCT04015232|79521753|FG000|Overall Study|Protocol Violation|1|||
44515452|NCT04015232|79521754|FG001|Overall Study|Protocol Violation|0|||
44515453|NCT04015232|79521753|FG000|Overall Study|Medical Grounds|3|||
44515454|NCT04015232|79521754|FG001|Overall Study|Medical Grounds|3|||
44515455|NCT04533204|79521766|FG000|Overall Study|Unable to understand training instructions|1|||
44515456|NCT04533204|79521767|FG001|Overall Study|Unable to understand training instructions|1|||
44515457|NCT04465422|79521775|FG000|Overall Study|Lost to Follow-up|0|||
44515458|NCT04465422|79521776|FG001|Overall Study|Lost to Follow-up|2|||
44515459|NCT04014062|79521786|FG000|Period I: Dosing|Medical Grounds|4|||
44515460|NCT04014062|79521787|FG001|Period I: Dosing|Medical Grounds|5|||
44382310|NCT00729937|79388265|FG001|Overall Study|Death|0|||
44144109|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
44144110|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44144111|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
44144112|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44144113|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
44144114|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
44144115|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
44144116|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
44144117|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
44144118|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
44382311|NCT00729937|79388266|FG002|Overall Study|Death|1|||
44515461|NCT04014062|79521786|FG000|Period I: Dosing|Withdrawal by Subject|3|||
44515462|NCT04014062|79521787|FG001|Period I: Dosing|Withdrawal by Subject|1|||
44515463|NCT04531098|79521801|FG000|Stage I|Adverse Event|0|||
44515464|NCT04531098|79521802|FG001|Stage I|Adverse Event|0|||
44515465|NCT04531098|79521803|FG002|Stage I|Adverse Event|3|||
44515466|NCT04531098|79521801|FG000|Stage I|Protocol Violation|0|||
44515467|NCT04531098|79521802|FG001|Stage I|Protocol Violation|0|||
44515468|NCT04531098|79521803|FG002|Stage I|Protocol Violation|5|||
44515469|NCT04531098|79521801|FG000|Stage I|Withdrawal by Subject|0|||
44515470|NCT04531098|79521802|FG001|Stage I|Withdrawal by Subject|5|||
44515471|NCT04531098|79521803|FG002|Stage I|Withdrawal by Subject|10|||
44515472|NCT04531098|79521801|FG000|Stage II|Adverse Event|1|||
44515473|NCT04531098|79521802|FG001|Stage II|Adverse Event|2|||
44249907|NCT01500278|79084155|FG001|Week 13 - Week 104|Withdrawn in error|0|||
44354874|NCT01190124|79359287|FG002|Overall Study|Death|0|||
44382312|NCT00729937|79388267|FG003|Overall Study|Death|0|||
44382313|NCT00729937|79388268|FG004|Overall Study|Death|0|||
44382314|NCT00729937|79388269|FG005|Overall Study|Death|1|||
44382315|NCT00729937|79388264|FG000|Overall Study|Withdrawal by Subject|3|||
44382316|NCT00729937|79388265|FG001|Overall Study|Withdrawal by Subject|5|||
44382317|NCT00729937|79388266|FG002|Overall Study|Withdrawal by Subject|6|||
44382318|NCT00729937|79388267|FG003|Overall Study|Withdrawal by Subject|0|||
44382319|NCT00729937|79388268|FG004|Overall Study|Withdrawal by Subject|4|||
44382320|NCT00729937|79388269|FG005|Overall Study|Withdrawal by Subject|2|||
44382321|NCT00729937|79388264|FG000|Overall Study|Randomized but not treated|12|||
44382322|NCT00729937|79388265|FG001|Overall Study|Randomized but not treated|6|||
44382323|NCT00729937|79388266|FG002|Overall Study|Randomized but not treated|1|||
44382324|NCT00729937|79388267|FG003|Overall Study|Randomized but not treated|0|||
44382325|NCT00729937|79388268|FG004|Overall Study|Randomized but not treated|1|||
44382326|NCT00729937|79388269|FG005|Overall Study|Randomized but not treated|3|||
44382327|NCT00729937|79388264|FG000|Overall Study|Did not meet eligibility criteria|2|||
44382328|NCT00729937|79388265|FG001|Overall Study|Did not meet eligibility criteria|1|||
44515474|NCT04531098|79521803|FG002|Stage II|Adverse Event|0|||
44515475|NCT04531098|79521801|FG000|Stage II|Protocol Violation|1|||
44515476|NCT04531098|79521802|FG001|Stage II|Protocol Violation|2|||
44515477|NCT04531098|79521803|FG002|Stage II|Protocol Violation|0|||
44515478|NCT04531098|79521801|FG000|Stage II|Withdrawal by Subject|3|||
44515479|NCT04531098|79521802|FG001|Stage II|Withdrawal by Subject|1|||
44515480|NCT04531098|79521803|FG002|Stage II|Withdrawal by Subject|0|||
44515481|NCT04531098|79521801|FG000|Stage II|Moved from study area|8|||
44515482|NCT04531098|79521802|FG001|Stage II|Moved from study area|5|||
44515483|NCT04531098|79521803|FG002|Stage II|Moved from study area|0|||
44515484|NCT04144166|79521811|FG000|Overall Study|Discharged before study start|1|||
44515485|NCT04144166|79521811|FG000|Overall Study|Pregnancy|1|||
44354875|NCT01190124|79359285|FG000|Overall Study|Therapeutic Failure|12|||
44354876|NCT01190124|79359286|FG001|Overall Study|Therapeutic Failure|0|||
44354877|NCT01190124|79359287|FG002|Overall Study|Therapeutic Failure|1|||
44354878|NCT01190124|79359285|FG000|Overall Study|Lost to Follow-up|2|||
44354879|NCT01190124|79359286|FG001|Overall Study|Lost to Follow-up|0|||
44354880|NCT01190124|79359287|FG002|Overall Study|Lost to Follow-up|0|||
44354881|NCT01189890|79359300|FG000|Overall Study|Adverse Event|3|||
44354882|NCT01189890|79359301|FG001|Overall Study|Adverse Event|4|||
44354883|NCT01189890|79359300|FG000|Overall Study|Lack of Efficacy|7|||
44354884|NCT01189890|79359301|FG001|Overall Study|Lack of Efficacy|2|||
44354885|NCT01189890|79359300|FG000|Overall Study|Lost to Follow-up|1|||
44354886|NCT01189890|79359301|FG001|Overall Study|Lost to Follow-up|7|||
44354887|NCT01189890|79359300|FG000|Overall Study|Protocol Violation|1|||
44354888|NCT01189890|79359301|FG001|Overall Study|Protocol Violation|5|||
44354889|NCT01189890|79359300|FG000|Overall Study|Withdrawal by Subject|15|||
44354890|NCT01189890|79359301|FG001|Overall Study|Withdrawal by Subject|11|||
44354891|NCT01189890|79359300|FG000|Overall Study|Non Compliance|0|||
44354892|NCT01189890|79359301|FG001|Overall Study|Non Compliance|1|||
44354893|NCT01189890|79359300|FG000|Overall Study|Physician Decision|5|||
44354894|NCT01189890|79359301|FG001|Overall Study|Physician Decision|4|||
44354895|NCT01189890|79359300|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
44382329|NCT00729937|79388266|FG002|Overall Study|Did not meet eligibility criteria|0|||
44382330|NCT00729937|79388267|FG003|Overall Study|Did not meet eligibility criteria|0|||
44382331|NCT00729937|79388268|FG004|Overall Study|Did not meet eligibility criteria|0|||
44382332|NCT00729937|79388269|FG005|Overall Study|Did not meet eligibility criteria|0|||
44382333|NCT00729937|79388264|FG000|Overall Study|Incarcerated|0|||
44515486|NCT04144166|79521811|FG000|Overall Study|Nail polish could not be removed from finger|1|||
44144119|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
44144120|NCT01376245|78933356|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44144121|NCT01376245|78933357|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
44144122|NCT01376245|78933358|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
44144123|NCT01376245|78933359|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
44144124|NCT01376245|78933360|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
44144125|NCT01674621|78933375|FG000|Overall Study|Adverse Event|3|||
44144126|NCT01674621|78933376|FG001|Overall Study|Adverse Event|2|||
44144127|NCT01674621|78933377|FG002|Overall Study|Adverse Event|5|||
44144128|NCT01674621|78933378|FG003|Overall Study|Adverse Event|5|||
44144129|NCT01674621|78933379|FG004|Overall Study|Adverse Event|1|||
44144130|NCT01674621|78933375|FG000|Overall Study|Inability to Complete Study Procedures|0|||
44144131|NCT01674621|78933376|FG001|Overall Study|Inability to Complete Study Procedures|0|||
44249908|NCT01500278|79084154|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
44249909|NCT01500278|79084155|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
44249910|NCT01500278|79084154|FG000|Week 13 - Week 104|Protocol deviation|1|||
44249911|NCT01500278|79084155|FG001|Week 13 - Week 104|Protocol deviation|0|||
44249912|NCT01500278|79084154|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
44249913|NCT01500278|79084155|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
44382334|NCT00729937|79388265|FG001|Overall Study|Incarcerated|2|||
44382335|NCT00729937|79388266|FG002|Overall Study|Incarcerated|1|||
44382336|NCT00729937|79388267|FG003|Overall Study|Incarcerated|1|||
44515487|NCT04142450|79521820|FG000|Overall Study|Screen Failure|1|||
44515488|NCT04142450|79521820|FG000|Overall Study|Lost to Follow-up|1|||
44515489|NCT04529850|79521824|FG000|Overall Study|Death|2|||
44515490|NCT04529850|79521824|FG000|Overall Study|Physician Decision|1|||
44515491|NCT04529850|79521824|FG000|Overall Study|Withdrawal by Subject|2|||
44515492|NCT04225676|79521828|FG000|Overall Study|Physician Decision|1|||
44515493|NCT04225676|79521828|FG000|Overall Study|Lack of Efficacy|1|||
44515494|NCT04225676|79521828|FG000|Overall Study|Study terminated by sponsor|3|||
44515495|NCT04142216|79521836|FG000|Overall Study|Hospitalization|0|||
44515496|NCT04142216|79521837|FG001|Overall Study|Hospitalization|2|||
44515497|NCT04142216|79521836|FG000|Overall Study|Death|3|||
44515498|NCT04142216|79521837|FG001|Overall Study|Death|1|||
44515499|NCT04142216|79521836|FG000|Overall Study|Referral to another hemodialysis unit|3|||
44515500|NCT04142216|79521837|FG001|Overall Study|Referral to another hemodialysis unit|2|||
44515501|NCT04142216|79521836|FG000|Overall Study|Use of clove|0|||
44515502|NCT04142216|79521837|FG001|Overall Study|Use of clove|1|||
44515503|NCT04140890|79521845|FG000|Overall Study|Withdrawal by Subject|0|||
44515504|NCT04140890|79521846|FG001|Overall Study|Withdrawal by Subject|1|||
44515505|NCT03700320|79521857|FG000|Overall Study|Adverse Event|5|||
44515506|NCT03700320|79521858|FG001|Overall Study|Adverse Event|31|||
44515507|NCT03700320|79521857|FG000|Overall Study|Lack of Efficacy|2|||
44515508|NCT03700320|79521858|FG001|Overall Study|Lack of Efficacy|5|||
44515509|NCT03700320|79521857|FG000|Overall Study|Withdrawal by Subject|29|||
44515510|NCT03700320|79521858|FG001|Overall Study|Withdrawal by Subject|75|||
44515511|NCT03700320|79521857|FG000|Overall Study|Lost to Follow-up|16|||
44515512|NCT03700320|79521858|FG001|Overall Study|Lost to Follow-up|23|||
44515513|NCT03700320|79521857|FG000|Overall Study|Pregnancy|2|||
44515514|NCT03700320|79521858|FG001|Overall Study|Pregnancy|4|||
44515515|NCT03700320|79521857|FG000|Overall Study|Protocol Deviation|7|||
44382337|NCT00729937|79388268|FG004|Overall Study|Incarcerated|0|||
44382338|NCT00729937|79388269|FG005|Overall Study|Incarcerated|0|||
44515516|NCT03700320|79521858|FG001|Overall Study|Protocol Deviation|31|||
44515517|NCT03700320|79521857|FG000|Overall Study|Non-compliance with Study Drug|1|||
44515518|NCT03700320|79521858|FG001|Overall Study|Non-compliance with Study Drug|3|||
44515519|NCT03700320|79521857|FG000|Overall Study|Reason not Specified|0|||
44515520|NCT03700320|79521858|FG001|Overall Study|Reason not Specified|1|||
44515521|NCT04139018|79521866|FG000|Overall Study|Screen fail|1|||
44515522|NCT04139018|79521867|FG001|Overall Study|Screen fail|0|||
44515523|NCT04139018|79521866|FG000|Overall Study|Withdrawal by Subject|2|||
44515524|NCT04139018|79521867|FG001|Overall Study|Withdrawal by Subject|0|||
44515525|NCT04139018|79521866|FG000|Overall Study|Lost to Follow-up|0|||
44249914|NCT01500278|79084154|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
44515526|NCT04139018|79521867|FG001|Overall Study|Lost to Follow-up|1|||
44515527|NCT04527978|79521875|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
44515528|NCT04527978|79521876|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
44515529|NCT04136444|79521887|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
44382339|NCT00729859|79388286|FG000|Overall Study|Adverse Event|0|||
44382340|NCT00729859|79388287|FG001|Overall Study|Adverse Event|1|||
44382341|NCT00729859|79388288|FG002|Overall Study|Adverse Event|0|||
44382342|NCT00729859|79388286|FG000|Overall Study|Withdrawal by Subject|0|||
44382343|NCT00729859|79388287|FG001|Overall Study|Withdrawal by Subject|1|||
44382344|NCT00729859|79388288|FG002|Overall Study|Withdrawal by Subject|0|||
44382345|NCT00810394|79388304|FG000|Overall Study|Withdrawal by Subject|3|||
44382346|NCT00736333|79388308|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
44144132|NCT01674621|78933377|FG002|Overall Study|Inability to Complete Study Procedures|0|||
44382347|NCT00736333|79388308|FG000|Overall Study|Data Missing|2|||
44144133|NCT01674621|78933378|FG003|Overall Study|Inability to Complete Study Procedures|0|||
44144134|NCT01674621|78933379|FG004|Overall Study|Inability to Complete Study Procedures|2|||
44144135|NCT01674621|78933375|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
44382348|NCT00736333|79388308|FG000|Overall Study|Tumor Progression|75|||
44382349|NCT00736333|79388308|FG000|Overall Study|Toxicity|6|||
44382350|NCT00736333|79388308|FG000|Overall Study|Withdrawal by Subject|10|||
44382351|NCT00736333|79388308|FG000|Overall Study|Death|7|||
44382352|NCT00736333|79388308|FG000|Overall Study|Other|4|||
44382353|NCT00736255|79388314|FG000|Overall Study|Adverse Event|1|||
44382354|NCT00736255|79388315|FG001|Overall Study|Adverse Event|0|||
44382355|NCT00736255|79388314|FG000|Overall Study|Physician Decision|1|||
44382356|NCT00736255|79388315|FG001|Overall Study|Physician Decision|0|||
44382357|NCT00736255|79388314|FG000|Overall Study|Non-compliance|1|||
44382358|NCT00736255|79388315|FG001|Overall Study|Non-compliance|1|||
44382359|NCT03920254|79388324|FG000|Overall Study|Adverse Event|1|||
44382360|NCT03920254|79388325|FG001|Overall Study|Adverse Event|0|||
44382361|NCT03920254|79388326|FG002|Overall Study|Adverse Event|0|||
44382362|NCT03920254|79388324|FG000|Overall Study|Physician Decision|0|||
44382363|NCT03920254|79388325|FG001|Overall Study|Physician Decision|1|||
44382364|NCT03920254|79388326|FG002|Overall Study|Physician Decision|2|||
44382365|NCT03920254|79388324|FG000|Overall Study|Study Terminated By Sponsor|12|||
44382366|NCT03920254|79388325|FG001|Overall Study|Study Terminated By Sponsor|17|||
44382367|NCT03920254|79388326|FG002|Overall Study|Study Terminated By Sponsor|12|||
44382368|NCT03920254|79388324|FG000|Overall Study|Withdrawal by Subject|0|||
44382369|NCT03920254|79388325|FG001|Overall Study|Withdrawal by Subject|0|||
44382370|NCT03920254|79388326|FG002|Overall Study|Withdrawal by Subject|1|||
44382371|NCT00729469|79388336|FG000|Overall Study|Adverse Event|14|||
44382372|NCT00729469|79388337|FG001|Overall Study|Adverse Event|25|||
44382373|NCT00729469|79388336|FG000|Overall Study|Lost to Follow-up|9|||
44382374|NCT00729469|79388337|FG001|Overall Study|Lost to Follow-up|9|||
44382375|NCT00729469|79388336|FG000|Overall Study|Protocol Violation|2|||
44382376|NCT00729469|79388337|FG001|Overall Study|Protocol Violation|1|||
44382377|NCT00729469|79388336|FG000|Overall Study|Withdrawal by Subject|19|||
44382378|NCT00729469|79388337|FG001|Overall Study|Withdrawal by Subject|8|||
44382379|NCT00729469|79388336|FG000|Overall Study|Other-Not mentioned|9|||
44382380|NCT00729469|79388337|FG001|Overall Study|Other-Not mentioned|4|||
44382381|NCT00742183|79388345|FG000|Overall Study|Adverse Event|2|||
44382382|NCT00742183|79388346|FG001|Overall Study|Adverse Event|2|||
44382383|NCT00742183|79388345|FG000|Overall Study|Death|1|||
44144136|NCT01674621|78933376|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
44382384|NCT00742183|79388346|FG001|Overall Study|Death|0|||
44382385|NCT00742183|79388345|FG000|Overall Study|Physician Decision|0|||
44382386|NCT00742183|79388346|FG001|Overall Study|Physician Decision|2|||
44382387|NCT00742183|79388345|FG000|Overall Study|Lost to Follow-up|4|||
44382388|NCT00742183|79388346|FG001|Overall Study|Lost to Follow-up|4|||
44382389|NCT00742183|79388345|FG000|Overall Study|Required skin-graft|1|||
44144137|NCT01674621|78933377|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
44144138|NCT01674621|78933378|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
44144139|NCT01674621|78933379|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
44144140|NCT01674621|78933375|FG000|Overall Study|Withdrawal by Subject|2|||
44144141|NCT01674621|78933376|FG001|Overall Study|Withdrawal by Subject|5|||
44144142|NCT01674621|78933377|FG002|Overall Study|Withdrawal by Subject|2|||
44144143|NCT01674621|78933378|FG003|Overall Study|Withdrawal by Subject|0|||
44144144|NCT01674621|78933379|FG004|Overall Study|Withdrawal by Subject|1|||
44144145|NCT01674621|78933375|FG000|Overall Study|Other than specified|0|||
44144146|NCT01674621|78933376|FG001|Overall Study|Other than specified|1|||
44144147|NCT01674621|78933377|FG002|Overall Study|Other than specified|0|||
44144148|NCT01674621|78933378|FG003|Overall Study|Other than specified|0|||
44144149|NCT01674621|78933379|FG004|Overall Study|Other than specified|2|||
44144150|NCT02730169|78933396|FG000|Overall Study|Protocol Violation|1|||
44144151|NCT02730169|78933397|FG001|Overall Study|Protocol Violation|0|||
44144152|NCT02730169|78933398|FG002|Overall Study|Protocol Violation|0|||
44144153|NCT02730169|78933399|FG003|Overall Study|Protocol Violation|1|||
44144154|NCT02730169|78933396|FG000|Overall Study|Adverse Event|2|||
44144155|NCT02730169|78933397|FG001|Overall Study|Adverse Event|3|||
44144156|NCT02730169|78933398|FG002|Overall Study|Adverse Event|3|||
44144157|NCT02730169|78933399|FG003|Overall Study|Adverse Event|0|||
44144158|NCT02730169|78933396|FG000|Overall Study|Adverse Event of Special Interest|0|||
44144159|NCT02730169|78933397|FG001|Overall Study|Adverse Event of Special Interest|1|||
44144160|NCT02730169|78933398|FG002|Overall Study|Adverse Event of Special Interest|2|||
44144161|NCT02730169|78933399|FG003|Overall Study|Adverse Event of Special Interest|0|||
44144162|NCT02730169|78933396|FG000|Overall Study|Withdrawal by Subject|6|||
44144163|NCT02730169|78933397|FG001|Overall Study|Withdrawal by Subject|11|||
44144164|NCT02730169|78933398|FG002|Overall Study|Withdrawal by Subject|6|||
44144165|NCT02730169|78933399|FG003|Overall Study|Withdrawal by Subject|8|||
44144166|NCT02730169|78933396|FG000|Overall Study|Lost to Follow-up|5|||
44144167|NCT02730169|78933397|FG001|Overall Study|Lost to Follow-up|6|||
44144168|NCT02730169|78933398|FG002|Overall Study|Lost to Follow-up|5|||
44144169|NCT02730169|78933399|FG003|Overall Study|Lost to Follow-up|6|||
44144170|NCT02730169|78933396|FG000|Overall Study|Other|0|||
44144171|NCT02730169|78933397|FG001|Overall Study|Other|0|||
44144172|NCT02730169|78933398|FG002|Overall Study|Other|1|||
44144173|NCT02730169|78933399|FG003|Overall Study|Other|1|||
44144174|NCT02648217|78933411|FG000|Overall Study|Adverse Event|0|||
44144175|NCT02648217|78933412|FG001|Overall Study|Adverse Event|1|||
44144176|NCT02648217|78933411|FG000|Overall Study|Lost to Follow-up|1|||
44144177|NCT02648217|78933412|FG001|Overall Study|Lost to Follow-up|1|||
44144178|NCT02648217|78933411|FG000|Overall Study|Withdrawal by Subject|4|||
44144179|NCT02648217|78933412|FG001|Overall Study|Withdrawal by Subject|3|||
44144180|NCT02648217|78933411|FG000|Overall Study|Unclassified|5|||
44144181|NCT02648217|78933412|FG001|Overall Study|Unclassified|0|||
44144182|NCT00709735|78933420|FG000|Overall Study|Lost to Follow-up|1|||
44144183|NCT00709735|78933421|FG001|Overall Study|Lost to Follow-up|1|||
44144184|NCT00709735|78933420|FG000|Overall Study|Relapse into Opioid Abuse|0|||
44144185|NCT00709735|78933421|FG001|Overall Study|Relapse into Opioid Abuse|1|||
44144186|NCT00709735|78933420|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
44144187|NCT00709735|78933421|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
44144188|NCT02647905|78933427|FG000|Overall Study|Lost to Follow-up|1|||
44144189|NCT02647905|78933427|FG000|Overall Study|Withdrawal by Subject|2|||
44144190|NCT04185909|78933440|FG000|Overall Study|Lost to Follow-up|1|||
44144191|NCT04076943|78933444|FG000|Overall Study|Withdrawal by Subject|12|||
44144192|NCT04076943|78933444|FG000|Overall Study|Adverse Event|1|||
44144193|NCT04076943|78933444|FG000|Overall Study|Progressive Disease|2|||
44144194|NCT04076943|78933444|FG000|Overall Study|Death|13|||
44144195|NCT04076943|78933444|FG000|Overall Study|Other than specified|6|||
44144196|NCT00708643|78933450|FG000|Overall Study|Adverse Event|0|||
44144197|NCT00708643|78933451|FG001|Overall Study|Adverse Event|1|||
44144198|NCT05425563|78933504|FG000|Overall Study|Withdrawal by Subject|17|||
44144199|NCT05097963|78933514|FG000|Overall Study|Protocol Violation|13|||
44144200|NCT05097963|78933514|FG000|Overall Study|Withdrawal by Subject|21|||
44144201|NCT04529096|78933529|FG000|Overall Study|Adverse Event|6|||
44144202|NCT04529096|78933530|FG001|Overall Study|Adverse Event|1|||
44144203|NCT04529096|78933529|FG000|Overall Study|Lack of Efficacy|1|||
44144204|NCT04529096|78933530|FG001|Overall Study|Lack of Efficacy|0|||
44144205|NCT04529096|78933529|FG000|Overall Study|Lost to Follow-up|1|||
44144206|NCT04529096|78933530|FG001|Overall Study|Lost to Follow-up|1|||
44382390|NCT00742183|79388346|FG001|Overall Study|Required skin-graft|1|||
44515530|NCT04136444|79521888|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
44515531|NCT04425252|79521902|FG000|Overall Study|Withdrawal by Subject|2|||
44515532|NCT04425252|79521903|FG001|Overall Study|Withdrawal by Subject|1|||
44515533|NCT04425252|79521902|FG000|Overall Study|Lost to Follow-up|1|||
44515534|NCT04425252|79521903|FG001|Overall Study|Lost to Follow-up|0|||
44515535|NCT04425252|79521902|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
44515536|NCT04425252|79521903|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
44515537|NCT03696576|79521914|FG000|Overall Study|Soreness of throat after therapy|1|||
44515538|NCT03696576|79521915|FG001|Overall Study|Soreness of throat after therapy|1|||
44515539|NCT03696576|79521914|FG000|Overall Study|Lost to Follow-up|2|||
44515540|NCT03696576|79521915|FG001|Overall Study|Lost to Follow-up|4|||
44515541|NCT04003610|79521924|FG000|Overall Study|Lost to Follow-up|0|||
44515542|NCT04003610|79521925|FG001|Overall Study|Lost to Follow-up|1|||
44515543|NCT04003610|79521926|FG002|Overall Study|Lost to Follow-up|0|||
44515544|NCT04003610|79521924|FG000|Overall Study|Death|0|||
44515545|NCT04003610|79521925|FG001|Overall Study|Death|0|||
44515546|NCT04003610|79521926|FG002|Overall Study|Death|3|||
44515547|NCT04003610|79521924|FG000|Overall Study|Study Terminated by Sponsor|0|||
44515548|NCT04003610|79521925|FG001|Overall Study|Study Terminated by Sponsor|0|||
44515549|NCT04003610|79521926|FG002|Overall Study|Study Terminated by Sponsor|3|||
44515550|NCT03999554|79521940|FG000|Overall Study|Lost to Follow-up|4|||
44515551|NCT03999554|79521941|FG001|Overall Study|Lost to Follow-up|5|||
44515552|NCT03999554|79521942|FG002|Overall Study|Lost to Follow-up|4|||
44515553|NCT03999554|79521943|FG003|Overall Study|Lost to Follow-up|5|||
44515554|NCT03999554|79521944|FG004|Overall Study|Lost to Follow-up|8|||
44515555|NCT03999554|79521940|FG000|Overall Study|Protocol Violation|0|||
44515556|NCT03999554|79521941|FG001|Overall Study|Protocol Violation|0|||
44515557|NCT03999554|79521942|FG002|Overall Study|Protocol Violation|5|||
44382391|NCT00742183|79388345|FG000|Overall Study|Withdrawal by Subject|1|||
44382392|NCT00742183|79388346|FG001|Overall Study|Withdrawal by Subject|0|||
44382393|NCT00742183|79388345|FG000|Overall Study|Lack of Efficacy|0|||
44515558|NCT03999554|79521943|FG003|Overall Study|Protocol Violation|0|||
44515559|NCT03999554|79521944|FG004|Overall Study|Protocol Violation|0|||
44382394|NCT00742183|79388346|FG001|Overall Study|Lack of Efficacy|3|||
44382395|NCT00808444|79388354|FG000|Overall Study|Withdrawal by Subject|1|||
44515560|NCT03999554|79521940|FG000|Overall Study|Pregnancy|0|||
44515561|NCT03999554|79521941|FG001|Overall Study|Pregnancy|0|||
44515562|NCT03999554|79521942|FG002|Overall Study|Pregnancy|1|||
44515563|NCT03999554|79521943|FG003|Overall Study|Pregnancy|0|||
44515564|NCT03999554|79521944|FG004|Overall Study|Pregnancy|0|||
44515565|NCT03999554|79521940|FG000|Overall Study|Withdrawal by Subject|2|||
44515566|NCT03999554|79521941|FG001|Overall Study|Withdrawal by Subject|2|||
44515567|NCT03999554|79521942|FG002|Overall Study|Withdrawal by Subject|2|||
44515568|NCT03999554|79521943|FG003|Overall Study|Withdrawal by Subject|1|||
44515569|NCT03999554|79521944|FG004|Overall Study|Withdrawal by Subject|1|||
44515570|NCT03999554|79521940|FG000|Overall Study|failure to comply with protocol requirements|0|||
44515571|NCT03999554|79521941|FG001|Overall Study|failure to comply with protocol requirements|0|||
44382396|NCT00808444|79388355|FG001|Overall Study|Withdrawal by Subject|0|||
44382397|NCT00808444|79388354|FG000|Overall Study|Lost to Follow-up|0|||
44382398|NCT00808444|79388355|FG001|Overall Study|Lost to Follow-up|1|||
44382399|NCT00742027|79388361|FG000|Overall Study|Disease Progression|76|||
44382400|NCT00742027|79388361|FG000|Overall Study|New Cancer Therapy|19|||
44382401|NCT00742027|79388361|FG000|Overall Study|Withdrawal by Subject|18|||
44382402|NCT00742027|79388361|FG000|Overall Study|Death|7|||
44382403|NCT00742027|79388361|FG000|Overall Study|Lost to Follow-up|4|||
44382404|NCT00742027|79388361|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
44515572|NCT03999554|79521942|FG002|Overall Study|failure to comply with protocol requirements|0|||
44515573|NCT03999554|79521943|FG003|Overall Study|failure to comply with protocol requirements|1|||
44515574|NCT03999554|79521944|FG004|Overall Study|failure to comply with protocol requirements|0|||
44144207|NCT04529096|78933529|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44144208|NCT04529096|78933530|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44249915|NCT01500278|79084155|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
44249916|NCT01500278|79084154|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
44382405|NCT00742027|79388361|FG000|Overall Study|Missing|2|||
44382406|NCT00742027|79388361|FG000|Overall Study|Administrative Problems|1|||
44382407|NCT03996369|79388367|FG000|Overall Study|Protocol deviation|1|||
44382408|NCT03996369|79388368|FG001|Overall Study|Protocol deviation|1|||
44382409|NCT03996369|79388367|FG000|Overall Study|Physician Decision|4|||
44515575|NCT04129346|79521959|FG000|Overall Study|Death|1|||
44144209|NCT04529096|78933529|FG000|Overall Study|Physician Decision|1|||
44144210|NCT04529096|78933530|FG001|Overall Study|Physician Decision|3|||
44144211|NCT04529096|78933529|FG000|Overall Study|Withdrawal by Subject|5|||
44144212|NCT04529096|78933530|FG001|Overall Study|Withdrawal by Subject|0|||
44144213|NCT04442503|78933538|FG000|Overall Study|Adverse Event|1|||
44144214|NCT04442503|78933539|FG001|Overall Study|Adverse Event|1|||
44144215|NCT04442503|78933538|FG000|Overall Study|Lost to Follow-up|8|||
44144216|NCT04442503|78933539|FG001|Overall Study|Lost to Follow-up|6|||
44144217|NCT04442503|78933538|FG000|Overall Study|Physician Decision|0|||
44144218|NCT04442503|78933539|FG001|Overall Study|Physician Decision|2|||
44144219|NCT04442503|78933538|FG000|Overall Study|Withdrawal by Subject|3|||
44144220|NCT04442503|78933539|FG001|Overall Study|Withdrawal by Subject|4|||
44144221|NCT04442503|78933538|FG000|Overall Study|Reason not Specified|0|||
44144222|NCT04442503|78933539|FG001|Overall Study|Reason not Specified|1|||
44144223|NCT04442503|78933538|FG000|Overall Study|Randomized but not Treated|3|||
44144224|NCT04442503|78933539|FG001|Overall Study|Randomized but not Treated|1|||
44144225|NCT04109976|78933552|FG000|Overall Study|Withdrawal by Subject|1|||
44144226|NCT04109976|78933553|FG001|Overall Study|Withdrawal by Subject|0|||
44144227|NCT04068519|78933559|FG000|Dose Verification|Death|15|||
44144228|NCT04068519|78933559|FG000|Dose Verification|Withdrawal by Subject|1|||
44144229|NCT04068519|78933559|FG000|Pharmacokinetic Sub-study|Death|35|||
44144230|NCT04068519|78933559|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
44144231|NCT04068519|78933559|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
44144232|NCT04068519|78933559|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
44144233|NCT04068519|78933559|FG000|Indication Expansion|Death|152|||
44144234|NCT04068519|78933559|FG000|Indication Expansion|Withdrawal by Subject|10|||
44144235|NCT04068519|78933559|FG000|Indication Expansion|Lost to Follow-up|7|||
44144236|NCT03810365|78933586|FG000|Overall Study|Lost to Follow-up|2|||
44144237|NCT03810365|78933587|FG001|Overall Study|Lost to Follow-up|1|||
44144238|NCT03810365|78933586|FG000|Overall Study|Withdrawal by Subject|4|||
44144239|NCT03810365|78933587|FG001|Overall Study|Withdrawal by Subject|3|||
44144240|NCT03810365|78933586|FG000|Overall Study|referred for Sleep apnea|0|||
44144241|NCT03810365|78933587|FG001|Overall Study|referred for Sleep apnea|3|||
44144242|NCT03605758|78933595|FG000|Overall Study|Lost to Follow-up|2|||
44144243|NCT03605758|78933596|FG001|Overall Study|Lost to Follow-up|1|||
44144244|NCT03605758|78933595|FG000|Overall Study|Illness|0|||
44144245|NCT03605758|78933596|FG001|Overall Study|Illness|1|||
44144246|NCT03605758|78933595|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
44144247|NCT03605758|78933596|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
44144248|NCT03016975|78933610|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
44144249|NCT03016975|78933611|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
44144250|NCT03016975|78933612|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
44144251|NCT03016975|78933610|FG000|At 6 Months Follow-up|Death|2|||
44144252|NCT03016975|78933611|FG001|At 6 Months Follow-up|Death|0|||
44249917|NCT01500278|79084155|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
44249918|NCT01500278|79084154|FG000|Week 13 - Week 104|Relocation|0|||
44144253|NCT03016975|78933612|FG002|At 6 Months Follow-up|Death|0|||
44144254|NCT03016975|78933610|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
44144255|NCT03016975|78933611|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
44144256|NCT03016975|78933612|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
44144257|NCT03016975|78933610|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
44249919|NCT01500278|79084155|FG001|Week 13 - Week 104|Relocation|1|||
44277952|NCT02113956|79239005|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
44277953|NCT02113956|79239004|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
44277954|NCT02113956|79239005|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
44277955|NCT02113956|79239004|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
44277956|NCT02113956|79239005|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
44277957|NCT02070588|79239014|FG000|Overall Study|Withdrawal by Subject|29|||
44277958|NCT02070588|79239015|FG001|Overall Study|Withdrawal by Subject|1|||
44382410|NCT03996369|79388368|FG001|Overall Study|Physician Decision|2|||
44144258|NCT03016975|78933611|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
44144259|NCT03016975|78933612|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
44144260|NCT03016975|78933610|FG000|At 6 Months Follow-up|Aborted implant|1|||
44382411|NCT03996369|79388367|FG000|Overall Study|Participant decision|0|||
44382412|NCT03996369|79388368|FG001|Overall Study|Participant decision|1|||
44382413|NCT03996369|79388367|FG000|Overall Study|Lack of Efficacy|4|||
44382414|NCT03996369|79388368|FG001|Overall Study|Lack of Efficacy|0|||
44382415|NCT03996369|79388367|FG000|Overall Study|Adverse Event|9|||
44382416|NCT03996369|79388368|FG001|Overall Study|Adverse Event|0|||
44277959|NCT02070588|79239016|FG002|Overall Study|Withdrawal by Subject|0|||
44277960|NCT02070588|79239014|FG000|Overall Study|Writhdrawal due to early termination|9|||
44382417|NCT03996369|79388367|FG000|Overall Study|Withdrawal by Subject|6|||
44382418|NCT03996369|79388368|FG001|Overall Study|Withdrawal by Subject|8|||
44382419|NCT03996369|79388367|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
44382420|NCT03996369|79388368|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
44382421|NCT03996369|79388367|FG000|Overall Study|Lost to Follow-up|0|||
44382422|NCT03996369|79388368|FG001|Overall Study|Lost to Follow-up|1|||
44382423|NCT00808210|79388376|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
44515576|NCT04129346|79521960|FG001|Overall Study|Death|0|||
44515577|NCT04526574|79521968|FG000|Overall Study|Protocol Violation|3|||
44515578|NCT04526574|79521969|FG001|Overall Study|Protocol Violation|1|||
44515579|NCT04526574|79521968|FG000|Overall Study|Withdrawal by Subject|12|||
44515580|NCT04526574|79521969|FG001|Overall Study|Withdrawal by Subject|9|||
44515581|NCT04526574|79521968|FG000|Overall Study|Other|1|||
44515582|NCT04526574|79521969|FG001|Overall Study|Other|2|||
44515583|NCT04526574|79521968|FG000|Overall Study|Adverse Event|1|||
44515584|NCT04526574|79521969|FG001|Overall Study|Adverse Event|1|||
44515585|NCT04526574|79521968|FG000|Overall Study|Death|2|||
44515586|NCT04526574|79521969|FG001|Overall Study|Death|3|||
44515587|NCT04526574|79521968|FG000|Overall Study|Lost to Follow-up|9|||
44515588|NCT04526574|79521969|FG001|Overall Study|Lost to Follow-up|9|||
44515589|NCT04526574|79521968|FG000|Overall Study|No longer meets eligibility criteria|8|||
44515590|NCT04526574|79521969|FG001|Overall Study|No longer meets eligibility criteria|8|||
44144261|NCT03016975|78933611|FG001|At 6 Months Follow-up|Aborted implant|0|||
44144262|NCT03016975|78933612|FG002|At 6 Months Follow-up|Aborted implant|0|||
44144263|NCT03016975|78933610|FG000|At 2 Year Follow-up|Death|1|||
44515591|NCT03993392|79521979|FG000|Overall Study|Withdrawal by Subject|3|||
44515592|NCT03993392|79521979|FG000|Overall Study|Lost to Follow-up|2|||
44515593|NCT03993392|79521979|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
44515594|NCT04422990|79521986|FG000|Overall Study|Withdrawal by Subject|0|||
44515595|NCT04422990|79521987|FG001|Overall Study|Withdrawal by Subject|1|||
44515596|NCT04422990|79521986|FG000|Overall Study|Travel|3|||
44515597|NCT04422990|79521987|FG001|Overall Study|Travel|0|||
44515598|NCT04377308|79521998|FG000|Overall Study|Withdrawal by Subject|0|||
44515599|NCT04377308|79521999|FG001|Overall Study|Withdrawal by Subject|1|||
44515600|NCT04447404|79522007|FG000|Overall Study|Death|2|||
44515601|NCT04447404|79522008|FG001|Overall Study|Death|0|||
44515602|NCT03988166|79522014|FG000|Overall Study|Lost to Follow-up|2|||
44515603|NCT03988166|79522014|FG000|Overall Study|Death|1|||
44515604|NCT03988088|79522023|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
44515605|NCT03988088|79522024|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
44515606|NCT03988088|79522025|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
44515607|NCT03988088|79522026|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
44515608|NCT03988088|79522023|FG000|Open-Label Addendum|Lost to Follow-up|0|||
44515609|NCT03988088|79522024|FG001|Open-Label Addendum|Lost to Follow-up|0|||
44144264|NCT03016975|78933611|FG001|At 2 Year Follow-up|Death|0|||
44144265|NCT03016975|78933612|FG002|At 2 Year Follow-up|Death|0|||
44144266|NCT03016975|78933610|FG000|At 3 Year Follow-up|Death|1|||
44144267|NCT03016975|78933611|FG001|At 3 Year Follow-up|Death|0|||
44144268|NCT03016975|78933612|FG002|At 3 Year Follow-up|Death|0|||
44144269|NCT03016975|78933610|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
44144270|NCT03016975|78933611|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
44144271|NCT03016975|78933612|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
44144272|NCT03016975|78933610|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
44144273|NCT03016975|78933611|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
44144274|NCT03016975|78933612|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
44144275|NCT02911792|78933635|FG000|Overall Study|Lost to Follow-up|3|||
44144276|NCT02911792|78933636|FG001|Overall Study|Lost to Follow-up|3|||
44144277|NCT02911792|78933637|FG002|Overall Study|Lost to Follow-up|3|||
44144278|NCT02911792|78933638|FG003|Overall Study|Lost to Follow-up|3|||
44144279|NCT01867606|78933688|FG000|Overall Study|Withdrawal by Subject|10|||
44144280|NCT01867606|78933689|FG001|Overall Study|Withdrawal by Subject|14|||
44144281|NCT01867606|78933688|FG000|Overall Study|Protocol Violation|0|||
44144282|NCT01867606|78933689|FG001|Overall Study|Protocol Violation|1|||
44144283|NCT01828112|78933703|FG000|Overall Study|Adverse Event|6|||
44144284|NCT01828112|78933704|FG001|Overall Study|Adverse Event|8|||
44144285|NCT01828112|78933703|FG000|Overall Study|Death|9|||
44249920|NCT01500278|79084154|FG000|Week 13 - Week 104|Sponsor decision|0|||
44249921|NCT01500278|79084155|FG001|Week 13 - Week 104|Sponsor decision|2|||
44249922|NCT01500278|79084154|FG000|Week 13 - Week 104|Medical monitor decision|0|||
44249923|NCT01500278|79084155|FG001|Week 13 - Week 104|Medical monitor decision|2|||
44249924|NCT01500278|79084154|FG000|Week 13 - Week 104|Personal reason|0|||
44249925|NCT01500278|79084155|FG001|Week 13 - Week 104|Personal reason|1|||
44249926|NCT01500278|79084154|FG000|Week 13 - Week 104|Not completed|0|||
44249927|NCT01500278|79084155|FG001|Week 13 - Week 104|Not completed|1|||
44515610|NCT03988088|79522025|FG002|Open-Label Addendum|Lost to Follow-up|1|||
44515611|NCT03988088|79522026|FG003|Open-Label Addendum|Lost to Follow-up|0|||
44515612|NCT03987932|79522037|FG000|Overall Study|Lost to Follow-up|2|||
44515613|NCT03987932|79522038|FG001|Overall Study|Lost to Follow-up|1|||
44144286|NCT01828112|78933704|FG001|Overall Study|Death|5|||
44144287|NCT01828112|78933703|FG000|Overall Study|Physician Decision|5|||
44144288|NCT01828112|78933704|FG001|Overall Study|Physician Decision|5|||
44144289|NCT01828112|78933703|FG000|Overall Study|Progressive disease|56|||
44144290|NCT01828112|78933704|FG001|Overall Study|Progressive disease|82|||
44144291|NCT01828112|78933703|FG000|Overall Study|Subject/guardian decision|6|||
44144292|NCT01828112|78933704|FG001|Overall Study|Subject/guardian decision|8|||
44144293|NCT01740427|78933712|FG000|Overall Study|Ongoing|45|||
44144294|NCT01740427|78933713|FG001|Overall Study|Ongoing|5|||
44144295|NCT01740427|78933712|FG000|Overall Study|Objective Progression or Relapse|281|||
44144296|NCT01740427|78933713|FG001|Overall Study|Objective Progression or Relapse|171|||
44144297|NCT01740427|78933712|FG000|Overall Study|Adverse Event|31|||
44144298|NCT01740427|78933713|FG001|Overall Study|Adverse Event|9|||
44144299|NCT01740427|78933712|FG000|Overall Study|Global Deterioration of Health Status|28|||
44144300|NCT01740427|78933713|FG001|Overall Study|Global Deterioration of Health Status|12|||
44144301|NCT01740427|78933712|FG000|Overall Study|Participant Refused Continued Treatment|26|||
44144302|NCT01740427|78933713|FG001|Overall Study|Participant Refused Continued Treatment|15|||
44144303|NCT01740427|78933712|FG000|Overall Study|Unspecified reasons|15|||
44144304|NCT01740427|78933713|FG001|Overall Study|Unspecified reasons|4|||
44144305|NCT01740427|78933712|FG000|Overall Study|Death|10|||
44144306|NCT01740427|78933713|FG001|Overall Study|Death|3|||
44144307|NCT01740427|78933712|FG000|Overall Study|Protocol Violation|5|||
44144308|NCT01740427|78933713|FG001|Overall Study|Protocol Violation|3|||
44144309|NCT01740427|78933712|FG000|Overall Study|Lost to Follow-up|2|||
44144310|NCT01740427|78933713|FG001|Overall Study|Lost to Follow-up|0|||
44144311|NCT01740427|78933712|FG000|Overall Study|Site Terminated by Sponsor|1|||
44144312|NCT01740427|78933713|FG001|Overall Study|Site Terminated by Sponsor|0|||
44144313|NCT01657682|78933722|FG000|Overall Study|Lost to Follow-up|1|||
44144314|NCT01657682|78933723|FG001|Overall Study|Lost to Follow-up|0|||
44144315|NCT01657682|78933724|FG002|Overall Study|Lost to Follow-up|0|||
44144316|NCT01657682|78933722|FG000|Overall Study|Withdrawal by Subject|0|||
44144317|NCT01657682|78933723|FG001|Overall Study|Withdrawal by Subject|1|||
44144318|NCT01657682|78933724|FG002|Overall Study|Withdrawal by Subject|1|||
44249928|NCT01500278|79084154|FG000|Week 13 - Week 104|Death|2|||
44249929|NCT01500278|79084155|FG001|Week 13 - Week 104|Death|4|||
44249930|NCT01500278|79084154|FG000|Week 13 - Week 104|Adverse Event|54|||
44144319|NCT01657682|78933722|FG000|Overall Study|Adverse Event|0|||
44144320|NCT01657682|78933723|FG001|Overall Study|Adverse Event|1|||
44144321|NCT01657682|78933724|FG002|Overall Study|Adverse Event|0|||
44144322|NCT01556243|78933744|FG000|Overall Study|Ineligible|34|||
44144323|NCT01556243|78933744|FG000|Overall Study|Converted to mastectomy|14|||
44144324|NCT01556243|78933744|FG000|Overall Study|Unable to achieve negative margins|2|||
44249931|NCT01500278|79084155|FG001|Week 13 - Week 104|Adverse Event|54|||
44249932|NCT00086281|79084178|FG000|Phase 1|Adverse Event|0|||
44249933|NCT00086281|79084179|FG001|Phase 1|Adverse Event|0|||
44249934|NCT00086281|79084180|FG002|Phase 1|Adverse Event|0|||
44249935|NCT00086281|79084181|FG003|Phase 1|Adverse Event|0|||
44144325|NCT01556243|78933744|FG000|Overall Study|Withdrawal by Subject|16|||
44144326|NCT00819156|78933789|FG000|Overall Study|Adverse Event|1|||
44249936|NCT00086281|79084182|FG004|Phase 1|Adverse Event|0|||
44249937|NCT00086281|79084183|FG005|Phase 1|Adverse Event|0|||
44144327|NCT00819156|78933790|FG001|Overall Study|Adverse Event|4|||
44144328|NCT00819156|78933791|FG002|Overall Study|Adverse Event|2|||
44144329|NCT00819156|78933792|FG003|Overall Study|Adverse Event|1|||
44249938|NCT00086281|79084184|FG006|Phase 1|Adverse Event|0|||
44144330|NCT00819156|78933793|FG004|Overall Study|Adverse Event|2|||
44144331|NCT00819156|78933794|FG005|Overall Study|Adverse Event|3|||
44144332|NCT00819156|78933789|FG000|Overall Study|Withdrawal by Subject|0|||
44144333|NCT00819156|78933790|FG001|Overall Study|Withdrawal by Subject|3|||
44144334|NCT00819156|78933791|FG002|Overall Study|Withdrawal by Subject|2|||
44144335|NCT00819156|78933792|FG003|Overall Study|Withdrawal by Subject|0|||
44144336|NCT00819156|78933793|FG004|Overall Study|Withdrawal by Subject|1|||
44144337|NCT00819156|78933794|FG005|Overall Study|Withdrawal by Subject|0|||
44144338|NCT00819156|78933789|FG000|Overall Study|Protocol Violation|1|||
44144339|NCT00819156|78933790|FG001|Overall Study|Protocol Violation|0|||
44144340|NCT00819156|78933791|FG002|Overall Study|Protocol Violation|1|||
44144341|NCT00819156|78933792|FG003|Overall Study|Protocol Violation|0|||
44144342|NCT00819156|78933793|FG004|Overall Study|Protocol Violation|0|||
44144343|NCT00819156|78933794|FG005|Overall Study|Protocol Violation|1|||
44144344|NCT00819156|78933789|FG000|Overall Study|Lost to Follow-up|0|||
44144345|NCT00819156|78933790|FG001|Overall Study|Lost to Follow-up|1|||
44144346|NCT00819156|78933791|FG002|Overall Study|Lost to Follow-up|0|||
44144347|NCT00819156|78933792|FG003|Overall Study|Lost to Follow-up|0|||
44144348|NCT00819156|78933793|FG004|Overall Study|Lost to Follow-up|0|||
44144349|NCT00819156|78933794|FG005|Overall Study|Lost to Follow-up|2|||
44144350|NCT00819156|78933789|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
44277961|NCT02070588|79239015|FG001|Overall Study|Writhdrawal due to early termination|0|||
44277962|NCT02070588|79239016|FG002|Overall Study|Writhdrawal due to early termination|0|||
44277963|NCT02070588|79239014|FG000|Overall Study|Adverse Event|1|||
44144351|NCT00819156|78933790|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
44144352|NCT00819156|78933791|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
44144353|NCT00819156|78933792|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
44144354|NCT00819156|78933793|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
44144355|NCT00819156|78933794|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
44144356|NCT00819156|78933789|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
44144357|NCT00819156|78933790|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
44144358|NCT00819156|78933791|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
44144359|NCT00819156|78933792|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
44144360|NCT00819156|78933793|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
44144361|NCT00819156|78933794|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
44144362|NCT00819156|78933789|FG000|Overall Study|Prostate-specific antigen progression|0|||
44144363|NCT00819156|78933790|FG001|Overall Study|Prostate-specific antigen progression|0|||
44144364|NCT00819156|78933791|FG002|Overall Study|Prostate-specific antigen progression|0|||
44144365|NCT00819156|78933792|FG003|Overall Study|Prostate-specific antigen progression|0|||
44144366|NCT00819156|78933793|FG004|Overall Study|Prostate-specific antigen progression|1|||
44144367|NCT00819156|78933794|FG005|Overall Study|Prostate-specific antigen progression|0|||
44144368|NCT00818623|78933824|FG000|Overall Study|Adverse Event|1|||
44144369|NCT00818623|78933825|FG001|Overall Study|Adverse Event|0|||
44144370|NCT00818623|78933826|FG002|Overall Study|Adverse Event|1|||
44144371|NCT00818623|78933827|FG003|Overall Study|Adverse Event|0|||
44144372|NCT00818623|78933828|FG004|Overall Study|Adverse Event|0|||
44249939|NCT00086281|79084185|FG007|Phase 1|Adverse Event|0|||
44249940|NCT00086281|79084186|FG008|Phase 1|Adverse Event|0|||
44249941|NCT00086281|79084187|FG009|Phase 1|Adverse Event|1|||
44515614|NCT03987932|79522039|FG002|Overall Study|Lost to Follow-up|1|||
44515615|NCT03987932|79522037|FG000|Overall Study|Non-study related elective surgery|0|||
44515616|NCT03987932|79522038|FG001|Overall Study|Non-study related elective surgery|0|||
44515617|NCT03987932|79522039|FG002|Overall Study|Non-study related elective surgery|1|||
44515618|NCT03987620|79522049|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
44515619|NCT03987620|79522050|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
44515620|NCT03987620|79522049|FG000|Overall Study|Adverse Event|3|||
44515621|NCT03987620|79522050|FG001|Overall Study|Adverse Event|0|||
44515622|NCT03987620|79522049|FG000|Overall Study|Lost to Follow-up|1|||
44515623|NCT03987620|79522050|FG001|Overall Study|Lost to Follow-up|2|||
44515624|NCT03987620|79522049|FG000|Overall Study|Physician Decision|0|||
44515625|NCT03987620|79522050|FG001|Overall Study|Physician Decision|1|||
44515626|NCT03987620|79522049|FG000|Overall Study|Pregnancy|1|||
44515627|NCT03987620|79522050|FG001|Overall Study|Pregnancy|0|||
44515628|NCT03987620|79522049|FG000|Overall Study|Withdrawal by Subject|7|||
44515629|NCT03987620|79522050|FG001|Overall Study|Withdrawal by Subject|1|||
44515630|NCT03987620|79522049|FG000|Overall Study|Other|2|||
44515631|NCT03987620|79522050|FG001|Overall Study|Other|5|||
44515632|NCT04376060|79522056|FG000|Overall Study|Physician Decision|1|||
44515633|NCT04413552|79522070|FG000|Overall Study|Adverse Event|0|||
44515634|NCT04413552|79522071|FG001|Overall Study|Adverse Event|0|||
44515635|NCT04413552|79522072|FG002|Overall Study|Adverse Event|0|||
44515636|NCT04413552|79522073|FG003|Overall Study|Adverse Event|0|||
44515637|NCT04413552|79522074|FG004|Overall Study|Adverse Event|0|||
44515638|NCT04413552|79522075|FG005|Overall Study|Adverse Event|0|||
44515639|NCT04413552|79522076|FG006|Overall Study|Adverse Event|1|||
44515640|NCT04413552|79522077|FG007|Overall Study|Adverse Event|0|||
44515641|NCT04413552|79522078|FG008|Overall Study|Adverse Event|0|||
44515642|NCT04413552|79522079|FG009|Overall Study|Adverse Event|0|||
44515643|NCT03987074|79522110|FG000|Overall Study|Withdrew Consent|1|||
44515644|NCT03987074|79522111|FG001|Overall Study|Withdrew Consent|1|||
44515645|NCT03987074|79522112|FG002|Overall Study|Withdrew Consent|0|||
44515646|NCT03987074|79522113|FG003|Overall Study|Withdrew Consent|2|||
44515647|NCT03987074|79522114|FG004|Overall Study|Withdrew Consent|1|||
44515648|NCT03987074|79522110|FG000|Overall Study|Adverse Event|2|||
44515649|NCT03987074|79522111|FG001|Overall Study|Adverse Event|1|||
44515650|NCT03987074|79522112|FG002|Overall Study|Adverse Event|0|||
44515651|NCT03987074|79522113|FG003|Overall Study|Adverse Event|0|||
44144373|NCT00818623|78933829|FG005|Overall Study|Adverse Event|1|||
44249942|NCT00086281|79084188|FG010|Phase 1|Adverse Event|2|||
44249943|NCT00086281|79084189|FG011|Phase 1|Adverse Event|1|||
44249944|NCT00086281|79084190|FG012|Phase 1|Adverse Event|1|||
44249945|NCT00086281|79084191|FG013|Phase 1|Adverse Event|1|||
44515652|NCT03987074|79522114|FG004|Overall Study|Adverse Event|1|||
44515653|NCT03987074|79522110|FG000|Overall Study|Lost to Follow-up|0|||
44144374|NCT00818623|78933830|FG006|Overall Study|Adverse Event|0|||
44144375|NCT00818623|78933831|FG007|Overall Study|Adverse Event|0|||
44144376|NCT00818623|78933824|FG000|Overall Study|Bad prostate specific antigen response|0|||
44144377|NCT00818623|78933825|FG001|Overall Study|Bad prostate specific antigen response|3|||
44144378|NCT00818623|78933826|FG002|Overall Study|Bad prostate specific antigen response|2|||
44144379|NCT00818623|78933827|FG003|Overall Study|Bad prostate specific antigen response|5|||
44144380|NCT00818623|78933828|FG004|Overall Study|Bad prostate specific antigen response|0|||
44144381|NCT00818623|78933829|FG005|Overall Study|Bad prostate specific antigen response|1|||
44144382|NCT00818623|78933830|FG006|Overall Study|Bad prostate specific antigen response|0|||
44144383|NCT00818623|78933831|FG007|Overall Study|Bad prostate specific antigen response|0|||
44144384|NCT00818623|78933824|FG000|Overall Study|Withdrawal by Subject|0|||
44144385|NCT00818623|78933825|FG001|Overall Study|Withdrawal by Subject|1|||
44515654|NCT03987074|79522111|FG001|Overall Study|Lost to Follow-up|0|||
44515655|NCT03987074|79522112|FG002|Overall Study|Lost to Follow-up|1|||
44515656|NCT03987074|79522113|FG003|Overall Study|Lost to Follow-up|1|||
44515657|NCT03987074|79522114|FG004|Overall Study|Lost to Follow-up|0|||
44515658|NCT03987074|79522110|FG000|Overall Study|Investigator's Discretion|0|||
44515659|NCT03987074|79522111|FG001|Overall Study|Investigator's Discretion|0|||
44515660|NCT03987074|79522112|FG002|Overall Study|Investigator's Discretion|0|||
44515661|NCT03987074|79522113|FG003|Overall Study|Investigator's Discretion|1|||
44144386|NCT00818623|78933826|FG002|Overall Study|Withdrawal by Subject|1|||
44144387|NCT00818623|78933827|FG003|Overall Study|Withdrawal by Subject|0|||
44144388|NCT00818623|78933828|FG004|Overall Study|Withdrawal by Subject|0|||
44144389|NCT00818623|78933829|FG005|Overall Study|Withdrawal by Subject|1|||
44144390|NCT00818623|78933830|FG006|Overall Study|Withdrawal by Subject|1|||
44144391|NCT00818623|78933831|FG007|Overall Study|Withdrawal by Subject|1|||
44144392|NCT00818623|78933824|FG000|Overall Study|Protocol Violation|1|||
44144393|NCT00818623|78933825|FG001|Overall Study|Protocol Violation|0|||
44144394|NCT00818623|78933826|FG002|Overall Study|Protocol Violation|0|||
44144395|NCT00818623|78933827|FG003|Overall Study|Protocol Violation|0|||
44144396|NCT00818623|78933828|FG004|Overall Study|Protocol Violation|1|||
44144397|NCT00818623|78933829|FG005|Overall Study|Protocol Violation|0|||
44144398|NCT00818623|78933830|FG006|Overall Study|Protocol Violation|1|||
44144399|NCT00818623|78933831|FG007|Overall Study|Protocol Violation|0|||
44144400|NCT00818623|78933824|FG000|Overall Study|Need of additional treatment|0|||
44144401|NCT00818623|78933825|FG001|Overall Study|Need of additional treatment|0|||
44144402|NCT00818623|78933826|FG002|Overall Study|Need of additional treatment|0|||
44144403|NCT00818623|78933827|FG003|Overall Study|Need of additional treatment|0|||
44144404|NCT00818623|78933828|FG004|Overall Study|Need of additional treatment|1|||
44144405|NCT00818623|78933829|FG005|Overall Study|Need of additional treatment|0|||
44144406|NCT00818623|78933830|FG006|Overall Study|Need of additional treatment|0|||
44144407|NCT00818623|78933831|FG007|Overall Study|Need of additional treatment|0|||
44144408|NCT00818623|78933824|FG000|Overall Study|Lack of trial drug at site|0|||
44144409|NCT00818623|78933825|FG001|Overall Study|Lack of trial drug at site|0|||
44144410|NCT00818623|78933826|FG002|Overall Study|Lack of trial drug at site|0|||
44144411|NCT00818623|78933827|FG003|Overall Study|Lack of trial drug at site|0|||
44144412|NCT00818623|78933828|FG004|Overall Study|Lack of trial drug at site|2|||
44144413|NCT00818623|78933829|FG005|Overall Study|Lack of trial drug at site|0|||
44144414|NCT00818623|78933830|FG006|Overall Study|Lack of trial drug at site|1|||
44144415|NCT00818623|78933831|FG007|Overall Study|Lack of trial drug at site|0|||
44144416|NCT00818623|78933824|FG000|Overall Study|Disease progression|0|||
44144417|NCT00818623|78933825|FG001|Overall Study|Disease progression|0|||
44144418|NCT00818623|78933826|FG002|Overall Study|Disease progression|0|||
44144419|NCT00818623|78933827|FG003|Overall Study|Disease progression|0|||
44144420|NCT00818623|78933828|FG004|Overall Study|Disease progression|0|||
44144421|NCT00818623|78933829|FG005|Overall Study|Disease progression|0|||
44144422|NCT00818623|78933830|FG006|Overall Study|Disease progression|1|||
44144423|NCT00818623|78933831|FG007|Overall Study|Disease progression|0|||
44144424|NCT01285557|78933859|FG000|Overall Study|Death|173|||
44144425|NCT01285557|78933860|FG001|Overall Study|Death|90|||
44144426|NCT01285557|78933859|FG000|Overall Study|Lost to Follow-up|6|||
44144427|NCT01285557|78933860|FG001|Overall Study|Lost to Follow-up|2|||
44144428|NCT01285557|78933859|FG000|Overall Study|Withdrew Consent|6|||
44144429|NCT01285557|78933860|FG001|Overall Study|Withdrew Consent|1|||
44144430|NCT01285557|78933859|FG000|Overall Study|Sponsor Study Termination|23|||
44144431|NCT01285557|78933860|FG001|Overall Study|Sponsor Study Termination|13|||
44144432|NCT01285557|78933859|FG000|Overall Study|Randomized but not treated|1|||
44144433|NCT01285557|78933860|FG001|Overall Study|Randomized but not treated|1|||
44144434|NCT01285557|78933859|FG000|Overall Study|Study follow-up ongoing|28|||
44144435|NCT01285557|78933860|FG001|Overall Study|Study follow-up ongoing|14|||
44144436|NCT01285557|78933859|FG000|Overall Study|Sponsor Decision|2|||
44144437|NCT01285557|78933860|FG001|Overall Study|Sponsor Decision|1|||
44144438|NCT01376167|78933913|FG000|Overall Study|Lost to Follow-up|2|||
44144439|NCT01376167|78933914|FG001|Overall Study|Lost to Follow-up|4|||
44144440|NCT01376167|78933915|FG002|Overall Study|Lost to Follow-up|2|||
44144441|NCT01376167|78933913|FG000|Overall Study|Physician Decision|1|||
44144442|NCT01376167|78933914|FG001|Overall Study|Physician Decision|1|||
44144443|NCT01376167|78933915|FG002|Overall Study|Physician Decision|0|||
44144444|NCT01376167|78933913|FG000|Overall Study|Withdrawal by Subject|1|||
44144445|NCT01376167|78933914|FG001|Overall Study|Withdrawal by Subject|5|||
44144446|NCT01376167|78933915|FG002|Overall Study|Withdrawal by Subject|4|||
44144447|NCT02647281|78933935|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144448|NCT02647281|78933936|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144449|NCT02647281|78933937|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144450|NCT02647281|78933938|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144451|NCT02647281|78933939|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144452|NCT02647281|78933940|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144453|NCT02647281|78933941|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144454|NCT02647281|78933942|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
44144455|NCT02647281|78933943|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
44144456|NCT02729545|78933974|FG000|Overall Study|Pregnancy|1|||
44144457|NCT02729545|78933975|FG001|Overall Study|Pregnancy|1|||
44144458|NCT02729545|78933974|FG000|Overall Study|Lost to Follow-up|0|||
44144459|NCT02729545|78933975|FG001|Overall Study|Lost to Follow-up|1|||
44144460|NCT02729545|78933974|FG000|Overall Study|Withdrawal by Subject|2|||
44144461|NCT02729545|78933975|FG001|Overall Study|Withdrawal by Subject|3|||
44144462|NCT01376089|78933983|FG000|Overall Study|Patient received no contrast media|3|||
44144463|NCT01376089|78933984|FG001|Overall Study|Patient received no contrast media|4|||
44144464|NCT00706849|78933996|FG000|Treatment Period|Adverse Event|0|||
44144465|NCT00706849|78933997|FG001|Treatment Period|Adverse Event|9|||
44144466|NCT00706849|78933996|FG000|Treatment Period|Other|0|||
44144467|NCT00706849|78933997|FG001|Treatment Period|Other|1|||
44144468|NCT00706849|78933996|FG000|Follow-up Period|Withdrawal by Subject|0|||
44249946|NCT00086281|79084192|FG014|Phase 1|Adverse Event|2|||
44144469|NCT00706849|78933997|FG001|Follow-up Period|Withdrawal by Subject|2|||
44249947|NCT00086281|79084178|FG000|Phase 1|Protocol Violation|0|||
44249948|NCT00086281|79084179|FG001|Phase 1|Protocol Violation|0|||
44249949|NCT00086281|79084180|FG002|Phase 1|Protocol Violation|0|||
44515662|NCT03987074|79522114|FG004|Overall Study|Investigator's Discretion|0|||
44515663|NCT04439214|79522126|FG000|Overall Study|Adverse Event|13|||
44515664|NCT04439214|79522126|FG000|Overall Study|Disease progression|16|||
44515665|NCT04439214|79522126|FG000|Overall Study|Death|1|||
44515666|NCT04439214|79522126|FG000|Overall Study|Withdrawal by Subject|2|||
44515667|NCT04439214|79522126|FG000|Overall Study|Declining health|1|||
44515668|NCT04439214|79522126|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
44515669|NCT04439214|79522126|FG000|Overall Study|Ineligible|5|||
44515670|NCT03696342|79522132|FG000|Overall Study|Lost to Follow-up|1|||
44515671|NCT03696342|79522133|FG001|Overall Study|Lost to Follow-up|0|||
44515672|NCT04411680|79522141|FG000|Treatment Period|Adverse Event|3|||
44144470|NCT00706849|78933996|FG000|Follow-up Period|Protocol non-compliance|0|||
44144471|NCT00706849|78933997|FG001|Follow-up Period|Protocol non-compliance|1|||
44249950|NCT00086281|79084181|FG003|Phase 1|Protocol Violation|0|||
44515673|NCT04411680|79522142|FG001|Treatment Period|Adverse Event|0|||
44144472|NCT00707161|78934003|FG000|Overall Study|Physician Decision|6|||
44144473|NCT02130466|78934021|FG000|Overall Study|Death|4|||
44382424|NCT00808210|79388377|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
44277964|NCT02070588|79239015|FG001|Overall Study|Adverse Event|0|||
44144474|NCT02130466|78934022|FG001|Overall Study|Death|1|||
44144475|NCT02130466|78934023|FG002|Overall Study|Death|1|||
44144476|NCT02130466|78934024|FG003|Overall Study|Death|3|||
44144477|NCT02130466|78934025|FG004|Overall Study|Death|2|||
44144478|NCT02130466|78934026|FG005|Overall Study|Death|30|||
44277965|NCT02070588|79239016|FG002|Overall Study|Adverse Event|0|||
44382425|NCT00808210|79388376|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
44382426|NCT00808210|79388377|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
44382427|NCT00808210|79388376|FG000|Double-Blind TX Period|Adverse Event|0|||
44515674|NCT04411680|79522141|FG000|Treatment Period|Discharged from hospital|18|||
44144479|NCT02130466|78934027|FG006|Overall Study|Death|45|||
44515675|NCT04411680|79522142|FG001|Treatment Period|Discharged from hospital|7|||
44515676|NCT04411680|79522141|FG000|Treatment Period|Missed 1 or more doses|8|||
44515677|NCT04411680|79522142|FG001|Treatment Period|Missed 1 or more doses|0|||
44515678|NCT04411680|79522141|FG000|Treatment Period|Transferred to another hospital|0|||
44515679|NCT04411680|79522142|FG001|Treatment Period|Transferred to another hospital|1|||
44515680|NCT04411680|79522141|FG000|Follow up Period|Withdrawal by Subject|2|||
44515681|NCT04411680|79522142|FG001|Follow up Period|Withdrawal by Subject|0|||
44515682|NCT04411680|79522141|FG000|Follow up Period|Lost to Follow-up|5|||
44515683|NCT04411680|79522142|FG001|Follow up Period|Lost to Follow-up|6|||
44515684|NCT04411680|79522141|FG000|Follow up Period|Death|11|||
44515685|NCT04411680|79522142|FG001|Follow up Period|Death|8|||
44515686|NCT04410198|79522148|FG000|Overall Study|Death|10|||
44515687|NCT04410198|79522148|FG000|Overall Study|Withdrawal by Subject|7|||
44515688|NCT04410198|79522148|FG000|Overall Study|Transferred/Relocation|4|||
44515689|NCT04410198|79522148|FG000|Overall Study|Kidney Transplant|9|||
44515690|NCT04410198|79522148|FG000|Overall Study|Adverse Event|4|||
44144480|NCT02130466|78934028|FG007|Overall Study|Death|2|||
44144481|NCT02130466|78934029|FG008|Overall Study|Death|3|||
44515691|NCT04410198|79522148|FG000|Overall Study|Physician Decision|2|||
44515692|NCT04410198|79522148|FG000|Overall Study|Other than specified|1|||
44515693|NCT04161144|79522154|FG000|Overall Study|Withdrawal by Subject|0|||
44515694|NCT04161144|79522155|FG001|Overall Study|Withdrawal by Subject|1|||
44515695|NCT04161144|79522154|FG000|Overall Study|Protocol Violation|1|||
44515696|NCT04161144|79522155|FG001|Overall Study|Protocol Violation|0|||
44515697|NCT03984812|79522172|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515698|NCT03984812|79522173|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515699|NCT03984812|79522174|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
44144482|NCT02130466|78934030|FG009|Overall Study|Death|4|||
44277966|NCT02111850|79239035|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44515700|NCT03984812|79522175|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515701|NCT03984812|79522176|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515702|NCT03984812|79522177|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515703|NCT03984812|79522178|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515704|NCT03984812|79522179|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44144483|NCT02130466|78934031|FG010|Overall Study|Death|5|||
44515705|NCT03984812|79522180|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515706|NCT03984812|79522181|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515707|NCT03984812|79522182|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
44515708|NCT04160988|79522209|FG000|Overall Study|poor image quality|28|||
44515709|NCT04153188|79522230|FG000|Overall Study|Lost to Follow-up|1|||
44515710|NCT04153188|79522231|FG001|Overall Study|Lost to Follow-up|1|||
44515711|NCT04153188|79522230|FG000|Overall Study|Withdrawal by Subject|2|||
44515712|NCT04153188|79522231|FG001|Overall Study|Withdrawal by Subject|0|||
44515713|NCT04153188|79522230|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
44144484|NCT02130466|78934032|FG011|Overall Study|Death|3|||
44144485|NCT02130466|78934033|FG012|Overall Study|Death|11|||
44144486|NCT02130466|78934034|FG013|Overall Study|Death|7|||
44144487|NCT02130466|78934021|FG000|Overall Study|Lost to Follow-up|1|||
44144488|NCT02130466|78934022|FG001|Overall Study|Lost to Follow-up|0|||
44144489|NCT02130466|78934023|FG002|Overall Study|Lost to Follow-up|0|||
44144490|NCT02130466|78934024|FG003|Overall Study|Lost to Follow-up|0|||
44144491|NCT02130466|78934025|FG004|Overall Study|Lost to Follow-up|0|||
44144492|NCT02130466|78934026|FG005|Overall Study|Lost to Follow-up|1|||
44144493|NCT02130466|78934027|FG006|Overall Study|Lost to Follow-up|0|||
44144494|NCT02130466|78934028|FG007|Overall Study|Lost to Follow-up|0|||
44144495|NCT02130466|78934029|FG008|Overall Study|Lost to Follow-up|0|||
44144496|NCT02130466|78934030|FG009|Overall Study|Lost to Follow-up|0|||
44144497|NCT02130466|78934031|FG010|Overall Study|Lost to Follow-up|0|||
44249951|NCT00086281|79084182|FG004|Phase 1|Protocol Violation|0|||
44249952|NCT00086281|79084183|FG005|Phase 1|Protocol Violation|0|||
44249953|NCT00086281|79084184|FG006|Phase 1|Protocol Violation|0|||
44249954|NCT00086281|79084185|FG007|Phase 1|Protocol Violation|0|||
44249955|NCT00086281|79084186|FG008|Phase 1|Protocol Violation|0|||
44249956|NCT00086281|79084187|FG009|Phase 1|Protocol Violation|0|||
44249957|NCT00086281|79084188|FG010|Phase 1|Protocol Violation|1|||
44249958|NCT00086281|79084189|FG011|Phase 1|Protocol Violation|0|||
44249959|NCT00086281|79084190|FG012|Phase 1|Protocol Violation|0|||
44249960|NCT00086281|79084191|FG013|Phase 1|Protocol Violation|0|||
44249961|NCT00086281|79084192|FG014|Phase 1|Protocol Violation|0|||
44249962|NCT00086281|79084178|FG000|Phase 1|Serious Adverse Event|0|||
44249963|NCT00086281|79084179|FG001|Phase 1|Serious Adverse Event|0|||
44249964|NCT00086281|79084180|FG002|Phase 1|Serious Adverse Event|0|||
44144498|NCT02130466|78934032|FG011|Overall Study|Lost to Follow-up|0|||
44249965|NCT00086281|79084181|FG003|Phase 1|Serious Adverse Event|0|||
44249966|NCT00086281|79084182|FG004|Phase 1|Serious Adverse Event|0|||
44249967|NCT00086281|79084183|FG005|Phase 1|Serious Adverse Event|0|||
44249968|NCT00086281|79084184|FG006|Phase 1|Serious Adverse Event|0|||
44249969|NCT00086281|79084185|FG007|Phase 1|Serious Adverse Event|0|||
44144499|NCT02130466|78934033|FG012|Overall Study|Lost to Follow-up|1|||
44144500|NCT02130466|78934034|FG013|Overall Study|Lost to Follow-up|0|||
44144501|NCT02130466|78934021|FG000|Overall Study|Physician Decision|0|||
44249970|NCT00086281|79084186|FG008|Phase 1|Serious Adverse Event|0|||
44249971|NCT00086281|79084187|FG009|Phase 1|Serious Adverse Event|0|||
44515714|NCT04153188|79522231|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
44515715|NCT04113746|79522239|FG000|Overall Study|Lost to Follow-up|4|||
44515716|NCT04113746|79522240|FG001|Overall Study|Lost to Follow-up|4|||
44515717|NCT03611010|79522250|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
44249972|NCT00086281|79084188|FG010|Phase 1|Serious Adverse Event|0|||
44249973|NCT00086281|79084189|FG011|Phase 1|Serious Adverse Event|0|||
44249974|NCT00086281|79084190|FG012|Phase 1|Serious Adverse Event|0|||
44515718|NCT03611010|79522251|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
44515719|NCT03611010|79522252|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
44515720|NCT03611010|79522253|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
44515721|NCT04357782|79522268|FG000|Overall Study|Discharged from hospital|1|||
44515722|NCT04357782|79522269|FG001|Overall Study|Discharged from hospital|0|||
44515723|NCT04357782|79522268|FG000|Overall Study|Death|0|||
44515724|NCT04357782|79522269|FG001|Overall Study|Death|2|||
44515725|NCT03980522|79522280|FG000|Treatment Period|Adverse Event|1|||
44515726|NCT03980522|79522281|FG001|Treatment Period|Adverse Event|0|||
44515727|NCT03980522|79522282|FG002|Treatment Period|Adverse Event|0|||
44515728|NCT03980522|79522283|FG003|Treatment Period|Adverse Event|0|||
44515729|NCT03980522|79522284|FG004|Treatment Period|Adverse Event|0|||
44515730|NCT04402866|79522302|FG000|Overall Study|Discontinued Prior to Treatment|0|||
44515731|NCT04402866|79522303|FG001|Overall Study|Discontinued Prior to Treatment|0|||
44515732|NCT04402866|79522304|FG002|Overall Study|Discontinued Prior to Treatment|0|||
44515733|NCT04402866|79522305|FG003|Overall Study|Discontinued Prior to Treatment|0|||
44515734|NCT04402866|79522306|FG004|Overall Study|Discontinued Prior to Treatment|2|||
44515735|NCT04402866|79522307|FG005|Overall Study|Discontinued Prior to Treatment|3|||
44515736|NCT04402866|79522302|FG000|Overall Study|Adverse Event|2|||
44515737|NCT04402866|79522303|FG001|Overall Study|Adverse Event|1|||
44515738|NCT04402866|79522304|FG002|Overall Study|Adverse Event|0|||
44515739|NCT04402866|79522305|FG003|Overall Study|Adverse Event|0|||
44515740|NCT04402866|79522306|FG004|Overall Study|Adverse Event|13|||
44515741|NCT04402866|79522307|FG005|Overall Study|Adverse Event|8|||
44515742|NCT04402866|79522302|FG000|Overall Study|Miscellaneous|0|||
44515743|NCT04402866|79522303|FG001|Overall Study|Miscellaneous|0|||
44515744|NCT04402866|79522304|FG002|Overall Study|Miscellaneous|1|||
44515745|NCT04402866|79522305|FG003|Overall Study|Miscellaneous|0|||
44515746|NCT04402866|79522306|FG004|Overall Study|Miscellaneous|0|||
44515747|NCT04402866|79522307|FG005|Overall Study|Miscellaneous|0|||
44515748|NCT04402866|79522302|FG000|Overall Study|Lost to Follow-up|0|||
44515749|NCT04402866|79522303|FG001|Overall Study|Lost to Follow-up|0|||
44515750|NCT04402866|79522304|FG002|Overall Study|Lost to Follow-up|0|||
44515751|NCT04402866|79522305|FG003|Overall Study|Lost to Follow-up|0|||
44515752|NCT04402866|79522306|FG004|Overall Study|Lost to Follow-up|0|||
44515753|NCT04402866|79522307|FG005|Overall Study|Lost to Follow-up|1|||
44249975|NCT00086281|79084191|FG013|Phase 1|Serious Adverse Event|0|||
44515754|NCT04402866|79522302|FG000|Overall Study|Withdrawal by Subject|0|||
44515755|NCT04402866|79522303|FG001|Overall Study|Withdrawal by Subject|0|||
44515756|NCT04402866|79522304|FG002|Overall Study|Withdrawal by Subject|0|||
44515757|NCT04402866|79522305|FG003|Overall Study|Withdrawal by Subject|0|||
44515758|NCT04402866|79522306|FG004|Overall Study|Withdrawal by Subject|0|||
44515759|NCT04402866|79522307|FG005|Overall Study|Withdrawal by Subject|2|||
44515760|NCT04400682|79522319|FG000|Period 1|Withdrawal by Subject|1|||
44515761|NCT04400682|79522320|FG001|Period 1|Withdrawal by Subject|4|||
44515762|NCT03066778|79522328|FG000|Overall Study|Death|195|||
44515763|NCT03066778|79522329|FG001|Overall Study|Death|205|||
44515764|NCT03066778|79522328|FG000|Overall Study|Withdrawal by Subject|5|||
44515765|NCT03066778|79522329|FG001|Overall Study|Withdrawal by Subject|7|||
44515766|NCT04348656|79522338|FG000|Overall Study|Withdrawal by Subject|2|||
44515767|NCT04348656|79522339|FG001|Overall Study|Withdrawal by Subject|0|||
44515768|NCT04348656|79522338|FG000|Overall Study|Lost to Follow-up|11|||
44515769|NCT04348656|79522339|FG001|Overall Study|Lost to Follow-up|6|||
44515770|NCT04347954|79522355|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
44515771|NCT04347954|79522356|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
44515772|NCT04347954|79522357|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
44515773|NCT04347954|79522355|FG000|Overall Study|Lost to Follow-up|0|||
44515774|NCT04347954|79522356|FG001|Overall Study|Lost to Follow-up|1|||
44515775|NCT04347954|79522357|FG002|Overall Study|Lost to Follow-up|0|||
44515776|NCT03065530|79522369|FG000|Overall Study|Lack of Efficacy|1|||
44515777|NCT03065530|79522370|FG001|Overall Study|Lack of Efficacy|1|||
44515778|NCT03065530|79522371|FG002|Overall Study|Lack of Efficacy|0|||
44515779|NCT03065530|79522372|FG003|Overall Study|Lack of Efficacy|1|||
44515780|NCT03065530|79522369|FG000|Overall Study|Protocol Violation|1|||
44515781|NCT03065530|79522370|FG001|Overall Study|Protocol Violation|0|||
44515782|NCT03065530|79522371|FG002|Overall Study|Protocol Violation|1|||
44515783|NCT03065530|79522372|FG003|Overall Study|Protocol Violation|1|||
44515784|NCT03979820|79522394|FG000|Overall Study|Protocol Violation|1|||
44515785|NCT03979820|79522395|FG001|Overall Study|Protocol Violation|0|||
44354541|NCT01195662|79358975|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
44382428|NCT00808210|79388377|FG001|Double-Blind TX Period|Adverse Event|1|||
44382429|NCT00808210|79388376|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
44382430|NCT00808210|79388377|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
44382431|NCT00808210|79388376|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
44382432|NCT00808210|79388377|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
44382433|NCT00808210|79388376|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
44382434|NCT00808210|79388377|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
44515786|NCT03979820|79522396|FG002|Overall Study|Protocol Violation|0|||
44515787|NCT03979820|79522397|FG003|Overall Study|Protocol Violation|0|||
44515788|NCT03979820|79522394|FG000|Overall Study|Withdrawal by Subject|0|||
44515789|NCT03979820|79522395|FG001|Overall Study|Withdrawal by Subject|0|||
44515790|NCT03979820|79522396|FG002|Overall Study|Withdrawal by Subject|1|||
44515791|NCT03979820|79522397|FG003|Overall Study|Withdrawal by Subject|0|||
44515792|NCT03979820|79522394|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
44515793|NCT03979820|79522395|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
44515794|NCT03979820|79522396|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
44515795|NCT03979820|79522397|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
44515796|NCT03647488|79522414|FG000|Overall Study|Progressive disease|10|||
44515797|NCT03647488|79522415|FG001|Overall Study|Progressive disease|0|||
44277967|NCT02111850|79239036|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277968|NCT02111850|79239037|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277969|NCT02111850|79239038|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277970|NCT02111850|79239039|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
44277971|NCT02111850|79239040|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277972|NCT02111850|79239041|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277973|NCT02111850|79239042|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277974|NCT02111850|79239043|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277975|NCT02111850|79239044|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277976|NCT02111850|79239045|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
44277977|NCT02087904|79239075|FG000|Overall Study|Did Not Receive Study Drug|0|||
44277978|NCT02087904|79239076|FG001|Overall Study|Did Not Receive Study Drug|0|||
44277979|NCT02087904|79239077|FG002|Overall Study|Did Not Receive Study Drug|2|||
44277980|NCT02087904|79239078|FG003|Overall Study|Did Not Receive Study Drug|1|||
44277981|NCT02087904|79239075|FG000|Overall Study|Adverse Event|8|||
44277982|NCT02087904|79239076|FG001|Overall Study|Adverse Event|4|||
44277983|NCT02087904|79239077|FG002|Overall Study|Adverse Event|4|||
44277984|NCT02087904|79239078|FG003|Overall Study|Adverse Event|12|||
44277985|NCT02087904|79239075|FG000|Overall Study|Lack of Efficacy|3|||
44277986|NCT02087904|79239076|FG001|Overall Study|Lack of Efficacy|6|||
44277987|NCT02087904|79239077|FG002|Overall Study|Lack of Efficacy|3|||
44277988|NCT02087904|79239078|FG003|Overall Study|Lack of Efficacy|2|||
44277989|NCT02087904|79239075|FG000|Overall Study|Other|6|||
44277990|NCT02087904|79239076|FG001|Overall Study|Other|2|||
44277991|NCT02087904|79239077|FG002|Overall Study|Other|4|||
44277992|NCT02087904|79239078|FG003|Overall Study|Other|4|||
44277993|NCT02087904|79239075|FG000|Overall Study|Withdrawal by Subject|8|||
44277994|NCT02087904|79239076|FG001|Overall Study|Withdrawal by Subject|3|||
44277995|NCT02087904|79239077|FG002|Overall Study|Withdrawal by Subject|7|||
44277996|NCT02087904|79239078|FG003|Overall Study|Withdrawal by Subject|4|||
44277997|NCT02087904|79239075|FG000|Overall Study|Lost to Follow-up|0|||
44277998|NCT02087904|79239076|FG001|Overall Study|Lost to Follow-up|4|||
44277999|NCT02087904|79239077|FG002|Overall Study|Lost to Follow-up|2|||
44278000|NCT02087904|79239078|FG003|Overall Study|Lost to Follow-up|2|||
44278001|NCT02087670|79239090|FG000|Overall Study|Withdrawal by Subject|3|||
44278002|NCT02087670|79239091|FG001|Overall Study|Withdrawal by Subject|2|||
44278003|NCT02086968|79239099|FG000|Overall Study|Adverse Event|1|||
44278004|NCT02086968|79239100|FG001|Overall Study|Adverse Event|5|||
44278005|NCT02086968|79239099|FG000|Overall Study|Lost to Follow-up|2|||
44278006|NCT02086968|79239100|FG001|Overall Study|Lost to Follow-up|3|||
44278007|NCT02086968|79239099|FG000|Overall Study|Study drug received outside protocol|0|||
44278008|NCT02086968|79239100|FG001|Overall Study|Study drug received outside protocol|1|||
44515798|NCT03647488|79522416|FG002|Overall Study|Progressive disease|0|||
44515799|NCT03647488|79522414|FG000|Overall Study|Adverse Event|5|||
44515800|NCT03647488|79522415|FG001|Overall Study|Adverse Event|0|||
44515801|NCT03647488|79522416|FG002|Overall Study|Adverse Event|0|||
44515802|NCT03647488|79522414|FG000|Overall Study|Clinical progression|2|||
44515803|NCT03647488|79522415|FG001|Overall Study|Clinical progression|0|||
44515804|NCT03647488|79522416|FG002|Overall Study|Clinical progression|0|||
44515805|NCT03647488|79522414|FG000|Overall Study|Participant refused to take investigational product|1|||
44515806|NCT03647488|79522415|FG001|Overall Study|Participant refused to take investigational product|0|||
44515807|NCT03647488|79522416|FG002|Overall Study|Participant refused to take investigational product|0|||
44515808|NCT03693950|79522424|FG000|Overall Study|Withdrawal by Subject|1|||
44515809|NCT03693950|79522425|FG001|Overall Study|Withdrawal by Subject|0|||
44515810|NCT04110314|79522437|FG000|Overall Study|Did not meet inclusion criteria|35255|||
44515811|NCT04110314|79522438|FG001|Overall Study|Did not meet inclusion criteria|35104|||
44515812|NCT04110314|79522439|FG002|Overall Study|Did not meet inclusion criteria|35636|||
44515813|NCT04110314|79522440|FG003|Overall Study|Did not meet inclusion criteria|35135|||
44515814|NCT04110314|79522441|FG004|Overall Study|Did not meet inclusion criteria|35247|||
44515815|NCT04110314|79522442|FG005|Overall Study|Did not meet inclusion criteria|35727|||
44515816|NCT04098458|79522454|FG000|Overall Study|Death|1|||
44515817|NCT04098458|79522454|FG000|Overall Study|did not meet study inclusion criteria|3|||
44515818|NCT03447262|79522459|FG000|Overall Study|Adverse Event|7|||
44515819|NCT03447262|79522459|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
44515820|NCT03447262|79522459|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
44515821|NCT03447262|79522459|FG000|Overall Study|Death|2|||
44515822|NCT03447262|79522459|FG000|Overall Study|Study Termination by Sponsor|455|||
44515823|NCT03447262|79522459|FG000|Overall Study|Other|4|||
44515824|NCT04094870|79522468|FG000|Overall Study|Lost to Follow-up|1|||
44515825|NCT04094870|79522469|FG001|Overall Study|Lost to Follow-up|1|||
44515826|NCT04399356|79522484|FG000|Overall Study|Lost to Follow-up|1|||
44515827|NCT04399356|79522485|FG001|Overall Study|Lost to Follow-up|1|||
44515828|NCT04399356|79522484|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
44144502|NCT02130466|78934022|FG001|Overall Study|Physician Decision|0|||
44144503|NCT02130466|78934023|FG002|Overall Study|Physician Decision|0|||
44515829|NCT04399356|79522485|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
44515830|NCT04399356|79522484|FG000|Overall Study|Withdrawal by Subject|1|||
44515831|NCT04399356|79522485|FG001|Overall Study|Withdrawal by Subject|0|||
44144504|NCT02130466|78934024|FG003|Overall Study|Physician Decision|0|||
44249976|NCT00086281|79084192|FG014|Phase 1|Serious Adverse Event|1|||
44515832|NCT03692676|79522495|FG000|Overall Study|exclude patients with prior use|4424|||
44515833|NCT03692676|79522496|FG001|Overall Study|exclude patients with prior use|24726|||
44515834|NCT03692676|79522497|FG002|Overall Study|exclude patients with prior use|0|||
44515835|NCT03692676|79522498|FG003|Overall Study|exclude patients with prior use|0|||
44249977|NCT00086281|79084178|FG000|Phase 2|Adverse Event|0|||
44249978|NCT00086281|79084179|FG001|Phase 2|Adverse Event|0|||
44249979|NCT00086281|79084180|FG002|Phase 2|Adverse Event|0|||
44249980|NCT00086281|79084181|FG003|Phase 2|Adverse Event|0|||
44249981|NCT00086281|79084182|FG004|Phase 2|Adverse Event|0|||
44249982|NCT00086281|79084183|FG005|Phase 2|Adverse Event|0|||
44249983|NCT00086281|79084184|FG006|Phase 2|Adverse Event|0|||
44249984|NCT00086281|79084185|FG007|Phase 2|Adverse Event|0|||
44249985|NCT00086281|79084186|FG008|Phase 2|Adverse Event|0|||
44249986|NCT00086281|79084187|FG009|Phase 2|Adverse Event|0|||
44249987|NCT00086281|79084188|FG010|Phase 2|Adverse Event|0|||
44249988|NCT00086281|79084189|FG011|Phase 2|Adverse Event|0|||
44515836|NCT03692676|79522495|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
44515837|NCT03692676|79522496|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
44249989|NCT00086281|79084190|FG012|Phase 2|Adverse Event|1|||
44249990|NCT00086281|79084191|FG013|Phase 2|Adverse Event|1|||
44249991|NCT00086281|79084192|FG014|Phase 2|Adverse Event|0|||
44249992|NCT00086047|79084204|FG000|Overall Study|Lost to Follow-up|7|||
44249993|NCT00086047|79084205|FG001|Overall Study|Lost to Follow-up|6|||
44249994|NCT00086047|79084204|FG000|Overall Study|Physician Decision|0|||
44278009|NCT02086968|79239099|FG000|Overall Study|Physician Decision|4|||
44278010|NCT02086968|79239100|FG001|Overall Study|Physician Decision|0|||
44278011|NCT02086968|79239099|FG000|Overall Study|Withdrawal by Subject|1|||
44278012|NCT02086968|79239100|FG001|Overall Study|Withdrawal by Subject|4|||
44278013|NCT02086110|79239108|FG000|Overall Study|Withdrawal by Subject|1|||
44278014|NCT02086110|79239109|FG001|Overall Study|Withdrawal by Subject|1|||
44278015|NCT02085252|79239118|FG000|Overall Study|Withdrawal of Consent|1|||
44278016|NCT02085252|79239119|FG001|Overall Study|Withdrawal of Consent|0|||
44278017|NCT02085252|79239118|FG000|Overall Study|Adverse Event|0|||
44278018|NCT02085252|79239119|FG001|Overall Study|Adverse Event|1|||
44278019|NCT02085252|79239118|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
44278020|NCT02085252|79239119|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
44278021|NCT02085252|79239118|FG000|Overall Study|Reason Not Specified|0|||
44278022|NCT02085252|79239119|FG001|Overall Study|Reason Not Specified|1|||
44278023|NCT02085252|79239118|FG000|Overall Study|Reason Unknown|0|||
44278024|NCT02085252|79239119|FG001|Overall Study|Reason Unknown|1|||
44278025|NCT02084238|79239125|FG000|Overall Study|Lost to Follow-up|2|||
44278026|NCT02084082|79239138|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
44515838|NCT03692676|79522497|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
44515839|NCT03692676|79522498|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
44515840|NCT03692676|79522495|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
44515841|NCT03692676|79522496|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
44515842|NCT03692676|79522497|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
44515843|NCT03692676|79522498|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
44515844|NCT03692676|79522495|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
44515845|NCT03692676|79522496|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
44515846|NCT03692676|79522497|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
44515847|NCT03692676|79522498|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
44515848|NCT03692676|79522495|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
44515849|NCT03692676|79522496|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
44515850|NCT03692676|79522497|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
44515851|NCT03692676|79522498|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
44515852|NCT03692676|79522495|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
44515853|NCT03692676|79522496|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
44515854|NCT03692676|79522497|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
44249995|NCT00086047|79084205|FG001|Overall Study|Physician Decision|1|||
44249996|NCT01478828|79084217|FG000|Overall Study|Adverse Event|1|||
44249997|NCT00085423|79084222|FG000|Overall Study|Withdrawal by Subject|1|||
44249998|NCT00085423|79084222|FG000|Overall Study|screen failure|1|||
44249999|NCT00084487|79084226|FG000|Overall Study|Death|1|||
44250000|NCT01425281|79084266|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
44250001|NCT01425281|79084267|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
44250002|NCT01425281|79084266|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
44278027|NCT02084082|79239139|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
44278028|NCT02084082|79239140|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
44278029|NCT02084082|79239141|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
44515855|NCT03692676|79522498|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
44515856|NCT03692676|79522495|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
44515857|NCT03692676|79522496|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
44515858|NCT03692676|79522497|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
44515859|NCT03692676|79522498|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
44515860|NCT03692676|79522495|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
44515861|NCT03692676|79522496|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
44515862|NCT03692676|79522497|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
44515863|NCT03692676|79522498|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
44515864|NCT03692676|79522495|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
44515865|NCT03692676|79522496|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
44515866|NCT03692676|79522497|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
44515867|NCT03692676|79522498|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
44515868|NCT03692676|79522495|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
44515869|NCT03692676|79522496|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
44515870|NCT03692676|79522497|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
44515871|NCT03692676|79522498|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
44515872|NCT03692676|79522495|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
44515873|NCT03692676|79522496|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
44515874|NCT03692676|79522497|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
44515875|NCT03692676|79522498|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
44515876|NCT03692676|79522495|FG000|Overall Study|Other|0|||
44515877|NCT03692676|79522496|FG001|Overall Study|Other|805|||
44515878|NCT03692676|79522497|FG002|Overall Study|Other|758|||
44515879|NCT03692676|79522498|FG003|Overall Study|Other|277|||
44515880|NCT03692676|79522495|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
44515881|NCT03692676|79522496|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
44515882|NCT03692676|79522497|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
44515883|NCT03692676|79522498|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
44515884|NCT04122534|79522508|FG000|Overall Study|Lost to Follow-up|4|||
44515885|NCT04091360|79522518|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515886|NCT04091360|79522519|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515887|NCT04091360|79522520|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515888|NCT04091360|79522521|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515889|NCT04091360|79522522|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515890|NCT04091360|79522523|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515891|NCT04091360|79522524|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44250003|NCT01425281|79084267|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
44250004|NCT01425281|79084266|FG000|At 180-day Clinical Follow-up|Death|0|||
44515892|NCT04091360|79522525|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
44515893|NCT04091360|79522526|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
44515894|NCT04091360|79522527|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
44515895|NCT04091360|79522518|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515896|NCT04091360|79522519|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515897|NCT04091360|79522520|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515898|NCT04091360|79522521|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515899|NCT04091360|79522522|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515900|NCT04091360|79522523|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515901|NCT04091360|79522524|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
44515902|NCT04091360|79522525|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
44515903|NCT04091360|79522526|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515904|NCT04091360|79522527|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
44515905|NCT04091360|79522518|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515906|NCT04091360|79522519|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515907|NCT04091360|79522520|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515908|NCT04091360|79522521|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515909|NCT04091360|79522522|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515910|NCT04091360|79522523|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515911|NCT04091360|79522524|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
44515912|NCT04091360|79522525|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515913|NCT04091360|79522526|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
44515914|NCT04091360|79522527|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
44515915|NCT04346628|79522551|FG000|Overall Study|Lost to Follow-up|4|||
44515916|NCT04346628|79522552|FG001|Overall Study|Lost to Follow-up|4|||
44515917|NCT04346628|79522551|FG000|Overall Study|Withdrew (had personal reasons)|2|||
44515918|NCT04346628|79522552|FG001|Overall Study|Withdrew (had personal reasons)|5|||
44515919|NCT04346628|79522551|FG000|Overall Study|Withdrew (medication intolerant)|0|||
44515920|NCT04346628|79522552|FG001|Overall Study|Withdrew (medication intolerant)|3|||
44515921|NCT04346628|79522551|FG000|Overall Study|Withdrew (declined intervention)|0|||
44515922|NCT04346628|79522552|FG001|Overall Study|Withdrew (declined intervention)|1|||
44278030|NCT02084082|79239138|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
44278031|NCT02084082|79239139|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
44278032|NCT02084082|79239140|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
44278033|NCT02084082|79239141|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
44278034|NCT02083926|79239153|FG000|Overall Study|Withdrawal by Subject|1|||
44515923|NCT03681470|79522558|FG000|Overall Study|Lack of Efficacy|3|||
44515924|NCT03681470|79522558|FG000|Overall Study|Lost to Follow-up|1|||
44515925|NCT03681470|79522558|FG000|Overall Study|Protocol Violation|3|||
44515926|NCT03681470|79522558|FG000|Overall Study|Withdrawal by Subject|1|||
44515927|NCT04343976|79522564|FG000|Overall Study|Withdrawal by Subject|0|||
44515928|NCT04343976|79522565|FG001|Overall Study|Withdrawal by Subject|1|||
44515929|NCT03322540|79522573|FG000|Overall Study|Death|21|||
44515930|NCT03322540|79522574|FG001|Overall Study|Death|28|||
44278035|NCT02083926|79239154|FG001|Overall Study|Withdrawal by Subject|0|||
44278036|NCT02083380|79239164|FG000|Overall Study|Lack of Efficacy|68|||
44278037|NCT02083380|79239165|FG001|Overall Study|Lack of Efficacy|79|||
44278038|NCT02083380|79239166|FG002|Overall Study|Lack of Efficacy|64|||
44278039|NCT02083380|79239164|FG000|Overall Study|Withdrawal by Subject|9|||
44278040|NCT02083380|79239165|FG001|Overall Study|Withdrawal by Subject|3|||
44278041|NCT02083380|79239166|FG002|Overall Study|Withdrawal by Subject|7|||
44278042|NCT02083380|79239164|FG000|Overall Study|Physician Decision|1|||
44515931|NCT03322540|79522573|FG000|Overall Study|Lost to Follow-up|0|||
44515932|NCT03322540|79522574|FG001|Overall Study|Lost to Follow-up|1|||
44515933|NCT03322540|79522573|FG000|Overall Study|Physician Decision|7|||
44515934|NCT03322540|79522574|FG001|Overall Study|Physician Decision|6|||
44515935|NCT03322540|79522573|FG000|Overall Study|Withdrawal by Subject|3|||
44278043|NCT02083380|79239165|FG001|Overall Study|Physician Decision|6|||
44278044|NCT02083380|79239166|FG002|Overall Study|Physician Decision|3|||
44278045|NCT02083380|79239164|FG000|Overall Study|Adverse Event|0|||
44515936|NCT03322540|79522574|FG001|Overall Study|Withdrawal by Subject|1|||
44515937|NCT03322540|79522573|FG000|Overall Study|Study terminated by sponsor|0|||
44515938|NCT03322540|79522574|FG001|Overall Study|Study terminated by sponsor|1|||
44515939|NCT04339296|79522584|FG000|Overall Study|Refuse to participate after allocation|1|||
44515940|NCT04339296|79522585|FG001|Overall Study|Refuse to participate after allocation|1|||
44515941|NCT04339296|79522584|FG000|Overall Study|Withdrew after completion of baseline|2|||
44515942|NCT04339296|79522585|FG001|Overall Study|Withdrew after completion of baseline|1|||
44515943|NCT04339296|79522584|FG000|Overall Study|Lost to Follow-up|0|||
44515944|NCT04339296|79522585|FG001|Overall Study|Lost to Follow-up|4|||
44515945|NCT04339296|79522584|FG000|Overall Study|Discontinued intervention|5|||
44515946|NCT04339296|79522585|FG001|Overall Study|Discontinued intervention|3|||
44515947|NCT02025556|79522594|FG000|Overall Study|Adverse Event|0|||
44515948|NCT02025556|79522595|FG001|Overall Study|Adverse Event|4|||
44515949|NCT02025556|79522596|FG002|Overall Study|Adverse Event|2|||
44515950|NCT02025556|79522594|FG000|Overall Study|Lack of Efficacy|2|||
44515951|NCT02025556|79522595|FG001|Overall Study|Lack of Efficacy|1|||
44515952|NCT02025556|79522596|FG002|Overall Study|Lack of Efficacy|0|||
44515953|NCT02025556|79522594|FG000|Overall Study|Protocol Violation|2|||
44515954|NCT02025556|79522595|FG001|Overall Study|Protocol Violation|1|||
44515955|NCT02025556|79522596|FG002|Overall Study|Protocol Violation|0|||
44515956|NCT02025556|79522594|FG000|Overall Study|Withdrawal by Subject|0|||
44515957|NCT02025556|79522595|FG001|Overall Study|Withdrawal by Subject|3|||
44515958|NCT02025556|79522596|FG002|Overall Study|Withdrawal by Subject|6|||
44515959|NCT02025556|79522594|FG000|Overall Study|Lost to Follow-up|2|||
44515960|NCT02025556|79522595|FG001|Overall Study|Lost to Follow-up|4|||
44515961|NCT02025556|79522596|FG002|Overall Study|Lost to Follow-up|0|||
44515962|NCT02025556|79522594|FG000|Overall Study|Reason not reported|0|||
44515963|NCT02025556|79522595|FG001|Overall Study|Reason not reported|0|||
44515964|NCT02025556|79522596|FG002|Overall Study|Reason not reported|1|||
44515965|NCT04334460|79522606|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
44515966|NCT04334460|79522607|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
44515967|NCT04334460|79522606|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
44515968|NCT04334460|79522607|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
44515969|NCT04334148|79522616|FG000|Overall Study|positive nasal swab at baseline|0|||
44515970|NCT04334148|79522617|FG001|Overall Study|positive nasal swab at baseline|1|||
44515971|NCT04399122|79522625|FG000|Overall Study|Lost to Follow-up|2|||
44515972|NCT04399122|79522626|FG001|Overall Study|Lost to Follow-up|0|||
44515973|NCT04399122|79522625|FG000|Overall Study|Withdrawal by Subject|1|||
44515974|NCT04399122|79522626|FG001|Overall Study|Withdrawal by Subject|0|||
44515975|NCT04398732|79522647|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
44515976|NCT04398030|79522653|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
44515977|NCT04398030|79522654|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
44515978|NCT04398030|79522653|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
44515979|NCT04398030|79522654|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
44515980|NCT03064438|79522662|FG000|Overall Study|Lost to Follow-up|1|||
44515981|NCT03064438|79522663|FG001|Overall Study|Lost to Follow-up|0|||
44515982|NCT03064438|79522662|FG000|Overall Study|Withdrawal by Subject|0|||
44515983|NCT03064438|79522663|FG001|Overall Study|Withdrawal by Subject|1|||
44515984|NCT04327986|79522669|FG000|Overall Study|Physician Decision|2|||
44515985|NCT04327986|79522670|FG001|Overall Study|Physician Decision|0|||
44515986|NCT04327986|79522671|FG002|Overall Study|Physician Decision|0|||
44515987|NCT04327986|79522669|FG000|Overall Study|Death|1|||
44515988|NCT04327986|79522670|FG001|Overall Study|Death|0|||
44515989|NCT04327986|79522671|FG002|Overall Study|Death|0|||
44515990|NCT04322682|79522677|FG000|Overall Study|Withdrawal by Subject|33|||
44515991|NCT04322682|79522678|FG001|Overall Study|Withdrawal by Subject|47|||
44515992|NCT04322682|79522677|FG000|Overall Study|Death|5|||
44144505|NCT02130466|78934025|FG004|Overall Study|Physician Decision|0|||
44144506|NCT02130466|78934026|FG005|Overall Study|Physician Decision|1|||
44278046|NCT02083380|79239165|FG001|Overall Study|Adverse Event|0|||
44278047|NCT02083380|79239166|FG002|Overall Study|Adverse Event|1|||
44278048|NCT02083380|79239164|FG000|Overall Study|Lost to Follow-up|5|||
44278049|NCT02083380|79239165|FG001|Overall Study|Lost to Follow-up|3|||
44278050|NCT02083380|79239166|FG002|Overall Study|Lost to Follow-up|3|||
44278051|NCT02083380|79239164|FG000|Overall Study|Other|8|||
44278052|NCT02083380|79239165|FG001|Overall Study|Other|4|||
44515993|NCT04322682|79522678|FG001|Overall Study|Death|9|||
44515994|NCT04322682|79522677|FG000|Overall Study|Lost to Follow-up|4|||
44515995|NCT04322682|79522678|FG001|Overall Study|Lost to Follow-up|8|||
44515996|NCT04322682|79522677|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
44515997|NCT04322682|79522678|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
44515998|NCT04322526|79522686|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
44515999|NCT04322526|79522687|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
44278053|NCT02083380|79239166|FG002|Overall Study|Other|6|||
44278054|NCT02109744|79239181|FG000|Overall Study|Death|1|||
44516000|NCT04322526|79522686|FG000|Washout (1 Week)|Lost to Follow-up|1|||
44516001|NCT04322526|79522687|FG001|Washout (1 Week)|Lost to Follow-up|2|||
44516002|NCT04115358|79522696|FG000|Overall Study|exfoliation|0|||
44516003|NCT04115358|79522697|FG001|Overall Study|exfoliation|0|||
44516004|NCT04115358|79522698|FG002|Overall Study|exfoliation|1|||
44516005|NCT04109118|79522707|FG000|Overall Study|Lost to Follow-up|3|||
44516006|NCT04105998|79522714|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
44516007|NCT04105998|79522715|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
44516008|NCT04397718|79522723|FG000|Overall Study|Death|7|||
44516009|NCT04397718|79522724|FG001|Overall Study|Death|11|||
44516010|NCT04397718|79522723|FG000|Overall Study|Lost to Follow-up|0|||
44516011|NCT04397718|79522724|FG001|Overall Study|Lost to Follow-up|4|||
44516012|NCT04105218|79522732|FG000|Overall Study|Withdrawal by Subject|3|||
44516013|NCT04105218|79522733|FG001|Overall Study|Withdrawal by Subject|2|||
44516014|NCT04105218|79522732|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
44516015|NCT04105218|79522733|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
44516016|NCT04105218|79522732|FG000|Overall Study|Failed screening tests|2|||
44516017|NCT04105218|79522733|FG001|Overall Study|Failed screening tests|1|||
44516018|NCT04317690|79522744|FG000|Overall Study|did not have complete information for primary outcome|0|||
44516019|NCT04317690|79522745|FG001|Overall Study|did not have complete information for primary outcome|4|||
44516020|NCT04317690|79522746|FG002|Overall Study|did not have complete information for primary outcome|0|||
44516021|NCT04317690|79522747|FG003|Overall Study|did not have complete information for primary outcome|2|||
44516022|NCT04317690|79522748|FG004|Overall Study|did not have complete information for primary outcome|0|||
44516023|NCT03721276|79522775|FG000|Overall Study|Lost to Follow-up|5|||
44516024|NCT03721276|79522776|FG001|Overall Study|Lost to Follow-up|3|||
44516025|NCT03721276|79522775|FG000|Overall Study|Adverse Event|0|||
44516026|NCT03721276|79522776|FG001|Overall Study|Adverse Event|1|||
44516027|NCT03269344|79522791|FG000|Overall Study|Protocol Violation|4|||
44516028|NCT03269344|79522792|FG001|Overall Study|Protocol Violation|3|||
44516029|NCT04389840|79522804|FG000|Overall Study|Adverse Event|0|||
44516030|NCT04389840|79522805|FG001|Overall Study|Adverse Event|0|||
44516031|NCT04389840|79522806|FG002|Overall Study|Adverse Event|0|||
44516032|NCT04389840|79522807|FG003|Overall Study|Adverse Event|1|||
44516033|NCT04389840|79522808|FG004|Overall Study|Adverse Event|0|||
44516034|NCT04389840|79522809|FG005|Overall Study|Adverse Event|0|||
44516035|NCT04389840|79522804|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
44516036|NCT04389840|79522805|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
44516037|NCT04389840|79522806|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
44516038|NCT04389840|79522807|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
44516039|NCT04389840|79522808|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
44516040|NCT04389840|79522809|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
44516041|NCT04389840|79522804|FG000|Overall Study|Death|0|||
44516042|NCT04389840|79522805|FG001|Overall Study|Death|1|||
44516043|NCT04389840|79522806|FG002|Overall Study|Death|0|||
44516044|NCT04389840|79522807|FG003|Overall Study|Death|0|||
44516045|NCT04389840|79522808|FG004|Overall Study|Death|0|||
44516046|NCT04389840|79522809|FG005|Overall Study|Death|0|||
44516047|NCT04307940|79522832|FG000|Overall Study|Adverse Event|1|||
44516048|NCT04307940|79522833|FG001|Overall Study|Adverse Event|0|||
44516049|NCT04307940|79522834|FG002|Overall Study|Adverse Event|0|||
44516050|NCT04307940|79522832|FG000|Overall Study|Withdrawal by Subject|2|||
44516051|NCT04307940|79522833|FG001|Overall Study|Withdrawal by Subject|3|||
44516052|NCT04307940|79522834|FG002|Overall Study|Withdrawal by Subject|1|||
44516053|NCT04307940|79522832|FG000|Overall Study|Lost to Follow-up|2|||
44516054|NCT04307940|79522833|FG001|Overall Study|Lost to Follow-up|0|||
44516055|NCT04307940|79522834|FG002|Overall Study|Lost to Follow-up|1|||
44516056|NCT02054104|79522844|FG000|Overall Study|Did not want to continue due to college classes|1|||
44516057|NCT02054104|79522845|FG001|Overall Study|Did not want to continue due to college classes|0|||
44516058|NCT02054104|79522844|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
44278055|NCT02109744|79239182|FG001|Overall Study|Death|1|||
44516059|NCT02054104|79522845|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
44516060|NCT02054104|79522844|FG000|Overall Study|No evidence of immunologic response|2|||
44516061|NCT02054104|79522845|FG001|Overall Study|No evidence of immunologic response|2|||
44516062|NCT02054104|79522844|FG000|Overall Study|Disease Progression On Study|4|||
44278056|NCT02109744|79239181|FG000|Overall Study|no marrow exam|1|||
44516063|NCT02054104|79522845|FG001|Overall Study|Disease Progression On Study|5|||
44516064|NCT02054104|79522844|FG000|Overall Study|Diagnosis of lymphoma|0|||
44516065|NCT02054104|79522845|FG001|Overall Study|Diagnosis of lymphoma|1|||
44516066|NCT02054104|79522844|FG000|Overall Study|Inconclusive response|0|||
44516067|NCT02054104|79522845|FG001|Overall Study|Inconclusive response|1|||
44516068|NCT04090242|79522853|FG000|Overall Study|Withdrawal by Subject|1|||
44516069|NCT04090242|79522854|FG001|Overall Study|Withdrawal by Subject|0|||
44516070|NCT04090164|79522863|FG000|Overall Study|incomplete data on file|245|||
44516071|NCT04090164|79522864|FG001|Overall Study|incomplete data on file|0|||
44516072|NCT04292730|79522884|FG000|Overall Study|Lost to Follow-up|8|||
44516073|NCT04292730|79522885|FG001|Overall Study|Lost to Follow-up|12|||
44516074|NCT04292730|79522886|FG002|Overall Study|Lost to Follow-up|12|||
44516075|NCT04292730|79522887|FG003|Overall Study|Lost to Follow-up|48|||
44516076|NCT04292730|79522884|FG000|Overall Study|Death|2|||
44516077|NCT04292730|79522885|FG001|Overall Study|Death|2|||
44516078|NCT04292730|79522886|FG002|Overall Study|Death|4|||
44516079|NCT04292730|79522887|FG003|Overall Study|Death|12|||
44516080|NCT04292730|79522884|FG000|Overall Study|Withdrew Consent|2|||
44516081|NCT04292730|79522885|FG001|Overall Study|Withdrew Consent|2|||
44516082|NCT04292730|79522886|FG002|Overall Study|Withdrew Consent|5|||
44516083|NCT04292730|79522887|FG003|Overall Study|Withdrew Consent|6|||
44516084|NCT04292730|79522884|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44516085|NCT04292730|79522885|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44516086|NCT04292730|79522886|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44516087|NCT04292730|79522887|FG003|Overall Study|Non-Compliance with Study Drug|0|||
44516088|NCT04292730|79522884|FG000|Overall Study|Protocol Violation|0|||
44516089|NCT04292730|79522885|FG001|Overall Study|Protocol Violation|0|||
44516090|NCT04292730|79522886|FG002|Overall Study|Protocol Violation|1|||
44516091|NCT04292730|79522887|FG003|Overall Study|Protocol Violation|0|||
44516092|NCT04292730|79522884|FG000|Overall Study|Randomized but not Treated|8|||
44516093|NCT04292730|79522885|FG001|Overall Study|Randomized but not Treated|4|||
44516094|NCT04292730|79522886|FG002|Overall Study|Randomized but not Treated|0|||
44516095|NCT04292730|79522887|FG003|Overall Study|Randomized but not Treated|14|||
44516096|NCT02861014|79522896|FG000|Primary Analysis|Adverse Event|7|||
44516097|NCT02861014|79522896|FG000|Primary Analysis|Death|1|||
44516098|NCT02861014|79522896|FG000|Primary Analysis|Lack of Efficacy|3|||
44516099|NCT02861014|79522896|FG000|Primary Analysis|Physician Decision|2|||
44516100|NCT02861014|79522896|FG000|Primary Analysis|Pregnancy|4|||
44516101|NCT02861014|79522896|FG000|Primary Analysis|Protocol Violation|2|||
44516102|NCT02861014|79522896|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
44516103|NCT02861014|79522896|FG000|Primary Analysis|Withdrawal by Subject|14|||
44516104|NCT02861014|79522896|FG000|Primary Analysis|Commercial ocrelizumab|3|||
44516105|NCT02861014|79522896|FG000|Safety Follow-up|Adverse Event|1|||
44516106|NCT02861014|79522896|FG000|Safety Follow-up|Pregnancy|1|||
44516107|NCT02861014|79522896|FG000|Safety Follow-up|Withdrawal by Subject|9|||
44516108|NCT02861014|79522896|FG000|Safety Follow-up|Study terminated by sponsor|1|||
44516109|NCT02861014|79522896|FG000|Safety Follow-up|Physician Decision|1|||
44382435|NCT00736099|79388385|FG000|Overall Study|Adverse Event|61|||
44382436|NCT00736099|79388386|FG001|Overall Study|Adverse Event|18|||
44382437|NCT00736099|79388385|FG000|Overall Study|Protocol Violation|10|||
44382438|NCT00736099|79388386|FG001|Overall Study|Protocol Violation|4|||
44382439|NCT00736099|79388385|FG000|Overall Study|Lost to Follow-up|12|||
44382440|NCT00736099|79388386|FG001|Overall Study|Lost to Follow-up|5|||
44382441|NCT00736099|79388385|FG000|Overall Study|Withdrawal by Subject|42|||
44382442|NCT00736099|79388386|FG001|Overall Study|Withdrawal by Subject|13|||
44382443|NCT00736099|79388385|FG000|Overall Study|Lack of Efficacy|15|||
44382444|NCT00736099|79388386|FG001|Overall Study|Lack of Efficacy|8|||
44382445|NCT00736099|79388385|FG000|Overall Study|Other reason|43|||
44382446|NCT00736099|79388386|FG001|Overall Study|Other reason|10|||
44516110|NCT02861014|79522896|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
44516111|NCT02861014|79522896|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
44516112|NCT04382586|79522904|FG000|Overall Study|Death|3|||
44516113|NCT04382586|79522905|FG001|Overall Study|Death|4|||
44516114|NCT04382586|79522904|FG000|Overall Study|Lost to Follow-up|11|||
44516115|NCT04382586|79522905|FG001|Overall Study|Lost to Follow-up|8|||
44516116|NCT04382586|79522904|FG000|Overall Study|Withdrawal by Subject|3|||
44516117|NCT04382586|79522905|FG001|Overall Study|Withdrawal by Subject|1|||
44516118|NCT04382586|79522904|FG000|Overall Study|Physician Decision|0|||
44516119|NCT04382586|79522905|FG001|Overall Study|Physician Decision|3|||
44516120|NCT04480710|79522915|FG000|Overall Study|Adverse Event|0|||
44382447|NCT00735943|79388392|FG000|Overall Study|Lost to Follow-up|1|||
44382448|NCT00735943|79388392|FG000|Overall Study|Adverse Event|1|||
44516121|NCT04480710|79522916|FG001|Overall Study|Adverse Event|2|||
44516122|NCT04480710|79522917|FG002|Overall Study|Adverse Event|0|||
44382449|NCT00735709|79388400|FG000|Overall Study|Adverse Event|2|||
44382450|NCT00735709|79388401|FG001|Overall Study|Adverse Event|3|||
44382451|NCT00735709|79388402|FG002|Overall Study|Adverse Event|1|||
44516123|NCT04480710|79522918|FG003|Overall Study|Adverse Event|0|||
44516124|NCT04480710|79522915|FG000|Overall Study|Withdrawal by Subject|0|||
44516125|NCT04480710|79522916|FG001|Overall Study|Withdrawal by Subject|1|||
44516126|NCT04480710|79522917|FG002|Overall Study|Withdrawal by Subject|0|||
44516127|NCT04480710|79522918|FG003|Overall Study|Withdrawal by Subject|0|||
44516128|NCT04480710|79522915|FG000|Overall Study|Physician Decision|0|||
44516129|NCT04480710|79522916|FG001|Overall Study|Physician Decision|0|||
44516130|NCT04480710|79522917|FG002|Overall Study|Physician Decision|1|||
44516131|NCT04480710|79522918|FG003|Overall Study|Physician Decision|0|||
44516132|NCT04268316|79522937|FG000|Overall Study|Withdrawal by Subject|2|||
44516133|NCT04268316|79522938|FG001|Overall Study|Withdrawal by Subject|1|||
44516134|NCT04268316|79522939|FG002|Overall Study|Withdrawal by Subject|0|||
44516135|NCT01971970|79522949|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
44516136|NCT01971970|79522950|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
44516137|NCT01971970|79522949|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
44516138|NCT01971970|79522950|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
44516139|NCT01971970|79522949|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
44516140|NCT01971970|79522950|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
44516141|NCT01971970|79522949|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
44250005|NCT01425281|79084267|FG001|At 180-day Clinical Follow-up|Death|1|||
44250006|NCT01425281|79084266|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
44250007|NCT01425281|79084267|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
44250008|NCT01425281|79084266|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
44250009|NCT01425281|79084267|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
44250010|NCT01425281|79084266|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
44250011|NCT01425281|79084267|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
44250012|NCT01425281|79084266|FG000|At 2-year Clinical Follow-up|Death|2|||
44250013|NCT01425281|79084267|FG001|At 2-year Clinical Follow-up|Death|0|||
44250014|NCT01425281|79084266|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
44250015|NCT01425281|79084267|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
44278057|NCT02109744|79239182|FG001|Overall Study|no marrow exam|0|||
44278058|NCT02109432|79239188|FG000|Overall Study|Withdrawal by Subject|1|||
44278059|NCT02109042|79239192|FG000|Overall Study|Sponsor Decision|15|||
44278060|NCT02066922|79239197|FG000|Overall Study|Adverse Event|1|||
44278061|NCT02108262|79239208|FG000|Overall Study|Non-compliance|0|||
44278062|NCT02108262|79239209|FG001|Overall Study|Non-compliance|2|||
44278063|NCT02108262|79239210|FG002|Overall Study|Non-compliance|1|||
44278064|NCT02108262|79239211|FG003|Overall Study|Non-compliance|1|||
44278065|NCT02108262|79239208|FG000|Overall Study|Randomized by error/screen failure|0|||
44278066|NCT02108262|79239209|FG001|Overall Study|Randomized by error/screen failure|0|||
44278067|NCT02108262|79239210|FG002|Overall Study|Randomized by error/screen failure|1|||
44278068|NCT02108262|79239211|FG003|Overall Study|Randomized by error/screen failure|0|||
44278069|NCT02108262|79239208|FG000|Overall Study|Distance to center|0|||
44278070|NCT02108262|79239209|FG001|Overall Study|Distance to center|1|||
44278071|NCT02108262|79239210|FG002|Overall Study|Distance to center|1|||
44278072|NCT02108262|79239211|FG003|Overall Study|Distance to center|0|||
44278073|NCT02108262|79239208|FG000|Overall Study|Adverse Event|0|||
44278074|NCT02108262|79239209|FG001|Overall Study|Adverse Event|11|||
44278075|NCT02108262|79239210|FG002|Overall Study|Adverse Event|6|||
44278076|NCT02108262|79239211|FG003|Overall Study|Adverse Event|12|||
44278077|NCT02108262|79239208|FG000|Overall Study|Death|0|||
44278078|NCT02108262|79239209|FG001|Overall Study|Death|2|||
44278079|NCT02108262|79239210|FG002|Overall Study|Death|2|||
44278080|NCT02108262|79239211|FG003|Overall Study|Death|1|||
44278081|NCT02108262|79239208|FG000|Overall Study|Lost to Follow-up|0|||
44278082|NCT02108262|79239209|FG001|Overall Study|Lost to Follow-up|0|||
44278083|NCT02108262|79239210|FG002|Overall Study|Lost to Follow-up|1|||
44382452|NCT00735709|79388403|FG003|Overall Study|Adverse Event|5|||
44382453|NCT00735709|79388400|FG000|Overall Study|Lack of Efficacy|8|||
44516142|NCT01971970|79522950|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
44382454|NCT00735709|79388401|FG001|Overall Study|Lack of Efficacy|4|||
44382455|NCT00735709|79388402|FG002|Overall Study|Lack of Efficacy|2|||
44382456|NCT00735709|79388403|FG003|Overall Study|Lack of Efficacy|3|||
44382457|NCT00735709|79388400|FG000|Overall Study|Noncompliance|0|||
44382458|NCT00735709|79388401|FG001|Overall Study|Noncompliance|0|||
44382459|NCT00735709|79388402|FG002|Overall Study|Noncompliance|1|||
44382460|NCT00735709|79388403|FG003|Overall Study|Noncompliance|0|||
44382461|NCT00735709|79388400|FG000|Overall Study|Protocol deviations|1|||
44516143|NCT01971970|79522949|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
44382462|NCT00735709|79388401|FG001|Overall Study|Protocol deviations|2|||
44516144|NCT01971970|79522950|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
44516145|NCT01971970|79522949|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
44144507|NCT02130466|78934027|FG006|Overall Study|Physician Decision|1|||
44250016|NCT01425281|79084266|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
44278084|NCT02108262|79239211|FG003|Overall Study|Lost to Follow-up|0|||
44382463|NCT00735709|79388402|FG002|Overall Study|Protocol deviations|1|||
44278085|NCT02108262|79239208|FG000|Overall Study|Physician Decision|0|||
44278086|NCT02108262|79239209|FG001|Overall Study|Physician Decision|0|||
44278087|NCT02108262|79239210|FG002|Overall Study|Physician Decision|2|||
44278088|NCT02108262|79239211|FG003|Overall Study|Physician Decision|0|||
44382464|NCT00735709|79388403|FG003|Overall Study|Protocol deviations|1|||
44516146|NCT01971970|79522950|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
44516147|NCT01971970|79522949|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
44516148|NCT01971970|79522950|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
44516149|NCT04079790|79522965|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
44516150|NCT04079790|79522966|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
44516151|NCT04079790|79522967|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
44516152|NCT04079790|79522968|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
44516153|NCT04079790|79522965|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
44250017|NCT01425281|79084267|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
44250018|NCT01425281|79084266|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
44250019|NCT01425281|79084267|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
44250020|NCT01425281|79084266|FG000|At 3-year Clinical Follow-up|Death|2|||
44250021|NCT01425281|79084267|FG001|At 3-year Clinical Follow-up|Death|3|||
44250022|NCT01425281|79084266|FG000|At 4-year Clinical Follow-up|Death|7|||
44250023|NCT01425281|79084267|FG001|At 4-year Clinical Follow-up|Death|3|||
44250024|NCT01425281|79084266|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
44250025|NCT01425281|79084267|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
44250026|NCT01425281|79084266|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
44250027|NCT01425281|79084267|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
44250028|NCT01425281|79084266|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
44250029|NCT01425281|79084267|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
44250030|NCT01425281|79084266|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
44250031|NCT01425281|79084267|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
44250032|NCT01425281|79084266|FG000|At 5-year Clinical Follow-up|Death|2|||
44250033|NCT01425281|79084267|FG001|At 5-year Clinical Follow-up|Death|0|||
44250034|NCT01425281|79084266|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
44250035|NCT01425281|79084267|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
44250036|NCT01425281|79084266|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
44250037|NCT01425281|79084267|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
44250038|NCT01425281|79084266|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
44250039|NCT01425281|79084267|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
44250040|NCT02648724|79084295|FG000|Overall Study|Withdrawal by Subject|0|||
44250041|NCT02648724|79084296|FG001|Overall Study|Withdrawal by Subject|1|||
44250042|NCT02648724|79084297|FG002|Overall Study|Withdrawal by Subject|1|||
44250043|NCT02648724|79084298|FG003|Overall Study|Withdrawal by Subject|0|||
44250044|NCT02648724|79084299|FG004|Overall Study|Withdrawal by Subject|1|||
44250045|NCT02648724|79084300|FG005|Overall Study|Withdrawal by Subject|0|||
44250046|NCT02648724|79084301|FG006|Overall Study|Withdrawal by Subject|0|||
44250047|NCT02648724|79084295|FG000|Overall Study|Progressive disease|2|||
44250048|NCT02648724|79084296|FG001|Overall Study|Progressive disease|2|||
44250049|NCT02648724|79084297|FG002|Overall Study|Progressive disease|2|||
44250050|NCT02648724|79084298|FG003|Overall Study|Progressive disease|3|||
44250051|NCT02648724|79084299|FG004|Overall Study|Progressive disease|22|||
44250052|NCT02648724|79084300|FG005|Overall Study|Progressive disease|7|||
44250053|NCT02648724|79084301|FG006|Overall Study|Progressive disease|8|||
44250054|NCT02648724|79084295|FG000|Overall Study|Other reason (unknown)|1|||
44250055|NCT02648724|79084296|FG001|Overall Study|Other reason (unknown)|0|||
44250056|NCT02648724|79084297|FG002|Overall Study|Other reason (unknown)|0|||
44250057|NCT02648724|79084298|FG003|Overall Study|Other reason (unknown)|0|||
44250058|NCT02648724|79084299|FG004|Overall Study|Other reason (unknown)|0|||
44250059|NCT02648724|79084300|FG005|Overall Study|Other reason (unknown)|0|||
44250060|NCT02648724|79084301|FG006|Overall Study|Other reason (unknown)|0|||
44250061|NCT02648724|79084295|FG000|Overall Study|Protocol Violation|0|||
44250062|NCT02648724|79084296|FG001|Overall Study|Protocol Violation|0|||
44250063|NCT02648724|79084297|FG002|Overall Study|Protocol Violation|0|||
44250064|NCT02648724|79084298|FG003|Overall Study|Protocol Violation|0|||
44144508|NCT02130466|78934028|FG007|Overall Study|Physician Decision|0|||
44144509|NCT02130466|78934029|FG008|Overall Study|Physician Decision|0|||
44144510|NCT02130466|78934030|FG009|Overall Study|Physician Decision|0|||
44144511|NCT02130466|78934031|FG010|Overall Study|Physician Decision|0|||
44144512|NCT02130466|78934032|FG011|Overall Study|Physician Decision|0|||
44144513|NCT02130466|78934033|FG012|Overall Study|Physician Decision|0|||
44144514|NCT02130466|78934034|FG013|Overall Study|Physician Decision|0|||
44250065|NCT02648724|79084299|FG004|Overall Study|Protocol Violation|1|||
44250066|NCT02648724|79084300|FG005|Overall Study|Protocol Violation|0|||
44250067|NCT02648724|79084301|FG006|Overall Study|Protocol Violation|0|||
44250068|NCT02648724|79084295|FG000|Overall Study|Death|0|||
44382465|NCT00735709|79388400|FG000|Overall Study|Voluntary Withdrawal|1|||
44144515|NCT02130466|78934021|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
44144516|NCT02130466|78934022|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
44382466|NCT00735709|79388401|FG001|Overall Study|Voluntary Withdrawal|3|||
44516154|NCT04079790|79522966|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
44516155|NCT04079790|79522967|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
44516156|NCT04079790|79522968|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
44516157|NCT04079790|79522965|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
44516158|NCT04079790|79522966|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
44516159|NCT04079790|79522967|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
44516160|NCT04079790|79522968|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
44516161|NCT04259346|79522996|FG000|Overall Study|Lost to Follow-up|1|||
44516162|NCT04259346|79522997|FG001|Overall Study|Lost to Follow-up|3|||
44516163|NCT04259346|79522996|FG000|Overall Study|Protocol Violation|1|||
44516164|NCT04259346|79522997|FG001|Overall Study|Protocol Violation|0|||
44516165|NCT04259346|79522996|FG000|Overall Study|Withdrawal by Subject|1|||
44516166|NCT04259346|79522997|FG001|Overall Study|Withdrawal by Subject|0|||
44516167|NCT04259346|79522996|FG000|Overall Study|Adverse Event|1|||
44516168|NCT04259346|79522997|FG001|Overall Study|Adverse Event|1|||
44516169|NCT04230876|79523005|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
44516170|NCT04230876|79523006|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
44516171|NCT04228302|79523018|FG000|Overall Study|Adverse Event|0|||
44516172|NCT04228302|79523019|FG001|Overall Study|Adverse Event|0|||
44516173|NCT04228302|79523020|FG002|Overall Study|Adverse Event|0|||
44516174|NCT04228302|79523021|FG003|Overall Study|Adverse Event|0|||
44516175|NCT04228302|79523022|FG004|Overall Study|Adverse Event|1|||
44516176|NCT04228302|79523023|FG005|Overall Study|Adverse Event|0|||
44516177|NCT01348100|79523044|FG000|Overall Study|Subject Withdrew Consent|0|||
44516178|NCT01348100|79523045|FG001|Overall Study|Subject Withdrew Consent|0|||
44516179|NCT01348100|79523046|FG002|Overall Study|Subject Withdrew Consent|2|||
44516180|NCT01348100|79523047|FG003|Overall Study|Subject Withdrew Consent|0|||
44516181|NCT01348100|79523048|FG004|Overall Study|Subject Withdrew Consent|1|||
44516182|NCT01348100|79523049|FG005|Overall Study|Subject Withdrew Consent|0|||
44516183|NCT01348100|79523050|FG006|Overall Study|Subject Withdrew Consent|1|||
44516184|NCT01348100|79523044|FG000|Overall Study|Protocol Deviation|0|||
44516185|NCT01348100|79523045|FG001|Overall Study|Protocol Deviation|0|||
44516186|NCT01348100|79523046|FG002|Overall Study|Protocol Deviation|0|||
44516187|NCT01348100|79523047|FG003|Overall Study|Protocol Deviation|1|||
44516188|NCT01348100|79523048|FG004|Overall Study|Protocol Deviation|0|||
44516189|NCT01348100|79523049|FG005|Overall Study|Protocol Deviation|0|||
44516190|NCT01348100|79523050|FG006|Overall Study|Protocol Deviation|0|||
44516191|NCT01348100|79523044|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44516192|NCT01348100|79523045|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44516193|NCT01348100|79523046|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44516194|NCT01348100|79523047|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44516195|NCT01348100|79523048|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44516196|NCT01348100|79523049|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
44516197|NCT01348100|79523050|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44516198|NCT01348100|79523044|FG000|Overall Study|Lost to Follow-up|0|||
44516199|NCT01348100|79523045|FG001|Overall Study|Lost to Follow-up|0|||
44516200|NCT01348100|79523046|FG002|Overall Study|Lost to Follow-up|0|||
44516201|NCT01348100|79523047|FG003|Overall Study|Lost to Follow-up|0|||
44516202|NCT01348100|79523048|FG004|Overall Study|Lost to Follow-up|0|||
44516203|NCT01348100|79523049|FG005|Overall Study|Lost to Follow-up|0|||
44516204|NCT01348100|79523050|FG006|Overall Study|Lost to Follow-up|1|||
44516205|NCT01348100|79523044|FG000|Overall Study|Administrative Problems|0|||
44516206|NCT01348100|79523045|FG001|Overall Study|Administrative Problems|0|||
44516207|NCT01348100|79523046|FG002|Overall Study|Administrative Problems|0|||
44516208|NCT01348100|79523047|FG003|Overall Study|Administrative Problems|0|||
44516209|NCT01348100|79523048|FG004|Overall Study|Administrative Problems|0|||
44516210|NCT01348100|79523049|FG005|Overall Study|Administrative Problems|1|||
44516211|NCT01348100|79523050|FG006|Overall Study|Administrative Problems|1|||
44516212|NCT03676634|79523071|FG000|Overall Study|Red blood cell loss|1|||
44516213|NCT03676634|79523071|FG000|Overall Study|Out-of-limit pulse|2|||
44516214|NCT03675776|79523078|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
44516215|NCT03675776|79523079|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
44516216|NCT03675776|79523080|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
44516217|NCT03675776|79523078|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
44516218|NCT03675776|79523079|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
44516219|NCT03675776|79523080|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
44516220|NCT03673670|79523094|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
44516221|NCT03673670|79523095|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
44516222|NCT03673670|79523096|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
44516223|NCT03673670|79523097|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
44516224|NCT03673670|79523098|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
44516225|NCT03673670|79523099|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
44516226|NCT03673670|79523094|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
44516227|NCT03673670|79523095|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
44516228|NCT03673670|79523096|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
44516229|NCT03673670|79523097|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
44516230|NCT03673670|79523098|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
44516231|NCT03673670|79523099|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
44516232|NCT03673670|79523094|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
44516233|NCT03673670|79523095|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
44516234|NCT03673670|79523096|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
44516235|NCT03673670|79523097|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
44516236|NCT03673670|79523098|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
44516237|NCT03673670|79523099|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
44516238|NCT03673670|79523094|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
44516239|NCT03673670|79523095|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
44516240|NCT03673670|79523096|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
44516241|NCT03673670|79523097|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
44516242|NCT03673670|79523098|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
44516243|NCT03673670|79523099|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
44516244|NCT03673670|79523094|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
44516245|NCT03673670|79523095|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
44516246|NCT03673670|79523096|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
44516247|NCT03673670|79523097|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
44516248|NCT03673670|79523098|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
44516249|NCT03673670|79523099|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
44516250|NCT03673670|79523094|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
44516251|NCT03673670|79523095|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
44516252|NCT03673670|79523096|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
44516253|NCT03673670|79523097|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
44516254|NCT03673670|79523098|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
44516255|NCT03673670|79523099|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
44516256|NCT03673670|79523094|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
44516257|NCT03673670|79523095|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
44516258|NCT03673670|79523096|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
44516259|NCT03673670|79523097|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
44516260|NCT03673670|79523098|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
44516261|NCT03673670|79523099|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
44516262|NCT04369742|79523118|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
44516263|NCT04369742|79523119|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
44516264|NCT04369742|79523118|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
44516265|NCT04369742|79523119|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
44144517|NCT02130466|78934023|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
44144518|NCT02130466|78934024|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
44516266|NCT04369430|79523127|FG000|Overall Study|Adverse Event|2|||
44516267|NCT04369430|79523128|FG001|Overall Study|Adverse Event|3|||
44516268|NCT04369430|79523127|FG000|Overall Study|Death|1|||
44516269|NCT04369430|79523128|FG001|Overall Study|Death|0|||
44516270|NCT04369430|79523127|FG000|Overall Study|Withdrawal by Subject|4|||
44516271|NCT04369430|79523128|FG001|Overall Study|Withdrawal by Subject|3|||
44516272|NCT04369430|79523127|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
44516273|NCT04369430|79523128|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
44516274|NCT04369430|79523127|FG000|Overall Study|Lost to Follow-up|0|||
44516275|NCT04369430|79523128|FG001|Overall Study|Lost to Follow-up|1|||
44516276|NCT04363736|79523136|FG000|Overall Study|Withdrawal by Subject|1|||
44516277|NCT04363736|79523137|FG001|Overall Study|Withdrawal by Subject|0|||
44516278|NCT04363736|79523136|FG000|Overall Study|Lost to Follow-up|10|||
44516279|NCT04363736|79523137|FG001|Overall Study|Lost to Follow-up|7|||
44516280|NCT04363736|79523136|FG000|Overall Study|Death|8|||
44516281|NCT04363736|79523137|FG001|Overall Study|Death|6|||
44516282|NCT04362176|79523145|FG000|Overall Study|Lost to Follow-up|5|||
44516283|NCT04362176|79523146|FG001|Overall Study|Lost to Follow-up|8|||
44516284|NCT04362176|79523145|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
44250069|NCT02648724|79084296|FG001|Overall Study|Death|0|||
44250070|NCT02648724|79084297|FG002|Overall Study|Death|0|||
44250071|NCT02648724|79084298|FG003|Overall Study|Death|0|||
44250072|NCT02648724|79084299|FG004|Overall Study|Death|0|||
44250073|NCT02648724|79084300|FG005|Overall Study|Death|0|||
44250074|NCT02648724|79084301|FG006|Overall Study|Death|3|||
44250075|NCT02648724|79084295|FG000|Overall Study|Physician Decision|0|||
44250076|NCT02648724|79084296|FG001|Overall Study|Physician Decision|0|||
44250077|NCT02648724|79084297|FG002|Overall Study|Physician Decision|0|||
44250078|NCT02648724|79084298|FG003|Overall Study|Physician Decision|0|||
44278089|NCT02108262|79239208|FG000|Overall Study|Withdrawal by Subject|0|||
44278090|NCT02108262|79239209|FG001|Overall Study|Withdrawal by Subject|7|||
44278091|NCT02108262|79239210|FG002|Overall Study|Withdrawal by Subject|3|||
44278092|NCT02108262|79239211|FG003|Overall Study|Withdrawal by Subject|4|||
44278093|NCT02108262|79239208|FG000|Overall Study|Due to key hepatic values|0|||
44278094|NCT02108262|79239209|FG001|Overall Study|Due to key hepatic values|1|||
44278095|NCT02108262|79239210|FG002|Overall Study|Due to key hepatic values|0|||
44278096|NCT02108262|79239211|FG003|Overall Study|Due to key hepatic values|0|||
44382467|NCT00735709|79388402|FG002|Overall Study|Voluntary Withdrawal|5|||
44382468|NCT00735709|79388403|FG003|Overall Study|Voluntary Withdrawal|7|||
44382469|NCT00735709|79388400|FG000|Overall Study|Lost to Follow-up|0|||
44382470|NCT00735709|79388401|FG001|Overall Study|Lost to Follow-up|1|||
44382471|NCT00735709|79388402|FG002|Overall Study|Lost to Follow-up|1|||
44382472|NCT00735709|79388403|FG003|Overall Study|Lost to Follow-up|1|||
44382473|NCT00735709|79388400|FG000|Overall Study|Excluded medication|1|||
44382474|NCT00735709|79388401|FG001|Overall Study|Excluded medication|0|||
44382475|NCT00735709|79388402|FG002|Overall Study|Excluded medication|0|||
44382476|NCT00735709|79388403|FG003|Overall Study|Excluded medication|1|||
44382477|NCT00729157|79388413|FG000|Overall Study|Withdrawal by Subject|1|||
44382478|NCT00728689|79388419|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
44382479|NCT00728689|79388420|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
44382480|NCT00727909|79388428|FG000|Overall Study|Withdrawal by Subject|5|||
44382481|NCT00727909|79388429|FG001|Overall Study|Withdrawal by Subject|11|||
44382482|NCT00727909|79388430|FG002|Overall Study|Withdrawal by Subject|8|||
44382483|NCT00727909|79388431|FG003|Overall Study|Withdrawal by Subject|5|||
44382484|NCT00727909|79388428|FG000|Overall Study|Death|0|||
44382485|NCT00727909|79388429|FG001|Overall Study|Death|0|||
44382486|NCT00727909|79388430|FG002|Overall Study|Death|1|||
44382487|NCT00727909|79388431|FG003|Overall Study|Death|0|||
44382488|NCT00726895|79388435|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
44382489|NCT00726895|79388436|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44382490|NCT00585325|79388445|FG000|Overall Study|Withdrawal by Subject|1|||
44382491|NCT00585325|79388446|FG001|Overall Study|Withdrawal by Subject|1|||
44382492|NCT00726661|79388454|FG000|Overall Study|Lost to Follow-up|36|||
44382493|NCT00726661|79388455|FG001|Overall Study|Lost to Follow-up|11|||
44382494|NCT00726661|79388454|FG000|Overall Study|Withdrawal by Subject|17|||
44382495|NCT00726661|79388455|FG001|Overall Study|Withdrawal by Subject|13|||
44382496|NCT00726661|79388454|FG000|Overall Study|Trial terminated by sponsor|214|||
44382497|NCT00726661|79388455|FG001|Overall Study|Trial terminated by sponsor|187|||
44382498|NCT00726661|79388454|FG000|Overall Study|Death|475|||
44382499|NCT00726661|79388455|FG001|Overall Study|Death|159|||
44382500|NCT00726661|79388454|FG000|Overall Study|Physician Decision|25|||
44382501|NCT00726661|79388455|FG001|Overall Study|Physician Decision|13|||
44382502|NCT00726661|79388454|FG000|Overall Study|Other|47|||
44382503|NCT00726661|79388455|FG001|Overall Study|Other|35|||
44516285|NCT04362176|79523146|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
44516286|NCT04079816|79523152|FG000|Overall Study|Request of Subject|2|||
44516287|NCT04079816|79523152|FG000|Overall Study|Unable to draw samples|1|||
44516288|NCT04079114|79523156|FG000|Overall Study|Study prematuely terminated.|166|||
44250079|NCT02648724|79084299|FG004|Overall Study|Physician Decision|1|||
44250080|NCT02648724|79084300|FG005|Overall Study|Physician Decision|0|||
44278097|NCT02108262|79239208|FG000|Overall Study|Unable to contact patient|0|||
44278098|NCT02108262|79239209|FG001|Overall Study|Unable to contact patient|3|||
44382504|NCT00741091|79388471|FG000|Overall Study|Death|13|||
44516289|NCT03055936|79523164|FG000|Overall Study|Adverse Event|0|||
44516290|NCT03055936|79523165|FG001|Overall Study|Adverse Event|1|||
44516291|NCT03055936|79523166|FG002|Overall Study|Adverse Event|1|||
44516292|NCT03055936|79523167|FG003|Overall Study|Adverse Event|1|||
44516293|NCT03055936|79523164|FG000|Overall Study|Personal reason|2|||
44516294|NCT03055936|79523165|FG001|Overall Study|Personal reason|0|||
44516295|NCT03055936|79523166|FG002|Overall Study|Personal reason|1|||
44516296|NCT03055936|79523167|FG003|Overall Study|Personal reason|0|||
44516297|NCT03891524|79523209|FG000|Overall Study|Death|0|||
44516298|NCT03891524|79523210|FG001|Overall Study|Death|0|||
44516299|NCT03891524|79523211|FG002|Overall Study|Death|0|||
44516300|NCT03891524|79523212|FG003|Overall Study|Death|0|||
44516301|NCT03891524|79523213|FG004|Overall Study|Death|0|||
44516302|NCT03891524|79523214|FG005|Overall Study|Death|0|||
44516303|NCT03891524|79523215|FG006|Overall Study|Death|0|||
44516304|NCT03891524|79523216|FG007|Overall Study|Death|1|||
44516305|NCT03891524|79523209|FG000|Overall Study|Withdrawal by Subject|0|||
44516306|NCT03891524|79523210|FG001|Overall Study|Withdrawal by Subject|1|||
44516307|NCT03891524|79523211|FG002|Overall Study|Withdrawal by Subject|2|||
44516308|NCT03891524|79523212|FG003|Overall Study|Withdrawal by Subject|1|||
44516309|NCT03891524|79523213|FG004|Overall Study|Withdrawal by Subject|2|||
44516310|NCT03891524|79523214|FG005|Overall Study|Withdrawal by Subject|2|||
44516311|NCT03891524|79523215|FG006|Overall Study|Withdrawal by Subject|2|||
44516312|NCT03891524|79523216|FG007|Overall Study|Withdrawal by Subject|1|||
44516313|NCT03055624|79523251|FG000|Overall Study|Study closed|9|||
44516314|NCT01346176|79523258|FG000|Recruited|Protocol Violation|1|||
44516315|NCT01346176|79523259|FG001|Recruited|Protocol Violation|0|||
44516316|NCT01346176|79523260|FG002|Recruited|Protocol Violation|0|||
44516317|NCT01346176|79523258|FG000|Completed Advance Directive|Death|3|||
44516318|NCT01346176|79523259|FG001|Completed Advance Directive|Death|2|||
44516319|NCT01346176|79523260|FG002|Completed Advance Directive|Death|2|||
44516320|NCT01346176|79523258|FG000|Completed Advance Directive|Became Ineligible|3|||
44516321|NCT01346176|79523259|FG001|Completed Advance Directive|Became Ineligible|0|||
44516322|NCT01346176|79523260|FG002|Completed Advance Directive|Became Ineligible|1|||
44516323|NCT01346176|79523258|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
44516324|NCT01346176|79523259|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
44516325|NCT01346176|79523260|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
44516326|NCT01346176|79523258|FG000|Completed Satisfaction Survey|Death|3|||
44516327|NCT01346176|79523259|FG001|Completed Satisfaction Survey|Death|0|||
44516328|NCT01346176|79523260|FG002|Completed Satisfaction Survey|Death|2|||
44516329|NCT01346176|79523258|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
44516330|NCT01346176|79523259|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
44516331|NCT01346176|79523260|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
44516332|NCT04075604|79523271|FG000|Overall Study|Adverse Event|0|||
44516333|NCT04075604|79523272|FG001|Overall Study|Adverse Event|0|||
44516334|NCT04075604|79523273|FG002|Overall Study|Adverse Event|3|||
44516335|NCT04075604|79523271|FG000|Overall Study|Participant request to discontinue study treatment|0|||
44516336|NCT04075604|79523272|FG001|Overall Study|Participant request to discontinue study treatment|0|||
44516337|NCT04075604|79523273|FG002|Overall Study|Participant request to discontinue study treatment|1|||
44516338|NCT04075604|79523271|FG000|Overall Study|Participant withdrew consent|0|||
44516339|NCT04075604|79523272|FG001|Overall Study|Participant withdrew consent|0|||
44516340|NCT04075604|79523273|FG002|Overall Study|Participant withdrew consent|1|||
44382505|NCT00741091|79388471|FG000|Overall Study|Lost to Follow-up|16|||
44382506|NCT00741091|79388471|FG000|Overall Study|Withdrawal by Subject|6|||
44382507|NCT00741091|79388471|FG000|Overall Study|Missed Visit|22|||
44382508|NCT00741013|79388478|FG000|Overall Study|Adverse Event|1|||
44382509|NCT00741013|79388479|FG001|Overall Study|Adverse Event|0|||
44382510|NCT00741013|79388480|FG002|Overall Study|Adverse Event|0|||
44382511|NCT00741013|79388478|FG000|Overall Study|Withdrawal by Subject|0|||
44382512|NCT00741013|79388479|FG001|Overall Study|Withdrawal by Subject|0|||
44382513|NCT00741013|79388480|FG002|Overall Study|Withdrawal by Subject|1|||
44382514|NCT00741013|79388478|FG000|Overall Study|Discovered failed screen after enrolled|0|||
44382515|NCT00741013|79388479|FG001|Overall Study|Discovered failed screen after enrolled|2|||
44382516|NCT00741013|79388480|FG002|Overall Study|Discovered failed screen after enrolled|0|||
44382517|NCT00740857|79388491|FG000|Overall Study|Withdrawal by Subject|1|||
44516341|NCT04075604|79523271|FG000|Overall Study|Other reasons|1|||
44516342|NCT04075604|79523272|FG001|Overall Study|Other reasons|0|||
44516343|NCT04075604|79523273|FG002|Overall Study|Other reasons|0|||
44382518|NCT00740857|79388492|FG001|Overall Study|Withdrawal by Subject|0|||
44516344|NCT04075604|79523271|FG000|Overall Study|Disease progression|0|||
44516345|NCT04075604|79523272|FG001|Overall Study|Disease progression|1|||
44516346|NCT04075604|79523273|FG002|Overall Study|Disease progression|0|||
44516347|NCT04075604|79523271|FG000|Overall Study|Study drug toxicity|0|||
44516348|NCT04075604|79523272|FG001|Overall Study|Study drug toxicity|5|||
44516349|NCT04075604|79523273|FG002|Overall Study|Study drug toxicity|1|||
44516350|NCT03796208|79523283|FG000|Overall Study|Withdrawal by Subject|3|||
44516351|NCT03796208|79523284|FG001|Overall Study|Withdrawal by Subject|0|||
44516352|NCT03796208|79523283|FG000|Overall Study|Loss of pregnancy|1|||
44516353|NCT03796208|79523284|FG001|Overall Study|Loss of pregnancy|1|||
44516354|NCT03796208|79523283|FG000|Overall Study|Changed prenatal clinics|0|||
44516355|NCT03796208|79523284|FG001|Overall Study|Changed prenatal clinics|5|||
44516356|NCT03796208|79523283|FG000|Overall Study|Lost to Follow-up|20|||
44516357|NCT03796208|79523284|FG001|Overall Study|Lost to Follow-up|16|||
44516358|NCT01318876|79523290|FG000|Day 8 Survey|email address invalid|96|||
44516359|NCT01318876|79523290|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
44516360|NCT01318876|79523290|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
44516361|NCT03668600|79523294|FG000|Overall Study|Study Terminated by the Sponsor|157|||
44516362|NCT03668600|79523294|FG000|Overall Study|Protocol Violation|1|||
44516363|NCT03668600|79523294|FG000|Overall Study|Pregnancy|1|||
44516364|NCT03668600|79523294|FG000|Overall Study|Lost to Follow-up|7|||
44516365|NCT03668600|79523294|FG000|Overall Study|Withdrawal by Subject|56|||
44516366|NCT03668600|79523294|FG000|Overall Study|Lack of Efficacy|7|||
44516367|NCT03668600|79523294|FG000|Overall Study|Adverse Event|1|||
44516368|NCT04073186|79523298|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
44516369|NCT04073186|79523298|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
44516370|NCT04073186|79523298|FG000|First Wearing Cycle|Protocol Violation|1|||
44516371|NCT04073186|79523298|FG000|First Wearing Cycle|Lens Discomfort|2|||
44516372|NCT04073186|79523298|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
44516373|NCT04073186|79523298|FG000|Second Wearing Cycle|Adverse Event|1|||
44516374|NCT03054064|79523303|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
44516375|NCT03054064|79523303|FG000|Overall Study|Investigator Decision|2|||
44516376|NCT03054064|79523303|FG000|Overall Study|Bladder Issue|1|||
44516377|NCT03054064|79523303|FG000|Overall Study|High Blood Pressure|1|||
44516378|NCT03054064|79523303|FG000|Overall Study|Change in Status|1|||
44516379|NCT03053518|79523307|FG000|Overall Study|Withdrawal by Subject|3|||
44516380|NCT03053518|79523307|FG000|Overall Study|Lost to Follow-up|2|||
44516381|NCT03053518|79523307|FG000|Overall Study|Ineligible|5|||
44278099|NCT02108262|79239210|FG002|Overall Study|Unable to contact patient|1|||
44278100|NCT02108262|79239211|FG003|Overall Study|Unable to contact patient|2|||
44278101|NCT02108262|79239208|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
44278102|NCT02108262|79239209|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
44278103|NCT02108262|79239210|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
44278104|NCT02108262|79239211|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
44278105|NCT02108262|79239208|FG000|Overall Study|Patient did not want another infusion|0|||
44278106|NCT02108262|79239209|FG001|Overall Study|Patient did not want another infusion|3|||
44278107|NCT02108262|79239210|FG002|Overall Study|Patient did not want another infusion|3|||
44278108|NCT02108262|79239211|FG003|Overall Study|Patient did not want another infusion|2|||
44278109|NCT02108262|79239208|FG000|Overall Study|Vacation|0|||
44278110|NCT02108262|79239209|FG001|Overall Study|Vacation|1|||
44278111|NCT02108262|79239210|FG002|Overall Study|Vacation|0|||
44278112|NCT02108262|79239211|FG003|Overall Study|Vacation|0|||
44278113|NCT02108262|79239208|FG000|Overall Study|Patient decision|0|||
44278114|NCT02108262|79239209|FG001|Overall Study|Patient decision|7|||
44278115|NCT02108262|79239210|FG002|Overall Study|Patient decision|9|||
44278116|NCT02108262|79239211|FG003|Overall Study|Patient decision|14|||
44278117|NCT02108262|79239208|FG000|Overall Study|Missed IV due to pharmacy error|0|||
44278118|NCT02108262|79239209|FG001|Overall Study|Missed IV due to pharmacy error|0|||
44278119|NCT02108262|79239210|FG002|Overall Study|Missed IV due to pharmacy error|1|||
44278120|NCT02108262|79239211|FG003|Overall Study|Missed IV due to pharmacy error|0|||
44278121|NCT02107482|79239220|FG000|Overall Study|inconveinence|2|||
44278122|NCT02107482|79239220|FG000|Overall Study|Lost to Follow-up|1|||
44278123|NCT02107482|79239220|FG000|Overall Study|Lack of Efficacy|1|||
44278124|NCT02066298|79239230|FG000|Overall Study|Lost to Follow-up|3|||
44278125|NCT02066298|79239231|FG001|Overall Study|Lost to Follow-up|2|||
44278126|NCT02066298|79239232|FG002|Overall Study|Lost to Follow-up|3|||
44278127|NCT02066298|79239233|FG003|Overall Study|Lost to Follow-up|2|||
44278128|NCT02066298|79239234|FG004|Overall Study|Lost to Follow-up|3|||
44516382|NCT04015336|79523311|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
44516383|NCT04071158|79523334|FG000|Overall Study|Lost to Follow-up|1|||
44516384|NCT04071158|79523335|FG001|Overall Study|Lost to Follow-up|2|||
44516385|NCT04071158|79523336|FG002|Overall Study|Lost to Follow-up|3|||
44516386|NCT04071158|79523337|FG003|Overall Study|Lost to Follow-up|3|||
44144519|NCT02130466|78934025|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
44516387|NCT04071158|79523338|FG004|Overall Study|Lost to Follow-up|5|||
44516388|NCT04071158|79523334|FG000|Overall Study|Randomized but not treated|2|||
44278129|NCT02066298|79239235|FG005|Overall Study|Lost to Follow-up|4|||
44278130|NCT02066298|79239230|FG000|Overall Study|Withdrawal by Subject|6|||
44278131|NCT02066298|79239231|FG001|Overall Study|Withdrawal by Subject|6|||
44278132|NCT02066298|79239232|FG002|Overall Study|Withdrawal by Subject|6|||
44278133|NCT02066298|79239233|FG003|Overall Study|Withdrawal by Subject|4|||
44278134|NCT02066298|79239234|FG004|Overall Study|Withdrawal by Subject|5|||
44516389|NCT04071158|79523335|FG001|Overall Study|Randomized but not treated|2|||
44516390|NCT04071158|79523336|FG002|Overall Study|Randomized but not treated|0|||
44516391|NCT04071158|79523337|FG003|Overall Study|Randomized but not treated|0|||
44516392|NCT04071158|79523338|FG004|Overall Study|Randomized but not treated|0|||
44516393|NCT01317940|79523362|FG000|Overall Study|Death|1|||
44516394|NCT01317940|79523363|FG001|Overall Study|Death|0|||
44516395|NCT01317940|79523364|FG002|Overall Study|Death|1|||
44516396|NCT01317940|79523365|FG003|Overall Study|Death|0|||
44516397|NCT01317940|79523366|FG004|Overall Study|Death|0|||
44516398|NCT01317940|79523367|FG005|Overall Study|Death|0|||
44516399|NCT01317940|79523362|FG000|Overall Study|Lost to Follow-up|0|||
44516400|NCT01317940|79523363|FG001|Overall Study|Lost to Follow-up|0|||
44516401|NCT01317940|79523364|FG002|Overall Study|Lost to Follow-up|1|||
44516402|NCT01317940|79523365|FG003|Overall Study|Lost to Follow-up|1|||
44516403|NCT01317940|79523366|FG004|Overall Study|Lost to Follow-up|1|||
44516404|NCT01317940|79523367|FG005|Overall Study|Lost to Follow-up|0|||
44516405|NCT01317940|79523362|FG000|Overall Study|Change in therapy plan|0|||
44516406|NCT01317940|79523363|FG001|Overall Study|Change in therapy plan|0|||
44516407|NCT01317940|79523364|FG002|Overall Study|Change in therapy plan|3|||
44516408|NCT01317940|79523365|FG003|Overall Study|Change in therapy plan|0|||
44516409|NCT01317940|79523366|FG004|Overall Study|Change in therapy plan|0|||
44516410|NCT01317940|79523367|FG005|Overall Study|Change in therapy plan|0|||
44516411|NCT01345786|79523386|FG000|Overall Study|Adverse Event|0|||
44516412|NCT01345786|79523387|FG001|Overall Study|Adverse Event|1|||
44516413|NCT01345786|79523388|FG002|Overall Study|Adverse Event|3|||
44516414|NCT01345786|79523389|FG003|Overall Study|Adverse Event|1|||
44516415|NCT01345786|79523386|FG000|Overall Study|Subject withdrew consent|2|||
44516416|NCT01345786|79523387|FG001|Overall Study|Subject withdrew consent|2|||
44516417|NCT01345786|79523388|FG002|Overall Study|Subject withdrew consent|1|||
44516418|NCT01345786|79523389|FG003|Overall Study|Subject withdrew consent|0|||
44516419|NCT01345786|79523386|FG000|Overall Study|Noncompliance with protocol|1|||
44516420|NCT01345786|79523387|FG001|Overall Study|Noncompliance with protocol|0|||
44516421|NCT01345786|79523388|FG002|Overall Study|Noncompliance with protocol|1|||
44516422|NCT01345786|79523389|FG003|Overall Study|Noncompliance with protocol|0|||
44516423|NCT01345786|79523386|FG000|Overall Study|Administrative|3|||
44516424|NCT01345786|79523387|FG001|Overall Study|Administrative|5|||
44516425|NCT01345786|79523388|FG002|Overall Study|Administrative|0|||
44516426|NCT01345786|79523389|FG003|Overall Study|Administrative|0|||
44516427|NCT01345786|79523386|FG000|Overall Study|Lost to Follow-up|0|||
44516428|NCT01345786|79523387|FG001|Overall Study|Lost to Follow-up|0|||
44516429|NCT01345786|79523388|FG002|Overall Study|Lost to Follow-up|0|||
44516430|NCT01345786|79523389|FG003|Overall Study|Lost to Follow-up|2|||
44516431|NCT01317550|79523403|FG000|Overall Study|Withdrawal by Subject|1|||
44516432|NCT01317550|79523404|FG001|Overall Study|Withdrawal by Subject|0|||
44516433|NCT01317550|79523405|FG002|Overall Study|Withdrawal by Subject|0|||
44516434|NCT01317550|79523406|FG003|Overall Study|Withdrawal by Subject|0|||
44516435|NCT01317550|79523403|FG000|Overall Study|Lack of compliance study med|1|||
44250081|NCT02648724|79084301|FG006|Overall Study|Physician Decision|1|||
44250082|NCT02648724|79084295|FG000|Overall Study|Transferred to named patient program|0|||
44278135|NCT02066298|79239235|FG005|Overall Study|Withdrawal by Subject|8|||
44278136|NCT02066298|79239230|FG000|Overall Study|Physician Decision|0|||
44278137|NCT02066298|79239231|FG001|Overall Study|Physician Decision|0|||
44278138|NCT02066298|79239232|FG002|Overall Study|Physician Decision|1|||
44250083|NCT02648724|79084296|FG001|Overall Study|Transferred to named patient program|0|||
44250084|NCT02648724|79084297|FG002|Overall Study|Transferred to named patient program|0|||
44250085|NCT02648724|79084298|FG003|Overall Study|Transferred to named patient program|0|||
44250086|NCT02648724|79084299|FG004|Overall Study|Transferred to named patient program|0|||
44250087|NCT02648724|79084300|FG005|Overall Study|Transferred to named patient program|1|||
44278139|NCT02066298|79239233|FG003|Overall Study|Physician Decision|0|||
44278140|NCT02066298|79239234|FG004|Overall Study|Physician Decision|1|||
44278141|NCT02066298|79239235|FG005|Overall Study|Physician Decision|0|||
44278142|NCT02082912|79239249|FG000|Overall Study|Physician Decision|0|||
44278143|NCT02082912|79239250|FG001|Overall Study|Physician Decision|1|||
44278144|NCT02082522|79239258|FG000|Overall Study|Sponsor termination|5|||
44278145|NCT02082522|79239259|FG001|Overall Study|Sponsor termination|3|||
44516436|NCT01317550|79523404|FG001|Overall Study|Lack of compliance study med|0|||
44516437|NCT01317550|79523405|FG002|Overall Study|Lack of compliance study med|0|||
44516438|NCT01317550|79523406|FG003|Overall Study|Lack of compliance study med|0|||
44516439|NCT01317472|79523418|FG000|Overall Study|Withdrawal by Subject|1|||
44516440|NCT01317472|79523419|FG001|Overall Study|Withdrawal by Subject|0|||
44516441|NCT01317472|79523418|FG000|Overall Study|Unrelated hospitalization|1|||
44516442|NCT01317472|79523419|FG001|Overall Study|Unrelated hospitalization|0|||
44382519|NCT00740857|79388493|FG002|Overall Study|Withdrawal by Subject|0|||
44516443|NCT01345630|79523427|FG000|Overall Study|Adverse Event|22|||
44278146|NCT02082522|79239258|FG000|Overall Study|Withdrawal by Subject|2|||
44278147|NCT02082522|79239259|FG001|Overall Study|Withdrawal by Subject|4|||
44278148|NCT02082522|79239258|FG000|Overall Study|Death|1|||
44278149|NCT02082522|79239259|FG001|Overall Study|Death|0|||
44278150|NCT02082522|79239258|FG000|Overall Study|Lost to Follow-up|1|||
44516444|NCT01345630|79523428|FG001|Overall Study|Adverse Event|23|||
44516445|NCT01345630|79523427|FG000|Overall Study|Lost to Follow-up|17|||
44516446|NCT01345630|79523428|FG001|Overall Study|Lost to Follow-up|16|||
44516447|NCT01345630|79523427|FG000|Overall Study|Protocol Violation|4|||
44516448|NCT01345630|79523428|FG001|Overall Study|Protocol Violation|1|||
44516449|NCT01345630|79523427|FG000|Overall Study|Medication error without associated AE|0|||
44516450|NCT01345630|79523428|FG001|Overall Study|Medication error without associated AE|1|||
44516451|NCT01345630|79523427|FG000|Overall Study|Study terminated by sponsor|254|||
44516452|NCT01345630|79523428|FG001|Overall Study|Study terminated by sponsor|285|||
44516453|NCT01345630|79523427|FG000|Overall Study|Other reasons|6|||
44516454|NCT01345630|79523428|FG001|Overall Study|Other reasons|8|||
44516455|NCT01345630|79523427|FG000|Overall Study|Withdrawn due to pregnancy|1|||
44516456|NCT01345630|79523428|FG001|Overall Study|Withdrawn due to pregnancy|2|||
44516457|NCT01345630|79523427|FG000|Overall Study|No longer willing to participate|9|||
44516458|NCT01345630|79523428|FG001|Overall Study|No longer willing to participate|12|||
44516459|NCT01345630|79523427|FG000|Overall Study|Insufficient clinical response|48|||
44516460|NCT01345630|79523428|FG001|Overall Study|Insufficient clinical response|11|||
44516461|NCT03693612|79523445|FG000|Overall Study|Lost to Follow-up|0|||
44516462|NCT03693612|79523446|FG001|Overall Study|Lost to Follow-up|0|||
44516463|NCT03693612|79523447|FG002|Overall Study|Lost to Follow-up|0|||
44516464|NCT03693612|79523448|FG003|Overall Study|Lost to Follow-up|0|||
44516465|NCT03693612|79523449|FG004|Overall Study|Lost to Follow-up|1|||
44516466|NCT03693612|79523450|FG005|Overall Study|Lost to Follow-up|0|||
44516467|NCT03693612|79523451|FG006|Overall Study|Lost to Follow-up|0|||
44516468|NCT03693612|79523445|FG000|Overall Study|Withdrawal by Subject|0|||
44516469|NCT03693612|79523446|FG001|Overall Study|Withdrawal by Subject|0|||
44250088|NCT02648724|79084301|FG006|Overall Study|Transferred to named patient program|0|||
44250089|NCT01402817|79084333|FG000|Overall Study|Withdrawal by Subject|3|||
44250090|NCT01402817|79084333|FG000|Overall Study|Study Suspended by FDA|8|||
44250091|NCT01425203|79084340|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
44250092|NCT01425203|79084341|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
44250093|NCT01425203|79084342|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
44250094|NCT01425203|79084340|FG000|Treatment Phase|Failure at futility timepoint|8|||
44250095|NCT01425203|79084341|FG001|Treatment Phase|Failure at futility timepoint|27|||
44516470|NCT03693612|79523447|FG002|Overall Study|Withdrawal by Subject|1|||
44278151|NCT02082522|79239259|FG001|Overall Study|Lost to Follow-up|0|||
44516471|NCT03693612|79523448|FG003|Overall Study|Withdrawal by Subject|0|||
44516472|NCT03693612|79523449|FG004|Overall Study|Withdrawal by Subject|2|||
44516473|NCT03693612|79523450|FG005|Overall Study|Withdrawal by Subject|0|||
44516474|NCT03693612|79523451|FG006|Overall Study|Withdrawal by Subject|0|||
44516475|NCT03693612|79523445|FG000|Overall Study|Study Terminated by Sponsor|0|||
44144520|NCT02130466|78934026|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
44144521|NCT02130466|78934027|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
44144522|NCT02130466|78934028|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
44144523|NCT02130466|78934029|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
44144524|NCT02130466|78934030|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
44144525|NCT02130466|78934031|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
44144526|NCT02130466|78934032|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
44144527|NCT02130466|78934033|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
44144528|NCT02130466|78934034|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
44144529|NCT02130466|78934021|FG000|Overall Study|Withdrawal by Subject|1|||
44144530|NCT02130466|78934022|FG001|Overall Study|Withdrawal by Subject|0|||
44144531|NCT02130466|78934023|FG002|Overall Study|Withdrawal by Subject|0|||
44144532|NCT02130466|78934024|FG003|Overall Study|Withdrawal by Subject|0|||
44250096|NCT01425203|79084342|FG002|Treatment Phase|Failure at futility timepoint|0|||
44250097|NCT01425203|79084340|FG000|Treatment Phase|Other virologic failure criteria|5|||
44250098|NCT01425203|79084341|FG001|Treatment Phase|Other virologic failure criteria|3|||
44250099|NCT01425203|79084342|FG002|Treatment Phase|Other virologic failure criteria|0|||
44250100|NCT01425203|79084340|FG000|Treatment Phase|Unidentified reasons|11|||
44250101|NCT01425203|79084341|FG001|Treatment Phase|Unidentified reasons|5|||
44250102|NCT01425203|79084342|FG002|Treatment Phase|Unidentified reasons|0|||
44250103|NCT01425203|79084340|FG000|Treatment Phase|Did not receive treatment|0|||
44144533|NCT02130466|78934025|FG004|Overall Study|Withdrawal by Subject|0|||
44144534|NCT02130466|78934026|FG005|Overall Study|Withdrawal by Subject|1|||
44144535|NCT02130466|78934027|FG006|Overall Study|Withdrawal by Subject|0|||
44144536|NCT02130466|78934028|FG007|Overall Study|Withdrawal by Subject|0|||
44144537|NCT02130466|78934029|FG008|Overall Study|Withdrawal by Subject|1|||
44144538|NCT02130466|78934030|FG009|Overall Study|Withdrawal by Subject|0|||
44144539|NCT02130466|78934031|FG010|Overall Study|Withdrawal by Subject|0|||
44144540|NCT02130466|78934032|FG011|Overall Study|Withdrawal by Subject|0|||
44144541|NCT02130466|78934033|FG012|Overall Study|Withdrawal by Subject|0|||
44144542|NCT02130466|78934034|FG013|Overall Study|Withdrawal by Subject|0|||
44144543|NCT02163538|78934083|FG000|Overall Study|Protocol Violation|1|||
44144544|NCT02163538|78934084|FG001|Overall Study|Protocol Violation|0|||
44144545|NCT02163538|78934083|FG000|Overall Study|Physician Decision|0|||
44144546|NCT02163538|78934084|FG001|Overall Study|Physician Decision|1|||
44144547|NCT02163226|78934092|FG000|Overall Study|Death|2|||
44144548|NCT02163226|78934093|FG001|Overall Study|Death|1|||
44144549|NCT02163226|78934092|FG000|Overall Study|Withdrawal by Subject|5|||
44144550|NCT02163226|78934093|FG001|Overall Study|Withdrawal by Subject|2|||
44144551|NCT02163226|78934092|FG000|Overall Study|Returned home, local radiotherapy|3|||
44144552|NCT02163226|78934093|FG001|Overall Study|Returned home, local radiotherapy|0|||
44144553|NCT02163226|78934092|FG000|Overall Study|Repeat imaging showed no disease|2|||
44144554|NCT02163226|78934093|FG001|Overall Study|Repeat imaging showed no disease|0|||
44144555|NCT02163226|78934092|FG000|Overall Study|Incomplete radiotherapy|3|||
44144556|NCT02163226|78934093|FG001|Overall Study|Incomplete radiotherapy|0|||
44144557|NCT02163226|78934092|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
44144558|NCT02163226|78934093|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
44144559|NCT02163226|78934092|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
44144560|NCT02163226|78934093|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
44144561|NCT02163226|78934092|FG000|Overall Study|ineligible|0|||
44144562|NCT02163226|78934093|FG001|Overall Study|ineligible|3|||
44144563|NCT02193178|78934099|FG000|Overall Study|Lost to Follow-up|1|||
44144564|NCT02193178|78934099|FG000|Overall Study|Dry eyes|1|||
44144565|NCT02129608|78934120|FG000|Overall Study|Lost to Follow-up|0|||
44144566|NCT02129608|78934121|FG001|Overall Study|Lost to Follow-up|1|||
44144567|NCT02129608|78934122|FG002|Overall Study|Lost to Follow-up|1|||
44144568|NCT02129608|78934120|FG000|Overall Study|Withdrawal by Subject|0|||
44144569|NCT02129608|78934121|FG001|Overall Study|Withdrawal by Subject|0|||
44144570|NCT02129608|78934122|FG002|Overall Study|Withdrawal by Subject|2|||
44144571|NCT01631188|78934130|FG000|Overall Study|Physician Decision|75|||
44144572|NCT02129062|78934134|FG000|Overall Study|Death|1|||
44144573|NCT02129062|78934134|FG000|Overall Study|Disease Progression|2|||
44144574|NCT02162758|78934140|FG000|Overall Study|Study termination|0|||
44278152|NCT02082522|79239258|FG000|Overall Study|Physician Decision|3|||
44144575|NCT02162758|78934141|FG001|Overall Study|Study termination|1|||
44144576|NCT02192164|78934147|FG000|Overall Study|Other|8|||
44278153|NCT02082522|79239259|FG001|Overall Study|Physician Decision|1|||
44278154|NCT02082522|79239258|FG000|Overall Study|Disease progression|2|||
44144577|NCT02192164|78934147|FG000|Overall Study|Withdrawal by Subject|1|||
44144578|NCT02192164|78934147|FG000|Overall Study|Physician Decision|4|||
44144579|NCT02192164|78934147|FG000|Overall Study|Did not meet the exclusion criteria|1|||
44144580|NCT02191618|78934154|FG000|Overall Study|Withdrawal by Subject|3|||
44144581|NCT02191618|78934154|FG000|Overall Study|Missed Visit|4|||
44250104|NCT01425203|79084341|FG001|Treatment Phase|Did not receive treatment|1|||
44516476|NCT03693612|79523446|FG001|Overall Study|Study Terminated by Sponsor|1|||
44516477|NCT03693612|79523447|FG002|Overall Study|Study Terminated by Sponsor|0|||
44516478|NCT03693612|79523448|FG003|Overall Study|Study Terminated by Sponsor|0|||
44516479|NCT03693612|79523449|FG004|Overall Study|Study Terminated by Sponsor|3|||
44516480|NCT03693612|79523450|FG005|Overall Study|Study Terminated by Sponsor|0|||
44516481|NCT03693612|79523451|FG006|Overall Study|Study Terminated by Sponsor|0|||
44250105|NCT01425203|79084342|FG002|Treatment Phase|Did not receive treatment|0|||
44250106|NCT01425203|79084340|FG000|Crossover Phase|Failure at futility timepoint|0|||
44250107|NCT01425203|79084341|FG001|Crossover Phase|Failure at futility timepoint|0|||
44250108|NCT01425203|79084342|FG002|Crossover Phase|Failure at futility timepoint|3|||
44278155|NCT02082522|79239259|FG001|Overall Study|Disease progression|2|||
44382520|NCT00808132|79388506|FG000|Overall Study|Adverse Event|34|||
44382521|NCT00808132|79388507|FG001|Overall Study|Adverse Event|33|||
44382522|NCT00808132|79388508|FG002|Overall Study|Adverse Event|16|||
44382523|NCT00808132|79388509|FG003|Overall Study|Adverse Event|31|||
44382524|NCT00808132|79388510|FG004|Overall Study|Adverse Event|33|||
44516482|NCT04223232|79523467|FG000|Overall Study|Withdrawal by Subject|1|||
44516483|NCT04206384|79523471|FG000|Overall Study|Withdrawal by Subject|8|||
44516484|NCT04206384|79523471|FG000|Overall Study|Adverse Event|2|||
44516485|NCT04051944|79523477|FG000|Overall Study|Study ending|1|||
44516486|NCT04051944|79523478|FG001|Overall Study|Study ending|1|||
44516487|NCT04051944|79523477|FG000|Overall Study|Early study termination by participant|1|||
44382525|NCT00808132|79388506|FG000|Overall Study|Death|0|||
44144582|NCT02646891|78934168|FG000|Overall Study|Adverse Event|0|||
44144583|NCT02646891|78934169|FG001|Overall Study|Adverse Event|1|||
44144584|NCT02646891|78934170|FG002|Overall Study|Adverse Event|0|||
44250109|NCT01425203|79084340|FG000|Crossover Phase|Other virologic failure criteria|0|||
44250110|NCT01425203|79084341|FG001|Crossover Phase|Other virologic failure criteria|0|||
44250111|NCT01425203|79084342|FG002|Crossover Phase|Other virologic failure criteria|3|||
44250112|NCT00081289|79084352|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
44516488|NCT04051944|79523478|FG001|Overall Study|Early study termination by participant|0|||
44516489|NCT04051944|79523477|FG000|Overall Study|Withdrawal by Subject|2|||
44516490|NCT04051944|79523478|FG001|Overall Study|Withdrawal by Subject|2|||
44516491|NCT04051944|79523477|FG000|Overall Study|Lack of Efficacy|3|||
44516492|NCT04051944|79523478|FG001|Overall Study|Lack of Efficacy|0|||
44516493|NCT04051944|79523477|FG000|Overall Study|Adverse event, non- fatal|1|||
44516494|NCT04051944|79523478|FG001|Overall Study|Adverse event, non- fatal|1|||
44516495|NCT04050618|79523486|FG000|First Intervention|Withdrawal by Subject|2|||
44516496|NCT04050618|79523487|FG001|First Intervention|Withdrawal by Subject|0|||
44516497|NCT04050618|79523486|FG000|Second Intervention|Withdrawal by Subject|1|||
44516498|NCT04050618|79523487|FG001|Second Intervention|Withdrawal by Subject|0|||
44516499|NCT04067492|79523504|FG000|Overall Study|Lost to Follow-up|0|||
44516500|NCT04067492|79523505|FG001|Overall Study|Lost to Follow-up|0|||
44516501|NCT04067492|79523506|FG002|Overall Study|Lost to Follow-up|0|||
44144585|NCT02646891|78934171|FG003|Overall Study|Adverse Event|0|||
44144586|NCT02646891|78934172|FG004|Overall Study|Adverse Event|0|||
44278156|NCT02082522|79239258|FG000|Overall Study|Chemotherapy change|1|||
44278157|NCT02082522|79239259|FG001|Overall Study|Chemotherapy change|3|||
44278158|NCT02082210|79239271|FG000|Overall Study|Death|0|||
44278159|NCT02082210|79239272|FG001|Overall Study|Death|0|||
44278160|NCT02082210|79239273|FG002|Overall Study|Death|1|||
44278161|NCT02082210|79239274|FG003|Overall Study|Death|1|||
44278162|NCT02082210|79239275|FG004|Overall Study|Death|1|||
44278163|NCT02082210|79239276|FG005|Overall Study|Death|0|||
44278164|NCT02082210|79239271|FG000|Overall Study|Withdrawal by Subject|0|||
44278165|NCT02082210|79239272|FG001|Overall Study|Withdrawal by Subject|0|||
44278166|NCT02082210|79239273|FG002|Overall Study|Withdrawal by Subject|0|||
44278167|NCT02082210|79239274|FG003|Overall Study|Withdrawal by Subject|1|||
44278168|NCT02082210|79239275|FG004|Overall Study|Withdrawal by Subject|2|||
44144587|NCT02646891|78934173|FG005|Overall Study|Adverse Event|0|||
44144588|NCT02646891|78934174|FG006|Overall Study|Adverse Event|0|||
44278169|NCT02082210|79239276|FG005|Overall Study|Withdrawal by Subject|2|||
44278170|NCT02082210|79239271|FG000|Overall Study|Clinical Progression|0|||
44278171|NCT02082210|79239272|FG001|Overall Study|Clinical Progression|0|||
44278172|NCT02082210|79239273|FG002|Overall Study|Clinical Progression|0|||
44278173|NCT02082210|79239274|FG003|Overall Study|Clinical Progression|1|||
44278174|NCT02082210|79239275|FG004|Overall Study|Clinical Progression|0|||
44278175|NCT02082210|79239276|FG005|Overall Study|Clinical Progression|0|||
44278176|NCT02082210|79239271|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
44278177|NCT02082210|79239272|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
44278178|NCT02082210|79239273|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
44278179|NCT02082210|79239274|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
44278180|NCT02082210|79239275|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
44278181|NCT02082210|79239276|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
44278182|NCT02082210|79239271|FG000|Overall Study|Physician Decision|0|||
44278183|NCT02082210|79239272|FG001|Overall Study|Physician Decision|0|||
44278184|NCT02082210|79239273|FG002|Overall Study|Physician Decision|1|||
44278185|NCT02082210|79239274|FG003|Overall Study|Physician Decision|1|||
44278186|NCT02082210|79239275|FG004|Overall Study|Physician Decision|0|||
44278187|NCT02082210|79239276|FG005|Overall Study|Physician Decision|0|||
44278188|NCT02107092|79239302|FG000|Overall Study|Miscellaneous|3|||
44278189|NCT02107092|79239302|FG000|Overall Study|Subject compliance|3|||
44278190|NCT02107092|79239302|FG000|Overall Study|Hypo-or hyperkalemia|2|||
44278191|NCT02107092|79239302|FG000|Overall Study|Met ECG withdrawal criteria|3|||
44278192|NCT02107092|79239302|FG000|Overall Study|Physician Decision|3|||
44278193|NCT02107092|79239302|FG000|Overall Study|Lost to Follow-up|2|||
44278194|NCT02107092|79239302|FG000|Overall Study|Withdrawal by Subject|9|||
44278195|NCT02107092|79239302|FG000|Overall Study|Adverse Event|7|||
44278196|NCT02107092|79239302|FG000|Overall Study|Expected progression of CKD|12|||
44278197|NCT02107014|79239306|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
44278198|NCT01624974|79239312|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
44278199|NCT01624974|79239313|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
44278200|NCT01624974|79239312|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
44278201|NCT01624974|79239313|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
44278202|NCT01624974|79239312|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
44278203|NCT01624974|79239313|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
44278204|NCT01624974|79239312|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
44278205|NCT01624974|79239313|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
44278206|NCT01624974|79239312|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
44516502|NCT04067492|79523507|FG003|Overall Study|Lost to Follow-up|0|||
44516503|NCT04067492|79523508|FG004|Overall Study|Lost to Follow-up|0|||
44516504|NCT04067492|79523509|FG005|Overall Study|Lost to Follow-up|1|||
44516505|NCT04067492|79523504|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
44516506|NCT04067492|79523505|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
44516507|NCT04067492|79523506|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
44516508|NCT04067492|79523507|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
44144589|NCT02646891|78934175|FG007|Overall Study|Adverse Event|0|||
44144590|NCT02646891|78934176|FG008|Overall Study|Adverse Event|0|||
44278207|NCT01624974|79239313|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
44278208|NCT01624974|79239312|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
44516509|NCT04067492|79523508|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
44278209|NCT01624974|79239313|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
44278210|NCT01624974|79239312|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
44278211|NCT01624974|79239313|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
44278212|NCT01624974|79239312|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
44278213|NCT01624974|79239313|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
44278214|NCT01624974|79239312|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
44278215|NCT01624974|79239313|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
44144591|NCT02646891|78934177|FG009|Overall Study|Adverse Event|0|||
44144592|NCT02646891|78934168|FG000|Overall Study|Lost to Follow-up|0|||
44144593|NCT02646891|78934169|FG001|Overall Study|Lost to Follow-up|0|||
44144594|NCT02646891|78934170|FG002|Overall Study|Lost to Follow-up|0|||
44144595|NCT02646891|78934171|FG003|Overall Study|Lost to Follow-up|0|||
44144596|NCT02646891|78934172|FG004|Overall Study|Lost to Follow-up|0|||
44144597|NCT02646891|78934173|FG005|Overall Study|Lost to Follow-up|0|||
44144598|NCT02646891|78934174|FG006|Overall Study|Lost to Follow-up|2|||
44144599|NCT02646891|78934175|FG007|Overall Study|Lost to Follow-up|2|||
44144600|NCT02646891|78934176|FG008|Overall Study|Lost to Follow-up|2|||
44144601|NCT02646891|78934177|FG009|Overall Study|Lost to Follow-up|2|||
44144602|NCT02646891|78934168|FG000|Overall Study|Protocol Violation|0|||
44144603|NCT02646891|78934169|FG001|Overall Study|Protocol Violation|0|||
44144604|NCT02646891|78934170|FG002|Overall Study|Protocol Violation|0|||
44144605|NCT02646891|78934171|FG003|Overall Study|Protocol Violation|0|||
44250113|NCT00081289|79084353|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
44250114|NCT00081289|79084352|FG000|Overall Study|Ineligible / no protocol treatment|3|||
44250115|NCT00081289|79084353|FG001|Overall Study|Ineligible / no protocol treatment|4|||
44250116|NCT01478594|79084362|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
44250117|NCT01478594|79084363|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
44250118|NCT01478594|79084362|FG000|Overall Study|Death|45|||
44144606|NCT02646891|78934172|FG004|Overall Study|Protocol Violation|0|||
44144607|NCT02646891|78934173|FG005|Overall Study|Protocol Violation|0|||
44144608|NCT02646891|78934174|FG006|Overall Study|Protocol Violation|1|||
44144609|NCT02646891|78934175|FG007|Overall Study|Protocol Violation|1|||
44144610|NCT02646891|78934176|FG008|Overall Study|Protocol Violation|0|||
44144611|NCT02646891|78934177|FG009|Overall Study|Protocol Violation|0|||
44144612|NCT02646891|78934168|FG000|Overall Study|Withdrawal by Subject|2|||
44144613|NCT02646891|78934169|FG001|Overall Study|Withdrawal by Subject|0|||
44144614|NCT02646891|78934170|FG002|Overall Study|Withdrawal by Subject|1|||
44144615|NCT02646891|78934171|FG003|Overall Study|Withdrawal by Subject|0|||
44144616|NCT02646891|78934172|FG004|Overall Study|Withdrawal by Subject|0|||
44144617|NCT02646891|78934173|FG005|Overall Study|Withdrawal by Subject|0|||
44144618|NCT02646891|78934174|FG006|Overall Study|Withdrawal by Subject|5|||
44144619|NCT02646891|78934175|FG007|Overall Study|Withdrawal by Subject|9|||
44144620|NCT02646891|78934176|FG008|Overall Study|Withdrawal by Subject|7|||
44144621|NCT02646891|78934177|FG009|Overall Study|Withdrawal by Subject|3|||
44144622|NCT02646891|78934168|FG000|Overall Study|Death|0|||
44250119|NCT01478594|79084363|FG001|Overall Study|Death|18|||
44250120|NCT01478594|79084362|FG000|Overall Study|Lost to Follow-up|3|||
44250121|NCT01478594|79084363|FG001|Overall Study|Lost to Follow-up|1|||
44250122|NCT01478594|79084362|FG000|Overall Study|Withdrawal by Subject|9|||
44354542|NCT01195272|79358984|FG000|Overall Study|Adverse Event|1|||
44144623|NCT02646891|78934169|FG001|Overall Study|Death|0|||
44144624|NCT02646891|78934170|FG002|Overall Study|Death|0|||
44144625|NCT02646891|78934171|FG003|Overall Study|Death|0|||
44144626|NCT02646891|78934172|FG004|Overall Study|Death|0|||
44250123|NCT01478594|79084363|FG001|Overall Study|Withdrawal by Subject|3|||
44250124|NCT01478594|79084362|FG000|Overall Study|Study Closed by Sponsor|8|||
44250125|NCT01478594|79084363|FG001|Overall Study|Study Closed by Sponsor|5|||
44250126|NCT01424813|79084424|FG000|Overall Study|Withdrawal by Subject|3|||
44250127|NCT01424813|79084425|FG001|Overall Study|Withdrawal by Subject|0|||
44250128|NCT01424813|79084424|FG000|Overall Study|Protocol Violation|1|||
44144627|NCT02646891|78934173|FG005|Overall Study|Death|0|||
44144628|NCT02646891|78934174|FG006|Overall Study|Death|1|||
44144629|NCT02646891|78934175|FG007|Overall Study|Death|1|||
44144630|NCT02646891|78934176|FG008|Overall Study|Death|1|||
44144631|NCT02646891|78934177|FG009|Overall Study|Death|0|||
44144632|NCT02646423|78934213|FG000|Overall Study|Adverse Event|5|||
44144633|NCT02646423|78934214|FG001|Overall Study|Adverse Event|7|||
44144634|NCT02646423|78934213|FG000|Overall Study|Ineligible|2|||
44144635|NCT02646423|78934214|FG001|Overall Study|Ineligible|1|||
44144636|NCT02647359|78934250|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
44144637|NCT02647359|78934251|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
44144638|NCT02647359|78934250|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
44144639|NCT02647359|78934251|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
44144640|NCT02647359|78934250|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
44144641|NCT02647359|78934251|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
44144642|NCT02647359|78934250|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
44144643|NCT02647359|78934251|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
44144644|NCT02647359|78934250|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
44144645|NCT02647359|78934251|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
44144646|NCT02647359|78934250|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
44144647|NCT02647359|78934251|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
44144648|NCT02645409|78934263|FG000|Overall Study|Withdrawal by Subject|3|||
44144649|NCT02645409|78934264|FG001|Overall Study|Withdrawal by Subject|0|||
44144650|NCT02645409|78934263|FG000|Overall Study|Physician Decision|1|||
44144651|NCT02645409|78934264|FG001|Overall Study|Physician Decision|0|||
44144652|NCT01597479|78934271|FG000|Overall Study|Protocol Violation|1|||
44144653|NCT01597479|78934272|FG001|Overall Study|Protocol Violation|0|||
44144654|NCT01597479|78934271|FG000|Overall Study|Lost to Follow-up|1|||
44144655|NCT01597479|78934272|FG001|Overall Study|Lost to Follow-up|0|||
44144656|NCT04248465|78934281|FG000|Randomized-Controlled Period|Death|12|||
44144657|NCT04248465|78934282|FG001|Randomized-Controlled Period|Death|5|||
44144658|NCT04248465|78934281|FG000|Randomized-Controlled Period|Adverse Event|2|||
44144659|NCT04248465|78934282|FG001|Randomized-Controlled Period|Adverse Event|0|||
44144660|NCT04248465|78934281|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
44144661|NCT04248465|78934282|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
44144662|NCT04248465|78934281|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
44144663|NCT04248465|78934282|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
44144664|NCT04248465|78934281|FG000|Randomized-Controlled Period|Physician Decision|1|||
44144665|NCT04248465|78934282|FG001|Randomized-Controlled Period|Physician Decision|1|||
44516510|NCT04067492|79523509|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
44516511|NCT04067492|79523504|FG000|Overall Study|COVID-19 epidemiological situation|0|||
44516512|NCT04067492|79523505|FG001|Overall Study|COVID-19 epidemiological situation|0|||
44516513|NCT04067492|79523506|FG002|Overall Study|COVID-19 epidemiological situation|0|||
44516514|NCT04067492|79523507|FG003|Overall Study|COVID-19 epidemiological situation|1|||
44516515|NCT04067492|79523508|FG004|Overall Study|COVID-19 epidemiological situation|0|||
44516516|NCT04067492|79523509|FG005|Overall Study|COVID-19 epidemiological situation|0|||
44516517|NCT04375878|79523527|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
44516518|NCT04375878|79523528|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
44516519|NCT04375878|79523529|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
44516520|NCT04375878|79523530|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
44516521|NCT04375878|79523531|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
44144666|NCT04248465|78934281|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
44144667|NCT04248465|78934282|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
44516522|NCT04375878|79523532|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
44144668|NCT04248465|78934281|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
44144669|NCT04248465|78934282|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
44144670|NCT04248465|78934281|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
44144671|NCT04248465|78934282|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
44144672|NCT02643693|78934290|FG000|Overall Study|Physician Decision|0|||
44144673|NCT02643693|78934291|FG001|Overall Study|Physician Decision|1|||
44144674|NCT02643693|78934292|FG002|Overall Study|Physician Decision|0|||
44144675|NCT02643693|78934293|FG003|Overall Study|Physician Decision|0|||
44144676|NCT02643693|78934294|FG004|Overall Study|Physician Decision|0|||
44144677|NCT02643693|78934295|FG005|Overall Study|Physician Decision|0|||
44144678|NCT02643693|78934290|FG000|Overall Study|Withdrawal by Subject|0|||
44144679|NCT02643693|78934291|FG001|Overall Study|Withdrawal by Subject|1|||
44144680|NCT02643693|78934292|FG002|Overall Study|Withdrawal by Subject|0|||
44144681|NCT02643693|78934293|FG003|Overall Study|Withdrawal by Subject|0|||
44144682|NCT02643693|78934294|FG004|Overall Study|Withdrawal by Subject|0|||
44144683|NCT02643693|78934295|FG005|Overall Study|Withdrawal by Subject|0|||
44144684|NCT02643693|78934290|FG000|Overall Study|Protocol Adherence Issues|2|||
44144685|NCT02643693|78934291|FG001|Overall Study|Protocol Adherence Issues|0|||
44144686|NCT02643693|78934292|FG002|Overall Study|Protocol Adherence Issues|1|||
44144687|NCT02643693|78934293|FG003|Overall Study|Protocol Adherence Issues|0|||
44144688|NCT02643693|78934294|FG004|Overall Study|Protocol Adherence Issues|0|||
44144689|NCT02643693|78934295|FG005|Overall Study|Protocol Adherence Issues|1|||
44144690|NCT02726113|78934305|FG000|Total Enrollment|Physician Decision|0|||
44144691|NCT02726113|78934306|FG001|Total Enrollment|Physician Decision|1|||
44144692|NCT02726113|78934305|FG000|Total Enrollment|Protocol Violation|1|||
44144693|NCT02726113|78934306|FG001|Total Enrollment|Protocol Violation|0|||
44144694|NCT02726113|78934305|FG000|Total Enrollment|Withdrawal by Subject|2|||
44144695|NCT02726113|78934306|FG001|Total Enrollment|Withdrawal by Subject|1|||
44144696|NCT02726113|78934305|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
44144697|NCT02726113|78934306|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
44144698|NCT02726113|78934305|FG000|Genomic Analysis|Protocol Violation|1|||
44144699|NCT02726113|78934306|FG001|Genomic Analysis|Protocol Violation|0|||
44144700|NCT02726113|78934305|FG000|Genomic Analysis|Withdrawal by Subject|2|||
44144701|NCT02726113|78934306|FG001|Genomic Analysis|Withdrawal by Subject|1|||
44144702|NCT02726113|78934305|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
44144703|NCT02726113|78934306|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
44144704|NCT01361919|78934324|FG000|Overall Study|technical issues|10|||
44144705|NCT01361919|78934325|FG001|Overall Study|technical issues|12|||
44144706|NCT01361919|78934326|FG002|Overall Study|technical issues|10|||
44516523|NCT04375878|79523527|FG000|Crossover First and Second Interventions|Adverse Event|0|||
44516524|NCT04375878|79523528|FG001|Crossover First and Second Interventions|Adverse Event|0|||
44516525|NCT04375878|79523529|FG002|Crossover First and Second Interventions|Adverse Event|1|||
44516526|NCT04375878|79523530|FG003|Crossover First and Second Interventions|Adverse Event|0|||
44516527|NCT04375878|79523531|FG004|Crossover First and Second Interventions|Adverse Event|0|||
44516528|NCT04375878|79523532|FG005|Crossover First and Second Interventions|Adverse Event|0|||
44516529|NCT04375878|79523527|FG000|Extension Phase|Withdrawal by Subject|0|||
44516530|NCT04375878|79523528|FG001|Extension Phase|Withdrawal by Subject|0|||
44516531|NCT04375878|79523529|FG002|Extension Phase|Withdrawal by Subject|0|||
44516532|NCT04375878|79523530|FG003|Extension Phase|Withdrawal by Subject|0|||
44516533|NCT04375878|79523531|FG004|Extension Phase|Withdrawal by Subject|1|||
44516534|NCT04375878|79523532|FG005|Extension Phase|Withdrawal by Subject|0|||
44516535|NCT04189224|79523552|FG000|Period 2|Adverse Event|0|||
44516536|NCT04189224|79523553|FG001|Period 2|Adverse Event|1|||
44516537|NCT04186806|79523561|FG000|Period 1: 7 Days|Adverse Event|1|||
44144707|NCT02642679|78934334|FG000|Overall Study|Withdrawal by Subject|1|||
44144708|NCT02642679|78934334|FG000|Overall Study|Physician Decision|1|||
44144709|NCT02642679|78934334|FG000|Overall Study|Physician Decision|1|||
44144710|NCT00705523|78934340|FG000|Overall Study|Lost to Follow-up|2|||
44144711|NCT00705523|78934341|FG001|Overall Study|Lost to Follow-up|3|||
44516538|NCT04186806|79523562|FG001|Period 1: 7 Days|Adverse Event|0|||
44516539|NCT04041414|79523571|FG000|Overall Study|Lost to Follow-up|1|||
44516540|NCT04041414|79523572|FG001|Overall Study|Lost to Follow-up|2|||
44144712|NCT02725411|78934350|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
44144713|NCT02725411|78934351|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
44144714|NCT02725411|78934352|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
44144715|NCT02725411|78934350|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
44144716|NCT02725411|78934351|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
44144717|NCT02725411|78934352|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
44144718|NCT02725411|78934350|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
44144719|NCT02725411|78934351|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
44144720|NCT02725411|78934352|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
44144721|NCT02725411|78934350|FG000|Treatment Period (56 Weeks)|Other|1|||
44144722|NCT02725411|78934351|FG001|Treatment Period (56 Weeks)|Other|4|||
44144723|NCT02725411|78934352|FG002|Treatment Period (56 Weeks)|Other|5|||
44278216|NCT01624974|79239312|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
44278217|NCT01624974|79239313|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
44278218|NCT01624974|79239312|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
44278219|NCT01624974|79239313|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
44278220|NCT01624974|79239312|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
44278221|NCT01624974|79239313|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
44278222|NCT02065518|79239324|FG000|Overall Study|Lost to Follow-up|3|||
44278223|NCT02065518|79239325|FG001|Overall Study|Lost to Follow-up|4|||
44382526|NCT00808132|79388507|FG001|Overall Study|Death|0|||
44382527|NCT00808132|79388508|FG002|Overall Study|Death|0|||
44382528|NCT00808132|79388509|FG003|Overall Study|Death|0|||
44382529|NCT00808132|79388510|FG004|Overall Study|Death|1|||
44144724|NCT02725411|78934350|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
44144725|NCT02725411|78934351|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
44144726|NCT02725411|78934352|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
44144727|NCT02725411|78934350|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
44250129|NCT01424813|79084425|FG001|Overall Study|Protocol Violation|0|||
44250130|NCT01424813|79084424|FG000|Overall Study|Other|1|||
44250131|NCT01424813|79084425|FG001|Overall Study|Other|2|||
44250132|NCT00080899|79084431|FG000|Overall Study|Adverse Event|1|||
44250133|NCT00089635|79084435|FG000|Overall Study|Adverse Event|2|||
44250134|NCT00089635|79084435|FG000|Overall Study|Death|17|||
44250135|NCT00089635|79084435|FG000|Overall Study|Disease Progression|12|||
44250136|NCT00089635|79084435|FG000|Overall Study|Lost to Follow-up|3|||
44250137|NCT00089635|79084435|FG000|Overall Study|Withdrawal by Subject|6|||
44250138|NCT00089635|79084435|FG000|Overall Study|Ineligibility determined|1|||
44250139|NCT00089635|79084435|FG000|Overall Study|Other|2|||
44250140|NCT01500200|79084449|FG000|Stage 1|Adverse Event|1|||
44250141|NCT01500200|79084450|FG001|Stage 1|Adverse Event|4|||
44250142|NCT01500200|79084451|FG002|Stage 1|Adverse Event|5|||
44278224|NCT02065518|79239326|FG002|Overall Study|Lost to Follow-up|0|||
44382530|NCT00808132|79388506|FG000|Overall Study|Physician Decision|0|||
44144728|NCT02725411|78934351|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
44144729|NCT02725411|78934352|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
44144730|NCT02725411|78934350|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
44144731|NCT02725411|78934351|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
44144732|NCT02725411|78934352|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
44144733|NCT02725411|78934350|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
44144734|NCT02725411|78934351|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
44144735|NCT02725411|78934352|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
44144736|NCT02725411|78934350|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
44144737|NCT02725411|78934351|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
44144738|NCT02725411|78934352|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
44144739|NCT02725411|78934350|FG000|Follow-up Period (24 Weeks)|Other|1|||
44144740|NCT02725411|78934351|FG001|Follow-up Period (24 Weeks)|Other|4|||
44144741|NCT02725411|78934352|FG002|Follow-up Period (24 Weeks)|Other|2|||
44144742|NCT02725411|78934350|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
44144743|NCT02725411|78934351|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
44144744|NCT02725411|78934352|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
44144745|NCT02190604|78934388|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144746|NCT02190604|78934389|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144747|NCT02190604|78934390|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144748|NCT02190604|78934391|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144749|NCT02190604|78934392|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144750|NCT02190604|78934393|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144751|NCT02190604|78934394|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144752|NCT02190604|78934395|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144753|NCT02190604|78934396|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144754|NCT02190604|78934397|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144755|NCT02190604|78934398|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144756|NCT02190604|78934399|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144757|NCT02190604|78934400|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144758|NCT02190604|78934401|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144759|NCT02190604|78934402|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
44144760|NCT02190604|78934403|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144761|NCT02190604|78934404|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144762|NCT02190604|78934405|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144763|NCT02190604|78934406|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
44144764|NCT02190604|78934388|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144765|NCT02190604|78934389|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144766|NCT02190604|78934390|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144767|NCT02190604|78934391|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144768|NCT02190604|78934392|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144769|NCT02190604|78934393|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144770|NCT02190604|78934394|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144771|NCT02190604|78934395|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44516541|NCT04370028|79523581|FG000|Overall Study|Withdrawal by Subject|695|||
44516542|NCT04370028|79523581|FG000|Overall Study|Protocol Violation|9|||
44516543|NCT04370028|79523581|FG000|Overall Study|Adverse Event|3|||
44516544|NCT04037748|79523594|FG000|Treatment Period 1|Withdrawal by Subject|3|||
44516545|NCT04037748|79523595|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44516546|NCT04037748|79523594|FG000|Treatment Period 1|Adverse Event|1|||
44516547|NCT04037748|79523595|FG001|Treatment Period 1|Adverse Event|1|||
44516548|NCT04037748|79523594|FG000|Treatment Period 1|Protocol Violation|4|||
44144772|NCT02190604|78934396|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144773|NCT02190604|78934397|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144774|NCT02190604|78934398|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144775|NCT02190604|78934399|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144776|NCT02190604|78934400|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144777|NCT02190604|78934401|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
44144778|NCT02190604|78934402|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144779|NCT02190604|78934403|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144780|NCT02190604|78934404|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144781|NCT02190604|78934405|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144782|NCT02190604|78934406|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
44144783|NCT02127970|78934465|FG000|Overall Study|Adverse Event|2|||
44144784|NCT02127970|78934466|FG001|Overall Study|Adverse Event|1|||
44144785|NCT02127970|78934465|FG000|Overall Study|Death|1|||
44144786|NCT02127970|78934466|FG001|Overall Study|Death|1|||
44144787|NCT02127970|78934465|FG000|Overall Study|Lost to Follow-up|14|||
44516549|NCT04037748|79523595|FG001|Treatment Period 1|Protocol Violation|5|||
44516550|NCT04037748|79523594|FG000|Treatment Period 2|Adverse Event|0|||
44516551|NCT04037748|79523595|FG001|Treatment Period 2|Adverse Event|1|||
44144788|NCT02127970|78934466|FG001|Overall Study|Lost to Follow-up|14|||
44144789|NCT02127970|78934465|FG000|Overall Study|Reason not Specified|4|||
44144790|NCT02127970|78934466|FG001|Overall Study|Reason not Specified|7|||
44144791|NCT02127970|78934465|FG000|Overall Study|Pregnancy|0|||
44144792|NCT02127970|78934466|FG001|Overall Study|Pregnancy|1|||
44144793|NCT02127970|78934465|FG000|Overall Study|Subject Withdrew Consent|5|||
44144794|NCT02127970|78934466|FG001|Overall Study|Subject Withdrew Consent|3|||
44144795|NCT03549871|78934474|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
44144796|NCT03549871|78934475|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
44144797|NCT03549871|78934474|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
44144798|NCT03549871|78934475|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
44144799|NCT03549871|78934474|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
44144800|NCT03549871|78934475|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
44144801|NCT03549871|78934474|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
44144802|NCT03549871|78934475|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
44144803|NCT03549871|78934474|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
44144804|NCT03549871|78934475|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
44144805|NCT03549871|78934474|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
44250143|NCT01500200|79084452|FG003|Stage 1|Adverse Event|0|||
44144806|NCT03549871|78934475|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
44144807|NCT03549871|78934474|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
44144808|NCT03549871|78934475|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
44144809|NCT03549871|78934474|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
44144810|NCT03549871|78934475|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
44144811|NCT03549871|78934474|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
44144812|NCT03549871|78934475|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
44144813|NCT03549871|78934474|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
44144814|NCT03549871|78934475|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
44144815|NCT03549871|78934474|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
44144816|NCT03549871|78934475|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
44144817|NCT00705367|78934498|FG000|Long-term Extension Period|Adverse Event|2|||
44144818|NCT00705367|78934499|FG001|Long-term Extension Period|Adverse Event|0|||
44144819|NCT00705367|78934498|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
44144820|NCT00705367|78934499|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
44144821|NCT00705367|78934498|FG000|Long-term Extension Period|Lack of Efficacy|1|||
44250144|NCT01500200|79084453|FG004|Stage 1|Adverse Event|0|||
44250145|NCT01500200|79084454|FG005|Stage 1|Adverse Event|0|||
44144822|NCT00705367|78934499|FG001|Long-term Extension Period|Lack of Efficacy|0|||
44144823|NCT00705367|78934498|FG000|Long-term Extension Period|No longer met study criteria|1|||
44144824|NCT00705367|78934499|FG001|Long-term Extension Period|No longer met study criteria|0|||
44144825|NCT00705367|78934498|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
44144826|NCT00705367|78934499|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
44144827|NCT00705289|78934507|FG000|Overall Study|Subject or treating physician's choice|131|||
44144828|NCT00703963|78934530|FG000|Overall Study|Withdrawal by Subject|7|||
44144829|NCT00703963|78934531|FG001|Overall Study|Withdrawal by Subject|13|||
44144830|NCT00703963|78934530|FG000|Overall Study|Physician Decision|0|||
44144831|NCT00703963|78934531|FG001|Overall Study|Physician Decision|1|||
44144832|NCT02721355|78934539|FG000|Overall Study|Lost to Follow-up|6|||
44144833|NCT02721355|78934540|FG001|Overall Study|Lost to Follow-up|1|||
44144834|NCT02733991|78934548|FG000|Overall Study|Adverse Event|1|||
44144835|NCT02733991|78934549|FG001|Overall Study|Adverse Event|0|||
44144836|NCT02733991|78934548|FG000|Overall Study|Withdrawal by Subject|0|||
44144837|NCT02733991|78934549|FG001|Overall Study|Withdrawal by Subject|5|||
44144838|NCT00702949|78934558|FG000|Overall Study|Refusal|3|||
44144839|NCT00702949|78934559|FG001|Overall Study|Refusal|2|||
44144840|NCT00702949|78934560|FG002|Overall Study|Refusal|2|||
44144841|NCT00702949|78934558|FG000|Overall Study|Adverse Event|1|||
44144842|NCT00702949|78934559|FG001|Overall Study|Adverse Event|6|||
44144843|NCT00702949|78934560|FG002|Overall Study|Adverse Event|3|||
44144844|NCT00702949|78934558|FG000|Overall Study|Other Medical Reason/unknown|1|||
44144845|NCT00702949|78934559|FG001|Overall Study|Other Medical Reason/unknown|1|||
44144846|NCT00702949|78934560|FG002|Overall Study|Other Medical Reason/unknown|3|||
44144847|NCT00702715|78934572|FG000|Overall Study|Lost to Follow-up|1|||
44144848|NCT00702715|78934573|FG001|Overall Study|Lost to Follow-up|0|||
44144849|NCT00702403|78934579|FG000|From Consent to Engraftment|Progressive leukemia|6|||
44144850|NCT00702403|78934579|FG000|From Consent to Engraftment|Critically ill|2|||
44144851|NCT00702403|78934579|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
44144852|NCT00702403|78934579|FG000|From Consent to Engraftment|Myocardial infarction|1|||
44144853|NCT00702403|78934579|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
44144854|NCT00702403|78934579|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
44382531|NCT00808132|79388507|FG001|Overall Study|Physician Decision|1|||
44382532|NCT00808132|79388508|FG002|Overall Study|Physician Decision|0|||
44516552|NCT04037748|79523594|FG000|Treatment Period 2|Protocol Violation|2|||
44144855|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
44144856|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
44144857|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Non-compliance|2|||
44144858|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
44144859|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
44250146|NCT01500200|79084449|FG000|Stage 1|Lost to Follow-up|2|||
44250147|NCT01500200|79084450|FG001|Stage 1|Lost to Follow-up|2|||
44250148|NCT01500200|79084451|FG002|Stage 1|Lost to Follow-up|1|||
44250149|NCT01500200|79084452|FG003|Stage 1|Lost to Follow-up|0|||
44250150|NCT01500200|79084453|FG004|Stage 1|Lost to Follow-up|0|||
44250151|NCT01500200|79084454|FG005|Stage 1|Lost to Follow-up|0|||
44250152|NCT01500200|79084449|FG000|Stage 1|Withdrawal by Subject|3|||
44250153|NCT01500200|79084450|FG001|Stage 1|Withdrawal by Subject|0|||
44250154|NCT01500200|79084451|FG002|Stage 1|Withdrawal by Subject|0|||
44250155|NCT01500200|79084452|FG003|Stage 1|Withdrawal by Subject|0|||
44250156|NCT01500200|79084453|FG004|Stage 1|Withdrawal by Subject|0|||
44250157|NCT01500200|79084454|FG005|Stage 1|Withdrawal by Subject|0|||
44250158|NCT01500200|79084449|FG000|Stage 1|Noncompliance with Study Drug|1|||
44250159|NCT01500200|79084450|FG001|Stage 1|Noncompliance with Study Drug|0|||
44250160|NCT01500200|79084451|FG002|Stage 1|Noncompliance with Study Drug|0|||
44516553|NCT04037748|79523595|FG001|Treatment Period 2|Protocol Violation|0|||
44516554|NCT04036110|79523604|FG000|Overall Study|Lost to Follow-up|3|||
44516555|NCT04036110|79523605|FG001|Overall Study|Lost to Follow-up|2|||
44516556|NCT04036110|79523606|FG002|Overall Study|Lost to Follow-up|1|||
44516557|NCT04036110|79523604|FG000|Overall Study|Study Suspended|4|||
44516558|NCT04036110|79523605|FG001|Overall Study|Study Suspended|5|||
44516559|NCT04036110|79523606|FG002|Overall Study|Study Suspended|1|||
44516560|NCT03053050|79523617|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
44516561|NCT03053050|79523618|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
44516562|NCT03053050|79523619|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
44516563|NCT03053050|79523620|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
44382533|NCT00808132|79388509|FG003|Overall Study|Physician Decision|0|||
44516564|NCT03053050|79523617|FG000|Randomized Phase|Withdrew Consent|16|||
44144860|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Suicide|1|||
44144861|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
44144862|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
44144863|NCT00702403|78934579|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
44144864|NCT00702325|78934588|FG000|Overall Study|Adverse Event|1|||
44144865|NCT00702325|78934589|FG001|Overall Study|Adverse Event|0|||
44250161|NCT01500200|79084452|FG003|Stage 1|Noncompliance with Study Drug|0|||
44250162|NCT01500200|79084453|FG004|Stage 1|Noncompliance with Study Drug|0|||
44250163|NCT01500200|79084454|FG005|Stage 1|Noncompliance with Study Drug|0|||
44250164|NCT01500200|79084449|FG000|Stage 1|Physician Decision|1|||
44250165|NCT01500200|79084450|FG001|Stage 1|Physician Decision|0|||
44250166|NCT01500200|79084451|FG002|Stage 1|Physician Decision|0|||
44250167|NCT01500200|79084452|FG003|Stage 1|Physician Decision|0|||
44250168|NCT01500200|79084453|FG004|Stage 1|Physician Decision|0|||
44250169|NCT01500200|79084454|FG005|Stage 1|Physician Decision|0|||
44250170|NCT01500200|79084449|FG000|Stage 2|Adverse Event|0|||
44144866|NCT00702325|78934588|FG000|Overall Study|Withdrawal by Subject|7|||
44144867|NCT00702325|78934589|FG001|Overall Study|Withdrawal by Subject|7|||
44144868|NCT00702325|78934588|FG000|Overall Study|Lost to Follow-up|3|||
44144869|NCT00702325|78934589|FG001|Overall Study|Lost to Follow-up|4|||
44144870|NCT00702325|78934588|FG000|Overall Study|Incorrect enrollment|5|||
44144871|NCT00702325|78934589|FG001|Overall Study|Incorrect enrollment|7|||
44144872|NCT00702325|78934588|FG000|Overall Study|Developed study discontinuation criteria|18|||
44144873|NCT00702325|78934589|FG001|Overall Study|Developed study discontinuation criteria|28|||
44144874|NCT00702325|78934588|FG000|Overall Study|Severe noncompliance to protocol|3|||
44144875|NCT00702325|78934589|FG001|Overall Study|Severe noncompliance to protocol|3|||
44144876|NCT00702325|78934588|FG000|Overall Study|Termination due to lab results|1|||
44144877|NCT00702325|78934589|FG001|Overall Study|Termination due to lab results|0|||
44144878|NCT00702325|78934588|FG000|Overall Study|Didn't follow study medication dosage|0|||
44144879|NCT00702325|78934589|FG001|Overall Study|Didn't follow study medication dosage|2|||
44144880|NCT00702325|78934588|FG000|Overall Study|Withdrew consent|0|||
44144881|NCT00702325|78934589|FG001|Overall Study|Withdrew consent|1|||
44144882|NCT00702325|78934588|FG000|Overall Study|Incorrectly Discontinued|0|||
44144883|NCT00702325|78934589|FG001|Overall Study|Incorrectly Discontinued|1|||
44144884|NCT02719171|78934600|FG000|Overall Study|Adverse Event|1|||
44144885|NCT02719171|78934601|FG001|Overall Study|Adverse Event|2|||
44144886|NCT02719171|78934602|FG002|Overall Study|Adverse Event|0|||
44144887|NCT02719171|78934603|FG003|Overall Study|Adverse Event|0|||
44144888|NCT02719171|78934604|FG004|Overall Study|Adverse Event|2|||
44144889|NCT02719171|78934600|FG000|Overall Study|Lost to Follow-up|0|||
44144890|NCT02719171|78934601|FG001|Overall Study|Lost to Follow-up|0|||
44144891|NCT02719171|78934602|FG002|Overall Study|Lost to Follow-up|1|||
44144892|NCT02719171|78934603|FG003|Overall Study|Lost to Follow-up|0|||
44144893|NCT02719171|78934604|FG004|Overall Study|Lost to Follow-up|0|||
44144894|NCT02719171|78934600|FG000|Overall Study|Subject Withdrawal|0|||
44144895|NCT02719171|78934601|FG001|Overall Study|Subject Withdrawal|2|||
44144896|NCT02719171|78934602|FG002|Overall Study|Subject Withdrawal|2|||
44144897|NCT02719171|78934603|FG003|Overall Study|Subject Withdrawal|1|||
44144898|NCT02719171|78934604|FG004|Overall Study|Subject Withdrawal|0|||
44144899|NCT02719171|78934600|FG000|Overall Study|Other|0|||
44144900|NCT02719171|78934601|FG001|Overall Study|Other|0|||
44144901|NCT02719171|78934602|FG002|Overall Study|Other|0|||
44144902|NCT02719171|78934603|FG003|Overall Study|Other|1|||
44144903|NCT02719171|78934604|FG004|Overall Study|Other|0|||
44144904|NCT02718625|78934621|FG000|Overall Study|Adverse Event|0|||
44144905|NCT02718625|78934622|FG001|Overall Study|Adverse Event|1|||
44144906|NCT02718625|78934621|FG000|Overall Study|Termination of Study by Sponsor|0|||
44144907|NCT02718625|78934622|FG001|Overall Study|Termination of Study by Sponsor|1|||
44144908|NCT02716987|78934634|FG000|Overall Study|Ligand synthesis failure|0|||
44144909|NCT02716987|78934635|FG001|Overall Study|Ligand synthesis failure|0|||
44144910|NCT02716987|78934636|FG002|Overall Study|Ligand synthesis failure|1|||
44144911|NCT02716987|78934637|FG003|Overall Study|Ligand synthesis failure|0|||
44250171|NCT01500200|79084450|FG001|Stage 2|Adverse Event|0|||
44250172|NCT01500200|79084451|FG002|Stage 2|Adverse Event|0|||
44516565|NCT03053050|79523618|FG001|Randomized Phase|Withdrew Consent|8|||
44516566|NCT03053050|79523619|FG002|Randomized Phase|Withdrew Consent|9|||
44516567|NCT03053050|79523620|FG003|Randomized Phase|Withdrew Consent|0|||
44516568|NCT03053050|79523617|FG000|Randomized Phase|Investigator's Discretion|6|||
44516569|NCT03053050|79523618|FG001|Randomized Phase|Investigator's Discretion|6|||
44516570|NCT03053050|79523619|FG002|Randomized Phase|Investigator's Discretion|3|||
44516571|NCT03053050|79523620|FG003|Randomized Phase|Investigator's Discretion|0|||
44516572|NCT03053050|79523617|FG000|Randomized Phase|Lost to Follow-up|5|||
44516573|NCT03053050|79523618|FG001|Randomized Phase|Lost to Follow-up|1|||
44516574|NCT03053050|79523619|FG002|Randomized Phase|Lost to Follow-up|1|||
44144912|NCT02716987|78934638|FG004|Overall Study|Ligand synthesis failure|0|||
44144913|NCT02716987|78934639|FG005|Overall Study|Ligand synthesis failure|0|||
44250173|NCT01500200|79084452|FG003|Stage 2|Adverse Event|0|||
44144914|NCT02716987|78934634|FG000|Overall Study|Withdrawal by Subject|0|||
44144915|NCT02716987|78934635|FG001|Overall Study|Withdrawal by Subject|0|||
44144916|NCT02716987|78934636|FG002|Overall Study|Withdrawal by Subject|0|||
44144917|NCT02716987|78934637|FG003|Overall Study|Withdrawal by Subject|0|||
44144918|NCT02716987|78934638|FG004|Overall Study|Withdrawal by Subject|1|||
44144919|NCT02716987|78934639|FG005|Overall Study|Withdrawal by Subject|1|||
44144920|NCT00701779|78934664|FG000|Overall Study|Adverse Event|6|||
44144921|NCT00701779|78934664|FG000|Overall Study|Lost to Follow-up|1|||
44144922|NCT00701779|78934664|FG000|Overall Study|Withdrawal by Subject|2|||
44144923|NCT03707977|78934687|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
44144924|NCT03707977|78934688|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
44144925|NCT03707977|78934689|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
44144926|NCT03707977|78934687|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
44144927|NCT03707977|78934688|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
44144928|NCT03707977|78934689|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
44144929|NCT03332095|78934705|FG000|Overall Study|Lost to Follow-up|1|||
44144930|NCT03332095|78934706|FG001|Overall Study|Lost to Follow-up|0|||
44144931|NCT03332095|78934705|FG000|Overall Study|Pregnancy|0|||
44144932|NCT03332095|78934706|FG001|Overall Study|Pregnancy|1|||
44144933|NCT02764489|78934713|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
44144934|NCT02764489|78934714|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
44144935|NCT02764489|78934713|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
44144936|NCT02764489|78934714|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
44144937|NCT02764489|78934713|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
44144938|NCT02764489|78934714|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
44144939|NCT02764489|78934713|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
44144940|NCT02764489|78934714|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
44144941|NCT02001623|78934739|FG000|Overall Study|Disease Progression|2|||
44144942|NCT02001623|78934740|FG001|Overall Study|Disease Progression|2|||
44144943|NCT02001623|78934741|FG002|Overall Study|Disease Progression|3|||
44144944|NCT02001623|78934742|FG003|Overall Study|Disease Progression|2|||
44144945|NCT02001623|78934743|FG004|Overall Study|Disease Progression|3|||
44144946|NCT02001623|78934744|FG005|Overall Study|Disease Progression|2|||
44144947|NCT02001623|78934745|FG006|Overall Study|Disease Progression|3|||
44144948|NCT02001623|78934746|FG007|Overall Study|Disease Progression|3|||
44144949|NCT02001623|78934747|FG008|Overall Study|Disease Progression|7|||
44144950|NCT02001623|78934748|FG009|Overall Study|Disease Progression|40|||
44144951|NCT02001623|78934749|FG010|Overall Study|Disease Progression|5|||
44144952|NCT02001623|78934750|FG011|Overall Study|Disease Progression|9|||
44144953|NCT02001623|78934751|FG012|Overall Study|Disease Progression|9|||
44144954|NCT02001623|78934752|FG013|Overall Study|Disease Progression|20|||
44144955|NCT02001623|78934753|FG014|Overall Study|Disease Progression|9|||
44144956|NCT02001623|78934739|FG000|Overall Study|Physician Decision|0|||
44144957|NCT02001623|78934740|FG001|Overall Study|Physician Decision|0|||
44144958|NCT02001623|78934741|FG002|Overall Study|Physician Decision|0|||
44144959|NCT02001623|78934742|FG003|Overall Study|Physician Decision|0|||
44144960|NCT02001623|78934743|FG004|Overall Study|Physician Decision|0|||
44144961|NCT02001623|78934744|FG005|Overall Study|Physician Decision|0|||
44144962|NCT02001623|78934745|FG006|Overall Study|Physician Decision|0|||
44144963|NCT02001623|78934746|FG007|Overall Study|Physician Decision|0|||
44144964|NCT02001623|78934747|FG008|Overall Study|Physician Decision|3|||
44144965|NCT02001623|78934748|FG009|Overall Study|Physician Decision|2|||
44144966|NCT02001623|78934749|FG010|Overall Study|Physician Decision|3|||
44250174|NCT01500200|79084453|FG004|Stage 2|Adverse Event|5|||
44250175|NCT01500200|79084454|FG005|Stage 2|Adverse Event|4|||
44250176|NCT01478360|79084470|FG000|Overall Study|Lost to Follow-up|1|||
44250177|NCT01478360|79084471|FG001|Overall Study|Lost to Follow-up|0|||
44250178|NCT01478360|79084470|FG000|Overall Study|Adverse Event|0|||
44250179|NCT01478360|79084471|FG001|Overall Study|Adverse Event|1|||
44250180|NCT01478360|79084470|FG000|Overall Study|Administrative problems|1|||
44144967|NCT02001623|78934750|FG011|Overall Study|Physician Decision|3|||
44144968|NCT02001623|78934751|FG012|Overall Study|Physician Decision|1|||
44144969|NCT02001623|78934752|FG013|Overall Study|Physician Decision|2|||
44144970|NCT02001623|78934753|FG014|Overall Study|Physician Decision|1|||
44250181|NCT01478360|79084471|FG001|Overall Study|Administrative problems|2|||
44382534|NCT00808132|79388510|FG004|Overall Study|Physician Decision|0|||
44144971|NCT02001623|78934739|FG000|Overall Study|Death|0|||
44144972|NCT02001623|78934740|FG001|Overall Study|Death|1|||
44144973|NCT02001623|78934741|FG002|Overall Study|Death|0|||
44144974|NCT02001623|78934742|FG003|Overall Study|Death|0|||
44144975|NCT02001623|78934743|FG004|Overall Study|Death|0|||
44144976|NCT02001623|78934744|FG005|Overall Study|Death|0|||
44144977|NCT02001623|78934745|FG006|Overall Study|Death|0|||
44144978|NCT02001623|78934746|FG007|Overall Study|Death|0|||
44144979|NCT02001623|78934747|FG008|Overall Study|Death|0|||
44144980|NCT02001623|78934748|FG009|Overall Study|Death|0|||
44144981|NCT02001623|78934749|FG010|Overall Study|Death|0|||
44250182|NCT01461980|79084489|FG000|Overall Study|Other|9|||
44144982|NCT02001623|78934750|FG011|Overall Study|Death|0|||
44144983|NCT02001623|78934751|FG012|Overall Study|Death|0|||
44144984|NCT02001623|78934752|FG013|Overall Study|Death|0|||
44250183|NCT01461980|79084490|FG001|Overall Study|Other|8|||
44250184|NCT01461980|79084491|FG002|Overall Study|Other|6|||
44250185|NCT01461980|79084489|FG000|Overall Study|Medication error|7|||
44250186|NCT01461980|79084490|FG001|Overall Study|Medication error|5|||
44250187|NCT01461980|79084491|FG002|Overall Study|Medication error|6|||
44250188|NCT01461980|79084489|FG000|Overall Study|Adverse Event|12|||
44144985|NCT02001623|78934753|FG014|Overall Study|Death|0|||
44144986|NCT02001623|78934739|FG000|Overall Study|Adverse Event|0|||
44144987|NCT02001623|78934740|FG001|Overall Study|Adverse Event|0|||
44144988|NCT02001623|78934741|FG002|Overall Study|Adverse Event|0|||
44144989|NCT02001623|78934742|FG003|Overall Study|Adverse Event|0|||
44144990|NCT02001623|78934743|FG004|Overall Study|Adverse Event|0|||
44144991|NCT02001623|78934744|FG005|Overall Study|Adverse Event|1|||
44144992|NCT02001623|78934745|FG006|Overall Study|Adverse Event|0|||
44144993|NCT02001623|78934746|FG007|Overall Study|Adverse Event|3|||
44144994|NCT02001623|78934747|FG008|Overall Study|Adverse Event|4|||
44144995|NCT02001623|78934748|FG009|Overall Study|Adverse Event|6|||
44144996|NCT02001623|78934749|FG010|Overall Study|Adverse Event|4|||
44144997|NCT02001623|78934750|FG011|Overall Study|Adverse Event|0|||
44144998|NCT02001623|78934751|FG012|Overall Study|Adverse Event|3|||
44144999|NCT02001623|78934752|FG013|Overall Study|Adverse Event|5|||
44145000|NCT02001623|78934753|FG014|Overall Study|Adverse Event|6|||
44145001|NCT02001623|78934739|FG000|Overall Study|Other - Miscellaneous|0|||
44145002|NCT02001623|78934740|FG001|Overall Study|Other - Miscellaneous|0|||
44145003|NCT02001623|78934741|FG002|Overall Study|Other - Miscellaneous|0|||
44145004|NCT02001623|78934742|FG003|Overall Study|Other - Miscellaneous|0|||
44250189|NCT01461980|79084490|FG001|Overall Study|Adverse Event|5|||
44250190|NCT01461980|79084491|FG002|Overall Study|Adverse Event|6|||
44250191|NCT01461980|79084489|FG000|Overall Study|Protocol Violation|12|||
44250192|NCT01461980|79084490|FG001|Overall Study|Protocol Violation|19|||
44250193|NCT01461980|79084491|FG002|Overall Study|Protocol Violation|16|||
44278225|NCT02065518|79239327|FG003|Overall Study|Lost to Follow-up|3|||
44278226|NCT02065518|79239324|FG000|Overall Study|Withdrawal by Subject|3|||
44278227|NCT02065518|79239325|FG001|Overall Study|Withdrawal by Subject|4|||
44278228|NCT02065518|79239326|FG002|Overall Study|Withdrawal by Subject|9|||
44278229|NCT02065518|79239327|FG003|Overall Study|Withdrawal by Subject|2|||
44278230|NCT01624662|79239341|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
44278231|NCT01624662|79239342|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
44278232|NCT01624662|79239343|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
44382535|NCT00808132|79388506|FG000|Overall Study|Lost to Follow-up|8|||
44382536|NCT00808132|79388507|FG001|Overall Study|Lost to Follow-up|10|||
44516575|NCT03053050|79523620|FG003|Randomized Phase|Lost to Follow-up|0|||
44516576|NCT03053050|79523617|FG000|Randomized Phase|Adverse Event|0|||
44516577|NCT03053050|79523618|FG001|Randomized Phase|Adverse Event|1|||
44516578|NCT03053050|79523619|FG002|Randomized Phase|Adverse Event|0|||
44516579|NCT03053050|79523620|FG003|Randomized Phase|Adverse Event|0|||
44516580|NCT03053050|79523617|FG000|Randomized Phase|Randomized but Never Treated|2|||
44516581|NCT03053050|79523618|FG001|Randomized Phase|Randomized but Never Treated|2|||
44145005|NCT02001623|78934743|FG004|Overall Study|Other - Miscellaneous|0|||
44145006|NCT02001623|78934744|FG005|Overall Study|Other - Miscellaneous|0|||
44145007|NCT02001623|78934745|FG006|Overall Study|Other - Miscellaneous|0|||
44145008|NCT02001623|78934746|FG007|Overall Study|Other - Miscellaneous|0|||
44145009|NCT02001623|78934747|FG008|Overall Study|Other - Miscellaneous|0|||
44145010|NCT02001623|78934748|FG009|Overall Study|Other - Miscellaneous|1|||
44145011|NCT02001623|78934749|FG010|Overall Study|Other - Miscellaneous|0|||
44145012|NCT02001623|78934750|FG011|Overall Study|Other - Miscellaneous|0|||
44250194|NCT01461980|79084489|FG000|Overall Study|No longer meets eligibility criteria|18|||
44278233|NCT01624662|79239344|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
44516582|NCT03053050|79523619|FG002|Randomized Phase|Randomized but Never Treated|2|||
44145013|NCT02001623|78934751|FG012|Overall Study|Other - Miscellaneous|0|||
44516583|NCT03053050|79523620|FG003|Randomized Phase|Randomized but Never Treated|0|||
44516584|NCT03053050|79523617|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
44278234|NCT01624662|79239341|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
44278235|NCT01624662|79239342|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
44278236|NCT01624662|79239343|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
44278237|NCT01624662|79239344|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
44278238|NCT01624662|79239341|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
44278239|NCT01624662|79239342|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
44278240|NCT01624662|79239343|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
44278241|NCT01624662|79239344|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
44278242|NCT01624662|79239341|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
44278243|NCT01624662|79239342|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
44278244|NCT01624662|79239343|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
44278245|NCT01624662|79239344|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
44278246|NCT01624662|79239341|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
44278247|NCT01624662|79239342|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
44278248|NCT01624662|79239343|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
44278249|NCT01624662|79239344|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
44278250|NCT01624662|79239341|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
44278251|NCT01624662|79239342|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
44278252|NCT01624662|79239343|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
44278253|NCT01624662|79239344|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
44278254|NCT01624662|79239341|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
44278255|NCT01624662|79239342|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
44278256|NCT01624662|79239343|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
44278257|NCT01624662|79239344|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
44278258|NCT01624506|79239367|FG000|Overall Study|Lost to Follow-up|29|||
44278259|NCT01624506|79239368|FG001|Overall Study|Lost to Follow-up|15|||
44278260|NCT01624506|79239367|FG000|Overall Study|Withdrawal by Subject|9|||
44278261|NCT01624506|79239368|FG001|Overall Study|Withdrawal by Subject|2|||
44278262|NCT01624506|79239367|FG000|Overall Study|Death|1|||
44278263|NCT01624506|79239368|FG001|Overall Study|Death|0|||
44278264|NCT01624506|79239367|FG000|Overall Study|LINX explants|23|||
44278265|NCT01624506|79239368|FG001|Overall Study|LINX explants|0|||
44278266|NCT01624506|79239367|FG000|Overall Study|Adverse Event|3|||
44278267|NCT01624506|79239368|FG001|Overall Study|Adverse Event|0|||
44278268|NCT02106390|79239377|FG000|Overall Study|Withdrawal by Subject|15|||
44278269|NCT02106390|79239378|FG001|Overall Study|Withdrawal by Subject|16|||
44278270|NCT02106390|79239379|FG002|Overall Study|Withdrawal by Subject|15|||
44278271|NCT02106390|79239377|FG000|Overall Study|Lost to Follow-up|25|||
44278272|NCT02106390|79239378|FG001|Overall Study|Lost to Follow-up|20|||
44278273|NCT02106390|79239379|FG002|Overall Study|Lost to Follow-up|13|||
44278274|NCT02106390|79239377|FG000|Overall Study|Other: Administrative Reason|8|||
44278275|NCT02106390|79239378|FG001|Overall Study|Other: Administrative Reason|5|||
44278276|NCT02106390|79239379|FG002|Overall Study|Other: Administrative Reason|12|||
44278277|NCT02106390|79239377|FG000|Overall Study|Other: Unspecified|1|||
44278278|NCT02106390|79239378|FG001|Overall Study|Other: Unspecified|4|||
44278279|NCT02106390|79239379|FG002|Overall Study|Other: Unspecified|2|||
44278280|NCT02106390|79239377|FG000|Overall Study|Adverse Event|0|||
44278281|NCT02106390|79239378|FG001|Overall Study|Adverse Event|2|||
44278282|NCT02106390|79239379|FG002|Overall Study|Adverse Event|1|||
44278283|NCT02106390|79239377|FG000|Overall Study|Protocol Violation|0|||
44278284|NCT02106390|79239378|FG001|Overall Study|Protocol Violation|1|||
44278285|NCT02106390|79239379|FG002|Overall Study|Protocol Violation|0|||
44278286|NCT02064894|79239393|FG000|Overall Study|Withdrawal by Subject|43|||
44278287|NCT02064894|79239394|FG001|Overall Study|Withdrawal by Subject|102|||
44278288|NCT02064894|79239395|FG002|Overall Study|Withdrawal by Subject|115|||
44278289|NCT02081586|79239407|FG000|Overall Study|Lost to Follow-up|0|||
44278290|NCT02081586|79239408|FG001|Overall Study|Lost to Follow-up|1|||
44278291|NCT02081586|79239409|FG002|Overall Study|Lost to Follow-up|0|||
44278292|NCT02081586|79239410|FG003|Overall Study|Lost to Follow-up|1|||
44278293|NCT02081586|79239407|FG000|Overall Study|Head injury not related to study|0|||
44278294|NCT02081586|79239408|FG001|Overall Study|Head injury not related to study|0|||
44278295|NCT02081586|79239409|FG002|Overall Study|Head injury not related to study|1|||
44278296|NCT02081586|79239410|FG003|Overall Study|Head injury not related to study|0|||
44278297|NCT02081196|79239422|FG000|Overall Study|Lost to Follow-up|1|||
44278298|NCT02064816|79239430|FG000|Overall Study|Adverse Event|3|||
44278299|NCT02064816|79239431|FG001|Overall Study|Adverse Event|2|||
44278300|NCT02064816|79239430|FG000|Overall Study|Withdrawal by Subject|2|||
44145014|NCT02001623|78934752|FG013|Overall Study|Other - Miscellaneous|1|||
44278301|NCT02064816|79239431|FG001|Overall Study|Withdrawal by Subject|1|||
44278302|NCT02064816|79239430|FG000|Overall Study|Lost to Follow-up|2|||
44278303|NCT02064816|79239431|FG001|Overall Study|Lost to Follow-up|1|||
44278304|NCT02064816|79239430|FG000|Overall Study|Therapeutic failure|0|||
44278305|NCT02064816|79239431|FG001|Overall Study|Therapeutic failure|1|||
44516585|NCT03053050|79523618|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
44516586|NCT03053050|79523619|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
44516587|NCT03053050|79523620|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
44516588|NCT03053050|79523617|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
44516589|NCT03053050|79523618|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
44516590|NCT03053050|79523619|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
44516591|NCT03053050|79523620|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
44516592|NCT03053050|79523617|FG000|Open-label Phase|Withdrew Consent|0|||
44516593|NCT03053050|79523618|FG001|Open-label Phase|Withdrew Consent|0|||
44516594|NCT03053050|79523619|FG002|Open-label Phase|Withdrew Consent|0|||
44516595|NCT03053050|79523620|FG003|Open-label Phase|Withdrew Consent|6|||
44516596|NCT03053050|79523617|FG000|Open-label Phase|Investigator's Discretion|0|||
44516597|NCT03053050|79523618|FG001|Open-label Phase|Investigator's Discretion|0|||
44516598|NCT03053050|79523619|FG002|Open-label Phase|Investigator's Discretion|0|||
44382537|NCT00808132|79388508|FG002|Overall Study|Lost to Follow-up|11|||
44382538|NCT00808132|79388509|FG003|Overall Study|Lost to Follow-up|8|||
44382539|NCT00808132|79388510|FG004|Overall Study|Lost to Follow-up|9|||
44382540|NCT00808132|79388506|FG000|Overall Study|Protocol Violation|8|||
44382541|NCT00808132|79388507|FG001|Overall Study|Protocol Violation|9|||
44382542|NCT00808132|79388508|FG002|Overall Study|Protocol Violation|4|||
44382543|NCT00808132|79388509|FG003|Overall Study|Protocol Violation|9|||
44382544|NCT00808132|79388510|FG004|Overall Study|Protocol Violation|5|||
44516599|NCT03053050|79523620|FG003|Open-label Phase|Investigator's Discretion|4|||
44516600|NCT04369950|79523631|FG000|Overall Study|Protocol Violation|2|||
44516601|NCT04369950|79523632|FG001|Overall Study|Protocol Violation|2|||
44516602|NCT04035564|79523640|FG000|Overall Study|Protocol Violation|1|||
44516603|NCT04035564|79523641|FG001|Overall Study|Protocol Violation|2|||
44516604|NCT04035564|79523640|FG000|Overall Study|No laboratory available|2|||
44516605|NCT04035564|79523641|FG001|Overall Study|No laboratory available|2|||
44516606|NCT04035564|79523640|FG000|Overall Study|Guardian declined consent|1|||
44516607|NCT04035564|79523641|FG001|Overall Study|Guardian declined consent|2|||
44516608|NCT02955602|79523650|FG000|Overall Study|Adverse Event|0|||
44516609|NCT02955602|79523651|FG001|Overall Study|Adverse Event|3|||
44516610|NCT02955602|79523652|FG002|Overall Study|Adverse Event|0|||
44516611|NCT02955602|79523650|FG000|Overall Study|Withdrawal of informed consent|1|||
44516612|NCT02955602|79523651|FG001|Overall Study|Withdrawal of informed consent|3|||
44516613|NCT02955602|79523652|FG002|Overall Study|Withdrawal of informed consent|2|||
44516614|NCT02955602|79523650|FG000|Overall Study|Lost to Follow-up|0|||
44516615|NCT02955602|79523651|FG001|Overall Study|Lost to Follow-up|0|||
44516616|NCT02955602|79523652|FG002|Overall Study|Lost to Follow-up|1|||
44145015|NCT02001623|78934753|FG014|Overall Study|Other - Miscellaneous|0|||
44145016|NCT02001623|78934739|FG000|Overall Study|Withdrawal by Subject|1|||
44145017|NCT02001623|78934740|FG001|Overall Study|Withdrawal by Subject|0|||
44145018|NCT02001623|78934741|FG002|Overall Study|Withdrawal by Subject|0|||
44145019|NCT02001623|78934742|FG003|Overall Study|Withdrawal by Subject|0|||
44145020|NCT02001623|78934743|FG004|Overall Study|Withdrawal by Subject|0|||
44145021|NCT02001623|78934744|FG005|Overall Study|Withdrawal by Subject|0|||
44145022|NCT02001623|78934745|FG006|Overall Study|Withdrawal by Subject|0|||
44145023|NCT02001623|78934746|FG007|Overall Study|Withdrawal by Subject|0|||
44145024|NCT02001623|78934747|FG008|Overall Study|Withdrawal by Subject|1|||
44145025|NCT02001623|78934748|FG009|Overall Study|Withdrawal by Subject|3|||
44145026|NCT02001623|78934749|FG010|Overall Study|Withdrawal by Subject|2|||
44145027|NCT02001623|78934750|FG011|Overall Study|Withdrawal by Subject|2|||
44145028|NCT02001623|78934751|FG012|Overall Study|Withdrawal by Subject|1|||
44145029|NCT02001623|78934752|FG013|Overall Study|Withdrawal by Subject|5|||
44145030|NCT02001623|78934753|FG014|Overall Study|Withdrawal by Subject|2|||
44145031|NCT02001623|78934739|FG000|Overall Study|Lost to Follow-up|0|||
44145032|NCT02001623|78934740|FG001|Overall Study|Lost to Follow-up|0|||
44382545|NCT00808132|79388506|FG000|Overall Study|Withdrawal by Subject|27|||
44516617|NCT02955602|79523650|FG000|Overall Study|Other|0|||
44516618|NCT02955602|79523651|FG001|Overall Study|Other|1|||
44516619|NCT02955602|79523652|FG002|Overall Study|Other|3|||
44516620|NCT04179786|79523660|FG000|Overall Study|Withdrawal by Subject|8|||
44516621|NCT04175808|79523664|FG000|Part A|Miscellaneous|2|||
44516622|NCT04175808|79523665|FG001|Part A|Miscellaneous|0|||
44516623|NCT04175808|79523666|FG002|Part A|Miscellaneous|0|||
44516624|NCT04175808|79523667|FG003|Part A|Miscellaneous|0|||
44516625|NCT04175808|79523668|FG004|Part A|Miscellaneous|0|||
44516626|NCT04175808|79523669|FG005|Part A|Miscellaneous|0|||
44516627|NCT04175808|79523670|FG006|Part A|Miscellaneous|0|||
44145033|NCT02001623|78934741|FG002|Overall Study|Lost to Follow-up|0|||
44145034|NCT02001623|78934742|FG003|Overall Study|Lost to Follow-up|0|||
44145035|NCT02001623|78934743|FG004|Overall Study|Lost to Follow-up|0|||
44382546|NCT00808132|79388507|FG001|Overall Study|Withdrawal by Subject|18|||
44382547|NCT00808132|79388508|FG002|Overall Study|Withdrawal by Subject|2|||
44516628|NCT04057196|79523686|FG000|Overall Study|Withdrawal by Subject|3|||
44516629|NCT04057196|79523686|FG000|Overall Study|Death|3|||
44516630|NCT04027686|79523692|FG000|Overall Study|Lost to Follow-up|2|||
44145036|NCT02001623|78934744|FG005|Overall Study|Lost to Follow-up|0|||
44145037|NCT02001623|78934745|FG006|Overall Study|Lost to Follow-up|0|||
44145038|NCT02001623|78934746|FG007|Overall Study|Lost to Follow-up|0|||
44145039|NCT02001623|78934747|FG008|Overall Study|Lost to Follow-up|0|||
44145040|NCT02001623|78934748|FG009|Overall Study|Lost to Follow-up|1|||
44145041|NCT02001623|78934749|FG010|Overall Study|Lost to Follow-up|0|||
44145042|NCT02001623|78934750|FG011|Overall Study|Lost to Follow-up|0|||
44145043|NCT02001623|78934751|FG012|Overall Study|Lost to Follow-up|0|||
44145044|NCT02001623|78934752|FG013|Overall Study|Lost to Follow-up|0|||
44145045|NCT02001623|78934753|FG014|Overall Study|Lost to Follow-up|0|||
44145046|NCT02001623|78934739|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
44145047|NCT02001623|78934740|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
44145048|NCT02001623|78934741|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
44145049|NCT02001623|78934742|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
44145050|NCT02001623|78934743|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
44145051|NCT02001623|78934744|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
44145052|NCT02001623|78934745|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
44145053|NCT02001623|78934746|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
44145054|NCT02001623|78934747|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
44145055|NCT02001623|78934748|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
44145056|NCT02001623|78934749|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
44145057|NCT02001623|78934750|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
44145058|NCT02001623|78934751|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
44145059|NCT02001623|78934752|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
44145060|NCT02001623|78934753|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
44145061|NCT02001623|78934739|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
44145062|NCT02001623|78934740|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
44145063|NCT02001623|78934741|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
44145064|NCT02001623|78934742|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
44145065|NCT02001623|78934743|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
44145066|NCT02001623|78934744|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
44145067|NCT02001623|78934745|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
44145068|NCT02001623|78934746|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
44145069|NCT02001623|78934747|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
44145070|NCT02001623|78934748|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
44145071|NCT02001623|78934749|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
44145072|NCT02001623|78934750|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
44145073|NCT02001623|78934751|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
44145074|NCT02001623|78934752|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
44145075|NCT02001623|78934753|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
44145076|NCT02713867|78934804|FG000|Randomization|Other Reason|2|||
44145077|NCT02713867|78934805|FG001|Randomization|Other Reason|1|||
44145078|NCT02713867|78934804|FG000|Randomization|Participant Withdrew consent|0|||
44145079|NCT02713867|78934805|FG001|Randomization|Participant Withdrew consent|2|||
44145080|NCT02713867|78934804|FG000|Treatment Period|Other Reasons|22|||
44145081|NCT02713867|78934805|FG001|Treatment Period|Other Reasons|28|||
44145082|NCT02713867|78934804|FG000|Treatment Period|Administrative reason by sponsor|21|||
44145083|NCT02713867|78934805|FG001|Treatment Period|Administrative reason by sponsor|16|||
44145084|NCT02713867|78934804|FG000|Treatment Period|No longer meets study criteria|2|||
44145085|NCT02713867|78934805|FG001|Treatment Period|No longer meets study criteria|1|||
44145086|NCT02713867|78934804|FG000|Treatment Period|Poor/Non Compliance|1|||
44145087|NCT02713867|78934805|FG001|Treatment Period|Poor/Non Compliance|0|||
44382548|NCT00808132|79388509|FG003|Overall Study|Withdrawal by Subject|7|||
44382549|NCT00808132|79388510|FG004|Overall Study|Withdrawal by Subject|16|||
44382550|NCT00808132|79388506|FG000|Overall Study|Other|6|||
44382551|NCT00808132|79388507|FG001|Overall Study|Other|4|||
44382552|NCT00808132|79388508|FG002|Overall Study|Other|6|||
44382553|NCT00808132|79388509|FG003|Overall Study|Other|2|||
44382554|NCT00808132|79388510|FG004|Overall Study|Other|15|||
44382555|NCT00808132|79388506|FG000|Overall Study|Randomized, but not treated|10|||
44382556|NCT00808132|79388507|FG001|Overall Study|Randomized, but not treated|7|||
44145088|NCT02713867|78934804|FG000|Treatment Period|Maximum Clinical Benefit|5|||
44145089|NCT02713867|78934805|FG001|Treatment Period|Maximum Clinical Benefit|6|||
44145090|NCT02713867|78934804|FG000|Treatment Period|Withdrew consent|3|||
44145091|NCT02713867|78934805|FG001|Treatment Period|Withdrew consent|6|||
44145092|NCT02713867|78934804|FG000|Treatment Period|Requested to Discontinue|8|||
44145093|NCT02713867|78934805|FG001|Treatment Period|Requested to Discontinue|8|||
44145094|NCT02713867|78934804|FG000|Treatment Period|AE unrelated to Study Drug|11|||
44145095|NCT02713867|78934805|FG001|Treatment Period|AE unrelated to Study Drug|10|||
44145096|NCT02713867|78934804|FG000|Treatment Period|Death|7|||
44145097|NCT02713867|78934805|FG001|Treatment Period|Death|3|||
44145098|NCT02713867|78934804|FG000|Treatment Period|Study Drug Toxicity|16|||
44145099|NCT02713867|78934805|FG001|Treatment Period|Study Drug Toxicity|19|||
44382557|NCT00808132|79388508|FG002|Overall Study|Randomized, but not treated|9|||
44382558|NCT00808132|79388509|FG003|Overall Study|Randomized, but not treated|8|||
44382559|NCT00808132|79388510|FG004|Overall Study|Randomized, but not treated|9|||
44516631|NCT04027686|79523693|FG001|Overall Study|Lost to Follow-up|0|||
44516632|NCT04027686|79523692|FG000|Overall Study|Withdrawal by Subject|0|||
44516633|NCT04027686|79523693|FG001|Overall Study|Withdrawal by Subject|1|||
44145100|NCT02713867|78934804|FG000|Treatment Period|Disease Progression|82|||
44145101|NCT02713867|78934805|FG001|Treatment Period|Disease Progression|83|||
44145102|NCT02730455|78934814|FG000|Overall Study|Death|5|||
44145103|NCT02730455|78934815|FG001|Overall Study|Death|6|||
44145104|NCT02730455|78934816|FG002|Overall Study|Death|4|||
44145105|NCT02730455|78934814|FG000|Overall Study|Consent withdrawn|2|||
44145106|NCT02730455|78934815|FG001|Overall Study|Consent withdrawn|4|||
44145107|NCT02730455|78934816|FG002|Overall Study|Consent withdrawn|1|||
44145108|NCT02730455|78934814|FG000|Overall Study|Lost to Follow-up|3|||
44145109|NCT02730455|78934815|FG001|Overall Study|Lost to Follow-up|1|||
44145110|NCT02730455|78934816|FG002|Overall Study|Lost to Follow-up|4|||
44145111|NCT02730455|78934814|FG000|Overall Study|Other|1|||
44145112|NCT02730455|78934815|FG001|Overall Study|Other|1|||
44145113|NCT02730455|78934816|FG002|Overall Study|Other|2|||
44145114|NCT02730455|78934814|FG000|Overall Study|Other|2|||
44145115|NCT02730455|78934815|FG001|Overall Study|Other|2|||
44145116|NCT02730455|78934816|FG002|Overall Study|Other|0|||
44145117|NCT04440449|78934826|FG000|Overall Study|Lost to Follow-up|2|||
44145118|NCT04440449|78934827|FG001|Overall Study|Lost to Follow-up|0|||
44145119|NCT00701311|78934834|FG000|Overall Study|Lack of Efficacy|3|||
44250195|NCT01461980|79084490|FG001|Overall Study|No longer meets eligibility criteria|9|||
44250196|NCT01461980|79084491|FG002|Overall Study|No longer meets eligibility criteria|19|||
44250197|NCT01461980|79084489|FG000|Overall Study|Lost to Follow-up|52|||
44250198|NCT01461980|79084490|FG001|Overall Study|Lost to Follow-up|53|||
44250199|NCT01461980|79084491|FG002|Overall Study|Lost to Follow-up|51|||
44250200|NCT01461980|79084489|FG000|Overall Study|No longer willing to participate|52|||
44250201|NCT01461980|79084490|FG001|Overall Study|No longer willing to participate|38|||
44278306|NCT02064816|79239430|FG000|Overall Study|Other|1|||
44278307|NCT02064816|79239431|FG001|Overall Study|Other|3|||
44278308|NCT02080260|79239437|FG000|Overall Study|Death|18|||
44278309|NCT02080260|79239437|FG000|Overall Study|Withdrawal by Subject|1|||
44278310|NCT01624194|79239443|FG000|Overall Study|Lost to Follow-up|1|||
44278311|NCT01624194|79239444|FG001|Overall Study|Lost to Follow-up|0|||
44278312|NCT01624194|79239443|FG000|Overall Study|Withdrawal by Subject|1|||
44278313|NCT01624194|79239444|FG001|Overall Study|Withdrawal by Subject|0|||
44278314|NCT02079636|79239466|FG000|Overall Study|Death|2|||
44278315|NCT02079636|79239467|FG001|Overall Study|Death|1|||
44278316|NCT02079636|79239468|FG002|Overall Study|Death|0|||
44278317|NCT02079636|79239469|FG003|Overall Study|Death|5|||
44278318|NCT02079636|79239470|FG004|Overall Study|Death|1|||
44278319|NCT02079636|79239471|FG005|Overall Study|Death|2|||
44278320|NCT02079636|79239472|FG006|Overall Study|Death|1|||
44278321|NCT02079636|79239473|FG007|Overall Study|Death|0|||
44516634|NCT03052426|79523706|FG000|Overall Study|Withdrawal by Subject|0|||
44516635|NCT03052426|79523707|FG001|Overall Study|Withdrawal by Subject|1|||
44516636|NCT03052426|79523708|FG002|Overall Study|Withdrawal by Subject|0|||
44516637|NCT03052426|79523706|FG000|Overall Study|Lost to Follow-up|2|||
44516638|NCT03052426|79523707|FG001|Overall Study|Lost to Follow-up|0|||
44516639|NCT03052426|79523708|FG002|Overall Study|Lost to Follow-up|1|||
44145120|NCT00701311|78934834|FG000|Overall Study|Adverse Event|3|||
44145121|NCT00701311|78934834|FG000|Overall Study|Withdrawal by Subject|2|||
44145122|NCT02730377|78934840|FG000|Overall Study|Other|5|||
44250202|NCT01461980|79084491|FG002|Overall Study|No longer willing to participate|54|||
44250203|NCT01461980|79084489|FG000|Overall Study|Randomized but not vaccinated|4|||
44250204|NCT01461980|79084490|FG001|Overall Study|Randomized but not vaccinated|8|||
44250205|NCT01461980|79084491|FG002|Overall Study|Randomized but not vaccinated|7|||
44250206|NCT01424501|79084506|FG000|Overall Study|Withdrawal by Subject|1|||
44250207|NCT01424501|79084507|FG001|Overall Study|Withdrawal by Subject|0|||
44145123|NCT02730377|78934841|FG001|Overall Study|Other|4|||
44250208|NCT01424501|79084508|FG002|Overall Study|Withdrawal by Subject|1|||
44250209|NCT01424501|79084509|FG003|Overall Study|Withdrawal by Subject|0|||
44145124|NCT02730377|78934840|FG000|Overall Study|Death|1|||
44145125|NCT02730377|78934841|FG001|Overall Study|Death|8|||
44145126|NCT02730377|78934840|FG000|Overall Study|Inadequate glycaemic control|368|||
44145127|NCT02730377|78934841|FG001|Overall Study|Inadequate glycaemic control|473|||
44145128|NCT02730377|78934840|FG000|Overall Study|Adverse Event|79|||
44145129|NCT02730377|78934841|FG001|Overall Study|Adverse Event|41|||
44250210|NCT01424501|79084510|FG004|Overall Study|Withdrawal by Subject|0|||
44250211|NCT01424501|79084511|FG005|Overall Study|Withdrawal by Subject|0|||
44145130|NCT02730377|78934840|FG000|Overall Study|Protocol Violation|23|||
44250212|NCT01424501|79084506|FG000|Overall Study|Lost to Follow-up|0|||
44250213|NCT01424501|79084507|FG001|Overall Study|Lost to Follow-up|1|||
44278322|NCT02079636|79239474|FG008|Overall Study|Death|0|||
44145131|NCT02730377|78934841|FG001|Overall Study|Protocol Violation|30|||
44278323|NCT02079636|79239475|FG009|Overall Study|Death|0|||
44278324|NCT02079636|79239476|FG010|Overall Study|Death|0|||
44278325|NCT02079636|79239477|FG011|Overall Study|Death|1|||
44516640|NCT03688880|79523723|FG000|Overall Study|Withdrawal by Subject|0|||
44516641|NCT03688880|79523724|FG001|Overall Study|Withdrawal by Subject|2|||
44516642|NCT03688880|79523723|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
44516643|NCT03688880|79523724|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
44516644|NCT03688880|79523723|FG000|Overall Study|Lost to Follow-up|4|||
44516645|NCT03688880|79523724|FG001|Overall Study|Lost to Follow-up|7|||
44250214|NCT01424501|79084508|FG002|Overall Study|Lost to Follow-up|1|||
44250215|NCT01424501|79084509|FG003|Overall Study|Lost to Follow-up|0|||
44250216|NCT01424501|79084510|FG004|Overall Study|Lost to Follow-up|0|||
44250217|NCT01424501|79084511|FG005|Overall Study|Lost to Follow-up|0|||
44250218|NCT01401959|79084592|FG000|Enrolled|Withdrawal by Subject|1|||
44250219|NCT01401959|79084593|FG001|Enrolled|Withdrawal by Subject|0|||
44250220|NCT01401959|79084594|FG002|Enrolled|Withdrawal by Subject|0|||
44250221|NCT01401959|79084592|FG000|Treated|Disease Progression|2|||
44250222|NCT01401959|79084593|FG001|Treated|Disease Progression|2|||
44250223|NCT01401959|79084594|FG002|Treated|Disease Progression|1|||
44250224|NCT01401959|79084592|FG000|Treated|Adverse Event|4|||
44250225|NCT01401959|79084593|FG001|Treated|Adverse Event|3|||
44250226|NCT01401959|79084594|FG002|Treated|Adverse Event|2|||
44250227|NCT01401959|79084592|FG000|Treated|Withdrawal by Subject|1|||
44516646|NCT03688880|79523723|FG000|Overall Study|Adverse Event|0|||
44516647|NCT03688880|79523724|FG001|Overall Study|Adverse Event|2|||
44516648|NCT03688880|79523723|FG000|Overall Study|Device deficiencies|0|||
44516649|NCT03688880|79523724|FG001|Overall Study|Device deficiencies|2|||
44516650|NCT03688880|79523723|FG000|Overall Study|Other|10|||
44516651|NCT03688880|79523724|FG001|Overall Study|Other|16|||
44516652|NCT03051178|79523730|FG000|Overall Study|Withdrawal by Subject|5|||
44250228|NCT01401959|79084593|FG001|Treated|Withdrawal by Subject|2|||
44250229|NCT01401959|79084594|FG002|Treated|Withdrawal by Subject|2|||
44250230|NCT01401959|79084592|FG000|Treated|Protocol Violation|0|||
44278326|NCT02079636|79239478|FG012|Overall Study|Death|1|||
44516653|NCT03051100|79523736|FG000|Overall Study|Withdrawal by Subject|1|||
44250231|NCT01401959|79084593|FG001|Treated|Protocol Violation|1|||
44250232|NCT01401959|79084594|FG002|Treated|Protocol Violation|0|||
44250233|NCT01478048|79084624|FG000|Overall Study|Disease Progression|52|||
44250234|NCT01478048|79084625|FG001|Overall Study|Disease Progression|35|||
44250235|NCT01478048|79084624|FG000|Overall Study|study drug toxicity|11|||
44250236|NCT01478048|79084625|FG001|Overall Study|study drug toxicity|14|||
44250237|NCT01478048|79084624|FG000|Overall Study|Adverse Event|2|||
44250238|NCT01478048|79084625|FG001|Overall Study|Adverse Event|11|||
44250239|NCT01478048|79084624|FG000|Overall Study|subject request to discontinue treatment|3|||
44250240|NCT01478048|79084625|FG001|Overall Study|subject request to discontinue treatment|5|||
44250241|NCT01478048|79084624|FG000|Overall Study|Withdrawal by Subject|2|||
44278327|NCT02079636|79239479|FG013|Overall Study|Death|0|||
44516654|NCT03051100|79523737|FG001|Overall Study|Withdrawal by Subject|0|||
44250242|NCT01478048|79084625|FG001|Overall Study|Withdrawal by Subject|5|||
44250243|NCT01478048|79084624|FG000|Overall Study|non-specified|6|||
44250244|NCT01478048|79084625|FG001|Overall Study|non-specified|4|||
44278328|NCT02079636|79239480|FG014|Overall Study|Death|2|||
44278329|NCT02079636|79239466|FG000|Overall Study|Adverse Event|1|||
44516655|NCT01343368|79523745|FG000|Overall Study|Death|1|||
44250245|NCT01478048|79084624|FG000|Overall Study|poor/non-compliance|0|||
44250246|NCT01478048|79084625|FG001|Overall Study|poor/non-compliance|1|||
44250247|NCT01478048|79084624|FG000|Overall Study|no longer meets study criteria|1|||
44250248|NCT01478048|79084625|FG001|Overall Study|no longer meets study criteria|0|||
44250249|NCT01424189|79084633|FG000|Overall Study|Adverse Event|1|||
44250250|NCT01424189|79084634|FG001|Overall Study|Adverse Event|0|||
44250251|NCT01424189|79084633|FG000|Overall Study|Lost to Follow-up|4|||
44278330|NCT02079636|79239467|FG001|Overall Study|Adverse Event|1|||
44516656|NCT01343368|79523746|FG001|Overall Study|Death|0|||
44516657|NCT01343368|79523745|FG000|Overall Study|Lost to Follow-up|1|||
44516658|NCT01343368|79523746|FG001|Overall Study|Lost to Follow-up|0|||
44278331|NCT02079636|79239468|FG002|Overall Study|Adverse Event|0|||
44516659|NCT02955212|79523754|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
44250252|NCT01424189|79084634|FG001|Overall Study|Lost to Follow-up|1|||
44250253|NCT01424189|79084633|FG000|Overall Study|Withdrawal by Subject|4|||
44250254|NCT01424189|79084634|FG001|Overall Study|Withdrawal by Subject|4|||
44250255|NCT01424189|79084633|FG000|Overall Study|Subject moved|1|||
44250256|NCT01424189|79084634|FG001|Overall Study|Subject moved|0|||
44250257|NCT01424189|79084633|FG000|Overall Study|Death|3|||
44250258|NCT01424189|79084634|FG001|Overall Study|Death|1|||
44250259|NCT01401647|79084647|FG000|Overall Study|Withdrawal by Subject|1|||
44516660|NCT02955212|79523755|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
44516661|NCT02955212|79523754|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
44516662|NCT02955212|79523755|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
44516663|NCT02955212|79523754|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
44516664|NCT02955212|79523755|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
44516665|NCT02955212|79523754|FG000|Period 1: Double-blind Treatment Period|Other|3|||
44516666|NCT02955212|79523755|FG001|Period 1: Double-blind Treatment Period|Other|2|||
44516667|NCT02955212|79523754|FG000|Period 2: Open-label Extension|Adverse Event|11|||
44516668|NCT02955212|79523755|FG001|Period 2: Open-label Extension|Adverse Event|7|||
44145132|NCT02730377|78934840|FG000|Overall Study|Lack of Efficacy|4|||
44145133|NCT02730377|78934841|FG001|Overall Study|Lack of Efficacy|13|||
44145134|NCT02730377|78934840|FG000|Overall Study|Pregnancy|0|||
44145135|NCT02730377|78934841|FG001|Overall Study|Pregnancy|1|||
44145136|NCT02730377|78934840|FG000|Overall Study|Withdrawal by Subject|45|||
44145137|NCT02730377|78934841|FG001|Overall Study|Withdrawal by Subject|42|||
44145138|NCT02730377|78934840|FG000|Overall Study|Lost to Follow-up|25|||
44145139|NCT02730377|78934841|FG001|Overall Study|Lost to Follow-up|21|||
44145140|NCT02714569|78934858|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
44145141|NCT02714569|78934859|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
44145142|NCT02714569|78934860|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
44278332|NCT02079636|79239469|FG003|Overall Study|Adverse Event|1|||
44516669|NCT02955212|79523754|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
44516670|NCT02955212|79523755|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
44516671|NCT02955212|79523754|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
44516672|NCT02955212|79523755|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
44516673|NCT02955212|79523754|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
44516674|NCT02955212|79523755|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
44516675|NCT02955212|79523754|FG000|Period 2: Open-label Extension|Other|2|||
44516676|NCT02955212|79523755|FG001|Period 2: Open-label Extension|Other|4|||
44516677|NCT03050398|79523762|FG000|Overall Study|Study terminated by sponsor|8|||
44516678|NCT03662750|79523766|FG000|Overall Study|Withdrawal by Subject|1|||
44516679|NCT04052204|79523770|FG000|Overall Study|Death|1|||
44516680|NCT04052204|79523771|FG001|Overall Study|Death|0|||
44516681|NCT04052204|79523772|FG002|Overall Study|Death|0|||
44516682|NCT04052204|79523770|FG000|Overall Study|Progressive disease|1|||
44516683|NCT04052204|79523771|FG001|Overall Study|Progressive disease|0|||
44516684|NCT04052204|79523772|FG002|Overall Study|Progressive disease|0|||
44516685|NCT04052204|79523770|FG000|Overall Study|Other|1|||
44516686|NCT04052204|79523771|FG001|Overall Study|Other|0|||
44516687|NCT04052204|79523772|FG002|Overall Study|Other|0|||
44516688|NCT04050722|79523778|FG000|Overall Study|Withdrawal by Subject|1|||
44516689|NCT04050722|79523779|FG001|Overall Study|Withdrawal by Subject|0|||
44516690|NCT04049552|79523785|FG000|Overall Study|Lost to Follow-up|1|||
44516691|NCT03048058|79523793|FG000|Overall Study|Lost to Follow-up|4|||
44516692|NCT03048058|79523794|FG001|Overall Study|Lost to Follow-up|0|||
44516693|NCT03048058|79523793|FG000|Overall Study|Withdrawal by Subject|0|||
44516694|NCT03048058|79523794|FG001|Overall Study|Withdrawal by Subject|4|||
44250260|NCT01401647|79084648|FG001|Overall Study|Withdrawal by Subject|5|||
44250261|NCT01401647|79084649|FG002|Overall Study|Withdrawal by Subject|2|||
44250262|NCT01401647|79084647|FG000|Overall Study|Lost to Follow-up|3|||
44250263|NCT01401647|79084648|FG001|Overall Study|Lost to Follow-up|3|||
44250264|NCT01401647|79084649|FG002|Overall Study|Lost to Follow-up|1|||
44250265|NCT01499810|79084657|FG000|Overall Study|Lost to Follow-up|10|||
44250266|NCT01499810|79084657|FG000|Overall Study|Protocol Violation|1|||
44250267|NCT01499810|79084657|FG000|Overall Study|Withdrawal by Subject|1|||
44250268|NCT01423253|79084662|FG000|Overall Study|Adverse Event|2|||
44250269|NCT01423253|79084662|FG000|Overall Study|Lack of Efficacy|2|||
44250270|NCT01423253|79084662|FG000|Overall Study|Lost to Follow-up|1|||
44250271|NCT01423253|79084662|FG000|Overall Study|Protocol Violation|2|||
44250272|NCT01423253|79084662|FG000|Overall Study|Withdrawal by Subject|2|||
44250273|NCT01477892|79084668|FG000|Overall Study|Withdrawal by Subject|0|||
44250274|NCT01477892|79084669|FG001|Overall Study|Withdrawal by Subject|2|||
44250275|NCT01422239|79084682|FG000|Overall Study|Lost to Follow-up|4|||
44250276|NCT01422239|79084683|FG001|Overall Study|Lost to Follow-up|3|||
44250277|NCT01499576|79084689|FG000|Overall Study|Physician Decision|12|||
44250278|NCT01499576|79084689|FG000|Overall Study|Withdrawal by Subject|9|||
44250279|NCT01476722|79084703|FG000|Overall Study|Adverse Event|1|||
44250280|NCT01476644|79084716|FG000|Overall Study|Death|5|||
44250281|NCT01476644|79084716|FG000|Overall Study|moved to another state|2|||
44278333|NCT02079636|79239470|FG004|Overall Study|Adverse Event|1|||
44278334|NCT02079636|79239471|FG005|Overall Study|Adverse Event|2|||
44278335|NCT02079636|79239472|FG006|Overall Study|Adverse Event|0|||
44278336|NCT02079636|79239473|FG007|Overall Study|Adverse Event|0|||
44278337|NCT02079636|79239474|FG008|Overall Study|Adverse Event|0|||
44278338|NCT02079636|79239475|FG009|Overall Study|Adverse Event|0|||
44278339|NCT02079636|79239476|FG010|Overall Study|Adverse Event|0|||
44516695|NCT03047980|79523800|FG000|Overall Study|Adverse Event|1|||
44516696|NCT04048382|79523806|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
44516697|NCT04048382|79523807|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
44516698|NCT04048382|79523806|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
44145143|NCT02714569|78934861|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
44145144|NCT02714569|78934862|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
44145145|NCT02714569|78934863|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
44250282|NCT01476644|79084716|FG000|Overall Study|Lost to Follow-up|19|||
44278340|NCT02079636|79239477|FG011|Overall Study|Adverse Event|0|||
44145146|NCT02714569|78934864|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
44145147|NCT02714569|78934865|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
44250283|NCT01476644|79084716|FG000|Overall Study|Withdrawal by Subject|13|||
44516699|NCT04048382|79523807|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
44516700|NCT04048382|79523806|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
44516701|NCT04048382|79523807|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
44516702|NCT04047446|79523815|FG000|Overall Study|Physician Decision|1|||
44278341|NCT02079636|79239478|FG012|Overall Study|Adverse Event|0|||
44278342|NCT02079636|79239479|FG013|Overall Study|Adverse Event|0|||
44278343|NCT02079636|79239480|FG014|Overall Study|Adverse Event|0|||
44516703|NCT04047446|79523816|FG001|Overall Study|Physician Decision|0|||
44516704|NCT03655106|79523824|FG000|Overall Study|Withdrawal by Subject|3|||
44516705|NCT03655106|79523825|FG001|Overall Study|Withdrawal by Subject|2|||
44516706|NCT03655106|79523824|FG000|Overall Study|Lost to Follow-up|2|||
44516707|NCT03655106|79523825|FG001|Overall Study|Lost to Follow-up|1|||
44145148|NCT02714569|78934866|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
44250284|NCT01421459|79084740|FG000|Overall Study|Adverse Event|6|||
44250285|NCT01421459|79084741|FG001|Overall Study|Adverse Event|10|||
44250286|NCT01421459|79084740|FG000|Overall Study|Death|1|||
44250287|NCT01421459|79084741|FG001|Overall Study|Death|1|||
44250288|NCT01421459|79084740|FG000|Overall Study|Lack of Efficacy|1|||
44250289|NCT01421459|79084741|FG001|Overall Study|Lack of Efficacy|2|||
44250290|NCT01421459|79084740|FG000|Overall Study|Lost to Follow-up|8|||
44250291|NCT01421459|79084741|FG001|Overall Study|Lost to Follow-up|9|||
44250292|NCT01421459|79084740|FG000|Overall Study|Physician Decision|9|||
44250293|NCT01421459|79084741|FG001|Overall Study|Physician Decision|9|||
44250294|NCT01421459|79084740|FG000|Overall Study|Protocol Violation|8|||
44250295|NCT01421459|79084741|FG001|Overall Study|Protocol Violation|5|||
44250296|NCT01421459|79084740|FG000|Overall Study|Withdrawal by Subject|12|||
44250297|NCT01421459|79084741|FG001|Overall Study|Withdrawal by Subject|16|||
44250298|NCT01498952|79084749|FG000|Overall Study|Death|2|||
44250299|NCT01498952|79084750|FG001|Overall Study|Death|2|||
44250300|NCT01498952|79084751|FG002|Overall Study|Death|0|||
44250301|NCT01498952|79084752|FG003|Overall Study|Death|0|||
44250302|NCT01498952|79084753|FG004|Overall Study|Death|0|||
44250303|NCT01461044|79084785|FG000|Overall Study|Death|58|||
44250304|NCT01461044|79084786|FG001|Overall Study|Death|35|||
44278344|NCT02079636|79239466|FG000|Overall Study|Progressive disease|0|||
44250305|NCT01461044|79084785|FG000|Overall Study|Lost to Follow-up|12|||
44250306|NCT01461044|79084786|FG001|Overall Study|Lost to Follow-up|5|||
44516708|NCT03655106|79523824|FG000|Overall Study|Duplicate Enrollment|1|||
44516709|NCT03655106|79523825|FG001|Overall Study|Duplicate Enrollment|1|||
44145149|NCT02714569|78934867|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
44250307|NCT01421303|79084819|FG000|Overall Study|Lost to Follow-up|13|||
44250308|NCT01421303|79084819|FG000|Overall Study|Non compliance with study procedure|1|||
44516710|NCT03655106|79523824|FG000|Overall Study|Protocol Violation|3|||
44516711|NCT03655106|79523825|FG001|Overall Study|Protocol Violation|0|||
44516712|NCT03630302|79523831|FG000|Surgery|hardware issue prevented LFP recordings|1|||
44516713|NCT03630302|79523831|FG000|3 Month Visit|Adverse Event|2|||
44516714|NCT03630302|79523831|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
44516715|NCT04041440|79523837|FG000|Overall Study|Withdrawal by Subject|0|||
44516716|NCT04041440|79523838|FG001|Overall Study|Withdrawal by Subject|1|||
44516717|NCT04041440|79523837|FG000|Overall Study|Lost to Follow-up|0|||
44516718|NCT04041440|79523838|FG001|Overall Study|Lost to Follow-up|1|||
44516719|NCT03654560|79523847|FG000|Overall Study|Death|3|||
44516720|NCT03654560|79523848|FG001|Overall Study|Death|1|||
44516721|NCT03654560|79523847|FG000|Overall Study|Lost to Follow-up|1|||
44516722|NCT03654560|79523848|FG001|Overall Study|Lost to Follow-up|0|||
44516723|NCT03629054|79523856|FG000|Period 2 (4 Days)|Not treated|0|||
44516724|NCT03629054|79523857|FG001|Period 2 (4 Days)|Not treated|1|||
44516725|NCT03628898|79523863|FG000|Overall Study|Device deficiency|1|||
44516726|NCT03628508|79523867|FG000|Overall Study|Lost to Follow-up|1|||
44516727|NCT03045328|79523871|FG000|Overall Study|Withdrawal by Subject|2|||
44516728|NCT02154490|79523877|FG000|Overall Study|No tissue submitted|23|||
44516729|NCT02154490|79523877|FG000|Overall Study|No biomarker results|167|||
44516730|NCT02154490|79523877|FG000|Overall Study|Not assigned to a sub-study|270|||
44145150|NCT02714569|78934868|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
44145151|NCT02714569|78934858|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145152|NCT02714569|78934859|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145153|NCT02714569|78934860|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145154|NCT02714569|78934861|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
44145155|NCT02714569|78934862|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145156|NCT02714569|78934863|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145157|NCT02714569|78934864|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145158|NCT02714569|78934865|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145159|NCT02714569|78934866|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145160|NCT02714569|78934867|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145161|NCT02714569|78934868|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
44145162|NCT02714569|78934858|FG000|Part A Third Intervention|Adverse Event|0|||
44145163|NCT02714569|78934859|FG001|Part A Third Intervention|Adverse Event|0|||
44145164|NCT02714569|78934860|FG002|Part A Third Intervention|Adverse Event|1|||
44145165|NCT02714569|78934861|FG003|Part A Third Intervention|Adverse Event|0|||
44145166|NCT02714569|78934862|FG004|Part A Third Intervention|Adverse Event|0|||
44145167|NCT02714569|78934863|FG005|Part A Third Intervention|Adverse Event|0|||
44145168|NCT02714569|78934864|FG006|Part A Third Intervention|Adverse Event|0|||
44145169|NCT02714569|78934865|FG007|Part A Third Intervention|Adverse Event|0|||
44145170|NCT02714569|78934866|FG008|Part A Third Intervention|Adverse Event|0|||
44145171|NCT02714569|78934867|FG009|Part A Third Intervention|Adverse Event|0|||
44145172|NCT02714569|78934868|FG010|Part A Third Intervention|Adverse Event|0|||
44145173|NCT02714569|78934858|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
44145174|NCT02714569|78934859|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145175|NCT02714569|78934860|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145176|NCT02714569|78934861|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145177|NCT02714569|78934862|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145178|NCT02714569|78934863|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
44145179|NCT02714569|78934864|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145180|NCT02714569|78934865|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145181|NCT02714569|78934866|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145182|NCT02714569|78934867|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145183|NCT02714569|78934868|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
44145184|NCT02714569|78934858|FG000|Part B (Overall)|Lost to Follow-up|0|||
44145185|NCT02714569|78934859|FG001|Part B (Overall)|Lost to Follow-up|0|||
44145186|NCT02714569|78934860|FG002|Part B (Overall)|Lost to Follow-up|0|||
44145187|NCT02714569|78934861|FG003|Part B (Overall)|Lost to Follow-up|0|||
44145188|NCT02714569|78934862|FG004|Part B (Overall)|Lost to Follow-up|0|||
44250309|NCT01421303|79084819|FG000|Overall Study|Other|7|||
44516731|NCT02154490|79523877|FG000|Overall Study|Did not register to a sub-study|749|||
44516732|NCT03627494|79523893|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
44516733|NCT03627494|79523894|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516734|NCT03627494|79523895|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
44516735|NCT03627494|79523896|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516736|NCT03627494|79523897|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516737|NCT03627494|79523898|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516738|NCT03627494|79523899|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516739|NCT03627494|79523900|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516740|NCT03627494|79523901|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516741|NCT03627494|79523902|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516742|NCT03627494|79523903|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
44145189|NCT02714569|78934863|FG005|Part B (Overall)|Lost to Follow-up|0|||
44145190|NCT02714569|78934864|FG006|Part B (Overall)|Lost to Follow-up|1|||
44145191|NCT02714569|78934865|FG007|Part B (Overall)|Lost to Follow-up|0|||
44145192|NCT02714569|78934866|FG008|Part B (Overall)|Lost to Follow-up|0|||
44145193|NCT02714569|78934867|FG009|Part B (Overall)|Lost to Follow-up|0|||
44145194|NCT02714569|78934868|FG010|Part B (Overall)|Lost to Follow-up|0|||
44145195|NCT02714569|78934858|FG000|Part B (Overall)|Withdrawal by Subject|0|||
44145196|NCT02714569|78934859|FG001|Part B (Overall)|Withdrawal by Subject|0|||
44145197|NCT02714569|78934860|FG002|Part B (Overall)|Withdrawal by Subject|0|||
44145198|NCT02714569|78934861|FG003|Part B (Overall)|Withdrawal by Subject|0|||
44278345|NCT02079636|79239467|FG001|Overall Study|Progressive disease|0|||
44278346|NCT02079636|79239468|FG002|Overall Study|Progressive disease|0|||
44278347|NCT02079636|79239469|FG003|Overall Study|Progressive disease|2|||
44278348|NCT02079636|79239470|FG004|Overall Study|Progressive disease|0|||
44278349|NCT02079636|79239471|FG005|Overall Study|Progressive disease|0|||
44278350|NCT02079636|79239472|FG006|Overall Study|Progressive disease|0|||
44278351|NCT02079636|79239473|FG007|Overall Study|Progressive disease|0|||
44278352|NCT02079636|79239474|FG008|Overall Study|Progressive disease|0|||
44278353|NCT02079636|79239475|FG009|Overall Study|Progressive disease|0|||
44278354|NCT02079636|79239476|FG010|Overall Study|Progressive disease|0|||
44278355|NCT02079636|79239477|FG011|Overall Study|Progressive disease|0|||
44278356|NCT02079636|79239478|FG012|Overall Study|Progressive disease|1|||
44278357|NCT02079636|79239479|FG013|Overall Study|Progressive disease|0|||
44278358|NCT02079636|79239480|FG014|Overall Study|Progressive disease|0|||
44278359|NCT02079636|79239466|FG000|Overall Study|Withdrawal by Subject|0|||
44278360|NCT02079636|79239467|FG001|Overall Study|Withdrawal by Subject|0|||
44278361|NCT02079636|79239468|FG002|Overall Study|Withdrawal by Subject|0|||
44382560|NCT00808132|79388506|FG000|Overall Study|Unsatisfactory response|5|||
44382561|NCT00808132|79388507|FG001|Overall Study|Unsatisfactory response|6|||
44382562|NCT00808132|79388508|FG002|Overall Study|Unsatisfactory response|6|||
44382563|NCT00808132|79388509|FG003|Overall Study|Unsatisfactory response|4|||
44382564|NCT00808132|79388510|FG004|Overall Study|Unsatisfactory response|12|||
44382565|NCT00727441|79388525|FG000|Overall Study|Disease Progression|11|||
44382566|NCT00727441|79388526|FG001|Overall Study|Disease Progression|14|||
44382567|NCT00727441|79388527|FG002|Overall Study|Disease Progression|17|||
44382568|NCT00727441|79388525|FG000|Overall Study|Eligibility|7|||
44382569|NCT00727441|79388526|FG001|Overall Study|Eligibility|5|||
44382570|NCT00727441|79388527|FG002|Overall Study|Eligibility|7|||
44382571|NCT00727441|79388525|FG000|Overall Study|Death|0|||
44382572|NCT00727441|79388526|FG001|Overall Study|Death|1|||
44382573|NCT00727441|79388527|FG002|Overall Study|Death|1|||
44382574|NCT00727441|79388525|FG000|Overall Study|Physician Decision|0|||
44382575|NCT00727441|79388526|FG001|Overall Study|Physician Decision|1|||
44382576|NCT00727441|79388527|FG002|Overall Study|Physician Decision|0|||
44382577|NCT00727441|79388525|FG000|Overall Study|Withdrawal by Subject|0|||
44516743|NCT03627494|79523904|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
44516744|NCT03627494|79523893|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516745|NCT03627494|79523894|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516746|NCT03627494|79523895|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516747|NCT03627494|79523896|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516748|NCT03627494|79523897|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516749|NCT03627494|79523898|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516750|NCT03627494|79523899|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516751|NCT03627494|79523900|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
44145199|NCT02714569|78934862|FG004|Part B (Overall)|Withdrawal by Subject|0|||
44145200|NCT02714569|78934863|FG005|Part B (Overall)|Withdrawal by Subject|0|||
44278362|NCT02079636|79239469|FG003|Overall Study|Withdrawal by Subject|4|||
44278363|NCT02079636|79239470|FG004|Overall Study|Withdrawal by Subject|0|||
44278364|NCT02079636|79239471|FG005|Overall Study|Withdrawal by Subject|1|||
44278365|NCT02079636|79239472|FG006|Overall Study|Withdrawal by Subject|0|||
44278366|NCT02079636|79239473|FG007|Overall Study|Withdrawal by Subject|0|||
44278367|NCT02079636|79239474|FG008|Overall Study|Withdrawal by Subject|0|||
44278368|NCT02079636|79239475|FG009|Overall Study|Withdrawal by Subject|2|||
44278369|NCT02079636|79239476|FG010|Overall Study|Withdrawal by Subject|1|||
44278370|NCT02079636|79239477|FG011|Overall Study|Withdrawal by Subject|1|||
44278371|NCT02079636|79239478|FG012|Overall Study|Withdrawal by Subject|1|||
44278372|NCT02079636|79239479|FG013|Overall Study|Withdrawal by Subject|0|||
44278373|NCT02079636|79239480|FG014|Overall Study|Withdrawal by Subject|2|||
44278374|NCT02079636|79239466|FG000|Overall Study|Physician Decision|0|||
44278375|NCT02079636|79239467|FG001|Overall Study|Physician Decision|0|||
44278376|NCT02079636|79239468|FG002|Overall Study|Physician Decision|0|||
44278377|NCT02079636|79239469|FG003|Overall Study|Physician Decision|0|||
44278378|NCT02079636|79239470|FG004|Overall Study|Physician Decision|0|||
44278379|NCT02079636|79239471|FG005|Overall Study|Physician Decision|1|||
44278380|NCT02079636|79239472|FG006|Overall Study|Physician Decision|0|||
44278381|NCT02079636|79239473|FG007|Overall Study|Physician Decision|0|||
44278382|NCT02079636|79239474|FG008|Overall Study|Physician Decision|0|||
44382578|NCT00727441|79388526|FG001|Overall Study|Withdrawal by Subject|1|||
44382579|NCT00727441|79388527|FG002|Overall Study|Withdrawal by Subject|0|||
44382580|NCT00717769|79388541|FG000|Overall Study|Adverse Event|9|||
44278383|NCT02079636|79239475|FG009|Overall Study|Physician Decision|1|||
44278384|NCT02079636|79239476|FG010|Overall Study|Physician Decision|1|||
44278385|NCT02079636|79239477|FG011|Overall Study|Physician Decision|0|||
44278386|NCT02079636|79239478|FG012|Overall Study|Physician Decision|0|||
44278387|NCT02079636|79239479|FG013|Overall Study|Physician Decision|0|||
44278388|NCT02079636|79239480|FG014|Overall Study|Physician Decision|1|||
44278389|NCT02079636|79239466|FG000|Overall Study|Lost to Follow-up|0|||
44278390|NCT02079636|79239467|FG001|Overall Study|Lost to Follow-up|0|||
44278391|NCT02079636|79239468|FG002|Overall Study|Lost to Follow-up|0|||
44278392|NCT02079636|79239469|FG003|Overall Study|Lost to Follow-up|0|||
44278393|NCT02079636|79239470|FG004|Overall Study|Lost to Follow-up|0|||
44278394|NCT02079636|79239471|FG005|Overall Study|Lost to Follow-up|0|||
44278395|NCT02079636|79239472|FG006|Overall Study|Lost to Follow-up|0|||
44278396|NCT02079636|79239473|FG007|Overall Study|Lost to Follow-up|1|||
44278397|NCT02079636|79239474|FG008|Overall Study|Lost to Follow-up|0|||
44278398|NCT02079636|79239475|FG009|Overall Study|Lost to Follow-up|0|||
44278399|NCT02079636|79239476|FG010|Overall Study|Lost to Follow-up|0|||
44278400|NCT02079636|79239477|FG011|Overall Study|Lost to Follow-up|0|||
44278401|NCT02079636|79239478|FG012|Overall Study|Lost to Follow-up|0|||
44278402|NCT02079636|79239479|FG013|Overall Study|Lost to Follow-up|0|||
44278403|NCT02079636|79239480|FG014|Overall Study|Lost to Follow-up|0|||
44278404|NCT02079246|79239544|FG000|OLEX|Withdrawal before treatment|1|||
44278405|NCT02079246|79239545|FG001|OLEX|Withdrawal before treatment|0|||
44250310|NCT01421303|79084819|FG000|Overall Study|Withdrawal by Subject|1|||
44250311|NCT01475474|79084823|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
44250312|NCT01475474|79084823|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
44250313|NCT01400243|79084830|FG000|Overall Study|Protocol Violation|8|||
44250314|NCT01400243|79084831|FG001|Overall Study|Protocol Violation|11|||
44250315|NCT01475162|79084848|FG000|Overall Study|Physician Decision|1|||
44250316|NCT01475162|79084848|FG000|Overall Study|Death|10|||
44250317|NCT01475162|79084848|FG000|Overall Study|Study closed for safety|3|||
44250318|NCT01421225|79084855|FG000|Overall Study|Withdrawal by Subject|0|||
44250319|NCT01421225|79084856|FG001|Overall Study|Withdrawal by Subject|1|||
44250320|NCT01498640|79084872|FG000|Overall Study|Lost to Follow-up|1|||
44250321|NCT01498640|79084872|FG000|Overall Study|Death|1|||
44250322|NCT01498640|79084872|FG000|Overall Study|Other|3|||
44250323|NCT01498484|79084884|FG000|Overall Study|Death|6|||
44250324|NCT01498484|79084885|FG001|Overall Study|Death|3|||
44250325|NCT01498484|79084886|FG002|Overall Study|Death|1|||
44250326|NCT01498484|79084887|FG003|Overall Study|Death|1|||
44250327|NCT01498484|79084888|FG004|Overall Study|Death|0|||
44250328|NCT01498484|79084889|FG005|Overall Study|Death|0|||
44250329|NCT01498484|79084890|FG006|Overall Study|Death|10|||
44250330|NCT01498484|79084891|FG007|Overall Study|Death|1|||
44250331|NCT01498484|79084892|FG008|Overall Study|Death|0|||
44250332|NCT01498484|79084884|FG000|Overall Study|Physician Decision|3|||
44250333|NCT01498484|79084885|FG001|Overall Study|Physician Decision|2|||
44250334|NCT01498484|79084886|FG002|Overall Study|Physician Decision|1|||
44250335|NCT01498484|79084887|FG003|Overall Study|Physician Decision|1|||
44250336|NCT01498484|79084888|FG004|Overall Study|Physician Decision|0|||
44250337|NCT01498484|79084889|FG005|Overall Study|Physician Decision|0|||
44250338|NCT01498484|79084890|FG006|Overall Study|Physician Decision|8|||
44250339|NCT01498484|79084891|FG007|Overall Study|Physician Decision|13|||
44250340|NCT01498484|79084892|FG008|Overall Study|Physician Decision|1|||
44250341|NCT01498484|79084884|FG000|Overall Study|Adverse Event|0|||
44250342|NCT01498484|79084885|FG001|Overall Study|Adverse Event|0|||
44250343|NCT01498484|79084886|FG002|Overall Study|Adverse Event|0|||
44250344|NCT01498484|79084887|FG003|Overall Study|Adverse Event|0|||
44250345|NCT01498484|79084888|FG004|Overall Study|Adverse Event|0|||
44250346|NCT01498484|79084889|FG005|Overall Study|Adverse Event|1|||
44250347|NCT01498484|79084890|FG006|Overall Study|Adverse Event|0|||
44250348|NCT01498484|79084891|FG007|Overall Study|Adverse Event|0|||
44250349|NCT01498484|79084892|FG008|Overall Study|Adverse Event|0|||
44250350|NCT01498484|79084884|FG000|Overall Study|Withdrawal by Subject|0|||
44250351|NCT01498484|79084885|FG001|Overall Study|Withdrawal by Subject|0|||
44278406|NCT02079246|79239544|FG000|OLEX|Death|11|||
44278407|NCT02079246|79239545|FG001|OLEX|Death|0|||
44278408|NCT02079246|79239544|FG000|OLEX|Adverse Event|66|||
44278409|NCT02079246|79239545|FG001|OLEX|Adverse Event|0|||
44250352|NCT01498484|79084886|FG002|Overall Study|Withdrawal by Subject|0|||
44250353|NCT01498484|79084887|FG003|Overall Study|Withdrawal by Subject|1|||
44250354|NCT01498484|79084888|FG004|Overall Study|Withdrawal by Subject|0|||
44250355|NCT01498484|79084889|FG005|Overall Study|Withdrawal by Subject|0|||
44250356|NCT01498484|79084890|FG006|Overall Study|Withdrawal by Subject|1|||
44250357|NCT01498484|79084891|FG007|Overall Study|Withdrawal by Subject|0|||
44250358|NCT01498484|79084892|FG008|Overall Study|Withdrawal by Subject|0|||
44250359|NCT01498484|79084884|FG000|Overall Study|Other|5|||
44250360|NCT01498484|79084885|FG001|Overall Study|Other|2|||
44278410|NCT02079246|79239544|FG000|OLEX|Withdrawal by Subject|60|||
44278411|NCT02079246|79239545|FG001|OLEX|Withdrawal by Subject|0|||
44278412|NCT02079246|79239544|FG000|OLEX|Lost to Follow-up|6|||
44278413|NCT02079246|79239545|FG001|OLEX|Lost to Follow-up|0|||
44278414|NCT02079246|79239544|FG000|OLEX|Protocol Violation|6|||
44278415|NCT02079246|79239545|FG001|OLEX|Protocol Violation|0|||
44278416|NCT02079246|79239544|FG000|OLEX|Lack of Efficacy|3|||
44278417|NCT02079246|79239545|FG001|OLEX|Lack of Efficacy|0|||
44278418|NCT02079246|79239544|FG000|OLEX|Results of the lead-in studies|58|||
44278419|NCT02079246|79239545|FG001|OLEX|Results of the lead-in studies|0|||
44278420|NCT02079246|79239544|FG000|OLEX|Other: Disallowed medication|8|||
44278421|NCT02079246|79239545|FG001|OLEX|Other: Disallowed medication|0|||
44278422|NCT02079246|79239544|FG000|OLEX|Other: Insufficient compliance|2|||
44278423|NCT02079246|79239545|FG001|OLEX|Other: Insufficient compliance|0|||
44278424|NCT02079246|79239544|FG000|OLEX|Other: Caregiver unavailable|3|||
44278425|NCT02079246|79239545|FG001|OLEX|Other: Caregiver unavailable|0|||
44278426|NCT02079246|79239544|FG000|OLEX|Other: Coordinator decision|1|||
44278427|NCT02079246|79239545|FG001|OLEX|Other: Coordinator decision|0|||
44278428|NCT02079246|79239544|FG000|OLEX|Other: Worsening of condition|1|||
44278429|NCT02079246|79239545|FG001|OLEX|Other: Worsening of condition|0|||
44278430|NCT02079246|79239544|FG000|OLEX|Other: Moved to nursing home|1|||
44278431|NCT02079246|79239545|FG001|OLEX|Other: Moved to nursing home|0|||
44278432|NCT02079246|79239544|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
44278433|NCT02079246|79239545|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
44278434|NCT02079246|79239544|FG000|OLEX-MEM|Adverse Event|0|||
44278435|NCT02079246|79239545|FG001|OLEX-MEM|Adverse Event|6|||
44278436|NCT02079246|79239544|FG000|OLEX-MEM|Withdrawal by Subject|0|||
44278437|NCT02079246|79239545|FG001|OLEX-MEM|Withdrawal by Subject|7|||
44278438|NCT02079246|79239544|FG000|OLEX-MEM|Protocol Violation|0|||
44516752|NCT03627494|79523901|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
44516753|NCT03627494|79523902|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516754|NCT03627494|79523903|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
44516755|NCT03627494|79523904|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
44250361|NCT01498484|79084886|FG002|Overall Study|Other|0|||
44250362|NCT01498484|79084887|FG003|Overall Study|Other|0|||
44250363|NCT01498484|79084888|FG004|Overall Study|Other|1|||
44250364|NCT01498484|79084889|FG005|Overall Study|Other|0|||
44250365|NCT01498484|79084890|FG006|Overall Study|Other|3|||
44250366|NCT01498484|79084891|FG007|Overall Study|Other|0|||
44250367|NCT01498484|79084892|FG008|Overall Study|Other|1|||
44250368|NCT01474772|79084901|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
44250369|NCT01474772|79084902|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
44250370|NCT01474772|79084901|FG000|Period 1|AE not Related to Study Drug|1|||
44250371|NCT01474772|79084902|FG001|Period 1|AE not Related to Study Drug|0|||
44145201|NCT02714569|78934864|FG006|Part B (Overall)|Withdrawal by Subject|0|||
44145202|NCT02714569|78934865|FG007|Part B (Overall)|Withdrawal by Subject|1|||
44250372|NCT01474772|79084901|FG000|Period 1|Withdrawal by Subject|3|||
44250373|NCT01474772|79084902|FG001|Period 1|Withdrawal by Subject|1|||
44250374|NCT01474772|79084901|FG000|Period 1|Lost to Follow-up|1|||
44250375|NCT01474772|79084902|FG001|Period 1|Lost to Follow-up|0|||
44250376|NCT01474772|79084901|FG000|Period 1|Reason not Specified|1|||
44250377|NCT01474772|79084902|FG001|Period 1|Reason not Specified|1|||
44250378|NCT01474772|79084901|FG000|Washout|AE not Related to Study Drug|2|||
44516756|NCT03627494|79523893|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
44278439|NCT02079246|79239545|FG001|OLEX-MEM|Protocol Violation|2|||
44278440|NCT02079246|79239544|FG000|OLEX-MEM|Lost to Follow-up|0|||
44516757|NCT03627494|79523894|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516758|NCT03627494|79523895|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516759|NCT03627494|79523896|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516760|NCT03627494|79523897|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516761|NCT03627494|79523898|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516762|NCT03627494|79523899|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516763|NCT03627494|79523900|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
44145203|NCT02714569|78934866|FG008|Part B (Overall)|Withdrawal by Subject|0|||
44145204|NCT02714569|78934867|FG009|Part B (Overall)|Withdrawal by Subject|1|||
44278441|NCT02079246|79239545|FG001|OLEX-MEM|Lost to Follow-up|1|||
44278442|NCT02079246|79239544|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
44278443|NCT02079246|79239545|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
44382581|NCT00717769|79388542|FG001|Overall Study|Adverse Event|6|||
44250379|NCT01474772|79084902|FG001|Washout|AE not Related to Study Drug|0|||
44250380|NCT01474772|79084901|FG000|Washout|Withdrawal by Subject|1|||
44278444|NCT02077374|79239556|FG000|Overall Study|Withdrawal by Subject|0|||
44278445|NCT02077374|79239557|FG001|Overall Study|Withdrawal by Subject|1|||
44250381|NCT01474772|79084902|FG001|Washout|Withdrawal by Subject|0|||
44250382|NCT01474772|79084901|FG000|Washout|Lost to Follow-up|0|||
44278446|NCT02077374|79239556|FG000|Overall Study|Protocol Violation|0|||
44278447|NCT02077374|79239557|FG001|Overall Study|Protocol Violation|1|||
44278448|NCT02077140|79239571|FG000|Overall Study|Lost to Follow-up|4|||
44250383|NCT01474772|79084902|FG001|Washout|Lost to Follow-up|1|||
44250384|NCT01474772|79084901|FG000|Washout|Reason not Specified|0|||
44516764|NCT03627494|79523901|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516765|NCT03627494|79523902|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
44516766|NCT03627494|79523903|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
44516767|NCT03627494|79523904|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
44516768|NCT03627416|79523945|FG000|Overall Study|Adverse Event|0|||
44516769|NCT03627416|79523946|FG001|Overall Study|Adverse Event|1|||
44516770|NCT00097539|79523959|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
44516771|NCT00097539|79523960|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
44516772|NCT00097539|79523961|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
44516773|NCT00097539|79523962|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
44516774|NCT00097539|79523963|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
44516775|NCT00097539|79523964|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
44516776|NCT00097539|79523965|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
44516777|NCT00097539|79523959|FG000|Overall Study|Withdrawal by Subject|925|||
44516778|NCT00097539|79523960|FG001|Overall Study|Withdrawal by Subject|323|||
44516779|NCT00097539|79523961|FG002|Overall Study|Withdrawal by Subject|346|||
44516780|NCT00097539|79523962|FG003|Overall Study|Withdrawal by Subject|217|||
44516781|NCT00097539|79523963|FG004|Overall Study|Withdrawal by Subject|68|||
44516782|NCT00097539|79523964|FG005|Overall Study|Withdrawal by Subject|229|||
44516783|NCT00097539|79523965|FG006|Overall Study|Withdrawal by Subject|3|||
44516784|NCT00097539|79523959|FG000|Overall Study|Participant Non-compliant|2140|||
44516785|NCT00097539|79523960|FG001|Overall Study|Participant Non-compliant|567|||
44516786|NCT00097539|79523961|FG002|Overall Study|Participant Non-compliant|1067|||
44516787|NCT00097539|79523962|FG003|Overall Study|Participant Non-compliant|353|||
44516788|NCT00097539|79523963|FG004|Overall Study|Participant Non-compliant|136|||
44516789|NCT00097539|79523964|FG005|Overall Study|Participant Non-compliant|543|||
44516790|NCT00097539|79523965|FG006|Overall Study|Participant Non-compliant|18|||
44516791|NCT00097539|79523959|FG000|Overall Study|Lack of Efficacy|249|||
44516792|NCT00097539|79523960|FG001|Overall Study|Lack of Efficacy|122|||
44516793|NCT00097539|79523961|FG002|Overall Study|Lack of Efficacy|202|||
44516794|NCT00097539|79523962|FG003|Overall Study|Lack of Efficacy|105|||
44516795|NCT00097539|79523963|FG004|Overall Study|Lack of Efficacy|45|||
44516796|NCT00097539|79523964|FG005|Overall Study|Lack of Efficacy|228|||
44516797|NCT00097539|79523965|FG006|Overall Study|Lack of Efficacy|5|||
44516798|NCT00097539|79523959|FG000|Overall Study|Adverse Event|78|||
44516799|NCT00097539|79523960|FG001|Overall Study|Adverse Event|133|||
44516800|NCT00097539|79523961|FG002|Overall Study|Adverse Event|37|||
44516801|NCT00097539|79523962|FG003|Overall Study|Adverse Event|27|||
44516802|NCT00097539|79523963|FG004|Overall Study|Adverse Event|30|||
44516803|NCT00097539|79523964|FG005|Overall Study|Adverse Event|59|||
44250385|NCT01474772|79084902|FG001|Washout|Reason not Specified|1|||
44250386|NCT01474772|79084901|FG000|Period 2|Death|0|||
44250387|NCT01474772|79084902|FG001|Period 2|Death|1|||
44250388|NCT01474772|79084901|FG000|Period 2|AE Related to Study Drug|0|||
44250389|NCT01474772|79084902|FG001|Period 2|AE Related to Study Drug|1|||
44250390|NCT01474772|79084901|FG000|Period 2|AE not Related to Study Drug|4|||
44250391|NCT01474772|79084902|FG001|Period 2|AE not Related to Study Drug|1|||
44250392|NCT01474772|79084901|FG000|Period 2|Lack of Efficacy|1|||
44250393|NCT01474772|79084902|FG001|Period 2|Lack of Efficacy|0|||
44250394|NCT01474772|79084901|FG000|Period 2|Withdrawal by Subject|3|||
44250395|NCT01474772|79084902|FG001|Period 2|Withdrawal by Subject|4|||
44250396|NCT01474772|79084901|FG000|Period 2|Lost to Follow-up|1|||
44250397|NCT01474772|79084902|FG001|Period 2|Lost to Follow-up|1|||
44250398|NCT01474772|79084901|FG000|Period 2|Reason not Specified|0|||
44250399|NCT01474772|79084902|FG001|Period 2|Reason not Specified|2|||
44250400|NCT01474772|79084901|FG000|Follow-up|AE not Related to Study Drug|0|||
44516804|NCT00097539|79523965|FG006|Overall Study|Adverse Event|1|||
44516805|NCT00097539|79523959|FG000|Overall Study|Death|2|||
44516806|NCT00097539|79523960|FG001|Overall Study|Death|7|||
44516807|NCT00097539|79523961|FG002|Overall Study|Death|0|||
44516808|NCT00097539|79523962|FG003|Overall Study|Death|0|||
44516809|NCT00097539|79523963|FG004|Overall Study|Death|1|||
44516810|NCT00097539|79523964|FG005|Overall Study|Death|3|||
44516811|NCT00097539|79523965|FG006|Overall Study|Death|0|||
44516812|NCT00097539|79523959|FG000|Overall Study|Reasons Other Than Above|3602|||
44250401|NCT01474772|79084902|FG001|Follow-up|AE not Related to Study Drug|1|||
44250402|NCT01421147|79084910|FG000|Treatment Period|Adverse Event|2|||
44250403|NCT01421147|79084911|FG001|Treatment Period|Adverse Event|3|||
44250404|NCT01421147|79084910|FG000|Treatment Period|Lost to Follow-up|2|||
44250405|NCT01421147|79084911|FG001|Treatment Period|Lost to Follow-up|1|||
44250406|NCT01421147|79084910|FG000|Treatment Period|Physician Decision|2|||
44516813|NCT00097539|79523960|FG001|Overall Study|Reasons Other Than Above|1382|||
44516814|NCT00097539|79523961|FG002|Overall Study|Reasons Other Than Above|1757|||
44516815|NCT00097539|79523962|FG003|Overall Study|Reasons Other Than Above|692|||
44516816|NCT00097539|79523963|FG004|Overall Study|Reasons Other Than Above|361|||
44516817|NCT00097539|79523964|FG005|Overall Study|Reasons Other Than Above|1244|||
44516818|NCT00097539|79523965|FG006|Overall Study|Reasons Other Than Above|34|||
44516819|NCT00097539|79523959|FG000|Overall Study|Reason not Specified|111|||
44516820|NCT00097539|79523960|FG001|Overall Study|Reason not Specified|49|||
44516821|NCT00097539|79523961|FG002|Overall Study|Reason not Specified|53|||
44516822|NCT00097539|79523962|FG003|Overall Study|Reason not Specified|21|||
44516823|NCT00097539|79523963|FG004|Overall Study|Reason not Specified|11|||
44516824|NCT00097539|79523964|FG005|Overall Study|Reason not Specified|40|||
44516825|NCT00097539|79523965|FG006|Overall Study|Reason not Specified|2|||
44516826|NCT03925324|79523983|FG000|Overall Study|Death|1|||
44516827|NCT03925324|79523984|FG001|Overall Study|Death|1|||
44516828|NCT03042910|79523990|FG000|Overall Study|Adverse Event|1|||
44516829|NCT03042910|79523990|FG000|Overall Study|Disease Progression|2|||
44516830|NCT03042910|79523990|FG000|Overall Study|Withdrawal by Subject|3|||
44516831|NCT03042910|79523990|FG000|Overall Study|Enrolled but not treated|1|||
44516832|NCT03059446|79523994|FG000|Overall Study|Adverse Event|11|||
44516833|NCT03059446|79523994|FG000|Overall Study|Withdrawal of Consent|16|||
44516834|NCT03059446|79523994|FG000|Overall Study|Lost to Follow-up|3|||
44516835|NCT03059446|79523994|FG000|Overall Study|Protocol Violation|1|||
44516836|NCT03059446|79523994|FG000|Overall Study|Study Terminated by Sponsor|131|||
44516837|NCT03059446|79523994|FG000|Overall Study|Reason not Specified|5|||
44516838|NCT00090519|79524000|FG000|Overall Study|Adverse Event|5|||
44516839|NCT00090519|79524001|FG001|Overall Study|Adverse Event|4|||
44516840|NCT00090519|79524000|FG000|Overall Study|Death|9|||
44516841|NCT00090519|79524001|FG001|Overall Study|Death|9|||
44516842|NCT00090519|79524000|FG000|Overall Study|Lost to Follow-up|26|||
44516843|NCT00090519|79524001|FG001|Overall Study|Lost to Follow-up|29|||
44516844|NCT00090519|79524000|FG000|Overall Study|Withdrawal by Subject|28|||
44516845|NCT00090519|79524001|FG001|Overall Study|Withdrawal by Subject|29|||
44516846|NCT00090519|79524000|FG000|Overall Study|Physician Decision|2|||
44516847|NCT00090519|79524001|FG001|Overall Study|Physician Decision|3|||
44516848|NCT00090519|79524000|FG000|Overall Study|Sponsor Decision|3|||
44145205|NCT02714569|78934868|FG010|Part B (Overall)|Withdrawal by Subject|0|||
44516849|NCT00090519|79524001|FG001|Overall Study|Sponsor Decision|1|||
44516850|NCT00096993|79524031|FG000|Overall Study|Death|1|||
44516851|NCT00096993|79524032|FG001|Overall Study|Death|0|||
44516852|NCT00096993|79524031|FG000|Overall Study|Disease progression|56|||
44516853|NCT00096993|79524032|FG001|Overall Study|Disease progression|53|||
44516854|NCT00096993|79524031|FG000|Overall Study|Adverse Event|2|||
44516855|NCT00096993|79524032|FG001|Overall Study|Adverse Event|8|||
44516856|NCT00096993|79524031|FG000|Overall Study|Subject's decision|3|||
44516857|NCT00096993|79524032|FG001|Overall Study|Subject's decision|1|||
44516858|NCT00096993|79524031|FG000|Overall Study|Physician Decision|2|||
44516859|NCT00096993|79524032|FG001|Overall Study|Physician Decision|1|||
44516860|NCT00096993|79524031|FG000|Overall Study|Non-compliance|0|||
44516861|NCT00096993|79524032|FG001|Overall Study|Non-compliance|1|||
44516862|NCT00096993|79524031|FG000|Overall Study|Other unspecified|1|||
44516863|NCT00096993|79524032|FG001|Overall Study|Other unspecified|1|||
44516864|NCT03040336|79524040|FG000|Overall Study|Death|1|||
44516865|NCT03040336|79524041|FG001|Overall Study|Death|0|||
44516866|NCT03040336|79524040|FG000|Overall Study|Withdrawal by Subject|2|||
44516867|NCT03040336|79524041|FG001|Overall Study|Withdrawal by Subject|3|||
44516868|NCT00072189|79524048|FG000|Overall Study|Withdrawal by Subject|1|||
44516869|NCT03040024|79524055|FG000|Overall Study|Adverse Event|0|||
44516870|NCT03040024|79524056|FG001|Overall Study|Adverse Event|1|||
44516871|NCT03040024|79524057|FG002|Overall Study|Adverse Event|0|||
44516872|NCT03040024|79524055|FG000|Overall Study|Death|0|||
44516873|NCT03040024|79524056|FG001|Overall Study|Death|1|||
44516874|NCT03040024|79524057|FG002|Overall Study|Death|0|||
44516875|NCT03040024|79524055|FG000|Overall Study|Physician Decision|0|||
44516876|NCT03040024|79524056|FG001|Overall Study|Physician Decision|0|||
44516877|NCT03040024|79524057|FG002|Overall Study|Physician Decision|1|||
44516878|NCT03039790|79524085|FG000|Overall Study|Lost to Follow-up|2|||
44516879|NCT03039790|79524086|FG001|Overall Study|Lost to Follow-up|0|||
44516880|NCT03039790|79524087|FG002|Overall Study|Lost to Follow-up|1|||
44516881|NCT03039790|79524088|FG003|Overall Study|Lost to Follow-up|1|||
44516882|NCT03039790|79524089|FG004|Overall Study|Lost to Follow-up|0|||
44516883|NCT03039790|79524090|FG005|Overall Study|Lost to Follow-up|1|||
44516884|NCT03039790|79524091|FG006|Overall Study|Lost to Follow-up|1|||
44516885|NCT03039790|79524092|FG007|Overall Study|Lost to Follow-up|1|||
44516886|NCT03039790|79524093|FG008|Overall Study|Lost to Follow-up|0|||
44516887|NCT03039790|79524094|FG009|Overall Study|Lost to Follow-up|1|||
44516888|NCT03039790|79524095|FG010|Overall Study|Lost to Follow-up|1|||
44516889|NCT03039790|79524096|FG011|Overall Study|Lost to Follow-up|0|||
44516890|NCT03039790|79524097|FG012|Overall Study|Lost to Follow-up|1|||
44516891|NCT03039790|79524098|FG013|Overall Study|Lost to Follow-up|0|||
44516892|NCT03039790|79524099|FG014|Overall Study|Lost to Follow-up|3|||
44516893|NCT03039790|79524100|FG015|Overall Study|Lost to Follow-up|1|||
44516894|NCT03039790|79524101|FG016|Overall Study|Lost to Follow-up|2|||
44516895|NCT03039790|79524102|FG017|Overall Study|Lost to Follow-up|2|||
44516896|NCT03039790|79524103|FG018|Overall Study|Lost to Follow-up|1|||
44516897|NCT03039790|79524104|FG019|Overall Study|Lost to Follow-up|3|||
44516898|NCT03039790|79524085|FG000|Overall Study|Withdrawal of Consent|1|||
44516899|NCT03039790|79524086|FG001|Overall Study|Withdrawal of Consent|0|||
44516900|NCT03039790|79524087|FG002|Overall Study|Withdrawal of Consent|0|||
44516901|NCT03039790|79524088|FG003|Overall Study|Withdrawal of Consent|1|||
44516902|NCT03039790|79524089|FG004|Overall Study|Withdrawal of Consent|0|||
44516903|NCT03039790|79524090|FG005|Overall Study|Withdrawal of Consent|0|||
44516904|NCT03039790|79524091|FG006|Overall Study|Withdrawal of Consent|0|||
44516905|NCT03039790|79524092|FG007|Overall Study|Withdrawal of Consent|0|||
44516906|NCT03039790|79524093|FG008|Overall Study|Withdrawal of Consent|0|||
44516907|NCT03039790|79524094|FG009|Overall Study|Withdrawal of Consent|1|||
44516908|NCT03039790|79524095|FG010|Overall Study|Withdrawal of Consent|0|||
44516909|NCT03039790|79524096|FG011|Overall Study|Withdrawal of Consent|0|||
44516910|NCT03039790|79524097|FG012|Overall Study|Withdrawal of Consent|2|||
44516911|NCT03039790|79524098|FG013|Overall Study|Withdrawal of Consent|0|||
44516912|NCT03039790|79524099|FG014|Overall Study|Withdrawal of Consent|1|||
44516913|NCT03039790|79524100|FG015|Overall Study|Withdrawal of Consent|5|||
44516914|NCT03039790|79524101|FG016|Overall Study|Withdrawal of Consent|3|||
44516915|NCT03039790|79524102|FG017|Overall Study|Withdrawal of Consent|0|||
44278449|NCT02077140|79239572|FG001|Overall Study|Lost to Follow-up|1|||
44278450|NCT02077140|79239573|FG002|Overall Study|Lost to Follow-up|2|||
44278451|NCT02077140|79239574|FG003|Overall Study|Lost to Follow-up|2|||
44278452|NCT02077140|79239575|FG004|Overall Study|Lost to Follow-up|3|||
44278453|NCT02077140|79239571|FG000|Overall Study|Withdrawal by Subject|0|||
44278454|NCT02077140|79239572|FG001|Overall Study|Withdrawal by Subject|1|||
44278455|NCT02077140|79239573|FG002|Overall Study|Withdrawal by Subject|0|||
44278456|NCT02077140|79239574|FG003|Overall Study|Withdrawal by Subject|2|||
44278457|NCT02077140|79239575|FG004|Overall Study|Withdrawal by Subject|2|||
44278458|NCT02047110|79239594|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
44278459|NCT02047110|79239595|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
44278460|NCT02047110|79239596|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
44278461|NCT02047110|79239597|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
44278462|NCT02047110|79239594|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
44278463|NCT02047110|79239595|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
44278464|NCT02047110|79239596|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
44278465|NCT02047110|79239597|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
44278466|NCT02047110|79239594|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
44278467|NCT02047110|79239595|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
44278468|NCT02047110|79239596|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
44278469|NCT02047110|79239597|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
44278470|NCT02047110|79239594|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
44278471|NCT02047110|79239595|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
44278472|NCT02047110|79239596|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
44278473|NCT02047110|79239597|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
44278474|NCT02047110|79239594|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
44278475|NCT02047110|79239595|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
44278476|NCT02047110|79239596|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
44278477|NCT02047110|79239597|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
44278478|NCT02047110|79239594|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
44278479|NCT02047110|79239595|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
44278480|NCT02047110|79239596|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
44278481|NCT02047110|79239597|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
44278482|NCT02047110|79239594|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
44278483|NCT02047110|79239595|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
44278484|NCT02047110|79239596|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
44278485|NCT02047110|79239597|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
44278486|NCT02047110|79239594|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
44278487|NCT02047110|79239595|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
44278488|NCT02047110|79239596|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
44278489|NCT02047110|79239597|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
44278490|NCT02047110|79239594|FG000|Escape Treatment Period|Adverse Event|1|||
44278491|NCT02047110|79239595|FG001|Escape Treatment Period|Adverse Event|2|||
44278492|NCT02047110|79239596|FG002|Escape Treatment Period|Adverse Event|2|||
44278493|NCT02047110|79239597|FG003|Escape Treatment Period|Adverse Event|0|||
44278494|NCT02047110|79239594|FG000|Escape Treatment Period|Other than specified|1|||
44278495|NCT02047110|79239595|FG001|Escape Treatment Period|Other than specified|2|||
44278496|NCT02047110|79239596|FG002|Escape Treatment Period|Other than specified|0|||
44278497|NCT02047110|79239597|FG003|Escape Treatment Period|Other than specified|1|||
44278498|NCT02047110|79239594|FG000|OLE Treatment Period|Other than specified|0|||
44382582|NCT00717769|79388543|FG002|Overall Study|Adverse Event|1|||
44516916|NCT03039790|79524103|FG018|Overall Study|Withdrawal of Consent|2|||
44516917|NCT03039790|79524104|FG019|Overall Study|Withdrawal of Consent|5|||
44516918|NCT03039790|79524085|FG000|Overall Study|Death|0|||
44516919|NCT03039790|79524086|FG001|Overall Study|Death|0|||
44516920|NCT03039790|79524087|FG002|Overall Study|Death|0|||
44516921|NCT03039790|79524088|FG003|Overall Study|Death|0|||
44516922|NCT03039790|79524089|FG004|Overall Study|Death|0|||
44516923|NCT03039790|79524090|FG005|Overall Study|Death|0|||
44516924|NCT03039790|79524091|FG006|Overall Study|Death|0|||
44516925|NCT03039790|79524092|FG007|Overall Study|Death|0|||
44516926|NCT03039790|79524093|FG008|Overall Study|Death|0|||
44516927|NCT03039790|79524094|FG009|Overall Study|Death|0|||
44516928|NCT03039790|79524095|FG010|Overall Study|Death|0|||
44516929|NCT03039790|79524096|FG011|Overall Study|Death|0|||
44516930|NCT03039790|79524097|FG012|Overall Study|Death|0|||
44516931|NCT03039790|79524098|FG013|Overall Study|Death|0|||
44516932|NCT03039790|79524099|FG014|Overall Study|Death|0|||
44516933|NCT03039790|79524100|FG015|Overall Study|Death|1|||
44516934|NCT03039790|79524101|FG016|Overall Study|Death|3|||
44145206|NCT02714569|78934858|FG000|Part B (Overall)|Adverse Event|0|||
44145207|NCT02714569|78934859|FG001|Part B (Overall)|Adverse Event|0|||
44516935|NCT03039790|79524102|FG017|Overall Study|Death|0|||
44516936|NCT03039790|79524103|FG018|Overall Study|Death|2|||
44516937|NCT03039790|79524104|FG019|Overall Study|Death|0|||
44516938|NCT03039790|79524085|FG000|Overall Study|Reason, not Specified|1|||
44516939|NCT03039790|79524086|FG001|Overall Study|Reason, not Specified|0|||
44516940|NCT03039790|79524087|FG002|Overall Study|Reason, not Specified|0|||
44145208|NCT02714569|78934860|FG002|Part B (Overall)|Adverse Event|0|||
44250407|NCT01421147|79084911|FG001|Treatment Period|Physician Decision|2|||
44250408|NCT01421147|79084910|FG000|Treatment Period|Withdrawal by Subject|10|||
44250409|NCT01421147|79084911|FG001|Treatment Period|Withdrawal by Subject|5|||
44250410|NCT01421147|79084910|FG000|Extension Period|Adverse Event|0|||
44250411|NCT01421147|79084911|FG001|Extension Period|Adverse Event|2|||
44250412|NCT01421147|79084910|FG000|Extension Period|Death|0|||
44250413|NCT01421147|79084911|FG001|Extension Period|Death|1|||
44250414|NCT01421147|79084910|FG000|Extension Period|Lost to Follow-up|2|||
44250415|NCT01421147|79084911|FG001|Extension Period|Lost to Follow-up|5|||
44250416|NCT01421147|79084910|FG000|Extension Period|Physician Decision|1|||
44250417|NCT01421147|79084911|FG001|Extension Period|Physician Decision|0|||
44250418|NCT01421147|79084910|FG000|Extension Period|Withdrawal by Subject|5|||
44250419|NCT01421147|79084911|FG001|Extension Period|Withdrawal by Subject|3|||
44250420|NCT01497938|79084928|FG000|Overall Study|Adverse Event|0|||
44250421|NCT01497938|79084929|FG001|Overall Study|Adverse Event|1|||
44278499|NCT02047110|79239595|FG001|OLE Treatment Period|Other than specified|0|||
44278500|NCT02047110|79239596|FG002|OLE Treatment Period|Other than specified|1|||
44278501|NCT02047110|79239597|FG003|OLE Treatment Period|Other than specified|0|||
44278502|NCT02046564|79239616|FG000|Overall Study|Adverse Event|6|||
44278503|NCT02046564|79239617|FG001|Overall Study|Adverse Event|3|||
44278504|NCT02046564|79239616|FG000|Overall Study|Physician Decision|0|||
44278505|NCT02046564|79239617|FG001|Overall Study|Physician Decision|1|||
44278506|NCT02046564|79239616|FG000|Overall Study|Protocol Violation|3|||
44278507|NCT02046564|79239617|FG001|Overall Study|Protocol Violation|1|||
44278508|NCT02046564|79239616|FG000|Overall Study|Withdrawal by Subject|4|||
44278509|NCT02046564|79239617|FG001|Overall Study|Withdrawal by Subject|10|||
44278510|NCT02046564|79239616|FG000|Overall Study|Subject met withdrawal criteria|2|||
44278511|NCT02046564|79239617|FG001|Overall Study|Subject met withdrawal criteria|5|||
44278512|NCT02046174|79239623|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
44278513|NCT02046174|79239624|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
44278514|NCT02045862|79239712|FG000|Overall Study|Death|0|||
44278515|NCT02045862|79239713|FG001|Overall Study|Death|0|||
44278516|NCT02045862|79239714|FG002|Overall Study|Death|1|||
44278517|NCT02045862|79239712|FG000|Overall Study|Miscellaneous|5|||
44278518|NCT02045862|79239713|FG001|Overall Study|Miscellaneous|0|||
44278519|NCT02045862|79239714|FG002|Overall Study|Miscellaneous|8|||
44250422|NCT01497938|79084928|FG000|Overall Study|Physician Decision|0|||
44250423|NCT01497938|79084929|FG001|Overall Study|Physician Decision|1|||
44250424|NCT01497938|79084928|FG000|Overall Study|Withdrawal by Subject|4|||
44250425|NCT01497938|79084929|FG001|Overall Study|Withdrawal by Subject|0|||
44250426|NCT01497938|79084928|FG000|Overall Study|Device Violation|1|||
44516941|NCT03039790|79524088|FG003|Overall Study|Reason, not Specified|0|||
44278520|NCT02045862|79239712|FG000|Overall Study|Withdrawal by Patient|18|||
44516942|NCT03039790|79524089|FG004|Overall Study|Reason, not Specified|0|||
44250427|NCT01497938|79084929|FG001|Overall Study|Device Violation|0|||
44250428|NCT01460342|79084979|FG000|Overall Study|Adverse Event|5|||
44278521|NCT02045862|79239713|FG001|Overall Study|Withdrawal by Patient|27|||
44278522|NCT02045862|79239714|FG002|Overall Study|Withdrawal by Patient|57|||
44278523|NCT02045862|79239712|FG000|Overall Study|Protocol Violation|0|||
44278524|NCT02045862|79239713|FG001|Overall Study|Protocol Violation|0|||
44516943|NCT03039790|79524090|FG005|Overall Study|Reason, not Specified|0|||
44516944|NCT03039790|79524091|FG006|Overall Study|Reason, not Specified|0|||
44516945|NCT03039790|79524092|FG007|Overall Study|Reason, not Specified|0|||
44516946|NCT03039790|79524093|FG008|Overall Study|Reason, not Specified|0|||
44516947|NCT03039790|79524094|FG009|Overall Study|Reason, not Specified|0|||
44516948|NCT03039790|79524095|FG010|Overall Study|Reason, not Specified|0|||
44516949|NCT03039790|79524096|FG011|Overall Study|Reason, not Specified|0|||
44516950|NCT03039790|79524097|FG012|Overall Study|Reason, not Specified|0|||
44516951|NCT03039790|79524098|FG013|Overall Study|Reason, not Specified|0|||
44516952|NCT03039790|79524099|FG014|Overall Study|Reason, not Specified|0|||
44516953|NCT03039790|79524100|FG015|Overall Study|Reason, not Specified|0|||
44516954|NCT03039790|79524101|FG016|Overall Study|Reason, not Specified|2|||
44516955|NCT03039790|79524102|FG017|Overall Study|Reason, not Specified|0|||
44516956|NCT03039790|79524103|FG018|Overall Study|Reason, not Specified|1|||
44516957|NCT03039790|79524104|FG019|Overall Study|Reason, not Specified|0|||
44516958|NCT03038620|79524177|FG000|Overall Study|Lost to Follow-up|18|||
44516959|NCT03038620|79524178|FG001|Overall Study|Lost to Follow-up|23|||
44516960|NCT03038620|79524177|FG000|Overall Study|Withdrawal by Subject|0|||
44516961|NCT03038620|79524178|FG001|Overall Study|Withdrawal by Subject|15|||
44516962|NCT03038620|79524177|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
44516963|NCT03038620|79524178|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
44278525|NCT02045862|79239714|FG002|Overall Study|Protocol Violation|6|||
44278526|NCT02045862|79239712|FG000|Overall Study|Lack of Efficacy|8|||
44516964|NCT01350934|79524199|FG000|Base Study|Adverse Event|6|||
44516965|NCT01350934|79524200|FG001|Base Study|Adverse Event|0|||
44250429|NCT01460342|79084980|FG001|Overall Study|Adverse Event|4|||
44516966|NCT01350934|79524199|FG000|Base Study|Lost to Follow-up|1|||
44516967|NCT01350934|79524200|FG001|Base Study|Lost to Follow-up|0|||
44516968|NCT01350934|79524199|FG000|Base Study|Protocol Violation|1|||
44516969|NCT01350934|79524200|FG001|Base Study|Protocol Violation|1|||
44516970|NCT01350934|79524199|FG000|Base Study|Withdrawal by Subject|1|||
44516971|NCT01350934|79524200|FG001|Base Study|Withdrawal by Subject|2|||
44516972|NCT01350934|79524199|FG000|Base Study|Non-Compliance With Study Drug|2|||
44516973|NCT01350934|79524200|FG001|Base Study|Non-Compliance With Study Drug|0|||
44516974|NCT01350934|79524199|FG000|Extension Study|Adverse Event|2|||
44516975|NCT01350934|79524200|FG001|Extension Study|Adverse Event|1|||
44516976|NCT01350934|79524199|FG000|Extension Study|Lost to Follow-up|2|||
44516977|NCT01350934|79524200|FG001|Extension Study|Lost to Follow-up|0|||
44516978|NCT01350934|79524199|FG000|Extension Study|Protocol Violation|1|||
44516979|NCT01350934|79524200|FG001|Extension Study|Protocol Violation|1|||
44250430|NCT01460342|79084979|FG000|Overall Study|Lost to Follow-up|1|||
44250431|NCT01460342|79084980|FG001|Overall Study|Lost to Follow-up|2|||
44250432|NCT01460342|79084979|FG000|Overall Study|Protocol Violation|0|||
44250433|NCT01460342|79084980|FG001|Overall Study|Protocol Violation|1|||
44250434|NCT01460342|79084979|FG000|Overall Study|Withdrawal by Subject|3|||
44250435|NCT01460342|79084980|FG001|Overall Study|Withdrawal by Subject|4|||
44250436|NCT01460342|79084979|FG000|Overall Study|Physician Decision|1|||
44516980|NCT01350934|79524199|FG000|Extension Study|Lack of Efficacy|0|||
44516981|NCT01350934|79524200|FG001|Extension Study|Lack of Efficacy|1|||
44516982|NCT01350934|79524199|FG000|Extension Study|Withdrawal by Subject|0|||
44145209|NCT02714569|78934861|FG003|Part B (Overall)|Adverse Event|0|||
44250437|NCT01460342|79084980|FG001|Overall Study|Physician Decision|3|||
44278527|NCT02045862|79239713|FG001|Overall Study|Lack of Efficacy|4|||
44278528|NCT02045862|79239714|FG002|Overall Study|Lack of Efficacy|13|||
44516983|NCT01350934|79524200|FG001|Extension Study|Withdrawal by Subject|1|||
44516984|NCT03622580|79524224|FG000|Overall Study|Death|16|||
44516985|NCT03622580|79524225|FG001|Overall Study|Death|21|||
44516986|NCT03622580|79524226|FG002|Overall Study|Death|13|||
44516987|NCT03622580|79524224|FG000|Overall Study|Adverse Event|6|||
44516988|NCT03622580|79524225|FG001|Overall Study|Adverse Event|6|||
44516989|NCT03622580|79524226|FG002|Overall Study|Adverse Event|5|||
44516990|NCT03622580|79524224|FG000|Overall Study|Withdrawal by Subject|12|||
44278529|NCT02045862|79239712|FG000|Overall Study|Randomized but not Received Study Drug|0|||
44516991|NCT03622580|79524225|FG001|Overall Study|Withdrawal by Subject|7|||
44516992|NCT03622580|79524226|FG002|Overall Study|Withdrawal by Subject|19|||
44516993|NCT03622580|79524224|FG000|Overall Study|Lost to Follow-up|12|||
44516994|NCT03622580|79524225|FG001|Overall Study|Lost to Follow-up|9|||
44516995|NCT03622580|79524226|FG002|Overall Study|Lost to Follow-up|9|||
44516996|NCT03622580|79524224|FG000|Overall Study|Protocol Violation|1|||
44516997|NCT03622580|79524225|FG001|Overall Study|Protocol Violation|0|||
44516998|NCT03622580|79524226|FG002|Overall Study|Protocol Violation|1|||
44516999|NCT03622580|79524224|FG000|Overall Study|Physician Decision|3|||
44517000|NCT03622580|79524225|FG001|Overall Study|Physician Decision|0|||
44517001|NCT03622580|79524226|FG002|Overall Study|Physician Decision|1|||
44517002|NCT03622580|79524224|FG000|Overall Study|Pregnancy|0|||
44517003|NCT03622580|79524225|FG001|Overall Study|Pregnancy|1|||
44517004|NCT03622580|79524226|FG002|Overall Study|Pregnancy|0|||
44517005|NCT03622580|79524224|FG000|Overall Study|Lack of Efficacy|0|||
44517006|NCT03622580|79524225|FG001|Overall Study|Lack of Efficacy|0|||
44517007|NCT03622580|79524226|FG002|Overall Study|Lack of Efficacy|1|||
44517008|NCT03622580|79524224|FG000|Overall Study|Other|2|||
44517009|NCT03622580|79524225|FG001|Overall Study|Other|0|||
44517010|NCT03622580|79524226|FG002|Overall Study|Other|3|||
44517011|NCT00461032|79524237|FG000|Overall Study|Adverse Event|5|||
44517012|NCT00461032|79524238|FG001|Overall Study|Adverse Event|6|||
44517013|NCT00461032|79524237|FG000|Overall Study|Lack of Efficacy|5|||
44517014|NCT00461032|79524238|FG001|Overall Study|Lack of Efficacy|1|||
44517015|NCT00461032|79524237|FG000|Overall Study|Lost to Follow-up|7|||
44517016|NCT00461032|79524238|FG001|Overall Study|Lost to Follow-up|12|||
44517017|NCT00461032|79524237|FG000|Overall Study|Protocol Violation|4|||
44517018|NCT00461032|79524238|FG001|Overall Study|Protocol Violation|4|||
44145210|NCT02714569|78934862|FG004|Part B (Overall)|Adverse Event|0|||
44145211|NCT02714569|78934863|FG005|Part B (Overall)|Adverse Event|0|||
44145212|NCT02714569|78934864|FG006|Part B (Overall)|Adverse Event|0|||
44145213|NCT02714569|78934865|FG007|Part B (Overall)|Adverse Event|0|||
44145214|NCT02714569|78934866|FG008|Part B (Overall)|Adverse Event|0|||
44145215|NCT02714569|78934867|FG009|Part B (Overall)|Adverse Event|1|||
44145216|NCT02714569|78934868|FG010|Part B (Overall)|Adverse Event|0|||
44517019|NCT00461032|79524237|FG000|Overall Study|Withdrawal by Subject|7|||
44517020|NCT00461032|79524238|FG001|Overall Study|Withdrawal by Subject|15|||
44517021|NCT00461032|79524237|FG000|Overall Study|Patient Moved or Relocated|2|||
44517022|NCT00461032|79524238|FG001|Overall Study|Patient Moved or Relocated|1|||
44517023|NCT00461032|79524237|FG000|Overall Study|Other|7|||
44517024|NCT00461032|79524238|FG001|Overall Study|Other|5|||
44517025|NCT00090142|79524244|FG000|Treatment Period I|Lost to Follow-up|1|||
44517026|NCT00090142|79524245|FG001|Treatment Period I|Lost to Follow-up|2|||
44517027|NCT00090142|79524244|FG000|Treatment Period I|Protocol Violation|2|||
44517028|NCT00090142|79524245|FG001|Treatment Period I|Protocol Violation|0|||
44517029|NCT00090142|79524244|FG000|Treatment Period I|Withdrawal by Subject|2|||
44517030|NCT00090142|79524245|FG001|Treatment Period I|Withdrawal by Subject|0|||
44517031|NCT00090142|79524244|FG000|Treatment Period I|Other|0|||
44517032|NCT00090142|79524245|FG001|Treatment Period I|Other|1|||
44517033|NCT00090142|79524244|FG000|Treatment Period II|Other|1|||
44517034|NCT00090142|79524245|FG001|Treatment Period II|Other|0|||
44517035|NCT03622112|79524262|FG000|Overall Study|Withdrawal by Subject|6|||
44517036|NCT03622112|79524263|FG001|Overall Study|Withdrawal by Subject|2|||
44517037|NCT03622112|79524264|FG002|Overall Study|Withdrawal by Subject|4|||
44517038|NCT03622112|79524265|FG003|Overall Study|Withdrawal by Subject|2|||
44517039|NCT03622112|79524266|FG004|Overall Study|Withdrawal by Subject|1|||
44517040|NCT03622112|79524267|FG005|Overall Study|Withdrawal by Subject|2|||
44517041|NCT03622112|79524268|FG006|Overall Study|Withdrawal by Subject|2|||
44517042|NCT03622112|79524262|FG000|Overall Study|Death|0|||
44517043|NCT03622112|79524263|FG001|Overall Study|Death|0|||
44517044|NCT03622112|79524264|FG002|Overall Study|Death|0|||
44517045|NCT03622112|79524265|FG003|Overall Study|Death|1|||
44517046|NCT03622112|79524266|FG004|Overall Study|Death|0|||
44517047|NCT03622112|79524267|FG005|Overall Study|Death|0|||
44517048|NCT03622112|79524268|FG006|Overall Study|Death|0|||
44517049|NCT03622112|79524262|FG000|Overall Study|Lost to Follow-up|1|||
44517050|NCT03622112|79524263|FG001|Overall Study|Lost to Follow-up|1|||
44517051|NCT03622112|79524264|FG002|Overall Study|Lost to Follow-up|0|||
44517052|NCT03622112|79524265|FG003|Overall Study|Lost to Follow-up|0|||
44517053|NCT03622112|79524266|FG004|Overall Study|Lost to Follow-up|0|||
44517054|NCT03622112|79524267|FG005|Overall Study|Lost to Follow-up|0|||
44517055|NCT03622112|79524268|FG006|Overall Study|Lost to Follow-up|0|||
44517056|NCT03622112|79524262|FG000|Overall Study|Study-specific withdrawal criteria|10|||
44517057|NCT03622112|79524263|FG001|Overall Study|Study-specific withdrawal criteria|8|||
44517058|NCT03622112|79524264|FG002|Overall Study|Study-specific withdrawal criteria|7|||
44517059|NCT03622112|79524265|FG003|Overall Study|Study-specific withdrawal criteria|6|||
44517060|NCT03622112|79524266|FG004|Overall Study|Study-specific withdrawal criteria|4|||
44517061|NCT03622112|79524267|FG005|Overall Study|Study-specific withdrawal criteria|18|||
44517062|NCT03622112|79524268|FG006|Overall Study|Study-specific withdrawal criteria|4|||
44517063|NCT03622112|79524262|FG000|Overall Study|Protocol Violation|2|||
44517064|NCT03622112|79524263|FG001|Overall Study|Protocol Violation|0|||
44517065|NCT03622112|79524264|FG002|Overall Study|Protocol Violation|1|||
44517066|NCT03622112|79524265|FG003|Overall Study|Protocol Violation|1|||
44517067|NCT03622112|79524266|FG004|Overall Study|Protocol Violation|0|||
44517068|NCT03622112|79524267|FG005|Overall Study|Protocol Violation|0|||
44517069|NCT03622112|79524268|FG006|Overall Study|Protocol Violation|0|||
44517070|NCT03622112|79524262|FG000|Overall Study|Adverse Event|6|||
44517071|NCT03622112|79524263|FG001|Overall Study|Adverse Event|8|||
44517072|NCT03622112|79524264|FG002|Overall Study|Adverse Event|4|||
44517073|NCT03622112|79524265|FG003|Overall Study|Adverse Event|11|||
44517074|NCT03622112|79524266|FG004|Overall Study|Adverse Event|4|||
44517075|NCT03622112|79524267|FG005|Overall Study|Adverse Event|20|||
44517076|NCT03622112|79524268|FG006|Overall Study|Adverse Event|2|||
44517077|NCT03622112|79524262|FG000|Overall Study|Reason not specified|0|||
44517078|NCT03622112|79524263|FG001|Overall Study|Reason not specified|1|||
44517079|NCT03622112|79524264|FG002|Overall Study|Reason not specified|0|||
44517080|NCT03622112|79524265|FG003|Overall Study|Reason not specified|1|||
44517081|NCT03622112|79524266|FG004|Overall Study|Reason not specified|1|||
44517082|NCT03622112|79524267|FG005|Overall Study|Reason not specified|2|||
44517083|NCT03622112|79524268|FG006|Overall Study|Reason not specified|1|||
44517084|NCT04032158|79524286|FG000|Overall Study|Study Termination|2|||
44517085|NCT04032158|79524287|FG001|Overall Study|Study Termination|1|||
44145217|NCT02713789|78934931|FG000|Overall Study|Lost to Follow-up|0|||
44145218|NCT02713789|78934932|FG001|Overall Study|Lost to Follow-up|1|||
44278530|NCT02045862|79239713|FG001|Overall Study|Randomized but not Received Study Drug|2|||
44278531|NCT02045862|79239714|FG002|Overall Study|Randomized but not Received Study Drug|8|||
44517086|NCT03620708|79524296|FG000|Overall Study|Lost to Follow-up|1|||
44517087|NCT03620708|79524297|FG001|Overall Study|Lost to Follow-up|1|||
44517088|NCT03620708|79524298|FG002|Overall Study|Lost to Follow-up|2|||
44145219|NCT02713789|78934933|FG002|Overall Study|Lost to Follow-up|1|||
44517089|NCT03620708|79524296|FG000|Overall Study|Withdrawal by Subject|0|||
44517090|NCT03620708|79524297|FG001|Overall Study|Withdrawal by Subject|0|||
44517091|NCT03620708|79524298|FG002|Overall Study|Withdrawal by Subject|1|||
44517092|NCT03654326|79524308|FG000|Overall Study|Withdrawal by Subject|5|||
44517093|NCT03654326|79524309|FG001|Overall Study|Withdrawal by Subject|3|||
44517094|NCT03654326|79524308|FG000|Overall Study|Physician Decision|0|||
44517095|NCT03654326|79524309|FG001|Overall Study|Physician Decision|1|||
44145220|NCT04445051|78934943|FG000|Overall Study|Adverse Event|0|||
44145221|NCT04445051|78934944|FG001|Overall Study|Adverse Event|0|||
44145222|NCT04445051|78934945|FG002|Overall Study|Adverse Event|1|||
44145223|NCT04445051|78934946|FG003|Overall Study|Adverse Event|0|||
44145224|NCT04445051|78934947|FG004|Overall Study|Adverse Event|0|||
44517096|NCT03654326|79524308|FG000|Overall Study|Unable to adhere to study schedule|0|||
44517097|NCT03654326|79524309|FG001|Overall Study|Unable to adhere to study schedule|1|||
44517098|NCT03654326|79524308|FG000|Overall Study|Lost to Follow-up|1|||
44517099|NCT03654326|79524309|FG001|Overall Study|Lost to Follow-up|1|||
44517100|NCT04025684|79524319|FG000|Overall Study|Withdrawal by Subject|1|||
44517101|NCT04025684|79524320|FG001|Overall Study|Withdrawal by Subject|1|||
44517102|NCT04025684|79524321|FG002|Overall Study|Withdrawal by Subject|0|||
44517103|NCT04025684|79524322|FG003|Overall Study|Withdrawal by Subject|0|||
44517104|NCT04025684|79524319|FG000|Overall Study|Multiple reasons|1|||
44517105|NCT04025684|79524320|FG001|Overall Study|Multiple reasons|3|||
44517106|NCT04025684|79524321|FG002|Overall Study|Multiple reasons|0|||
44517107|NCT04025684|79524322|FG003|Overall Study|Multiple reasons|1|||
44517108|NCT03617588|79524334|FG000|Overall Study|Withdrawal by Subject|1|||
44517109|NCT03617588|79524335|FG001|Overall Study|Withdrawal by Subject|0|||
44517110|NCT03616106|79524347|FG000|Overall Study|Removed by PI|6|||
44517111|NCT03616106|79524348|FG001|Overall Study|Removed by PI|0|||
44517112|NCT03616106|79524347|FG000|Overall Study|Withdrawal by Subject|1|||
44517113|NCT03616106|79524348|FG001|Overall Study|Withdrawal by Subject|1|||
44517114|NCT03616106|79524347|FG000|Overall Study|Lost to Follow-up|7|||
44517115|NCT03616106|79524348|FG001|Overall Study|Lost to Follow-up|0|||
44517116|NCT04019054|79524355|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
44517117|NCT04019054|79524356|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
44517118|NCT04019054|79524355|FG000|Overall Study|Withdrawal by Subject|3|||
44517119|NCT04019054|79524356|FG001|Overall Study|Withdrawal by Subject|1|||
44517120|NCT00071799|79524364|FG000|Overall Study|Adverse Event|19|||
44517121|NCT00071799|79524365|FG001|Overall Study|Adverse Event|10|||
44517122|NCT00071799|79524364|FG000|Overall Study|Protocol Violation|1|||
44517123|NCT00071799|79524365|FG001|Overall Study|Protocol Violation|7|||
44517124|NCT00071799|79524364|FG000|Overall Study|Lost to Follow-up|1|||
44517125|NCT00071799|79524365|FG001|Overall Study|Lost to Follow-up|1|||
44517126|NCT00071799|79524364|FG000|Overall Study|Withdrawal by Subject|15|||
44517127|NCT00071799|79524365|FG001|Overall Study|Withdrawal by Subject|37|||
44517128|NCT00071799|79524364|FG000|Overall Study|Physician Decision|0|||
44517129|NCT00071799|79524365|FG001|Overall Study|Physician Decision|2|||
44517130|NCT00071799|79524364|FG000|Overall Study|Lack of Efficacy|11|||
44517131|NCT00071799|79524365|FG001|Overall Study|Lack of Efficacy|18|||
44517132|NCT00071799|79524364|FG000|Overall Study|Disease Progression|23|||
44517133|NCT00071799|79524365|FG001|Overall Study|Disease Progression|20|||
44517134|NCT00071799|79524364|FG000|Overall Study|Different Central+Local Pathology Review|0|||
44517135|NCT00071799|79524365|FG001|Overall Study|Different Central+Local Pathology Review|1|||
44517136|NCT00071799|79524364|FG000|Overall Study|Not Documented|0|||
44517137|NCT00071799|79524365|FG001|Overall Study|Not Documented|2|||
44517138|NCT03615482|79524379|FG000|Overall Study|Death|1|||
44517139|NCT03615482|79524380|FG001|Overall Study|Death|0|||
44517140|NCT03615482|79524379|FG000|Overall Study|Lost to Follow-up|7|||
44517141|NCT03615482|79524380|FG001|Overall Study|Lost to Follow-up|7|||
44517142|NCT03615482|79524379|FG000|Overall Study|Physician Decision|2|||
44517143|NCT03615482|79524380|FG001|Overall Study|Physician Decision|3|||
44145225|NCT04445051|78934948|FG005|Overall Study|Adverse Event|0|||
44145226|NCT04086121|78934962|FG000|Overall Study|Other than listed|8|||
44145227|NCT04086121|78934962|FG000|Overall Study|Withdrawal by Subject|3|||
44145228|NCT04086121|78934962|FG000|Overall Study|Lost to Follow-up|2|||
44145229|NCT04086121|78934962|FG000|Overall Study|Adverse Event|1|||
44517144|NCT03615482|79524379|FG000|Overall Study|Withdrawal by Subject|7|||
44278532|NCT02045862|79239712|FG000|Overall Study|Adverse Event|7|||
44517145|NCT03615482|79524380|FG001|Overall Study|Withdrawal by Subject|7|||
44517146|NCT00090363|79524389|FG000|Overall Study|Lost to Follow-up|1|||
44517147|NCT00090363|79524390|FG001|Overall Study|Lost to Follow-up|2|||
44517148|NCT00090363|79524391|FG002|Overall Study|Lost to Follow-up|1|||
44517149|NCT00090363|79524389|FG000|Overall Study|Withdrawal by Subject|7|||
44517150|NCT00090363|79524390|FG001|Overall Study|Withdrawal by Subject|7|||
44517151|NCT00090363|79524391|FG002|Overall Study|Withdrawal by Subject|6|||
44278533|NCT02045862|79239713|FG001|Overall Study|Adverse Event|5|||
44517152|NCT00090363|79524389|FG000|Overall Study|Study-specific discontinuation criteria|75|||
44517153|NCT00090363|79524390|FG001|Overall Study|Study-specific discontinuation criteria|74|||
44145230|NCT02729909|78934969|FG000|Overall Study|Lost to Follow-up|0|||
44145231|NCT02729909|78934970|FG001|Overall Study|Lost to Follow-up|1|||
44145232|NCT02729909|78934969|FG000|Overall Study|Lack of Efficacy|0|||
44382583|NCT00717769|79388541|FG000|Overall Study|Lack of compliance|0|||
44382584|NCT00717769|79388542|FG001|Overall Study|Lack of compliance|2|||
44382585|NCT00717769|79388543|FG002|Overall Study|Lack of compliance|0|||
44382586|NCT00717769|79388541|FG000|Overall Study|Lost to Follow-up|3|||
44382587|NCT00717769|79388542|FG001|Overall Study|Lost to Follow-up|4|||
44382588|NCT00717769|79388543|FG002|Overall Study|Lost to Follow-up|0|||
44382589|NCT00717769|79388541|FG000|Overall Study|Lack of Efficacy|1|||
44382590|NCT00717769|79388542|FG001|Overall Study|Lack of Efficacy|2|||
44382591|NCT00717769|79388543|FG002|Overall Study|Lack of Efficacy|0|||
44382592|NCT00717769|79388541|FG000|Overall Study|Protocol Violation|0|||
44382593|NCT00717769|79388542|FG001|Overall Study|Protocol Violation|2|||
44382594|NCT00717769|79388543|FG002|Overall Study|Protocol Violation|0|||
44382595|NCT00717769|79388541|FG000|Overall Study|Sponsor decision|1|||
44382596|NCT00717769|79388542|FG001|Overall Study|Sponsor decision|0|||
44382597|NCT00717769|79388543|FG002|Overall Study|Sponsor decision|10|||
44382598|NCT00717769|79388541|FG000|Overall Study|Withdrew consent|2|||
44382599|NCT00717769|79388542|FG001|Overall Study|Withdrew consent|2|||
44382600|NCT00717769|79388543|FG002|Overall Study|Withdrew consent|0|||
44382601|NCT04153929|79388561|FG000|Overall Study|Other than listed|2|||
44382602|NCT04153929|79388562|FG001|Overall Study|Other than listed|2|||
44382603|NCT04153929|79388563|FG002|Overall Study|Other than listed|0|||
44382604|NCT04153929|79388564|FG003|Overall Study|Other than listed|1|||
44382605|NCT04153929|79388565|FG004|Overall Study|Other than listed|0|||
44382606|NCT04153929|79388566|FG005|Overall Study|Other than listed|2|||
44382607|NCT04153929|79388567|FG006|Overall Study|Other than listed|2|||
44382608|NCT04153929|79388568|FG007|Overall Study|Other than listed|1|||
44382609|NCT04153929|79388561|FG000|Overall Study|Lost to Follow-up|2|||
44382610|NCT04153929|79388562|FG001|Overall Study|Lost to Follow-up|1|||
44382611|NCT04153929|79388563|FG002|Overall Study|Lost to Follow-up|0|||
44382612|NCT04153929|79388564|FG003|Overall Study|Lost to Follow-up|1|||
44382613|NCT04153929|79388565|FG004|Overall Study|Lost to Follow-up|1|||
44382614|NCT04153929|79388566|FG005|Overall Study|Lost to Follow-up|0|||
44382615|NCT04153929|79388567|FG006|Overall Study|Lost to Follow-up|0|||
44382616|NCT04153929|79388568|FG007|Overall Study|Lost to Follow-up|0|||
44382617|NCT04153929|79388561|FG000|Overall Study|Withdrawal by Subject|3|||
44382618|NCT04153929|79388562|FG001|Overall Study|Withdrawal by Subject|1|||
44382619|NCT04153929|79388563|FG002|Overall Study|Withdrawal by Subject|0|||
44382620|NCT04153929|79388564|FG003|Overall Study|Withdrawal by Subject|3|||
44382621|NCT04153929|79388565|FG004|Overall Study|Withdrawal by Subject|1|||
44382622|NCT04153929|79388566|FG005|Overall Study|Withdrawal by Subject|0|||
44382623|NCT04153929|79388567|FG006|Overall Study|Withdrawal by Subject|1|||
44382624|NCT04153929|79388568|FG007|Overall Study|Withdrawal by Subject|0|||
44382625|NCT04153929|79388561|FG000|Overall Study|Protocol Violation|0|||
44382626|NCT04153929|79388562|FG001|Overall Study|Protocol Violation|0|||
44382627|NCT04153929|79388563|FG002|Overall Study|Protocol Violation|0|||
44382628|NCT04153929|79388564|FG003|Overall Study|Protocol Violation|0|||
44382629|NCT04153929|79388565|FG004|Overall Study|Protocol Violation|0|||
44382630|NCT04153929|79388566|FG005|Overall Study|Protocol Violation|0|||
44382631|NCT04153929|79388567|FG006|Overall Study|Protocol Violation|1|||
44382632|NCT04153929|79388568|FG007|Overall Study|Protocol Violation|2|||
44382633|NCT04153929|79388561|FG000|Overall Study|Adverse Event|3|||
44382634|NCT04153929|79388562|FG001|Overall Study|Adverse Event|5|||
44382635|NCT04153929|79388563|FG002|Overall Study|Adverse Event|5|||
44382636|NCT04153929|79388564|FG003|Overall Study|Adverse Event|11|||
44382637|NCT04153929|79388565|FG004|Overall Study|Adverse Event|15|||
44382638|NCT04153929|79388566|FG005|Overall Study|Adverse Event|4|||
44145233|NCT02729909|78934970|FG001|Overall Study|Lack of Efficacy|2|||
44145234|NCT02729909|78934969|FG000|Overall Study|Significant Protocol Deviation|0|||
44145235|NCT02729909|78934970|FG001|Overall Study|Significant Protocol Deviation|2|||
44382639|NCT04153929|79388567|FG006|Overall Study|Adverse Event|8|||
44382640|NCT04153929|79388568|FG007|Overall Study|Adverse Event|2|||
44382641|NCT04153929|79388561|FG000|Overall Study|Not treated|1|||
44382642|NCT04153929|79388562|FG001|Overall Study|Not treated|0|||
44382643|NCT04153929|79388563|FG002|Overall Study|Not treated|0|||
44382644|NCT04153929|79388564|FG003|Overall Study|Not treated|0|||
44382645|NCT04153929|79388565|FG004|Overall Study|Not treated|0|||
44382646|NCT04153929|79388566|FG005|Overall Study|Not treated|0|||
44382647|NCT04153929|79388567|FG006|Overall Study|Not treated|1|||
44382648|NCT04153929|79388568|FG007|Overall Study|Not treated|0|||
44382649|NCT00591214|79388586|FG000|Overall Study|Physician Decision|7|||
44382650|NCT00591214|79388586|FG000|Overall Study|Withdrawal by Subject|1|||
44382651|NCT00725725|79388593|FG000|Overall Study|Adverse Event|1|||
44517154|NCT00090363|79524391|FG002|Overall Study|Study-specific discontinuation criteria|62|||
44517155|NCT00090363|79524389|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44517156|NCT00090363|79524390|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44517157|NCT00090363|79524391|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
44517158|NCT00090363|79524389|FG000|Overall Study|Consent expired|7|||
44517159|NCT00090363|79524390|FG001|Overall Study|Consent expired|10|||
44517160|NCT00090363|79524391|FG002|Overall Study|Consent expired|9|||
44517161|NCT00090363|79524389|FG000|Overall Study|Reasons not specified|2|||
44278534|NCT02045862|79239714|FG002|Overall Study|Adverse Event|27|||
44278535|NCT02045862|79239712|FG000|Overall Study|Lost to Follow-up|1|||
44278536|NCT02045862|79239713|FG001|Overall Study|Lost to Follow-up|2|||
44278537|NCT02045862|79239714|FG002|Overall Study|Lost to Follow-up|6|||
44278538|NCT02075658|79239724|FG000|Overall Study|Physician Decision|2|||
44278539|NCT02075658|79239725|FG001|Overall Study|Physician Decision|2|||
44278540|NCT02063880|79239733|FG000|Overall Study|Death|21|||
44278541|NCT02063880|79239734|FG001|Overall Study|Death|18|||
44278542|NCT02063880|79239733|FG000|Overall Study|Lost to Follow-up|7|||
44278543|NCT02063880|79239734|FG001|Overall Study|Lost to Follow-up|7|||
44278544|NCT02063880|79239733|FG000|Overall Study|Ineligible|0|||
44278545|NCT02063880|79239734|FG001|Overall Study|Ineligible|2|||
44278546|NCT02044848|79239742|FG000|Overall Study|Administrative Problems|2|||
44278547|NCT02044848|79239743|FG001|Overall Study|Administrative Problems|3|||
44278548|NCT02044458|79239751|FG000|Overall Study|Protocol Violation|3|||
44278549|NCT02044458|79239752|FG001|Overall Study|Protocol Violation|8|||
44278550|NCT02044302|79239760|FG000|Overall Study|study terminated|2|||
44278551|NCT02044302|79239761|FG001|Overall Study|study terminated|0|||
44278552|NCT02062944|79239765|FG000|Overall Study|Lost to Follow-up|1|||
44278553|NCT02062944|79239765|FG000|Overall Study|New hemotological disorder identified|1|||
44278554|NCT02062944|79239765|FG000|Overall Study|Uncontrolled Hypertension|1|||
44278555|NCT02062944|79239765|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
44278556|NCT02062632|79239770|FG000|Overall Study|No treatment data|1|||
44278557|NCT02062398|79239774|FG000|Overall Study|Implant removal|1|||
44278558|NCT02061540|79239778|FG000|Overall Study|Adverse Event|2|||
44278559|NCT02061540|79239778|FG000|Overall Study|Withdrawal by Subject|2|||
44278560|NCT02043366|79239793|FG000|Overall Study|Lost to Follow-up|2|||
44278561|NCT02043366|79239794|FG001|Overall Study|Lost to Follow-up|2|||
44278562|NCT02043366|79239795|FG002|Overall Study|Lost to Follow-up|2|||
44278563|NCT02043366|79239796|FG003|Overall Study|Lost to Follow-up|2|||
44278564|NCT02043366|79239797|FG004|Overall Study|Lost to Follow-up|2|||
44278565|NCT02043366|79239798|FG005|Overall Study|Lost to Follow-up|2|||
44278566|NCT02060370|79239814|FG000|Overall Study|Physician Decision|1|||
44278567|NCT01622088|79239818|FG000|Overall Study|Adverse Event|20|||
44278568|NCT01622088|79239818|FG000|Overall Study|Lost to Follow-up|1|||
44278569|NCT01622088|79239818|FG000|Overall Study|Withdrawal by Subject|20|||
44278570|NCT01622088|79239818|FG000|Overall Study|Investigator Decision|1|||
44278571|NCT01622088|79239818|FG000|Overall Study|Death|53|||
44278572|NCT01622088|79239818|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
44278573|NCT01621542|79239829|FG000|Overall Study|Adverse Event|0|||
44278574|NCT01621542|79239830|FG001|Overall Study|Adverse Event|0|||
44278575|NCT01621542|79239831|FG002|Overall Study|Adverse Event|1|||
44278576|NCT01621542|79239832|FG003|Overall Study|Adverse Event|3|||
44278577|NCT01621542|79239833|FG004|Overall Study|Adverse Event|0|||
44278578|NCT01621542|79239834|FG005|Overall Study|Adverse Event|0|||
44517162|NCT00090363|79524390|FG001|Overall Study|Reasons not specified|1|||
44517163|NCT00090363|79524391|FG002|Overall Study|Reasons not specified|1|||
44517164|NCT00090363|79524389|FG000|Overall Study|Continuing on study off treatment|14|||
44517165|NCT00090363|79524390|FG001|Overall Study|Continuing on study off treatment|13|||
44517166|NCT00090363|79524391|FG002|Overall Study|Continuing on study off treatment|16|||
44517167|NCT03652610|79524401|FG000|Overall Study|Lost to Follow-up|1|||
44517168|NCT03652610|79524402|FG001|Overall Study|Lost to Follow-up|0|||
44382652|NCT00725725|79388594|FG001|Overall Study|Adverse Event|3|||
44517169|NCT03652610|79524401|FG000|Overall Study|Withdrawal by Subject|3|||
44517170|NCT03652610|79524402|FG001|Overall Study|Withdrawal by Subject|5|||
44517171|NCT03615404|79524408|FG000|Overall Study|Death|1|||
44278579|NCT01621542|79239829|FG000|Overall Study|Death|0|||
44278580|NCT01621542|79239830|FG001|Overall Study|Death|1|||
44278581|NCT01621542|79239831|FG002|Overall Study|Death|0|||
44278582|NCT01621542|79239832|FG003|Overall Study|Death|0|||
44278583|NCT01621542|79239833|FG004|Overall Study|Death|0|||
44278584|NCT01621542|79239834|FG005|Overall Study|Death|0|||
44278585|NCT01621542|79239829|FG000|Overall Study|Physician Decision|1|||
44278586|NCT01621542|79239830|FG001|Overall Study|Physician Decision|0|||
44517172|NCT03615404|79524408|FG000|Overall Study|vaccine did not pass quality assurance|1|||
44517173|NCT03614156|79524415|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
44278587|NCT01621542|79239831|FG002|Overall Study|Physician Decision|1|||
44278588|NCT01621542|79239832|FG003|Overall Study|Physician Decision|13|||
44278589|NCT01621542|79239833|FG004|Overall Study|Physician Decision|3|||
44382653|NCT00725725|79388595|FG002|Overall Study|Adverse Event|2|||
44278590|NCT01621542|79239834|FG005|Overall Study|Physician Decision|1|||
44278591|NCT01621542|79239829|FG000|Overall Study|Withdrawal by Subject|2|||
44278592|NCT01621542|79239830|FG001|Overall Study|Withdrawal by Subject|0|||
44278593|NCT01621542|79239831|FG002|Overall Study|Withdrawal by Subject|1|||
44278594|NCT01621542|79239832|FG003|Overall Study|Withdrawal by Subject|3|||
44278595|NCT01621542|79239833|FG004|Overall Study|Withdrawal by Subject|3|||
44278596|NCT01621542|79239834|FG005|Overall Study|Withdrawal by Subject|3|||
44278597|NCT01621542|79239829|FG000|Overall Study|progression/treatment failure|2|||
44278598|NCT01621542|79239830|FG001|Overall Study|progression/treatment failure|4|||
44278599|NCT01621542|79239831|FG002|Overall Study|progression/treatment failure|3|||
44278600|NCT01621542|79239832|FG003|Overall Study|progression/treatment failure|7|||
44278601|NCT01621542|79239833|FG004|Overall Study|progression/treatment failure|3|||
44278602|NCT01621542|79239834|FG005|Overall Study|progression/treatment failure|5|||
44278603|NCT01621542|79239829|FG000|Overall Study|Protocol Violation|0|||
44278604|NCT01621542|79239830|FG001|Overall Study|Protocol Violation|0|||
44278605|NCT01621542|79239831|FG002|Overall Study|Protocol Violation|0|||
44278606|NCT01621542|79239832|FG003|Overall Study|Protocol Violation|1|||
44278607|NCT01621542|79239833|FG004|Overall Study|Protocol Violation|0|||
44278608|NCT01621542|79239834|FG005|Overall Study|Protocol Violation|0|||
44278609|NCT01621542|79239829|FG000|Overall Study|study stopped by sponsor|0|||
44278610|NCT01621542|79239830|FG001|Overall Study|study stopped by sponsor|0|||
44278611|NCT01621542|79239831|FG002|Overall Study|study stopped by sponsor|0|||
44278612|NCT01621542|79239832|FG003|Overall Study|study stopped by sponsor|1|||
44278613|NCT01621542|79239833|FG004|Overall Study|study stopped by sponsor|0|||
44278614|NCT01621542|79239834|FG005|Overall Study|study stopped by sponsor|0|||
44278615|NCT02021292|79239850|FG000|Overall Study|Physician Decision|0|||
44278616|NCT02021292|79239851|FG001|Overall Study|Physician Decision|1|||
44278617|NCT02021292|79239850|FG000|Overall Study|Lost to Follow-up|0|||
44278618|NCT02021292|79239851|FG001|Overall Study|Lost to Follow-up|1|||
44278619|NCT02021292|79239850|FG000|Overall Study|Death|0|||
44278620|NCT02021292|79239851|FG001|Overall Study|Death|1|||
44278621|NCT02059980|79239861|FG000|Overall Study|Lost to Follow-up|2|||
44278622|NCT02059980|79239862|FG001|Overall Study|Lost to Follow-up|1|||
44278623|NCT02043132|79239870|FG000|Overall Study|Lost to Follow-up|1|||
44278624|NCT02043132|79239871|FG001|Overall Study|Lost to Follow-up|1|||
44278625|NCT02043132|79239870|FG000|Overall Study|screen failures|4|||
44278626|NCT02043132|79239871|FG001|Overall Study|screen failures|8|||
44278627|NCT02059434|79239886|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
44278628|NCT02059434|79239887|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
44278629|NCT02059434|79239888|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
44278630|NCT02059434|79239889|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
44278631|NCT02059434|79239890|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
44278632|NCT02059434|79239891|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
44278633|NCT02059434|79239892|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
44278634|NCT02059434|79239893|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
44278635|NCT02059434|79239894|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
44278636|NCT02059434|79239886|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
44278637|NCT02059434|79239887|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
44278638|NCT02059434|79239888|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
44278639|NCT02059434|79239889|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
44278640|NCT02059434|79239890|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
44278641|NCT02059434|79239891|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
44278642|NCT02059434|79239892|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
44278643|NCT02059434|79239893|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
44278644|NCT02059434|79239894|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
44278645|NCT02059434|79239886|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
44278646|NCT02059434|79239887|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
44278647|NCT02059434|79239888|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
44278648|NCT02059434|79239889|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
44278649|NCT02059434|79239890|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
44278650|NCT02059434|79239891|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
44278651|NCT02059434|79239892|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
44278652|NCT02059434|79239893|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
44278653|NCT02059434|79239894|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
44278654|NCT02059434|79239886|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
44278655|NCT02059434|79239887|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
44278656|NCT02059434|79239888|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
44278657|NCT02059434|79239889|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
44278658|NCT02059434|79239890|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
44278659|NCT02059434|79239891|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
44278660|NCT02059434|79239892|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
44278661|NCT02059434|79239893|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
44250438|NCT01460342|79084979|FG000|Overall Study|Lack of Efficacy|1|||
44250439|NCT01460342|79084980|FG001|Overall Study|Lack of Efficacy|0|||
44250440|NCT01459796|79085012|FG000|Overall Study|Non compliance with protocol|2|||
44250441|NCT01459796|79085013|FG001|Overall Study|Non compliance with protocol|4|||
44250442|NCT01459796|79085012|FG000|Overall Study|Adverse Event|5|||
44250443|NCT01459796|79085013|FG001|Overall Study|Adverse Event|5|||
44250444|NCT01459796|79085012|FG000|Overall Study|Withdrawal by Subject|6|||
44250445|NCT01459796|79085013|FG001|Overall Study|Withdrawal by Subject|3|||
44250446|NCT01459796|79085012|FG000|Overall Study|Lost to Follow-up|5|||
44250447|NCT01459796|79085013|FG001|Overall Study|Lost to Follow-up|4|||
44250448|NCT01459796|79085012|FG000|Overall Study|Reason unspecified|1|||
44250449|NCT01459796|79085013|FG001|Overall Study|Reason unspecified|2|||
44250450|NCT01459796|79085012|FG000|Overall Study|Decision by the sponsor|75|||
44250451|NCT01459796|79085013|FG001|Overall Study|Decision by the sponsor|108|||
44250452|NCT01459718|79085023|FG000|Overall Study|Physician Decision|1|||
44250453|NCT01459718|79085023|FG000|Overall Study|Lost to Follow-up|1|||
44250454|NCT01459718|79085023|FG000|Overall Study|Adverse Event|1|||
44250455|NCT04008069|79085027|FG000|Open-Label Period|Adverse Event|1|||
44278662|NCT02059434|79239894|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
44278663|NCT02059434|79239886|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278664|NCT02059434|79239887|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278665|NCT02059434|79239888|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278666|NCT02059434|79239889|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278667|NCT02059434|79239890|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278668|NCT02059434|79239891|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278669|NCT02059434|79239892|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278670|NCT02059434|79239893|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
44278671|NCT02059434|79239894|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
44278672|NCT02059278|79239924|FG000|Overall Study|Adverse Event|1|||
44278673|NCT02059278|79239925|FG001|Overall Study|Adverse Event|1|||
44278674|NCT02059278|79239924|FG000|Overall Study|Lost to Follow-up|1|||
44517174|NCT03614156|79524416|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
44250456|NCT04008069|79085028|FG001|Open-Label Period|Adverse Event|0|||
44250457|NCT04008069|79085029|FG002|Open-Label Period|Adverse Event|0|||
44278675|NCT02059278|79239925|FG001|Overall Study|Lost to Follow-up|0|||
44382654|NCT00725725|79388593|FG000|Overall Study|Lost to Follow-up|2|||
44382655|NCT00725725|79388594|FG001|Overall Study|Lost to Follow-up|0|||
44517175|NCT03614156|79524417|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
44517176|NCT03614156|79524418|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
44517177|NCT03614156|79524415|FG000|Open-Label Treatment Period|Adverse Event|7|||
44517178|NCT03614156|79524416|FG001|Open-Label Treatment Period|Adverse Event|0|||
44517179|NCT03614156|79524417|FG002|Open-Label Treatment Period|Adverse Event|0|||
44517180|NCT03614156|79524418|FG003|Open-Label Treatment Period|Adverse Event|0|||
44517181|NCT03614156|79524415|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
44250458|NCT04008069|79085027|FG000|Open-Label Period|Lack of Efficacy|4|||
44250459|NCT04008069|79085028|FG001|Open-Label Period|Lack of Efficacy|0|||
44250460|NCT04008069|79085029|FG002|Open-Label Period|Lack of Efficacy|0|||
44278676|NCT02059278|79239924|FG000|Overall Study|Withdrawal by Subject|0|||
44278677|NCT02059278|79239925|FG001|Overall Study|Withdrawal by Subject|3|||
44382656|NCT00725725|79388595|FG002|Overall Study|Lost to Follow-up|2|||
44250461|NCT04008069|79085027|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
44278678|NCT02059278|79239924|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
44278679|NCT02059278|79239925|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
44278680|NCT02020512|79239931|FG000|Overall Study|Adverse Event|1|||
44278681|NCT02020512|79239931|FG000|Overall Study|Lost to Follow-up|3|||
44517182|NCT03614156|79524416|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
44517183|NCT03614156|79524417|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
44517184|NCT03614156|79524418|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
44517185|NCT03614156|79524415|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
44517186|NCT03614156|79524416|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
44517187|NCT03614156|79524417|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
44517188|NCT03614156|79524418|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
44250462|NCT04008069|79085028|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
44250463|NCT04008069|79085029|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
44250464|NCT04008069|79085027|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
44250465|NCT04008069|79085028|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
44250466|NCT04008069|79085029|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
44250467|NCT01474538|79085045|FG000|Treatment Period 1|Death|1|||
44250468|NCT01474538|79085046|FG001|Treatment Period 1|Death|0|||
44250469|NCT01474538|79085045|FG000|Treatment Period 1|Physician Decision|1|||
44250470|NCT01474538|79085046|FG001|Treatment Period 1|Physician Decision|0|||
44250471|NCT01474538|79085045|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44250472|NCT01474538|79085046|FG001|Treatment Period 1|Withdrawal by Subject|3|||
44278682|NCT02020512|79239931|FG000|Overall Study|Protocol Violation|4|||
44278683|NCT02041962|79239937|FG000|Overall Study|Lost Aetna Coverage|43|||
44517189|NCT03614156|79524415|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
44250473|NCT01474538|79085045|FG000|Treatment Period 1|Protocol Violation|0|||
44278684|NCT02041962|79239938|FG001|Overall Study|Lost Aetna Coverage|40|||
44517190|NCT03614156|79524416|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
44145236|NCT02729909|78934969|FG000|Overall Study|Voluntary Withdrawal|1|||
44145237|NCT02729909|78934970|FG001|Overall Study|Voluntary Withdrawal|0|||
44145238|NCT02713243|78934978|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
44145239|NCT02713243|78934979|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
44145240|NCT02713243|78934978|FG000|Overall Study|Administrative problems|0|||
44145241|NCT02713243|78934979|FG001|Overall Study|Administrative problems|1|||
44145242|NCT02713243|78934978|FG000|Overall Study|Protocol deviation|0|||
44145243|NCT02713243|78934979|FG001|Overall Study|Protocol deviation|1|||
44145244|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
44145245|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
44145246|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
44145247|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
44145248|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
44145249|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
44145250|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
44145251|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
44145252|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
44145253|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
44145254|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
44145255|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
44145256|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
44145257|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
44145258|NCT03434041|78934987|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
44145259|NCT03434041|78934988|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
44145260|NCT03434041|78934987|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
44145261|NCT03434041|78934988|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
44278685|NCT02041962|79239937|FG000|Overall Study|Death|1|||
44278686|NCT02041962|79239938|FG001|Overall Study|Death|1|||
44278687|NCT02041962|79239937|FG000|Overall Study|Lost to Follow-up|37|||
44278688|NCT02041962|79239938|FG001|Overall Study|Lost to Follow-up|32|||
44278689|NCT02041962|79239937|FG000|Overall Study|Withdrawal by Subject|0|||
44278690|NCT02041962|79239938|FG001|Overall Study|Withdrawal by Subject|11|||
44278691|NCT02041494|79239946|FG000|Overall Study|Death|1|||
44278692|NCT02041494|79239947|FG001|Overall Study|Death|3|||
44278693|NCT02041494|79239946|FG000|Overall Study|Lost to Follow-up|2|||
44278694|NCT02041494|79239947|FG001|Overall Study|Lost to Follow-up|6|||
44382657|NCT00725725|79388593|FG000|Overall Study|Withdrawal by Subject|1|||
44517191|NCT03614156|79524417|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
44517192|NCT03614156|79524418|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
44517193|NCT03614156|79524415|FG000|Open-Label Treatment Period|Protocol Violation|2|||
44517194|NCT03614156|79524416|FG001|Open-Label Treatment Period|Protocol Violation|0|||
44517195|NCT03614156|79524417|FG002|Open-Label Treatment Period|Protocol Violation|0|||
44517196|NCT03614156|79524418|FG003|Open-Label Treatment Period|Protocol Violation|0|||
44517197|NCT03614156|79524415|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
44517198|NCT03614156|79524416|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
44517199|NCT03614156|79524417|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
44517200|NCT03614156|79524418|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
44517201|NCT03614156|79524415|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
44517202|NCT03614156|79524416|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
44517203|NCT03614156|79524417|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
44517204|NCT03614156|79524418|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
44517205|NCT03614156|79524415|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
44145262|NCT03434041|78934987|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
44145263|NCT03434041|78934988|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
44278695|NCT02041494|79239946|FG000|Overall Study|study terminated|16|||
44278696|NCT02041494|79239947|FG001|Overall Study|study terminated|11|||
44382658|NCT00725725|79388594|FG001|Overall Study|Withdrawal by Subject|0|||
44250474|NCT01474538|79085046|FG001|Treatment Period 1|Protocol Violation|1|||
44250475|NCT01474538|79085045|FG000|Treatment Period 2|Death|1|||
44250476|NCT01474538|79085046|FG001|Treatment Period 2|Death|0|||
44250477|NCT01474538|79085045|FG000|Treatment Period 2|Adverse Event|1|||
44250478|NCT01474538|79085046|FG001|Treatment Period 2|Adverse Event|1|||
44250479|NCT01474538|79085045|FG000|Treatment Period 2|Withdrawal by Subject|2|||
44250480|NCT01474538|79085046|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44250481|NCT01474538|79085045|FG000|Treatment Period 2|Sponsor decision|1|||
44250482|NCT01474538|79085046|FG001|Treatment Period 2|Sponsor decision|0|||
44250483|NCT01474538|79085045|FG000|Treatment Period 2|Physician Decision|0|||
44250484|NCT01474538|79085046|FG001|Treatment Period 2|Physician Decision|1|||
44250485|NCT01474538|79085045|FG000|Treatment Period 2|Protocol Violation|1|||
44250486|NCT01474538|79085046|FG001|Treatment Period 2|Protocol Violation|0|||
44250487|NCT02647788|79085054|FG000|Overall Study|Lost to Follow-up|13|||
44250488|NCT02647788|79085055|FG001|Overall Study|Lost to Follow-up|11|||
44250489|NCT02647788|79085054|FG000|Overall Study|Did not want opiate|0|||
44278697|NCT02041104|79239978|FG000|Overall Study|Lost to Follow-up|1|||
44278698|NCT02041104|79239979|FG001|Overall Study|Lost to Follow-up|4|||
44278699|NCT02041104|79239978|FG000|Overall Study|discomfort during OGTT|0|||
44278700|NCT02041104|79239979|FG001|Overall Study|discomfort during OGTT|3|||
44278701|NCT02019420|79239989|FG000|Overall Study|Did not receive study drug|2|||
44278702|NCT02019420|79239990|FG001|Overall Study|Did not receive study drug|2|||
44278703|NCT02019420|79239989|FG000|Overall Study|Withdrawal by Subject|1|||
44278704|NCT02019420|79239990|FG001|Overall Study|Withdrawal by Subject|3|||
44278705|NCT02019420|79239989|FG000|Overall Study|At request of sponsor or investigator|0|||
44278706|NCT02019420|79239990|FG001|Overall Study|At request of sponsor or investigator|1|||
44278707|NCT02019420|79239989|FG000|Overall Study|Death|104|||
44278708|NCT02019420|79239990|FG001|Overall Study|Death|99|||
44278709|NCT02019420|79239989|FG000|Overall Study|Transferred to other care facility|1|||
44278710|NCT02019420|79239990|FG001|Overall Study|Transferred to other care facility|1|||
44278711|NCT02019264|79239998|FG000|Overall Study|Not treated|6|||
44517206|NCT03614156|79524416|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
44250490|NCT02647788|79085055|FG001|Overall Study|Did not want opiate|1|||
44250491|NCT02647788|79085054|FG000|Overall Study|Withdrawal by Subject|1|||
44278712|NCT02019264|79239999|FG001|Overall Study|Not treated|4|||
44517207|NCT03614156|79524417|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
44517208|NCT03614156|79524418|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
44517209|NCT03614156|79524415|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
44517210|NCT03614156|79524416|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
44517211|NCT03614156|79524417|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
44517212|NCT03614156|79524418|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
44517213|NCT03614156|79524415|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44517214|NCT03614156|79524416|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
44517215|NCT03614156|79524417|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
44517216|NCT03614156|79524418|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
44517217|NCT03614156|79524415|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
44517218|NCT03614156|79524416|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
44517219|NCT03614156|79524417|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
44517220|NCT03614156|79524418|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
44517221|NCT03614156|79524415|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
44517222|NCT03614156|79524416|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
44517223|NCT03614156|79524417|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
44278713|NCT02019264|79239998|FG000|Overall Study|Lost to Follow-up|50|||
44278714|NCT02019264|79239999|FG001|Overall Study|Lost to Follow-up|47|||
44278715|NCT02019264|79239998|FG000|Overall Study|Withdrawal by Subject|142|||
44517224|NCT03614156|79524418|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
44517225|NCT03614156|79524415|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
44517226|NCT03614156|79524416|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
44517227|NCT03614156|79524417|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
44517228|NCT03614156|79524418|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
44517229|NCT03614156|79524415|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
44517230|NCT03614156|79524416|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
44517231|NCT03614156|79524417|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
44517232|NCT03614156|79524418|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
44517233|NCT03614156|79524415|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
44517234|NCT03614156|79524416|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
44250492|NCT02647788|79085055|FG001|Overall Study|Withdrawal by Subject|0|||
44250493|NCT02647788|79085054|FG000|Overall Study|Felt itchy with assigned medication|1|||
44250494|NCT02647788|79085055|FG001|Overall Study|Felt itchy with assigned medication|0|||
44250495|NCT02647788|79085054|FG000|Overall Study|Felt nauseous with assigned medication|1|||
44250496|NCT02647788|79085055|FG001|Overall Study|Felt nauseous with assigned medication|1|||
44250497|NCT01459016|79085061|FG000|Overall Study|Withdrawal by Subject|11|||
44250498|NCT01459016|79085061|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
44250499|NCT01458392|79085103|FG000|Overall Study|Death|2|||
44250500|NCT01458392|79085104|FG001|Overall Study|Death|11|||
44250501|NCT01458392|79085105|FG002|Overall Study|Death|22|||
44250502|NCT01458392|79085103|FG000|Overall Study|At the discretion of the sponsor|0|||
44250503|NCT01458392|79085104|FG001|Overall Study|At the discretion of the sponsor|2|||
44250504|NCT01458392|79085105|FG002|Overall Study|At the discretion of the sponsor|7|||
44250505|NCT01458392|79085103|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
44250506|NCT01458392|79085104|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
44145264|NCT03434041|78934987|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
44250507|NCT01458392|79085105|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
44354543|NCT01195272|79358984|FG000|Overall Study|Lack of Efficacy|3|||
44354544|NCT01194804|79358988|FG000|Overall Study|Withdrawal by Subject|1|||
44354545|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
44354546|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
44354547|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
44354548|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
44354549|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
44354550|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
44354551|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
44354552|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
44354553|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
44354554|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
44354555|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
44354556|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
44354557|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
44354558|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
44354559|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
44354560|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
44354561|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
44354562|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
44354563|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
44354564|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
44517235|NCT03614156|79524417|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
44517236|NCT03614156|79524418|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
44517237|NCT03614156|79524415|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
44517238|NCT03614156|79524416|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
44145265|NCT03434041|78934988|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
44145266|NCT00708461|78935003|FG000|Overall Study|Lost to Follow-up|18|||
44145267|NCT00708461|78935004|FG001|Overall Study|Lost to Follow-up|11|||
44145268|NCT00708461|78935003|FG000|Overall Study|Withdrawal by Subject|8|||
44145269|NCT00708461|78935004|FG001|Overall Study|Withdrawal by Subject|9|||
44145270|NCT00708461|78935003|FG000|Overall Study|left workforce|115|||
44145271|NCT00708461|78935004|FG001|Overall Study|left workforce|180|||
44145272|NCT00700999|78935012|FG000|Overall Study|Lost to Follow-up|7|||
44145273|NCT00700999|78935013|FG001|Overall Study|Lost to Follow-up|7|||
44145274|NCT00700999|78935012|FG000|Overall Study|Excluded - did not meet study criteria|0|||
44145275|NCT00700999|78935013|FG001|Overall Study|Excluded - did not meet study criteria|1|||
44145276|NCT00700999|78935012|FG000|Overall Study|Withdrawal by Subject|8|||
44145277|NCT00700999|78935013|FG001|Overall Study|Withdrawal by Subject|1|||
44145278|NCT02729831|78935023|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
44145279|NCT02729831|78935024|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
44145280|NCT02729831|78935025|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
44145281|NCT02729831|78935026|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
44145282|NCT02729831|78935023|FG000|1 Week Post-visit|Lost to Follow-up|43|||
44145283|NCT02729831|78935024|FG001|1 Week Post-visit|Lost to Follow-up|40|||
44145284|NCT02729831|78935025|FG002|1 Week Post-visit|Lost to Follow-up|38|||
44145285|NCT02729831|78935026|FG003|1 Week Post-visit|Lost to Follow-up|36|||
44145286|NCT02729831|78935023|FG000|6 Month Follow-up|Lost to Follow-up|54|||
44145287|NCT02729831|78935024|FG001|6 Month Follow-up|Lost to Follow-up|51|||
44145288|NCT02729831|78935025|FG002|6 Month Follow-up|Lost to Follow-up|48|||
44145289|NCT02729831|78935026|FG003|6 Month Follow-up|Lost to Follow-up|42|||
44145290|NCT02729831|78935023|FG000|6 Month Follow-up|Death|1|||
44145291|NCT02729831|78935024|FG001|6 Month Follow-up|Death|3|||
44145292|NCT02729831|78935025|FG002|6 Month Follow-up|Death|0|||
44145293|NCT02729831|78935026|FG003|6 Month Follow-up|Death|1|||
44145294|NCT02729753|78935038|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
44145295|NCT02729753|78935039|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
44145296|NCT00709319|78935048|FG000|Overall Study|Death|4|||
44145297|NCT00709319|78935048|FG000|Overall Study|Withdrawal by Subject|2|||
44145298|NCT02729051|78935093|FG000|Overall Study|Adverse Event|21|||
44145299|NCT02729051|78935094|FG001|Overall Study|Adverse Event|11|||
44145300|NCT02729051|78935093|FG000|Overall Study|Lack of Efficacy|1|||
44145301|NCT02729051|78935094|FG001|Overall Study|Lack of Efficacy|1|||
44145302|NCT02729051|78935093|FG000|Overall Study|Lost to Follow-up|1|||
44145303|NCT02729051|78935094|FG001|Overall Study|Lost to Follow-up|2|||
44517239|NCT03614156|79524417|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
44517240|NCT03614156|79524418|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
44517241|NCT03614078|79524430|FG000|Overall Study|Withdrawal by Subject|2|||
44517242|NCT03614078|79524431|FG001|Overall Study|Withdrawal by Subject|2|||
44517243|NCT03614078|79524432|FG002|Overall Study|Withdrawal by Subject|3|||
44517244|NCT03614078|79524430|FG000|Overall Study|Participant Did Not Return for Visit|0|||
44517245|NCT03614078|79524431|FG001|Overall Study|Participant Did Not Return for Visit|1|||
44517246|NCT03614078|79524432|FG002|Overall Study|Participant Did Not Return for Visit|0|||
44145304|NCT02729051|78935093|FG000|Overall Study|Physician Decision|1|||
44517247|NCT03614078|79524430|FG000|Overall Study|High Neutrophils|0|||
44517248|NCT03614078|79524431|FG001|Overall Study|High Neutrophils|0|||
44145305|NCT02729051|78935094|FG001|Overall Study|Physician Decision|1|||
44145306|NCT02729051|78935093|FG000|Overall Study|Withdrawal by Subject|6|||
44145307|NCT02729051|78935094|FG001|Overall Study|Withdrawal by Subject|17|||
44145308|NCT00707993|78935102|FG000|Overall Study|Adverse Event|16|||
44145309|NCT00707993|78935103|FG001|Overall Study|Adverse Event|20|||
44145310|NCT00707993|78935102|FG000|Overall Study|Protocol Violation|4|||
44145311|NCT00707993|78935103|FG001|Overall Study|Protocol Violation|7|||
44145312|NCT00707993|78935102|FG000|Overall Study|Lost to Follow-up|0|||
44145313|NCT00707993|78935103|FG001|Overall Study|Lost to Follow-up|4|||
44145314|NCT00707993|78935102|FG000|Overall Study|Withdrawal by Subject|12|||
44145315|NCT00707993|78935103|FG001|Overall Study|Withdrawal by Subject|16|||
44145316|NCT00707993|78935102|FG000|Overall Study|Hyperglycemic Rescue|55|||
44145317|NCT00707993|78935103|FG001|Overall Study|Hyperglycemic Rescue|47|||
44250508|NCT01421069|79085117|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
44250509|NCT01421069|79085117|FG000|Parent Study|Failed to return|3|||
44250510|NCT01421069|79085117|FG000|Parent Study|Withdrawal by Subject|1|||
44250511|NCT01421069|79085117|FG000|Parent Study|Lost to Follow-up|2|||
44382659|NCT00725725|79388595|FG002|Overall Study|Withdrawal by Subject|1|||
44382660|NCT00725725|79388593|FG000|Overall Study|Protocol Violation|0|||
44145318|NCT00707993|78935102|FG000|Overall Study|Other|2|||
44145319|NCT00707993|78935103|FG001|Overall Study|Other|0|||
44382661|NCT00725725|79388594|FG001|Overall Study|Protocol Violation|1|||
44382662|NCT00725725|79388595|FG002|Overall Study|Protocol Violation|0|||
44382663|NCT00725101|79388603|FG000|Overall Study|Death|3|||
44382664|NCT00725101|79388603|FG000|Overall Study|Lost to Follow-up|353|||
44382665|NCT00725101|79388603|FG000|Overall Study|Protocol Violation|1|||
44382666|NCT00725101|79388603|FG000|Overall Study|Withdrawal by Subject|127|||
44382667|NCT00725101|79388603|FG000|Overall Study|not specified/no reason given|11|||
44517249|NCT03614078|79524432|FG002|Overall Study|High Neutrophils|2|||
44517250|NCT03614078|79524430|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
44517251|NCT03614078|79524431|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
44517252|NCT03614078|79524432|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
44517253|NCT03614078|79524430|FG000|Overall Study|Exacerbation of Psoriasis|0|||
44517254|NCT03614078|79524431|FG001|Overall Study|Exacerbation of Psoriasis|1|||
44517255|NCT03614078|79524432|FG002|Overall Study|Exacerbation of Psoriasis|0|||
44517256|NCT03614078|79524430|FG000|Overall Study|Adverse Event|0|||
44517257|NCT03614078|79524431|FG001|Overall Study|Adverse Event|2|||
44517258|NCT03614078|79524432|FG002|Overall Study|Adverse Event|0|||
44517259|NCT03614078|79524430|FG000|Overall Study|Dizziness and Rash|0|||
44382668|NCT00585169|79388607|FG000|Overall Study|Withdrawal by Subject|1|||
44250512|NCT01421069|79085117|FG000|Parent Study|Lack of Efficacy|1|||
44382669|NCT00807742|79388615|FG000|Overall Study|Death|9|||
44382670|NCT00807742|79388616|FG001|Overall Study|Death|2|||
44517260|NCT03614078|79524431|FG001|Overall Study|Dizziness and Rash|1|||
44517261|NCT03614078|79524432|FG002|Overall Study|Dizziness and Rash|0|||
44145320|NCT00708227|78935113|FG000|Overall Study|Physician Decision|0|||
44145321|NCT00708227|78935114|FG001|Overall Study|Physician Decision|3|||
44145322|NCT00708227|78935115|FG002|Overall Study|Physician Decision|1|||
44145323|NCT00708227|78935116|FG003|Overall Study|Physician Decision|2|||
44145324|NCT00708227|78935113|FG000|Overall Study|Withdrawal by Subject|1|||
44145325|NCT00708227|78935114|FG001|Overall Study|Withdrawal by Subject|2|||
44145326|NCT00708227|78935115|FG002|Overall Study|Withdrawal by Subject|0|||
44145327|NCT00708227|78935116|FG003|Overall Study|Withdrawal by Subject|1|||
44145328|NCT02425891|78935148|FG000|Overall Study|Death|333|||
44145329|NCT02425891|78935149|FG001|Overall Study|Death|314|||
44145330|NCT02425891|78935148|FG000|Overall Study|Lost to Follow-up|4|||
44145331|NCT02425891|78935149|FG001|Overall Study|Lost to Follow-up|6|||
44145332|NCT02425891|78935148|FG000|Overall Study|Non-Compliance|1|||
44145333|NCT02425891|78935149|FG001|Overall Study|Non-Compliance|1|||
44145334|NCT02425891|78935148|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
44145335|NCT02425891|78935149|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
44145336|NCT02425891|78935148|FG000|Overall Study|Physician Decision|0|||
44145337|NCT02425891|78935149|FG001|Overall Study|Physician Decision|1|||
44145338|NCT02425891|78935148|FG000|Overall Study|Protocol Violation|1|||
44145339|NCT02425891|78935149|FG001|Overall Study|Protocol Violation|1|||
44145340|NCT02425891|78935148|FG000|Overall Study|Study Terminated By Sponsor|85|||
44145341|NCT02425891|78935149|FG001|Overall Study|Study Terminated By Sponsor|95|||
44145342|NCT02425891|78935148|FG000|Overall Study|Withdrawal by Subject|27|||
44145343|NCT02425891|78935149|FG001|Overall Study|Withdrawal by Subject|32|||
44145344|NCT03241225|78935159|FG000|Overall Study|Lost to Follow-up|2|||
44145345|NCT03241225|78935160|FG001|Overall Study|Lost to Follow-up|1|||
44145346|NCT03241225|78935159|FG000|Overall Study|Protocol Violation|4|||
44145347|NCT03241225|78935160|FG001|Overall Study|Protocol Violation|1|||
44145348|NCT03241225|78935159|FG000|Overall Study|Withdrawal by Subject|1|||
44145349|NCT03241225|78935160|FG001|Overall Study|Withdrawal by Subject|0|||
44145350|NCT01597245|78935170|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
44145351|NCT01597245|78935171|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
44145352|NCT01597245|78935172|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
44145353|NCT01597245|78935173|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
44145354|NCT01597245|78935174|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145355|NCT01597245|78935175|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145356|NCT01597245|78935176|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145357|NCT01597245|78935177|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145358|NCT01597245|78935178|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145359|NCT01597245|78935179|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145360|NCT01597245|78935180|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145361|NCT01597245|78935181|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145362|NCT01597245|78935182|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145363|NCT01597245|78935183|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145364|NCT01597245|78935184|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145365|NCT01597245|78935185|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145366|NCT01597245|78935186|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145367|NCT01597245|78935187|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145368|NCT01597245|78935188|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145369|NCT01597245|78935189|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145370|NCT01597245|78935190|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
44145371|NCT01597245|78935170|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
44145372|NCT01597245|78935171|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
44145373|NCT01597245|78935172|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
44250513|NCT01421069|79085117|FG000|Overall Period for Extension Study|Other|2|||
44250514|NCT01421069|79085117|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
44517262|NCT03613454|79524442|FG000|Overall Study|Protocol Violation|1|||
44517263|NCT03613454|79524443|FG001|Overall Study|Protocol Violation|0|||
44517264|NCT03613454|79524442|FG000|Overall Study|Protocol Violation|0|||
44517265|NCT03613454|79524443|FG001|Overall Study|Protocol Violation|1|||
44517266|NCT03581786|79524451|FG000|Overall Study|Death|17|||
44517267|NCT03581786|79524452|FG001|Overall Study|Death|12|||
44517268|NCT03581786|79524451|FG000|Overall Study|Withdrawal by Subject|2|||
44145374|NCT01597245|78935173|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
44145375|NCT01597245|78935174|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145376|NCT01597245|78935175|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145377|NCT01597245|78935176|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145378|NCT01597245|78935177|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145379|NCT01597245|78935178|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44517269|NCT03581786|79524452|FG001|Overall Study|Withdrawal by Subject|4|||
44517270|NCT03581786|79524451|FG000|Overall Study|Lost to Follow-up|1|||
44517271|NCT03581786|79524452|FG001|Overall Study|Lost to Follow-up|0|||
44517272|NCT03581786|79524451|FG000|Overall Study|reason other than specified above|0|||
44278716|NCT02019264|79239999|FG001|Overall Study|Withdrawal by Subject|117|||
44517273|NCT03581786|79524452|FG001|Overall Study|reason other than specified above|1|||
44517274|NCT03581786|79524451|FG000|Overall Study|Ongoing in the study|123|||
44517275|NCT03581786|79524452|FG001|Overall Study|Ongoing in the study|129|||
44517276|NCT03580382|79524460|FG000|Overall Study|Early Termination of Study|0|||
44517277|NCT03580382|79524461|FG001|Overall Study|Early Termination of Study|3|||
44278717|NCT02019264|79239998|FG000|Overall Study|Administrative reason|36|||
44278718|NCT02019264|79239999|FG001|Overall Study|Administrative reason|28|||
44517278|NCT03579290|79524466|FG000|Overall Study|Lost to Follow-up|9|||
44517279|NCT03611582|79524472|FG000|Overall Study|Adverse Event|26|||
44517280|NCT03611582|79524473|FG001|Overall Study|Adverse Event|6|||
44517281|NCT03611582|79524472|FG000|Overall Study|Protocol Violation|0|||
44517282|NCT03611582|79524473|FG001|Overall Study|Protocol Violation|1|||
44517283|NCT03611582|79524472|FG000|Overall Study|Pregnancy|1|||
44517284|NCT03611582|79524473|FG001|Overall Study|Pregnancy|2|||
44517285|NCT03611582|79524472|FG000|Overall Study|Lack of Efficacy|0|||
44517286|NCT03611582|79524473|FG001|Overall Study|Lack of Efficacy|1|||
44517287|NCT03611582|79524472|FG000|Overall Study|At the discretion of the investigator|1|||
44517288|NCT03611582|79524473|FG001|Overall Study|At the discretion of the investigator|0|||
44517289|NCT03611582|79524472|FG000|Overall Study|Safety concern as judged by the investigator|1|||
44517290|NCT03611582|79524473|FG001|Overall Study|Safety concern as judged by the investigator|2|||
44517291|NCT03611582|79524472|FG000|Overall Study|Withdrawal by Subject|4|||
44278719|NCT02019264|79239998|FG000|Overall Study|Missing|14|||
44517292|NCT03611582|79524473|FG001|Overall Study|Withdrawal by Subject|3|||
44517293|NCT03611582|79524472|FG000|Overall Study|Lost to Follow-up|18|||
44517294|NCT03611582|79524473|FG001|Overall Study|Lost to Follow-up|7|||
44517295|NCT03611582|79524472|FG000|Overall Study|other|17|||
44517296|NCT03611582|79524473|FG001|Overall Study|other|16|||
44517297|NCT04015518|79524484|FG000|Overall Study|Adverse Event|6|||
44517298|NCT04015518|79524485|FG001|Overall Study|Adverse Event|1|||
44517299|NCT04015518|79524486|FG002|Overall Study|Adverse Event|1|||
44517300|NCT04015518|79524487|FG003|Overall Study|Adverse Event|3|||
44517301|NCT04015518|79524488|FG004|Overall Study|Adverse Event|3|||
44517302|NCT04015518|79524484|FG000|Overall Study|Lack of Efficacy|1|||
44517303|NCT04015518|79524485|FG001|Overall Study|Lack of Efficacy|0|||
44517304|NCT04015518|79524486|FG002|Overall Study|Lack of Efficacy|1|||
44517305|NCT04015518|79524487|FG003|Overall Study|Lack of Efficacy|0|||
44517306|NCT04015518|79524488|FG004|Overall Study|Lack of Efficacy|4|||
44517307|NCT04015518|79524484|FG000|Overall Study|Lost to Follow-up|0|||
44250515|NCT01421069|79085117|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
44250516|NCT01421069|79085117|FG000|Overall Period for Extension Study|Pregnancy|1|||
44250517|NCT01421069|79085117|FG000|Overall Period for Extension Study|Adverse Event|1|||
44250518|NCT01421069|79085117|FG000|Overall Period for Extension Study|Protocol Violation|1|||
44250519|NCT01421069|79085117|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
44250520|NCT01421069|79085117|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
44250521|NCT01421069|79085117|FG000|Active Treatment Period|Other|1|||
44250522|NCT01421069|79085117|FG000|Active Treatment Period|No longer willing to participate in study|8|||
44250523|NCT01421069|79085117|FG000|Active Treatment Period|Insufficient clinical response|1|||
44250524|NCT01421069|79085117|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
44250525|NCT01421069|79085117|FG000|Active Treatment Period|Pregnancy|1|||
44250526|NCT01421069|79085117|FG000|Active Treatment Period|Adverse Event|1|||
44250527|NCT01421069|79085117|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
44250528|NCT01421069|79085117|FG000|Active Treatment Period|Enrolled in observational period|29|||
44250529|NCT01421069|79085117|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
44250530|NCT01421069|79085117|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
44250531|NCT01421069|79085117|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
44250532|NCT01421069|79085117|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
44250533|NCT01421069|79085117|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
44250534|NCT01421069|79085117|FG000|2b. Retreatment Period|Protocol Violation|1|||
44250535|NCT01421069|79085117|FG000|Observational Period|Other|1|||
44250536|NCT01421069|79085117|FG000|Observational Period|No longer willing to participate in study|4|||
44250537|NCT01421069|79085117|FG000|Observational Period|Lost to Follow-up|3|||
44250538|NCT01473836|79085149|FG000|Overall Study|Adverse Event|4|||
44250539|NCT01473836|79085149|FG000|Overall Study|Lack of Efficacy|1|||
44250540|NCT01473836|79085149|FG000|Overall Study|Does not meet entrance criteria|1|||
44250541|NCT01473758|79085174|FG000|Cycle 1|Adverse Event|10|||
44250542|NCT01473758|79085175|FG001|Cycle 1|Adverse Event|2|||
44250543|NCT01473758|79085176|FG002|Cycle 1|Adverse Event|0|||
44250544|NCT01473758|79085177|FG003|Cycle 1|Adverse Event|0|||
44250545|NCT01473758|79085174|FG000|Cycle 1|Withdrawal by Subject|1|||
44250546|NCT01473758|79085175|FG001|Cycle 1|Withdrawal by Subject|1|||
44250547|NCT01473758|79085176|FG002|Cycle 1|Withdrawal by Subject|0|||
44250548|NCT01473758|79085177|FG003|Cycle 1|Withdrawal by Subject|0|||
44250549|NCT01473758|79085174|FG000|Cycle 2|Adverse Event|0|||
44250550|NCT01473758|79085175|FG001|Cycle 2|Adverse Event|0|||
44250551|NCT01473758|79085176|FG002|Cycle 2|Adverse Event|5|||
44250552|NCT01473758|79085177|FG003|Cycle 2|Adverse Event|0|||
44250553|NCT01420679|79085187|FG000|Overall Study|Disease Progression|3|||
44250554|NCT01420679|79085188|FG001|Overall Study|Disease Progression|2|||
44250555|NCT01420679|79085187|FG000|Overall Study|Adverse Event|4|||
44250556|NCT01420679|79085188|FG001|Overall Study|Adverse Event|0|||
44250557|NCT01420679|79085187|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
44250558|NCT01420679|79085188|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
44250559|NCT01420679|79085187|FG000|Overall Study|Patient Decision|1|||
44250560|NCT01420679|79085188|FG001|Overall Study|Patient Decision|0|||
44250561|NCT01420679|79085187|FG000|Overall Study|Investigator Decision|1|||
44250562|NCT01420679|79085188|FG001|Overall Study|Investigator Decision|2|||
44250563|NCT01420679|79085187|FG000|Overall Study|Sponsor Decision|3|||
44250564|NCT01420679|79085188|FG001|Overall Study|Sponsor Decision|3|||
44250565|NCT01420679|79085187|FG000|Overall Study|Other|1|||
44250566|NCT01420679|79085188|FG001|Overall Study|Other|0|||
44517308|NCT04015518|79524485|FG001|Overall Study|Lost to Follow-up|0|||
44250567|NCT01496846|79085205|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
44250568|NCT01496846|79085206|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
44517309|NCT04015518|79524486|FG002|Overall Study|Lost to Follow-up|0|||
44517310|NCT04015518|79524487|FG003|Overall Study|Lost to Follow-up|0|||
44250569|NCT01496846|79085207|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
44517311|NCT04015518|79524488|FG004|Overall Study|Lost to Follow-up|1|||
44517312|NCT04015518|79524484|FG000|Overall Study|Withdrawal by Subject|0|||
44517313|NCT04015518|79524485|FG001|Overall Study|Withdrawal by Subject|1|||
44517314|NCT04015518|79524486|FG002|Overall Study|Withdrawal by Subject|0|||
44517315|NCT04015518|79524487|FG003|Overall Study|Withdrawal by Subject|1|||
44517316|NCT04015518|79524488|FG004|Overall Study|Withdrawal by Subject|1|||
44517317|NCT04015518|79524484|FG000|Overall Study|Patient did not come for consecutive visits|0|||
44145380|NCT01597245|78935179|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145381|NCT01597245|78935180|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145382|NCT01597245|78935181|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145383|NCT01597245|78935182|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145384|NCT01597245|78935183|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145385|NCT01597245|78935184|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145386|NCT01597245|78935185|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145387|NCT01597245|78935186|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145388|NCT01597245|78935187|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145389|NCT01597245|78935188|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145390|NCT01597245|78935189|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44145391|NCT01597245|78935190|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
44250570|NCT01496846|79085208|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
44517318|NCT04015518|79524485|FG001|Overall Study|Patient did not come for consecutive visits|1|||
44517319|NCT04015518|79524486|FG002|Overall Study|Patient did not come for consecutive visits|0|||
44517320|NCT04015518|79524487|FG003|Overall Study|Patient did not come for consecutive visits|0|||
44517321|NCT04015518|79524488|FG004|Overall Study|Patient did not come for consecutive visits|0|||
44517322|NCT04015518|79524484|FG000|Overall Study|not willing to travel due to Covid-19|0|||
44517323|NCT04015518|79524485|FG001|Overall Study|not willing to travel due to Covid-19|0|||
44517324|NCT04015518|79524486|FG002|Overall Study|not willing to travel due to Covid-19|1|||
44517325|NCT04015518|79524487|FG003|Overall Study|not willing to travel due to Covid-19|0|||
44517326|NCT04015518|79524488|FG004|Overall Study|not willing to travel due to Covid-19|0|||
44517327|NCT04015518|79524484|FG000|Overall Study|Patient wants to discontinue treatment|0|||
44517328|NCT04015518|79524485|FG001|Overall Study|Patient wants to discontinue treatment|0|||
44517329|NCT04015518|79524486|FG002|Overall Study|Patient wants to discontinue treatment|0|||
44517330|NCT04015518|79524487|FG003|Overall Study|Patient wants to discontinue treatment|1|||
44517331|NCT04015518|79524488|FG004|Overall Study|Patient wants to discontinue treatment|0|||
44517332|NCT04015518|79524484|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
44517333|NCT04015518|79524485|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
44250571|NCT01496846|79085209|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
44250572|NCT01496846|79085210|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
44250573|NCT00964002|79085221|FG000|Overall Study|Protocol Violation|8|||
44250574|NCT01399697|79085233|FG000|Overall Study|Adverse Event|13|||
44250575|NCT01399697|79085234|FG001|Overall Study|Adverse Event|3|||
44145392|NCT01597245|78935170|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
44145393|NCT01597245|78935171|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
44145394|NCT01597245|78935172|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
44517334|NCT04015518|79524486|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
44517335|NCT04015518|79524487|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
44517336|NCT04015518|79524488|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
44517337|NCT04015518|79524484|FG000|Overall Study|Pregnancy|0|||
44517338|NCT04015518|79524485|FG001|Overall Study|Pregnancy|0|||
44517339|NCT04015518|79524486|FG002|Overall Study|Pregnancy|0|||
44517340|NCT04015518|79524487|FG003|Overall Study|Pregnancy|0|||
44517341|NCT04015518|79524488|FG004|Overall Study|Pregnancy|1|||
44517342|NCT04015518|79524484|FG000|Overall Study|Personal reasons|1|||
44517343|NCT04015518|79524485|FG001|Overall Study|Personal reasons|0|||
44145395|NCT01597245|78935173|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
44145396|NCT01597245|78935174|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44517344|NCT04015518|79524486|FG002|Overall Study|Personal reasons|0|||
44517345|NCT04015518|79524487|FG003|Overall Study|Personal reasons|0|||
44250576|NCT01399697|79085235|FG002|Overall Study|Adverse Event|1|||
44250577|NCT01399697|79085233|FG000|Overall Study|Lost to Follow-up|2|||
44517346|NCT04015518|79524488|FG004|Overall Study|Personal reasons|1|||
44517347|NCT04015518|79524484|FG000|Overall Study|Withdrew consent|1|||
44517348|NCT04015518|79524485|FG001|Overall Study|Withdrew consent|0|||
44517349|NCT04015518|79524486|FG002|Overall Study|Withdrew consent|0|||
44145397|NCT01597245|78935175|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145398|NCT01597245|78935176|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44517350|NCT04015518|79524487|FG003|Overall Study|Withdrew consent|0|||
44517351|NCT04015518|79524488|FG004|Overall Study|Withdrew consent|0|||
44517352|NCT04015518|79524484|FG000|Overall Study|Prostate carcinoma|1|||
44517353|NCT04015518|79524485|FG001|Overall Study|Prostate carcinoma|0|||
44517354|NCT04015518|79524486|FG002|Overall Study|Prostate carcinoma|0|||
44517355|NCT04015518|79524487|FG003|Overall Study|Prostate carcinoma|0|||
44145399|NCT01597245|78935177|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145400|NCT01597245|78935178|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145401|NCT01597245|78935179|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145402|NCT01597245|78935180|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145403|NCT01597245|78935181|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145404|NCT01597245|78935182|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145405|NCT01597245|78935183|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145406|NCT01597245|78935184|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145407|NCT01597245|78935185|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145408|NCT01597245|78935186|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145409|NCT01597245|78935187|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145410|NCT01597245|78935188|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145411|NCT01597245|78935189|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145412|NCT01597245|78935190|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
44145413|NCT01597245|78935170|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
44250578|NCT01399697|79085234|FG001|Overall Study|Lost to Follow-up|0|||
44517356|NCT04015518|79524488|FG004|Overall Study|Prostate carcinoma|0|||
44517357|NCT04015518|79524484|FG000|Overall Study|Could not keep appointments due to work|1|||
44517358|NCT04015518|79524485|FG001|Overall Study|Could not keep appointments due to work|0|||
44517359|NCT04015518|79524486|FG002|Overall Study|Could not keep appointments due to work|0|||
44517360|NCT04015518|79524487|FG003|Overall Study|Could not keep appointments due to work|0|||
44145414|NCT01597245|78935171|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
44145415|NCT01597245|78935172|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
44145416|NCT01597245|78935173|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145417|NCT01597245|78935174|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145418|NCT01597245|78935175|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44250579|NCT01399697|79085235|FG002|Overall Study|Lost to Follow-up|0|||
44250580|NCT01399697|79085233|FG000|Overall Study|Withdrawal by Subject|8|||
44517361|NCT04015518|79524488|FG004|Overall Study|Could not keep appointments due to work|0|||
44517362|NCT03577730|79524505|FG000|Overall Study|Physician Decision|3|||
44517363|NCT03577730|79524506|FG001|Overall Study|Physician Decision|1|||
44517364|NCT03577730|79524505|FG000|Overall Study|Did not receive allocated intervention|1|||
44517365|NCT03577730|79524506|FG001|Overall Study|Did not receive allocated intervention|0|||
44517366|NCT03608774|79524514|FG000|Overall Study|Lost to Follow-up|5|||
44145419|NCT01597245|78935176|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145420|NCT01597245|78935177|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145421|NCT01597245|78935178|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145422|NCT01597245|78935179|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44278720|NCT02019264|79239999|FG001|Overall Study|Missing|11|||
44517367|NCT03608774|79524515|FG001|Overall Study|Lost to Follow-up|5|||
44517368|NCT03608774|79524514|FG000|Overall Study|Withdrawal by Subject|1|||
44517369|NCT03608774|79524515|FG001|Overall Study|Withdrawal by Subject|0|||
44517370|NCT03608774|79524514|FG000|Overall Study|Protocol Violation|1|||
44517371|NCT03608774|79524515|FG001|Overall Study|Protocol Violation|0|||
44517372|NCT03608774|79524514|FG000|Overall Study|Not eligible at enrollment|0|||
44517373|NCT03608774|79524515|FG001|Overall Study|Not eligible at enrollment|1|||
44517374|NCT03608774|79524514|FG000|Overall Study|Health related event|0|||
44517375|NCT03608774|79524515|FG001|Overall Study|Health related event|1|||
44517376|NCT04021524|79524523|FG000|Overall Study|Change in surgical intervention|0|||
44517377|NCT04021524|79524524|FG001|Overall Study|Change in surgical intervention|1|||
44517378|NCT03607682|79524530|FG000|Overall Study|Withdrawal by Subject|1|||
44517379|NCT03607682|79524530|FG000|Overall Study|Disease progression|1|||
44517380|NCT03606668|79524534|FG000|Overall Study|Screen Failure|1|||
44517381|NCT03606668|79524534|FG000|Overall Study|Lost to Follow-up|1|||
44145423|NCT01597245|78935180|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44517382|NCT03601052|79524538|FG000|Overall Study|Lost to Follow-up|2|||
44517383|NCT03600740|79524547|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
44145424|NCT01597245|78935181|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145425|NCT01597245|78935182|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145426|NCT01597245|78935183|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145427|NCT01597245|78935184|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145428|NCT01597245|78935185|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145429|NCT01597245|78935186|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145430|NCT01597245|78935187|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145431|NCT01597245|78935188|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145432|NCT01597245|78935189|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145433|NCT01597245|78935190|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
44145434|NCT01597245|78935170|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
44145435|NCT01597245|78935171|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145436|NCT01597245|78935172|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145437|NCT01597245|78935173|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
44145438|NCT01597245|78935174|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145439|NCT01597245|78935175|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145440|NCT01597245|78935176|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145441|NCT01597245|78935177|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145442|NCT01597245|78935178|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145443|NCT01597245|78935179|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145444|NCT01597245|78935180|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145445|NCT01597245|78935181|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145446|NCT01597245|78935182|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145447|NCT01597245|78935183|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145448|NCT01597245|78935184|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145449|NCT01597245|78935185|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145450|NCT01597245|78935186|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145451|NCT01597245|78935187|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145452|NCT01597245|78935188|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44250581|NCT01399697|79085234|FG001|Overall Study|Withdrawal by Subject|0|||
44250582|NCT01399697|79085235|FG002|Overall Study|Withdrawal by Subject|0|||
44250583|NCT01399697|79085233|FG000|Overall Study|Investigator Decisión|1|||
44250584|NCT01399697|79085234|FG001|Overall Study|Investigator Decisión|0|||
44250585|NCT01399697|79085235|FG002|Overall Study|Investigator Decisión|2|||
44250586|NCT01399697|79085233|FG000|Overall Study|Lack of Efficacy|9|||
44250587|NCT01399697|79085234|FG001|Overall Study|Lack of Efficacy|0|||
44250588|NCT01399697|79085235|FG002|Overall Study|Lack of Efficacy|1|||
44250589|NCT01399697|79085233|FG000|Overall Study|Protocol Violation|2|||
44250590|NCT01399697|79085234|FG001|Overall Study|Protocol Violation|0|||
44250591|NCT01399697|79085235|FG002|Overall Study|Protocol Violation|0|||
44250592|NCT01399697|79085233|FG000|Overall Study|Non-Compliant|1|||
44278721|NCT02019108|79240007|FG000|Overall Study|Lost to Follow-up|5|||
44278722|NCT02019108|79240008|FG001|Overall Study|Lost to Follow-up|7|||
44278723|NCT02018562|79240016|FG000|Overall Study|Withdrawal by Subject|2|||
44278724|NCT02018562|79240017|FG001|Overall Study|Withdrawal by Subject|0|||
44278725|NCT02018562|79240016|FG000|Overall Study|Discharged prior to study completion|1|||
44278726|NCT02018562|79240017|FG001|Overall Study|Discharged prior to study completion|0|||
44250593|NCT01399697|79085234|FG001|Overall Study|Non-Compliant|0|||
44250594|NCT01399697|79085235|FG002|Overall Study|Non-Compliant|0|||
44250595|NCT01399697|79085233|FG000|Overall Study|Inclusion Error|2|||
44278727|NCT02058966|79240023|FG000|Open-Label Methamphetamine|Adverse Event|1|||
44278728|NCT02058966|79240023|FG000|First Intervention|Withdrawal by Subject|1|||
44278729|NCT02017860|79240035|FG000|Overall Study|Adverse Event|1|||
44278730|NCT02017860|79240035|FG000|Overall Study|Withdrawal by Subject|1|||
44278731|NCT02040870|79240039|FG000|Overall Study|Completed treatment phase|6|||
44278732|NCT02040870|79240039|FG000|Overall Study|Adverse Event|7|||
44517384|NCT03600428|79524553|FG000|Overall Study|Not eligible|0|||
44145453|NCT01597245|78935189|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145454|NCT01597245|78935190|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
44145455|NCT01597245|78935170|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
44145456|NCT01597245|78935171|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
44145457|NCT01597245|78935172|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
44145458|NCT01597245|78935173|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145459|NCT01597245|78935174|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44250596|NCT01399697|79085234|FG001|Overall Study|Inclusion Error|0|||
44250597|NCT01399697|79085235|FG002|Overall Study|Inclusion Error|0|||
44250598|NCT01399697|79085233|FG000|Overall Study|Positive result for hepatitis B|1|||
44250599|NCT01399697|79085234|FG001|Overall Study|Positive result for hepatitis B|0|||
44250600|NCT01399697|79085235|FG002|Overall Study|Positive result for hepatitis B|0|||
44278733|NCT02040870|79240039|FG000|Overall Study|Progressive disease|58|||
44278734|NCT02040870|79240039|FG000|Overall Study|Physician Decision|6|||
44145460|NCT01597245|78935175|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145461|NCT01597245|78935176|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145462|NCT01597245|78935177|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145463|NCT01597245|78935178|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145464|NCT01597245|78935179|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145465|NCT01597245|78935180|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145466|NCT01597245|78935181|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145467|NCT01597245|78935182|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145468|NCT01597245|78935183|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145469|NCT01597245|78935184|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145470|NCT01597245|78935185|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145471|NCT01597245|78935186|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145472|NCT01597245|78935187|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145473|NCT01597245|78935188|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145474|NCT01597245|78935189|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145475|NCT01597245|78935190|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
44145476|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145477|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145478|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145479|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145480|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145481|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
44145482|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
44145483|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145484|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145485|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145486|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145487|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145488|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145489|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145490|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145491|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145492|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145493|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145494|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145495|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145496|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
44145497|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145498|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145499|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145500|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145501|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
44278735|NCT02040870|79240039|FG000|Overall Study|Subject/guardian decision|10|||
44278736|NCT02040870|79240039|FG000|Overall Study|Lost to Follow-up|3|||
44145502|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
44278737|NCT02040870|79240039|FG000|Overall Study|Death|13|||
44278738|NCT02016690|79240043|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
44382671|NCT00807742|79388615|FG000|Overall Study|Withdrawal by Subject|2|||
44382672|NCT00807742|79388616|FG001|Overall Study|Withdrawal by Subject|1|||
44517385|NCT03600428|79524554|FG001|Overall Study|Not eligible|1|||
44517386|NCT03600428|79524553|FG000|Overall Study|Lost to Follow-up|5|||
44517387|NCT03600428|79524554|FG001|Overall Study|Lost to Follow-up|4|||
44517388|NCT03575702|79524562|FG000|Overall Study|Withdrawal by Subject|1|||
44517389|NCT03575702|79524563|FG001|Overall Study|Withdrawal by Subject|1|||
44517390|NCT03575702|79524562|FG000|Overall Study|Lost to Follow-up|1|||
44517391|NCT03575702|79524563|FG001|Overall Study|Lost to Follow-up|2|||
44517392|NCT03575702|79524562|FG000|Overall Study|Protocol Violation|0|||
44517393|NCT03575702|79524563|FG001|Overall Study|Protocol Violation|1|||
44517394|NCT03575702|79524562|FG000|Overall Study|Patient non compliance|4|||
44517395|NCT03575702|79524563|FG001|Overall Study|Patient non compliance|0|||
44517396|NCT03573908|79524571|FG000|Treatment Period|Adverse Event|4|||
44517397|NCT03573908|79524572|FG001|Treatment Period|Adverse Event|9|||
44517398|NCT03573908|79524573|FG002|Treatment Period|Adverse Event|0|||
44517399|NCT03573908|79524574|FG003|Treatment Period|Adverse Event|0|||
44517400|NCT03573908|79524575|FG004|Treatment Period|Adverse Event|0|||
44517401|NCT03573908|79524571|FG000|Treatment Period|Protocol Violation|1|||
44517402|NCT03573908|79524572|FG001|Treatment Period|Protocol Violation|0|||
44517403|NCT03573908|79524573|FG002|Treatment Period|Protocol Violation|0|||
44517404|NCT03573908|79524574|FG003|Treatment Period|Protocol Violation|0|||
44517405|NCT03573908|79524575|FG004|Treatment Period|Protocol Violation|0|||
44517406|NCT03573908|79524571|FG000|Treatment Period|Withdrawal by Subject|7|||
44517407|NCT03573908|79524572|FG001|Treatment Period|Withdrawal by Subject|5|||
44382673|NCT00807742|79388615|FG000|Overall Study|Lost to Follow-up|35|||
44382674|NCT00807742|79388616|FG001|Overall Study|Lost to Follow-up|51|||
44382675|NCT00724945|79388622|FG000|Period 1|non-compliance|1|||
44382676|NCT00724945|79388623|FG001|Period 1|non-compliance|0|||
44382677|NCT00724945|79388622|FG000|Period 1|Adverse Event|1|||
44382678|NCT00724945|79388623|FG001|Period 1|Adverse Event|1|||
44517408|NCT03573908|79524573|FG002|Treatment Period|Withdrawal by Subject|0|||
44517409|NCT03573908|79524574|FG003|Treatment Period|Withdrawal by Subject|0|||
44517410|NCT03573908|79524575|FG004|Treatment Period|Withdrawal by Subject|0|||
44517411|NCT03573908|79524571|FG000|Treatment Period|Lost to Follow-up|7|||
44517412|NCT03573908|79524572|FG001|Treatment Period|Lost to Follow-up|6|||
44517413|NCT03573908|79524573|FG002|Treatment Period|Lost to Follow-up|0|||
44517414|NCT03573908|79524574|FG003|Treatment Period|Lost to Follow-up|0|||
44250601|NCT01399697|79085233|FG000|Overall Study|Clinical RA remission|1|||
44250602|NCT01399697|79085234|FG001|Overall Study|Clinical RA remission|0|||
44250603|NCT01399697|79085235|FG002|Overall Study|Clinical RA remission|0|||
44382679|NCT00724945|79388622|FG000|Period 1|Lost to Follow-up|1|||
44382680|NCT00724945|79388623|FG001|Period 1|Lost to Follow-up|0|||
44517415|NCT03573908|79524575|FG004|Treatment Period|Lost to Follow-up|0|||
44517416|NCT03573908|79524571|FG000|Treatment Period|Pregnancy|1|||
44517417|NCT03573908|79524572|FG001|Treatment Period|Pregnancy|0|||
44382681|NCT00724945|79388622|FG000|Period 2|lens comfort issue|3|||
44382682|NCT00724945|79388623|FG001|Period 2|lens comfort issue|0|||
44517418|NCT03573908|79524573|FG002|Treatment Period|Pregnancy|0|||
44517419|NCT03573908|79524574|FG003|Treatment Period|Pregnancy|0|||
44517420|NCT03573908|79524575|FG004|Treatment Period|Pregnancy|0|||
44517421|NCT03573908|79524571|FG000|Treatment Period|Other, Not Specified|4|||
44517422|NCT03573908|79524572|FG001|Treatment Period|Other, Not Specified|6|||
44517423|NCT03573908|79524573|FG002|Treatment Period|Other, Not Specified|0|||
44517424|NCT03573908|79524574|FG003|Treatment Period|Other, Not Specified|0|||
44517425|NCT03573908|79524575|FG004|Treatment Period|Other, Not Specified|0|||
44517426|NCT03573908|79524571|FG000|Randomized Withdrawal Period|Adverse Event|0|||
44517427|NCT03573908|79524572|FG001|Randomized Withdrawal Period|Adverse Event|0|||
44517428|NCT03573908|79524573|FG002|Randomized Withdrawal Period|Adverse Event|3|||
44517429|NCT03573908|79524574|FG003|Randomized Withdrawal Period|Adverse Event|0|||
44517430|NCT03573908|79524575|FG004|Randomized Withdrawal Period|Adverse Event|0|||
44517431|NCT03573908|79524571|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44517432|NCT03573908|79524572|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44517433|NCT03573908|79524573|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44517434|NCT03573908|79524574|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44517435|NCT03573908|79524575|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
44517436|NCT03573908|79524571|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
44517437|NCT03573908|79524572|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
44517438|NCT03573908|79524573|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
44517439|NCT03573908|79524574|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
44517440|NCT03573908|79524575|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
44517441|NCT03573908|79524571|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
44517442|NCT03573908|79524572|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
44517443|NCT03573908|79524573|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
44517444|NCT03573908|79524574|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
44517445|NCT03573908|79524575|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
44517446|NCT03573830|79524586|FG000|Overall Study|Dropped without completing treatment|0|||
44517447|NCT03573830|79524587|FG001|Overall Study|Dropped without completing treatment|7|||
44517448|NCT03573830|79524586|FG000|Overall Study|Lost to Follow-up|4|||
44517449|NCT03573830|79524587|FG001|Overall Study|Lost to Follow-up|0|||
44517450|NCT03595904|79524594|FG000|Overall Study|Protocol Violation|3|||
44517451|NCT03595904|79524595|FG001|Overall Study|Protocol Violation|1|||
44517452|NCT03595904|79524594|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
44517453|NCT03595904|79524595|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
44517454|NCT03595904|79524594|FG000|Overall Study|Insurance complications|1|||
44517455|NCT03595904|79524595|FG001|Overall Study|Insurance complications|0|||
44517456|NCT03595904|79524594|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
44145503|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
44145504|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
44145505|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145506|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
44145507|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145508|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145509|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44250604|NCT01399697|79085233|FG000|Overall Study|Sponsor Decision|1|||
44250605|NCT01399697|79085234|FG001|Overall Study|Sponsor Decision|0|||
44250606|NCT01399697|79085235|FG002|Overall Study|Sponsor Decision|0|||
44250607|NCT01473602|79085269|FG000|Overall Study|Adverse Event|1|||
44250608|NCT01473602|79085270|FG001|Overall Study|Adverse Event|2|||
44517457|NCT03595904|79524595|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
44517458|NCT03595280|79524604|FG000|Overall Study|Lost to Follow-up|6|||
44517459|NCT03595280|79524605|FG001|Overall Study|Lost to Follow-up|9|||
44517460|NCT03595280|79524606|FG002|Overall Study|Lost to Follow-up|15|||
44517461|NCT03593876|79524614|FG000|Overall Study|Withdrawal by Subject|1|||
44250609|NCT01473602|79085269|FG000|Overall Study|Death|0|||
44250610|NCT01473602|79085270|FG001|Overall Study|Death|1|||
44145510|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145511|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145512|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145513|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145514|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145515|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145516|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145517|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
44145518|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145519|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145520|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145521|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145522|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145523|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
44145524|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145525|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44250611|NCT01473602|79085269|FG000|Overall Study|Lost to Follow-up|1|||
44250612|NCT01473602|79085270|FG001|Overall Study|Lost to Follow-up|1|||
44250613|NCT01473602|79085269|FG000|Overall Study|Withdrawal by Subject|5|||
44250614|NCT01473602|79085270|FG001|Overall Study|Withdrawal by Subject|4|||
44250615|NCT01473602|79085269|FG000|Overall Study|Physician Decision|1|||
44250616|NCT01473602|79085270|FG001|Overall Study|Physician Decision|0|||
44250617|NCT01496612|79085278|FG000|1st Intervention|Adverse Event|1|||
44145526|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
44250618|NCT01496612|79085279|FG001|1st Intervention|Adverse Event|0|||
44145527|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145528|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
44145529|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
44145530|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
44145531|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145532|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145533|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145534|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145535|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145536|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44250619|NCT01496612|79085278|FG000|1st Intervention|Withdrawal by Subject|1|||
44250620|NCT01496612|79085279|FG001|1st Intervention|Withdrawal by Subject|0|||
44250621|NCT00790218|79085296|FG000|Overall Study|Death|1|||
44250622|NCT00790218|79085297|FG001|Overall Study|Death|0|||
44278739|NCT02016690|79240043|FG000|Overall Study|Excluded from SAS: Duplication|2|||
44382683|NCT00724945|79388622|FG000|Period 2|lens physiology issue|1|||
44145537|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44145538|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
44382684|NCT00724945|79388623|FG001|Period 2|lens physiology issue|0|||
44517462|NCT03593876|79524614|FG000|Overall Study|Discharged home before intervention completion|2|||
44517463|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Adverse Event|5|||
44517464|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Adverse Event|8|||
44145539|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145540|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145541|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145542|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145543|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
44250623|NCT00790218|79085298|FG002|Overall Study|Death|0|||
44250624|NCT01457924|79085324|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
44250625|NCT01457924|79085325|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
44250626|NCT01457924|79085326|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
44250627|NCT01457924|79085327|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
44250628|NCT01457924|79085328|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
44250629|NCT01457924|79085324|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
44250630|NCT01457924|79085325|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
44250631|NCT01457924|79085326|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
44250632|NCT01457924|79085327|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
44382685|NCT00803452|79388631|FG000|Overall Study|Adverse Event|0|||
44517465|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Adverse Event|4|||
44517466|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Adverse Event|8|||
44517467|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
44517468|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
44517469|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
44517470|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
44145544|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
44145545|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
44145546|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
44145547|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
44145548|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
44145549|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
44145550|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
44145551|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
44145552|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145553|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145554|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145555|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145556|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145557|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145558|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145559|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
44145560|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145561|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145562|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145563|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145564|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
44145565|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
44145566|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
44145567|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145568|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
44145569|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
44145570|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
44145571|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
44145572|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
44145573|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145574|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44278740|NCT02016690|79240043|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
44517471|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
44517472|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
44517473|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
44517474|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
44517475|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Physician Decision|1|||
44517476|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Physician Decision|0|||
44517477|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Physician Decision|0|||
44517478|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Physician Decision|0|||
44517479|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
44517480|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
44517481|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
44517482|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
44517483|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Pregnancy|0|||
44517484|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Pregnancy|1|||
44517485|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Pregnancy|0|||
44517486|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Pregnancy|0|||
44517487|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
44517488|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
44517489|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
44517490|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
44250633|NCT01457924|79085328|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
44250634|NCT01457924|79085324|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
44250635|NCT01457924|79085325|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
44517491|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Death|0|||
44517492|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Death|1|||
44517493|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Death|0|||
44517494|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Death|0|||
44517495|NCT00071487|79524622|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
44517496|NCT00071487|79524623|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
44517497|NCT00071487|79524624|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
44517498|NCT00071487|79524625|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
44517499|NCT00071487|79524622|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
44145575|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145576|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145577|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145578|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145579|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145580|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
44145581|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145582|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145583|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145584|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145585|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
44145586|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145587|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44250636|NCT01457924|79085326|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
44250637|NCT01457924|79085327|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
44250638|NCT01457924|79085328|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
44250639|NCT01457924|79085324|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
44250640|NCT01457924|79085325|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
44250641|NCT01457924|79085326|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
44250642|NCT01457924|79085327|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
44250643|NCT01457924|79085328|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
44250644|NCT01457924|79085324|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
44278741|NCT02016690|79240043|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
44382686|NCT00803452|79388632|FG001|Overall Study|Adverse Event|2|||
44382687|NCT00803452|79388631|FG000|Overall Study|Lost to Follow-up|0|||
44250645|NCT01457924|79085325|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
44382688|NCT00803452|79388632|FG001|Overall Study|Lost to Follow-up|3|||
44382689|NCT00589108|79388641|FG000|Overall Study|Lost to Follow-up|1|||
44382690|NCT00589108|79388642|FG001|Overall Study|Lost to Follow-up|1|||
44382691|NCT00589108|79388643|FG002|Overall Study|Lost to Follow-up|1|||
44517500|NCT00071487|79524623|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
44517501|NCT00071487|79524624|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
44382692|NCT00589108|79388641|FG000|Overall Study|Death|3|||
44382693|NCT00589108|79388642|FG001|Overall Study|Death|3|||
44517502|NCT00071487|79524625|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
44517503|NCT00071487|79524622|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
44517504|NCT00071487|79524623|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
44517505|NCT00071487|79524624|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
44517506|NCT00071487|79524625|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
44517507|NCT00071487|79524622|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
44517508|NCT00071487|79524623|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
44517509|NCT00071487|79524624|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
44517510|NCT00071487|79524625|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
44517511|NCT00071487|79524622|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
44517512|NCT00071487|79524623|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
44517513|NCT00071487|79524624|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
44517514|NCT00071487|79524625|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
44517515|NCT00071487|79524622|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
44517516|NCT00071487|79524623|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
44517517|NCT00071487|79524624|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
44250646|NCT01457924|79085326|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
44250647|NCT01457924|79085327|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
44250648|NCT01457924|79085328|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
44278742|NCT02016690|79240043|FG000|Overall Study|Did not meet inclusion criteria|13|||
44382694|NCT00589108|79388643|FG002|Overall Study|Death|4|||
44382695|NCT00717067|79388656|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
44382696|NCT00717067|79388657|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
44382697|NCT00717067|79388658|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
44145588|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145589|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
44145590|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
44145591|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
44145592|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145593|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
44145594|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145595|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145596|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145597|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145598|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44517518|NCT00071487|79524625|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
44145599|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145600|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145601|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
44145602|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145603|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145604|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145605|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145606|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
44145607|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
44145608|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
44145609|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145610|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
44145611|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
44145612|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
44145613|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
44145614|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
44145615|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145616|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145617|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145618|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145619|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145620|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145621|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145622|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
44145623|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145624|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145625|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145626|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145627|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145628|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
44145629|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145630|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145631|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
44145632|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
44145633|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
44145634|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
44145635|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44517519|NCT00071487|79524622|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
44517520|NCT00071487|79524623|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
44517521|NCT00071487|79524624|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
44517522|NCT00071487|79524625|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
44517523|NCT03591146|79524642|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
44517524|NCT03591146|79524643|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
44517525|NCT03591146|79524644|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
44517526|NCT03591146|79524645|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
44517527|NCT03591146|79524646|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
44517528|NCT03591146|79524642|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
44145636|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145637|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145638|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145639|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145640|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145641|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145642|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145643|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
44145644|NCT01597245|78935170|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145645|NCT01597245|78935171|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145646|NCT01597245|78935172|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145647|NCT01597245|78935173|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145648|NCT01597245|78935174|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145649|NCT01597245|78935175|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145650|NCT01597245|78935176|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145651|NCT01597245|78935177|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145652|NCT01597245|78935178|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145653|NCT01597245|78935179|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145654|NCT01597245|78935180|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
44145655|NCT01597245|78935181|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145656|NCT01597245|78935182|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145657|NCT01597245|78935183|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145658|NCT01597245|78935184|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44278743|NCT02016690|79240043|FG000|Overall Study|Hospitalized for RSV at study start|3|||
44145659|NCT01597245|78935185|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145660|NCT01597245|78935186|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145661|NCT01597245|78935187|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145662|NCT01597245|78935188|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44382698|NCT00717067|79388659|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
44145663|NCT01597245|78935189|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44517529|NCT03591146|79524643|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
44517530|NCT03591146|79524644|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
44517531|NCT03591146|79524645|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
44517532|NCT03591146|79524646|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
44517533|NCT03591146|79524642|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
44517534|NCT03591146|79524643|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
44517535|NCT03591146|79524644|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
44517536|NCT03591146|79524645|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
44517537|NCT03591146|79524646|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
44517538|NCT03591146|79524642|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
44517539|NCT03591146|79524643|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
44517540|NCT03591146|79524644|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
44145664|NCT01597245|78935190|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
44145665|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145666|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44517541|NCT03591146|79524645|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
44145667|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145668|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145669|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145670|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145671|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145672|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145673|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145674|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145675|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145676|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145677|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145678|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
44382699|NCT00717067|79388660|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
44382700|NCT00802438|79388682|FG000|Overall Study|Screen Failure|20|||
44382701|NCT00802438|79388682|FG000|Overall Study|Withdrawal by Subject|7|||
44382702|NCT00802438|79388682|FG000|Overall Study|Physician Decision|1|||
44382703|NCT00588952|79388692|FG000|Overall Study|Adverse Event|0|||
44382704|NCT00588952|79388693|FG001|Overall Study|Adverse Event|2|||
44517542|NCT03591146|79524646|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
44517543|NCT00096447|79524658|FG000|Overall Study|Never treated|1|||
44517544|NCT03590366|79524669|FG000|Overall Study|Adverse Event|0|||
44517545|NCT03590366|79524670|FG001|Overall Study|Adverse Event|3|||
44145679|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
44382705|NCT00588952|79388692|FG000|Overall Study|Withdrawal by Subject|3|||
44382706|NCT00588952|79388693|FG001|Overall Study|Withdrawal by Subject|5|||
44382707|NCT01021748|79388708|FG000|Overall Study|Adverse Event|2|||
44382708|NCT01021748|79388709|FG001|Overall Study|Adverse Event|1|||
44517546|NCT03590366|79524669|FG000|Overall Study|Lost to Follow-up|3|||
44517547|NCT03590366|79524670|FG001|Overall Study|Lost to Follow-up|3|||
44517548|NCT03590366|79524669|FG000|Overall Study|Withdrawal by Subject|0|||
44517549|NCT03590366|79524670|FG001|Overall Study|Withdrawal by Subject|2|||
44517550|NCT03588572|79524678|FG000|Visitation 1|Lack of Efficacy|1|||
44517551|NCT03588572|79524679|FG001|Visitation 1|Lack of Efficacy|1|||
44517552|NCT03588572|79524678|FG000|Visitation 2|Lost to Follow-up|1|||
44517553|NCT03588572|79524679|FG001|Visitation 2|Lost to Follow-up|1|||
44517554|NCT03588572|79524678|FG000|Visitation 2|Lack of Efficacy|0|||
44517555|NCT03588572|79524679|FG001|Visitation 2|Lack of Efficacy|1|||
44517556|NCT03588572|79524678|FG000|Visitation 2|Withdrawal by Subject|1|||
44517557|NCT03588572|79524679|FG001|Visitation 2|Withdrawal by Subject|0|||
44517558|NCT03588572|79524678|FG000|Visitation 3|Lost to Follow-up|1|||
44517559|NCT03588572|79524679|FG001|Visitation 3|Lost to Follow-up|1|||
44517560|NCT03588572|79524678|FG000|Visitation 3|Physician Decision|1|||
44517561|NCT03588572|79524679|FG001|Visitation 3|Physician Decision|1|||
44517562|NCT03588572|79524678|FG000|Visitation 3|Withdrawal by Subject|1|||
44517563|NCT03588572|79524679|FG001|Visitation 3|Withdrawal by Subject|0|||
44517564|NCT00090285|79524687|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
44517565|NCT00090285|79524688|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
44517566|NCT00090285|79524689|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
44517567|NCT00090285|79524690|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
44517568|NCT00090285|79524691|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
44517569|NCT00090285|79524692|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
44517570|NCT00090285|79524687|FG000|Base Study Vaccination Period|Adverse Event|2|||
44517571|NCT00090285|79524688|FG001|Base Study Vaccination Period|Adverse Event|4|||
44517572|NCT00090285|79524689|FG002|Base Study Vaccination Period|Adverse Event|0|||
44517573|NCT00090285|79524690|FG003|Base Study Vaccination Period|Adverse Event|0|||
44517574|NCT00090285|79524691|FG004|Base Study Vaccination Period|Adverse Event|0|||
44517575|NCT00090285|79524692|FG005|Base Study Vaccination Period|Adverse Event|0|||
44517576|NCT00090285|79524687|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
44517577|NCT00090285|79524688|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
44517578|NCT00090285|79524689|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
44517579|NCT00090285|79524690|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
44517580|NCT00090285|79524691|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
44517581|NCT00090285|79524692|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
44517582|NCT00090285|79524687|FG000|Base Study Vaccination Period|Protocol Violation|2|||
44517583|NCT00090285|79524688|FG001|Base Study Vaccination Period|Protocol Violation|3|||
44517584|NCT00090285|79524689|FG002|Base Study Vaccination Period|Protocol Violation|0|||
44517585|NCT00090285|79524690|FG003|Base Study Vaccination Period|Protocol Violation|0|||
44517586|NCT00090285|79524691|FG004|Base Study Vaccination Period|Protocol Violation|0|||
44517587|NCT00090285|79524692|FG005|Base Study Vaccination Period|Protocol Violation|0|||
44517588|NCT00090285|79524687|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
44517589|NCT00090285|79524688|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
44517590|NCT00090285|79524689|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
44517591|NCT00090285|79524690|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
44517592|NCT00090285|79524691|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
44145680|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
44145681|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44250649|NCT01457924|79085324|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
44517593|NCT00090285|79524692|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
44517594|NCT00090285|79524687|FG000|Base Study Vaccination Period|Uncooperative|2|||
44517595|NCT00090285|79524688|FG001|Base Study Vaccination Period|Uncooperative|2|||
44517596|NCT00090285|79524689|FG002|Base Study Vaccination Period|Uncooperative|0|||
44517597|NCT00090285|79524690|FG003|Base Study Vaccination Period|Uncooperative|0|||
44145682|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44145683|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44517598|NCT00090285|79524691|FG004|Base Study Vaccination Period|Uncooperative|0|||
44517599|NCT00090285|79524692|FG005|Base Study Vaccination Period|Uncooperative|0|||
44517600|NCT00090285|79524687|FG000|Base Study Vaccination Period|Moved|20|||
44517601|NCT00090285|79524688|FG001|Base Study Vaccination Period|Moved|21|||
44517602|NCT00090285|79524689|FG002|Base Study Vaccination Period|Moved|0|||
44517603|NCT00090285|79524690|FG003|Base Study Vaccination Period|Moved|0|||
44517604|NCT00090285|79524691|FG004|Base Study Vaccination Period|Moved|0|||
44517605|NCT00090285|79524692|FG005|Base Study Vaccination Period|Moved|0|||
44517606|NCT00090285|79524687|FG000|Base Study Vaccination Period|Site Terminated|1|||
44517607|NCT00090285|79524688|FG001|Base Study Vaccination Period|Site Terminated|0|||
44517608|NCT00090285|79524689|FG002|Base Study Vaccination Period|Site Terminated|0|||
44517609|NCT00090285|79524690|FG003|Base Study Vaccination Period|Site Terminated|0|||
44517610|NCT00090285|79524691|FG004|Base Study Vaccination Period|Site Terminated|0|||
44517611|NCT00090285|79524692|FG005|Base Study Vaccination Period|Site Terminated|0|||
44517612|NCT00090285|79524687|FG000|Base Study Vaccination Period|Other|2|||
44517613|NCT00090285|79524688|FG001|Base Study Vaccination Period|Other|2|||
44517614|NCT00090285|79524689|FG002|Base Study Vaccination Period|Other|0|||
44517615|NCT00090285|79524690|FG003|Base Study Vaccination Period|Other|0|||
44517616|NCT00090285|79524691|FG004|Base Study Vaccination Period|Other|0|||
44517617|NCT00090285|79524692|FG005|Base Study Vaccination Period|Other|0|||
44517618|NCT00090285|79524687|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
44517619|NCT00090285|79524688|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
44517620|NCT00090285|79524689|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
44517621|NCT00090285|79524690|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
44517622|NCT00090285|79524691|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
44517623|NCT00090285|79524692|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
44517624|NCT00090285|79524687|FG000|Base Study Vaccination Period|HIV positive|1|||
44517625|NCT00090285|79524688|FG001|Base Study Vaccination Period|HIV positive|1|||
44517626|NCT00090285|79524689|FG002|Base Study Vaccination Period|HIV positive|0|||
44517627|NCT00090285|79524690|FG003|Base Study Vaccination Period|HIV positive|0|||
44517628|NCT00090285|79524691|FG004|Base Study Vaccination Period|HIV positive|0|||
44517629|NCT00090285|79524692|FG005|Base Study Vaccination Period|HIV positive|0|||
44517630|NCT00090285|79524687|FG000|Base Study Follow-up Period|Adverse Event|3|||
44517631|NCT00090285|79524688|FG001|Base Study Follow-up Period|Adverse Event|10|||
44517632|NCT00090285|79524689|FG002|Base Study Follow-up Period|Adverse Event|0|||
44517633|NCT00090285|79524690|FG003|Base Study Follow-up Period|Adverse Event|0|||
44517634|NCT00090285|79524691|FG004|Base Study Follow-up Period|Adverse Event|0|||
44517635|NCT00090285|79524692|FG005|Base Study Follow-up Period|Adverse Event|0|||
44517636|NCT00090285|79524687|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
44517637|NCT00090285|79524688|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
44517638|NCT00090285|79524689|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
44517639|NCT00090285|79524690|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
44517640|NCT00090285|79524691|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
44517641|NCT00090285|79524692|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
44517642|NCT00090285|79524687|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
44517643|NCT00090285|79524688|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
44517644|NCT00090285|79524689|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
44517645|NCT00090285|79524690|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
44517646|NCT00090285|79524691|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
44517647|NCT00090285|79524692|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
44517648|NCT00090285|79524687|FG000|Base Study Follow-up Period|Moved|41|||
44517649|NCT00090285|79524688|FG001|Base Study Follow-up Period|Moved|36|||
44517650|NCT00090285|79524689|FG002|Base Study Follow-up Period|Moved|0|||
44517651|NCT00090285|79524690|FG003|Base Study Follow-up Period|Moved|0|||
44517652|NCT00090285|79524691|FG004|Base Study Follow-up Period|Moved|0|||
44517653|NCT00090285|79524692|FG005|Base Study Follow-up Period|Moved|0|||
44517654|NCT00090285|79524687|FG000|Base Study Follow-up Period|Other|2|||
44517655|NCT00090285|79524688|FG001|Base Study Follow-up Period|Other|0|||
44517656|NCT00090285|79524689|FG002|Base Study Follow-up Period|Other|0|||
44517657|NCT00090285|79524690|FG003|Base Study Follow-up Period|Other|0|||
44278744|NCT02016300|79240049|FG000|Overall Study|Lost to Follow-up|0|||
44517658|NCT00090285|79524691|FG004|Base Study Follow-up Period|Other|0|||
44517659|NCT00090285|79524692|FG005|Base Study Follow-up Period|Other|0|||
44517660|NCT00090285|79524687|FG000|Base Study Follow-up Period|Protocol Violation|1|||
44517661|NCT00090285|79524688|FG001|Base Study Follow-up Period|Protocol Violation|0|||
44517662|NCT00090285|79524689|FG002|Base Study Follow-up Period|Protocol Violation|0|||
44517663|NCT00090285|79524690|FG003|Base Study Follow-up Period|Protocol Violation|0|||
44517664|NCT00090285|79524691|FG004|Base Study Follow-up Period|Protocol Violation|0|||
44517665|NCT00090285|79524692|FG005|Base Study Follow-up Period|Protocol Violation|0|||
44517666|NCT00090285|79524687|FG000|Base Study Follow-up Period|Uncooperative|3|||
44517667|NCT00090285|79524688|FG001|Base Study Follow-up Period|Uncooperative|4|||
44517668|NCT00090285|79524689|FG002|Base Study Follow-up Period|Uncooperative|0|||
44517669|NCT00090285|79524690|FG003|Base Study Follow-up Period|Uncooperative|0|||
44517670|NCT00090285|79524691|FG004|Base Study Follow-up Period|Uncooperative|0|||
44517671|NCT00090285|79524692|FG005|Base Study Follow-up Period|Uncooperative|0|||
44517672|NCT00090285|79524687|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
44517673|NCT00090285|79524688|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
44517674|NCT00090285|79524689|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
44517675|NCT00090285|79524690|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
44517676|NCT00090285|79524691|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
44517677|NCT00090285|79524692|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
44250650|NCT01457924|79085325|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
44250651|NCT01457924|79085326|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
44250652|NCT01457924|79085327|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
44250653|NCT01457924|79085328|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
44250654|NCT01457924|79085324|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
44250655|NCT01457924|79085325|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
44250656|NCT01457924|79085326|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
44250657|NCT01457924|79085327|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
44250658|NCT01457924|79085328|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
44278745|NCT02016300|79240050|FG001|Overall Study|Lost to Follow-up|3|||
44278746|NCT02040090|79240058|FG000|Overall Study|Adverse Event|2|||
44517678|NCT00090285|79524687|FG000|Extension 1|Adverse Event|0|||
44517679|NCT00090285|79524688|FG001|Extension 1|Adverse Event|0|||
44517680|NCT00090285|79524689|FG002|Extension 1|Adverse Event|2|||
44517681|NCT00090285|79524690|FG003|Extension 1|Adverse Event|0|||
44517682|NCT00090285|79524691|FG004|Extension 1|Adverse Event|0|||
44517683|NCT00090285|79524692|FG005|Extension 1|Adverse Event|0|||
44517684|NCT00090285|79524687|FG000|Extension 1|Lost to Follow-up|0|||
44517685|NCT00090285|79524688|FG001|Extension 1|Lost to Follow-up|0|||
44517686|NCT00090285|79524689|FG002|Extension 1|Lost to Follow-up|35|||
44517687|NCT00090285|79524690|FG003|Extension 1|Lost to Follow-up|0|||
44517688|NCT00090285|79524691|FG004|Extension 1|Lost to Follow-up|0|||
44517689|NCT00090285|79524692|FG005|Extension 1|Lost to Follow-up|0|||
44517690|NCT00090285|79524687|FG000|Extension 1|Withdrawal by Subject|0|||
44517691|NCT00090285|79524688|FG001|Extension 1|Withdrawal by Subject|0|||
44517692|NCT00090285|79524689|FG002|Extension 1|Withdrawal by Subject|13|||
44517693|NCT00090285|79524690|FG003|Extension 1|Withdrawal by Subject|1|||
44517694|NCT00090285|79524691|FG004|Extension 1|Withdrawal by Subject|0|||
44517695|NCT00090285|79524692|FG005|Extension 1|Withdrawal by Subject|0|||
44517696|NCT00090285|79524687|FG000|Extension 1|Other|0|||
44517697|NCT00090285|79524688|FG001|Extension 1|Other|0|||
44517698|NCT00090285|79524689|FG002|Extension 1|Other|4|||
44517699|NCT00090285|79524690|FG003|Extension 1|Other|0|||
44517700|NCT00090285|79524691|FG004|Extension 1|Other|0|||
44517701|NCT00090285|79524692|FG005|Extension 1|Other|0|||
44517702|NCT00090285|79524687|FG000|Extension 1|Moved|0|||
44517703|NCT00090285|79524688|FG001|Extension 1|Moved|0|||
44517704|NCT00090285|79524689|FG002|Extension 1|Moved|3|||
44517705|NCT00090285|79524690|FG003|Extension 1|Moved|0|||
44517706|NCT00090285|79524691|FG004|Extension 1|Moved|0|||
44517707|NCT00090285|79524692|FG005|Extension 1|Moved|0|||
44517708|NCT00090285|79524687|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
44517709|NCT00090285|79524688|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
44517710|NCT00090285|79524689|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
44517711|NCT00090285|79524690|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
44517712|NCT00090285|79524691|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
44278747|NCT02040090|79240059|FG001|Overall Study|Adverse Event|0|||
44278748|NCT02040090|79240058|FG000|Overall Study|Physician Decision|1|||
44278749|NCT02040090|79240059|FG001|Overall Study|Physician Decision|0|||
44278750|NCT02040090|79240058|FG000|Overall Study|Withdrawal by Subject|0|||
44278751|NCT02040090|79240059|FG001|Overall Study|Withdrawal by Subject|1|||
44278752|NCT02040090|79240058|FG000|Overall Study|Lost to Follow-up|0|||
44278753|NCT02040090|79240059|FG001|Overall Study|Lost to Follow-up|1|||
44278754|NCT02058498|79240065|FG000|Overall Study|Withdrawal by Subject|4|||
44278755|NCT02039778|79240069|FG000|Overall Study|Death|2|||
44278756|NCT02039778|79240069|FG000|Overall Study|Withdrawal by Subject|1|||
44517713|NCT00090285|79524692|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
44517714|NCT00090285|79524687|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44517715|NCT00090285|79524688|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44278757|NCT02039778|79240069|FG000|Overall Study|Never started the protocol treatment|1|||
44517716|NCT00090285|79524689|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44517717|NCT00090285|79524690|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
44517718|NCT00090285|79524691|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
44517719|NCT00090285|79524692|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
44278758|NCT02015754|79240073|FG000|Overall Study|Disease progression|5|||
44517720|NCT00090285|79524687|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44517721|NCT00090285|79524688|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44517722|NCT00090285|79524689|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44517723|NCT00090285|79524690|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
44517724|NCT00090285|79524691|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
44517725|NCT00090285|79524692|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
44517726|NCT00090285|79524687|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
44517727|NCT00090285|79524688|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
44517728|NCT00090285|79524689|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
44517729|NCT00090285|79524690|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
44517730|NCT00090285|79524691|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
44517731|NCT00090285|79524692|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
44517732|NCT00070941|79524710|FG000|Overall Study|Adverse Event|10|||
44517733|NCT00070941|79524711|FG001|Overall Study|Adverse Event|8|||
44517734|NCT00070941|79524712|FG002|Overall Study|Adverse Event|4|||
44517735|NCT00070707|79524722|FG000|Overall Study|Adverse Event|1|||
44517736|NCT00070707|79524723|FG001|Overall Study|Adverse Event|2|||
44517737|NCT00070707|79524722|FG000|Overall Study|Lack of Efficacy|4|||
44517738|NCT00070707|79524723|FG001|Overall Study|Lack of Efficacy|1|||
44517739|NCT00070707|79524722|FG000|Overall Study|Protocol Violation|8|||
44517740|NCT00070707|79524723|FG001|Overall Study|Protocol Violation|4|||
44517741|NCT00070707|79524722|FG000|Overall Study|Unrelated to Study Medication|1|||
44517742|NCT00070707|79524723|FG001|Overall Study|Unrelated to Study Medication|0|||
44517743|NCT03036124|79524731|FG000|Overall Study|Lost to Follow-up|0|||
44517744|NCT03036124|79524732|FG001|Overall Study|Lost to Follow-up|2|||
44517745|NCT03036124|79524731|FG000|Overall Study|Withdrawal by Subject|5|||
44517746|NCT03036124|79524732|FG001|Overall Study|Withdrawal by Subject|4|||
44517747|NCT00070317|79524738|FG000|Overall Study|Inevaluable (Never Treated)|1|||
44517748|NCT00070317|79524738|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
44517749|NCT00070317|79524738|FG000|Overall Study|Ineligible required test not done|1|||
44517750|NCT00070317|79524738|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
44517751|NCT00070317|79524738|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
44517752|NCT03649412|79524744|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
44517753|NCT03649412|79524745|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
44517754|NCT03649412|79524744|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
44517755|NCT03649412|79524745|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
44517756|NCT03649412|79524744|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
44517757|NCT03649412|79524745|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
44517758|NCT03649412|79524744|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
44517759|NCT03649412|79524745|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
44517760|NCT03649412|79524744|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
44517761|NCT03649412|79524745|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
44517762|NCT03649412|79524744|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
44517763|NCT03649412|79524745|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
44517764|NCT03587636|79524790|FG000|Overall Study|Lost to Follow-up|2|||
44517765|NCT03587636|79524791|FG001|Overall Study|Lost to Follow-up|5|||
44517766|NCT03586544|79524809|FG000|First Intervention|Adverse Event|0|||
44517767|NCT03586544|79524810|FG001|First Intervention|Adverse Event|1|||
44517768|NCT03586544|79524809|FG000|Second Intervention|Withdrawal by Subject|0|||
44517769|NCT03586544|79524810|FG001|Second Intervention|Withdrawal by Subject|1|||
44517770|NCT03585296|79524816|FG000|Overall Study|Adverse Event|1|||
44517771|NCT03585296|79524816|FG000|Overall Study|Lost to Follow-up|2|||
44517772|NCT03585296|79524816|FG000|Overall Study|Withdrawal by Subject|2|||
44517773|NCT03589768|79524824|FG000|Overall Study|Death|1|||
44517774|NCT03589768|79524825|FG001|Overall Study|Death|0|||
44517775|NCT03589768|79524826|FG002|Overall Study|Death|8|||
44517776|NCT03589768|79524827|FG003|Overall Study|Death|3|||
44517777|NCT03589768|79524824|FG000|Overall Study|Withdrawal by Subject|2|||
44517778|NCT03589768|79524825|FG001|Overall Study|Withdrawal by Subject|0|||
44382709|NCT01021748|79388710|FG002|Overall Study|Adverse Event|2|||
44517779|NCT03589768|79524826|FG002|Overall Study|Withdrawal by Subject|0|||
44517780|NCT03589768|79524827|FG003|Overall Study|Withdrawal by Subject|0|||
44517781|NCT03589768|79524824|FG000|Overall Study|Protocol Violation|1|||
44517782|NCT03589768|79524825|FG001|Overall Study|Protocol Violation|0|||
44517783|NCT03589768|79524826|FG002|Overall Study|Protocol Violation|0|||
44517784|NCT03589768|79524827|FG003|Overall Study|Protocol Violation|0|||
44517785|NCT02892422|79524837|FG000|Overall Study|Enrolled not treated|4|||
44517786|NCT02892422|79524837|FG000|Overall Study|Adverse Event|38|||
44517787|NCT02892422|79524837|FG000|Overall Study|Lack of Efficacy|32|||
44517788|NCT02892422|79524837|FG000|Overall Study|Non-compliance with study drug|11|||
44517789|NCT02892422|79524837|FG000|Overall Study|Protocol Violation|4|||
44517790|NCT02892422|79524837|FG000|Overall Study|Withdrawal by Subject|56|||
44517791|NCT02892422|79524837|FG000|Overall Study|Lost to Follow-up|5|||
44517792|NCT02892422|79524837|FG000|Overall Study|sponsor information 16159A results|21|||
44517793|NCT02892422|79524837|FG000|Overall Study|withdrawal of consent|13|||
44517794|NCT02892422|79524837|FG000|Overall Study|exclusion criteria met|3|||
44517795|NCT02892422|79524837|FG000|Overall Study|moving elsewhere|4|||
44517796|NCT02892422|79524837|FG000|Overall Study|non-compliance|10|||
44517797|NCT02892422|79524837|FG000|Overall Study|patient legally incapable|1|||
44517798|NCT02892422|79524837|FG000|Overall Study|patient decision|7|||
44517799|NCT02892422|79524837|FG000|Overall Study|Investigator decision|1|||
44517800|NCT03571646|79524843|FG000|Overall Study|Adverse Event|1|||
44517801|NCT03571646|79524844|FG001|Overall Study|Adverse Event|0|||
44517802|NCT03571646|79524843|FG000|Overall Study|Withdrawal by Subject|1|||
44517803|NCT03571646|79524844|FG001|Overall Study|Withdrawal by Subject|1|||
44517804|NCT03645434|79524850|FG000|Period 1|Adverse Event|0|||
44517805|NCT03645434|79524851|FG001|Period 1|Adverse Event|0|||
44517806|NCT03645434|79524852|FG002|Period 1|Adverse Event|0|||
44517807|NCT03645434|79524853|FG003|Period 1|Adverse Event|1|||
44517808|NCT03645434|79524854|FG004|Period 1|Adverse Event|0|||
44517809|NCT03645434|79524855|FG005|Period 1|Adverse Event|0|||
44517810|NCT03645434|79524850|FG000|Period 1|COPD exacerbation|0|||
44517811|NCT03645434|79524851|FG001|Period 1|COPD exacerbation|0|||
44517812|NCT03645434|79524852|FG002|Period 1|COPD exacerbation|0|||
44517813|NCT03645434|79524853|FG003|Period 1|COPD exacerbation|0|||
44517814|NCT03645434|79524854|FG004|Period 1|COPD exacerbation|1|||
44517815|NCT03645434|79524855|FG005|Period 1|COPD exacerbation|0|||
44517816|NCT00089505|79524867|FG000|Overall Study|Death|4|||
44517817|NCT00089505|79524868|FG001|Overall Study|Death|1|||
44517818|NCT00089505|79524869|FG002|Overall Study|Death|5|||
44517819|NCT00089505|79524870|FG003|Overall Study|Death|8|||
44517820|NCT00089505|79524867|FG000|Overall Study|Withdrawal by Subject|3|||
44517821|NCT00089505|79524868|FG001|Overall Study|Withdrawal by Subject|0|||
44517822|NCT00089505|79524869|FG002|Overall Study|Withdrawal by Subject|6|||
44517823|NCT00089505|79524870|FG003|Overall Study|Withdrawal by Subject|6|||
44517824|NCT00089505|79524867|FG000|Overall Study|Lost to Follow-up|1|||
44517825|NCT00089505|79524868|FG001|Overall Study|Lost to Follow-up|1|||
44517826|NCT00089505|79524869|FG002|Overall Study|Lost to Follow-up|9|||
44517827|NCT00089505|79524870|FG003|Overall Study|Lost to Follow-up|7|||
44517828|NCT00089505|79524867|FG000|Overall Study|Physician Decision|1|||
44517829|NCT00089505|79524868|FG001|Overall Study|Physician Decision|0|||
44517830|NCT00089505|79524869|FG002|Overall Study|Physician Decision|0|||
44517831|NCT00089505|79524870|FG003|Overall Study|Physician Decision|0|||
44517832|NCT00089505|79524867|FG000|Overall Study|Protocol Violation|0|||
44517833|NCT00089505|79524868|FG001|Overall Study|Protocol Violation|0|||
44517834|NCT00089505|79524869|FG002|Overall Study|Protocol Violation|1|||
44517835|NCT00089505|79524870|FG003|Overall Study|Protocol Violation|0|||
44517836|NCT04009824|79524885|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
44517837|NCT04009824|79524886|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
44517838|NCT04009824|79524887|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
44517839|NCT04009824|79524888|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
44517840|NCT04009824|79524889|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
44517841|NCT03555890|79524905|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44517842|NCT03555890|79524906|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44517843|NCT03555890|79524907|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44517844|NCT03555890|79524908|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
44517845|NCT03688074|79524920|FG000|Overall Study|Adverse Event|0|||
44517846|NCT03688074|79524921|FG001|Overall Study|Adverse Event|1|||
44517847|NCT03688074|79524920|FG000|Overall Study|Other|1|||
44517848|NCT03688074|79524921|FG001|Overall Study|Other|0|||
44517849|NCT03630120|79524931|FG000|Overall Study|Disease progression|0|||
44517850|NCT03630120|79524932|FG001|Overall Study|Disease progression|1|||
44517851|NCT03630120|79524933|FG002|Overall Study|Disease progression|1|||
44517852|NCT03630120|79524934|FG003|Overall Study|Disease progression|1|||
44517853|NCT03555266|79524946|FG000|Overall Study|Protocol Violation|6|||
44517854|NCT03555266|79524947|FG001|Overall Study|Protocol Violation|4|||
44517855|NCT03629886|79524955|FG000|Overall Study|Migrated / moved from the study area|0|||
44517856|NCT03629886|79524956|FG001|Overall Study|Migrated / moved from the study area|55|||
44517857|NCT03629886|79524955|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
44517858|NCT03629886|79524956|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
44517859|NCT03629886|79524955|FG000|Overall Study|Study vaccine not administrated|0|||
44517860|NCT03629886|79524956|FG001|Overall Study|Study vaccine not administrated|3|||
44517861|NCT03629886|79524955|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
44517862|NCT03629886|79524956|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
44517863|NCT03629886|79524955|FG000|Overall Study|Refused vaccination step of the study|0|||
44517864|NCT03629886|79524956|FG001|Overall Study|Refused vaccination step of the study|44|||
44517865|NCT03656874|79524965|FG000|Overall Study|Lost to Follow-up|3|||
44517866|NCT03656874|79524966|FG001|Overall Study|Lost to Follow-up|17|||
44517867|NCT03554486|79524974|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
44145684|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44250659|NCT01457924|79085324|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
44250660|NCT01457924|79085325|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
44250661|NCT01457924|79085326|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
44517868|NCT03554486|79524975|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
44517869|NCT03554486|79524976|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
44517870|NCT03554486|79524974|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
44517871|NCT03554486|79524975|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
44517872|NCT03554486|79524976|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
44145685|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
44517873|NCT03554486|79524974|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
44517874|NCT03554486|79524975|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
44517875|NCT03554486|79524976|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
44517878|NCT03571256|79524995|FG000|Overall Study|Adverse Event|3|||
44517879|NCT03571256|79524996|FG001|Overall Study|Adverse Event|0|||
44250662|NCT01457924|79085327|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
44250663|NCT01457924|79085328|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
44517880|NCT03571256|79524997|FG002|Overall Study|Adverse Event|1|||
44517881|NCT03571256|79524995|FG000|Overall Study|Withdrawal by Subject|3|||
44517882|NCT03571256|79524996|FG001|Overall Study|Withdrawal by Subject|1|||
44517883|NCT03571256|79524997|FG002|Overall Study|Withdrawal by Subject|1|||
44517884|NCT03571256|79524995|FG000|Overall Study|Other than specified|0|||
44517885|NCT03571256|79524996|FG001|Overall Study|Other than specified|1|||
44517886|NCT03571256|79524997|FG002|Overall Study|Other than specified|1|||
44517887|NCT03571256|79524995|FG000|Overall Study|Protocol Violation|0|||
44517888|NCT03571256|79524996|FG001|Overall Study|Protocol Violation|1|||
44517889|NCT03571256|79524997|FG002|Overall Study|Protocol Violation|1|||
44517890|NCT03570554|79525011|FG000|Overall Study|Non-compliance with study drug|0|||
44517891|NCT03570554|79525012|FG001|Overall Study|Non-compliance with study drug|0|||
44517892|NCT03570554|79525013|FG002|Overall Study|Non-compliance with study drug|1|||
44517893|NCT03570554|79525014|FG003|Overall Study|Non-compliance with study drug|0|||
44517894|NCT03570554|79525011|FG000|Overall Study|Adverse Event|0|||
44517895|NCT03570554|79525012|FG001|Overall Study|Adverse Event|0|||
44517896|NCT03570554|79525013|FG002|Overall Study|Adverse Event|0|||
44517897|NCT03570554|79525014|FG003|Overall Study|Adverse Event|1|||
44517898|NCT04004208|79525026|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44517899|NCT04004208|79525027|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44517900|NCT04004208|79525026|FG000|Overall Study|Death|3|||
44517901|NCT04004208|79525027|FG001|Overall Study|Death|0|||
44517902|NCT04004208|79525026|FG000|Overall Study|COVID-19 pandemic|1|||
44517903|NCT04004208|79525027|FG001|Overall Study|COVID-19 pandemic|0|||
44517904|NCT04004208|79525026|FG000|Overall Study|Physician Decision|1|||
44517905|NCT04004208|79525027|FG001|Overall Study|Physician Decision|0|||
44517906|NCT04004208|79525026|FG000|Overall Study|Adverse Event|1|||
44517907|NCT04004208|79525027|FG001|Overall Study|Adverse Event|1|||
44517908|NCT03643952|79525033|FG000|Overall Study|Lack of Efficacy|1|||
44517909|NCT03035032|79525045|FG000|Overall Study|Adverse Event|2|||
44517910|NCT03035032|79525045|FG000|Overall Study|Death|9|||
44517911|NCT03035032|79525045|FG000|Overall Study|Lost to Follow-up|1|||
44517912|NCT03035032|79525045|FG000|Overall Study|Progressive Disease|22|||
44517913|NCT03035032|79525045|FG000|Overall Study|Protocol Violation|2|||
44517914|NCT03035032|79525045|FG000|Overall Study|Withdrawal by Subject|2|||
44517915|NCT03035032|79525045|FG000|Overall Study|Physician Decision|5|||
44517916|NCT03629184|79525051|FG000|Overall Study|Withdrawal by Subject|2|||
44517917|NCT03629184|79525052|FG001|Overall Study|Withdrawal by Subject|1|||
44517918|NCT03629184|79525051|FG000|Overall Study|Physician Decision|1|||
44517919|NCT03629184|79525052|FG001|Overall Study|Physician Decision|0|||
44517920|NCT03549338|79525070|FG000|Overall Study|Progressive Disease|1|||
44517921|NCT03549338|79525071|FG001|Overall Study|Progressive Disease|0|||
44517922|NCT03549338|79525072|FG002|Overall Study|Progressive Disease|0|||
44517923|NCT03549338|79525070|FG000|Overall Study|Clinical Progression|0|||
44517924|NCT03549338|79525071|FG001|Overall Study|Clinical Progression|1|||
44517925|NCT03549338|79525072|FG002|Overall Study|Clinical Progression|0|||
44517926|NCT03629028|79525080|FG000|Overall Study|Lost to Follow-up|26|||
44517927|NCT03629028|79525081|FG001|Overall Study|Lost to Follow-up|23|||
44517928|NCT03629028|79525080|FG000|Overall Study|Pregnancy|4|||
44517929|NCT03629028|79525081|FG001|Overall Study|Pregnancy|2|||
44517930|NCT03629028|79525080|FG000|Overall Study|intolerance to examination|2|||
44250664|NCT01457924|79085324|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
44250665|NCT01457924|79085325|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
44250666|NCT01457924|79085326|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
44382710|NCT01021748|79388711|FG003|Overall Study|Adverse Event|0|||
44517931|NCT03629028|79525081|FG001|Overall Study|intolerance to examination|0|||
44517932|NCT03549104|79525099|FG000|Overall Study|Physician Decision|2|||
44517933|NCT03549104|79525100|FG001|Overall Study|Physician Decision|0|||
44517934|NCT03549104|79525099|FG000|Overall Study|Withdrawal by Subject|5|||
44517935|NCT03549104|79525100|FG001|Overall Study|Withdrawal by Subject|2|||
44517936|NCT03549104|79525099|FG000|Overall Study|Covid shelter in place|1|||
44517937|NCT03549104|79525100|FG001|Overall Study|Covid shelter in place|2|||
44517938|NCT02892344|79525108|FG000|Overall Study|Protocol deviation|3|||
44517939|NCT02892344|79525109|FG001|Overall Study|Protocol deviation|4|||
44517940|NCT02892344|79525108|FG000|Overall Study|Adverse Event|1|||
44517941|NCT02892344|79525109|FG001|Overall Study|Adverse Event|8|||
44517942|NCT02892344|79525108|FG000|Overall Study|Lost to Follow-up|0|||
44517943|NCT02892344|79525109|FG001|Overall Study|Lost to Follow-up|1|||
44517944|NCT02892344|79525108|FG000|Overall Study|Non-compliance with study treatment|0|||
44517945|NCT02892344|79525109|FG001|Overall Study|Non-compliance with study treatment|1|||
44517946|NCT02892344|79525108|FG000|Overall Study|Physician Decision|0|||
44517947|NCT02892344|79525109|FG001|Overall Study|Physician Decision|2|||
44517948|NCT02892344|79525108|FG000|Overall Study|Subject/guardian decision|0|||
44517949|NCT02892344|79525109|FG001|Overall Study|Subject/guardian decision|4|||
44517950|NCT02892344|79525108|FG000|Overall Study|Technical problems|0|||
44517951|NCT02892344|79525109|FG001|Overall Study|Technical problems|1|||
44517952|NCT03567980|79525115|FG000|Overall Study|Adverse Event|1|||
44517953|NCT02894840|79525123|FG000|Overall Study|Lost to Follow-up|1|||
44517954|NCT02894840|79525124|FG001|Overall Study|Lost to Follow-up|0|||
44517955|NCT02894840|79525125|FG002|Overall Study|Lost to Follow-up|3|||
44517956|NCT02894840|79525126|FG003|Overall Study|Lost to Follow-up|0|||
44517957|NCT03358030|79525145|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
44517958|NCT03358030|79525146|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
44517959|NCT03358030|79525147|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
44517960|NCT03358030|79525148|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
44517961|NCT03358030|79525145|FG000|Overall Study|Ineligibility|0|||
44517962|NCT03358030|79525146|FG001|Overall Study|Ineligibility|0|||
44517963|NCT03358030|79525147|FG002|Overall Study|Ineligibility|0|||
44517964|NCT03358030|79525148|FG003|Overall Study|Ineligibility|2|||
44517965|NCT03358030|79525145|FG000|Overall Study|Voluntary Withdrawal|1|||
44517966|NCT03358030|79525146|FG001|Overall Study|Voluntary Withdrawal|1|||
44517967|NCT03358030|79525147|FG002|Overall Study|Voluntary Withdrawal|3|||
44517968|NCT03358030|79525148|FG003|Overall Study|Voluntary Withdrawal|1|||
44517969|NCT03358030|79525145|FG000|Overall Study|Other|0|||
44517970|NCT03358030|79525146|FG001|Overall Study|Other|0|||
44517971|NCT03358030|79525147|FG002|Overall Study|Other|1|||
44517972|NCT03358030|79525148|FG003|Overall Study|Other|0|||
44517973|NCT03566810|79525162|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
44517974|NCT03566810|79525163|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
44517975|NCT03566810|79525164|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
44517976|NCT03566810|79525165|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
44517977|NCT03628716|79525188|FG000|Overall Study|Adverse Event|1|||
44517978|NCT03628716|79525189|FG001|Overall Study|Adverse Event|1|||
44517979|NCT03628716|79525188|FG000|Overall Study|Death|1|||
44517980|NCT03628716|79525189|FG001|Overall Study|Death|0|||
44517981|NCT03628716|79525188|FG000|Overall Study|Lack of Efficacy|15|||
44517982|NCT03628716|79525189|FG001|Overall Study|Lack of Efficacy|20|||
44517983|NCT03628716|79525188|FG000|Overall Study|Withdrawal by Subject|1|||
44145686|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145687|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145688|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145689|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145690|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44517984|NCT03628716|79525189|FG001|Overall Study|Withdrawal by Subject|2|||
44517985|NCT03628716|79525188|FG000|Overall Study|Study Terminated by Sponsor|1|||
44145691|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145692|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44517986|NCT03628716|79525189|FG001|Overall Study|Study Terminated by Sponsor|0|||
44517987|NCT04002960|79525197|FG000|Overall Study|Withdrawn prior to Completion|2|||
44517988|NCT04002648|79525203|FG000|Overall Study|Lost to Follow-up|2|||
44517989|NCT04002648|79525204|FG001|Overall Study|Lost to Follow-up|0|||
44517990|NCT00088413|79525225|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
44517991|NCT00088413|79525226|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
44517992|NCT00088413|79525227|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
44517993|NCT00088413|79525228|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
44382711|NCT01021748|79388712|FG004|Overall Study|Adverse Event|2|||
44382712|NCT01021748|79388713|FG005|Overall Study|Adverse Event|0|||
44382713|NCT01021748|79388714|FG006|Overall Study|Adverse Event|1|||
44382714|NCT01021748|79388715|FG007|Overall Study|Adverse Event|0|||
44382715|NCT01021748|79388716|FG008|Overall Study|Adverse Event|7|||
44382716|NCT01021748|79388708|FG000|Overall Study|Physician Decision|1|||
44382717|NCT01021748|79388709|FG001|Overall Study|Physician Decision|0|||
44382718|NCT01021748|79388710|FG002|Overall Study|Physician Decision|1|||
44382719|NCT01021748|79388711|FG003|Overall Study|Physician Decision|1|||
44382720|NCT01021748|79388712|FG004|Overall Study|Physician Decision|0|||
44382721|NCT01021748|79388713|FG005|Overall Study|Physician Decision|0|||
44382722|NCT01021748|79388714|FG006|Overall Study|Physician Decision|1|||
44382723|NCT01021748|79388715|FG007|Overall Study|Physician Decision|1|||
44382724|NCT01021748|79388716|FG008|Overall Study|Physician Decision|2|||
44382725|NCT01021748|79388708|FG000|Overall Study|Progressive Disease|3|||
44382726|NCT01021748|79388709|FG001|Overall Study|Progressive Disease|3|||
44382727|NCT01021748|79388710|FG002|Overall Study|Progressive Disease|4|||
44382728|NCT01021748|79388711|FG003|Overall Study|Progressive Disease|6|||
44382729|NCT01021748|79388712|FG004|Overall Study|Progressive Disease|7|||
44382730|NCT01021748|79388713|FG005|Overall Study|Progressive Disease|3|||
44382731|NCT01021748|79388714|FG006|Overall Study|Progressive Disease|0|||
44382732|NCT01021748|79388715|FG007|Overall Study|Progressive Disease|5|||
44382733|NCT01021748|79388716|FG008|Overall Study|Progressive Disease|6|||
44382734|NCT01021748|79388708|FG000|Overall Study|Withdrawal by Subject|0|||
44382735|NCT01021748|79388709|FG001|Overall Study|Withdrawal by Subject|0|||
44382736|NCT01021748|79388710|FG002|Overall Study|Withdrawal by Subject|0|||
44382737|NCT01021748|79388711|FG003|Overall Study|Withdrawal by Subject|0|||
44382738|NCT01021748|79388712|FG004|Overall Study|Withdrawal by Subject|0|||
44382739|NCT01021748|79388713|FG005|Overall Study|Withdrawal by Subject|0|||
44382740|NCT01021748|79388714|FG006|Overall Study|Withdrawal by Subject|1|||
44382741|NCT01021748|79388715|FG007|Overall Study|Withdrawal by Subject|0|||
44382742|NCT01021748|79388716|FG008|Overall Study|Withdrawal by Subject|1|||
44382743|NCT01021748|79388708|FG000|Overall Study|Not Treated|0|||
44382744|NCT01021748|79388709|FG001|Overall Study|Not Treated|1|||
44382745|NCT01021748|79388710|FG002|Overall Study|Not Treated|0|||
44382746|NCT01021748|79388711|FG003|Overall Study|Not Treated|0|||
44382747|NCT01021748|79388712|FG004|Overall Study|Not Treated|0|||
44382748|NCT01021748|79388713|FG005|Overall Study|Not Treated|0|||
44382749|NCT01021748|79388714|FG006|Overall Study|Not Treated|0|||
44382750|NCT01021748|79388715|FG007|Overall Study|Not Treated|0|||
44382751|NCT01021748|79388716|FG008|Overall Study|Not Treated|0|||
44382752|NCT00802360|79388740|FG000|Overall Study|Stimulation failure|4|||
44382753|NCT00802360|79388741|FG001|Overall Study|Stimulation failure|0|||
44382754|NCT00802360|79388742|FG002|Overall Study|Stimulation failure|3|||
44382755|NCT00802360|79388743|FG003|Overall Study|Stimulation failure|3|||
44382756|NCT00802360|79388740|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
44382757|NCT00802360|79388741|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
44382758|NCT00802360|79388742|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
44382759|NCT00802360|79388743|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
44382760|NCT00802360|79388740|FG000|Overall Study|Cycle cancelled|0|||
44382761|NCT00802360|79388741|FG001|Overall Study|Cycle cancelled|1|||
44382762|NCT00802360|79388742|FG002|Overall Study|Cycle cancelled|1|||
44382763|NCT00802360|79388743|FG003|Overall Study|Cycle cancelled|1|||
44382764|NCT00802360|79388740|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
44382765|NCT00802360|79388741|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
44517994|NCT00088413|79525225|FG000|Overall Study|Adverse Events/Side Effects|0|||
44382766|NCT00802360|79388742|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
44382767|NCT00802360|79388743|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
44382768|NCT00802360|79388740|FG000|Overall Study|No positive serum pregnancy|17|||
44382769|NCT00802360|79388741|FG001|Overall Study|No positive serum pregnancy|20|||
44382770|NCT00802360|79388742|FG002|Overall Study|No positive serum pregnancy|14|||
44382771|NCT00802360|79388743|FG003|Overall Study|No positive serum pregnancy|10|||
44382772|NCT00802360|79388740|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
44382773|NCT00802360|79388741|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
44382774|NCT00802360|79388742|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
44382775|NCT00802360|79388743|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
44517995|NCT00088413|79525226|FG001|Overall Study|Adverse Events/Side Effects|1|||
44382776|NCT00802360|79388740|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
44382777|NCT00802360|79388741|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
44382778|NCT00802360|79388742|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
44382779|NCT00802360|79388743|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
44382780|NCT00802360|79388740|FG000|Overall Study|Other|2|||
44382781|NCT00802360|79388741|FG001|Overall Study|Other|3|||
44382782|NCT00802360|79388742|FG002|Overall Study|Other|6|||
44382783|NCT00802360|79388743|FG003|Overall Study|Other|3|||
44382784|NCT01026038|79388758|FG000|Overall Study|Lost to Follow-up|1|||
44382785|NCT01026038|79388759|FG001|Overall Study|Lost to Follow-up|1|||
44382786|NCT01026038|79388760|FG002|Overall Study|Lost to Follow-up|0|||
44382787|NCT00801892|79388779|FG000|Main Study Period|Withdrawal by Subject|0|||
44382788|NCT00801892|79388780|FG001|Main Study Period|Withdrawal by Subject|1|||
44382789|NCT00801892|79388779|FG000|Sham Crossover Period|Lost to Follow-up|0|||
44382790|NCT00801892|79388780|FG001|Sham Crossover Period|Lost to Follow-up|2|||
44382791|NCT02680587|79388794|FG000|Overall Study|Withdrawal by Subject|1|||
44382792|NCT02680587|79388795|FG001|Overall Study|Withdrawal by Subject|0|||
44382793|NCT00589420|79388805|FG000|Overall Study|screen failure|1|||
44382794|NCT01025336|79388814|FG000|Overall Study|Protocol Violation|0|||
44382795|NCT01025336|79388815|FG001|Overall Study|Protocol Violation|0|||
44382796|NCT01025336|79388816|FG002|Overall Study|Protocol Violation|0|||
44382797|NCT01025336|79388817|FG003|Overall Study|Protocol Violation|2|||
44382798|NCT01025336|79388818|FG004|Overall Study|Protocol Violation|0|||
44382799|NCT00796978|79388852|FG000|Overall Study|Cardiac adverse event|5|||
44382800|NCT00796978|79388852|FG000|Overall Study|Adverse Event|4|||
44382801|NCT00796978|79388852|FG000|Overall Study|Withdrawal by Subject|3|||
44382802|NCT00796822|79388858|FG000|Overall Study|Lost to Follow-up|2|||
44382803|NCT00796822|79388859|FG001|Overall Study|Lost to Follow-up|0|||
44382804|NCT00796822|79388858|FG000|Overall Study|Adverse Event|1|||
44382805|NCT00796822|79388859|FG001|Overall Study|Adverse Event|0|||
44382806|NCT01020812|79388865|FG000|Overall Study|Physician Decision|1|||
44382807|NCT01020812|79388865|FG000|Overall Study|Withdrawal by Subject|1|||
44382808|NCT01020812|79388865|FG000|Overall Study|Protocol Violation|1|||
44382809|NCT01032044|79388871|FG000|Overall Study|Protocol Violation|14|||
44382810|NCT01032044|79388872|FG001|Overall Study|Protocol Violation|8|||
44382811|NCT01032044|79388871|FG000|Overall Study|Adverse Event|0|||
44382812|NCT01032044|79388872|FG001|Overall Study|Adverse Event|1|||
44382813|NCT01032044|79388871|FG000|Overall Study|Lost to Follow-up|11|||
44382814|NCT01032044|79388872|FG001|Overall Study|Lost to Follow-up|11|||
44382815|NCT01024946|79388878|FG000|Overall Study|Screen Failure|3|||
44382816|NCT01024946|79388878|FG000|Overall Study|Withdrawal by Subject|1|||
44382817|NCT01024946|79388878|FG000|Overall Study|Adverse Event|1|||
44382818|NCT00724867|79388882|FG000|Overall Study|Adverse Event|25|||
44382819|NCT00724867|79388882|FG000|Overall Study|Lack of Efficacy|14|||
44382820|NCT00724867|79388882|FG000|Overall Study|Lost to Follow-up|12|||
44382821|NCT00724867|79388882|FG000|Overall Study|Non-compliance with study drug|6|||
44382822|NCT00724867|79388882|FG000|Overall Study|Physician Decision|17|||
44382823|NCT00724867|79388882|FG000|Overall Study|Protocol Violation|1|||
44382824|NCT00724867|79388882|FG000|Overall Study|Withdrawal by Subject|31|||
44382825|NCT00724867|79388882|FG000|Overall Study|Sponsor decision to end study|14|||
44382826|NCT00724867|79388882|FG000|Overall Study|Subject incarcerated|1|||
44382827|NCT00724867|79388882|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
44382828|NCT00724867|79388882|FG000|Overall Study|Subject moved out of state|1|||
44382829|NCT00724867|79388882|FG000|Overall Study|Elected to exit due to site closure|2|||
44382830|NCT00724711|79388891|FG000|Overall Study|Adverse Event|7|||
44382831|NCT00724711|79388892|FG001|Overall Study|Adverse Event|3|||
44382832|NCT00724711|79388891|FG000|Overall Study|Pregnancy|0|||
44382833|NCT00724711|79388892|FG001|Overall Study|Pregnancy|1|||
44517996|NCT00088413|79525227|FG002|Overall Study|Adverse Events/Side Effects|1|||
44517997|NCT00088413|79525228|FG003|Overall Study|Adverse Events/Side Effects|0|||
44517998|NCT00088413|79525225|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
44517999|NCT00088413|79525226|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
44518000|NCT00088413|79525227|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
44518001|NCT00088413|79525228|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
44518002|NCT00088413|79525225|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
44278759|NCT02015754|79240073|FG000|Overall Study|Change in treatment modality|5|||
44278760|NCT02015754|79240073|FG000|Overall Study|Lost to Follow-up|1|||
44278761|NCT02015676|79240080|FG000|Overall Study|Adverse Event|2|||
44278762|NCT02015676|79240081|FG001|Overall Study|Adverse Event|18|||
44382834|NCT00724711|79388891|FG000|Overall Study|Lack of Efficacy|0|||
44382835|NCT00724711|79388892|FG001|Overall Study|Lack of Efficacy|1|||
44382836|NCT00724711|79388891|FG000|Overall Study|Physician Decision|0|||
44382837|NCT00724711|79388892|FG001|Overall Study|Physician Decision|3|||
44382838|NCT00724711|79388891|FG000|Overall Study|Withdrawal by Subject|5|||
44382839|NCT00724711|79388892|FG001|Overall Study|Withdrawal by Subject|4|||
44382840|NCT00724711|79388891|FG000|Overall Study|Lost to Follow-up|4|||
44278763|NCT02015676|79240082|FG002|Overall Study|Adverse Event|0|||
44382841|NCT00724711|79388892|FG001|Overall Study|Lost to Follow-up|5|||
44382842|NCT00724711|79388891|FG000|Overall Study|Protocol Violation|1|||
44382843|NCT00724711|79388892|FG001|Overall Study|Protocol Violation|0|||
44382844|NCT01024244|79388903|FG000|Overall Study|Adverse Event|1|||
44382845|NCT01024244|79388904|FG001|Overall Study|Adverse Event|2|||
44382846|NCT01024244|79388905|FG002|Overall Study|Adverse Event|0|||
44382847|NCT01024244|79388906|FG003|Overall Study|Adverse Event|1|||
44382848|NCT01024244|79388907|FG004|Overall Study|Adverse Event|2|||
44382849|NCT01024244|79388903|FG000|Overall Study|Entry Criteria Not Met|0|||
44382850|NCT01024244|79388904|FG001|Overall Study|Entry Criteria Not Met|1|||
44145693|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44278764|NCT02015676|79240080|FG000|Overall Study|Lack of Efficacy|2|||
44278765|NCT02015676|79240081|FG001|Overall Study|Lack of Efficacy|4|||
44278766|NCT02015676|79240082|FG002|Overall Study|Lack of Efficacy|0|||
44278767|NCT02015676|79240080|FG000|Overall Study|Protocol Violation|1|||
44278768|NCT02015676|79240081|FG001|Overall Study|Protocol Violation|0|||
44278769|NCT02015676|79240082|FG002|Overall Study|Protocol Violation|0|||
44278770|NCT02015676|79240080|FG000|Overall Study|Withdrawal by Subject|1|||
44278771|NCT02015676|79240081|FG001|Overall Study|Withdrawal by Subject|7|||
44278772|NCT02015676|79240082|FG002|Overall Study|Withdrawal by Subject|1|||
44278773|NCT02015676|79240080|FG000|Overall Study|Administrative reasons|0|||
44278774|NCT02015676|79240081|FG001|Overall Study|Administrative reasons|3|||
44278775|NCT02015676|79240082|FG002|Overall Study|Administrative reasons|1|||
44278776|NCT02015676|79240080|FG000|Overall Study|Death|0|||
44278777|NCT02015676|79240081|FG001|Overall Study|Death|1|||
44278778|NCT02015676|79240082|FG002|Overall Study|Death|0|||
44278779|NCT02015676|79240080|FG000|Overall Study|Disease progression|3|||
44278780|NCT02015676|79240081|FG001|Overall Study|Disease progression|1|||
44278781|NCT02015676|79240082|FG002|Overall Study|Disease progression|1|||
44278782|NCT02015520|79240090|FG000|Overall Study|Lack of Efficacy|1|||
44278783|NCT02015520|79240091|FG001|Overall Study|Lack of Efficacy|0|||
44278784|NCT02015520|79240092|FG002|Overall Study|Lack of Efficacy|3|||
44278785|NCT02015520|79240093|FG003|Overall Study|Lack of Efficacy|2|||
44278786|NCT02015520|79240090|FG000|Overall Study|Adverse Event|0|||
44278787|NCT02015520|79240091|FG001|Overall Study|Adverse Event|0|||
44278788|NCT02015520|79240092|FG002|Overall Study|Adverse Event|0|||
44278789|NCT02015520|79240093|FG003|Overall Study|Adverse Event|1|||
44278790|NCT02015520|79240090|FG000|Overall Study|Withdrawal by Subject|2|||
44278791|NCT02015520|79240091|FG001|Overall Study|Withdrawal by Subject|2|||
44278792|NCT02015520|79240092|FG002|Overall Study|Withdrawal by Subject|1|||
44278793|NCT02015520|79240093|FG003|Overall Study|Withdrawal by Subject|0|||
44278794|NCT02015520|79240090|FG000|Overall Study|Death|1|||
44278795|NCT02015520|79240091|FG001|Overall Study|Death|0|||
44278796|NCT02015520|79240092|FG002|Overall Study|Death|0|||
44278797|NCT02015520|79240093|FG003|Overall Study|Death|0|||
44278798|NCT02015520|79240090|FG000|Overall Study|Lost to Follow-up|0|||
44278799|NCT02015520|79240091|FG001|Overall Study|Lost to Follow-up|0|||
44278800|NCT02015520|79240092|FG002|Overall Study|Lost to Follow-up|1|||
44278801|NCT02015520|79240093|FG003|Overall Study|Lost to Follow-up|0|||
44278802|NCT02015520|79240090|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
44278803|NCT02015520|79240091|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
44278804|NCT02015520|79240092|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
44278805|NCT02015520|79240093|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
44278806|NCT02015520|79240090|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
44278807|NCT02015520|79240091|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
44278808|NCT02015520|79240092|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
44278809|NCT02015520|79240093|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
44278810|NCT02058108|79240105|FG000|Overall Study|Abnormal Laboratory Values|0|||
44278811|NCT02058108|79240106|FG001|Overall Study|Abnormal Laboratory Values|1|||
44145694|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145695|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145696|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145697|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145698|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44250667|NCT01457924|79085327|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
44250668|NCT01457924|79085328|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
44250669|NCT01457924|79085324|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
44250670|NCT01457924|79085325|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
44250671|NCT01457924|79085326|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
44250672|NCT01457924|79085327|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
44250673|NCT01457924|79085328|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
44250674|NCT01457924|79085324|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
44278812|NCT02058108|79240105|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
44145699|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
44145700|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
44145701|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
44145702|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44250675|NCT01457924|79085325|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
44278813|NCT02058108|79240106|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
44250676|NCT01457924|79085326|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
44278814|NCT02058108|79240105|FG000|Overall Study|No longer requires study drug|0|||
44278815|NCT02058108|79240106|FG001|Overall Study|No longer requires study drug|1|||
44278816|NCT02058108|79240105|FG000|Overall Study|Withdrawal by Subject|1|||
44278817|NCT02058108|79240106|FG001|Overall Study|Withdrawal by Subject|0|||
44382851|NCT01024244|79388905|FG002|Overall Study|Entry Criteria Not Met|0|||
44382852|NCT01024244|79388906|FG003|Overall Study|Entry Criteria Not Met|0|||
44382853|NCT01024244|79388907|FG004|Overall Study|Entry Criteria Not Met|0|||
44382854|NCT01024244|79388903|FG000|Overall Study|Lack of Efficacy|1|||
44382855|NCT01024244|79388904|FG001|Overall Study|Lack of Efficacy|0|||
44382856|NCT01024244|79388905|FG002|Overall Study|Lack of Efficacy|0|||
44382857|NCT01024244|79388906|FG003|Overall Study|Lack of Efficacy|0|||
44382858|NCT01024244|79388907|FG004|Overall Study|Lack of Efficacy|0|||
44382859|NCT01024244|79388903|FG000|Overall Study|Protocol Violation|1|||
44382860|NCT01024244|79388904|FG001|Overall Study|Protocol Violation|0|||
44382861|NCT01024244|79388905|FG002|Overall Study|Protocol Violation|0|||
44382862|NCT01024244|79388906|FG003|Overall Study|Protocol Violation|0|||
44382863|NCT01024244|79388907|FG004|Overall Study|Protocol Violation|2|||
44382864|NCT01024244|79388903|FG000|Overall Study|Sponsor Decision|14|||
44382865|NCT01024244|79388904|FG001|Overall Study|Sponsor Decision|7|||
44382866|NCT01024244|79388905|FG002|Overall Study|Sponsor Decision|14|||
44382867|NCT01024244|79388906|FG003|Overall Study|Sponsor Decision|12|||
44382868|NCT01024244|79388907|FG004|Overall Study|Sponsor Decision|10|||
44382869|NCT01024244|79388903|FG000|Overall Study|Withdrawal by Subject|0|||
44382870|NCT01024244|79388904|FG001|Overall Study|Withdrawal by Subject|1|||
44382871|NCT01024244|79388905|FG002|Overall Study|Withdrawal by Subject|0|||
44382872|NCT01024244|79388906|FG003|Overall Study|Withdrawal by Subject|0|||
44382873|NCT01024244|79388907|FG004|Overall Study|Withdrawal by Subject|0|||
44382874|NCT00721279|79388921|FG000|Overall Study|Lack of Efficacy|6|||
44382875|NCT00721279|79388922|FG001|Overall Study|Lack of Efficacy|3|||
44382876|NCT00721279|79388921|FG000|Overall Study|Tolerability insufficient|5|||
44382877|NCT00721279|79388922|FG001|Overall Study|Tolerability insufficient|2|||
44382878|NCT00721279|79388921|FG000|Overall Study|Withdrawal by Subject|13|||
44382879|NCT00721279|79388922|FG001|Overall Study|Withdrawal by Subject|3|||
44382880|NCT00721279|79388921|FG000|Overall Study|Other|12|||
44382881|NCT00721279|79388922|FG001|Overall Study|Other|16|||
44382882|NCT01030952|79388931|FG000|Overall Study|Protocol Violation|0|||
44382883|NCT01030952|79388932|FG001|Overall Study|Protocol Violation|1|||
44382884|NCT01030952|79388931|FG000|Overall Study|Informed consent withdrawal|1|||
44382885|NCT01030952|79388932|FG001|Overall Study|Informed consent withdrawal|0|||
44278818|NCT02058108|79240105|FG000|Overall Study|Administrative problems|3|||
44278819|NCT02058108|79240106|FG001|Overall Study|Administrative problems|3|||
44278820|NCT02058108|79240105|FG000|Overall Study|Protocol Violation|0|||
44278821|NCT02058108|79240106|FG001|Overall Study|Protocol Violation|1|||
44278822|NCT02057874|79240114|FG000|Overall Study|participant did not return for scan|1|||
44278823|NCT02038920|79240121|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
44382886|NCT01030952|79388931|FG000|Overall Study|Lost to Follow-up|0|||
44382887|NCT01030952|79388932|FG001|Overall Study|Lost to Follow-up|1|||
44382888|NCT01030952|79388931|FG000|Overall Study|Unexplained|1|||
44382889|NCT01030952|79388932|FG001|Overall Study|Unexplained|1|||
44382890|NCT01030874|79388942|FG000|Overall Study|Withdrawal by Subject|1|||
44382891|NCT01030874|79388943|FG001|Overall Study|Withdrawal by Subject|0|||
44382892|NCT01030874|79388942|FG000|Overall Study|Discharged in first 2 weeks|17|||
44518003|NCT00088413|79525226|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
44250677|NCT01457924|79085327|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
44250678|NCT01457924|79085328|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
44250679|NCT01457924|79085324|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
44250680|NCT01457924|79085325|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
44250681|NCT01457924|79085326|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
44250682|NCT01457924|79085327|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
44250683|NCT01457924|79085328|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
44250684|NCT01457924|79085324|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
44250685|NCT01457924|79085325|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
44250686|NCT01457924|79085326|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
44250687|NCT01457924|79085327|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
44250688|NCT01457924|79085328|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
44250689|NCT01399619|79085349|FG000|Overall Study|Adverse Event|10|||
44250690|NCT01399619|79085350|FG001|Overall Study|Adverse Event|0|||
44250691|NCT01399619|79085351|FG002|Overall Study|Adverse Event|4|||
44278824|NCT02038920|79240122|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
44382893|NCT01030874|79388943|FG001|Overall Study|Discharged in first 2 weeks|16|||
44382894|NCT03611751|79388952|FG000|Pre-treatment|Randomized but not treated|1|||
44382895|NCT03611751|79388953|FG001|Pre-treatment|Randomized but not treated|1|||
44382896|NCT03611751|79388954|FG002|Pre-treatment|Randomized but not treated|0|||
44382897|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
44382898|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
44382899|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
44382900|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
44250692|NCT01399619|79085352|FG003|Overall Study|Adverse Event|10|||
44278825|NCT02038920|79240123|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
44278826|NCT02038920|79240124|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
44278827|NCT02038920|79240125|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
44278828|NCT02038920|79240126|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
44278829|NCT02038920|79240121|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
44278830|NCT02038920|79240122|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
44382901|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
44382902|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
44382903|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
44382904|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
44382905|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
44382906|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
44382907|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
44382908|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
44382909|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
44382910|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
44382911|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
44382912|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
44382913|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
44382914|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
44382915|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
44382916|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
44382917|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
44382918|NCT03611751|79388952|FG000|Treatment Week 0 - Week 16|Death|0|||
44382919|NCT03611751|79388953|FG001|Treatment Week 0 - Week 16|Death|0|||
44382920|NCT03611751|79388954|FG002|Treatment Week 0 - Week 16|Death|1|||
44382921|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
44382922|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
44382923|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
44382924|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
44382925|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
44382926|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
44382927|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
44382928|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
44382929|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
44382930|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
44382931|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
44382932|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
44382933|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
44382934|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
44382935|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
44382936|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
44382937|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
44382938|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
44382939|NCT03611751|79388952|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
44382940|NCT03611751|79388953|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
44382941|NCT03611751|79388954|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
44382942|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
44382943|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
44382944|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
44382945|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
44382946|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
44382947|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
44382948|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
44382949|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
44382950|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
44382951|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
44382952|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
44382953|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
44382954|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
44518004|NCT00088413|79525227|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
44518005|NCT00088413|79525228|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
44518006|NCT00088413|79525225|FG000|Overall Study|Death|0|||
44518007|NCT00088413|79525226|FG001|Overall Study|Death|1|||
44278831|NCT02038920|79240123|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
44382955|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
44382956|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
44382957|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
44382958|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
44382959|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
44518008|NCT00088413|79525227|FG002|Overall Study|Death|0|||
44382960|NCT03611751|79388952|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
44382961|NCT03611751|79388953|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
44518009|NCT00088413|79525228|FG003|Overall Study|Death|0|||
44518010|NCT00088413|79525225|FG000|Overall Study|Progressive disease|9|||
44145703|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145704|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145705|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145706|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
44145707|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145708|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145709|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145710|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145711|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145712|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145713|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145714|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145715|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145716|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145717|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145718|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145719|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145720|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145721|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
44145722|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
44145723|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145724|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145725|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145726|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44145727|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
44518011|NCT00088413|79525226|FG001|Overall Study|Progressive disease|11|||
44518012|NCT00088413|79525227|FG002|Overall Study|Progressive disease|8|||
44518013|NCT00088413|79525228|FG003|Overall Study|Progressive disease|14|||
44518014|NCT00088413|79525225|FG000|Overall Study|Other|0|||
44518015|NCT00088413|79525226|FG001|Overall Study|Other|1|||
44518016|NCT00088413|79525227|FG002|Overall Study|Other|0|||
44518017|NCT00088413|79525228|FG003|Overall Study|Other|0|||
44145728|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145729|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145730|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145731|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145732|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145733|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145734|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145735|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145736|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145737|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145738|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145739|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44250693|NCT01399619|79085349|FG000|Overall Study|Lack of Efficacy|9|||
44250694|NCT01399619|79085350|FG001|Overall Study|Lack of Efficacy|0|||
44250695|NCT01399619|79085351|FG002|Overall Study|Lack of Efficacy|5|||
44250696|NCT01399619|79085352|FG003|Overall Study|Lack of Efficacy|0|||
44250697|NCT01399619|79085349|FG000|Overall Study|Withdrawal by Subject|6|||
44250698|NCT01399619|79085350|FG001|Overall Study|Withdrawal by Subject|0|||
44250699|NCT01399619|79085351|FG002|Overall Study|Withdrawal by Subject|3|||
44250700|NCT01399619|79085352|FG003|Overall Study|Withdrawal by Subject|4|||
44250701|NCT01399619|79085349|FG000|Overall Study|Protocol Violation|0|||
44250702|NCT01399619|79085350|FG001|Overall Study|Protocol Violation|0|||
44250703|NCT01399619|79085351|FG002|Overall Study|Protocol Violation|0|||
44250704|NCT01399619|79085352|FG003|Overall Study|Protocol Violation|1|||
44250705|NCT01399619|79085349|FG000|Overall Study|Not treated|0|||
44250706|NCT01399619|79085350|FG001|Overall Study|Not treated|0|||
44250707|NCT01399619|79085351|FG002|Overall Study|Not treated|0|||
44250708|NCT01399619|79085352|FG003|Overall Study|Not treated|2|||
44250709|NCT01496456|79085367|FG000|Overall Study|Protocol Violation|1|||
44250710|NCT01496456|79085367|FG000|Overall Study|Lost to Follow-up|7|||
44250711|NCT01673646|79085567|FG000|Overall Study|Adverse Event|2|||
44382962|NCT03611751|79388954|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
44518018|NCT00088413|79525225|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
44382963|NCT00721123|79388971|FG000|Overall Study|Adverse Event|96|||
44382964|NCT00721123|79388971|FG000|Overall Study|Death|10|||
44382965|NCT00721123|79388971|FG000|Overall Study|Insufficient Therapeutic Response|21|||
44382966|NCT00721123|79388971|FG000|Overall Study|Protocol Violation|1|||
44382967|NCT00721123|79388971|FG000|Overall Study|Refused Treatment|41|||
44382968|NCT00721123|79388971|FG000|Overall Study|Failure to Return|9|||
44382969|NCT00721123|79388971|FG000|Overall Study|Withdrawal by Subject|5|||
44382970|NCT00720499|79388991|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
44382971|NCT00720499|79388992|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
44382972|NCT00720499|79388991|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
44382973|NCT00720499|79388992|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
44382974|NCT00720499|79388991|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
44382975|NCT00720499|79388992|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
44382976|NCT00724243|79388999|FG000|Overall Study|Lack of Efficacy|10|||
44382977|NCT00724243|79388999|FG000|Overall Study|Adverse Event|5|||
44382978|NCT00720343|79389003|FG000|Overall Study|Physician Decision|3|||
44382979|NCT00720343|79389003|FG000|Overall Study|No data|3|||
44382980|NCT00720109|79389009|FG000|Induction Period|Did not meet eligibility criteria|3|||
44382981|NCT00720109|79389010|FG001|Induction Period|Did not meet eligibility criteria|0|||
44382982|NCT00720109|79389011|FG002|Induction Period|Did not meet eligibility criteria|0|||
44382983|NCT00720109|79389009|FG000|Induction Period|Bone Marrow Transplant|2|||
44382984|NCT00720109|79389010|FG001|Induction Period|Bone Marrow Transplant|0|||
44382985|NCT00720109|79389011|FG002|Induction Period|Bone Marrow Transplant|0|||
44382986|NCT00720109|79389009|FG000|Induction Period|Physician Decision|1|||
44382987|NCT00720109|79389010|FG001|Induction Period|Physician Decision|0|||
44382988|NCT00720109|79389011|FG002|Induction Period|Physician Decision|0|||
44382989|NCT00720109|79389009|FG000|Risk Stratification Period|Adverse Event|0|||
44382990|NCT00720109|79389010|FG001|Risk Stratification Period|Adverse Event|1|||
44382991|NCT00720109|79389011|FG002|Risk Stratification Period|Adverse Event|0|||
44382992|NCT00720109|79389009|FG000|Risk Stratification Period|Physician Decision|0|||
44382993|NCT00720109|79389010|FG001|Risk Stratification Period|Physician Decision|2|||
44382994|NCT00720109|79389011|FG002|Risk Stratification Period|Physician Decision|1|||
44382995|NCT00720109|79389009|FG000|Risk Stratification Period|Bone marrow transplant|0|||
44382996|NCT00720109|79389010|FG001|Risk Stratification Period|Bone marrow transplant|9|||
44382997|NCT00720109|79389011|FG002|Risk Stratification Period|Bone marrow transplant|7|||
44382998|NCT00720109|79389009|FG000|Risk Stratification Period|Disease progression or relapse|0|||
44382999|NCT00720109|79389010|FG001|Risk Stratification Period|Disease progression or relapse|2|||
44383000|NCT00720109|79389011|FG002|Risk Stratification Period|Disease progression or relapse|0|||
44383001|NCT00720109|79389009|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
44383002|NCT00720109|79389010|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
44383003|NCT00720109|79389011|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
44383004|NCT01015118|79389022|FG000|Overall Study|Protocol Violation|5|||
44383005|NCT01015118|79389023|FG001|Overall Study|Protocol Violation|6|||
44383006|NCT01015118|79389022|FG000|Overall Study|Withdrawal by Subject|103|||
44383007|NCT01015118|79389023|FG001|Overall Study|Withdrawal by Subject|27|||
44383008|NCT01015118|79389022|FG000|Overall Study|Other Adverse Event (AE)|141|||
44383009|NCT01015118|79389023|FG001|Overall Study|Other Adverse Event (AE)|33|||
44383010|NCT01015118|79389022|FG000|Overall Study|Worsening or AE of underlying disease|5|||
44383011|NCT01015118|79389023|FG001|Overall Study|Worsening or AE of underlying disease|4|||
44383012|NCT01015118|79389022|FG000|Overall Study|Progressive disease|364|||
44383013|NCT01015118|79389023|FG001|Overall Study|Progressive disease|229|||
44383014|NCT01015118|79389022|FG000|Overall Study|Not treated|9|||
44383015|NCT01015118|79389023|FG001|Overall Study|Not treated|5|||
44383016|NCT01015118|79389022|FG000|Overall Study|Other than stated above|42|||
44383017|NCT01015118|79389023|FG001|Overall Study|Other than stated above|23|||
44383018|NCT00800176|79389035|FG000|Overall Study|Adverse Event|2|||
44383019|NCT00800176|79389036|FG001|Overall Study|Adverse Event|1|||
44383020|NCT00800176|79389037|FG002|Overall Study|Adverse Event|0|||
44383021|NCT00800176|79389038|FG003|Overall Study|Adverse Event|2|||
44383022|NCT00800176|79389039|FG004|Overall Study|Adverse Event|1|||
44383023|NCT00800176|79389040|FG005|Overall Study|Adverse Event|1|||
44383024|NCT00800176|79389035|FG000|Overall Study|Refused treatment|3|||
44383025|NCT00800176|79389036|FG001|Overall Study|Refused treatment|2|||
44383026|NCT00800176|79389037|FG002|Overall Study|Refused treatment|0|||
44383027|NCT00800176|79389038|FG003|Overall Study|Refused treatment|0|||
44383028|NCT00800176|79389039|FG004|Overall Study|Refused treatment|1|||
44383029|NCT00800176|79389040|FG005|Overall Study|Refused treatment|4|||
44383030|NCT00800176|79389035|FG000|Overall Study|Failure to return|3|||
44383031|NCT00800176|79389036|FG001|Overall Study|Failure to return|3|||
44383032|NCT00800176|79389037|FG002|Overall Study|Failure to return|0|||
44383033|NCT00800176|79389038|FG003|Overall Study|Failure to return|2|||
44383034|NCT00800176|79389039|FG004|Overall Study|Failure to return|0|||
44383035|NCT00800176|79389040|FG005|Overall Study|Failure to return|0|||
44383036|NCT00800176|79389035|FG000|Overall Study|Other|1|||
44383037|NCT00800176|79389036|FG001|Overall Study|Other|0|||
44383038|NCT00800176|79389037|FG002|Overall Study|Other|0|||
44145740|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44383039|NCT00800176|79389038|FG003|Overall Study|Other|0|||
44383040|NCT00800176|79389039|FG004|Overall Study|Other|2|||
44383041|NCT00800176|79389040|FG005|Overall Study|Other|0|||
44518019|NCT00088413|79525226|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
44518020|NCT00088413|79525227|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
44518021|NCT00088413|79525228|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
44518022|NCT03995784|79525240|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
44518023|NCT00086385|79525255|FG000|Overall Study|Death|2|||
44145741|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145742|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
44145743|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
44383042|NCT00715429|79389056|FG000|Overall Study|Did not complete the study diary|0|||
44383043|NCT00715429|79389057|FG001|Overall Study|Did not complete the study diary|1|||
44383044|NCT00715117|79389079|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
44383045|NCT00715117|79389080|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
44518024|NCT00086385|79525256|FG001|Overall Study|Death|2|||
44518025|NCT00086385|79525257|FG002|Overall Study|Death|1|||
44518026|NCT00086385|79525258|FG003|Overall Study|Death|1|||
44145744|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145745|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145746|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145747|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145748|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
44145749|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145750|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44518027|NCT03993288|79525270|FG000|Overall Study|Lost to Follow-up|2|||
44250712|NCT01673646|79085568|FG001|Overall Study|Adverse Event|1|||
44250713|NCT01673646|79085569|FG002|Overall Study|Adverse Event|1|||
44250714|NCT01673646|79085567|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44250715|NCT01673646|79085568|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44250716|NCT01673646|79085569|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44250717|NCT01673646|79085567|FG000|Overall Study|Condition no longer requires study drug|0|||
44250718|NCT01673646|79085568|FG001|Overall Study|Condition no longer requires study drug|1|||
44250719|NCT01673646|79085569|FG002|Overall Study|Condition no longer requires study drug|0|||
44250720|NCT01673646|79085567|FG000|Overall Study|Withdrawal by Subject|0|||
44250721|NCT01673646|79085568|FG001|Overall Study|Withdrawal by Subject|2|||
44250722|NCT01673646|79085569|FG002|Overall Study|Withdrawal by Subject|2|||
44250723|NCT01673646|79085567|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
44250724|NCT01673646|79085568|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
44250725|NCT01673646|79085569|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
44250726|NCT02647944|79085609|FG000|Overall Study|Withdrawal by Subject|0|||
44250727|NCT02647944|79085610|FG001|Overall Study|Withdrawal by Subject|3|||
44250728|NCT02647944|79085609|FG000|Overall Study|Adverse Event|2|||
44250729|NCT02647944|79085610|FG001|Overall Study|Adverse Event|0|||
44250730|NCT01397825|79085665|FG000|Overall Study|Progressive Disease|10|||
44250731|NCT01397825|79085666|FG001|Overall Study|Progressive Disease|3|||
44250732|NCT01397825|79085667|FG002|Overall Study|Progressive Disease|11|||
44250733|NCT01397825|79085668|FG003|Overall Study|Progressive Disease|1|||
44250734|NCT01397825|79085669|FG004|Overall Study|Progressive Disease|0|||
44250735|NCT01397825|79085665|FG000|Overall Study|Symptomatic Deterioration|2|||
44250736|NCT01397825|79085666|FG001|Overall Study|Symptomatic Deterioration|0|||
44250737|NCT01397825|79085667|FG002|Overall Study|Symptomatic Deterioration|4|||
44250738|NCT01397825|79085668|FG003|Overall Study|Symptomatic Deterioration|0|||
44250739|NCT01397825|79085669|FG004|Overall Study|Symptomatic Deterioration|0|||
44383046|NCT00723229|79389093|FG000|First Intervention|Lost to Follow-up|7|||
44383047|NCT00723229|79389094|FG001|First Intervention|Lost to Follow-up|3|||
44383048|NCT01030718|79389109|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
44383049|NCT01030718|79389110|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
44383050|NCT01030718|79389111|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
44383051|NCT01030718|79389109|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
44383052|NCT01030718|79389110|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
44383053|NCT01030718|79389111|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
44383054|NCT01030718|79389109|FG000|Studies CA180-031 and -036 Combined|Death|0|||
44383055|NCT01030718|79389110|FG001|Studies CA180-031 and -036 Combined|Death|1|||
44383056|NCT01030718|79389111|FG002|Studies CA180-031 and -036 Combined|Death|0|||
44383057|NCT01030718|79389109|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
44383058|NCT01030718|79389110|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
44383059|NCT01030718|79389111|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
44383060|NCT01030718|79389109|FG000|Study CA180-036 Only|insufficient effect|1|||
44383061|NCT01030718|79389110|FG001|Study CA180-036 Only|insufficient effect|1|||
44383062|NCT01030718|79389111|FG002|Study CA180-036 Only|insufficient effect|5|||
44383063|NCT01030718|79389109|FG000|Study CA180-036 Only|Adverse Event|2|||
44383064|NCT01030718|79389110|FG001|Study CA180-036 Only|Adverse Event|3|||
44383065|NCT01030718|79389111|FG002|Study CA180-036 Only|Adverse Event|0|||
44383066|NCT01030718|79389109|FG000|Study CA180-036 Only|Death|0|||
44383067|NCT01030718|79389110|FG001|Study CA180-036 Only|Death|1|||
44383068|NCT01030718|79389111|FG002|Study CA180-036 Only|Death|0|||
44383069|NCT01030718|79389109|FG000|Study CA180-036 Only|Other Reasons|0|||
44383070|NCT01030718|79389110|FG001|Study CA180-036 Only|Other Reasons|2|||
44383071|NCT01030718|79389111|FG002|Study CA180-036 Only|Other Reasons|0|||
44383072|NCT00722761|79389131|FG000|Overall Study|Lost to Follow-up|1|||
44383073|NCT00722761|79389132|FG001|Overall Study|Lost to Follow-up|4|||
44383074|NCT00722761|79389131|FG000|Overall Study|Withdrawal by Subject|5|||
44383075|NCT00722761|79389132|FG001|Overall Study|Withdrawal by Subject|2|||
44383076|NCT00719953|79389138|FG000|Overall Study|Adverse Event|4|||
44383077|NCT01019486|79389145|FG000|Overall Study|Withdrawal by Subject|1|||
44278832|NCT02038920|79240124|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
44278833|NCT02038920|79240125|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
44278834|NCT02038920|79240126|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
44278835|NCT02038920|79240121|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
44278836|NCT02038920|79240122|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
44278837|NCT02038920|79240123|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
44278838|NCT02038920|79240124|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
44278839|NCT02038920|79240125|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
44278840|NCT02038920|79240126|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
44278841|NCT02038920|79240121|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
44278842|NCT02038920|79240122|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
44278843|NCT02038920|79240123|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
44278844|NCT02038920|79240124|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
44278845|NCT02038920|79240125|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
44278846|NCT02038920|79240126|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
44278847|NCT02038920|79240121|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
44278848|NCT02038920|79240122|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
44278849|NCT02038920|79240123|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
44278850|NCT02038920|79240124|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
44278851|NCT02038920|79240125|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
44278852|NCT02038920|79240126|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
44278853|NCT02038920|79240121|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
44278854|NCT02038920|79240122|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
44278855|NCT02038920|79240123|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
44278856|NCT02038920|79240124|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
44278857|NCT02038920|79240125|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
44278858|NCT02038920|79240126|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
44278859|NCT02038920|79240121|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
44278860|NCT02038920|79240122|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
44278861|NCT02038920|79240123|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
44383078|NCT01019486|79389146|FG001|Overall Study|Withdrawal by Subject|1|||
44383079|NCT01019486|79389147|FG002|Overall Study|Withdrawal by Subject|1|||
44383080|NCT02803203|79389156|FG000|Overall Study|Adverse Event|4|||
44383081|NCT02803203|79389156|FG000|Overall Study|Death|4|||
44518028|NCT03993288|79525271|FG001|Overall Study|Lost to Follow-up|1|||
44518029|NCT03993288|79525270|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
44518030|NCT03993288|79525271|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
44518031|NCT03993288|79525270|FG000|Overall Study|wrong randomization|0|||
44518032|NCT03993288|79525271|FG001|Overall Study|wrong randomization|1|||
44518033|NCT03993288|79525270|FG000|Overall Study|improper enrollment|0|||
44518034|NCT03993288|79525271|FG001|Overall Study|improper enrollment|1|||
44518035|NCT03993288|79525270|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
44518036|NCT03993288|79525271|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
44518037|NCT03993288|79525270|FG000|Overall Study|developed SAE|2|||
44518038|NCT03993288|79525271|FG001|Overall Study|developed SAE|0|||
44145751|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145752|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145753|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145754|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145755|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145756|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145757|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145758|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145759|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145760|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145761|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145762|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
44145763|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
44145764|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
44145765|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145766|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145767|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44278862|NCT02038920|79240124|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
44278863|NCT02038920|79240125|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
44278864|NCT02038920|79240126|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
44278865|NCT02038920|79240121|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
44278866|NCT02038920|79240122|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
44278867|NCT02038920|79240123|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
44278868|NCT02038920|79240124|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
44278869|NCT02038920|79240125|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
44278870|NCT02038920|79240126|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
44278871|NCT02038920|79240121|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
44278872|NCT02038920|79240122|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
44278873|NCT02038920|79240123|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
44278874|NCT02038920|79240124|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
44278875|NCT02038920|79240125|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
44278876|NCT02038920|79240126|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
44278877|NCT02038920|79240121|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
44278878|NCT02038920|79240122|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
44278879|NCT02038920|79240123|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
44278880|NCT02038920|79240124|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
44278881|NCT02038920|79240125|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
44278882|NCT02038920|79240126|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
44278883|NCT02038920|79240121|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
44278884|NCT02038920|79240122|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
44278885|NCT02038920|79240123|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
44278886|NCT02038920|79240124|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
44278887|NCT02038920|79240125|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
44278888|NCT02038920|79240126|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
44278889|NCT02038920|79240121|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
44278890|NCT02038920|79240122|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
44278891|NCT02038920|79240123|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
44278892|NCT02038920|79240124|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
44278893|NCT02038920|79240125|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
44278894|NCT02038920|79240126|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
44278895|NCT02038764|79240148|FG000|Overall Study|Adverse Event|0|||
44278896|NCT02038764|79240149|FG001|Overall Study|Adverse Event|0|||
44278897|NCT02038764|79240150|FG002|Overall Study|Adverse Event|1|||
44278898|NCT02038764|79240151|FG003|Overall Study|Adverse Event|0|||
44278899|NCT02038764|79240152|FG004|Overall Study|Adverse Event|0|||
44278900|NCT02038764|79240148|FG000|Overall Study|Lost to Follow-up|0|||
44278901|NCT02038764|79240149|FG001|Overall Study|Lost to Follow-up|1|||
44278902|NCT02038764|79240150|FG002|Overall Study|Lost to Follow-up|0|||
44278903|NCT02038764|79240151|FG003|Overall Study|Lost to Follow-up|0|||
44278904|NCT02038764|79240152|FG004|Overall Study|Lost to Follow-up|0|||
44278905|NCT02038764|79240148|FG000|Overall Study|Withdrawal by Subject|0|||
44278906|NCT02038764|79240149|FG001|Overall Study|Withdrawal by Subject|0|||
44278907|NCT02038764|79240150|FG002|Overall Study|Withdrawal by Subject|0|||
44278908|NCT02038764|79240151|FG003|Overall Study|Withdrawal by Subject|0|||
44278909|NCT02038764|79240152|FG004|Overall Study|Withdrawal by Subject|1|||
44278910|NCT02038764|79240148|FG000|Overall Study|Other|1|||
44278911|NCT02038764|79240149|FG001|Overall Study|Other|0|||
44278912|NCT02038764|79240150|FG002|Overall Study|Other|1|||
44278913|NCT02038764|79240151|FG003|Overall Study|Other|0|||
44278914|NCT02038764|79240152|FG004|Overall Study|Other|0|||
44278915|NCT02014740|79240170|FG000|Overall Study|Lost to Follow-up|4|||
44278916|NCT02014740|79240171|FG001|Overall Study|Lost to Follow-up|4|||
44278917|NCT02014740|79240170|FG000|Overall Study|Withdrawal by Subject|2|||
44278918|NCT02014740|79240171|FG001|Overall Study|Withdrawal by Subject|1|||
44278919|NCT02014584|79240179|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
44278920|NCT02014584|79240180|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
44278921|NCT02014584|79240181|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
44278922|NCT02014584|79240182|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
44278923|NCT02014584|79240183|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
44278924|NCT02014584|79240184|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
44278925|NCT02014584|79240179|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
44278926|NCT02014584|79240180|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
44278927|NCT02014584|79240181|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
44278928|NCT02014584|79240182|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
44383082|NCT02803203|79389156|FG000|Overall Study|Progressive disease|29|||
44383083|NCT02803203|79389156|FG000|Overall Study|Withdrawal by Subject|8|||
44383084|NCT02803203|79389156|FG000|Overall Study|Complete resection of target disease|2|||
44383085|NCT02803203|79389156|FG000|Overall Study|Switched to commercial Osi|1|||
44383086|NCT02803203|79389156|FG000|Overall Study|Participant moved away|1|||
44383087|NCT00714493|79389161|FG000|Overall Study|Adverse Event|11|||
44383088|NCT00714493|79389161|FG000|Overall Study|Death|3|||
44383089|NCT00714493|79389161|FG000|Overall Study|Lack of Efficacy|10|||
44383090|NCT00714493|79389161|FG000|Overall Study|Lost to Follow-up|3|||
44383091|NCT00714493|79389161|FG000|Overall Study|Protocol Violation|12|||
44383092|NCT00714493|79389161|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
44518039|NCT03993288|79525270|FG000|Overall Study|consent withdrawal|1|||
44518040|NCT03993288|79525271|FG001|Overall Study|consent withdrawal|0|||
44518041|NCT03993288|79525270|FG000|Overall Study|did not follow the treatment schedule|1|||
44518042|NCT03993288|79525271|FG001|Overall Study|did not follow the treatment schedule|0|||
44518043|NCT03993288|79525270|FG000|Overall Study|did not follow the treatment regimen|1|||
44518044|NCT03993288|79525271|FG001|Overall Study|did not follow the treatment regimen|0|||
44518045|NCT03993288|79525270|FG000|Overall Study|Adverse Event|1|||
44518046|NCT03993288|79525271|FG001|Overall Study|Adverse Event|0|||
44518047|NCT03993288|79525270|FG000|Overall Study|Withdrawal by Subject|1|||
44518048|NCT03993288|79525271|FG001|Overall Study|Withdrawal by Subject|1|||
44518049|NCT03991494|79525277|FG000|Overall Study|Progressive Disease|4|||
44383093|NCT00714493|79389161|FG000|Overall Study|OTHER|2|||
44383094|NCT01019252|79389167|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
44383095|NCT01019252|79389168|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
44383096|NCT01019252|79389167|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
44383097|NCT01019252|79389168|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
44383098|NCT01019252|79389167|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
44383099|NCT01019252|79389168|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
44383100|NCT01019252|79389167|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
44383101|NCT01019252|79389168|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
44383102|NCT01013870|79389176|FG000|Overall Study|Lost to Follow-up|1|||
44383103|NCT01013870|79389177|FG001|Overall Study|Lost to Follow-up|3|||
44383104|NCT01013792|79389185|FG000|Overall Study|Study suspended|2|||
44383105|NCT01013792|79389186|FG001|Overall Study|Study suspended|1|||
44383106|NCT01013792|79389185|FG000|Overall Study|Adverse Event|0|||
44383107|NCT01013792|79389186|FG001|Overall Study|Adverse Event|3|||
44383108|NCT01013792|79389185|FG000|Overall Study|Lost to Follow-up|0|||
44383109|NCT01013792|79389186|FG001|Overall Study|Lost to Follow-up|1|||
44383110|NCT01018862|79389195|FG000|Overall Study|Adverse Event|2|||
44383111|NCT01018862|79389196|FG001|Overall Study|Adverse Event|0|||
44383112|NCT01018862|79389197|FG002|Overall Study|Adverse Event|6|||
44383113|NCT01018862|79389195|FG000|Overall Study|Lack of Efficacy|1|||
44383114|NCT01018862|79389196|FG001|Overall Study|Lack of Efficacy|0|||
44383115|NCT01018862|79389197|FG002|Overall Study|Lack of Efficacy|2|||
44383116|NCT01018862|79389195|FG000|Overall Study|Lost to Follow-up|3|||
44383117|NCT01018862|79389196|FG001|Overall Study|Lost to Follow-up|1|||
44383118|NCT01018862|79389197|FG002|Overall Study|Lost to Follow-up|0|||
44383119|NCT01018862|79389195|FG000|Overall Study|Protocol Violation|1|||
44383120|NCT01018862|79389196|FG001|Overall Study|Protocol Violation|3|||
44383121|NCT01018862|79389197|FG002|Overall Study|Protocol Violation|3|||
44383122|NCT01018862|79389195|FG000|Overall Study|Withdrawal by Subject|1|||
44383123|NCT01018862|79389196|FG001|Overall Study|Withdrawal by Subject|2|||
44383124|NCT01018862|79389197|FG002|Overall Study|Withdrawal by Subject|1|||
44383125|NCT01018862|79389195|FG000|Overall Study|administrative problems|5|||
44383126|NCT01018862|79389196|FG001|Overall Study|administrative problems|4|||
44383127|NCT01018862|79389197|FG002|Overall Study|administrative problems|4|||
44383128|NCT01018394|79389207|FG000|Overall Study|Withdrawal by Subject|5|||
44383129|NCT01018394|79389208|FG001|Overall Study|Withdrawal by Subject|5|||
44383130|NCT01018394|79389207|FG000|Overall Study|Lost to Follow-up|4|||
44383131|NCT01018394|79389208|FG001|Overall Study|Lost to Follow-up|3|||
44383132|NCT01017146|79389216|FG000|Overall Study|Adverse Event|11|||
44383133|NCT01017146|79389217|FG001|Overall Study|Adverse Event|1|||
44383134|NCT01017146|79389216|FG000|Overall Study|Lost to Follow-up|14|||
44383135|NCT01017146|79389217|FG001|Overall Study|Lost to Follow-up|14|||
44383136|NCT01017146|79389216|FG000|Overall Study|Noncompliance with Study Product|1|||
44383137|NCT01017146|79389217|FG001|Overall Study|Noncompliance with Study Product|1|||
44383138|NCT01017146|79389216|FG000|Overall Study|Withdrawal by Subject|32|||
44383139|NCT01017146|79389217|FG001|Overall Study|Withdrawal by Subject|16|||
44383140|NCT01017146|79389216|FG000|Overall Study|Relocation|0|||
44383141|NCT01017146|79389217|FG001|Overall Study|Relocation|4|||
44383142|NCT01017146|79389216|FG000|Overall Study|Pregnancy|2|||
44383143|NCT01017146|79389217|FG001|Overall Study|Pregnancy|1|||
44383144|NCT01017146|79389216|FG000|Overall Study|Protocol Violation|2|||
44383145|NCT01017146|79389217|FG001|Overall Study|Protocol Violation|0|||
44383146|NCT01017146|79389216|FG000|Overall Study|Took Excluded Medication|2|||
44383147|NCT01017146|79389217|FG001|Overall Study|Took Excluded Medication|0|||
44383148|NCT01017146|79389216|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
44383149|NCT01017146|79389217|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
44383150|NCT01017146|79389216|FG000|Overall Study|Change in Work Situation|1|||
44383151|NCT01017146|79389217|FG001|Overall Study|Change in Work Situation|0|||
44383152|NCT01010750|79389229|FG000|Second Intervention|Adverse Event|0|||
44383153|NCT01010750|79389230|FG001|Second Intervention|Adverse Event|1|||
44383154|NCT01010750|79389231|FG002|Second Intervention|Adverse Event|0|||
44518050|NCT00086307|79525286|FG000|Overall Study|Lack of Efficacy|1|||
44145768|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145769|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
44145770|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
44383155|NCT01010750|79389232|FG003|Second Intervention|Adverse Event|0|||
44383156|NCT01010750|79389233|FG004|Second Intervention|Adverse Event|0|||
44383157|NCT01010750|79389234|FG005|Second Intervention|Adverse Event|0|||
44383158|NCT01012622|79389242|FG000|Overall Study|Withdrawal by Subject|6|||
44250740|NCT01397825|79085665|FG000|Overall Study|Adverse Event|0|||
44383159|NCT01012622|79389242|FG000|Overall Study|Lost to Follow-up|5|||
44383160|NCT01012622|79389242|FG000|Overall Study|Adverse Event|7|||
44383161|NCT01012622|79389242|FG000|Overall Study|non-compliance with the drug|9|||
44383162|NCT01012622|79389242|FG000|Overall Study|Other|1|||
44145771|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
44518051|NCT00086307|79525287|FG001|Overall Study|Lack of Efficacy|1|||
44145772|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145773|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145774|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
44383163|NCT01012622|79389242|FG000|Overall Study|screening failure|1|||
44383164|NCT01012622|79389242|FG000|Overall Study|withdrawal of consent by a parent|2|||
44383165|NCT00722371|79389253|FG000|Overall Study|Adverse Event|6|||
44383166|NCT00722371|79389254|FG001|Overall Study|Adverse Event|13|||
44383167|NCT00722371|79389255|FG002|Overall Study|Adverse Event|9|||
44383168|NCT00722371|79389256|FG003|Overall Study|Adverse Event|10|||
44383169|NCT00722371|79389257|FG004|Overall Study|Adverse Event|6|||
44383170|NCT00722371|79389258|FG005|Overall Study|Adverse Event|8|||
44383171|NCT00722371|79389259|FG006|Overall Study|Adverse Event|4|||
44383172|NCT00722371|79389253|FG000|Overall Study|Contraindication|0|||
44383173|NCT00722371|79389254|FG001|Overall Study|Contraindication|0|||
44383174|NCT00722371|79389255|FG002|Overall Study|Contraindication|1|||
44383175|NCT00722371|79389256|FG003|Overall Study|Contraindication|0|||
44383176|NCT00722371|79389257|FG004|Overall Study|Contraindication|0|||
44383177|NCT00722371|79389258|FG005|Overall Study|Contraindication|0|||
44383178|NCT00722371|79389259|FG006|Overall Study|Contraindication|0|||
44383179|NCT00722371|79389253|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
44383180|NCT00722371|79389254|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
44383181|NCT00722371|79389255|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
44383182|NCT00722371|79389256|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
44383183|NCT00722371|79389257|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
44383184|NCT00722371|79389258|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
44383185|NCT00722371|79389259|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
44383186|NCT00722371|79389253|FG000|Overall Study|Excluded medication|0|||
44383187|NCT00722371|79389254|FG001|Overall Study|Excluded medication|1|||
44383188|NCT00722371|79389255|FG002|Overall Study|Excluded medication|1|||
44383189|NCT00722371|79389256|FG003|Overall Study|Excluded medication|0|||
44383190|NCT00722371|79389257|FG004|Overall Study|Excluded medication|0|||
44383191|NCT00722371|79389258|FG005|Overall Study|Excluded medication|0|||
44383192|NCT00722371|79389259|FG006|Overall Study|Excluded medication|1|||
44383193|NCT00722371|79389253|FG000|Overall Study|Hyperglycemia|2|||
44383194|NCT00722371|79389254|FG001|Overall Study|Hyperglycemia|6|||
44383195|NCT00722371|79389255|FG002|Overall Study|Hyperglycemia|4|||
44383196|NCT00722371|79389256|FG003|Overall Study|Hyperglycemia|2|||
44383197|NCT00722371|79389257|FG004|Overall Study|Hyperglycemia|5|||
44383198|NCT00722371|79389258|FG005|Overall Study|Hyperglycemia|1|||
44383199|NCT00722371|79389259|FG006|Overall Study|Hyperglycemia|1|||
44383200|NCT00722371|79389253|FG000|Overall Study|Hypoglycemia|1|||
44383201|NCT00722371|79389254|FG001|Overall Study|Hypoglycemia|0|||
44383202|NCT00722371|79389255|FG002|Overall Study|Hypoglycemia|0|||
44383203|NCT00722371|79389256|FG003|Overall Study|Hypoglycemia|0|||
44383204|NCT00722371|79389257|FG004|Overall Study|Hypoglycemia|0|||
44383205|NCT00722371|79389258|FG005|Overall Study|Hypoglycemia|0|||
44383206|NCT00722371|79389259|FG006|Overall Study|Hypoglycemia|0|||
44383207|NCT00722371|79389253|FG000|Overall Study|Lack of Efficacy|4|||
44383208|NCT00722371|79389254|FG001|Overall Study|Lack of Efficacy|6|||
44383209|NCT00722371|79389255|FG002|Overall Study|Lack of Efficacy|6|||
44383210|NCT00722371|79389256|FG003|Overall Study|Lack of Efficacy|6|||
44383211|NCT00722371|79389257|FG004|Overall Study|Lack of Efficacy|2|||
44383212|NCT00722371|79389258|FG005|Overall Study|Lack of Efficacy|3|||
44383213|NCT00722371|79389259|FG006|Overall Study|Lack of Efficacy|0|||
44383214|NCT00722371|79389253|FG000|Overall Study|Lost to Follow-up|11|||
44383215|NCT00722371|79389254|FG001|Overall Study|Lost to Follow-up|14|||
44383216|NCT00722371|79389255|FG002|Overall Study|Lost to Follow-up|21|||
44383217|NCT00722371|79389256|FG003|Overall Study|Lost to Follow-up|13|||
44383218|NCT00722371|79389257|FG004|Overall Study|Lost to Follow-up|8|||
44518052|NCT00086307|79525288|FG002|Overall Study|Lack of Efficacy|2|||
44145775|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145776|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145777|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145778|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
44383219|NCT00722371|79389258|FG005|Overall Study|Lost to Follow-up|16|||
44145779|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
44383220|NCT00722371|79389259|FG006|Overall Study|Lost to Follow-up|13|||
44383221|NCT00722371|79389253|FG000|Overall Study|Physician Decision|5|||
44383222|NCT00722371|79389254|FG001|Overall Study|Physician Decision|2|||
44145780|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
44383223|NCT00722371|79389255|FG002|Overall Study|Physician Decision|2|||
44383224|NCT00722371|79389256|FG003|Overall Study|Physician Decision|5|||
44383225|NCT00722371|79389257|FG004|Overall Study|Physician Decision|2|||
44383226|NCT00722371|79389258|FG005|Overall Study|Physician Decision|3|||
44383227|NCT00722371|79389259|FG006|Overall Study|Physician Decision|4|||
44383228|NCT00722371|79389253|FG000|Overall Study|Pregnancy|1|||
44383229|NCT00722371|79389254|FG001|Overall Study|Pregnancy|1|||
44383230|NCT00722371|79389255|FG002|Overall Study|Pregnancy|0|||
44250741|NCT01397825|79085666|FG001|Overall Study|Adverse Event|1|||
44250742|NCT01397825|79085667|FG002|Overall Study|Adverse Event|5|||
44250743|NCT01397825|79085668|FG003|Overall Study|Adverse Event|1|||
44250744|NCT01397825|79085669|FG004|Overall Study|Adverse Event|0|||
44518053|NCT00086307|79525286|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
44518054|NCT00086307|79525287|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
44518055|NCT00086307|79525288|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
44518056|NCT00086307|79525286|FG000|Overall Study|Nausea and headaches|0|||
44518057|NCT00086307|79525287|FG001|Overall Study|Nausea and headaches|0|||
44518058|NCT00086307|79525288|FG002|Overall Study|Nausea and headaches|1|||
44518059|NCT00086307|79525286|FG000|Overall Study|Constipation and sleepiness|0|||
44518060|NCT00086307|79525287|FG001|Overall Study|Constipation and sleepiness|0|||
44250745|NCT01397825|79085665|FG000|Overall Study|Withdrawal by Subject|1|||
44250746|NCT01397825|79085666|FG001|Overall Study|Withdrawal by Subject|0|||
44250747|NCT01397825|79085667|FG002|Overall Study|Withdrawal by Subject|5|||
44250748|NCT01397825|79085668|FG003|Overall Study|Withdrawal by Subject|1|||
44250749|NCT01397825|79085669|FG004|Overall Study|Withdrawal by Subject|0|||
44250750|NCT01397747|79085692|FG000|Overall Study|Multitarget DNA test excluded|689|||
44250751|NCT01397747|79085692|FG000|Overall Study|Colonoscopy excluded|304|||
44250752|NCT01397747|79085692|FG000|Overall Study|FIT excluded|34|||
44250753|NCT01397201|79085730|FG000|Overall Study|Not treated|0|||
44250754|NCT01397201|79085731|FG001|Overall Study|Not treated|0|||
44250755|NCT01397201|79085732|FG002|Overall Study|Not treated|1|||
44250756|NCT01397201|79085733|FG003|Overall Study|Not treated|0|||
44250757|NCT01397201|79085734|FG004|Overall Study|Not treated|0|||
44250758|NCT01397201|79085730|FG000|Overall Study|Not yet defined|3|||
44250759|NCT01397201|79085731|FG001|Overall Study|Not yet defined|6|||
44250760|NCT01397201|79085732|FG002|Overall Study|Not yet defined|5|||
44250761|NCT01397201|79085733|FG003|Overall Study|Not yet defined|5|||
44250762|NCT01397201|79085734|FG004|Overall Study|Not yet defined|4|||
44250763|NCT01397201|79085730|FG000|Overall Study|Adverse Event|2|||
44250764|NCT01397201|79085731|FG001|Overall Study|Adverse Event|0|||
44250765|NCT01397201|79085732|FG002|Overall Study|Adverse Event|0|||
44250766|NCT01397201|79085733|FG003|Overall Study|Adverse Event|0|||
44250767|NCT01397201|79085734|FG004|Overall Study|Adverse Event|0|||
44250768|NCT01393613|79085768|FG000|Overall Study|Adverse Event|11|||
44250769|NCT01393613|79085769|FG001|Overall Study|Adverse Event|11|||
44250770|NCT01393613|79085770|FG002|Overall Study|Adverse Event|13|||
44250771|NCT01393613|79085771|FG003|Overall Study|Adverse Event|22|||
44250772|NCT01393613|79085768|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
44250773|NCT01393613|79085769|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
44250774|NCT01393613|79085770|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
44250775|NCT01393613|79085771|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
44250776|NCT01393613|79085768|FG000|Overall Study|Physician Decision|2|||
44250777|NCT01393613|79085769|FG001|Overall Study|Physician Decision|0|||
44250778|NCT01393613|79085770|FG002|Overall Study|Physician Decision|0|||
44250779|NCT01393613|79085771|FG003|Overall Study|Physician Decision|1|||
44250780|NCT01393613|79085768|FG000|Overall Study|Withdrawal by Subject|15|||
44250781|NCT01393613|79085769|FG001|Overall Study|Withdrawal by Subject|25|||
44250782|NCT01393613|79085770|FG002|Overall Study|Withdrawal by Subject|23|||
44250783|NCT01393613|79085771|FG003|Overall Study|Withdrawal by Subject|21|||
44250784|NCT01393613|79085768|FG000|Overall Study|Protocol Deviation|2|||
44518061|NCT00086307|79525288|FG002|Overall Study|Constipation and sleepiness|1|||
44383231|NCT00722371|79389256|FG003|Overall Study|Pregnancy|0|||
44383232|NCT00722371|79389257|FG004|Overall Study|Pregnancy|0|||
44383233|NCT00722371|79389258|FG005|Overall Study|Pregnancy|1|||
44383234|NCT00722371|79389259|FG006|Overall Study|Pregnancy|0|||
44383235|NCT00722371|79389253|FG000|Overall Study|Protocol Violation|6|||
44383236|NCT00722371|79389254|FG001|Overall Study|Protocol Violation|1|||
44383237|NCT00722371|79389255|FG002|Overall Study|Protocol Violation|0|||
44383238|NCT00722371|79389256|FG003|Overall Study|Protocol Violation|1|||
44145781|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145782|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
44250785|NCT01393613|79085769|FG001|Overall Study|Protocol Deviation|1|||
44250786|NCT01393613|79085770|FG002|Overall Study|Protocol Deviation|0|||
44250787|NCT01393613|79085771|FG003|Overall Study|Protocol Deviation|0|||
44383239|NCT00722371|79389257|FG004|Overall Study|Protocol Violation|4|||
44383240|NCT00722371|79389258|FG005|Overall Study|Protocol Violation|2|||
44383241|NCT00722371|79389259|FG006|Overall Study|Protocol Violation|1|||
44383242|NCT00722371|79389253|FG000|Overall Study|Withdrawal by Subject|18|||
44383243|NCT00722371|79389254|FG001|Overall Study|Withdrawal by Subject|27|||
44383244|NCT00722371|79389255|FG002|Overall Study|Withdrawal by Subject|19|||
44383245|NCT00722371|79389256|FG003|Overall Study|Withdrawal by Subject|23|||
44383246|NCT00722371|79389257|FG004|Overall Study|Withdrawal by Subject|19|||
44383247|NCT00722371|79389258|FG005|Overall Study|Withdrawal by Subject|18|||
44250788|NCT01393613|79085768|FG000|Overall Study|Lack of Efficacy|9|||
44250789|NCT01393613|79085769|FG001|Overall Study|Lack of Efficacy|20|||
44250790|NCT01393613|79085770|FG002|Overall Study|Lack of Efficacy|16|||
44250791|NCT01393613|79085771|FG003|Overall Study|Lack of Efficacy|21|||
44250792|NCT01396421|79085821|FG000|Overall Study|Lost to Follow-up|0|||
44278929|NCT02014584|79240183|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
44383248|NCT00722371|79389259|FG006|Overall Study|Withdrawal by Subject|26|||
44383249|NCT00722137|79389277|FG000|Overall Study|Overt Disease Progression|5|||
44383250|NCT00722137|79389278|FG001|Overall Study|Overt Disease Progression|4|||
44383251|NCT00722137|79389277|FG000|Overall Study|Adverse Event|17|||
44383252|NCT00722137|79389278|FG001|Overall Study|Adverse Event|21|||
44383253|NCT00722137|79389277|FG000|Overall Study|Death|12|||
44250793|NCT01396421|79085822|FG001|Overall Study|Lost to Follow-up|0|||
44250794|NCT01396421|79085823|FG002|Overall Study|Lost to Follow-up|0|||
44250795|NCT01396421|79085824|FG003|Overall Study|Lost to Follow-up|1|||
44250796|NCT01396421|79085821|FG000|Overall Study|Adverse Event|17|||
44250797|NCT01396421|79085822|FG001|Overall Study|Adverse Event|15|||
44250798|NCT01396421|79085823|FG002|Overall Study|Adverse Event|12|||
44383254|NCT00722137|79389278|FG001|Overall Study|Death|7|||
44383255|NCT00722137|79389277|FG000|Overall Study|Withdrawal by Subject|6|||
44383256|NCT00722137|79389278|FG001|Overall Study|Withdrawal by Subject|9|||
44383257|NCT00722137|79389277|FG000|Overall Study|Other Reason Unknown|3|||
44383258|NCT00722137|79389278|FG001|Overall Study|Other Reason Unknown|4|||
44383259|NCT00722137|79389277|FG000|Overall Study|Randomized But Not Treated|2|||
44383260|NCT00722137|79389278|FG001|Overall Study|Randomized But Not Treated|3|||
44383261|NCT00796666|79389292|FG000|Overall Study|Death|2|||
44383262|NCT00796666|79389293|FG001|Overall Study|Death|4|||
44383263|NCT00796666|79389292|FG000|Overall Study|Withdrawal by Subject|2|||
44383264|NCT00796666|79389293|FG001|Overall Study|Withdrawal by Subject|0|||
44383265|NCT00796666|79389292|FG000|Overall Study|Adverse Event|7|||
44383266|NCT00796666|79389293|FG001|Overall Study|Adverse Event|5|||
44383267|NCT00796666|79389292|FG000|Overall Study|Protocol Violation|1|||
44383268|NCT00796666|79389293|FG001|Overall Study|Protocol Violation|0|||
44383269|NCT00796666|79389292|FG000|Overall Study|Other|1|||
44383270|NCT00796666|79389293|FG001|Overall Study|Other|0|||
44383271|NCT00796666|79389292|FG000|Overall Study|Terminated by sponsor|53|||
44383272|NCT00796666|79389293|FG001|Overall Study|Terminated by sponsor|55|||
44383273|NCT00796666|79389292|FG000|Overall Study|Randomized and not treated|1|||
44383274|NCT00796666|79389293|FG001|Overall Study|Randomized and not treated|0|||
44383275|NCT00799708|79389302|FG000|Overall Study|non-compliance|1|||
44383276|NCT00799708|79389303|FG001|Overall Study|non-compliance|0|||
44383277|NCT00799708|79389304|FG002|Overall Study|non-compliance|0|||
44383278|NCT00796510|79389316|FG000|Overall Study|Death|1|||
44383279|NCT00796510|79389317|FG001|Overall Study|Death|0|||
44383280|NCT00796510|79389316|FG000|Overall Study|Study Terminated|2|||
44383281|NCT00796510|79389317|FG001|Overall Study|Study Terminated|0|||
44383282|NCT00588640|79389323|FG000|Overall Study|Physician Decision|1|||
44383283|NCT00588640|79389323|FG000|Overall Study|Ineligible Patient|1|||
44383284|NCT01016912|79389332|FG000|End of Treatment Period|Lack of Efficacy|0|||
44383285|NCT01016912|79389333|FG001|End of Treatment Period|Lack of Efficacy|1|||
44383286|NCT01016912|79389334|FG002|End of Treatment Period|Lack of Efficacy|0|||
44383287|NCT01016912|79389335|FG003|End of Treatment Period|Lack of Efficacy|4|||
44383288|NCT01016912|79389336|FG004|End of Treatment Period|Lack of Efficacy|4|||
44383289|NCT01016912|79389332|FG000|End of Treatment Period|Adverse Event|0|||
44383290|NCT01016912|79389333|FG001|End of Treatment Period|Adverse Event|1|||
44383291|NCT01016912|79389334|FG002|End of Treatment Period|Adverse Event|1|||
44383292|NCT01016912|79389335|FG003|End of Treatment Period|Adverse Event|0|||
44383293|NCT01016912|79389336|FG004|End of Treatment Period|Adverse Event|0|||
44383294|NCT01016912|79389332|FG000|End of Treatment Period|Completed double-blind period only|0|||
44383295|NCT01016912|79389333|FG001|End of Treatment Period|Completed double-blind period only|1|||
44383296|NCT01016912|79389334|FG002|End of Treatment Period|Completed double-blind period only|0|||
44145783|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145784|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
44145785|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
44145786|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145787|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145788|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145789|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145790|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
44145791|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145792|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145793|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145794|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145795|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145796|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145797|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145798|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44383297|NCT01016912|79389335|FG003|End of Treatment Period|Completed double-blind period only|0|||
44145799|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145800|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44278930|NCT02014584|79240184|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
44278931|NCT02014584|79240179|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
44383298|NCT01016912|79389336|FG004|End of Treatment Period|Completed double-blind period only|0|||
44383299|NCT01016912|79389332|FG000|Follow-up Period|Other reason|0|||
44383300|NCT01016912|79389333|FG001|Follow-up Period|Other reason|0|||
44383301|NCT01016912|79389334|FG002|Follow-up Period|Other reason|1|||
44383302|NCT01016912|79389335|FG003|Follow-up Period|Other reason|1|||
44383303|NCT01016912|79389336|FG004|Follow-up Period|Other reason|0|||
44383304|NCT00802672|79389371|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
44383305|NCT00802672|79389372|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
44383306|NCT00802672|79389373|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
44383307|NCT00802672|79389371|FG000|Overall Study|Adverse Event|1|||
44518062|NCT00086307|79525286|FG000|Overall Study|Suicidal ideation|0|||
44278932|NCT02014584|79240180|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
44278933|NCT02014584|79240181|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
44278934|NCT02014584|79240182|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
44278935|NCT02014584|79240183|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
44278936|NCT02014584|79240184|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
44278937|NCT02014584|79240179|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
44278938|NCT02014584|79240180|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
44278939|NCT02014584|79240181|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
44278940|NCT02014584|79240182|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
44278941|NCT02014584|79240183|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
44278942|NCT02014584|79240184|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
44278943|NCT02014584|79240179|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
44278944|NCT02014584|79240180|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
44278945|NCT02014584|79240181|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
44278946|NCT02014584|79240182|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
44278947|NCT02014584|79240183|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
44278948|NCT02014584|79240184|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
44278949|NCT02014272|79240196|FG000|Intervention Period 1|Withdrawal by Subject|1|||
44278950|NCT02014272|79240197|FG001|Intervention Period 1|Withdrawal by Subject|0|||
44278951|NCT02014272|79240196|FG000|Intervention Period 1|Adverse Event|0|||
44278952|NCT02014272|79240197|FG001|Intervention Period 1|Adverse Event|1|||
44278953|NCT02037984|79240211|FG000|Overall Study|Lack of Efficacy|0|||
44278954|NCT02037984|79240212|FG001|Overall Study|Lack of Efficacy|0|||
44278955|NCT02037984|79240213|FG002|Overall Study|Lack of Efficacy|3|||
44278956|NCT02037984|79240214|FG003|Overall Study|Lack of Efficacy|10|||
44278957|NCT02037984|79240215|FG004|Overall Study|Lack of Efficacy|2|||
44278958|NCT02037984|79240216|FG005|Overall Study|Lack of Efficacy|2|||
44278959|NCT02037984|79240217|FG006|Overall Study|Lack of Efficacy|4|||
44278960|NCT02037984|79240218|FG007|Overall Study|Lack of Efficacy|3|||
44278961|NCT02037984|79240211|FG000|Overall Study|Lost to Follow-up|1|||
44278962|NCT02037984|79240212|FG001|Overall Study|Lost to Follow-up|0|||
44278963|NCT02037984|79240213|FG002|Overall Study|Lost to Follow-up|3|||
44278964|NCT02037984|79240214|FG003|Overall Study|Lost to Follow-up|5|||
44278965|NCT02037984|79240215|FG004|Overall Study|Lost to Follow-up|2|||
44278966|NCT02037984|79240216|FG005|Overall Study|Lost to Follow-up|2|||
44278967|NCT02037984|79240217|FG006|Overall Study|Lost to Follow-up|2|||
44278968|NCT02037984|79240218|FG007|Overall Study|Lost to Follow-up|4|||
44278969|NCT02037984|79240211|FG000|Overall Study|Physician Decision|0|||
44278970|NCT02037984|79240212|FG001|Overall Study|Physician Decision|0|||
44278971|NCT02037984|79240213|FG002|Overall Study|Physician Decision|0|||
44278972|NCT02037984|79240214|FG003|Overall Study|Physician Decision|0|||
44278973|NCT02037984|79240215|FG004|Overall Study|Physician Decision|0|||
44278974|NCT02037984|79240216|FG005|Overall Study|Physician Decision|0|||
44278975|NCT02037984|79240217|FG006|Overall Study|Physician Decision|1|||
44278976|NCT02037984|79240218|FG007|Overall Study|Physician Decision|0|||
44278977|NCT02037984|79240211|FG000|Overall Study|Protocol Violation|0|||
44278978|NCT02037984|79240212|FG001|Overall Study|Protocol Violation|0|||
44278979|NCT02037984|79240213|FG002|Overall Study|Protocol Violation|0|||
44278980|NCT02037984|79240214|FG003|Overall Study|Protocol Violation|0|||
44278981|NCT02037984|79240215|FG004|Overall Study|Protocol Violation|0|||
44278982|NCT02037984|79240216|FG005|Overall Study|Protocol Violation|1|||
44278983|NCT02037984|79240217|FG006|Overall Study|Protocol Violation|2|||
44278984|NCT02037984|79240218|FG007|Overall Study|Protocol Violation|0|||
44278985|NCT02037984|79240211|FG000|Overall Study|Technical Problems|0|||
44278986|NCT02037984|79240212|FG001|Overall Study|Technical Problems|0|||
44278987|NCT02037984|79240213|FG002|Overall Study|Technical Problems|3|||
44278988|NCT02037984|79240214|FG003|Overall Study|Technical Problems|3|||
44518063|NCT00086307|79525287|FG001|Overall Study|Suicidal ideation|0|||
44518064|NCT00086307|79525288|FG002|Overall Study|Suicidal ideation|1|||
44518065|NCT00086307|79525286|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
44518066|NCT00086307|79525287|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
44518067|NCT00086307|79525288|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
44518068|NCT00086307|79525286|FG000|Overall Study|Withdrawal by Subject|0|||
44518069|NCT00086307|79525287|FG001|Overall Study|Withdrawal by Subject|0|||
44278989|NCT02037984|79240215|FG004|Overall Study|Technical Problems|2|||
44278990|NCT02037984|79240216|FG005|Overall Study|Technical Problems|3|||
44278991|NCT02037984|79240217|FG006|Overall Study|Technical Problems|4|||
44278992|NCT02037984|79240218|FG007|Overall Study|Technical Problems|2|||
44518070|NCT00086307|79525288|FG002|Overall Study|Withdrawal by Subject|2|||
44518071|NCT03624972|79525299|FG000|Overall Study|Lost to Follow-up|2|||
44518072|NCT03624972|79525300|FG001|Overall Study|Lost to Follow-up|0|||
44278993|NCT02037984|79240211|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44278994|NCT02037984|79240212|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44278995|NCT02037984|79240213|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
44383308|NCT00802672|79389372|FG001|Overall Study|Adverse Event|1|||
44383309|NCT00802672|79389373|FG002|Overall Study|Adverse Event|1|||
44383310|NCT00802672|79389371|FG000|Overall Study|Protocol Violation|2|||
44383311|NCT00802672|79389372|FG001|Overall Study|Protocol Violation|1|||
44383312|NCT00802672|79389373|FG002|Overall Study|Protocol Violation|1|||
44383313|NCT00802672|79389371|FG000|Overall Study|Lost to Follow-up|5|||
44383314|NCT00802672|79389372|FG001|Overall Study|Lost to Follow-up|5|||
44383315|NCT00802672|79389373|FG002|Overall Study|Lost to Follow-up|3|||
44383316|NCT00802672|79389371|FG000|Overall Study|Withdrawal by Subject|1|||
44383317|NCT00802672|79389372|FG001|Overall Study|Withdrawal by Subject|1|||
44383318|NCT00802672|79389373|FG002|Overall Study|Withdrawal by Subject|2|||
44383319|NCT00802672|79389371|FG000|Overall Study|other|3|||
44383320|NCT00802672|79389372|FG001|Overall Study|other|1|||
44383321|NCT00802672|79389373|FG002|Overall Study|other|2|||
44383322|NCT00714415|79389383|FG000|Overall Study|Lack of Efficacy|1|||
44383323|NCT00714415|79389384|FG001|Overall Study|Lack of Efficacy|0|||
44383324|NCT00714415|79389383|FG000|Overall Study|Death|1|||
44383325|NCT00714415|79389384|FG001|Overall Study|Death|0|||
44383326|NCT00714259|79389390|FG000|Overall Study|Death|2|||
44383327|NCT00796120|79389396|FG000|Overall Study|Death|3|||
44383328|NCT00796120|79389397|FG001|Overall Study|Death|0|||
44383329|NCT00796120|79389396|FG000|Overall Study|Adverse Event|11|||
44383330|NCT00796120|79389397|FG001|Overall Study|Adverse Event|6|||
44383331|NCT00796120|79389396|FG000|Overall Study|Progressive disease|22|||
44383332|NCT00796120|79389397|FG001|Overall Study|Progressive disease|13|||
44383333|NCT00796120|79389396|FG000|Overall Study|Participant refusal|3|||
44383334|NCT00796120|79389397|FG001|Overall Study|Participant refusal|4|||
44383335|NCT00796120|79389396|FG000|Overall Study|Other|6|||
44383336|NCT00796120|79389397|FG001|Overall Study|Other|17|||
44518073|NCT03624972|79525301|FG002|Overall Study|Lost to Follow-up|0|||
44518074|NCT03624972|79525299|FG000|Overall Study|Withdrawal by Subject|0|||
44518075|NCT03624972|79525300|FG001|Overall Study|Withdrawal by Subject|2|||
44278996|NCT02037984|79240214|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
44278997|NCT02037984|79240215|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
44278998|NCT02037984|79240216|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
44518076|NCT03624972|79525301|FG002|Overall Study|Withdrawal by Subject|0|||
44518077|NCT03988842|79525310|FG000|Overall Study|Death|1|||
44518078|NCT02668822|79525317|FG000|Overall Study|Protocol Violation|2|||
44518079|NCT02668822|79525318|FG001|Overall Study|Protocol Violation|0|||
44518080|NCT02668822|79525317|FG000|Overall Study|Study Terminated by Sponsor|7|||
44518081|NCT02668822|79525318|FG001|Overall Study|Study Terminated by Sponsor|9|||
44518082|NCT02524288|79525324|FG000|Overall Study|Adverse Event|115|||
44518083|NCT02524288|79525324|FG000|Overall Study|Lost to Follow-up|216|||
44518084|NCT02524288|79525324|FG000|Overall Study|Non-Compliance With Protocol|32|||
44518085|NCT02524288|79525324|FG000|Overall Study|Non-Compliance With Study Drug|14|||
44518086|NCT02524288|79525324|FG000|Overall Study|Pregnancy Wish|6|||
44518087|NCT02524288|79525324|FG000|Overall Study|Protocol Violation|6|||
44518088|NCT02524288|79525324|FG000|Overall Study|Screen Failure|2|||
44518089|NCT02524288|79525324|FG000|Overall Study|Site Discontinued Study Participation|1|||
44518090|NCT02524288|79525324|FG000|Overall Study|Study Terminated By Sponsor|1417|||
44518091|NCT02524288|79525324|FG000|Overall Study|Subject Moved|32|||
44250799|NCT01396421|79085824|FG003|Overall Study|Adverse Event|32|||
44250800|NCT01396421|79085821|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
44250801|NCT01396421|79085822|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
44250802|NCT01396421|79085823|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
44250803|NCT01396421|79085824|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
44250804|NCT01396421|79085821|FG000|Overall Study|Physician Decision|1|||
44250805|NCT01396421|79085822|FG001|Overall Study|Physician Decision|1|||
44250806|NCT01396421|79085823|FG002|Overall Study|Physician Decision|0|||
44250807|NCT01396421|79085824|FG003|Overall Study|Physician Decision|3|||
44250808|NCT01396421|79085821|FG000|Overall Study|Withdrawal by Subject|31|||
44278999|NCT02037984|79240217|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
44383337|NCT00796120|79389396|FG000|Overall Study|Physician Decision|16|||
44383338|NCT00796120|79389397|FG001|Overall Study|Physician Decision|17|||
44383339|NCT00796120|79389396|FG000|Overall Study|Randomized but not treated|0|||
44383340|NCT00796120|79389397|FG001|Overall Study|Randomized but not treated|3|||
44383341|NCT00795886|79389403|FG000|Overall Study|Death|10|||
44383342|NCT00719563|79389410|FG000|Overall Study|Adverse Event|16|||
44518092|NCT02524288|79525324|FG000|Overall Study|Withdrawal by Subject|76|||
44518093|NCT02524288|79525324|FG000|Overall Study|Pregnancy|22|||
44250809|NCT01396421|79085822|FG001|Overall Study|Withdrawal by Subject|24|||
44250810|NCT01396421|79085823|FG002|Overall Study|Withdrawal by Subject|13|||
44250811|NCT01396421|79085824|FG003|Overall Study|Withdrawal by Subject|21|||
44250812|NCT01396421|79085821|FG000|Overall Study|Protocol Deviation|2|||
44383343|NCT00719563|79389411|FG001|Overall Study|Adverse Event|13|||
44383344|NCT00719563|79389410|FG000|Overall Study|Medical condition changed|3|||
44518094|NCT02524288|79525324|FG000|Overall Study|Physician Decision|2|||
44518095|NCT03624504|79525328|FG000|Overall Study|Unsuccessful Implant|1|||
44518096|NCT02954952|79525335|FG000|Overall Study|Withdrawal by Subject|1|||
44383345|NCT00719563|79389411|FG001|Overall Study|Medical condition changed|5|||
44383346|NCT00719563|79389410|FG000|Overall Study|Lack of Efficacy|3|||
44383347|NCT00719563|79389411|FG001|Overall Study|Lack of Efficacy|7|||
44383348|NCT00719563|79389410|FG000|Overall Study|Personal reasons|6|||
44383349|NCT00719563|79389411|FG001|Overall Study|Personal reasons|7|||
44383350|NCT00719563|79389410|FG000|Overall Study|Unknown reasons|4|||
44383351|NCT00719563|79389411|FG001|Overall Study|Unknown reasons|6|||
44383352|NCT00719563|79389410|FG000|Overall Study|Noncompliant|1|||
44383353|NCT00719563|79389411|FG001|Overall Study|Noncompliant|1|||
44383354|NCT00719563|79389410|FG000|Overall Study|Lost to Follow-up|5|||
44383355|NCT00719563|79389411|FG001|Overall Study|Lost to Follow-up|3|||
44383356|NCT00795184|79389418|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
44383357|NCT00795184|79389419|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
44383358|NCT00718861|79389430|FG000|Overall Study|Withdrawal by Subject|15|||
44383359|NCT00718861|79389431|FG001|Overall Study|Withdrawal by Subject|10|||
44383360|NCT00718861|79389430|FG000|Overall Study|Adverse Event|2|||
44383361|NCT00718861|79389431|FG001|Overall Study|Adverse Event|1|||
44383362|NCT00718861|79389430|FG000|Overall Study|Lost to Follow-up|2|||
44383363|NCT00718861|79389431|FG001|Overall Study|Lost to Follow-up|1|||
44383364|NCT00718861|79389430|FG000|Overall Study|Administrative Problems|1|||
44383365|NCT00718861|79389431|FG001|Overall Study|Administrative Problems|1|||
44383366|NCT00718861|79389430|FG000|Overall Study|Death|1|||
44383367|NCT00718861|79389431|FG001|Overall Study|Death|5|||
44383368|NCT01016600|79389441|FG000|Overall Study|Did not start treatment|1|||
44383369|NCT01016600|79389442|FG001|Overall Study|Did not start treatment|0|||
44383370|NCT01016600|79389443|FG002|Overall Study|Did not start treatment|0|||
44383371|NCT01016600|79389444|FG003|Overall Study|Did not start treatment|0|||
44383372|NCT01016132|79389455|FG000|Overall Study|Discomfort|1|||
44383373|NCT01015820|79389461|FG000|Overall Study|Suboptimal measurements|1|||
44383374|NCT01015820|79389462|FG001|Overall Study|Suboptimal measurements|0|||
44383375|NCT01010204|79389485|FG000|Overall Study|Lost to Follow-up|2|||
44383376|NCT01010204|79389486|FG001|Overall Study|Lost to Follow-up|2|||
44383377|NCT01010204|79389485|FG000|Overall Study|Adverse Event|1|||
44383378|NCT01010204|79389486|FG001|Overall Study|Adverse Event|3|||
44383379|NCT01010204|79389485|FG000|Overall Study|Withdrawal by Subject|2|||
44279000|NCT02037984|79240218|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
44383380|NCT01010204|79389486|FG001|Overall Study|Withdrawal by Subject|3|||
44383381|NCT01010204|79389485|FG000|Overall Study|psychiatric hospitalization|2|||
44383382|NCT01010204|79389486|FG001|Overall Study|psychiatric hospitalization|1|||
44383383|NCT00718549|79389492|FG000|Induction Phase|Disease Progression|1|||
44383384|NCT00718549|79389493|FG001|Induction Phase|Disease Progression|0|||
44383385|NCT00718549|79389494|FG002|Induction Phase|Disease Progression|0|||
44383386|NCT00718549|79389492|FG000|Induction Phase|Eligibility Criteria Violation|2|||
44383387|NCT00718549|79389493|FG001|Induction Phase|Eligibility Criteria Violation|0|||
44383388|NCT00718549|79389494|FG002|Induction Phase|Eligibility Criteria Violation|0|||
44383389|NCT00718549|79389492|FG000|Induction Phase|Early Termination - No Additional Info|59|||
44383390|NCT00718549|79389493|FG001|Induction Phase|Early Termination - No Additional Info|0|||
44383391|NCT00718549|79389494|FG002|Induction Phase|Early Termination - No Additional Info|0|||
44279001|NCT02037984|79240211|FG000|Overall Study|Withdrawal by Subject|0|||
44279002|NCT02037984|79240212|FG001|Overall Study|Withdrawal by Subject|0|||
44279003|NCT02037984|79240213|FG002|Overall Study|Withdrawal by Subject|0|||
44279004|NCT02037984|79240214|FG003|Overall Study|Withdrawal by Subject|1|||
44279005|NCT02037984|79240215|FG004|Overall Study|Withdrawal by Subject|1|||
44279006|NCT02037984|79240216|FG005|Overall Study|Withdrawal by Subject|3|||
44279007|NCT02037984|79240217|FG006|Overall Study|Withdrawal by Subject|0|||
44279008|NCT02037984|79240218|FG007|Overall Study|Withdrawal by Subject|1|||
44279009|NCT02057406|79240249|FG000|Overall Study|Physician Decision|0|||
44279010|NCT02057406|79240250|FG001|Overall Study|Physician Decision|0|||
44279011|NCT02057406|79240251|FG002|Overall Study|Physician Decision|2|||
44279012|NCT02057406|79240249|FG000|Overall Study|Withdrawal by Subject|0|||
44383392|NCT00718549|79389492|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
44383393|NCT00718549|79389493|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
44383394|NCT00718549|79389494|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
44383395|NCT00718549|79389492|FG000|Maintenance/ Observation Phase|Death|0|||
44383396|NCT00718549|79389493|FG001|Maintenance/ Observation Phase|Death|1|||
44279013|NCT02057406|79240250|FG001|Overall Study|Withdrawal by Subject|2|||
44279014|NCT02057406|79240251|FG002|Overall Study|Withdrawal by Subject|0|||
44279015|NCT02057406|79240249|FG000|Overall Study|Lost to Follow-up|0|||
44279016|NCT02057406|79240250|FG001|Overall Study|Lost to Follow-up|0|||
44279017|NCT02057406|79240251|FG002|Overall Study|Lost to Follow-up|1|||
44279018|NCT02057406|79240249|FG000|Overall Study|Death|1|||
44383397|NCT00718549|79389494|FG002|Maintenance/ Observation Phase|Death|2|||
44383398|NCT00718549|79389492|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
44383399|NCT00718549|79389493|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
44383400|NCT00718549|79389494|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
44383401|NCT00718549|79389492|FG000|Maintenance/ Observation Phase|Progression|0|||
44383402|NCT00718549|79389493|FG001|Maintenance/ Observation Phase|Progression|5|||
44383403|NCT00718549|79389494|FG002|Maintenance/ Observation Phase|Progression|14|||
44383404|NCT00718549|79389492|FG000|Maintenance/ Observation Phase|Relapse|0|||
44383405|NCT00718549|79389493|FG001|Maintenance/ Observation Phase|Relapse|3|||
44383406|NCT00718549|79389494|FG002|Maintenance/ Observation Phase|Relapse|2|||
44383407|NCT00793624|79389511|FG000|Overall Study|Adverse Event|18|||
44383408|NCT00793624|79389512|FG001|Overall Study|Adverse Event|16|||
44383409|NCT00793624|79389513|FG002|Overall Study|Adverse Event|15|||
44383410|NCT00793624|79389514|FG003|Overall Study|Adverse Event|20|||
44383411|NCT00793624|79389511|FG000|Overall Study|Lost to Follow-up|2|||
44383412|NCT00793624|79389512|FG001|Overall Study|Lost to Follow-up|2|||
44383413|NCT00793624|79389513|FG002|Overall Study|Lost to Follow-up|4|||
44383414|NCT00793624|79389514|FG003|Overall Study|Lost to Follow-up|0|||
44383415|NCT00793624|79389511|FG000|Overall Study|Withdrawal by Subject|20|||
44383416|NCT00793624|79389512|FG001|Overall Study|Withdrawal by Subject|9|||
44383417|NCT00793624|79389513|FG002|Overall Study|Withdrawal by Subject|11|||
44383418|NCT00793624|79389514|FG003|Overall Study|Withdrawal by Subject|14|||
44383419|NCT00793624|79389511|FG000|Overall Study|Lack of Efficacy|9|||
44383420|NCT00793624|79389512|FG001|Overall Study|Lack of Efficacy|2|||
44383421|NCT00793624|79389513|FG002|Overall Study|Lack of Efficacy|1|||
44383422|NCT00793624|79389514|FG003|Overall Study|Lack of Efficacy|3|||
44383423|NCT00793624|79389511|FG000|Overall Study|Non compliance with protocol|2|||
44383424|NCT00793624|79389512|FG001|Overall Study|Non compliance with protocol|3|||
44383425|NCT00793624|79389513|FG002|Overall Study|Non compliance with protocol|2|||
44383426|NCT00793624|79389514|FG003|Overall Study|Non compliance with protocol|3|||
44383427|NCT00793624|79389511|FG000|Overall Study|Other reason not described above|6|||
44383428|NCT00793624|79389512|FG001|Overall Study|Other reason not described above|4|||
44383429|NCT00793624|79389513|FG002|Overall Study|Other reason not described above|6|||
44383430|NCT00793624|79389514|FG003|Overall Study|Other reason not described above|3|||
44383431|NCT00794950|79389532|FG000|BCG Induction|Withdrawal by Subject|2|||
44383432|NCT00794950|79389532|FG000|BCG Induction|ineligible|3|||
44383433|NCT00794950|79389532|FG000|BCG Induction|noncompliant w. BCG|1|||
44383434|NCT00794950|79389532|FG000|BCG Induction|Adverse Event|1|||
44383435|NCT00794950|79389532|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
44383436|NCT00794950|79389532|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
44383437|NCT00794950|79389532|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
44383438|NCT00794950|79389532|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
44383439|NCT00793546|79389539|FG000|Overall Study|Death|3|||
44383440|NCT00793546|79389540|FG001|Overall Study|Death|0|||
44383441|NCT00793546|79389539|FG000|Overall Study|Lost to Follow-up|1|||
44383442|NCT00793546|79389540|FG001|Overall Study|Lost to Follow-up|0|||
44383443|NCT00793546|79389539|FG000|Overall Study|Withdrawal by Subject|1|||
44383444|NCT00793546|79389540|FG001|Overall Study|Withdrawal by Subject|1|||
44383445|NCT00793546|79389539|FG000|Overall Study|Study Terminated by Sponsor|8|||
44383446|NCT00793546|79389540|FG001|Overall Study|Study Terminated by Sponsor|27|||
44383447|NCT00793546|79389539|FG000|Overall Study|Other|1|||
44383448|NCT00793546|79389540|FG001|Overall Study|Other|0|||
44383449|NCT00798694|79389550|FG000|Overall Study|Lost to Follow-up|1|||
44383450|NCT00798694|79389551|FG001|Overall Study|Lost to Follow-up|1|||
44383451|NCT00798694|79389550|FG000|Overall Study|Physician Decision|1|||
44383452|NCT00798694|79389551|FG001|Overall Study|Physician Decision|0|||
44383453|NCT00718315|79389566|FG000|Overall Study|Adverse Event|1|||
44383454|NCT00718315|79389567|FG001|Overall Study|Adverse Event|2|||
44383455|NCT00718315|79389568|FG002|Overall Study|Adverse Event|3|||
44383456|NCT00718315|79389566|FG000|Overall Study|Death|6|||
44383457|NCT00718315|79389567|FG001|Overall Study|Death|6|||
44383458|NCT00718315|79389568|FG002|Overall Study|Death|5|||
44383459|NCT00718315|79389566|FG000|Overall Study|Lost to Follow-up|2|||
44250813|NCT01396421|79085822|FG001|Overall Study|Protocol Deviation|1|||
44250814|NCT01396421|79085823|FG002|Overall Study|Protocol Deviation|1|||
44250815|NCT01396421|79085824|FG003|Overall Study|Protocol Deviation|0|||
44250816|NCT01396421|79085821|FG000|Overall Study|Lack of Efficacy|7|||
44250817|NCT01396421|79085822|FG001|Overall Study|Lack of Efficacy|17|||
44250818|NCT01396421|79085823|FG002|Overall Study|Lack of Efficacy|7|||
44250819|NCT01396421|79085824|FG003|Overall Study|Lack of Efficacy|18|||
44383460|NCT00718315|79389567|FG001|Overall Study|Lost to Follow-up|3|||
44383461|NCT00718315|79389568|FG002|Overall Study|Lost to Follow-up|4|||
44383462|NCT00718315|79389566|FG000|Overall Study|Protocol Violation|5|||
44383463|NCT00718315|79389567|FG001|Overall Study|Protocol Violation|5|||
44383464|NCT00718315|79389568|FG002|Overall Study|Protocol Violation|3|||
44383465|NCT00718315|79389566|FG000|Overall Study|Erlotinib dose decreased|4|||
44383466|NCT00718315|79389567|FG001|Overall Study|Erlotinib dose decreased|3|||
44383467|NCT00718315|79389568|FG002|Overall Study|Erlotinib dose decreased|1|||
44383468|NCT00718315|79389566|FG000|Overall Study|Use of Minocyclin|1|||
44383469|NCT00718315|79389567|FG001|Overall Study|Use of Minocyclin|1|||
44383470|NCT00718315|79389568|FG002|Overall Study|Use of Minocyclin|1|||
44383471|NCT00718315|79389566|FG000|Overall Study|Disease progression|0|||
44383472|NCT00718315|79389567|FG001|Overall Study|Disease progression|1|||
44383473|NCT00718315|79389568|FG002|Overall Study|Disease progression|1|||
44383474|NCT00718315|79389566|FG000|Overall Study|Other|0|||
44383475|NCT00718315|79389567|FG001|Overall Study|Other|0|||
44383476|NCT00718315|79389568|FG002|Overall Study|Other|1|||
44383477|NCT00718315|79389566|FG000|Overall Study|Use of ATB and Corticoids|0|||
44383478|NCT00718315|79389567|FG001|Overall Study|Use of ATB and Corticoids|1|||
44383479|NCT00718315|79389568|FG002|Overall Study|Use of ATB and Corticoids|2|||
44383480|NCT00798304|79389579|FG000|Overall Study|Adverse Event|0|||
44383481|NCT00798304|79389580|FG001|Overall Study|Adverse Event|1|||
44383482|NCT00798304|79389581|FG002|Overall Study|Adverse Event|1|||
44383483|NCT00798304|79389579|FG000|Overall Study|Discontinuation by Sponsor|14|||
44383484|NCT00798304|79389580|FG001|Overall Study|Discontinuation by Sponsor|21|||
44383485|NCT00798304|79389581|FG002|Overall Study|Discontinuation by Sponsor|9|||
44383486|NCT00718237|79389591|FG000|Overall Study|Adverse Event|1|||
44383487|NCT00718237|79389592|FG001|Overall Study|Adverse Event|3|||
44383488|NCT00718237|79389591|FG000|Overall Study|Lost to Follow-up|2|||
44383489|NCT00718237|79389592|FG001|Overall Study|Lost to Follow-up|2|||
44383490|NCT00718237|79389591|FG000|Overall Study|Physician Decision|1|||
44383491|NCT00718237|79389592|FG001|Overall Study|Physician Decision|0|||
44383492|NCT00718237|79389591|FG000|Overall Study|Withdrawal by Subject|9|||
44383493|NCT00718237|79389592|FG001|Overall Study|Withdrawal by Subject|10|||
44383494|NCT00793780|79389602|FG000|Overall Study|Withdrawal by Subject|2|||
44383495|NCT00793780|79389603|FG001|Overall Study|Withdrawal by Subject|1|||
44383496|NCT02643303|79389618|FG000|Overall Study|Progressive Disease|4|||
44383497|NCT02643303|79389619|FG001|Overall Study|Progressive Disease|4|||
44383498|NCT02643303|79389620|FG002|Overall Study|Progressive Disease|1|||
44383499|NCT02643303|79389621|FG003|Overall Study|Progressive Disease|12|||
44383500|NCT02643303|79389622|FG004|Overall Study|Progressive Disease|6|||
44383501|NCT02643303|79389623|FG005|Overall Study|Progressive Disease|4|||
44383502|NCT02643303|79389624|FG006|Overall Study|Progressive Disease|8|||
44383503|NCT02643303|79389625|FG007|Overall Study|Progressive Disease|2|||
44383504|NCT02643303|79389626|FG008|Overall Study|Progressive Disease|6|||
44383505|NCT02643303|79389618|FG000|Overall Study|Adverse Event|0|||
44383506|NCT02643303|79389619|FG001|Overall Study|Adverse Event|1|||
44383507|NCT02643303|79389620|FG002|Overall Study|Adverse Event|0|||
44383508|NCT02643303|79389621|FG003|Overall Study|Adverse Event|0|||
44383509|NCT02643303|79389622|FG004|Overall Study|Adverse Event|1|||
44383510|NCT02643303|79389623|FG005|Overall Study|Adverse Event|0|||
44383511|NCT02643303|79389624|FG006|Overall Study|Adverse Event|0|||
44383512|NCT02643303|79389625|FG007|Overall Study|Adverse Event|0|||
44383513|NCT02643303|79389626|FG008|Overall Study|Adverse Event|0|||
44383514|NCT02643303|79389618|FG000|Overall Study|Withdrawal by Subject|0|||
44383515|NCT02643303|79389619|FG001|Overall Study|Withdrawal by Subject|0|||
44383516|NCT02643303|79389620|FG002|Overall Study|Withdrawal by Subject|0|||
44518097|NCT02954952|79525336|FG001|Overall Study|Withdrawal by Subject|0|||
44518098|NCT02954952|79525337|FG002|Overall Study|Withdrawal by Subject|0|||
44518099|NCT02954952|79525335|FG000|Overall Study|No data collected|0|||
44518100|NCT02954952|79525336|FG001|Overall Study|No data collected|1|||
44518101|NCT02954952|79525337|FG002|Overall Study|No data collected|0|||
44518102|NCT03547154|79525347|FG000|Overall Study|Disease Progression/Recurrence|6|||
44250820|NCT01396265|79085882|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
44250821|NCT02647866|79085927|FG000|Overall Study|Adverse Event|0|||
44250822|NCT02647866|79085928|FG001|Overall Study|Adverse Event|0|||
44250823|NCT02647866|79085929|FG002|Overall Study|Adverse Event|2|||
44250824|NCT02647866|79085930|FG003|Overall Study|Adverse Event|2|||
44250825|NCT02647866|79085931|FG004|Overall Study|Adverse Event|1|||
44250826|NCT02647866|79085927|FG000|Overall Study|Disease Worsening|3|||
44250827|NCT02647866|79085928|FG001|Overall Study|Disease Worsening|1|||
44250828|NCT02647866|79085929|FG002|Overall Study|Disease Worsening|0|||
44250829|NCT02647866|79085930|FG003|Overall Study|Disease Worsening|0|||
44250830|NCT02647866|79085931|FG004|Overall Study|Disease Worsening|1|||
44279019|NCT02057406|79240250|FG001|Overall Study|Death|0|||
44383517|NCT02643303|79389621|FG003|Overall Study|Withdrawal by Subject|1|||
44383518|NCT02643303|79389622|FG004|Overall Study|Withdrawal by Subject|0|||
44383519|NCT02643303|79389623|FG005|Overall Study|Withdrawal by Subject|0|||
44518103|NCT03547154|79525348|FG001|Overall Study|Disease Progression/Recurrence|14|||
44250831|NCT02647866|79085927|FG000|Overall Study|Withdrawal by Subject|1|||
44383520|NCT02643303|79389624|FG006|Overall Study|Withdrawal by Subject|1|||
44383521|NCT02643303|79389625|FG007|Overall Study|Withdrawal by Subject|1|||
44383522|NCT02643303|79389626|FG008|Overall Study|Withdrawal by Subject|1|||
44383523|NCT00790036|79389648|FG000|Overall Study|Abnormal lab values|3|||
44383524|NCT00790036|79389649|FG001|Overall Study|Abnormal lab values|2|||
44279020|NCT02057406|79240251|FG002|Overall Study|Death|0|||
44383525|NCT00790036|79389648|FG000|Overall Study|Administrative problems|5|||
44383526|NCT00790036|79389649|FG001|Overall Study|Administrative problems|9|||
44383527|NCT00790036|79389648|FG000|Overall Study|Adverse Event|113|||
44383528|NCT00790036|79389649|FG001|Overall Study|Adverse Event|44|||
44383529|NCT00790036|79389648|FG000|Overall Study|Death|1|||
44383530|NCT00790036|79389649|FG001|Overall Study|Death|0|||
44383531|NCT00790036|79389648|FG000|Overall Study|Disease progression|24|||
44383532|NCT00790036|79389649|FG001|Overall Study|Disease progression|48|||
44383533|NCT00790036|79389648|FG000|Overall Study|Lost to Follow-up|1|||
44383534|NCT00790036|79389649|FG001|Overall Study|Lost to Follow-up|2|||
44383535|NCT00790036|79389648|FG000|Overall Study|Protocol Violation|10|||
44383536|NCT00790036|79389649|FG001|Overall Study|Protocol Violation|2|||
44383537|NCT00790036|79389648|FG000|Overall Study|Withdrawal by Subject|18|||
44383538|NCT00790036|79389649|FG001|Overall Study|Withdrawal by Subject|7|||
44383539|NCT00790036|79389648|FG000|Overall Study|Subject/guardian decision|20|||
44383540|NCT00790036|79389649|FG001|Overall Study|Subject/guardian decision|7|||
44383541|NCT00789958|79389656|FG000|Overall Study|Adverse Event|3|||
44383542|NCT00789958|79389656|FG000|Overall Study|Withdrawal by Subject|4|||
44383543|NCT00789958|79389656|FG000|Overall Study|Progression|3|||
44383544|NCT00789958|79389656|FG000|Overall Study|not protocol specified|1|||
44383545|NCT00789958|79389656|FG000|Overall Study|Not eligible/not analyzable|26|||
44383546|NCT00789880|79389668|FG000|Overall Study|Adverse Event|0|||
44383547|NCT00789880|79389669|FG001|Overall Study|Adverse Event|0|||
44383548|NCT00789880|79389670|FG002|Overall Study|Adverse Event|0|||
44383549|NCT00789880|79389671|FG003|Overall Study|Adverse Event|0|||
44383550|NCT00789880|79389672|FG004|Overall Study|Adverse Event|1|||
44383551|NCT00789880|79389673|FG005|Overall Study|Adverse Event|0|||
44383552|NCT00789880|79389668|FG000|Overall Study|Protocol Violation|0|||
44383553|NCT00789880|79389669|FG001|Overall Study|Protocol Violation|1|||
44383554|NCT00789880|79389670|FG002|Overall Study|Protocol Violation|0|||
44383555|NCT00789880|79389671|FG003|Overall Study|Protocol Violation|1|||
44383556|NCT00789880|79389672|FG004|Overall Study|Protocol Violation|0|||
44383557|NCT00789880|79389673|FG005|Overall Study|Protocol Violation|0|||
44383558|NCT00789880|79389668|FG000|Overall Study|Withdrawal by Subject|1|||
44383559|NCT00789880|79389669|FG001|Overall Study|Withdrawal by Subject|0|||
44383560|NCT00789880|79389670|FG002|Overall Study|Withdrawal by Subject|0|||
44383561|NCT00789880|79389671|FG003|Overall Study|Withdrawal by Subject|0|||
44518104|NCT03547154|79525347|FG000|Overall Study|Adverse Event|26|||
44518105|NCT03547154|79525348|FG001|Overall Study|Adverse Event|31|||
44518106|NCT03547154|79525347|FG000|Overall Study|Protocol Violation|6|||
44518107|NCT03547154|79525348|FG001|Overall Study|Protocol Violation|1|||
44518108|NCT03547154|79525347|FG000|Overall Study|Physician Decision|4|||
44518109|NCT03547154|79525348|FG001|Overall Study|Physician Decision|3|||
44518110|NCT03547154|79525347|FG000|Overall Study|Insufficient Therapeutic Response|13|||
44518111|NCT03547154|79525348|FG001|Overall Study|Insufficient Therapeutic Response|10|||
44518112|NCT03547154|79525347|FG000|Overall Study|Withdrawal by Subject|10|||
44250832|NCT02647866|79085928|FG001|Overall Study|Withdrawal by Subject|1|||
44250833|NCT02647866|79085929|FG002|Overall Study|Withdrawal by Subject|2|||
44250834|NCT02647866|79085930|FG003|Overall Study|Withdrawal by Subject|4|||
44250835|NCT02647866|79085931|FG004|Overall Study|Withdrawal by Subject|4|||
44250836|NCT02647866|79085927|FG000|Overall Study|Physician Decision|0|||
44250837|NCT02647866|79085928|FG001|Overall Study|Physician Decision|1|||
44250838|NCT02647866|79085929|FG002|Overall Study|Physician Decision|1|||
44250839|NCT02647866|79085930|FG003|Overall Study|Physician Decision|0|||
44383562|NCT00789880|79389672|FG004|Overall Study|Withdrawal by Subject|2|||
44383563|NCT00789880|79389673|FG005|Overall Study|Withdrawal by Subject|0|||
44383564|NCT00792298|79389687|FG000|Treatment Period 1|Adverse Event|0|||
44383565|NCT00792298|79389688|FG001|Treatment Period 1|Adverse Event|1|||
44383566|NCT00792298|79389689|FG002|Treatment Period 1|Adverse Event|0|||
44383567|NCT00792298|79389690|FG003|Treatment Period 1|Adverse Event|1|||
44383568|NCT00792298|79389691|FG004|Treatment Period 1|Adverse Event|0|||
44383569|NCT00792298|79389692|FG005|Treatment Period 1|Adverse Event|1|||
44383570|NCT00792298|79389693|FG006|Treatment Period 1|Adverse Event|1|||
44383571|NCT00792298|79389694|FG007|Treatment Period 1|Adverse Event|0|||
44383572|NCT00792298|79389687|FG000|Treatment Period 1|Lack of Efficacy|0|||
44383573|NCT00792298|79389688|FG001|Treatment Period 1|Lack of Efficacy|0|||
44383574|NCT00792298|79389689|FG002|Treatment Period 1|Lack of Efficacy|1|||
44383575|NCT00792298|79389690|FG003|Treatment Period 1|Lack of Efficacy|0|||
44383576|NCT00792298|79389691|FG004|Treatment Period 1|Lack of Efficacy|0|||
44383577|NCT00792298|79389692|FG005|Treatment Period 1|Lack of Efficacy|0|||
44383578|NCT00792298|79389693|FG006|Treatment Period 1|Lack of Efficacy|0|||
44383579|NCT00792298|79389694|FG007|Treatment Period 1|Lack of Efficacy|0|||
44383580|NCT00792298|79389687|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44383581|NCT00792298|79389688|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44383582|NCT00792298|79389689|FG002|Treatment Period 1|Withdrawal by Subject|1|||
44383583|NCT00792298|79389690|FG003|Treatment Period 1|Withdrawal by Subject|2|||
44383584|NCT00792298|79389691|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44383585|NCT00792298|79389692|FG005|Treatment Period 1|Withdrawal by Subject|2|||
44383586|NCT00792298|79389693|FG006|Treatment Period 1|Withdrawal by Subject|1|||
44383587|NCT00792298|79389694|FG007|Treatment Period 1|Withdrawal by Subject|0|||
44383588|NCT00792298|79389687|FG000|Treatment Period 1|Lost to Follow-up|0|||
44383589|NCT00792298|79389688|FG001|Treatment Period 1|Lost to Follow-up|0|||
44383590|NCT00792298|79389689|FG002|Treatment Period 1|Lost to Follow-up|0|||
44383591|NCT00792298|79389690|FG003|Treatment Period 1|Lost to Follow-up|0|||
44383592|NCT00792298|79389691|FG004|Treatment Period 1|Lost to Follow-up|0|||
44383593|NCT00792298|79389692|FG005|Treatment Period 1|Lost to Follow-up|0|||
44383594|NCT00792298|79389693|FG006|Treatment Period 1|Lost to Follow-up|1|||
44383595|NCT00792298|79389694|FG007|Treatment Period 1|Lost to Follow-up|0|||
44383596|NCT00792298|79389687|FG000|Treatment Period 1|Physician Decision|0|||
44383597|NCT00792298|79389688|FG001|Treatment Period 1|Physician Decision|0|||
44383598|NCT00792298|79389689|FG002|Treatment Period 1|Physician Decision|0|||
44383599|NCT00792298|79389690|FG003|Treatment Period 1|Physician Decision|1|||
44383600|NCT00792298|79389691|FG004|Treatment Period 1|Physician Decision|0|||
44383601|NCT00792298|79389692|FG005|Treatment Period 1|Physician Decision|0|||
44383602|NCT00792298|79389693|FG006|Treatment Period 1|Physician Decision|1|||
44383603|NCT00792298|79389694|FG007|Treatment Period 1|Physician Decision|0|||
44383604|NCT00792298|79389687|FG000|Treatment Period 1|Protocol Violation|0|||
44383605|NCT00792298|79389688|FG001|Treatment Period 1|Protocol Violation|0|||
44383606|NCT00792298|79389689|FG002|Treatment Period 1|Protocol Violation|0|||
44383607|NCT00792298|79389690|FG003|Treatment Period 1|Protocol Violation|0|||
44383608|NCT00792298|79389691|FG004|Treatment Period 1|Protocol Violation|0|||
44383609|NCT00792298|79389692|FG005|Treatment Period 1|Protocol Violation|0|||
44383610|NCT00792298|79389693|FG006|Treatment Period 1|Protocol Violation|0|||
44383611|NCT00792298|79389694|FG007|Treatment Period 1|Protocol Violation|1|||
44383612|NCT00792298|79389687|FG000|Washout|Adverse Event|0|||
44383613|NCT00792298|79389688|FG001|Washout|Adverse Event|0|||
44383614|NCT00792298|79389689|FG002|Washout|Adverse Event|0|||
44383615|NCT00792298|79389690|FG003|Washout|Adverse Event|0|||
44383616|NCT00792298|79389691|FG004|Washout|Adverse Event|0|||
44383617|NCT00792298|79389692|FG005|Washout|Adverse Event|1|||
44383618|NCT00792298|79389693|FG006|Washout|Adverse Event|0|||
44383619|NCT00792298|79389694|FG007|Washout|Adverse Event|0|||
44383620|NCT00792298|79389687|FG000|Washout|Withdrawal by Subject|0|||
44383621|NCT00792298|79389688|FG001|Washout|Withdrawal by Subject|0|||
44383622|NCT00792298|79389689|FG002|Washout|Withdrawal by Subject|1|||
44383623|NCT00792298|79389690|FG003|Washout|Withdrawal by Subject|0|||
44383624|NCT00792298|79389691|FG004|Washout|Withdrawal by Subject|0|||
44383625|NCT00792298|79389692|FG005|Washout|Withdrawal by Subject|1|||
44383626|NCT00792298|79389693|FG006|Washout|Withdrawal by Subject|0|||
44383627|NCT00792298|79389694|FG007|Washout|Withdrawal by Subject|0|||
44383628|NCT00792298|79389687|FG000|Treatment Period 2|Lack of Efficacy|0|||
44383629|NCT00792298|79389688|FG001|Treatment Period 2|Lack of Efficacy|0|||
44383630|NCT00792298|79389689|FG002|Treatment Period 2|Lack of Efficacy|0|||
44383631|NCT00792298|79389690|FG003|Treatment Period 2|Lack of Efficacy|0|||
44383632|NCT00792298|79389691|FG004|Treatment Period 2|Lack of Efficacy|1|||
44383633|NCT00792298|79389692|FG005|Treatment Period 2|Lack of Efficacy|0|||
44383634|NCT00792298|79389693|FG006|Treatment Period 2|Lack of Efficacy|0|||
44383635|NCT00792298|79389694|FG007|Treatment Period 2|Lack of Efficacy|0|||
44383636|NCT00792298|79389687|FG000|Treatment Period 2|Physician Decision|0|||
44250840|NCT02647866|79085931|FG004|Overall Study|Physician Decision|2|||
44250841|NCT02647866|79085927|FG000|Overall Study|Death|0|||
44250842|NCT02647866|79085928|FG001|Overall Study|Death|1|||
44383637|NCT00792298|79389688|FG001|Treatment Period 2|Physician Decision|0|||
44383638|NCT00792298|79389689|FG002|Treatment Period 2|Physician Decision|0|||
44383639|NCT00792298|79389690|FG003|Treatment Period 2|Physician Decision|0|||
44383640|NCT00792298|79389691|FG004|Treatment Period 2|Physician Decision|0|||
44383641|NCT00792298|79389692|FG005|Treatment Period 2|Physician Decision|0|||
44383642|NCT00792298|79389693|FG006|Treatment Period 2|Physician Decision|1|||
44383643|NCT00792298|79389694|FG007|Treatment Period 2|Physician Decision|0|||
44383644|NCT00792298|79389687|FG000|Treatment Period 2|Pregnancy|0|||
44383645|NCT00792298|79389688|FG001|Treatment Period 2|Pregnancy|0|||
44383646|NCT00792298|79389689|FG002|Treatment Period 2|Pregnancy|1|||
44383647|NCT00792298|79389690|FG003|Treatment Period 2|Pregnancy|0|||
44383648|NCT00792298|79389691|FG004|Treatment Period 2|Pregnancy|0|||
44383649|NCT00792298|79389692|FG005|Treatment Period 2|Pregnancy|0|||
44383650|NCT00792298|79389693|FG006|Treatment Period 2|Pregnancy|0|||
44383651|NCT00792298|79389694|FG007|Treatment Period 2|Pregnancy|0|||
44383652|NCT00792298|79389687|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44383653|NCT00792298|79389688|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44383654|NCT00792298|79389689|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44383655|NCT00792298|79389690|FG003|Treatment Period 2|Withdrawal by Subject|2|||
44383656|NCT00792298|79389691|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44383657|NCT00792298|79389692|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44383658|NCT00792298|79389693|FG006|Treatment Period 2|Withdrawal by Subject|0|||
44383659|NCT00792298|79389694|FG007|Treatment Period 2|Withdrawal by Subject|2|||
44383660|NCT00718159|79389718|FG000|Overall Study|Progressive Disease|3|||
44383661|NCT00718159|79389719|FG001|Overall Study|Progressive Disease|3|||
44383662|NCT00718159|79389720|FG002|Overall Study|Progressive Disease|2|||
44383663|NCT00718159|79389721|FG003|Overall Study|Progressive Disease|0|||
44383664|NCT00718159|79389722|FG004|Overall Study|Progressive Disease|6|||
44383665|NCT00718159|79389723|FG005|Overall Study|Progressive Disease|0|||
44383666|NCT00718159|79389724|FG006|Overall Study|Progressive Disease|0|||
44383667|NCT00718159|79389718|FG000|Overall Study|Death due to Adverse Event|0|||
44383668|NCT00718159|79389719|FG001|Overall Study|Death due to Adverse Event|0|||
44383669|NCT00718159|79389720|FG002|Overall Study|Death due to Adverse Event|0|||
44383670|NCT00718159|79389721|FG003|Overall Study|Death due to Adverse Event|2|||
44383671|NCT00718159|79389722|FG004|Overall Study|Death due to Adverse Event|2|||
44383672|NCT00718159|79389723|FG005|Overall Study|Death due to Adverse Event|0|||
44383673|NCT00718159|79389724|FG006|Overall Study|Death due to Adverse Event|0|||
44383674|NCT00718159|79389718|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
44383675|NCT00718159|79389719|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
44383676|NCT00718159|79389720|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
44383677|NCT00718159|79389721|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
44383678|NCT00718159|79389722|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
44383679|NCT00718159|79389723|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
44383680|NCT00718159|79389724|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
44383681|NCT00718159|79389718|FG000|Overall Study|Investigator Decision|0|||
44383682|NCT00718159|79389719|FG001|Overall Study|Investigator Decision|0|||
44383683|NCT00718159|79389720|FG002|Overall Study|Investigator Decision|0|||
44383684|NCT00718159|79389721|FG003|Overall Study|Investigator Decision|0|||
44383685|NCT00718159|79389722|FG004|Overall Study|Investigator Decision|0|||
44383686|NCT00718159|79389723|FG005|Overall Study|Investigator Decision|1|||
44383687|NCT00718159|79389724|FG006|Overall Study|Investigator Decision|1|||
44383688|NCT00718081|79389743|FG000|Overall Study|Adverse Event|0|||
44383689|NCT00718081|79389744|FG001|Overall Study|Adverse Event|1|||
44383690|NCT00718081|79389745|FG002|Overall Study|Adverse Event|0|||
44383691|NCT00718081|79389743|FG000|Overall Study|Lack of Efficacy|7|||
44383692|NCT00718081|79389744|FG001|Overall Study|Lack of Efficacy|3|||
44383693|NCT00718081|79389745|FG002|Overall Study|Lack of Efficacy|21|||
44383694|NCT00788710|79389756|FG000|Overall Study|Adverse Event|1|||
44383695|NCT00788710|79389757|FG001|Overall Study|Adverse Event|3|||
44383696|NCT00788710|79389758|FG002|Overall Study|Adverse Event|4|||
44383697|NCT00788710|79389756|FG000|Overall Study|Lack of Efficacy|0|||
44383698|NCT00788710|79389757|FG001|Overall Study|Lack of Efficacy|0|||
44518113|NCT03547154|79525348|FG001|Overall Study|Withdrawal by Subject|6|||
44518114|NCT03547154|79525347|FG000|Overall Study|Not Selected|0|||
44518115|NCT03547154|79525348|FG001|Overall Study|Not Selected|1|||
44518116|NCT03547154|79525347|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
44518117|NCT03547154|79525348|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
44518118|NCT02275546|79525354|FG000|Treatment Period 2|Withdrawal by Subject|2|||
44518119|NCT02275546|79525355|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44145801|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44383699|NCT00788710|79389758|FG002|Overall Study|Lack of Efficacy|1|||
44518120|NCT02275546|79525354|FG000|Treatment Period 2|Protocol Violation|0|||
44518121|NCT02275546|79525355|FG001|Treatment Period 2|Protocol Violation|1|||
44383700|NCT00788710|79389756|FG000|Overall Study|Lost to Follow-up|0|||
44383701|NCT00788710|79389757|FG001|Overall Study|Lost to Follow-up|1|||
44518122|NCT03624192|79525361|FG000|Overall Study|Lost to Follow-up|1|||
44145802|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44383702|NCT00788710|79389758|FG002|Overall Study|Lost to Follow-up|0|||
44383703|NCT00788710|79389756|FG000|Overall Study|Physician Decision|2|||
44383704|NCT00788710|79389757|FG001|Overall Study|Physician Decision|1|||
44383705|NCT00788710|79389758|FG002|Overall Study|Physician Decision|0|||
44383706|NCT00788710|79389756|FG000|Overall Study|Protocol Violation|0|||
44383707|NCT00788710|79389757|FG001|Overall Study|Protocol Violation|1|||
44383708|NCT00788710|79389758|FG002|Overall Study|Protocol Violation|1|||
44383709|NCT00788710|79389756|FG000|Overall Study|Withdrawal by Subject|2|||
44383710|NCT00788710|79389757|FG001|Overall Study|Withdrawal by Subject|2|||
44383711|NCT00788710|79389758|FG002|Overall Study|Withdrawal by Subject|0|||
44383712|NCT00787930|79389766|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
44383713|NCT00588094|79389776|FG000|Overall Study|Adverse Event|3|||
44383714|NCT00588094|79389776|FG000|Overall Study|Progression of Disease|2|||
44383715|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
44383716|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
44383717|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
44383718|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
44383719|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
44383720|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
44383721|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
44383722|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
44383723|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
44383724|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
44383725|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
44383726|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
44383727|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
44383728|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
44383729|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
44383730|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
44383731|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
44383732|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
44383733|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
44383734|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
44383735|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
44383736|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
44383737|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
44383738|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
44383739|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
44383740|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
44383741|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
44383742|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
44383743|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
44383744|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
44383745|NCT00784654|79389780|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
44383746|NCT00784654|79389781|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
44250843|NCT02647866|79085929|FG002|Overall Study|Death|0|||
44250844|NCT02647866|79085930|FG003|Overall Study|Death|0|||
44250845|NCT02647866|79085931|FG004|Overall Study|Death|0|||
44250846|NCT02647866|79085927|FG000|Overall Study|Subject moved to different country|1|||
44250847|NCT02647866|79085928|FG001|Overall Study|Subject moved to different country|0|||
44250848|NCT02647866|79085929|FG002|Overall Study|Subject moved to different country|0|||
44250849|NCT02647866|79085930|FG003|Overall Study|Subject moved to different country|0|||
44250850|NCT02647866|79085931|FG004|Overall Study|Subject moved to different country|0|||
44250851|NCT01396187|79085991|FG000|Overall Study|Adverse Event|0|||
44250852|NCT01396187|79085992|FG001|Overall Study|Adverse Event|1|||
44250853|NCT01396187|79085993|FG002|Overall Study|Adverse Event|0|||
44279021|NCT02057406|79240249|FG000|Overall Study|Protocol Violation|0|||
44279022|NCT02057406|79240250|FG001|Overall Study|Protocol Violation|1|||
44279023|NCT02057406|79240251|FG002|Overall Study|Protocol Violation|0|||
44279024|NCT02057406|79240249|FG000|Overall Study|Patient transportation issues|0|||
44279025|NCT02057406|79240250|FG001|Overall Study|Patient transportation issues|0|||
44279026|NCT02057406|79240251|FG002|Overall Study|Patient transportation issues|1|||
44279027|NCT02036580|79240262|FG000|Overall Study|Withdrawal by Subject|0|||
44383747|NCT00784654|79389782|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
44383748|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
44383749|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
44383750|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
44383751|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
44250854|NCT01396187|79085994|FG003|Overall Study|Adverse Event|0|||
44250855|NCT01396187|79085995|FG004|Overall Study|Adverse Event|0|||
44279028|NCT02036580|79240263|FG001|Overall Study|Withdrawal by Subject|1|||
44279029|NCT02036580|79240264|FG002|Overall Study|Withdrawal by Subject|0|||
44279030|NCT02036580|79240262|FG000|Overall Study|Adverse Event|1|||
44383752|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
44383753|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
44383754|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
44383755|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
44383756|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
44518123|NCT03624192|79525362|FG001|Overall Study|Lost to Follow-up|1|||
44518124|NCT03034954|79525372|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
44518125|NCT03034954|79525373|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
44518126|NCT03546842|79525379|FG000|Overall Study|Protocol Violation|1|||
44518127|NCT03546842|79525379|FG000|Overall Study|Withdrawal by Subject|2|||
44518128|NCT03640052|79525383|FG000|Overall Study|Lost to Follow-up|0|||
44145803|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145804|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145805|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
44145806|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
44145807|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145808|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145809|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145810|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145811|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
44145812|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145813|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145814|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145815|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145816|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145817|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44279031|NCT02036580|79240263|FG001|Overall Study|Adverse Event|0|||
44279032|NCT02036580|79240264|FG002|Overall Study|Adverse Event|0|||
44145818|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145819|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145820|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145821|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145822|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145823|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145824|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145825|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145826|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
44145827|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
44145828|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44145829|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44250856|NCT01396187|79085991|FG000|Overall Study|Withdrawal by Subject|0|||
44250857|NCT01396187|79085992|FG001|Overall Study|Withdrawal by Subject|1|||
44250858|NCT01396187|79085993|FG002|Overall Study|Withdrawal by Subject|1|||
44250859|NCT01396187|79085994|FG003|Overall Study|Withdrawal by Subject|0|||
44250860|NCT01396187|79085995|FG004|Overall Study|Withdrawal by Subject|0|||
44250861|NCT01396187|79085991|FG000|Overall Study|Other|1|||
44250862|NCT01396187|79085992|FG001|Overall Study|Other|1|||
44250863|NCT01396187|79085993|FG002|Overall Study|Other|0|||
44250864|NCT01396187|79085994|FG003|Overall Study|Other|0|||
44250865|NCT01396187|79085995|FG004|Overall Study|Other|1|||
44279033|NCT02014116|79240281|FG000|Overall Study|Progressive Disease|3|||
44279034|NCT02014116|79240282|FG001|Overall Study|Progressive Disease|4|||
44279035|NCT02014116|79240283|FG002|Overall Study|Progressive Disease|2|||
44279036|NCT02014116|79240284|FG003|Overall Study|Progressive Disease|6|||
44279037|NCT02014116|79240285|FG004|Overall Study|Progressive Disease|1|||
44279038|NCT02014116|79240286|FG005|Overall Study|Progressive Disease|13|||
44279039|NCT02014116|79240287|FG006|Overall Study|Progressive Disease|1|||
44383757|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
44383758|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
44518129|NCT03640052|79525384|FG001|Overall Study|Lost to Follow-up|1|||
44518130|NCT03640052|79525385|FG002|Overall Study|Lost to Follow-up|0|||
44518131|NCT03640052|79525386|FG003|Overall Study|Lost to Follow-up|0|||
44518132|NCT03640052|79525387|FG004|Overall Study|Lost to Follow-up|0|||
44518133|NCT00068601|79525401|FG000|Overall Study|Ineligible|11|||
44518134|NCT00068601|79525402|FG001|Overall Study|Ineligible|13|||
44518135|NCT00068601|79525401|FG000|Overall Study|Not evaluable: withdrew consent|5|||
44518136|NCT00068601|79525402|FG001|Overall Study|Not evaluable: withdrew consent|4|||
44250866|NCT01392677|79086042|FG000|Overall Study|Adverse Event|3|||
44250867|NCT01392677|79086043|FG001|Overall Study|Adverse Event|1|||
44250868|NCT01392677|79086042|FG000|Overall Study|Withdrawal by Subject|0|||
44279040|NCT02014116|79240288|FG007|Overall Study|Progressive Disease|3|||
44518137|NCT00068601|79525401|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
44383759|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
44383760|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Adverse Event|0|||
44383761|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Adverse Event|1|||
44383762|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Adverse Event|1|||
44383763|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
44383764|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
44383765|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
44383766|NCT00784654|79389780|FG000|Randomized Withdrawal Period|Family reasons|0|||
44383767|NCT00784654|79389781|FG001|Randomized Withdrawal Period|Family reasons|0|||
44383768|NCT00784654|79389782|FG002|Randomized Withdrawal Period|Family reasons|1|||
44383769|NCT00787150|79389796|FG000|Overall Study|Adverse Event|4|||
44383770|NCT00787150|79389797|FG001|Overall Study|Adverse Event|4|||
44383771|NCT00787150|79389798|FG002|Overall Study|Adverse Event|4|||
44383772|NCT00787150|79389796|FG000|Overall Study|Physician Decision|1|||
44383773|NCT00787150|79389797|FG001|Overall Study|Physician Decision|2|||
44383774|NCT00787150|79389798|FG002|Overall Study|Physician Decision|1|||
44383775|NCT00787150|79389796|FG000|Overall Study|Withdrawal by Subject|2|||
44383776|NCT00787150|79389797|FG001|Overall Study|Withdrawal by Subject|1|||
44383777|NCT00787150|79389798|FG002|Overall Study|Withdrawal by Subject|0|||
44383778|NCT00787150|79389796|FG000|Overall Study|Dosing incorrect study durg|2|||
44383779|NCT00787150|79389797|FG001|Overall Study|Dosing incorrect study durg|0|||
44383780|NCT00787150|79389798|FG002|Overall Study|Dosing incorrect study durg|0|||
44383781|NCT00786838|79389808|FG000|Overall Study|Physician Decision|4|||
44383782|NCT00786838|79389808|FG000|Overall Study|Death|4|||
44383783|NCT00786838|79389808|FG000|Overall Study|Adverse Event|6|||
44383784|NCT00786838|79389808|FG000|Overall Study|Progressive disease|31|||
44383785|NCT00786838|79389808|FG000|Overall Study|Withdrawal by Subject|4|||
44383786|NCT00785980|79389817|FG000|7 Day Washout Period|Protocol Violation|3|||
44383787|NCT00791518|79389824|FG000|Overall Study|Protocol Violation|93|||
44383788|NCT00785512|79389845|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
44383789|NCT00785512|79389846|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
44383790|NCT00785512|79389845|FG000|Overall Study|Adverse Event|0|||
44383791|NCT00785512|79389846|FG001|Overall Study|Adverse Event|0|||
44383792|NCT00785512|79389845|FG000|Overall Study|Lack of Efficacy|0|||
44383793|NCT00785512|79389846|FG001|Overall Study|Lack of Efficacy|2|||
44383794|NCT00785512|79389845|FG000|Overall Study|Withdrawal by Subject|0|||
44383795|NCT00785512|79389846|FG001|Overall Study|Withdrawal by Subject|1|||
44383796|NCT00785512|79389845|FG000|Overall Study|Lost to Follow-up|3|||
44383797|NCT00785512|79389846|FG001|Overall Study|Lost to Follow-up|0|||
44383798|NCT00785512|79389845|FG000|Overall Study|Precedure Refused|0|||
44383799|NCT00785512|79389846|FG001|Overall Study|Precedure Refused|0|||
44383800|NCT00785512|79389845|FG000|Overall Study|IVRS Programing Error|0|||
44383801|NCT00785512|79389846|FG001|Overall Study|IVRS Programing Error|0|||
44383802|NCT00785512|79389845|FG000|Overall Study|Physician Decision|0|||
44383803|NCT00785512|79389846|FG001|Overall Study|Physician Decision|0|||
44383804|NCT00785512|79389845|FG000|Overall Study|Lack of compliance|0|||
44383805|NCT00785512|79389846|FG001|Overall Study|Lack of compliance|1|||
44383806|NCT00785356|79389856|FG000|Overall Study|Study prematurely terminated|8|||
44383807|NCT00785044|79389864|FG000|Overall Study|Dosed at non-participating sites|152|||
44383808|NCT00785044|79389864|FG000|Overall Study|Death|77|||
44383809|NCT00785044|79389864|FG000|Overall Study|Lost to Follow-up|266|||
44383810|NCT00785044|79389864|FG000|Overall Study|Withdrawal by Subject|1|||
44383811|NCT00784810|79389871|FG000|Overall Study|Adverse Event|32|||
44383812|NCT00784810|79389872|FG001|Overall Study|Adverse Event|20|||
44383813|NCT00784810|79389871|FG000|Overall Study|Lack of Efficacy|14|||
44383814|NCT00784810|79389872|FG001|Overall Study|Lack of Efficacy|11|||
44383815|NCT00784810|79389871|FG000|Overall Study|Withdrawal by Subject|11|||
44383816|NCT00784810|79389872|FG001|Overall Study|Withdrawal by Subject|9|||
44383817|NCT00784810|79389871|FG000|Overall Study|Administrative|5|||
44383818|NCT00784810|79389872|FG001|Overall Study|Administrative|8|||
44383819|NCT00784810|79389871|FG000|Overall Study|Lost to Follow-up|1|||
44383820|NCT00784810|79389872|FG001|Overall Study|Lost to Follow-up|1|||
44383821|NCT00791128|79389878|FG000|Overall Study|Adverse Event|4|||
44383822|NCT00791128|79389878|FG000|Overall Study|Device migration|2|||
44518138|NCT00068601|79525402|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
44383823|NCT00791128|79389878|FG000|Overall Study|non-compliance by subject|2|||
44383824|NCT00791128|79389878|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
44518139|NCT00068601|79525401|FG000|Overall Study|Death|11|||
44518140|NCT00068601|79525402|FG001|Overall Study|Death|3|||
44518141|NCT00068601|79525401|FG000|Overall Study|Lost to Follow-up|3|||
44518142|NCT00068601|79525402|FG001|Overall Study|Lost to Follow-up|2|||
44518143|NCT00068601|79525401|FG000|Overall Study|Missing primary outcome data|30|||
44383825|NCT00776230|79389898|FG000|Overall Study|Lost to Follow-up|2|||
44383826|NCT00776230|79389899|FG001|Overall Study|Lost to Follow-up|1|||
44383827|NCT00776230|79389900|FG002|Overall Study|Lost to Follow-up|5|||
44383828|NCT00776230|79389898|FG000|Overall Study|Not vaccinated at Day 0|1|||
44518144|NCT00068601|79525402|FG001|Overall Study|Missing primary outcome data|34|||
44145830|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44250869|NCT01392677|79086043|FG001|Overall Study|Withdrawal by Subject|2|||
44250870|NCT01392677|79086042|FG000|Overall Study|Incorrect enrollment|2|||
44250871|NCT01392677|79086043|FG001|Overall Study|Incorrect enrollment|3|||
44250872|NCT01392677|79086042|FG000|Overall Study|Other reason|3|||
44250873|NCT01392677|79086043|FG001|Overall Study|Other reason|2|||
44250874|NCT01392443|79086092|FG000|Overall Study|Disease progression|30|||
44250875|NCT01392443|79086092|FG000|Overall Study|Adverse Event|24|||
44250876|NCT01392443|79086092|FG000|Overall Study|Death|7|||
44250877|NCT01392443|79086092|FG000|Overall Study|Withdrawal by Subject|5|||
44250878|NCT01392443|79086092|FG000|Overall Study|Lost to Follow-up|1|||
44279041|NCT02014116|79240289|FG008|Overall Study|Progressive Disease|7|||
44279042|NCT02014116|79240281|FG000|Overall Study|Adverse Event|0|||
44279043|NCT02014116|79240282|FG001|Overall Study|Adverse Event|0|||
44279044|NCT02014116|79240283|FG002|Overall Study|Adverse Event|0|||
44279045|NCT02014116|79240284|FG003|Overall Study|Adverse Event|0|||
44279046|NCT02014116|79240285|FG004|Overall Study|Adverse Event|1|||
44279047|NCT02014116|79240286|FG005|Overall Study|Adverse Event|0|||
44279048|NCT02014116|79240287|FG006|Overall Study|Adverse Event|0|||
44279049|NCT02014116|79240288|FG007|Overall Study|Adverse Event|1|||
44279050|NCT02014116|79240289|FG008|Overall Study|Adverse Event|0|||
44279051|NCT02014116|79240281|FG000|Overall Study|Lost to Follow-up|0|||
44279052|NCT02014116|79240282|FG001|Overall Study|Lost to Follow-up|0|||
44279053|NCT02014116|79240283|FG002|Overall Study|Lost to Follow-up|0|||
44279054|NCT02014116|79240284|FG003|Overall Study|Lost to Follow-up|0|||
44279055|NCT02014116|79240285|FG004|Overall Study|Lost to Follow-up|0|||
44279056|NCT02014116|79240286|FG005|Overall Study|Lost to Follow-up|1|||
44279057|NCT02014116|79240287|FG006|Overall Study|Lost to Follow-up|0|||
44279058|NCT02014116|79240288|FG007|Overall Study|Lost to Follow-up|0|||
44279059|NCT02014116|79240289|FG008|Overall Study|Lost to Follow-up|1|||
44279060|NCT02014116|79240281|FG000|Overall Study|Death|0|||
44279061|NCT02014116|79240282|FG001|Overall Study|Death|0|||
44279062|NCT02014116|79240283|FG002|Overall Study|Death|0|||
44279063|NCT02014116|79240284|FG003|Overall Study|Death|0|||
44279064|NCT02014116|79240285|FG004|Overall Study|Death|0|||
44279065|NCT02014116|79240286|FG005|Overall Study|Death|0|||
44279066|NCT02014116|79240287|FG006|Overall Study|Death|0|||
44279067|NCT02014116|79240288|FG007|Overall Study|Death|1|||
44279068|NCT02014116|79240289|FG008|Overall Study|Death|1|||
44279069|NCT02014116|79240281|FG000|Overall Study|Withdrawal by Subject|0|||
44279070|NCT02014116|79240282|FG001|Overall Study|Withdrawal by Subject|0|||
44279071|NCT02014116|79240283|FG002|Overall Study|Withdrawal by Subject|1|||
44279072|NCT02014116|79240284|FG003|Overall Study|Withdrawal by Subject|1|||
44279073|NCT02014116|79240285|FG004|Overall Study|Withdrawal by Subject|0|||
44279074|NCT02014116|79240286|FG005|Overall Study|Withdrawal by Subject|1|||
44279075|NCT02014116|79240287|FG006|Overall Study|Withdrawal by Subject|0|||
44279076|NCT02014116|79240288|FG007|Overall Study|Withdrawal by Subject|0|||
44279077|NCT02014116|79240289|FG008|Overall Study|Withdrawal by Subject|0|||
44279078|NCT02014116|79240281|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
44279079|NCT02014116|79240282|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
44279080|NCT02014116|79240283|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
44279081|NCT02014116|79240284|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
44279082|NCT02014116|79240285|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
44279083|NCT02014116|79240286|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
44279084|NCT02014116|79240287|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
44279085|NCT02014116|79240288|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
44279086|NCT02014116|79240289|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
44279087|NCT02014116|79240281|FG000|Overall Study|Physician Decision|0|||
44279088|NCT02014116|79240282|FG001|Overall Study|Physician Decision|0|||
44279089|NCT02014116|79240283|FG002|Overall Study|Physician Decision|0|||
44279090|NCT02014116|79240284|FG003|Overall Study|Physician Decision|0|||
44279091|NCT02014116|79240285|FG004|Overall Study|Physician Decision|0|||
44279092|NCT02014116|79240286|FG005|Overall Study|Physician Decision|0|||
44279093|NCT02014116|79240287|FG006|Overall Study|Physician Decision|0|||
44279094|NCT02014116|79240288|FG007|Overall Study|Physician Decision|0|||
44279095|NCT02014116|79240289|FG008|Overall Study|Physician Decision|1|||
44279096|NCT02057250|79240316|FG000|AID Assessment Phase|Adverse Event|3|||
44279097|NCT02057250|79240317|FG001|AID Assessment Phase|Adverse Event|2|||
44518145|NCT03638258|79525411|FG000|Overall Study|Adverse Event|1|||
44279098|NCT02057250|79240318|FG002|AID Assessment Phase|Adverse Event|6|||
44279099|NCT02057250|79240319|FG003|AID Assessment Phase|Adverse Event|1|||
44279100|NCT02057250|79240320|FG004|AID Assessment Phase|Adverse Event|0|||
44279101|NCT02057250|79240316|FG000|AID Assessment Phase|Other than specified above|1|||
44279102|NCT02057250|79240317|FG001|AID Assessment Phase|Other than specified above|1|||
44279103|NCT02057250|79240318|FG002|AID Assessment Phase|Other than specified above|1|||
44518146|NCT03638258|79525412|FG001|Overall Study|Adverse Event|0|||
44279104|NCT02057250|79240319|FG003|AID Assessment Phase|Other than specified above|1|||
44250879|NCT01392443|79086092|FG000|Overall Study|Protocol Violation|1|||
44279105|NCT02057250|79240320|FG004|AID Assessment Phase|Other than specified above|0|||
44279106|NCT02057250|79240316|FG000|Extension Phase|Adverse Event|0|||
44279107|NCT02057250|79240317|FG001|Extension Phase|Adverse Event|0|||
44383829|NCT00776230|79389899|FG001|Overall Study|Not vaccinated at Day 0|0|||
44383830|NCT00776230|79389900|FG002|Overall Study|Not vaccinated at Day 0|0|||
44383831|NCT00776230|79389898|FG000|Overall Study|Withdrawal by Subject|0|||
44383832|NCT00776230|79389899|FG001|Overall Study|Withdrawal by Subject|1|||
44383833|NCT00776230|79389900|FG002|Overall Study|Withdrawal by Subject|0|||
44383834|NCT00776230|79389898|FG000|Overall Study|Subject missed Visit 4|0|||
44383835|NCT00776230|79389899|FG001|Overall Study|Subject missed Visit 4|1|||
44383836|NCT00776230|79389900|FG002|Overall Study|Subject missed Visit 4|0|||
44383837|NCT00775606|79389910|FG000|Overall Study|Study sponsor terminated funding|3|||
44383838|NCT00775606|79389911|FG001|Overall Study|Study sponsor terminated funding|0|||
44383839|NCT02960763|79389930|FG000|Step 1|Withdrawal by Subject|10|||
44383840|NCT02960763|79389931|FG001|Step 1|Withdrawal by Subject|8|||
44383841|NCT02960763|79389932|FG002|Step 1|Withdrawal by Subject|13|||
44383842|NCT02960763|79389933|FG003|Step 1|Withdrawal by Subject|0|||
44383843|NCT02960763|79389934|FG004|Step 1|Withdrawal by Subject|0|||
44383844|NCT02960763|79389930|FG000|Step 1|Lost to Follow-up|7|||
44383845|NCT02960763|79389931|FG001|Step 1|Lost to Follow-up|9|||
44383846|NCT02960763|79389932|FG002|Step 1|Lost to Follow-up|12|||
44383847|NCT02960763|79389933|FG003|Step 1|Lost to Follow-up|0|||
44383848|NCT02960763|79389934|FG004|Step 1|Lost to Follow-up|0|||
44383849|NCT02960763|79389930|FG000|Step 1|Death|1|||
44383850|NCT02960763|79389931|FG001|Step 1|Death|1|||
44383851|NCT02960763|79389932|FG002|Step 1|Death|1|||
44383852|NCT02960763|79389933|FG003|Step 1|Death|0|||
44383853|NCT02960763|79389934|FG004|Step 1|Death|0|||
44383854|NCT02960763|79389930|FG000|Step 1|Investigator discretion|1|||
44383855|NCT02960763|79389931|FG001|Step 1|Investigator discretion|0|||
44383856|NCT02960763|79389932|FG002|Step 1|Investigator discretion|1|||
44383857|NCT02960763|79389933|FG003|Step 1|Investigator discretion|0|||
44383858|NCT02960763|79389934|FG004|Step 1|Investigator discretion|0|||
44383859|NCT02960763|79389930|FG000|Step 1|Other|0|||
44383860|NCT02960763|79389931|FG001|Step 1|Other|0|||
44383861|NCT02960763|79389932|FG002|Step 1|Other|1|||
44383862|NCT02960763|79389933|FG003|Step 1|Other|0|||
44383863|NCT02960763|79389934|FG004|Step 1|Other|0|||
44383864|NCT02960763|79389930|FG000|Step 2|Withdrawal by Subject|0|||
44383865|NCT02960763|79389931|FG001|Step 2|Withdrawal by Subject|0|||
44383866|NCT02960763|79389932|FG002|Step 2|Withdrawal by Subject|0|||
44383867|NCT02960763|79389933|FG003|Step 2|Withdrawal by Subject|7|||
44383868|NCT02960763|79389934|FG004|Step 2|Withdrawal by Subject|3|||
44383869|NCT02960763|79389930|FG000|Step 2|Lost to Follow-up|0|||
44383870|NCT02960763|79389931|FG001|Step 2|Lost to Follow-up|0|||
44383871|NCT02960763|79389932|FG002|Step 2|Lost to Follow-up|0|||
44383872|NCT02960763|79389933|FG003|Step 2|Lost to Follow-up|4|||
44383873|NCT02960763|79389934|FG004|Step 2|Lost to Follow-up|1|||
44383874|NCT02960763|79389930|FG000|Step 2|Investigator discretion|0|||
44383875|NCT02960763|79389931|FG001|Step 2|Investigator discretion|0|||
44383876|NCT02960763|79389932|FG002|Step 2|Investigator discretion|0|||
44383877|NCT02960763|79389933|FG003|Step 2|Investigator discretion|0|||
44383878|NCT02960763|79389934|FG004|Step 2|Investigator discretion|1|||
44250880|NCT01391819|79086096|FG000|Overall Study|Withdrawal by Subject|56|||
44250881|NCT01391819|79086096|FG000|Overall Study|Migrated/moved from study area|82|||
44250882|NCT01391819|79086096|FG000|Overall Study|Lost to Follow-up|252|||
44250883|NCT01391819|79086096|FG000|Overall Study|Death|3|||
44250884|NCT01391819|79086096|FG000|Overall Study|Other|9|||
44250885|NCT03845023|79086107|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
44250886|NCT03845023|79086108|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
44250887|NCT03845023|79086109|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
44250888|NCT03845023|79086110|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
44250889|NCT03845023|79086107|FG000|Follow-Up (14 Days)|Adverse Event|0|||
44279108|NCT02057250|79240318|FG002|Extension Phase|Adverse Event|0|||
44383879|NCT00775528|79389946|FG000|Overall Study|Protocol Violation|1|||
44383880|NCT00775450|79389955|FG000|Overall Study|Serious Adverse Event|2|||
44383881|NCT00775450|79389956|FG001|Overall Study|Serious Adverse Event|0|||
44383882|NCT00775450|79389957|FG002|Overall Study|Serious Adverse Event|0|||
44383883|NCT00775450|79389958|FG003|Overall Study|Serious Adverse Event|0|||
44250890|NCT03845023|79086108|FG001|Follow-Up (14 Days)|Adverse Event|0|||
44279109|NCT02057250|79240319|FG003|Extension Phase|Adverse Event|0|||
44383884|NCT00775450|79389959|FG004|Overall Study|Serious Adverse Event|0|||
44383885|NCT00775450|79389955|FG000|Overall Study|Protocol Violation|0|||
44383886|NCT00775450|79389956|FG001|Overall Study|Protocol Violation|0|||
44383887|NCT00775450|79389957|FG002|Overall Study|Protocol Violation|0|||
44383888|NCT00775450|79389958|FG003|Overall Study|Protocol Violation|0|||
44383889|NCT00775450|79389959|FG004|Overall Study|Protocol Violation|1|||
44383890|NCT00775450|79389955|FG000|Overall Study|Withdrawal by Subject|1|||
44518147|NCT03638258|79525413|FG002|Overall Study|Adverse Event|2|||
44518148|NCT03638258|79525411|FG000|Overall Study|Lost to Follow-up|2|||
44518149|NCT03638258|79525412|FG001|Overall Study|Lost to Follow-up|4|||
44518150|NCT03638258|79525413|FG002|Overall Study|Lost to Follow-up|5|||
44518151|NCT03638258|79525411|FG000|Overall Study|Pregnancy|0|||
44518152|NCT03638258|79525412|FG001|Overall Study|Pregnancy|0|||
44518153|NCT03638258|79525413|FG002|Overall Study|Pregnancy|1|||
44383891|NCT00775450|79389956|FG001|Overall Study|Withdrawal by Subject|0|||
44383892|NCT00775450|79389957|FG002|Overall Study|Withdrawal by Subject|0|||
44383893|NCT00775450|79389958|FG003|Overall Study|Withdrawal by Subject|0|||
44383894|NCT00775450|79389959|FG004|Overall Study|Withdrawal by Subject|1|||
44383895|NCT00775138|79389975|FG000|Overall Study|Withdrawal by Subject|0|||
44383896|NCT00775138|79389976|FG001|Overall Study|Withdrawal by Subject|0|||
44383897|NCT00775138|79389977|FG002|Overall Study|Withdrawal by Subject|2|||
44383898|NCT00775138|79389978|FG003|Overall Study|Withdrawal by Subject|2|||
44383899|NCT00775138|79389975|FG000|Overall Study|Adverse Event|0|||
44383900|NCT00775138|79389976|FG001|Overall Study|Adverse Event|0|||
44383901|NCT00775138|79389977|FG002|Overall Study|Adverse Event|1|||
44383902|NCT00775138|79389978|FG003|Overall Study|Adverse Event|0|||
44383903|NCT04605991|79389990|FG000|Overall Study|Adverse Event|5|||
44383904|NCT04605991|79389990|FG000|Overall Study|Lack of Efficacy|1|||
44383905|NCT04605991|79389990|FG000|Overall Study|Lost to Follow-up|8|||
44383906|NCT04605991|79389990|FG000|Overall Study|Physician Decision|4|||
44383907|NCT04605991|79389990|FG000|Overall Study|Withdrawal by Subject|14|||
44383908|NCT04605991|79389990|FG000|Overall Study|Non-compliance with study|1|||
44383909|NCT00783796|79389994|FG000|Overall Study|Did not receive any stent|4|||
44383910|NCT00783796|79389994|FG000|Overall Study|Received non-XIENCE V stent|1|||
44383911|NCT00783796|79389994|FG000|Overall Study|Received commercial XIENCE V stent|1|||
44383912|NCT00783718|79390003|FG000|Induction Phase|Adverse Event|4|||
44383913|NCT00783718|79390004|FG001|Induction Phase|Adverse Event|0|||
44383914|NCT00783718|79390005|FG002|Induction Phase|Adverse Event|7|||
44383915|NCT00783718|79390006|FG003|Induction Phase|Adverse Event|0|||
44383916|NCT00783718|79390007|FG004|Induction Phase|Adverse Event|0|||
44383917|NCT00783718|79390008|FG005|Induction Phase|Adverse Event|0|||
44383918|NCT00783718|79390009|FG006|Induction Phase|Adverse Event|0|||
44383919|NCT00783718|79390003|FG000|Induction Phase|Protocol Violation|1|||
44383920|NCT00783718|79390004|FG001|Induction Phase|Protocol Violation|1|||
44383921|NCT00783718|79390005|FG002|Induction Phase|Protocol Violation|6|||
44383922|NCT00783718|79390006|FG003|Induction Phase|Protocol Violation|0|||
44383923|NCT00783718|79390007|FG004|Induction Phase|Protocol Violation|0|||
44383924|NCT00783718|79390008|FG005|Induction Phase|Protocol Violation|0|||
44383925|NCT00783718|79390009|FG006|Induction Phase|Protocol Violation|0|||
44383926|NCT00783718|79390003|FG000|Induction Phase|Lack of Efficacy|5|||
44383927|NCT00783718|79390004|FG001|Induction Phase|Lack of Efficacy|2|||
44383928|NCT00783718|79390005|FG002|Induction Phase|Lack of Efficacy|14|||
44383929|NCT00783718|79390006|FG003|Induction Phase|Lack of Efficacy|0|||
44383930|NCT00783718|79390007|FG004|Induction Phase|Lack of Efficacy|0|||
44383931|NCT00783718|79390008|FG005|Induction Phase|Lack of Efficacy|0|||
44383932|NCT00783718|79390009|FG006|Induction Phase|Lack of Efficacy|0|||
44383933|NCT00783718|79390003|FG000|Induction Phase|Withdrawal by Subject|3|||
44383934|NCT00783718|79390004|FG001|Induction Phase|Withdrawal by Subject|4|||
44383935|NCT00783718|79390005|FG002|Induction Phase|Withdrawal by Subject|8|||
44383936|NCT00783718|79390006|FG003|Induction Phase|Withdrawal by Subject|0|||
44383937|NCT00783718|79390007|FG004|Induction Phase|Withdrawal by Subject|0|||
44383938|NCT00783718|79390008|FG005|Induction Phase|Withdrawal by Subject|0|||
44383939|NCT00783718|79390009|FG006|Induction Phase|Withdrawal by Subject|0|||
44383940|NCT00783718|79390003|FG000|Induction Phase|Lost to Follow-up|1|||
44383941|NCT00783718|79390004|FG001|Induction Phase|Lost to Follow-up|0|||
44383942|NCT00783718|79390005|FG002|Induction Phase|Lost to Follow-up|1|||
44383943|NCT00783718|79390006|FG003|Induction Phase|Lost to Follow-up|0|||
44383944|NCT00783718|79390007|FG004|Induction Phase|Lost to Follow-up|0|||
44518154|NCT03638258|79525411|FG000|Overall Study|Protocol Violation|0|||
44518155|NCT03638258|79525412|FG001|Overall Study|Protocol Violation|0|||
44383945|NCT00783718|79390008|FG005|Induction Phase|Lost to Follow-up|0|||
44518156|NCT03638258|79525413|FG002|Overall Study|Protocol Violation|1|||
44518157|NCT03638258|79525411|FG000|Overall Study|Withdrawal by Subject|4|||
44518158|NCT03638258|79525412|FG001|Overall Study|Withdrawal by Subject|5|||
44518159|NCT03638258|79525413|FG002|Overall Study|Withdrawal by Subject|12|||
44383946|NCT00783718|79390009|FG006|Induction Phase|Lost to Follow-up|0|||
44383947|NCT00783718|79390003|FG000|Maintenance Phase|Adverse Event|12|||
44383948|NCT00783718|79390004|FG001|Maintenance Phase|Adverse Event|0|||
44383949|NCT00783718|79390005|FG002|Maintenance Phase|Adverse Event|0|||
44383950|NCT00783718|79390006|FG003|Maintenance Phase|Adverse Event|15|||
44383951|NCT00783718|79390007|FG004|Maintenance Phase|Adverse Event|7|||
44383952|NCT00783718|79390008|FG005|Maintenance Phase|Adverse Event|6|||
44383953|NCT00783718|79390009|FG006|Maintenance Phase|Adverse Event|16|||
44518160|NCT03638258|79525411|FG000|Overall Study|Lack of Efficacy|0|||
44518161|NCT03638258|79525412|FG001|Overall Study|Lack of Efficacy|0|||
44518162|NCT03638258|79525413|FG002|Overall Study|Lack of Efficacy|2|||
44383954|NCT00783718|79390003|FG000|Maintenance Phase|Protocol Violation|1|||
44383955|NCT00783718|79390004|FG001|Maintenance Phase|Protocol Violation|0|||
44383956|NCT00783718|79390005|FG002|Maintenance Phase|Protocol Violation|0|||
44383957|NCT00783718|79390006|FG003|Maintenance Phase|Protocol Violation|0|||
44383958|NCT00783718|79390007|FG004|Maintenance Phase|Protocol Violation|0|||
44383959|NCT00783718|79390008|FG005|Maintenance Phase|Protocol Violation|0|||
44383960|NCT00783718|79390009|FG006|Maintenance Phase|Protocol Violation|2|||
44383961|NCT00783718|79390003|FG000|Maintenance Phase|Lack of Efficacy|83|||
44383962|NCT00783718|79390004|FG001|Maintenance Phase|Lack of Efficacy|0|||
44383963|NCT00783718|79390005|FG002|Maintenance Phase|Lack of Efficacy|0|||
44383964|NCT00783718|79390006|FG003|Maintenance Phase|Lack of Efficacy|61|||
44383965|NCT00783718|79390007|FG004|Maintenance Phase|Lack of Efficacy|31|||
44383966|NCT00783718|79390008|FG005|Maintenance Phase|Lack of Efficacy|33|||
44383967|NCT00783718|79390009|FG006|Maintenance Phase|Lack of Efficacy|155|||
44383968|NCT00783718|79390003|FG000|Maintenance Phase|Withdrawal by Subject|6|||
44383969|NCT00783718|79390004|FG001|Maintenance Phase|Withdrawal by Subject|0|||
44383970|NCT00783718|79390005|FG002|Maintenance Phase|Withdrawal by Subject|0|||
44383971|NCT00783718|79390006|FG003|Maintenance Phase|Withdrawal by Subject|2|||
44383972|NCT00783718|79390007|FG004|Maintenance Phase|Withdrawal by Subject|5|||
44383973|NCT00783718|79390008|FG005|Maintenance Phase|Withdrawal by Subject|2|||
44383974|NCT00783718|79390009|FG006|Maintenance Phase|Withdrawal by Subject|20|||
44383975|NCT00783718|79390003|FG000|Maintenance Phase|Lost to Follow-up|3|||
44383976|NCT00783718|79390004|FG001|Maintenance Phase|Lost to Follow-up|0|||
44383977|NCT00783718|79390005|FG002|Maintenance Phase|Lost to Follow-up|0|||
44383978|NCT00783718|79390006|FG003|Maintenance Phase|Lost to Follow-up|0|||
44279110|NCT02057250|79240320|FG004|Extension Phase|Adverse Event|15|||
44279111|NCT02057250|79240316|FG000|Extension Phase|Lack of Efficacy|0|||
44279112|NCT02057250|79240317|FG001|Extension Phase|Lack of Efficacy|0|||
44279113|NCT02057250|79240318|FG002|Extension Phase|Lack of Efficacy|0|||
44383979|NCT00783718|79390007|FG004|Maintenance Phase|Lost to Follow-up|2|||
44383980|NCT00783718|79390008|FG005|Maintenance Phase|Lost to Follow-up|0|||
44383981|NCT00783718|79390009|FG006|Maintenance Phase|Lost to Follow-up|2|||
44383982|NCT00774748|79390028|FG000|Overall Study|Lost to Follow-up|3|||
44383983|NCT00587860|79390038|FG000|Overall Study|Lost to Follow-up|2|||
44383984|NCT00587860|79390039|FG001|Overall Study|Lost to Follow-up|2|||
44383985|NCT00587860|79390038|FG000|Overall Study|Withdrawal by Subject|3|||
44383986|NCT00587860|79390039|FG001|Overall Study|Withdrawal by Subject|3|||
44383987|NCT00583453|79390047|FG000|Overall Study|discontinued intervention|0|||
44383988|NCT00583453|79390048|FG001|Overall Study|discontinued intervention|2|||
44383989|NCT00583219|79390056|FG000|Phase 2|Withdrawal by Subject|1|||
44383990|NCT01072175|79390076|FG000|Part A (Drug-Drug Interaction)|Death|1|||
44383991|NCT01072175|79390077|FG001|Part A (Drug-Drug Interaction)|Death|0|||
44383992|NCT01072175|79390078|FG002|Part A (Drug-Drug Interaction)|Death|0|||
44383993|NCT01072175|79390079|FG003|Part A (Drug-Drug Interaction)|Death|0|||
44383994|NCT01072175|79390080|FG004|Part A (Drug-Drug Interaction)|Death|0|||
44383995|NCT01072175|79390081|FG005|Part A (Drug-Drug Interaction)|Death|0|||
44383996|NCT01072175|79390082|FG006|Part A (Drug-Drug Interaction)|Death|0|||
44383997|NCT01072175|79390083|FG007|Part A (Drug-Drug Interaction)|Death|0|||
44383998|NCT01072175|79390084|FG008|Part A (Drug-Drug Interaction)|Death|0|||
44383999|NCT01072175|79390085|FG009|Part A (Drug-Drug Interaction)|Death|0|||
44384000|NCT01072175|79390086|FG010|Part A (Drug-Drug Interaction)|Death|0|||
44384001|NCT01072175|79390087|FG011|Part A (Drug-Drug Interaction)|Death|0|||
44384002|NCT01072175|79390088|FG012|Part A (Drug-Drug Interaction)|Death|0|||
44384003|NCT01072175|79390076|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
44384004|NCT01072175|79390077|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384005|NCT01072175|79390078|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384006|NCT01072175|79390079|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384007|NCT01072175|79390080|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384008|NCT01072175|79390081|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384009|NCT01072175|79390082|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384010|NCT01072175|79390083|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384011|NCT01072175|79390084|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44518163|NCT01670656|79525427|FG000|Overall Study|Non-compliance with study drug|0|||
44279114|NCT02057250|79240319|FG003|Extension Phase|Lack of Efficacy|0|||
44384012|NCT01072175|79390085|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384013|NCT01072175|79390086|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44518164|NCT01670656|79525428|FG001|Overall Study|Non-compliance with study drug|0|||
44145831|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44384014|NCT01072175|79390087|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384015|NCT01072175|79390088|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
44384016|NCT01072175|79390076|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
44518165|NCT01670656|79525429|FG002|Overall Study|Non-compliance with study drug|3|||
44518166|NCT01670656|79525430|FG003|Overall Study|Non-compliance with study drug|0|||
44279115|NCT02057250|79240320|FG004|Extension Phase|Lack of Efficacy|10|||
44384017|NCT01072175|79390077|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384018|NCT01072175|79390078|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384019|NCT01072175|79390079|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384020|NCT01072175|79390080|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384021|NCT01072175|79390081|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384022|NCT01072175|79390082|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44279116|NCT02057250|79240316|FG000|Extension Phase|Entered in this period but not treated|0|||
44384023|NCT01072175|79390083|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44250891|NCT03845023|79086109|FG002|Follow-Up (14 Days)|Adverse Event|1|||
44250892|NCT03845023|79086110|FG003|Follow-Up (14 Days)|Adverse Event|1|||
44250893|NCT01395017|79086172|FG000|Overall Study|Lost to Follow-up|1|||
44250894|NCT01395017|79086173|FG001|Overall Study|Lost to Follow-up|0|||
44250895|NCT01395017|79086172|FG000|Overall Study|Adverse Event|26|||
44384024|NCT01072175|79390084|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384025|NCT01072175|79390085|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384026|NCT01072175|79390086|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384027|NCT01072175|79390087|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384028|NCT01072175|79390088|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
44384029|NCT01072175|79390076|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
44384030|NCT01072175|79390077|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
44384031|NCT01072175|79390078|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
44384032|NCT01072175|79390079|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
44384033|NCT01072175|79390080|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
44384034|NCT01072175|79390081|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
44384035|NCT01072175|79390082|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
44384036|NCT01072175|79390083|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
44384037|NCT01072175|79390084|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
44384038|NCT01072175|79390085|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
44384039|NCT01072175|79390086|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
44384040|NCT01072175|79390087|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
44384041|NCT01072175|79390088|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
44384042|NCT01072175|79390076|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384043|NCT01072175|79390077|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384044|NCT01072175|79390078|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
44384045|NCT01072175|79390079|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44250896|NCT01395017|79086173|FG001|Overall Study|Adverse Event|12|||
44250897|NCT01395017|79086172|FG000|Overall Study|Physician Decision|11|||
44250898|NCT01395017|79086173|FG001|Overall Study|Physician Decision|15|||
44250899|NCT01395017|79086172|FG000|Overall Study|Withdrawal by Subject|14|||
44250900|NCT01395017|79086173|FG001|Overall Study|Withdrawal by Subject|8|||
44250901|NCT01395017|79086172|FG000|Overall Study|Protocol deviation|1|||
44250902|NCT01395017|79086173|FG001|Overall Study|Protocol deviation|2|||
44279117|NCT02057250|79240317|FG001|Extension Phase|Entered in this period but not treated|0|||
44279118|NCT02057250|79240318|FG002|Extension Phase|Entered in this period but not treated|0|||
44279119|NCT02057250|79240319|FG003|Extension Phase|Entered in this period but not treated|0|||
44279120|NCT02057250|79240320|FG004|Extension Phase|Entered in this period but not treated|4|||
44279121|NCT02057250|79240316|FG000|Extension Phase|Other than specified above|0|||
44279122|NCT02057250|79240317|FG001|Extension Phase|Other than specified above|0|||
44279123|NCT02057250|79240318|FG002|Extension Phase|Other than specified above|0|||
44279124|NCT02057250|79240319|FG003|Extension Phase|Other than specified above|0|||
44279125|NCT02057250|79240320|FG004|Extension Phase|Other than specified above|7|||
44279126|NCT02036502|79240340|FG000|Part 1:Dose Determination/Escalation|Death|3|||
44250903|NCT01395017|79086172|FG000|Overall Study|Death|4|||
44250904|NCT01395017|79086173|FG001|Overall Study|Death|3|||
44279127|NCT02036502|79240341|FG001|Part 1:Dose Determination/Escalation|Death|2|||
44279128|NCT02036502|79240342|FG002|Part 1:Dose Determination/Escalation|Death|0|||
44279129|NCT02036502|79240343|FG003|Part 1:Dose Determination/Escalation|Death|0|||
44279130|NCT02036502|79240344|FG004|Part 1:Dose Determination/Escalation|Death|0|||
44279131|NCT02036502|79240345|FG005|Part 1:Dose Determination/Escalation|Death|0|||
44279132|NCT02036502|79240346|FG006|Part 1:Dose Determination/Escalation|Death|0|||
44279133|NCT02036502|79240347|FG007|Part 1:Dose Determination/Escalation|Death|0|||
44279134|NCT02036502|79240340|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
44279135|NCT02036502|79240341|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44279136|NCT02036502|79240342|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44279137|NCT02036502|79240343|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44279138|NCT02036502|79240344|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44279139|NCT02036502|79240345|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44279140|NCT02036502|79240346|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44250905|NCT01395017|79086172|FG000|Overall Study|Disease progression|42|||
44384046|NCT01072175|79390080|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
44384047|NCT01072175|79390081|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384048|NCT01072175|79390082|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384049|NCT01072175|79390083|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384050|NCT01072175|79390084|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384051|NCT01072175|79390085|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384052|NCT01072175|79390086|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384053|NCT01072175|79390087|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384054|NCT01072175|79390088|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
44384055|NCT01072175|79390076|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384056|NCT01072175|79390077|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
44384057|NCT01072175|79390078|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384058|NCT01072175|79390079|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
44384059|NCT01072175|79390080|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
44384060|NCT01072175|79390081|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384061|NCT01072175|79390082|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384062|NCT01072175|79390083|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384063|NCT01072175|79390084|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384064|NCT01072175|79390085|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384065|NCT01072175|79390086|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384066|NCT01072175|79390087|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384067|NCT01072175|79390088|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
44384068|NCT01072175|79390076|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384069|NCT01072175|79390077|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384070|NCT01072175|79390078|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
44384071|NCT01072175|79390079|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
44384072|NCT01072175|79390080|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
44384073|NCT01072175|79390081|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384074|NCT01072175|79390082|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384075|NCT01072175|79390083|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384076|NCT01072175|79390084|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384077|NCT01072175|79390085|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384078|NCT01072175|79390086|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384079|NCT01072175|79390087|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384080|NCT01072175|79390088|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
44384081|NCT01072175|79390076|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384082|NCT01072175|79390077|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
44384083|NCT01072175|79390078|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384084|NCT01072175|79390079|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
44384085|NCT01072175|79390080|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
44384086|NCT01072175|79390081|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384087|NCT01072175|79390082|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384088|NCT01072175|79390083|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384089|NCT01072175|79390084|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384090|NCT01072175|79390085|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384091|NCT01072175|79390086|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384092|NCT01072175|79390087|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384093|NCT01072175|79390088|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
44384094|NCT01072175|79390076|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
44384095|NCT01072175|79390077|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
44384096|NCT01072175|79390078|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
44384097|NCT01072175|79390079|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
44384098|NCT01072175|79390080|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
44384099|NCT01072175|79390081|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
44384100|NCT01072175|79390082|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
44384101|NCT01072175|79390083|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
44384102|NCT01072175|79390084|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
44384103|NCT01072175|79390085|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
44384104|NCT01072175|79390086|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
44518167|NCT01670656|79525431|FG004|Overall Study|Non-compliance with study drug|1|||
44518168|NCT01670656|79525427|FG000|Overall Study|Pregnancy|0|||
44518169|NCT01670656|79525428|FG001|Overall Study|Pregnancy|0|||
44518170|NCT01670656|79525429|FG002|Overall Study|Pregnancy|0|||
44518171|NCT01670656|79525430|FG003|Overall Study|Pregnancy|0|||
44518172|NCT01670656|79525431|FG004|Overall Study|Pregnancy|1|||
44518173|NCT01670656|79525427|FG000|Overall Study|Withdrawal by Subject|1|||
44145832|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
44384105|NCT01072175|79390087|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
44384106|NCT01072175|79390088|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
44384107|NCT01072175|79390076|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384108|NCT01072175|79390077|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384109|NCT01072175|79390078|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44250906|NCT01395017|79086173|FG001|Overall Study|Disease progression|58|||
44250907|NCT01395017|79086172|FG000|Overall Study|Sponsor discontinued study|1|||
44250908|NCT01395017|79086173|FG001|Overall Study|Sponsor discontinued study|4|||
44250909|NCT02647320|79086202|FG000|Overall Study|Adverse Event|0|||
44250910|NCT02647320|79086203|FG001|Overall Study|Adverse Event|1|||
44250911|NCT02647320|79086204|FG002|Overall Study|Adverse Event|3|||
44250912|NCT02647320|79086205|FG003|Overall Study|Adverse Event|2|||
44250913|NCT02647320|79086206|FG004|Overall Study|Adverse Event|1|||
44250914|NCT02647320|79086202|FG000|Overall Study|Protocol Violation|0|||
44250915|NCT02647320|79086203|FG001|Overall Study|Protocol Violation|0|||
44250916|NCT02647320|79086204|FG002|Overall Study|Protocol Violation|3|||
44250917|NCT02647320|79086205|FG003|Overall Study|Protocol Violation|0|||
44250918|NCT02647320|79086206|FG004|Overall Study|Protocol Violation|0|||
44250919|NCT02647320|79086202|FG000|Overall Study|Withdrawal by Subject|7|||
44250920|NCT02647320|79086203|FG001|Overall Study|Withdrawal by Subject|4|||
44250921|NCT02647320|79086204|FG002|Overall Study|Withdrawal by Subject|2|||
44250922|NCT02647320|79086205|FG003|Overall Study|Withdrawal by Subject|2|||
44250923|NCT02647320|79086206|FG004|Overall Study|Withdrawal by Subject|7|||
44250924|NCT02647320|79086202|FG000|Overall Study|Persistent hyperglycemia|0|||
44250925|NCT02647320|79086203|FG001|Overall Study|Persistent hyperglycemia|1|||
44279141|NCT02036502|79240347|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
44279142|NCT02036502|79240340|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279143|NCT02036502|79240341|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
44279144|NCT02036502|79240342|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279145|NCT02036502|79240343|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279146|NCT02036502|79240344|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279147|NCT02036502|79240345|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279148|NCT02036502|79240346|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279149|NCT02036502|79240347|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
44279150|NCT02036502|79240340|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
44279151|NCT02036502|79240341|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
44279152|NCT02036502|79240342|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
44279153|NCT02036502|79240343|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
44279154|NCT02036502|79240344|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
44279155|NCT02036502|79240345|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
44279156|NCT02036502|79240346|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
44279157|NCT02036502|79240347|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
44279158|NCT02036502|79240340|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
44279159|NCT02036502|79240341|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
44279160|NCT02036502|79240342|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
44279161|NCT02036502|79240343|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
44279162|NCT02036502|79240344|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
44279163|NCT02036502|79240345|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
44279164|NCT02036502|79240346|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
44279165|NCT02036502|79240347|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
44279166|NCT02036502|79240340|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279167|NCT02036502|79240341|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279168|NCT02036502|79240342|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
44279169|NCT02036502|79240343|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279170|NCT02036502|79240344|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279171|NCT02036502|79240345|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279172|NCT02036502|79240346|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279173|NCT02036502|79240347|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
44279174|NCT02036502|79240340|FG000|Part 2:Dose Confirmation|Death|0|||
44279175|NCT02036502|79240341|FG001|Part 2:Dose Confirmation|Death|0|||
44279176|NCT02036502|79240342|FG002|Part 2:Dose Confirmation|Death|1|||
44279177|NCT02036502|79240343|FG003|Part 2:Dose Confirmation|Death|0|||
44279178|NCT02036502|79240344|FG004|Part 2:Dose Confirmation|Death|0|||
44279179|NCT02036502|79240345|FG005|Part 2:Dose Confirmation|Death|0|||
44279180|NCT02036502|79240346|FG006|Part 2:Dose Confirmation|Death|0|||
44279181|NCT02036502|79240347|FG007|Part 2:Dose Confirmation|Death|0|||
44384110|NCT01072175|79390079|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384111|NCT01072175|79390080|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44145833|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44250926|NCT02647320|79086204|FG002|Overall Study|Persistent hyperglycemia|1|||
44250927|NCT02647320|79086205|FG003|Overall Study|Persistent hyperglycemia|1|||
44250928|NCT02647320|79086206|FG004|Overall Study|Persistent hyperglycemia|1|||
44384112|NCT01072175|79390081|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
44384113|NCT01072175|79390082|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
44384114|NCT01072175|79390083|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
44384115|NCT01072175|79390084|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384116|NCT01072175|79390085|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384117|NCT01072175|79390086|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384118|NCT01072175|79390087|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384119|NCT01072175|79390088|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
44384120|NCT01072175|79390076|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384121|NCT01072175|79390077|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384122|NCT01072175|79390078|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384123|NCT01072175|79390079|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384124|NCT01072175|79390080|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384125|NCT01072175|79390081|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384126|NCT01072175|79390082|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
44384127|NCT01072175|79390083|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
44384128|NCT01072175|79390084|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384129|NCT01072175|79390085|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384130|NCT01072175|79390086|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384131|NCT01072175|79390087|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384132|NCT01072175|79390088|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
44384133|NCT01072175|79390076|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384134|NCT01072175|79390077|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384135|NCT01072175|79390078|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384136|NCT01072175|79390079|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384137|NCT01072175|79390080|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384138|NCT01072175|79390081|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
44384139|NCT01072175|79390082|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
44384140|NCT01072175|79390083|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
44384141|NCT01072175|79390084|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384142|NCT01072175|79390085|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384143|NCT01072175|79390086|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384144|NCT01072175|79390087|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384145|NCT01072175|79390088|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
44384146|NCT01072175|79390076|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384147|NCT01072175|79390077|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384148|NCT01072175|79390078|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384149|NCT01072175|79390079|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384150|NCT01072175|79390080|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384151|NCT01072175|79390081|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
44384152|NCT01072175|79390082|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
44384153|NCT01072175|79390083|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384154|NCT01072175|79390084|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384155|NCT01072175|79390085|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384156|NCT01072175|79390086|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384157|NCT01072175|79390087|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44279182|NCT02036502|79240340|FG000|Part 2:Dose Confirmation|Not treated|0|||
44279183|NCT02036502|79240341|FG001|Part 2:Dose Confirmation|Not treated|0|||
44279184|NCT02036502|79240342|FG002|Part 2:Dose Confirmation|Not treated|0|||
44279185|NCT02036502|79240343|FG003|Part 2:Dose Confirmation|Not treated|1|||
44279186|NCT02036502|79240344|FG004|Part 2:Dose Confirmation|Not treated|0|||
44279187|NCT02036502|79240345|FG005|Part 2:Dose Confirmation|Not treated|0|||
44279188|NCT02036502|79240346|FG006|Part 2:Dose Confirmation|Not treated|0|||
44279189|NCT02036502|79240347|FG007|Part 2:Dose Confirmation|Not treated|0|||
44279190|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Adverse Event|0|||
44279191|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Adverse Event|0|||
44279192|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Adverse Event|0|||
44279193|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Adverse Event|0|||
44279194|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Adverse Event|0|||
44279195|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Adverse Event|4|||
44279196|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Adverse Event|0|||
44279197|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Adverse Event|2|||
44279198|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Death|0|||
44279199|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Death|0|||
44279200|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Death|0|||
44279201|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Death|0|||
44145834|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44384158|NCT01072175|79390088|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
44384159|NCT01072175|79390076|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384160|NCT01072175|79390077|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384161|NCT01072175|79390078|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384162|NCT01072175|79390079|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384163|NCT01072175|79390080|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384164|NCT01072175|79390081|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384165|NCT01072175|79390082|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384166|NCT01072175|79390083|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384167|NCT01072175|79390084|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
44384168|NCT01072175|79390085|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384169|NCT01072175|79390086|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384170|NCT01072175|79390087|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384171|NCT01072175|79390088|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
44384172|NCT01072175|79390076|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384173|NCT01072175|79390077|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384174|NCT01072175|79390078|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44145835|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145836|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145837|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44384175|NCT01072175|79390079|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44145838|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145839|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145840|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145841|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145842|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145843|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44250929|NCT02647320|79086202|FG000|Overall Study|Study terminated by sponsor|1|||
44250930|NCT02647320|79086203|FG001|Overall Study|Study terminated by sponsor|1|||
44250931|NCT02647320|79086204|FG002|Overall Study|Study terminated by sponsor|1|||
44250932|NCT02647320|79086205|FG003|Overall Study|Study terminated by sponsor|1|||
44250933|NCT02647320|79086206|FG004|Overall Study|Study terminated by sponsor|2|||
44250934|NCT02647320|79086202|FG000|Overall Study|Reason not provided|0|||
44250935|NCT02647320|79086203|FG001|Overall Study|Reason not provided|0|||
44250936|NCT02647320|79086204|FG002|Overall Study|Reason not provided|1|||
44384176|NCT01072175|79390080|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384177|NCT01072175|79390081|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384178|NCT01072175|79390082|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384179|NCT01072175|79390083|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44518174|NCT01670656|79525428|FG001|Overall Study|Withdrawal by Subject|1|||
44384180|NCT01072175|79390084|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
44518175|NCT01670656|79525429|FG002|Overall Study|Withdrawal by Subject|0|||
44518176|NCT01670656|79525430|FG003|Overall Study|Withdrawal by Subject|0|||
44518177|NCT01670656|79525431|FG004|Overall Study|Withdrawal by Subject|0|||
44518178|NCT01670656|79525427|FG000|Overall Study|Non-compliance with protocol|0|||
44518179|NCT01670656|79525428|FG001|Overall Study|Non-compliance with protocol|3|||
44518180|NCT01670656|79525429|FG002|Overall Study|Non-compliance with protocol|1|||
44518181|NCT01670656|79525430|FG003|Overall Study|Non-compliance with protocol|1|||
44518182|NCT01670656|79525431|FG004|Overall Study|Non-compliance with protocol|2|||
44518183|NCT01670656|79525427|FG000|Overall Study|Adverse Event|2|||
44145844|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145845|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145846|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145847|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
44250937|NCT02647320|79086205|FG003|Overall Study|Reason not provided|0|||
44279202|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Death|0|||
44279203|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Death|24|||
44279204|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Death|0|||
44279205|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Death|3|||
44279206|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
44279207|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
44384181|NCT01072175|79390085|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384182|NCT01072175|79390086|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384183|NCT01072175|79390087|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384184|NCT01072175|79390088|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
44384185|NCT01072175|79390076|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384186|NCT01072175|79390077|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384187|NCT01072175|79390078|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384188|NCT01072175|79390079|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384189|NCT01072175|79390080|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384190|NCT01072175|79390081|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384191|NCT01072175|79390082|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384192|NCT01072175|79390083|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384193|NCT01072175|79390084|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
44384194|NCT01072175|79390085|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384195|NCT01072175|79390086|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384196|NCT01072175|79390087|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384197|NCT01072175|79390088|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
44384198|NCT01072175|79390076|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384199|NCT01072175|79390077|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384200|NCT01072175|79390078|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384201|NCT01072175|79390079|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384202|NCT01072175|79390080|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384203|NCT01072175|79390081|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384204|NCT01072175|79390082|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384205|NCT01072175|79390083|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384206|NCT01072175|79390084|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
44384207|NCT01072175|79390085|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384208|NCT01072175|79390086|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384209|NCT01072175|79390087|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384210|NCT01072175|79390088|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
44384211|NCT01072175|79390076|FG000|Part D (HPMC Capsules)|Death|0|||
44384212|NCT01072175|79390077|FG001|Part D (HPMC Capsules)|Death|0|||
44384213|NCT01072175|79390078|FG002|Part D (HPMC Capsules)|Death|0|||
44384214|NCT01072175|79390079|FG003|Part D (HPMC Capsules)|Death|0|||
44384215|NCT01072175|79390080|FG004|Part D (HPMC Capsules)|Death|0|||
44384216|NCT01072175|79390081|FG005|Part D (HPMC Capsules)|Death|0|||
44279208|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
44279209|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
44279210|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
44279211|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
44279212|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
44279213|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
44279214|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Physician Decision|0|||
44279215|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Physician Decision|0|||
44279216|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Physician Decision|0|||
44279217|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Physician Decision|0|||
44279218|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Physician Decision|0|||
44279219|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Physician Decision|1|||
44279220|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Physician Decision|0|||
44279221|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Physician Decision|0|||
44279222|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
44384217|NCT01072175|79390082|FG006|Part D (HPMC Capsules)|Death|0|||
44384218|NCT01072175|79390083|FG007|Part D (HPMC Capsules)|Death|0|||
44384219|NCT01072175|79390084|FG008|Part D (HPMC Capsules)|Death|0|||
44384220|NCT01072175|79390085|FG009|Part D (HPMC Capsules)|Death|10|||
44384221|NCT01072175|79390086|FG010|Part D (HPMC Capsules)|Death|12|||
44145848|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
44279223|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
44279224|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
44384222|NCT01072175|79390087|FG011|Part D (HPMC Capsules)|Death|28|||
44279225|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
44279226|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
44279227|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
44279228|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
44279229|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
44279230|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
44279231|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
44279232|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
44279233|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
44279234|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
44279235|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
44279236|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
44279237|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
44279238|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
44279239|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
44279240|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
44279241|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
44279242|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
44279243|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
44279244|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
44279245|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
44279246|NCT02036502|79240340|FG000|Part 3:Dose Expansion|Not Treated|0|||
44279247|NCT02036502|79240341|FG001|Part 3:Dose Expansion|Not Treated|0|||
44279248|NCT02036502|79240342|FG002|Part 3:Dose Expansion|Not Treated|0|||
44518184|NCT01670656|79525428|FG001|Overall Study|Adverse Event|2|||
44518185|NCT01670656|79525429|FG002|Overall Study|Adverse Event|2|||
44518186|NCT01670656|79525430|FG003|Overall Study|Adverse Event|3|||
44518187|NCT01670656|79525431|FG004|Overall Study|Adverse Event|3|||
44518188|NCT01670656|79525427|FG000|Overall Study|Subject withdrew consent|0|||
44518189|NCT01670656|79525428|FG001|Overall Study|Subject withdrew consent|1|||
44518190|NCT01670656|79525429|FG002|Overall Study|Subject withdrew consent|2|||
44518191|NCT01670656|79525430|FG003|Overall Study|Subject withdrew consent|1|||
44518192|NCT01670656|79525431|FG004|Overall Study|Subject withdrew consent|1|||
44518193|NCT01670656|79525427|FG000|Overall Study|Lost to Follow-up|0|||
44250938|NCT02647320|79086206|FG004|Overall Study|Reason not provided|2|||
44250939|NCT02647320|79086202|FG000|Overall Study|Lost to Follow-up|1|||
44250940|NCT02647320|79086203|FG001|Overall Study|Lost to Follow-up|1|||
44250941|NCT02647320|79086204|FG002|Overall Study|Lost to Follow-up|0|||
44250942|NCT02647320|79086205|FG003|Overall Study|Lost to Follow-up|0|||
44250943|NCT02647320|79086206|FG004|Overall Study|Lost to Follow-up|0|||
44250944|NCT02647320|79086202|FG000|Overall Study|Develop anemia|1|||
44250945|NCT02647320|79086203|FG001|Overall Study|Develop anemia|0|||
44250946|NCT02647320|79086204|FG002|Overall Study|Develop anemia|0|||
44250947|NCT02647320|79086205|FG003|Overall Study|Develop anemia|0|||
44250948|NCT02647320|79086206|FG004|Overall Study|Develop anemia|0|||
44250949|NCT02647320|79086202|FG000|Overall Study|Lack of Efficacy|0|||
44250950|NCT02647320|79086203|FG001|Overall Study|Lack of Efficacy|0|||
44250951|NCT02647320|79086204|FG002|Overall Study|Lack of Efficacy|0|||
44250952|NCT02647320|79086205|FG003|Overall Study|Lack of Efficacy|1|||
44250953|NCT02647320|79086206|FG004|Overall Study|Lack of Efficacy|0|||
44250954|NCT02647320|79086202|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
44250955|NCT02647320|79086203|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
44250956|NCT02647320|79086204|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
44250957|NCT02647320|79086205|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
44250958|NCT02647320|79086206|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
44250959|NCT03458325|79086229|FG000|Overall Study|Withdrawal by Subject|1|||
44250960|NCT02644122|79086264|FG000|Overall Study|Withdrawal by Subject|1|||
44250961|NCT01394939|79086290|FG000|Overall Study|Adverse Event|1|||
44250962|NCT01394939|79086291|FG001|Overall Study|Adverse Event|3|||
44250963|NCT01394939|79086292|FG002|Overall Study|Adverse Event|0|||
44250964|NCT01394939|79086293|FG003|Overall Study|Adverse Event|2|||
44250965|NCT01394939|79086290|FG000|Overall Study|Death|0|||
44250966|NCT01394939|79086291|FG001|Overall Study|Death|2|||
44250967|NCT01394939|79086292|FG002|Overall Study|Death|0|||
44250968|NCT01394939|79086293|FG003|Overall Study|Death|0|||
44250969|NCT01394939|79086290|FG000|Overall Study|Physician Decision|0|||
44250970|NCT01394939|79086291|FG001|Overall Study|Physician Decision|1|||
44250971|NCT01394939|79086292|FG002|Overall Study|Physician Decision|0|||
44250972|NCT01394939|79086293|FG003|Overall Study|Physician Decision|0|||
44250973|NCT01394939|79086290|FG000|Overall Study|Withdrawal by Subject|0|||
44250974|NCT01394939|79086291|FG001|Overall Study|Withdrawal by Subject|2|||
44250975|NCT01394939|79086292|FG002|Overall Study|Withdrawal by Subject|0|||
44250976|NCT01394939|79086293|FG003|Overall Study|Withdrawal by Subject|2|||
44384223|NCT01072175|79390088|FG012|Part D (HPMC Capsules)|Death|26|||
44384224|NCT01072175|79390076|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
44384225|NCT01072175|79390077|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
44384226|NCT01072175|79390078|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
44384227|NCT01072175|79390079|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
44384228|NCT01072175|79390080|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
44384229|NCT01072175|79390081|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
44384230|NCT01072175|79390082|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
44384231|NCT01072175|79390083|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
44384232|NCT01072175|79390084|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
44384233|NCT01072175|79390085|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
44384234|NCT01072175|79390086|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
44384235|NCT01072175|79390087|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
44384236|NCT01072175|79390088|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
44384237|NCT01072175|79390076|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384238|NCT01072175|79390077|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384239|NCT01072175|79390078|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384240|NCT01072175|79390079|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384241|NCT01072175|79390080|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384242|NCT01072175|79390081|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384243|NCT01072175|79390082|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384244|NCT01072175|79390083|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384245|NCT01072175|79390084|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384246|NCT01072175|79390085|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
44384247|NCT01072175|79390086|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
44384248|NCT01072175|79390087|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
44384249|NCT01072175|79390088|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
44384250|NCT01072175|79390076|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384251|NCT01072175|79390077|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384252|NCT01072175|79390078|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384253|NCT01072175|79390079|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384254|NCT01072175|79390080|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384255|NCT01072175|79390081|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384256|NCT01072175|79390082|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384257|NCT01072175|79390083|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384258|NCT01072175|79390084|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
44384259|NCT01072175|79390085|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
44384260|NCT01072175|79390086|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
44250977|NCT01394939|79086290|FG000|Overall Study|Others|0|||
44384261|NCT01072175|79390087|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
44384262|NCT01072175|79390088|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
44384263|NCT01072175|79390076|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44384264|NCT01072175|79390077|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44518194|NCT01670656|79525428|FG001|Overall Study|Lost to Follow-up|0|||
44518195|NCT01670656|79525429|FG002|Overall Study|Lost to Follow-up|0|||
44518196|NCT01670656|79525430|FG003|Overall Study|Lost to Follow-up|0|||
44518197|NCT01670656|79525431|FG004|Overall Study|Lost to Follow-up|3|||
44518198|NCT01670656|79525427|FG000|Overall Study|Subject moved|0|||
44518199|NCT01670656|79525428|FG001|Overall Study|Subject moved|0|||
44518200|NCT01670656|79525429|FG002|Overall Study|Subject moved|0|||
44250978|NCT01394939|79086291|FG001|Overall Study|Others|2|||
44250979|NCT01394939|79086292|FG002|Overall Study|Others|0|||
44250980|NCT01394939|79086293|FG003|Overall Study|Others|3|||
44384265|NCT01072175|79390078|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44384266|NCT01072175|79390079|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44518201|NCT01670656|79525430|FG003|Overall Study|Subject moved|1|||
44518202|NCT01670656|79525431|FG004|Overall Study|Subject moved|0|||
44518203|NCT00068445|79525445|FG000|Randomization|Cancel|1|||
44384267|NCT01072175|79390080|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44518204|NCT00068445|79525446|FG001|Randomization|Cancel|3|||
44384268|NCT01072175|79390081|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44384269|NCT01072175|79390082|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44518205|NCT00068445|79525445|FG000|Randomization|Ineligible|1|||
44250981|NCT01394627|79086311|FG000|First Intervention (1 Day)|poor intravenous access|0|||
44518206|NCT00068445|79525446|FG001|Randomization|Ineligible|1|||
44518207|NCT00068445|79525445|FG000|Treatment|Refused Further Treatment|13|||
44250982|NCT01394627|79086312|FG001|First Intervention (1 Day)|poor intravenous access|1|||
44518208|NCT00068445|79525446|FG001|Treatment|Refused Further Treatment|10|||
44518209|NCT00068445|79525445|FG000|Treatment|Adverse Event|7|||
44145849|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145850|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145851|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145852|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145853|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
44145854|NCT01597245|78935170|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145855|NCT01597245|78935171|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145856|NCT01597245|78935172|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145857|NCT01597245|78935173|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145858|NCT01597245|78935174|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145859|NCT01597245|78935175|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145860|NCT01597245|78935176|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145861|NCT01597245|78935177|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145862|NCT01597245|78935178|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145863|NCT01597245|78935179|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145864|NCT01597245|78935180|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145865|NCT01597245|78935181|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145866|NCT01597245|78935182|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145867|NCT01597245|78935183|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
44145868|NCT01597245|78935184|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145869|NCT01597245|78935185|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44250983|NCT01394627|79086311|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
44250984|NCT01394627|79086312|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
44250985|NCT01391663|79086331|FG000|Overall Study|Withdrawal by Subject|0|||
44518210|NCT00068445|79525446|FG001|Treatment|Adverse Event|1|||
44518211|NCT00068445|79525445|FG000|Treatment|Other (Specifics not available)|9|||
44518212|NCT00068445|79525446|FG001|Treatment|Other (Specifics not available)|5|||
44518213|NCT03653208|79525461|FG000|Overall Study|Withdrawal by Subject|0|||
44518214|NCT03653208|79525462|FG001|Overall Study|Withdrawal by Subject|0|||
44518215|NCT03653208|79525463|FG002|Overall Study|Withdrawal by Subject|0|||
44518216|NCT03653208|79525464|FG003|Overall Study|Withdrawal by Subject|0|||
44518217|NCT03653208|79525465|FG004|Overall Study|Withdrawal by Subject|1|||
44518218|NCT03653208|79525466|FG005|Overall Study|Withdrawal by Subject|0|||
44518219|NCT03653208|79525467|FG006|Overall Study|Withdrawal by Subject|0|||
44518220|NCT03653208|79525468|FG007|Overall Study|Withdrawal by Subject|1|||
44518221|NCT03653208|79525469|FG008|Overall Study|Withdrawal by Subject|1|||
44518222|NCT03545984|79525491|FG000|Overall Study|CSF cases not present during rotation|11|||
44518223|NCT03545984|79525492|FG001|Overall Study|CSF cases not present during rotation|9|||
44518224|NCT03033784|79525500|FG000|Overall Study|Anxiety related to MRI scanner|0|||
44518225|NCT03033784|79525501|FG001|Overall Study|Anxiety related to MRI scanner|1|||
44518226|NCT03033784|79525502|FG002|Overall Study|Anxiety related to MRI scanner|0|||
44518227|NCT03033784|79525503|FG003|Overall Study|Anxiety related to MRI scanner|0|||
44518228|NCT03033784|79525504|FG004|Overall Study|Anxiety related to MRI scanner|0|||
44518229|NCT03033784|79525505|FG005|Overall Study|Anxiety related to MRI scanner|0|||
44518230|NCT03033784|79525506|FG006|Overall Study|Anxiety related to MRI scanner|0|||
44518231|NCT03033784|79525507|FG007|Overall Study|Anxiety related to MRI scanner|0|||
44145870|NCT01597245|78935186|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145871|NCT01597245|78935187|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44518232|NCT03033784|79525508|FG008|Overall Study|Anxiety related to MRI scanner|0|||
44518233|NCT03033784|79525509|FG009|Overall Study|Anxiety related to MRI scanner|0|||
44518234|NCT03033784|79525510|FG010|Overall Study|Anxiety related to MRI scanner|0|||
44518235|NCT03033784|79525511|FG011|Overall Study|Anxiety related to MRI scanner|0|||
44518236|NCT03033784|79525512|FG012|Overall Study|Anxiety related to MRI scanner|0|||
44279249|NCT02036502|79240343|FG003|Part 3:Dose Expansion|Not Treated|0|||
44279250|NCT02036502|79240344|FG004|Part 3:Dose Expansion|Not Treated|0|||
44279251|NCT02036502|79240345|FG005|Part 3:Dose Expansion|Not Treated|2|||
44279252|NCT02036502|79240346|FG006|Part 3:Dose Expansion|Not Treated|0|||
44384270|NCT01072175|79390083|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44384271|NCT01072175|79390084|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44384272|NCT01072175|79390085|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44384273|NCT01072175|79390086|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
44384274|NCT01072175|79390087|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
44384275|NCT01072175|79390088|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
44145872|NCT01597245|78935188|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145873|NCT01597245|78935189|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44145874|NCT01597245|78935190|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
44384276|NCT01071317|79390122|FG000|Overall Study|Lost to Follow-up|2|||
44384277|NCT01071317|79390123|FG001|Overall Study|Lost to Follow-up|2|||
44384278|NCT00783094|79390140|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
44384279|NCT00783094|79390141|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
44384280|NCT00783094|79390142|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
44384281|NCT00783094|79390140|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
44384282|NCT00783094|79390141|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
44384283|NCT00783094|79390142|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
44384284|NCT00783094|79390140|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
44384285|NCT00783094|79390141|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
44384286|NCT00783094|79390142|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
44384287|NCT00783094|79390140|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
44384288|NCT00783094|79390141|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
44384289|NCT00783094|79390142|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
44384290|NCT00783094|79390140|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
44384291|NCT00783094|79390141|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
44384292|NCT00783094|79390142|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
44384293|NCT00783094|79390140|FG000|Open-Label Extension Period|Adverse Event|12|||
44384294|NCT00783094|79390141|FG001|Open-Label Extension Period|Adverse Event|7|||
44384295|NCT00783094|79390142|FG002|Open-Label Extension Period|Adverse Event|16|||
44384296|NCT00783094|79390140|FG000|Open-Label Extension Period|Death|0|||
44384297|NCT00783094|79390141|FG001|Open-Label Extension Period|Death|0|||
44384298|NCT00783094|79390142|FG002|Open-Label Extension Period|Death|1|||
44384299|NCT00783094|79390140|FG000|Open-Label Extension Period|Protocol Violation|4|||
44384300|NCT00783094|79390141|FG001|Open-Label Extension Period|Protocol Violation|5|||
44384301|NCT00783094|79390142|FG002|Open-Label Extension Period|Protocol Violation|7|||
44384302|NCT00783094|79390140|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
44384303|NCT00783094|79390141|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
44384304|NCT00783094|79390142|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
44145875|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145876|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145877|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145878|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145879|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145880|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145881|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145882|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44384305|NCT00783094|79390140|FG000|Open-Label Extension Period|Physician Decision|4|||
44518237|NCT03033784|79525500|FG000|Overall Study|Withdrawal by Subject|0|||
44145883|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44250986|NCT01391663|79086332|FG001|Overall Study|Withdrawal by Subject|0|||
44250987|NCT01391663|79086333|FG002|Overall Study|Withdrawal by Subject|1|||
44250988|NCT01391663|79086334|FG003|Overall Study|Withdrawal by Subject|0|||
44250989|NCT02641392|79086355|FG000|Overall Study|Lost to Follow-up|0|||
44250990|NCT02641392|79086356|FG001|Overall Study|Lost to Follow-up|0|||
44250991|NCT02641392|79086357|FG002|Overall Study|Lost to Follow-up|2|||
44250992|NCT02641392|79086355|FG000|Overall Study|Withdrawal by Subject|0|||
44250993|NCT02641392|79086356|FG001|Overall Study|Withdrawal by Subject|0|||
44250994|NCT02641392|79086357|FG002|Overall Study|Withdrawal by Subject|17|||
44250995|NCT02641392|79086355|FG000|Overall Study|Adverse Event|0|||
44250996|NCT02641392|79086356|FG001|Overall Study|Adverse Event|1|||
44250997|NCT02641392|79086357|FG002|Overall Study|Adverse Event|25|||
44250998|NCT02641392|79086355|FG000|Overall Study|Study Terminated by Sponsor|4|||
44250999|NCT02641392|79086356|FG001|Overall Study|Study Terminated by Sponsor|12|||
44251000|NCT02641392|79086357|FG002|Overall Study|Study Terminated by Sponsor|144|||
44251001|NCT02641392|79086355|FG000|Overall Study|Lack of Efficacy|0|||
44384306|NCT00783094|79390141|FG001|Open-Label Extension Period|Physician Decision|2|||
44384307|NCT00783094|79390142|FG002|Open-Label Extension Period|Physician Decision|3|||
44384308|NCT00783094|79390140|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
44384309|NCT00783094|79390141|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
44384310|NCT00783094|79390142|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
44384311|NCT00790582|79390155|FG000|Overall Study|Death|14|||
44384312|NCT00790582|79390156|FG001|Overall Study|Death|32|||
44384313|NCT00790582|79390155|FG000|Overall Study|Physician Decision|7|||
44384314|NCT00790582|79390156|FG001|Overall Study|Physician Decision|1|||
44384315|NCT00790582|79390155|FG000|Overall Study|Lost to Follow-up|3|||
44384316|NCT00790582|79390156|FG001|Overall Study|Lost to Follow-up|3|||
44384317|NCT00790582|79390155|FG000|Overall Study|Withdrawal by Subject|7|||
44384318|NCT00790582|79390156|FG001|Overall Study|Withdrawal by Subject|51|||
44384319|NCT01048541|79390164|FG000|Overall Study|Withdrawal by Subject|1|||
44384320|NCT01048541|79390165|FG001|Overall Study|Withdrawal by Subject|0|||
44384321|NCT00774046|79390171|FG000|Screening|Not eligible|56|||
44384322|NCT00774046|79390171|FG000|Enrollment|Desired other therapy/refused|28|||
44384323|NCT00774046|79390171|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
44384324|NCT01046903|79390175|FG000|Overall Study|Lost to Follow-up|16|||
44384325|NCT01046903|79390175|FG000|Overall Study|Adverse Event|4|||
44384326|NCT01046903|79390175|FG000|Overall Study|Withdrawal by Subject|3|||
44384327|NCT01046903|79390175|FG000|Overall Study|Other|5|||
44384328|NCT00773968|79390179|FG000|Overall Study|Adverse Event|2|||
44384329|NCT00773968|79390179|FG000|Overall Study|Death|1|||
44384330|NCT00773968|79390179|FG000|Overall Study|Failure to Return|2|||
44384331|NCT00773968|79390179|FG000|Overall Study|Lack of Efficacy|3|||
44384332|NCT00773968|79390179|FG000|Overall Study|Protocol Violation|1|||
44384333|NCT00773968|79390179|FG000|Overall Study|Withdrawal by Subject|11|||
44384334|NCT00773968|79390179|FG000|Overall Study|Screen Failure|17|||
44384335|NCT00773968|79390179|FG000|Overall Study|Other|8|||
44384336|NCT00782626|79390183|FG000|Overall Study|Adverse Event|1|||
44384337|NCT00782626|79390183|FG000|Overall Study|Progressive Disease|5|||
44384338|NCT00782626|79390183|FG000|Overall Study|Other Complicating Disease|1|||
44384339|NCT01071083|79390192|FG000|Overall Study|Adverse Event|1|||
44384340|NCT01071083|79390193|FG001|Overall Study|Adverse Event|0|||
44384341|NCT01071083|79390194|FG002|Overall Study|Adverse Event|1|||
44384342|NCT01071083|79390195|FG003|Overall Study|Adverse Event|0|||
44384343|NCT01071083|79390196|FG004|Overall Study|Adverse Event|1|||
44384344|NCT01071083|79390192|FG000|Overall Study|Withdrawal by Subject|3|||
44384345|NCT01071083|79390193|FG001|Overall Study|Withdrawal by Subject|0|||
44384346|NCT01071083|79390194|FG002|Overall Study|Withdrawal by Subject|2|||
44384347|NCT01071083|79390195|FG003|Overall Study|Withdrawal by Subject|0|||
44384348|NCT01071083|79390196|FG004|Overall Study|Withdrawal by Subject|3|||
44384349|NCT01071083|79390192|FG000|Overall Study|Physician Decision|1|||
44384350|NCT01071083|79390193|FG001|Overall Study|Physician Decision|0|||
44384351|NCT01071083|79390194|FG002|Overall Study|Physician Decision|0|||
44384352|NCT01071083|79390195|FG003|Overall Study|Physician Decision|1|||
44384353|NCT01071083|79390196|FG004|Overall Study|Physician Decision|1|||
44384354|NCT01071083|79390192|FG000|Overall Study|Early Rescue|1|||
44384355|NCT01071083|79390193|FG001|Overall Study|Early Rescue|0|||
44384356|NCT01071083|79390194|FG002|Overall Study|Early Rescue|0|||
44384357|NCT01071083|79390195|FG003|Overall Study|Early Rescue|0|||
44384358|NCT01071083|79390196|FG004|Overall Study|Early Rescue|1|||
44384359|NCT01071083|79390192|FG000|Overall Study|Subject Moved|0|||
44384360|NCT01071083|79390193|FG001|Overall Study|Subject Moved|1|||
44384361|NCT01071083|79390194|FG002|Overall Study|Subject Moved|0|||
44518238|NCT03033784|79525501|FG001|Overall Study|Withdrawal by Subject|0|||
44518239|NCT03033784|79525502|FG002|Overall Study|Withdrawal by Subject|0|||
44518240|NCT03033784|79525503|FG003|Overall Study|Withdrawal by Subject|0|||
44518241|NCT03033784|79525504|FG004|Overall Study|Withdrawal by Subject|0|||
44518242|NCT03033784|79525505|FG005|Overall Study|Withdrawal by Subject|0|||
44518243|NCT03033784|79525506|FG006|Overall Study|Withdrawal by Subject|0|||
44145884|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145885|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44384362|NCT01071083|79390195|FG003|Overall Study|Subject Moved|0|||
44384363|NCT01071083|79390196|FG004|Overall Study|Subject Moved|0|||
44384364|NCT01071083|79390192|FG000|Overall Study|Images Not Usable (Motion)|0|||
44384365|NCT01071083|79390193|FG001|Overall Study|Images Not Usable (Motion)|1|||
44384366|NCT01071083|79390194|FG002|Overall Study|Images Not Usable (Motion)|0|||
44384367|NCT01071083|79390195|FG003|Overall Study|Images Not Usable (Motion)|0|||
44384368|NCT01071083|79390196|FG004|Overall Study|Images Not Usable (Motion)|0|||
44384369|NCT01071083|79390192|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
44384370|NCT01071083|79390193|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
44384371|NCT01071083|79390194|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
44384372|NCT01071083|79390195|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
44384373|NCT01071083|79390196|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
44518244|NCT03033784|79525507|FG007|Overall Study|Withdrawal by Subject|0|||
44384374|NCT01071083|79390192|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
44279253|NCT02036502|79240347|FG007|Part 3:Dose Expansion|Not Treated|0|||
44279254|NCT02056626|79240371|FG000|Overall Study|patient did not follow directions|3|||
44279255|NCT02056626|79240372|FG001|Overall Study|patient did not follow directions|1|||
44279256|NCT02056626|79240373|FG002|Overall Study|patient did not follow directions|0|||
44279257|NCT02056626|79240374|FG003|Overall Study|patient did not follow directions|0|||
44279258|NCT02035332|79240384|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
44279259|NCT02056392|79240394|FG000|Overall Study|Lost to Follow-up|0|||
44279260|NCT02056392|79240395|FG001|Overall Study|Lost to Follow-up|1|||
44279261|NCT02056392|79240396|FG002|Overall Study|Lost to Follow-up|2|||
44279262|NCT02056392|79240397|FG003|Overall Study|Lost to Follow-up|0|||
44279263|NCT02056392|79240398|FG004|Overall Study|Lost to Follow-up|0|||
44279264|NCT02056392|79240399|FG005|Overall Study|Lost to Follow-up|0|||
44279265|NCT02056392|79240394|FG000|Overall Study|Protocol Violation|1|||
44279266|NCT02056392|79240395|FG001|Overall Study|Protocol Violation|0|||
44279267|NCT02056392|79240396|FG002|Overall Study|Protocol Violation|1|||
44279268|NCT02056392|79240397|FG003|Overall Study|Protocol Violation|0|||
44279269|NCT02056392|79240398|FG004|Overall Study|Protocol Violation|0|||
44279270|NCT02056392|79240399|FG005|Overall Study|Protocol Violation|0|||
44279271|NCT02056392|79240394|FG000|Overall Study|Withdrawal by Subject|1|||
44279272|NCT02056392|79240395|FG001|Overall Study|Withdrawal by Subject|0|||
44279273|NCT02056392|79240396|FG002|Overall Study|Withdrawal by Subject|0|||
44279274|NCT02056392|79240397|FG003|Overall Study|Withdrawal by Subject|0|||
44279275|NCT02056392|79240398|FG004|Overall Study|Withdrawal by Subject|1|||
44279276|NCT02056392|79240399|FG005|Overall Study|Withdrawal by Subject|0|||
44279277|NCT02034708|79240409|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
44279278|NCT02034708|79240410|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
44279279|NCT02034708|79240409|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
44279280|NCT02034708|79240410|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
44279281|NCT02034708|79240409|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
44279282|NCT02034708|79240410|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
44279283|NCT02034708|79240409|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
44279284|NCT02034708|79240410|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
44279285|NCT02034552|79240424|FG000|Overall Study|Never treated|3|||
44279286|NCT02034552|79240425|FG001|Overall Study|Never treated|2|||
44279287|NCT02034552|79240426|FG002|Overall Study|Never treated|0|||
44279288|NCT02034552|79240424|FG000|Overall Study|Radiological progression|3|||
44279289|NCT02034552|79240425|FG001|Overall Study|Radiological progression|5|||
44279290|NCT02034552|79240426|FG002|Overall Study|Radiological progression|4|||
44279291|NCT02034552|79240424|FG000|Overall Study|AE not assoc. with disease progression|1|||
44279292|NCT02034552|79240425|FG001|Overall Study|AE not assoc. with disease progression|4|||
44279293|NCT02034552|79240426|FG002|Overall Study|AE not assoc. with disease progression|2|||
44279294|NCT02034552|79240424|FG000|Overall Study|AE associated with disease progression|0|||
44279295|NCT02034552|79240425|FG001|Overall Study|AE associated with disease progression|1|||
44279296|NCT02034552|79240426|FG002|Overall Study|AE associated with disease progression|0|||
44279297|NCT02034552|79240424|FG000|Overall Study|Withdrawal by Subject|2|||
44279298|NCT02034552|79240425|FG001|Overall Study|Withdrawal by Subject|1|||
44279299|NCT02034552|79240426|FG002|Overall Study|Withdrawal by Subject|1|||
44279300|NCT02034552|79240424|FG000|Overall Study|Non-compliance with study drug|0|||
44279301|NCT02034552|79240425|FG001|Overall Study|Non-compliance with study drug|0|||
44279302|NCT02034552|79240426|FG002|Overall Study|Non-compliance with study drug|1|||
44279303|NCT02034552|79240424|FG000|Overall Study|Clinical progression|5|||
44279304|NCT02034552|79240425|FG001|Overall Study|Clinical progression|7|||
44279305|NCT02034552|79240426|FG002|Overall Study|Clinical progression|9|||
44279306|NCT02034474|79240436|FG000|Overall Study|Adverse Event|3|||
44279307|NCT02034474|79240437|FG001|Overall Study|Adverse Event|2|||
44279308|NCT02034474|79240436|FG000|Overall Study|Withdrawal by Subject|1|||
44279309|NCT02034474|79240437|FG001|Overall Study|Withdrawal by Subject|2|||
44279310|NCT02011542|79240445|FG000|Overall Study|Physician Decision|1|||
44279311|NCT02011386|79240449|FG000|Overall Study|Non-compliance|2|||
44279312|NCT02011386|79240449|FG000|Overall Study|Lack of Efficacy|3|||
44279313|NCT02010684|79240455|FG000|Overall Study|Lost to Follow-up|8|||
44279314|NCT02010684|79240456|FG001|Overall Study|Lost to Follow-up|18|||
44279315|NCT02010684|79240455|FG000|Overall Study|Withdrawal by Subject|4|||
44279316|NCT02010684|79240456|FG001|Overall Study|Withdrawal by Subject|5|||
44279317|NCT02034162|79240464|FG000|Double-blind|Lost to Follow-up|3|||
44279318|NCT02034162|79240465|FG001|Double-blind|Lost to Follow-up|0|||
44279319|NCT02034162|79240466|FG002|Double-blind|Lost to Follow-up|0|||
44279320|NCT02034162|79240464|FG000|Double-blind|Physician Decision|1|||
44279321|NCT02034162|79240465|FG001|Double-blind|Physician Decision|0|||
44279322|NCT02034162|79240466|FG002|Double-blind|Physician Decision|0|||
44279323|NCT02034162|79240464|FG000|Double-blind|Protocol Violation|0|||
44279324|NCT02034162|79240465|FG001|Double-blind|Protocol Violation|1|||
44279325|NCT02034162|79240466|FG002|Double-blind|Protocol Violation|0|||
44279326|NCT02034162|79240464|FG000|Double-blind|Withdrawal by Subject|5|||
44279327|NCT02034162|79240465|FG001|Double-blind|Withdrawal by Subject|7|||
44384375|NCT01071083|79390193|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
44384376|NCT01071083|79390194|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
44384377|NCT01071083|79390195|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
44384378|NCT01071083|79390196|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
44384379|NCT01071083|79390192|FG000|Overall Study|Subject Refused to Continue|1|||
44384380|NCT01071083|79390193|FG001|Overall Study|Subject Refused to Continue|0|||
44384381|NCT01071083|79390194|FG002|Overall Study|Subject Refused to Continue|0|||
44384382|NCT01071083|79390195|FG003|Overall Study|Subject Refused to Continue|0|||
44384383|NCT01071083|79390196|FG004|Overall Study|Subject Refused to Continue|0|||
44384384|NCT01070771|79390208|FG000|Overall Study|Adverse Event|2|||
44384385|NCT01070771|79390208|FG000|Overall Study|Protocol Violation|1|||
44384386|NCT01070381|79390213|FG000|Period 2, 1 Week of Wear|Handling|0|||
44384387|NCT01070381|79390214|FG001|Period 2, 1 Week of Wear|Handling|1|||
44384388|NCT01070381|79390213|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
44384389|NCT01070381|79390214|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
44384390|NCT01010126|79390235|FG000|Overall Study|Withdrawal by Subject|1|||
44384391|NCT01010126|79390236|FG001|Overall Study|Withdrawal by Subject|0|||
44384392|NCT01010126|79390237|FG002|Overall Study|Withdrawal by Subject|1|||
44384393|NCT01010126|79390238|FG003|Overall Study|Withdrawal by Subject|0|||
44384394|NCT01010126|79390239|FG004|Overall Study|Withdrawal by Subject|3|||
44384395|NCT01010126|79390240|FG005|Overall Study|Withdrawal by Subject|0|||
44384396|NCT01043705|79390257|FG000|Overall Study|Death|28|||
44384397|NCT01043705|79390258|FG001|Overall Study|Death|60|||
44384398|NCT01043705|79390259|FG002|Overall Study|Death|26|||
44518245|NCT03033784|79525508|FG008|Overall Study|Withdrawal by Subject|0|||
44518246|NCT03033784|79525509|FG009|Overall Study|Withdrawal by Subject|0|||
44518247|NCT03033784|79525510|FG010|Overall Study|Withdrawal by Subject|0|||
44145886|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145887|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145888|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145889|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145890|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
44145891|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
44145892|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
44145893|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
44145894|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
44145895|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
44145896|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145897|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145898|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145899|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145900|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145901|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145902|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145903|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44251002|NCT02641392|79086356|FG001|Overall Study|Lack of Efficacy|0|||
44251003|NCT02641392|79086357|FG002|Overall Study|Lack of Efficacy|101|||
44251004|NCT02641392|79086355|FG000|Overall Study|Miscellaneous|0|||
44251005|NCT02641392|79086356|FG001|Overall Study|Miscellaneous|0|||
44251006|NCT02641392|79086357|FG002|Overall Study|Miscellaneous|3|||
44251007|NCT02641392|79086355|FG000|Overall Study|Death|0|||
44251008|NCT02641392|79086356|FG001|Overall Study|Death|0|||
44251009|NCT02641392|79086357|FG002|Overall Study|Death|1|||
44251010|NCT04440007|79086367|FG000|Overall Study|Adverse Event|0|||
44251011|NCT04440007|79086368|FG001|Overall Study|Adverse Event|1|||
44251012|NCT04440007|79086367|FG000|Overall Study|Lost to Follow-up|1|||
44251013|NCT04440007|79086368|FG001|Overall Study|Lost to Follow-up|3|||
44251014|NCT04440007|79086367|FG000|Overall Study|Death|7|||
44251015|NCT04440007|79086368|FG001|Overall Study|Death|2|||
44251016|NCT04440007|79086367|FG000|Overall Study|Physician Decision|1|||
44251017|NCT04440007|79086368|FG001|Overall Study|Physician Decision|1|||
44279328|NCT02034162|79240466|FG002|Double-blind|Withdrawal by Subject|0|||
44279329|NCT02034006|79240479|FG000|Overall Study|Withdrawal by Subject|7|||
44279330|NCT02034006|79240479|FG000|Overall Study|Lost to Follow-up|5|||
44279331|NCT02034006|79240479|FG000|Overall Study|Death|1|||
44279332|NCT02034006|79240479|FG000|Overall Study|Pregnancy|1|||
44279333|NCT02054910|79240488|FG000|Overall Study|Lost to Follow-up|4|||
44279334|NCT02054910|79240489|FG001|Overall Study|Lost to Follow-up|1|||
44279335|NCT02033850|79240499|FG000|Overall Study|Death|1|||
44279336|NCT02033850|79240500|FG001|Overall Study|Death|0|||
44384399|NCT01043705|79390257|FG000|Overall Study|Lost to Follow-up|27|||
44384400|NCT01043705|79390258|FG001|Overall Study|Lost to Follow-up|12|||
44384401|NCT01043705|79390259|FG002|Overall Study|Lost to Follow-up|0|||
44384402|NCT01043705|79390257|FG000|Overall Study|Multiple Reasons|4|||
44384403|NCT01043705|79390258|FG001|Overall Study|Multiple Reasons|7|||
44279337|NCT02033850|79240499|FG000|Overall Study|unrelated medical reason|1|||
44279338|NCT02033850|79240500|FG001|Overall Study|unrelated medical reason|1|||
44384404|NCT01043705|79390259|FG002|Overall Study|Multiple Reasons|0|||
44384405|NCT01043705|79390257|FG000|Overall Study|Protocol Violation|2|||
44384406|NCT01043705|79390258|FG001|Overall Study|Protocol Violation|1|||
44384407|NCT01043705|79390259|FG002|Overall Study|Protocol Violation|0|||
44384408|NCT01043705|79390257|FG000|Overall Study|Withdrawal by Subject|8|||
44384409|NCT01043705|79390258|FG001|Overall Study|Withdrawal by Subject|6|||
44384410|NCT01043705|79390259|FG002|Overall Study|Withdrawal by Subject|0|||
44384411|NCT01043705|79390257|FG000|Overall Study|Site Closure|8|||
44384412|NCT01043705|79390258|FG001|Overall Study|Site Closure|0|||
44384413|NCT01043705|79390259|FG002|Overall Study|Site Closure|0|||
44384414|NCT01043705|79390257|FG000|Overall Study|Subsequent Procedure|9|||
44384415|NCT01043705|79390258|FG001|Overall Study|Subsequent Procedure|24|||
44384416|NCT01043705|79390259|FG002|Overall Study|Subsequent Procedure|29|||
44384417|NCT01043705|79390257|FG000|Overall Study|Adverse Event|0|||
44384418|NCT01043705|79390258|FG001|Overall Study|Adverse Event|2|||
44384419|NCT01043705|79390259|FG002|Overall Study|Adverse Event|0|||
44384420|NCT01043705|79390257|FG000|Overall Study|Screen Fail|21|||
44384421|NCT01043705|79390258|FG001|Overall Study|Screen Fail|0|||
44384422|NCT01043705|79390259|FG002|Overall Study|Screen Fail|0|||
44384423|NCT01043705|79390257|FG000|Overall Study|Other|0|||
44384424|NCT01043705|79390258|FG001|Overall Study|Other|19|||
44384425|NCT01043705|79390259|FG002|Overall Study|Other|25|||
44145904|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145905|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145906|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145907|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145908|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44279339|NCT02054130|79240510|FG000|Overall Study|Withdrawal by Subject|4|||
44279340|NCT02054130|79240511|FG001|Overall Study|Withdrawal by Subject|4|||
44279341|NCT02054130|79240512|FG002|Overall Study|Withdrawal by Subject|7|||
44279342|NCT02054130|79240513|FG003|Overall Study|Withdrawal by Subject|10|||
44279343|NCT02054130|79240510|FG000|Overall Study|Death|0|||
44279344|NCT02054130|79240511|FG001|Overall Study|Death|1|||
44279345|NCT02054130|79240512|FG002|Overall Study|Death|0|||
44145909|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145910|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44251018|NCT04440007|79086367|FG000|Overall Study|Withdrawal by Subject|2|||
44251019|NCT04440007|79086368|FG001|Overall Study|Withdrawal by Subject|1|||
44251020|NCT04440007|79086367|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
44251021|NCT04440007|79086368|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
44251022|NCT04440007|79086367|FG000|Overall Study|Discontinued prior to dosing|0|||
44251023|NCT04440007|79086368|FG001|Overall Study|Discontinued prior to dosing|2|||
44251024|NCT01391507|79086378|FG000|Overall Study|Death|0|||
44251025|NCT01391507|79086379|FG001|Overall Study|Death|0|||
44251026|NCT01391507|79086380|FG002|Overall Study|Death|0|||
44251027|NCT01391507|79086381|FG003|Overall Study|Death|1|||
44251028|NCT01391507|79086378|FG000|Overall Study|Adverse Event|1|||
44251029|NCT01391507|79086379|FG001|Overall Study|Adverse Event|1|||
44251030|NCT01391507|79086380|FG002|Overall Study|Adverse Event|2|||
44251031|NCT01391507|79086381|FG003|Overall Study|Adverse Event|2|||
44251032|NCT01391507|79086378|FG000|Overall Study|Withdrawal by Subject|1|||
44251033|NCT01391507|79086379|FG001|Overall Study|Withdrawal by Subject|2|||
44251034|NCT01391507|79086380|FG002|Overall Study|Withdrawal by Subject|1|||
44145911|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44145912|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
44251035|NCT01391507|79086381|FG003|Overall Study|Withdrawal by Subject|1|||
44251036|NCT01391507|79086378|FG000|Overall Study|Lack of Efficacy|0|||
44384426|NCT01070303|79390278|FG000|Overall Study|Adverse Event|39|||
44384427|NCT01070303|79390278|FG000|Overall Study|Withdrawal by Subject|20|||
44518248|NCT03033784|79525511|FG011|Overall Study|Withdrawal by Subject|0|||
44518249|NCT03033784|79525512|FG012|Overall Study|Withdrawal by Subject|2|||
44145913|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
44145914|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
44145915|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
44251037|NCT01391507|79086379|FG001|Overall Study|Lack of Efficacy|0|||
44251038|NCT01391507|79086380|FG002|Overall Study|Lack of Efficacy|0|||
44279346|NCT02054130|79240513|FG003|Overall Study|Death|0|||
44279347|NCT02054130|79240510|FG000|Overall Study|Lost to Follow-up|0|||
44279348|NCT02054130|79240511|FG001|Overall Study|Lost to Follow-up|0|||
44384428|NCT01070303|79390278|FG000|Overall Study|Lost to Follow-up|9|||
44384429|NCT01070303|79390278|FG000|Overall Study|Protocol Violation|0|||
44384430|NCT01070303|79390278|FG000|Overall Study|Lack of Efficacy|2|||
44384431|NCT01070303|79390278|FG000|Overall Study|Administrative Reason|1|||
44251039|NCT01391507|79086381|FG003|Overall Study|Lack of Efficacy|1|||
44251040|NCT01391507|79086378|FG000|Overall Study|Protocol Violation|2|||
44251041|NCT01391507|79086379|FG001|Overall Study|Protocol Violation|1|||
44251042|NCT01391507|79086380|FG002|Overall Study|Protocol Violation|1|||
44251043|NCT01391507|79086381|FG003|Overall Study|Protocol Violation|2|||
44251044|NCT01473524|79086403|FG000|DB Phase|Adverse Event|4|||
44251045|NCT01473524|79086404|FG001|DB Phase|Adverse Event|8|||
44251046|NCT01473524|79086405|FG002|DB Phase|Adverse Event|2|||
44251047|NCT01473524|79086406|FG003|DB Phase|Adverse Event|0|||
44279349|NCT02054130|79240512|FG002|Overall Study|Lost to Follow-up|1|||
44279350|NCT02054130|79240513|FG003|Overall Study|Lost to Follow-up|2|||
44384432|NCT01070303|79390278|FG000|Overall Study|Other|18|||
44384433|NCT01009814|79390293|FG000|Overall Study|No longer met study criteria|1|||
44384434|NCT01009814|79390294|FG001|Overall Study|No longer met study criteria|1|||
44384435|NCT01009814|79390295|FG002|Overall Study|No longer met study criteria|0|||
44384436|NCT01009814|79390296|FG003|Overall Study|No longer met study criteria|0|||
44384437|NCT01009814|79390297|FG004|Overall Study|No longer met study criteria|0|||
44384438|NCT03824587|79390315|FG000|Run-in Period|Screen Failure|0|||
44384439|NCT03824587|79390316|FG001|Run-in Period|Screen Failure|275|||
44384440|NCT03824587|79390315|FG000|Treatment Period|Adverse Event|4|||
44384441|NCT03824587|79390316|FG001|Treatment Period|Adverse Event|1|||
44384442|NCT03824587|79390315|FG000|Treatment Period|Withdrawal by Subject|0|||
44384443|NCT03824587|79390316|FG001|Treatment Period|Withdrawal by Subject|1|||
44384444|NCT03824587|79390315|FG000|Treatment Period|Kidney Transplant|1|||
44384445|NCT03824587|79390316|FG001|Treatment Period|Kidney Transplant|1|||
44384446|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
44384447|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
44384448|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
44384449|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
44384450|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
44384451|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
44384452|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
44384453|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
44384454|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
44384455|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
44384456|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
44384457|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
44384458|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
44384459|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
44384460|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
44384461|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
44384462|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
44384463|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
44384464|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
44384465|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
44384466|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
44384467|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
44384468|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
44384469|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
44384470|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
44384471|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
44384472|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
44518250|NCT00038649|79525523|FG000|Overall Study|Adverse Event|9|||
44518251|NCT03544268|79525529|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
44518252|NCT03544268|79525530|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
44518253|NCT03652818|79525541|FG000|Overall Study|Adverse Event|1|||
44518254|NCT03652818|79525542|FG001|Overall Study|Adverse Event|0|||
44251048|NCT01473524|79086407|FG004|DB Phase|Adverse Event|0|||
44251049|NCT01473524|79086408|FG005|DB Phase|Adverse Event|0|||
44251050|NCT01473524|79086403|FG000|DB Phase|Death|1|||
44251051|NCT01473524|79086404|FG001|DB Phase|Death|0|||
44251052|NCT01473524|79086405|FG002|DB Phase|Death|0|||
44251053|NCT01473524|79086406|FG003|DB Phase|Death|0|||
44251054|NCT01473524|79086407|FG004|DB Phase|Death|0|||
44251055|NCT01473524|79086408|FG005|DB Phase|Death|0|||
44251056|NCT01473524|79086403|FG000|DB Phase|Withdrawal by Subject|2|||
44251057|NCT01473524|79086404|FG001|DB Phase|Withdrawal by Subject|1|||
44251058|NCT01473524|79086405|FG002|DB Phase|Withdrawal by Subject|1|||
44251059|NCT01473524|79086406|FG003|DB Phase|Withdrawal by Subject|0|||
44251060|NCT01473524|79086407|FG004|DB Phase|Withdrawal by Subject|0|||
44251061|NCT01473524|79086408|FG005|DB Phase|Withdrawal by Subject|0|||
44251062|NCT01473524|79086403|FG000|LTSE Phase|Withdrawal by Subject|0|||
44279351|NCT02054130|79240510|FG000|Overall Study|Missed dose|4|||
44251063|NCT01473524|79086404|FG001|LTSE Phase|Withdrawal by Subject|0|||
44145916|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
44145917|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145918|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44384473|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
44384474|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
44384475|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
44145919|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145920|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145921|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145922|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44384476|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
44384477|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
44384478|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
44384479|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
44384480|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
44384481|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
44384482|NCT00773734|79390326|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
44384483|NCT00773734|79390327|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
44384484|NCT00773734|79390328|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
44384485|NCT00773734|79390329|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
44384486|NCT00773734|79390330|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
44384487|NCT00773734|79390331|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
44384488|NCT00773734|79390326|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
44384489|NCT00773734|79390327|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
44384490|NCT00773734|79390328|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
44384491|NCT00773734|79390329|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
44384492|NCT00773734|79390330|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
44384493|NCT00773734|79390331|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
44384494|NCT00773734|79390326|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
44384495|NCT00773734|79390327|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
44384496|NCT00773734|79390328|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
44384497|NCT00773734|79390329|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
44384498|NCT00773734|79390330|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
44384499|NCT00773734|79390331|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
44384500|NCT00773734|79390326|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
44384501|NCT00773734|79390327|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
44384502|NCT00773734|79390328|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
44384503|NCT00773734|79390329|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
44518255|NCT03652818|79525543|FG002|Overall Study|Adverse Event|0|||
44518256|NCT03652818|79525544|FG003|Overall Study|Adverse Event|0|||
44518257|NCT03652818|79525545|FG004|Overall Study|Adverse Event|0|||
44518258|NCT03652818|79525541|FG000|Overall Study|Physician Decision|1|||
44518259|NCT03652818|79525542|FG001|Overall Study|Physician Decision|0|||
44518260|NCT03652818|79525543|FG002|Overall Study|Physician Decision|0|||
44518261|NCT03652818|79525544|FG003|Overall Study|Physician Decision|0|||
44145923|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145924|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145925|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145926|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145927|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145928|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145929|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145930|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145931|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145932|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145933|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
44251064|NCT01473524|79086405|FG002|LTSE Phase|Withdrawal by Subject|0|||
44251065|NCT01473524|79086406|FG003|LTSE Phase|Withdrawal by Subject|3|||
44251066|NCT01473524|79086407|FG004|LTSE Phase|Withdrawal by Subject|3|||
44251067|NCT01473524|79086408|FG005|LTSE Phase|Withdrawal by Subject|6|||
44251068|NCT01473524|79086403|FG000|LTSE Phase|Death|0|||
44251069|NCT01473524|79086404|FG001|LTSE Phase|Death|0|||
44251070|NCT01473524|79086405|FG002|LTSE Phase|Death|0|||
44251071|NCT01473524|79086406|FG003|LTSE Phase|Death|0|||
44251072|NCT01473524|79086407|FG004|LTSE Phase|Death|1|||
44251073|NCT01473524|79086408|FG005|LTSE Phase|Death|0|||
44251074|NCT01473524|79086403|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
44251075|NCT01473524|79086404|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
44251076|NCT01473524|79086405|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
44518262|NCT03652818|79525545|FG004|Overall Study|Physician Decision|0|||
44518263|NCT03652818|79525541|FG000|Overall Study|Lost to Follow-up|0|||
44518264|NCT03652818|79525542|FG001|Overall Study|Lost to Follow-up|1|||
44518265|NCT03652818|79525543|FG002|Overall Study|Lost to Follow-up|2|||
44518266|NCT03652818|79525544|FG003|Overall Study|Lost to Follow-up|1|||
44518267|NCT03652818|79525545|FG004|Overall Study|Lost to Follow-up|1|||
44518268|NCT03619902|79525557|FG000|Overall Study|Termination of Study by Investigator|1|||
44518269|NCT03619902|79525557|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
44518270|NCT00620464|79525563|FG000|Overall Study|Adverse Event|15|||
44518271|NCT00620464|79525564|FG001|Overall Study|Adverse Event|17|||
44518272|NCT00620464|79525563|FG000|Overall Study|Lost to Follow-up|1|||
44279352|NCT02054130|79240511|FG001|Overall Study|Missed dose|6|||
44518273|NCT00620464|79525564|FG001|Overall Study|Lost to Follow-up|1|||
44251077|NCT01473524|79086406|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
44251078|NCT01473524|79086407|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
44251079|NCT01473524|79086408|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
44251080|NCT01473524|79086403|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
44251081|NCT01473524|79086404|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
44251082|NCT01473524|79086405|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
44251083|NCT01473524|79086406|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
44251084|NCT01473524|79086407|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
44251085|NCT01473524|79086408|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
44279353|NCT02054130|79240512|FG002|Overall Study|Missed dose|7|||
44279354|NCT02054130|79240513|FG003|Overall Study|Missed dose|10|||
44279355|NCT02009046|79240528|FG000|Overall Study|Lost to Follow-up|256|||
44279356|NCT02009046|79240529|FG001|Overall Study|Lost to Follow-up|206|||
44279357|NCT02052960|79240545|FG000|Overall Study|Adverse Event|19|||
44279358|NCT02052960|79240546|FG001|Overall Study|Adverse Event|17|||
44279359|NCT02052960|79240545|FG000|Overall Study|Protocol Violation|4|||
44279360|NCT02052960|79240546|FG001|Overall Study|Protocol Violation|3|||
44279361|NCT02052960|79240545|FG000|Overall Study|Withdrawal by Subject|6|||
44279362|NCT02052960|79240546|FG001|Overall Study|Withdrawal by Subject|11|||
44279363|NCT02052960|79240545|FG000|Overall Study|Other|25|||
44279364|NCT02052960|79240546|FG001|Overall Study|Other|15|||
44279365|NCT02008890|79240558|FG000|Period 1|Withdrawal by Subject|7|||
44279366|NCT02008890|79240559|FG001|Period 1|Withdrawal by Subject|7|||
44279367|NCT02008890|79240560|FG002|Period 1|Withdrawal by Subject|5|||
44279368|NCT02008890|79240561|FG003|Period 1|Withdrawal by Subject|0|||
44279369|NCT02008890|79240562|FG004|Period 1|Withdrawal by Subject|0|||
44279370|NCT02008890|79240558|FG000|Period 1|Pregnancy|1|||
44279371|NCT02008890|79240559|FG001|Period 1|Pregnancy|0|||
44279372|NCT02008890|79240560|FG002|Period 1|Pregnancy|0|||
44279373|NCT02008890|79240561|FG003|Period 1|Pregnancy|0|||
44279374|NCT02008890|79240562|FG004|Period 1|Pregnancy|0|||
44279375|NCT02008890|79240558|FG000|Period 1|Physician Decision|1|||
44279376|NCT02008890|79240559|FG001|Period 1|Physician Decision|0|||
44279377|NCT02008890|79240560|FG002|Period 1|Physician Decision|1|||
44279378|NCT02008890|79240561|FG003|Period 1|Physician Decision|0|||
44279379|NCT02008890|79240562|FG004|Period 1|Physician Decision|0|||
44279380|NCT02008890|79240558|FG000|Period 1|Adverse Event|6|||
44279381|NCT02008890|79240559|FG001|Period 1|Adverse Event|8|||
44279382|NCT02008890|79240560|FG002|Period 1|Adverse Event|6|||
44279383|NCT02008890|79240561|FG003|Period 1|Adverse Event|0|||
44279384|NCT02008890|79240562|FG004|Period 1|Adverse Event|0|||
44279385|NCT02008890|79240558|FG000|Period 2|Adverse Event|12|||
44279386|NCT02008890|79240559|FG001|Period 2|Adverse Event|7|||
44279387|NCT02008890|79240560|FG002|Period 2|Adverse Event|0|||
44279388|NCT02008890|79240561|FG003|Period 2|Adverse Event|5|||
44279389|NCT02008890|79240562|FG004|Period 2|Adverse Event|5|||
44279390|NCT02008890|79240558|FG000|Period 2|Withdrawal by Subject|11|||
44279391|NCT02008890|79240559|FG001|Period 2|Withdrawal by Subject|8|||
44518274|NCT00620464|79525563|FG000|Overall Study|Planning Pregnancy|1|||
44518275|NCT00620464|79525564|FG001|Overall Study|Planning Pregnancy|4|||
44518276|NCT00620464|79525563|FG000|Overall Study|Personal|2|||
44279392|NCT02008890|79240560|FG002|Period 2|Withdrawal by Subject|0|||
44279393|NCT02008890|79240561|FG003|Period 2|Withdrawal by Subject|7|||
44384504|NCT00773734|79390330|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
44384505|NCT00773734|79390331|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
44384506|NCT00773734|79390326|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
44384507|NCT00773734|79390327|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
44384508|NCT00773734|79390328|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
44384509|NCT00773734|79390329|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
44384510|NCT00773734|79390330|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
44384511|NCT00773734|79390331|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
44384512|NCT00773734|79390326|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
44384513|NCT00773734|79390327|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
44384514|NCT00773734|79390328|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
44384515|NCT00773734|79390329|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
44384516|NCT00773734|79390330|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
44279394|NCT02008890|79240562|FG004|Period 2|Withdrawal by Subject|2|||
44384517|NCT00773734|79390331|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
44384518|NCT00773734|79390326|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
44384519|NCT00773734|79390327|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
44384520|NCT00773734|79390328|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
44384521|NCT00773734|79390329|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
44384522|NCT00773734|79390330|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
44518277|NCT00620464|79525564|FG001|Overall Study|Personal|2|||
44518278|NCT00620464|79525563|FG000|Overall Study|Used prohibited medication|1|||
44518279|NCT00620464|79525564|FG001|Overall Study|Used prohibited medication|0|||
44384523|NCT00773734|79390331|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
44384524|NCT00773734|79390326|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
44384525|NCT00773734|79390327|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
44384526|NCT00773734|79390328|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
44384527|NCT00773734|79390329|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
44384528|NCT00773734|79390330|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
44384529|NCT00773734|79390331|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
44384530|NCT00773734|79390326|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
44384531|NCT00773734|79390327|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
44384532|NCT00773734|79390328|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
44384533|NCT00773734|79390329|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
44279395|NCT02008890|79240558|FG000|Period 2|Physician Decision|4|||
44279396|NCT02008890|79240559|FG001|Period 2|Physician Decision|0|||
44279397|NCT02008890|79240560|FG002|Period 2|Physician Decision|0|||
44279398|NCT02008890|79240561|FG003|Period 2|Physician Decision|2|||
44279399|NCT02008890|79240562|FG004|Period 2|Physician Decision|1|||
44279400|NCT02008890|79240558|FG000|Period 2|Lost to Follow-up|0|||
44279401|NCT02008890|79240559|FG001|Period 2|Lost to Follow-up|0|||
44279402|NCT02008890|79240560|FG002|Period 2|Lost to Follow-up|1|||
44279403|NCT02008890|79240561|FG003|Period 2|Lost to Follow-up|0|||
44279404|NCT02008890|79240562|FG004|Period 2|Lost to Follow-up|0|||
44279405|NCT02008890|79240558|FG000|Extension Period|Withdrawal by Subject|3|||
44279406|NCT02008890|79240559|FG001|Extension Period|Withdrawal by Subject|2|||
44384534|NCT00773734|79390330|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
44384535|NCT00773734|79390331|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
44384536|NCT00773734|79390326|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
44384537|NCT00773734|79390327|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
44384538|NCT00773734|79390328|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
44384539|NCT00773734|79390329|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
44384540|NCT00773734|79390330|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
44518280|NCT03652662|79525572|FG000|Overall Study|Withdrawal by Subject|2|||
44518281|NCT03652662|79525573|FG001|Overall Study|Withdrawal by Subject|1|||
44518282|NCT03652662|79525572|FG000|Overall Study|Lost to Follow-up|1|||
44518283|NCT03652662|79525573|FG001|Overall Study|Lost to Follow-up|0|||
44518284|NCT03560258|79525582|FG000|Overall Study|Lost to Follow-up|3|||
44279407|NCT02008890|79240560|FG002|Extension Period|Withdrawal by Subject|0|||
44279408|NCT02008890|79240561|FG003|Extension Period|Withdrawal by Subject|4|||
44279409|NCT02008890|79240562|FG004|Extension Period|Withdrawal by Subject|2|||
44279410|NCT02008890|79240558|FG000|Extension Period|Lost to Follow-up|1|||
44279411|NCT02008890|79240559|FG001|Extension Period|Lost to Follow-up|0|||
44279412|NCT02008890|79240560|FG002|Extension Period|Lost to Follow-up|0|||
44384541|NCT00773734|79390331|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
44384542|NCT00773734|79390326|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
44384543|NCT00773734|79390327|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
44384544|NCT00773734|79390328|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
44384545|NCT00773734|79390329|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
44384546|NCT00773734|79390330|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
44384547|NCT00773734|79390331|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
44384548|NCT00773734|79390326|FG000|Extension: Active Treatment Week 24-52|Other|0|||
44384549|NCT00773734|79390327|FG001|Extension: Active Treatment Week 24-52|Other|0|||
44384550|NCT00773734|79390328|FG002|Extension: Active Treatment Week 24-52|Other|1|||
44384551|NCT00773734|79390329|FG003|Extension: Active Treatment Week 24-52|Other|2|||
44384552|NCT00773734|79390330|FG004|Extension: Active Treatment Week 24-52|Other|0|||
44384553|NCT00773734|79390331|FG005|Extension: Active Treatment Week 24-52|Other|1|||
44384554|NCT00773734|79390326|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
44384555|NCT00773734|79390327|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
44384556|NCT00773734|79390328|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
44384557|NCT00773734|79390329|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
44384558|NCT00773734|79390330|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
44384559|NCT00773734|79390331|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
44384560|NCT00773734|79390326|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
44384561|NCT00773734|79390327|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
44384562|NCT00773734|79390328|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
44384563|NCT00773734|79390329|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
44384564|NCT00773734|79390330|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
44384565|NCT00773734|79390331|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
44384566|NCT00773734|79390326|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
44384567|NCT00773734|79390327|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
44384568|NCT00773734|79390328|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
44384569|NCT00773734|79390329|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
44384570|NCT00773734|79390330|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
44384571|NCT00773734|79390331|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
44384572|NCT00773734|79390326|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
44384573|NCT00773734|79390327|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
44384574|NCT00773734|79390328|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
44384575|NCT00773734|79390329|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
44384576|NCT00773734|79390330|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
44384577|NCT00773734|79390331|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
44384578|NCT01009580|79390390|FG000|Overall Study|Adverse Event|4|||
44384579|NCT01009580|79390391|FG001|Overall Study|Adverse Event|4|||
44384580|NCT01009580|79390390|FG000|Overall Study|Lack of Efficacy|0|||
44384581|NCT01009580|79390391|FG001|Overall Study|Lack of Efficacy|1|||
44384582|NCT01009580|79390390|FG000|Overall Study|Protocol Violation|2|||
44384583|NCT01009580|79390391|FG001|Overall Study|Protocol Violation|3|||
44518285|NCT03560258|79525583|FG001|Overall Study|Lost to Follow-up|0|||
44518286|NCT03560258|79525584|FG002|Overall Study|Lost to Follow-up|0|||
44518287|NCT03560258|79525582|FG000|Overall Study|Protocol Violation|0|||
44384584|NCT01009580|79390390|FG000|Overall Study|Withdrawal Criteria|4|||
44384585|NCT01009580|79390391|FG001|Overall Study|Withdrawal Criteria|6|||
44384586|NCT01009580|79390390|FG000|Overall Study|Unclassified|17|||
44384587|NCT01009580|79390391|FG001|Overall Study|Unclassified|21|||
44384588|NCT01009346|79390397|FG000|Overall Study|Adverse Event|4|||
44384589|NCT01001702|79390402|FG000|Overall Study|Lost to Follow-up|7|||
44384590|NCT01001702|79390402|FG000|Overall Study|Adverse Event|7|||
44384591|NCT01001702|79390402|FG000|Overall Study|Sponsor Discontinued Study|4|||
44384592|NCT01001702|79390402|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
44518288|NCT03560258|79525583|FG001|Overall Study|Protocol Violation|1|||
44518289|NCT03560258|79525584|FG002|Overall Study|Protocol Violation|0|||
44251086|NCT01473524|79086403|FG000|LTSE Phase|Lost to Follow-up|0|||
44251087|NCT01473524|79086404|FG001|LTSE Phase|Lost to Follow-up|0|||
44251088|NCT01473524|79086405|FG002|LTSE Phase|Lost to Follow-up|0|||
44251089|NCT01473524|79086406|FG003|LTSE Phase|Lost to Follow-up|1|||
44251090|NCT01473524|79086407|FG004|LTSE Phase|Lost to Follow-up|3|||
44251091|NCT01473524|79086408|FG005|LTSE Phase|Lost to Follow-up|2|||
44251092|NCT01473524|79086403|FG000|LTSE Phase|Principal Investigator Decision|0|||
44251093|NCT01473524|79086404|FG001|LTSE Phase|Principal Investigator Decision|0|||
44251094|NCT01473524|79086405|FG002|LTSE Phase|Principal Investigator Decision|0|||
44251095|NCT01473524|79086406|FG003|LTSE Phase|Principal Investigator Decision|1|||
44251096|NCT01473524|79086407|FG004|LTSE Phase|Principal Investigator Decision|1|||
44251097|NCT01473524|79086408|FG005|LTSE Phase|Principal Investigator Decision|3|||
44251098|NCT01473524|79086403|FG000|LTSE Phase|Liver Transplantation|0|||
44384593|NCT01001702|79390402|FG000|Overall Study|Investigator withdrew Subject|10|||
44518290|NCT03560258|79525582|FG000|Overall Study|Withdrawal by Subject|0|||
44518291|NCT03560258|79525583|FG001|Overall Study|Withdrawal by Subject|0|||
44384594|NCT01001702|79390402|FG000|Overall Study|Withdrawal by Subject|19|||
44384595|NCT01001702|79390402|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
44384596|NCT01070069|79390411|FG000|Overall Study|Death|1|||
44384597|NCT01070069|79390412|FG001|Overall Study|Death|0|||
44384598|NCT01070069|79390413|FG002|Overall Study|Death|2|||
44384599|NCT01070069|79390414|FG003|Overall Study|Death|0|||
44384600|NCT01070069|79390415|FG004|Overall Study|Death|1|||
44384601|NCT01070069|79390411|FG000|Overall Study|Withdrawal by Subject|1|||
44384602|NCT01070069|79390412|FG001|Overall Study|Withdrawal by Subject|1|||
44384603|NCT01070069|79390413|FG002|Overall Study|Withdrawal by Subject|4|||
44384604|NCT01070069|79390414|FG003|Overall Study|Withdrawal by Subject|0|||
44384605|NCT01070069|79390415|FG004|Overall Study|Withdrawal by Subject|0|||
44384606|NCT01070069|79390411|FG000|Overall Study|Lost to Follow-up|4|||
44384607|NCT01070069|79390412|FG001|Overall Study|Lost to Follow-up|1|||
44384608|NCT01070069|79390413|FG002|Overall Study|Lost to Follow-up|0|||
44384609|NCT01070069|79390414|FG003|Overall Study|Lost to Follow-up|0|||
44384610|NCT01070069|79390415|FG004|Overall Study|Lost to Follow-up|3|||
44384611|NCT01068665|79390432|FG000|Overall Study|Adverse Event|5|||
44384612|NCT01068665|79390433|FG001|Overall Study|Adverse Event|4|||
44145934|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145935|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
44145936|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
44145937|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
44251099|NCT01473524|79086404|FG001|LTSE Phase|Liver Transplantation|0|||
44251100|NCT01473524|79086405|FG002|LTSE Phase|Liver Transplantation|0|||
44251101|NCT01473524|79086406|FG003|LTSE Phase|Liver Transplantation|0|||
44251102|NCT01473524|79086407|FG004|LTSE Phase|Liver Transplantation|0|||
44251103|NCT01473524|79086408|FG005|LTSE Phase|Liver Transplantation|1|||
44251104|NCT01473524|79086403|FG000|LTSE Phase|Pregnancy|0|||
44251105|NCT01473524|79086404|FG001|LTSE Phase|Pregnancy|0|||
44251106|NCT01473524|79086405|FG002|LTSE Phase|Pregnancy|0|||
44251107|NCT01473524|79086406|FG003|LTSE Phase|Pregnancy|1|||
44251108|NCT01473524|79086407|FG004|LTSE Phase|Pregnancy|0|||
44251109|NCT01473524|79086408|FG005|LTSE Phase|Pregnancy|0|||
44251110|NCT01473524|79086403|FG000|LTSE Phase|Protocol Violation|0|||
44251111|NCT01473524|79086404|FG001|LTSE Phase|Protocol Violation|0|||
44251112|NCT01473524|79086405|FG002|LTSE Phase|Protocol Violation|0|||
44251113|NCT01473524|79086406|FG003|LTSE Phase|Protocol Violation|0|||
44251114|NCT01473524|79086407|FG004|LTSE Phase|Protocol Violation|0|||
44251115|NCT01473524|79086408|FG005|LTSE Phase|Protocol Violation|1|||
44251116|NCT01390649|79086439|FG000|Overall Study|Physician Decision|1|||
44251117|NCT01390181|79086443|FG000|Overall Study|Lost to Follow-up|1|||
44251118|NCT01390181|79086443|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
44251119|NCT02641080|79086449|FG000|Overall Study|Physician Decision|2|||
44251120|NCT02641080|79086450|FG001|Overall Study|Physician Decision|0|||
44251121|NCT02641080|79086449|FG000|Overall Study|Withdrawal by Subject|0|||
44384613|NCT01068665|79390432|FG000|Overall Study|Lack of Efficacy|0|||
44384614|NCT01068665|79390433|FG001|Overall Study|Lack of Efficacy|2|||
44384615|NCT01068665|79390432|FG000|Overall Study|Protocol Violation|5|||
44384616|NCT01068665|79390433|FG001|Overall Study|Protocol Violation|2|||
44384617|NCT01068665|79390432|FG000|Overall Study|Withdrawal Criteria|3|||
44384618|NCT01068665|79390433|FG001|Overall Study|Withdrawal Criteria|9|||
44384619|NCT01068665|79390432|FG000|Overall Study|Other|17|||
44518292|NCT03560258|79525584|FG002|Overall Study|Withdrawal by Subject|1|||
44518293|NCT02768662|79525592|FG000|Overall Study|Adverse Event|1|||
44518294|NCT02768662|79525592|FG000|Overall Study|Lost to Follow-up|4|||
44518295|NCT02768662|79525592|FG000|Overall Study|Withdrawal by Subject|3|||
44518296|NCT02768662|79525592|FG000|Overall Study|Study terminated by Sponsor|78|||
44518297|NCT03539432|79525598|FG000|Overall Study|Lost to Follow-up|0|||
44518298|NCT03539432|79525599|FG001|Overall Study|Lost to Follow-up|1|||
44518299|NCT03615924|79525607|FG000|Overall Study|Withdrawal by Subject|2|||
44518300|NCT03615924|79525608|FG001|Overall Study|Withdrawal by Subject|5|||
44518301|NCT03615924|79525607|FG000|Overall Study|Death|3|||
44518302|NCT03615924|79525608|FG001|Overall Study|Death|1|||
44518303|NCT03615924|79525607|FG000|Overall Study|Lost to Follow-up|1|||
44518304|NCT03615924|79525608|FG001|Overall Study|Lost to Follow-up|0|||
44518305|NCT03615924|79525607|FG000|Overall Study|Randomized in error|1|||
44518306|NCT03615924|79525608|FG001|Overall Study|Randomized in error|0|||
44518307|NCT03615924|79525607|FG000|Overall Study|Study termination by Sponsor|94|||
44518308|NCT03615924|79525608|FG001|Overall Study|Study termination by Sponsor|86|||
44518309|NCT03535844|79525616|FG000|Overall Study|Withdrawal by Subject|0|||
44518310|NCT03535844|79525617|FG001|Overall Study|Withdrawal by Subject|1|||
44518311|NCT03533114|79525625|FG000|Overall|Adverse Event|16|||
44518312|NCT03533114|79525626|FG001|Overall|Adverse Event|11|||
44384620|NCT01068665|79390433|FG001|Overall Study|Other|12|||
44384621|NCT01001390|79390439|FG000|Overall Study|Failure to wear AFO device|2|||
44384622|NCT01001390|79390440|FG001|Overall Study|Failure to wear AFO device|0|||
44384623|NCT00772954|79390448|FG000|Overall Study|Adverse Event|0|||
44384624|NCT00772954|79390449|FG001|Overall Study|Adverse Event|0|||
44384625|NCT00772954|79390450|FG002|Overall Study|Adverse Event|1|||
44384626|NCT00781768|79390464|FG000|Overall Study|Not transplanted.|0|||
44384627|NCT00781768|79390465|FG001|Overall Study|Not transplanted.|2|||
44384628|NCT01005680|79390473|FG000|Overall Study|Lost to Follow-up|4|||
44384629|NCT01005680|79390474|FG001|Overall Study|Lost to Follow-up|6|||
44384630|NCT01005680|79390473|FG000|Overall Study|Withdrawal by Subject|1|||
44384631|NCT01005680|79390474|FG001|Overall Study|Withdrawal by Subject|4|||
44384632|NCT01005680|79390473|FG000|Overall Study|Physician Decision|1|||
44384633|NCT01005680|79390474|FG001|Overall Study|Physician Decision|1|||
44384634|NCT01005602|79390483|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
44384635|NCT01005602|79390484|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
44384636|NCT01068509|79390500|FG000|Overall Study|Death|0|||
44384637|NCT01068509|79390501|FG001|Overall Study|Death|0|||
44384638|NCT01068509|79390502|FG002|Overall Study|Death|1|||
44384639|NCT01068509|79390500|FG000|Overall Study|Disease Progression|5|||
44518313|NCT03533114|79525625|FG000|Overall|Consent Withdrawal by Participant|7|||
44518314|NCT03533114|79525626|FG001|Overall|Consent Withdrawal by Participant|6|||
44251122|NCT02641080|79086450|FG001|Overall Study|Withdrawal by Subject|1|||
44251123|NCT02641080|79086449|FG000|Overall Study|Rehab Center denied use of pumps|0|||
44251124|NCT02641080|79086450|FG001|Overall Study|Rehab Center denied use of pumps|3|||
44251125|NCT02641080|79086449|FG000|Overall Study|Lost to Follow-up|0|||
44251126|NCT02641080|79086450|FG001|Overall Study|Lost to Follow-up|3|||
44251127|NCT01457846|79086458|FG000|Overall Study|Death before treatment|1|||
44251128|NCT01457846|79086459|FG001|Overall Study|Death before treatment|2|||
44251129|NCT01457846|79086458|FG000|Overall Study|Did not receive treatment|0|||
44251130|NCT01457846|79086459|FG001|Overall Study|Did not receive treatment|1|||
44251131|NCT01457846|79086458|FG000|Overall Study|Death|27|||
44251132|NCT01457846|79086459|FG001|Overall Study|Death|16|||
44251133|NCT01457846|79086458|FG000|Overall Study|Unclassified reason for not completed|11|||
44251134|NCT01457846|79086459|FG001|Overall Study|Unclassified reason for not completed|10|||
44251135|NCT01457846|79086458|FG000|Overall Study|Withdrawal by Subject|1|||
44251136|NCT01457846|79086459|FG001|Overall Study|Withdrawal by Subject|1|||
44251137|NCT01457846|79086458|FG000|Overall Study|Lost to Follow-up|1|||
44251138|NCT01457846|79086459|FG001|Overall Study|Lost to Follow-up|0|||
44251139|NCT01496066|79086471|FG000|Overall Study|Lost to Follow-up|8|||
44251140|NCT01496066|79086472|FG001|Overall Study|Lost to Follow-up|5|||
44251141|NCT01496066|79086471|FG000|Overall Study|Explant|3|||
44251142|NCT01496066|79086472|FG001|Overall Study|Explant|0|||
44251143|NCT01496066|79086471|FG000|Overall Study|Death|1|||
44251144|NCT01496066|79086472|FG001|Overall Study|Death|4|||
44251145|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
44251146|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
44251147|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
44251148|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
44251149|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
44251150|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
44251151|NCT01389323|79086485|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
44251152|NCT01389323|79086485|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
44251153|NCT01389323|79086485|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
44251154|NCT01389323|79086485|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
44251155|NCT01389323|79086485|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
44251156|NCT01389245|79086496|FG000|Overall Study|Protocol Violation|10|||
44251157|NCT01389245|79086496|FG000|Overall Study|Lost to Follow-up|3|||
44251158|NCT01389245|79086496|FG000|Overall Study|Withdrawal by Subject|2|||
44251159|NCT01494818|79086502|FG000|Overall Study|Relocation|1|||
44251160|NCT01494818|79086503|FG001|Overall Study|Relocation|2|||
44251161|NCT01494818|79086502|FG000|Overall Study|Lost to Follow-up|1|||
44518315|NCT03533114|79525625|FG000|Overall|Lack of Efficacy|5|||
44518316|NCT03533114|79525626|FG001|Overall|Lack of Efficacy|3|||
44518317|NCT03533114|79525625|FG000|Overall|Lost to Follow-up|1|||
44145938|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44251162|NCT01494818|79086503|FG001|Overall Study|Lost to Follow-up|0|||
44251163|NCT01494584|79086509|FG000|Overall Study|Study Closed/Terminated|1|||
44251164|NCT01388543|79086534|FG000|Day 14|Adverse Event|1|||
44251165|NCT01388543|79086535|FG001|Day 14|Adverse Event|4|||
44384640|NCT01068509|79390501|FG001|Overall Study|Disease Progression|20|||
44384641|NCT01068509|79390502|FG002|Overall Study|Disease Progression|18|||
44384642|NCT01068509|79390500|FG000|Overall Study|Lost to Follow-up|1|||
44384643|NCT01068509|79390501|FG001|Overall Study|Lost to Follow-up|0|||
44384644|NCT01068509|79390502|FG002|Overall Study|Lost to Follow-up|0|||
44518318|NCT03533114|79525626|FG001|Overall|Lost to Follow-up|1|||
44518319|NCT03533114|79525625|FG000|Overall|Physician Decision|0|||
44518320|NCT03533114|79525626|FG001|Overall|Physician Decision|2|||
44384645|NCT01068509|79390500|FG000|Overall Study|Withdrew Consent|0|||
44384646|NCT01068509|79390501|FG001|Overall Study|Withdrew Consent|1|||
44384647|NCT01068509|79390502|FG002|Overall Study|Withdrew Consent|2|||
44384648|NCT01068509|79390500|FG000|Overall Study|Reason Not Specified|0|||
44384649|NCT01068509|79390501|FG001|Overall Study|Reason Not Specified|1|||
44384650|NCT01068509|79390502|FG002|Overall Study|Reason Not Specified|0|||
44384651|NCT01009034|79390509|FG000|Overall Study|Lost to Follow-up|2|||
44384652|NCT01009034|79390509|FG000|Overall Study|Withdrawal by Subject|2|||
44384653|NCT00768430|79390515|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
44384654|NCT00768430|79390516|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
44384655|NCT01064297|79390525|FG000|Overall Study|Lost to Follow-up|791|||
44384656|NCT01064297|79390526|FG001|Overall Study|Lost to Follow-up|48|||
44384657|NCT01064297|79390527|FG002|Overall Study|Lost to Follow-up|133|||
44384658|NCT00781456|79390544|FG000|Overall Study|Adverse Event|3|||
44384659|NCT00781456|79390545|FG001|Overall Study|Adverse Event|3|||
44384660|NCT00781456|79390544|FG000|Overall Study|Withdrawal by Subject|3|||
44384661|NCT00781456|79390545|FG001|Overall Study|Withdrawal by Subject|5|||
44384662|NCT00781456|79390544|FG000|Overall Study|Protocol Violation|4|||
44384663|NCT00781456|79390545|FG001|Overall Study|Protocol Violation|1|||
44384664|NCT00781456|79390544|FG000|Overall Study|Noncompliance With Protocol|1|||
44384665|NCT00781456|79390545|FG001|Overall Study|Noncompliance With Protocol|1|||
44384666|NCT00781456|79390544|FG000|Overall Study|Lost to Follow-up|10|||
44384667|NCT00781456|79390545|FG001|Overall Study|Lost to Follow-up|5|||
44384668|NCT00781456|79390544|FG000|Overall Study|Other Reason, Unknown|0|||
44384669|NCT00781456|79390545|FG001|Overall Study|Other Reason, Unknown|1|||
44384670|NCT00587158|79390553|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
44384671|NCT00587158|79390554|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
44279413|NCT02008890|79240561|FG003|Extension Period|Lost to Follow-up|0|||
44384672|NCT00587158|79390553|FG000|Overall Study|Physician Decision|0|||
44384673|NCT00587158|79390554|FG001|Overall Study|Physician Decision|1|||
44384674|NCT00587158|79390553|FG000|Overall Study|Lost to Follow-up|1|||
44384675|NCT00587158|79390554|FG001|Overall Study|Lost to Follow-up|2|||
44384676|NCT00587158|79390553|FG000|Overall Study|Death|0|||
44384677|NCT00587158|79390554|FG001|Overall Study|Death|1|||
44384678|NCT00587158|79390553|FG000|Overall Study|Subject did not want to take study med|0|||
44384679|NCT00587158|79390554|FG001|Overall Study|Subject did not want to take study med|1|||
44384680|NCT00582907|79390560|FG000|1st Course|Withdrawal by Subject|1|||
44384681|NCT00582907|79390561|FG001|1st Course|Withdrawal by Subject|0|||
44384682|NCT00582907|79390562|FG002|1st Course|Withdrawal by Subject|0|||
44384683|NCT00582907|79390563|FG003|1st Course|Withdrawal by Subject|0|||
44384684|NCT00582907|79390560|FG000|1st Course|Lost to Follow-up|0|||
44384685|NCT00582907|79390561|FG001|1st Course|Lost to Follow-up|0|||
44384686|NCT00582907|79390562|FG002|1st Course|Lost to Follow-up|0|||
44384687|NCT00582907|79390563|FG003|1st Course|Lost to Follow-up|1|||
44384688|NCT00582907|79390560|FG000|2nd Course|Lack of Efficacy|1|||
44384689|NCT00582907|79390561|FG001|2nd Course|Lack of Efficacy|0|||
44384690|NCT00582907|79390562|FG002|2nd Course|Lack of Efficacy|0|||
44384691|NCT00582907|79390563|FG003|2nd Course|Lack of Efficacy|0|||
44384692|NCT01062113|79390572|FG000|Overall Study|Adverse Event|1|||
44384693|NCT01062113|79390573|FG001|Overall Study|Adverse Event|0|||
44384694|NCT01062113|79390574|FG002|Overall Study|Adverse Event|0|||
44384695|NCT01062113|79390572|FG000|Overall Study|Lack of Efficacy|38|||
44384696|NCT01062113|79390573|FG001|Overall Study|Lack of Efficacy|22|||
44384697|NCT01062113|79390574|FG002|Overall Study|Lack of Efficacy|31|||
44384698|NCT01062113|79390572|FG000|Overall Study|Withdrawal by Subject|1|||
44384699|NCT01062113|79390573|FG001|Overall Study|Withdrawal by Subject|0|||
44384700|NCT01062113|79390574|FG002|Overall Study|Withdrawal by Subject|0|||
44384701|NCT00772330|79390582|FG000|Overall Study|Lost to Follow-up|3|||
44384702|NCT01038869|79390589|FG000|Overall Study|Withdrawal by Subject|1|||
44384703|NCT01038869|79390589|FG000|Overall Study|Lost to Follow-up|6|||
44384704|NCT01038713|79390600|FG000|Overall Study|Patient to hospice|1|||
44384705|NCT01038713|79390601|FG001|Overall Study|Patient to hospice|1|||
44384706|NCT01038713|79390602|FG002|Overall Study|Patient to hospice|1|||
44384707|NCT01038713|79390600|FG000|Overall Study|Lost to Follow-up|3|||
44384708|NCT01038713|79390601|FG001|Overall Study|Lost to Follow-up|0|||
44384709|NCT01038713|79390602|FG002|Overall Study|Lost to Follow-up|0|||
44384710|NCT01038713|79390600|FG000|Overall Study|Neuroendocrine Tumor|0|||
44384711|NCT01038713|79390601|FG001|Overall Study|Neuroendocrine Tumor|1|||
44384712|NCT01038713|79390602|FG002|Overall Study|Neuroendocrine Tumor|0|||
44384713|NCT01038713|79390600|FG000|Overall Study|died from PEP|0|||
44384714|NCT01038713|79390601|FG001|Overall Study|died from PEP|1|||
44384715|NCT01038713|79390602|FG002|Overall Study|died from PEP|0|||
44384716|NCT01038713|79390600|FG000|Overall Study|Autoimmune Pancreatitis|1|||
44384717|NCT01038713|79390601|FG001|Overall Study|Autoimmune Pancreatitis|0|||
44384718|NCT01038713|79390602|FG002|Overall Study|Autoimmune Pancreatitis|0|||
44384719|NCT00768040|79390612|FG000|Overall Study|Adverse Event|3|||
44384720|NCT00768040|79390613|FG001|Overall Study|Adverse Event|2|||
44384721|NCT00768040|79390612|FG000|Overall Study|Abnormal laboratory value|1|||
44384722|NCT00768040|79390613|FG001|Overall Study|Abnormal laboratory value|1|||
44384723|NCT00767806|79390621|FG000|Overall Study|Adverse Event|30|||
44384724|NCT00767806|79390622|FG001|Overall Study|Adverse Event|11|||
44384725|NCT00767806|79390621|FG000|Overall Study|Withdrawal by Subject|8|||
44384726|NCT00767806|79390622|FG001|Overall Study|Withdrawal by Subject|13|||
44384727|NCT00767806|79390621|FG000|Overall Study|Protocol Violation|6|||
44384728|NCT00767806|79390622|FG001|Overall Study|Protocol Violation|5|||
44384729|NCT00767806|79390621|FG000|Overall Study|Lack of Efficacy|1|||
44384730|NCT00767806|79390622|FG001|Overall Study|Lack of Efficacy|9|||
44384731|NCT00767806|79390621|FG000|Overall Study|Physician Decision|4|||
44279414|NCT02008890|79240562|FG004|Extension Period|Lost to Follow-up|0|||
44279415|NCT02008890|79240558|FG000|Extension Period|Adverse Event|1|||
44279416|NCT02008890|79240559|FG001|Extension Period|Adverse Event|3|||
44384732|NCT00767806|79390622|FG001|Overall Study|Physician Decision|3|||
44384733|NCT00767806|79390621|FG000|Overall Study|Lost to Follow-up|1|||
44384734|NCT00767806|79390622|FG001|Overall Study|Lost to Follow-up|4|||
44384735|NCT00767806|79390621|FG000|Overall Study|Entry Criteria Not Met|1|||
44384736|NCT00767806|79390622|FG001|Overall Study|Entry Criteria Not Met|1|||
44384737|NCT00767806|79390621|FG000|Overall Study|Sponsor Decision|0|||
44384738|NCT00767806|79390622|FG001|Overall Study|Sponsor Decision|1|||
44384739|NCT00780910|79390628|FG000|Overall Study|Adverse Event|2|||
44384740|NCT00767104|79390634|FG000|Overall Study|Lost to Follow-up|1|||
44384741|NCT00767104|79390635|FG001|Overall Study|Lost to Follow-up|2|||
44384742|NCT00771472|79390643|FG000|Overall Study|Physician Decision|2|||
44384743|NCT00771472|79390644|FG001|Overall Study|Physician Decision|3|||
44384744|NCT00771472|79390643|FG000|Overall Study|Progressive Disease|3|||
44384745|NCT00771472|79390644|FG001|Overall Study|Progressive Disease|1|||
44384746|NCT00771472|79390643|FG000|Overall Study|Protocol Violation|1|||
44384747|NCT00771472|79390644|FG001|Overall Study|Protocol Violation|0|||
44384748|NCT00771316|79390651|FG000|Overall Study|Adverse Event|0|||
44384749|NCT00771316|79390652|FG001|Overall Study|Adverse Event|1|||
44384750|NCT00771316|79390651|FG000|Overall Study|Patient withdrew consent|1|||
44384751|NCT00771316|79390652|FG001|Overall Study|Patient withdrew consent|0|||
44384752|NCT00771316|79390651|FG000|Overall Study|Discontinued due to early termination|1|||
44145939|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44251166|NCT00512317|79086554|FG000|Overall Study|Insufficient clinical response|36|||
44279417|NCT02008890|79240560|FG002|Extension Period|Adverse Event|0|||
44279418|NCT02008890|79240561|FG003|Extension Period|Adverse Event|0|||
44279419|NCT02008890|79240562|FG004|Extension Period|Adverse Event|2|||
44279420|NCT02052414|79240577|FG000|Overall Study|Adverse Event|12|||
44279421|NCT02052414|79240577|FG000|Overall Study|Lack of Efficacy|2|||
44279422|NCT02052414|79240577|FG000|Overall Study|Withdrawal by Subject|3|||
44279423|NCT02007954|79240582|FG000|Overall Study|Received liver transplant|3|||
44279424|NCT02007954|79240582|FG000|Overall Study|Switch in treatment modality|2|||
44279425|NCT02007954|79240582|FG000|Overall Study|Disease progression and unrelated AE|1|||
44279426|NCT02007954|79240582|FG000|Overall Study|Death|1|||
44279427|NCT02049450|79240586|FG000|Overall Study|Adverse Event|2|||
44279428|NCT02049450|79240586|FG000|Overall Study|Withdrawal by Subject|1|||
44279429|NCT02049450|79240586|FG000|Overall Study|Patients/guardian decision|1|||
44279430|NCT02031432|79240597|FG000|Overall Study|Protocol Violation|1|||
44279431|NCT02031432|79240597|FG000|Overall Study|Lack of Efficacy|5|||
44279432|NCT02031432|79240597|FG000|Overall Study|Cancer Progression|2|||
44279433|NCT02031432|79240597|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
44384753|NCT00771316|79390652|FG001|Overall Study|Discontinued due to early termination|0|||
44384754|NCT05133323|79390661|FG000|Overall Study|Lack of Efficacy|0|||
44251167|NCT00512317|79086554|FG000|Overall Study|Withdrawal by Subject|23|||
44251168|NCT00512317|79086554|FG000|Overall Study|Sponsor closure of study|21|||
44251169|NCT00512317|79086554|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
44251170|NCT00512317|79086554|FG000|Overall Study|Adverse Event|13|||
44251171|NCT00512317|79086554|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
44251172|NCT00512317|79086554|FG000|Overall Study|Lost to Follow-up|2|||
44251173|NCT00512317|79086554|FG000|Overall Study|Other|2|||
44251174|NCT01494506|79086570|FG000|Overall Study|Lack of Efficacy|77|||
44251175|NCT01494506|79086571|FG001|Overall Study|Lack of Efficacy|83|||
44279434|NCT02031432|79240597|FG000|Overall Study|Adverse Event|8|||
44279435|NCT02031432|79240597|FG000|Overall Study|Withdrawal by Subject|5|||
44279436|NCT02031432|79240597|FG000|Overall Study|Lost to Follow-up|1|||
44279437|NCT02031432|79240597|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
44384755|NCT05133323|79390662|FG001|Overall Study|Lack of Efficacy|0|||
44384756|NCT05133323|79390663|FG002|Overall Study|Lack of Efficacy|1|||
44384757|NCT05133323|79390661|FG000|Overall Study|Withdrawal by Subject|2|||
44384758|NCT05133323|79390662|FG001|Overall Study|Withdrawal by Subject|1|||
44384759|NCT05133323|79390663|FG002|Overall Study|Withdrawal by Subject|0|||
44384760|NCT05116046|79390674|FG000|Overall Study|Withdrawal by parent/guardian|2|||
44384761|NCT05116046|79390675|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44279438|NCT02031432|79240597|FG000|Overall Study|Death|10|||
44384762|NCT05116046|79390676|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44384763|NCT05116046|79390674|FG000|Overall Study|Study terminated by sponsor|14|||
44384764|NCT05116046|79390675|FG001|Overall Study|Study terminated by sponsor|16|||
44384765|NCT05116046|79390676|FG002|Overall Study|Study terminated by sponsor|1|||
44384766|NCT04964414|79390696|FG000|Overall Study|Lost to Follow-up|10|||
44384767|NCT04964414|79390697|FG001|Overall Study|Lost to Follow-up|8|||
44384768|NCT04964414|79390696|FG000|Overall Study|Withdrawal by Subject|1|||
44384769|NCT04964414|79390697|FG001|Overall Study|Withdrawal by Subject|1|||
44384770|NCT04937816|79390710|FG000|Overall Study|Study drug stopped, reason missing|5|||
44384771|NCT04937816|79390711|FG001|Overall Study|Study drug stopped, reason missing|3|||
44384772|NCT04937816|79390712|FG002|Overall Study|Study drug stopped, reason missing|4|||
44384773|NCT04937816|79390713|FG003|Overall Study|Study drug stopped, reason missing|6|||
44384774|NCT04937816|79390714|FG004|Overall Study|Study drug stopped, reason missing|1|||
44384775|NCT04937816|79390715|FG005|Overall Study|Study drug stopped, reason missing|0|||
44384776|NCT04937816|79390716|FG006|Overall Study|Study drug stopped, reason missing|0|||
44384777|NCT04937816|79390710|FG000|Overall Study|Other than stated below|173|||
44384778|NCT04937816|79390711|FG001|Overall Study|Other than stated below|143|||
44384779|NCT04937816|79390712|FG002|Overall Study|Other than stated below|125|||
44384780|NCT04937816|79390713|FG003|Overall Study|Other than stated below|44|||
44279439|NCT02031276|79240604|FG000|Period 1 Double-blind IV|Adverse Event|6|||
44279440|NCT02031276|79240605|FG001|Period 1 Double-blind IV|Adverse Event|5|||
44279441|NCT02031276|79240606|FG002|Period 1 Double-blind IV|Adverse Event|1|||
44279442|NCT02031276|79240604|FG000|Period 1 Double-blind IV|Other|0|||
44279443|NCT02031276|79240605|FG001|Period 1 Double-blind IV|Other|1|||
44279444|NCT02031276|79240606|FG002|Period 1 Double-blind IV|Other|0|||
44279445|NCT02031276|79240604|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
44279446|NCT02031276|79240605|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
44279447|NCT02031276|79240606|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
44279448|NCT02031276|79240604|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
44279449|NCT02031276|79240605|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
44279450|NCT02031276|79240606|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
44279451|NCT02031276|79240604|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
44279452|NCT02031276|79240605|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
44279453|NCT02031276|79240606|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
44279454|NCT02031276|79240604|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
44384781|NCT04937816|79390714|FG004|Overall Study|Other than stated below|45|||
44384782|NCT04937816|79390715|FG005|Overall Study|Other than stated below|28|||
44384783|NCT04937816|79390716|FG006|Overall Study|Other than stated below|31|||
44384784|NCT04937816|79390710|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
44384785|NCT04937816|79390711|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
44384786|NCT04937816|79390712|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
44384787|NCT04937816|79390713|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
44384788|NCT04937816|79390714|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
44384789|NCT04937816|79390715|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
44384790|NCT04937816|79390716|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
44384791|NCT04937816|79390710|FG000|Overall Study|Lost to Follow-up|15|||
44518321|NCT03533114|79525625|FG000|Overall|Protocol deviation|1|||
44518322|NCT03533114|79525626|FG001|Overall|Protocol deviation|1|||
44251176|NCT01494506|79086572|FG002|Overall Study|Lack of Efficacy|57|||
44251177|NCT01494506|79086570|FG000|Overall Study|Adverse Event|17|||
44251178|NCT01494506|79086571|FG001|Overall Study|Adverse Event|10|||
44251179|NCT01494506|79086572|FG002|Overall Study|Adverse Event|11|||
44251180|NCT01494506|79086570|FG000|Overall Study|Death|9|||
44251181|NCT01494506|79086571|FG001|Overall Study|Death|5|||
44251182|NCT01494506|79086572|FG002|Overall Study|Death|2|||
44251183|NCT01494506|79086570|FG000|Overall Study|Physician Decision|7|||
44251184|NCT01494506|79086571|FG001|Overall Study|Physician Decision|5|||
44251185|NCT01494506|79086572|FG002|Overall Study|Physician Decision|4|||
44251186|NCT01494506|79086570|FG000|Overall Study|Withdrawal by Subject|17|||
44251187|NCT01494506|79086571|FG001|Overall Study|Withdrawal by Subject|20|||
44384792|NCT04937816|79390711|FG001|Overall Study|Lost to Follow-up|9|||
44384793|NCT04937816|79390712|FG002|Overall Study|Lost to Follow-up|6|||
44384794|NCT04937816|79390713|FG003|Overall Study|Lost to Follow-up|6|||
44384795|NCT04937816|79390714|FG004|Overall Study|Lost to Follow-up|16|||
44384796|NCT04937816|79390715|FG005|Overall Study|Lost to Follow-up|11|||
44384797|NCT04937816|79390716|FG006|Overall Study|Lost to Follow-up|17|||
44384798|NCT04937816|79390710|FG000|Overall Study|Protocol Violation|15|||
44384799|NCT04937816|79390711|FG001|Overall Study|Protocol Violation|15|||
44384800|NCT04937816|79390712|FG002|Overall Study|Protocol Violation|12|||
44251188|NCT01494506|79086572|FG002|Overall Study|Withdrawal by Subject|14|||
44279455|NCT02031276|79240605|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
44279456|NCT02031276|79240606|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
44279457|NCT02031276|79240604|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
44384801|NCT04937816|79390713|FG003|Overall Study|Protocol Violation|30|||
44518323|NCT03533114|79525625|FG000|Overall|Failure to meet randomization criteria|1|||
44384802|NCT04937816|79390714|FG004|Overall Study|Protocol Violation|24|||
44384803|NCT04937816|79390715|FG005|Overall Study|Protocol Violation|5|||
44384804|NCT04937816|79390716|FG006|Overall Study|Protocol Violation|5|||
44384805|NCT04937816|79390710|FG000|Overall Study|Adverse Event|303|||
44384806|NCT04937816|79390711|FG001|Overall Study|Adverse Event|267|||
44384807|NCT04937816|79390712|FG002|Overall Study|Adverse Event|273|||
44384808|NCT04937816|79390713|FG003|Overall Study|Adverse Event|553|||
44384809|NCT04937816|79390714|FG004|Overall Study|Adverse Event|575|||
44384810|NCT04937816|79390715|FG005|Overall Study|Adverse Event|343|||
44384811|NCT04937816|79390716|FG006|Overall Study|Adverse Event|337|||
44384812|NCT04937816|79390710|FG000|Overall Study|Not treated|4|||
44384813|NCT04937816|79390711|FG001|Overall Study|Not treated|2|||
44384814|NCT04937816|79390712|FG002|Overall Study|Not treated|2|||
44384815|NCT04937816|79390713|FG003|Overall Study|Not treated|2|||
44384816|NCT04937816|79390714|FG004|Overall Study|Not treated|1|||
44384817|NCT04937816|79390715|FG005|Overall Study|Not treated|4|||
44384818|NCT04937816|79390716|FG006|Overall Study|Not treated|0|||
44384819|NCT04908683|79390742|FG000|Overall Study|Failure to meet continuation criteria|34|||
44384820|NCT04908683|79390743|FG001|Overall Study|Failure to meet continuation criteria|22|||
44384821|NCT04908683|79390742|FG000|Overall Study|Initiated prohibited medication|3|||
44384822|NCT04908683|79390743|FG001|Overall Study|Initiated prohibited medication|0|||
44384823|NCT04908683|79390742|FG000|Overall Study|Randomized by mistake|1|||
44384824|NCT04908683|79390743|FG001|Overall Study|Randomized by mistake|0|||
44384825|NCT04908683|79390742|FG000|Overall Study|Lost to Follow-up|679|||
44384826|NCT04908683|79390743|FG001|Overall Study|Lost to Follow-up|341|||
44384827|NCT04908683|79390742|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
44384828|NCT04908683|79390743|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
44384829|NCT04908683|79390742|FG000|Overall Study|Physician Decision|44|||
44384830|NCT04908683|79390743|FG001|Overall Study|Physician Decision|35|||
44384831|NCT04908683|79390742|FG000|Overall Study|Technical problems|12|||
44384832|NCT04908683|79390743|FG001|Overall Study|Technical problems|9|||
44384833|NCT04908683|79390742|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
44384834|NCT04908683|79390743|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
44384835|NCT04908683|79390742|FG000|Overall Study|Protocol Violation|2|||
44384836|NCT04908683|79390743|FG001|Overall Study|Protocol Violation|0|||
44384837|NCT04908683|79390742|FG000|Overall Study|Withdrawal by Subject|1188|||
44384838|NCT04908683|79390743|FG001|Overall Study|Withdrawal by Subject|570|||
44384839|NCT04908683|79390742|FG000|Overall Study|Site Closure by Sponsor|6|||
44384840|NCT04908683|79390743|FG001|Overall Study|Site Closure by Sponsor|3|||
44384841|NCT04908683|79390742|FG000|Overall Study|Adverse Event|21|||
44384842|NCT04908683|79390743|FG001|Overall Study|Adverse Event|11|||
44384843|NCT04908683|79390742|FG000|Overall Study|Death|101|||
44384844|NCT04908683|79390743|FG001|Overall Study|Death|61|||
44384845|NCT04908683|79390742|FG000|Overall Study|Sponsor's decision|14398|||
44384846|NCT04908683|79390743|FG001|Overall Study|Sponsor's decision|7205|||
44384847|NCT04908683|79390742|FG000|Overall Study|Other|92|||
44384848|NCT04908683|79390743|FG001|Overall Study|Other|50|||
44384849|NCT04908683|79390742|FG000|Overall Study|Randomized not vaccinated|108|||
44384850|NCT04908683|79390743|FG001|Overall Study|Randomized not vaccinated|52|||
44384851|NCT04863898|79390758|FG000|Overall Study|Away from study clinic during intervention training period|2|||
44384852|NCT04863898|79390758|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
44384853|NCT04863898|79390758|FG000|Overall Study|Lost to Follow-up|3|||
44384854|NCT04863898|79390758|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
44384855|NCT04863898|79390758|FG000|Overall Study|No longer employed at clinic|3|||
44384856|NCT04599166|79390767|FG000|Overall Study|Technological failure connecting to study app|80|||
44384857|NCT04439318|79390772|FG000|Overall Study|Ineligible|1|||
44384858|NCT04439318|79390772|FG000|Overall Study|Never Started Treatment|3|||
44384859|NCT04439318|79390772|FG000|Overall Study|Adverse Event|10|||
44384860|NCT04439318|79390772|FG000|Overall Study|Death|2|||
44384861|NCT04439318|79390772|FG000|Overall Study|Disease Progression|25|||
44384862|NCT04439318|79390772|FG000|Overall Study|Other Complicating Disease|2|||
44251189|NCT01494506|79086570|FG000|Overall Study|Clinical Deterioration|21|||
44384863|NCT04439318|79390772|FG000|Overall Study|Withdrawal by Subject|4|||
44384864|NCT04439318|79390772|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
44384865|NCT04439318|79390772|FG000|Overall Study|Non-Compliance|1|||
44384866|NCT04439318|79390772|FG000|Overall Study|Still on Treatment|1|||
44384867|NCT04348500|79390778|FG000|Overall Study|Death|2|||
44384868|NCT04348500|79390779|FG001|Overall Study|Death|2|||
44384869|NCT04348500|79390778|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
44384870|NCT04348500|79390779|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
44384871|NCT04237116|79390787|FG000|Overall Study|Adverse Event|0|||
44384872|NCT04237116|79390788|FG001|Overall Study|Adverse Event|1|||
44384873|NCT04237116|79390787|FG000|Overall Study|Study terminated by Sponsor|4|||
44384874|NCT04237116|79390788|FG001|Overall Study|Study terminated by Sponsor|1|||
44384875|NCT04191616|79390794|FG000|Overall Study|Death|26|||
44384876|NCT04191616|79390794|FG000|Overall Study|Withdrawal by Subject|1|||
44384877|NCT04191616|79390794|FG000|Overall Study|Sponsor decision|2|||
44384878|NCT04191616|79390794|FG000|Overall Study|Continuing study|25|||
44384879|NCT04139317|79390800|FG000|Overall Study|Adverse Event|10|||
44384880|NCT04139317|79390801|FG001|Overall Study|Adverse Event|2|||
44384881|NCT04139317|79390800|FG000|Overall Study|Death|6|||
44384882|NCT04139317|79390801|FG001|Overall Study|Death|4|||
44384883|NCT04139317|79390800|FG000|Overall Study|Lost to Follow-up|1|||
44384884|NCT04139317|79390801|FG001|Overall Study|Lost to Follow-up|0|||
44384885|NCT04139317|79390800|FG000|Overall Study|Physician Decision|3|||
44384886|NCT04139317|79390801|FG001|Overall Study|Physician Decision|1|||
44384887|NCT04139317|79390800|FG000|Overall Study|Progressive Disease|19|||
44384888|NCT04139317|79390801|FG001|Overall Study|Progressive Disease|9|||
44384889|NCT04139317|79390800|FG000|Overall Study|Subject Decision|2|||
44384890|NCT04139317|79390801|FG001|Overall Study|Subject Decision|2|||
44384891|NCT04081337|79390812|FG000|Overall Study|Adverse Event|0|||
44384892|NCT04081337|79390813|FG001|Overall Study|Adverse Event|1|||
44384893|NCT04081337|79390812|FG000|Overall Study|Withdrawal by Subject|2|||
44384894|NCT04081337|79390813|FG001|Overall Study|Withdrawal by Subject|0|||
44384895|NCT04081337|79390812|FG000|Overall Study|Physician Decision|1|||
44384896|NCT04081337|79390813|FG001|Overall Study|Physician Decision|2|||
44384897|NCT04081337|79390812|FG000|Overall Study|Lost to Follow-up|1|||
44384898|NCT04081337|79390813|FG001|Overall Study|Lost to Follow-up|0|||
44384899|NCT03625141|79390821|FG000|Overall Study|Death|11|||
44384900|NCT03625141|79390822|FG001|Overall Study|Death|37|||
44384901|NCT03625141|79390821|FG000|Overall Study|Withdrawal by Subject|1|||
44518324|NCT03533114|79525626|FG001|Overall|Failure to meet randomization criteria|2|||
44518325|NCT03533114|79525625|FG000|Overall|Non-Compliance with study drug|0|||
44384902|NCT03625141|79390822|FG001|Overall Study|Withdrawal by Subject|0|||
44384903|NCT03625141|79390821|FG000|Overall Study|Withdrawl of Consent|0|||
44518326|NCT03533114|79525626|FG001|Overall|Non-Compliance with study drug|1|||
44518327|NCT03533114|79525625|FG000|Overall|Other|0|||
44518328|NCT03533114|79525626|FG001|Overall|Other|1|||
44518329|NCT03533114|79525625|FG000|Open Label Titration and Optimization|Adverse Event|11|||
44518330|NCT03533114|79525626|FG001|Open Label Titration and Optimization|Adverse Event|8|||
44518331|NCT03533114|79525625|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
44518332|NCT03533114|79525626|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
44279458|NCT02031276|79240605|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
44518333|NCT03533114|79525625|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
44518334|NCT03533114|79525626|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
44518335|NCT03533114|79525625|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
44145940|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145941|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44279459|NCT02031276|79240606|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
44279460|NCT02031276|79240604|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
44279461|NCT02031276|79240605|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
44279462|NCT02031276|79240606|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
44279463|NCT02031276|79240604|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
44279464|NCT02031276|79240605|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
44279465|NCT02031276|79240606|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
44279466|NCT02007720|79240620|FG000|Overall Study|Withdrawal by Subject|9|||
44279467|NCT02007720|79240621|FG001|Overall Study|Withdrawal by Subject|11|||
44518336|NCT03533114|79525626|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
44145942|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44279468|NCT02007720|79240620|FG000|Overall Study|study terminated by sponsor|58|||
44279469|NCT02007720|79240621|FG001|Overall Study|study terminated by sponsor|54|||
44279470|NCT02007720|79240620|FG000|Overall Study|technical problem|4|||
44384904|NCT03625141|79390822|FG001|Overall Study|Withdrawl of Consent|1|||
44384905|NCT03625141|79390821|FG000|Overall Study|Continuing in study|3|||
44384906|NCT03625141|79390822|FG001|Overall Study|Continuing in study|27|||
44384907|NCT03486457|79390859|FG000|Up to Month 3|Adverse Event|2|||
44384908|NCT03486457|79390860|FG001|Up to Month 3|Adverse Event|5|||
44384909|NCT03486457|79390859|FG000|Up to Month 3|Lack of Efficacy|1|||
44384910|NCT03486457|79390860|FG001|Up to Month 3|Lack of Efficacy|0|||
44384911|NCT03486457|79390859|FG000|Up to Month 3|Withdrawal by Subject|1|||
44384912|NCT03486457|79390860|FG001|Up to Month 3|Withdrawal by Subject|0|||
44384913|NCT03486457|79390859|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
44518337|NCT03533114|79525625|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
44518338|NCT03533114|79525626|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
44518339|NCT03533114|79525625|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
44518340|NCT03533114|79525626|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
44518341|NCT03533114|79525625|FG000|Stable Dose|Adverse Event|0|||
44518342|NCT03533114|79525626|FG001|Stable Dose|Adverse Event|2|||
44518343|NCT03533114|79525625|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
44279471|NCT02007720|79240621|FG001|Overall Study|technical problem|2|||
44279472|NCT02007720|79240620|FG000|Overall Study|patient followd less than 165 days|11|||
44384914|NCT03486457|79390860|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
44384915|NCT03486457|79390859|FG000|Up to Month 3|Other|1|||
44384916|NCT03486457|79390860|FG001|Up to Month 3|Other|0|||
44384917|NCT03486457|79390859|FG000|Month 3 to Month 6|Adverse Event|2|||
44384918|NCT03486457|79390860|FG001|Month 3 to Month 6|Adverse Event|0|||
44384919|NCT03486457|79390859|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
44384920|NCT03486457|79390860|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
44384921|NCT03486457|79390859|FG000|Month 3 to Month 6|Pregnancy|0|||
44384922|NCT03486457|79390860|FG001|Month 3 to Month 6|Pregnancy|1|||
44384923|NCT03486457|79390859|FG000|Month 3 to Month 6|Other|1|||
44384924|NCT03486457|79390860|FG001|Month 3 to Month 6|Other|0|||
44384925|NCT03379727|79390877|FG000|Overall Study|Lack of Efficacy|73|||
44384926|NCT03379727|79390877|FG000|Overall Study|Adverse Event|32|||
44384927|NCT03379727|79390877|FG000|Overall Study|Death|18|||
44384928|NCT03379727|79390877|FG000|Overall Study|Patient/guardian decision|17|||
44384929|NCT03379727|79390877|FG000|Overall Study|Physician Decision|104|||
44384930|NCT03379727|79390877|FG000|Overall Study|Protocol Violation|4|||
44384931|NCT03379727|79390877|FG000|Overall Study|Lost to Follow-up|1|||
44384932|NCT03246529|79390911|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
44384933|NCT03246529|79390912|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
44384934|NCT03246529|79390913|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
44384935|NCT03246529|79390911|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
44384936|NCT03246529|79390912|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
44279473|NCT02007720|79240621|FG001|Overall Study|patient followd less than 165 days|5|||
44279474|NCT01363440|79240631|FG000|Overall Study|Adverse Event|5|||
44279475|NCT01363440|79240632|FG001|Overall Study|Adverse Event|4|||
44279476|NCT01363440|79240633|FG002|Overall Study|Adverse Event|4|||
44279477|NCT01363440|79240631|FG000|Overall Study|Death|3|||
44279478|NCT01363440|79240632|FG001|Overall Study|Death|7|||
44279479|NCT01363440|79240633|FG002|Overall Study|Death|5|||
44279480|NCT01363440|79240631|FG000|Overall Study|Withdrawal by Subject|9|||
44384937|NCT03246529|79390913|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
44384938|NCT03246529|79390911|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
44384939|NCT03246529|79390912|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
44384940|NCT03246529|79390913|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
44384941|NCT03246529|79390911|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
44384942|NCT03246529|79390912|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
44384943|NCT03246529|79390913|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
44384944|NCT03246529|79390911|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
44384945|NCT03246529|79390912|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
44251190|NCT01494506|79086571|FG001|Overall Study|Clinical Deterioration|17|||
44251191|NCT01494506|79086572|FG002|Overall Study|Clinical Deterioration|13|||
44251192|NCT01494506|79086570|FG000|Overall Study|Sponsor Decision|0|||
44251193|NCT01494506|79086571|FG001|Overall Study|Sponsor Decision|0|||
44251194|NCT01494506|79086572|FG002|Overall Study|Sponsor Decision|1|||
44251195|NCT01494506|79086570|FG000|Overall Study|Other|0|||
44251196|NCT01494506|79086571|FG001|Overall Study|Other|3|||
44251197|NCT01494506|79086572|FG002|Overall Study|Other|1|||
44251198|NCT02643420|79086584|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
44251199|NCT02643420|79086585|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
44251200|NCT02643420|79086584|FG000|Overall Study|Withdrawal by Subject|25|||
44251201|NCT02643420|79086585|FG001|Overall Study|Withdrawal by Subject|19|||
44279481|NCT01363440|79240632|FG001|Overall Study|Withdrawal by Subject|11|||
44279482|NCT01363440|79240633|FG002|Overall Study|Withdrawal by Subject|11|||
44279483|NCT01363440|79240631|FG000|Overall Study|Lost to Follow-up|2|||
44279484|NCT01363440|79240632|FG001|Overall Study|Lost to Follow-up|4|||
44384946|NCT03246529|79390913|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
44384947|NCT03246529|79390911|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
44518344|NCT03533114|79525626|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
44518345|NCT03533114|79525625|FG000|Stable Dose|Lack of Efficacy|1|||
44518346|NCT03533114|79525626|FG001|Stable Dose|Lack of Efficacy|0|||
44384948|NCT03246529|79390912|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
44279485|NCT01363440|79240633|FG002|Overall Study|Lost to Follow-up|5|||
44279486|NCT01363440|79240631|FG000|Overall Study|Other|4|||
44518347|NCT03533114|79525625|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
44518348|NCT03533114|79525626|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
44518349|NCT03533114|79525625|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
44518350|NCT03533114|79525626|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
44518351|NCT03533114|79525625|FG000|Open-Label Safety Extension|Adverse Event|3|||
44518352|NCT03533114|79525626|FG001|Open-Label Safety Extension|Adverse Event|0|||
44518353|NCT03533114|79525625|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
44518354|NCT03533114|79525626|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
44518355|NCT03533114|79525625|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
44251202|NCT02643420|79086584|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
44251203|NCT02643420|79086585|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
44251204|NCT02643420|79086584|FG000|Overall Study|Lost to Follow-up|6|||
44251205|NCT02643420|79086585|FG001|Overall Study|Lost to Follow-up|10|||
44251206|NCT02643420|79086584|FG000|Overall Study|Investigator Decision|2|||
44251207|NCT02643420|79086585|FG001|Overall Study|Investigator Decision|4|||
44251208|NCT02643420|79086584|FG000|Overall Study|Sponsor decision|1|||
44251209|NCT02643420|79086585|FG001|Overall Study|Sponsor decision|1|||
44251210|NCT02643420|79086584|FG000|Overall Study|Death|0|||
44251211|NCT02643420|79086585|FG001|Overall Study|Death|2|||
44251212|NCT02643420|79086584|FG000|Overall Study|Reason not Specified|8|||
44251213|NCT02643420|79086585|FG001|Overall Study|Reason not Specified|7|||
44279487|NCT01363440|79240632|FG001|Overall Study|Other|5|||
44279488|NCT01363440|79240633|FG002|Overall Study|Other|2|||
44279489|NCT02007252|79240646|FG000|Overall Study|Administrative problems|3|||
44279490|NCT02007252|79240647|FG001|Overall Study|Administrative problems|7|||
44279491|NCT02007252|79240646|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44279492|NCT02007252|79240647|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44279493|NCT02007252|79240646|FG000|Overall Study|Adverse Event|7|||
44279494|NCT02007252|79240647|FG001|Overall Study|Adverse Event|4|||
44279495|NCT02007096|79240655|FG000|Overall Study|medication not available|2|||
44384949|NCT03246529|79390913|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
44384950|NCT03246529|79390911|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
44384951|NCT03246529|79390912|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
44384952|NCT03246529|79390913|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
44384953|NCT03246529|79390911|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
44384954|NCT03246529|79390912|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
44384955|NCT03246529|79390913|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
44384956|NCT03246529|79390911|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
44384957|NCT03246529|79390912|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
44384958|NCT03246529|79390913|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
44384959|NCT03033576|79390929|FG000|Overall Study|Ineligible|1|||
44384960|NCT03033576|79390930|FG001|Overall Study|Ineligible|1|||
44384961|NCT03033576|79390929|FG000|Overall Study|Adverse Event|4|||
44384962|NCT03033576|79390930|FG001|Overall Study|Adverse Event|20|||
44384963|NCT03033576|79390929|FG000|Overall Study|Progression/relapse|9|||
44384964|NCT03033576|79390930|FG001|Overall Study|Progression/relapse|36|||
44384965|NCT03033576|79390929|FG000|Overall Study|Death|1|||
44384966|NCT03033576|79390930|FG001|Overall Study|Death|1|||
44384967|NCT03033576|79390929|FG000|Overall Study|Patient refusal|1|||
44384968|NCT03033576|79390930|FG001|Overall Study|Patient refusal|6|||
44384969|NCT03033576|79390929|FG000|Overall Study|Other, unspecified reasons|0|||
44384970|NCT03033576|79390930|FG001|Overall Study|Other, unspecified reasons|4|||
44384971|NCT03033576|79390929|FG000|Overall Study|Currently on protocol therapy|0|||
44384972|NCT03033576|79390930|FG001|Overall Study|Currently on protocol therapy|2|||
44384973|NCT02568423|79390965|FG000|Overall Study|Lost to Follow-up|0|||
44384974|NCT02568423|79390966|FG001|Overall Study|Lost to Follow-up|2|||
44384975|NCT02568423|79390967|FG002|Overall Study|Lost to Follow-up|0|||
44384976|NCT02568423|79390968|FG003|Overall Study|Lost to Follow-up|0|||
44384977|NCT02568423|79390969|FG004|Overall Study|Lost to Follow-up|0|||
44279496|NCT02007096|79240656|FG001|Overall Study|medication not available|0|||
44279497|NCT02007096|79240655|FG000|Overall Study|did not inject saline|0|||
44279498|NCT02007096|79240656|FG001|Overall Study|did not inject saline|3|||
44518356|NCT03533114|79525626|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
44518357|NCT03533114|79525625|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
44518358|NCT03533114|79525626|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
44518359|NCT03533114|79525625|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
44518360|NCT03533114|79525626|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
44518361|NCT03033394|79525634|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
44518362|NCT03033394|79525634|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
44518363|NCT03033394|79525634|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
44518364|NCT03033394|79525634|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
44518365|NCT03033394|79525634|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
44518366|NCT03981822|79525651|FG000|Overall Study|Lost to Follow-up|0|||
44518367|NCT03981822|79525652|FG001|Overall Study|Lost to Follow-up|1|||
44518368|NCT03981822|79525653|FG002|Overall Study|Lost to Follow-up|1|||
44518369|NCT03981822|79525654|FG003|Overall Study|Lost to Follow-up|0|||
44518370|NCT03981822|79525655|FG004|Overall Study|Lost to Follow-up|6|||
44518371|NCT03981822|79525656|FG005|Overall Study|Lost to Follow-up|4|||
44518372|NCT03981822|79525657|FG006|Overall Study|Lost to Follow-up|4|||
44518373|NCT03981822|79525658|FG007|Overall Study|Lost to Follow-up|2|||
44518374|NCT03981822|79525651|FG000|Overall Study|Withdrawal by Subject|0|||
44518375|NCT03981822|79525652|FG001|Overall Study|Withdrawal by Subject|1|||
44384978|NCT02568423|79390970|FG005|Overall Study|Lost to Follow-up|0|||
44384979|NCT02568423|79390971|FG006|Overall Study|Lost to Follow-up|0|||
44518376|NCT03981822|79525653|FG002|Overall Study|Withdrawal by Subject|0|||
44518377|NCT03981822|79525654|FG003|Overall Study|Withdrawal by Subject|0|||
44518378|NCT03981822|79525655|FG004|Overall Study|Withdrawal by Subject|0|||
44518379|NCT03981822|79525656|FG005|Overall Study|Withdrawal by Subject|1|||
44518380|NCT03981822|79525657|FG006|Overall Study|Withdrawal by Subject|0|||
44518381|NCT03981822|79525658|FG007|Overall Study|Withdrawal by Subject|2|||
44518382|NCT03981822|79525651|FG000|Overall Study|COVID-19 Related|0|||
44518383|NCT03981822|79525652|FG001|Overall Study|COVID-19 Related|0|||
44518384|NCT03981822|79525653|FG002|Overall Study|COVID-19 Related|0|||
44518385|NCT03981822|79525654|FG003|Overall Study|COVID-19 Related|0|||
44518386|NCT03981822|79525655|FG004|Overall Study|COVID-19 Related|2|||
44518387|NCT03981822|79525656|FG005|Overall Study|COVID-19 Related|1|||
44518388|NCT03981822|79525657|FG006|Overall Study|COVID-19 Related|2|||
44518389|NCT03981822|79525658|FG007|Overall Study|COVID-19 Related|1|||
44518390|NCT03650556|79525670|FG000|Overall Study|Death|2|||
44518391|NCT03650556|79525670|FG000|Overall Study|Withdrawal by Subject|20|||
44518392|NCT03650556|79525670|FG000|Overall Study|Physician Decision|2|||
44384980|NCT02568423|79390972|FG007|Overall Study|Lost to Follow-up|0|||
44384981|NCT02568423|79390965|FG000|Overall Study|Physician Decision|0|||
44384982|NCT02568423|79390966|FG001|Overall Study|Physician Decision|0|||
44384983|NCT02568423|79390967|FG002|Overall Study|Physician Decision|0|||
44384984|NCT02568423|79390968|FG003|Overall Study|Physician Decision|0|||
44384985|NCT02568423|79390969|FG004|Overall Study|Physician Decision|0|||
44384986|NCT02568423|79390970|FG005|Overall Study|Physician Decision|1|||
44251214|NCT01456130|79086608|FG000|Overall Study|Adverse Event|4|||
44251215|NCT01456130|79086608|FG000|Overall Study|Voluntary Withdrawal|1|||
44251216|NCT01456130|79086608|FG000|Overall Study|Lack of Efficacy|4|||
44251217|NCT01456130|79086608|FG000|Overall Study|Other|1|||
44251218|NCT01456052|79086615|FG000|Overall Study|Adverse Event|1|||
44251219|NCT01456052|79086616|FG001|Overall Study|Adverse Event|1|||
44251220|NCT01456052|79086617|FG002|Overall Study|Adverse Event|2|||
44251221|NCT01456052|79086615|FG000|Overall Study|Consent withdrawn|0|||
44251222|NCT01456052|79086616|FG001|Overall Study|Consent withdrawn|2|||
44251223|NCT01456052|79086617|FG002|Overall Study|Consent withdrawn|1|||
44251224|NCT01456052|79086615|FG000|Overall Study|Protocol Violation|0|||
44251225|NCT01456052|79086616|FG001|Overall Study|Protocol Violation|1|||
44251226|NCT01456052|79086617|FG002|Overall Study|Protocol Violation|0|||
44251227|NCT01456052|79086615|FG000|Overall Study|Physician Decision|1|||
44251228|NCT01456052|79086616|FG001|Overall Study|Physician Decision|0|||
44251229|NCT01456052|79086617|FG002|Overall Study|Physician Decision|1|||
44384987|NCT02568423|79390971|FG006|Overall Study|Physician Decision|0|||
44384988|NCT02568423|79390972|FG007|Overall Study|Physician Decision|0|||
44384989|NCT01970345|79390996|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
44384990|NCT01970345|79390997|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
44384991|NCT01970345|79390996|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
44518393|NCT03650556|79525670|FG000|Overall Study|Lost to Follow-up|8|||
44251230|NCT01456052|79086615|FG000|Overall Study|Treatment Failure|0|||
44251231|NCT01456052|79086616|FG001|Overall Study|Treatment Failure|1|||
44518394|NCT03650556|79525670|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
44518395|NCT03650556|79525670|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
44518396|NCT03531632|79525678|FG000|Overall Study|Adverse Event|0|||
44518397|NCT03531632|79525679|FG001|Overall Study|Adverse Event|0|||
44518398|NCT03531632|79525680|FG002|Overall Study|Adverse Event|1|||
44518399|NCT03531632|79525678|FG000|Overall Study|Death|4|||
44518400|NCT03531632|79525679|FG001|Overall Study|Death|0|||
44518401|NCT03531632|79525680|FG002|Overall Study|Death|14|||
44518402|NCT03531632|79525678|FG000|Overall Study|Study Terminated|1|||
44518403|NCT03531632|79525679|FG001|Overall Study|Study Terminated|3|||
44251232|NCT01456052|79086617|FG002|Overall Study|Treatment Failure|1|||
44251233|NCT01387607|79086628|FG000|Overall Study|Adverse Event|23|||
44251234|NCT01387607|79086629|FG001|Overall Study|Adverse Event|11|||
44251235|NCT01387607|79086628|FG000|Overall Study|Lack of Efficacy|8|||
44251236|NCT01387607|79086629|FG001|Overall Study|Lack of Efficacy|6|||
44251237|NCT01387607|79086628|FG000|Overall Study|Lost to Follow-up|2|||
44251238|NCT01387607|79086629|FG001|Overall Study|Lost to Follow-up|1|||
44251239|NCT01387607|79086628|FG000|Overall Study|No longer meets eligibility criteria|0|||
44251240|NCT01387607|79086629|FG001|Overall Study|No longer meets eligibility criteria|1|||
44251241|NCT01387607|79086628|FG000|Overall Study|Protocol Violation|1|||
44251242|NCT01387607|79086629|FG001|Overall Study|Protocol Violation|5|||
44251243|NCT01387607|79086628|FG000|Overall Study|Withdrawal by Subject|13|||
44251244|NCT01387607|79086629|FG001|Overall Study|Withdrawal by Subject|14|||
44251245|NCT01387607|79086628|FG000|Overall Study|Other|1|||
44251246|NCT01387607|79086629|FG001|Overall Study|Other|1|||
44251247|NCT01387607|79086628|FG000|Overall Study|Randomized, not treated|3|||
44251248|NCT01387607|79086629|FG001|Overall Study|Randomized, not treated|6|||
44251249|NCT03451045|79086638|FG000|Overall Study|Lack of Efficacy|3|||
44251250|NCT03451045|79086639|FG001|Overall Study|Lack of Efficacy|2|||
44251251|NCT03451045|79086640|FG002|Overall Study|Lack of Efficacy|2|||
44251252|NCT03451045|79086638|FG000|Overall Study|Physician Decision|1|||
44251253|NCT03451045|79086639|FG001|Overall Study|Physician Decision|1|||
44251254|NCT03451045|79086640|FG002|Overall Study|Physician Decision|1|||
44251255|NCT03451045|79086638|FG000|Overall Study|Withdrawal by Subject|4|||
44251256|NCT03451045|79086639|FG001|Overall Study|Withdrawal by Subject|0|||
44251257|NCT03451045|79086640|FG002|Overall Study|Withdrawal by Subject|5|||
44251258|NCT03451045|79086638|FG000|Overall Study|Pregnancy|0|||
44251259|NCT03451045|79086639|FG001|Overall Study|Pregnancy|0|||
44251260|NCT03451045|79086640|FG002|Overall Study|Pregnancy|2|||
44251261|NCT03451045|79086638|FG000|Overall Study|Adverse Event|7|||
44251262|NCT03451045|79086639|FG001|Overall Study|Adverse Event|1|||
44251263|NCT03451045|79086640|FG002|Overall Study|Adverse Event|3|||
44251264|NCT03451045|79086638|FG000|Overall Study|Non-compliance with study|2|||
44251265|NCT03451045|79086639|FG001|Overall Study|Non-compliance with study|0|||
44251266|NCT03451045|79086640|FG002|Overall Study|Non-compliance with study|1|||
44251267|NCT03451045|79086638|FG000|Overall Study|any other reason|10|||
44251268|NCT03451045|79086639|FG001|Overall Study|any other reason|2|||
44251269|NCT03451045|79086640|FG002|Overall Study|any other reason|13|||
44251270|NCT03219567|79086651|FG000|Overall Study|Withdrawal by Subject|0|||
44251271|NCT03219567|79086652|FG001|Overall Study|Withdrawal by Subject|1|||
44251272|NCT01386125|79086661|FG000|Overall Study|Lost to Follow-up|3|||
44251273|NCT01386125|79086662|FG001|Overall Study|Lost to Follow-up|9|||
44251274|NCT01386125|79086661|FG000|Overall Study|Physician Decision|0|||
44251275|NCT01386125|79086662|FG001|Overall Study|Physician Decision|1|||
44251276|NCT01386125|79086661|FG000|Overall Study|Protocol Violation|5|||
44251277|NCT01386125|79086662|FG001|Overall Study|Protocol Violation|7|||
44251278|NCT01386125|79086661|FG000|Overall Study|Disease Progress|1|||
44251279|NCT01386125|79086662|FG001|Overall Study|Disease Progress|2|||
44251280|NCT01386125|79086661|FG000|Overall Study|Withdrawal by Subject|13|||
44251281|NCT01386125|79086662|FG001|Overall Study|Withdrawal by Subject|12|||
44251282|NCT01386125|79086661|FG000|Overall Study|Adverse Event|2|||
44251283|NCT01386125|79086662|FG001|Overall Study|Adverse Event|5|||
44251284|NCT01386125|79086661|FG000|Overall Study|Lack of Efficacy|0|||
44251285|NCT01386125|79086662|FG001|Overall Study|Lack of Efficacy|1|||
44251286|NCT01386125|79086661|FG000|Overall Study|Participant Leaving Country|1|||
44251287|NCT01386125|79086662|FG001|Overall Study|Participant Leaving Country|0|||
44251288|NCT01384877|79086670|FG000|Treatment 2|Lost to Follow-up|2|||
44251289|NCT01384877|79086671|FG001|Treatment 2|Lost to Follow-up|2|||
44251290|NCT00114517|79086681|FG000|Overall Study|Adverse Event|6|||
44251291|NCT00114517|79086682|FG001|Overall Study|Adverse Event|1|||
44251292|NCT00114517|79086683|FG002|Overall Study|Adverse Event|6|||
44251293|NCT00114517|79086684|FG003|Overall Study|Adverse Event|3|||
44251294|NCT00114517|79086681|FG000|Overall Study|Lost to Follow-up|2|||
44251295|NCT00114517|79086682|FG001|Overall Study|Lost to Follow-up|2|||
44251296|NCT00114517|79086683|FG002|Overall Study|Lost to Follow-up|2|||
44384992|NCT01970345|79390997|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
44518404|NCT03531632|79525680|FG002|Overall Study|Study Terminated|11|||
44518405|NCT03979638|79525691|FG000|Period 1|Physician Decision|1|||
44518406|NCT03979638|79525692|FG001|Period 1|Physician Decision|1|||
44251297|NCT00114517|79086684|FG003|Overall Study|Lost to Follow-up|1|||
44251298|NCT00114517|79086681|FG000|Overall Study|Too busy|3|||
44251299|NCT00114517|79086682|FG001|Overall Study|Too busy|1|||
44251300|NCT00114517|79086683|FG002|Overall Study|Too busy|1|||
44384993|NCT01735955|79391006|FG000|Overall Study|Administrative problems|1|||
44279499|NCT02007096|79240655|FG000|Overall Study|did not follow postoperative protocol|8|||
44279500|NCT02007096|79240656|FG001|Overall Study|did not follow postoperative protocol|11|||
44279501|NCT02007096|79240655|FG000|Overall Study|converted to open surgery|1|||
44279502|NCT02007096|79240656|FG001|Overall Study|converted to open surgery|1|||
44384994|NCT01735955|79391006|FG000|Overall Study|Patient/guardian decision|1|||
44384995|NCT01735955|79391006|FG000|Overall Study|Patient withdrew consent|2|||
44384996|NCT01735955|79391006|FG000|Overall Study|Physician Decision|4|||
44384997|NCT01735955|79391006|FG000|Overall Study|Disease progression|24|||
44384998|NCT01735955|79391006|FG000|Overall Study|Adverse Event|5|||
44384999|NCT01456221|79391012|FG000|Overall Study|Withdrawal by Subject|56|||
44385000|NCT01456221|79391013|FG001|Overall Study|Withdrawal by Subject|49|||
44145943|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145944|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145945|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145946|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44279503|NCT02007096|79240655|FG000|Overall Study|no mesh placed|0|||
44279504|NCT02007096|79240656|FG001|Overall Study|no mesh placed|1|||
44279505|NCT02006706|79240662|FG000|Overall Study|Lost to Follow-up|1|||
44279506|NCT02049138|79240669|FG000|Overall Study|Adverse Event|46|||
44279507|NCT02049138|79240670|FG001|Overall Study|Adverse Event|25|||
44279508|NCT02049138|79240671|FG002|Overall Study|Adverse Event|1|||
44279509|NCT02049138|79240669|FG000|Overall Study|Withdrawal by Subject|57|||
44279510|NCT02049138|79240670|FG001|Overall Study|Withdrawal by Subject|21|||
44279511|NCT02049138|79240671|FG002|Overall Study|Withdrawal by Subject|5|||
44279512|NCT02049138|79240669|FG000|Overall Study|Lost to Follow-up|18|||
44279513|NCT02049138|79240670|FG001|Overall Study|Lost to Follow-up|5|||
44279514|NCT02049138|79240671|FG002|Overall Study|Lost to Follow-up|1|||
44279515|NCT02049138|79240669|FG000|Overall Study|Lack of Efficacy|10|||
44279516|NCT02049138|79240670|FG001|Overall Study|Lack of Efficacy|26|||
44279517|NCT02049138|79240671|FG002|Overall Study|Lack of Efficacy|1|||
44279518|NCT02049138|79240669|FG000|Overall Study|Non-Compliance|15|||
44279519|NCT02049138|79240670|FG001|Overall Study|Non-Compliance|6|||
44279520|NCT02049138|79240671|FG002|Overall Study|Non-Compliance|0|||
44385001|NCT01456221|79391012|FG000|Overall Study|Lost to Follow-up|1|||
44385002|NCT01456221|79391013|FG001|Overall Study|Lost to Follow-up|4|||
44385003|NCT01456221|79391012|FG000|Overall Study|Received medication|3|||
44385004|NCT01456221|79391013|FG001|Overall Study|Received medication|2|||
44385005|NCT01456221|79391012|FG000|Overall Study|Incomplete data|4|||
44385006|NCT01456221|79391013|FG001|Overall Study|Incomplete data|2|||
44385007|NCT00085202|79391021|FG000|Overall Study|Still on therapy|2|||
44385008|NCT00085202|79391022|FG001|Overall Study|Still on therapy|0|||
44385009|NCT00085202|79391021|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
44385010|NCT00085202|79391022|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
44385011|NCT00085202|79391021|FG000|Overall Study|Excessive toxicity|6|||
44385012|NCT00085202|79391022|FG001|Overall Study|Excessive toxicity|5|||
44385013|NCT00085202|79391021|FG000|Overall Study|Non-specified|3|||
44385014|NCT00085202|79391022|FG001|Overall Study|Non-specified|5|||
44518407|NCT03979638|79525691|FG000|Period 1|Withdrawal by Subject|4|||
44518408|NCT03979638|79525692|FG001|Period 1|Withdrawal by Subject|3|||
44518409|NCT03979638|79525691|FG000|Period 1|Study terminated by Sponsor|1|||
44518410|NCT03979638|79525692|FG001|Period 1|Study terminated by Sponsor|3|||
44518411|NCT03979638|79525691|FG000|Period 1|Protocol Violation|1|||
44518412|NCT03979638|79525692|FG001|Period 1|Protocol Violation|0|||
44518413|NCT03979638|79525691|FG000|Period 2|Study terminated by Sponsor|1|||
44518414|NCT03979638|79525692|FG001|Period 2|Study terminated by Sponsor|1|||
44279521|NCT02049138|79240669|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
44385015|NCT00085202|79391021|FG000|Overall Study|Withdrawal by Subject|2|||
44385016|NCT00085202|79391022|FG001|Overall Study|Withdrawal by Subject|1|||
44385017|NCT00085202|79391021|FG000|Overall Study|Physician Decision|4|||
44279522|NCT02049138|79240670|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
44279523|NCT02049138|79240671|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
44279524|NCT02049138|79240669|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
44279525|NCT02049138|79240670|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
44385018|NCT00085202|79391022|FG001|Overall Study|Physician Decision|1|||
44385019|NCT00085202|79391021|FG000|Overall Study|Progressive disease|1|||
44385020|NCT00085202|79391022|FG001|Overall Study|Progressive disease|11|||
44385021|NCT05066165|79391052|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
44385022|NCT05066165|79391053|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
44385023|NCT05066165|79391052|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
44385024|NCT05066165|79391053|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
44385025|NCT04731298|79391065|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
44385026|NCT04731298|79391066|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
44385027|NCT04676412|79391075|FG000|Overall Study|Death|17|||
44385028|NCT04676412|79391076|FG001|Overall Study|Death|23|||
44385029|NCT04676412|79391075|FG000|Overall Study|Withdrawal by Subject|0|||
44385030|NCT04676412|79391076|FG001|Overall Study|Withdrawal by Subject|2|||
44385031|NCT04676412|79391075|FG000|Overall Study|Participants ongoing|32|||
44385032|NCT04676412|79391076|FG001|Overall Study|Participants ongoing|33|||
44385033|NCT04641975|79391086|FG000|Overall Study|Protocol Violation|1|||
44385034|NCT04641975|79391087|FG001|Overall Study|Protocol Violation|2|||
44385035|NCT04641975|79391088|FG002|Overall Study|Protocol Violation|0|||
44385036|NCT04641975|79391089|FG003|Overall Study|Protocol Violation|0|||
44385037|NCT04641975|79391086|FG000|Overall Study|Adverse Event|0|||
44385038|NCT04641975|79391087|FG001|Overall Study|Adverse Event|0|||
44385039|NCT04641975|79391088|FG002|Overall Study|Adverse Event|1|||
44385040|NCT04641975|79391089|FG003|Overall Study|Adverse Event|1|||
44385041|NCT04641975|79391086|FG000|Overall Study|Withdrawal by Subject|1|||
44385042|NCT04641975|79391087|FG001|Overall Study|Withdrawal by Subject|0|||
44385043|NCT04641975|79391088|FG002|Overall Study|Withdrawal by Subject|0|||
44385044|NCT04641975|79391089|FG003|Overall Study|Withdrawal by Subject|0|||
44385045|NCT04633200|79391104|FG000|Overall Study|Lost to Follow-up|3|||
44385046|NCT04633200|79391105|FG001|Overall Study|Lost to Follow-up|5|||
44385047|NCT03439137|79391132|FG000|Overall Study|Adverse Event|16|||
44385048|NCT03439137|79391133|FG001|Overall Study|Adverse Event|12|||
44385049|NCT03439137|79391132|FG000|Overall Study|Physician Decision|0|||
44385050|NCT03439137|79391133|FG001|Overall Study|Physician Decision|5|||
44385051|NCT03439137|79391132|FG000|Overall Study|Withdrawal by Subject|14|||
44385052|NCT03439137|79391133|FG001|Overall Study|Withdrawal by Subject|4|||
44385053|NCT03439137|79391132|FG000|Overall Study|Conducting rescue therapy|2|||
44385054|NCT03439137|79391133|FG001|Overall Study|Conducting rescue therapy|1|||
44385055|NCT03439137|79391132|FG000|Overall Study|Difficult to control Hb|10|||
44385056|NCT03439137|79391133|FG001|Overall Study|Difficult to control Hb|2|||
44385057|NCT03439137|79391132|FG000|Overall Study|Initiation of a renal transplant|0|||
44385058|NCT03439137|79391133|FG001|Overall Study|Initiation of a renal transplant|2|||
44385059|NCT03402386|79391139|FG000|Overall Study|Adverse Event|3|||
44279526|NCT02049138|79240671|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
44385060|NCT03402386|79391139|FG000|Overall Study|Physician Decision|1|||
44385061|NCT03402386|79391139|FG000|Overall Study|Difficult to control Hb|2|||
44385062|NCT03329196|79391145|FG000|Overall Study|Adverse Event|10|||
44385063|NCT03329196|79391146|FG001|Overall Study|Adverse Event|5|||
44385064|NCT03329196|79391145|FG000|Overall Study|Physician Decision|2|||
44385065|NCT03329196|79391146|FG001|Overall Study|Physician Decision|2|||
44385066|NCT03329196|79391145|FG000|Overall Study|Withdrawal by Subject|11|||
44385067|NCT03329196|79391146|FG001|Overall Study|Withdrawal by Subject|3|||
44385068|NCT03329196|79391145|FG000|Overall Study|Hepatic function abnormalities|0|||
44279527|NCT02049138|79240669|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
44279528|NCT02049138|79240670|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
44279529|NCT02049138|79240671|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
44279530|NCT02049138|79240669|FG000|Overall Study|Other|15|||
44279531|NCT02049138|79240670|FG001|Overall Study|Other|13|||
44279532|NCT02049138|79240671|FG002|Overall Study|Other|0|||
44279533|NCT02049138|79240669|FG000|Overall Study|Missing|0|||
44279534|NCT02049138|79240670|FG001|Overall Study|Missing|1|||
44279535|NCT02049138|79240671|FG002|Overall Study|Missing|0|||
44279536|NCT02048904|79240682|FG000|Overall Study|Withdrawal by Subject|7|||
44385069|NCT03329196|79391146|FG001|Overall Study|Hepatic function abnormalities|1|||
44385070|NCT03329196|79391145|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
44279537|NCT02048904|79240682|FG000|Overall Study|Physician Decision|70|||
44279538|NCT02006628|79240688|FG000|Overall Study|Adverse Event|1|||
44279539|NCT02006628|79240689|FG001|Overall Study|Adverse Event|1|||
44385071|NCT03329196|79391146|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
44385072|NCT03329196|79391145|FG000|Overall Study|Difficult to control Hb|2|||
44385073|NCT03329196|79391146|FG001|Overall Study|Difficult to control Hb|3|||
44385074|NCT03329196|79391145|FG000|Overall Study|Dialysis or renal transplant|13|||
44385075|NCT03329196|79391146|FG001|Overall Study|Dialysis or renal transplant|15|||
44385076|NCT02949219|79391152|FG000|Overall Study|Withdrawal by Subject|1|||
44385077|NCT02873195|79391162|FG000|Overall Study|Ineligible|5|||
44385078|NCT02873195|79391163|FG001|Overall Study|Ineligible|0|||
44385079|NCT02026232|79391186|FG000|Overall Study|incomplete visit/missing data|3|||
44385080|NCT02026232|79391187|FG001|Overall Study|incomplete visit/missing data|2|||
44385081|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
44385082|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
44385083|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
44385084|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
44385085|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
44385086|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
44385087|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
44385088|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
44385089|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
44385090|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
44385091|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
44385092|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
44385093|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
44385094|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
44385095|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
44385096|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
44385097|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
44385098|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
44385099|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
44385100|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
44385101|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
44385102|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
44385103|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
44385104|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
44385105|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
44385106|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
44385107|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
44385108|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
44385109|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
44385110|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
44385111|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
44385112|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
44385113|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
44385114|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
44385115|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
44385116|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
44385117|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
44385118|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
44385119|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
44385120|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
44385121|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
44385122|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
44518415|NCT03655054|79525707|FG000|Overall Study|Lost to Follow-up|1|||
44279540|NCT02006628|79240688|FG000|Overall Study|Withdrawal by Subject|2|||
44279541|NCT02006628|79240689|FG001|Overall Study|Withdrawal by Subject|1|||
44279542|NCT02048826|79240697|FG000|Overall Study|Withdrawal by Subject|1|||
44279543|NCT02048826|79240698|FG001|Overall Study|Withdrawal by Subject|0|||
44279544|NCT02006472|79240709|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
44279545|NCT02006472|79240710|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
44279546|NCT02006472|79240711|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
44279547|NCT02006472|79240712|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
44251301|NCT00114517|79086684|FG003|Overall Study|Too busy|2|||
44279548|NCT02006472|79240713|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
44279549|NCT02006472|79240709|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
44279550|NCT02006472|79240710|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
44279551|NCT02006472|79240711|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
44279552|NCT02006472|79240712|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
44279553|NCT02006472|79240713|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
44279554|NCT02006472|79240709|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
44279555|NCT02006472|79240710|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
44279556|NCT02006472|79240711|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
44279557|NCT02006472|79240712|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
44279558|NCT02006472|79240713|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
44279559|NCT02006472|79240709|FG000|Period 1 (Through Week 26)|Other|1|||
44279560|NCT02006472|79240710|FG001|Period 1 (Through Week 26)|Other|5|||
44279561|NCT02006472|79240711|FG002|Period 1 (Through Week 26)|Other|0|||
44279562|NCT02006472|79240712|FG003|Period 1 (Through Week 26)|Other|2|||
44279563|NCT02006472|79240713|FG004|Period 1 (Through Week 26)|Other|3|||
44385123|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
44385124|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
44385125|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
44385126|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
44385127|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
44385128|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
44385129|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
44385130|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
44385131|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
44518416|NCT03615144|79525713|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
44518417|NCT03615144|79525714|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
44518418|NCT03682302|79525724|FG000|Overall Study|Lost to Follow-up|1|||
44518419|NCT03682302|79525725|FG001|Overall Study|Lost to Follow-up|2|||
44518420|NCT03682302|79525726|FG002|Overall Study|Lost to Follow-up|0|||
44518421|NCT03682302|79525727|FG003|Overall Study|Lost to Follow-up|1|||
44518422|NCT03682302|79525724|FG000|Overall Study|Study drug was not administered|0|||
44518423|NCT03682302|79525725|FG001|Overall Study|Study drug was not administered|0|||
44518424|NCT03682302|79525726|FG002|Overall Study|Study drug was not administered|1|||
44518425|NCT03682302|79525727|FG003|Overall Study|Study drug was not administered|1|||
44518426|NCT03522506|79525741|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44518427|NCT03522506|79525742|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44518428|NCT03522506|79525743|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44518429|NCT03522506|79525744|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
44518430|NCT03522506|79525741|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44518431|NCT03522506|79525742|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44518432|NCT03522506|79525743|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
44518433|NCT03522506|79525744|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
44518434|NCT02892734|79525775|FG000|Treatment on Study|Progressive Disease|2|||
44518435|NCT02892734|79525775|FG000|Follow up for 2 Years|Death|2|||
44518436|NCT02892734|79525775|FG000|Follow up for 2 Years|Study closed early|1|||
44518437|NCT00055497|79525783|FG000|Overall Study|Adverse Event|1|||
44518438|NCT00055497|79525784|FG001|Overall Study|Adverse Event|1|||
44518439|NCT00055497|79525785|FG002|Overall Study|Adverse Event|1|||
44518440|NCT00055497|79525786|FG003|Overall Study|Adverse Event|28|||
44518441|NCT00055497|79525783|FG000|Overall Study|Withdrawal by Subject|3|||
44518442|NCT00055497|79525784|FG001|Overall Study|Withdrawal by Subject|1|||
44518443|NCT00055497|79525785|FG002|Overall Study|Withdrawal by Subject|1|||
44518444|NCT00055497|79525786|FG003|Overall Study|Withdrawal by Subject|15|||
44518445|NCT00055497|79525783|FG000|Overall Study|Lost to Follow-up|0|||
44518446|NCT00055497|79525784|FG001|Overall Study|Lost to Follow-up|1|||
44518447|NCT00055497|79525785|FG002|Overall Study|Lost to Follow-up|0|||
44518448|NCT00055497|79525786|FG003|Overall Study|Lost to Follow-up|5|||
44518449|NCT00055497|79525783|FG000|Overall Study|Protocol Violation|0|||
44518450|NCT00055497|79525784|FG001|Overall Study|Protocol Violation|0|||
44518451|NCT00055497|79525785|FG002|Overall Study|Protocol Violation|0|||
44518452|NCT00055497|79525786|FG003|Overall Study|Protocol Violation|3|||
44518453|NCT00055497|79525783|FG000|Overall Study|Lack of Efficacy|1|||
44145947|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44518454|NCT00055497|79525784|FG001|Overall Study|Lack of Efficacy|0|||
44518455|NCT00055497|79525785|FG002|Overall Study|Lack of Efficacy|0|||
44518456|NCT00055497|79525786|FG003|Overall Study|Lack of Efficacy|27|||
44518457|NCT00055497|79525783|FG000|Overall Study|Administrative Reasons|0|||
44518458|NCT00055497|79525784|FG001|Overall Study|Administrative Reasons|0|||
44518459|NCT00055497|79525785|FG002|Overall Study|Administrative Reasons|0|||
44145948|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44279564|NCT02006472|79240709|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
44518460|NCT00055497|79525786|FG003|Overall Study|Administrative Reasons|1|||
44518461|NCT00055497|79525783|FG000|Overall Study|Other|0|||
44518462|NCT00055497|79525784|FG001|Overall Study|Other|0|||
44518463|NCT00055497|79525785|FG002|Overall Study|Other|0|||
44518464|NCT00055497|79525786|FG003|Overall Study|Other|11|||
44518465|NCT03615066|79525804|FG000|Main Study|Withdrew Consent|0|||
44518466|NCT03615066|79525805|FG001|Main Study|Withdrew Consent|1|||
44518467|NCT03615066|79525806|FG002|Main Study|Withdrew Consent|1|||
44145949|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44385132|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
44385133|NCT02008357|79391195|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
44385134|NCT02008357|79391196|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
44385135|NCT02008357|79391195|FG000|Open-label Extension Period|Adverse Event|8|||
44385136|NCT02008357|79391196|FG001|Open-label Extension Period|Adverse Event|7|||
44385137|NCT02008357|79391195|FG000|Open-label Extension Period|Death|7|||
44385138|NCT02008357|79391196|FG001|Open-label Extension Period|Death|4|||
44385139|NCT02008357|79391195|FG000|Open-label Extension Period|Lack of Efficacy|9|||
44385140|NCT02008357|79391196|FG001|Open-label Extension Period|Lack of Efficacy|5|||
44385141|NCT02008357|79391195|FG000|Open-label Extension Period|Lost to Follow-up|2|||
44385142|NCT02008357|79391196|FG001|Open-label Extension Period|Lost to Follow-up|2|||
44385143|NCT02008357|79391195|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
44385144|NCT02008357|79391196|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
44385145|NCT02008357|79391195|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
44385146|NCT02008357|79391196|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
44385147|NCT02008357|79391195|FG000|Open-label Extension Period|Safety Risk|2|||
44385148|NCT02008357|79391196|FG001|Open-label Extension Period|Safety Risk|1|||
44385149|NCT02008357|79391195|FG000|Open-label Extension Period|Non-Compliance|0|||
44385150|NCT02008357|79391196|FG001|Open-label Extension Period|Non-Compliance|1|||
44518468|NCT03615066|79525804|FG000|Main Study|Lost to Follow-up|0|||
44145950|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145951|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145952|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145953|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145954|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145955|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
44145956|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
44145957|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
44145958|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
44145959|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145960|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145961|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145962|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145963|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145964|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145965|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145966|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44251302|NCT00114517|79086681|FG000|Overall Study|Moved from area|0|||
44251303|NCT00114517|79086682|FG001|Overall Study|Moved from area|3|||
44251304|NCT00114517|79086683|FG002|Overall Study|Moved from area|2|||
44251305|NCT00114517|79086684|FG003|Overall Study|Moved from area|1|||
44251306|NCT00114517|79086681|FG000|Overall Study|Did not want estradiol|1|||
44251307|NCT00114517|79086682|FG001|Overall Study|Did not want estradiol|1|||
44279565|NCT02006472|79240710|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
44279566|NCT02006472|79240711|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
44279567|NCT02006472|79240712|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
44279568|NCT02006472|79240713|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
44279569|NCT02006472|79240709|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
44279570|NCT02006472|79240710|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
44279571|NCT02006472|79240711|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
44279572|NCT02006472|79240712|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
44385151|NCT02008357|79391195|FG000|Open-label Extension Period|Investigator Recommendation|0|||
44518469|NCT03615066|79525805|FG001|Main Study|Lost to Follow-up|0|||
44518470|NCT03615066|79525806|FG002|Main Study|Lost to Follow-up|1|||
44251308|NCT00114517|79086683|FG002|Overall Study|Did not want estradiol|0|||
44251309|NCT00114517|79086684|FG003|Overall Study|Did not want estradiol|0|||
44251310|NCT00114517|79086681|FG000|Overall Study|Armed-services duty|0|||
44251311|NCT00114517|79086682|FG001|Overall Study|Armed-services duty|1|||
44251312|NCT00114517|79086683|FG002|Overall Study|Armed-services duty|0|||
44251313|NCT00114517|79086684|FG003|Overall Study|Armed-services duty|1|||
44518471|NCT03615066|79525804|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
44518472|NCT03615066|79525805|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
44518473|NCT03615066|79525806|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
44518474|NCT03615066|79525804|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
44279573|NCT02006472|79240713|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
44279574|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
44279575|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
44279576|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
44279577|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
44279578|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
44279579|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
44279580|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
44279581|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
44279582|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
44279583|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
44279584|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
44279585|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
44279586|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
44279587|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
44279588|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
44279589|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Other|0|||
44279590|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Other|1|||
44279591|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Other|0|||
44279592|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Other|1|||
44279593|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Other|0|||
44279594|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Not treated|0|||
44279595|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Not treated|0|||
44279596|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Not treated|2|||
44279597|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Not treated|0|||
44279598|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Not treated|0|||
44279599|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
44279600|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
44279601|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
44279602|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
44279603|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
44279604|NCT02006472|79240709|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
44279605|NCT02006472|79240710|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
44279606|NCT02006472|79240711|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
44279607|NCT02006472|79240712|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
44279608|NCT02006472|79240713|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
44279609|NCT02005692|79240730|FG000|Overall Study|Protocol Violation|1|||
44279610|NCT02005692|79240730|FG000|Overall Study|Withdrawal by Subject|1|||
44279611|NCT02005692|79240730|FG000|Overall Study|Discharged earlier than anticipated|5|||
44279612|NCT02029638|79240738|FG000|Overall Study|Death|0|||
44279613|NCT02029638|79240739|FG001|Overall Study|Death|0|||
44279614|NCT02029638|79240740|FG002|Overall Study|Death|1|||
44279615|NCT02029638|79240738|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
44279616|NCT02029638|79240739|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
44279617|NCT02029638|79240740|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
44279618|NCT02047734|79240751|FG000|Overall Study|Adverse Event|18|||
44279619|NCT02047734|79240752|FG001|Overall Study|Adverse Event|13|||
44279620|NCT02047734|79240753|FG002|Overall Study|Adverse Event|13|||
44279621|NCT02047734|79240751|FG000|Overall Study|Lack of Efficacy|4|||
44279622|NCT02047734|79240752|FG001|Overall Study|Lack of Efficacy|5|||
44279623|NCT02047734|79240753|FG002|Overall Study|Lack of Efficacy|1|||
44279624|NCT02047734|79240751|FG000|Overall Study|Protocol Violation|3|||
44279625|NCT02047734|79240752|FG001|Overall Study|Protocol Violation|1|||
44279626|NCT02047734|79240753|FG002|Overall Study|Protocol Violation|1|||
44279627|NCT02047734|79240751|FG000|Overall Study|Lost to Follow-up|1|||
44279628|NCT02047734|79240752|FG001|Overall Study|Lost to Follow-up|4|||
44279629|NCT02047734|79240753|FG002|Overall Study|Lost to Follow-up|0|||
44279630|NCT02047734|79240751|FG000|Overall Study|Death|0|||
44279631|NCT02047734|79240752|FG001|Overall Study|Death|1|||
44279632|NCT02047734|79240753|FG002|Overall Study|Death|0|||
44518475|NCT03615066|79525805|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
44279633|NCT02047734|79240751|FG000|Overall Study|Withdrawal by Subject|30|||
44279634|NCT02047734|79240752|FG001|Overall Study|Withdrawal by Subject|31|||
44279635|NCT02047734|79240753|FG002|Overall Study|Withdrawal by Subject|19|||
44279636|NCT02047734|79240751|FG000|Overall Study|Physician Decision|7|||
44279637|NCT02047734|79240752|FG001|Overall Study|Physician Decision|6|||
44279638|NCT02047734|79240753|FG002|Overall Study|Physician Decision|5|||
44279639|NCT02047734|79240751|FG000|Overall Study|Miscellaneous|2|||
44279640|NCT02047734|79240752|FG001|Overall Study|Miscellaneous|4|||
44279641|NCT02047734|79240753|FG002|Overall Study|Miscellaneous|6|||
44518476|NCT03615066|79525806|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
44145967|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44279642|NCT02047734|79240751|FG000|Overall Study|Did Not Receive Study Drug|2|||
44279643|NCT02047734|79240752|FG001|Overall Study|Did Not Receive Study Drug|4|||
44279644|NCT02047734|79240753|FG002|Overall Study|Did Not Receive Study Drug|1|||
44279645|NCT02053350|79240761|FG000|Overall Study|Withdrawal by Subject|1|||
44279646|NCT02053350|79240761|FG000|Overall Study|Adverse Event|4|||
44279647|NCT01994850|79240765|FG000|Overall Study|Physician Decision|1|||
44279648|NCT01994850|79240765|FG000|Overall Study|Withdrawal by Subject|1|||
44279649|NCT02027844|79240772|FG000|Overall Study|Withdrawal by Subject|3|||
44279650|NCT02027844|79240773|FG001|Overall Study|Withdrawal by Subject|2|||
44279651|NCT02027844|79240774|FG002|Overall Study|Withdrawal by Subject|1|||
44385152|NCT02008357|79391196|FG001|Open-label Extension Period|Investigator Recommendation|1|||
44385153|NCT02008357|79391195|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
44385154|NCT02008357|79391196|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
44385155|NCT02008357|79391195|FG000|Open-label Extension Period|Coordinating Center Request|2|||
44385156|NCT02008357|79391196|FG001|Open-label Extension Period|Coordinating Center Request|4|||
44385157|NCT02008357|79391195|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
44385158|NCT02008357|79391196|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
44385159|NCT02008357|79391195|FG000|Open-label Extension Period|Study Ended|20|||
44385160|NCT02008357|79391196|FG001|Open-label Extension Period|Study Ended|25|||
44385161|NCT02008357|79391195|FG000|Open-label Extension Period|Personal Reasons|0|||
44385162|NCT02008357|79391196|FG001|Open-label Extension Period|Personal Reasons|1|||
44385163|NCT02008357|79391195|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
44385164|NCT02008357|79391196|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
44385165|NCT02008357|79391195|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
44385166|NCT02008357|79391196|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
44385167|NCT02008357|79391195|FG000|Open-label Extension Period|Other|2|||
44385168|NCT02008357|79391196|FG001|Open-label Extension Period|Other|0|||
44385169|NCT01784068|79391206|FG000|NTCS Phase|Adverse Event|5|||
44385170|NCT01784068|79391207|FG001|NTCS Phase|Adverse Event|0|||
44385171|NCT01784068|79391206|FG000|NTCS Phase|Physician Decision|2|||
44385172|NCT01784068|79391207|FG001|NTCS Phase|Physician Decision|0|||
44385173|NCT01784068|79391206|FG000|NTCS Phase|Patient/guardian decision|3|||
44385174|NCT01784068|79391207|FG001|NTCS Phase|Patient/guardian decision|0|||
44385175|NCT01784068|79391206|FG000|NTCS Phase|Death|2|||
44385176|NCT01784068|79391207|FG001|NTCS Phase|Death|0|||
44385177|NCT01784068|79391206|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
44385178|NCT01784068|79391207|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
44385179|NCT01784068|79391206|FG000|TFR Phase|Physician Decision|0|||
44385180|NCT01784068|79391207|FG001|TFR Phase|Physician Decision|1|||
44385181|NCT01784068|79391206|FG000|TFR Phase|Patient/guardian decision|0|||
44385182|NCT01784068|79391207|FG001|TFR Phase|Patient/guardian decision|3|||
44385183|NCT01784068|79391206|FG000|TFR Phase|Death|0|||
44385184|NCT01784068|79391207|FG001|TFR Phase|Death|1|||
44385185|NCT01784068|79391206|FG000|TFR Phase|Lack of Efficacy|0|||
44385186|NCT01784068|79391207|FG001|TFR Phase|Lack of Efficacy|88|||
44385187|NCT00775463|79391220|FG000|Overall Study|Withdrawal by Subject|0|||
44385188|NCT00775463|79391221|FG001|Overall Study|Withdrawal by Subject|1|||
44385189|NCT00775463|79391220|FG000|Overall Study|Adverse Event|7|||
44385190|NCT00775463|79391221|FG001|Overall Study|Adverse Event|9|||
44518477|NCT03615066|79525804|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
44518478|NCT03615066|79525805|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
44518479|NCT03615066|79525806|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
44518480|NCT03527966|79525820|FG000|Overall Study|Lost to Follow-up|3|||
44518481|NCT03527966|79525821|FG001|Overall Study|Lost to Follow-up|0|||
44145968|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44279652|NCT02027844|79240772|FG000|Overall Study|Lost to Follow-up|0|||
44279653|NCT02027844|79240773|FG001|Overall Study|Lost to Follow-up|2|||
44279654|NCT02027844|79240774|FG002|Overall Study|Lost to Follow-up|1|||
44385191|NCT00775463|79391220|FG000|Overall Study|Protocol Violation|2|||
44518482|NCT03808545|79525829|FG000|Overall Study|Withdrawal by Subject|1|||
44518483|NCT03808545|79525830|FG001|Overall Study|Withdrawal by Subject|1|||
44518484|NCT03807843|79525839|FG000|Overall Study|Lost to Follow-up|1|||
44518485|NCT03807843|79525840|FG001|Overall Study|Lost to Follow-up|0|||
44385192|NCT00775463|79391221|FG001|Overall Study|Protocol Violation|2|||
44385193|NCT00775463|79391220|FG000|Overall Study|Lost to Follow-up|1|||
44385194|NCT00775463|79391221|FG001|Overall Study|Lost to Follow-up|0|||
44385195|NCT00775463|79391220|FG000|Overall Study|Lack of Efficacy|1|||
44385196|NCT00775463|79391221|FG001|Overall Study|Lack of Efficacy|1|||
44518486|NCT03519932|79525846|FG000|First Intervention|Adverse Event|1|||
44145969|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44279655|NCT02027844|79240772|FG000|Overall Study|Protocol Violation|0|||
44518487|NCT03519932|79525847|FG001|First Intervention|Adverse Event|3|||
44279656|NCT02027844|79240773|FG001|Overall Study|Protocol Violation|2|||
44279657|NCT02027844|79240774|FG002|Overall Study|Protocol Violation|0|||
44145970|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44518488|NCT03806127|79525860|FG000|Overall Study|Withdrawal by Subject|4|||
44518489|NCT03806127|79525861|FG001|Overall Study|Withdrawal by Subject|5|||
44518490|NCT03806127|79525860|FG000|Overall Study|Protocol Violation|3|||
44518491|NCT03806127|79525861|FG001|Overall Study|Protocol Violation|1|||
44518492|NCT03806127|79525860|FG000|Overall Study|Adverse Event|3|||
44518493|NCT03806127|79525861|FG001|Overall Study|Adverse Event|0|||
44518494|NCT03806127|79525860|FG000|Overall Study|Unable to Complete Procedures|0|||
44518495|NCT03806127|79525861|FG001|Overall Study|Unable to Complete Procedures|1|||
44518496|NCT03806127|79525860|FG000|Overall Study|Pregnancy|0|||
44518497|NCT03806127|79525861|FG001|Overall Study|Pregnancy|1|||
44518498|NCT03806127|79525860|FG000|Overall Study|Lost to Follow-up|5|||
44518499|NCT03806127|79525861|FG001|Overall Study|Lost to Follow-up|1|||
44518500|NCT03806127|79525860|FG000|Overall Study|Physician Decision|1|||
44518501|NCT03806127|79525861|FG001|Overall Study|Physician Decision|1|||
44518502|NCT03806127|79525860|FG000|Overall Study|Could Not Come Due to Covid|1|||
44518503|NCT03806127|79525861|FG001|Overall Study|Could Not Come Due to Covid|0|||
44518504|NCT03806127|79525860|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
44518505|NCT03806127|79525861|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
44518506|NCT03806127|79525860|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
44518507|NCT03806127|79525861|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
44518508|NCT03806127|79525860|FG000|Overall Study|Covid 19 Restrictions|2|||
44518509|NCT03806127|79525861|FG001|Overall Study|Covid 19 Restrictions|0|||
44518510|NCT03806127|79525860|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
44518511|NCT03806127|79525861|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
44518512|NCT03806127|79525860|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
44518513|NCT03806127|79525861|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
44518514|NCT03650400|79525869|FG000|Overall Study|Study terminated by sponsor|0|||
44518515|NCT03650400|79525870|FG001|Overall Study|Study terminated by sponsor|5|||
44518516|NCT00038103|79525878|FG000|Overall Study|Adverse Event|5|||
44518517|NCT00038103|79525879|FG001|Overall Study|Adverse Event|6|||
44518518|NCT00038103|79525878|FG000|Overall Study|Lack of Efficacy|48|||
44518519|NCT00038103|79525879|FG001|Overall Study|Lack of Efficacy|41|||
44518520|NCT00038103|79525878|FG000|Overall Study|Withdrawal by Subject|0|||
44518521|NCT00038103|79525879|FG001|Overall Study|Withdrawal by Subject|3|||
44518522|NCT00038103|79525878|FG000|Overall Study|Lost to Follow-up|0|||
44518523|NCT00038103|79525879|FG001|Overall Study|Lost to Follow-up|3|||
44518524|NCT00038103|79525878|FG000|Overall Study|Protocol Violation|0|||
44518525|NCT00038103|79525879|FG001|Overall Study|Protocol Violation|2|||
44518526|NCT00038103|79525878|FG000|Overall Study|Sponsor Decision|0|||
44518527|NCT00038103|79525879|FG001|Overall Study|Sponsor Decision|1|||
44518528|NCT00038103|79525878|FG000|Overall Study|Randomized/never treated|2|||
44145971|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44279658|NCT02027844|79240772|FG000|Overall Study|Incomlete data|2|||
44279659|NCT02027844|79240773|FG001|Overall Study|Incomlete data|0|||
44279660|NCT02027844|79240774|FG002|Overall Study|Incomlete data|0|||
44279661|NCT01994382|79240799|FG000|Overall Study|Informed consent withdrawn|0|||
44279662|NCT01994382|79240800|FG001|Overall Study|Informed consent withdrawn|0|||
44279663|NCT01994382|79240801|FG002|Overall Study|Informed consent withdrawn|0|||
44279664|NCT01994382|79240802|FG003|Overall Study|Informed consent withdrawn|0|||
44279665|NCT01994382|79240803|FG004|Overall Study|Informed consent withdrawn|0|||
44518529|NCT00038103|79525879|FG001|Overall Study|Randomized/never treated|0|||
44518530|NCT03680742|79525885|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
44518531|NCT03678870|79525891|FG000|Overall Study|prescribed non- protocol medications|10|||
44518532|NCT03678870|79525892|FG001|Overall Study|prescribed non- protocol medications|6|||
44518533|NCT03678870|79525891|FG000|Overall Study|Lost to Follow-up|3|||
44518534|NCT03678870|79525892|FG001|Overall Study|Lost to Follow-up|2|||
44518535|NCT03805971|79525898|FG000|Overall Study|Withdrawal by Subject|1|||
44279666|NCT01994382|79240804|FG005|Overall Study|Informed consent withdrawn|0|||
44279667|NCT01994382|79240805|FG006|Overall Study|Informed consent withdrawn|1|||
44518536|NCT03805971|79525898|FG000|Overall Study|Protocol Violation|2|||
44518537|NCT03032380|79525905|FG000|Overall Study|Adverse Event|0|||
44518538|NCT03032380|79525906|FG001|Overall Study|Adverse Event|1|||
44518539|NCT03032380|79525905|FG000|Overall Study|Lack of Efficacy|1|||
44518540|NCT03032380|79525906|FG001|Overall Study|Lack of Efficacy|0|||
44518541|NCT03032380|79525905|FG000|Overall Study|Withdrawal by Subject|2|||
44518542|NCT03032380|79525906|FG001|Overall Study|Withdrawal by Subject|3|||
44518543|NCT03032380|79525905|FG000|Overall Study|Recovery|0|||
44518544|NCT03032380|79525906|FG001|Overall Study|Recovery|1|||
44518545|NCT03032380|79525905|FG000|Overall Study|Death|39|||
44518546|NCT03032380|79525906|FG001|Overall Study|Death|34|||
44518547|NCT03032380|79525905|FG000|Overall Study|Other - Miscellaneous|0|||
44145972|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44385197|NCT00406640|79391235|FG000|Acute Phase|Adverse Event|18|||
44385198|NCT00406640|79391236|FG001|Acute Phase|Adverse Event|13|||
44385199|NCT00406640|79391235|FG000|Acute Phase|Failed to Return|5|||
44385200|NCT00406640|79391236|FG001|Acute Phase|Failed to Return|1|||
44385201|NCT00406640|79391235|FG000|Acute Phase|Physician Decision|0|||
44385202|NCT00406640|79391236|FG001|Acute Phase|Physician Decision|1|||
44385203|NCT00406640|79391235|FG000|Acute Phase|Lost to Follow-up|7|||
44385204|NCT00406640|79391236|FG001|Acute Phase|Lost to Follow-up|4|||
44385205|NCT00406640|79391235|FG000|Acute Phase|Protocol deviation|4|||
44385206|NCT00406640|79391236|FG001|Acute Phase|Protocol deviation|10|||
44385207|NCT00406640|79391235|FG000|Acute Phase|Protocol Violation|3|||
44385208|NCT00406640|79391236|FG001|Acute Phase|Protocol Violation|2|||
44385209|NCT00406640|79391235|FG000|Acute Phase|Withdrawal by Subject|11|||
44385210|NCT00406640|79391236|FG001|Acute Phase|Withdrawal by Subject|9|||
44385211|NCT00406640|79391235|FG000|Acute Phase|Lack of Efficacy|3|||
44385212|NCT00406640|79391236|FG001|Acute Phase|Lack of Efficacy|3|||
44385213|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
44385214|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
44385215|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Death|1|||
44385216|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Death|0|||
44518548|NCT03032380|79525906|FG001|Overall Study|Other - Miscellaneous|1|||
44518549|NCT03519854|79525930|FG000|Overall Study|Technical Error|0|||
44518550|NCT03519854|79525931|FG001|Overall Study|Technical Error|0|||
44518551|NCT03519854|79525932|FG002|Overall Study|Technical Error|1|||
44518552|NCT03519854|79525933|FG003|Overall Study|Technical Error|0|||
44518553|NCT03519854|79525934|FG004|Overall Study|Technical Error|0|||
44518554|NCT03519854|79525935|FG005|Overall Study|Technical Error|0|||
44518555|NCT03519854|79525936|FG006|Overall Study|Technical Error|0|||
44518556|NCT03519854|79525937|FG007|Overall Study|Technical Error|0|||
44518557|NCT03519854|79525938|FG008|Overall Study|Technical Error|0|||
44518558|NCT03519854|79525939|FG009|Overall Study|Technical Error|0|||
44518559|NCT03519854|79525940|FG010|Overall Study|Technical Error|0|||
44518560|NCT03519854|79525941|FG011|Overall Study|Technical Error|0|||
44518561|NCT03519854|79525942|FG012|Overall Study|Technical Error|0|||
44518562|NCT03519854|79525943|FG013|Overall Study|Technical Error|0|||
44518563|NCT03519854|79525944|FG014|Overall Study|Technical Error|0|||
44518564|NCT03519854|79525945|FG015|Overall Study|Technical Error|0|||
44518565|NCT03519854|79525946|FG016|Overall Study|Technical Error|0|||
44518566|NCT03519854|79525947|FG017|Overall Study|Technical Error|0|||
44518567|NCT03479216|79525987|FG000|Overall Study|Withdrawal by Subject|3|||
44518568|NCT03479216|79525988|FG001|Overall Study|Withdrawal by Subject|2|||
44518569|NCT03479216|79525987|FG000|Overall Study|Physician Decision|2|||
44518570|NCT03479216|79525988|FG001|Overall Study|Physician Decision|3|||
44518571|NCT03518840|79525994|FG000|Overall Study|Lost to Follow-up|6|||
44518572|NCT03436082|79526003|FG000|Overall Study|Did not undergo procedure|1|||
44518573|NCT03436082|79526004|FG001|Overall Study|Did not undergo procedure|0|||
44518574|NCT03677934|79526012|FG000|Overall Study|Adverse Event|1|||
44518575|NCT03677934|79526013|FG001|Overall Study|Adverse Event|1|||
44518576|NCT03677934|79526012|FG000|Overall Study|Death|8|||
44518577|NCT03677934|79526013|FG001|Overall Study|Death|4|||
44518578|NCT03677934|79526012|FG000|Overall Study|Lost to Follow-up|3|||
44385217|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
44385218|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
44385219|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
44385220|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
44518579|NCT03677934|79526013|FG001|Overall Study|Lost to Follow-up|0|||
44518580|NCT03677934|79526012|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44518581|NCT03677934|79526013|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44518582|NCT03677934|79526012|FG000|Overall Study|Physician Decision|0|||
44518583|NCT03677934|79526013|FG001|Overall Study|Physician Decision|1|||
44518584|NCT03677934|79526012|FG000|Overall Study|Withdrawal by Subject|1|||
44385221|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
44385222|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
44385223|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|non-compliance|7|||
44385224|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|non-compliance|5|||
44518585|NCT03677934|79526013|FG001|Overall Study|Withdrawal by Subject|7|||
44518586|NCT03435692|79526025|FG000|Overall Study|Lack of Efficacy|2|||
44518587|NCT03435692|79526026|FG001|Overall Study|Lack of Efficacy|2|||
44518588|NCT03435692|79526027|FG002|Overall Study|Lack of Efficacy|0|||
44518589|NCT03475316|79526041|FG000|6 Month Intervention|Adverse Event|2|||
44518590|NCT03475316|79526042|FG001|6 Month Intervention|Adverse Event|1|||
44518591|NCT03475316|79526041|FG000|6 Month Intervention|Withdrawal by Subject|2|||
44518592|NCT03475316|79526042|FG001|6 Month Intervention|Withdrawal by Subject|0|||
44518593|NCT03475316|79526041|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
44518594|NCT03475316|79526042|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
44518595|NCT03475316|79526041|FG000|9 Months|Study stopped due to COVID pandemic|3|||
44518596|NCT03475316|79526042|FG001|9 Months|Study stopped due to COVID pandemic|4|||
44518597|NCT03673956|79526052|FG000|Overall Study|Lost to Follow-up|1|||
44518598|NCT03673956|79526053|FG001|Overall Study|Lost to Follow-up|0|||
44518599|NCT03673956|79526054|FG002|Overall Study|Lost to Follow-up|0|||
44518600|NCT03673956|79526055|FG003|Overall Study|Lost to Follow-up|0|||
44518601|NCT03673956|79526052|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
44518602|NCT03673956|79526053|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
44518603|NCT03673956|79526054|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
44518604|NCT03673956|79526055|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
44518605|NCT03673098|79526067|FG000|Overall Study|Lost to Follow-up|2|||
44518606|NCT03673098|79526068|FG001|Overall Study|Lost to Follow-up|3|||
44518607|NCT03673098|79526067|FG000|Overall Study|Withdrawal by Subject|6|||
44518608|NCT03673098|79526068|FG001|Overall Study|Withdrawal by Subject|1|||
44518609|NCT03673098|79526067|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
44518610|NCT03673098|79526068|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
44518611|NCT03435224|79526081|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
44518612|NCT03672396|79526085|FG000|Overall Study|Withdrawal by Subject|4|||
44518613|NCT03672396|79526085|FG000|Overall Study|Physician Decision|1|||
44518614|NCT03672396|79526085|FG000|Overall Study|Adverse Event|1|||
44518615|NCT03434834|79526089|FG000|Overall Study|unable to swallow OCT probe|16|||
44518616|NCT03605862|79526095|FG000|Overall Study|Withdrawal by Subject|12|||
44145973|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145974|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145975|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
44145976|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145977|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
44145978|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
44145979|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
44145980|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145981|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145982|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145983|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145984|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145985|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145986|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145987|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145988|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145989|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145990|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145991|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145992|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145993|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145994|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145995|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145996|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
44145997|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145998|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
44145999|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
44385225|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
44385226|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
44146000|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
44146001|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146002|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146003|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44385227|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
44385228|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
44518617|NCT03605862|79526096|FG001|Overall Study|Withdrawal by Subject|9|||
44518618|NCT03605862|79526095|FG000|Overall Study|Adverse Event|2|||
44518619|NCT03605862|79526096|FG001|Overall Study|Adverse Event|1|||
44518620|NCT03605862|79526095|FG000|Overall Study|Physician Decision|3|||
44518621|NCT03605862|79526096|FG001|Overall Study|Physician Decision|1|||
44518622|NCT03605862|79526095|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
44518623|NCT03605862|79526096|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
44518624|NCT03672006|79526105|FG000|Overall Study|exclusion criteria met|0|||
44518625|NCT03672006|79526106|FG001|Overall Study|exclusion criteria met|1|||
44518626|NCT03512288|79526116|FG000|Overall Study|Adverse Event|1|||
44518627|NCT03512288|79526117|FG001|Overall Study|Adverse Event|0|||
44146004|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146005|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146006|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146007|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146008|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44251314|NCT00114517|79086681|FG000|Overall Study|Competing family issue|0|||
44518628|NCT03512288|79526116|FG000|Overall Study|Lost to Follow-up|12|||
44518629|NCT03512288|79526117|FG001|Overall Study|Lost to Follow-up|15|||
44518630|NCT03512288|79526116|FG000|Overall Study|Physician Decision|0|||
44518631|NCT03512288|79526117|FG001|Overall Study|Physician Decision|2|||
44518632|NCT03512288|79526116|FG000|Overall Study|Protocol Violation|6|||
44518633|NCT03512288|79526117|FG001|Overall Study|Protocol Violation|4|||
44518634|NCT03512288|79526116|FG000|Overall Study|Medication error without associated adverse event|1|||
44518635|NCT03512288|79526117|FG001|Overall Study|Medication error without associated adverse event|0|||
44518636|NCT03512288|79526116|FG000|Overall Study|No longer met eligibility criteria|5|||
44518637|NCT03512288|79526117|FG001|Overall Study|No longer met eligibility criteria|2|||
44518638|NCT03512288|79526116|FG000|Overall Study|Withdrawal by parent/guardian|14|||
44518639|NCT03512288|79526117|FG001|Overall Study|Withdrawal by parent/guardian|18|||
44518640|NCT03512288|79526116|FG000|Overall Study|Other|1|||
44518641|NCT03512288|79526117|FG001|Overall Study|Other|1|||
44518642|NCT03512288|79526116|FG000|Overall Study|Randomized but not treated|1|||
44518643|NCT03512288|79526117|FG001|Overall Study|Randomized but not treated|1|||
44518644|NCT03031678|79526123|FG000|Overall Study|Study closed prior to completion|1|||
44518645|NCT03669588|79526133|FG000|Overall Study|Adverse Event|1|||
44251315|NCT00114517|79086682|FG001|Overall Study|Competing family issue|1|||
44251316|NCT00114517|79086683|FG002|Overall Study|Competing family issue|0|||
44251317|NCT00114517|79086684|FG003|Overall Study|Competing family issue|1|||
44251318|NCT00114517|79086681|FG000|Overall Study|Physician Decision|0|||
44518646|NCT03669588|79526134|FG001|Overall Study|Adverse Event|0|||
44518647|NCT03669588|79526133|FG000|Overall Study|Physician Decision|0|||
44518648|NCT03669588|79526134|FG001|Overall Study|Physician Decision|1|||
44518649|NCT03669588|79526133|FG000|Overall Study|Protocol Violation|1|||
44518650|NCT03669588|79526134|FG001|Overall Study|Protocol Violation|0|||
44518651|NCT03669588|79526133|FG000|Overall Study|Sponsor Decision|1|||
44518652|NCT03669588|79526134|FG001|Overall Study|Sponsor Decision|1|||
44518653|NCT03669588|79526133|FG000|Overall Study|Withdrawal by Subject|1|||
44518654|NCT03669588|79526134|FG001|Overall Study|Withdrawal by Subject|4|||
44518655|NCT03669588|79526133|FG000|Overall Study|Rescue Therapy Needed|0|||
44146009|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146010|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44518656|NCT03669588|79526134|FG001|Overall Study|Rescue Therapy Needed|1|||
44518657|NCT03598140|79526142|FG000|Overall Study|enrolled but didn't start|1|||
44518658|NCT03598140|79526143|FG001|Overall Study|enrolled but didn't start|0|||
44518659|NCT03644550|79526149|FG000|Overall Study|Withdrawal by Subject|3|||
44518660|NCT03644550|79526149|FG000|Overall Study|Progressive disease|15|||
44518661|NCT00054717|79526156|FG000|Overall Study|Randomized but not treated|2|||
44518662|NCT00054717|79526157|FG001|Overall Study|Randomized but not treated|8|||
44518663|NCT00054717|79526156|FG000|Overall Study|Adverse Event|70|||
44518664|NCT00054717|79526157|FG001|Overall Study|Adverse Event|22|||
44518665|NCT00054717|79526156|FG000|Overall Study|Protocol Violation|18|||
44518666|NCT00054717|79526157|FG001|Overall Study|Protocol Violation|19|||
44518667|NCT00054717|79526156|FG000|Overall Study|Lost to Follow-up|23|||
44518668|NCT00054717|79526157|FG001|Overall Study|Lost to Follow-up|13|||
44518669|NCT00054717|79526156|FG000|Overall Study|Withdrawal by Subject|32|||
44518670|NCT00054717|79526157|FG001|Overall Study|Withdrawal by Subject|20|||
44518671|NCT00054717|79526156|FG000|Overall Study|Other reason not defined above|117|||
44518672|NCT00054717|79526157|FG001|Overall Study|Other reason not defined above|217|||
44518673|NCT03430856|79526166|FG000|Overall Study|Adverse Event|0|||
44518674|NCT03430856|79526167|FG001|Overall Study|Adverse Event|1|||
44518675|NCT03430856|79526168|FG002|Overall Study|Adverse Event|0|||
44518676|NCT03430856|79526166|FG000|Overall Study|Rescue criteria|1|||
44518677|NCT03430856|79526167|FG001|Overall Study|Rescue criteria|1|||
44146011|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146012|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44251319|NCT00114517|79086682|FG001|Overall Study|Physician Decision|1|||
44279668|NCT01994382|79240806|FG007|Overall Study|Informed consent withdrawn|0|||
44279669|NCT01994382|79240807|FG008|Overall Study|Informed consent withdrawn|0|||
44279670|NCT01994382|79240808|FG009|Overall Study|Informed consent withdrawn|0|||
44279671|NCT01994382|79240809|FG010|Overall Study|Informed consent withdrawn|0|||
44279672|NCT01994382|79240810|FG011|Overall Study|Informed consent withdrawn|0|||
44279673|NCT01994382|79240811|FG012|Overall Study|Informed consent withdrawn|0|||
44279674|NCT01994382|79240812|FG013|Overall Study|Informed consent withdrawn|0|||
44279675|NCT01994382|79240813|FG014|Overall Study|Informed consent withdrawn|0|||
44279676|NCT01994382|79240814|FG015|Overall Study|Informed consent withdrawn|0|||
44518678|NCT03430856|79526168|FG002|Overall Study|Rescue criteria|0|||
44518679|NCT03430856|79526166|FG000|Overall Study|Voluntary withdrawal of consent|1|||
44518680|NCT03430856|79526167|FG001|Overall Study|Voluntary withdrawal of consent|1|||
44518681|NCT03430856|79526168|FG002|Overall Study|Voluntary withdrawal of consent|1|||
44518682|NCT03731364|79526184|FG000|Overall Study|Adverse Event|0|||
44518683|NCT03731364|79526185|FG001|Overall Study|Adverse Event|0|||
44518684|NCT03731364|79526186|FG002|Overall Study|Adverse Event|1|||
44518685|NCT03731364|79526187|FG003|Overall Study|Adverse Event|2|||
44518686|NCT03731364|79526188|FG004|Overall Study|Adverse Event|1|||
44518687|NCT03510182|79526200|FG000|Overall Study|Withdrawal by Subject|2|||
44279677|NCT01994382|79240815|FG016|Overall Study|Informed consent withdrawn|0|||
44279678|NCT01994382|79240799|FG000|Overall Study|Progressive disease|3|||
44279679|NCT01994382|79240800|FG001|Overall Study|Progressive disease|4|||
44279680|NCT01994382|79240801|FG002|Overall Study|Progressive disease|4|||
44279681|NCT01994382|79240802|FG003|Overall Study|Progressive disease|3|||
44279682|NCT01994382|79240803|FG004|Overall Study|Progressive disease|2|||
44518688|NCT00066807|79526206|FG000|Overall Study|Study was terminated early|14|||
44518689|NCT00066807|79526207|FG001|Overall Study|Study was terminated early|15|||
44518690|NCT03428750|79526215|FG000|Overall Study|Withdrawal by Subject|11|||
44518691|NCT03428750|79526216|FG001|Overall Study|Withdrawal by Subject|10|||
44518692|NCT03428750|79526215|FG000|Overall Study|Lost to Follow-up|3|||
44518693|NCT03428750|79526216|FG001|Overall Study|Lost to Follow-up|9|||
44518694|NCT03428750|79526215|FG000|Overall Study|Adverse Event|9|||
44518695|NCT03428750|79526216|FG001|Overall Study|Adverse Event|1|||
44146013|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146014|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146015|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146016|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146017|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
44146018|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146019|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146020|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
44146021|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
44146022|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146023|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146024|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146025|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146026|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146027|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146028|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146029|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146030|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146031|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146032|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146033|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146034|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146035|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146036|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146037|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146038|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
44146039|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146040|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146041|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
44146042|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
44146043|NCT01597245|78935170|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44518696|NCT03428750|79526215|FG000|Overall Study|Protocol Violation|1|||
44518697|NCT03428750|79526216|FG001|Overall Study|Protocol Violation|0|||
44146044|NCT01597245|78935171|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146045|NCT01597245|78935172|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146046|NCT01597245|78935173|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146047|NCT01597245|78935174|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146048|NCT01597245|78935175|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146049|NCT01597245|78935176|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146050|NCT01597245|78935177|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146051|NCT01597245|78935178|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146052|NCT01597245|78935179|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146053|NCT01597245|78935180|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146054|NCT01597245|78935181|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146055|NCT01597245|78935182|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44251320|NCT00114517|79086683|FG002|Overall Study|Physician Decision|0|||
44251321|NCT00114517|79086684|FG003|Overall Study|Physician Decision|0|||
44251322|NCT00114517|79086681|FG000|Overall Study|Lost interest|0|||
44251323|NCT00114517|79086682|FG001|Overall Study|Lost interest|0|||
44251324|NCT00114517|79086683|FG002|Overall Study|Lost interest|1|||
44251325|NCT00114517|79086684|FG003|Overall Study|Lost interest|0|||
44251326|NCT00114517|79086681|FG000|Overall Study|Weight increase|0|||
44251327|NCT00114517|79086682|FG001|Overall Study|Weight increase|0|||
44251328|NCT00114517|79086683|FG002|Overall Study|Weight increase|1|||
44251329|NCT00114517|79086684|FG003|Overall Study|Weight increase|0|||
44518698|NCT03428750|79526215|FG000|Overall Study|Administrative|0|||
44518699|NCT03428750|79526216|FG001|Overall Study|Administrative|1|||
44518700|NCT03666858|79526245|FG000|Cohort 1|Adverse Event|1|||
44518701|NCT03666858|79526246|FG001|Cohort 1|Adverse Event|0|||
44518702|NCT03666858|79526245|FG000|Cohort 2|Adverse Event|0|||
44518703|NCT03666858|79526246|FG001|Cohort 2|Adverse Event|1|||
44518704|NCT00054639|79526252|FG000|Overall Study|Lack of Efficacy|1|||
44518705|NCT00054639|79526252|FG000|Overall Study|Physician Decision|1|||
44518706|NCT03428360|79526256|FG000|Overall Study|Informed consent withdrawn|5|||
44518707|NCT03428360|79526256|FG000|Overall Study|Withdrawal by Subject|4|||
44518708|NCT03428360|79526256|FG000|Overall Study|Lost to Follow-up|5|||
44518709|NCT03428360|79526256|FG000|Overall Study|Physician Decision|2|||
44518710|NCT03428360|79526256|FG000|Overall Study|Informed consent withdrawn|5|||
44518711|NCT03428360|79526256|FG000|Overall Study|Study terminated by sponsor|10|||
44385229|NCT00406640|79391235|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
44385230|NCT00406640|79391236|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
44385231|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
44385232|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
44385233|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
44385234|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
44385235|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
44385236|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
44385237|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
44385238|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
44385239|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
44385240|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
44385241|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
44385242|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
44385243|NCT00406640|79391235|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
44385244|NCT00406640|79391236|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
44385245|NCT00229931|79391250|FG000|Overall Study|Death|1|||
44385246|NCT00229931|79391251|FG001|Overall Study|Death|0|||
44385247|NCT00229931|79391250|FG000|Overall Study|Lost to Follow-up|3|||
44385248|NCT00229931|79391251|FG001|Overall Study|Lost to Follow-up|2|||
44385249|NCT00150969|79391259|FG000|24 Month Main Study|Adverse Event|3|||
44385250|NCT00150969|79391260|FG001|24 Month Main Study|Adverse Event|4|||
44385251|NCT00150969|79391259|FG000|24 Month Main Study|Death|1|||
44385252|NCT00150969|79391260|FG001|24 Month Main Study|Death|1|||
44385253|NCT00150969|79391259|FG000|24 Month Main Study|Lack of Efficacy|1|||
44385254|NCT00150969|79391260|FG001|24 Month Main Study|Lack of Efficacy|8|||
44385255|NCT00150969|79391259|FG000|24 Month Main Study|Lost to Follow-up|3|||
44385256|NCT00150969|79391260|FG001|24 Month Main Study|Lost to Follow-up|2|||
44385257|NCT00150969|79391259|FG000|24 Month Main Study|Protocol Violation|4|||
44385258|NCT00150969|79391260|FG001|24 Month Main Study|Protocol Violation|2|||
44385259|NCT00150969|79391259|FG000|24 Month Main Study|Withdrawal by Subject|7|||
44385260|NCT00150969|79391260|FG001|24 Month Main Study|Withdrawal by Subject|4|||
44385261|NCT00150969|79391259|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
44385262|NCT00150969|79391260|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
44385263|NCT00150969|79391259|FG000|24-48 Month Extension|Lack of Efficacy|0|||
44385264|NCT00150969|79391260|FG001|24-48 Month Extension|Lack of Efficacy|1|||
44518712|NCT03428360|79526256|FG000|Overall Study|Non-compliant with study|1|||
44518713|NCT03428360|79526256|FG000|Overall Study|Non-compliant with study drug|3|||
44518714|NCT03428360|79526256|FG000|Overall Study|Death|3|||
44518715|NCT03428360|79526256|FG000|Overall Study|Adverse Event|1|||
44518716|NCT03428360|79526256|FG000|Overall Study|Not on antiepileptic drug|1|||
44518717|NCT03427892|79526264|FG000|Overall Study|Lost to Follow-up|2|||
44518718|NCT03595332|79526270|FG000|Overall Study|Lost to Follow-up|16|||
44518719|NCT03595332|79526271|FG001|Overall Study|Lost to Follow-up|22|||
44518720|NCT03595332|79526270|FG000|Overall Study|Unable to retrieve ID from school|0|||
44518721|NCT03595332|79526271|FG001|Overall Study|Unable to retrieve ID from school|2|||
44518722|NCT03427268|79526280|FG000|Overall Study|Progressive disease|25|||
44518723|NCT03427268|79526280|FG000|Overall Study|Never treated|2|||
44518724|NCT03427268|79526280|FG000|Overall Study|Compassionate use|1|||
44251330|NCT00114517|79086681|FG000|Overall Study|Concern about blood clots|0|||
44251331|NCT00114517|79086682|FG001|Overall Study|Concern about blood clots|0|||
44385265|NCT00150969|79391259|FG000|24-48 Month Extension|Adverse Event|1|||
44385266|NCT00150969|79391260|FG001|24-48 Month Extension|Adverse Event|3|||
44385267|NCT00150969|79391259|FG000|24-48 Month Extension|Other Reason|81|||
44385268|NCT00150969|79391260|FG001|24-48 Month Extension|Other Reason|91|||
44518725|NCT03427268|79526280|FG000|Overall Study|Withdrawal by Subject|1|||
44518726|NCT03427268|79526280|FG000|Overall Study|Adverse Event|3|||
44518727|NCT03509948|79526284|FG000|Overall Study|Protocol Violation|0|||
44518728|NCT03509948|79526285|FG001|Overall Study|Protocol Violation|1|||
44385269|NCT00770770|79391269|FG000|Overall Study|Lost to Follow-up|1|||
44518729|NCT03466658|79526291|FG000|Overall Study|Withdrawal by Subject|3|||
44518730|NCT03425396|79526302|FG000|Overall Study|Lost to Follow-up|2|||
44518731|NCT03425396|79526303|FG001|Overall Study|Lost to Follow-up|5|||
44518732|NCT03425396|79526304|FG002|Overall Study|Lost to Follow-up|2|||
44518733|NCT03425396|79526305|FG003|Overall Study|Lost to Follow-up|0|||
44518734|NCT03425396|79526306|FG004|Overall Study|Lost to Follow-up|0|||
44518735|NCT03425396|79526302|FG000|Overall Study|Withdrawal by Subject|0|||
44518736|NCT03425396|79526303|FG001|Overall Study|Withdrawal by Subject|1|||
44518737|NCT03425396|79526304|FG002|Overall Study|Withdrawal by Subject|0|||
44518738|NCT03425396|79526305|FG003|Overall Study|Withdrawal by Subject|1|||
44518739|NCT03425396|79526306|FG004|Overall Study|Withdrawal by Subject|0|||
44518740|NCT03425396|79526302|FG000|Overall Study|Other|0|||
44518741|NCT03425396|79526303|FG001|Overall Study|Other|1|||
44518742|NCT03425396|79526304|FG002|Overall Study|Other|1|||
44518743|NCT03425396|79526305|FG003|Overall Study|Other|0|||
44518744|NCT03425396|79526306|FG004|Overall Study|Other|1|||
44518745|NCT00032487|79526320|FG000|Overall Study|Withdrawal by Subject|67|||
44518746|NCT00032487|79526321|FG001|Overall Study|Withdrawal by Subject|43|||
44518747|NCT00032487|79526320|FG000|Overall Study|Adverse Event|3|||
44518748|NCT00032487|79526321|FG001|Overall Study|Adverse Event|7|||
44518749|NCT00032487|79526320|FG000|Overall Study|Lost to Follow-up|57|||
44518750|NCT00032487|79526321|FG001|Overall Study|Lost to Follow-up|58|||
44518751|NCT00032487|79526320|FG000|Overall Study|Had other reason|12|||
44518752|NCT00032487|79526321|FG001|Overall Study|Had other reason|12|||
44251332|NCT00114517|79086683|FG002|Overall Study|Concern about blood clots|1|||
44251333|NCT00114517|79086684|FG003|Overall Study|Concern about blood clots|0|||
44251334|NCT00114517|79086681|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
44251335|NCT00114517|79086682|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
44251336|NCT00114517|79086683|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
44251337|NCT00114517|79086684|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
44251338|NCT01384019|79086737|FG000|Overall Study|Withdrawal by Subject|3|||
44251339|NCT01384019|79086738|FG001|Overall Study|Withdrawal by Subject|0|||
44251340|NCT01384019|79086737|FG000|Overall Study|Death|1|||
44251341|NCT01384019|79086738|FG001|Overall Study|Death|0|||
44251342|NCT01384019|79086737|FG000|Overall Study|MRI refusal|6|||
44251343|NCT01384019|79086738|FG001|Overall Study|MRI refusal|6|||
44251344|NCT00033631|79086746|FG000|Overall Study|Protocol Violation|14|||
44251345|NCT00033631|79086747|FG001|Overall Study|Protocol Violation|11|||
44251346|NCT00033631|79086746|FG000|Overall Study|Withdrawal by Subject|4|||
44518753|NCT03641508|79526329|FG000|First Injection|Lost to Follow-up|2|||
44518754|NCT03641508|79526330|FG001|First Injection|Lost to Follow-up|0|||
44518755|NCT03465878|79526338|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
44518756|NCT03465878|79526339|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
44518757|NCT03465878|79526340|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
44251347|NCT00033631|79086747|FG001|Overall Study|Withdrawal by Subject|4|||
44518758|NCT03465878|79526341|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
44518759|NCT03465878|79526338|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
44518760|NCT03465878|79526339|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
44518761|NCT03465878|79526340|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
44518762|NCT03465878|79526341|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
44518763|NCT03465878|79526338|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
44518764|NCT03465878|79526339|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
44518765|NCT03465878|79526340|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
44518766|NCT03465878|79526341|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
44518767|NCT03637374|79526369|FG000|Overall Study|Death|2|||
44518768|NCT03637374|79526370|FG001|Overall Study|Death|0|||
44518769|NCT03421730|79526376|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44146056|NCT01597245|78935183|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44251348|NCT01471574|79086758|FG000|Treatment Period|Lack of Efficacy|12|||
44385270|NCT00770770|79391270|FG001|Overall Study|Lost to Follow-up|0|||
44385271|NCT00770770|79391269|FG000|Overall Study|Withdrawal by Subject|1|||
44385272|NCT00770770|79391270|FG001|Overall Study|Withdrawal by Subject|0|||
44385273|NCT00770770|79391269|FG000|Overall Study|Death|0|||
44385274|NCT00770770|79391270|FG001|Overall Study|Death|1|||
44518770|NCT03421730|79526377|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
44518771|NCT03421730|79526378|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518772|NCT03421730|79526379|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518773|NCT03421730|79526380|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518774|NCT03421730|79526381|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518775|NCT03421730|79526382|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518776|NCT03421730|79526383|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518777|NCT03421730|79526384|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518778|NCT03421730|79526385|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518779|NCT03421730|79526386|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518780|NCT03421730|79526387|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
44518781|NCT03421730|79526376|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518782|NCT03421730|79526377|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518783|NCT03421730|79526378|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518784|NCT03421730|79526379|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518785|NCT03421730|79526380|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
44518786|NCT03421730|79526381|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518787|NCT03421730|79526382|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518788|NCT03421730|79526383|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44146057|NCT01597245|78935184|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44251349|NCT01471574|79086759|FG001|Treatment Period|Lack of Efficacy|4|||
44251350|NCT01471574|79086760|FG002|Treatment Period|Lack of Efficacy|14|||
44251351|NCT01471574|79086761|FG003|Treatment Period|Lack of Efficacy|1|||
44251352|NCT01471574|79086758|FG000|Treatment Period|Adverse Event|7|||
44251353|NCT01471574|79086759|FG001|Treatment Period|Adverse Event|3|||
44251354|NCT01471574|79086760|FG002|Treatment Period|Adverse Event|6|||
44251355|NCT01471574|79086761|FG003|Treatment Period|Adverse Event|1|||
44251356|NCT01471574|79086758|FG000|Treatment Period|Withdrawal by Subject|5|||
44251357|NCT01471574|79086759|FG001|Treatment Period|Withdrawal by Subject|1|||
44251358|NCT01471574|79086760|FG002|Treatment Period|Withdrawal by Subject|1|||
44385275|NCT00770770|79391269|FG000|Overall Study|Study Terminated|8|||
44385276|NCT00770770|79391270|FG001|Overall Study|Study Terminated|0|||
44146058|NCT01597245|78935185|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146059|NCT01597245|78935186|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44279683|NCT01994382|79240804|FG005|Overall Study|Progressive disease|3|||
44279684|NCT01994382|79240805|FG006|Overall Study|Progressive disease|3|||
44279685|NCT01994382|79240806|FG007|Overall Study|Progressive disease|6|||
44279686|NCT01994382|79240807|FG008|Overall Study|Progressive disease|2|||
44279687|NCT01994382|79240808|FG009|Overall Study|Progressive disease|2|||
44279688|NCT01994382|79240809|FG010|Overall Study|Progressive disease|13|||
44279689|NCT01994382|79240810|FG011|Overall Study|Progressive disease|8|||
44279690|NCT01994382|79240811|FG012|Overall Study|Progressive disease|7|||
44279691|NCT01994382|79240812|FG013|Overall Study|Progressive disease|3|||
44279692|NCT01994382|79240813|FG014|Overall Study|Progressive disease|6|||
44279693|NCT01994382|79240814|FG015|Overall Study|Progressive disease|44|||
44279694|NCT01994382|79240815|FG016|Overall Study|Progressive disease|28|||
44279695|NCT01994382|79240799|FG000|Overall Study|Physician Decision|0|||
44279696|NCT01994382|79240800|FG001|Overall Study|Physician Decision|1|||
44279697|NCT01994382|79240801|FG002|Overall Study|Physician Decision|0|||
44279698|NCT01994382|79240802|FG003|Overall Study|Physician Decision|0|||
44279699|NCT01994382|79240803|FG004|Overall Study|Physician Decision|0|||
44279700|NCT01994382|79240804|FG005|Overall Study|Physician Decision|0|||
44279701|NCT01994382|79240805|FG006|Overall Study|Physician Decision|0|||
44279702|NCT01994382|79240806|FG007|Overall Study|Physician Decision|0|||
44279703|NCT01994382|79240807|FG008|Overall Study|Physician Decision|0|||
44279704|NCT01994382|79240808|FG009|Overall Study|Physician Decision|0|||
44279705|NCT01994382|79240809|FG010|Overall Study|Physician Decision|3|||
44279706|NCT01994382|79240810|FG011|Overall Study|Physician Decision|1|||
44279707|NCT01994382|79240811|FG012|Overall Study|Physician Decision|1|||
44279708|NCT01994382|79240812|FG013|Overall Study|Physician Decision|0|||
44279709|NCT01994382|79240813|FG014|Overall Study|Physician Decision|1|||
44279710|NCT01994382|79240814|FG015|Overall Study|Physician Decision|4|||
44279711|NCT01994382|79240815|FG016|Overall Study|Physician Decision|2|||
44279712|NCT01994382|79240799|FG000|Overall Study|Death|0|||
44279713|NCT01994382|79240800|FG001|Overall Study|Death|0|||
44279714|NCT01994382|79240801|FG002|Overall Study|Death|0|||
44279715|NCT01994382|79240802|FG003|Overall Study|Death|0|||
44279716|NCT01994382|79240803|FG004|Overall Study|Death|1|||
44279717|NCT01994382|79240804|FG005|Overall Study|Death|0|||
44279718|NCT01994382|79240805|FG006|Overall Study|Death|0|||
44279719|NCT01994382|79240806|FG007|Overall Study|Death|0|||
44279720|NCT01994382|79240807|FG008|Overall Study|Death|1|||
44279721|NCT01994382|79240808|FG009|Overall Study|Death|1|||
44279722|NCT01994382|79240809|FG010|Overall Study|Death|0|||
44279723|NCT01994382|79240810|FG011|Overall Study|Death|0|||
44279724|NCT01994382|79240811|FG012|Overall Study|Death|0|||
44279725|NCT01994382|79240812|FG013|Overall Study|Death|0|||
44279726|NCT01994382|79240813|FG014|Overall Study|Death|0|||
44279727|NCT01994382|79240814|FG015|Overall Study|Death|1|||
44279728|NCT01994382|79240815|FG016|Overall Study|Death|0|||
44279729|NCT01994382|79240799|FG000|Overall Study|Adverse Event|0|||
44279730|NCT01994382|79240800|FG001|Overall Study|Adverse Event|1|||
44279731|NCT01994382|79240801|FG002|Overall Study|Adverse Event|2|||
44279732|NCT01994382|79240802|FG003|Overall Study|Adverse Event|0|||
44279733|NCT01994382|79240803|FG004|Overall Study|Adverse Event|0|||
44279734|NCT01994382|79240804|FG005|Overall Study|Adverse Event|0|||
44279735|NCT01994382|79240805|FG006|Overall Study|Adverse Event|0|||
44279736|NCT01994382|79240806|FG007|Overall Study|Adverse Event|0|||
44279737|NCT01994382|79240807|FG008|Overall Study|Adverse Event|0|||
44279738|NCT01994382|79240808|FG009|Overall Study|Adverse Event|0|||
44279739|NCT01994382|79240809|FG010|Overall Study|Adverse Event|15|||
44279740|NCT01994382|79240810|FG011|Overall Study|Adverse Event|2|||
44279741|NCT01994382|79240811|FG012|Overall Study|Adverse Event|7|||
44279742|NCT01994382|79240812|FG013|Overall Study|Adverse Event|3|||
44279743|NCT01994382|79240813|FG014|Overall Study|Adverse Event|17|||
44279744|NCT01994382|79240814|FG015|Overall Study|Adverse Event|6|||
44279745|NCT01994382|79240815|FG016|Overall Study|Adverse Event|3|||
44279746|NCT01994382|79240799|FG000|Overall Study|Other than specified|0|||
44279747|NCT01994382|79240800|FG001|Overall Study|Other than specified|0|||
44279748|NCT01994382|79240801|FG002|Overall Study|Other than specified|0|||
44279749|NCT01994382|79240802|FG003|Overall Study|Other than specified|0|||
44279750|NCT01994382|79240803|FG004|Overall Study|Other than specified|0|||
44279751|NCT01994382|79240804|FG005|Overall Study|Other than specified|0|||
44279752|NCT01994382|79240805|FG006|Overall Study|Other than specified|0|||
44279753|NCT01994382|79240806|FG007|Overall Study|Other than specified|0|||
44279754|NCT01994382|79240807|FG008|Overall Study|Other than specified|0|||
44279755|NCT01994382|79240808|FG009|Overall Study|Other than specified|0|||
44279756|NCT01994382|79240809|FG010|Overall Study|Other than specified|2|||
44279757|NCT01994382|79240810|FG011|Overall Study|Other than specified|0|||
44279758|NCT01994382|79240811|FG012|Overall Study|Other than specified|2|||
44279759|NCT01994382|79240812|FG013|Overall Study|Other than specified|0|||
44279760|NCT01994382|79240813|FG014|Overall Study|Other than specified|0|||
44279761|NCT01994382|79240814|FG015|Overall Study|Other than specified|4|||
44385277|NCT00766636|79391278|FG000|Overall Study|Withdrawal by Subject|1|||
44385278|NCT00766636|79391279|FG001|Overall Study|Withdrawal by Subject|1|||
44385279|NCT00766636|79391278|FG000|Overall Study|Incomplete Treatment|0|||
44385280|NCT00766636|79391279|FG001|Overall Study|Incomplete Treatment|1|||
44385281|NCT00766636|79391278|FG000|Overall Study|Adverse Event|1|||
44385282|NCT00766636|79391279|FG001|Overall Study|Adverse Event|0|||
44385283|NCT00766636|79391278|FG000|Overall Study|Disease Progression|1|||
44385284|NCT00766636|79391279|FG001|Overall Study|Disease Progression|0|||
44385285|NCT00770692|79391289|FG000|Overall Study|Withdrawal by Subject|7|||
44385286|NCT00770692|79391290|FG001|Overall Study|Withdrawal by Subject|9|||
44385287|NCT00770692|79391291|FG002|Overall Study|Withdrawal by Subject|9|||
44385288|NCT00770692|79391292|FG003|Overall Study|Withdrawal by Subject|6|||
44385289|NCT00770692|79391289|FG000|Overall Study|Adverse Event|3|||
44385290|NCT00770692|79391290|FG001|Overall Study|Adverse Event|0|||
44385291|NCT00770692|79391291|FG002|Overall Study|Adverse Event|4|||
44385292|NCT00770692|79391292|FG003|Overall Study|Adverse Event|4|||
44385293|NCT00770692|79391289|FG000|Overall Study|Investigator judgment|2|||
44385294|NCT00770692|79391290|FG001|Overall Study|Investigator judgment|0|||
44385295|NCT00770692|79391291|FG002|Overall Study|Investigator judgment|1|||
44385296|NCT00770692|79391292|FG003|Overall Study|Investigator judgment|1|||
44385297|NCT02743819|79391306|FG000|Overall Study|Lack of Efficacy|5|||
44385298|NCT02743819|79391306|FG000|Overall Study|Death|2|||
44385299|NCT02743819|79391306|FG000|Overall Study|Adverse Event|1|||
44385300|NCT01004822|79391318|FG000|Overall Study|Objective progression or relapse|3|||
44385301|NCT01004822|79391319|FG001|Overall Study|Objective progression or relapse|3|||
44518789|NCT03421730|79526384|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518790|NCT03421730|79526385|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44146060|NCT01597245|78935187|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44279762|NCT01994382|79240815|FG016|Overall Study|Other than specified|4|||
44251359|NCT01471574|79086761|FG003|Treatment Period|Withdrawal by Subject|0|||
44251360|NCT01471574|79086758|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
44251361|NCT01471574|79086759|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
44251362|NCT01471574|79086760|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
44251363|NCT01471574|79086761|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
44251364|NCT01471574|79086758|FG000|Treatment Period|Lost to Follow-up|1|||
44251365|NCT01471574|79086759|FG001|Treatment Period|Lost to Follow-up|2|||
44279763|NCT01994382|79240799|FG000|Overall Study|Withdrawal by Subject|0|||
44279764|NCT01994382|79240800|FG001|Overall Study|Withdrawal by Subject|0|||
44279765|NCT01994382|79240801|FG002|Overall Study|Withdrawal by Subject|0|||
44279766|NCT01994382|79240802|FG003|Overall Study|Withdrawal by Subject|0|||
44279767|NCT01994382|79240803|FG004|Overall Study|Withdrawal by Subject|0|||
44279768|NCT01994382|79240804|FG005|Overall Study|Withdrawal by Subject|0|||
44279769|NCT01994382|79240805|FG006|Overall Study|Withdrawal by Subject|0|||
44279770|NCT01994382|79240806|FG007|Overall Study|Withdrawal by Subject|0|||
44279771|NCT01994382|79240807|FG008|Overall Study|Withdrawal by Subject|0|||
44279772|NCT01994382|79240808|FG009|Overall Study|Withdrawal by Subject|0|||
44251366|NCT01471574|79086760|FG002|Treatment Period|Lost to Follow-up|2|||
44251367|NCT01471574|79086761|FG003|Treatment Period|Lost to Follow-up|0|||
44251368|NCT01471574|79086758|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
44251369|NCT01471574|79086759|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
44279773|NCT01994382|79240809|FG010|Overall Study|Withdrawal by Subject|6|||
44279774|NCT01994382|79240810|FG011|Overall Study|Withdrawal by Subject|0|||
44279775|NCT01994382|79240811|FG012|Overall Study|Withdrawal by Subject|2|||
44279776|NCT01994382|79240812|FG013|Overall Study|Withdrawal by Subject|0|||
44279777|NCT01994382|79240813|FG014|Overall Study|Withdrawal by Subject|4|||
44279778|NCT01994382|79240814|FG015|Overall Study|Withdrawal by Subject|3|||
44279779|NCT01994382|79240815|FG016|Overall Study|Withdrawal by Subject|0|||
44279780|NCT01994382|79240799|FG000|Overall Study|Lost to Follow-up|0|||
44279781|NCT01994382|79240800|FG001|Overall Study|Lost to Follow-up|0|||
44279782|NCT01994382|79240801|FG002|Overall Study|Lost to Follow-up|0|||
44279783|NCT01994382|79240802|FG003|Overall Study|Lost to Follow-up|0|||
44518791|NCT03421730|79526386|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44279784|NCT01994382|79240803|FG004|Overall Study|Lost to Follow-up|0|||
44518792|NCT03421730|79526387|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
44518793|NCT00054327|79526407|FG000|Overall Study|Engraftment failure|1|||
44518794|NCT00054327|79526408|FG001|Overall Study|Engraftment failure|0|||
44518795|NCT00054327|79526409|FG002|Overall Study|Engraftment failure|0|||
44518796|NCT00054327|79526410|FG003|Overall Study|Engraftment failure|0|||
44518797|NCT00054327|79526411|FG004|Overall Study|Engraftment failure|0|||
44279785|NCT01994382|79240804|FG005|Overall Study|Lost to Follow-up|0|||
44279786|NCT01994382|79240805|FG006|Overall Study|Lost to Follow-up|0|||
44385302|NCT01004822|79391320|FG002|Overall Study|Objective progression or relapse|0|||
44385303|NCT01004822|79391321|FG003|Overall Study|Objective progression or relapse|1|||
44385304|NCT01004822|79391322|FG004|Overall Study|Objective progression or relapse|2|||
44385305|NCT01004822|79391323|FG005|Overall Study|Objective progression or relapse|2|||
44518798|NCT00054327|79526412|FG005|Overall Study|Engraftment failure|0|||
44518799|NCT03503162|79526426|FG000|Overall Study|did not meet eligibility|1|||
44518800|NCT03029650|79526430|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
44518801|NCT03029650|79526431|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
44518802|NCT03029650|79526430|FG000|Washout (1 Week)|Physician Decision|0|||
44518803|NCT03029650|79526431|FG001|Washout (1 Week)|Physician Decision|1|||
44518804|NCT03462680|79526443|FG000|Overall Study|Withdrawal by Subject|3|||
44518805|NCT03462680|79526444|FG001|Overall Study|Withdrawal by Subject|5|||
44518806|NCT03636906|79526453|FG000|Overall Study|Adverse Event|0|||
44518807|NCT03636906|79526454|FG001|Overall Study|Adverse Event|0|||
44518808|NCT03636906|79526455|FG002|Overall Study|Adverse Event|1|||
44518809|NCT03636906|79526453|FG000|Overall Study|Lost to Follow-up|1|||
44518810|NCT03636906|79526454|FG001|Overall Study|Lost to Follow-up|0|||
44518811|NCT03636906|79526455|FG002|Overall Study|Lost to Follow-up|0|||
44518812|NCT03636906|79526453|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
44518813|NCT03636906|79526454|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
44518814|NCT03636906|79526455|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
44518815|NCT03636906|79526453|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
44518816|NCT03636906|79526454|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
44518817|NCT03636906|79526455|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
44518818|NCT03636906|79526453|FG000|Overall Study|Other|0|||
44518819|NCT03636906|79526454|FG001|Overall Study|Other|0|||
44518820|NCT03636906|79526455|FG002|Overall Study|Other|1|||
44518821|NCT03028870|79526473|FG000|Overall Study|Adverse Event|7|||
44518822|NCT03028870|79526474|FG001|Overall Study|Adverse Event|4|||
44518823|NCT03028870|79526475|FG002|Overall Study|Adverse Event|3|||
44518824|NCT03028870|79526476|FG003|Overall Study|Adverse Event|3|||
44518825|NCT03028870|79526473|FG000|Overall Study|Withdrawal by Subject|1|||
44518826|NCT03028870|79526474|FG001|Overall Study|Withdrawal by Subject|1|||
44518827|NCT03028870|79526475|FG002|Overall Study|Withdrawal by Subject|1|||
44518828|NCT03028870|79526476|FG003|Overall Study|Withdrawal by Subject|2|||
44518829|NCT03028870|79526473|FG000|Overall Study|Lost to Follow-up|1|||
44518830|NCT03028870|79526474|FG001|Overall Study|Lost to Follow-up|0|||
44518831|NCT03028870|79526475|FG002|Overall Study|Lost to Follow-up|0|||
44518832|NCT03028870|79526476|FG003|Overall Study|Lost to Follow-up|0|||
44518833|NCT03028870|79526473|FG000|Overall Study|Lack of Efficacy|3|||
44518834|NCT03028870|79526474|FG001|Overall Study|Lack of Efficacy|0|||
44518835|NCT03028870|79526475|FG002|Overall Study|Lack of Efficacy|0|||
44518836|NCT03028870|79526476|FG003|Overall Study|Lack of Efficacy|0|||
44518837|NCT03028870|79526473|FG000|Overall Study|Administrative|5|||
44518838|NCT03028870|79526474|FG001|Overall Study|Administrative|5|||
44518839|NCT03028870|79526475|FG002|Overall Study|Administrative|12|||
44518840|NCT03028870|79526476|FG003|Overall Study|Administrative|4|||
44518841|NCT03663582|79526486|FG000|Overall Study|Physician Decision|1|||
44518842|NCT03502616|79526492|FG000|Up to Week 16|Withdrawal by Subject|1|||
44518843|NCT03502616|79526493|FG001|Up to Week 16|Withdrawal by Subject|2|||
44518844|NCT03502616|79526492|FG000|Up to Week 16|Lost to Follow-up|0|||
44279787|NCT01994382|79240806|FG007|Overall Study|Lost to Follow-up|0|||
44279788|NCT01994382|79240807|FG008|Overall Study|Lost to Follow-up|0|||
44279789|NCT01994382|79240808|FG009|Overall Study|Lost to Follow-up|0|||
44279790|NCT01994382|79240809|FG010|Overall Study|Lost to Follow-up|1|||
44279791|NCT01994382|79240810|FG011|Overall Study|Lost to Follow-up|0|||
44279792|NCT01994382|79240811|FG012|Overall Study|Lost to Follow-up|0|||
44279793|NCT01994382|79240812|FG013|Overall Study|Lost to Follow-up|0|||
44279794|NCT01994382|79240813|FG014|Overall Study|Lost to Follow-up|0|||
44279795|NCT01994382|79240814|FG015|Overall Study|Lost to Follow-up|0|||
44279796|NCT01994382|79240815|FG016|Overall Study|Lost to Follow-up|0|||
44279797|NCT01994382|79240799|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279798|NCT01994382|79240800|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279799|NCT01994382|79240801|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279800|NCT01994382|79240802|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279801|NCT01994382|79240803|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279802|NCT01994382|79240804|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279803|NCT01994382|79240805|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279804|NCT01994382|79240806|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279805|NCT01994382|79240807|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44518845|NCT03502616|79526493|FG001|Up to Week 16|Lost to Follow-up|1|||
44518846|NCT03502616|79526492|FG000|Up to Week 16|Randomized, but not treated|1|||
44518847|NCT03502616|79526493|FG001|Up to Week 16|Randomized, but not treated|0|||
44518848|NCT03502616|79526492|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
44518849|NCT03502616|79526493|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
44518850|NCT03502616|79526492|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
44518851|NCT03502616|79526493|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
44385306|NCT01004822|79391324|FG006|Overall Study|Objective progression or relapse|1|||
44385307|NCT01004822|79391325|FG007|Overall Study|Objective progression or relapse|4|||
44385308|NCT01004822|79391318|FG000|Overall Study|Global deterioration of health status|0|||
44385309|NCT01004822|79391319|FG001|Overall Study|Global deterioration of health status|0|||
44385310|NCT01004822|79391320|FG002|Overall Study|Global deterioration of health status|0|||
44385311|NCT01004822|79391321|FG003|Overall Study|Global deterioration of health status|1|||
44385312|NCT01004822|79391322|FG004|Overall Study|Global deterioration of health status|0|||
44385313|NCT01004822|79391323|FG005|Overall Study|Global deterioration of health status|0|||
44385314|NCT01004822|79391324|FG006|Overall Study|Global deterioration of health status|1|||
44385315|NCT01004822|79391325|FG007|Overall Study|Global deterioration of health status|0|||
44146061|NCT01597245|78935188|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146062|NCT01597245|78935189|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
44146063|NCT01597245|78935190|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
44146064|NCT00707057|78935225|FG000|Overall Study|Withdrawal by Subject|8|||
44146065|NCT00707057|78935226|FG001|Overall Study|Withdrawal by Subject|3|||
44251370|NCT01471574|79086760|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
44385316|NCT01004822|79391318|FG000|Overall Study|No longer willing to continue|0|||
44385317|NCT01004822|79391319|FG001|Overall Study|No longer willing to continue|0|||
44385318|NCT01004822|79391320|FG002|Overall Study|No longer willing to continue|0|||
44385319|NCT01004822|79391321|FG003|Overall Study|No longer willing to continue|1|||
44385320|NCT01004822|79391322|FG004|Overall Study|No longer willing to continue|2|||
44385321|NCT01004822|79391323|FG005|Overall Study|No longer willing to continue|1|||
44385322|NCT01004822|79391324|FG006|Overall Study|No longer willing to continue|1|||
44385323|NCT01004822|79391325|FG007|Overall Study|No longer willing to continue|0|||
44385324|NCT01004822|79391318|FG000|Overall Study|Adverse Event|0|||
44385325|NCT01004822|79391319|FG001|Overall Study|Adverse Event|0|||
44385326|NCT01004822|79391320|FG002|Overall Study|Adverse Event|0|||
44385327|NCT01004822|79391321|FG003|Overall Study|Adverse Event|0|||
44385328|NCT01004822|79391322|FG004|Overall Study|Adverse Event|0|||
44385329|NCT01004822|79391323|FG005|Overall Study|Adverse Event|0|||
44385330|NCT01004822|79391324|FG006|Overall Study|Adverse Event|1|||
44385331|NCT01004822|79391325|FG007|Overall Study|Adverse Event|1|||
44385332|NCT01004822|79391318|FG000|Overall Study|Other|0|||
44385333|NCT01004822|79391319|FG001|Overall Study|Other|0|||
44385334|NCT01004822|79391320|FG002|Overall Study|Other|4|||
44385335|NCT01004822|79391321|FG003|Overall Study|Other|1|||
44385336|NCT01004822|79391322|FG004|Overall Study|Other|0|||
44385337|NCT01004822|79391323|FG005|Overall Study|Other|1|||
44385338|NCT01004822|79391324|FG006|Overall Study|Other|0|||
44385339|NCT01004822|79391325|FG007|Overall Study|Other|0|||
44385340|NCT01001234|79391350|FG000|Overall Study|Withdrawal by Subject|2|||
44385341|NCT01001234|79391351|FG001|Overall Study|Withdrawal by Subject|0|||
44385342|NCT01001234|79391352|FG002|Overall Study|Withdrawal by Subject|3|||
44385343|NCT01001234|79391353|FG003|Overall Study|Withdrawal by Subject|0|||
44385344|NCT01001234|79391354|FG004|Overall Study|Withdrawal by Subject|0|||
44385345|NCT01001234|79391350|FG000|Overall Study|Protocol Violation|34|||
44385346|NCT01001234|79391351|FG001|Overall Study|Protocol Violation|3|||
44385347|NCT01001234|79391352|FG002|Overall Study|Protocol Violation|19|||
44385348|NCT01001234|79391353|FG003|Overall Study|Protocol Violation|18|||
44385349|NCT01001234|79391354|FG004|Overall Study|Protocol Violation|0|||
44385350|NCT01001234|79391350|FG000|Overall Study|Lost to Follow-up|0|||
44385351|NCT01001234|79391351|FG001|Overall Study|Lost to Follow-up|0|||
44385352|NCT01001234|79391352|FG002|Overall Study|Lost to Follow-up|1|||
44385353|NCT01001234|79391353|FG003|Overall Study|Lost to Follow-up|2|||
44385354|NCT01001234|79391354|FG004|Overall Study|Lost to Follow-up|0|||
44385355|NCT01001234|79391350|FG000|Overall Study|Physician Decision|1|||
44385356|NCT01001234|79391351|FG001|Overall Study|Physician Decision|0|||
44385357|NCT01001234|79391352|FG002|Overall Study|Physician Decision|0|||
44385358|NCT01001234|79391353|FG003|Overall Study|Physician Decision|0|||
44385359|NCT01001234|79391354|FG004|Overall Study|Physician Decision|0|||
44385360|NCT01001234|79391350|FG000|Overall Study|Not Treated: Adverse Event|1|||
44385361|NCT01001234|79391351|FG001|Overall Study|Not Treated: Adverse Event|0|||
44385362|NCT01001234|79391352|FG002|Overall Study|Not Treated: Adverse Event|0|||
44385363|NCT01001234|79391353|FG003|Overall Study|Not Treated: Adverse Event|0|||
44385364|NCT01001234|79391354|FG004|Overall Study|Not Treated: Adverse Event|0|||
44385365|NCT01001234|79391350|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
44385366|NCT01001234|79391351|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
44385367|NCT01001234|79391352|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
44385368|NCT01001234|79391353|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
44385369|NCT01001234|79391354|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
44146066|NCT00707057|78935225|FG000|Overall Study|Dosed incorrectly|0|||
44279806|NCT01994382|79240808|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279807|NCT01994382|79240809|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
44279808|NCT01994382|79240810|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279809|NCT01994382|79240811|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
44279810|NCT01994382|79240812|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279811|NCT01994382|79240813|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
44279812|NCT01994382|79240814|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
44279813|NCT01994382|79240815|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
44279814|NCT01994382|79240799|FG000|Overall Study|Protocol violation/noncompliance|0|||
44279815|NCT01994382|79240800|FG001|Overall Study|Protocol violation/noncompliance|0|||
44279816|NCT01994382|79240801|FG002|Overall Study|Protocol violation/noncompliance|0|||
44279817|NCT01994382|79240802|FG003|Overall Study|Protocol violation/noncompliance|0|||
44279818|NCT01994382|79240803|FG004|Overall Study|Protocol violation/noncompliance|0|||
44279819|NCT01994382|79240804|FG005|Overall Study|Protocol violation/noncompliance|0|||
44279820|NCT01994382|79240805|FG006|Overall Study|Protocol violation/noncompliance|0|||
44279821|NCT01994382|79240806|FG007|Overall Study|Protocol violation/noncompliance|0|||
44279822|NCT01994382|79240807|FG008|Overall Study|Protocol violation/noncompliance|0|||
44279823|NCT01994382|79240808|FG009|Overall Study|Protocol violation/noncompliance|0|||
44279824|NCT01994382|79240809|FG010|Overall Study|Protocol violation/noncompliance|0|||
44279825|NCT01994382|79240810|FG011|Overall Study|Protocol violation/noncompliance|1|||
44279826|NCT01994382|79240811|FG012|Overall Study|Protocol violation/noncompliance|0|||
44279827|NCT01994382|79240812|FG013|Overall Study|Protocol violation/noncompliance|0|||
44279828|NCT01994382|79240813|FG014|Overall Study|Protocol violation/noncompliance|0|||
44279829|NCT01994382|79240814|FG015|Overall Study|Protocol violation/noncompliance|0|||
44279830|NCT01994382|79240815|FG016|Overall Study|Protocol violation/noncompliance|2|||
44279831|NCT01994382|79240799|FG000|Overall Study|Rolled over to Phase 2a|0|||
44279832|NCT01994382|79240800|FG001|Overall Study|Rolled over to Phase 2a|0|||
44279833|NCT01994382|79240801|FG002|Overall Study|Rolled over to Phase 2a|1|||
44279834|NCT01994382|79240802|FG003|Overall Study|Rolled over to Phase 2a|0|||
44279835|NCT01994382|79240803|FG004|Overall Study|Rolled over to Phase 2a|0|||
44279836|NCT01994382|79240804|FG005|Overall Study|Rolled over to Phase 2a|0|||
44279837|NCT01994382|79240805|FG006|Overall Study|Rolled over to Phase 2a|0|||
44279838|NCT01994382|79240806|FG007|Overall Study|Rolled over to Phase 2a|0|||
44279839|NCT01994382|79240807|FG008|Overall Study|Rolled over to Phase 2a|0|||
44279840|NCT01994382|79240808|FG009|Overall Study|Rolled over to Phase 2a|2|||
44279841|NCT01994382|79240809|FG010|Overall Study|Rolled over to Phase 2a|0|||
44251371|NCT01471574|79086761|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
44251372|NCT01471574|79086758|FG000|Treatment Period|Other|1|||
44251373|NCT01471574|79086759|FG001|Treatment Period|Other|0|||
44251374|NCT01471574|79086760|FG002|Treatment Period|Other|0|||
44251375|NCT01471574|79086761|FG003|Treatment Period|Other|0|||
44251376|NCT01471574|79086758|FG000|Follow-up Period|Withdrawal by Subject|3|||
44251377|NCT01471574|79086759|FG001|Follow-up Period|Withdrawal by Subject|0|||
44251378|NCT01471574|79086760|FG002|Follow-up Period|Withdrawal by Subject|3|||
44251379|NCT01471574|79086761|FG003|Follow-up Period|Withdrawal by Subject|1|||
44251380|NCT01471574|79086758|FG000|Follow-up Period|Lost to Follow-up|4|||
44279842|NCT01994382|79240810|FG011|Overall Study|Rolled over to Phase 2a|0|||
44279843|NCT01994382|79240811|FG012|Overall Study|Rolled over to Phase 2a|0|||
44279844|NCT01994382|79240812|FG013|Overall Study|Rolled over to Phase 2a|0|||
44279845|NCT01994382|79240813|FG014|Overall Study|Rolled over to Phase 2a|0|||
44385370|NCT01001234|79391350|FG000|Overall Study|Not Treated: Protocol Violation|3|||
44385371|NCT01001234|79391351|FG001|Overall Study|Not Treated: Protocol Violation|0|||
44385372|NCT01001234|79391352|FG002|Overall Study|Not Treated: Protocol Violation|0|||
44385373|NCT01001234|79391353|FG003|Overall Study|Not Treated: Protocol Violation|0|||
44385374|NCT01001234|79391354|FG004|Overall Study|Not Treated: Protocol Violation|0|||
44385375|NCT01001234|79391350|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
44385376|NCT01001234|79391351|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
44385377|NCT01001234|79391352|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
44385378|NCT01001234|79391353|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
44385379|NCT01001234|79391354|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
44385380|NCT01001234|79391350|FG000|Overall Study|Not Treated: Pregnancy|3|||
44385381|NCT01001234|79391351|FG001|Overall Study|Not Treated: Pregnancy|0|||
44385382|NCT01001234|79391352|FG002|Overall Study|Not Treated: Pregnancy|0|||
44385383|NCT01001234|79391353|FG003|Overall Study|Not Treated: Pregnancy|0|||
44385384|NCT01001234|79391354|FG004|Overall Study|Not Treated: Pregnancy|0|||
44385385|NCT01001234|79391350|FG000|Overall Study|Not Treated: Physician Decision|37|||
44385386|NCT01001234|79391351|FG001|Overall Study|Not Treated: Physician Decision|4|||
44385387|NCT01001234|79391352|FG002|Overall Study|Not Treated: Physician Decision|0|||
44385388|NCT01001234|79391353|FG003|Overall Study|Not Treated: Physician Decision|0|||
44518852|NCT03028012|79526514|FG000|Overall Study|Lost to Follow-up|2|||
44146067|NCT00707057|78935226|FG001|Overall Study|Dosed incorrectly|1|||
44146068|NCT02639247|78935234|FG000|Overall Study|Lost to Follow-up|2|||
44385389|NCT01001234|79391354|FG004|Overall Study|Not Treated: Physician Decision|0|||
44385390|NCT01001234|79391350|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
44385391|NCT01001234|79391351|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
44385392|NCT01001234|79391352|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
44385393|NCT01001234|79391353|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
44385394|NCT01001234|79391354|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
44385395|NCT01004510|79391360|FG000|Overall Study|Adverse Event|1|||
44385396|NCT01004432|79391364|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
44385397|NCT01004432|79391365|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
44385398|NCT01004432|79391366|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
44385399|NCT01004432|79391367|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
44385400|NCT01004432|79391368|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
44385401|NCT01004432|79391364|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
44385402|NCT01004432|79391365|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
44385403|NCT01004432|79391366|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
44385404|NCT01004432|79391367|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
44385405|NCT01004432|79391368|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
44385406|NCT01004432|79391364|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
44385407|NCT01004432|79391365|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
44385408|NCT01004432|79391366|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
44385409|NCT01004432|79391367|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
44385410|NCT01004432|79391368|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
44385411|NCT01004432|79391364|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
44385412|NCT01004432|79391365|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
44385413|NCT01004432|79391366|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
44518853|NCT03028012|79526515|FG001|Overall Study|Lost to Follow-up|3|||
44518854|NCT03028012|79526516|FG002|Overall Study|Lost to Follow-up|3|||
44146069|NCT02639247|78935235|FG001|Overall Study|Lost to Follow-up|1|||
44146070|NCT02639247|78935234|FG000|Overall Study|Death|2|||
44146071|NCT02639247|78935235|FG001|Overall Study|Death|0|||
44146072|NCT02639247|78935234|FG000|Overall Study|Withdrew Consent|0|||
44146073|NCT02639247|78935235|FG001|Overall Study|Withdrew Consent|1|||
44146074|NCT02639247|78935234|FG000|Overall Study|Protocol Violation|1|||
44146075|NCT02639247|78935235|FG001|Overall Study|Protocol Violation|0|||
44146076|NCT00706901|78935244|FG000|Overall Study|Lost to Follow-up|2|||
44146077|NCT00706901|78935245|FG001|Overall Study|Lost to Follow-up|3|||
44146078|NCT00706901|78935246|FG002|Overall Study|Lost to Follow-up|2|||
44146079|NCT00706901|78935244|FG000|Overall Study|Withdrawal by Subject|4|||
44146080|NCT00706901|78935245|FG001|Overall Study|Withdrawal by Subject|2|||
44146081|NCT00706901|78935246|FG002|Overall Study|Withdrawal by Subject|5|||
44146082|NCT00706901|78935244|FG000|Overall Study|In Jail|1|||
44146083|NCT00706901|78935245|FG001|Overall Study|In Jail|0|||
44146084|NCT00706901|78935246|FG002|Overall Study|In Jail|1|||
44146085|NCT00706901|78935244|FG000|Overall Study|Death|1|||
44146086|NCT00706901|78935245|FG001|Overall Study|Death|0|||
44146087|NCT00706901|78935246|FG002|Overall Study|Death|0|||
44146088|NCT05274217|78935257|FG000|Overall Study|Study terminated.|11|||
44146089|NCT05274217|78935258|FG001|Overall Study|Study terminated.|0|||
44146090|NCT05070546|78935270|FG000|Overall Study|Death|0|||
44146091|NCT05070546|78935271|FG001|Overall Study|Death|0|||
44146092|NCT05070546|78935272|FG002|Overall Study|Death|0|||
44146093|NCT05070546|78935273|FG003|Overall Study|Death|0|||
44146094|NCT05070546|78935274|FG004|Overall Study|Death|0|||
44146095|NCT05070546|78935275|FG005|Overall Study|Death|1|||
44146096|NCT05070546|78935270|FG000|Overall Study|Lost to Follow-up|8|||
44146097|NCT05070546|78935271|FG001|Overall Study|Lost to Follow-up|2|||
44146098|NCT05070546|78935272|FG002|Overall Study|Lost to Follow-up|7|||
44146099|NCT05070546|78935273|FG003|Overall Study|Lost to Follow-up|1|||
44146100|NCT05070546|78935274|FG004|Overall Study|Lost to Follow-up|2|||
44146101|NCT05070546|78935275|FG005|Overall Study|Lost to Follow-up|0|||
44146102|NCT05070546|78935270|FG000|Overall Study|Withdrawal by Subject|1|||
44146103|NCT05070546|78935271|FG001|Overall Study|Withdrawal by Subject|1|||
44146104|NCT05070546|78935272|FG002|Overall Study|Withdrawal by Subject|3|||
44146105|NCT05070546|78935273|FG003|Overall Study|Withdrawal by Subject|0|||
44146106|NCT05070546|78935274|FG004|Overall Study|Withdrawal by Subject|0|||
44146107|NCT05070546|78935275|FG005|Overall Study|Withdrawal by Subject|0|||
44146108|NCT05070546|78935270|FG000|Overall Study|Other|0|||
44146109|NCT05070546|78935271|FG001|Overall Study|Other|0|||
44146110|NCT05070546|78935272|FG002|Overall Study|Other|0|||
44146111|NCT05070546|78935273|FG003|Overall Study|Other|0|||
44146112|NCT05070546|78935274|FG004|Overall Study|Other|3|||
44146113|NCT05070546|78935275|FG005|Overall Study|Other|0|||
44385414|NCT01004432|79391367|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
44385415|NCT01004432|79391368|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
44385416|NCT01004432|79391364|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
44385417|NCT01004432|79391365|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
44385418|NCT01004432|79391366|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
44385419|NCT01004432|79391367|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
44385420|NCT01004432|79391368|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
44385421|NCT01004432|79391364|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
44385422|NCT01004432|79391365|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
44385423|NCT01004432|79391366|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
44385424|NCT01004432|79391367|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
44385425|NCT01004432|79391368|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
44385426|NCT01004432|79391364|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
44385427|NCT01004432|79391365|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
44385428|NCT01004432|79391366|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
44385429|NCT01004432|79391367|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
44385430|NCT01004432|79391368|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
44385431|NCT01004432|79391364|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
44385432|NCT01004432|79391365|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
44385433|NCT01004432|79391366|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
44385434|NCT01004432|79391367|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
44385435|NCT01004432|79391368|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
44385436|NCT01004432|79391364|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
44385437|NCT01004432|79391365|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
44385438|NCT01004432|79391366|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
44385439|NCT01004432|79391367|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
44385440|NCT01004432|79391368|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
44385441|NCT01004432|79391364|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
44385442|NCT01004432|79391365|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
44385443|NCT01004432|79391366|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
44385444|NCT01004432|79391367|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
44385445|NCT01004432|79391368|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
44385446|NCT01004432|79391364|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
44385447|NCT01004432|79391365|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
44385448|NCT01004432|79391366|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
44385449|NCT01004432|79391367|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
44385450|NCT01004432|79391368|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
44385451|NCT01004432|79391364|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
44385452|NCT01004432|79391365|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
44385453|NCT01004432|79391366|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
44385454|NCT01004432|79391367|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
44385455|NCT01004432|79391368|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
44385456|NCT01004432|79391364|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
44385457|NCT01004432|79391365|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
44385458|NCT01004432|79391366|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
44385459|NCT01004432|79391367|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
44385460|NCT01004432|79391368|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
44385461|NCT01004432|79391364|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
44385462|NCT01004432|79391365|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
44385463|NCT01004432|79391366|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
44385464|NCT01004432|79391367|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
44518855|NCT03635190|79526525|FG000|Overall Study|Lost to Follow-up|4|||
44518856|NCT03635190|79526525|FG000|Overall Study|Death|3|||
44385465|NCT01004432|79391368|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
44385466|NCT01004432|79391364|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
44385467|NCT01004432|79391365|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
44385468|NCT01004432|79391366|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
44385469|NCT01004432|79391367|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
44385470|NCT01004432|79391368|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
44385471|NCT01000610|79391382|FG000|Overall Study|Adverse Event|1|||
44385472|NCT01000610|79391382|FG000|Overall Study|Lost to Follow-up|4|||
44385473|NCT01000610|79391382|FG000|Overall Study|Treatment failure|1|||
44385474|NCT01877655|79391388|FG000|Overall Study|Death|57|||
44385475|NCT01877655|79391389|FG001|Overall Study|Death|52|||
44385476|NCT01877655|79391388|FG000|Overall Study|Withdrawal by Subject|18|||
44385477|NCT01877655|79391389|FG001|Overall Study|Withdrawal by Subject|26|||
44385478|NCT01877655|79391388|FG000|Overall Study|Physician Decision|11|||
44251381|NCT01471574|79086759|FG001|Follow-up Period|Lost to Follow-up|1|||
44385479|NCT01877655|79391389|FG001|Overall Study|Physician Decision|10|||
44385480|NCT01877655|79391388|FG000|Overall Study|Miscellaneous|4|||
44385481|NCT01877655|79391389|FG001|Overall Study|Miscellaneous|4|||
44385482|NCT01877655|79391388|FG000|Overall Study|Randomized but Never Received Drug|8|||
44251382|NCT01471574|79086760|FG002|Follow-up Period|Lost to Follow-up|3|||
44251383|NCT01471574|79086761|FG003|Follow-up Period|Lost to Follow-up|2|||
44251384|NCT01471574|79086758|FG000|Follow-up Period|Death|0|||
44251385|NCT01471574|79086759|FG001|Follow-up Period|Death|0|||
44251386|NCT01471574|79086760|FG002|Follow-up Period|Death|1|||
44251387|NCT01471574|79086761|FG003|Follow-up Period|Death|0|||
44251388|NCT01471574|79086758|FG000|Follow-up Period|Follow-up no longer required|0|||
44251389|NCT01471574|79086759|FG001|Follow-up Period|Follow-up no longer required|1|||
44251390|NCT01471574|79086760|FG002|Follow-up Period|Follow-up no longer required|0|||
44251391|NCT01471574|79086761|FG003|Follow-up Period|Follow-up no longer required|0|||
44251392|NCT01383707|79086777|FG000|Overall Study|Consent withdrawal|6|||
44251393|NCT01383707|79086777|FG000|Overall Study|Death|19|||
44251394|NCT01383707|79086777|FG000|Overall Study|Other|8|||
44251395|NCT01383707|79086777|FG000|Overall Study|Sponsor's decision|2|||
44251396|NCT01383707|79086777|FG000|Overall Study|Adverse Event|14|||
44251397|NCT01383707|79086777|FG000|Overall Study|Progressive disease|23|||
44251398|NCT01383317|79086783|FG000|Overall Study|Lost to Follow-up|2|||
44518857|NCT03635190|79526525|FG000|Overall Study|Withdrawal by Subject|1|||
44385483|NCT01877655|79391389|FG001|Overall Study|Randomized but Never Received Drug|5|||
44385484|NCT00586924|79391401|FG000|Overall Study|Adverse event/serious adverse event|0|||
44385485|NCT00586924|79391402|FG001|Overall Study|Adverse event/serious adverse event|0|||
44385486|NCT00586924|79391403|FG002|Overall Study|Adverse event/serious adverse event|0|||
44385487|NCT00586924|79391404|FG003|Overall Study|Adverse event/serious adverse event|1|||
44385488|NCT00586924|79391405|FG004|Overall Study|Adverse event/serious adverse event|0|||
44385489|NCT00586924|79391406|FG005|Overall Study|Adverse event/serious adverse event|2|||
44385490|NCT00586924|79391401|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
44385491|NCT00586924|79391402|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
44518858|NCT03635190|79526525|FG000|Overall Study|Patient moved and did not return for follow up|1|||
44518859|NCT03634800|79526532|FG000|Overall Study|Adverse Event|1|||
44518860|NCT03634800|79526532|FG000|Overall Study|Disease Progression|4|||
44518861|NCT03634800|79526532|FG000|Overall Study|Withdrawal by Subject|1|||
44518862|NCT03027466|79526540|FG000|Overall Study|Opting out of the app|1869|||
44518863|NCT03027466|79526541|FG001|Overall Study|Opting out of the app|1819|||
44251399|NCT01383317|79086784|FG001|Overall Study|Lost to Follow-up|1|||
44251400|NCT01383317|79086783|FG000|Overall Study|Death|1|||
44251401|NCT01383317|79086784|FG001|Overall Study|Death|0|||
44251402|NCT01383317|79086783|FG000|Overall Study|Adverse Event|0|||
44251403|NCT01383317|79086784|FG001|Overall Study|Adverse Event|1|||
44251404|NCT01455428|79086792|FG000|Overall Study|Protocol Violation|2|||
44251405|NCT01455428|79086793|FG001|Overall Study|Protocol Violation|1|||
44251406|NCT01455428|79086792|FG000|Overall Study|Adverse Event|6|||
44251407|NCT01455428|79086793|FG001|Overall Study|Adverse Event|2|||
44251408|NCT01455428|79086792|FG000|Overall Study|Lost to Follow-up|1|||
44251409|NCT01455428|79086793|FG001|Overall Study|Lost to Follow-up|1|||
44251410|NCT01455428|79086792|FG000|Overall Study|Withdrawal by Subject|2|||
44251411|NCT01455428|79086793|FG001|Overall Study|Withdrawal by Subject|5|||
44385492|NCT00586924|79391403|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
44385493|NCT00586924|79391404|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
44518864|NCT03027466|79526542|FG002|Overall Study|Opting out of the app|1743|||
44518865|NCT03027466|79526543|FG003|Overall Study|Opting out of the app|1821|||
44518866|NCT03662334|79526555|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
44518867|NCT03662334|79526556|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
44518868|NCT02955186|79526564|FG000|Overall Study|Withdrawal by Subject|6|||
44518869|NCT02955186|79526565|FG001|Overall Study|Withdrawal by Subject|2|||
44518870|NCT02955186|79526564|FG000|Overall Study|Protocol Violation|1|||
44518871|NCT02955186|79526565|FG001|Overall Study|Protocol Violation|0|||
44518872|NCT03502070|79526571|FG000|Overall Study|Withdrawal by Subject|1|||
44518873|NCT03502070|79526571|FG000|Overall Study|Screen Failure|1|||
44518874|NCT03586830|79526579|FG000|Overall Study|Site terminated by Sponsor|1|||
44518875|NCT03586830|79526580|FG001|Overall Study|Site terminated by Sponsor|4|||
44518876|NCT03586830|79526581|FG002|Overall Study|Site terminated by Sponsor|3|||
44518877|NCT03586830|79526582|FG003|Overall Study|Site terminated by Sponsor|3|||
44518878|NCT03586830|79526579|FG000|Overall Study|Lost to Follow-up|0|||
44251412|NCT01455428|79086792|FG000|Overall Study|Did not meet entrance criteria|0|||
44385494|NCT00586924|79391405|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
44385495|NCT00586924|79391406|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
44518879|NCT03586830|79526580|FG001|Overall Study|Lost to Follow-up|2|||
44518880|NCT03586830|79526581|FG002|Overall Study|Lost to Follow-up|2|||
44251413|NCT01455428|79086793|FG001|Overall Study|Did not meet entrance criteria|2|||
44251414|NCT01455428|79086792|FG000|Overall Study|Insufficient clinical response|0|||
44385496|NCT00586924|79391401|FG000|Overall Study|Disease progression|0|||
44385497|NCT00586924|79391402|FG001|Overall Study|Disease progression|0|||
44279846|NCT01994382|79240814|FG015|Overall Study|Rolled over to Phase 2a|0|||
44279847|NCT01994382|79240815|FG016|Overall Study|Rolled over to Phase 2a|0|||
44279848|NCT02003898|79240858|FG000|Overall Study|Death|3|||
44279849|NCT02003898|79240858|FG000|Overall Study|Lost to Follow-up|12|||
44279850|NCT02003898|79240858|FG000|Overall Study|Withdrawal by Subject|52|||
44279851|NCT01994226|79240864|FG000|Overall Study|Protocol Violation|13|||
44279852|NCT01994226|79240865|FG001|Overall Study|Protocol Violation|10|||
44279853|NCT01994226|79240864|FG000|Overall Study|Early Cessation of treatment|6|||
44279854|NCT01994226|79240865|FG001|Overall Study|Early Cessation of treatment|11|||
44279855|NCT02002884|79240874|FG000|Main Period (MP)|Other|0|||
44279856|NCT02002884|79240875|FG001|Main Period (MP)|Other|3|||
44279857|NCT02002884|79240876|FG002|Main Period (MP)|Other|3|||
44279858|NCT02002884|79240877|FG003|Main Period (MP)|Other|0|||
44279859|NCT02002884|79240874|FG000|Main Period (MP)|Adverse Event|0|||
44279860|NCT02002884|79240875|FG001|Main Period (MP)|Adverse Event|1|||
44279861|NCT02002884|79240876|FG002|Main Period (MP)|Adverse Event|1|||
44279862|NCT02002884|79240877|FG003|Main Period (MP)|Adverse Event|0|||
44279863|NCT02002884|79240874|FG000|Main Period (MP)|Withdrawal by Subject|6|||
44385498|NCT00586924|79391403|FG002|Overall Study|Disease progression|0|||
44385499|NCT00586924|79391404|FG003|Overall Study|Disease progression|1|||
44385500|NCT00586924|79391405|FG004|Overall Study|Disease progression|1|||
44385501|NCT00586924|79391406|FG005|Overall Study|Disease progression|0|||
44385502|NCT00586924|79391401|FG000|Overall Study|Development of neutralizing antibodies|2|||
44385503|NCT00586924|79391402|FG001|Overall Study|Development of neutralizing antibodies|2|||
44385504|NCT00586924|79391403|FG002|Overall Study|Development of neutralizing antibodies|2|||
44385505|NCT00586924|79391404|FG003|Overall Study|Development of neutralizing antibodies|0|||
44385506|NCT00586924|79391405|FG004|Overall Study|Development of neutralizing antibodies|0|||
44385507|NCT00586924|79391406|FG005|Overall Study|Development of neutralizing antibodies|22|||
44385508|NCT00586924|79391401|FG000|Overall Study|Complete response|0|||
44385509|NCT00586924|79391402|FG001|Overall Study|Complete response|1|||
44385510|NCT00586924|79391403|FG002|Overall Study|Complete response|0|||
44385511|NCT00586924|79391404|FG003|Overall Study|Complete response|0|||
44385512|NCT00586924|79391405|FG004|Overall Study|Complete response|2|||
44385513|NCT00586924|79391406|FG005|Overall Study|Complete response|2|||
44385514|NCT00586924|79391401|FG000|Overall Study|Other|1|||
44385515|NCT00586924|79391402|FG001|Overall Study|Other|0|||
44385516|NCT00586924|79391403|FG002|Overall Study|Other|1|||
44385517|NCT00586924|79391404|FG003|Overall Study|Other|1|||
44385518|NCT00586924|79391405|FG004|Overall Study|Other|1|||
44385519|NCT00586924|79391406|FG005|Overall Study|Other|6|||
44385520|NCT01000376|79391422|FG000|Cycle 1 Day 1|Adverse Event|1|||
44385521|NCT01000376|79391423|FG001|Cycle 1 Day 1|Adverse Event|0|||
44385522|NCT01000376|79391422|FG000|Cycle 1 Day 1|Progressive Disease|1|||
44385523|NCT01000376|79391423|FG001|Cycle 1 Day 1|Progressive Disease|0|||
44385524|NCT01038635|79391438|FG000|Overall Study|Disease Progression|2|||
44385525|NCT01038635|79391439|FG001|Overall Study|Disease Progression|0|||
44385526|NCT01038635|79391440|FG002|Overall Study|Disease Progression|0|||
44385527|NCT01038635|79391441|FG003|Overall Study|Disease Progression|0|||
44385528|NCT01038635|79391442|FG004|Overall Study|Disease Progression|0|||
44385529|NCT01038635|79391443|FG005|Overall Study|Disease Progression|0|||
44385530|NCT01038635|79391444|FG006|Overall Study|Disease Progression|1|||
44385531|NCT01038635|79391445|FG007|Overall Study|Disease Progression|4|||
44385532|NCT01038635|79391446|FG008|Overall Study|Disease Progression|0|||
44385533|NCT01038635|79391438|FG000|Overall Study|Death|0|||
44385534|NCT01038635|79391439|FG001|Overall Study|Death|0|||
44385535|NCT01038635|79391440|FG002|Overall Study|Death|0|||
44385536|NCT01038635|79391441|FG003|Overall Study|Death|0|||
44385537|NCT01038635|79391442|FG004|Overall Study|Death|1|||
44279864|NCT02002884|79240875|FG001|Main Period (MP)|Withdrawal by Subject|2|||
44279865|NCT02002884|79240876|FG002|Main Period (MP)|Withdrawal by Subject|2|||
44279866|NCT02002884|79240877|FG003|Main Period (MP)|Withdrawal by Subject|0|||
44279867|NCT02002884|79240874|FG000|Main Period (MP)|Lost to Follow-up|0|||
44279868|NCT02002884|79240875|FG001|Main Period (MP)|Lost to Follow-up|0|||
44385538|NCT01038635|79391443|FG005|Overall Study|Death|0|||
44385539|NCT01038635|79391444|FG006|Overall Study|Death|1|||
44385540|NCT01038635|79391445|FG007|Overall Study|Death|1|||
44385541|NCT01038635|79391446|FG008|Overall Study|Death|2|||
44385542|NCT01000064|79391467|FG000|Overall Study|Withdrawal by Subject|1|||
44385543|NCT01000064|79391468|FG001|Overall Study|Withdrawal by Subject|1|||
44385544|NCT00766090|79391479|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385545|NCT00766090|79391480|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385546|NCT00766090|79391481|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385547|NCT00766090|79391482|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385548|NCT00766090|79391483|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385549|NCT00766090|79391484|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385550|NCT00766090|79391485|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385551|NCT00766090|79391486|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385552|NCT00766090|79391487|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
44385553|NCT00766090|79391488|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385554|NCT00766090|79391489|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44251415|NCT01455428|79086793|FG001|Overall Study|Insufficient clinical response|2|||
44251416|NCT01455428|79086792|FG000|Overall Study|Did not receive treatment|1|||
44251417|NCT01455428|79086793|FG001|Overall Study|Did not receive treatment|1|||
44251418|NCT01455428|79086792|FG000|Overall Study|Other|2|||
44251419|NCT01455428|79086793|FG001|Overall Study|Other|4|||
44251420|NCT01383161|79086801|FG000|Overall Study|Adverse Event|5|||
44251421|NCT01383161|79086802|FG001|Overall Study|Adverse Event|1|||
44251422|NCT01383161|79086801|FG000|Overall Study|Withdrawal by Subject|0|||
44251423|NCT01383161|79086802|FG001|Overall Study|Withdrawal by Subject|2|||
44251424|NCT01383161|79086801|FG000|Overall Study|Lack of Efficacy|0|||
44251425|NCT01383161|79086802|FG001|Overall Study|Lack of Efficacy|1|||
44251426|NCT01382225|79086828|FG000|Overall Study|Adverse Event|3|||
44279869|NCT02002884|79240876|FG002|Main Period (MP)|Lost to Follow-up|2|||
44279870|NCT02002884|79240877|FG003|Main Period (MP)|Lost to Follow-up|0|||
44279871|NCT02002884|79240874|FG000|Open-Label Extension Period (OLEX)|Other|0|||
44518881|NCT03586830|79526582|FG003|Overall Study|Lost to Follow-up|1|||
44518882|NCT03586830|79526579|FG000|Overall Study|Withdrawal by Subject|1|||
44518883|NCT03586830|79526580|FG001|Overall Study|Withdrawal by Subject|0|||
44518884|NCT03586830|79526581|FG002|Overall Study|Withdrawal by Subject|3|||
44251427|NCT01382225|79086829|FG001|Overall Study|Adverse Event|2|||
44251428|NCT01382225|79086828|FG000|Overall Study|Protocol Violation|2|||
44251429|NCT01382225|79086829|FG001|Overall Study|Protocol Violation|1|||
44251430|NCT01382225|79086828|FG000|Overall Study|Subject Withdrew Consent|5|||
44279872|NCT02002884|79240875|FG001|Open-Label Extension Period (OLEX)|Other|0|||
44279873|NCT02002884|79240876|FG002|Open-Label Extension Period (OLEX)|Other|0|||
44279874|NCT02002884|79240877|FG003|Open-Label Extension Period (OLEX)|Other|24|||
44279875|NCT02002884|79240874|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
44279876|NCT02002884|79240875|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
44279877|NCT02002884|79240876|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
44279878|NCT02002884|79240877|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
44279879|NCT02002884|79240874|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
44279880|NCT02002884|79240875|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
44279881|NCT02002884|79240876|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
44279882|NCT02002884|79240877|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
44279883|NCT02002884|79240874|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
44279884|NCT02002884|79240875|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
44279885|NCT02002884|79240876|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
44279886|NCT02002884|79240877|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
44279887|NCT02002884|79240874|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
44279888|NCT02002884|79240875|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
44279889|NCT02002884|79240876|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
44279890|NCT02002884|79240877|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
44279891|NCT02002182|79240889|FG000|Overall Study|Withdraw from study|3|||
44279892|NCT02002182|79240890|FG001|Overall Study|Withdraw from study|1|||
44279893|NCT02002182|79240889|FG000|Overall Study|Health Reasons|1|||
44279894|NCT02002182|79240890|FG001|Overall Study|Health Reasons|0|||
44279895|NCT02002182|79240889|FG000|Overall Study|Death|1|||
44279896|NCT02002182|79240890|FG001|Overall Study|Death|0|||
44279897|NCT01990950|79240896|FG000|Overall Study|Death|3|||
44279898|NCT01990950|79240896|FG000|Overall Study|Lost to Follow-up|2|||
44279899|NCT01990950|79240896|FG000|Overall Study|Withdrawal by Subject|6|||
44279900|NCT02001558|79240902|FG000|Overall Study|Lost to Follow-up|8|||
44279901|NCT02001558|79240903|FG001|Overall Study|Lost to Follow-up|14|||
44279902|NCT02023866|79240909|FG000|Overall Study|Non-compliance|2|||
44385555|NCT00766090|79391490|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44385556|NCT00766090|79391479|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
44518885|NCT03586830|79526582|FG003|Overall Study|Withdrawal by Subject|1|||
44518886|NCT03026530|79526594|FG000|Overall Study|Lost to Follow-up|19|||
44251431|NCT01382225|79086829|FG001|Overall Study|Subject Withdrew Consent|2|||
44279903|NCT02023866|79240909|FG000|Overall Study|Adverse Event|3|||
44279904|NCT02023866|79240909|FG000|Overall Study|Withdrawal by Subject|1|||
44279905|NCT02023242|79240915|FG000|Overall Study|Lost to Follow-up|3|||
44279906|NCT02023242|79240916|FG001|Overall Study|Lost to Follow-up|1|||
44279907|NCT02023242|79240915|FG000|Overall Study|Death|0|||
44279908|NCT02023242|79240916|FG001|Overall Study|Death|1|||
44279909|NCT01967940|79240925|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
44279910|NCT01967940|79240926|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
44279911|NCT01967940|79240927|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
44385557|NCT00766090|79391480|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385558|NCT00766090|79391481|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385559|NCT00766090|79391482|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385560|NCT00766090|79391483|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385561|NCT00766090|79391484|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385562|NCT00766090|79391485|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385563|NCT00766090|79391486|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385564|NCT00766090|79391487|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385565|NCT00766090|79391488|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385566|NCT00766090|79391489|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385567|NCT00766090|79391490|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
44385568|NCT00766090|79391479|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
44385569|NCT00766090|79391480|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385570|NCT00766090|79391481|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385571|NCT00766090|79391482|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
44385572|NCT00766090|79391483|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385573|NCT00766090|79391484|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385574|NCT00766090|79391485|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385575|NCT00766090|79391486|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385576|NCT00766090|79391487|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385577|NCT00766090|79391488|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385578|NCT00766090|79391489|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385579|NCT00766090|79391490|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44385580|NCT00766090|79391479|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385581|NCT00766090|79391480|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385582|NCT00766090|79391481|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
44385583|NCT00766090|79391482|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385584|NCT00766090|79391483|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385585|NCT00766090|79391484|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385586|NCT00766090|79391485|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385587|NCT00766090|79391486|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385588|NCT00766090|79391487|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385589|NCT00766090|79391488|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385590|NCT00766090|79391489|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385591|NCT00766090|79391490|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
44385592|NCT00766090|79391479|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385593|NCT00766090|79391480|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385594|NCT00766090|79391481|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385595|NCT00766090|79391482|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385596|NCT00766090|79391483|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
44385597|NCT00766090|79391484|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385598|NCT00766090|79391485|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385599|NCT00766090|79391486|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385600|NCT00766090|79391487|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385601|NCT00766090|79391488|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385602|NCT00766090|79391489|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385603|NCT00766090|79391490|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44385604|NCT00766090|79391479|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385605|NCT00766090|79391480|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385606|NCT00766090|79391481|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
44385607|NCT00766090|79391482|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385608|NCT00766090|79391483|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385609|NCT00766090|79391484|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385610|NCT00766090|79391485|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44146114|NCT05070546|78935270|FG000|Overall Study|Randomized but not vaccinated|1|||
44251432|NCT01382225|79086828|FG000|Overall Study|Other|4|||
44251433|NCT01382225|79086829|FG001|Overall Study|Other|2|||
44251434|NCT01381679|79086835|FG000|Overall Study|Adverse Event|3|||
44251435|NCT01381679|79086835|FG000|Overall Study|Lost to Follow-up|885|||
44385611|NCT00766090|79391486|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385612|NCT00766090|79391487|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385613|NCT00766090|79391488|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385614|NCT00766090|79391489|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44385615|NCT00766090|79391490|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
44146115|NCT05070546|78935271|FG001|Overall Study|Randomized but not vaccinated|0|||
44146116|NCT05070546|78935272|FG002|Overall Study|Randomized but not vaccinated|1|||
44146117|NCT05070546|78935273|FG003|Overall Study|Randomized but not vaccinated|1|||
44146118|NCT05070546|78935274|FG004|Overall Study|Randomized but not vaccinated|3|||
44146119|NCT05070546|78935275|FG005|Overall Study|Randomized but not vaccinated|0|||
44146120|NCT05032950|78935294|FG000|Overall Study|Adverse Event|0|||
44146121|NCT05032950|78935295|FG001|Overall Study|Adverse Event|0|||
44251436|NCT01455194|79086842|FG000|Overall Study|Screen Failure|20|||
44385616|NCT00766090|79391479|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
44385617|NCT00766090|79391480|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
44385618|NCT00766090|79391481|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
44385619|NCT00766090|79391482|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
44385620|NCT00766090|79391483|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
44385621|NCT00766090|79391484|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
44385622|NCT00766090|79391485|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
44385623|NCT00766090|79391486|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
44146122|NCT05032950|78935296|FG002|Overall Study|Adverse Event|1|||
44146123|NCT05032950|78935297|FG003|Overall Study|Adverse Event|1|||
44146124|NCT05032950|78935298|FG004|Overall Study|Adverse Event|0|||
44146125|NCT05032950|78935299|FG005|Overall Study|Adverse Event|0|||
44146126|NCT04776161|78935319|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
44146127|NCT04776161|78935320|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
44146128|NCT04776161|78935321|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
44146129|NCT04776161|78935319|FG000|Overall Study|Withdrawal by Subject|1|||
44146130|NCT04776161|78935320|FG001|Overall Study|Withdrawal by Subject|0|||
44146131|NCT04776161|78935321|FG002|Overall Study|Withdrawal by Subject|1|||
44146132|NCT04776161|78935319|FG000|Overall Study|Adverse Event|0|||
44146133|NCT04776161|78935320|FG001|Overall Study|Adverse Event|1|||
44146134|NCT04776161|78935321|FG002|Overall Study|Adverse Event|1|||
44146135|NCT04268823|78935335|FG000|Overall Study|Adverse Event|1|||
44146136|NCT04268823|78935336|FG001|Overall Study|Adverse Event|0|||
44146137|NCT04268823|78935335|FG000|Overall Study|Participant Decision|1|||
44146138|NCT04268823|78935336|FG001|Overall Study|Participant Decision|0|||
44385624|NCT00766090|79391487|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
44385625|NCT00766090|79391488|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
44385626|NCT00766090|79391489|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
44385627|NCT00766090|79391490|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
44385628|NCT00766090|79391479|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385629|NCT00766090|79391480|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385630|NCT00766090|79391481|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385631|NCT00766090|79391482|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385632|NCT00766090|79391483|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385633|NCT00766090|79391484|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
44385634|NCT00766090|79391485|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385635|NCT00766090|79391486|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385636|NCT00766090|79391487|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385637|NCT00766090|79391488|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385638|NCT00766090|79391489|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385639|NCT00766090|79391490|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
44385640|NCT00766090|79391479|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385641|NCT00766090|79391480|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
44385642|NCT00766090|79391481|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385643|NCT00766090|79391482|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
44385644|NCT00766090|79391483|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385645|NCT00766090|79391484|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385646|NCT00766090|79391485|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385647|NCT00766090|79391486|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385648|NCT00766090|79391487|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385649|NCT00766090|79391488|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385650|NCT00766090|79391489|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
44385651|NCT00766090|79391490|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
44385652|NCT00766090|79391479|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44518887|NCT03026530|79526595|FG001|Overall Study|Lost to Follow-up|24|||
44518888|NCT03026530|79526594|FG000|Overall Study|Protocol Violation|2|||
44518889|NCT03026530|79526595|FG001|Overall Study|Protocol Violation|5|||
44518890|NCT03418376|79526605|FG000|Overall Study|Musculoskeletal injury|1|||
44518891|NCT03418376|79526606|FG001|Overall Study|Musculoskeletal injury|2|||
44518892|NCT03418376|79526607|FG002|Overall Study|Musculoskeletal injury|1|||
44146139|NCT04226495|78935345|FG000|Overall Study|Withdrawal by Subject|3|||
44146140|NCT04226495|78935346|FG001|Overall Study|Withdrawal by Subject|3|||
44146141|NCT04226495|78935345|FG000|Overall Study|PI discretion|2|||
44251437|NCT01455194|79086843|FG001|Overall Study|Screen Failure|0|||
44251438|NCT01455194|79086844|FG002|Overall Study|Screen Failure|0|||
44518893|NCT03418376|79526608|FG003|Overall Study|Musculoskeletal injury|0|||
44518894|NCT03418376|79526605|FG000|Overall Study|Personal reasons|0|||
44518895|NCT03418376|79526606|FG001|Overall Study|Personal reasons|2|||
44518896|NCT03418376|79526607|FG002|Overall Study|Personal reasons|2|||
44146142|NCT04226495|78935346|FG001|Overall Study|PI discretion|4|||
44146143|NCT04060212|78935352|FG000|Overall Study|Withdrawal by Subject|7|||
44251439|NCT01455194|79086845|FG003|Overall Study|Screen Failure|0|||
44146144|NCT04007991|78935358|FG000|Overall Study|Withdrawal by Subject|1|||
44385653|NCT00766090|79391480|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385654|NCT00766090|79391481|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385655|NCT00766090|79391482|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385656|NCT00766090|79391483|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
44385657|NCT00766090|79391484|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385658|NCT00766090|79391485|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385659|NCT00766090|79391486|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385660|NCT00766090|79391487|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385661|NCT00766090|79391488|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385662|NCT00766090|79391489|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44385663|NCT00766090|79391490|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
44146145|NCT04007991|78935359|FG001|Overall Study|Withdrawal by Subject|1|||
44146146|NCT04007991|78935358|FG000|Overall Study|Physician Decision|1|||
44385664|NCT00580801|79391507|FG000|Overall Study|Physician Decision|1|||
44385665|NCT00580801|79391508|FG001|Overall Study|Physician Decision|0|||
44385666|NCT00580801|79391509|FG002|Overall Study|Physician Decision|0|||
44385667|NCT00580801|79391507|FG000|Overall Study|Adverse Event|2|||
44385668|NCT00580801|79391508|FG001|Overall Study|Adverse Event|0|||
44385669|NCT00580801|79391509|FG002|Overall Study|Adverse Event|0|||
44385670|NCT00580801|79391507|FG000|Overall Study|Lost to Follow-up|2|||
44385671|NCT00580801|79391508|FG001|Overall Study|Lost to Follow-up|0|||
44385672|NCT00580801|79391509|FG002|Overall Study|Lost to Follow-up|0|||
44385673|NCT00580801|79391507|FG000|Overall Study|Reached a virologic endpoint|0|||
44385674|NCT00580801|79391508|FG001|Overall Study|Reached a virologic endpoint|1|||
44385675|NCT00580801|79391509|FG002|Overall Study|Reached a virologic endpoint|2|||
44146147|NCT04007991|78935359|FG001|Overall Study|Physician Decision|1|||
44146148|NCT04007991|78935358|FG000|Overall Study|Non-compliance with Study Drug|0|||
44146149|NCT04007991|78935359|FG001|Overall Study|Non-compliance with Study Drug|1|||
44146150|NCT04007991|78935358|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
44146151|NCT04007991|78935359|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
44146152|NCT04007991|78935358|FG000|Overall Study|Adverse event, non-fatal|5|||
44146153|NCT04007991|78935359|FG001|Overall Study|Adverse event, non-fatal|0|||
44146154|NCT04007991|78935358|FG000|Overall Study|Lost to Follow-up|2|||
44146155|NCT04007991|78935359|FG001|Overall Study|Lost to Follow-up|1|||
44146156|NCT03935217|78935380|FG000|Overall Study|Adverse Event|1|||
44146157|NCT03935217|78935381|FG001|Overall Study|Adverse Event|0|||
44385676|NCT00580801|79391507|FG000|Overall Study|Participant non-compliant|0|||
44385677|NCT00580801|79391508|FG001|Overall Study|Participant non-compliant|0|||
44385678|NCT00580801|79391509|FG002|Overall Study|Participant non-compliant|1|||
44385679|NCT00580801|79391507|FG000|Overall Study|Travel|1|||
44385680|NCT00580801|79391508|FG001|Overall Study|Travel|0|||
44385681|NCT00580801|79391509|FG002|Overall Study|Travel|0|||
44385682|NCT01059539|79391517|FG000|Overall Study|Adverse Event|66|||
44385683|NCT01059539|79391517|FG000|Overall Study|Insufficient Therapeutic Response|26|||
44385684|NCT01059539|79391517|FG000|Overall Study|Protocol Violation|55|||
44385685|NCT01059539|79391517|FG000|Overall Study|Withdrawal of Consent|80|||
44385686|NCT01059539|79391517|FG000|Overall Study|Lost to Follow-up|42|||
44385687|NCT01059539|79391517|FG000|Overall Study|Reason Not Specified|2|||
44385688|NCT00999908|79391521|FG000|Treatment Period 1|Subject withdrew consent|2|||
44385689|NCT00999908|79391522|FG001|Treatment Period 1|Subject withdrew consent|0|||
44385690|NCT00999908|79391523|FG002|Treatment Period 1|Subject withdrew consent|0|||
44385691|NCT00999908|79391521|FG000|Treatment Period 2|Protocol Violation|1|||
44146158|NCT03935217|78935380|FG000|Overall Study|Lost to Follow-up|0|||
44146159|NCT03935217|78935381|FG001|Overall Study|Lost to Follow-up|1|||
44146160|NCT03935217|78935380|FG000|Overall Study|Withdrawal by Subject|0|||
44146161|NCT03935217|78935381|FG001|Overall Study|Withdrawal by Subject|2|||
44385692|NCT00999908|79391522|FG001|Treatment Period 2|Protocol Violation|0|||
44385693|NCT00999908|79391523|FG002|Treatment Period 2|Protocol Violation|0|||
44385694|NCT00580723|79391531|FG000|Overall Study|Did not want to participate in extension|3|||
44385695|NCT00580723|79391531|FG000|Overall Study|Lost to Follow-up|5|||
44385696|NCT00999596|79391535|FG000|Overall Study|Statistical population not required|101|||
44385697|NCT04676867|79391544|FG000|Overall Study|Screen failure|0|||
44385698|NCT04676867|79391545|FG001|Overall Study|Screen failure|0|||
44385699|NCT04676867|79391546|FG002|Overall Study|Screen failure|6|||
44385700|NCT04676867|79391547|FG003|Overall Study|Screen failure|2|||
44385701|NCT04676867|79391544|FG000|Overall Study|Death|0|||
44385702|NCT04676867|79391545|FG001|Overall Study|Death|0|||
44385703|NCT04676867|79391546|FG002|Overall Study|Death|1|||
44385704|NCT04676867|79391547|FG003|Overall Study|Death|0|||
44385705|NCT04676867|79391544|FG000|Overall Study|Withdrawal by Subject|2|||
44385706|NCT04676867|79391545|FG001|Overall Study|Withdrawal by Subject|2|||
44385707|NCT04676867|79391546|FG002|Overall Study|Withdrawal by Subject|4|||
44385708|NCT04676867|79391547|FG003|Overall Study|Withdrawal by Subject|4|||
44385709|NCT04676867|79391544|FG000|Overall Study|Lost to Follow-up|1|||
44385710|NCT04676867|79391545|FG001|Overall Study|Lost to Follow-up|0|||
44385711|NCT04676867|79391546|FG002|Overall Study|Lost to Follow-up|0|||
44385712|NCT04676867|79391547|FG003|Overall Study|Lost to Follow-up|0|||
44385713|NCT00770224|79391557|FG000|Step 1: Induction|Adverse Event|3|||
44385714|NCT00770224|79391558|FG001|Step 1: Induction|Adverse Event|0|||
44385715|NCT00770224|79391557|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
44385716|NCT00770224|79391558|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
44385717|NCT00770224|79391557|FG000|Step 1: Induction|Other reason not protocol specified|2|||
44385718|NCT00770224|79391558|FG001|Step 1: Induction|Other reason not protocol specified|0|||
44385719|NCT00770224|79391557|FG000|Step 1: Induction|Ineligible|2|||
44385720|NCT00770224|79391558|FG001|Step 1: Induction|Ineligible|0|||
44385721|NCT00770224|79391557|FG000|Step 1: Induction|No protocol treatment given|1|||
44251440|NCT01455194|79086842|FG000|Overall Study|Randomisation Failure|90|||
44251441|NCT01455194|79086843|FG001|Overall Study|Randomisation Failure|0|||
44279912|NCT01967940|79240928|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
44279913|NCT01967940|79240925|FG000|Part 2|Adverse Event|0|||
44279914|NCT01967940|79240926|FG001|Part 2|Adverse Event|0|||
44279915|NCT01967940|79240927|FG002|Part 2|Adverse Event|0|||
44279916|NCT01967940|79240928|FG003|Part 2|Adverse Event|1|||
44279917|NCT01967940|79240925|FG000|Part 2|Unknown Reason|0|||
44279918|NCT01967940|79240926|FG001|Part 2|Unknown Reason|0|||
44279919|NCT01967940|79240927|FG002|Part 2|Unknown Reason|0|||
44279920|NCT01967940|79240928|FG003|Part 2|Unknown Reason|1|||
44279921|NCT01990560|79240938|FG000|Overall Study|Withdrawal by Subject|1|||
44279922|NCT01998984|79240946|FG000|Overall Study|Adverse Event|0|||
44279923|NCT01998984|79240947|FG001|Overall Study|Adverse Event|0|||
44279924|NCT01998984|79240948|FG002|Overall Study|Adverse Event|0|||
44279925|NCT01998984|79240949|FG003|Overall Study|Adverse Event|1|||
44279926|NCT01998984|79240946|FG000|Overall Study|Lost to Follow-up|0|||
44279927|NCT01998984|79240947|FG001|Overall Study|Lost to Follow-up|1|||
44279928|NCT01998984|79240948|FG002|Overall Study|Lost to Follow-up|0|||
44279929|NCT01998984|79240949|FG003|Overall Study|Lost to Follow-up|1|||
44279930|NCT01998984|79240946|FG000|Overall Study|Withdrawal by Subject|0|||
44279931|NCT01998984|79240947|FG001|Overall Study|Withdrawal by Subject|0|||
44279932|NCT01998984|79240948|FG002|Overall Study|Withdrawal by Subject|1|||
44279933|NCT01998984|79240949|FG003|Overall Study|Withdrawal by Subject|0|||
44385722|NCT00770224|79391558|FG001|Step 1: Induction|No protocol treatment given|0|||
44385723|NCT00770224|79391557|FG000|Step 2: Maintenance|Adverse Event|0|||
44146162|NCT03806933|78935395|FG000|Main Period|Physician Decision|0|||
44251442|NCT01455194|79086844|FG002|Overall Study|Randomisation Failure|0|||
44251443|NCT01455194|79086845|FG003|Overall Study|Randomisation Failure|0|||
44251444|NCT01455194|79086842|FG000|Overall Study|Deterioration in asthma|12|||
44251445|NCT01455194|79086843|FG001|Overall Study|Deterioration in asthma|6|||
44251446|NCT01455194|79086844|FG002|Overall Study|Deterioration in asthma|14|||
44251447|NCT01455194|79086845|FG003|Overall Study|Deterioration in asthma|9|||
44251448|NCT01455194|79086842|FG000|Overall Study|Adverse Event|1|||
44279934|NCT01998984|79240946|FG000|Overall Study|Other|0|||
44251449|NCT01455194|79086843|FG001|Overall Study|Adverse Event|1|||
44251450|NCT01455194|79086844|FG002|Overall Study|Adverse Event|1|||
44279935|NCT01998984|79240947|FG001|Overall Study|Other|0|||
44279936|NCT01998984|79240948|FG002|Overall Study|Other|0|||
44279937|NCT01998984|79240949|FG003|Overall Study|Other|1|||
44279938|NCT01967706|79240961|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
44279939|NCT01967706|79240962|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
44279940|NCT01967706|79240963|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
44279941|NCT01967706|79240964|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
44385724|NCT00770224|79391558|FG001|Step 2: Maintenance|Adverse Event|10|||
44279942|NCT01967628|79240975|FG000|Overall Study|Withdrawal by Subject|2|||
44385725|NCT00770224|79391557|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
44385726|NCT00770224|79391558|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
44279943|NCT01967628|79240976|FG001|Overall Study|Withdrawal by Subject|0|||
44279944|NCT01967628|79240975|FG000|Overall Study|Unable to complete bronchoscopy|4|||
44279945|NCT01967628|79240976|FG001|Overall Study|Unable to complete bronchoscopy|6|||
44279946|NCT01967628|79240975|FG000|Overall Study|Lost to Follow-up|1|||
44279947|NCT01967628|79240976|FG001|Overall Study|Lost to Follow-up|0|||
44279948|NCT01967628|79240975|FG000|Overall Study|Low protein concentration in sample|20|||
44279949|NCT01967628|79240976|FG001|Overall Study|Low protein concentration in sample|25|||
44279950|NCT01998906|79240985|FG000|Overall Study|Participants ongoing in follow-up|77|||
44385727|NCT00770224|79391557|FG000|Step 2: Maintenance|Progression/relapse|0|||
44385728|NCT00770224|79391558|FG001|Step 2: Maintenance|Progression/relapse|1|||
44385729|NCT00770224|79391557|FG000|Step 2: Maintenance|Death|0|||
44385730|NCT00770224|79391558|FG001|Step 2: Maintenance|Death|2|||
44385731|NCT00770224|79391557|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
44385732|NCT00770224|79391558|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
44385733|NCT00770224|79391557|FG000|Step 2: Maintenance|Ineligible|0|||
44385734|NCT00770224|79391558|FG001|Step 2: Maintenance|Ineligible|2|||
44385735|NCT02389465|79391569|FG000|Overall Study|Lost to Follow-up|1|||
44385736|NCT02389465|79391570|FG001|Overall Study|Lost to Follow-up|3|||
44385737|NCT02389465|79391571|FG002|Overall Study|Lost to Follow-up|3|||
44385738|NCT02389465|79391572|FG003|Overall Study|Lost to Follow-up|0|||
44385739|NCT02389465|79391569|FG000|Overall Study|Physician Decision|0|||
44385740|NCT02389465|79391570|FG001|Overall Study|Physician Decision|0|||
44385741|NCT02389465|79391571|FG002|Overall Study|Physician Decision|0|||
44385742|NCT02389465|79391572|FG003|Overall Study|Physician Decision|1|||
44385743|NCT02389465|79391569|FG000|Overall Study|Withdrawal by Subject|0|||
44385744|NCT02389465|79391570|FG001|Overall Study|Withdrawal by Subject|1|||
44385745|NCT02389465|79391571|FG002|Overall Study|Withdrawal by Subject|2|||
44385746|NCT02389465|79391572|FG003|Overall Study|Withdrawal by Subject|2|||
44385747|NCT01057589|79391582|FG000|Overall Study|Disease Progression|35|||
44385748|NCT01057589|79391582|FG000|Overall Study|Adverse Event|10|||
44385749|NCT01057589|79391582|FG000|Overall Study|Physician Decision|8|||
44385750|NCT01057589|79391582|FG000|Overall Study|Withdrawal by Subject|3|||
44385751|NCT01057589|79391582|FG000|Overall Study|Sponsor Decision|1|||
44385752|NCT01057589|79391582|FG000|Overall Study|Death|8|||
44518897|NCT03418376|79526608|FG003|Overall Study|Personal reasons|1|||
44518898|NCT03418376|79526605|FG000|Overall Study|Exacerbation|0|||
44518899|NCT03418376|79526606|FG001|Overall Study|Exacerbation|1|||
44518900|NCT03418376|79526607|FG002|Overall Study|Exacerbation|0|||
44518901|NCT03418376|79526608|FG003|Overall Study|Exacerbation|0|||
44251451|NCT01455194|79086845|FG003|Overall Study|Adverse Event|3|||
44251452|NCT01455194|79086842|FG000|Overall Study|Withdrawal by Subject|21|||
44251453|NCT01455194|79086843|FG001|Overall Study|Withdrawal by Subject|16|||
44251454|NCT01455194|79086844|FG002|Overall Study|Withdrawal by Subject|12|||
44251455|NCT01455194|79086845|FG003|Overall Study|Withdrawal by Subject|9|||
44251456|NCT01455194|79086842|FG000|Overall Study|Lost to Follow-up|2|||
44251457|NCT01455194|79086843|FG001|Overall Study|Lost to Follow-up|0|||
44251458|NCT01455194|79086844|FG002|Overall Study|Lost to Follow-up|1|||
44251459|NCT01455194|79086845|FG003|Overall Study|Lost to Follow-up|1|||
44251460|NCT01455194|79086842|FG000|Overall Study|Pregnancy|0|||
44251461|NCT01455194|79086843|FG001|Overall Study|Pregnancy|1|||
44251462|NCT01455194|79086844|FG002|Overall Study|Pregnancy|1|||
44251463|NCT01455194|79086845|FG003|Overall Study|Pregnancy|0|||
44279951|NCT01998906|79240986|FG001|Overall Study|Participants ongoing in follow-up|60|||
44279952|NCT01998906|79240987|FG002|Overall Study|Participants ongoing in follow-up|58|||
44279953|NCT01998906|79240985|FG000|Overall Study|Death|21|||
44279954|NCT01998906|79240986|FG001|Overall Study|Death|30|||
44279955|NCT01998906|79240987|FG002|Overall Study|Death|17|||
44279956|NCT01998906|79240985|FG000|Overall Study|Lack of Efficacy|10|||
44279957|NCT01998906|79240986|FG001|Overall Study|Lack of Efficacy|9|||
44279958|NCT01998906|79240987|FG002|Overall Study|Lack of Efficacy|8|||
44279959|NCT01998906|79240985|FG000|Overall Study|Failure to return|0|||
44279960|NCT01998906|79240986|FG001|Overall Study|Failure to return|2|||
44279961|NCT01998906|79240987|FG002|Overall Study|Failure to return|4|||
44279962|NCT01998906|79240985|FG000|Overall Study|Violation of Selection Criteria|0|||
44279963|NCT01998906|79240986|FG001|Overall Study|Violation of Selection Criteria|0|||
44279964|NCT01998906|79240987|FG002|Overall Study|Violation of Selection Criteria|1|||
44279965|NCT01998906|79240985|FG000|Overall Study|Withdrawal by Subject|1|||
44279966|NCT01998906|79240986|FG001|Overall Study|Withdrawal by Subject|4|||
44279967|NCT01998906|79240987|FG002|Overall Study|Withdrawal by Subject|3|||
44279968|NCT01998906|79240985|FG000|Overall Study|Administrative/Other|2|||
44279969|NCT01998906|79240986|FG001|Overall Study|Administrative/Other|1|||
44279970|NCT01998906|79240987|FG002|Overall Study|Administrative/Other|3|||
44279971|NCT01998906|79240985|FG000|Overall Study|Other|3|||
44279972|NCT01998906|79240986|FG001|Overall Study|Other|8|||
44279973|NCT01998906|79240987|FG002|Overall Study|Other|4|||
44385753|NCT01057589|79391582|FG000|Overall Study|Lost to Follow-up|1|||
44385754|NCT01716117|79391588|FG000|Overall Study|Death|5|||
44385755|NCT01716117|79391589|FG001|Overall Study|Death|2|||
44385756|NCT01716117|79391588|FG000|Overall Study|Withdrawal by Subject|2|||
44279974|NCT01967550|79241000|FG000|Overall Study|Withdrawal by Subject|1|||
44279975|NCT01967550|79241001|FG001|Overall Study|Withdrawal by Subject|0|||
44251464|NCT01455194|79086842|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
44251465|NCT01455194|79086843|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
44251466|NCT01455194|79086844|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
44251467|NCT01455194|79086845|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
44251468|NCT01455194|79086842|FG000|Overall Study|Miscellaneous|4|||
44251469|NCT01455194|79086843|FG001|Overall Study|Miscellaneous|5|||
44251470|NCT01455194|79086844|FG002|Overall Study|Miscellaneous|1|||
44251471|NCT01455194|79086845|FG003|Overall Study|Miscellaneous|4|||
44251472|NCT01454726|79086869|FG000|Overall Study|Withdrawal by Subject|0|||
44385757|NCT01716117|79391589|FG001|Overall Study|Withdrawal by Subject|0|||
44385758|NCT00579553|79391605|FG000|Overall Study|Lost to Follow-up|16|||
44385759|NCT00579553|79391606|FG001|Overall Study|Lost to Follow-up|13|||
44385760|NCT01650831|79391612|FG000|Overall Study|Screen failure|1|||
44385761|NCT00581893|79391620|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
44385762|NCT00581893|79391621|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
44385763|NCT00770146|79391629|FG000|Treatment Period|Withdrawal by Subject|6|||
44385764|NCT00770146|79391630|FG001|Treatment Period|Withdrawal by Subject|13|||
44385765|NCT00770146|79391629|FG000|Treatment Period|Adverse Event|2|||
44385766|NCT00770146|79391630|FG001|Treatment Period|Adverse Event|26|||
44385767|NCT00770146|79391629|FG000|Treatment Period|Other|1|||
44385768|NCT00770146|79391630|FG001|Treatment Period|Other|5|||
44385769|NCT00770146|79391629|FG000|Treatment Period|Protocol non-compliance|0|||
44385770|NCT00770146|79391630|FG001|Treatment Period|Protocol non-compliance|1|||
44385771|NCT00770146|79391629|FG000|Follow-up Period|Withdrawal by Subject|7|||
44385772|NCT00770146|79391630|FG001|Follow-up Period|Withdrawal by Subject|13|||
44385773|NCT00770146|79391629|FG000|Follow-up Period|Adverse Event|0|||
44385774|NCT00770146|79391630|FG001|Follow-up Period|Adverse Event|2|||
44385775|NCT00770146|79391629|FG000|Follow-up Period|Other|4|||
44385776|NCT00770146|79391630|FG001|Follow-up Period|Other|5|||
44385777|NCT01056341|79391641|FG000|Overall Study|Treatment Intolerance|0|||
44385778|NCT01056341|79391642|FG001|Overall Study|Treatment Intolerance|2|||
44385779|NCT01056341|79391643|FG002|Overall Study|Treatment Intolerance|0|||
44385780|NCT01056341|79391644|FG003|Overall Study|Treatment Intolerance|2|||
44385781|NCT01056341|79391645|FG004|Overall Study|Treatment Intolerance|0|||
44385782|NCT01056341|79391641|FG000|Overall Study|Lack of Efficacy|32|||
44385783|NCT01056341|79391642|FG001|Overall Study|Lack of Efficacy|30|||
44385784|NCT01056341|79391643|FG002|Overall Study|Lack of Efficacy|7|||
44251473|NCT01454726|79086870|FG001|Overall Study|Withdrawal by Subject|1|||
44251474|NCT01361568|79086882|FG000|Overall Study|Adverse Event|0|||
44251475|NCT01361568|79086883|FG001|Overall Study|Adverse Event|0|||
44251476|NCT01361568|79086884|FG002|Overall Study|Adverse Event|0|||
44279976|NCT01967550|79241000|FG000|Overall Study|Adverse Event|2|||
44279977|NCT01967550|79241001|FG001|Overall Study|Adverse Event|0|||
44279978|NCT01967550|79241000|FG000|Overall Study|Protocol Violation|2|||
44279979|NCT01967550|79241001|FG001|Overall Study|Protocol Violation|1|||
44279980|NCT01967550|79241000|FG000|Overall Study|Non Compliance|0|||
44279981|NCT01967550|79241001|FG001|Overall Study|Non Compliance|1|||
44385785|NCT01056341|79391644|FG003|Overall Study|Lack of Efficacy|25|||
44385786|NCT01056341|79391645|FG004|Overall Study|Lack of Efficacy|9|||
44385787|NCT01056341|79391641|FG000|Overall Study|Other reasons|4|||
44279982|NCT01989546|79241007|FG000|Overall Study|Clinical Progression|1|||
44385788|NCT01056341|79391642|FG001|Overall Study|Other reasons|4|||
44385789|NCT01056341|79391643|FG002|Overall Study|Other reasons|8|||
44385790|NCT01056341|79391644|FG003|Overall Study|Other reasons|9|||
44385791|NCT01056341|79391645|FG004|Overall Study|Other reasons|5|||
44385792|NCT00999518|79391668|FG000|Overall Study|Adverse Event|1|||
44385793|NCT00999518|79391669|FG001|Overall Study|Adverse Event|6|||
44146163|NCT03806933|78935396|FG001|Main Period|Physician Decision|0|||
44251477|NCT01361568|79086885|FG003|Overall Study|Adverse Event|0|||
44279983|NCT01989546|79241007|FG000|Overall Study|Disease progression on study|8|||
44279984|NCT01997892|79241011|FG000|Overall Study|Physician Decision|2|||
44251478|NCT01361568|79086886|FG004|Overall Study|Adverse Event|1|||
44279985|NCT01997892|79241011|FG000|Overall Study|Lost to Follow-up|6|||
44251479|NCT01361568|79086887|FG005|Overall Study|Adverse Event|0|||
44279986|NCT01997892|79241011|FG000|Overall Study|Death|14|||
44279987|NCT01997892|79241011|FG000|Overall Study|Renal transplant|8|||
44385794|NCT00999518|79391670|FG002|Overall Study|Adverse Event|3|||
44385795|NCT00999518|79391671|FG003|Overall Study|Adverse Event|1|||
44385796|NCT00999518|79391672|FG004|Overall Study|Adverse Event|2|||
44385797|NCT00999518|79391668|FG000|Overall Study|Lack of Efficacy|2|||
44385798|NCT00999518|79391669|FG001|Overall Study|Lack of Efficacy|0|||
44385799|NCT00999518|79391670|FG002|Overall Study|Lack of Efficacy|0|||
44385800|NCT00999518|79391671|FG003|Overall Study|Lack of Efficacy|2|||
44279988|NCT01997892|79241011|FG000|Overall Study|Other|3|||
44279989|NCT01997892|79241011|FG000|Overall Study|Study completion data not recorded|35|||
44385801|NCT00999518|79391672|FG004|Overall Study|Lack of Efficacy|2|||
44251480|NCT01361568|79086882|FG000|Overall Study|Physician Decision|0|||
44279990|NCT01989468|79241023|FG000|Overall Study|Adverse Event|10|||
44279991|NCT01989468|79241024|FG001|Overall Study|Adverse Event|15|||
44279992|NCT01989468|79241025|FG002|Overall Study|Adverse Event|4|||
44518902|NCT03585504|79526620|FG000|Overall Study|Lost to Follow-up|26|||
44518903|NCT03585504|79526621|FG001|Overall Study|Lost to Follow-up|29|||
44518904|NCT03417830|79526629|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
44518905|NCT03417830|79526630|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
44518906|NCT03576768|79526641|FG000|Overall Study|Lost to Follow-up|3|||
44518907|NCT03576768|79526642|FG001|Overall Study|Lost to Follow-up|3|||
44518908|NCT03576768|79526643|FG002|Overall Study|Lost to Follow-up|0|||
44518909|NCT03576768|79526644|FG003|Overall Study|Lost to Follow-up|0|||
44518910|NCT03576066|79526656|FG000|Overall Study|Noncompliance with study drug|0|||
44146164|NCT03806933|78935397|FG002|Main Period|Physician Decision|0|||
44279993|NCT01989468|79241026|FG003|Overall Study|Adverse Event|5|||
44279994|NCT01989468|79241027|FG004|Overall Study|Adverse Event|4|||
44279995|NCT01989468|79241023|FG000|Overall Study|Lack of Efficacy|11|||
44279996|NCT01989468|79241024|FG001|Overall Study|Lack of Efficacy|11|||
44279997|NCT01989468|79241025|FG002|Overall Study|Lack of Efficacy|7|||
44279998|NCT01989468|79241026|FG003|Overall Study|Lack of Efficacy|4|||
44279999|NCT01989468|79241027|FG004|Overall Study|Lack of Efficacy|2|||
44280000|NCT01989468|79241023|FG000|Overall Study|Lost to Follow-up|5|||
44280001|NCT01989468|79241024|FG001|Overall Study|Lost to Follow-up|2|||
44280002|NCT01989468|79241025|FG002|Overall Study|Lost to Follow-up|0|||
44280003|NCT01989468|79241026|FG003|Overall Study|Lost to Follow-up|1|||
44280004|NCT01989468|79241027|FG004|Overall Study|Lost to Follow-up|1|||
44280005|NCT01989468|79241023|FG000|Overall Study|Physician Decision|4|||
44280006|NCT01989468|79241024|FG001|Overall Study|Physician Decision|1|||
44280007|NCT01989468|79241025|FG002|Overall Study|Physician Decision|0|||
44280008|NCT01989468|79241026|FG003|Overall Study|Physician Decision|1|||
44280009|NCT01989468|79241027|FG004|Overall Study|Physician Decision|0|||
44280010|NCT01989468|79241023|FG000|Overall Study|Pregnancy|0|||
44280011|NCT01989468|79241024|FG001|Overall Study|Pregnancy|1|||
44280012|NCT01989468|79241025|FG002|Overall Study|Pregnancy|0|||
44280013|NCT01989468|79241026|FG003|Overall Study|Pregnancy|0|||
44280014|NCT01989468|79241027|FG004|Overall Study|Pregnancy|0|||
44280015|NCT01989468|79241023|FG000|Overall Study|Technical Problems|3|||
44280016|NCT01989468|79241024|FG001|Overall Study|Technical Problems|1|||
44280017|NCT01989468|79241025|FG002|Overall Study|Technical Problems|3|||
44280018|NCT01989468|79241026|FG003|Overall Study|Technical Problems|1|||
44280019|NCT01989468|79241027|FG004|Overall Study|Technical Problems|0|||
44280020|NCT01989468|79241023|FG000|Overall Study|Subject Guardian Decision|11|||
44280021|NCT01989468|79241024|FG001|Overall Study|Subject Guardian Decision|6|||
44280022|NCT01989468|79241025|FG002|Overall Study|Subject Guardian Decision|4|||
44280023|NCT01989468|79241026|FG003|Overall Study|Subject Guardian Decision|4|||
44280024|NCT01989468|79241027|FG004|Overall Study|Subject Guardian Decision|1|||
44280025|NCT01989468|79241023|FG000|Overall Study|Death|3|||
44280026|NCT01989468|79241024|FG001|Overall Study|Death|0|||
44280027|NCT01989468|79241025|FG002|Overall Study|Death|1|||
44280028|NCT01989468|79241026|FG003|Overall Study|Death|0|||
44280029|NCT01989468|79241027|FG004|Overall Study|Death|0|||
44280030|NCT01989156|79241043|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
44280031|NCT01989156|79241044|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
44280032|NCT01989156|79241045|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
44280033|NCT01989156|79241043|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
44280034|NCT01989156|79241044|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
44280035|NCT01989156|79241045|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
44280036|NCT01989156|79241043|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
44280037|NCT01989156|79241044|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
44280038|NCT01989156|79241045|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
44280039|NCT01989156|79241043|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
44280040|NCT01989156|79241044|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
44280041|NCT01989156|79241045|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
44280042|NCT01989156|79241043|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
44280043|NCT01989156|79241044|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
44280044|NCT01989156|79241045|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
44280045|NCT01989156|79241043|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
44280046|NCT01989156|79241044|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
44280047|NCT01989156|79241045|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
44280048|NCT01989156|79241043|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
44280049|NCT01989156|79241044|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
44280050|NCT01989156|79241045|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
44280051|NCT01989156|79241043|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
44280052|NCT01989156|79241044|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
44280053|NCT01989156|79241045|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
44280054|NCT01620762|79241056|FG000|Overall Study|Protocol Violation|1|||
44518911|NCT03576066|79526657|FG001|Overall Study|Noncompliance with study drug|1|||
44518912|NCT03557034|79526669|FG000|Overall Study|Withdrawal by Subject|1|||
44518913|NCT03557034|79526670|FG001|Overall Study|Withdrawal by Subject|0|||
44518914|NCT03583554|79526676|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
44518915|NCT03583554|79526677|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
44280055|NCT01620762|79241057|FG001|Overall Study|Protocol Violation|1|||
44280056|NCT01620762|79241058|FG002|Overall Study|Protocol Violation|1|||
44280057|NCT01620762|79241056|FG000|Overall Study|Adverse Event|9|||
44280058|NCT01620762|79241057|FG001|Overall Study|Adverse Event|5|||
44280059|NCT01620762|79241058|FG002|Overall Study|Adverse Event|2|||
44280060|NCT01620762|79241056|FG000|Overall Study|Withdrawal by Subject|23|||
44280061|NCT01620762|79241057|FG001|Overall Study|Withdrawal by Subject|26|||
44280062|NCT01620762|79241058|FG002|Overall Study|Withdrawal by Subject|27|||
44280063|NCT01620762|79241056|FG000|Overall Study|Lost to Follow-up|11|||
44280064|NCT01620762|79241057|FG001|Overall Study|Lost to Follow-up|17|||
44280065|NCT01620762|79241058|FG002|Overall Study|Lost to Follow-up|10|||
44280066|NCT01620762|79241056|FG000|Overall Study|Protocol deviation|1|||
44280067|NCT01620762|79241057|FG001|Overall Study|Protocol deviation|1|||
44280068|NCT01620762|79241058|FG002|Overall Study|Protocol deviation|6|||
44280069|NCT01620762|79241056|FG000|Overall Study|Subject deterioration|0|||
44280070|NCT01620762|79241057|FG001|Overall Study|Subject deterioration|1|||
44280071|NCT01620762|79241058|FG002|Overall Study|Subject deterioration|1|||
44280072|NCT01620762|79241056|FG000|Overall Study|Non-specified|3|||
44280073|NCT01620762|79241057|FG001|Overall Study|Non-specified|6|||
44280074|NCT01620762|79241058|FG002|Overall Study|Non-specified|5|||
44280075|NCT01620762|79241056|FG000|Overall Study|Use of prohibted therapies|0|||
44280076|NCT01620762|79241057|FG001|Overall Study|Use of prohibted therapies|1|||
44280077|NCT01620762|79241058|FG002|Overall Study|Use of prohibted therapies|1|||
44280078|NCT01966068|79241068|FG000|Overall Study|Withdrawal by Subject|57|||
44280079|NCT01966068|79241068|FG000|Overall Study|Lost to Follow-up|81|||
44280080|NCT01620528|79241076|FG000|Treatment Period|Did Not Receive Study Drug|0|||
44280081|NCT01620528|79241077|FG001|Treatment Period|Did Not Receive Study Drug|0|||
44280082|NCT01620528|79241078|FG002|Treatment Period|Did Not Receive Study Drug|1|||
44280083|NCT01620528|79241076|FG000|Treatment Period|Withdrawal by Subject|35|||
44280084|NCT01620528|79241077|FG001|Treatment Period|Withdrawal by Subject|21|||
44280085|NCT01620528|79241078|FG002|Treatment Period|Withdrawal by Subject|16|||
44280086|NCT01620528|79241076|FG000|Treatment Period|Adverse Event|17|||
44280087|NCT01620528|79241077|FG001|Treatment Period|Adverse Event|13|||
44280088|NCT01620528|79241078|FG002|Treatment Period|Adverse Event|21|||
44280089|NCT01620528|79241076|FG000|Treatment Period|Lost to Follow-up|16|||
44280090|NCT01620528|79241077|FG001|Treatment Period|Lost to Follow-up|8|||
44280091|NCT01620528|79241078|FG002|Treatment Period|Lost to Follow-up|14|||
44280092|NCT01620528|79241076|FG000|Treatment Period|Other|9|||
44280093|NCT01620528|79241077|FG001|Treatment Period|Other|5|||
44280094|NCT01620528|79241078|FG002|Treatment Period|Other|7|||
44280095|NCT01620528|79241076|FG000|Treatment Period|Subject Noncompliant|11|||
44280096|NCT01620528|79241077|FG001|Treatment Period|Subject Noncompliant|2|||
44280097|NCT01620528|79241078|FG002|Treatment Period|Subject Noncompliant|2|||
44280098|NCT01620528|79241076|FG000|Treatment Period|Pregnancy|7|||
44280099|NCT01620528|79241077|FG001|Treatment Period|Pregnancy|2|||
44280100|NCT01620528|79241078|FG002|Treatment Period|Pregnancy|2|||
44280101|NCT01620528|79241076|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
44280102|NCT01620528|79241077|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
44280103|NCT01620528|79241078|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
44280104|NCT01620528|79241076|FG000|Treatment Period|Exclusionary Medication Received|0|||
44280105|NCT01620528|79241077|FG001|Treatment Period|Exclusionary Medication Received|1|||
44280106|NCT01620528|79241078|FG002|Treatment Period|Exclusionary Medication Received|0|||
44280107|NCT01620528|79241076|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
44280108|NCT01620528|79241077|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
44280109|NCT01620528|79241078|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
44280110|NCT01620528|79241076|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
44280111|NCT01620528|79241077|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
44280112|NCT01620528|79241078|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
44280113|NCT01620528|79241076|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
44280114|NCT01620528|79241077|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
44280115|NCT01620528|79241078|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
44280116|NCT01620528|79241076|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
44280117|NCT01620528|79241077|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
44280118|NCT01620528|79241078|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
44280119|NCT01620528|79241076|FG000|Post-Treatment Follow-Up Period|Other|6|||
44280120|NCT01620528|79241077|FG001|Post-Treatment Follow-Up Period|Other|4|||
44280121|NCT01620528|79241078|FG002|Post-Treatment Follow-Up Period|Other|2|||
44280122|NCT01965834|79241086|FG000|Overall Study|Lack of Efficacy|4|||
44146165|NCT03806933|78935398|FG003|Main Period|Physician Decision|1|||
44385802|NCT00999518|79391668|FG000|Overall Study|Lost to Follow-up|0|||
44385803|NCT00999518|79391669|FG001|Overall Study|Lost to Follow-up|0|||
44385804|NCT00999518|79391670|FG002|Overall Study|Lost to Follow-up|0|||
44385805|NCT00999518|79391671|FG003|Overall Study|Lost to Follow-up|4|||
44385806|NCT00999518|79391672|FG004|Overall Study|Lost to Follow-up|1|||
44385807|NCT00999518|79391668|FG000|Overall Study|Did not meet entrance criteria|0|||
44385808|NCT00999518|79391669|FG001|Overall Study|Did not meet entrance criteria|0|||
44385809|NCT00999518|79391670|FG002|Overall Study|Did not meet entrance criteria|0|||
44385810|NCT00999518|79391671|FG003|Overall Study|Did not meet entrance criteria|0|||
44385811|NCT00999518|79391672|FG004|Overall Study|Did not meet entrance criteria|1|||
44385812|NCT00999518|79391668|FG000|Overall Study|Study terminated by sponsor|10|||
44385813|NCT00999518|79391669|FG001|Overall Study|Study terminated by sponsor|6|||
44385814|NCT00999518|79391670|FG002|Overall Study|Study terminated by sponsor|5|||
44385815|NCT00999518|79391671|FG003|Overall Study|Study terminated by sponsor|5|||
44385816|NCT00999518|79391672|FG004|Overall Study|Study terminated by sponsor|9|||
44385817|NCT00999518|79391668|FG000|Overall Study|Pregnancy|0|||
44385818|NCT00999518|79391669|FG001|Overall Study|Pregnancy|0|||
44385819|NCT00999518|79391670|FG002|Overall Study|Pregnancy|1|||
44385820|NCT00999518|79391671|FG003|Overall Study|Pregnancy|0|||
44385821|NCT00999518|79391672|FG004|Overall Study|Pregnancy|0|||
44385822|NCT00999518|79391668|FG000|Overall Study|Protocol Violation|0|||
44385823|NCT00999518|79391669|FG001|Overall Study|Protocol Violation|1|||
44385824|NCT00999518|79391670|FG002|Overall Study|Protocol Violation|0|||
44385825|NCT00999518|79391671|FG003|Overall Study|Protocol Violation|0|||
44385826|NCT00999518|79391672|FG004|Overall Study|Protocol Violation|2|||
44385827|NCT00999518|79391668|FG000|Overall Study|Withdrawal by Subject|5|||
44385828|NCT00999518|79391669|FG001|Overall Study|Withdrawal by Subject|4|||
44385829|NCT00999518|79391670|FG002|Overall Study|Withdrawal by Subject|10|||
44385830|NCT00999518|79391671|FG003|Overall Study|Withdrawal by Subject|6|||
44385831|NCT00999518|79391672|FG004|Overall Study|Withdrawal by Subject|1|||
44385832|NCT00999518|79391668|FG000|Overall Study|Other|5|||
44385833|NCT00999518|79391669|FG001|Overall Study|Other|7|||
44385834|NCT00999518|79391670|FG002|Overall Study|Other|1|||
44385835|NCT00999518|79391671|FG003|Overall Study|Other|4|||
44385836|NCT00999518|79391672|FG004|Overall Study|Other|5|||
44385837|NCT00999518|79391668|FG000|Overall Study|Randomized but not Treated|1|||
44385838|NCT00999518|79391669|FG001|Overall Study|Randomized but not Treated|1|||
44385839|NCT00999518|79391670|FG002|Overall Study|Randomized but not Treated|2|||
44385840|NCT00999518|79391671|FG003|Overall Study|Randomized but not Treated|0|||
44385841|NCT00999518|79391672|FG004|Overall Study|Randomized but not Treated|1|||
44385842|NCT01056263|79391688|FG000|Overall Study|Adverse Event|12|||
44385843|NCT01056263|79391688|FG000|Overall Study|Death|1|||
44385844|NCT01056263|79391688|FG000|Overall Study|Withdrawal by Subject|1|||
44385845|NCT01056263|79391688|FG000|Overall Study|Lack of Efficacy|29|||
44385846|NCT01056263|79391688|FG000|Overall Study|Progressive disease|2|||
44385847|NCT01056263|79391688|FG000|Overall Study|Neoplasm progression|1|||
44385848|NCT01056263|79391688|FG000|Overall Study|Objective progression or relapse|1|||
44385849|NCT01056263|79391688|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
44385850|NCT01056107|79391696|FG000|Overall Study|Withdrawal by Subject|0|||
44385851|NCT01056107|79391697|FG001|Overall Study|Withdrawal by Subject|1|||
44385852|NCT01056107|79391698|FG002|Overall Study|Withdrawal by Subject|3|||
44385853|NCT01056107|79391699|FG003|Overall Study|Withdrawal by Subject|0|||
44385854|NCT01003886|79391709|FG000|Overall Study|Lack of Efficacy|5|||
44385855|NCT01003886|79391709|FG000|Overall Study|Lost to Follow-up|169|||
44385856|NCT01003886|79391709|FG000|Overall Study|Withdrawal by Subject|39|||
44146166|NCT03806933|78935395|FG000|Main Period|Pregnancy|0|||
44251481|NCT01361568|79086883|FG001|Overall Study|Physician Decision|0|||
44251482|NCT01361568|79086884|FG002|Overall Study|Physician Decision|0|||
44251483|NCT01361568|79086885|FG003|Overall Study|Physician Decision|0|||
44251484|NCT01361568|79086886|FG004|Overall Study|Physician Decision|0|||
44251485|NCT01361568|79086887|FG005|Overall Study|Physician Decision|1|||
44251486|NCT01361568|79086882|FG000|Overall Study|Withdrawal by Subject|2|||
44385857|NCT01003886|79391709|FG000|Overall Study|Other|14|||
44385858|NCT01003886|79391709|FG000|Overall Study|Adverse Event|3|||
44385859|NCT01003184|79391715|FG000|Overall Study|Adverse Event|12|||
44385860|NCT01003184|79391716|FG001|Overall Study|Adverse Event|5|||
44385861|NCT01003184|79391715|FG000|Overall Study|Lost to Follow-up|1|||
44385862|NCT01003184|79391716|FG001|Overall Study|Lost to Follow-up|0|||
44385863|NCT01003184|79391715|FG000|Overall Study|Loss of glucose control|1|||
44385864|NCT01003184|79391716|FG001|Overall Study|Loss of glucose control|1|||
44385865|NCT01003184|79391715|FG000|Overall Study|Protocol Violation|3|||
44385866|NCT01003184|79391716|FG001|Overall Study|Protocol Violation|0|||
44385867|NCT01003184|79391715|FG000|Overall Study|Withdrawal by Subject|1|||
44385868|NCT01003184|79391716|FG001|Overall Study|Withdrawal by Subject|6|||
44146167|NCT03806933|78935396|FG001|Main Period|Pregnancy|0|||
44146168|NCT03806933|78935397|FG002|Main Period|Pregnancy|1|||
44146169|NCT03806933|78935398|FG003|Main Period|Pregnancy|0|||
44251487|NCT01361568|79086883|FG001|Overall Study|Withdrawal by Subject|1|||
44385869|NCT01003184|79391715|FG000|Overall Study|Physician Decision|1|||
44385870|NCT01003184|79391716|FG001|Overall Study|Physician Decision|0|||
44385871|NCT01029353|79391726|FG000|Overall Study|Lost to Follow-up|4|||
44385872|NCT01029353|79391727|FG001|Overall Study|Lost to Follow-up|5|||
44385873|NCT01029353|79391728|FG002|Overall Study|Lost to Follow-up|5|||
44385874|NCT01029353|79391729|FG003|Overall Study|Lost to Follow-up|4|||
44385875|NCT01029353|79391726|FG000|Overall Study|Consent Withdrawn|2|||
44385876|NCT01029353|79391727|FG001|Overall Study|Consent Withdrawn|0|||
44385877|NCT01029353|79391728|FG002|Overall Study|Consent Withdrawn|0|||
44385878|NCT01029353|79391729|FG003|Overall Study|Consent Withdrawn|0|||
44385879|NCT01029353|79391726|FG000|Overall Study|Primary Outcome Indeterminate|1|||
44385880|NCT01029353|79391727|FG001|Overall Study|Primary Outcome Indeterminate|3|||
44385881|NCT01029353|79391728|FG002|Overall Study|Primary Outcome Indeterminate|2|||
44385882|NCT01029353|79391729|FG003|Overall Study|Primary Outcome Indeterminate|0|||
44385883|NCT01008410|79391741|FG000|Overall Study|Adverse Event|13|||
44385884|NCT01008410|79391742|FG001|Overall Study|Adverse Event|7|||
44385885|NCT01008410|79391741|FG000|Overall Study|Withdrawal by Subject|6|||
44385886|NCT01008410|79391742|FG001|Overall Study|Withdrawal by Subject|2|||
44385887|NCT01008410|79391741|FG000|Overall Study|Lost to Follow-up|1|||
44385888|NCT01008410|79391742|FG001|Overall Study|Lost to Follow-up|0|||
44385889|NCT01008410|79391741|FG000|Overall Study|Noncompliance|1|||
44385890|NCT01008410|79391742|FG001|Overall Study|Noncompliance|0|||
44385891|NCT01008410|79391741|FG000|Overall Study|Low Cortisol|2|||
44385892|NCT01008410|79391742|FG001|Overall Study|Low Cortisol|0|||
44385893|NCT01008410|79391741|FG000|Overall Study|Lack of Efficacy|2|||
44385894|NCT01008410|79391742|FG001|Overall Study|Lack of Efficacy|6|||
44385895|NCT01008410|79391741|FG000|Overall Study|Met Exclusion Criterion|0|||
44385896|NCT01008410|79391742|FG001|Overall Study|Met Exclusion Criterion|1|||
44385897|NCT01023269|79391748|FG000|Overall Study|early termination of the study|2|||
44385898|NCT01023269|79391749|FG001|Overall Study|early termination of the study|0|||
44385899|NCT01007942|79391781|FG000|Overall Study|Adverse Event|29|||
44385900|NCT01007942|79391782|FG001|Overall Study|Adverse Event|14|||
44385901|NCT01007942|79391781|FG000|Overall Study|Abnormal test procedure|0|||
44385902|NCT01007942|79391782|FG001|Overall Study|Abnormal test procedure|1|||
44385903|NCT01007942|79391781|FG000|Overall Study|Disease progression|217|||
44385904|NCT01007942|79391782|FG001|Overall Study|Disease progression|242|||
44385905|NCT01007942|79391781|FG000|Overall Study|New cancer therapy|5|||
44385906|NCT01007942|79391782|FG001|Overall Study|New cancer therapy|1|||
44385907|NCT01007942|79391781|FG000|Overall Study|Protocol Violation|1|||
44385908|NCT01007942|79391782|FG001|Overall Study|Protocol Violation|1|||
44385909|NCT01007942|79391781|FG000|Overall Study|Withdrawal by Subject|19|||
44385910|NCT01007942|79391782|FG001|Overall Study|Withdrawal by Subject|14|||
44385911|NCT01007942|79391781|FG000|Overall Study|Lost to Follow-up|1|||
44385912|NCT01007942|79391782|FG001|Overall Study|Lost to Follow-up|0|||
44385913|NCT01007942|79391781|FG000|Overall Study|Administrative problems|2|||
44385914|NCT01007942|79391782|FG001|Overall Study|Administrative problems|0|||
44385915|NCT01007942|79391781|FG000|Overall Study|Death|3|||
44385916|NCT01007942|79391782|FG001|Overall Study|Death|2|||
44385917|NCT01007942|79391781|FG000|Overall Study|Patients untreated|4|||
44385918|NCT01007942|79391782|FG001|Overall Study|Patients untreated|3|||
44385919|NCT01023035|79391795|FG000|Treatment Period|Adverse Event|27|||
44385920|NCT01023035|79391796|FG001|Treatment Period|Adverse Event|32|||
44385921|NCT01023035|79391797|FG002|Treatment Period|Adverse Event|50|||
44385922|NCT01023035|79391795|FG000|Treatment Period|Non-Medical Reasons|19|||
44385923|NCT01023035|79391796|FG001|Treatment Period|Non-Medical Reasons|22|||
44385924|NCT01023035|79391797|FG002|Treatment Period|Non-Medical Reasons|44|||
44518916|NCT03583554|79526678|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
44518917|NCT03948178|79526689|FG000|Overall Study|Protocol Violation|1|||
44518918|NCT03948178|79526689|FG000|Overall Study|Lost to Follow-up|2|||
44251488|NCT01361568|79086884|FG002|Overall Study|Withdrawal by Subject|0|||
44385925|NCT01023035|79391795|FG000|Treatment Period|Treatment Failure|26|||
44385926|NCT01023035|79391796|FG001|Treatment Period|Treatment Failure|31|||
44385927|NCT01023035|79391797|FG002|Treatment Period|Treatment Failure|24|||
44518919|NCT03948178|79526689|FG000|Overall Study|Withdrawal by Subject|2|||
44385928|NCT01023035|79391795|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
44385929|NCT01023035|79391796|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
44385930|NCT01023035|79391797|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
44385931|NCT01023035|79391795|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
44385932|NCT01023035|79391796|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
44385933|NCT01023035|79391797|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
44385934|NCT01028651|79391807|FG000|Overall Study|Death|2|||
44385935|NCT01028651|79391807|FG000|Overall Study|Adverse Event|1|||
44518920|NCT03948178|79526689|FG000|Overall Study|Reason not known|2|||
44251489|NCT01361568|79086885|FG003|Overall Study|Withdrawal by Subject|0|||
44251490|NCT01361568|79086886|FG004|Overall Study|Withdrawal by Subject|0|||
44251491|NCT01361568|79086887|FG005|Overall Study|Withdrawal by Subject|1|||
44251492|NCT03084367|79086902|FG000|Overall Study|Lost to Follow-up|32|||
44251493|NCT03084367|79086902|FG000|Overall Study|Withdrawal by Subject|4|||
44385936|NCT01028027|79391815|FG000|Overall Study|Lost to Follow-up|4|||
44385937|NCT01028027|79391816|FG001|Overall Study|Lost to Follow-up|1|||
44385938|NCT01028027|79391815|FG000|Overall Study|Withdrawal by Subject|5|||
44385939|NCT01028027|79391816|FG001|Overall Study|Withdrawal by Subject|3|||
44385940|NCT01028027|79391815|FG000|Overall Study|Adverse Event|4|||
44385941|NCT01028027|79391816|FG001|Overall Study|Adverse Event|7|||
44385942|NCT01028027|79391815|FG000|Overall Study|Protocol Violation|3|||
44385943|NCT01028027|79391816|FG001|Overall Study|Protocol Violation|1|||
44385944|NCT01028027|79391815|FG000|Overall Study|Lack of Efficacy|0|||
44385945|NCT01028027|79391816|FG001|Overall Study|Lack of Efficacy|1|||
44385946|NCT01007552|79391822|FG000|Overall Study|Withdrawal by Subject|1|||
44385947|NCT01007396|79391826|FG000|Overall Study|Lost to Follow-up|47|||
44385948|NCT00998738|79391830|FG000|Overall Study|Uknown|1|||
44385949|NCT00997334|79391834|FG000|Overall Study|still on therapy|12|||
44385950|NCT00997334|79391834|FG000|Overall Study|Adverse Event|3|||
44385951|NCT00997334|79391834|FG000|Overall Study|Patient non-compliance|1|||
44385952|NCT00997334|79391834|FG000|Overall Study|Withdrawal by Subject|3|||
44385953|NCT00997334|79391834|FG000|Overall Study|Death|2|||
44385954|NCT00997334|79391834|FG000|Overall Study|Urgent Palliative Care|2|||
44385955|NCT00997334|79391834|FG000|Overall Study|No lesion amenable|1|||
44385956|NCT00997334|79391834|FG000|Overall Study|Ineligible|1|||
44385957|NCT00996944|79391840|FG000|Double-blind Treatment Period|Adverse Event|2|||
44385958|NCT00996944|79391841|FG001|Double-blind Treatment Period|Adverse Event|1|||
44385959|NCT00996944|79391840|FG000|Double-blind Treatment Period|Protocol Violation|1|||
44385960|NCT00996944|79391841|FG001|Double-blind Treatment Period|Protocol Violation|0|||
44385961|NCT00996944|79391840|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
44385962|NCT00996944|79391841|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
44385963|NCT00996944|79391840|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
44385964|NCT00996944|79391841|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
44385965|NCT00996944|79391840|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
44385966|NCT00996944|79391841|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
44385967|NCT01002482|79391851|FG000|Overall Study|Withdrawal by Subject|14|||
44385968|NCT01002482|79391852|FG001|Overall Study|Withdrawal by Subject|21|||
44385969|NCT01002482|79391851|FG000|Overall Study|Included twice|1|||
44385970|NCT01002482|79391852|FG001|Overall Study|Included twice|0|||
44385971|NCT01027949|79391858|FG000|Overall Study|Death|174|||
44385972|NCT01027949|79391858|FG000|Overall Study|Progressive Disease|163|||
44385973|NCT01027949|79391858|FG000|Overall Study|Adverse Event|172|||
44385974|NCT01027949|79391858|FG000|Overall Study|Withdrawal by Subject|113|||
44385975|NCT01027949|79391858|FG000|Overall Study|Lost to Follow-up|17|||
44385976|NCT01027949|79391858|FG000|Overall Study|Protocol Violation|13|||
44385977|NCT01027949|79391858|FG000|Overall Study|PI Decision|8|||
44385978|NCT01027949|79391858|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
44385979|NCT01027949|79391858|FG000|Overall Study|Non-compliance with Study Procedures|7|||
44385980|NCT01027949|79391858|FG000|Overall Study|Lung Transplant|5|||
44385981|NCT01027949|79391858|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
44385982|NCT01027949|79391858|FG000|Overall Study|Use of Excluded Medication|2|||
44385983|NCT01027949|79391858|FG000|Overall Study|Patient Self-discontinuation|1|||
44385984|NCT01027949|79391858|FG000|Overall Study|Pregnancy|1|||
44385985|NCT01027949|79391858|FG000|Overall Study|Surgery|1|||
44385986|NCT01038323|79391865|FG000|Overall Study|Withdrawal by Subject|3|||
44385987|NCT01038323|79391866|FG001|Overall Study|Withdrawal by Subject|2|||
44385988|NCT01038323|79391867|FG002|Overall Study|Withdrawal by Subject|4|||
44385989|NCT01027871|79391878|FG000|Overall Study|Physician Decision|1|||
44385990|NCT01027871|79391879|FG001|Overall Study|Physician Decision|5|||
44251494|NCT03084367|79086902|FG000|Overall Study|Other|1|||
44251495|NCT01454570|79086915|FG000|Overall Study|Withdrawal by Subject|2|||
44251496|NCT01454570|79086915|FG000|Overall Study|Screen Failure|7|||
44251497|NCT01494350|79086928|FG000|Overall Study|Worsening of lesion|1|||
44251498|NCT03281629|79086938|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
44251499|NCT03281629|79086939|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
44251500|NCT03281629|79086938|FG000|Overall Study|Death|0|||
44385991|NCT01027871|79391880|FG002|Overall Study|Physician Decision|0|||
44385992|NCT01027871|79391878|FG000|Overall Study|Protocol Violation|0|||
44385993|NCT01027871|79391879|FG001|Overall Study|Protocol Violation|2|||
44385994|NCT01027871|79391880|FG002|Overall Study|Protocol Violation|2|||
44385995|NCT01027871|79391878|FG000|Overall Study|Withdrawal by Subject|1|||
44385996|NCT01027871|79391879|FG001|Overall Study|Withdrawal by Subject|2|||
44385997|NCT01027871|79391880|FG002|Overall Study|Withdrawal by Subject|2|||
44385998|NCT01027871|79391878|FG000|Overall Study|Adverse Event|0|||
44385999|NCT01027871|79391879|FG001|Overall Study|Adverse Event|2|||
44251501|NCT03281629|79086939|FG001|Overall Study|Death|1|||
44386000|NCT01027871|79391880|FG002|Overall Study|Adverse Event|2|||
44386001|NCT01027871|79391878|FG000|Overall Study|Sponsor Decision|0|||
44386002|NCT01027871|79391879|FG001|Overall Study|Sponsor Decision|2|||
44280123|NCT01965600|79241090|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
44280124|NCT01965600|79241091|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
44280125|NCT01965600|79241092|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
44280126|NCT01965600|79241093|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
44280127|NCT01965600|79241090|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
44280128|NCT01965600|79241091|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
44386003|NCT01027871|79391880|FG002|Overall Study|Sponsor Decision|0|||
44386004|NCT01027871|79391878|FG000|Overall Study|Discontinued Prior to Treatment|0|||
44386005|NCT01027871|79391879|FG001|Overall Study|Discontinued Prior to Treatment|0|||
44386006|NCT01027871|79391880|FG002|Overall Study|Discontinued Prior to Treatment|1|||
44386007|NCT01021553|79391896|FG000|Overall Study|Adverse Event|1|||
44386008|NCT01021553|79391897|FG001|Overall Study|Adverse Event|0|||
44386009|NCT01021553|79391898|FG002|Overall Study|Adverse Event|0|||
44386010|NCT01021553|79391896|FG000|Overall Study|Lack of Efficacy|2|||
44386011|NCT01021553|79391897|FG001|Overall Study|Lack of Efficacy|2|||
44386012|NCT01021553|79391898|FG002|Overall Study|Lack of Efficacy|0|||
44386013|NCT01021553|79391896|FG000|Overall Study|Protocol Violation|0|||
44386014|NCT01021553|79391897|FG001|Overall Study|Protocol Violation|2|||
44386015|NCT01021553|79391898|FG002|Overall Study|Protocol Violation|2|||
44386016|NCT01021553|79391896|FG000|Overall Study|Lost to Follow-up|0|||
44386017|NCT01021553|79391897|FG001|Overall Study|Lost to Follow-up|0|||
44386018|NCT01021553|79391898|FG002|Overall Study|Lost to Follow-up|1|||
44386019|NCT01021553|79391896|FG000|Overall Study|Withdrawal by Subject|1|||
44386020|NCT01021553|79391897|FG001|Overall Study|Withdrawal by Subject|1|||
44386021|NCT01021553|79391898|FG002|Overall Study|Withdrawal by Subject|0|||
44386022|NCT01026389|79391913|FG000|Overall Study|Withdrawal by Subject|1|||
44386023|NCT01026389|79391914|FG001|Overall Study|Withdrawal by Subject|3|||
44386024|NCT01026389|79391913|FG000|Overall Study|change of treatment, patient moved|4|||
44386025|NCT01026389|79391914|FG001|Overall Study|change of treatment, patient moved|2|||
44386026|NCT01006616|79391924|FG000|Period 1 (6 Months)|Adverse Event|10|||
44386027|NCT01006616|79391925|FG001|Period 1 (6 Months)|Adverse Event|31|||
44386028|NCT01006616|79391926|FG002|Period 1 (6 Months)|Adverse Event|37|||
44386029|NCT01006616|79391927|FG003|Period 1 (6 Months)|Adverse Event|9|||
44386030|NCT01006616|79391924|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
44386031|NCT01006616|79391925|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
44386032|NCT01006616|79391926|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
44386033|NCT01006616|79391927|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
44386034|NCT01006616|79391924|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
44386035|NCT01006616|79391925|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
44386036|NCT01006616|79391926|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
44386037|NCT01006616|79391927|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
44386038|NCT01006616|79391924|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
44280129|NCT01965600|79241092|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
44280130|NCT01965600|79241093|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
44280131|NCT01965600|79241090|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
44280132|NCT01965600|79241091|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
44386039|NCT01006616|79391925|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
44386040|NCT01006616|79391926|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
44386041|NCT01006616|79391927|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
44386042|NCT01006616|79391924|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
44386043|NCT01006616|79391925|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
44386044|NCT01006616|79391926|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
44386045|NCT01006616|79391927|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
44386046|NCT01006616|79391924|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
44386047|NCT01006616|79391925|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
44386048|NCT01006616|79391926|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
44386049|NCT01006616|79391927|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
44386050|NCT01006616|79391924|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
44386051|NCT01006616|79391925|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
44386052|NCT01006616|79391926|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
44280133|NCT01965600|79241092|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
44386053|NCT01006616|79391927|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
44386054|NCT01006616|79391924|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
44386055|NCT01006616|79391925|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
44386056|NCT01006616|79391926|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
44386057|NCT01006616|79391927|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
44518921|NCT03948178|79526689|FG000|Overall Study|Personal reason|14|||
44280134|NCT01965600|79241093|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
44386058|NCT01006616|79391924|FG000|Period 1 (6 Months)|Not Treated|0|||
44386059|NCT01006616|79391925|FG001|Period 1 (6 Months)|Not Treated|0|||
44386060|NCT01006616|79391926|FG002|Period 1 (6 Months)|Not Treated|1|||
44386061|NCT01006616|79391927|FG003|Period 1 (6 Months)|Not Treated|1|||
44386062|NCT01006616|79391924|FG000|Period 2 (18 Months)|Adverse Event|6|||
44386063|NCT01006616|79391925|FG001|Period 2 (18 Months)|Adverse Event|6|||
44386064|NCT01006616|79391926|FG002|Period 2 (18 Months)|Adverse Event|6|||
44386065|NCT01006616|79391927|FG003|Period 2 (18 Months)|Adverse Event|4|||
44386066|NCT01006616|79391924|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
44386067|NCT01006616|79391925|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
44386068|NCT01006616|79391926|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
44386069|NCT01006616|79391927|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
44386070|NCT01006616|79391924|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
44386071|NCT01006616|79391925|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
44386072|NCT01006616|79391926|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
44386073|NCT01006616|79391927|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
44386074|NCT01006616|79391924|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
44386075|NCT01006616|79391925|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
44386076|NCT01006616|79391926|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
44386077|NCT01006616|79391927|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
44386078|NCT01006616|79391924|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
44386079|NCT01006616|79391925|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
44386080|NCT01006616|79391926|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
44386081|NCT01006616|79391927|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
44386082|NCT01006616|79391924|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
44386083|NCT01006616|79391925|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
44386084|NCT01006616|79391926|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
44386085|NCT01006616|79391927|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
44386086|NCT01006616|79391924|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
44386087|NCT01006616|79391925|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
44386088|NCT01006616|79391926|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
44386089|NCT01006616|79391927|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
44386090|NCT01006616|79391924|FG000|Period 2 (18 Months)|Study Terminated|63|||
44386091|NCT01006616|79391925|FG001|Period 2 (18 Months)|Study Terminated|46|||
44280135|NCT01965600|79241090|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
44280136|NCT01965600|79241091|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
44280137|NCT01965600|79241092|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
44280138|NCT01965600|79241093|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
44280139|NCT01965600|79241090|FG000|Second Intervention|Study terminated by Sponsor|0|||
44280140|NCT01965600|79241091|FG001|Second Intervention|Study terminated by Sponsor|0|||
44280141|NCT01965600|79241092|FG002|Second Intervention|Study terminated by Sponsor|2|||
44280142|NCT01965600|79241093|FG003|Second Intervention|Study terminated by Sponsor|2|||
44280143|NCT01996332|79241101|FG000|Overall Study|Adverse Event|117|||
44280144|NCT01996332|79241101|FG000|Overall Study|Lack of Efficacy|1245|||
44280145|NCT01996332|79241101|FG000|Overall Study|Death|264|||
44280146|NCT01996332|79241101|FG000|Overall Study|Protocol Violation|9|||
44280147|NCT01996332|79241101|FG000|Overall Study|Withdrawal by Subject|71|||
44280148|NCT01996332|79241101|FG000|Overall Study|Other|20|||
44280149|NCT01996332|79241101|FG000|Overall Study|Clinical Deterioration|28|||
44280150|NCT01996332|79241101|FG000|Overall Study|Physician Decision|17|||
44280151|NCT01996332|79241101|FG000|Overall Study|Lost to Follow-up|34|||
44280152|NCT01996254|79241107|FG000|Overall Study|Change in Eligibility|0|||
44280153|NCT01996254|79241108|FG001|Overall Study|Change in Eligibility|2|||
44280154|NCT01996254|79241109|FG002|Overall Study|Change in Eligibility|0|||
44280155|NCT01996254|79241107|FG000|Overall Study|Withdrawal by Subject|0|||
44280156|NCT01996254|79241108|FG001|Overall Study|Withdrawal by Subject|3|||
44386092|NCT01006616|79391926|FG002|Period 2 (18 Months)|Study Terminated|44|||
44386093|NCT01006616|79391927|FG003|Period 2 (18 Months)|Study Terminated|70|||
44386094|NCT00996632|79391939|FG000|Overall Study|Physician Decision|0|||
44386095|NCT00996632|79391940|FG001|Overall Study|Physician Decision|0|||
44386096|NCT01025843|79391956|FG000|Washout 4|Withdrawal by Subject|0|||
44386097|NCT01025843|79391957|FG001|Washout 4|Withdrawal by Subject|0|||
44280157|NCT01996254|79241109|FG002|Overall Study|Withdrawal by Subject|4|||
44280158|NCT01996254|79241107|FG000|Overall Study|Lost to Follow-up|1|||
44280159|NCT01996254|79241108|FG001|Overall Study|Lost to Follow-up|0|||
44280160|NCT01996254|79241109|FG002|Overall Study|Lost to Follow-up|4|||
44280161|NCT01987986|79241123|FG000|Overall Study|Lost to Follow-up|1|||
44280162|NCT01987986|79241124|FG001|Overall Study|Lost to Follow-up|0|||
44386098|NCT01025843|79391958|FG002|Washout 4|Withdrawal by Subject|1|||
44386099|NCT01025843|79391959|FG003|Washout 4|Withdrawal by Subject|1|||
44386100|NCT01025843|79391960|FG004|Washout 4|Withdrawal by Subject|0|||
44386101|NCT01025843|79391961|FG005|Washout 4|Withdrawal by Subject|0|||
44280163|NCT01987986|79241125|FG002|Overall Study|Lost to Follow-up|0|||
44280164|NCT01987986|79241126|FG003|Overall Study|Lost to Follow-up|0|||
44386102|NCT01025843|79391962|FG006|Washout 4|Withdrawal by Subject|0|||
44386103|NCT01025843|79391963|FG007|Washout 4|Withdrawal by Subject|0|||
44386104|NCT01025843|79391964|FG008|Washout 4|Withdrawal by Subject|0|||
44386105|NCT01025843|79391965|FG009|Washout 4|Withdrawal by Subject|0|||
44386106|NCT01036763|79391993|FG000|Overall Study|Adverse Event|25|||
44386107|NCT01036763|79391993|FG000|Overall Study|Lost to Follow-up|28|||
44386108|NCT01036763|79391993|FG000|Overall Study|Other reason (not specified)|40|||
44386109|NCT01021007|79391999|FG000|Overall Study|Lost to Follow-up|1|||
44386110|NCT01021007|79392000|FG001|Overall Study|Lost to Follow-up|1|||
44386111|NCT01021007|79391999|FG000|Overall Study|Adverse Event|1|||
44386112|NCT01021007|79392000|FG001|Overall Study|Adverse Event|3|||
44386113|NCT01020773|79392008|FG000|Overall Study|Withdrawal by Subject|4|||
44386114|NCT01020773|79392009|FG001|Overall Study|Withdrawal by Subject|3|||
44518922|NCT03948178|79526689|FG000|Overall Study|Disease progression|30|||
44518923|NCT03948178|79526689|FG000|Overall Study|Adverse Event|12|||
44280165|NCT01987986|79241123|FG000|Overall Study|Adverse Event|1|||
44280166|NCT01987986|79241124|FG001|Overall Study|Adverse Event|0|||
44280167|NCT01987986|79241125|FG002|Overall Study|Adverse Event|2|||
44280168|NCT01987986|79241126|FG003|Overall Study|Adverse Event|0|||
44280169|NCT01987908|79241136|FG000|Placebo Lead-in Period|Adverse Event|2|||
44280170|NCT01987908|79241137|FG001|Placebo Lead-in Period|Adverse Event|0|||
44280171|NCT01987908|79241138|FG002|Placebo Lead-in Period|Adverse Event|0|||
44280172|NCT01987908|79241136|FG000|Placebo Lead-in Period|Physician Decision|2|||
44280173|NCT01987908|79241137|FG001|Placebo Lead-in Period|Physician Decision|0|||
44280174|NCT01987908|79241138|FG002|Placebo Lead-in Period|Physician Decision|0|||
44280175|NCT01987908|79241136|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
44280176|NCT01987908|79241137|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
44280177|NCT01987908|79241138|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
44280178|NCT01987908|79241136|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
44280179|NCT01987908|79241137|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
44280180|NCT01987908|79241138|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
44280181|NCT01987908|79241136|FG000|Treatment Period|Adverse Event|0|||
44280182|NCT01987908|79241137|FG001|Treatment Period|Adverse Event|1|||
44280183|NCT01987908|79241138|FG002|Treatment Period|Adverse Event|1|||
44280184|NCT01987908|79241136|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
44280185|NCT01987908|79241137|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
44280186|NCT01987908|79241138|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
44280187|NCT01987908|79241136|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
44280188|NCT01987908|79241137|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
44280189|NCT01987908|79241138|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
44280190|NCT01995552|79241162|FG000|Overall Study|Protocol Violation|1|||
44280191|NCT01995552|79241162|FG000|Overall Study|Lack of Efficacy|15|||
44280192|NCT01995552|79241162|FG000|Overall Study|Death|1|||
44280193|NCT01987830|79241168|FG000|Overall Study|Never received baseline scan|1|||
44280194|NCT01987596|79241174|FG000|Overall Study|Physician Decision|1|||
44280195|NCT01987596|79241175|FG001|Overall Study|Physician Decision|0|||
44280196|NCT01987596|79241174|FG000|Overall Study|Progressive Disease; missing all period|0|||
44280197|NCT01987596|79241175|FG001|Overall Study|Progressive Disease; missing all period|1|||
44280198|NCT01964976|79241189|FG000|Overall Study|Protocol Violation|31|||
44280199|NCT01964898|79241198|FG000|Overall Study|ineligible post-randomization|1|||
44280200|NCT01964898|79241199|FG001|Overall Study|ineligible post-randomization|1|||
44280201|NCT01964898|79241198|FG000|Overall Study|did not receive the allocated interventi|2|||
44280202|NCT01964898|79241199|FG001|Overall Study|did not receive the allocated interventi|1|||
44280203|NCT01964898|79241198|FG000|Overall Study|Lost to Follow-up|3|||
44280204|NCT01964898|79241199|FG001|Overall Study|Lost to Follow-up|5|||
44280205|NCT01964898|79241198|FG000|Overall Study|Withdrawal by Subject|1|||
44280206|NCT01964898|79241199|FG001|Overall Study|Withdrawal by Subject|0|||
44280207|NCT01964352|79241209|FG000|Overall Study|Adverse Event|13|||
44518924|NCT03948178|79526689|FG000|Overall Study|Sponsor terminated study|164|||
44518925|NCT03520920|79526696|FG000|Overall Study|Death|13|||
44280208|NCT01964352|79241210|FG001|Overall Study|Adverse Event|3|||
44280209|NCT01964352|79241211|FG002|Overall Study|Adverse Event|4|||
44280210|NCT01964352|79241212|FG003|Overall Study|Adverse Event|3|||
44280211|NCT01964352|79241209|FG000|Overall Study|Lack of Efficacy|6|||
44280212|NCT01964352|79241210|FG001|Overall Study|Lack of Efficacy|0|||
44280213|NCT01964352|79241211|FG002|Overall Study|Lack of Efficacy|0|||
44280214|NCT01964352|79241212|FG003|Overall Study|Lack of Efficacy|0|||
44280215|NCT01964352|79241209|FG000|Overall Study|Protocol Violation|2|||
44386115|NCT01020305|79392015|FG000|Overall Study|Adverse Event|2|||
44386116|NCT01036529|79392021|FG000|Overall Study|Adverse Event|0|||
44518926|NCT03520920|79526697|FG001|Overall Study|Death|1|||
44518927|NCT03520920|79526698|FG002|Overall Study|Death|0|||
44518928|NCT03520920|79526696|FG000|Overall Study|Withdrawal by Subject|2|||
44280216|NCT01964352|79241210|FG001|Overall Study|Protocol Violation|4|||
44280217|NCT01964352|79241211|FG002|Overall Study|Protocol Violation|0|||
44518929|NCT03520920|79526697|FG001|Overall Study|Withdrawal by Subject|1|||
44280218|NCT01964352|79241212|FG003|Overall Study|Protocol Violation|2|||
44280219|NCT01964352|79241209|FG000|Overall Study|Lost to Follow-up|1|||
44280220|NCT01964352|79241210|FG001|Overall Study|Lost to Follow-up|0|||
44280221|NCT01964352|79241211|FG002|Overall Study|Lost to Follow-up|0|||
44280222|NCT01964352|79241212|FG003|Overall Study|Lost to Follow-up|1|||
44386117|NCT01036529|79392022|FG001|Overall Study|Adverse Event|1|||
44386118|NCT01036529|79392021|FG000|Overall Study|Lost to Follow-up|0|||
44386119|NCT01036529|79392022|FG001|Overall Study|Lost to Follow-up|1|||
44386120|NCT01036529|79392021|FG000|Overall Study|Physician Decision|1|||
44386121|NCT01036529|79392022|FG001|Overall Study|Physician Decision|0|||
44386122|NCT01036529|79392021|FG000|Overall Study|Withdrawal by Subject|1|||
44386123|NCT01036529|79392022|FG001|Overall Study|Withdrawal by Subject|1|||
44386124|NCT01036529|79392021|FG000|Overall Study|Sponsor study termination|11|||
44386125|NCT01036529|79392022|FG001|Overall Study|Sponsor study termination|12|||
44386126|NCT01024751|79392030|FG000|Enrolled Participants|Ineligible at baseline|3|||
44386127|NCT01024751|79392031|FG001|Enrolled Participants|Ineligible at baseline|4|||
44386128|NCT01024751|79392030|FG000|Eligible Participants|Withdrawal by Subject|0|||
44386129|NCT01024751|79392031|FG001|Eligible Participants|Withdrawal by Subject|1|||
44386130|NCT01024751|79392030|FG000|Eligible Participants|Lost to Follow-up|0|||
44386131|NCT01024751|79392031|FG001|Eligible Participants|Lost to Follow-up|1|||
44386132|NCT01024751|79392030|FG000|Eligible Participants|Ineligible|0|||
44386133|NCT01024751|79392031|FG001|Eligible Participants|Ineligible|1|||
44386134|NCT01019369|79392039|FG000|Overall Study|Lost to Follow-up|10|||
44386135|NCT01019369|79392040|FG001|Overall Study|Lost to Follow-up|6|||
44386136|NCT01019369|79392039|FG000|Overall Study|Withdrawal by Subject|0|||
44386137|NCT01019369|79392040|FG001|Overall Study|Withdrawal by Subject|1|||
44386138|NCT01019135|79392050|FG000|Overall Study|Did not receive allocated intervention|12|||
44386139|NCT01019135|79392051|FG001|Overall Study|Did not receive allocated intervention|6|||
44386140|NCT01019135|79392052|FG002|Overall Study|Did not receive allocated intervention|25|||
44386141|NCT01019135|79392050|FG000|Overall Study|Did not attend CR|8|||
44386142|NCT01019135|79392051|FG001|Overall Study|Did not attend CR|13|||
44386143|NCT01019135|79392052|FG002|Overall Study|Did not attend CR|6|||
44386144|NCT01018979|79392062|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
44386145|NCT01018979|79392063|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
44386146|NCT01018979|79392062|FG000|Overall Study|Not received at least one dose|0|||
44386147|NCT01018979|79392063|FG001|Overall Study|Not received at least one dose|1|||
44386148|NCT01572493|79392081|FG000|Overall Study|Physician Decision|1|||
44386149|NCT01572493|79392082|FG001|Overall Study|Physician Decision|0|||
44386150|NCT01572493|79392083|FG002|Overall Study|Physician Decision|0|||
44386151|NCT01572493|79392084|FG003|Overall Study|Physician Decision|0|||
44280223|NCT01964352|79241209|FG000|Overall Study|Withdrawal by Subject|4|||
44280224|NCT01964352|79241210|FG001|Overall Study|Withdrawal by Subject|2|||
44280225|NCT01964352|79241211|FG002|Overall Study|Withdrawal by Subject|1|||
44280226|NCT01964352|79241212|FG003|Overall Study|Withdrawal by Subject|0|||
44280227|NCT01964352|79241209|FG000|Overall Study|Other than stated above|0|||
44280228|NCT01964352|79241210|FG001|Overall Study|Other than stated above|2|||
44280229|NCT01964352|79241211|FG002|Overall Study|Other than stated above|1|||
44280230|NCT01964352|79241212|FG003|Overall Study|Other than stated above|2|||
44280231|NCT01946412|79241222|FG000|Overall Study|Adverse Event|1|||
44280232|NCT01946412|79241222|FG000|Overall Study|Non-Compliance|1|||
44280233|NCT01946412|79241222|FG000|Overall Study|Continued with commercial Kalydeco|2|||
44280234|NCT01946412|79241222|FG000|Overall Study|Difficulty in swallowing|1|||
44280235|NCT01946178|79241228|FG000|Overall Study|Pregnancy|1|||
44280236|NCT01946178|79241228|FG000|Overall Study|Lost to Follow-up|1|||
44280237|NCT01945944|79241238|FG000|Overall Study|Adverse Event|0|||
44280238|NCT01945944|79241239|FG001|Overall Study|Adverse Event|2|||
44280239|NCT01945944|79241238|FG000|Overall Study|Physician Decision|1|||
44280240|NCT01945944|79241239|FG001|Overall Study|Physician Decision|0|||
44280241|NCT01945944|79241238|FG000|Overall Study|Withdrawal by Subject|0|||
44280242|NCT01945944|79241239|FG001|Overall Study|Withdrawal by Subject|1|||
44280243|NCT01945866|79241249|FG000|Overall Study|Eyes did not complete or were dropped|2|||
44280244|NCT01945866|79241250|FG001|Overall Study|Eyes did not complete or were dropped|0|||
44280245|NCT01986114|79241257|FG000|Overall Study|Adverse Event|59|||
44280246|NCT01986114|79241257|FG000|Overall Study|Lack of Efficacy|23|||
44280247|NCT01986114|79241257|FG000|Overall Study|Withdrawal by Subject|58|||
44280248|NCT01986114|79241257|FG000|Overall Study|Noncompliance|3|||
44280249|NCT01986114|79241257|FG000|Overall Study|Protocol Violation|1|||
44280250|NCT01986114|79241257|FG000|Overall Study|Lost to Follow-up|5|||
44386152|NCT01572493|79392085|FG004|Overall Study|Physician Decision|0|||
44386153|NCT01572493|79392086|FG005|Overall Study|Physician Decision|0|||
44386154|NCT01572493|79392087|FG006|Overall Study|Physician Decision|0|||
44386155|NCT01572493|79392088|FG007|Overall Study|Physician Decision|0|||
44386156|NCT01572493|79392089|FG008|Overall Study|Physician Decision|0|||
44386157|NCT01572493|79392081|FG000|Overall Study|Switched to alternative treatment|0|||
44280251|NCT01986114|79241257|FG000|Overall Study|Other reason|7|||
44280252|NCT01945710|79241270|FG000|Overall Study|Progressive Disease|5|||
44386158|NCT01572493|79392082|FG001|Overall Study|Switched to alternative treatment|1|||
44386159|NCT01572493|79392083|FG002|Overall Study|Switched to alternative treatment|2|||
44386160|NCT01572493|79392084|FG003|Overall Study|Switched to alternative treatment|1|||
44280253|NCT01945710|79241271|FG001|Overall Study|Progressive Disease|4|||
44280254|NCT01945710|79241272|FG002|Overall Study|Progressive Disease|3|||
44386161|NCT01572493|79392085|FG004|Overall Study|Switched to alternative treatment|2|||
44386162|NCT01572493|79392086|FG005|Overall Study|Switched to alternative treatment|0|||
44386163|NCT01572493|79392087|FG006|Overall Study|Switched to alternative treatment|2|||
44386164|NCT01572493|79392088|FG007|Overall Study|Switched to alternative treatment|0|||
44386165|NCT01572493|79392089|FG008|Overall Study|Switched to alternative treatment|2|||
44386166|NCT01572493|79392081|FG000|Overall Study|Death|0|||
44386167|NCT01572493|79392082|FG001|Overall Study|Death|0|||
44386168|NCT01572493|79392083|FG002|Overall Study|Death|0|||
44386169|NCT01572493|79392084|FG003|Overall Study|Death|1|||
44386170|NCT01572493|79392085|FG004|Overall Study|Death|0|||
44280255|NCT01945710|79241273|FG003|Overall Study|Progressive Disease|2|||
44386171|NCT01572493|79392086|FG005|Overall Study|Death|1|||
44386172|NCT01572493|79392087|FG006|Overall Study|Death|0|||
44386173|NCT01572493|79392088|FG007|Overall Study|Death|0|||
44386174|NCT01572493|79392089|FG008|Overall Study|Death|0|||
44386175|NCT01572493|79392081|FG000|Overall Study|Adverse Event|0|||
44386176|NCT01572493|79392082|FG001|Overall Study|Adverse Event|0|||
44386177|NCT01572493|79392083|FG002|Overall Study|Adverse Event|0|||
44386178|NCT01572493|79392084|FG003|Overall Study|Adverse Event|0|||
44386179|NCT01572493|79392085|FG004|Overall Study|Adverse Event|0|||
44386180|NCT01572493|79392086|FG005|Overall Study|Adverse Event|0|||
44386181|NCT01572493|79392087|FG006|Overall Study|Adverse Event|1|||
44386182|NCT01572493|79392088|FG007|Overall Study|Adverse Event|0|||
44386183|NCT01572493|79392089|FG008|Overall Study|Adverse Event|0|||
44386184|NCT01018511|79392116|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
44386185|NCT01018511|79392117|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
44386186|NCT01018511|79392118|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
44386187|NCT01018511|79392119|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
44146170|NCT03806933|78935395|FG000|Main Period|Withdrawal by Subject|2|||
44251502|NCT03281629|79086938|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
44251503|NCT03281629|79086939|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
44251504|NCT00218543|79086945|FG000|Overall Study|Lost to Follow-up|8|||
44251505|NCT00218543|79086945|FG000|Overall Study|relocated|1|||
44280256|NCT01945710|79241274|FG004|Overall Study|Progressive Disease|7|||
44280257|NCT01945710|79241275|FG005|Overall Study|Progressive Disease|3|||
44251506|NCT00218543|79086945|FG000|Overall Study|Withdrawal by Subject|1|||
44251507|NCT00218543|79086945|FG000|Overall Study|Physician Decision|3|||
44251508|NCT00218543|79086945|FG000|Overall Study|Adverse Event|2|||
44251509|NCT00216671|79086960|FG000|Overall Study|Adverse Event|4|||
44251510|NCT00216671|79086961|FG001|Overall Study|Adverse Event|9|||
44251511|NCT00216671|79086960|FG000|Overall Study|Pregnancy|0|||
44251512|NCT00216671|79086961|FG001|Overall Study|Pregnancy|1|||
44280258|NCT01945710|79241276|FG006|Overall Study|Progressive Disease|19|||
44280259|NCT01945710|79241270|FG000|Overall Study|Adverse Event|0|||
44280260|NCT01945710|79241271|FG001|Overall Study|Adverse Event|1|||
44280261|NCT01945710|79241272|FG002|Overall Study|Adverse Event|0|||
44280262|NCT01945710|79241273|FG003|Overall Study|Adverse Event|0|||
44280263|NCT01945710|79241274|FG004|Overall Study|Adverse Event|0|||
44280264|NCT01945710|79241275|FG005|Overall Study|Adverse Event|0|||
44280265|NCT01945710|79241276|FG006|Overall Study|Adverse Event|0|||
44280266|NCT01945710|79241270|FG000|Overall Study|Other|2|||
44280267|NCT01945710|79241271|FG001|Overall Study|Other|0|||
44280268|NCT01945710|79241272|FG002|Overall Study|Other|3|||
44280269|NCT01945710|79241273|FG003|Overall Study|Other|1|||
44280270|NCT01945710|79241274|FG004|Overall Study|Other|1|||
44280271|NCT01945710|79241275|FG005|Overall Study|Other|0|||
44146171|NCT03806933|78935396|FG001|Main Period|Withdrawal by Subject|1|||
44251513|NCT00216671|79086960|FG000|Overall Study|Withdrawal by Subject|4|||
44251514|NCT00216671|79086961|FG001|Overall Study|Withdrawal by Subject|2|||
44280272|NCT01945710|79241276|FG006|Overall Study|Other|4|||
44280273|NCT01945710|79241270|FG000|Overall Study|Withdrawal by Subject|0|||
44280274|NCT01945710|79241271|FG001|Overall Study|Withdrawal by Subject|1|||
44280275|NCT01945710|79241272|FG002|Overall Study|Withdrawal by Subject|1|||
44280276|NCT01945710|79241273|FG003|Overall Study|Withdrawal by Subject|0|||
44280277|NCT01945710|79241274|FG004|Overall Study|Withdrawal by Subject|1|||
44386188|NCT01018511|79392116|FG000|Overall Study|Adverse Event|5|||
44386189|NCT01018511|79392117|FG001|Overall Study|Adverse Event|9|||
44146172|NCT03806933|78935397|FG002|Main Period|Withdrawal by Subject|1|||
44251515|NCT00216671|79086960|FG000|Overall Study|Refused Injections|3|||
44251516|NCT00216671|79086961|FG001|Overall Study|Refused Injections|13|||
44280278|NCT01945710|79241275|FG005|Overall Study|Withdrawal by Subject|0|||
44386190|NCT01018511|79392118|FG002|Overall Study|Adverse Event|13|||
44386191|NCT01018511|79392119|FG003|Overall Study|Adverse Event|10|||
44386192|NCT01018511|79392116|FG000|Overall Study|Lack of Efficacy|4|||
44146173|NCT03806933|78935398|FG003|Main Period|Withdrawal by Subject|2|||
44146174|NCT03806933|78935395|FG000|Main Period|Lost to Follow-up|2|||
44146175|NCT03806933|78935396|FG001|Main Period|Lost to Follow-up|2|||
44146176|NCT03806933|78935397|FG002|Main Period|Lost to Follow-up|0|||
44146177|NCT03806933|78935398|FG003|Main Period|Lost to Follow-up|0|||
44146178|NCT03806933|78935395|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
44386193|NCT01018511|79392117|FG001|Overall Study|Lack of Efficacy|1|||
44386194|NCT01018511|79392118|FG002|Overall Study|Lack of Efficacy|1|||
44386195|NCT01018511|79392119|FG003|Overall Study|Lack of Efficacy|2|||
44386196|NCT01018511|79392116|FG000|Overall Study|Withdrawal by Subject|6|||
44386197|NCT01018511|79392117|FG001|Overall Study|Withdrawal by Subject|5|||
44386198|NCT01018511|79392118|FG002|Overall Study|Withdrawal by Subject|11|||
44386199|NCT01018511|79392119|FG003|Overall Study|Withdrawal by Subject|9|||
44386200|NCT01018511|79392116|FG000|Overall Study|Lost to Follow-up|0|||
44386201|NCT01018511|79392117|FG001|Overall Study|Lost to Follow-up|0|||
44386202|NCT01018511|79392118|FG002|Overall Study|Lost to Follow-up|1|||
44386203|NCT01018511|79392119|FG003|Overall Study|Lost to Follow-up|0|||
44386204|NCT01018511|79392116|FG000|Overall Study|Protocol Violation|5|||
44386205|NCT01018511|79392117|FG001|Overall Study|Protocol Violation|8|||
44386206|NCT01018511|79392118|FG002|Overall Study|Protocol Violation|7|||
44386207|NCT01018511|79392119|FG003|Overall Study|Protocol Violation|9|||
44386208|NCT01018511|79392116|FG000|Overall Study|Miscellaneous|0|||
44386209|NCT01018511|79392117|FG001|Overall Study|Miscellaneous|2|||
44386210|NCT01018511|79392118|FG002|Overall Study|Miscellaneous|0|||
44386211|NCT01018511|79392119|FG003|Overall Study|Miscellaneous|0|||
44386212|NCT00996476|79392140|FG000|Overall Study|Withdrawal by Subject|1|||
44386213|NCT00996476|79392141|FG001|Overall Study|Withdrawal by Subject|2|||
44386214|NCT00996476|79392142|FG002|Overall Study|Withdrawal by Subject|1|||
44386215|NCT00996476|79392143|FG003|Overall Study|Withdrawal by Subject|0|||
44386216|NCT00996476|79392144|FG004|Overall Study|Withdrawal by Subject|1|||
44386217|NCT00996476|79392140|FG000|Overall Study|Adverse Event|0|||
44386218|NCT00996476|79392141|FG001|Overall Study|Adverse Event|1|||
44386219|NCT00996476|79392142|FG002|Overall Study|Adverse Event|0|||
44386220|NCT00996476|79392143|FG003|Overall Study|Adverse Event|0|||
44386221|NCT00996476|79392144|FG004|Overall Study|Adverse Event|1|||
44386222|NCT02269267|79392161|FG000|Overall Study|Death|5|||
44386223|NCT01017731|79392165|FG000|Overall Study|Lost to Follow-up|2|||
44386224|NCT01017731|79392165|FG000|Overall Study|Withdrawal by Subject|3|||
44386225|NCT01017731|79392165|FG000|Overall Study|Physician Decision|2|||
44386226|NCT01017731|79392165|FG000|Overall Study|Adverse Event|1|||
44386227|NCT01035905|79392172|FG000|Overall Study|Lack of Efficacy|1|||
44386228|NCT01035905|79392173|FG001|Overall Study|Lack of Efficacy|1|||
44386229|NCT00779584|79392197|FG000|Overall Study|Protocol Violation|0|||
44386230|NCT00779584|79392198|FG001|Overall Study|Protocol Violation|0|||
44386231|NCT00779584|79392199|FG002|Overall Study|Protocol Violation|0|||
44386232|NCT00779584|79392200|FG003|Overall Study|Protocol Violation|0|||
44386233|NCT00779584|79392201|FG004|Overall Study|Protocol Violation|0|||
44386234|NCT00779584|79392202|FG005|Overall Study|Protocol Violation|1|||
44386235|NCT00779584|79392203|FG006|Overall Study|Protocol Violation|0|||
44386236|NCT00779584|79392204|FG007|Overall Study|Protocol Violation|0|||
44386237|NCT00779584|79392205|FG008|Overall Study|Protocol Violation|0|||
44386238|NCT00779584|79392197|FG000|Overall Study|Withdrawal by Subject|1|||
44386239|NCT00779584|79392198|FG001|Overall Study|Withdrawal by Subject|1|||
44386240|NCT00779584|79392199|FG002|Overall Study|Withdrawal by Subject|2|||
44386241|NCT00779584|79392200|FG003|Overall Study|Withdrawal by Subject|0|||
44386242|NCT00779584|79392201|FG004|Overall Study|Withdrawal by Subject|0|||
44386243|NCT00779584|79392202|FG005|Overall Study|Withdrawal by Subject|2|||
44386244|NCT00779584|79392203|FG006|Overall Study|Withdrawal by Subject|1|||
44386245|NCT00779584|79392204|FG007|Overall Study|Withdrawal by Subject|0|||
44386246|NCT00779584|79392205|FG008|Overall Study|Withdrawal by Subject|0|||
44386247|NCT00779584|79392197|FG000|Overall Study|Lost to Follow-up|0|||
44518930|NCT03520920|79526698|FG002|Overall Study|Withdrawal by Subject|0|||
44518931|NCT03520920|79526696|FG000|Overall Study|Study Terminated by the Sponsor|5|||
44386248|NCT00779584|79392198|FG001|Overall Study|Lost to Follow-up|0|||
44386249|NCT00779584|79392199|FG002|Overall Study|Lost to Follow-up|0|||
44386250|NCT00779584|79392200|FG003|Overall Study|Lost to Follow-up|0|||
44386251|NCT00779584|79392201|FG004|Overall Study|Lost to Follow-up|1|||
44518932|NCT03520920|79526697|FG001|Overall Study|Study Terminated by the Sponsor|14|||
44518933|NCT03520920|79526698|FG002|Overall Study|Study Terminated by the Sponsor|5|||
44251517|NCT00216671|79086960|FG000|Overall Study|No Need to Continue Medication|1|||
44386252|NCT00779584|79392202|FG005|Overall Study|Lost to Follow-up|0|||
44386253|NCT00779584|79392203|FG006|Overall Study|Lost to Follow-up|0|||
44386254|NCT00779584|79392204|FG007|Overall Study|Lost to Follow-up|0|||
44386255|NCT00779584|79392205|FG008|Overall Study|Lost to Follow-up|0|||
44386256|NCT00779584|79392197|FG000|Overall Study|Progression of Disease|0|||
44386257|NCT00779584|79392198|FG001|Overall Study|Progression of Disease|1|||
44518934|NCT02953340|79526714|FG000|Overall Study|Death|0|||
44518935|NCT02953340|79526715|FG001|Overall Study|Death|1|||
44518936|NCT02953340|79526714|FG000|Overall Study|Investigator Decision|3|||
44386258|NCT00779584|79392199|FG002|Overall Study|Progression of Disease|2|||
44386259|NCT00779584|79392200|FG003|Overall Study|Progression of Disease|6|||
44386260|NCT00779584|79392201|FG004|Overall Study|Progression of Disease|5|||
44386261|NCT00779584|79392202|FG005|Overall Study|Progression of Disease|1|||
44386262|NCT00779584|79392203|FG006|Overall Study|Progression of Disease|4|||
44386263|NCT00779584|79392204|FG007|Overall Study|Progression of Disease|2|||
44386264|NCT00779584|79392205|FG008|Overall Study|Progression of Disease|1|||
44386265|NCT00779584|79392197|FG000|Overall Study|Adverse Event|1|||
44386266|NCT00779584|79392198|FG001|Overall Study|Adverse Event|0|||
44386267|NCT00779584|79392199|FG002|Overall Study|Adverse Event|2|||
44386268|NCT00779584|79392200|FG003|Overall Study|Adverse Event|0|||
44386269|NCT00779584|79392201|FG004|Overall Study|Adverse Event|0|||
44386270|NCT00779584|79392202|FG005|Overall Study|Adverse Event|0|||
44386271|NCT00779584|79392203|FG006|Overall Study|Adverse Event|2|||
44386272|NCT00779584|79392204|FG007|Overall Study|Adverse Event|1|||
44386273|NCT00779584|79392205|FG008|Overall Study|Adverse Event|1|||
44386274|NCT00779584|79392197|FG000|Overall Study|Symptomatic Deterioration|1|||
44280279|NCT01945710|79241276|FG006|Overall Study|Withdrawal by Subject|0|||
44280280|NCT01945242|79241296|FG000|Overall Study|Physician Decision|3|||
44280281|NCT01945242|79241297|FG001|Overall Study|Physician Decision|3|||
44280282|NCT01945086|79241307|FG000|Overall Study|Withdrawal by Subject|1|||
44280283|NCT01945086|79241308|FG001|Overall Study|Withdrawal by Subject|0|||
44280284|NCT01945086|79241309|FG002|Overall Study|Withdrawal by Subject|1|||
44280285|NCT01945086|79241307|FG000|Overall Study|Adverse Event|0|||
44280286|NCT01945086|79241308|FG001|Overall Study|Adverse Event|0|||
44280287|NCT01945086|79241309|FG002|Overall Study|Adverse Event|1|||
44280288|NCT01963728|79241319|FG000|Overall Study|Study terminated early|0|||
44280289|NCT01963728|79241320|FG001|Overall Study|Study terminated early|1|||
44280290|NCT01963260|79241336|FG000|Overall Study|Withdrawal by Subject|2|||
44280291|NCT01963260|79241337|FG001|Overall Study|Withdrawal by Subject|0|||
44280292|NCT01963260|79241338|FG002|Overall Study|Withdrawal by Subject|0|||
44386275|NCT00779584|79392198|FG001|Overall Study|Symptomatic Deterioration|1|||
44386276|NCT00779584|79392199|FG002|Overall Study|Symptomatic Deterioration|1|||
44386277|NCT00779584|79392200|FG003|Overall Study|Symptomatic Deterioration|0|||
44386278|NCT00779584|79392201|FG004|Overall Study|Symptomatic Deterioration|0|||
44386279|NCT00779584|79392202|FG005|Overall Study|Symptomatic Deterioration|1|||
44386280|NCT00779584|79392203|FG006|Overall Study|Symptomatic Deterioration|1|||
44386281|NCT00779584|79392204|FG007|Overall Study|Symptomatic Deterioration|0|||
44386282|NCT00779584|79392205|FG008|Overall Study|Symptomatic Deterioration|0|||
44386283|NCT00779584|79392197|FG000|Overall Study|Ongoing in Study|0|||
44386284|NCT00779584|79392198|FG001|Overall Study|Ongoing in Study|0|||
44386285|NCT00779584|79392199|FG002|Overall Study|Ongoing in Study|0|||
44386286|NCT00779584|79392200|FG003|Overall Study|Ongoing in Study|0|||
44386287|NCT00779584|79392201|FG004|Overall Study|Ongoing in Study|1|||
44386288|NCT00779584|79392202|FG005|Overall Study|Ongoing in Study|1|||
44386289|NCT00779584|79392203|FG006|Overall Study|Ongoing in Study|0|||
44386290|NCT00779584|79392204|FG007|Overall Study|Ongoing in Study|0|||
44386291|NCT00779584|79392205|FG008|Overall Study|Ongoing in Study|0|||
44386292|NCT00995930|79392227|FG000|Overall Study|Protocol deviation|2|||
44386293|NCT00995930|79392228|FG001|Overall Study|Protocol deviation|5|||
44386294|NCT00995930|79392227|FG000|Overall Study|Death|0|||
44386295|NCT00995930|79392228|FG001|Overall Study|Death|1|||
44386296|NCT00995930|79392227|FG000|Overall Study|Administrative problems|4|||
44386297|NCT00995930|79392228|FG001|Overall Study|Administrative problems|2|||
44386298|NCT00995930|79392227|FG000|Overall Study|Lost to Follow-up|1|||
44386299|NCT00995930|79392228|FG001|Overall Study|Lost to Follow-up|2|||
44386300|NCT00995930|79392227|FG000|Overall Study|Withdrawal by Subject|3|||
44386301|NCT00995930|79392228|FG001|Overall Study|Withdrawal by Subject|4|||
44386302|NCT00995930|79392227|FG000|Overall Study|Adverse Event|11|||
44386303|NCT00995930|79392228|FG001|Overall Study|Adverse Event|14|||
44280293|NCT01963260|79241339|FG003|Overall Study|Withdrawal by Subject|1|||
44280294|NCT01963260|79241340|FG004|Overall Study|Withdrawal by Subject|2|||
44280295|NCT01963260|79241341|FG005|Overall Study|Withdrawal by Subject|0|||
44280296|NCT01963260|79241342|FG006|Overall Study|Withdrawal by Subject|0|||
44280297|NCT01963260|79241343|FG007|Overall Study|Withdrawal by Subject|0|||
44280298|NCT01963260|79241344|FG008|Overall Study|Withdrawal by Subject|0|||
44280299|NCT01963260|79241345|FG009|Overall Study|Withdrawal by Subject|0|||
44280300|NCT01962948|79241378|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
44280301|NCT01962948|79241379|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
44386304|NCT00779506|79392235|FG000|Overall Study|Screening Failed|2|||
44386305|NCT00779506|79392235|FG000|Overall Study|Adverse Event|4|||
44386306|NCT00779506|79392235|FG000|Overall Study|Lack of Efficacy|11|||
44386307|NCT00779506|79392235|FG000|Overall Study|Protocol Violation|5|||
44386308|NCT00779506|79392235|FG000|Overall Study|Withdrawal by Subject|6|||
44386309|NCT00779506|79392235|FG000|Overall Study|Lost to Follow-up|1|||
44386310|NCT00995774|79392241|FG000|Training Period 2|Withdrawal by Subject|2|||
44386311|NCT00995774|79392242|FG001|Training Period 2|Withdrawal by Subject|0|||
44146179|NCT03806933|78935396|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
44386312|NCT00765388|79392248|FG000|Period 1|Lack of Efficacy|1|||
44146180|NCT03806933|78935397|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
44280302|NCT01962948|79241380|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
44280303|NCT01962948|79241381|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
44280304|NCT01985334|79241396|FG000|Overall Study|Administrative problems|1|||
44280305|NCT01985334|79241397|FG001|Overall Study|Administrative problems|1|||
44280306|NCT01985334|79241398|FG002|Overall Study|Administrative problems|0|||
44386313|NCT00765388|79392249|FG001|Period 1|Lack of Efficacy|2|||
44386314|NCT00765388|79392248|FG000|Period 1|Lost to Follow-up|0|||
44386315|NCT00765388|79392249|FG001|Period 1|Lost to Follow-up|1|||
44280307|NCT01985334|79241399|FG003|Overall Study|Administrative problems|2|||
44280308|NCT01985334|79241400|FG004|Overall Study|Administrative problems|0|||
44386316|NCT00765388|79392248|FG000|Period 1|Herpes Zoster|0|||
44386317|NCT00765388|79392249|FG001|Period 1|Herpes Zoster|1|||
44386318|NCT00765388|79392248|FG000|Period 1|Hip operation|0|||
44386319|NCT00765388|79392249|FG001|Period 1|Hip operation|1|||
44386320|NCT00769132|79392264|FG000|Period 1|Adverse Event|1|||
44386321|NCT00769132|79392265|FG001|Period 1|Adverse Event|0|||
44386322|NCT00769132|79392266|FG002|Period 1|Adverse Event|0|||
44280309|NCT01985334|79241401|FG005|Overall Study|Administrative problems|1|||
44280310|NCT01985334|79241402|FG006|Overall Study|Administrative problems|1|||
44280311|NCT01985334|79241403|FG007|Overall Study|Administrative problems|3|||
44280312|NCT01985334|79241396|FG000|Overall Study|Death|1|||
44280313|NCT01985334|79241397|FG001|Overall Study|Death|0|||
44280314|NCT01985334|79241398|FG002|Overall Study|Death|0|||
44280315|NCT01985334|79241399|FG003|Overall Study|Death|3|||
44280316|NCT01985334|79241400|FG004|Overall Study|Death|0|||
44280317|NCT01985334|79241401|FG005|Overall Study|Death|0|||
44280318|NCT01985334|79241402|FG006|Overall Study|Death|1|||
44280319|NCT01985334|79241403|FG007|Overall Study|Death|2|||
44280320|NCT01985334|79241396|FG000|Overall Study|Worsening of disease|0|||
44280321|NCT01985334|79241397|FG001|Overall Study|Worsening of disease|0|||
44280322|NCT01985334|79241398|FG002|Overall Study|Worsening of disease|0|||
44280323|NCT01985334|79241399|FG003|Overall Study|Worsening of disease|1|||
44280324|NCT01985334|79241400|FG004|Overall Study|Worsening of disease|0|||
44280325|NCT01985334|79241401|FG005|Overall Study|Worsening of disease|3|||
44280326|NCT01985334|79241402|FG006|Overall Study|Worsening of disease|0|||
44280327|NCT01985334|79241403|FG007|Overall Study|Worsening of disease|1|||
44280328|NCT01985334|79241396|FG000|Overall Study|Other|2|||
44280329|NCT01985334|79241397|FG001|Overall Study|Other|9|||
44386323|NCT00769132|79392267|FG003|Period 1|Adverse Event|1|||
44518937|NCT02953340|79526715|FG001|Overall Study|Investigator Decision|3|||
44518938|NCT02953340|79526714|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
44518939|NCT02953340|79526715|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
44518940|NCT02953340|79526714|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
44518941|NCT02953340|79526715|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
44518942|NCT02953340|79526714|FG000|Overall Study|Withdrawal by Subject|9|||
44518943|NCT02953340|79526715|FG001|Overall Study|Withdrawal by Subject|9|||
44518944|NCT02953340|79526714|FG000|Overall Study|Sponsor decision|0|||
44518945|NCT02953340|79526715|FG001|Overall Study|Sponsor decision|2|||
44518946|NCT02953340|79526714|FG000|Overall Study|Lost to Follow-up|3|||
44518947|NCT02953340|79526715|FG001|Overall Study|Lost to Follow-up|2|||
44518948|NCT02953340|79526714|FG000|Overall Study|Reason not specified|2|||
44518949|NCT02953340|79526715|FG001|Overall Study|Reason not specified|2|||
44518950|NCT03554772|79526731|FG000|Overall Study|Lost to Follow-up|0|||
44518951|NCT03554772|79526732|FG001|Overall Study|Lost to Follow-up|0|||
44518952|NCT03554772|79526733|FG002|Overall Study|Lost to Follow-up|0|||
44518953|NCT03554772|79526734|FG003|Overall Study|Lost to Follow-up|2|||
44518954|NCT03573804|79526744|FG000|Overall Study|claustrophobia or MRI table problems|10|||
44146181|NCT03806933|78935398|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
44280330|NCT01985334|79241398|FG002|Overall Study|Other|7|||
44280331|NCT01985334|79241399|FG003|Overall Study|Other|17|||
44280332|NCT01985334|79241400|FG004|Overall Study|Other|4|||
44280333|NCT01985334|79241401|FG005|Overall Study|Other|8|||
44280334|NCT01985334|79241402|FG006|Overall Study|Other|4|||
44280335|NCT01985334|79241403|FG007|Overall Study|Other|7|||
44280336|NCT01985334|79241396|FG000|Overall Study|Protocol deviation|6|||
44386324|NCT00769132|79392264|FG000|Period 2|Withdrawal by Subject|0|||
44518955|NCT03417440|79526762|FG000|Overall Study|Lost to Follow-up|0|||
44518956|NCT03417440|79526763|FG001|Overall Study|Lost to Follow-up|1|||
44280337|NCT01985334|79241397|FG001|Overall Study|Protocol deviation|31|||
44280338|NCT01985334|79241398|FG002|Overall Study|Protocol deviation|25|||
44280339|NCT01985334|79241399|FG003|Overall Study|Protocol deviation|84|||
44386325|NCT00769132|79392265|FG001|Period 2|Withdrawal by Subject|0|||
44386326|NCT00769132|79392266|FG002|Period 2|Withdrawal by Subject|0|||
44386327|NCT00769132|79392267|FG003|Period 2|Withdrawal by Subject|1|||
44386328|NCT00769132|79392264|FG000|Period 3|Withdrawal by Subject|1|||
44386329|NCT00769132|79392265|FG001|Period 3|Withdrawal by Subject|0|||
44280340|NCT01985334|79241400|FG004|Overall Study|Protocol deviation|17|||
44280341|NCT01985334|79241401|FG005|Overall Study|Protocol deviation|47|||
44280342|NCT01985334|79241402|FG006|Overall Study|Protocol deviation|15|||
44280343|NCT01985334|79241403|FG007|Overall Study|Protocol deviation|42|||
44280344|NCT01985334|79241396|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
44280345|NCT01985334|79241397|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
44280346|NCT01985334|79241398|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
44280347|NCT01985334|79241399|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
44386330|NCT00769132|79392266|FG002|Period 3|Withdrawal by Subject|0|||
44386331|NCT00769132|79392267|FG003|Period 3|Withdrawal by Subject|0|||
44386332|NCT00769132|79392264|FG000|Period 4|Withdrawal by Subject|0|||
44386333|NCT00769132|79392265|FG001|Period 4|Withdrawal by Subject|1|||
44386334|NCT00769132|79392266|FG002|Period 4|Withdrawal by Subject|0|||
44386335|NCT00769132|79392267|FG003|Period 4|Withdrawal by Subject|0|||
44386336|NCT00991952|79392279|FG000|Overall Study|Adverse Event|0|||
44386337|NCT00991952|79392280|FG001|Overall Study|Adverse Event|1|||
44386338|NCT00779038|79392286|FG000|Overall Study|Study Prematurely Terminated|13|||
44386339|NCT00765076|79392293|FG000|Overall Study|Adverse Event|1|||
44386340|NCT00765076|79392294|FG001|Overall Study|Adverse Event|0|||
44386341|NCT00765076|79392295|FG002|Overall Study|Adverse Event|0|||
44386342|NCT00765076|79392293|FG000|Overall Study|Withdrawal by Subject|0|||
44386343|NCT00765076|79392294|FG001|Overall Study|Withdrawal by Subject|0|||
44386344|NCT00765076|79392295|FG002|Overall Study|Withdrawal by Subject|1|||
44386345|NCT00994682|79392305|FG000|Double Bilnd|Withdrawal by Subject|5|||
44386346|NCT00994682|79392306|FG001|Double Bilnd|Withdrawal by Subject|6|||
44386347|NCT00994682|79392305|FG000|Double Bilnd|Lost to Follow-up|3|||
44386348|NCT00994682|79392306|FG001|Double Bilnd|Lost to Follow-up|3|||
44386349|NCT00994682|79392305|FG000|Double Bilnd|Adverse Event|1|||
44386350|NCT00994682|79392306|FG001|Double Bilnd|Adverse Event|0|||
44386351|NCT00994682|79392305|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
44386352|NCT00994682|79392306|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
44386353|NCT00994682|79392305|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
44386354|NCT00994682|79392306|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
44386355|NCT00994682|79392305|FG000|Pioglitazone Open Label|Physician Decision|6|||
44386356|NCT00994682|79392306|FG001|Pioglitazone Open Label|Physician Decision|1|||
44386357|NCT00768898|79392316|FG000|Overall Study|Unrelated injury|1|||
44386358|NCT00768898|79392316|FG000|Overall Study|Headache|1|||
44386359|NCT00994448|79392327|FG000|Overall Study|Adverse Event|1|||
44251518|NCT00216671|79086961|FG001|Overall Study|No Need to Continue Medication|1|||
44251519|NCT00216671|79086960|FG000|Overall Study|Insufficient Response|9|||
44251520|NCT00216671|79086961|FG001|Overall Study|Insufficient Response|4|||
44251521|NCT00216671|79086960|FG000|Overall Study|Lost to Follow-up|3|||
44251522|NCT00216671|79086961|FG001|Overall Study|Lost to Follow-up|5|||
44251523|NCT00216671|79086960|FG000|Overall Study|Non compliant|2|||
44251524|NCT00216671|79086961|FG001|Overall Study|Non compliant|2|||
44251525|NCT00216671|79086960|FG000|Overall Study|Ineligible|0|||
44251526|NCT00216671|79086961|FG001|Overall Study|Ineligible|2|||
44251527|NCT00216671|79086960|FG000|Overall Study|Physician Decision|1|||
44251528|NCT00216671|79086961|FG001|Overall Study|Physician Decision|1|||
44251529|NCT00216671|79086960|FG000|Overall Study|Protocol Violation|3|||
44251530|NCT00216671|79086961|FG001|Overall Study|Protocol Violation|5|||
44251531|NCT00216671|79086960|FG000|Overall Study|Relapse|1|||
44251532|NCT00216671|79086961|FG001|Overall Study|Relapse|0|||
44251533|NCT00216671|79086960|FG000|Overall Study|Investigator Illness|0|||
44251534|NCT00216671|79086961|FG001|Overall Study|Investigator Illness|1|||
44251535|NCT00216671|79086960|FG000|Overall Study|Patient Moved|0|||
44251536|NCT00216671|79086961|FG001|Overall Study|Patient Moved|1|||
44251537|NCT00216671|79086960|FG000|Overall Study|Ineligible, no efficacy data|2|||
44251538|NCT00216671|79086961|FG001|Overall Study|Ineligible, no efficacy data|2|||
44251539|NCT00216671|79086960|FG000|Overall Study|Insufficient Response Adverse Event|2|||
44251540|NCT00216671|79086961|FG001|Overall Study|Insufficient Response Adverse Event|1|||
44251541|NCT00216203|79086967|FG000|Overall Study|Withdrawal by Subject|2|||
44251542|NCT02644668|79087002|FG000|Overall Study|Adverse Event|2|||
44251543|NCT02644668|79087003|FG001|Overall Study|Adverse Event|0|||
44251544|NCT02644668|79087004|FG002|Overall Study|Adverse Event|1|||
44251545|NCT02644668|79087002|FG000|Overall Study|Protocol Violation|0|||
44280348|NCT01985334|79241400|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
44280349|NCT01985334|79241401|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
44280350|NCT01985334|79241402|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
44386360|NCT00994448|79392328|FG001|Overall Study|Adverse Event|0|||
44386361|NCT00994448|79392327|FG000|Overall Study|Lost to Follow-up|5|||
44386362|NCT00994448|79392328|FG001|Overall Study|Lost to Follow-up|1|||
44386363|NCT00994448|79392327|FG000|Overall Study|Withdrawal by Subject|1|||
44386364|NCT00994448|79392328|FG001|Overall Study|Withdrawal by Subject|1|||
44386365|NCT00994448|79392327|FG000|Overall Study|Physician Decision|1|||
44386366|NCT00994448|79392328|FG001|Overall Study|Physician Decision|0|||
44386367|NCT00991406|79392334|FG000|Overall Study|One participant did not respond to FES.|1|||
44386368|NCT01017575|79392343|FG000|Overall Study|Lack of Efficacy|0|||
44386369|NCT01017575|79392344|FG001|Overall Study|Lack of Efficacy|1|||
44386370|NCT01017575|79392345|FG002|Overall Study|Lack of Efficacy|0|||
44386371|NCT01017575|79392346|FG003|Overall Study|Lack of Efficacy|1|||
44386372|NCT01017575|79392347|FG004|Overall Study|Lack of Efficacy|1|||
44386373|NCT01017575|79392343|FG000|Overall Study|Adverse Event|0|||
44386374|NCT01017575|79392344|FG001|Overall Study|Adverse Event|1|||
44386375|NCT01017575|79392345|FG002|Overall Study|Adverse Event|0|||
44386376|NCT01017575|79392346|FG003|Overall Study|Adverse Event|0|||
44386377|NCT01017575|79392347|FG004|Overall Study|Adverse Event|2|||
44386378|NCT01017575|79392343|FG000|Overall Study|Withdrawal by Subject|1|||
44386379|NCT01017575|79392344|FG001|Overall Study|Withdrawal by Subject|0|||
44386380|NCT01017575|79392345|FG002|Overall Study|Withdrawal by Subject|0|||
44386381|NCT01017575|79392346|FG003|Overall Study|Withdrawal by Subject|0|||
44386382|NCT01017575|79392347|FG004|Overall Study|Withdrawal by Subject|0|||
44386383|NCT01017263|79392359|FG000|Overall Study|not eligible|12|||
44386384|NCT00768664|79392363|FG000|Overall Study|Death|57|||
44386385|NCT00768664|79392363|FG000|Overall Study|Lost to Follow-up|2|||
44386386|NCT00768664|79392363|FG000|Overall Study|Other|9|||
44386387|NCT00768664|79392363|FG000|Overall Study|Participant refused|1|||
44386388|NCT00778336|79392371|FG000|Index Procedure-Discharge|Death|6|||
44386389|NCT00778336|79392372|FG001|Index Procedure-Discharge|Death|3|||
44386390|NCT00778336|79392373|FG002|Index Procedure-Discharge|Death|2|||
44386391|NCT00778336|79392374|FG003|Index Procedure-Discharge|Death|0|||
44386392|NCT00778336|79392371|FG000|3 Month Follow Up|Lost to Follow-up|15|||
44386393|NCT00778336|79392372|FG001|3 Month Follow Up|Lost to Follow-up|20|||
44386394|NCT00778336|79392373|FG002|3 Month Follow Up|Lost to Follow-up|3|||
44386395|NCT00778336|79392374|FG003|3 Month Follow Up|Lost to Follow-up|0|||
44386396|NCT00778336|79392371|FG000|3 Month Follow Up|Death|8|||
44386397|NCT00778336|79392372|FG001|3 Month Follow Up|Death|3|||
44386398|NCT00778336|79392373|FG002|3 Month Follow Up|Death|2|||
44386399|NCT00778336|79392374|FG003|3 Month Follow Up|Death|0|||
44386400|NCT01253161|79392384|FG000|Overall Study|Adverse Event|1|||
44386401|NCT00581113|79392390|FG000|Overall Study|Withdrawal by Subject|0|||
44386402|NCT00581113|79392391|FG001|Overall Study|Withdrawal by Subject|1|||
44386403|NCT01016015|79392397|FG000|Overall Study|Not Treated|3|||
44386404|NCT01016015|79392397|FG000|Overall Study|Withdrawal by Subject|1|||
44386405|NCT01016015|79392397|FG000|Overall Study|Adverse Event|15|||
44386406|NCT01015703|79392406|FG000|Overall Study|Withdrawal by Subject|0|||
44386407|NCT01015703|79392407|FG001|Overall Study|Withdrawal by Subject|1|||
44386408|NCT01015703|79392408|FG002|Overall Study|Withdrawal by Subject|0|||
44386409|NCT01015703|79392409|FG003|Overall Study|Withdrawal by Subject|0|||
44386410|NCT01015703|79392410|FG004|Overall Study|Withdrawal by Subject|0|||
44386411|NCT01015703|79392406|FG000|Overall Study|Adverse Event|1|||
44386412|NCT01015703|79392407|FG001|Overall Study|Adverse Event|0|||
44386413|NCT01015703|79392408|FG002|Overall Study|Adverse Event|0|||
44386414|NCT01015703|79392409|FG003|Overall Study|Adverse Event|0|||
44518957|NCT03417440|79526764|FG002|Overall Study|Lost to Follow-up|0|||
44518958|NCT03417440|79526765|FG003|Overall Study|Lost to Follow-up|0|||
44518959|NCT03417440|79526766|FG004|Overall Study|Lost to Follow-up|1|||
44518960|NCT03417440|79526767|FG005|Overall Study|Lost to Follow-up|0|||
44518961|NCT03417440|79526768|FG006|Overall Study|Lost to Follow-up|0|||
44518962|NCT03417440|79526769|FG007|Overall Study|Lost to Follow-up|0|||
44251546|NCT02644668|79087003|FG001|Overall Study|Protocol Violation|0|||
44251547|NCT02644668|79087004|FG002|Overall Study|Protocol Violation|1|||
44251548|NCT02644668|79087002|FG000|Overall Study|Withdrawal by Subject|0|||
44251549|NCT02644668|79087003|FG001|Overall Study|Withdrawal by Subject|0|||
44251550|NCT02644668|79087004|FG002|Overall Study|Withdrawal by Subject|1|||
44251551|NCT02644356|79087023|FG000|Overall Study|Withdrawal by Subject|2|||
44251552|NCT01494038|79087055|FG000|Overall Study|Protocol Violation|1|||
44251553|NCT01494038|79087056|FG001|Overall Study|Protocol Violation|1|||
44251554|NCT01494038|79087055|FG000|Overall Study|Lost to Follow-up|18|||
44251555|NCT01494038|79087056|FG001|Overall Study|Lost to Follow-up|20|||
44251556|NCT01494038|79087055|FG000|Overall Study|Withdrawal by Subject|44|||
44386415|NCT01015703|79392410|FG004|Overall Study|Adverse Event|0|||
44386416|NCT01015703|79392406|FG000|Overall Study|Protocol Violation|1|||
44386417|NCT01015703|79392407|FG001|Overall Study|Protocol Violation|0|||
44386418|NCT01015703|79392408|FG002|Overall Study|Protocol Violation|0|||
44386419|NCT01015703|79392409|FG003|Overall Study|Protocol Violation|0|||
44386420|NCT01015703|79392410|FG004|Overall Study|Protocol Violation|0|||
44386421|NCT04439071|79392424|FG000|Overall Study|Lost to Follow-up|0|||
44386422|NCT04439071|79392425|FG001|Overall Study|Lost to Follow-up|3|||
44386423|NCT04439071|79392424|FG000|Overall Study|Withdrawal by Subject|3|||
44386424|NCT04439071|79392425|FG001|Overall Study|Withdrawal by Subject|8|||
44386425|NCT04439071|79392424|FG000|Overall Study|Death|6|||
44386426|NCT04439071|79392425|FG001|Overall Study|Death|4|||
44386427|NCT04439071|79392424|FG000|Overall Study|Other than specified|3|||
44518963|NCT03417440|79526762|FG000|Overall Study|Withdrawal by Subject|2|||
44386428|NCT04439071|79392425|FG001|Overall Study|Other than specified|3|||
44386429|NCT04439071|79392424|FG000|Overall Study|Randomized but not treated|2|||
44386430|NCT04439071|79392425|FG001|Overall Study|Randomized but not treated|0|||
44386431|NCT01017029|79392433|FG000|Overall Study|Lost to Follow-up|1|||
44386432|NCT01017029|79392434|FG001|Overall Study|Lost to Follow-up|0|||
44280351|NCT01985334|79241403|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
44280352|NCT01985334|79241396|FG000|Overall Study|Subject withdrawal of consent|3|||
44280353|NCT01985334|79241397|FG001|Overall Study|Subject withdrawal of consent|6|||
44386433|NCT01017029|79392433|FG000|Overall Study|Administrative problem|0|||
44386434|NCT01017029|79392434|FG001|Overall Study|Administrative problem|1|||
44386435|NCT01017029|79392433|FG000|Overall Study|Death|3|||
44386436|NCT01017029|79392434|FG001|Overall Study|Death|1|||
44386437|NCT00994214|79392444|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
44386438|NCT00994214|79392445|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
44386439|NCT00994214|79392446|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
44386440|NCT00994214|79392447|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
44386441|NCT00994214|79392444|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
44386442|NCT00994214|79392445|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
44386443|NCT00994214|79392446|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
44386444|NCT00994214|79392447|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
44386445|NCT00994214|79392444|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
44386446|NCT00994214|79392445|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
44386447|NCT00994214|79392446|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
44386448|NCT00994214|79392447|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
44386449|NCT00994214|79392444|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
44386450|NCT00994214|79392445|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
44386451|NCT00994214|79392446|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
44386452|NCT00994214|79392447|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
44386453|NCT00994214|79392444|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
44280354|NCT01985334|79241398|FG002|Overall Study|Subject withdrawal of consent|2|||
44280355|NCT01985334|79241399|FG003|Overall Study|Subject withdrawal of consent|28|||
44280356|NCT01985334|79241400|FG004|Overall Study|Subject withdrawal of consent|4|||
44386454|NCT00994214|79392445|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
44386455|NCT00994214|79392446|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
44386456|NCT00994214|79392447|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
44386457|NCT00994214|79392444|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
44386458|NCT00994214|79392445|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
44386459|NCT00994214|79392446|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
44386460|NCT00994214|79392447|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
44386461|NCT01034657|79392475|FG000|Core Phase|Withdrawal by Subject|1|||
44386462|NCT01034657|79392476|FG001|Core Phase|Withdrawal by Subject|0|||
44386463|NCT01034657|79392477|FG002|Core Phase|Withdrawal by Subject|0|||
44386464|NCT01034657|79392475|FG000|Core Phase|Lack of Efficacy|2|||
44386465|NCT01034657|79392476|FG001|Core Phase|Lack of Efficacy|0|||
44386466|NCT01034657|79392477|FG002|Core Phase|Lack of Efficacy|0|||
44386467|NCT01034657|79392475|FG000|Core Phase|Abnormal laboratory value|1|||
44386468|NCT01034657|79392476|FG001|Core Phase|Abnormal laboratory value|0|||
44386469|NCT01034657|79392477|FG002|Core Phase|Abnormal laboratory value|0|||
44386470|NCT01034657|79392475|FG000|Core Phase|Adverse Event|8|||
44386471|NCT01034657|79392476|FG001|Core Phase|Adverse Event|0|||
44386472|NCT01034657|79392477|FG002|Core Phase|Adverse Event|0|||
44386473|NCT01034657|79392475|FG000|Core Phase|Protocol Violation|2|||
44386474|NCT01034657|79392476|FG001|Core Phase|Protocol Violation|0|||
44386475|NCT01034657|79392477|FG002|Core Phase|Protocol Violation|0|||
44386476|NCT01034657|79392475|FG000|Randomized Phase|Withdrawal by Subject|0|||
44386477|NCT01034657|79392476|FG001|Randomized Phase|Withdrawal by Subject|2|||
44386478|NCT01034657|79392477|FG002|Randomized Phase|Withdrawal by Subject|0|||
44280357|NCT01985334|79241401|FG005|Overall Study|Subject withdrawal of consent|19|||
44280358|NCT01985334|79241402|FG006|Overall Study|Subject withdrawal of consent|0|||
44280359|NCT01985334|79241403|FG007|Overall Study|Subject withdrawal of consent|20|||
44386479|NCT01034657|79392475|FG000|Randomized Phase|Lack of Efficacy|5|||
44386480|NCT01034657|79392476|FG001|Randomized Phase|Lack of Efficacy|1|||
44386481|NCT01034657|79392477|FG002|Randomized Phase|Lack of Efficacy|0|||
44386482|NCT01034657|79392475|FG000|Randomized Phase|Abnormal laboratory value|0|||
44386483|NCT01034657|79392476|FG001|Randomized Phase|Abnormal laboratory value|1|||
44280360|NCT01985334|79241396|FG000|Overall Study|Adverse Event|0|||
44386484|NCT01034657|79392477|FG002|Randomized Phase|Abnormal laboratory value|0|||
44386485|NCT01034657|79392475|FG000|Randomized Phase|Adverse Event|0|||
44386486|NCT01034657|79392476|FG001|Randomized Phase|Adverse Event|2|||
44386487|NCT01034657|79392477|FG002|Randomized Phase|Adverse Event|1|||
44386488|NCT01014767|79392491|FG000|Overall Study|PI left institution, data unavailable|12|||
44386489|NCT01014767|79392492|FG001|Overall Study|PI left institution, data unavailable|1|||
44386490|NCT01014767|79392493|FG002|Overall Study|PI left institution, data unavailable|4|||
44386491|NCT01014767|79392494|FG003|Overall Study|PI left institution, data unavailable|1|||
44386492|NCT02016781|79392506|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
44386493|NCT02016781|79392507|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
44386494|NCT02016781|79392506|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
44386495|NCT02016781|79392507|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
44386496|NCT02016781|79392506|FG000|Final Database Lock|Withdrawal by Subject|2|||
44386497|NCT02016781|79392507|FG001|Final Database Lock|Withdrawal by Subject|1|||
44386498|NCT02016781|79392506|FG000|Final Database Lock|Lost to Follow-up|11|||
44386499|NCT02016781|79392507|FG001|Final Database Lock|Lost to Follow-up|4|||
44386500|NCT02016781|79392506|FG000|Final Database Lock|Missing data|0|||
44386501|NCT02016781|79392507|FG001|Final Database Lock|Missing data|3|||
44386502|NCT01014689|79392515|FG000|Overall Study|Lack of Efficacy|0|||
44386503|NCT01014689|79392516|FG001|Overall Study|Lack of Efficacy|1|||
44386504|NCT01014689|79392515|FG000|Overall Study|Adverse Event|3|||
44386505|NCT01014689|79392516|FG001|Overall Study|Adverse Event|0|||
44386506|NCT01014689|79392515|FG000|Overall Study|Withdrawal by Subject|5|||
44386507|NCT01014689|79392516|FG001|Overall Study|Withdrawal by Subject|4|||
44386508|NCT01014689|79392515|FG000|Overall Study|Protocol Violation|1|||
44386509|NCT01014689|79392516|FG001|Overall Study|Protocol Violation|1|||
44386510|NCT01014689|79392515|FG000|Overall Study|Lost to Follow-up|3|||
44386511|NCT01014689|79392516|FG001|Overall Study|Lost to Follow-up|7|||
44386512|NCT01014689|79392515|FG000|Overall Study|Pregnancy|1|||
44386513|NCT01014689|79392516|FG001|Overall Study|Pregnancy|0|||
44386514|NCT01014533|79392524|FG000|Overall Study|Protocol Violation|3|||
44386515|NCT01014533|79392525|FG001|Overall Study|Protocol Violation|2|||
44386516|NCT01014533|79392524|FG000|Overall Study|Withdrawal by Subject|2|||
44386517|NCT01014533|79392525|FG001|Overall Study|Withdrawal by Subject|0|||
44386518|NCT01014533|79392524|FG000|Overall Study|unable to come to appointment|0|||
44386519|NCT01014533|79392525|FG001|Overall Study|unable to come to appointment|3|||
44386520|NCT01014143|79392548|FG000|Second Intervention|Lost to Follow-up|2|||
44386521|NCT01014143|79392549|FG001|Second Intervention|Lost to Follow-up|0|||
44386522|NCT01014143|79392550|FG002|Second Intervention|Lost to Follow-up|0|||
44386523|NCT01013753|79392558|FG000|Overall Study|Adverse Event|8|||
44386524|NCT01013753|79392558|FG000|Overall Study|Protocol Violation|3|||
44386525|NCT01013753|79392558|FG000|Overall Study|Lost to Follow-up|1|||
44386526|NCT01013753|79392558|FG000|Overall Study|Withdrawal by Subject|2|||
44386527|NCT01013753|79392558|FG000|Overall Study|Other|2|||
44386528|NCT00757042|79392583|FG000|Overall Study|Lost to Follow-up|0|||
44386529|NCT00757042|79392584|FG001|Overall Study|Lost to Follow-up|0|||
44386530|NCT00757042|79392585|FG002|Overall Study|Lost to Follow-up|0|||
44386531|NCT00757042|79392586|FG003|Overall Study|Lost to Follow-up|0|||
44386532|NCT00757042|79392587|FG004|Overall Study|Lost to Follow-up|0|||
44386533|NCT00757042|79392588|FG005|Overall Study|Lost to Follow-up|0|||
44386534|NCT00757042|79392589|FG006|Overall Study|Lost to Follow-up|0|||
44386535|NCT00757042|79392590|FG007|Overall Study|Lost to Follow-up|0|||
44386536|NCT00757042|79392591|FG008|Overall Study|Lost to Follow-up|1|||
44386537|NCT00757042|79392592|FG009|Overall Study|Lost to Follow-up|0|||
44386538|NCT00757042|79392593|FG010|Overall Study|Lost to Follow-up|0|||
44386539|NCT00757042|79392583|FG000|Overall Study|Ineligibility Determined|0|||
44386540|NCT00757042|79392584|FG001|Overall Study|Ineligibility Determined|0|||
44386541|NCT00757042|79392585|FG002|Overall Study|Ineligibility Determined|0|||
44386542|NCT00757042|79392586|FG003|Overall Study|Ineligibility Determined|0|||
44386543|NCT00757042|79392587|FG004|Overall Study|Ineligibility Determined|0|||
44386544|NCT00757042|79392588|FG005|Overall Study|Ineligibility Determined|0|||
44386545|NCT00757042|79392589|FG006|Overall Study|Ineligibility Determined|0|||
44386546|NCT00757042|79392590|FG007|Overall Study|Ineligibility Determined|0|||
44386547|NCT00757042|79392591|FG008|Overall Study|Ineligibility Determined|0|||
44386548|NCT00757042|79392592|FG009|Overall Study|Ineligibility Determined|0|||
44386549|NCT00757042|79392593|FG010|Overall Study|Ineligibility Determined|1|||
44386550|NCT00757042|79392583|FG000|Overall Study|Withdrawal by Subject|0|||
44386551|NCT00757042|79392584|FG001|Overall Study|Withdrawal by Subject|0|||
44386552|NCT00757042|79392585|FG002|Overall Study|Withdrawal by Subject|0|||
44386553|NCT00757042|79392586|FG003|Overall Study|Withdrawal by Subject|0|||
44386554|NCT00757042|79392587|FG004|Overall Study|Withdrawal by Subject|0|||
44386555|NCT00757042|79392588|FG005|Overall Study|Withdrawal by Subject|0|||
44386556|NCT00757042|79392589|FG006|Overall Study|Withdrawal by Subject|0|||
44386557|NCT00757042|79392590|FG007|Overall Study|Withdrawal by Subject|0|||
44386558|NCT00757042|79392591|FG008|Overall Study|Withdrawal by Subject|0|||
44386559|NCT00757042|79392592|FG009|Overall Study|Withdrawal by Subject|1|||
44386560|NCT00757042|79392593|FG010|Overall Study|Withdrawal by Subject|0|||
44386561|NCT01013597|79392624|FG000|Overall Study|Withdrawal by Subject|1|||
44386562|NCT01013285|79392643|FG000|Overall Study|Death|48|||
44386563|NCT01013285|79392644|FG001|Overall Study|Death|89|||
44386564|NCT01033643|79392654|FG000|Overall Study|Withdrew Consent|0|||
44386565|NCT01033643|79392655|FG001|Overall Study|Withdrew Consent|3|||
44386566|NCT01033643|79392656|FG002|Overall Study|Withdrew Consent|0|||
44386567|NCT01033643|79392657|FG003|Overall Study|Withdrew Consent|0|||
44386568|NCT01033643|79392658|FG004|Overall Study|Withdrew Consent|0|||
44386569|NCT01033643|79392659|FG005|Overall Study|Withdrew Consent|1|||
44386570|NCT01013207|79392673|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
44386571|NCT01033487|79392677|FG000|Fourth Intervention Period|Adverse Event|0|||
44386572|NCT01033487|79392678|FG001|Fourth Intervention Period|Adverse Event|0|||
44386573|NCT01033487|79392679|FG002|Fourth Intervention Period|Adverse Event|0|||
44386574|NCT01033487|79392680|FG003|Fourth Intervention Period|Adverse Event|0|||
44386575|NCT01033487|79392681|FG004|Fourth Intervention Period|Adverse Event|0|||
44386576|NCT01033487|79392682|FG005|Fourth Intervention Period|Adverse Event|0|||
44386577|NCT01033487|79392683|FG006|Fourth Intervention Period|Adverse Event|0|||
44386578|NCT01033487|79392684|FG007|Fourth Intervention Period|Adverse Event|0|||
44386579|NCT01033487|79392685|FG008|Fourth Intervention Period|Adverse Event|1|||
44386580|NCT01033487|79392686|FG009|Fourth Intervention Period|Adverse Event|0|||
44386581|NCT01033019|79392702|FG000|Overall Study|Withdrawal by Subject|1|||
44386582|NCT01033019|79392703|FG001|Overall Study|Withdrawal by Subject|0|||
44386583|NCT00603447|79392717|FG000|Overall Study|Adverse Event|0|||
44386584|NCT00603447|79392718|FG001|Overall Study|Adverse Event|1|||
44386585|NCT00603447|79392719|FG002|Overall Study|Adverse Event|1|||
44386586|NCT00603447|79392720|FG003|Overall Study|Adverse Event|2|||
44386587|NCT00603447|79392721|FG004|Overall Study|Adverse Event|1|||
44386588|NCT00603447|79392722|FG005|Overall Study|Adverse Event|2|||
44386589|NCT00603447|79392723|FG006|Overall Study|Adverse Event|10|||
44386590|NCT00603447|79392717|FG000|Overall Study|Other|0|||
44386591|NCT00603447|79392718|FG001|Overall Study|Other|0|||
44386592|NCT00603447|79392719|FG002|Overall Study|Other|1|||
44386593|NCT00603447|79392720|FG003|Overall Study|Other|0|||
44386594|NCT00603447|79392721|FG004|Overall Study|Other|3|||
44386595|NCT00603447|79392722|FG005|Overall Study|Other|0|||
44386596|NCT00603447|79392723|FG006|Overall Study|Other|13|||
44386597|NCT00603447|79392717|FG000|Overall Study|Withdrew Consent|0|||
44386598|NCT00603447|79392718|FG001|Overall Study|Withdrew Consent|2|||
44386599|NCT00603447|79392719|FG002|Overall Study|Withdrew Consent|0|||
44386600|NCT00603447|79392720|FG003|Overall Study|Withdrew Consent|0|||
44386601|NCT00603447|79392721|FG004|Overall Study|Withdrew Consent|1|||
44386602|NCT00603447|79392722|FG005|Overall Study|Withdrew Consent|0|||
44386603|NCT00603447|79392723|FG006|Overall Study|Withdrew Consent|1|||
44386604|NCT00778258|79392748|FG000|Overall Study|Adverse Event|1|||
44386605|NCT00778258|79392749|FG001|Overall Study|Adverse Event|0|||
44386606|NCT00778258|79392750|FG002|Overall Study|Adverse Event|0|||
44386607|NCT00778258|79392751|FG003|Overall Study|Adverse Event|0|||
44386608|NCT00778258|79392752|FG004|Overall Study|Adverse Event|0|||
44386609|NCT00778258|79392753|FG005|Overall Study|Adverse Event|1|||
44386610|NCT00778258|79392754|FG006|Overall Study|Adverse Event|0|||
44386611|NCT00778258|79392755|FG007|Overall Study|Adverse Event|0|||
44386612|NCT00778258|79392756|FG008|Overall Study|Adverse Event|0|||
44386613|NCT00778258|79392748|FG000|Overall Study|Lost to Follow-up|0|||
44386614|NCT00778258|79392749|FG001|Overall Study|Lost to Follow-up|0|||
44386615|NCT00778258|79392750|FG002|Overall Study|Lost to Follow-up|2|||
44386616|NCT00778258|79392751|FG003|Overall Study|Lost to Follow-up|0|||
44386617|NCT00778258|79392752|FG004|Overall Study|Lost to Follow-up|0|||
44386618|NCT00778258|79392753|FG005|Overall Study|Lost to Follow-up|3|||
44386619|NCT00778258|79392754|FG006|Overall Study|Lost to Follow-up|2|||
44386620|NCT00778258|79392755|FG007|Overall Study|Lost to Follow-up|2|||
44386621|NCT00778258|79392756|FG008|Overall Study|Lost to Follow-up|0|||
44251557|NCT01494038|79087056|FG001|Overall Study|Withdrawal by Subject|34|||
44251558|NCT01494038|79087055|FG000|Overall Study|Not able to get to clinic|21|||
44251559|NCT01494038|79087056|FG001|Overall Study|Not able to get to clinic|15|||
44251560|NCT01494038|79087055|FG000|Overall Study|Not willing to adhere to reqs|2|||
44251561|NCT01494038|79087056|FG001|Overall Study|Not willing to adhere to reqs|9|||
44251562|NCT01494038|79087055|FG000|Overall Study|Death|2|||
44251563|NCT01494038|79087056|FG001|Overall Study|Death|4|||
44251564|NCT02640612|79087093|FG000|Overall Study|Adverse Event|6|||
44518964|NCT03417440|79526763|FG001|Overall Study|Withdrawal by Subject|0|||
44251565|NCT02640612|79087094|FG001|Overall Study|Adverse Event|7|||
44386622|NCT00778258|79392748|FG000|Overall Study|Withdrawal by Subject|6|||
44386623|NCT00778258|79392749|FG001|Overall Study|Withdrawal by Subject|2|||
44386624|NCT00778258|79392750|FG002|Overall Study|Withdrawal by Subject|8|||
44386625|NCT00778258|79392751|FG003|Overall Study|Withdrawal by Subject|2|||
44386626|NCT00778258|79392752|FG004|Overall Study|Withdrawal by Subject|0|||
44386627|NCT00778258|79392753|FG005|Overall Study|Withdrawal by Subject|6|||
44386628|NCT00778258|79392754|FG006|Overall Study|Withdrawal by Subject|12|||
44386629|NCT00778258|79392755|FG007|Overall Study|Withdrawal by Subject|12|||
44386630|NCT00778258|79392756|FG008|Overall Study|Withdrawal by Subject|4|||
44386631|NCT00778258|79392748|FG000|Overall Study|New Contraindication|0|||
44386632|NCT00778258|79392749|FG001|Overall Study|New Contraindication|0|||
44386633|NCT00778258|79392750|FG002|Overall Study|New Contraindication|0|||
44386634|NCT00778258|79392751|FG003|Overall Study|New Contraindication|0|||
44386635|NCT00778258|79392752|FG004|Overall Study|New Contraindication|0|||
44386636|NCT00778258|79392753|FG005|Overall Study|New Contraindication|0|||
44386637|NCT00778258|79392754|FG006|Overall Study|New Contraindication|0|||
44386638|NCT00778258|79392755|FG007|Overall Study|New Contraindication|1|||
44386639|NCT00778258|79392756|FG008|Overall Study|New Contraindication|0|||
44386640|NCT00778258|79392748|FG000|Overall Study|Non-compliance|0|||
44386641|NCT00778258|79392749|FG001|Overall Study|Non-compliance|0|||
44386642|NCT00778258|79392750|FG002|Overall Study|Non-compliance|0|||
44386643|NCT00778258|79392751|FG003|Overall Study|Non-compliance|1|||
44386644|NCT00778258|79392752|FG004|Overall Study|Non-compliance|0|||
44386645|NCT00778258|79392753|FG005|Overall Study|Non-compliance|0|||
44386646|NCT00778258|79392754|FG006|Overall Study|Non-compliance|0|||
44386647|NCT00778258|79392755|FG007|Overall Study|Non-compliance|0|||
44386648|NCT00778258|79392756|FG008|Overall Study|Non-compliance|0|||
44386649|NCT00778258|79392748|FG000|Overall Study|Other|0|||
44386650|NCT00778258|79392749|FG001|Overall Study|Other|0|||
44386651|NCT00778258|79392750|FG002|Overall Study|Other|0|||
44386652|NCT00778258|79392751|FG003|Overall Study|Other|0|||
44386653|NCT00778258|79392752|FG004|Overall Study|Other|0|||
44386654|NCT00778258|79392753|FG005|Overall Study|Other|0|||
44386655|NCT00778258|79392754|FG006|Overall Study|Other|1|||
44386656|NCT00778258|79392755|FG007|Overall Study|Other|0|||
44386657|NCT00778258|79392756|FG008|Overall Study|Other|0|||
44386658|NCT00988208|79392784|FG000|Overall Study|Adverse Event|71|||
44386659|NCT00988208|79392785|FG001|Overall Study|Adverse Event|122|||
44386660|NCT00988208|79392784|FG000|Overall Study|Disease Progression|103|||
44386661|NCT00988208|79392785|FG001|Overall Study|Disease Progression|89|||
44386662|NCT00988208|79392784|FG000|Overall Study|Withdrawal by Subject|50|||
44386663|NCT00988208|79392785|FG001|Overall Study|Withdrawal by Subject|57|||
44386664|NCT00988208|79392784|FG000|Overall Study|Death|9|||
44386665|NCT00988208|79392785|FG001|Overall Study|Death|15|||
44386666|NCT00988208|79392784|FG000|Overall Study|Lost to Follow-up|2|||
44386667|NCT00988208|79392785|FG001|Overall Study|Lost to Follow-up|3|||
44386668|NCT00988208|79392784|FG000|Overall Study|Protocol Violation|9|||
44386669|NCT00988208|79392785|FG001|Overall Study|Protocol Violation|2|||
44386670|NCT00988208|79392784|FG000|Overall Study|Sponsor Decision|102|||
44386671|NCT00988208|79392785|FG001|Overall Study|Sponsor Decision|78|||
44386672|NCT00988208|79392784|FG000|Overall Study|Clinical Progression|17|||
44386673|NCT00988208|79392785|FG001|Overall Study|Clinical Progression|16|||
44386674|NCT00988208|79392784|FG000|Overall Study|Biochemical Progression|21|||
44386675|NCT00988208|79392785|FG001|Overall Study|Biochemical Progression|7|||
44386676|NCT00988208|79392784|FG000|Overall Study|Clinical Deterioration|7|||
44386677|NCT00988208|79392785|FG001|Overall Study|Clinical Deterioration|14|||
44386678|NCT00988208|79392784|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
44386679|NCT00988208|79392785|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
44386680|NCT00988208|79392784|FG000|Overall Study|Other|8|||
44386681|NCT00988208|79392785|FG001|Overall Study|Other|3|||
44386682|NCT00990704|79392793|FG000|Overall Study|Adverse Event|1|||
44386683|NCT00990704|79392794|FG001|Overall Study|Adverse Event|1|||
44386684|NCT00990704|79392793|FG000|Overall Study|Physician Decision|0|||
44386685|NCT00990704|79392794|FG001|Overall Study|Physician Decision|1|||
44386686|NCT04089553|79392802|FG000|Overall Study|Death|12|||
44386687|NCT04089553|79392803|FG001|Overall Study|Death|11|||
44386688|NCT04089553|79392802|FG000|Overall Study|Lost to Follow-up|2|||
44386689|NCT04089553|79392803|FG001|Overall Study|Lost to Follow-up|2|||
44386690|NCT04089553|79392802|FG000|Overall Study|Progressive disease|0|||
44386691|NCT04089553|79392803|FG001|Overall Study|Progressive disease|1|||
44386692|NCT04089553|79392802|FG000|Overall Study|Withdrawal by Subject|5|||
44386693|NCT04089553|79392803|FG001|Overall Study|Withdrawal by Subject|2|||
44386694|NCT04089553|79392802|FG000|Overall Study|Other|6|||
44386695|NCT04089553|79392803|FG001|Overall Study|Other|2|||
44386696|NCT00993668|79392812|FG000|Single-Blind Period|Adverse Event|1|||
44386697|NCT00993668|79392813|FG001|Single-Blind Period|Adverse Event|1|||
44386698|NCT00993668|79392812|FG000|Single-Blind Period|Lack of Efficacy|0|||
44386699|NCT00993668|79392813|FG001|Single-Blind Period|Lack of Efficacy|1|||
44386700|NCT00993668|79392812|FG000|Single-Blind Period|Lost to Follow-up|3|||
44518965|NCT03417440|79526764|FG002|Overall Study|Withdrawal by Subject|2|||
44518966|NCT03417440|79526765|FG003|Overall Study|Withdrawal by Subject|1|||
44518967|NCT03417440|79526766|FG004|Overall Study|Withdrawal by Subject|1|||
44386701|NCT00993668|79392813|FG001|Single-Blind Period|Lost to Follow-up|1|||
44386702|NCT00993668|79392812|FG000|Open-Label Period|Adverse Event|9|||
44386703|NCT00993668|79392813|FG001|Open-Label Period|Adverse Event|8|||
44518968|NCT03417440|79526767|FG005|Overall Study|Withdrawal by Subject|0|||
44386704|NCT00993668|79392812|FG000|Open-Label Period|Lack of Efficacy|4|||
44386705|NCT00993668|79392813|FG001|Open-Label Period|Lack of Efficacy|3|||
44386706|NCT00993668|79392812|FG000|Open-Label Period|Withdrawal by Subject|4|||
44386707|NCT00993668|79392813|FG001|Open-Label Period|Withdrawal by Subject|3|||
44386708|NCT00993668|79392812|FG000|Open-Label Period|Lost to Follow-up|6|||
44386709|NCT00993668|79392813|FG001|Open-Label Period|Lost to Follow-up|1|||
44386710|NCT00778102|79392822|FG000|Overall Study|Adverse Event|8|||
44386711|NCT00778102|79392823|FG001|Overall Study|Adverse Event|5|||
44386712|NCT00778102|79392822|FG000|Overall Study|Death|1|||
44386713|NCT00778102|79392823|FG001|Overall Study|Death|1|||
44386714|NCT00778102|79392822|FG000|Overall Study|Lost to Follow-up|1|||
44386715|NCT00778102|79392823|FG001|Overall Study|Lost to Follow-up|0|||
44386716|NCT00778102|79392822|FG000|Overall Study|Violation of Selection Criteria|1|||
44386717|NCT00778102|79392823|FG001|Overall Study|Violation of Selection Criteria|1|||
44386718|NCT00778102|79392822|FG000|Overall Study|Protocol Violation|0|||
44386719|NCT00778102|79392823|FG001|Overall Study|Protocol Violation|1|||
44386720|NCT00778102|79392822|FG000|Overall Study|Refused Treatment|2|||
44386721|NCT00778102|79392823|FG001|Overall Study|Refused Treatment|3|||
44386722|NCT00778102|79392822|FG000|Overall Study|Withdrawal by Subject|1|||
44386723|NCT00778102|79392823|FG001|Overall Study|Withdrawal by Subject|1|||
44386724|NCT00778102|79392822|FG000|Overall Study|Administrative Reason|7|||
44386725|NCT00778102|79392823|FG001|Overall Study|Administrative Reason|10|||
44386726|NCT00756886|79392831|FG000|Overall Study|Lost to Follow-up|1|||
44386727|NCT00756886|79392832|FG001|Overall Study|Lost to Follow-up|0|||
44386728|NCT00756886|79392831|FG000|Overall Study|Adverse Event|0|||
44386729|NCT00756886|79392832|FG001|Overall Study|Adverse Event|3|||
44386730|NCT00756886|79392831|FG000|Overall Study|Lack of Efficacy|1|||
44386731|NCT00756886|79392832|FG001|Overall Study|Lack of Efficacy|0|||
44386732|NCT00756886|79392831|FG000|Overall Study|Ineligible|9|||
44386733|NCT00756886|79392832|FG001|Overall Study|Ineligible|4|||
44386734|NCT00756730|79392840|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
44386735|NCT00756730|79392841|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
44386736|NCT00756730|79392840|FG000|Overall Study|persistent low-level viremmia|0|||
44386737|NCT00756730|79392841|FG001|Overall Study|persistent low-level viremmia|1|||
44386738|NCT00984620|79392849|FG000|Overall Study|Adverse Event|5|||
44386739|NCT00984620|79392850|FG001|Overall Study|Adverse Event|5|||
44386740|NCT00984620|79392849|FG000|Overall Study|Lost to Follow-up|1|||
44386741|NCT00984620|79392850|FG001|Overall Study|Lost to Follow-up|1|||
44386742|NCT00984620|79392849|FG000|Overall Study|Withdrawal by Subject|0|||
44386743|NCT00984620|79392850|FG001|Overall Study|Withdrawal by Subject|2|||
44386744|NCT00984620|79392849|FG000|Overall Study|reason other than listed above|0|||
44386745|NCT00984620|79392850|FG001|Overall Study|reason other than listed above|4|||
44386746|NCT00777946|79392861|FG000|Overall Study|Adverse Event|11|||
44386747|NCT00777946|79392862|FG001|Overall Study|Adverse Event|1|||
44386748|NCT00777946|79392863|FG002|Overall Study|Adverse Event|3|||
44386749|NCT00777946|79392861|FG000|Overall Study|Lack of Efficacy|0|||
44386750|NCT00777946|79392862|FG001|Overall Study|Lack of Efficacy|0|||
44386751|NCT00777946|79392863|FG002|Overall Study|Lack of Efficacy|9|||
44386752|NCT00777946|79392861|FG000|Overall Study|Condition no longer required study drug|1|||
44386753|NCT00777946|79392862|FG001|Overall Study|Condition no longer required study drug|0|||
44386754|NCT00777946|79392863|FG002|Overall Study|Condition no longer required study drug|0|||
44386755|NCT00777946|79392861|FG000|Overall Study|Patient withdrew consent|3|||
44386756|NCT00777946|79392862|FG001|Overall Study|Patient withdrew consent|2|||
44386757|NCT00777946|79392863|FG002|Overall Study|Patient withdrew consent|3|||
44386758|NCT00777946|79392861|FG000|Overall Study|Lost to Follow-up|3|||
44386759|NCT00777946|79392862|FG001|Overall Study|Lost to Follow-up|1|||
44386760|NCT00777946|79392863|FG002|Overall Study|Lost to Follow-up|0|||
44386761|NCT00777946|79392861|FG000|Overall Study|Protocol deviation|2|||
44386762|NCT00777946|79392862|FG001|Overall Study|Protocol deviation|1|||
44386763|NCT00777946|79392863|FG002|Overall Study|Protocol deviation|1|||
44386764|NCT00777946|79392861|FG000|Overall Study|Randomized in error|1|||
44386765|NCT00777946|79392862|FG001|Overall Study|Randomized in error|1|||
44386766|NCT00777946|79392863|FG002|Overall Study|Randomized in error|0|||
44518969|NCT03417440|79526768|FG006|Overall Study|Withdrawal by Subject|0|||
44386767|NCT00990314|79392871|FG000|Overall Study|Death|2|||
44518970|NCT03417440|79526769|FG007|Overall Study|Withdrawal by Subject|1|||
44518971|NCT03458702|79526792|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
44518972|NCT03458702|79526793|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
44518973|NCT03458702|79526792|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
44518974|NCT03458702|79526793|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
44518975|NCT03454412|79526799|FG000|Baseline Assesment|Physician Decision|12|||
44386768|NCT00990314|79392871|FG000|Overall Study|Adverse Event|2|||
44386769|NCT00990314|79392871|FG000|Overall Study|Withdrawal by Subject|3|||
44386770|NCT00990314|79392871|FG000|Overall Study|Non-Compliance|1|||
44386771|NCT00990314|79392871|FG000|Overall Study|Physician Decision|3|||
44251566|NCT02640612|79087095|FG002|Overall Study|Adverse Event|2|||
44386772|NCT00990314|79392871|FG000|Overall Study|Lack of Efficacy|1|||
44386773|NCT00756652|79392877|FG000|Original Phase|Withdrawal by Subject|864|||
44386774|NCT00756652|79392878|FG001|Original Phase|Withdrawal by Subject|23|||
44386775|NCT00756652|79392877|FG000|Original Phase|Lost to Follow-up|601|||
44386776|NCT00756652|79392878|FG001|Original Phase|Lost to Follow-up|0|||
44386777|NCT00756652|79392877|FG000|Original Phase|Other Discontinuation|797|||
44386778|NCT00756652|79392878|FG001|Original Phase|Other Discontinuation|5|||
44386779|NCT00756652|79392877|FG000|Original Phase|Participant Noncompliance|18622|||
44386780|NCT00756652|79392878|FG001|Original Phase|Participant Noncompliance|424|||
44386781|NCT00756652|79392877|FG000|Original Phase|Unknown Discontinuation Reason|2|||
44386782|NCT00756652|79392878|FG001|Original Phase|Unknown Discontinuation Reason|0|||
44386783|NCT00756652|79392877|FG000|Original Phase|Participants without data|3259|||
44386784|NCT00756652|79392878|FG001|Original Phase|Participants without data|466|||
44386785|NCT00756652|79392877|FG000|Original Phase|Death|168|||
44386786|NCT00756652|79392878|FG001|Original Phase|Death|1|||
44386787|NCT00756652|79392877|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
44386788|NCT00756652|79392878|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
44386789|NCT00756652|79392877|FG000|Re-Op Phase|Withdrawal by Subject|62|||
44386790|NCT00756652|79392878|FG001|Re-Op Phase|Withdrawal by Subject|0|||
44386791|NCT00756652|79392877|FG000|Re-Op Phase|Death|6|||
44386792|NCT00756652|79392878|FG001|Re-Op Phase|Death|0|||
44386793|NCT00756652|79392877|FG000|Re-Op Phase|Lost to Follow-up|340|||
44386794|NCT00756652|79392878|FG001|Re-Op Phase|Lost to Follow-up|0|||
44386795|NCT00756652|79392877|FG000|Re-Op Phase|Site Closed|2454|||
44386796|NCT00756652|79392878|FG001|Re-Op Phase|Site Closed|0|||
44386797|NCT00756652|79392877|FG000|Re-Op Phase|Withdrawn after explant|14|||
44386798|NCT00756652|79392878|FG001|Re-Op Phase|Withdrawn after explant|0|||
44386799|NCT00777556|79392882|FG000|Overall Study|Inappropriate self-selection|34|||
44386800|NCT00777556|79392882|FG000|Overall Study|Dispensed but did not use product|12|||
44386801|NCT00777556|79392882|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
44386802|NCT00602979|79392891|FG000|Overall Study|Lost to Follow-up|3|||
44386803|NCT00602979|79392892|FG001|Overall Study|Lost to Follow-up|2|||
44386804|NCT00602979|79392893|FG002|Overall Study|Lost to Follow-up|3|||
44386805|NCT00602979|79392894|FG003|Overall Study|Lost to Follow-up|2|||
44386806|NCT00602979|79392895|FG004|Overall Study|Lost to Follow-up|3|||
44386807|NCT00602979|79392891|FG000|Overall Study|Failed Intubation|0|||
44386808|NCT00602979|79392892|FG001|Overall Study|Failed Intubation|1|||
44386809|NCT00602979|79392893|FG002|Overall Study|Failed Intubation|0|||
44386810|NCT00602979|79392894|FG003|Overall Study|Failed Intubation|1|||
44386811|NCT00602979|79392895|FG004|Overall Study|Failed Intubation|0|||
44386812|NCT04081363|79392909|FG000|Overall Study|Withdrawal by Subject|1|||
44386813|NCT04081363|79392910|FG001|Overall Study|Withdrawal by Subject|0|||
44386814|NCT00777088|79392925|FG000|Overall Study|PED Treatment not attempted|1|||
44386815|NCT00763282|79392941|FG000|Overall Study|Withdrawal by Subject|6|||
44386816|NCT00763282|79392942|FG001|Overall Study|Withdrawal by Subject|5|||
44386817|NCT00763282|79392941|FG000|Overall Study|Death|4|||
44386818|NCT00763282|79392942|FG001|Overall Study|Death|3|||
44386819|NCT00763282|79392941|FG000|Overall Study|Lost to Follow-up|22|||
44386820|NCT00763282|79392942|FG001|Overall Study|Lost to Follow-up|26|||
44386821|NCT00988598|79392952|FG000|Overall Study|Withdrawal by Subject|2|||
44386822|NCT00988598|79392953|FG001|Overall Study|Withdrawal by Subject|0|||
44386823|NCT00979628|79392962|FG000|Overall Study|received regimen < 24 hours|7|||
44386824|NCT00979628|79392963|FG001|Overall Study|received regimen < 24 hours|6|||
44386825|NCT00979628|79392964|FG002|Overall Study|received regimen < 24 hours|5|||
44386826|NCT00979628|79392962|FG000|Overall Study|received steroids|1|||
44386827|NCT00979628|79392963|FG001|Overall Study|received steroids|1|||
44386828|NCT00979628|79392964|FG002|Overall Study|received steroids|0|||
44386829|NCT00979628|79392962|FG000|Overall Study|transferred to ICU|1|||
44386830|NCT00979628|79392963|FG001|Overall Study|transferred to ICU|2|||
44386831|NCT00979628|79392964|FG002|Overall Study|transferred to ICU|1|||
44386832|NCT00762970|79392978|FG000|Overall Study|Withdrawal by Subject|7|||
44386833|NCT00762970|79392979|FG001|Overall Study|Withdrawal by Subject|4|||
44386834|NCT00762970|79392980|FG002|Overall Study|Withdrawal by Subject|0|||
44386835|NCT00762970|79392978|FG000|Overall Study|Protocol Violation|3|||
44386836|NCT00762970|79392979|FG001|Overall Study|Protocol Violation|1|||
44518976|NCT03452540|79526803|FG000|Overall Study|Adverse Event|1|||
44518977|NCT03452540|79526803|FG000|Overall Study|Withdrawal by Subject|1|||
44518978|NCT03452540|79526803|FG000|Overall Study|Other SAE and AE|2|||
44518979|NCT03573336|79526810|FG000|Overall Study|Study terminated|2|||
44518980|NCT03573336|79526811|FG001|Overall Study|Study terminated|4|||
44518981|NCT03573336|79526812|FG002|Overall Study|Study terminated|2|||
44518982|NCT03500198|79526822|FG000|Overall Study|Lost to Follow-up|0|||
44518983|NCT03500198|79526823|FG001|Overall Study|Lost to Follow-up|1|||
44518984|NCT03553758|79526831|FG000|Overall Study|Lost to Follow-up|1|||
44386837|NCT00762970|79392980|FG002|Overall Study|Protocol Violation|1|||
44386838|NCT00762970|79392978|FG000|Overall Study|Lost to Follow-up|1|||
44386839|NCT00762970|79392979|FG001|Overall Study|Lost to Follow-up|2|||
44386840|NCT00762970|79392980|FG002|Overall Study|Lost to Follow-up|0|||
44386841|NCT00762970|79392978|FG000|Overall Study|Difficulty of handling lens|1|||
44386842|NCT00762970|79392979|FG001|Overall Study|Difficulty of handling lens|2|||
44518985|NCT03552198|79526841|FG000|Overall Study|Lost to Follow-up|42|||
44518986|NCT03552198|79526842|FG001|Overall Study|Lost to Follow-up|48|||
44518987|NCT03552198|79526843|FG002|Overall Study|Lost to Follow-up|15|||
44386843|NCT00762970|79392980|FG002|Overall Study|Difficulty of handling lens|0|||
44386844|NCT00988442|79392990|FG000|Overall Study|Death|1|||
44386845|NCT00988442|79392991|FG001|Overall Study|Death|2|||
44251567|NCT02640612|79087093|FG000|Overall Study|Death|1|||
44280361|NCT01985334|79241397|FG001|Overall Study|Adverse Event|8|||
44280362|NCT01985334|79241398|FG002|Overall Study|Adverse Event|2|||
44280363|NCT01985334|79241399|FG003|Overall Study|Adverse Event|26|||
44280364|NCT01985334|79241400|FG004|Overall Study|Adverse Event|3|||
44280365|NCT01985334|79241401|FG005|Overall Study|Adverse Event|18|||
44280366|NCT01985334|79241402|FG006|Overall Study|Adverse Event|3|||
44280367|NCT01985334|79241403|FG007|Overall Study|Adverse Event|15|||
44280368|NCT01985334|79241396|FG000|Overall Study|Other|4|||
44280369|NCT01985334|79241397|FG001|Overall Study|Other|2|||
44280370|NCT01985334|79241398|FG002|Overall Study|Other|3|||
44280371|NCT01985334|79241399|FG003|Overall Study|Other|10|||
44280372|NCT01985334|79241400|FG004|Overall Study|Other|1|||
44280373|NCT01985334|79241401|FG005|Overall Study|Other|6|||
44280374|NCT01985334|79241402|FG006|Overall Study|Other|2|||
44280375|NCT01985334|79241403|FG007|Overall Study|Other|2|||
44251568|NCT02640612|79087094|FG001|Overall Study|Death|0|||
44251569|NCT02640612|79087095|FG002|Overall Study|Death|0|||
44251570|NCT02640612|79087093|FG000|Overall Study|Withdrawal by Subject|10|||
44251571|NCT02640612|79087094|FG001|Overall Study|Withdrawal by Subject|3|||
44280376|NCT01985334|79241396|FG000|Overall Study|Medication non-compliance|0|||
44280377|NCT01985334|79241397|FG001|Overall Study|Medication non-compliance|4|||
44280378|NCT01985334|79241398|FG002|Overall Study|Medication non-compliance|1|||
44280379|NCT01985334|79241399|FG003|Overall Study|Medication non-compliance|6|||
44280380|NCT01985334|79241400|FG004|Overall Study|Medication non-compliance|2|||
44280381|NCT01985334|79241401|FG005|Overall Study|Medication non-compliance|3|||
44280382|NCT01985334|79241402|FG006|Overall Study|Medication non-compliance|1|||
44280383|NCT01985334|79241403|FG007|Overall Study|Medication non-compliance|3|||
44280384|NCT01985334|79241396|FG000|Overall Study|Use of prohibited treatment|1|||
44280385|NCT01985334|79241397|FG001|Overall Study|Use of prohibited treatment|4|||
44280386|NCT01985334|79241398|FG002|Overall Study|Use of prohibited treatment|1|||
44280387|NCT01985334|79241399|FG003|Overall Study|Use of prohibited treatment|2|||
44280388|NCT01985334|79241400|FG004|Overall Study|Use of prohibited treatment|1|||
44280389|NCT01985334|79241401|FG005|Overall Study|Use of prohibited treatment|6|||
44280390|NCT01985334|79241402|FG006|Overall Study|Use of prohibited treatment|2|||
44280391|NCT01985334|79241403|FG007|Overall Study|Use of prohibited treatment|0|||
44280392|NCT01985334|79241396|FG000|Overall Study|Investigator decision|0|||
44518988|NCT03552198|79526844|FG003|Overall Study|Lost to Follow-up|19|||
44251572|NCT02640612|79087095|FG002|Overall Study|Withdrawal by Subject|3|||
44251573|NCT02640612|79087093|FG000|Overall Study|Lost to Follow-up|4|||
44251574|NCT02640612|79087094|FG001|Overall Study|Lost to Follow-up|1|||
44251575|NCT02640612|79087095|FG002|Overall Study|Lost to Follow-up|1|||
44251576|NCT02640612|79087093|FG000|Overall Study|Protocol Violation|0|||
44251577|NCT02640612|79087094|FG001|Overall Study|Protocol Violation|2|||
44251578|NCT02640612|79087095|FG002|Overall Study|Protocol Violation|0|||
44251579|NCT02640612|79087093|FG000|Overall Study|Lack of Efficacy|1|||
44251580|NCT02640612|79087094|FG001|Overall Study|Lack of Efficacy|1|||
44251581|NCT02640612|79087095|FG002|Overall Study|Lack of Efficacy|0|||
44251582|NCT00639769|79087103|FG000|Overall Study|Death|2|||
44251583|NCT00639769|79087103|FG000|Overall Study|Adverse Event|7|||
44251584|NCT00639769|79087103|FG000|Overall Study|Lack of Efficacy|1|||
44280393|NCT01985334|79241397|FG001|Overall Study|Investigator decision|3|||
44280394|NCT01985334|79241398|FG002|Overall Study|Investigator decision|0|||
44280395|NCT01985334|79241399|FG003|Overall Study|Investigator decision|7|||
44280396|NCT01985334|79241400|FG004|Overall Study|Investigator decision|1|||
44518989|NCT03552198|79526841|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
44518990|NCT03552198|79526842|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
44518991|NCT03552198|79526843|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
44518992|NCT03552198|79526844|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
44518993|NCT03552198|79526841|FG000|Overall Study|Did not receive air alerts|1|||
44518994|NCT03552198|79526842|FG001|Overall Study|Did not receive air alerts|0|||
44518995|NCT03552198|79526843|FG002|Overall Study|Did not receive air alerts|0|||
44518996|NCT03552198|79526844|FG003|Overall Study|Did not receive air alerts|1|||
44518997|NCT02954354|79526857|FG000|Overall Study|Adverse Event|2|||
44518998|NCT02954354|79526858|FG001|Overall Study|Adverse Event|2|||
44518999|NCT02954354|79526859|FG002|Overall Study|Adverse Event|4|||
44519000|NCT02954354|79526857|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
44519001|NCT02954354|79526858|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
44519002|NCT02954354|79526859|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
44251585|NCT00639769|79087103|FG000|Overall Study|Disease progression|26|||
44251586|NCT00639769|79087103|FG000|Overall Study|Withdrawal by Subject|4|||
44251587|NCT00639457|79087109|FG000|Overall Study|Withdrawal by Subject|2|||
44280397|NCT01985334|79241401|FG005|Overall Study|Investigator decision|1|||
44386846|NCT00988442|79392990|FG000|Overall Study|Lost to Follow-up|0|||
44251588|NCT00639457|79087110|FG001|Overall Study|Withdrawal by Subject|3|||
44519003|NCT02954354|79526857|FG000|Overall Study|Lack of Efficacy|0|||
44280398|NCT01985334|79241402|FG006|Overall Study|Investigator decision|0|||
44280399|NCT01985334|79241403|FG007|Overall Study|Investigator decision|4|||
44386847|NCT00988442|79392991|FG001|Overall Study|Lost to Follow-up|1|||
44386848|NCT00988442|79392990|FG000|Overall Study|Early Study Closure|29|||
44386849|NCT00988442|79392991|FG001|Overall Study|Early Study Closure|25|||
44386850|NCT00992186|79393000|FG000|Overall Study|Withdrawal by Subject|2|||
44386851|NCT00992186|79393000|FG000|Overall Study|Protocol Violation|1|||
44386852|NCT00992186|79393000|FG000|Overall Study|Physician Decision|1|||
44386853|NCT00992186|79393000|FG000|Overall Study|Adverse Event|9|||
44386854|NCT00992186|79393000|FG000|Overall Study|Progressive Disease|30|||
44386855|NCT00992186|79393000|FG000|Overall Study|Refusal To Receive Study Agent|3|||
44386856|NCT00992108|79393007|FG000|Overall Study|Lost to Follow-up|0|||
44386857|NCT00992108|79393008|FG001|Overall Study|Lost to Follow-up|1|||
44386858|NCT00752986|79393017|FG000|Overall Study|Withdrawal by Subject|2|||
44386859|NCT00752986|79393018|FG001|Overall Study|Withdrawal by Subject|1|||
44386860|NCT00752986|79393019|FG002|Overall Study|Withdrawal by Subject|2|||
44386861|NCT00752986|79393017|FG000|Overall Study|Protocol Violation|3|||
44386862|NCT00752986|79393018|FG001|Overall Study|Protocol Violation|0|||
44386863|NCT00752986|79393019|FG002|Overall Study|Protocol Violation|0|||
44386864|NCT00762892|79393029|FG000|Overall Study|Lost to Follow-up|2|||
44386865|NCT00762892|79393030|FG001|Overall Study|Lost to Follow-up|5|||
44386866|NCT00762892|79393029|FG000|Overall Study|Withdrawal by Subject|0|||
44386867|NCT00762892|79393030|FG001|Overall Study|Withdrawal by Subject|1|||
44386868|NCT00762892|79393029|FG000|Overall Study|Death|1|||
44386869|NCT00762892|79393030|FG001|Overall Study|Death|0|||
44386870|NCT00762892|79393029|FG000|Overall Study|Pregnancy|1|||
44386871|NCT00762892|79393030|FG001|Overall Study|Pregnancy|0|||
44386872|NCT00762892|79393029|FG000|Overall Study|Incarceration|1|||
44386873|NCT00762892|79393030|FG001|Overall Study|Incarceration|0|||
44386874|NCT00755716|79393039|FG000|Overall Study|Adverse Event|1|||
44386875|NCT00755716|79393040|FG001|Overall Study|Adverse Event|4|||
44386876|NCT00755716|79393041|FG002|Overall Study|Adverse Event|1|||
44386877|NCT00755716|79393039|FG000|Overall Study|Lack of Efficacy|2|||
44386878|NCT00755716|79393040|FG001|Overall Study|Lack of Efficacy|0|||
44386879|NCT00755716|79393041|FG002|Overall Study|Lack of Efficacy|0|||
44386880|NCT00755716|79393039|FG000|Overall Study|Lost to Follow-up|5|||
44386881|NCT00755716|79393040|FG001|Overall Study|Lost to Follow-up|3|||
44386882|NCT00755716|79393041|FG002|Overall Study|Lost to Follow-up|1|||
44386883|NCT00755716|79393039|FG000|Overall Study|work schedule issues|0|||
44386884|NCT00755716|79393040|FG001|Overall Study|work schedule issues|1|||
44386885|NCT00755716|79393041|FG002|Overall Study|work schedule issues|1|||
44386886|NCT00755326|79393051|FG000|Overall Study|Lost to Follow-up|2|||
44386887|NCT00755326|79393052|FG001|Overall Study|Lost to Follow-up|3|||
44386888|NCT03084471|79393059|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
44386889|NCT03084471|79393059|FG000|Overall Study|Condition under investigation worsened|84|||
44386890|NCT03084471|79393059|FG000|Overall Study|Lack of therapeutic response|2|||
44386891|NCT03084471|79393059|FG000|Overall Study|Protocol Violation|1|||
44386892|NCT03084471|79393059|FG000|Overall Study|Adverse Event|73|||
44386893|NCT03084471|79393059|FG000|Overall Study|Withdrawal by Subject|12|||
44386894|NCT03084471|79393059|FG000|Overall Study|Disease relapse|181|||
44386895|NCT03084471|79393059|FG000|Overall Study|Subjective disease progression|359|||
44386896|NCT03084471|79393059|FG000|Overall Study|Other (as recorded)|33|||
44386897|NCT03084471|79393059|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
44386898|NCT00754936|79393066|FG000|Overall Study|Lost to Follow-up|3|||
44386899|NCT00754936|79393066|FG000|Overall Study|Physician Decision|1|||
44386900|NCT00754936|79393066|FG000|Overall Study|Withdrawal by Subject|2|||
44386901|NCT00754936|79393066|FG000|Overall Study|Side Effects|3|||
44386902|NCT00754936|79393066|FG000|Overall Study|Inter-current medical events|3|||
44386903|NCT00762502|79393073|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
44386904|NCT00762502|79393074|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
44386905|NCT00762502|79393075|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
44386906|NCT00762502|79393073|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
44386907|NCT00762502|79393074|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
44386908|NCT00762502|79393075|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
44386909|NCT00762502|79393073|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
44386910|NCT00762502|79393074|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
44386911|NCT00762502|79393075|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
44386912|NCT00762268|79393083|FG000|Overall Study|Withdrawal by Subject|3|||
44386913|NCT00762268|79393084|FG001|Overall Study|Withdrawal by Subject|3|||
44386914|NCT00975884|79393092|FG000|Overall Study|Adverse Event|1|||
44386915|NCT00975884|79393093|FG001|Overall Study|Adverse Event|0|||
44386916|NCT00975884|79393092|FG000|Overall Study|Lost to Follow-up|5|||
44386917|NCT00975884|79393093|FG001|Overall Study|Lost to Follow-up|3|||
44386918|NCT00975884|79393092|FG000|Overall Study|Withdrawal by Subject|9|||
44386919|NCT00975884|79393093|FG001|Overall Study|Withdrawal by Subject|9|||
44386920|NCT00975884|79393092|FG000|Overall Study|Other|1|||
44519004|NCT02954354|79526858|FG001|Overall Study|Lack of Efficacy|2|||
44386921|NCT00975884|79393093|FG001|Overall Study|Other|3|||
44386922|NCT00578227|79393112|FG000|Overall Study|Lost to Follow-up|0|||
44386923|NCT00578227|79393113|FG001|Overall Study|Lost to Follow-up|1|||
44386924|NCT00578227|79393114|FG002|Overall Study|Lost to Follow-up|1|||
44386925|NCT00578227|79393112|FG000|Overall Study|Withdrawal by Subject|5|||
44386926|NCT00578227|79393113|FG001|Overall Study|Withdrawal by Subject|1|||
44386927|NCT00578227|79393114|FG002|Overall Study|Withdrawal by Subject|3|||
44386928|NCT00978380|79393124|FG000|Overall Study|Protocol Violation|2|||
44386929|NCT00978380|79393124|FG000|Overall Study|Withdrawal criteria|9|||
44386930|NCT00978380|79393124|FG000|Overall Study|Unclassified|8|||
44386931|NCT00577993|79393132|FG000|Overall Study|Adverse Event|1|||
44386932|NCT00577993|79393133|FG001|Overall Study|Adverse Event|0|||
44386933|NCT00577993|79393134|FG002|Overall Study|Adverse Event|0|||
44386934|NCT00577993|79393132|FG000|Overall Study|Death|0|||
44386935|NCT00577993|79393133|FG001|Overall Study|Death|1|||
44386936|NCT00577993|79393134|FG002|Overall Study|Death|1|||
44386937|NCT00577993|79393132|FG000|Overall Study|Lack of Efficacy|0|||
44386938|NCT00577993|79393133|FG001|Overall Study|Lack of Efficacy|1|||
44386939|NCT00577993|79393134|FG002|Overall Study|Lack of Efficacy|0|||
44519005|NCT02954354|79526859|FG002|Overall Study|Lack of Efficacy|0|||
44386940|NCT00577993|79393132|FG000|Overall Study|Protocol Violation|2|||
44386941|NCT00577993|79393133|FG001|Overall Study|Protocol Violation|3|||
44386942|NCT00577993|79393134|FG002|Overall Study|Protocol Violation|0|||
44386943|NCT00577993|79393132|FG000|Overall Study|Withdrawal by Subject|1|||
44386944|NCT00577993|79393133|FG001|Overall Study|Withdrawal by Subject|0|||
44386945|NCT00577993|79393134|FG002|Overall Study|Withdrawal by Subject|2|||
44386946|NCT00577993|79393132|FG000|Overall Study|Conversion|2|||
44386947|NCT00577993|79393133|FG001|Overall Study|Conversion|5|||
44386948|NCT00577993|79393134|FG002|Overall Study|Conversion|0|||
44386949|NCT00577993|79393132|FG000|Overall Study|Uninsured|1|||
44386950|NCT00577993|79393133|FG001|Overall Study|Uninsured|0|||
44386951|NCT00577993|79393134|FG002|Overall Study|Uninsured|0|||
44386952|NCT00975806|79393143|FG000|Overall Study|Adverse Event|2|||
44386953|NCT00975806|79393144|FG001|Overall Study|Adverse Event|1|||
44386954|NCT00975806|79393145|FG002|Overall Study|Adverse Event|2|||
44386955|NCT00975806|79393143|FG000|Overall Study|Disease Progression|1|||
44386956|NCT00975806|79393144|FG001|Overall Study|Disease Progression|5|||
44386957|NCT00975806|79393145|FG002|Overall Study|Disease Progression|1|||
44386958|NCT00975806|79393143|FG000|Overall Study|Withdrawal by Subject|1|||
44386959|NCT00975806|79393144|FG001|Overall Study|Withdrawal by Subject|0|||
44386960|NCT00975806|79393145|FG002|Overall Study|Withdrawal by Subject|0|||
44386961|NCT00975806|79393143|FG000|Overall Study|Death|0|||
44386962|NCT00975806|79393144|FG001|Overall Study|Death|1|||
44386963|NCT00975806|79393145|FG002|Overall Study|Death|0|||
44386964|NCT00975806|79393143|FG000|Overall Study|Physician decision and disease related|1|||
44386965|NCT00975806|79393144|FG001|Overall Study|Physician decision and disease related|0|||
44386966|NCT00975806|79393145|FG002|Overall Study|Physician decision and disease related|1|||
44386967|NCT00978068|79393157|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
44386968|NCT00978068|79393158|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
44386969|NCT00978068|79393157|FG000|Overall Study|Death|1|||
44519006|NCT02954354|79526857|FG000|Overall Study|Withdrawal by Subject|17|||
44519007|NCT02954354|79526858|FG001|Overall Study|Withdrawal by Subject|9|||
44519008|NCT02954354|79526859|FG002|Overall Study|Withdrawal by Subject|11|||
44519009|NCT02954354|79526857|FG000|Overall Study|Lost to Follow-up|12|||
44519010|NCT02954354|79526858|FG001|Overall Study|Lost to Follow-up|5|||
44519011|NCT02954354|79526859|FG002|Overall Study|Lost to Follow-up|0|||
44519012|NCT02954354|79526857|FG000|Overall Study|Miscellaneous|2|||
44386970|NCT00978068|79393158|FG001|Overall Study|Death|2|||
44386971|NCT00978068|79393157|FG000|Overall Study|Lost to Follow-up|1|||
44519013|NCT02954354|79526858|FG001|Overall Study|Miscellaneous|2|||
44519014|NCT02954354|79526859|FG002|Overall Study|Miscellaneous|1|||
44519015|NCT03519516|79526871|FG000|Overall Study|Adverse Event|0|||
44519016|NCT03519516|79526872|FG001|Overall Study|Adverse Event|1|||
44519017|NCT03519204|79526880|FG000|Overall Study|Lost to Follow-up|3|||
44519018|NCT03519204|79526881|FG001|Overall Study|Lost to Follow-up|8|||
44519019|NCT03519204|79526880|FG000|Overall Study|Withdrawal by Subject|9|||
44519020|NCT03519204|79526881|FG001|Overall Study|Withdrawal by Subject|7|||
44386972|NCT00978068|79393158|FG001|Overall Study|Lost to Follow-up|2|||
44386973|NCT00978068|79393157|FG000|Overall Study|Physician Decision|0|||
44386974|NCT00978068|79393158|FG001|Overall Study|Physician Decision|1|||
44386975|NCT00978068|79393157|FG000|Overall Study|Unable to Comply with Study|0|||
44386976|NCT00978068|79393158|FG001|Overall Study|Unable to Comply with Study|2|||
44386977|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
44386978|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
44386979|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
44519021|NCT03519204|79526880|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44519022|NCT03519204|79526881|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44519023|NCT03518658|79526893|FG000|Overall Study|Other|51|||
44519024|NCT03518658|79526894|FG001|Overall Study|Other|0|||
44519025|NCT03518112|79526902|FG000|Overall Study|Withdrawal by Subject|1|||
44386980|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
44386981|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44386982|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44386983|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
44386984|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
44386985|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
44386986|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
44386987|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
44386988|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44386989|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
44386990|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
44386991|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44386992|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
44386993|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
44386994|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
44386995|NCT00603525|79393170|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
44386996|NCT00603525|79393171|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
44386997|NCT00603525|79393172|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
44386998|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
44386999|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
44387000|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
44387001|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
44387002|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
44387003|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
44387004|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
44387005|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
44387006|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
44387007|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
44387008|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
44387009|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
44387010|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
44387011|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
44519026|NCT03517566|79526911|FG000|Overall Study|Adverse Event|5|||
44519027|NCT03517566|79526912|FG001|Overall Study|Adverse Event|2|||
44519028|NCT03517566|79526913|FG002|Overall Study|Adverse Event|2|||
44519029|NCT03517566|79526914|FG003|Overall Study|Adverse Event|8|||
44519030|NCT03517566|79526915|FG004|Overall Study|Adverse Event|7|||
44519031|NCT03517566|79526911|FG000|Overall Study|Lack of Efficacy|3|||
44519032|NCT03517566|79526912|FG001|Overall Study|Lack of Efficacy|2|||
44519033|NCT03517566|79526913|FG002|Overall Study|Lack of Efficacy|1|||
44519034|NCT03517566|79526914|FG003|Overall Study|Lack of Efficacy|1|||
44519035|NCT03517566|79526915|FG004|Overall Study|Lack of Efficacy|4|||
44519036|NCT03517566|79526911|FG000|Overall Study|Lost to Follow-up|3|||
44519037|NCT03517566|79526912|FG001|Overall Study|Lost to Follow-up|1|||
44519038|NCT03517566|79526913|FG002|Overall Study|Lost to Follow-up|1|||
44519039|NCT03517566|79526914|FG003|Overall Study|Lost to Follow-up|1|||
44280400|NCT01985334|79241396|FG000|Overall Study|Lost to Follow-up|0|||
44280401|NCT01985334|79241397|FG001|Overall Study|Lost to Follow-up|2|||
44280402|NCT01985334|79241398|FG002|Overall Study|Lost to Follow-up|0|||
44519040|NCT03517566|79526915|FG004|Overall Study|Lost to Follow-up|0|||
44519041|NCT03517566|79526911|FG000|Overall Study|Physician Decision|1|||
44519042|NCT03517566|79526912|FG001|Overall Study|Physician Decision|1|||
44519043|NCT03517566|79526913|FG002|Overall Study|Physician Decision|0|||
44519044|NCT03517566|79526914|FG003|Overall Study|Physician Decision|1|||
44519045|NCT03517566|79526915|FG004|Overall Study|Physician Decision|0|||
44519046|NCT03517566|79526911|FG000|Overall Study|Pregnancy|0|||
44519047|NCT03517566|79526912|FG001|Overall Study|Pregnancy|1|||
44519048|NCT03517566|79526913|FG002|Overall Study|Pregnancy|0|||
44519049|NCT03517566|79526914|FG003|Overall Study|Pregnancy|0|||
44519050|NCT03517566|79526915|FG004|Overall Study|Pregnancy|0|||
44519051|NCT03517566|79526911|FG000|Overall Study|Protocol Deviation|0|||
44519052|NCT03517566|79526912|FG001|Overall Study|Protocol Deviation|1|||
44519053|NCT03517566|79526913|FG002|Overall Study|Protocol Deviation|0|||
44519054|NCT03517566|79526914|FG003|Overall Study|Protocol Deviation|1|||
44519055|NCT03517566|79526915|FG004|Overall Study|Protocol Deviation|1|||
44519056|NCT03517566|79526911|FG000|Overall Study|Study terminated by Sponsor|11|||
44519057|NCT03517566|79526912|FG001|Overall Study|Study terminated by Sponsor|5|||
44519058|NCT03517566|79526913|FG002|Overall Study|Study terminated by Sponsor|6|||
44519059|NCT03517566|79526914|FG003|Overall Study|Study terminated by Sponsor|14|||
44519060|NCT03517566|79526915|FG004|Overall Study|Study terminated by Sponsor|12|||
44519061|NCT03517566|79526911|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
44519062|NCT03517566|79526912|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
44519063|NCT03517566|79526913|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
44519064|NCT03517566|79526914|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
44280403|NCT01985334|79241399|FG003|Overall Study|Lost to Follow-up|3|||
44519065|NCT03517566|79526915|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
44251589|NCT00639379|79087116|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
44251590|NCT00639379|79087117|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
44251591|NCT00639379|79087116|FG000|Period 1 - 2 Weeks|lens issue|3|||
44251592|NCT00639379|79087117|FG001|Period 1 - 2 Weeks|lens issue|0|||
44251593|NCT00639223|79087125|FG000|Overall Study|Lost to Follow-up|0|||
44251594|NCT00639223|79087126|FG001|Overall Study|Lost to Follow-up|2|||
44251595|NCT00638989|79087135|FG000|Overall Study|Lost to Follow-up|0|||
44251596|NCT00638989|79087136|FG001|Overall Study|Lost to Follow-up|0|||
44251597|NCT00638989|79087137|FG002|Overall Study|Lost to Follow-up|1|||
44251598|NCT00637273|79087158|FG000|Overall Study|Adverse Event|11|||
44251599|NCT00637273|79087159|FG001|Overall Study|Adverse Event|5|||
44251600|NCT00637273|79087160|FG002|Overall Study|Adverse Event|7|||
44251601|NCT00637273|79087158|FG000|Overall Study|Lost to Follow-up|8|||
44251602|NCT00637273|79087159|FG001|Overall Study|Lost to Follow-up|9|||
44251603|NCT00637273|79087160|FG002|Overall Study|Lost to Follow-up|13|||
44251604|NCT00637273|79087158|FG000|Overall Study|Protocol Violation|2|||
44387012|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
44387013|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
44387014|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
44387015|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
44387016|NCT00603525|79393170|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
44387017|NCT00603525|79393171|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
44387018|NCT00603525|79393172|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
44387019|NCT00603525|79393170|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
44387020|NCT00603525|79393171|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
44387021|NCT00603525|79393172|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
44387022|NCT00762034|79393185|FG000|Induction Period|Protocol Violation|1|||
44387023|NCT00762034|79393186|FG001|Induction Period|Protocol Violation|2|||
44387024|NCT00762034|79393185|FG000|Induction Period|Entry Criterion Not Met|12|||
44387025|NCT00762034|79393186|FG001|Induction Period|Entry Criterion Not Met|11|||
44387026|NCT00762034|79393185|FG000|Induction Period|Adverse Event|27|||
44387027|NCT00762034|79393186|FG001|Induction Period|Adverse Event|38|||
44387028|NCT00762034|79393185|FG000|Induction Period|Lost to Follow-up|1|||
44387029|NCT00762034|79393186|FG001|Induction Period|Lost to Follow-up|1|||
44387030|NCT00762034|79393185|FG000|Induction Period|Progressive Disease|73|||
44387031|NCT00762034|79393186|FG001|Induction Period|Progressive Disease|55|||
44387032|NCT00762034|79393185|FG000|Induction Period|Physician Decision|21|||
44387033|NCT00762034|79393186|FG001|Induction Period|Physician Decision|20|||
44387034|NCT00762034|79393185|FG000|Induction Period|Withdrawal by Subject|15|||
44387035|NCT00762034|79393186|FG001|Induction Period|Withdrawal by Subject|19|||
44387036|NCT00762034|79393185|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
44387037|NCT00762034|79393186|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
44387038|NCT00762034|79393185|FG000|Induction Period|Deaths Due to Study Disease|9|||
44387039|NCT00762034|79393186|FG001|Induction Period|Deaths Due to Study Disease|9|||
44387040|NCT00762034|79393185|FG000|Maintenance Period|Protocol Violation|1|||
44519066|NCT03916744|79526931|FG000|Overall Study|Withdrawal by Subject|0|||
44519067|NCT03916744|79526932|FG001|Overall Study|Withdrawal by Subject|1|||
44519068|NCT03916744|79526933|FG002|Overall Study|Withdrawal by Subject|2|||
44519069|NCT03639610|79526948|FG000|Overall Study|Adverse Event|7|||
44519070|NCT03639610|79526949|FG001|Overall Study|Adverse Event|1|||
44519071|NCT03639610|79526950|FG002|Overall Study|Adverse Event|0|||
44519072|NCT03639610|79526948|FG000|Overall Study|Physician Decision|3|||
44519073|NCT03639610|79526949|FG001|Overall Study|Physician Decision|1|||
44519074|NCT03639610|79526950|FG002|Overall Study|Physician Decision|0|||
44519075|NCT03639610|79526948|FG000|Overall Study|Disease progression|8|||
44519076|NCT03639610|79526949|FG001|Overall Study|Disease progression|5|||
44519077|NCT03639610|79526950|FG002|Overall Study|Disease progression|3|||
44251605|NCT00637273|79087159|FG001|Overall Study|Protocol Violation|4|||
44251606|NCT00637273|79087160|FG002|Overall Study|Protocol Violation|1|||
44251607|NCT00637273|79087158|FG000|Overall Study|Withdrawal of Consent|18|||
44251608|NCT00637273|79087159|FG001|Overall Study|Withdrawal of Consent|6|||
44387041|NCT00762034|79393186|FG001|Maintenance Period|Protocol Violation|3|||
44387042|NCT00762034|79393185|FG000|Maintenance Period|Entry Criterion Not Met|0|||
44387043|NCT00762034|79393186|FG001|Maintenance Period|Entry Criterion Not Met|2|||
44387044|NCT00762034|79393185|FG000|Maintenance Period|Adverse Event|42|||
44387045|NCT00762034|79393186|FG001|Maintenance Period|Adverse Event|26|||
44519078|NCT03639610|79526948|FG000|Overall Study|Study terminated by sponsor|2|||
44519079|NCT03639610|79526949|FG001|Overall Study|Study terminated by sponsor|1|||
44519080|NCT03639610|79526950|FG002|Overall Study|Study terminated by sponsor|1|||
44519081|NCT03639610|79526948|FG000|Overall Study|Patient request to stop treatment|1|||
44519082|NCT03639610|79526949|FG001|Overall Study|Patient request to stop treatment|2|||
44251609|NCT00637273|79087160|FG002|Overall Study|Withdrawal of Consent|18|||
44251610|NCT00637273|79087158|FG000|Overall Study|Investigator Decision|1|||
44387046|NCT00762034|79393185|FG000|Maintenance Period|Progressive Disease|186|||
44146182|NCT03590613|78935429|FG000|Period 2, 4 Days|Physician Decision|0|||
44146183|NCT03590613|78935430|FG001|Period 2, 4 Days|Physician Decision|0|||
44146184|NCT03590613|78935431|FG002|Period 2, 4 Days|Physician Decision|0|||
44146185|NCT03590613|78935432|FG003|Period 2, 4 Days|Physician Decision|1|||
44146186|NCT02689258|78935473|FG000|Overall Study|Subject Non-Compliance|0|||
44146187|NCT02689258|78935474|FG001|Overall Study|Subject Non-Compliance|1|||
44146188|NCT02689258|78935475|FG002|Overall Study|Subject Non-Compliance|0|||
44146189|NCT02689258|78935476|FG003|Overall Study|Subject Non-Compliance|0|||
44146190|NCT02689258|78935477|FG004|Overall Study|Subject Non-Compliance|0|||
44146191|NCT02689258|78935478|FG005|Overall Study|Subject Non-Compliance|0|||
44146192|NCT02689258|78935479|FG006|Overall Study|Subject Non-Compliance|0|||
44146193|NCT02689258|78935480|FG007|Overall Study|Subject Non-Compliance|0|||
44146194|NCT02689258|78935481|FG008|Overall Study|Subject Non-Compliance|0|||
44146195|NCT02689258|78935482|FG009|Overall Study|Subject Non-Compliance|0|||
44146196|NCT02689258|78935483|FG010|Overall Study|Subject Non-Compliance|0|||
44146197|NCT02689258|78935484|FG011|Overall Study|Subject Non-Compliance|0|||
44146198|NCT02689258|78935473|FG000|Overall Study|Subject Refusal to Continue|0|||
44146199|NCT02689258|78935474|FG001|Overall Study|Subject Refusal to Continue|1|||
44146200|NCT02689258|78935475|FG002|Overall Study|Subject Refusal to Continue|0|||
44146201|NCT02689258|78935476|FG003|Overall Study|Subject Refusal to Continue|0|||
44146202|NCT02689258|78935477|FG004|Overall Study|Subject Refusal to Continue|0|||
44146203|NCT02689258|78935478|FG005|Overall Study|Subject Refusal to Continue|0|||
44146204|NCT02689258|78935479|FG006|Overall Study|Subject Refusal to Continue|0|||
44146205|NCT02689258|78935480|FG007|Overall Study|Subject Refusal to Continue|0|||
44146206|NCT02689258|78935481|FG008|Overall Study|Subject Refusal to Continue|1|||
44146207|NCT02689258|78935482|FG009|Overall Study|Subject Refusal to Continue|0|||
44146208|NCT02689258|78935483|FG010|Overall Study|Subject Refusal to Continue|0|||
44146209|NCT02689258|78935484|FG011|Overall Study|Subject Refusal to Continue|1|||
44146210|NCT02689258|78935473|FG000|Overall Study|Other|0|||
44146211|NCT02689258|78935474|FG001|Overall Study|Other|2|||
44146212|NCT02689258|78935475|FG002|Overall Study|Other|0|||
44146213|NCT02689258|78935476|FG003|Overall Study|Other|0|||
44146214|NCT02689258|78935477|FG004|Overall Study|Other|1|||
44146215|NCT02689258|78935478|FG005|Overall Study|Other|0|||
44146216|NCT02689258|78935479|FG006|Overall Study|Other|0|||
44146217|NCT02689258|78935480|FG007|Overall Study|Other|0|||
44146218|NCT02689258|78935481|FG008|Overall Study|Other|1|||
44146219|NCT02689258|78935482|FG009|Overall Study|Other|0|||
44146220|NCT02689258|78935483|FG010|Overall Study|Other|0|||
44146221|NCT02689258|78935484|FG011|Overall Study|Other|0|||
44146222|NCT02685735|78935507|FG000|Overall Study|Missing construct or pain data|23|||
44146223|NCT02685735|78935508|FG001|Overall Study|Missing construct or pain data|22|||
44146224|NCT02606136|78935533|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
44146225|NCT02606136|78935533|FG000|Overall Study|Withdrawal by Subject|1|||
44146226|NCT02292706|78935559|FG000|Overall Study|Lost to Follow-up|20|||
44146227|NCT02292706|78935560|FG001|Overall Study|Lost to Follow-up|44|||
44146228|NCT02292706|78935561|FG002|Overall Study|Lost to Follow-up|24|||
44146229|NCT02292706|78935562|FG003|Overall Study|Lost to Follow-up|61|||
44146230|NCT02292706|78935563|FG004|Overall Study|Lost to Follow-up|21|||
44387047|NCT00762034|79393186|FG001|Maintenance Period|Progressive Disease|224|||
44146231|NCT02292706|78935564|FG005|Overall Study|Lost to Follow-up|52|||
44146232|NCT02292706|78935565|FG006|Overall Study|Lost to Follow-up|25|||
44146233|NCT02292706|78935566|FG007|Overall Study|Lost to Follow-up|0|||
44146234|NCT02292706|78935559|FG000|Overall Study|Withdrew consent|15|||
44146235|NCT02292706|78935560|FG001|Overall Study|Withdrew consent|56|||
44146236|NCT02292706|78935561|FG002|Overall Study|Withdrew consent|43|||
44146237|NCT02292706|78935562|FG003|Overall Study|Withdrew consent|36|||
44146238|NCT02292706|78935563|FG004|Overall Study|Withdrew consent|13|||
44146239|NCT02292706|78935564|FG005|Overall Study|Withdrew consent|51|||
44146240|NCT02292706|78935565|FG006|Overall Study|Withdrew consent|20|||
44146241|NCT02292706|78935566|FG007|Overall Study|Withdrew consent|0|||
44146242|NCT02292706|78935559|FG000|Overall Study|Death|3|||
44146243|NCT02292706|78935560|FG001|Overall Study|Death|11|||
44387048|NCT00762034|79393185|FG000|Maintenance Period|Physician Decision|25|||
44146244|NCT02292706|78935561|FG002|Overall Study|Death|16|||
44146245|NCT02292706|78935562|FG003|Overall Study|Death|22|||
44146246|NCT02292706|78935563|FG004|Overall Study|Death|8|||
44146247|NCT02292706|78935564|FG005|Overall Study|Death|17|||
44146248|NCT02292706|78935565|FG006|Overall Study|Death|3|||
44146249|NCT02292706|78935566|FG007|Overall Study|Death|0|||
44146250|NCT02292706|78935559|FG000|Overall Study|Study terminated by sponsor|0|||
44146251|NCT02292706|78935560|FG001|Overall Study|Study terminated by sponsor|9|||
44146252|NCT02292706|78935561|FG002|Overall Study|Study terminated by sponsor|4|||
44146253|NCT02292706|78935562|FG003|Overall Study|Study terminated by sponsor|21|||
44146254|NCT02292706|78935563|FG004|Overall Study|Study terminated by sponsor|11|||
44146255|NCT02292706|78935564|FG005|Overall Study|Study terminated by sponsor|13|||
44146256|NCT02292706|78935565|FG006|Overall Study|Study terminated by sponsor|3|||
44146257|NCT02292706|78935566|FG007|Overall Study|Study terminated by sponsor|0|||
44387049|NCT00762034|79393186|FG001|Maintenance Period|Physician Decision|20|||
44387050|NCT00762034|79393185|FG000|Maintenance Period|Withdrawal by Subject|34|||
44387051|NCT00762034|79393186|FG001|Maintenance Period|Withdrawal by Subject|14|||
44387052|NCT00762034|79393185|FG000|Maintenance Period|Death not due to study disease|2|||
44387053|NCT00762034|79393186|FG001|Maintenance Period|Death not due to study disease|5|||
44387054|NCT00762034|79393185|FG000|Maintenance Period|Death due to study disease|3|||
44387055|NCT00762034|79393186|FG001|Maintenance Period|Death due to study disease|3|||
44387056|NCT00762034|79393185|FG000|Maintenance Period|Other|1|||
44387057|NCT00762034|79393186|FG001|Maintenance Period|Other|1|||
44387058|NCT00761956|79393218|FG000|Overall Study|Lost to Follow-up|6|||
44387059|NCT00761956|79393219|FG001|Overall Study|Lost to Follow-up|11|||
44387060|NCT00761956|79393218|FG000|Overall Study|Withdrawal by Subject|3|||
44387061|NCT00761956|79393219|FG001|Overall Study|Withdrawal by Subject|8|||
44387062|NCT00761956|79393218|FG000|Overall Study|Death|0|||
44387063|NCT00761956|79393219|FG001|Overall Study|Death|1|||
44387064|NCT00761956|79393218|FG000|Overall Study|Adverse Event|26|||
44387065|NCT00761956|79393219|FG001|Overall Study|Adverse Event|34|||
44387066|NCT00754624|79393225|FG000|Overall Study|Adverse Event|16|||
44387067|NCT00754624|79393225|FG000|Overall Study|Death|1|||
44387068|NCT00754624|79393225|FG000|Overall Study|Physician Decision|8|||
44387069|NCT00754624|79393225|FG000|Overall Study|Protocol Violation|1|||
44387070|NCT00754624|79393225|FG000|Overall Study|Withdrawal by Subject|28|||
44387071|NCT00754624|79393225|FG000|Overall Study|Various|12|||
44387072|NCT00754624|79393225|FG000|Overall Study|Lost to Follow-up|3|||
44387073|NCT00586846|79393238|FG000|Overall Study|Physician Decision|1|||
44387074|NCT00586846|79393238|FG000|Overall Study|Death|1|||
44387075|NCT00586846|79393238|FG000|Overall Study|Evaluable for Toxicity Only|4|||
44387076|NCT00973700|79393247|FG000|Overall Study|Withdrawal by Subject|2|||
44387077|NCT00973700|79393248|FG001|Overall Study|Withdrawal by Subject|2|||
44387078|NCT00973700|79393249|FG002|Overall Study|Withdrawal by Subject|8|||
44387079|NCT00973700|79393250|FG003|Overall Study|Withdrawal by Subject|4|||
44387080|NCT00973700|79393251|FG004|Overall Study|Withdrawal by Subject|4|||
44387081|NCT00973700|79393247|FG000|Overall Study|Lost to Follow-up|5|||
44387082|NCT00973700|79393248|FG001|Overall Study|Lost to Follow-up|0|||
44387083|NCT00973700|79393249|FG002|Overall Study|Lost to Follow-up|1|||
44387084|NCT00973700|79393250|FG003|Overall Study|Lost to Follow-up|8|||
44387085|NCT00973700|79393251|FG004|Overall Study|Lost to Follow-up|5|||
44387086|NCT00973700|79393247|FG000|Overall Study|Inappropriate enrolment|0|||
44387087|NCT00973700|79393248|FG001|Overall Study|Inappropriate enrolment|0|||
44387088|NCT00973700|79393249|FG002|Overall Study|Inappropriate enrolment|0|||
44387089|NCT00973700|79393250|FG003|Overall Study|Inappropriate enrolment|4|||
44387090|NCT00973700|79393251|FG004|Overall Study|Inappropriate enrolment|0|||
44387091|NCT00973700|79393247|FG000|Overall Study|Unable to Classify|0|||
44387092|NCT00973700|79393248|FG001|Overall Study|Unable to Classify|0|||
44387093|NCT00973700|79393249|FG002|Overall Study|Unable to Classify|1|||
44387094|NCT00973700|79393250|FG003|Overall Study|Unable to Classify|2|||
44387095|NCT00973700|79393251|FG004|Overall Study|Unable to Classify|1|||
44387096|NCT00754390|79393278|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
44387097|NCT00754390|79393278|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
44387098|NCT00754390|79393278|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
44387099|NCT00754390|79393278|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
44387100|NCT00754234|79393285|FG000|Overall Study|Withdrawal by Subject|3|||
44387101|NCT00753922|79393293|FG000|Overall Study|Lost to Follow-up|155|||
44387102|NCT00753922|79393294|FG001|Overall Study|Lost to Follow-up|24|||
44387103|NCT00753922|79393295|FG002|Overall Study|Lost to Follow-up|28|||
44387104|NCT00753922|79393296|FG003|Overall Study|Lost to Follow-up|5|||
44387105|NCT00753922|79393293|FG000|Overall Study|Withdrawal by Subject|9|||
44387106|NCT00753922|79393294|FG001|Overall Study|Withdrawal by Subject|11|||
44251611|NCT00637273|79087159|FG001|Overall Study|Investigator Decision|3|||
44251612|NCT00637273|79087160|FG002|Overall Study|Investigator Decision|1|||
44251613|NCT00637273|79087158|FG000|Overall Study|Administrative|2|||
44251614|NCT00637273|79087159|FG001|Overall Study|Administrative|0|||
44251615|NCT00637273|79087160|FG002|Overall Study|Administrative|0|||
44387107|NCT00753922|79393295|FG002|Overall Study|Withdrawal by Subject|4|||
44387108|NCT00753922|79393296|FG003|Overall Study|Withdrawal by Subject|2|||
44387109|NCT00753922|79393293|FG000|Overall Study|Patient Non-compliance|55|||
44387110|NCT00753922|79393294|FG001|Overall Study|Patient Non-compliance|22|||
44251616|NCT00637273|79087158|FG000|Overall Study|Loss of Glucose Control|1|||
44387111|NCT00753922|79393295|FG002|Overall Study|Patient Non-compliance|14|||
44387112|NCT00753922|79393296|FG003|Overall Study|Patient Non-compliance|11|||
44519083|NCT03639610|79526950|FG002|Overall Study|Patient request to stop treatment|0|||
44251617|NCT00637273|79087159|FG001|Overall Study|Loss of Glucose Control|1|||
44251618|NCT00637273|79087160|FG002|Overall Study|Loss of Glucose Control|1|||
44387113|NCT00753922|79393293|FG000|Overall Study|Patients Not Completing Visit|11|||
44387114|NCT00753922|79393294|FG001|Overall Study|Patients Not Completing Visit|0|||
44387115|NCT00753922|79393295|FG002|Overall Study|Patients Not Completing Visit|1|||
44387116|NCT00753922|79393296|FG003|Overall Study|Patients Not Completing Visit|0|||
44387117|NCT00753922|79393293|FG000|Overall Study|Death|2|||
44387118|NCT00753922|79393294|FG001|Overall Study|Death|23|||
44387119|NCT00753922|79393295|FG002|Overall Study|Death|2|||
44387120|NCT00753922|79393296|FG003|Overall Study|Death|1|||
44387121|NCT00753922|79393293|FG000|Overall Study|Discontinuation Due to Explantation|14|||
44387122|NCT00753922|79393294|FG001|Overall Study|Discontinuation Due to Explantation|14|||
44387123|NCT00753922|79393295|FG002|Overall Study|Discontinuation Due to Explantation|14|||
44387124|NCT00753922|79393296|FG003|Overall Study|Discontinuation Due to Explantation|4|||
44387125|NCT00761176|79393308|FG000|Overall Study|Death|1|||
44387126|NCT00761176|79393309|FG001|Overall Study|Death|0|||
44280404|NCT01985334|79241400|FG004|Overall Study|Lost to Follow-up|1|||
44280405|NCT01985334|79241401|FG005|Overall Study|Lost to Follow-up|4|||
44280406|NCT01985334|79241402|FG006|Overall Study|Lost to Follow-up|0|||
44280407|NCT01985334|79241403|FG007|Overall Study|Lost to Follow-up|3|||
44280408|NCT01944774|79241438|FG000|Overall Study|Withdrawal by Subject|2|||
44280409|NCT01944774|79241439|FG001|Overall Study|Withdrawal by Subject|3|||
44280410|NCT01944774|79241440|FG002|Overall Study|Withdrawal by Subject|3|||
44280411|NCT01944774|79241438|FG000|Overall Study|Adverse Event|3|||
44387127|NCT00761176|79393308|FG000|Overall Study|Withdrawal by Subject|1|||
44387128|NCT00761176|79393309|FG001|Overall Study|Withdrawal by Subject|1|||
44387129|NCT00760552|79393317|FG000|Overall Study|Death|2|||
44387130|NCT00760552|79393318|FG001|Overall Study|Death|0|||
44387131|NCT00760552|79393317|FG000|Overall Study|Lost to Follow-up|11|||
44387132|NCT00760552|79393318|FG001|Overall Study|Lost to Follow-up|10|||
44387133|NCT00753766|79393326|FG000|Overall Study|Physician Decision|1|||
44387134|NCT00753766|79393327|FG001|Overall Study|Physician Decision|0|||
44387135|NCT00976898|79393334|FG000|Overall Study|Protocol Violation|1|||
44387136|NCT00976898|79393334|FG000|Overall Study|Adverse Event|1|||
44387137|NCT00976898|79393334|FG000|Overall Study|Physician Decision|1|||
44387138|NCT00976898|79393334|FG000|Overall Study|Liver Transplant|1|||
44387139|NCT00976898|79393334|FG000|Overall Study|Progressive Disease|1|||
44387140|NCT02620579|79393346|FG000|Overall Study|Physician Decision|0|||
44387141|NCT02620579|79393347|FG001|Overall Study|Physician Decision|0|||
44387142|NCT02620579|79393348|FG002|Overall Study|Physician Decision|0|||
44387143|NCT02620579|79393349|FG003|Overall Study|Physician Decision|1|||
44387144|NCT02620579|79393346|FG000|Overall Study|Withdrawal by Subject|0|||
44387145|NCT02620579|79393347|FG001|Overall Study|Withdrawal by Subject|1|||
44387146|NCT02620579|79393348|FG002|Overall Study|Withdrawal by Subject|1|||
44387147|NCT02620579|79393349|FG003|Overall Study|Withdrawal by Subject|0|||
44387148|NCT00753688|79393365|FG000|Overall Study|Death|102|||
44387149|NCT00753688|79393366|FG001|Overall Study|Death|203|||
44387150|NCT00753688|79393365|FG000|Overall Study|Missing|4|||
44387151|NCT00753688|79393366|FG001|Overall Study|Missing|9|||
44519084|NCT02954406|79526968|FG000|Overall Study|Adverse Event|0|||
44519085|NCT02954406|79526969|FG001|Overall Study|Adverse Event|1|||
44251619|NCT00988351|79087170|FG000|Overall Study|Withdrawal by Subject|8|||
44251620|NCT00988351|79087171|FG001|Overall Study|Withdrawal by Subject|0|||
44251621|NCT00988351|79087170|FG000|Overall Study|Lost to Follow-up|6|||
44251622|NCT00988351|79087171|FG001|Overall Study|Lost to Follow-up|9|||
44251623|NCT00988351|79087170|FG000|Overall Study|not using CPAP|5|||
44251624|NCT00988351|79087171|FG001|Overall Study|not using CPAP|3|||
44251625|NCT00988117|79087177|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
44251626|NCT00988117|79087177|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
44251627|NCT00637195|79087184|FG000|Overall Study|Lost to Follow-up|1|||
44251628|NCT00637195|79087185|FG001|Overall Study|Lost to Follow-up|0|||
44251629|NCT00637195|79087184|FG000|Overall Study|Other|2|||
44251630|NCT00637195|79087185|FG001|Overall Study|Other|0|||
44251631|NCT00637195|79087184|FG000|Overall Study|Withdrawal by Subject|0|||
44251632|NCT00637195|79087185|FG001|Overall Study|Withdrawal by Subject|1|||
44251633|NCT00636961|79087203|FG000|Period 1|Administrative problems|1|||
44251634|NCT00636961|79087204|FG001|Period 1|Administrative problems|1|||
44251635|NCT00636961|79087203|FG000|Period 2|Adverse Event|1|||
44251636|NCT00636961|79087204|FG001|Period 2|Adverse Event|0|||
44251637|NCT00635089|79087219|FG000|Overall Study|Adverse Event|7|||
44251638|NCT00635089|79087219|FG000|Overall Study|Lack of Efficacy|28|||
44280412|NCT01944774|79241439|FG001|Overall Study|Adverse Event|2|||
44280413|NCT01944774|79241440|FG002|Overall Study|Adverse Event|3|||
44280414|NCT01944774|79241438|FG000|Overall Study|Lack of Efficacy|1|||
44387152|NCT00753688|79393365|FG000|Overall Study|Participant Withdrew Consent|2|||
44387153|NCT00753688|79393366|FG001|Overall Study|Participant Withdrew Consent|2|||
44387154|NCT00753688|79393365|FG000|Overall Study|Ongoing - in Follow-up|15|||
44387155|NCT00753688|79393366|FG001|Overall Study|Ongoing - in Follow-up|31|||
44387156|NCT00753688|79393365|FG000|Overall Study|Adverse Event|0|||
44519086|NCT02954406|79526970|FG002|Overall Study|Adverse Event|0|||
44519087|NCT02954406|79526971|FG003|Overall Study|Adverse Event|0|||
44519088|NCT02954406|79526972|FG004|Overall Study|Adverse Event|1|||
44251639|NCT00635089|79087219|FG000|Overall Study|Protocol Deviation|4|||
44251640|NCT00635089|79087219|FG000|Overall Study|Lost to Follow-up|8|||
44251641|NCT00635089|79087219|FG000|Overall Study|Other|31|||
44387157|NCT00753688|79393366|FG001|Overall Study|Adverse Event|1|||
44387158|NCT00586612|79393374|FG000|Primary Phase|Protocol Violation|1|||
44387159|NCT00586612|79393375|FG001|Primary Phase|Protocol Violation|0|||
44387160|NCT00586612|79393374|FG000|Primary Phase|Lost to Follow-up|0|||
44387161|NCT00586612|79393375|FG001|Primary Phase|Lost to Follow-up|1|||
44387162|NCT00586612|79393374|FG000|Primary Phase|Withdrawal by Subject|0|||
44387163|NCT00586612|79393375|FG001|Primary Phase|Withdrawal by Subject|2|||
44387164|NCT00586612|79393374|FG000|Booster Phase|Lost to Follow-up|3|||
44387165|NCT00586612|79393375|FG001|Booster Phase|Lost to Follow-up|1|||
44387166|NCT00586690|79393383|FG000|Overall Study|Death|2|||
44387167|NCT00586690|79393384|FG001|Overall Study|Death|0|||
44387168|NCT00586690|79393383|FG000|Overall Study|Disease Progression|10|||
44387169|NCT00586690|79393384|FG001|Overall Study|Disease Progression|0|||
44387170|NCT00586690|79393383|FG000|Overall Study|Adverse Event|1|||
44387171|NCT00586690|79393384|FG001|Overall Study|Adverse Event|0|||
44387172|NCT00586690|79393383|FG000|Overall Study|Lack of Efficacy|2|||
44387173|NCT00586690|79393384|FG001|Overall Study|Lack of Efficacy|0|||
44387174|NCT00586690|79393383|FG000|Overall Study|Lab can't accommodate|1|||
44387175|NCT00586690|79393384|FG001|Overall Study|Lab can't accommodate|0|||
44387176|NCT00976820|79393393|FG000|Overall Study|Lost to Follow-up|5|||
44387177|NCT00976820|79393394|FG001|Overall Study|Lost to Follow-up|16|||
44387178|NCT00976820|79393395|FG002|Overall Study|Lost to Follow-up|2|||
44387179|NCT00976820|79393396|FG003|Overall Study|Lost to Follow-up|3|||
44387180|NCT00976820|79393393|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
44387181|NCT00976820|79393394|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
44387182|NCT00976820|79393395|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
44387183|NCT00976820|79393396|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
44387184|NCT00976820|79393393|FG000|Overall Study|Withdrawal by Subject|2|||
44387185|NCT00976820|79393394|FG001|Overall Study|Withdrawal by Subject|4|||
44387186|NCT00976820|79393395|FG002|Overall Study|Withdrawal by Subject|1|||
44387187|NCT00976820|79393396|FG003|Overall Study|Withdrawal by Subject|4|||
44387188|NCT00760474|79393447|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
44387189|NCT00760474|79393448|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
44387190|NCT00760474|79393447|FG000|Placebo Washout Period|Other|0|||
44387191|NCT00760474|79393448|FG001|Placebo Washout Period|Other|1|||
44387192|NCT00760474|79393447|FG000|Period 2 (P2)|Lost to Follow-up|1|||
44387193|NCT00760474|79393448|FG001|Period 2 (P2)|Lost to Follow-up|0|||
44387194|NCT00760474|79393447|FG000|Period 2 (P2)|Adverse Event|0|||
44387195|NCT00760474|79393448|FG001|Period 2 (P2)|Adverse Event|1|||
44387196|NCT00975416|79393457|FG000|Overall Study|early discharge from tx|3|||
44387197|NCT00975416|79393458|FG001|Overall Study|early discharge from tx|5|||
44387198|NCT00760084|79393465|FG000|Overall Study|Physician Decision|5|||
44387199|NCT00760084|79393465|FG000|Overall Study|Withdrawal by Subject|2|||
44387200|NCT00760084|79393465|FG000|Overall Study|Progressive Disease|3|||
44387201|NCT00752206|79393471|FG000|Overall Study|Disease progression|8|||
44387202|NCT00752206|79393472|FG001|Overall Study|Disease progression|11|||
44387203|NCT00752206|79393471|FG000|Overall Study|Pregnancy|1|||
44387204|NCT00752206|79393472|FG001|Overall Study|Pregnancy|0|||
44387205|NCT00752128|79393478|FG000|Overall Study|Withdrawal by Subject|4|||
44387206|NCT00976508|79393485|FG000|Overall Study|Death|7|||
44387207|NCT00976508|79393486|FG001|Overall Study|Death|1|||
44387208|NCT00976508|79393485|FG000|Overall Study|Lost to Follow-up|1|||
44387209|NCT00976508|79393486|FG001|Overall Study|Lost to Follow-up|0|||
44387210|NCT00976508|79393485|FG000|Overall Study|Withdrawal by Subject|1|||
44387211|NCT00976508|79393486|FG001|Overall Study|Withdrawal by Subject|0|||
44387212|NCT00976508|79393485|FG000|Overall Study|Disease Progression|4|||
44387213|NCT00976508|79393486|FG001|Overall Study|Disease Progression|4|||
44387214|NCT00976508|79393485|FG000|Overall Study|Subject Enrolled in Hospice|1|||
44387215|NCT00976508|79393486|FG001|Overall Study|Subject Enrolled in Hospice|0|||
44387216|NCT00976508|79393485|FG000|Overall Study|Terminated by the Sponsor|0|||
44387217|NCT00976508|79393486|FG001|Overall Study|Terminated by the Sponsor|1|||
44387218|NCT00973622|79393497|FG000|Overall Study|did not attend MRI|14|||
44387219|NCT00973622|79393498|FG001|Overall Study|did not attend MRI|3|||
44387220|NCT00973622|79393497|FG000|Overall Study|did not pass MRI screen|6|||
44387221|NCT00973622|79393498|FG001|Overall Study|did not pass MRI screen|0|||
44387222|NCT00973622|79393497|FG000|Overall Study|did not complete rTMS sessions|11|||
44387223|NCT00973622|79393498|FG001|Overall Study|did not complete rTMS sessions|2|||
44387224|NCT04044716|79393506|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
44387225|NCT04044716|79393507|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
44387226|NCT04044716|79393508|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
44387227|NCT04044716|79393506|FG000|Overall Study|Lost to Follow-up|2|||
44387228|NCT04044716|79393507|FG001|Overall Study|Lost to Follow-up|3|||
44387229|NCT04044716|79393508|FG002|Overall Study|Lost to Follow-up|0|||
44387230|NCT04041284|79393517|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
44387231|NCT04041284|79393518|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
44387232|NCT04041284|79393517|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
44387233|NCT04041284|79393518|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
44387234|NCT04041284|79393517|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
44387235|NCT04041284|79393518|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
44387236|NCT04041284|79393517|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
44387237|NCT04041284|79393518|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
44387238|NCT04041284|79393517|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
44387239|NCT04041284|79393518|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
44387240|NCT04041284|79393517|FG000|DB Phase (12 Weeks)|Other than specified|1|||
44387241|NCT04041284|79393518|FG001|DB Phase (12 Weeks)|Other than specified|0|||
44387242|NCT04041284|79393517|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
44387243|NCT04041284|79393518|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
44387244|NCT04041284|79393517|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
44387245|NCT04041284|79393518|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
44387246|NCT04041284|79393517|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
44387247|NCT04041284|79393518|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
44387248|NCT04041284|79393517|FG000|OL Phase (12 Weeks)|Other than specified|6|||
44387249|NCT04041284|79393518|FG001|OL Phase (12 Weeks)|Other than specified|2|||
44387250|NCT00753454|79393528|FG000|Overall Study|Adverse Event|4|||
44387251|NCT00753454|79393528|FG000|Overall Study|Lack of Efficacy|1|||
44387252|NCT00753454|79393528|FG000|Overall Study|Lost to Follow-up|3|||
44387253|NCT00753454|79393528|FG000|Overall Study|Withdrawal by Subject|5|||
44387254|NCT00753454|79393528|FG000|Overall Study|Investigator Decision|1|||
44387255|NCT00976274|79393534|FG000|Overall Study|Lost to Follow-up|5|||
44387256|NCT00976274|79393535|FG001|Overall Study|Lost to Follow-up|5|||
44387257|NCT00976274|79393534|FG000|Overall Study|Withdrawal by Subject|1|||
44387258|NCT00976274|79393535|FG001|Overall Study|Withdrawal by Subject|1|||
44387259|NCT00976274|79393534|FG000|Overall Study|Physician Decision|1|||
44387260|NCT00976274|79393535|FG001|Overall Study|Physician Decision|2|||
44387261|NCT00759148|79393543|FG000|Overall Study|Adverse Event|1|||
44387262|NCT00759148|79393544|FG001|Overall Study|Adverse Event|6|||
44387263|NCT00759148|79393543|FG000|Overall Study|Withdrawal by Subject|3|||
44387264|NCT00759148|79393544|FG001|Overall Study|Withdrawal by Subject|7|||
44387265|NCT00759148|79393543|FG000|Overall Study|Lost to Follow-up|3|||
44387266|NCT00759148|79393544|FG001|Overall Study|Lost to Follow-up|9|||
44387267|NCT00759148|79393543|FG000|Overall Study|Treatment Failure|6|||
44387268|NCT00759148|79393544|FG001|Overall Study|Treatment Failure|10|||
44387269|NCT00759148|79393543|FG000|Overall Study|Reason not given|1|||
44387270|NCT00759148|79393544|FG001|Overall Study|Reason not given|0|||
44387271|NCT02794285|79393554|FG000|Overall Study|Adverse Event|11|||
44387272|NCT02794285|79393555|FG001|Overall Study|Adverse Event|4|||
44387273|NCT02794285|79393556|FG002|Overall Study|Adverse Event|5|||
44387274|NCT02794285|79393557|FG003|Overall Study|Adverse Event|8|||
44387275|NCT02794285|79393554|FG000|Overall Study|Condition Under Investigation Improved|1|||
44387276|NCT02794285|79393555|FG001|Overall Study|Condition Under Investigation Improved|0|||
44387277|NCT02794285|79393556|FG002|Overall Study|Condition Under Investigation Improved|0|||
44387278|NCT02794285|79393557|FG003|Overall Study|Condition Under Investigation Improved|0|||
44387279|NCT02794285|79393554|FG000|Overall Study|Condition Under Investigation Worsened|0|||
44387280|NCT02794285|79393555|FG001|Overall Study|Condition Under Investigation Worsened|2|||
44387281|NCT02794285|79393556|FG002|Overall Study|Condition Under Investigation Worsened|1|||
44387282|NCT02794285|79393557|FG003|Overall Study|Condition Under Investigation Worsened|0|||
44387283|NCT02794285|79393554|FG000|Overall Study|Death|2|||
44387284|NCT02794285|79393555|FG001|Overall Study|Death|1|||
44387285|NCT02794285|79393556|FG002|Overall Study|Death|2|||
44387286|NCT02794285|79393557|FG003|Overall Study|Death|0|||
44387287|NCT02794285|79393554|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
44251642|NCT01493414|79087236|FG000|Overall Study|Adverse Event|405|||
44251643|NCT01493414|79087236|FG000|Overall Study|Disease progression|204|||
44251644|NCT01493414|79087236|FG000|Overall Study|Death|101|||
44251645|NCT01493414|79087236|FG000|Overall Study|Physician Decision|93|||
44251646|NCT01493414|79087236|FG000|Overall Study|Withdrawal by Subject|79|||
44251647|NCT01493414|79087236|FG000|Overall Study|Protocol deviation|27|||
44251648|NCT01493414|79087236|FG000|Overall Study|Administrative problems|25|||
44251649|NCT01493414|79087236|FG000|Overall Study|Lost to Follow-up|16|||
44251650|NCT00634543|79087246|FG000|Overall Study|Other|1|||
44251651|NCT00634543|79087247|FG001|Overall Study|Other|2|||
44251652|NCT00634543|79087246|FG000|Overall Study|Protocol Violation|3|||
44251653|NCT00634543|79087247|FG001|Overall Study|Protocol Violation|3|||
44387288|NCT02794285|79393555|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
44387289|NCT02794285|79393556|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
44387290|NCT02794285|79393557|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
44387291|NCT02794285|79393554|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
44387292|NCT02794285|79393555|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
44387293|NCT02794285|79393556|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
44387294|NCT02794285|79393557|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
44251654|NCT00634543|79087246|FG000|Overall Study|Adverse Event|11|||
44251655|NCT00634543|79087247|FG001|Overall Study|Adverse Event|11|||
44251656|NCT00634543|79087246|FG000|Overall Study|Withdrawal by Subject|4|||
44251657|NCT00634543|79087247|FG001|Overall Study|Withdrawal by Subject|4|||
44387295|NCT02794285|79393554|FG000|Overall Study|Lack of Efficacy|10|||
44387296|NCT02794285|79393555|FG001|Overall Study|Lack of Efficacy|6|||
44387297|NCT02794285|79393556|FG002|Overall Study|Lack of Efficacy|3|||
44387298|NCT02794285|79393557|FG003|Overall Study|Lack of Efficacy|3|||
44387299|NCT02794285|79393554|FG000|Overall Study|Lost to Follow-up|5|||
44387300|NCT02794285|79393555|FG001|Overall Study|Lost to Follow-up|6|||
44387301|NCT02794285|79393556|FG002|Overall Study|Lost to Follow-up|3|||
44387302|NCT02794285|79393557|FG003|Overall Study|Lost to Follow-up|1|||
44387303|NCT02794285|79393554|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
44387304|NCT02794285|79393555|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
44387305|NCT02794285|79393556|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
44387306|NCT02794285|79393557|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
44387307|NCT02794285|79393554|FG000|Overall Study|Withdrawal by Subject|38|||
44387308|NCT02794285|79393555|FG001|Overall Study|Withdrawal by Subject|29|||
44387309|NCT02794285|79393556|FG002|Overall Study|Withdrawal by Subject|20|||
44387310|NCT02794285|79393557|FG003|Overall Study|Withdrawal by Subject|12|||
44387311|NCT02794285|79393554|FG000|Overall Study|Missing|1|||
44387312|NCT02794285|79393555|FG001|Overall Study|Missing|0|||
44387313|NCT02794285|79393556|FG002|Overall Study|Missing|0|||
44387314|NCT02794285|79393557|FG003|Overall Study|Missing|0|||
44387315|NCT02794285|79393554|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
44387316|NCT02794285|79393555|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
44387317|NCT02794285|79393556|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
44387318|NCT02794285|79393557|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
44387319|NCT02794285|79393554|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
44387320|NCT02794285|79393555|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
44387321|NCT02794285|79393556|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
44387322|NCT02794285|79393557|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
44387323|NCT00970268|79393569|FG000|Overall Study|Withdrawal by Subject|12|||
44387324|NCT00970268|79393570|FG001|Overall Study|Withdrawal by Subject|19|||
44387325|NCT00970268|79393569|FG000|Overall Study|Adverse Event|15|||
44387326|NCT00970268|79393570|FG001|Overall Study|Adverse Event|12|||
44387327|NCT00970268|79393569|FG000|Overall Study|Lack of Efficacy|3|||
44387328|NCT00970268|79393570|FG001|Overall Study|Lack of Efficacy|6|||
44387329|NCT00970268|79393569|FG000|Overall Study|Protocol Violation|4|||
44387330|NCT00970268|79393570|FG001|Overall Study|Protocol Violation|7|||
44387331|NCT00970268|79393569|FG000|Overall Study|Other Reason|3|||
44519089|NCT02954406|79526973|FG005|Overall Study|Adverse Event|0|||
44519090|NCT02954406|79526974|FG006|Overall Study|Adverse Event|0|||
44519091|NCT02954406|79526975|FG007|Overall Study|Adverse Event|0|||
44251658|NCT00634543|79087246|FG000|Overall Study|Lost to Follow-up|0|||
44251659|NCT00634543|79087247|FG001|Overall Study|Lost to Follow-up|1|||
44251660|NCT00985465|79087255|FG000|Overall Study|Withdrawal by Subject|1|||
44251661|NCT00985465|79087256|FG001|Overall Study|Withdrawal by Subject|2|||
44387332|NCT00970268|79393570|FG001|Overall Study|Other Reason|1|||
44387333|NCT00970268|79393569|FG000|Overall Study|COPD Exacerbation|4|||
44387334|NCT00970268|79393570|FG001|Overall Study|COPD Exacerbation|2|||
44387335|NCT00970268|79393569|FG000|Overall Study|Lost to Follow-up|1|||
44387336|NCT00970268|79393570|FG001|Overall Study|Lost to Follow-up|2|||
44387337|NCT00970268|79393569|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
44387338|NCT00970268|79393570|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
44387339|NCT00969332|79393582|FG000|Overall Study|Physician Decision|8|||
44387340|NCT00969332|79393582|FG000|Overall Study|Withdrawal by Subject|3|||
44387341|NCT00968864|79393587|FG000|Overall Study|Protocol exception/ not evaluable|1|||
44387342|NCT00758680|79393596|FG000|Overall Study|Adverse Event|0|||
44387343|NCT00758680|79393597|FG001|Overall Study|Adverse Event|0|||
44387344|NCT00758680|79393598|FG002|Overall Study|Adverse Event|0|||
44387345|NCT00758680|79393599|FG003|Overall Study|Adverse Event|0|||
44387346|NCT00758680|79393600|FG004|Overall Study|Adverse Event|0|||
44387347|NCT00758680|79393601|FG005|Overall Study|Adverse Event|0|||
44387348|NCT00758680|79393602|FG006|Overall Study|Adverse Event|0|||
44387349|NCT00758680|79393603|FG007|Overall Study|Adverse Event|1|||
44387350|NCT00758680|79393604|FG008|Overall Study|Adverse Event|0|||
44387351|NCT00758680|79393605|FG009|Overall Study|Adverse Event|1|||
44387352|NCT00758680|79393596|FG000|Overall Study|Laboratory Adverse Event|0|||
44251662|NCT00985465|79087255|FG000|Overall Study|Considered to be part of the other group|0|||
44387353|NCT00758680|79393597|FG001|Overall Study|Laboratory Adverse Event|0|||
44387354|NCT00758680|79393598|FG002|Overall Study|Laboratory Adverse Event|0|||
44387355|NCT00758680|79393599|FG003|Overall Study|Laboratory Adverse Event|0|||
44387356|NCT00758680|79393600|FG004|Overall Study|Laboratory Adverse Event|0|||
44387357|NCT00758680|79393601|FG005|Overall Study|Laboratory Adverse Event|0|||
44387358|NCT00758680|79393602|FG006|Overall Study|Laboratory Adverse Event|0|||
44387359|NCT00758680|79393603|FG007|Overall Study|Laboratory Adverse Event|0|||
44387360|NCT00758680|79393604|FG008|Overall Study|Laboratory Adverse Event|1|||
44519092|NCT02954406|79526976|FG008|Overall Study|Adverse Event|1|||
44387361|NCT00758680|79393605|FG009|Overall Study|Laboratory Adverse Event|0|||
44519093|NCT02954406|79526977|FG009|Overall Study|Adverse Event|1|||
44387362|NCT00758680|79393596|FG000|Overall Study|Withdrawal by Subject|0|||
44387363|NCT00758680|79393597|FG001|Overall Study|Withdrawal by Subject|0|||
44387364|NCT00758680|79393598|FG002|Overall Study|Withdrawal by Subject|0|||
44387365|NCT00758680|79393599|FG003|Overall Study|Withdrawal by Subject|0|||
44387366|NCT00758680|79393600|FG004|Overall Study|Withdrawal by Subject|0|||
44387367|NCT00758680|79393601|FG005|Overall Study|Withdrawal by Subject|0|||
44387368|NCT00758680|79393602|FG006|Overall Study|Withdrawal by Subject|1|||
44387369|NCT00758680|79393603|FG007|Overall Study|Withdrawal by Subject|0|||
44387370|NCT00758680|79393604|FG008|Overall Study|Withdrawal by Subject|1|||
44387371|NCT00758680|79393605|FG009|Overall Study|Withdrawal by Subject|0|||
44387372|NCT00758602|79393630|FG000|Overall Study|Adverse Event|11|||
44387373|NCT00758602|79393631|FG001|Overall Study|Adverse Event|10|||
44387374|NCT00758602|79393630|FG000|Overall Study|Lost to Follow-up|4|||
44387375|NCT00758602|79393631|FG001|Overall Study|Lost to Follow-up|3|||
44387376|NCT00758602|79393630|FG000|Overall Study|Withdrawal by Subject|1|||
44387377|NCT00758602|79393631|FG001|Overall Study|Withdrawal by Subject|3|||
44387378|NCT00758602|79393630|FG000|Overall Study|Protocol Violation|0|||
44387379|NCT00758602|79393631|FG001|Overall Study|Protocol Violation|2|||
44387380|NCT00758602|79393630|FG000|Overall Study|Death|0|||
44387381|NCT00758602|79393631|FG001|Overall Study|Death|1|||
44387382|NCT00758602|79393630|FG000|Overall Study|Reason not specified|3|||
44387383|NCT00758602|79393631|FG001|Overall Study|Reason not specified|3|||
44387384|NCT00711529|79393640|FG000|Overall Study|Protocol Violation|2|||
44387385|NCT00711529|79393641|FG001|Overall Study|Protocol Violation|0|||
44387386|NCT00711529|79393640|FG000|Overall Study|Withdrawal by Subject|2|||
44387387|NCT00711529|79393641|FG001|Overall Study|Withdrawal by Subject|6|||
44387388|NCT00601419|79393647|FG000|Overall Study|Lost to Follow-up|3|||
44387389|NCT00601419|79393647|FG000|Overall Study|Missed Visits|1|||
44387390|NCT00712933|79393667|FG000|Overall Study|Adverse Event|69|||
44387391|NCT00712933|79393667|FG000|Overall Study|Lack of Efficacy|6|||
44387392|NCT00712933|79393667|FG000|Overall Study|Lost to Follow-up|22|||
44387393|NCT00712933|79393667|FG000|Overall Study|Non-compliance with study drug|13|||
44387394|NCT00712933|79393667|FG000|Overall Study|Other Pregnancy|37|||
44387395|NCT00712933|79393667|FG000|Overall Study|Sponsor decision|14|||
44387396|NCT00712933|79393667|FG000|Overall Study|Withdrew consent|4|||
44387397|NCT00712933|79393667|FG000|Overall Study|Hip replacement surgery|1|||
44387398|NCT00712933|79393667|FG000|Overall Study|Involved in Clinical research|3|||
44387399|NCT00712933|79393667|FG000|Overall Study|Participant hospitalized|1|||
44387400|NCT00712933|79393667|FG000|Overall Study|Participant travelled overseas|2|||
44387401|NCT00712933|79393667|FG000|Overall Study|Death of patient|1|||
44387402|NCT00712933|79393667|FG000|Overall Study|Other Physician decision|1|||
44387403|NCT00712933|79393667|FG000|Overall Study|Not committed to contraception|1|||
44387404|NCT00712933|79393667|FG000|Overall Study|Participant received medication|1|||
44387405|NCT00712933|79393667|FG000|Overall Study|Physician Decision|36|||
44387406|NCT00712933|79393667|FG000|Overall Study|Protocol Violation|4|||
44387407|NCT00712933|79393667|FG000|Overall Study|Withdrawal by Subject|151|||
44387408|NCT00712543|79393677|FG000|Day 8-14|Lost to Follow-up|0|||
44387409|NCT00712543|79393678|FG001|Day 8-14|Lost to Follow-up|2|||
44387410|NCT00709111|79393684|FG000|Overall Study|Withdrawal by Subject|1|||
44387411|NCT00709111|79393684|FG000|Overall Study|Unable to attend clinic visits|1|||
44387412|NCT00710749|79393688|FG000|First Intervention|Withdrawal by Subject|1|||
44387413|NCT00710749|79393689|FG001|First Intervention|Withdrawal by Subject|0|||
44387414|NCT00699907|79393700|FG000|Overall Study|Withdrawal by Subject|2|||
44519094|NCT02954406|79526978|FG010|Overall Study|Adverse Event|0|||
44251663|NCT00985465|79087256|FG001|Overall Study|Considered to be part of the other group|1|||
44251664|NCT01049919|79087265|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
44251665|NCT01049919|79087266|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
44251666|NCT01049919|79087265|FG000|Overall Study|Withdrawal by Subject|5|||
44251667|NCT01049919|79087266|FG001|Overall Study|Withdrawal by Subject|0|||
44251668|NCT01049919|79087265|FG000|Overall Study|Lost to Follow-up|6|||
44251669|NCT01049919|79087266|FG001|Overall Study|Lost to Follow-up|1|||
44251670|NCT01049919|79087265|FG000|Overall Study|Physician Decision|2|||
44251671|NCT01049919|79087266|FG001|Overall Study|Physician Decision|0|||
44251672|NCT01049919|79087265|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
44519095|NCT02954406|79526968|FG000|Overall Study|Progressive Disease|3|||
44519096|NCT02954406|79526969|FG001|Overall Study|Progressive Disease|4|||
44251673|NCT01049919|79087266|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
44387415|NCT00699907|79393701|FG001|Overall Study|Withdrawal by Subject|1|||
44387416|NCT00699907|79393702|FG002|Overall Study|Withdrawal by Subject|0|||
44387417|NCT00699907|79393700|FG000|Overall Study|No usable sample|0|||
44280415|NCT01944774|79241439|FG001|Overall Study|Lack of Efficacy|2|||
44387418|NCT00699907|79393701|FG001|Overall Study|No usable sample|9|||
44387419|NCT00699907|79393702|FG002|Overall Study|No usable sample|8|||
44387420|NCT00710593|79393712|FG000|Overall Study|Incarceration|1|||
44387421|NCT00710593|79393713|FG001|Overall Study|Incarceration|0|||
44387422|NCT00710593|79393712|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
44387423|NCT00710593|79393713|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
44387424|NCT00710593|79393712|FG000|Overall Study|Lost to Follow-up|3|||
44387425|NCT00710593|79393713|FG001|Overall Study|Lost to Follow-up|1|||
44387426|NCT00710593|79393712|FG000|Overall Study|Moved out of area|1|||
44387427|NCT00710593|79393713|FG001|Overall Study|Moved out of area|0|||
44387428|NCT00710593|79393712|FG000|Overall Study|Failure to adhere or complete study eval|1|||
44387429|NCT00710593|79393713|FG001|Overall Study|Failure to adhere or complete study eval|1|||
44387430|NCT00710593|79393712|FG000|Overall Study|Protocol Violation|1|||
44280416|NCT01944774|79241440|FG002|Overall Study|Lack of Efficacy|2|||
44280417|NCT01944774|79241438|FG000|Overall Study|Lost to Follow-up|0|||
44280418|NCT01944774|79241439|FG001|Overall Study|Lost to Follow-up|1|||
44280419|NCT01944774|79241440|FG002|Overall Study|Lost to Follow-up|0|||
44280420|NCT01944462|79241451|FG000|PPPP Educational Program|Lost to Follow-up|60|||
44280421|NCT01943292|79241459|FG000|Overall Study|Withdrawal by Subject|1|||
44280422|NCT01943292|79241460|FG001|Overall Study|Withdrawal by Subject|0|||
44280423|NCT01943292|79241461|FG002|Overall Study|Withdrawal by Subject|0|||
44280424|NCT01961544|79241469|FG000|Overall Study|Protocol Violation|1|||
44387431|NCT00710593|79393713|FG001|Overall Study|Protocol Violation|1|||
44387432|NCT00710593|79393712|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
44387433|NCT00710593|79393713|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
44387434|NCT00599313|79393735|FG000|Overall Study|Adverse Event|19|||
44387435|NCT00599313|79393735|FG000|Overall Study|Disease Progression|12|||
44387436|NCT00599313|79393735|FG000|Overall Study|Patient Request|4|||
44387437|NCT00599313|79393735|FG000|Overall Study|Ineligible|1|||
44387438|NCT00708175|79393741|FG000|Overall Study|Adverse Event|4|||
44387439|NCT00708175|79393742|FG001|Overall Study|Adverse Event|5|||
44387440|NCT00708175|79393741|FG000|Overall Study|Protocol Violation|2|||
44387441|NCT00708175|79393742|FG001|Overall Study|Protocol Violation|3|||
44387442|NCT00708175|79393741|FG000|Overall Study|Lost to Follow-up|5|||
44387443|NCT00708175|79393742|FG001|Overall Study|Lost to Follow-up|3|||
44387444|NCT00708175|79393741|FG000|Overall Study|Withdrawal by Subject|5|||
44387445|NCT00708175|79393742|FG001|Overall Study|Withdrawal by Subject|7|||
44387446|NCT00708175|79393741|FG000|Overall Study|BMD loss >7%|2|||
44387447|NCT00708175|79393742|FG001|Overall Study|BMD loss >7%|3|||
44387448|NCT00707239|79393751|FG000|Overall Study|Adverse Event|5|||
44387449|NCT00707239|79393752|FG001|Overall Study|Adverse Event|3|||
44387450|NCT00707239|79393753|FG002|Overall Study|Adverse Event|2|||
44387451|NCT00707239|79393751|FG000|Overall Study|Death|3|||
44387452|NCT00707239|79393752|FG001|Overall Study|Death|1|||
44387453|NCT00707239|79393753|FG002|Overall Study|Death|3|||
44387454|NCT00707239|79393751|FG000|Overall Study|Physician Decision|1|||
44387455|NCT00707239|79393752|FG001|Overall Study|Physician Decision|1|||
44387456|NCT00707239|79393753|FG002|Overall Study|Physician Decision|2|||
44387457|NCT00707239|79393751|FG000|Overall Study|Protocol Violation|0|||
44387458|NCT00707239|79393752|FG001|Overall Study|Protocol Violation|0|||
44387459|NCT00707239|79393753|FG002|Overall Study|Protocol Violation|1|||
44387460|NCT00707239|79393751|FG000|Overall Study|Lack of Efficacy|1|||
44387461|NCT00707239|79393752|FG001|Overall Study|Lack of Efficacy|2|||
44280425|NCT01961544|79241469|FG000|Overall Study|Withdrawal by Subject|7|||
44280426|NCT01961544|79241469|FG000|Overall Study|Adverse Event|1|||
44280427|NCT01961544|79241469|FG000|Overall Study|Physician Decision|2|||
44280428|NCT01961544|79241469|FG000|Overall Study|Poor Tolerance|1|||
44280429|NCT01961544|79241469|FG000|Overall Study|Aggravation of Steral Pain|1|||
44280430|NCT01942590|79241475|FG000|Overall Study|Withdrawal by Subject|0|||
44280431|NCT01942590|79241476|FG001|Overall Study|Withdrawal by Subject|1|||
44387462|NCT00707239|79393753|FG002|Overall Study|Lack of Efficacy|0|||
44387463|NCT00707239|79393751|FG000|Overall Study|Randomized, but not treated|1|||
44387464|NCT00707239|79393752|FG001|Overall Study|Randomized, but not treated|1|||
44387465|NCT00707239|79393753|FG002|Overall Study|Randomized, but not treated|1|||
44387466|NCT00707239|79393751|FG000|Overall Study|Other|8|||
44387467|NCT00707239|79393752|FG001|Overall Study|Other|3|||
44387468|NCT00707239|79393753|FG002|Overall Study|Other|5|||
44387469|NCT00968708|79393766|FG000|Overall Study|Adverse Event|169|||
44387470|NCT00968708|79393767|FG001|Overall Study|Adverse Event|150|||
44387471|NCT00968708|79393766|FG000|Overall Study|Major Protocol Deviation|0|||
44387472|NCT00968708|79393767|FG001|Overall Study|Major Protocol Deviation|1|||
44387473|NCT00968708|79393766|FG000|Overall Study|Lost to Follow-up|19|||
44280432|NCT01942590|79241475|FG000|Overall Study|Adverse Event|1|||
44280433|NCT01942590|79241476|FG001|Overall Study|Adverse Event|0|||
44280434|NCT01984242|79241486|FG000|Overall Study|Death|52|||
44280435|NCT01984242|79241487|FG001|Overall Study|Death|50|||
44280436|NCT01984242|79241488|FG002|Overall Study|Death|52|||
44387474|NCT00968708|79393767|FG001|Overall Study|Lost to Follow-up|11|||
44387475|NCT00968708|79393766|FG000|Overall Study|Voluntary Withdrawal|104|||
44387476|NCT00968708|79393767|FG001|Overall Study|Voluntary Withdrawal|101|||
44387477|NCT00968708|79393766|FG000|Overall Study|Investigator Discretion|0|||
44387478|NCT00968708|79393767|FG001|Overall Study|Investigator Discretion|1|||
44387479|NCT00968708|79393766|FG000|Overall Study|Other|26|||
44387480|NCT00968708|79393767|FG001|Overall Study|Other|34|||
44387481|NCT00967694|79393773|FG000|Overall Study|Withdrawal by Subject|6|||
44387482|NCT00967616|79393779|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
44387483|NCT00967616|79393780|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
44387484|NCT00967616|79393779|FG000|Overall Study|Death|0|||
44387485|NCT00967616|79393780|FG001|Overall Study|Death|3|||
44387486|NCT00967616|79393779|FG000|Overall Study|Withdrawal by Subject|8|||
44387487|NCT00967616|79393780|FG001|Overall Study|Withdrawal by Subject|4|||
44387488|NCT00967616|79393779|FG000|Overall Study|Progressive Disease|31|||
44387489|NCT00967616|79393780|FG001|Overall Study|Progressive Disease|18|||
44387490|NCT00967616|79393779|FG000|Overall Study|Other|8|||
44387491|NCT00967616|79393780|FG001|Overall Study|Other|8|||
44387492|NCT00967616|79393779|FG000|Overall Study|Protocol Violation|1|||
44387493|NCT00967616|79393780|FG001|Overall Study|Protocol Violation|0|||
44387494|NCT00971204|79393790|FG000|Overall Study|Did not meet all criteria-not treated|14|||
44387495|NCT00971204|79393790|FG000|Overall Study|Lost to Follow-up|10|||
44387496|NCT00974090|79393796|FG000|Period 1: Double Blind Period|Adverse Event|2|||
44387497|NCT00974090|79393797|FG001|Period 1: Double Blind Period|Adverse Event|1|||
44280437|NCT01984242|79241486|FG000|Overall Study|Withdrawal by Subject|5|||
44280438|NCT01984242|79241487|FG001|Overall Study|Withdrawal by Subject|3|||
44280439|NCT01984242|79241488|FG002|Overall Study|Withdrawal by Subject|10|||
44280440|NCT01984242|79241486|FG000|Overall Study|Physician Decision|0|||
44280441|NCT01984242|79241487|FG001|Overall Study|Physician Decision|0|||
44280442|NCT01984242|79241488|FG002|Overall Study|Physician Decision|1|||
44280443|NCT01984242|79241486|FG000|Overall Study|Lost to Follow-up|4|||
44251674|NCT01049919|79087265|FG000|Overall Study|Early study termination by sponsor.|2|||
44251675|NCT01049919|79087266|FG001|Overall Study|Early study termination by sponsor.|0|||
44251676|NCT01049373|79087274|FG000|Overall Study|Protocol Violation|9|||
44251677|NCT01049373|79087275|FG001|Overall Study|Protocol Violation|9|||
44251678|NCT01049373|79087274|FG000|Overall Study|Withdrawal by Subject|8|||
44251679|NCT01049373|79087275|FG001|Overall Study|Withdrawal by Subject|5|||
44251680|NCT01049373|79087274|FG000|Overall Study|Adverse Event|3|||
44251681|NCT01049373|79087275|FG001|Overall Study|Adverse Event|3|||
44251682|NCT01049373|79087274|FG000|Overall Study|Lost to Follow-up|9|||
44251683|NCT01049373|79087275|FG001|Overall Study|Lost to Follow-up|4|||
44251684|NCT01049373|79087274|FG000|Overall Study|no evaluable study values|9|||
44251685|NCT01049373|79087275|FG001|Overall Study|no evaluable study values|21|||
44251686|NCT01049373|79087274|FG000|Overall Study|Other|1|||
44251687|NCT01049373|79087275|FG001|Overall Study|Other|1|||
44251688|NCT01049373|79087274|FG000|Overall Study|Non-cooperation|0|||
44251689|NCT01049373|79087275|FG001|Overall Study|Non-cooperation|1|||
44251690|NCT00985231|79087285|FG000|Overall Study|ineligible|1|||
44251691|NCT00985231|79087286|FG001|Overall Study|ineligible|0|||
44251692|NCT00985231|79087285|FG000|Overall Study|Protocol Violation|1|||
44251693|NCT00985231|79087286|FG001|Overall Study|Protocol Violation|0|||
44251694|NCT00985231|79087285|FG000|Overall Study|Withdrawal by Subject|1|||
44251695|NCT00985231|79087286|FG001|Overall Study|Withdrawal by Subject|0|||
44251696|NCT00985231|79087285|FG000|Overall Study|Lost to Follow-up|0|||
44251697|NCT00985231|79087286|FG001|Overall Study|Lost to Follow-up|1|||
44251698|NCT00985231|79087285|FG000|Overall Study|Study related symptoms & complaints|0|||
44251699|NCT00985231|79087286|FG001|Overall Study|Study related symptoms & complaints|2|||
44251700|NCT01048671|79087306|FG000|Overall Study|Protocol Violation|0|||
44251701|NCT01048671|79087307|FG001|Overall Study|Protocol Violation|1|||
44251702|NCT01048671|79087308|FG002|Overall Study|Protocol Violation|1|||
44251703|NCT01360866|79087320|FG000|Overall Study|Lost to Follow-up|11|||
44251704|NCT01360866|79087321|FG001|Overall Study|Lost to Follow-up|28|||
44280444|NCT01984242|79241487|FG001|Overall Study|Lost to Follow-up|0|||
44280445|NCT01984242|79241488|FG002|Overall Study|Lost to Follow-up|3|||
44280446|NCT01984242|79241486|FG000|Overall Study|Sponsor Decision|1|||
44280447|NCT01984242|79241487|FG001|Overall Study|Sponsor Decision|0|||
44280448|NCT01984242|79241488|FG002|Overall Study|Sponsor Decision|0|||
44280449|NCT01984242|79241486|FG000|Overall Study|Non-Compliance|1|||
44387498|NCT00974090|79393796|FG000|Period 1: Double Blind Period|Physician Decision|1|||
44387499|NCT00974090|79393797|FG001|Period 1: Double Blind Period|Physician Decision|0|||
44387500|NCT00974090|79393796|FG000|Period 2: Open-label Period|Adverse Event|4|||
44387501|NCT00974090|79393797|FG001|Period 2: Open-label Period|Adverse Event|6|||
44251705|NCT01360866|79087322|FG002|Overall Study|Lost to Follow-up|41|||
44251706|NCT01360866|79087323|FG003|Overall Study|Lost to Follow-up|0|||
44251707|NCT01360866|79087320|FG000|Overall Study|Adverse Event|56|||
44251708|NCT01360866|79087321|FG001|Overall Study|Adverse Event|61|||
44251709|NCT01360866|79087322|FG002|Overall Study|Adverse Event|134|||
44251710|NCT01360866|79087323|FG003|Overall Study|Adverse Event|6|||
44251711|NCT01360866|79087320|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
44280450|NCT01984242|79241487|FG001|Overall Study|Non-Compliance|0|||
44251712|NCT01360866|79087321|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
44280451|NCT01984242|79241488|FG002|Overall Study|Non-Compliance|0|||
44387502|NCT00974090|79393796|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
44387503|NCT00974090|79393797|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
44387504|NCT00974090|79393796|FG000|Period 2: Open-label Period|Physician Decision|0|||
44387505|NCT00974090|79393797|FG001|Period 2: Open-label Period|Physician Decision|3|||
44387506|NCT00974090|79393796|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
44387507|NCT00974090|79393797|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
44387508|NCT00971048|79393809|FG000|Overall Study|Protocol Violation|1|||
44387509|NCT00971048|79393810|FG001|Overall Study|Protocol Violation|2|||
44387510|NCT00971048|79393811|FG002|Overall Study|Protocol Violation|0|||
44387511|NCT00971048|79393812|FG003|Overall Study|Protocol Violation|1|||
44387512|NCT00971048|79393809|FG000|Overall Study|Adverse Event|0|||
44387513|NCT00971048|79393810|FG001|Overall Study|Adverse Event|0|||
44387514|NCT00971048|79393811|FG002|Overall Study|Adverse Event|1|||
44387515|NCT00971048|79393812|FG003|Overall Study|Adverse Event|0|||
44387516|NCT00971048|79393809|FG000|Overall Study|Physician Decision|0|||
44387517|NCT00971048|79393810|FG001|Overall Study|Physician Decision|0|||
44387518|NCT00971048|79393811|FG002|Overall Study|Physician Decision|0|||
44387519|NCT00971048|79393812|FG003|Overall Study|Physician Decision|1|||
44387520|NCT00699751|79393826|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
44387521|NCT00699751|79393827|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
44387522|NCT00699751|79393826|FG000|Period 1: Without/Before Drug Switch|Death|28|||
44387523|NCT00699751|79393827|FG001|Period 1: Without/Before Drug Switch|Death|29|||
44387524|NCT00699751|79393826|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
44387525|NCT00699751|79393827|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
44387526|NCT00699751|79393826|FG000|Period 1: Without/Before Drug Switch|Other|30|||
44387527|NCT00699751|79393827|FG001|Period 1: Without/Before Drug Switch|Other|20|||
44387528|NCT00699751|79393826|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
44387529|NCT00699751|79393827|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
44387530|NCT00699751|79393826|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
44387531|NCT00699751|79393827|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
44387532|NCT00699751|79393826|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
44387533|NCT00699751|79393827|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
44387534|NCT00699751|79393826|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
44387535|NCT00699751|79393827|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
44387536|NCT00970502|79393834|FG000|Overall Study|Withdrawal by Subject|1|||
44387537|NCT00967226|79393844|FG000|Overall Study|Adverse Event|0|||
44387538|NCT00967226|79393845|FG001|Overall Study|Adverse Event|5|||
44387539|NCT00967226|79393844|FG000|Overall Study|Protocol Violation|2|||
44387540|NCT00967226|79393845|FG001|Overall Study|Protocol Violation|0|||
44387541|NCT00967226|79393844|FG000|Overall Study|Physician Decision|0|||
44387542|NCT00967226|79393845|FG001|Overall Study|Physician Decision|1|||
44387543|NCT00706381|79393879|FG000|Overall Study|Lost to Follow-up|0|||
44387544|NCT00706381|79393880|FG001|Overall Study|Lost to Follow-up|1|||
44387545|NCT00706381|79393881|FG002|Overall Study|Lost to Follow-up|1|||
44387546|NCT00706381|79393882|FG003|Overall Study|Lost to Follow-up|0|||
44387547|NCT00964886|79393899|FG000|Overall Study|Lost to Follow-up|2|||
44387548|NCT00964886|79393900|FG001|Overall Study|Lost to Follow-up|2|||
44387549|NCT00964886|79393901|FG002|Overall Study|Lost to Follow-up|6|||
44387550|NCT00964886|79393902|FG003|Overall Study|Lost to Follow-up|4|||
44387551|NCT00964886|79393899|FG000|Overall Study|Withdrawal by Subject|6|||
44387552|NCT00964886|79393900|FG001|Overall Study|Withdrawal by Subject|2|||
44387553|NCT00964886|79393901|FG002|Overall Study|Withdrawal by Subject|5|||
44387554|NCT00964886|79393902|FG003|Overall Study|Withdrawal by Subject|3|||
44387555|NCT00964886|79393899|FG000|Overall Study|Adverse Event|3|||
44387556|NCT00964886|79393900|FG001|Overall Study|Adverse Event|1|||
44387557|NCT00964886|79393901|FG002|Overall Study|Adverse Event|5|||
44387558|NCT00964886|79393902|FG003|Overall Study|Adverse Event|2|||
44387559|NCT00964886|79393899|FG000|Overall Study|Protocol Violation|0|||
44387560|NCT00964886|79393900|FG001|Overall Study|Protocol Violation|2|||
44387561|NCT00964886|79393901|FG002|Overall Study|Protocol Violation|0|||
44387562|NCT00964886|79393902|FG003|Overall Study|Protocol Violation|0|||
44387563|NCT00705757|79393919|FG000|Overall Study|Lack of Efficacy|5|||
44387564|NCT00705757|79393920|FG001|Overall Study|Lack of Efficacy|1|||
44387565|NCT00705757|79393921|FG002|Overall Study|Lack of Efficacy|3|||
44387566|NCT00705757|79393919|FG000|Overall Study|Lost to Follow-up|7|||
44387567|NCT00705757|79393920|FG001|Overall Study|Lost to Follow-up|6|||
44387568|NCT00705757|79393921|FG002|Overall Study|Lost to Follow-up|6|||
44387569|NCT00705757|79393919|FG000|Overall Study|Withdrawal by Subject|1|||
44387570|NCT00705757|79393920|FG001|Overall Study|Withdrawal by Subject|1|||
44387571|NCT00705757|79393921|FG002|Overall Study|Withdrawal by Subject|2|||
44387572|NCT00960752|79393949|FG000|Overall Study|Adverse Event|0|||
44387573|NCT00960752|79393950|FG001|Overall Study|Adverse Event|0|||
44387574|NCT00960752|79393951|FG002|Overall Study|Adverse Event|1|||
44387575|NCT00960752|79393949|FG000|Overall Study|Progression|0|||
44387576|NCT00960752|79393950|FG001|Overall Study|Progression|0|||
44387577|NCT00960752|79393951|FG002|Overall Study|Progression|1|||
44387578|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
44387579|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
44387580|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
44387581|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387582|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
44387583|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
44387584|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387585|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387586|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387587|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387588|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387589|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387590|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387591|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387592|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387593|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387594|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
44387595|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
44387596|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387597|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
44387598|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
44387599|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
44387600|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
44387601|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387602|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387603|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387604|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387605|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387606|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387607|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387608|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387609|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387610|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387611|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
44387612|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
44387613|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
44387614|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
44387615|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
44387616|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
44387617|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
44387618|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387619|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387620|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387621|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387622|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387623|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387624|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387625|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387626|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387627|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387628|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
44387629|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387630|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
44387631|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
44387632|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387633|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
44387634|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
44387635|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387636|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387637|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387638|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387639|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387640|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387641|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44146258|NCT02292706|78935559|FG000|Overall Study|Investigator's discretion|4|||
44387642|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387643|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387644|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387645|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
44387646|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387647|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387648|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
44387649|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
44387650|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387651|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387652|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387653|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387654|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387655|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387656|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387657|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387658|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387659|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387660|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387661|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387662|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
44387663|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387664|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387665|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387666|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387667|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
44387668|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387669|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387670|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387671|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387672|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44280452|NCT01984242|79241486|FG000|Overall Study|Study terminated by Sponsor|38|||
44280453|NCT01984242|79241487|FG001|Overall Study|Study terminated by Sponsor|50|||
44280454|NCT01984242|79241488|FG002|Overall Study|Study terminated by Sponsor|34|||
44280455|NCT01984242|79241486|FG000|Overall Study|Disease Progression|0|||
44280456|NCT01984242|79241487|FG001|Overall Study|Disease Progression|0|||
44280457|NCT01984242|79241488|FG002|Overall Study|Disease Progression|1|||
44280458|NCT01941498|79241504|FG000|Overall Study|Relocated out of state|1|||
44280459|NCT01960998|79241525|FG000|Overall Study|Lost to Follow-up|3|||
44280460|NCT01960998|79241526|FG001|Overall Study|Lost to Follow-up|7|||
44280461|NCT01960998|79241525|FG000|Overall Study|Death|0|||
44280462|NCT01960998|79241526|FG001|Overall Study|Death|1|||
44280463|NCT01960998|79241525|FG000|Overall Study|Withdrawal by Subject|8|||
44280464|NCT01960998|79241526|FG001|Overall Study|Withdrawal by Subject|2|||
44280465|NCT01960998|79241525|FG000|Overall Study|lost computer access|0|||
44280466|NCT01960998|79241526|FG001|Overall Study|lost computer access|1|||
44280467|NCT01941186|79241536|FG000|Follow-up|Lost to Follow-up|1|||
44280468|NCT01941186|79241537|FG001|Follow-up|Lost to Follow-up|0|||
44280469|NCT01960842|79241556|FG000|Overall Study|Adverse Event|1|||
44280470|NCT01960842|79241556|FG000|Overall Study|Withdrawal by Subject|2|||
44280471|NCT01984164|79241562|FG000|Overall Study|Withdrawal by Subject|4|||
44280472|NCT01984164|79241563|FG001|Overall Study|Withdrawal by Subject|3|||
44280473|NCT01984164|79241562|FG000|Overall Study|Adverse Event|5|||
44280474|NCT01984164|79241563|FG001|Overall Study|Adverse Event|19|||
44280475|NCT01984164|79241562|FG000|Overall Study|Lost to Follow-up|1|||
44280476|NCT01984164|79241563|FG001|Overall Study|Lost to Follow-up|3|||
44280477|NCT01983930|79241571|FG000|Overall Study|Withdrawal by Subject|9|||
44280478|NCT01983930|79241572|FG001|Overall Study|Withdrawal by Subject|8|||
44280479|NCT01983930|79241571|FG000|Overall Study|Adverse Event|0|||
44280480|NCT01983930|79241572|FG001|Overall Study|Adverse Event|1|||
44280481|NCT01983774|79241585|FG000|Overall Study|Lung Transplant|0|||
44280482|NCT01983774|79241586|FG001|Overall Study|Lung Transplant|1|||
44280483|NCT01983774|79241585|FG000|Overall Study|Lost to Follow-up|1|||
44280484|NCT01983774|79241586|FG001|Overall Study|Lost to Follow-up|0|||
44280485|NCT01982682|79241594|FG000|Overall Study|Physician Decision|1|||
44280486|NCT01940484|79241599|FG000|Overall Study|Withdrawal by Subject|3|||
44280487|NCT01940484|79241599|FG000|Overall Study|Underwent transplantation|4|||
44387673|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387674|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44280488|NCT01940484|79241599|FG000|Overall Study|Death|2|||
44280489|NCT01940484|79241599|FG000|Overall Study|Adverse Event|1|||
44280490|NCT01939548|79241606|FG000|Overall Study|Non compliance|0|||
44280491|NCT01939548|79241607|FG001|Overall Study|Non compliance|2|||
44280492|NCT01939548|79241608|FG002|Overall Study|Non compliance|0|||
44280493|NCT01939548|79241606|FG000|Overall Study|Study Terminated by Sponsor|17|||
44280494|NCT01939548|79241607|FG001|Overall Study|Study Terminated by Sponsor|19|||
44280495|NCT01939548|79241608|FG002|Overall Study|Study Terminated by Sponsor|12|||
44387675|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387676|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387677|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387678|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387679|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
44387680|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387681|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
44387682|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387683|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387684|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387685|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387686|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387687|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387688|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387689|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387690|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387691|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387692|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387693|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387694|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387695|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387696|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
44387697|NCT00758524|79393965|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387698|NCT00758524|79393966|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
44387699|NCT00758524|79393967|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387700|NCT00758524|79393968|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387701|NCT00758524|79393969|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387702|NCT00758524|79393970|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387703|NCT00758524|79393971|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387704|NCT00758524|79393972|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387705|NCT00758524|79393973|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387706|NCT00758524|79393974|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387707|NCT00758524|79393975|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387708|NCT00758524|79393976|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387709|NCT00758524|79393977|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387710|NCT00758524|79393978|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387711|NCT00758524|79393979|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387712|NCT00758524|79393980|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387713|NCT00758524|79393981|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
44387714|NCT00758524|79393965|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387715|NCT00758524|79393966|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387716|NCT00758524|79393967|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387717|NCT00758524|79393968|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387718|NCT00758524|79393969|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387719|NCT00758524|79393970|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387720|NCT00758524|79393971|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387721|NCT00758524|79393972|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387722|NCT00758524|79393973|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
44251713|NCT01360866|79087322|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
44251714|NCT01360866|79087323|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
44251715|NCT01360866|79087320|FG000|Overall Study|Withdrawn by Investigator|9|||
44251716|NCT01360866|79087321|FG001|Overall Study|Withdrawn by Investigator|8|||
44251717|NCT01360866|79087322|FG002|Overall Study|Withdrawn by Investigator|31|||
44387723|NCT00758524|79393974|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387724|NCT00758524|79393975|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387725|NCT00758524|79393976|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387726|NCT00758524|79393977|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387727|NCT00758524|79393978|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387728|NCT00758524|79393979|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44251718|NCT01360866|79087323|FG003|Overall Study|Withdrawn by Investigator|2|||
44251719|NCT01360866|79087320|FG000|Overall Study|Withdrawal by participant|79|||
44251720|NCT01360866|79087321|FG001|Overall Study|Withdrawal by participant|89|||
44251721|NCT01360866|79087322|FG002|Overall Study|Withdrawal by participant|168|||
44387729|NCT00758524|79393980|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387730|NCT00758524|79393981|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
44387731|NCT00758524|79393965|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387732|NCT00758524|79393966|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387733|NCT00758524|79393967|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387734|NCT00758524|79393968|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387735|NCT00758524|79393969|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387736|NCT00758524|79393970|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387737|NCT00758524|79393971|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
44387738|NCT00758524|79393972|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44280496|NCT01939548|79241606|FG000|Overall Study|Insufficient Clinical Response|1|||
44387739|NCT00758524|79393973|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387740|NCT00758524|79393974|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387741|NCT00758524|79393975|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387742|NCT00758524|79393976|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387743|NCT00758524|79393977|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387744|NCT00758524|79393978|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387745|NCT00758524|79393979|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387746|NCT00758524|79393980|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387747|NCT00758524|79393981|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
44387748|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
44387749|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
44387750|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
44387751|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
44387752|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
44387753|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
44387754|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
44387755|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
44387756|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
44387757|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
44387758|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
44387759|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
44387760|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
44387761|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
44387762|NCT00757588|79394021|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
44387763|NCT00757588|79394022|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
44387764|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
44387765|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
44387766|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
44387767|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
44387768|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
44387769|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
44387770|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
44387771|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
44387772|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
44387773|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
44387774|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
44387775|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
44387776|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
44387777|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
44387778|NCT00757588|79394021|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
44387779|NCT00757588|79394022|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
44387780|NCT00744796|79394028|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
44387781|NCT00705679|79394037|FG000|Overall Study|Adverse Event|1|||
44251722|NCT01360866|79087323|FG003|Overall Study|Withdrawal by participant|8|||
44251723|NCT01360866|79087320|FG000|Overall Study|Protocol Deviation|25|||
44251724|NCT01360866|79087321|FG001|Overall Study|Protocol Deviation|33|||
44251725|NCT01360866|79087322|FG002|Overall Study|Protocol Deviation|61|||
44251726|NCT01360866|79087323|FG003|Overall Study|Protocol Deviation|2|||
44251727|NCT01360866|79087320|FG000|Overall Study|Lack of Efficacy|30|||
44251728|NCT01360866|79087321|FG001|Overall Study|Lack of Efficacy|40|||
44251729|NCT01360866|79087322|FG002|Overall Study|Lack of Efficacy|30|||
44251730|NCT01360866|79087323|FG003|Overall Study|Lack of Efficacy|4|||
44280497|NCT01939548|79241607|FG001|Overall Study|Insufficient Clinical Response|0|||
44280498|NCT01939548|79241608|FG002|Overall Study|Insufficient Clinical Response|0|||
44280499|NCT01939548|79241606|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
44280500|NCT01939548|79241607|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
44387782|NCT00705679|79394038|FG001|Overall Study|Adverse Event|1|||
44387783|NCT00705679|79394039|FG002|Overall Study|Adverse Event|0|||
44387784|NCT00705679|79394040|FG003|Overall Study|Adverse Event|0|||
44387785|NCT00705679|79394041|FG004|Overall Study|Adverse Event|0|||
44387786|NCT00705679|79394037|FG000|Overall Study|Death|0|||
44387787|NCT00705679|79394038|FG001|Overall Study|Death|0|||
44387788|NCT00705679|79394039|FG002|Overall Study|Death|3|||
44387789|NCT00705679|79394040|FG003|Overall Study|Death|2|||
44387790|NCT00705679|79394041|FG004|Overall Study|Death|1|||
44387791|NCT00705679|79394037|FG000|Overall Study|Lost to Follow-up|32|||
44387792|NCT00705679|79394038|FG001|Overall Study|Lost to Follow-up|60|||
44387793|NCT00705679|79394039|FG002|Overall Study|Lost to Follow-up|44|||
44387794|NCT00705679|79394040|FG003|Overall Study|Lost to Follow-up|30|||
44387795|NCT00705679|79394041|FG004|Overall Study|Lost to Follow-up|35|||
44387796|NCT00705679|79394037|FG000|Overall Study|Physician Decision|0|||
44387797|NCT00705679|79394038|FG001|Overall Study|Physician Decision|1|||
44387798|NCT00705679|79394039|FG002|Overall Study|Physician Decision|0|||
44387799|NCT00705679|79394040|FG003|Overall Study|Physician Decision|1|||
44387800|NCT00705679|79394041|FG004|Overall Study|Physician Decision|0|||
44387801|NCT00705679|79394037|FG000|Overall Study|Withdrawal by Subject|32|||
44387802|NCT00705679|79394038|FG001|Overall Study|Withdrawal by Subject|77|||
44387803|NCT00705679|79394039|FG002|Overall Study|Withdrawal by Subject|68|||
44387804|NCT00705679|79394040|FG003|Overall Study|Withdrawal by Subject|47|||
44387805|NCT00705679|79394041|FG004|Overall Study|Withdrawal by Subject|33|||
44387806|NCT00751348|79394064|FG000|Overall Study|Withdrawal by Subject|5|||
44387807|NCT00751348|79394065|FG001|Overall Study|Withdrawal by Subject|2|||
44387808|NCT00751348|79394064|FG000|Overall Study|Migration from study area|1|||
44387809|NCT00751348|79394065|FG001|Overall Study|Migration from study area|0|||
44387810|NCT00751114|79394073|FG000|Overall Study|Adverse Event|2|||
44387811|NCT00751114|79394074|FG001|Overall Study|Adverse Event|4|||
44387812|NCT00751114|79394073|FG000|Overall Study|Protocol Violation|8|||
44387813|NCT00751114|79394074|FG001|Overall Study|Protocol Violation|9|||
44387814|NCT00751114|79394073|FG000|Overall Study|Withdrawal by Subject|9|||
44387815|NCT00751114|79394074|FG001|Overall Study|Withdrawal by Subject|4|||
44387816|NCT00751114|79394073|FG000|Overall Study|Lost to Follow-up|4|||
44387817|NCT00751114|79394074|FG001|Overall Study|Lost to Follow-up|7|||
44387818|NCT00751114|79394073|FG000|Overall Study|Lack of Efficacy|0|||
44387819|NCT00751114|79394074|FG001|Overall Study|Lack of Efficacy|7|||
44387820|NCT00751114|79394073|FG000|Overall Study|Not Treated|13|||
44387821|NCT00751114|79394074|FG001|Overall Study|Not Treated|1|||
44387822|NCT00751114|79394073|FG000|Overall Study|Out of country for 2 months|1|||
44387823|NCT00751114|79394074|FG001|Overall Study|Out of country for 2 months|0|||
44387824|NCT00751114|79394073|FG000|Overall Study|Move to another city|1|||
44387825|NCT00751114|79394074|FG001|Overall Study|Move to another city|0|||
44387826|NCT00960440|79394084|FG000|Overall Study|Death|0|||
44387827|NCT00960440|79394085|FG001|Overall Study|Death|0|||
44387828|NCT00960440|79394086|FG002|Overall Study|Death|0|||
44387829|NCT00960440|79394087|FG003|Overall Study|Death|1|||
44387830|NCT00960440|79394084|FG000|Overall Study|Adverse Event|12|||
44387831|NCT00960440|79394085|FG001|Overall Study|Adverse Event|12|||
44387832|NCT00960440|79394086|FG002|Overall Study|Adverse Event|4|||
44387833|NCT00960440|79394087|FG003|Overall Study|Adverse Event|4|||
44387834|NCT00960440|79394084|FG000|Overall Study|Lack of Efficacy|2|||
44387835|NCT00960440|79394085|FG001|Overall Study|Lack of Efficacy|5|||
44387836|NCT00960440|79394086|FG002|Overall Study|Lack of Efficacy|3|||
44387837|NCT00960440|79394087|FG003|Overall Study|Lack of Efficacy|8|||
44519097|NCT02954406|79526970|FG002|Overall Study|Progressive Disease|3|||
44251731|NCT00985153|79087337|FG000|Overall Study|Lost to Follow-up|16|||
44251732|NCT00985153|79087338|FG001|Overall Study|Lost to Follow-up|19|||
44251733|NCT00985153|79087339|FG002|Overall Study|Lost to Follow-up|17|||
44251734|NCT00985153|79087340|FG003|Overall Study|Lost to Follow-up|20|||
44387838|NCT00960440|79394084|FG000|Overall Study|Protocol Violation|2|||
44387839|NCT00960440|79394085|FG001|Overall Study|Protocol Violation|8|||
44387840|NCT00960440|79394086|FG002|Overall Study|Protocol Violation|3|||
44387841|NCT00960440|79394087|FG003|Overall Study|Protocol Violation|4|||
44387842|NCT00960440|79394084|FG000|Overall Study|Withdrawal by Subject|9|||
44387843|NCT00960440|79394085|FG001|Overall Study|Withdrawal by Subject|5|||
44387844|NCT00960440|79394086|FG002|Overall Study|Withdrawal by Subject|2|||
44519098|NCT02954406|79526971|FG003|Overall Study|Progressive Disease|4|||
44519099|NCT02954406|79526972|FG004|Overall Study|Progressive Disease|3|||
44519100|NCT02954406|79526973|FG005|Overall Study|Progressive Disease|3|||
44519101|NCT02954406|79526974|FG006|Overall Study|Progressive Disease|2|||
44387845|NCT00960440|79394087|FG003|Overall Study|Withdrawal by Subject|1|||
44387846|NCT00960440|79394084|FG000|Overall Study|Other|1|||
44387847|NCT00960440|79394085|FG001|Overall Study|Other|1|||
44387848|NCT00960440|79394086|FG002|Overall Study|Other|1|||
44387849|NCT00960440|79394087|FG003|Overall Study|Other|0|||
44387850|NCT04909853|79394131|FG000|Part 1|Assigned but not treated|0|||
44387851|NCT04909853|79394132|FG001|Part 1|Assigned but not treated|0|||
44387852|NCT04909853|79394133|FG002|Part 1|Assigned but not treated|1|||
44387853|NCT04909853|79394134|FG003|Part 1|Assigned but not treated|0|||
44387854|NCT04909853|79394131|FG000|Part 2|Adverse Event|0|||
44387855|NCT04909853|79394132|FG001|Part 2|Adverse Event|0|||
44387856|NCT04909853|79394133|FG002|Part 2|Adverse Event|0|||
44387857|NCT04909853|79394134|FG003|Part 2|Adverse Event|1|||
44387858|NCT04811664|79394147|FG000|Overall Study|Lost to Follow-up|78|||
44251735|NCT00985153|79087337|FG000|Overall Study|Protocol Violation|3|||
44251736|NCT00985153|79087338|FG001|Overall Study|Protocol Violation|2|||
44251737|NCT00985153|79087339|FG002|Overall Study|Protocol Violation|4|||
44251738|NCT00985153|79087340|FG003|Overall Study|Protocol Violation|3|||
44251739|NCT00985153|79087337|FG000|Overall Study|Withdrawal by Subject|6|||
44280501|NCT01939548|79241608|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
44280502|NCT01939548|79241606|FG000|Overall Study|Withdrawal by Subject|4|||
44280503|NCT01939548|79241607|FG001|Overall Study|Withdrawal by Subject|4|||
44280504|NCT01939548|79241608|FG002|Overall Study|Withdrawal by Subject|1|||
44280505|NCT01939548|79241606|FG000|Overall Study|Protocol Violation|7|||
44280506|NCT01939548|79241607|FG001|Overall Study|Protocol Violation|6|||
44280507|NCT01939548|79241608|FG002|Overall Study|Protocol Violation|5|||
44280508|NCT01939548|79241606|FG000|Overall Study|Lost to Follow-up|5|||
44280509|NCT01939548|79241607|FG001|Overall Study|Lost to Follow-up|5|||
44280510|NCT01939548|79241608|FG002|Overall Study|Lost to Follow-up|3|||
44280511|NCT01939548|79241606|FG000|Overall Study|Adverse Event|2|||
44280512|NCT01939548|79241607|FG001|Overall Study|Adverse Event|9|||
44280513|NCT01939548|79241608|FG002|Overall Study|Adverse Event|7|||
44280514|NCT01939548|79241606|FG000|Overall Study|Death|0|||
44280515|NCT01939548|79241607|FG001|Overall Study|Death|0|||
44280516|NCT01939548|79241608|FG002|Overall Study|Death|1|||
44280517|NCT01939548|79241606|FG000|Overall Study|Participant dropped|0|||
44280518|NCT01939548|79241607|FG001|Overall Study|Participant dropped|0|||
44280519|NCT01939548|79241608|FG002|Overall Study|Participant dropped|1|||
44280520|NCT01939548|79241606|FG000|Overall Study|Participant unwilling to continue|0|||
44280521|NCT01939548|79241607|FG001|Overall Study|Participant unwilling to continue|1|||
44280522|NCT01939548|79241608|FG002|Overall Study|Participant unwilling to continue|0|||
44280523|NCT01939548|79241606|FG000|Overall Study|Participant withdrew consent|0|||
44280524|NCT01939548|79241607|FG001|Overall Study|Participant withdrew consent|2|||
44280525|NCT01939548|79241608|FG002|Overall Study|Participant withdrew consent|0|||
44280526|NCT01939548|79241606|FG000|Overall Study|Did not complete follow-up|0|||
44280527|NCT01939548|79241607|FG001|Overall Study|Did not complete follow-up|1|||
44280528|NCT01939548|79241608|FG002|Overall Study|Did not complete follow-up|0|||
44280529|NCT01960296|79241618|FG000|Overall Study|Postponed surgery|1|||
44280530|NCT01960296|79241619|FG001|Overall Study|Postponed surgery|0|||
44280531|NCT01960296|79241618|FG000|Overall Study|Received different procedure|1|||
44280532|NCT01960296|79241619|FG001|Overall Study|Received different procedure|3|||
44280533|NCT01982292|79241627|FG000|Overall Study|Adverse Event|2|||
44280534|NCT01982292|79241628|FG001|Overall Study|Adverse Event|0|||
44280535|NCT01982292|79241627|FG000|Overall Study|Death|1|||
44280536|NCT01982292|79241628|FG001|Overall Study|Death|0|||
44280537|NCT01982292|79241627|FG000|Overall Study|Lost to Follow-up|2|||
44280538|NCT01982292|79241628|FG001|Overall Study|Lost to Follow-up|0|||
44280539|NCT01982292|79241627|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
44280540|NCT01982292|79241628|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
44280541|NCT01982292|79241627|FG000|Overall Study|Protocol Deviation|1|||
44280542|NCT01982292|79241628|FG001|Overall Study|Protocol Deviation|0|||
44280543|NCT01982292|79241627|FG000|Overall Study|Patient/Guardian Decision|3|||
44280544|NCT01982292|79241628|FG001|Overall Study|Patient/Guardian Decision|1|||
44280545|NCT01982292|79241627|FG000|Overall Study|Technical Problems|2|||
44280546|NCT01982292|79241628|FG001|Overall Study|Technical Problems|0|||
44280547|NCT01939314|79241636|FG000|Overall Study|Withdrawal by Subject|3|||
44280548|NCT01939314|79241637|FG001|Overall Study|Withdrawal by Subject|1|||
44280549|NCT01939314|79241636|FG000|Overall Study|Protocol Violation|1|||
44280550|NCT01939314|79241637|FG001|Overall Study|Protocol Violation|0|||
44280551|NCT01939314|79241636|FG000|Overall Study|Pregnancy|0|||
44251740|NCT00985153|79087338|FG001|Overall Study|Withdrawal by Subject|11|||
44251741|NCT00985153|79087339|FG002|Overall Study|Withdrawal by Subject|11|||
44280552|NCT01939314|79241637|FG001|Overall Study|Pregnancy|1|||
44280553|NCT01939314|79241636|FG000|Overall Study|Lost to Follow-up|5|||
44280554|NCT01939314|79241637|FG001|Overall Study|Lost to Follow-up|6|||
44280555|NCT01939158|79241649|FG000|Overall Study|Adverse Event|1|||
44280556|NCT01939158|79241650|FG001|Overall Study|Adverse Event|0|||
44280557|NCT01939158|79241651|FG002|Overall Study|Adverse Event|0|||
44280558|NCT01939158|79241652|FG003|Overall Study|Adverse Event|0|||
44280559|NCT01939158|79241649|FG000|Overall Study|Withdrawal by Subject|22|||
44251742|NCT00985153|79087340|FG003|Overall Study|Withdrawal by Subject|10|||
44251743|NCT00985153|79087337|FG000|Overall Study|Missed One or More Bleeds|7|||
44280560|NCT01939158|79241650|FG001|Overall Study|Withdrawal by Subject|25|||
44280561|NCT01939158|79241651|FG002|Overall Study|Withdrawal by Subject|15|||
44280562|NCT01939158|79241652|FG003|Overall Study|Withdrawal by Subject|17|||
44387859|NCT04811664|79394148|FG001|Overall Study|Lost to Follow-up|125|||
44387860|NCT04811664|79394149|FG002|Overall Study|Lost to Follow-up|46|||
44387861|NCT04811664|79394147|FG000|Overall Study|Withdrawal by Subject|39|||
44387862|NCT04811664|79394148|FG001|Overall Study|Withdrawal by Subject|76|||
44387863|NCT04811664|79394149|FG002|Overall Study|Withdrawal by Subject|12|||
44387864|NCT04811664|79394147|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
44387865|NCT04811664|79394148|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
44387866|NCT04811664|79394149|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
44387867|NCT04811664|79394147|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
44387868|NCT04811664|79394148|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
44387869|NCT04811664|79394149|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
44387870|NCT04811664|79394147|FG000|Overall Study|Protocol Violation|0|||
44387871|NCT04811664|79394148|FG001|Overall Study|Protocol Violation|5|||
44387872|NCT04811664|79394149|FG002|Overall Study|Protocol Violation|11|||
44387873|NCT04811664|79394147|FG000|Overall Study|Study Terminated by Sponsor|4|||
44387874|NCT04811664|79394148|FG001|Overall Study|Study Terminated by Sponsor|3|||
44387875|NCT04811664|79394149|FG002|Overall Study|Study Terminated by Sponsor|34|||
44387876|NCT04811664|79394147|FG000|Overall Study|Early Study Closure|3|||
44387877|NCT04811664|79394148|FG001|Overall Study|Early Study Closure|7|||
44387878|NCT04811664|79394149|FG002|Overall Study|Early Study Closure|79|||
44387879|NCT04811664|79394147|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
44387880|NCT04811664|79394148|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
44387881|NCT04811664|79394149|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
44387882|NCT04119414|79394166|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
44387883|NCT03762265|79394195|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
44387884|NCT03762265|79394196|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
44387885|NCT03762265|79394195|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
44387886|NCT03762265|79394196|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
44387887|NCT03762265|79394195|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
44387888|NCT03762265|79394196|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
44387889|NCT03762265|79394195|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
44387890|NCT03762265|79394196|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
44387891|NCT03762265|79394195|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
44387892|NCT03762265|79394196|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
44387893|NCT03762265|79394195|FG000|BT Period: Weeks 1 to 37|Other|0|||
44387894|NCT03762265|79394196|FG001|BT Period: Weeks 1 to 37|Other|1|||
44387895|NCT03762265|79394195|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
44387896|NCT03762265|79394196|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
44387897|NCT03762265|79394195|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
44387898|NCT03762265|79394196|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
44387899|NCT03762265|79394195|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
44387900|NCT03762265|79394196|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
44387901|NCT03762265|79394195|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
44387902|NCT03762265|79394196|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
44387903|NCT03762265|79394195|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
44387904|NCT03762265|79394196|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
44387905|NCT03762265|79394195|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
44387906|NCT03762265|79394196|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
44387907|NCT03762265|79394195|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
44387908|NCT03762265|79394196|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
44387909|NCT03762265|79394195|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
44387910|NCT03762265|79394196|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
44387911|NCT03762265|79394195|FG000|LTE Period: Weeks 61 to 109|Other|1|||
44387912|NCT03762265|79394196|FG001|LTE Period: Weeks 61 to 109|Other|0|||
44280563|NCT01939158|79241649|FG000|Overall Study|Migrated/moved from study area|5|||
44280564|NCT01939158|79241650|FG001|Overall Study|Migrated/moved from study area|7|||
44280565|NCT01939158|79241651|FG002|Overall Study|Migrated/moved from study area|3|||
44280566|NCT01939158|79241652|FG003|Overall Study|Migrated/moved from study area|6|||
44280567|NCT01939158|79241649|FG000|Overall Study|Lost to Follow-up|18|||
44280568|NCT01939158|79241650|FG001|Overall Study|Lost to Follow-up|17|||
44280569|NCT01939158|79241651|FG002|Overall Study|Lost to Follow-up|17|||
44280570|NCT01939158|79241652|FG003|Overall Study|Lost to Follow-up|17|||
44280571|NCT01939158|79241649|FG000|Overall Study|Death|0|||
44280572|NCT01939158|79241650|FG001|Overall Study|Death|0|||
44280573|NCT01939158|79241651|FG002|Overall Study|Death|1|||
44280574|NCT01939158|79241652|FG003|Overall Study|Death|1|||
44280575|NCT01939158|79241649|FG000|Overall Study|No longer meets eligibility criteria|0|||
44280576|NCT01939158|79241650|FG001|Overall Study|No longer meets eligibility criteria|0|||
44387915|NCT03642938|79394246|FG000|Overall Study|Withdrawal by Subject|0|||
44387916|NCT03642938|79394247|FG001|Overall Study|Withdrawal by Subject|0|||
44387917|NCT03642938|79394248|FG002|Overall Study|Withdrawal by Subject|0|||
44387918|NCT03642938|79394249|FG003|Overall Study|Withdrawal by Subject|1|||
44387919|NCT03562767|79394262|FG000|Overall Study|Physician Decision|2|||
44387920|NCT03562767|79394263|FG001|Overall Study|Physician Decision|0|||
44387921|NCT03562767|79394264|FG002|Overall Study|Physician Decision|0|||
44387922|NCT03562767|79394262|FG000|Overall Study|Logistic Reason|1|||
44387923|NCT03562767|79394263|FG001|Overall Study|Logistic Reason|3|||
44387924|NCT03562767|79394264|FG002|Overall Study|Logistic Reason|0|||
44387925|NCT03333941|79394276|FG000|Overall Study|Lost to Follow-up|10|||
44387926|NCT03333941|79394276|FG000|Overall Study|Death|2|||
44387927|NCT03333941|79394276|FG000|Overall Study|Adverse Event|1|||
44387928|NCT03315754|79394280|FG000|Overall Study|COVID-19 complications leading to death|1|||
44387929|NCT03315754|79394280|FG000|Overall Study|insurance coverage issue|1|||
44387930|NCT02440711|79394299|FG000|Second Intervention|Lost to Follow-up|1|||
44387931|NCT02440711|79394300|FG001|Second Intervention|Lost to Follow-up|0|||
44387932|NCT02223767|79394310|FG000|Overall Study|Withdrawal by Subject|4|||
44387933|NCT02223767|79394311|FG001|Overall Study|Withdrawal by Subject|4|||
44387934|NCT01956773|79394330|FG000|Overall Study|Lost to Follow-up|628|||
44387935|NCT01956773|79394331|FG001|Overall Study|Lost to Follow-up|1|||
44387936|NCT01946529|79394340|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
44387937|NCT01946529|79394341|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
44387938|NCT01946529|79394342|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
44387939|NCT01946529|79394340|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
44387940|NCT01946529|79394341|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
44387941|NCT01946529|79394342|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
44387942|NCT01666808|79394364|FG000|Overall Study|Lost to Follow-up|9|||
44387943|NCT01666808|79394365|FG001|Overall Study|Lost to Follow-up|15|||
44387944|NCT01666808|79394364|FG000|Overall Study|Withdrawal by Subject|3|||
44387945|NCT01666808|79394365|FG001|Overall Study|Withdrawal by Subject|1|||
44387946|NCT01666808|79394364|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
44387947|NCT01666808|79394365|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
44387948|NCT00964028|79394382|FG000|Overall Study|Withdrawal by Subject|0|||
44387949|NCT00964028|79394383|FG001|Overall Study|Withdrawal by Subject|1|||
44387950|NCT00960206|79394392|FG000|Overall Study|Death|7|||
44387951|NCT00960206|79394393|FG001|Overall Study|Death|4|||
44387952|NCT00960206|79394394|FG002|Overall Study|Death|1|||
44387953|NCT00960206|79394392|FG000|Overall Study|Unwilling/Unable to return|1|||
44387954|NCT00960206|79394393|FG001|Overall Study|Unwilling/Unable to return|2|||
44387955|NCT00960206|79394394|FG002|Overall Study|Unwilling/Unable to return|0|||
44387956|NCT00960206|79394392|FG000|Overall Study|Lost to Follow-up|8|||
44387957|NCT00960206|79394393|FG001|Overall Study|Lost to Follow-up|14|||
44387958|NCT00960206|79394394|FG002|Overall Study|Lost to Follow-up|8|||
44519102|NCT02954406|79526975|FG007|Overall Study|Progressive Disease|2|||
44519103|NCT02954406|79526976|FG008|Overall Study|Progressive Disease|1|||
44519104|NCT02954406|79526977|FG009|Overall Study|Progressive Disease|1|||
44519105|NCT02954406|79526978|FG010|Overall Study|Progressive Disease|0|||
44519106|NCT02954406|79526968|FG000|Overall Study|Symptomatic Deterioration|0|||
44519107|NCT02954406|79526969|FG001|Overall Study|Symptomatic Deterioration|1|||
44519108|NCT02954406|79526970|FG002|Overall Study|Symptomatic Deterioration|0|||
44519109|NCT02954406|79526971|FG003|Overall Study|Symptomatic Deterioration|0|||
44519110|NCT02954406|79526972|FG004|Overall Study|Symptomatic Deterioration|0|||
44251744|NCT00985153|79087338|FG001|Overall Study|Missed One or More Bleeds|7|||
44519111|NCT02954406|79526973|FG005|Overall Study|Symptomatic Deterioration|0|||
44519112|NCT02954406|79526974|FG006|Overall Study|Symptomatic Deterioration|0|||
44519113|NCT02954406|79526975|FG007|Overall Study|Symptomatic Deterioration|0|||
44519114|NCT02954406|79526976|FG008|Overall Study|Symptomatic Deterioration|0|||
44519115|NCT02954406|79526977|FG009|Overall Study|Symptomatic Deterioration|0|||
44519116|NCT02954406|79526978|FG010|Overall Study|Symptomatic Deterioration|0|||
44251745|NCT00985153|79087339|FG002|Overall Study|Missed One or More Bleeds|8|||
44251746|NCT00985153|79087340|FG003|Overall Study|Missed One or More Bleeds|10|||
44251747|NCT00985153|79087337|FG000|Overall Study|Incomplete Safety Follow-up|3|||
44251748|NCT00985153|79087338|FG001|Overall Study|Incomplete Safety Follow-up|5|||
44251749|NCT00985153|79087339|FG002|Overall Study|Incomplete Safety Follow-up|4|||
44251750|NCT00985153|79087340|FG003|Overall Study|Incomplete Safety Follow-up|4|||
44251751|NCT01047345|79087352|FG000|Base Study|Adverse Event|3|||
44387959|NCT00960206|79394392|FG000|Overall Study|Withdrawal by Subject|2|||
44387960|NCT00960206|79394393|FG001|Overall Study|Withdrawal by Subject|4|||
44387961|NCT00960206|79394394|FG002|Overall Study|Withdrawal by Subject|0|||
44387962|NCT00960206|79394392|FG000|Overall Study|Revision of study component|2|||
44387963|NCT00960206|79394393|FG001|Overall Study|Revision of study component|2|||
44387964|NCT00960206|79394394|FG002|Overall Study|Revision of study component|2|||
44387965|NCT00960206|79394392|FG000|Overall Study|Missing 10 year data|20|||
44387966|NCT00960206|79394393|FG001|Overall Study|Missing 10 year data|1|||
44146259|NCT02292706|78935560|FG001|Overall Study|Investigator's discretion|9|||
44146260|NCT02292706|78935561|FG002|Overall Study|Investigator's discretion|7|||
44146261|NCT02292706|78935562|FG003|Overall Study|Investigator's discretion|11|||
44146262|NCT02292706|78935563|FG004|Overall Study|Investigator's discretion|4|||
44146263|NCT02292706|78935564|FG005|Overall Study|Investigator's discretion|10|||
44146264|NCT02292706|78935565|FG006|Overall Study|Investigator's discretion|1|||
44146265|NCT02292706|78935566|FG007|Overall Study|Investigator's discretion|0|||
44146266|NCT02292706|78935559|FG000|Overall Study|Liver transplant|1|||
44146267|NCT02292706|78935560|FG001|Overall Study|Liver transplant|1|||
44146268|NCT02292706|78935561|FG002|Overall Study|Liver transplant|11|||
44146269|NCT02292706|78935562|FG003|Overall Study|Liver transplant|16|||
44146270|NCT02292706|78935563|FG004|Overall Study|Liver transplant|5|||
44146271|NCT02292706|78935564|FG005|Overall Study|Liver transplant|6|||
44146272|NCT02292706|78935565|FG006|Overall Study|Liver transplant|5|||
44146273|NCT02292706|78935566|FG007|Overall Study|Liver transplant|0|||
44146274|NCT02292706|78935559|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
44146275|NCT02292706|78935560|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
44146276|NCT02292706|78935561|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
44146277|NCT02292706|78935562|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
44146278|NCT02292706|78935563|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
44146279|NCT02292706|78935564|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
44146280|NCT02292706|78935565|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
44146281|NCT02292706|78935566|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
44146282|NCT02292706|78935559|FG000|Overall Study|Subject terminated by sponsor|1|||
44146283|NCT02292706|78935560|FG001|Overall Study|Subject terminated by sponsor|0|||
44146284|NCT02292706|78935561|FG002|Overall Study|Subject terminated by sponsor|0|||
44146285|NCT02292706|78935562|FG003|Overall Study|Subject terminated by sponsor|2|||
44146286|NCT02292706|78935563|FG004|Overall Study|Subject terminated by sponsor|1|||
44146287|NCT02292706|78935564|FG005|Overall Study|Subject terminated by sponsor|0|||
44146288|NCT02292706|78935565|FG006|Overall Study|Subject terminated by sponsor|0|||
44146289|NCT02292706|78935566|FG007|Overall Study|Subject terminated by sponsor|0|||
44146290|NCT02292706|78935559|FG000|Overall Study|Missing|0|||
44146291|NCT02292706|78935560|FG001|Overall Study|Missing|0|||
44146292|NCT02292706|78935561|FG002|Overall Study|Missing|1|||
44146293|NCT02292706|78935562|FG003|Overall Study|Missing|1|||
44146294|NCT02292706|78935563|FG004|Overall Study|Missing|0|||
44146295|NCT02292706|78935564|FG005|Overall Study|Missing|1|||
44146296|NCT02292706|78935565|FG006|Overall Study|Missing|0|||
44146297|NCT02292706|78935566|FG007|Overall Study|Missing|0|||
44146298|NCT02292706|78935559|FG000|Overall Study|Virologic relapse or reinfection|1|||
44146299|NCT02292706|78935560|FG001|Overall Study|Virologic relapse or reinfection|0|||
44146300|NCT02292706|78935561|FG002|Overall Study|Virologic relapse or reinfection|0|||
44146301|NCT02292706|78935562|FG003|Overall Study|Virologic relapse or reinfection|1|||
44146302|NCT02292706|78935563|FG004|Overall Study|Virologic relapse or reinfection|0|||
44146303|NCT02292706|78935564|FG005|Overall Study|Virologic relapse or reinfection|1|||
44146304|NCT02292706|78935565|FG006|Overall Study|Virologic relapse or reinfection|0|||
44146305|NCT02292706|78935566|FG007|Overall Study|Virologic relapse or reinfection|0|||
44146306|NCT01930539|78935590|FG000|Overall Study|Withdrawal by Subject|2|||
44146307|NCT01930539|78935591|FG001|Overall Study|Withdrawal by Subject|2|||
44146308|NCT01459068|78935599|FG000|Overall Study|Withdrawal by Subject|8|||
44146309|NCT01459068|78935600|FG001|Overall Study|Withdrawal by Subject|18|||
44146310|NCT01459068|78935599|FG000|Overall Study|Lost to Follow-up|31|||
44251752|NCT01047345|79087353|FG001|Base Study|Adverse Event|0|||
44251753|NCT01047345|79087354|FG002|Base Study|Adverse Event|0|||
44146311|NCT01459068|78935600|FG001|Overall Study|Lost to Follow-up|15|||
44146312|NCT01459068|78935599|FG000|Overall Study|Death|0|||
44146313|NCT01459068|78935600|FG001|Overall Study|Death|1|||
44146314|NCT01216202|78935608|FG000|Overall Study|Withdrawal by Subject|8|||
44387967|NCT00960206|79394394|FG002|Overall Study|Missing 10 year data|1|||
44387968|NCT00751036|79394405|FG000|Overall Study|Disease Progression|28|||
44387969|NCT00751036|79394406|FG001|Overall Study|Disease Progression|29|||
44387970|NCT00751036|79394405|FG000|Overall Study|Adverse Event|6|||
44387971|NCT00751036|79394406|FG001|Overall Study|Adverse Event|4|||
44387972|NCT00751036|79394405|FG000|Overall Study|Administrative Problems|3|||
44387973|NCT00751036|79394406|FG001|Overall Study|Administrative Problems|4|||
44387974|NCT00751036|79394405|FG000|Overall Study|Withdrawal by Subject|5|||
44387975|NCT00751036|79394406|FG001|Overall Study|Withdrawal by Subject|2|||
44387976|NCT00751036|79394405|FG000|Overall Study|Death|3|||
44387977|NCT00751036|79394406|FG001|Overall Study|Death|3|||
44387978|NCT00751036|79394405|FG000|Overall Study|Lost to Follow-up|0|||
44387979|NCT00751036|79394406|FG001|Overall Study|Lost to Follow-up|1|||
44387980|NCT00751036|79394405|FG000|Overall Study|Protocol Violation|1|||
44387981|NCT00751036|79394406|FG001|Overall Study|Protocol Violation|0|||
44387982|NCT00751036|79394405|FG000|Overall Study|Missing end of Treatment Page|2|||
44387983|NCT00751036|79394406|FG001|Overall Study|Missing end of Treatment Page|3|||
44387984|NCT00961298|79394412|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
44387985|NCT00961298|79394412|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
44387986|NCT00961298|79394412|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
44387987|NCT00744328|79394419|FG000|Overall Study|Lost to Follow-up|2|||
44387988|NCT00744328|79394420|FG001|Overall Study|Lost to Follow-up|5|||
44387989|NCT00744328|79394421|FG002|Overall Study|Lost to Follow-up|3|||
44387990|NCT00744328|79394419|FG000|Overall Study|Withdrawal by Subject|5|||
44387991|NCT00744328|79394420|FG001|Overall Study|Withdrawal by Subject|3|||
44387992|NCT00744328|79394421|FG002|Overall Study|Withdrawal by Subject|4|||
44387993|NCT00744328|79394419|FG000|Overall Study|Found ineligible after randomization|0|||
44387994|NCT00744328|79394420|FG001|Overall Study|Found ineligible after randomization|0|||
44387995|NCT00744328|79394421|FG002|Overall Study|Found ineligible after randomization|1|||
44387996|NCT03245840|79394431|FG000|Overall Study|Adverse Event|6|||
44387997|NCT03245840|79394432|FG001|Overall Study|Adverse Event|0|||
44387998|NCT03245840|79394431|FG000|Overall Study|Death|2|||
44387999|NCT03245840|79394432|FG001|Overall Study|Death|0|||
44388000|NCT03245840|79394431|FG000|Overall Study|Withdrawal by Subject|31|||
44388001|NCT03245840|79394432|FG001|Overall Study|Withdrawal by Subject|1|||
44388002|NCT03245840|79394431|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
44388003|NCT03245840|79394432|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44388004|NCT03245840|79394431|FG000|Overall Study|Physician Decision|4|||
44388005|NCT03245840|79394432|FG001|Overall Study|Physician Decision|1|||
44388006|NCT03245840|79394431|FG000|Overall Study|Study Terminated by Sponsor|56|||
44388007|NCT03245840|79394432|FG001|Overall Study|Study Terminated by Sponsor|6|||
44519117|NCT02954406|79526968|FG000|Overall Study|Death|0|||
44519118|NCT02954406|79526969|FG001|Overall Study|Death|0|||
44519119|NCT02954406|79526970|FG002|Overall Study|Death|0|||
44519120|NCT02954406|79526971|FG003|Overall Study|Death|0|||
44519121|NCT02954406|79526972|FG004|Overall Study|Death|1|||
44519122|NCT02954406|79526973|FG005|Overall Study|Death|0|||
44519123|NCT02954406|79526974|FG006|Overall Study|Death|0|||
44519124|NCT02954406|79526975|FG007|Overall Study|Death|0|||
44519125|NCT02954406|79526976|FG008|Overall Study|Death|1|||
44519126|NCT02954406|79526977|FG009|Overall Study|Death|1|||
44519127|NCT02954406|79526978|FG010|Overall Study|Death|0|||
44519128|NCT02954406|79526968|FG000|Overall Study|Reason Not Specified|0|||
44519129|NCT02954406|79526969|FG001|Overall Study|Reason Not Specified|0|||
44519130|NCT02954406|79526970|FG002|Overall Study|Reason Not Specified|3|||
44519131|NCT02954406|79526971|FG003|Overall Study|Reason Not Specified|2|||
44519132|NCT02954406|79526972|FG004|Overall Study|Reason Not Specified|2|||
44519133|NCT02954406|79526973|FG005|Overall Study|Reason Not Specified|0|||
44519134|NCT02954406|79526974|FG006|Overall Study|Reason Not Specified|1|||
44519135|NCT02954406|79526975|FG007|Overall Study|Reason Not Specified|0|||
44519136|NCT02954406|79526976|FG008|Overall Study|Reason Not Specified|1|||
44519137|NCT02954406|79526977|FG009|Overall Study|Reason Not Specified|0|||
44519138|NCT02954406|79526978|FG010|Overall Study|Reason Not Specified|0|||
44519139|NCT03514914|79527008|FG000|Overall Study|Death|3|||
44519140|NCT03514914|79527009|FG001|Overall Study|Death|3|||
44519141|NCT03514914|79527008|FG000|Overall Study|Lost to Follow-up|117|||
44388008|NCT03245840|79394431|FG000|Overall Study|Site Terminated by Sponsor|4|||
44388009|NCT03245840|79394432|FG001|Overall Study|Site Terminated by Sponsor|0|||
44519142|NCT03514914|79527009|FG001|Overall Study|Lost to Follow-up|89|||
44519143|NCT03513588|79527018|FG000|Overall Study|Lost to Follow-up|0|||
44519144|NCT03513588|79527019|FG001|Overall Study|Lost to Follow-up|1|||
44519145|NCT03513588|79527020|FG002|Overall Study|Lost to Follow-up|1|||
44519146|NCT03513588|79527018|FG000|Overall Study|Study dosing paused by sponsor|1|||
44519147|NCT03513588|79527019|FG001|Overall Study|Study dosing paused by sponsor|1|||
44519148|NCT03513588|79527020|FG002|Overall Study|Study dosing paused by sponsor|0|||
44519149|NCT03513588|79527018|FG000|Overall Study|Death|0|||
44388010|NCT03245840|79394431|FG000|Overall Study|Lost to Follow-up|12|||
44388011|NCT03245840|79394432|FG001|Overall Study|Lost to Follow-up|2|||
44388012|NCT03245840|79394431|FG000|Overall Study|Pregnancy|2|||
44388013|NCT03245840|79394432|FG001|Overall Study|Pregnancy|0|||
44388014|NCT03245840|79394431|FG000|Overall Study|Non-Compliance with Study Drug|2|||
44388015|NCT03245840|79394432|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44388016|NCT03245840|79394431|FG000|Overall Study|Not treated|1|||
44388017|NCT03245840|79394432|FG001|Overall Study|Not treated|1|||
44388018|NCT00959894|79394438|FG000|Overall Study|Lost to Follow-up|10|||
44388019|NCT00959894|79394438|FG000|Overall Study|Adverse Event|3|||
44388020|NCT00959894|79394438|FG000|Overall Study|Withdrawal by Subject|1|||
44388021|NCT00959894|79394438|FG000|Overall Study|Need for contraindicated medication|1|||
44388022|NCT00959894|79394438|FG000|Overall Study|Subject moved out of town|1|||
44388023|NCT00750880|79394443|FG000|Overall Study|Adverse Event|76|||
44388024|NCT00750880|79394443|FG000|Overall Study|Death|4|||
44388025|NCT00750880|79394443|FG000|Overall Study|Lack of Efficacy|46|||
44388026|NCT00750880|79394443|FG000|Overall Study|Lost to Follow-up|10|||
44388027|NCT00750880|79394443|FG000|Overall Study|Protocol Violation|15|||
44388028|NCT00750880|79394443|FG000|Overall Study|Withdrawal by Subject|33|||
44388029|NCT00750880|79394443|FG000|Overall Study|Physician Decision|20|||
44388030|NCT00750880|79394443|FG000|Overall Study|Administrative|11|||
44388031|NCT00746590|79394448|FG000|Overall Study|Death|1|||
44388032|NCT01032629|79394455|FG000|Overall Study|Closed Site|21|||
44388033|NCT01032629|79394456|FG001|Overall Study|Closed Site|18|||
44388034|NCT01032629|79394457|FG002|Overall Study|Closed Site|16|||
44388035|NCT01032629|79394455|FG000|Overall Study|Withdrawal by Subject|50|||
44388036|NCT01032629|79394456|FG001|Overall Study|Withdrawal by Subject|36|||
44388037|NCT01032629|79394457|FG002|Overall Study|Withdrawal by Subject|35|||
44388038|NCT01032629|79394455|FG000|Overall Study|Lost to Follow-up|74|||
44388039|NCT01032629|79394456|FG001|Overall Study|Lost to Follow-up|47|||
44388040|NCT01032629|79394457|FG002|Overall Study|Lost to Follow-up|37|||
44388041|NCT00749944|79394468|FG000|Overall Study|Lost to Follow-up|2|||
44388042|NCT00749944|79394469|FG001|Overall Study|Lost to Follow-up|1|||
44388043|NCT00749944|79394468|FG000|Overall Study|Other|1|||
44388044|NCT00749944|79394469|FG001|Overall Study|Other|0|||
44388045|NCT00749944|79394468|FG000|Overall Study|Withdrawal by Subject|2|||
44388046|NCT00749944|79394469|FG001|Overall Study|Withdrawal by Subject|0|||
44388047|NCT00749398|79394475|FG000|Overall Study|Lack of Efficacy|7|||
44388048|NCT00749398|79394475|FG000|Overall Study|Adverse Event|4|||
44388049|NCT00749398|79394475|FG000|Overall Study|Serious adverse event|11|||
44388050|NCT00749398|79394475|FG000|Overall Study|Withdrawal by Subject|17|||
44388051|NCT00749398|79394475|FG000|Overall Study|Lost to Follow-up|11|||
44251754|NCT01047345|79087352|FG000|Base Study|Lost to Follow-up|4|||
44251755|NCT01047345|79087353|FG001|Base Study|Lost to Follow-up|1|||
44251756|NCT01047345|79087354|FG002|Base Study|Lost to Follow-up|0|||
44251757|NCT01047345|79087352|FG000|Base Study|Protocol Violation|3|||
44251758|NCT01047345|79087353|FG001|Base Study|Protocol Violation|1|||
44251759|NCT01047345|79087354|FG002|Base Study|Protocol Violation|0|||
44251760|NCT01047345|79087352|FG000|Base Study|Withdrawal by Subject|12|||
44251761|NCT01047345|79087353|FG001|Base Study|Withdrawal by Subject|4|||
44251762|NCT01047345|79087354|FG002|Base Study|Withdrawal by Subject|0|||
44251763|NCT01047345|79087352|FG000|Extension|Withdrawal by Subject|0|||
44251764|NCT01047345|79087353|FG001|Extension|Withdrawal by Subject|0|||
44251765|NCT01047345|79087354|FG002|Extension|Withdrawal by Subject|1|||
44251766|NCT01047345|79087352|FG000|Extension|Lost to Follow-up|0|||
44251767|NCT01047345|79087353|FG001|Extension|Lost to Follow-up|0|||
44251768|NCT01047345|79087354|FG002|Extension|Lost to Follow-up|5|||
44251769|NCT01046877|79087362|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
44251770|NCT01046877|79087362|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
44251771|NCT00984061|79087366|FG000|Clarithromycin Alone|Protocol Violation|1|||
44251772|NCT01046643|79087375|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
44251773|NCT01046643|79087376|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
44251774|NCT01046643|79087377|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
44388052|NCT00749398|79394475|FG000|Overall Study|Reason not specified|2|||
44388053|NCT00749398|79394475|FG000|Overall Study|Unknown reason|1|||
44388054|NCT00746356|79394479|FG000|Overall Study|Withdrawal by Subject|2|||
44388055|NCT00746356|79394480|FG001|Overall Study|Withdrawal by Subject|3|||
44388056|NCT00746356|79394479|FG000|Overall Study|Death|7|||
44251775|NCT01046643|79087378|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
44251776|NCT00983905|79087388|FG000|Theophylline Alone|Adverse Event|1|||
44251777|NCT00983905|79087388|FG000|Colchicine Alone|Adverse Event|2|||
44251778|NCT01046565|79087395|FG000|Overall Study|Adverse Event|2|||
44388057|NCT00746356|79394480|FG001|Overall Study|Death|3|||
44388058|NCT00746356|79394479|FG000|Overall Study|Lost to Follow-up|1|||
44388059|NCT00746356|79394480|FG001|Overall Study|Lost to Follow-up|0|||
44388060|NCT00746356|79394479|FG000|Overall Study|Removal of Device|0|||
44388061|NCT00746356|79394480|FG001|Overall Study|Removal of Device|1|||
44251779|NCT01046565|79087395|FG000|Overall Study|Withdrawal by Subject|7|||
44388062|NCT00746356|79394479|FG000|Overall Study|Patient relocated|1|||
44388063|NCT00746356|79394480|FG001|Overall Study|Patient relocated|0|||
44388064|NCT01012973|79394490|FG000|Overall Study|Adverse Event|5|||
44388065|NCT01012973|79394491|FG001|Overall Study|Adverse Event|5|||
44388066|NCT01012973|79394490|FG000|Overall Study|Lack of Efficacy|0|||
44388067|NCT01012973|79394491|FG001|Overall Study|Lack of Efficacy|5|||
44388068|NCT01012973|79394490|FG000|Overall Study|Lost to Follow-up|1|||
44388069|NCT01012973|79394491|FG001|Overall Study|Lost to Follow-up|0|||
44388070|NCT01012973|79394490|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
44388071|NCT01012973|79394491|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
44388072|NCT01012973|79394490|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
44388073|NCT01012973|79394491|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
44388074|NCT01012973|79394490|FG000|Overall Study|Protocol Violation|5|||
44388075|NCT01012973|79394491|FG001|Overall Study|Protocol Violation|2|||
44388076|NCT01012973|79394490|FG000|Overall Study|Withdrawal by Subject|4|||
44388077|NCT01012973|79394491|FG001|Overall Study|Withdrawal by Subject|6|||
44388078|NCT00748540|79394501|FG000|Overall Study|Physician Decision|1|||
44388079|NCT01012739|79394505|FG000|Treatment Period 1|Adverse Event|0|||
44388080|NCT01012739|79394506|FG001|Treatment Period 1|Adverse Event|0|||
44388081|NCT01012739|79394507|FG002|Treatment Period 1|Adverse Event|0|||
44388082|NCT01012739|79394508|FG003|Treatment Period 1|Adverse Event|1|||
44388083|NCT01012739|79394505|FG000|Treatment Period 2|Abnormal test procedure results|0|||
44388084|NCT01012739|79394506|FG001|Treatment Period 2|Abnormal test procedure results|0|||
44388085|NCT01012739|79394507|FG002|Treatment Period 2|Abnormal test procedure results|0|||
44388086|NCT01012739|79394508|FG003|Treatment Period 2|Abnormal test procedure results|1|||
44388087|NCT00742924|79394523|FG000|Overall Study|Adverse Event|0|||
44388088|NCT00742924|79394524|FG001|Overall Study|Adverse Event|0|||
44388089|NCT00742924|79394525|FG002|Overall Study|Adverse Event|1|||
44388090|NCT00742924|79394526|FG003|Overall Study|Adverse Event|1|||
44388091|NCT00742924|79394523|FG000|Overall Study|Lack of Efficacy|5|||
44388092|NCT00742924|79394524|FG001|Overall Study|Lack of Efficacy|1|||
44388093|NCT00742924|79394525|FG002|Overall Study|Lack of Efficacy|2|||
44388094|NCT00742924|79394526|FG003|Overall Study|Lack of Efficacy|4|||
44388095|NCT00742924|79394523|FG000|Overall Study|Physician Decision|0|||
44388096|NCT00742924|79394524|FG001|Overall Study|Physician Decision|0|||
44388097|NCT00742924|79394525|FG002|Overall Study|Physician Decision|0|||
44388098|NCT00742924|79394526|FG003|Overall Study|Physician Decision|1|||
44388099|NCT00742924|79394523|FG000|Overall Study|Withdrawal by Subject|0|||
44388100|NCT00742924|79394524|FG001|Overall Study|Withdrawal by Subject|1|||
44519150|NCT03513588|79527019|FG001|Overall Study|Death|0|||
44519151|NCT03513588|79527020|FG002|Overall Study|Death|1|||
44519152|NCT03512028|79527032|FG000|Overall Study|Withdrawal by Subject|2|||
44519153|NCT03512028|79527033|FG001|Overall Study|Withdrawal by Subject|0|||
44251780|NCT00983827|79087404|FG000|Overall Study|Withdrawal by Subject|1|||
44519154|NCT03512028|79527032|FG000|Overall Study|Protocol Violation|2|||
44519155|NCT03512028|79527033|FG001|Overall Study|Protocol Violation|0|||
44519156|NCT03511326|79527039|FG000|Overall Study|Withdrawal by Subject|1|||
44519157|NCT03508830|79527045|FG000|Overall Study|Withdrawal by Subject|3|||
44519158|NCT03508830|79527046|FG001|Overall Study|Withdrawal by Subject|4|||
44251781|NCT00983749|79087410|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
44388101|NCT00742924|79394525|FG002|Overall Study|Withdrawal by Subject|1|||
44388102|NCT00742924|79394526|FG003|Overall Study|Withdrawal by Subject|0|||
44388103|NCT00698815|79394539|FG000|Overall Study|Death|1|||
44388104|NCT00698815|79394540|FG001|Overall Study|Death|2|||
44388105|NCT00698815|79394541|FG002|Overall Study|Death|4|||
44388106|NCT00698815|79394539|FG000|Overall Study|Withdrawal by Subject|6|||
44519159|NCT03508830|79527045|FG000|Overall Study|Physician Decision|2|||
44519160|NCT03508830|79527046|FG001|Overall Study|Physician Decision|2|||
44388107|NCT00698815|79394540|FG001|Overall Study|Withdrawal by Subject|3|||
44146315|NCT01216202|78935609|FG001|Overall Study|Withdrawal by Subject|0|||
44146316|NCT01216202|78935608|FG000|Overall Study|Death|0|||
44146317|NCT01216202|78935609|FG001|Overall Study|Death|2|||
44280577|NCT01939158|79241651|FG002|Overall Study|No longer meets eligibility criteria|1|||
44280578|NCT01939158|79241652|FG003|Overall Study|No longer meets eligibility criteria|0|||
44519161|NCT03508050|79527054|FG000|Overall Study|Pleural adhesions|1|||
44519162|NCT03508050|79527055|FG001|Overall Study|Pleural adhesions|0|||
44519163|NCT03508050|79527054|FG000|Overall Study|Mucus plug|1|||
44519164|NCT03508050|79527055|FG001|Overall Study|Mucus plug|0|||
44519165|NCT03508050|79527054|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
44519166|NCT03508050|79527055|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
44519167|NCT03508050|79527054|FG000|Overall Study|Sustained desaturation|0|||
44519168|NCT03508050|79527055|FG001|Overall Study|Sustained desaturation|1|||
44146318|NCT01216202|78935608|FG000|Overall Study|Lost to Follow-up|14|||
44146319|NCT01216202|78935609|FG001|Overall Study|Lost to Follow-up|0|||
44519169|NCT03569202|79527064|FG000|Part 3|Physician Decision|1|||
44519170|NCT03569202|79527065|FG001|Part 3|Physician Decision|0|||
44519171|NCT03569202|79527064|FG000|Part 3|Other|1|||
44519172|NCT03569202|79527065|FG001|Part 3|Other|1|||
44519173|NCT03568500|79527074|FG000|Overall Study|Lost to Follow-up|1|||
44280579|NCT01939158|79241649|FG000|Overall Study|Other|1|||
44388108|NCT00698815|79394541|FG002|Overall Study|Withdrawal by Subject|2|||
44388109|NCT00698815|79394539|FG000|Overall Study|MD discretion|2|||
44388110|NCT00698815|79394540|FG001|Overall Study|MD discretion|7|||
44388111|NCT00698815|79394541|FG002|Overall Study|MD discretion|2|||
44388112|NCT00698815|79394539|FG000|Overall Study|Did not receive protocol treatment|1|||
44388113|NCT00698815|79394540|FG001|Overall Study|Did not receive protocol treatment|2|||
44388114|NCT00698815|79394541|FG002|Overall Study|Did not receive protocol treatment|2|||
44388115|NCT00745498|79394552|FG000|Overall Study|Lost to Follow-up|1|||
44388116|NCT00745498|79394553|FG001|Overall Study|Lost to Follow-up|1|||
44388117|NCT00745498|79394554|FG002|Overall Study|Lost to Follow-up|3|||
44388118|NCT00745498|79394552|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
44388119|NCT00745498|79394553|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
44388120|NCT00745498|79394554|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
44388121|NCT00745498|79394552|FG000|Overall Study|Non-PDR related VH|0|||
44388122|NCT00745498|79394553|FG001|Overall Study|Non-PDR related VH|1|||
44388123|NCT00745498|79394554|FG002|Overall Study|Non-PDR related VH|1|||
44388124|NCT00745498|79394552|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
44388125|NCT00745498|79394553|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
44388126|NCT00745498|79394554|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
44388127|NCT00744874|79394562|FG000|Overall Study|Lost to Follow-up|1|||
44388128|NCT00744874|79394562|FG000|Overall Study|Withdrawal by Subject|1|||
44388129|NCT00744874|79394562|FG000|Overall Study|Study Device not available at procedure|1|||
44388130|NCT00744874|79394562|FG000|Overall Study|Unable to accomodate schedule|1|||
44388131|NCT00576901|79394573|FG000|Overall Study|Withdrawal by Subject|1|||
44388132|NCT00576901|79394573|FG000|Overall Study|Disease course|1|||
44388133|NCT00576901|79394573|FG000|Overall Study|Protocol Violation|1|||
44388134|NCT00699283|79394579|FG000|Overall Study|Lack of Efficacy|15|||
44388135|NCT00699283|79394580|FG001|Overall Study|Lack of Efficacy|5|||
44388136|NCT00699283|79394579|FG000|Overall Study|Lost to Follow-up|2|||
44280580|NCT01939158|79241650|FG001|Overall Study|Other|3|||
44280581|NCT01939158|79241651|FG002|Overall Study|Other|4|||
44280582|NCT01939158|79241652|FG003|Overall Study|Other|3|||
44280583|NCT01939002|79241668|FG000|Overall Study|Adverse Event|13|||
44280584|NCT01939002|79241669|FG001|Overall Study|Adverse Event|13|||
44280585|NCT01939002|79241668|FG000|Overall Study|Withdrawal by Subject|5|||
44280586|NCT01939002|79241669|FG001|Overall Study|Withdrawal by Subject|3|||
44280587|NCT01939002|79241668|FG000|Overall Study|Other|1|||
44280588|NCT01939002|79241669|FG001|Overall Study|Other|2|||
44280589|NCT01938846|79241683|FG000|Overall Study|Progressive disease|26|||
44280590|NCT01938846|79241684|FG001|Overall Study|Progressive disease|18|||
44280591|NCT01938846|79241685|FG002|Overall Study|Progressive disease|16|||
44280592|NCT01938846|79241683|FG000|Overall Study|Adverse Event|8|||
44280593|NCT01938846|79241684|FG001|Overall Study|Adverse Event|4|||
44280594|NCT01938846|79241685|FG002|Overall Study|Adverse Event|3|||
44280595|NCT01938846|79241683|FG000|Overall Study|Withdrawal by Subject|2|||
44280596|NCT01938846|79241684|FG001|Overall Study|Withdrawal by Subject|2|||
44280597|NCT01938846|79241685|FG002|Overall Study|Withdrawal by Subject|1|||
44280598|NCT01938846|79241683|FG000|Overall Study|Other than listed|5|||
44280599|NCT01938846|79241684|FG001|Overall Study|Other than listed|1|||
44280600|NCT01938846|79241685|FG002|Overall Study|Other than listed|4|||
44280601|NCT01960140|79241726|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
44280602|NCT01981356|79241736|FG000|Overall Study|Lost to Follow-up|4|||
44280603|NCT01981356|79241737|FG001|Overall Study|Lost to Follow-up|1|||
44280604|NCT01981356|79241736|FG000|Overall Study|Withdrawal by Subject|1|||
44280605|NCT01981356|79241737|FG001|Overall Study|Withdrawal by Subject|1|||
44280606|NCT01981356|79241736|FG000|Overall Study|Protocol Violation|2|||
44280607|NCT01981356|79241737|FG001|Overall Study|Protocol Violation|0|||
44280608|NCT01981122|79241746|FG000|Overall Study|Withdrawal by Subject|0|||
44280609|NCT01981122|79241747|FG001|Overall Study|Withdrawal by Subject|2|||
44280610|NCT01981122|79241746|FG000|Overall Study|Protocol Violation|0|||
44280611|NCT01981122|79241747|FG001|Overall Study|Protocol Violation|1|||
44280612|NCT01981122|79241746|FG000|Overall Study|Lost to Follow-up|0|||
44280613|NCT01981122|79241747|FG001|Overall Study|Lost to Follow-up|1|||
44388137|NCT00699283|79394580|FG001|Overall Study|Lost to Follow-up|0|||
44388138|NCT00699283|79394579|FG000|Overall Study|Withdrawal by Subject|1|||
44388139|NCT00699283|79394580|FG001|Overall Study|Withdrawal by Subject|0|||
44388140|NCT00699283|79394579|FG000|Overall Study|Other Reason|5|||
44388141|NCT00699283|79394580|FG001|Overall Study|Other Reason|1|||
44388142|NCT00699283|79394579|FG000|Overall Study|SAE, non-fatal|1|||
44280614|NCT01981122|79241746|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
44280615|NCT01981122|79241747|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
44280616|NCT01981122|79241746|FG000|Overall Study|Death|14|||
44280617|NCT01981122|79241747|FG001|Overall Study|Death|15|||
44280618|NCT01980888|79241755|FG000|Overall Study|Study Terminated by Sponsor|116|||
44280619|NCT01980888|79241756|FG001|Overall Study|Study Terminated by Sponsor|122|||
44388143|NCT00699283|79394580|FG001|Overall Study|SAE, non-fatal|1|||
44388144|NCT00699283|79394579|FG000|Overall Study|AE, non-serious non-fatal|8|||
44388145|NCT00699283|79394580|FG001|Overall Study|AE, non-serious non-fatal|1|||
44388146|NCT00699283|79394579|FG000|Overall Study|AE of unknown type|1|||
44388147|NCT00699283|79394580|FG001|Overall Study|AE of unknown type|0|||
44388148|NCT00740584|79394585|FG000|Overall Study|Withdrawal by Subject|1|||
44388149|NCT01023815|79394594|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
44388150|NCT01023815|79394595|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
44388151|NCT01023815|79394596|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
44388152|NCT01023815|79394597|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
44388153|NCT01023815|79394594|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
44388154|NCT01023815|79394595|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
44388155|NCT01023815|79394596|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
44388156|NCT01023815|79394597|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
44388157|NCT01023815|79394594|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
44388158|NCT01023815|79394595|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
44388159|NCT01023815|79394596|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
44388160|NCT01023815|79394597|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
44388161|NCT01023815|79394594|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
44388162|NCT01023815|79394595|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
44388163|NCT01023815|79394596|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
44388164|NCT01023815|79394597|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
44388165|NCT01023815|79394594|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
44388166|NCT01023815|79394595|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
44388167|NCT01023815|79394596|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
44388168|NCT01023815|79394597|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
44388169|NCT01023659|79394611|FG000|Overall Study|Lost to Follow-up|73|||
44388170|NCT01023659|79394612|FG001|Overall Study|Lost to Follow-up|228|||
44388171|NCT01023659|79394613|FG002|Overall Study|Lost to Follow-up|99|||
44388172|NCT00740116|79394624|FG000|Overall Study|Withdrawal by Subject|1|||
44388173|NCT00740116|79394625|FG001|Overall Study|Withdrawal by Subject|1|||
44388174|NCT00740116|79394624|FG000|Overall Study|Protocol Violation|1|||
44388175|NCT00740116|79394625|FG001|Overall Study|Protocol Violation|4|||
44388176|NCT00698581|79394635|FG000|Overall Study|Lack of Efficacy|23|||
44388177|NCT00698581|79394636|FG001|Overall Study|Lack of Efficacy|11|||
44388178|NCT00698581|79394635|FG000|Overall Study|Withdrawal by Subject|6|||
44388179|NCT00698581|79394636|FG001|Overall Study|Withdrawal by Subject|0|||
44388180|NCT00698581|79394635|FG000|Overall Study|Other reason|9|||
44388181|NCT00698581|79394636|FG001|Overall Study|Other reason|1|||
44388182|NCT00698581|79394635|FG000|Overall Study|SAE, non-fatal|1|||
44388183|NCT00698581|79394636|FG001|Overall Study|SAE, non-fatal|0|||
44388184|NCT00698581|79394635|FG000|Overall Study|AE, non-serious non-fatal|4|||
44388185|NCT00698581|79394636|FG001|Overall Study|AE, non-serious non-fatal|0|||
44388186|NCT00698581|79394635|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44388187|NCT00698581|79394636|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
44388188|NCT00698581|79394635|FG000|Overall Study|AE of unknown type|1|||
44388189|NCT00698581|79394636|FG001|Overall Study|AE of unknown type|0|||
44388190|NCT01023581|79394650|FG000|Overall Study|Adverse Event|4|||
44388191|NCT01023581|79394651|FG001|Overall Study|Adverse Event|4|||
44388192|NCT01023581|79394652|FG002|Overall Study|Adverse Event|7|||
44388193|NCT01023581|79394653|FG003|Overall Study|Adverse Event|3|||
44388194|NCT01023581|79394654|FG004|Overall Study|Adverse Event|2|||
44388195|NCT01023581|79394655|FG005|Overall Study|Adverse Event|5|||
44388196|NCT01023581|79394656|FG006|Overall Study|Adverse Event|11|||
44388197|NCT01023581|79394650|FG000|Overall Study|Major protocol deviation|2|||
44388198|NCT01023581|79394651|FG001|Overall Study|Major protocol deviation|0|||
44388199|NCT01023581|79394652|FG002|Overall Study|Major protocol deviation|3|||
44388200|NCT01023581|79394653|FG003|Overall Study|Major protocol deviation|0|||
44388201|NCT01023581|79394654|FG004|Overall Study|Major protocol deviation|0|||
44388202|NCT01023581|79394655|FG005|Overall Study|Major protocol deviation|0|||
44388203|NCT01023581|79394656|FG006|Overall Study|Major protocol deviation|0|||
44388204|NCT01023581|79394650|FG000|Overall Study|Lost to Follow-up|4|||
44519174|NCT03568500|79527075|FG001|Overall Study|Lost to Follow-up|1|||
44519175|NCT03568500|79527076|FG002|Overall Study|Lost to Follow-up|2|||
44388205|NCT01023581|79394651|FG001|Overall Study|Lost to Follow-up|8|||
44388206|NCT01023581|79394652|FG002|Overall Study|Lost to Follow-up|7|||
44388207|NCT01023581|79394653|FG003|Overall Study|Lost to Follow-up|2|||
44519176|NCT03568500|79527074|FG000|Overall Study|Adverse Event|1|||
44519177|NCT03568500|79527075|FG001|Overall Study|Adverse Event|1|||
44388208|NCT01023581|79394654|FG004|Overall Study|Lost to Follow-up|5|||
44388209|NCT01023581|79394655|FG005|Overall Study|Lost to Follow-up|2|||
44388210|NCT01023581|79394656|FG006|Overall Study|Lost to Follow-up|2|||
44388211|NCT01023581|79394650|FG000|Overall Study|Withdrawal by Subject|13|||
44388212|NCT01023581|79394651|FG001|Overall Study|Withdrawal by Subject|8|||
44519178|NCT03568500|79527076|FG002|Overall Study|Adverse Event|2|||
44519179|NCT03568500|79527074|FG000|Overall Study|Physician Decision|1|||
44388213|NCT01023581|79394652|FG002|Overall Study|Withdrawal by Subject|16|||
44388214|NCT01023581|79394653|FG003|Overall Study|Withdrawal by Subject|10|||
44388215|NCT01023581|79394654|FG004|Overall Study|Withdrawal by Subject|6|||
44388216|NCT01023581|79394655|FG005|Overall Study|Withdrawal by Subject|8|||
44388217|NCT01023581|79394656|FG006|Overall Study|Withdrawal by Subject|5|||
44388218|NCT01023581|79394650|FG000|Overall Study|Pregnancy|0|||
44388219|NCT01023581|79394651|FG001|Overall Study|Pregnancy|0|||
44388220|NCT01023581|79394652|FG002|Overall Study|Pregnancy|0|||
44388221|NCT01023581|79394653|FG003|Overall Study|Pregnancy|2|||
44388222|NCT01023581|79394654|FG004|Overall Study|Pregnancy|0|||
44388223|NCT01023581|79394655|FG005|Overall Study|Pregnancy|1|||
44388224|NCT01023581|79394656|FG006|Overall Study|Pregnancy|0|||
44388225|NCT01023581|79394650|FG000|Overall Study|Lack of Efficacy|9|||
44388226|NCT01023581|79394651|FG001|Overall Study|Lack of Efficacy|3|||
44388227|NCT01023581|79394652|FG002|Overall Study|Lack of Efficacy|6|||
44388228|NCT01023581|79394653|FG003|Overall Study|Lack of Efficacy|2|||
44388229|NCT01023581|79394654|FG004|Overall Study|Lack of Efficacy|1|||
44388230|NCT01023581|79394655|FG005|Overall Study|Lack of Efficacy|2|||
44388231|NCT01023581|79394656|FG006|Overall Study|Lack of Efficacy|1|||
44388232|NCT01023581|79394650|FG000|Overall Study|Physician Decision|2|||
44388233|NCT01023581|79394651|FG001|Overall Study|Physician Decision|0|||
44388234|NCT01023581|79394652|FG002|Overall Study|Physician Decision|2|||
44388235|NCT01023581|79394653|FG003|Overall Study|Physician Decision|1|||
44388236|NCT01023581|79394654|FG004|Overall Study|Physician Decision|1|||
44388237|NCT01023581|79394655|FG005|Overall Study|Physician Decision|1|||
44388238|NCT01023581|79394656|FG006|Overall Study|Physician Decision|1|||
44388239|NCT01023581|79394650|FG000|Overall Study|Other|1|||
44388240|NCT01023581|79394651|FG001|Overall Study|Other|0|||
44388241|NCT01023581|79394652|FG002|Overall Study|Other|1|||
44388242|NCT01023581|79394653|FG003|Overall Study|Other|0|||
44388243|NCT01023581|79394654|FG004|Overall Study|Other|1|||
44388244|NCT01023581|79394655|FG005|Overall Study|Other|0|||
44388245|NCT01023581|79394656|FG006|Overall Study|Other|0|||
44388246|NCT00962780|79394674|FG000|Overall Study|Death|0|||
44388247|NCT00962780|79394675|FG001|Overall Study|Death|1|||
44388248|NCT00962780|79394674|FG000|Overall Study|Protocol Violation|9|||
44388249|NCT00962780|79394675|FG001|Overall Study|Protocol Violation|4|||
44388250|NCT00962780|79394674|FG000|Overall Study|Withdrawal by Subject|1|||
44388251|NCT00962780|79394675|FG001|Overall Study|Withdrawal by Subject|8|||
44388252|NCT00962780|79394674|FG000|Overall Study|Other|0|||
44388253|NCT00962780|79394675|FG001|Overall Study|Other|1|||
44388254|NCT00739882|79394689|FG000|Double-blind Period|Adverse Event|1|||
44388255|NCT00739882|79394690|FG001|Double-blind Period|Adverse Event|2|||
44388256|NCT00739882|79394689|FG000|Double-blind Period|Protocol Violation|1|||
44388257|NCT00739882|79394690|FG001|Double-blind Period|Protocol Violation|0|||
44388258|NCT00739882|79394689|FG000|Double-blind Period|Lack of Efficacy|1|||
44388259|NCT00739882|79394690|FG001|Double-blind Period|Lack of Efficacy|1|||
44388260|NCT00739882|79394689|FG000|Double-blind Period|Other|16|||
44388261|NCT00739882|79394690|FG001|Double-blind Period|Other|8|||
44388262|NCT00739882|79394689|FG000|Open-label Period|Adverse Event|1|||
44388263|NCT00739882|79394690|FG001|Open-label Period|Adverse Event|0|||
44388264|NCT00739882|79394689|FG000|Open-label Period|Other|9|||
44388265|NCT00739882|79394690|FG001|Open-label Period|Other|5|||
44388266|NCT00961220|79394698|FG000|Overall Study|Adverse Event|3|||
44388267|NCT00961220|79394698|FG000|Overall Study|Lack of Efficacy|1|||
44388268|NCT00961220|79394698|FG000|Overall Study|No IV access for O6BG|1|||
44388269|NCT00961220|79394698|FG000|Overall Study|O6BG no longer supplied|1|||
44388270|NCT00961220|79394698|FG000|Overall Study|Complete Response prior to 12 courses|1|||
44388271|NCT00734656|79394704|FG000|Lab Session 1|Withdrawal by Subject|2|||
44388272|NCT00734656|79394705|FG001|Lab Session 1|Withdrawal by Subject|0|||
44388273|NCT00734656|79394706|FG002|Lab Session 1|Withdrawal by Subject|0|||
44388274|NCT00734656|79394707|FG003|Lab Session 1|Withdrawal by Subject|0|||
44146320|NCT01186016|78935619|FG000|Overall Study|Withdrawal by Subject|46|||
44388275|NCT00734656|79394704|FG000|Washout 1|Withdrawal by Subject|1|||
44388276|NCT00734656|79394705|FG001|Washout 1|Withdrawal by Subject|5|||
44146321|NCT01186016|78935620|FG001|Overall Study|Withdrawal by Subject|29|||
44146322|NCT01113749|78935628|FG000|Overall Study|Lost to Follow-up|1|||
44146323|NCT01113749|78935629|FG001|Overall Study|Lost to Follow-up|2|||
44388277|NCT00734656|79394706|FG002|Washout 1|Withdrawal by Subject|2|||
44388278|NCT00734656|79394707|FG003|Washout 1|Withdrawal by Subject|3|||
44388279|NCT00734656|79394704|FG000|Lab Session 2|Withdrawal by Subject|1|||
44388280|NCT00734656|79394705|FG001|Lab Session 2|Withdrawal by Subject|0|||
44388281|NCT00734656|79394706|FG002|Lab Session 2|Withdrawal by Subject|0|||
44388282|NCT00734656|79394707|FG003|Lab Session 2|Withdrawal by Subject|1|||
44388283|NCT00734656|79394704|FG000|Washout 2|Withdrawal by Subject|1|||
44388284|NCT00734656|79394705|FG001|Washout 2|Withdrawal by Subject|1|||
44388285|NCT00734656|79394706|FG002|Washout 2|Withdrawal by Subject|1|||
44146324|NCT01060384|78935635|FG000|Overall Study|Withdrawal by Subject|0|||
44388286|NCT00734656|79394707|FG003|Washout 2|Withdrawal by Subject|0|||
44388287|NCT00734656|79394704|FG000|Washout 3|Withdrawal by Subject|1|||
44388288|NCT00734656|79394705|FG001|Washout 3|Withdrawal by Subject|0|||
44388289|NCT00734656|79394706|FG002|Washout 3|Withdrawal by Subject|0|||
44388290|NCT00734656|79394707|FG003|Washout 3|Withdrawal by Subject|1|||
44388291|NCT00734656|79394704|FG000|Lab Session 4|Withdrawal by Subject|0|||
44388292|NCT00734656|79394705|FG001|Lab Session 4|Withdrawal by Subject|0|||
44388293|NCT00734656|79394706|FG002|Lab Session 4|Withdrawal by Subject|0|||
44519180|NCT03568500|79527075|FG001|Overall Study|Physician Decision|0|||
44519181|NCT03568500|79527076|FG002|Overall Study|Physician Decision|0|||
44519182|NCT03568500|79527074|FG000|Overall Study|Withdrawal by Subject|4|||
44519183|NCT03568500|79527075|FG001|Overall Study|Withdrawal by Subject|2|||
44519184|NCT03568500|79527076|FG002|Overall Study|Withdrawal by Subject|0|||
44519185|NCT03568500|79527074|FG000|Overall Study|Technical Problems|2|||
44519186|NCT03568500|79527075|FG001|Overall Study|Technical Problems|1|||
44519187|NCT03568500|79527076|FG002|Overall Study|Technical Problems|0|||
44519188|NCT03568500|79527074|FG000|Overall Study|Participant Noncompliance|1|||
44519189|NCT03568500|79527075|FG001|Overall Study|Participant Noncompliance|1|||
44519190|NCT03568500|79527076|FG002|Overall Study|Participant Noncompliance|0|||
44519191|NCT03504852|79527101|FG000|Overall Study|Withdrawal of informed consent|2|||
44519192|NCT03504852|79527102|FG001|Overall Study|Withdrawal of informed consent|1|||
44519193|NCT03504852|79527103|FG002|Overall Study|Withdrawal of informed consent|0|||
44519194|NCT03504852|79527101|FG000|Overall Study|Withdrawal by Subject|5|||
44519195|NCT03504852|79527102|FG001|Overall Study|Withdrawal by Subject|5|||
44519196|NCT03504852|79527103|FG002|Overall Study|Withdrawal by Subject|1|||
44519197|NCT03504852|79527101|FG000|Overall Study|Lost to Follow-up|4|||
44519198|NCT03504852|79527102|FG001|Overall Study|Lost to Follow-up|1|||
44519199|NCT03504852|79527103|FG002|Overall Study|Lost to Follow-up|0|||
44519200|NCT03504852|79527101|FG000|Overall Study|New therapy for study indication|1|||
44519201|NCT03504852|79527102|FG001|Overall Study|New therapy for study indication|0|||
44519202|NCT03504852|79527103|FG002|Overall Study|New therapy for study indication|0|||
44519203|NCT03504852|79527101|FG000|Overall Study|Lack of Efficacy|1|||
44519204|NCT03504852|79527102|FG001|Overall Study|Lack of Efficacy|2|||
44519205|NCT03504852|79527103|FG002|Overall Study|Lack of Efficacy|0|||
44519206|NCT03504852|79527101|FG000|Overall Study|Death|0|||
44519207|NCT03504852|79527102|FG001|Overall Study|Death|1|||
44519208|NCT03504852|79527103|FG002|Overall Study|Death|0|||
44519209|NCT03504852|79527101|FG000|Overall Study|Adverse Event|4|||
44519210|NCT03504852|79527102|FG001|Overall Study|Adverse Event|8|||
44519211|NCT03504852|79527103|FG002|Overall Study|Adverse Event|2|||
44519212|NCT03025828|79527113|FG000|Overall Study|Lost to Follow-up|1|||
44519213|NCT03546816|79527119|FG000|Overall Study|Adverse Event|5|||
44519214|NCT03546816|79527120|FG001|Overall Study|Adverse Event|3|||
44519215|NCT03546816|79527119|FG000|Overall Study|Lack of Efficacy|2|||
44519216|NCT03546816|79527120|FG001|Overall Study|Lack of Efficacy|4|||
44519217|NCT03546816|79527119|FG000|Overall Study|Pregnancy|1|||
44519218|NCT03546816|79527120|FG001|Overall Study|Pregnancy|0|||
44519219|NCT03546816|79527119|FG000|Overall Study|Physician Decision|2|||
44519220|NCT03546816|79527120|FG001|Overall Study|Physician Decision|0|||
44519221|NCT03546816|79527119|FG000|Overall Study|Withdrawal by Subject|8|||
44519222|NCT03546816|79527120|FG001|Overall Study|Withdrawal by Subject|10|||
44519223|NCT03546816|79527119|FG000|Overall Study|Lost to Follow-up|3|||
44519224|NCT03546816|79527120|FG001|Overall Study|Lost to Follow-up|2|||
44519225|NCT03024970|79527128|FG000|First Intervention|Adverse Event|1|||
44519226|NCT03024970|79527129|FG001|First Intervention|Adverse Event|0|||
44519227|NCT03024970|79527128|FG000|Second Intervention|Lost to Follow-up|1|||
44519228|NCT03024970|79527129|FG001|Second Intervention|Lost to Follow-up|0|||
44519229|NCT03500094|79527135|FG000|Overall Study|Withdrawal by Subject|1|||
44519230|NCT03500094|79527135|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
44519231|NCT03500094|79527135|FG000|Overall Study|Lost to Follow-up|1|||
44519232|NCT03566550|79527143|FG000|Overall Study|Withdrawal by Subject|0|||
44519233|NCT03566550|79527144|FG001|Overall Study|Withdrawal by Subject|1|||
44519234|NCT03566238|79527153|FG000|Overall Study|Adverse Event|0|||
44519235|NCT03566238|79527154|FG001|Overall Study|Adverse Event|1|||
44251782|NCT00983749|79087411|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
44251783|NCT01046253|79087419|FG000|Second Intervention|Adverse Event|0|||
44251784|NCT01046253|79087420|FG001|Second Intervention|Adverse Event|1|||
44388294|NCT00734656|79394707|FG003|Lab Session 4|Withdrawal by Subject|1|||
44519236|NCT03566238|79527155|FG002|Overall Study|Adverse Event|0|||
44251785|NCT01046253|79087419|FG000|Second Intervention|Protocol Violation|0|||
44519237|NCT03566238|79527153|FG000|Overall Study|Lack of Efficacy|4|||
44519238|NCT03566238|79527154|FG001|Overall Study|Lack of Efficacy|2|||
44519239|NCT03566238|79527155|FG002|Overall Study|Lack of Efficacy|5|||
44519240|NCT03566238|79527153|FG000|Overall Study|Other|1|||
44519241|NCT03566238|79527154|FG001|Overall Study|Other|0|||
44519242|NCT03566238|79527155|FG002|Overall Study|Other|0|||
44519243|NCT02894502|79527166|FG000|Baseline|Withdrawal by Subject|24|||
44519244|NCT02894502|79527167|FG001|Baseline|Withdrawal by Subject|31|||
44519245|NCT02894502|79527168|FG002|Baseline|Withdrawal by Subject|36|||
44519246|NCT02894502|79527166|FG000|Baseline|Death|3|||
44519247|NCT02894502|79527167|FG001|Baseline|Death|1|||
44388295|NCT00739648|79394719|FG000|Overall Study|Adverse Event|3|||
44388296|NCT00739648|79394720|FG001|Overall Study|Adverse Event|15|||
44388297|NCT00739648|79394719|FG000|Overall Study|Withdrawal by Subject|13|||
44388298|NCT00739648|79394720|FG001|Overall Study|Withdrawal by Subject|25|||
44388299|NCT00739648|79394719|FG000|Overall Study|Lost to Follow-up|4|||
44388300|NCT00739648|79394720|FG001|Overall Study|Lost to Follow-up|7|||
44388301|NCT00739648|79394719|FG000|Overall Study|Death|2|||
44388302|NCT00739648|79394720|FG001|Overall Study|Death|0|||
44388303|NCT00739648|79394719|FG000|Overall Study|Do not know|4|||
44388304|NCT00739648|79394720|FG001|Overall Study|Do not know|6|||
44388305|NCT01032239|79394732|FG000|Overall Study|Lost to Follow-up|3|||
44388306|NCT01032239|79394733|FG001|Overall Study|Lost to Follow-up|2|||
44388307|NCT01032239|79394732|FG000|Overall Study|Withdrawal by Subject|2|||
44388308|NCT01032239|79394733|FG001|Overall Study|Withdrawal by Subject|3|||
44388309|NCT01032239|79394732|FG000|Overall Study|Death|1|||
44388310|NCT01032239|79394733|FG001|Overall Study|Death|0|||
44388311|NCT01032239|79394732|FG000|Overall Study|Protocol Violation|1|||
44388312|NCT01032239|79394733|FG001|Overall Study|Protocol Violation|0|||
44388313|NCT00734578|79394742|FG000|Overall Study|Adverse Event|4|||
44388314|NCT00734578|79394743|FG001|Overall Study|Adverse Event|6|||
44388315|NCT00734578|79394744|FG002|Overall Study|Adverse Event|1|||
44388316|NCT00734578|79394742|FG000|Overall Study|Protocol Violation|8|||
44388317|NCT00734578|79394743|FG001|Overall Study|Protocol Violation|6|||
44388318|NCT00734578|79394744|FG002|Overall Study|Protocol Violation|3|||
44388319|NCT00734578|79394742|FG000|Overall Study|Withdrawal by Subject|7|||
44388320|NCT00734578|79394743|FG001|Overall Study|Withdrawal by Subject|8|||
44388321|NCT00734578|79394744|FG002|Overall Study|Withdrawal by Subject|11|||
44388322|NCT00734578|79394742|FG000|Overall Study|Lost to Follow-up|9|||
44388323|NCT00734578|79394743|FG001|Overall Study|Lost to Follow-up|3|||
44388324|NCT00734578|79394744|FG002|Overall Study|Lost to Follow-up|5|||
44388325|NCT00734578|79394742|FG000|Overall Study|Lack of Efficacy|3|||
44388326|NCT00734578|79394743|FG001|Overall Study|Lack of Efficacy|2|||
44388327|NCT00734578|79394744|FG002|Overall Study|Lack of Efficacy|5|||
44388328|NCT00734578|79394742|FG000|Overall Study|Randomized in error|1|||
44388329|NCT00734578|79394743|FG001|Overall Study|Randomized in error|0|||
44388330|NCT00734578|79394744|FG002|Overall Study|Randomized in error|0|||
44388331|NCT00734578|79394742|FG000|Overall Study|Exclusion criteria|1|||
44388332|NCT00734578|79394743|FG001|Overall Study|Exclusion criteria|0|||
44388333|NCT00734578|79394744|FG002|Overall Study|Exclusion criteria|0|||
44388334|NCT00739102|79394752|FG000|Overall Study|Death|5|||
44388335|NCT00739102|79394752|FG000|Overall Study|Withdrawal by Subject|10|||
44388336|NCT00959192|79394760|FG000|Overall Study|Adverse Event|1|||
44388337|NCT00959192|79394761|FG001|Overall Study|Adverse Event|1|||
44388338|NCT00959192|79394762|FG002|Overall Study|Adverse Event|1|||
44388339|NCT00959192|79394763|FG003|Overall Study|Adverse Event|0|||
44388340|NCT00959192|79394760|FG000|Overall Study|Investigator Request|1|||
44388341|NCT00959192|79394761|FG001|Overall Study|Investigator Request|0|||
44388342|NCT00959192|79394762|FG002|Overall Study|Investigator Request|0|||
44388343|NCT00959192|79394763|FG003|Overall Study|Investigator Request|0|||
44388344|NCT00959192|79394760|FG000|Overall Study|Caregiver Request|0|||
44388345|NCT00959192|79394761|FG001|Overall Study|Caregiver Request|0|||
44388346|NCT00959192|79394762|FG002|Overall Study|Caregiver Request|2|||
44388347|NCT00959192|79394763|FG003|Overall Study|Caregiver Request|1|||
44388348|NCT00696787|79394777|FG000|Overall Study|Adverse Event|1|||
44388349|NCT00696787|79394778|FG001|Overall Study|Adverse Event|0|||
44280620|NCT01980888|79241755|FG000|Overall Study|Withdrew Consent|17|||
44280621|NCT01980888|79241756|FG001|Overall Study|Withdrew Consent|6|||
44280622|NCT01980888|79241755|FG000|Overall Study|Investigator's Discretion|8|||
44280623|NCT01980888|79241756|FG001|Overall Study|Investigator's Discretion|3|||
44280624|NCT01980888|79241755|FG000|Overall Study|Non-Compliance with Study Drug|3|||
44280625|NCT01980888|79241756|FG001|Overall Study|Non-Compliance with Study Drug|2|||
44280626|NCT01937364|79241773|FG000|Overall Study|Adverse Event|2|||
44280627|NCT01937364|79241774|FG001|Overall Study|Adverse Event|1|||
44280628|NCT01979952|79241782|FG000|Overall Study|Adverse Event|4|||
44280629|NCT01979952|79241783|FG001|Overall Study|Adverse Event|5|||
44280630|NCT01979952|79241782|FG000|Overall Study|Protocol Violation|1|||
44280631|NCT01979952|79241783|FG001|Overall Study|Protocol Violation|0|||
44388350|NCT00696787|79394779|FG002|Overall Study|Adverse Event|6|||
44388351|NCT00696787|79394777|FG000|Overall Study|Discontinuation by Sponsor|9|||
44388352|NCT00696787|79394778|FG001|Overall Study|Discontinuation by Sponsor|13|||
44388353|NCT00696787|79394779|FG002|Overall Study|Discontinuation by Sponsor|14|||
44388354|NCT00696787|79394777|FG000|Overall Study|Lack of Efficacy|0|||
44388355|NCT00696787|79394778|FG001|Overall Study|Lack of Efficacy|1|||
44280632|NCT01979952|79241782|FG000|Overall Study|Withdrawal by Subject|2|||
44280633|NCT01979952|79241783|FG001|Overall Study|Withdrawal by Subject|1|||
44280634|NCT01979952|79241782|FG000|Overall Study|Other than specified above|1|||
44388356|NCT00696787|79394779|FG002|Overall Study|Lack of Efficacy|0|||
44388357|NCT00696787|79394777|FG000|Overall Study|Lost to Follow-up|4|||
44388358|NCT00696787|79394778|FG001|Overall Study|Lost to Follow-up|0|||
44388359|NCT00696787|79394779|FG002|Overall Study|Lost to Follow-up|3|||
44388360|NCT00696787|79394777|FG000|Overall Study|Withdrawal by Subject|0|||
44388361|NCT00696787|79394778|FG001|Overall Study|Withdrawal by Subject|3|||
44388362|NCT00696787|79394779|FG002|Overall Study|Withdrawal by Subject|2|||
44388363|NCT00696787|79394777|FG000|Overall Study|Failed to return|1|||
44388364|NCT00696787|79394778|FG001|Overall Study|Failed to return|3|||
44388365|NCT00696787|79394779|FG002|Overall Study|Failed to return|1|||
44388366|NCT01012037|79394790|FG000|Overall Study|Adverse Event|0|||
44388367|NCT01012037|79394791|FG001|Overall Study|Adverse Event|8|||
44388368|NCT01012037|79394792|FG002|Overall Study|Adverse Event|3|||
44388369|NCT01012037|79394790|FG000|Overall Study|Protocol Violation|0|||
44388370|NCT01012037|79394791|FG001|Overall Study|Protocol Violation|3|||
44388371|NCT01012037|79394792|FG002|Overall Study|Protocol Violation|5|||
44388372|NCT01012037|79394790|FG000|Overall Study|Withdrawal by Subject|0|||
44388373|NCT01012037|79394791|FG001|Overall Study|Withdrawal by Subject|4|||
44388374|NCT01012037|79394792|FG002|Overall Study|Withdrawal by Subject|1|||
44388375|NCT01012037|79394790|FG000|Overall Study|Other reason (not specified)|1|||
44388376|NCT01012037|79394791|FG001|Overall Study|Other reason (not specified)|1|||
44388377|NCT01012037|79394792|FG002|Overall Study|Other reason (not specified)|1|||
44388378|NCT00734032|79394804|FG000|Overall Study|Adverse Event|0|||
44388379|NCT00734032|79394805|FG001|Overall Study|Adverse Event|1|||
44388380|NCT00734032|79394806|FG002|Overall Study|Adverse Event|0|||
44388381|NCT00734032|79394807|FG003|Overall Study|Adverse Event|0|||
44388382|NCT01010633|79394819|FG000|Overall Study|Adverse Event|1|||
44388383|NCT01010633|79394820|FG001|Overall Study|Adverse Event|1|||
44388384|NCT01010633|79394819|FG000|Overall Study|Protocol Violation|1|||
44388385|NCT01010633|79394820|FG001|Overall Study|Protocol Violation|2|||
44388386|NCT01010633|79394819|FG000|Overall Study|Withdrawal by Subject|2|||
44388387|NCT01010633|79394820|FG001|Overall Study|Withdrawal by Subject|1|||
44388388|NCT01010633|79394819|FG000|Overall Study|Investigator decision|0|||
44388389|NCT01010633|79394820|FG001|Overall Study|Investigator decision|1|||
44388390|NCT00733954|79394828|FG000|Overall Study|Lost to Follow-up|5|||
44388391|NCT00733954|79394829|FG001|Overall Study|Lost to Follow-up|2|||
44388392|NCT00733954|79394828|FG000|Overall Study|Protocol Violation|1|||
44388393|NCT00733954|79394829|FG001|Overall Study|Protocol Violation|0|||
44388394|NCT00733954|79394828|FG000|Overall Study|Withdrawal by Subject|2|||
44388395|NCT00733954|79394829|FG001|Overall Study|Withdrawal by Subject|0|||
44388396|NCT00733408|79394835|FG000|Overall Study|Adverse Event|4|||
44388397|NCT01010867|79394839|FG000|Overall Study|< 50% adherence to probiotic|1|||
44388398|NCT00576823|79394846|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
44388399|NCT00576823|79394847|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
44388400|NCT00576823|79394848|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
44388401|NCT00576823|79394846|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
44388402|NCT00576823|79394847|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
44388403|NCT00576823|79394848|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
44388404|NCT00732940|79394861|FG000|Overall Study|Withdrawal by Subject|1|||
44388405|NCT00732940|79394862|FG001|Overall Study|Withdrawal by Subject|2|||
44388406|NCT00732940|79394861|FG000|Overall Study|Adverse Event|0|||
44388407|NCT00732940|79394862|FG001|Overall Study|Adverse Event|1|||
44388408|NCT00732940|79394861|FG000|Overall Study|Lost to Follow-up|1|||
44519248|NCT02894502|79527168|FG002|Baseline|Death|9|||
44519249|NCT02894502|79527166|FG000|First Follow up|Withdrawal by Subject|32|||
44519250|NCT02894502|79527167|FG001|First Follow up|Withdrawal by Subject|29|||
44251786|NCT01046253|79087420|FG001|Second Intervention|Protocol Violation|1|||
44251787|NCT00983515|79087426|FG000|Ritonavir Alone|liver panel out of range|6|||
44251788|NCT00983515|79087426|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
44251789|NCT00982735|79087433|FG000|Overall Study|Lost to Follow-up|6|||
44251790|NCT00982735|79087433|FG000|Overall Study|Patient ineligible for trial|224|||
44251791|NCT01361178|79087439|FG000|Overall Study|Death|13|||
44251792|NCT01361178|79087440|FG001|Overall Study|Death|0|||
44251793|NCT00981799|79087450|FG000|Overall Study|Adverse Event|1|||
44251794|NCT00981799|79087451|FG001|Overall Study|Adverse Event|1|||
44251795|NCT00981799|79087452|FG002|Overall Study|Adverse Event|0|||
44388409|NCT00732940|79394862|FG001|Overall Study|Lost to Follow-up|0|||
44388410|NCT00962390|79394872|FG000|Overall Study|Adverse Event|0|||
44388411|NCT00962390|79394873|FG001|Overall Study|Adverse Event|0|||
44388412|NCT00962390|79394874|FG002|Overall Study|Adverse Event|3|||
44388413|NCT00962390|79394875|FG003|Overall Study|Adverse Event|1|||
44388414|NCT00962390|79394872|FG000|Overall Study|Lost to Follow-up|2|||
44388415|NCT00962390|79394873|FG001|Overall Study|Lost to Follow-up|2|||
44388416|NCT00962390|79394874|FG002|Overall Study|Lost to Follow-up|0|||
44388417|NCT00962390|79394875|FG003|Overall Study|Lost to Follow-up|0|||
44388418|NCT00962390|79394872|FG000|Overall Study|Protocol Violation|1|||
44388419|NCT00962390|79394873|FG001|Overall Study|Protocol Violation|0|||
44388420|NCT00962390|79394874|FG002|Overall Study|Protocol Violation|0|||
44388421|NCT00962390|79394875|FG003|Overall Study|Protocol Violation|0|||
44388422|NCT00962390|79394872|FG000|Overall Study|Withdrawal by Subject|1|||
44388423|NCT00962390|79394873|FG001|Overall Study|Withdrawal by Subject|1|||
44388424|NCT00962390|79394874|FG002|Overall Study|Withdrawal by Subject|1|||
44388425|NCT00962390|79394875|FG003|Overall Study|Withdrawal by Subject|0|||
44388426|NCT00732472|79394889|FG000|Overall Study|Adverse Event|0|||
44388427|NCT00732472|79394890|FG001|Overall Study|Adverse Event|1|||
44388428|NCT00732472|79394891|FG002|Overall Study|Adverse Event|1|||
44388429|NCT00732472|79394892|FG003|Overall Study|Adverse Event|1|||
44388430|NCT00732472|79394889|FG000|Overall Study|Protocol Violation|0|||
44388431|NCT00732472|79394890|FG001|Overall Study|Protocol Violation|0|||
44388432|NCT00732472|79394891|FG002|Overall Study|Protocol Violation|0|||
44388433|NCT00732472|79394892|FG003|Overall Study|Protocol Violation|1|||
44388434|NCT00732472|79394889|FG000|Overall Study|Withdrawal by Subject|0|||
44388435|NCT00732472|79394890|FG001|Overall Study|Withdrawal by Subject|2|||
44388436|NCT00732472|79394891|FG002|Overall Study|Withdrawal by Subject|0|||
44388437|NCT00732472|79394892|FG003|Overall Study|Withdrawal by Subject|1|||
44388438|NCT00960986|79394907|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
44388439|NCT00960986|79394908|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
44388440|NCT00960986|79394909|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
44388441|NCT00960986|79394910|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
44388442|NCT00960986|79394907|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
44388443|NCT00960986|79394908|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
44388444|NCT00960986|79394909|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
44388445|NCT00960986|79394910|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
44388446|NCT00960986|79394907|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
44388447|NCT00960986|79394908|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
44388448|NCT00960986|79394909|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
44388449|NCT00960986|79394910|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
44388450|NCT00960986|79394907|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
44388451|NCT00960986|79394908|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
44388452|NCT00960986|79394909|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
44388453|NCT00960986|79394910|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
44388454|NCT00960986|79394907|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
44388455|NCT00960986|79394908|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
44388456|NCT00960986|79394909|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
44388457|NCT00960986|79394910|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
44388458|NCT00960986|79394907|FG000|Period 3 (7-week Therapy Period)|Death|0|||
44388459|NCT00960986|79394908|FG001|Period 3 (7-week Therapy Period)|Death|0|||
44388460|NCT00960986|79394909|FG002|Period 3 (7-week Therapy Period)|Death|1|||
44388461|NCT00960986|79394910|FG003|Period 3 (7-week Therapy Period)|Death|0|||
44388462|NCT00960986|79394907|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
44388463|NCT00960986|79394908|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
44388464|NCT00960986|79394909|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
44388465|NCT00960986|79394910|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
44388466|NCT00960986|79394907|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
44388467|NCT00960986|79394908|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
44388468|NCT00960986|79394909|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
44388469|NCT00960986|79394910|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
44388470|NCT00960986|79394907|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
44388471|NCT00960986|79394908|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
44388472|NCT00960986|79394909|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
44388473|NCT00960986|79394910|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
44388474|NCT00960986|79394907|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
44388475|NCT00960986|79394908|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
44388476|NCT00960986|79394909|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
44388477|NCT00960986|79394910|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
44388478|NCT00732238|79394922|FG000|Overall Study|Bacteremia|4|||
44388479|NCT00732238|79394923|FG001|Overall Study|Bacteremia|1|||
44519251|NCT02894502|79527168|FG002|First Follow up|Withdrawal by Subject|37|||
44519252|NCT02894502|79527166|FG000|First Follow up|Death|2|||
44519253|NCT02894502|79527167|FG001|First Follow up|Death|2|||
44388480|NCT00732238|79394922|FG000|Overall Study|Asymptomatic bacteriuria|1|||
44388481|NCT00732238|79394923|FG001|Overall Study|Asymptomatic bacteriuria|0|||
44388482|NCT00958880|79394933|FG000|Overall Study|Lost to Follow-up|2|||
44388483|NCT00958880|79394934|FG001|Overall Study|Lost to Follow-up|2|||
44388484|NCT00732160|79394944|FG000|Overall Study|Adverse Event|1|||
44388485|NCT00732160|79394945|FG001|Overall Study|Adverse Event|0|||
44388486|NCT00732160|79394946|FG002|Overall Study|Adverse Event|1|||
44388487|NCT00732160|79394947|FG003|Overall Study|Adverse Event|1|||
44388488|NCT00732160|79394944|FG000|Overall Study|scheduling|4|||
44388489|NCT00732160|79394945|FG001|Overall Study|scheduling|4|||
44388490|NCT00732160|79394946|FG002|Overall Study|scheduling|2|||
44388491|NCT00732160|79394947|FG003|Overall Study|scheduling|1|||
44388492|NCT00958724|79394957|FG000|Overall Study|Disease Progression|6|||
44388493|NCT00738400|79394963|FG000|Overall Study|Adverse Event|3|||
44388494|NCT00738400|79394964|FG001|Overall Study|Adverse Event|1|||
44388495|NCT00738400|79394963|FG000|Overall Study|Withdrawal by Subject|0|||
44388496|NCT00738400|79394964|FG001|Overall Study|Withdrawal by Subject|1|||
44388497|NCT00738400|79394963|FG000|Overall Study|Lack of Efficacy|0|||
44388498|NCT00738400|79394964|FG001|Overall Study|Lack of Efficacy|1|||
44388499|NCT00738400|79394963|FG000|Overall Study|Lost to Follow-up|0|||
44388500|NCT00738400|79394964|FG001|Overall Study|Lost to Follow-up|3|||
44388501|NCT00738400|79394963|FG000|Overall Study|Protocol Violation|1|||
44388502|NCT00738400|79394964|FG001|Overall Study|Protocol Violation|0|||
44388503|NCT00738400|79394963|FG000|Overall Study|Non-compliant with study medication|0|||
44388504|NCT00738400|79394964|FG001|Overall Study|Non-compliant with study medication|1|||
44388505|NCT01009463|79394974|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
44388506|NCT01009463|79394975|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44388507|NCT01009463|79394976|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44388508|NCT01009463|79394977|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44388509|NCT01009463|79394978|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44388510|NCT01009463|79394974|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
44388511|NCT01009463|79394975|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
44388512|NCT01009463|79394976|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
44388513|NCT01009463|79394977|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
44388514|NCT01009463|79394978|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
44388515|NCT01009463|79394974|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
44388516|NCT01009463|79394975|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44388517|NCT01009463|79394976|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44388518|NCT01009463|79394977|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44388519|NCT01009463|79394978|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44388520|NCT01009463|79394974|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
44388521|NCT01009463|79394975|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
44388522|NCT01009463|79394976|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
44388523|NCT01009463|79394977|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
44388524|NCT01009463|79394978|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
44388525|NCT01009463|79394974|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
44388526|NCT01009463|79394975|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44388527|NCT01009463|79394976|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44388528|NCT01009463|79394977|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44388529|NCT01009463|79394978|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44388530|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
44388531|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
44388532|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
44388533|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
44388534|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
44388535|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44388536|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
44388537|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
44388538|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
44388539|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
44388540|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
44388541|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
44388542|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
44388543|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
44388544|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
44388545|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
44388546|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
44388547|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
44388548|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
44388549|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
44388550|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
44388551|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
44388552|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
44388553|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
44388554|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
44388555|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
44388556|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
44388557|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
44388558|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
44388559|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
44388560|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44388561|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
44388562|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
44388563|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
44388564|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
44388565|NCT01009463|79394974|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
44388566|NCT01009463|79394975|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
44388567|NCT01009463|79394976|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
44388568|NCT01009463|79394977|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
44388569|NCT01009463|79394978|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
44388570|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
44388571|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
44388572|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
44388573|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
44388574|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
44388575|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
44388576|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
44388577|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
44388578|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
44388579|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
44388580|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
44388581|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
44388582|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
44388583|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
44388584|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
44388585|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
44388586|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
44388587|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
44388588|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
44388589|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
44388590|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
44388591|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
44388592|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
44388593|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
44388594|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
44388595|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
44388596|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
44388597|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
44388598|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
44388599|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
44388600|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
44388601|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
44388602|NCT00958568|79394989|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
44388603|NCT00958568|79394990|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
44388604|NCT00958568|79394991|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
44388605|NCT00958568|79394992|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
44388606|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
44388607|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
44388608|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
44388609|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
44388610|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
44388611|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
44388612|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
44388613|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
44388614|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
44388615|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
44388616|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
44388617|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
44388618|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
44388619|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
44388620|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
44388621|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
44388622|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
44519254|NCT02894502|79527168|FG002|First Follow up|Death|3|||
44519255|NCT02894502|79527166|FG000|Second Follow up|Withdrawal by Subject|13|||
44251796|NCT00981799|79087453|FG003|Overall Study|Adverse Event|0|||
44388623|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
44388624|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
44388625|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
44388626|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
44388627|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
44388628|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
44388629|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
44388630|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
44388631|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
44388632|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
44388633|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
44388634|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
44388635|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
44388636|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
44388637|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
44388638|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
44388639|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
44388640|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
44388641|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
44388642|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
44388643|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
44388644|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
44388645|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
44388646|NCT00958568|79394989|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
44388647|NCT00958568|79394990|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
44388648|NCT00958568|79394991|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
44388649|NCT00958568|79394992|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
44388650|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
44388651|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
44388652|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
44388653|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
44388654|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
44519256|NCT02894502|79527167|FG001|Second Follow up|Withdrawal by Subject|15|||
44519257|NCT02894502|79527168|FG002|Second Follow up|Withdrawal by Subject|13|||
44519258|NCT02894502|79527166|FG000|Second Follow up|Death|2|||
44519259|NCT02894502|79527167|FG001|Second Follow up|Death|3|||
44519260|NCT02894502|79527168|FG002|Second Follow up|Death|1|||
44519261|NCT02894502|79527166|FG000|Third Follow up|Withdrawal by Subject|5|||
44251797|NCT00981175|79087467|FG000|Primary Dose Vaccination|Adverse Event|1|||
44251798|NCT00981175|79087468|FG001|Primary Dose Vaccination|Adverse Event|0|||
44251799|NCT00981175|79087467|FG000|Primary Dose Vaccination|Protocol Violation|0|||
44251800|NCT00981175|79087468|FG001|Primary Dose Vaccination|Protocol Violation|1|||
44251801|NCT00981175|79087467|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
44251802|NCT00981175|79087468|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
44251803|NCT00981175|79087467|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
44251804|NCT00981175|79087468|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
44251805|NCT00981019|79087481|FG000|Overall Study|Did not respond|65|||
44251806|NCT00981019|79087481|FG000|Overall Study|Did not match target population|94|||
44251807|NCT00981019|79087481|FG000|Overall Study|Inadvertent exclusion|239|||
44251808|NCT00981019|79087481|FG000|Overall Study|Hit the survey after closure|79|||
44251809|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
44251810|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
44251811|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
44251812|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
44251813|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
44251814|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
44251815|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
44251816|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
44251817|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
44251818|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
44251819|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
44251820|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
44251821|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
44251822|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
44251823|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
44388655|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
44388656|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
44388657|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
44388658|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
44388659|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
44388660|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
44388661|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
44388662|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
44388663|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
44388664|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
44388665|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
44388666|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
44388667|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
44388668|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
44388669|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
44388670|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
44388671|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
44388672|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
44388673|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
44388674|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
44388675|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
44388676|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
44388677|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
44388678|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
44388679|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
44388680|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
44388681|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
44388682|NCT00958568|79394989|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
44388683|NCT00958568|79394990|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
44388684|NCT00958568|79394991|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
44388685|NCT00958568|79394992|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
44388686|NCT00958412|79395003|FG000|Overall Study|Study prematurely terminated|18|||
44388687|NCT00958256|79395007|FG000|Overall Study|Adverse Event|3|||
44388688|NCT00696709|79395016|FG000|Overall Study|Withdrawal by Subject|1|||
44388689|NCT00696709|79395017|FG001|Overall Study|Withdrawal by Subject|2|||
44388690|NCT00696709|79395018|FG002|Overall Study|Withdrawal by Subject|1|||
44388691|NCT00696709|79395019|FG003|Overall Study|Withdrawal by Subject|4|||
44388692|NCT00696709|79395020|FG004|Overall Study|Withdrawal by Subject|3|||
44388693|NCT00696709|79395016|FG000|Overall Study|Protocol Violation|1|||
44388694|NCT00696709|79395017|FG001|Overall Study|Protocol Violation|0|||
44388695|NCT00696709|79395018|FG002|Overall Study|Protocol Violation|0|||
44388696|NCT00696709|79395019|FG003|Overall Study|Protocol Violation|0|||
44388697|NCT00696709|79395020|FG004|Overall Study|Protocol Violation|0|||
44388698|NCT00696709|79395016|FG000|Overall Study|Lost to Follow-up|1|||
44388699|NCT00696709|79395017|FG001|Overall Study|Lost to Follow-up|1|||
44388700|NCT00696709|79395018|FG002|Overall Study|Lost to Follow-up|0|||
44388701|NCT00696709|79395019|FG003|Overall Study|Lost to Follow-up|0|||
44388702|NCT00696709|79395020|FG004|Overall Study|Lost to Follow-up|0|||
44388703|NCT00696709|79395016|FG000|Overall Study|Adverse Event|0|||
44388704|NCT00696709|79395017|FG001|Overall Study|Adverse Event|0|||
44388705|NCT00696709|79395018|FG002|Overall Study|Adverse Event|0|||
44388706|NCT00696709|79395019|FG003|Overall Study|Adverse Event|1|||
44388707|NCT00696709|79395020|FG004|Overall Study|Adverse Event|0|||
44388708|NCT01006265|79395040|FG000|Overall Study|Lost to Follow-up|1|||
44388709|NCT01006265|79395041|FG001|Overall Study|Lost to Follow-up|0|||
44388710|NCT01006265|79395042|FG002|Overall Study|Lost to Follow-up|1|||
44388711|NCT01006265|79395043|FG003|Overall Study|Lost to Follow-up|0|||
44388712|NCT01006265|79395040|FG000|Overall Study|Withdrawal by Subject|4|||
44388713|NCT01006265|79395041|FG001|Overall Study|Withdrawal by Subject|7|||
44388714|NCT01006265|79395042|FG002|Overall Study|Withdrawal by Subject|5|||
44251824|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
44251825|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
44251826|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
44388715|NCT01006265|79395043|FG003|Overall Study|Withdrawal by Subject|5|||
44388716|NCT01006265|79395040|FG000|Overall Study|Administrative reason|1|||
44388717|NCT01006265|79395041|FG001|Overall Study|Administrative reason|2|||
44388718|NCT01006265|79395042|FG002|Overall Study|Administrative reason|3|||
44388719|NCT01006265|79395043|FG003|Overall Study|Administrative reason|0|||
44388720|NCT01008995|79395055|FG000|Controlled Period|Adverse Event|1|||
44388721|NCT01008995|79395056|FG001|Controlled Period|Adverse Event|2|||
44388722|NCT01008995|79395057|FG002|Controlled Period|Adverse Event|0|||
44388723|NCT01008995|79395058|FG003|Controlled Period|Adverse Event|0|||
44388724|NCT01008995|79395055|FG000|Controlled Period|Other|2|||
44388725|NCT01008995|79395056|FG001|Controlled Period|Other|1|||
44388726|NCT01008995|79395057|FG002|Controlled Period|Other|0|||
44388727|NCT01008995|79395058|FG003|Controlled Period|Other|0|||
44388728|NCT01008995|79395055|FG000|After Controlled Period|Adverse Event|0|||
44388729|NCT01008995|79395056|FG001|After Controlled Period|Adverse Event|0|||
44388730|NCT01008995|79395057|FG002|After Controlled Period|Adverse Event|1|||
44388731|NCT01008995|79395058|FG003|After Controlled Period|Adverse Event|1|||
44388732|NCT01008995|79395055|FG000|After Controlled Period|Other|0|||
44388733|NCT01008995|79395056|FG001|After Controlled Period|Other|0|||
44388734|NCT01008995|79395057|FG002|After Controlled Period|Other|1|||
44388735|NCT01008995|79395058|FG003|After Controlled Period|Other|0|||
44388736|NCT00957944|79395068|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
44388737|NCT00957944|79395069|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
44388738|NCT01005875|79395075|FG000|Overall Study|Death|3|||
44388739|NCT01005719|79395079|FG000|Period 1|Adverse Event|0|||
44388740|NCT01005719|79395080|FG001|Period 1|Adverse Event|0|||
44388741|NCT01005719|79395081|FG002|Period 1|Adverse Event|0|||
44388742|NCT01005719|79395082|FG003|Period 1|Adverse Event|1|||
44388743|NCT01005719|79395083|FG004|Period 1|Adverse Event|0|||
44388744|NCT01005719|79395084|FG005|Period 1|Adverse Event|0|||
44388745|NCT01005719|79395079|FG000|Period 1|Delay in completing study procedures|0|||
44388746|NCT01005719|79395080|FG001|Period 1|Delay in completing study procedures|0|||
44388747|NCT01005719|79395081|FG002|Period 1|Delay in completing study procedures|0|||
44388748|NCT01005719|79395082|FG003|Period 1|Delay in completing study procedures|0|||
44388749|NCT01005719|79395083|FG004|Period 1|Delay in completing study procedures|0|||
44388750|NCT01005719|79395084|FG005|Period 1|Delay in completing study procedures|1|||
44388751|NCT01005719|79395079|FG000|Period 2|Adverse Event|0|||
44388752|NCT01005719|79395080|FG001|Period 2|Adverse Event|0|||
44388753|NCT01005719|79395081|FG002|Period 2|Adverse Event|0|||
44388754|NCT01005719|79395082|FG003|Period 2|Adverse Event|0|||
44388755|NCT01005719|79395083|FG004|Period 2|Adverse Event|1|||
44388756|NCT01005719|79395084|FG005|Period 2|Adverse Event|1|||
44388757|NCT00953576|79395095|FG000|Overall Study|Adverse Event|0|||
44388758|NCT00953576|79395096|FG001|Overall Study|Adverse Event|1|||
44388759|NCT00953576|79395095|FG000|Overall Study|Ineligible after Consent|2|||
44388760|NCT00953576|79395096|FG001|Overall Study|Ineligible after Consent|0|||
44388761|NCT01005329|79395105|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
44388762|NCT01005251|79395115|FG000|Overall Study|Withdrawal by Subject|2|||
44388763|NCT01005251|79395116|FG001|Overall Study|Withdrawal by Subject|5|||
44251827|NCT01045161|79087488|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
44251828|NCT01045161|79087489|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
44251829|NCT01045161|79087490|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
44251830|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
44251831|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
44280635|NCT01979952|79241783|FG001|Overall Study|Other than specified above|0|||
44280636|NCT01999218|79241792|FG000|Overall Study|Hyperglycemia|18|||
44280637|NCT01999218|79241793|FG001|Overall Study|Hyperglycemia|17|||
44280638|NCT01999218|79241794|FG002|Overall Study|Hyperglycemia|17|||
44280639|NCT01999218|79241792|FG000|Overall Study|Lack of Efficacy|1|||
44280640|NCT01999218|79241793|FG001|Overall Study|Lack of Efficacy|0|||
44280641|NCT01999218|79241794|FG002|Overall Study|Lack of Efficacy|1|||
44280642|NCT01999218|79241792|FG000|Overall Study|Lost to Follow-up|22|||
44280643|NCT01999218|79241793|FG001|Overall Study|Lost to Follow-up|17|||
44280644|NCT01999218|79241794|FG002|Overall Study|Lost to Follow-up|18|||
44280645|NCT01999218|79241792|FG000|Overall Study|Non-Compliance With Study Drug|6|||
44280646|NCT01999218|79241793|FG001|Overall Study|Non-Compliance With Study Drug|4|||
44388764|NCT01005251|79395117|FG002|Overall Study|Withdrawal by Subject|3|||
44251832|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
44251833|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
44251834|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
44251835|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
44280647|NCT01999218|79241794|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44280648|NCT01999218|79241792|FG000|Overall Study|Physician Decision|1|||
44280649|NCT01999218|79241793|FG001|Overall Study|Physician Decision|4|||
44388765|NCT01005251|79395118|FG003|Overall Study|Withdrawal by Subject|4|||
44388766|NCT01005251|79395119|FG004|Overall Study|Withdrawal by Subject|9|||
44388767|NCT01005251|79395115|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
44388768|NCT01005251|79395116|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44388769|NCT01005251|79395117|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
44388770|NCT01005251|79395118|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
44388771|NCT01005251|79395119|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
44388772|NCT01005251|79395115|FG000|Overall Study|Adverse Event|2|||
44388773|NCT01005251|79395116|FG001|Overall Study|Adverse Event|6|||
44388774|NCT01005251|79395117|FG002|Overall Study|Adverse Event|8|||
44388775|NCT01005251|79395118|FG003|Overall Study|Adverse Event|5|||
44519262|NCT02894502|79527167|FG001|Third Follow up|Withdrawal by Subject|6|||
44519263|NCT02894502|79527168|FG002|Third Follow up|Withdrawal by Subject|3|||
44519264|NCT02894502|79527166|FG000|Third Follow up|Death|1|||
44519265|NCT02894502|79527167|FG001|Third Follow up|Death|1|||
44519266|NCT02894502|79527168|FG002|Third Follow up|Death|0|||
44519267|NCT03449030|79527189|FG000|Overall Study|Withdrawal by Subject|0|||
44519268|NCT03449030|79527190|FG001|Overall Study|Withdrawal by Subject|0|||
44519269|NCT03449030|79527191|FG002|Overall Study|Withdrawal by Subject|0|||
44519270|NCT03449030|79527192|FG003|Overall Study|Withdrawal by Subject|1|||
44519271|NCT03449030|79527193|FG004|Overall Study|Withdrawal by Subject|1|||
44519272|NCT03449030|79527194|FG005|Overall Study|Withdrawal by Subject|1|||
44519273|NCT03449030|79527195|FG006|Overall Study|Withdrawal by Subject|1|||
44519274|NCT03449030|79527196|FG007|Overall Study|Withdrawal by Subject|2|||
44519275|NCT03449030|79527197|FG008|Overall Study|Withdrawal by Subject|0|||
44519276|NCT03449030|79527198|FG009|Overall Study|Withdrawal by Subject|0|||
44519277|NCT03449030|79527189|FG000|Overall Study|Symptomatic Deterioration|0|||
44519278|NCT03449030|79527190|FG001|Overall Study|Symptomatic Deterioration|1|||
44519279|NCT03449030|79527191|FG002|Overall Study|Symptomatic Deterioration|0|||
44519280|NCT03449030|79527192|FG003|Overall Study|Symptomatic Deterioration|0|||
44519281|NCT03449030|79527193|FG004|Overall Study|Symptomatic Deterioration|0|||
44519282|NCT03449030|79527194|FG005|Overall Study|Symptomatic Deterioration|1|||
44519283|NCT03449030|79527195|FG006|Overall Study|Symptomatic Deterioration|1|||
44519284|NCT03449030|79527196|FG007|Overall Study|Symptomatic Deterioration|0|||
44519285|NCT03449030|79527197|FG008|Overall Study|Symptomatic Deterioration|2|||
44519286|NCT03449030|79527198|FG009|Overall Study|Symptomatic Deterioration|0|||
44519287|NCT03449030|79527189|FG000|Overall Study|Progressive Disease|1|||
44519288|NCT03449030|79527190|FG001|Overall Study|Progressive Disease|0|||
44519289|NCT03449030|79527191|FG002|Overall Study|Progressive Disease|1|||
44519290|NCT03449030|79527192|FG003|Overall Study|Progressive Disease|4|||
44519291|NCT03449030|79527193|FG004|Overall Study|Progressive Disease|5|||
44519292|NCT03449030|79527194|FG005|Overall Study|Progressive Disease|3|||
44519293|NCT03449030|79527195|FG006|Overall Study|Progressive Disease|0|||
44519294|NCT03449030|79527196|FG007|Overall Study|Progressive Disease|1|||
44519295|NCT03449030|79527197|FG008|Overall Study|Progressive Disease|1|||
44519296|NCT03449030|79527198|FG009|Overall Study|Progressive Disease|1|||
44519297|NCT03449030|79527189|FG000|Overall Study|Adverse Event|0|||
44519298|NCT03449030|79527190|FG001|Overall Study|Adverse Event|0|||
44519299|NCT03449030|79527191|FG002|Overall Study|Adverse Event|0|||
44519300|NCT03449030|79527192|FG003|Overall Study|Adverse Event|0|||
44519301|NCT03449030|79527193|FG004|Overall Study|Adverse Event|0|||
44519302|NCT03449030|79527194|FG005|Overall Study|Adverse Event|2|||
44519303|NCT03449030|79527195|FG006|Overall Study|Adverse Event|0|||
44519304|NCT03449030|79527196|FG007|Overall Study|Adverse Event|0|||
44519305|NCT03449030|79527197|FG008|Overall Study|Adverse Event|0|||
44519306|NCT03449030|79527198|FG009|Overall Study|Adverse Event|0|||
44519307|NCT03449030|79527189|FG000|Overall Study|Death|0|||
44519308|NCT03449030|79527190|FG001|Overall Study|Death|0|||
44519309|NCT03449030|79527191|FG002|Overall Study|Death|0|||
44519310|NCT03449030|79527192|FG003|Overall Study|Death|0|||
44519311|NCT03449030|79527193|FG004|Overall Study|Death|1|||
44519312|NCT03449030|79527194|FG005|Overall Study|Death|0|||
44251836|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
44251837|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
44251838|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
44251839|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
44251840|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
44251841|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
44251842|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
44251843|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
44251844|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
44280650|NCT01999218|79241794|FG002|Overall Study|Physician Decision|6|||
44280651|NCT01999218|79241792|FG000|Overall Study|Protocol Violation|4|||
44388776|NCT01005251|79395119|FG004|Overall Study|Adverse Event|4|||
44388777|NCT01005251|79395115|FG000|Overall Study|Protocol Violation|1|||
44519313|NCT03449030|79527195|FG006|Overall Study|Death|0|||
44519314|NCT03449030|79527196|FG007|Overall Study|Death|0|||
44519315|NCT03449030|79527197|FG008|Overall Study|Death|0|||
44519316|NCT03449030|79527198|FG009|Overall Study|Death|0|||
44519317|NCT03448406|79527223|FG000|Overall Study|Noncompliance of scheduled visits|1|||
44388778|NCT01005251|79395116|FG001|Overall Study|Protocol Violation|0|||
44388779|NCT01005251|79395117|FG002|Overall Study|Protocol Violation|0|||
44519318|NCT03448406|79527224|FG001|Overall Study|Noncompliance of scheduled visits|2|||
44519319|NCT03448406|79527223|FG000|Overall Study|Withdrawal by Subject|1|||
44519320|NCT03448406|79527224|FG001|Overall Study|Withdrawal by Subject|2|||
44519321|NCT03448406|79527223|FG000|Overall Study|Protocol Violation|1|||
44519322|NCT03448406|79527224|FG001|Overall Study|Protocol Violation|0|||
44519323|NCT03448406|79527223|FG000|Overall Study|Adverse Event|8|||
44388780|NCT01005251|79395118|FG003|Overall Study|Protocol Violation|0|||
44388781|NCT01005251|79395119|FG004|Overall Study|Protocol Violation|2|||
44388782|NCT01005251|79395115|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
44388783|NCT01005251|79395116|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
44388784|NCT01005251|79395117|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
44388785|NCT01005251|79395118|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
44388786|NCT01005251|79395119|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
44251845|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
44251846|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
44251847|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
44251848|NCT01045161|79087488|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
44251849|NCT01045161|79087489|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
44388787|NCT01005251|79395115|FG000|Overall Study|Lost to Follow-up|1|||
44388788|NCT01005251|79395116|FG001|Overall Study|Lost to Follow-up|4|||
44388789|NCT01005251|79395117|FG002|Overall Study|Lost to Follow-up|2|||
44388790|NCT01005251|79395118|FG003|Overall Study|Lost to Follow-up|0|||
44388791|NCT01005251|79395119|FG004|Overall Study|Lost to Follow-up|0|||
44388792|NCT01005251|79395115|FG000|Overall Study|Physician Decision|0|||
44388793|NCT01005251|79395116|FG001|Overall Study|Physician Decision|0|||
44388794|NCT01005251|79395117|FG002|Overall Study|Physician Decision|0|||
44388795|NCT01005251|79395118|FG003|Overall Study|Physician Decision|0|||
44388796|NCT01005251|79395119|FG004|Overall Study|Physician Decision|2|||
44388797|NCT01005251|79395115|FG000|Overall Study|Patient moved|1|||
44388798|NCT01005251|79395116|FG001|Overall Study|Patient moved|0|||
44388799|NCT01005251|79395117|FG002|Overall Study|Patient moved|0|||
44388800|NCT01005251|79395118|FG003|Overall Study|Patient moved|0|||
44388801|NCT01005251|79395119|FG004|Overall Study|Patient moved|0|||
44388802|NCT01005251|79395115|FG000|Overall Study|Wrong drug dispensed|0|||
44388803|NCT01005251|79395116|FG001|Overall Study|Wrong drug dispensed|1|||
44388804|NCT01005251|79395117|FG002|Overall Study|Wrong drug dispensed|0|||
44388805|NCT01005251|79395118|FG003|Overall Study|Wrong drug dispensed|0|||
44388806|NCT01005251|79395119|FG004|Overall Study|Wrong drug dispensed|0|||
44388807|NCT01005251|79395115|FG000|Overall Study|Randomized in error|0|||
44146325|NCT01060384|78935636|FG001|Overall Study|Withdrawal by Subject|1|||
44280652|NCT01999218|79241793|FG001|Overall Study|Protocol Violation|5|||
44146326|NCT01060384|78935637|FG002|Overall Study|Withdrawal by Subject|0|||
44251850|NCT01045161|79087490|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
44251851|NCT00633217|79087509|FG000|Overall Study|Adverse Event|5|||
44251852|NCT00633217|79087510|FG001|Overall Study|Adverse Event|9|||
44251853|NCT00633217|79087509|FG000|Overall Study|Lack of Efficacy|0|||
44251854|NCT00633217|79087510|FG001|Overall Study|Lack of Efficacy|2|||
44251855|NCT00633217|79087509|FG000|Overall Study|Protocol Violation|3|||
44251856|NCT00633217|79087510|FG001|Overall Study|Protocol Violation|7|||
44251857|NCT00633217|79087509|FG000|Overall Study|Lost to Follow-up|2|||
44251858|NCT00633217|79087510|FG001|Overall Study|Lost to Follow-up|2|||
44251859|NCT00633217|79087509|FG000|Overall Study|Investigator Discretion|2|||
44251860|NCT00633217|79087510|FG001|Overall Study|Investigator Discretion|0|||
44251861|NCT00633217|79087509|FG000|Overall Study|Withdrew Consent|3|||
44251862|NCT00633217|79087510|FG001|Overall Study|Withdrew Consent|3|||
44251863|NCT01673490|79087516|FG000|Overall Study|Lost to Follow-up|1|||
44251864|NCT01673490|79087516|FG000|Overall Study|Adverse Event|3|||
44251865|NCT01673490|79087516|FG000|Overall Study|Withdrawal by Subject|3|||
44251866|NCT00215657|79087528|FG000|Overall Study|Adverse Event|5|||
44251867|NCT00215657|79087529|FG001|Overall Study|Adverse Event|1|||
44251868|NCT00215657|79087530|FG002|Overall Study|Adverse Event|3|||
44251869|NCT00215657|79087531|FG003|Overall Study|Adverse Event|0|||
44251870|NCT00215657|79087532|FG004|Overall Study|Adverse Event|3|||
44251871|NCT00215657|79087533|FG005|Overall Study|Adverse Event|1|||
44251872|NCT00215657|79087534|FG006|Overall Study|Adverse Event|0|||
44251873|NCT00215657|79087535|FG007|Overall Study|Adverse Event|3|||
44251874|NCT00215657|79087528|FG000|Overall Study|Withdrawal by Subject|6|||
44251875|NCT00215657|79087529|FG001|Overall Study|Withdrawal by Subject|3|||
44251876|NCT00215657|79087530|FG002|Overall Study|Withdrawal by Subject|3|||
44280653|NCT01999218|79241794|FG002|Overall Study|Protocol Violation|4|||
44280654|NCT01999218|79241792|FG000|Overall Study|Screen failure|0|||
44280655|NCT01999218|79241793|FG001|Overall Study|Screen failure|1|||
44280656|NCT01999218|79241794|FG002|Overall Study|Screen failure|0|||
44251877|NCT00215657|79087531|FG003|Overall Study|Withdrawal by Subject|1|||
44251878|NCT00215657|79087532|FG004|Overall Study|Withdrawal by Subject|6|||
44146327|NCT01060384|78935638|FG003|Overall Study|Withdrawal by Subject|0|||
44251879|NCT00215657|79087533|FG005|Overall Study|Withdrawal by Subject|1|||
44251880|NCT00215657|79087534|FG006|Overall Study|Withdrawal by Subject|10|||
44251881|NCT00215657|79087535|FG007|Overall Study|Withdrawal by Subject|3|||
44388808|NCT01005251|79395116|FG001|Overall Study|Randomized in error|0|||
44388809|NCT01005251|79395117|FG002|Overall Study|Randomized in error|1|||
44388810|NCT01005251|79395118|FG003|Overall Study|Randomized in error|1|||
44388811|NCT01005251|79395119|FG004|Overall Study|Randomized in error|0|||
44280657|NCT01999218|79241792|FG000|Overall Study|Study Terminated By Sponsor|7|||
44280658|NCT01999218|79241793|FG001|Overall Study|Study Terminated By Sponsor|5|||
44280659|NCT01999218|79241794|FG002|Overall Study|Study Terminated By Sponsor|12|||
44280660|NCT01999218|79241792|FG000|Overall Study|Participant moves|2|||
44388812|NCT01005251|79395115|FG000|Overall Study|Lack of Efficacy|0|||
44388813|NCT01005251|79395116|FG001|Overall Study|Lack of Efficacy|0|||
44388814|NCT01005251|79395117|FG002|Overall Study|Lack of Efficacy|1|||
44388815|NCT01005251|79395118|FG003|Overall Study|Lack of Efficacy|1|||
44388816|NCT01005251|79395119|FG004|Overall Study|Lack of Efficacy|0|||
44388817|NCT03048578|79395133|FG000|Overall Study|Withdrawal by Subject|5|||
44388818|NCT03048578|79395134|FG001|Overall Study|Withdrawal by Subject|6|||
44388819|NCT03048578|79395133|FG000|Overall Study|Lost to Follow-up|22|||
44388820|NCT03048578|79395134|FG001|Overall Study|Lost to Follow-up|10|||
44388821|NCT03048578|79395133|FG000|Overall Study|Adverse Event|1|||
44388822|NCT03048578|79395134|FG001|Overall Study|Adverse Event|2|||
44388823|NCT03048578|79395133|FG000|Overall Study|Terminated|3|||
44388824|NCT03048578|79395134|FG001|Overall Study|Terminated|2|||
44388825|NCT01008449|79395142|FG000|Overall Study|Lost to Follow-up|29|||
44519324|NCT03448406|79527224|FG001|Overall Study|Adverse Event|9|||
44519325|NCT03499028|79527232|FG000|Overall Study|Lost to Follow-up|12|||
44519326|NCT03499028|79527233|FG001|Overall Study|Lost to Follow-up|9|||
44519327|NCT03499028|79527232|FG000|Overall Study|Withdrawal by Subject|5|||
44519328|NCT03499028|79527233|FG001|Overall Study|Withdrawal by Subject|8|||
44519329|NCT03499028|79527232|FG000|Overall Study|Unplanned SNF discharge|5|||
44519330|NCT03499028|79527233|FG001|Overall Study|Unplanned SNF discharge|8|||
44519331|NCT03498560|79527241|FG000|Overall Study|Found Ineligible|2|||
44519332|NCT03498560|79527241|FG000|Overall Study|Withdrawal by Subject|14|||
44519333|NCT03498560|79527241|FG000|Overall Study|Lost to Follow-up|4|||
44519334|NCT03498560|79527241|FG000|Overall Study|Death|1|||
44519335|NCT00064701|79527249|FG000|One Year Post-transplant|Did not receive study drug|7|||
44519336|NCT00064701|79527250|FG001|One Year Post-transplant|Did not receive study drug|12|||
44519337|NCT00064701|79527251|FG002|One Year Post-transplant|Did not receive study drug|11|||
44519338|NCT00064701|79527249|FG000|One Year Post-transplant|Adverse Event|23|||
44519339|NCT00064701|79527250|FG001|One Year Post-transplant|Adverse Event|19|||
44519340|NCT00064701|79527251|FG002|One Year Post-transplant|Adverse Event|37|||
44519341|NCT00064701|79527249|FG000|One Year Post-transplant|Rejection|0|||
44519342|NCT00064701|79527250|FG001|One Year Post-transplant|Rejection|1|||
44519343|NCT00064701|79527251|FG002|One Year Post-transplant|Rejection|16|||
44519344|NCT00064701|79527249|FG000|One Year Post-transplant|Non-compliance|4|||
44519345|NCT00064701|79527250|FG001|One Year Post-transplant|Non-compliance|2|||
44519346|NCT00064701|79527251|FG002|One Year Post-transplant|Non-compliance|5|||
44519347|NCT00064701|79527249|FG000|One Year Post-transplant|Graft Failure|3|||
44519348|NCT00064701|79527250|FG001|One Year Post-transplant|Graft Failure|2|||
44519349|NCT00064701|79527251|FG002|One Year Post-transplant|Graft Failure|1|||
44519350|NCT00064701|79527249|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
44519351|NCT00064701|79527250|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
44519352|NCT00064701|79527251|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
44519353|NCT00064701|79527249|FG000|One Year Post-transplant|Lost to Follow-up|1|||
44519354|NCT00064701|79527250|FG001|One Year Post-transplant|Lost to Follow-up|0|||
44519355|NCT00064701|79527251|FG002|One Year Post-transplant|Lost to Follow-up|0|||
44519356|NCT00064701|79527249|FG000|One Year Post-transplant|Converted to rapamycin|1|||
44519357|NCT00064701|79527250|FG001|One Year Post-transplant|Converted to rapamycin|0|||
44519358|NCT00064701|79527251|FG002|One Year Post-transplant|Converted to rapamycin|0|||
44519359|NCT00064701|79527249|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
44519360|NCT00064701|79527250|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
44519361|NCT00064701|79527251|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
44519362|NCT00064701|79527249|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
44519363|NCT00064701|79527250|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
44519364|NCT00064701|79527251|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
44146328|NCT01060384|78935639|FG004|Overall Study|Withdrawal by Subject|0|||
44146329|NCT01060384|78935635|FG000|Overall Study|Death|0|||
44519365|NCT00064701|79527249|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
44519366|NCT00064701|79527250|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
44519367|NCT00064701|79527251|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
44519368|NCT00064701|79527249|FG000|One Year Post-transplant|Poor absorption|0|||
44519369|NCT00064701|79527250|FG001|One Year Post-transplant|Poor absorption|1|||
44519370|NCT00064701|79527251|FG002|One Year Post-transplant|Poor absorption|0|||
44519371|NCT00064701|79527249|FG000|One Year Post-transplant|Pancreas transplant|0|||
44519372|NCT00064701|79527250|FG001|One Year Post-transplant|Pancreas transplant|0|||
44519373|NCT00064701|79527251|FG002|One Year Post-transplant|Pancreas transplant|1|||
44280661|NCT01999218|79241793|FG001|Overall Study|Participant moves|5|||
44388826|NCT01008449|79395143|FG001|Overall Study|Lost to Follow-up|19|||
44388827|NCT00696241|79395154|FG000|Overall Study|Adverse Event|11|||
44388828|NCT00696241|79395155|FG001|Overall Study|Adverse Event|3|||
44388829|NCT00696241|79395156|FG002|Overall Study|Adverse Event|6|||
44388830|NCT00696241|79395157|FG003|Overall Study|Adverse Event|4|||
44519374|NCT00064701|79527249|FG000|Clinical Continuation Phase|Adverse Event|12|||
44519375|NCT00064701|79527250|FG001|Clinical Continuation Phase|Adverse Event|21|||
44519376|NCT00064701|79527251|FG002|Clinical Continuation Phase|Adverse Event|14|||
44519377|NCT00064701|79527249|FG000|Clinical Continuation Phase|Non-compliance|8|||
44519378|NCT00064701|79527250|FG001|Clinical Continuation Phase|Non-compliance|6|||
44519379|NCT00064701|79527251|FG002|Clinical Continuation Phase|Non-compliance|7|||
44519380|NCT00064701|79527249|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
44519381|NCT00064701|79527250|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
44519382|NCT00064701|79527251|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
44519383|NCT00064701|79527249|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
44280662|NCT01999218|79241794|FG002|Overall Study|Participant moves|3|||
44280663|NCT01999218|79241792|FG000|Overall Study|Withdrawal by Subject|28|||
44280664|NCT01999218|79241793|FG001|Overall Study|Withdrawal by Subject|29|||
44280665|NCT01999218|79241794|FG002|Overall Study|Withdrawal by Subject|34|||
44280666|NCT01999218|79241792|FG000|Overall Study|Creatinine/eGFR|0|||
44280667|NCT01999218|79241793|FG001|Overall Study|Creatinine/eGFR|0|||
44280668|NCT01999218|79241794|FG002|Overall Study|Creatinine/eGFR|1|||
44280669|NCT01999218|79241792|FG000|Overall Study|Death|7|||
44280670|NCT01999218|79241793|FG001|Overall Study|Death|1|||
44280671|NCT01999218|79241794|FG002|Overall Study|Death|2|||
44280672|NCT01999218|79241792|FG000|Overall Study|Excluded Medication|1|||
44280673|NCT01999218|79241793|FG001|Overall Study|Excluded Medication|1|||
44280674|NCT01999218|79241794|FG002|Overall Study|Excluded Medication|2|||
44388831|NCT00696241|79395158|FG004|Overall Study|Adverse Event|5|||
44388832|NCT00696241|79395154|FG000|Overall Study|Protocol Violation|1|||
44388833|NCT00696241|79395155|FG001|Overall Study|Protocol Violation|1|||
44388834|NCT00696241|79395156|FG002|Overall Study|Protocol Violation|2|||
44388835|NCT00696241|79395157|FG003|Overall Study|Protocol Violation|0|||
44388836|NCT00696241|79395158|FG004|Overall Study|Protocol Violation|3|||
44388837|NCT00696241|79395154|FG000|Overall Study|Lost to Follow-up|1|||
44388838|NCT00696241|79395155|FG001|Overall Study|Lost to Follow-up|4|||
44388839|NCT00696241|79395156|FG002|Overall Study|Lost to Follow-up|1|||
44388840|NCT00696241|79395157|FG003|Overall Study|Lost to Follow-up|2|||
44388841|NCT00696241|79395158|FG004|Overall Study|Lost to Follow-up|0|||
44388842|NCT00696241|79395154|FG000|Overall Study|Withdrawal by Subject|4|||
44388843|NCT00696241|79395155|FG001|Overall Study|Withdrawal by Subject|8|||
44519384|NCT00064701|79527250|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
44146330|NCT01060384|78935636|FG001|Overall Study|Death|0|||
44146331|NCT01060384|78935637|FG002|Overall Study|Death|0|||
44146332|NCT01060384|78935638|FG003|Overall Study|Death|0|||
44146333|NCT01060384|78935639|FG004|Overall Study|Death|1|||
44146334|NCT01060384|78935635|FG000|Overall Study|Intercurrent illness|0|||
44146335|NCT01060384|78935636|FG001|Overall Study|Intercurrent illness|0|||
44146336|NCT01060384|78935637|FG002|Overall Study|Intercurrent illness|0|||
44146337|NCT01060384|78935638|FG003|Overall Study|Intercurrent illness|0|||
44146338|NCT01060384|78935639|FG004|Overall Study|Intercurrent illness|1|||
44146339|NCT00580047|78935662|FG000|Overall Study|Lost to Follow-up|1|||
44146340|NCT00580047|78935663|FG001|Overall Study|Lost to Follow-up|1|||
44146341|NCT00580047|78935664|FG002|Overall Study|Lost to Follow-up|0|||
44146342|NCT00580047|78935662|FG000|Overall Study|Withdrawal by Subject|1|||
44146343|NCT00580047|78935663|FG001|Overall Study|Withdrawal by Subject|1|||
44146344|NCT00580047|78935664|FG002|Overall Study|Withdrawal by Subject|2|||
44146345|NCT00580047|78935662|FG000|Overall Study|Withdrawal by Subject|1|||
44146346|NCT00580047|78935663|FG001|Overall Study|Withdrawal by Subject|0|||
44146347|NCT00580047|78935664|FG002|Overall Study|Withdrawal by Subject|0|||
44146348|NCT00561340|78935677|FG000|Overall Study|refused to drink pediasure|6|||
44146349|NCT00561340|78935678|FG001|Overall Study|refused to drink pediasure|0|||
44146350|NCT00292045|78935684|FG000|Core Study (Through Week 13)|Adverse Event|1|||
44146351|NCT00292045|78935684|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
44146352|NCT00084799|78935690|FG000|Overall Study|Disease Progression|1|||
44146353|NCT00084799|78935691|FG001|Overall Study|Disease Progression|0|||
44146354|NCT00072410|78935699|FG000|Overall Study|Progressive disease|0|||
44146355|NCT00072410|78935700|FG001|Overall Study|Progressive disease|3|||
44146356|NCT00066729|78935706|FG000|Overall Study|Lost to Follow-up|1|||
44146357|NCT00066729|78935706|FG000|Overall Study|Disease progression|1|||
44146358|NCT00006046|78935724|FG000|Overall Study|Adverse Event|3|||
44146359|NCT00006046|78935725|FG001|Overall Study|Adverse Event|0|||
44146360|NCT00006046|78935726|FG002|Overall Study|Adverse Event|0|||
44146361|NCT00006046|78935727|FG003|Overall Study|Adverse Event|0|||
44146362|NCT00006046|78935728|FG004|Overall Study|Adverse Event|0|||
44146363|NCT00006046|78935724|FG000|Overall Study|Disease Progression|2|||
44146364|NCT00006046|78935725|FG001|Overall Study|Disease Progression|0|||
44146365|NCT00006046|78935726|FG002|Overall Study|Disease Progression|0|||
44146366|NCT00006046|78935727|FG003|Overall Study|Disease Progression|0|||
44146367|NCT00006046|78935728|FG004|Overall Study|Disease Progression|0|||
44146368|NCT00003102|78935743|FG000|Overall Study|Physician Decision|1|||
44146369|NCT00003102|78935744|FG001|Overall Study|Physician Decision|1|||
44146370|NCT00003102|78935745|FG002|Overall Study|Physician Decision|0|||
44146371|NCT00003102|78935743|FG000|Overall Study|Progressive Disease|0|||
44146372|NCT00003102|78935744|FG001|Overall Study|Progressive Disease|1|||
44146373|NCT00003102|78935745|FG002|Overall Study|Progressive Disease|0|||
44146374|NCT00003102|78935743|FG000|Overall Study|Adverse Event|0|||
44146375|NCT00003102|78935744|FG001|Overall Study|Adverse Event|1|||
44146376|NCT00003102|78935745|FG002|Overall Study|Adverse Event|1|||
44146377|NCT00003102|78935743|FG000|Overall Study|Death|0|||
44146378|NCT00003102|78935744|FG001|Overall Study|Death|0|||
44146379|NCT00003102|78935745|FG002|Overall Study|Death|1|||
44146380|NCT01673373|78935753|FG000|Overall Study|Death|2|||
44146381|NCT01236547|78935762|FG000|Overall Study|Protocol Violation|0|||
44146382|NCT01236547|78935763|FG001|Overall Study|Protocol Violation|1|||
44146383|NCT01236547|78935764|FG002|Overall Study|Protocol Violation|1|||
44146384|NCT01236547|78935765|FG003|Overall Study|Protocol Violation|6|||
44146385|NCT01236547|78935766|FG004|Overall Study|Protocol Violation|12|||
44146386|NCT02167945|78935779|FG000|Overall Study|Adverse Event|16|||
44146387|NCT02167945|78935779|FG000|Overall Study|Withdrew Consent|42|||
44146388|NCT02167945|78935779|FG000|Overall Study|Lost to Follow-up|122|||
44146389|NCT02167945|78935779|FG000|Overall Study|COVID-19 logistical restrictions|6|||
44280675|NCT01999218|79241792|FG000|Overall Study|Adverse Event|9|||
44388844|NCT00696241|79395156|FG002|Overall Study|Withdrawal by Subject|6|||
44146390|NCT02167945|78935779|FG000|Overall Study|Other, not specified|63|||
44146391|NCT01375075|78935797|FG000|Overall Study|Adverse Event|0|||
44146392|NCT01375075|78935798|FG001|Overall Study|Adverse Event|0|||
44146393|NCT01375075|78935799|FG002|Overall Study|Adverse Event|3|||
44146394|NCT01375075|78935800|FG003|Overall Study|Adverse Event|1|||
44146395|NCT01375075|78935801|FG004|Overall Study|Adverse Event|0|||
44146396|NCT01375075|78935802|FG005|Overall Study|Adverse Event|1|||
44146397|NCT01375075|78935797|FG000|Overall Study|Entry Criterion Not Met|1|||
44146398|NCT01375075|78935798|FG001|Overall Study|Entry Criterion Not Met|0|||
44146399|NCT01375075|78935799|FG002|Overall Study|Entry Criterion Not Met|0|||
44146400|NCT01375075|78935800|FG003|Overall Study|Entry Criterion Not Met|0|||
44146401|NCT01375075|78935801|FG004|Overall Study|Entry Criterion Not Met|0|||
44146402|NCT01375075|78935802|FG005|Overall Study|Entry Criterion Not Met|1|||
44146403|NCT01375075|78935797|FG000|Overall Study|Withdrawal by Subject|0|||
44146404|NCT01375075|78935798|FG001|Overall Study|Withdrawal by Subject|1|||
44146405|NCT01375075|78935799|FG002|Overall Study|Withdrawal by Subject|0|||
44146406|NCT01375075|78935800|FG003|Overall Study|Withdrawal by Subject|0|||
44388845|NCT00696241|79395157|FG003|Overall Study|Withdrawal by Subject|1|||
44388846|NCT00696241|79395158|FG004|Overall Study|Withdrawal by Subject|0|||
44388847|NCT00696241|79395154|FG000|Overall Study|Lack of Efficacy|1|||
44388848|NCT00696241|79395155|FG001|Overall Study|Lack of Efficacy|5|||
44388849|NCT00696241|79395156|FG002|Overall Study|Lack of Efficacy|4|||
44388850|NCT00696241|79395157|FG003|Overall Study|Lack of Efficacy|5|||
44388851|NCT00696241|79395158|FG004|Overall Study|Lack of Efficacy|3|||
44388852|NCT00696241|79395154|FG000|Overall Study|Other|6|||
44388853|NCT00696241|79395155|FG001|Overall Study|Other|1|||
44388854|NCT00696241|79395156|FG002|Overall Study|Other|5|||
44388855|NCT00696241|79395157|FG003|Overall Study|Other|2|||
44388856|NCT00696241|79395158|FG004|Overall Study|Other|1|||
44388857|NCT00957008|79395174|FG000|Overall Study|Withdrawal by Subject|13|||
44388858|NCT00957008|79395175|FG001|Overall Study|Withdrawal by Subject|10|||
44388859|NCT00957008|79395176|FG002|Overall Study|Withdrawal by Subject|12|||
44388860|NCT00957008|79395177|FG003|Overall Study|Withdrawal by Subject|16|||
44388861|NCT00957008|79395174|FG000|Overall Study|Lost to Follow-up|3|||
44388862|NCT00957008|79395175|FG001|Overall Study|Lost to Follow-up|1|||
44388863|NCT00957008|79395176|FG002|Overall Study|Lost to Follow-up|3|||
44388864|NCT00957008|79395177|FG003|Overall Study|Lost to Follow-up|4|||
44388865|NCT00957008|79395174|FG000|Overall Study|Physician Decision|1|||
44388866|NCT00957008|79395175|FG001|Overall Study|Physician Decision|0|||
44388867|NCT00957008|79395176|FG002|Overall Study|Physician Decision|1|||
44388868|NCT00957008|79395177|FG003|Overall Study|Physician Decision|1|||
44388869|NCT00957008|79395174|FG000|Overall Study|Relocated; Family conflict|4|||
44388870|NCT00957008|79395175|FG001|Overall Study|Relocated; Family conflict|1|||
44388871|NCT00957008|79395176|FG002|Overall Study|Relocated; Family conflict|1|||
44388872|NCT00957008|79395177|FG003|Overall Study|Relocated; Family conflict|3|||
44388873|NCT00952484|79395194|FG000|Overall Study|Withdrawal by Subject|0|||
44388874|NCT00952484|79395195|FG001|Overall Study|Withdrawal by Subject|1|||
44388875|NCT00952484|79395196|FG002|Overall Study|Withdrawal by Subject|0|||
44388876|NCT00689611|79395207|FG000|Overall Study|Death|6|||
44388877|NCT00689611|79395208|FG001|Overall Study|Death|9|||
44388878|NCT00689611|79395207|FG000|Overall Study|Withdrawal by Subject|8|||
44388879|NCT00689611|79395208|FG001|Overall Study|Withdrawal by Subject|9|||
44388880|NCT00689611|79395207|FG000|Overall Study|Lost to Follow-up|27|||
44388881|NCT00689611|79395208|FG001|Overall Study|Lost to Follow-up|28|||
44388882|NCT00689299|79395217|FG000|Overall Study|Adverse Event|2|||
44388883|NCT00689299|79395218|FG001|Overall Study|Adverse Event|1|||
44388884|NCT00689299|79395219|FG002|Overall Study|Adverse Event|1|||
44388885|NCT00689299|79395217|FG000|Overall Study|Lost to Follow-up|0|||
44388886|NCT00689299|79395218|FG001|Overall Study|Lost to Follow-up|1|||
44388887|NCT00689299|79395219|FG002|Overall Study|Lost to Follow-up|1|||
44388888|NCT00689299|79395217|FG000|Overall Study|Withdrawal by Subject|4|||
44388889|NCT00689299|79395218|FG001|Overall Study|Withdrawal by Subject|1|||
44388890|NCT00689299|79395219|FG002|Overall Study|Withdrawal by Subject|3|||
44388891|NCT00689299|79395217|FG000|Overall Study|Protocol Violation|1|||
44388892|NCT00689299|79395218|FG001|Overall Study|Protocol Violation|0|||
44388893|NCT00689299|79395219|FG002|Overall Study|Protocol Violation|0|||
44388894|NCT02506244|79395230|FG000|Overall Study|Did not undergo active monitoring|458|||
44388895|NCT02506244|79395231|FG001|Overall Study|Did not undergo active monitoring|459|||
44388896|NCT02506244|79395232|FG002|Overall Study|Did not undergo active monitoring|0|||
44388897|NCT00948974|79395242|FG000|Overall Study|Lost to Follow-up|23|||
44388898|NCT00948974|79395243|FG001|Overall Study|Lost to Follow-up|20|||
44388899|NCT01007435|79395253|FG000|Overall Study|Adverse Event|16|||
44388900|NCT01007435|79395254|FG001|Overall Study|Adverse Event|25|||
44388901|NCT01007435|79395255|FG002|Overall Study|Adverse Event|47|||
44388902|NCT01007435|79395256|FG003|Overall Study|Adverse Event|31|||
44388903|NCT01007435|79395253|FG000|Overall Study|Death|2|||
44388904|NCT01007435|79395254|FG001|Overall Study|Death|4|||
44388905|NCT01007435|79395255|FG002|Overall Study|Death|2|||
44388906|NCT01007435|79395256|FG003|Overall Study|Death|1|||
44388907|NCT01007435|79395253|FG000|Overall Study|Insufficient Therapeutic Response|21|||
44388908|NCT01007435|79395254|FG001|Overall Study|Insufficient Therapeutic Response|7|||
44388909|NCT01007435|79395255|FG002|Overall Study|Insufficient Therapeutic Response|2|||
44519385|NCT00064701|79527251|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
44519386|NCT00064701|79527249|FG000|Clinical Continuation Phase|Graft Failure|5|||
44280676|NCT01999218|79241793|FG001|Overall Study|Adverse Event|7|||
44280677|NCT01999218|79241794|FG002|Overall Study|Adverse Event|7|||
44388910|NCT01007435|79395256|FG003|Overall Study|Insufficient Therapeutic Response|9|||
44280678|NCT01999218|79241792|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
44280679|NCT01999218|79241793|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
44388911|NCT01007435|79395253|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
44388912|NCT01007435|79395254|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
44388913|NCT01007435|79395255|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
44388914|NCT01007435|79395256|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
44388915|NCT01007435|79395253|FG000|Overall Study|Other Protocol Violation|2|||
44519387|NCT00064701|79527250|FG001|Clinical Continuation Phase|Graft Failure|5|||
44388916|NCT01007435|79395254|FG001|Overall Study|Other Protocol Violation|0|||
44388917|NCT01007435|79395255|FG002|Overall Study|Other Protocol Violation|1|||
44388918|NCT01007435|79395256|FG003|Overall Study|Other Protocol Violation|0|||
44388919|NCT01007435|79395253|FG000|Overall Study|Refused Treatment|13|||
44388920|NCT01007435|79395254|FG001|Overall Study|Refused Treatment|13|||
44388921|NCT01007435|79395255|FG002|Overall Study|Refused Treatment|5|||
44388922|NCT01007435|79395256|FG003|Overall Study|Refused Treatment|8|||
44388923|NCT01007435|79395253|FG000|Overall Study|Failure to Return|5|||
44388924|NCT01007435|79395254|FG001|Overall Study|Failure to Return|4|||
44388925|NCT01007435|79395255|FG002|Overall Study|Failure to Return|3|||
44388926|NCT01007435|79395256|FG003|Overall Study|Failure to Return|6|||
44388927|NCT01007435|79395253|FG000|Overall Study|Reason not Specified|1|||
44388928|NCT01007435|79395254|FG001|Overall Study|Reason not Specified|1|||
44388929|NCT01007435|79395255|FG002|Overall Study|Reason not Specified|2|||
44388930|NCT01007435|79395256|FG003|Overall Study|Reason not Specified|1|||
44388931|NCT00948896|79395274|FG000|Randomization to 24 Months of Age|Death|1|||
44388932|NCT00948896|79395275|FG001|Randomization to 24 Months of Age|Death|0|||
44388933|NCT00948896|79395276|FG002|Randomization to 24 Months of Age|Death|0|||
44388934|NCT00948896|79395277|FG003|Randomization to 24 Months of Age|Death|0|||
44388935|NCT00948896|79395278|FG004|Randomization to 24 Months of Age|Death|2|||
44388936|NCT00948896|79395279|FG005|Randomization to 24 Months of Age|Death|1|||
44388937|NCT00948896|79395280|FG006|Randomization to 24 Months of Age|Death|2|||
44388938|NCT00948896|79395281|FG007|Randomization to 24 Months of Age|Death|1|||
44388939|NCT00948896|79395274|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
44388940|NCT00948896|79395275|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
44388941|NCT00948896|79395276|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
44388942|NCT00948896|79395277|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
44388943|NCT00948896|79395278|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
44388944|NCT00948896|79395279|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
44388945|NCT00948896|79395280|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
44388946|NCT00948896|79395281|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
44388947|NCT00948896|79395274|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
44388948|NCT00948896|79395275|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
44388949|NCT00948896|79395276|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
44388950|NCT00948896|79395277|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
44388951|NCT00948896|79395278|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
44388952|NCT00948896|79395279|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
44388953|NCT00948896|79395280|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
44388954|NCT00948896|79395281|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
44388955|NCT00948896|79395274|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
44388956|NCT00948896|79395275|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
44388957|NCT00948896|79395276|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
44388958|NCT00948896|79395277|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
44388959|NCT00948896|79395278|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
44388960|NCT00948896|79395279|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
44388961|NCT00948896|79395280|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
44388962|NCT00948896|79395281|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
44388963|NCT00948896|79395274|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
44388964|NCT00948896|79395275|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
44388965|NCT00948896|79395276|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
44388966|NCT00948896|79395277|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
44388967|NCT00948896|79395278|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
44388968|NCT00948896|79395279|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
44388969|NCT00948896|79395280|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
44388970|NCT00948896|79395281|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
44388971|NCT00948896|79395274|FG000|24 Months of Age to 36 Months of Age|Death|0|||
44388972|NCT00948896|79395275|FG001|24 Months of Age to 36 Months of Age|Death|2|||
44388973|NCT00948896|79395276|FG002|24 Months of Age to 36 Months of Age|Death|2|||
44388974|NCT00948896|79395277|FG003|24 Months of Age to 36 Months of Age|Death|0|||
44388975|NCT00948896|79395278|FG004|24 Months of Age to 36 Months of Age|Death|0|||
44388976|NCT00948896|79395279|FG005|24 Months of Age to 36 Months of Age|Death|1|||
44388977|NCT00948896|79395280|FG006|24 Months of Age to 36 Months of Age|Death|0|||
44388978|NCT00948896|79395281|FG007|24 Months of Age to 36 Months of Age|Death|0|||
44388979|NCT00948896|79395274|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
44388980|NCT00948896|79395275|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
44388981|NCT00948896|79395276|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
44388982|NCT00948896|79395277|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
44388983|NCT00948896|79395278|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
44388984|NCT00948896|79395279|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
44388985|NCT00948896|79395280|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
44388986|NCT00948896|79395281|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
44388987|NCT00948896|79395274|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
44388988|NCT00948896|79395275|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
44388989|NCT00948896|79395276|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
44388990|NCT00948896|79395277|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
44388991|NCT00948896|79395278|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
44388992|NCT00948896|79395279|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
44388993|NCT00948896|79395280|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
44388994|NCT00948896|79395281|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
44388995|NCT00948896|79395274|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
44388996|NCT00948896|79395275|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
44388997|NCT00948896|79395276|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
44388998|NCT00948896|79395277|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
44388999|NCT00948896|79395278|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
44389000|NCT00948896|79395279|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
44389001|NCT00948896|79395280|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
44389002|NCT00948896|79395281|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
44389003|NCT00948896|79395274|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389004|NCT00948896|79395275|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389005|NCT00948896|79395276|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389006|NCT00948896|79395277|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
44389007|NCT00948896|79395278|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389008|NCT00948896|79395279|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389009|NCT00948896|79395280|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389010|NCT00948896|79395281|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
44389011|NCT01004159|79395303|FG000|Overall Study|Adverse Event|2|||
44389012|NCT01004159|79395303|FG000|Overall Study|Disease Progression|18|||
44389013|NCT00948818|79395309|FG000|Overall Study|Adverse Event|10|||
44389014|NCT00948818|79395310|FG001|Overall Study|Adverse Event|32|||
44389015|NCT00948818|79395309|FG000|Overall Study|Protocol Violation|9|||
44389016|NCT00948818|79395310|FG001|Overall Study|Protocol Violation|10|||
44389017|NCT00948818|79395309|FG000|Overall Study|Withdrawal by Subject|25|||
44389018|NCT00948818|79395310|FG001|Overall Study|Withdrawal by Subject|25|||
44389019|NCT00948818|79395309|FG000|Overall Study|Lost to Follow-up|10|||
44389020|NCT00948818|79395310|FG001|Overall Study|Lost to Follow-up|17|||
44389021|NCT00948818|79395309|FG000|Overall Study|Lack of Efficacy|4|||
44389022|NCT00948818|79395310|FG001|Overall Study|Lack of Efficacy|5|||
44389023|NCT00948818|79395309|FG000|Overall Study|Other Reason|4|||
44389024|NCT00948818|79395310|FG001|Overall Study|Other Reason|5|||
44389025|NCT00948506|79395321|FG000|Overall Study|Withdrawal by Subject|3|||
44389026|NCT00948506|79395322|FG001|Overall Study|Withdrawal by Subject|1|||
44389027|NCT00955682|79395333|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
44389028|NCT00955682|79395334|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
44389029|NCT00689221|79395350|FG000|Overall Study|Ongoing at cut-off date|39|||
44389030|NCT00689221|79395351|FG001|Overall Study|Ongoing at cut-off date|36|||
44389031|NCT01875445|79395359|FG000|Overall Study|Lost to Follow-up|5|||
44389032|NCT01875445|79395360|FG001|Overall Study|Lost to Follow-up|0|||
44389033|NCT01875445|79395359|FG000|Overall Study|Withdrawal by Subject|2|||
44389034|NCT01875445|79395360|FG001|Overall Study|Withdrawal by Subject|0|||
44389035|NCT00688909|79395366|FG000|Overall Study|Adverse Event|28|||
44389036|NCT00688909|79395366|FG000|Overall Study|Patient withdrew consent|2|||
44389037|NCT00688909|79395366|FG000|Overall Study|Administrative problems|1|||
44389038|NCT00688909|79395366|FG000|Overall Study|Protocol Violation|2|||
44389039|NCT00948428|79395374|FG000|Overall Study|Withdrawal by Subject|6|||
44389040|NCT00948428|79395375|FG001|Overall Study|Withdrawal by Subject|12|||
44389041|NCT00948428|79395376|FG002|Overall Study|Withdrawal by Subject|7|||
44389042|NCT00948428|79395374|FG000|Overall Study|Adverse Event|6|||
44389043|NCT00948428|79395375|FG001|Overall Study|Adverse Event|3|||
44389044|NCT00948428|79395376|FG002|Overall Study|Adverse Event|0|||
44389045|NCT00948428|79395374|FG000|Overall Study|Lost to Follow-up|2|||
44389046|NCT00948428|79395375|FG001|Overall Study|Lost to Follow-up|1|||
44389047|NCT00948428|79395376|FG002|Overall Study|Lost to Follow-up|1|||
44389048|NCT00948428|79395374|FG000|Overall Study|Death|2|||
44389049|NCT00948428|79395375|FG001|Overall Study|Death|0|||
44389050|NCT00948428|79395376|FG002|Overall Study|Death|0|||
44389051|NCT00948428|79395374|FG000|Overall Study|Intercurrent Illness|1|||
44389052|NCT00948428|79395375|FG001|Overall Study|Intercurrent Illness|0|||
44389053|NCT00948428|79395376|FG002|Overall Study|Intercurrent Illness|0|||
44389054|NCT00948428|79395374|FG000|Overall Study|Non-compliance|1|||
44389055|NCT00948428|79395375|FG001|Overall Study|Non-compliance|2|||
44389056|NCT00948428|79395376|FG002|Overall Study|Non-compliance|0|||
44389057|NCT00948194|79395386|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
44389058|NCT00948194|79395387|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
44389059|NCT00691483|79395395|FG000|Overall Study|Adverse Event|14|||
44389060|NCT00691483|79395396|FG001|Overall Study|Adverse Event|6|||
44280680|NCT01999218|79241794|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
44146407|NCT01375075|78935801|FG004|Overall Study|Withdrawal by Subject|0|||
44146408|NCT01375075|78935802|FG005|Overall Study|Withdrawal by Subject|1|||
44146409|NCT00706433|78935824|FG000|Overall Study|Lost to Follow-up|3|||
44146410|NCT00706433|78935825|FG001|Overall Study|Lost to Follow-up|1|||
44146411|NCT00706433|78935826|FG002|Overall Study|Lost to Follow-up|6|||
44146412|NCT00706433|78935827|FG003|Overall Study|Lost to Follow-up|0|||
44146413|NCT00706433|78935824|FG000|Overall Study|Withdrawal by Subject|1|||
44146414|NCT00706433|78935825|FG001|Overall Study|Withdrawal by Subject|2|||
44146415|NCT00706433|78935826|FG002|Overall Study|Withdrawal by Subject|3|||
44146416|NCT00706433|78935827|FG003|Overall Study|Withdrawal by Subject|1|||
44146417|NCT00706433|78935824|FG000|Overall Study|Adverse Event|0|||
44146418|NCT00706433|78935825|FG001|Overall Study|Adverse Event|0|||
44146419|NCT00706433|78935826|FG002|Overall Study|Adverse Event|1|||
44146420|NCT00706433|78935827|FG003|Overall Study|Adverse Event|0|||
44146421|NCT00706433|78935824|FG000|Overall Study|Protocol Violation|1|||
44146422|NCT00706433|78935825|FG001|Overall Study|Protocol Violation|0|||
44146423|NCT00706433|78935826|FG002|Overall Study|Protocol Violation|0|||
44146424|NCT00706433|78935827|FG003|Overall Study|Protocol Violation|0|||
44280681|NCT01937130|79241806|FG000|Overall Study|Withdrawal by Subject|0|||
44280682|NCT01937130|79241807|FG001|Overall Study|Withdrawal by Subject|0|||
44280683|NCT01937130|79241808|FG002|Overall Study|Withdrawal by Subject|0|||
44280684|NCT01937130|79241809|FG003|Overall Study|Withdrawal by Subject|1|||
44280685|NCT01937130|79241806|FG000|Overall Study|Adverse Event|0|||
44280686|NCT01937130|79241807|FG001|Overall Study|Adverse Event|1|||
44280687|NCT01937130|79241808|FG002|Overall Study|Adverse Event|0|||
44280688|NCT01937130|79241809|FG003|Overall Study|Adverse Event|1|||
44280689|NCT01937130|79241806|FG000|Overall Study|Death|1|||
44280690|NCT01937130|79241807|FG001|Overall Study|Death|1|||
44280691|NCT01937130|79241808|FG002|Overall Study|Death|1|||
44280692|NCT01937130|79241809|FG003|Overall Study|Death|0|||
44280693|NCT01937130|79241806|FG000|Overall Study|Lost to Follow-up|2|||
44280694|NCT01937130|79241807|FG001|Overall Study|Lost to Follow-up|0|||
44280695|NCT01937130|79241808|FG002|Overall Study|Lost to Follow-up|2|||
44280696|NCT01937130|79241809|FG003|Overall Study|Lost to Follow-up|0|||
44280697|NCT01937130|79241806|FG000|Overall Study|Physician Decision|0|||
44280698|NCT01937130|79241807|FG001|Overall Study|Physician Decision|1|||
44280699|NCT01937130|79241808|FG002|Overall Study|Physician Decision|0|||
44280700|NCT01937130|79241809|FG003|Overall Study|Physician Decision|0|||
44280701|NCT01937130|79241806|FG000|Overall Study|Patients unable to swallow|0|||
44280702|NCT01937130|79241807|FG001|Overall Study|Patients unable to swallow|1|||
44280703|NCT01937130|79241808|FG002|Overall Study|Patients unable to swallow|0|||
44280704|NCT01937130|79241809|FG003|Overall Study|Patients unable to swallow|0|||
44280705|NCT01937130|79241806|FG000|Overall Study|Patient lost to FU due to death|2|||
44280706|NCT01937130|79241807|FG001|Overall Study|Patient lost to FU due to death|0|||
44280707|NCT01937130|79241808|FG002|Overall Study|Patient lost to FU due to death|0|||
44280708|NCT01937130|79241809|FG003|Overall Study|Patient lost to FU due to death|0|||
44280709|NCT01936974|79241821|FG000|Overall Study|Physician Decision|2|||
44280710|NCT01936974|79241822|FG001|Overall Study|Physician Decision|5|||
44280711|NCT01959516|79241828|FG000|Epoch 1|Adverse Event|4|||
44280712|NCT01959516|79241829|FG001|Epoch 1|Adverse Event|1|||
44389061|NCT00691483|79395395|FG000|Overall Study|Lost to Follow-up|17|||
44389062|NCT00691483|79395396|FG001|Overall Study|Lost to Follow-up|10|||
44389063|NCT00691483|79395395|FG000|Overall Study|Withdrawal by Subject|24|||
44146425|NCT00706433|78935824|FG000|Overall Study|new job|0|||
44146426|NCT00706433|78935825|FG001|Overall Study|new job|0|||
44146427|NCT00706433|78935826|FG002|Overall Study|new job|0|||
44280713|NCT01959516|79241828|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
44280714|NCT01959516|79241829|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
44280715|NCT01959516|79241828|FG000|Epoch 1|Subject withdrew consent|3|||
44280716|NCT01959516|79241829|FG001|Epoch 1|Subject withdrew consent|2|||
44280717|NCT01959516|79241828|FG000|Epoch 1|Administrative problems|1|||
44280718|NCT01959516|79241829|FG001|Epoch 1|Administrative problems|0|||
44280719|NCT01959516|79241828|FG000|Epoch 1|Use of prohibited treatment|1|||
44280720|NCT01959516|79241829|FG001|Epoch 1|Use of prohibited treatment|0|||
44280721|NCT01959516|79241828|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
44146428|NCT00706433|78935827|FG003|Overall Study|new job|1|||
44146429|NCT02638623|78935839|FG000|Overall Study|Surgery timing|5|||
44146430|NCT02638623|78935840|FG001|Overall Study|Surgery timing|6|||
44146431|NCT02638623|78935839|FG000|Overall Study|Not given intervention|2|||
44146432|NCT02638623|78935840|FG001|Overall Study|Not given intervention|0|||
44146433|NCT02637141|78935849|FG000|Overall Study|Adverse Event|1|||
44389064|NCT00691483|79395396|FG001|Overall Study|Withdrawal by Subject|7|||
44389065|NCT00691483|79395395|FG000|Overall Study|Other known cause|6|||
44389066|NCT00691483|79395396|FG001|Overall Study|Other known cause|1|||
44389067|NCT00691483|79395395|FG000|Overall Study|Randomized by not treated|7|||
44389068|NCT00691483|79395396|FG001|Overall Study|Randomized by not treated|1|||
44389069|NCT00691093|79395402|FG000|Overall Study|Adverse Event|1|||
44389070|NCT00691093|79395402|FG000|Overall Study|Lost to Follow-up|1|||
44389071|NCT00691093|79395402|FG000|Overall Study|Lack of Efficacy|1|||
44389072|NCT00691093|79395402|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
44389073|NCT00947882|79395415|FG000|Overall Study|Adverse Event|0|||
44389074|NCT00947882|79395416|FG001|Overall Study|Adverse Event|1|||
44389075|NCT00947882|79395417|FG002|Overall Study|Adverse Event|4|||
44389076|NCT00947882|79395418|FG003|Overall Study|Adverse Event|4|||
44389077|NCT00947882|79395415|FG000|Overall Study|Withdrawal by Subject|2|||
44389078|NCT00947882|79395416|FG001|Overall Study|Withdrawal by Subject|0|||
44389079|NCT00947882|79395417|FG002|Overall Study|Withdrawal by Subject|8|||
44389080|NCT00947882|79395418|FG003|Overall Study|Withdrawal by Subject|2|||
44389081|NCT00947882|79395415|FG000|Overall Study|Protocol Violation|0|||
44389082|NCT00947882|79395416|FG001|Overall Study|Protocol Violation|0|||
44389083|NCT00947882|79395417|FG002|Overall Study|Protocol Violation|1|||
44389084|NCT00947882|79395418|FG003|Overall Study|Protocol Violation|0|||
44389085|NCT00947882|79395415|FG000|Overall Study|Lost to Follow-up|0|||
44389086|NCT00947882|79395416|FG001|Overall Study|Lost to Follow-up|2|||
44389087|NCT00947882|79395417|FG002|Overall Study|Lost to Follow-up|1|||
44389088|NCT00947882|79395418|FG003|Overall Study|Lost to Follow-up|0|||
44389089|NCT00947882|79395415|FG000|Overall Study|Other/Unknown|10|||
44389090|NCT00947882|79395416|FG001|Overall Study|Other/Unknown|13|||
44389091|NCT00947882|79395417|FG002|Overall Study|Other/Unknown|3|||
44389092|NCT00947882|79395418|FG003|Overall Study|Other/Unknown|6|||
44389093|NCT00947882|79395415|FG000|Overall Study|Trial Terminated by Sponsor|62|||
44389094|NCT00947882|79395416|FG001|Overall Study|Trial Terminated by Sponsor|61|||
44389095|NCT00947882|79395417|FG002|Overall Study|Trial Terminated by Sponsor|62|||
44389096|NCT00947882|79395418|FG003|Overall Study|Trial Terminated by Sponsor|70|||
44389097|NCT00688753|79395429|FG000|Overall Study|Disease progression|55|||
44389098|NCT00688753|79395429|FG000|Overall Study|Missing|1|||
44389099|NCT00688753|79395429|FG000|Overall Study|Death|9|||
44389100|NCT00688753|79395429|FG000|Overall Study|Withdrawal by Subject|3|||
44389101|NCT00688753|79395429|FG000|Overall Study|Adverse Event|20|||
44389102|NCT00688753|79395429|FG000|Overall Study|Protocol Violation|1|||
44389103|NCT00688753|79395429|FG000|Overall Study|Lost to Follow-up|3|||
44389104|NCT00951080|79395435|FG000|Overall Study|Adverse Event|3|||
44389105|NCT00951080|79395436|FG001|Overall Study|Adverse Event|3|||
44389106|NCT00951080|79395435|FG000|Overall Study|Lost to Follow-up|0|||
44389107|NCT00951080|79395436|FG001|Overall Study|Lost to Follow-up|1|||
44389108|NCT00951080|79395435|FG000|Overall Study|Physician Decision|4|||
44389109|NCT00951080|79395436|FG001|Overall Study|Physician Decision|1|||
44389110|NCT00951080|79395435|FG000|Overall Study|Other|19|||
44389111|NCT00951080|79395436|FG001|Overall Study|Other|22|||
44389112|NCT00946322|79395442|FG000|Pre-treatment|participant failure to follow up|1|||
44389113|NCT00946322|79395442|FG000|Post-treatment|participant failure to follow up|2|||
44389114|NCT00950690|79395446|FG000|Overall Study|Death|4|||
44389115|NCT00950690|79395446|FG000|Overall Study|Adverse Event|15|||
44389116|NCT00950690|79395446|FG000|Overall Study|Lack of Efficacy|22|||
44146434|NCT02637141|78935850|FG001|Overall Study|Adverse Event|1|||
44146435|NCT02637141|78935851|FG002|Overall Study|Adverse Event|0|||
44146436|NCT02637141|78935849|FG000|Overall Study|Withdrawal by Subject|1|||
44146437|NCT02637141|78935850|FG001|Overall Study|Withdrawal by Subject|1|||
44280722|NCT01959516|79241829|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
44280723|NCT01959516|79241828|FG000|Epoch 1|Protocol deviation|0|||
44280724|NCT01959516|79241829|FG001|Epoch 1|Protocol deviation|1|||
44280725|NCT01959516|79241828|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
44280726|NCT01959516|79241829|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
44280727|NCT01959516|79241828|FG000|Epoch 2|Subject withdrew consent|1|||
44389117|NCT00950690|79395446|FG000|Overall Study|Lost to Follow-up|40|||
44389118|NCT00950690|79395446|FG000|Overall Study|Other|163|||
44389119|NCT00694369|79395455|FG000|Overall Study|Adverse Event|0|||
44389120|NCT00694369|79395456|FG001|Overall Study|Adverse Event|1|||
44389121|NCT00694369|79395457|FG002|Overall Study|Adverse Event|0|||
44389122|NCT00694369|79395458|FG003|Overall Study|Adverse Event|1|||
44389123|NCT00694369|79395459|FG004|Overall Study|Adverse Event|3|||
44389124|NCT00694369|79395455|FG000|Overall Study|Lost to Follow-up|0|||
44389125|NCT00694369|79395456|FG001|Overall Study|Lost to Follow-up|0|||
44389126|NCT00694369|79395457|FG002|Overall Study|Lost to Follow-up|1|||
44280728|NCT01959516|79241829|FG001|Epoch 2|Subject withdrew consent|0|||
44280729|NCT01959516|79241828|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
44389127|NCT00694369|79395458|FG003|Overall Study|Lost to Follow-up|1|||
44389128|NCT00694369|79395459|FG004|Overall Study|Lost to Follow-up|0|||
44389129|NCT00694369|79395455|FG000|Overall Study|Physician Decision|0|||
44389130|NCT00694369|79395456|FG001|Overall Study|Physician Decision|0|||
44389131|NCT00694369|79395457|FG002|Overall Study|Physician Decision|0|||
44389132|NCT00694369|79395458|FG003|Overall Study|Physician Decision|0|||
44389133|NCT00694369|79395459|FG004|Overall Study|Physician Decision|1|||
44389134|NCT00694369|79395455|FG000|Overall Study|Protocol Violation|0|||
44389135|NCT00694369|79395456|FG001|Overall Study|Protocol Violation|1|||
44389136|NCT00694369|79395457|FG002|Overall Study|Protocol Violation|0|||
44389137|NCT00694369|79395458|FG003|Overall Study|Protocol Violation|0|||
44389138|NCT00694369|79395459|FG004|Overall Study|Protocol Violation|0|||
44389139|NCT00694369|79395455|FG000|Overall Study|Withdrawal by Subject|1|||
44389140|NCT00694369|79395456|FG001|Overall Study|Withdrawal by Subject|1|||
44389141|NCT00694369|79395457|FG002|Overall Study|Withdrawal by Subject|1|||
44389142|NCT00694369|79395458|FG003|Overall Study|Withdrawal by Subject|1|||
44389143|NCT00694369|79395459|FG004|Overall Study|Withdrawal by Subject|2|||
44389144|NCT00513019|79395473|FG000|Overall Study|Adverse Event|1|||
44389145|NCT00513019|79395474|FG001|Overall Study|Adverse Event|0|||
44389146|NCT00513019|79395473|FG000|Overall Study|Withdrawal by Subject|4|||
44389147|NCT00513019|79395474|FG001|Overall Study|Withdrawal by Subject|5|||
44389148|NCT00954512|79395495|FG000|Overall Study|Withdrawal by Subject|0|||
44389149|NCT00954512|79395496|FG001|Overall Study|Withdrawal by Subject|0|||
44389150|NCT00954512|79395497|FG002|Overall Study|Withdrawal by Subject|0|||
44389151|NCT00954512|79395498|FG003|Overall Study|Withdrawal by Subject|0|||
44389152|NCT00954512|79395499|FG004|Overall Study|Withdrawal by Subject|0|||
44389153|NCT00954512|79395500|FG005|Overall Study|Withdrawal by Subject|1|||
44389154|NCT00954512|79395495|FG000|Overall Study|Adverse Event|0|||
44389155|NCT00954512|79395496|FG001|Overall Study|Adverse Event|0|||
44389156|NCT00954512|79395497|FG002|Overall Study|Adverse Event|0|||
44389157|NCT00954512|79395498|FG003|Overall Study|Adverse Event|0|||
44389158|NCT00954512|79395499|FG004|Overall Study|Adverse Event|1|||
44389159|NCT00954512|79395500|FG005|Overall Study|Adverse Event|2|||
44389160|NCT00954512|79395495|FG000|Overall Study|Physician Decision|0|||
44389161|NCT00954512|79395496|FG001|Overall Study|Physician Decision|1|||
44389162|NCT00954512|79395497|FG002|Overall Study|Physician Decision|0|||
44389163|NCT00954512|79395498|FG003|Overall Study|Physician Decision|1|||
44389164|NCT00954512|79395499|FG004|Overall Study|Physician Decision|0|||
44389165|NCT00954512|79395500|FG005|Overall Study|Physician Decision|0|||
44389166|NCT00954512|79395495|FG000|Overall Study|Symptomatic Deterioration|0|||
44389167|NCT00954512|79395496|FG001|Overall Study|Symptomatic Deterioration|1|||
44389168|NCT00954512|79395497|FG002|Overall Study|Symptomatic Deterioration|0|||
44389169|NCT00954512|79395498|FG003|Overall Study|Symptomatic Deterioration|0|||
44389170|NCT00954512|79395499|FG004|Overall Study|Symptomatic Deterioration|2|||
44389171|NCT00954512|79395500|FG005|Overall Study|Symptomatic Deterioration|0|||
44280730|NCT01959516|79241829|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
44280731|NCT01979016|79241837|FG000|Overall Study|Withdrawal by Subject|2|||
44280732|NCT01979016|79241838|FG001|Overall Study|Withdrawal by Subject|0|||
44280733|NCT01979016|79241837|FG000|Overall Study|Adverse Event|0|||
44280734|NCT01979016|79241838|FG001|Overall Study|Adverse Event|1|||
44280735|NCT01935336|79241848|FG000|Overall Study|Adverse Event|1|||
44280736|NCT01935336|79241849|FG001|Overall Study|Adverse Event|0|||
44280737|NCT01935336|79241850|FG002|Overall Study|Adverse Event|0|||
44280738|NCT01935336|79241851|FG003|Overall Study|Adverse Event|0|||
44280739|NCT01935336|79241848|FG000|Overall Study|Progressive disease|5|||
44280740|NCT01935336|79241849|FG001|Overall Study|Progressive disease|3|||
44280741|NCT01935336|79241850|FG002|Overall Study|Progressive disease|47|||
44280742|NCT01935336|79241851|FG003|Overall Study|Progressive disease|66|||
44280743|NCT01978236|79241867|FG000|Overall Study|Discontinued due to study close|2|||
44280744|NCT01977846|79241873|FG000|Total Study - Prospective|Death|0|||
44280745|NCT01977846|79241874|FG001|Total Study - Prospective|Death|1|||
44280746|NCT01977846|79241873|FG000|Total Study - Prospective|Lost to Follow-up|0|||
44389172|NCT00954512|79395495|FG000|Overall Study|Progression of Disease|2|||
44389173|NCT00954512|79395496|FG001|Overall Study|Progression of Disease|1|||
44389174|NCT00954512|79395497|FG002|Overall Study|Progression of Disease|0|||
44389175|NCT00954512|79395498|FG003|Overall Study|Progression of Disease|1|||
44389176|NCT00954512|79395499|FG004|Overall Study|Progression of Disease|1|||
44389177|NCT00954512|79395500|FG005|Overall Study|Progression of Disease|1|||
44389178|NCT00691015|79395513|FG000|Overall Study|Refused further treatment|1|||
44389179|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
44280747|NCT01977846|79241874|FG001|Total Study - Prospective|Lost to Follow-up|8|||
44280748|NCT01977846|79241873|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
44280749|NCT01977846|79241874|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
44389180|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
44389181|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
44389182|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
44389183|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
44389184|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
44280750|NCT01977846|79241873|FG000|Total Study - Prospective|Not available at time of visit|0|||
44280751|NCT01977846|79241874|FG001|Total Study - Prospective|Not available at time of visit|5|||
44389185|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
44389186|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
44389187|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
44389188|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
44389189|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
44389190|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
44389191|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
44389192|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
44389193|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
44389194|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
44389195|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
44389196|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
44389197|NCT00950300|79395519|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
44389198|NCT00950300|79395520|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
44389199|NCT00950300|79395519|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
44389200|NCT00950300|79395520|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
44389201|NCT00950300|79395519|FG000|TFFU Period|Death|4|||
44389202|NCT00950300|79395520|FG001|TFFU Period|Death|1|||
44389203|NCT00950300|79395519|FG000|TFFU Period|Refused Treatment|10|||
44389204|NCT00950300|79395520|FG001|TFFU Period|Refused Treatment|11|||
44389205|NCT00950300|79395519|FG000|TFFU Period|Failure to Return|16|||
44389206|NCT00950300|79395520|FG001|TFFU Period|Failure to Return|16|||
44389207|NCT00950300|79395519|FG000|TFFU Period|Recurrence of Disease|63|||
44389208|NCT00950300|79395520|FG001|TFFU Period|Recurrence of Disease|72|||
44389209|NCT00950300|79395519|FG000|TFFU Period|Other|4|||
44389210|NCT00950300|79395520|FG001|TFFU Period|Other|3|||
44389211|NCT00950300|79395519|FG000|SFU Period|Death|44|||
44251882|NCT00215657|79087528|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
44251883|NCT00215657|79087529|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
44251884|NCT00215657|79087530|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
44251885|NCT00215657|79087531|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
44251886|NCT00215657|79087532|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
44251887|NCT00215657|79087533|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
44251888|NCT00215657|79087534|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
44251889|NCT00215657|79087535|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
44251890|NCT00215657|79087528|FG000|Overall Study|Insufficient testosterone response|5|||
44251891|NCT00215657|79087529|FG001|Overall Study|Insufficient testosterone response|4|||
44389212|NCT00950300|79395520|FG001|SFU Period|Death|42|||
44389213|NCT00950300|79395519|FG000|SFU Period|Lost to Follow-up|30|||
44389214|NCT00950300|79395520|FG001|SFU Period|Lost to Follow-up|28|||
44389215|NCT00950300|79395519|FG000|SFU Period|Withdrawal by Subject|4|||
44389216|NCT00950300|79395520|FG001|SFU Period|Withdrawal by Subject|8|||
44389217|NCT00949988|79395527|FG000|Overall Study|Withdrawal by Subject|3|||
44389218|NCT00731692|79395534|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
44389219|NCT00731692|79395535|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
44389220|NCT00731692|79395536|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
44389221|NCT00731692|79395534|FG000|Core Study (36 Months)|Physician Decision|1|||
44389222|NCT00731692|79395535|FG001|Core Study (36 Months)|Physician Decision|0|||
44389223|NCT00731692|79395536|FG002|Core Study (36 Months)|Physician Decision|2|||
44389224|NCT00731692|79395534|FG000|Core Study (36 Months)|Death|2|||
44389225|NCT00731692|79395535|FG001|Core Study (36 Months)|Death|1|||
44389226|NCT00731692|79395536|FG002|Core Study (36 Months)|Death|2|||
44389227|NCT00731692|79395534|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
44389228|NCT00731692|79395535|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
44389229|NCT00731692|79395536|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
44389230|NCT00731692|79395534|FG000|Core Study (36 Months)|Administrative|2|||
44389231|NCT00731692|79395535|FG001|Core Study (36 Months)|Administrative|2|||
44389232|NCT00731692|79395536|FG002|Core Study (36 Months)|Administrative|6|||
44389233|NCT00731692|79395534|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
44389234|NCT00731692|79395535|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
44519388|NCT00064701|79527251|FG002|Clinical Continuation Phase|Graft Failure|2|||
44519389|NCT00064701|79527249|FG000|Clinical Continuation Phase|Rejection|1|||
44519390|NCT00064701|79527250|FG001|Clinical Continuation Phase|Rejection|2|||
44251892|NCT00215657|79087530|FG002|Overall Study|Insufficient testosterone response|1|||
44251893|NCT00215657|79087531|FG003|Overall Study|Insufficient testosterone response|12|||
44389235|NCT00731692|79395536|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
44389236|NCT00731692|79395534|FG000|Core Study (36 Months)|Protocol Violation|4|||
44389237|NCT00731692|79395535|FG001|Core Study (36 Months)|Protocol Violation|5|||
44389238|NCT00731692|79395536|FG002|Core Study (36 Months)|Protocol Violation|8|||
44389239|NCT00731692|79395534|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
44389240|NCT00731692|79395535|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
44389241|NCT00731692|79395536|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
44389242|NCT00731692|79395534|FG000|Core Study (36 Months)|Adverse Event|25|||
44389243|NCT00731692|79395535|FG001|Core Study (36 Months)|Adverse Event|28|||
44389244|NCT00731692|79395536|FG002|Core Study (36 Months)|Adverse Event|29|||
44389245|NCT00731692|79395534|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
44389246|NCT00731692|79395535|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
44389247|NCT00731692|79395536|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
44389248|NCT00731692|79395534|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
44389249|NCT00731692|79395535|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
44389250|NCT00731692|79395536|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
44389251|NCT00731692|79395534|FG000|Extension Phase|Abnormal test procedure|0|||
44389252|NCT00731692|79395535|FG001|Extension Phase|Abnormal test procedure|0|||
44389253|NCT00731692|79395536|FG002|Extension Phase|Abnormal test procedure|1|||
44389254|NCT00731692|79395534|FG000|Extension Phase|Abnormal lab values|0|||
44389255|NCT00731692|79395535|FG001|Extension Phase|Abnormal lab values|0|||
44389256|NCT00731692|79395536|FG002|Extension Phase|Abnormal lab values|1|||
44389257|NCT00731692|79395534|FG000|Extension Phase|Lost to Follow-up|0|||
44389258|NCT00731692|79395535|FG001|Extension Phase|Lost to Follow-up|1|||
44389259|NCT00731692|79395536|FG002|Extension Phase|Lost to Follow-up|4|||
44389260|NCT00731692|79395534|FG000|Extension Phase|Withdrawal by Subject|4|||
44389261|NCT00731692|79395535|FG001|Extension Phase|Withdrawal by Subject|5|||
44389262|NCT00731692|79395536|FG002|Extension Phase|Withdrawal by Subject|3|||
44389263|NCT00731692|79395534|FG000|Extension Phase|Adverse Event|1|||
44389264|NCT00731692|79395535|FG001|Extension Phase|Adverse Event|1|||
44389265|NCT00731692|79395536|FG002|Extension Phase|Adverse Event|15|||
44389266|NCT00687193|79395558|FG000|Overall Study|Adverse Event|0|||
44389267|NCT00687193|79395559|FG001|Overall Study|Adverse Event|1|||
44389268|NCT00687193|79395560|FG002|Overall Study|Adverse Event|2|||
44389269|NCT00687193|79395561|FG003|Overall Study|Adverse Event|3|||
44389270|NCT00687193|79395562|FG004|Overall Study|Adverse Event|0|||
44389271|NCT00687193|79395563|FG005|Overall Study|Adverse Event|2|||
44389272|NCT00687193|79395558|FG000|Overall Study|Lack of Efficacy|1|||
44389273|NCT00687193|79395559|FG001|Overall Study|Lack of Efficacy|1|||
44519391|NCT00064701|79527251|FG002|Clinical Continuation Phase|Rejection|2|||
44519392|NCT00064701|79527249|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
44519393|NCT00064701|79527250|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
44519394|NCT00064701|79527251|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
44519395|NCT00064701|79527249|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
44519396|NCT00064701|79527250|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
44519397|NCT00064701|79527251|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
44519398|NCT00064701|79527249|FG000|Clinical Continuation Phase|Physician Decision|1|||
44519399|NCT00064701|79527250|FG001|Clinical Continuation Phase|Physician Decision|3|||
44519400|NCT00064701|79527251|FG002|Clinical Continuation Phase|Physician Decision|0|||
44519401|NCT00064701|79527249|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
44519402|NCT00064701|79527250|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
44519403|NCT00064701|79527251|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
44519404|NCT00064701|79527249|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
44519405|NCT00064701|79527250|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
44519406|NCT00064701|79527251|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
44519407|NCT00064701|79527249|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
44519408|NCT00064701|79527250|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
44519409|NCT00064701|79527251|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
44519410|NCT00064701|79527249|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
44519411|NCT00064701|79527250|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
44519412|NCT00064701|79527251|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
44519413|NCT00064701|79527249|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
44519414|NCT00064701|79527250|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
44146438|NCT02637141|78935851|FG002|Overall Study|Withdrawal by Subject|1|||
44146439|NCT02637063|78935862|FG000|Overall Study|Lost to Follow-up|3|||
44389274|NCT00687193|79395560|FG002|Overall Study|Lack of Efficacy|0|||
44389275|NCT00687193|79395561|FG003|Overall Study|Lack of Efficacy|0|||
44389276|NCT00687193|79395562|FG004|Overall Study|Lack of Efficacy|0|||
44389277|NCT00687193|79395563|FG005|Overall Study|Lack of Efficacy|2|||
44389278|NCT00687193|79395558|FG000|Overall Study|Protocol Violation|1|||
44389279|NCT00687193|79395559|FG001|Overall Study|Protocol Violation|2|||
44389280|NCT00687193|79395560|FG002|Overall Study|Protocol Violation|0|||
44389281|NCT00687193|79395561|FG003|Overall Study|Protocol Violation|1|||
44389282|NCT00687193|79395562|FG004|Overall Study|Protocol Violation|2|||
44389283|NCT00687193|79395563|FG005|Overall Study|Protocol Violation|0|||
44519415|NCT00064701|79527251|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
44519416|NCT00064701|79527249|FG000|Clinical Continuation Phase|Patient opted out|0|||
44389284|NCT00730912|79395583|FG000|Overall Study|Discontinued|0|||
44389285|NCT00730912|79395584|FG001|Overall Study|Discontinued|0|||
44146440|NCT02637063|78935863|FG001|Overall Study|Lost to Follow-up|2|||
44146441|NCT02637063|78935864|FG002|Overall Study|Lost to Follow-up|3|||
44146442|NCT02637063|78935862|FG000|Overall Study|Withdrawal by Subject|2|||
44146443|NCT02637063|78935863|FG001|Overall Study|Withdrawal by Subject|2|||
44146444|NCT02637063|78935864|FG002|Overall Study|Withdrawal by Subject|3|||
44146445|NCT02635737|78935872|FG000|Overall Study|Protocol Violation|1|||
44146446|NCT02636907|78935876|FG000|Autoinjector Assessment Period|Adverse Event|2|||
44146447|NCT02636907|78935876|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
44146448|NCT02636907|78935876|FG000|Extension Phase|Adverse Event|2|||
44146449|NCT02636907|78935876|FG000|Extension Phase|Withdrawal by Subject|4|||
44146450|NCT02636907|78935876|FG000|Extension Phase|Physician Decision|1|||
44146451|NCT02636907|78935876|FG000|Extension Phase|Lost to Follow-up|2|||
44146452|NCT02636907|78935876|FG000|Extension Phase|Lack of Efficacy|1|||
44389286|NCT00730912|79395585|FG002|Overall Study|Discontinued|1|||
44389287|NCT00730756|79395595|FG000|Overall Study|Adverse Event|2|||
44389288|NCT00730756|79395596|FG001|Overall Study|Adverse Event|0|||
44389289|NCT00730756|79395595|FG000|Overall Study|Lack of Efficacy|1|||
44519417|NCT00064701|79527250|FG001|Clinical Continuation Phase|Patient opted out|0|||
44519418|NCT00064701|79527251|FG002|Clinical Continuation Phase|Patient opted out|1|||
44519419|NCT00064077|79527263|FG000|Overall Study|Improper prior treatment|1|||
44519420|NCT00064077|79527264|FG001|Overall Study|Improper prior treatment|0|||
44519421|NCT00064077|79527265|FG002|Overall Study|Improper prior treatment|0|||
44519422|NCT00064077|79527266|FG003|Overall Study|Improper prior treatment|0|||
44519423|NCT00064077|79527263|FG000|Overall Study|Poor risk|2|||
44519424|NCT00064077|79527264|FG001|Overall Study|Poor risk|0|||
44519425|NCT00064077|79527265|FG002|Overall Study|Poor risk|1|||
44519426|NCT00064077|79527266|FG003|Overall Study|Poor risk|1|||
44519427|NCT00064077|79527263|FG000|Overall Study|Pathology|10|||
44519428|NCT00064077|79527264|FG001|Overall Study|Pathology|7|||
44519429|NCT00064077|79527265|FG002|Overall Study|Pathology|3|||
44519430|NCT00064077|79527266|FG003|Overall Study|Pathology|4|||
44519431|NCT00064077|79527263|FG000|Overall Study|No surgery|0|||
44519432|NCT00064077|79527264|FG001|Overall Study|No surgery|0|||
44519433|NCT00064077|79527265|FG002|Overall Study|No surgery|1|||
44519434|NCT00064077|79527266|FG003|Overall Study|No surgery|0|||
44519435|NCT00064077|79527263|FG000|Overall Study|No tumor|0|||
44519436|NCT00064077|79527264|FG001|Overall Study|No tumor|0|||
44519437|NCT00064077|79527265|FG002|Overall Study|No tumor|1|||
44519438|NCT00064077|79527266|FG003|Overall Study|No tumor|0|||
44519439|NCT00064077|79527263|FG000|Overall Study|Other reasons|2|||
44519440|NCT00064077|79527264|FG001|Overall Study|Other reasons|2|||
44519441|NCT00064077|79527265|FG002|Overall Study|Other reasons|1|||
44519442|NCT00064077|79527266|FG003|Overall Study|Other reasons|2|||
44519443|NCT00063999|79527278|FG000|Overall Study|Withdrawal by Subject|1|||
44519444|NCT00063999|79527279|FG001|Overall Study|Withdrawal by Subject|0|||
44519445|NCT00063999|79527278|FG000|Overall Study|Ineligible|44|||
44519446|NCT00063999|79527279|FG001|Overall Study|Ineligible|24|||
44519447|NCT03131440|79527324|FG000|Overall Study|Withdrawal by Subject|1|||
44519448|NCT03131440|79527325|FG001|Overall Study|Withdrawal by Subject|3|||
44519449|NCT03131440|79527326|FG002|Overall Study|Withdrawal by Subject|0|||
44519450|NCT03131440|79527327|FG003|Overall Study|Withdrawal by Subject|0|||
44519451|NCT03131440|79527328|FG004|Overall Study|Withdrawal by Subject|1|||
44519452|NCT03131440|79527329|FG005|Overall Study|Withdrawal by Subject|0|||
44519453|NCT03131440|79527330|FG006|Overall Study|Withdrawal by Subject|0|||
44519454|NCT03131440|79527331|FG007|Overall Study|Withdrawal by Subject|1|||
44519455|NCT03131440|79527332|FG008|Overall Study|Withdrawal by Subject|1|||
44519456|NCT03131440|79527333|FG009|Overall Study|Withdrawal by Subject|1|||
44519457|NCT03131440|79527334|FG010|Overall Study|Withdrawal by Subject|0|||
44519458|NCT03131440|79527335|FG011|Overall Study|Withdrawal by Subject|1|||
44519459|NCT03131440|79527336|FG012|Overall Study|Withdrawal by Subject|1|||
44519460|NCT03131440|79527337|FG013|Overall Study|Withdrawal by Subject|0|||
44519461|NCT03131440|79527338|FG014|Overall Study|Withdrawal by Subject|1|||
44519462|NCT03131440|79527339|FG015|Overall Study|Withdrawal by Subject|0|||
44519463|NCT03131440|79527340|FG016|Overall Study|Withdrawal by Subject|0|||
44519464|NCT03131440|79527341|FG017|Overall Study|Withdrawal by Subject|0|||
44519465|NCT03131440|79527342|FG018|Overall Study|Withdrawal by Subject|1|||
44146453|NCT01374919|78935880|FG000|Overall Study|Withdrawal by Subject|2|||
44519466|NCT03131440|79527343|FG019|Overall Study|Withdrawal by Subject|0|||
44519467|NCT03131440|79527344|FG020|Overall Study|Withdrawal by Subject|1|||
44519468|NCT03131440|79527345|FG021|Overall Study|Withdrawal by Subject|1|||
44519469|NCT03131440|79527346|FG022|Overall Study|Withdrawal by Subject|1|||
44146454|NCT02726945|78935891|FG000|Overall Study|Withdrawal by Subject|0|||
44146455|NCT02726945|78935892|FG001|Overall Study|Withdrawal by Subject|0|||
44389290|NCT00730756|79395596|FG001|Overall Study|Lack of Efficacy|1|||
44519470|NCT03131440|79527347|FG023|Overall Study|Withdrawal by Subject|0|||
44519471|NCT03131440|79527348|FG024|Overall Study|Withdrawal by Subject|0|||
44519472|NCT03131440|79527349|FG025|Overall Study|Withdrawal by Subject|0|||
44519473|NCT03131440|79527350|FG026|Overall Study|Withdrawal by Subject|0|||
44519474|NCT03131440|79527351|FG027|Overall Study|Withdrawal by Subject|0|||
44389291|NCT00730756|79395595|FG000|Overall Study|Protocol Deviation|1|||
44389292|NCT00730756|79395596|FG001|Overall Study|Protocol Deviation|2|||
44389293|NCT00730756|79395595|FG000|Overall Study|Lost to Follow-up|0|||
44389294|NCT00730756|79395596|FG001|Overall Study|Lost to Follow-up|1|||
44389295|NCT00730756|79395595|FG000|Overall Study|Withdrew Consent|0|||
44389296|NCT00730756|79395596|FG001|Overall Study|Withdrew Consent|1|||
44389297|NCT00730132|79395602|FG000|Overall Study|Protocol Violation|154|||
44389298|NCT00730132|79395602|FG000|Overall Study|Death|1|||
44389299|NCT00737464|79395609|FG000|Overall Study|Adverse Event|1|||
44389300|NCT00737464|79395609|FG000|Overall Study|Death|6|||
44389301|NCT00737464|79395609|FG000|Overall Study|Other - Failure to Return|1|||
44389302|NCT00737464|79395609|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
44389303|NCT00737464|79395609|FG000|Overall Study|Other reasons|4|||
44389304|NCT00729586|79395615|FG000|Overall Study|Ineligible|0|||
44389305|NCT00729586|79395616|FG001|Overall Study|Ineligible|1|||
44389306|NCT00729586|79395615|FG000|Overall Study|never treated|1|||
44389307|NCT00729586|79395616|FG001|Overall Study|never treated|0|||
44389308|NCT00949910|79395623|FG000|Overall Study|Progressive Disease|3750|||
44389309|NCT00949910|79395623|FG000|Overall Study|Symptomatic Deterioration|1088|||
44389310|NCT00949910|79395623|FG000|Overall Study|Lost to Follow-up|100|||
44389311|NCT00949910|79395623|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
44389312|NCT00949910|79395623|FG000|Overall Study|Participant Refusal|390|||
44389313|NCT00949910|79395623|FG000|Overall Study|Death Due to Malignant Disease|456|||
44389314|NCT00949910|79395623|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
44389315|NCT00949910|79395623|FG000|Overall Study|Death Due to Adverse Event|115|||
44389316|NCT00949910|79395623|FG000|Overall Study|Death Due to Toxicity|3|||
44389317|NCT00949910|79395623|FG000|Overall Study|Death from Unknown Cause|5|||
44389318|NCT00949910|79395623|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
44389319|NCT00949910|79395623|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
44389320|NCT00949910|79395623|FG000|Overall Study|Switched to Commercial Treatment|4|||
44389321|NCT00949910|79395623|FG000|Overall Study|Violation of Eligibility|23|||
44389322|NCT00949910|79395623|FG000|Overall Study|Logistical Reasons|13|||
44389323|NCT00949910|79395623|FG000|Overall Study|Non-Compliance|10|||
44389324|NCT00949910|79395623|FG000|Overall Study|Prolonged Dosing Interruption|4|||
44389325|NCT00949910|79395623|FG000|Overall Study|Adverse Event|83|||
44389326|NCT00949910|79395623|FG000|Overall Study|Serious Adverse Event|6|||
44389327|NCT00949910|79395623|FG000|Overall Study|Physician/Participant Decision|7|||
44389328|NCT00949910|79395623|FG000|Overall Study|Other|4|||
44389329|NCT00949910|79395623|FG000|Overall Study|No Data|9|||
44389330|NCT00686959|79395629|FG000|Overall Study|Participants censored (no death events)|124|||
44389331|NCT00686959|79395630|FG001|Overall Study|Participants censored (no death events)|117|||
44389332|NCT00946088|79395638|FG000|Overall Study|Withdrawal by Subject|0|||
44389333|NCT00946088|79395639|FG001|Overall Study|Withdrawal by Subject|1|||
44389334|NCT00736996|79395650|FG000|Overall Study|Lost to Follow-up|1|||
44389335|NCT00736996|79395651|FG001|Overall Study|Lost to Follow-up|9|||
44389336|NCT00736996|79395652|FG002|Overall Study|Lost to Follow-up|2|||
44389337|NCT00728962|79395666|FG000|Implant Placement Surgery|Adverse Event|8|||
44389338|NCT00728962|79395666|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
44389339|NCT00728962|79395666|FG000|Implant Placement Surgery|Protocol Violation|1|||
44389340|NCT00728962|79395666|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
44389341|NCT00728962|79395666|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
44389342|NCT00954122|79395670|FG000|Overall Study|Withdrawal by Subject|5|||
44389343|NCT00954122|79395670|FG000|Overall Study|Adverse Event|1|||
44389344|NCT00954122|79395670|FG000|Overall Study|Safety Reason|1|||
44389345|NCT00586066|79395677|FG000|Overall Study|Lost to Follow-up|6|||
44389346|NCT00586066|79395678|FG001|Overall Study|Lost to Follow-up|3|||
44389347|NCT00586066|79395677|FG000|Overall Study|Lack of Efficacy|5|||
44389348|NCT00586066|79395678|FG001|Overall Study|Lack of Efficacy|3|||
44146456|NCT02726945|78935893|FG002|Overall Study|Withdrawal by Subject|1|||
44146457|NCT02726945|78935891|FG000|Overall Study|Elected to have total knee replacement|0|||
44146458|NCT02726945|78935892|FG001|Overall Study|Elected to have total knee replacement|1|||
44146459|NCT02726945|78935893|FG002|Overall Study|Elected to have total knee replacement|0|||
44146460|NCT02635347|78935903|FG000|Overall Study|Failed screening|20|||
44389349|NCT00586066|79395677|FG000|Overall Study|Adverse Event|2|||
44389350|NCT00586066|79395678|FG001|Overall Study|Adverse Event|2|||
44146461|NCT02635347|78935904|FG001|Overall Study|Failed screening|7|||
44389351|NCT00586066|79395677|FG000|Overall Study|Physician Decision|1|||
44389352|NCT00586066|79395678|FG001|Overall Study|Physician Decision|0|||
44389353|NCT00586066|79395677|FG000|Overall Study|Withdrawal of consent|4|||
44389354|NCT00586066|79395678|FG001|Overall Study|Withdrawal of consent|2|||
44389355|NCT00728494|79395686|FG000|Overall Study|Adverse Event|7|||
44389356|NCT00728494|79395687|FG001|Overall Study|Adverse Event|0|||
44389357|NCT00728494|79395686|FG000|Overall Study|Withdrawal by Subject|0|||
44389358|NCT00728494|79395687|FG001|Overall Study|Withdrawal by Subject|2|||
44389359|NCT00728494|79395686|FG000|Overall Study|Lack of Efficacy|2|||
44389360|NCT00728494|79395687|FG001|Overall Study|Lack of Efficacy|4|||
44389361|NCT00728494|79395686|FG000|Overall Study|No data available|0|||
44389362|NCT00728494|79395687|FG001|Overall Study|No data available|1|||
44389363|NCT00728416|79395695|FG000|Overall Study|Adverse Event|1|||
44389364|NCT00728416|79395696|FG001|Overall Study|Adverse Event|1|||
44389365|NCT00728416|79395695|FG000|Overall Study|Treatment Failure|0|||
44389366|NCT00728416|79395696|FG001|Overall Study|Treatment Failure|1|||
44389367|NCT00728416|79395695|FG000|Overall Study|Withdrawal by Subject|1|||
44389368|NCT00728416|79395696|FG001|Overall Study|Withdrawal by Subject|0|||
44389369|NCT00728182|79395704|FG000|Overall Study|Adverse Event|1|||
44389370|NCT00728182|79395705|FG001|Overall Study|Adverse Event|0|||
44389371|NCT00728182|79395704|FG000|Overall Study|Lost to Follow-up|2|||
44389372|NCT00728182|79395705|FG001|Overall Study|Lost to Follow-up|0|||
44389373|NCT00728182|79395704|FG000|Overall Study|Death|0|||
44389374|NCT00728182|79395705|FG001|Overall Study|Death|2|||
44389375|NCT00728182|79395704|FG000|Overall Study|Protocol Noncompliance|0|||
44389376|NCT00728182|79395705|FG001|Overall Study|Protocol Noncompliance|1|||
44389377|NCT00941330|79395715|FG000|Overall Study|Other|1|||
44389378|NCT00941330|79395716|FG001|Overall Study|Other|0|||
44389379|NCT00941330|79395715|FG000|Overall Study|Physician Decision|0|||
44389380|NCT00941330|79395716|FG001|Overall Study|Physician Decision|2|||
44389381|NCT00686881|79395724|FG000|Overall Study|Withdrawal by Subject|11|||
44389382|NCT00686881|79395725|FG001|Overall Study|Withdrawal by Subject|18|||
44389383|NCT00686881|79395724|FG000|Overall Study|Lost to Follow-up|0|||
44389384|NCT00686881|79395725|FG001|Overall Study|Lost to Follow-up|1|||
44389385|NCT00686881|79395724|FG000|Overall Study|Treatment-related adverse event|10|||
44389386|NCT00686881|79395725|FG001|Overall Study|Treatment-related adverse event|9|||
44389387|NCT00686881|79395724|FG000|Overall Study|Met discontinuation criteria|5|||
44389388|NCT00686881|79395725|FG001|Overall Study|Met discontinuation criteria|0|||
44389389|NCT00686881|79395724|FG000|Overall Study|Onset of malignant tumor|11|||
44389390|NCT00686881|79395725|FG001|Overall Study|Onset of malignant tumor|11|||
44389391|NCT00686881|79395724|FG000|Overall Study|Lack of Efficacy|4|||
44389392|NCT00686881|79395725|FG001|Overall Study|Lack of Efficacy|3|||
44389393|NCT00686881|79395724|FG000|Overall Study|Physician Decision|1|||
44389394|NCT00686881|79395725|FG001|Overall Study|Physician Decision|0|||
44389395|NCT00686881|79395724|FG000|Overall Study|Circumstances of site|1|||
44389396|NCT00686881|79395725|FG001|Overall Study|Circumstances of site|1|||
44389397|NCT00686881|79395724|FG000|Overall Study|Did not meet protocol eligibility|1|||
44389398|NCT00686881|79395725|FG001|Overall Study|Did not meet protocol eligibility|0|||
44389399|NCT00686881|79395724|FG000|Overall Study|Irregular visits|1|||
44389400|NCT00686881|79395725|FG001|Overall Study|Irregular visits|0|||
44389401|NCT00686881|79395724|FG000|Overall Study|Study discontinuation|35|||
44389402|NCT00686881|79395725|FG001|Overall Study|Study discontinuation|32|||
44389403|NCT00686881|79395724|FG000|Overall Study|Never received study drug|2|||
44389404|NCT00686881|79395725|FG001|Overall Study|Never received study drug|6|||
44389405|NCT00727714|79395733|FG000|Overall Study|Lost to Follow-up|2|||
44389406|NCT00727558|79395739|FG000|Overall Study|Lens issue|0|||
44389407|NCT00727558|79395740|FG001|Overall Study|Lens issue|1|||
44389408|NCT00727558|79395739|FG000|Overall Study|Adverse Event|0|||
44389409|NCT00727558|79395740|FG001|Overall Study|Adverse Event|1|||
44389410|NCT00727558|79395739|FG000|Overall Study|Subject unable to return for follow-up|1|||
44389411|NCT00727558|79395740|FG001|Overall Study|Subject unable to return for follow-up|1|||
44389412|NCT00727558|79395739|FG000|Overall Study|Lost to Follow-up|1|||
44389413|NCT00727558|79395740|FG001|Overall Study|Lost to Follow-up|0|||
44389414|NCT00688597|79395749|FG000|Overall Study|Adverse Event|2|||
44389415|NCT00688597|79395750|FG001|Overall Study|Adverse Event|0|||
44389416|NCT00688597|79395751|FG002|Overall Study|Adverse Event|0|||
44389417|NCT00688597|79395749|FG000|Overall Study|Physician Decision|1|||
44389418|NCT00688597|79395750|FG001|Overall Study|Physician Decision|0|||
44389419|NCT00688597|79395751|FG002|Overall Study|Physician Decision|0|||
44389420|NCT00735904|79395759|FG000|Overall Study|Adverse Event|3|||
44389421|NCT00735904|79395759|FG000|Overall Study|Death|20|||
44389422|NCT00735904|79395759|FG000|Overall Study|Protocol Violation|1|||
44389423|NCT00735904|79395759|FG000|Overall Study|Withdrawal by Subject|1|||
44389424|NCT00735904|79395759|FG000|Overall Study|Study Terminated by Sponsor|5|||
44251894|NCT00215657|79087532|FG004|Overall Study|Insufficient testosterone response|8|||
44251895|NCT00215657|79087533|FG005|Overall Study|Insufficient testosterone response|12|||
44389425|NCT00735904|79395759|FG000|Overall Study|Other|8|||
44389426|NCT00688519|79395765|FG000|Overall Study|Adverse Event|2|||
44389427|NCT00688519|79395766|FG001|Overall Study|Adverse Event|3|||
44389428|NCT00688519|79395765|FG000|Overall Study|Lost to Follow-up|3|||
44389429|NCT00688519|79395766|FG001|Overall Study|Lost to Follow-up|3|||
44389430|NCT00688519|79395765|FG000|Overall Study|Lack of Efficacy|3|||
44389431|NCT00688519|79395766|FG001|Overall Study|Lack of Efficacy|1|||
44389432|NCT00688519|79395765|FG000|Overall Study|Withdrawal by Subject|7|||
44519475|NCT03131440|79527352|FG028|Overall Study|Withdrawal by Subject|0|||
44251896|NCT00215657|79087534|FG006|Overall Study|Insufficient testosterone response|4|||
44389433|NCT00688519|79395766|FG001|Overall Study|Withdrawal by Subject|6|||
44389434|NCT00688519|79395765|FG000|Overall Study|Prohibited medication|1|||
44389435|NCT00688519|79395766|FG001|Overall Study|Prohibited medication|0|||
44389436|NCT00688519|79395765|FG000|Overall Study|Non-compliance|0|||
44389437|NCT00688519|79395766|FG001|Overall Study|Non-compliance|1|||
44389438|NCT00688519|79395765|FG000|Overall Study|Subject moved out of state|1|||
44389439|NCT00688519|79395766|FG001|Overall Study|Subject moved out of state|0|||
44389440|NCT00688519|79395765|FG000|Overall Study|Investigator decision|1|||
44389441|NCT00688519|79395766|FG001|Overall Study|Investigator decision|0|||
44389442|NCT00688519|79395765|FG000|Overall Study|Subject moved out of area|1|||
44389443|NCT00688519|79395766|FG001|Overall Study|Subject moved out of area|0|||
44389444|NCT00688519|79395765|FG000|Overall Study|Pregnancy|0|||
44389445|NCT00688519|79395766|FG001|Overall Study|Pregnancy|1|||
44251897|NCT00215657|79087535|FG007|Overall Study|Insufficient testosterone response|7|||
44251898|NCT00215657|79087528|FG000|Overall Study|Other|3|||
44251899|NCT00215657|79087529|FG001|Overall Study|Other|1|||
44251900|NCT00215657|79087530|FG002|Overall Study|Other|2|||
44251901|NCT00215657|79087531|FG003|Overall Study|Other|3|||
44389446|NCT00721630|79395772|FG000|Overall Study|Participant found to be ineligible|1|||
44389447|NCT00686725|79395778|FG000|Overall Study|Adverse Event|1|||
44389448|NCT00686725|79395779|FG001|Overall Study|Adverse Event|1|||
44389449|NCT00686725|79395778|FG000|Overall Study|Progressive Disease|17|||
44389450|NCT00686725|79395779|FG001|Overall Study|Progressive Disease|23|||
44389451|NCT00686725|79395778|FG000|Overall Study|Lost to Follow-up|7|||
44389452|NCT00686725|79395779|FG001|Overall Study|Lost to Follow-up|5|||
44389453|NCT00686725|79395778|FG000|Overall Study|Death|6|||
44389454|NCT00686725|79395779|FG001|Overall Study|Death|3|||
44389455|NCT00686725|79395778|FG000|Overall Study|Withdrawal by Subject|13|||
44389456|NCT00686725|79395779|FG001|Overall Study|Withdrawal by Subject|4|||
44389457|NCT00686725|79395778|FG000|Overall Study|Protocol Violation|1|||
44389458|NCT00686725|79395779|FG001|Overall Study|Protocol Violation|3|||
44389459|NCT00686725|79395778|FG000|Overall Study|Other|1|||
44389460|NCT00686725|79395779|FG001|Overall Study|Other|3|||
44389461|NCT00727402|79395785|FG000|Overall Study|Physician Decision|116|||
44389462|NCT00727246|79395793|FG000|Overall Study|could not complete MRI|0|||
44389463|NCT00727246|79395794|FG001|Overall Study|could not complete MRI|1|||
44389464|NCT00727246|79395795|FG002|Overall Study|could not complete MRI|0|||
44389465|NCT00727246|79395796|FG003|Overall Study|could not complete MRI|1|||
44389466|NCT00727246|79395793|FG000|Overall Study|incidental finding|0|||
44389467|NCT00727246|79395794|FG001|Overall Study|incidental finding|0|||
44389468|NCT00727246|79395795|FG002|Overall Study|incidental finding|0|||
44389469|NCT00727246|79395796|FG003|Overall Study|incidental finding|1|||
44389470|NCT00727246|79395793|FG000|Overall Study|withdrawn|0|||
44389471|NCT00727246|79395794|FG001|Overall Study|withdrawn|0|||
44389472|NCT00727246|79395795|FG002|Overall Study|withdrawn|1|||
44389473|NCT00727246|79395796|FG003|Overall Study|withdrawn|0|||
44389474|NCT00686647|79395806|FG000|Overall Study|Lost to Follow-up|1|||
44389475|NCT00686647|79395806|FG000|Overall Study|Death|1|||
44389476|NCT00687973|79395813|FG000|Overall Study|Adverse Event|18|||
44389477|NCT00687973|79395814|FG001|Overall Study|Adverse Event|28|||
44389478|NCT00687973|79395813|FG000|Overall Study|Lack of Efficacy|2|||
44389479|NCT00687973|79395814|FG001|Overall Study|Lack of Efficacy|3|||
44389480|NCT00687973|79395813|FG000|Overall Study|Protocol Violation|1|||
44389481|NCT00687973|79395814|FG001|Overall Study|Protocol Violation|2|||
44389482|NCT00687973|79395813|FG000|Overall Study|Administrative Reasons|0|||
44389483|NCT00687973|79395814|FG001|Overall Study|Administrative Reasons|2|||
44389484|NCT00687973|79395813|FG000|Overall Study|Withdrawal by Subject|3|||
44389485|NCT00687973|79395814|FG001|Overall Study|Withdrawal by Subject|3|||
44389486|NCT00721396|79395825|FG000|Overall Study|Adverse Event|4|||
44389487|NCT00721396|79395826|FG001|Overall Study|Adverse Event|7|||
44389488|NCT00721396|79395827|FG002|Overall Study|Adverse Event|2|||
44389489|NCT00721396|79395828|FG003|Overall Study|Adverse Event|0|||
44251902|NCT00215657|79087532|FG004|Overall Study|Other|5|||
44389490|NCT00721396|79395825|FG000|Overall Study|Withdrawal by Subject|12|||
44389491|NCT00721396|79395826|FG001|Overall Study|Withdrawal by Subject|15|||
44389492|NCT00721396|79395827|FG002|Overall Study|Withdrawal by Subject|3|||
44389493|NCT00721396|79395828|FG003|Overall Study|Withdrawal by Subject|7|||
44389494|NCT00721396|79395825|FG000|Overall Study|Lost to Follow-up|7|||
44389495|NCT00721396|79395826|FG001|Overall Study|Lost to Follow-up|9|||
44389496|NCT00721396|79395827|FG002|Overall Study|Lost to Follow-up|3|||
44389497|NCT00721396|79395828|FG003|Overall Study|Lost to Follow-up|3|||
44389498|NCT00721396|79395825|FG000|Overall Study|Protocol Violation|4|||
44389499|NCT00721396|79395826|FG001|Overall Study|Protocol Violation|3|||
44389500|NCT00721396|79395827|FG002|Overall Study|Protocol Violation|1|||
44389501|NCT00721396|79395828|FG003|Overall Study|Protocol Violation|0|||
44389502|NCT00721396|79395825|FG000|Overall Study|Inappropriate enrollment|0|||
44389503|NCT00721396|79395826|FG001|Overall Study|Inappropriate enrollment|2|||
44389504|NCT00721396|79395827|FG002|Overall Study|Inappropriate enrollment|0|||
44251903|NCT00215657|79087533|FG005|Overall Study|Other|4|||
44251904|NCT00215657|79087534|FG006|Overall Study|Other|6|||
44389505|NCT00721396|79395828|FG003|Overall Study|Inappropriate enrollment|0|||
44251905|NCT00215657|79087535|FG007|Overall Study|Other|1|||
44389506|NCT00721396|79395825|FG000|Overall Study|Administrative reason|3|||
44389507|NCT00721396|79395826|FG001|Overall Study|Administrative reason|0|||
44389508|NCT00721396|79395827|FG002|Overall Study|Administrative reason|1|||
44389509|NCT00721396|79395828|FG003|Overall Study|Administrative reason|0|||
44389510|NCT00943826|79395845|FG000|Concurrent Phase|Adverse Event|50|||
44389511|NCT00943826|79395846|FG001|Concurrent Phase|Adverse Event|27|||
44389512|NCT00943826|79395845|FG000|Concurrent Phase|Withdrew consent|3|||
44389513|NCT00943826|79395846|FG001|Concurrent Phase|Withdrew consent|7|||
44389514|NCT00943826|79395845|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
44389515|NCT00943826|79395846|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
44389516|NCT00943826|79395845|FG000|Concurrent Phase|Administrative reasons|2|||
44389517|NCT00943826|79395846|FG001|Concurrent Phase|Administrative reasons|1|||
44389518|NCT00943826|79395845|FG000|Concurrent Phase|Protocol Violation|1|||
44389519|NCT00943826|79395846|FG001|Concurrent Phase|Protocol Violation|0|||
44389520|NCT00943826|79395845|FG000|Maintenance Phase|Adverse Event|31|||
44389521|NCT00943826|79395846|FG001|Maintenance Phase|Adverse Event|30|||
44389522|NCT00943826|79395845|FG000|Maintenance Phase|Withdrew consent|2|||
44389523|NCT00943826|79395846|FG001|Maintenance Phase|Withdrew consent|4|||
44389524|NCT00943826|79395845|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
44389525|NCT00943826|79395846|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
44389526|NCT00943826|79395845|FG000|Maintenance Phase|Administrative reasons|4|||
44389527|NCT00943826|79395846|FG001|Maintenance Phase|Administrative reasons|1|||
44389528|NCT00943826|79395845|FG000|Maintenance Phase|Failure to return|0|||
44389529|NCT00943826|79395846|FG001|Maintenance Phase|Failure to return|1|||
44389530|NCT00943826|79395845|FG000|Monotherapy Phase|Adverse Event|42|||
44389531|NCT00943826|79395846|FG001|Monotherapy Phase|Adverse Event|5|||
44389532|NCT00943826|79395845|FG000|Monotherapy Phase|Administrative reasons|11|||
44389533|NCT00943826|79395846|FG001|Monotherapy Phase|Administrative reasons|5|||
44389534|NCT00943826|79395845|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
44389535|NCT00943826|79395846|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
44389536|NCT00943826|79395845|FG000|Monotherapy Phase|Withdrew Consent|2|||
44389537|NCT00943826|79395846|FG001|Monotherapy Phase|Withdrew Consent|3|||
44389538|NCT00943826|79395845|FG000|Monotherapy Phase|Failure to return|2|||
44389539|NCT00943826|79395846|FG001|Monotherapy Phase|Failure to return|1|||
44389540|NCT00943826|79395845|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
44389541|NCT00943826|79395846|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
44389542|NCT00943826|79395845|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
44389543|NCT00943826|79395846|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
44389544|NCT00943826|79395845|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
44389545|NCT00943826|79395846|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
44389546|NCT00943826|79395845|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
44389547|NCT00943826|79395846|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
44389548|NCT01004003|79395862|FG000|Overall Study|Progressive disease|2|||
44389549|NCT01004003|79395863|FG001|Overall Study|Progressive disease|1|||
44389550|NCT01004003|79395864|FG002|Overall Study|Progressive disease|1|||
44389551|NCT01004003|79395865|FG003|Overall Study|Progressive disease|0|||
44389552|NCT01004003|79395866|FG004|Overall Study|Progressive disease|2|||
44389553|NCT01004003|79395867|FG005|Overall Study|Progressive disease|1|||
44389554|NCT01004003|79395868|FG006|Overall Study|Progressive disease|1|||
44389555|NCT01004003|79395869|FG007|Overall Study|Progressive disease|39|||
44389556|NCT01004003|79395870|FG008|Overall Study|Progressive disease|22|||
44389557|NCT01004003|79395862|FG000|Overall Study|Adverse Event|4|||
44389558|NCT01004003|79395863|FG001|Overall Study|Adverse Event|2|||
44389559|NCT01004003|79395864|FG002|Overall Study|Adverse Event|3|||
44389560|NCT01004003|79395865|FG003|Overall Study|Adverse Event|3|||
44389561|NCT01004003|79395866|FG004|Overall Study|Adverse Event|2|||
44389562|NCT01004003|79395867|FG005|Overall Study|Adverse Event|2|||
44389563|NCT01004003|79395868|FG006|Overall Study|Adverse Event|7|||
44389564|NCT01004003|79395869|FG007|Overall Study|Adverse Event|21|||
44389565|NCT01004003|79395870|FG008|Overall Study|Adverse Event|6|||
44389566|NCT01004003|79395862|FG000|Overall Study|Refused to continue taking trial med.|0|||
44389567|NCT01004003|79395863|FG001|Overall Study|Refused to continue taking trial med.|0|||
44389568|NCT01004003|79395864|FG002|Overall Study|Refused to continue taking trial med.|0|||
44389569|NCT01004003|79395865|FG003|Overall Study|Refused to continue taking trial med.|0|||
44389570|NCT01004003|79395866|FG004|Overall Study|Refused to continue taking trial med.|0|||
44389571|NCT01004003|79395867|FG005|Overall Study|Refused to continue taking trial med.|0|||
44389572|NCT01004003|79395868|FG006|Overall Study|Refused to continue taking trial med.|0|||
44389573|NCT01004003|79395869|FG007|Overall Study|Refused to continue taking trial med.|0|||
44389574|NCT01004003|79395870|FG008|Overall Study|Refused to continue taking trial med.|2|||
44519476|NCT03131440|79527353|FG029|Overall Study|Withdrawal by Subject|0|||
44519477|NCT03131440|79527354|FG030|Overall Study|Withdrawal by Subject|1|||
44519478|NCT03131440|79527355|FG031|Overall Study|Withdrawal by Subject|0|||
44519479|NCT03131440|79527324|FG000|Overall Study|Lost to Follow-up|0|||
44251906|NCT00633061|79087555|FG000|Overall Study|Study closed|86|||
44389575|NCT01004003|79395862|FG000|Overall Study|Other|0|||
44389576|NCT01004003|79395863|FG001|Overall Study|Other|0|||
44389577|NCT01004003|79395864|FG002|Overall Study|Other|0|||
44389578|NCT01004003|79395865|FG003|Overall Study|Other|0|||
44389579|NCT01004003|79395866|FG004|Overall Study|Other|0|||
44389580|NCT01004003|79395867|FG005|Overall Study|Other|1|||
44389581|NCT01004003|79395868|FG006|Overall Study|Other|0|||
44389582|NCT01004003|79395869|FG007|Overall Study|Other|0|||
44389583|NCT01004003|79395870|FG008|Overall Study|Other|0|||
44389584|NCT00943670|79395892|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
44389585|NCT00943670|79395892|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
44389586|NCT00943670|79395892|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
44389587|NCT00943670|79395892|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
44280752|NCT01977846|79241873|FG000|Total Study - Prospective|No show|0|||
44280753|NCT01977846|79241874|FG001|Total Study - Prospective|No show|1|||
44280754|NCT01977846|79241873|FG000|Total Study - Prospective|Protocol Violation|0|||
44280755|NCT01977846|79241874|FG001|Total Study - Prospective|Protocol Violation|1|||
44280756|NCT01934790|79241881|FG000|Treatment|Adverse Event|3|||
44389588|NCT00943670|79395892|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
44389589|NCT00943670|79395892|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
44389590|NCT00943670|79395892|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
44389591|NCT00943670|79395892|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
44389592|NCT00943670|79395892|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
44389593|NCT00943670|79395892|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
44389594|NCT00938366|79395909|FG000|Overall Study|Withdrawal by Subject|1|||
44389595|NCT00938366|79395910|FG001|Overall Study|Withdrawal by Subject|0|||
44389596|NCT00943592|79395916|FG000|Overall Study|Death|3|||
44389597|NCT00943124|79395920|FG000|Period 1|Withdrawal by Subject|1|||
44389598|NCT00943124|79395921|FG001|Period 1|Withdrawal by Subject|1|||
44389599|NCT00943124|79395920|FG000|Period 1|Did Not Follow Study Procedures|1|||
44389600|NCT00943124|79395921|FG001|Period 1|Did Not Follow Study Procedures|0|||
44389601|NCT00943124|79395920|FG000|Period 1|Personal Reasons|0|||
44389602|NCT00943124|79395921|FG001|Period 1|Personal Reasons|1|||
44389603|NCT00726622|79395929|FG000|Overall Study|Withdrawal by Subject|16|||
44389604|NCT00726622|79395930|FG001|Overall Study|Withdrawal by Subject|2|||
44389605|NCT00726622|79395929|FG000|Overall Study|Physician Decision|0|||
44389606|NCT00726622|79395930|FG001|Overall Study|Physician Decision|1|||
44389607|NCT00726622|79395929|FG000|Overall Study|Metastasis|2|||
44389608|NCT00726622|79395930|FG001|Overall Study|Metastasis|0|||
44389609|NCT00940316|79395939|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
44389610|NCT00940316|79395940|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
44389611|NCT00940316|79395941|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
44389612|NCT00940316|79395939|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
44389613|NCT00940316|79395940|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
44389614|NCT00940316|79395941|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
44389615|NCT00940316|79395939|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
44389616|NCT00940316|79395940|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
44389617|NCT00940316|79395941|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
44389618|NCT00940316|79395939|FG000|Treated After Cycle 5|Adverse Event|0|||
44389619|NCT00940316|79395940|FG001|Treated After Cycle 5|Adverse Event|0|||
44146462|NCT02726399|78935924|FG000|Overall Study|Participant Non-Compliance|1|||
44280757|NCT01934790|79241881|FG000|Treatment|Clinical progression|6|||
44280758|NCT01934790|79241881|FG000|Treatment|Radiological progression|4|||
44280759|NCT01934790|79241881|FG000|Treatment|Withdrawal by Subject|2|||
44280760|NCT01934790|79241881|FG000|Treatment|Study drug never administered|1|||
44280761|NCT01934790|79241881|FG000|Active Follow up|Death|20|||
44389620|NCT00940316|79395941|FG002|Treated After Cycle 5|Adverse Event|1|||
44389621|NCT00940316|79395939|FG000|Treated After Cycle 5|Progressive disease|0|||
44389622|NCT00940316|79395940|FG001|Treated After Cycle 5|Progressive disease|1|||
44389623|NCT00940316|79395941|FG002|Treated After Cycle 5|Progressive disease|0|||
44389624|NCT00726388|79395957|FG000|Overall Study|Withdrawal by Subject|5|||
44389625|NCT00726388|79395957|FG000|Overall Study|Adverse Event|3|||
44389626|NCT00726388|79395957|FG000|Overall Study|Lost to Follow-up|10|||
44389627|NCT00726388|79395957|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
44389628|NCT00726388|79395957|FG000|Overall Study|Other|5|||
44389629|NCT00726388|79395957|FG000|Overall Study|Enrolled, Not Treated|79|||
44389630|NCT00572455|79395975|FG000|Stage I (14 Days)|Adverse Event|0|||
44389631|NCT00572455|79395976|FG001|Stage I (14 Days)|Adverse Event|0|||
44389632|NCT00572455|79395977|FG002|Stage I (14 Days)|Adverse Event|0|||
44389633|NCT00572455|79395978|FG003|Stage I (14 Days)|Adverse Event|0|||
44389634|NCT00572455|79395979|FG004|Stage I (14 Days)|Adverse Event|0|||
44389635|NCT00572455|79395980|FG005|Stage I (14 Days)|Adverse Event|3|||
44389636|NCT00572455|79395981|FG006|Stage I (14 Days)|Adverse Event|0|||
44389637|NCT00572455|79395982|FG007|Stage I (14 Days)|Adverse Event|0|||
44389638|NCT00572455|79395983|FG008|Stage I (14 Days)|Adverse Event|0|||
44389639|NCT00572455|79395984|FG009|Stage I (14 Days)|Adverse Event|0|||
44389640|NCT00572455|79395985|FG010|Stage I (14 Days)|Adverse Event|0|||
44389641|NCT00572455|79395986|FG011|Stage I (14 Days)|Adverse Event|0|||
44389642|NCT00572455|79395987|FG012|Stage I (14 Days)|Adverse Event|0|||
44389643|NCT00572455|79395988|FG013|Stage I (14 Days)|Adverse Event|0|||
44389644|NCT00572455|79395975|FG000|Stage I (14 Days)|Other|0|||
44389645|NCT00572455|79395976|FG001|Stage I (14 Days)|Other|0|||
44389646|NCT00572455|79395977|FG002|Stage I (14 Days)|Other|0|||
44389647|NCT00572455|79395978|FG003|Stage I (14 Days)|Other|0|||
44389648|NCT00572455|79395979|FG004|Stage I (14 Days)|Other|1|||
44389649|NCT00572455|79395980|FG005|Stage I (14 Days)|Other|0|||
44389650|NCT00572455|79395981|FG006|Stage I (14 Days)|Other|0|||
44389651|NCT00572455|79395982|FG007|Stage I (14 Days)|Other|0|||
44389652|NCT00572455|79395983|FG008|Stage I (14 Days)|Other|0|||
44389653|NCT00572455|79395984|FG009|Stage I (14 Days)|Other|0|||
44389654|NCT00572455|79395985|FG010|Stage I (14 Days)|Other|0|||
44389655|NCT00572455|79395986|FG011|Stage I (14 Days)|Other|0|||
44389656|NCT00572455|79395987|FG012|Stage I (14 Days)|Other|0|||
44389657|NCT00572455|79395988|FG013|Stage I (14 Days)|Other|0|||
44389658|NCT00572455|79395975|FG000|Stage II (28 Days)|Adverse Event|0|||
44389659|NCT00572455|79395976|FG001|Stage II (28 Days)|Adverse Event|0|||
44389660|NCT00572455|79395977|FG002|Stage II (28 Days)|Adverse Event|0|||
44389661|NCT00572455|79395978|FG003|Stage II (28 Days)|Adverse Event|0|||
44389662|NCT00572455|79395979|FG004|Stage II (28 Days)|Adverse Event|0|||
44389663|NCT00572455|79395980|FG005|Stage II (28 Days)|Adverse Event|0|||
44389664|NCT00572455|79395981|FG006|Stage II (28 Days)|Adverse Event|0|||
44389665|NCT00572455|79395982|FG007|Stage II (28 Days)|Adverse Event|0|||
44389666|NCT00572455|79395983|FG008|Stage II (28 Days)|Adverse Event|1|||
44389667|NCT00572455|79395984|FG009|Stage II (28 Days)|Adverse Event|3|||
44389668|NCT00572455|79395985|FG010|Stage II (28 Days)|Adverse Event|3|||
44389669|NCT00572455|79395986|FG011|Stage II (28 Days)|Adverse Event|4|||
44389670|NCT00572455|79395987|FG012|Stage II (28 Days)|Adverse Event|5|||
44389671|NCT00572455|79395988|FG013|Stage II (28 Days)|Adverse Event|1|||
44389672|NCT00572455|79395975|FG000|Stage II (28 Days)|Death|0|||
44389673|NCT00572455|79395976|FG001|Stage II (28 Days)|Death|0|||
44146463|NCT02726399|78935924|FG000|Overall Study|Adverse Event|2|||
44146464|NCT02726399|78935924|FG000|Overall Study|Progression of disease|4|||
44146465|NCT02634801|78935931|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
44146466|NCT02634801|78935932|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
44146467|NCT02634801|78935933|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
44146468|NCT02634801|78935931|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
44389674|NCT00572455|79395977|FG002|Stage II (28 Days)|Death|0|||
44389675|NCT00572455|79395978|FG003|Stage II (28 Days)|Death|0|||
44389676|NCT00572455|79395979|FG004|Stage II (28 Days)|Death|0|||
44389677|NCT00572455|79395980|FG005|Stage II (28 Days)|Death|0|||
44389678|NCT00572455|79395981|FG006|Stage II (28 Days)|Death|0|||
44389679|NCT00572455|79395982|FG007|Stage II (28 Days)|Death|0|||
44146469|NCT02634801|78935932|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
44146470|NCT02634801|78935933|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
44389680|NCT00572455|79395983|FG008|Stage II (28 Days)|Death|1|||
44389681|NCT00572455|79395984|FG009|Stage II (28 Days)|Death|0|||
44389682|NCT00572455|79395985|FG010|Stage II (28 Days)|Death|0|||
44389683|NCT00572455|79395986|FG011|Stage II (28 Days)|Death|0|||
44389684|NCT00572455|79395987|FG012|Stage II (28 Days)|Death|0|||
44389685|NCT00572455|79395988|FG013|Stage II (28 Days)|Death|0|||
44389686|NCT00572455|79395975|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
44389687|NCT00572455|79395976|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
44389688|NCT00572455|79395977|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
44389689|NCT00572455|79395978|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
44389690|NCT00572455|79395979|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
44389691|NCT00572455|79395980|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
44389692|NCT00572455|79395981|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
44389693|NCT00572455|79395982|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
44389694|NCT00572455|79395983|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
44389695|NCT00572455|79395984|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
44389696|NCT00572455|79395985|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
44389697|NCT00572455|79395986|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
44146471|NCT02634801|78935931|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
44146472|NCT02634801|78935932|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
44146473|NCT02634801|78935933|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
44146474|NCT02634801|78935931|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
44146475|NCT02634801|78935932|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
44146476|NCT02634801|78935933|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
44146477|NCT02634801|78935931|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
44146478|NCT02634801|78935932|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
44146479|NCT02634801|78935933|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
44146480|NCT02634801|78935931|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
44146481|NCT02634801|78935932|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
44146482|NCT02634801|78935933|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
44146483|NCT02634801|78935931|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
44280762|NCT01934790|79241881|FG000|Active Follow up|Physician Decision|2|||
44280763|NCT01934790|79241881|FG000|Active Follow up|Progressive disease|1|||
44280764|NCT01934790|79241881|FG000|Active Follow up|Other reason|1|||
44280765|NCT01934556|79241888|FG000|Overall Study|Withdrawal by Subject|0|||
44280766|NCT01934556|79241889|FG001|Overall Study|Withdrawal by Subject|1|||
44280767|NCT01934556|79241890|FG002|Overall Study|Withdrawal by Subject|1|||
44280768|NCT01934556|79241888|FG000|Overall Study|Lost to Follow-up|4|||
44280769|NCT01934556|79241889|FG001|Overall Study|Lost to Follow-up|10|||
44389698|NCT00572455|79395987|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
44146484|NCT02634801|78935932|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
44146485|NCT02634801|78935933|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
44146486|NCT02634801|78935931|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
44146487|NCT02634801|78935932|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
44146488|NCT02634801|78935933|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
44146489|NCT02634801|78935931|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
44146490|NCT02634801|78935932|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
44146491|NCT02634801|78935933|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
44146492|NCT02634801|78935931|FG000|Follow-up Period|Lost to Follow-up|3|||
44146493|NCT02634801|78935932|FG001|Follow-up Period|Lost to Follow-up|1|||
44146494|NCT02634801|78935933|FG002|Follow-up Period|Lost to Follow-up|2|||
44146495|NCT02634801|78935931|FG000|Follow-up Period|Physician Decision|0|||
44146496|NCT02634801|78935932|FG001|Follow-up Period|Physician Decision|0|||
44146497|NCT02634801|78935933|FG002|Follow-up Period|Physician Decision|1|||
44146498|NCT02634801|78935931|FG000|Follow-up Period|Withdrawal by Subject|1|||
44146499|NCT02634801|78935932|FG001|Follow-up Period|Withdrawal by Subject|2|||
44146500|NCT02634801|78935933|FG002|Follow-up Period|Withdrawal by Subject|5|||
44146501|NCT02634801|78935931|FG000|Follow-up Period|Adverse Event|1|||
44146502|NCT02634801|78935932|FG001|Follow-up Period|Adverse Event|5|||
44146503|NCT02634801|78935933|FG002|Follow-up Period|Adverse Event|0|||
44146504|NCT02724839|78935948|FG000|Overall Study|Withdrawal by Subject|1|||
44146505|NCT02724839|78935949|FG001|Overall Study|Withdrawal by Subject|1|||
44146506|NCT02724839|78935950|FG002|Overall Study|Withdrawal by Subject|0|||
44146507|NCT02724839|78935948|FG000|Overall Study|Lost to Follow-up|0|||
44146508|NCT02724839|78935949|FG001|Overall Study|Lost to Follow-up|3|||
44146509|NCT02724839|78935950|FG002|Overall Study|Lost to Follow-up|2|||
44146510|NCT02724839|78935948|FG000|Overall Study|Physician Decision|0|||
44146511|NCT02724839|78935949|FG001|Overall Study|Physician Decision|0|||
44146512|NCT02724839|78935950|FG002|Overall Study|Physician Decision|3|||
44146513|NCT01375751|78935968|FG000|Overall Study|Other|0|||
44146514|NCT01375751|78935969|FG001|Overall Study|Other|1|||
44146515|NCT01375751|78935970|FG002|Overall Study|Other|0|||
44146516|NCT00705575|78935980|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44146517|NCT00705575|78935981|FG001|Overall Study|Abnormal laboratory value(s)|3|||
44146518|NCT00705575|78935980|FG000|Overall Study|Abnormal test procedure result(s)|2|||
44280770|NCT01934556|79241890|FG002|Overall Study|Lost to Follow-up|7|||
44389699|NCT00572455|79395988|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
44146519|NCT00705575|78935981|FG001|Overall Study|Abnormal test procedure result(s)|12|||
44146520|NCT00705575|78935980|FG000|Overall Study|Adverse Event|11|||
44146521|NCT00705575|78935981|FG001|Overall Study|Adverse Event|15|||
44389700|NCT00572455|79395975|FG000|Stage II (28 Days)|Other|0|||
44389701|NCT00572455|79395976|FG001|Stage II (28 Days)|Other|0|||
44389702|NCT00572455|79395977|FG002|Stage II (28 Days)|Other|0|||
44389703|NCT00572455|79395978|FG003|Stage II (28 Days)|Other|0|||
44519480|NCT03131440|79527325|FG001|Overall Study|Lost to Follow-up|0|||
44519481|NCT03131440|79527326|FG002|Overall Study|Lost to Follow-up|0|||
44519482|NCT03131440|79527327|FG003|Overall Study|Lost to Follow-up|0|||
44519483|NCT03131440|79527328|FG004|Overall Study|Lost to Follow-up|0|||
44519484|NCT03131440|79527329|FG005|Overall Study|Lost to Follow-up|1|||
44519485|NCT03131440|79527330|FG006|Overall Study|Lost to Follow-up|0|||
44519486|NCT03131440|79527331|FG007|Overall Study|Lost to Follow-up|0|||
44519487|NCT03131440|79527332|FG008|Overall Study|Lost to Follow-up|0|||
44519488|NCT03131440|79527333|FG009|Overall Study|Lost to Follow-up|0|||
44519489|NCT03131440|79527334|FG010|Overall Study|Lost to Follow-up|0|||
44519490|NCT03131440|79527335|FG011|Overall Study|Lost to Follow-up|0|||
44519491|NCT03131440|79527336|FG012|Overall Study|Lost to Follow-up|0|||
44519492|NCT03131440|79527337|FG013|Overall Study|Lost to Follow-up|0|||
44519493|NCT03131440|79527338|FG014|Overall Study|Lost to Follow-up|0|||
44519494|NCT03131440|79527339|FG015|Overall Study|Lost to Follow-up|0|||
44519495|NCT03131440|79527340|FG016|Overall Study|Lost to Follow-up|0|||
44519496|NCT03131440|79527341|FG017|Overall Study|Lost to Follow-up|0|||
44519497|NCT03131440|79527342|FG018|Overall Study|Lost to Follow-up|0|||
44280771|NCT01934556|79241888|FG000|Overall Study|Death|1|||
44280772|NCT01934556|79241889|FG001|Overall Study|Death|5|||
44519498|NCT03131440|79527343|FG019|Overall Study|Lost to Follow-up|2|||
44280773|NCT01934556|79241890|FG002|Overall Study|Death|2|||
44280774|NCT01977690|79241900|FG000|Overall Study|Withdrawal by Subject|0|||
44280775|NCT01977690|79241901|FG001|Overall Study|Withdrawal by Subject|4|||
44280776|NCT01934010|79241976|FG000|Overall Study|Adverse Event|1|||
44280777|NCT01934010|79241977|FG001|Overall Study|Adverse Event|1|||
44280778|NCT01934010|79241978|FG002|Overall Study|Adverse Event|0|||
44280779|NCT01934010|79241976|FG000|Overall Study|Withdrawal by Subject|15|||
44280780|NCT01934010|79241977|FG001|Overall Study|Withdrawal by Subject|6|||
44280781|NCT01934010|79241978|FG002|Overall Study|Withdrawal by Subject|2|||
44280782|NCT01934010|79241976|FG000|Overall Study|Lost to Follow-up|7|||
44519499|NCT03131440|79527344|FG020|Overall Study|Lost to Follow-up|1|||
44519500|NCT03131440|79527345|FG021|Overall Study|Lost to Follow-up|0|||
44146522|NCT00705575|78935980|FG000|Overall Study|Lost to Follow-up|3|||
44146523|NCT00705575|78935981|FG001|Overall Study|Lost to Follow-up|4|||
44146524|NCT00705575|78935980|FG000|Overall Study|Protocol Violation|2|||
44280783|NCT01934010|79241977|FG001|Overall Study|Lost to Follow-up|4|||
44280784|NCT01934010|79241978|FG002|Overall Study|Lost to Follow-up|0|||
44280785|NCT01620138|79241997|FG000|Overall Study|Withdrawal by Subject|3|||
44280786|NCT01620138|79241998|FG001|Overall Study|Withdrawal by Subject|0|||
44280787|NCT01620138|79241997|FG000|Overall Study|Lack of Efficacy|1|||
44280788|NCT01620138|79241998|FG001|Overall Study|Lack of Efficacy|0|||
44280789|NCT01620138|79241997|FG000|Overall Study|Adverse Event|2|||
44280790|NCT01620138|79241998|FG001|Overall Study|Adverse Event|0|||
44280791|NCT01977612|79242006|FG000|Overall Study|Lost to Follow-up|1|||
44280792|NCT01977612|79242007|FG001|Overall Study|Lost to Follow-up|1|||
44389704|NCT00572455|79395979|FG004|Stage II (28 Days)|Other|0|||
44146525|NCT00705575|78935981|FG001|Overall Study|Protocol Violation|2|||
44280793|NCT01932996|79242015|FG000|Overall Study|Protocol Violation|2|||
44519501|NCT03131440|79527346|FG022|Overall Study|Lost to Follow-up|1|||
44519502|NCT03131440|79527347|FG023|Overall Study|Lost to Follow-up|0|||
44519503|NCT03131440|79527348|FG024|Overall Study|Lost to Follow-up|1|||
44146526|NCT00705575|78935980|FG000|Overall Study|Withdrawal by Subject|5|||
44280794|NCT01932996|79242016|FG001|Overall Study|Protocol Violation|0|||
44280795|NCT01932762|79242026|FG000|Overall Study|Withdrawal by Subject|1|||
44389705|NCT00572455|79395980|FG005|Stage II (28 Days)|Other|0|||
44519504|NCT03131440|79527349|FG025|Overall Study|Lost to Follow-up|0|||
44519505|NCT03131440|79527350|FG026|Overall Study|Lost to Follow-up|0|||
44519506|NCT03131440|79527351|FG027|Overall Study|Lost to Follow-up|2|||
44519507|NCT03131440|79527352|FG028|Overall Study|Lost to Follow-up|0|||
44519508|NCT03131440|79527353|FG029|Overall Study|Lost to Follow-up|2|||
44519509|NCT03131440|79527354|FG030|Overall Study|Lost to Follow-up|0|||
44519510|NCT03131440|79527355|FG031|Overall Study|Lost to Follow-up|0|||
44519511|NCT03131440|79527324|FG000|Overall Study|Death|0|||
44519512|NCT03131440|79527325|FG001|Overall Study|Death|0|||
44519513|NCT03131440|79527326|FG002|Overall Study|Death|0|||
44519514|NCT03131440|79527327|FG003|Overall Study|Death|0|||
44519515|NCT03131440|79527328|FG004|Overall Study|Death|0|||
44519516|NCT03131440|79527329|FG005|Overall Study|Death|0|||
44519517|NCT03131440|79527330|FG006|Overall Study|Death|0|||
44519518|NCT03131440|79527331|FG007|Overall Study|Death|0|||
44519519|NCT03131440|79527332|FG008|Overall Study|Death|0|||
44519520|NCT03131440|79527333|FG009|Overall Study|Death|0|||
44519521|NCT03131440|79527334|FG010|Overall Study|Death|0|||
44519522|NCT03131440|79527335|FG011|Overall Study|Death|0|||
44519523|NCT03131440|79527336|FG012|Overall Study|Death|0|||
44519524|NCT03131440|79527337|FG013|Overall Study|Death|0|||
44519525|NCT03131440|79527338|FG014|Overall Study|Death|0|||
44519526|NCT03131440|79527339|FG015|Overall Study|Death|0|||
44519527|NCT03131440|79527340|FG016|Overall Study|Death|0|||
44519528|NCT03131440|79527341|FG017|Overall Study|Death|0|||
44519529|NCT03131440|79527342|FG018|Overall Study|Death|0|||
44519530|NCT03131440|79527343|FG019|Overall Study|Death|0|||
44519531|NCT03131440|79527344|FG020|Overall Study|Death|0|||
44519532|NCT03131440|79527345|FG021|Overall Study|Death|0|||
44519533|NCT03131440|79527346|FG022|Overall Study|Death|0|||
44519534|NCT03131440|79527347|FG023|Overall Study|Death|0|||
44519535|NCT03131440|79527348|FG024|Overall Study|Death|0|||
44519536|NCT03131440|79527349|FG025|Overall Study|Death|1|||
44519537|NCT03131440|79527350|FG026|Overall Study|Death|0|||
44519538|NCT03131440|79527351|FG027|Overall Study|Death|0|||
44519539|NCT03131440|79527352|FG028|Overall Study|Death|0|||
44519540|NCT03131440|79527353|FG029|Overall Study|Death|0|||
44389706|NCT00572455|79395981|FG006|Stage II (28 Days)|Other|0|||
44389707|NCT00572455|79395982|FG007|Stage II (28 Days)|Other|0|||
44389708|NCT00572455|79395983|FG008|Stage II (28 Days)|Other|1|||
44389709|NCT00572455|79395984|FG009|Stage II (28 Days)|Other|0|||
44519541|NCT03131440|79527354|FG030|Overall Study|Death|0|||
44519542|NCT03131440|79527355|FG031|Overall Study|Death|0|||
44519543|NCT02915302|79527400|FG000|Overall Study|Adverse Event|3|||
44519544|NCT02915302|79527401|FG001|Overall Study|Adverse Event|0|||
44519545|NCT02915302|79527400|FG000|Overall Study|Protocol Violation|20|||
44519546|NCT02915302|79527401|FG001|Overall Study|Protocol Violation|27|||
44519547|NCT02915302|79527400|FG000|Overall Study|Lost to Follow-up|19|||
44519548|NCT02915302|79527401|FG001|Overall Study|Lost to Follow-up|22|||
44519549|NCT02915302|79527400|FG000|Overall Study|Withdrawal by Subject|22|||
44519550|NCT02915302|79527401|FG001|Overall Study|Withdrawal by Subject|29|||
44519551|NCT02915302|79527400|FG000|Overall Study|Other|1|||
44519552|NCT02915302|79527401|FG001|Overall Study|Other|0|||
44519553|NCT03023878|79527407|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
44519554|NCT03023878|79527407|FG000|Pre-Study Run-In Period|Death|1|||
44519555|NCT03023878|79527407|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
44519556|NCT03023878|79527407|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
44519557|NCT03023878|79527407|FG000|Treatment Period|Disease Progression|1|||
44519558|NCT03023878|79527407|FG000|Treatment Period|Withdrawal by Subject|1|||
44519559|NCT03023878|79527407|FG000|Treatment Period|Adverse Event|1|||
44519560|NCT03023878|79527407|FG000|Long Term Follow-Up Period|Death|2|||
44519561|NCT03022630|79527413|FG000|Overall Study|Death|9|||
44519562|NCT03022630|79527414|FG001|Overall Study|Death|7|||
44519563|NCT03022630|79527413|FG000|Overall Study|Withdrawal by Subject|0|||
44389710|NCT00572455|79395985|FG010|Stage II (28 Days)|Other|0|||
44389711|NCT00572455|79395986|FG011|Stage II (28 Days)|Other|0|||
44389712|NCT00572455|79395987|FG012|Stage II (28 Days)|Other|0|||
44389713|NCT00572455|79395988|FG013|Stage II (28 Days)|Other|0|||
44389714|NCT00572455|79395975|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
44389715|NCT00572455|79395976|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
44519564|NCT03022630|79527414|FG001|Overall Study|Withdrawal by Subject|5|||
44519565|NCT03023722|79527425|FG000|Overall Study|No follow-up assessment|4|||
44519566|NCT03022084|79527431|FG000|Overall Study|Lost to Follow-up|2|||
44519567|NCT03022084|79527432|FG001|Overall Study|Lost to Follow-up|3|||
44389716|NCT00572455|79395977|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
44389717|NCT00572455|79395978|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
44519568|NCT03021304|79527438|FG000|Overall Study|Lack of Efficacy|1|||
44519569|NCT03496298|79527449|FG000|Overall Study|Adverse Event|49|||
44519570|NCT03496298|79527450|FG001|Overall Study|Adverse Event|68|||
44519571|NCT03496298|79527451|FG002|Overall Study|Adverse Event|79|||
44519572|NCT03496298|79527449|FG000|Overall Study|Study terminated by Sponsor|1050|||
44519573|NCT03496298|79527450|FG001|Overall Study|Study terminated by Sponsor|1063|||
44519574|NCT03496298|79527451|FG002|Overall Study|Study terminated by Sponsor|1071|||
44519575|NCT03496298|79527449|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
44519576|NCT03496298|79527450|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
44519577|NCT03496298|79527451|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
44519578|NCT03496298|79527449|FG000|Overall Study|Withdrawal by Subject|176|||
44389718|NCT00572455|79395979|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
44389719|NCT00572455|79395980|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
44389720|NCT00572455|79395981|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
44389721|NCT00572455|79395982|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
44389722|NCT00572455|79395983|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
44389723|NCT00572455|79395984|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
44389724|NCT00572455|79395985|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
44389725|NCT00572455|79395986|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
44389726|NCT00572455|79395987|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
44389727|NCT00572455|79395988|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
44389728|NCT01003691|79396022|FG000|Overall Study|Adverse Event|0|||
44389729|NCT01003691|79396023|FG001|Overall Study|Adverse Event|0|||
44389730|NCT01003691|79396024|FG002|Overall Study|Adverse Event|0|||
44389731|NCT01003691|79396025|FG003|Overall Study|Adverse Event|1|||
44389732|NCT00686335|79396036|FG000|Run-in Period|Adverse Event|1|||
44389733|NCT00686335|79396036|FG000|Run-in Period|asthma exacerbation|1|||
44389734|NCT00686335|79396036|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
44389735|NCT01002989|79396042|FG000|Overall Study|exclusion criteria, no consent|5|||
44389736|NCT00685945|79396046|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
44389737|NCT01007123|79396060|FG000|Overall Study|Adverse Event|3|||
44389738|NCT01007123|79396061|FG001|Overall Study|Adverse Event|4|||
44389739|NCT01007123|79396062|FG002|Overall Study|Adverse Event|7|||
44389740|NCT01007123|79396063|FG003|Overall Study|Adverse Event|1|||
44389741|NCT01007123|79396060|FG000|Overall Study|Lack of Efficacy|1|||
44389742|NCT01007123|79396061|FG001|Overall Study|Lack of Efficacy|0|||
44389743|NCT01007123|79396062|FG002|Overall Study|Lack of Efficacy|1|||
44389744|NCT01007123|79396063|FG003|Overall Study|Lack of Efficacy|4|||
44389745|NCT01007123|79396060|FG000|Overall Study|Protocol Violation|1|||
44389746|NCT01007123|79396061|FG001|Overall Study|Protocol Violation|1|||
44389747|NCT01007123|79396062|FG002|Overall Study|Protocol Violation|2|||
44389748|NCT01007123|79396063|FG003|Overall Study|Protocol Violation|1|||
44389749|NCT01007123|79396060|FG000|Overall Study|Withdrawal by Subject|1|||
44389750|NCT01007123|79396061|FG001|Overall Study|Withdrawal by Subject|0|||
44389751|NCT01007123|79396062|FG002|Overall Study|Withdrawal by Subject|1|||
44389752|NCT01007123|79396063|FG003|Overall Study|Withdrawal by Subject|0|||
44389753|NCT01007123|79396060|FG000|Overall Study|Lost to Follow-up|0|||
44389754|NCT01007123|79396061|FG001|Overall Study|Lost to Follow-up|1|||
44389755|NCT01007123|79396062|FG002|Overall Study|Lost to Follow-up|0|||
44389756|NCT01007123|79396063|FG003|Overall Study|Lost to Follow-up|0|||
44389757|NCT00687739|79396078|FG000|Overall Study|Lost to Follow-up|2|||
44389758|NCT00687739|79396079|FG001|Overall Study|Lost to Follow-up|2|||
44389759|NCT00687739|79396080|FG002|Overall Study|Lost to Follow-up|1|||
44389760|NCT00687739|79396081|FG003|Overall Study|Lost to Follow-up|2|||
44389761|NCT00687739|79396078|FG000|Overall Study|Adverse Event|0|||
44389762|NCT00687739|79396079|FG001|Overall Study|Adverse Event|1|||
44389763|NCT00687739|79396080|FG002|Overall Study|Adverse Event|1|||
44389764|NCT00687739|79396081|FG003|Overall Study|Adverse Event|0|||
44389765|NCT01006889|79396093|FG000|Overall Study|Withdrawal by Subject|3|||
44389766|NCT01001429|79396100|FG000|Overall Study|surgery cancelled|0|||
44389767|NCT01001429|79396101|FG001|Overall Study|surgery cancelled|1|||
44389768|NCT01000961|79396131|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
44389769|NCT01000961|79396132|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44389770|NCT01000961|79396131|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
44389771|NCT01000961|79396132|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
44389772|NCT01000805|79396142|FG000|Overall Study|Adverse Event|21|||
44389773|NCT01000805|79396143|FG001|Overall Study|Adverse Event|9|||
44389774|NCT01000805|79396142|FG000|Overall Study|Lack of Efficacy|5|||
44389775|NCT01000805|79396143|FG001|Overall Study|Lack of Efficacy|16|||
44389776|NCT01000805|79396142|FG000|Overall Study|Lost to Follow-up|16|||
44389777|NCT01000805|79396143|FG001|Overall Study|Lost to Follow-up|21|||
44519579|NCT03496298|79527450|FG001|Overall Study|Withdrawal by Subject|154|||
44389778|NCT01000805|79396142|FG000|Overall Study|Physician Decision|0|||
44389779|NCT01000805|79396143|FG001|Overall Study|Physician Decision|1|||
44389780|NCT01000805|79396142|FG000|Overall Study|Protocol Violation|12|||
44389781|NCT01000805|79396143|FG001|Overall Study|Protocol Violation|8|||
44389782|NCT01000805|79396142|FG000|Overall Study|Withdrawal by Subject|16|||
44389783|NCT01000805|79396143|FG001|Overall Study|Withdrawal by Subject|6|||
44389784|NCT01000805|79396142|FG000|Overall Study|Sponsor Decision|0|||
44389785|NCT01000805|79396143|FG001|Overall Study|Sponsor Decision|1|||
44389786|NCT00684307|79396155|FG000|Overall Study|Adverse Event|11|||
44389787|NCT00684307|79396156|FG001|Overall Study|Adverse Event|6|||
44389788|NCT00684307|79396157|FG002|Overall Study|Adverse Event|15|||
44389789|NCT00684307|79396158|FG003|Overall Study|Adverse Event|16|||
44389790|NCT00684307|79396159|FG004|Overall Study|Adverse Event|8|||
44389791|NCT00684307|79396155|FG000|Overall Study|Development of increasing Liver Function|0|||
44389792|NCT00684307|79396156|FG001|Overall Study|Development of increasing Liver Function|2|||
44519580|NCT03496298|79527451|FG002|Overall Study|Withdrawal by Subject|151|||
44389793|NCT00684307|79396157|FG002|Overall Study|Development of increasing Liver Function|0|||
44389794|NCT00684307|79396158|FG003|Overall Study|Development of increasing Liver Function|1|||
44389795|NCT00684307|79396159|FG004|Overall Study|Development of increasing Liver Function|0|||
44389796|NCT00684307|79396155|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
44389797|NCT00684307|79396156|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
44146527|NCT00705575|78935981|FG001|Overall Study|Withdrawal by Subject|10|||
44146528|NCT02636595|78935987|FG000|Overall Study|Lost to Follow-up|1|||
44146529|NCT02636595|78935987|FG000|Overall Study|Other|1|||
44280796|NCT01932762|79242027|FG001|Overall Study|Withdrawal by Subject|2|||
44280797|NCT01932762|79242028|FG002|Overall Study|Withdrawal by Subject|0|||
44280798|NCT01932762|79242029|FG003|Overall Study|Withdrawal by Subject|0|||
44280799|NCT01932762|79242026|FG000|Overall Study|Lost to Follow-up|4|||
44280800|NCT01932762|79242027|FG001|Overall Study|Lost to Follow-up|0|||
44280801|NCT01932762|79242028|FG002|Overall Study|Lost to Follow-up|0|||
44280802|NCT01932762|79242029|FG003|Overall Study|Lost to Follow-up|1|||
44280803|NCT01932762|79242026|FG000|Overall Study|Physician Decision|1|||
44280804|NCT01932762|79242027|FG001|Overall Study|Physician Decision|0|||
44280805|NCT01932762|79242028|FG002|Overall Study|Physician Decision|0|||
44280806|NCT01932762|79242029|FG003|Overall Study|Physician Decision|0|||
44280807|NCT01618968|79242043|FG000|Overall Study|Adverse Event|1|||
44280808|NCT01618968|79242044|FG001|Overall Study|Adverse Event|0|||
44280809|NCT01618968|79242045|FG002|Overall Study|Adverse Event|0|||
44280810|NCT01618968|79242046|FG003|Overall Study|Adverse Event|0|||
44280811|NCT01618968|79242043|FG000|Overall Study|Death|0|||
44280812|NCT01618968|79242044|FG001|Overall Study|Death|0|||
44280813|NCT01618968|79242045|FG002|Overall Study|Death|0|||
44280814|NCT01618968|79242046|FG003|Overall Study|Death|1|||
44280815|NCT01932294|79242055|FG000|Overall Study|Death|43|||
44280816|NCT01932294|79242055|FG000|Overall Study|Lost to Follow-up|8|||
44280817|NCT01932294|79242055|FG000|Overall Study|VAD Implantation|20|||
44280818|NCT01932294|79242055|FG000|Overall Study|Heart Transplantation|16|||
44280819|NCT01932294|79242055|FG000|Overall Study|Transferred to other hospitals|12|||
44280820|NCT01931670|79242063|FG000|Treatment Period|Exclusionary Medication Received|1|||
44280821|NCT01931670|79242064|FG001|Treatment Period|Exclusionary Medication Received|1|||
44280822|NCT01931670|79242065|FG002|Treatment Period|Exclusionary Medication Received|1|||
44280823|NCT01931670|79242063|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
44280824|NCT01931670|79242064|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
44280825|NCT01931670|79242065|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
44280826|NCT01931670|79242063|FG000|Treatment Period|Subject Noncompliant|4|||
44280827|NCT01931670|79242064|FG001|Treatment Period|Subject Noncompliant|9|||
44280828|NCT01931670|79242065|FG002|Treatment Period|Subject Noncompliant|5|||
44280829|NCT01931670|79242063|FG000|Treatment Period|Adverse Event|19|||
44280830|NCT01931670|79242064|FG001|Treatment Period|Adverse Event|8|||
44280831|NCT01931670|79242065|FG002|Treatment Period|Adverse Event|21|||
44280832|NCT01931670|79242063|FG000|Treatment Period|Lack of Efficacy|11|||
44280833|NCT01931670|79242064|FG001|Treatment Period|Lack of Efficacy|2|||
44280834|NCT01931670|79242065|FG002|Treatment Period|Lack of Efficacy|2|||
44280835|NCT01931670|79242063|FG000|Treatment Period|Pregnancy|7|||
44280836|NCT01931670|79242064|FG001|Treatment Period|Pregnancy|2|||
44280837|NCT01931670|79242065|FG002|Treatment Period|Pregnancy|0|||
44280838|NCT01931670|79242063|FG000|Treatment Period|Other|8|||
44280839|NCT01931670|79242064|FG001|Treatment Period|Other|7|||
44280840|NCT01931670|79242065|FG002|Treatment Period|Other|2|||
44280841|NCT01931670|79242063|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
44280842|NCT01931670|79242064|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
44280843|NCT01931670|79242065|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
44280844|NCT01931670|79242063|FG000|Treatment Period|Lost to Follow-up|19|||
44280845|NCT01931670|79242064|FG001|Treatment Period|Lost to Follow-up|5|||
44280846|NCT01931670|79242065|FG002|Treatment Period|Lost to Follow-up|7|||
44280847|NCT01931670|79242063|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
44280848|NCT01931670|79242064|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
44280849|NCT01931670|79242065|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
44389798|NCT00684307|79396157|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
44389799|NCT00684307|79396158|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
44389800|NCT00684307|79396159|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
44389801|NCT00684307|79396155|FG000|Overall Study|Incorrect enrolment or randomization|4|||
44389802|NCT00684307|79396156|FG001|Overall Study|Incorrect enrolment or randomization|0|||
44389803|NCT00684307|79396157|FG002|Overall Study|Incorrect enrolment or randomization|0|||
44389804|NCT00684307|79396158|FG003|Overall Study|Incorrect enrolment or randomization|0|||
44389805|NCT00684307|79396159|FG004|Overall Study|Incorrect enrolment or randomization|0|||
44389806|NCT00684307|79396155|FG000|Overall Study|Interupted IP for more than 7 days|0|||
44389807|NCT00684307|79396156|FG001|Overall Study|Interupted IP for more than 7 days|4|||
44389808|NCT00684307|79396157|FG002|Overall Study|Interupted IP for more than 7 days|1|||
44389809|NCT00684307|79396158|FG003|Overall Study|Interupted IP for more than 7 days|3|||
44389810|NCT00684307|79396159|FG004|Overall Study|Interupted IP for more than 7 days|3|||
44389811|NCT00684307|79396155|FG000|Overall Study|Severe non compliance to protocol|1|||
44389812|NCT00684307|79396156|FG001|Overall Study|Severe non compliance to protocol|0|||
44389813|NCT00684307|79396157|FG002|Overall Study|Severe non compliance to protocol|0|||
44389814|NCT00684307|79396158|FG003|Overall Study|Severe non compliance to protocol|1|||
44389815|NCT00684307|79396159|FG004|Overall Study|Severe non compliance to protocol|2|||
44389816|NCT00684307|79396155|FG000|Overall Study|Participant not willing to continue|7|||
44389817|NCT00684307|79396156|FG001|Overall Study|Participant not willing to continue|10|||
44389818|NCT00684307|79396157|FG002|Overall Study|Participant not willing to continue|11|||
44389819|NCT00684307|79396158|FG003|Overall Study|Participant not willing to continue|5|||
44389820|NCT00684307|79396159|FG004|Overall Study|Participant not willing to continue|8|||
44389821|NCT00684307|79396155|FG000|Overall Study|Criteria from the CSR|0|||
44389822|NCT00684307|79396156|FG001|Overall Study|Criteria from the CSR|0|||
44389823|NCT00684307|79396157|FG002|Overall Study|Criteria from the CSR|1|||
44389824|NCT00684307|79396158|FG003|Overall Study|Criteria from the CSR|3|||
44389825|NCT00684307|79396159|FG004|Overall Study|Criteria from the CSR|3|||
44389826|NCT00683917|79396174|FG000|Overall Study|Study prematurely terminated|10|||
44389827|NCT00687271|79396186|FG000|Overall Study|Adverse Event|1|||
44389828|NCT00687271|79396187|FG001|Overall Study|Adverse Event|3|||
44389829|NCT00687271|79396188|FG002|Overall Study|Adverse Event|1|||
44389830|NCT00687271|79396189|FG003|Overall Study|Adverse Event|0|||
44389831|NCT00687271|79396186|FG000|Overall Study|Lost to Follow-up|0|||
44389832|NCT00687271|79396187|FG001|Overall Study|Lost to Follow-up|1|||
44389833|NCT00687271|79396188|FG002|Overall Study|Lost to Follow-up|0|||
44389834|NCT00687271|79396189|FG003|Overall Study|Lost to Follow-up|0|||
44389835|NCT00687271|79396186|FG000|Overall Study|Protocol Violation|2|||
44389836|NCT00687271|79396187|FG001|Overall Study|Protocol Violation|1|||
44389837|NCT00687271|79396188|FG002|Overall Study|Protocol Violation|1|||
44389838|NCT00687271|79396189|FG003|Overall Study|Protocol Violation|0|||
44389839|NCT00687271|79396186|FG000|Overall Study|Withdrawal by Subject|0|||
44389840|NCT00687271|79396187|FG001|Overall Study|Withdrawal by Subject|1|||
44389841|NCT00687271|79396188|FG002|Overall Study|Withdrawal by Subject|3|||
44389842|NCT00687271|79396189|FG003|Overall Study|Withdrawal by Subject|0|||
44389843|NCT04617275|79396207|FG000|Treatment Period|Adverse Event|1|||
44389844|NCT04617275|79396208|FG001|Treatment Period|Adverse Event|6|||
44389845|NCT04617275|79396209|FG002|Treatment Period|Adverse Event|4|||
44389846|NCT04617275|79396210|FG003|Treatment Period|Adverse Event|6|||
44389847|NCT04617275|79396211|FG004|Treatment Period|Adverse Event|7|||
44389848|NCT04617275|79396212|FG005|Treatment Period|Adverse Event|8|||
44389849|NCT04617275|79396213|FG006|Treatment Period|Adverse Event|0|||
44389850|NCT04617275|79396214|FG007|Treatment Period|Adverse Event|12|||
44389851|NCT04617275|79396207|FG000|Treatment Period|Lost to Follow-up|0|||
44389852|NCT04617275|79396208|FG001|Treatment Period|Lost to Follow-up|0|||
44389853|NCT04617275|79396209|FG002|Treatment Period|Lost to Follow-up|2|||
44389854|NCT04617275|79396210|FG003|Treatment Period|Lost to Follow-up|0|||
44389855|NCT04617275|79396211|FG004|Treatment Period|Lost to Follow-up|0|||
44389856|NCT04617275|79396212|FG005|Treatment Period|Lost to Follow-up|3|||
44389857|NCT04617275|79396213|FG006|Treatment Period|Lost to Follow-up|0|||
44389858|NCT04617275|79396214|FG007|Treatment Period|Lost to Follow-up|2|||
44389859|NCT04617275|79396207|FG000|Treatment Period|No longer meets eligibility criteria|0|||
44389860|NCT04617275|79396208|FG001|Treatment Period|No longer meets eligibility criteria|0|||
44389861|NCT04617275|79396209|FG002|Treatment Period|No longer meets eligibility criteria|0|||
44389862|NCT04617275|79396210|FG003|Treatment Period|No longer meets eligibility criteria|1|||
44389863|NCT04617275|79396211|FG004|Treatment Period|No longer meets eligibility criteria|0|||
44389864|NCT04617275|79396212|FG005|Treatment Period|No longer meets eligibility criteria|0|||
44389865|NCT04617275|79396213|FG006|Treatment Period|No longer meets eligibility criteria|0|||
44389866|NCT04617275|79396214|FG007|Treatment Period|No longer meets eligibility criteria|0|||
44389867|NCT04617275|79396207|FG000|Treatment Period|Other|0|||
44389868|NCT04617275|79396208|FG001|Treatment Period|Other|1|||
44389869|NCT04617275|79396209|FG002|Treatment Period|Other|0|||
44389870|NCT04617275|79396210|FG003|Treatment Period|Other|0|||
44389871|NCT04617275|79396211|FG004|Treatment Period|Other|0|||
44389872|NCT04617275|79396212|FG005|Treatment Period|Other|0|||
44389873|NCT04617275|79396213|FG006|Treatment Period|Other|0|||
44389874|NCT04617275|79396214|FG007|Treatment Period|Other|0|||
44389875|NCT04617275|79396207|FG000|Treatment Period|Withdrawal by Subject|2|||
44146530|NCT02636361|78935991|FG000|Period 4|Physician Decision|0|||
44389876|NCT04617275|79396208|FG001|Treatment Period|Withdrawal by Subject|0|||
44389877|NCT04617275|79396209|FG002|Treatment Period|Withdrawal by Subject|0|||
44389878|NCT04617275|79396210|FG003|Treatment Period|Withdrawal by Subject|2|||
44389879|NCT04617275|79396211|FG004|Treatment Period|Withdrawal by Subject|2|||
44389880|NCT04617275|79396212|FG005|Treatment Period|Withdrawal by Subject|0|||
44389881|NCT04617275|79396213|FG006|Treatment Period|Withdrawal by Subject|1|||
44389882|NCT04617275|79396214|FG007|Treatment Period|Withdrawal by Subject|2|||
44389883|NCT04617275|79396207|FG000|Follow-up Period|Adverse Event|1|||
44389884|NCT04617275|79396208|FG001|Follow-up Period|Adverse Event|1|||
44389885|NCT04617275|79396209|FG002|Follow-up Period|Adverse Event|2|||
44389886|NCT04617275|79396210|FG003|Follow-up Period|Adverse Event|3|||
44389887|NCT04617275|79396211|FG004|Follow-up Period|Adverse Event|4|||
44389888|NCT04617275|79396212|FG005|Follow-up Period|Adverse Event|3|||
44389889|NCT04617275|79396213|FG006|Follow-up Period|Adverse Event|0|||
44389890|NCT04617275|79396214|FG007|Follow-up Period|Adverse Event|3|||
44389891|NCT04617275|79396207|FG000|Follow-up Period|Lost to Follow-up|0|||
44389892|NCT04617275|79396208|FG001|Follow-up Period|Lost to Follow-up|1|||
44389893|NCT04617275|79396209|FG002|Follow-up Period|Lost to Follow-up|2|||
44389894|NCT04617275|79396210|FG003|Follow-up Period|Lost to Follow-up|0|||
44389895|NCT04617275|79396211|FG004|Follow-up Period|Lost to Follow-up|0|||
44389896|NCT04617275|79396212|FG005|Follow-up Period|Lost to Follow-up|4|||
44389897|NCT04617275|79396213|FG006|Follow-up Period|Lost to Follow-up|0|||
44389898|NCT04617275|79396214|FG007|Follow-up Period|Lost to Follow-up|3|||
44389899|NCT04617275|79396207|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
44389900|NCT04617275|79396208|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
44389901|NCT04617275|79396209|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
44389902|NCT04617275|79396210|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
44389903|NCT04617275|79396211|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
44389904|NCT04617275|79396212|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
44389905|NCT04617275|79396213|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
44389906|NCT04617275|79396214|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
44389907|NCT04617275|79396207|FG000|Follow-up Period|Other|0|||
44389908|NCT04617275|79396208|FG001|Follow-up Period|Other|1|||
44389909|NCT04617275|79396209|FG002|Follow-up Period|Other|0|||
44389910|NCT04617275|79396210|FG003|Follow-up Period|Other|0|||
44389911|NCT04617275|79396211|FG004|Follow-up Period|Other|0|||
44389912|NCT04617275|79396212|FG005|Follow-up Period|Other|0|||
44389913|NCT04617275|79396213|FG006|Follow-up Period|Other|0|||
44389914|NCT04617275|79396214|FG007|Follow-up Period|Other|0|||
44389915|NCT04617275|79396207|FG000|Follow-up Period|Withdrawal by Subject|2|||
44389916|NCT04617275|79396208|FG001|Follow-up Period|Withdrawal by Subject|0|||
44389917|NCT04617275|79396209|FG002|Follow-up Period|Withdrawal by Subject|0|||
44389918|NCT04617275|79396210|FG003|Follow-up Period|Withdrawal by Subject|2|||
44389919|NCT04617275|79396211|FG004|Follow-up Period|Withdrawal by Subject|2|||
44389920|NCT04617275|79396212|FG005|Follow-up Period|Withdrawal by Subject|0|||
44389921|NCT04617275|79396213|FG006|Follow-up Period|Withdrawal by Subject|1|||
44389922|NCT04617275|79396214|FG007|Follow-up Period|Withdrawal by Subject|2|||
44389923|NCT01031537|79396249|FG000|Overall Study|medical reasons not related to study|3|||
44389924|NCT01031537|79396249|FG000|Overall Study|Lack of Efficacy|1|||
44389925|NCT01031537|79396249|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
44389926|NCT01031537|79396249|FG000|Overall Study|moved, met exclusion criteria|10|||
44389927|NCT01031537|79396249|FG000|Overall Study|Withdrawal by Subject|5|||
44389928|NCT01031537|79396249|FG000|Overall Study|PI removal, no longer met eligibility|12|||
44389929|NCT01031381|79396253|FG000|Overall Study|Physician Decision|3|||
44389930|NCT01031381|79396253|FG000|Overall Study|Withdrawal by Subject|6|||
44389931|NCT00685399|79396265|FG000|Treatment Period 1|Withdrawal by Subject|2|||
44389932|NCT00685399|79396266|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44389933|NCT00685399|79396267|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44389934|NCT00685399|79396268|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44389935|NCT00685399|79396269|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44389936|NCT00685399|79396270|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44389937|NCT00685399|79396271|FG006|Treatment Period 1|Withdrawal by Subject|0|||
44389938|NCT00685399|79396272|FG007|Treatment Period 1|Withdrawal by Subject|0|||
44389939|NCT00685399|79396265|FG000|Treatment Period 1|Protocol Violation|1|||
44389940|NCT00685399|79396266|FG001|Treatment Period 1|Protocol Violation|0|||
44389941|NCT00685399|79396267|FG002|Treatment Period 1|Protocol Violation|0|||
44389942|NCT00685399|79396268|FG003|Treatment Period 1|Protocol Violation|0|||
44389943|NCT00685399|79396269|FG004|Treatment Period 1|Protocol Violation|0|||
44389944|NCT00685399|79396270|FG005|Treatment Period 1|Protocol Violation|0|||
44389945|NCT00685399|79396271|FG006|Treatment Period 1|Protocol Violation|0|||
44389946|NCT00685399|79396272|FG007|Treatment Period 1|Protocol Violation|0|||
44389947|NCT00685399|79396265|FG000|Treatment Period 1|Administrative|2|||
44389948|NCT00685399|79396266|FG001|Treatment Period 1|Administrative|0|||
44389949|NCT00685399|79396267|FG002|Treatment Period 1|Administrative|0|||
44389950|NCT00685399|79396268|FG003|Treatment Period 1|Administrative|0|||
44389951|NCT00685399|79396269|FG004|Treatment Period 1|Administrative|0|||
44389952|NCT00685399|79396270|FG005|Treatment Period 1|Administrative|0|||
44389953|NCT00685399|79396271|FG006|Treatment Period 1|Administrative|0|||
44389954|NCT00685399|79396272|FG007|Treatment Period 1|Administrative|0|||
44389955|NCT00685399|79396265|FG000|Treatment Period 1|Lack of Efficacy|1|||
44389956|NCT00685399|79396266|FG001|Treatment Period 1|Lack of Efficacy|0|||
44389957|NCT00685399|79396267|FG002|Treatment Period 1|Lack of Efficacy|0|||
44389958|NCT00685399|79396268|FG003|Treatment Period 1|Lack of Efficacy|0|||
44389959|NCT00685399|79396269|FG004|Treatment Period 1|Lack of Efficacy|0|||
44389960|NCT00685399|79396270|FG005|Treatment Period 1|Lack of Efficacy|0|||
44146531|NCT02636361|78935992|FG001|Period 4|Physician Decision|0|||
44389961|NCT00685399|79396271|FG006|Treatment Period 1|Lack of Efficacy|0|||
44389962|NCT00685399|79396272|FG007|Treatment Period 1|Lack of Efficacy|0|||
44389963|NCT00685399|79396265|FG000|Treatment Period 2|Administrative Problems|0|||
44389964|NCT00685399|79396266|FG001|Treatment Period 2|Administrative Problems|2|||
44389965|NCT00685399|79396267|FG002|Treatment Period 2|Administrative Problems|1|||
44389966|NCT00685399|79396268|FG003|Treatment Period 2|Administrative Problems|0|||
44389967|NCT00685399|79396269|FG004|Treatment Period 2|Administrative Problems|0|||
44389968|NCT00685399|79396270|FG005|Treatment Period 2|Administrative Problems|0|||
44389969|NCT00685399|79396271|FG006|Treatment Period 2|Administrative Problems|0|||
44519581|NCT03496298|79527449|FG000|Overall Study|Other|29|||
44519582|NCT03496298|79527450|FG001|Overall Study|Other|20|||
44519583|NCT03496298|79527451|FG002|Overall Study|Other|23|||
44519584|NCT03496298|79527449|FG000|Overall Study|Randomized and not treated|1|||
44519585|NCT03496298|79527450|FG001|Overall Study|Randomized and not treated|1|||
44519586|NCT03496298|79527451|FG002|Overall Study|Randomized and not treated|1|||
44389970|NCT00685399|79396272|FG007|Treatment Period 2|Administrative Problems|0|||
44389971|NCT00685399|79396265|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44389972|NCT00685399|79396266|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44389973|NCT00685399|79396267|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44389974|NCT00685399|79396268|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44389975|NCT00685399|79396269|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44389976|NCT00685399|79396270|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44389977|NCT00685399|79396271|FG006|Treatment Period 2|Withdrawal by Subject|0|||
44389978|NCT00685399|79396272|FG007|Treatment Period 2|Withdrawal by Subject|2|||
44389979|NCT00685399|79396265|FG000|Treatment Period 2|Adverse Event|0|||
44389980|NCT00685399|79396266|FG001|Treatment Period 2|Adverse Event|0|||
44389981|NCT00685399|79396267|FG002|Treatment Period 2|Adverse Event|0|||
44389982|NCT00685399|79396268|FG003|Treatment Period 2|Adverse Event|0|||
44389983|NCT00685399|79396269|FG004|Treatment Period 2|Adverse Event|0|||
44146532|NCT02636361|78935993|FG002|Period 4|Physician Decision|0|||
44146533|NCT02636361|78935994|FG003|Period 4|Physician Decision|1|||
44146534|NCT02636361|78935995|FG004|Period 4|Physician Decision|0|||
44146535|NCT02636283|78936011|FG000|Overall Study|Adverse Event|2|||
44146536|NCT02636283|78936012|FG001|Overall Study|Adverse Event|0|||
44146537|NCT02636283|78936011|FG000|Overall Study|Trial Terminated Prematurely|0|||
44146538|NCT02636283|78936012|FG001|Overall Study|Trial Terminated Prematurely|3|||
44146539|NCT04430855|78936020|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
44146540|NCT04430855|78936021|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
44146541|NCT04430855|78936020|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
44146542|NCT04430855|78936021|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
44389984|NCT00685399|79396270|FG005|Treatment Period 2|Adverse Event|1|||
44389985|NCT00685399|79396271|FG006|Treatment Period 2|Adverse Event|0|||
44389986|NCT00685399|79396272|FG007|Treatment Period 2|Adverse Event|0|||
44389987|NCT00685399|79396265|FG000|Treatment Period 2|Lack of Efficacy|0|||
44389988|NCT00685399|79396266|FG001|Treatment Period 2|Lack of Efficacy|10|||
44389989|NCT00685399|79396267|FG002|Treatment Period 2|Lack of Efficacy|2|||
44389990|NCT00685399|79396268|FG003|Treatment Period 2|Lack of Efficacy|0|||
44389991|NCT00685399|79396269|FG004|Treatment Period 2|Lack of Efficacy|0|||
44389992|NCT00685399|79396270|FG005|Treatment Period 2|Lack of Efficacy|1|||
44389993|NCT00685399|79396271|FG006|Treatment Period 2|Lack of Efficacy|0|||
44389994|NCT00685399|79396272|FG007|Treatment Period 2|Lack of Efficacy|0|||
44389995|NCT00685399|79396265|FG000|Extension|Administrative Issues|0|||
44389996|NCT00685399|79396266|FG001|Extension|Administrative Issues|0|||
44389997|NCT00685399|79396267|FG002|Extension|Administrative Issues|0|||
44389998|NCT00685399|79396268|FG003|Extension|Administrative Issues|1|||
44389999|NCT00685399|79396269|FG004|Extension|Administrative Issues|0|||
44390000|NCT00685399|79396270|FG005|Extension|Administrative Issues|0|||
44390001|NCT00685399|79396271|FG006|Extension|Administrative Issues|0|||
44390002|NCT00685399|79396272|FG007|Extension|Administrative Issues|0|||
44390003|NCT00685399|79396265|FG000|Extension|Withdrawal by Subject|0|||
44390004|NCT00685399|79396266|FG001|Extension|Withdrawal by Subject|0|||
44519587|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
44519588|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
44519589|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
44390005|NCT00685399|79396267|FG002|Extension|Withdrawal by Subject|0|||
44519590|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
44519591|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
44146543|NCT04430855|78936020|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
44146544|NCT04430855|78936021|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
44146545|NCT04430855|78936020|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
44390006|NCT00685399|79396268|FG003|Extension|Withdrawal by Subject|1|||
44390007|NCT00685399|79396269|FG004|Extension|Withdrawal by Subject|0|||
44390008|NCT00685399|79396270|FG005|Extension|Withdrawal by Subject|0|||
44390009|NCT00685399|79396271|FG006|Extension|Withdrawal by Subject|0|||
44390010|NCT00685399|79396272|FG007|Extension|Withdrawal by Subject|0|||
44519592|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
44390011|NCT00685399|79396265|FG000|Extension|Protocol Violation|0|||
44390012|NCT00685399|79396266|FG001|Extension|Protocol Violation|0|||
44390013|NCT00685399|79396267|FG002|Extension|Protocol Violation|0|||
44390014|NCT00685399|79396268|FG003|Extension|Protocol Violation|1|||
44390015|NCT00685399|79396269|FG004|Extension|Protocol Violation|0|||
44390016|NCT00685399|79396270|FG005|Extension|Protocol Violation|0|||
44390017|NCT00685399|79396271|FG006|Extension|Protocol Violation|0|||
44390018|NCT00685399|79396272|FG007|Extension|Protocol Violation|0|||
44390019|NCT00685399|79396265|FG000|Extension|Lack of Efficacy|0|||
44390020|NCT00685399|79396266|FG001|Extension|Lack of Efficacy|0|||
44390021|NCT00685399|79396267|FG002|Extension|Lack of Efficacy|0|||
44390022|NCT00685399|79396268|FG003|Extension|Lack of Efficacy|2|||
44390023|NCT00685399|79396269|FG004|Extension|Lack of Efficacy|0|||
44390024|NCT00685399|79396270|FG005|Extension|Lack of Efficacy|0|||
44390025|NCT00685399|79396271|FG006|Extension|Lack of Efficacy|0|||
44390026|NCT00685399|79396272|FG007|Extension|Lack of Efficacy|0|||
44390027|NCT00685399|79396265|FG000|Extension|Adverse Event|0|||
44390028|NCT00685399|79396266|FG001|Extension|Adverse Event|0|||
44390029|NCT00685399|79396267|FG002|Extension|Adverse Event|0|||
44390030|NCT00685399|79396268|FG003|Extension|Adverse Event|2|||
44390031|NCT00685399|79396269|FG004|Extension|Adverse Event|0|||
44390032|NCT00685399|79396270|FG005|Extension|Adverse Event|0|||
44390033|NCT00685399|79396271|FG006|Extension|Adverse Event|0|||
44390034|NCT00685399|79396272|FG007|Extension|Adverse Event|0|||
44390035|NCT00685165|79396299|FG000|Washout Period of 14 Days|Adverse Event|1|||
44390036|NCT00685165|79396300|FG001|Washout Period of 14 Days|Adverse Event|0|||
44390037|NCT00683449|79396311|FG000|Overall Study|Lost to Follow-up|0|||
44390038|NCT00683449|79396312|FG001|Overall Study|Lost to Follow-up|1|||
44390039|NCT00683449|79396313|FG002|Overall Study|Lost to Follow-up|0|||
44390040|NCT00683449|79396314|FG003|Overall Study|Lost to Follow-up|0|||
44390041|NCT00683449|79396315|FG004|Overall Study|Lost to Follow-up|0|||
44390042|NCT00683293|79396334|FG000|Overall Study|Withdrawal by Subject|2|||
44390043|NCT00683293|79396335|FG001|Overall Study|Withdrawal by Subject|3|||
44390044|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Death|0|||
44390045|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Death|0|||
44390046|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Death|0|||
44390047|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Death|0|||
44390048|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Death|1|||
44390049|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Death|0|||
44390050|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Death|0|||
44390051|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Death|0|||
44390052|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
44390053|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
44519593|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
44519594|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
44519595|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
44519596|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
44519597|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
44519598|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
44519599|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
44519600|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
44519601|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
44519602|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
44519603|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
44519604|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
44519605|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
44519606|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
44519607|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
44519608|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
44519609|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
44519610|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
44519611|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
44519612|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
44519613|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
44146546|NCT04430855|78936021|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
44146547|NCT04430855|78936020|FG000|Period 1 (Weeks 1-12)|Other|0|||
44146548|NCT04430855|78936021|FG001|Period 1 (Weeks 1-12)|Other|1|||
44146549|NCT04430855|78936020|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
44390054|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
44390055|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
44390056|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
44390057|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
44390058|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
44390059|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
44519614|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
44390060|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
44390061|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
44390062|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
44390063|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
44390064|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
44390065|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
44390066|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
44390067|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
44390068|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
44390069|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
44390070|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
44390071|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
44390072|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
44390073|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
44390074|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
44390075|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
44390076|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
44390077|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
44390078|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
44390079|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
44390080|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
44390081|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
44390082|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
44390083|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
44390084|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
44390085|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
44390086|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
44390087|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
44390088|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
44390089|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
44390090|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
44390091|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
44390092|NCT00726232|79396347|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
44390093|NCT00726232|79396348|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390094|NCT00726232|79396349|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390095|NCT00726232|79396350|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390096|NCT00726232|79396351|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390097|NCT00726232|79396352|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390098|NCT00726232|79396353|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390099|NCT00726232|79396354|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
44390100|NCT00726232|79396347|FG000|Expansion Phase|Death|0|||
44390101|NCT00726232|79396348|FG001|Expansion Phase|Death|0|||
44390102|NCT00726232|79396349|FG002|Expansion Phase|Death|0|||
44390103|NCT00726232|79396350|FG003|Expansion Phase|Death|0|||
44390104|NCT00726232|79396351|FG004|Expansion Phase|Death|0|||
44390105|NCT00726232|79396352|FG005|Expansion Phase|Death|0|||
44390106|NCT00726232|79396353|FG006|Expansion Phase|Death|0|||
44390107|NCT00726232|79396354|FG007|Expansion Phase|Death|1|||
44390108|NCT00726232|79396347|FG000|Expansion Phase|Adverse Event|0|||
44390109|NCT00726232|79396348|FG001|Expansion Phase|Adverse Event|0|||
44390110|NCT00726232|79396349|FG002|Expansion Phase|Adverse Event|0|||
44390111|NCT00726232|79396350|FG003|Expansion Phase|Adverse Event|0|||
44390112|NCT00726232|79396351|FG004|Expansion Phase|Adverse Event|0|||
44390113|NCT00726232|79396352|FG005|Expansion Phase|Adverse Event|0|||
44519615|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
44519616|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
44519617|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
44519618|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
44519619|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
44519620|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44519621|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
44519622|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
44519623|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
44519624|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44519625|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44519626|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44251907|NCT00633061|79087556|FG001|Overall Study|Study closed|0|||
44519627|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44519628|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44251908|NCT00632827|79087564|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
44390114|NCT00726232|79396353|FG006|Expansion Phase|Adverse Event|6|||
44390115|NCT00726232|79396354|FG007|Expansion Phase|Adverse Event|11|||
44390116|NCT00726232|79396347|FG000|Expansion Phase|Withdrawal by Subject|0|||
44519629|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44519630|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
44519631|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519632|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519633|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519634|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519635|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
44519636|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519637|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519638|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519639|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519640|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519641|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
44519642|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
44519643|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519644|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519645|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519646|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519647|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519648|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519649|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519650|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519651|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519652|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
44519653|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
44519654|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
44519655|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
44519656|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
44519657|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
44519658|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
44519659|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
44519660|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
44519661|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
44519662|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
44519663|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
44519664|NCT02914522|79527464|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519665|NCT02914522|79527465|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
44519666|NCT02914522|79527466|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519667|NCT02914522|79527467|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519668|NCT02914522|79527468|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
44519669|NCT02914522|79527469|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
44519670|NCT02914522|79527470|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519671|NCT02914522|79527471|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519672|NCT02914522|79527472|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519673|NCT02914522|79527473|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519674|NCT02914522|79527474|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
44519675|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
44519676|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
44251909|NCT00632827|79087564|FG000|Overall Study|Death|2|||
44519677|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
44519678|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
44519679|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
44519680|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
44519681|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
44251910|NCT00632827|79087564|FG000|Overall Study|Adverse Event|5|||
44251911|NCT00632827|79087564|FG000|Overall Study|Lost to Follow-up|1|||
44251912|NCT00214019|79087569|FG000|Overall Study|Lost to Follow-up|11|||
44251913|NCT00214019|79087569|FG000|Overall Study|Withdrawal by Subject|2|||
44390117|NCT00726232|79396348|FG001|Expansion Phase|Withdrawal by Subject|0|||
44390118|NCT00726232|79396349|FG002|Expansion Phase|Withdrawal by Subject|0|||
44390119|NCT00726232|79396350|FG003|Expansion Phase|Withdrawal by Subject|0|||
44251914|NCT00214019|79087569|FG000|Overall Study|Screen Failed prior to randomization|17|||
44251915|NCT00210119|79087576|FG000|Overall Study|Protocol Violation|1|||
44390120|NCT00726232|79396351|FG004|Expansion Phase|Withdrawal by Subject|0|||
44390121|NCT00726232|79396352|FG005|Expansion Phase|Withdrawal by Subject|0|||
44390122|NCT00726232|79396353|FG006|Expansion Phase|Withdrawal by Subject|2|||
44390123|NCT00726232|79396354|FG007|Expansion Phase|Withdrawal by Subject|3|||
44390124|NCT00726232|79396347|FG000|Expansion Phase|Disease progression|0|||
44390125|NCT00726232|79396348|FG001|Expansion Phase|Disease progression|0|||
44390126|NCT00726232|79396349|FG002|Expansion Phase|Disease progression|0|||
44390127|NCT00726232|79396350|FG003|Expansion Phase|Disease progression|0|||
44390128|NCT00726232|79396351|FG004|Expansion Phase|Disease progression|0|||
44390129|NCT00726232|79396352|FG005|Expansion Phase|Disease progression|0|||
44390130|NCT00726232|79396353|FG006|Expansion Phase|Disease progression|4|||
44390131|NCT00726232|79396354|FG007|Expansion Phase|Disease progression|0|||
44390132|NCT00726232|79396347|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
44390133|NCT00726232|79396348|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
44390134|NCT00726232|79396349|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
44390135|NCT00726232|79396350|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
44390136|NCT00726232|79396351|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
44390137|NCT00726232|79396352|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
44390138|NCT00726232|79396353|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
44390139|NCT00726232|79396354|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
44519682|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
44280850|NCT01931670|79242063|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
44280851|NCT01931670|79242064|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
44280852|NCT01931670|79242065|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
44280853|NCT01931670|79242063|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
44280854|NCT01931670|79242064|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
44280855|NCT01931670|79242065|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
44280856|NCT01931670|79242063|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
44280857|NCT01931670|79242064|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
44280858|NCT01931670|79242065|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
44280859|NCT01931670|79242063|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
44280860|NCT01931670|79242064|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
44280861|NCT01931670|79242065|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
44280862|NCT01931670|79242063|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
44280863|NCT01931670|79242064|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
44280864|NCT01931670|79242065|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
44280865|NCT01977456|79242073|FG000|Overall Study|Death|5|||
44280866|NCT01957644|79242082|FG000|Overall Study|Adverse Event|4|||
44280867|NCT01957644|79242083|FG001|Overall Study|Adverse Event|2|||
44280868|NCT01957644|79242084|FG002|Overall Study|Adverse Event|0|||
44280869|NCT01957644|79242085|FG003|Overall Study|Adverse Event|0|||
44280870|NCT01957644|79242086|FG004|Overall Study|Adverse Event|1|||
44280871|NCT01957644|79242082|FG000|Overall Study|Progressive disease / relapse|0|||
44280872|NCT01957644|79242083|FG001|Overall Study|Progressive disease / relapse|1|||
44280873|NCT01957644|79242084|FG002|Overall Study|Progressive disease / relapse|0|||
44280874|NCT01957644|79242085|FG003|Overall Study|Progressive disease / relapse|1|||
44280875|NCT01957644|79242086|FG004|Overall Study|Progressive disease / relapse|0|||
44280876|NCT01957644|79242082|FG000|Overall Study|Other reason|1|||
44280877|NCT01957644|79242083|FG001|Overall Study|Other reason|2|||
44280878|NCT01957644|79242084|FG002|Overall Study|Other reason|1|||
44280879|NCT01957644|79242085|FG003|Overall Study|Other reason|1|||
44280880|NCT01957644|79242086|FG004|Overall Study|Other reason|0|||
44280881|NCT01957644|79242082|FG000|Overall Study|Withdrawal by Subject|1|||
44280882|NCT01957644|79242083|FG001|Overall Study|Withdrawal by Subject|0|||
44280883|NCT01957644|79242084|FG002|Overall Study|Withdrawal by Subject|0|||
44280884|NCT01957644|79242085|FG003|Overall Study|Withdrawal by Subject|0|||
44280885|NCT01957644|79242086|FG004|Overall Study|Withdrawal by Subject|0|||
44280886|NCT01957644|79242082|FG000|Overall Study|Protocol Violation|0|||
44280887|NCT01957644|79242083|FG001|Overall Study|Protocol Violation|1|||
44280888|NCT01957644|79242084|FG002|Overall Study|Protocol Violation|0|||
44280889|NCT01957644|79242085|FG003|Overall Study|Protocol Violation|0|||
44280890|NCT01957644|79242086|FG004|Overall Study|Protocol Violation|0|||
44280891|NCT01931202|79242103|FG000|Overall Study|Withdrawal by Subject|0|||
44280892|NCT01931202|79242104|FG001|Overall Study|Withdrawal by Subject|0|||
44280893|NCT01931202|79242105|FG002|Overall Study|Withdrawal by Subject|2|||
44280894|NCT01931202|79242103|FG000|Overall Study|Lost to Follow-up|0|||
44280895|NCT01931202|79242104|FG001|Overall Study|Lost to Follow-up|5|||
44390140|NCT00726232|79396347|FG000|Expansion Phase|Per Investigator: lack of response|0|||
44390141|NCT00726232|79396348|FG001|Expansion Phase|Per Investigator: lack of response|0|||
44390142|NCT00726232|79396349|FG002|Expansion Phase|Per Investigator: lack of response|0|||
44519683|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
44390143|NCT00726232|79396350|FG003|Expansion Phase|Per Investigator: lack of response|0|||
44390144|NCT00726232|79396351|FG004|Expansion Phase|Per Investigator: lack of response|0|||
44390145|NCT00726232|79396352|FG005|Expansion Phase|Per Investigator: lack of response|0|||
44390146|NCT00726232|79396353|FG006|Expansion Phase|Per Investigator: lack of response|1|||
44390147|NCT00726232|79396354|FG007|Expansion Phase|Per Investigator: lack of response|7|||
44519684|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
44519685|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
44519686|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
44519687|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
44519688|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
44519689|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
44519690|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
44519691|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
44519692|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
44519693|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
44519694|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
44519695|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
44519696|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
44519697|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519698|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519699|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519700|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519701|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519702|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519703|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
44519704|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
44519705|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
44519706|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
44519707|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
44519708|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
44519709|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
44519710|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
44519711|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
44519712|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
44519713|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
44519714|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
44519715|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
44519716|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
44519717|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
44519718|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
44519719|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
44519720|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
44519721|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
44519722|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
44519723|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
44519724|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
44519725|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
44519726|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
44519727|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
44519728|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
44519729|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
44519730|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519731|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519732|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519733|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519734|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519735|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519736|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519737|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
44146550|NCT04430855|78936021|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
44251916|NCT00210119|79087576|FG000|Overall Study|Withdrawal by Subject|1|||
44519738|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
44519739|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44390148|NCT00726232|79396347|FG000|Expansion Phase|Unspecified reason|0|||
44390149|NCT00726232|79396348|FG001|Expansion Phase|Unspecified reason|0|||
44390150|NCT00726232|79396349|FG002|Expansion Phase|Unspecified reason|0|||
44390151|NCT00726232|79396350|FG003|Expansion Phase|Unspecified reason|0|||
44390152|NCT00726232|79396351|FG004|Expansion Phase|Unspecified reason|0|||
44390153|NCT00726232|79396352|FG005|Expansion Phase|Unspecified reason|0|||
44390154|NCT00726232|79396353|FG006|Expansion Phase|Unspecified reason|1|||
44390155|NCT00726232|79396354|FG007|Expansion Phase|Unspecified reason|0|||
44390156|NCT00720382|79396375|FG000|Overall Study|Adverse Event|54|||
44390157|NCT00720382|79396376|FG001|Overall Study|Adverse Event|17|||
44390158|NCT00720382|79396375|FG000|Overall Study|Lack of Efficacy|18|||
44390159|NCT00720382|79396376|FG001|Overall Study|Lack of Efficacy|7|||
44390160|NCT00720382|79396375|FG000|Overall Study|Non-Compliance|15|||
44390161|NCT00720382|79396376|FG001|Overall Study|Non-Compliance|5|||
44390162|NCT00720382|79396375|FG000|Overall Study|Withdrawal by Subject|47|||
44390163|NCT00720382|79396376|FG001|Overall Study|Withdrawal by Subject|11|||
44390164|NCT00720382|79396375|FG000|Overall Study|Lost to Follow-up|28|||
44390165|NCT00720382|79396376|FG001|Overall Study|Lost to Follow-up|14|||
44390166|NCT00720382|79396375|FG000|Overall Study|administrative|14|||
44390167|NCT00720382|79396376|FG001|Overall Study|administrative|5|||
44390168|NCT00720226|79396384|FG000|Overall Study|Withdrawal by Subject|7|||
44390169|NCT00720226|79396385|FG001|Overall Study|Withdrawal by Subject|4|||
44390170|NCT00725920|79396393|FG000|Overall Study|Lack of Efficacy|3|||
44390171|NCT00725920|79396394|FG001|Overall Study|Lack of Efficacy|6|||
44390172|NCT00725842|79396400|FG000|Overall Study|Lost to Follow-up|19|||
44390173|NCT00725842|79396400|FG000|Overall Study|Death|1|||
44390174|NCT00725842|79396400|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
44390175|NCT00725842|79396400|FG000|Overall Study|Consent date prior to study start date|5|||
44390176|NCT00725842|79396400|FG000|Overall Study|Inclusion criterion not met|1|||
44390177|NCT00725842|79396400|FG000|Overall Study|No Visit 1 data|1|||
44390178|NCT00725764|79396404|FG000|Overall Study|Withdrawal by Subject|2|||
44390179|NCT00725764|79396404|FG000|Overall Study|Physician Decision|1|||
44390180|NCT00725764|79396404|FG000|Overall Study|Progressive Disease|7|||
44390181|NCT00725764|79396404|FG000|Overall Study|Lost to Follow-up|1|||
44390182|NCT00725764|79396404|FG000|Overall Study|Death|1|||
44390183|NCT00725764|79396404|FG000|Overall Study|Participant non compliant with protocol|1|||
44390184|NCT00725764|79396404|FG000|Overall Study|Decline in performance status|1|||
44390185|NCT00725608|79396409|FG000|Overall Study|Lost to Follow-up|60|||
44390186|NCT00725608|79396409|FG000|Overall Study|Adverse Event|14|||
44390187|NCT00725608|79396409|FG000|Overall Study|Individual reasons|86|||
44390188|NCT00725608|79396409|FG000|Overall Study|Other|7|||
44390189|NCT00725452|79396413|FG000|Overall Study|Adverse Event|3|||
44390190|NCT00725452|79396413|FG000|Overall Study|Lack of Efficacy|2|||
44390191|NCT00725452|79396413|FG000|Overall Study|Reason not specified|1|||
44390192|NCT00725452|79396413|FG000|Overall Study|Physician Decision|1|||
44390193|NCT00725452|79396413|FG000|Overall Study|Withdrawal by Subject|3|||
44390194|NCT00725452|79396413|FG000|Overall Study|Lost to Follow-up|1|||
44390195|NCT00725296|79396417|FG000|Overall Study|Adverse Event|11|||
44390196|NCT00725296|79396417|FG000|Overall Study|Lack of Efficacy|7|||
44390197|NCT00725296|79396417|FG000|Overall Study|Withdrawal by Subject|3|||
44390198|NCT00725296|79396417|FG000|Overall Study|Non-Compliance|2|||
44390199|NCT00725296|79396417|FG000|Overall Study|Lost to Follow-up|1|||
44390200|NCT00725296|79396417|FG000|Overall Study|Other|38|||
44390201|NCT00719680|79396422|FG000|Overall Study|Adverse Event|1|||
44390202|NCT00719680|79396422|FG000|Overall Study|Lost to Follow-up|1|||
44390203|NCT00719680|79396422|FG000|Overall Study|Withdrawal by Subject|3|||
44390204|NCT00719212|79396426|FG000|Overall Study|Death|41|||
44390205|NCT00719212|79396426|FG000|Overall Study|Lost to Follow-up|2|||
44390206|NCT00719212|79396426|FG000|Overall Study|Withdrawal by Subject|1|||
44390207|NCT00585052|79396430|FG000|Overall Study|Withdrawal by Subject|1|||
44390208|NCT00724282|79396434|FG000|Overall Study|Withdrawal by Subject|3|||
44390209|NCT00724282|79396434|FG000|Overall Study|Physician Decision|1|||
44146551|NCT04430855|78936020|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
44390210|NCT00724126|79396440|FG000|Overall Study|Adverse Event|2|||
44390211|NCT00724126|79396441|FG001|Overall Study|Adverse Event|0|||
44390212|NCT00724126|79396440|FG000|Overall Study|Withdrawal by Subject|8|||
44390213|NCT00724126|79396441|FG001|Overall Study|Withdrawal by Subject|6|||
44390214|NCT00724126|79396440|FG000|Overall Study|Lost to Follow-up|6|||
44390215|NCT00724126|79396441|FG001|Overall Study|Lost to Follow-up|6|||
44390216|NCT00724126|79396440|FG000|Overall Study|Noncompliance|2|||
44390217|NCT00724126|79396441|FG001|Overall Study|Noncompliance|1|||
44146552|NCT04430855|78936021|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
44390218|NCT00724126|79396440|FG000|Overall Study|Subject randomized although ineligible|1|||
44390219|NCT00724126|79396441|FG001|Overall Study|Subject randomized although ineligible|1|||
44390220|NCT00724126|79396440|FG000|Overall Study|Subject had to leave vicinity of site|0|||
44390221|NCT00724126|79396441|FG001|Overall Study|Subject had to leave vicinity of site|1|||
44390222|NCT00723892|79396449|FG000|Overall Study|Participant not tracked|33|||
44390223|NCT00723892|79396450|FG001|Overall Study|Participant not tracked|35|||
44390224|NCT00723892|79396449|FG000|Overall Study|Virological criterion|24|||
44390225|NCT00723892|79396450|FG001|Overall Study|Virological criterion|9|||
44390226|NCT00723892|79396449|FG000|Overall Study|Withdrawal by Subject|6|||
44390227|NCT00723892|79396450|FG001|Overall Study|Withdrawal by Subject|9|||
44390228|NCT00723892|79396449|FG000|Overall Study|End planned|11|||
44390229|NCT00723892|79396450|FG001|Overall Study|End planned|7|||
44390230|NCT00723892|79396449|FG000|Overall Study|Bad tolerance|5|||
44390231|NCT00723892|79396450|FG001|Overall Study|Bad tolerance|5|||
44390232|NCT00723892|79396449|FG000|Overall Study|Multiple reasons|17|||
44390233|NCT00723892|79396450|FG001|Overall Study|Multiple reasons|12|||
44390234|NCT00723892|79396449|FG000|Overall Study|Other|6|||
44390235|NCT00723892|79396450|FG001|Overall Study|Other|3|||
44390236|NCT00723892|79396449|FG000|Overall Study|Study end|1|||
44390237|NCT00723892|79396450|FG001|Overall Study|Study end|3|||
44390238|NCT00723892|79396449|FG000|Overall Study|Weight loss|1|||
44390239|NCT00723892|79396450|FG001|Overall Study|Weight loss|3|||
44390240|NCT00723892|79396449|FG000|Overall Study|Alcohol abuse|0|||
44390241|NCT00723892|79396450|FG001|Overall Study|Alcohol abuse|1|||
44390242|NCT00723892|79396449|FG000|Overall Study|Intercurrent infection|2|||
44390243|NCT00723892|79396450|FG001|Overall Study|Intercurrent infection|0|||
44390244|NCT00723892|79396449|FG000|Overall Study|Drug addiction|1|||
44390245|NCT00723892|79396450|FG001|Overall Study|Drug addiction|0|||
44390246|NCT00718666|79396459|FG000|Booster Phase Year 5|No active participation request|0|||
44390247|NCT00718666|79396460|FG001|Booster Phase Year 5|No active participation request|0|||
44390248|NCT00718666|79396461|FG002|Booster Phase Year 5|No active participation request|1|||
44390249|NCT00718666|79396459|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
44390250|NCT00718666|79396460|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
44390251|NCT00718666|79396461|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
44390252|NCT00718666|79396459|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
44390253|NCT00718666|79396460|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
44390254|NCT00718666|79396461|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
44390255|NCT00718666|79396459|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
44390256|NCT00718666|79396460|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
44390257|NCT00718666|79396461|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
44390258|NCT03950440|79396482|FG000|Overall Study|Death|8|||
44390259|NCT03950440|79396483|FG001|Overall Study|Death|2|||
44390260|NCT03950440|79396484|FG002|Overall Study|Death|1|||
44390261|NCT00718510|79396494|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
44390262|NCT00718510|79396495|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44390263|NCT00718510|79396494|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
44390264|NCT00718510|79396495|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
44390265|NCT00585286|79396501|FG000|Overall Study|Lost to Follow-up|1|||
44390266|NCT00723190|79396505|FG000|Overall Study|Withdrawal by Subject|45|||
44390267|NCT00723190|79396505|FG000|Overall Study|Lost to Follow-up|37|||
44390268|NCT00723190|79396505|FG000|Overall Study|Adverse Event|18|||
44390269|NCT00723190|79396505|FG000|Overall Study|Lack of Efficacy|16|||
44390270|NCT00723190|79396505|FG000|Overall Study|Protocol Violation|15|||
44519740|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
44519741|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519742|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519743|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519744|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519745|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519746|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519747|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519748|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44519749|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
44519750|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
44390271|NCT00723190|79396505|FG000|Overall Study|Other-Premature Discontinuation|9|||
44390272|NCT00723190|79396505|FG000|Overall Study|Other-Not included in safety population|2|||
44519751|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
44251917|NCT01044459|79087582|FG000|Overall Study|Withdrawal by Subject|21|||
44251918|NCT01044459|79087583|FG001|Overall Study|Withdrawal by Subject|28|||
44251919|NCT01044459|79087582|FG000|Overall Study|Terminated by Sponsor|22|||
44390273|NCT00722800|79396511|FG000|Overall Study|Withdrawal by Subject|1|||
44390274|NCT00722800|79396512|FG001|Overall Study|Withdrawal by Subject|0|||
44390275|NCT00722800|79396511|FG000|Overall Study|Physician Decision|1|||
44390276|NCT00722800|79396512|FG001|Overall Study|Physician Decision|0|||
44390277|NCT00718042|79396524|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
44390278|NCT00718042|79396525|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
44251920|NCT01044459|79087583|FG001|Overall Study|Terminated by Sponsor|21|||
44251921|NCT01044459|79087582|FG000|Overall Study|Adverse Event|22|||
44519752|NCT02914522|79527464|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44251922|NCT01044459|79087583|FG001|Overall Study|Adverse Event|20|||
44519753|NCT02914522|79527465|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519754|NCT02914522|79527466|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519755|NCT02914522|79527467|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519756|NCT02914522|79527468|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519757|NCT02914522|79527469|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519758|NCT02914522|79527470|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519759|NCT02914522|79527471|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519760|NCT02914522|79527472|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519761|NCT02914522|79527473|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
44519762|NCT02914522|79527474|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
44519763|NCT02924428|79527503|FG000|Overall Study|Adverse Event|1|||
44519764|NCT02924428|79527504|FG001|Overall Study|Adverse Event|0|||
44519765|NCT02924428|79527503|FG000|Overall Study|Physician Decision|1|||
44519766|NCT02924428|79527504|FG001|Overall Study|Physician Decision|0|||
44519767|NCT02924428|79527503|FG000|Overall Study|Lost to Follow-up|2|||
44519768|NCT02924428|79527504|FG001|Overall Study|Lost to Follow-up|4|||
44519769|NCT02924428|79527503|FG000|Overall Study|Pregnancy|0|||
44519770|NCT02924428|79527504|FG001|Overall Study|Pregnancy|1|||
44519771|NCT00062751|79527515|FG000|Overall Study|Disease progression|24|||
44519772|NCT00062751|79527516|FG001|Overall Study|Disease progression|17|||
44519773|NCT00062751|79527517|FG002|Overall Study|Disease progression|24|||
44519774|NCT00062751|79527518|FG003|Overall Study|Disease progression|2|||
44519775|NCT00062751|79527519|FG004|Overall Study|Disease progression|2|||
44519776|NCT00062751|79527515|FG000|Overall Study|Adverse Event|4|||
44519777|NCT00062751|79527516|FG001|Overall Study|Adverse Event|7|||
44519778|NCT00062751|79527517|FG002|Overall Study|Adverse Event|2|||
44519779|NCT00062751|79527518|FG003|Overall Study|Adverse Event|2|||
44519780|NCT00062751|79527519|FG004|Overall Study|Adverse Event|2|||
44519781|NCT00062751|79527515|FG000|Overall Study|Other|2|||
44519782|NCT00062751|79527516|FG001|Overall Study|Other|3|||
44519783|NCT00062751|79527517|FG002|Overall Study|Other|1|||
44519784|NCT00062751|79527518|FG003|Overall Study|Other|0|||
44519785|NCT00062751|79527519|FG004|Overall Study|Other|1|||
44519786|NCT00062751|79527515|FG000|Overall Study|Withdrawal by Subject|1|||
44519787|NCT00062751|79527516|FG001|Overall Study|Withdrawal by Subject|2|||
44519788|NCT00062751|79527517|FG002|Overall Study|Withdrawal by Subject|2|||
44519789|NCT00062751|79527518|FG003|Overall Study|Withdrawal by Subject|1|||
44519790|NCT00062751|79527519|FG004|Overall Study|Withdrawal by Subject|0|||
44519791|NCT00062751|79527515|FG000|Overall Study|Symptomatic deterioration|1|||
44519792|NCT00062751|79527516|FG001|Overall Study|Symptomatic deterioration|1|||
44519793|NCT00062751|79527517|FG002|Overall Study|Symptomatic deterioration|0|||
44519794|NCT00062751|79527518|FG003|Overall Study|Symptomatic deterioration|0|||
44519795|NCT00062751|79527519|FG004|Overall Study|Symptomatic deterioration|1|||
44519796|NCT00062751|79527515|FG000|Overall Study|Death|1|||
44519797|NCT00062751|79527516|FG001|Overall Study|Death|0|||
44519798|NCT00062751|79527517|FG002|Overall Study|Death|1|||
44519799|NCT00062751|79527518|FG003|Overall Study|Death|0|||
44519800|NCT00062751|79527519|FG004|Overall Study|Death|0|||
44519801|NCT00062439|79527536|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
44519802|NCT00062439|79527536|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
44519803|NCT00062439|79527536|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
44519804|NCT00062439|79527536|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
44519805|NCT00062439|79527536|FG000|Post Chemoradiation Assessment|Death|1|||
44519806|NCT00062439|79527536|FG000|Post Chemoradiation Assessment|Disease progression|2|||
44519807|NCT00062439|79527536|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
44519808|NCT00062439|79527536|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
44519809|NCT00062439|79527536|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
44519810|NCT00062439|79527536|FG000|Surgery|Physician Decision|4|||
44519811|NCT00062439|79527536|FG000|Surgery|Death|1|||
44519812|NCT00062439|79527536|FG000|Surgery|Adverse Event|2|||
44519813|NCT00062439|79527536|FG000|Consolidation Chemotherapy|Adverse Event|2|||
44519814|NCT00051363|79527547|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
44519815|NCT00051363|79527548|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
44519816|NCT00051363|79527547|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
44519817|NCT00051363|79527548|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
44519818|NCT00051363|79527547|FG000|Overall Study|Death|2|||
44519819|NCT00051363|79527548|FG001|Overall Study|Death|2|||
44519820|NCT00051363|79527547|FG000|Overall Study|Excluded Pre-Randomization|2|||
44519821|NCT00051363|79527548|FG001|Overall Study|Excluded Pre-Randomization|5|||
44519822|NCT00031551|79527556|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
44519823|NCT00031551|79527557|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
44519824|NCT00049257|79527567|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
44519825|NCT00049257|79527567|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
44519826|NCT00049257|79527567|FG000|Carboplatin, Paclitaxel|Death|2|||
44519827|NCT00049257|79527567|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
44519828|NCT03020992|79527571|FG000|Overall Study|Adverse Event|5|||
44519829|NCT03020992|79527571|FG000|Overall Study|Withdrawal by Subject|1|||
44519830|NCT03020914|79527578|FG000|Overall Study|Surgery Cancelled|1|||
44519831|NCT03020914|79527579|FG001|Overall Study|Surgery Cancelled|0|||
44519832|NCT03018340|79527587|FG000|Overall Study|Adverse Event|1|||
44519833|NCT03018340|79527588|FG001|Overall Study|Adverse Event|2|||
44519834|NCT03018340|79527587|FG000|Overall Study|Withdrawal by Subject|0|||
44519835|NCT03018340|79527588|FG001|Overall Study|Withdrawal by Subject|8|||
44519836|NCT03018340|79527587|FG000|Overall Study|Lack of Efficacy|0|||
44519837|NCT03018340|79527588|FG001|Overall Study|Lack of Efficacy|1|||
44519838|NCT03018340|79527587|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
44519839|NCT03018340|79527588|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
44519840|NCT03018340|79527587|FG000|Overall Study|Lost to Follow-up|1|||
44519841|NCT03018340|79527588|FG001|Overall Study|Lost to Follow-up|7|||
44251923|NCT01044459|79087582|FG000|Overall Study|Lack of Efficacy|23|||
44251924|NCT01044459|79087583|FG001|Overall Study|Lack of Efficacy|12|||
44251925|NCT01044459|79087582|FG000|Overall Study|Protocol Violation|11|||
44251926|NCT01044459|79087583|FG001|Overall Study|Protocol Violation|16|||
44519842|NCT03018340|79527587|FG000|Overall Study|Protocol Violation|3|||
44519843|NCT03018340|79527588|FG001|Overall Study|Protocol Violation|7|||
44519844|NCT03018340|79527587|FG000|Overall Study|Not further specified|0|||
44519845|NCT03018340|79527588|FG001|Overall Study|Not further specified|1|||
44519846|NCT03016078|79527598|FG000|Overall Study|Protocol Violation|1|||
44519847|NCT03016078|79527598|FG000|Overall Study|Protocol Violation|1|||
44519848|NCT00048165|79527604|FG000|Completed 6 Months Study|Administration/Other|8|||
44519849|NCT00048165|79527605|FG001|Completed 6 Months Study|Administration/Other|8|||
44519850|NCT00048165|79527604|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
44519851|NCT00048165|79527605|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
44519852|NCT00048165|79527604|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
44519853|NCT00048165|79527605|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
44519854|NCT00048165|79527604|FG000|Completed 6 Months Study|Death|12|||
44519855|NCT00048165|79527605|FG001|Completed 6 Months Study|Death|6|||
44519856|NCT00048165|79527604|FG000|Completed 6 Months Study|Insufficient therapy|1|||
44251927|NCT01044459|79087582|FG000|Overall Study|Other Reason|7|||
44251928|NCT01044459|79087583|FG001|Overall Study|Other Reason|14|||
44251929|NCT01044459|79087582|FG000|Overall Study|COPD exacerbation|9|||
44251930|NCT01044459|79087583|FG001|Overall Study|COPD exacerbation|8|||
44251931|NCT01044459|79087582|FG000|Overall Study|Lost to Follow-up|18|||
44519857|NCT00048165|79527605|FG001|Completed 6 Months Study|Insufficient therapy|4|||
44519858|NCT00048165|79527604|FG000|Completed 6 Months Study|Other violation|4|||
44519859|NCT00048165|79527605|FG001|Completed 6 Months Study|Other violation|6|||
44519860|NCT00048165|79527604|FG000|Completed 6 Months Study|Refused treatment|5|||
44251932|NCT01044459|79087583|FG001|Overall Study|Lost to Follow-up|12|||
44251933|NCT00980005|79087591|FG000|Overall Study|Withdrawal by Subject|6|||
44251934|NCT00980005|79087592|FG001|Overall Study|Withdrawal by Subject|17|||
44251935|NCT00980005|79087591|FG000|Overall Study|Lost to Follow-up|37|||
44251936|NCT00980005|79087592|FG001|Overall Study|Lost to Follow-up|43|||
44251937|NCT00980005|79087591|FG000|Overall Study|Other|4|||
44390279|NCT00718042|79396526|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
44390280|NCT00718042|79396527|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
44390281|NCT00718042|79396528|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
44390282|NCT00718042|79396529|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
44390283|NCT00718042|79396524|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
44390284|NCT00718042|79396525|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
44390285|NCT00718042|79396526|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
44390286|NCT00718042|79396527|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
44390287|NCT00718042|79396528|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
44390288|NCT00718042|79396529|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
44390289|NCT00718042|79396524|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
44390290|NCT00718042|79396525|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
44390291|NCT00718042|79396526|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
44390292|NCT00718042|79396527|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
44390293|NCT00718042|79396528|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
44390294|NCT00718042|79396529|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
44390295|NCT00718042|79396524|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
44390296|NCT00718042|79396525|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
44390297|NCT00718042|79396526|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
44390298|NCT00718042|79396527|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
44390299|NCT00718042|79396528|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
44390300|NCT00718042|79396529|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
44390301|NCT00718042|79396524|FG000|Donor Follow-up|Lost to Follow-up|13|||
44390302|NCT00718042|79396525|FG001|Donor Follow-up|Lost to Follow-up|0|||
44390303|NCT00718042|79396526|FG002|Donor Follow-up|Lost to Follow-up|0|||
44519861|NCT00048165|79527605|FG001|Completed 6 Months Study|Refused treatment|5|||
44519862|NCT00048165|79527604|FG000|Completed 6 Months Study|Violation criteria|0|||
44519863|NCT00048165|79527605|FG001|Completed 6 Months Study|Violation criteria|2|||
44519864|NCT00048165|79527604|FG000|Completed 6 Months Study|Did not receive study drug|6|||
44519865|NCT00048165|79527605|FG001|Completed 6 Months Study|Did not receive study drug|6|||
44519866|NCT00048165|79527604|FG000|Completed 12 Months Study|Administration/Other|0|||
44519867|NCT00048165|79527605|FG001|Completed 12 Months Study|Administration/Other|2|||
44519868|NCT00048165|79527604|FG000|Completed 12 Months Study|Death|2|||
44519869|NCT00048165|79527605|FG001|Completed 12 Months Study|Death|1|||
44519870|NCT00048165|79527604|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
44519871|NCT00048165|79527605|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
44519872|NCT00059787|79527613|FG000|Overall Study|Adverse Event|13|||
44519873|NCT00059787|79527613|FG000|Overall Study|disease progression|2|||
44519874|NCT00059787|79527613|FG000|Overall Study|ineligible|1|||
44519875|NCT00059787|79527613|FG000|Overall Study|Other|4|||
44519876|NCT00058539|79527618|FG000|Overall Study|Disease progression|24|||
44519877|NCT00058539|79527618|FG000|Overall Study|Adverse Event|3|||
44519878|NCT00058539|79527618|FG000|Overall Study|Withdrawal by Subject|5|||
44519879|NCT00058539|79527618|FG000|Overall Study|Physician Decision|9|||
44519880|NCT00058539|79527618|FG000|Overall Study|Death|1|||
44519881|NCT03015532|79527630|FG000|Overall Study|Adverse Event|0|||
44519882|NCT03015532|79527631|FG001|Overall Study|Adverse Event|0|||
44519883|NCT03015532|79527632|FG002|Overall Study|Adverse Event|0|||
44519884|NCT03015532|79527633|FG003|Overall Study|Adverse Event|0|||
44519885|NCT03015532|79527634|FG004|Overall Study|Adverse Event|0|||
44519886|NCT03015532|79527635|FG005|Overall Study|Adverse Event|2|||
44519887|NCT03015532|79527636|FG006|Overall Study|Adverse Event|1|||
44519888|NCT03015532|79527637|FG007|Overall Study|Adverse Event|0|||
44519889|NCT03015532|79527630|FG000|Overall Study|Withdrawal by Subject|0|||
44519890|NCT03015532|79527631|FG001|Overall Study|Withdrawal by Subject|0|||
44519891|NCT03015532|79527632|FG002|Overall Study|Withdrawal by Subject|0|||
44519892|NCT03015532|79527633|FG003|Overall Study|Withdrawal by Subject|0|||
44390304|NCT00718042|79396527|FG003|Donor Follow-up|Lost to Follow-up|0|||
44390305|NCT00718042|79396528|FG004|Donor Follow-up|Lost to Follow-up|19|||
44390306|NCT00718042|79396529|FG005|Donor Follow-up|Lost to Follow-up|0|||
44390307|NCT00741598|79396543|FG000|Overall Study|Lost to Follow-up|3|||
44251938|NCT00980005|79087592|FG001|Overall Study|Other|3|||
44390308|NCT00741598|79396544|FG001|Overall Study|Lost to Follow-up|4|||
44390309|NCT00741598|79396543|FG000|Overall Study|Lack of Efficacy|1|||
44390310|NCT00741598|79396544|FG001|Overall Study|Lack of Efficacy|2|||
44519893|NCT03015532|79527634|FG004|Overall Study|Withdrawal by Subject|0|||
44519894|NCT03015532|79527635|FG005|Overall Study|Withdrawal by Subject|0|||
44519895|NCT03015532|79527636|FG006|Overall Study|Withdrawal by Subject|1|||
44519896|NCT03015532|79527637|FG007|Overall Study|Withdrawal by Subject|0|||
44519897|NCT00047463|79527659|FG000|Overall Study|Withdrawal by Subject|0|||
44390311|NCT00741598|79396543|FG000|Overall Study|Physician Decision|1|||
44390312|NCT00741598|79396544|FG001|Overall Study|Physician Decision|1|||
44390313|NCT00741598|79396543|FG000|Overall Study|Pregnancy|1|||
44390314|NCT00741598|79396544|FG001|Overall Study|Pregnancy|0|||
44390315|NCT00741598|79396543|FG000|Overall Study|Withdrawal by Subject|3|||
44390316|NCT00741598|79396544|FG001|Overall Study|Withdrawal by Subject|2|||
44390317|NCT00717886|79396551|FG000|Overall Study|Withdrawal by Subject|3|||
44390318|NCT00717886|79396551|FG000|Overall Study|Treatment Failure|1|||
44390319|NCT00741286|79396557|FG000|Overall Study|Lost to Follow-up|15|||
44390320|NCT00741286|79396558|FG001|Overall Study|Lost to Follow-up|10|||
44390321|NCT00741286|79396557|FG000|Overall Study|Adverse Event|1|||
44390322|NCT00741286|79396558|FG001|Overall Study|Adverse Event|6|||
44390323|NCT00741286|79396557|FG000|Overall Study|Protocol Violation|3|||
44390324|NCT00741286|79396558|FG001|Overall Study|Protocol Violation|2|||
44390325|NCT00741286|79396557|FG000|Overall Study|Primary Outcome|1|||
44390326|NCT00741286|79396558|FG001|Overall Study|Primary Outcome|1|||
44390327|NCT00716482|79396564|FG000|Overall Study|Lost to Follow-up|6|||
44390328|NCT00716482|79396564|FG000|Overall Study|Inadequate acquisition or analysis|50|||
44390329|NCT00716482|79396564|FG000|Overall Study|no pathology obtained|10|||
44390330|NCT00716482|79396564|FG000|Overall Study|technical/machine error|28|||
44390331|NCT00716482|79396564|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
44390332|NCT00716092|79396577|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
44390333|NCT00716092|79396578|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
44390334|NCT00716092|79396579|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
44390335|NCT00715624|79396589|FG000|Overall Study|Adverse Event|12|||
44390336|NCT00715624|79396590|FG001|Overall Study|Adverse Event|37|||
44390337|NCT00715624|79396589|FG000|Overall Study|Lack of Efficacy|11|||
44390338|NCT00715624|79396590|FG001|Overall Study|Lack of Efficacy|11|||
44390339|NCT00715624|79396589|FG000|Overall Study|Lost to Follow-up|1|||
44390340|NCT00715624|79396590|FG001|Overall Study|Lost to Follow-up|2|||
44390341|NCT00715624|79396589|FG000|Overall Study|Protocol Violation|1|||
44390342|NCT00715624|79396590|FG001|Overall Study|Protocol Violation|0|||
44390343|NCT00715624|79396589|FG000|Overall Study|Withdrawal by Subject|11|||
44390344|NCT00715624|79396590|FG001|Overall Study|Withdrawal by Subject|25|||
44390345|NCT00715624|79396589|FG000|Overall Study|Familial and personal reasons|10|||
44390346|NCT00715624|79396590|FG001|Overall Study|Familial and personal reasons|22|||
44390347|NCT00715624|79396589|FG000|Overall Study|Poor compliance|6|||
44390348|NCT00715624|79396590|FG001|Overall Study|Poor compliance|13|||
44390349|NCT00715624|79396589|FG000|Overall Study|Sponsor decision|0|||
44390350|NCT00715624|79396590|FG001|Overall Study|Sponsor decision|4|||
44390351|NCT00715624|79396589|FG000|Overall Study|Incorrect randomization (not treated)|0|||
44390352|NCT00715624|79396590|FG001|Overall Study|Incorrect randomization (not treated)|1|||
44390353|NCT00715624|79396589|FG000|Overall Study|Other|0|||
44390354|NCT00715624|79396590|FG001|Overall Study|Other|1|||
44390355|NCT00576199|79396596|FG000|Overall Study|Adverse Event|12|||
44390356|NCT00576199|79396596|FG000|Overall Study|Insufficient Therapeutic Response|14|||
44390357|NCT00576199|79396596|FG000|Overall Study|Refused Treatment|2|||
44390358|NCT00576199|79396596|FG000|Overall Study|Reason Unspecified|2|||
44390359|NCT00715078|79396603|FG000|Overall Study|Death|29|||
44390360|NCT00715078|79396604|FG001|Overall Study|Death|36|||
44390361|NCT00715078|79396605|FG002|Overall Study|Death|36|||
44390362|NCT00715078|79396603|FG000|Overall Study|Withdrawal by Subject|1|||
44390363|NCT00715078|79396604|FG001|Overall Study|Withdrawal by Subject|0|||
44390364|NCT00715078|79396605|FG002|Overall Study|Withdrawal by Subject|1|||
44390365|NCT00715078|79396603|FG000|Overall Study|Unable to start due to disease prog.|0|||
44390366|NCT00715078|79396604|FG001|Overall Study|Unable to start due to disease prog.|0|||
44390367|NCT00715078|79396605|FG002|Overall Study|Unable to start due to disease prog.|1|||
44251939|NCT01044303|79087602|FG000|Overall Study|Lost to Follow-up|2|||
44519898|NCT00047463|79527660|FG001|Overall Study|Withdrawal by Subject|3|||
44251940|NCT00983437|79087609|FG000|Overall Study|Adverse Event|9|||
44251941|NCT00983437|79087609|FG000|Overall Study|Lack of Efficacy|1|||
44251942|NCT00983437|79087609|FG000|Overall Study|Withdrawal by Subject|8|||
44251943|NCT00983437|79087609|FG000|Overall Study|Noncompliance to Study Procedures|1|||
44390368|NCT00679627|79396615|FG000|Overall Study|Death|41|||
44390369|NCT00679627|79396616|FG001|Overall Study|Death|29|||
44390370|NCT00679627|79396615|FG000|Overall Study|Adverse Event|43|||
44390371|NCT00679627|79396616|FG001|Overall Study|Adverse Event|53|||
44390372|NCT00679627|79396615|FG000|Overall Study|Withdrawal by Subject|168|||
44390373|NCT00679627|79396616|FG001|Overall Study|Withdrawal by Subject|172|||
44390374|NCT00679627|79396615|FG000|Overall Study|Lost to Follow-up|22|||
44390375|NCT00679627|79396616|FG001|Overall Study|Lost to Follow-up|26|||
44390376|NCT00679627|79396615|FG000|Overall Study|Early Study Closure|425|||
44390377|NCT00679627|79396616|FG001|Overall Study|Early Study Closure|405|||
44390378|NCT00714688|79396625|FG000|Overall Study|Lack of Efficacy|14|||
44390379|NCT00714688|79396626|FG001|Overall Study|Lack of Efficacy|1|||
44390380|NCT00714688|79396627|FG002|Overall Study|Lack of Efficacy|4|||
44390381|NCT00714688|79396625|FG000|Overall Study|Withdrawal by Subject|4|||
44390382|NCT00714688|79396626|FG001|Overall Study|Withdrawal by Subject|3|||
44390383|NCT00714688|79396627|FG002|Overall Study|Withdrawal by Subject|3|||
44390384|NCT00714688|79396625|FG000|Overall Study|Lost to Follow-up|5|||
44390385|NCT00714688|79396626|FG001|Overall Study|Lost to Follow-up|2|||
44390386|NCT00714688|79396627|FG002|Overall Study|Lost to Follow-up|0|||
44390387|NCT00714688|79396625|FG000|Overall Study|Adverse Event|2|||
44390388|NCT00714688|79396626|FG001|Overall Study|Adverse Event|15|||
44390389|NCT00714688|79396627|FG002|Overall Study|Adverse Event|19|||
44390390|NCT00714688|79396625|FG000|Overall Study|Subject Non-compliant|3|||
44390391|NCT00714688|79396626|FG001|Overall Study|Subject Non-compliant|5|||
44390392|NCT00714688|79396627|FG002|Overall Study|Subject Non-compliant|5|||
44390393|NCT00714688|79396625|FG000|Overall Study|Ineligible to Continue the Study|0|||
44390394|NCT00714688|79396626|FG001|Overall Study|Ineligible to Continue the Study|1|||
44390395|NCT00714688|79396627|FG002|Overall Study|Ineligible to Continue the Study|1|||
44390396|NCT00714688|79396625|FG000|Overall Study|Sponsor's Decision|0|||
44390397|NCT00714688|79396626|FG001|Overall Study|Sponsor's Decision|2|||
44390398|NCT00714688|79396627|FG002|Overall Study|Sponsor's Decision|0|||
44390399|NCT00714688|79396625|FG000|Overall Study|Other|1|||
44390400|NCT00714688|79396626|FG001|Overall Study|Other|6|||
44390401|NCT00714688|79396627|FG002|Overall Study|Other|5|||
44390402|NCT00679549|79396637|FG000|Overall Study|dropout|2|||
44390403|NCT00679549|79396638|FG001|Overall Study|dropout|4|||
44390404|NCT00679549|79396637|FG000|Overall Study|missing outcome echocardiograms|4|||
44390405|NCT00679549|79396638|FG001|Overall Study|missing outcome echocardiograms|5|||
44390406|NCT01031069|79396648|FG000|Overall Study|Serious Adverse Event|0|||
44390407|NCT01031069|79396649|FG001|Overall Study|Serious Adverse Event|1|||
44390408|NCT01031069|79396650|FG002|Overall Study|Serious Adverse Event|0|||
44390409|NCT01031069|79396651|FG003|Overall Study|Serious Adverse Event|0|||
44390410|NCT01031069|79396648|FG000|Overall Study|Withdrawal by Subject|2|||
44390411|NCT01031069|79396649|FG001|Overall Study|Withdrawal by Subject|3|||
44390412|NCT01031069|79396650|FG002|Overall Study|Withdrawal by Subject|18|||
44390413|NCT01031069|79396651|FG003|Overall Study|Withdrawal by Subject|18|||
44390414|NCT01031069|79396648|FG000|Overall Study|Migrated/moved from study area|1|||
44390415|NCT01031069|79396649|FG001|Overall Study|Migrated/moved from study area|2|||
44390416|NCT01031069|79396650|FG002|Overall Study|Migrated/moved from study area|1|||
44390417|NCT01031069|79396651|FG003|Overall Study|Migrated/moved from study area|1|||
44390418|NCT01031069|79396648|FG000|Overall Study|Lost to Follow-up|9|||
44390419|NCT01031069|79396649|FG001|Overall Study|Lost to Follow-up|5|||
44390420|NCT01031069|79396650|FG002|Overall Study|Lost to Follow-up|21|||
44390421|NCT01031069|79396651|FG003|Overall Study|Lost to Follow-up|15|||
44390422|NCT01031069|79396648|FG000|Overall Study|Other|0|||
44390423|NCT01031069|79396649|FG001|Overall Study|Other|0|||
44390424|NCT01031069|79396650|FG002|Overall Study|Other|1|||
44390425|NCT01031069|79396651|FG003|Overall Study|Other|0|||
44390426|NCT00679081|79396663|FG000|Overall Study|Lost to Follow-up|1|||
44390427|NCT00682435|79396671|FG000|Overall Study|Insufficient data|5|||
44390428|NCT00682435|79396671|FG000|Overall Study|Erroneously enrolled twice|2|||
44390429|NCT00713830|79396677|FG000|Overall Study|Adverse Event|23|||
44390430|NCT00713830|79396678|FG001|Overall Study|Adverse Event|71|||
44390431|NCT00713830|79396677|FG000|Overall Study|Lack of Efficacy|24|||
44390432|NCT00713830|79396678|FG001|Overall Study|Lack of Efficacy|16|||
44390433|NCT00713830|79396677|FG000|Overall Study|Lost to Follow-up|2|||
44390434|NCT00713830|79396678|FG001|Overall Study|Lost to Follow-up|9|||
44390435|NCT00713830|79396677|FG000|Overall Study|Withdrawal by Subject|13|||
44390436|NCT00713830|79396678|FG001|Overall Study|Withdrawal by Subject|23|||
44390437|NCT00713830|79396677|FG000|Overall Study|Poor Compliance to Protocol|7|||
44390438|NCT00713830|79396678|FG001|Overall Study|Poor Compliance to Protocol|14|||
44519899|NCT03015220|79527673|FG000|Overall Study|Withdrawal by Subject|3|||
44519900|NCT03015220|79527674|FG001|Overall Study|Withdrawal by Subject|2|||
44519901|NCT03015220|79527675|FG002|Overall Study|Withdrawal by Subject|2|||
44519902|NCT03015220|79527676|FG003|Overall Study|Withdrawal by Subject|2|||
44519903|NCT03015220|79527673|FG000|Overall Study|Lost to Follow-up|0|||
44519904|NCT03015220|79527674|FG001|Overall Study|Lost to Follow-up|0|||
44519905|NCT03015220|79527675|FG002|Overall Study|Lost to Follow-up|1|||
44519906|NCT03015220|79527676|FG003|Overall Study|Lost to Follow-up|0|||
44519907|NCT00022659|79527686|FG000|Overall Study|Ineligible: wrong primary|1|||
44390439|NCT00713830|79396677|FG000|Overall Study|Familial and Personal Reasons|9|||
44390440|NCT00713830|79396678|FG001|Overall Study|Familial and Personal Reasons|34|||
44390441|NCT00713830|79396677|FG000|Overall Study|Sponsor Decision|4|||
44390442|NCT00713830|79396678|FG001|Overall Study|Sponsor Decision|10|||
44390443|NCT00681811|79396686|FG000|Overall Study|Adverse Event|1|||
44390444|NCT00681811|79396687|FG001|Overall Study|Adverse Event|1|||
44390445|NCT00681811|79396686|FG000|Overall Study|Withdrawal by Subject|2|||
44390446|NCT00681811|79396687|FG001|Overall Study|Withdrawal by Subject|2|||
44390447|NCT00681811|79396686|FG000|Overall Study|Non-compliance|0|||
44390448|NCT00681811|79396687|FG001|Overall Study|Non-compliance|1|||
44390449|NCT00681187|79396706|FG000|Overall Study|Withdrawal by Subject|1|||
44390450|NCT00681187|79396707|FG001|Overall Study|Withdrawal by Subject|0|||
44519908|NCT00022659|79527686|FG000|Overall Study|Never treated|1|||
44390451|NCT00681187|79396706|FG000|Overall Study|Death|0|||
44390452|NCT00681187|79396707|FG001|Overall Study|Death|1|||
44390453|NCT00681187|79396706|FG000|Overall Study|Adverse Event|0|||
44390454|NCT00681187|79396707|FG001|Overall Study|Adverse Event|1|||
44390455|NCT00681109|79396729|FG000|Overall Study|Lost to Follow-up|2|||
44390456|NCT00681109|79396730|FG001|Overall Study|Lost to Follow-up|6|||
44390457|NCT00681109|79396731|FG002|Overall Study|Lost to Follow-up|0|||
44390458|NCT02588950|79396742|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
44390459|NCT02588950|79396743|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
44390460|NCT02588950|79396744|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
44390461|NCT02588950|79396745|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
44390462|NCT02588950|79396742|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
44390463|NCT02588950|79396743|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
44390464|NCT02588950|79396744|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
44280896|NCT01931202|79242105|FG002|Overall Study|Lost to Follow-up|2|||
44280897|NCT01930890|79242120|FG000|Overall Study|Study Termination|14|||
44390465|NCT02588950|79396745|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
44390466|NCT00680407|79396758|FG000|Overall Study|Lost to Follow-up|3|||
44390467|NCT00680407|79396759|FG001|Overall Study|Lost to Follow-up|3|||
44390468|NCT00680407|79396760|FG002|Overall Study|Lost to Follow-up|1|||
44390469|NCT00680407|79396758|FG000|Overall Study|Withdrawal by Subject|5|||
44390470|NCT00680407|79396759|FG001|Overall Study|Withdrawal by Subject|2|||
44390471|NCT00680407|79396760|FG002|Overall Study|Withdrawal by Subject|2|||
44390472|NCT00677365|79396772|FG000|Overall Study|Adverse Event|2|||
44390473|NCT00677365|79396773|FG001|Overall Study|Adverse Event|1|||
44390474|NCT00677365|79396774|FG002|Overall Study|Adverse Event|1|||
44390475|NCT00677365|79396775|FG003|Overall Study|Adverse Event|2|||
44390476|NCT00677365|79396772|FG000|Overall Study|Withdrawal by Subject|0|||
44390477|NCT00677365|79396773|FG001|Overall Study|Withdrawal by Subject|0|||
44390478|NCT00677365|79396774|FG002|Overall Study|Withdrawal by Subject|1|||
44390479|NCT00677365|79396775|FG003|Overall Study|Withdrawal by Subject|0|||
44390480|NCT00677365|79396772|FG000|Overall Study|Other reason|0|||
44390481|NCT00677365|79396773|FG001|Overall Study|Other reason|0|||
44390482|NCT00677365|79396774|FG002|Overall Study|Other reason|0|||
44390483|NCT00677365|79396775|FG003|Overall Study|Other reason|1|||
44390484|NCT00680017|79396787|FG000|Overall Study|Adverse Event|13|||
44390485|NCT00680017|79396788|FG001|Overall Study|Adverse Event|7|||
44390486|NCT00680017|79396787|FG000|Overall Study|Withdrawal by Subject|2|||
44390487|NCT00680017|79396788|FG001|Overall Study|Withdrawal by Subject|5|||
44390488|NCT00680017|79396787|FG000|Overall Study|Lost to Follow-up|2|||
44390489|NCT00680017|79396788|FG001|Overall Study|Lost to Follow-up|0|||
44390490|NCT00676663|79396796|FG000|Overall Study|Death|43|||
44390491|NCT00676663|79396797|FG001|Overall Study|Death|27|||
44390492|NCT00676663|79396796|FG000|Overall Study|Withdrew Consent|1|||
44390493|NCT00676663|79396797|FG001|Overall Study|Withdrew Consent|8|||
44390494|NCT00676663|79396796|FG000|Overall Study|Lost to Follow-up|1|||
44519909|NCT03014674|79527697|FG000|Overall Study|Withdrawal by Subject|1|||
44519910|NCT03014674|79527698|FG001|Overall Study|Withdrawal by Subject|0|||
44519911|NCT03014674|79527699|FG002|Overall Study|Withdrawal by Subject|0|||
44280898|NCT01930890|79242121|FG001|Overall Study|Study Termination|28|||
44280899|NCT01930890|79242122|FG002|Overall Study|Study Termination|13|||
44280900|NCT01930890|79242123|FG003|Overall Study|Study Termination|25|||
44280901|NCT01930890|79242120|FG000|Overall Study|Death|0|||
44280902|NCT01930890|79242121|FG001|Overall Study|Death|0|||
44280903|NCT01930890|79242122|FG002|Overall Study|Death|0|||
44280904|NCT01930890|79242123|FG003|Overall Study|Death|1|||
44280905|NCT01930890|79242120|FG000|Overall Study|Investigator Decision|0|||
44280906|NCT01930890|79242121|FG001|Overall Study|Investigator Decision|1|||
44280907|NCT01930890|79242122|FG002|Overall Study|Investigator Decision|0|||
44280908|NCT01930890|79242123|FG003|Overall Study|Investigator Decision|0|||
44280909|NCT01930890|79242120|FG000|Overall Study|Consent Withdrawn|0|||
44280910|NCT01930890|79242121|FG001|Overall Study|Consent Withdrawn|3|||
44280911|NCT01930890|79242122|FG002|Overall Study|Consent Withdrawn|0|||
44280912|NCT01930890|79242123|FG003|Overall Study|Consent Withdrawn|1|||
44280913|NCT01930890|79242120|FG000|Overall Study|Adverse Event|0|||
44280914|NCT01930890|79242121|FG001|Overall Study|Adverse Event|1|||
44280915|NCT01930890|79242122|FG002|Overall Study|Adverse Event|0|||
44280916|NCT01930890|79242123|FG003|Overall Study|Adverse Event|0|||
44390495|NCT00676663|79396797|FG001|Overall Study|Lost to Follow-up|3|||
44390496|NCT00678691|79396807|FG000|Overall Study|Adverse Event|6|||
44390497|NCT00678691|79396808|FG001|Overall Study|Adverse Event|4|||
44390498|NCT00679939|79396816|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
44390499|NCT00679939|79396817|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
44390500|NCT00679939|79396816|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
44390501|NCT00679939|79396817|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
44390502|NCT00679939|79396816|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
44390503|NCT00679939|79396817|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
44390504|NCT00679939|79396816|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
44519912|NCT03018106|79527709|FG000|Overall Study|Lost to Follow-up|0|||
44390505|NCT00679939|79396817|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
44390506|NCT00679939|79396816|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
44390507|NCT00679939|79396817|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
44390508|NCT00679939|79396816|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
44390509|NCT00679939|79396817|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
44390510|NCT00679939|79396816|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
44390511|NCT00679939|79396817|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
44390512|NCT00679939|79396816|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
44390513|NCT00679939|79396817|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
44390514|NCT00679939|79396816|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
44390515|NCT00679939|79396817|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
44390516|NCT00679939|79396816|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
44390517|NCT00679939|79396817|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
44390518|NCT00673933|79396827|FG000|Overall Study|Withdrawal by Subject|2|||
44390519|NCT00673933|79396827|FG000|Overall Study|Lost to Follow-up|1|||
44390520|NCT00571519|79396840|FG000|Overall Study|Subject withdrew consent|0|||
44390521|NCT00571519|79396841|FG001|Overall Study|Subject withdrew consent|1|||
44390522|NCT00571519|79396842|FG002|Overall Study|Subject withdrew consent|0|||
44390523|NCT00571519|79396843|FG003|Overall Study|Subject withdrew consent|2|||
44390524|NCT00571519|79396844|FG004|Overall Study|Subject withdrew consent|1|||
44390525|NCT00571519|79396845|FG005|Overall Study|Subject withdrew consent|1|||
44390526|NCT00571519|79396846|FG006|Overall Study|Subject withdrew consent|2|||
44390527|NCT00571519|79396840|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
44390528|NCT00571519|79396841|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
44390529|NCT00571519|79396842|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
44390530|NCT00571519|79396843|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
44390531|NCT00571519|79396844|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
44390532|NCT00571519|79396845|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
44390533|NCT00571519|79396846|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
44390534|NCT00571519|79396840|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
44390535|NCT00571519|79396841|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
44390536|NCT00571519|79396842|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
44390537|NCT00571519|79396843|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
44390538|NCT00571519|79396844|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
44390539|NCT00571519|79396845|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
44390540|NCT00571519|79396846|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
44390541|NCT00571519|79396840|FG000|Overall Study|Termination of study by Sponsor|2|||
44390542|NCT00571519|79396841|FG001|Overall Study|Termination of study by Sponsor|7|||
44390543|NCT00571519|79396842|FG002|Overall Study|Termination of study by Sponsor|10|||
44390544|NCT00571519|79396843|FG003|Overall Study|Termination of study by Sponsor|24|||
44390545|NCT00571519|79396844|FG004|Overall Study|Termination of study by Sponsor|8|||
44390546|NCT00571519|79396845|FG005|Overall Study|Termination of study by Sponsor|9|||
44390547|NCT00571519|79396846|FG006|Overall Study|Termination of study by Sponsor|22|||
44390548|NCT00571519|79396840|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
44390549|NCT00571519|79396841|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
44390550|NCT00571519|79396842|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
44519913|NCT03018106|79527710|FG001|Overall Study|Lost to Follow-up|1|||
44519914|NCT03018028|79527719|FG000|Overall Study|Withdrawal by Subject|3|||
44519915|NCT03018028|79527720|FG001|Overall Study|Withdrawal by Subject|0|||
44519916|NCT03018028|79527721|FG002|Overall Study|Withdrawal by Subject|1|||
44519917|NCT03018028|79527722|FG003|Overall Study|Withdrawal by Subject|2|||
44519918|NCT03018028|79527723|FG004|Overall Study|Withdrawal by Subject|0|||
44519919|NCT03010462|79527737|FG000|Overall Study|Withdrawal by Subject|3|||
44519920|NCT03010462|79527738|FG001|Overall Study|Withdrawal by Subject|1|||
44519921|NCT00021255|79527747|FG000|Overall Study|Death|1|||
44519922|NCT00021255|79527748|FG001|Overall Study|Death|0|||
44146553|NCT04430855|78936020|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
44146554|NCT04430855|78936021|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
44146555|NCT01375673|78936031|FG000|Overall Study|Withdrawal by Subject|0|||
44146556|NCT01375673|78936032|FG001|Overall Study|Withdrawal by Subject|1|||
44146557|NCT02723591|78936040|FG000|Overall Study|Adverse Event|48|||
44146558|NCT02723591|78936041|FG001|Overall Study|Adverse Event|40|||
44146559|NCT02723591|78936040|FG000|Overall Study|Death|2|||
44251944|NCT00983437|79087609|FG000|Overall Study|Lost to Follow-up|2|||
44251945|NCT00983437|79087609|FG000|Overall Study|Other Reason|26|||
44519923|NCT00021255|79527749|FG002|Overall Study|Death|2|||
44146560|NCT02723591|78936041|FG001|Overall Study|Death|2|||
44251946|NCT01042977|79087615|FG000|Overall Study|Adverse Event|4|||
44146561|NCT02723591|78936040|FG000|Overall Study|Lack of Efficacy|4|||
44390551|NCT00571519|79396843|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
44390552|NCT00571519|79396844|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
44390553|NCT00571519|79396845|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
44390554|NCT00571519|79396846|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
44390555|NCT00676195|79396862|FG000|Overall Study|Lost to Follow-up|1|||
44390556|NCT00676195|79396862|FG000|Overall Study|Adverse Event|1|||
44390557|NCT00676195|79396862|FG000|Overall Study|Physician Decision|1|||
44390558|NCT00675103|79396867|FG000|Overall Study|Lack of Efficacy|2|||
44390559|NCT00675103|79396867|FG000|Overall Study|Adverse Event|1|||
44390560|NCT00675025|79396873|FG000|Overall Study|Study Terminated by Sponsor|38|||
44390561|NCT00675025|79396874|FG001|Overall Study|Study Terminated by Sponsor|42|||
44390562|NCT00675025|79396873|FG000|Overall Study|Adverse Event|6|||
44390563|NCT00675025|79396874|FG001|Overall Study|Adverse Event|11|||
44390564|NCT00675025|79396873|FG000|Overall Study|Lost to Follow-up|6|||
44390565|NCT00675025|79396874|FG001|Overall Study|Lost to Follow-up|4|||
44390566|NCT00675025|79396873|FG000|Overall Study|Withdrawal by Subject|4|||
44390567|NCT00675025|79396874|FG001|Overall Study|Withdrawal by Subject|6|||
44390568|NCT00678379|79396892|FG000|Overall Study|Injection performed after tonsillectomy|2|||
44390569|NCT00678379|79396893|FG001|Overall Study|Injection performed after tonsillectomy|0|||
44390570|NCT00678379|79396894|FG002|Overall Study|Injection performed after tonsillectomy|1|||
44390571|NCT00678379|79396892|FG000|Overall Study|Incomplete Data|4|||
44390572|NCT00678379|79396893|FG001|Overall Study|Incomplete Data|3|||
44390573|NCT00678379|79396894|FG002|Overall Study|Incomplete Data|3|||
44390574|NCT00674323|79396905|FG000|Overall Study|Adverse Event|0|||
44390575|NCT00674323|79396906|FG001|Overall Study|Adverse Event|1|||
44390576|NCT00674323|79396907|FG002|Overall Study|Adverse Event|0|||
44390577|NCT00674323|79396905|FG000|Overall Study|Protocol Violation|1|||
44390578|NCT00674323|79396906|FG001|Overall Study|Protocol Violation|0|||
44390579|NCT00674323|79396907|FG002|Overall Study|Protocol Violation|0|||
44390580|NCT00678301|79396917|FG000|Overall Study|Non-compliance with study procedures|0|||
44390581|NCT00678301|79396918|FG001|Overall Study|Non-compliance with study procedures|1|||
44390582|NCT00678301|79396917|FG000|Overall Study|Adverse Event|1|||
44390583|NCT00678301|79396918|FG001|Overall Study|Adverse Event|0|||
44390584|NCT00678301|79396917|FG000|Overall Study|Withdrawal by Subject|4|||
44390585|NCT00678301|79396918|FG001|Overall Study|Withdrawal by Subject|0|||
44390586|NCT00678301|79396917|FG000|Overall Study|Lost to Follow-up|3|||
44390587|NCT00678301|79396918|FG001|Overall Study|Lost to Follow-up|1|||
44390588|NCT00939770|79396932|FG000|Overall Study|Adverse Event|1|||
44390589|NCT00939770|79396933|FG001|Overall Study|Adverse Event|1|||
44390590|NCT00939770|79396934|FG002|Overall Study|Adverse Event|0|||
44390591|NCT00939770|79396935|FG003|Overall Study|Adverse Event|0|||
44390592|NCT00939770|79396936|FG004|Overall Study|Adverse Event|6|||
44390593|NCT00939770|79396937|FG005|Overall Study|Adverse Event|2|||
44390594|NCT00939770|79396938|FG006|Overall Study|Adverse Event|1|||
44390595|NCT00939770|79396939|FG007|Overall Study|Adverse Event|1|||
44390596|NCT00939770|79396932|FG000|Overall Study|Lack of Efficacy|4|||
44390597|NCT00939770|79396933|FG001|Overall Study|Lack of Efficacy|6|||
44390598|NCT00939770|79396934|FG002|Overall Study|Lack of Efficacy|13|||
44390599|NCT00939770|79396935|FG003|Overall Study|Lack of Efficacy|9|||
44390600|NCT00939770|79396936|FG004|Overall Study|Lack of Efficacy|16|||
44390601|NCT00939770|79396937|FG005|Overall Study|Lack of Efficacy|8|||
44390602|NCT00939770|79396938|FG006|Overall Study|Lack of Efficacy|11|||
44390603|NCT00939770|79396939|FG007|Overall Study|Lack of Efficacy|1|||
44390604|NCT00939770|79396932|FG000|Overall Study|Lost to Follow-up|0|||
44390605|NCT00939770|79396933|FG001|Overall Study|Lost to Follow-up|0|||
44390606|NCT00939770|79396934|FG002|Overall Study|Lost to Follow-up|0|||
44390607|NCT00939770|79396935|FG003|Overall Study|Lost to Follow-up|0|||
44390608|NCT00939770|79396936|FG004|Overall Study|Lost to Follow-up|1|||
44390609|NCT00939770|79396937|FG005|Overall Study|Lost to Follow-up|0|||
44390610|NCT00939770|79396938|FG006|Overall Study|Lost to Follow-up|0|||
44390611|NCT00939770|79396939|FG007|Overall Study|Lost to Follow-up|0|||
44390612|NCT00939770|79396932|FG000|Overall Study|Physician Decision|0|||
44390613|NCT00939770|79396933|FG001|Overall Study|Physician Decision|0|||
44390614|NCT00939770|79396934|FG002|Overall Study|Physician Decision|2|||
44390615|NCT00939770|79396935|FG003|Overall Study|Physician Decision|0|||
44390616|NCT00939770|79396936|FG004|Overall Study|Physician Decision|7|||
44390617|NCT00939770|79396937|FG005|Overall Study|Physician Decision|1|||
44390618|NCT00939770|79396938|FG006|Overall Study|Physician Decision|0|||
44146562|NCT02723591|78936041|FG001|Overall Study|Lack of Efficacy|3|||
44146563|NCT02723591|78936040|FG000|Overall Study|Lost to Follow-up|1|||
44146564|NCT02723591|78936041|FG001|Overall Study|Lost to Follow-up|7|||
44146565|NCT02723591|78936040|FG000|Overall Study|Protocol Violation|20|||
44146566|NCT02723591|78936041|FG001|Overall Study|Protocol Violation|23|||
44146567|NCT02723591|78936040|FG000|Overall Study|Withdrawal by Subject|4|||
44146568|NCT02723591|78936041|FG001|Overall Study|Withdrawal by Subject|8|||
44390619|NCT00939770|79396939|FG007|Overall Study|Physician Decision|6|||
44390620|NCT00939770|79396932|FG000|Overall Study|Protocol Violation|0|||
44390621|NCT00939770|79396933|FG001|Overall Study|Protocol Violation|0|||
44390622|NCT00939770|79396934|FG002|Overall Study|Protocol Violation|0|||
44390623|NCT00939770|79396935|FG003|Overall Study|Protocol Violation|0|||
44390624|NCT00939770|79396936|FG004|Overall Study|Protocol Violation|1|||
44390625|NCT00939770|79396937|FG005|Overall Study|Protocol Violation|0|||
44390626|NCT00939770|79396938|FG006|Overall Study|Protocol Violation|0|||
44390627|NCT00939770|79396939|FG007|Overall Study|Protocol Violation|0|||
44390628|NCT00939770|79396932|FG000|Overall Study|Withdrawal by Subject|0|||
44390629|NCT00939770|79396933|FG001|Overall Study|Withdrawal by Subject|1|||
44390630|NCT00939770|79396934|FG002|Overall Study|Withdrawal by Subject|5|||
44390631|NCT00939770|79396935|FG003|Overall Study|Withdrawal by Subject|2|||
44390632|NCT00939770|79396936|FG004|Overall Study|Withdrawal by Subject|6|||
44390633|NCT00939770|79396937|FG005|Overall Study|Withdrawal by Subject|0|||
44390634|NCT00939770|79396938|FG006|Overall Study|Withdrawal by Subject|2|||
44390635|NCT00939770|79396939|FG007|Overall Study|Withdrawal by Subject|2|||
44390636|NCT00939692|79396972|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
44390637|NCT00939692|79396973|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
44390638|NCT00939692|79396972|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
44390639|NCT00939692|79396973|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
44390640|NCT04672252|79396981|FG000|Overall Study|Protocol Violation|1|||
44390641|NCT04672252|79396982|FG001|Overall Study|Protocol Violation|0|||
44390642|NCT00584740|79396990|FG000|Overall Study|Adverse Event|1|||
44390643|NCT00584740|79396991|FG001|Overall Study|Adverse Event|1|||
44390644|NCT00584740|79396990|FG000|Overall Study|Lack of Efficacy|8|||
44390645|NCT00584740|79396991|FG001|Overall Study|Lack of Efficacy|2|||
44390646|NCT00584740|79396990|FG000|Overall Study|Withdrawal by Subject|3|||
44390647|NCT00584740|79396991|FG001|Overall Study|Withdrawal by Subject|2|||
44390648|NCT00584740|79396990|FG000|Overall Study|Lost to Follow-up|0|||
44390649|NCT00584740|79396991|FG001|Overall Study|Lost to Follow-up|1|||
44390650|NCT00942968|79396997|FG000|Overall Study|Adverse Event|60|||
44390651|NCT00942968|79396997|FG000|Overall Study|Death|76|||
44390652|NCT00942968|79396997|FG000|Overall Study|Protocol Violation|9|||
44390653|NCT00942968|79396997|FG000|Overall Study|Lost to Follow-up|4|||
44390654|NCT00942968|79396997|FG000|Overall Study|Withdrawal by Subject|44|||
44390655|NCT00942968|79396997|FG000|Overall Study|Sponsor request|5|||
44390656|NCT00942968|79396997|FG000|Overall Study|Physician Decision|11|||
44390657|NCT00942968|79396997|FG000|Overall Study|Progression of disease|12|||
44390658|NCT00942968|79396997|FG000|Overall Study|Inferior vena cava filter placement|4|||
44390659|NCT00942968|79396997|FG000|Overall Study|Pulmonary embolism (PE)|1|||
44390660|NCT00942968|79396997|FG000|Overall Study|Participant required pancreatic biopsy|1|||
44390661|NCT00942968|79396997|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
44519924|NCT00021255|79527747|FG000|Overall Study|Breast cancer relapse|5|||
44519925|NCT00021255|79527748|FG001|Overall Study|Breast cancer relapse|18|||
44519926|NCT00021255|79527749|FG002|Overall Study|Breast cancer relapse|11|||
44519927|NCT00021255|79527747|FG000|Overall Study|Second primary malignancy|0|||
44519928|NCT00021255|79527748|FG001|Overall Study|Second primary malignancy|4|||
44519929|NCT00021255|79527749|FG002|Overall Study|Second primary malignancy|1|||
44519930|NCT00021255|79527747|FG000|Overall Study|Withdrawal by Subject|41|||
44519931|NCT00021255|79527748|FG001|Overall Study|Withdrawal by Subject|64|||
44519932|NCT00021255|79527749|FG002|Overall Study|Withdrawal by Subject|26|||
44519933|NCT00021255|79527747|FG000|Overall Study|Lost to Follow-up|0|||
44519934|NCT00021255|79527748|FG001|Overall Study|Lost to Follow-up|2|||
44519935|NCT00021255|79527749|FG002|Overall Study|Lost to Follow-up|3|||
44519936|NCT00021255|79527747|FG000|Overall Study|Cardiac toxicity|0|||
44519937|NCT00021255|79527748|FG001|Overall Study|Cardiac toxicity|61|||
44519938|NCT00021255|79527749|FG002|Overall Study|Cardiac toxicity|32|||
44519939|NCT00021255|79527747|FG000|Overall Study|Herceptin toxicity|0|||
44519940|NCT00021255|79527748|FG001|Overall Study|Herceptin toxicity|22|||
44390662|NCT00942734|79397001|FG000|Overall Study|Adverse Event|2|||
44390663|NCT00942734|79397001|FG000|Overall Study|Protocol Violation|3|||
44390664|NCT00942734|79397001|FG000|Overall Study|Disease Progression|2|||
44390665|NCT00942734|79397001|FG000|Overall Study|Physician Decision|1|||
44390666|NCT00584194|79397005|FG000|Overall Study|Other|135|||
44390667|NCT00942422|79397009|FG000|Overall Study|Withdrawal by Subject|1|||
44390668|NCT00942422|79397009|FG000|Overall Study|Death|1|||
44390669|NCT00942422|79397009|FG000|Overall Study|Progressive diease|1|||
44390670|NCT00677833|79397017|FG000|Overall Study|Withdrawal by Subject|4|||
44390671|NCT00677833|79397018|FG001|Overall Study|Withdrawal by Subject|0|||
44390672|NCT00677833|79397019|FG002|Overall Study|Withdrawal by Subject|1|||
44390673|NCT00677833|79397020|FG003|Overall Study|Withdrawal by Subject|3|||
44390674|NCT00677833|79397017|FG000|Overall Study|Lost to Follow-up|0|||
44390675|NCT00677833|79397018|FG001|Overall Study|Lost to Follow-up|0|||
44390676|NCT00677833|79397019|FG002|Overall Study|Lost to Follow-up|1|||
44519941|NCT00021255|79527749|FG002|Overall Study|Herceptin toxicity|6|||
44519942|NCT00021255|79527747|FG000|Overall Study|Adverse Event|46|||
44519943|NCT00021255|79527748|FG001|Overall Study|Adverse Event|30|||
44519944|NCT00021255|79527749|FG002|Overall Study|Adverse Event|18|||
44390677|NCT00677833|79397020|FG003|Overall Study|Lost to Follow-up|0|||
44390678|NCT00942266|79397030|FG000|Overall Study|Withdrawal by Subject|1|||
44390679|NCT00942266|79397031|FG001|Overall Study|Withdrawal by Subject|0|||
44390680|NCT00942266|79397030|FG000|Overall Study|Adverse Event|2|||
44390681|NCT00942266|79397031|FG001|Overall Study|Adverse Event|1|||
44390682|NCT00942266|79397030|FG000|Overall Study|Disease Progression|38|||
44390683|NCT00942266|79397031|FG001|Overall Study|Disease Progression|11|||
44390684|NCT00942266|79397030|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
44390685|NCT00942266|79397031|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
44390686|NCT00942266|79397030|FG000|Overall Study|Intercurrent illness|0|||
44390687|NCT00942266|79397031|FG001|Overall Study|Intercurrent illness|1|||
44390688|NCT00942266|79397030|FG000|Overall Study|Physician Decision|2|||
44390689|NCT00942266|79397031|FG001|Overall Study|Physician Decision|0|||
44390690|NCT00942266|79397030|FG000|Overall Study|medical deterioration (pneumonia)|0|||
44390691|NCT00942266|79397031|FG001|Overall Study|medical deterioration (pneumonia)|1|||
44390692|NCT00942188|79397041|FG000|Overall Study|Adverse Event|0|||
44390693|NCT00942188|79397042|FG001|Overall Study|Adverse Event|3|||
44390694|NCT00942188|79397043|FG002|Overall Study|Adverse Event|2|||
44390695|NCT00942188|79397044|FG003|Overall Study|Adverse Event|0|||
44390696|NCT00942188|79397041|FG000|Overall Study|Lack of Efficacy|0|||
44390697|NCT00942188|79397042|FG001|Overall Study|Lack of Efficacy|0|||
44390698|NCT00942188|79397043|FG002|Overall Study|Lack of Efficacy|0|||
44390699|NCT00942188|79397044|FG003|Overall Study|Lack of Efficacy|1|||
44390700|NCT00942188|79397041|FG000|Overall Study|Protocol Violation|1|||
44390701|NCT00942188|79397042|FG001|Overall Study|Protocol Violation|1|||
44390702|NCT00942188|79397043|FG002|Overall Study|Protocol Violation|0|||
44390703|NCT00942188|79397044|FG003|Overall Study|Protocol Violation|0|||
44390704|NCT00942188|79397041|FG000|Overall Study|Lost to Follow-up|2|||
44390705|NCT00942188|79397042|FG001|Overall Study|Lost to Follow-up|1|||
44390706|NCT00942188|79397043|FG002|Overall Study|Lost to Follow-up|2|||
44390707|NCT00942188|79397044|FG003|Overall Study|Lost to Follow-up|0|||
44390708|NCT00942188|79397041|FG000|Overall Study|Withdrawal by Subject|1|||
44390709|NCT00942188|79397042|FG001|Overall Study|Withdrawal by Subject|3|||
44390710|NCT00942188|79397043|FG002|Overall Study|Withdrawal by Subject|4|||
44390711|NCT00942188|79397044|FG003|Overall Study|Withdrawal by Subject|2|||
44390712|NCT00942188|79397041|FG000|Overall Study|Physician Decision|0|||
44390713|NCT00942188|79397042|FG001|Overall Study|Physician Decision|0|||
44390714|NCT00942188|79397043|FG002|Overall Study|Physician Decision|1|||
44390715|NCT00942188|79397044|FG003|Overall Study|Physician Decision|0|||
44390716|NCT00942188|79397041|FG000|Overall Study|Sponsor Decision|0|||
44390717|NCT00942188|79397042|FG001|Overall Study|Sponsor Decision|2|||
44390718|NCT00942188|79397043|FG002|Overall Study|Sponsor Decision|0|||
44390719|NCT00942188|79397044|FG003|Overall Study|Sponsor Decision|1|||
44390720|NCT00673231|79397058|FG000|Overall Study|Withdrawal by Subject|14|||
44390721|NCT00673231|79397059|FG001|Overall Study|Withdrawal by Subject|10|||
44390722|NCT00673231|79397060|FG002|Overall Study|Withdrawal by Subject|8|||
44390723|NCT00673231|79397061|FG003|Overall Study|Withdrawal by Subject|6|||
44390724|NCT00673231|79397058|FG000|Overall Study|Adverse Event|6|||
44390725|NCT00673231|79397059|FG001|Overall Study|Adverse Event|5|||
44390726|NCT00673231|79397060|FG002|Overall Study|Adverse Event|9|||
44390727|NCT00673231|79397061|FG003|Overall Study|Adverse Event|6|||
44390728|NCT00673231|79397058|FG000|Overall Study|Lost to Follow-up|1|||
44390729|NCT00673231|79397059|FG001|Overall Study|Lost to Follow-up|2|||
44390730|NCT00673231|79397060|FG002|Overall Study|Lost to Follow-up|1|||
44390731|NCT00673231|79397061|FG003|Overall Study|Lost to Follow-up|2|||
44390732|NCT00673231|79397058|FG000|Overall Study|Death|0|||
44390733|NCT00673231|79397059|FG001|Overall Study|Death|0|||
44390734|NCT00673231|79397060|FG002|Overall Study|Death|1|||
44390735|NCT00673231|79397061|FG003|Overall Study|Death|0|||
44390736|NCT00673231|79397058|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
44390737|NCT00673231|79397059|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
44390738|NCT00673231|79397060|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
44390739|NCT00673231|79397061|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
44390740|NCT00672841|79397073|FG000|Overall Study|Comfort care|1|||
44390741|NCT00672841|79397074|FG001|Overall Study|Comfort care|4|||
44390742|NCT00672841|79397073|FG000|Overall Study|icteric specimens|0|||
44390743|NCT00672841|79397074|FG001|Overall Study|icteric specimens|3|||
44390744|NCT00672841|79397073|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
44390745|NCT00672841|79397074|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
44390746|NCT00672841|79397073|FG000|Overall Study|Adverse Event|0|||
44390747|NCT00672841|79397074|FG001|Overall Study|Adverse Event|3|||
44390748|NCT00672841|79397073|FG000|Overall Study|Pregnancy|0|||
44390749|NCT00672841|79397074|FG001|Overall Study|Pregnancy|1|||
44390750|NCT00673465|79397083|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390751|NCT00673465|79397084|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390752|NCT00673465|79397085|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390753|NCT00673465|79397086|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390754|NCT00673465|79397087|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
44390755|NCT00673465|79397088|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
44390756|NCT00673465|79397089|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390757|NCT00673465|79397090|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390758|NCT00673465|79397091|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390759|NCT00673465|79397092|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390760|NCT00673465|79397093|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390761|NCT00673465|79397094|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
44390762|NCT00673465|79397083|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390763|NCT00673465|79397084|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390764|NCT00673465|79397085|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390765|NCT00673465|79397086|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390766|NCT00673465|79397087|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
44390767|NCT00673465|79397088|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390768|NCT00673465|79397089|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390769|NCT00673465|79397090|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390770|NCT00673465|79397091|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390771|NCT00673465|79397092|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390772|NCT00673465|79397093|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390773|NCT00673465|79397094|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
44390774|NCT00941798|79397104|FG000|Overall Study|Withdrawal by Subject|72|||
44390775|NCT00941798|79397105|FG001|Overall Study|Withdrawal by Subject|74|||
44390776|NCT00941798|79397104|FG000|Overall Study|Adverse Event|43|||
44390777|NCT00941798|79397105|FG001|Overall Study|Adverse Event|23|||
44390778|NCT00941798|79397104|FG000|Overall Study|Lost to Follow-up|29|||
44390779|NCT00941798|79397105|FG001|Overall Study|Lost to Follow-up|23|||
44390780|NCT00941798|79397104|FG000|Overall Study|Protocol Violation|17|||
44390781|NCT00941798|79397105|FG001|Overall Study|Protocol Violation|20|||
44390782|NCT00941798|79397104|FG000|Overall Study|Administrative problems|13|||
44390783|NCT00941798|79397105|FG001|Overall Study|Administrative problems|23|||
44390784|NCT00941798|79397104|FG000|Overall Study|Lack of Efficacy|10|||
44390785|NCT00941798|79397105|FG001|Overall Study|Lack of Efficacy|17|||
44390786|NCT00941798|79397104|FG000|Overall Study|Patient's inability to use device|6|||
44390787|NCT00941798|79397105|FG001|Overall Study|Patient's inability to use device|1|||
44146569|NCT02723591|78936040|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
44146570|NCT02723591|78936041|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
44146571|NCT02723591|78936040|FG000|Overall Study|Miscellaneous|5|||
44251947|NCT01042977|79087616|FG001|Overall Study|Adverse Event|12|||
44251948|NCT01042977|79087615|FG000|Overall Study|Death|2|||
44390788|NCT00941798|79397104|FG000|Overall Study|Abnormal test procedure results|3|||
44390789|NCT00941798|79397105|FG001|Overall Study|Abnormal test procedure results|1|||
44390790|NCT00941798|79397104|FG000|Overall Study|Abnormal laboratory values|1|||
44390791|NCT00941798|79397105|FG001|Overall Study|Abnormal laboratory values|2|||
44390792|NCT00941798|79397104|FG000|Overall Study|Death|0|||
44390793|NCT00941798|79397105|FG001|Overall Study|Death|1|||
44390794|NCT00583102|79397111|FG000|Overall Study|Adverse Event|3|||
44390795|NCT05208866|79397119|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
44390796|NCT04745351|79397134|FG000|Overall Study|Death|51|||
44390797|NCT04745351|79397135|FG001|Overall Study|Death|25|||
44390798|NCT04745351|79397134|FG000|Overall Study|Lost to Follow-up|9|||
44390799|NCT04745351|79397135|FG001|Overall Study|Lost to Follow-up|3|||
44390800|NCT04745351|79397134|FG000|Overall Study|Randomized but Never Treated|3|||
44390801|NCT04745351|79397135|FG001|Overall Study|Randomized but Never Treated|3|||
44390802|NCT04745351|79397134|FG000|Overall Study|Adverse Event|4|||
44390803|NCT04745351|79397135|FG001|Overall Study|Adverse Event|0|||
44390804|NCT04745351|79397134|FG000|Overall Study|Withdrew Consent|1|||
44390805|NCT04745351|79397135|FG001|Overall Study|Withdrew Consent|2|||
44390806|NCT04745351|79397134|FG000|Overall Study|Investigator's Discretion|2|||
44390807|NCT04745351|79397135|FG001|Overall Study|Investigator's Discretion|0|||
44390808|NCT04745351|79397134|FG000|Overall Study|Protocol Violation|1|||
44390809|NCT04745351|79397135|FG001|Overall Study|Protocol Violation|0|||
44390810|NCT04427501|79397160|FG000|Overall Study|Death|0|||
44390811|NCT04427501|79397161|FG001|Overall Study|Death|0|||
44390812|NCT04427501|79397162|FG002|Overall Study|Death|0|||
44390813|NCT04427501|79397163|FG003|Overall Study|Death|0|||
44390814|NCT04427501|79397164|FG004|Overall Study|Death|0|||
44390815|NCT04427501|79397165|FG005|Overall Study|Death|15|||
44146572|NCT02723591|78936041|FG001|Overall Study|Miscellaneous|6|||
44251949|NCT01042977|79087616|FG001|Overall Study|Death|1|||
44251950|NCT01042977|79087615|FG000|Overall Study|Withdrawal by Subject|8|||
44390816|NCT04427501|79397166|FG006|Overall Study|Death|0|||
44390817|NCT04427501|79397167|FG007|Overall Study|Death|0|||
44251951|NCT01042977|79087616|FG001|Overall Study|Withdrawal by Subject|16|||
44390818|NCT04427501|79397168|FG008|Overall Study|Death|0|||
44390819|NCT04427501|79397169|FG009|Overall Study|Death|0|||
44390820|NCT04427501|79397160|FG000|Overall Study|Lost to Follow-up|5|||
44390821|NCT04427501|79397161|FG001|Overall Study|Lost to Follow-up|1|||
44390822|NCT04427501|79397162|FG002|Overall Study|Lost to Follow-up|2|||
44390823|NCT04427501|79397163|FG003|Overall Study|Lost to Follow-up|0|||
44390824|NCT04427501|79397164|FG004|Overall Study|Lost to Follow-up|2|||
44390825|NCT04427501|79397165|FG005|Overall Study|Lost to Follow-up|11|||
44390826|NCT04427501|79397166|FG006|Overall Study|Lost to Follow-up|10|||
44390827|NCT04427501|79397167|FG007|Overall Study|Lost to Follow-up|10|||
44390828|NCT04427501|79397168|FG008|Overall Study|Lost to Follow-up|2|||
44390829|NCT04427501|79397169|FG009|Overall Study|Lost to Follow-up|5|||
44390830|NCT04427501|79397160|FG000|Overall Study|Physician Decision|0|||
44390831|NCT04427501|79397161|FG001|Overall Study|Physician Decision|3|||
44390832|NCT04427501|79397162|FG002|Overall Study|Physician Decision|0|||
44390833|NCT04427501|79397163|FG003|Overall Study|Physician Decision|0|||
44390834|NCT04427501|79397164|FG004|Overall Study|Physician Decision|0|||
44390835|NCT04427501|79397165|FG005|Overall Study|Physician Decision|0|||
44390836|NCT04427501|79397166|FG006|Overall Study|Physician Decision|2|||
44390837|NCT04427501|79397167|FG007|Overall Study|Physician Decision|0|||
44390838|NCT04427501|79397168|FG008|Overall Study|Physician Decision|0|||
44390839|NCT04427501|79397169|FG009|Overall Study|Physician Decision|0|||
44390840|NCT04427501|79397160|FG000|Overall Study|Withdrawal by Subject|9|||
44390841|NCT04427501|79397161|FG001|Overall Study|Withdrawal by Subject|2|||
44390842|NCT04427501|79397162|FG002|Overall Study|Withdrawal by Subject|2|||
44390843|NCT04427501|79397163|FG003|Overall Study|Withdrawal by Subject|3|||
44390844|NCT04427501|79397164|FG004|Overall Study|Withdrawal by Subject|7|||
44390845|NCT04427501|79397165|FG005|Overall Study|Withdrawal by Subject|25|||
44390846|NCT04427501|79397166|FG006|Overall Study|Withdrawal by Subject|15|||
44390847|NCT04427501|79397167|FG007|Overall Study|Withdrawal by Subject|7|||
44390848|NCT04427501|79397168|FG008|Overall Study|Withdrawal by Subject|4|||
44390849|NCT04427501|79397169|FG009|Overall Study|Withdrawal by Subject|1|||
44390850|NCT04427501|79397160|FG000|Overall Study|Other - as reported by the investigator|1|||
44390851|NCT04427501|79397161|FG001|Overall Study|Other - as reported by the investigator|0|||
44390852|NCT04427501|79397162|FG002|Overall Study|Other - as reported by the investigator|0|||
44390853|NCT04427501|79397163|FG003|Overall Study|Other - as reported by the investigator|0|||
44519945|NCT00021255|79527747|FG000|Overall Study|Protocol Violation|0|||
44519946|NCT00021255|79527748|FG001|Overall Study|Protocol Violation|2|||
44519947|NCT00021255|79527749|FG002|Overall Study|Protocol Violation|0|||
44519948|NCT00021255|79527747|FG000|Overall Study|Other than specified above|0|||
44519949|NCT00021255|79527748|FG001|Overall Study|Other than specified above|38|||
44519950|NCT00021255|79527749|FG002|Overall Study|Other than specified above|19|||
44519951|NCT00021255|79527747|FG000|Overall Study|Missing|0|||
44519952|NCT00021255|79527748|FG001|Overall Study|Missing|27|||
44519953|NCT00021255|79527749|FG002|Overall Study|Missing|13|||
44519954|NCT00021255|79527747|FG000|Overall Study|Randomized but not treated|28|||
44519955|NCT00021255|79527748|FG001|Overall Study|Randomized but not treated|2|||
44519956|NCT00021255|79527749|FG002|Overall Study|Randomized but not treated|18|||
44519957|NCT03012334|79527767|FG000|Period 1|Withdrawal by Subject|0|||
44519958|NCT03012334|79527768|FG001|Period 1|Withdrawal by Subject|0|||
44519959|NCT03012334|79527769|FG002|Period 1|Withdrawal by Subject|0|||
44390854|NCT04427501|79397164|FG004|Overall Study|Other - as reported by the investigator|0|||
44390855|NCT04427501|79397165|FG005|Overall Study|Other - as reported by the investigator|6|||
44390856|NCT04427501|79397166|FG006|Overall Study|Other - as reported by the investigator|6|||
44390857|NCT04427501|79397167|FG007|Overall Study|Other - as reported by the investigator|0|||
44390858|NCT04427501|79397168|FG008|Overall Study|Other - as reported by the investigator|0|||
44519960|NCT03012334|79527770|FG003|Period 1|Withdrawal by Subject|0|||
44519961|NCT03012334|79527771|FG004|Period 1|Withdrawal by Subject|0|||
44519962|NCT03012334|79527772|FG005|Period 1|Withdrawal by Subject|0|||
44519963|NCT03012334|79527773|FG006|Period 1|Withdrawal by Subject|0|||
44519964|NCT03012334|79527774|FG007|Period 1|Withdrawal by Subject|0|||
44519965|NCT03012334|79527775|FG008|Period 1|Withdrawal by Subject|0|||
44519966|NCT03012334|79527776|FG009|Period 1|Withdrawal by Subject|1|||
44519967|NCT03012334|79527767|FG000|Period 2|Withdrawal by Subject|0|||
44519968|NCT03012334|79527768|FG001|Period 2|Withdrawal by Subject|1|||
44519969|NCT03012334|79527769|FG002|Period 2|Withdrawal by Subject|0|||
44519970|NCT03012334|79527770|FG003|Period 2|Withdrawal by Subject|0|||
44519971|NCT03012334|79527771|FG004|Period 2|Withdrawal by Subject|0|||
44519972|NCT03012334|79527772|FG005|Period 2|Withdrawal by Subject|0|||
44519973|NCT03012334|79527773|FG006|Period 2|Withdrawal by Subject|0|||
44519974|NCT03012334|79527774|FG007|Period 2|Withdrawal by Subject|0|||
44519975|NCT03012334|79527775|FG008|Period 2|Withdrawal by Subject|0|||
44519976|NCT03012334|79527776|FG009|Period 2|Withdrawal by Subject|0|||
44519977|NCT03012334|79527767|FG000|Period 2|Protocol Violation|0|||
44519978|NCT03012334|79527768|FG001|Period 2|Protocol Violation|0|||
44519979|NCT03012334|79527769|FG002|Period 2|Protocol Violation|1|||
44519980|NCT03012334|79527770|FG003|Period 2|Protocol Violation|0|||
44519981|NCT03012334|79527771|FG004|Period 2|Protocol Violation|0|||
44519982|NCT03012334|79527772|FG005|Period 2|Protocol Violation|0|||
44519983|NCT03012334|79527773|FG006|Period 2|Protocol Violation|0|||
44519984|NCT03012334|79527774|FG007|Period 2|Protocol Violation|1|||
44519985|NCT03012334|79527775|FG008|Period 2|Protocol Violation|0|||
44519986|NCT03012334|79527776|FG009|Period 2|Protocol Violation|0|||
44519987|NCT03012334|79527767|FG000|Period 4|Non-Compliance|0|||
44519988|NCT03012334|79527768|FG001|Period 4|Non-Compliance|0|||
44519989|NCT03012334|79527769|FG002|Period 4|Non-Compliance|0|||
44519990|NCT03012334|79527770|FG003|Period 4|Non-Compliance|0|||
44519991|NCT03012334|79527771|FG004|Period 4|Non-Compliance|0|||
44519992|NCT03012334|79527772|FG005|Period 4|Non-Compliance|0|||
44519993|NCT03012334|79527773|FG006|Period 4|Non-Compliance|1|||
44519994|NCT03012334|79527774|FG007|Period 4|Non-Compliance|0|||
44519995|NCT03012334|79527775|FG008|Period 4|Non-Compliance|0|||
44519996|NCT03012334|79527776|FG009|Period 4|Non-Compliance|0|||
44519997|NCT03012334|79527767|FG000|Period 4|Adverse Event|0|||
44519998|NCT03012334|79527768|FG001|Period 4|Adverse Event|0|||
44519999|NCT03012334|79527769|FG002|Period 4|Adverse Event|0|||
44520000|NCT03012334|79527770|FG003|Period 4|Adverse Event|0|||
44520001|NCT03012334|79527771|FG004|Period 4|Adverse Event|0|||
44520002|NCT03012334|79527772|FG005|Period 4|Adverse Event|0|||
44520003|NCT03012334|79527773|FG006|Period 4|Adverse Event|0|||
44520004|NCT03012334|79527774|FG007|Period 4|Adverse Event|0|||
44520005|NCT03012334|79527775|FG008|Period 4|Adverse Event|1|||
44520006|NCT03012334|79527776|FG009|Period 4|Adverse Event|0|||
44520007|NCT03565068|79527798|FG000|Overall Study|Protocol Violation|0|||
44520008|NCT03565068|79527799|FG001|Overall Study|Protocol Violation|0|||
44520009|NCT03565068|79527800|FG002|Overall Study|Protocol Violation|0|||
44520010|NCT03565068|79527801|FG003|Overall Study|Protocol Violation|0|||
44520011|NCT03565068|79527802|FG004|Overall Study|Protocol Violation|1|||
44520012|NCT03565068|79527803|FG005|Overall Study|Protocol Violation|0|||
44520013|NCT03565068|79527804|FG006|Overall Study|Protocol Violation|0|||
44520014|NCT03565068|79527805|FG007|Overall Study|Protocol Violation|1|||
44520015|NCT03565068|79527806|FG008|Overall Study|Protocol Violation|0|||
44390859|NCT04427501|79397169|FG009|Overall Study|Other - as reported by the investigator|0|||
44390860|NCT03439124|79397221|FG000|Overall Study|Adverse Event|2|||
44390861|NCT03439124|79397222|FG001|Overall Study|Adverse Event|0|||
44390862|NCT03439124|79397221|FG000|Overall Study|Lost to Follow-up|1|||
44390863|NCT03439124|79397222|FG001|Overall Study|Lost to Follow-up|0|||
44390864|NCT03439124|79397221|FG000|Overall Study|Other reasons|1|||
44390865|NCT03439124|79397222|FG001|Overall Study|Other reasons|0|||
44520016|NCT03565068|79527798|FG000|Overall Study|Sponsor decision|0|||
44520017|NCT03565068|79527799|FG001|Overall Study|Sponsor decision|0|||
44520018|NCT03565068|79527800|FG002|Overall Study|Sponsor decision|0|||
44520019|NCT03565068|79527801|FG003|Overall Study|Sponsor decision|0|||
44520020|NCT03565068|79527802|FG004|Overall Study|Sponsor decision|1|||
44520021|NCT03565068|79527803|FG005|Overall Study|Sponsor decision|1|||
44520022|NCT03565068|79527804|FG006|Overall Study|Sponsor decision|0|||
44520023|NCT03565068|79527805|FG007|Overall Study|Sponsor decision|0|||
44520024|NCT03565068|79527806|FG008|Overall Study|Sponsor decision|0|||
44520025|NCT03565068|79527798|FG000|Overall Study|Withdrawal by Subject|0|||
44520026|NCT03565068|79527799|FG001|Overall Study|Withdrawal by Subject|0|||
44520027|NCT03565068|79527800|FG002|Overall Study|Withdrawal by Subject|1|||
44520028|NCT03565068|79527801|FG003|Overall Study|Withdrawal by Subject|0|||
44520029|NCT03565068|79527802|FG004|Overall Study|Withdrawal by Subject|2|||
44520030|NCT03565068|79527803|FG005|Overall Study|Withdrawal by Subject|0|||
44520031|NCT03565068|79527804|FG006|Overall Study|Withdrawal by Subject|1|||
44520032|NCT03565068|79527805|FG007|Overall Study|Withdrawal by Subject|5|||
44520033|NCT03565068|79527806|FG008|Overall Study|Withdrawal by Subject|1|||
44520034|NCT03565068|79527798|FG000|Overall Study|Physician Decision|0|||
44520035|NCT03565068|79527799|FG001|Overall Study|Physician Decision|0|||
44520036|NCT03565068|79527800|FG002|Overall Study|Physician Decision|0|||
44520037|NCT03565068|79527801|FG003|Overall Study|Physician Decision|0|||
44520038|NCT03565068|79527802|FG004|Overall Study|Physician Decision|0|||
44390866|NCT03212989|79397241|FG000|Overall Study|Physician Decision|8|||
44390867|NCT03200548|79397249|FG000|Overall Study|Withdrawal by Subject|5|||
44390868|NCT03200548|79397250|FG001|Overall Study|Withdrawal by Subject|11|||
44390869|NCT03200548|79397251|FG002|Overall Study|Withdrawal by Subject|7|||
44390870|NCT03200548|79397252|FG003|Overall Study|Withdrawal by Subject|6|||
44390871|NCT03158688|79397264|FG000|Overall Study|Withdrawal by Subject|14|||
44390872|NCT03158688|79397265|FG001|Overall Study|Withdrawal by Subject|28|||
44390873|NCT03158688|79397264|FG000|Overall Study|Decision by sponsor|13|||
44390874|NCT03158688|79397265|FG001|Overall Study|Decision by sponsor|37|||
44390875|NCT03158688|79397264|FG000|Overall Study|Lost to Follow-up|4|||
44390876|NCT03158688|79397265|FG001|Overall Study|Lost to Follow-up|3|||
44390877|NCT03158688|79397264|FG000|Overall Study|Death|74|||
44390878|NCT03158688|79397265|FG001|Overall Study|Death|142|||
44390879|NCT03137173|79397273|FG000|Overall Study|Withdrawal by Subject|8|||
44390880|NCT03137173|79397274|FG001|Overall Study|Withdrawal by Subject|13|||
44390881|NCT03137173|79397273|FG000|Overall Study|Death|1|||
44390882|NCT03137173|79397274|FG001|Overall Study|Death|3|||
44390883|NCT03137173|79397273|FG000|Overall Study|Physician Decision|1|||
44390884|NCT03137173|79397274|FG001|Overall Study|Physician Decision|0|||
44390885|NCT03137173|79397273|FG000|Overall Study|Lost to Follow-up|13|||
44390886|NCT03137173|79397274|FG001|Overall Study|Lost to Follow-up|18|||
44390887|NCT03137173|79397273|FG000|Overall Study|Other reasons|3|||
44390888|NCT03137173|79397274|FG001|Overall Study|Other reasons|2|||
44390889|NCT01575808|79397303|FG000|Overall Study|Death|2|||
44390890|NCT01575808|79397304|FG001|Overall Study|Death|0|||
44390891|NCT01575808|79397303|FG000|Overall Study|Withdrawal by Subject|1|||
44390892|NCT01575808|79397304|FG001|Overall Study|Withdrawal by Subject|0|||
44390893|NCT01546753|79397314|FG000|Overall Study|anxiety|1|||
44390894|NCT01546753|79397315|FG001|Overall Study|anxiety|1|||
44390895|NCT01546753|79397314|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
44390896|NCT01546753|79397315|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
44390897|NCT00941720|79397328|FG000|Overall Study|Withdrawal by Subject|1|||
44390898|NCT00941720|79397328|FG000|Overall Study|Insurance denied participation|11|||
44390899|NCT00941720|79397328|FG000|Overall Study|ineligible|2|||
44390900|NCT00933686|79397334|FG000|Overall Study|Protocol Violation|0|||
44390901|NCT00933686|79397335|FG001|Overall Study|Protocol Violation|1|||
44390902|NCT00933686|79397334|FG000|Overall Study|Lost to Follow-up|2|||
44390903|NCT00933686|79397335|FG001|Overall Study|Lost to Follow-up|2|||
44390904|NCT00933686|79397334|FG000|Overall Study|Withdrawal by Subject|6|||
44390905|NCT00933686|79397335|FG001|Overall Study|Withdrawal by Subject|5|||
44390906|NCT00933686|79397334|FG000|Overall Study|Adverse Event|1|||
44390907|NCT00933686|79397335|FG001|Overall Study|Adverse Event|1|||
44390908|NCT00933686|79397334|FG000|Overall Study|Physician Decision|1|||
44390909|NCT00933686|79397335|FG001|Overall Study|Physician Decision|0|||
44390910|NCT00933686|79397334|FG000|Overall Study|Failure to show up at endpoint visits|0|||
44390911|NCT00933686|79397335|FG001|Overall Study|Failure to show up at endpoint visits|2|||
44390912|NCT00937040|79397343|FG000|Overall Study|Adverse Event|5|||
44390913|NCT00937040|79397344|FG001|Overall Study|Adverse Event|8|||
44390914|NCT00937040|79397343|FG000|Overall Study|Lost to Follow-up|12|||
44390915|NCT00937040|79397344|FG001|Overall Study|Lost to Follow-up|12|||
44390916|NCT00937040|79397343|FG000|Overall Study|Protocol Violation|3|||
44390917|NCT00937040|79397344|FG001|Overall Study|Protocol Violation|0|||
44390918|NCT00937040|79397343|FG000|Overall Study|Withdrawal by Subject|13|||
44390919|NCT00937040|79397344|FG001|Overall Study|Withdrawal by Subject|7|||
44390920|NCT00937040|79397343|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
44390921|NCT00937040|79397344|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
44390922|NCT00937040|79397343|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
44390923|NCT00937040|79397344|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
44390924|NCT00673387|79397358|FG000|Overall Study|Withdrawal by Subject|15|||
44390925|NCT00673387|79397359|FG001|Overall Study|Withdrawal by Subject|16|||
44390926|NCT00673387|79397360|FG002|Overall Study|Withdrawal by Subject|20|||
44390927|NCT00673387|79397361|FG003|Overall Study|Withdrawal by Subject|16|||
44390928|NCT00673387|79397362|FG004|Overall Study|Withdrawal by Subject|18|||
44390929|NCT00673387|79397363|FG005|Overall Study|Withdrawal by Subject|21|||
44390930|NCT00673387|79397364|FG006|Overall Study|Withdrawal by Subject|15|||
44390931|NCT00673387|79397365|FG007|Overall Study|Withdrawal by Subject|21|||
44390932|NCT00673387|79397358|FG000|Overall Study|Adverse Event|3|||
44390933|NCT00673387|79397359|FG001|Overall Study|Adverse Event|1|||
44390934|NCT00673387|79397360|FG002|Overall Study|Adverse Event|5|||
44390935|NCT00673387|79397361|FG003|Overall Study|Adverse Event|2|||
44390936|NCT00673387|79397362|FG004|Overall Study|Adverse Event|6|||
44390937|NCT00673387|79397363|FG005|Overall Study|Adverse Event|2|||
44390938|NCT00673387|79397364|FG006|Overall Study|Adverse Event|5|||
44390939|NCT00673387|79397365|FG007|Overall Study|Adverse Event|5|||
44390940|NCT00673387|79397358|FG000|Overall Study|Physician Decision|0|||
44390941|NCT00673387|79397359|FG001|Overall Study|Physician Decision|0|||
44390942|NCT00673387|79397360|FG002|Overall Study|Physician Decision|0|||
44390943|NCT00673387|79397361|FG003|Overall Study|Physician Decision|0|||
44390944|NCT00673387|79397362|FG004|Overall Study|Physician Decision|0|||
44390945|NCT00673387|79397363|FG005|Overall Study|Physician Decision|5|||
44390946|NCT00673387|79397364|FG006|Overall Study|Physician Decision|1|||
44390947|NCT00673387|79397365|FG007|Overall Study|Physician Decision|1|||
44390948|NCT00673387|79397358|FG000|Overall Study|Protocol Violation|3|||
44390949|NCT00673387|79397359|FG001|Overall Study|Protocol Violation|0|||
44390950|NCT00673387|79397360|FG002|Overall Study|Protocol Violation|1|||
44390951|NCT00673387|79397361|FG003|Overall Study|Protocol Violation|2|||
44390952|NCT00673387|79397362|FG004|Overall Study|Protocol Violation|0|||
44390953|NCT00673387|79397363|FG005|Overall Study|Protocol Violation|1|||
44390954|NCT00673387|79397364|FG006|Overall Study|Protocol Violation|1|||
44390955|NCT00673387|79397365|FG007|Overall Study|Protocol Violation|3|||
44390956|NCT00673387|79397358|FG000|Overall Study|Lost to Follow-up|8|||
44390957|NCT00673387|79397359|FG001|Overall Study|Lost to Follow-up|6|||
44390958|NCT00673387|79397360|FG002|Overall Study|Lost to Follow-up|5|||
44390959|NCT00673387|79397361|FG003|Overall Study|Lost to Follow-up|6|||
44390960|NCT00673387|79397362|FG004|Overall Study|Lost to Follow-up|6|||
44390961|NCT00673387|79397363|FG005|Overall Study|Lost to Follow-up|5|||
44390962|NCT00673387|79397364|FG006|Overall Study|Lost to Follow-up|8|||
44390963|NCT00673387|79397365|FG007|Overall Study|Lost to Follow-up|5|||
44390964|NCT00933608|79397395|FG000|Overall Study|Adverse Event|4|||
44390965|NCT00933608|79397396|FG001|Overall Study|Adverse Event|2|||
44390966|NCT00933608|79397395|FG000|Overall Study|Physician Decision|1|||
44390967|NCT00933608|79397396|FG001|Overall Study|Physician Decision|0|||
44390968|NCT00574951|79397402|FG000|Overall Study|Ineligible - improper prior treatment|1|||
44390969|NCT01557751|79397406|FG000|Overall Study|Physician Decision|3|||
44390970|NCT00936884|79397412|FG000|Double-blind|Withdrawal by Subject|6|||
44390971|NCT00936884|79397413|FG001|Double-blind|Withdrawal by Subject|4|||
44390972|NCT00936884|79397414|FG002|Double-blind|Withdrawal by Subject|0|||
44390973|NCT00936884|79397412|FG000|Double-blind|Death|2|||
44390974|NCT00936884|79397413|FG001|Double-blind|Death|1|||
44390975|NCT00936884|79397414|FG002|Double-blind|Death|0|||
44390976|NCT00936884|79397412|FG000|Double-blind|Lack of Efficacy|1|||
44390977|NCT00936884|79397413|FG001|Double-blind|Lack of Efficacy|1|||
44390978|NCT00936884|79397414|FG002|Double-blind|Lack of Efficacy|0|||
44390979|NCT00936884|79397412|FG000|Double-blind|Adverse Event|1|||
44390980|NCT00936884|79397413|FG001|Double-blind|Adverse Event|0|||
44390981|NCT00936884|79397414|FG002|Double-blind|Adverse Event|0|||
44390982|NCT00936884|79397412|FG000|Double-blind|Physician Decision|1|||
44390983|NCT00936884|79397413|FG001|Double-blind|Physician Decision|0|||
44390984|NCT00936884|79397414|FG002|Double-blind|Physician Decision|0|||
44390985|NCT00936884|79397412|FG000|Double-blind|No post baseline diary entry|1|||
44390986|NCT00936884|79397413|FG001|Double-blind|No post baseline diary entry|0|||
44390987|NCT00936884|79397414|FG002|Double-blind|No post baseline diary entry|0|||
44390988|NCT00936884|79397412|FG000|Double-blind|Did not receive study drug|0|||
44390989|NCT00936884|79397413|FG001|Double-blind|Did not receive study drug|1|||
44390990|NCT00936884|79397414|FG002|Double-blind|Did not receive study drug|0|||
44390991|NCT00668863|79397430|FG000|Overall Study|Objective Progression or Relapse|42|||
44390992|NCT00668863|79397430|FG000|Overall Study|Adverse Event|13|||
44390993|NCT00668863|79397430|FG000|Overall Study|Study Terminated by Sponsor|8|||
44390994|NCT00668863|79397430|FG000|Overall Study|Global Deterioration of Health Status|4|||
44390995|NCT00668863|79397430|FG000|Overall Study|Withdrawal by Subject|1|||
44390996|NCT00668863|79397430|FG000|Overall Study|Surgery|1|||
44390997|NCT00668863|79397430|FG000|Overall Study|Subject's work scheduling problem|1|||
44390998|NCT00668863|79397430|FG000|Overall Study|Physician Decision|1|||
44520039|NCT03565068|79527803|FG005|Overall Study|Physician Decision|0|||
44520040|NCT03565068|79527804|FG006|Overall Study|Physician Decision|0|||
44520041|NCT03565068|79527805|FG007|Overall Study|Physician Decision|1|||
44520042|NCT03565068|79527806|FG008|Overall Study|Physician Decision|0|||
44520043|NCT03565068|79527798|FG000|Overall Study|Lost to Follow-up|0|||
44390999|NCT00935012|79397434|FG000|Overall Study|Death|19|||
44391000|NCT00935012|79397434|FG000|Overall Study|Withdrawal by Subject|3|||
44391001|NCT00935012|79397434|FG000|Overall Study|Other|5|||
44391002|NCT00935012|79397434|FG000|Overall Study|Adverse Event|2|||
44391003|NCT00932360|79397438|FG000|Washout (One Week)|Withdrawal by Subject|0|||
44391004|NCT00932360|79397439|FG001|Washout (One Week)|Withdrawal by Subject|0|||
44391005|NCT00932360|79397440|FG002|Washout (One Week)|Withdrawal by Subject|0|||
44391006|NCT00932360|79397441|FG003|Washout (One Week)|Withdrawal by Subject|0|||
44391007|NCT00932360|79397442|FG004|Washout (One Week)|Withdrawal by Subject|2|||
44391008|NCT00932360|79397443|FG005|Washout (One Week)|Withdrawal by Subject|0|||
44391009|NCT00668707|79397459|FG000|Overall Study|Cancer Recurrence|58|||
44391010|NCT00668707|79397460|FG001|Overall Study|Cancer Recurrence|58|||
44391011|NCT00668707|79397459|FG000|Overall Study|Withdrawal by Subject|117|||
44391012|NCT00668707|79397460|FG001|Overall Study|Withdrawal by Subject|100|||
44391013|NCT00668707|79397459|FG000|Overall Study|Lost to Follow-up|3|||
44391014|NCT00668707|79397460|FG001|Overall Study|Lost to Follow-up|6|||
44391015|NCT00668707|79397459|FG000|Overall Study|Protocol Violation|10|||
44391016|NCT00668707|79397460|FG001|Overall Study|Protocol Violation|12|||
44391017|NCT00668707|79397459|FG000|Overall Study|Death|11|||
44391018|NCT00668707|79397460|FG001|Overall Study|Death|4|||
44391019|NCT00668395|79397474|FG000|Overall Study|Withdrawal by Subject|4|||
44391020|NCT00668395|79397475|FG001|Overall Study|Withdrawal by Subject|4|||
44391021|NCT00668395|79397476|FG002|Overall Study|Withdrawal by Subject|1|||
44391022|NCT00668395|79397474|FG000|Overall Study|Adverse Event|1|||
44391023|NCT00668395|79397475|FG001|Overall Study|Adverse Event|1|||
44391024|NCT00668395|79397476|FG002|Overall Study|Adverse Event|0|||
44391025|NCT00668395|79397474|FG000|Overall Study|Physician Decision|1|||
44391026|NCT00668395|79397475|FG001|Overall Study|Physician Decision|1|||
44391027|NCT00668395|79397476|FG002|Overall Study|Physician Decision|0|||
44391028|NCT00668317|79397484|FG000|Overall Study|Adverse Event|2|||
44391029|NCT00670111|79397505|FG000|Enrollment to One Month|Testing Failure|0|||
44391030|NCT00670111|79397506|FG001|Enrollment to One Month|Testing Failure|0|||
44391031|NCT00670111|79397507|FG002|Enrollment to One Month|Testing Failure|13|||
44391032|NCT00670111|79397505|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
44391033|NCT00670111|79397506|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
44391034|NCT00670111|79397507|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
44391035|NCT00670111|79397505|FG000|Enrollment to One Month|Physician Decision|1|||
44391036|NCT00670111|79397506|FG001|Enrollment to One Month|Physician Decision|0|||
44391037|NCT00670111|79397507|FG002|Enrollment to One Month|Physician Decision|0|||
44391038|NCT00672139|79397517|FG000|Overall Study|Death|14|||
44391039|NCT00672139|79397518|FG001|Overall Study|Death|23|||
44391040|NCT00672139|79397517|FG000|Overall Study|Withdrawal by Subject|2|||
44391041|NCT00672139|79397518|FG001|Overall Study|Withdrawal by Subject|11|||
44391042|NCT00672139|79397517|FG000|Overall Study|Adverse Event|4|||
44391043|NCT00672139|79397518|FG001|Overall Study|Adverse Event|7|||
44391044|NCT00672139|79397517|FG000|Overall Study|Physician Decision|2|||
44391045|NCT00672139|79397518|FG001|Overall Study|Physician Decision|0|||
44391046|NCT00672139|79397517|FG000|Overall Study|Lack of Efficacy|4|||
44391047|NCT00672139|79397518|FG001|Overall Study|Lack of Efficacy|1|||
44391048|NCT00672139|79397517|FG000|Overall Study|Protocol Violation|1|||
44391049|NCT00672139|79397518|FG001|Overall Study|Protocol Violation|1|||
44391050|NCT00672139|79397517|FG000|Overall Study|hospice discharge, caregiver requests|3|||
44391051|NCT00672139|79397518|FG001|Overall Study|hospice discharge, caregiver requests|2|||
44391052|NCT00570739|79397528|FG000|Overall Study|Adverse Event|8|||
44391053|NCT00570739|79397529|FG001|Overall Study|Adverse Event|6|||
44391054|NCT00570739|79397530|FG002|Overall Study|Adverse Event|2|||
44391055|NCT00570739|79397531|FG003|Overall Study|Adverse Event|2|||
44391056|NCT00570739|79397528|FG000|Overall Study|Lost to Follow-up|4|||
44391057|NCT00570739|79397529|FG001|Overall Study|Lost to Follow-up|5|||
44391058|NCT00570739|79397530|FG002|Overall Study|Lost to Follow-up|4|||
44391059|NCT00570739|79397531|FG003|Overall Study|Lost to Follow-up|1|||
44391060|NCT00570739|79397528|FG000|Overall Study|Physician Decision|1|||
44391061|NCT00570739|79397529|FG001|Overall Study|Physician Decision|1|||
44391062|NCT00570739|79397530|FG002|Overall Study|Physician Decision|0|||
44391063|NCT00570739|79397531|FG003|Overall Study|Physician Decision|0|||
44391064|NCT00570739|79397528|FG000|Overall Study|Withdrawal by Subject|7|||
44391065|NCT00570739|79397529|FG001|Overall Study|Withdrawal by Subject|7|||
44391066|NCT00570739|79397530|FG002|Overall Study|Withdrawal by Subject|3|||
44391067|NCT00570739|79397531|FG003|Overall Study|Withdrawal by Subject|5|||
44391068|NCT00570739|79397528|FG000|Overall Study|Required restricted medication|0|||
44391069|NCT00570739|79397529|FG001|Overall Study|Required restricted medication|0|||
44391070|NCT00570739|79397530|FG002|Overall Study|Required restricted medication|1|||
44391071|NCT00570739|79397531|FG003|Overall Study|Required restricted medication|0|||
44391072|NCT00570739|79397528|FG000|Overall Study|Met discontinuation criteria|1|||
44251952|NCT01042977|79087615|FG000|Overall Study|Lost to Follow-up|0|||
44251953|NCT01042977|79087616|FG001|Overall Study|Lost to Follow-up|2|||
44251954|NCT01042977|79087615|FG000|Overall Study|Poor/non-compliance|3|||
44391073|NCT00570739|79397529|FG001|Overall Study|Met discontinuation criteria|0|||
44391074|NCT00570739|79397530|FG002|Overall Study|Met discontinuation criteria|1|||
44391075|NCT00570739|79397531|FG003|Overall Study|Met discontinuation criteria|1|||
44391076|NCT00570739|79397528|FG000|Overall Study|Other|0|||
44391077|NCT00570739|79397529|FG001|Overall Study|Other|2|||
44391078|NCT00570739|79397530|FG002|Overall Study|Other|5|||
44391079|NCT00570739|79397531|FG003|Overall Study|Other|3|||
44391080|NCT03689530|79397563|FG000|Overall Study|Withdrawal by Subject|53|||
44251955|NCT01042977|79087616|FG001|Overall Study|Poor/non-compliance|4|||
44391081|NCT03689530|79397564|FG001|Overall Study|Withdrawal by Subject|16|||
44391082|NCT04188106|79397570|FG000|Overall Study|Lost to Follow-up|5|||
44391083|NCT04188106|79397570|FG000|Overall Study|Non-Compliance|1|||
44391084|NCT00669955|79397578|FG000|Overall Study|Adverse Event|3|||
44391085|NCT00669955|79397579|FG001|Overall Study|Adverse Event|5|||
44280917|NCT01930188|79242136|FG000|Overall Study|unclassified|4|||
44391086|NCT00669955|79397578|FG000|Overall Study|Death|0|||
44391087|NCT00669955|79397579|FG001|Overall Study|Death|1|||
44391088|NCT00669955|79397578|FG000|Overall Study|Withdrawal by Subject|2|||
44520044|NCT03565068|79527799|FG001|Overall Study|Lost to Follow-up|0|||
44520045|NCT03565068|79527800|FG002|Overall Study|Lost to Follow-up|0|||
44391089|NCT00669955|79397579|FG001|Overall Study|Withdrawal by Subject|3|||
44391090|NCT00669955|79397578|FG000|Overall Study|Lost to Follow-up|5|||
44391091|NCT00669955|79397579|FG001|Overall Study|Lost to Follow-up|7|||
44391092|NCT00669955|79397578|FG000|Overall Study|Protocol Violation|2|||
44391093|NCT00669955|79397579|FG001|Overall Study|Protocol Violation|7|||
44391094|NCT00669955|79397578|FG000|Overall Study|Investigator Sponsor Judgement|0|||
44391095|NCT00669955|79397579|FG001|Overall Study|Investigator Sponsor Judgement|1|||
44391096|NCT00669955|79397578|FG000|Overall Study|not compliant with study drug/visit|2|||
44391097|NCT00669955|79397579|FG001|Overall Study|not compliant with study drug/visit|3|||
44391098|NCT00671749|79397585|FG000|Overall Study|Adverse Event|2|||
44391099|NCT00671749|79397585|FG000|Overall Study|Withdrawal by Subject|4|||
44520046|NCT03565068|79527801|FG003|Overall Study|Lost to Follow-up|0|||
44520047|NCT03565068|79527802|FG004|Overall Study|Lost to Follow-up|0|||
44520048|NCT03565068|79527803|FG005|Overall Study|Lost to Follow-up|0|||
44520049|NCT03565068|79527804|FG006|Overall Study|Lost to Follow-up|0|||
44520050|NCT03565068|79527805|FG007|Overall Study|Lost to Follow-up|1|||
44520051|NCT03565068|79527806|FG008|Overall Study|Lost to Follow-up|0|||
44520052|NCT00010803|79527865|FG000|Overall Study|Withdrawal by Subject|97|||
44520053|NCT00010803|79527866|FG001|Overall Study|Withdrawal by Subject|98|||
44520054|NCT02914834|79527874|FG000|Overall Study|Study halted due to COVID|1|||
44391100|NCT00671749|79397585|FG000|Overall Study|Protocol Violation|1|||
44391101|NCT00671749|79397585|FG000|Overall Study|Lost to Follow-up|1|||
44391102|NCT00669877|79397589|FG000|Overall Study|Disease Progression/Death|4|||
44391103|NCT00882999|79397600|FG000|Overall Study|Adverse Event|0|||
44391104|NCT00882999|79397601|FG001|Overall Study|Adverse Event|0|||
44391105|NCT00882999|79397602|FG002|Overall Study|Adverse Event|0|||
44391106|NCT00882999|79397603|FG003|Overall Study|Adverse Event|0|||
44391107|NCT00882999|79397604|FG004|Overall Study|Adverse Event|1|||
44391108|NCT00882999|79397605|FG005|Overall Study|Adverse Event|0|||
44391109|NCT00882999|79397606|FG006|Overall Study|Adverse Event|0|||
44391110|NCT00882999|79397600|FG000|Overall Study|Death|0|||
44391111|NCT00882999|79397601|FG001|Overall Study|Death|1|||
44391112|NCT00882999|79397602|FG002|Overall Study|Death|0|||
44391113|NCT00882999|79397603|FG003|Overall Study|Death|0|||
44391114|NCT00882999|79397604|FG004|Overall Study|Death|0|||
44391115|NCT00882999|79397605|FG005|Overall Study|Death|0|||
44391116|NCT00882999|79397606|FG006|Overall Study|Death|0|||
44391117|NCT00882999|79397600|FG000|Overall Study|Withdrawal by Subject|7|||
44391118|NCT00882999|79397601|FG001|Overall Study|Withdrawal by Subject|6|||
44391119|NCT00882999|79397602|FG002|Overall Study|Withdrawal by Subject|3|||
44391120|NCT00882999|79397603|FG003|Overall Study|Withdrawal by Subject|3|||
44391121|NCT00882999|79397604|FG004|Overall Study|Withdrawal by Subject|6|||
44391122|NCT00882999|79397605|FG005|Overall Study|Withdrawal by Subject|5|||
44391123|NCT00882999|79397606|FG006|Overall Study|Withdrawal by Subject|5|||
44391124|NCT00882999|79397600|FG000|Overall Study|Lost to Follow-up|0|||
44391125|NCT00882999|79397601|FG001|Overall Study|Lost to Follow-up|1|||
44391126|NCT00882999|79397602|FG002|Overall Study|Lost to Follow-up|1|||
44391127|NCT00882999|79397603|FG003|Overall Study|Lost to Follow-up|2|||
44391128|NCT00882999|79397604|FG004|Overall Study|Lost to Follow-up|1|||
44391129|NCT00882999|79397605|FG005|Overall Study|Lost to Follow-up|1|||
44391130|NCT00882999|79397606|FG006|Overall Study|Lost to Follow-up|2|||
44391131|NCT00882999|79397600|FG000|Overall Study|Physician Decision|1|||
44391132|NCT00882999|79397601|FG001|Overall Study|Physician Decision|0|||
44391133|NCT00882999|79397602|FG002|Overall Study|Physician Decision|0|||
44391134|NCT00882999|79397603|FG003|Overall Study|Physician Decision|0|||
44280918|NCT01930188|79242137|FG001|Overall Study|unclassified|5|||
44280919|NCT01930188|79242138|FG002|Overall Study|unclassified|3|||
44280920|NCT01930188|79242136|FG000|Overall Study|Missing follow-up information|2|||
44280921|NCT01930188|79242137|FG001|Overall Study|Missing follow-up information|2|||
44280922|NCT01930188|79242138|FG002|Overall Study|Missing follow-up information|3|||
44280923|NCT01930188|79242136|FG000|Overall Study|Lost to Follow-up|5|||
44280924|NCT01930188|79242137|FG001|Overall Study|Lost to Follow-up|2|||
44280925|NCT01930188|79242138|FG002|Overall Study|Lost to Follow-up|2|||
44280926|NCT01930188|79242136|FG000|Overall Study|Death|2|||
44280927|NCT01930188|79242137|FG001|Overall Study|Death|1|||
44280928|NCT01930188|79242138|FG002|Overall Study|Death|3|||
44280929|NCT01930188|79242136|FG000|Overall Study|Withdrawal by Subject|9|||
44280930|NCT01930188|79242137|FG001|Overall Study|Withdrawal by Subject|11|||
44391135|NCT00882999|79397604|FG004|Overall Study|Physician Decision|0|||
44391136|NCT00882999|79397605|FG005|Overall Study|Physician Decision|1|||
44391137|NCT00882999|79397606|FG006|Overall Study|Physician Decision|1|||
44391138|NCT00671437|79397629|FG000|Overall Study|Progressive disease before C1 week 8|8|||
44391139|NCT00671437|79397629|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
44391140|NCT00671437|79397629|FG000|Overall Study|Adverse Event|3|||
44391141|NCT00671437|79397629|FG000|Overall Study|Ineligible post-hoc|1|||
44391142|NCT00882921|79397641|FG000|Overall Study|Death|2|||
44391143|NCT00882921|79397641|FG000|Overall Study|Other|3|||
44280931|NCT01930188|79242138|FG002|Overall Study|Withdrawal by Subject|8|||
44280932|NCT01977222|79242147|FG000|Overall Study|Withdrawal by Subject|1|||
44280933|NCT01957488|79242151|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
44280934|NCT01957488|79242152|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
44280935|NCT01957488|79242153|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
44280936|NCT01957488|79242154|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
44280937|NCT01957488|79242155|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
44280938|NCT01957488|79242156|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
44280939|NCT01957488|79242151|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
44280940|NCT01957488|79242152|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
44280941|NCT01957488|79242153|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
44280942|NCT01957488|79242154|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
44280943|NCT01957488|79242155|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
44280944|NCT01957488|79242156|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
44280945|NCT01957488|79242151|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
44280946|NCT01957488|79242152|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
44280947|NCT01957488|79242153|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
44280948|NCT01957488|79242154|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
44280949|NCT01957488|79242155|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
44280950|NCT01957488|79242156|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
44280951|NCT01957488|79242151|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
44280952|NCT01957488|79242152|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
44280953|NCT01957488|79242153|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
44280954|NCT01957488|79242154|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
44280955|NCT01957488|79242155|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
44280956|NCT01957488|79242156|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
44280957|NCT01957488|79242151|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
44280958|NCT01957488|79242152|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
44520055|NCT02914834|79527875|FG001|Overall Study|Study halted due to COVID|1|||
44520056|NCT02914834|79527874|FG000|Overall Study|1 subject withdrew|0|||
44520057|NCT02914834|79527875|FG001|Overall Study|1 subject withdrew|1|||
44520058|NCT03497130|79527883|FG000|Overall Study|Lost to Follow-up|1|||
44520059|NCT03497130|79527884|FG001|Overall Study|Lost to Follow-up|1|||
44520060|NCT03006562|79527892|FG000|Overall Study|Lost to Follow-up|0|||
44520061|NCT03006562|79527893|FG001|Overall Study|Lost to Follow-up|1|||
44520062|NCT03007966|79527901|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
44520063|NCT03007966|79527902|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
44520064|NCT03007888|79527909|FG000|First Intervention (14 Days)|Adverse Event|1|||
44520065|NCT03007888|79527910|FG001|First Intervention (14 Days)|Adverse Event|0|||
44520066|NCT03541044|79527919|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
44520067|NCT03541044|79527920|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
44520068|NCT03541044|79527919|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
44520069|NCT03541044|79527920|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
44520070|NCT00009945|79527930|FG000|Overall Study|no follow up data|7|||
44146573|NCT00705341|78936049|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
44146574|NCT00705341|78936050|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
44280959|NCT01957488|79242153|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
44280960|NCT01957488|79242154|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
44280961|NCT01957488|79242155|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
44280962|NCT01957488|79242156|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
44280963|NCT01957488|79242151|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
44280964|NCT01957488|79242152|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
44280965|NCT01957488|79242153|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
44391144|NCT00882921|79397641|FG000|Overall Study|Lost to Follow-up|2|||
44391145|NCT00882921|79397641|FG000|Overall Study|Termination By Investigator|3|||
44520071|NCT00009945|79527931|FG001|Overall Study|no follow up data|5|||
44520072|NCT03540030|79527939|FG000|Overall Study|Withdrawal by Subject|2|||
44520073|NCT03540030|79527940|FG001|Overall Study|Withdrawal by Subject|1|||
44520074|NCT03540030|79527939|FG000|Overall Study|screen fail|7|||
44520075|NCT03540030|79527940|FG001|Overall Study|screen fail|1|||
44146575|NCT00705341|78936051|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
44520076|NCT03540030|79527939|FG000|Overall Study|never had surgery after signing consent|9|||
44280966|NCT01957488|79242154|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
44280967|NCT01957488|79242155|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
44280968|NCT01957488|79242156|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
44520077|NCT03540030|79527940|FG001|Overall Study|never had surgery after signing consent|1|||
44520078|NCT03003676|79527948|FG000|Overall Study|Lack of Efficacy|5|||
44520079|NCT03003676|79527949|FG001|Overall Study|Lack of Efficacy|7|||
44391146|NCT00882921|79397641|FG000|Overall Study|Withdrawal Of Consent|1|||
44391147|NCT00582712|79397646|FG000|Overall Study|Adverse Event|1|||
44391148|NCT00582712|79397646|FG000|Overall Study|Lack of Efficacy|1|||
44391149|NCT00582712|79397646|FG000|Overall Study|Withdrawal by Subject|1|||
44391150|NCT00582712|79397646|FG000|Overall Study|Complicating disease requiring treatment|1|||
44391151|NCT00582790|79397650|FG000|Overall Study|Rapid progression of disease|1|||
44391152|NCT00881751|79397657|FG000|Overall Study|Physician Decision|0|||
44391153|NCT00881751|79397658|FG001|Overall Study|Physician Decision|1|||
44391154|NCT00881751|79397657|FG000|Overall Study|Adverse Event|0|||
44391155|NCT00881751|79397658|FG001|Overall Study|Adverse Event|2|||
44391156|NCT00881751|79397657|FG000|Overall Study|Withdrawal by Subject|0|||
44391157|NCT00881751|79397658|FG001|Overall Study|Withdrawal by Subject|2|||
44391158|NCT00934856|79397670|FG000|Feasibility Part|Progressive disease|4|||
44391159|NCT00934856|79397671|FG001|Feasibility Part|Progressive disease|4|||
44391160|NCT00934856|79397672|FG002|Feasibility Part|Progressive disease|2|||
44391161|NCT00934856|79397673|FG003|Feasibility Part|Progressive disease|3|||
44391162|NCT00934856|79397674|FG004|Feasibility Part|Progressive disease|0|||
44391163|NCT00934856|79397675|FG005|Feasibility Part|Progressive disease|0|||
44391164|NCT00934856|79397670|FG000|Feasibility Part|Physician Decision|0|||
44391165|NCT00934856|79397671|FG001|Feasibility Part|Physician Decision|0|||
44391166|NCT00934856|79397672|FG002|Feasibility Part|Physician Decision|1|||
44391167|NCT00934856|79397673|FG003|Feasibility Part|Physician Decision|0|||
44391168|NCT00934856|79397674|FG004|Feasibility Part|Physician Decision|0|||
44391169|NCT00934856|79397675|FG005|Feasibility Part|Physician Decision|0|||
44391170|NCT00934856|79397670|FG000|Feasibility Part|Adverse Event|1|||
44391171|NCT00934856|79397671|FG001|Feasibility Part|Adverse Event|1|||
44391172|NCT00934856|79397672|FG002|Feasibility Part|Adverse Event|0|||
44391173|NCT00934856|79397673|FG003|Feasibility Part|Adverse Event|1|||
44391174|NCT00934856|79397674|FG004|Feasibility Part|Adverse Event|0|||
44391175|NCT00934856|79397675|FG005|Feasibility Part|Adverse Event|2|||
44391176|NCT00934856|79397670|FG000|Feasibility Part|Withdrawal by Subject|0|||
44391177|NCT00934856|79397671|FG001|Feasibility Part|Withdrawal by Subject|0|||
44391178|NCT00934856|79397672|FG002|Feasibility Part|Withdrawal by Subject|0|||
44391179|NCT00934856|79397673|FG003|Feasibility Part|Withdrawal by Subject|1|||
44391180|NCT00934856|79397674|FG004|Feasibility Part|Withdrawal by Subject|0|||
44391181|NCT00934856|79397675|FG005|Feasibility Part|Withdrawal by Subject|1|||
44391182|NCT00934856|79397670|FG000|Extension Part|Adverse Event|0|||
44391183|NCT00934856|79397671|FG001|Extension Part|Adverse Event|0|||
44391184|NCT00934856|79397672|FG002|Extension Part|Adverse Event|0|||
44391185|NCT00934856|79397673|FG003|Extension Part|Adverse Event|1|||
44391186|NCT00934856|79397674|FG004|Extension Part|Adverse Event|4|||
44391187|NCT00934856|79397675|FG005|Extension Part|Adverse Event|4|||
44391188|NCT00934856|79397670|FG000|Extension Part|Progressive disease|0|||
44391189|NCT00934856|79397671|FG001|Extension Part|Progressive disease|0|||
44391190|NCT00934856|79397672|FG002|Extension Part|Progressive disease|0|||
44391191|NCT00934856|79397673|FG003|Extension Part|Progressive disease|1|||
44391192|NCT00934856|79397674|FG004|Extension Part|Progressive disease|0|||
44391193|NCT00934856|79397675|FG005|Extension Part|Progressive disease|0|||
44391194|NCT00934856|79397670|FG000|Extension Part|Non-compliance with drug|0|||
44391195|NCT00934856|79397671|FG001|Extension Part|Non-compliance with drug|0|||
44391196|NCT00934856|79397672|FG002|Extension Part|Non-compliance with drug|0|||
44391197|NCT00934856|79397673|FG003|Extension Part|Non-compliance with drug|0|||
44391198|NCT00934856|79397674|FG004|Extension Part|Non-compliance with drug|0|||
44391199|NCT00934856|79397675|FG005|Extension Part|Non-compliance with drug|1|||
44391200|NCT00934700|79397709|FG000|Overall Study|missing scan|5|||
44391201|NCT00934700|79397710|FG001|Overall Study|missing scan|9|||
44391202|NCT00934700|79397709|FG000|Overall Study|Death|8|||
44391203|NCT00934700|79397710|FG001|Overall Study|Death|3|||
44391204|NCT00930176|79397717|FG000|Overall Study|Death|1|||
44391205|NCT00669409|79397727|FG000|Part 2|Withdrawal by Subject|0|||
44391206|NCT00669409|79397728|FG001|Part 2|Withdrawal by Subject|0|||
44391207|NCT00669409|79397729|FG002|Part 2|Withdrawal by Subject|0|||
44391208|NCT00669409|79397730|FG003|Part 2|Withdrawal by Subject|0|||
44391209|NCT00669409|79397731|FG004|Part 2|Withdrawal by Subject|0|||
44520080|NCT03003676|79527948|FG000|Overall Study|Withdrawal by Subject|0|||
44520081|NCT03003676|79527949|FG001|Overall Study|Withdrawal by Subject|1|||
44520082|NCT03003676|79527948|FG000|Overall Study|Hepatitis B infection|1|||
44520083|NCT03003676|79527949|FG001|Overall Study|Hepatitis B infection|0|||
44146576|NCT00705341|78936052|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
44391210|NCT00669409|79397732|FG005|Part 2|Withdrawal by Subject|0|||
44391211|NCT00669409|79397733|FG006|Part 2|Withdrawal by Subject|0|||
44146577|NCT00705341|78936049|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
44391212|NCT00669409|79397734|FG007|Part 2|Withdrawal by Subject|0|||
44391213|NCT00669409|79397735|FG008|Part 2|Withdrawal by Subject|0|||
44391214|NCT00669409|79397736|FG009|Part 2|Withdrawal by Subject|1|||
44391215|NCT00669409|79397737|FG010|Part 2|Withdrawal by Subject|0|||
44391216|NCT00669331|79397766|FG000|Randomisation to First Dose|Adverse Event|1|||
44391217|NCT00669331|79397767|FG001|Randomisation to First Dose|Adverse Event|0|||
44391218|NCT00669331|79397766|FG000|Randomisation to First Dose|Protocol Violation|1|||
44391219|NCT00669331|79397767|FG001|Randomisation to First Dose|Protocol Violation|0|||
44391220|NCT00669331|79397766|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
44391221|NCT00669331|79397767|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
44391222|NCT00669331|79397766|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
44391223|NCT00669331|79397767|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
44391224|NCT00669331|79397766|FG000|Randomisation to First Dose|Death|1|||
44391225|NCT00669331|79397767|FG001|Randomisation to First Dose|Death|0|||
44391226|NCT00669331|79397766|FG000|Randomisation to First Dose|Sponsor decision|0|||
44391227|NCT00669331|79397767|FG001|Randomisation to First Dose|Sponsor decision|1|||
44391228|NCT00669331|79397766|FG000|Randomisation to First Dose|Randomised in error|3|||
44391229|NCT00669331|79397767|FG001|Randomisation to First Dose|Randomised in error|10|||
44391230|NCT00669331|79397766|FG000|Blinded Treatment Period|Adverse Event|16|||
44391231|NCT00669331|79397767|FG001|Blinded Treatment Period|Adverse Event|10|||
44391232|NCT00669331|79397766|FG000|Blinded Treatment Period|Protocol Violation|1|||
44391233|NCT00669331|79397767|FG001|Blinded Treatment Period|Protocol Violation|1|||
44391234|NCT00669331|79397766|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
44391235|NCT00669331|79397767|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
44391236|NCT00669331|79397766|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
44391237|NCT00669331|79397767|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
44391238|NCT00669331|79397766|FG000|Blinded Treatment Period|Death|0|||
44391239|NCT00669331|79397767|FG001|Blinded Treatment Period|Death|2|||
44391240|NCT00669331|79397766|FG000|Blinded Treatment Period|Physician Decision|3|||
44391241|NCT00669331|79397767|FG001|Blinded Treatment Period|Physician Decision|3|||
44391242|NCT00669331|79397766|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
44391243|NCT00669331|79397767|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
44391244|NCT00932126|79397775|FG000|Overall Study|Adverse Event|0|||
44391245|NCT00932126|79397776|FG001|Overall Study|Adverse Event|0|||
44391246|NCT00932126|79397777|FG002|Overall Study|Adverse Event|0|||
44391247|NCT00932126|79397778|FG003|Overall Study|Adverse Event|0|||
44391248|NCT00932126|79397779|FG004|Overall Study|Adverse Event|0|||
44391249|NCT00932126|79397780|FG005|Overall Study|Adverse Event|0|||
44391250|NCT00932126|79397781|FG006|Overall Study|Adverse Event|1|||
44391251|NCT00932126|79397782|FG007|Overall Study|Adverse Event|2|||
44391252|NCT00932126|79397775|FG000|Overall Study|Protocol Violation|0|||
44391253|NCT00932126|79397776|FG001|Overall Study|Protocol Violation|0|||
44391254|NCT00932126|79397777|FG002|Overall Study|Protocol Violation|0|||
44391255|NCT00932126|79397778|FG003|Overall Study|Protocol Violation|0|||
44391256|NCT00932126|79397779|FG004|Overall Study|Protocol Violation|1|||
44391257|NCT00932126|79397780|FG005|Overall Study|Protocol Violation|0|||
44391258|NCT00932126|79397781|FG006|Overall Study|Protocol Violation|0|||
44391259|NCT00932126|79397782|FG007|Overall Study|Protocol Violation|0|||
44391260|NCT00932126|79397775|FG000|Overall Study|Withdrawal by Subject|0|||
44391261|NCT00932126|79397776|FG001|Overall Study|Withdrawal by Subject|0|||
44391262|NCT00932126|79397777|FG002|Overall Study|Withdrawal by Subject|1|||
44391263|NCT00932126|79397778|FG003|Overall Study|Withdrawal by Subject|0|||
44391264|NCT00932126|79397779|FG004|Overall Study|Withdrawal by Subject|0|||
44391265|NCT00932126|79397780|FG005|Overall Study|Withdrawal by Subject|0|||
44391266|NCT00932126|79397781|FG006|Overall Study|Withdrawal by Subject|0|||
44391267|NCT00932126|79397782|FG007|Overall Study|Withdrawal by Subject|1|||
44391268|NCT00932126|79397775|FG000|Overall Study|Objective progression or relapse|3|||
44391269|NCT00932126|79397776|FG001|Overall Study|Objective progression or relapse|3|||
44391270|NCT00932126|79397777|FG002|Overall Study|Objective progression or relapse|2|||
44391271|NCT00932126|79397778|FG003|Overall Study|Objective progression or relapse|3|||
44391272|NCT00932126|79397779|FG004|Overall Study|Objective progression or relapse|3|||
44391273|NCT00932126|79397780|FG005|Overall Study|Objective progression or relapse|3|||
44391274|NCT00932126|79397781|FG006|Overall Study|Objective progression or relapse|3|||
44391275|NCT00932126|79397782|FG007|Overall Study|Objective progression or relapse|5|||
44391276|NCT00932126|79397775|FG000|Overall Study|Other|0|||
44520084|NCT00047385|79527959|FG000|Overall Study|Death before any screening|2|||
44520085|NCT00047385|79527960|FG001|Overall Study|Death before any screening|5|||
44520086|NCT00047385|79527959|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
44520087|NCT00047385|79527960|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
44520088|NCT00047385|79527959|FG000|Overall Study|Eligible for screening but had no screen|260|||
44146578|NCT00705341|78936050|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
44146579|NCT00705341|78936051|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
44391277|NCT00932126|79397776|FG001|Overall Study|Other|0|||
44391278|NCT00932126|79397777|FG002|Overall Study|Other|0|||
44391279|NCT00932126|79397778|FG003|Overall Study|Other|0|||
44391280|NCT00932126|79397779|FG004|Overall Study|Other|1|||
44520089|NCT00047385|79527960|FG001|Overall Study|Eligible for screening but had no screen|492|||
44391281|NCT00932126|79397780|FG005|Overall Study|Other|0|||
44391282|NCT00932126|79397781|FG006|Overall Study|Other|1|||
44391283|NCT00932126|79397782|FG007|Overall Study|Other|2|||
44391284|NCT00667225|79397804|FG000|Overall Study|Subject had no more lesions to treat.|1|||
44391285|NCT00667225|79397805|FG001|Overall Study|Subject had no more lesions to treat.|0|||
44391286|NCT00667225|79397804|FG000|Overall Study|Lost to Follow-up|0|||
44391287|NCT00667225|79397805|FG001|Overall Study|Lost to Follow-up|1|||
44391288|NCT00929864|79397813|FG000|Overall Study|Death|1|||
44391289|NCT00929864|79397814|FG001|Overall Study|Death|1|||
44391290|NCT00929864|79397813|FG000|Overall Study|Adverse Event|11|||
44391291|NCT00929864|79397814|FG001|Overall Study|Adverse Event|30|||
44391292|NCT00929864|79397813|FG000|Overall Study|Lack of Efficacy|19|||
44391293|NCT00929864|79397814|FG001|Overall Study|Lack of Efficacy|16|||
44391294|NCT00929864|79397813|FG000|Overall Study|Lost to Follow-up|7|||
44391295|NCT00929864|79397814|FG001|Overall Study|Lost to Follow-up|12|||
44391296|NCT00929864|79397813|FG000|Overall Study|Withdrawal by Subject|20|||
44391297|NCT00929864|79397814|FG001|Overall Study|Withdrawal by Subject|9|||
44391298|NCT00929864|79397813|FG000|Overall Study|No longer met criteria|2|||
44391299|NCT00929864|79397814|FG001|Overall Study|No longer met criteria|1|||
44391300|NCT00929864|79397813|FG000|Overall Study|Poor or non-compliance|3|||
44391301|NCT00929864|79397814|FG001|Overall Study|Poor or non-compliance|3|||
44391302|NCT00929864|79397813|FG000|Overall Study|Pregnancy|0|||
44391303|NCT00929864|79397814|FG001|Overall Study|Pregnancy|3|||
44391304|NCT00929864|79397813|FG000|Overall Study|Administrative reason by Sponsor|1|||
44391305|NCT00929864|79397814|FG001|Overall Study|Administrative reason by Sponsor|1|||
44391306|NCT00929864|79397813|FG000|Overall Study|Non-specified|2|||
44391307|NCT00929864|79397814|FG001|Overall Study|Non-specified|7|||
44391308|NCT00597753|79397822|FG000|Overall Study|Adverse Event|6|||
44391309|NCT00597753|79397823|FG001|Overall Study|Adverse Event|2|||
44391310|NCT00597753|79397822|FG000|Overall Study|Death|55|||
44391311|NCT00597753|79397823|FG001|Overall Study|Death|29|||
44391312|NCT00597753|79397822|FG000|Overall Study|Lack of Efficacy|2|||
44391313|NCT00597753|79397823|FG001|Overall Study|Lack of Efficacy|0|||
44391314|NCT00597753|79397822|FG000|Overall Study|Lost to Follow-up|10|||
44391315|NCT00597753|79397823|FG001|Overall Study|Lost to Follow-up|3|||
44391316|NCT00597753|79397822|FG000|Overall Study|Physician Decision|5|||
44391317|NCT00597753|79397823|FG001|Overall Study|Physician Decision|1|||
44391318|NCT00597753|79397822|FG000|Overall Study|Pregnancy|1|||
44391319|NCT00597753|79397823|FG001|Overall Study|Pregnancy|0|||
44391320|NCT00597753|79397822|FG000|Overall Study|Withdrawal by Subject|35|||
44391321|NCT00597753|79397823|FG001|Overall Study|Withdrawal by Subject|12|||
44391322|NCT00597753|79397822|FG000|Overall Study|Discontinued Dialysis|0|||
44391323|NCT00597753|79397823|FG001|Overall Study|Discontinued Dialysis|1|||
44391324|NCT00597753|79397822|FG000|Overall Study|Never dosed|2|||
44391325|NCT00597753|79397823|FG001|Overall Study|Never dosed|0|||
44391326|NCT00597753|79397822|FG000|Overall Study|Noncompliance|2|||
44391327|NCT00597753|79397823|FG001|Overall Study|Noncompliance|1|||
44391328|NCT00597753|79397822|FG000|Overall Study|Relocation|17|||
44391329|NCT00597753|79397823|FG001|Overall Study|Relocation|6|||
44391330|NCT00597753|79397822|FG000|Overall Study|Renal transplant|10|||
44391331|NCT00597753|79397823|FG001|Overall Study|Renal transplant|3|||
44391332|NCT00597753|79397822|FG000|Overall Study|Site closed by sponsor|19|||
44391333|NCT00597753|79397823|FG001|Overall Study|Site closed by sponsor|7|||
44391334|NCT00597753|79397822|FG000|Overall Study|Site elected to close|2|||
44391335|NCT00597753|79397823|FG001|Overall Study|Site elected to close|4|||
44391336|NCT00665431|79397832|FG000|Overall Study|Adverse Event|16|||
44391337|NCT00665431|79397833|FG001|Overall Study|Adverse Event|22|||
44391338|NCT00665431|79397834|FG002|Overall Study|Adverse Event|6|||
44391339|NCT00665431|79397832|FG000|Overall Study|Withdrawal by Subject|17|||
44391340|NCT00665431|79397833|FG001|Overall Study|Withdrawal by Subject|25|||
44391341|NCT00665431|79397834|FG002|Overall Study|Withdrawal by Subject|15|||
44391342|NCT00665431|79397832|FG000|Overall Study|Lost to Follow-up|3|||
44391343|NCT00665431|79397833|FG001|Overall Study|Lost to Follow-up|3|||
44391344|NCT00665431|79397834|FG002|Overall Study|Lost to Follow-up|1|||
44391345|NCT00665431|79397832|FG000|Overall Study|Other|4|||
44391346|NCT00665431|79397833|FG001|Overall Study|Other|7|||
44391347|NCT00665431|79397834|FG002|Overall Study|Other|2|||
44391348|NCT00934622|79397842|FG000|Overall Study|Lost to Follow-up|7|||
44391349|NCT00934622|79397842|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
44391350|NCT00881361|79397848|FG000|Overall Study|Terminated prior to surgery|27|||
44146580|NCT00705341|78936052|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
44391351|NCT00881361|79397849|FG001|Overall Study|Terminated prior to surgery|7|||
44391352|NCT00881361|79397850|FG002|Overall Study|Terminated prior to surgery|0|||
44391353|NCT00881361|79397848|FG000|Overall Study|Ineligible|17|||
44391354|NCT00881361|79397849|FG001|Overall Study|Ineligible|2|||
44391355|NCT00881361|79397850|FG002|Overall Study|Ineligible|2|||
44391356|NCT01000727|79397861|FG000|Overall Study|Lost to Follow-up|41|||
44146581|NCT02723201|78936063|FG000|Second Intervention Period|Protocol Violation|1|||
44391357|NCT01000727|79397862|FG001|Overall Study|Lost to Follow-up|43|||
44391358|NCT01000727|79397861|FG000|Overall Study|Withdrawal by Subject|111|||
44391359|NCT01000727|79397862|FG001|Overall Study|Withdrawal by Subject|109|||
44391360|NCT01000727|79397861|FG000|Overall Study|Study closed/terminated|23|||
44391361|NCT01000727|79397862|FG001|Overall Study|Study closed/terminated|24|||
44391362|NCT00881205|79397872|FG000|Overall Study|Adverse Event|8|||
44391363|NCT00881205|79397873|FG001|Overall Study|Adverse Event|3|||
44391364|NCT00881205|79397872|FG000|Overall Study|Withdrawal by Subject|1|||
44391365|NCT00881205|79397873|FG001|Overall Study|Withdrawal by Subject|2|||
44391366|NCT00881205|79397872|FG000|Overall Study|Lost to Follow-up|0|||
44391367|NCT00881205|79397873|FG001|Overall Study|Lost to Follow-up|1|||
44391368|NCT00881205|79397872|FG000|Overall Study|Administrative problems|1|||
44391369|NCT00881205|79397873|FG001|Overall Study|Administrative problems|1|||
44391370|NCT00881205|79397872|FG000|Overall Study|Condition no longer requires drug|1|||
44391371|NCT00881205|79397873|FG001|Overall Study|Condition no longer requires drug|0|||
44391372|NCT00879879|79397880|FG000|Overall Study|Death|1|||
44391373|NCT00879879|79397880|FG000|Overall Study|Withdrawal by Subject|1|||
44391374|NCT00879879|79397880|FG000|Overall Study|Physician Decision|1|||
44391375|NCT00661999|79397889|FG000|Overall Study|Adverse Event|11|||
44391376|NCT00661999|79397890|FG001|Overall Study|Adverse Event|5|||
44391377|NCT00661999|79397891|FG002|Overall Study|Adverse Event|8|||
44391378|NCT00661999|79397889|FG000|Overall Study|Death|8|||
44391379|NCT00661999|79397890|FG001|Overall Study|Death|6|||
44391380|NCT00661999|79397891|FG002|Overall Study|Death|3|||
44391381|NCT00661999|79397889|FG000|Overall Study|Other Reasons|5|||
44391382|NCT00661999|79397890|FG001|Overall Study|Other Reasons|12|||
44391383|NCT00661999|79397891|FG002|Overall Study|Other Reasons|23|||
44391384|NCT00661999|79397889|FG000|Overall Study|Withdrawal by Subject|30|||
44391385|NCT00661999|79397890|FG001|Overall Study|Withdrawal by Subject|23|||
44391386|NCT00661999|79397891|FG002|Overall Study|Withdrawal by Subject|14|||
44391387|NCT00661999|79397889|FG000|Overall Study|Alternative Treatment|1|||
44391388|NCT00661999|79397890|FG001|Overall Study|Alternative Treatment|0|||
44391389|NCT00661999|79397891|FG002|Overall Study|Alternative Treatment|0|||
44391390|NCT00661999|79397889|FG000|Overall Study|Other Medical Problems|4|||
44391391|NCT00661999|79397890|FG001|Overall Study|Other Medical Problems|4|||
44391392|NCT00661999|79397891|FG002|Overall Study|Other Medical Problems|9|||
44391393|NCT00665353|79397899|FG000|Study Step 1|Adverse Event|1|||
44391394|NCT00665353|79397899|FG000|Study Step 1|Withdrawal by Subject|2|||
44391395|NCT00665353|79397899|FG000|Study Step 2|Lost to Follow-up|2|||
44391396|NCT00665353|79397899|FG000|Study Step 2|Lack of Efficacy|12|||
44391397|NCT00597207|79397905|FG000|Overall Study|Lost to Follow-up|5|||
44391398|NCT00597207|79397906|FG001|Overall Study|Lost to Follow-up|7|||
44391399|NCT00879645|79397916|FG000|Overall Study|Adverse Event|1|||
44391400|NCT00879645|79397917|FG001|Overall Study|Adverse Event|0|||
44391401|NCT00879645|79397918|FG002|Overall Study|Adverse Event|0|||
44391402|NCT00879645|79397919|FG003|Overall Study|Adverse Event|0|||
44391403|NCT00664105|79397929|FG000|Overall Study|Death|3|||
44391404|NCT00664105|79397929|FG000|Overall Study|Withdrawal by Subject|5|||
44391405|NCT00664105|79397929|FG000|Overall Study|Adverse Event|9|||
44391406|NCT00664105|79397929|FG000|Overall Study|Disease progression|7|||
44391407|NCT00661687|79397934|FG000|Overall Study|Study related symptoms and complaints|5|||
44391408|NCT00661687|79397934|FG000|Overall Study|Positive slit lamp findings|4|||
44391409|NCT00661687|79397934|FG000|Overall Study|Inability to maintain wearing schedule|3|||
44391410|NCT00661687|79397934|FG000|Overall Study|Physician Decision|1|||
44391411|NCT00661687|79397934|FG000|Overall Study|Adverse Event|2|||
44391412|NCT00596817|79397943|FG000|Open-label Period|Adverse Event|0|||
44391413|NCT00596817|79397944|FG001|Open-label Period|Adverse Event|49|||
44391414|NCT00596817|79397943|FG000|Open-label Period|Lack of Efficacy|0|||
44391415|NCT00596817|79397944|FG001|Open-label Period|Lack of Efficacy|33|||
44391416|NCT00596817|79397943|FG000|Open-label Period|Other Reasons|0|||
44391417|NCT00596817|79397944|FG001|Open-label Period|Other Reasons|65|||
44391418|NCT00596817|79397943|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
44391419|NCT00596817|79397944|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
44391420|NCT00596817|79397943|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
44391421|NCT00596817|79397944|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
44391422|NCT00596817|79397943|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
44391423|NCT00596817|79397944|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
44391424|NCT00596817|79397943|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
44391425|NCT00596817|79397944|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
44391426|NCT00596817|79397943|FG000|Double-blind Period|Adverse Event|5|||
44391427|NCT00596817|79397944|FG001|Double-blind Period|Adverse Event|16|||
44391428|NCT00596817|79397943|FG000|Double-blind Period|Lack of Efficacy|52|||
44391429|NCT00596817|79397944|FG001|Double-blind Period|Lack of Efficacy|28|||
44391430|NCT00596817|79397943|FG000|Double-blind Period|Non-compliance With Study Product|3|||
44391431|NCT00596817|79397944|FG001|Double-blind Period|Non-compliance With Study Product|4|||
44391432|NCT00596817|79397943|FG000|Double-blind Period|Protocol Violation|11|||
44520090|NCT03002818|79527966|FG000|Overall Study|Decision of the investigator|1|||
44391433|NCT00596817|79397944|FG001|Double-blind Period|Protocol Violation|8|||
44391434|NCT00596817|79397943|FG000|Double-blind Period|Withdrawal of Consent|7|||
44391435|NCT00596817|79397944|FG001|Double-blind Period|Withdrawal of Consent|3|||
44391436|NCT00596817|79397943|FG000|Double-blind Period|Lost to Follow-up|0|||
44391437|NCT00596817|79397944|FG001|Double-blind Period|Lost to Follow-up|2|||
44391438|NCT00596817|79397943|FG000|Double-blind Period|Other Reasons|10|||
44391439|NCT00596817|79397944|FG001|Double-blind Period|Other Reasons|18|||
44391440|NCT01000649|79397955|FG000|Overall Study|Adverse Event|5|||
44391441|NCT01000649|79397956|FG001|Overall Study|Adverse Event|1|||
44391442|NCT01000649|79397957|FG002|Overall Study|Adverse Event|2|||
44391443|NCT01000649|79397958|FG003|Overall Study|Adverse Event|4|||
44391444|NCT01000649|79397955|FG000|Overall Study|Lost to Follow-up|0|||
44391445|NCT01000649|79397956|FG001|Overall Study|Lost to Follow-up|2|||
44391446|NCT01000649|79397957|FG002|Overall Study|Lost to Follow-up|0|||
44391447|NCT01000649|79397958|FG003|Overall Study|Lost to Follow-up|2|||
44391448|NCT00879411|79397967|FG000|Overall Study|lost to follow-up (non-AE)|162|||
44391449|NCT01000493|79397973|FG000|Overall Study|Adverse Event|3|||
44391450|NCT01000493|79397974|FG001|Overall Study|Adverse Event|6|||
44391451|NCT01000493|79397973|FG000|Overall Study|Lack of Efficacy|1|||
44391452|NCT01000493|79397974|FG001|Overall Study|Lack of Efficacy|1|||
44391453|NCT01000493|79397973|FG000|Overall Study|Protocol Violation|1|||
44391454|NCT01000493|79397974|FG001|Overall Study|Protocol Violation|8|||
44391455|NCT01000493|79397973|FG000|Overall Study|Study closed/terminated|25|||
44391456|NCT01000493|79397974|FG001|Overall Study|Study closed/terminated|23|||
44391457|NCT01000493|79397973|FG000|Overall Study|Lost to Follow-up|5|||
44391458|NCT01000493|79397974|FG001|Overall Study|Lost to Follow-up|9|||
44391459|NCT01000493|79397973|FG000|Overall Study|Physician Decision|1|||
44391460|NCT01000493|79397974|FG001|Overall Study|Physician Decision|1|||
44391461|NCT01000493|79397973|FG000|Overall Study|Withdrawal by Subject|3|||
44391462|NCT01000493|79397974|FG001|Overall Study|Withdrawal by Subject|7|||
44391463|NCT00666757|79397982|FG000|Overall Study|Lost to Follow-up|39|||
44391464|NCT00666757|79397983|FG001|Overall Study|Lost to Follow-up|35|||
44391465|NCT00666757|79397982|FG000|Overall Study|Protocol Violation|23|||
44391466|NCT00666757|79397983|FG001|Overall Study|Protocol Violation|24|||
44391467|NCT00666757|79397982|FG000|Overall Study|Adverse Event|22|||
44391468|NCT00666757|79397983|FG001|Overall Study|Adverse Event|12|||
44391469|NCT00666757|79397982|FG000|Overall Study|Withdrawal by Subject|13|||
44391470|NCT00666757|79397983|FG001|Overall Study|Withdrawal by Subject|17|||
44391471|NCT00666757|79397982|FG000|Overall Study|Lack of Efficacy|3|||
44391472|NCT00666757|79397983|FG001|Overall Study|Lack of Efficacy|6|||
44391473|NCT00666757|79397982|FG000|Overall Study|Physician Decision|0|||
44391474|NCT00666757|79397983|FG001|Overall Study|Physician Decision|2|||
44391475|NCT00666757|79397982|FG000|Overall Study|Sponsor decision|0|||
44391476|NCT00666757|79397983|FG001|Overall Study|Sponsor decision|1|||
44391477|NCT01000337|79397994|FG000|Overall Study|Lost to Follow-up|4|||
44391478|NCT01000337|79397995|FG001|Overall Study|Lost to Follow-up|3|||
44391479|NCT00666679|79398003|FG000|First Intervention|Lost to Follow-up|1|||
44391480|NCT00666679|79398004|FG001|First Intervention|Lost to Follow-up|0|||
44391481|NCT00666679|79398003|FG000|First Intervention|Protocol Violation|1|||
44391482|NCT00666679|79398004|FG001|First Intervention|Protocol Violation|0|||
44391483|NCT00666679|79398003|FG000|First Intervention|Withdrawal by Subject|1|||
44391484|NCT00666679|79398004|FG001|First Intervention|Withdrawal by Subject|0|||
44391485|NCT00666679|79398003|FG000|First Intervention|Randomized did not start treatment|1|||
44520091|NCT03002194|79527970|FG000|Overall Study|Lost to Follow-up|6|||
44520092|NCT03002194|79527970|FG000|Overall Study|Adverse Event|1|||
44391486|NCT00666679|79398004|FG001|First Intervention|Randomized did not start treatment|1|||
44391487|NCT00666679|79398003|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
44391488|NCT00666679|79398004|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
44391489|NCT00666679|79398003|FG000|Washout Period of 1 Week|Protocol Violation|0|||
44391490|NCT00666679|79398004|FG001|Washout Period of 1 Week|Protocol Violation|1|||
44520093|NCT03002194|79527970|FG000|Overall Study|Lack of Efficacy|1|||
44520094|NCT03002194|79527970|FG000|Overall Study|Withdrawal by Subject|2|||
44520095|NCT02912650|79527978|FG000|Overall Study|Withdrawal by Subject|1|||
44520096|NCT02912650|79527979|FG001|Overall Study|Withdrawal by Subject|0|||
44391491|NCT00666679|79398003|FG000|Second Intervention|Adverse Event|1|||
44391492|NCT00666679|79398004|FG001|Second Intervention|Adverse Event|0|||
44391493|NCT00666679|79398003|FG000|Second Intervention|Death|0|||
44391494|NCT00666679|79398004|FG001|Second Intervention|Death|1|||
44391495|NCT00595413|79398014|FG000|Overall Study|Adverse Event|0|||
44391496|NCT00595413|79398015|FG001|Overall Study|Adverse Event|2|||
44391497|NCT00595413|79398016|FG002|Overall Study|Adverse Event|1|||
44520097|NCT02912650|79527980|FG002|Overall Study|Withdrawal by Subject|1|||
44391498|NCT00595413|79398017|FG003|Overall Study|Adverse Event|1|||
44391499|NCT00595413|79398014|FG000|Overall Study|Lost to Follow-up|2|||
44520098|NCT02912650|79527981|FG003|Overall Study|Withdrawal by Subject|5|||
44520099|NCT02912650|79527978|FG000|Overall Study|Adverse Event|0|||
44391500|NCT00595413|79398015|FG001|Overall Study|Lost to Follow-up|2|||
44391501|NCT00595413|79398016|FG002|Overall Study|Lost to Follow-up|1|||
44391502|NCT00595413|79398017|FG003|Overall Study|Lost to Follow-up|3|||
44391503|NCT00595413|79398014|FG000|Overall Study|Death|0|||
44391504|NCT00595413|79398015|FG001|Overall Study|Death|0|||
44391505|NCT00595413|79398016|FG002|Overall Study|Death|1|||
44391506|NCT00595413|79398017|FG003|Overall Study|Death|0|||
44391507|NCT00595413|79398014|FG000|Overall Study|Other|5|||
44391508|NCT00595413|79398015|FG001|Overall Study|Other|1|||
44391509|NCT00595413|79398016|FG002|Overall Study|Other|5|||
44391510|NCT00595413|79398017|FG003|Overall Study|Other|0|||
44391511|NCT01000025|79398029|FG000|Overall Study|Adverse Event|43|||
44391512|NCT01000025|79398030|FG001|Overall Study|Adverse Event|2|||
44391513|NCT01000025|79398029|FG000|Overall Study|Withdrawal by Subject|13|||
44391514|NCT01000025|79398030|FG001|Overall Study|Withdrawal by Subject|8|||
44391515|NCT01000025|79398029|FG000|Overall Study|Death|23|||
44391516|NCT01000025|79398030|FG001|Overall Study|Death|13|||
44391517|NCT01000025|79398029|FG000|Overall Study|Lack of Efficacy|363|||
44391518|NCT01000025|79398030|FG001|Overall Study|Lack of Efficacy|208|||
44391519|NCT01000025|79398029|FG000|Overall Study|Intercurrent Illness|26|||
44391520|NCT01000025|79398030|FG001|Overall Study|Intercurrent Illness|7|||
44146582|NCT02723201|78936064|FG001|Second Intervention Period|Protocol Violation|0|||
44146583|NCT02723201|78936065|FG002|Second Intervention Period|Protocol Violation|0|||
44146584|NCT02723201|78936063|FG000|Second Intervention Period|Adverse Event|1|||
44146585|NCT02723201|78936064|FG001|Second Intervention Period|Adverse Event|0|||
44146586|NCT02723201|78936065|FG002|Second Intervention Period|Adverse Event|0|||
44146587|NCT03846479|78936079|FG000|Overall Study|Death|8|||
44146588|NCT03846479|78936079|FG000|Overall Study|Lost to Follow-up|1|||
44146589|NCT00705263|78936083|FG000|Overall Study|Withdrawal by Subject|2|||
44146590|NCT00704405|78936101|FG000|Overall Study (NC Population)|Adverse Event|1|||
44146591|NCT00704405|78936102|FG001|Overall Study (NC Population)|Adverse Event|0|||
44146592|NCT00704405|78936103|FG002|Overall Study (NC Population)|Adverse Event|0|||
44146593|NCT00704405|78936104|FG003|Overall Study (NC Population)|Adverse Event|0|||
44146594|NCT00704405|78936105|FG004|Overall Study (NC Population)|Adverse Event|0|||
44146595|NCT00704405|78936101|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
44146596|NCT00704405|78936102|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
44146597|NCT00704405|78936103|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
44146598|NCT00704405|78936104|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
44146599|NCT00704405|78936105|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
44146600|NCT00704405|78936101|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
44146601|NCT00704405|78936102|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
44146602|NCT00704405|78936103|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
44146603|NCT00704405|78936104|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
44146604|NCT00704405|78936105|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
44146605|NCT00704405|78936101|FG000|Overall Study (NC Population)|Other|0|||
44146606|NCT00704405|78936102|FG001|Overall Study (NC Population)|Other|0|||
44146607|NCT00704405|78936103|FG002|Overall Study (NC Population)|Other|0|||
44146608|NCT00704405|78936104|FG003|Overall Study (NC Population)|Other|0|||
44146609|NCT00704405|78936105|FG004|Overall Study (NC Population)|Other|1|||
44146610|NCT00704405|78936101|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
44146611|NCT00704405|78936102|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
44146612|NCT00704405|78936103|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
44146613|NCT00704405|78936104|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
44146614|NCT00704405|78936105|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
44146615|NCT00704405|78936101|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
44146616|NCT00704405|78936102|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
44146617|NCT00704405|78936103|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
44146618|NCT00704405|78936104|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
44146619|NCT00704405|78936105|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
44146620|NCT01534481|78936125|FG000|Overall Study|Lost to Follow-up|29|||
44146621|NCT01534481|78936126|FG001|Overall Study|Lost to Follow-up|24|||
44146622|NCT01534481|78936125|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
44146623|NCT01534481|78936126|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
44146624|NCT00704171|78936134|FG000|Overall Study|Withdrawal by Subject|1|||
44146625|NCT00704171|78936135|FG001|Overall Study|Withdrawal by Subject|0|||
44146626|NCT00703781|78936143|FG000|Overall Study|Withdrawal by Subject|1|||
44146627|NCT00703781|78936144|FG001|Overall Study|Withdrawal by Subject|2|||
44146628|NCT00703781|78936143|FG000|Overall Study|Cancelled surgery|1|||
44146629|NCT00703781|78936144|FG001|Overall Study|Cancelled surgery|0|||
44146630|NCT00703157|78936152|FG000|Overall Study|Lost to Follow-up|0|||
44146631|NCT00703157|78936153|FG001|Overall Study|Lost to Follow-up|1|||
44146632|NCT00703157|78936152|FG000|Overall Study|source data permanently lost/ other|4|||
44391521|NCT00595335|79398038|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
44391522|NCT00595335|79398039|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
44391523|NCT00595335|79398038|FG000|Baseline to Six Months|Disease Progression|1|||
44391524|NCT00595335|79398039|FG001|Baseline to Six Months|Disease Progression|1|||
44391525|NCT00595335|79398038|FG000|Baseline to Six Months|Adverse Event|1|||
44391526|NCT00595335|79398039|FG001|Baseline to Six Months|Adverse Event|0|||
44391527|NCT00595335|79398038|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
44391528|NCT00595335|79398039|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
44391529|NCT00595335|79398038|FG000|Six Months to Twelve Months|Disease Progression|1|||
44391530|NCT00595335|79398039|FG001|Six Months to Twelve Months|Disease Progression|0|||
44391531|NCT00661609|79398049|FG000|Overall Study|Adverse Event|4|||
44391532|NCT00661609|79398049|FG000|Overall Study|Death|20|||
44391533|NCT00661609|79398049|FG000|Overall Study|Withdrawal by Subject|2|||
44391534|NCT00661609|79398049|FG000|Overall Study|PI Decision|1|||
44391535|NCT00661609|79398049|FG000|Overall Study|Survival follow up stage discontinued|11|||
44391536|NCT00661609|79398049|FG000|Overall Study|Disease progression|3|||
44391537|NCT00661531|79398053|FG000|Overall Study|Withdrawal by Subject|3|||
44391538|NCT00998309|79398057|FG000|Overall Study|Protocol Violation|4|||
44391539|NCT00999713|79398111|FG000|Overall Study|Physician Decision|2|||
44391540|NCT00999713|79398112|FG001|Overall Study|Physician Decision|0|||
44391541|NCT00997373|79398120|FG000|Overall Study|Withdrawal by Subject|5|||
44391542|NCT00997373|79398121|FG001|Overall Study|Withdrawal by Subject|0|||
44391543|NCT00997373|79398120|FG000|Overall Study|wrong tumor type|4|||
44391544|NCT00997373|79398121|FG001|Overall Study|wrong tumor type|0|||
44391545|NCT00997373|79398120|FG000|Overall Study|could not have hysterectomy|6|||
44391546|NCT00997373|79398121|FG001|Overall Study|could not have hysterectomy|0|||
44391547|NCT00663871|79398129|FG000|Overall Study|Lost to Follow-up|5|||
44391548|NCT00663871|79398130|FG001|Overall Study|Lost to Follow-up|5|||
44391549|NCT00663871|79398129|FG000|Overall Study|Withdrawal by Subject|5|||
44391550|NCT00663871|79398130|FG001|Overall Study|Withdrawal by Subject|2|||
44391551|NCT04152447|79398140|FG000|Overall Study|Lost to Follow-up|1|||
44391552|NCT04152447|79398141|FG001|Overall Study|Lost to Follow-up|0|||
44391553|NCT04152447|79398140|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
44391554|NCT04152447|79398141|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
44391555|NCT04152447|79398140|FG000|Overall Study|Withdrawal by Subject|0|||
44391556|NCT04152447|79398141|FG001|Overall Study|Withdrawal by Subject|1|||
44391557|NCT04152447|79398140|FG000|Overall Study|Found ineligible after enrolling|1|||
44391558|NCT04152447|79398141|FG001|Overall Study|Found ineligible after enrolling|1|||
44391559|NCT04152447|79398140|FG000|Overall Study|Did not receive VR headset in time.|0|||
44391560|NCT04152447|79398141|FG001|Overall Study|Did not receive VR headset in time.|2|||
44391561|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
44391562|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
44391563|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
44391564|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
44391565|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
44391566|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
44391567|NCT00996593|79398147|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
44391568|NCT00996593|79398147|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
44391569|NCT00996593|79398147|FG000|Long-Term Follow-Up|Site Closed|1|||
44391570|NCT00570661|79398151|FG000|Overall Study|Disease worsening|5|||
44391571|NCT00570661|79398151|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
44391572|NCT00570661|79398151|FG000|Overall Study|Adverse Event|1|||
44391573|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
44391574|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
44391575|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
44391576|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
44391577|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
44391578|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
44391579|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
44391580|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
44251956|NCT01042977|79087615|FG000|Overall Study|Subject no longer meets study criteria|15|||
44251957|NCT01042977|79087616|FG001|Overall Study|Subject no longer meets study criteria|13|||
44251958|NCT01042977|79087615|FG000|Overall Study|Incorrect enrollment|6|||
44251959|NCT01042977|79087616|FG001|Overall Study|Incorrect enrollment|4|||
44251960|NCT01042977|79087615|FG000|Overall Study|Safety|0|||
44251961|NCT01042977|79087616|FG001|Overall Study|Safety|2|||
44251962|NCT01042977|79087615|FG000|Overall Study|Administrative reason by sponsor|0|||
44251963|NCT01042977|79087616|FG001|Overall Study|Administrative reason by sponsor|1|||
44251964|NCT01042977|79087615|FG000|Overall Study|Various|3|||
44251965|NCT01042977|79087616|FG001|Overall Study|Various|0|||
44391581|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
44391582|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
44391583|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
44391584|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
44391585|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
44391586|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
44391587|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
44520100|NCT02912650|79527979|FG001|Overall Study|Adverse Event|0|||
44251966|NCT01041573|79087626|FG000|Overall Study|Withdrawal by Subject|2|||
44391588|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
44391589|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
44391590|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
44391591|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
44391592|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
44391593|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
44391594|NCT00934544|79398158|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
44391595|NCT00934544|79398159|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
44391596|NCT00934544|79398160|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
44391597|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
44391598|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
44391599|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
44391600|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
44391601|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
44391602|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
44391603|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
44391604|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
44391605|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
44391606|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
44391607|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
44391608|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
44391609|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
44391610|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
44391611|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
44391612|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
44391613|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
44391614|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
44391615|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
44391616|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
44391617|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
44391618|NCT00934544|79398158|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
44391619|NCT00934544|79398159|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
44391620|NCT00934544|79398160|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
44391621|NCT00999167|79398179|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
44391622|NCT00999167|79398180|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
44391623|NCT00999167|79398181|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
44391624|NCT00999167|79398179|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
44391625|NCT00999167|79398180|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
44391626|NCT00999167|79398181|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
44391627|NCT00999167|79398179|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
44391628|NCT00999167|79398180|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
44391629|NCT00999167|79398181|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
44391630|NCT00999167|79398179|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
44391631|NCT00999167|79398180|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
44391632|NCT00999167|79398181|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
44391633|NCT00999167|79398179|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
44391634|NCT00999167|79398180|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
44391635|NCT00999167|79398181|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
44391636|NCT00999167|79398179|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
44391637|NCT00999167|79398180|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
44391638|NCT00999167|79398181|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
44391639|NCT00999167|79398179|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
44391640|NCT00999167|79398180|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
44391641|NCT00999167|79398181|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
44391642|NCT00999167|79398179|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
44391643|NCT00999167|79398180|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
44391644|NCT00999167|79398181|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
44391645|NCT00570505|79398191|FG000|Overall Study|Adverse Event|7|||
44251967|NCT01041573|79087627|FG001|Overall Study|Withdrawal by Subject|5|||
44251968|NCT01041573|79087628|FG002|Overall Study|Withdrawal by Subject|2|||
44251969|NCT01041573|79087629|FG003|Overall Study|Withdrawal by Subject|0|||
44251970|NCT01041573|79087626|FG000|Overall Study|Death|1|||
44391646|NCT00570505|79398191|FG000|Overall Study|Withdrawal by Subject|7|||
44391647|NCT00570505|79398191|FG000|Overall Study|Lost to Follow-up|23|||
44391648|NCT00570505|79398191|FG000|Overall Study|Other loss to follow-up|4|||
44391649|NCT00931892|79398197|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
44391650|NCT00931892|79398198|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
44391651|NCT00666211|79398246|FG000|Overall Study|Withdrawal by Subject|10|||
44391652|NCT00666211|79398247|FG001|Overall Study|Withdrawal by Subject|13|||
44391653|NCT00666211|79398246|FG000|Overall Study|went off medication, no more pain|1|||
44391654|NCT00666211|79398247|FG001|Overall Study|went off medication, no more pain|0|||
44391655|NCT00666211|79398246|FG000|Overall Study|patient non-compliant|6|||
44391656|NCT00666211|79398247|FG001|Overall Study|patient non-compliant|6|||
44391657|NCT00666211|79398246|FG000|Overall Study|disease progression|1|||
44391658|NCT00666211|79398247|FG001|Overall Study|disease progression|8|||
44391659|NCT00666211|79398246|FG000|Overall Study|Lost to Follow-up|2|||
44391660|NCT00666211|79398247|FG001|Overall Study|Lost to Follow-up|0|||
44391661|NCT00666211|79398246|FG000|Overall Study|toxicity|0|||
44391662|NCT00666211|79398247|FG001|Overall Study|toxicity|2|||
44391663|NCT00666211|79398246|FG000|Overall Study|hospital admission|0|||
44391664|NCT00666211|79398247|FG001|Overall Study|hospital admission|5|||
44391665|NCT00666211|79398246|FG000|Overall Study|Death|0|||
44391666|NCT00666211|79398247|FG001|Overall Study|Death|2|||
44391667|NCT00666211|79398246|FG000|Overall Study|off tx for other complicating disease|0|||
44391668|NCT00666211|79398247|FG001|Overall Study|off tx for other complicating disease|1|||
44391669|NCT00666211|79398246|FG000|Overall Study|Physician Decision|0|||
44391670|NCT00666211|79398247|FG001|Overall Study|Physician Decision|1|||
44391671|NCT00878709|79398255|FG000|Overall Study|Withdrawal by Subject|197|||
44391672|NCT00878709|79398256|FG001|Overall Study|Withdrawal by Subject|120|||
44391673|NCT00878709|79398255|FG000|Overall Study|Lost to Follow-up|35|||
44391674|NCT00878709|79398256|FG001|Overall Study|Lost to Follow-up|33|||
44391675|NCT00878709|79398255|FG000|Overall Study|Other Reasons|93|||
44391676|NCT00878709|79398256|FG001|Overall Study|Other Reasons|84|||
44391677|NCT00927758|79398263|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
44391678|NCT00927758|79398264|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
44391679|NCT00927758|79398265|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
44391680|NCT00927758|79398266|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
44391681|NCT00927758|79398267|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
44520101|NCT02912650|79527980|FG002|Overall Study|Adverse Event|1|||
44520102|NCT02912650|79527981|FG003|Overall Study|Adverse Event|0|||
44520103|NCT03004924|79527994|FG000|Overall Study|Adverse Event|6|||
44520104|NCT03004924|79527995|FG001|Overall Study|Adverse Event|5|||
44520105|NCT03004924|79527996|FG002|Overall Study|Adverse Event|10|||
44520106|NCT03004924|79527994|FG000|Overall Study|Protocol Violation|4|||
44520107|NCT03004924|79527995|FG001|Overall Study|Protocol Violation|0|||
44520108|NCT03004924|79527996|FG002|Overall Study|Protocol Violation|1|||
44520109|NCT03004924|79527994|FG000|Overall Study|Withdrawal by Subject|5|||
44520110|NCT03004924|79527995|FG001|Overall Study|Withdrawal by Subject|3|||
44520111|NCT03004924|79527996|FG002|Overall Study|Withdrawal by Subject|5|||
44520112|NCT03004924|79527994|FG000|Overall Study|Lost to Follow-up|6|||
44520113|NCT03004924|79527995|FG001|Overall Study|Lost to Follow-up|1|||
44520114|NCT03004924|79527996|FG002|Overall Study|Lost to Follow-up|4|||
44520115|NCT03004924|79527994|FG000|Overall Study|Lack of Efficacy|2|||
44520116|NCT03004924|79527995|FG001|Overall Study|Lack of Efficacy|4|||
44520117|NCT03004924|79527996|FG002|Overall Study|Lack of Efficacy|2|||
44520118|NCT03004924|79527994|FG000|Overall Study|Physician Decision|1|||
44520119|NCT03004924|79527995|FG001|Overall Study|Physician Decision|0|||
44520120|NCT03004924|79527996|FG002|Overall Study|Physician Decision|1|||
44520121|NCT03004924|79527994|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44251971|NCT01041573|79087627|FG001|Overall Study|Death|0|||
44251972|NCT01041573|79087628|FG002|Overall Study|Death|0|||
44251973|NCT01041573|79087629|FG003|Overall Study|Death|0|||
44251974|NCT01041573|79087626|FG000|Overall Study|Lost to Follow-up|0|||
44251975|NCT01041573|79087627|FG001|Overall Study|Lost to Follow-up|1|||
44251976|NCT01041573|79087628|FG002|Overall Study|Lost to Follow-up|2|||
44251977|NCT01041573|79087629|FG003|Overall Study|Lost to Follow-up|1|||
44391682|NCT00927758|79398268|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
44520122|NCT03004924|79527995|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44391683|NCT00927758|79398263|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
44520123|NCT03004924|79527996|FG002|Overall Study|Withdrawal by parent/guardian|2|||
44251978|NCT01041573|79087626|FG000|Overall Study|Adverse Event|0|||
44391684|NCT00927758|79398264|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
44391685|NCT00927758|79398265|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
44391686|NCT00927758|79398266|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
44520124|NCT03004924|79527994|FG000|Overall Study|Screen Failure|1|||
44251979|NCT01041573|79087627|FG001|Overall Study|Adverse Event|2|||
44251980|NCT01041573|79087628|FG002|Overall Study|Adverse Event|0|||
44520125|NCT03004924|79527995|FG001|Overall Study|Screen Failure|0|||
44520126|NCT03004924|79527996|FG002|Overall Study|Screen Failure|0|||
44520127|NCT03004924|79527994|FG000|Overall Study|Pregnancy|0|||
44520128|NCT03004924|79527995|FG001|Overall Study|Pregnancy|1|||
44520129|NCT03004924|79527996|FG002|Overall Study|Pregnancy|0|||
44391687|NCT00927758|79398267|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
44391688|NCT00927758|79398268|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
44520130|NCT03004924|79527994|FG000|Overall Study|Terminated by Sponsor|0|||
44520131|NCT03004924|79527995|FG001|Overall Study|Terminated by Sponsor|0|||
44520132|NCT03004924|79527996|FG002|Overall Study|Terminated by Sponsor|1|||
44520133|NCT03004924|79527994|FG000|Overall Study|Missed Study Visit|0|||
44520134|NCT03004924|79527995|FG001|Overall Study|Missed Study Visit|0|||
44520135|NCT03004924|79527996|FG002|Overall Study|Missed Study Visit|2|||
44520136|NCT03004924|79527994|FG000|Overall Study|HSV1 Positive|1|||
44520137|NCT03004924|79527995|FG001|Overall Study|HSV1 Positive|0|||
44520138|NCT03004924|79527996|FG002|Overall Study|HSV1 Positive|0|||
44520139|NCT03002038|79528007|FG000|Overall Study|Adverse Event|3|||
44520140|NCT03002038|79528008|FG001|Overall Study|Adverse Event|1|||
44520141|NCT03002038|79528007|FG000|Overall Study|Withdrawal by Subject|8|||
44520142|NCT03002038|79528008|FG001|Overall Study|Withdrawal by Subject|4|||
44520143|NCT03002038|79528007|FG000|Overall Study|Immigration to another region|0|||
44520144|NCT03002038|79528008|FG001|Overall Study|Immigration to another region|2|||
44520145|NCT02911948|79528016|FG000|Overall Study|Protocol Violation|0|||
44520146|NCT02911948|79528017|FG001|Overall Study|Protocol Violation|1|||
44520147|NCT02911948|79528016|FG000|Overall Study|Withdrawal by Subject|0|||
44520148|NCT02911948|79528017|FG001|Overall Study|Withdrawal by Subject|2|||
44520149|NCT02911948|79528016|FG000|Overall Study|Lack of Efficacy|0|||
44520150|NCT02911948|79528017|FG001|Overall Study|Lack of Efficacy|1|||
44520151|NCT02911948|79528016|FG000|Overall Study|Unclassified|0|||
44520152|NCT02911948|79528017|FG001|Overall Study|Unclassified|3|||
44520153|NCT02996968|79528025|FG000|Overall Study|Withdrawal by Subject|1|||
44520154|NCT02996968|79528026|FG001|Overall Study|Withdrawal by Subject|0|||
44520155|NCT00027027|79528037|FG000|Overall Study|Adverse Event|0|||
44520156|NCT00027027|79528038|FG001|Overall Study|Adverse Event|0|||
44520157|NCT00027027|79528039|FG002|Overall Study|Adverse Event|1|||
44146633|NCT00703157|78936153|FG001|Overall Study|source data permanently lost/ other|1|||
44146634|NCT02722967|78936164|FG000|Overall Study|Adverse Event|1|||
44280969|NCT01957488|79242151|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
44280970|NCT01957488|79242152|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
44280971|NCT01957488|79242153|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
44280972|NCT01957488|79242154|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
44280973|NCT01957488|79242155|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
44280974|NCT01957488|79242156|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
44280975|NCT01957488|79242151|FG000|Test Period 2 (2 Weeks)|Other|1|||
44280976|NCT01957488|79242152|FG001|Test Period 2 (2 Weeks)|Other|0|||
44280977|NCT01957488|79242153|FG002|Test Period 2 (2 Weeks)|Other|0|||
44280978|NCT01957488|79242154|FG003|Test Period 2 (2 Weeks)|Other|0|||
44280979|NCT01957488|79242155|FG004|Test Period 2 (2 Weeks)|Other|0|||
44280980|NCT01957488|79242156|FG005|Test Period 2 (2 Weeks)|Other|0|||
44280981|NCT01957488|79242151|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
44280982|NCT01957488|79242152|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
44280983|NCT01957488|79242153|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
44280984|NCT01957488|79242154|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
44280985|NCT01957488|79242155|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
44280986|NCT01957488|79242156|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
44280987|NCT01957488|79242151|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
44280988|NCT01957488|79242152|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
44280989|NCT01957488|79242153|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
44280990|NCT01957488|79242154|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
44280991|NCT01957488|79242155|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
44280992|NCT01957488|79242156|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
44280993|NCT01957488|79242151|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
44280994|NCT01957488|79242152|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
44391689|NCT00927368|79398279|FG000|Overall Study|enrollment in another study|1|||
44520158|NCT00027027|79528040|FG003|Overall Study|Adverse Event|0|||
44520159|NCT00027027|79528041|FG004|Overall Study|Adverse Event|1|||
44146635|NCT02722967|78936165|FG001|Overall Study|Adverse Event|0|||
44146636|NCT02722967|78936166|FG002|Overall Study|Adverse Event|0|||
44146637|NCT02722967|78936164|FG000|Overall Study|Lost to Follow-up|0|||
44280995|NCT01957488|79242153|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
44280996|NCT01957488|79242154|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
44280997|NCT01957488|79242155|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
44280998|NCT01957488|79242156|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
44520160|NCT00027027|79528037|FG000|Overall Study|Admitted for Signs of PD|0|||
44520161|NCT00027027|79528038|FG001|Overall Study|Admitted for Signs of PD|0|||
44520162|NCT00027027|79528039|FG002|Overall Study|Admitted for Signs of PD|0|||
44520163|NCT00027027|79528040|FG003|Overall Study|Admitted for Signs of PD|0|||
44520164|NCT00027027|79528041|FG004|Overall Study|Admitted for Signs of PD|1|||
44520165|NCT00027027|79528037|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
44520166|NCT00027027|79528038|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
44146638|NCT02722967|78936165|FG001|Overall Study|Lost to Follow-up|1|||
44391690|NCT00927368|79398280|FG001|Overall Study|enrollment in another study|1|||
44391691|NCT00927368|79398281|FG002|Overall Study|enrollment in another study|2|||
44391692|NCT00927368|79398279|FG000|Overall Study|Lost to Follow-up|4|||
44391693|NCT00927368|79398280|FG001|Overall Study|Lost to Follow-up|0|||
44391694|NCT00927368|79398281|FG002|Overall Study|Lost to Follow-up|0|||
44391695|NCT00927368|79398279|FG000|Overall Study|equipment failure|1|||
44391696|NCT00927368|79398280|FG001|Overall Study|equipment failure|0|||
44391697|NCT00927368|79398281|FG002|Overall Study|equipment failure|0|||
44391698|NCT00927368|79398279|FG000|Overall Study|ineligible post randomization|0|||
44391699|NCT00927368|79398280|FG001|Overall Study|ineligible post randomization|3|||
44391700|NCT00927368|79398281|FG002|Overall Study|ineligible post randomization|1|||
44391701|NCT00927368|79398279|FG000|Overall Study|cancellation of surgery|0|||
44391702|NCT00927368|79398280|FG001|Overall Study|cancellation of surgery|1|||
44391703|NCT00927368|79398281|FG002|Overall Study|cancellation of surgery|2|||
44251981|NCT01041573|79087629|FG003|Overall Study|Adverse Event|0|||
44391704|NCT00662857|79398289|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
44391705|NCT00662857|79398290|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
44391706|NCT00662857|79398289|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
44391707|NCT00662857|79398290|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
44391708|NCT00662857|79398289|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
44391709|NCT00662857|79398290|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
44391710|NCT00878553|79398303|FG000|Sleep Study|Withdrawal by Subject|2|||
44391711|NCT00878553|79398304|FG001|Sleep Study|Withdrawal by Subject|0|||
44391712|NCT00878553|79398305|FG002|Sleep Study|Withdrawal by Subject|0|||
44391713|NCT00878553|79398306|FG003|Sleep Study|Withdrawal by Subject|0|||
44391714|NCT00878553|79398307|FG004|Sleep Study|Withdrawal by Subject|0|||
44391715|NCT00878553|79398303|FG000|Sleep Study|Lost to Follow-up|1|||
44391716|NCT00878553|79398304|FG001|Sleep Study|Lost to Follow-up|0|||
44391717|NCT00878553|79398305|FG002|Sleep Study|Lost to Follow-up|0|||
44391718|NCT00878553|79398306|FG003|Sleep Study|Lost to Follow-up|0|||
44391719|NCT00878553|79398307|FG004|Sleep Study|Lost to Follow-up|0|||
44391720|NCT00878553|79398303|FG000|Sleep Study|car accident|1|||
44391721|NCT00878553|79398304|FG001|Sleep Study|car accident|0|||
44391722|NCT00878553|79398305|FG002|Sleep Study|car accident|0|||
44391723|NCT00878553|79398306|FG003|Sleep Study|car accident|0|||
44391724|NCT00878553|79398307|FG004|Sleep Study|car accident|0|||
44391725|NCT00878553|79398303|FG000|Sleep Study|family emergency|1|||
44391726|NCT00878553|79398304|FG001|Sleep Study|family emergency|0|||
44391727|NCT00878553|79398305|FG002|Sleep Study|family emergency|0|||
44391728|NCT00878553|79398306|FG003|Sleep Study|family emergency|0|||
44391729|NCT00878553|79398307|FG004|Sleep Study|family emergency|0|||
44391730|NCT00878553|79398303|FG000|PK Study|Withdrawal by Subject|0|||
44391731|NCT00878553|79398304|FG001|PK Study|Withdrawal by Subject|0|||
44391732|NCT00878553|79398305|FG002|PK Study|Withdrawal by Subject|0|||
44391733|NCT00878553|79398306|FG003|PK Study|Withdrawal by Subject|1|||
44391734|NCT00878553|79398307|FG004|PK Study|Withdrawal by Subject|0|||
44391735|NCT00996437|79398326|FG000|Overall Study|Death|1|||
44391736|NCT00996437|79398327|FG001|Overall Study|Death|0|||
44391737|NCT00996437|79398326|FG000|Overall Study|Dropped|2|||
44391738|NCT00996437|79398327|FG001|Overall Study|Dropped|2|||
44391739|NCT00996437|79398326|FG000|Overall Study|Missed|2|||
44391740|NCT00996437|79398327|FG001|Overall Study|Missed|5|||
44391741|NCT00662311|79398336|FG000|Overall Study|Respiratory Infection|1|||
44391742|NCT00662311|79398337|FG001|Overall Study|Respiratory Infection|0|||
44391743|NCT00662311|79398338|FG002|Overall Study|Respiratory Infection|0|||
44391744|NCT00929708|79398351|FG000|Overall Study|Protocol Violation|2|||
44391745|NCT00929708|79398352|FG001|Overall Study|Protocol Violation|1|||
44391746|NCT00929708|79398353|FG002|Overall Study|Protocol Violation|1|||
44391747|NCT00929708|79398354|FG003|Overall Study|Protocol Violation|1|||
44391748|NCT00929708|79398355|FG004|Overall Study|Protocol Violation|1|||
44251982|NCT01041573|79087626|FG000|Overall Study|relocation|1|||
44391749|NCT00929708|79398351|FG000|Overall Study|Withdrawal by Subject|2|||
44391750|NCT00929708|79398352|FG001|Overall Study|Withdrawal by Subject|0|||
44391751|NCT00929708|79398353|FG002|Overall Study|Withdrawal by Subject|0|||
44391752|NCT00929708|79398354|FG003|Overall Study|Withdrawal by Subject|2|||
44391753|NCT00929708|79398355|FG004|Overall Study|Withdrawal by Subject|1|||
44391754|NCT00929708|79398351|FG000|Overall Study|Adverse Event|0|||
44391755|NCT00929708|79398352|FG001|Overall Study|Adverse Event|0|||
44520167|NCT00027027|79528039|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
44146639|NCT02722967|78936166|FG002|Overall Study|Lost to Follow-up|0|||
44391756|NCT00929708|79398353|FG002|Overall Study|Adverse Event|0|||
44391757|NCT00929708|79398354|FG003|Overall Study|Adverse Event|0|||
44391758|NCT00929708|79398355|FG004|Overall Study|Adverse Event|3|||
44391759|NCT00929708|79398351|FG000|Overall Study|Physician Decision|0|||
44391760|NCT00929708|79398352|FG001|Overall Study|Physician Decision|2|||
44520168|NCT00027027|79528040|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
44280999|NCT01957488|79242151|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
44281000|NCT01957488|79242152|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
44281001|NCT01957488|79242153|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
44281002|NCT01957488|79242154|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
44281003|NCT01957488|79242155|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
44281004|NCT01957488|79242156|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
44281005|NCT01957488|79242151|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
44281006|NCT01957488|79242152|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
44281007|NCT01957488|79242153|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
44520169|NCT00027027|79528041|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
44520170|NCT00027027|79528037|FG000|Overall Study|PD Requiring Surgery|0|||
44520171|NCT00027027|79528038|FG001|Overall Study|PD Requiring Surgery|0|||
44520172|NCT00027027|79528039|FG002|Overall Study|PD Requiring Surgery|1|||
44520173|NCT00027027|79528040|FG003|Overall Study|PD Requiring Surgery|0|||
44520174|NCT00027027|79528041|FG004|Overall Study|PD Requiring Surgery|0|||
44520175|NCT00027027|79528037|FG000|Overall Study|Physician Decision Due To PD|2|||
44520176|NCT00027027|79528038|FG001|Overall Study|Physician Decision Due To PD|3|||
44520177|NCT00027027|79528039|FG002|Overall Study|Physician Decision Due To PD|2|||
44520178|NCT00027027|79528040|FG003|Overall Study|Physician Decision Due To PD|3|||
44520179|NCT00027027|79528041|FG004|Overall Study|Physician Decision Due To PD|5|||
44251983|NCT01041573|79087627|FG001|Overall Study|relocation|4|||
44251984|NCT01041573|79087628|FG002|Overall Study|relocation|3|||
44251985|NCT01041573|79087629|FG003|Overall Study|relocation|1|||
44251986|NCT01041573|79087626|FG000|Overall Study|further blood extraction|0|||
44251987|NCT01041573|79087627|FG001|Overall Study|further blood extraction|1|||
44251988|NCT01041573|79087628|FG002|Overall Study|further blood extraction|0|||
44251989|NCT01041573|79087629|FG003|Overall Study|further blood extraction|0|||
44251990|NCT01041573|79087626|FG000|Overall Study|positive to anti-HCV|1|||
44251991|NCT01041573|79087627|FG001|Overall Study|positive to anti-HCV|0|||
44251992|NCT01041573|79087628|FG002|Overall Study|positive to anti-HCV|0|||
44251993|NCT01041573|79087629|FG003|Overall Study|positive to anti-HCV|0|||
44251994|NCT01041495|79087656|FG000|Overall Study|Withdrawal by Subject|2|||
44251995|NCT01041495|79087657|FG001|Overall Study|Withdrawal by Subject|5|||
44251996|NCT01041495|79087656|FG000|Overall Study|Adverse Event|2|||
44251997|NCT01041495|79087657|FG001|Overall Study|Adverse Event|1|||
44251998|NCT01041495|79087656|FG000|Overall Study|Lost to Follow-up|0|||
44251999|NCT01041495|79087657|FG001|Overall Study|Lost to Follow-up|1|||
44252000|NCT01041417|79087665|FG000|Overall Study|Adverse Event|5|||
44252001|NCT01041417|79087666|FG001|Overall Study|Adverse Event|2|||
44252002|NCT01041417|79087665|FG000|Overall Study|Lost to Follow-up|1|||
44252003|NCT01041417|79087666|FG001|Overall Study|Lost to Follow-up|1|||
44252004|NCT01041417|79087665|FG000|Overall Study|Death|1|||
44252005|NCT01041417|79087666|FG001|Overall Study|Death|0|||
44252006|NCT01040871|79087676|FG000|Overall Study|Adverse Event|6|||
44252007|NCT01040871|79087677|FG001|Overall Study|Adverse Event|2|||
44252008|NCT01040871|79087676|FG000|Overall Study|Withdrawal by Subject|2|||
44252009|NCT01040871|79087677|FG001|Overall Study|Withdrawal by Subject|0|||
44252010|NCT01040871|79087676|FG000|Overall Study|Death|1|||
44252011|NCT01040871|79087677|FG001|Overall Study|Death|3|||
44252012|NCT01040871|79087676|FG000|Overall Study|Lack of Efficacy|1|||
44252013|NCT01040871|79087677|FG001|Overall Study|Lack of Efficacy|1|||
44252014|NCT01040871|79087676|FG000|Overall Study|drug supply issue|1|||
44252015|NCT01040871|79087677|FG001|Overall Study|drug supply issue|0|||
44252016|NCT01040871|79087676|FG000|Overall Study|Randomized and Not Treated|2|||
44252017|NCT01040871|79087677|FG001|Overall Study|Randomized and Not Treated|1|||
44252018|NCT01040169|79087685|FG000|Overall Study|Lost to Follow-up|3|||
44252019|NCT01040169|79087686|FG001|Overall Study|Lost to Follow-up|8|||
44252020|NCT01673178|79087706|FG000|Overall Study|Lost to Follow-up|0|||
44252021|NCT01673178|79087707|FG001|Overall Study|Lost to Follow-up|1|||
44252022|NCT01673178|79087708|FG002|Overall Study|Lost to Follow-up|0|||
44252023|NCT01673178|79087709|FG003|Overall Study|Lost to Follow-up|0|||
44252024|NCT01673178|79087710|FG004|Overall Study|Lost to Follow-up|0|||
44252025|NCT01673178|79087706|FG000|Overall Study|Withdrawal by Subject|0|||
44252026|NCT01673178|79087707|FG001|Overall Study|Withdrawal by Subject|0|||
44252027|NCT01673178|79087708|FG002|Overall Study|Withdrawal by Subject|1|||
44252028|NCT01673178|79087709|FG003|Overall Study|Withdrawal by Subject|4|||
44252029|NCT01673178|79087710|FG004|Overall Study|Withdrawal by Subject|2|||
44252030|NCT01673178|79087706|FG000|Overall Study|Protocol Violation|1|||
44252031|NCT01673178|79087707|FG001|Overall Study|Protocol Violation|1|||
44520180|NCT00027027|79528037|FG000|Overall Study|Withdrawal by Subject|0|||
44252032|NCT01673178|79087708|FG002|Overall Study|Protocol Violation|0|||
44252033|NCT01673178|79087709|FG003|Overall Study|Protocol Violation|1|||
44252034|NCT01673178|79087710|FG004|Overall Study|Protocol Violation|0|||
44252035|NCT01673178|79087706|FG000|Overall Study|Adverse Event|1|||
44520181|NCT00027027|79528038|FG001|Overall Study|Withdrawal by Subject|0|||
44281008|NCT01957488|79242154|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
44281009|NCT01957488|79242155|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
44281010|NCT01957488|79242156|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
44281011|NCT01976364|79242164|FG000|Main Study (36 Months)|Adverse Event|63|||
44281012|NCT01976364|79242165|FG001|Main Study (36 Months)|Adverse Event|0|||
44281013|NCT01976364|79242166|FG002|Main Study (36 Months)|Adverse Event|0|||
44281014|NCT01976364|79242164|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
44520182|NCT00027027|79528039|FG002|Overall Study|Withdrawal by Subject|0|||
44520183|NCT00027027|79528040|FG003|Overall Study|Withdrawal by Subject|0|||
44520184|NCT00027027|79528041|FG004|Overall Study|Withdrawal by Subject|1|||
44520185|NCT00046839|79528059|FG000|Overall Study|Ineligible / No protocol treatment|0|||
44520186|NCT00046839|79528060|FG001|Overall Study|Ineligible / No protocol treatment|2|||
44520187|NCT00046839|79528059|FG000|Overall Study|Withdrawal of consent|1|||
44520188|NCT00046839|79528060|FG001|Overall Study|Withdrawal of consent|0|||
44520189|NCT00006903|79528069|FG000|Overall Study|Still receiving treatment|0|||
44520190|NCT00006903|79528070|FG001|Overall Study|Still receiving treatment|0|||
44520191|NCT00006903|79528071|FG002|Overall Study|Still receiving treatment|1|||
44520192|NCT00006903|79528069|FG000|Overall Study|Refused further treatment|0|||
44520193|NCT00006903|79528070|FG001|Overall Study|Refused further treatment|2|||
44391761|NCT00929708|79398353|FG002|Overall Study|Physician Decision|2|||
44391762|NCT00929708|79398354|FG003|Overall Study|Physician Decision|2|||
44391763|NCT00929708|79398355|FG004|Overall Study|Physician Decision|1|||
44391764|NCT00929708|79398351|FG000|Overall Study|Lost to Follow-up|0|||
44391765|NCT00929708|79398352|FG001|Overall Study|Lost to Follow-up|0|||
44391766|NCT00929708|79398353|FG002|Overall Study|Lost to Follow-up|0|||
44391767|NCT00929708|79398354|FG003|Overall Study|Lost to Follow-up|1|||
44391768|NCT00929708|79398355|FG004|Overall Study|Lost to Follow-up|0|||
44391769|NCT00996281|79398369|FG000|Overall Study|Adverse Event|75|||
44391770|NCT00996281|79398370|FG001|Overall Study|Adverse Event|37|||
44391771|NCT00996281|79398369|FG000|Overall Study|Major Protocol Deviation|6|||
44391772|NCT00996281|79398370|FG001|Overall Study|Major Protocol Deviation|7|||
44391773|NCT00996281|79398369|FG000|Overall Study|Lost to Follow-up|14|||
44391774|NCT00996281|79398370|FG001|Overall Study|Lost to Follow-up|16|||
44391775|NCT00996281|79398369|FG000|Overall Study|Withdrawal by Subject|31|||
44391776|NCT00996281|79398370|FG001|Overall Study|Withdrawal by Subject|20|||
44391777|NCT00996281|79398369|FG000|Overall Study|Lack of Efficacy|0|||
44391778|NCT00996281|79398370|FG001|Overall Study|Lack of Efficacy|2|||
44391779|NCT00996281|79398369|FG000|Overall Study|Other|5|||
44391780|NCT00996281|79398370|FG001|Overall Study|Other|7|||
44391781|NCT00996203|79398376|FG000|Overall Study|Adverse Event|3|||
44391782|NCT00996203|79398376|FG000|Overall Study|Lost to Follow-up|1|||
44391783|NCT00996203|79398376|FG000|Overall Study|Lack of Efficacy|1|||
44391784|NCT00996203|79398376|FG000|Overall Study|Protocol Violation|2|||
44391785|NCT00877929|79398383|FG000|Overall Study|Adverse Event|11|||
44391786|NCT00877929|79398384|FG001|Overall Study|Adverse Event|20|||
44391787|NCT00877929|79398383|FG000|Overall Study|Protocol Violation|3|||
44391788|NCT00877929|79398384|FG001|Overall Study|Protocol Violation|3|||
44391789|NCT00877929|79398383|FG000|Overall Study|Lost to Follow-up|0|||
44391790|NCT00877929|79398384|FG001|Overall Study|Lost to Follow-up|1|||
44391791|NCT00877929|79398383|FG000|Overall Study|Withdrawal by Subject|4|||
44391792|NCT00877929|79398384|FG001|Overall Study|Withdrawal by Subject|4|||
44391793|NCT00877929|79398383|FG000|Overall Study|Lack of Efficacy|0|||
44391794|NCT00877929|79398384|FG001|Overall Study|Lack of Efficacy|1|||
44391795|NCT00877929|79398383|FG000|Overall Study|Other reason (not specified)|2|||
44391796|NCT00877929|79398384|FG001|Overall Study|Other reason (not specified)|6|||
44391797|NCT00931268|79398394|FG000|Overall Study|Lost to Follow-up|6|||
44391798|NCT00996125|79398400|FG000|Overall Study|Adverse Event|0|||
44391799|NCT00996125|79398401|FG001|Overall Study|Adverse Event|2|||
44391800|NCT00996125|79398400|FG000|Overall Study|Lost to Follow-up|1|||
44391801|NCT00996125|79398401|FG001|Overall Study|Lost to Follow-up|6|||
44391802|NCT00996125|79398400|FG000|Overall Study|Withdrawal by Subject|4|||
44520194|NCT00006903|79528071|FG002|Overall Study|Refused further treatment|1|||
44520195|NCT00006903|79528069|FG000|Overall Study|Adverse Event|0|||
44520196|NCT00006903|79528070|FG001|Overall Study|Adverse Event|0|||
44520197|NCT00006903|79528071|FG002|Overall Study|Adverse Event|1|||
44391803|NCT00996125|79398401|FG001|Overall Study|Withdrawal by Subject|3|||
44281015|NCT01976364|79242165|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
44391804|NCT04211363|79398409|FG000|Overall Study|Adverse Event|5|||
44391805|NCT04211363|79398410|FG001|Overall Study|Adverse Event|2|||
44391806|NCT04211363|79398409|FG000|Overall Study|Physician Decision|0|||
44391807|NCT04211363|79398410|FG001|Overall Study|Physician Decision|1|||
44391808|NCT04211363|79398409|FG000|Overall Study|Protocol Violation|1|||
44391809|NCT04211363|79398410|FG001|Overall Study|Protocol Violation|0|||
44391810|NCT04211363|79398409|FG000|Overall Study|Pregnancy|1|||
44391811|NCT04211363|79398410|FG001|Overall Study|Pregnancy|0|||
44391812|NCT04211363|79398409|FG000|Overall Study|Lost to Follow-up|12|||
44520198|NCT00006903|79528069|FG000|Overall Study|Death|0|||
44520199|NCT00006903|79528070|FG001|Overall Study|Death|1|||
44520200|NCT00006903|79528071|FG002|Overall Study|Death|0|||
44520201|NCT00006903|79528069|FG000|Overall Study|Patient never treated|0|||
44520202|NCT00006903|79528070|FG001|Overall Study|Patient never treated|0|||
44520203|NCT00006903|79528071|FG002|Overall Study|Patient never treated|1|||
44520204|NCT00006903|79528069|FG000|Overall Study|Ineligible|10|||
44520205|NCT00006903|79528070|FG001|Overall Study|Ineligible|1|||
44520206|NCT00006903|79528071|FG002|Overall Study|Ineligible|2|||
44520207|NCT00026793|79528079|FG000|Overall Study|Death on study due to underlying disease|4|||
44520208|NCT00026793|79528079|FG000|Overall Study|Physician Decision|2|||
44520209|NCT00026793|79528079|FG000|Overall Study|Off study|2|||
44520210|NCT03539484|79528090|FG000|Overall Study|Death|1|||
44520211|NCT03539484|79528091|FG001|Overall Study|Death|0|||
44520212|NCT03539484|79528092|FG002|Overall Study|Death|0|||
44520213|NCT03539484|79528093|FG003|Overall Study|Death|2|||
44520214|NCT03539484|79528094|FG004|Overall Study|Death|8|||
44146640|NCT02722967|78936164|FG000|Overall Study|Non-compliance with patch wearing|2|||
44146641|NCT02722967|78936165|FG001|Overall Study|Non-compliance with patch wearing|1|||
44252036|NCT01673178|79087707|FG001|Overall Study|Adverse Event|0|||
44252037|NCT01673178|79087708|FG002|Overall Study|Adverse Event|0|||
44252038|NCT01673178|79087709|FG003|Overall Study|Adverse Event|2|||
44252039|NCT01673178|79087710|FG004|Overall Study|Adverse Event|0|||
44252040|NCT01673178|79087706|FG000|Overall Study|Other|1|||
44252041|NCT01673178|79087707|FG001|Overall Study|Other|0|||
44252042|NCT01673178|79087708|FG002|Overall Study|Other|2|||
44252043|NCT01673178|79087709|FG003|Overall Study|Other|1|||
44252044|NCT01673178|79087710|FG004|Overall Study|Other|0|||
44281016|NCT01976364|79242166|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
44281017|NCT01976364|79242164|FG000|Main Study (36 Months)|Other|13|||
44281018|NCT01976364|79242165|FG001|Main Study (36 Months)|Other|0|||
44281019|NCT01976364|79242166|FG002|Main Study (36 Months)|Other|0|||
44281020|NCT01976364|79242164|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
44281021|NCT01976364|79242165|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
44281022|NCT01976364|79242166|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
44281023|NCT01976364|79242164|FG000|Main Study (36 Months)|Medication error|1|||
44281024|NCT01976364|79242165|FG001|Main Study (36 Months)|Medication error|0|||
44391813|NCT04211363|79398410|FG001|Overall Study|Lost to Follow-up|4|||
44391814|NCT04211363|79398409|FG000|Overall Study|Withdrawal by Subject|11|||
44391815|NCT04211363|79398410|FG001|Overall Study|Withdrawal by Subject|11|||
44391816|NCT04211363|79398409|FG000|Overall Study|Other|1|||
44391817|NCT04211363|79398410|FG001|Overall Study|Other|2|||
44391818|NCT00995345|79398421|FG000|Overall Study|Withdrawal by Subject|4|||
44391819|NCT00995345|79398422|FG001|Overall Study|Withdrawal by Subject|2|||
44391820|NCT00995345|79398423|FG002|Overall Study|Withdrawal by Subject|1|||
44391821|NCT00995345|79398424|FG003|Overall Study|Withdrawal by Subject|3|||
44391822|NCT00995345|79398425|FG004|Overall Study|Withdrawal by Subject|1|||
44391823|NCT00995345|79398421|FG000|Overall Study|Adverse Event|3|||
44391824|NCT00995345|79398422|FG001|Overall Study|Adverse Event|1|||
44391825|NCT00995345|79398423|FG002|Overall Study|Adverse Event|2|||
44391826|NCT00995345|79398424|FG003|Overall Study|Adverse Event|0|||
44252045|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
44391827|NCT00995345|79398425|FG004|Overall Study|Adverse Event|1|||
44391828|NCT00995345|79398421|FG000|Overall Study|Lost to Follow-up|2|||
44391829|NCT00995345|79398422|FG001|Overall Study|Lost to Follow-up|2|||
44391830|NCT00995345|79398423|FG002|Overall Study|Lost to Follow-up|2|||
44520215|NCT03539484|79528095|FG005|Overall Study|Death|3|||
44520216|NCT03539484|79528096|FG006|Overall Study|Death|0|||
44520217|NCT03539484|79528090|FG000|Overall Study|Lost to Follow-up|0|||
44520218|NCT03539484|79528091|FG001|Overall Study|Lost to Follow-up|1|||
44520219|NCT03539484|79528092|FG002|Overall Study|Lost to Follow-up|0|||
44391831|NCT00995345|79398424|FG003|Overall Study|Lost to Follow-up|1|||
44391832|NCT00995345|79398425|FG004|Overall Study|Lost to Follow-up|0|||
44391833|NCT00995345|79398421|FG000|Overall Study|all other reasons combined|2|||
44391834|NCT00995345|79398422|FG001|Overall Study|all other reasons combined|2|||
44391835|NCT00995345|79398423|FG002|Overall Study|all other reasons combined|2|||
44391836|NCT00995345|79398424|FG003|Overall Study|all other reasons combined|1|||
44391837|NCT00995345|79398425|FG004|Overall Study|all other reasons combined|3|||
44391838|NCT00660907|79398439|FG000|Overall Study|Incorrect Enrollment|1|||
44391839|NCT00660907|79398440|FG001|Overall Study|Incorrect Enrollment|1|||
44391840|NCT00660907|79398439|FG000|Overall Study|Adverse Event|33|||
44391841|NCT00660907|79398440|FG001|Overall Study|Adverse Event|19|||
44391842|NCT00660907|79398439|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
44391843|NCT00660907|79398440|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
44391844|NCT00660907|79398439|FG000|Overall Study|Withdrawal by Subject|23|||
44391845|NCT00660907|79398440|FG001|Overall Study|Withdrawal by Subject|32|||
44391846|NCT00660907|79398439|FG000|Overall Study|Lost to Follow-up|3|||
44391847|NCT00660907|79398440|FG001|Overall Study|Lost to Follow-up|3|||
44391848|NCT00660907|79398439|FG000|Overall Study|Poor/Non-Compliance|5|||
44391849|NCT00660907|79398440|FG001|Overall Study|Poor/Non-Compliance|1|||
44391850|NCT00660907|79398439|FG000|Overall Study|Safety|1|||
44391851|NCT00660907|79398440|FG001|Overall Study|Safety|0|||
44391852|NCT00660907|79398439|FG000|Overall Study|Death|1|||
44391853|NCT00660907|79398440|FG001|Overall Study|Death|3|||
44391854|NCT00660907|79398439|FG000|Overall Study|Various|11|||
44391855|NCT00660907|79398440|FG001|Overall Study|Various|8|||
44391856|NCT00877773|79398446|FG000|Overall Study|Disease Progression|44|||
44391857|NCT00659815|79398452|FG000|Overall Study|Study related symptoms and complaints|2|||
44391858|NCT00659815|79398453|FG001|Overall Study|Study related symptoms and complaints|1|||
44391859|NCT00659815|79398452|FG000|Overall Study|Inability to maintain wearing schedule|1|||
44391860|NCT00659815|79398453|FG001|Overall Study|Inability to maintain wearing schedule|2|||
44391861|NCT00659815|79398452|FG000|Overall Study|Withdrawal by Subject|1|||
44391862|NCT00659815|79398453|FG001|Overall Study|Withdrawal by Subject|1|||
44391863|NCT00994643|79398459|FG000|Overall Study|Withdrawal by Subject|1|||
44391864|NCT00660829|79398465|FG000|Overall Study|Adverse Event|3|||
44391865|NCT00660829|79398466|FG001|Overall Study|Adverse Event|4|||
44391866|NCT00660829|79398465|FG000|Overall Study|Lack of Efficacy|2|||
44391867|NCT00660829|79398466|FG001|Overall Study|Lack of Efficacy|3|||
44391868|NCT00660829|79398465|FG000|Overall Study|Non-Compliance|0|||
44391869|NCT00660829|79398466|FG001|Overall Study|Non-Compliance|4|||
44391870|NCT00660829|79398465|FG000|Overall Study|Withdrawal by Subject|1|||
44391871|NCT00660829|79398466|FG001|Overall Study|Withdrawal by Subject|2|||
44391872|NCT00660829|79398465|FG000|Overall Study|Lost to Follow-up|3|||
44391873|NCT00660829|79398466|FG001|Overall Study|Lost to Follow-up|2|||
44391874|NCT00660829|79398465|FG000|Overall Study|Other|9|||
44391875|NCT00660829|79398466|FG001|Overall Study|Other|4|||
44391876|NCT00877383|79398474|FG000|Overall Study|Adverse Event|13|||
44391877|NCT00877383|79398475|FG001|Overall Study|Adverse Event|14|||
44146642|NCT02722967|78936166|FG002|Overall Study|Non-compliance with patch wearing|1|||
44146643|NCT02722967|78936164|FG000|Overall Study|Withdrawal by Subject|1|||
44146644|NCT02722967|78936165|FG001|Overall Study|Withdrawal by Subject|0|||
44146645|NCT02722967|78936166|FG002|Overall Study|Withdrawal by Subject|1|||
44146646|NCT02722967|78936164|FG000|Overall Study|Physician Decision|1|||
44146647|NCT02722967|78936165|FG001|Overall Study|Physician Decision|0|||
44146648|NCT02722967|78936166|FG002|Overall Study|Physician Decision|0|||
44146649|NCT02722967|78936164|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
44146650|NCT02722967|78936165|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
44146651|NCT02722967|78936166|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
44146652|NCT02722499|78936177|FG000|Overall Study|Lost to Follow-up|2|||
44146653|NCT02722499|78936178|FG001|Overall Study|Lost to Follow-up|0|||
44146654|NCT02722499|78936179|FG002|Overall Study|Lost to Follow-up|1|||
44146655|NCT02721875|78936189|FG000|Overall Study|Progressive disease/relapse|1|||
44146656|NCT02721875|78936190|FG001|Overall Study|Progressive disease/relapse|0|||
44146657|NCT02721251|78936199|FG000|Overall Study|Withdrawal by Subject|8|||
44252046|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
44391878|NCT00877383|79398474|FG000|Overall Study|Lost to Follow-up|5|||
44391879|NCT00877383|79398475|FG001|Overall Study|Lost to Follow-up|3|||
44391880|NCT00877383|79398474|FG000|Overall Study|Subject withdrew consent|3|||
44391881|NCT00877383|79398475|FG001|Overall Study|Subject withdrew consent|12|||
44391882|NCT00877383|79398474|FG000|Overall Study|Subject no longer requires study drug|2|||
44146658|NCT02721251|78936200|FG001|Overall Study|Withdrawal by Subject|7|||
44146659|NCT02721251|78936201|FG002|Overall Study|Withdrawal by Subject|9|||
44391883|NCT00877383|79398475|FG001|Overall Study|Subject no longer requires study drug|0|||
44391884|NCT00877383|79398474|FG000|Overall Study|Administrative problems|2|||
44391885|NCT00877383|79398475|FG001|Overall Study|Administrative problems|0|||
44391886|NCT00877383|79398474|FG000|Overall Study|Protocol deviation|2|||
44391887|NCT00877383|79398475|FG001|Overall Study|Protocol deviation|6|||
44391888|NCT00877383|79398474|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44146660|NCT02721251|78936199|FG000|Overall Study|poor adherence|2|||
44146661|NCT02721251|78936200|FG001|Overall Study|poor adherence|2|||
44146662|NCT02721251|78936201|FG002|Overall Study|poor adherence|2|||
44391889|NCT00877383|79398475|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44391890|NCT00877383|79398474|FG000|Overall Study|Death|1|||
44391891|NCT00877383|79398475|FG001|Overall Study|Death|2|||
44391892|NCT00993473|79398483|FG000|Overall Study|Adverse Event|0|||
44391893|NCT00993473|79398484|FG001|Overall Study|Adverse Event|2|||
44391894|NCT00993473|79398483|FG000|Overall Study|Protocol Violation|1|||
44146663|NCT00702221|78936212|FG000|Overall Study|Adverse Event|4|||
44146664|NCT00702221|78936213|FG001|Overall Study|Adverse Event|3|||
44146665|NCT00702143|78936222|FG000|Overall Study|Lost to Follow-up|0|||
44146666|NCT00702143|78936223|FG001|Overall Study|Lost to Follow-up|0|||
44146667|NCT00702143|78936224|FG002|Overall Study|Lost to Follow-up|1|||
44146668|NCT00702923|78936230|FG000|Overall Study|Adverse Event|1|||
44146669|NCT02633787|78936235|FG000|Overall Study|Withdrawal by Subject|1|||
44391895|NCT00993473|79398484|FG001|Overall Study|Protocol Violation|2|||
44391896|NCT00993473|79398483|FG000|Overall Study|Lost to Follow-up|1|||
44391897|NCT00993473|79398484|FG001|Overall Study|Lost to Follow-up|0|||
44391898|NCT00993473|79398483|FG000|Overall Study|Withdrawal by Subject|1|||
44391899|NCT00993473|79398484|FG001|Overall Study|Withdrawal by Subject|5|||
44391900|NCT00993473|79398483|FG000|Overall Study|Technical problem with CGM device|0|||
44391901|NCT00993473|79398484|FG001|Overall Study|Technical problem with CGM device|1|||
44391902|NCT00993473|79398483|FG000|Overall Study|Family event|1|||
44391903|NCT00993473|79398484|FG001|Overall Study|Family event|0|||
44391904|NCT00660595|79398492|FG000|Overall Study|Lost to Follow-up|0|||
44520220|NCT03539484|79528093|FG003|Overall Study|Lost to Follow-up|0|||
44520221|NCT03539484|79528094|FG004|Overall Study|Lost to Follow-up|1|||
44146670|NCT02719691|78936246|FG000|Overall Study|Physician Decision|0|||
44146671|NCT02719691|78936247|FG001|Overall Study|Physician Decision|0|||
44391905|NCT00660595|79398493|FG001|Overall Study|Lost to Follow-up|1|||
44391906|NCT00660595|79398492|FG000|Overall Study|Did not consent to participate in study|12|||
44391907|NCT00660595|79398493|FG001|Overall Study|Did not consent to participate in study|8|||
44391908|NCT00660595|79398492|FG000|Overall Study|Participant left hospital|1|||
44391909|NCT00660595|79398493|FG001|Overall Study|Participant left hospital|0|||
44391910|NCT00660595|79398492|FG000|Overall Study|Non Specified reasons|5|||
44391911|NCT00660595|79398493|FG001|Overall Study|Non Specified reasons|0|||
44391912|NCT00929240|79398499|FG000|Initial Treatment Phase|Adverse Event|31|||
44391913|NCT00929240|79398500|FG001|Initial Treatment Phase|Adverse Event|0|||
44391914|NCT00929240|79398501|FG002|Initial Treatment Phase|Adverse Event|0|||
44391915|NCT00929240|79398499|FG000|Initial Treatment Phase|Disease progression|41|||
44391916|NCT00929240|79398500|FG001|Initial Treatment Phase|Disease progression|0|||
44391917|NCT00929240|79398501|FG002|Initial Treatment Phase|Disease progression|0|||
44391918|NCT00929240|79398499|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
44391919|NCT00929240|79398500|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
44391920|NCT00929240|79398501|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
44391921|NCT00929240|79398499|FG000|Initial Treatment Phase|Protocol Violation|5|||
44391922|NCT00929240|79398500|FG001|Initial Treatment Phase|Protocol Violation|0|||
44391923|NCT00929240|79398501|FG002|Initial Treatment Phase|Protocol Violation|0|||
44391924|NCT00929240|79398499|FG000|Initial Treatment Phase|Death|2|||
44391925|NCT00929240|79398500|FG001|Initial Treatment Phase|Death|0|||
44391926|NCT00929240|79398501|FG002|Initial Treatment Phase|Death|0|||
44391927|NCT00929240|79398499|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
44391928|NCT00929240|79398500|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
44391929|NCT00929240|79398501|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
44391930|NCT00929240|79398499|FG000|Initial Treatment Phase|Physician Decision|4|||
44391931|NCT00929240|79398500|FG001|Initial Treatment Phase|Physician Decision|0|||
44391932|NCT00929240|79398501|FG002|Initial Treatment Phase|Physician Decision|0|||
44391933|NCT00929240|79398499|FG000|Maintenance Phase|Disease progression|0|||
44391934|NCT00929240|79398500|FG001|Maintenance Phase|Disease progression|73|||
44391935|NCT00929240|79398501|FG002|Maintenance Phase|Disease progression|60|||
44520222|NCT03539484|79528095|FG005|Overall Study|Lost to Follow-up|0|||
44520223|NCT03539484|79528096|FG006|Overall Study|Lost to Follow-up|0|||
44146672|NCT02719691|78936248|FG002|Overall Study|Physician Decision|1|||
44146673|NCT02719691|78936249|FG003|Overall Study|Physician Decision|0|||
44146674|NCT02719691|78936250|FG004|Overall Study|Physician Decision|0|||
44391936|NCT00929240|79398499|FG000|Maintenance Phase|Adverse Event|0|||
44391937|NCT00929240|79398500|FG001|Maintenance Phase|Adverse Event|9|||
44391938|NCT00929240|79398501|FG002|Maintenance Phase|Adverse Event|12|||
44391939|NCT00929240|79398499|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44391940|NCT00929240|79398500|FG001|Maintenance Phase|Withdrawal by Subject|2|||
44391941|NCT00929240|79398501|FG002|Maintenance Phase|Withdrawal by Subject|6|||
44391942|NCT00929240|79398499|FG000|Maintenance Phase|Protocol Violation|0|||
44391943|NCT00929240|79398500|FG001|Maintenance Phase|Protocol Violation|1|||
44520224|NCT03539484|79528090|FG000|Overall Study|Withdrawal by Subject|0|||
44520225|NCT03539484|79528091|FG001|Overall Study|Withdrawal by Subject|0|||
44391944|NCT00929240|79398501|FG002|Maintenance Phase|Protocol Violation|0|||
44391945|NCT00929240|79398499|FG000|Maintenance Phase|Health authority/Study termination|0|||
44391946|NCT00929240|79398500|FG001|Maintenance Phase|Health authority/Study termination|1|||
44391947|NCT00929240|79398501|FG002|Maintenance Phase|Health authority/Study termination|2|||
44391948|NCT00929240|79398499|FG000|Maintenance Phase|Physician Decision|0|||
44391949|NCT00929240|79398500|FG001|Maintenance Phase|Physician Decision|2|||
44391950|NCT00929240|79398501|FG002|Maintenance Phase|Physician Decision|1|||
44391951|NCT00929240|79398499|FG000|Maintenance Phase|Change of treatment|0|||
44391952|NCT00929240|79398500|FG001|Maintenance Phase|Change of treatment|4|||
44391953|NCT00929240|79398501|FG002|Maintenance Phase|Change of treatment|0|||
44391954|NCT00929240|79398499|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
44391955|NCT00929240|79398500|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
44391956|NCT00929240|79398501|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
44391957|NCT00929240|79398499|FG000|Maintenance Phase|Participant not treated|0|||
44391958|NCT00929240|79398500|FG001|Maintenance Phase|Participant not treated|2|||
44391959|NCT00929240|79398501|FG002|Maintenance Phase|Participant not treated|0|||
44391960|NCT00993317|79398512|FG000|Overall Study|Adverse Event|2|||
44391961|NCT00993317|79398513|FG001|Overall Study|Adverse Event|4|||
44391962|NCT00993317|79398512|FG000|Overall Study|Lack of Efficacy|18|||
44391963|NCT00993317|79398513|FG001|Overall Study|Lack of Efficacy|18|||
44391964|NCT00993317|79398512|FG000|Overall Study|Withdrawal by Subject|0|||
44281025|NCT01976364|79242166|FG002|Main Study (36 Months)|Medication error|0|||
44391965|NCT00993317|79398513|FG001|Overall Study|Withdrawal by Subject|2|||
44391966|NCT00993317|79398512|FG000|Overall Study|Investigator's opinion|0|||
44520226|NCT03539484|79528092|FG002|Overall Study|Withdrawal by Subject|0|||
44520227|NCT03539484|79528093|FG003|Overall Study|Withdrawal by Subject|0|||
44520228|NCT03539484|79528094|FG004|Overall Study|Withdrawal by Subject|2|||
44520229|NCT03539484|79528095|FG005|Overall Study|Withdrawal by Subject|0|||
44520230|NCT03539484|79528096|FG006|Overall Study|Withdrawal by Subject|1|||
44520231|NCT03539484|79528090|FG000|Overall Study|Study Terminated by Sponsor|0|||
44520232|NCT03539484|79528091|FG001|Overall Study|Study Terminated by Sponsor|0|||
44520233|NCT03539484|79528092|FG002|Overall Study|Study Terminated by Sponsor|1|||
44520234|NCT03539484|79528093|FG003|Overall Study|Study Terminated by Sponsor|1|||
44520235|NCT03539484|79528094|FG004|Overall Study|Study Terminated by Sponsor|2|||
44520236|NCT03539484|79528095|FG005|Overall Study|Study Terminated by Sponsor|2|||
44520237|NCT03539484|79528096|FG006|Overall Study|Study Terminated by Sponsor|1|||
44520238|NCT03561090|79528119|FG000|Overall Study|Adverse Event|11|||
44520239|NCT03561090|79528120|FG001|Overall Study|Adverse Event|7|||
44520240|NCT03561090|79528119|FG000|Overall Study|Non-Compliance With Study Drug|2|||
44520241|NCT03561090|79528120|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44520242|NCT03561090|79528119|FG000|Overall Study|Protocol Violation|2|||
44520243|NCT03561090|79528120|FG001|Overall Study|Protocol Violation|2|||
44520244|NCT03561090|79528119|FG000|Overall Study|Withdrawal by Subject|7|||
44520245|NCT03561090|79528120|FG001|Overall Study|Withdrawal by Subject|7|||
44520246|NCT03561090|79528119|FG000|Overall Study|Lost to Follow-up|7|||
44520247|NCT03561090|79528120|FG001|Overall Study|Lost to Follow-up|2|||
44520248|NCT03561090|79528119|FG000|Overall Study|Study Terminated by Sponsor|10|||
44520249|NCT03561090|79528120|FG001|Overall Study|Study Terminated by Sponsor|15|||
44520250|NCT03561090|79528119|FG000|Overall Study|Randomized by Mistake|1|||
44520251|NCT03561090|79528120|FG001|Overall Study|Randomized by Mistake|1|||
44520252|NCT03561090|79528119|FG000|Overall Study|Other Not Specified|0|||
44520253|NCT03561090|79528120|FG001|Overall Study|Other Not Specified|2|||
44520254|NCT02996500|79528134|FG000|Overall Study|Adverse Event|1|||
44520255|NCT02996500|79528135|FG001|Overall Study|Adverse Event|1|||
44520256|NCT02996500|79528136|FG002|Overall Study|Adverse Event|4|||
44520257|NCT02996500|79528137|FG003|Overall Study|Adverse Event|3|||
44520258|NCT02996500|79528138|FG004|Overall Study|Adverse Event|1|||
44520259|NCT02996500|79528139|FG005|Overall Study|Adverse Event|2|||
44520260|NCT02996500|79528134|FG000|Overall Study|Lack of Efficacy|0|||
44520261|NCT02996500|79528135|FG001|Overall Study|Lack of Efficacy|0|||
44520262|NCT02996500|79528136|FG002|Overall Study|Lack of Efficacy|0|||
44520263|NCT02996500|79528137|FG003|Overall Study|Lack of Efficacy|0|||
44520264|NCT02996500|79528138|FG004|Overall Study|Lack of Efficacy|2|||
44520265|NCT02996500|79528139|FG005|Overall Study|Lack of Efficacy|0|||
44520266|NCT02996500|79528134|FG000|Overall Study|Lost to Follow-up|1|||
44520267|NCT02996500|79528135|FG001|Overall Study|Lost to Follow-up|0|||
44520268|NCT02996500|79528136|FG002|Overall Study|Lost to Follow-up|0|||
44520269|NCT02996500|79528137|FG003|Overall Study|Lost to Follow-up|0|||
44520270|NCT02996500|79528138|FG004|Overall Study|Lost to Follow-up|0|||
44520271|NCT02996500|79528139|FG005|Overall Study|Lost to Follow-up|1|||
44391967|NCT00993317|79398513|FG001|Overall Study|Investigator's opinion|1|||
44391968|NCT00993317|79398512|FG000|Overall Study|Early study termination at the site|1|||
44520272|NCT02996500|79528134|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44520273|NCT02996500|79528135|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44520274|NCT02996500|79528136|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
44520275|NCT02996500|79528137|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
44391969|NCT00993317|79398513|FG001|Overall Study|Early study termination at the site|0|||
44391970|NCT01030133|79398521|FG000|Overall Study|failed to experience pain at level 7/10|2|||
44391971|NCT01030133|79398522|FG001|Overall Study|failed to experience pain at level 7/10|2|||
44391972|NCT00877071|79398532|FG000|Overall Study|disease progression|2|||
44391973|NCT00987389|79398538|FG000|Overall Study|Ineligible|0|||
44391974|NCT00987389|79398539|FG001|Overall Study|Ineligible|3|||
44391975|NCT00987389|79398540|FG002|Overall Study|Ineligible|0|||
44391976|NCT00987389|79398541|FG003|Overall Study|Ineligible|0|||
44391977|NCT00987389|79398538|FG000|Overall Study|Lost to Follow-up|4|||
44391978|NCT00987389|79398539|FG001|Overall Study|Lost to Follow-up|1|||
44391979|NCT00987389|79398540|FG002|Overall Study|Lost to Follow-up|3|||
44391980|NCT00987389|79398541|FG003|Overall Study|Lost to Follow-up|1|||
44391981|NCT00987389|79398538|FG000|Overall Study|Withdrawal by Subject|4|||
44391982|NCT00987389|79398539|FG001|Overall Study|Withdrawal by Subject|3|||
44391983|NCT00987389|79398540|FG002|Overall Study|Withdrawal by Subject|2|||
44391984|NCT00987389|79398541|FG003|Overall Study|Withdrawal by Subject|1|||
44391985|NCT00987389|79398538|FG000|Overall Study|Withdrawn from Treatment|0|||
44391986|NCT00987389|79398539|FG001|Overall Study|Withdrawn from Treatment|1|||
44391987|NCT00987389|79398540|FG002|Overall Study|Withdrawn from Treatment|0|||
44391988|NCT00987389|79398541|FG003|Overall Study|Withdrawn from Treatment|0|||
44391989|NCT00987389|79398538|FG000|Overall Study|Multiple different reasons|1|||
44391990|NCT00987389|79398539|FG001|Overall Study|Multiple different reasons|0|||
44391991|NCT00987389|79398540|FG002|Overall Study|Multiple different reasons|3|||
44391992|NCT00987389|79398541|FG003|Overall Study|Multiple different reasons|1|||
44391993|NCT00929162|79398551|FG000|Overall Study|Adverse Event|8|||
44391994|NCT00929162|79398552|FG001|Overall Study|Adverse Event|5|||
44391995|NCT00929162|79398551|FG000|Overall Study|Withdrawal by Subject|3|||
44391996|NCT00929162|79398552|FG001|Overall Study|Withdrawal by Subject|1|||
44391997|NCT00929162|79398551|FG000|Overall Study|Protocol Violation|32|||
44391998|NCT00929162|79398552|FG001|Overall Study|Protocol Violation|30|||
44391999|NCT00929162|79398551|FG000|Overall Study|Other termination reason|5|||
44392000|NCT00929162|79398552|FG001|Overall Study|Other termination reason|6|||
44392001|NCT00992459|79398560|FG000|Overall Study|Withdrawal by Subject|0|||
44392002|NCT00992459|79398561|FG001|Overall Study|Withdrawal by Subject|1|||
44392003|NCT00992459|79398560|FG000|Overall Study|Adverse Event|1|||
44392004|NCT00992459|79398561|FG001|Overall Study|Adverse Event|0|||
44392005|NCT00930722|79398567|FG000|Overall Study|Lost to Follow-up|16|||
44392006|NCT00930722|79398567|FG000|Overall Study|No longer willing to participate|9|||
44392007|NCT00930722|79398567|FG000|Overall Study|Study terminated by sponsor|2|||
44392008|NCT00992225|79398571|FG000|Overall Study|Entry Criteria Not Met|8|||
44392009|NCT00992225|79398571|FG000|Overall Study|Adverse Event|2|||
44392010|NCT00659581|79398575|FG000|Overall Study|Adverse Event|1006|||
44392011|NCT00659581|79398575|FG000|Overall Study|Lack of Efficacy|1183|||
44392012|NCT00659581|79398575|FG000|Overall Study|Other|6393|||
44392013|NCT00991289|79398579|FG000|Overall Study|Adverse Event|1|||
44392014|NCT00991289|79398579|FG000|Overall Study|Physician Decision|2|||
44392015|NCT00991289|79398579|FG000|Overall Study|Withdrawal by Subject|3|||
44392016|NCT00991289|79398579|FG000|Overall Study|Lost to Follow-up|4|||
44392017|NCT00991289|79398579|FG000|Overall Study|Protocol Violation|2|||
44392018|NCT00930644|79398583|FG000|Overall Study|Withdrawal by Subject|4|||
44392019|NCT00930644|79398583|FG000|Overall Study|Physician Decision|2|||
44392020|NCT00930644|79398583|FG000|Overall Study|Death|1|||
44392021|NCT00930644|79398583|FG000|Overall Study|Adverse Event|16|||
44392022|NCT00990821|79398604|FG000|Overall Study|Withdrawal by Subject|0|||
44252047|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
44252048|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
44252049|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
44252050|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
44252051|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
44252052|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
44252053|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
44252054|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
44252055|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
44252056|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
44252057|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
44252058|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
44252059|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
44252060|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
44252061|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
44252062|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
44392023|NCT00990821|79398605|FG001|Overall Study|Withdrawal by Subject|2|||
44392024|NCT00990821|79398606|FG002|Overall Study|Withdrawal by Subject|0|||
44392025|NCT00990821|79398607|FG003|Overall Study|Withdrawal by Subject|0|||
44392026|NCT00990821|79398608|FG004|Overall Study|Withdrawal by Subject|3|||
44392027|NCT00990821|79398609|FG005|Overall Study|Withdrawal by Subject|3|||
44392028|NCT00990821|79398610|FG006|Overall Study|Withdrawal by Subject|1|||
44392029|NCT00990821|79398611|FG007|Overall Study|Withdrawal by Subject|0|||
44392030|NCT00990821|79398612|FG008|Overall Study|Withdrawal by Subject|0|||
44392031|NCT00990821|79398613|FG009|Overall Study|Withdrawal by Subject|1|||
44392032|NCT00990821|79398614|FG010|Overall Study|Withdrawal by Subject|3|||
44392033|NCT00990821|79398615|FG011|Overall Study|Withdrawal by Subject|5|||
44392034|NCT00990821|79398616|FG012|Overall Study|Withdrawal by Subject|2|||
44392035|NCT00990821|79398617|FG013|Overall Study|Withdrawal by Subject|1|||
44392036|NCT00990665|79398634|FG000|Overall Study|Unsuccessful Implant|8|||
44392037|NCT00990665|79398634|FG000|Overall Study|Death|29|||
44392038|NCT00990665|79398634|FG000|Overall Study|Heart Transplant|1|||
44392039|NCT00990665|79398634|FG000|Overall Study|Withdrawal by Subject|6|||
44392040|NCT00990665|79398634|FG000|Overall Study|Lost to Follow-up|1|||
44392041|NCT00990665|79398634|FG000|Overall Study|System Explant|3|||
44392042|NCT00658567|79398643|FG000|Overall Study|Adverse Event|5|||
44392043|NCT00658567|79398644|FG001|Overall Study|Adverse Event|2|||
44392044|NCT00658567|79398645|FG002|Overall Study|Adverse Event|3|||
44392045|NCT00658567|79398643|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
44392046|NCT00658567|79398644|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
44392047|NCT00658567|79398645|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
44392048|NCT00658567|79398643|FG000|Overall Study|Physician Decision|0|||
44392049|NCT00658567|79398644|FG001|Overall Study|Physician Decision|1|||
44392050|NCT00658567|79398645|FG002|Overall Study|Physician Decision|0|||
44392051|NCT00658567|79398643|FG000|Overall Study|At Discretion of Sponsor|1|||
44392052|NCT00658567|79398644|FG001|Overall Study|At Discretion of Sponsor|1|||
44392053|NCT00658567|79398645|FG002|Overall Study|At Discretion of Sponsor|1|||
44392054|NCT00875433|79398653|FG000|Overall Study|Progressive disease|41|||
44392055|NCT00875433|79398653|FG000|Overall Study|Other Adverse Event|14|||
44392056|NCT00875433|79398653|FG000|Overall Study|Withdrawal by Subject|2|||
44392057|NCT00875433|79398653|FG000|Overall Study|Other|3|||
44392058|NCT00985985|79398661|FG000|Overall Study|Adverse Event|4|||
44392059|NCT00985985|79398662|FG001|Overall Study|Adverse Event|2|||
44392060|NCT00985985|79398663|FG002|Overall Study|Adverse Event|2|||
44392061|NCT00985985|79398664|FG003|Overall Study|Adverse Event|2|||
44392062|NCT00985985|79398661|FG000|Overall Study|Lost to Follow-up|4|||
44392063|NCT00985985|79398662|FG001|Overall Study|Lost to Follow-up|11|||
44392064|NCT00985985|79398663|FG002|Overall Study|Lost to Follow-up|2|||
44392065|NCT00985985|79398664|FG003|Overall Study|Lost to Follow-up|3|||
44392066|NCT00985985|79398661|FG000|Overall Study|Protocol Violation|1|||
44392067|NCT00985985|79398662|FG001|Overall Study|Protocol Violation|2|||
44392068|NCT00985985|79398663|FG002|Overall Study|Protocol Violation|0|||
44392069|NCT00985985|79398664|FG003|Overall Study|Protocol Violation|1|||
44252063|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
44252064|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
44252065|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
44252066|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
44252067|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
44252068|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
44252069|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
44252070|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
44252071|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
44252072|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
44252073|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
44252074|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
44252075|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
44252076|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
44252077|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
44252078|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
44252079|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
44252080|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
44252081|NCT03593213|79087739|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
44252082|NCT03593213|79087740|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
44252083|NCT03593213|79087741|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
44392070|NCT00985985|79398661|FG000|Overall Study|Lack of Efficacy|5|||
44392071|NCT00985985|79398662|FG001|Overall Study|Lack of Efficacy|6|||
44392072|NCT00985985|79398663|FG002|Overall Study|Lack of Efficacy|1|||
44392073|NCT00985985|79398664|FG003|Overall Study|Lack of Efficacy|3|||
44252084|NCT03593213|79087742|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
44252085|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
44252086|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
44252087|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
44281026|NCT01976364|79242164|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
44392074|NCT00985985|79398661|FG000|Overall Study|Withdrawal by Subject|4|||
44392075|NCT00985985|79398662|FG001|Overall Study|Withdrawal by Subject|2|||
44392076|NCT00985985|79398663|FG002|Overall Study|Withdrawal by Subject|2|||
44392077|NCT00985985|79398664|FG003|Overall Study|Withdrawal by Subject|2|||
44392078|NCT00985985|79398661|FG000|Overall Study|Other Reason|6|||
44392079|NCT00985985|79398662|FG001|Overall Study|Other Reason|1|||
44392080|NCT00985985|79398663|FG002|Overall Study|Other Reason|4|||
44392081|NCT00985985|79398664|FG003|Overall Study|Other Reason|2|||
44392082|NCT00923936|79398681|FG000|Overall Study|progressive disease on study|2|||
44392083|NCT00923936|79398682|FG001|Overall Study|progressive disease on study|1|||
44392084|NCT00923936|79398681|FG000|Overall Study|Adverse Event|2|||
44392085|NCT00923936|79398682|FG001|Overall Study|Adverse Event|1|||
44392086|NCT00923936|79398681|FG000|Overall Study|Lost to follow up|2|||
44392087|NCT00923936|79398682|FG001|Overall Study|Lost to follow up|0|||
44392088|NCT00923936|79398681|FG000|Overall Study|Continuing in follow up period|2|||
44392089|NCT00923936|79398682|FG001|Overall Study|Continuing in follow up period|1|||
44392090|NCT00924950|79398690|FG000|Overall Study|Lost to Follow-up|2|||
44392091|NCT00988637|79398699|FG000|Overall Study|Lost to Follow-up|2|||
44392092|NCT00988637|79398700|FG001|Overall Study|Lost to Follow-up|1|||
44392093|NCT00988637|79398699|FG000|Overall Study|Withdrawal by Subject|1|||
44392094|NCT00988637|79398700|FG001|Overall Study|Withdrawal by Subject|1|||
44392095|NCT00988637|79398699|FG000|Overall Study|non-compliance with study drug|0|||
44392096|NCT00988637|79398700|FG001|Overall Study|non-compliance with study drug|1|||
44392097|NCT00923156|79398709|FG000|Overall Study|Adverse Event|0|||
44392098|NCT00923156|79398710|FG001|Overall Study|Adverse Event|2|||
44392099|NCT00923156|79398711|FG002|Overall Study|Adverse Event|1|||
44392100|NCT00923156|79398709|FG000|Overall Study|Abnormal laboratory values|0|||
44392101|NCT00923156|79398710|FG001|Overall Study|Abnormal laboratory values|0|||
44392102|NCT00923156|79398711|FG002|Overall Study|Abnormal laboratory values|1|||
44392103|NCT00923156|79398709|FG000|Overall Study|Withdrawal by Subject|0|||
44392104|NCT00923156|79398710|FG001|Overall Study|Withdrawal by Subject|1|||
44392105|NCT00923156|79398711|FG002|Overall Study|Withdrawal by Subject|0|||
44392106|NCT00923156|79398709|FG000|Overall Study|Death|0|||
44392107|NCT00923156|79398710|FG001|Overall Study|Death|1|||
44392108|NCT00923156|79398711|FG002|Overall Study|Death|0|||
44392109|NCT00923156|79398709|FG000|Overall Study|Lack of Efficacy|0|||
44392110|NCT00923156|79398710|FG001|Overall Study|Lack of Efficacy|0|||
44392111|NCT00923156|79398711|FG002|Overall Study|Lack of Efficacy|1|||
44392112|NCT00874731|79398719|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
44392113|NCT00874731|79398720|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
44392114|NCT00874731|79398721|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
44392115|NCT00874731|79398719|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
44392116|NCT00874731|79398720|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
44392117|NCT00874731|79398721|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
44392118|NCT00874731|79398719|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
44392119|NCT00874731|79398720|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
44392120|NCT00874731|79398721|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
44392121|NCT00924638|79398731|FG000|Overall Study|Death|3|||
44392122|NCT00924638|79398732|FG001|Overall Study|Death|2|||
44392123|NCT00924638|79398731|FG000|Overall Study|Lost to Follow-up|1|||
44392124|NCT00924638|79398732|FG001|Overall Study|Lost to Follow-up|1|||
44392125|NCT00924638|79398731|FG000|Overall Study|Withdrawal by Subject|5|||
44392126|NCT00924638|79398732|FG001|Overall Study|Withdrawal by Subject|7|||
44520276|NCT02996500|79528138|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
44520277|NCT02996500|79528139|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
44520278|NCT02996500|79528134|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44520279|NCT02996500|79528135|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44520280|NCT02996500|79528136|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44392127|NCT00924638|79398731|FG000|Overall Study|Physician Decision|3|||
44392128|NCT00924638|79398732|FG001|Overall Study|Physician Decision|3|||
44392129|NCT00874497|79398740|FG000|Overall Study|Lost to Follow-up|2|||
44392130|NCT00874497|79398741|FG001|Overall Study|Lost to Follow-up|4|||
44392131|NCT00874497|79398740|FG000|Overall Study|Adverse Event|9|||
44392132|NCT00874497|79398741|FG001|Overall Study|Adverse Event|4|||
44392133|NCT00874497|79398740|FG000|Overall Study|Sponsor Discontinued Trial|7|||
44392134|NCT00874497|79398741|FG001|Overall Study|Sponsor Discontinued Trial|3|||
44392135|NCT00874497|79398740|FG000|Overall Study|Met Withdrawal Criteria|4|||
44392136|NCT00874497|79398741|FG001|Overall Study|Met Withdrawal Criteria|2|||
44392137|NCT00874497|79398740|FG000|Overall Study|Physician Decision|1|||
44520281|NCT02996500|79528137|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44392138|NCT00874497|79398741|FG001|Overall Study|Physician Decision|1|||
44392139|NCT00874497|79398740|FG000|Overall Study|Withdrawal by Subject|5|||
44392140|NCT00874497|79398741|FG001|Overall Study|Withdrawal by Subject|4|||
44392141|NCT00924560|79398750|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
44392142|NCT00924560|79398751|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
44392143|NCT00924560|79398752|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
44392144|NCT00924560|79398750|FG000|Overall Study|Non Compliance with the Protocol|20|||
44392145|NCT00924560|79398751|FG001|Overall Study|Non Compliance with the Protocol|15|||
44392146|NCT00924560|79398752|FG002|Overall Study|Non Compliance with the Protocol|4|||
44392147|NCT00924560|79398750|FG000|Overall Study|Physician Decision|2|||
44392148|NCT00924560|79398751|FG001|Overall Study|Physician Decision|3|||
44392149|NCT00924560|79398752|FG002|Overall Study|Physician Decision|4|||
44392150|NCT00924560|79398750|FG000|Overall Study|Withdrawal by Subject|50|||
44392151|NCT00924560|79398751|FG001|Overall Study|Withdrawal by Subject|44|||
44392152|NCT00924560|79398752|FG002|Overall Study|Withdrawal by Subject|18|||
44392153|NCT00924560|79398750|FG000|Overall Study|Adverse Event|39|||
44392154|NCT00924560|79398751|FG001|Overall Study|Adverse Event|33|||
44392155|NCT00924560|79398752|FG002|Overall Study|Adverse Event|0|||
44392156|NCT00924560|79398750|FG000|Overall Study|Pregnancy|5|||
44392157|NCT00924560|79398751|FG001|Overall Study|Pregnancy|7|||
44392158|NCT00924560|79398752|FG002|Overall Study|Pregnancy|1|||
44392159|NCT00924560|79398750|FG000|Overall Study|Lost to Follow-up|78|||
44392160|NCT00924560|79398751|FG001|Overall Study|Lost to Follow-up|94|||
44392161|NCT00924560|79398752|FG002|Overall Study|Lost to Follow-up|45|||
44392162|NCT00924560|79398750|FG000|Overall Study|Miscellaneous Reasons|13|||
44392163|NCT00924560|79398751|FG001|Overall Study|Miscellaneous Reasons|10|||
44392164|NCT00924560|79398752|FG002|Overall Study|Miscellaneous Reasons|10|||
44392165|NCT00923078|79398765|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
44392166|NCT00923078|79398766|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
44392167|NCT00923078|79398767|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
44392168|NCT00923078|79398765|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
44392169|NCT00923078|79398766|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
44392170|NCT00923078|79398767|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
44392171|NCT00978731|79398778|FG000|Overall Study|Death|4|||
44392172|NCT00978731|79398779|FG001|Overall Study|Death|1|||
44392173|NCT00978731|79398780|FG002|Overall Study|Death|1|||
44520282|NCT02996500|79528138|FG004|Overall Study|Non-Compliance With Study Drug|0|||
44520283|NCT02996500|79528139|FG005|Overall Study|Non-Compliance With Study Drug|1|||
44520284|NCT02996500|79528134|FG000|Overall Study|Progressive Disease|1|||
44520285|NCT02996500|79528135|FG001|Overall Study|Progressive Disease|0|||
44520286|NCT02996500|79528136|FG002|Overall Study|Progressive Disease|0|||
44520287|NCT02996500|79528137|FG003|Overall Study|Progressive Disease|0|||
44520288|NCT02996500|79528138|FG004|Overall Study|Progressive Disease|0|||
44520289|NCT02996500|79528139|FG005|Overall Study|Progressive Disease|0|||
44520290|NCT02996500|79528134|FG000|Overall Study|Other|2|||
44520291|NCT02996500|79528135|FG001|Overall Study|Other|0|||
44520292|NCT02996500|79528136|FG002|Overall Study|Other|2|||
44520293|NCT02996500|79528137|FG003|Overall Study|Other|0|||
44520294|NCT02996500|79528138|FG004|Overall Study|Other|0|||
44520295|NCT02996500|79528139|FG005|Overall Study|Other|0|||
44520296|NCT02996500|79528134|FG000|Overall Study|Protocol Violation|0|||
44520297|NCT02996500|79528135|FG001|Overall Study|Protocol Violation|0|||
44520298|NCT02996500|79528136|FG002|Overall Study|Protocol Violation|0|||
44520299|NCT02996500|79528137|FG003|Overall Study|Protocol Violation|1|||
44146675|NCT02719691|78936251|FG005|Overall Study|Physician Decision|0|||
44146676|NCT02719691|78936252|FG006|Overall Study|Physician Decision|0|||
44146677|NCT02719691|78936246|FG000|Overall Study|Withdrawal by Subject|0|||
44146678|NCT02719691|78936247|FG001|Overall Study|Withdrawal by Subject|0|||
44146679|NCT02719691|78936248|FG002|Overall Study|Withdrawal by Subject|0|||
44146680|NCT02719691|78936249|FG003|Overall Study|Withdrawal by Subject|0|||
44146681|NCT02719691|78936250|FG004|Overall Study|Withdrawal by Subject|0|||
44146682|NCT02719691|78936251|FG005|Overall Study|Withdrawal by Subject|1|||
44281027|NCT01976364|79242165|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
44146683|NCT02719691|78936252|FG006|Overall Study|Withdrawal by Subject|0|||
44392174|NCT00978731|79398781|FG003|Overall Study|Death|0|||
44392175|NCT00978731|79398778|FG000|Overall Study|Lost to Follow-up|0|||
44392176|NCT00978731|79398779|FG001|Overall Study|Lost to Follow-up|0|||
44392177|NCT00978731|79398780|FG002|Overall Study|Lost to Follow-up|0|||
44392178|NCT00978731|79398781|FG003|Overall Study|Lost to Follow-up|1|||
44392179|NCT00978731|79398778|FG000|Overall Study|Adverse Event|5|||
44520300|NCT02996500|79528138|FG004|Overall Study|Protocol Violation|0|||
44520301|NCT02996500|79528139|FG005|Overall Study|Protocol Violation|0|||
44520302|NCT02996500|79528134|FG000|Overall Study|Withdrawal by Subject|3|||
44146684|NCT02720081|78936271|FG000|Overall Study|Adverse Event|0|||
44146685|NCT02720081|78936272|FG001|Overall Study|Adverse Event|3|||
44392180|NCT00978731|79398779|FG001|Overall Study|Adverse Event|2|||
44392181|NCT00978731|79398780|FG002|Overall Study|Adverse Event|0|||
44520303|NCT02996500|79528135|FG001|Overall Study|Withdrawal by Subject|0|||
44392182|NCT00978731|79398781|FG003|Overall Study|Adverse Event|0|||
44392183|NCT00978731|79398778|FG000|Overall Study|Participant's request|1|||
44392184|NCT00978731|79398779|FG001|Overall Study|Participant's request|0|||
44392185|NCT00978731|79398780|FG002|Overall Study|Participant's request|0|||
44392186|NCT00978731|79398781|FG003|Overall Study|Participant's request|0|||
44392187|NCT00978731|79398778|FG000|Overall Study|Administrative reason|3|||
44392188|NCT00978731|79398779|FG001|Overall Study|Administrative reason|3|||
44392189|NCT00978731|79398780|FG002|Overall Study|Administrative reason|1|||
44392190|NCT00978731|79398781|FG003|Overall Study|Administrative reason|0|||
44392191|NCT00978731|79398778|FG000|Overall Study|Deterioration without progression|0|||
44392192|NCT00978731|79398779|FG001|Overall Study|Deterioration without progression|1|||
44392193|NCT00978731|79398780|FG002|Overall Study|Deterioration without progression|0|||
44392194|NCT00978731|79398781|FG003|Overall Study|Deterioration without progression|0|||
44392195|NCT00978731|79398778|FG000|Overall Study|Disease progression/relapse|5|||
44392196|NCT00978731|79398779|FG001|Overall Study|Disease progression/relapse|4|||
44392197|NCT00978731|79398780|FG002|Overall Study|Disease progression/relapse|2|||
44392198|NCT00978731|79398781|FG003|Overall Study|Disease progression/relapse|2|||
44392199|NCT00978731|79398778|FG000|Overall Study|Study closure|3|||
44392200|NCT00978731|79398779|FG001|Overall Study|Study closure|4|||
44392201|NCT00978731|79398780|FG002|Overall Study|Study closure|1|||
44392202|NCT00978731|79398781|FG003|Overall Study|Study closure|1|||
44392203|NCT00978731|79398778|FG000|Overall Study|No response|1|||
44392204|NCT00978731|79398779|FG001|Overall Study|No response|0|||
44392205|NCT00978731|79398780|FG002|Overall Study|No response|0|||
44392206|NCT00978731|79398781|FG003|Overall Study|No response|0|||
44392207|NCT05056870|79398795|FG000|Period 1|Site COVID-19 Related|3|||
44392208|NCT05056870|79398796|FG001|Period 1|Site COVID-19 Related|3|||
44392209|NCT05056870|79398795|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
44392210|NCT05056870|79398796|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
44392211|NCT05056870|79398795|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
44392212|NCT05056870|79398796|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
44392213|NCT05056870|79398795|FG000|Period 2|COVID-19 Related|1|||
44392214|NCT05056870|79398796|FG001|Period 2|COVID-19 Related|0|||
44392215|NCT05056870|79398795|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
44392216|NCT05056870|79398796|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
44392217|NCT04488822|79398820|FG000|Overall Study|Adverse Event|8|||
44392218|NCT04488822|79398820|FG000|Overall Study|Withdrawal by Subject|1|||
44392219|NCT04396626|79398833|FG000|Overall Study|Premature termination of study|975|||
44392220|NCT04242186|79398837|FG000|Overall Study|Death|5|||
44392221|NCT03934216|79398844|FG000|Randomization|Randomized in Error|1|||
44392222|NCT03934216|79398845|FG001|Randomization|Randomized in Error|1|||
44392223|NCT03934216|79398844|FG000|Treatment Period|Adverse Event|10|||
44392224|NCT03934216|79398845|FG001|Treatment Period|Adverse Event|3|||
44392225|NCT03934216|79398844|FG000|Treatment Period|Withdrawal by Participant|6|||
44392226|NCT03934216|79398845|FG001|Treatment Period|Withdrawal by Participant|2|||
44392227|NCT03934216|79398844|FG000|Treatment Period|Other Reasons|2|||
44392228|NCT03934216|79398845|FG001|Treatment Period|Other Reasons|2|||
44392229|NCT03183128|79398882|FG000|Overall Study|Adverse Event|1|||
44392230|NCT03183128|79398883|FG001|Overall Study|Adverse Event|2|||
44392231|NCT03183128|79398882|FG000|Overall Study|Withdrawal by Subject|1|||
44392232|NCT03183128|79398883|FG001|Overall Study|Withdrawal by Subject|8|||
44392233|NCT03183128|79398882|FG000|Overall Study|Protocol Violation|2|||
44392234|NCT03183128|79398883|FG001|Overall Study|Protocol Violation|0|||
44392235|NCT03183128|79398882|FG000|Overall Study|Lack of Efficacy|4|||
44392236|NCT03183128|79398883|FG001|Overall Study|Lack of Efficacy|27|||
44392237|NCT03183128|79398882|FG000|Overall Study|Lost to Follow-up|1|||
44252088|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
44252089|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
44252090|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
44252091|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
44392238|NCT03183128|79398883|FG001|Overall Study|Lost to Follow-up|0|||
44392239|NCT03183128|79398882|FG000|Overall Study|Death|2|||
44392240|NCT03183128|79398883|FG001|Overall Study|Death|0|||
44392241|NCT03183128|79398882|FG000|Overall Study|Physician Decision|1|||
44392242|NCT03183128|79398883|FG001|Overall Study|Physician Decision|0|||
44392243|NCT02308488|79398916|FG000|Overall Study|Withdrawal by Subject|2|||
44392244|NCT02159950|79398922|FG000|Overall Study|Adverse Event|0|||
44392245|NCT02159950|79398923|FG001|Overall Study|Adverse Event|1|||
44392246|NCT02159950|79398922|FG000|Overall Study|Progression|0|||
44392247|NCT02159950|79398923|FG001|Overall Study|Progression|1|||
44392248|NCT02152137|79398929|FG000|Overall Study|Withdrawal by Subject|1|||
44392249|NCT02152137|79398929|FG000|Overall Study|Originally assigned to Arm B|3|||
44392250|NCT02007512|79398937|FG000|Double Blind Treatment Period|Adverse Event|4|||
44392251|NCT02007512|79398938|FG001|Double Blind Treatment Period|Adverse Event|2|||
44392252|NCT02007512|79398939|FG002|Double Blind Treatment Period|Adverse Event|6|||
44392253|NCT02007512|79398940|FG003|Double Blind Treatment Period|Adverse Event|2|||
44392254|NCT02007512|79398937|FG000|Double Blind Treatment Period|Death|1|||
44392255|NCT02007512|79398938|FG001|Double Blind Treatment Period|Death|0|||
44392256|NCT02007512|79398939|FG002|Double Blind Treatment Period|Death|0|||
44392257|NCT02007512|79398940|FG003|Double Blind Treatment Period|Death|0|||
44392258|NCT02007512|79398937|FG000|Double Blind Treatment Period|Disease progression|44|||
44392259|NCT02007512|79398938|FG001|Double Blind Treatment Period|Disease progression|49|||
44392260|NCT02007512|79398939|FG002|Double Blind Treatment Period|Disease progression|45|||
44392261|NCT02007512|79398940|FG003|Double Blind Treatment Period|Disease progression|51|||
44392262|NCT02007512|79398937|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
44392263|NCT02007512|79398938|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
44392264|NCT02007512|79398939|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
44392265|NCT02007512|79398940|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
44392266|NCT02007512|79398937|FG000|Double Blind Treatment Period|Protocol Violation|0|||
44392267|NCT02007512|79398938|FG001|Double Blind Treatment Period|Protocol Violation|0|||
44392268|NCT02007512|79398939|FG002|Double Blind Treatment Period|Protocol Violation|0|||
44392269|NCT02007512|79398940|FG003|Double Blind Treatment Period|Protocol Violation|1|||
44392270|NCT02007512|79398937|FG000|Double Blind Treatment Period|Other|0|||
44392271|NCT02007512|79398938|FG001|Double Blind Treatment Period|Other|0|||
44392272|NCT02007512|79398939|FG002|Double Blind Treatment Period|Other|1|||
44392273|NCT02007512|79398940|FG003|Double Blind Treatment Period|Other|2|||
44392274|NCT02007512|79398937|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
44392275|NCT02007512|79398938|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
44392276|NCT02007512|79398939|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
44392277|NCT02007512|79398940|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
44392278|NCT02007512|79398937|FG000|Open Label Treatment Period|Adverse Event|0|||
44392279|NCT02007512|79398938|FG001|Open Label Treatment Period|Adverse Event|1|||
44392280|NCT02007512|79398939|FG002|Open Label Treatment Period|Adverse Event|0|||
44392281|NCT02007512|79398940|FG003|Open Label Treatment Period|Adverse Event|0|||
44392282|NCT02007512|79398937|FG000|Open Label Treatment Period|Other|0|||
44392283|NCT02007512|79398938|FG001|Open Label Treatment Period|Other|0|||
44520304|NCT02996500|79528136|FG002|Overall Study|Withdrawal by Subject|3|||
44520305|NCT02996500|79528137|FG003|Overall Study|Withdrawal by Subject|0|||
44520306|NCT02996500|79528138|FG004|Overall Study|Withdrawal by Subject|2|||
44520307|NCT02996500|79528139|FG005|Overall Study|Withdrawal by Subject|0|||
44520308|NCT00006489|79528161|FG000|Overall Study|Adverse Event|3|||
44520309|NCT00006489|79528162|FG001|Overall Study|Adverse Event|2|||
44520310|NCT00006489|79528163|FG002|Overall Study|Adverse Event|4|||
44520311|NCT00006489|79528164|FG003|Overall Study|Adverse Event|3|||
44520312|NCT00006489|79528161|FG000|Overall Study|Withdrawal by Subject|10|||
44520313|NCT00006489|79528162|FG001|Overall Study|Withdrawal by Subject|9|||
44520314|NCT00006489|79528163|FG002|Overall Study|Withdrawal by Subject|9|||
44520315|NCT00006489|79528164|FG003|Overall Study|Withdrawal by Subject|6|||
44520316|NCT00006489|79528161|FG000|Overall Study|Scheduling Conflict|0|||
44520317|NCT00006489|79528162|FG001|Overall Study|Scheduling Conflict|3|||
44520318|NCT00006489|79528163|FG002|Overall Study|Scheduling Conflict|2|||
44520319|NCT00006489|79528164|FG003|Overall Study|Scheduling Conflict|1|||
44520320|NCT00006489|79528161|FG000|Overall Study|Death|0|||
44520321|NCT00006489|79528162|FG001|Overall Study|Death|0|||
44520322|NCT00006489|79528163|FG002|Overall Study|Death|0|||
44520323|NCT00006489|79528164|FG003|Overall Study|Death|1|||
44520324|NCT03535974|79528177|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
44520325|NCT03535974|79528178|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
44520326|NCT03535974|79528179|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
44520327|NCT03535974|79528177|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
44520328|NCT03535974|79528178|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
44520329|NCT03535974|79528179|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
44520330|NCT00025233|79528187|FG000|Overall Study|Ineligible: wrong cell type|1|||
44520331|NCT00025233|79528187|FG000|Overall Study|Ineligible: wrong primary|1|||
44520332|NCT00025233|79528187|FG000|Overall Study|Ineligible: improper prior treatment|1|||
44520333|NCT00025233|79528187|FG000|Overall Study|Never treated|1|||
44520334|NCT00025155|79528197|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
44520335|NCT00025155|79528197|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
44146686|NCT02720081|78936271|FG000|Overall Study|Protocol Violation|4|||
44392284|NCT02007512|79398939|FG002|Open Label Treatment Period|Other|0|||
44392285|NCT02007512|79398940|FG003|Open Label Treatment Period|Other|1|||
44392286|NCT02007512|79398937|FG000|Open Label Treatment Period|Disease progression|0|||
44392287|NCT02007512|79398938|FG001|Open Label Treatment Period|Disease progression|17|||
44392288|NCT02007512|79398939|FG002|Open Label Treatment Period|Disease progression|0|||
44520336|NCT02998996|79528212|FG000|Overall Study|Lost to Follow-up|0|||
44520337|NCT02998996|79528213|FG001|Overall Study|Lost to Follow-up|0|||
44520338|NCT02998996|79528214|FG002|Overall Study|Lost to Follow-up|1|||
44520339|NCT02998996|79528215|FG003|Overall Study|Lost to Follow-up|0|||
44520340|NCT02998996|79528216|FG004|Overall Study|Lost to Follow-up|0|||
44392289|NCT02007512|79398940|FG003|Open Label Treatment Period|Disease progression|11|||
44392290|NCT02007512|79398937|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
44392291|NCT02007512|79398938|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
44392292|NCT02007512|79398939|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
44392293|NCT02007512|79398940|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
44392294|NCT01942135|79398955|FG000|Overall Study|Adverse Event|9|||
44392295|NCT01942135|79398956|FG001|Overall Study|Adverse Event|3|||
44392296|NCT01942135|79398955|FG000|Overall Study|Global deterioration of health status|8|||
44392297|NCT01942135|79398956|FG001|Overall Study|Global deterioration of health status|3|||
44392298|NCT01942135|79398955|FG000|Overall Study|Randomized Not Treated|2|||
44392299|NCT01942135|79398956|FG001|Overall Study|Randomized Not Treated|2|||
44392300|NCT01942135|79398955|FG000|Overall Study|Death|0|||
44392301|NCT01942135|79398956|FG001|Overall Study|Death|1|||
44392302|NCT01942135|79398955|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
44146687|NCT02720081|78936272|FG001|Overall Study|Protocol Violation|1|||
44146688|NCT04248933|78936278|FG000|Overall Study|Lost to Follow-up|9|||
44146689|NCT04248933|78936278|FG000|Overall Study|Withdrawal by Subject|2|||
44146690|NCT02718131|78936284|FG000|Overall Study|Withdrawal by Subject|1|||
44146691|NCT02718131|78936285|FG001|Overall Study|Withdrawal by Subject|0|||
44146692|NCT02718131|78936284|FG000|Overall Study|Adverse Event|1|||
44146693|NCT02718131|78936285|FG001|Overall Study|Adverse Event|0|||
44146694|NCT02718131|78936284|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
44146695|NCT02718131|78936285|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
44146696|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
44146697|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
44146698|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
44146699|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
44146700|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
44146701|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
44146702|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
44146703|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
44146704|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
44146705|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
44146706|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
44146707|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
44146708|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
44146709|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
44146710|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
44146711|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
44146712|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
44146713|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
44146714|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
44392303|NCT01942135|79398956|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
44392304|NCT01942135|79398955|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
44392305|NCT01942135|79398956|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
44252092|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
44252093|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
44392306|NCT01942135|79398955|FG000|Overall Study|Withdrawal by Subject|4|||
44392307|NCT01942135|79398956|FG001|Overall Study|Withdrawal by Subject|2|||
44392308|NCT01942135|79398955|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
44392309|NCT01942135|79398956|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
44392310|NCT00978341|79398984|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
44392311|NCT00978341|79398985|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
44392312|NCT00978029|79398995|FG000|Overall Study|Adverse Event|1|||
44392313|NCT00978029|79398996|FG001|Overall Study|Adverse Event|2|||
44392314|NCT00978029|79398997|FG002|Overall Study|Adverse Event|5|||
44392315|NCT00978029|79398995|FG000|Overall Study|Withdrawal by Subject|0|||
44392316|NCT00978029|79398996|FG001|Overall Study|Withdrawal by Subject|0|||
44392317|NCT00978029|79398997|FG002|Overall Study|Withdrawal by Subject|1|||
44392318|NCT00978029|79398995|FG000|Overall Study|Protocol Violation|0|||
44392319|NCT00978029|79398996|FG001|Overall Study|Protocol Violation|1|||
44392320|NCT00978029|79398997|FG002|Overall Study|Protocol Violation|0|||
44520341|NCT02998996|79528217|FG005|Overall Study|Lost to Follow-up|0|||
44520342|NCT02998996|79528212|FG000|Overall Study|Pregnancy|0|||
44392321|NCT00871377|79399005|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
44392322|NCT00871377|79399006|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
44146715|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
44146716|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
44146717|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
44392323|NCT00871377|79399007|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
44392324|NCT00871377|79399008|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
44392325|NCT00871377|79399009|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
44392326|NCT00871377|79399010|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
44392327|NCT00871377|79399005|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
44392328|NCT00871377|79399006|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
44392329|NCT00871377|79399007|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
44392330|NCT00871377|79399008|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
44392331|NCT00871377|79399009|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
44392332|NCT00871377|79399010|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
44392333|NCT00871377|79399005|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
44392334|NCT00871377|79399006|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392335|NCT00871377|79399007|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392336|NCT00871377|79399008|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392337|NCT00871377|79399009|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392338|NCT00871377|79399010|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392339|NCT00871377|79399005|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392340|NCT00871377|79399006|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392341|NCT00871377|79399007|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392342|NCT00871377|79399008|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392343|NCT00871377|79399009|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
44392344|NCT00871377|79399010|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
44392345|NCT00871377|79399005|FG000|Third Intervention (10 Weeks)|Death|0|||
44392346|NCT00871377|79399006|FG001|Third Intervention (10 Weeks)|Death|0|||
44392347|NCT00871377|79399007|FG002|Third Intervention (10 Weeks)|Death|0|||
44392348|NCT00871377|79399008|FG003|Third Intervention (10 Weeks)|Death|1|||
44392349|NCT00871377|79399009|FG004|Third Intervention (10 Weeks)|Death|0|||
44392350|NCT00871377|79399010|FG005|Third Intervention (10 Weeks)|Death|0|||
44392351|NCT00977561|79399020|FG000|Overall Study|Death|3|||
44392352|NCT00977561|79399021|FG001|Overall Study|Death|2|||
44392353|NCT00977561|79399020|FG000|Overall Study|Study terminated|0|||
44392354|NCT00977561|79399021|FG001|Overall Study|Study terminated|2|||
44392355|NCT00977561|79399020|FG000|Overall Study|Other|2|||
44392356|NCT00977561|79399021|FG001|Overall Study|Other|0|||
44392357|NCT00594165|79399029|FG000|Overall Study|Major protocol violation|1|||
44392358|NCT00594165|79399029|FG000|Overall Study|Lack of Efficacy|12|||
44392359|NCT00594165|79399029|FG000|Overall Study|Adverse Event|52|||
44392360|NCT00594165|79399029|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
44392361|NCT00594165|79399029|FG000|Overall Study|Subject withdrew consent|27|||
44392362|NCT00594165|79399029|FG000|Overall Study|Study ended per sponsor|102|||
44392363|NCT00594165|79399029|FG000|Overall Study|Lost to Follow-up|4|||
44392364|NCT00594165|79399029|FG000|Overall Study|Other: PI discretion|5|||
44392365|NCT00594165|79399029|FG000|Overall Study|Other: Subject moving|3|||
44392366|NCT00594165|79399029|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
44392367|NCT00594165|79399029|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
44392368|NCT00594165|79399029|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
44392369|NCT00594165|79399029|FG000|Overall Study|Other: Site terminated participation|2|||
44392370|NCT00975923|79399035|FG000|Overall Study|Withdrawal by Subject|0|||
44392371|NCT00975923|79399036|FG001|Overall Study|Withdrawal by Subject|1|||
44392372|NCT00928070|79399045|FG000|Overall Study|Lost to Follow-up|1|||
44392373|NCT00928070|79399046|FG001|Overall Study|Lost to Follow-up|2|||
44392374|NCT00928070|79399045|FG000|Overall Study|Withdrawal by Subject|10|||
44392375|NCT00928070|79399046|FG001|Overall Study|Withdrawal by Subject|3|||
44392376|NCT00928070|79399045|FG000|Overall Study|Adverse Event|14|||
44392377|NCT00928070|79399046|FG001|Overall Study|Adverse Event|26|||
44392378|NCT00928070|79399045|FG000|Overall Study|Lack of Efficacy|9|||
44392379|NCT00928070|79399046|FG001|Overall Study|Lack of Efficacy|5|||
44252094|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
44252095|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
44252096|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
44252097|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
44252098|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
44252099|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
44252100|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
44392380|NCT00928070|79399045|FG000|Overall Study|Did not meet entrance criteria|16|||
44392381|NCT00928070|79399046|FG001|Overall Study|Did not meet entrance criteria|9|||
44392382|NCT00928070|79399045|FG000|Overall Study|Protocol Violation|6|||
44392383|NCT00928070|79399046|FG001|Overall Study|Protocol Violation|5|||
44392384|NCT00928070|79399045|FG000|Overall Study|Randomized but not treated|2|||
44392385|NCT00928070|79399046|FG001|Overall Study|Randomized but not treated|2|||
44392386|NCT00928070|79399045|FG000|Overall Study|Other|5|||
44392387|NCT00928070|79399046|FG001|Overall Study|Other|5|||
44392388|NCT00924404|79399054|FG000|Overall Study|Lost to Follow-up|6|||
44392389|NCT00924404|79399055|FG001|Overall Study|Lost to Follow-up|4|||
44392390|NCT00976937|79399063|FG000|Overall Study|Adverse Event|4|||
44392391|NCT00976937|79399064|FG001|Overall Study|Adverse Event|5|||
44392392|NCT00976937|79399063|FG000|Overall Study|Lost to Follow-up|2|||
44392393|NCT00976937|79399064|FG001|Overall Study|Lost to Follow-up|1|||
44392394|NCT00976937|79399063|FG000|Overall Study|Withdrawal by Subject|5|||
44392395|NCT00976937|79399064|FG001|Overall Study|Withdrawal by Subject|3|||
44392396|NCT00976937|79399063|FG000|Overall Study|Poor compliance to protocol|3|||
44392397|NCT00976937|79399064|FG001|Overall Study|Poor compliance to protocol|0|||
44392398|NCT00976937|79399063|FG000|Overall Study|Personal and Familial Reason|2|||
44392399|NCT00976937|79399064|FG001|Overall Study|Personal and Familial Reason|2|||
44392400|NCT00976703|79399072|FG000|Overall Study|Physician Decision|1|||
44392401|NCT00976703|79399073|FG001|Overall Study|Physician Decision|1|||
44392402|NCT00976703|79399072|FG000|Overall Study|ineligible for study|2|||
44392403|NCT00976703|79399073|FG001|Overall Study|ineligible for study|2|||
44392404|NCT00975689|79399081|FG000|Overall Study|Adverse Event|0|||
44392405|NCT00975689|79399082|FG001|Overall Study|Adverse Event|3|||
44392406|NCT00975689|79399081|FG000|Overall Study|Withdrawal by Subject|1|||
44392407|NCT00975689|79399082|FG001|Overall Study|Withdrawal by Subject|0|||
44146718|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
44392408|NCT00975689|79399081|FG000|Overall Study|Physician Decision|1|||
44392409|NCT00975689|79399082|FG001|Overall Study|Physician Decision|0|||
44392410|NCT00922766|79399088|FG000|Overall Study|Death|3|||
44392411|NCT00922766|79399088|FG000|Overall Study|Withdrawal by Subject|2|||
44392412|NCT00922766|79399088|FG000|Overall Study|Other|1|||
44392413|NCT00922766|79399088|FG000|Overall Study|Adverse Event|1|||
44392414|NCT00917852|79399092|FG000|Overall Study|Death|6|||
44392415|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
44520343|NCT02998996|79528213|FG001|Overall Study|Pregnancy|1|||
44146719|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
44520344|NCT02998996|79528214|FG002|Overall Study|Pregnancy|0|||
44520345|NCT02998996|79528215|FG003|Overall Study|Pregnancy|0|||
44146720|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
44146721|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
44392416|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
44392417|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
44392418|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
44392419|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
44392420|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
44392421|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
44392422|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
44392423|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
44392424|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
44392425|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
44392426|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
44392427|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
44392428|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
44392429|NCT00976391|79399099|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
44392430|NCT00976391|79399100|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
44392431|NCT00976391|79399099|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
44392432|NCT00976391|79399100|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
44392433|NCT00976391|79399099|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
44392434|NCT00976391|79399100|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
44392435|NCT00976391|79399099|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
44392436|NCT00976391|79399100|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
44392437|NCT00976391|79399099|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
44392438|NCT00976391|79399100|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
44146722|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
44392439|NCT00976391|79399099|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
44392440|NCT00976391|79399100|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
44392441|NCT00976391|79399099|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
44392442|NCT00976391|79399100|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
44392443|NCT00917462|79399106|FG000|Overall Study|Clinical Deterioration|1|||
44392444|NCT00979901|79399114|FG000|Overall Study|Adverse Event|1|||
44392445|NCT00979901|79399115|FG001|Overall Study|Adverse Event|3|||
44392446|NCT00979901|79399116|FG002|Overall Study|Adverse Event|9|||
44520346|NCT02998996|79528216|FG004|Overall Study|Pregnancy|0|||
44520347|NCT02998996|79528217|FG005|Overall Study|Pregnancy|0|||
44520348|NCT02998996|79528212|FG000|Overall Study|Family reasons|0|||
44520349|NCT02998996|79528213|FG001|Overall Study|Family reasons|0|||
44520350|NCT02998996|79528214|FG002|Overall Study|Family reasons|0|||
44520351|NCT02998996|79528215|FG003|Overall Study|Family reasons|0|||
44520352|NCT02998996|79528216|FG004|Overall Study|Family reasons|1|||
44520353|NCT02998996|79528217|FG005|Overall Study|Family reasons|0|||
44520354|NCT02994940|79528233|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
44392447|NCT00979901|79399117|FG003|Overall Study|Adverse Event|2|||
44392448|NCT00979901|79399114|FG000|Overall Study|Lack of Efficacy|8|||
44392449|NCT00979901|79399115|FG001|Overall Study|Lack of Efficacy|4|||
44392450|NCT00979901|79399116|FG002|Overall Study|Lack of Efficacy|9|||
44392451|NCT00979901|79399117|FG003|Overall Study|Lack of Efficacy|0|||
44392452|NCT00979901|79399114|FG000|Overall Study|Lost to Follow-up|1|||
44392453|NCT00979901|79399115|FG001|Overall Study|Lost to Follow-up|1|||
44392454|NCT00979901|79399116|FG002|Overall Study|Lost to Follow-up|2|||
44392455|NCT00979901|79399117|FG003|Overall Study|Lost to Follow-up|0|||
44392456|NCT00979901|79399114|FG000|Overall Study|Protocol Violation|2|||
44392457|NCT00979901|79399115|FG001|Overall Study|Protocol Violation|2|||
44392458|NCT00979901|79399116|FG002|Overall Study|Protocol Violation|7|||
44392459|NCT00979901|79399117|FG003|Overall Study|Protocol Violation|1|||
44392460|NCT00979901|79399114|FG000|Overall Study|Withdrawal by Subject|2|||
44392461|NCT00979901|79399115|FG001|Overall Study|Withdrawal by Subject|1|||
44392462|NCT00979901|79399116|FG002|Overall Study|Withdrawal by Subject|1|||
44392463|NCT00979901|79399117|FG003|Overall Study|Withdrawal by Subject|1|||
44392464|NCT00979901|79399114|FG000|Overall Study|Noncompliance|1|||
44392465|NCT00979901|79399115|FG001|Overall Study|Noncompliance|0|||
44392466|NCT00979901|79399116|FG002|Overall Study|Noncompliance|0|||
44392467|NCT00979901|79399117|FG003|Overall Study|Noncompliance|0|||
44392468|NCT00979901|79399114|FG000|Overall Study|out-of-state|1|||
44392469|NCT00979901|79399115|FG001|Overall Study|out-of-state|0|||
44392470|NCT00979901|79399116|FG002|Overall Study|out-of-state|0|||
44392471|NCT00979901|79399117|FG003|Overall Study|out-of-state|0|||
44392472|NCT00979901|79399114|FG000|Overall Study|vacation|1|||
44392473|NCT00979901|79399115|FG001|Overall Study|vacation|0|||
44392474|NCT00979901|79399116|FG002|Overall Study|vacation|0|||
44392475|NCT00979901|79399117|FG003|Overall Study|vacation|0|||
44392476|NCT00979901|79399114|FG000|Overall Study|elevated lab values pre-randomization|1|||
44392477|NCT00979901|79399115|FG001|Overall Study|elevated lab values pre-randomization|0|||
44392478|NCT00979901|79399116|FG002|Overall Study|elevated lab values pre-randomization|0|||
44392479|NCT00979901|79399117|FG003|Overall Study|elevated lab values pre-randomization|0|||
44392480|NCT00979901|79399114|FG000|Overall Study|Discontinued in Error|0|||
44392481|NCT00979901|79399115|FG001|Overall Study|Discontinued in Error|1|||
44392482|NCT00979901|79399116|FG002|Overall Study|Discontinued in Error|0|||
44392483|NCT00979901|79399117|FG003|Overall Study|Discontinued in Error|0|||
44392484|NCT00979901|79399114|FG000|Overall Study|Left Country|0|||
44392485|NCT00979901|79399115|FG001|Overall Study|Left Country|0|||
44392486|NCT00979901|79399116|FG002|Overall Study|Left Country|1|||
44392487|NCT00979901|79399117|FG003|Overall Study|Left Country|0|||
44392488|NCT00979901|79399114|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
44392489|NCT00979901|79399115|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
44392490|NCT00979901|79399116|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
44392491|NCT00979901|79399117|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
44392492|NCT00975611|79399126|FG000|Overall Study|Screen Fail|16|||
44392493|NCT00975611|79399126|FG000|Overall Study|Physician Decision|1|||
44392494|NCT00970307|79399133|FG000|Overall Study|Serious Adverse Event|1|||
44392495|NCT00970307|79399134|FG001|Overall Study|Serious Adverse Event|0|||
44392496|NCT00970307|79399135|FG002|Overall Study|Serious Adverse Event|0|||
44392497|NCT00970307|79399133|FG000|Overall Study|Withdrawal by Subject|2|||
44392498|NCT00970307|79399134|FG001|Overall Study|Withdrawal by Subject|3|||
44392499|NCT00970307|79399135|FG002|Overall Study|Withdrawal by Subject|2|||
44392500|NCT00917384|79399145|FG000|Overall Study|Lost to Follow-up|4|||
44392501|NCT00917384|79399146|FG001|Overall Study|Lost to Follow-up|2|||
44392502|NCT00917384|79399145|FG000|Overall Study|Withdrawal by Subject|10|||
44392503|NCT00917384|79399146|FG001|Overall Study|Withdrawal by Subject|2|||
44392504|NCT00864513|79399152|FG000|Overall Study|Withdrawal by Subject|3|||
44392505|NCT00917150|79399160|FG000|Overall Study|Adverse Event|12|||
44392506|NCT00917150|79399161|FG001|Overall Study|Adverse Event|7|||
44392507|NCT00917150|79399162|FG002|Overall Study|Adverse Event|12|||
44392508|NCT00917150|79399163|FG003|Overall Study|Adverse Event|11|||
44392509|NCT00917150|79399160|FG000|Overall Study|Death|1|||
44392510|NCT00917150|79399161|FG001|Overall Study|Death|4|||
44392511|NCT00917150|79399162|FG002|Overall Study|Death|3|||
44392512|NCT00917150|79399163|FG003|Overall Study|Death|2|||
44392513|NCT00917150|79399160|FG000|Overall Study|Lost to Follow-up|1|||
44392514|NCT00917150|79399161|FG001|Overall Study|Lost to Follow-up|0|||
44392515|NCT00917150|79399162|FG002|Overall Study|Lost to Follow-up|4|||
44392516|NCT00917150|79399163|FG003|Overall Study|Lost to Follow-up|2|||
44392517|NCT00917150|79399160|FG000|Overall Study|Physician Decision|0|||
44392518|NCT00917150|79399161|FG001|Overall Study|Physician Decision|2|||
44392519|NCT00917150|79399162|FG002|Overall Study|Physician Decision|0|||
44392520|NCT00917150|79399163|FG003|Overall Study|Physician Decision|1|||
44392521|NCT00917150|79399160|FG000|Overall Study|Protocol Violation|5|||
44392522|NCT00917150|79399161|FG001|Overall Study|Protocol Violation|5|||
44392523|NCT00917150|79399162|FG002|Overall Study|Protocol Violation|3|||
44392524|NCT00917150|79399163|FG003|Overall Study|Protocol Violation|5|||
44392525|NCT00917150|79399160|FG000|Overall Study|Withdrawal by Subject|15|||
44392526|NCT00917150|79399161|FG001|Overall Study|Withdrawal by Subject|16|||
44392527|NCT00917150|79399162|FG002|Overall Study|Withdrawal by Subject|18|||
44392528|NCT00917150|79399163|FG003|Overall Study|Withdrawal by Subject|11|||
44392529|NCT00917150|79399160|FG000|Overall Study|Other than specified|3|||
44392530|NCT00917150|79399161|FG001|Overall Study|Other than specified|3|||
44392531|NCT00917150|79399162|FG002|Overall Study|Other than specified|2|||
44392532|NCT00917150|79399163|FG003|Overall Study|Other than specified|2|||
44392533|NCT00659425|79399183|FG000|Overall Study|Disease progression|1|||
44392534|NCT00659425|79399184|FG001|Overall Study|Disease progression|0|||
44392535|NCT00659425|79399185|FG002|Overall Study|Disease progression|0|||
44392536|NCT00659425|79399186|FG003|Overall Study|Disease progression|1|||
44392537|NCT00659425|79399187|FG004|Overall Study|Disease progression|0|||
44392538|NCT00659425|79399188|FG005|Overall Study|Disease progression|2|||
44392539|NCT00659425|79399189|FG006|Overall Study|Disease progression|4|||
44392540|NCT00659425|79399190|FG007|Overall Study|Disease progression|3|||
44392541|NCT00659425|79399191|FG008|Overall Study|Disease progression|5|||
44392542|NCT00659425|79399192|FG009|Overall Study|Disease progression|3|||
44392543|NCT00659425|79399183|FG000|Overall Study|Death|0|||
44392544|NCT00659425|79399184|FG001|Overall Study|Death|0|||
44392545|NCT00659425|79399185|FG002|Overall Study|Death|0|||
44392546|NCT00659425|79399186|FG003|Overall Study|Death|1|||
44392547|NCT00659425|79399187|FG004|Overall Study|Death|0|||
44392548|NCT00659425|79399188|FG005|Overall Study|Death|0|||
44392549|NCT00659425|79399189|FG006|Overall Study|Death|1|||
44392550|NCT00659425|79399190|FG007|Overall Study|Death|0|||
44392551|NCT00659425|79399191|FG008|Overall Study|Death|0|||
44392552|NCT00659425|79399192|FG009|Overall Study|Death|0|||
44392553|NCT00659425|79399183|FG000|Overall Study|Adverse Event|0|||
44392554|NCT00659425|79399184|FG001|Overall Study|Adverse Event|0|||
44392555|NCT00659425|79399185|FG002|Overall Study|Adverse Event|0|||
44392556|NCT00659425|79399186|FG003|Overall Study|Adverse Event|0|||
44392557|NCT00659425|79399187|FG004|Overall Study|Adverse Event|0|||
44392558|NCT00659425|79399188|FG005|Overall Study|Adverse Event|1|||
44392559|NCT00659425|79399189|FG006|Overall Study|Adverse Event|0|||
44392560|NCT00659425|79399190|FG007|Overall Study|Adverse Event|3|||
44392561|NCT00659425|79399191|FG008|Overall Study|Adverse Event|1|||
44392562|NCT00659425|79399192|FG009|Overall Study|Adverse Event|4|||
44392563|NCT00659425|79399183|FG000|Overall Study|Investigator Discretion|0|||
44392564|NCT00659425|79399184|FG001|Overall Study|Investigator Discretion|0|||
44392565|NCT00659425|79399185|FG002|Overall Study|Investigator Discretion|0|||
44392566|NCT00659425|79399186|FG003|Overall Study|Investigator Discretion|0|||
44392567|NCT00659425|79399187|FG004|Overall Study|Investigator Discretion|0|||
44392568|NCT00659425|79399188|FG005|Overall Study|Investigator Discretion|1|||
44392569|NCT00659425|79399189|FG006|Overall Study|Investigator Discretion|0|||
44146723|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
44146724|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
44146725|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
44146726|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
44146727|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
44146728|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
44146729|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
44146730|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
44146731|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
44146732|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
44146733|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
44146734|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
44146735|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
44146736|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
44252101|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
44252102|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
44252103|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
44252104|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
44252105|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
44252106|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
44392570|NCT00659425|79399190|FG007|Overall Study|Investigator Discretion|3|||
44392571|NCT00659425|79399191|FG008|Overall Study|Investigator Discretion|0|||
44392572|NCT00659425|79399192|FG009|Overall Study|Investigator Discretion|0|||
44392573|NCT00659425|79399183|FG000|Overall Study|Other|0|||
44392574|NCT00659425|79399184|FG001|Overall Study|Other|1|||
44392575|NCT00659425|79399185|FG002|Overall Study|Other|1|||
44392576|NCT00659425|79399186|FG003|Overall Study|Other|2|||
44520355|NCT02994940|79528234|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
44392577|NCT00659425|79399187|FG004|Overall Study|Other|4|||
44392578|NCT00659425|79399188|FG005|Overall Study|Other|0|||
44392579|NCT00659425|79399189|FG006|Overall Study|Other|3|||
44392580|NCT00659425|79399190|FG007|Overall Study|Other|2|||
44392581|NCT00659425|79399191|FG008|Overall Study|Other|0|||
44392582|NCT00659425|79399192|FG009|Overall Study|Other|6|||
44392583|NCT00656851|79399229|FG000|Overall Study|Withdrawal by Subject|0|||
44392584|NCT00656851|79399230|FG001|Overall Study|Withdrawal by Subject|4|||
44392585|NCT00656617|79399236|FG000|Overall Study|Adverse Event|1|||
44392586|NCT00656617|79399236|FG000|Overall Study|Death|2|||
44392587|NCT00656617|79399236|FG000|Overall Study|Insurance Issues|2|||
44392588|NCT00656617|79399236|FG000|Overall Study|Move to different clinical trial|2|||
44392589|NCT00659269|79399243|FG000|Overall Study|Physician Decision|1|||
44392590|NCT00659269|79399244|FG001|Overall Study|Physician Decision|1|||
44392591|NCT00658333|79399261|FG000|Overall Study|Adverse Event|2|||
44392592|NCT00658333|79399262|FG001|Overall Study|Adverse Event|1|||
44392593|NCT00570037|79399270|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
44392594|NCT00570037|79399271|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
44392595|NCT00863655|79399279|FG000|Overall Study|Protocol Violation|4|||
44392596|NCT00863655|79399280|FG001|Overall Study|Protocol Violation|0|||
44392597|NCT00863655|79399279|FG000|Overall Study|Adverse Event|52|||
44392598|NCT00863655|79399280|FG001|Overall Study|Adverse Event|8|||
44392599|NCT00863655|79399279|FG000|Overall Study|Withdrawal by Subject|47|||
44392600|NCT00863655|79399280|FG001|Overall Study|Withdrawal by Subject|7|||
44392601|NCT00863655|79399279|FG000|Overall Study|Administrative problems|1|||
44392602|NCT00863655|79399280|FG001|Overall Study|Administrative problems|0|||
44392603|NCT00863655|79399279|FG000|Overall Study|Death|7|||
44392604|NCT00863655|79399280|FG001|Overall Study|Death|1|||
44392605|NCT00863655|79399279|FG000|Overall Study|New cancer therapy|5|||
44392606|NCT00863655|79399280|FG001|Overall Study|New cancer therapy|1|||
44392607|NCT00863655|79399279|FG000|Overall Study|Disease progression|364|||
44392608|NCT00863655|79399280|FG001|Overall Study|Disease progression|221|||
44392609|NCT00863655|79399279|FG000|Overall Study|Treatment completed as per protocol|5|||
44392610|NCT00863655|79399280|FG001|Overall Study|Treatment completed as per protocol|1|||
44392611|NCT00658723|79399288|FG000|Overall Study|Lost to Follow-up|0|||
44392612|NCT00658723|79399289|FG001|Overall Study|Lost to Follow-up|2|||
44392613|NCT00658723|79399290|FG002|Overall Study|Lost to Follow-up|2|||
44392614|NCT00658723|79399288|FG000|Overall Study|Death|2|||
44392615|NCT00658723|79399289|FG001|Overall Study|Death|1|||
44392616|NCT00658723|79399290|FG002|Overall Study|Death|4|||
44392617|NCT00658723|79399288|FG000|Overall Study|Scheduling Issue|1|||
44392618|NCT00658723|79399289|FG001|Overall Study|Scheduling Issue|1|||
44392619|NCT00658723|79399290|FG002|Overall Study|Scheduling Issue|0|||
44392620|NCT00658723|79399288|FG000|Overall Study|Withdrawal by Subject|1|||
44392621|NCT00658723|79399289|FG001|Overall Study|Withdrawal by Subject|0|||
44392622|NCT00658723|79399290|FG002|Overall Study|Withdrawal by Subject|1|||
44392623|NCT00593385|79399301|FG000|Overall Study|Death|14|||
44392624|NCT00593385|79399301|FG000|Overall Study|Lost to Follow-up|17|||
44392625|NCT00593385|79399301|FG000|Overall Study|Withdrawal by Subject|9|||
44392626|NCT00658021|79399310|FG000|28-Week Treatment Period|Adverse Event|3|||
44392627|NCT00658021|79399311|FG001|28-Week Treatment Period|Adverse Event|1|||
44392628|NCT00658021|79399312|FG002|28-Week Treatment Period|Adverse Event|0|||
44392629|NCT00658021|79399310|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
44392630|NCT00658021|79399311|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
44392631|NCT00658021|79399312|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
44392632|NCT00658021|79399310|FG000|28-Week Treatment Period|Protocol Violation|0|||
44392633|NCT00658021|79399311|FG001|28-Week Treatment Period|Protocol Violation|2|||
44392634|NCT00658021|79399312|FG002|28-Week Treatment Period|Protocol Violation|1|||
44392635|NCT00658021|79399310|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
44392636|NCT00658021|79399311|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
44392637|NCT00658021|79399312|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
44392638|NCT00658021|79399310|FG000|28-Week Treatment Period|Physician Decision|1|||
44392639|NCT00658021|79399311|FG001|28-Week Treatment Period|Physician Decision|2|||
44392640|NCT00658021|79399312|FG002|28-Week Treatment Period|Physician Decision|1|||
44392641|NCT00658021|79399310|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
44392642|NCT00658021|79399311|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
44281028|NCT01976364|79242166|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
44392643|NCT00658021|79399312|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
44392644|NCT00658021|79399310|FG000|28-Week Treatment Period|Loss of glucose control|1|||
44392645|NCT00658021|79399311|FG001|28-Week Treatment Period|Loss of glucose control|1|||
44392646|NCT00658021|79399312|FG002|28-Week Treatment Period|Loss of glucose control|10|||
44392647|NCT00658021|79399310|FG000|28-Week Treatment Period|Other|2|||
44281029|NCT01976364|79242164|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
44281030|NCT01976364|79242165|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
44392648|NCT00658021|79399311|FG001|28-Week Treatment Period|Other|3|||
44392649|NCT00658021|79399312|FG002|28-Week Treatment Period|Other|1|||
44281031|NCT01976364|79242166|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
44392650|NCT00658021|79399310|FG000|28-Week Treatment Period|Did not receive treatment|2|||
44392651|NCT00658021|79399311|FG001|28-Week Treatment Period|Did not receive treatment|0|||
44392652|NCT00658021|79399312|FG002|28-Week Treatment Period|Did not receive treatment|0|||
44392653|NCT00658021|79399310|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
44392654|NCT00658021|79399311|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
44392655|NCT00658021|79399312|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
44392656|NCT00658021|79399310|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
44392657|NCT00658021|79399311|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
44392658|NCT00658021|79399312|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
44392659|NCT00920816|79399326|FG000|Overall Study|Death|116|||
44392660|NCT00920816|79399327|FG001|Overall Study|Death|63|||
44392661|NCT00920816|79399328|FG002|Overall Study|Death|8|||
44392662|NCT00920816|79399329|FG003|Overall Study|Death|3|||
44392663|NCT00920816|79399326|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
44392664|NCT00920816|79399327|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
44392665|NCT00920816|79399328|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
44392666|NCT00920816|79399329|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
44392667|NCT00920816|79399326|FG000|Overall Study|Global deterioration of health status|2|||
44392668|NCT00920816|79399327|FG001|Overall Study|Global deterioration of health status|0|||
44392669|NCT00920816|79399328|FG002|Overall Study|Global deterioration of health status|0|||
44392670|NCT00920816|79399329|FG003|Overall Study|Global deterioration of health status|0|||
44392671|NCT00920816|79399326|FG000|Overall Study|Objective progression or relapse|6|||
44392672|NCT00920816|79399327|FG001|Overall Study|Objective progression or relapse|2|||
44392673|NCT00920816|79399328|FG002|Overall Study|Objective progression or relapse|0|||
44392674|NCT00920816|79399329|FG003|Overall Study|Objective progression or relapse|0|||
44392675|NCT00920816|79399326|FG000|Overall Study|Other|26|||
44392676|NCT00920816|79399327|FG001|Overall Study|Other|15|||
44392677|NCT00920816|79399328|FG002|Overall Study|Other|1|||
44392678|NCT00920816|79399329|FG003|Overall Study|Other|2|||
44392679|NCT00920816|79399326|FG000|Overall Study|Lost to Follow-up|11|||
44392680|NCT00920816|79399327|FG001|Overall Study|Lost to Follow-up|2|||
44392681|NCT00920816|79399328|FG002|Overall Study|Lost to Follow-up|0|||
44392682|NCT00920816|79399329|FG003|Overall Study|Lost to Follow-up|0|||
44392683|NCT00920816|79399326|FG000|Overall Study|Adverse Event|1|||
44392684|NCT00920816|79399327|FG001|Overall Study|Adverse Event|1|||
44392685|NCT00920816|79399328|FG002|Overall Study|Adverse Event|1|||
44392686|NCT00920816|79399329|FG003|Overall Study|Adverse Event|0|||
44392687|NCT00920816|79399326|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
44392688|NCT00920816|79399327|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
44392689|NCT00920816|79399328|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
44392690|NCT00920816|79399329|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
44392691|NCT00920816|79399326|FG000|Overall Study|Randomized but not treated|3|||
44392692|NCT00920816|79399327|FG001|Overall Study|Randomized but not treated|0|||
44392693|NCT00920816|79399328|FG002|Overall Study|Randomized but not treated|0|||
44392694|NCT00920816|79399329|FG003|Overall Study|Randomized but not treated|0|||
44392695|NCT00657709|79399344|FG000|Overall Study|AE or Death|7|||
44392696|NCT00657709|79399345|FG001|Overall Study|AE or Death|7|||
44392697|NCT00657709|79399346|FG002|Overall Study|AE or Death|6|||
44392698|NCT00657709|79399347|FG003|Overall Study|AE or Death|7|||
44392699|NCT00657709|79399348|FG004|Overall Study|AE or Death|1|||
44392700|NCT00657709|79399344|FG000|Overall Study|Withdrawal by Subject|7|||
44392701|NCT00657709|79399345|FG001|Overall Study|Withdrawal by Subject|15|||
44392702|NCT00657709|79399346|FG002|Overall Study|Withdrawal by Subject|15|||
44252107|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
44392703|NCT00657709|79399347|FG003|Overall Study|Withdrawal by Subject|5|||
44392704|NCT00657709|79399348|FG004|Overall Study|Withdrawal by Subject|9|||
44392705|NCT00657709|79399344|FG000|Overall Study|Lost to Follow-up|9|||
44392706|NCT00657709|79399345|FG001|Overall Study|Lost to Follow-up|9|||
44392707|NCT00657709|79399346|FG002|Overall Study|Lost to Follow-up|7|||
44392708|NCT00657709|79399347|FG003|Overall Study|Lost to Follow-up|1|||
44252108|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
44252109|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
44252110|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
44252111|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
44392709|NCT00657709|79399348|FG004|Overall Study|Lost to Follow-up|21|||
44252112|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
44252113|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
44392710|NCT00657709|79399344|FG000|Overall Study|Protocol Violation|0|||
44392711|NCT00657709|79399345|FG001|Overall Study|Protocol Violation|2|||
44392712|NCT00657709|79399346|FG002|Overall Study|Protocol Violation|0|||
44392713|NCT00657709|79399347|FG003|Overall Study|Protocol Violation|1|||
44392714|NCT00657709|79399348|FG004|Overall Study|Protocol Violation|2|||
44392715|NCT00915356|79399375|FG000|Overall Study|Withdrawal by Subject|1|||
44392716|NCT00915356|79399376|FG001|Overall Study|Withdrawal by Subject|0|||
44392717|NCT00915356|79399377|FG002|Overall Study|Withdrawal by Subject|0|||
44392718|NCT00915356|79399378|FG003|Overall Study|Withdrawal by Subject|0|||
44392719|NCT00915356|79399379|FG004|Overall Study|Withdrawal by Subject|0|||
44392720|NCT00657553|79399393|FG000|Overall Study|low accrual, no analysis run|5|||
44392721|NCT00657553|79399394|FG001|Overall Study|low accrual, no analysis run|5|||
44392722|NCT00862719|79399404|FG000|Overall Study|Disease Progression|5|||
44392723|NCT00862719|79399405|FG001|Overall Study|Disease Progression|0|||
44392724|NCT00862719|79399406|FG002|Overall Study|Disease Progression|1|||
44392725|NCT00862719|79399407|FG003|Overall Study|Disease Progression|0|||
44392726|NCT00862719|79399404|FG000|Overall Study|Death|5|||
44392727|NCT00862719|79399405|FG001|Overall Study|Death|6|||
44392728|NCT00862719|79399406|FG002|Overall Study|Death|1|||
44392729|NCT00862719|79399407|FG003|Overall Study|Death|1|||
44392730|NCT00862719|79399404|FG000|Overall Study|Engraftment failure|0|||
44392731|NCT00862719|79399405|FG001|Overall Study|Engraftment failure|0|||
44392732|NCT00862719|79399406|FG002|Overall Study|Engraftment failure|1|||
44392733|NCT00862719|79399407|FG003|Overall Study|Engraftment failure|0|||
44392734|NCT00862719|79399404|FG000|Overall Study|Veno-Occlusive Disease|0|||
44392735|NCT00862719|79399405|FG001|Overall Study|Veno-Occlusive Disease|0|||
44392736|NCT00862719|79399406|FG002|Overall Study|Veno-Occlusive Disease|1|||
44392737|NCT00862719|79399407|FG003|Overall Study|Veno-Occlusive Disease|0|||
44392738|NCT00862641|79399421|FG000|Overall Study|Randomized, but drug not received|1|||
44392739|NCT00862641|79399422|FG001|Overall Study|Randomized, but drug not received|4|||
44392740|NCT00862641|79399423|FG002|Overall Study|Randomized, but drug not received|1|||
44392741|NCT00862641|79399424|FG003|Overall Study|Randomized, but drug not received|4|||
44392742|NCT00861471|79399434|FG000|Overall Study|Withdrawal by Subject|1|||
44392743|NCT00861471|79399434|FG000|Overall Study|Adverse Event|2|||
44392744|NCT00861471|79399434|FG000|Overall Study|Lack of Efficacy|3|||
44392745|NCT00861471|79399434|FG000|Overall Study|treatment for lumbar laminectomy|1|||
44392746|NCT00861471|79399434|FG000|Overall Study|Physician Decision|2|||
44392747|NCT00860067|79399441|FG000|Overall Study|Lost to Follow-up|46|||
44392748|NCT00860067|79399442|FG001|Overall Study|Lost to Follow-up|9|||
44392749|NCT00860067|79399443|FG002|Overall Study|Lost to Follow-up|9|||
44392750|NCT00860067|79399441|FG000|Overall Study|Withdrawal by Subject|4|||
44392751|NCT00860067|79399442|FG001|Overall Study|Withdrawal by Subject|0|||
44392752|NCT00860067|79399443|FG002|Overall Study|Withdrawal by Subject|0|||
44392753|NCT00860067|79399441|FG000|Overall Study|Pregnancy|1|||
44392754|NCT00860067|79399442|FG001|Overall Study|Pregnancy|0|||
44392755|NCT00860067|79399443|FG002|Overall Study|Pregnancy|0|||
44392756|NCT00858117|79399454|FG000|Treatment on Study|Adverse Event|2|||
44392757|NCT00858117|79399454|FG000|Follow up for 5 Years|Death|4|||
44392758|NCT00858117|79399454|FG000|Follow up for 5 Years|No further data collected for study|9|||
44392759|NCT00652951|79399461|FG000|Booster Phase|Adverse event, non-fatal|0|||
44392760|NCT00652951|79399462|FG001|Booster Phase|Adverse event, non-fatal|1|||
44392761|NCT00652951|79399463|FG002|Booster Phase|Adverse event, non-fatal|0|||
44392762|NCT00652951|79399461|FG000|Booster Phase|Other|1|||
44392763|NCT00652951|79399462|FG001|Booster Phase|Other|0|||
44392764|NCT00652951|79399463|FG002|Booster Phase|Other|0|||
44392765|NCT00848211|79399475|FG000|Overall Study|Protocol Violation|0|||
44392766|NCT00848211|79399476|FG001|Overall Study|Protocol Violation|1|||
44392767|NCT00848211|79399477|FG002|Overall Study|Protocol Violation|1|||
44392768|NCT00848211|79399478|FG003|Overall Study|Protocol Violation|0|||
44520356|NCT02994940|79528233|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
44252114|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
44252115|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
44252116|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
44392769|NCT00848211|79399475|FG000|Overall Study|Adverse Event|0|||
44392770|NCT00848211|79399476|FG001|Overall Study|Adverse Event|0|||
44392771|NCT00848211|79399477|FG002|Overall Study|Adverse Event|0|||
44392772|NCT00848211|79399478|FG003|Overall Study|Adverse Event|0|||
44392773|NCT00592683|79399490|FG000|Overall Study|Found ineligible|0|||
44392774|NCT00592683|79399491|FG001|Overall Study|Found ineligible|1|||
44392775|NCT00592683|79399490|FG000|Overall Study|Withdrawal by Subject|1|||
44392776|NCT00592683|79399491|FG001|Overall Study|Withdrawal by Subject|0|||
44392777|NCT00592683|79399490|FG000|Overall Study|Adverse Event|0|||
44392778|NCT00592683|79399491|FG001|Overall Study|Adverse Event|2|||
44392779|NCT00592683|79399490|FG000|Overall Study|Protocol Violation|1|||
44392780|NCT00592683|79399491|FG001|Overall Study|Protocol Violation|0|||
44392781|NCT00592683|79399490|FG000|Overall Study|Study drug expired|1|||
44392782|NCT00592683|79399491|FG001|Overall Study|Study drug expired|0|||
44392783|NCT00592683|79399490|FG000|Overall Study|Other|1|||
44392784|NCT00592683|79399491|FG001|Overall Study|Other|0|||
44392785|NCT00592683|79399490|FG000|Overall Study|Lost to Follow-up|0|||
44392786|NCT00592683|79399491|FG001|Overall Study|Lost to Follow-up|1|||
44392787|NCT00847665|79399499|FG000|Overall Study|Withdrawal by Subject|1|||
44281032|NCT01976364|79242164|FG000|Main Study (36 Months)|Protocol Violation|13|||
44281033|NCT01976364|79242165|FG001|Main Study (36 Months)|Protocol Violation|0|||
44281034|NCT01976364|79242166|FG002|Main Study (36 Months)|Protocol Violation|0|||
44392788|NCT00847665|79399500|FG001|Overall Study|Withdrawal by Subject|0|||
44392789|NCT00916370|79399508|FG000|Overall Study|Death|3|||
44392790|NCT00916370|79399509|FG001|Overall Study|Death|1|||
44392791|NCT00916370|79399508|FG000|Overall Study|Withdrawal by Subject|2|||
44392792|NCT00916370|79399509|FG001|Overall Study|Withdrawal by Subject|0|||
44392793|NCT00916370|79399508|FG000|Overall Study|Physician Decision|0|||
44392794|NCT00916370|79399509|FG001|Overall Study|Physician Decision|1|||
44392795|NCT00847197|79399518|FG000|Overall Study|Adverse Event|21|||
44392796|NCT00847197|79399519|FG001|Overall Study|Adverse Event|3|||
44392797|NCT00847197|79399518|FG000|Overall Study|Protocol Violation|0|||
44392798|NCT00847197|79399519|FG001|Overall Study|Protocol Violation|1|||
44392799|NCT00847197|79399518|FG000|Overall Study|Withdrawal by Subject|3|||
44392800|NCT00847197|79399519|FG001|Overall Study|Withdrawal by Subject|1|||
44392801|NCT00654901|79399529|FG000|Overall Study|Lost to Follow-up|1|||
44392802|NCT00654901|79399530|FG001|Overall Study|Lost to Follow-up|0|||
44392803|NCT00654901|79399531|FG002|Overall Study|Lost to Follow-up|1|||
44392804|NCT00654901|79399532|FG003|Overall Study|Lost to Follow-up|0|||
44392805|NCT00654901|79399529|FG000|Overall Study|Withdrawal by Subject|3|||
44392806|NCT00654901|79399530|FG001|Overall Study|Withdrawal by Subject|0|||
44392807|NCT00654901|79399531|FG002|Overall Study|Withdrawal by Subject|1|||
44392808|NCT00654901|79399532|FG003|Overall Study|Withdrawal by Subject|0|||
44392809|NCT00846807|79399542|FG000|Overall Study|Adverse Event|270|||
44392810|NCT00846807|79399542|FG000|Overall Study|Lost to Follow-up|94|||
44392811|NCT00846807|79399542|FG000|Overall Study|Withdrawal by Subject|56|||
44520357|NCT02994940|79528234|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
44520358|NCT02994940|79528233|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
44520359|NCT02994940|79528234|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
44520360|NCT02994394|79528242|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
44520361|NCT02994394|79528243|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
44281035|NCT01976364|79242164|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
44281036|NCT01976364|79242165|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
44281037|NCT01976364|79242166|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
44281038|NCT01976364|79242164|FG000|Main Study (36 Months)|Death|5|||
44281039|NCT01976364|79242165|FG001|Main Study (36 Months)|Death|0|||
44281040|NCT01976364|79242166|FG002|Main Study (36 Months)|Death|0|||
44281041|NCT01976364|79242164|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
44146737|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
44146738|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
44281042|NCT01976364|79242165|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
44281043|NCT01976364|79242166|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
44281044|NCT01976364|79242164|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
44281045|NCT01976364|79242165|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
44281046|NCT01976364|79242166|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
44281047|NCT01976364|79242164|FG000|Sub-study (12 Months)|Protocol Violation|0|||
44281048|NCT01976364|79242165|FG001|Sub-study (12 Months)|Protocol Violation|1|||
44281049|NCT01976364|79242166|FG002|Sub-study (12 Months)|Protocol Violation|1|||
44281050|NCT01976364|79242164|FG000|Sub-study (12 Months)|Adverse Event|0|||
44281051|NCT01976364|79242165|FG001|Sub-study (12 Months)|Adverse Event|4|||
44281052|NCT01976364|79242166|FG002|Sub-study (12 Months)|Adverse Event|3|||
44281053|NCT01956240|79242177|FG000|Overall Study|Lost to Follow-up|6|||
44281054|NCT01956240|79242178|FG001|Overall Study|Lost to Follow-up|20|||
44281055|NCT01956240|79242177|FG000|Overall Study|Adverse Event|17|||
44281056|NCT01956240|79242178|FG001|Overall Study|Adverse Event|4|||
44281057|NCT01929876|79242184|FG000|Period 2|Non-Compliance|1|||
44281058|NCT01929408|79242188|FG000|Overall Study|received HCT as initial treatment|8|||
44520362|NCT02994394|79528244|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
44281059|NCT01929018|79242194|FG000|Overall Study|Lost to Follow-up|1|||
44281060|NCT01929018|79242195|FG001|Overall Study|Lost to Follow-up|0|||
44392812|NCT00846807|79399542|FG000|Overall Study|Non compliant with European label|7|||
44392813|NCT00846807|79399542|FG000|Overall Study|Switch to other anticoagulants|89|||
44392814|NCT00846807|79399542|FG000|Overall Study|No prescription after hospital discharge|56|||
44392815|NCT00846807|79399542|FG000|Overall Study|Other|60|||
44392816|NCT00846495|79399548|FG000|Overall Study|Lost to Follow-up|1|||
44392817|NCT00846495|79399549|FG001|Overall Study|Lost to Follow-up|0|||
44392818|NCT00846495|79399548|FG000|Overall Study|Adverse Event|5|||
44392819|NCT00846495|79399549|FG001|Overall Study|Adverse Event|1|||
44520363|NCT02994394|79528245|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
44520364|NCT02994394|79528246|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
44392820|NCT00846495|79399548|FG000|Overall Study|Lack of Efficacy|1|||
44392821|NCT00846495|79399549|FG001|Overall Study|Lack of Efficacy|2|||
44392822|NCT00846495|79399548|FG000|Overall Study|Physician Decision|1|||
44392823|NCT00846495|79399549|FG001|Overall Study|Physician Decision|0|||
44392824|NCT00654745|79399555|FG000|Overall Study|Adverse Event|12|||
44392825|NCT00654745|79399555|FG000|Overall Study|Lost to Follow-up|7|||
44392826|NCT00654745|79399555|FG000|Overall Study|Protocol Violation|11|||
44392827|NCT00654745|79399555|FG000|Overall Study|Withdrawal by Subject|10|||
44392828|NCT00654745|79399555|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
44392829|NCT00846027|79399565|FG000|Overall Study|Death|3|||
44392830|NCT00846027|79399565|FG000|Overall Study|Disease Progression|30|||
44392831|NCT00846027|79399565|FG000|Overall Study|Toxicity|12|||
44392832|NCT00846027|79399565|FG000|Overall Study|Patient Decision|7|||
44392833|NCT00846027|79399565|FG000|Overall Study|Investigator Discretion|29|||
44392834|NCT00846027|79399565|FG000|Overall Study|Protocol Violation|2|||
44392835|NCT00846027|79399565|FG000|Overall Study|Subject Not Treated|7|||
44392836|NCT00646399|79399571|FG000|Overall Study|Death|63|||
44392837|NCT00646399|79399572|FG001|Overall Study|Death|53|||
44392838|NCT00646399|79399571|FG000|Overall Study|Withdrawal by Subject|9|||
44392839|NCT00646399|79399572|FG001|Overall Study|Withdrawal by Subject|10|||
44392840|NCT00646399|79399571|FG000|Overall Study|Other Reason|11|||
44392841|NCT00646399|79399572|FG001|Overall Study|Other Reason|11|||
44392842|NCT00652327|79399580|FG000|Overall Study|Adverse Event|0|||
44392843|NCT00652327|79399581|FG001|Overall Study|Adverse Event|2|||
44392844|NCT00652327|79399580|FG000|Overall Study|Lost to Follow-up|0|||
44392845|NCT00652327|79399581|FG001|Overall Study|Lost to Follow-up|3|||
44392846|NCT00645853|79399589|FG000|Overall Study|Adverse Event|18|||
44392847|NCT00645853|79399590|FG001|Overall Study|Adverse Event|7|||
44392848|NCT00645853|79399589|FG000|Overall Study|AZ study closure in Hungary|60|||
44392849|NCT00645853|79399590|FG001|Overall Study|AZ study closure in Hungary|40|||
44392850|NCT00645853|79399589|FG000|Overall Study|Withdrawal by Subject|5|||
44392851|NCT00645853|79399590|FG001|Overall Study|Withdrawal by Subject|2|||
44392852|NCT00645853|79399589|FG000|Overall Study|Protocol Violation|0|||
44392853|NCT00645853|79399590|FG001|Overall Study|Protocol Violation|2|||
44392854|NCT00645853|79399589|FG000|Overall Study|Discontinuation criteria|2|||
44392855|NCT00645853|79399590|FG001|Overall Study|Discontinuation criteria|2|||
44392856|NCT00645853|79399589|FG000|Overall Study|recall of ICF, planned operation, death|7|||
44392857|NCT00645853|79399590|FG001|Overall Study|recall of ICF, planned operation, death|4|||
44392858|NCT00652093|79399602|FG000|Overall Study|Withdrawal by Subject|0|||
44392859|NCT00652093|79399603|FG001|Overall Study|Withdrawal by Subject|0|||
44392860|NCT00652093|79399604|FG002|Overall Study|Withdrawal by Subject|1|||
44392861|NCT00652093|79399605|FG003|Overall Study|Withdrawal by Subject|0|||
44392862|NCT00652093|79399606|FG004|Overall Study|Withdrawal by Subject|1|||
44392863|NCT00652093|79399607|FG005|Overall Study|Withdrawal by Subject|0|||
44392864|NCT00652093|79399602|FG000|Overall Study|Physician Decision|0|||
44392865|NCT00652093|79399603|FG001|Overall Study|Physician Decision|0|||
44392866|NCT00652093|79399604|FG002|Overall Study|Physician Decision|0|||
44392867|NCT00652093|79399605|FG003|Overall Study|Physician Decision|0|||
44392868|NCT00652093|79399606|FG004|Overall Study|Physician Decision|1|||
44392869|NCT00652093|79399607|FG005|Overall Study|Physician Decision|0|||
44392870|NCT00651937|79399623|FG000|Overall Study|Withdrawal by Subject|4|||
44392871|NCT00651937|79399624|FG001|Overall Study|Withdrawal by Subject|1|||
44392872|NCT00654355|79399632|FG000|Overall Study|Lost to Follow-up|2|||
44392873|NCT00654355|79399633|FG001|Overall Study|Lost to Follow-up|2|||
44392874|NCT00651313|79399641|FG000|Overall Study|Adverse Event|0|||
44392875|NCT00651313|79399642|FG001|Overall Study|Adverse Event|1|||
44392876|NCT00651313|79399641|FG000|Overall Study|Withdrawal by Subject|3|||
44392877|NCT00651313|79399642|FG001|Overall Study|Withdrawal by Subject|1|||
44392878|NCT00651313|79399641|FG000|Overall Study|Lost to Follow-up|1|||
44392879|NCT00651313|79399642|FG001|Overall Study|Lost to Follow-up|1|||
44392880|NCT00651313|79399641|FG000|Overall Study|Adminstrative Discontinuation|2|||
44520365|NCT02994394|79528247|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
44252117|NCT03593213|79087739|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
44392881|NCT00651313|79399642|FG001|Overall Study|Adminstrative Discontinuation|3|||
44520366|NCT02994394|79528242|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
44281061|NCT01929018|79242194|FG000|Overall Study|Hospitalization|0|||
44392882|NCT00969761|79399660|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
44392883|NCT00969761|79399661|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392884|NCT00969761|79399662|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392885|NCT00969761|79399663|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
44392886|NCT00969761|79399664|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392887|NCT00969761|79399665|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392888|NCT00969761|79399666|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392889|NCT00969761|79399667|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392890|NCT00969761|79399668|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
44392891|NCT00969761|79399669|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
44520367|NCT02994394|79528243|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
44392892|NCT00969761|79399670|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392893|NCT00969761|79399671|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
44392894|NCT00969761|79399660|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392895|NCT00969761|79399661|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392896|NCT00969761|79399662|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
44392897|NCT00969761|79399663|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392898|NCT00969761|79399664|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392899|NCT00969761|79399665|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392900|NCT00969761|79399666|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392901|NCT00969761|79399667|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392902|NCT00969761|79399668|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392903|NCT00969761|79399669|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392904|NCT00969761|79399670|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392905|NCT00969761|79399671|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
44392906|NCT00969761|79399660|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392907|NCT00969761|79399661|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392908|NCT00969761|79399662|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
44392909|NCT00969761|79399663|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392910|NCT00969761|79399664|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392911|NCT00969761|79399665|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392912|NCT00969761|79399666|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392913|NCT00969761|79399667|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392914|NCT00969761|79399668|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392915|NCT00969761|79399669|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392916|NCT00969761|79399670|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392917|NCT00969761|79399671|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
44392918|NCT00969761|79399660|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392919|NCT00969761|79399661|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392920|NCT00969761|79399662|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392921|NCT00969761|79399663|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392922|NCT00969761|79399664|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392923|NCT00969761|79399665|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392924|NCT00969761|79399666|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392925|NCT00969761|79399667|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392926|NCT00969761|79399668|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
44392927|NCT00969761|79399669|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392928|NCT00969761|79399670|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392929|NCT00969761|79399671|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
44392930|NCT00969761|79399660|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
44392931|NCT00969761|79399661|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
44392932|NCT00969761|79399662|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
44392933|NCT00969761|79399663|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
44392934|NCT00969761|79399664|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
44392935|NCT00969761|79399665|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
44392936|NCT00969761|79399666|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
44392937|NCT00969761|79399667|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
44392938|NCT00969761|79399668|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
44392939|NCT00969761|79399669|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
44392940|NCT00969761|79399670|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
44392941|NCT00969761|79399671|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
44392942|NCT00969761|79399660|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392943|NCT00969761|79399661|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392944|NCT00969761|79399662|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392945|NCT00969761|79399663|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
44392946|NCT00969761|79399664|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
44392947|NCT00969761|79399665|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44520368|NCT02994394|79528244|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
44520369|NCT02994394|79528245|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
44520370|NCT02994394|79528246|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
44392948|NCT00969761|79399666|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392949|NCT00969761|79399667|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392950|NCT00969761|79399668|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
44392951|NCT00969761|79399669|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392952|NCT00969761|79399670|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392953|NCT00969761|79399671|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
44392954|NCT00845871|79399697|FG000|Assessment Period|Adverse Event|2|||
44392955|NCT00845871|79399697|FG000|Assessment Period|Abnormal laboratory values|1|||
44392956|NCT00845871|79399697|FG000|Assessment Period|Abnormal test procedure results|1|||
44392957|NCT00845871|79399697|FG000|Assessment Period|Patient withdrew consent|3|||
44392958|NCT00915278|79399727|FG000|Overall Study|Death|1|||
44392959|NCT00915278|79399728|FG001|Overall Study|Death|0|||
44392960|NCT00915278|79399729|FG002|Overall Study|Death|0|||
44281062|NCT01929018|79242195|FG001|Overall Study|Hospitalization|1|||
44281063|NCT01928940|79242203|FG000|Overall Study|Adverse Event|0|||
44281064|NCT01928940|79242204|FG001|Overall Study|Adverse Event|1|||
44281065|NCT01928862|79242216|FG000|Overall Study|Lost to Follow-up|1|||
44281066|NCT01928862|79242217|FG001|Overall Study|Lost to Follow-up|0|||
44281067|NCT01928862|79242218|FG002|Overall Study|Lost to Follow-up|0|||
44281068|NCT01928862|79242219|FG003|Overall Study|Lost to Follow-up|0|||
44281069|NCT01928862|79242220|FG004|Overall Study|Lost to Follow-up|1|||
44281070|NCT01954056|79242235|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
44281071|NCT01954056|79242236|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
44281072|NCT01953354|79242244|FG000|Overall Study|Withdrawal by Subject|0|||
44281073|NCT01953354|79242245|FG001|Overall Study|Withdrawal by Subject|1|||
44281074|NCT01953354|79242244|FG000|Overall Study|Decision of Sponsor|0|||
44281075|NCT01953354|79242245|FG001|Overall Study|Decision of Sponsor|1|||
44281076|NCT01953354|79242244|FG000|Overall Study|Disease Exacerbation|1|||
44281077|NCT01953354|79242245|FG001|Overall Study|Disease Exacerbation|0|||
44281078|NCT01975272|79242254|FG000|Overall Study|Excluded after protocol amendment|1|||
44281079|NCT01975272|79242255|FG001|Overall Study|Excluded after protocol amendment|1|||
44281080|NCT01975272|79242256|FG002|Overall Study|Excluded after protocol amendment|2|||
44281081|NCT01951638|79242269|FG000|Treatment Period|Protocol Violation|0|||
44281082|NCT01951638|79242270|FG001|Treatment Period|Protocol Violation|0|||
44281083|NCT01951638|79242271|FG002|Treatment Period|Protocol Violation|0|||
44281084|NCT01951638|79242272|FG003|Treatment Period|Protocol Violation|2|||
44281085|NCT01951638|79242273|FG004|Treatment Period|Protocol Violation|0|||
44281086|NCT01951638|79242269|FG000|Treatment Period|Protocol-driven decision point|1|||
44281087|NCT01951638|79242270|FG001|Treatment Period|Protocol-driven decision point|3|||
44281088|NCT01951638|79242271|FG002|Treatment Period|Protocol-driven decision point|0|||
44281089|NCT01951638|79242272|FG003|Treatment Period|Protocol-driven decision point|0|||
44281090|NCT01951638|79242273|FG004|Treatment Period|Protocol-driven decision point|0|||
44281091|NCT01951638|79242269|FG000|Treatment Period|Logistical difficulties|0|||
44281092|NCT01951638|79242270|FG001|Treatment Period|Logistical difficulties|1|||
44281093|NCT01951638|79242271|FG002|Treatment Period|Logistical difficulties|1|||
44281094|NCT01951638|79242272|FG003|Treatment Period|Logistical difficulties|0|||
44281095|NCT01951638|79242273|FG004|Treatment Period|Logistical difficulties|0|||
44281096|NCT01951638|79242269|FG000|Treatment Period|Withdrawal by Subject|9|||
44281097|NCT01951638|79242270|FG001|Treatment Period|Withdrawal by Subject|6|||
44281098|NCT01951638|79242271|FG002|Treatment Period|Withdrawal by Subject|4|||
44281099|NCT01951638|79242272|FG003|Treatment Period|Withdrawal by Subject|5|||
44281100|NCT01951638|79242273|FG004|Treatment Period|Withdrawal by Subject|4|||
44281101|NCT01951638|79242269|FG000|Treatment Period|Death|0|||
44281102|NCT01951638|79242270|FG001|Treatment Period|Death|0|||
44281103|NCT01951638|79242271|FG002|Treatment Period|Death|0|||
44281104|NCT01951638|79242272|FG003|Treatment Period|Death|3|||
44281105|NCT01951638|79242273|FG004|Treatment Period|Death|1|||
44392961|NCT00915278|79399730|FG003|Overall Study|Death|0|||
44392962|NCT00915278|79399731|FG004|Overall Study|Death|0|||
44392963|NCT00915278|79399732|FG005|Overall Study|Death|0|||
44392964|NCT00915278|79399727|FG000|Overall Study|Lost to Follow-up|0|||
44252118|NCT03593213|79087740|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
44252119|NCT03593213|79087741|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
44252120|NCT03593213|79087742|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
44252121|NCT00013611|79087786|FG000|Overall Study|Lost to Follow-up|91|||
44252122|NCT00013611|79087787|FG001|Overall Study|Lost to Follow-up|100|||
44252123|NCT00010257|79087795|FG000|Overall Study|Withdrawal by Subject|1|||
44252124|NCT00010257|79087796|FG001|Overall Study|Withdrawal by Subject|0|||
44252125|NCT00211757|79087834|FG000|Overall Study|Withdrawal by Subject|1|||
44281106|NCT01951638|79242269|FG000|Treatment Period|Adverse Event|3|||
44281107|NCT01951638|79242270|FG001|Treatment Period|Adverse Event|4|||
44281108|NCT01951638|79242271|FG002|Treatment Period|Adverse Event|8|||
44281109|NCT01951638|79242272|FG003|Treatment Period|Adverse Event|6|||
44392965|NCT00915278|79399728|FG001|Overall Study|Lost to Follow-up|1|||
44392966|NCT00915278|79399729|FG002|Overall Study|Lost to Follow-up|0|||
44252126|NCT00211757|79087835|FG001|Overall Study|Withdrawal by Subject|1|||
44392967|NCT00915278|79399730|FG003|Overall Study|Lost to Follow-up|0|||
44252127|NCT00211757|79087834|FG000|Overall Study|Lack of Efficacy|0|||
44281110|NCT01951638|79242273|FG004|Treatment Period|Adverse Event|5|||
44392968|NCT00915278|79399731|FG004|Overall Study|Lost to Follow-up|0|||
44392969|NCT00915278|79399732|FG005|Overall Study|Lost to Follow-up|0|||
44392970|NCT00915278|79399727|FG000|Overall Study|Withdrawal by Subject|0|||
44392971|NCT00915278|79399728|FG001|Overall Study|Withdrawal by Subject|1|||
44392972|NCT00915278|79399729|FG002|Overall Study|Withdrawal by Subject|0|||
44392973|NCT00915278|79399730|FG003|Overall Study|Withdrawal by Subject|0|||
44392974|NCT00915278|79399731|FG004|Overall Study|Withdrawal by Subject|1|||
44392975|NCT00915278|79399732|FG005|Overall Study|Withdrawal by Subject|4|||
44392976|NCT00915278|79399727|FG000|Overall Study|Adverse Event|4|||
44392977|NCT00915278|79399728|FG001|Overall Study|Adverse Event|1|||
44392978|NCT00915278|79399729|FG002|Overall Study|Adverse Event|0|||
44392979|NCT00915278|79399730|FG003|Overall Study|Adverse Event|0|||
44392980|NCT00915278|79399731|FG004|Overall Study|Adverse Event|0|||
44392981|NCT00915278|79399732|FG005|Overall Study|Adverse Event|0|||
44392982|NCT00915278|79399727|FG000|Overall Study|Progressive disease/clinical progression|0|||
44392983|NCT00915278|79399728|FG001|Overall Study|Progressive disease/clinical progression|0|||
44392984|NCT00915278|79399729|FG002|Overall Study|Progressive disease/clinical progression|0|||
44392985|NCT00915278|79399730|FG003|Overall Study|Progressive disease/clinical progression|3|||
44392986|NCT00915278|79399731|FG004|Overall Study|Progressive disease/clinical progression|1|||
44392987|NCT00915278|79399732|FG005|Overall Study|Progressive disease/clinical progression|2|||
44392988|NCT00915278|79399727|FG000|Overall Study|Infusion related AEs|0|||
44392989|NCT00915278|79399728|FG001|Overall Study|Infusion related AEs|0|||
44392990|NCT00915278|79399729|FG002|Overall Study|Infusion related AEs|0|||
44392991|NCT00915278|79399730|FG003|Overall Study|Infusion related AEs|0|||
44392992|NCT00915278|79399731|FG004|Overall Study|Infusion related AEs|0|||
44392993|NCT00915278|79399732|FG005|Overall Study|Infusion related AEs|2|||
44392994|NCT00915278|79399727|FG000|Overall Study|Admission to hospice|0|||
44392995|NCT00915278|79399728|FG001|Overall Study|Admission to hospice|0|||
44392996|NCT00915278|79399729|FG002|Overall Study|Admission to hospice|1|||
44392997|NCT00915278|79399730|FG003|Overall Study|Admission to hospice|0|||
44392998|NCT00915278|79399731|FG004|Overall Study|Admission to hospice|0|||
44392999|NCT00915278|79399732|FG005|Overall Study|Admission to hospice|0|||
44393000|NCT00844857|79399748|FG000|Overall Study|Adverse Event|24|||
44393001|NCT00844857|79399749|FG001|Overall Study|Adverse Event|5|||
44393002|NCT00844857|79399748|FG000|Overall Study|Sponsor Decision|1|||
44393003|NCT00844857|79399749|FG001|Overall Study|Sponsor Decision|1|||
44393004|NCT00844857|79399748|FG000|Overall Study|Physician Decision|2|||
44393005|NCT00844857|79399749|FG001|Overall Study|Physician Decision|0|||
44393006|NCT00844857|79399748|FG000|Overall Study|Parent/Caregiver Decision|6|||
44393007|NCT00844857|79399749|FG001|Overall Study|Parent/Caregiver Decision|2|||
44393008|NCT00844857|79399748|FG000|Overall Study|Withdrawal by Subject|8|||
44393009|NCT00844857|79399749|FG001|Overall Study|Withdrawal by Subject|7|||
44393010|NCT00844857|79399748|FG000|Overall Study|Protocol Violation|6|||
44393011|NCT00844857|79399749|FG001|Overall Study|Protocol Violation|0|||
44393012|NCT00844857|79399748|FG000|Overall Study|Lack of Efficacy|5|||
44393013|NCT00844857|79399749|FG001|Overall Study|Lack of Efficacy|5|||
44393014|NCT00844857|79399748|FG000|Overall Study|Clinical Relapse|0|||
44393015|NCT00844857|79399749|FG001|Overall Study|Clinical Relapse|1|||
44393016|NCT00844857|79399748|FG000|Overall Study|Entry Criteria Not Met|0|||
44393017|NCT00844857|79399749|FG001|Overall Study|Entry Criteria Not Met|1|||
44393018|NCT00844857|79399748|FG000|Overall Study|Lost to Follow-up|2|||
44393019|NCT00844857|79399749|FG001|Overall Study|Lost to Follow-up|3|||
44393020|NCT00844857|79399748|FG000|Overall Study|Did Not Take Study Drug|3|||
44393021|NCT00844857|79399749|FG001|Overall Study|Did Not Take Study Drug|1|||
44393022|NCT00844857|79399748|FG000|Overall Study|Good Clinical Practice Violations|21|||
44393023|NCT00844857|79399749|FG001|Overall Study|Good Clinical Practice Violations|11|||
44393024|NCT00569803|79399766|FG000|Overall Study|Lost to Follow-up|1|||
44520371|NCT02994394|79528247|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
44520372|NCT02998840|79528265|FG000|Overall Study|Lost to Follow-up|1|||
44520373|NCT02998840|79528266|FG001|Overall Study|Lost to Follow-up|1|||
44520374|NCT02998840|79528267|FG002|Overall Study|Lost to Follow-up|2|||
44520375|NCT02998840|79528268|FG003|Overall Study|Lost to Follow-up|3|||
44252128|NCT00211757|79087835|FG001|Overall Study|Lack of Efficacy|1|||
44252129|NCT02639052|79087852|FG000|Overall Study|Lost to Follow-up|1|||
44252130|NCT02635776|79087959|FG000|Overall Study|Physician Decision|1|||
44252131|NCT02635776|79087960|FG001|Overall Study|Physician Decision|0|||
44520376|NCT02998840|79528265|FG000|Overall Study|Withdrawal by Subject|1|||
44146739|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
44252132|NCT02635776|79087959|FG000|Overall Study|Adverse Event|51|||
44393025|NCT00569803|79399767|FG001|Overall Study|Lost to Follow-up|0|||
44393026|NCT00569803|79399768|FG002|Overall Study|Lost to Follow-up|0|||
44393027|NCT00569803|79399769|FG003|Overall Study|Lost to Follow-up|0|||
44393028|NCT00569803|79399770|FG004|Overall Study|Lost to Follow-up|0|||
44393029|NCT00569803|79399771|FG005|Overall Study|Lost to Follow-up|0|||
44393030|NCT00569803|79399772|FG006|Overall Study|Lost to Follow-up|0|||
44393031|NCT00569803|79399773|FG007|Overall Study|Lost to Follow-up|0|||
44393032|NCT00569803|79399766|FG000|Overall Study|injection syringe leaked during dosing|0|||
44393033|NCT00569803|79399767|FG001|Overall Study|injection syringe leaked during dosing|0|||
44393034|NCT00569803|79399768|FG002|Overall Study|injection syringe leaked during dosing|0|||
44393035|NCT00569803|79399769|FG003|Overall Study|injection syringe leaked during dosing|1|||
44393036|NCT00569803|79399770|FG004|Overall Study|injection syringe leaked during dosing|0|||
44393037|NCT00569803|79399771|FG005|Overall Study|injection syringe leaked during dosing|0|||
44393038|NCT00569803|79399772|FG006|Overall Study|injection syringe leaked during dosing|0|||
44393039|NCT00569803|79399773|FG007|Overall Study|injection syringe leaked during dosing|0|||
44393040|NCT00569803|79399766|FG000|Overall Study|Withdrawal by Subject|0|||
44393041|NCT00569803|79399767|FG001|Overall Study|Withdrawal by Subject|0|||
44393042|NCT00569803|79399768|FG002|Overall Study|Withdrawal by Subject|0|||
44393043|NCT00569803|79399769|FG003|Overall Study|Withdrawal by Subject|0|||
44393044|NCT00569803|79399770|FG004|Overall Study|Withdrawal by Subject|0|||
44393045|NCT00569803|79399771|FG005|Overall Study|Withdrawal by Subject|0|||
44393046|NCT00569803|79399772|FG006|Overall Study|Withdrawal by Subject|0|||
44393047|NCT00569803|79399773|FG007|Overall Study|Withdrawal by Subject|1|||
44393048|NCT00920426|79399798|FG000|ITZ111451|Adverse Event|1|||
44393049|NCT00920426|79399799|FG001|ITZ111451|Adverse Event|0|||
44393050|NCT00920426|79399800|FG002|ITZ111451|Adverse Event|0|||
44393051|NCT00920426|79399801|FG003|ITZ111451|Adverse Event|0|||
44393052|NCT00644995|79399815|FG000|Overall Study|Lost to Follow-up|1|||
44393053|NCT00644995|79399816|FG001|Overall Study|Lost to Follow-up|4|||
44393054|NCT00644995|79399815|FG000|Overall Study|Refused|1|||
44393055|NCT00644995|79399816|FG001|Overall Study|Refused|0|||
44393056|NCT00914966|79399824|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
44393057|NCT00914966|79399824|FG000|Step 1: 1500 Units|Physician Decision|1|||
44393058|NCT00914966|79399824|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
44393059|NCT00914810|79399835|FG000|Overall Study|Withdrawal by Subject|1|||
44393060|NCT00914810|79399836|FG001|Overall Study|Withdrawal by Subject|0|||
44393061|NCT00914810|79399835|FG000|Overall Study|Relocated out of state|1|||
44393062|NCT00914810|79399836|FG001|Overall Study|Relocated out of state|0|||
44393063|NCT00914810|79399835|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
44393064|NCT00914810|79399836|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
44393065|NCT00644917|79399842|FG000|Overall Study|Withdrawal by Subject|2|||
44393066|NCT00914732|79399853|FG000|Overall Study|Lost to Follow-up|6|||
44393067|NCT00914732|79399854|FG001|Overall Study|Lost to Follow-up|7|||
44393068|NCT00914732|79399855|FG002|Overall Study|Lost to Follow-up|9|||
44393069|NCT00914732|79399853|FG000|Overall Study|Withdrawal by Subject|3|||
44393070|NCT00914732|79399854|FG001|Overall Study|Withdrawal by Subject|0|||
44393071|NCT00914732|79399855|FG002|Overall Study|Withdrawal by Subject|2|||
44393072|NCT00914732|79399853|FG000|Overall Study|Adverse Event|1|||
44393073|NCT00914732|79399854|FG001|Overall Study|Adverse Event|0|||
44393074|NCT00914732|79399855|FG002|Overall Study|Adverse Event|0|||
44393075|NCT00844545|79399864|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
44393076|NCT00844545|79399864|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
44393077|NCT00844545|79399864|FG000|Extension Treatment Period|Adverse Event|2|||
44393078|NCT00844545|79399864|FG000|Post Treatment Period|Withdrawal by Subject|1|||
44393079|NCT00651157|79399869|FG000|Overall Study|Death|1|||
44393080|NCT00651157|79399869|FG000|Overall Study|Protocol Violation|1|||
44393081|NCT00843843|79399875|FG000|Overall Study|Physician Decision|1|||
44393082|NCT00843843|79399876|FG001|Overall Study|Physician Decision|1|||
44393083|NCT00843843|79399875|FG000|Overall Study|Protocol Violation|1|||
44393084|NCT00843843|79399876|FG001|Overall Study|Protocol Violation|1|||
44393085|NCT00650845|79399884|FG000|Overall Study|Withdrawal by Subject|5|||
44393086|NCT00650845|79399885|FG001|Overall Study|Withdrawal by Subject|0|||
44393087|NCT00650845|79399884|FG000|Overall Study|Protocol Violation|0|||
44393088|NCT00650845|79399885|FG001|Overall Study|Protocol Violation|13|||
44393089|NCT00842985|79399892|FG000|Screening|Did not meet entrance requirements|27|||
44393090|NCT00842985|79399892|FG000|First Intervention|Withdrawal by Subject|3|||
44393091|NCT00842985|79399892|FG000|First Intervention|Protocol Violation|3|||
44393092|NCT00842985|79399892|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
44393093|NCT00842985|79399892|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
44520377|NCT02998840|79528266|FG001|Overall Study|Withdrawal by Subject|1|||
44252133|NCT02635776|79087960|FG001|Overall Study|Adverse Event|3|||
44252134|NCT02635776|79087959|FG000|Overall Study|Withdrawal by Subject|41|||
44393094|NCT00842829|79399901|FG000|Dose Titration Period|Adverse Event|11|||
44393095|NCT00842829|79399902|FG001|Dose Titration Period|Adverse Event|10|||
44393096|NCT00842829|79399903|FG002|Dose Titration Period|Adverse Event|0|||
44252135|NCT02635776|79087960|FG001|Overall Study|Withdrawal by Subject|7|||
44393097|NCT00842829|79399901|FG000|Dose Titration Period|Lack of Efficacy|4|||
44393098|NCT00842829|79399902|FG001|Dose Titration Period|Lack of Efficacy|1|||
44393099|NCT00842829|79399903|FG002|Dose Titration Period|Lack of Efficacy|0|||
44393100|NCT00842829|79399901|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
44393101|NCT00842829|79399902|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
44393102|NCT00842829|79399903|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
44393103|NCT00842829|79399901|FG000|Dose Titration Period|Withdrawal by Subject|2|||
44252136|NCT02635776|79087959|FG000|Overall Study|Lost to Follow-up|4|||
44393104|NCT00842829|79399902|FG001|Dose Titration Period|Withdrawal by Subject|6|||
44393105|NCT00842829|79399903|FG002|Dose Titration Period|Withdrawal by Subject|0|||
44393106|NCT00842829|79399901|FG000|Dose Titration Period|Other|5|||
44393107|NCT00842829|79399902|FG001|Dose Titration Period|Other|4|||
44393108|NCT00842829|79399903|FG002|Dose Titration Period|Other|0|||
44393109|NCT00842829|79399901|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
44393110|NCT00842829|79399902|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
44393111|NCT00842829|79399903|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
44393112|NCT00842829|79399901|FG000|Dose Titration Period|Non-compliance to study drug|2|||
44393113|NCT00842829|79399902|FG001|Dose Titration Period|Non-compliance to study drug|1|||
44393114|NCT00842829|79399903|FG002|Dose Titration Period|Non-compliance to study drug|0|||
44393115|NCT00842829|79399901|FG000|Treatment Period|Adverse Event|0|||
44393116|NCT00842829|79399902|FG001|Treatment Period|Adverse Event|0|||
44393117|NCT00842829|79399903|FG002|Treatment Period|Adverse Event|15|||
44393118|NCT00842829|79399901|FG000|Treatment Period|Lack of Efficacy|0|||
44393119|NCT00842829|79399902|FG001|Treatment Period|Lack of Efficacy|0|||
44393120|NCT00842829|79399903|FG002|Treatment Period|Lack of Efficacy|6|||
44393121|NCT00842829|79399901|FG000|Treatment Period|Unstable persistent cancer pain|0|||
44393122|NCT00842829|79399902|FG001|Treatment Period|Unstable persistent cancer pain|0|||
44393123|NCT00842829|79399903|FG002|Treatment Period|Unstable persistent cancer pain|5|||
44393124|NCT00842829|79399901|FG000|Treatment Period|Withdrawal by Subject|0|||
44393125|NCT00842829|79399902|FG001|Treatment Period|Withdrawal by Subject|0|||
44393126|NCT00842829|79399903|FG002|Treatment Period|Withdrawal by Subject|11|||
44393127|NCT00842829|79399901|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
44393128|NCT00842829|79399902|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
44393129|NCT00842829|79399903|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
44393130|NCT00842829|79399901|FG000|Treatment Period|Protocol Violation|0|||
44393131|NCT00842829|79399902|FG001|Treatment Period|Protocol Violation|0|||
44393132|NCT00842829|79399903|FG002|Treatment Period|Protocol Violation|2|||
44393133|NCT00842829|79399901|FG000|Treatment Period|Other|0|||
44393134|NCT00842829|79399902|FG001|Treatment Period|Other|0|||
44393135|NCT00842829|79399903|FG002|Treatment Period|Other|18|||
44393136|NCT00842829|79399901|FG000|Treatment Period|Non-compliance to study procedures|0|||
44393137|NCT00842829|79399902|FG001|Treatment Period|Non-compliance to study procedures|0|||
44393138|NCT00842829|79399903|FG002|Treatment Period|Non-compliance to study procedures|4|||
44393139|NCT00842829|79399901|FG000|Treatment Period|Unclear completion status|0|||
44393140|NCT00842829|79399902|FG001|Treatment Period|Unclear completion status|0|||
44393141|NCT00842829|79399903|FG002|Treatment Period|Unclear completion status|1|||
44393142|NCT00842829|79399901|FG000|Continuation Period|Adverse Event|0|||
44393143|NCT00842829|79399902|FG001|Continuation Period|Adverse Event|0|||
44393144|NCT00842829|79399903|FG002|Continuation Period|Adverse Event|32|||
44393145|NCT00842829|79399901|FG000|Continuation Period|Lack of Efficacy|0|||
44393146|NCT00842829|79399902|FG001|Continuation Period|Lack of Efficacy|0|||
44393147|NCT00842829|79399903|FG002|Continuation Period|Lack of Efficacy|6|||
44393148|NCT00842829|79399901|FG000|Continuation Period|Unstable persistent cancer pain|0|||
44393149|NCT00842829|79399902|FG001|Continuation Period|Unstable persistent cancer pain|0|||
44393150|NCT00842829|79399903|FG002|Continuation Period|Unstable persistent cancer pain|3|||
44393151|NCT00842829|79399901|FG000|Continuation Period|Withdrawal by Subject|0|||
44393152|NCT00842829|79399902|FG001|Continuation Period|Withdrawal by Subject|0|||
44393153|NCT00842829|79399903|FG002|Continuation Period|Withdrawal by Subject|10|||
44393154|NCT00842829|79399901|FG000|Continuation Period|Other|0|||
44393155|NCT00842829|79399902|FG001|Continuation Period|Other|0|||
44393156|NCT00842829|79399903|FG002|Continuation Period|Other|7|||
44393157|NCT00842829|79399901|FG000|Continuation Period|Non-compliance to study procedures|0|||
44520378|NCT02998840|79528267|FG002|Overall Study|Withdrawal by Subject|0|||
44520379|NCT02998840|79528268|FG003|Overall Study|Withdrawal by Subject|1|||
44520380|NCT02998840|79528265|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
44520381|NCT02998840|79528266|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
44252137|NCT02635776|79087960|FG001|Overall Study|Lost to Follow-up|0|||
44252138|NCT02635776|79087959|FG000|Overall Study|Other reasons|5|||
44252139|NCT02635776|79087960|FG001|Overall Study|Other reasons|1|||
44252140|NCT02704403|79087974|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
44393158|NCT00842829|79399902|FG001|Continuation Period|Non-compliance to study procedures|0|||
44393159|NCT00842829|79399903|FG002|Continuation Period|Non-compliance to study procedures|2|||
44393160|NCT00842829|79399901|FG000|Continuation Period|Non-compliance to study drug|0|||
44393161|NCT00842829|79399902|FG001|Continuation Period|Non-compliance to study drug|0|||
44393162|NCT00842829|79399903|FG002|Continuation Period|Non-compliance to study drug|1|||
44393163|NCT00653263|79399915|FG000|Overall Study|Withdrawal by Subject|1|||
44393164|NCT00653263|79399915|FG000|Overall Study|Physician Decision|1|||
44393165|NCT00842361|79399921|FG000|Overall Study|Protocol Violation|1|||
44393166|NCT00842361|79399922|FG001|Overall Study|Protocol Violation|0|||
44393167|NCT00842361|79399921|FG000|Overall Study|Unclassified|0|||
44281111|NCT01951638|79242269|FG000|Follow-up Period|Protocol Violation|0|||
44393168|NCT00842361|79399922|FG001|Overall Study|Unclassified|2|||
44393169|NCT00841035|79399928|FG000|Phase 1 Overall Study|Physician Decision|13|||
44393170|NCT00642811|79399939|FG000|Overall Study|Adverse Event|2|||
44393171|NCT00642811|79399940|FG001|Overall Study|Adverse Event|3|||
44393172|NCT00642811|79399941|FG002|Overall Study|Adverse Event|0|||
44393173|NCT00642811|79399942|FG003|Overall Study|Adverse Event|0|||
44393174|NCT00642811|79399943|FG004|Overall Study|Adverse Event|0|||
44393175|NCT00642811|79399944|FG005|Overall Study|Adverse Event|1|||
44393176|NCT00642811|79399939|FG000|Overall Study|Developement of discontinuation criteria|0|||
44393177|NCT00642811|79399940|FG001|Overall Study|Developement of discontinuation criteria|0|||
44393178|NCT00642811|79399941|FG002|Overall Study|Developement of discontinuation criteria|0|||
44393179|NCT00642811|79399942|FG003|Overall Study|Developement of discontinuation criteria|0|||
44393180|NCT00642811|79399943|FG004|Overall Study|Developement of discontinuation criteria|1|||
44393181|NCT00642811|79399944|FG005|Overall Study|Developement of discontinuation criteria|0|||
44393182|NCT00642811|79399939|FG000|Overall Study|Severe Non-compliance to protocol|1|||
44393183|NCT00642811|79399940|FG001|Overall Study|Severe Non-compliance to protocol|0|||
44393184|NCT00642811|79399941|FG002|Overall Study|Severe Non-compliance to protocol|0|||
44393185|NCT00642811|79399942|FG003|Overall Study|Severe Non-compliance to protocol|0|||
44393186|NCT00642811|79399943|FG004|Overall Study|Severe Non-compliance to protocol|0|||
44393187|NCT00642811|79399944|FG005|Overall Study|Severe Non-compliance to protocol|0|||
44393188|NCT00642811|79399939|FG000|Overall Study|Other|0|||
44393189|NCT00642811|79399940|FG001|Overall Study|Other|1|||
44393190|NCT00642811|79399941|FG002|Overall Study|Other|0|||
44393191|NCT00642811|79399942|FG003|Overall Study|Other|1|||
44393192|NCT00642811|79399943|FG004|Overall Study|Other|0|||
44393193|NCT00642811|79399944|FG005|Overall Study|Other|0|||
44393194|NCT00838929|79399961|FG000|Overall Study|Protocol Violation|0|||
44393195|NCT00838929|79399962|FG001|Overall Study|Protocol Violation|1|||
44393196|NCT00838929|79399963|FG002|Overall Study|Protocol Violation|0|||
44393197|NCT00838929|79399961|FG000|Overall Study|Disease progression|0|||
44393198|NCT00838929|79399962|FG001|Overall Study|Disease progression|2|||
44393199|NCT00838929|79399963|FG002|Overall Study|Disease progression|1|||
44393200|NCT00916058|79399976|FG000|Phase 1|Screen Failure|0|||
44393201|NCT00916058|79399977|FG001|Phase 1|Screen Failure|0|||
44393202|NCT00916058|79399978|FG002|Phase 1|Screen Failure|0|||
44393203|NCT00916058|79399979|FG003|Phase 1|Screen Failure|0|||
44393204|NCT00916058|79399980|FG004|Phase 1|Screen Failure|0|||
44393205|NCT00916058|79399981|FG005|Phase 1|Screen Failure|1|||
44393206|NCT00916058|79399982|FG006|Phase 1|Screen Failure|0|||
44393207|NCT00916058|79399976|FG000|Phase 2|Screen Failure|0|||
44393208|NCT00916058|79399977|FG001|Phase 2|Screen Failure|0|||
44393209|NCT00916058|79399978|FG002|Phase 2|Screen Failure|0|||
44393210|NCT00916058|79399979|FG003|Phase 2|Screen Failure|0|||
44393211|NCT00916058|79399980|FG004|Phase 2|Screen Failure|0|||
44393212|NCT00916058|79399981|FG005|Phase 2|Screen Failure|0|||
44393213|NCT00916058|79399982|FG006|Phase 2|Screen Failure|3|||
44393214|NCT00912782|79400002|FG000|Overall Study|Death|2|||
44393215|NCT00912782|79400003|FG001|Overall Study|Death|1|||
44393216|NCT00912782|79400002|FG000|Overall Study|Lost to Follow-up|0|||
44393217|NCT00912782|79400003|FG001|Overall Study|Lost to Follow-up|1|||
44393218|NCT00912782|79400002|FG000|Overall Study|Did not receive vascular access type|1|||
44393219|NCT00912782|79400003|FG001|Overall Study|Did not receive vascular access type|2|||
44393220|NCT00912782|79400002|FG000|Overall Study|Relocated before study completion|0|||
44393221|NCT00912782|79400003|FG001|Overall Study|Relocated before study completion|1|||
44393222|NCT03444038|79400009|FG000|Overall Study|Adverse Event|12|||
44393223|NCT03444038|79400009|FG000|Overall Study|Withdrawal by Subject|7|||
44393224|NCT03444038|79400009|FG000|Overall Study|Lost to Follow-up|1|||
44393225|NCT03444038|79400009|FG000|Overall Study|Physician Decision|2|||
44281112|NCT01951638|79242270|FG001|Follow-up Period|Protocol Violation|0|||
44281113|NCT01951638|79242271|FG002|Follow-up Period|Protocol Violation|0|||
44281114|NCT01951638|79242272|FG003|Follow-up Period|Protocol Violation|1|||
44281115|NCT01951638|79242273|FG004|Follow-up Period|Protocol Violation|0|||
44393226|NCT03444038|79400009|FG000|Overall Study|Lack of Efficacy|7|||
44393227|NCT00911534|79400015|FG000|Overall Study|Adverse Event|4|||
44393228|NCT00911534|79400016|FG001|Overall Study|Adverse Event|4|||
44393229|NCT00911534|79400015|FG000|Overall Study|Lost to Follow-up|2|||
44393230|NCT00911534|79400016|FG001|Overall Study|Lost to Follow-up|4|||
44393231|NCT00911534|79400015|FG000|Overall Study|Withdrawal by Subject|2|||
44393232|NCT00911534|79400016|FG001|Overall Study|Withdrawal by Subject|1|||
44393233|NCT00911534|79400015|FG000|Overall Study|Lack of Efficacy|4|||
44393234|NCT00911534|79400016|FG001|Overall Study|Lack of Efficacy|1|||
44393235|NCT00911534|79400015|FG000|Overall Study|Withdrawal of consent|1|||
44393236|NCT00911534|79400016|FG001|Overall Study|Withdrawal of consent|4|||
44393237|NCT00911534|79400015|FG000|Overall Study|Other|2|||
44393238|NCT00911534|79400016|FG001|Overall Study|Other|2|||
44393239|NCT00911300|79400024|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
44393240|NCT00911300|79400025|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
44393241|NCT00911300|79400024|FG000|Overall Study|Death|1|||
44393242|NCT00911300|79400025|FG001|Overall Study|Death|0|||
44393243|NCT00911300|79400024|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
44393244|NCT00911300|79400025|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
44393245|NCT00911300|79400024|FG000|Overall Study|Adverse Event|14|||
44393246|NCT00911300|79400025|FG001|Overall Study|Adverse Event|6|||
44393247|NCT00911300|79400024|FG000|Overall Study|Protocol Violation|3|||
44393248|NCT00911300|79400025|FG001|Overall Study|Protocol Violation|2|||
44393249|NCT00911300|79400024|FG000|Overall Study|Consent Withdrawn|4|||
44393250|NCT00911300|79400025|FG001|Overall Study|Consent Withdrawn|12|||
44393251|NCT00911300|79400024|FG000|Overall Study|Coronary Angiography Performed|1|||
44393252|NCT00911300|79400025|FG001|Overall Study|Coronary Angiography Performed|0|||
44393253|NCT00911300|79400024|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
44393254|NCT00911300|79400025|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
44393255|NCT00911300|79400024|FG000|Overall Study|Received Commercial Treatment|1|||
44393256|NCT00911300|79400025|FG001|Overall Study|Received Commercial Treatment|0|||
44393257|NCT00911300|79400024|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
44393258|NCT00911300|79400025|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
44393259|NCT00911300|79400024|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
44393260|NCT00911300|79400025|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
44393261|NCT00911300|79400024|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
44393262|NCT00911300|79400025|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
44393263|NCT00911300|79400024|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
44393264|NCT00911300|79400025|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
44393265|NCT00911300|79400024|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
44393266|NCT00911300|79400025|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
44393267|NCT00911300|79400024|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
44393268|NCT00911300|79400025|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
44393269|NCT00911300|79400024|FG000|Overall Study|International Normalized Ratio Too High|0|||
44393270|NCT00911300|79400025|FG001|Overall Study|International Normalized Ratio Too High|1|||
44393271|NCT00911300|79400024|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
44393272|NCT00911300|79400025|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
44393273|NCT00911300|79400024|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
44393274|NCT00911300|79400025|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
44393275|NCT00911300|79400024|FG000|Overall Study|Physician Decision|0|||
44393276|NCT00911300|79400025|FG001|Overall Study|Physician Decision|1|||
44393277|NCT00911300|79400024|FG000|Overall Study|Treatment Stopped by Mistake|0|||
44393278|NCT00911300|79400025|FG001|Overall Study|Treatment Stopped by Mistake|1|||
44393279|NCT00911300|79400024|FG000|Overall Study|Randomized; No Study Medication Received|0|||
44393280|NCT00911300|79400025|FG001|Overall Study|Randomized; No Study Medication Received|2|||
44393281|NCT00911144|79400034|FG000|Overall Study|Withdrawal by Subject|16|||
44393282|NCT00911144|79400035|FG001|Overall Study|Withdrawal by Subject|5|||
44393283|NCT00910988|79400045|FG000|Overall Study|Lost to Follow-up|2|||
44393284|NCT00910988|79400046|FG001|Overall Study|Lost to Follow-up|4|||
44393285|NCT00910988|79400047|FG002|Overall Study|Lost to Follow-up|3|||
44281116|NCT01951638|79242269|FG000|Follow-up Period|Logistical difficulties|0|||
44393286|NCT00910988|79400048|FG003|Overall Study|Lost to Follow-up|0|||
44393287|NCT00644059|79400077|FG000|Overall Study|Lost to Follow-up|37|||
44393288|NCT00644059|79400078|FG001|Overall Study|Lost to Follow-up|34|||
44393289|NCT00644059|79400079|FG002|Overall Study|Lost to Follow-up|16|||
44393290|NCT00644059|79400077|FG000|Overall Study|Withdrawal by Subject|52|||
44393291|NCT00644059|79400078|FG001|Overall Study|Withdrawal by Subject|60|||
44393292|NCT00644059|79400079|FG002|Overall Study|Withdrawal by Subject|30|||
44393293|NCT00644059|79400077|FG000|Overall Study|Adverse Event|8|||
44393294|NCT00644059|79400078|FG001|Overall Study|Adverse Event|5|||
44393295|NCT00644059|79400079|FG002|Overall Study|Adverse Event|1|||
44393296|NCT00644059|79400077|FG000|Overall Study|Inappropriate Enrollment|1|||
44393297|NCT00644059|79400078|FG001|Overall Study|Inappropriate Enrollment|3|||
44393298|NCT00644059|79400079|FG002|Overall Study|Inappropriate Enrollment|0|||
44393299|NCT00644059|79400077|FG000|Overall Study|Protocol Deviation/violation|20|||
44281117|NCT01951638|79242270|FG001|Follow-up Period|Logistical difficulties|2|||
44281118|NCT01951638|79242271|FG002|Follow-up Period|Logistical difficulties|0|||
44281119|NCT01951638|79242272|FG003|Follow-up Period|Logistical difficulties|0|||
44281120|NCT01951638|79242273|FG004|Follow-up Period|Logistical difficulties|1|||
44281121|NCT01951638|79242269|FG000|Follow-up Period|Withdrawal by Subject|1|||
44281122|NCT01951638|79242270|FG001|Follow-up Period|Withdrawal by Subject|5|||
44393300|NCT00644059|79400078|FG001|Overall Study|Protocol Deviation/violation|19|||
44393301|NCT00644059|79400079|FG002|Overall Study|Protocol Deviation/violation|15|||
44393302|NCT00644059|79400077|FG000|Overall Study|Unable to classify|6|||
44393303|NCT00644059|79400078|FG001|Overall Study|Unable to classify|2|||
44393304|NCT00644059|79400079|FG002|Overall Study|Unable to classify|3|||
44393305|NCT00910910|79400130|FG000|Overall Study|Adverse Event|63|||
44393306|NCT00910910|79400131|FG001|Overall Study|Adverse Event|35|||
44393307|NCT00910910|79400130|FG000|Overall Study|PD without histologic change|27|||
44393308|NCT00910910|79400131|FG001|Overall Study|PD without histologic change|23|||
44393309|NCT00910910|79400130|FG000|Overall Study|PD with histologic change|0|||
44393310|NCT00910910|79400131|FG001|Overall Study|PD with histologic change|2|||
44393311|NCT00910910|79400130|FG000|Overall Study|Withdrawal by Subject|7|||
44393312|NCT00910910|79400131|FG001|Overall Study|Withdrawal by Subject|5|||
44393313|NCT00910910|79400130|FG000|Overall Study|Lost to Follow-up|2|||
44393314|NCT00910910|79400131|FG001|Overall Study|Lost to Follow-up|2|||
44393315|NCT00910910|79400130|FG000|Overall Study|Death|9|||
44393316|NCT00910910|79400131|FG001|Overall Study|Death|3|||
44393317|NCT00910910|79400130|FG000|Overall Study|Protocol Violation|2|||
44393318|NCT00910910|79400131|FG001|Overall Study|Protocol Violation|2|||
44393319|NCT00910910|79400130|FG000|Overall Study|Completed 13 cycles of treatment|0|||
44393320|NCT00910910|79400131|FG001|Overall Study|Completed 13 cycles of treatment|118|||
44393321|NCT00910910|79400130|FG000|Overall Study|Other|114|||
44393322|NCT00910910|79400131|FG001|Overall Study|Other|32|||
44393323|NCT00910910|79400130|FG000|Overall Study|Untreated before cycle 1|1|||
44281123|NCT01951638|79242271|FG002|Follow-up Period|Withdrawal by Subject|2|||
44281124|NCT01951638|79242272|FG003|Follow-up Period|Withdrawal by Subject|1|||
44281125|NCT01951638|79242273|FG004|Follow-up Period|Withdrawal by Subject|2|||
44281126|NCT01951638|79242269|FG000|Follow-up Period|Lost to Follow-up|0|||
44281127|NCT01951638|79242270|FG001|Follow-up Period|Lost to Follow-up|1|||
44281128|NCT01951638|79242271|FG002|Follow-up Period|Lost to Follow-up|0|||
44393324|NCT00910910|79400131|FG001|Overall Study|Untreated before cycle 1|2|||
44393325|NCT00911768|79400139|FG000|Overall Study|Protocol Violation|5|||
44393326|NCT00911768|79400140|FG001|Overall Study|Protocol Violation|4|||
44393327|NCT00911768|79400139|FG000|Overall Study|Withdrawal by Subject|1|||
44393328|NCT00911768|79400140|FG001|Overall Study|Withdrawal by Subject|0|||
44393329|NCT00909038|79400146|FG000|Overall Study|Protocol Violation|187|||
44393330|NCT00909038|79400146|FG000|Overall Study|Non-evaluable Subjects|230|||
44393331|NCT00909428|79400153|FG000|Overall Study|Lost to Follow-up|13|||
44393332|NCT00909428|79400154|FG001|Overall Study|Lost to Follow-up|10|||
44393333|NCT00909428|79400155|FG002|Overall Study|Lost to Follow-up|9|||
44393334|NCT00908960|79400165|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
44393335|NCT00908960|79400166|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
44393336|NCT00908960|79400167|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
44393337|NCT00650767|79400185|FG000|Overall Study|Adverse Event|0|||
44393338|NCT00650767|79400186|FG001|Overall Study|Adverse Event|3|||
44393339|NCT00650767|79400187|FG002|Overall Study|Adverse Event|10|||
44393340|NCT00650767|79400188|FG003|Overall Study|Adverse Event|8|||
44393341|NCT00650767|79400185|FG000|Overall Study|Death|1|||
44393342|NCT00650767|79400186|FG001|Overall Study|Death|0|||
44393343|NCT00650767|79400187|FG002|Overall Study|Death|0|||
44393344|NCT00650767|79400188|FG003|Overall Study|Death|0|||
44393345|NCT00650767|79400185|FG000|Overall Study|Withdrawal by Subject|2|||
44393346|NCT00650767|79400186|FG001|Overall Study|Withdrawal by Subject|4|||
44393347|NCT00650767|79400187|FG002|Overall Study|Withdrawal by Subject|3|||
44393348|NCT00650767|79400188|FG003|Overall Study|Withdrawal by Subject|3|||
44393349|NCT00650767|79400185|FG000|Overall Study|Lost to Follow-up|1|||
44393350|NCT00650767|79400186|FG001|Overall Study|Lost to Follow-up|1|||
44393351|NCT00650767|79400187|FG002|Overall Study|Lost to Follow-up|1|||
44393352|NCT00650767|79400188|FG003|Overall Study|Lost to Follow-up|0|||
44393353|NCT00650767|79400185|FG000|Overall Study|Other|1|||
44393354|NCT00650767|79400186|FG001|Overall Study|Other|1|||
44393355|NCT00650767|79400187|FG002|Overall Study|Other|0|||
44393356|NCT00650767|79400188|FG003|Overall Study|Other|0|||
44393357|NCT00973349|79400214|FG000|Overall Study|Adverse Event|0|||
44393358|NCT00973349|79400215|FG001|Overall Study|Adverse Event|0|||
44393359|NCT00973349|79400216|FG002|Overall Study|Adverse Event|0|||
44393360|NCT00973349|79400217|FG003|Overall Study|Adverse Event|0|||
44281129|NCT01951638|79242272|FG003|Follow-up Period|Lost to Follow-up|1|||
44281130|NCT01951638|79242273|FG004|Follow-up Period|Lost to Follow-up|0|||
44281131|NCT01951638|79242269|FG000|Follow-up Period|Death|1|||
44393361|NCT00973349|79400218|FG004|Overall Study|Adverse Event|1|||
44393362|NCT00973349|79400219|FG005|Overall Study|Adverse Event|0|||
44393363|NCT00973349|79400220|FG006|Overall Study|Adverse Event|0|||
44393364|NCT00973349|79400221|FG007|Overall Study|Adverse Event|0|||
44393365|NCT00973349|79400222|FG008|Overall Study|Adverse Event|1|||
44393366|NCT00973349|79400223|FG009|Overall Study|Adverse Event|0|||
44393367|NCT00973349|79400224|FG010|Overall Study|Adverse Event|0|||
44393368|NCT00973349|79400225|FG011|Overall Study|Adverse Event|0|||
44281132|NCT01951638|79242270|FG001|Follow-up Period|Death|0|||
44393369|NCT00973349|79400226|FG012|Overall Study|Adverse Event|0|||
44393370|NCT00973349|79400227|FG013|Overall Study|Adverse Event|0|||
44393371|NCT00973349|79400228|FG014|Overall Study|Adverse Event|1|||
44393372|NCT00973349|79400229|FG015|Overall Study|Adverse Event|0|||
44393373|NCT00973349|79400214|FG000|Overall Study|Withdrawal by Subject|1|||
44393374|NCT00973349|79400215|FG001|Overall Study|Withdrawal by Subject|2|||
44393375|NCT00973349|79400216|FG002|Overall Study|Withdrawal by Subject|2|||
44393376|NCT00973349|79400217|FG003|Overall Study|Withdrawal by Subject|3|||
44393377|NCT00973349|79400218|FG004|Overall Study|Withdrawal by Subject|2|||
44393378|NCT00973349|79400219|FG005|Overall Study|Withdrawal by Subject|0|||
44393379|NCT00973349|79400220|FG006|Overall Study|Withdrawal by Subject|2|||
44393380|NCT00973349|79400221|FG007|Overall Study|Withdrawal by Subject|2|||
44393381|NCT00973349|79400222|FG008|Overall Study|Withdrawal by Subject|0|||
44393382|NCT00973349|79400223|FG009|Overall Study|Withdrawal by Subject|2|||
44393383|NCT00973349|79400224|FG010|Overall Study|Withdrawal by Subject|0|||
44393384|NCT00973349|79400225|FG011|Overall Study|Withdrawal by Subject|1|||
44393385|NCT00973349|79400226|FG012|Overall Study|Withdrawal by Subject|0|||
44393386|NCT00973349|79400227|FG013|Overall Study|Withdrawal by Subject|0|||
44393387|NCT00973349|79400228|FG014|Overall Study|Withdrawal by Subject|0|||
44393388|NCT00973349|79400229|FG015|Overall Study|Withdrawal by Subject|0|||
44393389|NCT00973349|79400214|FG000|Overall Study|Lost to Follow-up|3|||
44393390|NCT00973349|79400215|FG001|Overall Study|Lost to Follow-up|1|||
44393391|NCT00973349|79400216|FG002|Overall Study|Lost to Follow-up|2|||
44393392|NCT00973349|79400217|FG003|Overall Study|Lost to Follow-up|2|||
44393393|NCT00973349|79400218|FG004|Overall Study|Lost to Follow-up|1|||
44520382|NCT02998840|79528267|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
44520383|NCT02998840|79528268|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
44520384|NCT00023673|79528279|FG000|Overall Study|Ineligible / no protocol treatment|0|||
44520385|NCT00023673|79528280|FG001|Overall Study|Ineligible / no protocol treatment|0|||
44520386|NCT00023673|79528281|FG002|Overall Study|Ineligible / no protocol treatment|0|||
44520387|NCT00023673|79528282|FG003|Overall Study|Ineligible / no protocol treatment|1|||
44520388|NCT00023673|79528279|FG000|Overall Study|Patient withdrew consent|0|||
44520389|NCT00023673|79528280|FG001|Overall Study|Patient withdrew consent|0|||
44520390|NCT00023673|79528281|FG002|Overall Study|Patient withdrew consent|0|||
44520391|NCT00023673|79528282|FG003|Overall Study|Patient withdrew consent|1|||
44520392|NCT01069900|79528294|FG000|Overall Study|Technical problems|0|||
44520393|NCT01069900|79528295|FG001|Overall Study|Technical problems|1|||
44520394|NCT01069900|79528294|FG000|Overall Study|Lost to Follow-up|7|||
44520395|NCT01069900|79528295|FG001|Overall Study|Lost to Follow-up|1|||
44520396|NCT01069900|79528294|FG000|Overall Study|Withdrawal by Subject|6|||
44520397|NCT01069900|79528295|FG001|Overall Study|Withdrawal by Subject|1|||
44520398|NCT01069900|79528294|FG000|Overall Study|Protocol Violation|4|||
44520399|NCT01069900|79528295|FG001|Overall Study|Protocol Violation|1|||
44520400|NCT01069900|79528294|FG000|Overall Study|Insufficient Therapeutic effect|1|||
44520401|NCT01069900|79528295|FG001|Overall Study|Insufficient Therapeutic effect|0|||
44520402|NCT01069120|79528303|FG000|Overall Study|Study prematurely terminated|27|||
44520403|NCT00006237|79528311|FG000|Overall Study|Adverse Event|39|||
44520404|NCT00006237|79528312|FG001|Overall Study|Adverse Event|29|||
44520405|NCT00006237|79528311|FG000|Overall Study|Death|1|||
44520406|NCT00006237|79528312|FG001|Overall Study|Death|0|||
44520407|NCT00006237|79528311|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
44520408|NCT00006237|79528312|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
44520409|NCT00006237|79528311|FG000|Overall Study|Progression/relapse|54|||
44520410|NCT00006237|79528312|FG001|Overall Study|Progression/relapse|2|||
44520411|NCT00006237|79528311|FG000|Overall Study|Not eligible|9|||
44520412|NCT00006237|79528312|FG001|Overall Study|Not eligible|20|||
44520413|NCT00006237|79528311|FG000|Overall Study|Withdrawal by Subject|0|||
44520414|NCT00006237|79528312|FG001|Overall Study|Withdrawal by Subject|1|||
44520415|NCT00006237|79528311|FG000|Overall Study|Not protocol specified|14|||
44520416|NCT00006237|79528312|FG001|Overall Study|Not protocol specified|5|||
44520417|NCT02993926|79528321|FG000|Enantone Treatment Phase|Adverse Event|1|||
44520418|NCT02993926|79528322|FG001|Enantone Treatment Phase|Adverse Event|0|||
44520419|NCT02993926|79528323|FG002|Enantone Treatment Phase|Adverse Event|0|||
44520420|NCT02993926|79528321|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
44520421|NCT02993926|79528322|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
44520422|NCT02993926|79528323|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
44520423|NCT02993926|79528321|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
44520424|NCT02993926|79528322|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
44281133|NCT01951638|79242271|FG002|Follow-up Period|Death|1|||
44520425|NCT02993926|79528323|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
44520426|NCT02993926|79528321|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
44520427|NCT02993926|79528322|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
44520428|NCT02993926|79528323|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
44520429|NCT02993224|79528333|FG000|Core Phase - Period 1|Adverse Event|4|||
44520430|NCT02993224|79528333|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
44520431|NCT02993224|79528333|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
44520432|NCT02993224|79528333|FG000|Core Phase- Period 2|Adverse Event|1|||
44520433|NCT02993224|79528333|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
44520434|NCT02993224|79528333|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
44520435|NCT02993224|79528333|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
44520436|NCT02993224|79528333|FG000|Extension Phase|Adverse Event|3|||
44520437|NCT02993224|79528333|FG000|Extension Phase|Withdrawal by Subject|3|||
44520438|NCT02993224|79528333|FG000|Extension Phase|Lost to Follow-up|2|||
44520439|NCT02993224|79528333|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
44520440|NCT03495908|79528341|FG000|Overall Study|Withdrawal by Subject|3|||
44520441|NCT03495908|79528342|FG001|Overall Study|Withdrawal by Subject|1|||
44520442|NCT03495908|79528341|FG000|Overall Study|Lost to Follow-up|1|||
44520443|NCT03495908|79528342|FG001|Overall Study|Lost to Follow-up|4|||
44520444|NCT03495908|79528341|FG000|Overall Study|Adverse Event|0|||
44520445|NCT03495908|79528342|FG001|Overall Study|Adverse Event|2|||
44520446|NCT03495908|79528341|FG000|Overall Study|Death|1|||
44520447|NCT03495908|79528342|FG001|Overall Study|Death|0|||
44520448|NCT03495908|79528341|FG000|Overall Study|Physician Decision|5|||
44520449|NCT03495908|79528342|FG001|Overall Study|Physician Decision|4|||
44520450|NCT03495908|79528341|FG000|Overall Study|No documented reason|0|||
44520451|NCT03495908|79528342|FG001|Overall Study|No documented reason|2|||
44520452|NCT02992288|79528354|FG000|Overall Study|Adverse Event|8|||
44520453|NCT02992288|79528355|FG001|Overall Study|Adverse Event|2|||
44520454|NCT02992288|79528356|FG002|Overall Study|Adverse Event|2|||
44520455|NCT02992288|79528357|FG003|Overall Study|Adverse Event|2|||
44520456|NCT02992288|79528358|FG004|Overall Study|Adverse Event|2|||
44520457|NCT02992288|79528359|FG005|Overall Study|Adverse Event|7|||
44520458|NCT02992288|79528354|FG000|Overall Study|Non-compliance with study drug|0|||
44520459|NCT02992288|79528355|FG001|Overall Study|Non-compliance with study drug|1|||
44520460|NCT02992288|79528356|FG002|Overall Study|Non-compliance with study drug|1|||
44393394|NCT00973349|79400219|FG005|Overall Study|Lost to Follow-up|3|||
44393395|NCT00973349|79400220|FG006|Overall Study|Lost to Follow-up|0|||
44393396|NCT00973349|79400221|FG007|Overall Study|Lost to Follow-up|1|||
44393397|NCT00973349|79400222|FG008|Overall Study|Lost to Follow-up|2|||
44393398|NCT00973349|79400223|FG009|Overall Study|Lost to Follow-up|1|||
44393399|NCT00973349|79400224|FG010|Overall Study|Lost to Follow-up|0|||
44393400|NCT00973349|79400225|FG011|Overall Study|Lost to Follow-up|1|||
44393401|NCT00973349|79400226|FG012|Overall Study|Lost to Follow-up|0|||
44393402|NCT00973349|79400227|FG013|Overall Study|Lost to Follow-up|0|||
44393403|NCT00973349|79400228|FG014|Overall Study|Lost to Follow-up|0|||
44393404|NCT00973349|79400229|FG015|Overall Study|Lost to Follow-up|1|||
44393405|NCT00973349|79400214|FG000|Overall Study|Inappropriate enrolment|0|||
44393406|NCT00973349|79400215|FG001|Overall Study|Inappropriate enrolment|0|||
44393407|NCT00973349|79400216|FG002|Overall Study|Inappropriate enrolment|1|||
44393408|NCT00973349|79400217|FG003|Overall Study|Inappropriate enrolment|0|||
44393409|NCT00973349|79400218|FG004|Overall Study|Inappropriate enrolment|0|||
44393410|NCT00973349|79400219|FG005|Overall Study|Inappropriate enrolment|0|||
44393411|NCT00973349|79400220|FG006|Overall Study|Inappropriate enrolment|0|||
44393412|NCT00973349|79400221|FG007|Overall Study|Inappropriate enrolment|0|||
44393413|NCT00973349|79400222|FG008|Overall Study|Inappropriate enrolment|0|||
44393414|NCT00973349|79400223|FG009|Overall Study|Inappropriate enrolment|2|||
44393415|NCT00973349|79400224|FG010|Overall Study|Inappropriate enrolment|0|||
44393416|NCT00973349|79400225|FG011|Overall Study|Inappropriate enrolment|0|||
44393417|NCT00973349|79400226|FG012|Overall Study|Inappropriate enrolment|1|||
44393418|NCT00973349|79400227|FG013|Overall Study|Inappropriate enrolment|0|||
44252141|NCT02704403|79087975|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
44252142|NCT02704403|79087974|FG000|Overall Study|Administrative reasons by sponsor|1251|||
44252143|NCT02704403|79087975|FG001|Overall Study|Administrative reasons by sponsor|616|||
44393419|NCT00973349|79400228|FG014|Overall Study|Inappropriate enrolment|1|||
44393420|NCT00973349|79400229|FG015|Overall Study|Inappropriate enrolment|1|||
44393421|NCT00973349|79400214|FG000|Overall Study|Protocol Violation|0|||
44520461|NCT02992288|79528357|FG003|Overall Study|Non-compliance with study drug|0|||
44520462|NCT02992288|79528358|FG004|Overall Study|Non-compliance with study drug|1|||
44520463|NCT02992288|79528359|FG005|Overall Study|Non-compliance with study drug|0|||
44520464|NCT02992288|79528354|FG000|Overall Study|Physician Decision|3|||
44520465|NCT02992288|79528355|FG001|Overall Study|Physician Decision|0|||
44252144|NCT02704403|79087974|FG000|Overall Study|Death|4|||
44520466|NCT02992288|79528356|FG002|Overall Study|Physician Decision|1|||
44252145|NCT02704403|79087975|FG001|Overall Study|Death|3|||
44393422|NCT00973349|79400215|FG001|Overall Study|Protocol Violation|0|||
44393423|NCT00973349|79400216|FG002|Overall Study|Protocol Violation|0|||
44393424|NCT00973349|79400217|FG003|Overall Study|Protocol Violation|0|||
44393425|NCT00973349|79400218|FG004|Overall Study|Protocol Violation|0|||
44393426|NCT00973349|79400219|FG005|Overall Study|Protocol Violation|0|||
44393427|NCT00973349|79400220|FG006|Overall Study|Protocol Violation|0|||
44393428|NCT00973349|79400221|FG007|Overall Study|Protocol Violation|0|||
44393429|NCT00973349|79400222|FG008|Overall Study|Protocol Violation|1|||
44393430|NCT00973349|79400223|FG009|Overall Study|Protocol Violation|0|||
44393431|NCT00973349|79400224|FG010|Overall Study|Protocol Violation|0|||
44393432|NCT00973349|79400225|FG011|Overall Study|Protocol Violation|0|||
44393433|NCT00973349|79400226|FG012|Overall Study|Protocol Violation|0|||
44393434|NCT00973349|79400227|FG013|Overall Study|Protocol Violation|0|||
44393435|NCT00973349|79400228|FG014|Overall Study|Protocol Violation|0|||
44393436|NCT00973349|79400229|FG015|Overall Study|Protocol Violation|0|||
44393437|NCT00973349|79400214|FG000|Overall Study|Unable to classify|0|||
44393438|NCT00973349|79400215|FG001|Overall Study|Unable to classify|0|||
44393439|NCT00973349|79400216|FG002|Overall Study|Unable to classify|0|||
44393440|NCT00973349|79400217|FG003|Overall Study|Unable to classify|0|||
44393441|NCT00973349|79400218|FG004|Overall Study|Unable to classify|1|||
44393442|NCT00973349|79400219|FG005|Overall Study|Unable to classify|1|||
44393443|NCT00973349|79400220|FG006|Overall Study|Unable to classify|0|||
44393444|NCT00973349|79400221|FG007|Overall Study|Unable to classify|0|||
44393445|NCT00973349|79400222|FG008|Overall Study|Unable to classify|0|||
44393446|NCT00973349|79400223|FG009|Overall Study|Unable to classify|1|||
44393447|NCT00973349|79400224|FG010|Overall Study|Unable to classify|0|||
44393448|NCT00973349|79400225|FG011|Overall Study|Unable to classify|0|||
44393449|NCT00973349|79400226|FG012|Overall Study|Unable to classify|0|||
44393450|NCT00973349|79400227|FG013|Overall Study|Unable to classify|0|||
44393451|NCT00973349|79400228|FG014|Overall Study|Unable to classify|0|||
44393452|NCT00973349|79400229|FG015|Overall Study|Unable to classify|0|||
44393453|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Death|20|||
44393454|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Death|26|||
44393455|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
44393456|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
44393457|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
44393458|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
44393459|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
44393460|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
44393461|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
44393462|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
44393463|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
44393464|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
44393465|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
44393466|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
44393467|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
44393468|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
44393469|NCT00643201|79400257|FG000|Randomized, Completed 6 Months of Study|Other|107|||
44393470|NCT00643201|79400258|FG001|Randomized, Completed 6 Months of Study|Other|107|||
44393471|NCT00643201|79400257|FG000|Completed Study Follow Up|Death|28|||
44393472|NCT00643201|79400258|FG001|Completed Study Follow Up|Death|34|||
44393473|NCT00643201|79400257|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
44393474|NCT00643201|79400258|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
44393475|NCT00643201|79400257|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
44393476|NCT00643201|79400258|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
44393477|NCT00643201|79400257|FG000|Completed Study Follow Up|non-specified|1|||
44393478|NCT00643201|79400258|FG001|Completed Study Follow Up|non-specified|0|||
44393479|NCT00643123|79400268|FG000|Overall Study|Lost to Follow-up|4|||
44393480|NCT00643123|79400269|FG001|Overall Study|Lost to Follow-up|0|||
44252146|NCT02704403|79087974|FG000|Overall Study|Endpoint event|52|||
44252147|NCT02704403|79087975|FG001|Overall Study|Endpoint event|24|||
44252148|NCT02704403|79087974|FG000|Overall Study|Lost to Follow-up|22|||
44252149|NCT02704403|79087975|FG001|Overall Study|Lost to Follow-up|11|||
44252150|NCT02704403|79087974|FG000|Overall Study|Protocol Violation|15|||
44393481|NCT00643123|79400268|FG000|Overall Study|Withdrawal by Subject|1|||
44393482|NCT00643123|79400269|FG001|Overall Study|Withdrawal by Subject|1|||
44393483|NCT00968981|79400278|FG000|Overall Study|Adverse Event|2|||
44393484|NCT00968981|79400279|FG001|Overall Study|Adverse Event|0|||
44393485|NCT00968981|79400280|FG002|Overall Study|Adverse Event|0|||
44393486|NCT00968981|79400278|FG000|Overall Study|Disease Progression|14|||
44393487|NCT00968981|79400279|FG001|Overall Study|Disease Progression|16|||
44393488|NCT00968981|79400280|FG002|Overall Study|Disease Progression|13|||
44393489|NCT00968981|79400278|FG000|Overall Study|Lost to Follow-up|0|||
44393490|NCT00968981|79400279|FG001|Overall Study|Lost to Follow-up|0|||
44393491|NCT00968981|79400280|FG002|Overall Study|Lost to Follow-up|1|||
44393492|NCT00968981|79400278|FG000|Overall Study|Physician Decision|5|||
44393493|NCT00968981|79400279|FG001|Overall Study|Physician Decision|3|||
44393494|NCT00968981|79400280|FG002|Overall Study|Physician Decision|5|||
44393495|NCT00968981|79400278|FG000|Overall Study|Withdrawal by Subject|1|||
44393496|NCT00968981|79400279|FG001|Overall Study|Withdrawal by Subject|3|||
44393497|NCT00968981|79400280|FG002|Overall Study|Withdrawal by Subject|3|||
44393498|NCT00641719|79400291|FG000|Overall Study|Lack of Efficacy|1|||
44393499|NCT00641719|79400292|FG001|Overall Study|Lack of Efficacy|2|||
44393500|NCT00641719|79400291|FG000|Overall Study|Adverse Event|24|||
44393501|NCT00641719|79400292|FG001|Overall Study|Adverse Event|29|||
44393502|NCT00641719|79400291|FG000|Overall Study|Withdrawal by Subject|4|||
44393503|NCT00641719|79400292|FG001|Overall Study|Withdrawal by Subject|4|||
44393504|NCT00641719|79400291|FG000|Overall Study|Reason Not Specified|1|||
44393505|NCT00641719|79400292|FG001|Overall Study|Reason Not Specified|2|||
44393506|NCT00648895|79400300|FG000|Overall Study|Lack of Efficacy|0|||
44393507|NCT00648895|79400301|FG001|Overall Study|Lack of Efficacy|1|||
44393508|NCT00975221|79400309|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
44393509|NCT00975221|79400310|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
44393510|NCT00975221|79400309|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
44393511|NCT00975221|79400310|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
44393512|NCT00975221|79400309|FG000|Titration Phase (Weeks 1-12)|Other|0|||
44393513|NCT00975221|79400310|FG001|Titration Phase (Weeks 1-12)|Other|1|||
44393514|NCT00975221|79400309|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
44393515|NCT00975221|79400310|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
44393516|NCT00975221|79400309|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
44393517|NCT00975221|79400310|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
44393518|NCT00975221|79400309|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
44393519|NCT00975221|79400310|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
44393520|NCT00972179|79400325|FG000|Overall Study|Noncompliance|1|||
44393521|NCT00972179|79400326|FG001|Overall Study|Noncompliance|0|||
44393522|NCT00972179|79400327|FG002|Overall Study|Noncompliance|0|||
44393523|NCT00972179|79400328|FG003|Overall Study|Noncompliance|0|||
44393524|NCT00972179|79400329|FG004|Overall Study|Noncompliance|1|||
44393525|NCT00972179|79400330|FG005|Overall Study|Noncompliance|0|||
44393526|NCT00972179|79400331|FG006|Overall Study|Noncompliance|1|||
44393527|NCT00972179|79400325|FG000|Overall Study|Withdrawal by Subject|0|||
44393528|NCT00972179|79400326|FG001|Overall Study|Withdrawal by Subject|3|||
44393529|NCT00972179|79400327|FG002|Overall Study|Withdrawal by Subject|0|||
44393530|NCT00972179|79400328|FG003|Overall Study|Withdrawal by Subject|1|||
44393531|NCT00972179|79400329|FG004|Overall Study|Withdrawal by Subject|0|||
44393532|NCT00972179|79400330|FG005|Overall Study|Withdrawal by Subject|0|||
44393533|NCT00972179|79400331|FG006|Overall Study|Withdrawal by Subject|2|||
44393534|NCT00972179|79400325|FG000|Overall Study|Administrative Decision|0|||
44393535|NCT00972179|79400326|FG001|Overall Study|Administrative Decision|0|||
44393536|NCT00972179|79400327|FG002|Overall Study|Administrative Decision|0|||
44393537|NCT00972179|79400328|FG003|Overall Study|Administrative Decision|0|||
44393538|NCT00972179|79400329|FG004|Overall Study|Administrative Decision|1|||
44393539|NCT00972179|79400330|FG005|Overall Study|Administrative Decision|0|||
44393540|NCT00972179|79400331|FG006|Overall Study|Administrative Decision|0|||
44393541|NCT00972179|79400325|FG000|Overall Study|Lost to Follow-up|0|||
44393542|NCT00972179|79400326|FG001|Overall Study|Lost to Follow-up|0|||
44393543|NCT00972179|79400327|FG002|Overall Study|Lost to Follow-up|1|||
44393544|NCT00972179|79400328|FG003|Overall Study|Lost to Follow-up|0|||
44393545|NCT00972179|79400329|FG004|Overall Study|Lost to Follow-up|0|||
44393546|NCT00972179|79400330|FG005|Overall Study|Lost to Follow-up|3|||
44393547|NCT00972179|79400331|FG006|Overall Study|Lost to Follow-up|1|||
44393548|NCT00906698|79400357|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
44393549|NCT00906698|79400358|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
44393550|NCT00906698|79400359|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
44393551|NCT00906698|79400360|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
44393552|NCT00906698|79400361|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
44393553|NCT00906698|79400362|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
44252151|NCT02704403|79087975|FG001|Overall Study|Protocol Violation|15|||
44393554|NCT00906698|79400357|FG000|Overall Study|Adverse Event|0|||
44393555|NCT00906698|79400358|FG001|Overall Study|Adverse Event|0|||
44393556|NCT00906698|79400359|FG002|Overall Study|Adverse Event|2|||
44393557|NCT00906698|79400360|FG003|Overall Study|Adverse Event|0|||
44393558|NCT00906698|79400361|FG004|Overall Study|Adverse Event|4|||
44393559|NCT00906698|79400362|FG005|Overall Study|Adverse Event|1|||
44393560|NCT00906698|79400357|FG000|Overall Study|Disease progression|3|||
44393561|NCT00906698|79400358|FG001|Overall Study|Disease progression|12|||
44393562|NCT00906698|79400359|FG002|Overall Study|Disease progression|4|||
44393563|NCT00906698|79400360|FG003|Overall Study|Disease progression|4|||
44393564|NCT00906698|79400361|FG004|Overall Study|Disease progression|12|||
44393565|NCT00906698|79400362|FG005|Overall Study|Disease progression|4|||
44393566|NCT00906698|79400357|FG000|Overall Study|Withdrawal by Subject|0|||
44393567|NCT00906698|79400358|FG001|Overall Study|Withdrawal by Subject|0|||
44393568|NCT00906698|79400359|FG002|Overall Study|Withdrawal by Subject|0|||
44393569|NCT00906698|79400360|FG003|Overall Study|Withdrawal by Subject|0|||
44393570|NCT00906698|79400361|FG004|Overall Study|Withdrawal by Subject|1|||
44393571|NCT00906698|79400362|FG005|Overall Study|Withdrawal by Subject|0|||
44393572|NCT00906698|79400357|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
44393573|NCT00906698|79400358|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
44393574|NCT00906698|79400359|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
44393575|NCT00906698|79400360|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
44393576|NCT00906698|79400361|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
44393577|NCT00906698|79400362|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
44393578|NCT00972023|79400394|FG000|Overall Study|Withdrawal by Subject|1|||
44393579|NCT00971945|79400400|FG000|Overall Study|Progressive Disease|3|||
44393580|NCT00971945|79400400|FG000|Overall Study|Change in treatment policy|1|||
44393581|NCT00971945|79400400|FG000|Overall Study|Other reasons|2|||
44393582|NCT00971867|79400404|FG000|Overall Study|Adverse Event|4|||
44393583|NCT00971867|79400404|FG000|Overall Study|Participant Withdrew Consent|1|||
44393584|NCT00971867|79400404|FG000|Overall Study|Disease Progression|6|||
44393585|NCT00971321|79400410|FG000|Up to Month 7|Withdrawal by Subject|1|||
44393586|NCT00971321|79400411|FG001|Up to Month 7|Withdrawal by Subject|0|||
44393587|NCT00971321|79400410|FG000|Up to Month 7|Migrated/moved from study area|3|||
44393588|NCT00971321|79400411|FG001|Up to Month 7|Migrated/moved from study area|2|||
44393589|NCT00971321|79400410|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
44393590|NCT00971321|79400411|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
44393591|NCT00971321|79400410|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
44393592|NCT00971321|79400411|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
44393593|NCT00971321|79400410|FG000|Up to Month 11-12|Lost to Follow-up|1|||
44393594|NCT00971321|79400411|FG001|Up to Month 11-12|Lost to Follow-up|0|||
44393595|NCT00648739|79400417|FG000|Overall Study|Adverse Event|1|||
44393596|NCT00648739|79400418|FG001|Overall Study|Adverse Event|0|||
44393597|NCT00648739|79400419|FG002|Overall Study|Adverse Event|1|||
44393598|NCT00648739|79400420|FG003|Overall Study|Adverse Event|2|||
44393599|NCT00648739|79400421|FG004|Overall Study|Adverse Event|1|||
44393600|NCT00648739|79400422|FG005|Overall Study|Adverse Event|0|||
44393601|NCT00648739|79400423|FG006|Overall Study|Adverse Event|0|||
44393602|NCT00648739|79400417|FG000|Overall Study|Withdrawal by Subject|1|||
44393603|NCT00648739|79400418|FG001|Overall Study|Withdrawal by Subject|0|||
44393604|NCT00648739|79400419|FG002|Overall Study|Withdrawal by Subject|1|||
44393605|NCT00648739|79400420|FG003|Overall Study|Withdrawal by Subject|0|||
44393606|NCT00648739|79400421|FG004|Overall Study|Withdrawal by Subject|0|||
44393607|NCT00648739|79400422|FG005|Overall Study|Withdrawal by Subject|2|||
44393608|NCT00648739|79400423|FG006|Overall Study|Withdrawal by Subject|0|||
44393609|NCT00648739|79400417|FG000|Overall Study|Lack of Efficacy|0|||
44393610|NCT00648739|79400418|FG001|Overall Study|Lack of Efficacy|0|||
44393611|NCT00648739|79400419|FG002|Overall Study|Lack of Efficacy|0|||
44393612|NCT00648739|79400420|FG003|Overall Study|Lack of Efficacy|0|||
44393613|NCT00648739|79400421|FG004|Overall Study|Lack of Efficacy|1|||
44393614|NCT00648739|79400422|FG005|Overall Study|Lack of Efficacy|2|||
44393615|NCT00648739|79400423|FG006|Overall Study|Lack of Efficacy|0|||
44393616|NCT00648739|79400417|FG000|Overall Study|Investigator Considered it Advisable|0|||
44393617|NCT00648739|79400418|FG001|Overall Study|Investigator Considered it Advisable|0|||
44393618|NCT00648739|79400419|FG002|Overall Study|Investigator Considered it Advisable|0|||
44393619|NCT00648739|79400420|FG003|Overall Study|Investigator Considered it Advisable|0|||
44393620|NCT00648739|79400421|FG004|Overall Study|Investigator Considered it Advisable|0|||
44393621|NCT00648739|79400422|FG005|Overall Study|Investigator Considered it Advisable|1|||
44393622|NCT00648739|79400423|FG006|Overall Study|Investigator Considered it Advisable|1|||
44393623|NCT00648739|79400417|FG000|Overall Study|Death|0|||
44393624|NCT00648739|79400418|FG001|Overall Study|Death|1|||
44393625|NCT00648739|79400419|FG002|Overall Study|Death|0|||
44393626|NCT00648739|79400420|FG003|Overall Study|Death|0|||
44393627|NCT00648739|79400421|FG004|Overall Study|Death|0|||
44393628|NCT00648739|79400422|FG005|Overall Study|Death|0|||
44393629|NCT00648739|79400423|FG006|Overall Study|Death|0|||
44393630|NCT00648739|79400417|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
44393631|NCT00648739|79400418|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
44167840|NCT02528357|78961051|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44393632|NCT00648739|79400419|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
44393633|NCT00648739|79400420|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
44393634|NCT00648739|79400421|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
44393635|NCT00648739|79400422|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
44393636|NCT00648739|79400423|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
44393637|NCT00648739|79400417|FG000|Overall Study|Follow-up Visits Not Completed|0|||
44393638|NCT00648739|79400418|FG001|Overall Study|Follow-up Visits Not Completed|1|||
44393639|NCT00648739|79400419|FG002|Overall Study|Follow-up Visits Not Completed|0|||
44393640|NCT00648739|79400420|FG003|Overall Study|Follow-up Visits Not Completed|0|||
44393641|NCT00648739|79400421|FG004|Overall Study|Follow-up Visits Not Completed|0|||
44393642|NCT00648739|79400422|FG005|Overall Study|Follow-up Visits Not Completed|0|||
44393643|NCT00648739|79400423|FG006|Overall Study|Follow-up Visits Not Completed|0|||
44393644|NCT00648037|79400444|FG000|Overall Study|Not Treated|1|||
44393645|NCT00648037|79400444|FG000|Overall Study|Withdrawal by Subject|1|||
44393646|NCT00648037|79400444|FG000|Overall Study|Adverse Event|11|||
44146740|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
44146741|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
44146742|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
44146743|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
44146744|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
44146745|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
44146746|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
44146747|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
44146748|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
44146749|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
44146750|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
44146751|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
44146752|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
44146753|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
44146754|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
44146755|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
44146756|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
44146757|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
44146758|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
44146759|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
44146760|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
44146761|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
44146762|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
44146763|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
44146764|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
44146765|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
44146766|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
44146767|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
44146768|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
44146769|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
44146770|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
44146771|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
44146772|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
44146773|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
44146774|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
44146775|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
44146776|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
44146777|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
44146778|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
44146779|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
44146780|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
44146781|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
44146782|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
44146783|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
44146784|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
44146785|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
44393647|NCT00648037|79400444|FG000|Overall Study|Relapse|2|||
44393648|NCT00648037|79400444|FG000|Overall Study|Other|1|||
44393649|NCT00627523|79400450|FG000|Overall Study|Lack of Efficacy|1|||
44393650|NCT00627523|79400451|FG001|Overall Study|Lack of Efficacy|0|||
44393651|NCT00627523|79400450|FG000|Overall Study|Withdrawal by Subject|0|||
44146786|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
44393652|NCT00627523|79400451|FG001|Overall Study|Withdrawal by Subject|2|||
44393653|NCT00627523|79400450|FG000|Overall Study|Other|1|||
44393654|NCT00627523|79400451|FG001|Overall Study|Other|0|||
44393655|NCT00640393|79400457|FG000|Part 1|Lost to Follow-up|2|||
44393656|NCT00640393|79400458|FG001|Part 1|Lost to Follow-up|0|||
44393657|NCT00640393|79400459|FG002|Part 1|Lost to Follow-up|0|||
44393658|NCT00640393|79400457|FG000|Part 1|Withdrawal by Subject|3|||
44393659|NCT00640393|79400458|FG001|Part 1|Withdrawal by Subject|0|||
44393660|NCT00640393|79400459|FG002|Part 1|Withdrawal by Subject|0|||
44393661|NCT00640393|79400457|FG000|Randomization|Withdrawn per protocol|17|||
44393662|NCT00640393|79400458|FG001|Randomization|Withdrawn per protocol|0|||
44393663|NCT00640393|79400459|FG002|Randomization|Withdrawn per protocol|0|||
44393664|NCT00640393|79400457|FG000|Randomization|Never randomized by site|2|||
44146787|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
44146788|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
44146789|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
44146790|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
44146791|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
44146792|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
44146793|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
44146794|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
44146795|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
44146796|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
44393665|NCT00640393|79400458|FG001|Randomization|Never randomized by site|0|||
44393666|NCT00640393|79400459|FG002|Randomization|Never randomized by site|0|||
44393667|NCT00640393|79400457|FG000|Part 2|Lost to Follow-up|0|||
44393668|NCT00640393|79400458|FG001|Part 2|Lost to Follow-up|2|||
44393669|NCT00640393|79400459|FG002|Part 2|Lost to Follow-up|2|||
44393670|NCT00640393|79400457|FG000|Part 2|Withdrawal by Subject|0|||
44393671|NCT00640393|79400458|FG001|Part 2|Withdrawal by Subject|6|||
44393672|NCT00640393|79400459|FG002|Part 2|Withdrawal by Subject|1|||
44393673|NCT00640393|79400457|FG000|Part 2|Non-adherence|0|||
44393674|NCT00640393|79400458|FG001|Part 2|Non-adherence|1|||
44393675|NCT00640393|79400459|FG002|Part 2|Non-adherence|0|||
44393676|NCT00640393|79400457|FG000|Part 2|Adverse Event|0|||
44393677|NCT00640393|79400458|FG001|Part 2|Adverse Event|1|||
44393678|NCT00640393|79400459|FG002|Part 2|Adverse Event|0|||
44393679|NCT00907478|79400470|FG000|Overall Study|Ineligibility determined|0|||
44393680|NCT00907478|79400471|FG001|Overall Study|Ineligibility determined|0|||
44393681|NCT00907478|79400472|FG002|Overall Study|Ineligibility determined|1|||
44393682|NCT00907478|79400470|FG000|Overall Study|Noncompliance|0|||
44393683|NCT00907478|79400471|FG001|Overall Study|Noncompliance|0|||
44393684|NCT00907478|79400472|FG002|Overall Study|Noncompliance|1|||
44393685|NCT00907478|79400470|FG000|Overall Study|Adverse Event|3|||
44393686|NCT00907478|79400471|FG001|Overall Study|Adverse Event|1|||
44393687|NCT00907478|79400472|FG002|Overall Study|Adverse Event|2|||
44393688|NCT00907478|79400470|FG000|Overall Study|Withdrawal by Subject|8|||
44393689|NCT00907478|79400471|FG001|Overall Study|Withdrawal by Subject|9|||
44393690|NCT00907478|79400472|FG002|Overall Study|Withdrawal by Subject|6|||
44393691|NCT00907478|79400470|FG000|Overall Study|Requirement for alternative therapy|1|||
44393692|NCT00907478|79400471|FG001|Overall Study|Requirement for alternative therapy|2|||
44393693|NCT00907478|79400472|FG002|Overall Study|Requirement for alternative therapy|3|||
44393694|NCT00907478|79400470|FG000|Overall Study|Physician Decision|2|||
44393695|NCT00907478|79400471|FG001|Overall Study|Physician Decision|0|||
44393696|NCT00907478|79400472|FG002|Overall Study|Physician Decision|3|||
44393697|NCT00907478|79400470|FG000|Overall Study|Death|4|||
44393698|NCT00907478|79400471|FG001|Overall Study|Death|2|||
44393699|NCT00907478|79400472|FG002|Overall Study|Death|1|||
44393700|NCT00907478|79400470|FG000|Overall Study|Protocol-specified criteria|5|||
44393701|NCT00907478|79400471|FG001|Overall Study|Protocol-specified criteria|2|||
44393702|NCT00907478|79400472|FG002|Overall Study|Protocol-specified criteria|3|||
44393703|NCT00907478|79400470|FG000|Overall Study|Pregnancy|0|||
44393704|NCT00907478|79400471|FG001|Overall Study|Pregnancy|1|||
44393705|NCT00907478|79400472|FG002|Overall Study|Pregnancy|1|||
44393706|NCT00907478|79400470|FG000|Overall Study|Lost to Follow-up|1|||
44393707|NCT00907478|79400471|FG001|Overall Study|Lost to Follow-up|0|||
44393708|NCT00907478|79400472|FG002|Overall Study|Lost to Follow-up|0|||
44393709|NCT00907478|79400470|FG000|Overall Study|Other|3|||
44393710|NCT00907478|79400471|FG001|Overall Study|Other|0|||
44393711|NCT00907478|79400472|FG002|Overall Study|Other|1|||
44393712|NCT00627445|79400484|FG000|Overall Study|Adverse Event|3|||
44393713|NCT00627445|79400485|FG001|Overall Study|Adverse Event|3|||
44393714|NCT00627445|79400484|FG000|Overall Study|Lack of Efficacy|0|||
44393715|NCT00627445|79400485|FG001|Overall Study|Lack of Efficacy|1|||
44393716|NCT00627445|79400484|FG000|Overall Study|Other|6|||
44393717|NCT00627445|79400485|FG001|Overall Study|Other|8|||
44393718|NCT00905840|79400493|FG000|Overall Study|Lost to Follow-up|11|||
44393719|NCT00905840|79400493|FG000|Overall Study|Death|3|||
44393720|NCT00905840|79400493|FG000|Overall Study|Withdrawal by Subject|1|||
44393721|NCT00905840|79400493|FG000|Overall Study|Adverse Event|1|||
44393722|NCT00626821|79400500|FG000|Overall Study|Adverse Event|44|||
44393723|NCT00626821|79400500|FG000|Overall Study|Protocol Violation|33|||
44393724|NCT00626821|79400500|FG000|Overall Study|Withdrawal by Subject|10|||
44393725|NCT00626821|79400500|FG000|Overall Study|Physician Decision|9|||
44393726|NCT00626821|79400500|FG000|Overall Study|Product dysfunction|21|||
44393727|NCT00626821|79400500|FG000|Overall Study|other/unknown reason|104|||
44393728|NCT00625183|79400504|FG000|Overall Study|Disease Progression|1|||
44393729|NCT00904982|79400514|FG000|Overall Study|Withdrawal by Subject|2|||
44393730|NCT00904982|79400515|FG001|Overall Study|Withdrawal by Subject|0|||
44393731|NCT00904982|79400516|FG002|Overall Study|Withdrawal by Subject|0|||
44393732|NCT00904982|79400517|FG003|Overall Study|Withdrawal by Subject|0|||
44393733|NCT00640315|79400529|FG000|Overall Study|Withdrawal by Subject|0|||
44393734|NCT00640315|79400530|FG001|Overall Study|Withdrawal by Subject|1|||
44393735|NCT00904748|79400536|FG000|Overall Study|Withdrawal by Subject|1|||
44393736|NCT00904748|79400537|FG001|Overall Study|Withdrawal by Subject|1|||
44393737|NCT00904748|79400538|FG002|Overall Study|Withdrawal by Subject|1|||
44393738|NCT00904748|79400539|FG003|Overall Study|Withdrawal by Subject|2|||
44393739|NCT00904748|79400540|FG004|Overall Study|Withdrawal by Subject|0|||
44393740|NCT00904748|79400541|FG005|Overall Study|Withdrawal by Subject|0|||
44393741|NCT00904748|79400536|FG000|Overall Study|Adverse Event|0|||
44393742|NCT00904748|79400537|FG001|Overall Study|Adverse Event|0|||
44393743|NCT00904748|79400538|FG002|Overall Study|Adverse Event|0|||
44393744|NCT00904748|79400539|FG003|Overall Study|Adverse Event|0|||
44393745|NCT00904748|79400540|FG004|Overall Study|Adverse Event|1|||
44393746|NCT00904748|79400541|FG005|Overall Study|Adverse Event|0|||
44393747|NCT00574405|79400552|FG000|Overall Study|Withdrawal by Subject|3|||
44146797|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
44146798|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
44252152|NCT02704403|79087974|FG000|Overall Study|Adverse Event|2|||
44252153|NCT02704403|79087975|FG001|Overall Study|Adverse Event|0|||
44252154|NCT02704403|79087974|FG000|Overall Study|Withdrawal by Subject|85|||
44281134|NCT01951638|79242272|FG003|Follow-up Period|Death|4|||
44281135|NCT01951638|79242273|FG004|Follow-up Period|Death|1|||
44281136|NCT01951638|79242269|FG000|Follow-up Period|Adverse Event|0|||
44281137|NCT01951638|79242270|FG001|Follow-up Period|Adverse Event|1|||
44281138|NCT01951638|79242271|FG002|Follow-up Period|Adverse Event|2|||
44281139|NCT01951638|79242272|FG003|Follow-up Period|Adverse Event|1|||
44281140|NCT01951638|79242273|FG004|Follow-up Period|Adverse Event|1|||
44281141|NCT01928472|79242289|FG000|Overall Study|Death|0|||
44281142|NCT01928472|79242290|FG001|Overall Study|Death|0|||
44281143|NCT01928472|79242291|FG002|Overall Study|Death|1|||
44281144|NCT01928472|79242292|FG003|Overall Study|Death|0|||
44281145|NCT01928472|79242289|FG000|Overall Study|Withdrawal by Subject|4|||
44281146|NCT01928472|79242290|FG001|Overall Study|Withdrawal by Subject|4|||
44252155|NCT02704403|79087975|FG001|Overall Study|Withdrawal by Subject|45|||
44252156|NCT02704403|79087974|FG000|Overall Study|Investigator decision|1|||
44252157|NCT02704403|79087975|FG001|Overall Study|Investigator decision|1|||
44252158|NCT02704403|79087974|FG000|Overall Study|Follow-up not possible|1|||
44252159|NCT02704403|79087975|FG001|Overall Study|Follow-up not possible|2|||
44252160|NCT02636868|79088010|FG000|Overall Study|Death|0|||
44252161|NCT02636868|79088011|FG001|Overall Study|Death|1|||
44252162|NCT02636868|79088012|FG002|Overall Study|Death|2|||
44252163|NCT02635386|79088093|FG000|Overall Study|Pregnancy|2|||
44252164|NCT02635386|79088094|FG001|Overall Study|Pregnancy|0|||
44252165|NCT02635386|79088095|FG002|Overall Study|Pregnancy|0|||
44252166|NCT02635386|79088096|FG003|Overall Study|Pregnancy|0|||
44252167|NCT02635386|79088097|FG004|Overall Study|Pregnancy|2|||
44252168|NCT02635386|79088093|FG000|Overall Study|Withdrawal by Subject|1|||
44252169|NCT02635386|79088094|FG001|Overall Study|Withdrawal by Subject|1|||
44252170|NCT02635386|79088095|FG002|Overall Study|Withdrawal by Subject|0|||
44252171|NCT02635386|79088096|FG003|Overall Study|Withdrawal by Subject|1|||
44252172|NCT02635386|79088097|FG004|Overall Study|Withdrawal by Subject|0|||
44252173|NCT02635386|79088093|FG000|Overall Study|Physician Decision|0|||
44252174|NCT02635386|79088094|FG001|Overall Study|Physician Decision|1|||
44252175|NCT02635386|79088095|FG002|Overall Study|Physician Decision|0|||
44252176|NCT02635386|79088096|FG003|Overall Study|Physician Decision|0|||
44252177|NCT02635386|79088097|FG004|Overall Study|Physician Decision|0|||
44252178|NCT02635386|79088093|FG000|Overall Study|Moved Out of State|0|||
44252179|NCT02635386|79088094|FG001|Overall Study|Moved Out of State|1|||
44252180|NCT02635386|79088095|FG002|Overall Study|Moved Out of State|0|||
44281147|NCT01928472|79242291|FG002|Overall Study|Withdrawal by Subject|1|||
44281148|NCT01928472|79242292|FG003|Overall Study|Withdrawal by Subject|2|||
44281149|NCT01928472|79242289|FG000|Overall Study|Lost to Follow-up|2|||
44281150|NCT01928472|79242290|FG001|Overall Study|Lost to Follow-up|3|||
44393748|NCT00574405|79400553|FG001|Overall Study|Withdrawal by Subject|2|||
44393749|NCT00971243|79400564|FG000|Double Blind Period|Adverse Event|2|||
44393750|NCT00971243|79400565|FG001|Double Blind Period|Adverse Event|3|||
44393751|NCT00971243|79400566|FG002|Double Blind Period|Adverse Event|2|||
44393752|NCT00971243|79400567|FG003|Double Blind Period|Adverse Event|2|||
44393753|NCT00971243|79400568|FG004|Double Blind Period|Adverse Event|3|||
44393754|NCT00971243|79400564|FG000|Double Blind Period|Lost to Follow-up|0|||
44393755|NCT00971243|79400565|FG001|Double Blind Period|Lost to Follow-up|1|||
44393756|NCT00971243|79400566|FG002|Double Blind Period|Lost to Follow-up|1|||
44393757|NCT00971243|79400567|FG003|Double Blind Period|Lost to Follow-up|0|||
44393758|NCT00971243|79400568|FG004|Double Blind Period|Lost to Follow-up|1|||
44393759|NCT00971243|79400564|FG000|Double Blind Period|Physician Decision|10|||
44393760|NCT00971243|79400565|FG001|Double Blind Period|Physician Decision|6|||
44393761|NCT00971243|79400566|FG002|Double Blind Period|Physician Decision|7|||
44393762|NCT00971243|79400567|FG003|Double Blind Period|Physician Decision|6|||
44393763|NCT00971243|79400568|FG004|Double Blind Period|Physician Decision|7|||
44393764|NCT00971243|79400564|FG000|Double Blind Period|Protocol Violation|2|||
44393765|NCT00971243|79400565|FG001|Double Blind Period|Protocol Violation|0|||
44393766|NCT00971243|79400566|FG002|Double Blind Period|Protocol Violation|3|||
44393767|NCT00971243|79400567|FG003|Double Blind Period|Protocol Violation|2|||
44393768|NCT00971243|79400568|FG004|Double Blind Period|Protocol Violation|2|||
44393769|NCT00971243|79400564|FG000|Double Blind Period|Withdrawal by Subject|4|||
44393770|NCT00971243|79400565|FG001|Double Blind Period|Withdrawal by Subject|1|||
44393771|NCT00971243|79400566|FG002|Double Blind Period|Withdrawal by Subject|4|||
44393772|NCT00971243|79400567|FG003|Double Blind Period|Withdrawal by Subject|4|||
44393773|NCT00971243|79400568|FG004|Double Blind Period|Withdrawal by Subject|4|||
44393774|NCT00971243|79400564|FG000|Double Blind Period|Other reasons|1|||
44393775|NCT00971243|79400565|FG001|Double Blind Period|Other reasons|0|||
44393776|NCT00971243|79400566|FG002|Double Blind Period|Other reasons|2|||
44393777|NCT00971243|79400567|FG003|Double Blind Period|Other reasons|0|||
44393778|NCT00971243|79400568|FG004|Double Blind Period|Other reasons|1|||
44393779|NCT00971243|79400564|FG000|Open-label Period|Adverse Event|1|||
44393780|NCT00971243|79400565|FG001|Open-label Period|Adverse Event|0|||
44393781|NCT00971243|79400566|FG002|Open-label Period|Adverse Event|1|||
44393782|NCT00971243|79400567|FG003|Open-label Period|Adverse Event|1|||
44393783|NCT00971243|79400568|FG004|Open-label Period|Adverse Event|0|||
44393784|NCT00971243|79400564|FG000|Open-label Period|Physician Decision|5|||
44393785|NCT00971243|79400565|FG001|Open-label Period|Physician Decision|9|||
44393786|NCT00971243|79400566|FG002|Open-label Period|Physician Decision|3|||
44393787|NCT00971243|79400567|FG003|Open-label Period|Physician Decision|7|||
44393788|NCT00971243|79400568|FG004|Open-label Period|Physician Decision|2|||
44393789|NCT00971243|79400564|FG000|Open-label Period|Protocol Violation|1|||
44393790|NCT00971243|79400565|FG001|Open-label Period|Protocol Violation|1|||
44393791|NCT00971243|79400566|FG002|Open-label Period|Protocol Violation|1|||
44393792|NCT00971243|79400567|FG003|Open-label Period|Protocol Violation|0|||
44393793|NCT00971243|79400568|FG004|Open-label Period|Protocol Violation|1|||
44393794|NCT00971243|79400564|FG000|Open-label Period|Withdrawal by Subject|1|||
44393795|NCT00971243|79400565|FG001|Open-label Period|Withdrawal by Subject|0|||
44393796|NCT00971243|79400566|FG002|Open-label Period|Withdrawal by Subject|0|||
44393797|NCT00971243|79400567|FG003|Open-label Period|Withdrawal by Subject|2|||
44393798|NCT00971243|79400568|FG004|Open-label Period|Withdrawal by Subject|1|||
44393799|NCT00971243|79400564|FG000|Open-label Period|Other reason|0|||
44393800|NCT00971243|79400565|FG001|Open-label Period|Other reason|0|||
44393801|NCT00971243|79400566|FG002|Open-label Period|Other reason|0|||
44393802|NCT00971243|79400567|FG003|Open-label Period|Other reason|0|||
44393803|NCT00971243|79400568|FG004|Open-label Period|Other reason|2|||
44393804|NCT00568555|79400582|FG000|Overall Study|Withdrawal by Subject|1|||
44393805|NCT00568555|79400583|FG001|Overall Study|Withdrawal by Subject|1|||
44393806|NCT00904670|79400591|FG000|Open Label Phase|Withdrawal by Subject|2|||
44393807|NCT00904670|79400592|FG001|Open Label Phase|Withdrawal by Subject|0|||
44393808|NCT00904670|79400591|FG000|Open Label Phase|Adverse Event|2|||
44393809|NCT00904670|79400592|FG001|Open Label Phase|Adverse Event|0|||
44393810|NCT00904670|79400591|FG000|Open Label Phase|Lack of Efficacy|1|||
44393811|NCT00904670|79400592|FG001|Open Label Phase|Lack of Efficacy|0|||
44393812|NCT00904670|79400591|FG000|Open Label Phase|Lost to Follow-up|1|||
44393813|NCT00904670|79400592|FG001|Open Label Phase|Lost to Follow-up|0|||
44393814|NCT00638443|79400600|FG000|First Intervention|Adverse Event|2|||
44393815|NCT00638443|79400601|FG001|First Intervention|Adverse Event|1|||
44252181|NCT02635386|79088096|FG003|Overall Study|Moved Out of State|0|||
44520467|NCT02992288|79528357|FG003|Overall Study|Physician Decision|0|||
44393816|NCT00636181|79400612|FG000|Overall Study|Withdrawal by Subject|8|||
44393817|NCT00636181|79400613|FG001|Overall Study|Withdrawal by Subject|6|||
44393818|NCT00636181|79400614|FG002|Overall Study|Withdrawal by Subject|10|||
44393819|NCT00968669|79400626|FG000|Overall Study|Lost to Follow-up|5|||
44393820|NCT00968669|79400627|FG001|Overall Study|Lost to Follow-up|2|||
44393821|NCT00968669|79400628|FG002|Overall Study|Lost to Follow-up|1|||
44393822|NCT00968669|79400629|FG003|Overall Study|Lost to Follow-up|4|||
44393823|NCT00968669|79400626|FG000|Overall Study|Withdrawal by Subject|9|||
44393824|NCT00968669|79400627|FG001|Overall Study|Withdrawal by Subject|7|||
44393825|NCT00968669|79400628|FG002|Overall Study|Withdrawal by Subject|5|||
44393826|NCT00968669|79400629|FG003|Overall Study|Withdrawal by Subject|3|||
44393827|NCT00968669|79400626|FG000|Overall Study|Pregnancy|0|||
44393828|NCT00968669|79400627|FG001|Overall Study|Pregnancy|0|||
44393829|NCT00968669|79400628|FG002|Overall Study|Pregnancy|2|||
44393830|NCT00968669|79400629|FG003|Overall Study|Pregnancy|0|||
44393831|NCT00968669|79400626|FG000|Overall Study|AE|1|||
44393832|NCT00968669|79400627|FG001|Overall Study|AE|0|||
44393833|NCT00968669|79400628|FG002|Overall Study|AE|0|||
44393834|NCT00968669|79400629|FG003|Overall Study|AE|0|||
44393835|NCT00968669|79400626|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
44393836|NCT00968669|79400627|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
44393837|NCT00968669|79400628|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
44393838|NCT00968669|79400629|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
44393839|NCT00968669|79400626|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
44393840|NCT00968669|79400627|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
44393841|NCT00968669|79400628|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
44393842|NCT00968669|79400629|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
44393843|NCT00968669|79400626|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
44393844|NCT00968669|79400627|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
44393845|NCT00968669|79400628|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
44393846|NCT00968669|79400629|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
44393847|NCT00968669|79400626|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
44393848|NCT00968669|79400627|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
44393849|NCT00968669|79400628|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
44393850|NCT00968669|79400629|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
44393851|NCT00968669|79400626|FG000|Overall Study|EARLY WITHDRAWAL|0|||
44393852|NCT00968669|79400627|FG001|Overall Study|EARLY WITHDRAWAL|1|||
44393853|NCT00968669|79400628|FG002|Overall Study|EARLY WITHDRAWAL|0|||
44393854|NCT00968669|79400629|FG003|Overall Study|EARLY WITHDRAWAL|0|||
44393855|NCT00968669|79400626|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
44393856|NCT00968669|79400627|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
44393857|NCT00968669|79400628|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
44393858|NCT00968669|79400629|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
44393859|NCT00968669|79400626|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
44393860|NCT00968669|79400627|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
44393861|NCT00968669|79400628|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
44393862|NCT00968669|79400629|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
44393863|NCT00968669|79400626|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
44393864|NCT00968669|79400627|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
44252182|NCT02635386|79088097|FG004|Overall Study|Moved Out of State|0|||
44252183|NCT02635386|79088093|FG000|Overall Study|Noncompliant|0|||
44252184|NCT02635386|79088094|FG001|Overall Study|Noncompliant|2|||
44252185|NCT02635386|79088095|FG002|Overall Study|Noncompliant|1|||
44252186|NCT02635386|79088096|FG003|Overall Study|Noncompliant|1|||
44252187|NCT02635386|79088097|FG004|Overall Study|Noncompliant|1|||
44252188|NCT02635386|79088093|FG000|Overall Study|side effects|0|||
44252189|NCT02635386|79088094|FG001|Overall Study|side effects|0|||
44252190|NCT02635386|79088095|FG002|Overall Study|side effects|1|||
44252191|NCT02635386|79088096|FG003|Overall Study|side effects|4|||
44252192|NCT02635386|79088097|FG004|Overall Study|side effects|6|||
44252193|NCT02635386|79088093|FG000|Overall Study|needed other major surgery|0|||
44252194|NCT02635386|79088094|FG001|Overall Study|needed other major surgery|1|||
44252195|NCT02635386|79088095|FG002|Overall Study|needed other major surgery|0|||
44252196|NCT02635386|79088096|FG003|Overall Study|needed other major surgery|0|||
44252197|NCT02635386|79088097|FG004|Overall Study|needed other major surgery|0|||
44252198|NCT02635386|79088093|FG000|Overall Study|Other medical problems not drug related|0|||
44252199|NCT02635386|79088094|FG001|Overall Study|Other medical problems not drug related|0|||
44252200|NCT02635386|79088095|FG002|Overall Study|Other medical problems not drug related|0|||
44252201|NCT02635386|79088096|FG003|Overall Study|Other medical problems not drug related|1|||
44252202|NCT02635386|79088097|FG004|Overall Study|Other medical problems not drug related|0|||
44252203|NCT02634606|79088195|FG000|Overall Study|unable to obtain the drug at start|13|||
44281151|NCT01928472|79242291|FG002|Overall Study|Lost to Follow-up|4|||
44393865|NCT00968669|79400628|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
44393866|NCT00968669|79400629|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
44393867|NCT00968669|79400626|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
44393868|NCT00968669|79400627|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
44393869|NCT00968669|79400628|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
44393870|NCT00968669|79400629|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
44393871|NCT00968669|79400626|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
44252204|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
44252205|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
44252206|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
44252207|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
44281152|NCT01928472|79242292|FG003|Overall Study|Lost to Follow-up|0|||
44393872|NCT00968669|79400627|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
44393873|NCT00968669|79400628|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
44393874|NCT00968669|79400629|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
44393875|NCT00968669|79400626|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
44393876|NCT00968669|79400627|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
44393877|NCT00968669|79400628|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
44393878|NCT00968669|79400629|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
44393879|NCT00968669|79400626|FG000|Overall Study|SPONSOR DECISION|0|||
44393880|NCT00968669|79400627|FG001|Overall Study|SPONSOR DECISION|1|||
44393881|NCT00968669|79400628|FG002|Overall Study|SPONSOR DECISION|0|||
44393882|NCT00968669|79400629|FG003|Overall Study|SPONSOR DECISION|0|||
44393883|NCT00968669|79400626|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
44393884|NCT00968669|79400627|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
44393885|NCT00968669|79400628|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
44393886|NCT00968669|79400629|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
44393887|NCT00968669|79400626|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
44393888|NCT00968669|79400627|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
44393889|NCT00968669|79400628|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
44393890|NCT00968669|79400629|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
44146799|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
44146800|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
44146801|NCT02717195|78936320|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
44146802|NCT02717195|78936321|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
44146803|NCT02717195|78936322|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
44146804|NCT02717195|78936323|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
44146805|NCT02717195|78936324|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
44146806|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
44146807|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
44146808|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
44146809|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
44146810|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
44146811|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
44146812|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
44146813|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
44146814|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
44146815|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
44146816|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
44146817|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
44146818|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
44146819|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
44146820|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
44146821|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
44146822|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
44146823|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
44146824|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
44146825|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
44146826|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44252208|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
44252209|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
44281153|NCT01928472|79242289|FG000|Overall Study|Administrative Reason|2|||
44281154|NCT01928472|79242290|FG001|Overall Study|Administrative Reason|1|||
44393891|NCT00968669|79400626|FG000|Overall Study|SUBJECT INCARCERATED|0|||
44393892|NCT00968669|79400627|FG001|Overall Study|SUBJECT INCARCERATED|1|||
44393893|NCT00968669|79400628|FG002|Overall Study|SUBJECT INCARCERATED|0|||
44146827|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44252210|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
44252211|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
44252212|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
44252213|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
44252214|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
44252215|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
44252216|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
44281155|NCT01928472|79242291|FG002|Overall Study|Administrative Reason|0|||
44146828|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
44146829|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
44252217|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
44252218|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
44393894|NCT00968669|79400629|FG003|Overall Study|SUBJECT INCARCERATED|0|||
44146830|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
44146831|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
44146832|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
44146833|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
44146834|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
44146835|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
44146836|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
44146837|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
44146838|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
44146839|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
44146840|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
44146841|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
44146842|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
44146843|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
44146844|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
44146845|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
44146846|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
44146847|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
44146848|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
44146849|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
44146850|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
44146851|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
44146852|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
44520468|NCT02992288|79528358|FG004|Overall Study|Physician Decision|0|||
44520469|NCT02992288|79528359|FG005|Overall Study|Physician Decision|1|||
44520470|NCT02992288|79528354|FG000|Overall Study|Death|2|||
44520471|NCT02992288|79528355|FG001|Overall Study|Death|0|||
44520472|NCT02992288|79528356|FG002|Overall Study|Death|2|||
44520473|NCT02992288|79528357|FG003|Overall Study|Death|1|||
44520474|NCT02992288|79528358|FG004|Overall Study|Death|2|||
44520475|NCT02992288|79528359|FG005|Overall Study|Death|0|||
44520476|NCT02992288|79528354|FG000|Overall Study|Lost to Follow-up|0|||
44520477|NCT02992288|79528355|FG001|Overall Study|Lost to Follow-up|0|||
44520478|NCT02992288|79528356|FG002|Overall Study|Lost to Follow-up|0|||
44520479|NCT02992288|79528357|FG003|Overall Study|Lost to Follow-up|1|||
44520480|NCT02992288|79528358|FG004|Overall Study|Lost to Follow-up|0|||
44520481|NCT02992288|79528359|FG005|Overall Study|Lost to Follow-up|0|||
44520482|NCT02992288|79528354|FG000|Overall Study|Protocol Violation|0|||
44520483|NCT02992288|79528355|FG001|Overall Study|Protocol Violation|0|||
44520484|NCT02992288|79528356|FG002|Overall Study|Protocol Violation|0|||
44520485|NCT02992288|79528357|FG003|Overall Study|Protocol Violation|0|||
44520486|NCT02992288|79528358|FG004|Overall Study|Protocol Violation|0|||
44520487|NCT02992288|79528359|FG005|Overall Study|Protocol Violation|1|||
44520488|NCT02992288|79528354|FG000|Overall Study|Withdrawal by Subject|4|||
44520489|NCT02992288|79528355|FG001|Overall Study|Withdrawal by Subject|2|||
44520490|NCT02992288|79528356|FG002|Overall Study|Withdrawal by Subject|1|||
44520491|NCT02992288|79528357|FG003|Overall Study|Withdrawal by Subject|5|||
44520492|NCT02992288|79528358|FG004|Overall Study|Withdrawal by Subject|3|||
44520493|NCT02992288|79528359|FG005|Overall Study|Withdrawal by Subject|4|||
44520494|NCT02992132|79528376|FG000|Overall Study|Adverse Event|4|||
44520495|NCT02992132|79528377|FG001|Overall Study|Adverse Event|1|||
44520496|NCT02992132|79528378|FG002|Overall Study|Adverse Event|3|||
44520497|NCT02992132|79528376|FG000|Overall Study|Lack of Efficacy|2|||
44520498|NCT02992132|79528377|FG001|Overall Study|Lack of Efficacy|0|||
44520499|NCT02992132|79528378|FG002|Overall Study|Lack of Efficacy|0|||
44520500|NCT02992132|79528376|FG000|Overall Study|Non-compliance with study drug|2|||
44520501|NCT02992132|79528377|FG001|Overall Study|Non-compliance with study drug|0|||
44520502|NCT02992132|79528378|FG002|Overall Study|Non-compliance with study drug|0|||
44520503|NCT02992132|79528376|FG000|Overall Study|Progressive disease|1|||
44520504|NCT02992132|79528377|FG001|Overall Study|Progressive disease|0|||
44146853|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
44252219|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
44520505|NCT02992132|79528378|FG002|Overall Study|Progressive disease|0|||
44520506|NCT02992132|79528376|FG000|Overall Study|Protocol Violation|2|||
44520507|NCT02992132|79528377|FG001|Overall Study|Protocol Violation|2|||
44520508|NCT02992132|79528378|FG002|Overall Study|Protocol Violation|0|||
44520509|NCT02992132|79528376|FG000|Overall Study|Caregiver withdrew consent|2|||
44252220|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
44520510|NCT02992132|79528377|FG001|Overall Study|Caregiver withdrew consent|3|||
44520511|NCT02992132|79528378|FG002|Overall Study|Caregiver withdrew consent|2|||
44520512|NCT02992132|79528376|FG000|Overall Study|Withdrawal by Subject|0|||
44520513|NCT02992132|79528377|FG001|Overall Study|Withdrawal by Subject|2|||
44520514|NCT02992132|79528378|FG002|Overall Study|Withdrawal by Subject|1|||
44520515|NCT02992132|79528376|FG000|Overall Study|Physician Decision|0|||
44520516|NCT02992132|79528377|FG001|Overall Study|Physician Decision|0|||
44520517|NCT02992132|79528378|FG002|Overall Study|Physician Decision|1|||
44520518|NCT03444584|79528388|FG000|Overall Study|Withdrawal by Subject|0|||
44520519|NCT03444584|79528389|FG001|Overall Study|Withdrawal by Subject|1|||
44520520|NCT03444584|79528388|FG000|Overall Study|Other|0|||
44520521|NCT03444584|79528389|FG001|Overall Study|Other|1|||
44520522|NCT02989168|79528398|FG000|Overall Study|Withdrawal by Subject|2|||
44520523|NCT02989168|79528399|FG001|Overall Study|Withdrawal by Subject|0|||
44520524|NCT02989168|79528398|FG000|Overall Study|Physician Decision|0|||
44520525|NCT02989168|79528399|FG001|Overall Study|Physician Decision|1|||
44520526|NCT02989168|79528398|FG000|Overall Study|Adverse Event|1|||
44520527|NCT02989168|79528399|FG001|Overall Study|Adverse Event|2|||
44520528|NCT02989168|79528398|FG000|Overall Study|Sponsor stopped study.|1|||
44520529|NCT02989168|79528399|FG001|Overall Study|Sponsor stopped study.|0|||
44520530|NCT02988622|79528407|FG000|Overall Study|Lost to Follow-up|17|||
44520531|NCT03412604|79528413|FG000|Overall Study|Withdrawal by Subject|1|||
44520532|NCT02991430|79528420|FG000|Treatment Period 1|Adverse Event|1|||
44520533|NCT02991430|79528421|FG001|Treatment Period 1|Adverse Event|0|||
44520534|NCT02991430|79528422|FG002|Treatment Period 1|Adverse Event|2|||
44520535|NCT02991430|79528420|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44520536|NCT02991430|79528421|FG001|Treatment Period 1|Withdrawal by Subject|4|||
44252221|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
44252222|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
44252223|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
44252224|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
44252225|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
44252226|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
44252227|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
44252228|NCT01672866|79088241|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
44252229|NCT01672866|79088242|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
44252230|NCT01672866|79088243|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
44252231|NCT01672866|79088241|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
44252232|NCT01672866|79088242|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
44252233|NCT01672866|79088243|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
44252234|NCT01672866|79088241|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
44252235|NCT01672866|79088242|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
44252236|NCT01672866|79088243|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
44252237|NCT01672866|79088241|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
44252238|NCT01672866|79088242|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
44252239|NCT01672866|79088243|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
44252240|NCT01672866|79088241|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
44252241|NCT01672866|79088242|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
44252242|NCT01672866|79088243|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
44252243|NCT04465877|79088469|FG000|Overall Study|Noncompliant with study requirements|0|||
44252244|NCT04465877|79088470|FG001|Overall Study|Noncompliant with study requirements|0|||
44252245|NCT04465877|79088471|FG002|Overall Study|Noncompliant with study requirements|1|||
44252246|NCT04465877|79088472|FG003|Overall Study|Noncompliant with study requirements|0|||
44252247|NCT04267133|79088529|FG000|Overall Study|Withdrawal by Subject|1|||
44252248|NCT04267133|79088529|FG000|Overall Study|Adverse Event|4|||
44252249|NCT02631876|79088660|FG000|Overall Study|Death|96|||
44252250|NCT02631876|79088661|FG001|Overall Study|Death|50|||
44252251|NCT02631876|79088660|FG000|Overall Study|Investigator's discretion|1|||
44252252|NCT02631876|79088661|FG001|Overall Study|Investigator's discretion|0|||
44252253|NCT02631876|79088660|FG000|Overall Study|Lost to Follow-up|2|||
44252254|NCT02631876|79088661|FG001|Overall Study|Lost to Follow-up|0|||
44252255|NCT02631876|79088660|FG000|Overall Study|Withdrawal by Subject|16|||
44520537|NCT02991430|79528422|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44520538|NCT02991430|79528420|FG000|Treatment Period 2|Study Termination|6|||
44520539|NCT02991430|79528421|FG001|Treatment Period 2|Study Termination|3|||
44520540|NCT02991430|79528422|FG002|Treatment Period 2|Study Termination|3|||
44252256|NCT02631876|79088661|FG001|Overall Study|Withdrawal by Subject|9|||
44252257|NCT02631876|79088660|FG000|Overall Study|Other than specified|4|||
44252258|NCT02631876|79088661|FG001|Overall Study|Other than specified|4|||
44281156|NCT01928472|79242292|FG003|Overall Study|Administrative Reason|0|||
44520541|NCT02991430|79528420|FG000|Treatment Period 2|Lost to Follow-up|0|||
44520542|NCT02991430|79528421|FG001|Treatment Period 2|Lost to Follow-up|0|||
44146854|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
44252259|NCT02633046|79088690|FG000|Overall Study|Adverse Event|8|||
44252260|NCT02633046|79088690|FG000|Overall Study|Physician Decision|7|||
44252261|NCT02633046|79088690|FG000|Overall Study|Withdrawal by Subject|8|||
44252262|NCT02633046|79088690|FG000|Overall Study|Increased proteinuria|2|||
44281157|NCT01928472|79242289|FG000|Overall Study|Unclassified|0|||
44520543|NCT02991430|79528422|FG002|Treatment Period 2|Lost to Follow-up|1|||
44393895|NCT00968669|79400626|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
44393896|NCT00968669|79400627|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
44393897|NCT00968669|79400628|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
44393898|NCT00968669|79400629|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
44393899|NCT00968669|79400626|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
44393900|NCT00968669|79400627|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
44393901|NCT00968669|79400628|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
44393902|NCT00968669|79400629|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
44393903|NCT00568399|79400639|FG000|Overall Study|Death|2|||
44393904|NCT00568399|79400639|FG000|Overall Study|Adverse Event|5|||
44393905|NCT00568399|79400639|FG000|Overall Study|Withdrawal by Subject|8|||
44393906|NCT00975143|79400645|FG000|Overall Study|Adverse Event|19|||
44393907|NCT00975143|79400646|FG001|Overall Study|Adverse Event|15|||
44393908|NCT00975143|79400645|FG000|Overall Study|Withdrawal by Subject|15|||
44393909|NCT00975143|79400646|FG001|Overall Study|Withdrawal by Subject|15|||
44393910|NCT00975143|79400645|FG000|Overall Study|Lost to Follow-up|20|||
44393911|NCT00975143|79400646|FG001|Overall Study|Lost to Follow-up|16|||
44393912|NCT00975143|79400645|FG000|Overall Study|Non-compliance|5|||
44393913|NCT00975143|79400646|FG001|Overall Study|Non-compliance|8|||
44393914|NCT00975143|79400645|FG000|Overall Study|Physician Decision|1|||
44393915|NCT00975143|79400646|FG001|Overall Study|Physician Decision|2|||
44393916|NCT00975143|79400645|FG000|Overall Study|Details not available|10|||
44393917|NCT00975143|79400646|FG001|Overall Study|Details not available|4|||
44393918|NCT00974675|79400669|FG000|Overall Study|Adverse Event|2|||
44393919|NCT00974675|79400670|FG001|Overall Study|Adverse Event|1|||
44393920|NCT00974675|79400671|FG002|Overall Study|Adverse Event|1|||
44393921|NCT00974675|79400672|FG003|Overall Study|Adverse Event|1|||
44393922|NCT00974675|79400669|FG000|Overall Study|Physician Decision|0|||
44393923|NCT00974675|79400670|FG001|Overall Study|Physician Decision|0|||
44393924|NCT00974675|79400671|FG002|Overall Study|Physician Decision|1|||
44393925|NCT00974675|79400672|FG003|Overall Study|Physician Decision|0|||
44393926|NCT00974675|79400669|FG000|Overall Study|Participant on holiday; unable to attend|0|||
44393927|NCT00974675|79400670|FG001|Overall Study|Participant on holiday; unable to attend|0|||
44393928|NCT00974675|79400671|FG002|Overall Study|Participant on holiday; unable to attend|0|||
44393929|NCT00974675|79400672|FG003|Overall Study|Participant on holiday; unable to attend|1|||
44393930|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
44393931|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
44393932|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
44393933|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
44393934|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
44393935|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Death|1|||
44393936|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Death|0|||
44393937|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Death|0|||
44393938|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Death|0|||
44393939|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Death|0|||
44393940|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
44393941|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
44393942|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
44393943|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
44393944|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
44393945|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
44393946|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
44393947|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
44520544|NCT02991430|79528420|FG000|Post-treatment Observation Period|Study Termination|3|||
44520545|NCT02991430|79528421|FG001|Post-treatment Observation Period|Study Termination|6|||
44146855|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
44146856|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
44146857|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
44146858|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
44146859|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
44146860|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
44146861|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
44146862|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
44146863|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
44393948|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
44393949|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
44393950|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
44393951|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
44393952|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
44393953|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
44393954|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
44393955|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
44393956|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
44393957|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
44393958|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
44393959|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
44393960|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
44393961|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
44393962|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
44393963|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
44393964|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
44393965|NCT00634933|79400685|FG000|Part A: Baseline to Week 24|Other|1|||
44393966|NCT00634933|79400686|FG001|Part A: Baseline to Week 24|Other|8|||
44393967|NCT00634933|79400687|FG002|Part A: Baseline to Week 24|Other|5|||
44393968|NCT00634933|79400688|FG003|Part A: Baseline to Week 24|Other|0|||
44393969|NCT00634933|79400689|FG004|Part A: Baseline to Week 24|Other|0|||
44393970|NCT00634933|79400685|FG000|Between Part A and Part B|Physician Decision|0|||
44393971|NCT00634933|79400686|FG001|Between Part A and Part B|Physician Decision|1|||
44393972|NCT00634933|79400687|FG002|Between Part A and Part B|Physician Decision|0|||
44393973|NCT00634933|79400688|FG003|Between Part A and Part B|Physician Decision|0|||
44393974|NCT00634933|79400689|FG004|Between Part A and Part B|Physician Decision|0|||
44393975|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
44393976|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
44393977|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
44393978|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
44393979|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
44393980|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
44393981|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
44393982|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
44393983|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
44393984|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
44393985|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
44393986|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
44393987|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
44393988|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
44393989|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
44393990|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
44393991|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
44393992|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
44393993|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
44393994|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
44393995|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
44393996|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
44393997|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
44393998|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
44393999|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
44394000|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
44394001|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
44394002|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
44394003|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
44394004|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
44394005|NCT00634933|79400685|FG000|Part B: Week 24 to Week 52|Other|0|||
44394006|NCT00634933|79400686|FG001|Part B: Week 24 to Week 52|Other|0|||
44394007|NCT00634933|79400687|FG002|Part B: Week 24 to Week 52|Other|5|||
44394008|NCT00634933|79400688|FG003|Part B: Week 24 to Week 52|Other|0|||
44394009|NCT00634933|79400689|FG004|Part B: Week 24 to Week 52|Other|1|||
44394010|NCT00967499|79400703|FG000|Overall Study|Adverse Event|0|||
44394011|NCT00967499|79400704|FG001|Overall Study|Adverse Event|1|||
44394012|NCT00967499|79400703|FG000|Overall Study|Protocol Violation|1|||
44394013|NCT00967499|79400704|FG001|Overall Study|Protocol Violation|0|||
44394014|NCT00967499|79400703|FG000|Overall Study|Sponsor Decision|1|||
44394015|NCT00967499|79400704|FG001|Overall Study|Sponsor Decision|0|||
44394016|NCT00967499|79400703|FG000|Overall Study|Randomized but not treated|63|||
44394017|NCT00967499|79400704|FG001|Overall Study|Randomized but not treated|59|||
44394018|NCT03909971|79400712|FG000|Overall Study|Other Reasons Not Specified|0|||
44394019|NCT03909971|79400713|FG001|Overall Study|Other Reasons Not Specified|1|||
44394020|NCT03909971|79400712|FG000|Overall Study|Global Deterioration of Health Status|2|||
44394021|NCT03909971|79400713|FG001|Overall Study|Global Deterioration of Health Status|1|||
44394022|NCT03909971|79400712|FG000|Overall Study|Progressive Disease|6|||
44394023|NCT03909971|79400713|FG001|Overall Study|Progressive Disease|14|||
44394024|NCT03909971|79400712|FG000|Overall Study|Death|2|||
44394025|NCT03909971|79400713|FG001|Overall Study|Death|6|||
44394026|NCT00967343|79400720|FG000|Overall Study|Study termination by sponsor|12|||
44394027|NCT00967343|79400720|FG000|Overall Study|Death|24|||
44394028|NCT00967343|79400720|FG000|Overall Study|Relapse|1|||
44394029|NCT00967343|79400720|FG000|Overall Study|Lost to Follow-up|1|||
44394030|NCT00973973|79400726|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
44394031|NCT00973973|79400727|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
44394032|NCT00973973|79400726|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
44394033|NCT00973973|79400727|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
44394034|NCT00973973|79400726|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
44394035|NCT00973973|79400727|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
44394036|NCT00973973|79400726|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
44394037|NCT00973973|79400727|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
44394038|NCT00973973|79400726|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
44394039|NCT00973973|79400727|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
44394040|NCT00973973|79400726|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
44394041|NCT00973973|79400727|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
44394042|NCT00973973|79400726|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
44394043|NCT00973973|79400727|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
44394044|NCT00973973|79400726|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
44394045|NCT00973973|79400727|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
44394046|NCT00973973|79400726|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
44394047|NCT00973973|79400727|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
44394048|NCT00973973|79400726|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
44394049|NCT00973973|79400727|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
44394050|NCT00973973|79400726|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
44394051|NCT00973973|79400727|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
44394052|NCT00973973|79400726|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
44394053|NCT00973973|79400727|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
44394054|NCT00633139|79400736|FG000|Overall Study|Non compliance|0|||
44394055|NCT00633139|79400737|FG001|Overall Study|Non compliance|0|||
44394056|NCT00633139|79400738|FG002|Overall Study|Non compliance|1|||
44394057|NCT00633139|79400736|FG000|Overall Study|Withdrawal by Subject|0|||
44394058|NCT00633139|79400737|FG001|Overall Study|Withdrawal by Subject|1|||
44394059|NCT00633139|79400738|FG002|Overall Study|Withdrawal by Subject|0|||
44394060|NCT00965081|79400748|FG000|Overall Study|Adverse Event|14|||
44394061|NCT00965081|79400749|FG001|Overall Study|Adverse Event|9|||
44394062|NCT00965081|79400748|FG000|Overall Study|Lack of Efficacy|2|||
44394063|NCT00965081|79400749|FG001|Overall Study|Lack of Efficacy|5|||
44394064|NCT00965081|79400748|FG000|Overall Study|Lost to Follow-up|4|||
44394065|NCT00965081|79400749|FG001|Overall Study|Lost to Follow-up|5|||
44394066|NCT00965081|79400748|FG000|Overall Study|Physician Decision|2|||
44394067|NCT00965081|79400749|FG001|Overall Study|Physician Decision|0|||
44394068|NCT00965081|79400748|FG000|Overall Study|Protocol Violation|2|||
44394069|NCT00965081|79400749|FG001|Overall Study|Protocol Violation|5|||
44394070|NCT00965081|79400748|FG000|Overall Study|Sponsor Decision|1|||
44394071|NCT00965081|79400749|FG001|Overall Study|Sponsor Decision|0|||
44394072|NCT00965081|79400748|FG000|Overall Study|Withdrawal by Subject|4|||
44394073|NCT00965081|79400749|FG001|Overall Study|Withdrawal by Subject|7|||
44394074|NCT00965081|79400748|FG000|Overall Study|Switched to Rescue Arm|5|||
44394075|NCT00965081|79400749|FG001|Overall Study|Switched to Rescue Arm|12|||
44394076|NCT00961649|79400760|FG000|Overall Study|Adverse Event|4|||
44394077|NCT00961649|79400761|FG001|Overall Study|Adverse Event|0|||
44394078|NCT00961649|79400762|FG002|Overall Study|Adverse Event|0|||
44394079|NCT00961649|79400763|FG003|Overall Study|Adverse Event|2|||
44394080|NCT00961649|79400760|FG000|Overall Study|Inadequate control of IOP|0|||
44394081|NCT00961649|79400761|FG001|Overall Study|Inadequate control of IOP|0|||
44394082|NCT00961649|79400762|FG002|Overall Study|Inadequate control of IOP|0|||
44394083|NCT00961649|79400763|FG003|Overall Study|Inadequate control of IOP|1|||
44394084|NCT00961649|79400760|FG000|Overall Study|Patient has travel plans during holidays|0|||
44394085|NCT00961649|79400761|FG001|Overall Study|Patient has travel plans during holidays|0|||
44146864|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
44146865|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
44146866|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
44252263|NCT02633046|79088690|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
44252264|NCT02633046|79088690|FG000|Overall Study|Mutual decision patient and physician|1|||
44252265|NCT01672788|79088749|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
44252266|NCT01672788|79088750|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
44394086|NCT00961649|79400762|FG002|Overall Study|Patient has travel plans during holidays|1|||
44394087|NCT00961649|79400763|FG003|Overall Study|Patient has travel plans during holidays|0|||
44394088|NCT00961649|79400760|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
44394089|NCT00961649|79400761|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
44394090|NCT00961649|79400762|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
44394091|NCT00961649|79400763|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
44394092|NCT00961649|79400760|FG000|Overall Study|Study terminated by sponsor|4|||
44394093|NCT00961649|79400761|FG001|Overall Study|Study terminated by sponsor|4|||
44394094|NCT00961649|79400762|FG002|Overall Study|Study terminated by sponsor|4|||
44394095|NCT00961649|79400763|FG003|Overall Study|Study terminated by sponsor|1|||
44394096|NCT00632125|79400773|FG000|Overall Study|Death|82|||
44394097|NCT00632125|79400773|FG000|Overall Study|Withdrawal by Subject|44|||
44394098|NCT00632125|79400773|FG000|Overall Study|Adverse Event|36|||
44394099|NCT00632125|79400773|FG000|Overall Study|Renal transplantation|17|||
44394100|NCT00632125|79400773|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
44394101|NCT00632125|79400773|FG000|Overall Study|Non-compliance|8|||
44394102|NCT00632125|79400773|FG000|Overall Study|Development of uncontrolled hypertension|5|||
44394103|NCT00632125|79400773|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
44394104|NCT00903968|79400779|FG000|Overall Study|Adverse Event|0|||
44394105|NCT00903968|79400780|FG001|Overall Study|Adverse Event|0|||
44394106|NCT00903968|79400781|FG002|Overall Study|Adverse Event|0|||
44394107|NCT00903968|79400782|FG003|Overall Study|Adverse Event|0|||
44394108|NCT00903968|79400783|FG004|Overall Study|Adverse Event|0|||
44394109|NCT00903968|79400784|FG005|Overall Study|Adverse Event|0|||
44394110|NCT00903968|79400785|FG006|Overall Study|Adverse Event|1|||
44252267|NCT01672788|79088751|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
44252268|NCT01672788|79088752|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
44252269|NCT02632110|79088767|FG000|Overall Study|Withdrawal by Subject|1|||
44252270|NCT02632110|79088768|FG001|Overall Study|Withdrawal by Subject|1|||
44252271|NCT02632110|79088769|FG002|Overall Study|Withdrawal by Subject|0|||
44252272|NCT02632110|79088770|FG003|Overall Study|Withdrawal by Subject|0|||
44252273|NCT02632110|79088771|FG004|Overall Study|Withdrawal by Subject|1|||
44252274|NCT02632110|79088772|FG005|Overall Study|Withdrawal by Subject|1|||
44252275|NCT02632110|79088773|FG006|Overall Study|Withdrawal by Subject|3|||
44252276|NCT02632110|79088774|FG007|Overall Study|Withdrawal by Subject|3|||
44281158|NCT01928472|79242290|FG001|Overall Study|Unclassified|0|||
44281159|NCT01928472|79242291|FG002|Overall Study|Unclassified|1|||
44281160|NCT01928472|79242292|FG003|Overall Study|Unclassified|0|||
44281161|NCT01351415|79244145|FG000|Overall Study|Withdrawal by Subject|15|||
44281162|NCT01351415|79244146|FG001|Overall Study|Withdrawal by Subject|17|||
44281163|NCT01351415|79244145|FG000|Overall Study|Trial termination by the Sponsor|28|||
44394111|NCT00903968|79400786|FG007|Overall Study|Adverse Event|8|||
44394112|NCT00903968|79400779|FG000|Overall Study|DLT|0|||
44394113|NCT00903968|79400780|FG001|Overall Study|DLT|0|||
44394114|NCT00903968|79400781|FG002|Overall Study|DLT|0|||
44394115|NCT00903968|79400782|FG003|Overall Study|DLT|0|||
44394116|NCT00903968|79400783|FG004|Overall Study|DLT|0|||
44252277|NCT02632110|79088775|FG008|Overall Study|Withdrawal by Subject|1|||
44281164|NCT01351415|79244146|FG001|Overall Study|Trial termination by the Sponsor|19|||
44281165|NCT01351415|79244145|FG000|Overall Study|Lost to Follow-up|5|||
44281166|NCT01351415|79244146|FG001|Overall Study|Lost to Follow-up|7|||
44281167|NCT01351415|79244145|FG000|Overall Study|Death|190|||
44281168|NCT01351415|79244146|FG001|Overall Study|Death|187|||
44281169|NCT01351415|79244145|FG000|Overall Study|Physician Decision|2|||
44281170|NCT01351415|79244146|FG001|Overall Study|Physician Decision|3|||
44281171|NCT01351415|79244145|FG000|Overall Study|Reason unknown|0|||
44281172|NCT01351415|79244146|FG001|Overall Study|Reason unknown|2|||
44281173|NCT01351415|79244145|FG000|Overall Study|Never Started|5|||
44281174|NCT01351415|79244146|FG001|Overall Study|Never Started|5|||
44281175|NCT04811339|79244254|FG000|Overall Study|lack of transportation not wanting to return|4|||
44281176|NCT04811339|79244255|FG001|Overall Study|lack of transportation not wanting to return|8|||
44281177|NCT04811339|79244256|FG002|Overall Study|lack of transportation not wanting to return|0|||
44281178|NCT04811339|79244254|FG000|Overall Study|Adverse Event|3|||
44281179|NCT04811339|79244255|FG001|Overall Study|Adverse Event|0|||
44394117|NCT00903968|79400784|FG005|Overall Study|DLT|0|||
44394118|NCT00903968|79400785|FG006|Overall Study|DLT|2|||
44394119|NCT00903968|79400786|FG007|Overall Study|DLT|0|||
44394120|NCT00903968|79400779|FG000|Overall Study|Withdrawal by Subject|1|||
44394121|NCT00903968|79400780|FG001|Overall Study|Withdrawal by Subject|0|||
44394122|NCT00903968|79400781|FG002|Overall Study|Withdrawal by Subject|1|||
44394123|NCT00903968|79400782|FG003|Overall Study|Withdrawal by Subject|0|||
44394124|NCT00903968|79400783|FG004|Overall Study|Withdrawal by Subject|1|||
44394125|NCT00903968|79400784|FG005|Overall Study|Withdrawal by Subject|1|||
44252278|NCT02632110|79088776|FG009|Overall Study|Withdrawal by Subject|1|||
44394126|NCT00903968|79400785|FG006|Overall Study|Withdrawal by Subject|0|||
44281180|NCT04811339|79244256|FG002|Overall Study|Adverse Event|0|||
44281181|NCT04811339|79244254|FG000|Overall Study|Lost to Follow-up|1|||
44281182|NCT04811339|79244255|FG001|Overall Study|Lost to Follow-up|0|||
44281183|NCT04811339|79244256|FG002|Overall Study|Lost to Follow-up|0|||
44281184|NCT04811339|79244254|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
44394127|NCT00903968|79400786|FG007|Overall Study|Withdrawal by Subject|4|||
44394128|NCT00903968|79400779|FG000|Overall Study|Non-Compliance|0|||
44394129|NCT00903968|79400780|FG001|Overall Study|Non-Compliance|0|||
44394130|NCT00903968|79400781|FG002|Overall Study|Non-Compliance|0|||
44394131|NCT00903968|79400782|FG003|Overall Study|Non-Compliance|0|||
44394132|NCT00903968|79400783|FG004|Overall Study|Non-Compliance|0|||
44394133|NCT00903968|79400784|FG005|Overall Study|Non-Compliance|1|||
44394134|NCT00903968|79400785|FG006|Overall Study|Non-Compliance|0|||
44394135|NCT00903968|79400786|FG007|Overall Study|Non-Compliance|0|||
44394136|NCT00903968|79400779|FG000|Overall Study|Physician Decision|0|||
44394137|NCT00903968|79400780|FG001|Overall Study|Physician Decision|0|||
44394138|NCT00903968|79400781|FG002|Overall Study|Physician Decision|0|||
44394139|NCT00903968|79400782|FG003|Overall Study|Physician Decision|0|||
44394140|NCT00903968|79400783|FG004|Overall Study|Physician Decision|0|||
44394141|NCT00903968|79400784|FG005|Overall Study|Physician Decision|1|||
44394142|NCT00903968|79400785|FG006|Overall Study|Physician Decision|0|||
44394143|NCT00903968|79400786|FG007|Overall Study|Physician Decision|0|||
44394144|NCT00903968|79400779|FG000|Overall Study|Progressive Disease|2|||
44394145|NCT00903968|79400780|FG001|Overall Study|Progressive Disease|3|||
44394146|NCT00903968|79400781|FG002|Overall Study|Progressive Disease|2|||
44394147|NCT00903968|79400782|FG003|Overall Study|Progressive Disease|3|||
44394148|NCT00903968|79400783|FG004|Overall Study|Progressive Disease|3|||
44394149|NCT00903968|79400784|FG005|Overall Study|Progressive Disease|3|||
44394150|NCT00903968|79400785|FG006|Overall Study|Progressive Disease|0|||
44394151|NCT00903968|79400786|FG007|Overall Study|Progressive Disease|18|||
44394152|NCT00903968|79400779|FG000|Overall Study|Lack of Efficacy|0|||
44394153|NCT00903968|79400780|FG001|Overall Study|Lack of Efficacy|0|||
44394154|NCT00903968|79400781|FG002|Overall Study|Lack of Efficacy|0|||
44394155|NCT00903968|79400782|FG003|Overall Study|Lack of Efficacy|0|||
44394156|NCT00903968|79400783|FG004|Overall Study|Lack of Efficacy|0|||
44394157|NCT00903968|79400784|FG005|Overall Study|Lack of Efficacy|0|||
44281185|NCT04811339|79244255|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
44281186|NCT04811339|79244256|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
44281187|NCT04811339|79244254|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
44281188|NCT04811339|79244255|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
44281189|NCT04811339|79244256|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
44281190|NCT04811339|79244254|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
44281191|NCT04811339|79244255|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
44281192|NCT04811339|79244256|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
44394158|NCT00903968|79400785|FG006|Overall Study|Lack of Efficacy|0|||
44394159|NCT00903968|79400786|FG007|Overall Study|Lack of Efficacy|3|||
44394160|NCT00903344|79400809|FG000|Overall Study|Pregnancy|2|||
44394161|NCT00903344|79400810|FG001|Overall Study|Pregnancy|3|||
44394162|NCT00903344|79400809|FG000|Overall Study|Lost to Follow-up|3|||
44394163|NCT00903344|79400810|FG001|Overall Study|Lost to Follow-up|0|||
44394164|NCT00903032|79400818|FG000|Overall Study|Withdrawal by Subject|5|||
44394165|NCT00903032|79400819|FG001|Overall Study|Withdrawal by Subject|3|||
44394166|NCT00903032|79400818|FG000|Overall Study|Lost to Follow-up|2|||
44394167|NCT00903032|79400819|FG001|Overall Study|Lost to Follow-up|2|||
44394168|NCT00902564|79400834|FG000|Overall Study|Withdrawal by Subject|2|||
44394169|NCT00626197|79400841|FG000|Overall Study|Did not cooperate|2|||
44394170|NCT00626197|79400842|FG001|Overall Study|Did not cooperate|6|||
44394171|NCT00626197|79400843|FG002|Overall Study|Did not cooperate|1|||
44394172|NCT00626197|79400841|FG000|Overall Study|Failure to return|6|||
44394173|NCT00626197|79400842|FG001|Overall Study|Failure to return|5|||
44394174|NCT00626197|79400843|FG002|Overall Study|Failure to return|6|||
44394175|NCT00626197|79400841|FG000|Overall Study|Adverse event, serious fatal|3|||
44394176|NCT00626197|79400842|FG001|Overall Study|Adverse event, serious fatal|6|||
44394177|NCT00626197|79400843|FG002|Overall Study|Adverse event, serious fatal|6|||
44394178|NCT00626197|79400841|FG000|Overall Study|Adverse Event|1|||
44394179|NCT00626197|79400842|FG001|Overall Study|Adverse Event|1|||
44394180|NCT00626197|79400843|FG002|Overall Study|Adverse Event|2|||
44394181|NCT00626197|79400841|FG000|Overall Study|Withdrawal by Subject|17|||
44394182|NCT00626197|79400842|FG001|Overall Study|Withdrawal by Subject|17|||
44394183|NCT00626197|79400843|FG002|Overall Study|Withdrawal by Subject|7|||
44394184|NCT00626197|79400841|FG000|Overall Study|Administrative reasons|15|||
44394185|NCT00626197|79400842|FG001|Overall Study|Administrative reasons|19|||
44394186|NCT00626197|79400843|FG002|Overall Study|Administrative reasons|55|||
44394187|NCT00626275|79400857|FG000|Part A - Treatment Period 1|Adverse Event|1|||
44394188|NCT00626275|79400858|FG001|Part A - Treatment Period 1|Adverse Event|0|||
44394189|NCT00626275|79400859|FG002|Part A - Treatment Period 1|Adverse Event|0|||
44394190|NCT00626275|79400860|FG003|Part A - Treatment Period 1|Adverse Event|0|||
44394191|NCT00626275|79400861|FG004|Part A - Treatment Period 1|Adverse Event|0|||
44394192|NCT00626275|79400862|FG005|Part A - Treatment Period 1|Adverse Event|0|||
44394193|NCT00626275|79400863|FG006|Part A - Treatment Period 1|Adverse Event|0|||
44394194|NCT00626275|79400864|FG007|Part A - Treatment Period 1|Adverse Event|0|||
44394195|NCT00626275|79400857|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394196|NCT00626275|79400858|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394197|NCT00626275|79400859|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
44394198|NCT00626275|79400860|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394199|NCT00626275|79400861|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394200|NCT00626275|79400862|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394201|NCT00626275|79400863|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394202|NCT00626275|79400864|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
44394203|NCT00626275|79400857|FG000|Part B|Lost to Follow-up|0|||
44394204|NCT00626275|79400858|FG001|Part B|Lost to Follow-up|0|||
44394205|NCT00626275|79400859|FG002|Part B|Lost to Follow-up|0|||
44394206|NCT00626275|79400860|FG003|Part B|Lost to Follow-up|0|||
44394207|NCT00626275|79400861|FG004|Part B|Lost to Follow-up|0|||
44394208|NCT00626275|79400862|FG005|Part B|Lost to Follow-up|0|||
44394209|NCT00626275|79400863|FG006|Part B|Lost to Follow-up|1|||
44394210|NCT00626275|79400864|FG007|Part B|Lost to Follow-up|0|||
44394211|NCT00626275|79400857|FG000|Part B|Withdrawal by Subject|0|||
44394212|NCT00626275|79400858|FG001|Part B|Withdrawal by Subject|0|||
44394213|NCT00626275|79400859|FG002|Part B|Withdrawal by Subject|0|||
44394214|NCT00626275|79400860|FG003|Part B|Withdrawal by Subject|0|||
44394215|NCT00626275|79400861|FG004|Part B|Withdrawal by Subject|0|||
44394216|NCT00626275|79400862|FG005|Part B|Withdrawal by Subject|0|||
44394217|NCT00626275|79400863|FG006|Part B|Withdrawal by Subject|0|||
44394218|NCT00626275|79400864|FG007|Part B|Withdrawal by Subject|1|||
44394219|NCT00623935|79400878|FG000|Overall Study|Death|1|||
44394220|NCT00623935|79400878|FG000|Overall Study|Patient Declined Transplant|1|||
44394221|NCT00623779|79400885|FG000|Overall Study|Adverse Event|1|||
44394222|NCT00623779|79400886|FG001|Overall Study|Adverse Event|3|||
44394223|NCT00623779|79400887|FG002|Overall Study|Adverse Event|0|||
44394224|NCT00623779|79400885|FG000|Overall Study|Criteria from CSR|2|||
44394225|NCT00623779|79400886|FG001|Overall Study|Criteria from CSR|0|||
44394226|NCT00623779|79400887|FG002|Overall Study|Criteria from CSR|1|||
44394227|NCT00629707|79400918|FG000|Overall Study|Withdrawal by Subject|0|||
44394228|NCT00629707|79400919|FG001|Overall Study|Withdrawal by Subject|1|||
44394229|NCT00629707|79400918|FG000|Overall Study|Physician Decision|0|||
44394230|NCT00629707|79400919|FG001|Overall Study|Physician Decision|1|||
44394231|NCT00902330|79400927|FG000|Overall Study|Too overwhelmed by treatment|2|||
44394232|NCT00902330|79400928|FG001|Overall Study|Too overwhelmed by treatment|5|||
44394233|NCT00902330|79400927|FG000|Overall Study|Adverse Event|1|||
44394234|NCT00902330|79400928|FG001|Overall Study|Adverse Event|0|||
44394235|NCT00902330|79400927|FG000|Overall Study|No post baseline data|1|||
44394236|NCT00902330|79400928|FG001|Overall Study|No post baseline data|0|||
44394237|NCT00901394|79400965|FG000|Overall Study|Physician Decision|1|||
44394238|NCT00901394|79400966|FG001|Overall Study|Physician Decision|1|||
44394239|NCT00901394|79400967|FG002|Overall Study|Physician Decision|2|||
44394240|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394241|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394242|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394243|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
44394244|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394245|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
44394246|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394247|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394248|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394249|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394250|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394251|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394252|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394253|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394254|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394255|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394256|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394257|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394258|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394259|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394260|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394261|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394262|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
44394263|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
44394264|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
44394265|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
44394266|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
44394267|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
44394268|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
44394269|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
44394270|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394271|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394272|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394273|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394274|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394275|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394276|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394277|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394278|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394279|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394280|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394281|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394282|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394283|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394284|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394285|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
44394286|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
44394287|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
44394288|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
44394289|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
44394290|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
44394291|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
44394292|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
44394293|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
44394294|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394295|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394296|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394297|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394298|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394299|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394300|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394301|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394302|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394303|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394304|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394305|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394306|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394307|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394308|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
44394309|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394310|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394311|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
44394312|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394313|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
44394314|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394315|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394316|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394317|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394318|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394319|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394320|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394321|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394322|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44146867|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
44394323|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394324|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394325|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394326|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394327|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394328|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394329|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394330|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394331|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
44394332|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
44394333|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394334|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394335|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
44394336|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394337|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394338|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394339|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394340|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394341|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394342|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394343|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394344|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394345|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394346|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394347|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394348|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394349|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394350|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394351|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394352|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394353|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394354|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
44394355|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394356|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394357|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
44394358|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394359|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394360|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394361|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394362|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394363|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394364|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394365|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394366|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394367|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394368|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394369|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394370|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394371|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394372|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394373|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394374|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394375|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394376|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394377|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
44394378|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394379|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394380|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
44394381|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394382|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394383|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394384|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394385|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394386|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394387|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394388|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394389|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394390|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394391|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394392|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44520546|NCT02991430|79528422|FG002|Post-treatment Observation Period|Study Termination|5|||
44520547|NCT03411902|79528432|FG000|Overall Study|Lost to Follow-up|3|||
44520548|NCT03411902|79528433|FG001|Overall Study|Lost to Follow-up|0|||
44394393|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394394|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394395|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394396|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394397|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394398|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394399|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394400|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
44394401|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394402|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394403|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394404|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
44394405|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394406|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394407|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394408|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394409|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394410|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394411|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394412|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394413|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394414|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394415|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394416|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394417|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394418|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394419|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394420|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394421|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394422|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394423|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
44394424|NCT00896532|79400983|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394425|NCT00896532|79400984|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
44394426|NCT00896532|79400985|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394427|NCT00896532|79400986|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
44394428|NCT00896532|79400987|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
44394429|NCT00896532|79400988|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394430|NCT00896532|79400989|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394431|NCT00896532|79400990|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394432|NCT00896532|79400991|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394433|NCT00896532|79400992|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394434|NCT00896532|79400993|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394435|NCT00896532|79400994|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394436|NCT00896532|79400995|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394437|NCT00896532|79400996|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394438|NCT00896532|79400997|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394439|NCT00896532|79400998|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394440|NCT00896532|79400999|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394441|NCT00896532|79401000|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44520549|NCT03494816|79528439|FG000|Overall Study|Protocol Violation|2|||
44520550|NCT03494816|79528439|FG000|Overall Study|Physician Decision|2|||
44520551|NCT03494816|79528439|FG000|Overall Study|Did not start trial treatment|1|||
44520552|NCT03494816|79528439|FG000|Overall Study|Adverse Event|1|||
44520553|NCT03492554|79528449|FG000|Overall Study|Protocol Violation|0|||
44520554|NCT03492554|79528450|FG001|Overall Study|Protocol Violation|14|||
44520555|NCT04936334|79528495|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
44520556|NCT04822597|79528505|FG000|Overall Study|Withdrawal by Subject|0|||
44520557|NCT04822597|79528506|FG001|Overall Study|Withdrawal by Subject|1|||
44520558|NCT04822597|79528507|FG002|Overall Study|Withdrawal by Subject|1|||
44520559|NCT04822597|79528508|FG003|Overall Study|Withdrawal by Subject|0|||
44520560|NCT04822597|79528505|FG000|Overall Study|Physician Decision|0|||
44520561|NCT04822597|79528506|FG001|Overall Study|Physician Decision|0|||
44520562|NCT04822597|79528507|FG002|Overall Study|Physician Decision|1|||
44394442|NCT00896532|79401001|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44520563|NCT04822597|79528508|FG003|Overall Study|Physician Decision|1|||
44520564|NCT04822597|79528505|FG000|Overall Study|Subject withdrawn after enrollment|0|||
44394443|NCT00896532|79401002|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394444|NCT00896532|79401003|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394445|NCT00896532|79401004|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394446|NCT00896532|79401005|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
44394447|NCT00896532|79400983|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394448|NCT00896532|79400984|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394449|NCT00896532|79400985|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394450|NCT00896532|79400986|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44252279|NCT01672710|79089018|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
44252280|NCT01672710|79089019|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
44252281|NCT01672710|79089018|FG000|3 Month Follow up|Lost to Follow-up|2|||
44252282|NCT01672710|79089019|FG001|3 Month Follow up|Lost to Follow-up|3|||
44252283|NCT01672710|79089018|FG000|3 Month Follow up|follow up due after termination date|4|||
44394451|NCT00896532|79400987|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394452|NCT00896532|79400988|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394453|NCT00896532|79400989|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394454|NCT00896532|79400990|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394455|NCT00896532|79400991|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
44394456|NCT00896532|79400992|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394457|NCT00896532|79400993|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394458|NCT00896532|79400994|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394459|NCT00896532|79400995|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394460|NCT00896532|79400996|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394461|NCT00896532|79400997|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394462|NCT00896532|79400998|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394463|NCT00896532|79400999|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394464|NCT00896532|79401000|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394465|NCT00896532|79401001|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394466|NCT00896532|79401002|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394467|NCT00896532|79401003|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394468|NCT00896532|79401004|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394469|NCT00896532|79401005|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
44394470|NCT00896532|79400983|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394471|NCT00896532|79400984|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394472|NCT00896532|79400985|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394473|NCT00896532|79400986|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394474|NCT00896532|79400987|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394475|NCT00896532|79400988|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394476|NCT00896532|79400989|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394477|NCT00896532|79400990|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394478|NCT00896532|79400991|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394479|NCT00896532|79400992|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394480|NCT00896532|79400993|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394481|NCT00896532|79400994|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394482|NCT00896532|79400995|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
44394483|NCT00896532|79400996|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394484|NCT00896532|79400997|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394485|NCT00896532|79400998|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394486|NCT00896532|79400999|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394487|NCT00896532|79401000|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394488|NCT00896532|79401001|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394489|NCT00896532|79401002|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394490|NCT00896532|79401003|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394491|NCT00896532|79401004|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394492|NCT00896532|79401005|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
44394493|NCT00896532|79400983|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394494|NCT00896532|79400984|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394495|NCT00896532|79400985|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394496|NCT00896532|79400986|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44520565|NCT04822597|79528506|FG001|Overall Study|Subject withdrawn after enrollment|1|||
44252284|NCT01672710|79089019|FG001|3 Month Follow up|follow up due after termination date|1|||
44252285|NCT02630472|79089054|FG000|Overall Study|Physician Decision|10|||
44252286|NCT02630472|79089055|FG001|Overall Study|Physician Decision|0|||
44252287|NCT01670526|79089091|FG000|Overall Study|Withdrawal by Subject|3|||
44281193|NCT04811339|79244254|FG000|Overall Study|Withdrawal by Subject|0|||
44394497|NCT00896532|79400987|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394498|NCT00896532|79400988|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394499|NCT00896532|79400989|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394500|NCT00896532|79400990|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394501|NCT00896532|79400991|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394502|NCT00896532|79400992|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394503|NCT00896532|79400993|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
44394504|NCT00896532|79400994|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394505|NCT00896532|79400995|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
44394506|NCT00896532|79400996|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394507|NCT00896532|79400997|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394508|NCT00896532|79400998|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394509|NCT00896532|79400999|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394510|NCT00896532|79401000|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394511|NCT00896532|79401001|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394512|NCT00896532|79401002|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394513|NCT00896532|79401003|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394514|NCT00896532|79401004|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394515|NCT00896532|79401005|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
44394516|NCT00896532|79400983|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394517|NCT00896532|79400984|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394518|NCT00896532|79400985|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394519|NCT00896532|79400986|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394520|NCT00896532|79400987|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394521|NCT00896532|79400988|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394522|NCT00896532|79400989|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394523|NCT00896532|79400990|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394524|NCT00896532|79400991|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394525|NCT00896532|79400992|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394526|NCT00896532|79400993|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394527|NCT00896532|79400994|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394528|NCT00896532|79400995|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
44394529|NCT00896532|79400996|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
44394530|NCT00896532|79400997|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394531|NCT00896532|79400998|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394532|NCT00896532|79400999|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394533|NCT00896532|79401000|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394534|NCT00896532|79401001|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394535|NCT00896532|79401002|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394536|NCT00896532|79401003|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394537|NCT00896532|79401004|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394538|NCT00896532|79401005|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
44394539|NCT00896532|79400983|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
44394540|NCT00896532|79400984|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
44394541|NCT00896532|79400985|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
44394542|NCT00896532|79400986|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
44394543|NCT00896532|79400987|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
44394544|NCT00896532|79400988|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
44394545|NCT00896532|79400989|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
44394546|NCT00896532|79400990|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
44394547|NCT00896532|79400991|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
44394548|NCT00896532|79400992|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
44394549|NCT00896532|79400993|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
44394550|NCT00896532|79400994|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
44394551|NCT00896532|79400995|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
44394552|NCT00896532|79400996|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
44394553|NCT00896532|79400997|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
44394554|NCT00896532|79400998|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
44394555|NCT00896532|79400999|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
44394556|NCT00896532|79401000|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
44394557|NCT00896532|79401001|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
44281194|NCT04811339|79244255|FG001|Overall Study|Withdrawal by Subject|3|||
44281195|NCT04811339|79244256|FG002|Overall Study|Withdrawal by Subject|0|||
44146868|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
44146869|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
44146870|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
44146871|NCT02717195|78936320|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
44146872|NCT02717195|78936321|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
44146873|NCT02717195|78936322|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
44146874|NCT02717195|78936323|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
44146875|NCT02717195|78936324|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
44146876|NCT00701441|78936339|FG000|Overall Study|failure in cpap compliance|0|||
44146877|NCT00701441|78936340|FG001|Overall Study|failure in cpap compliance|4|||
44146878|NCT02628873|78936352|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
44146879|NCT02628873|78936353|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
44146880|NCT02628873|78936352|FG000|Second Test (1 Hour)|Physician Decision|1|||
44146881|NCT02628873|78936353|FG001|Second Test (1 Hour)|Physician Decision|0|||
44146882|NCT02629965|78936363|FG000|Period 1|Adverse Event|1|||
44146883|NCT02629965|78936364|FG001|Period 1|Adverse Event|0|||
44146884|NCT02629965|78936363|FG000|Period 1|Unexpected worsening of disease|2|||
44146885|NCT02629965|78936364|FG001|Period 1|Unexpected worsening of disease|0|||
44146886|NCT02629965|78936363|FG000|Period 1|Other than listed above|1|||
44146887|NCT02629965|78936364|FG001|Period 1|Other than listed above|2|||
44146888|NCT02629965|78936363|FG000|Period 2|Adverse Event|1|||
44146889|NCT02629965|78936364|FG001|Period 2|Adverse Event|0|||
44146890|NCT01671111|78936370|FG000|Overall Study|Adverse Event|2|||
44146891|NCT01671111|78936370|FG000|Overall Study|Lack of Efficacy|1|||
44146892|NCT01671111|78936370|FG000|Overall Study|Withdrawal by Subject|2|||
44146893|NCT01671111|78936370|FG000|Overall Study|Physician Decision|1|||
44146894|NCT01671111|78936370|FG000|Overall Study|Other|24|||
44146895|NCT01671345|78936376|FG000|Overall Study|Lost to Follow-up|10|||
44146896|NCT01671345|78936377|FG001|Overall Study|Lost to Follow-up|6|||
44146897|NCT01671345|78936376|FG000|Overall Study|visit with non-participating physician|3|||
44146898|NCT01671345|78936377|FG001|Overall Study|visit with non-participating physician|3|||
44146899|NCT02487095|78936396|FG000|Dose Expansion|Unable to scan/restage participant|0|||
44146900|NCT02487095|78936397|FG001|Dose Expansion|Unable to scan/restage participant|0|||
44146901|NCT02487095|78936398|FG002|Dose Expansion|Unable to scan/restage participant|0|||
44146902|NCT02487095|78936399|FG003|Dose Expansion|Unable to scan/restage participant|0|||
44146903|NCT02487095|78936400|FG004|Dose Expansion|Unable to scan/restage participant|1|||
44146904|NCT03855137|78936423|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
44146905|NCT03855137|78936424|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
44146906|NCT03855137|78936425|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
44146907|NCT03855137|78936423|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
44146908|NCT03855137|78936424|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
44146909|NCT03855137|78936425|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
44146910|NCT03855137|78936423|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
44146911|NCT03855137|78936424|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
44146912|NCT03855137|78936425|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
44146913|NCT03855137|78936423|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
44146914|NCT03855137|78936424|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
44146915|NCT03855137|78936425|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
44146916|NCT03855137|78936423|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
44146917|NCT03855137|78936424|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
44146918|NCT03855137|78936425|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
44146919|NCT03855137|78936423|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
44146920|NCT03855137|78936424|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
44146921|NCT03855137|78936425|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
44146922|NCT03855137|78936423|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
44146923|NCT03855137|78936424|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
44146924|NCT03855137|78936425|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
44146925|NCT03855137|78936423|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
44146926|NCT03855137|78936424|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
44146927|NCT03855137|78936425|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
44146928|NCT03855137|78936423|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
44146929|NCT03855137|78936424|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
44146930|NCT03855137|78936425|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
44146931|NCT03855137|78936423|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
44146932|NCT03855137|78936424|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
44146933|NCT03855137|78936425|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
44146934|NCT00701363|78936447|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
44146935|NCT00701363|78936448|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
44394558|NCT00896532|79401002|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
44394559|NCT00896532|79401003|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
44394560|NCT00896532|79401004|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
44394561|NCT00896532|79401005|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
44394562|NCT00896532|79400983|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394563|NCT00896532|79400984|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394564|NCT00896532|79400985|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394565|NCT00896532|79400986|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394566|NCT00896532|79400987|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394567|NCT00896532|79400988|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394568|NCT00896532|79400989|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394569|NCT00896532|79400990|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394570|NCT00896532|79400991|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394571|NCT00896532|79400992|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394572|NCT00896532|79400993|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394573|NCT00896532|79400994|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394574|NCT00896532|79400995|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394575|NCT00896532|79400996|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394576|NCT00896532|79400997|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394577|NCT00896532|79400998|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
44394578|NCT00896532|79400999|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
44394579|NCT00896532|79401000|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394580|NCT00896532|79401001|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394581|NCT00896532|79401002|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394582|NCT00896532|79401003|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394583|NCT00896532|79401004|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394584|NCT00896532|79401005|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
44394585|NCT00896532|79400983|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394586|NCT00896532|79400984|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394587|NCT00896532|79400985|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394588|NCT00896532|79400986|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394589|NCT00896532|79400987|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394590|NCT00896532|79400988|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394591|NCT00896532|79400989|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394592|NCT00896532|79400990|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394593|NCT00896532|79400991|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394594|NCT00896532|79400992|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394595|NCT00896532|79400993|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394596|NCT00896532|79400994|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394597|NCT00896532|79400995|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394598|NCT00896532|79400996|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394599|NCT00896532|79400997|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394600|NCT00896532|79400998|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
44394601|NCT00896532|79400999|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
44394602|NCT00896532|79401000|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
44394603|NCT00896532|79401001|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394604|NCT00896532|79401002|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394605|NCT00896532|79401003|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394606|NCT00896532|79401004|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394607|NCT00896532|79401005|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
44394608|NCT00896532|79400983|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394609|NCT00896532|79400984|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394610|NCT00896532|79400985|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394611|NCT00896532|79400986|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394612|NCT00896532|79400987|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394613|NCT00896532|79400988|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394614|NCT00896532|79400989|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394615|NCT00896532|79400990|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394616|NCT00896532|79400991|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394617|NCT00896532|79400992|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394618|NCT00896532|79400993|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394619|NCT00896532|79400994|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394620|NCT00896532|79400995|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394621|NCT00896532|79400996|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394622|NCT00896532|79400997|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394623|NCT00896532|79400998|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394624|NCT00896532|79400999|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
44394625|NCT00896532|79401000|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394626|NCT00896532|79401001|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394627|NCT00896532|79401002|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44520566|NCT04822597|79528507|FG002|Overall Study|Subject withdrawn after enrollment|0|||
44520567|NCT04822597|79528508|FG003|Overall Study|Subject withdrawn after enrollment|1|||
44520568|NCT04822597|79528505|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
44520569|NCT04822597|79528506|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
44520570|NCT04822597|79528507|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
44520571|NCT04822597|79528508|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
44520572|NCT04639245|79528518|FG000|Overall Study|Death|1|||
44520573|NCT04599465|79528522|FG000|Overall Study|Physician Decision|1|||
44520574|NCT04599465|79528522|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
44520575|NCT04104646|79528569|FG000|Overall Study|Withdrawal by Subject|1|||
44520576|NCT04104646|79528570|FG001|Overall Study|Withdrawal by Subject|1|||
44520577|NCT04104646|79528569|FG000|Overall Study|Lost to Follow-up|1|||
44520578|NCT04104646|79528570|FG001|Overall Study|Lost to Follow-up|0|||
44520579|NCT04104646|79528569|FG000|Overall Study|Physician Decision|2|||
44520580|NCT04104646|79528570|FG001|Overall Study|Physician Decision|0|||
44520581|NCT03919669|79528581|FG000|Overall Study|Withdrawal by Subject|1|||
44520582|NCT03919669|79528582|FG001|Overall Study|Withdrawal by Subject|0|||
44520583|NCT03919669|79528583|FG002|Overall Study|Withdrawal by Subject|0|||
44520584|NCT03772665|79528594|FG000|Overall Study|Protocol Violation|1|||
44520585|NCT03772665|79528595|FG001|Overall Study|Protocol Violation|0|||
44520586|NCT03594110|79528612|FG000|Overall Study|Participant concerned about study treatment|23|||
44520587|NCT03594110|79528613|FG001|Overall Study|Participant concerned about study treatment|28|||
44520588|NCT03594110|79528612|FG000|Overall Study|Doctor advice|38|||
44520589|NCT03594110|79528613|FG001|Overall Study|Doctor advice|40|||
44520590|NCT03594110|79528612|FG000|Overall Study|Participants' wish|89|||
44520591|NCT03594110|79528613|FG001|Overall Study|Participants' wish|68|||
44520592|NCT03594110|79528612|FG000|Overall Study|Adverse Event|119|||
44520593|NCT03594110|79528613|FG001|Overall Study|Adverse Event|116|||
44520594|NCT03594110|79528612|FG000|Overall Study|Study drug stopped, reason missing|337|||
44520595|NCT03594110|79528613|FG001|Overall Study|Study drug stopped, reason missing|295|||
44520596|NCT03594110|79528612|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
44520597|NCT03594110|79528613|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
44520598|NCT03594110|79528612|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
44520599|NCT03594110|79528613|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
44520600|NCT03594110|79528612|FG000|Overall Study|Contraindicated drug started|32|||
44520601|NCT03594110|79528613|FG001|Overall Study|Contraindicated drug started|18|||
44520602|NCT03594110|79528612|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
44520603|NCT03594110|79528613|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
44520604|NCT03594110|79528612|FG000|Overall Study|Death|129|||
44520605|NCT03594110|79528613|FG001|Overall Study|Death|120|||
44520606|NCT03024996|79528642|FG000|Overall Study|Death|57|||
44520607|NCT03024996|79528643|FG001|Overall Study|Death|55|||
44520608|NCT03024996|79528642|FG000|Overall Study|Disease relapse|1|||
44520609|NCT03024996|79528643|FG001|Overall Study|Disease relapse|0|||
44520610|NCT03024996|79528642|FG000|Overall Study|Lost to Follow-up|5|||
44520611|NCT03024996|79528643|FG001|Overall Study|Lost to Follow-up|10|||
44520612|NCT03024996|79528642|FG000|Overall Study|Other|3|||
44520613|NCT03024996|79528643|FG001|Overall Study|Other|3|||
44520614|NCT03024996|79528642|FG000|Overall Study|Physician Decision|0|||
44520615|NCT03024996|79528643|FG001|Overall Study|Physician Decision|1|||
44520616|NCT03024996|79528642|FG000|Overall Study|Study terminated by sponsor|303|||
44520617|NCT03024996|79528643|FG001|Overall Study|Study terminated by sponsor|283|||
44520618|NCT03024996|79528642|FG000|Overall Study|Withdrawal by Subject|21|||
44520619|NCT03024996|79528643|FG001|Overall Study|Withdrawal by Subject|36|||
44520620|NCT02642965|79528667|FG000|Overall Study|Lack of Efficacy|4|||
44520621|NCT02642965|79528667|FG000|Overall Study|Physician Decision|9|||
44520622|NCT03443414|79528704|FG000|Overall Study|Adverse Event|6|||
44520623|NCT03443414|79528705|FG001|Overall Study|Adverse Event|0|||
44520624|NCT03443414|79528706|FG002|Overall Study|Adverse Event|4|||
44520625|NCT03443414|79528707|FG003|Overall Study|Adverse Event|2|||
44520626|NCT03443414|79528708|FG004|Overall Study|Adverse Event|3|||
44520627|NCT03443414|79528704|FG000|Overall Study|Withdrawal by Subject|3|||
44520628|NCT03443414|79528705|FG001|Overall Study|Withdrawal by Subject|2|||
44520629|NCT03443414|79528706|FG002|Overall Study|Withdrawal by Subject|2|||
44520630|NCT03443414|79528707|FG003|Overall Study|Withdrawal by Subject|2|||
44520631|NCT03443414|79528708|FG004|Overall Study|Withdrawal by Subject|1|||
44394628|NCT00896532|79401003|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394629|NCT00896532|79401004|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394630|NCT00896532|79401005|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
44394631|NCT00896532|79400983|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
44394632|NCT00896532|79400984|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
44394633|NCT00896532|79400985|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
44394634|NCT00896532|79400986|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
44394635|NCT00896532|79400987|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
44394636|NCT00896532|79400988|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
44394637|NCT00896532|79400989|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
44394638|NCT00896532|79400990|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
44394639|NCT00896532|79400991|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
44394640|NCT00896532|79400992|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
44394641|NCT00896532|79400993|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
44394642|NCT00896532|79400994|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
44394643|NCT00896532|79400995|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
44394644|NCT00896532|79400996|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
44394645|NCT00896532|79400997|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
44394646|NCT00896532|79400998|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
44394647|NCT00896532|79400999|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
44394648|NCT00896532|79401000|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
44394649|NCT00896532|79401001|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
44394650|NCT00896532|79401002|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
44394651|NCT00896532|79401003|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
44394652|NCT00896532|79401004|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
44394653|NCT00896532|79401005|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
44394654|NCT00896532|79400983|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394655|NCT00896532|79400984|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394656|NCT00896532|79400985|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394657|NCT00896532|79400986|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394658|NCT00896532|79400987|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394659|NCT00896532|79400988|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394660|NCT00896532|79400989|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394661|NCT00896532|79400990|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394662|NCT00896532|79400991|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394663|NCT00896532|79400992|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394664|NCT00896532|79400993|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394665|NCT00896532|79400994|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394666|NCT00896532|79400995|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394667|NCT00896532|79400996|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394668|NCT00896532|79400997|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394669|NCT00896532|79400998|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394670|NCT00896532|79400999|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
44394671|NCT00896532|79401000|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394672|NCT00896532|79401001|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394673|NCT00896532|79401002|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394674|NCT00896532|79401003|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394675|NCT00896532|79401004|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394676|NCT00896532|79401005|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
44394677|NCT00896532|79400983|FG000|Months 48-72: Follow-on Phase|Death|0|||
44394678|NCT00896532|79400984|FG001|Months 48-72: Follow-on Phase|Death|0|||
44394679|NCT00896532|79400985|FG002|Months 48-72: Follow-on Phase|Death|0|||
44394680|NCT00896532|79400986|FG003|Months 48-72: Follow-on Phase|Death|0|||
44394681|NCT00896532|79400987|FG004|Months 48-72: Follow-on Phase|Death|0|||
44394682|NCT00896532|79400988|FG005|Months 48-72: Follow-on Phase|Death|0|||
44394683|NCT00896532|79400989|FG006|Months 48-72: Follow-on Phase|Death|0|||
44394684|NCT00896532|79400990|FG007|Months 48-72: Follow-on Phase|Death|0|||
44394685|NCT00896532|79400991|FG008|Months 48-72: Follow-on Phase|Death|0|||
44394686|NCT00896532|79400992|FG009|Months 48-72: Follow-on Phase|Death|0|||
44394687|NCT00896532|79400993|FG010|Months 48-72: Follow-on Phase|Death|0|||
44394688|NCT00896532|79400994|FG011|Months 48-72: Follow-on Phase|Death|0|||
44394689|NCT00896532|79400995|FG012|Months 48-72: Follow-on Phase|Death|0|||
44252288|NCT01670526|79089092|FG001|Overall Study|Withdrawal by Subject|1|||
44252289|NCT01670526|79089091|FG000|Overall Study|Lost to Follow-up|9|||
44252290|NCT01670526|79089092|FG001|Overall Study|Lost to Follow-up|5|||
44252291|NCT02630706|79089136|FG000|Overall Study|Adverse Event|2|||
44394690|NCT00896532|79400996|FG013|Months 48-72: Follow-on Phase|Death|0|||
44394691|NCT00896532|79400997|FG014|Months 48-72: Follow-on Phase|Death|0|||
44394692|NCT00896532|79400998|FG015|Months 48-72: Follow-on Phase|Death|0|||
44394693|NCT00896532|79400999|FG016|Months 48-72: Follow-on Phase|Death|0|||
44394694|NCT00896532|79401000|FG017|Months 48-72: Follow-on Phase|Death|0|||
44394695|NCT00896532|79401001|FG018|Months 48-72: Follow-on Phase|Death|1|||
44394696|NCT00896532|79401002|FG019|Months 48-72: Follow-on Phase|Death|0|||
44394697|NCT00896532|79401003|FG020|Months 48-72: Follow-on Phase|Death|0|||
44394698|NCT00896532|79401004|FG021|Months 48-72: Follow-on Phase|Death|0|||
44394699|NCT00896532|79401005|FG022|Months 48-72: Follow-on Phase|Death|0|||
44394700|NCT00896532|79400983|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394701|NCT00896532|79400984|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394702|NCT00896532|79400985|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394703|NCT00896532|79400986|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394704|NCT00896532|79400987|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394705|NCT00896532|79400988|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394706|NCT00896532|79400989|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394707|NCT00896532|79400990|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394708|NCT00896532|79400991|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394709|NCT00896532|79400992|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394710|NCT00896532|79400993|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394711|NCT00896532|79400994|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394712|NCT00896532|79400995|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394713|NCT00896532|79400996|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394714|NCT00896532|79400997|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394715|NCT00896532|79400998|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394716|NCT00896532|79400999|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394717|NCT00896532|79401000|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394718|NCT00896532|79401001|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394719|NCT00896532|79401002|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394720|NCT00896532|79401003|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394721|NCT00896532|79401004|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
44394722|NCT00896532|79401005|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
44394723|NCT00896532|79400983|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394724|NCT00896532|79400984|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394725|NCT00896532|79400985|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394726|NCT00896532|79400986|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394727|NCT00896532|79400987|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394728|NCT00896532|79400988|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394729|NCT00896532|79400989|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394730|NCT00896532|79400990|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394731|NCT00896532|79400991|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394732|NCT00896532|79400992|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394733|NCT00896532|79400993|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394734|NCT00896532|79400994|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394735|NCT00896532|79400995|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394736|NCT00896532|79400996|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394737|NCT00896532|79400997|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394738|NCT00896532|79400998|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394739|NCT00896532|79400999|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44520632|NCT03443414|79528704|FG000|Overall Study|Death|0|||
44520633|NCT03443414|79528705|FG001|Overall Study|Death|1|||
44252292|NCT02630706|79089137|FG001|Overall Study|Adverse Event|1|||
44252293|NCT02630706|79089138|FG002|Overall Study|Adverse Event|1|||
44252294|NCT02630706|79089136|FG000|Overall Study|Lost to Follow-up|0|||
44252295|NCT02630706|79089137|FG001|Overall Study|Lost to Follow-up|1|||
44252296|NCT02630706|79089138|FG002|Overall Study|Lost to Follow-up|2|||
44281196|NCT04811339|79244254|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
44281197|NCT04811339|79244255|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
44281198|NCT04811339|79244256|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
44394740|NCT00896532|79401000|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44252297|NCT02630706|79089136|FG000|Overall Study|Physician Decision|1|||
44252298|NCT02630706|79089137|FG001|Overall Study|Physician Decision|1|||
44252299|NCT02630706|79089138|FG002|Overall Study|Physician Decision|0|||
44252300|NCT02630706|79089136|FG000|Overall Study|Pregnancy|0|||
44252301|NCT02630706|79089137|FG001|Overall Study|Pregnancy|1|||
44252302|NCT02630706|79089138|FG002|Overall Study|Pregnancy|0|||
44252303|NCT02630706|79089136|FG000|Overall Study|Withdrawal by Subject|4|||
44252304|NCT02630706|79089137|FG001|Overall Study|Withdrawal by Subject|5|||
44394741|NCT00896532|79401001|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394742|NCT00896532|79401002|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394743|NCT00896532|79401003|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394744|NCT00896532|79401004|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
44394745|NCT00896532|79401005|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
44394746|NCT00574873|79401054|FG000|Overall Study|Withdrawal by Subject|18|||
44394747|NCT00574873|79401055|FG001|Overall Study|Withdrawal by Subject|19|||
44394748|NCT00574873|79401054|FG000|Overall Study|Investigator request|18|||
44394749|NCT00574873|79401055|FG001|Overall Study|Investigator request|8|||
44394750|NCT00574873|79401054|FG000|Overall Study|Death|15|||
44394751|NCT00574873|79401055|FG001|Overall Study|Death|14|||
44394752|NCT00574873|79401054|FG000|Overall Study|Lost to Follow-up|14|||
44394753|NCT00574873|79401055|FG001|Overall Study|Lost to Follow-up|5|||
44394754|NCT00574873|79401054|FG000|Overall Study|Other|40|||
44394755|NCT00574873|79401055|FG001|Overall Study|Other|4|||
44394756|NCT00574873|79401054|FG000|Overall Study|Discontinuation of study by sponsor|5|||
44394757|NCT00574873|79401055|FG001|Overall Study|Discontinuation of study by sponsor|199|||
44394758|NCT00574873|79401054|FG000|Overall Study|Blank, site closed per local regulations|2|||
44394759|NCT00574873|79401055|FG001|Overall Study|Blank, site closed per local regulations|2|||
44394760|NCT00574873|79401054|FG000|Overall Study|Extension Study|126|||
44394761|NCT00574873|79401055|FG001|Overall Study|Extension Study|0|||
44394762|NCT00902174|79401063|FG000|Overall Study|Adverse Event|27|||
44394763|NCT00902174|79401064|FG001|Overall Study|Adverse Event|7|||
44394764|NCT00902174|79401063|FG000|Overall Study|Lack of Efficacy|1|||
44394765|NCT00902174|79401064|FG001|Overall Study|Lack of Efficacy|5|||
44394766|NCT00902174|79401063|FG000|Overall Study|Death|2|||
44394767|NCT00902174|79401064|FG001|Overall Study|Death|2|||
44394768|NCT00902174|79401063|FG000|Overall Study|Withdrawal by Subject|2|||
44394769|NCT00902174|79401064|FG001|Overall Study|Withdrawal by Subject|1|||
44394770|NCT00902174|79401063|FG000|Overall Study|Abnormal labs|1|||
44394771|NCT00902174|79401064|FG001|Overall Study|Abnormal labs|1|||
44394772|NCT00902174|79401063|FG000|Overall Study|Protocol Violation|1|||
44394773|NCT00902174|79401064|FG001|Overall Study|Protocol Violation|1|||
44394774|NCT00902174|79401063|FG000|Overall Study|Administration problem|0|||
44394775|NCT00902174|79401064|FG001|Overall Study|Administration problem|1|||
44394776|NCT00623623|79401075|FG000|Overall Study|Previous enrolment into this study|1|||
44394777|NCT00623623|79401076|FG001|Overall Study|Previous enrolment into this study|1|||
44394778|NCT00896454|79401082|FG000|Overall Study|Death|10|||
44394779|NCT00896454|79401082|FG000|Overall Study|Adverse Event|8|||
44394780|NCT00896454|79401082|FG000|Overall Study|Disease Progression|5|||
44394781|NCT00896454|79401082|FG000|Overall Study|Other|4|||
44394782|NCT00896454|79401082|FG000|Overall Study|Requirement for alternative therapy|3|||
44394783|NCT00896454|79401082|FG000|Overall Study|Ongoing in study|2|||
44394784|NCT00896454|79401082|FG000|Overall Study|Withdrawal by Subject|1|||
44394785|NCT00629239|79401088|FG000|Overall Study|Adverse Event|7|||
44394786|NCT00629239|79401089|FG001|Overall Study|Adverse Event|4|||
44394787|NCT00629239|79401088|FG000|Overall Study|Physician Decision|1|||
44394788|NCT00629239|79401089|FG001|Overall Study|Physician Decision|0|||
44394789|NCT00625807|79401097|FG000|Overall Study|schedule conflict|2|||
44394790|NCT00625807|79401098|FG001|Overall Study|schedule conflict|8|||
44394791|NCT00629083|79401108|FG000|Overall Study|Adverse Event|0|||
44394792|NCT00629083|79401109|FG001|Overall Study|Adverse Event|2|||
44394793|NCT00629083|79401108|FG000|Overall Study|Lack of Efficacy|3|||
44394794|NCT00629083|79401109|FG001|Overall Study|Lack of Efficacy|1|||
44394795|NCT00629083|79401108|FG000|Overall Study|Withdrawal by Subject|10|||
44394796|NCT00629083|79401109|FG001|Overall Study|Withdrawal by Subject|2|||
44394797|NCT00629083|79401108|FG000|Overall Study|Lost to Follow-up|12|||
44394798|NCT00629083|79401109|FG001|Overall Study|Lost to Follow-up|8|||
44394799|NCT00629083|79401108|FG000|Overall Study|Moved out of country/state|2|||
44394800|NCT00629083|79401109|FG001|Overall Study|Moved out of country/state|1|||
44394801|NCT00629083|79401108|FG000|Overall Study|Refused to return for 12 month visit|1|||
44394802|NCT00629083|79401109|FG001|Overall Study|Refused to return for 12 month visit|0|||
44394803|NCT00901628|79401119|FG000|Overall Study|disconnection of catheter|4|||
44394804|NCT00901628|79401120|FG001|Overall Study|disconnection of catheter|8|||
44394805|NCT00901628|79401119|FG000|Overall Study|disconnection of drain|0|||
44520634|NCT03443414|79528706|FG002|Overall Study|Death|0|||
44394806|NCT00901628|79401120|FG001|Overall Study|disconnection of drain|1|||
44394807|NCT00901628|79401119|FG000|Overall Study|peroneal nerve palsy|0|||
44394808|NCT00901628|79401120|FG001|Overall Study|peroneal nerve palsy|1|||
44520635|NCT03443414|79528707|FG003|Overall Study|Death|1|||
44520636|NCT03443414|79528708|FG004|Overall Study|Death|0|||
44520637|NCT03443414|79528704|FG000|Overall Study|Reason not specified|2|||
44520638|NCT03443414|79528705|FG001|Overall Study|Reason not specified|0|||
44520639|NCT03443414|79528706|FG002|Overall Study|Reason not specified|0|||
44520640|NCT03443414|79528707|FG003|Overall Study|Reason not specified|0|||
44520641|NCT03443414|79528708|FG004|Overall Study|Reason not specified|1|||
44520642|NCT02991118|79528722|FG000|Overall Study|Death|3|||
44394809|NCT00623545|79401126|FG000|Overall Study|Adverse Event|6|||
44394810|NCT00623545|79401126|FG000|Overall Study|Withdrawal by Subject|4|||
44394811|NCT00628927|79401133|FG000|Overall Study|Problems performing blood draw|6|||
44394812|NCT00628927|79401134|FG001|Overall Study|Problems performing blood draw|0|||
44394813|NCT00628927|79401133|FG000|Overall Study|Lost to Follow-up|1|||
44394814|NCT00628927|79401134|FG001|Overall Study|Lost to Follow-up|0|||
44394815|NCT00628927|79401133|FG000|Overall Study|Equipment failure|1|||
44394816|NCT00628927|79401134|FG001|Overall Study|Equipment failure|0|||
44394817|NCT00623467|79401145|FG000|Overall Study|Lost to Follow-up|1|||
44394818|NCT00623467|79401145|FG000|Overall Study|Protocol Violation|4|||
44394819|NCT00623467|79401145|FG000|Overall Study|Withdrawal by Subject|2|||
44394820|NCT00838539|79401163|FG000|Overall Study|Disease Progression|2|||
44394821|NCT00838539|79401164|FG001|Overall Study|Disease Progression|4|||
44394822|NCT00838539|79401165|FG002|Overall Study|Disease Progression|3|||
44394823|NCT00838539|79401166|FG003|Overall Study|Disease Progression|2|||
44394824|NCT00838539|79401167|FG004|Overall Study|Disease Progression|4|||
44394825|NCT00838539|79401168|FG005|Overall Study|Disease Progression|2|||
44394826|NCT00838539|79401169|FG006|Overall Study|Disease Progression|3|||
44394827|NCT00838539|79401170|FG007|Overall Study|Disease Progression|4|||
44394828|NCT00838539|79401171|FG008|Overall Study|Disease Progression|4|||
44394829|NCT00838539|79401172|FG009|Overall Study|Disease Progression|5|||
44394830|NCT00838539|79401173|FG010|Overall Study|Disease Progression|1|||
44394831|NCT00838539|79401174|FG011|Overall Study|Disease Progression|4|||
44394832|NCT00838539|79401163|FG000|Overall Study|Adverse Event|1|||
44394833|NCT00838539|79401164|FG001|Overall Study|Adverse Event|1|||
44394834|NCT00838539|79401165|FG002|Overall Study|Adverse Event|1|||
44394835|NCT00838539|79401166|FG003|Overall Study|Adverse Event|1|||
44394836|NCT00838539|79401167|FG004|Overall Study|Adverse Event|2|||
44394837|NCT00838539|79401168|FG005|Overall Study|Adverse Event|1|||
44394838|NCT00838539|79401169|FG006|Overall Study|Adverse Event|0|||
44394839|NCT00838539|79401170|FG007|Overall Study|Adverse Event|2|||
44394840|NCT00838539|79401171|FG008|Overall Study|Adverse Event|0|||
44394841|NCT00838539|79401172|FG009|Overall Study|Adverse Event|1|||
44394842|NCT00838539|79401173|FG010|Overall Study|Adverse Event|2|||
44394843|NCT00838539|79401174|FG011|Overall Study|Adverse Event|0|||
44394844|NCT00838539|79401163|FG000|Overall Study|Withdrawal by Subject|0|||
44394845|NCT00838539|79401164|FG001|Overall Study|Withdrawal by Subject|1|||
44394846|NCT00838539|79401165|FG002|Overall Study|Withdrawal by Subject|0|||
44394847|NCT00838539|79401166|FG003|Overall Study|Withdrawal by Subject|0|||
44394848|NCT00838539|79401167|FG004|Overall Study|Withdrawal by Subject|0|||
44394849|NCT00838539|79401168|FG005|Overall Study|Withdrawal by Subject|0|||
44394850|NCT00838539|79401169|FG006|Overall Study|Withdrawal by Subject|0|||
44394851|NCT00838539|79401170|FG007|Overall Study|Withdrawal by Subject|0|||
44394852|NCT00838539|79401171|FG008|Overall Study|Withdrawal by Subject|0|||
44394853|NCT00838539|79401172|FG009|Overall Study|Withdrawal by Subject|1|||
44394854|NCT00838539|79401173|FG010|Overall Study|Withdrawal by Subject|2|||
44394855|NCT00838539|79401174|FG011|Overall Study|Withdrawal by Subject|0|||
44394856|NCT00838539|79401163|FG000|Overall Study|Death|0|||
44394857|NCT00838539|79401164|FG001|Overall Study|Death|0|||
44394858|NCT00838539|79401165|FG002|Overall Study|Death|0|||
44394859|NCT00838539|79401166|FG003|Overall Study|Death|0|||
44394860|NCT00838539|79401167|FG004|Overall Study|Death|0|||
44394861|NCT00838539|79401168|FG005|Overall Study|Death|0|||
44394862|NCT00838539|79401169|FG006|Overall Study|Death|1|||
44394863|NCT00838539|79401170|FG007|Overall Study|Death|0|||
44394864|NCT00838539|79401171|FG008|Overall Study|Death|0|||
44394865|NCT00838539|79401172|FG009|Overall Study|Death|0|||
44394866|NCT00838539|79401173|FG010|Overall Study|Death|0|||
44394867|NCT00838539|79401174|FG011|Overall Study|Death|0|||
44394868|NCT00838539|79401163|FG000|Overall Study|Physician Decision|0|||
44394869|NCT00838539|79401164|FG001|Overall Study|Physician Decision|0|||
44394870|NCT00838539|79401165|FG002|Overall Study|Physician Decision|0|||
44520643|NCT02991118|79528723|FG001|Overall Study|Death|8|||
44520644|NCT02991118|79528722|FG000|Overall Study|Protocol Violation|0|||
44520645|NCT02991118|79528723|FG001|Overall Study|Protocol Violation|3|||
44520646|NCT02991118|79528722|FG000|Overall Study|Physician Decision|0|||
44394871|NCT00838539|79401166|FG003|Overall Study|Physician Decision|0|||
44394872|NCT00838539|79401167|FG004|Overall Study|Physician Decision|0|||
44394873|NCT00838539|79401168|FG005|Overall Study|Physician Decision|0|||
44394874|NCT00838539|79401169|FG006|Overall Study|Physician Decision|0|||
44394875|NCT00838539|79401170|FG007|Overall Study|Physician Decision|0|||
44394876|NCT00838539|79401171|FG008|Overall Study|Physician Decision|1|||
44394877|NCT00838539|79401172|FG009|Overall Study|Physician Decision|0|||
44394878|NCT00838539|79401173|FG010|Overall Study|Physician Decision|0|||
44394879|NCT00838539|79401174|FG011|Overall Study|Physician Decision|0|||
44394880|NCT00838539|79401163|FG000|Overall Study|Clinical Progression|0|||
44394881|NCT00838539|79401164|FG001|Overall Study|Clinical Progression|0|||
44394882|NCT00838539|79401165|FG002|Overall Study|Clinical Progression|0|||
44394883|NCT00838539|79401166|FG003|Overall Study|Clinical Progression|0|||
44394884|NCT00838539|79401167|FG004|Overall Study|Clinical Progression|0|||
44394885|NCT00838539|79401168|FG005|Overall Study|Clinical Progression|0|||
44394886|NCT00838539|79401169|FG006|Overall Study|Clinical Progression|1|||
44394887|NCT00838539|79401170|FG007|Overall Study|Clinical Progression|0|||
44394888|NCT00838539|79401171|FG008|Overall Study|Clinical Progression|0|||
44394889|NCT00838539|79401172|FG009|Overall Study|Clinical Progression|0|||
44394890|NCT00838539|79401173|FG010|Overall Study|Clinical Progression|0|||
44394891|NCT00838539|79401174|FG011|Overall Study|Clinical Progression|0|||
44394892|NCT00838539|79401163|FG000|Overall Study|Symptomatic Deterioration|0|||
44394893|NCT00838539|79401164|FG001|Overall Study|Symptomatic Deterioration|0|||
44394894|NCT00838539|79401165|FG002|Overall Study|Symptomatic Deterioration|1|||
44394895|NCT00838539|79401166|FG003|Overall Study|Symptomatic Deterioration|1|||
44394896|NCT00838539|79401167|FG004|Overall Study|Symptomatic Deterioration|0|||
44394897|NCT00838539|79401168|FG005|Overall Study|Symptomatic Deterioration|1|||
44394898|NCT00838539|79401169|FG006|Overall Study|Symptomatic Deterioration|0|||
44394899|NCT00838539|79401170|FG007|Overall Study|Symptomatic Deterioration|0|||
44394900|NCT00838539|79401171|FG008|Overall Study|Symptomatic Deterioration|0|||
44394901|NCT00838539|79401172|FG009|Overall Study|Symptomatic Deterioration|1|||
44394902|NCT00838539|79401173|FG010|Overall Study|Symptomatic Deterioration|0|||
44394903|NCT00838539|79401174|FG011|Overall Study|Symptomatic Deterioration|0|||
44394904|NCT00837759|79401214|FG000|Overall Study|Protocol Violation|3|||
44394905|NCT00837759|79401214|FG000|Overall Study|Lost to Follow-up|1|||
44394906|NCT00891774|79401218|FG000|Overall Study|Lost to Follow-up|5|||
44394907|NCT00891774|79401218|FG000|Overall Study|Illness (Self/Mother)|3|||
44394908|NCT00891774|79401218|FG000|Overall Study|Withdrawal by Subject|2|||
44394909|NCT00891774|79401218|FG000|Overall Study|Protocol Violation|4|||
44394910|NCT05421754|79401222|FG000|Overall Study|Technical issue with sensor|1|||
44394911|NCT04644276|79401235|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
44394912|NCT04644276|79401236|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
44394913|NCT04644276|79401237|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
44394914|NCT01596621|79401303|FG000|Overall Study|Death|4|||
44394915|NCT01596621|79401303|FG000|Overall Study|Withdrawal by Subject|9|||
44394916|NCT01596621|79401303|FG000|Overall Study|Disease Progression|49|||
44394917|NCT01596621|79401303|FG000|Overall Study|Lost to Follow-up|3|||
44394918|NCT01596621|79401303|FG000|Overall Study|Other than specified|13|||
44394919|NCT01337245|79401307|FG000|Overall Study|Lost to Follow-up|1|||
44394920|NCT00566098|79401317|FG000|Collection of MILs|Withdrawal by Subject|1|||
44394921|NCT00566098|79401317|FG000|Collection of MILs|Relapsed|1|||
44394922|NCT00566098|79401317|FG000|Generation of MILs Product|Relapsed|1|||
44394923|NCT00566098|79401317|FG000|Administration of ASCT+MILs|Death|10|||
44394924|NCT00566098|79401317|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
44394925|NCT00248287|79401324|FG000|Overall Study|Adverse Event|11|||
44394926|NCT00248287|79401325|FG001|Overall Study|Adverse Event|10|||
44394927|NCT00248287|79401324|FG000|Overall Study|Death|1|||
44394928|NCT00248287|79401325|FG001|Overall Study|Death|0|||
44394929|NCT00248287|79401324|FG000|Overall Study|Lost to Follow-up|0|||
44394930|NCT00248287|79401325|FG001|Overall Study|Lost to Follow-up|1|||
44394931|NCT00248287|79401324|FG000|Overall Study|Investigator Request|4|||
44394932|NCT00248287|79401325|FG001|Overall Study|Investigator Request|3|||
44394933|NCT00248287|79401324|FG000|Overall Study|Patient Request|5|||
44394934|NCT00248287|79401325|FG001|Overall Study|Patient Request|3|||
44394935|NCT00248287|79401324|FG000|Overall Study|Other|3|||
44394936|NCT00248287|79401325|FG001|Overall Study|Other|2|||
44394937|NCT00837213|79401333|FG000|Overall Study|Lost to Follow-up|3|||
44394938|NCT00837213|79401334|FG001|Overall Study|Lost to Follow-up|2|||
44394939|NCT00837213|79401333|FG000|Overall Study|Withdrawal by Subject|2|||
44394940|NCT00837213|79401334|FG001|Overall Study|Withdrawal by Subject|2|||
44394941|NCT00837213|79401333|FG000|Overall Study|not stated|1|||
44394942|NCT00837213|79401334|FG001|Overall Study|not stated|1|||
44394943|NCT00902486|79401344|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
44394944|NCT00902486|79401345|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
44394945|NCT00902486|79401346|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
44394946|NCT00902486|79401347|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
44394947|NCT00902486|79401348|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
44394948|NCT00902486|79401349|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
44394949|NCT00902486|79401344|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
44394950|NCT00902486|79401345|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
44394951|NCT00902486|79401346|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
44394952|NCT00902486|79401347|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
44394953|NCT00902486|79401348|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
44394954|NCT00902486|79401349|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
44394955|NCT00902486|79401344|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
44394956|NCT00902486|79401345|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
44394957|NCT00902486|79401346|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
44520647|NCT02991118|79528723|FG001|Overall Study|Physician Decision|1|||
44394958|NCT00902486|79401347|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
44394959|NCT00902486|79401348|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
44394960|NCT00902486|79401349|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
44394961|NCT00902486|79401344|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
44394962|NCT00902486|79401345|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
44394963|NCT00902486|79401346|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
44394964|NCT00902486|79401347|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
44394965|NCT00902486|79401348|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
44394966|NCT00902486|79401349|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
44394967|NCT00902486|79401344|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
44394968|NCT00902486|79401345|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
44394969|NCT00902486|79401346|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
44394970|NCT00902486|79401347|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
44394971|NCT00902486|79401348|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
44394972|NCT00902486|79401349|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
44394973|NCT00902486|79401344|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
44394974|NCT00902486|79401345|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
44394975|NCT00902486|79401346|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
44394976|NCT00902486|79401347|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
44394977|NCT00902486|79401348|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
44394978|NCT00902486|79401349|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
44394979|NCT00902486|79401344|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
44394980|NCT00902486|79401345|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
44394981|NCT00902486|79401346|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
44394982|NCT00902486|79401347|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
44394983|NCT00902486|79401348|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
44394984|NCT00902486|79401349|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
44394985|NCT00902486|79401344|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
44394986|NCT00902486|79401345|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
44394987|NCT00902486|79401346|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
44394988|NCT00902486|79401347|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
44394989|NCT00902486|79401348|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
44394990|NCT00902486|79401349|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
44394991|NCT00902486|79401344|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
44394992|NCT00902486|79401345|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
44394993|NCT00902486|79401346|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
44394994|NCT00902486|79401347|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
44394995|NCT00902486|79401348|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
44394996|NCT00902486|79401349|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
44394997|NCT00902486|79401344|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
44394998|NCT00902486|79401345|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
44394999|NCT00902486|79401346|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
44395000|NCT00902486|79401347|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
44395001|NCT00902486|79401348|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
44395002|NCT00902486|79401349|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
44395003|NCT00902486|79401344|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
44395004|NCT00902486|79401345|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
44395005|NCT00902486|79401346|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
44395006|NCT00902486|79401347|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
44395007|NCT00902486|79401348|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
44395008|NCT00902486|79401349|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
44395009|NCT00836745|79401379|FG000|Overall Study|Death|2|||
44395010|NCT00836745|79401379|FG000|Overall Study|Lost to Follow-up|10|||
44395011|NCT00836745|79401379|FG000|Overall Study|Adverse Event|3|||
44395012|NCT00836745|79401379|FG000|Overall Study|Objective progression or relapse|4|||
44395013|NCT00836745|79401379|FG000|Overall Study|Other|2|||
44395014|NCT00891618|79401383|FG000|Overall Study|Withdrawal by Subject|1|||
44395015|NCT00836589|79401387|FG000|Overall Study|Lost to Follow-up|246|||
44395016|NCT00836589|79401387|FG000|Overall Study|Death|429|||
44395017|NCT00836589|79401387|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
44395018|NCT00574795|79401399|FG000|Infant Series|Withdrawal by Subject|2|||
44395019|NCT00574795|79401399|FG000|Infant Series|Protocol Violation|2|||
44395020|NCT00574795|79401399|FG000|Infant Series|Adverse Event|1|||
44395021|NCT00574795|79401399|FG000|After Infant Series|Withdrawal by Subject|1|||
44146936|NCT00701363|78936449|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
44146937|NCT00701363|78936450|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
44395022|NCT00574795|79401399|FG000|After Infant Series|Adverse Event|2|||
44395023|NCT00574795|79401399|FG000|Toddler Dose|Withdrawal by Subject|1|||
44395024|NCT02297516|79401416|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
44395025|NCT02297516|79401417|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
44395026|NCT02297516|79401416|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
44395027|NCT02297516|79401417|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
44395028|NCT02297516|79401416|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
44395029|NCT02297516|79401417|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
44395030|NCT00836277|79401430|FG000|Overall Study|Not evaluable for response|6|||
44395031|NCT00835731|79401436|FG000|Overall Study|Withdrawal by Subject|1|||
44395032|NCT00835731|79401437|FG001|Overall Study|Withdrawal by Subject|0|||
44395033|NCT00835731|79401436|FG000|Overall Study|Physician Decision|1|||
44395034|NCT00835731|79401437|FG001|Overall Study|Physician Decision|1|||
44395035|NCT00835341|79401445|FG000|Overall Study|Lost to Follow-up|3|||
44395036|NCT00835341|79401446|FG001|Overall Study|Lost to Follow-up|12|||
44395037|NCT00574249|79401454|FG000|Overall Study|Adverse Event|6|||
44395038|NCT00574249|79401455|FG001|Overall Study|Adverse Event|18|||
44395039|NCT00574249|79401454|FG000|Overall Study|Lack of Efficacy|5|||
44395040|NCT00574249|79401455|FG001|Overall Study|Lack of Efficacy|3|||
44395041|NCT00574249|79401454|FG000|Overall Study|Lost to Follow-up|4|||
44395042|NCT00574249|79401455|FG001|Overall Study|Lost to Follow-up|3|||
44395043|NCT00574249|79401454|FG000|Overall Study|Protocol Violation|5|||
44395044|NCT00574249|79401455|FG001|Overall Study|Protocol Violation|2|||
44520648|NCT02991118|79528722|FG000|Overall Study|Moved out of the country|0|||
44520649|NCT02991118|79528723|FG001|Overall Study|Moved out of the country|1|||
44520650|NCT02991118|79528722|FG000|Overall Study|Adverse Event|2|||
44520651|NCT02991118|79528723|FG001|Overall Study|Adverse Event|2|||
44520652|NCT02991118|79528722|FG000|Overall Study|Withdrawal by Subject|1|||
44520653|NCT02991118|79528723|FG001|Overall Study|Withdrawal by Subject|7|||
44520654|NCT02991118|79528722|FG000|Overall Study|Could not attend study visits|0|||
44520655|NCT02991118|79528723|FG001|Overall Study|Could not attend study visits|1|||
44520656|NCT02991118|79528722|FG000|Overall Study|Lost to Follow-up|1|||
44520657|NCT02991118|79528723|FG001|Overall Study|Lost to Follow-up|9|||
44520658|NCT03491150|79528731|FG000|Overall Study|Adverse Event|1|||
44520659|NCT03491150|79528732|FG001|Overall Study|Adverse Event|0|||
44520660|NCT03491150|79528731|FG000|Overall Study|Study Terminated by Sponsor|74|||
44520661|NCT03491150|79528732|FG001|Overall Study|Study Terminated by Sponsor|70|||
44520662|NCT03491150|79528731|FG000|Overall Study|Other|0|||
44520663|NCT03491150|79528732|FG001|Overall Study|Other|1|||
44520664|NCT03491150|79528731|FG000|Overall Study|Withdrawal by Subject|1|||
44520665|NCT03491150|79528732|FG001|Overall Study|Withdrawal by Subject|2|||
44520666|NCT02991040|79528738|FG000|Overall Study|Withdrawal by Subject|2|||
44520667|NCT02991040|79528738|FG000|Overall Study|Lost to Follow-up|2|||
44520668|NCT02910466|79528744|FG000|Overall Study|Adverse Event|1|||
44520669|NCT02910466|79528744|FG000|Overall Study|Withdrawal by Subject|3|||
44520670|NCT02910466|79528744|FG000|Overall Study|Lost to Follow-up|5|||
44520671|NCT02910466|79528744|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
44520672|NCT02910466|79528744|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
44520673|NCT03415178|79528750|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
44520674|NCT03415178|79528751|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
44520675|NCT03415178|79528750|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
44520676|NCT03415178|79528751|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
44520677|NCT01068730|79528761|FG000|Period 3|Personal reason|1|||
44520678|NCT01068730|79528762|FG001|Period 3|Personal reason|0|||
44520679|NCT01068730|79528763|FG002|Period 3|Personal reason|0|||
44520680|NCT01068730|79528764|FG003|Period 3|Personal reason|0|||
44520681|NCT01068730|79528761|FG000|Period 4|Family emergency|0|||
44520682|NCT01068730|79528762|FG001|Period 4|Family emergency|1|||
44520683|NCT01068730|79528763|FG002|Period 4|Family emergency|0|||
44520684|NCT01068730|79528764|FG003|Period 4|Family emergency|0|||
44520685|NCT01068652|79528783|FG000|Overall Study|Adverse Event|4|||
44252305|NCT02630706|79089138|FG002|Overall Study|Withdrawal by Subject|7|||
44395045|NCT00574249|79401454|FG000|Overall Study|History of carcinoma|1|||
44395046|NCT00574249|79401455|FG001|Overall Study|History of carcinoma|0|||
44395047|NCT00574249|79401454|FG000|Overall Study|Withdrawal by Subject|3|||
44395048|NCT00574249|79401455|FG001|Overall Study|Withdrawal by Subject|0|||
44395049|NCT00574249|79401454|FG000|Overall Study|Physician Decision|1|||
44395050|NCT00574249|79401455|FG001|Overall Study|Physician Decision|0|||
44520686|NCT01068652|79528784|FG001|Overall Study|Adverse Event|0|||
44520687|NCT01068652|79528783|FG000|Overall Study|Lack of Efficacy|0|||
44520688|NCT01068652|79528784|FG001|Overall Study|Lack of Efficacy|2|||
44520689|NCT01068652|79528783|FG000|Overall Study|Lost to Follow-up|2|||
44520690|NCT01068652|79528784|FG001|Overall Study|Lost to Follow-up|1|||
44520691|NCT01068652|79528783|FG000|Overall Study|Protocol Violation|3|||
44520692|NCT01068652|79528784|FG001|Overall Study|Protocol Violation|6|||
44520693|NCT01068652|79528783|FG000|Overall Study|Withdrawal criteria|1|||
44520694|NCT01068652|79528784|FG001|Overall Study|Withdrawal criteria|2|||
44395051|NCT00574249|79401454|FG000|Overall Study|Pregnancy|1|||
44395052|NCT00574249|79401455|FG001|Overall Study|Pregnancy|0|||
44395053|NCT00574249|79401454|FG000|Overall Study|Excluded by company|0|||
44395054|NCT00574249|79401455|FG001|Overall Study|Excluded by company|1|||
44395055|NCT00574249|79401454|FG000|Overall Study|PPD test taken twice|0|||
44395056|NCT00574249|79401455|FG001|Overall Study|PPD test taken twice|1|||
44395057|NCT00891228|79401464|FG000|Overall Study|Adverse Event|0|||
44395058|NCT00891228|79401465|FG001|Overall Study|Adverse Event|2|||
44395059|NCT00891228|79401466|FG002|Overall Study|Adverse Event|3|||
44395060|NCT00891228|79401464|FG000|Overall Study|Withdrawal by Subject|2|||
44395061|NCT00891228|79401465|FG001|Overall Study|Withdrawal by Subject|4|||
44395062|NCT00891228|79401466|FG002|Overall Study|Withdrawal by Subject|5|||
44395063|NCT00891228|79401464|FG000|Overall Study|Protocol Violation|3|||
44395064|NCT00891228|79401465|FG001|Overall Study|Protocol Violation|1|||
44395065|NCT00891228|79401466|FG002|Overall Study|Protocol Violation|2|||
44395066|NCT00891228|79401464|FG000|Overall Study|Physician Decision|2|||
44395067|NCT00891228|79401465|FG001|Overall Study|Physician Decision|1|||
44395068|NCT00891228|79401466|FG002|Overall Study|Physician Decision|0|||
44395069|NCT00891228|79401464|FG000|Overall Study|Lost to Follow-up|4|||
44395070|NCT00891228|79401465|FG001|Overall Study|Lost to Follow-up|4|||
44395071|NCT00891228|79401466|FG002|Overall Study|Lost to Follow-up|5|||
44395072|NCT00891228|79401464|FG000|Overall Study|Pregnancy|0|||
44395073|NCT00891228|79401465|FG001|Overall Study|Pregnancy|1|||
44395074|NCT00891228|79401466|FG002|Overall Study|Pregnancy|0|||
44395075|NCT00896168|79401476|FG000|Overall Study|Adverse Event|4|||
44395076|NCT00896168|79401477|FG001|Overall Study|Adverse Event|7|||
44395077|NCT00896168|79401476|FG000|Overall Study|Treatment failure|8|||
44395078|NCT00896168|79401477|FG001|Overall Study|Treatment failure|10|||
44395079|NCT00896168|79401476|FG000|Overall Study|Lost to Follow-up|1|||
44395080|NCT00896168|79401477|FG001|Overall Study|Lost to Follow-up|1|||
44395081|NCT00896168|79401476|FG000|Overall Study|Other|1|||
44395082|NCT00896168|79401477|FG001|Overall Study|Other|1|||
44395083|NCT00833703|79401485|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
44395084|NCT00833703|79401486|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
44395085|NCT00833547|79401494|FG000|Overall Study|Withdrawal by Subject|2|||
44395086|NCT00833547|79401495|FG001|Overall Study|Withdrawal by Subject|2|||
44395087|NCT00833469|79401501|FG000|Overall Study|Withdrawal by Subject|1|||
44395088|NCT00833469|79401501|FG000|Overall Study|Lost to Follow-up|1|||
44395089|NCT00832377|79401505|FG000|Overall Study|Protocol Violation|1|||
44395090|NCT00892008|79401509|FG000|Overall Study|Death|5|||
44395091|NCT00892008|79401509|FG000|Overall Study|Lack of Efficacy|3|||
44395092|NCT00892008|79401509|FG000|Overall Study|Lost to Follow-up|142|||
44395093|NCT00892008|79401509|FG000|Overall Study|Other|378|||
44395094|NCT00892008|79401509|FG000|Overall Study|Adverse Event|37|||
44395095|NCT00623233|79401513|FG000|Overall Study|Adverse Event|10|||
44395096|NCT00623233|79401513|FG000|Overall Study|Physician Decision|10|||
44395097|NCT00623233|79401513|FG000|Overall Study|Lost to Follow-up|1|||
44395098|NCT00623233|79401513|FG000|Overall Study|Withdrawal by Subject|3|||
44395099|NCT03369236|79401528|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
44395100|NCT03369236|79401529|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
44395101|NCT03369236|79401528|FG000|Open-label Extension Period|Lack of Efficacy|2|||
44395102|NCT03369236|79401529|FG001|Open-label Extension Period|Lack of Efficacy|1|||
44395103|NCT03369236|79401528|FG000|Open-label Extension Period|Adverse Event|0|||
44395104|NCT03369236|79401529|FG001|Open-label Extension Period|Adverse Event|1|||
44395105|NCT03369236|79401528|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
44395106|NCT03369236|79401529|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
44395107|NCT00621751|79401543|FG000|Overall Study|Adverse Event|0|||
44395108|NCT00621751|79401544|FG001|Overall Study|Adverse Event|1|||
44395109|NCT00891930|79401561|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
44395110|NCT00891930|79401561|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
44395111|NCT00891930|79401561|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
44395112|NCT00891930|79401561|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
44395113|NCT00891930|79401561|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
44395114|NCT00891462|79401572|FG000|Overall Study|Withdrawal by Subject|9|||
44395115|NCT00891462|79401573|FG001|Overall Study|Withdrawal by Subject|6|||
44146938|NCT00701363|78936447|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
44395116|NCT00891462|79401574|FG002|Overall Study|Withdrawal by Subject|7|||
44395117|NCT00891462|79401572|FG000|Overall Study|Adverse Event|7|||
44395118|NCT00891462|79401573|FG001|Overall Study|Adverse Event|8|||
44520695|NCT01068652|79528783|FG000|Overall Study|Patient was not eligible|1|||
44520696|NCT01068652|79528784|FG001|Overall Study|Patient was not eligible|0|||
44395119|NCT00891462|79401574|FG002|Overall Study|Adverse Event|7|||
44395120|NCT00891462|79401572|FG000|Overall Study|Lack of Efficacy|10|||
44395121|NCT00891462|79401573|FG001|Overall Study|Lack of Efficacy|5|||
44395122|NCT00891462|79401574|FG002|Overall Study|Lack of Efficacy|1|||
44395123|NCT00891462|79401572|FG000|Overall Study|COPD exacerbation|7|||
44395124|NCT00891462|79401573|FG001|Overall Study|COPD exacerbation|4|||
44395125|NCT00891462|79401574|FG002|Overall Study|COPD exacerbation|1|||
44395126|NCT00891462|79401572|FG000|Overall Study|Other Reason|2|||
44395127|NCT00891462|79401573|FG001|Overall Study|Other Reason|5|||
44395128|NCT00891462|79401574|FG002|Overall Study|Other Reason|3|||
44395129|NCT00891462|79401572|FG000|Overall Study|Protocol Violation|2|||
44395130|NCT00891462|79401573|FG001|Overall Study|Protocol Violation|1|||
44395131|NCT00891462|79401574|FG002|Overall Study|Protocol Violation|3|||
44395132|NCT00891462|79401572|FG000|Overall Study|Inclusion/exclusion criteria|0|||
44395133|NCT00891462|79401573|FG001|Overall Study|Inclusion/exclusion criteria|2|||
44395134|NCT00891462|79401574|FG002|Overall Study|Inclusion/exclusion criteria|2|||
44395135|NCT00891462|79401572|FG000|Overall Study|Lost to Follow-up|0|||
44395136|NCT00891462|79401573|FG001|Overall Study|Lost to Follow-up|2|||
44395137|NCT00891462|79401574|FG002|Overall Study|Lost to Follow-up|0|||
44395138|NCT00900146|79401589|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
44395139|NCT00900146|79401590|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
44395140|NCT00900146|79401591|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
44395141|NCT00900146|79401592|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
44395142|NCT00900146|79401593|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
44395143|NCT00900146|79401589|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
44395144|NCT00900146|79401590|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
44395145|NCT00900146|79401591|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
44395146|NCT00900146|79401592|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
44395147|NCT00900146|79401593|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
44395148|NCT00900146|79401589|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
44395149|NCT00900146|79401590|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
44395150|NCT00900146|79401591|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
44395151|NCT00900146|79401592|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
44395152|NCT00900146|79401593|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
44395153|NCT00900146|79401589|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
44395154|NCT00900146|79401590|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
44395155|NCT00900146|79401591|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
44395156|NCT00900146|79401592|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
44395157|NCT00900146|79401593|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
44395158|NCT00900146|79401589|FG000|Intermediate: Period III|Lost to Follow-up|2|||
44395159|NCT00900146|79401590|FG001|Intermediate: Period III|Lost to Follow-up|0|||
44395160|NCT00900146|79401591|FG002|Intermediate: Period III|Lost to Follow-up|0|||
44395161|NCT00900146|79401592|FG003|Intermediate: Period III|Lost to Follow-up|0|||
44395162|NCT00900146|79401593|FG004|Intermediate: Period III|Lost to Follow-up|1|||
44395163|NCT00900146|79401589|FG000|Intermediate: Period III|Administrative problems|85|||
44395164|NCT00900146|79401590|FG001|Intermediate: Period III|Administrative problems|92|||
44395165|NCT00900146|79401591|FG002|Intermediate: Period III|Administrative problems|84|||
44395166|NCT00900146|79401592|FG003|Intermediate: Period III|Administrative problems|90|||
44395167|NCT00900146|79401593|FG004|Intermediate: Period III|Administrative problems|163|||
44395168|NCT00895310|79401605|FG000|Overall Study|Withdrawal by Subject|1|||
44395169|NCT00895154|79401611|FG000|Overall Study|Lost to Follow-up|1|||
44395170|NCT00895154|79401612|FG001|Overall Study|Lost to Follow-up|1|||
44395171|NCT00895154|79401611|FG000|Overall Study|Withdrawal by Subject|0|||
44395172|NCT00895154|79401612|FG001|Overall Study|Withdrawal by Subject|1|||
44395173|NCT00888654|79401618|FG000|Overall Study|Problems swallowing oral meds.|1|||
44395174|NCT00888654|79401618|FG000|Overall Study|Not enough oral meds before surgery|3|||
44395175|NCT00888654|79401618|FG000|Overall Study|Surgery aborted|2|||
44395176|NCT00888654|79401618|FG000|Overall Study|Withdrawal by Subject|1|||
44395177|NCT00888654|79401618|FG000|Overall Study|Inelig. due to contraindication of med|1|||
44395178|NCT00888654|79401618|FG000|Overall Study|Change in surg date|1|||
44395179|NCT00888654|79401618|FG000|Overall Study|Stopped meds due to headaches|1|||
44395180|NCT00899678|79401625|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
44395181|NCT00899678|79401626|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
44395182|NCT00899678|79401627|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
44395183|NCT00899678|79401625|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
44395184|NCT00899678|79401626|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
44395185|NCT00899678|79401627|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
44395186|NCT00899678|79401625|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
44395187|NCT00899678|79401626|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
44146939|NCT00701363|78936448|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
44395188|NCT00899678|79401627|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
44395189|NCT00899678|79401625|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
44395190|NCT00899678|79401626|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
44146940|NCT00701363|78936449|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
44395191|NCT00899678|79401627|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
44395192|NCT00899678|79401625|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
44395193|NCT00899678|79401626|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
44395194|NCT00899678|79401627|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
44395195|NCT00899678|79401625|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
44395196|NCT00899678|79401626|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
44395197|NCT00899678|79401627|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
44395198|NCT00899678|79401625|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
44395199|NCT00899678|79401626|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
44395200|NCT00899678|79401627|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
44395201|NCT00899678|79401625|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
44395202|NCT00899678|79401626|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
44395203|NCT00899678|79401627|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
44395204|NCT00899678|79401625|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
44395205|NCT00899678|79401626|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
44395206|NCT00899678|79401627|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
44395207|NCT00887484|79401635|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
44395208|NCT00887484|79401635|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
44395209|NCT00887484|79401635|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
44395210|NCT00886938|79401644|FG000|Overall Study|Adverse Event|1|||
44395211|NCT00886938|79401644|FG000|Overall Study|Withdrawal by Subject|1|||
44395212|NCT00620659|79401648|FG000|Treatment Period 1|Adverse Event|1|||
44395213|NCT00620659|79401649|FG001|Treatment Period 1|Adverse Event|0|||
44395214|NCT00620659|79401650|FG002|Treatment Period 1|Adverse Event|0|||
44395215|NCT00620659|79401651|FG003|Treatment Period 1|Adverse Event|3|||
44395216|NCT00620659|79401652|FG004|Treatment Period 1|Adverse Event|0|||
44395217|NCT00620659|79401653|FG005|Treatment Period 1|Adverse Event|0|||
44395218|NCT00620659|79401648|FG000|Treatment Period 1|Protocol Violation|1|||
44395219|NCT00620659|79401649|FG001|Treatment Period 1|Protocol Violation|0|||
44395220|NCT00620659|79401650|FG002|Treatment Period 1|Protocol Violation|0|||
44395221|NCT00620659|79401651|FG003|Treatment Period 1|Protocol Violation|0|||
44395222|NCT00620659|79401652|FG004|Treatment Period 1|Protocol Violation|0|||
44395223|NCT00620659|79401653|FG005|Treatment Period 1|Protocol Violation|0|||
44395224|NCT00620659|79401648|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44395225|NCT00620659|79401649|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44395226|NCT00620659|79401650|FG002|Treatment Period 1|Withdrawal by Subject|1|||
44395227|NCT00620659|79401651|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44395228|NCT00620659|79401652|FG004|Treatment Period 1|Withdrawal by Subject|1|||
44395229|NCT00620659|79401653|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44395230|NCT00620659|79401648|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
44395231|NCT00620659|79401649|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
44395232|NCT00620659|79401650|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
44395233|NCT00620659|79401651|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
44395234|NCT00620659|79401652|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
44395235|NCT00620659|79401653|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
44395236|NCT00620659|79401648|FG000|Treatment Period 2|Adverse Event|0|||
44395237|NCT00620659|79401649|FG001|Treatment Period 2|Adverse Event|3|||
44395238|NCT00620659|79401650|FG002|Treatment Period 2|Adverse Event|0|||
44395239|NCT00620659|79401651|FG003|Treatment Period 2|Adverse Event|0|||
44395240|NCT00620659|79401652|FG004|Treatment Period 2|Adverse Event|2|||
44395241|NCT00620659|79401653|FG005|Treatment Period 2|Adverse Event|0|||
44395242|NCT00620659|79401648|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44395243|NCT00620659|79401649|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44395244|NCT00620659|79401650|FG002|Treatment Period 2|Withdrawal by Subject|1|||
44395245|NCT00620659|79401651|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44395246|NCT00620659|79401652|FG004|Treatment Period 2|Withdrawal by Subject|3|||
44395247|NCT00620659|79401653|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44395248|NCT00620659|79401648|FG000|Placebo Washout Period 2|Adverse Event|2|||
44395249|NCT00620659|79401649|FG001|Placebo Washout Period 2|Adverse Event|0|||
44395250|NCT00620659|79401650|FG002|Placebo Washout Period 2|Adverse Event|0|||
44395251|NCT00620659|79401651|FG003|Placebo Washout Period 2|Adverse Event|0|||
44395252|NCT00620659|79401652|FG004|Placebo Washout Period 2|Adverse Event|0|||
44395253|NCT00620659|79401653|FG005|Placebo Washout Period 2|Adverse Event|0|||
44395254|NCT00620659|79401648|FG000|Treatment Period 3|Adverse Event|0|||
44395255|NCT00620659|79401649|FG001|Treatment Period 3|Adverse Event|2|||
44395256|NCT00620659|79401650|FG002|Treatment Period 3|Adverse Event|0|||
44395257|NCT00620659|79401651|FG003|Treatment Period 3|Adverse Event|0|||
44395258|NCT00620659|79401652|FG004|Treatment Period 3|Adverse Event|0|||
44395259|NCT00620659|79401653|FG005|Treatment Period 3|Adverse Event|0|||
44395260|NCT00620659|79401648|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44395261|NCT00620659|79401649|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44395262|NCT00620659|79401650|FG002|Treatment Period 3|Withdrawal by Subject|0|||
44395263|NCT00620659|79401651|FG003|Treatment Period 3|Withdrawal by Subject|1|||
44395264|NCT00620659|79401652|FG004|Treatment Period 3|Withdrawal by Subject|0|||
44395265|NCT00620659|79401653|FG005|Treatment Period 3|Withdrawal by Subject|0|||
44395266|NCT00894686|79401666|FG000|Overall Study|Withdrawal by Subject|50|||
44395267|NCT00894686|79401666|FG000|Overall Study|Physician Decision|1|||
44395268|NCT00894686|79401666|FG000|Overall Study|Other|5|||
44395269|NCT00885846|79401673|FG000|Overall Study|Withdrawal by Subject|2|||
44395270|NCT00885846|79401674|FG001|Overall Study|Withdrawal by Subject|5|||
44395271|NCT00885846|79401675|FG002|Overall Study|Withdrawal by Subject|2|||
44395272|NCT00621517|79401685|FG000|Overall Study|Lost to Follow-up|3|||
44395273|NCT00621517|79401686|FG001|Overall Study|Lost to Follow-up|3|||
44395274|NCT00621517|79401685|FG000|Overall Study|Withdrawal by Subject|3|||
44395275|NCT00621517|79401686|FG001|Overall Study|Withdrawal by Subject|4|||
44395276|NCT00621517|79401685|FG000|Overall Study|Adverse Event|1|||
44395277|NCT00621517|79401686|FG001|Overall Study|Adverse Event|0|||
44395278|NCT05333900|79401694|FG000|Overall Study|Protocol Violation|0|||
44395279|NCT05333900|79401695|FG001|Overall Study|Protocol Violation|1|||
44395280|NCT05333900|79401694|FG000|Overall Study|Withdrawal by Subject|0|||
44395281|NCT05333900|79401695|FG001|Overall Study|Withdrawal by Subject|1|||
44395282|NCT05333900|79401694|FG000|Overall Study|COVID-19 Pandemic|1|||
44395283|NCT05333900|79401695|FG001|Overall Study|COVID-19 Pandemic|1|||
44395284|NCT00573937|79401703|FG000|Overall Study|Study Terminated|0|||
44395285|NCT00573937|79401704|FG001|Overall Study|Study Terminated|1|||
44395286|NCT00573859|79401710|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
44395287|NCT00573859|79401710|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
44395288|NCT00831441|79401716|FG000|Randomized|Death|82|||
44395289|NCT00831441|79401717|FG001|Randomized|Death|81|||
44395290|NCT00831441|79401716|FG000|Randomized|Adverse Event|248|||
44395291|NCT00831441|79401717|FG001|Randomized|Adverse Event|321|||
44395292|NCT00831441|79401716|FG000|Randomized|Emergency procedure|2|||
44395293|NCT00831441|79401717|FG001|Randomized|Emergency procedure|2|||
44395294|NCT00831441|79401716|FG000|Randomized|Elective procedure|26|||
44395295|NCT00831441|79401717|FG001|Randomized|Elective procedure|25|||
44395296|NCT00831441|79401716|FG000|Randomized|Physician Decision|26|||
44395297|NCT00831441|79401717|FG001|Randomized|Physician Decision|35|||
44395298|NCT00831441|79401716|FG000|Randomized|No longer met criteria|13|||
44395299|NCT00831441|79401717|FG001|Randomized|No longer met criteria|19|||
44395300|NCT00831441|79401716|FG000|Randomized|Withdrawal by Subject|178|||
44395301|NCT00831441|79401717|FG001|Randomized|Withdrawal by Subject|212|||
44395302|NCT00831441|79401716|FG000|Randomized|Lost to Follow-up|26|||
44395303|NCT00831441|79401717|FG001|Randomized|Lost to Follow-up|35|||
44395304|NCT00831441|79401716|FG000|Randomized|Administrative reason by sponsor|2780|||
44395305|NCT00831441|79401717|FG001|Randomized|Administrative reason by sponsor|2671|||
44395306|NCT00831441|79401716|FG000|Randomized|poor/non-compliance|30|||
44395307|NCT00831441|79401717|FG001|Randomized|poor/non-compliance|38|||
44395308|NCT00831441|79401716|FG000|Randomized|non-specified|276|||
44395309|NCT00831441|79401717|FG001|Randomized|non-specified|266|||
44395310|NCT00831441|79401716|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
44395311|NCT00831441|79401717|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
44146941|NCT00701363|78936450|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
44146942|NCT00701363|78936447|FG000|Treatment Phase 1|Adverse Event|7|||
44146943|NCT00701363|78936448|FG001|Treatment Phase 1|Adverse Event|0|||
44146944|NCT00701363|78936449|FG002|Treatment Phase 1|Adverse Event|0|||
44146945|NCT00701363|78936450|FG003|Treatment Phase 1|Adverse Event|0|||
44146946|NCT00701363|78936447|FG000|Treatment Phase 1|Protocol Violation|1|||
44146947|NCT00701363|78936448|FG001|Treatment Phase 1|Protocol Violation|0|||
44146948|NCT00701363|78936449|FG002|Treatment Phase 1|Protocol Violation|0|||
44146949|NCT00701363|78936450|FG003|Treatment Phase 1|Protocol Violation|0|||
44146950|NCT00701363|78936447|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
44146951|NCT00701363|78936448|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
44146952|NCT00701363|78936449|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
44146953|NCT00701363|78936450|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
44395312|NCT00831441|79401716|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
44395313|NCT00831441|79401717|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
44395314|NCT00831441|79401716|FG000|Follow Up (30 Days)|Death|63|||
44395315|NCT00831441|79401717|FG001|Follow Up (30 Days)|Death|86|||
44395316|NCT00831441|79401716|FG000|Follow Up (30 Days)|non-specified|16|||
44395317|NCT00831441|79401717|FG001|Follow Up (30 Days)|non-specified|26|||
44395318|NCT00831441|79401716|FG000|Follow Up (30 Days)|missing end of study status|0|||
44520697|NCT01068652|79528783|FG000|Overall Study|Unclassified|7|||
44146954|NCT00701363|78936447|FG000|Treatment Phase 1|Lack of Efficacy|1|||
44146955|NCT00701363|78936448|FG001|Treatment Phase 1|Lack of Efficacy|0|||
44146956|NCT00701363|78936449|FG002|Treatment Phase 1|Lack of Efficacy|0|||
44146957|NCT00701363|78936450|FG003|Treatment Phase 1|Lack of Efficacy|0|||
44395319|NCT00831441|79401717|FG001|Follow Up (30 Days)|missing end of study status|1|||
44395320|NCT00831129|79401726|FG000|Overall Study|Adverse Event|0|||
44146958|NCT00701363|78936447|FG000|Treatment Phase 2|Adverse Event|0|||
44146959|NCT00701363|78936448|FG001|Treatment Phase 2|Adverse Event|0|||
44146960|NCT00701363|78936449|FG002|Treatment Phase 2|Adverse Event|1|||
44395321|NCT00831129|79401727|FG001|Overall Study|Adverse Event|1|||
44395322|NCT00831129|79401726|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
44395323|NCT00831129|79401727|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
44395324|NCT00620113|79401737|FG000|Overall Study|Adverse Event|3|||
44395325|NCT00620113|79401738|FG001|Overall Study|Adverse Event|2|||
44146961|NCT00701363|78936450|FG003|Treatment Phase 2|Adverse Event|0|||
44146962|NCT00701363|78936447|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
44146963|NCT00701363|78936448|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
44146964|NCT00701363|78936449|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
44146965|NCT00701363|78936450|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
44146966|NCT01670877|78936474|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
44146967|NCT01670877|78936475|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
44146968|NCT01670877|78936476|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
44146969|NCT01670877|78936477|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
44395326|NCT00620113|79401739|FG002|Overall Study|Adverse Event|2|||
44395327|NCT00620113|79401740|FG003|Overall Study|Adverse Event|1|||
44395328|NCT00620113|79401737|FG000|Overall Study|Lack of Efficacy|2|||
44395329|NCT00620113|79401738|FG001|Overall Study|Lack of Efficacy|3|||
44395330|NCT00620113|79401739|FG002|Overall Study|Lack of Efficacy|0|||
44395331|NCT00620113|79401740|FG003|Overall Study|Lack of Efficacy|2|||
44395332|NCT00620113|79401737|FG000|Overall Study|Physician Decision|1|||
44395333|NCT00620113|79401738|FG001|Overall Study|Physician Decision|0|||
44395334|NCT00620113|79401739|FG002|Overall Study|Physician Decision|0|||
44395335|NCT00620113|79401740|FG003|Overall Study|Physician Decision|2|||
44395336|NCT00620113|79401737|FG000|Overall Study|Protocol Violation|2|||
44395337|NCT00620113|79401738|FG001|Overall Study|Protocol Violation|1|||
44395338|NCT00620113|79401739|FG002|Overall Study|Protocol Violation|0|||
44395339|NCT00620113|79401740|FG003|Overall Study|Protocol Violation|0|||
44395340|NCT00620113|79401737|FG000|Overall Study|Withdrawal by Subject|5|||
44395341|NCT00620113|79401738|FG001|Overall Study|Withdrawal by Subject|1|||
44395342|NCT00620113|79401739|FG002|Overall Study|Withdrawal by Subject|3|||
44395343|NCT00620113|79401740|FG003|Overall Study|Withdrawal by Subject|5|||
44395344|NCT00830115|79401750|FG000|Overall Study|Adverse Event|2|||
44395345|NCT00830115|79401750|FG000|Overall Study|Improvement/recovery|1|||
44395346|NCT00830037|79401758|FG000|Overall Study|Withdrawal by Subject|2|||
44395347|NCT00830037|79401759|FG001|Overall Study|Withdrawal by Subject|3|||
44395348|NCT00830037|79401758|FG000|Overall Study|Lost to Follow-up|1|||
44395349|NCT00830037|79401759|FG001|Overall Study|Lost to Follow-up|2|||
44395350|NCT00830037|79401758|FG000|Overall Study|Active when terminated by DSMB|15|||
44395351|NCT00830037|79401759|FG001|Overall Study|Active when terminated by DSMB|14|||
44395352|NCT00829413|79401765|FG000|Overall Study|No study drug admimnistered|13|||
44395353|NCT00829413|79401765|FG000|Overall Study|Training Patients|67|||
44395354|NCT00829413|79401765|FG000|Overall Study|No truth standard procedure available|9|||
44395355|NCT00829413|79401765|FG000|Overall Study|Technically inadequate truth standard|2|||
44395356|NCT00829413|79401765|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
44395357|NCT00829179|79401776|FG000|Overall Study|Withdrawal by Subject|1|||
44395358|NCT00591591|79401782|FG000|Overall Study|Withdrawal by Subject|1|||
44395359|NCT00591591|79401783|FG001|Overall Study|Withdrawal by Subject|37|||
44395360|NCT00591591|79401782|FG000|Overall Study|Lack of Efficacy|10|||
44395361|NCT00591591|79401783|FG001|Overall Study|Lack of Efficacy|2|||
44395362|NCT00828945|79401789|FG000|Overall Study|Death|4|||
44395363|NCT00828945|79401789|FG000|Overall Study|Participant was missing|1|||
44395364|NCT00828945|79401789|FG000|Overall Study|Other|36|||
44395365|NCT00966875|79401802|FG000|Part A|Adverse Event|2|||
44395366|NCT00966875|79401803|FG001|Part A|Adverse Event|1|||
44395367|NCT00966875|79401804|FG002|Part A|Adverse Event|0|||
44395368|NCT00966875|79401805|FG003|Part A|Adverse Event|1|||
44395369|NCT00966875|79401806|FG004|Part A|Adverse Event|0|||
44395370|NCT00966875|79401807|FG005|Part A|Adverse Event|1|||
44395371|NCT00966875|79401808|FG006|Part A|Adverse Event|0|||
44395372|NCT00966875|79401809|FG007|Part A|Adverse Event|3|||
44395373|NCT00966875|79401810|FG008|Part A|Adverse Event|3|||
44395374|NCT00966875|79401802|FG000|Part A|Entry Criteria|0|||
44395375|NCT00966875|79401803|FG001|Part A|Entry Criteria|0|||
44395376|NCT00966875|79401804|FG002|Part A|Entry Criteria|0|||
44395377|NCT00966875|79401805|FG003|Part A|Entry Criteria|0|||
44395378|NCT00966875|79401806|FG004|Part A|Entry Criteria|0|||
44395379|NCT00966875|79401807|FG005|Part A|Entry Criteria|2|||
44395380|NCT00966875|79401808|FG006|Part A|Entry Criteria|0|||
44395381|NCT00966875|79401809|FG007|Part A|Entry Criteria|0|||
44395382|NCT00966875|79401810|FG008|Part A|Entry Criteria|0|||
44395383|NCT00966875|79401802|FG000|Part A|Lack of Efficacy|0|||
44395384|NCT00966875|79401803|FG001|Part A|Lack of Efficacy|1|||
44395385|NCT00966875|79401804|FG002|Part A|Lack of Efficacy|0|||
44520698|NCT01068652|79528784|FG001|Overall Study|Unclassified|4|||
44395386|NCT00966875|79401805|FG003|Part A|Lack of Efficacy|0|||
44146970|NCT01670877|78936478|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
44395387|NCT00966875|79401806|FG004|Part A|Lack of Efficacy|0|||
44395388|NCT00966875|79401807|FG005|Part A|Lack of Efficacy|0|||
44395389|NCT00966875|79401808|FG006|Part A|Lack of Efficacy|4|||
44395390|NCT00966875|79401809|FG007|Part A|Lack of Efficacy|0|||
44395391|NCT00966875|79401810|FG008|Part A|Lack of Efficacy|0|||
44395392|NCT00966875|79401802|FG000|Part A|Lost to Follow-up|2|||
44395393|NCT00966875|79401803|FG001|Part A|Lost to Follow-up|0|||
44395394|NCT00966875|79401804|FG002|Part A|Lost to Follow-up|0|||
44395395|NCT00966875|79401805|FG003|Part A|Lost to Follow-up|0|||
44395396|NCT00966875|79401806|FG004|Part A|Lost to Follow-up|0|||
44395397|NCT00966875|79401807|FG005|Part A|Lost to Follow-up|1|||
44395398|NCT00966875|79401808|FG006|Part A|Lost to Follow-up|0|||
44395399|NCT00966875|79401809|FG007|Part A|Lost to Follow-up|0|||
44395400|NCT00966875|79401810|FG008|Part A|Lost to Follow-up|0|||
44395401|NCT00966875|79401802|FG000|Part A|Parent/Caregiver Decision|0|||
44395402|NCT00966875|79401803|FG001|Part A|Parent/Caregiver Decision|0|||
44395403|NCT00966875|79401804|FG002|Part A|Parent/Caregiver Decision|0|||
44395404|NCT00966875|79401805|FG003|Part A|Parent/Caregiver Decision|1|||
44395405|NCT00966875|79401806|FG004|Part A|Parent/Caregiver Decision|0|||
44395406|NCT00966875|79401807|FG005|Part A|Parent/Caregiver Decision|0|||
44146971|NCT01670877|78936479|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
44395407|NCT00966875|79401808|FG006|Part A|Parent/Caregiver Decision|0|||
44395408|NCT00966875|79401809|FG007|Part A|Parent/Caregiver Decision|0|||
44395409|NCT00966875|79401810|FG008|Part A|Parent/Caregiver Decision|0|||
44395410|NCT00966875|79401802|FG000|Part A|Physician Decision|0|||
44395411|NCT00966875|79401803|FG001|Part A|Physician Decision|0|||
44395412|NCT00966875|79401804|FG002|Part A|Physician Decision|0|||
44395413|NCT00966875|79401805|FG003|Part A|Physician Decision|0|||
44395414|NCT00966875|79401806|FG004|Part A|Physician Decision|1|||
44395415|NCT00966875|79401807|FG005|Part A|Physician Decision|0|||
44395416|NCT00966875|79401808|FG006|Part A|Physician Decision|1|||
44395417|NCT00966875|79401809|FG007|Part A|Physician Decision|0|||
44395418|NCT00966875|79401810|FG008|Part A|Physician Decision|2|||
44395419|NCT00966875|79401802|FG000|Part A|Sponsor Decision|0|||
44395420|NCT00966875|79401803|FG001|Part A|Sponsor Decision|0|||
44395421|NCT00966875|79401804|FG002|Part A|Sponsor Decision|1|||
44395422|NCT00966875|79401805|FG003|Part A|Sponsor Decision|0|||
44395423|NCT00966875|79401806|FG004|Part A|Sponsor Decision|1|||
44395424|NCT00966875|79401807|FG005|Part A|Sponsor Decision|0|||
44395425|NCT00966875|79401808|FG006|Part A|Sponsor Decision|0|||
44395426|NCT00966875|79401809|FG007|Part A|Sponsor Decision|2|||
44395427|NCT00966875|79401810|FG008|Part A|Sponsor Decision|1|||
44395428|NCT00966875|79401802|FG000|Part A|Withdrawal by Subject|2|||
44395429|NCT00966875|79401803|FG001|Part A|Withdrawal by Subject|2|||
44395430|NCT00966875|79401804|FG002|Part A|Withdrawal by Subject|1|||
44395431|NCT00966875|79401805|FG003|Part A|Withdrawal by Subject|1|||
44395432|NCT00966875|79401806|FG004|Part A|Withdrawal by Subject|3|||
44395433|NCT00966875|79401807|FG005|Part A|Withdrawal by Subject|0|||
44395434|NCT00966875|79401808|FG006|Part A|Withdrawal by Subject|5|||
44520699|NCT02921776|79528796|FG000|Overall Study|patient deterioration, fatigue|2|||
44520700|NCT02921776|79528797|FG001|Overall Study|patient deterioration, fatigue|6|||
44520701|NCT02921776|79528798|FG002|Overall Study|patient deterioration, fatigue|0|||
44520702|NCT02921776|79528799|FG003|Overall Study|patient deterioration, fatigue|0|||
44520703|NCT02921776|79528800|FG004|Overall Study|patient deterioration, fatigue|0|||
44520704|NCT02921776|79528801|FG005|Overall Study|patient deterioration, fatigue|0|||
44520705|NCT02921776|79528802|FG006|Overall Study|patient deterioration, fatigue|0|||
44520706|NCT02921776|79528803|FG007|Overall Study|patient deterioration, fatigue|0|||
44520707|NCT02921776|79528796|FG000|Overall Study|Withdrawal by Subject|0|||
44520708|NCT02921776|79528797|FG001|Overall Study|Withdrawal by Subject|2|||
44146972|NCT01670877|78936474|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
44395435|NCT00966875|79401809|FG007|Part A|Withdrawal by Subject|1|||
44395436|NCT00966875|79401810|FG008|Part A|Withdrawal by Subject|1|||
44395437|NCT00966875|79401802|FG000|Part A|Protocol Violation|0|||
44395438|NCT00966875|79401803|FG001|Part A|Protocol Violation|0|||
44395439|NCT00966875|79401804|FG002|Part A|Protocol Violation|0|||
44395440|NCT00966875|79401805|FG003|Part A|Protocol Violation|0|||
44395441|NCT00966875|79401806|FG004|Part A|Protocol Violation|0|||
44395442|NCT00966875|79401807|FG005|Part A|Protocol Violation|0|||
44395443|NCT00966875|79401808|FG006|Part A|Protocol Violation|2|||
44395444|NCT00966875|79401809|FG007|Part A|Protocol Violation|1|||
44395445|NCT00966875|79401810|FG008|Part A|Protocol Violation|1|||
44395446|NCT00966875|79401802|FG000|Part B|Adverse Event|0|||
44395447|NCT00966875|79401803|FG001|Part B|Adverse Event|1|||
44395448|NCT00966875|79401804|FG002|Part B|Adverse Event|1|||
44395449|NCT00966875|79401805|FG003|Part B|Adverse Event|0|||
44395450|NCT00966875|79401806|FG004|Part B|Adverse Event|1|||
44395451|NCT00966875|79401807|FG005|Part B|Adverse Event|0|||
44395452|NCT00966875|79401808|FG006|Part B|Adverse Event|5|||
44520709|NCT02921776|79528798|FG002|Overall Study|Withdrawal by Subject|0|||
44395453|NCT00966875|79401809|FG007|Part B|Adverse Event|2|||
44395454|NCT00966875|79401810|FG008|Part B|Adverse Event|2|||
44395455|NCT00966875|79401802|FG000|Part B|Death|0|||
44395456|NCT00966875|79401803|FG001|Part B|Death|0|||
44395457|NCT00966875|79401804|FG002|Part B|Death|1|||
44395458|NCT00966875|79401805|FG003|Part B|Death|0|||
44395459|NCT00966875|79401806|FG004|Part B|Death|0|||
44395460|NCT00966875|79401807|FG005|Part B|Death|0|||
44395461|NCT00966875|79401808|FG006|Part B|Death|0|||
44395462|NCT00966875|79401809|FG007|Part B|Death|1|||
44395463|NCT00966875|79401810|FG008|Part B|Death|0|||
44395464|NCT00966875|79401802|FG000|Part B|Lack of Efficacy|2|||
44395465|NCT00966875|79401803|FG001|Part B|Lack of Efficacy|1|||
44395466|NCT00966875|79401804|FG002|Part B|Lack of Efficacy|1|||
44395467|NCT00966875|79401805|FG003|Part B|Lack of Efficacy|1|||
44395468|NCT00966875|79401806|FG004|Part B|Lack of Efficacy|2|||
44395469|NCT00966875|79401807|FG005|Part B|Lack of Efficacy|3|||
44395470|NCT00966875|79401808|FG006|Part B|Lack of Efficacy|12|||
44395471|NCT00966875|79401809|FG007|Part B|Lack of Efficacy|9|||
44395472|NCT00966875|79401810|FG008|Part B|Lack of Efficacy|6|||
44395473|NCT00966875|79401802|FG000|Part B|Lost to Follow-up|0|||
44395474|NCT00966875|79401803|FG001|Part B|Lost to Follow-up|0|||
44395475|NCT00966875|79401804|FG002|Part B|Lost to Follow-up|0|||
44395476|NCT00966875|79401805|FG003|Part B|Lost to Follow-up|1|||
44395477|NCT00966875|79401806|FG004|Part B|Lost to Follow-up|0|||
44395478|NCT00966875|79401807|FG005|Part B|Lost to Follow-up|0|||
44395479|NCT00966875|79401808|FG006|Part B|Lost to Follow-up|0|||
44395480|NCT00966875|79401809|FG007|Part B|Lost to Follow-up|0|||
44395481|NCT00966875|79401810|FG008|Part B|Lost to Follow-up|1|||
44395482|NCT00966875|79401802|FG000|Part B|Physician Decision|0|||
44395483|NCT00966875|79401803|FG001|Part B|Physician Decision|0|||
44395484|NCT00966875|79401804|FG002|Part B|Physician Decision|1|||
44395485|NCT00966875|79401805|FG003|Part B|Physician Decision|0|||
44395486|NCT00966875|79401806|FG004|Part B|Physician Decision|2|||
44395487|NCT00966875|79401807|FG005|Part B|Physician Decision|1|||
44395488|NCT00966875|79401808|FG006|Part B|Physician Decision|0|||
44395489|NCT00966875|79401809|FG007|Part B|Physician Decision|0|||
44395490|NCT00966875|79401810|FG008|Part B|Physician Decision|2|||
44395491|NCT00966875|79401802|FG000|Part B|Sponsor Decision|1|||
44395492|NCT00966875|79401803|FG001|Part B|Sponsor Decision|0|||
44395493|NCT00966875|79401804|FG002|Part B|Sponsor Decision|0|||
44395494|NCT00966875|79401805|FG003|Part B|Sponsor Decision|0|||
44395495|NCT00966875|79401806|FG004|Part B|Sponsor Decision|0|||
44395496|NCT00966875|79401807|FG005|Part B|Sponsor Decision|1|||
44395497|NCT00966875|79401808|FG006|Part B|Sponsor Decision|0|||
44395498|NCT00966875|79401809|FG007|Part B|Sponsor Decision|2|||
44395499|NCT00966875|79401810|FG008|Part B|Sponsor Decision|1|||
44395500|NCT00966875|79401802|FG000|Part B|Withdrawal by Subject|2|||
44395501|NCT00966875|79401803|FG001|Part B|Withdrawal by Subject|1|||
44520710|NCT02921776|79528799|FG003|Overall Study|Withdrawal by Subject|1|||
44520711|NCT02921776|79528800|FG004|Overall Study|Withdrawal by Subject|1|||
44520712|NCT02921776|79528801|FG005|Overall Study|Withdrawal by Subject|0|||
44520713|NCT02921776|79528802|FG006|Overall Study|Withdrawal by Subject|8|||
44520714|NCT02921776|79528803|FG007|Overall Study|Withdrawal by Subject|1|||
44520715|NCT02921776|79528796|FG000|Overall Study|Death|0|||
44520716|NCT02921776|79528797|FG001|Overall Study|Death|0|||
44520717|NCT02921776|79528798|FG002|Overall Study|Death|0|||
44520718|NCT02921776|79528799|FG003|Overall Study|Death|2|||
44520719|NCT02921776|79528800|FG004|Overall Study|Death|0|||
44520720|NCT02921776|79528801|FG005|Overall Study|Death|0|||
44520721|NCT02921776|79528802|FG006|Overall Study|Death|0|||
44520722|NCT02921776|79528803|FG007|Overall Study|Death|0|||
44520723|NCT02921776|79528796|FG000|Overall Study|extubation or early discharge|0|||
44520724|NCT02921776|79528797|FG001|Overall Study|extubation or early discharge|0|||
44520725|NCT02921776|79528798|FG002|Overall Study|extubation or early discharge|0|||
44520726|NCT02921776|79528799|FG003|Overall Study|extubation or early discharge|5|||
44395502|NCT00966875|79401804|FG002|Part B|Withdrawal by Subject|2|||
44395503|NCT00966875|79401805|FG003|Part B|Withdrawal by Subject|1|||
44395504|NCT00966875|79401806|FG004|Part B|Withdrawal by Subject|2|||
44395505|NCT00966875|79401807|FG005|Part B|Withdrawal by Subject|1|||
44395506|NCT00966875|79401808|FG006|Part B|Withdrawal by Subject|4|||
44520727|NCT02921776|79528800|FG004|Overall Study|extubation or early discharge|5|||
44395507|NCT00966875|79401809|FG007|Part B|Withdrawal by Subject|5|||
44520728|NCT02921776|79528801|FG005|Overall Study|extubation or early discharge|0|||
44520729|NCT02921776|79528802|FG006|Overall Study|extubation or early discharge|0|||
44395508|NCT00966875|79401810|FG008|Part B|Withdrawal by Subject|5|||
44395509|NCT00966875|79401802|FG000|Part B|Entry Criteria|0|||
44395510|NCT00966875|79401803|FG001|Part B|Entry Criteria|0|||
44395511|NCT00966875|79401804|FG002|Part B|Entry Criteria|0|||
44395512|NCT00966875|79401805|FG003|Part B|Entry Criteria|0|||
44395513|NCT00966875|79401806|FG004|Part B|Entry Criteria|0|||
44520730|NCT02921776|79528803|FG007|Overall Study|extubation or early discharge|0|||
44520731|NCT02921776|79528796|FG000|Overall Study|Lost to Follow-up|0|||
44520732|NCT02921776|79528797|FG001|Overall Study|Lost to Follow-up|0|||
44520733|NCT02921776|79528798|FG002|Overall Study|Lost to Follow-up|0|||
44395514|NCT00966875|79401807|FG005|Part B|Entry Criteria|0|||
44395515|NCT00966875|79401808|FG006|Part B|Entry Criteria|1|||
44395516|NCT00966875|79401809|FG007|Part B|Entry Criteria|0|||
44395517|NCT00966875|79401810|FG008|Part B|Entry Criteria|1|||
44395518|NCT00828711|79401886|FG000|Overall Study|Lost to Follow-up|1|||
44395519|NCT00828711|79401887|FG001|Overall Study|Lost to Follow-up|0|||
44395520|NCT00828711|79401888|FG002|Overall Study|Lost to Follow-up|0|||
44395521|NCT00966719|79401898|FG000|Overall Study|Lost to Follow-up|6|||
44395522|NCT00966719|79401899|FG001|Overall Study|Lost to Follow-up|11|||
44395523|NCT00818649|79401905|FG000|Overall Study|Declining performance status|2|||
44395524|NCT00818649|79401905|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
44395525|NCT00818649|79401905|FG000|Overall Study|Adverse Event|1|||
44395526|NCT00961571|79401910|FG000|Overall Study|Physician Decision|39|||
44395527|NCT00964223|79401914|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
44395528|NCT00620815|79401922|FG000|Overall Study|Adverse Event|1|||
44395529|NCT00620815|79401923|FG001|Overall Study|Adverse Event|1|||
44395530|NCT00620815|79401924|FG002|Overall Study|Adverse Event|2|||
44395531|NCT00620815|79401922|FG000|Overall Study|Withdrawal by Subject|1|||
44395532|NCT00620815|79401923|FG001|Overall Study|Withdrawal by Subject|2|||
44395533|NCT00620815|79401924|FG002|Overall Study|Withdrawal by Subject|0|||
44395534|NCT00620815|79401922|FG000|Overall Study|Lost to Follow-up|1|||
44395535|NCT00620815|79401923|FG001|Overall Study|Lost to Follow-up|6|||
44395536|NCT00620815|79401924|FG002|Overall Study|Lost to Follow-up|3|||
44395537|NCT00620815|79401922|FG000|Overall Study|Inappropriate enrolment|0|||
44395538|NCT00620815|79401923|FG001|Overall Study|Inappropriate enrolment|0|||
44395539|NCT00620815|79401924|FG002|Overall Study|Inappropriate enrolment|1|||
44395540|NCT00620815|79401922|FG000|Overall Study|Protocol Violation|1|||
44395541|NCT00620815|79401923|FG001|Overall Study|Protocol Violation|2|||
44395542|NCT00620815|79401924|FG002|Overall Study|Protocol Violation|1|||
44395543|NCT03372941|79401950|FG000|Overall Study|Lost to Follow-up|2|||
44395544|NCT03372941|79401951|FG001|Overall Study|Lost to Follow-up|4|||
44395545|NCT00619957|79401959|FG000|Month 24 Double-Blind|Adverse Event|9|||
44395546|NCT00619957|79401960|FG001|Month 24 Double-Blind|Adverse Event|7|||
44281199|NCT04811339|79244254|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
44281200|NCT04811339|79244255|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
44281201|NCT04811339|79244256|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
44281202|NCT04332107|79244268|FG000|Day 3|Lost to Follow-up|23|||
44281203|NCT04332107|79244269|FG001|Day 3|Lost to Follow-up|14|||
44281204|NCT04332107|79244268|FG000|Day 3|Missing outcome data|3|||
44281205|NCT04332107|79244269|FG001|Day 3|Missing outcome data|6|||
44281206|NCT04332107|79244268|FG000|Day 14|Lost to Follow-up|13|||
44281207|NCT04332107|79244269|FG001|Day 14|Lost to Follow-up|4|||
44281208|NCT04332107|79244268|FG000|Day 14|Missing outcome data|4|||
44281209|NCT04332107|79244269|FG001|Day 14|Missing outcome data|4|||
44281210|NCT04332107|79244268|FG000|Day 21|Lost to Follow-up|10|||
44281211|NCT04332107|79244269|FG001|Day 21|Lost to Follow-up|2|||
44281212|NCT03075839|79244288|FG000|Overall Study|Lost to Follow-up|4|||
44281213|NCT02919683|79244294|FG000|Post-Surgery Follow-Up|Death|2|||
44395547|NCT00619957|79401959|FG000|Month 24 Double-Blind|Protocol Violation|1|||
44395548|NCT00619957|79401960|FG001|Month 24 Double-Blind|Protocol Violation|0|||
44395549|NCT00619957|79401959|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
44395550|NCT00619957|79401960|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
44395551|NCT00619957|79401959|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
44395552|NCT00619957|79401960|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
44395553|NCT00619957|79401959|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
44395554|NCT00619957|79401960|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
44395555|NCT00619957|79401959|FG000|Month 48 Open-Label|Adverse Event|4|||
44395556|NCT00619957|79401960|FG001|Month 48 Open-Label|Adverse Event|4|||
44395557|NCT00619957|79401959|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
44395558|NCT00619957|79401960|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
44395559|NCT00619957|79401959|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
44395560|NCT00619957|79401960|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
44395561|NCT00961415|79401970|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
44520734|NCT02921776|79528799|FG003|Overall Study|Lost to Follow-up|0|||
44146973|NCT01670877|78936475|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
44281214|NCT02919683|79244295|FG001|Post-Surgery Follow-Up|Death|2|||
44281215|NCT02919683|79244294|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
44281216|NCT02919683|79244295|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
44281217|NCT01928082|79244302|FG000|Overall Study|Study terminated.|1|||
44281218|NCT01972776|79244312|FG000|Part 1|Withdrawal by Subject|0|||
44281219|NCT01972776|79244313|FG001|Part 1|Withdrawal by Subject|0|||
44395562|NCT00961415|79401971|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
44395563|NCT00961415|79401972|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
44395564|NCT00961415|79401970|FG000|Induction Treatment Phase|Death|77|||
44395565|NCT00961415|79401971|FG001|Induction Treatment Phase|Death|0|||
44395566|NCT00961415|79401972|FG002|Induction Treatment Phase|Death|0|||
44395567|NCT00961415|79401970|FG000|Induction Treatment Phase|Protocol Violation|1|||
44395568|NCT00961415|79401971|FG001|Induction Treatment Phase|Protocol Violation|0|||
44395569|NCT00961415|79401972|FG002|Induction Treatment Phase|Protocol Violation|0|||
44281220|NCT01972776|79244314|FG002|Part 1|Withdrawal by Subject|1|||
44281221|NCT01972776|79244315|FG003|Part 1|Withdrawal by Subject|0|||
44281222|NCT01972776|79244316|FG004|Part 1|Withdrawal by Subject|0|||
44395570|NCT00961415|79401970|FG000|Induction Treatment Phase|Physician Decision|2|||
44395571|NCT00961415|79401971|FG001|Induction Treatment Phase|Physician Decision|0|||
44395572|NCT00961415|79401972|FG002|Induction Treatment Phase|Physician Decision|0|||
44395573|NCT00961415|79401970|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
44395574|NCT00961415|79401971|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
44395575|NCT00961415|79401972|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
44395576|NCT00961415|79401970|FG000|Induction Treatment Phase|Other Reason|5|||
44395577|NCT00961415|79401971|FG001|Induction Treatment Phase|Other Reason|0|||
44395578|NCT00961415|79401972|FG002|Induction Treatment Phase|Other Reason|0|||
44395579|NCT00961415|79401970|FG000|Maintenance Treatment Phase|Death|0|||
44395580|NCT00961415|79401971|FG001|Maintenance Treatment Phase|Death|42|||
44395581|NCT00961415|79401972|FG002|Maintenance Treatment Phase|Death|34|||
44395582|NCT00961415|79401970|FG000|Maintenance Treatment Phase|Investigators decision|0|||
44395583|NCT00961415|79401971|FG001|Maintenance Treatment Phase|Investigators decision|2|||
44395584|NCT00961415|79401972|FG002|Maintenance Treatment Phase|Investigators decision|0|||
44395585|NCT00961415|79401970|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44395586|NCT00961415|79401971|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
44395587|NCT00961415|79401972|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
44395588|NCT00961415|79401970|FG000|Maintenance Treatment Phase|Other reason|0|||
44395589|NCT00961415|79401971|FG001|Maintenance Treatment Phase|Other reason|1|||
44395590|NCT00961415|79401972|FG002|Maintenance Treatment Phase|Other reason|3|||
44395591|NCT00963599|79401990|FG000|Overall Study|Adverse Event|2|||
44395592|NCT00963599|79401991|FG001|Overall Study|Adverse Event|0|||
44395593|NCT00963599|79401992|FG002|Overall Study|Adverse Event|1|||
44395594|NCT00963599|79401993|FG003|Overall Study|Adverse Event|2|||
44395595|NCT00963599|79401990|FG000|Overall Study|Lack of Efficacy|0|||
44395596|NCT00963599|79401991|FG001|Overall Study|Lack of Efficacy|2|||
44395597|NCT00963599|79401992|FG002|Overall Study|Lack of Efficacy|1|||
44395598|NCT00963599|79401993|FG003|Overall Study|Lack of Efficacy|4|||
44395599|NCT00963599|79401990|FG000|Overall Study|Lost to Follow-up|0|||
44395600|NCT00963599|79401991|FG001|Overall Study|Lost to Follow-up|1|||
44395601|NCT00963599|79401992|FG002|Overall Study|Lost to Follow-up|1|||
44395602|NCT00963599|79401993|FG003|Overall Study|Lost to Follow-up|1|||
44395603|NCT00963599|79401990|FG000|Overall Study|Protocol Violation|2|||
44395604|NCT00963599|79401991|FG001|Overall Study|Protocol Violation|2|||
44395605|NCT00963599|79401992|FG002|Overall Study|Protocol Violation|3|||
44395606|NCT00963599|79401993|FG003|Overall Study|Protocol Violation|4|||
44395607|NCT00963599|79401990|FG000|Overall Study|Withdrawal by Subject|2|||
44395608|NCT00963599|79401991|FG001|Overall Study|Withdrawal by Subject|1|||
44395609|NCT00963599|79401992|FG002|Overall Study|Withdrawal by Subject|3|||
44395610|NCT00963599|79401993|FG003|Overall Study|Withdrawal by Subject|3|||
44395611|NCT00619801|79402005|FG000|Overall Study|Lack of Efficacy|0|||
44395612|NCT00619801|79402006|FG001|Overall Study|Lack of Efficacy|1|||
44395613|NCT00619801|79402005|FG000|Overall Study|Withdrawal by Subject|1|||
44395614|NCT00619801|79402006|FG001|Overall Study|Withdrawal by Subject|1|||
44395615|NCT00619801|79402005|FG000|Overall Study|Loss of efficacy|0|||
44395616|NCT00619801|79402006|FG001|Overall Study|Loss of efficacy|1|||
44395617|NCT00962741|79402012|FG000|Overall Study|Failed to return|3|||
44395618|NCT00962741|79402012|FG000|Overall Study|Lost to Follow-up|2|||
44395619|NCT00962741|79402012|FG000|Overall Study|Withdrawal by Subject|1|||
44395620|NCT00962741|79402012|FG000|Overall Study|Lack of Efficacy|1|||
44395621|NCT00962741|79402012|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
44520735|NCT02921776|79528800|FG004|Overall Study|Lost to Follow-up|0|||
44520736|NCT02921776|79528801|FG005|Overall Study|Lost to Follow-up|2|||
44520737|NCT02921776|79528802|FG006|Overall Study|Lost to Follow-up|3|||
44252306|NCT02089997|79089315|FG000|Overall Study|Case report forms uncollected|99|||
44252307|NCT02089997|79089315|FG000|Overall Study|Protocol Violation|147|||
44252308|NCT01363661|79089321|FG000|Overall Study|Adverse Event|9|||
44252309|NCT01363661|79089322|FG001|Overall Study|Adverse Event|2|||
44520738|NCT02921776|79528803|FG007|Overall Study|Lost to Follow-up|6|||
44520739|NCT02922634|79528827|FG000|Overall Study|Withdrawal by Subject|5|||
44520740|NCT02922634|79528827|FG000|Overall Study|Did not have their surgery|5|||
44520741|NCT00023595|79528843|FG000|5 Year Follow up|Lost to Follow-up|2|||
44520742|NCT00023595|79528844|FG001|5 Year Follow up|Lost to Follow-up|2|||
44520743|NCT00023595|79528845|FG002|5 Year Follow up|Lost to Follow-up|1|||
44520744|NCT00023595|79528846|FG003|5 Year Follow up|Lost to Follow-up|7|||
44520745|NCT00023595|79528847|FG004|5 Year Follow up|Lost to Follow-up|3|||
44520746|NCT00023595|79528843|FG000|10 Year Follow up|Lost to Follow-up|12|||
44520747|NCT00023595|79528844|FG001|10 Year Follow up|Lost to Follow-up|10|||
44520748|NCT00023595|79528845|FG002|10 Year Follow up|Lost to Follow-up|3|||
44520749|NCT00023595|79528846|FG003|10 Year Follow up|Lost to Follow-up|0|||
44395622|NCT00619645|79402016|FG000|Overall Study|Adverse Event|1|||
44395623|NCT00619177|79402020|FG000|Overall Study|Adverse Event|18|||
44395624|NCT00619177|79402020|FG000|Overall Study|Lost to Follow-up|2|||
44520750|NCT00023595|79528847|FG004|10 Year Follow up|Lost to Follow-up|0|||
44520751|NCT02920528|79528873|FG000|Overall Study|Incomplete Data|1|||
44395625|NCT00619177|79402020|FG000|Overall Study|Lack of Efficacy|1|||
44395626|NCT00619177|79402020|FG000|Overall Study|Missing termination information|481|||
44395627|NCT00619177|79402020|FG000|Overall Study|Not specified reasons|6|||
44395628|NCT00818259|79402031|FG000|Part I|Withdrawal by Subject|1|||
44395629|NCT00818259|79402032|FG001|Part I|Withdrawal by Subject|0|||
44395630|NCT00818259|79402033|FG002|Part I|Withdrawal by Subject|0|||
44395631|NCT00818259|79402034|FG003|Part I|Withdrawal by Subject|0|||
44395632|NCT00818259|79402035|FG004|Part I|Withdrawal by Subject|0|||
44395633|NCT00818259|79402036|FG005|Part I|Withdrawal by Subject|0|||
44395634|NCT00818259|79402037|FG006|Part I|Withdrawal by Subject|0|||
44395635|NCT00818259|79402038|FG007|Part I|Withdrawal by Subject|0|||
44395636|NCT00818259|79402039|FG008|Part I|Withdrawal by Subject|0|||
44395637|NCT00818259|79402031|FG000|Part II|Physician Decision|0|||
44395638|NCT00818259|79402032|FG001|Part II|Physician Decision|0|||
44395639|NCT00818259|79402033|FG002|Part II|Physician Decision|1|||
44395640|NCT00818259|79402034|FG003|Part II|Physician Decision|0|||
44395641|NCT00818259|79402035|FG004|Part II|Physician Decision|0|||
44395642|NCT00818259|79402036|FG005|Part II|Physician Decision|0|||
44520752|NCT02920528|79528874|FG001|Overall Study|Incomplete Data|1|||
44520753|NCT02920528|79528875|FG002|Overall Study|Incomplete Data|1|||
44146974|NCT01670877|78936476|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
44146975|NCT01670877|78936477|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
44146976|NCT01670877|78936478|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
44146977|NCT01670877|78936479|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
44146978|NCT01670877|78936474|FG000|Part I and Part 2|Grade 2 vomiting|0|||
44146979|NCT01670877|78936475|FG001|Part I and Part 2|Grade 2 vomiting|0|||
44146980|NCT01670877|78936476|FG002|Part I and Part 2|Grade 2 vomiting|0|||
44146981|NCT01670877|78936477|FG003|Part I and Part 2|Grade 2 vomiting|1|||
44146982|NCT01670877|78936478|FG004|Part I and Part 2|Grade 2 vomiting|0|||
44146983|NCT01670877|78936479|FG005|Part I and Part 2|Grade 2 vomiting|0|||
44146984|NCT01670877|78936474|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
44146985|NCT01670877|78936475|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
44146986|NCT01670877|78936476|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
44146987|NCT01670877|78936477|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
44146988|NCT01670877|78936478|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
44146989|NCT01670877|78936479|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
44146990|NCT01670877|78936474|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
44146991|NCT01670877|78936475|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
44146992|NCT01670877|78936476|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
44146993|NCT01670877|78936477|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
44146994|NCT01670877|78936478|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
44146995|NCT01670877|78936479|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
44146996|NCT00701129|78936493|FG000|Overall Study|Death|2|||
44146997|NCT01670721|78936497|FG000|Overall Study|Participant's decision|15|||
44146998|NCT01670721|78936497|FG000|Overall Study|Other than specified above|38|||
44146999|NCT02711137|78936516|FG000|Overall Study|Death|1|||
44147000|NCT02711137|78936517|FG001|Overall Study|Death|4|||
44147001|NCT02711137|78936518|FG002|Overall Study|Death|5|||
44147002|NCT02711137|78936519|FG003|Overall Study|Death|5|||
44147003|NCT02711137|78936520|FG004|Overall Study|Death|3|||
44147004|NCT02711137|78936521|FG005|Overall Study|Death|1|||
44147005|NCT02711137|78936522|FG006|Overall Study|Death|61|||
44147006|NCT02711137|78936523|FG007|Overall Study|Death|3|||
44147007|NCT02711137|78936524|FG008|Overall Study|Death|0|||
44147008|NCT02711137|78936525|FG009|Overall Study|Death|1|||
44147009|NCT02711137|78936526|FG010|Overall Study|Death|1|||
44147010|NCT02711137|78936527|FG011|Overall Study|Death|1|||
44147011|NCT02711137|78936528|FG012|Overall Study|Death|0|||
44147012|NCT02711137|78936529|FG013|Overall Study|Death|0|||
44281223|NCT01972776|79244317|FG005|Part 1|Withdrawal by Subject|0|||
44520754|NCT02920528|79528873|FG000|Overall Study|Adverse Event|0|||
44520755|NCT02920528|79528874|FG001|Overall Study|Adverse Event|0|||
44520756|NCT02920528|79528875|FG002|Overall Study|Adverse Event|3|||
44520757|NCT02920528|79528873|FG000|Overall Study|Did not meet inclusion criteria|2|||
44520758|NCT02920528|79528874|FG001|Overall Study|Did not meet inclusion criteria|0|||
44147013|NCT02711137|78936530|FG014|Overall Study|Death|0|||
44147014|NCT02711137|78936516|FG000|Overall Study|Study Terminated by Sponsor|0|||
44147015|NCT02711137|78936517|FG001|Overall Study|Study Terminated by Sponsor|0|||
44281224|NCT01972776|79244312|FG000|Part 1|Adverse Event|0|||
44281225|NCT01972776|79244313|FG001|Part 1|Adverse Event|0|||
44281226|NCT01972776|79244314|FG002|Part 1|Adverse Event|1|||
44281227|NCT01972776|79244315|FG003|Part 1|Adverse Event|1|||
44395643|NCT00818259|79402037|FG006|Part II|Physician Decision|0|||
44395644|NCT00818259|79402038|FG007|Part II|Physician Decision|0|||
44395645|NCT00818259|79402039|FG008|Part II|Physician Decision|0|||
44520759|NCT02920528|79528875|FG002|Overall Study|Did not meet inclusion criteria|1|||
44395646|NCT00818259|79402031|FG000|Part II|Lack of Efficacy|0|||
44395647|NCT00818259|79402032|FG001|Part II|Lack of Efficacy|0|||
44395648|NCT00818259|79402033|FG002|Part II|Lack of Efficacy|0|||
44395649|NCT00818259|79402034|FG003|Part II|Lack of Efficacy|1|||
44395650|NCT00818259|79402035|FG004|Part II|Lack of Efficacy|0|||
44395651|NCT00818259|79402036|FG005|Part II|Lack of Efficacy|0|||
44147016|NCT02711137|78936518|FG002|Overall Study|Study Terminated by Sponsor|1|||
44395652|NCT00818259|79402037|FG006|Part II|Lack of Efficacy|0|||
44395653|NCT00818259|79402038|FG007|Part II|Lack of Efficacy|0|||
44395654|NCT00818259|79402039|FG008|Part II|Lack of Efficacy|0|||
44520760|NCT01068418|79528883|FG000|Overall Study|Physician Decision|12|||
44281228|NCT01972776|79244316|FG004|Part 1|Adverse Event|0|||
44281229|NCT01972776|79244317|FG005|Part 1|Adverse Event|0|||
44281230|NCT01972776|79244312|FG000|Part 2|Adverse Event|0|||
44281231|NCT01972776|79244313|FG001|Part 2|Adverse Event|0|||
44281232|NCT01972776|79244314|FG002|Part 2|Adverse Event|0|||
44281233|NCT01972776|79244315|FG003|Part 2|Adverse Event|0|||
44395655|NCT00818259|79402031|FG000|Part II|Not Treated|0|||
44520761|NCT01068262|79528891|FG000|Overall Study|Adverse Event|2|||
44520762|NCT01068262|79528892|FG001|Overall Study|Adverse Event|0|||
44147017|NCT02711137|78936519|FG003|Overall Study|Study Terminated by Sponsor|0|||
44147018|NCT02711137|78936520|FG004|Overall Study|Study Terminated by Sponsor|0|||
44147019|NCT02711137|78936521|FG005|Overall Study|Study Terminated by Sponsor|0|||
44147020|NCT02711137|78936522|FG006|Overall Study|Study Terminated by Sponsor|1|||
44147021|NCT02711137|78936523|FG007|Overall Study|Study Terminated by Sponsor|0|||
44147022|NCT02711137|78936524|FG008|Overall Study|Study Terminated by Sponsor|0|||
44520763|NCT01068262|79528893|FG002|Overall Study|Adverse Event|1|||
44520764|NCT01068262|79528894|FG003|Overall Study|Adverse Event|0|||
44520765|NCT01068262|79528891|FG000|Overall Study|Protocol Violation|1|||
44520766|NCT01068262|79528892|FG001|Overall Study|Protocol Violation|0|||
44520767|NCT01068262|79528893|FG002|Overall Study|Protocol Violation|0|||
44147023|NCT02711137|78936525|FG009|Overall Study|Study Terminated by Sponsor|0|||
44147024|NCT02711137|78936526|FG010|Overall Study|Study Terminated by Sponsor|0|||
44147025|NCT02711137|78936527|FG011|Overall Study|Study Terminated by Sponsor|0|||
44147026|NCT02711137|78936528|FG012|Overall Study|Study Terminated by Sponsor|0|||
44147027|NCT02711137|78936529|FG013|Overall Study|Study Terminated by Sponsor|0|||
44147028|NCT02711137|78936530|FG014|Overall Study|Study Terminated by Sponsor|0|||
44147029|NCT02711137|78936516|FG000|Overall Study|Physician Decision|1|||
44147030|NCT02711137|78936517|FG001|Overall Study|Physician Decision|0|||
44147031|NCT02711137|78936518|FG002|Overall Study|Physician Decision|2|||
44147032|NCT02711137|78936519|FG003|Overall Study|Physician Decision|1|||
44147033|NCT02711137|78936520|FG004|Overall Study|Physician Decision|1|||
44147034|NCT02711137|78936521|FG005|Overall Study|Physician Decision|0|||
44147035|NCT02711137|78936522|FG006|Overall Study|Physician Decision|12|||
44147036|NCT02711137|78936523|FG007|Overall Study|Physician Decision|2|||
44147037|NCT02711137|78936524|FG008|Overall Study|Physician Decision|1|||
44147038|NCT02711137|78936525|FG009|Overall Study|Physician Decision|1|||
44147039|NCT02711137|78936526|FG010|Overall Study|Physician Decision|3|||
44147040|NCT02711137|78936527|FG011|Overall Study|Physician Decision|2|||
44147041|NCT02711137|78936528|FG012|Overall Study|Physician Decision|1|||
44147042|NCT02711137|78936529|FG013|Overall Study|Physician Decision|1|||
44147043|NCT02711137|78936530|FG014|Overall Study|Physician Decision|2|||
44147044|NCT02711137|78936516|FG000|Overall Study|Other|0|||
44147045|NCT02711137|78936517|FG001|Overall Study|Other|1|||
44147046|NCT02711137|78936518|FG002|Overall Study|Other|0|||
44147047|NCT02711137|78936519|FG003|Overall Study|Other|0|||
44147048|NCT02711137|78936520|FG004|Overall Study|Other|0|||
44147049|NCT02711137|78936521|FG005|Overall Study|Other|0|||
44147050|NCT02711137|78936522|FG006|Overall Study|Other|3|||
44147051|NCT02711137|78936523|FG007|Overall Study|Other|0|||
44147052|NCT02711137|78936524|FG008|Overall Study|Other|0|||
44147053|NCT02711137|78936525|FG009|Overall Study|Other|0|||
44147054|NCT02711137|78936526|FG010|Overall Study|Other|0|||
44147055|NCT02711137|78936527|FG011|Overall Study|Other|0|||
44147056|NCT02711137|78936528|FG012|Overall Study|Other|0|||
44147057|NCT02711137|78936529|FG013|Overall Study|Other|0|||
44147058|NCT02711137|78936530|FG014|Overall Study|Other|1|||
44147059|NCT02711137|78936516|FG000|Overall Study|Withdrawal by Subject|1|||
44147060|NCT02711137|78936517|FG001|Overall Study|Withdrawal by Subject|0|||
44147061|NCT02711137|78936518|FG002|Overall Study|Withdrawal by Subject|0|||
44147062|NCT02711137|78936519|FG003|Overall Study|Withdrawal by Subject|1|||
44147063|NCT02711137|78936520|FG004|Overall Study|Withdrawal by Subject|1|||
44147064|NCT02711137|78936521|FG005|Overall Study|Withdrawal by Subject|0|||
44147065|NCT02711137|78936522|FG006|Overall Study|Withdrawal by Subject|7|||
44147066|NCT02711137|78936523|FG007|Overall Study|Withdrawal by Subject|0|||
44520768|NCT01068262|79528894|FG003|Overall Study|Protocol Violation|0|||
44520769|NCT01068262|79528891|FG000|Overall Study|Withdrawal by Subject|0|||
44147067|NCT02711137|78936524|FG008|Overall Study|Withdrawal by Subject|0|||
44147068|NCT02711137|78936525|FG009|Overall Study|Withdrawal by Subject|0|||
44281234|NCT01972776|79244316|FG004|Part 2|Adverse Event|3|||
44395656|NCT00818259|79402032|FG001|Part II|Not Treated|0|||
44395657|NCT00818259|79402033|FG002|Part II|Not Treated|0|||
44520770|NCT01068262|79528892|FG001|Overall Study|Withdrawal by Subject|1|||
44147069|NCT02711137|78936526|FG010|Overall Study|Withdrawal by Subject|0|||
44147070|NCT02711137|78936527|FG011|Overall Study|Withdrawal by Subject|0|||
44147071|NCT02711137|78936528|FG012|Overall Study|Withdrawal by Subject|0|||
44147072|NCT02711137|78936529|FG013|Overall Study|Withdrawal by Subject|1|||
44147073|NCT02711137|78936530|FG014|Overall Study|Withdrawal by Subject|0|||
44147074|NCT02711137|78936516|FG000|Overall Study|Lost to Follow-up|1|||
44147075|NCT02711137|78936517|FG001|Overall Study|Lost to Follow-up|0|||
44147076|NCT02711137|78936518|FG002|Overall Study|Lost to Follow-up|0|||
44147077|NCT02711137|78936519|FG003|Overall Study|Lost to Follow-up|0|||
44147078|NCT02711137|78936520|FG004|Overall Study|Lost to Follow-up|0|||
44147079|NCT02711137|78936521|FG005|Overall Study|Lost to Follow-up|0|||
44147080|NCT02711137|78936522|FG006|Overall Study|Lost to Follow-up|2|||
44147081|NCT02711137|78936523|FG007|Overall Study|Lost to Follow-up|0|||
44147082|NCT02711137|78936524|FG008|Overall Study|Lost to Follow-up|0|||
44147083|NCT02711137|78936525|FG009|Overall Study|Lost to Follow-up|0|||
44147084|NCT02711137|78936526|FG010|Overall Study|Lost to Follow-up|0|||
44147085|NCT02711137|78936527|FG011|Overall Study|Lost to Follow-up|0|||
44147086|NCT02711137|78936528|FG012|Overall Study|Lost to Follow-up|0|||
44147087|NCT02711137|78936529|FG013|Overall Study|Lost to Follow-up|0|||
44147088|NCT02711137|78936530|FG014|Overall Study|Lost to Follow-up|0|||
44147089|NCT02710045|78936570|FG000|Overall Study|Death|1|||
44147090|NCT02710045|78936571|FG001|Overall Study|Death|2|||
44147091|NCT02710045|78936572|FG002|Overall Study|Death|0|||
44147092|NCT02710045|78936570|FG000|Overall Study|Withdrawal by Subject|6|||
44147093|NCT02710045|78936571|FG001|Overall Study|Withdrawal by Subject|6|||
44147094|NCT02710045|78936572|FG002|Overall Study|Withdrawal by Subject|2|||
44147095|NCT02710045|78936570|FG000|Overall Study|Protocol Violation|1|||
44147096|NCT02710045|78936571|FG001|Overall Study|Protocol Violation|2|||
44147097|NCT02710045|78936572|FG002|Overall Study|Protocol Violation|3|||
44147098|NCT02710045|78936570|FG000|Overall Study|Lost to Follow-up|3|||
44147099|NCT02710045|78936571|FG001|Overall Study|Lost to Follow-up|6|||
44147100|NCT02710045|78936572|FG002|Overall Study|Lost to Follow-up|7|||
44147101|NCT02710045|78936570|FG000|Overall Study|Physician Decision|0|||
44252310|NCT01363661|79089321|FG000|Overall Study|Withdrawal by Subject|1|||
44252311|NCT01363661|79089322|FG001|Overall Study|Withdrawal by Subject|1|||
44252312|NCT01363661|79089321|FG000|Overall Study|Protocol Violation|1|||
44252313|NCT01363661|79089322|FG001|Overall Study|Protocol Violation|0|||
44395658|NCT00818259|79402034|FG003|Part II|Not Treated|1|||
44395659|NCT00818259|79402035|FG004|Part II|Not Treated|0|||
44395660|NCT00818259|79402036|FG005|Part II|Not Treated|0|||
44252314|NCT01363661|79089321|FG000|Overall Study|Lost to Follow-up|3|||
44395661|NCT00818259|79402037|FG006|Part II|Not Treated|0|||
44395662|NCT00818259|79402038|FG007|Part II|Not Treated|0|||
44395663|NCT00818259|79402039|FG008|Part II|Not Treated|0|||
44395664|NCT00818259|79402031|FG000|Part IV|Physician Decision|0|||
44395665|NCT00818259|79402032|FG001|Part IV|Physician Decision|0|||
44395666|NCT00818259|79402033|FG002|Part IV|Physician Decision|0|||
44395667|NCT00818259|79402034|FG003|Part IV|Physician Decision|0|||
44395668|NCT00818259|79402035|FG004|Part IV|Physician Decision|0|||
44395669|NCT00818259|79402036|FG005|Part IV|Physician Decision|1|||
44395670|NCT00818259|79402037|FG006|Part IV|Physician Decision|0|||
44395671|NCT00818259|79402038|FG007|Part IV|Physician Decision|0|||
44395672|NCT00818259|79402039|FG008|Part IV|Physician Decision|0|||
44395673|NCT00818259|79402031|FG000|Part V|Adverse Event|0|||
44395674|NCT00818259|79402032|FG001|Part V|Adverse Event|0|||
44395675|NCT00818259|79402033|FG002|Part V|Adverse Event|0|||
44395676|NCT00818259|79402034|FG003|Part V|Adverse Event|0|||
44395677|NCT00818259|79402035|FG004|Part V|Adverse Event|0|||
44395678|NCT00818259|79402036|FG005|Part V|Adverse Event|0|||
44395679|NCT00818259|79402037|FG006|Part V|Adverse Event|0|||
44252315|NCT01363661|79089322|FG001|Overall Study|Lost to Follow-up|1|||
44395680|NCT00818259|79402038|FG007|Part V|Adverse Event|1|||
44395681|NCT00818259|79402039|FG008|Part V|Adverse Event|0|||
44395682|NCT00619099|79402057|FG000|Overall Study|Progressive Disease|7|||
44395683|NCT00619099|79402058|FG001|Overall Study|Progressive Disease|5|||
44395684|NCT00619099|79402057|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
44395685|NCT00619099|79402058|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
44395686|NCT00619099|79402057|FG000|Overall Study|Adverse Event|4|||
44395687|NCT00619099|79402058|FG001|Overall Study|Adverse Event|3|||
44395688|NCT00619099|79402057|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
44395689|NCT00619099|79402058|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
44395690|NCT00619099|79402057|FG000|Overall Study|Withdrawal by Subject|10|||
44395691|NCT00619099|79402058|FG001|Overall Study|Withdrawal by Subject|2|||
44395692|NCT00619099|79402057|FG000|Overall Study|Physician Decision|9|||
44147102|NCT02710045|78936571|FG001|Overall Study|Physician Decision|0|||
44147103|NCT02710045|78936572|FG002|Overall Study|Physician Decision|1|||
44147104|NCT02710045|78936570|FG000|Overall Study|Poor Attendance|0|||
44147105|NCT02710045|78936571|FG001|Overall Study|Poor Attendance|1|||
44147106|NCT02710045|78936572|FG002|Overall Study|Poor Attendance|0|||
44147107|NCT02714153|78936580|FG000|Overall Study|Death|1|||
44395693|NCT00619099|79402058|FG001|Overall Study|Physician Decision|6|||
44395694|NCT00962585|79402068|FG000|Overall Study|Adverse Event|0|||
44395695|NCT00962585|79402069|FG001|Overall Study|Adverse Event|2|||
44395696|NCT00962585|79402070|FG002|Overall Study|Adverse Event|1|||
44395697|NCT00962585|79402071|FG003|Overall Study|Adverse Event|0|||
44395698|NCT00962585|79402068|FG000|Overall Study|Lost to Follow-up|3|||
44395699|NCT00962585|79402069|FG001|Overall Study|Lost to Follow-up|0|||
44395700|NCT00962585|79402070|FG002|Overall Study|Lost to Follow-up|1|||
44395701|NCT00962585|79402071|FG003|Overall Study|Lost to Follow-up|0|||
44395702|NCT00962585|79402068|FG000|Overall Study|Protocol Violation|0|||
44395703|NCT00962585|79402069|FG001|Overall Study|Protocol Violation|0|||
44395704|NCT00962585|79402070|FG002|Overall Study|Protocol Violation|1|||
44395705|NCT00962585|79402071|FG003|Overall Study|Protocol Violation|0|||
44395706|NCT00962585|79402068|FG000|Overall Study|Withdrawal by Subject|1|||
44395707|NCT00962585|79402069|FG001|Overall Study|Withdrawal by Subject|0|||
44395708|NCT00962585|79402070|FG002|Overall Study|Withdrawal by Subject|0|||
44395709|NCT00962585|79402071|FG003|Overall Study|Withdrawal by Subject|0|||
44395710|NCT00962585|79402068|FG000|Overall Study|Withdrew Consent|2|||
44395711|NCT00962585|79402069|FG001|Overall Study|Withdrew Consent|0|||
44395712|NCT00962585|79402070|FG002|Overall Study|Withdrew Consent|0|||
44395713|NCT00962585|79402071|FG003|Overall Study|Withdrew Consent|0|||
44395714|NCT00621985|79402083|FG000|Dexamethasone Admission|Adverse Event|1|||
44395715|NCT00961259|79402093|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
44395716|NCT00961259|79402094|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
44395717|NCT00961259|79402095|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
44395718|NCT00961181|79402104|FG000|Overall Study|Death|2|||
44395719|NCT00961181|79402104|FG000|Overall Study|Withdrawal by Subject|2|||
44395720|NCT00961181|79402104|FG000|Overall Study|Lost to Follow-up|1|||
44395721|NCT00817635|79402113|FG000|Overall Study|Adverse Event|1|||
44395722|NCT00817635|79402114|FG001|Overall Study|Adverse Event|0|||
44395723|NCT00817635|79402115|FG002|Overall Study|Adverse Event|0|||
44395724|NCT00817635|79402116|FG003|Overall Study|Adverse Event|1|||
44395725|NCT00817635|79402117|FG004|Overall Study|Adverse Event|1|||
44395726|NCT00817635|79402113|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
44395727|NCT00817635|79402114|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
44395728|NCT00817635|79402115|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
44395729|NCT00817635|79402116|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
44395730|NCT00817635|79402117|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
44395731|NCT00817635|79402113|FG000|Overall Study|Withdrawal by Subject|2|||
44395732|NCT00817635|79402114|FG001|Overall Study|Withdrawal by Subject|1|||
44395733|NCT00817635|79402115|FG002|Overall Study|Withdrawal by Subject|0|||
44395734|NCT00817635|79402116|FG003|Overall Study|Withdrawal by Subject|1|||
44395735|NCT00817635|79402117|FG004|Overall Study|Withdrawal by Subject|2|||
44395736|NCT00817635|79402113|FG000|Overall Study|Lost to Follow-up|0|||
44395737|NCT00817635|79402114|FG001|Overall Study|Lost to Follow-up|1|||
44395738|NCT00817635|79402115|FG002|Overall Study|Lost to Follow-up|0|||
44395739|NCT00817635|79402116|FG003|Overall Study|Lost to Follow-up|1|||
44395740|NCT00817635|79402117|FG004|Overall Study|Lost to Follow-up|0|||
44395741|NCT00817635|79402113|FG000|Overall Study|Administrative Problems|0|||
44395742|NCT00817635|79402114|FG001|Overall Study|Administrative Problems|0|||
44395743|NCT00817635|79402115|FG002|Overall Study|Administrative Problems|0|||
44395744|NCT00817635|79402116|FG003|Overall Study|Administrative Problems|0|||
44395745|NCT00817635|79402117|FG004|Overall Study|Administrative Problems|1|||
44281235|NCT01972776|79244317|FG005|Part 2|Adverse Event|0|||
44281236|NCT01972776|79244312|FG000|Part 2|Administrative problems|0|||
44281237|NCT01972776|79244313|FG001|Part 2|Administrative problems|0|||
44281238|NCT01972776|79244314|FG002|Part 2|Administrative problems|0|||
44281239|NCT01972776|79244315|FG003|Part 2|Administrative problems|0|||
44281240|NCT01972776|79244316|FG004|Part 2|Administrative problems|10|||
44281241|NCT01972776|79244317|FG005|Part 2|Administrative problems|7|||
44281242|NCT03763331|79244333|FG000|Overall Study|Lost to Follow-up|1|||
44281243|NCT03763331|79244334|FG001|Overall Study|Lost to Follow-up|0|||
44281244|NCT03763331|79244333|FG000|Overall Study|Withdrawal by Subject|1|||
44281245|NCT03763331|79244334|FG001|Overall Study|Withdrawal by Subject|0|||
44281246|NCT03763331|79244333|FG000|Overall Study|Non-compliance|0|||
44281247|NCT03763331|79244334|FG001|Overall Study|Non-compliance|3|||
44281248|NCT00001259|79244361|FG000|Study 2|Adverse Event|0|||
44281249|NCT00001259|79244362|FG001|Study 2|Adverse Event|0|||
44395746|NCT00817635|79402113|FG000|Overall Study|Protocol Violation|5|||
44395747|NCT00817635|79402114|FG001|Overall Study|Protocol Violation|1|||
44395748|NCT00817635|79402115|FG002|Overall Study|Protocol Violation|3|||
44395749|NCT00817635|79402116|FG003|Overall Study|Protocol Violation|2|||
44395750|NCT00817635|79402117|FG004|Overall Study|Protocol Violation|3|||
44395751|NCT00817479|79402138|FG000|Overall Study|Physician Decision|1|||
44395752|NCT00817479|79402139|FG001|Overall Study|Physician Decision|1|||
44395753|NCT00961961|79402149|FG000|Phase I|Withdrawal by Subject|7|||
44281250|NCT00001259|79244363|FG002|Study 2|Adverse Event|0|||
44281251|NCT00001259|79244364|FG003|Study 2|Adverse Event|0|||
44281252|NCT00001259|79244365|FG004|Study 2|Adverse Event|2|||
44281253|NCT00001259|79244366|FG005|Study 2|Adverse Event|0|||
44281254|NCT00001259|79244367|FG006|Study 2|Adverse Event|0|||
44281255|NCT01926444|79244381|FG000|Overall Study|Colonoscopy not performed|0|||
44281256|NCT01926444|79244382|FG001|Overall Study|Colonoscopy not performed|0|||
44281257|NCT01926444|79244383|FG002|Overall Study|Colonoscopy not performed|4|||
44281258|NCT01926444|79244384|FG003|Overall Study|Colonoscopy not performed|2|||
44281259|NCT05003167|79244394|FG000|Overall Study|Withdrawal by Subject|1|||
44281260|NCT04988035|79244400|FG000|Overall Study|Death|19|||
44281261|NCT04988035|79244401|FG001|Overall Study|Death|13|||
44281262|NCT04988035|79244400|FG000|Overall Study|Lost to Follow-up|12|||
44281263|NCT04988035|79244401|FG001|Overall Study|Lost to Follow-up|6|||
44281264|NCT04988035|79244400|FG000|Overall Study|Protocol Violation|0|||
44281265|NCT04988035|79244401|FG001|Overall Study|Protocol Violation|1|||
44281266|NCT04988035|79244400|FG000|Overall Study|Withdrawal by Subject|2|||
44281267|NCT04988035|79244401|FG001|Overall Study|Withdrawal by Subject|4|||
44281268|NCT04988035|79244400|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
44281269|NCT04988035|79244401|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
44281270|NCT04847674|79244419|FG000|Overall Study|Withdrawal by Subject|0|||
44281271|NCT04847674|79244420|FG001|Overall Study|Withdrawal by Subject|1|||
44281272|NCT04847674|79244421|FG002|Overall Study|Withdrawal by Subject|0|||
44281273|NCT04847674|79244419|FG000|Overall Study|Lost to Follow-up|0|||
44281274|NCT04847674|79244420|FG001|Overall Study|Lost to Follow-up|0|||
44281275|NCT04847674|79244421|FG002|Overall Study|Lost to Follow-up|2|||
44281276|NCT04847674|79244419|FG000|Overall Study|Other than specified|21|||
44281277|NCT04847674|79244420|FG001|Overall Study|Other than specified|20|||
44281278|NCT04847674|79244421|FG002|Overall Study|Other than specified|20|||
44281279|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
44281280|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
44281281|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
44281282|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
44281283|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
44147108|NCT04369469|78936586|FG000|Overall Study|Lost to Follow-up|2|||
44147109|NCT04369469|78936587|FG001|Overall Study|Lost to Follow-up|4|||
44395754|NCT00961961|79402150|FG001|Phase I|Withdrawal by Subject|0|||
44395755|NCT00961961|79402151|FG002|Phase I|Withdrawal by Subject|0|||
44395756|NCT00961961|79402152|FG003|Phase I|Withdrawal by Subject|0|||
44395757|NCT00961961|79402149|FG000|Phase I|Lost to Follow-up|10|||
44520771|NCT01068262|79528893|FG002|Overall Study|Withdrawal by Subject|0|||
44520772|NCT01068262|79528894|FG003|Overall Study|Withdrawal by Subject|0|||
44520773|NCT02920450|79528907|FG000|Overall Study|Death|1|||
44520774|NCT02920450|79528908|FG001|Overall Study|Death|0|||
44520775|NCT02920450|79528909|FG002|Overall Study|Death|0|||
44520776|NCT02920450|79528910|FG003|Overall Study|Death|0|||
44520777|NCT02920450|79528907|FG000|Overall Study|Withdrawal by Subject|1|||
44520778|NCT02920450|79528908|FG001|Overall Study|Withdrawal by Subject|0|||
44520779|NCT02920450|79528909|FG002|Overall Study|Withdrawal by Subject|0|||
44520780|NCT02920450|79528910|FG003|Overall Study|Withdrawal by Subject|0|||
44520781|NCT01066936|79528921|FG000|Overall Study|Death|2|||
44520782|NCT01066936|79528921|FG000|Overall Study|Device revised/removed|1|||
44520783|NCT01066936|79528921|FG000|Overall Study|Lost to Follow-up|3|||
44520784|NCT01066936|79528921|FG000|Overall Study|Withdrawal by Subject|4|||
44395758|NCT00961961|79402150|FG001|Phase I|Lost to Follow-up|0|||
44395759|NCT00961961|79402151|FG002|Phase I|Lost to Follow-up|0|||
44395760|NCT00961961|79402152|FG003|Phase I|Lost to Follow-up|0|||
44395761|NCT00961961|79402149|FG000|Phase I|Lack of Efficacy|94|||
44395762|NCT00961961|79402150|FG001|Phase I|Lack of Efficacy|0|||
44395763|NCT00961961|79402151|FG002|Phase I|Lack of Efficacy|0|||
44395764|NCT00961961|79402152|FG003|Phase I|Lack of Efficacy|0|||
44147110|NCT04369469|78936586|FG000|Overall Study|Physician Decision|2|||
44147111|NCT04369469|78936587|FG001|Overall Study|Physician Decision|1|||
44147112|NCT04369469|78936586|FG000|Overall Study|Withdrawal by Subject|2|||
44147113|NCT04369469|78936587|FG001|Overall Study|Withdrawal by Subject|3|||
44147114|NCT04369469|78936586|FG000|Overall Study|Adverse Event|1|||
44395765|NCT00961961|79402149|FG000|Phase I|Adverse Event|7|||
44395766|NCT00961961|79402150|FG001|Phase I|Adverse Event|0|||
44395767|NCT00961961|79402151|FG002|Phase I|Adverse Event|0|||
44395768|NCT00961961|79402152|FG003|Phase I|Adverse Event|0|||
44395769|NCT00961961|79402149|FG000|Phase I|Physician Decision|8|||
44395770|NCT00961961|79402150|FG001|Phase I|Physician Decision|0|||
44395771|NCT00961961|79402151|FG002|Phase I|Physician Decision|0|||
44520785|NCT02919436|79528929|FG000|Overall Study|Did not undergo surgery|16|||
44520786|NCT02919436|79528930|FG001|Overall Study|Did not undergo surgery|20|||
44281284|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
44281285|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
44281286|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
44281287|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Patient Request|1|||
44281288|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Patient Request|0|||
44395772|NCT00961961|79402152|FG003|Phase I|Physician Decision|0|||
44395773|NCT00961961|79402149|FG000|Phase II|Lost to Follow-up|0|||
44395774|NCT00961961|79402150|FG001|Phase II|Lost to Follow-up|0|||
44395775|NCT00961961|79402151|FG002|Phase II|Lost to Follow-up|10|||
44395776|NCT00961961|79402152|FG003|Phase II|Lost to Follow-up|7|||
44395777|NCT00961961|79402149|FG000|Phase II|Adverse Event|0|||
44395778|NCT00961961|79402150|FG001|Phase II|Adverse Event|0|||
44395779|NCT00961961|79402151|FG002|Phase II|Adverse Event|0|||
44395780|NCT00961961|79402152|FG003|Phase II|Adverse Event|1|||
44395781|NCT00961961|79402149|FG000|Phase II|Physician Decision|0|||
44395782|NCT00961961|79402150|FG001|Phase II|Physician Decision|0|||
44395783|NCT00961961|79402151|FG002|Phase II|Physician Decision|1|||
44395784|NCT00961961|79402152|FG003|Phase II|Physician Decision|0|||
44395785|NCT00961961|79402149|FG000|Phase II|Withdrawal by Subject|0|||
44395786|NCT00961961|79402150|FG001|Phase II|Withdrawal by Subject|0|||
44395787|NCT00961961|79402151|FG002|Phase II|Withdrawal by Subject|1|||
44395788|NCT00961961|79402152|FG003|Phase II|Withdrawal by Subject|0|||
44395789|NCT00817089|79402176|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
44395790|NCT00817089|79402177|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
44395791|NCT00817089|79402178|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
44395792|NCT00817089|79402179|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
44395793|NCT00817089|79402176|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
44395794|NCT00817089|79402177|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
44395795|NCT00817089|79402178|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
44395796|NCT00817089|79402179|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
44395797|NCT00815919|79402193|FG000|Overall Study|Unrelated Fungal Infection|1|||
44395798|NCT00815919|79402193|FG000|Overall Study|AML Relapse|1|||
44395799|NCT00815919|79402193|FG000|Overall Study|Lack of Efficacy|2|||
44395800|NCT00957905|79402199|FG000|Part B|Not Treated|0|||
44395801|NCT00957905|79402200|FG001|Part B|Not Treated|1|||
44395802|NCT00957905|79402199|FG000|Part B|Physician Decision|0|||
44395803|NCT00957905|79402200|FG001|Part B|Physician Decision|1|||
44395804|NCT00957905|79402199|FG000|Part B|Death|0|||
44395805|NCT00957905|79402200|FG001|Part B|Death|1|||
44395806|NCT00957905|79402199|FG000|Part B|Protocol Violation|0|||
44395807|NCT00957905|79402200|FG001|Part B|Protocol Violation|1|||
44395808|NCT00960323|79402206|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
44395809|NCT00617929|79402214|FG000|Overall Study|Physician Decision|1|||
44395810|NCT00815295|79402221|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
44395811|NCT00815295|79402222|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
44395812|NCT00815295|79402223|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
44395813|NCT00814983|79402233|FG000|Overall Study|Screen failure|1|||
44395814|NCT00814983|79402234|FG001|Overall Study|Screen failure|0|||
44395815|NCT00814983|79402233|FG000|Overall Study|Withdrawal by Subject|1|||
44395816|NCT00814983|79402234|FG001|Overall Study|Withdrawal by Subject|0|||
44395817|NCT00814983|79402233|FG000|Overall Study|Graft failure|1|||
44395818|NCT00814983|79402234|FG001|Overall Study|Graft failure|0|||
44395819|NCT00960869|79402242|FG000|Overall Study|Adverse Event|17|||
44395820|NCT00960869|79402243|FG001|Overall Study|Adverse Event|26|||
44395821|NCT00960869|79402242|FG000|Overall Study|Withdrawal by Subject|16|||
44395822|NCT00960869|79402243|FG001|Overall Study|Withdrawal by Subject|14|||
44395823|NCT00960869|79402242|FG000|Overall Study|Lost to Follow-up|1|||
44395824|NCT00960869|79402243|FG001|Overall Study|Lost to Follow-up|4|||
44395825|NCT00960869|79402242|FG000|Overall Study|Misc|19|||
44395826|NCT00960869|79402243|FG001|Overall Study|Misc|18|||
44395827|NCT00618787|79402251|FG000|Overall Study|Adverse Event|0|||
44395828|NCT00618787|79402252|FG001|Overall Study|Adverse Event|1|||
44395829|NCT00618787|79402251|FG000|Overall Study|Withdrawal by Subject|2|||
44395830|NCT00618787|79402252|FG001|Overall Study|Withdrawal by Subject|1|||
44395831|NCT00618787|79402251|FG000|Overall Study|Lost to Follow-up|1|||
44395832|NCT00618787|79402252|FG001|Overall Study|Lost to Follow-up|0|||
44395833|NCT00813813|79402260|FG000|Overall Study|Withdrawal by Subject|1|||
44395834|NCT00813813|79402261|FG001|Overall Study|Withdrawal by Subject|1|||
44520787|NCT02919436|79528929|FG000|Overall Study|Enrolled before trial registration|44|||
44520788|NCT02919436|79528930|FG001|Overall Study|Enrolled before trial registration|33|||
44520789|NCT03804879|79528940|FG000|Overall Study|Adverse Event|3|||
44520790|NCT03804879|79528941|FG001|Overall Study|Adverse Event|0|||
44520791|NCT03804879|79528940|FG000|Overall Study|Study Terminated By Sponsor|10|||
44252316|NCT02628600|79089330|FG000|Overall Study|Death|2|||
44395835|NCT00813813|79402260|FG000|Overall Study|Lost to Follow-up|2|||
44395836|NCT00813813|79402261|FG001|Overall Study|Lost to Follow-up|7|||
44395837|NCT00813813|79402260|FG000|Overall Study|Other|0|||
44395838|NCT00813813|79402261|FG001|Overall Study|Other|1|||
44395839|NCT05317312|79402271|FG000|Overall Study|Withdrawal by Subject|0|||
44395840|NCT05317312|79402272|FG001|Overall Study|Withdrawal by Subject|1|||
44395841|NCT05317312|79402273|FG002|Overall Study|Withdrawal by Subject|0|||
44395842|NCT05317312|79402274|FG003|Overall Study|Withdrawal by Subject|0|||
44395843|NCT05317312|79402271|FG000|Overall Study|Lost to Follow-up|0|||
44395844|NCT05317312|79402272|FG001|Overall Study|Lost to Follow-up|0|||
44520792|NCT03804879|79528941|FG001|Overall Study|Study Terminated By Sponsor|12|||
44520793|NCT03804879|79528940|FG000|Overall Study|Withdrawal by Subject|3|||
44395845|NCT05317312|79402273|FG002|Overall Study|Lost to Follow-up|0|||
44395846|NCT05317312|79402274|FG003|Overall Study|Lost to Follow-up|1|||
44395847|NCT05317312|79402271|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
44395848|NCT05317312|79402272|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
44395849|NCT05317312|79402273|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
44395850|NCT05317312|79402274|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
44395851|NCT04644315|79402284|FG000|Overall Study|Subject withdrawal of consent|1|||
44395852|NCT04410523|79402294|FG000|Overall Study|Study terminated by sponsor|1|||
44395853|NCT04410523|79402295|FG001|Overall Study|Study terminated by sponsor|3|||
44395854|NCT04410523|79402296|FG002|Overall Study|Study terminated by sponsor|2|||
44395855|NCT04410523|79402297|FG003|Overall Study|Study terminated by sponsor|6|||
44395856|NCT04410523|79402298|FG004|Overall Study|Study terminated by sponsor|3|||
44395857|NCT04410523|79402299|FG005|Overall Study|Study terminated by sponsor|4|||
44395858|NCT04410523|79402294|FG000|Overall Study|Adverse Event|1|||
44395859|NCT04410523|79402295|FG001|Overall Study|Adverse Event|0|||
44395860|NCT04410523|79402296|FG002|Overall Study|Adverse Event|0|||
44395861|NCT04410523|79402297|FG003|Overall Study|Adverse Event|0|||
44395862|NCT04410523|79402298|FG004|Overall Study|Adverse Event|0|||
44395863|NCT04410523|79402299|FG005|Overall Study|Adverse Event|2|||
44395864|NCT04410523|79402294|FG000|Overall Study|Lost to Follow-up|0|||
44395865|NCT04410523|79402295|FG001|Overall Study|Lost to Follow-up|1|||
44395866|NCT04410523|79402296|FG002|Overall Study|Lost to Follow-up|0|||
44395867|NCT04410523|79402297|FG003|Overall Study|Lost to Follow-up|0|||
44395868|NCT04410523|79402298|FG004|Overall Study|Lost to Follow-up|0|||
44395869|NCT04410523|79402299|FG005|Overall Study|Lost to Follow-up|0|||
44395870|NCT04410523|79402294|FG000|Overall Study|Physician Decision|0|||
44395871|NCT04410523|79402295|FG001|Overall Study|Physician Decision|1|||
44395872|NCT04410523|79402296|FG002|Overall Study|Physician Decision|0|||
44395873|NCT04410523|79402297|FG003|Overall Study|Physician Decision|0|||
44395874|NCT04410523|79402298|FG004|Overall Study|Physician Decision|0|||
44395875|NCT04410523|79402299|FG005|Overall Study|Physician Decision|0|||
44395876|NCT04410523|79402294|FG000|Overall Study|Pregnancy|0|||
44395877|NCT04410523|79402295|FG001|Overall Study|Pregnancy|0|||
44395878|NCT04410523|79402296|FG002|Overall Study|Pregnancy|0|||
44395879|NCT04410523|79402297|FG003|Overall Study|Pregnancy|0|||
44395880|NCT04410523|79402298|FG004|Overall Study|Pregnancy|0|||
44395881|NCT04410523|79402299|FG005|Overall Study|Pregnancy|1|||
44395882|NCT04410523|79402294|FG000|Overall Study|Protocol deviation|0|||
44395883|NCT04410523|79402295|FG001|Overall Study|Protocol deviation|0|||
44395884|NCT04410523|79402296|FG002|Overall Study|Protocol deviation|0|||
44395885|NCT04410523|79402297|FG003|Overall Study|Protocol deviation|0|||
44395886|NCT04410523|79402298|FG004|Overall Study|Protocol deviation|0|||
44395887|NCT04410523|79402299|FG005|Overall Study|Protocol deviation|2|||
44395888|NCT04410523|79402294|FG000|Overall Study|Subject decision|2|||
44395889|NCT04410523|79402295|FG001|Overall Study|Subject decision|0|||
44395890|NCT04410523|79402296|FG002|Overall Study|Subject decision|0|||
44395891|NCT04410523|79402297|FG003|Overall Study|Subject decision|1|||
44395892|NCT04410523|79402298|FG004|Overall Study|Subject decision|0|||
44395893|NCT04410523|79402299|FG005|Overall Study|Subject decision|1|||
44395894|NCT03889418|79402338|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
44395895|NCT03889418|79402339|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395896|NCT03889418|79402340|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44147115|NCT04369469|78936587|FG001|Overall Study|Adverse Event|0|||
44281289|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
44281290|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
44281291|NCT04649060|79244433|FG000|Arm A/Arm B Treatment|Other|1|||
44281292|NCT04649060|79244434|FG001|Arm A/Arm B Treatment|Other|0|||
44281293|NCT04649060|79244433|FG000|Crossover (Arm B)|Adverse Event|0|||
44281294|NCT04649060|79244434|FG001|Crossover (Arm B)|Adverse Event|1|||
44281295|NCT04649060|79244433|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
44281296|NCT04649060|79244434|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
44281297|NCT04640272|79244441|FG000|Overall Study|Subject moved out of area|1|||
44281298|NCT04511650|79244448|FG000|Overall Study|Lost to Follow-up|1|||
44281299|NCT04511650|79244449|FG001|Overall Study|Lost to Follow-up|0|||
44281300|NCT04511650|79244450|FG002|Overall Study|Lost to Follow-up|0|||
44281301|NCT04511650|79244448|FG000|Overall Study|Withdrawal by Subject|1|||
44281302|NCT04511650|79244449|FG001|Overall Study|Withdrawal by Subject|0|||
44281303|NCT04511650|79244450|FG002|Overall Study|Withdrawal by Subject|0|||
44281304|NCT04511650|79244448|FG000|Overall Study|reason not provided|0|||
44281305|NCT04511650|79244449|FG001|Overall Study|reason not provided|0|||
44281306|NCT04511650|79244450|FG002|Overall Study|reason not provided|1|||
44281307|NCT04511650|79244448|FG000|Overall Study|Death|1|||
44281308|NCT04511650|79244449|FG001|Overall Study|Death|1|||
44281309|NCT04511650|79244450|FG002|Overall Study|Death|1|||
44281310|NCT04285580|79244469|FG000|Overall Study|Protocol Violation|0|||
44395897|NCT03889418|79402341|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44281311|NCT04285580|79244470|FG001|Overall Study|Protocol Violation|1|||
44281312|NCT04200248|79244488|FG000|Overall Study|Personal reasons|0|||
44395898|NCT03889418|79402342|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395899|NCT03889418|79402343|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395900|NCT03889418|79402344|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395901|NCT03889418|79402345|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395902|NCT03889418|79402346|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395903|NCT03889418|79402347|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
44395904|NCT03889418|79402338|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395905|NCT03889418|79402339|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
44395906|NCT03889418|79402340|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
44395907|NCT03889418|79402341|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395908|NCT03889418|79402342|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395909|NCT03889418|79402343|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395910|NCT03889418|79402344|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44281313|NCT04200248|79244489|FG001|Overall Study|Personal reasons|0|||
44281314|NCT04200248|79244490|FG002|Overall Study|Personal reasons|1|||
44281315|NCT04200248|79244488|FG000|Overall Study|Discontinued prior to treatment|3|||
44281316|NCT04200248|79244489|FG001|Overall Study|Discontinued prior to treatment|3|||
44281317|NCT04200248|79244490|FG002|Overall Study|Discontinued prior to treatment|2|||
44281318|NCT04137887|79244500|FG000|Overall Study|Death|102|||
44281319|NCT04137887|79244501|FG001|Overall Study|Death|92|||
44395911|NCT03889418|79402345|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395912|NCT03889418|79402346|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395913|NCT03889418|79402347|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
44395914|NCT03889418|79402338|FG000|October-December 2019 (Month 7-9)|Death|0|||
44395915|NCT03889418|79402339|FG001|October-December 2019 (Month 7-9)|Death|0|||
44395916|NCT03889418|79402340|FG002|October-December 2019 (Month 7-9)|Death|0|||
44395917|NCT03889418|79402341|FG003|October-December 2019 (Month 7-9)|Death|0|||
44395918|NCT03889418|79402342|FG004|October-December 2019 (Month 7-9)|Death|0|||
44395919|NCT03889418|79402343|FG005|October-December 2019 (Month 7-9)|Death|0|||
44395920|NCT03889418|79402344|FG006|October-December 2019 (Month 7-9)|Death|0|||
44395921|NCT03889418|79402345|FG007|October-December 2019 (Month 7-9)|Death|0|||
44395922|NCT03889418|79402346|FG008|October-December 2019 (Month 7-9)|Death|1|||
44395923|NCT03889418|79402347|FG009|October-December 2019 (Month 7-9)|Death|0|||
44395924|NCT03889418|79402338|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395925|NCT03889418|79402339|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395926|NCT03889418|79402340|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395927|NCT03889418|79402341|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
44395928|NCT03889418|79402342|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395929|NCT03889418|79402343|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395930|NCT03889418|79402344|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395931|NCT03889418|79402345|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
44395932|NCT03889418|79402346|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395933|NCT03889418|79402347|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
44395934|NCT03889418|79402338|FG000|April - June 2020 (Month 13-15)|Death|0|||
44395935|NCT03889418|79402339|FG001|April - June 2020 (Month 13-15)|Death|1|||
44395936|NCT03889418|79402340|FG002|April - June 2020 (Month 13-15)|Death|0|||
44395937|NCT03889418|79402341|FG003|April - June 2020 (Month 13-15)|Death|0|||
44395938|NCT03889418|79402342|FG004|April - June 2020 (Month 13-15)|Death|0|||
44395939|NCT03889418|79402343|FG005|April - June 2020 (Month 13-15)|Death|0|||
44395940|NCT03889418|79402344|FG006|April - June 2020 (Month 13-15)|Death|0|||
44395941|NCT03889418|79402345|FG007|April - June 2020 (Month 13-15)|Death|0|||
44395942|NCT03889418|79402346|FG008|April - June 2020 (Month 13-15)|Death|0|||
44395943|NCT03889418|79402347|FG009|April - June 2020 (Month 13-15)|Death|0|||
44395944|NCT03889418|79402338|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395945|NCT03889418|79402339|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395946|NCT03889418|79402340|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395947|NCT03889418|79402341|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
44395948|NCT03889418|79402342|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395949|NCT03889418|79402343|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395950|NCT03889418|79402344|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395951|NCT03889418|79402345|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395952|NCT03889418|79402346|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44520794|NCT03804879|79528941|FG001|Overall Study|Withdrawal by Subject|1|||
44520795|NCT03803475|79528948|FG000|Overall Study|Physician Decision|1|||
44520796|NCT00005937|79528952|FG000|Overall Study|Lack of Efficacy|5|||
44520797|NCT03443024|79528960|FG000|Overall Study|Adverse Event|2|||
44520798|NCT03443024|79528961|FG001|Overall Study|Adverse Event|4|||
44147116|NCT04369469|78936586|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
44281320|NCT04137887|79244500|FG000|Overall Study|Withdrawal by Subject|2|||
44281321|NCT04137887|79244501|FG001|Overall Study|Withdrawal by Subject|3|||
44281322|NCT04137887|79244500|FG000|Overall Study|Randomized but not treated|0|||
44395953|NCT03889418|79402347|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
44395954|NCT03889418|79402338|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
44395955|NCT03889418|79402339|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
44395956|NCT03889418|79402340|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
44395957|NCT03889418|79402341|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
44395958|NCT03889418|79402342|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
44395959|NCT03889418|79402343|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
44395960|NCT03889418|79402344|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
44395961|NCT03889418|79402345|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
44395962|NCT03889418|79402346|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
44395963|NCT03889418|79402347|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
44395964|NCT03889418|79402338|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
44395965|NCT03889418|79402339|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
44395966|NCT03889418|79402340|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
44395967|NCT03889418|79402341|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
44395968|NCT03889418|79402342|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
44395969|NCT03889418|79402343|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
44395970|NCT03889418|79402344|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
44395971|NCT03889418|79402345|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
44395972|NCT03889418|79402346|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
44395973|NCT03889418|79402347|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
44395974|NCT03749109|79402357|FG000|Overall Study|Adverse Event|2|||
44395975|NCT03749109|79402358|FG001|Overall Study|Adverse Event|0|||
44395976|NCT03497689|79402365|FG000|Overall Study|Adverse Event|2|||
44395977|NCT03497689|79402365|FG000|Overall Study|Death|1|||
44395978|NCT03497689|79402365|FG000|Overall Study|Physician Decision|1|||
44395979|NCT03497689|79402365|FG000|Overall Study|Withdrawal by Subject|1|||
44395980|NCT03497689|79402365|FG000|Overall Study|Protocol Violation|2|||
44395981|NCT03492437|79402369|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44395982|NCT03492437|79402370|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44395983|NCT03193853|79402376|FG000|Overall Study|Death|6|||
44395984|NCT02756637|79402382|FG000|Overall Study|Not eligible for initial SWOG study|10|||
44395985|NCT02756637|79402383|FG001|Overall Study|Not eligible for initial SWOG study|10|||
44395986|NCT02756637|79402382|FG000|Overall Study|No available NLR value|44|||
44395987|NCT02756637|79402383|FG001|Overall Study|No available NLR value|44|||
44395988|NCT02756637|79402382|FG000|Overall Study|Did not complete curative therapy|33|||
44395989|NCT02756637|79402383|FG001|Overall Study|Did not complete curative therapy|0|||
44395990|NCT02041195|79402397|FG000|Overall Study|Adverse Event|1|||
44395991|NCT02041195|79402398|FG001|Overall Study|Adverse Event|2|||
44395992|NCT02041195|79402399|FG002|Overall Study|Adverse Event|0|||
44395993|NCT02041195|79402400|FG003|Overall Study|Adverse Event|0|||
44395994|NCT02041195|79402401|FG004|Overall Study|Adverse Event|0|||
44395995|NCT02041195|79402402|FG005|Overall Study|Adverse Event|0|||
44395996|NCT02041195|79402403|FG006|Overall Study|Adverse Event|3|||
44395997|NCT02041195|79402404|FG007|Overall Study|Adverse Event|0|||
44395998|NCT02041195|79402397|FG000|Overall Study|Withdrawal by Subject|1|||
44395999|NCT02041195|79402398|FG001|Overall Study|Withdrawal by Subject|0|||
44396000|NCT02041195|79402399|FG002|Overall Study|Withdrawal by Subject|0|||
44396001|NCT02041195|79402400|FG003|Overall Study|Withdrawal by Subject|0|||
44396002|NCT02041195|79402401|FG004|Overall Study|Withdrawal by Subject|0|||
44396003|NCT02041195|79402402|FG005|Overall Study|Withdrawal by Subject|0|||
44396004|NCT02041195|79402403|FG006|Overall Study|Withdrawal by Subject|4|||
44396005|NCT02041195|79402404|FG007|Overall Study|Withdrawal by Subject|3|||
44396006|NCT02041195|79402397|FG000|Overall Study|Unable to comply with study visits|0|||
44396007|NCT02041195|79402398|FG001|Overall Study|Unable to comply with study visits|1|||
44396008|NCT02041195|79402399|FG002|Overall Study|Unable to comply with study visits|0|||
44396009|NCT02041195|79402400|FG003|Overall Study|Unable to comply with study visits|0|||
44396010|NCT02041195|79402401|FG004|Overall Study|Unable to comply with study visits|1|||
44396011|NCT02041195|79402402|FG005|Overall Study|Unable to comply with study visits|0|||
44396012|NCT02041195|79402403|FG006|Overall Study|Unable to comply with study visits|0|||
44396013|NCT02041195|79402404|FG007|Overall Study|Unable to comply with study visits|0|||
44396014|NCT01583218|79402463|FG000|Overall Study|Withdrawal by Subject|43|||
44396015|NCT01583218|79402464|FG001|Overall Study|Withdrawal by Subject|29|||
44396016|NCT01583218|79402463|FG000|Overall Study|Death|206|||
44396017|NCT01583218|79402464|FG001|Overall Study|Death|211|||
44396018|NCT01583218|79402463|FG000|Overall Study|Lost to Follow-up|11|||
44396019|NCT01583218|79402464|FG001|Overall Study|Lost to Follow-up|17|||
44396020|NCT01583218|79402463|FG000|Overall Study|Adverse event or serious adverse event|3|||
44396021|NCT01583218|79402464|FG001|Overall Study|Adverse event or serious adverse event|3|||
44396022|NCT01583218|79402463|FG000|Overall Study|Patient /Family decision|3|||
44396023|NCT01583218|79402464|FG001|Overall Study|Patient /Family decision|0|||
44396024|NCT01583218|79402463|FG000|Overall Study|Cannot contact patient directly|1|||
44396025|NCT01583218|79402464|FG001|Overall Study|Cannot contact patient directly|2|||
44396026|NCT01583218|79402463|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
44396027|NCT01583218|79402464|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
44281323|NCT04137887|79244501|FG001|Overall Study|Randomized but not treated|1|||
44281324|NCT04074590|79244509|FG000|Overall Study|Adverse Event|1|||
44281325|NCT04074590|79244510|FG001|Overall Study|Adverse Event|0|||
44281326|NCT04074590|79244509|FG000|Overall Study|Physician Decision|1|||
44281327|NCT04074590|79244510|FG001|Overall Study|Physician Decision|0|||
44281328|NCT04074590|79244509|FG000|Overall Study|Withdrawal by Subject|2|||
44281329|NCT04074590|79244510|FG001|Overall Study|Withdrawal by Subject|0|||
44281330|NCT03557008|79244547|FG000|Overall Study|Withdrawal by Subject|2|||
44281331|NCT03557008|79244548|FG001|Overall Study|Withdrawal by Subject|2|||
44281332|NCT03557008|79244547|FG000|Overall Study|Early termination from study|3|||
44281333|NCT03557008|79244548|FG001|Overall Study|Early termination from study|1|||
44520799|NCT03443024|79528962|FG002|Overall Study|Adverse Event|3|||
44520800|NCT03443024|79528963|FG003|Overall Study|Adverse Event|1|||
44520801|NCT03443024|79528960|FG000|Overall Study|Lost to Follow-up|9|||
44520802|NCT03443024|79528961|FG001|Overall Study|Lost to Follow-up|9|||
44520803|NCT03443024|79528962|FG002|Overall Study|Lost to Follow-up|7|||
44520804|NCT03443024|79528963|FG003|Overall Study|Lost to Follow-up|5|||
44520805|NCT03443024|79528960|FG000|Overall Study|Withdrawal by Subject|8|||
44520806|NCT03443024|79528961|FG001|Overall Study|Withdrawal by Subject|15|||
44281342|NCT02366728|79244566|FG000|Overall Study|Death|0|||
44281343|NCT02366728|79244567|FG001|Overall Study|Death|0|||
44281344|NCT02366728|79244568|FG002|Overall Study|Death|1|||
44281345|NCT02366728|79244566|FG000|Overall Study|Adverse Event|1|||
44281346|NCT02366728|79244567|FG001|Overall Study|Adverse Event|0|||
44281347|NCT02366728|79244568|FG002|Overall Study|Adverse Event|0|||
44281348|NCT02366728|79244566|FG000|Overall Study|Screen Failure|2|||
44281349|NCT02366728|79244567|FG001|Overall Study|Screen Failure|1|||
44396028|NCT01583218|79402463|FG000|Overall Study|Patient did not wish to attend visits|0|||
44396029|NCT01583218|79402464|FG001|Overall Study|Patient did not wish to attend visits|1|||
44396030|NCT01583218|79402463|FG000|Overall Study|Patient randomized but not dosed|17|||
44396031|NCT01583218|79402464|FG001|Overall Study|Patient randomized but not dosed|16|||
44396032|NCT01583218|79402463|FG000|Overall Study|Patient was assessed via phone in person|1|||
44396033|NCT01583218|79402464|FG001|Overall Study|Patient was assessed via phone in person|0|||
44396034|NCT01583218|79402463|FG000|Overall Study|Patient deemed ineligible after random|2|||
44396035|NCT01583218|79402464|FG001|Overall Study|Patient deemed ineligible after random|0|||
44396036|NCT01583218|79402463|FG000|Overall Study|Patient was early terminated from study|0|||
44396037|NCT01583218|79402464|FG001|Overall Study|Patient was early terminated from study|1|||
44396038|NCT01583218|79402463|FG000|Overall Study|Patient was randomized due to mistake|1|||
44396039|NCT01583218|79402464|FG001|Overall Study|Patient was randomized due to mistake|0|||
44396040|NCT01583218|79402463|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
44396041|NCT01583218|79402464|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
44396042|NCT01583218|79402463|FG000|Overall Study|Withdraw of consent on day of random|1|||
44396043|NCT01583218|79402464|FG001|Overall Study|Withdraw of consent on day of random|0|||
44396044|NCT00742859|79402474|FG000|Overall Study|Adverse Event|5|||
44396045|NCT00742859|79402475|FG001|Overall Study|Adverse Event|6|||
44396046|NCT00742859|79402476|FG002|Overall Study|Adverse Event|3|||
44396047|NCT00742859|79402477|FG003|Overall Study|Adverse Event|1|||
44147117|NCT04369469|78936587|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
44147118|NCT04369469|78936586|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
44147119|NCT04369469|78936587|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
44281350|NCT02366728|79244568|FG002|Overall Study|Screen Failure|0|||
44281351|NCT02366728|79244566|FG000|Overall Study|Only yielded 2 vaccines|1|||
44281352|NCT02366728|79244567|FG001|Overall Study|Only yielded 2 vaccines|0|||
44281353|NCT02366728|79244568|FG002|Overall Study|Only yielded 2 vaccines|0|||
44281354|NCT02355002|79244578|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
44281355|NCT02355002|79244579|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
44281356|NCT02355002|79244578|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
44281357|NCT02355002|79244579|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
44281358|NCT02355002|79244578|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
44281359|NCT02355002|79244579|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
44281360|NCT02355002|79244578|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
44281361|NCT02355002|79244579|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
44281362|NCT02355002|79244578|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
44281363|NCT02355002|79244579|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
44281364|NCT02355002|79244578|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
44281365|NCT02355002|79244579|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
44396048|NCT00742859|79402474|FG000|Overall Study|Death|1|||
44281366|NCT02355002|79244578|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
44281367|NCT02355002|79244579|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
44281368|NCT02246920|79244589|FG000|Overall Study|Adverse Event|3|||
44281369|NCT02246920|79244590|FG001|Overall Study|Adverse Event|1|||
44281370|NCT02246920|79244591|FG002|Overall Study|Adverse Event|1|||
44281371|NCT02246920|79244589|FG000|Overall Study|Lost to Follow-up|2|||
44396049|NCT00742859|79402475|FG001|Overall Study|Death|0|||
44396050|NCT00742859|79402476|FG002|Overall Study|Death|0|||
44520807|NCT03443024|79528962|FG002|Overall Study|Withdrawal by Subject|9|||
44520808|NCT03443024|79528963|FG003|Overall Study|Withdrawal by Subject|23|||
44281372|NCT02246920|79244590|FG001|Overall Study|Lost to Follow-up|1|||
44281373|NCT02246920|79244591|FG002|Overall Study|Lost to Follow-up|0|||
44281374|NCT02246920|79244589|FG000|Overall Study|Protocol Violation|2|||
44281375|NCT02246920|79244590|FG001|Overall Study|Protocol Violation|5|||
44281376|NCT02246920|79244591|FG002|Overall Study|Protocol Violation|1|||
44281377|NCT02246920|79244589|FG000|Overall Study|Withdrawal by Subject|0|||
44281378|NCT02246920|79244590|FG001|Overall Study|Withdrawal by Subject|0|||
44281379|NCT02246920|79244591|FG002|Overall Study|Withdrawal by Subject|1|||
44281380|NCT01832402|79244601|FG000|Overall Study|Lost to Follow-up|2|||
44281381|NCT01832402|79244602|FG001|Overall Study|Lost to Follow-up|0|||
44281382|NCT01832402|79244601|FG000|Overall Study|Withdrawal by Subject|3|||
44281383|NCT01832402|79244602|FG001|Overall Study|Withdrawal by Subject|3|||
44281384|NCT01832402|79244601|FG000|Overall Study|Declining Performance status|2|||
44281385|NCT01832402|79244602|FG001|Overall Study|Declining Performance status|1|||
44520809|NCT03443024|79528960|FG000|Overall Study|Physician Decision|1|||
44520810|NCT03443024|79528961|FG001|Overall Study|Physician Decision|2|||
44520811|NCT03443024|79528962|FG002|Overall Study|Physician Decision|0|||
44520812|NCT03443024|79528963|FG003|Overall Study|Physician Decision|1|||
44520813|NCT03443024|79528960|FG000|Overall Study|Sponsor Decision|1|||
44520814|NCT03443024|79528961|FG001|Overall Study|Sponsor Decision|1|||
44520815|NCT03443024|79528962|FG002|Overall Study|Sponsor Decision|0|||
44520816|NCT03443024|79528963|FG003|Overall Study|Sponsor Decision|0|||
44520817|NCT03443024|79528960|FG000|Overall Study|Protocol Deviation|0|||
44520818|NCT03443024|79528961|FG001|Overall Study|Protocol Deviation|0|||
44520819|NCT03443024|79528962|FG002|Overall Study|Protocol Deviation|0|||
44520820|NCT03443024|79528963|FG003|Overall Study|Protocol Deviation|2|||
44520821|NCT02908516|79528975|FG000|Overall Study|Study Terminated|3|||
44520822|NCT02908516|79528976|FG001|Overall Study|Study Terminated|3|||
44520823|NCT02907892|79528984|FG000|Overall Study|Lost to Follow-up|27|||
44520824|NCT02907892|79528985|FG001|Overall Study|Lost to Follow-up|40|||
44520825|NCT02906644|79528993|FG000|First 2 Weeks|Withdrawal by Subject|0|||
44520826|NCT02906644|79528994|FG001|First 2 Weeks|Withdrawal by Subject|2|||
44520827|NCT02906644|79528993|FG000|First 2 Weeks|Physician Decision|1|||
44520828|NCT02906644|79528994|FG001|First 2 Weeks|Physician Decision|1|||
44520829|NCT02906644|79528993|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
44520830|NCT02906644|79528994|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
44520831|NCT02906644|79528993|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
44520832|NCT02906644|79528994|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
44520833|NCT03410108|79529001|FG000|Overall Study|Ongoing|41|||
44520834|NCT03410108|79529001|FG000|Overall Study|Adverse Event|4|||
44520835|NCT03410108|79529001|FG000|Overall Study|Progressive Disease|58|||
44520836|NCT03410108|79529001|FG000|Overall Study|Withdrawal by Subject|1|||
44520837|NCT02982772|79529010|FG000|Intervention|Lost to Follow-up|19|||
44520838|NCT02982772|79529011|FG001|Intervention|Lost to Follow-up|13|||
44520839|NCT02982772|79529010|FG000|1M Follow-Up|Lost to Follow-up|21|||
44147120|NCT04369469|78936586|FG000|Overall Study|Unable to Provide Consent|0|||
44147121|NCT04369469|78936587|FG001|Overall Study|Unable to Provide Consent|1|||
44281386|NCT00667628|79244619|FG000|Overall Study|Lost to Follow-up|1|||
44281387|NCT00667628|79244620|FG001|Overall Study|Lost to Follow-up|0|||
44281388|NCT00667628|79244619|FG000|Overall Study|Death|6|||
44281389|NCT00667628|79244620|FG001|Overall Study|Death|6|||
44281390|NCT00667628|79244619|FG000|Overall Study|Investigator Considers in Best Interest|1|||
44281391|NCT00667628|79244620|FG001|Overall Study|Investigator Considers in Best Interest|0|||
44281392|NCT00667628|79244619|FG000|Overall Study|Sponsor Terminated Study|17|||
44281393|NCT00667628|79244620|FG001|Overall Study|Sponsor Terminated Study|21|||
44281394|NCT01597908|79244632|FG000|Randomized Phase|Death|217|||
44281395|NCT01597908|79244633|FG001|Randomized Phase|Death|238|||
44281396|NCT01597908|79244634|FG002|Randomized Phase|Death|0|||
44396051|NCT00742859|79402477|FG003|Overall Study|Death|1|||
44520840|NCT02982772|79529011|FG001|1M Follow-Up|Lost to Follow-up|18|||
44520841|NCT02982772|79529010|FG000|3M Follow-Up|Lost to Follow-up|17|||
44281397|NCT01597908|79244632|FG000|Randomized Phase|Sponsor Decision|93|||
44281398|NCT01597908|79244633|FG001|Randomized Phase|Sponsor Decision|39|||
44520842|NCT02982772|79529011|FG001|3M Follow-Up|Lost to Follow-up|11|||
44520843|NCT02982772|79529010|FG000|6M Follow-Up|Lost to Follow-up|11|||
44520844|NCT02982772|79529011|FG001|6M Follow-Up|Lost to Follow-up|9|||
44520845|NCT02982772|79529010|FG000|12M Follow-Up|Lost to Follow-up|11|||
44520846|NCT02982772|79529011|FG001|12M Follow-Up|Lost to Follow-up|5|||
44520847|NCT03488108|79529021|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
44520848|NCT03488108|79529022|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
44520849|NCT03488108|79529021|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
44520850|NCT03488108|79529022|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
44520851|NCT03440918|79529032|FG000|Overall Study|Protocol Violation|0|||
44520852|NCT03440918|79529033|FG001|Overall Study|Protocol Violation|16|||
44520853|NCT03486392|79529044|FG000|Overall Study|Lost to Follow-up|0|||
44520854|NCT03486392|79529045|FG001|Overall Study|Lost to Follow-up|0|||
44147122|NCT04647383|78936610|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
44520855|NCT03486392|79529046|FG002|Overall Study|Lost to Follow-up|8|||
44147123|NCT04647383|78936611|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
44281399|NCT01597908|79244634|FG002|Randomized Phase|Sponsor Decision|0|||
44281400|NCT01597908|79244632|FG000|Randomized Phase|Lost to Follow-up|9|||
44281401|NCT01597908|79244633|FG001|Randomized Phase|Lost to Follow-up|16|||
44396052|NCT00742859|79402474|FG000|Overall Study|Physician Decision|1|||
44396053|NCT00742859|79402475|FG001|Overall Study|Physician Decision|2|||
44396054|NCT00742859|79402476|FG002|Overall Study|Physician Decision|0|||
44396055|NCT00742859|79402477|FG003|Overall Study|Physician Decision|0|||
44396056|NCT00742859|79402474|FG000|Overall Study|Withdrawal by Subject|4|||
44396057|NCT00742859|79402475|FG001|Overall Study|Withdrawal by Subject|2|||
44396058|NCT00742859|79402476|FG002|Overall Study|Withdrawal by Subject|4|||
44396059|NCT00742859|79402477|FG003|Overall Study|Withdrawal by Subject|1|||
44396060|NCT00742859|79402474|FG000|Overall Study|Endpoint|0|||
44396061|NCT00742859|79402475|FG001|Overall Study|Endpoint|1|||
44396062|NCT00742859|79402476|FG002|Overall Study|Endpoint|1|||
44147124|NCT04647383|78936612|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
44147125|NCT04647383|78936613|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
44147126|NCT01670097|78936625|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
44147127|NCT01670097|78936626|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
44147128|NCT01670097|78936625|FG000|Overall Study|Study burden|1|||
44147129|NCT01670097|78936626|FG001|Overall Study|Study burden|0|||
44147130|NCT01670097|78936625|FG000|Overall Study|COPD exacerbation|0|||
44147131|NCT01670097|78936626|FG001|Overall Study|COPD exacerbation|1|||
44147132|NCT01670097|78936625|FG000|Overall Study|Neutropenia|0|||
44396063|NCT00742859|79402477|FG003|Overall Study|Endpoint|2|||
44396064|NCT00742859|79402474|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
44396065|NCT00742859|79402475|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
44396066|NCT00742859|79402476|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
44396067|NCT00742859|79402477|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
44396068|NCT00742859|79402474|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
44396069|NCT00742859|79402475|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
44396070|NCT00742859|79402476|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
44396071|NCT00742859|79402477|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
44396072|NCT00742859|79402474|FG000|Overall Study|Sponsor request patient out of town|0|||
44396073|NCT00742859|79402475|FG001|Overall Study|Sponsor request patient out of town|0|||
44396074|NCT00742859|79402476|FG002|Overall Study|Sponsor request patient out of town|1|||
44396075|NCT00742859|79402477|FG003|Overall Study|Sponsor request patient out of town|1|||
44520856|NCT03486392|79529047|FG003|Overall Study|Lost to Follow-up|5|||
44147133|NCT01670097|78936626|FG001|Overall Study|Neutropenia|1|||
44147134|NCT01670097|78936625|FG000|Overall Study|Clinical deterioration|0|||
44520857|NCT03486392|79529048|FG004|Overall Study|Lost to Follow-up|2|||
44520858|NCT03486392|79529044|FG000|Overall Study|Withdrawal by Subject|3|||
44520859|NCT03486392|79529045|FG001|Overall Study|Withdrawal by Subject|0|||
44520860|NCT03486392|79529046|FG002|Overall Study|Withdrawal by Subject|6|||
44520861|NCT03486392|79529047|FG003|Overall Study|Withdrawal by Subject|4|||
44520862|NCT03486392|79529048|FG004|Overall Study|Withdrawal by Subject|1|||
44147135|NCT01670097|78936626|FG001|Overall Study|Clinical deterioration|1|||
44147136|NCT01670097|78936625|FG000|Overall Study|Disease progression|0|||
44147137|NCT01670097|78936626|FG001|Overall Study|Disease progression|1|||
44147138|NCT01670019|78936634|FG000|Overall Study|Adverse Event|3|||
44147139|NCT01670019|78936635|FG001|Overall Study|Adverse Event|0|||
44252317|NCT02628600|79089331|FG001|Overall Study|Death|1|||
44252318|NCT02628600|79089330|FG000|Overall Study|Adverse Event|3|||
44252319|NCT02628600|79089331|FG001|Overall Study|Adverse Event|20|||
44252320|NCT02628600|79089330|FG000|Overall Study|Protocol Violation|0|||
44252321|NCT02628600|79089331|FG001|Overall Study|Protocol Violation|1|||
44252322|NCT02628600|79089330|FG000|Overall Study|Lack of Efficacy|2|||
44252323|NCT02628600|79089331|FG001|Overall Study|Lack of Efficacy|0|||
44252324|NCT02628600|79089330|FG000|Overall Study|Withdrawal by Subject|13|||
44252325|NCT02628600|79089331|FG001|Overall Study|Withdrawal by Subject|8|||
44252326|NCT02628600|79089330|FG000|Overall Study|Lost to Follow-up|1|||
44252327|NCT02628600|79089331|FG001|Overall Study|Lost to Follow-up|0|||
44252328|NCT02628600|79089330|FG000|Overall Study|Physician Decision|2|||
44252329|NCT02628600|79089331|FG001|Overall Study|Physician Decision|2|||
44252330|NCT02628600|79089330|FG000|Overall Study|Other not specified|1|||
44396076|NCT00742859|79402474|FG000|Overall Study|Site error|0|||
44396077|NCT00742859|79402475|FG001|Overall Study|Site error|0|||
44396078|NCT00742859|79402476|FG002|Overall Study|Site error|1|||
44396079|NCT00742859|79402477|FG003|Overall Study|Site error|1|||
44396080|NCT00667342|79402490|FG000|Overall Study|Protocol Violation|1|||
44396081|NCT00667342|79402491|FG001|Overall Study|Protocol Violation|0|||
44396082|NCT00667342|79402492|FG002|Overall Study|Protocol Violation|0|||
44396083|NCT00667342|79402490|FG000|Overall Study|Withdrawal by Subject|1|||
44396084|NCT00667342|79402491|FG001|Overall Study|Withdrawal by Subject|0|||
44396085|NCT00667342|79402492|FG002|Overall Study|Withdrawal by Subject|0|||
44396086|NCT00667342|79402490|FG000|Overall Study|Physician Decision|3|||
44396087|NCT00667342|79402491|FG001|Overall Study|Physician Decision|0|||
44396088|NCT00667342|79402492|FG002|Overall Study|Physician Decision|0|||
44396089|NCT00667342|79402490|FG000|Overall Study|Relapse or tumor progression|9|||
44396090|NCT00667342|79402491|FG001|Overall Study|Relapse or tumor progression|0|||
44396091|NCT00667342|79402492|FG002|Overall Study|Relapse or tumor progression|7|||
44396092|NCT00667342|79402490|FG000|Overall Study|Adverse Event|0|||
44396093|NCT00667342|79402491|FG001|Overall Study|Adverse Event|0|||
44396094|NCT00667342|79402492|FG002|Overall Study|Adverse Event|1|||
44396095|NCT00667342|79402490|FG000|Overall Study|Ineligible|0|||
44396096|NCT00667342|79402491|FG001|Overall Study|Ineligible|0|||
44396097|NCT00667342|79402492|FG002|Overall Study|Ineligible|1|||
44396098|NCT00375609|79402509|FG000|Overall Study|Did not receive treatment|1|||
44396099|NCT00375609|79402510|FG001|Overall Study|Did not receive treatment|0|||
44396100|NCT00375609|79402511|FG002|Overall Study|Did not receive treatment|0|||
44396101|NCT00375609|79402509|FG000|Overall Study|Adverse Event|0|||
44396102|NCT00375609|79402510|FG001|Overall Study|Adverse Event|3|||
44396103|NCT00375609|79402511|FG002|Overall Study|Adverse Event|0|||
44396104|NCT00375609|79402509|FG000|Overall Study|Lost to Follow-up|1|||
44396105|NCT00375609|79402510|FG001|Overall Study|Lost to Follow-up|0|||
44396106|NCT00375609|79402511|FG002|Overall Study|Lost to Follow-up|0|||
44396107|NCT00375609|79402509|FG000|Overall Study|Physician Decision|0|||
44396108|NCT00375609|79402510|FG001|Overall Study|Physician Decision|0|||
44396109|NCT00375609|79402511|FG002|Overall Study|Physician Decision|1|||
44396110|NCT00375609|79402509|FG000|Overall Study|Withdrawal by Subject|1|||
44396111|NCT00375609|79402510|FG001|Overall Study|Withdrawal by Subject|4|||
44396112|NCT00375609|79402511|FG002|Overall Study|Withdrawal by Subject|0|||
44396113|NCT00375609|79402509|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
44396114|NCT00375609|79402510|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
44396115|NCT00375609|79402511|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
44396116|NCT00960011|79402521|FG000|Overall Study|Death|5|||
44396117|NCT00960011|79402522|FG001|Overall Study|Death|0|||
44396118|NCT00960011|79402521|FG000|Overall Study|Lost to Follow-up|6|||
44396119|NCT00960011|79402522|FG001|Overall Study|Lost to Follow-up|2|||
44396120|NCT00617851|79402566|FG000|Overall Study|Death|0|||
44396121|NCT00617851|79402567|FG001|Overall Study|Death|0|||
44396122|NCT00617851|79402568|FG002|Overall Study|Death|0|||
44396123|NCT00617851|79402569|FG003|Overall Study|Death|1|||
44396124|NCT00617851|79402566|FG000|Overall Study|Withdrawal by Subject|14|||
44396125|NCT00617851|79402567|FG001|Overall Study|Withdrawal by Subject|7|||
44396126|NCT00617851|79402568|FG002|Overall Study|Withdrawal by Subject|12|||
44396127|NCT00617851|79402569|FG003|Overall Study|Withdrawal by Subject|4|||
44396128|NCT00617851|79402566|FG000|Overall Study|Lost to Follow-up|27|||
44396129|NCT00617851|79402567|FG001|Overall Study|Lost to Follow-up|29|||
44396130|NCT00617851|79402568|FG002|Overall Study|Lost to Follow-up|31|||
44396131|NCT00617851|79402569|FG003|Overall Study|Lost to Follow-up|19|||
44396132|NCT00617851|79402566|FG000|Overall Study|Inappropriate Enrollment|5|||
44396133|NCT00617851|79402567|FG001|Overall Study|Inappropriate Enrollment|4|||
44396134|NCT00617851|79402568|FG002|Overall Study|Inappropriate Enrollment|1|||
44396135|NCT00617851|79402569|FG003|Overall Study|Inappropriate Enrollment|1|||
44396136|NCT00617851|79402566|FG000|Overall Study|Unable to classify|1|||
44396137|NCT00617851|79402567|FG001|Overall Study|Unable to classify|0|||
44396138|NCT00617851|79402568|FG002|Overall Study|Unable to classify|1|||
44396139|NCT00617851|79402569|FG003|Overall Study|Unable to classify|0|||
44396140|NCT00812955|79402593|FG000|Overall Study|Adverse Event|7|||
44396141|NCT00812955|79402594|FG001|Overall Study|Adverse Event|6|||
44520863|NCT03486392|79529044|FG000|Overall Study|Death|0|||
44520864|NCT03486392|79529045|FG001|Overall Study|Death|0|||
44396142|NCT00812955|79402595|FG002|Overall Study|Adverse Event|3|||
44147140|NCT01670019|78936634|FG000|Overall Study|Withdrawal by Subject|6|||
44396143|NCT00812955|79402596|FG003|Overall Study|Adverse Event|4|||
44396144|NCT00812955|79402593|FG000|Overall Study|Lost to Follow-up|2|||
44396145|NCT00812955|79402594|FG001|Overall Study|Lost to Follow-up|1|||
44396146|NCT00812955|79402595|FG002|Overall Study|Lost to Follow-up|1|||
44396147|NCT00812955|79402596|FG003|Overall Study|Lost to Follow-up|2|||
44520865|NCT03486392|79529046|FG002|Overall Study|Death|0|||
44396148|NCT00812955|79402593|FG000|Overall Study|Withdrawal by Subject|1|||
44396149|NCT00812955|79402594|FG001|Overall Study|Withdrawal by Subject|0|||
44396150|NCT00812955|79402595|FG002|Overall Study|Withdrawal by Subject|1|||
44520866|NCT03486392|79529047|FG003|Overall Study|Death|0|||
44396151|NCT00812955|79402596|FG003|Overall Study|Withdrawal by Subject|2|||
44396152|NCT00812955|79402593|FG000|Overall Study|randomized in error|0|||
44396153|NCT00812955|79402594|FG001|Overall Study|randomized in error|0|||
44396154|NCT00812955|79402595|FG002|Overall Study|randomized in error|1|||
44281402|NCT01597908|79244634|FG002|Randomized Phase|Lost to Follow-up|0|||
44281403|NCT01597908|79244632|FG000|Randomized Phase|Physician Decision|6|||
44281404|NCT01597908|79244633|FG001|Randomized Phase|Physician Decision|3|||
44281405|NCT01597908|79244634|FG002|Randomized Phase|Physician Decision|0|||
44281406|NCT01597908|79244632|FG000|Randomized Phase|Withdrawal by Subject|26|||
44281407|NCT01597908|79244633|FG001|Randomized Phase|Withdrawal by Subject|22|||
44281408|NCT01597908|79244634|FG002|Randomized Phase|Withdrawal by Subject|0|||
44281409|NCT01597908|79244632|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
44281410|NCT01597908|79244633|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
44281411|NCT01597908|79244634|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
44281412|NCT01597908|79244632|FG000|Crossover Phase|Death|0|||
44281413|NCT01597908|79244633|FG001|Crossover Phase|Death|0|||
44281414|NCT01597908|79244634|FG002|Crossover Phase|Death|11|||
44281415|NCT01597908|79244632|FG000|Crossover Phase|Withdrawal by Subject|0|||
44281416|NCT01597908|79244633|FG001|Crossover Phase|Withdrawal by Subject|0|||
44281417|NCT01597908|79244634|FG002|Crossover Phase|Withdrawal by Subject|3|||
44520867|NCT03486392|79529048|FG004|Overall Study|Death|1|||
44520868|NCT02981602|79529065|FG000|Overall Study|Adverse Event|0|||
44520869|NCT02981602|79529066|FG001|Overall Study|Adverse Event|0|||
44520870|NCT02981602|79529067|FG002|Overall Study|Adverse Event|0|||
44520871|NCT02981602|79529068|FG003|Overall Study|Adverse Event|1|||
44520872|NCT02981602|79529069|FG004|Overall Study|Adverse Event|0|||
44520873|NCT02981524|79529082|FG000|Overall Study|Progressive Disease|14|||
44520874|NCT02981524|79529082|FG000|Overall Study|Death (unrelated)|1|||
44520875|NCT02981524|79529082|FG000|Overall Study|Treatment Related Toxicity|1|||
44520876|NCT02981524|79529082|FG000|Overall Study|Withdrawal by Subject|1|||
44520877|NCT03486314|79529086|FG000|Part A|Adverse Event|1|||
44520878|NCT03486314|79529087|FG001|Part A|Adverse Event|0|||
44520879|NCT03486314|79529088|FG002|Part A|Adverse Event|0|||
44520880|NCT03486314|79529086|FG000|Part A|Symptomatic Deterioration|2|||
44520881|NCT03486314|79529087|FG001|Part A|Symptomatic Deterioration|0|||
44520882|NCT03486314|79529088|FG002|Part A|Symptomatic Deterioration|0|||
44520883|NCT02905006|79529102|FG000|Overall Study|Adverse Event|1|||
44520884|NCT02905006|79529103|FG001|Overall Study|Adverse Event|1|||
44520885|NCT02905006|79529104|FG002|Overall Study|Adverse Event|1|||
44520886|NCT02905006|79529105|FG003|Overall Study|Adverse Event|1|||
44520887|NCT02905006|79529106|FG004|Overall Study|Adverse Event|0|||
44520888|NCT02905006|79529107|FG005|Overall Study|Adverse Event|1|||
44520889|NCT02905006|79529102|FG000|Overall Study|Lack of Efficacy|1|||
44520890|NCT02905006|79529103|FG001|Overall Study|Lack of Efficacy|0|||
44520891|NCT02905006|79529104|FG002|Overall Study|Lack of Efficacy|0|||
44520892|NCT02905006|79529105|FG003|Overall Study|Lack of Efficacy|0|||
44520893|NCT02905006|79529106|FG004|Overall Study|Lack of Efficacy|0|||
44520894|NCT02905006|79529107|FG005|Overall Study|Lack of Efficacy|0|||
44520895|NCT02905006|79529102|FG000|Overall Study|Protocol Violation|2|||
44520896|NCT02905006|79529103|FG001|Overall Study|Protocol Violation|0|||
44281418|NCT01597908|79244632|FG000|Crossover Phase|Sponsor Decision|0|||
44281419|NCT01597908|79244633|FG001|Crossover Phase|Sponsor Decision|0|||
44396155|NCT00812955|79402596|FG003|Overall Study|randomized in error|0|||
44520897|NCT02905006|79529104|FG002|Overall Study|Protocol Violation|0|||
44520898|NCT02905006|79529105|FG003|Overall Study|Protocol Violation|0|||
44520899|NCT02905006|79529106|FG004|Overall Study|Protocol Violation|0|||
44520900|NCT02905006|79529107|FG005|Overall Study|Protocol Violation|0|||
44520901|NCT02905006|79529102|FG000|Overall Study|Lost to Follow-up|0|||
44520902|NCT02905006|79529103|FG001|Overall Study|Lost to Follow-up|0|||
44520903|NCT02905006|79529104|FG002|Overall Study|Lost to Follow-up|0|||
44520904|NCT02905006|79529105|FG003|Overall Study|Lost to Follow-up|1|||
44396156|NCT00619489|79402612|FG000|Overall Study|Adverse Event|0|||
44520905|NCT02905006|79529106|FG004|Overall Study|Lost to Follow-up|1|||
44520906|NCT02905006|79529107|FG005|Overall Study|Lost to Follow-up|0|||
44520907|NCT02905006|79529102|FG000|Overall Study|Withdrawal by Subject|0|||
44520908|NCT02905006|79529103|FG001|Overall Study|Withdrawal by Subject|0|||
44252331|NCT02628600|79089331|FG001|Overall Study|Other not specified|0|||
44520909|NCT02905006|79529104|FG002|Overall Study|Withdrawal by Subject|1|||
44520910|NCT02905006|79529105|FG003|Overall Study|Withdrawal by Subject|1|||
44520911|NCT02905006|79529106|FG004|Overall Study|Withdrawal by Subject|0|||
44520912|NCT02905006|79529107|FG005|Overall Study|Withdrawal by Subject|1|||
44281420|NCT01597908|79244634|FG002|Crossover Phase|Sponsor Decision|20|||
44281421|NCT01951170|79244643|FG000|Overall Study|Investigator decision|1|||
44520913|NCT02905006|79529102|FG000|Overall Study|Screening exclusion criteria met|1|||
44281422|NCT01951092|79244647|FG000|Overall Study|Lost to Follow-up|10|||
44281423|NCT01951092|79244647|FG000|Overall Study|Incarceration|1|||
44281424|NCT01951092|79244647|FG000|Overall Study|Transfer of Care|1|||
44281425|NCT01949532|79244653|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
44281426|NCT01949532|79244654|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
44281427|NCT01949142|79244662|FG000|Overall Study|Withdrawal of consent|1|||
44281428|NCT01949142|79244663|FG001|Overall Study|Withdrawal of consent|0|||
44281429|NCT01949142|79244662|FG000|Overall Study|Lost to Follow-up|1|||
44281430|NCT01949142|79244663|FG001|Overall Study|Lost to Follow-up|1|||
44281431|NCT01949142|79244662|FG000|Overall Study|Parent changed their mind|1|||
44281432|NCT01949142|79244663|FG001|Overall Study|Parent changed their mind|0|||
44281433|NCT01948908|79244673|FG000|Overall Study|Protocol Violation|1|||
44396157|NCT00619489|79402613|FG001|Overall Study|Adverse Event|7|||
44396158|NCT00619489|79402612|FG000|Overall Study|Withdrawal by Subject|1|||
44396159|NCT00619489|79402613|FG001|Overall Study|Withdrawal by Subject|1|||
44396160|NCT00619489|79402612|FG000|Overall Study|Lack of Efficacy|0|||
44396161|NCT00619489|79402613|FG001|Overall Study|Lack of Efficacy|11|||
44396162|NCT00619489|79402612|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
44396163|NCT00619489|79402613|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
44396164|NCT00959699|79402621|FG000|Treatment Period|Adverse Event|3|||
44396165|NCT00959699|79402622|FG001|Treatment Period|Adverse Event|13|||
44396166|NCT00959699|79402621|FG000|Treatment Period|Lack of Efficacy|15|||
44396167|NCT00959699|79402622|FG001|Treatment Period|Lack of Efficacy|6|||
44396168|NCT00959699|79402621|FG000|Treatment Period|Lost to Follow-up|0|||
44396169|NCT00959699|79402622|FG001|Treatment Period|Lost to Follow-up|1|||
44396170|NCT00959699|79402621|FG000|Treatment Period|Withdrawal by Subject|1|||
44396171|NCT00959699|79402622|FG001|Treatment Period|Withdrawal by Subject|3|||
44396172|NCT00959699|79402621|FG000|Treatment Period|Non-Compliance with Protocol|0|||
44396173|NCT00959699|79402622|FG001|Treatment Period|Non-Compliance with Protocol|1|||
44396174|NCT00959699|79402621|FG000|Treatment Period|Did not receive treatment|0|||
44396175|NCT00959699|79402622|FG001|Treatment Period|Did not receive treatment|1|||
44396176|NCT00959699|79402621|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
44396177|NCT00959699|79402622|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
44396178|NCT00959699|79402621|FG000|Follow-up Period|Lost to Follow-up|3|||
44396179|NCT00959699|79402622|FG001|Follow-up Period|Lost to Follow-up|2|||
44396180|NCT00959699|79402621|FG000|Follow-up Period|Withdrawal by Subject|3|||
44252332|NCT00591318|79089348|FG000|Overall Study|Lack of Efficacy|2|||
44252333|NCT00591318|79089349|FG001|Overall Study|Lack of Efficacy|0|||
44252334|NCT00591318|79089348|FG000|Overall Study|Adverse Event|2|||
44252335|NCT00591318|79089349|FG001|Overall Study|Adverse Event|0|||
44252336|NCT01360632|79089362|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
44252337|NCT01360632|79089363|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
44252338|NCT01360632|79089364|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
44252339|NCT01360632|79089365|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
44252340|NCT01360632|79089366|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
44252341|NCT01360632|79089362|FG000|Phase A (8 Weeks)|Adverse Event|60|||
44252342|NCT01360632|79089363|FG001|Phase A (8 Weeks)|Adverse Event|0|||
44252343|NCT01360632|79089364|FG002|Phase A (8 Weeks)|Adverse Event|0|||
44252344|NCT01360632|79089365|FG003|Phase A (8 Weeks)|Adverse Event|0|||
44252345|NCT01360632|79089366|FG004|Phase A (8 Weeks)|Adverse Event|0|||
44252346|NCT01360632|79089362|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
44252347|NCT01360632|79089363|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
44252348|NCT01360632|79089364|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
44252349|NCT01360632|79089365|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
44252350|NCT01360632|79089366|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
44252351|NCT01360632|79089362|FG000|Phase A (8 Weeks)|Physician Decision|10|||
44252352|NCT01360632|79089363|FG001|Phase A (8 Weeks)|Physician Decision|0|||
44252353|NCT01360632|79089364|FG002|Phase A (8 Weeks)|Physician Decision|0|||
44252354|NCT01360632|79089365|FG003|Phase A (8 Weeks)|Physician Decision|0|||
44281434|NCT01948908|79244674|FG001|Overall Study|Protocol Violation|0|||
44396181|NCT00959699|79402622|FG001|Follow-up Period|Withdrawal by Subject|4|||
44281435|NCT01948908|79244675|FG002|Overall Study|Protocol Violation|2|||
44281436|NCT01925274|79244686|FG000|Overall Study|Death|1|||
44396182|NCT00617773|79402629|FG000|Overall Study|Physician Decision|1|||
44396183|NCT00617773|79402629|FG000|Overall Study|Lack of compliance with the protocol|1|||
44396184|NCT00617773|79402629|FG000|Overall Study|Withdrawal by Subject|1|||
44396185|NCT00617773|79402629|FG000|Overall Study|Death|1|||
44396186|NCT00617773|79402629|FG000|Overall Study|Progressive disease|19|||
44396187|NCT00617773|79402629|FG000|Overall Study|Protocol Violation|1|||
44396188|NCT00956813|79402635|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
44396189|NCT00956813|79402636|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
44396190|NCT00956813|79402635|FG000|Flaxseed and Placebo|Ineligible|3|||
44396191|NCT00956813|79402636|FG001|Flaxseed and Placebo|Ineligible|1|||
44396192|NCT00955955|79402646|FG000|Overall Study|Lost to Follow-up|2|||
44396193|NCT00955955|79402647|FG001|Overall Study|Lost to Follow-up|0|||
44396194|NCT00955955|79402648|FG002|Overall Study|Lost to Follow-up|0|||
44396195|NCT00955721|79402664|FG000|Overall Study|Physician Decision|1|||
44396196|NCT00955721|79402665|FG001|Overall Study|Physician Decision|0|||
44396197|NCT00955721|79402664|FG000|Overall Study|Death|1|||
44396198|NCT00955721|79402665|FG001|Overall Study|Death|0|||
44396199|NCT00955721|79402664|FG000|Overall Study|Withdrawal by Subject|1|||
44396200|NCT00955721|79402665|FG001|Overall Study|Withdrawal by Subject|0|||
44396201|NCT00573469|79402675|FG000|Overall Study|Adverse Event|1|||
44396202|NCT00573469|79402676|FG001|Overall Study|Adverse Event|1|||
44396203|NCT00573469|79402677|FG002|Overall Study|Adverse Event|1|||
44396204|NCT00573469|79402675|FG000|Overall Study|Withdrawal by Subject|0|||
44396205|NCT00573469|79402676|FG001|Overall Study|Withdrawal by Subject|2|||
44396206|NCT00573469|79402677|FG002|Overall Study|Withdrawal by Subject|0|||
44396207|NCT00573469|79402675|FG000|Overall Study|Other|5|||
44396208|NCT00573469|79402676|FG001|Overall Study|Other|1|||
44396209|NCT00573469|79402677|FG002|Overall Study|Other|3|||
44396210|NCT00812565|79402693|FG000|Overall Study|Did Not Receive Study Medication|1|||
44396211|NCT00812565|79402694|FG001|Overall Study|Did Not Receive Study Medication|1|||
44396212|NCT00812565|79402695|FG002|Overall Study|Did Not Receive Study Medication|0|||
44396213|NCT00812565|79402696|FG003|Overall Study|Did Not Receive Study Medication|0|||
44396214|NCT00812565|79402697|FG004|Overall Study|Did Not Receive Study Medication|0|||
44396215|NCT00812565|79402698|FG005|Overall Study|Did Not Receive Study Medication|0|||
44396216|NCT00812565|79402699|FG006|Overall Study|Did Not Receive Study Medication|0|||
44396217|NCT00812565|79402700|FG007|Overall Study|Did Not Receive Study Medication|0|||
44396218|NCT00812565|79402693|FG000|Overall Study|Adverse Event|0|||
44396219|NCT00812565|79402694|FG001|Overall Study|Adverse Event|0|||
44396220|NCT00812565|79402695|FG002|Overall Study|Adverse Event|0|||
44396221|NCT00812565|79402696|FG003|Overall Study|Adverse Event|2|||
44147141|NCT01670019|78936635|FG001|Overall Study|Withdrawal by Subject|0|||
44147142|NCT01669629|78936641|FG000|Period 1|protocol deviation|1|||
44147143|NCT01669629|78936642|FG001|Period 1|protocol deviation|2|||
44147144|NCT00701051|78936650|FG000|Screening|Failed Screening|40|||
44147145|NCT00701051|78936651|FG001|Screening|Failed Screening|0|||
44147146|NCT00701051|78936652|FG002|Screening|Failed Screening|0|||
44147147|NCT00701051|78936650|FG000|Screening|Time conflicts|19|||
44147148|NCT00701051|78936651|FG001|Screening|Time conflicts|0|||
44147149|NCT00701051|78936652|FG002|Screening|Time conflicts|0|||
44147150|NCT00701051|78936650|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
44147151|NCT00701051|78936651|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
44147152|NCT00701051|78936652|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
44147153|NCT00700817|78936663|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
44147154|NCT00700817|78936664|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
44147155|NCT00700817|78936665|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
44147156|NCT00700817|78936666|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
44147157|NCT00700817|78936667|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
44396222|NCT00812565|79402697|FG004|Overall Study|Adverse Event|0|||
44396223|NCT00812565|79402698|FG005|Overall Study|Adverse Event|0|||
44396224|NCT00812565|79402699|FG006|Overall Study|Adverse Event|0|||
44396225|NCT00812565|79402700|FG007|Overall Study|Adverse Event|1|||
44396226|NCT00812565|79402693|FG000|Overall Study|Did Not Come to Study Visit|1|||
44396227|NCT00812565|79402694|FG001|Overall Study|Did Not Come to Study Visit|0|||
44396228|NCT00812565|79402695|FG002|Overall Study|Did Not Come to Study Visit|0|||
44396229|NCT00812565|79402696|FG003|Overall Study|Did Not Come to Study Visit|0|||
44396230|NCT00812565|79402697|FG004|Overall Study|Did Not Come to Study Visit|0|||
44396231|NCT00812565|79402698|FG005|Overall Study|Did Not Come to Study Visit|0|||
44396232|NCT00812565|79402699|FG006|Overall Study|Did Not Come to Study Visit|0|||
44396233|NCT00812565|79402700|FG007|Overall Study|Did Not Come to Study Visit|0|||
44396234|NCT00812565|79402693|FG000|Overall Study|Withdrawal of Consent|1|||
44396235|NCT00812565|79402694|FG001|Overall Study|Withdrawal of Consent|0|||
44147158|NCT00700817|78936663|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
44396236|NCT00812565|79402695|FG002|Overall Study|Withdrawal of Consent|0|||
44396237|NCT00812565|79402696|FG003|Overall Study|Withdrawal of Consent|0|||
44147159|NCT00700817|78936664|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
44147160|NCT00700817|78936665|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
44396238|NCT00812565|79402697|FG004|Overall Study|Withdrawal of Consent|1|||
44396239|NCT00812565|79402698|FG005|Overall Study|Withdrawal of Consent|0|||
44396240|NCT00812565|79402699|FG006|Overall Study|Withdrawal of Consent|0|||
44396241|NCT00812565|79402700|FG007|Overall Study|Withdrawal of Consent|0|||
44396242|NCT00812565|79402693|FG000|Overall Study|Reason Not Specified|0|||
44396243|NCT00812565|79402694|FG001|Overall Study|Reason Not Specified|0|||
44396244|NCT00812565|79402695|FG002|Overall Study|Reason Not Specified|0|||
44396245|NCT00812565|79402696|FG003|Overall Study|Reason Not Specified|0|||
44396246|NCT00812565|79402697|FG004|Overall Study|Reason Not Specified|0|||
44396247|NCT00812565|79402698|FG005|Overall Study|Reason Not Specified|1|||
44396248|NCT00812565|79402699|FG006|Overall Study|Reason Not Specified|0|||
44396249|NCT00812565|79402700|FG007|Overall Study|Reason Not Specified|0|||
44396250|NCT00812487|79402720|FG000|Overall Study|Lost to Follow-up|2|||
44396251|NCT00812487|79402721|FG001|Overall Study|Lost to Follow-up|0|||
44396252|NCT00812487|79402720|FG000|Overall Study|Withdrawal by Subject|3|||
44396253|NCT00812487|79402721|FG001|Overall Study|Withdrawal by Subject|2|||
44396254|NCT00812487|79402720|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
44396255|NCT00812487|79402721|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
44396256|NCT00812487|79402720|FG000|Overall Study|Protocol Violation|0|||
44396257|NCT00812487|79402721|FG001|Overall Study|Protocol Violation|1|||
44396258|NCT00617461|79402731|FG000|First Treatment Intervention Period|Adverse Event|2|||
44396259|NCT00617461|79402732|FG001|First Treatment Intervention Period|Adverse Event|0|||
44396260|NCT00617461|79402731|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
44396261|NCT00617461|79402732|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
44396262|NCT00617461|79402731|FG000|First Treatment Intervention Period|Protocol Violation|2|||
44396263|NCT00617461|79402732|FG001|First Treatment Intervention Period|Protocol Violation|1|||
44396264|NCT00617461|79402731|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
44396265|NCT00617461|79402732|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
44396266|NCT00617461|79402731|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
44396267|NCT00617461|79402732|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
44396268|NCT00617461|79402731|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
44396269|NCT00617461|79402732|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
44396270|NCT00617461|79402731|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
44396271|NCT00617461|79402732|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
44396272|NCT00617461|79402731|FG000|Second Treatment Intervention Period|Adverse Event|0|||
44396273|NCT00617461|79402732|FG001|Second Treatment Intervention Period|Adverse Event|1|||
44396274|NCT00617461|79402731|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
44396275|NCT00617461|79402732|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
44396276|NCT00617461|79402731|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
44396277|NCT00617461|79402732|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
44396278|NCT00617461|79402731|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
44396279|NCT00617461|79402732|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
44396280|NCT00812331|79402759|FG000|Overall Study|Adverse Event|1|||
44396281|NCT00812331|79402760|FG001|Overall Study|Adverse Event|0|||
44396282|NCT00812331|79402761|FG002|Overall Study|Adverse Event|0|||
44396283|NCT00812331|79402762|FG003|Overall Study|Adverse Event|0|||
44396284|NCT00812331|79402763|FG004|Overall Study|Adverse Event|0|||
44396285|NCT00812253|79402773|FG000|Overall Study|Withdrawal by Subject|3|||
44396286|NCT00812253|79402774|FG001|Overall Study|Withdrawal by Subject|2|||
44396287|NCT00812253|79402773|FG000|Overall Study|Protocol Violation|1|||
44396288|NCT00812253|79402774|FG001|Overall Study|Protocol Violation|1|||
44396289|NCT00812253|79402773|FG000|Overall Study|Lost to Follow-up|2|||
44396290|NCT00812253|79402774|FG001|Overall Study|Lost to Follow-up|0|||
44396291|NCT00616759|79402782|FG000|Overall Study|Physician Decision|2|||
44396292|NCT00616759|79402783|FG001|Overall Study|Physician Decision|0|||
44396293|NCT00616759|79402782|FG000|Overall Study|Withdrawal by Subject|1|||
44396294|NCT00616759|79402783|FG001|Overall Study|Withdrawal by Subject|2|||
44396295|NCT00812097|79402793|FG000|Overall Study|Death|3|||
44281437|NCT01925274|79244687|FG001|Overall Study|Death|0|||
44281438|NCT01925274|79244688|FG002|Overall Study|Death|0|||
44281439|NCT01925274|79244686|FG000|Overall Study|Lost to Follow-up|0|||
44396296|NCT00812097|79402794|FG001|Overall Study|Death|10|||
44396297|NCT00812097|79402795|FG002|Overall Study|Death|3|||
44396298|NCT00812097|79402796|FG003|Overall Study|Death|3|||
44396299|NCT00812097|79402793|FG000|Overall Study|Withdrawal by Subject|14|||
44396300|NCT00812097|79402794|FG001|Overall Study|Withdrawal by Subject|12|||
44396301|NCT00812097|79402795|FG002|Overall Study|Withdrawal by Subject|8|||
44396302|NCT00812097|79402796|FG003|Overall Study|Withdrawal by Subject|2|||
44396303|NCT00812097|79402793|FG000|Overall Study|Lost to Follow-up|90|||
44520914|NCT02905006|79529103|FG001|Overall Study|Screening exclusion criteria met|0|||
44520915|NCT02905006|79529104|FG002|Overall Study|Screening exclusion criteria met|0|||
44520916|NCT02905006|79529105|FG003|Overall Study|Screening exclusion criteria met|0|||
44520917|NCT02905006|79529106|FG004|Overall Study|Screening exclusion criteria met|0|||
44396304|NCT00812097|79402794|FG001|Overall Study|Lost to Follow-up|14|||
44396305|NCT00812097|79402795|FG002|Overall Study|Lost to Follow-up|17|||
44396306|NCT00812097|79402796|FG003|Overall Study|Lost to Follow-up|5|||
44396307|NCT00812097|79402793|FG000|Overall Study|Explantation of study device(s)|27|||
44396308|NCT00812097|79402794|FG001|Overall Study|Explantation of study device(s)|29|||
44396309|NCT00812097|79402795|FG002|Overall Study|Explantation of study device(s)|14|||
44396310|NCT00812097|79402796|FG003|Overall Study|Explantation of study device(s)|20|||
44396311|NCT00812097|79402793|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
44396312|NCT00812097|79402794|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
44396313|NCT00812097|79402795|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
44396314|NCT00812097|79402796|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
44396315|NCT00811941|79402808|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
44396316|NCT00811941|79402809|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
44396317|NCT00811941|79402808|FG000|All Treated Patients|Adverse Event|2|||
44396318|NCT00811941|79402809|FG001|All Treated Patients|Adverse Event|43|||
44396319|NCT00811941|79402808|FG000|All Treated Patients|Lack of Efficacy|2|||
44396320|NCT00811941|79402809|FG001|All Treated Patients|Lack of Efficacy|3|||
44396321|NCT00811941|79402808|FG000|All Treated Patients|Non-compliance|1|||
44147161|NCT00700817|78936666|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
44147162|NCT00700817|78936667|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
44147163|NCT00700817|78936663|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
44396322|NCT00811941|79402809|FG001|All Treated Patients|Non-compliance|8|||
44396323|NCT00811941|79402808|FG000|All Treated Patients|Protocol Violation|5|||
44396324|NCT00811941|79402809|FG001|All Treated Patients|Protocol Violation|17|||
44520918|NCT02905006|79529107|FG005|Overall Study|Screening exclusion criteria met|0|||
44520919|NCT02905006|79529102|FG000|Overall Study|Lab withdrawal criterion met|0|||
44520920|NCT02905006|79529103|FG001|Overall Study|Lab withdrawal criterion met|1|||
44520921|NCT02905006|79529104|FG002|Overall Study|Lab withdrawal criterion met|2|||
44396325|NCT00811941|79402808|FG000|All Treated Patients|Withdrawal by Subject|35|||
44396326|NCT00811941|79402809|FG001|All Treated Patients|Withdrawal by Subject|94|||
44396327|NCT00811941|79402808|FG000|All Treated Patients|Lost to Follow-up|3|||
44396328|NCT00811941|79402809|FG001|All Treated Patients|Lost to Follow-up|12|||
44396329|NCT00811941|79402808|FG000|All Treated Patients|Other Reason|4|||
44396330|NCT00811941|79402809|FG001|All Treated Patients|Other Reason|14|||
44396331|NCT00811473|79402817|FG000|Overall Study|Adverse Event|3|||
44396332|NCT00811473|79402818|FG001|Overall Study|Adverse Event|12|||
44396333|NCT00811473|79402817|FG000|Overall Study|Lost to Follow-up|5|||
44396334|NCT00811473|79402818|FG001|Overall Study|Lost to Follow-up|1|||
44396335|NCT00811473|79402817|FG000|Overall Study|Withdrawal by Subject|2|||
44396336|NCT00811473|79402818|FG001|Overall Study|Withdrawal by Subject|4|||
44396337|NCT00811473|79402817|FG000|Overall Study|Severe non-compliance to protocol|2|||
44396338|NCT00811473|79402818|FG001|Overall Study|Severe non-compliance to protocol|4|||
44396339|NCT00811473|79402817|FG000|Overall Study|Lack of therapeutic response|4|||
44396340|NCT00811473|79402818|FG001|Overall Study|Lack of therapeutic response|1|||
44396341|NCT00811473|79402817|FG000|Overall Study|Condition under investigation worsened|1|||
44396342|NCT00811473|79402818|FG001|Overall Study|Condition under investigation worsened|3|||
44396343|NCT00811473|79402817|FG000|Overall Study|Other 2|4|||
44396344|NCT00811473|79402818|FG001|Overall Study|Other 2|1|||
44396345|NCT00811473|79402817|FG000|Overall Study|Incorrect Enrollment|1|||
44396346|NCT00811473|79402818|FG001|Overall Study|Incorrect Enrollment|0|||
44396347|NCT00811473|79402817|FG000|Overall Study|Safety Reasons|1|||
44396348|NCT00811473|79402818|FG001|Overall Study|Safety Reasons|0|||
44396349|NCT00617305|79402831|FG000|Overall Study|Adverse Event|4|||
44396350|NCT00617305|79402832|FG001|Overall Study|Adverse Event|0|||
44396351|NCT00617305|79402833|FG002|Overall Study|Adverse Event|0|||
44396352|NCT00617305|79402831|FG000|Overall Study|Death|1|||
44396353|NCT00617305|79402832|FG001|Overall Study|Death|0|||
44396354|NCT00617305|79402833|FG002|Overall Study|Death|0|||
44396355|NCT00617305|79402831|FG000|Overall Study|Physician Decision|1|||
44396356|NCT00617305|79402832|FG001|Overall Study|Physician Decision|0|||
44396357|NCT00617305|79402833|FG002|Overall Study|Physician Decision|0|||
44520922|NCT02905006|79529105|FG003|Overall Study|Lab withdrawal criterion met|2|||
44520923|NCT02905006|79529106|FG004|Overall Study|Lab withdrawal criterion met|2|||
44520924|NCT02905006|79529107|FG005|Overall Study|Lab withdrawal criterion met|1|||
44520925|NCT02905006|79529102|FG000|Overall Study|Positive for Tuberculosis|0|||
44520926|NCT02905006|79529103|FG001|Overall Study|Positive for Tuberculosis|1|||
44520927|NCT02905006|79529104|FG002|Overall Study|Positive for Tuberculosis|0|||
44520928|NCT02905006|79529105|FG003|Overall Study|Positive for Tuberculosis|0|||
44520929|NCT02905006|79529106|FG004|Overall Study|Positive for Tuberculosis|0|||
44520930|NCT02905006|79529107|FG005|Overall Study|Positive for Tuberculosis|0|||
44147164|NCT00700817|78936664|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
44147165|NCT00700817|78936665|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
44520931|NCT02905006|79529102|FG000|Overall Study|Subject positive for Hep B|0|||
44396358|NCT00617305|79402831|FG000|Overall Study|Protocol Violation|1|||
44396359|NCT00617305|79402832|FG001|Overall Study|Protocol Violation|0|||
44520932|NCT02905006|79529103|FG001|Overall Study|Subject positive for Hep B|0|||
44396360|NCT00617305|79402833|FG002|Overall Study|Protocol Violation|1|||
44396361|NCT00617305|79402831|FG000|Overall Study|Withdrawal by Subject|1|||
44396362|NCT00617305|79402832|FG001|Overall Study|Withdrawal by Subject|0|||
44396363|NCT00617305|79402833|FG002|Overall Study|Withdrawal by Subject|0|||
44396364|NCT00811395|79402850|FG000|Extension Treatment|Adverse Event|1|||
44396365|NCT00811395|79402851|FG001|Extension Treatment|Adverse Event|2|||
44396366|NCT00811395|79402852|FG002|Extension Treatment|Adverse Event|2|||
44396367|NCT00811395|79402853|FG003|Extension Treatment|Adverse Event|2|||
44396368|NCT00811395|79402854|FG004|Extension Treatment|Adverse Event|0|||
44396369|NCT00811395|79402855|FG005|Extension Treatment|Adverse Event|1|||
44396370|NCT00811395|79402850|FG000|Extension Treatment|Progressive disease|1|||
44396371|NCT00811395|79402851|FG001|Extension Treatment|Progressive disease|1|||
44396372|NCT00811395|79402852|FG002|Extension Treatment|Progressive disease|0|||
44396373|NCT00811395|79402853|FG003|Extension Treatment|Progressive disease|0|||
44396374|NCT00811395|79402854|FG004|Extension Treatment|Progressive disease|0|||
44396375|NCT00811395|79402855|FG005|Extension Treatment|Progressive disease|0|||
44396376|NCT00811395|79402850|FG000|Extension Treatment|Participant did not wish to continue|0|||
44396377|NCT00811395|79402851|FG001|Extension Treatment|Participant did not wish to continue|3|||
44396378|NCT00811395|79402852|FG002|Extension Treatment|Participant did not wish to continue|0|||
44396379|NCT00811395|79402853|FG003|Extension Treatment|Participant did not wish to continue|1|||
44396380|NCT00811395|79402854|FG004|Extension Treatment|Participant did not wish to continue|0|||
44396381|NCT00811395|79402855|FG005|Extension Treatment|Participant did not wish to continue|1|||
44396382|NCT00811395|79402850|FG000|Extension Treatment|Other than above|0|||
44396383|NCT00811395|79402851|FG001|Extension Treatment|Other than above|0|||
44396384|NCT00811395|79402852|FG002|Extension Treatment|Other than above|1|||
44396385|NCT00811395|79402853|FG003|Extension Treatment|Other than above|0|||
44396386|NCT00811395|79402854|FG004|Extension Treatment|Other than above|0|||
44396387|NCT00811395|79402855|FG005|Extension Treatment|Other than above|0|||
44396388|NCT00955409|79402882|FG000|Overall Study|Lack of Efficacy|1|||
44396389|NCT00955409|79402883|FG001|Overall Study|Lack of Efficacy|0|||
44396390|NCT00955409|79402884|FG002|Overall Study|Lack of Efficacy|0|||
44396391|NCT00955409|79402885|FG003|Overall Study|Lack of Efficacy|0|||
44396392|NCT00955409|79402886|FG004|Overall Study|Lack of Efficacy|0|||
44396393|NCT00955409|79402887|FG005|Overall Study|Lack of Efficacy|0|||
44396394|NCT00955409|79402888|FG006|Overall Study|Lack of Efficacy|0|||
44396395|NCT00955409|79402889|FG007|Overall Study|Lack of Efficacy|0|||
44396396|NCT00955409|79402890|FG008|Overall Study|Lack of Efficacy|0|||
44396397|NCT00955409|79402891|FG009|Overall Study|Lack of Efficacy|0|||
44396398|NCT00955409|79402882|FG000|Overall Study|Withdrawal by Subject|1|||
44396399|NCT00955409|79402883|FG001|Overall Study|Withdrawal by Subject|0|||
44396400|NCT00955409|79402884|FG002|Overall Study|Withdrawal by Subject|5|||
44396401|NCT00955409|79402885|FG003|Overall Study|Withdrawal by Subject|2|||
44396402|NCT00955409|79402886|FG004|Overall Study|Withdrawal by Subject|0|||
44396403|NCT00955409|79402887|FG005|Overall Study|Withdrawal by Subject|0|||
44396404|NCT00955409|79402888|FG006|Overall Study|Withdrawal by Subject|2|||
44396405|NCT00955409|79402889|FG007|Overall Study|Withdrawal by Subject|0|||
44396406|NCT00955409|79402890|FG008|Overall Study|Withdrawal by Subject|1|||
44396407|NCT00955409|79402891|FG009|Overall Study|Withdrawal by Subject|0|||
44396408|NCT00955409|79402882|FG000|Overall Study|Caregiver Request|2|||
44396409|NCT00955409|79402883|FG001|Overall Study|Caregiver Request|0|||
44396410|NCT00955409|79402884|FG002|Overall Study|Caregiver Request|6|||
44396411|NCT00955409|79402885|FG003|Overall Study|Caregiver Request|5|||
44396412|NCT00955409|79402886|FG004|Overall Study|Caregiver Request|0|||
44396413|NCT00955409|79402887|FG005|Overall Study|Caregiver Request|2|||
44520933|NCT02905006|79529104|FG002|Overall Study|Subject positive for Hep B|1|||
44520934|NCT02905006|79529105|FG003|Overall Study|Subject positive for Hep B|0|||
44520935|NCT02905006|79529106|FG004|Overall Study|Subject positive for Hep B|0|||
44520936|NCT02905006|79529107|FG005|Overall Study|Subject positive for Hep B|0|||
44520937|NCT02905006|79529102|FG000|Overall Study|Patient moved abroad|0|||
44520938|NCT02905006|79529103|FG001|Overall Study|Patient moved abroad|0|||
44520939|NCT02905006|79529104|FG002|Overall Study|Patient moved abroad|0|||
44520940|NCT02905006|79529105|FG003|Overall Study|Patient moved abroad|1|||
44520941|NCT02905006|79529106|FG004|Overall Study|Patient moved abroad|0|||
44396414|NCT00955409|79402888|FG006|Overall Study|Caregiver Request|3|||
44396415|NCT00955409|79402889|FG007|Overall Study|Caregiver Request|1|||
44396416|NCT00955409|79402890|FG008|Overall Study|Caregiver Request|3|||
44396417|NCT00955409|79402891|FG009|Overall Study|Caregiver Request|0|||
44396418|NCT00955409|79402882|FG000|Overall Study|Investigator Request|0|||
44520942|NCT02905006|79529107|FG005|Overall Study|Patient moved abroad|0|||
44520943|NCT02905006|79529102|FG000|Overall Study|Patient randomized by mistake|0|||
44396419|NCT00955409|79402883|FG001|Overall Study|Investigator Request|0|||
44396420|NCT00955409|79402884|FG002|Overall Study|Investigator Request|1|||
44396421|NCT00955409|79402885|FG003|Overall Study|Investigator Request|0|||
44396422|NCT00955409|79402886|FG004|Overall Study|Investigator Request|0|||
44396423|NCT00955409|79402887|FG005|Overall Study|Investigator Request|0|||
44396424|NCT00955409|79402888|FG006|Overall Study|Investigator Request|0|||
44520944|NCT02905006|79529103|FG001|Overall Study|Patient randomized by mistake|0|||
44520945|NCT02905006|79529104|FG002|Overall Study|Patient randomized by mistake|0|||
44520946|NCT02905006|79529105|FG003|Overall Study|Patient randomized by mistake|0|||
44520947|NCT02905006|79529106|FG004|Overall Study|Patient randomized by mistake|0|||
44520948|NCT02905006|79529107|FG005|Overall Study|Patient randomized by mistake|1|||
44396425|NCT00955409|79402889|FG007|Overall Study|Investigator Request|0|||
44396426|NCT00955409|79402890|FG008|Overall Study|Investigator Request|0|||
44396427|NCT00955409|79402891|FG009|Overall Study|Investigator Request|0|||
44396428|NCT00955409|79402882|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
44396429|NCT00955409|79402883|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
44396430|NCT00955409|79402884|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
44396431|NCT00955409|79402885|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
44396432|NCT00955409|79402886|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
44396433|NCT00955409|79402887|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
44396434|NCT00955409|79402888|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
44396435|NCT00955409|79402889|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
44396436|NCT00955409|79402890|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
44396437|NCT00955409|79402891|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
44396438|NCT00955409|79402882|FG000|Overall Study|Lost to Follow-up|0|||
44396439|NCT00955409|79402883|FG001|Overall Study|Lost to Follow-up|0|||
44396440|NCT00955409|79402884|FG002|Overall Study|Lost to Follow-up|1|||
44396441|NCT00955409|79402885|FG003|Overall Study|Lost to Follow-up|0|||
44396442|NCT00955409|79402886|FG004|Overall Study|Lost to Follow-up|0|||
44396443|NCT00955409|79402887|FG005|Overall Study|Lost to Follow-up|0|||
44396444|NCT00955409|79402888|FG006|Overall Study|Lost to Follow-up|1|||
44396445|NCT00955409|79402889|FG007|Overall Study|Lost to Follow-up|0|||
44396446|NCT00955409|79402890|FG008|Overall Study|Lost to Follow-up|0|||
44396447|NCT00955409|79402891|FG009|Overall Study|Lost to Follow-up|0|||
44396448|NCT00955409|79402882|FG000|Overall Study|Failed to Return|2|||
44396449|NCT00955409|79402883|FG001|Overall Study|Failed to Return|0|||
44396450|NCT00955409|79402884|FG002|Overall Study|Failed to Return|0|||
44396451|NCT00955409|79402885|FG003|Overall Study|Failed to Return|0|||
44396452|NCT00955409|79402886|FG004|Overall Study|Failed to Return|0|||
44396453|NCT00955409|79402887|FG005|Overall Study|Failed to Return|0|||
44396454|NCT00955409|79402888|FG006|Overall Study|Failed to Return|0|||
44396455|NCT00955409|79402889|FG007|Overall Study|Failed to Return|2|||
44396456|NCT00955409|79402890|FG008|Overall Study|Failed to Return|0|||
44396457|NCT00955409|79402891|FG009|Overall Study|Failed to Return|0|||
44396458|NCT00955409|79402882|FG000|Overall Study|Adverse Event (AE)|2|||
44396459|NCT00955409|79402883|FG001|Overall Study|Adverse Event (AE)|0|||
44396460|NCT00955409|79402884|FG002|Overall Study|Adverse Event (AE)|0|||
44396461|NCT00955409|79402885|FG003|Overall Study|Adverse Event (AE)|0|||
44396462|NCT00955409|79402886|FG004|Overall Study|Adverse Event (AE)|0|||
44396463|NCT00955409|79402887|FG005|Overall Study|Adverse Event (AE)|1|||
44396464|NCT00955409|79402888|FG006|Overall Study|Adverse Event (AE)|2|||
44396465|NCT00955409|79402889|FG007|Overall Study|Adverse Event (AE)|0|||
44396466|NCT00955409|79402890|FG008|Overall Study|Adverse Event (AE)|2|||
44396467|NCT00955409|79402891|FG009|Overall Study|Adverse Event (AE)|0|||
44396468|NCT00955409|79402882|FG000|Overall Study|Reason not Specified|2|||
44396469|NCT00955409|79402883|FG001|Overall Study|Reason not Specified|1|||
44396470|NCT00955409|79402884|FG002|Overall Study|Reason not Specified|13|||
44396471|NCT00955409|79402885|FG003|Overall Study|Reason not Specified|1|||
44396472|NCT00955409|79402886|FG004|Overall Study|Reason not Specified|2|||
44520949|NCT01066780|79529145|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
44520950|NCT01066780|79529146|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
44520951|NCT02975206|79529153|FG000|Overall Study|Withdrawal by Subject|14|||
44520952|NCT02975206|79529154|FG001|Overall Study|Withdrawal by Subject|11|||
44520953|NCT02975206|79529155|FG002|Overall Study|Withdrawal by Subject|11|||
44520954|NCT02975206|79529153|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
44520955|NCT02975206|79529154|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
44520956|NCT02975206|79529155|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
44520957|NCT01066156|79529163|FG000|Overall Study|ineligible|2|||
44520958|NCT01066156|79529163|FG000|Overall Study|Lost to Follow-up|7|||
44396473|NCT00955409|79402887|FG005|Overall Study|Reason not Specified|0|||
44396474|NCT00955409|79402888|FG006|Overall Study|Reason not Specified|16|||
44396475|NCT00955409|79402889|FG007|Overall Study|Reason not Specified|0|||
44396476|NCT00955409|79402890|FG008|Overall Study|Reason not Specified|8|||
44396477|NCT00955409|79402891|FG009|Overall Study|Reason not Specified|1|||
44396478|NCT00615901|79402917|FG000|Overall Study|Withdrawal by Subject|2|||
44396479|NCT00615901|79402917|FG000|Overall Study|Adverse Event|7|||
44520959|NCT01066156|79529163|FG000|Overall Study|Withdrawal by Subject|1|||
44520960|NCT02980042|79529169|FG000|Overall Study|Lost to Follow-up|5|||
44396480|NCT00616603|79402929|FG000|Overall Study|Physician Decision|2|||
44396481|NCT00616603|79402930|FG001|Overall Study|Physician Decision|0|||
44396482|NCT00616603|79402931|FG002|Overall Study|Physician Decision|2|||
44396483|NCT00573313|79402943|FG000|Overall Study|Protocol Violation|5|||
44396484|NCT00573313|79402944|FG001|Overall Study|Protocol Violation|0|||
44396485|NCT00573313|79402945|FG002|Overall Study|Protocol Violation|6|||
44396486|NCT00573313|79402946|FG003|Overall Study|Protocol Violation|0|||
44396487|NCT00953615|79402953|FG000|Overall Study|Adverse Event|1|||
44396488|NCT00810615|79402959|FG000|Overall Study|Withdrawal by Subject|1|||
44396489|NCT00810615|79402960|FG001|Overall Study|Withdrawal by Subject|1|||
44396490|NCT00573391|79402980|FG000|Overall Study|study stopped|2|||
44396491|NCT00573391|79402981|FG001|Overall Study|study stopped|2|||
44396492|NCT00573391|79402980|FG000|Overall Study|Death|1|||
44396493|NCT00573391|79402981|FG001|Overall Study|Death|0|||
44396494|NCT00590967|79402989|FG000|Overall Study|Withdrawal by Subject|1|||
44396495|NCT00590967|79402990|FG001|Overall Study|Withdrawal by Subject|1|||
44396496|NCT00590967|79402989|FG000|Overall Study|Ineligible|1|||
44396497|NCT00590967|79402990|FG001|Overall Study|Ineligible|0|||
44396498|NCT00590967|79402989|FG000|Overall Study|Poor performance status|0|||
44396499|NCT00590967|79402990|FG001|Overall Study|Poor performance status|1|||
44396500|NCT00590967|79402989|FG000|Overall Study|Non-compliant|0|||
44396501|NCT00590967|79402990|FG001|Overall Study|Non-compliant|2|||
44396502|NCT00590967|79402989|FG000|Overall Study|Did not sign consent form|0|||
44396503|NCT00590967|79402990|FG001|Overall Study|Did not sign consent form|1|||
44396504|NCT00590967|79402989|FG000|Overall Study|Did not receive chemo per protocol|1|||
44396505|NCT00590967|79402990|FG001|Overall Study|Did not receive chemo per protocol|0|||
44396506|NCT05102162|79403019|FG000|Overall Study|Withdrawal by Subject|3|||
44396507|NCT05102162|79403020|FG001|Overall Study|Withdrawal by Subject|0|||
44396508|NCT05102162|79403019|FG000|Overall Study|Baseline cultures negative|4|||
44396509|NCT05102162|79403020|FG001|Overall Study|Baseline cultures negative|2|||
44396510|NCT05102162|79403019|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
44396511|NCT05102162|79403020|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
44396512|NCT05102162|79403019|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
44396513|NCT05102162|79403020|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
44396514|NCT04899349|79403028|FG000|Overall Study|Study terminated by Sponsor|2|||
44396515|NCT04899349|79403029|FG001|Overall Study|Study terminated by Sponsor|0|||
44396516|NCT04891107|79403035|FG000|Overall Study|Physician Decision|1|||
44396517|NCT04891107|79403035|FG000|Overall Study|Withdrawal by Subject|1|||
44396518|NCT04891107|79403035|FG000|Overall Study|Screen failure after consent|1|||
44396519|NCT04848220|79403042|FG000|Overall Study|Unable to proceed to study procedure|0|||
44396520|NCT04848220|79403043|FG001|Overall Study|Unable to proceed to study procedure|1|||
44396521|NCT04848220|79403044|FG002|Overall Study|Unable to proceed to study procedure|0|||
44396522|NCT04848220|79403042|FG000|Overall Study|Fractional flow not significant|0|||
44396523|NCT04848220|79403043|FG001|Overall Study|Fractional flow not significant|1|||
44396524|NCT04848220|79403044|FG002|Overall Study|Fractional flow not significant|0|||
44396525|NCT04743804|79403054|FG000|Overall Study|Other|1|||
44396526|NCT04743804|79403055|FG001|Overall Study|Other|0|||
44396527|NCT04743804|79403054|FG000|Overall Study|Withdrawal by Subject|0|||
44396528|NCT04743804|79403055|FG001|Overall Study|Withdrawal by Subject|1|||
44396529|NCT04743804|79403054|FG000|Overall Study|Study Terminated by Sponsor|1|||
44396530|NCT04743804|79403055|FG001|Overall Study|Study Terminated by Sponsor|4|||
44396531|NCT04743804|79403054|FG000|Overall Study|Physician Decision|0|||
44396532|NCT04743804|79403055|FG001|Overall Study|Physician Decision|1|||
44396533|NCT04743804|79403054|FG000|Overall Study|Death|3|||
44396534|NCT04743804|79403055|FG001|Overall Study|Death|0|||
44396535|NCT04659161|79403063|FG000|Overall Study|Adverse Event|10|||
44396536|NCT04659161|79403064|FG001|Overall Study|Adverse Event|6|||
44396537|NCT04659161|79403063|FG000|Overall Study|Withdrawal by Subject|13|||
44396538|NCT04659161|79403064|FG001|Overall Study|Withdrawal by Subject|12|||
44396539|NCT04659161|79403063|FG000|Overall Study|Other|9|||
44396540|NCT04659161|79403064|FG001|Overall Study|Other|8|||
44396541|NCT04640766|79403070|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
44396542|NCT04214288|79403078|FG000|Overall Study|Ongoing in the study|41|||
44396543|NCT04214288|79403079|FG001|Overall Study|Ongoing in the study|51|||
44396544|NCT04214288|79403080|FG002|Overall Study|Ongoing in the study|12|||
44396545|NCT04214288|79403081|FG003|Overall Study|Ongoing in the study|39|||
44396546|NCT04214288|79403078|FG000|Overall Study|Adverse Event|1|||
44396547|NCT04214288|79403079|FG001|Overall Study|Adverse Event|0|||
44396548|NCT04214288|79403080|FG002|Overall Study|Adverse Event|0|||
44396549|NCT04214288|79403081|FG003|Overall Study|Adverse Event|0|||
44396550|NCT04214288|79403078|FG000|Overall Study|Death|22|||
44396551|NCT04214288|79403079|FG001|Overall Study|Death|13|||
44396552|NCT04214288|79403080|FG002|Overall Study|Death|7|||
44396553|NCT04214288|79403081|FG003|Overall Study|Death|19|||
44396554|NCT04214288|79403078|FG000|Overall Study|Lost to Follow-up|1|||
44396555|NCT04214288|79403079|FG001|Overall Study|Lost to Follow-up|2|||
44396556|NCT04214288|79403080|FG002|Overall Study|Lost to Follow-up|1|||
44396557|NCT04214288|79403081|FG003|Overall Study|Lost to Follow-up|0|||
44396558|NCT04214288|79403078|FG000|Overall Study|Other|1|||
44396559|NCT04214288|79403079|FG001|Overall Study|Other|2|||
44396560|NCT04214288|79403080|FG002|Overall Study|Other|0|||
44396561|NCT04214288|79403081|FG003|Overall Study|Other|6|||
44396562|NCT04214288|79403078|FG000|Overall Study|Protocol Violation|0|||
44396563|NCT04214288|79403079|FG001|Overall Study|Protocol Violation|1|||
44396564|NCT04214288|79403080|FG002|Overall Study|Protocol Violation|0|||
44396565|NCT04214288|79403081|FG003|Overall Study|Protocol Violation|0|||
44396566|NCT04214288|79403078|FG000|Overall Study|Withdrawal by Subject|8|||
44396567|NCT04214288|79403079|FG001|Overall Study|Withdrawal by Subject|4|||
44396568|NCT04214288|79403080|FG002|Overall Study|Withdrawal by Subject|0|||
44396569|NCT04214288|79403081|FG003|Overall Study|Withdrawal by Subject|9|||
44396570|NCT04118166|79403091|FG000|Overall Study|Adverse Event|1|||
44396571|NCT04034251|79403143|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
44396572|NCT04034251|79403144|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
44396573|NCT04034251|79403145|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
44396576|NCT03778294|79403159|FG000|Overall Study|Death|1|||
44396577|NCT03778294|79403159|FG000|Overall Study|Issues with insurance|1|||
44396578|NCT03778294|79403159|FG000|Overall Study|disease progression before treatment|2|||
44396579|NCT03662542|79403170|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
44396580|NCT03662542|79403171|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44520961|NCT02980042|79529170|FG001|Overall Study|Lost to Follow-up|0|||
44520962|NCT02980042|79529169|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
44520963|NCT02980042|79529170|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
44520964|NCT01066000|79529188|FG000|Overall Study|Protocol Violation|4|||
44520965|NCT01066000|79529188|FG000|Overall Study|Death|3|||
44520966|NCT01066000|79529188|FG000|Overall Study|Withdrawal by Subject|1|||
44520967|NCT01066000|79529188|FG000|Overall Study|Adverse Event|1|||
44520968|NCT01065844|79529192|FG000|Overall Study|Adverse Event|5|||
44520969|NCT00004635|79529198|FG000|Period One|refused|2|||
44520970|NCT00004635|79529199|FG001|Period One|refused|1|||
44147166|NCT00700817|78936666|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
44147167|NCT00700817|78936667|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
44147168|NCT00700817|78936663|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
44147169|NCT00700817|78936664|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
44147170|NCT00700817|78936665|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
44147171|NCT00700817|78936666|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
44147172|NCT00700817|78936667|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
44147173|NCT00700817|78936663|FG000|Week 0-26 (Main Period)|Unclassified|14|||
44147174|NCT00700817|78936664|FG001|Week 0-26 (Main Period)|Unclassified|4|||
44147175|NCT00700817|78936665|FG002|Week 0-26 (Main Period)|Unclassified|8|||
44147176|NCT00700817|78936666|FG003|Week 0-26 (Main Period)|Unclassified|0|||
44147177|NCT00700817|78936667|FG004|Week 0-26 (Main Period)|Unclassified|0|||
44147178|NCT00700817|78936663|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
44147179|NCT00700817|78936664|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
44147180|NCT00700817|78936665|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
44147181|NCT00700817|78936666|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
44147182|NCT00700817|78936667|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
44147183|NCT00700817|78936663|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
44147184|NCT00700817|78936664|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
44147185|NCT00700817|78936665|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
44252355|NCT01360632|79089366|FG004|Phase A (8 Weeks)|Physician Decision|0|||
44252356|NCT01360632|79089362|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
44252357|NCT01360632|79089363|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
44252358|NCT01360632|79089364|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
44252359|NCT01360632|79089365|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
44252360|NCT01360632|79089366|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
44252361|NCT01360632|79089362|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
44252362|NCT01360632|79089363|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
44252363|NCT01360632|79089364|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
44252364|NCT01360632|79089365|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
44396581|NCT03662542|79403172|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44520971|NCT00004635|79529198|FG000|Period One|Withdrawal by Subject|1|||
44147186|NCT00700817|78936666|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
44520972|NCT00004635|79529199|FG001|Period One|Withdrawal by Subject|1|||
44520973|NCT00004635|79529198|FG000|Period One|Protocol Violation|1|||
44147187|NCT00700817|78936667|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
44147188|NCT00700817|78936663|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
44281440|NCT01925274|79244687|FG001|Overall Study|Lost to Follow-up|1|||
44520974|NCT00004635|79529199|FG001|Period One|Protocol Violation|0|||
44147189|NCT00700817|78936664|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
44396582|NCT03662542|79403173|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44396583|NCT03662542|79403174|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44396584|NCT03662542|79403175|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44396585|NCT03662542|79403176|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44396586|NCT03662542|79403177|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44396587|NCT03662542|79403178|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
44396588|NCT03662542|79403170|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396589|NCT03662542|79403171|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
44396590|NCT03662542|79403172|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396591|NCT03662542|79403173|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396592|NCT03662542|79403174|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396593|NCT03662542|79403175|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396594|NCT03662542|79403176|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396595|NCT03662542|79403177|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396596|NCT03662542|79403178|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
44396597|NCT03662542|79403170|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
44396598|NCT03662542|79403171|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
44396599|NCT03662542|79403172|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
44396600|NCT03662542|79403173|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
44396601|NCT03662542|79403174|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
44396602|NCT03662542|79403175|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
44396603|NCT03662542|79403176|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
44396604|NCT03662542|79403177|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
44396605|NCT03662542|79403178|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
44396606|NCT03662542|79403170|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
44396607|NCT03662542|79403171|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44520975|NCT00004635|79529198|FG000|Period One|PSA did not go <5 ng/mL|1|||
44520976|NCT00004635|79529199|FG001|Period One|PSA did not go <5 ng/mL|0|||
44520977|NCT00004635|79529198|FG000|Period One|second malignancy|1|||
44520978|NCT00004635|79529199|FG001|Period One|second malignancy|0|||
44520979|NCT00004635|79529198|FG000|Period One|progressed|0|||
44520980|NCT00004635|79529199|FG001|Period One|progressed|2|||
44520981|NCT00004635|79529198|FG000|Period One|health problem|0|||
44147190|NCT00700817|78936665|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
44147191|NCT00700817|78936666|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
44147192|NCT00700817|78936667|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
44396608|NCT03662542|79403172|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44396609|NCT03662542|79403173|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44520982|NCT00004635|79529199|FG001|Period One|health problem|1|||
44520983|NCT00004635|79529198|FG000|Period One|discrepancy in data entry|0|||
44147193|NCT00700817|78936663|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
44147194|NCT00700817|78936664|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
44147195|NCT00700817|78936665|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
44147196|NCT00700817|78936666|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
44147197|NCT00700817|78936667|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
44147198|NCT00700817|78936663|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
44147199|NCT00700817|78936664|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
44147200|NCT00700817|78936665|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
44147201|NCT00700817|78936666|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
44147202|NCT00700817|78936667|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
44147203|NCT00700817|78936663|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
44147204|NCT00700817|78936664|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
44147205|NCT00700817|78936665|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
44396610|NCT03662542|79403174|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44396611|NCT03662542|79403175|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44396612|NCT03662542|79403176|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44520984|NCT00004635|79529199|FG001|Period One|discrepancy in data entry|1|||
44520985|NCT00004635|79529198|FG000|Period Two|progression|2|||
44520986|NCT00004635|79529199|FG001|Period Two|progression|3|||
44520987|NCT00004635|79529198|FG000|Period Two|Adverse Event|1|||
44520988|NCT00004635|79529199|FG001|Period Two|Adverse Event|0|||
44520989|NCT00004635|79529198|FG000|Period Two|refused|0|||
44520990|NCT00004635|79529199|FG001|Period Two|refused|2|||
44520991|NCT00004635|79529198|FG000|Period Two|health problem|1|||
44520992|NCT00004635|79529199|FG001|Period Two|health problem|1|||
44147206|NCT00700817|78936666|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
44520993|NCT00004635|79529198|FG000|Period Two|travel issues|0|||
44520994|NCT00004635|79529199|FG001|Period Two|travel issues|1|||
44520995|NCT00004635|79529198|FG000|Period Two|secondary malignancy|1|||
44520996|NCT00004635|79529199|FG001|Period Two|secondary malignancy|1|||
44520997|NCT00004635|79529198|FG000|Period Two|Lost to Follow-up|1|||
44520998|NCT00004635|79529199|FG001|Period Two|Lost to Follow-up|0|||
44147207|NCT00700817|78936667|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
44147208|NCT00700817|78936663|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
44147209|NCT00700817|78936664|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
44147210|NCT00700817|78936665|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
44252365|NCT01360632|79089366|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
44252366|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
44252367|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
44396613|NCT03662542|79403177|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44396614|NCT03662542|79403178|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
44396615|NCT03662542|79403170|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396616|NCT03662542|79403171|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396617|NCT03662542|79403172|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396618|NCT03662542|79403173|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396619|NCT03662542|79403174|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396620|NCT03662542|79403175|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
44396621|NCT03662542|79403176|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396622|NCT03662542|79403177|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396623|NCT03662542|79403178|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
44396624|NCT03662542|79403170|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396625|NCT03662542|79403171|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396626|NCT03662542|79403172|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396627|NCT03662542|79403173|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
44396628|NCT03662542|79403174|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
44396629|NCT03662542|79403175|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396630|NCT03662542|79403176|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396631|NCT03662542|79403177|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396632|NCT03662542|79403178|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
44396633|NCT03662542|79403170|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
44396634|NCT03662542|79403171|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
44396635|NCT03662542|79403172|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
44396636|NCT03662542|79403173|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
44396637|NCT03662542|79403174|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
44396638|NCT03662542|79403175|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
44396639|NCT03662542|79403176|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
44396640|NCT03662542|79403177|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
44396641|NCT03662542|79403178|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
44396642|NCT03662542|79403170|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396643|NCT03662542|79403171|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396644|NCT03662542|79403172|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396645|NCT03662542|79403173|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396646|NCT03662542|79403174|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
44396647|NCT03662542|79403175|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
44396648|NCT03662542|79403176|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396649|NCT03662542|79403177|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396650|NCT03662542|79403178|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
44396651|NCT03662542|79403170|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396652|NCT03662542|79403171|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396653|NCT03662542|79403172|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44252368|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
44252369|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
44396654|NCT03662542|79403173|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396655|NCT03662542|79403174|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396656|NCT03662542|79403175|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
44396657|NCT03662542|79403176|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396658|NCT03662542|79403177|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396659|NCT03662542|79403178|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
44396660|NCT03662542|79403170|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396661|NCT03662542|79403171|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396662|NCT03662542|79403172|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396663|NCT03662542|79403173|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396664|NCT03662542|79403174|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396665|NCT03662542|79403175|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396666|NCT03662542|79403176|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396667|NCT03662542|79403177|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
44396668|NCT03662542|79403178|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
44396669|NCT03662542|79403170|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396670|NCT03662542|79403171|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396671|NCT03662542|79403172|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396672|NCT03662542|79403173|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396673|NCT03662542|79403174|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396674|NCT03662542|79403175|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396675|NCT03662542|79403176|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
44396676|NCT03662542|79403177|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
44396677|NCT03662542|79403178|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
44396678|NCT03662542|79403170|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396679|NCT03662542|79403171|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396680|NCT03662542|79403172|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396681|NCT03662542|79403173|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396682|NCT03662542|79403174|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396683|NCT03662542|79403175|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396684|NCT03662542|79403176|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
44396685|NCT03662542|79403177|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
44396686|NCT03662542|79403178|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
44396687|NCT03662542|79403170|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
44396688|NCT03662542|79403171|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
44396689|NCT03662542|79403172|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
44396690|NCT03662542|79403173|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
44396691|NCT03662542|79403174|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
44396692|NCT03662542|79403175|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
44396693|NCT03662542|79403176|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
44396694|NCT03662542|79403177|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
44396695|NCT03662542|79403178|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
44396696|NCT03555591|79403201|FG000|Overall Study|Protocol Violation|77|||
44396697|NCT03525392|79403210|FG000|Overall Study|Adverse Event|1|||
44396698|NCT03525392|79403211|FG001|Overall Study|Adverse Event|0|||
44396699|NCT03525392|79403212|FG002|Overall Study|Adverse Event|2|||
44396700|NCT03525392|79403213|FG003|Overall Study|Adverse Event|0|||
44396701|NCT03525392|79403214|FG004|Overall Study|Adverse Event|0|||
44396702|NCT03525392|79403210|FG000|Overall Study|Progressive disease|0|||
44396703|NCT03525392|79403211|FG001|Overall Study|Progressive disease|1|||
44396704|NCT03525392|79403212|FG002|Overall Study|Progressive disease|1|||
44396705|NCT03525392|79403213|FG003|Overall Study|Progressive disease|3|||
44396706|NCT03525392|79403214|FG004|Overall Study|Progressive disease|1|||
44396707|NCT03496662|79403230|FG000|Overall Study|Adverse Event|1|||
44396708|NCT03496662|79403231|FG001|Overall Study|Adverse Event|0|||
44396709|NCT03496662|79403232|FG002|Overall Study|Adverse Event|1|||
44396710|NCT03496662|79403230|FG000|Overall Study|Physician Decision|1|||
44396711|NCT03496662|79403231|FG001|Overall Study|Physician Decision|0|||
44396712|NCT03496662|79403232|FG002|Overall Study|Physician Decision|3|||
44396713|NCT03496662|79403230|FG000|Overall Study|Withdrawal by Subject|0|||
44396714|NCT03496662|79403231|FG001|Overall Study|Withdrawal by Subject|0|||
44396715|NCT03496662|79403232|FG002|Overall Study|Withdrawal by Subject|2|||
44396716|NCT03496662|79403230|FG000|Overall Study|Death|0|||
44396717|NCT03496662|79403231|FG001|Overall Study|Death|0|||
44396718|NCT03496662|79403232|FG002|Overall Study|Death|2|||
44281441|NCT01925274|79244688|FG002|Overall Study|Lost to Follow-up|0|||
44281442|NCT01925274|79244686|FG000|Overall Study|Withdrawal by Subject|1|||
44281443|NCT01925274|79244687|FG001|Overall Study|Withdrawal by Subject|2|||
44396719|NCT03496662|79403230|FG000|Overall Study|Noncompliance|0|||
44396720|NCT03496662|79403231|FG001|Overall Study|Noncompliance|0|||
44396721|NCT03496662|79403232|FG002|Overall Study|Noncompliance|1|||
44396722|NCT03472885|79403240|FG000|24-Week Treatment Period|Adverse Event|1|||
44396723|NCT03117049|79403258|FG000|Overall Study|Continued the follow-up period|109|||
44396724|NCT03117049|79403259|FG001|Overall Study|Continued the follow-up period|129|||
44396725|NCT03117049|79403258|FG000|Overall Study|Died|82|||
44396726|NCT03117049|79403259|FG001|Overall Study|Died|93|||
44396727|NCT03117049|79403258|FG000|Overall Study|Consent withdrawal|7|||
44396728|NCT03117049|79403259|FG001|Overall Study|Consent withdrawal|6|||
44396729|NCT03117049|79403258|FG000|Overall Study|Missing contact|3|||
44396730|NCT03117049|79403259|FG001|Overall Study|Missing contact|3|||
44396731|NCT02716038|79403278|FG000|Overall Study|Not evaluable|1|||
44396732|NCT02716038|79403278|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
44396733|NCT02716038|79403278|FG000|Overall Study|Unresectable|3|||
44396734|NCT02512068|79403284|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
44396735|NCT02512068|79403285|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
44396736|NCT02512068|79403284|FG000|Overall Study|Major Protocol Deviation|1|||
44396737|NCT02512068|79403285|FG001|Overall Study|Major Protocol Deviation|0|||
44396738|NCT02512068|79403284|FG000|Overall Study|Voluntary Withdrawal|0|||
44396739|NCT02512068|79403285|FG001|Overall Study|Voluntary Withdrawal|1|||
44396740|NCT02512068|79403284|FG000|Overall Study|Lack of Efficacy|0|||
44396741|NCT02512068|79403285|FG001|Overall Study|Lack of Efficacy|1|||
44396742|NCT02512068|79403284|FG000|Overall Study|Reason Not Specified|3|||
44396743|NCT02512068|79403285|FG001|Overall Study|Reason Not Specified|5|||
44396744|NCT02324569|79403302|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
44396745|NCT02324569|79403303|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
44396746|NCT02324569|79403302|FG000|Overall Study|Voluntary Withdrawal|3|||
44396747|NCT02324569|79403303|FG001|Overall Study|Voluntary Withdrawal|6|||
44396748|NCT02324569|79403302|FG000|Overall Study|Lack of Efficacy|2|||
44396749|NCT02324569|79403303|FG001|Overall Study|Lack of Efficacy|3|||
44396750|NCT02324569|79403302|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
44396751|NCT02324569|79403303|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
44396752|NCT02324569|79403302|FG000|Overall Study|Inconvenient Schedule|2|||
44396753|NCT02324569|79403303|FG001|Overall Study|Inconvenient Schedule|0|||
44396754|NCT02038075|79403341|FG000|Overall Study|Withdrawal by Subject|3|||
44396755|NCT02038075|79403342|FG001|Overall Study|Withdrawal by Subject|0|||
44396756|NCT01864746|79403350|FG000|Overall Study|Disease recurrence|25|||
44396757|NCT01864746|79403351|FG001|Overall Study|Disease recurrence|40|||
44396758|NCT01864746|79403350|FG000|Overall Study|Second primary invasive nonbreast|2|||
44396759|NCT01864746|79403351|FG001|Overall Study|Second primary invasive nonbreast|3|||
44396760|NCT01864746|79403350|FG000|Overall Study|Death|2|||
44396761|NCT01864746|79403351|FG001|Overall Study|Death|1|||
44396762|NCT01864746|79403350|FG000|Overall Study|Adverse Event|33|||
44396763|NCT01864746|79403351|FG001|Overall Study|Adverse Event|5|||
44396764|NCT01864746|79403350|FG000|Overall Study|Withdrawal by Subject|56|||
44396765|NCT01864746|79403351|FG001|Overall Study|Withdrawal by Subject|41|||
44396766|NCT01864746|79403350|FG000|Overall Study|Physician Decision|5|||
44396767|NCT01864746|79403351|FG001|Overall Study|Physician Decision|6|||
44396768|NCT00590577|79403398|FG000|Overall Study|Lack of Efficacy|31|||
44396769|NCT00590577|79403399|FG001|Overall Study|Lack of Efficacy|28|||
44396770|NCT00590577|79403400|FG002|Overall Study|Lack of Efficacy|23|||
44396771|NCT00590577|79403401|FG003|Overall Study|Lack of Efficacy|45|||
44396772|NCT00590577|79403398|FG000|Overall Study|Withdrawal by Subject|23|||
44396773|NCT00590577|79403399|FG001|Overall Study|Withdrawal by Subject|28|||
44396774|NCT00590577|79403400|FG002|Overall Study|Withdrawal by Subject|30|||
44396775|NCT00590577|79403401|FG003|Overall Study|Withdrawal by Subject|26|||
44396776|NCT00590577|79403398|FG000|Overall Study|Adverse Event|10|||
44396777|NCT00590577|79403399|FG001|Overall Study|Adverse Event|10|||
44396778|NCT00590577|79403400|FG002|Overall Study|Adverse Event|13|||
44396779|NCT00590577|79403401|FG003|Overall Study|Adverse Event|11|||
44396780|NCT00590577|79403398|FG000|Overall Study|Lost to Follow-up|12|||
44396781|NCT00590577|79403399|FG001|Overall Study|Lost to Follow-up|6|||
44396782|NCT00590577|79403400|FG002|Overall Study|Lost to Follow-up|6|||
44396783|NCT00590577|79403401|FG003|Overall Study|Lost to Follow-up|9|||
44396784|NCT00590577|79403398|FG000|Overall Study|Pregnancy|0|||
44396785|NCT00590577|79403399|FG001|Overall Study|Pregnancy|1|||
44396786|NCT00590577|79403400|FG002|Overall Study|Pregnancy|0|||
44396787|NCT00590577|79403401|FG003|Overall Study|Pregnancy|0|||
44396788|NCT00590577|79403398|FG000|Overall Study|Various reasons|1|||
44396789|NCT00590577|79403399|FG001|Overall Study|Various reasons|3|||
44396790|NCT00590577|79403400|FG002|Overall Study|Various reasons|1|||
44396791|NCT00590577|79403401|FG003|Overall Study|Various reasons|2|||
44396792|NCT00614575|79403411|FG000|Overall Study|Adverse Event|106|||
44396793|NCT00614575|79403411|FG000|Overall Study|Lost to Follow-up|55|||
44396794|NCT00614575|79403411|FG000|Overall Study|Lack of Efficacy|14|||
44396795|NCT00614575|79403411|FG000|Overall Study|Withdrawal by Subject|6|||
44396796|NCT00614575|79403411|FG000|Overall Study|Death|3|||
44396797|NCT00614575|79403411|FG000|Overall Study|Physician Decision|2|||
44396798|NCT00614575|79403411|FG000|Overall Study|No data were collected.|18|||
44396799|NCT00614575|79403411|FG000|Overall Study|Irregularly enrolled patients|23|||
44396800|NCT00614575|79403411|FG000|Overall Study|No treatment|1|||
44396801|NCT00805935|79403419|FG000|Overall Study|Stimulation Failure|1|||
44396802|NCT00805935|79403420|FG001|Overall Study|Stimulation Failure|5|||
44396803|NCT00805935|79403421|FG002|Overall Study|Stimulation Failure|2|||
44396804|NCT00805935|79403422|FG003|Overall Study|Stimulation Failure|2|||
44396805|NCT00805935|79403419|FG000|Overall Study|Cycle cancelled|0|||
44396806|NCT00805935|79403420|FG001|Overall Study|Cycle cancelled|0|||
44396807|NCT00805935|79403421|FG002|Overall Study|Cycle cancelled|2|||
44396808|NCT00805935|79403422|FG003|Overall Study|Cycle cancelled|0|||
44396809|NCT00805935|79403419|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
44396810|NCT00805935|79403420|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
44396811|NCT00805935|79403421|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
44396812|NCT00805935|79403422|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
44396813|NCT00805935|79403419|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
44396814|NCT00805935|79403420|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
44396815|NCT00805935|79403421|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
44396816|NCT00805935|79403422|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
44396817|NCT00805935|79403419|FG000|Overall Study|Lost to Follow-up|1|||
44396818|NCT00805935|79403420|FG001|Overall Study|Lost to Follow-up|0|||
44396819|NCT00805935|79403421|FG002|Overall Study|Lost to Follow-up|0|||
44396820|NCT00805935|79403422|FG003|Overall Study|Lost to Follow-up|0|||
44396821|NCT00805935|79403419|FG000|Overall Study|No positive serum pregnancy|8|||
44396822|NCT00805935|79403420|FG001|Overall Study|No positive serum pregnancy|7|||
44396823|NCT00805935|79403421|FG002|Overall Study|No positive serum pregnancy|6|||
44396824|NCT00805935|79403422|FG003|Overall Study|No positive serum pregnancy|5|||
44396825|NCT00805935|79403419|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
44396826|NCT00805935|79403420|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
44396827|NCT00805935|79403421|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
44396828|NCT00805935|79403422|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
44396829|NCT00805935|79403419|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
44396830|NCT00805935|79403420|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
44396831|NCT00805935|79403421|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
44396832|NCT00805935|79403422|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
44396833|NCT00805935|79403419|FG000|Overall Study|Biochemical pregnancy|0|||
44396834|NCT00805935|79403420|FG001|Overall Study|Biochemical pregnancy|1|||
44396835|NCT00805935|79403421|FG002|Overall Study|Biochemical pregnancy|0|||
44396836|NCT00805935|79403422|FG003|Overall Study|Biochemical pregnancy|0|||
44396837|NCT00805935|79403419|FG000|Overall Study|Chemical pregnancy|0|||
44396838|NCT00805935|79403420|FG001|Overall Study|Chemical pregnancy|5|||
44396839|NCT00805935|79403421|FG002|Overall Study|Chemical pregnancy|3|||
44396840|NCT00805935|79403422|FG003|Overall Study|Chemical pregnancy|2|||
44396841|NCT00805935|79403419|FG000|Overall Study|Ectopic pregnancy|0|||
44396842|NCT00805935|79403420|FG001|Overall Study|Ectopic pregnancy|0|||
44396843|NCT00805935|79403421|FG002|Overall Study|Ectopic pregnancy|1|||
44396844|NCT00805935|79403422|FG003|Overall Study|Ectopic pregnancy|0|||
44396845|NCT00805935|79403419|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
44396846|NCT00805935|79403420|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
44396847|NCT00805935|79403421|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
44396848|NCT00805935|79403422|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
44147211|NCT00700817|78936666|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
44147212|NCT00700817|78936667|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
44147213|NCT00700817|78936663|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
44252370|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
44252371|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Adverse Event|0|||
44281444|NCT01925274|79244688|FG002|Overall Study|Withdrawal by Subject|0|||
44281445|NCT01925274|79244686|FG000|Overall Study|Study terminated by sponsor|4|||
44252372|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Adverse Event|3|||
44252373|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Adverse Event|9|||
44252374|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Adverse Event|3|||
44252375|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Adverse Event|0|||
44252376|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
44252377|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
44252378|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
44252379|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
44252380|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
44252381|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Physician Decision|0|||
44252382|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Physician Decision|0|||
44252383|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Physician Decision|0|||
44252384|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Physician Decision|1|||
44252385|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Physician Decision|0|||
44252386|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
44252387|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
44281446|NCT01925274|79244687|FG001|Overall Study|Study terminated by sponsor|0|||
44396849|NCT00805545|79403436|FG000|Overall Study|Protocol Violation|3|||
44396850|NCT00805545|79403437|FG001|Overall Study|Protocol Violation|2|||
44396851|NCT00805545|79403436|FG000|Overall Study|Protocol Violation|3|||
44396852|NCT00805545|79403437|FG001|Overall Study|Protocol Violation|1|||
44396853|NCT00590031|79403469|FG000|Overall Study|Adverse Event|3|||
44396854|NCT00590031|79403469|FG000|Overall Study|Withdrawal by Subject|1|||
44396855|NCT00590031|79403469|FG000|Overall Study|Metastatic Disease|1|||
44252388|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
44252389|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
44252390|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
44252391|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
44252392|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
44252393|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
44252394|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
44252395|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
44252396|NCT01360632|79089362|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
44252397|NCT01360632|79089363|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
44281447|NCT01925274|79244688|FG002|Overall Study|Study terminated by sponsor|0|||
44281448|NCT01925274|79244686|FG000|Overall Study|Protocol amendment|1|||
44281449|NCT01925274|79244687|FG001|Overall Study|Protocol amendment|3|||
44281450|NCT01925274|79244688|FG002|Overall Study|Protocol amendment|6|||
44281451|NCT01948830|79244700|FG000|Overall Study|Physician Decision|1|||
44281452|NCT01948830|79244701|FG001|Overall Study|Physician Decision|3|||
44281453|NCT01948830|79244700|FG000|Overall Study|Protocol deviation|1|||
44281454|NCT01948830|79244701|FG001|Overall Study|Protocol deviation|2|||
44281455|NCT01948830|79244700|FG000|Overall Study|Lost to Follow-up|5|||
44281456|NCT01948830|79244701|FG001|Overall Study|Lost to Follow-up|4|||
44281457|NCT01948830|79244700|FG000|Overall Study|Withdrawal by Subject|14|||
44281458|NCT01948830|79244701|FG001|Overall Study|Withdrawal by Subject|17|||
44281459|NCT01948830|79244700|FG000|Overall Study|Adverse Event|9|||
44281460|NCT01948830|79244701|FG001|Overall Study|Adverse Event|2|||
44281461|NCT01948830|79244700|FG000|Overall Study|Death|3|||
44281462|NCT01948830|79244701|FG001|Overall Study|Death|4|||
44281463|NCT01972464|79244709|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
44281464|NCT01972464|79244710|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
44281465|NCT01972464|79244709|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
44281466|NCT01972464|79244710|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
44281467|NCT01972464|79244709|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
44281468|NCT01972464|79244710|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
44281469|NCT01972464|79244709|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
44281470|NCT01972464|79244710|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
44281471|NCT01948050|79244719|FG000|Overall Study|Withdrawal by Subject|0|||
44281472|NCT01948050|79244720|FG001|Overall Study|Withdrawal by Subject|1|||
44281473|NCT01947894|79244729|FG000|Overall Study|Other|3|||
44281474|NCT01947894|79244730|FG001|Overall Study|Other|4|||
44281475|NCT01947894|79244731|FG002|Overall Study|Other|3|||
44281476|NCT01947894|79244729|FG000|Overall Study|Withdrawal by Subject|12|||
44281477|NCT01947894|79244730|FG001|Overall Study|Withdrawal by Subject|4|||
44281478|NCT01947894|79244731|FG002|Overall Study|Withdrawal by Subject|1|||
44281479|NCT01947894|79244729|FG000|Overall Study|Death|12|||
44281480|NCT01947894|79244730|FG001|Overall Study|Death|1|||
44281481|NCT01947894|79244731|FG002|Overall Study|Death|0|||
44281482|NCT01947894|79244729|FG000|Overall Study|Physician Decision|2|||
44281483|NCT01947894|79244730|FG001|Overall Study|Physician Decision|0|||
44281484|NCT01947894|79244731|FG002|Overall Study|Physician Decision|0|||
44281485|NCT01947894|79244729|FG000|Overall Study|Adverse Event|5|||
44281486|NCT01947894|79244730|FG001|Overall Study|Adverse Event|1|||
44281487|NCT01947894|79244731|FG002|Overall Study|Adverse Event|0|||
44281488|NCT01947894|79244729|FG000|Overall Study|Switched to other growth hormone brand|53|||
44281489|NCT01947894|79244730|FG001|Overall Study|Switched to other growth hormone brand|8|||
44281490|NCT01947894|79244731|FG002|Overall Study|Switched to other growth hormone brand|23|||
44281491|NCT01947582|79244739|FG000|Overall Study|Withdrawal by Subject|1|||
44281492|NCT01924806|79244745|FG000|Overall Study|Physician Decision|2|||
44281493|NCT01924806|79244746|FG001|Overall Study|Physician Decision|1|||
44281494|NCT01924182|79244754|FG000|Overall Study|Withdrawal by Subject|1|||
44281495|NCT01924182|79244755|FG001|Overall Study|Withdrawal by Subject|0|||
44281496|NCT01972308|79244763|FG000|Overall Study|Withdrawal by Subject|0|||
44281497|NCT01972308|79244764|FG001|Overall Study|Withdrawal by Subject|1|||
44281498|NCT01972308|79244763|FG000|Overall Study|Lost to Follow-up|4|||
44281499|NCT01972308|79244764|FG001|Overall Study|Lost to Follow-up|6|||
44281500|NCT01972308|79244763|FG000|Overall Study|Death|4|||
44281501|NCT01972308|79244764|FG001|Overall Study|Death|1|||
44281502|NCT01946880|79244774|FG000|Overall Study|Lost to Follow-up|1|||
44281503|NCT01946880|79244775|FG001|Overall Study|Lost to Follow-up|0|||
44281504|NCT01946880|79244774|FG000|Overall Study|Physician Decision|1|||
44281505|NCT01946880|79244775|FG001|Overall Study|Physician Decision|1|||
44281506|NCT01946880|79244774|FG000|Overall Study|Withdrawal by Subject|3|||
44281507|NCT01946880|79244775|FG001|Overall Study|Withdrawal by Subject|2|||
44281508|NCT01946880|79244774|FG000|Overall Study|Met Primary Endpoint|1|||
44281509|NCT01946880|79244775|FG001|Overall Study|Met Primary Endpoint|0|||
44281510|NCT01946880|79244774|FG000|Overall Study|Personal and Family Issues|1|||
44281511|NCT01946880|79244775|FG001|Overall Study|Personal and Family Issues|0|||
44281512|NCT01972152|79244781|FG000|First Treatment Visit|Lost to Follow-up|0|||
44520999|NCT00004635|79529198|FG000|Period Two|discrepancy in data entry|0|||
44521000|NCT00004635|79529199|FG001|Period Two|discrepancy in data entry|1|||
44521001|NCT00004563|79529210|FG000|Overall Study|Withdrawal by Subject|20|||
44521002|NCT00004563|79529211|FG001|Overall Study|Withdrawal by Subject|16|||
44521003|NCT00004563|79529210|FG000|Overall Study|Lack of Efficacy|3|||
44521004|NCT00004563|79529211|FG001|Overall Study|Lack of Efficacy|5|||
44521005|NCT00004563|79529210|FG000|Overall Study|Death|2|||
44521006|NCT00004563|79529211|FG001|Overall Study|Death|3|||
44521007|NCT00003645|79529219|FG000|Overall Study|Death|4|||
44521008|NCT00003645|79529220|FG001|Overall Study|Death|1|||
44521009|NCT00003645|79529219|FG000|Overall Study|Lost to Follow-up|7|||
44521010|NCT00003645|79529220|FG001|Overall Study|Lost to Follow-up|8|||
44521011|NCT00003645|79529219|FG000|Overall Study|Withdrawal by Subject|1|||
44521012|NCT00003645|79529220|FG001|Overall Study|Withdrawal by Subject|3|||
44521013|NCT00003537|79529228|FG000|Overall Study|Not evalauable|1|||
44521014|NCT00003531|79529232|FG000|Overall Study|Not evaluable|10|||
44521015|NCT02918968|79529238|FG000|1st Line AAT|Progressive disease|9|||
44521016|NCT02918968|79529239|FG001|1st Line AAT|Progressive disease|4|||
44521017|NCT02918968|79529238|FG000|1st Line AAT|Adverse Event|12|||
44521018|NCT02918968|79529239|FG001|1st Line AAT|Adverse Event|3|||
44521019|NCT02918968|79529238|FG000|1st Line AAT|Physician Decision|4|||
44396856|NCT00590031|79403469|FG000|Overall Study|Admin Hold|1|||
44396857|NCT00615199|79403477|FG000|Overall Study|Adverse Event|3|||
44396858|NCT00615199|79403478|FG001|Overall Study|Adverse Event|1|||
44396859|NCT00615199|79403479|FG002|Overall Study|Adverse Event|1|||
44396860|NCT00615199|79403480|FG003|Overall Study|Adverse Event|0|||
44396861|NCT00615199|79403477|FG000|Overall Study|Lack of Efficacy|2|||
44396862|NCT00615199|79403478|FG001|Overall Study|Lack of Efficacy|0|||
44396863|NCT00615199|79403479|FG002|Overall Study|Lack of Efficacy|0|||
44396864|NCT00615199|79403480|FG003|Overall Study|Lack of Efficacy|1|||
44396865|NCT00615199|79403477|FG000|Overall Study|Lost to Follow-up|1|||
44396866|NCT00615199|79403478|FG001|Overall Study|Lost to Follow-up|0|||
44396867|NCT00615199|79403479|FG002|Overall Study|Lost to Follow-up|0|||
44396868|NCT00615199|79403480|FG003|Overall Study|Lost to Follow-up|0|||
44396869|NCT00615199|79403477|FG000|Overall Study|Other|0|||
44396870|NCT00615199|79403478|FG001|Overall Study|Other|0|||
44396871|NCT00615199|79403479|FG002|Overall Study|Other|0|||
44396872|NCT00615199|79403480|FG003|Overall Study|Other|1|||
44396873|NCT00615199|79403477|FG000|Overall Study|Withdrawal by Subject|2|||
44396874|NCT00615199|79403478|FG001|Overall Study|Withdrawal by Subject|1|||
44396875|NCT00615199|79403479|FG002|Overall Study|Withdrawal by Subject|0|||
44396876|NCT00615199|79403480|FG003|Overall Study|Withdrawal by Subject|0|||
44396877|NCT00613951|79403493|FG000|Overall Study|Adverse Event|1|||
44396878|NCT00613951|79403494|FG001|Overall Study|Adverse Event|0|||
44396879|NCT00613951|79403495|FG002|Overall Study|Adverse Event|1|||
44396880|NCT00613951|79403493|FG000|Overall Study|Lack of Efficacy|0|||
44396881|NCT00613951|79403494|FG001|Overall Study|Lack of Efficacy|1|||
44396882|NCT00613951|79403495|FG002|Overall Study|Lack of Efficacy|1|||
44396883|NCT00613951|79403493|FG000|Overall Study|Protocol Violation|1|||
44396884|NCT00613951|79403494|FG001|Overall Study|Protocol Violation|1|||
44396885|NCT00613951|79403495|FG002|Overall Study|Protocol Violation|1|||
44396886|NCT00613951|79403493|FG000|Overall Study|Unclassified|5|||
44396887|NCT00613951|79403494|FG001|Overall Study|Unclassified|3|||
44396888|NCT00613951|79403495|FG002|Overall Study|Unclassified|2|||
44396889|NCT00805467|79403510|FG000|Overall Study|Lack of Efficacy|0|||
44396890|NCT00805467|79403511|FG001|Overall Study|Lack of Efficacy|8|||
44396891|NCT00805467|79403512|FG002|Overall Study|Lack of Efficacy|13|||
44396892|NCT00805467|79403513|FG003|Overall Study|Lack of Efficacy|86|||
44396893|NCT00805467|79403510|FG000|Overall Study|Lost to Follow-up|0|||
44396894|NCT00805467|79403511|FG001|Overall Study|Lost to Follow-up|1|||
44396895|NCT00805467|79403512|FG002|Overall Study|Lost to Follow-up|7|||
44396896|NCT00805467|79403513|FG003|Overall Study|Lost to Follow-up|21|||
44396897|NCT00805467|79403510|FG000|Overall Study|Withdrawal by Subject|0|||
44396898|NCT00805467|79403511|FG001|Overall Study|Withdrawal by Subject|6|||
44396899|NCT00805467|79403512|FG002|Overall Study|Withdrawal by Subject|45|||
44396900|NCT00805467|79403513|FG003|Overall Study|Withdrawal by Subject|50|||
44396901|NCT00805467|79403510|FG000|Overall Study|Protocol Violation|0|||
44396902|NCT00805467|79403511|FG001|Overall Study|Protocol Violation|3|||
44521020|NCT02918968|79529239|FG001|1st Line AAT|Physician Decision|2|||
44521021|NCT02918968|79529238|FG000|1st Line AAT|Withdrawal by Subject|2|||
44521022|NCT02918968|79529239|FG001|1st Line AAT|Withdrawal by Subject|1|||
44521023|NCT02918968|79529238|FG000|1st Line AAT|Lost to Follow-up|0|||
44521024|NCT02918968|79529239|FG001|1st Line AAT|Lost to Follow-up|1|||
44396903|NCT00805467|79403512|FG002|Overall Study|Protocol Violation|0|||
44396904|NCT00805467|79403513|FG003|Overall Study|Protocol Violation|5|||
44396905|NCT00805467|79403510|FG000|Overall Study|Adverse Event|0|||
44396906|NCT00805467|79403511|FG001|Overall Study|Adverse Event|13|||
44396907|NCT00805467|79403512|FG002|Overall Study|Adverse Event|26|||
44396908|NCT00805467|79403513|FG003|Overall Study|Adverse Event|57|||
44396909|NCT00805467|79403510|FG000|Overall Study|Death|0|||
44521025|NCT02918968|79529238|FG000|1st Line AAT|Death|1|||
44396910|NCT00805467|79403511|FG001|Overall Study|Death|2|||
44396911|NCT00805467|79403512|FG002|Overall Study|Death|7|||
44396912|NCT00805467|79403513|FG003|Overall Study|Death|5|||
44396913|NCT00805467|79403510|FG000|Overall Study|Physician Decision|0|||
44396914|NCT00805467|79403511|FG001|Overall Study|Physician Decision|1|||
44396915|NCT00805467|79403512|FG002|Overall Study|Physician Decision|2|||
44396916|NCT00805467|79403513|FG003|Overall Study|Physician Decision|6|||
44396917|NCT00805467|79403510|FG000|Overall Study|Not reported|0|||
44396918|NCT00805467|79403511|FG001|Overall Study|Not reported|0|||
44396919|NCT00805467|79403512|FG002|Overall Study|Not reported|3|||
44396920|NCT00805467|79403513|FG003|Overall Study|Not reported|7|||
44396921|NCT00958841|79403523|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44396922|NCT00958841|79403523|FG000|Overall Study|Abnormal test procedure result(s)|3|||
44396923|NCT00958841|79403523|FG000|Overall Study|Administrative problems|1|||
44396924|NCT00958841|79403523|FG000|Overall Study|Adverse Event|8|||
44396925|NCT00958841|79403523|FG000|Overall Study|New cancer therapy|5|||
44396926|NCT00958841|79403523|FG000|Overall Study|Withdrawal by Subject|1|||
44396927|NCT00958841|79403523|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
44396928|NCT00958841|79403523|FG000|Overall Study|Completed M6/did not enter extension|27|||
44396929|NCT00958841|79403523|FG000|Overall Study|Discontinued prior to M*|28|||
44396930|NCT03927105|79403586|FG000|Overall Study|Death|1|||
44396931|NCT03927105|79403586|FG000|Overall Study|In observation for potential re-treatment|2|||
44396932|NCT03927105|79403586|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
44396933|NCT00613327|79403590|FG000|Overall Study|Adverse Event|38|||
44396934|NCT00613327|79403590|FG000|Overall Study|Lost to Follow-up|8|||
44396935|NCT00613327|79403590|FG000|Overall Study|Withdrawal by Subject|6|||
44396936|NCT00613327|79403590|FG000|Overall Study|Protocol Violation|2|||
44396937|NCT00613327|79403590|FG000|Overall Study|Other|47|||
44396938|NCT00954941|79403596|FG000|Overall Study|Received treatment at home|1|||
44396939|NCT00954941|79403597|FG001|Overall Study|Received treatment at home|0|||
44396940|NCT00954941|79403596|FG000|Overall Study|Withdrawal by Subject|1|||
44396941|NCT00954941|79403597|FG001|Overall Study|Withdrawal by Subject|0|||
44396942|NCT00954941|79403596|FG000|Overall Study|Insurance Denial|2|||
44396943|NCT00954941|79403597|FG001|Overall Study|Insurance Denial|2|||
44396944|NCT00954941|79403596|FG000|Overall Study|Physician Decision|2|||
44396945|NCT00954941|79403597|FG001|Overall Study|Physician Decision|2|||
44396946|NCT00954941|79403596|FG000|Overall Study|Ineligible|2|||
44396947|NCT00954941|79403597|FG001|Overall Study|Ineligible|2|||
44396948|NCT00954941|79403596|FG000|Overall Study|Adverse Event|0|||
44396949|NCT00954941|79403597|FG001|Overall Study|Adverse Event|1|||
44396950|NCT00954707|79403603|FG000|Overall Study|Death|34|||
44396951|NCT00954707|79403603|FG000|Overall Study|Withdrawal by Subject|100|||
44396952|NCT00954707|79403603|FG000|Overall Study|Lost to Follow-up|33|||
44396953|NCT00589797|79403609|FG000|Overall Study|Death|1|||
44396954|NCT00589797|79403610|FG001|Overall Study|Death|0|||
44396955|NCT00589797|79403609|FG000|Overall Study|Lost to Follow-up|12|||
44396956|NCT00589797|79403610|FG001|Overall Study|Lost to Follow-up|9|||
44396957|NCT00589797|79403609|FG000|Overall Study|Physician Decision|8|||
44396958|NCT00589797|79403610|FG001|Overall Study|Physician Decision|3|||
44396959|NCT00589797|79403609|FG000|Overall Study|Withdrawal by Subject|6|||
44396960|NCT00589797|79403610|FG001|Overall Study|Withdrawal by Subject|5|||
44521026|NCT02918968|79529239|FG001|1st Line AAT|Death|0|||
44521027|NCT02918968|79529238|FG000|1st Line AAT|Miscellaneous|1|||
44521028|NCT02918968|79529239|FG001|1st Line AAT|Miscellaneous|0|||
44521029|NCT02918968|79529238|FG000|2nd Line AAT|Progressive disease|21|||
44521030|NCT02918968|79529239|FG001|2nd Line AAT|Progressive disease|3|||
44281513|NCT01972152|79244782|FG001|First Treatment Visit|Lost to Follow-up|1|||
44281514|NCT01972152|79244783|FG002|First Treatment Visit|Lost to Follow-up|0|||
44281515|NCT01972152|79244784|FG003|First Treatment Visit|Lost to Follow-up|0|||
44281516|NCT01972152|79244785|FG004|First Treatment Visit|Lost to Follow-up|0|||
44281517|NCT01972152|79244786|FG005|First Treatment Visit|Lost to Follow-up|0|||
44281518|NCT01972152|79244781|FG000|Second Treatment Visit|Protocol Violation|0|||
44281519|NCT01972152|79244782|FG001|Second Treatment Visit|Protocol Violation|1|||
44396961|NCT00589797|79403609|FG000|Overall Study|Non-Randomized Training Subjects|46|||
44396962|NCT00589797|79403610|FG001|Overall Study|Non-Randomized Training Subjects|6|||
44396963|NCT00613171|79403616|FG000|Overall Study|Adverse Event|7|||
44396964|NCT00613171|79403616|FG000|Overall Study|Withdrawal by Subject|3|||
44396965|NCT00613171|79403616|FG000|Overall Study|Reason not Specified|4|||
44396966|NCT00896480|79403621|FG000|Overall Study|Disease progression/recurrence|21|||
44396967|NCT00953225|79403630|FG000|Overall Study|Withdrawal by Subject|2|||
44396968|NCT00953225|79403631|FG001|Overall Study|Withdrawal by Subject|0|||
44396969|NCT00613015|79403643|FG000|Overall Study|Lost to Follow-up|0|||
44521031|NCT02918968|79529238|FG000|2nd Line AAT|Adverse Event|2|||
44396970|NCT00613015|79403644|FG001|Overall Study|Lost to Follow-up|1|||
44521032|NCT02918968|79529239|FG001|2nd Line AAT|Adverse Event|5|||
44396971|NCT00613015|79403645|FG002|Overall Study|Lost to Follow-up|3|||
44396972|NCT00613015|79403646|FG003|Overall Study|Lost to Follow-up|3|||
44396973|NCT00613015|79403647|FG004|Overall Study|Lost to Follow-up|2|||
44281520|NCT01972152|79244783|FG002|Second Treatment Visit|Protocol Violation|0|||
44281521|NCT01972152|79244784|FG003|Second Treatment Visit|Protocol Violation|0|||
44281522|NCT01972152|79244785|FG004|Second Treatment Visit|Protocol Violation|0|||
44281523|NCT01972152|79244786|FG005|Second Treatment Visit|Protocol Violation|0|||
44396974|NCT00613015|79403648|FG005|Overall Study|Lost to Follow-up|3|||
44396975|NCT00803595|79403665|FG000|Overall Study|Adverse Event|3|||
44396976|NCT00803595|79403666|FG001|Overall Study|Adverse Event|4|||
44396977|NCT00803595|79403667|FG002|Overall Study|Adverse Event|1|||
44396978|NCT00803595|79403665|FG000|Overall Study|Protocol Violation|7|||
44396979|NCT00803595|79403666|FG001|Overall Study|Protocol Violation|2|||
44396980|NCT00803595|79403667|FG002|Overall Study|Protocol Violation|12|||
44396981|NCT00803595|79403665|FG000|Overall Study|Withdrawal by Subject|5|||
44396982|NCT00803595|79403666|FG001|Overall Study|Withdrawal by Subject|2|||
44396983|NCT00803595|79403667|FG002|Overall Study|Withdrawal by Subject|3|||
44396984|NCT00953927|79403677|FG000|Overall Study|Lost to Follow-up|61|||
44396985|NCT00953927|79403678|FG001|Overall Study|Lost to Follow-up|65|||
44396986|NCT00953927|79403677|FG000|Overall Study|Withdrawal by Subject|36|||
44396987|NCT00953927|79403678|FG001|Overall Study|Withdrawal by Subject|25|||
44396988|NCT00953927|79403677|FG000|Overall Study|Death|7|||
44396989|NCT00953927|79403678|FG001|Overall Study|Death|4|||
44396990|NCT00953927|79403677|FG000|Overall Study|Other study discontinuation|1|||
44396991|NCT00953927|79403678|FG001|Overall Study|Other study discontinuation|1|||
44396992|NCT00611767|79403686|FG000|Overall Study|Withdrawal by Subject|4|||
44396993|NCT00611767|79403687|FG001|Overall Study|Withdrawal by Subject|1|||
44396994|NCT00611767|79403686|FG000|Overall Study|Thiopental not available|3|||
44396995|NCT00611767|79403687|FG001|Overall Study|Thiopental not available|0|||
44396996|NCT00611767|79403686|FG000|Overall Study|didn't like the medication|1|||
44396997|NCT00611767|79403687|FG001|Overall Study|didn't like the medication|1|||
44396998|NCT00611767|79403686|FG000|Overall Study|Physician Decision|1|||
44396999|NCT00611767|79403687|FG001|Overall Study|Physician Decision|0|||
44397000|NCT00803361|79403695|FG000|Overall Study|Adverse Event|13|||
44397001|NCT00803361|79403696|FG001|Overall Study|Adverse Event|3|||
44397002|NCT00803361|79403695|FG000|Overall Study|Lack of Efficacy|4|||
44397003|NCT00803361|79403696|FG001|Overall Study|Lack of Efficacy|13|||
44397004|NCT00803361|79403695|FG000|Overall Study|Lost to Follow-up|1|||
44397005|NCT00803361|79403696|FG001|Overall Study|Lost to Follow-up|2|||
44397006|NCT00803361|79403695|FG000|Overall Study|Physician Decision|1|||
44397007|NCT00803361|79403696|FG001|Overall Study|Physician Decision|0|||
44397008|NCT00803361|79403695|FG000|Overall Study|Protocol Violation|2|||
44521033|NCT02918968|79529238|FG000|2nd Line AAT|Physician Decision|0|||
44521034|NCT02918968|79529239|FG001|2nd Line AAT|Physician Decision|1|||
44521035|NCT02918968|79529238|FG000|2nd Line AAT|Withdrawal by Subject|2|||
44521036|NCT02918968|79529239|FG001|2nd Line AAT|Withdrawal by Subject|2|||
44521037|NCT02918968|79529238|FG000|2nd Line AAT|Death|0|||
44521038|NCT02918968|79529239|FG001|2nd Line AAT|Death|1|||
44521039|NCT01065766|79529247|FG000|Overall Study|Assessed before the contracted date|1|||
44521040|NCT01065766|79529247|FG000|Overall Study|Contraindication to administration|6|||
44521041|NCT01065766|79529247|FG000|Overall Study|Violated dosage/administration|25|||
44147214|NCT00700817|78936664|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
44147215|NCT00700817|78936665|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
44147216|NCT00700817|78936666|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
44147217|NCT00700817|78936667|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
44147218|NCT00700817|78936663|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
44147219|NCT00700817|78936664|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
44252398|NCT01360632|79089364|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
44252399|NCT01360632|79089365|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
44252400|NCT01360632|79089366|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
44252401|NCT01360632|79089362|FG000|Phase A+|Lost to Follow-up|0|||
44252402|NCT01360632|79089363|FG001|Phase A+|Lost to Follow-up|0|||
44252403|NCT01360632|79089364|FG002|Phase A+|Lost to Follow-up|0|||
44252404|NCT01360632|79089365|FG003|Phase A+|Lost to Follow-up|0|||
44281524|NCT01972074|79244800|FG000|Overall Study|Adverse Event|4|||
44281525|NCT01972074|79244801|FG001|Overall Study|Adverse Event|1|||
44397009|NCT00803361|79403696|FG001|Overall Study|Protocol Violation|4|||
44397010|NCT00803361|79403695|FG000|Overall Study|Withdrawal by Subject|5|||
44397011|NCT00803361|79403696|FG001|Overall Study|Withdrawal by Subject|6|||
44397012|NCT00611533|79403702|FG000|First Intervention (6 Weeks)|Never started study|0|||
44252405|NCT01360632|79089366|FG004|Phase A+|Lost to Follow-up|2|||
44252406|NCT01360632|79089362|FG000|Phase A+|Adverse Event|0|||
44397013|NCT00611533|79403703|FG001|First Intervention (6 Weeks)|Never started study|1|||
44397014|NCT00611533|79403702|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
44397015|NCT00611533|79403703|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
44252407|NCT01360632|79089363|FG001|Phase A+|Adverse Event|0|||
44281526|NCT01972074|79244802|FG002|Overall Study|Adverse Event|0|||
44397016|NCT00611533|79403702|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
44521042|NCT01063972|79529253|FG000|Overall Study|Death|12|||
44521043|NCT01063972|79529254|FG001|Overall Study|Death|11|||
44521044|NCT01063972|79529253|FG000|Overall Study|Incarcerated|2|||
44397017|NCT00611533|79403703|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
44397018|NCT00953147|79403722|FG000|Overall Study|Adverse Event|8|||
44397019|NCT00953147|79403723|FG001|Overall Study|Adverse Event|16|||
44397020|NCT00953147|79403724|FG002|Overall Study|Adverse Event|6|||
44397021|NCT00953147|79403722|FG000|Overall Study|Protocol Violation|2|||
44397022|NCT00953147|79403723|FG001|Overall Study|Protocol Violation|8|||
44397023|NCT00953147|79403724|FG002|Overall Study|Protocol Violation|4|||
44397024|NCT00953147|79403722|FG000|Overall Study|Withdrawal by Subject|13|||
44397025|NCT00953147|79403723|FG001|Overall Study|Withdrawal by Subject|15|||
44397026|NCT00953147|79403724|FG002|Overall Study|Withdrawal by Subject|12|||
44397027|NCT00953147|79403722|FG000|Overall Study|Lost to Follow-up|8|||
44397028|NCT00953147|79403723|FG001|Overall Study|Lost to Follow-up|9|||
44397029|NCT00953147|79403724|FG002|Overall Study|Lost to Follow-up|4|||
44397030|NCT00953147|79403722|FG000|Overall Study|Physician Decision|2|||
44397031|NCT00953147|79403723|FG001|Overall Study|Physician Decision|7|||
44397032|NCT00953147|79403724|FG002|Overall Study|Physician Decision|3|||
44397033|NCT00953147|79403722|FG000|Overall Study|Other|4|||
44397034|NCT00953147|79403723|FG001|Overall Study|Other|11|||
44397035|NCT00953147|79403724|FG002|Overall Study|Other|13|||
44397036|NCT00803205|79403734|FG000|Overall Study|Adverse Event|7|||
44397037|NCT00803205|79403735|FG001|Overall Study|Adverse Event|2|||
44397038|NCT00803205|79403734|FG000|Overall Study|Lost to Follow-up|1|||
44397039|NCT00803205|79403735|FG001|Overall Study|Lost to Follow-up|0|||
44397040|NCT00803205|79403734|FG000|Overall Study|Withdrawal by Subject|9|||
44397041|NCT00803205|79403735|FG001|Overall Study|Withdrawal by Subject|9|||
44397042|NCT00803205|79403734|FG000|Overall Study|Physician Decision|1|||
44397043|NCT00803205|79403735|FG001|Overall Study|Physician Decision|0|||
44397044|NCT00803205|79403734|FG000|Overall Study|Protocol Violation|1|||
44397045|NCT00803205|79403735|FG001|Overall Study|Protocol Violation|1|||
44397046|NCT00803205|79403734|FG000|Overall Study|Medical Monitor Decision|1|||
44397047|NCT00803205|79403735|FG001|Overall Study|Medical Monitor Decision|0|||
44397048|NCT00803205|79403734|FG000|Overall Study|Acquired a Lung Infection|0|||
44397049|NCT00803205|79403735|FG001|Overall Study|Acquired a Lung Infection|1|||
44397050|NCT00803205|79403734|FG000|Overall Study|Sponsor Decision|0|||
44397051|NCT00803205|79403735|FG001|Overall Study|Sponsor Decision|1|||
44397052|NCT00952523|79403741|FG000|Overall Study|Withdrawal by Subject|7|||
44397053|NCT02232737|79403750|FG000|Overall Study|Lost to Follow-up|18|||
44397054|NCT02232737|79403751|FG001|Overall Study|Lost to Follow-up|28|||
44397055|NCT02232737|79403752|FG002|Overall Study|Lost to Follow-up|33|||
44397056|NCT02232737|79403750|FG000|Overall Study|Personal reasons|7|||
44397057|NCT02232737|79403751|FG001|Overall Study|Personal reasons|8|||
44397058|NCT02232737|79403752|FG002|Overall Study|Personal reasons|14|||
44397059|NCT02232737|79403750|FG000|Overall Study|Adverse Event|6|||
44397060|NCT02232737|79403751|FG001|Overall Study|Adverse Event|3|||
44397061|NCT02232737|79403752|FG002|Overall Study|Adverse Event|8|||
44397062|NCT02232737|79403750|FG000|Overall Study|Incarcerated|2|||
44397063|NCT02232737|79403751|FG001|Overall Study|Incarcerated|1|||
44397064|NCT02232737|79403752|FG002|Overall Study|Incarcerated|2|||
44397065|NCT02232737|79403750|FG000|Overall Study|Withdrawal by Subject|0|||
44397066|NCT02232737|79403751|FG001|Overall Study|Withdrawal by Subject|1|||
44397067|NCT02232737|79403752|FG002|Overall Study|Withdrawal by Subject|2|||
44397068|NCT02232737|79403750|FG000|Overall Study|Death|0|||
44397069|NCT02232737|79403751|FG001|Overall Study|Death|1|||
44397070|NCT02232737|79403752|FG002|Overall Study|Death|1|||
44397071|NCT02232737|79403750|FG000|Overall Study|Physician Decision|1|||
44397072|NCT02232737|79403751|FG001|Overall Study|Physician Decision|3|||
44397073|NCT02232737|79403752|FG002|Overall Study|Physician Decision|1|||
44397074|NCT02232737|79403750|FG000|Overall Study|Protocol Violation|1|||
44397075|NCT02232737|79403751|FG001|Overall Study|Protocol Violation|0|||
44397076|NCT02232737|79403752|FG002|Overall Study|Protocol Violation|1|||
44397077|NCT02232737|79403750|FG000|Overall Study|Reason unknown|1|||
44397078|NCT02232737|79403751|FG001|Overall Study|Reason unknown|0|||
44397079|NCT02232737|79403752|FG002|Overall Study|Reason unknown|0|||
44397080|NCT00952367|79403760|FG000|Overall Study|Withdrawal by Subject|2|||
44397081|NCT00952367|79403760|FG000|Overall Study|Noncoordination|1|||
44252408|NCT01360632|79089364|FG002|Phase A+|Adverse Event|0|||
44252409|NCT01360632|79089365|FG003|Phase A+|Adverse Event|0|||
44252410|NCT01360632|79089366|FG004|Phase A+|Adverse Event|2|||
44252411|NCT01360632|79089362|FG000|Phase A+|Met Withdrawal Criteria|0|||
44252412|NCT01360632|79089363|FG001|Phase A+|Met Withdrawal Criteria|0|||
44252413|NCT01360632|79089364|FG002|Phase A+|Met Withdrawal Criteria|0|||
44252414|NCT01360632|79089365|FG003|Phase A+|Met Withdrawal Criteria|0|||
44252415|NCT01360632|79089366|FG004|Phase A+|Met Withdrawal Criteria|7|||
44252416|NCT01360632|79089362|FG000|Phase A+|Physician Decision|0|||
44252417|NCT01360632|79089363|FG001|Phase A+|Physician Decision|0|||
44397082|NCT00952367|79403760|FG000|Overall Study|Protocol Violation|3|||
44397083|NCT00948857|79403766|FG000|Overall Study|Lost to Follow-up|1|||
44397084|NCT00948857|79403767|FG001|Overall Study|Lost to Follow-up|0|||
44397085|NCT00948389|79403782|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
44397086|NCT00948389|79403783|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
44252418|NCT01360632|79089364|FG002|Phase A+|Physician Decision|0|||
44252419|NCT01360632|79089365|FG003|Phase A+|Physician Decision|0|||
44252420|NCT01360632|79089366|FG004|Phase A+|Physician Decision|3|||
44252421|NCT01360632|79089362|FG000|Phase A+|Withdrawal by Subject|0|||
44252422|NCT01360632|79089363|FG001|Phase A+|Withdrawal by Subject|0|||
44252423|NCT01360632|79089364|FG002|Phase A+|Withdrawal by Subject|0|||
44521045|NCT01063972|79529254|FG001|Overall Study|Incarcerated|1|||
44521046|NCT00003483|79529260|FG000|Overall Study|Not evaluable|1|||
44521047|NCT00003477|79529264|FG000|Overall Study|Not evalauable|4|||
44521048|NCT00003471|79529268|FG000|Overall Study|Not evaluable|4|||
44521049|NCT04185220|79529274|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
44521050|NCT04185220|79529275|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
44521051|NCT04185220|79529274|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
44521052|NCT04185220|79529275|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
44521053|NCT00002931|79529282|FG000|Overall Study|rapidly progressing disease during|2|||
44521054|NCT02918266|79529297|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
44521055|NCT02918266|79529298|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521056|NCT02918266|79529299|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521057|NCT02918266|79529300|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521058|NCT02918266|79529301|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521059|NCT02918266|79529302|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521060|NCT02918266|79529303|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
44252424|NCT01360632|79089365|FG003|Phase A+|Withdrawal by Subject|0|||
44252425|NCT01360632|79089366|FG004|Phase A+|Withdrawal by Subject|8|||
44252426|NCT01360632|79089362|FG000|Phase A+|Protocol Deviation|0|||
44252427|NCT01360632|79089363|FG001|Phase A+|Protocol Deviation|0|||
44252428|NCT01360632|79089364|FG002|Phase A+|Protocol Deviation|0|||
44252429|NCT01360632|79089365|FG003|Phase A+|Protocol Deviation|0|||
44252430|NCT01360632|79089366|FG004|Phase A+|Protocol Deviation|3|||
44252431|NCT04157400|79089412|FG000|Overall Study|Withdrawal by Subject|1|||
44252432|NCT04157400|79089412|FG000|Overall Study|Lost to Follow-up|3|||
44252433|NCT02626182|79089486|FG000|Overall Study|Adverse Event|2|||
44252434|NCT02626182|79089487|FG001|Overall Study|Adverse Event|0|||
44252435|NCT01669902|79089594|FG000|Overall Study|Adverse Event|11|||
44252436|NCT01669902|79089594|FG000|Overall Study|Lack of Efficacy|10|||
44252437|NCT01669902|79089594|FG000|Overall Study|Other|8|||
44521061|NCT02918266|79529304|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521062|NCT02918266|79529305|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
44147220|NCT00700817|78936665|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
44252438|NCT01670292|79089627|FG000|Overall Study|Lost to Follow-up|14|||
44252439|NCT01360554|79089864|FG000|Overall Study|Death|359|||
44252440|NCT01360554|79089865|FG001|Overall Study|Death|371|||
44252441|NCT01360554|79089864|FG000|Overall Study|Lost to Follow-up|4|||
44252442|NCT01360554|79089865|FG001|Overall Study|Lost to Follow-up|4|||
44252443|NCT01360554|79089864|FG000|Overall Study|Withdrawal by Subject|23|||
44252444|NCT01360554|79089865|FG001|Overall Study|Withdrawal by Subject|24|||
44252445|NCT01360554|79089864|FG000|Overall Study|Study terminated by sponsor|49|||
44252446|NCT01360554|79089865|FG001|Overall Study|Study terminated by sponsor|37|||
44252447|NCT01360554|79089864|FG000|Overall Study|Other, not specified|1|||
44252448|NCT01360554|79089865|FG001|Overall Study|Other, not specified|0|||
44252449|NCT01360554|79089864|FG000|Overall Study|Randomized but not treated.|3|||
44252450|NCT01360554|79089865|FG001|Overall Study|Randomized but not treated.|3|||
44252451|NCT01360398|79089887|FG000|Overall Study|Withdrawal by Subject|14|||
44252452|NCT01360398|79089887|FG000|Overall Study|Other|7|||
44252453|NCT01360398|79089887|FG000|Overall Study|Migrated/moved from study area|1|||
44252454|NCT02626026|79089897|FG000|Overall Study|Randomized but Never Treated|0|||
44252455|NCT02626026|79089898|FG001|Overall Study|Randomized but Never Treated|0|||
44252456|NCT02626026|79089899|FG002|Overall Study|Randomized but Never Treated|0|||
44147221|NCT00700817|78936666|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
44147222|NCT00700817|78936667|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
44147223|NCT00700817|78936663|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
44147224|NCT00700817|78936664|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
44252457|NCT02626026|79089900|FG003|Overall Study|Randomized but Never Treated|0|||
44252458|NCT02626026|79089901|FG004|Overall Study|Randomized but Never Treated|1|||
44252459|NCT02626026|79089902|FG005|Overall Study|Randomized but Never Treated|0|||
44252460|NCT01765296|79090162|FG000|Overall Study|Protocol Violation|0|||
44252461|NCT01765296|79090163|FG001|Overall Study|Protocol Violation|5|||
44252462|NCT01765296|79090164|FG002|Overall Study|Protocol Violation|4|||
44397087|NCT00948389|79403784|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
44397088|NCT00948389|79403785|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
44397089|NCT00948389|79403786|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
44397090|NCT00948389|79403782|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
44397091|NCT00948389|79403783|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
44397092|NCT00948389|79403784|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
44397093|NCT00948389|79403785|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
44397094|NCT00948389|79403786|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
44397095|NCT00948389|79403782|FG000|Overall Study|Both Progression and Toxicity|1|||
44397096|NCT00948389|79403783|FG001|Overall Study|Both Progression and Toxicity|0|||
44397097|NCT00948389|79403784|FG002|Overall Study|Both Progression and Toxicity|0|||
44397098|NCT00948389|79403785|FG003|Overall Study|Both Progression and Toxicity|0|||
44397099|NCT00948389|79403786|FG004|Overall Study|Both Progression and Toxicity|0|||
44397100|NCT00948155|79403802|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
44397101|NCT00948155|79403803|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
44397102|NCT00948155|79403802|FG000|Washout 14 Days|Lost to Follow-up|1|||
44397103|NCT00948155|79403803|FG001|Washout 14 Days|Lost to Follow-up|2|||
44397104|NCT00958217|79403813|FG000|Overall Study|Death|2|||
44397105|NCT00958217|79403814|FG001|Overall Study|Death|1|||
44397106|NCT00958217|79403813|FG000|Overall Study|Withdrawal by Subject|4|||
44397107|NCT00958217|79403814|FG001|Overall Study|Withdrawal by Subject|3|||
44397108|NCT00958217|79403813|FG000|Overall Study|Lost to Follow-up|17|||
44397109|NCT00958217|79403814|FG001|Overall Study|Lost to Follow-up|19|||
44397110|NCT00958217|79403813|FG000|Overall Study|Moved out of area|1|||
44397111|NCT00958217|79403814|FG001|Overall Study|Moved out of area|1|||
44397112|NCT00958217|79403813|FG000|Overall Study|Inpatient hospitalization|0|||
44397113|NCT00958217|79403814|FG001|Overall Study|Inpatient hospitalization|1|||
44397114|NCT00891020|79403824|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
44397115|NCT00891020|79403825|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
44397116|NCT00891020|79403826|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
44397117|NCT00891020|79403824|FG000|24 Week Treatment Period|Death|0|||
44397118|NCT00891020|79403825|FG001|24 Week Treatment Period|Death|2|||
44397119|NCT00891020|79403826|FG002|24 Week Treatment Period|Death|0|||
44397120|NCT00891020|79403824|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
44397121|NCT00891020|79403825|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
44397122|NCT00891020|79403826|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
44397123|NCT00891020|79403824|FG000|24 Week Treatment Period|Failure to return|4|||
44397124|NCT00891020|79403825|FG001|24 Week Treatment Period|Failure to return|5|||
44397125|NCT00891020|79403826|FG002|24 Week Treatment Period|Failure to return|5|||
44397126|NCT00891020|79403824|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
44397127|NCT00891020|79403825|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
44397128|NCT00891020|79403826|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
44397129|NCT00891020|79403824|FG000|24 Week Treatment Period|Other protocol violation|1|||
44397130|NCT00891020|79403825|FG001|24 Week Treatment Period|Other protocol violation|1|||
44397131|NCT00891020|79403826|FG002|24 Week Treatment Period|Other protocol violation|2|||
44397132|NCT00891020|79403824|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
44397133|NCT00891020|79403825|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
44397134|NCT00891020|79403826|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
44397135|NCT00891020|79403824|FG000|24 Week Treatment Period|Withdrew consent|6|||
44397136|NCT00891020|79403825|FG001|24 Week Treatment Period|Withdrew consent|3|||
44397137|NCT00891020|79403826|FG002|24 Week Treatment Period|Withdrew consent|15|||
44397138|NCT00891020|79403824|FG000|24 Week Treatment Period|Administrative/Other|5|||
44397139|NCT00891020|79403825|FG001|24 Week Treatment Period|Administrative/Other|6|||
44397140|NCT00891020|79403826|FG002|24 Week Treatment Period|Administrative/Other|1|||
44397141|NCT00891020|79403824|FG000|Long-term Extension Period|Adverse Event|1|||
44397142|NCT00891020|79403825|FG001|Long-term Extension Period|Adverse Event|11|||
44397143|NCT00891020|79403826|FG002|Long-term Extension Period|Adverse Event|10|||
44397144|NCT00891020|79403824|FG000|Long-term Extension Period|Death|0|||
44397145|NCT00891020|79403825|FG001|Long-term Extension Period|Death|0|||
44397146|NCT00891020|79403826|FG002|Long-term Extension Period|Death|1|||
44397147|NCT00891020|79403824|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
44397148|NCT00891020|79403825|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
44397149|NCT00891020|79403826|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
44397150|NCT00891020|79403824|FG000|Long-term Extension Period|Protocol Violation|0|||
44397151|NCT00891020|79403825|FG001|Long-term Extension Period|Protocol Violation|1|||
44397152|NCT00891020|79403826|FG002|Long-term Extension Period|Protocol Violation|1|||
44397153|NCT00891020|79403824|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
44397154|NCT00891020|79403825|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
44397155|NCT00891020|79403826|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
44397156|NCT00891020|79403824|FG000|Long-term Extension Period|Failure to return|0|||
44397157|NCT00891020|79403825|FG001|Long-term Extension Period|Failure to return|2|||
44397158|NCT00891020|79403826|FG002|Long-term Extension Period|Failure to return|3|||
44397159|NCT00891020|79403824|FG000|Long-term Extension Period|Administrative|1|||
44397160|NCT00891020|79403825|FG001|Long-term Extension Period|Administrative|2|||
44397161|NCT00891020|79403826|FG002|Long-term Extension Period|Administrative|2|||
44397162|NCT00611455|79403838|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
44397163|NCT00611455|79403839|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
44397164|NCT00611455|79403840|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
44397165|NCT00611455|79403838|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
44397166|NCT00611455|79403839|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44397167|NCT00611455|79403840|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44397168|NCT00611455|79403838|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
44252463|NCT01765296|79090162|FG000|Overall Study|Withdrawal by Subject|4|||
44252464|NCT01765296|79090163|FG001|Overall Study|Withdrawal by Subject|2|||
44252465|NCT01765296|79090164|FG002|Overall Study|Withdrawal by Subject|2|||
44252466|NCT01765296|79090162|FG000|Overall Study|Adverse Event|1|||
44252467|NCT01765296|79090163|FG001|Overall Study|Adverse Event|13|||
44252468|NCT01765296|79090164|FG002|Overall Study|Adverse Event|5|||
44252469|NCT01765296|79090162|FG000|Overall Study|Lack of Efficacy|0|||
44252470|NCT01765296|79090163|FG001|Overall Study|Lack of Efficacy|0|||
44252471|NCT01765296|79090164|FG002|Overall Study|Lack of Efficacy|2|||
44252472|NCT02089685|79090238|FG000|Overall Study|Adverse Event|1|||
44252473|NCT02089685|79090239|FG001|Overall Study|Adverse Event|0|||
44252474|NCT02089685|79090240|FG002|Overall Study|Adverse Event|0|||
44252475|NCT02089685|79090241|FG003|Overall Study|Adverse Event|0|||
44252476|NCT02089685|79090242|FG004|Overall Study|Adverse Event|1|||
44252477|NCT02089685|79090243|FG005|Overall Study|Adverse Event|0|||
44252478|NCT02089685|79090238|FG000|Overall Study|Clinical Progression|4|||
44252479|NCT02089685|79090239|FG001|Overall Study|Clinical Progression|0|||
44252480|NCT02089685|79090240|FG002|Overall Study|Clinical Progression|0|||
44252481|NCT02089685|79090241|FG003|Overall Study|Clinical Progression|5|||
44252482|NCT02089685|79090242|FG004|Overall Study|Clinical Progression|1|||
44252483|NCT02089685|79090243|FG005|Overall Study|Clinical Progression|2|||
44252484|NCT02089685|79090238|FG000|Overall Study|Excluded Medication|1|||
44252485|NCT02089685|79090239|FG001|Overall Study|Excluded Medication|0|||
44252486|NCT02089685|79090240|FG002|Overall Study|Excluded Medication|0|||
44252487|NCT02089685|79090241|FG003|Overall Study|Excluded Medication|11|||
44252488|NCT02089685|79090242|FG004|Overall Study|Excluded Medication|2|||
44252489|NCT02089685|79090243|FG005|Overall Study|Excluded Medication|1|||
44252490|NCT02089685|79090238|FG000|Overall Study|Progressive disease|13|||
44252491|NCT02089685|79090239|FG001|Overall Study|Progressive disease|10|||
44252492|NCT02089685|79090240|FG002|Overall Study|Progressive disease|3|||
44252493|NCT02089685|79090241|FG003|Overall Study|Progressive disease|51|||
44252494|NCT02089685|79090242|FG004|Overall Study|Progressive disease|17|||
44252495|NCT02089685|79090243|FG005|Overall Study|Progressive disease|12|||
44252496|NCT02089685|79090238|FG000|Overall Study|Follow up ended by sponsor|2|||
44252497|NCT02089685|79090239|FG001|Overall Study|Follow up ended by sponsor|2|||
44252498|NCT02089685|79090240|FG002|Overall Study|Follow up ended by sponsor|0|||
44252499|NCT02089685|79090241|FG003|Overall Study|Follow up ended by sponsor|70|||
44252500|NCT02089685|79090242|FG004|Overall Study|Follow up ended by sponsor|26|||
44252501|NCT02089685|79090243|FG005|Overall Study|Follow up ended by sponsor|26|||
44252502|NCT02089685|79090238|FG000|Overall Study|Withdrawal by Subject|0|||
44252503|NCT02089685|79090239|FG001|Overall Study|Withdrawal by Subject|2|||
44252504|NCT02089685|79090240|FG002|Overall Study|Withdrawal by Subject|0|||
44252505|NCT02089685|79090241|FG003|Overall Study|Withdrawal by Subject|8|||
44252506|NCT02089685|79090242|FG004|Overall Study|Withdrawal by Subject|1|||
44252507|NCT02089685|79090243|FG005|Overall Study|Withdrawal by Subject|1|||
44252508|NCT02089685|79090238|FG000|Overall Study|Status not recorded|1|||
44252509|NCT02089685|79090239|FG001|Overall Study|Status not recorded|0|||
44252510|NCT02089685|79090240|FG002|Overall Study|Status not recorded|0|||
44252511|NCT02089685|79090241|FG003|Overall Study|Status not recorded|0|||
44252512|NCT02089685|79090242|FG004|Overall Study|Status not recorded|1|||
44252513|NCT02089685|79090243|FG005|Overall Study|Status not recorded|0|||
44252514|NCT02089685|79090238|FG000|Overall Study|Death|0|||
44252515|NCT02089685|79090239|FG001|Overall Study|Death|0|||
44252516|NCT02089685|79090240|FG002|Overall Study|Death|0|||
44252517|NCT02089685|79090241|FG003|Overall Study|Death|7|||
44252518|NCT02089685|79090242|FG004|Overall Study|Death|2|||
44252519|NCT02089685|79090243|FG005|Overall Study|Death|5|||
44252520|NCT02089685|79090238|FG000|Overall Study|Lost to Follow-up|0|||
44252521|NCT02089685|79090239|FG001|Overall Study|Lost to Follow-up|0|||
44252522|NCT02089685|79090240|FG002|Overall Study|Lost to Follow-up|0|||
44252523|NCT02089685|79090241|FG003|Overall Study|Lost to Follow-up|1|||
44252524|NCT02089685|79090242|FG004|Overall Study|Lost to Follow-up|0|||
44252525|NCT02089685|79090243|FG005|Overall Study|Lost to Follow-up|0|||
44252526|NCT02089685|79090238|FG000|Overall Study|Physician Decision|0|||
44252527|NCT02089685|79090239|FG001|Overall Study|Physician Decision|0|||
44252528|NCT02089685|79090240|FG002|Overall Study|Physician Decision|0|||
44252529|NCT02089685|79090241|FG003|Overall Study|Physician Decision|0|||
44252530|NCT02089685|79090242|FG004|Overall Study|Physician Decision|0|||
44397169|NCT00611455|79403839|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
44397170|NCT00611455|79403840|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
44397171|NCT00611455|79403838|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
44397172|NCT00611455|79403839|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
44397173|NCT00611455|79403840|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44397174|NCT00611455|79403838|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
44397175|NCT00611455|79403839|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
44397176|NCT00611455|79403840|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
44397177|NCT00611455|79403838|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
44397178|NCT00611455|79403839|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
44397179|NCT00611455|79403840|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
44397180|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
44397181|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
44397182|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
44397183|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
44397184|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
44397185|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
44252531|NCT02089685|79090243|FG005|Overall Study|Physician Decision|4|||
44252532|NCT02089685|79090238|FG000|Overall Study|Screen failure|1|||
44252533|NCT02089685|79090239|FG001|Overall Study|Screen failure|0|||
44252534|NCT02089685|79090240|FG002|Overall Study|Screen failure|0|||
44252535|NCT02089685|79090241|FG003|Overall Study|Screen failure|0|||
44252536|NCT02089685|79090242|FG004|Overall Study|Screen failure|0|||
44252537|NCT02089685|79090243|FG005|Overall Study|Screen failure|0|||
44252538|NCT05282004|79090301|FG000|Overall Study|Adverse Event|2|||
44252539|NCT05004649|79090305|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
44252540|NCT05004649|79090305|FG000|Overall Study|Lost to Follow-up|1|||
44252541|NCT05004649|79090305|FG000|Overall Study|Withdrawal by Subject|2|||
44252542|NCT05004649|79090305|FG000|Overall Study|COVID-19|1|||
44252543|NCT04666298|79090315|FG000|Overall Study|Subject decision|1|||
44252544|NCT04666298|79090316|FG001|Overall Study|Subject decision|0|||
44252545|NCT04666298|79090317|FG002|Overall Study|Subject decision|0|||
44252546|NCT04666298|79090318|FG003|Overall Study|Subject decision|2|||
44252547|NCT04666298|79090315|FG000|Overall Study|Death|1|||
44252548|NCT04666298|79090316|FG001|Overall Study|Death|0|||
44252549|NCT04666298|79090317|FG002|Overall Study|Death|0|||
44397186|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
44397187|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
44397188|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
44397189|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
44397190|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
44397191|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
44397192|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
44397193|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
44397194|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
44397195|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
44397196|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
44397197|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
44397198|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
44397199|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
44397200|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
44397201|NCT00611455|79403838|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
44397202|NCT00611455|79403839|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
44397203|NCT00611455|79403840|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
44397204|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
44397205|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
44521063|NCT02918266|79529306|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44521064|NCT02918266|79529307|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
44252550|NCT04666298|79090318|FG003|Overall Study|Death|0|||
44252551|NCT04666298|79090315|FG000|Overall Study|Lost to Follow-up|0|||
44252552|NCT04666298|79090316|FG001|Overall Study|Lost to Follow-up|0|||
44252553|NCT04666298|79090317|FG002|Overall Study|Lost to Follow-up|0|||
44252554|NCT04666298|79090318|FG003|Overall Study|Lost to Follow-up|1|||
44252555|NCT04666298|79090315|FG000|Overall Study|Physician Decision|0|||
44252556|NCT04666298|79090316|FG001|Overall Study|Physician Decision|0|||
44252557|NCT04666298|79090317|FG002|Overall Study|Physician Decision|0|||
44252558|NCT04666298|79090318|FG003|Overall Study|Physician Decision|1|||
44397206|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
44252559|NCT04666298|79090315|FG000|Overall Study|Protocol deviation|0|||
44252560|NCT04666298|79090316|FG001|Overall Study|Protocol deviation|0|||
44252561|NCT04666298|79090317|FG002|Overall Study|Protocol deviation|1|||
44252562|NCT04666298|79090318|FG003|Overall Study|Protocol deviation|0|||
44521065|NCT00041067|79529327|FG000|Overall Study|Adverse Event|20|||
44397207|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
44397208|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
44397209|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
44397210|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
44397211|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
44397212|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
44397213|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
44397214|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
44397215|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
44397216|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
44397217|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
44397218|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
44397219|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
44397220|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
44397221|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
44397222|NCT00611455|79403838|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
44397223|NCT00611455|79403839|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
44397224|NCT00611455|79403840|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
44397225|NCT00952289|79403852|FG000|All Participants|Death|9|||
44397226|NCT00952289|79403853|FG001|All Participants|Death|9|||
44397227|NCT00952289|79403852|FG000|All Participants|Adverse Event|8|||
44397228|NCT00952289|79403853|FG001|All Participants|Adverse Event|8|||
44397229|NCT00952289|79403852|FG000|All Participants|Disease progression|3|||
44397230|NCT00952289|79403853|FG001|All Participants|Disease progression|12|||
44397231|NCT00952289|79403852|FG000|All Participants|Withdrawal by Subject|1|||
44397232|NCT00952289|79403853|FG001|All Participants|Withdrawal by Subject|10|||
44397233|NCT00952289|79403852|FG000|All Participants|Data lost during site relocation|0|||
44397234|NCT00952289|79403853|FG001|All Participants|Data lost during site relocation|1|||
44397235|NCT00952289|79403852|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
44397236|NCT00952289|79403853|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
44397237|NCT00952289|79403852|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
44397238|NCT00952289|79403853|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
44397239|NCT00952289|79403852|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
44397240|NCT00952289|79403853|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
44521066|NCT00041067|79529327|FG000|Overall Study|Progression|19|||
44521067|NCT00041067|79529327|FG000|Overall Study|Patient refusal|12|||
44521068|NCT00041067|79529327|FG000|Overall Study|Other reasons|23|||
44521069|NCT00041067|79529327|FG000|Overall Study|Ineligible|2|||
44521070|NCT01063036|79529332|FG000|Participants Treated With Study Drug|Adverse Event|1|||
44521071|NCT01063036|79529332|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
44521072|NCT01063036|79529332|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
44521073|NCT01063036|79529332|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
44521074|NCT01063036|79529332|FG000|Participants Treated With Study Drug|Pregnancy|1|||
44521075|NCT01063036|79529332|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
44521076|NCT01063036|79529332|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
44521077|NCT01063036|79529332|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
44252563|NCT04188301|79090357|FG000|Month 3|Lost to Follow-up|0|||
44252564|NCT04188301|79090358|FG001|Month 3|Lost to Follow-up|0|||
44397241|NCT00952289|79403852|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
44397242|NCT00952289|79403853|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
44397243|NCT00952289|79403852|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
44397244|NCT00952289|79403853|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
44397245|NCT00612313|79403861|FG000|Overall Study|Withdrawal by Subject|6|||
44397246|NCT00612313|79403862|FG001|Overall Study|Withdrawal by Subject|9|||
44397247|NCT00612313|79403861|FG000|Overall Study|Lost to Follow-up|11|||
44397248|NCT00612313|79403862|FG001|Overall Study|Lost to Follow-up|4|||
44521078|NCT00040365|79529336|FG000|Overall Study|Death|1|||
44521079|NCT00040365|79529336|FG000|Overall Study|Progressive disease|7|||
44521080|NCT00040365|79529336|FG000|Overall Study|Lost to Follow-up|3|||
44521081|NCT02974114|79529343|FG000|Overall Study|Other (Not specified)|0|||
44252565|NCT04188301|79090359|FG002|Month 3|Lost to Follow-up|1|||
44252566|NCT04188301|79090357|FG000|Month 12|Lost to Follow-up|0|||
44252567|NCT04188301|79090358|FG001|Month 12|Lost to Follow-up|0|||
44252568|NCT04188301|79090359|FG002|Month 12|Lost to Follow-up|2|||
44521082|NCT02974114|79529344|FG001|Overall Study|Other (Not specified)|1|||
44397249|NCT00890552|79403874|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
44397250|NCT00890552|79403874|FG000|On-treatment|Early prog disease/ death|10|||
44397251|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
44397252|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
44397253|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
44397254|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
44397255|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
44397256|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
44397257|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
44397258|NCT00946985|79403878|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
44397259|NCT00946985|79403878|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
44397260|NCT00611923|79403884|FG000|Overall Study|Withdrawal by Subject|2|||
44397261|NCT00611923|79403885|FG001|Overall Study|Withdrawal by Subject|2|||
44397262|NCT00609973|79403895|FG000|Overall Study|Adverse Event|2|||
44397263|NCT00609973|79403896|FG001|Overall Study|Adverse Event|1|||
44397264|NCT00609973|79403895|FG000|Overall Study|Protocol Violation|4|||
44397265|NCT00609973|79403896|FG001|Overall Study|Protocol Violation|3|||
44397266|NCT00609973|79403895|FG000|Overall Study|Lost to Follow-up|2|||
44397267|NCT00609973|79403896|FG001|Overall Study|Lost to Follow-up|1|||
44397268|NCT00609973|79403895|FG000|Overall Study|Withdrawal by Subject|0|||
44397269|NCT00609973|79403896|FG001|Overall Study|Withdrawal by Subject|1|||
44397270|NCT00803049|79403906|FG000|Overall Study|Adverse Event|21|||
44397271|NCT00803049|79403907|FG001|Overall Study|Adverse Event|33|||
44397272|NCT00803049|79403908|FG002|Overall Study|Adverse Event|13|||
44397273|NCT00803049|79403909|FG003|Overall Study|Adverse Event|27|||
44397274|NCT00803049|79403906|FG000|Overall Study|Lack of Efficacy|10|||
44397275|NCT00803049|79403907|FG001|Overall Study|Lack of Efficacy|19|||
44397276|NCT00803049|79403908|FG002|Overall Study|Lack of Efficacy|6|||
44397277|NCT00803049|79403909|FG003|Overall Study|Lack of Efficacy|13|||
44521083|NCT02974114|79529345|FG002|Overall Study|Other (Not specified)|2|||
44521084|NCT00001959|79529355|FG000|Overall Study|newly diagnosed colon cancer|1|||
44397278|NCT00803049|79403906|FG000|Overall Study|Lost to Follow-up|0|||
44397279|NCT00803049|79403907|FG001|Overall Study|Lost to Follow-up|2|||
44397280|NCT00803049|79403908|FG002|Overall Study|Lost to Follow-up|0|||
44397281|NCT00803049|79403909|FG003|Overall Study|Lost to Follow-up|3|||
44397282|NCT00803049|79403906|FG000|Overall Study|Death|2|||
44397283|NCT00803049|79403907|FG001|Overall Study|Death|1|||
44397284|NCT00803049|79403908|FG002|Overall Study|Death|0|||
44397285|NCT00803049|79403909|FG003|Overall Study|Death|2|||
44397286|NCT00803049|79403906|FG000|Overall Study|Progressive Disease|6|||
44397287|NCT00803049|79403907|FG001|Overall Study|Progressive Disease|10|||
44397288|NCT00803049|79403908|FG002|Overall Study|Progressive Disease|6|||
44397289|NCT00803049|79403909|FG003|Overall Study|Progressive Disease|6|||
44397290|NCT00803049|79403906|FG000|Overall Study|Withdrawal by Subject|19|||
44397291|NCT00803049|79403907|FG001|Overall Study|Withdrawal by Subject|43|||
44397292|NCT00803049|79403908|FG002|Overall Study|Withdrawal by Subject|16|||
44397293|NCT00803049|79403909|FG003|Overall Study|Withdrawal by Subject|44|||
44397294|NCT00803049|79403906|FG000|Overall Study|Protocol Violation|0|||
44397295|NCT00803049|79403907|FG001|Overall Study|Protocol Violation|1|||
44397296|NCT00803049|79403908|FG002|Overall Study|Protocol Violation|1|||
44397297|NCT00803049|79403909|FG003|Overall Study|Protocol Violation|0|||
44397298|NCT00803049|79403906|FG000|Overall Study|Randomized and Not Treated|0|||
44397299|NCT00803049|79403907|FG001|Overall Study|Randomized and Not Treated|0|||
44397300|NCT00803049|79403908|FG002|Overall Study|Randomized and Not Treated|0|||
44397301|NCT00803049|79403909|FG003|Overall Study|Randomized and Not Treated|2|||
44397302|NCT00803049|79403906|FG000|Overall Study|Other than Specified Above|3|||
44397303|NCT00803049|79403907|FG001|Overall Study|Other than Specified Above|9|||
44397304|NCT00803049|79403908|FG002|Overall Study|Other than Specified Above|2|||
44397305|NCT00803049|79403909|FG003|Overall Study|Other than Specified Above|5|||
44397306|NCT00890084|79403919|FG000|Overall Study|Adverse Event|16|||
44397307|NCT00890084|79403919|FG000|Overall Study|Lost to Follow-up|126|||
44397308|NCT00802893|79403932|FG000|Overall Study|study terminated|3|||
44397309|NCT00608569|79403953|FG000|Overall Study|Death|4|||
44397310|NCT00608569|79403954|FG001|Overall Study|Death|3|||
44397311|NCT00608569|79403953|FG000|Overall Study|Lost to Follow-up|4|||
44397312|NCT00608569|79403954|FG001|Overall Study|Lost to Follow-up|5|||
44397313|NCT00608569|79403953|FG000|Overall Study|Withdrawal by Subject|1|||
44397314|NCT00608569|79403954|FG001|Overall Study|Withdrawal by Subject|0|||
44397315|NCT00608569|79403953|FG000|Overall Study|Adverse Event|1|||
44397316|NCT00608569|79403954|FG001|Overall Study|Adverse Event|0|||
44521085|NCT00001959|79529355|FG000|Overall Study|disabling sedation|1|||
44521086|NCT00001959|79529355|FG000|Overall Study|non-compliance|1|||
44397317|NCT00608569|79403953|FG000|Overall Study|Unable to adhere with study requirements|0|||
44397318|NCT00608569|79403954|FG001|Overall Study|Unable to adhere with study requirements|1|||
44397319|NCT00610675|79403960|FG000|Overall Study|Untreated|4|||
44397320|NCT00610675|79403960|FG000|Overall Study|Adverse Event|67|||
44521087|NCT00001941|79529359|FG000|Overall Study|not treated- rapidly progressing disease|0|||
44397321|NCT00610675|79403960|FG000|Overall Study|Insufficient Effect|31|||
44397322|NCT00610675|79403960|FG000|Overall Study|Withdrawal by Subject|28|||
44397323|NCT00610675|79403960|FG000|Overall Study|Reasons unrelated to trial|27|||
44397324|NCT00610675|79403960|FG000|Overall Study|Lack of Compliance|7|||
44397325|NCT00610675|79403960|FG000|Overall Study|Lost to Follow-up|31|||
44397326|NCT00610675|79403960|FG000|Overall Study|Other reason (not specified)|25|||
44397327|NCT00888134|79403964|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
44397328|NCT00888134|79403964|FG000|Follow-up|being followed for long-term survival|1|||
44397329|NCT00573157|79403971|FG000|Overall Study|Adverse Event|3|||
44397330|NCT00573157|79403972|FG001|Overall Study|Adverse Event|1|||
44397331|NCT00573157|79403971|FG000|Overall Study|Other|1|||
44397332|NCT00573157|79403972|FG001|Overall Study|Other|1|||
44397333|NCT00802737|79403981|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
44397334|NCT00802737|79403982|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
44397335|NCT00802737|79403983|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
44397336|NCT00802737|79403981|FG000|Overall Study|Death|6|||
44397337|NCT00802737|79403982|FG001|Overall Study|Death|5|||
44397338|NCT00802737|79403983|FG002|Overall Study|Death|1|||
44397339|NCT00802737|79403981|FG000|Overall Study|Adverse Event|1|||
44397340|NCT00802737|79403982|FG001|Overall Study|Adverse Event|0|||
44397341|NCT00802737|79403983|FG002|Overall Study|Adverse Event|0|||
44397342|NCT00802737|79403981|FG000|Overall Study|Received Prohibited Therapy|1|||
44397343|NCT00802737|79403982|FG001|Overall Study|Received Prohibited Therapy|0|||
44397344|NCT00802737|79403983|FG002|Overall Study|Received Prohibited Therapy|0|||
44397345|NCT00802737|79403981|FG000|Overall Study|Ongoing CLL-Treatment|0|||
44397346|NCT00802737|79403982|FG001|Overall Study|Ongoing CLL-Treatment|1|||
44397347|NCT00802737|79403983|FG002|Overall Study|Ongoing CLL-Treatment|0|||
44397348|NCT00802737|79403981|FG000|Overall Study|Participant too Unwell|0|||
44397349|NCT00802737|79403982|FG001|Overall Study|Participant too Unwell|2|||
44397350|NCT00802737|79403983|FG002|Overall Study|Participant too Unwell|0|||
44397351|NCT00588861|79403994|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
44397352|NCT00588861|79403995|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
44397353|NCT00588861|79403994|FG000|6 Months|Patients did not return for follow-up|98|||
44397354|NCT00588861|79403995|FG001|6 Months|Patients did not return for follow-up|73|||
44397355|NCT00588861|79403994|FG000|1 Year|Patients did not return for follow-up|89|||
44397356|NCT00588861|79403995|FG001|1 Year|Patients did not return for follow-up|82|||
44397357|NCT00588861|79403994|FG000|2 Years|Patients did not return for follow-up|92|||
44397358|NCT00588861|79403995|FG001|2 Years|Patients did not return for follow-up|87|||
44397359|NCT00588861|79403994|FG000|4 Years|Patients did not return for follow-up|91|||
44397360|NCT00588861|79403995|FG001|4 Years|Patients did not return for follow-up|103|||
44397361|NCT00588861|79403994|FG000|6 Years|Patients did not return for follow-up|104|||
44397362|NCT00588861|79403995|FG001|6 Years|Patients did not return for follow-up|109|||
44397363|NCT00588861|79403994|FG000|8 Years|Patients did not return for follow-up|105|||
44397364|NCT00588861|79403995|FG001|8 Years|Patients did not return for follow-up|114|||
44397365|NCT00588861|79403994|FG000|10 Years|Incomplete due to study termination|107|||
44397366|NCT00588861|79403995|FG001|10 Years|Incomplete due to study termination|114|||
44397367|NCT00887978|79404003|FG000|Overall Study|Adverse Event|18|||
44397368|NCT00887978|79404004|FG001|Overall Study|Adverse Event|5|||
44397369|NCT00887978|79404003|FG000|Overall Study|Clinical Worsening|4|||
44397370|NCT00887978|79404004|FG001|Overall Study|Clinical Worsening|4|||
44397371|NCT00887978|79404003|FG000|Overall Study|Death|2|||
44397372|NCT00887978|79404004|FG001|Overall Study|Death|3|||
44521088|NCT00001941|79529360|FG001|Overall Study|not treated- rapidly progressing disease|0|||
44147225|NCT00700817|78936665|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
44147226|NCT00700817|78936666|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
44147227|NCT00700817|78936667|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
44147228|NCT02625909|78936679|FG000|Overall Study|Death|2|||
44147229|NCT02625909|78936680|FG001|Overall Study|Death|0|||
44147230|NCT02625909|78936679|FG000|Overall Study|Lost to Follow-up|3|||
44147231|NCT02625909|78936680|FG001|Overall Study|Lost to Follow-up|5|||
44147232|NCT02625909|78936679|FG000|Overall Study|Lack of Efficacy|9|||
44147233|NCT02625909|78936680|FG001|Overall Study|Lack of Efficacy|2|||
44147234|NCT02625909|78936679|FG000|Overall Study|Reinfection|3|||
44147235|NCT02625909|78936680|FG001|Overall Study|Reinfection|2|||
44147236|NCT02623959|78936688|FG000|Overall Study|Progression|0|||
44147237|NCT02623959|78936689|FG001|Overall Study|Progression|1|||
44147238|NCT00700739|78936699|FG000|Overall Study|Lost to Follow-up|4|||
44147239|NCT00700739|78936700|FG001|Overall Study|Lost to Follow-up|4|||
44147240|NCT02623335|78936709|FG000|Overall Study|Death|8|||
44147241|NCT02623335|78936710|FG001|Overall Study|Death|7|||
44147242|NCT02623335|78936709|FG000|Overall Study|Lost to Follow-up|15|||
44147243|NCT02623335|78936710|FG001|Overall Study|Lost to Follow-up|23|||
44147244|NCT02623335|78936709|FG000|Overall Study|Withdrawal by Subject|2|||
44397373|NCT00887978|79404003|FG000|Overall Study|Withdrawal by Subject|1|||
44397374|NCT00887978|79404004|FG001|Overall Study|Withdrawal by Subject|2|||
44397375|NCT00887978|79404003|FG000|Overall Study|Lost to Follow-up|0|||
44397376|NCT00887978|79404004|FG001|Overall Study|Lost to Follow-up|1|||
44397377|NCT00608023|79404013|FG000|Overall Study|Withdrawal by Subject|8|||
44397378|NCT00608023|79404014|FG001|Overall Study|Withdrawal by Subject|10|||
44397379|NCT00608023|79404015|FG002|Overall Study|Withdrawal by Subject|7|||
44397380|NCT00608023|79404013|FG000|Overall Study|Adverse Event|1|||
44397381|NCT00608023|79404014|FG001|Overall Study|Adverse Event|4|||
44397382|NCT00608023|79404015|FG002|Overall Study|Adverse Event|5|||
44397383|NCT00608023|79404013|FG000|Overall Study|Lost to Follow-up|2|||
44252569|NCT04188301|79090357|FG000|Month 12|Death|1|||
44252570|NCT04188301|79090358|FG001|Month 12|Death|1|||
44252571|NCT04188301|79090359|FG002|Month 12|Death|0|||
44252572|NCT04188301|79090357|FG000|Month 18|Lost to Follow-up|6|||
44252573|NCT04188301|79090358|FG001|Month 18|Lost to Follow-up|0|||
44252574|NCT04188301|79090359|FG002|Month 18|Lost to Follow-up|0|||
44252575|NCT04006925|79090369|FG000|Overall Study|Side effects|2|||
44252576|NCT04006925|79090370|FG001|Overall Study|Side effects|0|||
44252577|NCT03597061|79090382|FG000|Overall Study|Lost to Follow-up|1|||
44252578|NCT03597061|79090383|FG001|Overall Study|Lost to Follow-up|0|||
44252579|NCT03597061|79090382|FG000|Overall Study|Protocol Violation|0|||
44252580|NCT03597061|79090383|FG001|Overall Study|Protocol Violation|1|||
44252581|NCT03148795|79090411|FG000|Overall Study|Death|6|||
44252582|NCT03148795|79090411|FG000|Overall Study|Adverse Event|5|||
44252583|NCT03148795|79090411|FG000|Overall Study|Other|15|||
44252584|NCT03148795|79090411|FG000|Overall Study|No Longer Clinically Benefitting|2|||
44252585|NCT03148795|79090411|FG000|Overall Study|Global Deterioration Of Health Status|6|||
44252586|NCT03148795|79090411|FG000|Overall Study|Withdrawal by Subject|2|||
44252587|NCT03148795|79090411|FG000|Overall Study|Progressive Disease|62|||
44252588|NCT03148795|79090411|FG000|Overall Study|Ongoing|30|||
44252589|NCT03146845|79090417|FG000|Overall Study|Reference ulcer healed|1|||
44252590|NCT03146845|79090418|FG001|Overall Study|Reference ulcer healed|0|||
44252591|NCT03146845|79090417|FG000|Overall Study|Physician Decision|1|||
44252592|NCT03146845|79090418|FG001|Overall Study|Physician Decision|0|||
44252593|NCT03146845|79090417|FG000|Overall Study|Adverse Event|1|||
44252594|NCT03146845|79090418|FG001|Overall Study|Adverse Event|0|||
44252595|NCT03146845|79090417|FG000|Overall Study|Withdrawal by Subject|2|||
44252596|NCT03146845|79090418|FG001|Overall Study|Withdrawal by Subject|0|||
44252597|NCT03146845|79090417|FG000|Overall Study|Noncompliance|0|||
44252598|NCT03146845|79090418|FG001|Overall Study|Noncompliance|1|||
44252599|NCT03146845|79090417|FG000|Overall Study|Protocol Violation|0|||
44252600|NCT03146845|79090418|FG001|Overall Study|Protocol Violation|2|||
44252601|NCT03146845|79090417|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
44252602|NCT03146845|79090418|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
44281527|NCT01972074|79244800|FG000|Overall Study|Lack of Efficacy|1|||
44281528|NCT01972074|79244801|FG001|Overall Study|Lack of Efficacy|1|||
44397384|NCT00608023|79404014|FG001|Overall Study|Lost to Follow-up|2|||
44397385|NCT00608023|79404015|FG002|Overall Study|Lost to Follow-up|1|||
44397386|NCT00608023|79404013|FG000|Overall Study|Protocol Violation|1|||
44521089|NCT00001941|79529361|FG002|Overall Study|not treated- rapidly progressing disease|0|||
44521090|NCT00001941|79529362|FG003|Overall Study|not treated- rapidly progressing disease|0|||
44521091|NCT00001941|79529363|FG004|Overall Study|not treated- rapidly progressing disease|1|||
44521092|NCT01061866|79529368|FG000|Overall Study|Adverse Event|2|||
44521093|NCT01061008|79529374|FG000|Overall Study|Badiocephalic fistula failed|3|||
44521094|NCT01061008|79529375|FG001|Overall Study|Badiocephalic fistula failed|2|||
44521095|NCT01061008|79529374|FG000|Overall Study|Death|1|||
44252603|NCT02975700|79090424|FG000|Overall Study|Adverse Event|1|||
44397387|NCT00608023|79404014|FG001|Overall Study|Protocol Violation|3|||
44397388|NCT00608023|79404015|FG002|Overall Study|Protocol Violation|1|||
44397389|NCT00608023|79404013|FG000|Overall Study|Unknown reason|0|||
44397390|NCT00608023|79404014|FG001|Overall Study|Unknown reason|3|||
44281529|NCT01972074|79244802|FG002|Overall Study|Lack of Efficacy|0|||
44397391|NCT00608023|79404015|FG002|Overall Study|Unknown reason|0|||
44397392|NCT00802659|79404030|FG000|Overall Study|Physician Decision|0|||
44397393|NCT00802659|79404031|FG001|Overall Study|Physician Decision|1|||
44397394|NCT00802659|79404032|FG002|Overall Study|Physician Decision|0|||
44397395|NCT00802659|79404033|FG003|Overall Study|Physician Decision|0|||
44397396|NCT00607789|79404045|FG000|Overall Study|Adverse Event|3|||
44397397|NCT00607789|79404046|FG001|Overall Study|Adverse Event|0|||
44397398|NCT00607789|79404045|FG000|Overall Study|Lack of Efficacy|0|||
44281530|NCT01972074|79244800|FG000|Overall Study|Lost to Follow-up|0|||
44281531|NCT01972074|79244801|FG001|Overall Study|Lost to Follow-up|1|||
44281532|NCT01972074|79244802|FG002|Overall Study|Lost to Follow-up|1|||
44397399|NCT00607789|79404046|FG001|Overall Study|Lack of Efficacy|1|||
44252604|NCT02975700|79090424|FG000|Overall Study|Progressive disease|3|||
44281533|NCT01972074|79244800|FG000|Overall Study|Withdrawal by Subject|1|||
44281534|NCT01972074|79244801|FG001|Overall Study|Withdrawal by Subject|1|||
44397400|NCT00607789|79404045|FG000|Overall Study|Inadequate adherence|3|||
44281535|NCT01972074|79244802|FG002|Overall Study|Withdrawal by Subject|1|||
44281536|NCT01972074|79244800|FG000|Overall Study|Scanner Unavailable|0|||
44281537|NCT01972074|79244801|FG001|Overall Study|Scanner Unavailable|0|||
44281538|NCT01972074|79244802|FG002|Overall Study|Scanner Unavailable|1|||
44281539|NCT01970982|79244812|FG000|Overall Study|Withdrawal by Subject|0|||
44281540|NCT01970982|79244813|FG001|Overall Study|Withdrawal by Subject|0|||
44281541|NCT01970982|79244814|FG002|Overall Study|Withdrawal by Subject|2|||
44281542|NCT01946802|79244823|FG000|Overall Study|Death|1|||
44281543|NCT01946802|79244823|FG000|Overall Study|Withdrawal by Subject|2|||
44281544|NCT01946802|79244823|FG000|Overall Study|Combined septic shock|1|||
44281545|NCT01946802|79244823|FG000|Overall Study|Protocol Violation|1|||
44397401|NCT00607789|79404046|FG001|Overall Study|Inadequate adherence|0|||
44397402|NCT00607789|79404045|FG000|Overall Study|Lost to Follow-up|0|||
44397403|NCT00607789|79404046|FG001|Overall Study|Lost to Follow-up|5|||
44397404|NCT00607789|79404045|FG000|Overall Study|Withdrawal by Subject|1|||
44397405|NCT00607789|79404046|FG001|Overall Study|Withdrawal by Subject|0|||
44397406|NCT00887822|79404054|FG000|Overall Study|Insufficient therapeutic response|53|||
44397407|NCT00887822|79404055|FG001|Overall Study|Insufficient therapeutic response|55|||
44397408|NCT00887822|79404054|FG000|Overall Study|Adverse Event|14|||
44397409|NCT00887822|79404055|FG001|Overall Study|Adverse Event|17|||
44397410|NCT00887822|79404054|FG000|Overall Study|Failure to return|11|||
44397411|NCT00887822|79404055|FG001|Overall Study|Failure to return|11|||
44397412|NCT00887822|79404054|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
44397413|NCT00887822|79404055|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
44397414|NCT00887822|79404054|FG000|Overall Study|Administrative/Other than specified|5|||
44397415|NCT00887822|79404055|FG001|Overall Study|Administrative/Other than specified|4|||
44397416|NCT00887822|79404054|FG000|Overall Study|Death|2|||
44397417|NCT00887822|79404055|FG001|Overall Study|Death|3|||
44397418|NCT00887822|79404054|FG000|Overall Study|Protocol Violation|0|||
44397419|NCT00887822|79404055|FG001|Overall Study|Protocol Violation|1|||
44397420|NCT00887822|79404054|FG000|Overall Study|Randomized but not treated|0|||
44397421|NCT00887822|79404055|FG001|Overall Study|Randomized but not treated|1|||
44397422|NCT00951665|79404067|FG000|Phase 1b|Adverse Event|2|||
44397423|NCT00951665|79404068|FG001|Phase 1b|Adverse Event|1|||
44397424|NCT00951665|79404069|FG002|Phase 1b|Adverse Event|0|||
44397425|NCT00951665|79404070|FG003|Phase 1b|Adverse Event|1|||
44397426|NCT00951665|79404071|FG004|Phase 1b|Adverse Event|0|||
44397427|NCT00951665|79404072|FG005|Phase 1b|Adverse Event|0|||
44397428|NCT00951665|79404067|FG000|Phase 1b|Death|1|||
44397429|NCT00951665|79404068|FG001|Phase 1b|Death|0|||
44397430|NCT00951665|79404069|FG002|Phase 1b|Death|2|||
44397431|NCT00951665|79404070|FG003|Phase 1b|Death|0|||
44397432|NCT00951665|79404071|FG004|Phase 1b|Death|0|||
44397433|NCT00951665|79404072|FG005|Phase 1b|Death|0|||
44397434|NCT00951665|79404067|FG000|Phase 1b|Physician Decision|4|||
44397435|NCT00951665|79404068|FG001|Phase 1b|Physician Decision|0|||
44397436|NCT00951665|79404069|FG002|Phase 1b|Physician Decision|1|||
44397437|NCT00951665|79404070|FG003|Phase 1b|Physician Decision|0|||
44397438|NCT00951665|79404071|FG004|Phase 1b|Physician Decision|0|||
44397439|NCT00951665|79404072|FG005|Phase 1b|Physician Decision|0|||
44397440|NCT00951665|79404067|FG000|Phase 1b|Withdrawal by Subject|0|||
44397441|NCT00951665|79404068|FG001|Phase 1b|Withdrawal by Subject|1|||
44397442|NCT00951665|79404069|FG002|Phase 1b|Withdrawal by Subject|0|||
44397443|NCT00951665|79404070|FG003|Phase 1b|Withdrawal by Subject|0|||
44397444|NCT00951665|79404071|FG004|Phase 1b|Withdrawal by Subject|0|||
44397445|NCT00951665|79404072|FG005|Phase 1b|Withdrawal by Subject|0|||
44397446|NCT00951665|79404067|FG000|Phase 1b|Disease Progression|13|||
44397447|NCT00951665|79404068|FG001|Phase 1b|Disease Progression|2|||
44397448|NCT00951665|79404069|FG002|Phase 1b|Disease Progression|14|||
44397449|NCT00951665|79404070|FG003|Phase 1b|Disease Progression|0|||
44397450|NCT00951665|79404071|FG004|Phase 1b|Disease Progression|0|||
44397451|NCT00951665|79404072|FG005|Phase 1b|Disease Progression|0|||
44397452|NCT00951665|79404067|FG000|Phase 1b|Protocol Violation|2|||
44397453|NCT00951665|79404068|FG001|Phase 1b|Protocol Violation|0|||
44397454|NCT00951665|79404069|FG002|Phase 1b|Protocol Violation|0|||
44397455|NCT00951665|79404070|FG003|Phase 1b|Protocol Violation|0|||
44397456|NCT00951665|79404071|FG004|Phase 1b|Protocol Violation|0|||
44397457|NCT00951665|79404072|FG005|Phase 1b|Protocol Violation|0|||
44521096|NCT01061008|79529375|FG001|Overall Study|Death|0|||
44521097|NCT01061008|79529374|FG000|Overall Study|Withdrawal by Subject|1|||
44281546|NCT01618266|79244827|FG000|Overall Study|Lost to Follow-up|9|||
44281547|NCT01618266|79244827|FG000|Overall Study|Treatment satisfaction|10|||
44397458|NCT00951665|79404067|FG000|Phase 2a|Adverse Event|0|||
44397459|NCT00951665|79404068|FG001|Phase 2a|Adverse Event|0|||
44397460|NCT00951665|79404069|FG002|Phase 2a|Adverse Event|0|||
44397461|NCT00951665|79404070|FG003|Phase 2a|Adverse Event|0|||
44397462|NCT00951665|79404071|FG004|Phase 2a|Adverse Event|2|||
44397463|NCT00951665|79404072|FG005|Phase 2a|Adverse Event|0|||
44397464|NCT00951665|79404067|FG000|Phase 2a|Death|0|||
44397465|NCT00951665|79404068|FG001|Phase 2a|Death|0|||
44397466|NCT00951665|79404069|FG002|Phase 2a|Death|0|||
44397467|NCT00951665|79404070|FG003|Phase 2a|Death|0|||
44397468|NCT00951665|79404071|FG004|Phase 2a|Death|1|||
44397469|NCT00951665|79404072|FG005|Phase 2a|Death|1|||
44397470|NCT00951665|79404067|FG000|Phase 2a|Lost to Follow-up|0|||
44397471|NCT00951665|79404068|FG001|Phase 2a|Lost to Follow-up|0|||
44397472|NCT00951665|79404069|FG002|Phase 2a|Lost to Follow-up|0|||
44397473|NCT00951665|79404070|FG003|Phase 2a|Lost to Follow-up|0|||
44397474|NCT00951665|79404071|FG004|Phase 2a|Lost to Follow-up|1|||
44397475|NCT00951665|79404072|FG005|Phase 2a|Lost to Follow-up|0|||
44397476|NCT00951665|79404067|FG000|Phase 2a|Physician Decision|0|||
44397477|NCT00951665|79404068|FG001|Phase 2a|Physician Decision|0|||
44397478|NCT00951665|79404069|FG002|Phase 2a|Physician Decision|0|||
44397479|NCT00951665|79404070|FG003|Phase 2a|Physician Decision|0|||
44397480|NCT00951665|79404071|FG004|Phase 2a|Physician Decision|0|||
44397481|NCT00951665|79404072|FG005|Phase 2a|Physician Decision|1|||
44397482|NCT00951665|79404067|FG000|Phase 2a|Withdrawal by Subject|0|||
44397483|NCT00951665|79404068|FG001|Phase 2a|Withdrawal by Subject|0|||
44397484|NCT00951665|79404069|FG002|Phase 2a|Withdrawal by Subject|0|||
44521098|NCT01061008|79529375|FG001|Overall Study|Withdrawal by Subject|3|||
44521099|NCT01061008|79529374|FG000|Overall Study|Unable to exercise following surgery|1|||
44521100|NCT01061008|79529375|FG001|Overall Study|Unable to exercise following surgery|0|||
44521101|NCT01061008|79529374|FG000|Overall Study|Adverse Event|0|||
44521102|NCT01061008|79529375|FG001|Overall Study|Adverse Event|1|||
44521103|NCT00039741|79529385|FG000|Overall Study|Death|0|||
44521104|NCT00039741|79529386|FG001|Overall Study|Death|1|||
44521105|NCT00039741|79529387|FG002|Overall Study|Death|0|||
44521106|NCT00039741|79529388|FG003|Overall Study|Death|0|||
44521107|NCT00039741|79529385|FG000|Overall Study|Lost to Follow-up|3|||
44281548|NCT01618266|79244827|FG000|Overall Study|Other reasons|11|||
44281549|NCT01618266|79244827|FG000|Overall Study|Lack of Efficacy|23|||
44281550|NCT01618266|79244827|FG000|Overall Study|Protocol Violation|43|||
44281551|NCT01919112|79244834|FG000|Secondary Analysis-day 30|Death|1|||
44521108|NCT00039741|79529386|FG001|Overall Study|Lost to Follow-up|1|||
44521109|NCT00039741|79529387|FG002|Overall Study|Lost to Follow-up|5|||
44521110|NCT00039741|79529388|FG003|Overall Study|Lost to Follow-up|2|||
44521111|NCT00039741|79529385|FG000|Overall Study|Confounding medical condition|1|||
44521112|NCT00039741|79529386|FG001|Overall Study|Confounding medical condition|0|||
44521113|NCT00039741|79529387|FG002|Overall Study|Confounding medical condition|0|||
44521114|NCT00039741|79529388|FG003|Overall Study|Confounding medical condition|0|||
44521115|NCT00039741|79529385|FG000|Overall Study|Not able to get to clinic|5|||
44521116|NCT00039741|79529386|FG001|Overall Study|Not able to get to clinic|2|||
44521117|NCT00039741|79529387|FG002|Overall Study|Not able to get to clinic|0|||
44521118|NCT00039741|79529388|FG003|Overall Study|Not able to get to clinic|3|||
44521119|NCT00039741|79529385|FG000|Overall Study|Moved|3|||
44521120|NCT00039741|79529386|FG001|Overall Study|Moved|2|||
44521121|NCT00039741|79529387|FG002|Overall Study|Moved|3|||
44521122|NCT00039741|79529388|FG003|Overall Study|Moved|6|||
44521123|NCT00039741|79529385|FG000|Overall Study|Non-compliance with protocol|1|||
44521124|NCT00039741|79529386|FG001|Overall Study|Non-compliance with protocol|0|||
44521125|NCT00039741|79529387|FG002|Overall Study|Non-compliance with protocol|1|||
44521126|NCT00039741|79529388|FG003|Overall Study|Non-compliance with protocol|0|||
44521127|NCT00039741|79529385|FG000|Overall Study|Withdrew consent|0|||
44521128|NCT00039741|79529386|FG001|Overall Study|Withdrew consent|5|||
44521129|NCT00039741|79529387|FG002|Overall Study|Withdrew consent|0|||
44521130|NCT00039741|79529388|FG003|Overall Study|Withdrew consent|1|||
44281552|NCT01919112|79244835|FG001|Secondary Analysis-day 30|Death|1|||
44281553|NCT01919112|79244836|FG002|Secondary Analysis-day 30|Death|1|||
44281554|NCT01919112|79244834|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
44281555|NCT01919112|79244835|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
44281556|NCT01919112|79244836|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
44281557|NCT01918332|79244848|FG000|Overall Study|Adverse Event|0|||
44281558|NCT01918332|79244849|FG001|Overall Study|Adverse Event|0|||
44281559|NCT01918332|79244850|FG002|Overall Study|Adverse Event|0|||
44281560|NCT01918332|79244851|FG003|Overall Study|Adverse Event|1|||
44281561|NCT01918332|79244848|FG000|Overall Study|Withdrawal by Subject|2|||
44281562|NCT01918332|79244849|FG001|Overall Study|Withdrawal by Subject|3|||
44281563|NCT01918332|79244850|FG002|Overall Study|Withdrawal by Subject|2|||
44281564|NCT01918332|79244851|FG003|Overall Study|Withdrawal by Subject|3|||
44281565|NCT01918332|79244848|FG000|Overall Study|Protocol Violation|6|||
44281566|NCT01918332|79244849|FG001|Overall Study|Protocol Violation|2|||
44397485|NCT00951665|79404070|FG003|Phase 2a|Withdrawal by Subject|0|||
44397486|NCT00951665|79404071|FG004|Phase 2a|Withdrawal by Subject|2|||
44397487|NCT00951665|79404072|FG005|Phase 2a|Withdrawal by Subject|0|||
44397488|NCT00951665|79404067|FG000|Phase 2a|Disease Progression|0|||
44521131|NCT00039741|79529385|FG000|Overall Study|Missed final visit|2|||
44521132|NCT00039741|79529386|FG001|Overall Study|Missed final visit|1|||
44281567|NCT01918332|79244850|FG002|Overall Study|Protocol Violation|6|||
44397489|NCT00951665|79404068|FG001|Phase 2a|Disease Progression|0|||
44397490|NCT00951665|79404069|FG002|Phase 2a|Disease Progression|0|||
44397491|NCT00951665|79404070|FG003|Phase 2a|Disease Progression|0|||
44397492|NCT00951665|79404071|FG004|Phase 2a|Disease Progression|6|||
44397493|NCT00951665|79404072|FG005|Phase 2a|Disease Progression|5|||
44397494|NCT00801099|79404106|FG000|Overall Study|Lost to Follow-up|101|||
44397495|NCT00887744|79404110|FG000|Overall Study|Adverse Event|3|||
44397496|NCT00887744|79404110|FG000|Overall Study|Death|1|||
44397497|NCT00887744|79404110|FG000|Overall Study|Lost to Follow-up|3|||
44397498|NCT00887744|79404110|FG000|Overall Study|Withdrawal by Subject|18|||
44397499|NCT00887744|79404110|FG000|Overall Study|Various reasons|9|||
44397500|NCT00951509|79404114|FG000|Overall Study|Withdrawal by Subject|2|||
44397501|NCT00610441|79404126|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
44397502|NCT00610441|79404127|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
44397503|NCT00610441|79404128|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
44397504|NCT00610441|79404129|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
44397505|NCT00610441|79404126|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
44397506|NCT00610441|79404127|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
44397507|NCT00610441|79404128|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
44397508|NCT00610441|79404129|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
44397509|NCT00610441|79404126|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
44397510|NCT00610441|79404127|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
44397511|NCT00610441|79404128|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
44397512|NCT00610441|79404129|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
44397513|NCT00610441|79404126|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
44397514|NCT00610441|79404127|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
44397515|NCT00610441|79404128|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
44397516|NCT00610441|79404129|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
44397517|NCT00610441|79404126|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
44397518|NCT00610441|79404127|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
44397519|NCT00610441|79404128|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
44397520|NCT00610441|79404129|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
44397521|NCT00610441|79404126|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
44397522|NCT00610441|79404127|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
44397523|NCT00610441|79404128|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
44397524|NCT00610441|79404129|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
44397525|NCT00610441|79404126|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
44397526|NCT00610441|79404127|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
44397527|NCT00610441|79404128|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
44397528|NCT00610441|79404129|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
44397529|NCT00610441|79404126|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
44397530|NCT00610441|79404127|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
44397531|NCT00610441|79404128|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
44397532|NCT00610441|79404129|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
44397533|NCT00610441|79404126|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
44397534|NCT00610441|79404127|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
44397535|NCT00610441|79404128|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
44397536|NCT00610441|79404129|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
44397537|NCT00799617|79404143|FG000|Main Testosterone Trial|Randomized in error|1|||
44397538|NCT00799617|79404144|FG001|Main Testosterone Trial|Randomized in error|1|||
44397539|NCT00799617|79404143|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
44397540|NCT00799617|79404144|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
44397541|NCT00799617|79404143|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
44397542|NCT00799617|79404144|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
44397543|NCT00799617|79404143|FG000|Sexual Funtion Trial|No Baseline Data|4|||
44397544|NCT00799617|79404144|FG001|Sexual Funtion Trial|No Baseline Data|7|||
44397545|NCT00799617|79404143|FG000|Physical Function Trial|Lost to Follow-up|6|||
44397546|NCT00799617|79404144|FG001|Physical Function Trial|Lost to Follow-up|11|||
44397547|NCT00799617|79404143|FG000|Vitality Trial|Lost to Follow-up|7|||
44397548|NCT00799617|79404144|FG001|Vitality Trial|Lost to Follow-up|22|||
44397549|NCT00799617|79404143|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
44397550|NCT00799617|79404144|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
44397551|NCT00799617|79404143|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
44397552|NCT00799617|79404144|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
44397553|NCT00799617|79404143|FG000|Bone Trial|Month 12 scan not available|6|||
44397554|NCT00799617|79404144|FG001|Bone Trial|Month 12 scan not available|16|||
44397555|NCT00799617|79404143|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
44147245|NCT02623335|78936710|FG001|Overall Study|Withdrawal by Subject|5|||
44147246|NCT02623335|78936709|FG000|Overall Study|Protocol Violation|2|||
44147247|NCT02623335|78936710|FG001|Overall Study|Protocol Violation|1|||
44397556|NCT00799617|79404144|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
44397557|NCT00799617|79404143|FG000|Anemia Trial|Withdrawal by Subject|3|||
44147248|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
44147249|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
44147250|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
44147251|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
44147252|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
44147253|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
44147254|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
44147255|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
44147256|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
44147257|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
44147258|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
44147259|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
44147260|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
44252605|NCT02975700|79090424|FG000|Overall Study|Failed screening criteria|2|||
44252606|NCT02895360|79090434|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
44252607|NCT02895360|79090435|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
44252608|NCT02895360|79090436|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
44252609|NCT02895360|79090437|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
44252610|NCT02895360|79090438|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
44252611|NCT02895360|79090439|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
44252612|NCT02895360|79090434|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
44252613|NCT02895360|79090435|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
44252614|NCT02895360|79090436|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
44252615|NCT02895360|79090437|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
44252616|NCT02895360|79090438|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
44252617|NCT02895360|79090439|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
44252618|NCT02895360|79090434|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
44252619|NCT02895360|79090435|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
44252620|NCT02895360|79090436|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
44252621|NCT02895360|79090437|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
44252622|NCT02895360|79090438|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
44252623|NCT02895360|79090439|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
44252624|NCT02895360|79090434|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
44252625|NCT02895360|79090435|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
44252626|NCT02895360|79090436|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
44252627|NCT02895360|79090437|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
44252628|NCT02895360|79090438|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
44252629|NCT02895360|79090439|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
44252630|NCT02895360|79090434|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
44252631|NCT02895360|79090435|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
44252632|NCT02895360|79090436|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
44252633|NCT02895360|79090437|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
44252634|NCT02895360|79090438|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
44252635|NCT02895360|79090439|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
44252636|NCT02895360|79090434|FG000|Phase 2a|Adverse Event|0|||
44252637|NCT02895360|79090435|FG001|Phase 2a|Adverse Event|0|||
44252638|NCT02895360|79090436|FG002|Phase 2a|Adverse Event|0|||
44252639|NCT02895360|79090437|FG003|Phase 2a|Adverse Event|0|||
44252640|NCT02895360|79090438|FG004|Phase 2a|Adverse Event|0|||
44252641|NCT02895360|79090439|FG005|Phase 2a|Adverse Event|1|||
44147261|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
44147262|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
44147263|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
44147264|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
44147265|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
44147266|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
44147267|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
44147268|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
44147269|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
44147270|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
44147271|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
44147272|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
44147273|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
44147274|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
44147275|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
44147276|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
44252642|NCT02895360|79090434|FG000|Phase 2a|Progressive disease|0|||
44252643|NCT02895360|79090435|FG001|Phase 2a|Progressive disease|0|||
44252644|NCT02895360|79090436|FG002|Phase 2a|Progressive disease|0|||
44252645|NCT02895360|79090437|FG003|Phase 2a|Progressive disease|0|||
44252646|NCT02895360|79090438|FG004|Phase 2a|Progressive disease|11|||
44252647|NCT02895360|79090439|FG005|Phase 2a|Progressive disease|11|||
44252648|NCT02863809|79090473|FG000|Overall Study|Adverse Event|8|||
44252649|NCT02863809|79090474|FG001|Overall Study|Adverse Event|8|||
44252650|NCT02863809|79090473|FG000|Overall Study|Withdrawal by Subject|0|||
44252651|NCT02863809|79090474|FG001|Overall Study|Withdrawal by Subject|1|||
44252652|NCT02863809|79090473|FG000|Overall Study|Lost to Follow-up|1|||
44252653|NCT02863809|79090474|FG001|Overall Study|Lost to Follow-up|1|||
44252654|NCT02863809|79090473|FG000|Overall Study|Death|1|||
44252655|NCT02863809|79090474|FG001|Overall Study|Death|0|||
44252656|NCT02753530|79090498|FG000|Overall Study|Adverse Event|7|||
44252657|NCT02753530|79090499|FG001|Overall Study|Adverse Event|1|||
44252658|NCT02753530|79090498|FG000|Overall Study|Death|0|||
44252659|NCT02753530|79090499|FG001|Overall Study|Death|1|||
44252660|NCT02753530|79090498|FG000|Overall Study|Physician Decision|0|||
44252661|NCT02753530|79090499|FG001|Overall Study|Physician Decision|1|||
44252662|NCT02753530|79090498|FG000|Overall Study|Protocol Violation|1|||
44252663|NCT02753530|79090499|FG001|Overall Study|Protocol Violation|0|||
44252664|NCT02753530|79090498|FG000|Overall Study|Withdrawal by Subject|4|||
44252665|NCT02753530|79090499|FG001|Overall Study|Withdrawal by Subject|3|||
44252666|NCT02289079|79090511|FG000|Overall Study|Physician Decision|2|||
44252667|NCT02289079|79090512|FG001|Overall Study|Physician Decision|0|||
44252668|NCT02289079|79090511|FG000|Overall Study|Lost to Follow-up|0|||
44397558|NCT00799617|79404144|FG001|Anemia Trial|Withdrawal by Subject|3|||
44397559|NCT00607087|79404153|FG000|Overall Study|Withdrawal by Subject|9|||
44397560|NCT00607087|79404154|FG001|Overall Study|Withdrawal by Subject|4|||
44397561|NCT00607087|79404155|FG002|Overall Study|Withdrawal by Subject|4|||
44397562|NCT00607087|79404153|FG000|Overall Study|Adverse Event|3|||
44147277|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
44147278|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
44147279|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
44147280|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
44252669|NCT02289079|79090512|FG001|Overall Study|Lost to Follow-up|1|||
44252670|NCT00602667|79090579|FG000|Overall Study|Still on Therapy|0|||
44252671|NCT00602667|79090580|FG001|Overall Study|Still on Therapy|2|||
44252672|NCT00602667|79090581|FG002|Overall Study|Still on Therapy|2|||
44252673|NCT00602667|79090579|FG000|Overall Study|Death|0|||
44252674|NCT00602667|79090580|FG001|Overall Study|Death|1|||
44252675|NCT00602667|79090581|FG002|Overall Study|Death|1|||
44252676|NCT00602667|79090579|FG000|Overall Study|Family request|3|||
44281568|NCT01918332|79244851|FG003|Overall Study|Protocol Violation|3|||
44281569|NCT01918332|79244848|FG000|Overall Study|lipid result by central lab did not meet|0|||
44281570|NCT01918332|79244849|FG001|Overall Study|lipid result by central lab did not meet|0|||
44281571|NCT01918332|79244850|FG002|Overall Study|lipid result by central lab did not meet|1|||
44281572|NCT01918332|79244851|FG003|Overall Study|lipid result by central lab did not meet|0|||
44281573|NCT01922934|79244863|FG000|Eligible Patients|Death|0|||
44281574|NCT01922934|79244864|FG001|Eligible Patients|Death|7|||
44281575|NCT01922934|79244863|FG000|Eligible Patients|Physician Decision|17|||
44281576|NCT01922934|79244864|FG001|Eligible Patients|Physician Decision|0|||
44281577|NCT01922934|79244863|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
44281578|NCT01922934|79244864|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
44281579|NCT01922934|79244863|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
44281580|NCT01922934|79244864|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
44281581|NCT01922934|79244863|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
44281582|NCT01922934|79244864|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
44281583|NCT01922934|79244863|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
44281584|NCT01922934|79244864|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
44281585|NCT01970592|79244872|FG000|Overall Study|Withdrawal by Subject|4|||
44281586|NCT01970592|79244872|FG000|Overall Study|Physician Decision|1|||
44281587|NCT01970592|79244872|FG000|Overall Study|Adverse Event|1|||
44281588|NCT01920594|79244878|FG000|Overall Study|Adverse Event|4|||
44281589|NCT01920594|79244879|FG001|Overall Study|Adverse Event|2|||
44281590|NCT01920594|79244878|FG000|Overall Study|Lost to Follow-up|1|||
44281591|NCT01920594|79244879|FG001|Overall Study|Lost to Follow-up|0|||
44281592|NCT01920594|79244878|FG000|Overall Study|Recovery|2|||
44281593|NCT01920594|79244879|FG001|Overall Study|Recovery|0|||
44281594|NCT01920594|79244878|FG000|Overall Study|Investigator discretion|0|||
44281595|NCT01920594|79244879|FG001|Overall Study|Investigator discretion|1|||
44281596|NCT01917084|79244885|FG000|Overall Study|Withdrawal by Subject|1|||
44281597|NCT01917006|79244896|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
44281598|NCT01917006|79244897|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
44281599|NCT01917006|79244898|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
44281600|NCT01917006|79244899|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
44252677|NCT00602667|79090580|FG001|Overall Study|Family request|25|||
44252678|NCT00602667|79090581|FG002|Overall Study|Family request|6|||
44252679|NCT00602667|79090579|FG000|Overall Study|Excessive toxicity|1|||
44397563|NCT00607087|79404154|FG001|Overall Study|Adverse Event|2|||
44397564|NCT00607087|79404155|FG002|Overall Study|Adverse Event|3|||
44397565|NCT00607087|79404153|FG000|Overall Study|Other reason|1|||
44397566|NCT00607087|79404154|FG001|Overall Study|Other reason|5|||
44397567|NCT00607087|79404155|FG002|Overall Study|Other reason|2|||
44397568|NCT00607087|79404153|FG000|Overall Study|Poor compliance to protocol|1|||
44397569|NCT00607087|79404154|FG001|Overall Study|Poor compliance to protocol|0|||
44397570|NCT00607087|79404155|FG002|Overall Study|Poor compliance to protocol|1|||
44397571|NCT00607087|79404153|FG000|Overall Study|Lost to Follow-up|1|||
44397572|NCT00607087|79404154|FG001|Overall Study|Lost to Follow-up|0|||
44397573|NCT00607087|79404155|FG002|Overall Study|Lost to Follow-up|0|||
44397574|NCT00607087|79404153|FG000|Period 1|Withdrawal by Subject|7|||
44397575|NCT00607087|79404154|FG001|Period 1|Withdrawal by Subject|2|||
44397576|NCT00607087|79404155|FG002|Period 1|Withdrawal by Subject|3|||
44397577|NCT00607087|79404153|FG000|Period 1|Adverse Event|3|||
44397578|NCT00607087|79404154|FG001|Period 1|Adverse Event|0|||
44397579|NCT00607087|79404155|FG002|Period 1|Adverse Event|0|||
44397580|NCT00607087|79404153|FG000|Period 1|Poor compliance to protocol|1|||
44397581|NCT00607087|79404154|FG001|Period 1|Poor compliance to protocol|0|||
44397582|NCT00607087|79404155|FG002|Period 1|Poor compliance to protocol|0|||
44397583|NCT00607087|79404153|FG000|Period 1|Lost to Follow-up|1|||
44397584|NCT00607087|79404154|FG001|Period 1|Lost to Follow-up|0|||
44397585|NCT00607087|79404155|FG002|Period 1|Lost to Follow-up|0|||
44397586|NCT00607087|79404153|FG000|Period 1|Other reason|0|||
44397587|NCT00607087|79404154|FG001|Period 1|Other reason|4|||
44397588|NCT00607087|79404155|FG002|Period 1|Other reason|2|||
44397589|NCT00607087|79404153|FG000|Period 2|Withdrawal by Subject|0|||
44397590|NCT00607087|79404154|FG001|Period 2|Withdrawal by Subject|1|||
44397591|NCT00607087|79404155|FG002|Period 2|Withdrawal by Subject|1|||
44397592|NCT00607087|79404153|FG000|Period 2|Other reason|1|||
44397593|NCT00607087|79404154|FG001|Period 2|Other reason|1|||
44397594|NCT00607087|79404155|FG002|Period 2|Other reason|0|||
44397595|NCT00607087|79404153|FG000|Period 2|Adverse Event|0|||
44397596|NCT00607087|79404154|FG001|Period 2|Adverse Event|1|||
44397597|NCT00607087|79404155|FG002|Period 2|Adverse Event|3|||
44397598|NCT00607087|79404153|FG000|Period 2|Poor compliance to protocol|0|||
44397599|NCT00607087|79404154|FG001|Period 2|Poor compliance to protocol|0|||
44397600|NCT00607087|79404155|FG002|Period 2|Poor compliance to protocol|1|||
44397601|NCT00607087|79404153|FG000|Period 3|Withdrawal by Subject|2|||
44397602|NCT00607087|79404154|FG001|Period 3|Withdrawal by Subject|1|||
44397603|NCT00607087|79404155|FG002|Period 3|Withdrawal by Subject|0|||
44397604|NCT00607087|79404153|FG000|Period 3|Adverse Event|0|||
44397605|NCT00607087|79404154|FG001|Period 3|Adverse Event|1|||
44397606|NCT00607087|79404155|FG002|Period 3|Adverse Event|0|||
44397607|NCT00610363|79404165|FG000|Overall Study|Non-compliance with protocol|0|||
44397608|NCT00610363|79404166|FG001|Overall Study|Non-compliance with protocol|1|||
44397609|NCT00610363|79404165|FG000|Overall Study|Adverse Event|3|||
44397610|NCT00610363|79404166|FG001|Overall Study|Adverse Event|1|||
44397611|NCT00610363|79404165|FG000|Overall Study|Lack of Efficacy|2|||
44397612|NCT00610363|79404166|FG001|Overall Study|Lack of Efficacy|0|||
44397613|NCT00610363|79404165|FG000|Overall Study|Lost to Follow-up|4|||
44397614|NCT00610363|79404166|FG001|Overall Study|Lost to Follow-up|0|||
44397615|NCT00610363|79404165|FG000|Overall Study|Withdrawal by Subject|1|||
44397616|NCT00610363|79404166|FG001|Overall Study|Withdrawal by Subject|0|||
44397617|NCT00610363|79404165|FG000|Overall Study|Other than specified above|1|||
44397618|NCT00610363|79404166|FG001|Overall Study|Other than specified above|1|||
44397619|NCT00887588|79404175|FG000|Core Period|Death|1|||
44397620|NCT00887588|79404176|FG001|Core Period|Death|1|||
44397621|NCT00887588|79404175|FG000|Core Period|Lost to Follow-up|3|||
44397622|NCT00887588|79404176|FG001|Core Period|Lost to Follow-up|1|||
44397623|NCT00887588|79404175|FG000|Core Period|Withdrawal by Subject|6|||
44397624|NCT00887588|79404176|FG001|Core Period|Withdrawal by Subject|8|||
44147281|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
44397625|NCT00887588|79404175|FG000|Core Period|Adverse Event|9|||
44397626|NCT00887588|79404176|FG001|Core Period|Adverse Event|11|||
44397627|NCT00887588|79404175|FG000|Extension Period|Adverse Event|4|||
44397628|NCT00887588|79404176|FG001|Extension Period|Adverse Event|4|||
44397629|NCT00887588|79404175|FG000|Extension Period|Death|0|||
44397630|NCT00887588|79404176|FG001|Extension Period|Death|1|||
44397631|NCT00887588|79404175|FG000|Extension Period|Protocol deviation|1|||
44521133|NCT00039741|79529387|FG002|Overall Study|Missed final visit|2|||
44147282|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
44147283|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
44147284|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
44147285|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
44147286|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
44521134|NCT00039741|79529388|FG003|Overall Study|Missed final visit|2|||
44521135|NCT02973802|79529398|FG000|Overall Study|Lost to Follow-up|1|||
44281601|NCT01917006|79244900|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
44281602|NCT01917006|79244901|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
44521136|NCT02973802|79529398|FG000|Overall Study|Withdrawal by Subject|1|||
44521137|NCT02973100|79529407|FG000|Overall Study|Adverse Event|1|||
44521138|NCT02973100|79529408|FG001|Overall Study|Adverse Event|2|||
44521139|NCT02973100|79529409|FG002|Overall Study|Adverse Event|1|||
44521140|NCT02973100|79529410|FG003|Overall Study|Adverse Event|2|||
44521141|NCT02973100|79529407|FG000|Overall Study|Lost to Follow-up|3|||
44521142|NCT02973100|79529408|FG001|Overall Study|Lost to Follow-up|1|||
44252680|NCT00602667|79090580|FG001|Overall Study|Excessive toxicity|1|||
44281603|NCT01917006|79244902|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
44281604|NCT01917006|79244903|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
44281605|NCT01917006|79244896|FG000|Randomized-treatment Period|Personal Reasons|0|||
44281606|NCT01917006|79244897|FG001|Randomized-treatment Period|Personal Reasons|0|||
44281607|NCT01917006|79244898|FG002|Randomized-treatment Period|Personal Reasons|0|||
44281608|NCT01917006|79244899|FG003|Randomized-treatment Period|Personal Reasons|0|||
44281609|NCT01917006|79244900|FG004|Randomized-treatment Period|Personal Reasons|0|||
44281610|NCT01917006|79244901|FG005|Randomized-treatment Period|Personal Reasons|1|||
44281611|NCT01917006|79244902|FG006|Randomized-treatment Period|Personal Reasons|0|||
44281612|NCT01917006|79244903|FG007|Randomized-treatment Period|Personal Reasons|0|||
44281613|NCT01917006|79244896|FG000|Randomized-treatment Period|Protocol Violation|1|||
44281614|NCT01917006|79244897|FG001|Randomized-treatment Period|Protocol Violation|0|||
44281615|NCT01917006|79244898|FG002|Randomized-treatment Period|Protocol Violation|0|||
44281616|NCT01917006|79244899|FG003|Randomized-treatment Period|Protocol Violation|0|||
44281617|NCT01917006|79244900|FG004|Randomized-treatment Period|Protocol Violation|0|||
44281618|NCT01917006|79244901|FG005|Randomized-treatment Period|Protocol Violation|0|||
44281619|NCT01917006|79244902|FG006|Randomized-treatment Period|Protocol Violation|0|||
44281620|NCT01917006|79244903|FG007|Randomized-treatment Period|Protocol Violation|0|||
44281621|NCT01917006|79244896|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44281622|NCT01917006|79244897|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44281623|NCT01917006|79244898|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44281624|NCT01917006|79244899|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44281625|NCT01917006|79244900|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44521143|NCT02973100|79529409|FG002|Overall Study|Lost to Follow-up|1|||
44252681|NCT00602667|79090581|FG002|Overall Study|Excessive toxicity|0|||
44252682|NCT00602667|79090579|FG000|Overall Study|Second malignancy|0|||
44252683|NCT00602667|79090580|FG001|Overall Study|Second malignancy|1|||
44252684|NCT00602667|79090581|FG002|Overall Study|Second malignancy|0|||
44252685|NCT00602667|79090579|FG000|Overall Study|Physician Decision|2|||
44252686|NCT00602667|79090580|FG001|Overall Study|Physician Decision|3|||
44252687|NCT00602667|79090581|FG002|Overall Study|Physician Decision|8|||
44252688|NCT00602667|79090579|FG000|Overall Study|Progressive disease|13|||
44252689|NCT00602667|79090580|FG001|Overall Study|Progressive disease|48|||
44252690|NCT00602667|79090581|FG002|Overall Study|Progressive disease|45|||
44252691|NCT00602667|79090579|FG000|Overall Study|Progressive disease prior to therapy|0|||
44252692|NCT00602667|79090580|FG001|Overall Study|Progressive disease prior to therapy|0|||
44252693|NCT00602667|79090581|FG002|Overall Study|Progressive disease prior to therapy|1|||
44252694|NCT02088905|79090620|FG000|Overall Study|Withdrawal by Subject|5|||
44252695|NCT02088905|79090621|FG001|Overall Study|Withdrawal by Subject|1|||
44252696|NCT02088047|79090629|FG000|Overall Study|Withdrawal by Subject|1|||
44252697|NCT02088047|79090630|FG001|Overall Study|Withdrawal by Subject|0|||
44252698|NCT02086565|79090656|FG000|Overall Study|Lost to Follow-up|9|||
44252699|NCT02086565|79090657|FG001|Overall Study|Lost to Follow-up|7|||
44252700|NCT02086565|79090656|FG000|Overall Study|Withdrawal by Subject|2|||
44252701|NCT02086565|79090657|FG001|Overall Study|Withdrawal by Subject|1|||
44252702|NCT02086565|79090656|FG000|Overall Study|Death|3|||
44252703|NCT02086565|79090657|FG001|Overall Study|Death|2|||
44252704|NCT02086565|79090656|FG000|Overall Study|withdrawn by research team|2|||
44252705|NCT02086565|79090657|FG001|Overall Study|withdrawn by research team|2|||
44252706|NCT02085941|79090665|FG000|Overall Study|Lack of Efficacy|1|||
44252707|NCT02085941|79090666|FG001|Overall Study|Lack of Efficacy|0|||
44252708|NCT02085941|79090665|FG000|Overall Study|Death|6|||
44252709|NCT02085941|79090666|FG001|Overall Study|Death|1|||
44252710|NCT02085941|79090665|FG000|Overall Study|Lost to Follow-up|1|||
44397632|NCT00887588|79404176|FG001|Extension Period|Protocol deviation|0|||
44397633|NCT00887588|79404175|FG000|Extension Period|Lost to Follow-up|1|||
44397634|NCT00887588|79404176|FG001|Extension Period|Lost to Follow-up|0|||
44397635|NCT00945893|79404184|FG000|Overall Study|Lost to Follow-up|2|||
44397636|NCT00945893|79404185|FG001|Overall Study|Lost to Follow-up|8|||
44397637|NCT00945893|79404184|FG000|Overall Study|Withdrawal of consent|1|||
44147287|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
44147288|NCT00700427|78936720|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
44397638|NCT00945893|79404185|FG001|Overall Study|Withdrawal of consent|2|||
44397639|NCT00799383|79404197|FG000|Overall Study|Protocol Violation|1|||
44397640|NCT00799383|79404198|FG001|Overall Study|Protocol Violation|1|||
44397641|NCT00799383|79404197|FG000|Overall Study|Adverse Event|0|||
44397642|NCT00799383|79404198|FG001|Overall Study|Adverse Event|1|||
44397643|NCT00799383|79404197|FG000|Overall Study|Lost to Follow-up|1|||
44397644|NCT00799383|79404198|FG001|Overall Study|Lost to Follow-up|2|||
44397645|NCT00799383|79404197|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
44397646|NCT00799383|79404198|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
44397647|NCT00799383|79404197|FG000|Overall Study|Withdrawal by Subject|0|||
44397648|NCT00799383|79404198|FG001|Overall Study|Withdrawal by Subject|1|||
44397649|NCT00610207|79404204|FG000|Overall Study|Lost to Follow-up|3|||
44397650|NCT00798759|79404210|FG000|Overall Study|Adverse Event|3|||
44397651|NCT00798759|79404211|FG001|Overall Study|Adverse Event|3|||
44397652|NCT00798759|79404210|FG000|Overall Study|Lost to Follow-up|1|||
44397653|NCT00798759|79404211|FG001|Overall Study|Lost to Follow-up|1|||
44397654|NCT00798759|79404210|FG000|Overall Study|Protocol Violation|4|||
44397655|NCT00798759|79404211|FG001|Overall Study|Protocol Violation|8|||
44397656|NCT00798759|79404210|FG000|Overall Study|Other|0|||
44147289|NCT00700427|78936721|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
44147290|NCT00700427|78936722|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
44147291|NCT00700427|78936723|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
44147292|NCT00700427|78936724|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
44147293|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
44147294|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
44147295|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
44147296|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
44147297|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
44147298|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
44147299|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
44147300|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
44147301|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
44147302|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
44147303|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
44147304|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
44147305|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
44147306|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
44147307|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
44147308|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
44147309|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
44147310|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
44147311|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
44147312|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
44147313|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
44147314|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
44147315|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
44147316|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
44147317|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
44147318|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
44252711|NCT02085941|79090666|FG001|Overall Study|Lost to Follow-up|0|||
44252712|NCT02085941|79090665|FG000|Overall Study|Physician Decision|0|||
44397657|NCT00798759|79404211|FG001|Overall Study|Other|1|||
44397658|NCT00887432|79404219|FG000|Overall Study|Start Excluded Therapy|3|||
44397659|NCT00887432|79404220|FG001|Overall Study|Start Excluded Therapy|0|||
44397660|NCT00887432|79404219|FG000|Overall Study|Did not complete treatment|6|||
44397661|NCT00887432|79404220|FG001|Overall Study|Did not complete treatment|8|||
44397662|NCT00887432|79404219|FG000|Overall Study|Protocol Violation|2|||
44397663|NCT00887432|79404220|FG001|Overall Study|Protocol Violation|3|||
44397664|NCT00887432|79404219|FG000|Overall Study|Withdrawal by Subject|3|||
44397665|NCT00887432|79404220|FG001|Overall Study|Withdrawal by Subject|2|||
44397666|NCT00887432|79404219|FG000|Overall Study|Lost to Follow-up|1|||
44397667|NCT00887432|79404220|FG001|Overall Study|Lost to Follow-up|0|||
44397668|NCT00887432|79404219|FG000|Overall Study|No reason provided|0|||
44397669|NCT00887432|79404220|FG001|Overall Study|No reason provided|1|||
44397670|NCT00951275|79404226|FG000|Overall Study|Administrative Reason|1|||
44281626|NCT01917006|79244901|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44281627|NCT01917006|79244902|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
44281628|NCT01917006|79244903|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
44281629|NCT01917006|79244896|FG000|Open-label Period|Adverse Event|0|||
44281630|NCT01917006|79244897|FG001|Open-label Period|Adverse Event|0|||
44397671|NCT00951275|79404226|FG000|Overall Study|Adverse Event|7|||
44397672|NCT00951275|79404226|FG000|Overall Study|Withdrawal by Subject|4|||
44397673|NCT00951275|79404226|FG000|Overall Study|Protocol Violation|1|||
44397674|NCT00798603|79404230|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
44397675|NCT00798603|79404230|FG000|Overall Study|Withdrawal by Subject|10|||
44397676|NCT00798603|79404230|FG000|Overall Study|Adverse Event|22|||
44397677|NCT00798603|79404230|FG000|Overall Study|Physician Decision|1|||
44397678|NCT00798603|79404230|FG000|Overall Study|Lack of insurance coverage|1|||
44397679|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
44397680|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
44397681|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
44397682|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
44521144|NCT02973100|79529410|FG003|Overall Study|Lost to Follow-up|0|||
44521145|NCT02973100|79529407|FG000|Overall Study|Withdrawal by Subject|3|||
44521146|NCT02973100|79529408|FG001|Overall Study|Withdrawal by Subject|5|||
44521147|NCT02973100|79529409|FG002|Overall Study|Withdrawal by Subject|1|||
44521148|NCT02973100|79529410|FG003|Overall Study|Withdrawal by Subject|4|||
44521149|NCT02973100|79529407|FG000|Overall Study|Notification of change in address|0|||
44521150|NCT02973100|79529408|FG001|Overall Study|Notification of change in address|0|||
44521151|NCT02973100|79529409|FG002|Overall Study|Notification of change in address|0|||
44521152|NCT02973100|79529410|FG003|Overall Study|Notification of change in address|1|||
44521153|NCT02973100|79529407|FG000|Overall Study|Failed to attend Safety followup period|0|||
44521154|NCT02973100|79529408|FG001|Overall Study|Failed to attend Safety followup period|0|||
44521155|NCT02973100|79529409|FG002|Overall Study|Failed to attend Safety followup period|1|||
44521156|NCT02973100|79529410|FG003|Overall Study|Failed to attend Safety followup period|0|||
44521157|NCT01060540|79529425|FG000|Overall Study|Withdrawal by Subject|10|||
44521158|NCT01060540|79529426|FG001|Overall Study|Withdrawal by Subject|20|||
44397683|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
44397684|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
44397685|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
44397686|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
44397687|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
44397688|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
44397689|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
44397690|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
44397691|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
44397692|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
44397693|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
44397694|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
44397695|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
44397696|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
44397697|NCT00887354|79404236|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
44397698|NCT00887354|79404237|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
44397699|NCT00887354|79404236|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
44521159|NCT01060540|79529425|FG000|Overall Study|Lost to Follow-up|52|||
44521160|NCT01060540|79529426|FG001|Overall Study|Lost to Follow-up|43|||
44521161|NCT01060540|79529425|FG000|Overall Study|Death|2|||
44521162|NCT01060540|79529426|FG001|Overall Study|Death|1|||
44252713|NCT02085941|79090666|FG001|Overall Study|Physician Decision|2|||
44252714|NCT02085785|79090674|FG000|Overall Study|Withdrawal by Subject|2|||
44252715|NCT02085785|79090675|FG001|Overall Study|Withdrawal by Subject|1|||
44397700|NCT00887354|79404237|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
44397701|NCT00887354|79404236|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
44397702|NCT00887354|79404237|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
44397703|NCT00887354|79404236|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
44521163|NCT01060540|79529425|FG000|Overall Study|Physician Decision|0|||
44521164|NCT01060540|79529426|FG001|Overall Study|Physician Decision|1|||
44252716|NCT02085785|79090674|FG000|Overall Study|Lost to Follow-up|0|||
44252717|NCT02085785|79090675|FG001|Overall Study|Lost to Follow-up|1|||
44252718|NCT02085161|79090703|FG000|Overall Study|Not Treated|1|||
44252719|NCT02085161|79090704|FG001|Overall Study|Not Treated|0|||
44281631|NCT01917006|79244898|FG002|Open-label Period|Adverse Event|0|||
44252720|NCT02085161|79090705|FG002|Overall Study|Not Treated|0|||
44252721|NCT02085161|79090706|FG003|Overall Study|Not Treated|0|||
44252722|NCT02085161|79090703|FG000|Overall Study|Adverse Event|8|||
44397704|NCT00887354|79404237|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
44397705|NCT00887354|79404236|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
44397706|NCT00887354|79404237|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
44397707|NCT00887354|79404236|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
44397708|NCT00887354|79404237|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
44397709|NCT00951041|79404246|FG000|Overall Study|Withdrawal by Subject|1|||
44397710|NCT00951041|79404247|FG001|Overall Study|Withdrawal by Subject|1|||
44397711|NCT00951041|79404246|FG000|Overall Study|Lost to Follow-up|1|||
44397712|NCT00951041|79404247|FG001|Overall Study|Lost to Follow-up|0|||
44397713|NCT00951041|79404246|FG000|Overall Study|Other|3|||
44397714|NCT00951041|79404247|FG001|Overall Study|Other|0|||
44397715|NCT02763462|79404254|FG000|Overall Study|Protocol Violation|6|||
44397716|NCT00610129|79404268|FG000|Overall Study|Not treated since patients ineligible|3|||
44397717|NCT00945815|79404272|FG000|Overall Study|Death|3|||
44397718|NCT00945815|79404272|FG000|Overall Study|Not protocol specified|1|||
44397719|NCT00945815|79404272|FG000|Overall Study|Ineligible|3|||
44397720|NCT00945815|79404272|FG000|Overall Study|Did not begin protocol therapy|1|||
44397721|NCT00606307|79404276|FG000|Overall Study|Adverse Event|2|||
44397722|NCT00606307|79404276|FG000|Overall Study|Withdrawal by Subject|2|||
44252723|NCT02085161|79090704|FG001|Overall Study|Adverse Event|5|||
44252724|NCT02085161|79090705|FG002|Overall Study|Adverse Event|4|||
44252725|NCT02085161|79090706|FG003|Overall Study|Adverse Event|5|||
44252726|NCT02085161|79090703|FG000|Overall Study|Protocol Violation|0|||
44252727|NCT02085161|79090704|FG001|Overall Study|Protocol Violation|1|||
44252728|NCT02085161|79090705|FG002|Overall Study|Protocol Violation|0|||
44252729|NCT02085161|79090706|FG003|Overall Study|Protocol Violation|1|||
44252730|NCT02085161|79090703|FG000|Overall Study|Withdrawal by Subject|2|||
44252731|NCT02085161|79090704|FG001|Overall Study|Withdrawal by Subject|4|||
44252732|NCT02085161|79090705|FG002|Overall Study|Withdrawal by Subject|0|||
44252733|NCT02085161|79090706|FG003|Overall Study|Withdrawal by Subject|3|||
44252734|NCT02085161|79090703|FG000|Overall Study|Other Reason|1|||
44252735|NCT02085161|79090704|FG001|Overall Study|Other Reason|0|||
44252736|NCT02085161|79090705|FG002|Overall Study|Other Reason|1|||
44252737|NCT02085161|79090706|FG003|Overall Study|Other Reason|1|||
44252738|NCT02082977|79091589|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
44252739|NCT02082977|79091590|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
44281632|NCT01917006|79244899|FG003|Open-label Period|Adverse Event|0|||
44397723|NCT00606307|79404276|FG000|Overall Study|Disease progression|6|||
44397724|NCT00606307|79404276|FG000|Overall Study|QTc prolongation|1|||
44397725|NCT00798369|79404286|FG000|Overall Study|Subject withdrew consent|0|||
44397726|NCT00798369|79404287|FG001|Overall Study|Subject withdrew consent|0|||
44397727|NCT00798369|79404288|FG002|Overall Study|Subject withdrew consent|1|||
44397728|NCT00798369|79404289|FG003|Overall Study|Subject withdrew consent|1|||
44397729|NCT00798369|79404290|FG004|Overall Study|Subject withdrew consent|0|||
44397730|NCT00798369|79404291|FG005|Overall Study|Subject withdrew consent|2|||
44397731|NCT00798369|79404286|FG000|Overall Study|Lost to Follow-up|1|||
44397732|NCT00798369|79404287|FG001|Overall Study|Lost to Follow-up|1|||
44397733|NCT00798369|79404288|FG002|Overall Study|Lost to Follow-up|1|||
44397734|NCT00798369|79404289|FG003|Overall Study|Lost to Follow-up|0|||
44397735|NCT00798369|79404290|FG004|Overall Study|Lost to Follow-up|1|||
44521165|NCT02972632|79529451|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
44521166|NCT02972632|79529451|FG000|Overall Study|Lost to Follow-up|4|||
44521167|NCT02972632|79529451|FG000|Overall Study|Voluntary Withdrawal|10|||
44521168|NCT01060150|79529455|FG000|Overall Study|Adverse Event|6|||
44397736|NCT00798369|79404291|FG005|Overall Study|Lost to Follow-up|0|||
44397737|NCT00798369|79404286|FG000|Overall Study|Adminstrative problems|0|||
44397738|NCT00798369|79404287|FG001|Overall Study|Adminstrative problems|0|||
44521169|NCT01060150|79529455|FG000|Overall Study|Lost to Follow-up|1|||
44521170|NCT01060150|79529455|FG000|Overall Study|Protocol Violation|6|||
44252740|NCT02082977|79091591|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
44252741|NCT02082977|79091592|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
44252742|NCT02082977|79091593|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
44252743|NCT02082977|79091594|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
44252744|NCT02082977|79091595|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
44281633|NCT01917006|79244900|FG004|Open-label Period|Adverse Event|0|||
44281634|NCT01917006|79244901|FG005|Open-label Period|Adverse Event|0|||
44281635|NCT01917006|79244902|FG006|Open-label Period|Adverse Event|0|||
44281636|NCT01917006|79244903|FG007|Open-label Period|Adverse Event|1|||
44397739|NCT00798369|79404288|FG002|Overall Study|Adminstrative problems|0|||
44397740|NCT00798369|79404289|FG003|Overall Study|Adminstrative problems|0|||
44397741|NCT00798369|79404290|FG004|Overall Study|Adminstrative problems|0|||
44397742|NCT00798369|79404291|FG005|Overall Study|Adminstrative problems|1|||
44521171|NCT01060150|79529455|FG000|Overall Study|Withdrawal by Subject|8|||
44252745|NCT02082977|79091596|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
44252746|NCT02082977|79091597|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
44252747|NCT02082977|79091598|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
44252748|NCT02082977|79091589|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252749|NCT02082977|79091590|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44521172|NCT01060150|79529455|FG000|Overall Study|Enrolled, but not treated|2|||
44521173|NCT02972242|79529461|FG000|Overall Study|Withdrawal by Subject|1|||
44521174|NCT02972242|79529462|FG001|Overall Study|Withdrawal by Subject|0|||
44521175|NCT02970292|79529470|FG000|Overall Study|Physician Decision|1|||
44521176|NCT02970292|79529471|FG001|Overall Study|Physician Decision|1|||
44521177|NCT02970292|79529470|FG000|Overall Study|Withdrawal by Subject|11|||
44521178|NCT02970292|79529471|FG001|Overall Study|Withdrawal by Subject|5|||
44521179|NCT02970292|79529470|FG000|Overall Study|Noncompliance with study drug|2|||
44521180|NCT02970292|79529471|FG001|Overall Study|Noncompliance with study drug|2|||
44521181|NCT02970292|79529470|FG000|Overall Study|Adverse Event|5|||
44521182|NCT02970292|79529471|FG001|Overall Study|Adverse Event|0|||
44281637|NCT01917006|79244896|FG000|Open-label Period|Lost to Follow-up|0|||
44281638|NCT01917006|79244897|FG001|Open-label Period|Lost to Follow-up|0|||
44281639|NCT01917006|79244898|FG002|Open-label Period|Lost to Follow-up|0|||
44281640|NCT01917006|79244899|FG003|Open-label Period|Lost to Follow-up|0|||
44281641|NCT01917006|79244900|FG004|Open-label Period|Lost to Follow-up|0|||
44281642|NCT01917006|79244901|FG005|Open-label Period|Lost to Follow-up|0|||
44281643|NCT01917006|79244902|FG006|Open-label Period|Lost to Follow-up|0|||
44281644|NCT01917006|79244903|FG007|Open-label Period|Lost to Follow-up|1|||
44281645|NCT01916304|79244920|FG000|Overall Study|Screening failure|17|||
44281646|NCT01916226|79244928|FG000|Overall Study|Adverse Event|1|||
44397743|NCT00950963|79404308|FG000|Overall Study|Lost to Follow-up|29|||
44397744|NCT00950963|79404309|FG001|Overall Study|Lost to Follow-up|24|||
44397745|NCT00608959|79404317|FG000|Part 1|Did not meet eligibility criteria|1|||
44397746|NCT00945659|79404330|FG000|Overall Study|Lost to Follow-up|7|||
44397747|NCT00945659|79404331|FG001|Overall Study|Lost to Follow-up|20|||
44397748|NCT00945659|79404332|FG002|Overall Study|Lost to Follow-up|17|||
44397749|NCT00941603|79404346|FG000|Overall Study|Adverse Event|10|||
44397750|NCT00941603|79404347|FG001|Overall Study|Adverse Event|15|||
44397751|NCT00941603|79404348|FG002|Overall Study|Adverse Event|5|||
44397752|NCT00941603|79404349|FG003|Overall Study|Adverse Event|1|||
44397753|NCT00941603|79404350|FG004|Overall Study|Adverse Event|4|||
44397754|NCT00941603|79404351|FG005|Overall Study|Adverse Event|0|||
44397755|NCT00941603|79404346|FG000|Overall Study|Lost to Follow-up|0|||
44397756|NCT00941603|79404347|FG001|Overall Study|Lost to Follow-up|0|||
44397757|NCT00941603|79404348|FG002|Overall Study|Lost to Follow-up|0|||
44397758|NCT00941603|79404349|FG003|Overall Study|Lost to Follow-up|1|||
44397759|NCT00941603|79404350|FG004|Overall Study|Lost to Follow-up|0|||
44397760|NCT00941603|79404351|FG005|Overall Study|Lost to Follow-up|2|||
44397761|NCT00941603|79404346|FG000|Overall Study|Withdrawal by Subject|0|||
44397762|NCT00941603|79404347|FG001|Overall Study|Withdrawal by Subject|0|||
44397763|NCT00941603|79404348|FG002|Overall Study|Withdrawal by Subject|0|||
44397764|NCT00941603|79404349|FG003|Overall Study|Withdrawal by Subject|2|||
44397765|NCT00941603|79404350|FG004|Overall Study|Withdrawal by Subject|0|||
44397766|NCT00941603|79404351|FG005|Overall Study|Withdrawal by Subject|1|||
44397767|NCT00941603|79404346|FG000|Overall Study|Protocol Violation|0|||
44397768|NCT00941603|79404347|FG001|Overall Study|Protocol Violation|1|||
44397769|NCT00941603|79404348|FG002|Overall Study|Protocol Violation|0|||
44397770|NCT00941603|79404349|FG003|Overall Study|Protocol Violation|0|||
44397771|NCT00941603|79404350|FG004|Overall Study|Protocol Violation|0|||
44397772|NCT00941603|79404351|FG005|Overall Study|Protocol Violation|0|||
44397773|NCT00941603|79404346|FG000|Overall Study|Did not meet protocol eligibility|1|||
44397774|NCT00941603|79404347|FG001|Overall Study|Did not meet protocol eligibility|0|||
44397775|NCT00941603|79404348|FG002|Overall Study|Did not meet protocol eligibility|0|||
44397776|NCT00941603|79404349|FG003|Overall Study|Did not meet protocol eligibility|0|||
44397777|NCT00941603|79404350|FG004|Overall Study|Did not meet protocol eligibility|0|||
44397778|NCT00941603|79404351|FG005|Overall Study|Did not meet protocol eligibility|0|||
44397779|NCT00797823|79404368|FG000|First Period (Initial Randomization)|Physician Decision|1|||
44397780|NCT00797823|79404369|FG001|First Period (Initial Randomization)|Physician Decision|0|||
44521183|NCT02970292|79529470|FG000|Overall Study|Lack of Efficacy|1|||
44521184|NCT02970292|79529471|FG001|Overall Study|Lack of Efficacy|0|||
44281647|NCT01916226|79244929|FG001|Overall Study|Adverse Event|0|||
44281648|NCT01916226|79244930|FG002|Overall Study|Adverse Event|1|||
44397781|NCT00797823|79404370|FG002|First Period (Initial Randomization)|Physician Decision|0|||
44397782|NCT00797667|79404380|FG000|Overall Study|Lack of Efficacy|0|||
44397783|NCT00797667|79404381|FG001|Overall Study|Lack of Efficacy|1|||
44397784|NCT00797667|79404382|FG002|Overall Study|Lack of Efficacy|0|||
44397785|NCT00797667|79404380|FG000|Overall Study|Lost to Follow-up|8|||
44397786|NCT00797667|79404381|FG001|Overall Study|Lost to Follow-up|12|||
44397787|NCT00797667|79404382|FG002|Overall Study|Lost to Follow-up|2|||
44397788|NCT00797667|79404380|FG000|Overall Study|Physician Decision|3|||
44521185|NCT02970292|79529470|FG000|Overall Study|Lost to Follow-up|1|||
44521186|NCT02970292|79529471|FG001|Overall Study|Lost to Follow-up|0|||
44281649|NCT01916226|79244931|FG003|Overall Study|Adverse Event|1|||
44397789|NCT00797667|79404381|FG001|Overall Study|Physician Decision|1|||
44397790|NCT00797667|79404382|FG002|Overall Study|Physician Decision|0|||
44397791|NCT00797667|79404380|FG000|Overall Study|Pregnancy|2|||
44521187|NCT02970292|79529470|FG000|Overall Study|Protocol Violation|2|||
44397792|NCT00797667|79404381|FG001|Overall Study|Pregnancy|0|||
44397793|NCT00797667|79404382|FG002|Overall Study|Pregnancy|0|||
44397794|NCT00797667|79404380|FG000|Overall Study|Protocol Violation|2|||
44397795|NCT00797667|79404381|FG001|Overall Study|Protocol Violation|7|||
44397796|NCT00797667|79404382|FG002|Overall Study|Protocol Violation|0|||
44397797|NCT00797667|79404380|FG000|Overall Study|Study Terminated by Sponsor|217|||
44397798|NCT00797667|79404381|FG001|Overall Study|Study Terminated by Sponsor|216|||
44397799|NCT00797667|79404382|FG002|Overall Study|Study Terminated by Sponsor|115|||
44397800|NCT00797667|79404380|FG000|Overall Study|Withdrawal by Subject|9|||
44397801|NCT00797667|79404381|FG001|Overall Study|Withdrawal by Subject|14|||
44397802|NCT00797667|79404382|FG002|Overall Study|Withdrawal by Subject|2|||
44397803|NCT00797667|79404380|FG000|Overall Study|Adverse Event|19|||
44397804|NCT00797667|79404381|FG001|Overall Study|Adverse Event|8|||
44397805|NCT00797667|79404382|FG002|Overall Study|Adverse Event|8|||
44397806|NCT00950807|79404390|FG000|Treatment Period 1|Lack of Efficacy|1|||
44397807|NCT00950807|79404391|FG001|Treatment Period 1|Lack of Efficacy|0|||
44397808|NCT00950807|79404392|FG002|Treatment Period 1|Lack of Efficacy|0|||
44397809|NCT00950807|79404393|FG003|Treatment Period 1|Lack of Efficacy|0|||
44397810|NCT00950807|79404394|FG004|Treatment Period 1|Lack of Efficacy|0|||
44397811|NCT00950807|79404395|FG005|Treatment Period 1|Lack of Efficacy|1|||
44397812|NCT00950807|79404396|FG006|Treatment Period 1|Lack of Efficacy|0|||
44397813|NCT00950807|79404397|FG007|Treatment Period 1|Lack of Efficacy|0|||
44397814|NCT00950807|79404398|FG008|Treatment Period 1|Lack of Efficacy|0|||
44397815|NCT00950807|79404399|FG009|Treatment Period 1|Lack of Efficacy|0|||
44397816|NCT00950807|79404390|FG000|Treatment Period 1|Protocol Violation|1|||
44397817|NCT00950807|79404391|FG001|Treatment Period 1|Protocol Violation|0|||
44397818|NCT00950807|79404392|FG002|Treatment Period 1|Protocol Violation|0|||
44397819|NCT00950807|79404393|FG003|Treatment Period 1|Protocol Violation|0|||
44397820|NCT00950807|79404394|FG004|Treatment Period 1|Protocol Violation|0|||
44397821|NCT00950807|79404395|FG005|Treatment Period 1|Protocol Violation|0|||
44397822|NCT00950807|79404396|FG006|Treatment Period 1|Protocol Violation|0|||
44397823|NCT00950807|79404397|FG007|Treatment Period 1|Protocol Violation|0|||
44397824|NCT00950807|79404398|FG008|Treatment Period 1|Protocol Violation|0|||
44397825|NCT00950807|79404399|FG009|Treatment Period 1|Protocol Violation|0|||
44397826|NCT00950807|79404390|FG000|Treatment Period 1|Lost to Follow-up|0|||
44397827|NCT00950807|79404391|FG001|Treatment Period 1|Lost to Follow-up|0|||
44397828|NCT00950807|79404392|FG002|Treatment Period 1|Lost to Follow-up|1|||
44397829|NCT00950807|79404393|FG003|Treatment Period 1|Lost to Follow-up|0|||
44397830|NCT00950807|79404394|FG004|Treatment Period 1|Lost to Follow-up|0|||
44397831|NCT00950807|79404395|FG005|Treatment Period 1|Lost to Follow-up|0|||
44397832|NCT00950807|79404396|FG006|Treatment Period 1|Lost to Follow-up|0|||
44397833|NCT00950807|79404397|FG007|Treatment Period 1|Lost to Follow-up|0|||
44397834|NCT00950807|79404398|FG008|Treatment Period 1|Lost to Follow-up|0|||
44397835|NCT00950807|79404399|FG009|Treatment Period 1|Lost to Follow-up|0|||
44397836|NCT00950807|79404390|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44397837|NCT00950807|79404391|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44397838|NCT00950807|79404392|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44397839|NCT00950807|79404393|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44397840|NCT00950807|79404394|FG004|Treatment Period 1|Withdrawal by Subject|1|||
44397841|NCT00950807|79404395|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44397842|NCT00950807|79404396|FG006|Treatment Period 1|Withdrawal by Subject|0|||
44397843|NCT00950807|79404397|FG007|Treatment Period 1|Withdrawal by Subject|0|||
44397844|NCT00950807|79404398|FG008|Treatment Period 1|Withdrawal by Subject|1|||
44397845|NCT00950807|79404399|FG009|Treatment Period 1|Withdrawal by Subject|0|||
44397846|NCT00950807|79404390|FG000|Treatment Period 1|Adverse Event|0|||
44397847|NCT00950807|79404391|FG001|Treatment Period 1|Adverse Event|0|||
44397848|NCT00950807|79404392|FG002|Treatment Period 1|Adverse Event|0|||
44397849|NCT00950807|79404393|FG003|Treatment Period 1|Adverse Event|0|||
44397850|NCT00950807|79404394|FG004|Treatment Period 1|Adverse Event|0|||
44397851|NCT00950807|79404395|FG005|Treatment Period 1|Adverse Event|1|||
44397852|NCT00950807|79404396|FG006|Treatment Period 1|Adverse Event|0|||
44397853|NCT00950807|79404397|FG007|Treatment Period 1|Adverse Event|0|||
44397854|NCT00950807|79404398|FG008|Treatment Period 1|Adverse Event|0|||
44397855|NCT00950807|79404399|FG009|Treatment Period 1|Adverse Event|0|||
44397856|NCT00950807|79404390|FG000|Washout Period 1|Lack of Efficacy|0|||
44397857|NCT00950807|79404391|FG001|Washout Period 1|Lack of Efficacy|0|||
44397858|NCT00950807|79404392|FG002|Washout Period 1|Lack of Efficacy|0|||
44397859|NCT00950807|79404393|FG003|Washout Period 1|Lack of Efficacy|0|||
44397860|NCT00950807|79404394|FG004|Washout Period 1|Lack of Efficacy|0|||
44397861|NCT00950807|79404395|FG005|Washout Period 1|Lack of Efficacy|0|||
44397862|NCT00950807|79404396|FG006|Washout Period 1|Lack of Efficacy|1|||
44397863|NCT00950807|79404397|FG007|Washout Period 1|Lack of Efficacy|0|||
44397864|NCT00950807|79404398|FG008|Washout Period 1|Lack of Efficacy|0|||
44397865|NCT00950807|79404399|FG009|Washout Period 1|Lack of Efficacy|0|||
44397866|NCT00950807|79404390|FG000|Washout Period 1|Withdrawal by Subject|0|||
44397867|NCT00950807|79404391|FG001|Washout Period 1|Withdrawal by Subject|0|||
44397868|NCT00950807|79404392|FG002|Washout Period 1|Withdrawal by Subject|0|||
44397869|NCT00950807|79404393|FG003|Washout Period 1|Withdrawal by Subject|0|||
44397870|NCT00950807|79404394|FG004|Washout Period 1|Withdrawal by Subject|0|||
44397871|NCT00950807|79404395|FG005|Washout Period 1|Withdrawal by Subject|0|||
44397872|NCT00950807|79404396|FG006|Washout Period 1|Withdrawal by Subject|0|||
44397873|NCT00950807|79404397|FG007|Washout Period 1|Withdrawal by Subject|0|||
44397874|NCT00950807|79404398|FG008|Washout Period 1|Withdrawal by Subject|1|||
44397875|NCT00950807|79404399|FG009|Washout Period 1|Withdrawal by Subject|0|||
44397876|NCT00950807|79404390|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
44397877|NCT00950807|79404391|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397878|NCT00950807|79404392|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397879|NCT00950807|79404393|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397880|NCT00950807|79404394|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397881|NCT00950807|79404395|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397882|NCT00950807|79404396|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
44397883|NCT00950807|79404397|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
44397884|NCT00950807|79404398|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397885|NCT00950807|79404399|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
44397886|NCT00950807|79404390|FG000|Washout Period 1|Adverse Event|2|||
44397887|NCT00950807|79404391|FG001|Washout Period 1|Adverse Event|0|||
44397888|NCT00950807|79404392|FG002|Washout Period 1|Adverse Event|0|||
44397889|NCT00950807|79404393|FG003|Washout Period 1|Adverse Event|1|||
44397890|NCT00950807|79404394|FG004|Washout Period 1|Adverse Event|1|||
44397891|NCT00950807|79404395|FG005|Washout Period 1|Adverse Event|0|||
44397892|NCT00950807|79404396|FG006|Washout Period 1|Adverse Event|0|||
44397893|NCT00950807|79404397|FG007|Washout Period 1|Adverse Event|0|||
44397894|NCT00950807|79404398|FG008|Washout Period 1|Adverse Event|0|||
44397895|NCT00950807|79404399|FG009|Washout Period 1|Adverse Event|0|||
44397896|NCT00950807|79404390|FG000|Treatment Period 2|Lack of Efficacy|1|||
44397897|NCT00950807|79404391|FG001|Treatment Period 2|Lack of Efficacy|0|||
44397898|NCT00950807|79404392|FG002|Treatment Period 2|Lack of Efficacy|0|||
44397899|NCT00950807|79404393|FG003|Treatment Period 2|Lack of Efficacy|0|||
44397900|NCT00950807|79404394|FG004|Treatment Period 2|Lack of Efficacy|0|||
44397901|NCT00950807|79404395|FG005|Treatment Period 2|Lack of Efficacy|0|||
44397902|NCT00950807|79404396|FG006|Treatment Period 2|Lack of Efficacy|0|||
44397903|NCT00950807|79404397|FG007|Treatment Period 2|Lack of Efficacy|0|||
44397904|NCT00950807|79404398|FG008|Treatment Period 2|Lack of Efficacy|0|||
44397905|NCT00950807|79404399|FG009|Treatment Period 2|Lack of Efficacy|0|||
44397906|NCT00950807|79404390|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44397907|NCT00950807|79404391|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44397908|NCT00950807|79404392|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44397909|NCT00950807|79404393|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44397910|NCT00950807|79404394|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44397911|NCT00950807|79404395|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44397912|NCT00950807|79404396|FG006|Treatment Period 2|Withdrawal by Subject|1|||
44397913|NCT00950807|79404397|FG007|Treatment Period 2|Withdrawal by Subject|2|||
44397914|NCT00950807|79404398|FG008|Treatment Period 2|Withdrawal by Subject|0|||
44397915|NCT00950807|79404399|FG009|Treatment Period 2|Withdrawal by Subject|0|||
44397916|NCT00950807|79404390|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
44397917|NCT00950807|79404391|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397918|NCT00950807|79404392|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397919|NCT00950807|79404393|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397920|NCT00950807|79404394|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397921|NCT00950807|79404395|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397922|NCT00950807|79404396|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397923|NCT00950807|79404397|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397924|NCT00950807|79404398|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397925|NCT00950807|79404399|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
44397926|NCT00950807|79404390|FG000|Treatment Period 2|Adverse Event|0|||
44397927|NCT00950807|79404391|FG001|Treatment Period 2|Adverse Event|1|||
44397928|NCT00950807|79404392|FG002|Treatment Period 2|Adverse Event|0|||
44397929|NCT00950807|79404393|FG003|Treatment Period 2|Adverse Event|1|||
44397930|NCT00950807|79404394|FG004|Treatment Period 2|Adverse Event|0|||
44397931|NCT00950807|79404395|FG005|Treatment Period 2|Adverse Event|1|||
44521188|NCT02970292|79529471|FG001|Overall Study|Protocol Violation|0|||
44521189|NCT02970292|79529470|FG000|Overall Study|Other|1|||
44521190|NCT02970292|79529471|FG001|Overall Study|Other|0|||
44397932|NCT00950807|79404396|FG006|Treatment Period 2|Adverse Event|0|||
44397933|NCT00950807|79404397|FG007|Treatment Period 2|Adverse Event|1|||
44397934|NCT00950807|79404398|FG008|Treatment Period 2|Adverse Event|0|||
44397935|NCT00950807|79404399|FG009|Treatment Period 2|Adverse Event|0|||
44521191|NCT02971228|79529477|FG000|Overall Study|Withdrawal by Subject|1|||
44521192|NCT02971228|79529478|FG001|Overall Study|Withdrawal by Subject|1|||
44521193|NCT02971228|79529479|FG002|Overall Study|Withdrawal by Subject|0|||
44521194|NCT02971228|79529480|FG003|Overall Study|Withdrawal by Subject|0|||
44397936|NCT00950807|79404390|FG000|Washout Period 2|Lack of Efficacy|1|||
44397937|NCT00950807|79404391|FG001|Washout Period 2|Lack of Efficacy|0|||
44397938|NCT00950807|79404392|FG002|Washout Period 2|Lack of Efficacy|0|||
44397939|NCT00950807|79404393|FG003|Washout Period 2|Lack of Efficacy|0|||
44397940|NCT00950807|79404394|FG004|Washout Period 2|Lack of Efficacy|0|||
44397941|NCT00950807|79404395|FG005|Washout Period 2|Lack of Efficacy|0|||
44397942|NCT00950807|79404396|FG006|Washout Period 2|Lack of Efficacy|0|||
44397943|NCT00950807|79404397|FG007|Washout Period 2|Lack of Efficacy|0|||
44397944|NCT00950807|79404398|FG008|Washout Period 2|Lack of Efficacy|0|||
44397945|NCT00950807|79404399|FG009|Washout Period 2|Lack of Efficacy|0|||
44397946|NCT00950807|79404390|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
44397947|NCT00950807|79404391|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
44397948|NCT00950807|79404392|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
44397949|NCT00950807|79404393|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
44397950|NCT00950807|79404394|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
44397951|NCT00950807|79404395|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
44397952|NCT00950807|79404396|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
44397953|NCT00950807|79404397|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
44397954|NCT00950807|79404398|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
44397955|NCT00950807|79404399|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
44397956|NCT00950807|79404390|FG000|Washout Period 2|Adverse Event|3|||
44397957|NCT00950807|79404391|FG001|Washout Period 2|Adverse Event|0|||
44397958|NCT00950807|79404392|FG002|Washout Period 2|Adverse Event|0|||
44397959|NCT00950807|79404393|FG003|Washout Period 2|Adverse Event|1|||
44397960|NCT00950807|79404394|FG004|Washout Period 2|Adverse Event|0|||
44397961|NCT00950807|79404395|FG005|Washout Period 2|Adverse Event|0|||
44397962|NCT00950807|79404396|FG006|Washout Period 2|Adverse Event|0|||
44397963|NCT00950807|79404397|FG007|Washout Period 2|Adverse Event|0|||
44397964|NCT00950807|79404398|FG008|Washout Period 2|Adverse Event|0|||
44397965|NCT00950807|79404399|FG009|Washout Period 2|Adverse Event|0|||
44397966|NCT00950807|79404390|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44397967|NCT00950807|79404391|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44397968|NCT00950807|79404392|FG002|Treatment Period 3|Withdrawal by Subject|0|||
44397969|NCT00950807|79404393|FG003|Treatment Period 3|Withdrawal by Subject|0|||
44397970|NCT00950807|79404394|FG004|Treatment Period 3|Withdrawal by Subject|0|||
44397971|NCT00950807|79404395|FG005|Treatment Period 3|Withdrawal by Subject|0|||
44397972|NCT00950807|79404396|FG006|Treatment Period 3|Withdrawal by Subject|0|||
44397973|NCT00950807|79404397|FG007|Treatment Period 3|Withdrawal by Subject|0|||
44397974|NCT00950807|79404398|FG008|Treatment Period 3|Withdrawal by Subject|0|||
44397975|NCT00950807|79404399|FG009|Treatment Period 3|Withdrawal by Subject|1|||
44397976|NCT00950807|79404390|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
44397977|NCT00950807|79404391|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397978|NCT00950807|79404392|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397979|NCT00950807|79404393|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397980|NCT00950807|79404394|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397981|NCT00950807|79404395|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397982|NCT00950807|79404396|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397983|NCT00950807|79404397|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
44397984|NCT00950807|79404398|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397985|NCT00950807|79404399|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
44397986|NCT00950807|79404390|FG000|Treatment Period 3|Adverse Event|0|||
44397987|NCT00950807|79404391|FG001|Treatment Period 3|Adverse Event|0|||
44397988|NCT00950807|79404392|FG002|Treatment Period 3|Adverse Event|0|||
44397989|NCT00950807|79404393|FG003|Treatment Period 3|Adverse Event|0|||
44397990|NCT00950807|79404394|FG004|Treatment Period 3|Adverse Event|0|||
44397991|NCT00950807|79404395|FG005|Treatment Period 3|Adverse Event|0|||
44397992|NCT00950807|79404396|FG006|Treatment Period 3|Adverse Event|1|||
44397993|NCT00950807|79404397|FG007|Treatment Period 3|Adverse Event|0|||
44397994|NCT00950807|79404398|FG008|Treatment Period 3|Adverse Event|0|||
44397995|NCT00950807|79404399|FG009|Treatment Period 3|Adverse Event|0|||
44397996|NCT00797511|79404421|FG000|Overall Study|Withdrawal by Subject|1|||
44397997|NCT00608881|79404428|FG000|Overall Study|Death|22|||
44397998|NCT00608881|79404429|FG001|Overall Study|Death|13|||
44147319|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
44397999|NCT00608881|79404428|FG000|Overall Study|Adverse Event|5|||
44147320|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
44398000|NCT00608881|79404429|FG001|Overall Study|Adverse Event|3|||
44398001|NCT00608881|79404428|FG000|Overall Study|Lost to Follow-up|28|||
44398002|NCT00608881|79404429|FG001|Overall Study|Lost to Follow-up|14|||
44398003|NCT00608881|79404428|FG000|Overall Study|Withdrawal by Subject|18|||
44398004|NCT00608881|79404429|FG001|Overall Study|Withdrawal by Subject|29|||
44398005|NCT00608881|79404428|FG000|Overall Study|Physician Decision|5|||
44398006|NCT00608881|79404429|FG001|Overall Study|Physician Decision|5|||
44398007|NCT00608881|79404428|FG000|Overall Study|Institutionalized|1|||
44398008|NCT00608881|79404429|FG001|Overall Study|Institutionalized|2|||
44398009|NCT00945191|79404435|FG000|Overall Study|Did not achieve a complete response|18|||
44398010|NCT00945191|79404435|FG000|Overall Study|Participant relocated to another state|1|||
44398011|NCT00945191|79404435|FG000|Overall Study|Disease progression|3|||
44398012|NCT00945191|79404435|FG000|Overall Study|Serious adverse event or adverse event|1|||
44398013|NCT00945191|79404435|FG000|Overall Study|Investigator's discretion|1|||
44398014|NCT00606931|79404439|FG000|Overall Study|Withdrawal by Subject|3|||
44398015|NCT00792909|79404446|FG000|Overall Study|Withdrawal by Subject|0|||
44398016|NCT00792909|79404447|FG001|Overall Study|Withdrawal by Subject|1|||
44398017|NCT00792909|79404448|FG002|Overall Study|Withdrawal by Subject|0|||
44398018|NCT00944645|79404459|FG000|Period 2|Adverse Event|1|||
44398019|NCT00944645|79404460|FG001|Period 2|Adverse Event|0|||
44398020|NCT00944645|79404459|FG000|Period 2|Lost to Follow-up|0|||
44398021|NCT00944645|79404460|FG001|Period 2|Lost to Follow-up|3|||
44398022|NCT00944645|79404459|FG000|Period 2|Withdrawal by Subject|7|||
44398023|NCT00944645|79404460|FG001|Period 2|Withdrawal by Subject|6|||
44398024|NCT00606229|79404466|FG000|Overall Study|Adverse Event|11|||
44398025|NCT00606229|79404466|FG000|Overall Study|Lack of Efficacy|1|||
44398026|NCT00606229|79404466|FG000|Overall Study|Withdrawal by Subject|4|||
44398027|NCT00606229|79404466|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
44398028|NCT00606229|79404466|FG000|Overall Study|change of residence or other commitments|2|||
44398029|NCT00950651|79404472|FG000|Overall Study|Adverse Event|17|||
44398030|NCT00950651|79404473|FG001|Overall Study|Adverse Event|20|||
44398031|NCT00950651|79404472|FG000|Overall Study|Death|1|||
44398032|NCT00950651|79404473|FG001|Overall Study|Death|0|||
44398033|NCT00950651|79404472|FG000|Overall Study|Lack of Efficacy|2|||
44398034|NCT00950651|79404473|FG001|Overall Study|Lack of Efficacy|2|||
44398035|NCT00950651|79404472|FG000|Overall Study|Protocol Violation|3|||
44398036|NCT00950651|79404473|FG001|Overall Study|Protocol Violation|4|||
44398037|NCT00950651|79404472|FG000|Overall Study|Withdrawal by Subject|8|||
44398038|NCT00950651|79404473|FG001|Overall Study|Withdrawal by Subject|9|||
44398039|NCT00605293|79404481|FG000|Overall Study|Death|2|||
44398040|NCT00605293|79404482|FG001|Overall Study|Death|1|||
44398041|NCT00605293|79404481|FG000|Overall Study|Insufficient Therapeutic Response|2|||
44398042|NCT00605293|79404482|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44398043|NCT00605293|79404481|FG000|Overall Study|Adverse Event|1|||
44398044|NCT00605293|79404482|FG001|Overall Study|Adverse Event|0|||
44398045|NCT00605293|79404481|FG000|Overall Study|Holidays Dialysis Out|1|||
44398046|NCT00605293|79404482|FG001|Overall Study|Holidays Dialysis Out|0|||
44398047|NCT00605293|79404481|FG000|Overall Study|Blood Transfusion|7|||
44398048|NCT00605293|79404482|FG001|Overall Study|Blood Transfusion|1|||
44398049|NCT00605293|79404481|FG000|Overall Study|Renal Transplantation|3|||
44398050|NCT00605293|79404482|FG001|Overall Study|Renal Transplantation|1|||
44398051|NCT00605293|79404481|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
44398052|NCT00605293|79404482|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
44398053|NCT00605293|79404481|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
44398054|NCT00605293|79404482|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
44398055|NCT00605293|79404481|FG000|Overall Study|Principal Investigator Decision|0|||
44398056|NCT00605293|79404482|FG001|Overall Study|Principal Investigator Decision|1|||
44398057|NCT00572533|79404490|FG000|Overall Study|Death|4|||
44398058|NCT00572533|79404491|FG001|Overall Study|Death|1|||
44398059|NCT00572533|79404490|FG000|Overall Study|Received Kidney Transplant|2|||
44398060|NCT00572533|79404491|FG001|Overall Study|Received Kidney Transplant|1|||
44398061|NCT00572533|79404490|FG000|Overall Study|Social Issues|1|||
44398062|NCT00572533|79404491|FG001|Overall Study|Social Issues|0|||
44398063|NCT00572533|79404490|FG000|Overall Study|Transfer out of Facility|0|||
44398064|NCT00572533|79404491|FG001|Overall Study|Transfer out of Facility|1|||
44398065|NCT00949715|79404499|FG000|Overall Study|Physician Decision|1|||
44398066|NCT00949715|79404500|FG001|Overall Study|Physician Decision|0|||
44398067|NCT00949715|79404499|FG000|Overall Study|Lost to Follow-up|1|||
44398068|NCT00949715|79404500|FG001|Overall Study|Lost to Follow-up|0|||
44398069|NCT00949715|79404499|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
44398070|NCT00949715|79404500|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
44398071|NCT00791661|79404508|FG000|7 Day Wash-out|Adverse Event|0|||
44398072|NCT00791661|79404509|FG001|7 Day Wash-out|Adverse Event|0|||
44398073|NCT00791661|79404510|FG002|7 Day Wash-out|Adverse Event|1|||
44398074|NCT00791661|79404508|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
44398075|NCT00791661|79404509|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
44398076|NCT00791661|79404510|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
44398077|NCT00943787|79404534|FG000|Overall Study|Physician Decision|4|||
44398078|NCT00943787|79404534|FG000|Overall Study|Withdrawal by Subject|3|||
44398079|NCT00949325|79404538|FG000|Overall Study|Adverse Event|0|||
44398080|NCT00949325|79404539|FG001|Overall Study|Adverse Event|2|||
44398081|NCT00949325|79404540|FG002|Overall Study|Adverse Event|0|||
44398082|NCT00943319|79404556|FG000|Overall Study|Death|1|||
44398083|NCT00790647|79404560|FG000|Overall Study|Adverse Event|1|||
44398084|NCT00790569|79404569|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
44398085|NCT00790569|79404570|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
44398086|NCT00790569|79404571|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
44398087|NCT00790569|79404569|FG000|End of Treatment (6 Month Interview)|Death|0|||
44398088|NCT00790569|79404570|FG001|End of Treatment (6 Month Interview)|Death|2|||
44398089|NCT00790569|79404571|FG002|End of Treatment (6 Month Interview)|Death|1|||
44398090|NCT00790569|79404569|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
44398091|NCT00790569|79404570|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
44398092|NCT00790569|79404571|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
44398093|NCT00790569|79404569|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
44398094|NCT00790569|79404570|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
44398095|NCT00790569|79404571|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
44398096|NCT00790569|79404569|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
44398097|NCT00790569|79404570|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
44398098|NCT00790569|79404571|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
44398099|NCT00790569|79404569|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
44398100|NCT00790569|79404570|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
44398101|NCT00790569|79404571|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
44398102|NCT00939029|79404581|FG000|Overall Study|Withdrawal by Subject|3|||
44398103|NCT00939029|79404582|FG001|Overall Study|Withdrawal by Subject|7|||
44398104|NCT00939029|79404581|FG000|Overall Study|Lost to Follow-up|3|||
44398105|NCT00939029|79404582|FG001|Overall Study|Lost to Follow-up|4|||
44398106|NCT00939029|79404581|FG000|Overall Study|Adverse Event|0|||
44398107|NCT00939029|79404582|FG001|Overall Study|Adverse Event|1|||
44398108|NCT00587847|79404588|FG000|Overall Study|Lack of Efficacy|5|||
44398109|NCT00587847|79404588|FG000|Overall Study|Adverse Event|2|||
44398110|NCT00784563|79404596|FG000|Years 1 & 2|Withdrawal by Subject|3|||
44398111|NCT00784563|79404597|FG001|Years 1 & 2|Withdrawal by Subject|2|||
44398112|NCT00784563|79404598|FG002|Years 1 & 2|Withdrawal by Subject|0|||
44398113|NCT00784563|79404596|FG000|Years 1 & 2|Adverse Event|0|||
44398114|NCT00784563|79404597|FG001|Years 1 & 2|Adverse Event|3|||
44398115|NCT00784563|79404598|FG002|Years 1 & 2|Adverse Event|0|||
44398116|NCT00784563|79404596|FG000|Year 3|Withdrawal by Subject|0|||
44398117|NCT00784563|79404597|FG001|Year 3|Withdrawal by Subject|0|||
44398118|NCT00784563|79404598|FG002|Year 3|Withdrawal by Subject|2|||
44398119|NCT00784563|79404596|FG000|Year 3|Adverse Event|0|||
44398120|NCT00784563|79404597|FG001|Year 3|Adverse Event|0|||
44398121|NCT00784563|79404598|FG002|Year 3|Adverse Event|1|||
44398122|NCT00938717|79404606|FG000|Overall Study|Adverse Event|10|||
44398123|NCT00938717|79404607|FG001|Overall Study|Adverse Event|41|||
44398124|NCT00938717|79404606|FG000|Overall Study|Protocol Violation|11|||
44398125|NCT00938717|79404607|FG001|Overall Study|Protocol Violation|8|||
44398126|NCT00938717|79404606|FG000|Overall Study|Withdrawal by Subject|26|||
44398127|NCT00938717|79404607|FG001|Overall Study|Withdrawal by Subject|24|||
44398128|NCT00938717|79404606|FG000|Overall Study|Lost to Follow-up|13|||
44398129|NCT00938717|79404607|FG001|Overall Study|Lost to Follow-up|18|||
44398130|NCT00938717|79404606|FG000|Overall Study|Lack of Efficacy|33|||
44521195|NCT02971228|79529481|FG004|Overall Study|Withdrawal by Subject|0|||
44521196|NCT02971228|79529477|FG000|Overall Study|Logistical challenges|0|||
44521197|NCT02971228|79529478|FG001|Overall Study|Logistical challenges|1|||
44521198|NCT02971228|79529479|FG002|Overall Study|Logistical challenges|0|||
44521199|NCT02971228|79529480|FG003|Overall Study|Logistical challenges|0|||
44521200|NCT02971228|79529481|FG004|Overall Study|Logistical challenges|0|||
44252750|NCT02082977|79091591|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252751|NCT02082977|79091592|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252752|NCT02082977|79091593|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252753|NCT02082977|79091594|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252754|NCT02082977|79091595|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252755|NCT02082977|79091596|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
44398131|NCT00938717|79404607|FG001|Overall Study|Lack of Efficacy|15|||
44398132|NCT00938717|79404606|FG000|Overall Study|Other reason|5|||
44398133|NCT00938717|79404607|FG001|Overall Study|Other reason|2|||
44398134|NCT00587223|79404613|FG000|Overall Study|Adverse Event|1|||
44398135|NCT00938639|79404622|FG000|Overall Study|Moved away from study area|0|||
44398136|NCT00938639|79404623|FG001|Overall Study|Moved away from study area|1|||
44398137|NCT00938639|79404622|FG000|Overall Study|Lost to Follow-up|1|||
44398138|NCT00938639|79404623|FG001|Overall Study|Lost to Follow-up|2|||
44398139|NCT00938639|79404622|FG000|Overall Study|Family issues|1|||
44398140|NCT00938639|79404623|FG001|Overall Study|Family issues|1|||
44398141|NCT00938639|79404622|FG000|Overall Study|Participant noncompliance|1|||
44521201|NCT01060072|79529494|FG000|Overall Study|Adverse Event|1|||
44521202|NCT01060072|79529495|FG001|Overall Study|Adverse Event|1|||
44252756|NCT02082977|79091597|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44521203|NCT01060072|79529494|FG000|Overall Study|Physician Decision|0|||
44521204|NCT01060072|79529495|FG001|Overall Study|Physician Decision|2|||
44398142|NCT00938639|79404623|FG001|Overall Study|Participant noncompliance|0|||
44398143|NCT00783705|79404635|FG000|Overall Study|Adverse Event|2|||
44398144|NCT00783705|79404636|FG001|Overall Study|Adverse Event|0|||
44398145|NCT00783705|79404635|FG000|Overall Study|Withdrawal by Subject|3|||
44398146|NCT00783705|79404636|FG001|Overall Study|Withdrawal by Subject|2|||
44398147|NCT00783705|79404635|FG000|Overall Study|Lost to Follow-up|1|||
44398148|NCT00783705|79404636|FG001|Overall Study|Lost to Follow-up|3|||
44398149|NCT00604669|79404642|FG000|Overall Study|lack of information in chart|7|||
44398150|NCT00938327|79404646|FG000|Overall Study|Adverse Event|2|||
44398151|NCT00938327|79404646|FG000|Overall Study|Protocol Violation|1|||
44398152|NCT00938327|79404646|FG000|Overall Study|Withdrawal by Subject|4|||
44398153|NCT00938327|79404646|FG000|Overall Study|Lost to Follow-up|37|||
44398154|NCT00938327|79404646|FG000|Overall Study|2nd dose received outside of the study|7|||
44398155|NCT00938327|79404646|FG000|Overall Study|Vaccine not received as out of stock|9|||
44398156|NCT00887198|79404652|FG000|Randomized Period|Ongoing|42|||
44398157|NCT00887198|79404653|FG001|Randomized Period|Ongoing|0|||
44398158|NCT00887198|79404654|FG002|Randomized Period|Ongoing|0|||
44398159|NCT00887198|79404652|FG000|Randomized Period|Adverse Event|50|||
44398160|NCT00887198|79404653|FG001|Randomized Period|Adverse Event|33|||
44398161|NCT00887198|79404654|FG002|Randomized Period|Adverse Event|0|||
44398162|NCT00887198|79404652|FG000|Randomized Period|Lost to Follow-up|1|||
44398163|NCT00887198|79404653|FG001|Randomized Period|Lost to Follow-up|0|||
44398164|NCT00887198|79404654|FG002|Randomized Period|Lost to Follow-up|0|||
44252757|NCT02082977|79091598|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
44252758|NCT02082977|79091589|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252759|NCT02082977|79091590|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252760|NCT02082977|79091591|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252761|NCT02082977|79091592|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252762|NCT02082977|79091593|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252763|NCT02082977|79091594|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
44252764|NCT02082977|79091595|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44521205|NCT01060072|79529494|FG000|Overall Study|Protocol Violation|0|||
44521206|NCT01060072|79529495|FG001|Overall Study|Protocol Violation|1|||
44521207|NCT01060072|79529494|FG000|Overall Study|Acute cholecystitis|1|||
44521208|NCT01060072|79529495|FG001|Overall Study|Acute cholecystitis|0|||
44521209|NCT01060072|79529494|FG000|Overall Study|Excluded Medications|0|||
44521210|NCT01060072|79529495|FG001|Overall Study|Excluded Medications|1|||
44521211|NCT02969590|79529503|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
44521212|NCT02969590|79529504|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
44521213|NCT02969590|79529505|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
44521214|NCT03345849|79529517|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
44521215|NCT03345849|79529518|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
44521216|NCT03345849|79529519|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
44521217|NCT03345849|79529520|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
44521218|NCT03345849|79529517|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
44521219|NCT03345849|79529518|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
44521220|NCT03345849|79529519|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
44521221|NCT03345849|79529520|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
44521222|NCT03345849|79529517|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
44521223|NCT03345849|79529518|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
44521224|NCT03345849|79529519|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
44521225|NCT03345849|79529520|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
44521226|NCT03345849|79529517|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
44521227|NCT03345849|79529518|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
44521228|NCT03345849|79529519|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
44521229|NCT03345849|79529520|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
44521230|NCT03345849|79529517|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
44521231|NCT03345849|79529518|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
44521232|NCT03345849|79529519|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
44521233|NCT03345849|79529520|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
44521234|NCT03345849|79529517|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
44252765|NCT02082977|79091596|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44398165|NCT00887198|79404652|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
44398166|NCT00887198|79404653|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
44398167|NCT00887198|79404654|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
44398168|NCT00887198|79404652|FG000|Randomized Period|Withdrawal by Subject|41|||
44398169|NCT00887198|79404653|FG001|Randomized Period|Withdrawal by Subject|56|||
44521235|NCT03345849|79529518|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
44521236|NCT03345849|79529519|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
44521237|NCT03345849|79529520|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
44521238|NCT03345849|79529517|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
44398170|NCT00887198|79404654|FG002|Randomized Period|Withdrawal by Subject|0|||
44398171|NCT00887198|79404652|FG000|Randomized Period|Progressive disease|366|||
44398172|NCT00887198|79404653|FG001|Randomized Period|Progressive disease|370|||
44398173|NCT00887198|79404654|FG002|Randomized Period|Progressive disease|0|||
44398174|NCT00887198|79404652|FG000|Randomized Period|Other|42|||
44398175|NCT00887198|79404653|FG001|Randomized Period|Other|30|||
44398176|NCT00887198|79404654|FG002|Randomized Period|Other|0|||
44398177|NCT00887198|79404652|FG000|Randomized Period|Randomized, Not treated|4|||
44398178|NCT00887198|79404653|FG001|Randomized Period|Randomized, Not treated|2|||
44398179|NCT00887198|79404654|FG002|Randomized Period|Randomized, Not treated|0|||
44398180|NCT00887198|79404652|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
44398181|NCT00887198|79404653|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
44398182|NCT00887198|79404654|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
44398183|NCT00887198|79404652|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
44398184|NCT00887198|79404653|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
44398185|NCT00887198|79404654|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
44398186|NCT00887198|79404652|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
44398187|NCT00887198|79404653|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
44398188|NCT00887198|79404654|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
44398189|NCT00887198|79404652|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
44398190|NCT00887198|79404653|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
44398191|NCT00887198|79404654|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
44398192|NCT00887198|79404652|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
44398193|NCT00887198|79404653|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
44398194|NCT00887198|79404654|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
44398195|NCT00887198|79404652|FG000|Cross Over (Placebo to AA)|Other|0|||
44398196|NCT00887198|79404653|FG001|Cross Over (Placebo to AA)|Other|0|||
44398197|NCT00887198|79404654|FG002|Cross Over (Placebo to AA)|Other|19|||
44398198|NCT00782067|79404662|FG000|Overall Study|Adverse Event|35|||
44398199|NCT00782067|79404662|FG000|Overall Study|Subject withdrew consent|11|||
44398200|NCT00782067|79404662|FG000|Overall Study|Lost to Follow-up|2|||
44398201|NCT00782067|79404662|FG000|Overall Study|Administrative problems|14|||
44398202|NCT00782067|79404662|FG000|Overall Study|Death|9|||
44398203|NCT00782067|79404662|FG000|Overall Study|Disease progression|43|||
44398204|NCT00782067|79404662|FG000|Overall Study|Protocol deviation|2|||
44398205|NCT00886340|79404668|FG000|Overall Study|Withdrawal by Subject|0|||
44398206|NCT00886340|79404669|FG001|Overall Study|Withdrawal by Subject|7|||
44398207|NCT00605215|79404678|FG000|Overall Study|Death|0|||
44398208|NCT00605215|79404679|FG001|Overall Study|Death|0|||
44398209|NCT00605215|79404680|FG002|Overall Study|Death|1|||
44398210|NCT00605215|79404678|FG000|Overall Study|Adverse Event|19|||
44398211|NCT00605215|79404679|FG001|Overall Study|Adverse Event|21|||
44398212|NCT00605215|79404680|FG002|Overall Study|Adverse Event|26|||
44398213|NCT00605215|79404678|FG000|Overall Study|Refusal to sign the re-consent form|8|||
44398214|NCT00605215|79404679|FG001|Overall Study|Refusal to sign the re-consent form|3|||
44398215|NCT00605215|79404680|FG002|Overall Study|Refusal to sign the re-consent form|3|||
44398216|NCT00605215|79404678|FG000|Overall Study|Withdrawal by Subject|39|||
44398217|NCT00605215|79404679|FG001|Overall Study|Withdrawal by Subject|37|||
44398218|NCT00605215|79404680|FG002|Overall Study|Withdrawal by Subject|27|||
44398219|NCT00605215|79404678|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
44398220|NCT00605215|79404679|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
44147321|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
44252766|NCT02082977|79091597|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252767|NCT02082977|79091598|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
44252768|NCT02082977|79091589|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
44252769|NCT02082977|79091590|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
44252770|NCT02082977|79091591|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
44398221|NCT00605215|79404680|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
44398222|NCT00605215|79404678|FG000|Overall Study|Protocol Violation|3|||
44398223|NCT00605215|79404679|FG001|Overall Study|Protocol Violation|4|||
44398224|NCT00605215|79404680|FG002|Overall Study|Protocol Violation|1|||
44398225|NCT00605215|79404678|FG000|Overall Study|Pregnancy|8|||
44398226|NCT00605215|79404679|FG001|Overall Study|Pregnancy|5|||
44398227|NCT00605215|79404680|FG002|Overall Study|Pregnancy|4|||
44398228|NCT00605215|79404678|FG000|Overall Study|Lost to Follow-up|8|||
44398229|NCT00605215|79404679|FG001|Overall Study|Lost to Follow-up|5|||
44398230|NCT00605215|79404680|FG002|Overall Study|Lost to Follow-up|2|||
44398231|NCT00605215|79404678|FG000|Overall Study|Other than specified|0|||
44398232|NCT00605215|79404679|FG001|Overall Study|Other than specified|2|||
44398233|NCT00605215|79404680|FG002|Overall Study|Other than specified|1|||
44398234|NCT00604279|79404690|FG000|Overall Study|Lack of Efficacy|22|||
44398235|NCT00604279|79404691|FG001|Overall Study|Lack of Efficacy|9|||
44398236|NCT00604279|79404690|FG000|Overall Study|Lost to Follow-up|9|||
44398237|NCT00604279|79404691|FG001|Overall Study|Lost to Follow-up|14|||
44398238|NCT00604279|79404690|FG000|Overall Study|Pregnancy|2|||
44398239|NCT00604279|79404691|FG001|Overall Study|Pregnancy|0|||
44398240|NCT00604279|79404690|FG000|Overall Study|Protocol Violation|3|||
44398241|NCT00604279|79404691|FG001|Overall Study|Protocol Violation|1|||
44398242|NCT00604279|79404690|FG000|Overall Study|Withdrawal by Subject|16|||
44398243|NCT00604279|79404691|FG001|Overall Study|Withdrawal by Subject|5|||
44521239|NCT03345849|79529518|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
44521240|NCT03345849|79529519|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
44521241|NCT03345849|79529520|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
44521242|NCT03345849|79529517|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
44521243|NCT03345849|79529518|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
44521244|NCT03345849|79529519|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
44521245|NCT03345849|79529520|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
44521246|NCT03345849|79529517|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
44521247|NCT03345849|79529518|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
44398244|NCT00604279|79404690|FG000|Overall Study|Adverse Event|4|||
44398245|NCT00604279|79404691|FG001|Overall Study|Adverse Event|5|||
44398246|NCT00604279|79404690|FG000|Overall Study|Other|8|||
44398247|NCT00604279|79404691|FG001|Overall Study|Other|4|||
44398248|NCT00938015|79404697|FG000|Overall Study|Death|2|||
44398249|NCT00938015|79404697|FG000|Overall Study|Lost to Follow-up|32|||
44398250|NCT00938015|79404697|FG000|Overall Study|Adverse Event|32|||
44398251|NCT00938015|79404697|FG000|Overall Study|Non-responder|52|||
44398252|NCT00938015|79404697|FG000|Overall Study|Reason not related to Etanercept|29|||
44398253|NCT00781911|79404703|FG000|Overall Study|Adverse Event|4|||
44398254|NCT00781911|79404704|FG001|Overall Study|Adverse Event|4|||
44398255|NCT00781911|79404703|FG000|Overall Study|Withdrawal by Subject|1|||
44398256|NCT00781911|79404704|FG001|Overall Study|Withdrawal by Subject|2|||
44398257|NCT00781911|79404703|FG000|Overall Study|Physician Decision|0|||
44398258|NCT00781911|79404704|FG001|Overall Study|Physician Decision|2|||
44398259|NCT00781911|79404703|FG000|Overall Study|Sponsor Decision|1|||
44398260|NCT00781911|79404704|FG001|Overall Study|Sponsor Decision|0|||
44398261|NCT00605917|79404712|FG000|Overall Study|Protocol Violation|79|||
44521248|NCT03345849|79529519|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
44521249|NCT03345849|79529520|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
44398262|NCT00781599|79404749|FG000|Overall Study|Lost to Follow-up|7|||
44398263|NCT00781599|79404750|FG001|Overall Study|Lost to Follow-up|4|||
44398264|NCT00605839|79404768|FG000|Overall Study|Protocol Violation|1|||
44398265|NCT00605839|79404769|FG001|Overall Study|Protocol Violation|0|||
44398266|NCT00605839|79404770|FG002|Overall Study|Protocol Violation|0|||
44398267|NCT00781365|79404780|FG000|Overall Study|Withdrawal by Subject|13|||
44398268|NCT00781365|79404781|FG001|Overall Study|Withdrawal by Subject|8|||
44398269|NCT00781365|79404780|FG000|Overall Study|Did Not Attend Visit|20|||
44398270|NCT00781365|79404781|FG001|Overall Study|Did Not Attend Visit|28|||
44398271|NCT00781365|79404780|FG000|Overall Study|Language barrier|1|||
44398272|NCT00781365|79404781|FG001|Overall Study|Language barrier|0|||
44398273|NCT00937547|79404790|FG000|Overall Study|misdiagnosis|1|||
44398274|NCT00937547|79404791|FG001|Overall Study|misdiagnosis|6|||
44398275|NCT00937547|79404792|FG002|Overall Study|misdiagnosis|7|||
44398276|NCT00780975|79404800|FG000|Overall Study|Progressive disease|3|||
44398277|NCT00780975|79404800|FG000|Overall Study|Toxicity|5|||
44398278|NCT00780273|79404804|FG000|Overall Study|Death|1|||
44398279|NCT00780273|79404804|FG000|Overall Study|Lost to Follow-up|1|||
44398280|NCT00779259|79404809|FG000|Quinine Alone|Adverse Event|2|||
44398281|NCT00779025|79404827|FG000|Overall Study|Withdrawal by Subject|1|||
44398282|NCT00936065|79404835|FG000|Overall Study|Adverse Event|1|||
44398283|NCT00936065|79404836|FG001|Overall Study|Adverse Event|0|||
44398284|NCT00936065|79404837|FG002|Overall Study|Adverse Event|1|||
44398285|NCT00936065|79404835|FG000|Overall Study|Lack of Efficacy|1|||
44521250|NCT03345849|79529517|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
44521251|NCT03345849|79529518|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
44521252|NCT03345849|79529519|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
44521253|NCT03345849|79529520|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
44521254|NCT03345849|79529517|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
44398286|NCT00936065|79404836|FG001|Overall Study|Lack of Efficacy|0|||
44398287|NCT00936065|79404837|FG002|Overall Study|Lack of Efficacy|1|||
44398288|NCT00936065|79404835|FG000|Overall Study|Lost to Follow-up|1|||
44398289|NCT00936065|79404836|FG001|Overall Study|Lost to Follow-up|0|||
44398290|NCT00936065|79404837|FG002|Overall Study|Lost to Follow-up|0|||
44398291|NCT00936065|79404835|FG000|Overall Study|Protocol Violation|1|||
44398292|NCT00936065|79404836|FG001|Overall Study|Protocol Violation|2|||
44398293|NCT00936065|79404837|FG002|Overall Study|Protocol Violation|1|||
44398294|NCT00936065|79404835|FG000|Overall Study|Withdrawal by Subject|0|||
44398295|NCT00936065|79404836|FG001|Overall Study|Withdrawal by Subject|2|||
44398296|NCT00936065|79404837|FG002|Overall Study|Withdrawal by Subject|4|||
44398297|NCT04441788|79404848|FG000|Overall Study|Voluntary Withdrawl|0|||
44398298|NCT04441788|79404849|FG001|Overall Study|Voluntary Withdrawl|1|||
44398299|NCT04441788|79404850|FG002|Overall Study|Voluntary Withdrawl|0|||
44398300|NCT04441788|79404848|FG000|Overall Study|Ineligibility|1|||
44398301|NCT04441788|79404849|FG001|Overall Study|Ineligibility|0|||
44398302|NCT04441788|79404850|FG002|Overall Study|Ineligibility|0|||
44398303|NCT04441788|79404848|FG000|Overall Study|Adverse Event|0|||
44398304|NCT04441788|79404849|FG001|Overall Study|Adverse Event|0|||
44398305|NCT04441788|79404850|FG002|Overall Study|Adverse Event|4|||
44398306|NCT04441788|79404848|FG000|Overall Study|Study Terminated by Sponsor|16|||
44398307|NCT04441788|79404849|FG001|Overall Study|Study Terminated by Sponsor|16|||
44398308|NCT04441788|79404850|FG002|Overall Study|Study Terminated by Sponsor|12|||
44398309|NCT00604825|79404866|FG000|Overall Study|Adverse Event|2|||
44398310|NCT00604825|79404867|FG001|Overall Study|Adverse Event|6|||
44398311|NCT00604825|79404868|FG002|Overall Study|Adverse Event|7|||
44398312|NCT00604825|79404869|FG003|Overall Study|Adverse Event|4|||
44398313|NCT00604825|79404866|FG000|Overall Study|Lost to Follow-up|0|||
44398314|NCT00604825|79404867|FG001|Overall Study|Lost to Follow-up|3|||
44398315|NCT00604825|79404868|FG002|Overall Study|Lost to Follow-up|1|||
44398316|NCT00604825|79404869|FG003|Overall Study|Lost to Follow-up|0|||
44398317|NCT00604825|79404866|FG000|Overall Study|Protocol Violation|0|||
44398318|NCT00604825|79404867|FG001|Overall Study|Protocol Violation|1|||
44398319|NCT00604825|79404868|FG002|Overall Study|Protocol Violation|0|||
44398320|NCT00604825|79404869|FG003|Overall Study|Protocol Violation|0|||
44398321|NCT00604825|79404866|FG000|Overall Study|Withdrawal by Subject|4|||
44398322|NCT00604825|79404867|FG001|Overall Study|Withdrawal by Subject|3|||
44398323|NCT00604825|79404868|FG002|Overall Study|Withdrawal by Subject|5|||
44398324|NCT00604825|79404869|FG003|Overall Study|Withdrawal by Subject|5|||
44398325|NCT00604825|79404866|FG000|Overall Study|Lack of Efficacy|3|||
44398326|NCT00604825|79404867|FG001|Overall Study|Lack of Efficacy|2|||
44398327|NCT00604825|79404868|FG002|Overall Study|Lack of Efficacy|1|||
44398328|NCT00604825|79404869|FG003|Overall Study|Lack of Efficacy|0|||
44398329|NCT00604825|79404866|FG000|Overall Study|Did not meet eligibility criteria|0|||
44398330|NCT00604825|79404867|FG001|Overall Study|Did not meet eligibility criteria|0|||
44398331|NCT00604825|79404868|FG002|Overall Study|Did not meet eligibility criteria|2|||
44398332|NCT00604825|79404869|FG003|Overall Study|Did not meet eligibility criteria|0|||
44398333|NCT00604825|79404866|FG000|Overall Study|Physician Decision|0|||
44398334|NCT00604825|79404867|FG001|Overall Study|Physician Decision|0|||
44398335|NCT00604825|79404868|FG002|Overall Study|Physician Decision|0|||
44398336|NCT00604825|79404869|FG003|Overall Study|Physician Decision|1|||
44398337|NCT00604825|79404866|FG000|Overall Study|Exclusion criterion met|0|||
44398338|NCT00604825|79404867|FG001|Overall Study|Exclusion criterion met|0|||
44398339|NCT00604825|79404868|FG002|Overall Study|Exclusion criterion met|0|||
44398340|NCT00604825|79404869|FG003|Overall Study|Exclusion criterion met|1|||
44398341|NCT00937391|79404881|FG000|Stage 2|Withdrawal by Subject|1|||
44398342|NCT00937157|79404898|FG000|Overall Study|Pregnancy|1|||
44398343|NCT00937157|79404898|FG000|Overall Study|Lost to Follow-up|3|||
44398344|NCT00777153|79404905|FG000|Overall Study|Lost to Follow-up|1|||
44398345|NCT00777153|79404906|FG001|Overall Study|Lost to Follow-up|1|||
44398346|NCT00777153|79404907|FG002|Overall Study|Lost to Follow-up|0|||
44398347|NCT00777153|79404905|FG000|Overall Study|Death|85|||
44398348|NCT00777153|79404906|FG001|Overall Study|Death|73|||
44398349|NCT00777153|79404907|FG002|Overall Study|Death|33|||
44398350|NCT00777153|79404905|FG000|Overall Study|Withdrawal by Subject|3|||
44398351|NCT00777153|79404906|FG001|Overall Study|Withdrawal by Subject|4|||
44398352|NCT00777153|79404907|FG002|Overall Study|Withdrawal by Subject|3|||
44398353|NCT00777153|79404905|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
44398354|NCT00777153|79404906|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
44398355|NCT00777153|79404907|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
44281650|NCT01916226|79244928|FG000|Overall Study|Lack of Efficacy|0|||
44281651|NCT01916226|79244929|FG001|Overall Study|Lack of Efficacy|0|||
44281652|NCT01916226|79244930|FG002|Overall Study|Lack of Efficacy|2|||
44281653|NCT01916226|79244931|FG003|Overall Study|Lack of Efficacy|1|||
44281654|NCT01916226|79244928|FG000|Overall Study|Protocol Violation|0|||
44281655|NCT01916226|79244929|FG001|Overall Study|Protocol Violation|1|||
44281656|NCT01916226|79244930|FG002|Overall Study|Protocol Violation|0|||
44521255|NCT03345849|79529518|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
44521256|NCT03345849|79529519|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
44281657|NCT01916226|79244931|FG003|Overall Study|Protocol Violation|1|||
44281658|NCT01916226|79244928|FG000|Overall Study|Physician Decision|0|||
44281659|NCT01916226|79244929|FG001|Overall Study|Physician Decision|0|||
44281660|NCT01916226|79244930|FG002|Overall Study|Physician Decision|0|||
44281661|NCT01916226|79244931|FG003|Overall Study|Physician Decision|1|||
44281662|NCT01969500|79244944|FG000|Overall Study|Death|0|||
44281663|NCT01969500|79244945|FG001|Overall Study|Death|1|||
44281664|NCT01969500|79244944|FG000|Overall Study|extended hospitalization|1|||
44398356|NCT00567541|79404921|FG000|Overall Study|Adverse Event|0|||
44398357|NCT00567541|79404922|FG001|Overall Study|Adverse Event|1|||
44398358|NCT00776997|79404928|FG000|Overall Study|Adverse Event|2|||
44398359|NCT00940823|79404934|FG000|Overall Study|Death|8|||
44398360|NCT00940823|79404935|FG001|Overall Study|Death|12|||
44398361|NCT00940823|79404934|FG000|Overall Study|Lost to Follow-up|27|||
44398362|NCT00940823|79404935|FG001|Overall Study|Lost to Follow-up|20|||
44398363|NCT00936611|79404943|FG000|Overall Study|Progressive Disease|3|||
44398364|NCT00936611|79404943|FG000|Overall Study|New Systemic Therapy|22|||
44398365|NCT00936611|79404943|FG000|Overall Study|Lost to Follow-up|1|||
44398366|NCT00936611|79404943|FG000|Overall Study|Withdrawal by Subject|2|||
44398367|NCT00936611|79404943|FG000|Overall Study|Still on Follow-up|1|||
44398368|NCT00936611|79404943|FG000|Overall Study|Still on Active Therapy|7|||
44398369|NCT00936611|79404943|FG000|Overall Study|Ineligible for Study Drug|3|||
44398370|NCT00936221|79404966|FG000|Overall Study|Withdrawal by Subject|1|||
44398371|NCT00936221|79404967|FG001|Overall Study|Withdrawal by Subject|1|||
44398372|NCT00776919|79404977|FG000|Overall Study|Withdrawal by Subject|16|||
44398373|NCT00776919|79404978|FG001|Overall Study|Withdrawal by Subject|14|||
44398374|NCT00776919|79404979|FG002|Overall Study|Withdrawal by Subject|15|||
44398375|NCT00776919|79404980|FG003|Overall Study|Withdrawal by Subject|26|||
44398376|NCT00776919|79404977|FG000|Overall Study|Lost to Follow-up|8|||
44398377|NCT00776919|79404978|FG001|Overall Study|Lost to Follow-up|12|||
44398378|NCT00776919|79404979|FG002|Overall Study|Lost to Follow-up|11|||
44398379|NCT00776919|79404980|FG003|Overall Study|Lost to Follow-up|8|||
44398380|NCT00776919|79404977|FG000|Overall Study|Adverse Event|1|||
44398381|NCT00776919|79404978|FG001|Overall Study|Adverse Event|0|||
44398382|NCT00776919|79404979|FG002|Overall Study|Adverse Event|2|||
44398383|NCT00776919|79404980|FG003|Overall Study|Adverse Event|2|||
44398384|NCT00776919|79404977|FG000|Overall Study|Protocol Violation|1|||
44398385|NCT00776919|79404978|FG001|Overall Study|Protocol Violation|2|||
44398386|NCT00776919|79404979|FG002|Overall Study|Protocol Violation|0|||
44398387|NCT00776919|79404980|FG003|Overall Study|Protocol Violation|1|||
44398388|NCT00776919|79404977|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
44398389|NCT00776919|79404978|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
44398390|NCT00776919|79404979|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
44398391|NCT00776919|79404980|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
44398392|NCT00775983|79405007|FG000|Overall Study|Protocol Violation|1|||
44398393|NCT00775983|79405008|FG001|Overall Study|Protocol Violation|2|||
44398394|NCT00775593|79405014|FG000|Overall Study|Unmet eligibility criteria|6|||
44398395|NCT00775593|79405014|FG000|Overall Study|Death|1|||
44398396|NCT00939809|79405018|FG000|Overall Study|Adverse Event|2|||
44398397|NCT00939809|79405018|FG000|Overall Study|Death|1|||
44398398|NCT00934661|79405024|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
44398399|NCT00934661|79405025|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
44398400|NCT00775437|79405031|FG000|Overall Study|Loss of efficacy|2|||
44398401|NCT00775437|79405031|FG000|Overall Study|Withdrawal by Subject|3|||
44398402|NCT00775437|79405031|FG000|Overall Study|Lost to Follow-up|1|||
44398403|NCT00775203|79405037|FG000|Overall Study|Adverse Event|25|||
44398404|NCT00775203|79405038|FG001|Overall Study|Adverse Event|6|||
44398405|NCT00775203|79405037|FG000|Overall Study|Lack of Efficacy|8|||
44398406|NCT00775203|79405038|FG001|Overall Study|Lack of Efficacy|9|||
44398407|NCT00775203|79405037|FG000|Overall Study|Withdrawal by Subject|11|||
44398408|NCT00775203|79405038|FG001|Overall Study|Withdrawal by Subject|9|||
44398409|NCT00775203|79405037|FG000|Overall Study|Lost to Follow-up|11|||
44398410|NCT00775203|79405038|FG001|Overall Study|Lost to Follow-up|15|||
44398411|NCT00775203|79405037|FG000|Overall Study|Administrative reason|2|||
44398412|NCT00775203|79405038|FG001|Overall Study|Administrative reason|0|||
44398413|NCT00775203|79405037|FG000|Overall Study|Noncompliance|4|||
44398414|NCT00775203|79405038|FG001|Overall Study|Noncompliance|2|||
44398415|NCT00775203|79405037|FG000|Overall Study|Protocol Violation|0|||
44521257|NCT03345849|79529520|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
44521258|NCT03011307|79529530|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
44398416|NCT00775203|79405038|FG001|Overall Study|Protocol Violation|1|||
44398417|NCT00775203|79405037|FG000|Overall Study|Entered other study|1|||
44398418|NCT00775203|79405038|FG001|Overall Study|Entered other study|0|||
44521259|NCT03011307|79529531|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
44521260|NCT03011307|79529530|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
44521261|NCT03011307|79529531|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
44398419|NCT00775203|79405037|FG000|Overall Study|Physician Decision|0|||
44398420|NCT00775203|79405038|FG001|Overall Study|Physician Decision|1|||
44398421|NCT00568321|79405047|FG000|Overall Study|Adverse Event|1|||
44398422|NCT00568321|79405048|FG001|Overall Study|Adverse Event|0|||
44398423|NCT00568321|79405049|FG002|Overall Study|Adverse Event|0|||
44398424|NCT00568321|79405047|FG000|Overall Study|Lack of Efficacy|8|||
44398425|NCT00568321|79405048|FG001|Overall Study|Lack of Efficacy|5|||
44398426|NCT00568321|79405049|FG002|Overall Study|Lack of Efficacy|6|||
44398427|NCT00568321|79405047|FG000|Overall Study|Lost to Follow-up|0|||
44398428|NCT00568321|79405048|FG001|Overall Study|Lost to Follow-up|0|||
44398429|NCT00568321|79405049|FG002|Overall Study|Lost to Follow-up|1|||
44398430|NCT00568321|79405047|FG000|Overall Study|Withdrawal by Subject|2|||
44398431|NCT00568321|79405048|FG001|Overall Study|Withdrawal by Subject|0|||
44398432|NCT00568321|79405049|FG002|Overall Study|Withdrawal by Subject|0|||
44398433|NCT00568321|79405047|FG000|Overall Study|Protocol Violation|0|||
44398434|NCT00568321|79405048|FG001|Overall Study|Protocol Violation|0|||
44398435|NCT00568321|79405049|FG002|Overall Study|Protocol Violation|1|||
44398436|NCT00568321|79405047|FG000|Overall Study|Randomized, not treated|2|||
44398437|NCT00568321|79405048|FG001|Overall Study|Randomized, not treated|0|||
44398438|NCT00568321|79405049|FG002|Overall Study|Randomized, not treated|1|||
44398439|NCT00774345|79405061|FG000|Pre-treatment|Other reasons|2|||
44398440|NCT00774345|79405062|FG001|Pre-treatment|Other reasons|0|||
44398441|NCT00774345|79405061|FG000|Treatment|Adverse Event|61|||
44398442|NCT00774345|79405062|FG001|Treatment|Adverse Event|15|||
44398443|NCT00774345|79405061|FG000|Treatment|Progressive Disease without histologic transformation|51|||
44398444|NCT00774345|79405062|FG001|Treatment|Progressive Disease without histologic transformation|111|||
44398445|NCT00774345|79405061|FG000|Treatment|Progressive Disease with histologic transformation|4|||
44398446|NCT00774345|79405062|FG001|Treatment|Progressive Disease with histologic transformation|2|||
44398447|NCT00774345|79405061|FG000|Treatment|Withdrawal by Subject|5|||
44398448|NCT00774345|79405062|FG001|Treatment|Withdrawal by Subject|2|||
44398449|NCT00774345|79405061|FG000|Treatment|Lost to Follow-up|1|||
44398450|NCT00774345|79405062|FG001|Treatment|Lost to Follow-up|1|||
44398451|NCT00774345|79405061|FG000|Treatment|Death|4|||
44398452|NCT00774345|79405062|FG001|Treatment|Death|0|||
44398453|NCT00774345|79405061|FG000|Treatment|Other Reasons|32|||
44398454|NCT00774345|79405062|FG001|Treatment|Other Reasons|26|||
44398455|NCT00773253|79405074|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
44398456|NCT00773253|79405075|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
44398457|NCT00773175|79405085|FG000|Overall Study|Adverse Event|2|||
44398458|NCT00773175|79405086|FG001|Overall Study|Adverse Event|0|||
44398459|NCT00773175|79405085|FG000|Overall Study|Consent Withdrawn|0|||
44398460|NCT00773175|79405086|FG001|Overall Study|Consent Withdrawn|2|||
44398461|NCT00566527|79405100|FG000|Overall Study|Reason not provided|3|||
44398462|NCT00566527|79405101|FG001|Overall Study|Reason not provided|11|||
44398463|NCT00566527|79405102|FG002|Overall Study|Reason not provided|10|||
44398464|NCT00566527|79405100|FG000|Overall Study|Adverse Event|2|||
44398465|NCT00566527|79405101|FG001|Overall Study|Adverse Event|0|||
44398466|NCT00566527|79405102|FG002|Overall Study|Adverse Event|1|||
44398467|NCT00566527|79405100|FG000|Overall Study|Physician Decision|3|||
44398468|NCT00566527|79405101|FG001|Overall Study|Physician Decision|8|||
44398469|NCT00566527|79405102|FG002|Overall Study|Physician Decision|20|||
44398470|NCT00566527|79405100|FG000|Overall Study|Lost to Follow-up|3|||
44398471|NCT00566527|79405101|FG001|Overall Study|Lost to Follow-up|4|||
44398472|NCT00566527|79405102|FG002|Overall Study|Lost to Follow-up|4|||
44398473|NCT00566527|79405100|FG000|Overall Study|Withdrawal by Subject|6|||
44398474|NCT00566527|79405101|FG001|Overall Study|Withdrawal by Subject|43|||
44398475|NCT00566527|79405102|FG002|Overall Study|Withdrawal by Subject|43|||
44398476|NCT00773097|79405112|FG000|Overall Study|Withdrawal by Subject|1|||
44398477|NCT00773097|79405112|FG000|Overall Study|Physician Decision|6|||
44398478|NCT00933335|79405118|FG000|Overall Study|Lost to Follow-up|1|||
44398479|NCT00933335|79405119|FG001|Overall Study|Lost to Follow-up|3|||
44398480|NCT00933335|79405118|FG000|Overall Study|Withdrawal by Subject|0|||
44398481|NCT00933335|79405119|FG001|Overall Study|Withdrawal by Subject|1|||
44398482|NCT00933335|79405118|FG000|Overall Study|Progressive Disease|0|||
44398483|NCT00933335|79405119|FG001|Overall Study|Progressive Disease|11|||
44398484|NCT00933335|79405118|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
44398485|NCT00933335|79405119|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
44398486|NCT00933335|79405118|FG000|Overall Study|Co-morbid Illness|1|||
44398487|NCT00933335|79405119|FG001|Overall Study|Co-morbid Illness|0|||
44398488|NCT00772941|79405131|FG000|Overall Study|CRFs not available|195|||
44398489|NCT00772941|79405131|FG000|Overall Study|Study not completed|16|||
44398490|NCT00772941|79405131|FG000|Overall Study|Missed Visits|374|||
44398491|NCT00772941|79405131|FG000|Overall Study|Poor Compliance|7|||
44398492|NCT00772941|79405131|FG000|Overall Study|GPSP Violation|90|||
44398493|NCT00772707|79405158|FG000|Overall Study|Withdrawn|3|||
44398494|NCT00772629|79405164|FG000|Overall Study|Subject was not vaccinated|1|||
44398495|NCT00772629|79405165|FG001|Overall Study|Subject was not vaccinated|0|||
44398496|NCT00939341|79405171|FG000|Overall Study|Adverse Event|15|||
44398497|NCT00939341|79405171|FG000|Overall Study|Pregnancy|1|||
44398498|NCT00939341|79405171|FG000|Overall Study|Lost to Follow-up|23|||
44398499|NCT00939341|79405171|FG000|Overall Study|Withdrawal by Subject|13|||
44398500|NCT00939341|79405171|FG000|Overall Study|Protocol Violation|6|||
44398501|NCT00939341|79405171|FG000|Overall Study|Incorrect enrolment|8|||
44398502|NCT04292470|79405200|FG000|Overall Study|Withdrawal by Subject|0|||
44398503|NCT04292470|79405201|FG001|Overall Study|Withdrawal by Subject|1|||
44398504|NCT04217590|79405209|FG000|Overall Study|Other|1|||
44398505|NCT04217590|79405210|FG001|Overall Study|Other|1|||
44398506|NCT04217590|79405209|FG000|Overall Study|Withdrawal by Subject|3|||
44398507|NCT04217590|79405210|FG001|Overall Study|Withdrawal by Subject|1|||
44398508|NCT04217590|79405209|FG000|Overall Study|Death|0|||
44398509|NCT04217590|79405210|FG001|Overall Study|Death|1|||
44398510|NCT03963232|79405218|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
44398511|NCT03963232|79405219|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
44398512|NCT03963232|79405218|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
44398513|NCT03963232|79405219|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
44398514|NCT03963232|79405218|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
44398515|NCT03963232|79405219|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
44398516|NCT03963232|79405218|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
44398517|NCT03963232|79405219|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
44398518|NCT03963232|79405218|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
44398519|NCT03963232|79405219|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
44398520|NCT03963232|79405218|FG000|Open-Label Treatment Phase|Adverse Event|1|||
44398521|NCT03963232|79405219|FG001|Open-Label Treatment Phase|Adverse Event|2|||
44398522|NCT03963232|79405218|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
44398523|NCT03963232|79405219|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
44398524|NCT03963232|79405218|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
44398525|NCT03963232|79405219|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
44147322|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
44147323|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
44147324|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
44147325|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
44147326|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
44147327|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
44147328|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
44147329|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
44147330|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
44147331|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
44147332|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
44147333|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
44147334|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
44147335|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
44147336|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
44147337|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
44147338|NCT00700427|78936720|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
44147339|NCT00700427|78936721|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
44147340|NCT00700427|78936722|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
44147341|NCT00700427|78936723|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
44147342|NCT00700427|78936724|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
44147343|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
44147344|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
44147345|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
44147346|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
44147347|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
44147348|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
44147349|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
44147350|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
44147351|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
44147352|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
44147353|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
44147354|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
44147355|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
44398526|NCT03963232|79405218|FG000|Open-Label Treatment Phase|Pregnancy|1|||
44398527|NCT03963232|79405219|FG001|Open-Label Treatment Phase|Pregnancy|0|||
44398528|NCT03963232|79405218|FG000|Follow-up Phase|Withdrawal by Subject|7|||
44398529|NCT03963232|79405219|FG001|Follow-up Phase|Withdrawal by Subject|5|||
44398530|NCT03963232|79405218|FG000|Follow-up Phase|Protocol Violation|0|||
44398531|NCT03963232|79405219|FG001|Follow-up Phase|Protocol Violation|2|||
44398532|NCT03963232|79405218|FG000|Follow-up Phase|Adverse Event|0|||
44398533|NCT03963232|79405219|FG001|Follow-up Phase|Adverse Event|1|||
44398534|NCT03963232|79405218|FG000|Follow-up Phase|Lost to Follow-up|0|||
44398535|NCT03963232|79405219|FG001|Follow-up Phase|Lost to Follow-up|1|||
44147356|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
44147357|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
44147358|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
44398536|NCT03856593|79405243|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
44398537|NCT03856593|79405244|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
44398538|NCT03785925|79405252|FG000|Overall Study|Withdrawal by Subject|15|||
44398539|NCT03785925|79405252|FG000|Overall Study|Lost to Follow-up|1|||
44398540|NCT03427411|79405263|FG000|Overall Study|Screen failure - platelets too low|0|||
44398541|NCT03427411|79405264|FG001|Overall Study|Screen failure - platelets too low|1|||
44398542|NCT03330106|79405272|FG000|Part A|Withdrawal by Subject|1|||
44398543|NCT03330106|79405273|FG001|Part A|Withdrawal by Subject|1|||
44398544|NCT03330106|79405274|FG002|Part A|Withdrawal by Subject|0|||
44398545|NCT03330106|79405275|FG003|Part A|Withdrawal by Subject|0|||
44398546|NCT03330106|79405272|FG000|Part A|Death|2|||
44398547|NCT03330106|79405273|FG001|Part A|Death|1|||
44398548|NCT03330106|79405274|FG002|Part A|Death|0|||
44398549|NCT03330106|79405275|FG003|Part A|Death|0|||
44398550|NCT03330106|79405272|FG000|Part A|Adverse Event|0|||
44521262|NCT03011307|79529530|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
44521263|NCT03011307|79529531|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
44521264|NCT03798717|79529543|FG000|Overall Study|Failed Screening|0|||
44521265|NCT03798717|79529544|FG001|Overall Study|Failed Screening|0|||
44521266|NCT03798717|79529545|FG002|Overall Study|Failed Screening|0|||
44521267|NCT03798717|79529546|FG003|Overall Study|Failed Screening|0|||
44521268|NCT03798717|79529547|FG004|Overall Study|Failed Screening|0|||
44521269|NCT03798717|79529548|FG005|Overall Study|Failed Screening|1|||
44521270|NCT03798717|79529543|FG000|Overall Study|Physician Decision|1|||
44521271|NCT03798717|79529544|FG001|Overall Study|Physician Decision|0|||
44521272|NCT03798717|79529545|FG002|Overall Study|Physician Decision|1|||
44521273|NCT03798717|79529546|FG003|Overall Study|Physician Decision|0|||
44521274|NCT03798717|79529547|FG004|Overall Study|Physician Decision|0|||
44521275|NCT03798717|79529548|FG005|Overall Study|Physician Decision|0|||
44521276|NCT03798717|79529543|FG000|Overall Study|Withdrawal by Subject|0|||
44521277|NCT03798717|79529544|FG001|Overall Study|Withdrawal by Subject|0|||
44521278|NCT03798717|79529545|FG002|Overall Study|Withdrawal by Subject|0|||
44521279|NCT03798717|79529546|FG003|Overall Study|Withdrawal by Subject|1|||
44398551|NCT03330106|79405273|FG001|Part A|Adverse Event|1|||
44398552|NCT03330106|79405274|FG002|Part A|Adverse Event|0|||
44398553|NCT03330106|79405275|FG003|Part A|Adverse Event|0|||
44398554|NCT03330106|79405272|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
44398555|NCT03330106|79405273|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
44398556|NCT03330106|79405274|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
44398557|NCT03330106|79405275|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
44398558|NCT03330106|79405272|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
44398559|NCT03330106|79405273|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
44398560|NCT03330106|79405274|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
44398561|NCT03330106|79405275|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
44398562|NCT03330106|79405272|FG000|Part A|Progressive Disease|0|||
44398563|NCT03330106|79405273|FG001|Part A|Progressive Disease|1|||
44398564|NCT03330106|79405274|FG002|Part A|Progressive Disease|0|||
44398565|NCT03330106|79405275|FG003|Part A|Progressive Disease|0|||
44398566|NCT03330106|79405272|FG000|Part B|Lost to Follow-up|0|||
44398567|NCT03330106|79405273|FG001|Part B|Lost to Follow-up|0|||
44398568|NCT03330106|79405274|FG002|Part B|Lost to Follow-up|0|||
44398569|NCT03330106|79405275|FG003|Part B|Lost to Follow-up|1|||
44398570|NCT03330106|79405272|FG000|Part B|Withdrawal by Subject|0|||
44398571|NCT03330106|79405273|FG001|Part B|Withdrawal by Subject|0|||
44398572|NCT03330106|79405274|FG002|Part B|Withdrawal by Subject|4|||
44398573|NCT03330106|79405275|FG003|Part B|Withdrawal by Subject|0|||
44398574|NCT03330106|79405272|FG000|Part B|Death|0|||
44398575|NCT03330106|79405273|FG001|Part B|Death|0|||
44398576|NCT03330106|79405274|FG002|Part B|Death|2|||
44398577|NCT03330106|79405275|FG003|Part B|Death|0|||
44398578|NCT03330106|79405272|FG000|Part B|Clinical Progression|0|||
44398579|NCT03330106|79405273|FG001|Part B|Clinical Progression|0|||
44398580|NCT03330106|79405274|FG002|Part B|Clinical Progression|1|||
44398581|NCT03330106|79405275|FG003|Part B|Clinical Progression|1|||
44521280|NCT03798717|79529547|FG004|Overall Study|Withdrawal by Subject|0|||
44398582|NCT03330106|79405272|FG000|Part B|Symptomatic Deterioration|0|||
44398583|NCT03330106|79405273|FG001|Part B|Symptomatic Deterioration|0|||
44398584|NCT03330106|79405274|FG002|Part B|Symptomatic Deterioration|0|||
44398585|NCT03330106|79405275|FG003|Part B|Symptomatic Deterioration|1|||
44398586|NCT03330106|79405272|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
44398587|NCT03330106|79405273|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
44398588|NCT03330106|79405274|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
44398589|NCT03330106|79405275|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
44521281|NCT03798717|79529548|FG005|Overall Study|Withdrawal by Subject|0|||
44521282|NCT03798717|79529543|FG000|Overall Study|Lost to Follow-up|1|||
44521283|NCT03798717|79529544|FG001|Overall Study|Lost to Follow-up|0|||
44398590|NCT03330106|79405272|FG000|Part B|Progressive Disease|0|||
44398591|NCT03330106|79405273|FG001|Part B|Progressive Disease|0|||
44398592|NCT03330106|79405274|FG002|Part B|Progressive Disease|11|||
44398593|NCT03330106|79405275|FG003|Part B|Progressive Disease|4|||
44398594|NCT03164564|79405287|FG000|Overall Study|Death|3|||
44398595|NCT03164564|79405288|FG001|Overall Study|Death|0|||
44398596|NCT03164564|79405287|FG000|Overall Study|Withdrawal by Subject|20|||
44398597|NCT03164564|79405288|FG001|Overall Study|Withdrawal by Subject|15|||
44398598|NCT03164564|79405287|FG000|Overall Study|Lost to Follow-up|2|||
44398599|NCT03164564|79405288|FG001|Overall Study|Lost to Follow-up|0|||
44398600|NCT03164564|79405287|FG000|Overall Study|Physician Decision|0|||
44398601|NCT03164564|79405288|FG001|Overall Study|Physician Decision|1|||
44398602|NCT03164564|79405287|FG000|Overall Study|Adverse Event|0|||
44398603|NCT03164564|79405288|FG001|Overall Study|Adverse Event|1|||
44398604|NCT03164564|79405287|FG000|Overall Study|Ongoing|1586|||
44398605|NCT03164564|79405288|FG001|Overall Study|Ongoing|1586|||
44398606|NCT02821754|79405304|FG000|Overall Study|Procedure not required prior to amendment change|13|||
44398607|NCT02821754|79405305|FG001|Overall Study|Procedure not required prior to amendment change|11|||
44398608|NCT02821754|79405306|FG002|Overall Study|Procedure not required prior to amendment change|0|||
44398609|NCT02821754|79405304|FG000|Overall Study|Participant's Clinical status|2|||
44398610|NCT02821754|79405305|FG001|Overall Study|Participant's Clinical status|0|||
44398611|NCT02821754|79405306|FG002|Overall Study|Participant's Clinical status|0|||
44398612|NCT02821754|79405304|FG000|Overall Study|Participant removed for noncompliance|1|||
44398613|NCT02821754|79405305|FG001|Overall Study|Participant removed for noncompliance|0|||
44398614|NCT02821754|79405306|FG002|Overall Study|Participant removed for noncompliance|0|||
44398615|NCT02821754|79405304|FG000|Overall Study|Drug not available.|0|||
44521284|NCT03798717|79529545|FG002|Overall Study|Lost to Follow-up|0|||
44521285|NCT03798717|79529546|FG003|Overall Study|Lost to Follow-up|1|||
44398616|NCT02821754|79405305|FG001|Overall Study|Drug not available.|0|||
44398617|NCT02821754|79405306|FG002|Overall Study|Drug not available.|1|||
44398618|NCT02821754|79405304|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
44398619|NCT02821754|79405305|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
44398620|NCT02821754|79405306|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
44398621|NCT02708108|79405314|FG000|Overall Study|Death|1|||
44398622|NCT02708108|79405315|FG001|Overall Study|Death|2|||
44398623|NCT02708108|79405314|FG000|Overall Study|Regimen change|1|||
44398624|NCT02708108|79405315|FG001|Overall Study|Regimen change|0|||
44398625|NCT02708108|79405314|FG000|Overall Study|No MRD and no imaging available|0|||
44398626|NCT02708108|79405315|FG001|Overall Study|No MRD and no imaging available|1|||
44398627|NCT02617589|79405324|FG000|Randomization|Request to Discontinue Study Treatment|1|||
44398628|NCT02617589|79405325|FG001|Randomization|Request to Discontinue Study Treatment|3|||
44398629|NCT02617589|79405324|FG000|Randomization|Participant Withdrew Consent|1|||
44398630|NCT02617589|79405325|FG001|Randomization|Participant Withdrew Consent|2|||
44398631|NCT02617589|79405324|FG000|Treatment|Other Reasons|3|||
44398632|NCT02617589|79405325|FG001|Treatment|Other Reasons|3|||
44398633|NCT02617589|79405324|FG000|Treatment|Poor/Non Compliance|1|||
44398634|NCT02617589|79405325|FG001|Treatment|Poor/Non Compliance|1|||
44398635|NCT02617589|79405324|FG000|Treatment|Maximum Clinical Benefit|0|||
44398636|NCT02617589|79405325|FG001|Treatment|Maximum Clinical Benefit|2|||
44398637|NCT02617589|79405324|FG000|Treatment|Participant Withdrew Consent|2|||
44398638|NCT02617589|79405325|FG001|Treatment|Participant Withdrew Consent|6|||
44398639|NCT02617589|79405324|FG000|Treatment|Participant Request to Discontinue|12|||
44398640|NCT02617589|79405325|FG001|Treatment|Participant Request to Discontinue|21|||
44398641|NCT02617589|79405324|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
44398642|NCT02617589|79405325|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
44398643|NCT02617589|79405324|FG000|Treatment|Death|1|||
44398644|NCT02617589|79405325|FG001|Treatment|Death|1|||
44398645|NCT02617589|79405324|FG000|Treatment|Study Drug Toxicity|27|||
44398646|NCT02617589|79405325|FG001|Treatment|Study Drug Toxicity|20|||
44398647|NCT02617589|79405324|FG000|Treatment|Disease Progression|216|||
44398648|NCT02617589|79405325|FG001|Treatment|Disease Progression|136|||
44398649|NCT02471807|79405331|FG000|Overall Study|Death|14|||
44398650|NCT02471807|79405331|FG000|Overall Study|Withdrawal by Subject|2|||
44398651|NCT02471807|79405331|FG000|Overall Study|Explant|5|||
44398652|NCT02471807|79405331|FG000|Overall Study|Lost to Follow-up|1|||
44521286|NCT03798717|79529547|FG004|Overall Study|Lost to Follow-up|0|||
44398653|NCT01899326|79405351|FG000|Overall Study|Withdrawal by Subject|1|||
44398654|NCT01899326|79405351|FG000|Overall Study|Adverse Event|2|||
44398655|NCT01899326|79405351|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
44398656|NCT01572480|79405356|FG000|Participants Enrolled|Withdrawal by Subject|1|||
44398657|NCT01572480|79405356|FG000|Drug Administration|Discontinued drug/Off Study|1|||
44398658|NCT01572480|79405356|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
44521287|NCT03798717|79529548|FG005|Overall Study|Lost to Follow-up|0|||
44521288|NCT03798717|79529543|FG000|Overall Study|Adverse Event|0|||
44521289|NCT03798717|79529544|FG001|Overall Study|Adverse Event|1|||
44398659|NCT01572480|79405356|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
44398660|NCT01126190|79405363|FG000|Double-Blind Phase|Death|0|||
44398661|NCT01126190|79405364|FG001|Double-Blind Phase|Death|1|||
44398662|NCT01126190|79405365|FG002|Double-Blind Phase|Death|0|||
44398663|NCT01126190|79405363|FG000|Double-Blind Phase|Adverse Event|1|||
44398664|NCT01126190|79405364|FG001|Double-Blind Phase|Adverse Event|2|||
44398665|NCT01126190|79405365|FG002|Double-Blind Phase|Adverse Event|0|||
44398666|NCT01126190|79405363|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
44398667|NCT01126190|79405364|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
44398668|NCT01126190|79405365|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
44398669|NCT01126190|79405363|FG000|Double-Blind Phase|Request of Investigator|1|||
44398670|NCT01126190|79405364|FG001|Double-Blind Phase|Request of Investigator|0|||
44398671|NCT01126190|79405365|FG002|Double-Blind Phase|Request of Investigator|0|||
44398672|NCT01126190|79405363|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
44398673|NCT01126190|79405364|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
44398674|NCT01126190|79405365|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
44398675|NCT01126190|79405363|FG000|Double-Blind Phase|Non-compliance|1|||
44398676|NCT01126190|79405364|FG001|Double-Blind Phase|Non-compliance|0|||
44398677|NCT01126190|79405365|FG002|Double-Blind Phase|Non-compliance|0|||
44398678|NCT01126190|79405363|FG000|Double-Blind Phase|Lost to Follow-up|1|||
44398679|NCT01126190|79405364|FG001|Double-Blind Phase|Lost to Follow-up|3|||
44398680|NCT01126190|79405365|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44398681|NCT01126190|79405363|FG000|Open-Label Phase|Death|0|||
44398682|NCT01126190|79405364|FG001|Open-Label Phase|Death|0|||
44398683|NCT01126190|79405365|FG002|Open-Label Phase|Death|1|||
44398684|NCT01126190|79405363|FG000|Open-Label Phase|Adverse Event|0|||
44398685|NCT01126190|79405364|FG001|Open-Label Phase|Adverse Event|0|||
44398686|NCT01126190|79405365|FG002|Open-Label Phase|Adverse Event|4|||
44398687|NCT01126190|79405363|FG000|Open-Label Phase|Withdrawal by Subject|0|||
44398688|NCT01126190|79405364|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44398689|NCT01126190|79405365|FG002|Open-Label Phase|Withdrawal by Subject|6|||
44398690|NCT00939185|79405398|FG000|Overall Study|Adverse Event|3|||
44398691|NCT00939185|79405398|FG000|Overall Study|Lack of Efficacy|1|||
44398692|NCT00939185|79405398|FG000|Overall Study|Lost to Follow-up|6|||
44398693|NCT00939185|79405398|FG000|Overall Study|Other|3|||
44398694|NCT00939185|79405398|FG000|Overall Study|Withdrawal by Subject|2|||
44398695|NCT00939185|79405398|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
44398696|NCT03977155|79405405|FG000|Overall Study|Adverse Event|3|||
44398697|NCT03977155|79405406|FG001|Overall Study|Adverse Event|0|||
44398698|NCT03977155|79405407|FG002|Overall Study|Adverse Event|0|||
44398699|NCT03977155|79405405|FG000|Overall Study|Lost to Follow-up|0|||
44398700|NCT03977155|79405406|FG001|Overall Study|Lost to Follow-up|1|||
44398701|NCT03977155|79405407|FG002|Overall Study|Lost to Follow-up|0|||
44398702|NCT03977155|79405405|FG000|Overall Study|Withdrawal by Subject|1|||
44398703|NCT03977155|79405406|FG001|Overall Study|Withdrawal by Subject|1|||
44398704|NCT03977155|79405407|FG002|Overall Study|Withdrawal by Subject|2|||
44398705|NCT03977155|79405405|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
44398706|NCT03977155|79405406|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
44398707|NCT03977155|79405407|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
44398708|NCT00930059|79405432|FG000|Overall Study|Death|1|||
44398709|NCT00930059|79405433|FG001|Overall Study|Death|0|||
44398710|NCT00930059|79405432|FG000|Overall Study|Did not meet entrance criteria|1|||
44398711|NCT00930059|79405433|FG001|Overall Study|Did not meet entrance criteria|1|||
44398712|NCT00930059|79405432|FG000|Overall Study|Withdrawal by Subject|3|||
44398713|NCT00930059|79405433|FG001|Overall Study|Withdrawal by Subject|4|||
44398714|NCT00930059|79405432|FG000|Overall Study|Other|1|||
44398715|NCT00930059|79405433|FG001|Overall Study|Other|0|||
44398716|NCT00930059|79405432|FG000|Overall Study|1 site terminated by sponsor|1|||
44398717|NCT00930059|79405433|FG001|Overall Study|1 site terminated by sponsor|1|||
44398718|NCT00930059|79405432|FG000|Overall Study|Adverse Event|1|||
44398719|NCT00930059|79405433|FG001|Overall Study|Adverse Event|6|||
44398720|NCT00772005|79405452|FG000|Overall Study|Adverse Event|9|||
44398721|NCT00772005|79405453|FG001|Overall Study|Adverse Event|14|||
44398722|NCT00772005|79405454|FG002|Overall Study|Adverse Event|10|||
44398723|NCT00772005|79405455|FG003|Overall Study|Adverse Event|13|||
44398724|NCT00772005|79405452|FG000|Overall Study|Lack of Efficacy|0|||
44398725|NCT00772005|79405453|FG001|Overall Study|Lack of Efficacy|1|||
44398726|NCT00772005|79405454|FG002|Overall Study|Lack of Efficacy|0|||
44398727|NCT00772005|79405455|FG003|Overall Study|Lack of Efficacy|0|||
44398728|NCT00772005|79405452|FG000|Overall Study|Withdrawal by Subject|3|||
44398729|NCT00772005|79405453|FG001|Overall Study|Withdrawal by Subject|7|||
44398730|NCT00772005|79405454|FG002|Overall Study|Withdrawal by Subject|10|||
44398731|NCT00772005|79405455|FG003|Overall Study|Withdrawal by Subject|2|||
44398732|NCT00772005|79405452|FG000|Overall Study|Protocol Violation|2|||
44398733|NCT00772005|79405453|FG001|Overall Study|Protocol Violation|4|||
44398734|NCT00772005|79405454|FG002|Overall Study|Protocol Violation|1|||
44398735|NCT00772005|79405455|FG003|Overall Study|Protocol Violation|6|||
44398736|NCT00772005|79405452|FG000|Overall Study|Lost to Follow-up|7|||
44398737|NCT00772005|79405453|FG001|Overall Study|Lost to Follow-up|3|||
44398738|NCT00772005|79405454|FG002|Overall Study|Lost to Follow-up|6|||
44398739|NCT00772005|79405455|FG003|Overall Study|Lost to Follow-up|3|||
44398740|NCT00772005|79405452|FG000|Overall Study|Non-compliance with study procedures|1|||
44398741|NCT00772005|79405453|FG001|Overall Study|Non-compliance with study procedures|1|||
44398742|NCT00772005|79405454|FG002|Overall Study|Non-compliance with study procedures|0|||
44398743|NCT00772005|79405455|FG003|Overall Study|Non-compliance with study procedures|1|||
44398744|NCT00772005|79405452|FG000|Overall Study|Non-compliance with drug administration|3|||
44398745|NCT00772005|79405453|FG001|Overall Study|Non-compliance with drug administration|0|||
44398746|NCT00772005|79405454|FG002|Overall Study|Non-compliance with drug administration|1|||
44398747|NCT00772005|79405455|FG003|Overall Study|Non-compliance with drug administration|1|||
44398748|NCT00939107|79405467|FG000|Overall Study|Lost to Follow-up|14|||
44398749|NCT00939107|79405468|FG001|Overall Study|Lost to Follow-up|12|||
44398750|NCT00927485|79405476|FG000|Overall Study|Adverse Event|4|||
44398751|NCT00927485|79405477|FG001|Overall Study|Adverse Event|2|||
44398752|NCT00927485|79405476|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
44398753|NCT00927485|79405477|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
44398754|NCT00927251|79405483|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
44398755|NCT00927095|79405490|FG000|Overall Study|Adverse Event|3|||
44398756|NCT00927095|79405491|FG001|Overall Study|Adverse Event|1|||
44398757|NCT00927095|79405492|FG002|Overall Study|Adverse Event|0|||
44398758|NCT00927095|79405490|FG000|Overall Study|Withdrawal by Subject|2|||
44398759|NCT00927095|79405491|FG001|Overall Study|Withdrawal by Subject|1|||
44398760|NCT00927095|79405492|FG002|Overall Study|Withdrawal by Subject|1|||
44398761|NCT00927095|79405490|FG000|Overall Study|Physician Decision|1|||
44398762|NCT00927095|79405491|FG001|Overall Study|Physician Decision|2|||
44398763|NCT00927095|79405492|FG002|Overall Study|Physician Decision|1|||
44398764|NCT00932165|79405500|FG000|Overall Study|Lost to Follow-up|1|||
44398765|NCT04888494|79405507|FG000|Overall Study|Lost to Follow-up|2|||
44398766|NCT04888494|79405508|FG001|Overall Study|Lost to Follow-up|3|||
44398767|NCT04888494|79405507|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
44398768|NCT04888494|79405508|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
44398769|NCT04573972|79405570|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
44398770|NCT04573972|79405571|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
44398771|NCT04391309|79405599|FG000|Overall Study|Death|1|||
44398772|NCT04391309|79405600|FG001|Overall Study|Death|1|||
44398773|NCT04391309|79405599|FG000|Overall Study|Lost to Follow-up|3|||
44398774|NCT04391309|79405600|FG001|Overall Study|Lost to Follow-up|2|||
44398775|NCT04391309|79405599|FG000|Overall Study|Withdrawal by Subject|2|||
44398776|NCT04391309|79405600|FG001|Overall Study|Withdrawal by Subject|2|||
44398777|NCT04202965|79405615|FG000|Overall Study|Adverse Event|3|||
44398778|NCT04202965|79405615|FG000|Overall Study|Did not meet inclusion criteria|1|||
44398779|NCT04056624|79405623|FG000|Overall Study|Withdrawal by Subject|0|||
44398780|NCT04056624|79405624|FG001|Overall Study|Withdrawal by Subject|0|||
44398781|NCT04056624|79405625|FG002|Overall Study|Withdrawal by Subject|1|||
44398782|NCT04056624|79405623|FG000|Overall Study|Protocol Violation|1|||
44398783|NCT04056624|79405624|FG001|Overall Study|Protocol Violation|2|||
44398784|NCT04056624|79405625|FG002|Overall Study|Protocol Violation|0|||
44398785|NCT03870763|79405645|FG000|Overall Study|Study terminated by sponsor|0|||
44398786|NCT03870763|79405646|FG001|Overall Study|Study terminated by sponsor|2|||
44398787|NCT03870763|79405647|FG002|Overall Study|Study terminated by sponsor|0|||
44398788|NCT03870763|79405645|FG000|Overall Study|Withdrawal by Subject|0|||
44398789|NCT03870763|79405646|FG001|Overall Study|Withdrawal by Subject|1|||
44398790|NCT03870763|79405647|FG002|Overall Study|Withdrawal by Subject|0|||
44398791|NCT03870763|79405645|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
44398792|NCT03870763|79405646|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
44398793|NCT03870763|79405647|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
44398794|NCT03647501|79405657|FG000|Overall Study|Lost to Follow-up|1|||
44398795|NCT03647501|79405658|FG001|Overall Study|Lost to Follow-up|1|||
44398796|NCT03647501|79405657|FG000|Overall Study|Withdrawal by Subject|0|||
44398797|NCT03647501|79405658|FG001|Overall Study|Withdrawal by Subject|1|||
44398798|NCT03587142|79405690|FG000|Overall Study|Lost to Follow-up|5|||
44398799|NCT03587142|79405691|FG001|Overall Study|Lost to Follow-up|3|||
44398800|NCT03587142|79405690|FG000|Overall Study|Did not complete the f4 visit|3|||
44398801|NCT03587142|79405691|FG001|Overall Study|Did not complete the f4 visit|7|||
44398802|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
44521290|NCT03798717|79529545|FG002|Overall Study|Adverse Event|0|||
44398803|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
44398804|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
44398805|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
44398806|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
44398807|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
44521291|NCT03798717|79529546|FG003|Overall Study|Adverse Event|0|||
44521292|NCT03798717|79529547|FG004|Overall Study|Adverse Event|0|||
44521293|NCT03798717|79529548|FG005|Overall Study|Adverse Event|0|||
44521294|NCT03798717|79529543|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
44521295|NCT03798717|79529544|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
44521296|NCT03798717|79529545|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
44521297|NCT03798717|79529546|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
44521298|NCT03798717|79529547|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
44521299|NCT03798717|79529548|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
44521300|NCT03798483|79529557|FG000|Overall Study|Lost to Follow-up|2|||
44521301|NCT03792477|79529570|FG000|Overall Study|Adverse Event|0|||
44521302|NCT03792477|79529571|FG001|Overall Study|Adverse Event|0|||
44398808|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
44398809|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
44398810|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
44398811|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
44398812|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
44398813|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
44398814|NCT03493854|79405699|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
44398815|NCT03493854|79405700|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
44398816|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
44398817|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
44521303|NCT03792477|79529572|FG002|Overall Study|Adverse Event|0|||
44521304|NCT03792477|79529573|FG003|Overall Study|Adverse Event|1|||
44521305|NCT03792477|79529574|FG004|Overall Study|Adverse Event|0|||
44521306|NCT03792477|79529570|FG000|Overall Study|Lost to Follow-up|0|||
44521307|NCT03792477|79529571|FG001|Overall Study|Lost to Follow-up|0|||
44521308|NCT03792477|79529572|FG002|Overall Study|Lost to Follow-up|2|||
44521309|NCT03792477|79529573|FG003|Overall Study|Lost to Follow-up|0|||
44521310|NCT03792477|79529574|FG004|Overall Study|Lost to Follow-up|0|||
44398818|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
44398819|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
44521311|NCT03792477|79529570|FG000|Overall Study|Other|0|||
44521312|NCT03792477|79529571|FG001|Overall Study|Other|0|||
44521313|NCT03792477|79529572|FG002|Overall Study|Other|0|||
44521314|NCT03792477|79529573|FG003|Overall Study|Other|0|||
44521315|NCT03792477|79529574|FG004|Overall Study|Other|1|||
44521316|NCT03790917|79529580|FG000|Overall Study|Death|1|||
44521317|NCT03788967|79529587|FG000|Overall Study|Lost to Follow-up|14|||
44521318|NCT03788967|79529588|FG001|Overall Study|Lost to Follow-up|10|||
44521319|NCT03788967|79529587|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
44521320|NCT03788967|79529588|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
44521321|NCT03788967|79529587|FG000|Overall Study|Participant Withdrawal of Consent|13|||
44521322|NCT03788967|79529588|FG001|Overall Study|Participant Withdrawal of Consent|5|||
44398820|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
44398821|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
44398822|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
44398823|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
44398824|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
44398825|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
44398826|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
44398827|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
44398828|NCT03493854|79405699|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
44398829|NCT03493854|79405700|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
44398830|NCT03493854|79405699|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
44398831|NCT03493854|79405700|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
44398832|NCT03493854|79405699|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
44398833|NCT03493854|79405700|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
44398834|NCT03188705|79405706|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
44398835|NCT03188705|79405706|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
44398836|NCT03032484|79405711|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
44398837|NCT03032484|79405712|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
44398838|NCT03032484|79405711|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
44398839|NCT03032484|79405712|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
44521323|NCT03788967|79529587|FG000|Overall Study|Adverse Event|1|||
44521324|NCT03788967|79529588|FG001|Overall Study|Adverse Event|1|||
44521325|NCT03788967|79529587|FG000|Overall Study|COVID-19|1|||
44521326|NCT03788967|79529588|FG001|Overall Study|COVID-19|2|||
44521327|NCT03782571|79529596|FG000|Period 1|Withdrawal by Subject|1|||
44521328|NCT03782571|79529597|FG001|Period 1|Withdrawal by Subject|0|||
44521329|NCT03782571|79529598|FG002|Period 1|Withdrawal by Subject|0|||
44521330|NCT03782571|79529599|FG003|Period 1|Withdrawal by Subject|0|||
44521331|NCT03782571|79529596|FG000|Period 3|Subject Unable to Attend V5|1|||
44521332|NCT03782571|79529597|FG001|Period 3|Subject Unable to Attend V5|0|||
44521333|NCT03782571|79529598|FG002|Period 3|Subject Unable to Attend V5|0|||
44521334|NCT03782571|79529599|FG003|Period 3|Subject Unable to Attend V5|0|||
44521335|NCT03782571|79529596|FG000|Period 3|Adverse Event|1|||
44521336|NCT03782571|79529597|FG001|Period 3|Adverse Event|0|||
44521337|NCT03782571|79529598|FG002|Period 3|Adverse Event|0|||
44521338|NCT03782571|79529599|FG003|Period 3|Adverse Event|0|||
44521339|NCT03783039|79529613|FG000|Overall Study|Death|2|||
44521340|NCT03783039|79529614|FG001|Overall Study|Death|1|||
44521341|NCT03776175|79529624|FG000|Treatment Period (42 Days)|Adverse Event|0|||
44521342|NCT03776175|79529625|FG001|Treatment Period (42 Days)|Adverse Event|1|||
44521343|NCT03776175|79529626|FG002|Treatment Period (42 Days)|Adverse Event|1|||
44521344|NCT03776175|79529627|FG003|Treatment Period (42 Days)|Adverse Event|0|||
44521345|NCT03776175|79529624|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
44521346|NCT03776175|79529625|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
44521347|NCT03776175|79529626|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
44521348|NCT03776175|79529627|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
44521349|NCT03776175|79529624|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
44521350|NCT03776175|79529625|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
44521351|NCT03776175|79529626|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
44521352|NCT03776175|79529627|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
44521353|NCT03776175|79529624|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
44521354|NCT03776175|79529625|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
44521355|NCT03776175|79529626|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
44521356|NCT03776175|79529627|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
44521357|NCT03776175|79529624|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
44521358|NCT03776175|79529625|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
44521359|NCT03776175|79529626|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
44521360|NCT03776175|79529627|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
44521361|NCT03776175|79529624|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
44521362|NCT03776175|79529625|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
44398840|NCT02975349|79405721|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44398841|NCT02975349|79405722|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44398842|NCT02975349|79405723|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
44398843|NCT02975349|79405724|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
44398844|NCT02975349|79405725|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44398845|NCT02975349|79405726|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44398846|NCT02975349|79405721|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
44521363|NCT03776175|79529626|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
44521364|NCT03776175|79529627|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
44147359|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
44147360|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
44147361|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
44147362|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
44398847|NCT02975349|79405722|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44398848|NCT02975349|79405723|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44398849|NCT02975349|79405724|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44398850|NCT02975349|79405725|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44398851|NCT02975349|79405726|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44398852|NCT02975349|79405721|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
44398853|NCT02975349|79405722|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
44521365|NCT02903914|79529645|FG000|Overall Study|Adverse Event|0|||
44521366|NCT02903914|79529646|FG001|Overall Study|Adverse Event|0|||
44521367|NCT02903914|79529647|FG002|Overall Study|Adverse Event|1|||
44521368|NCT02903914|79529648|FG003|Overall Study|Adverse Event|0|||
44521369|NCT02903914|79529649|FG004|Overall Study|Adverse Event|0|||
44521370|NCT02903914|79529650|FG005|Overall Study|Adverse Event|1|||
44521371|NCT02903914|79529651|FG006|Overall Study|Adverse Event|2|||
44521372|NCT02903914|79529652|FG007|Overall Study|Adverse Event|1|||
44521373|NCT02903914|79529645|FG000|Overall Study|Withdrawal by Subject|3|||
44521374|NCT02903914|79529646|FG001|Overall Study|Withdrawal by Subject|1|||
44521375|NCT02903914|79529647|FG002|Overall Study|Withdrawal by Subject|28|||
44521376|NCT02903914|79529648|FG003|Overall Study|Withdrawal by Subject|0|||
44521377|NCT02903914|79529649|FG004|Overall Study|Withdrawal by Subject|1|||
44147363|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
44521378|NCT02903914|79529650|FG005|Overall Study|Withdrawal by Subject|1|||
44521379|NCT02903914|79529651|FG006|Overall Study|Withdrawal by Subject|12|||
44521380|NCT02903914|79529652|FG007|Overall Study|Withdrawal by Subject|0|||
44521381|NCT02903914|79529645|FG000|Overall Study|Progressive Disease|1|||
44521382|NCT02903914|79529646|FG001|Overall Study|Progressive Disease|0|||
44521383|NCT02903914|79529647|FG002|Overall Study|Progressive Disease|4|||
44521384|NCT02903914|79529648|FG003|Overall Study|Progressive Disease|0|||
44398854|NCT02975349|79405723|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
44398855|NCT02975349|79405724|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
44398856|NCT02975349|79405725|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
44398857|NCT02975349|79405726|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
44398858|NCT02975349|79405721|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
44398859|NCT02975349|79405722|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
44398860|NCT02975349|79405723|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
44398861|NCT02975349|79405724|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
44398862|NCT02975349|79405725|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
44398863|NCT02975349|79405726|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
44398864|NCT02975349|79405721|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
44398865|NCT02975349|79405722|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
44398866|NCT02975349|79405723|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
44398867|NCT02975349|79405724|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
44398868|NCT02975349|79405725|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
44398869|NCT02975349|79405726|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
44398870|NCT02975349|79405721|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
44398871|NCT02975349|79405722|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
44398872|NCT02975349|79405723|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
44398873|NCT02975349|79405724|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
44398874|NCT02975349|79405725|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
44398875|NCT02975349|79405726|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
44398876|NCT02975349|79405721|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
44398877|NCT02975349|79405722|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
44398878|NCT02975349|79405723|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
44398879|NCT02975349|79405724|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
44398880|NCT02975349|79405725|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
44398881|NCT02975349|79405726|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
44398882|NCT02975349|79405721|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
44398883|NCT02975349|79405722|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
44398884|NCT02975349|79405723|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
44398885|NCT02975349|79405724|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
44398886|NCT02975349|79405725|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
44398887|NCT02975349|79405726|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
44398888|NCT02975349|79405721|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
44398889|NCT02975349|79405722|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
44398890|NCT02975349|79405723|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
44398891|NCT02975349|79405724|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
44398892|NCT02975349|79405725|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
44398893|NCT02975349|79405726|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
44398894|NCT02520141|79405797|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
44398895|NCT02329847|79405809|FG000|Overall Study|Death|4|||
44398896|NCT02329847|79405810|FG001|Overall Study|Death|4|||
44398897|NCT02329847|79405811|FG002|Overall Study|Death|22|||
44398898|NCT02329847|79405812|FG003|Overall Study|Death|12|||
44398899|NCT02329847|79405813|FG004|Overall Study|Death|20|||
44398900|NCT02329847|79405814|FG005|Overall Study|Death|13|||
44398901|NCT02329847|79405809|FG000|Overall Study|Lost to Follow-up|0|||
44398902|NCT02329847|79405810|FG001|Overall Study|Lost to Follow-up|0|||
44398903|NCT02329847|79405811|FG002|Overall Study|Lost to Follow-up|2|||
44398904|NCT02329847|79405812|FG003|Overall Study|Lost to Follow-up|3|||
44398905|NCT02329847|79405813|FG004|Overall Study|Lost to Follow-up|0|||
44398906|NCT02329847|79405814|FG005|Overall Study|Lost to Follow-up|1|||
44398907|NCT02329847|79405809|FG000|Overall Study|Physician Decision|0|||
44398908|NCT02329847|79405810|FG001|Overall Study|Physician Decision|0|||
44398909|NCT02329847|79405811|FG002|Overall Study|Physician Decision|0|||
44398910|NCT02329847|79405812|FG003|Overall Study|Physician Decision|0|||
44398911|NCT02329847|79405813|FG004|Overall Study|Physician Decision|1|||
44398912|NCT02329847|79405814|FG005|Overall Study|Physician Decision|0|||
44398913|NCT02329847|79405809|FG000|Overall Study|Withdrawal by Subject|2|||
44521385|NCT02903914|79529649|FG004|Overall Study|Progressive Disease|0|||
44398914|NCT02329847|79405810|FG001|Overall Study|Withdrawal by Subject|1|||
44398915|NCT02329847|79405811|FG002|Overall Study|Withdrawal by Subject|5|||
44398916|NCT02329847|79405812|FG003|Overall Study|Withdrawal by Subject|7|||
44398917|NCT02329847|79405813|FG004|Overall Study|Withdrawal by Subject|8|||
44398918|NCT02329847|79405814|FG005|Overall Study|Withdrawal by Subject|3|||
44398919|NCT02329847|79405809|FG000|Overall Study|Other|1|||
44398920|NCT02329847|79405810|FG001|Overall Study|Other|2|||
44521386|NCT02903914|79529650|FG005|Overall Study|Progressive Disease|0|||
44521387|NCT02903914|79529651|FG006|Overall Study|Progressive Disease|2|||
44521388|NCT02903914|79529652|FG007|Overall Study|Progressive Disease|4|||
44521389|NCT02903914|79529645|FG000|Overall Study|Death|0|||
44521390|NCT02903914|79529646|FG001|Overall Study|Death|0|||
44521391|NCT02903914|79529647|FG002|Overall Study|Death|9|||
44521392|NCT02903914|79529648|FG003|Overall Study|Death|0|||
44521393|NCT02903914|79529649|FG004|Overall Study|Death|1|||
44521394|NCT02903914|79529650|FG005|Overall Study|Death|3|||
44521395|NCT02903914|79529651|FG006|Overall Study|Death|24|||
44521396|NCT02903914|79529652|FG007|Overall Study|Death|0|||
44521397|NCT02903914|79529645|FG000|Overall Study|Lost to Follow-up|0|||
44521398|NCT02903914|79529646|FG001|Overall Study|Lost to Follow-up|1|||
44521399|NCT02903914|79529647|FG002|Overall Study|Lost to Follow-up|0|||
44521400|NCT02903914|79529648|FG003|Overall Study|Lost to Follow-up|0|||
44521401|NCT02903914|79529649|FG004|Overall Study|Lost to Follow-up|2|||
44521402|NCT02903914|79529650|FG005|Overall Study|Lost to Follow-up|0|||
44521403|NCT02903914|79529651|FG006|Overall Study|Lost to Follow-up|1|||
44521404|NCT02903914|79529652|FG007|Overall Study|Lost to Follow-up|0|||
44521405|NCT02903914|79529645|FG000|Overall Study|Physician Decision|0|||
44521406|NCT02903914|79529646|FG001|Overall Study|Physician Decision|0|||
44521407|NCT02903914|79529647|FG002|Overall Study|Physician Decision|1|||
44521408|NCT02903914|79529648|FG003|Overall Study|Physician Decision|0|||
44398921|NCT02329847|79405811|FG002|Overall Study|Other|6|||
44398922|NCT02329847|79405812|FG003|Overall Study|Other|13|||
44398923|NCT02329847|79405813|FG004|Overall Study|Other|10|||
44398924|NCT02329847|79405814|FG005|Overall Study|Other|3|||
44398925|NCT02314624|79405835|FG000|Overall Study|No participating patient|16|||
44398926|NCT02314624|79405836|FG001|Overall Study|No participating patient|13|||
44521409|NCT02903914|79529649|FG004|Overall Study|Physician Decision|0|||
44521410|NCT02903914|79529650|FG005|Overall Study|Physician Decision|0|||
44398927|NCT02314624|79405835|FG000|Overall Study|Participant withdrew|7|||
44398928|NCT02314624|79405836|FG001|Overall Study|Participant withdrew|2|||
44398929|NCT02314624|79405835|FG000|Overall Study|Lost to Follow-up|2|||
44398930|NCT02314624|79405836|FG001|Overall Study|Lost to Follow-up|5|||
44398931|NCT02314624|79405835|FG000|Overall Study|Dropped/Excluded by PI|6|||
44521411|NCT02903914|79529651|FG006|Overall Study|Physician Decision|1|||
44398932|NCT02314624|79405836|FG001|Overall Study|Dropped/Excluded by PI|6|||
44521412|NCT02903914|79529652|FG007|Overall Study|Physician Decision|0|||
44521413|NCT02903914|79529645|FG000|Overall Study|Symptomatic Deterioration|0|||
44521414|NCT02903914|79529646|FG001|Overall Study|Symptomatic Deterioration|0|||
44521415|NCT02903914|79529647|FG002|Overall Study|Symptomatic Deterioration|1|||
44521416|NCT02903914|79529648|FG003|Overall Study|Symptomatic Deterioration|0|||
44521417|NCT02903914|79529649|FG004|Overall Study|Symptomatic Deterioration|0|||
44521418|NCT02903914|79529650|FG005|Overall Study|Symptomatic Deterioration|0|||
44521419|NCT02903914|79529651|FG006|Overall Study|Symptomatic Deterioration|0|||
44521420|NCT02903914|79529652|FG007|Overall Study|Symptomatic Deterioration|0|||
44398933|NCT01419080|79405865|FG000|Overall Study|Withdrawal by Subject|75|||
44398934|NCT01419080|79405865|FG000|Overall Study|Death|30|||
44398935|NCT01419080|79405865|FG000|Overall Study|Lost to Follow-up|23|||
44398936|NCT01419080|79405865|FG000|Overall Study|Too Ill|3|||
44398937|NCT01164228|79405873|FG000|Overall Study|Progression|24|||
44398938|NCT01164228|79405874|FG001|Overall Study|Progression|25|||
44398939|NCT01164228|79405873|FG000|Overall Study|Adverse Event|13|||
44398940|NCT01164228|79405874|FG001|Overall Study|Adverse Event|7|||
44398941|NCT01164228|79405873|FG000|Overall Study|Death|1|||
44398942|NCT01164228|79405874|FG001|Overall Study|Death|1|||
44398943|NCT01164228|79405873|FG000|Overall Study|Withdrawal by Subject|2|||
44398944|NCT01164228|79405874|FG001|Overall Study|Withdrawal by Subject|0|||
44398945|NCT01164228|79405873|FG000|Overall Study|Physician Decision|1|||
44398946|NCT01164228|79405874|FG001|Overall Study|Physician Decision|2|||
44398947|NCT01164228|79405873|FG000|Overall Study|Symptomatic deterioration|1|||
44398948|NCT01164228|79405874|FG001|Overall Study|Symptomatic deterioration|0|||
44398949|NCT01164228|79405873|FG000|Overall Study|Never started treatment|1|||
44521421|NCT02903914|79529645|FG000|Overall Study|New Cancer Therapy|2|||
44521422|NCT02903914|79529646|FG001|Overall Study|New Cancer Therapy|2|||
44521423|NCT02903914|79529647|FG002|Overall Study|New Cancer Therapy|21|||
44521424|NCT02903914|79529648|FG003|Overall Study|New Cancer Therapy|4|||
44398950|NCT01164228|79405874|FG001|Overall Study|Never started treatment|3|||
44398951|NCT01164228|79405873|FG000|Overall Study|Ineligible|1|||
44398952|NCT01164228|79405874|FG001|Overall Study|Ineligible|0|||
44398953|NCT00554515|79405880|FG000|Overall Study|Withdrawal by Subject|3|||
44398954|NCT00554515|79405880|FG000|Overall Study|Disease progression|52|||
44521425|NCT02903914|79529649|FG004|Overall Study|New Cancer Therapy|3|||
44521426|NCT02903914|79529650|FG005|Overall Study|New Cancer Therapy|6|||
44521427|NCT02903914|79529651|FG006|Overall Study|New Cancer Therapy|55|||
44521428|NCT02903914|79529652|FG007|Overall Study|New Cancer Therapy|0|||
44398955|NCT00554515|79405880|FG000|Overall Study|Physician Decision|18|||
44521429|NCT02903914|79529645|FG000|Overall Study|Reasoning not specified|2|||
44521430|NCT02903914|79529646|FG001|Overall Study|Reasoning not specified|3|||
44521431|NCT02903914|79529647|FG002|Overall Study|Reasoning not specified|20|||
44398956|NCT00554515|79405880|FG000|Overall Study|Withdrawal by Subject|11|||
44398957|NCT00554515|79405880|FG000|Overall Study|Adverse Event|9|||
44398958|NCT00554515|79405880|FG000|Overall Study|Death|2|||
44398959|NCT00554515|79405880|FG000|Overall Study|Achieved Stable Disease|7|||
44398960|NCT00554515|79405880|FG000|Overall Study|Other|1|||
44398961|NCT00554515|79405880|FG000|Overall Study|Misc|15|||
44398962|NCT00049517|79405907|FG000|Induction|Disease progression|0|||
44398963|NCT00049517|79405908|FG001|Induction|Disease progression|0|||
44398964|NCT00049517|79405909|FG002|Induction|Disease progression|0|||
44398965|NCT00049517|79405910|FG003|Induction|Disease progression|0|||
44398966|NCT00049517|79405911|FG004|Induction|Disease progression|18|||
44398967|NCT00049517|79405912|FG005|Induction|Disease progression|11|||
44398968|NCT00049517|79405907|FG000|Induction|Adverse Event|0|||
44398969|NCT00049517|79405908|FG001|Induction|Adverse Event|0|||
44398970|NCT00049517|79405909|FG002|Induction|Adverse Event|0|||
44398971|NCT00049517|79405910|FG003|Induction|Adverse Event|0|||
44398972|NCT00049517|79405911|FG004|Induction|Adverse Event|5|||
44398973|NCT00049517|79405912|FG005|Induction|Adverse Event|7|||
44398974|NCT00049517|79405907|FG000|Induction|Death|0|||
44398975|NCT00049517|79405908|FG001|Induction|Death|0|||
44398976|NCT00049517|79405909|FG002|Induction|Death|0|||
44398977|NCT00049517|79405910|FG003|Induction|Death|0|||
44398978|NCT00049517|79405911|FG004|Induction|Death|9|||
44147364|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
44147365|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
44398979|NCT00049517|79405912|FG005|Induction|Death|6|||
44398980|NCT00049517|79405907|FG000|Induction|Withdrawal by Subject|0|||
44398981|NCT00049517|79405908|FG001|Induction|Withdrawal by Subject|0|||
44398982|NCT00049517|79405909|FG002|Induction|Withdrawal by Subject|0|||
44398983|NCT00049517|79405910|FG003|Induction|Withdrawal by Subject|0|||
44398984|NCT00049517|79405911|FG004|Induction|Withdrawal by Subject|1|||
44398985|NCT00049517|79405912|FG005|Induction|Withdrawal by Subject|3|||
44398986|NCT00049517|79405907|FG000|Induction|Alternative therapy|0|||
44398987|NCT00049517|79405908|FG001|Induction|Alternative therapy|0|||
44398988|NCT00049517|79405909|FG002|Induction|Alternative therapy|0|||
44398989|NCT00049517|79405910|FG003|Induction|Alternative therapy|0|||
44398990|NCT00049517|79405911|FG004|Induction|Alternative therapy|2|||
44398991|NCT00049517|79405912|FG005|Induction|Alternative therapy|2|||
44398992|NCT00049517|79405907|FG000|Induction|Other complicating disease|0|||
44398993|NCT00049517|79405908|FG001|Induction|Other complicating disease|0|||
44398994|NCT00049517|79405909|FG002|Induction|Other complicating disease|0|||
44398995|NCT00049517|79405910|FG003|Induction|Other complicating disease|0|||
44398996|NCT00049517|79405911|FG004|Induction|Other complicating disease|3|||
44398997|NCT00049517|79405912|FG005|Induction|Other complicating disease|0|||
44398998|NCT00049517|79405907|FG000|Induction|Reasons not reported|0|||
44398999|NCT00049517|79405908|FG001|Induction|Reasons not reported|0|||
44399000|NCT00049517|79405909|FG002|Induction|Reasons not reported|0|||
44399001|NCT00049517|79405910|FG003|Induction|Reasons not reported|0|||
44399002|NCT00049517|79405911|FG004|Induction|Reasons not reported|22|||
44399003|NCT00049517|79405912|FG005|Induction|Reasons not reported|25|||
44399004|NCT00049517|79405907|FG000|Conditioning/Transplant|Disease progression|14|||
44399005|NCT00049517|79405908|FG001|Conditioning/Transplant|Disease progression|6|||
44399006|NCT00049517|79405909|FG002|Conditioning/Transplant|Disease progression|10|||
44399007|NCT00049517|79405910|FG003|Conditioning/Transplant|Disease progression|6|||
44399008|NCT00049517|79405911|FG004|Conditioning/Transplant|Disease progression|0|||
44399009|NCT00049517|79405912|FG005|Conditioning/Transplant|Disease progression|0|||
44399010|NCT00049517|79405907|FG000|Conditioning/Transplant|Adverse Event|2|||
44399011|NCT00049517|79405908|FG001|Conditioning/Transplant|Adverse Event|1|||
44399012|NCT00049517|79405909|FG002|Conditioning/Transplant|Adverse Event|4|||
44399013|NCT00049517|79405910|FG003|Conditioning/Transplant|Adverse Event|8|||
44399014|NCT00049517|79405911|FG004|Conditioning/Transplant|Adverse Event|0|||
44399015|NCT00049517|79405912|FG005|Conditioning/Transplant|Adverse Event|0|||
44399016|NCT00049517|79405907|FG000|Conditioning/Transplant|Death|1|||
44399017|NCT00049517|79405908|FG001|Conditioning/Transplant|Death|0|||
44399018|NCT00049517|79405909|FG002|Conditioning/Transplant|Death|0|||
44399019|NCT00049517|79405910|FG003|Conditioning/Transplant|Death|2|||
44521432|NCT02903914|79529648|FG003|Overall Study|Reasoning not specified|3|||
44521433|NCT02903914|79529649|FG004|Overall Study|Reasoning not specified|3|||
44521434|NCT02903914|79529650|FG005|Overall Study|Reasoning not specified|3|||
44147366|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
44399020|NCT00049517|79405911|FG004|Conditioning/Transplant|Death|0|||
44399021|NCT00049517|79405912|FG005|Conditioning/Transplant|Death|0|||
44399022|NCT00049517|79405907|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
44399023|NCT00049517|79405908|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
44399024|NCT00049517|79405909|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
44399025|NCT00049517|79405910|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
44399026|NCT00049517|79405911|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
44399027|NCT00049517|79405912|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
44399028|NCT00049517|79405907|FG000|Conditioning/Transplant|Alternative therapy|4|||
44399029|NCT00049517|79405908|FG001|Conditioning/Transplant|Alternative therapy|4|||
44399030|NCT00049517|79405909|FG002|Conditioning/Transplant|Alternative therapy|2|||
44399031|NCT00049517|79405910|FG003|Conditioning/Transplant|Alternative therapy|1|||
44399032|NCT00049517|79405911|FG004|Conditioning/Transplant|Alternative therapy|1|||
44399033|NCT00049517|79405912|FG005|Conditioning/Transplant|Alternative therapy|0|||
44399034|NCT00049517|79405907|FG000|Conditioning/Transplant|Other complicating disease|2|||
44399035|NCT00049517|79405908|FG001|Conditioning/Transplant|Other complicating disease|0|||
44399036|NCT00049517|79405909|FG002|Conditioning/Transplant|Other complicating disease|0|||
44399037|NCT00049517|79405910|FG003|Conditioning/Transplant|Other complicating disease|4|||
44399038|NCT00049517|79405911|FG004|Conditioning/Transplant|Other complicating disease|0|||
44399039|NCT00049517|79405912|FG005|Conditioning/Transplant|Other complicating disease|1|||
44399040|NCT00049517|79405907|FG000|Conditioning/Transplant|Reasons not reported|25|||
44399041|NCT00049517|79405908|FG001|Conditioning/Transplant|Reasons not reported|31|||
44399042|NCT00049517|79405909|FG002|Conditioning/Transplant|Reasons not reported|18|||
44399043|NCT00049517|79405910|FG003|Conditioning/Transplant|Reasons not reported|15|||
44399044|NCT00049517|79405911|FG004|Conditioning/Transplant|Reasons not reported|5|||
44399045|NCT00049517|79405912|FG005|Conditioning/Transplant|Reasons not reported|5|||
44399046|NCT00926783|79405922|FG000|Overall Study|Incomplete CFAE Procedures|3|||
44399047|NCT00926783|79405923|FG001|Overall Study|Incomplete CFAE Procedures|3|||
44399048|NCT00929669|79405929|FG000|Overall Study|elevated glucose levels|1|||
44399049|NCT00566995|79405933|FG000|Overall Study|Toxicity|4|||
44399050|NCT00566995|79405933|FG000|Overall Study|Withdrew consent|3|||
44399051|NCT00926393|79405939|FG000|Overall Study|Withdrawal by Subject|1|||
44399052|NCT00926393|79405940|FG001|Overall Study|Withdrawal by Subject|2|||
44399053|NCT00926393|79405939|FG000|Overall Study|Adverse Event|1|||
44399054|NCT00926393|79405940|FG001|Overall Study|Adverse Event|1|||
44399055|NCT00926237|79405946|FG000|Overall Study|Withdrawal by Subject|2|||
44399056|NCT00926237|79405947|FG001|Overall Study|Withdrawal by Subject|1|||
44399057|NCT00931463|79405959|FG000|Overall Study|Death|8|||
44399058|NCT00931463|79405960|FG001|Overall Study|Death|4|||
44399059|NCT00931463|79405959|FG000|Overall Study|Withdrawal by Subject|5|||
44399060|NCT00931463|79405960|FG001|Overall Study|Withdrawal by Subject|0|||
44399061|NCT00931463|79405959|FG000|Overall Study|Lost to Follow-up|4|||
44399062|NCT00931463|79405960|FG001|Overall Study|Lost to Follow-up|1|||
44399063|NCT00929201|79405966|FG000|Period 1|Withdrawal by Subject|0|||
44399064|NCT00929201|79405967|FG001|Period 1|Withdrawal by Subject|1|||
44399065|NCT00926003|79405977|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
44399066|NCT00926003|79405978|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
44399067|NCT00926003|79405979|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
44399068|NCT00926003|79405977|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
44399069|NCT00926003|79405978|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
44399070|NCT00926003|79405979|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
44399071|NCT00928889|79405989|FG000|Overall Study|Lost to Follow-up|3|||
44399072|NCT00928889|79405990|FG001|Overall Study|Lost to Follow-up|1|||
44399073|NCT00928889|79405989|FG000|Overall Study|Protocol Violation|0|||
44399074|NCT00928889|79405990|FG001|Overall Study|Protocol Violation|1|||
44399075|NCT00928889|79405989|FG000|Overall Study|Adverse Event|1|||
44399076|NCT00928889|79405990|FG001|Overall Study|Adverse Event|0|||
44399077|NCT00928889|79405989|FG000|Overall Study|Other|1|||
44399078|NCT00928889|79405990|FG001|Overall Study|Other|0|||
44399079|NCT03978091|79406002|FG000|Overall Study|Lost to Follow-up|0|||
44399080|NCT03978091|79406003|FG001|Overall Study|Lost to Follow-up|0|||
44399081|NCT03978091|79406004|FG002|Overall Study|Lost to Follow-up|1|||
44399082|NCT03978091|79406005|FG003|Overall Study|Lost to Follow-up|0|||
44399083|NCT03978091|79406006|FG004|Overall Study|Lost to Follow-up|0|||
44399084|NCT03978091|79406007|FG005|Overall Study|Lost to Follow-up|0|||
44399085|NCT03978091|79406002|FG000|Overall Study|Withdrawal by Subject|0|||
44399086|NCT03978091|79406003|FG001|Overall Study|Withdrawal by Subject|0|||
44399087|NCT03978091|79406004|FG002|Overall Study|Withdrawal by Subject|0|||
44399088|NCT03978091|79406005|FG003|Overall Study|Withdrawal by Subject|1|||
44399089|NCT03978091|79406006|FG004|Overall Study|Withdrawal by Subject|1|||
44281665|NCT01969500|79244945|FG001|Overall Study|extended hospitalization|1|||
44399090|NCT03978091|79406007|FG005|Overall Study|Withdrawal by Subject|0|||
44281666|NCT01915914|79244951|FG000|Acute Phase|Withdrawal by Subject|4|||
44281667|NCT01915914|79244952|FG001|Acute Phase|Withdrawal by Subject|0|||
44281668|NCT01915914|79244953|FG002|Acute Phase|Withdrawal by Subject|0|||
44281669|NCT01915914|79244954|FG003|Acute Phase|Withdrawal by Subject|0|||
44399091|NCT00564733|79406030|FG000|Overall Study|Withdrawal by Subject|4|||
44399092|NCT00564733|79406030|FG000|Overall Study|Ineligible|5|||
44399093|NCT00931385|79406034|FG000|Overall Study|Adverse Event|2|||
44399094|NCT00931385|79406035|FG001|Overall Study|Adverse Event|1|||
44399095|NCT00931385|79406036|FG002|Overall Study|Adverse Event|0|||
44399096|NCT00931385|79406037|FG003|Overall Study|Adverse Event|3|||
44281670|NCT01915914|79244951|FG000|Acute Phase|Lost to Follow-up|4|||
44399097|NCT00931385|79406034|FG000|Overall Study|Protocol Violation|0|||
44399098|NCT00931385|79406035|FG001|Overall Study|Protocol Violation|0|||
44399099|NCT00931385|79406036|FG002|Overall Study|Protocol Violation|1|||
44399100|NCT00931385|79406037|FG003|Overall Study|Protocol Violation|0|||
44399101|NCT00931385|79406034|FG000|Overall Study|Withdrawal by Subject|0|||
44399102|NCT00931385|79406035|FG001|Overall Study|Withdrawal by Subject|1|||
44399103|NCT00931385|79406036|FG002|Overall Study|Withdrawal by Subject|0|||
44399104|NCT00931385|79406037|FG003|Overall Study|Withdrawal by Subject|1|||
44399105|NCT00931385|79406034|FG000|Overall Study|Lost to Follow-up|0|||
44399106|NCT00931385|79406035|FG001|Overall Study|Lost to Follow-up|0|||
44399107|NCT00931385|79406036|FG002|Overall Study|Lost to Follow-up|0|||
44399108|NCT00931385|79406037|FG003|Overall Study|Lost to Follow-up|1|||
44399109|NCT00565747|79406053|FG000|Overall Study|No embryo transfer|67|||
44399110|NCT00565747|79406054|FG001|Overall Study|No embryo transfer|73|||
44399111|NCT00563797|79406062|FG000|Overall Study|Lost to Follow-up|7|||
44399112|NCT00563797|79406063|FG001|Overall Study|Lost to Follow-up|2|||
44399113|NCT00771927|79406082|FG000|Overall Study|Adverse Event|100|||
44399114|NCT00771927|79406083|FG001|Overall Study|Adverse Event|105|||
44399115|NCT00771927|79406082|FG000|Overall Study|Lack of Efficacy|70|||
44399116|NCT00771927|79406083|FG001|Overall Study|Lack of Efficacy|42|||
44399117|NCT00771927|79406082|FG000|Overall Study|Lost to Follow-up|46|||
44399118|NCT00771927|79406083|FG001|Overall Study|Lost to Follow-up|46|||
44399119|NCT00771927|79406082|FG000|Overall Study|Withdrawal by Subject|16|||
44399120|NCT00771927|79406083|FG001|Overall Study|Withdrawal by Subject|17|||
44399121|NCT00771927|79406082|FG000|Overall Study|Other reason|23|||
44399122|NCT00771927|79406083|FG001|Overall Study|Other reason|27|||
44399123|NCT00771849|79406091|FG000|Overall Study|Lost to Follow-up|1|||
44399124|NCT00771849|79406092|FG001|Overall Study|Lost to Follow-up|2|||
44399125|NCT00771849|79406091|FG000|Overall Study|Withdrawal by Subject|1|||
44399126|NCT00771849|79406092|FG001|Overall Study|Withdrawal by Subject|1|||
44399127|NCT00771849|79406091|FG000|Overall Study|Not vaccinated|0|||
44399128|NCT00771849|79406092|FG001|Overall Study|Not vaccinated|1|||
44399129|NCT00564889|79406098|FG000|Overall Study|Death|7|||
44399130|NCT00564889|79406098|FG000|Overall Study|Adverse Event|12|||
44399131|NCT00564889|79406098|FG000|Overall Study|Alternative treatment|3|||
44399132|NCT00564889|79406098|FG000|Overall Study|Disease progression|3|||
44399133|NCT00564889|79406098|FG000|Overall Study|Other, not specified|4|||
44399134|NCT00560833|79406116|FG000|Overall Study|Adverse Event|16|||
44399135|NCT00560833|79406117|FG001|Overall Study|Adverse Event|10|||
44399136|NCT00560833|79406118|FG002|Overall Study|Adverse Event|25|||
44399137|NCT00560833|79406119|FG003|Overall Study|Adverse Event|23|||
44399138|NCT00560833|79406120|FG004|Overall Study|Adverse Event|35|||
44399139|NCT00560833|79406116|FG000|Overall Study|Lost to Follow-up|0|||
44399140|NCT00560833|79406117|FG001|Overall Study|Lost to Follow-up|0|||
44399141|NCT00560833|79406118|FG002|Overall Study|Lost to Follow-up|1|||
44399142|NCT00560833|79406119|FG003|Overall Study|Lost to Follow-up|0|||
44399143|NCT00560833|79406120|FG004|Overall Study|Lost to Follow-up|0|||
44399144|NCT00560833|79406116|FG000|Overall Study|Lack of Efficacy|22|||
44399145|NCT00560833|79406117|FG001|Overall Study|Lack of Efficacy|9|||
44399146|NCT00560833|79406118|FG002|Overall Study|Lack of Efficacy|6|||
44399147|NCT00560833|79406119|FG003|Overall Study|Lack of Efficacy|4|||
44399148|NCT00560833|79406120|FG004|Overall Study|Lack of Efficacy|4|||
44399149|NCT00560833|79406116|FG000|Overall Study|Participant uncooperative|5|||
44399150|NCT00560833|79406117|FG001|Overall Study|Participant uncooperative|5|||
44399151|NCT00560833|79406118|FG002|Overall Study|Participant uncooperative|4|||
44399152|NCT00560833|79406119|FG003|Overall Study|Participant uncooperative|4|||
44399153|NCT00560833|79406120|FG004|Overall Study|Participant uncooperative|2|||
44399154|NCT00560833|79406116|FG000|Overall Study|Other|1|||
44399155|NCT00560833|79406117|FG001|Overall Study|Other|1|||
44399156|NCT00560833|79406118|FG002|Overall Study|Other|3|||
44399157|NCT00560833|79406119|FG003|Overall Study|Other|0|||
44399158|NCT00560833|79406120|FG004|Overall Study|Other|0|||
44399159|NCT00560833|79406116|FG000|Overall Study|Never received drug|0|||
44399160|NCT00560833|79406117|FG001|Overall Study|Never received drug|1|||
44399161|NCT00560833|79406118|FG002|Overall Study|Never received drug|0|||
44399162|NCT00560833|79406119|FG003|Overall Study|Never received drug|0|||
44399163|NCT00560833|79406120|FG004|Overall Study|Never received drug|1|||
44399164|NCT00771615|79406141|FG000|Overall Study|Withdrawal by Subject|0|||
44399165|NCT00771615|79406142|FG001|Overall Study|Withdrawal by Subject|1|||
44399166|NCT00771615|79406143|FG002|Overall Study|Withdrawal by Subject|0|||
44399167|NCT00771615|79406144|FG003|Overall Study|Withdrawal by Subject|0|||
44399168|NCT00771615|79406145|FG004|Overall Study|Withdrawal by Subject|0|||
44399169|NCT00771615|79406146|FG005|Overall Study|Withdrawal by Subject|0|||
44399170|NCT00771615|79406147|FG006|Overall Study|Withdrawal by Subject|0|||
44399171|NCT00771615|79406148|FG007|Overall Study|Withdrawal by Subject|1|||
44399172|NCT00771615|79406149|FG008|Overall Study|Withdrawal by Subject|0|||
44399173|NCT00771615|79406141|FG000|Overall Study|Lost to Follow-up|1|||
44399174|NCT00771615|79406142|FG001|Overall Study|Lost to Follow-up|1|||
44399175|NCT00771615|79406143|FG002|Overall Study|Lost to Follow-up|1|||
44281671|NCT01915914|79244952|FG001|Acute Phase|Lost to Follow-up|0|||
44399176|NCT00771615|79406144|FG003|Overall Study|Lost to Follow-up|1|||
44399177|NCT00771615|79406145|FG004|Overall Study|Lost to Follow-up|0|||
44399178|NCT00771615|79406146|FG005|Overall Study|Lost to Follow-up|1|||
44399179|NCT00771615|79406147|FG006|Overall Study|Lost to Follow-up|1|||
44399180|NCT00771615|79406148|FG007|Overall Study|Lost to Follow-up|0|||
44521435|NCT02903914|79529651|FG006|Overall Study|Reasoning not specified|20|||
44521436|NCT02903914|79529652|FG007|Overall Study|Reasoning not specified|0|||
44521437|NCT02969044|79529674|FG000|Overall Study|Withdrawal by Subject|2|||
44521438|NCT02969044|79529675|FG001|Overall Study|Withdrawal by Subject|6|||
44521439|NCT02969044|79529674|FG000|Overall Study|Adverse Event|3|||
44399181|NCT00771615|79406149|FG008|Overall Study|Lost to Follow-up|0|||
44399182|NCT02723604|79406178|FG000|Overall Study|ineligible|1|||
44399183|NCT02723604|79406178|FG000|Overall Study|never received treatment|1|||
44399184|NCT00560755|79406182|FG000|Overall Study|Protocol Violation|15|||
44399185|NCT00560755|79406182|FG000|Overall Study|Withdrawal by Subject|26|||
44399186|NCT00560755|79406182|FG000|Overall Study|Lost to Follow-up|9|||
44399187|NCT00560755|79406182|FG000|Overall Study|Adverse Event|8|||
44399188|NCT00560755|79406182|FG000|Overall Study|Physician Decision|2|||
44399189|NCT00770991|79406189|FG000|Overall Study|Physician Decision|2|||
44399190|NCT00770991|79406190|FG001|Overall Study|Physician Decision|0|||
44399191|NCT00770991|79406189|FG000|Overall Study|Withdrawal by Subject|1|||
44399192|NCT00770991|79406190|FG001|Overall Study|Withdrawal by Subject|0|||
44399193|NCT00770991|79406189|FG000|Overall Study|Adverse Event|1|||
44399194|NCT00770991|79406190|FG001|Overall Study|Adverse Event|5|||
44399195|NCT00770991|79406189|FG000|Overall Study|Pregnancy|1|||
44399196|NCT00770991|79406190|FG001|Overall Study|Pregnancy|0|||
44399197|NCT00925769|79406201|FG000|Overall Study|Major toxicity|1|||
44399198|NCT00925769|79406202|FG001|Overall Study|Major toxicity|0|||
44399199|NCT00925769|79406203|FG002|Overall Study|Major toxicity|1|||
44399200|NCT00925769|79406204|FG003|Overall Study|Major toxicity|1|||
44399201|NCT00925769|79406205|FG004|Overall Study|Major toxicity|0|||
44399202|NCT00925769|79406206|FG005|Overall Study|Major toxicity|0|||
44399203|NCT00925769|79406201|FG000|Overall Study|Disease progression|4|||
44399204|NCT00925769|79406202|FG001|Overall Study|Disease progression|5|||
44399205|NCT00925769|79406203|FG002|Overall Study|Disease progression|3|||
44399206|NCT00925769|79406204|FG003|Overall Study|Disease progression|4|||
44399207|NCT00925769|79406205|FG004|Overall Study|Disease progression|2|||
44399208|NCT00925769|79406206|FG005|Overall Study|Disease progression|3|||
44399209|NCT00925769|79406201|FG000|Overall Study|Death|0|||
44399210|NCT00925769|79406202|FG001|Overall Study|Death|0|||
44399211|NCT00925769|79406203|FG002|Overall Study|Death|1|||
44399212|NCT00925769|79406204|FG003|Overall Study|Death|0|||
44399213|NCT00925769|79406205|FG004|Overall Study|Death|0|||
44399214|NCT00925769|79406206|FG005|Overall Study|Death|0|||
44399215|NCT00925769|79406201|FG000|Overall Study|Physician Decision|1|||
44399216|NCT00925769|79406202|FG001|Overall Study|Physician Decision|0|||
44399217|NCT00925769|79406203|FG002|Overall Study|Physician Decision|0|||
44399218|NCT00925769|79406204|FG003|Overall Study|Physician Decision|0|||
44399219|NCT00925769|79406205|FG004|Overall Study|Physician Decision|0|||
44399220|NCT00925769|79406206|FG005|Overall Study|Physician Decision|0|||
44399221|NCT00925769|79406201|FG000|Overall Study|Missing documentation|0|||
44399222|NCT00925769|79406202|FG001|Overall Study|Missing documentation|1|||
44399223|NCT00925769|79406203|FG002|Overall Study|Missing documentation|0|||
44399224|NCT00925769|79406204|FG003|Overall Study|Missing documentation|0|||
44399225|NCT00925769|79406205|FG004|Overall Study|Missing documentation|0|||
44399226|NCT00925769|79406206|FG005|Overall Study|Missing documentation|0|||
44399227|NCT00925769|79406201|FG000|Overall Study|End of study visit not done|0|||
44399228|NCT00925769|79406202|FG001|Overall Study|End of study visit not done|0|||
44399229|NCT00925769|79406203|FG002|Overall Study|End of study visit not done|1|||
44399230|NCT00925769|79406204|FG003|Overall Study|End of study visit not done|0|||
44399231|NCT00925769|79406205|FG004|Overall Study|End of study visit not done|0|||
44399232|NCT00925769|79406206|FG005|Overall Study|End of study visit not done|0|||
44399233|NCT00925769|79406201|FG000|Overall Study|Participant is unable to swallow drug|0|||
44399234|NCT00925769|79406202|FG001|Overall Study|Participant is unable to swallow drug|0|||
44399235|NCT00925769|79406203|FG002|Overall Study|Participant is unable to swallow drug|0|||
44399236|NCT00925769|79406204|FG003|Overall Study|Participant is unable to swallow drug|1|||
44399237|NCT00925769|79406205|FG004|Overall Study|Participant is unable to swallow drug|0|||
44399238|NCT00925769|79406206|FG005|Overall Study|Participant is unable to swallow drug|0|||
44399239|NCT00925769|79406201|FG000|Overall Study|Adverse Event|0|||
44399240|NCT00925769|79406202|FG001|Overall Study|Adverse Event|0|||
44399241|NCT00925769|79406203|FG002|Overall Study|Adverse Event|0|||
44399242|NCT00925769|79406204|FG003|Overall Study|Adverse Event|0|||
44399243|NCT00925769|79406205|FG004|Overall Study|Adverse Event|1|||
44399244|NCT00925769|79406206|FG005|Overall Study|Adverse Event|0|||
44399245|NCT00770913|79406225|FG000|Overall Study|Adverse Event|1|||
44399246|NCT00770913|79406226|FG001|Overall Study|Adverse Event|3|||
44521440|NCT02969044|79529675|FG001|Overall Study|Adverse Event|0|||
44521441|NCT02967562|79529683|FG000|Overall Study|Consent not obtained|1|||
44399247|NCT00770913|79406227|FG002|Overall Study|Adverse Event|6|||
44399248|NCT00770913|79406225|FG000|Overall Study|Refusal to continue participation|6|||
44399249|NCT00770913|79406226|FG001|Overall Study|Refusal to continue participation|4|||
44399250|NCT00770913|79406227|FG002|Overall Study|Refusal to continue participation|5|||
44399251|NCT00770913|79406225|FG000|Overall Study|Physician Decision|0|||
44399252|NCT00770913|79406226|FG001|Overall Study|Physician Decision|1|||
44399253|NCT00770913|79406227|FG002|Overall Study|Physician Decision|1|||
44399254|NCT00770913|79406225|FG000|Overall Study|Protocol Violation|3|||
44399255|NCT00770913|79406226|FG001|Overall Study|Protocol Violation|0|||
44399256|NCT00770913|79406227|FG002|Overall Study|Protocol Violation|1|||
44399257|NCT00770913|79406225|FG000|Overall Study|Incorrect drug was allocated|1|||
44399258|NCT00770913|79406226|FG001|Overall Study|Incorrect drug was allocated|0|||
44399259|NCT00770913|79406227|FG002|Overall Study|Incorrect drug was allocated|0|||
44399260|NCT00562861|79406237|FG000|Overall Study|Adverse Event|1|||
44399261|NCT00562861|79406238|FG001|Overall Study|Adverse Event|1|||
44399262|NCT00562861|79406237|FG000|Overall Study|Lack of Efficacy|5|||
44399263|NCT00562861|79406238|FG001|Overall Study|Lack of Efficacy|5|||
44399264|NCT00562861|79406237|FG000|Overall Study|noncompliance, moved|7|||
44399265|NCT00562861|79406238|FG001|Overall Study|noncompliance, moved|2|||
44399266|NCT00562861|79406237|FG000|Overall Study|Lost to Follow-up|7|||
44399267|NCT00562861|79406238|FG001|Overall Study|Lost to Follow-up|3|||
44399268|NCT00770679|79406244|FG000|Overall Study|Lost to Follow-up|3|||
44399269|NCT00770679|79406244|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
44399270|NCT00770601|79406248|FG000|Overall Study|Withdrawal by Subject|1|||
44399271|NCT00770367|79406254|FG000|First Intervention|Withdrawal by Subject|0|||
44399272|NCT00770367|79406255|FG001|First Intervention|Withdrawal by Subject|2|||
44399273|NCT00770367|79406254|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
44399274|NCT00770367|79406255|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
44399275|NCT00770367|79406254|FG000|Second Intervention|Lost to Follow-up|2|||
44399276|NCT00770367|79406255|FG001|Second Intervention|Lost to Follow-up|0|||
44399277|NCT00931307|79406263|FG000|Overall Study|Lack of Efficacy|12|||
44399278|NCT00931307|79406263|FG000|Overall Study|Biomicroscopy|1|||
44399279|NCT00930761|79406269|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
44399280|NCT00930761|79406270|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
44399281|NCT00930761|79406269|FG000|Overall Study|less than 3 music therapy sessions|0|||
44399282|NCT00930761|79406270|FG001|Overall Study|less than 3 music therapy sessions|3|||
44399283|NCT00770289|79406276|FG000|Overall Study|Other|6|||
44399284|NCT00770211|79406287|FG000|Overall Study|Lost to Follow-up|1|||
44399285|NCT00770211|79406288|FG001|Overall Study|Lost to Follow-up|0|||
44399286|NCT00770211|79406287|FG000|Overall Study|Withdrawal by Subject|0|||
44399287|NCT00770211|79406288|FG001|Overall Study|Withdrawal by Subject|2|||
44399288|NCT00928187|79406297|FG000|Overall Study|Death|1|||
44399289|NCT00928187|79406298|FG001|Overall Study|Death|2|||
44399290|NCT00928187|79406299|FG002|Overall Study|Death|3|||
44399291|NCT00928187|79406297|FG000|Overall Study|Lost to Follow-up|1|||
44399292|NCT00928187|79406298|FG001|Overall Study|Lost to Follow-up|2|||
44399293|NCT00928187|79406299|FG002|Overall Study|Lost to Follow-up|1|||
44399294|NCT00928187|79406297|FG000|Overall Study|Withdrawal by Subject|0|||
44399295|NCT00928187|79406298|FG001|Overall Study|Withdrawal by Subject|1|||
44399296|NCT00928187|79406299|FG002|Overall Study|Withdrawal by Subject|1|||
44399297|NCT00928187|79406297|FG000|Overall Study|Protocol Violation|0|||
44399298|NCT00928187|79406298|FG001|Overall Study|Protocol Violation|1|||
44399299|NCT00928187|79406299|FG002|Overall Study|Protocol Violation|0|||
44399300|NCT00769119|79406309|FG000|Overall Study|Voluntary discontinuation|0|||
44399301|NCT00769119|79406310|FG001|Overall Study|Voluntary discontinuation|2|||
44399302|NCT00769119|79406309|FG000|Overall Study|Adverse Event|1|||
44399303|NCT00769119|79406310|FG001|Overall Study|Adverse Event|1|||
44399304|NCT00769119|79406309|FG000|Overall Study|Disallowed medication|1|||
44399305|NCT00769119|79406310|FG001|Overall Study|Disallowed medication|0|||
44399306|NCT00927953|79406318|FG000|Overall Study|Death|2|||
44399307|NCT00927953|79406319|FG001|Overall Study|Death|1|||
44399308|NCT00768651|79406326|FG000|Overall Study|Withdrawal by Subject|1|||
44399309|NCT00756717|79406331|FG000|Overall Study|Withdrawal by Subject|2|||
44399310|NCT04987762|79406341|FG000|Overall Study|Study was Terminated by Sponsor|103|||
44399311|NCT04817332|79406368|FG000|Overall Study|Lost to Follow-up|3|||
44399312|NCT04817332|79406369|FG001|Overall Study|Lost to Follow-up|3|||
44521442|NCT02967562|79529684|FG001|Overall Study|Consent not obtained|0|||
44252771|NCT02082977|79091592|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
44521443|NCT02967562|79529683|FG000|Overall Study|High leak precluding analysis|1|||
44252772|NCT02082977|79091593|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
44399313|NCT04817332|79406368|FG000|Overall Study|Protocol Violation|2|||
44399314|NCT04817332|79406369|FG001|Overall Study|Protocol Violation|0|||
44399315|NCT04797637|79406377|FG000|Overall Study|Lost to Follow-up|23|||
44399316|NCT04797637|79406378|FG001|Overall Study|Lost to Follow-up|32|||
44399317|NCT04797637|79406377|FG000|Overall Study|Withdrawal by Subject|0|||
44399318|NCT04797637|79406378|FG001|Overall Study|Withdrawal by Subject|1|||
44399319|NCT04300296|79406411|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
44399320|NCT04300296|79406412|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
44399321|NCT04300296|79406413|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
44399322|NCT04300296|79406414|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
44399323|NCT04300296|79406415|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
44399324|NCT04300296|79406416|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
44399325|NCT04300296|79406411|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
44399326|NCT04300296|79406412|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
44399327|NCT04300296|79406413|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
44399328|NCT04300296|79406414|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
44399329|NCT04300296|79406415|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
44399330|NCT04300296|79406416|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
44399331|NCT04300296|79406411|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
44399332|NCT04300296|79406412|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
44399333|NCT04300296|79406413|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
44399334|NCT04300296|79406414|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
44399335|NCT04300296|79406415|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
44399336|NCT04300296|79406416|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
44399337|NCT04300296|79406411|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
44399338|NCT04300296|79406412|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
44399339|NCT04300296|79406413|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
44399340|NCT04300296|79406414|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
44399341|NCT04300296|79406415|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
44399342|NCT04300296|79406416|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
44399343|NCT04300296|79406411|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
44399344|NCT04300296|79406412|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
44399345|NCT04300296|79406413|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
44399346|NCT04300296|79406414|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
44521444|NCT02967562|79529684|FG001|Overall Study|High leak precluding analysis|1|||
44521445|NCT02968576|79529690|FG000|Overall Study|Pregnancy|0|||
44399347|NCT04300296|79406415|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
44399348|NCT04300296|79406416|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
44399349|NCT04300296|79406411|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
44399350|NCT04300296|79406412|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
44399351|NCT04300296|79406413|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
44399352|NCT04300296|79406414|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
44399353|NCT04300296|79406415|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
44399354|NCT04300296|79406416|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
44399355|NCT04300296|79406411|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
44399356|NCT04300296|79406412|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
44399357|NCT04300296|79406413|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
44399358|NCT04300296|79406414|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
44399359|NCT04300296|79406415|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
44399360|NCT04300296|79406416|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
44399361|NCT03989440|79406460|FG000|Overall Study|COVID-19 travel restrictions|0|||
44399362|NCT03989440|79406461|FG001|Overall Study|COVID-19 travel restrictions|0|||
44399363|NCT03989440|79406462|FG002|Overall Study|COVID-19 travel restrictions|1|||
44399364|NCT03989440|79406463|FG003|Overall Study|COVID-19 travel restrictions|0|||
44399365|NCT03989440|79406464|FG004|Overall Study|COVID-19 travel restrictions|0|||
44399366|NCT03989440|79406465|FG005|Overall Study|COVID-19 travel restrictions|0|||
44399367|NCT03989440|79406460|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
44399368|NCT03989440|79406461|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
44399369|NCT03989440|79406462|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
44399370|NCT03989440|79406463|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
44399371|NCT03989440|79406464|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
44399372|NCT03989440|79406465|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
44521446|NCT02968576|79529691|FG001|Overall Study|Pregnancy|1|||
44521447|NCT02966002|79529695|FG000|Overall Study|Withdrawal by Subject|2|||
44521448|NCT02966002|79529695|FG000|Overall Study|Adverse Event|1|||
44521449|NCT02966002|79529695|FG000|Overall Study|Lost to Follow-up|1|||
44521450|NCT02965846|79529702|FG000|Overall Study|Lost to Follow-up|1|||
44252773|NCT02082977|79091594|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
44252774|NCT02082977|79091595|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
44252775|NCT02082977|79091596|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
44399373|NCT03908437|79406483|FG000|Overall Study|Death|0|||
44399374|NCT03908437|79406484|FG001|Overall Study|Death|1|||
44399375|NCT03908437|79406483|FG000|Overall Study|Lost to Follow-up|31|||
44521451|NCT02965846|79529703|FG001|Overall Study|Lost to Follow-up|0|||
44281672|NCT01915914|79244953|FG002|Acute Phase|Lost to Follow-up|0|||
44521452|NCT02965846|79529704|FG002|Overall Study|Lost to Follow-up|0|||
44399376|NCT03908437|79406484|FG001|Overall Study|Lost to Follow-up|24|||
44399377|NCT03274895|79406509|FG000|Overall Study|Lack of Efficacy|1|||
44399378|NCT03274895|79406510|FG001|Overall Study|Lack of Efficacy|0|||
44399379|NCT03274895|79406509|FG000|Overall Study|Adverse Event|8|||
44399380|NCT03274895|79406510|FG001|Overall Study|Adverse Event|7|||
44399381|NCT03274895|79406509|FG000|Overall Study|Lost to Follow-up|1|||
44399382|NCT03274895|79406510|FG001|Overall Study|Lost to Follow-up|0|||
44399383|NCT03274895|79406509|FG000|Overall Study|Diagnosis not confirmed|3|||
44399384|NCT03274895|79406510|FG001|Overall Study|Diagnosis not confirmed|4|||
44399385|NCT03035201|79406523|FG000|Overall Study|Death|9|||
44399386|NCT03035201|79406524|FG001|Overall Study|Death|12|||
44399387|NCT03035201|79406525|FG002|Overall Study|Death|9|||
44399388|NCT03035201|79406526|FG003|Overall Study|Death|10|||
44399389|NCT03035201|79406523|FG000|Overall Study|Withdrawal by Subject|51|||
44521453|NCT02965846|79529702|FG000|Overall Study|Withdrawal by Subject|0|||
44521454|NCT02965846|79529703|FG001|Overall Study|Withdrawal by Subject|1|||
44521455|NCT02965846|79529704|FG002|Overall Study|Withdrawal by Subject|0|||
44521456|NCT02965846|79529702|FG000|Overall Study|Study Terminated By Sponsor|4|||
44399390|NCT03035201|79406524|FG001|Overall Study|Withdrawal by Subject|49|||
44399391|NCT03035201|79406525|FG002|Overall Study|Withdrawal by Subject|37|||
44399392|NCT03035201|79406526|FG003|Overall Study|Withdrawal by Subject|46|||
44399393|NCT03035201|79406523|FG000|Overall Study|Lost to Follow-up|67|||
44399394|NCT03035201|79406524|FG001|Overall Study|Lost to Follow-up|51|||
44399395|NCT03035201|79406525|FG002|Overall Study|Lost to Follow-up|64|||
44399396|NCT03035201|79406526|FG003|Overall Study|Lost to Follow-up|69|||
44399397|NCT02969915|79406548|FG000|Overall Study|Death|104|||
44521457|NCT02965846|79529703|FG001|Overall Study|Study Terminated By Sponsor|4|||
44521458|NCT02965846|79529704|FG002|Overall Study|Study Terminated By Sponsor|0|||
44521459|NCT02965846|79529702|FG000|Overall Study|Participants not randomized|0|||
44521460|NCT02965846|79529703|FG001|Overall Study|Participants not randomized|0|||
44521461|NCT02965846|79529704|FG002|Overall Study|Participants not randomized|33|||
44521462|NCT02900170|79529710|FG000|Overall Study|Lost to Follow-up|8|||
44521463|NCT02900092|79529714|FG000|Overall Study|Adverse Event|1|||
44521464|NCT02902120|79529722|FG000|Overall Study|Lack of Efficacy|1|||
44521465|NCT02965456|79529728|FG000|Overall Study|Lost to Follow-up|40|||
44521466|NCT02965456|79529729|FG001|Overall Study|Lost to Follow-up|18|||
44521467|NCT02965456|79529728|FG000|Overall Study|Subject Request|22|||
44521468|NCT02965456|79529729|FG001|Overall Study|Subject Request|13|||
44521469|NCT02965456|79529728|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
44521470|NCT02965456|79529729|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
44521471|NCT02965456|79529728|FG000|Overall Study|Adverse Event|3|||
44521472|NCT02965456|79529729|FG001|Overall Study|Adverse Event|0|||
44521473|NCT02965456|79529728|FG000|Overall Study|Noncompliance with Study Drug|1|||
44521474|NCT02965456|79529729|FG001|Overall Study|Noncompliance with Study Drug|1|||
44521475|NCT02965456|79529728|FG000|Overall Study|Worsening Condition|0|||
44521476|NCT02965456|79529729|FG001|Overall Study|Worsening Condition|2|||
44521477|NCT02965456|79529728|FG000|Overall Study|Lack of Efficacy|1|||
44521478|NCT02965456|79529729|FG001|Overall Study|Lack of Efficacy|0|||
44521479|NCT02965456|79529728|FG000|Overall Study|Physician Decision|0|||
44521480|NCT02965456|79529729|FG001|Overall Study|Physician Decision|1|||
44521481|NCT02965456|79529728|FG000|Overall Study|Pregnancy|1|||
44521482|NCT02965456|79529729|FG001|Overall Study|Pregnancy|0|||
44521483|NCT02965456|79529728|FG000|Overall Study|Protocol Violation|0|||
44521484|NCT02965456|79529729|FG001|Overall Study|Protocol Violation|1|||
44521485|NCT02965456|79529728|FG000|Overall Study|Participant ran out of study drug|0|||
44521486|NCT02965456|79529729|FG001|Overall Study|Participant ran out of study drug|1|||
44521487|NCT02965378|79529737|FG000|Overall Study|Progression|16|||
44521488|NCT02965378|79529738|FG001|Overall Study|Progression|4|||
44521489|NCT02965378|79529737|FG000|Overall Study|Adverse Event|5|||
44521490|NCT02965378|79529738|FG001|Overall Study|Adverse Event|2|||
44147367|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
44281673|NCT01915914|79244954|FG003|Acute Phase|Lost to Follow-up|0|||
44521491|NCT02965378|79529737|FG000|Overall Study|Death|2|||
44521492|NCT02965378|79529738|FG001|Overall Study|Death|0|||
44521493|NCT02965378|79529737|FG000|Overall Study|Refusal|2|||
44521494|NCT02965378|79529738|FG001|Overall Study|Refusal|1|||
44521495|NCT02965378|79529737|FG000|Overall Study|Not protocol specified|0|||
44399398|NCT02969915|79406549|FG001|Overall Study|Death|125|||
44521496|NCT02965378|79529738|FG001|Overall Study|Not protocol specified|2|||
44521497|NCT03772041|79529746|FG000|Overall Study|Adverse Event|8|||
44521498|NCT03772041|79529747|FG001|Overall Study|Adverse Event|3|||
44521499|NCT03772041|79529746|FG000|Overall Study|Withdrawal by Subject|0|||
44399399|NCT02969915|79406548|FG000|Overall Study|Lost to Follow-up|108|||
44399400|NCT02969915|79406549|FG001|Overall Study|Lost to Follow-up|112|||
44399401|NCT02969915|79406548|FG000|Overall Study|Censored due to COVID-19|481|||
44399402|NCT02969915|79406549|FG001|Overall Study|Censored due to COVID-19|471|||
44399403|NCT02906332|79406555|FG000|Overall Study|Withdrawal by Subject|1|||
44521500|NCT03772041|79529747|FG001|Overall Study|Withdrawal by Subject|2|||
44521501|NCT03772041|79529746|FG000|Overall Study|Protocol Violation|4|||
44521502|NCT03772041|79529747|FG001|Overall Study|Protocol Violation|2|||
44521503|NCT03772041|79529746|FG000|Overall Study|Physician Decision|2|||
44399404|NCT02755597|79406571|FG000|Overall Study|Withdrew consent|27|||
44399405|NCT02755597|79406572|FG001|Overall Study|Withdrew consent|11|||
44399406|NCT02755597|79406571|FG000|Overall Study|Lost to Follow-up|1|||
44399407|NCT02755597|79406572|FG001|Overall Study|Lost to Follow-up|0|||
44399408|NCT02755597|79406571|FG000|Overall Study|Death|78|||
44399409|NCT02755597|79406572|FG001|Overall Study|Death|36|||
44399410|NCT02755597|79406571|FG000|Overall Study|Study terminated by Sponsor|67|||
44399411|NCT02755597|79406572|FG001|Overall Study|Study terminated by Sponsor|47|||
44399412|NCT02755597|79406571|FG000|Overall Study|Other, not specified|20|||
44399413|NCT02755597|79406572|FG001|Overall Study|Other, not specified|3|||
44399414|NCT02755597|79406571|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
44399415|NCT02755597|79406572|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
44399416|NCT02598557|79406581|FG000|Overall Study|Withdrawal by Subject|1|||
44399417|NCT02598557|79406582|FG001|Overall Study|Withdrawal by Subject|0|||
44399418|NCT02598557|79406583|FG002|Overall Study|Withdrawal by Subject|1|||
44399419|NCT02598557|79406581|FG000|Overall Study|Participant did not start treatment|2|||
44399420|NCT02598557|79406582|FG001|Overall Study|Participant did not start treatment|1|||
44399421|NCT02598557|79406583|FG002|Overall Study|Participant did not start treatment|1|||
44399422|NCT02598557|79406581|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
44399423|NCT02598557|79406582|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
44399424|NCT02598557|79406583|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
44399425|NCT02598557|79406581|FG000|Overall Study|Adverse Event|1|||
44399426|NCT02598557|79406582|FG001|Overall Study|Adverse Event|1|||
44399427|NCT02598557|79406583|FG002|Overall Study|Adverse Event|0|||
44399428|NCT02340780|79406591|FG000|Overall Study|Ineligible|1|||
44399429|NCT01470417|79406606|FG000|Overall Study|Disease progression|0|||
44399430|NCT01470417|79406607|FG001|Overall Study|Disease progression|2|||
44399431|NCT00820248|79406641|FG000|Overall Study|No treated|4|||
44399432|NCT00820248|79406642|FG001|Overall Study|No treated|1|||
44399433|NCT00668642|79406659|FG000|First Off-cycle|Cancer progression|1|||
44399434|NCT00668642|79406660|FG001|First Off-cycle|Cancer progression|0|||
44399435|NCT00668642|79406659|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
44399436|NCT00668642|79406660|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
44399437|NCT00101101|79406675|FG000|Overall Study|never received vaccine|20|||
44399438|NCT03962101|79406679|FG000|Overall Study|Adverse Event|1|||
44399439|NCT03962101|79406679|FG000|Overall Study|Physician Decision|2|||
44399440|NCT03962101|79406679|FG000|Overall Study|Not related to medical events|1|||
44399441|NCT00923351|79406686|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
44399442|NCT00923351|79406687|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
44281674|NCT01915914|79244951|FG000|Acute Phase|Physician Decision|1|||
44399443|NCT00923351|79406688|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
44399444|NCT00755937|79406694|FG000|Recruitment|Unknown if infliximab received|164|||
44399445|NCT00755937|79406694|FG000|Observational Follow-up|Lost to Follow-up|148|||
44399446|NCT00755079|79406700|FG000|Overall Study|Lost to Follow-up|1|||
44399447|NCT00755079|79406701|FG001|Overall Study|Lost to Follow-up|3|||
44399448|NCT00755079|79406700|FG000|Overall Study|Adverse Event|0|||
44521504|NCT03772041|79529747|FG001|Overall Study|Physician Decision|3|||
44521505|NCT02899156|79529755|FG000|Overall Study|Death|1|||
44521506|NCT02899156|79529756|FG001|Overall Study|Death|0|||
44521507|NCT02899156|79529755|FG000|Overall Study|Physician Decision|0|||
44521508|NCT02899156|79529756|FG001|Overall Study|Physician Decision|1|||
44521509|NCT03773133|79529762|FG000|Overall Study|Screen Failure|8|||
44252776|NCT02082977|79091597|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
44252777|NCT02082977|79091598|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
44252778|NCT02082977|79091589|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252779|NCT02082977|79091590|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252780|NCT02082977|79091591|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252781|NCT02082977|79091592|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252782|NCT02082977|79091593|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252783|NCT02082977|79091594|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252784|NCT02082977|79091595|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252785|NCT02082977|79091596|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
44252786|NCT02082977|79091597|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44252787|NCT02082977|79091598|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
44399449|NCT00755079|79406701|FG001|Overall Study|Adverse Event|1|||
44399450|NCT00755079|79406700|FG000|Overall Study|Withdrawal by Subject|0|||
44399451|NCT00755079|79406701|FG001|Overall Study|Withdrawal by Subject|2|||
44399452|NCT00925301|79406709|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
44399453|NCT00925301|79406710|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
44399454|NCT00925301|79406711|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
44399455|NCT00925301|79406712|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
44399456|NCT00925301|79406709|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
44521510|NCT02969356|79529767|FG000|Overall Study|Adverse Event|7|||
44521511|NCT02969356|79529767|FG000|Overall Study|Consent withdrawn|2|||
44521512|NCT02969356|79529767|FG000|Overall Study|Lost to Follow-up|3|||
44521513|NCT02969356|79529767|FG000|Overall Study|Did not need to be reinjected|6|||
44521514|NCT02969356|79529767|FG000|Overall Study|Personal reasons|5|||
44521515|NCT02898454|79529774|FG000|Overall Study|Adverse Event|4|||
44399457|NCT00925301|79406710|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
44399458|NCT00925301|79406711|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
44521516|NCT02898454|79529775|FG001|Overall Study|Adverse Event|1|||
44147368|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
44147369|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
44147370|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
44147371|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
44147372|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
44147373|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
44147374|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
44147375|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
44147376|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
44147377|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
44147378|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
44147379|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
44147380|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
44399459|NCT00925301|79406712|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
44399460|NCT00925301|79406709|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
44399461|NCT00925301|79406710|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
44399462|NCT00925301|79406711|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
44399463|NCT00925301|79406712|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
44399464|NCT00925301|79406709|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
44399465|NCT00925301|79406710|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
44399466|NCT00925301|79406711|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
44399467|NCT00925301|79406712|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
44399468|NCT00925301|79406709|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
44399469|NCT00925301|79406710|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
44399470|NCT00925301|79406711|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
44399471|NCT00925301|79406712|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
44399472|NCT00925301|79406709|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
44399473|NCT00925301|79406710|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
44399474|NCT00925301|79406711|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
44399475|NCT00925301|79406712|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
44399476|NCT00925301|79406709|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
44399477|NCT00925301|79406710|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
44399478|NCT00925301|79406711|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
44399479|NCT00925301|79406712|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
44399480|NCT00754065|79406725|FG000|Overall Study|Never received treatment|12|||
44399481|NCT00754065|79406726|FG001|Overall Study|Never received treatment|2|||
44399482|NCT00754065|79406725|FG000|Overall Study|Adverse Event|19|||
44399483|NCT00754065|79406726|FG001|Overall Study|Adverse Event|25|||
44399484|NCT00754065|79406725|FG000|Overall Study|Lost to Follow-up|7|||
44399485|NCT00754065|79406726|FG001|Overall Study|Lost to Follow-up|11|||
44147381|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
44147382|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
44252788|NCT01624259|79091632|FG000|Overall Study|Adverse Event|18|||
44399486|NCT00754065|79406725|FG000|Overall Study|Protocol Violation|12|||
44399487|NCT00754065|79406726|FG001|Overall Study|Protocol Violation|10|||
44399488|NCT00754065|79406725|FG000|Overall Study|Withdrawal by Subject|4|||
44399489|NCT00754065|79406726|FG001|Overall Study|Withdrawal by Subject|5|||
44399490|NCT00754065|79406725|FG000|Overall Study|Pregnancy|6|||
44399491|NCT00754065|79406726|FG001|Overall Study|Pregnancy|0|||
44399492|NCT00754065|79406725|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
44399493|NCT00754065|79406726|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
44399494|NCT04138056|79406746|FG000|Primary Study|Lost to Follow-up|3|||
44399495|NCT04138056|79406747|FG001|Primary Study|Lost to Follow-up|4|||
44521517|NCT02898454|79529776|FG002|Overall Study|Adverse Event|2|||
44521518|NCT02898454|79529774|FG000|Overall Study|Protocol Violation|1|||
44147383|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
44252789|NCT01624259|79091633|FG001|Overall Study|Adverse Event|18|||
44399496|NCT04138056|79406748|FG002|Primary Study|Lost to Follow-up|1|||
44399497|NCT04138056|79406749|FG003|Primary Study|Lost to Follow-up|1|||
44399498|NCT04138056|79406750|FG004|Primary Study|Lost to Follow-up|4|||
44521519|NCT02898454|79529775|FG001|Overall Study|Protocol Violation|0|||
44521520|NCT02898454|79529776|FG002|Overall Study|Protocol Violation|1|||
44399499|NCT04138056|79406746|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
44399500|NCT04138056|79406747|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
44399501|NCT04138056|79406748|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
44399502|NCT04138056|79406749|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
44399503|NCT04138056|79406750|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
44399504|NCT04138056|79406746|FG000|Extension Study|Lost to Follow-up|1|||
44399505|NCT04138056|79406747|FG001|Extension Study|Lost to Follow-up|2|||
44399506|NCT04138056|79406748|FG002|Extension Study|Lost to Follow-up|1|||
44399507|NCT04138056|79406749|FG003|Extension Study|Lost to Follow-up|0|||
44399508|NCT04138056|79406750|FG004|Extension Study|Lost to Follow-up|1|||
44399509|NCT00753675|79406796|FG000|Overall Study|other reason|11|||
44399510|NCT00753675|79406797|FG001|Overall Study|other reason|12|||
44399511|NCT00753675|79406798|FG002|Overall Study|other reason|13|||
44399512|NCT00753675|79406796|FG000|Overall Study|Death|1|||
44399513|NCT00753675|79406797|FG001|Overall Study|Death|2|||
44399514|NCT00753675|79406798|FG002|Overall Study|Death|4|||
44399515|NCT00753675|79406796|FG000|Overall Study|Adverse Event|11|||
44399516|NCT00753675|79406797|FG001|Overall Study|Adverse Event|9|||
44399517|NCT00753675|79406798|FG002|Overall Study|Adverse Event|4|||
44399518|NCT00753675|79406796|FG000|Overall Study|Objective progression of disease|35|||
44399519|NCT00753675|79406797|FG001|Overall Study|Objective progression of disease|35|||
44399520|NCT00753675|79406798|FG002|Overall Study|Objective progression of disease|35|||
44399521|NCT00753675|79406796|FG000|Overall Study|Withdrawal by Subject|0|||
44399522|NCT00753675|79406797|FG001|Overall Study|Withdrawal by Subject|1|||
44399523|NCT00753675|79406798|FG002|Overall Study|Withdrawal by Subject|0|||
44399524|NCT00753675|79406796|FG000|Overall Study|Lost to Follow-up|1|||
44399525|NCT00753675|79406797|FG001|Overall Study|Lost to Follow-up|0|||
44399526|NCT00753675|79406798|FG002|Overall Study|Lost to Follow-up|0|||
44399527|NCT00586521|79406806|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
44399528|NCT00923273|79406815|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
44399529|NCT00923273|79406816|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
44399530|NCT00923273|79406817|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
44399531|NCT00923273|79406818|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
44399532|NCT00923273|79406819|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
44399533|NCT00923273|79406815|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
44399534|NCT00923273|79406816|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
44399535|NCT00923273|79406817|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
44399536|NCT00923273|79406818|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
44399537|NCT00923273|79406819|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
44399538|NCT00923195|79406839|FG000|Overall Study|Death|0|||
44399539|NCT00923195|79406840|FG001|Overall Study|Death|1|||
44399540|NCT00753519|79406848|FG000|Overall Study|Withdrawal by Subject|0|||
44399541|NCT00753519|79406849|FG001|Overall Study|Withdrawal by Subject|2|||
44399542|NCT00919061|79406857|FG000|Overall Study|Adverse Event|1|||
44399543|NCT00919061|79406857|FG000|Overall Study|Withdrawal by Subject|1|||
44399544|NCT00747435|79406861|FG000|Overall Study|Lost to Follow-up|2|||
44399545|NCT00747435|79406861|FG000|Overall Study|Withdrawal by Subject|3|||
44399546|NCT00747435|79406861|FG000|Overall Study|Still undergoing follow up|1|||
44399547|NCT00918749|79406868|FG000|Overall Study|Adverse Event|1|||
44399548|NCT00918749|79406869|FG001|Overall Study|Adverse Event|0|||
44399549|NCT00918749|79406870|FG002|Overall Study|Adverse Event|1|||
44399550|NCT00918749|79406868|FG000|Overall Study|Lost to Follow-up|0|||
44399551|NCT00918749|79406869|FG001|Overall Study|Lost to Follow-up|0|||
44399552|NCT00918749|79406870|FG002|Overall Study|Lost to Follow-up|1|||
44399553|NCT00918749|79406868|FG000|Overall Study|Withdrawal by Subject|5|||
44399554|NCT00918749|79406869|FG001|Overall Study|Withdrawal by Subject|3|||
44399555|NCT00918749|79406870|FG002|Overall Study|Withdrawal by Subject|5|||
44399556|NCT00918749|79406868|FG000|Overall Study|No Study Medication Taken|1|||
44399557|NCT00918749|79406869|FG001|Overall Study|No Study Medication Taken|0|||
44399558|NCT00918749|79406870|FG002|Overall Study|No Study Medication Taken|0|||
44399559|NCT00746733|79406878|FG000|Second Intervention|Adverse Event|1|||
44399560|NCT00746733|79406879|FG001|Second Intervention|Adverse Event|0|||
44521521|NCT02898454|79529774|FG000|Overall Study|Lack of Efficacy|4|||
44147384|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
44399561|NCT00746733|79406878|FG000|Third Intervention|Withdrawal by Subject|1|||
44399562|NCT00746733|79406879|FG001|Third Intervention|Withdrawal by Subject|1|||
44399563|NCT00745875|79406894|FG000|Overall Study|Continuing study treatment|4|||
44399564|NCT00745875|79406895|FG001|Overall Study|Continuing study treatment|4|||
44399565|NCT00555217|79406903|FG000|Overall Study|Withdrawal by Subject|35|||
44399566|NCT00555217|79406904|FG001|Overall Study|Withdrawal by Subject|31|||
44399567|NCT00555217|79406903|FG000|Overall Study|Lost to Follow-up|19|||
44399568|NCT00555217|79406904|FG001|Overall Study|Lost to Follow-up|20|||
44399569|NCT00555217|79406903|FG000|Overall Study|close out sites|21|||
44399570|NCT00555217|79406904|FG001|Overall Study|close out sites|17|||
44399571|NCT00745251|79406912|FG000|Overall Study|Adverse Event|1|||
44399572|NCT00745251|79406913|FG001|Overall Study|Adverse Event|2|||
44399573|NCT00745251|79406912|FG000|Overall Study|Withdrawal by Subject|1|||
44399574|NCT00745251|79406913|FG001|Overall Study|Withdrawal by Subject|1|||
44399575|NCT00745095|79406925|FG000|Overall Study|Declined to participate|1|||
44399576|NCT00745095|79406926|FG001|Overall Study|Declined to participate|0|||
44399577|NCT00745095|79406927|FG002|Overall Study|Declined to participate|0|||
44399578|NCT00745095|79406928|FG003|Overall Study|Declined to participate|0|||
44399579|NCT00745095|79406929|FG004|Overall Study|Declined to participate|92|||
44399580|NCT00745095|79406930|FG005|Overall Study|Declined to participate|95|||
44399581|NCT00745095|79406925|FG000|Overall Study|Ineligible due to GFR criteria|0|||
44399582|NCT00745095|79406926|FG001|Overall Study|Ineligible due to GFR criteria|2|||
44399583|NCT00745095|79406927|FG002|Overall Study|Ineligible due to GFR criteria|3|||
44399584|NCT00745095|79406928|FG003|Overall Study|Ineligible due to GFR criteria|3|||
44399585|NCT00745095|79406929|FG004|Overall Study|Ineligible due to GFR criteria|30|||
44399586|NCT00745095|79406930|FG005|Overall Study|Ineligible due to GFR criteria|28|||
44399587|NCT00744939|79406951|FG000|Overall Study|Withdrawal by Subject|9|||
44399588|NCT00744939|79406951|FG000|Overall Study|Protocol Violation|13|||
44399589|NCT00744939|79406951|FG000|Overall Study|Death|24|||
44399590|NCT00744939|79406951|FG000|Overall Study|distance|4|||
44399591|NCT00744939|79406951|FG000|Overall Study|Lost to Follow-up|12|||
44399592|NCT00744939|79406951|FG000|Overall Study|Medical history exclusionary|1|||
44399593|NCT00744939|79406951|FG000|Overall Study|Did not receive Magnevist|7|||
44399594|NCT00744939|79406951|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
44399595|NCT00744939|79406951|FG000|Overall Study|coma|1|||
44399596|NCT00744939|79406951|FG000|Overall Study|incorrect race|1|||
44252790|NCT01624259|79091632|FG000|Overall Study|Protocol Violation|1|||
44252791|NCT01624259|79091633|FG001|Overall Study|Protocol Violation|2|||
44252792|NCT01624259|79091632|FG000|Overall Study|Withdrawal by Subject|5|||
44252793|NCT01624259|79091633|FG001|Overall Study|Withdrawal by Subject|7|||
44252794|NCT01624259|79091632|FG000|Overall Study|Physician Decision|1|||
44252795|NCT01624259|79091633|FG001|Overall Study|Physician Decision|1|||
44252796|NCT01624259|79091632|FG000|Overall Study|Lost to Follow-up|2|||
44399597|NCT00744861|79406967|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
44399598|NCT00744861|79406968|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
44399599|NCT00744861|79406969|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
44399600|NCT00744861|79406970|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
44399601|NCT00744861|79406967|FG000|Feasibility Stage 1|Pregnancy|0|||
44399602|NCT00744861|79406968|FG001|Feasibility Stage 1|Pregnancy|1|||
44399603|NCT00744861|79406969|FG002|Feasibility Stage 1|Pregnancy|0|||
44399604|NCT00744861|79406970|FG003|Feasibility Stage 1|Pregnancy|0|||
44399605|NCT00744861|79406967|FG000|Pivotal Stage 2|Adverse Event|0|||
44399606|NCT00744861|79406968|FG001|Pivotal Stage 2|Adverse Event|0|||
44399607|NCT00744861|79406969|FG002|Pivotal Stage 2|Adverse Event|6|||
44399608|NCT00744861|79406970|FG003|Pivotal Stage 2|Adverse Event|11|||
44399609|NCT00744861|79406967|FG000|Pivotal Stage 2|Death|0|||
44521522|NCT02898454|79529775|FG001|Overall Study|Lack of Efficacy|1|||
44521523|NCT02898454|79529776|FG002|Overall Study|Lack of Efficacy|0|||
44521524|NCT02898454|79529774|FG000|Overall Study|Withdrawal by Subject|6|||
44521525|NCT02898454|79529775|FG001|Overall Study|Withdrawal by Subject|3|||
44252797|NCT01624259|79091633|FG001|Overall Study|Lost to Follow-up|3|||
44252798|NCT01624259|79091632|FG000|Overall Study|Abnormal laboratory measure|3|||
44252799|NCT01624259|79091633|FG001|Overall Study|Abnormal laboratory measure|0|||
44252800|NCT02081417|79091643|FG000|Overall Study|Lost to Follow-up|26|||
44252801|NCT02081417|79091644|FG001|Overall Study|Lost to Follow-up|23|||
44252802|NCT02081417|79091643|FG000|Overall Study|Moved Away|1|||
44252803|NCT02081417|79091644|FG001|Overall Study|Moved Away|2|||
44252804|NCT02081417|79091643|FG000|Overall Study|Incarcerated|2|||
44252805|NCT02081417|79091644|FG001|Overall Study|Incarcerated|2|||
44252806|NCT02081417|79091643|FG000|Overall Study|Death|4|||
44281675|NCT01915914|79244952|FG001|Acute Phase|Physician Decision|0|||
44281676|NCT01915914|79244953|FG002|Acute Phase|Physician Decision|0|||
44521526|NCT02898454|79529776|FG002|Overall Study|Withdrawal by Subject|3|||
44521527|NCT02898454|79529774|FG000|Overall Study|Lost to Follow-up|1|||
44399610|NCT00744861|79406968|FG001|Pivotal Stage 2|Death|0|||
44399611|NCT00744861|79406969|FG002|Pivotal Stage 2|Death|0|||
44399612|NCT00744861|79406970|FG003|Pivotal Stage 2|Death|1|||
44399613|NCT00744861|79406967|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
44399614|NCT00744861|79406968|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
44399615|NCT00744861|79406969|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
44399616|NCT00744861|79406970|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
44399617|NCT00744861|79406967|FG000|Pivotal Stage 2|Physician Decision|0|||
44521528|NCT02898454|79529775|FG001|Overall Study|Lost to Follow-up|0|||
44252807|NCT02081417|79091644|FG001|Overall Study|Death|3|||
44252808|NCT02081417|79091643|FG000|Overall Study|Withdrawal by Subject|4|||
44252809|NCT02081417|79091644|FG001|Overall Study|Withdrawal by Subject|0|||
44252810|NCT02081417|79091643|FG000|Overall Study|Admitted to Residential Treatment|2|||
44521529|NCT02898454|79529776|FG002|Overall Study|Lost to Follow-up|0|||
44521530|NCT02898454|79529774|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
44521531|NCT02898454|79529775|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
44521532|NCT02898454|79529776|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
44521533|NCT03772587|79529794|FG000|Overall Study|COVID-19|0|||
44521534|NCT03772587|79529795|FG001|Overall Study|COVID-19|0|||
44521535|NCT03772587|79529796|FG002|Overall Study|COVID-19|1|||
44521536|NCT03772587|79529797|FG003|Overall Study|COVID-19|1|||
44521537|NCT03772587|79529798|FG004|Overall Study|COVID-19|0|||
44521538|NCT03772587|79529794|FG000|Overall Study|Withdrawal by Subject|1|||
44252811|NCT02081417|79091644|FG001|Overall Study|Admitted to Residential Treatment|0|||
44252812|NCT02081417|79091643|FG000|Overall Study|Did not start treatment|17|||
44252813|NCT02081417|79091644|FG001|Overall Study|Did not start treatment|21|||
44252814|NCT02081183|79091652|FG000|Overall Study|Lost to Follow-up|0|||
44252815|NCT02081183|79091653|FG001|Overall Study|Lost to Follow-up|1|||
44252816|NCT02081183|79091652|FG000|Overall Study|Protocol Violation|1|||
44399618|NCT00744861|79406968|FG001|Pivotal Stage 2|Physician Decision|0|||
44399619|NCT00744861|79406969|FG002|Pivotal Stage 2|Physician Decision|3|||
44399620|NCT00744861|79406970|FG003|Pivotal Stage 2|Physician Decision|1|||
44399621|NCT00744861|79406967|FG000|Pivotal Stage 2|Protocol Violation|0|||
44399622|NCT00744861|79406968|FG001|Pivotal Stage 2|Protocol Violation|0|||
44399623|NCT00744861|79406969|FG002|Pivotal Stage 2|Protocol Violation|0|||
44399624|NCT00744861|79406970|FG003|Pivotal Stage 2|Protocol Violation|1|||
44399625|NCT00744861|79406967|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
44399626|NCT00744861|79406968|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
44399627|NCT00744861|79406969|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
44399628|NCT00744861|79406970|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
44399629|NCT00744861|79406967|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
44399630|NCT00744861|79406968|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
44399631|NCT00744861|79406969|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
44399632|NCT00744861|79406970|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
44399633|NCT03969589|79406980|FG000|Overall Study|Lost to Follow-up|3|||
44399634|NCT03969589|79406981|FG001|Overall Study|Lost to Follow-up|2|||
44399635|NCT03969589|79406980|FG000|Overall Study|Declined Follow-Up|0|||
44399636|NCT03969589|79406981|FG001|Overall Study|Declined Follow-Up|1|||
44399637|NCT00744627|79406989|FG000|Overall Study|Adverse Event|6|||
44399638|NCT00744627|79406990|FG001|Overall Study|Adverse Event|9|||
44399639|NCT00744627|79406989|FG000|Overall Study|Lack of Efficacy|7|||
44399640|NCT00744627|79406990|FG001|Overall Study|Lack of Efficacy|3|||
44399641|NCT00744627|79406989|FG000|Overall Study|Noncompliance|0|||
44399642|NCT00744627|79406990|FG001|Overall Study|Noncompliance|1|||
44399643|NCT00744627|79406989|FG000|Overall Study|Protocol Deviations|0|||
44399644|NCT00744627|79406990|FG001|Overall Study|Protocol Deviations|2|||
44399645|NCT00744627|79406989|FG000|Overall Study|Voluntary Withdrawal|9|||
44399646|NCT00744627|79406990|FG001|Overall Study|Voluntary Withdrawal|6|||
44399647|NCT00744627|79406989|FG000|Overall Study|Lost to Follow-up|2|||
44521539|NCT03772587|79529795|FG001|Overall Study|Withdrawal by Subject|0|||
44399648|NCT00744627|79406990|FG001|Overall Study|Lost to Follow-up|1|||
44399649|NCT00744627|79406989|FG000|Overall Study|Other|1|||
44399650|NCT00744627|79406990|FG001|Overall Study|Other|0|||
44399651|NCT03959137|79406996|FG000|Overall Study|Protocol Violation|6|||
44399652|NCT00562627|79407003|FG000|Overall Study|Protocol Violation|1|||
44399653|NCT00562627|79407004|FG001|Overall Study|Protocol Violation|1|||
44399654|NCT00562627|79407005|FG002|Overall Study|Protocol Violation|1|||
44399655|NCT00562159|79407015|FG000|Overall Study|Adverse Event|11|||
44252817|NCT02081183|79091653|FG001|Overall Study|Protocol Violation|0|||
44399656|NCT00562159|79407016|FG001|Overall Study|Adverse Event|8|||
44252818|NCT02081183|79091652|FG000|Overall Study|Other|3|||
44521540|NCT03772587|79529796|FG002|Overall Study|Withdrawal by Subject|0|||
44521541|NCT03772587|79529797|FG003|Overall Study|Withdrawal by Subject|0|||
44521542|NCT03772587|79529798|FG004|Overall Study|Withdrawal by Subject|0|||
44521543|NCT02963506|79529825|FG000|Double-Blind Period|Adverse Event|0|||
44521544|NCT02963506|79529826|FG001|Double-Blind Period|Adverse Event|0|||
44521545|NCT02963506|79529827|FG002|Double-Blind Period|Adverse Event|1|||
44521546|NCT02963506|79529828|FG003|Double-Blind Period|Adverse Event|0|||
44521547|NCT02963506|79529829|FG004|Double-Blind Period|Adverse Event|0|||
44521548|NCT02963506|79529830|FG005|Double-Blind Period|Adverse Event|0|||
44521549|NCT02963506|79529831|FG006|Double-Blind Period|Adverse Event|0|||
44521550|NCT02963506|79529832|FG007|Double-Blind Period|Adverse Event|0|||
44521551|NCT02963506|79529833|FG008|Double-Blind Period|Adverse Event|0|||
44521552|NCT02963506|79529834|FG009|Double-Blind Period|Adverse Event|0|||
44521553|NCT02963506|79529835|FG010|Double-Blind Period|Adverse Event|0|||
44521554|NCT02963506|79529836|FG011|Double-Blind Period|Adverse Event|0|||
44521555|NCT02963506|79529837|FG012|Double-Blind Period|Adverse Event|0|||
44521556|NCT02963506|79529825|FG000|Double-Blind Period|Death|0|||
44521557|NCT02963506|79529826|FG001|Double-Blind Period|Death|0|||
44521558|NCT02963506|79529827|FG002|Double-Blind Period|Death|0|||
44521559|NCT02963506|79529828|FG003|Double-Blind Period|Death|1|||
44521560|NCT02963506|79529829|FG004|Double-Blind Period|Death|0|||
44521561|NCT02963506|79529830|FG005|Double-Blind Period|Death|0|||
44521562|NCT02963506|79529831|FG006|Double-Blind Period|Death|0|||
44521563|NCT02963506|79529832|FG007|Double-Blind Period|Death|0|||
44521564|NCT02963506|79529833|FG008|Double-Blind Period|Death|0|||
44521565|NCT02963506|79529834|FG009|Double-Blind Period|Death|0|||
44521566|NCT02963506|79529835|FG010|Double-Blind Period|Death|0|||
44521567|NCT02963506|79529836|FG011|Double-Blind Period|Death|0|||
44521568|NCT02963506|79529837|FG012|Double-Blind Period|Death|0|||
44521569|NCT02963506|79529825|FG000|Double-Blind Period|Lost to Follow-up|0|||
44521570|NCT02963506|79529826|FG001|Double-Blind Period|Lost to Follow-up|1|||
44521571|NCT02963506|79529827|FG002|Double-Blind Period|Lost to Follow-up|0|||
44521572|NCT02963506|79529828|FG003|Double-Blind Period|Lost to Follow-up|0|||
44521573|NCT02963506|79529829|FG004|Double-Blind Period|Lost to Follow-up|0|||
44521574|NCT02963506|79529830|FG005|Double-Blind Period|Lost to Follow-up|0|||
44521575|NCT02963506|79529831|FG006|Double-Blind Period|Lost to Follow-up|0|||
44521576|NCT02963506|79529832|FG007|Double-Blind Period|Lost to Follow-up|0|||
44521577|NCT02963506|79529833|FG008|Double-Blind Period|Lost to Follow-up|0|||
44521578|NCT02963506|79529834|FG009|Double-Blind Period|Lost to Follow-up|0|||
44521579|NCT02963506|79529835|FG010|Double-Blind Period|Lost to Follow-up|0|||
44521580|NCT02963506|79529836|FG011|Double-Blind Period|Lost to Follow-up|0|||
44521581|NCT02963506|79529837|FG012|Double-Blind Period|Lost to Follow-up|0|||
44521582|NCT02963506|79529825|FG000|Double-Blind Period|Withdrawal by Subject|0|||
44521583|NCT02963506|79529826|FG001|Double-Blind Period|Withdrawal by Subject|0|||
44521584|NCT02963506|79529827|FG002|Double-Blind Period|Withdrawal by Subject|1|||
44521585|NCT02963506|79529828|FG003|Double-Blind Period|Withdrawal by Subject|1|||
44521586|NCT02963506|79529829|FG004|Double-Blind Period|Withdrawal by Subject|0|||
44521587|NCT02963506|79529830|FG005|Double-Blind Period|Withdrawal by Subject|0|||
44521588|NCT02963506|79529831|FG006|Double-Blind Period|Withdrawal by Subject|0|||
44521589|NCT02963506|79529832|FG007|Double-Blind Period|Withdrawal by Subject|0|||
44521590|NCT02963506|79529833|FG008|Double-Blind Period|Withdrawal by Subject|0|||
44521591|NCT02963506|79529834|FG009|Double-Blind Period|Withdrawal by Subject|0|||
44521592|NCT02963506|79529835|FG010|Double-Blind Period|Withdrawal by Subject|0|||
44521593|NCT02963506|79529836|FG011|Double-Blind Period|Withdrawal by Subject|0|||
44521594|NCT02963506|79529837|FG012|Double-Blind Period|Withdrawal by Subject|0|||
44521595|NCT02963506|79529825|FG000|Double-Blind Period|No compliance|0|||
44521596|NCT02963506|79529826|FG001|Double-Blind Period|No compliance|1|||
44521597|NCT02963506|79529827|FG002|Double-Blind Period|No compliance|0|||
44521598|NCT02963506|79529828|FG003|Double-Blind Period|No compliance|0|||
44521599|NCT02963506|79529829|FG004|Double-Blind Period|No compliance|0|||
44521600|NCT02963506|79529830|FG005|Double-Blind Period|No compliance|0|||
44281677|NCT01915914|79244954|FG003|Acute Phase|Physician Decision|0|||
44521601|NCT02963506|79529831|FG006|Double-Blind Period|No compliance|0|||
44521602|NCT02963506|79529832|FG007|Double-Blind Period|No compliance|0|||
44521603|NCT02963506|79529833|FG008|Double-Blind Period|No compliance|0|||
44521604|NCT02963506|79529834|FG009|Double-Blind Period|No compliance|0|||
44521605|NCT02963506|79529835|FG010|Double-Blind Period|No compliance|0|||
44521606|NCT02963506|79529836|FG011|Double-Blind Period|No compliance|0|||
44521607|NCT02963506|79529837|FG012|Double-Blind Period|No compliance|0|||
44521608|NCT02963506|79529825|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521609|NCT02963506|79529826|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
44252819|NCT02081183|79091653|FG001|Overall Study|Other|3|||
44521610|NCT02963506|79529827|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521611|NCT02963506|79529828|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521612|NCT02963506|79529829|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521613|NCT02963506|79529830|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521614|NCT02963506|79529831|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521615|NCT02963506|79529832|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521616|NCT02963506|79529833|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521617|NCT02963506|79529834|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521618|NCT02963506|79529835|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521619|NCT02963506|79529836|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521620|NCT02963506|79529837|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
44521621|NCT02963506|79529825|FG000|Dose-Blind Period|Adverse Event|0|||
44521622|NCT02963506|79529826|FG001|Dose-Blind Period|Adverse Event|0|||
44399657|NCT00562159|79407015|FG000|Overall Study|Lost to Follow-up|5|||
44399658|NCT00562159|79407016|FG001|Overall Study|Lost to Follow-up|4|||
44399659|NCT00562159|79407015|FG000|Overall Study|Withdrawal by Subject|9|||
44399660|NCT00562159|79407016|FG001|Overall Study|Withdrawal by Subject|8|||
44399661|NCT00562159|79407015|FG000|Overall Study|Protocol Violation|12|||
44399662|NCT00562159|79407016|FG001|Overall Study|Protocol Violation|12|||
44399663|NCT00562159|79407015|FG000|Overall Study|Did not meet protocol eligibility|1|||
44399664|NCT00562159|79407016|FG001|Overall Study|Did not meet protocol eligibility|1|||
44399665|NCT04223778|79407025|FG000|Overall Study|Ongoing|322|||
44399666|NCT04223778|79407026|FG001|Overall Study|Ongoing|326|||
44399667|NCT04223778|79407025|FG000|Overall Study|Death|0|||
44399668|NCT04223778|79407026|FG001|Overall Study|Death|1|||
44399669|NCT04223778|79407025|FG000|Overall Study|Lost to Follow-up|1|||
44399670|NCT04223778|79407026|FG001|Overall Study|Lost to Follow-up|5|||
44399671|NCT04223778|79407025|FG000|Overall Study|Physician Decision|3|||
44399672|NCT04223778|79407026|FG001|Overall Study|Physician Decision|1|||
44399673|NCT04223778|79407025|FG000|Overall Study|Withdrawal by Subject|10|||
44399674|NCT04223778|79407026|FG001|Overall Study|Withdrawal by Subject|1|||
44399675|NCT04223778|79407025|FG000|Overall Study|Lack of Efficacy|0|||
44399676|NCT04223778|79407026|FG001|Overall Study|Lack of Efficacy|2|||
44399677|NCT00921557|79407035|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
44399678|NCT00921557|79407036|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
44399679|NCT00921557|79407037|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
44399680|NCT00921557|79407035|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
44399681|NCT00921557|79407036|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
44399682|NCT00921557|79407037|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
44399683|NCT00921557|79407035|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
44399684|NCT00921557|79407036|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
44399685|NCT00921557|79407037|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
44399686|NCT00921557|79407035|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
44399687|NCT00921557|79407036|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
44399688|NCT00921557|79407037|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
44399689|NCT00921557|79407035|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
44399690|NCT00921557|79407036|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
44399691|NCT00921557|79407037|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
44399692|NCT00744471|79407054|FG000|Overall Study|Randomized but not treated|1|||
44399693|NCT00744471|79407055|FG001|Overall Study|Randomized but not treated|1|||
44399694|NCT00744471|79407056|FG002|Overall Study|Randomized but not treated|4|||
44399695|NCT00744471|79407057|FG003|Overall Study|Randomized but not treated|0|||
44399696|NCT00744471|79407054|FG000|Overall Study|Death|0|||
44399697|NCT00744471|79407055|FG001|Overall Study|Death|0|||
44399698|NCT00744471|79407056|FG002|Overall Study|Death|0|||
44399699|NCT00744471|79407057|FG003|Overall Study|Death|1|||
44399700|NCT00744471|79407054|FG000|Overall Study|Adverse Event|6|||
44399701|NCT00744471|79407055|FG001|Overall Study|Adverse Event|7|||
44399702|NCT00744471|79407056|FG002|Overall Study|Adverse Event|5|||
44399703|NCT00744471|79407057|FG003|Overall Study|Adverse Event|9|||
44521623|NCT02963506|79529827|FG002|Dose-Blind Period|Adverse Event|0|||
44521624|NCT02963506|79529828|FG003|Dose-Blind Period|Adverse Event|0|||
44399704|NCT00744471|79407054|FG000|Overall Study|Withdrawal by Subject|9|||
44399705|NCT00744471|79407055|FG001|Overall Study|Withdrawal by Subject|9|||
44399706|NCT00744471|79407056|FG002|Overall Study|Withdrawal by Subject|15|||
44399707|NCT00744471|79407057|FG003|Overall Study|Withdrawal by Subject|12|||
44399708|NCT00744471|79407054|FG000|Overall Study|Protocol Violation|1|||
44399709|NCT00744471|79407055|FG001|Overall Study|Protocol Violation|4|||
44399710|NCT00744471|79407056|FG002|Overall Study|Protocol Violation|1|||
44399711|NCT00744471|79407057|FG003|Overall Study|Protocol Violation|2|||
44399712|NCT00744471|79407054|FG000|Overall Study|Entered extension study|41|||
44399713|NCT00744471|79407055|FG001|Overall Study|Entered extension study|84|||
44399714|NCT00744471|79407056|FG002|Overall Study|Entered extension study|100|||
44399715|NCT00744471|79407057|FG003|Overall Study|Entered extension study|91|||
44399716|NCT00744471|79407054|FG000|Overall Study|Other|2|||
44399717|NCT00744471|79407055|FG001|Overall Study|Other|3|||
44399718|NCT00744471|79407056|FG002|Overall Study|Other|6|||
44399719|NCT00744471|79407057|FG003|Overall Study|Other|2|||
44399720|NCT00744471|79407054|FG000|Overall Study|Lack of Efficacy|83|||
44521625|NCT02963506|79529829|FG004|Dose-Blind Period|Adverse Event|0|||
44399721|NCT00744471|79407055|FG001|Overall Study|Lack of Efficacy|37|||
44399722|NCT00744471|79407056|FG002|Overall Study|Lack of Efficacy|19|||
44399723|NCT00744471|79407057|FG003|Overall Study|Lack of Efficacy|31|||
44521626|NCT02963506|79529830|FG005|Dose-Blind Period|Adverse Event|1|||
44521627|NCT02963506|79529831|FG006|Dose-Blind Period|Adverse Event|3|||
44399724|NCT00744471|79407054|FG000|Overall Study|Lost to Follow-up|0|||
44399725|NCT00744471|79407055|FG001|Overall Study|Lost to Follow-up|0|||
44399726|NCT00744471|79407056|FG002|Overall Study|Lost to Follow-up|2|||
44399727|NCT00744471|79407057|FG003|Overall Study|Lost to Follow-up|0|||
44399728|NCT00744237|79407070|FG000|Overall Study|Lack of Efficacy|1|||
44399729|NCT00744237|79407071|FG001|Overall Study|Lack of Efficacy|1|||
44399730|NCT00744237|79407072|FG002|Overall Study|Lack of Efficacy|0|||
44399731|NCT00744237|79407070|FG000|Overall Study|Withdrawal by Subject|9|||
44399732|NCT00744237|79407071|FG001|Overall Study|Withdrawal by Subject|5|||
44399733|NCT00744237|79407072|FG002|Overall Study|Withdrawal by Subject|3|||
44399734|NCT00744237|79407070|FG000|Overall Study|Lost to Follow-up|1|||
44399735|NCT00744237|79407071|FG001|Overall Study|Lost to Follow-up|1|||
44521628|NCT02963506|79529832|FG007|Dose-Blind Period|Adverse Event|2|||
44521629|NCT02963506|79529833|FG008|Dose-Blind Period|Adverse Event|2|||
44521630|NCT02963506|79529834|FG009|Dose-Blind Period|Adverse Event|2|||
44521631|NCT02963506|79529835|FG010|Dose-Blind Period|Adverse Event|1|||
44521632|NCT02963506|79529836|FG011|Dose-Blind Period|Adverse Event|1|||
44521633|NCT02963506|79529837|FG012|Dose-Blind Period|Adverse Event|6|||
44399736|NCT00744237|79407072|FG002|Overall Study|Lost to Follow-up|1|||
44399737|NCT00744237|79407070|FG000|Overall Study|Protocol Violation|3|||
44399738|NCT00744237|79407071|FG001|Overall Study|Protocol Violation|4|||
44399739|NCT00744237|79407072|FG002|Overall Study|Protocol Violation|3|||
44399740|NCT00744237|79407070|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
44399741|NCT00744237|79407071|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
44399742|NCT00744237|79407072|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
44399743|NCT00744237|79407070|FG000|Overall Study|Dosing Error|1|||
44399744|NCT00744237|79407071|FG001|Overall Study|Dosing Error|0|||
44399745|NCT00744237|79407072|FG002|Overall Study|Dosing Error|1|||
44399746|NCT00744237|79407070|FG000|Overall Study|Study Drug Error|1|||
44399747|NCT00744237|79407071|FG001|Overall Study|Study Drug Error|0|||
44399748|NCT00744237|79407072|FG002|Overall Study|Study Drug Error|0|||
44399749|NCT00744237|79407070|FG000|Overall Study|Prohibited Concomitant Medication|0|||
44399750|NCT00744237|79407071|FG001|Overall Study|Prohibited Concomitant Medication|0|||
44399751|NCT00744237|79407072|FG002|Overall Study|Prohibited Concomitant Medication|1|||
44399752|NCT00744237|79407070|FG000|Overall Study|Poor Compliance|0|||
44399753|NCT00744237|79407071|FG001|Overall Study|Poor Compliance|2|||
44399754|NCT00744237|79407072|FG002|Overall Study|Poor Compliance|0|||
44399755|NCT00744237|79407070|FG000|Overall Study|Administrative. Site Closed|1|||
44399756|NCT00744237|79407071|FG001|Overall Study|Administrative. Site Closed|1|||
44399757|NCT00744237|79407072|FG002|Overall Study|Administrative. Site Closed|1|||
44399758|NCT00744237|79407070|FG000|Overall Study|Adverse Event|9|||
44399759|NCT00744237|79407071|FG001|Overall Study|Adverse Event|13|||
44399760|NCT00744237|79407072|FG002|Overall Study|Adverse Event|5|||
44399761|NCT00743145|79407080|FG000|Overall Study|Withdrawal by Subject|1|||
44399762|NCT00743145|79407080|FG000|Overall Study|Adverse Event|2|||
44399763|NCT00743145|79407080|FG000|Overall Study|Pregnancy|1|||
44521634|NCT02963506|79529825|FG000|Dose-Blind Period|Lack of Efficacy|0|||
44521635|NCT02963506|79529826|FG001|Dose-Blind Period|Lack of Efficacy|0|||
44521636|NCT02963506|79529827|FG002|Dose-Blind Period|Lack of Efficacy|0|||
44521637|NCT02963506|79529828|FG003|Dose-Blind Period|Lack of Efficacy|0|||
44521638|NCT02963506|79529829|FG004|Dose-Blind Period|Lack of Efficacy|0|||
44521639|NCT02963506|79529830|FG005|Dose-Blind Period|Lack of Efficacy|0|||
44252820|NCT02080871|79091659|FG000|Overall Study|Death|1|||
44252821|NCT02080871|79091659|FG000|Overall Study|Lost to Follow-up|1|||
44399764|NCT00920855|79407097|FG000|Overall Study|Adverse Event|1|||
44399765|NCT00920855|79407098|FG001|Overall Study|Adverse Event|1|||
44399766|NCT00920855|79407099|FG002|Overall Study|Adverse Event|4|||
44399767|NCT00920855|79407097|FG000|Overall Study|Withdrawal by Subject|2|||
44399768|NCT00920855|79407098|FG001|Overall Study|Withdrawal by Subject|1|||
44521640|NCT02963506|79529831|FG006|Dose-Blind Period|Lack of Efficacy|0|||
44521641|NCT02963506|79529832|FG007|Dose-Blind Period|Lack of Efficacy|1|||
44399769|NCT00920855|79407099|FG002|Overall Study|Withdrawal by Subject|6|||
44399770|NCT00920855|79407097|FG000|Overall Study|Disease progression|2|||
44399771|NCT00920855|79407098|FG001|Overall Study|Disease progression|1|||
44399772|NCT00920855|79407099|FG002|Overall Study|Disease progression|10|||
44399773|NCT00920855|79407097|FG000|Overall Study|Noncompliance to study medication|0|||
44399774|NCT00920855|79407098|FG001|Overall Study|Noncompliance to study medication|0|||
44399775|NCT00920855|79407099|FG002|Overall Study|Noncompliance to study medication|1|||
44399776|NCT00920855|79407097|FG000|Overall Study|Response plateau; started maintenance|0|||
44399777|NCT00920855|79407098|FG001|Overall Study|Response plateau; started maintenance|0|||
44399778|NCT00920855|79407099|FG002|Overall Study|Response plateau; started maintenance|1|||
44399779|NCT00742209|79407113|FG000|Overall Study|Adverse Event|11|||
44399780|NCT00742209|79407114|FG001|Overall Study|Adverse Event|4|||
44399781|NCT00742209|79407115|FG002|Overall Study|Adverse Event|17|||
44399782|NCT00742209|79407116|FG003|Overall Study|Adverse Event|16|||
44399783|NCT00742209|79407117|FG004|Overall Study|Adverse Event|13|||
44399784|NCT00742209|79407113|FG000|Overall Study|Participant Withdrew Consent|8|||
44399785|NCT00742209|79407114|FG001|Overall Study|Participant Withdrew Consent|4|||
44399786|NCT00742209|79407115|FG002|Overall Study|Participant Withdrew Consent|14|||
44399787|NCT00742209|79407116|FG003|Overall Study|Participant Withdrew Consent|7|||
44399788|NCT00742209|79407117|FG004|Overall Study|Participant Withdrew Consent|4|||
44399789|NCT00742209|79407113|FG000|Overall Study|Protocol Violation|6|||
44399790|NCT00742209|79407114|FG001|Overall Study|Protocol Violation|5|||
44399791|NCT00742209|79407115|FG002|Overall Study|Protocol Violation|4|||
44399792|NCT00742209|79407116|FG003|Overall Study|Protocol Violation|5|||
44399793|NCT00742209|79407117|FG004|Overall Study|Protocol Violation|3|||
44399794|NCT00742209|79407113|FG000|Overall Study|Lost to Follow-up|3|||
44399795|NCT00742209|79407114|FG001|Overall Study|Lost to Follow-up|4|||
44399796|NCT00742209|79407115|FG002|Overall Study|Lost to Follow-up|5|||
44399797|NCT00742209|79407116|FG003|Overall Study|Lost to Follow-up|5|||
44399798|NCT00742209|79407117|FG004|Overall Study|Lost to Follow-up|3|||
44399799|NCT00742209|79407113|FG000|Overall Study|Lack of Efficacy|6|||
44399800|NCT00742209|79407114|FG001|Overall Study|Lack of Efficacy|1|||
44399801|NCT00742209|79407115|FG002|Overall Study|Lack of Efficacy|1|||
44399802|NCT00742209|79407116|FG003|Overall Study|Lack of Efficacy|3|||
44399803|NCT00742209|79407117|FG004|Overall Study|Lack of Efficacy|1|||
44399804|NCT00742209|79407113|FG000|Overall Study|Investigator Discretion|0|||
44399805|NCT00742209|79407114|FG001|Overall Study|Investigator Discretion|0|||
44399806|NCT00742209|79407115|FG002|Overall Study|Investigator Discretion|5|||
44399807|NCT00742209|79407116|FG003|Overall Study|Investigator Discretion|1|||
44399808|NCT00742209|79407117|FG004|Overall Study|Investigator Discretion|1|||
44399809|NCT00741819|79407130|FG000|Overall Study|Adverse Event|3|||
44399810|NCT00741819|79407130|FG000|Overall Study|Withdrawal by Subject|3|||
44399811|NCT00741819|79407130|FG000|Overall Study|Death|1|||
44399812|NCT00741819|79407130|FG000|Overall Study|Disease progression|1|||
44399813|NCT00924443|79407136|FG000|Overall Study|Physician Decision|2|||
44399814|NCT00924443|79407136|FG000|Overall Study|Protocol Violation|1|||
44399815|NCT00924287|79407140|FG000|Overall Study|Death|1|||
44399816|NCT00923975|79407144|FG000|Overall Study|Did not meet inclusion criteria|1|||
44399817|NCT00918203|79407180|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
44399818|NCT00918203|79407181|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
44399819|NCT00918203|79407182|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
44399820|NCT00918203|79407180|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
44399821|NCT00918203|79407181|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
44399822|NCT00918203|79407182|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
44399823|NCT00918203|79407180|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
44399824|NCT00918203|79407181|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
44399825|NCT00918203|79407182|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
44399826|NCT00918203|79407180|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
44521642|NCT02963506|79529833|FG008|Dose-Blind Period|Lack of Efficacy|0|||
44521643|NCT02963506|79529834|FG009|Dose-Blind Period|Lack of Efficacy|1|||
44147385|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
44147386|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
44147387|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
44399827|NCT00918203|79407181|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
44399828|NCT00918203|79407182|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
44399829|NCT00918281|79407194|FG000|Overall Study|Physician Decision|29|||
44399830|NCT02770716|79407203|FG000|Overall Study|Death|101|||
44399831|NCT02770716|79407204|FG001|Overall Study|Death|45|||
44399832|NCT02770716|79407203|FG000|Overall Study|Withdrawal by Subject|4|||
44399833|NCT02770716|79407204|FG001|Overall Study|Withdrawal by Subject|2|||
44399834|NCT02770716|79407203|FG000|Overall Study|Lost to Follow-up|1|||
44399835|NCT02770716|79407204|FG001|Overall Study|Lost to Follow-up|0|||
44399836|NCT02770716|79407203|FG000|Overall Study|Various reasons|6|||
44399837|NCT02770716|79407204|FG001|Overall Study|Various reasons|2|||
44399838|NCT00917579|79407210|FG000|Washout >= 2 Weeks|Adverse Event|1|||
44399839|NCT00917579|79407211|FG001|Washout >= 2 Weeks|Adverse Event|0|||
44399840|NCT00917579|79407210|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
44399841|NCT00917579|79407211|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
44399842|NCT00915551|79407219|FG000|Overall Study|Withdrawal by Subject|0|||
44521644|NCT02963506|79529835|FG010|Dose-Blind Period|Lack of Efficacy|0|||
44521645|NCT02963506|79529836|FG011|Dose-Blind Period|Lack of Efficacy|0|||
44521646|NCT02963506|79529837|FG012|Dose-Blind Period|Lack of Efficacy|0|||
44521647|NCT02963506|79529825|FG000|Dose-Blind Period|Lost to Follow-up|0|||
44521648|NCT02963506|79529826|FG001|Dose-Blind Period|Lost to Follow-up|0|||
44521649|NCT02963506|79529827|FG002|Dose-Blind Period|Lost to Follow-up|0|||
44521650|NCT02963506|79529828|FG003|Dose-Blind Period|Lost to Follow-up|0|||
44521651|NCT02963506|79529829|FG004|Dose-Blind Period|Lost to Follow-up|0|||
44521652|NCT02963506|79529830|FG005|Dose-Blind Period|Lost to Follow-up|1|||
44521653|NCT02963506|79529831|FG006|Dose-Blind Period|Lost to Follow-up|0|||
44521654|NCT02963506|79529832|FG007|Dose-Blind Period|Lost to Follow-up|0|||
44521655|NCT02963506|79529833|FG008|Dose-Blind Period|Lost to Follow-up|1|||
44521656|NCT02963506|79529834|FG009|Dose-Blind Period|Lost to Follow-up|0|||
44147388|NCT00700427|78936720|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
44252822|NCT02080481|79091665|FG000|Overall Study|Never received a block.|1|||
44252823|NCT02080481|79091666|FG001|Overall Study|Never received a block.|0|||
44399843|NCT00915551|79407220|FG001|Overall Study|Withdrawal by Subject|1|||
44399844|NCT00915473|79407228|FG000|Screening|Withdrawal by Subject|1|||
44399845|NCT00915473|79407229|FG001|Screening|Withdrawal by Subject|0|||
44399846|NCT00915473|79407228|FG000|4-week Follow Up|Lost to Follow-up|1|||
44399847|NCT00915473|79407229|FG001|4-week Follow Up|Lost to Follow-up|5|||
44399848|NCT00917501|79407237|FG000|Overall Study|Lost to Follow-up|4|||
44399849|NCT00917501|79407238|FG001|Overall Study|Lost to Follow-up|1|||
44399850|NCT00917501|79407237|FG000|Overall Study|Withdrawal by Subject|3|||
44399851|NCT00917501|79407238|FG001|Overall Study|Withdrawal by Subject|1|||
44399852|NCT00917501|79407237|FG000|Overall Study|Lack of Efficacy|1|||
44252824|NCT02080403|79091674|FG000|Overall Study|Adverse Event|5|||
44252825|NCT02080403|79091675|FG001|Overall Study|Adverse Event|1|||
44399853|NCT00917501|79407238|FG001|Overall Study|Lack of Efficacy|2|||
44399854|NCT00917501|79407237|FG000|Overall Study|trouble swollowing capsules|0|||
44252826|NCT02080403|79091674|FG000|Overall Study|Death|0|||
44252827|NCT02080403|79091675|FG001|Overall Study|Death|2|||
44399855|NCT00917501|79407238|FG001|Overall Study|trouble swollowing capsules|1|||
44399856|NCT00917267|79407257|FG000|Overall Study|Adverse Event|15|||
44399857|NCT00917267|79407258|FG001|Overall Study|Adverse Event|36|||
44399858|NCT00917267|79407257|FG000|Overall Study|Physician Decision|2|||
44399859|NCT00917267|79407258|FG001|Overall Study|Physician Decision|4|||
44399860|NCT00917267|79407257|FG000|Overall Study|Protocol Violation|9|||
44399861|NCT00917267|79407258|FG001|Overall Study|Protocol Violation|18|||
44399862|NCT00917267|79407257|FG000|Overall Study|Withdrawal by Subject|5|||
44399863|NCT00917267|79407258|FG001|Overall Study|Withdrawal by Subject|12|||
44399864|NCT00917267|79407257|FG000|Overall Study|Lost to follow up|0|||
44399865|NCT00917267|79407258|FG001|Overall Study|Lost to follow up|2|||
44399866|NCT00917267|79407257|FG000|Overall Study|Entry Criteria Not Met|1|||
44399867|NCT00917267|79407258|FG001|Overall Study|Entry Criteria Not Met|0|||
44399868|NCT00917267|79407257|FG000|Overall Study|Sponsor Decision|5|||
44399869|NCT00917267|79407258|FG001|Overall Study|Sponsor Decision|5|||
44399870|NCT00917267|79407257|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
44399871|NCT00917267|79407258|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
44399872|NCT00920699|79407271|FG000|Overall Study|Withdrawal by Subject|2|||
44399873|NCT00920699|79407272|FG001|Overall Study|Withdrawal by Subject|0|||
44399874|NCT00920699|79407273|FG002|Overall Study|Withdrawal by Subject|2|||
44399875|NCT00920699|79407271|FG000|Overall Study|no longer met eligibility|0|||
44399876|NCT00920699|79407272|FG001|Overall Study|no longer met eligibility|1|||
44399877|NCT00920699|79407273|FG002|Overall Study|no longer met eligibility|0|||
44252828|NCT02080403|79091674|FG000|Overall Study|Lost to Follow-up|2|||
44252829|NCT02080403|79091675|FG001|Overall Study|Lost to Follow-up|0|||
44399878|NCT00920699|79407271|FG000|Overall Study|Lost to Follow-up|0|||
44399879|NCT00920699|79407272|FG001|Overall Study|Lost to Follow-up|0|||
44399880|NCT00920699|79407273|FG002|Overall Study|Lost to Follow-up|2|||
44399881|NCT03462576|79407284|FG000|Overall Study|Protocol Violation|5|||
44399882|NCT03462576|79407285|FG001|Overall Study|Protocol Violation|11|||
44399883|NCT03462576|79407286|FG002|Overall Study|Protocol Violation|7|||
44399884|NCT03462576|79407284|FG000|Overall Study|Device Malfunction|0|||
44399885|NCT03462576|79407285|FG001|Overall Study|Device Malfunction|0|||
44399886|NCT03462576|79407286|FG002|Overall Study|Device Malfunction|1|||
44399887|NCT00916721|79407296|FG000|Overall Study|Lost to Follow-up|0|||
44399888|NCT00916721|79407297|FG001|Overall Study|Lost to Follow-up|1|||
44399889|NCT00916721|79407296|FG000|Overall Study|Adverse Event|6|||
44399890|NCT00916721|79407297|FG001|Overall Study|Adverse Event|3|||
44399891|NCT00916721|79407296|FG000|Overall Study|Withdrawal by Subject|2|||
44521657|NCT02963506|79529835|FG010|Dose-Blind Period|Lost to Follow-up|0|||
44521658|NCT02963506|79529836|FG011|Dose-Blind Period|Lost to Follow-up|1|||
44252830|NCT02080403|79091674|FG000|Overall Study|Pregnancy|0|||
44252831|NCT02080403|79091675|FG001|Overall Study|Pregnancy|1|||
44252832|NCT02080403|79091674|FG000|Overall Study|Protocol Violation|3|||
44399892|NCT00916721|79407297|FG001|Overall Study|Withdrawal by Subject|2|||
44399893|NCT00916721|79407296|FG000|Overall Study|Protocol Violation|2|||
44399894|NCT00916721|79407297|FG001|Overall Study|Protocol Violation|4|||
44399895|NCT00915005|79407305|FG000|Overall Study|Withdrawal by Subject|4|||
44399896|NCT00915005|79407306|FG001|Overall Study|Withdrawal by Subject|4|||
44399897|NCT00915005|79407305|FG000|Overall Study|Patient preferred protons therapy|6|||
44399898|NCT00915005|79407306|FG001|Overall Study|Patient preferred protons therapy|0|||
44399899|NCT00915005|79407305|FG000|Overall Study|Insurance denial|3|||
44399900|NCT00915005|79407306|FG001|Overall Study|Insurance denial|15|||
44399901|NCT01143246|79407314|FG000|Overall Study|Adverse Event|24|||
44399902|NCT01143246|79407315|FG001|Overall Study|Adverse Event|28|||
44399903|NCT01143246|79407314|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
44399904|NCT01143246|79407315|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
44399905|NCT01143246|79407314|FG000|Overall Study|Lost to Follow-up|0|||
44399906|NCT01143246|79407315|FG001|Overall Study|Lost to Follow-up|1|||
44399907|NCT01143246|79407314|FG000|Overall Study|Death|16|||
44399908|NCT01143246|79407315|FG001|Overall Study|Death|15|||
44399909|NCT01143246|79407314|FG000|Overall Study|Reason not Specified|3|||
44399910|NCT01143246|79407315|FG001|Overall Study|Reason not Specified|5|||
44399911|NCT00561925|79407329|FG000|14 Day Lead-In Period|Adverse Event|38|||
44399912|NCT00561925|79407330|FG001|14 Day Lead-In Period|Adverse Event|0|||
44399913|NCT00561925|79407331|FG002|14 Day Lead-In Period|Adverse Event|0|||
44399914|NCT00561925|79407332|FG003|14 Day Lead-In Period|Adverse Event|0|||
44399915|NCT00561925|79407333|FG004|14 Day Lead-In Period|Adverse Event|0|||
44399916|NCT00561925|79407329|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
44399917|NCT00561925|79407330|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
44399918|NCT00561925|79407331|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
44399919|NCT00561925|79407332|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
44399920|NCT00561925|79407333|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
44399921|NCT00561925|79407329|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
44399922|NCT00561925|79407330|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
44399923|NCT00561925|79407331|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
44399924|NCT00561925|79407332|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
44399925|NCT00561925|79407333|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
44399926|NCT00561925|79407329|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
44399927|NCT00561925|79407330|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
44521659|NCT02963506|79529837|FG012|Dose-Blind Period|Lost to Follow-up|0|||
44521660|NCT02963506|79529825|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
44521661|NCT02963506|79529826|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
44521662|NCT02963506|79529827|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
44521663|NCT02963506|79529828|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
44521664|NCT02963506|79529829|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
44521665|NCT02963506|79529830|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
44521666|NCT02963506|79529831|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
44521667|NCT02963506|79529832|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
44521668|NCT02963506|79529833|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
44521669|NCT02963506|79529834|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
44521670|NCT02963506|79529835|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
44521671|NCT02963506|79529836|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
44521672|NCT02963506|79529837|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
44521673|NCT02963506|79529825|FG000|Dose-Blind Period|Sponsor decision|0|||
44521674|NCT02963506|79529826|FG001|Dose-Blind Period|Sponsor decision|0|||
44521675|NCT02963506|79529827|FG002|Dose-Blind Period|Sponsor decision|0|||
44521676|NCT02963506|79529828|FG003|Dose-Blind Period|Sponsor decision|0|||
44521677|NCT02963506|79529829|FG004|Dose-Blind Period|Sponsor decision|0|||
44521678|NCT02963506|79529830|FG005|Dose-Blind Period|Sponsor decision|1|||
44521679|NCT02963506|79529831|FG006|Dose-Blind Period|Sponsor decision|0|||
44521680|NCT02963506|79529832|FG007|Dose-Blind Period|Sponsor decision|0|||
44521681|NCT02963506|79529833|FG008|Dose-Blind Period|Sponsor decision|0|||
44521682|NCT02963506|79529834|FG009|Dose-Blind Period|Sponsor decision|0|||
44399928|NCT00561925|79407331|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
44399929|NCT00561925|79407332|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
44399930|NCT00561925|79407333|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
44399931|NCT00561925|79407329|FG000|14 Day Lead-In Period|Other|5|||
44399932|NCT00561925|79407330|FG001|14 Day Lead-In Period|Other|0|||
44399933|NCT00561925|79407331|FG002|14 Day Lead-In Period|Other|0|||
44399934|NCT00561925|79407332|FG003|14 Day Lead-In Period|Other|0|||
44399935|NCT00561925|79407333|FG004|14 Day Lead-In Period|Other|0|||
44521683|NCT02963506|79529835|FG010|Dose-Blind Period|Sponsor decision|0|||
44521684|NCT02963506|79529836|FG011|Dose-Blind Period|Sponsor decision|0|||
44521685|NCT02963506|79529837|FG012|Dose-Blind Period|Sponsor decision|0|||
44521686|NCT02963506|79529825|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44399936|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
44521687|NCT02963506|79529826|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521688|NCT02963506|79529827|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521689|NCT02963506|79529828|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521690|NCT02963506|79529829|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521691|NCT02963506|79529830|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521692|NCT02963506|79529831|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521693|NCT02963506|79529832|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521694|NCT02963506|79529833|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521695|NCT02963506|79529834|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521696|NCT02963506|79529835|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521697|NCT02963506|79529836|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
44521698|NCT02963506|79529837|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
44521699|NCT01345162|79529856|FG000|Overall Study|Protocol Violation|2|||
44521700|NCT01345162|79529857|FG001|Overall Study|Protocol Violation|4|||
44521701|NCT01345318|79529863|FG000|Overall Study|Adverse Event|16|||
44521702|NCT01345318|79529863|FG000|Overall Study|Lack of Efficacy|17|||
44521703|NCT01345318|79529863|FG000|Overall Study|Lost to Follow-up|2|||
44521704|NCT01345318|79529863|FG000|Overall Study|Protocol Violation|1|||
44521705|NCT01345318|79529863|FG000|Overall Study|Withdrawal by Subject|41|||
44521706|NCT01345318|79529863|FG000|Overall Study|Other|3|||
44521707|NCT02961244|79529870|FG000|Overall Study|Protocol Violation|0|||
44521708|NCT02961244|79529871|FG001|Overall Study|Protocol Violation|1|||
44521709|NCT02961244|79529870|FG000|Overall Study|Withdrawal by Subject|1|||
44521710|NCT02961244|79529871|FG001|Overall Study|Withdrawal by Subject|2|||
44521711|NCT02961244|79529870|FG000|Overall Study|Surgery plan change after study approval|0|||
44521712|NCT02961244|79529871|FG001|Overall Study|Surgery plan change after study approval|2|||
44521713|NCT02961244|79529870|FG000|Overall Study|Lost to Follow-up|0|||
44521714|NCT02961244|79529871|FG001|Overall Study|Lost to Follow-up|2|||
44521715|NCT02961244|79529870|FG000|Overall Study|İnadequate data|0|||
44521716|NCT02961244|79529871|FG001|Overall Study|İnadequate data|2|||
44521717|NCT03771963|79529877|FG000|Overall Study|Lost to Follow-up|22|||
44521718|NCT03771963|79529877|FG000|Overall Study|Withdrawal of Consent|10|||
44521719|NCT02962648|79529881|FG000|Overall Study|Withdrawal by Subject|3|||
44521720|NCT02962648|79529881|FG000|Overall Study|Lost to Follow-up|3|||
44521721|NCT02962648|79529881|FG000|Overall Study|Physician Decision|1|||
44521722|NCT02962648|79529881|FG000|Overall Study|Subject had problems with transportation|2|||
44521723|NCT02962882|79529885|FG000|Overall Study|Adverse Event|2|||
44521724|NCT02962882|79529885|FG000|Overall Study|Withdrawal by Subject|2|||
44521725|NCT02962882|79529885|FG000|Overall Study|Transfer from ICU|32|||
44521726|NCT02961790|79529894|FG000|Overall Study|Canceled|4|||
44521727|NCT02961790|79529895|FG001|Overall Study|Canceled|5|||
44521728|NCT02961790|79529896|FG002|Overall Study|Canceled|1|||
44521729|NCT02961790|79529897|FG003|Overall Study|Canceled|4|||
44521730|NCT02961790|79529894|FG000|Overall Study|without baseline data|4|||
44521731|NCT02961790|79529895|FG001|Overall Study|without baseline data|0|||
44521732|NCT02961790|79529896|FG002|Overall Study|without baseline data|1|||
44521733|NCT02961790|79529897|FG003|Overall Study|without baseline data|0|||
44521734|NCT02961790|79529894|FG000|Overall Study|without post baseline data|7|||
44521735|NCT02961790|79529895|FG001|Overall Study|without post baseline data|6|||
44521736|NCT02961790|79529896|FG002|Overall Study|without post baseline data|4|||
44521737|NCT02961790|79529897|FG003|Overall Study|without post baseline data|1|||
44521738|NCT02960854|79529919|FG000|Overall Study|Not Disclosed|2|||
44521739|NCT02960854|79529920|FG001|Overall Study|Not Disclosed|2|||
44521740|NCT02960854|79529919|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
44521741|NCT02960854|79529920|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
44521742|NCT02960854|79529919|FG000|Overall Study|Subject Withdrew Consent|0|||
44521743|NCT02960854|79529920|FG001|Overall Study|Subject Withdrew Consent|1|||
44521744|NCT02960854|79529919|FG000|Overall Study|Death|4|||
44521745|NCT02960854|79529920|FG001|Overall Study|Death|6|||
44521746|NCT01344538|79529928|FG000|Overall Study|Adverse Event|1|||
44521747|NCT01344538|79529929|FG001|Overall Study|Adverse Event|1|||
44521748|NCT01344538|79529928|FG000|Overall Study|Lost to Follow-up|1|||
44521749|NCT01344538|79529929|FG001|Overall Study|Lost to Follow-up|0|||
44147389|NCT00700427|78936721|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
44281678|NCT01915914|79244951|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
44521750|NCT01344460|79529935|FG000|Overall Study|Withdrawal by Subject|1|||
44521751|NCT01344460|79529935|FG000|Overall Study|Lost to Follow-up|2|||
44521752|NCT03764631|79529945|FG000|Overall Study|Personal Reasons|3|||
44521753|NCT03764631|79529946|FG001|Overall Study|Personal Reasons|2|||
44521754|NCT03764631|79529945|FG000|Overall Study|Switching Therapy|3|||
44521755|NCT03764631|79529946|FG001|Overall Study|Switching Therapy|3|||
44521756|NCT03764631|79529945|FG000|Overall Study|Adverse Event|0|||
44521757|NCT03764631|79529946|FG001|Overall Study|Adverse Event|1|||
44521758|NCT03764631|79529945|FG000|Overall Study|Lost to Follow-up|33|||
44521759|NCT03764631|79529946|FG001|Overall Study|Lost to Follow-up|41|||
44521760|NCT03764631|79529945|FG000|Overall Study|No data as study site was closed|2|||
44521761|NCT03764631|79529946|FG001|Overall Study|No data as study site was closed|6|||
44521762|NCT02956486|79529965|FG000|Core Phase|Adverse Event|51|||
44521763|NCT02956486|79529966|FG001|Core Phase|Adverse Event|88|||
44521764|NCT02956486|79529967|FG002|Core Phase|Adverse Event|0|||
44521765|NCT02956486|79529965|FG000|Core Phase|Lost to Follow-up|8|||
44521766|NCT02956486|79529966|FG001|Core Phase|Lost to Follow-up|6|||
44521767|NCT02956486|79529967|FG002|Core Phase|Lost to Follow-up|0|||
44521768|NCT02956486|79529965|FG000|Core Phase|Inadequate therapeutic effect|4|||
44521769|NCT02956486|79529966|FG001|Core Phase|Inadequate therapeutic effect|5|||
44521770|NCT02956486|79529967|FG002|Core Phase|Inadequate therapeutic effect|0|||
44521771|NCT02956486|79529965|FG000|Core Phase|Withdrawal by Subject|101|||
44521772|NCT02956486|79529966|FG001|Core Phase|Withdrawal by Subject|104|||
44521773|NCT02956486|79529967|FG002|Core Phase|Withdrawal by Subject|0|||
44521774|NCT02956486|79529965|FG000|Core Phase|Study terminated by sponsor|888|||
44521775|NCT02956486|79529966|FG001|Core Phase|Study terminated by sponsor|848|||
44521776|NCT02956486|79529967|FG002|Core Phase|Study terminated by sponsor|0|||
44521777|NCT02956486|79529965|FG000|Core Phase|Other|27|||
44521778|NCT02956486|79529966|FG001|Core Phase|Other|18|||
44521779|NCT02956486|79529967|FG002|Core Phase|Other|0|||
44521780|NCT02956486|79529965|FG000|Core Phase|Not treated|0|||
44521781|NCT02956486|79529966|FG001|Core Phase|Not treated|3|||
44521782|NCT02956486|79529967|FG002|Core Phase|Not treated|0|||
44521783|NCT02956486|79529965|FG000|Extension Phase|Adverse Event|0|||
44521784|NCT02956486|79529966|FG001|Extension Phase|Adverse Event|0|||
44521785|NCT02956486|79529967|FG002|Extension Phase|Adverse Event|2|||
44521786|NCT02956486|79529965|FG000|Extension Phase|Study terminated by sponsor|0|||
44521787|NCT02956486|79529966|FG001|Extension Phase|Study terminated by sponsor|0|||
44521788|NCT02956486|79529967|FG002|Extension Phase|Study terminated by sponsor|16|||
44147390|NCT00700427|78936722|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
44252833|NCT02080403|79091675|FG001|Overall Study|Protocol Violation|7|||
44252834|NCT02080403|79091674|FG000|Overall Study|Withdrawal by Subject|5|||
44252835|NCT02080403|79091675|FG001|Overall Study|Withdrawal by Subject|1|||
44252836|NCT02080091|79091681|FG000|Overall Study|Study Terminated|22|||
44252837|NCT02080091|79091681|FG000|Overall Study|Death|1|||
44252838|NCT02080091|79091681|FG000|Overall Study|Withdrawal by Subject|1|||
44252839|NCT02080091|79091681|FG000|Overall Study|Other|1|||
44252840|NCT02079077|79091687|FG000|Overall Study|Lost to Follow-up|5|||
44252841|NCT02079077|79091688|FG001|Overall Study|Lost to Follow-up|7|||
44252842|NCT02079077|79091687|FG000|Overall Study|Became STIs Positive|1|||
44252843|NCT02079077|79091688|FG001|Overall Study|Became STIs Positive|2|||
44252844|NCT02078219|79091716|FG000|Overall Study|Other|2|||
44252845|NCT02078219|79091717|FG001|Overall Study|Other|2|||
44252846|NCT02078219|79091718|FG002|Overall Study|Other|3|||
44252847|NCT02078219|79091719|FG003|Overall Study|Other|0|||
44252848|NCT02078219|79091720|FG004|Overall Study|Other|1|||
44252849|NCT02078219|79091716|FG000|Overall Study|Withdrawal by Subject|0|||
44252850|NCT02078219|79091717|FG001|Overall Study|Withdrawal by Subject|1|||
44252851|NCT02078219|79091718|FG002|Overall Study|Withdrawal by Subject|0|||
44399937|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
44399938|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
44399939|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
44399940|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
44399941|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
44399942|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
44399943|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
44399944|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
44399945|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
44147391|NCT00700427|78936723|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
44147392|NCT00700427|78936724|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
44147393|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
44147394|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
44147395|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
44147396|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
44147397|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
44147398|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
44521789|NCT02956486|79529965|FG000|Extension Phase|Not Treated|0|||
44521790|NCT02956486|79529966|FG001|Extension Phase|Not Treated|0|||
44147399|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
44252852|NCT02078219|79091719|FG003|Overall Study|Withdrawal by Subject|1|||
44252853|NCT02078219|79091720|FG004|Overall Study|Withdrawal by Subject|1|||
44521791|NCT02956486|79529967|FG002|Extension Phase|Not Treated|1|||
44521792|NCT03445533|79529982|FG000|Overall Study|Progressive Disease|48|||
44521793|NCT03445533|79529983|FG001|Overall Study|Progressive Disease|81|||
44521794|NCT03445533|79529982|FG000|Overall Study|Adverse Event|60|||
44521795|NCT03445533|79529983|FG001|Overall Study|Adverse Event|64|||
44521796|NCT03445533|79529982|FG000|Overall Study|Death|9|||
44521797|NCT03445533|79529983|FG001|Overall Study|Death|19|||
44252854|NCT02078219|79091716|FG000|Overall Study|Protocol Violation|0|||
44252855|NCT02078219|79091717|FG001|Overall Study|Protocol Violation|0|||
44252856|NCT02078219|79091718|FG002|Overall Study|Protocol Violation|0|||
44399946|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
44399947|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
44399948|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
44399949|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
44399950|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
44399951|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
44399952|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
44399953|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
44399954|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
44399955|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
44399956|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
44399957|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
44399958|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
44399959|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
44399960|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
44399961|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
44399962|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
44399963|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
44399964|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
44399965|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
44399966|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Death|0|||
44399967|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Death|6|||
44399968|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Death|3|||
44399969|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Death|0|||
44399970|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Death|0|||
44399971|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
44399972|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
44399973|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
44399974|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
44399975|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
44399976|NCT00561925|79407329|FG000|144-week Double-blind, Double-dummy|Other|0|||
44399977|NCT00561925|79407330|FG001|144-week Double-blind, Double-dummy|Other|8|||
44399978|NCT00561925|79407331|FG002|144-week Double-blind, Double-dummy|Other|11|||
44399979|NCT00561925|79407332|FG003|144-week Double-blind, Double-dummy|Other|0|||
44399980|NCT00561925|79407333|FG004|144-week Double-blind, Double-dummy|Other|0|||
44399981|NCT00561925|79407329|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
44399982|NCT00561925|79407330|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
44399983|NCT00561925|79407331|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
44399984|NCT00561925|79407332|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
44399985|NCT00561925|79407333|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
44399986|NCT00549445|79407353|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
44399987|NCT00549445|79407354|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
44399988|NCT00601107|79407364|FG000|Overall Study|Adverse Event|0|||
44399989|NCT00601107|79407365|FG001|Overall Study|Adverse Event|1|||
44399990|NCT00601107|79407366|FG002|Overall Study|Adverse Event|3|||
44399991|NCT00601107|79407367|FG003|Overall Study|Adverse Event|0|||
44399992|NCT00601107|79407364|FG000|Overall Study|Withdrawal by Subject|5|||
44399993|NCT00601107|79407365|FG001|Overall Study|Withdrawal by Subject|4|||
44399994|NCT00601107|79407366|FG002|Overall Study|Withdrawal by Subject|7|||
44399995|NCT00601107|79407367|FG003|Overall Study|Withdrawal by Subject|4|||
44399996|NCT00601107|79407364|FG000|Overall Study|Lost to Follow-up|3|||
44399997|NCT00601107|79407365|FG001|Overall Study|Lost to Follow-up|3|||
44399998|NCT00601107|79407366|FG002|Overall Study|Lost to Follow-up|0|||
44399999|NCT00601107|79407367|FG003|Overall Study|Lost to Follow-up|3|||
44147400|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
44147401|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
44147402|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
44147403|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
44147404|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
44147405|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
44147406|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
44147407|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
44147408|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
44400000|NCT00601107|79407364|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
44400001|NCT00601107|79407365|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
44400002|NCT00601107|79407366|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
44400003|NCT00601107|79407367|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
44400004|NCT00601107|79407364|FG000|Overall Study|Worsening of Psoriasis|4|||
44400005|NCT00601107|79407365|FG001|Overall Study|Worsening of Psoriasis|1|||
44147409|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
44147410|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
44147411|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
44147412|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
44147413|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
44147414|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
44147415|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
44147416|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
44147417|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
44400006|NCT00601107|79407366|FG002|Overall Study|Worsening of Psoriasis|1|||
44400007|NCT00601107|79407367|FG003|Overall Study|Worsening of Psoriasis|4|||
44400008|NCT00601107|79407364|FG000|Overall Study|Undefined|1|||
44400009|NCT00601107|79407365|FG001|Overall Study|Undefined|0|||
44400010|NCT00601107|79407366|FG002|Overall Study|Undefined|1|||
44400011|NCT00601107|79407367|FG003|Overall Study|Undefined|0|||
44400012|NCT00914927|79407384|FG000|Overall Study|Adverse Event|0|||
44400013|NCT00914927|79407385|FG001|Overall Study|Adverse Event|0|||
44400014|NCT00914927|79407386|FG002|Overall Study|Adverse Event|0|||
44400015|NCT00914927|79407387|FG003|Overall Study|Adverse Event|0|||
44400016|NCT00914927|79407388|FG004|Overall Study|Adverse Event|1|||
44400017|NCT00914927|79407389|FG005|Overall Study|Adverse Event|0|||
44400018|NCT00914927|79407390|FG006|Overall Study|Adverse Event|0|||
44400019|NCT00914927|79407384|FG000|Overall Study|Withdrawal by Subject|0|||
44400020|NCT00914927|79407385|FG001|Overall Study|Withdrawal by Subject|1|||
44400021|NCT00914927|79407386|FG002|Overall Study|Withdrawal by Subject|0|||
44400022|NCT00914927|79407387|FG003|Overall Study|Withdrawal by Subject|1|||
44400023|NCT00914927|79407388|FG004|Overall Study|Withdrawal by Subject|0|||
44400024|NCT00914927|79407389|FG005|Overall Study|Withdrawal by Subject|0|||
44400025|NCT00914927|79407390|FG006|Overall Study|Withdrawal by Subject|0|||
44400026|NCT00914927|79407384|FG000|Overall Study|Lost to Follow-up|0|||
44400027|NCT00914927|79407385|FG001|Overall Study|Lost to Follow-up|0|||
44400028|NCT00914927|79407386|FG002|Overall Study|Lost to Follow-up|0|||
44400029|NCT00914927|79407387|FG003|Overall Study|Lost to Follow-up|1|||
44400030|NCT00914927|79407388|FG004|Overall Study|Lost to Follow-up|0|||
44400031|NCT00914927|79407389|FG005|Overall Study|Lost to Follow-up|0|||
44400032|NCT00914927|79407390|FG006|Overall Study|Lost to Follow-up|0|||
44400033|NCT00914927|79407384|FG000|Overall Study|Administrative/Other|2|||
44400034|NCT00914927|79407385|FG001|Overall Study|Administrative/Other|1|||
44400035|NCT00914927|79407386|FG002|Overall Study|Administrative/Other|0|||
44400036|NCT00914927|79407387|FG003|Overall Study|Administrative/Other|0|||
44400037|NCT00914927|79407388|FG004|Overall Study|Administrative/Other|1|||
44400038|NCT00914927|79407389|FG005|Overall Study|Administrative/Other|0|||
44400039|NCT00914927|79407390|FG006|Overall Study|Administrative/Other|0|||
44400040|NCT00914849|79407417|FG000|Overall Study|Withdrawal by Subject|1|||
44400041|NCT00914849|79407418|FG001|Overall Study|Withdrawal by Subject|0|||
44400042|NCT00914849|79407417|FG000|Overall Study|Not eligible|0|||
44400043|NCT00914849|79407418|FG001|Overall Study|Not eligible|1|||
44400044|NCT00912743|79407426|FG000|Overall Study|Adverse Event|3|||
44521798|NCT03445533|79529982|FG000|Overall Study|Miscellaneous|0|||
44521799|NCT03445533|79529983|FG001|Overall Study|Miscellaneous|16|||
44521800|NCT03445533|79529982|FG000|Overall Study|Withdrawal by Subject|3|||
44521801|NCT03445533|79529983|FG001|Overall Study|Withdrawal by Subject|4|||
44400045|NCT00912743|79407427|FG001|Overall Study|Adverse Event|1|||
44521802|NCT03445533|79529982|FG000|Overall Study|Physician Decision|1|||
44521803|NCT03445533|79529983|FG001|Overall Study|Physician Decision|3|||
44521804|NCT03445533|79529982|FG000|Overall Study|Sponsor Decision|0|||
44521805|NCT03445533|79529983|FG001|Overall Study|Sponsor Decision|1|||
44521806|NCT03445533|79529982|FG000|Overall Study|Lost to Follow-up|0|||
44521807|NCT03445533|79529983|FG001|Overall Study|Lost to Follow-up|1|||
44521808|NCT03445533|79529982|FG000|Overall Study|Never Received any Study Treatment|7|||
44521809|NCT03445533|79529983|FG001|Overall Study|Never Received any Study Treatment|4|||
44521810|NCT01337050|79529992|FG000|Overall Study|Death|0|||
44400046|NCT00912743|79407426|FG000|Overall Study|Lack of Efficacy|9|||
44521811|NCT01337050|79529993|FG001|Overall Study|Death|0|||
44147418|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
44400047|NCT00912743|79407427|FG001|Overall Study|Lack of Efficacy|18|||
44400048|NCT00912743|79407426|FG000|Overall Study|Toxicity|0|||
44521812|NCT01337050|79529994|FG002|Overall Study|Death|4|||
44400049|NCT00912743|79407427|FG001|Overall Study|Toxicity|1|||
44400050|NCT00912743|79407426|FG000|Overall Study|End of treatment form was not collected|1|||
44400051|NCT00912743|79407427|FG001|Overall Study|End of treatment form was not collected|0|||
44400052|NCT00914459|79407435|FG000|Overall Study|Protocol Violation|0|||
44400053|NCT00914459|79407436|FG001|Overall Study|Protocol Violation|1|||
44521813|NCT01337050|79529992|FG000|Overall Study|Other|4|||
44521814|NCT01337050|79529993|FG001|Overall Study|Other|6|||
44521815|NCT01337050|79529994|FG002|Overall Study|Other|8|||
44521816|NCT01337050|79529992|FG000|Overall Study|Participants refused further follow-up|0|||
44400054|NCT00914459|79407435|FG000|Overall Study|Parent/Legal guardian request|1|||
44400055|NCT00914459|79407436|FG001|Overall Study|Parent/Legal guardian request|0|||
44400056|NCT00912509|79407446|FG000|Overall Study|Lost to Follow-up|1|||
44400057|NCT00912509|79407447|FG001|Overall Study|Lost to Follow-up|0|||
44400058|NCT00912509|79407446|FG000|Overall Study|Lack of Efficacy|4|||
44400059|NCT00912509|79407447|FG001|Overall Study|Lack of Efficacy|3|||
44400060|NCT00913835|79407467|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
44400061|NCT00913835|79407468|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
44400062|NCT00913835|79407467|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
44400063|NCT00913835|79407468|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
44400064|NCT00913835|79407467|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
44400065|NCT00913835|79407468|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
44521817|NCT01337050|79529993|FG001|Overall Study|Participants refused further follow-up|7|||
44521818|NCT01337050|79529994|FG002|Overall Study|Participants refused further follow-up|7|||
44400066|NCT00913835|79407467|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
44400067|NCT00913835|79407468|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
44400068|NCT00913835|79407467|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
44400069|NCT00913835|79407468|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
44400070|NCT00913523|79407493|FG000|Overall Study|Withdrawal by Subject|3|||
44400071|NCT00913523|79407494|FG001|Overall Study|Withdrawal by Subject|2|||
44400072|NCT00913523|79407495|FG002|Overall Study|Withdrawal by Subject|2|||
44400073|NCT00913523|79407493|FG000|Overall Study|Lost to Follow-up|1|||
44400074|NCT00913523|79407494|FG001|Overall Study|Lost to Follow-up|1|||
44400075|NCT00913523|79407495|FG002|Overall Study|Lost to Follow-up|1|||
44400076|NCT00913523|79407493|FG000|Overall Study|Adverse Event|1|||
44400077|NCT00913523|79407494|FG001|Overall Study|Adverse Event|0|||
44400078|NCT00913523|79407495|FG002|Overall Study|Adverse Event|0|||
44400079|NCT00913523|79407493|FG000|Overall Study|Protocol Violation|5|||
44400080|NCT00913523|79407494|FG001|Overall Study|Protocol Violation|8|||
44400081|NCT00913523|79407495|FG002|Overall Study|Protocol Violation|8|||
44400082|NCT00913523|79407493|FG000|Overall Study|Pregnancy|1|||
44400083|NCT00913523|79407494|FG001|Overall Study|Pregnancy|3|||
44400084|NCT00913523|79407495|FG002|Overall Study|Pregnancy|0|||
44400085|NCT00913523|79407493|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
44400086|NCT00913523|79407494|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
44400087|NCT00913523|79407495|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
44400088|NCT00912197|79407505|FG000|Overall Study|Withdrawal by Subject|3|||
44400089|NCT00912197|79407506|FG001|Overall Study|Withdrawal by Subject|3|||
44400090|NCT00910247|79407514|FG000|Overall Study|Adverse Event|15|||
44400091|NCT00910247|79407514|FG000|Overall Study|Death|2|||
44400092|NCT00910247|79407514|FG000|Overall Study|Lost to Follow-up|10|||
44400093|NCT00910247|79407514|FG000|Overall Study|Physician Decision|3|||
44400094|NCT00910247|79407514|FG000|Overall Study|Protocol Violation|10|||
44400095|NCT00910247|79407514|FG000|Overall Study|Withdrawal by Subject|25|||
44400096|NCT00910247|79407514|FG000|Overall Study|Not collected|4|||
44400097|NCT00659334|79407525|FG000|Overall Study|Screen Failure|8|||
44400098|NCT00659334|79407526|FG001|Overall Study|Screen Failure|5|||
44400099|NCT00659334|79407527|FG002|Overall Study|Screen Failure|0|||
44400100|NCT00659334|79407528|FG003|Overall Study|Screen Failure|0|||
44400101|NCT00659334|79407529|FG004|Overall Study|Screen Failure|0|||
44400102|NCT00659334|79407530|FG005|Overall Study|Screen Failure|0|||
44400103|NCT00659334|79407531|FG006|Overall Study|Screen Failure|1|||
44400104|NCT00910091|79407553|FG000|Pre-assignment|Withdrawal by Subject|0|||
44400105|NCT00910091|79407554|FG001|Pre-assignment|Withdrawal by Subject|2|||
44400106|NCT00910091|79407553|FG000|Treatment and Survival|Withdrawal by Subject|3|||
44400107|NCT00910091|79407554|FG001|Treatment and Survival|Withdrawal by Subject|4|||
44400108|NCT00910091|79407553|FG000|Treatment and Survival|Adverse Event|1|||
44400109|NCT00910091|79407554|FG001|Treatment and Survival|Adverse Event|0|||
44400110|NCT00909857|79407563|FG000|Overall Study|Withdrawal by Subject|6|||
44400111|NCT00909857|79407564|FG001|Overall Study|Withdrawal by Subject|10|||
44400112|NCT00909857|79407563|FG000|Overall Study|Adverse Event|5|||
44521819|NCT01336972|79530006|FG000|Overall Study|Adverse Event|1|||
44521820|NCT01336972|79530007|FG001|Overall Study|Adverse Event|1|||
44521821|NCT01336972|79530008|FG002|Overall Study|Adverse Event|0|||
44400113|NCT00909857|79407564|FG001|Overall Study|Adverse Event|5|||
44521822|NCT03762681|79530025|FG000|Part 1|Withdrawal by Subject|0|||
44521823|NCT03762681|79530026|FG001|Part 1|Withdrawal by Subject|0|||
44521824|NCT03762681|79530027|FG002|Part 1|Withdrawal by Subject|0|||
44400114|NCT00909857|79407563|FG000|Overall Study|Lost to Follow-up|2|||
44400115|NCT00909857|79407564|FG001|Overall Study|Lost to Follow-up|5|||
44400116|NCT00909857|79407563|FG000|Overall Study|Protocol Violation|2|||
44400117|NCT00909857|79407564|FG001|Overall Study|Protocol Violation|1|||
44400118|NCT00909857|79407563|FG000|Overall Study|Pregnancy|1|||
44400119|NCT00909857|79407564|FG001|Overall Study|Pregnancy|0|||
44400120|NCT00909857|79407563|FG000|Overall Study|Other|1|||
44521825|NCT03762681|79530028|FG003|Part 1|Withdrawal by Subject|1|||
44400121|NCT00909857|79407564|FG001|Overall Study|Other|0|||
44400122|NCT00909857|79407563|FG000|Overall Study|Did not receive study medication|19|||
44400123|NCT00909857|79407564|FG001|Overall Study|Did not receive study medication|24|||
44400124|NCT00911807|79407573|FG000|Overall Study|Adverse Event|2|||
44400125|NCT00911807|79407574|FG001|Overall Study|Adverse Event|1|||
44400126|NCT00911807|79407575|FG002|Overall Study|Adverse Event|5|||
44400127|NCT00911807|79407573|FG000|Overall Study|Death|0|||
44400128|NCT00911807|79407574|FG001|Overall Study|Death|0|||
44400129|NCT00911807|79407575|FG002|Overall Study|Death|1|||
44400130|NCT00911807|79407573|FG000|Overall Study|Protocol Violation|6|||
44400131|NCT00911807|79407574|FG001|Overall Study|Protocol Violation|4|||
44400132|NCT00911807|79407575|FG002|Overall Study|Protocol Violation|9|||
44400133|NCT00911807|79407573|FG000|Overall Study|Withdrawal by Subject|8|||
44400134|NCT00911807|79407574|FG001|Overall Study|Withdrawal by Subject|10|||
44400135|NCT00911807|79407575|FG002|Overall Study|Withdrawal by Subject|7|||
44400136|NCT00911807|79407573|FG000|Overall Study|Organizational reasons|1|||
44400137|NCT00911807|79407574|FG001|Overall Study|Organizational reasons|3|||
44400138|NCT00911807|79407575|FG002|Overall Study|Organizational reasons|1|||
44400139|NCT04287920|79407602|FG000|Overall Study|Lost to Follow-up|1|||
44400140|NCT04287920|79407603|FG001|Overall Study|Lost to Follow-up|1|||
44400141|NCT04287920|79407602|FG000|Overall Study|Withdrawal by Subject|0|||
44400142|NCT04287920|79407603|FG001|Overall Study|Withdrawal by Subject|3|||
44400143|NCT00909779|79407611|FG000|Overall Study|Adverse Event|53|||
44400144|NCT00909779|79407612|FG001|Overall Study|Adverse Event|55|||
44400145|NCT00909779|79407611|FG000|Overall Study|Lack of Efficacy|7|||
44400146|NCT00909779|79407612|FG001|Overall Study|Lack of Efficacy|4|||
44400147|NCT00909779|79407611|FG000|Overall Study|Lost to Follow-up|19|||
44400148|NCT00909779|79407612|FG001|Overall Study|Lost to Follow-up|15|||
44521826|NCT03762681|79530029|FG004|Part 1|Withdrawal by Subject|0|||
44521827|NCT03762681|79530030|FG005|Part 1|Withdrawal by Subject|0|||
44521828|NCT03762681|79530031|FG006|Part 1|Withdrawal by Subject|0|||
44521829|NCT03762681|79530032|FG007|Part 1|Withdrawal by Subject|0|||
44521830|NCT03762681|79530025|FG000|Part 2a|Pandemic Travel Restrictions|0|||
44521831|NCT03762681|79530026|FG001|Part 2a|Pandemic Travel Restrictions|0|||
44400149|NCT00909779|79407611|FG000|Overall Study|Physician Decision|8|||
44400150|NCT00909779|79407612|FG001|Overall Study|Physician Decision|2|||
44400151|NCT00909779|79407611|FG000|Overall Study|Protocol Violation|2|||
44400152|NCT00909779|79407612|FG001|Overall Study|Protocol Violation|5|||
44400153|NCT00909779|79407611|FG000|Overall Study|Withdrawal by Subject|116|||
44400154|NCT00909779|79407612|FG001|Overall Study|Withdrawal by Subject|80|||
44400155|NCT00909779|79407611|FG000|Overall Study|Site Ceasing Operation|2|||
44400156|NCT00909779|79407612|FG001|Overall Study|Site Ceasing Operation|2|||
44400157|NCT00909779|79407611|FG000|Overall Study|Medical Monitor Decision|1|||
44400158|NCT00909779|79407612|FG001|Overall Study|Medical Monitor Decision|0|||
44400159|NCT00909779|79407611|FG000|Overall Study|Noncompliance|1|||
44400160|NCT00909779|79407612|FG001|Overall Study|Noncompliance|1|||
44400161|NCT00909779|79407611|FG000|Overall Study|Randomized in error|1|||
44400162|NCT00909779|79407612|FG001|Overall Study|Randomized in error|1|||
44400163|NCT00910871|79407620|FG000|Overall Study|Adverse Event|5|||
44400164|NCT00910871|79407620|FG000|Overall Study|Death|12|||
44400165|NCT00910871|79407620|FG000|Overall Study|Lost to Follow-up|8|||
44400166|NCT00910871|79407620|FG000|Overall Study|Protocol Violation|11|||
44400167|NCT00910871|79407620|FG000|Overall Study|Withdrawal by Subject|12|||
44400168|NCT00910871|79407620|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
44400169|NCT00910871|79407620|FG000|Overall Study|Undefined|1|||
44400170|NCT02631941|79407645|FG000|Overall Study|Physician Decision|0|||
44400171|NCT02631941|79407646|FG001|Overall Study|Physician Decision|1|||
44400172|NCT02631941|79407647|FG002|Overall Study|Physician Decision|0|||
44400173|NCT02631941|79407648|FG003|Overall Study|Physician Decision|0|||
44400174|NCT02631941|79407649|FG004|Overall Study|Physician Decision|0|||
44400175|NCT02631941|79407650|FG005|Overall Study|Physician Decision|0|||
44400176|NCT02631941|79407651|FG006|Overall Study|Physician Decision|0|||
44400177|NCT02631941|79407652|FG007|Overall Study|Physician Decision|0|||
44521832|NCT03762681|79530027|FG002|Part 2a|Pandemic Travel Restrictions|0|||
44521833|NCT03762681|79530028|FG003|Part 2a|Pandemic Travel Restrictions|0|||
44521834|NCT03762681|79530029|FG004|Part 2a|Pandemic Travel Restrictions|0|||
44521835|NCT03762681|79530030|FG005|Part 2a|Pandemic Travel Restrictions|0|||
44521836|NCT03762681|79530031|FG006|Part 2a|Pandemic Travel Restrictions|0|||
44521837|NCT03762681|79530032|FG007|Part 2a|Pandemic Travel Restrictions|1|||
44521838|NCT03764475|79530061|FG000|Overall Study|Adverse Event|11|||
44521839|NCT03764475|79530062|FG001|Overall Study|Adverse Event|2|||
44400178|NCT02631941|79407653|FG008|Overall Study|Physician Decision|0|||
44400179|NCT02631941|79407654|FG009|Overall Study|Physician Decision|0|||
44400180|NCT02631941|79407645|FG000|Overall Study|Adverse Event|0|||
44400181|NCT02631941|79407646|FG001|Overall Study|Adverse Event|1|||
44400182|NCT02631941|79407647|FG002|Overall Study|Adverse Event|0|||
44400183|NCT02631941|79407648|FG003|Overall Study|Adverse Event|0|||
44400184|NCT02631941|79407649|FG004|Overall Study|Adverse Event|0|||
44400185|NCT02631941|79407650|FG005|Overall Study|Adverse Event|0|||
44400186|NCT02631941|79407651|FG006|Overall Study|Adverse Event|0|||
44400187|NCT02631941|79407652|FG007|Overall Study|Adverse Event|0|||
44400188|NCT02631941|79407653|FG008|Overall Study|Adverse Event|0|||
44400189|NCT02631941|79407654|FG009|Overall Study|Adverse Event|0|||
44400190|NCT02631941|79407645|FG000|Overall Study|Withdrawal by Subject|0|||
44400191|NCT02631941|79407646|FG001|Overall Study|Withdrawal by Subject|0|||
44400192|NCT02631941|79407647|FG002|Overall Study|Withdrawal by Subject|0|||
44400193|NCT02631941|79407648|FG003|Overall Study|Withdrawal by Subject|0|||
44400194|NCT02631941|79407649|FG004|Overall Study|Withdrawal by Subject|1|||
44400195|NCT02631941|79407650|FG005|Overall Study|Withdrawal by Subject|0|||
44400196|NCT02631941|79407651|FG006|Overall Study|Withdrawal by Subject|0|||
44400197|NCT02631941|79407652|FG007|Overall Study|Withdrawal by Subject|1|||
44400198|NCT02631941|79407653|FG008|Overall Study|Withdrawal by Subject|0|||
44400199|NCT02631941|79407654|FG009|Overall Study|Withdrawal by Subject|0|||
44400200|NCT02631941|79407645|FG000|Overall Study|Lost to Follow-up|0|||
44400201|NCT02631941|79407646|FG001|Overall Study|Lost to Follow-up|0|||
44400202|NCT02631941|79407647|FG002|Overall Study|Lost to Follow-up|0|||
44400203|NCT02631941|79407648|FG003|Overall Study|Lost to Follow-up|0|||
44400204|NCT02631941|79407649|FG004|Overall Study|Lost to Follow-up|0|||
44400205|NCT02631941|79407650|FG005|Overall Study|Lost to Follow-up|0|||
44400206|NCT02631941|79407651|FG006|Overall Study|Lost to Follow-up|0|||
44400207|NCT02631941|79407652|FG007|Overall Study|Lost to Follow-up|0|||
44400208|NCT02631941|79407653|FG008|Overall Study|Lost to Follow-up|1|||
44400209|NCT02631941|79407654|FG009|Overall Study|Lost to Follow-up|0|||
44400210|NCT00908375|79407666|FG000|Overall Study|Withdrawal by Subject|2|||
44400211|NCT00908375|79407667|FG001|Overall Study|Withdrawal by Subject|4|||
44400212|NCT00908375|79407666|FG000|Overall Study|Lost to Follow-up|8|||
44400213|NCT00908375|79407667|FG001|Overall Study|Lost to Follow-up|6|||
44400214|NCT00909389|79407673|FG000|Overall Study|Adverse Event|6|||
44400215|NCT00909389|79407673|FG000|Overall Study|Death|4|||
44400216|NCT00909389|79407673|FG000|Overall Study|Poor Compliance|16|||
44400217|NCT00909389|79407673|FG000|Overall Study|Lost to Follow-up|4|||
44400218|NCT00909389|79407673|FG000|Overall Study|No Information|103|||
44400219|NCT00910715|79407680|FG000|Overall Study|Lost to Follow-up|22|||
44400220|NCT00910715|79407681|FG001|Overall Study|Lost to Follow-up|26|||
44400221|NCT00910715|79407682|FG002|Overall Study|Lost to Follow-up|0|||
44400222|NCT00600483|79407744|FG000|Overall Study|Lost to Follow-up|26|||
44400223|NCT00600483|79407745|FG001|Overall Study|Lost to Follow-up|47|||
44400224|NCT00600483|79407744|FG000|Overall Study|Randomized but not treated|10|||
44400225|NCT00600483|79407745|FG001|Overall Study|Randomized but not treated|0|||
44400226|NCT00600171|79407757|FG000|Overall Study|Adverse Event|0|||
44400227|NCT00600171|79407758|FG001|Overall Study|Adverse Event|1|||
44400228|NCT00600171|79407759|FG002|Overall Study|Adverse Event|0|||
44400229|NCT00600171|79407760|FG003|Overall Study|Adverse Event|0|||
44400230|NCT00600171|79407761|FG004|Overall Study|Adverse Event|1|||
44400231|NCT00600171|79407762|FG005|Overall Study|Adverse Event|0|||
44400232|NCT00600171|79407757|FG000|Overall Study|Lack of Efficacy|9|||
44400233|NCT00600171|79407758|FG001|Overall Study|Lack of Efficacy|12|||
44400234|NCT00600171|79407759|FG002|Overall Study|Lack of Efficacy|3|||
44400235|NCT00600171|79407760|FG003|Overall Study|Lack of Efficacy|5|||
44400236|NCT00600171|79407761|FG004|Overall Study|Lack of Efficacy|4|||
44400237|NCT00600171|79407762|FG005|Overall Study|Lack of Efficacy|0|||
44400238|NCT00600171|79407757|FG000|Overall Study|Protocol Violation|1|||
44400239|NCT00600171|79407758|FG001|Overall Study|Protocol Violation|2|||
44400240|NCT00600171|79407759|FG002|Overall Study|Protocol Violation|0|||
44400241|NCT00600171|79407760|FG003|Overall Study|Protocol Violation|1|||
44400242|NCT00600171|79407761|FG004|Overall Study|Protocol Violation|0|||
44400243|NCT00600171|79407762|FG005|Overall Study|Protocol Violation|0|||
44400244|NCT00600171|79407757|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
44400245|NCT00600171|79407758|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44400246|NCT00600171|79407759|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
44400247|NCT00600171|79407760|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
44400248|NCT00600171|79407761|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
44400249|NCT00600171|79407762|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
44400250|NCT00600171|79407757|FG000|Overall Study|Withdrawal by Subject|3|||
44400251|NCT00600171|79407758|FG001|Overall Study|Withdrawal by Subject|0|||
44400252|NCT00600171|79407759|FG002|Overall Study|Withdrawal by Subject|0|||
44400253|NCT00600171|79407760|FG003|Overall Study|Withdrawal by Subject|1|||
44400254|NCT00600171|79407761|FG004|Overall Study|Withdrawal by Subject|1|||
44400255|NCT00600171|79407762|FG005|Overall Study|Withdrawal by Subject|1|||
44400256|NCT00600171|79407757|FG000|Overall Study|Physician Decision|0|||
44400257|NCT00600171|79407758|FG001|Overall Study|Physician Decision|1|||
44400258|NCT00600171|79407759|FG002|Overall Study|Physician Decision|0|||
44400259|NCT00600171|79407760|FG003|Overall Study|Physician Decision|1|||
44400260|NCT00600171|79407761|FG004|Overall Study|Physician Decision|0|||
44521840|NCT03764475|79530061|FG000|Overall Study|Lost to Follow-up|24|||
44400261|NCT00600171|79407762|FG005|Overall Study|Physician Decision|2|||
44400262|NCT00600171|79407757|FG000|Overall Study|Lost to Follow-up|0|||
44400263|NCT00600171|79407758|FG001|Overall Study|Lost to Follow-up|0|||
44400264|NCT00600171|79407759|FG002|Overall Study|Lost to Follow-up|0|||
44400265|NCT00600171|79407760|FG003|Overall Study|Lost to Follow-up|1|||
44400266|NCT00600171|79407761|FG004|Overall Study|Lost to Follow-up|0|||
44400267|NCT00600171|79407762|FG005|Overall Study|Lost to Follow-up|0|||
44400268|NCT04035668|79407781|FG000|Overall Study|Adverse Event|3|||
44400269|NCT04035668|79407782|FG001|Overall Study|Adverse Event|4|||
44400270|NCT04035668|79407783|FG002|Overall Study|Adverse Event|2|||
44400271|NCT04035668|79407781|FG000|Overall Study|Lost to Follow-up|0|||
44400272|NCT04035668|79407782|FG001|Overall Study|Lost to Follow-up|1|||
44400273|NCT04035668|79407783|FG002|Overall Study|Lost to Follow-up|0|||
44400274|NCT04035668|79407781|FG000|Overall Study|Physician Decision|2|||
44400275|NCT04035668|79407782|FG001|Overall Study|Physician Decision|1|||
44400276|NCT04035668|79407783|FG002|Overall Study|Physician Decision|1|||
44400277|NCT04035668|79407781|FG000|Overall Study|Subject Decision|2|||
44400278|NCT04035668|79407782|FG001|Overall Study|Subject Decision|2|||
44400279|NCT04035668|79407783|FG002|Overall Study|Subject Decision|0|||
44400280|NCT00885495|79407803|FG000|Overall Study|Adverse Event|1|||
44400281|NCT00885495|79407804|FG001|Overall Study|Adverse Event|2|||
44400282|NCT00885495|79407803|FG000|Overall Study|Protocol Violation|0|||
44400283|NCT00885495|79407804|FG001|Overall Study|Protocol Violation|1|||
44400284|NCT00885495|79407803|FG000|Overall Study|Withdrawal by Subject|1|||
44400285|NCT00885495|79407804|FG001|Overall Study|Withdrawal by Subject|0|||
44400286|NCT00885105|79407817|FG000|Overall Study|Withdrawal by Subject|0|||
44400287|NCT00885105|79407818|FG001|Overall Study|Withdrawal by Subject|8|||
44400288|NCT00885105|79407817|FG000|Overall Study|Adverse Event|1|||
44400289|NCT00885105|79407818|FG001|Overall Study|Adverse Event|0|||
44521841|NCT03764475|79530062|FG001|Overall Study|Lost to Follow-up|10|||
44521842|NCT03764475|79530061|FG000|Overall Study|Withdrawal by Subject|26|||
44521843|NCT03764475|79530062|FG001|Overall Study|Withdrawal by Subject|10|||
44521844|NCT03764475|79530061|FG000|Overall Study|Lack of Efficacy|3|||
44521845|NCT03764475|79530062|FG001|Overall Study|Lack of Efficacy|0|||
44521846|NCT03764475|79530061|FG000|Overall Study|COVID-19 Disruption|2|||
44521847|NCT03764475|79530062|FG001|Overall Study|COVID-19 Disruption|0|||
44521848|NCT02872012|79530077|FG000|Overall Study|Withdrawal by Subject|1|||
44521849|NCT02872012|79530078|FG001|Overall Study|Withdrawal by Subject|0|||
44400290|NCT00885105|79407817|FG000|Overall Study|Protocol Violation|0|||
44400291|NCT00885105|79407818|FG001|Overall Study|Protocol Violation|2|||
44400292|NCT03945188|79407826|FG000|Overall Study|Protocol Violation|1|||
44400293|NCT03945188|79407827|FG001|Overall Study|Protocol Violation|0|||
44400294|NCT03945188|79407826|FG000|Overall Study|Disease worsening|79|||
44400295|NCT03945188|79407827|FG001|Overall Study|Disease worsening|73|||
44400296|NCT03945188|79407826|FG000|Overall Study|Physician Decision|2|||
44400297|NCT03945188|79407827|FG001|Overall Study|Physician Decision|2|||
44400298|NCT03945188|79407826|FG000|Overall Study|Lack of Efficacy|7|||
44400299|NCT03945188|79407827|FG001|Overall Study|Lack of Efficacy|4|||
44400300|NCT03945188|79407826|FG000|Overall Study|Pregnancy|2|||
44400301|NCT03945188|79407827|FG001|Overall Study|Pregnancy|0|||
44400302|NCT03945188|79407826|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
44400303|NCT03945188|79407827|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
44400304|NCT03945188|79407826|FG000|Overall Study|Adverse Event|10|||
44400305|NCT03945188|79407827|FG001|Overall Study|Adverse Event|5|||
44400306|NCT03945188|79407826|FG000|Overall Study|Other|2|||
44400307|NCT03945188|79407827|FG001|Overall Study|Other|2|||
44400308|NCT03945188|79407826|FG000|Overall Study|Lost to Follow-up|1|||
44400309|NCT03945188|79407827|FG001|Overall Study|Lost to Follow-up|2|||
44400310|NCT00884949|79407833|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
44400311|NCT00884949|79407833|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
44400312|NCT00884793|79407846|FG000|Overall Study|Withdrawal by Subject|1|||
44400313|NCT00884325|79407852|FG000|Overall Study|Lost to Follow-up|1|||
44400314|NCT00884325|79407853|FG001|Overall Study|Lost to Follow-up|2|||
44400315|NCT00884325|79407852|FG000|Overall Study|Lack of Efficacy|0|||
44400316|NCT00884325|79407853|FG001|Overall Study|Lack of Efficacy|1|||
44521850|NCT02872012|79530079|FG002|Overall Study|Withdrawal by Subject|0|||
44521851|NCT02872012|79530080|FG003|Overall Study|Withdrawal by Subject|0|||
44521852|NCT02872012|79530081|FG004|Overall Study|Withdrawal by Subject|0|||
44400317|NCT00884325|79407852|FG000|Overall Study|Withdrawal by Subject|1|||
44400318|NCT00884325|79407853|FG001|Overall Study|Withdrawal by Subject|1|||
44400319|NCT00884325|79407852|FG000|Overall Study|Not provided|1|||
44400320|NCT00884325|79407853|FG001|Overall Study|Not provided|0|||
44400321|NCT00883779|79407861|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
44400322|NCT00883779|79407862|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
44400323|NCT00883779|79407861|FG000|Primary Study Treatment Phase|Disease progression|75|||
44400324|NCT00883779|79407862|FG001|Primary Study Treatment Phase|Disease progression|59|||
44400325|NCT00883779|79407861|FG000|Primary Study Treatment Phase|Adverse Event|16|||
44400326|NCT00883779|79407862|FG001|Primary Study Treatment Phase|Adverse Event|16|||
44400327|NCT00883779|79407861|FG000|Primary Study Treatment Phase|Death|2|||
44400328|NCT00883779|79407862|FG001|Primary Study Treatment Phase|Death|3|||
44400329|NCT00883779|79407861|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
44400330|NCT00883779|79407862|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
44400331|NCT00883779|79407861|FG000|Primary Study Treatment Phase|Other|3|||
44400332|NCT00883779|79407862|FG001|Primary Study Treatment Phase|Other|0|||
44400333|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Adverse Event|2|||
44400334|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Adverse Event|3|||
44400335|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Death|1|||
44400336|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Death|3|||
44400337|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
44400338|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
44400339|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
44400340|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
44400341|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Disease progression|103|||
44400342|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Disease progression|122|||
44400343|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Other|3|||
44400344|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Other|0|||
44400345|NCT00883779|79407861|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
44400346|NCT00883779|79407862|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
44400347|NCT00883779|79407861|FG000|Off-study Phase|Death|185|||
44400348|NCT00883779|79407862|FG001|Off-study Phase|Death|174|||
44400349|NCT00883779|79407861|FG000|Off-study Phase|Refused treatment|1|||
44400350|NCT00883779|79407862|FG001|Off-study Phase|Refused treatment|1|||
44400351|NCT00883779|79407861|FG000|Off-study Phase|Failure to return|5|||
44400352|NCT00883779|79407862|FG001|Off-study Phase|Failure to return|6|||
44400353|NCT00883779|79407861|FG000|Off-study Phase|Other|18|||
44400354|NCT00883779|79407862|FG001|Off-study Phase|Other|21|||
44400355|NCT04159701|79407870|FG000|Period 1: Treatment Period|Pregnancy|1|||
44400356|NCT04159701|79407871|FG001|Period 1: Treatment Period|Pregnancy|0|||
44400357|NCT04159701|79407870|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
44400358|NCT04159701|79407871|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
44400359|NCT04159701|79407870|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
44400360|NCT04159701|79407871|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
44400361|NCT04159701|79407870|FG000|Washout Period|site terminated by sponsor|0|||
44400362|NCT04159701|79407871|FG001|Washout Period|site terminated by sponsor|1|||
44400363|NCT04159701|79407870|FG000|Washout Period|study terminated by sponsor|10|||
44400364|NCT04159701|79407871|FG001|Washout Period|study terminated by sponsor|3|||
44400365|NCT04159701|79407870|FG000|Washout Period|Withdrawal by Subject|1|||
44400366|NCT04159701|79407871|FG001|Washout Period|Withdrawal by Subject|0|||
44400367|NCT04159701|79407870|FG000|Washout Period|Inadvertent Enrollment|1|||
44400368|NCT04159701|79407871|FG001|Washout Period|Inadvertent Enrollment|0|||
44400369|NCT04159701|79407870|FG000|Washout Period|Miscellaneous|1|||
44400370|NCT04159701|79407871|FG001|Washout Period|Miscellaneous|0|||
44400371|NCT04159701|79407870|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
44400372|NCT04159701|79407871|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
44400373|NCT04159701|79407870|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
44400374|NCT04159701|79407871|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
44400375|NCT04159701|79407870|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
44400376|NCT04159701|79407871|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
44400377|NCT04159701|79407870|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
44400378|NCT04159701|79407871|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
44400379|NCT04159701|79407870|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
44400380|NCT04159701|79407871|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
44400381|NCT00880269|79407883|FG000|Overall Study|Protocol Violation|1|||
44400382|NCT00880269|79407884|FG001|Overall Study|Protocol Violation|0|||
44400383|NCT00880269|79407883|FG000|Overall Study|Disease Progression|13|||
44400384|NCT00880269|79407884|FG001|Overall Study|Disease Progression|11|||
44400385|NCT00880269|79407883|FG000|Overall Study|New Cancer Therapy|1|||
44400386|NCT00880269|79407884|FG001|Overall Study|New Cancer Therapy|0|||
44400387|NCT00880269|79407883|FG000|Overall Study|Death|4|||
44400388|NCT00880269|79407884|FG001|Overall Study|Death|2|||
44400389|NCT00880269|79407883|FG000|Overall Study|Lost to Follow-up|0|||
44400390|NCT00880269|79407884|FG001|Overall Study|Lost to Follow-up|1|||
44400391|NCT00880269|79407883|FG000|Overall Study|Withdrawal by Subject|3|||
44400392|NCT00880269|79407884|FG001|Overall Study|Withdrawal by Subject|4|||
44400393|NCT00880269|79407883|FG000|Overall Study|Adverse Event|10|||
44400394|NCT00880269|79407884|FG001|Overall Study|Adverse Event|9|||
44400395|NCT00880191|79407892|FG000|Overall Study|Refused further treatment|4|||
44400396|NCT00880191|79407893|FG001|Overall Study|Refused further treatment|1|||
44400397|NCT00880191|79407892|FG000|Overall Study|Adverse Event|8|||
44400398|NCT00880191|79407893|FG001|Overall Study|Adverse Event|6|||
44400399|NCT00880191|79407892|FG000|Overall Study|Hospitalization/efficacy|1|||
44400400|NCT00880191|79407893|FG001|Overall Study|Hospitalization/efficacy|1|||
44400401|NCT00597519|79407899|FG000|Overall Study|Death|1|||
44400402|NCT00879333|79407905|FG000|Overall Study|Adverse Event|94|||
44400403|NCT00879333|79407906|FG001|Overall Study|Adverse Event|34|||
44400404|NCT00879333|79407905|FG000|Overall Study|Abnormal Laboratory Value|1|||
44400405|NCT00879333|79407906|FG001|Overall Study|Abnormal Laboratory Value|0|||
44521853|NCT02959138|79530098|FG000|Overall Study|Enrolled but Never Treated|0|||
44147419|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
44147420|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
44147421|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
44147422|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
44147423|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
44147424|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
44147425|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
44147426|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
44147427|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
44147428|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
44147429|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
44147430|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
44147431|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
44147432|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
44147433|NCT00700427|78936720|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
44147434|NCT00700427|78936721|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
44147435|NCT00700427|78936722|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
44147436|NCT00700427|78936723|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
44147437|NCT00700427|78936724|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
44147438|NCT02128763|78936734|FG000|Overall Study|Death|1|||
44147439|NCT02128763|78936735|FG001|Overall Study|Death|0|||
44147440|NCT02128763|78936734|FG000|Overall Study|Lost to Follow-up|19|||
44147441|NCT02128763|78936735|FG001|Overall Study|Lost to Follow-up|16|||
44147442|NCT02124772|78936757|FG000|Overall Study|Lack of Efficacy|2|||
44147443|NCT02124772|78936758|FG001|Overall Study|Lack of Efficacy|0|||
44147444|NCT02124772|78936759|FG002|Overall Study|Lack of Efficacy|0|||
44147445|NCT02124772|78936760|FG003|Overall Study|Lack of Efficacy|1|||
44147446|NCT02124772|78936761|FG004|Overall Study|Lack of Efficacy|2|||
44147447|NCT02124772|78936762|FG005|Overall Study|Lack of Efficacy|3|||
44147448|NCT02124772|78936763|FG006|Overall Study|Lack of Efficacy|0|||
44147449|NCT02124772|78936764|FG007|Overall Study|Lack of Efficacy|2|||
44147450|NCT02124772|78936765|FG008|Overall Study|Lack of Efficacy|0|||
44147451|NCT02124772|78936766|FG009|Overall Study|Lack of Efficacy|1|||
44147452|NCT02124772|78936767|FG010|Overall Study|Lack of Efficacy|0|||
44147453|NCT02124772|78936768|FG011|Overall Study|Lack of Efficacy|0|||
44147454|NCT02124772|78936769|FG012|Overall Study|Lack of Efficacy|1|||
44147455|NCT02124772|78936757|FG000|Overall Study|Adverse Event|1|||
44147456|NCT02124772|78936758|FG001|Overall Study|Adverse Event|4|||
44147457|NCT02124772|78936759|FG002|Overall Study|Adverse Event|1|||
44147458|NCT02124772|78936760|FG003|Overall Study|Adverse Event|5|||
44147459|NCT02124772|78936761|FG004|Overall Study|Adverse Event|2|||
44147460|NCT02124772|78936762|FG005|Overall Study|Adverse Event|1|||
44400406|NCT00879333|79407905|FG000|Overall Study|Withdrawal by Subject|20|||
44147461|NCT02124772|78936763|FG006|Overall Study|Adverse Event|1|||
44147462|NCT02124772|78936764|FG007|Overall Study|Adverse Event|5|||
44147463|NCT02124772|78936765|FG008|Overall Study|Adverse Event|0|||
44147464|NCT02124772|78936766|FG009|Overall Study|Adverse Event|3|||
44147465|NCT02124772|78936767|FG010|Overall Study|Adverse Event|1|||
44147466|NCT02124772|78936768|FG011|Overall Study|Adverse Event|3|||
44147467|NCT02124772|78936769|FG012|Overall Study|Adverse Event|1|||
44147468|NCT02124772|78936757|FG000|Overall Study|Withdrawal consent|0|||
44147469|NCT02124772|78936758|FG001|Overall Study|Withdrawal consent|1|||
44147470|NCT02124772|78936759|FG002|Overall Study|Withdrawal consent|1|||
44400407|NCT00879333|79407906|FG001|Overall Study|Withdrawal by Subject|7|||
44400408|NCT00879333|79407905|FG000|Overall Study|Lost to Follow-up|2|||
44400409|NCT00879333|79407906|FG001|Overall Study|Lost to Follow-up|1|||
44400410|NCT00879333|79407905|FG000|Overall Study|Administrative Problems|2|||
44400411|NCT00879333|79407906|FG001|Overall Study|Administrative Problems|0|||
44521854|NCT02959138|79530099|FG001|Overall Study|Enrolled but Never Treated|1|||
44147471|NCT02124772|78936760|FG003|Overall Study|Withdrawal consent|1|||
44147472|NCT02124772|78936761|FG004|Overall Study|Withdrawal consent|0|||
44147473|NCT02124772|78936762|FG005|Overall Study|Withdrawal consent|1|||
44147474|NCT02124772|78936763|FG006|Overall Study|Withdrawal consent|1|||
44147475|NCT02124772|78936764|FG007|Overall Study|Withdrawal consent|0|||
44147476|NCT02124772|78936765|FG008|Overall Study|Withdrawal consent|0|||
44147477|NCT02124772|78936766|FG009|Overall Study|Withdrawal consent|1|||
44147478|NCT02124772|78936767|FG010|Overall Study|Withdrawal consent|0|||
44147479|NCT02124772|78936768|FG011|Overall Study|Withdrawal consent|1|||
44147480|NCT02124772|78936769|FG012|Overall Study|Withdrawal consent|0|||
44400412|NCT00879333|79407905|FG000|Overall Study|Death|16|||
44521855|NCT02959138|79530100|FG002|Overall Study|Enrolled but Never Treated|0|||
44521856|NCT01344226|79530112|FG000|Overall Study|Protocol Violation|2|||
44521857|NCT01344226|79530112|FG000|Overall Study|Withdrawal by Subject|3|||
44521858|NCT01344226|79530112|FG000|Overall Study|Lack of Efficacy|3|||
44521859|NCT02869438|79530118|FG000|Overall Study|Lost to Follow-up|1|||
44521860|NCT02869438|79530119|FG001|Overall Study|Lost to Follow-up|0|||
44521861|NCT02869438|79530118|FG000|Overall Study|Adverse Event|1|||
44521862|NCT02869438|79530119|FG001|Overall Study|Adverse Event|0|||
44521863|NCT02869438|79530118|FG000|Overall Study|Withdrawal by Subject|1|||
44521864|NCT02869438|79530119|FG001|Overall Study|Withdrawal by Subject|2|||
44521865|NCT02868892|79530125|FG000|Overall Study|Investigator left site and no follow-up|6|||
44521866|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Death|1|||
44147481|NCT02124772|78936757|FG000|Overall Study|Investigator discretion|0|||
44147482|NCT02124772|78936758|FG001|Overall Study|Investigator discretion|2|||
44400413|NCT00879333|79407906|FG001|Overall Study|Death|5|||
44400414|NCT00879333|79407905|FG000|Overall Study|Disease Progression|292|||
44400415|NCT00879333|79407906|FG001|Overall Study|Disease Progression|169|||
44400416|NCT00879333|79407905|FG000|Overall Study|Protocol Violation|1|||
44400417|NCT00879333|79407906|FG001|Overall Study|Protocol Violation|1|||
44400418|NCT03481556|79407918|FG000|Overall Study|Adverse Event|1|||
44400419|NCT03481556|79407919|FG001|Overall Study|Adverse Event|0|||
44400420|NCT03481556|79407920|FG002|Overall Study|Adverse Event|0|||
44400421|NCT03481556|79407921|FG003|Overall Study|Adverse Event|0|||
44400422|NCT03481556|79407918|FG000|Overall Study|Death|4|||
44400423|NCT03481556|79407919|FG001|Overall Study|Death|2|||
44400424|NCT03481556|79407920|FG002|Overall Study|Death|3|||
44400425|NCT03481556|79407921|FG003|Overall Study|Death|16|||
44400426|NCT03481556|79407918|FG000|Overall Study|Study Terminated by Sponsor|10|||
44400427|NCT03481556|79407919|FG001|Overall Study|Study Terminated by Sponsor|5|||
44400428|NCT03481556|79407920|FG002|Overall Study|Study Terminated by Sponsor|2|||
44400429|NCT03481556|79407921|FG003|Overall Study|Study Terminated by Sponsor|9|||
44400430|NCT00596427|79407939|FG000|Overall Study|Withdrawal by Subject|2|||
44400431|NCT00596427|79407940|FG001|Overall Study|Withdrawal by Subject|2|||
44400432|NCT00596427|79407939|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
44400433|NCT00596427|79407940|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
44400434|NCT00596427|79407939|FG000|Overall Study|Protocol Violation|1|||
44400435|NCT00596427|79407940|FG001|Overall Study|Protocol Violation|0|||
44400436|NCT02732210|79407949|FG000|Overall Study|Site Closed|0|||
44400437|NCT02732210|79407950|FG001|Overall Study|Site Closed|11|||
44400438|NCT02732210|79407949|FG000|Overall Study|Study Ended|13|||
44400439|NCT02732210|79407950|FG001|Overall Study|Study Ended|13|||
44400440|NCT02732210|79407949|FG000|Overall Study|Withdrawal by Subject|28|||
44400441|NCT02732210|79407950|FG001|Overall Study|Withdrawal by Subject|87|||
44400442|NCT02732210|79407949|FG000|Overall Study|Lost to Follow-up|5|||
44400443|NCT02732210|79407950|FG001|Overall Study|Lost to Follow-up|57|||
44400444|NCT02732210|79407949|FG000|Overall Study|Death|4|||
44400445|NCT02732210|79407950|FG001|Overall Study|Death|15|||
44400446|NCT02732210|79407949|FG000|Overall Study|Other|35|||
44400447|NCT02732210|79407950|FG001|Overall Study|Other|103|||
44400448|NCT02732210|79407949|FG000|Overall Study|Missing|0|||
44400449|NCT02732210|79407950|FG001|Overall Study|Missing|8|||
44400450|NCT00595959|79407956|FG000|Overall Study|Withdrawal by Subject|1|||
44400451|NCT00595959|79407956|FG000|Overall Study|Lost to Follow-up|1|||
44400452|NCT00436748|79407994|FG000|Overall Study|Ineligibility Determined|1|||
44400453|NCT00436748|79407995|FG001|Overall Study|Ineligibility Determined|1|||
44400454|NCT00436748|79407994|FG000|Overall Study|Adverse Event|0|||
44400455|NCT00436748|79407995|FG001|Overall Study|Adverse Event|2|||
44400456|NCT00436748|79407994|FG000|Overall Study|Consent Withdrawn|1|||
44400457|NCT00436748|79407995|FG001|Overall Study|Consent Withdrawn|4|||
44147483|NCT02124772|78936759|FG002|Overall Study|Investigator discretion|2|||
44281679|NCT01915914|79244952|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
44400458|NCT00436748|79407994|FG000|Overall Study|Administrative Decision|1|||
44400459|NCT00436748|79407995|FG001|Overall Study|Administrative Decision|0|||
44400460|NCT00436748|79407994|FG000|Overall Study|Lost to Follow-up|0|||
44400461|NCT00436748|79407995|FG001|Overall Study|Lost to Follow-up|1|||
44400462|NCT00436748|79407994|FG000|Overall Study|Protocol-specified Criteria|5|||
44400463|NCT00436748|79407995|FG001|Overall Study|Protocol-specified Criteria|4|||
44400464|NCT00436748|79407994|FG000|Overall Study|Other|3|||
44400465|NCT00436748|79407995|FG001|Overall Study|Other|0|||
44400466|NCT02703272|79408005|FG000|Overall Study|Death|4|||
44400467|NCT02703272|79408006|FG001|Overall Study|Death|9|||
44521867|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Death|1|||
44521868|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Death|0|||
44521869|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Death|0|||
44400468|NCT02703272|79408007|FG002|Overall Study|Death|19|||
44521870|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Death|1|||
44400469|NCT02703272|79408008|FG003|Overall Study|Death|10|||
44400470|NCT02703272|79408005|FG000|Overall Study|Withdrawal by Subject|0|||
44400471|NCT02703272|79408006|FG001|Overall Study|Withdrawal by Subject|0|||
44400472|NCT02703272|79408007|FG002|Overall Study|Withdrawal by Subject|4|||
44400473|NCT02703272|79408008|FG003|Overall Study|Withdrawal by Subject|2|||
44400474|NCT02703272|79408005|FG000|Overall Study|Study Terminated by Sponsor|6|||
44400475|NCT02703272|79408006|FG001|Overall Study|Study Terminated by Sponsor|1|||
44400476|NCT02703272|79408007|FG002|Overall Study|Study Terminated by Sponsor|12|||
44400477|NCT02703272|79408008|FG003|Overall Study|Study Terminated by Sponsor|4|||
44400478|NCT02703272|79408005|FG000|Overall Study|Other|1|||
44400479|NCT02703272|79408006|FG001|Overall Study|Other|0|||
44400480|NCT02703272|79408007|FG002|Overall Study|Other|0|||
44400481|NCT02703272|79408008|FG003|Overall Study|Other|0|||
44400482|NCT02568215|79408048|FG000|Overall Study|Death|1|||
44400483|NCT02568215|79408049|FG001|Overall Study|Death|2|||
44400484|NCT02568215|79408050|FG002|Overall Study|Death|0|||
44400485|NCT02568215|79408048|FG000|Overall Study|Physician Decision|2|||
44400486|NCT02568215|79408049|FG001|Overall Study|Physician Decision|2|||
44400487|NCT02568215|79408050|FG002|Overall Study|Physician Decision|2|||
44400488|NCT02568215|79408048|FG000|Overall Study|Lost to Follow-up|29|||
44400489|NCT02568215|79408049|FG001|Overall Study|Lost to Follow-up|32|||
44400490|NCT02568215|79408050|FG002|Overall Study|Lost to Follow-up|41|||
44400491|NCT02568215|79408048|FG000|Overall Study|Withdrawal by Subject|21|||
44400492|NCT02568215|79408049|FG001|Overall Study|Withdrawal by Subject|19|||
44400493|NCT02568215|79408050|FG002|Overall Study|Withdrawal by Subject|22|||
44400494|NCT02568215|79408048|FG000|Overall Study|Protocol Violation|1|||
44400495|NCT02568215|79408049|FG001|Overall Study|Protocol Violation|1|||
44400496|NCT02568215|79408050|FG002|Overall Study|Protocol Violation|0|||
44400497|NCT02568215|79408048|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
44400498|NCT02568215|79408049|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
44400499|NCT02568215|79408050|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
44400500|NCT02568215|79408048|FG000|Overall Study|Other|0|||
44400501|NCT02568215|79408049|FG001|Overall Study|Other|1|||
44400502|NCT02568215|79408050|FG002|Overall Study|Other|4|||
44400503|NCT00908141|79408087|FG000|Overall Study|Withdrawal by Subject|0|||
44400504|NCT00908141|79408088|FG001|Overall Study|Withdrawal by Subject|1|||
44400505|NCT00906347|79408096|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
44400506|NCT00906347|79408097|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
44400507|NCT00906347|79408096|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
44400508|NCT00906347|79408097|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
44400509|NCT00906347|79408096|FG000|Received Study Drug|Refused study drug|1|||
44400510|NCT00906347|79408097|FG001|Received Study Drug|Refused study drug|0|||
44400511|NCT00906347|79408096|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
44400512|NCT00906347|79408097|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
44400513|NCT00906035|79408106|FG000|Overall Study|Withdrawal by Subject|2|||
44400514|NCT00906035|79408107|FG001|Overall Study|Withdrawal by Subject|3|||
44400515|NCT00906035|79408108|FG002|Overall Study|Withdrawal by Subject|0|||
44400516|NCT00905489|79408116|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
44400517|NCT00905489|79408116|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
44400518|NCT00905489|79408116|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
44400519|NCT02704754|79408127|FG000|Overall Study|Lost to Follow-up|1|||
44400520|NCT02704754|79408128|FG001|Overall Study|Lost to Follow-up|1|||
44400521|NCT02704754|79408127|FG000|Overall Study|Lack of Efficacy|1|||
44400522|NCT02704754|79408128|FG001|Overall Study|Lack of Efficacy|0|||
44400523|NCT02704754|79408127|FG000|Overall Study|Withdrawal by Subject|1|||
44400524|NCT02704754|79408128|FG001|Overall Study|Withdrawal by Subject|0|||
44400525|NCT03170882|79408136|FG000|Overall Study|Death|17|||
44400526|NCT03170882|79408137|FG001|Overall Study|Death|29|||
44400527|NCT03170882|79408136|FG000|Overall Study|Lost to Follow-up|0|||
44400528|NCT03170882|79408137|FG001|Overall Study|Lost to Follow-up|1|||
44400529|NCT03170882|79408136|FG000|Overall Study|Withdrawal by Subject|4|||
44400530|NCT03170882|79408137|FG001|Overall Study|Withdrawal by Subject|7|||
44400531|NCT03170882|79408136|FG000|Overall Study|Reason not Specified|28|||
44400532|NCT03170882|79408137|FG001|Overall Study|Reason not Specified|36|||
44400533|NCT00907517|79408148|FG000|Overall Study|Progressive Disease|3|||
44400534|NCT00907517|79408149|FG001|Overall Study|Progressive Disease|3|||
44400535|NCT00907517|79408150|FG002|Overall Study|Progressive Disease|4|||
44400536|NCT00907517|79408151|FG003|Overall Study|Progressive Disease|4|||
44400537|NCT00907517|79408152|FG004|Overall Study|Progressive Disease|4|||
44400538|NCT00907517|79408148|FG000|Overall Study|Symptomatic Deterioration|0|||
44400539|NCT00907517|79408149|FG001|Overall Study|Symptomatic Deterioration|0|||
44400540|NCT00907517|79408150|FG002|Overall Study|Symptomatic Deterioration|0|||
44400541|NCT00907517|79408151|FG003|Overall Study|Symptomatic Deterioration|0|||
44400542|NCT00907517|79408152|FG004|Overall Study|Symptomatic Deterioration|1|||
44400543|NCT00905255|79408166|FG000|Overall Study|Adverse Event|7|||
44400544|NCT00905255|79408167|FG001|Overall Study|Adverse Event|5|||
44400545|NCT00905255|79408166|FG000|Overall Study|Withdrawal by Subject|5|||
44400546|NCT00905255|79408167|FG001|Overall Study|Withdrawal by Subject|4|||
44400547|NCT00905255|79408166|FG000|Overall Study|Familial and Personal Reasons|1|||
44400548|NCT00905255|79408167|FG001|Overall Study|Familial and Personal Reasons|0|||
44400549|NCT00905021|79408174|FG000|Overall Study|Adverse Event|2|||
44400550|NCT00906971|79408181|FG000|Overall Study|Withdrawal by Subject|8|||
44400551|NCT00906971|79408182|FG001|Overall Study|Withdrawal by Subject|2|||
44400552|NCT00906971|79408181|FG000|Overall Study|Lost to Follow-up|0|||
44400553|NCT00906971|79408182|FG001|Overall Study|Lost to Follow-up|1|||
44400554|NCT00903929|79408188|FG000|Overall Study|Withdrawal by Subject|0|||
44400555|NCT00903929|79408189|FG001|Overall Study|Withdrawal by Subject|0|||
44400556|NCT00903929|79408190|FG002|Overall Study|Withdrawal by Subject|1|||
44400557|NCT00903929|79408191|FG003|Overall Study|Withdrawal by Subject|2|||
44400558|NCT00903929|79408188|FG000|Overall Study|Adverse Event|0|||
44400559|NCT00903929|79408189|FG001|Overall Study|Adverse Event|0|||
44400560|NCT00903929|79408190|FG002|Overall Study|Adverse Event|0|||
44400561|NCT00903929|79408191|FG003|Overall Study|Adverse Event|1|||
44400562|NCT00903695|79408198|FG000|Overall Study|medical exclusion after 1st testing|1|||
44400563|NCT00903695|79408199|FG001|Overall Study|medical exclusion after 1st testing|0|||
44400564|NCT00903695|79408198|FG000|Overall Study|lung cancer|1|||
44400565|NCT00903695|79408199|FG001|Overall Study|lung cancer|0|||
44400566|NCT00903617|79408211|FG000|Overall Study|Adverse Event|0|||
44400567|NCT00903617|79408212|FG001|Overall Study|Adverse Event|1|||
44400568|NCT00903617|79408213|FG002|Overall Study|Adverse Event|1|||
44521871|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Death|0|||
44521872|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Death|0|||
44521873|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Death|0|||
44147484|NCT02124772|78936760|FG003|Overall Study|Investigator discretion|1|||
44147485|NCT02124772|78936761|FG004|Overall Study|Investigator discretion|1|||
44147486|NCT02124772|78936762|FG005|Overall Study|Investigator discretion|0|||
44147487|NCT02124772|78936763|FG006|Overall Study|Investigator discretion|1|||
44147488|NCT02124772|78936764|FG007|Overall Study|Investigator discretion|0|||
44147489|NCT02124772|78936765|FG008|Overall Study|Investigator discretion|0|||
44147490|NCT02124772|78936766|FG009|Overall Study|Investigator discretion|1|||
44147491|NCT02124772|78936767|FG010|Overall Study|Investigator discretion|0|||
44147492|NCT02124772|78936768|FG011|Overall Study|Investigator discretion|1|||
44147493|NCT02124772|78936769|FG012|Overall Study|Investigator discretion|0|||
44521874|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Death|0|||
44521875|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Death|0|||
44521876|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
44521877|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
44521878|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
44521879|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
44521880|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
44521881|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
44521882|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
44521883|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
44521884|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
44521885|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
44521886|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521887|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521888|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521889|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521890|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
44521891|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521892|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521893|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521894|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44147494|NCT02124772|78936757|FG000|Overall Study|Progressive disease|0|||
44147495|NCT02124772|78936758|FG001|Overall Study|Progressive disease|0|||
44147496|NCT02124772|78936759|FG002|Overall Study|Progressive disease|0|||
44147497|NCT02124772|78936760|FG003|Overall Study|Progressive disease|0|||
44147498|NCT02124772|78936761|FG004|Overall Study|Progressive disease|0|||
44147499|NCT02124772|78936762|FG005|Overall Study|Progressive disease|0|||
44252857|NCT02078219|79091719|FG003|Overall Study|Protocol Violation|1|||
44147500|NCT02124772|78936763|FG006|Overall Study|Progressive disease|1|||
44147501|NCT02124772|78936764|FG007|Overall Study|Progressive disease|1|||
44147502|NCT02124772|78936765|FG008|Overall Study|Progressive disease|0|||
44252858|NCT02078219|79091720|FG004|Overall Study|Protocol Violation|0|||
44400569|NCT00903617|79408214|FG003|Overall Study|Adverse Event|0|||
44400570|NCT00903617|79408211|FG000|Overall Study|Protocol-defined stopping criteria|0|||
44521895|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
44521896|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
44521897|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44147503|NCT02124772|78936766|FG009|Overall Study|Progressive disease|0|||
44147504|NCT02124772|78936767|FG010|Overall Study|Progressive disease|0|||
44147505|NCT02124772|78936768|FG011|Overall Study|Progressive disease|0|||
44147506|NCT02124772|78936769|FG012|Overall Study|Progressive disease|0|||
44147507|NCT02124772|78936757|FG000|Overall Study|Other|0|||
44252859|NCT02078219|79091716|FG000|Overall Study|Death|0|||
44252860|NCT02078219|79091717|FG001|Overall Study|Death|0|||
44400571|NCT00903617|79408212|FG001|Overall Study|Protocol-defined stopping criteria|2|||
44400572|NCT00903617|79408213|FG002|Overall Study|Protocol-defined stopping criteria|0|||
44400573|NCT00903617|79408214|FG003|Overall Study|Protocol-defined stopping criteria|0|||
44400574|NCT00903617|79408211|FG000|Overall Study|Lost to Follow-up|2|||
44400575|NCT00903617|79408212|FG001|Overall Study|Lost to Follow-up|0|||
44400576|NCT00903617|79408213|FG002|Overall Study|Lost to Follow-up|1|||
44400577|NCT00903617|79408214|FG003|Overall Study|Lost to Follow-up|1|||
44400578|NCT00903617|79408211|FG000|Overall Study|Withdrawal by Subject|1|||
44400579|NCT00903617|79408212|FG001|Overall Study|Withdrawal by Subject|2|||
44400580|NCT00903617|79408213|FG002|Overall Study|Withdrawal by Subject|3|||
44400581|NCT00903617|79408214|FG003|Overall Study|Withdrawal by Subject|0|||
44400582|NCT00903383|79408229|FG000|Overall Study|Adverse Event|1|||
44252861|NCT02078219|79091718|FG002|Overall Study|Death|0|||
44252862|NCT02078219|79091719|FG003|Overall Study|Death|1|||
44252863|NCT02078219|79091720|FG004|Overall Study|Death|0|||
44252864|NCT02078219|79091716|FG000|Overall Study|Adverse Event|1|||
44252865|NCT02078219|79091717|FG001|Overall Study|Adverse Event|1|||
44252866|NCT02078219|79091718|FG002|Overall Study|Adverse Event|3|||
44252867|NCT02078219|79091719|FG003|Overall Study|Adverse Event|1|||
44252868|NCT02078219|79091720|FG004|Overall Study|Adverse Event|0|||
44252869|NCT02075255|79091735|FG000|Overall Study|Study specific withdrawal criteria|0|||
44252870|NCT02075255|79091736|FG001|Overall Study|Study specific withdrawal criteria|1|||
44252871|NCT02075255|79091737|FG002|Overall Study|Study specific withdrawal criteria|1|||
44252872|NCT02075255|79091735|FG000|Overall Study|Withdrawal by Subject|4|||
44252873|NCT02075255|79091736|FG001|Overall Study|Withdrawal by Subject|1|||
44252874|NCT02075255|79091737|FG002|Overall Study|Withdrawal by Subject|0|||
44252875|NCT02075255|79091735|FG000|Overall Study|Lost to Follow-up|0|||
44521898|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44521899|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44521900|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44521901|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44521902|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44252876|NCT02075255|79091736|FG001|Overall Study|Lost to Follow-up|0|||
44252877|NCT02075255|79091737|FG002|Overall Study|Lost to Follow-up|1|||
44252878|NCT02075255|79091735|FG000|Overall Study|Adverse Event|0|||
44252879|NCT02075255|79091736|FG001|Overall Study|Adverse Event|0|||
44252880|NCT02075255|79091737|FG002|Overall Study|Adverse Event|1|||
44252881|NCT02075255|79091735|FG000|Overall Study|Death|0|||
44252882|NCT02075255|79091736|FG001|Overall Study|Death|2|||
44252883|NCT02075255|79091737|FG002|Overall Study|Death|0|||
44252884|NCT02400671|79091908|FG000|Overall Study|Death|5|||
44252885|NCT02400671|79091909|FG001|Overall Study|Death|3|||
44252886|NCT02400671|79091910|FG002|Overall Study|Death|4|||
44252887|NCT02400671|79091908|FG000|Overall Study|Lost to Follow-up|20|||
44252888|NCT02400671|79091909|FG001|Overall Study|Lost to Follow-up|27|||
44252889|NCT02400671|79091910|FG002|Overall Study|Lost to Follow-up|24|||
44252890|NCT02400671|79091908|FG000|Overall Study|Withdrawal by Subject|2|||
44252891|NCT02400671|79091909|FG001|Overall Study|Withdrawal by Subject|2|||
44400583|NCT00903383|79408230|FG001|Overall Study|Adverse Event|2|||
44400584|NCT00903383|79408231|FG002|Overall Study|Adverse Event|3|||
44400585|NCT00903383|79408232|FG003|Overall Study|Adverse Event|1|||
44400586|NCT00903383|79408229|FG000|Overall Study|Physician Decision|1|||
44400587|NCT00903383|79408230|FG001|Overall Study|Physician Decision|2|||
44400588|NCT00903383|79408231|FG002|Overall Study|Physician Decision|0|||
44400589|NCT00903383|79408232|FG003|Overall Study|Physician Decision|0|||
44400590|NCT00903383|79408229|FG000|Overall Study|Lost to Follow-up|0|||
44400591|NCT00903383|79408230|FG001|Overall Study|Lost to Follow-up|0|||
44400592|NCT00903383|79408231|FG002|Overall Study|Lost to Follow-up|0|||
44400593|NCT00903383|79408232|FG003|Overall Study|Lost to Follow-up|1|||
44400594|NCT00903383|79408229|FG000|Overall Study|Decision of Sponsor|1|||
44400595|NCT00903383|79408230|FG001|Overall Study|Decision of Sponsor|0|||
44400596|NCT00903383|79408231|FG002|Overall Study|Decision of Sponsor|0|||
44400597|NCT00903383|79408232|FG003|Overall Study|Decision of Sponsor|0|||
44400598|NCT00903383|79408229|FG000|Overall Study|Withdrawal by Subject|4|||
44521903|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44521904|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44521905|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
44252892|NCT02400671|79091910|FG002|Overall Study|Withdrawal by Subject|0|||
44252893|NCT00089999|79091920|FG000|Overall Study|Adverse Event|4|||
44400599|NCT00903383|79408230|FG001|Overall Study|Withdrawal by Subject|1|||
44400600|NCT00903383|79408231|FG002|Overall Study|Withdrawal by Subject|0|||
44521906|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
44521907|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44252894|NCT00089999|79091921|FG001|Overall Study|Adverse Event|7|||
44252895|NCT00089999|79091920|FG000|Overall Study|Withdrawal by Subject|0|||
44252896|NCT00089999|79091921|FG001|Overall Study|Withdrawal by Subject|4|||
44400601|NCT00903383|79408232|FG003|Overall Study|Withdrawal by Subject|2|||
44400602|NCT00903383|79408229|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
44400603|NCT00903383|79408230|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
44400604|NCT00903383|79408231|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
44400605|NCT00903383|79408232|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
44400606|NCT00903383|79408229|FG000|Overall Study|Patient Decision|0|||
44400607|NCT00903383|79408230|FG001|Overall Study|Patient Decision|0|||
44400608|NCT00903383|79408231|FG002|Overall Study|Patient Decision|0|||
44400609|NCT00903383|79408232|FG003|Overall Study|Patient Decision|1|||
44400610|NCT02314026|79408242|FG000|Overall Study|Protocol Violation|28|||
44400611|NCT01617096|79408252|FG000|Overall Study|Withdrawal by Subject|96|||
44521908|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44521909|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
44521910|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
44521911|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44521912|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44521913|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44521914|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44521915|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
44521916|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
44521917|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521918|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521919|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
44521920|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521921|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521922|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521923|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44147508|NCT02124772|78936758|FG001|Overall Study|Other|7|||
44147509|NCT02124772|78936759|FG002|Overall Study|Other|2|||
44147510|NCT02124772|78936760|FG003|Overall Study|Other|5|||
44147511|NCT02124772|78936761|FG004|Overall Study|Other|4|||
44281680|NCT01915914|79244953|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
44400612|NCT01617096|79408253|FG001|Overall Study|Withdrawal by Subject|81|||
44400613|NCT01617096|79408252|FG000|Overall Study|Lost to Follow-up|37|||
44400614|NCT01617096|79408253|FG001|Overall Study|Lost to Follow-up|32|||
44400615|NCT01617096|79408252|FG000|Overall Study|Physician Decision|10|||
44400616|NCT01617096|79408253|FG001|Overall Study|Physician Decision|18|||
44400617|NCT01617096|79408252|FG000|Overall Study|Death|4|||
44400618|NCT01617096|79408253|FG001|Overall Study|Death|3|||
44400619|NCT01617096|79408252|FG000|Overall Study|Other|1|||
44400620|NCT01617096|79408253|FG001|Overall Study|Other|3|||
44400621|NCT00900731|79408282|FG000|Overall Study|Adverse Event|31|||
44400622|NCT00900731|79408283|FG001|Overall Study|Adverse Event|27|||
44400623|NCT00900731|79408282|FG000|Overall Study|Withdrawal by Subject|8|||
44400624|NCT00900731|79408283|FG001|Overall Study|Withdrawal by Subject|7|||
44400625|NCT00900731|79408282|FG000|Overall Study|Protocol Deviation|8|||
44281681|NCT01915914|79244954|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
44281682|NCT01915914|79244951|FG000|Acute Phase|"Not Achieved treatment success"|1|||
44281683|NCT01915914|79244952|FG001|Acute Phase|"Not Achieved treatment success"|0|||
44400626|NCT00900731|79408283|FG001|Overall Study|Protocol Deviation|11|||
44400627|NCT00900731|79408282|FG000|Overall Study|Administrative Problems|5|||
44400628|NCT00900731|79408283|FG001|Overall Study|Administrative Problems|4|||
44400629|NCT00900731|79408282|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
44400630|NCT00900731|79408283|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
44400631|NCT00900731|79408282|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
44400632|NCT00900731|79408283|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
44400633|NCT00900731|79408282|FG000|Overall Study|Lost to Follow-up|2|||
44400634|NCT00900731|79408283|FG001|Overall Study|Lost to Follow-up|3|||
44400635|NCT00900731|79408282|FG000|Overall Study|Lack of Efficacy|1|||
44400636|NCT00900731|79408283|FG001|Overall Study|Lack of Efficacy|3|||
44400637|NCT00900731|79408282|FG000|Overall Study|Death|0|||
44400638|NCT00900731|79408283|FG001|Overall Study|Death|2|||
44400639|NCT03842436|79408289|FG000|Overall Study|Lost to Follow-up|1|||
44400640|NCT00602472|79408329|FG000|Overall Study|Adverse Event|5|||
44400641|NCT00602472|79408330|FG001|Overall Study|Adverse Event|23|||
44400642|NCT00602472|79408329|FG000|Overall Study|Protocol Violation|4|||
44400643|NCT00602472|79408330|FG001|Overall Study|Protocol Violation|19|||
44281684|NCT01915914|79244953|FG002|Acute Phase|"Not Achieved treatment success"|0|||
44400644|NCT00602472|79408329|FG000|Overall Study|Withdrawal by Subject|8|||
44400645|NCT00602472|79408330|FG001|Overall Study|Withdrawal by Subject|14|||
44521924|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521925|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
44521926|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
44400646|NCT00602472|79408329|FG000|Overall Study|Other incl. lack of efficacy|4|||
44521927|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
44521928|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
44521929|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
44521930|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
44521931|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
44521932|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
44521933|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
44400647|NCT00602472|79408330|FG001|Overall Study|Other incl. lack of efficacy|2|||
44400648|NCT00901901|79408365|FG000|Treatment Period|Adverse Event|120|||
44400649|NCT00901901|79408366|FG001|Treatment Period|Adverse Event|128|||
44400650|NCT00901901|79408365|FG000|Treatment Period|Withdrawal by Subject|26|||
44400651|NCT00901901|79408366|FG001|Treatment Period|Withdrawal by Subject|24|||
44400652|NCT00901901|79408365|FG000|Treatment Period|Physician Decision|2|||
44400653|NCT00901901|79408366|FG001|Treatment Period|Physician Decision|2|||
44400654|NCT00901901|79408365|FG000|Treatment Period|Lost to Follow-up|3|||
44400655|NCT00901901|79408366|FG001|Treatment Period|Lost to Follow-up|5|||
44400656|NCT00901901|79408365|FG000|Treatment Period|Noncompliance with study medication|4|||
44400657|NCT00901901|79408366|FG001|Treatment Period|Noncompliance with study medication|1|||
44400658|NCT00901901|79408365|FG000|Treatment Period|Missing|1|||
44400659|NCT00901901|79408366|FG001|Treatment Period|Missing|0|||
44400660|NCT00901901|79408365|FG000|Treatment Period|Never treated|0|||
44400661|NCT00901901|79408366|FG001|Treatment Period|Never treated|3|||
44400662|NCT00901901|79408365|FG000|Treatment Period|Protocol driven decision point|0|||
44400663|NCT00901901|79408366|FG001|Treatment Period|Protocol driven decision point|2|||
44400664|NCT00901901|79408365|FG000|Treatment Period|Study terminated by sponsor|2|||
44400665|NCT00901901|79408366|FG001|Treatment Period|Study terminated by sponsor|0|||
44400666|NCT00901901|79408365|FG000|Treatment Period|Protocol Violation|5|||
44400667|NCT00901901|79408366|FG001|Treatment Period|Protocol Violation|9|||
44400668|NCT00901901|79408365|FG000|Treatment Period|Switch to commercial drug|1|||
44400669|NCT00901901|79408366|FG001|Treatment Period|Switch to commercial drug|1|||
44400670|NCT00901901|79408365|FG000|Treatment Period|Transfer to treatment continuation study|5|||
44400671|NCT00901901|79408366|FG001|Treatment Period|Transfer to treatment continuation study|2|||
44400672|NCT00901901|79408365|FG000|Follow-up Period|Death|181|||
44400673|NCT00901901|79408366|FG001|Follow-up Period|Death|208|||
44400674|NCT00901901|79408365|FG000|Follow-up Period|Protocol driven decision point|47|||
44400675|NCT00901901|79408366|FG001|Follow-up Period|Protocol driven decision point|36|||
44400676|NCT00901901|79408365|FG000|Follow-up Period|Withdrawal by Subject|6|||
44400677|NCT00901901|79408366|FG001|Follow-up Period|Withdrawal by Subject|9|||
44400678|NCT00901901|79408365|FG000|Follow-up Period|Lost to Follow-up|12|||
44400679|NCT00901901|79408366|FG001|Follow-up Period|Lost to Follow-up|8|||
44400680|NCT00901901|79408365|FG000|Follow-up Period|Missing|94|||
44400681|NCT00901901|79408366|FG001|Follow-up Period|Missing|80|||
44400682|NCT02143778|79408374|FG000|Overall Study|Withdrawal by Subject|2|||
44521934|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
44521935|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
44521936|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
44521937|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
44521938|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
44521939|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44521940|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
44521941|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44521942|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44521943|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44521944|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44521945|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44147512|NCT02124772|78936762|FG005|Overall Study|Other|3|||
44147513|NCT02124772|78936763|FG006|Overall Study|Other|4|||
44400683|NCT02143778|79408374|FG000|Overall Study|Device malfunction|1|||
44400684|NCT00896363|79408418|FG000|Overall Study|Adverse Event|3|||
44400685|NCT00896363|79408419|FG001|Overall Study|Adverse Event|4|||
44400686|NCT00896363|79408420|FG002|Overall Study|Adverse Event|2|||
44400687|NCT00896363|79408418|FG000|Overall Study|Lack of Efficacy|0|||
44400688|NCT00896363|79408419|FG001|Overall Study|Lack of Efficacy|2|||
44400689|NCT00896363|79408420|FG002|Overall Study|Lack of Efficacy|1|||
44400690|NCT00896363|79408418|FG000|Overall Study|Withdrawal by Subject|3|||
44400691|NCT00896363|79408419|FG001|Overall Study|Withdrawal by Subject|5|||
44400692|NCT00896363|79408420|FG002|Overall Study|Withdrawal by Subject|5|||
44400693|NCT00900029|79408436|FG000|Overall Study|Lost to Follow-up|0|||
44400694|NCT00900029|79408437|FG001|Overall Study|Lost to Follow-up|2|||
44400695|NCT00900029|79408438|FG002|Overall Study|Lost to Follow-up|1|||
44400696|NCT00900029|79408439|FG003|Overall Study|Lost to Follow-up|4|||
44400697|NCT00900029|79408440|FG004|Overall Study|Lost to Follow-up|4|||
44400698|NCT00900029|79408436|FG000|Overall Study|Withdrawal by Subject|2|||
44400699|NCT00900029|79408437|FG001|Overall Study|Withdrawal by Subject|2|||
44400700|NCT00900029|79408438|FG002|Overall Study|Withdrawal by Subject|1|||
44400701|NCT00900029|79408439|FG003|Overall Study|Withdrawal by Subject|1|||
44400702|NCT00900029|79408440|FG004|Overall Study|Withdrawal by Subject|1|||
44400703|NCT00900029|79408436|FG000|Overall Study|Adverse Event|0|||
44400704|NCT00900029|79408437|FG001|Overall Study|Adverse Event|0|||
44400705|NCT00900029|79408438|FG002|Overall Study|Adverse Event|1|||
44400706|NCT00900029|79408439|FG003|Overall Study|Adverse Event|1|||
44400707|NCT00900029|79408440|FG004|Overall Study|Adverse Event|1|||
44400708|NCT00900029|79408436|FG000|Overall Study|Death|1|||
44400709|NCT00900029|79408437|FG001|Overall Study|Death|0|||
44400710|NCT00900029|79408438|FG002|Overall Study|Death|0|||
44400711|NCT00900029|79408439|FG003|Overall Study|Death|1|||
44400712|NCT00900029|79408440|FG004|Overall Study|Death|0|||
44400713|NCT00896051|79408458|FG000|Overall Study|Adverse Event|2|||
44400714|NCT00896051|79408459|FG001|Overall Study|Adverse Event|1|||
44400715|NCT00896051|79408458|FG000|Overall Study|Lost to Follow-up|3|||
44400716|NCT00896051|79408459|FG001|Overall Study|Lost to Follow-up|2|||
44400717|NCT00896051|79408458|FG000|Overall Study|Withdrawal by Subject|3|||
44400718|NCT00896051|79408459|FG001|Overall Study|Withdrawal by Subject|2|||
44400719|NCT00896051|79408458|FG000|Overall Study|Subject noncompliant|1|||
44400720|NCT00896051|79408459|FG001|Overall Study|Subject noncompliant|3|||
44400721|NCT00896051|79408458|FG000|Overall Study|Other|1|||
44400722|NCT00896051|79408459|FG001|Overall Study|Other|1|||
44400723|NCT00894647|79408476|FG000|Overall Study|Adverse Event|5|||
44400724|NCT00894647|79408477|FG001|Overall Study|Adverse Event|4|||
44400725|NCT00894647|79408476|FG000|Overall Study|Withdrawal by Subject|4|||
44400726|NCT00894647|79408477|FG001|Overall Study|Withdrawal by Subject|4|||
44400727|NCT00894647|79408476|FG000|Overall Study|Lost to Follow-up|0|||
44400728|NCT00894647|79408477|FG001|Overall Study|Lost to Follow-up|2|||
44400729|NCT00894647|79408476|FG000|Overall Study|Non-compliance with study procedures|0|||
44400730|NCT00894647|79408477|FG001|Overall Study|Non-compliance with study procedures|2|||
44400731|NCT00894647|79408476|FG000|Overall Study|Other, not due to AE|1|||
44400732|NCT00894647|79408477|FG001|Overall Study|Other, not due to AE|2|||
44400733|NCT00892775|79408485|FG000|Overall Study|Protocol Violation|1|||
44400734|NCT00892775|79408486|FG001|Overall Study|Protocol Violation|0|||
44400735|NCT00892775|79408485|FG000|Overall Study|Subject difficulties with blood drawing|1|||
44400736|NCT00892775|79408486|FG001|Overall Study|Subject difficulties with blood drawing|0|||
44400737|NCT00892775|79408485|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
44400738|NCT00892775|79408486|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
44400739|NCT00892775|79408485|FG000|Overall Study|Migrated/ moved from study area|1|||
44400740|NCT00892775|79408486|FG001|Overall Study|Migrated/ moved from study area|0|||
44400741|NCT00892775|79408485|FG000|Overall Study|Withdrawal by Subject|0|||
44400742|NCT00892775|79408486|FG001|Overall Study|Withdrawal by Subject|1|||
44400743|NCT00892775|79408485|FG000|Overall Study|Lost to Follow-up|1|||
44400744|NCT00892775|79408486|FG001|Overall Study|Lost to Follow-up|0|||
44400745|NCT00895895|79408497|FG000|Period 1|Adverse Event|7|||
44400746|NCT00895895|79408498|FG001|Period 1|Adverse Event|6|||
44400747|NCT00895895|79408499|FG002|Period 1|Adverse Event|4|||
44400748|NCT00895895|79408500|FG003|Period 1|Adverse Event|6|||
44400749|NCT00895895|79408501|FG004|Period 1|Adverse Event|7|||
44400750|NCT00895895|79408497|FG000|Period 1|Death|0|||
44400751|NCT00895895|79408498|FG001|Period 1|Death|0|||
44400752|NCT00895895|79408499|FG002|Period 1|Death|0|||
44400753|NCT00895895|79408500|FG003|Period 1|Death|0|||
44400754|NCT00895895|79408501|FG004|Period 1|Death|1|||
44400755|NCT00895895|79408497|FG000|Period 1|discontinued by sponsor|2|||
44147514|NCT02124772|78936764|FG007|Overall Study|Other|1|||
44147515|NCT02124772|78936765|FG008|Overall Study|Other|1|||
44147516|NCT02124772|78936766|FG009|Overall Study|Other|1|||
44147517|NCT02124772|78936767|FG010|Overall Study|Other|1|||
44147518|NCT02124772|78936768|FG011|Overall Study|Other|1|||
44400756|NCT00895895|79408498|FG001|Period 1|discontinued by sponsor|1|||
44400757|NCT00895895|79408499|FG002|Period 1|discontinued by sponsor|2|||
44400758|NCT00895895|79408500|FG003|Period 1|discontinued by sponsor|1|||
44400759|NCT00895895|79408501|FG004|Period 1|discontinued by sponsor|1|||
44400760|NCT00895895|79408497|FG000|Period 1|failed to return|0|||
44400761|NCT00895895|79408498|FG001|Period 1|failed to return|0|||
44400762|NCT00895895|79408499|FG002|Period 1|failed to return|1|||
44400763|NCT00895895|79408500|FG003|Period 1|failed to return|0|||
44400764|NCT00895895|79408501|FG004|Period 1|failed to return|1|||
44400765|NCT00895895|79408497|FG000|Period 1|investigator request|0|||
44400766|NCT00895895|79408498|FG001|Period 1|investigator request|1|||
44400767|NCT00895895|79408499|FG002|Period 1|investigator request|0|||
44400768|NCT00895895|79408500|FG003|Period 1|investigator request|0|||
44400769|NCT00895895|79408501|FG004|Period 1|investigator request|0|||
44400770|NCT00895895|79408497|FG000|Period 1|Lost to Follow-up|2|||
44400771|NCT00895895|79408498|FG001|Period 1|Lost to Follow-up|1|||
44400772|NCT00895895|79408499|FG002|Period 1|Lost to Follow-up|3|||
44400773|NCT00895895|79408500|FG003|Period 1|Lost to Follow-up|2|||
44400774|NCT00895895|79408501|FG004|Period 1|Lost to Follow-up|3|||
44400775|NCT00895895|79408497|FG000|Period 1|Other|1|||
44400776|NCT00895895|79408498|FG001|Period 1|Other|2|||
44400777|NCT00895895|79408499|FG002|Period 1|Other|1|||
44400778|NCT00895895|79408500|FG003|Period 1|Other|1|||
44400779|NCT00895895|79408501|FG004|Period 1|Other|1|||
44400780|NCT00895895|79408497|FG000|Period 1|Protocol Violation|0|||
44400781|NCT00895895|79408498|FG001|Period 1|Protocol Violation|1|||
44400782|NCT00895895|79408499|FG002|Period 1|Protocol Violation|0|||
44400783|NCT00895895|79408500|FG003|Period 1|Protocol Violation|0|||
44400784|NCT00895895|79408501|FG004|Period 1|Protocol Violation|0|||
44400785|NCT00895895|79408497|FG000|Period 1|Withdrawal by Subject|6|||
44400786|NCT00895895|79408498|FG001|Period 1|Withdrawal by Subject|6|||
44400787|NCT00895895|79408499|FG002|Period 1|Withdrawal by Subject|8|||
44400788|NCT00895895|79408500|FG003|Period 1|Withdrawal by Subject|2|||
44400789|NCT00895895|79408501|FG004|Period 1|Withdrawal by Subject|4|||
44400790|NCT00895895|79408497|FG000|Period 1|unsatisfactory response-efficacy|2|||
44400791|NCT00895895|79408498|FG001|Period 1|unsatisfactory response-efficacy|0|||
44400792|NCT00895895|79408499|FG002|Period 1|unsatisfactory response-efficacy|0|||
44400793|NCT00895895|79408500|FG003|Period 1|unsatisfactory response-efficacy|0|||
44400794|NCT00895895|79408501|FG004|Period 1|unsatisfactory response-efficacy|0|||
44400795|NCT00895895|79408497|FG000|Period 1|randomized and not treated|1|||
44400796|NCT00895895|79408498|FG001|Period 1|randomized and not treated|3|||
44400797|NCT00895895|79408499|FG002|Period 1|randomized and not treated|1|||
44400798|NCT00895895|79408500|FG003|Period 1|randomized and not treated|1|||
44400799|NCT00895895|79408501|FG004|Period 1|randomized and not treated|2|||
44400800|NCT00895895|79408497|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
44400801|NCT00895895|79408498|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
44400802|NCT00895895|79408499|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
44400803|NCT00895895|79408500|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
44400804|NCT00895895|79408501|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
44400805|NCT00895895|79408497|FG000|After Period 1, Prior to Period 2|Other|0|||
44400806|NCT00895895|79408498|FG001|After Period 1, Prior to Period 2|Other|0|||
44400807|NCT00895895|79408499|FG002|After Period 1, Prior to Period 2|Other|1|||
44400808|NCT00895895|79408500|FG003|After Period 1, Prior to Period 2|Other|0|||
44400809|NCT00895895|79408501|FG004|After Period 1, Prior to Period 2|Other|0|||
44400810|NCT00895895|79408497|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
44400811|NCT00895895|79408498|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
44400812|NCT00895895|79408499|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
44400813|NCT00895895|79408500|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
44400814|NCT00895895|79408501|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
44400815|NCT00895895|79408497|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
44400816|NCT00895895|79408498|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
44400817|NCT00895895|79408499|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
44400818|NCT00895895|79408500|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
44400819|NCT00895895|79408501|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
44400820|NCT00895895|79408497|FG000|Period 2|Adverse Event|3|||
44400821|NCT00895895|79408498|FG001|Period 2|Adverse Event|3|||
44400822|NCT00895895|79408499|FG002|Period 2|Adverse Event|5|||
44400823|NCT00895895|79408500|FG003|Period 2|Adverse Event|2|||
44400824|NCT00895895|79408501|FG004|Period 2|Adverse Event|5|||
44400825|NCT00895895|79408497|FG000|Period 2|Death|0|||
44400826|NCT00895895|79408498|FG001|Period 2|Death|0|||
44400827|NCT00895895|79408499|FG002|Period 2|Death|1|||
44400828|NCT00895895|79408500|FG003|Period 2|Death|0|||
44400829|NCT00895895|79408501|FG004|Period 2|Death|0|||
44400830|NCT00895895|79408497|FG000|Period 2|discontinued by sponsor|44|||
44400831|NCT00895895|79408498|FG001|Period 2|discontinued by sponsor|44|||
44400832|NCT00895895|79408499|FG002|Period 2|discontinued by sponsor|38|||
44400833|NCT00895895|79408500|FG003|Period 2|discontinued by sponsor|46|||
44400834|NCT00895895|79408501|FG004|Period 2|discontinued by sponsor|37|||
44400835|NCT00895895|79408497|FG000|Period 2|failed to return|2|||
44400836|NCT00895895|79408498|FG001|Period 2|failed to return|0|||
44400837|NCT00895895|79408499|FG002|Period 2|failed to return|0|||
44400838|NCT00895895|79408500|FG003|Period 2|failed to return|0|||
44400839|NCT00895895|79408501|FG004|Period 2|failed to return|0|||
44400840|NCT00895895|79408497|FG000|Period 2|investigator request|2|||
44400841|NCT00895895|79408498|FG001|Period 2|investigator request|0|||
44400842|NCT00895895|79408499|FG002|Period 2|investigator request|0|||
44400843|NCT00895895|79408500|FG003|Period 2|investigator request|0|||
44400844|NCT00895895|79408501|FG004|Period 2|investigator request|0|||
44400845|NCT00895895|79408497|FG000|Period 2|Lost to Follow-up|1|||
44400846|NCT00895895|79408498|FG001|Period 2|Lost to Follow-up|2|||
44400847|NCT00895895|79408499|FG002|Period 2|Lost to Follow-up|1|||
44400848|NCT00895895|79408500|FG003|Period 2|Lost to Follow-up|1|||
44400849|NCT00895895|79408501|FG004|Period 2|Lost to Follow-up|0|||
44400850|NCT00895895|79408497|FG000|Period 2|Other|1|||
44400851|NCT00895895|79408498|FG001|Period 2|Other|1|||
44400852|NCT00895895|79408499|FG002|Period 2|Other|3|||
44400853|NCT00895895|79408500|FG003|Period 2|Other|1|||
44400854|NCT00895895|79408501|FG004|Period 2|Other|1|||
44400855|NCT00895895|79408497|FG000|Period 2|Protocol Violation|1|||
44400856|NCT00895895|79408498|FG001|Period 2|Protocol Violation|0|||
44400857|NCT00895895|79408499|FG002|Period 2|Protocol Violation|1|||
44400858|NCT00895895|79408500|FG003|Period 2|Protocol Violation|1|||
44400859|NCT00895895|79408501|FG004|Period 2|Protocol Violation|1|||
44400860|NCT00895895|79408497|FG000|Period 2|Withdrawal by Subject|0|||
44400861|NCT00895895|79408498|FG001|Period 2|Withdrawal by Subject|2|||
44400862|NCT00895895|79408499|FG002|Period 2|Withdrawal by Subject|0|||
44400863|NCT00895895|79408500|FG003|Period 2|Withdrawal by Subject|3|||
44400864|NCT00895895|79408501|FG004|Period 2|Withdrawal by Subject|5|||
44400865|NCT00895895|79408497|FG000|Period 2|unsatisfactory response-efficacy|2|||
44400866|NCT00895895|79408498|FG001|Period 2|unsatisfactory response-efficacy|1|||
44400867|NCT00895895|79408499|FG002|Period 2|unsatisfactory response-efficacy|0|||
44400868|NCT00895895|79408500|FG003|Period 2|unsatisfactory response-efficacy|0|||
44400869|NCT00895895|79408501|FG004|Period 2|unsatisfactory response-efficacy|0|||
44400870|NCT00895661|79408519|FG000|Overall Study|Death|1|||
44400871|NCT00895661|79408519|FG000|Overall Study|reason unknown|2|||
44400872|NCT00895583|79408525|FG000|Overall Study|Adverse Event|28|||
44400873|NCT00895583|79408526|FG001|Overall Study|Adverse Event|4|||
44400874|NCT00895583|79408525|FG000|Overall Study|Death|2|||
44400875|NCT00895583|79408526|FG001|Overall Study|Death|1|||
44400876|NCT00895583|79408525|FG000|Overall Study|Physician Decision|3|||
44400877|NCT00895583|79408526|FG001|Overall Study|Physician Decision|1|||
44400878|NCT00895583|79408525|FG000|Overall Study|Lost to Follow-up|1|||
44400879|NCT00895583|79408526|FG001|Overall Study|Lost to Follow-up|3|||
44400880|NCT00895583|79408525|FG000|Overall Study|Protocol Violation|1|||
44400881|NCT00895583|79408526|FG001|Overall Study|Protocol Violation|0|||
44400882|NCT00895583|79408525|FG000|Overall Study|Withdrawal by Subject|4|||
44400883|NCT00895583|79408526|FG001|Overall Study|Withdrawal by Subject|2|||
44400884|NCT00895583|79408525|FG000|Overall Study|Lack of Efficacy|5|||
44400885|NCT00895583|79408526|FG001|Overall Study|Lack of Efficacy|0|||
44400886|NCT00895583|79408525|FG000|Overall Study|Other|0|||
44400887|NCT00895583|79408526|FG001|Overall Study|Other|1|||
44400888|NCT00894413|79408543|FG000|Overall Study|Physician Decision|0|||
44400889|NCT00894413|79408544|FG001|Overall Study|Physician Decision|2|||
44400890|NCT00894413|79408543|FG000|Overall Study|Adverse Event|0|||
44400891|NCT00894413|79408544|FG001|Overall Study|Adverse Event|2|||
44400892|NCT00894413|79408543|FG000|Overall Study|Withdrawal by Subject|0|||
44400893|NCT00894413|79408544|FG001|Overall Study|Withdrawal by Subject|4|||
44400894|NCT00895037|79408553|FG000|Overall Study|Death|0|||
44400895|NCT00895037|79408554|FG001|Overall Study|Death|2|||
44400896|NCT00895037|79408555|FG002|Overall Study|Death|1|||
44400897|NCT00892151|79408563|FG000|Overall Study|Protocol Violation|1|||
44521946|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
44521947|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44521948|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44521949|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
44400898|NCT01706705|79408567|FG000|Overall Study|Death|1|||
44400899|NCT01706705|79408567|FG000|Overall Study|Lack of Efficacy|13|||
44147519|NCT02124772|78936769|FG012|Overall Study|Other|0|||
44400900|NCT01706705|79408567|FG000|Overall Study|Non-clinical|6|||
44400901|NCT00894803|79408583|FG000|Overall Study|Death|20|||
44400902|NCT00894803|79408584|FG001|Overall Study|Death|4|||
44400903|NCT00894803|79408583|FG000|Overall Study|Lost to Follow-up|0|||
44400904|NCT00894803|79408584|FG001|Overall Study|Lost to Follow-up|1|||
44400905|NCT00601458|79408593|FG000|Overall Study|Dosing Error|1|||
44400906|NCT00601458|79408594|FG001|Overall Study|Dosing Error|0|||
44400907|NCT00601458|79408595|FG002|Overall Study|Dosing Error|0|||
44400908|NCT00601458|79408593|FG000|Overall Study|Incomplete Data|0|||
44400909|NCT00601458|79408594|FG001|Overall Study|Incomplete Data|2|||
44400910|NCT00601458|79408595|FG002|Overall Study|Incomplete Data|0|||
44147520|NCT02159482|78936821|FG000|Overall Study|Withdrawal by Subject|2|||
44400911|NCT00601458|79408593|FG000|Overall Study|Protocol Violation|3|||
44400912|NCT00601458|79408594|FG001|Overall Study|Protocol Violation|2|||
44400913|NCT00601458|79408595|FG002|Overall Study|Protocol Violation|1|||
44521950|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
44521951|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44400914|NCT00601458|79408593|FG000|Overall Study|Early Termination|0|||
44400915|NCT00601458|79408594|FG001|Overall Study|Early Termination|1|||
44400916|NCT00601458|79408595|FG002|Overall Study|Early Termination|1|||
44400917|NCT02141282|79408607|FG000|Overall Study|Adverse event, not related to progression|8|||
44400918|NCT02141282|79408608|FG001|Overall Study|Adverse event, not related to progression|1|||
44400919|NCT02141282|79408609|FG002|Overall Study|Adverse event, not related to progression|3|||
44400920|NCT02141282|79408610|FG003|Overall Study|Adverse event, not related to progression|1|||
44400921|NCT02141282|79408607|FG000|Overall Study|Adverse event, related to progression|1|||
44400922|NCT02141282|79408608|FG001|Overall Study|Adverse event, related to progression|0|||
44400923|NCT02141282|79408609|FG002|Overall Study|Adverse event, related to progression|2|||
44400924|NCT02141282|79408610|FG003|Overall Study|Adverse event, related to progression|0|||
44400925|NCT02141282|79408607|FG000|Overall Study|COVID-19 infection|1|||
44400926|NCT02141282|79408608|FG001|Overall Study|COVID-19 infection|0|||
44400927|NCT02141282|79408609|FG002|Overall Study|COVID-19 infection|0|||
44400928|NCT02141282|79408610|FG003|Overall Study|COVID-19 infection|0|||
44400929|NCT02141282|79408607|FG000|Overall Study|Lost to Follow-up|0|||
44400930|NCT02141282|79408608|FG001|Overall Study|Lost to Follow-up|0|||
44400931|NCT02141282|79408609|FG002|Overall Study|Lost to Follow-up|4|||
44400932|NCT02141282|79408610|FG003|Overall Study|Lost to Follow-up|2|||
44400933|NCT02141282|79408607|FG000|Overall Study|Other, not specified|14|||
44400934|NCT02141282|79408608|FG001|Overall Study|Other, not specified|11|||
44400935|NCT02141282|79408609|FG002|Overall Study|Other, not specified|23|||
44400936|NCT02141282|79408610|FG003|Overall Study|Other, not specified|9|||
44400937|NCT02141282|79408607|FG000|Overall Study|Progressive disease, Richter's|4|||
44400938|NCT02141282|79408608|FG001|Overall Study|Progressive disease, Richter's|1|||
44400939|NCT02141282|79408609|FG002|Overall Study|Progressive disease, Richter's|1|||
44400940|NCT02141282|79408610|FG003|Overall Study|Progressive disease, Richter's|1|||
44400941|NCT02141282|79408607|FG000|Overall Study|Progressive disease per protocol|12|||
44400942|NCT02141282|79408608|FG001|Overall Study|Progressive disease per protocol|7|||
44400943|NCT02141282|79408609|FG002|Overall Study|Progressive disease per protocol|9|||
44400944|NCT02141282|79408610|FG003|Overall Study|Progressive disease per protocol|2|||
44400945|NCT02141282|79408607|FG000|Overall Study|Stem cell transplant|1|||
44400946|NCT02141282|79408608|FG001|Overall Study|Stem cell transplant|0|||
44400947|NCT02141282|79408609|FG002|Overall Study|Stem cell transplant|1|||
44400948|NCT02141282|79408610|FG003|Overall Study|Stem cell transplant|0|||
44400949|NCT02141282|79408607|FG000|Overall Study|Study terminated by Sponsor|0|||
44400950|NCT02141282|79408608|FG001|Overall Study|Study terminated by Sponsor|1|||
44400951|NCT02141282|79408609|FG002|Overall Study|Study terminated by Sponsor|0|||
44400952|NCT02141282|79408610|FG003|Overall Study|Study terminated by Sponsor|0|||
44400953|NCT02141282|79408607|FG000|Overall Study|Subject non-compliance|0|||
44400954|NCT02141282|79408608|FG001|Overall Study|Subject non-compliance|0|||
44400955|NCT02141282|79408609|FG002|Overall Study|Subject non-compliance|1|||
44400956|NCT02141282|79408610|FG003|Overall Study|Subject non-compliance|0|||
44400957|NCT02141282|79408607|FG000|Overall Study|Withdrew consent|2|||
44400958|NCT02141282|79408608|FG001|Overall Study|Withdrew consent|0|||
44400959|NCT02141282|79408609|FG002|Overall Study|Withdrew consent|4|||
44400960|NCT02141282|79408610|FG003|Overall Study|Withdrew consent|0|||
44400961|NCT00003479|79408623|FG000|Overall Study|Not evaluable|3|||
44400962|NCT00891839|79408627|FG000|Overall Study|Adverse Event|2|||
44400963|NCT00891839|79408627|FG000|Overall Study|Withdrawal by Subject|2|||
44400964|NCT00891839|79408627|FG000|Overall Study|Disease progression|3|||
44400965|NCT00600756|79408633|FG000|Analysis After 6 Months|Adverse Event|43|||
44400966|NCT00600756|79408634|FG001|Analysis After 6 Months|Adverse Event|33|||
44400967|NCT00600756|79408633|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
44400968|NCT00600756|79408634|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
44400969|NCT00600756|79408633|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
44400970|NCT00600756|79408634|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
44521952|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44521953|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44147521|NCT02159482|78936821|FG000|Overall Study|Physician Decision|3|||
44400971|NCT00600756|79408633|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
44400972|NCT00600756|79408634|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
44400973|NCT00600756|79408633|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
44400974|NCT00600756|79408634|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
44400975|NCT00600756|79408633|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
44400976|NCT00600756|79408634|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
44400977|NCT00600756|79408633|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
44400978|NCT00600756|79408634|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
44400979|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
44400980|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
44400981|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
44400982|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
44400983|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
44400984|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
44400985|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
44400986|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
44400987|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
44400988|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
44521954|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44521955|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
44521956|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44521957|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44521958|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44521959|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44521960|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44521961|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44521962|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44521963|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44521964|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44521965|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44400989|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
44400990|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
44400991|NCT00600756|79408633|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
44400992|NCT00600756|79408634|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
44400993|NCT00890825|79408646|FG000|Overall Study|Withdrawal by Subject|1|||
44147522|NCT02622321|78936829|FG000|Overall Study|Withdrawal by Subject|2|||
44400994|NCT00890825|79408647|FG001|Overall Study|Withdrawal by Subject|0|||
44400995|NCT00890825|79408646|FG000|Overall Study|Alive at data cut off (DCO)|13|||
44400996|NCT00890825|79408647|FG001|Overall Study|Alive at data cut off (DCO)|14|||
44400997|NCT00890201|79408655|FG000|Overall Study|Protocol Violation|5|||
44400998|NCT00890201|79408656|FG001|Overall Study|Protocol Violation|56|||
44400999|NCT00891527|79408662|FG000|Overall Study|Withdrawal by Subject|2|||
44401000|NCT03861078|79408667|FG000|Overall Study|COVID-19 shut down|4|||
44401001|NCT03861078|79408667|FG000|Overall Study|Lost to Follow-up|1|||
44401002|NCT03861078|79408667|FG000|Overall Study|Protocol Violation|2|||
44401003|NCT03861078|79408667|FG000|Overall Study|lack of venous access|1|||
44401004|NCT04950465|79408678|FG000|Overall Study|Lost to Follow-up|1|||
44401005|NCT04950465|79408679|FG001|Overall Study|Lost to Follow-up|0|||
44401006|NCT04950465|79408680|FG002|Overall Study|Lost to Follow-up|0|||
44401007|NCT04495816|79408702|FG000|Overall Study|Lost to Follow-up|10|||
44521966|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521967|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521968|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
44521969|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521970|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
44521971|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521972|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521973|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521974|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44147523|NCT02622321|78936830|FG001|Overall Study|Withdrawal by Subject|0|||
44147524|NCT02622321|78936831|FG002|Overall Study|Withdrawal by Subject|0|||
44147525|NCT02622321|78936832|FG003|Overall Study|Withdrawal by Subject|0|||
44252897|NCT00089999|79091920|FG000|Overall Study|Lost to Follow-up|2|||
44401008|NCT04495816|79408703|FG001|Overall Study|Lost to Follow-up|4|||
44401009|NCT04495816|79408702|FG000|Overall Study|Withdrawal by Subject|3|||
44401010|NCT04495816|79408703|FG001|Overall Study|Withdrawal by Subject|5|||
44401011|NCT04267562|79408718|FG000|Assessed for Eligibility|Screen Failure|64|||
44401012|NCT04267562|79408718|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
44401013|NCT04267562|79408718|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
44401014|NCT04267562|79408718|FG000|Assessed for Eligibility|Site closure|6|||
44401015|NCT04267562|79408718|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
44401016|NCT04267562|79408718|FG000|Assessed for Eligibility|Physician Decision|1|||
44401017|NCT03891901|79408729|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
44401018|NCT03891901|79408730|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401019|NCT03891901|79408731|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401020|NCT03891901|79408732|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401021|NCT03891901|79408733|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401022|NCT03891901|79408734|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401023|NCT03891901|79408735|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401024|NCT03891901|79408736|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401025|NCT03891901|79408737|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
44401026|NCT03891901|79408729|FG000|Overall Study|Adverse Event|2|||
44401027|NCT03891901|79408730|FG001|Overall Study|Adverse Event|2|||
44401028|NCT03891901|79408731|FG002|Overall Study|Adverse Event|0|||
44401029|NCT03891901|79408732|FG003|Overall Study|Adverse Event|0|||
44401030|NCT03891901|79408733|FG004|Overall Study|Adverse Event|0|||
44401031|NCT03891901|79408734|FG005|Overall Study|Adverse Event|0|||
44401032|NCT03891901|79408735|FG006|Overall Study|Adverse Event|0|||
44401033|NCT03891901|79408736|FG007|Overall Study|Adverse Event|0|||
44401034|NCT03891901|79408737|FG008|Overall Study|Adverse Event|0|||
44401035|NCT03891901|79408729|FG000|Overall Study|Poor venous access|1|||
44401036|NCT03891901|79408730|FG001|Overall Study|Poor venous access|0|||
44401037|NCT03891901|79408731|FG002|Overall Study|Poor venous access|0|||
44401038|NCT03891901|79408732|FG003|Overall Study|Poor venous access|0|||
44401039|NCT03891901|79408733|FG004|Overall Study|Poor venous access|0|||
44521975|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
44521976|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
44521977|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
44521978|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
44521979|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
44521980|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
44521981|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
44521982|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
44521983|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
44521984|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
44521985|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
44521986|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521987|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521988|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521989|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
44521990|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
44521991|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521992|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521993|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521994|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521995|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44521996|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
44521997|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44521998|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
44521999|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
44522000|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
44522001|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522002|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522003|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522004|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44252898|NCT00089999|79091921|FG001|Overall Study|Lost to Follow-up|1|||
44252899|NCT00089999|79091920|FG000|Overall Study|Radiological Progression of Cancer|52|||
44252900|NCT00089999|79091921|FG001|Overall Study|Radiological Progression of Cancer|44|||
44401040|NCT03891901|79408734|FG005|Overall Study|Poor venous access|0|||
44401041|NCT03891901|79408735|FG006|Overall Study|Poor venous access|0|||
44522005|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522006|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
44522007|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522008|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522009|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522010|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
44522011|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522012|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522013|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522014|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522015|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
44522016|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522017|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522018|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44401042|NCT03891901|79408736|FG007|Overall Study|Poor venous access|0|||
44401043|NCT03891901|79408737|FG008|Overall Study|Poor venous access|0|||
44401044|NCT03891901|79408729|FG000|Overall Study|Withdrawal by Subject|0|||
44401045|NCT03891901|79408730|FG001|Overall Study|Withdrawal by Subject|2|||
44401046|NCT03891901|79408731|FG002|Overall Study|Withdrawal by Subject|0|||
44401047|NCT03891901|79408732|FG003|Overall Study|Withdrawal by Subject|0|||
44401048|NCT03891901|79408733|FG004|Overall Study|Withdrawal by Subject|0|||
44401049|NCT03891901|79408734|FG005|Overall Study|Withdrawal by Subject|0|||
44401050|NCT03891901|79408735|FG006|Overall Study|Withdrawal by Subject|0|||
44401051|NCT03891901|79408736|FG007|Overall Study|Withdrawal by Subject|0|||
44401052|NCT03891901|79408737|FG008|Overall Study|Withdrawal by Subject|0|||
44401053|NCT03827018|79408749|FG000|Overall Study|Adverse Event|1|||
44401054|NCT03827018|79408750|FG001|Overall Study|Adverse Event|0|||
44401055|NCT03827018|79408749|FG000|Overall Study|Withdrawal by Subject|2|||
44401056|NCT03827018|79408750|FG001|Overall Study|Withdrawal by Subject|2|||
44401057|NCT03827018|79408749|FG000|Overall Study|Lack of Efficacy|0|||
44401058|NCT03827018|79408750|FG001|Overall Study|Lack of Efficacy|1|||
44401059|NCT03575325|79408774|FG000|Overall Study|Death|1|||
44401060|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
44401061|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
44401062|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
44401063|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
44401064|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
44401065|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
44401066|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
44401067|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
44401068|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
44401069|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
44401070|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
44401071|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
44401072|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Death|1|||
44401073|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Death|2|||
44401074|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Death|2|||
44401075|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Death|0|||
44401076|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Death|0|||
44401077|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Death|0|||
44401078|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
44401079|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
44401080|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
44401081|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
44401082|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
44401083|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
44401084|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
44401085|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
44401086|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
44401087|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
44401088|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
44401089|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
44401090|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
44401091|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
44401092|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
44401093|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
44401094|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
44401095|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
44401096|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
44401097|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
44401098|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
44401099|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
44401100|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
44401101|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
44401102|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
44401103|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
44401104|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
44401105|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
44401106|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
44401107|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
44401108|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
44401109|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
44401110|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
44401111|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
44401112|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
44401113|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
44401114|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
44401115|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
44401116|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
44401117|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
44401118|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
44401119|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
44401120|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Site closure|0|||
44522019|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522020|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
44522021|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522022|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522023|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522024|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522025|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522026|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522027|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
44522028|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522029|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44401121|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Site closure|0|||
44401122|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Site closure|1|||
44401123|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Site closure|0|||
44401124|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Site closure|0|||
44401125|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Site closure|0|||
44401126|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
44401127|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
44401128|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
44401129|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
44401130|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
44252901|NCT00089999|79091920|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
44401131|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
44401132|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
44401133|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
44401134|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
44401135|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
44401136|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
44401137|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
44401138|NCT03439254|79408783|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
44401139|NCT03439254|79408784|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
44401140|NCT03439254|79408785|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
44401141|NCT03439254|79408786|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
44401142|NCT03439254|79408787|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
44401143|NCT03439254|79408788|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
44401144|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
44401145|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
44401146|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
44401147|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
44401148|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
44401149|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
44401150|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
44522030|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
44522031|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522032|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522033|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522034|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522035|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
44522036|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
44522037|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44401151|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
44401152|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
44401153|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
44401154|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
44401155|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
44401156|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
44401157|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
44401158|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
44401159|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
44401160|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
44522038|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44522039|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44522040|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
44522041|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44401161|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
44401162|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
44401163|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
44401164|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
44401165|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
44401166|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
44401167|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
44401168|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
44401169|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
44401170|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
44401171|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
44401172|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
44401173|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
44401174|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
44401175|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
44522042|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44522043|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44252902|NCT00089999|79091921|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
44252903|NCT00089999|79091920|FG000|Overall Study|Death|3|||
44252904|NCT00089999|79091921|FG001|Overall Study|Death|3|||
44522044|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44252905|NCT00089999|79091920|FG000|Overall Study|Poor General Condition|1|||
44522045|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
44522046|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
44522047|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44522048|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
44522049|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44522050|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
44522051|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44401176|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
44401177|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
44401178|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
44401179|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
44401180|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
44401181|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
44401182|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
44401183|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
44401184|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
44401185|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
44401186|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
44401187|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
44401188|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
44401189|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
44401190|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
44401191|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
44401192|NCT03439254|79408783|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
44401193|NCT03439254|79408784|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
44401194|NCT03439254|79408785|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
44401195|NCT03439254|79408786|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
44401196|NCT03439254|79408787|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
44401197|NCT03439254|79408788|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
44401198|NCT03434379|79408804|FG000|Global Period|Lost to Follow-up|3|||
44401199|NCT03434379|79408805|FG001|Global Period|Lost to Follow-up|6|||
44401200|NCT03434379|79408806|FG002|Global Period|Lost to Follow-up|0|||
44401201|NCT03434379|79408807|FG003|Global Period|Lost to Follow-up|0|||
44401202|NCT03434379|79408804|FG000|Global Period|Death|115|||
44401203|NCT03434379|79408805|FG001|Global Period|Death|228|||
44401204|NCT03434379|79408806|FG002|Global Period|Death|0|||
44401205|NCT03434379|79408807|FG003|Global Period|Death|0|||
44401206|NCT03434379|79408804|FG000|Global Period|Withdrawal by Subject|20|||
44401207|NCT03434379|79408805|FG001|Global Period|Withdrawal by Subject|21|||
44401208|NCT03434379|79408806|FG002|Global Period|Withdrawal by Subject|0|||
44401209|NCT03434379|79408807|FG003|Global Period|Withdrawal by Subject|0|||
44401210|NCT03434379|79408804|FG000|Global Period|Reason Unspecified|0|||
44401211|NCT03434379|79408805|FG001|Global Period|Reason Unspecified|1|||
44401212|NCT03434379|79408806|FG002|Global Period|Reason Unspecified|0|||
44401213|NCT03434379|79408807|FG003|Global Period|Reason Unspecified|0|||
44522052|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44522053|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44522054|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44522055|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
44522056|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Other|5|||
44522057|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Other|1|||
44522058|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Other|0|||
44522059|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Other|3|||
44522060|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Other|0|||
44522061|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Other|0|||
44522062|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Other|0|||
44147526|NCT02622321|78936829|FG000|Overall Study|Death|0|||
44147527|NCT02622321|78936830|FG001|Overall Study|Death|0|||
44147528|NCT02622321|78936831|FG002|Overall Study|Death|1|||
44147529|NCT02622321|78936832|FG003|Overall Study|Death|0|||
44147530|NCT02622321|78936829|FG000|Overall Study|Physician Decision|1|||
44147531|NCT02622321|78936830|FG001|Overall Study|Physician Decision|0|||
44147532|NCT02622321|78936831|FG002|Overall Study|Physician Decision|0|||
44401214|NCT03434379|79408804|FG000|Global Period|Study Ended by Sponsor|26|||
44401215|NCT03434379|79408805|FG001|Global Period|Study Ended by Sponsor|80|||
44401216|NCT03434379|79408806|FG002|Global Period|Study Ended by Sponsor|0|||
44401217|NCT03434379|79408807|FG003|Global Period|Study Ended by Sponsor|0|||
44401218|NCT03434379|79408804|FG000|Global Period|Physician Decision|1|||
44401219|NCT03434379|79408805|FG001|Global Period|Physician Decision|0|||
44401220|NCT03434379|79408806|FG002|Global Period|Physician Decision|0|||
44522063|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Other|0|||
44522064|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Other|0|||
44147533|NCT02622321|78936832|FG003|Overall Study|Physician Decision|0|||
44522065|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Other|0|||
44522066|NCT03352557|79530134|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522067|NCT03352557|79530135|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522068|NCT03352557|79530136|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522069|NCT03352557|79530137|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522070|NCT03352557|79530138|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
44522071|NCT03352557|79530139|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522072|NCT03352557|79530140|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522073|NCT03352557|79530141|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522074|NCT03352557|79530142|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522075|NCT03352557|79530143|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
44522076|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Death|0|||
44522077|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Death|0|||
44522078|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Death|0|||
44147534|NCT02187172|78936858|FG000|Overall Study|Lost to Follow-up|1|||
44147535|NCT02187172|78936859|FG001|Overall Study|Lost to Follow-up|2|||
44147536|NCT02187172|78936858|FG000|Overall Study|Lack of Efficacy|1|||
44147537|NCT02187172|78936859|FG001|Overall Study|Lack of Efficacy|2|||
44147538|NCT02187172|78936858|FG000|Overall Study|Adverse Event|0|||
44147539|NCT02187172|78936859|FG001|Overall Study|Adverse Event|1|||
44401221|NCT03434379|79408807|FG003|Global Period|Physician Decision|0|||
44401222|NCT03434379|79408804|FG000|China Extension Period|Lost to Follow-up|0|||
44401223|NCT03434379|79408805|FG001|China Extension Period|Lost to Follow-up|0|||
44401224|NCT03434379|79408806|FG002|China Extension Period|Lost to Follow-up|2|||
44401225|NCT03434379|79408807|FG003|China Extension Period|Lost to Follow-up|3|||
44401226|NCT03434379|79408804|FG000|China Extension Period|Death|0|||
44401227|NCT03434379|79408805|FG001|China Extension Period|Death|0|||
44401228|NCT03434379|79408806|FG002|China Extension Period|Death|46|||
44401229|NCT03434379|79408807|FG003|China Extension Period|Death|88|||
44401230|NCT03434379|79408804|FG000|China Extension Period|Withdrawal by Subject|0|||
44401231|NCT03434379|79408805|FG001|China Extension Period|Withdrawal by Subject|0|||
44401232|NCT03434379|79408806|FG002|China Extension Period|Withdrawal by Subject|8|||
44401233|NCT03434379|79408807|FG003|China Extension Period|Withdrawal by Subject|6|||
44401234|NCT03434379|79408804|FG000|China Extension Period|Study Ended by Sponsor|0|||
44401235|NCT03434379|79408805|FG001|China Extension Period|Study Ended by Sponsor|0|||
44401236|NCT03434379|79408806|FG002|China Extension Period|Study Ended by Sponsor|5|||
44401237|NCT03434379|79408807|FG003|China Extension Period|Study Ended by Sponsor|36|||
44401238|NCT03309046|79408821|FG000|Overall Study|Withdrawal by Subject|4|||
44401239|NCT03309046|79408822|FG001|Overall Study|Withdrawal by Subject|17|||
44147540|NCT02187172|78936858|FG000|Overall Study|Physician Decision|1|||
44147541|NCT02187172|78936859|FG001|Overall Study|Physician Decision|1|||
44147542|NCT02621931|78936870|FG000|Overall Study|Death|0|||
44147543|NCT02621931|78936871|FG001|Overall Study|Death|1|||
44147544|NCT02621931|78936872|FG002|Overall Study|Death|0|||
44147545|NCT02621931|78936870|FG000|Overall Study|Adverse Event|8|||
44147546|NCT02621931|78936871|FG001|Overall Study|Adverse Event|5|||
44147547|NCT02621931|78936872|FG002|Overall Study|Adverse Event|7|||
44147548|NCT02621931|78936870|FG000|Overall Study|Withdrawal by Subject|12|||
44147549|NCT02621931|78936871|FG001|Overall Study|Withdrawal by Subject|10|||
44147550|NCT02621931|78936872|FG002|Overall Study|Withdrawal by Subject|11|||
44147551|NCT02621931|78936870|FG000|Overall Study|Protocol Violation|2|||
44147552|NCT02621931|78936871|FG001|Overall Study|Protocol Violation|2|||
44147553|NCT02621931|78936872|FG002|Overall Study|Protocol Violation|2|||
44147554|NCT02621931|78936870|FG000|Overall Study|Pregnancy|2|||
44147555|NCT02621931|78936871|FG001|Overall Study|Pregnancy|0|||
44147556|NCT02621931|78936872|FG002|Overall Study|Pregnancy|0|||
44147557|NCT02621931|78936870|FG000|Overall Study|Noncompliance to study procedures|0|||
44401240|NCT03228186|79408828|FG000|Overall Study|Patient never started treatment|1|||
44401241|NCT02869633|79408834|FG000|Overall Study|Death|2|||
44401242|NCT02869633|79408835|FG001|Overall Study|Death|1|||
44522079|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Death|0|||
44522080|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Death|0|||
44522081|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Death|1|||
44522082|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Death|0|||
44147558|NCT02621931|78936871|FG001|Overall Study|Noncompliance to study procedures|1|||
44401243|NCT02869633|79408834|FG000|Overall Study|Patient refused follow-up|1|||
44401244|NCT02869633|79408835|FG001|Overall Study|Patient refused follow-up|0|||
44401245|NCT02869633|79408834|FG000|Overall Study|Provider discretion|1|||
44147559|NCT02621931|78936872|FG002|Overall Study|Noncompliance to study procedures|2|||
44147560|NCT02621931|78936870|FG000|Overall Study|Lost to Follow-up|8|||
44401246|NCT02869633|79408835|FG001|Overall Study|Provider discretion|0|||
44401247|NCT02869633|79408834|FG000|Overall Study|Investigator decision|1|||
44401248|NCT02869633|79408835|FG001|Overall Study|Investigator decision|0|||
44401249|NCT02869633|79408834|FG000|Overall Study|Lost to Follow-up|0|||
44147561|NCT02621931|78936871|FG001|Overall Study|Lost to Follow-up|7|||
44147562|NCT02621931|78936872|FG002|Overall Study|Lost to Follow-up|10|||
44147563|NCT02621931|78936870|FG000|Overall Study|Lack of Efficacy|0|||
44401250|NCT02869633|79408835|FG001|Overall Study|Lost to Follow-up|1|||
44401251|NCT02869633|79408834|FG000|Overall Study|Not eligible|6|||
44401252|NCT02869633|79408835|FG001|Overall Study|Not eligible|1|||
44401253|NCT02869633|79408834|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
44401254|NCT02869633|79408835|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
44401255|NCT02869633|79408834|FG000|Overall Study|Withdrawal by Subject|0|||
44401256|NCT02869633|79408835|FG001|Overall Study|Withdrawal by Subject|1|||
44401257|NCT02855268|79408845|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
44401258|NCT02855268|79408846|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
44401259|NCT02855268|79408845|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
44401260|NCT02855268|79408846|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
44401261|NCT02855268|79408845|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
44401262|NCT02855268|79408846|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
44401263|NCT02855268|79408845|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
44401264|NCT02855268|79408846|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
44401265|NCT02855268|79408845|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
44401266|NCT02855268|79408846|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
44401267|NCT02855268|79408845|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
44401268|NCT02855268|79408846|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
44401269|NCT02840721|79408861|FG000|Treatment Period|Adverse Event|1|||
44401270|NCT02840721|79408861|FG000|Follow-Up|Lack of Efficacy|1|||
44401271|NCT02840721|79408861|FG000|Follow-Up|Withdrawal by Subject|4|||
44401272|NCT02840721|79408861|FG000|Follow-Up|Withdrawal of Consent|2|||
44401273|NCT02777593|79408870|FG000|Overall Study|Still in study|28|||
44401274|NCT02777593|79408871|FG001|Overall Study|Still in study|71|||
44401275|NCT02777593|79408872|FG002|Overall Study|Still in study|5|||
44401276|NCT02777593|79408873|FG003|Overall Study|Still in study|6|||
44522083|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Death|1|||
44281685|NCT01915914|79244954|FG003|Acute Phase|"Not Achieved treatment success"|0|||
44281686|NCT01915914|79244951|FG000|Acute Phase|Missing|1|||
44401277|NCT02777593|79408874|FG004|Overall Study|Still in study|6|||
44401278|NCT02777593|79408870|FG000|Overall Study|Death|19|||
44401279|NCT02777593|79408871|FG001|Overall Study|Death|24|||
44401280|NCT02777593|79408872|FG002|Overall Study|Death|0|||
44401281|NCT02777593|79408873|FG003|Overall Study|Death|5|||
44401282|NCT02777593|79408874|FG004|Overall Study|Death|0|||
44401283|NCT02777593|79408870|FG000|Overall Study|Withdrawal by Subject|6|||
44401284|NCT02777593|79408871|FG001|Overall Study|Withdrawal by Subject|3|||
44401285|NCT02777593|79408872|FG002|Overall Study|Withdrawal by Subject|1|||
44401286|NCT02777593|79408873|FG003|Overall Study|Withdrawal by Subject|1|||
44401287|NCT02777593|79408874|FG004|Overall Study|Withdrawal by Subject|0|||
44401288|NCT02777593|79408870|FG000|Overall Study|Lost to Follow-up|4|||
44401289|NCT02777593|79408871|FG001|Overall Study|Lost to Follow-up|12|||
44401290|NCT02777593|79408872|FG002|Overall Study|Lost to Follow-up|4|||
44401291|NCT02777593|79408873|FG003|Overall Study|Lost to Follow-up|0|||
44401292|NCT02777593|79408874|FG004|Overall Study|Lost to Follow-up|0|||
44401293|NCT02777593|79408870|FG000|Overall Study|Physician Decision|2|||
44401294|NCT02777593|79408871|FG001|Overall Study|Physician Decision|2|||
44401295|NCT02777593|79408872|FG002|Overall Study|Physician Decision|0|||
44401296|NCT02777593|79408873|FG003|Overall Study|Physician Decision|0|||
44401297|NCT02777593|79408874|FG004|Overall Study|Physician Decision|0|||
44147564|NCT02621931|78936871|FG001|Overall Study|Lack of Efficacy|0|||
44147565|NCT02621931|78936872|FG002|Overall Study|Lack of Efficacy|1|||
44147566|NCT02621931|78936870|FG000|Overall Study|Other|1|||
44147567|NCT02621931|78936871|FG001|Overall Study|Other|1|||
44147568|NCT02621931|78936872|FG002|Overall Study|Other|3|||
44147569|NCT02621073|78936884|FG000|Overall Study|Lost to Follow-up|0|||
44147570|NCT02621073|78936885|FG001|Overall Study|Lost to Follow-up|1|||
44147571|NCT02621073|78936884|FG000|Overall Study|Physician Decision|3|||
44147572|NCT02621073|78936885|FG001|Overall Study|Physician Decision|2|||
44147573|NCT02158936|78936893|FG000|Overall Study|Study closed/ terminated|57|||
44147574|NCT02158936|78936894|FG001|Overall Study|Study closed/ terminated|77|||
44147575|NCT02158936|78936893|FG000|Overall Study|Azacitidine tx discontinued|53|||
44147576|NCT02158936|78936894|FG001|Overall Study|Azacitidine tx discontinued|46|||
44147577|NCT02158936|78936893|FG000|Overall Study|Adverse Event|39|||
44401298|NCT02777593|79408870|FG000|Overall Study|Discontinued due to Other|3|||
44401299|NCT02777593|79408871|FG001|Overall Study|Discontinued due to Other|0|||
44401300|NCT02777593|79408872|FG002|Overall Study|Discontinued due to Other|0|||
44401301|NCT02777593|79408873|FG003|Overall Study|Discontinued due to Other|0|||
44401302|NCT02777593|79408874|FG004|Overall Study|Discontinued due to Other|0|||
44401303|NCT02701283|79408889|FG000|Overall Study|Death|25|||
44401304|NCT02701283|79408890|FG001|Overall Study|Death|29|||
44401305|NCT02701283|79408891|FG002|Overall Study|Death|19|||
44401306|NCT02701283|79408889|FG000|Overall Study|Lost to Follow-up|3|||
44401307|NCT02701283|79408890|FG001|Overall Study|Lost to Follow-up|8|||
44401308|NCT02701283|79408891|FG002|Overall Study|Lost to Follow-up|1|||
44147578|NCT02158936|78936894|FG001|Overall Study|Adverse Event|24|||
44401309|NCT02701283|79408889|FG000|Overall Study|Withdrawal by Subject|12|||
44401310|NCT02701283|79408890|FG001|Overall Study|Withdrawal by Subject|41|||
44401311|NCT02701283|79408891|FG002|Overall Study|Withdrawal by Subject|1|||
44401312|NCT02701283|79408889|FG000|Overall Study|Missed 2-year visit|22|||
44401313|NCT02701283|79408890|FG001|Overall Study|Missed 2-year visit|27|||
44401314|NCT02701283|79408891|FG002|Overall Study|Missed 2-year visit|0|||
44401315|NCT02701283|79408889|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
44401316|NCT02701283|79408890|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
44401317|NCT02701283|79408891|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
44401318|NCT02399085|79408911|FG000|Overall Study|Adverse Event|16|||
44401319|NCT02399085|79408911|FG000|Overall Study|Death|2|||
44401320|NCT02399085|79408911|FG000|Overall Study|Withdrawal by Subject|8|||
44401321|NCT02399085|79408911|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
44401322|NCT02399085|79408911|FG000|Overall Study|Physician Decision|5|||
44401323|NCT01317160|79408919|FG000|Overall Study|Incorrect inclusion|1|||
44401324|NCT01317160|79408920|FG001|Overall Study|Incorrect inclusion|1|||
44401325|NCT01317160|79408919|FG000|Overall Study|Lost to Follow-up|3|||
44401326|NCT01317160|79408920|FG001|Overall Study|Lost to Follow-up|3|||
44401327|NCT01317160|79408919|FG000|Overall Study|Withdrawal by Subject|0|||
44401328|NCT01317160|79408920|FG001|Overall Study|Withdrawal by Subject|2|||
44401329|NCT00891371|79408926|FG000|Pre-assignment|Inclusion/exclusion|5|||
44401330|NCT00891371|79408926|FG000|Pre-assignment|Consent withdrawal|1|||
44401331|NCT00891371|79408926|FG000|Treatment|Lack of Efficacy|5|||
44401332|NCT00891371|79408926|FG000|Treatment|Adverse Event|2|||
44401333|NCT00891371|79408926|FG000|Treatment|Death|1|||
44401334|NCT00891371|79408926|FG000|Treatment|Lost to Follow-up|1|||
44401335|NCT00891293|79408930|FG000|Overall Study|Adverse Event|2|||
44401336|NCT00891293|79408930|FG000|Overall Study|Protocol Violation|2|||
44401337|NCT00891293|79408930|FG000|Overall Study|Laboratory abnormality|4|||
44401338|NCT00891293|79408930|FG000|Overall Study|Lost to Follow-up|7|||
44401339|NCT00891293|79408930|FG000|Overall Study|Subject withdrew consent|7|||
44401340|NCT00891293|79408930|FG000|Overall Study|Sponsor termination|62|||
44401341|NCT00889421|79408934|FG000|Overall Study|Lack of Efficacy|3|||
44401342|NCT00889265|79408938|FG000|Overall Study|Adverse Event|1|||
44401343|NCT00889265|79408938|FG000|Overall Study|Lost to Follow-up|5|||
44401344|NCT00889265|79408938|FG000|Overall Study|Protocol Violation|1|||
44401345|NCT00603746|79408948|FG000|Overall Study|Adverse Event|2|||
44401346|NCT00603746|79408949|FG001|Overall Study|Adverse Event|3|||
44401347|NCT00603746|79408950|FG002|Overall Study|Adverse Event|0|||
44401348|NCT00603746|79408951|FG003|Overall Study|Adverse Event|1|||
44401349|NCT00603746|79408952|FG004|Overall Study|Adverse Event|0|||
44401350|NCT00603746|79408953|FG005|Overall Study|Adverse Event|4|||
44401351|NCT00603746|79408948|FG000|Overall Study|Lack of Efficacy|34|||
44401352|NCT00603746|79408949|FG001|Overall Study|Lack of Efficacy|11|||
44401353|NCT00603746|79408950|FG002|Overall Study|Lack of Efficacy|6|||
44401354|NCT00603746|79408951|FG003|Overall Study|Lack of Efficacy|11|||
44401355|NCT00603746|79408952|FG004|Overall Study|Lack of Efficacy|12|||
44401356|NCT00603746|79408953|FG005|Overall Study|Lack of Efficacy|8|||
44401357|NCT00603746|79408948|FG000|Overall Study|Protocol Violation|0|||
44401358|NCT00603746|79408949|FG001|Overall Study|Protocol Violation|3|||
44401359|NCT00603746|79408950|FG002|Overall Study|Protocol Violation|1|||
44401360|NCT00603746|79408951|FG003|Overall Study|Protocol Violation|0|||
44401361|NCT00603746|79408952|FG004|Overall Study|Protocol Violation|1|||
44401362|NCT00603746|79408953|FG005|Overall Study|Protocol Violation|0|||
44401363|NCT00603746|79408948|FG000|Overall Study|Lost to Follow-up|0|||
44401364|NCT00603746|79408949|FG001|Overall Study|Lost to Follow-up|1|||
44401365|NCT00603746|79408950|FG002|Overall Study|Lost to Follow-up|1|||
44401366|NCT00603746|79408951|FG003|Overall Study|Lost to Follow-up|0|||
44401367|NCT00603746|79408952|FG004|Overall Study|Lost to Follow-up|0|||
44401368|NCT00603746|79408953|FG005|Overall Study|Lost to Follow-up|0|||
44401369|NCT00603746|79408948|FG000|Overall Study|Physician Decision|1|||
44401370|NCT00603746|79408949|FG001|Overall Study|Physician Decision|0|||
44401371|NCT00603746|79408950|FG002|Overall Study|Physician Decision|0|||
44401372|NCT00603746|79408951|FG003|Overall Study|Physician Decision|0|||
44401373|NCT00603746|79408952|FG004|Overall Study|Physician Decision|1|||
44401374|NCT00603746|79408953|FG005|Overall Study|Physician Decision|0|||
44401375|NCT00603746|79408948|FG000|Overall Study|Withdrawal by Subject|1|||
44401376|NCT00603746|79408949|FG001|Overall Study|Withdrawal by Subject|0|||
44401377|NCT00603746|79408950|FG002|Overall Study|Withdrawal by Subject|0|||
44401378|NCT00603746|79408951|FG003|Overall Study|Withdrawal by Subject|1|||
44401379|NCT00603746|79408952|FG004|Overall Study|Withdrawal by Subject|3|||
44401380|NCT00603746|79408953|FG005|Overall Study|Withdrawal by Subject|1|||
44401381|NCT00888329|79408969|FG000|Overall Study|Physician Decision|6|||
44401382|NCT00888329|79408970|FG001|Overall Study|Physician Decision|9|||
44401383|NCT00603590|79408978|FG000|Overall Study|Did not attend study clinic|39|||
44401384|NCT00603590|79408979|FG001|Overall Study|Did not attend study clinic|30|||
44401385|NCT00603590|79408978|FG000|Overall Study|Refused blood test|5|||
44401386|NCT00603590|79408979|FG001|Overall Study|Refused blood test|1|||
44401387|NCT00603590|79408978|FG000|Overall Study|Patient discontinued study drug|22|||
44401388|NCT00603590|79408979|FG001|Overall Study|Patient discontinued study drug|15|||
44401389|NCT00603590|79408978|FG000|Overall Study|Adverse Event|2|||
44401390|NCT00603590|79408979|FG001|Overall Study|Adverse Event|0|||
44401391|NCT00603590|79408978|FG000|Overall Study|Lost to Follow-up|8|||
44401392|NCT00603590|79408979|FG001|Overall Study|Lost to Follow-up|4|||
44401393|NCT00603590|79408978|FG000|Overall Study|Cardiovascular event|0|||
44401394|NCT00603590|79408979|FG001|Overall Study|Cardiovascular event|1|||
44401395|NCT00888173|79408985|FG000|Overall Study|Wrong Primary|1|||
44401396|NCT00888173|79408985|FG000|Overall Study|Ineligible: required test not done|1|||
44401397|NCT00887549|79408998|FG000|Induction Therapy|Adverse Event|8|||
44401398|NCT00887549|79408998|FG000|Induction Therapy|Physician Decision|1|||
44401399|NCT00887549|79408998|FG000|Induction Therapy|Progressive Disease|13|||
44401400|NCT00887549|79408998|FG000|Induction Therapy|Death due to Study Disease|4|||
44401401|NCT00887549|79408998|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
44401402|NCT00887549|79408998|FG000|Maintenance Therapy|Adverse Event|16|||
44401403|NCT00887549|79408998|FG000|Maintenance Therapy|Physician Decision|1|||
44401404|NCT00887549|79408998|FG000|Maintenance Therapy|Progressive Disease|25|||
44401405|NCT00887549|79408998|FG000|Maintenance Therapy|Death due to adverse event|1|||
44401406|NCT00887315|79409004|FG000|Overall Study|Study termination|7|||
44401407|NCT00887315|79409005|FG001|Overall Study|Study termination|4|||
44401408|NCT03608826|79409011|FG000|Overall Study|Death|3|||
44401409|NCT03608826|79409011|FG000|Overall Study|Heart Transplant|3|||
44401410|NCT03608826|79409011|FG000|Overall Study|Physician Decision|4|||
44401411|NCT00887159|79409018|FG000|Overall Study|Disease progression|6|||
44401412|NCT00887159|79409019|FG001|Overall Study|Disease progression|39|||
44401413|NCT00887159|79409020|FG002|Overall Study|Disease progression|33|||
44401414|NCT00887159|79409018|FG000|Overall Study|Adverse Event|3|||
44401415|NCT00887159|79409019|FG001|Overall Study|Adverse Event|4|||
44401416|NCT00887159|79409020|FG002|Overall Study|Adverse Event|17|||
44401417|NCT00887159|79409018|FG000|Overall Study|Death|2|||
44401418|NCT00887159|79409019|FG001|Overall Study|Death|2|||
44401419|NCT00887159|79409020|FG002|Overall Study|Death|0|||
44401420|NCT00887159|79409018|FG000|Overall Study|Withdrawal by Subject|4|||
44401421|NCT00887159|79409019|FG001|Overall Study|Withdrawal by Subject|4|||
44401422|NCT00887159|79409020|FG002|Overall Study|Withdrawal by Subject|2|||
44401423|NCT00887159|79409018|FG000|Overall Study|Alternative therapy|2|||
44401424|NCT00887159|79409019|FG001|Overall Study|Alternative therapy|0|||
44401425|NCT00887159|79409020|FG002|Overall Study|Alternative therapy|0|||
44401426|NCT00887159|79409018|FG000|Overall Study|Physician Decision|1|||
44401427|NCT00887159|79409019|FG001|Overall Study|Physician Decision|1|||
44401428|NCT00887159|79409020|FG002|Overall Study|Physician Decision|0|||
44401429|NCT00887159|79409018|FG000|Overall Study|Sympomatic deterioration|1|||
44401430|NCT00887159|79409019|FG001|Overall Study|Sympomatic deterioration|0|||
44401431|NCT00887159|79409020|FG002|Overall Study|Sympomatic deterioration|0|||
44401432|NCT00887159|79409018|FG000|Overall Study|Treatment delayed|1|||
44401433|NCT00887159|79409019|FG001|Overall Study|Treatment delayed|1|||
44401434|NCT00887159|79409020|FG002|Overall Study|Treatment delayed|0|||
44401435|NCT00887159|79409018|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
44401436|NCT00887159|79409019|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
44401437|NCT00887159|79409020|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
44401438|NCT00887159|79409018|FG000|Overall Study|Received more tx instead of observation|1|||
44401439|NCT00887159|79409019|FG001|Overall Study|Received more tx instead of observation|0|||
44401440|NCT00887159|79409020|FG002|Overall Study|Received more tx instead of observation|0|||
44401441|NCT00887159|79409018|FG000|Overall Study|Ineligible|5|||
44401442|NCT00887159|79409019|FG001|Overall Study|Ineligible|1|||
44401443|NCT00887159|79409020|FG002|Overall Study|Ineligible|0|||
44401444|NCT00887159|79409018|FG000|Overall Study|Never started assigned therapy|3|||
44401445|NCT00887159|79409019|FG001|Overall Study|Never started assigned therapy|3|||
44401446|NCT00887159|79409020|FG002|Overall Study|Never started assigned therapy|4|||
44401447|NCT00886769|79409032|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
44401448|NCT00886769|79409033|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
44401449|NCT00886613|79409042|FG000|Overall Study|Protocol deviation (Part B)|1|||
44401450|NCT00886613|79409043|FG001|Overall Study|Protocol deviation (Part B)|0|||
44401451|NCT00886613|79409044|FG002|Overall Study|Protocol deviation (Part B)|0|||
44401452|NCT00886613|79409042|FG000|Overall Study|Lost to follow-up (Part B)|1|||
44401453|NCT00886613|79409043|FG001|Overall Study|Lost to follow-up (Part B)|0|||
44401454|NCT00886613|79409044|FG002|Overall Study|Lost to follow-up (Part B)|1|||
44401455|NCT00886613|79409042|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
44401456|NCT00886613|79409043|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
44401457|NCT00886613|79409044|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
44401458|NCT00886379|79409060|FG000|Overall Study|Transferred Schools|0|||
44401459|NCT00886379|79409061|FG001|Overall Study|Transferred Schools|0|||
44401460|NCT00886379|79409062|FG002|Overall Study|Transferred Schools|2|||
44401461|NCT00886379|79409063|FG003|Overall Study|Transferred Schools|1|||
44401462|NCT00886379|79409064|FG004|Overall Study|Transferred Schools|1|||
44401463|NCT00886379|79409060|FG000|Overall Study|Final blood draw not obtained|3|||
44401464|NCT00886379|79409061|FG001|Overall Study|Final blood draw not obtained|3|||
44401465|NCT00886379|79409062|FG002|Overall Study|Final blood draw not obtained|4|||
44401466|NCT00886379|79409063|FG003|Overall Study|Final blood draw not obtained|2|||
44401467|NCT00886379|79409064|FG004|Overall Study|Final blood draw not obtained|2|||
44401468|NCT00599196|79409076|FG000|Overall Study|Lack of Efficacy|22|||
44401469|NCT00599196|79409076|FG000|Overall Study|Adverse Event|93|||
44401470|NCT00599196|79409076|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
44401471|NCT00599196|79409076|FG000|Overall Study|Subject withdrew consent|43|||
44401472|NCT00599196|79409076|FG000|Overall Study|Study ended per sponsor|197|||
44401473|NCT00599196|79409076|FG000|Overall Study|Lost to Follow-up|17|||
44401474|NCT00599196|79409076|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
44401475|NCT00599196|79409076|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
44401476|NCT00599196|79409076|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
44401477|NCT00599196|79409076|FG000|Overall Study|Other: Pt Moved To Australia|1|||
44401478|NCT00599196|79409076|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
44401479|NCT00599196|79409076|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
44401480|NCT00603512|79409085|FG000|Overall Study|Adverse Event|0|||
44401481|NCT00603512|79409086|FG001|Overall Study|Adverse Event|2|||
44401482|NCT00603512|79409087|FG002|Overall Study|Adverse Event|4|||
44401483|NCT00603512|79409088|FG003|Overall Study|Adverse Event|4|||
44401484|NCT00603512|79409089|FG004|Overall Study|Adverse Event|2|||
44401485|NCT00603512|79409085|FG000|Overall Study|Lack of Efficacy|0|||
44401486|NCT00603512|79409086|FG001|Overall Study|Lack of Efficacy|1|||
44401487|NCT00603512|79409087|FG002|Overall Study|Lack of Efficacy|0|||
44401488|NCT00603512|79409088|FG003|Overall Study|Lack of Efficacy|0|||
44401489|NCT00603512|79409089|FG004|Overall Study|Lack of Efficacy|1|||
44401490|NCT00603512|79409085|FG000|Overall Study|Other|2|||
44401491|NCT00603512|79409086|FG001|Overall Study|Other|1|||
44401492|NCT00603512|79409087|FG002|Overall Study|Other|0|||
44401493|NCT00603512|79409088|FG003|Overall Study|Other|1|||
44401494|NCT00603512|79409089|FG004|Overall Study|Other|1|||
44401495|NCT00603512|79409085|FG000|Overall Study|Withdrawal by Subject|0|||
44401496|NCT00603512|79409086|FG001|Overall Study|Withdrawal by Subject|0|||
44401497|NCT00603512|79409087|FG002|Overall Study|Withdrawal by Subject|0|||
44401498|NCT00603512|79409088|FG003|Overall Study|Withdrawal by Subject|0|||
44401499|NCT00603512|79409089|FG004|Overall Study|Withdrawal by Subject|1|||
44401500|NCT00603512|79409085|FG000|Overall Study|Randomized but not treated|0|||
44401501|NCT00603512|79409086|FG001|Overall Study|Randomized but not treated|1|||
44401502|NCT00603512|79409087|FG002|Overall Study|Randomized but not treated|1|||
44401503|NCT00603512|79409088|FG003|Overall Study|Randomized but not treated|2|||
44401504|NCT00603512|79409089|FG004|Overall Study|Randomized but not treated|0|||
44401505|NCT04242875|79409101|FG000|Overall Study|Adverse Event|2|||
44401506|NCT00603278|79409115|FG000|Overall Study|Lack of Efficacy|35|||
44401507|NCT00603278|79409116|FG001|Overall Study|Lack of Efficacy|10|||
44401508|NCT00603278|79409117|FG002|Overall Study|Lack of Efficacy|11|||
44401509|NCT00603278|79409118|FG003|Overall Study|Lack of Efficacy|8|||
44401510|NCT00603278|79409119|FG004|Overall Study|Lack of Efficacy|7|||
44401511|NCT00603278|79409120|FG005|Overall Study|Lack of Efficacy|14|||
44401512|NCT00603278|79409115|FG000|Overall Study|Adverse Event|0|||
44401513|NCT00603278|79409116|FG001|Overall Study|Adverse Event|3|||
44401514|NCT00603278|79409117|FG002|Overall Study|Adverse Event|1|||
44401515|NCT00603278|79409118|FG003|Overall Study|Adverse Event|0|||
44401516|NCT00603278|79409119|FG004|Overall Study|Adverse Event|2|||
44401517|NCT00603278|79409120|FG005|Overall Study|Adverse Event|1|||
44401518|NCT00603278|79409115|FG000|Overall Study|Withdrawal by Subject|2|||
44401519|NCT00603278|79409116|FG001|Overall Study|Withdrawal by Subject|3|||
44401520|NCT00603278|79409117|FG002|Overall Study|Withdrawal by Subject|1|||
44401521|NCT00603278|79409118|FG003|Overall Study|Withdrawal by Subject|2|||
44401522|NCT00603278|79409119|FG004|Overall Study|Withdrawal by Subject|1|||
44401523|NCT00603278|79409120|FG005|Overall Study|Withdrawal by Subject|2|||
44401524|NCT00603278|79409115|FG000|Overall Study|Protocol Violation|3|||
44401525|NCT00603278|79409116|FG001|Overall Study|Protocol Violation|0|||
44281687|NCT01915914|79244952|FG001|Acute Phase|Missing|0|||
44281688|NCT01915914|79244953|FG002|Acute Phase|Missing|0|||
44401526|NCT00603278|79409117|FG002|Overall Study|Protocol Violation|1|||
44401527|NCT00603278|79409118|FG003|Overall Study|Protocol Violation|1|||
44401528|NCT00603278|79409119|FG004|Overall Study|Protocol Violation|0|||
44401529|NCT00603278|79409120|FG005|Overall Study|Protocol Violation|1|||
44401530|NCT00603278|79409115|FG000|Overall Study|Physician Decision|0|||
44401531|NCT00603278|79409116|FG001|Overall Study|Physician Decision|1|||
44401532|NCT00603278|79409117|FG002|Overall Study|Physician Decision|0|||
44401533|NCT00603278|79409118|FG003|Overall Study|Physician Decision|0|||
44401534|NCT00603278|79409119|FG004|Overall Study|Physician Decision|2|||
44401535|NCT00603278|79409120|FG005|Overall Study|Physician Decision|1|||
44401536|NCT00603278|79409115|FG000|Overall Study|Lost to Follow-up|1|||
44401537|NCT00603278|79409116|FG001|Overall Study|Lost to Follow-up|0|||
44401538|NCT00603278|79409117|FG002|Overall Study|Lost to Follow-up|0|||
44401539|NCT00603278|79409118|FG003|Overall Study|Lost to Follow-up|0|||
44401540|NCT00603278|79409119|FG004|Overall Study|Lost to Follow-up|1|||
44401541|NCT00603278|79409120|FG005|Overall Study|Lost to Follow-up|0|||
44401542|NCT00876447|79409136|FG000|Overall Study|Other miscellaneous reasons|3|||
44401543|NCT00876447|79409137|FG001|Overall Study|Other miscellaneous reasons|8|||
44401544|NCT00876447|79409136|FG000|Overall Study|Site closure|19|||
44401545|NCT00876447|79409137|FG001|Overall Study|Site closure|14|||
44401546|NCT00876447|79409136|FG000|Overall Study|Protocol Violation|9|||
44401547|NCT00876447|79409137|FG001|Overall Study|Protocol Violation|3|||
44401548|NCT00876447|79409136|FG000|Overall Study|Personal reasons|30|||
44401549|NCT00876447|79409137|FG001|Overall Study|Personal reasons|28|||
44401550|NCT00876447|79409136|FG000|Overall Study|Lost to Follow-up|6|||
44401551|NCT00876447|79409137|FG001|Overall Study|Lost to Follow-up|15|||
44401552|NCT00876447|79409136|FG000|Overall Study|Pregnancy|4|||
44401553|NCT00876447|79409137|FG001|Overall Study|Pregnancy|2|||
44401554|NCT00876447|79409136|FG000|Overall Study|Lack of Efficacy|5|||
44401555|NCT00876447|79409137|FG001|Overall Study|Lack of Efficacy|3|||
44401556|NCT00876447|79409136|FG000|Overall Study|Adverse Event|4|||
44401557|NCT00876447|79409137|FG001|Overall Study|Adverse Event|8|||
44401558|NCT00598650|79409167|FG000|Overall Study|Withdrawal by Subject|3|||
44401559|NCT00598650|79409167|FG000|Overall Study|Adverse Event|18|||
44401560|NCT00598650|79409167|FG000|Overall Study|No treatment for 3 weeks|1|||
44401561|NCT00598650|79409167|FG000|Overall Study|Not eligible|1|||
44401562|NCT00598650|79409167|FG000|Overall Study|Prohibited Concomitant Medication|2|||
44401563|NCT00598650|79409167|FG000|Overall Study|Physician Decision|2|||
44401564|NCT04249076|79409174|FG000|Overall Study|Adverse Event|1|||
44401565|NCT04249076|79409175|FG001|Overall Study|Adverse Event|1|||
44401566|NCT04249076|79409174|FG000|Overall Study|Protocol Violation|1|||
44401567|NCT04249076|79409175|FG001|Overall Study|Protocol Violation|2|||
44401568|NCT04249076|79409174|FG000|Overall Study|Lack of Efficacy|0|||
44401569|NCT04249076|79409175|FG001|Overall Study|Lack of Efficacy|1|||
44401570|NCT04249076|79409174|FG000|Overall Study|Withdrawal by Subject|0|||
44401571|NCT04249076|79409175|FG001|Overall Study|Withdrawal by Subject|1|||
44401572|NCT04150107|79409183|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
44401573|NCT04150107|79409184|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
44401574|NCT04150107|79409183|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
44401575|NCT04150107|79409184|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
44401576|NCT00875979|79409194|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
44401577|NCT00875979|79409195|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
44401578|NCT00875979|79409194|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
44401579|NCT00875979|79409195|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
44401580|NCT00875979|79409194|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
44401581|NCT00875979|79409195|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
44401582|NCT00875979|79409194|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
44401583|NCT00875979|79409195|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
44401584|NCT00875979|79409194|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
44401585|NCT00875979|79409195|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
44401586|NCT00875979|79409194|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
44401587|NCT00875979|79409195|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
44401588|NCT00875979|79409194|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
44401589|NCT00875979|79409195|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
44401590|NCT00875979|79409194|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
44401591|NCT00875979|79409195|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
44401592|NCT00875979|79409194|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
44401593|NCT00875979|79409195|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
44401594|NCT00602420|79409203|FG000|Overall Study|Death|1|||
44401595|NCT00602420|79409204|FG001|Overall Study|Death|4|||
44401596|NCT00602420|79409203|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
44401597|NCT00602420|79409204|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
44401598|NCT00602420|79409203|FG000|Overall Study|Withdrawal by Subject|18|||
44401599|NCT00602420|79409204|FG001|Overall Study|Withdrawal by Subject|17|||
44401600|NCT00602420|79409203|FG000|Overall Study|Adverse Event|1|||
44401601|NCT00602420|79409204|FG001|Overall Study|Adverse Event|0|||
44401602|NCT00875667|79409218|FG000|Overall Study|Adverse Event|29|||
44401603|NCT00875667|79409219|FG001|Overall Study|Adverse Event|10|||
44401604|NCT00875667|79409218|FG000|Overall Study|Withdrawal by Subject|17|||
44401605|NCT00875667|79409219|FG001|Overall Study|Withdrawal by Subject|5|||
44401606|NCT00875667|79409218|FG000|Overall Study|Death|7|||
44401607|NCT00875667|79409219|FG001|Overall Study|Death|2|||
44401608|NCT00875667|79409218|FG000|Overall Study|Protocol Violation|2|||
44401609|NCT00875667|79409219|FG001|Overall Study|Protocol Violation|0|||
44401610|NCT00875667|79409218|FG000|Overall Study|Disease Progression|100|||
44401611|NCT00875667|79409219|FG001|Overall Study|Disease Progression|49|||
44401612|NCT00875667|79409218|FG000|Overall Study|Miscellaneous|12|||
44401613|NCT00875667|79409219|FG001|Overall Study|Miscellaneous|6|||
44401614|NCT00875667|79409218|FG000|Overall Study|Randomized but no Study Drug Given|3|||
44401615|NCT00875667|79409219|FG001|Overall Study|Randomized but no Study Drug Given|1|||
44401616|NCT00602030|79409229|FG000|Lead-in Phase|Disease Progression|2|||
44401617|NCT00602030|79409230|FG001|Lead-in Phase|Disease Progression|3|||
44401618|NCT00602030|79409231|FG002|Lead-in Phase|Disease Progression|0|||
44401619|NCT00602030|79409232|FG003|Lead-in Phase|Disease Progression|0|||
44401620|NCT00602030|79409233|FG004|Lead-in Phase|Disease Progression|0|||
44401621|NCT00602030|79409229|FG000|Lead-in Phase|Adverse Event|0|||
44401622|NCT00602030|79409230|FG001|Lead-in Phase|Adverse Event|2|||
44401623|NCT00602030|79409231|FG002|Lead-in Phase|Adverse Event|0|||
44401624|NCT00602030|79409232|FG003|Lead-in Phase|Adverse Event|0|||
44401625|NCT00602030|79409233|FG004|Lead-in Phase|Adverse Event|0|||
44401626|NCT00602030|79409229|FG000|Double-blind Phase|Disease progression|0|||
44401627|NCT00602030|79409230|FG001|Double-blind Phase|Disease progression|0|||
44401628|NCT00602030|79409231|FG002|Double-blind Phase|Disease progression|33|||
44401629|NCT00602030|79409232|FG003|Double-blind Phase|Disease progression|30|||
44401630|NCT00602030|79409233|FG004|Double-blind Phase|Disease progression|0|||
44401631|NCT00602030|79409229|FG000|Double-blind Phase|Adverse Event|0|||
44401632|NCT00602030|79409230|FG001|Double-blind Phase|Adverse Event|0|||
44401633|NCT00602030|79409231|FG002|Double-blind Phase|Adverse Event|9|||
44401634|NCT00602030|79409232|FG003|Double-blind Phase|Adverse Event|18|||
44401635|NCT00602030|79409233|FG004|Double-blind Phase|Adverse Event|0|||
44401636|NCT00602030|79409229|FG000|Double-blind Phase|Consent withdrawal|0|||
44401637|NCT00602030|79409230|FG001|Double-blind Phase|Consent withdrawal|0|||
44401638|NCT00602030|79409231|FG002|Double-blind Phase|Consent withdrawal|4|||
44401639|NCT00602030|79409232|FG003|Double-blind Phase|Consent withdrawal|3|||
44401640|NCT00602030|79409233|FG004|Double-blind Phase|Consent withdrawal|0|||
44401641|NCT00602030|79409229|FG000|Double-blind Phase|Death|0|||
44401642|NCT00602030|79409230|FG001|Double-blind Phase|Death|0|||
44401643|NCT00602030|79409231|FG002|Double-blind Phase|Death|3|||
44401644|NCT00602030|79409232|FG003|Double-blind Phase|Death|3|||
44401645|NCT00602030|79409233|FG004|Double-blind Phase|Death|0|||
44401646|NCT00602030|79409229|FG000|Double-blind Phase|Administrative decision|0|||
44401647|NCT00602030|79409230|FG001|Double-blind Phase|Administrative decision|0|||
44401648|NCT00602030|79409231|FG002|Double-blind Phase|Administrative decision|0|||
44401649|NCT00602030|79409232|FG003|Double-blind Phase|Administrative decision|2|||
44401650|NCT00602030|79409233|FG004|Double-blind Phase|Administrative decision|0|||
44401651|NCT00602030|79409229|FG000|Double-blind Phase|Ineligibility|0|||
44401652|NCT00602030|79409230|FG001|Double-blind Phase|Ineligibility|0|||
44401653|NCT00602030|79409231|FG002|Double-blind Phase|Ineligibility|0|||
44401654|NCT00602030|79409232|FG003|Double-blind Phase|Ineligibility|1|||
44401655|NCT00602030|79409233|FG004|Double-blind Phase|Ineligibility|0|||
44401656|NCT00602030|79409229|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
44401657|NCT00602030|79409230|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
44401658|NCT00602030|79409231|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
44401659|NCT00602030|79409232|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
44401660|NCT00602030|79409233|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
44401661|NCT00602030|79409229|FG000|Double-blind Phase|Reason not specified|0|||
44401662|NCT00602030|79409230|FG001|Double-blind Phase|Reason not specified|0|||
44401663|NCT00602030|79409231|FG002|Double-blind Phase|Reason not specified|4|||
44401664|NCT00602030|79409232|FG003|Double-blind Phase|Reason not specified|2|||
44401665|NCT00602030|79409233|FG004|Double-blind Phase|Reason not specified|0|||
44401666|NCT00602030|79409229|FG000|Crossover Phase|Disease Progression|0|||
44401667|NCT00602030|79409230|FG001|Crossover Phase|Disease Progression|0|||
44401668|NCT00602030|79409231|FG002|Crossover Phase|Disease Progression|0|||
44401669|NCT00602030|79409232|FG003|Crossover Phase|Disease Progression|0|||
44401670|NCT00602030|79409233|FG004|Crossover Phase|Disease Progression|11|||
44401671|NCT00602030|79409229|FG000|Crossover Phase|Adverse Event|0|||
44401672|NCT00602030|79409230|FG001|Crossover Phase|Adverse Event|0|||
44401673|NCT00602030|79409231|FG002|Crossover Phase|Adverse Event|0|||
44401674|NCT00602030|79409232|FG003|Crossover Phase|Adverse Event|0|||
44401675|NCT00602030|79409233|FG004|Crossover Phase|Adverse Event|3|||
44401676|NCT00602030|79409229|FG000|Crossover Phase|Consent withdrawal|0|||
44401677|NCT00602030|79409230|FG001|Crossover Phase|Consent withdrawal|0|||
44401678|NCT00602030|79409231|FG002|Crossover Phase|Consent withdrawal|0|||
44401679|NCT00602030|79409232|FG003|Crossover Phase|Consent withdrawal|0|||
44401680|NCT00602030|79409233|FG004|Crossover Phase|Consent withdrawal|2|||
44401681|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
44401682|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
44401683|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
44401684|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
44401685|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
44401686|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
44401687|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
44401688|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
44401689|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
44401690|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
44401691|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
44401692|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
44401693|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
44401694|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
44401695|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
44401696|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
44401697|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
44147579|NCT02158936|78936893|FG000|Overall Study|Withdrawal by Subject|15|||
44147580|NCT02158936|78936894|FG001|Overall Study|Withdrawal by Subject|16|||
44147581|NCT02158936|78936893|FG000|Overall Study|Physician Decision|15|||
44147582|NCT02158936|78936894|FG001|Overall Study|Physician Decision|13|||
44147583|NCT02158936|78936893|FG000|Overall Study|Lost to Follow-up|0|||
44147584|NCT02158936|78936894|FG001|Overall Study|Lost to Follow-up|1|||
44147585|NCT02158546|78936904|FG000|Overall Study|Physician Decision|0|||
44147586|NCT02158546|78936905|FG001|Overall Study|Physician Decision|1|||
44147587|NCT02158546|78936906|FG002|Overall Study|Physician Decision|0|||
44147588|NCT02158546|78936907|FG003|Overall Study|Physician Decision|0|||
44147589|NCT02158546|78936904|FG000|Overall Study|Non-compliance|0|||
44147590|NCT02158546|78936905|FG001|Overall Study|Non-compliance|1|||
44147591|NCT02158546|78936906|FG002|Overall Study|Non-compliance|0|||
44147592|NCT02158546|78936907|FG003|Overall Study|Non-compliance|1|||
44401698|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
44401699|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
44401700|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
44401701|NCT00549757|79409247|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
44401702|NCT00549757|79409248|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
44401703|NCT00549757|79409247|FG000|Extension Period (in Average 9 Months)|Death|143|||
44401704|NCT00549757|79409248|FG001|Extension Period (in Average 9 Months)|Death|136|||
44401705|NCT00549757|79409247|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
44401706|NCT00549757|79409248|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
44401707|NCT00549757|79409247|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
44401708|NCT00549757|79409248|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
44401709|NCT00549757|79409247|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
44401710|NCT00549757|79409248|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
44401711|NCT00549601|79409263|FG000|Randomized|Protocol Violation|0|||
44401712|NCT00549601|79409264|FG001|Randomized|Protocol Violation|0|||
44401713|NCT00549601|79409265|FG002|Randomized|Protocol Violation|1|||
44401714|NCT00549601|79409263|FG000|Randomized|Withdrawal by Subject|0|||
44401715|NCT00549601|79409264|FG001|Randomized|Withdrawal by Subject|1|||
44401716|NCT00549601|79409265|FG002|Randomized|Withdrawal by Subject|1|||
44401717|NCT00549601|79409263|FG000|Received Study Drug|Adverse Event|2|||
44401718|NCT00549601|79409264|FG001|Received Study Drug|Adverse Event|5|||
44401719|NCT00549601|79409265|FG002|Received Study Drug|Adverse Event|1|||
44401720|NCT00549601|79409263|FG000|Received Study Drug|Death|0|||
44401721|NCT00549601|79409264|FG001|Received Study Drug|Death|1|||
44401722|NCT00549601|79409265|FG002|Received Study Drug|Death|0|||
44401723|NCT00549601|79409263|FG000|Received Study Drug|Lost to Follow-up|0|||
44401724|NCT00549601|79409264|FG001|Received Study Drug|Lost to Follow-up|1|||
44401725|NCT00549601|79409265|FG002|Received Study Drug|Lost to Follow-up|1|||
44401726|NCT00549601|79409263|FG000|Received Study Drug|Protocol Violation|3|||
44401727|NCT00549601|79409264|FG001|Received Study Drug|Protocol Violation|4|||
44401728|NCT00549601|79409265|FG002|Received Study Drug|Protocol Violation|1|||
44401729|NCT00549601|79409263|FG000|Received Study Drug|Withdrawal by Subject|2|||
44401730|NCT00549601|79409264|FG001|Received Study Drug|Withdrawal by Subject|0|||
44401731|NCT00549601|79409265|FG002|Received Study Drug|Withdrawal by Subject|1|||
44401732|NCT00601640|79409291|FG000|Overall Study|Withdrawal by Subject|3|||
44401733|NCT00601640|79409292|FG001|Overall Study|Withdrawal by Subject|0|||
44147593|NCT02158546|78936904|FG000|Overall Study|Failure to meet eligibility criteria|0|||
44147594|NCT02158546|78936905|FG001|Overall Study|Failure to meet eligibility criteria|1|||
44147595|NCT02158546|78936906|FG002|Overall Study|Failure to meet eligibility criteria|0|||
44147596|NCT02158546|78936907|FG003|Overall Study|Failure to meet eligibility criteria|0|||
44147597|NCT02158546|78936904|FG000|Overall Study|Lack of Efficacy|1|||
44147598|NCT02158546|78936905|FG001|Overall Study|Lack of Efficacy|1|||
44147599|NCT02158546|78936906|FG002|Overall Study|Lack of Efficacy|0|||
44147600|NCT02158546|78936907|FG003|Overall Study|Lack of Efficacy|0|||
44281689|NCT01915914|79244954|FG003|Acute Phase|Missing|0|||
44401734|NCT00601640|79409293|FG002|Overall Study|Withdrawal by Subject|7|||
44401735|NCT00601640|79409291|FG000|Overall Study|Death|1|||
44401736|NCT00601640|79409292|FG001|Overall Study|Death|0|||
44401737|NCT00601640|79409293|FG002|Overall Study|Death|0|||
44401738|NCT00601640|79409291|FG000|Overall Study|Adverse Event|0|||
44401739|NCT00601640|79409292|FG001|Overall Study|Adverse Event|4|||
44401740|NCT00601640|79409293|FG002|Overall Study|Adverse Event|2|||
44401741|NCT00601640|79409291|FG000|Overall Study|intercurrent illness|1|||
44401742|NCT00601640|79409292|FG001|Overall Study|intercurrent illness|0|||
44401743|NCT00601640|79409293|FG002|Overall Study|intercurrent illness|0|||
44401744|NCT00601640|79409291|FG000|Overall Study|change in eligibility status|0|||
44401745|NCT00601640|79409292|FG001|Overall Study|change in eligibility status|1|||
44401746|NCT00601640|79409293|FG002|Overall Study|change in eligibility status|1|||
44401747|NCT02805725|79409308|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
44401748|NCT02805725|79409309|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
44401749|NCT02805725|79409310|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
44401750|NCT02805725|79409311|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
44401751|NCT02805725|79409312|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
44401752|NCT02805725|79409308|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
44401753|NCT02805725|79409309|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
44401754|NCT02805725|79409310|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
44401755|NCT02805725|79409311|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
44401756|NCT02805725|79409312|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
44401757|NCT02805725|79409308|FG000|Phase II|Protocol Violation|0|||
44401758|NCT02805725|79409309|FG001|Phase II|Protocol Violation|0|||
44401759|NCT02805725|79409310|FG002|Phase II|Protocol Violation|0|||
44401760|NCT02805725|79409311|FG003|Phase II|Protocol Violation|0|||
44401761|NCT02805725|79409312|FG004|Phase II|Protocol Violation|6|||
44401762|NCT00546871|79409329|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
44401763|NCT00546871|79409330|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
44147601|NCT02158546|78936904|FG000|Overall Study|Adverse Event|2|||
44147602|NCT02158546|78936905|FG001|Overall Study|Adverse Event|2|||
44281690|NCT01915914|79244951|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44401764|NCT00546871|79409329|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
44401765|NCT00546871|79409330|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
44401766|NCT00546871|79409329|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
44401767|NCT00546871|79409330|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
44401768|NCT00546871|79409329|FG000|Study Extension Period|Protocol Violation|1|||
44401769|NCT00546871|79409330|FG001|Study Extension Period|Protocol Violation|0|||
44401770|NCT00546871|79409329|FG000|Study Extension Period|Withdrawal by Subject|0|||
44401771|NCT00546871|79409330|FG001|Study Extension Period|Withdrawal by Subject|1|||
44401772|NCT03951805|79409363|FG000|Overall Study|Adverse Event|1|||
44401773|NCT03951805|79409364|FG001|Overall Study|Adverse Event|0|||
44401774|NCT03951805|79409365|FG002|Overall Study|Adverse Event|0|||
44401775|NCT03951805|79409366|FG003|Overall Study|Adverse Event|0|||
44401776|NCT03944707|79409378|FG000|Overall Study|Adverse Event|0|||
44401777|NCT03944707|79409379|FG001|Overall Study|Adverse Event|2|||
44401778|NCT03944707|79409378|FG000|Overall Study|Study terminated by sponsor|12|||
44401779|NCT03944707|79409379|FG001|Overall Study|Study terminated by sponsor|7|||
44401780|NCT03944707|79409378|FG000|Overall Study|Subject decision|0|||
44401781|NCT03944707|79409379|FG001|Overall Study|Subject decision|1|||
44401782|NCT00549055|79409385|FG000|Overall Study|Adverse Event|4|||
44522084|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Death|1|||
44522085|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Death|1|||
44522086|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522087|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522088|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522089|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522090|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522091|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
44522092|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522093|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522094|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522095|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
44522096|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522097|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522098|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522099|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522100|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44281691|NCT01915914|79244952|FG001|Maintenance Phase|Withdrawal by Subject|1|||
44401783|NCT00549055|79409385|FG000|Overall Study|Lack of Efficacy|18|||
44401784|NCT00549055|79409385|FG000|Overall Study|Stabilization|5|||
44401785|NCT00549055|79409385|FG000|Overall Study|Progression to fibrosis|2|||
44401786|NCT00549055|79409385|FG000|Overall Study|Decrease of size|1|||
44401787|NCT00549055|79409385|FG000|Overall Study|Active choroidal neovascula increased|1|||
44401788|NCT00549055|79409385|FG000|Overall Study|Vitreous hemorrhage|1|||
44401789|NCT00549055|79409385|FG000|Overall Study|Growth choroidal neovascularisation|1|||
44401790|NCT00549055|79409385|FG000|Overall Study|Choroidal neovascularization|1|||
44522101|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522102|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522103|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522104|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
44522105|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
44522106|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
44522107|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
44401791|NCT00549055|79409385|FG000|Overall Study|Very low visual acuity (VA)|1|||
44401792|NCT00883116|79409391|FG000|Overall Study|Adverse event unrelated to study drug|5|||
44401793|NCT00883116|79409392|FG001|Overall Study|Adverse event unrelated to study drug|10|||
44401794|NCT00883116|79409391|FG000|Overall Study|Death|6|||
44401795|NCT00883116|79409392|FG001|Overall Study|Death|2|||
44401796|NCT00883116|79409391|FG000|Overall Study|Disease progression|130|||
44401797|NCT00883116|79409392|FG001|Overall Study|Disease progression|128|||
44401798|NCT00883116|79409391|FG000|Overall Study|Lost to Follow-up|0|||
44401799|NCT00883116|79409392|FG001|Overall Study|Lost to Follow-up|1|||
44401800|NCT00883116|79409391|FG000|Overall Study|Maximum clinical benefit|13|||
44401801|NCT00883116|79409392|FG001|Overall Study|Maximum clinical benefit|46|||
44401802|NCT00883116|79409391|FG000|Overall Study|Not identified|3|||
44401803|NCT00883116|79409392|FG001|Overall Study|Not identified|6|||
44401804|NCT00883116|79409391|FG000|Overall Study|Study drug toxicity|36|||
44401805|NCT00883116|79409392|FG001|Overall Study|Study drug toxicity|16|||
44401806|NCT00883116|79409391|FG000|Overall Study|Withdrawal by Subject|14|||
44401807|NCT00883116|79409392|FG001|Overall Study|Withdrawal by Subject|8|||
44401808|NCT00883116|79409391|FG000|Overall Study|No longer meets study criteria|2|||
44401809|NCT00883116|79409392|FG001|Overall Study|No longer meets study criteria|2|||
44401810|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
44401811|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
44401812|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
44401813|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
44401814|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
44401815|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
44401816|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Personal issues|2|||
44401817|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Personal issues|0|||
44401818|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Personal issues|0|||
44401819|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Too busy|7|||
44401820|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Too busy|1|||
44401821|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Too busy|0|||
44401822|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Pain|2|||
44401823|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Pain|0|||
44401824|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Pain|0|||
44401825|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Moved|1|||
44401826|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Moved|0|||
44401827|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Moved|0|||
44401828|NCT00594399|79409411|FG000|Initial 3 Month Counseling|Family illness|1|||
44401829|NCT00594399|79409412|FG001|Initial 3 Month Counseling|Family illness|0|||
44401830|NCT00594399|79409413|FG002|Initial 3 Month Counseling|Family illness|0|||
44401831|NCT00594399|79409411|FG000|Rerandomization Arm 1 Only|Death|2|||
44401832|NCT00594399|79409412|FG001|Rerandomization Arm 1 Only|Death|1|||
44401833|NCT00594399|79409413|FG002|Rerandomization Arm 1 Only|Death|0|||
44401834|NCT00594399|79409411|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
44401835|NCT00594399|79409412|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
44401836|NCT00594399|79409413|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
44401837|NCT00546715|79409423|FG000|Overall Study|Withdrawal by Subject|0|||
44401838|NCT00546715|79409424|FG001|Overall Study|Withdrawal by Subject|1|||
44401839|NCT00546715|79409425|FG002|Overall Study|Withdrawal by Subject|0|||
44401840|NCT00546715|79409426|FG003|Overall Study|Withdrawal by Subject|0|||
44401841|NCT00874029|79409436|FG000|Overall Study|Withdrawal by Subject|10|||
44401842|NCT00874029|79409436|FG000|Overall Study|Pregnancy|4|||
44401843|NCT00874029|79409436|FG000|Overall Study|Physician Decision|1|||
44401844|NCT00874029|79409436|FG000|Overall Study|Adverse Event|1|||
44522108|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
44522109|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
44401845|NCT00874029|79409436|FG000|Overall Study|Lost to Follow-up|5|||
44401846|NCT00546637|79409452|FG000|Overall Study|Adverse Event|46|||
44401847|NCT00546637|79409453|FG001|Overall Study|Adverse Event|20|||
44401848|NCT00546637|79409452|FG000|Overall Study|Lack of Efficacy|5|||
44401849|NCT00546637|79409453|FG001|Overall Study|Lack of Efficacy|5|||
44401850|NCT00546637|79409452|FG000|Overall Study|Lost to Follow-up|2|||
44401851|NCT00546637|79409453|FG001|Overall Study|Lost to Follow-up|2|||
44401852|NCT00546637|79409452|FG000|Overall Study|Other|10|||
44401853|NCT00546637|79409453|FG001|Overall Study|Other|12|||
44401854|NCT00546637|79409452|FG000|Overall Study|Withdrawal by Subject|7|||
44401855|NCT00546637|79409453|FG001|Overall Study|Withdrawal by Subject|9|||
44401856|NCT00546637|79409452|FG000|Overall Study|Randomized, but not treated|3|||
44401857|NCT00546637|79409453|FG001|Overall Study|Randomized, but not treated|1|||
44401858|NCT00546481|79409461|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
44401859|NCT00546481|79409462|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
44401860|NCT00546481|79409463|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
44401861|NCT00546481|79409461|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
44401862|NCT00546481|79409462|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
44401863|NCT00546481|79409463|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
44401864|NCT00546481|79409461|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
44401865|NCT00546481|79409462|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
44401866|NCT00546481|79409463|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
44401867|NCT00546481|79409461|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
44401868|NCT00546481|79409462|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
44401869|NCT00546481|79409463|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
44401870|NCT00546481|79409461|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
44401871|NCT00546481|79409462|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
44401872|NCT00546481|79409463|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
44401873|NCT00546481|79409461|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
44401874|NCT00546481|79409462|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
44401875|NCT00546481|79409463|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
44401876|NCT00546481|79409461|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
44401877|NCT00546481|79409462|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
44401878|NCT00546481|79409463|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
44401879|NCT00546481|79409461|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
44401880|NCT00546481|79409462|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
44401881|NCT00546481|79409463|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
44401882|NCT00546481|79409461|FG000|Maintenance Phase (CERA)|Other Reason|0|||
44401883|NCT00546481|79409462|FG001|Maintenance Phase (CERA)|Other Reason|0|||
44401884|NCT00546481|79409463|FG002|Maintenance Phase (CERA)|Other Reason|1|||
44401885|NCT00880698|79409475|FG000|Overall Study|Death|0|||
44401886|NCT00880698|79409476|FG001|Overall Study|Death|0|||
44401887|NCT00880698|79409477|FG002|Overall Study|Death|1|||
44401888|NCT00880698|79409478|FG003|Overall Study|Death|2|||
44401889|NCT00880698|79409475|FG000|Overall Study|Lost to Follow-up|1|||
44401890|NCT00880698|79409476|FG001|Overall Study|Lost to Follow-up|3|||
44401891|NCT00880698|79409477|FG002|Overall Study|Lost to Follow-up|0|||
44401892|NCT00880698|79409478|FG003|Overall Study|Lost to Follow-up|1|||
44401893|NCT00880620|79409494|FG000|Overall Study|Adverse Event|4|||
44401894|NCT00880620|79409495|FG001|Overall Study|Adverse Event|5|||
44401895|NCT00880620|79409496|FG002|Overall Study|Adverse Event|15|||
44401896|NCT00880620|79409497|FG003|Overall Study|Adverse Event|15|||
44401897|NCT00880620|79409494|FG000|Overall Study|Death|0|||
44401898|NCT00880620|79409495|FG001|Overall Study|Death|0|||
44401899|NCT00880620|79409496|FG002|Overall Study|Death|1|||
44401900|NCT00880620|79409497|FG003|Overall Study|Death|0|||
44401901|NCT00880620|79409494|FG000|Overall Study|Lack of Efficacy|12|||
44401902|NCT00880620|79409495|FG001|Overall Study|Lack of Efficacy|4|||
44401903|NCT00880620|79409496|FG002|Overall Study|Lack of Efficacy|0|||
44401904|NCT00880620|79409497|FG003|Overall Study|Lack of Efficacy|1|||
44401905|NCT00880620|79409494|FG000|Overall Study|Lost to Follow-up|0|||
44401906|NCT00880620|79409495|FG001|Overall Study|Lost to Follow-up|1|||
44401907|NCT00880620|79409496|FG002|Overall Study|Lost to Follow-up|1|||
44401908|NCT00880620|79409497|FG003|Overall Study|Lost to Follow-up|0|||
44401909|NCT00880620|79409494|FG000|Overall Study|Protocol Violation|0|||
44401910|NCT00880620|79409495|FG001|Overall Study|Protocol Violation|1|||
44522110|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
44522111|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
44522112|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
44522113|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
44522114|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
44522115|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
44401911|NCT00880620|79409496|FG002|Overall Study|Protocol Violation|0|||
44401912|NCT00880620|79409497|FG003|Overall Study|Protocol Violation|2|||
44401913|NCT00880620|79409494|FG000|Overall Study|Withdrawal by Subject|4|||
44401914|NCT00880620|79409495|FG001|Overall Study|Withdrawal by Subject|3|||
44401915|NCT00880620|79409496|FG002|Overall Study|Withdrawal by Subject|1|||
44401916|NCT00880620|79409497|FG003|Overall Study|Withdrawal by Subject|3|||
44401917|NCT00880620|79409494|FG000|Overall Study|Noncompliance|0|||
44401918|NCT00880620|79409495|FG001|Overall Study|Noncompliance|0|||
44401919|NCT00880620|79409496|FG002|Overall Study|Noncompliance|1|||
44401920|NCT00880620|79409497|FG003|Overall Study|Noncompliance|1|||
44401921|NCT00880620|79409494|FG000|Overall Study|Other|1|||
44401922|NCT00880620|79409495|FG001|Overall Study|Other|1|||
44522116|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44522117|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44522118|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44522119|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44522120|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44522121|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
44522122|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
44522123|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
44522124|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
44401923|NCT00880620|79409496|FG002|Overall Study|Other|2|||
44401924|NCT00880620|79409497|FG003|Overall Study|Other|2|||
44401925|NCT00881868|79409523|FG000|Overall Study|Adverse Event|0|||
44401926|NCT00881868|79409524|FG001|Overall Study|Adverse Event|1|||
44401927|NCT00881868|79409523|FG000|Overall Study|Lost to Follow-up|2|||
44401928|NCT00881868|79409524|FG001|Overall Study|Lost to Follow-up|1|||
44522125|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
44401929|NCT00881868|79409523|FG000|Overall Study|Physician Decision|4|||
44401930|NCT00881868|79409524|FG001|Overall Study|Physician Decision|0|||
44401931|NCT00881868|79409523|FG000|Overall Study|Protocol Violation|2|||
44401932|NCT00881868|79409524|FG001|Overall Study|Protocol Violation|0|||
44401933|NCT00881712|79409533|FG000|Overall Study|Death|1|||
44401934|NCT00881712|79409534|FG001|Overall Study|Death|0|||
44401935|NCT00881712|79409535|FG002|Overall Study|Death|0|||
44401936|NCT00881712|79409533|FG000|Overall Study|Withdrawal by Subject|1|||
44401937|NCT00881712|79409534|FG001|Overall Study|Withdrawal by Subject|0|||
44401938|NCT00881712|79409535|FG002|Overall Study|Withdrawal by Subject|0|||
44401939|NCT03955471|79409543|FG000|Overall Study|Death|22|||
44401940|NCT03955471|79409543|FG000|Overall Study|Lost to Follow-up|1|||
44401941|NCT03955471|79409543|FG000|Overall Study|Withdrawal by Subject|6|||
44401942|NCT03955471|79409543|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
44401943|NCT00880542|79409547|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
44401944|NCT00880542|79409547|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
44401945|NCT00880542|79409547|FG000|REP: Surgical Resection|progressive disease|1|||
44522126|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522127|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522128|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522129|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522130|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522131|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44522132|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522133|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44522134|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
44522135|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
44522136|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
44522137|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
44522138|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
44522139|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
44522140|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
44522141|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
44522142|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
44522143|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
44522144|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
44147603|NCT02158546|78936906|FG002|Overall Study|Adverse Event|0|||
44147604|NCT02158546|78936907|FG003|Overall Study|Adverse Event|0|||
44147605|NCT02158546|78936904|FG000|Overall Study|Withdrawal by Subject|6|||
44147606|NCT02158546|78936905|FG001|Overall Study|Withdrawal by Subject|2|||
44401946|NCT00885534|79409551|FG000|Overall Study|Patient deemed ineligible|1|||
44401947|NCT00885378|79409557|FG000|Overall Study|Lack of Efficacy|2|||
44401948|NCT00885378|79409558|FG001|Overall Study|Lack of Efficacy|2|||
44401949|NCT00885378|79409557|FG000|Overall Study|Withdrawal by Subject|1|||
44401950|NCT00885378|79409558|FG001|Overall Study|Withdrawal by Subject|2|||
44401951|NCT00885378|79409557|FG000|Overall Study|Lost to Follow-up|1|||
44401952|NCT00885378|79409558|FG001|Overall Study|Lost to Follow-up|2|||
44401953|NCT00885378|79409557|FG000|Overall Study|Poor/Noncompliance|2|||
44401954|NCT00885378|79409558|FG001|Overall Study|Poor/Noncompliance|2|||
44401955|NCT00885378|79409557|FG000|Overall Study|Protocol Violation|2|||
44401956|NCT00885378|79409558|FG001|Overall Study|Protocol Violation|0|||
44401957|NCT00545779|79409564|FG000|Overall Study|Violation of selection criteria at entry|8|||
44401958|NCT00545779|79409564|FG000|Overall Study|Other protocol violation|1|||
44401959|NCT00545779|79409564|FG000|Overall Study|Did not cooperate|7|||
44401960|NCT00545779|79409564|FG000|Overall Study|Withdrawal by Subject|20|||
44401961|NCT00545779|79409564|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
44401962|NCT00545779|79409564|FG000|Overall Study|Failure to return|3|||
44401963|NCT00597714|79409574|FG000|Overall Study|Death|56|||
44401964|NCT00597714|79409575|FG001|Overall Study|Death|46|||
44401965|NCT00597714|79409576|FG002|Overall Study|Death|0|||
44401966|NCT00597714|79409574|FG000|Overall Study|Recipient death|0|||
44401967|NCT00597714|79409575|FG001|Overall Study|Recipient death|0|||
44401968|NCT00597714|79409576|FG002|Overall Study|Recipient death|10|||
44401969|NCT03938857|79409589|FG000|Overall Study|Physician Decision|1|||
44401970|NCT03938857|79409590|FG001|Overall Study|Physician Decision|0|||
44401971|NCT03938857|79409591|FG002|Overall Study|Physician Decision|0|||
44401972|NCT03938857|79409592|FG003|Overall Study|Physician Decision|0|||
44401973|NCT00884832|79409604|FG000|Overall Study|Withdrawal by Subject|0|||
44401974|NCT00884832|79409605|FG001|Overall Study|Withdrawal by Subject|1|||
44401975|NCT03938545|79409615|FG000|Overall Study|Lost to Follow-up|0|||
44401976|NCT03938545|79409616|FG001|Overall Study|Lost to Follow-up|0|||
44401977|NCT03938545|79409617|FG002|Overall Study|Lost to Follow-up|0|||
44401978|NCT03938545|79409618|FG003|Overall Study|Lost to Follow-up|1|||
44401979|NCT03938545|79409615|FG000|Overall Study|Non-compliance with study drug|0|||
44401980|NCT03938545|79409616|FG001|Overall Study|Non-compliance with study drug|0|||
44401981|NCT03938545|79409617|FG002|Overall Study|Non-compliance with study drug|1|||
44401982|NCT03938545|79409618|FG003|Overall Study|Non-compliance with study drug|0|||
44401983|NCT03938545|79409615|FG000|Overall Study|Pregnancy|1|||
44401984|NCT03938545|79409616|FG001|Overall Study|Pregnancy|0|||
44401985|NCT03938545|79409617|FG002|Overall Study|Pregnancy|0|||
44401986|NCT03938545|79409618|FG003|Overall Study|Pregnancy|0|||
44401987|NCT03938545|79409615|FG000|Overall Study|Study terminated by sponsor|6|||
44401988|NCT03938545|79409616|FG001|Overall Study|Study terminated by sponsor|4|||
44401989|NCT03938545|79409617|FG002|Overall Study|Study terminated by sponsor|2|||
44401990|NCT03938545|79409618|FG003|Overall Study|Study terminated by sponsor|4|||
44401991|NCT03938545|79409615|FG000|Overall Study|Withdrawal by Subject|0|||
44401992|NCT03938545|79409616|FG001|Overall Study|Withdrawal by Subject|1|||
44401993|NCT03938545|79409617|FG002|Overall Study|Withdrawal by Subject|0|||
44401994|NCT03938545|79409618|FG003|Overall Study|Withdrawal by Subject|0|||
44401995|NCT03938545|79409615|FG000|Overall Study|Adverse Event|1|||
44401996|NCT03938545|79409616|FG001|Overall Study|Adverse Event|0|||
44401997|NCT03938545|79409617|FG002|Overall Study|Adverse Event|0|||
44401998|NCT03938545|79409618|FG003|Overall Study|Adverse Event|0|||
44401999|NCT00879996|79409630|FG000|Overall Study|Lost to Follow-up|7|||
44402000|NCT00879996|79409631|FG001|Overall Study|Lost to Follow-up|6|||
44402001|NCT00879996|79409630|FG000|Overall Study|non-compliance|6|||
44402002|NCT00879996|79409631|FG001|Overall Study|non-compliance|4|||
44402003|NCT00879996|79409630|FG000|Overall Study|Physician Decision|1|||
44402004|NCT00879996|79409631|FG001|Overall Study|Physician Decision|2|||
44522145|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
44522146|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44522147|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44522148|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44252906|NCT00089999|79091921|FG001|Overall Study|Poor General Condition|0|||
44252907|NCT00089999|79091920|FG000|Overall Study|Clinical Progression|1|||
44252908|NCT00089999|79091921|FG001|Overall Study|Clinical Progression|2|||
44252909|NCT00089999|79091920|FG000|Overall Study|Physician Decision|2|||
44252910|NCT00089999|79091921|FG001|Overall Study|Physician Decision|2|||
44252911|NCT00089999|79091920|FG000|Overall Study|Patient Underwent Surgery|2|||
44402005|NCT00879996|79409630|FG000|Overall Study|psychiatric problem|0|||
44402006|NCT00879996|79409631|FG001|Overall Study|psychiatric problem|1|||
44402007|NCT00879996|79409630|FG000|Overall Study|put on parole|1|||
44402008|NCT00879996|79409631|FG001|Overall Study|put on parole|0|||
44402009|NCT00873093|79409644|FG000|Overall Study|Adverse Event|0|||
44402010|NCT00873093|79409645|FG001|Overall Study|Adverse Event|2|||
44402011|NCT00873093|79409646|FG002|Overall Study|Adverse Event|0|||
44402012|NCT00873093|79409647|FG003|Overall Study|Adverse Event|0|||
44402013|NCT00873093|79409648|FG004|Overall Study|Adverse Event|0|||
44402014|NCT00873093|79409644|FG000|Overall Study|Death|0|||
44402015|NCT00873093|79409645|FG001|Overall Study|Death|3|||
44252912|NCT00089999|79091921|FG001|Overall Study|Patient Underwent Surgery|0|||
44402016|NCT00873093|79409646|FG002|Overall Study|Death|2|||
44402017|NCT00873093|79409647|FG003|Overall Study|Death|0|||
44402018|NCT00873093|79409648|FG004|Overall Study|Death|0|||
44402019|NCT00873093|79409644|FG000|Overall Study|Physician Decision|0|||
44402020|NCT00873093|79409645|FG001|Overall Study|Physician Decision|17|||
44252913|NCT00089999|79091920|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
44252914|NCT00089999|79091921|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
44252915|NCT00089843|79091932|FG000|Overall Study|Withdrawal by Subject|1|||
44252916|NCT00089843|79091933|FG001|Overall Study|Withdrawal by Subject|4|||
44402021|NCT00873093|79409646|FG002|Overall Study|Physician Decision|10|||
44402022|NCT00873093|79409647|FG003|Overall Study|Physician Decision|10|||
44402023|NCT00873093|79409648|FG004|Overall Study|Physician Decision|2|||
44402024|NCT00873093|79409644|FG000|Overall Study|Withdrawal by Subject|1|||
44402025|NCT00873093|79409645|FG001|Overall Study|Withdrawal by Subject|4|||
44402026|NCT00873093|79409646|FG002|Overall Study|Withdrawal by Subject|4|||
44402027|NCT00873093|79409647|FG003|Overall Study|Withdrawal by Subject|0|||
44402028|NCT00873093|79409648|FG004|Overall Study|Withdrawal by Subject|0|||
44402029|NCT00873093|79409644|FG000|Overall Study|Ineligible|0|||
44402030|NCT00873093|79409645|FG001|Overall Study|Ineligible|1|||
44402031|NCT00873093|79409646|FG002|Overall Study|Ineligible|0|||
44402032|NCT00873093|79409647|FG003|Overall Study|Ineligible|1|||
44402033|NCT00873093|79409648|FG004|Overall Study|Ineligible|0|||
44402034|NCT00884286|79409672|FG000|Overall Study|Progressive disease|21|||
44402035|NCT00884286|79409673|FG001|Overall Study|Progressive disease|28|||
44402036|NCT00884286|79409672|FG000|Overall Study|Toxicity|4|||
44402037|NCT00884286|79409673|FG001|Overall Study|Toxicity|1|||
44402038|NCT00884286|79409672|FG000|Overall Study|Death|2|||
44402039|NCT00884286|79409673|FG001|Overall Study|Death|2|||
44402040|NCT00884286|79409672|FG000|Overall Study|Physician Decision|1|||
44402041|NCT00884286|79409673|FG001|Overall Study|Physician Decision|0|||
44402042|NCT00884286|79409672|FG000|Overall Study|Septic shock|1|||
44402043|NCT00884286|79409673|FG001|Overall Study|Septic shock|0|||
44402044|NCT00884286|79409672|FG000|Overall Study|Thrombus in right auricle|1|||
44402045|NCT00884286|79409673|FG001|Overall Study|Thrombus in right auricle|0|||
44402046|NCT00884286|79409672|FG000|Overall Study|Not treated|2|||
44402047|NCT00884286|79409673|FG001|Overall Study|Not treated|1|||
44402048|NCT00884286|79409672|FG000|Overall Study|Comprised lung carcinoma|0|||
44402049|NCT00884286|79409673|FG001|Overall Study|Comprised lung carcinoma|1|||
44402050|NCT00873015|79409684|FG000|Overall Study|Withdrawal by Subject|0|||
44402051|NCT00873015|79409685|FG001|Overall Study|Withdrawal by Subject|1|||
44402052|NCT00873015|79409686|FG002|Overall Study|Withdrawal by Subject|0|||
44402053|NCT00873015|79409687|FG003|Overall Study|Withdrawal by Subject|0|||
44402054|NCT03921151|79409702|FG000|Overall Study|Withdrawal by Subject|11|||
44402055|NCT03921151|79409703|FG001|Overall Study|Withdrawal by Subject|16|||
44402056|NCT00872001|79409715|FG000|Overall Study|Adverse Event|34|||
44402057|NCT00872001|79409716|FG001|Overall Study|Adverse Event|23|||
44402058|NCT00872001|79409715|FG000|Overall Study|Protocol Defined Clinical Event|5|||
44402059|NCT00872001|79409716|FG001|Overall Study|Protocol Defined Clinical Event|7|||
44402060|NCT00872001|79409715|FG000|Overall Study|Lost to Follow-up|13|||
44402061|NCT00872001|79409716|FG001|Overall Study|Lost to Follow-up|12|||
44402062|NCT00872001|79409715|FG000|Overall Study|Withdrawal by Subject|18|||
44402063|NCT00872001|79409716|FG001|Overall Study|Withdrawal by Subject|30|||
44402064|NCT00872001|79409715|FG000|Overall Study|Protocol Violation|5|||
44402065|NCT00872001|79409716|FG001|Overall Study|Protocol Violation|8|||
44402066|NCT00872001|79409715|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
44402067|NCT00872001|79409716|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
44402068|NCT00872001|79409715|FG000|Overall Study|Administrative|23|||
44402069|NCT00872001|79409716|FG001|Overall Study|Administrative|15|||
44402070|NCT00871923|79409724|FG000|Overall Study|Death|1|||
44402071|NCT00871923|79409724|FG000|Overall Study|Withdrawal by Subject|1|||
44402072|NCT03922945|79409731|FG000|Overall Study|Adverse Event|1|||
44402073|NCT03922945|79409732|FG001|Overall Study|Adverse Event|1|||
44402074|NCT03922945|79409733|FG002|Overall Study|Adverse Event|2|||
44402075|NCT03922945|79409731|FG000|Overall Study|Lost to Follow-up|13|||
44402076|NCT03922945|79409732|FG001|Overall Study|Lost to Follow-up|9|||
44402077|NCT03922945|79409733|FG002|Overall Study|Lost to Follow-up|20|||
44402078|NCT03922945|79409731|FG000|Overall Study|Lack of Efficacy|2|||
44252917|NCT00089843|79091934|FG002|Overall Study|Withdrawal by Subject|5|||
44252918|NCT00089843|79091935|FG003|Overall Study|Withdrawal by Subject|6|||
44402079|NCT03922945|79409732|FG001|Overall Study|Lack of Efficacy|0|||
44402080|NCT03922945|79409733|FG002|Overall Study|Lack of Efficacy|1|||
44252919|NCT00089843|79091932|FG000|Overall Study|Physician Decision|1|||
44402081|NCT03922945|79409731|FG000|Overall Study|Protocol Non-Compliance|0|||
44402082|NCT03922945|79409732|FG001|Overall Study|Protocol Non-Compliance|0|||
44402083|NCT03922945|79409733|FG002|Overall Study|Protocol Non-Compliance|1|||
44402084|NCT03922945|79409731|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
44402085|NCT03922945|79409732|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
44402086|NCT03922945|79409733|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
44402087|NCT03922945|79409731|FG000|Overall Study|All Other Personal Reasons|1|||
44402088|NCT03922945|79409732|FG001|Overall Study|All Other Personal Reasons|1|||
44402089|NCT03922945|79409733|FG002|Overall Study|All Other Personal Reasons|2|||
44252920|NCT00089843|79091933|FG001|Overall Study|Physician Decision|0|||
44402090|NCT03922477|79409744|FG000|Overall Study|Death|9|||
44402091|NCT03922477|79409744|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
44402092|NCT03922477|79409744|FG000|Overall Study|Physician Decision|1|||
44402093|NCT03922477|79409744|FG000|Overall Study|Withdrawal by Subject|2|||
44402094|NCT00867165|79409750|FG000|Overall Study|Adverse Event|3|||
44402095|NCT00867165|79409751|FG001|Overall Study|Adverse Event|0|||
44402096|NCT00867165|79409750|FG000|Overall Study|Withdrawal by Subject|1|||
44147607|NCT02158546|78936906|FG002|Overall Study|Withdrawal by Subject|1|||
44147608|NCT02158546|78936907|FG003|Overall Study|Withdrawal by Subject|0|||
44147609|NCT02158546|78936904|FG000|Overall Study|Lost to Follow-up|5|||
44147610|NCT02158546|78936905|FG001|Overall Study|Lost to Follow-up|4|||
44402097|NCT00867165|79409751|FG001|Overall Study|Withdrawal by Subject|0|||
44402098|NCT00867087|79409757|FG000|Overall Study|Other|1|||
44402099|NCT00867087|79409757|FG000|Overall Study|Withdrawal by Subject|4|||
44402100|NCT00867087|79409757|FG000|Overall Study|Death|37|||
44402101|NCT00545233|79409763|FG000|Overall Study|Adverse Event|10|||
44402102|NCT00545233|79409764|FG001|Overall Study|Adverse Event|5|||
44402103|NCT00545233|79409763|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
44402104|NCT00545233|79409764|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
44402105|NCT00545233|79409763|FG000|Overall Study|Protocol Violation|2|||
44402106|NCT00545233|79409764|FG001|Overall Study|Protocol Violation|0|||
44402107|NCT00545233|79409763|FG000|Overall Study|Refused Treatment|9|||
44402108|NCT00545233|79409764|FG001|Overall Study|Refused Treatment|7|||
44402109|NCT00545233|79409763|FG000|Overall Study|Failure to Return|4|||
44402110|NCT00545233|79409764|FG001|Overall Study|Failure to Return|6|||
44402111|NCT00545233|79409763|FG000|Overall Study|Insufficient response|14|||
44402112|NCT00545233|79409764|FG001|Overall Study|Insufficient response|15|||
44402113|NCT00545233|79409763|FG000|Overall Study|Physician Decision|2|||
44402114|NCT00545233|79409764|FG001|Overall Study|Physician Decision|1|||
44402115|NCT02393248|79409796|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402116|NCT02393248|79409797|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
44402117|NCT02393248|79409798|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402118|NCT02393248|79409799|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402119|NCT02393248|79409800|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402120|NCT02393248|79409801|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
44402121|NCT02393248|79409802|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
44402122|NCT02393248|79409803|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402123|NCT02393248|79409804|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402124|NCT02393248|79409805|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402125|NCT02393248|79409806|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402126|NCT02393248|79409807|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402127|NCT02393248|79409808|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402128|NCT02393248|79409809|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402129|NCT02393248|79409810|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402130|NCT02393248|79409811|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402131|NCT02393248|79409812|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402132|NCT02393248|79409813|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402133|NCT02393248|79409814|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402134|NCT02393248|79409815|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402135|NCT02393248|79409816|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402136|NCT02393248|79409817|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402137|NCT02393248|79409818|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402138|NCT02393248|79409819|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402139|NCT02393248|79409820|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
44402140|NCT02393248|79409796|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402141|NCT02393248|79409797|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
44402142|NCT02393248|79409798|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402143|NCT02393248|79409799|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402144|NCT02393248|79409800|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402145|NCT02393248|79409801|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402146|NCT02393248|79409802|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402147|NCT02393248|79409803|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402148|NCT02393248|79409804|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402149|NCT02393248|79409805|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402150|NCT02393248|79409806|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402151|NCT02393248|79409807|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402152|NCT02393248|79409808|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402153|NCT02393248|79409809|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402154|NCT02393248|79409810|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402155|NCT02393248|79409811|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402156|NCT02393248|79409812|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402157|NCT02393248|79409813|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402158|NCT02393248|79409814|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402159|NCT02393248|79409815|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402160|NCT02393248|79409816|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402161|NCT02393248|79409817|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402162|NCT02393248|79409818|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402163|NCT02393248|79409819|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402164|NCT02393248|79409820|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
44402165|NCT02393248|79409796|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
44402166|NCT02393248|79409797|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
44402167|NCT02393248|79409798|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
44402168|NCT02393248|79409799|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
44402169|NCT02393248|79409800|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
44402170|NCT02393248|79409801|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
44402171|NCT02393248|79409802|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
44402172|NCT02393248|79409803|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
44402173|NCT02393248|79409804|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
44402174|NCT02393248|79409805|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
44402175|NCT02393248|79409806|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
44402176|NCT02393248|79409807|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
44402177|NCT02393248|79409808|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
44402178|NCT02393248|79409809|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
44402179|NCT02393248|79409810|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
44402180|NCT02393248|79409811|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
44402181|NCT02393248|79409812|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
44402182|NCT02393248|79409813|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
44402183|NCT02393248|79409814|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
44402184|NCT02393248|79409815|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
44402185|NCT02393248|79409816|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
44402186|NCT02393248|79409817|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
44402187|NCT02393248|79409818|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
44402188|NCT02393248|79409819|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
44402189|NCT02393248|79409820|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
44402190|NCT02393248|79409796|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
44402191|NCT02393248|79409797|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402192|NCT02393248|79409798|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402193|NCT02393248|79409799|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402194|NCT02393248|79409800|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402195|NCT02393248|79409801|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402196|NCT02393248|79409802|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402197|NCT02393248|79409803|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402198|NCT02393248|79409804|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402199|NCT02393248|79409805|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402200|NCT02393248|79409806|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402201|NCT02393248|79409807|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402202|NCT02393248|79409808|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402203|NCT02393248|79409809|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402204|NCT02393248|79409810|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402205|NCT02393248|79409811|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402206|NCT02393248|79409812|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402207|NCT02393248|79409813|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402208|NCT02393248|79409814|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402209|NCT02393248|79409815|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402210|NCT02393248|79409816|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402211|NCT02393248|79409817|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402212|NCT02393248|79409818|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402213|NCT02393248|79409819|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44402214|NCT02393248|79409820|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
44147611|NCT02158546|78936906|FG002|Overall Study|Lost to Follow-up|0|||
44252921|NCT00089843|79091934|FG002|Overall Study|Physician Decision|0|||
44252922|NCT00089843|79091935|FG003|Overall Study|Physician Decision|1|||
44252923|NCT00089297|79091945|FG000|Overall Study|Adverse Event|9|||
44402215|NCT02393248|79409796|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402216|NCT02393248|79409797|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402217|NCT02393248|79409798|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402218|NCT02393248|79409799|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402219|NCT02393248|79409800|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44147612|NCT02158546|78936907|FG003|Overall Study|Lost to Follow-up|1|||
44147613|NCT02158546|78936904|FG000|Overall Study|Site Excluded|5|||
44402220|NCT02393248|79409801|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
44402221|NCT02393248|79409802|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
44402222|NCT02393248|79409803|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402223|NCT02393248|79409804|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402224|NCT02393248|79409805|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
44402225|NCT02393248|79409806|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402226|NCT02393248|79409807|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402227|NCT02393248|79409808|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402228|NCT02393248|79409809|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402229|NCT02393248|79409810|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402230|NCT02393248|79409811|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402231|NCT02393248|79409812|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402232|NCT02393248|79409813|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402233|NCT02393248|79409814|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402234|NCT02393248|79409815|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402235|NCT02393248|79409816|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402236|NCT02393248|79409817|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402237|NCT02393248|79409818|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402238|NCT02393248|79409819|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402239|NCT02393248|79409820|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
44402240|NCT02393248|79409796|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402241|NCT02393248|79409797|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402242|NCT02393248|79409798|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402243|NCT02393248|79409799|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402244|NCT02393248|79409800|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402245|NCT02393248|79409801|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402246|NCT02393248|79409802|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
44402247|NCT02393248|79409803|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402248|NCT02393248|79409804|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402249|NCT02393248|79409805|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402250|NCT02393248|79409806|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402251|NCT02393248|79409807|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402252|NCT02393248|79409808|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402253|NCT02393248|79409809|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402254|NCT02393248|79409810|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402255|NCT02393248|79409811|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402256|NCT02393248|79409812|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402257|NCT02393248|79409813|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402258|NCT02393248|79409814|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402259|NCT02393248|79409815|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402260|NCT02393248|79409816|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402261|NCT02393248|79409817|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402262|NCT02393248|79409818|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402263|NCT02393248|79409819|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402264|NCT02393248|79409820|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
44402265|NCT02393248|79409796|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402266|NCT02393248|79409797|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402267|NCT02393248|79409798|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402268|NCT02393248|79409799|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402269|NCT02393248|79409800|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402270|NCT02393248|79409801|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402271|NCT02393248|79409802|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44522149|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44522150|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44522151|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44522152|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44522153|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
44252924|NCT00089297|79091945|FG000|Overall Study|Death|1|||
44402272|NCT02393248|79409803|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402273|NCT02393248|79409804|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402274|NCT02393248|79409805|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402275|NCT02393248|79409806|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402276|NCT02393248|79409807|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
44402277|NCT02393248|79409808|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
44402278|NCT02393248|79409809|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
44402279|NCT02393248|79409810|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
44402280|NCT02393248|79409811|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402281|NCT02393248|79409812|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402282|NCT02393248|79409813|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402283|NCT02393248|79409814|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402284|NCT02393248|79409815|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402285|NCT02393248|79409816|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402286|NCT02393248|79409817|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402287|NCT02393248|79409818|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402288|NCT02393248|79409819|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402289|NCT02393248|79409820|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
44402290|NCT02393248|79409796|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402291|NCT02393248|79409797|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402292|NCT02393248|79409798|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402293|NCT02393248|79409799|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402294|NCT02393248|79409800|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402295|NCT02393248|79409801|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402296|NCT02393248|79409802|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402297|NCT02393248|79409803|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402298|NCT02393248|79409804|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402299|NCT02393248|79409805|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402300|NCT02393248|79409806|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
44402301|NCT02393248|79409807|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
44402302|NCT02393248|79409808|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402303|NCT02393248|79409809|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402304|NCT02393248|79409810|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402305|NCT02393248|79409811|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402306|NCT02393248|79409812|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402307|NCT02393248|79409813|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402308|NCT02393248|79409814|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402309|NCT02393248|79409815|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402310|NCT02393248|79409816|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402311|NCT02393248|79409817|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402312|NCT02393248|79409818|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402313|NCT02393248|79409819|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402314|NCT02393248|79409820|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
44402315|NCT02393248|79409796|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
44402316|NCT02393248|79409797|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
44402317|NCT02393248|79409798|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
44402318|NCT02393248|79409799|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
44402319|NCT02393248|79409800|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
44402320|NCT02393248|79409801|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
44402321|NCT02393248|79409802|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
44402322|NCT02393248|79409803|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
44402323|NCT02393248|79409804|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
44522154|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
44522155|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
44522156|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522157|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522158|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522159|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522160|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44402324|NCT02393248|79409805|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
44402325|NCT02393248|79409806|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
44402326|NCT02393248|79409807|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
44402327|NCT02393248|79409808|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
44402328|NCT02393248|79409809|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
44402329|NCT02393248|79409810|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
44402330|NCT02393248|79409811|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
44402331|NCT02393248|79409812|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
44522161|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522162|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522163|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
44522164|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522165|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
44522166|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522167|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522168|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44402332|NCT02393248|79409813|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
44402333|NCT02393248|79409814|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
44402334|NCT02393248|79409815|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
44402335|NCT02393248|79409816|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
44402336|NCT02393248|79409817|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
44402337|NCT02393248|79409818|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
44402338|NCT02393248|79409819|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
44402339|NCT02393248|79409820|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
44402340|NCT02393248|79409796|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402341|NCT02393248|79409797|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402342|NCT02393248|79409798|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402343|NCT02393248|79409799|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402344|NCT02393248|79409800|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402345|NCT02393248|79409801|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402346|NCT02393248|79409802|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402347|NCT02393248|79409803|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402348|NCT02393248|79409804|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402349|NCT02393248|79409805|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402350|NCT02393248|79409806|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402351|NCT02393248|79409807|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
44402352|NCT02393248|79409808|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402353|NCT02393248|79409809|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
44402354|NCT02393248|79409810|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402355|NCT02393248|79409811|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402356|NCT02393248|79409812|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402357|NCT02393248|79409813|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402358|NCT02393248|79409814|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402359|NCT02393248|79409815|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402360|NCT02393248|79409816|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402361|NCT02393248|79409817|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402362|NCT02393248|79409818|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402363|NCT02393248|79409819|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402364|NCT02393248|79409820|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
44402365|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402366|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44522169|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522170|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522171|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522172|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522173|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
44402367|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402368|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402369|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402370|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402371|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402372|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402373|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402374|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402375|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44522174|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44402376|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402377|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402378|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402379|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402380|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402381|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402382|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402383|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
44402384|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402385|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
44402386|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
44402387|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402388|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
44402389|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
44402390|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Death|0|||
44402391|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Death|0|||
44402392|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Death|0|||
44402393|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Death|0|||
44402394|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Death|0|||
44402395|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Death|0|||
44402396|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Death|0|||
44402397|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Death|0|||
44402398|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Death|0|||
44402399|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Death|0|||
44402400|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Death|0|||
44402401|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Death|0|||
44402402|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Death|0|||
44402403|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Death|0|||
44402404|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Death|0|||
44402405|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Death|1|||
44402406|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Death|7|||
44402407|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Death|5|||
44402408|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Death|5|||
44402409|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Death|3|||
44402410|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Death|7|||
44402411|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Death|5|||
44402412|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Death|6|||
44402413|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Death|3|||
44402414|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Death|0|||
44402415|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402416|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402417|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402418|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402419|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402420|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402421|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402422|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402423|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402424|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402425|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402426|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402427|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402428|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402429|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402430|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402431|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402432|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
44402433|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
44402434|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
44402435|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
44402436|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
44402437|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
44402438|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
44402439|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
44402440|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Disease Progression|0|||
44402441|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Disease Progression|0|||
44402442|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Disease Progression|0|||
44402443|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Disease Progression|0|||
44252925|NCT00089297|79091945|FG000|Overall Study|Withdrawal by Subject|12|||
44402444|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Disease Progression|0|||
44402445|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Disease Progression|0|||
44402446|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Disease Progression|0|||
44402447|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Disease Progression|0|||
44402448|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Disease Progression|0|||
44402449|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Disease Progression|0|||
44402450|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Disease Progression|0|||
44402451|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Disease Progression|0|||
44402452|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Disease Progression|0|||
44402453|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Disease Progression|0|||
44402454|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Disease Progression|0|||
44402455|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Disease Progression|0|||
44402456|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Disease Progression|0|||
44402457|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Disease Progression|0|||
44402458|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Disease Progression|0|||
44402459|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Disease Progression|0|||
44402460|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Disease Progression|2|||
44402461|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Disease Progression|1|||
44402462|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Disease Progression|0|||
44402463|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Disease Progression|0|||
44402464|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Disease Progression|0|||
44402465|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402466|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402467|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402468|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402469|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402470|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402471|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402472|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402473|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402474|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402475|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402476|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402477|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402478|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402479|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402480|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402481|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402482|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402483|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402484|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402485|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
44402486|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
44402487|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402488|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402489|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
44402490|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44522175|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
44522176|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522177|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522178|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44147614|NCT02158546|78936905|FG001|Overall Study|Site Excluded|5|||
44281692|NCT01915914|79244953|FG002|Maintenance Phase|Withdrawal by Subject|1|||
44281693|NCT01915914|79244954|FG003|Maintenance Phase|Withdrawal by Subject|0|||
44281694|NCT01915914|79244951|FG000|Maintenance Phase|Lost to Follow-up|0|||
44281695|NCT01915914|79244952|FG001|Maintenance Phase|Lost to Follow-up|4|||
44281696|NCT01915914|79244953|FG002|Maintenance Phase|Lost to Follow-up|1|||
44281697|NCT01915914|79244954|FG003|Maintenance Phase|Lost to Follow-up|0|||
44281698|NCT01915914|79244951|FG000|Maintenance Phase|Missing|0|||
44281699|NCT01915914|79244952|FG001|Maintenance Phase|Missing|1|||
44281700|NCT01915914|79244953|FG002|Maintenance Phase|Missing|0|||
44147615|NCT02158546|78936906|FG002|Overall Study|Site Excluded|3|||
44147616|NCT02158546|78936907|FG003|Overall Study|Site Excluded|4|||
44147617|NCT02123446|78936917|FG000|Washout Period (1 Day)|Physician Decision|1|||
44147618|NCT02123446|78936918|FG001|Washout Period (1 Day)|Physician Decision|0|||
44147619|NCT02123134|78936926|FG000|Overall Study|Withdrawal of consent|3|||
44147620|NCT02123134|78936927|FG001|Overall Study|Withdrawal of consent|2|||
44281701|NCT01915914|79244954|FG003|Maintenance Phase|Missing|0|||
44147621|NCT02123134|78936926|FG000|Overall Study|Administrative decision|0|||
44147622|NCT02123134|78936927|FG001|Overall Study|Administrative decision|1|||
44147623|NCT02185534|78936939|FG000|First Period|Withdrawal by Subject|0|||
44281702|NCT01915914|79244951|FG000|Follow-up Phase|Withdrawal by Subject|0|||
44147624|NCT02185534|78936940|FG001|First Period|Withdrawal by Subject|0|||
44147625|NCT02185534|78936941|FG002|First Period|Withdrawal by Subject|0|||
44147626|NCT02185534|78936942|FG003|First Period|Withdrawal by Subject|1|||
44147627|NCT02185534|78936943|FG004|First Period|Withdrawal by Subject|0|||
44147628|NCT02185534|78936944|FG005|First Period|Withdrawal by Subject|0|||
44147629|NCT02185534|78936939|FG000|First Washout Period|Withdrawal by Subject|1|||
44147630|NCT02185534|78936940|FG001|First Washout Period|Withdrawal by Subject|0|||
44147631|NCT02185534|78936941|FG002|First Washout Period|Withdrawal by Subject|0|||
44147632|NCT02185534|78936942|FG003|First Washout Period|Withdrawal by Subject|0|||
44147633|NCT02185534|78936943|FG004|First Washout Period|Withdrawal by Subject|1|||
44147634|NCT02185534|78936944|FG005|First Washout Period|Withdrawal by Subject|0|||
44147635|NCT02185534|78936939|FG000|First Washout Period|Protocol Violation|0|||
44147636|NCT02185534|78936940|FG001|First Washout Period|Protocol Violation|0|||
44147637|NCT02185534|78936941|FG002|First Washout Period|Protocol Violation|0|||
44147638|NCT02185534|78936942|FG003|First Washout Period|Protocol Violation|0|||
44147639|NCT02185534|78936943|FG004|First Washout Period|Protocol Violation|0|||
44147640|NCT02185534|78936944|FG005|First Washout Period|Protocol Violation|1|||
44147641|NCT02121808|78936953|FG000|Overall Study|Technical problem|3|||
44147642|NCT02157376|78936964|FG000|Overall Study|Death|10|||
44147643|NCT02157376|78936965|FG001|Overall Study|Death|4|||
44147644|NCT02157376|78936964|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44147645|NCT02157376|78936965|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44147646|NCT02157376|78936964|FG000|Overall Study|Withdrawal by Subject|3|||
44147647|NCT02157376|78936965|FG001|Overall Study|Withdrawal by Subject|8|||
44147648|NCT02157376|78936964|FG000|Overall Study|Not treated|8|||
44147649|NCT02157376|78936965|FG001|Overall Study|Not treated|3|||
44147650|NCT02157376|78936964|FG000|Overall Study|Investigator's misjudgement|1|||
44402491|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402492|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402493|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402494|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402495|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402496|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402497|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402498|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402499|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402500|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402501|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402502|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402503|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402504|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402505|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402506|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402507|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402508|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402509|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402510|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
44402511|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402512|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402513|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402514|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
44402515|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Adverse Event|0|||
44402516|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Adverse Event|0|||
44402517|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Adverse Event|0|||
44402518|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Adverse Event|0|||
44402519|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Adverse Event|0|||
44402520|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Adverse Event|0|||
44402521|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Adverse Event|0|||
44402522|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Adverse Event|0|||
44402523|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Adverse Event|0|||
44402524|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Adverse Event|0|||
44147651|NCT02157376|78936965|FG001|Overall Study|Investigator's misjudgement|2|||
44402525|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Adverse Event|0|||
44402526|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Adverse Event|0|||
44402527|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Adverse Event|0|||
44402528|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Adverse Event|0|||
44402529|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Adverse Event|0|||
44402530|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Adverse Event|0|||
44402531|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Adverse Event|0|||
44402532|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Adverse Event|0|||
44402533|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Adverse Event|0|||
44402534|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Adverse Event|0|||
44402535|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Adverse Event|0|||
44402536|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Adverse Event|0|||
44402537|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Adverse Event|0|||
44402538|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Adverse Event|1|||
44402539|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Adverse Event|0|||
44402540|NCT02393248|79409796|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402541|NCT02393248|79409797|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402542|NCT02393248|79409798|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402543|NCT02393248|79409799|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402544|NCT02393248|79409800|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402545|NCT02393248|79409801|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402546|NCT02393248|79409802|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402547|NCT02393248|79409803|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402548|NCT02393248|79409804|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402549|NCT02393248|79409805|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402550|NCT02393248|79409806|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44522179|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522180|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44147652|NCT02157298|78936973|FG000|Overall Study|Adverse Event|1|||
44147653|NCT02157298|78936974|FG001|Overall Study|Adverse Event|0|||
44147654|NCT02157298|78936973|FG000|Overall Study|Subject no longer meets study criteria|1|||
44147655|NCT02157298|78936974|FG001|Overall Study|Subject no longer meets study criteria|2|||
44147656|NCT02157298|78936973|FG000|Overall Study|Poor/Non-compliance|1|||
44147657|NCT02157298|78936974|FG001|Overall Study|Poor/Non-compliance|0|||
44147658|NCT02157298|78936973|FG000|Overall Study|Withdrawal by Subject|1|||
44147659|NCT02157298|78936974|FG001|Overall Study|Withdrawal by Subject|0|||
44147660|NCT02184988|78936980|FG000|Overall Study|Pregnancy|2|||
44147661|NCT02184988|78936980|FG000|Overall Study|Adverse Event|2|||
44147662|NCT02184988|78936980|FG000|Overall Study|moving away/travelling/unable to complet|6|||
44147663|NCT02184988|78936980|FG000|Overall Study|work scheduling issues|4|||
44147664|NCT02184988|78936980|FG000|Overall Study|various other reasons|9|||
44147665|NCT02184988|78936980|FG000|Overall Study|Lost to Follow-up|32|||
44147666|NCT02121262|78936986|FG000|Overall Study|Adverse Event|6|||
44147667|NCT02121262|78936987|FG001|Overall Study|Adverse Event|3|||
44147668|NCT02121262|78936986|FG000|Overall Study|Lack of Efficacy|3|||
44147669|NCT02121262|78936987|FG001|Overall Study|Lack of Efficacy|0|||
44147670|NCT02121262|78936986|FG000|Overall Study|Personal Reasons|19|||
44147671|NCT02121262|78936987|FG001|Overall Study|Personal Reasons|5|||
44147672|NCT02121262|78936986|FG000|Overall Study|Protocol Violation|1|||
44147673|NCT02121262|78936987|FG001|Overall Study|Protocol Violation|1|||
44147674|NCT02121262|78936986|FG000|Overall Study|Participant Dropped-out|0|||
44147675|NCT02121262|78936987|FG001|Overall Study|Participant Dropped-out|1|||
44147676|NCT02121262|78936986|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
44147677|NCT02121262|78936987|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
44147678|NCT02121262|78936986|FG000|Overall Study|Consent Withdrawn|1|||
44147679|NCT02121262|78936987|FG001|Overall Study|Consent Withdrawn|0|||
44402551|NCT02393248|79409807|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402552|NCT02393248|79409808|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402553|NCT02393248|79409809|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44147680|NCT02120950|78936995|FG000|Overall Study|Adverse Event|5|||
44147681|NCT02120950|78936996|FG001|Overall Study|Adverse Event|4|||
44147682|NCT02120950|78936997|FG002|Overall Study|Adverse Event|3|||
44147683|NCT02120950|78936995|FG000|Overall Study|Death|3|||
44147684|NCT02120950|78936996|FG001|Overall Study|Death|0|||
44147685|NCT02120950|78936997|FG002|Overall Study|Death|1|||
44147686|NCT02120950|78936995|FG000|Overall Study|Withdrawal by Subject|6|||
44147687|NCT02120950|78936996|FG001|Overall Study|Withdrawal by Subject|3|||
44147688|NCT02120950|78936997|FG002|Overall Study|Withdrawal by Subject|2|||
44147689|NCT02120950|78936995|FG000|Overall Study|Protocol Violation|1|||
44147690|NCT02120950|78936996|FG001|Overall Study|Protocol Violation|1|||
44402554|NCT02393248|79409810|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402555|NCT02393248|79409811|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402556|NCT02393248|79409812|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402557|NCT02393248|79409813|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402558|NCT02393248|79409814|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402559|NCT02393248|79409815|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402560|NCT02393248|79409816|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402561|NCT02393248|79409817|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402562|NCT02393248|79409818|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402563|NCT02393248|79409819|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
44402564|NCT02393248|79409820|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
44402565|NCT00601484|79409883|FG000|Overall Study|Adverse Event|0|||
44402566|NCT00601484|79409884|FG001|Overall Study|Adverse Event|1|||
44402567|NCT00601484|79409883|FG000|Overall Study|Lost to Follow-up|4|||
44402568|NCT00601484|79409884|FG001|Overall Study|Lost to Follow-up|3|||
44402569|NCT00601484|79409883|FG000|Overall Study|Lack of Efficacy|0|||
44402570|NCT00601484|79409884|FG001|Overall Study|Lack of Efficacy|2|||
44402571|NCT00601484|79409883|FG000|Overall Study|Withdrawal by Subject|1|||
44402572|NCT00601484|79409884|FG001|Overall Study|Withdrawal by Subject|1|||
44402573|NCT00601484|79409883|FG000|Overall Study|Randomized, but not treated|0|||
44402574|NCT00601484|79409884|FG001|Overall Study|Randomized, but not treated|1|||
44402575|NCT00883896|79409894|FG000|Overall Study|Lost to Follow-up|0|||
44402576|NCT00883896|79409895|FG001|Overall Study|Lost to Follow-up|0|||
44402577|NCT00883896|79409896|FG002|Overall Study|Lost to Follow-up|0|||
44402578|NCT00883896|79409897|FG003|Overall Study|Lost to Follow-up|2|||
44402579|NCT00883896|79409894|FG000|Overall Study|Withdrawal by Subject|5|||
44402580|NCT00883896|79409895|FG001|Overall Study|Withdrawal by Subject|0|||
44402581|NCT00883896|79409896|FG002|Overall Study|Withdrawal by Subject|1|||
44402582|NCT00883896|79409897|FG003|Overall Study|Withdrawal by Subject|3|||
44402583|NCT00883896|79409894|FG000|Overall Study|Lack of Efficacy|0|||
44402584|NCT00883896|79409895|FG001|Overall Study|Lack of Efficacy|0|||
44402585|NCT00883896|79409896|FG002|Overall Study|Lack of Efficacy|0|||
44402586|NCT00883896|79409897|FG003|Overall Study|Lack of Efficacy|2|||
44402587|NCT00883896|79409894|FG000|Overall Study|Other|1|||
44402588|NCT00883896|79409895|FG001|Overall Study|Other|0|||
44402589|NCT00883896|79409896|FG002|Overall Study|Other|0|||
44402590|NCT00883896|79409897|FG003|Overall Study|Other|0|||
44402591|NCT00867009|79409907|FG000|Induction Period|Nonserious Adverse Event|5|||
44402592|NCT00867009|79409907|FG000|Induction Period|Serious Adverse Event|10|||
44402593|NCT00867009|79409907|FG000|Induction Period|Death due to serious adverse event|6|||
44402594|NCT00867009|79409907|FG000|Induction Period|Death due to Study Disease|4|||
44402595|NCT00867009|79409907|FG000|Induction Period|Protocol Violation|1|||
44402596|NCT00867009|79409907|FG000|Induction Period|Withdrawal by Subject|8|||
44402597|NCT00867009|79409907|FG000|Induction Period|Physician Decision|3|||
44402598|NCT00867009|79409907|FG000|Induction Period|Progressive Disease (PD)|25|||
44402599|NCT00867009|79409907|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
44402600|NCT00601250|79409913|FG000|Overall Study|Adverse Event|3|||
44402601|NCT00601250|79409914|FG001|Overall Study|Adverse Event|9|||
44402602|NCT00601250|79409913|FG000|Overall Study|Protocol Violation|3|||
44402603|NCT00601250|79409914|FG001|Overall Study|Protocol Violation|2|||
44402604|NCT00601250|79409913|FG000|Overall Study|Lost to Follow-up|2|||
44402605|NCT00601250|79409914|FG001|Overall Study|Lost to Follow-up|6|||
44402606|NCT00601250|79409913|FG000|Overall Study|Withdrawal by Subject|4|||
44402607|NCT00601250|79409914|FG001|Overall Study|Withdrawal by Subject|13|||
44402608|NCT00601250|79409913|FG000|Overall Study|Other incl. lack of efficacy|2|||
44402609|NCT00601250|79409914|FG001|Overall Study|Other incl. lack of efficacy|9|||
44402610|NCT00866775|79409922|FG000|Overall Study|Adverse Event|5|||
44402611|NCT00866775|79409923|FG001|Overall Study|Adverse Event|19|||
44402612|NCT00866775|79409922|FG000|Overall Study|Death|1|||
44402613|NCT00866775|79409923|FG001|Overall Study|Death|0|||
44402614|NCT00866775|79409922|FG000|Overall Study|Lost to Follow-up|0|||
44522181|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522182|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44147691|NCT02120950|78936997|FG002|Overall Study|Protocol Violation|7|||
44252926|NCT00089297|79091945|FG000|Overall Study|Disease progression|2|||
44402615|NCT00866775|79409923|FG001|Overall Study|Lost to Follow-up|4|||
44402616|NCT00866775|79409922|FG000|Overall Study|Physician Decision|0|||
44402617|NCT00866775|79409923|FG001|Overall Study|Physician Decision|3|||
44402618|NCT00866775|79409922|FG000|Overall Study|Protocol Violation|3|||
44402619|NCT00866775|79409923|FG001|Overall Study|Protocol Violation|4|||
44402620|NCT00866775|79409922|FG000|Overall Study|Withdrawal by Subject|4|||
44402621|NCT00866775|79409923|FG001|Overall Study|Withdrawal by Subject|4|||
44402622|NCT00866775|79409922|FG000|Overall Study|met exit criteria|23|||
44402623|NCT00866775|79409923|FG001|Overall Study|met exit criteria|17|||
44402624|NCT00866775|79409922|FG000|Overall Study|discontinued due to communication error|0|||
44402625|NCT00866775|79409923|FG001|Overall Study|discontinued due to communication error|1|||
44402626|NCT03265210|79409933|FG000|Overall Study|Withdrawal by Subject|7|||
44402627|NCT03265210|79409934|FG001|Overall Study|Withdrawal by Subject|9|||
44402628|NCT03265210|79409933|FG000|Overall Study|Lost to Follow-up|2|||
44402629|NCT03265210|79409934|FG001|Overall Study|Lost to Follow-up|0|||
44402630|NCT03265210|79409933|FG000|Overall Study|Physician Decision|2|||
44402631|NCT03265210|79409934|FG001|Overall Study|Physician Decision|0|||
44402632|NCT03265210|79409933|FG000|Overall Study|Adverse Event|1|||
44402633|NCT03265210|79409934|FG001|Overall Study|Adverse Event|0|||
44402634|NCT00543985|79409940|FG000|Overall Study|Withdrawal by Subject|4|||
44402635|NCT00582556|79409955|FG000|Overall Study|Withdrawal by Subject|0|||
44402636|NCT00582556|79409956|FG001|Overall Study|Withdrawal by Subject|1|||
44402637|NCT00582556|79409957|FG002|Overall Study|Withdrawal by Subject|1|||
44402638|NCT00582556|79409955|FG000|Overall Study|Physician Decision|0|||
44402639|NCT00582556|79409956|FG001|Overall Study|Physician Decision|0|||
44402640|NCT00582556|79409957|FG002|Overall Study|Physician Decision|1|||
44402641|NCT00542269|79409969|FG000|Overall Study|Adverse Event|10|||
44402642|NCT00542269|79409970|FG001|Overall Study|Adverse Event|4|||
44402643|NCT00542269|79409971|FG002|Overall Study|Adverse Event|5|||
44402644|NCT00542269|79409969|FG000|Overall Study|Protocol Violation|1|||
44402645|NCT00542269|79409970|FG001|Overall Study|Protocol Violation|1|||
44402646|NCT00542269|79409971|FG002|Overall Study|Protocol Violation|0|||
44402647|NCT00542269|79409969|FG000|Overall Study|Withdrawal by Subject|1|||
44402648|NCT00542269|79409970|FG001|Overall Study|Withdrawal by Subject|0|||
44402649|NCT00542269|79409971|FG002|Overall Study|Withdrawal by Subject|0|||
44402650|NCT00542269|79409969|FG000|Overall Study|Administrative problems|1|||
44402651|NCT00542269|79409970|FG001|Overall Study|Administrative problems|1|||
44402652|NCT00542269|79409971|FG002|Overall Study|Administrative problems|1|||
44402653|NCT00866697|79409983|FG000|Overall Study|Study closed/terminated|156|||
44402654|NCT00866697|79409984|FG001|Overall Study|Study closed/terminated|138|||
44402655|NCT00866697|79409983|FG000|Overall Study|Lost to Follow-up|22|||
44402656|NCT00866697|79409984|FG001|Overall Study|Lost to Follow-up|28|||
44402657|NCT00866697|79409983|FG000|Overall Study|Physician Decision|3|||
44522183|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
44522184|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
44522185|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
44522186|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522187|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522188|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522189|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522190|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522191|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
44522192|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522193|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522194|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
44522195|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
44522196|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522197|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522198|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522199|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522200|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522201|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522202|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522203|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522204|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
44522205|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
44522206|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522207|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44147692|NCT02120950|78936995|FG000|Overall Study|Other reasons|5|||
44402658|NCT00866697|79409984|FG001|Overall Study|Physician Decision|5|||
44402659|NCT00866697|79409983|FG000|Overall Study|Withdrawal by Subject|33|||
44402660|NCT00866697|79409984|FG001|Overall Study|Withdrawal by Subject|57|||
44402661|NCT00542191|79409990|FG000|Overall Study|Death|3|||
44402662|NCT00600938|79409996|FG000|Core Study|Abnormal test procedure result(s)|3|||
44402663|NCT00600938|79409997|FG001|Core Study|Abnormal test procedure result(s)|2|||
44402664|NCT00600938|79409998|FG002|Core Study|Abnormal test procedure result(s)|0|||
44402665|NCT00600938|79409999|FG003|Core Study|Abnormal test procedure result(s)|0|||
44402666|NCT00600938|79409996|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
44402667|NCT00600938|79409997|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
44402668|NCT00600938|79409998|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
44402669|NCT00600938|79409999|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
44402670|NCT00600938|79409996|FG000|Core Study|Patient withdrew consent|7|||
44402671|NCT00600938|79409997|FG001|Core Study|Patient withdrew consent|12|||
44402672|NCT00600938|79409998|FG002|Core Study|Patient withdrew consent|0|||
44402673|NCT00600938|79409999|FG003|Core Study|Patient withdrew consent|0|||
44402674|NCT00600938|79409996|FG000|Core Study|Lost to Follow-up|3|||
44402675|NCT00600938|79409997|FG001|Core Study|Lost to Follow-up|2|||
44522208|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522209|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522210|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522211|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522212|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522213|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
44522214|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
44522215|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
44522216|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522217|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522218|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522219|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522220|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522221|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522222|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522223|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
44522224|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
44522225|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
44522226|NCT03352557|79530134|FG000|LTE Period: Week 80 to Week 173|Other|0|||
44522227|NCT03352557|79530135|FG001|LTE Period: Week 80 to Week 173|Other|0|||
44522228|NCT03352557|79530136|FG002|LTE Period: Week 80 to Week 173|Other|0|||
44522229|NCT03352557|79530137|FG003|LTE Period: Week 80 to Week 173|Other|0|||
44522230|NCT03352557|79530138|FG004|LTE Period: Week 80 to Week 173|Other|0|||
44522231|NCT03352557|79530139|FG005|LTE Period: Week 80 to Week 173|Other|0|||
44522232|NCT03352557|79530140|FG006|LTE Period: Week 80 to Week 173|Other|0|||
44522233|NCT03352557|79530141|FG007|LTE Period: Week 80 to Week 173|Other|1|||
44522234|NCT03352557|79530142|FG008|LTE Period: Week 80 to Week 173|Other|0|||
44522235|NCT03352557|79530143|FG009|LTE Period: Week 80 to Week 173|Other|0|||
44522236|NCT02866942|79530168|FG000|Overall Study|Invalid consent|1|||
44522237|NCT01336894|79530222|FG000|Follow-up|Study terminated prematurely|2|||
44522238|NCT01336894|79530223|FG001|Follow-up|Study terminated prematurely|7|||
44522239|NCT02572167|79530232|FG000|Overall Study|Withdrawal by Subject|0|||
44522240|NCT02572167|79530233|FG001|Overall Study|Withdrawal by Subject|3|||
44522241|NCT02572167|79530234|FG002|Overall Study|Withdrawal by Subject|0|||
44522242|NCT02572167|79530232|FG000|Overall Study|Lost to Follow-up|2|||
44522243|NCT02572167|79530233|FG001|Overall Study|Lost to Follow-up|5|||
44522244|NCT02572167|79530234|FG002|Overall Study|Lost to Follow-up|3|||
44522245|NCT02572167|79530232|FG000|Overall Study|Death|0|||
44522246|NCT02572167|79530233|FG001|Overall Study|Death|8|||
44522247|NCT02572167|79530234|FG002|Overall Study|Death|3|||
44522248|NCT02572167|79530232|FG000|Overall Study|Did not meet inclusion criteria|0|||
44522249|NCT02572167|79530233|FG001|Overall Study|Did not meet inclusion criteria|0|||
44522250|NCT02572167|79530234|FG002|Overall Study|Did not meet inclusion criteria|1|||
44147693|NCT02120950|78936996|FG001|Overall Study|Other reasons|4|||
44147694|NCT02120950|78936997|FG002|Overall Study|Other reasons|1|||
44147695|NCT02120950|78936995|FG000|Overall Study|Lost to Follow-up|0|||
44147696|NCT02120950|78936996|FG001|Overall Study|Lost to Follow-up|2|||
44147697|NCT02120950|78936997|FG002|Overall Study|Lost to Follow-up|1|||
44147698|NCT02120794|78937004|FG000|Overall Study|Withdrawal by Subject|43|||
44147699|NCT02120794|78937004|FG000|Overall Study|Adverse Event|10|||
44147700|NCT02120794|78937004|FG000|Overall Study|Physician Decision|4|||
44147701|NCT02120794|78937004|FG000|Overall Study|Due to insurance coverage|1|||
44147702|NCT02184442|78937010|FG000|Overall Study|Death|61|||
44147703|NCT02184442|78937011|FG001|Overall Study|Death|65|||
44402676|NCT00600938|79409998|FG002|Core Study|Lost to Follow-up|0|||
44522251|NCT02572167|79530232|FG000|Overall Study|Study closure by Sponsor|4|||
44522252|NCT02572167|79530233|FG001|Overall Study|Study closure by Sponsor|40|||
44522253|NCT02572167|79530234|FG002|Overall Study|Study closure by Sponsor|24|||
44522254|NCT01336738|79530248|FG000|Overall Study|Adverse Event|0|||
44402677|NCT00600938|79409999|FG003|Core Study|Lost to Follow-up|0|||
44522255|NCT01336738|79530249|FG001|Overall Study|Adverse Event|3|||
44522256|NCT01336738|79530250|FG002|Overall Study|Adverse Event|2|||
44522257|NCT01336738|79530251|FG003|Overall Study|Adverse Event|1|||
44522258|NCT01336738|79530252|FG004|Overall Study|Adverse Event|3|||
44402678|NCT00600938|79409996|FG000|Core Study|Death|1|||
44402679|NCT00600938|79409997|FG001|Core Study|Death|1|||
44402680|NCT00600938|79409998|FG002|Core Study|Death|0|||
44402681|NCT00600938|79409999|FG003|Core Study|Death|0|||
44402682|NCT00600938|79409996|FG000|Core Study|Protocol Violation|1|||
44402683|NCT00600938|79409997|FG001|Core Study|Protocol Violation|2|||
44402684|NCT00600938|79409998|FG002|Core Study|Protocol Violation|0|||
44402685|NCT00600938|79409999|FG003|Core Study|Protocol Violation|0|||
44402686|NCT00600938|79409996|FG000|Extension Study|Adverse Event|1|||
44402687|NCT00600938|79409997|FG001|Extension Study|Adverse Event|0|||
44402688|NCT00600938|79409998|FG002|Extension Study|Adverse Event|2|||
44402689|NCT00600938|79409999|FG003|Extension Study|Adverse Event|0|||
44402690|NCT00600938|79409996|FG000|Extension Study|Abnormal test procedure results|0|||
44402691|NCT00600938|79409997|FG001|Extension Study|Abnormal test procedure results|1|||
44402692|NCT00600938|79409998|FG002|Extension Study|Abnormal test procedure results|1|||
44402693|NCT00600938|79409999|FG003|Extension Study|Abnormal test procedure results|1|||
44402694|NCT00600938|79409996|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
44522259|NCT01336738|79530248|FG000|Overall Study|Lost to Follow-up|2|||
44522260|NCT01336738|79530249|FG001|Overall Study|Lost to Follow-up|1|||
44402695|NCT00600938|79409997|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
44402696|NCT00600938|79409998|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
44402697|NCT00600938|79409999|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
44402698|NCT00600938|79409996|FG000|Extension Study|Withdrawal by Subject|2|||
44402699|NCT00600938|79409997|FG001|Extension Study|Withdrawal by Subject|2|||
44402700|NCT00600938|79409998|FG002|Extension Study|Withdrawal by Subject|3|||
44402701|NCT00600938|79409999|FG003|Extension Study|Withdrawal by Subject|0|||
44402702|NCT00600938|79409996|FG000|Extension Study|Lost to Follow-up|1|||
44402703|NCT00600938|79409997|FG001|Extension Study|Lost to Follow-up|1|||
44402704|NCT00600938|79409998|FG002|Extension Study|Lost to Follow-up|2|||
44402705|NCT00600938|79409999|FG003|Extension Study|Lost to Follow-up|0|||
44402706|NCT00600938|79409996|FG000|Extension Study|Death|1|||
44522261|NCT01336738|79530250|FG002|Overall Study|Lost to Follow-up|2|||
44522262|NCT01336738|79530251|FG003|Overall Study|Lost to Follow-up|2|||
44522263|NCT01336738|79530252|FG004|Overall Study|Lost to Follow-up|2|||
44522264|NCT01336738|79530248|FG000|Overall Study|Did not meet entrance criteria|0|||
44522265|NCT01336738|79530249|FG001|Overall Study|Did not meet entrance criteria|1|||
44522266|NCT01336738|79530250|FG002|Overall Study|Did not meet entrance criteria|0|||
44522267|NCT01336738|79530251|FG003|Overall Study|Did not meet entrance criteria|0|||
44522268|NCT01336738|79530252|FG004|Overall Study|Did not meet entrance criteria|0|||
44522269|NCT01336738|79530248|FG000|Overall Study|Protocol Violation|0|||
44522270|NCT01336738|79530249|FG001|Overall Study|Protocol Violation|1|||
44522271|NCT01336738|79530250|FG002|Overall Study|Protocol Violation|0|||
44402707|NCT00600938|79409997|FG001|Extension Study|Death|0|||
44402708|NCT00600938|79409998|FG002|Extension Study|Death|0|||
44402709|NCT00600938|79409999|FG003|Extension Study|Death|0|||
44402710|NCT00543439|79410040|FG000|Period 1|Adverse Event|0|||
44402711|NCT00543439|79410041|FG001|Period 1|Adverse Event|2|||
44522272|NCT01336738|79530251|FG003|Overall Study|Protocol Violation|0|||
44522273|NCT01336738|79530252|FG004|Overall Study|Protocol Violation|0|||
44522274|NCT01336738|79530248|FG000|Overall Study|Withdrawal by Subject|2|||
44522275|NCT01336738|79530249|FG001|Overall Study|Withdrawal by Subject|0|||
44522276|NCT01336738|79530250|FG002|Overall Study|Withdrawal by Subject|2|||
44522277|NCT01336738|79530251|FG003|Overall Study|Withdrawal by Subject|1|||
44522278|NCT01336738|79530252|FG004|Overall Study|Withdrawal by Subject|1|||
44522279|NCT01336738|79530248|FG000|Overall Study|Other|3|||
44522280|NCT01336738|79530249|FG001|Overall Study|Other|3|||
44402712|NCT00543439|79410042|FG002|Period 1|Adverse Event|1|||
44402713|NCT00543439|79410040|FG000|Period 1|Withdrawal by Subject|1|||
44402714|NCT00543439|79410041|FG001|Period 1|Withdrawal by Subject|1|||
44522281|NCT01336738|79530250|FG002|Overall Study|Other|2|||
44522282|NCT01336738|79530251|FG003|Overall Study|Other|3|||
44522283|NCT01336738|79530252|FG004|Overall Study|Other|4|||
44522284|NCT02865538|79530269|FG000|Overall Study|Withdrawal by Subject|0|||
44522285|NCT02865538|79530270|FG001|Overall Study|Withdrawal by Subject|0|||
44522286|NCT02865538|79530271|FG002|Overall Study|Withdrawal by Subject|1|||
44522287|NCT02865538|79530272|FG003|Overall Study|Withdrawal by Subject|0|||
44522288|NCT02865538|79530273|FG004|Overall Study|Withdrawal by Subject|0|||
44522289|NCT02865538|79530269|FG000|Overall Study|Lost to Follow-up|1|||
44522290|NCT02865538|79530270|FG001|Overall Study|Lost to Follow-up|0|||
44522291|NCT02865538|79530271|FG002|Overall Study|Lost to Follow-up|0|||
44522292|NCT02865538|79530272|FG003|Overall Study|Lost to Follow-up|0|||
44402715|NCT00543439|79410042|FG002|Period 1|Withdrawal by Subject|0|||
44402716|NCT00543439|79410040|FG000|Period 1|Physician Decision|0|||
44402717|NCT00543439|79410041|FG001|Period 1|Physician Decision|0|||
44402718|NCT00543439|79410042|FG002|Period 1|Physician Decision|1|||
44402719|NCT00543439|79410040|FG000|Period 2|Protocol Violation|1|||
44522293|NCT02865538|79530273|FG004|Overall Study|Lost to Follow-up|0|||
44522294|NCT02860546|79530285|FG000|Overall Study|Clinical Progression|6|||
44522295|NCT02860546|79530285|FG000|Overall Study|Radiological Progression|12|||
44522296|NCT01982955|79530294|FG000|Overall Study|Randomized but not treated|0|||
44522297|NCT01982955|79530295|FG001|Overall Study|Randomized but not treated|0|||
44522298|NCT01982955|79530296|FG002|Overall Study|Randomized but not treated|0|||
44522299|NCT01982955|79530297|FG003|Overall Study|Randomized but not treated|1|||
44522300|NCT01982955|79530298|FG004|Overall Study|Randomized but not treated|0|||
44522301|NCT00396279|79530311|FG000|Overall Study|Ongoing in study|26|||
44522302|NCT00396279|79530311|FG000|Overall Study|Disease progression|2|||
44522303|NCT00396279|79530311|FG000|Overall Study|Withdrawal by Subject|1|||
44522304|NCT00396279|79530311|FG000|Overall Study|Physician Decision|1|||
44522305|NCT01347866|79530332|FG000|Overall Study|Death|0|||
44522306|NCT01347866|79530333|FG001|Overall Study|Death|0|||
44522307|NCT01347866|79530334|FG002|Overall Study|Death|0|||
44522308|NCT01347866|79530335|FG003|Overall Study|Death|1|||
44522309|NCT01347866|79530336|FG004|Overall Study|Death|2|||
44522310|NCT01347866|79530337|FG005|Overall Study|Death|2|||
44522311|NCT01347866|79530338|FG006|Overall Study|Death|1|||
44522312|NCT01347866|79530339|FG007|Overall Study|Death|0|||
44522313|NCT01347866|79530340|FG008|Overall Study|Death|4|||
44522314|NCT01347866|79530341|FG009|Overall Study|Death|1|||
44522315|NCT01347866|79530342|FG010|Overall Study|Death|3|||
44522316|NCT01347866|79530343|FG011|Overall Study|Death|1|||
44522317|NCT01347866|79530344|FG012|Overall Study|Death|2|||
44522318|NCT01347866|79530345|FG013|Overall Study|Death|0|||
44402720|NCT00543439|79410041|FG001|Period 2|Protocol Violation|0|||
44402721|NCT00543439|79410042|FG002|Period 2|Protocol Violation|1|||
44402722|NCT00543439|79410040|FG000|Period 2|Adverse Event|0|||
44402723|NCT00543439|79410041|FG001|Period 2|Adverse Event|1|||
44402724|NCT00543439|79410042|FG002|Period 2|Adverse Event|1|||
44402725|NCT00582166|79410059|FG000|Overall Study|Death|1|||
44402726|NCT00582166|79410059|FG000|Overall Study|Ineligible pathology|1|||
44402727|NCT00601172|79410065|FG000|Overall Study|Adverse Event|43|||
44402728|NCT00601172|79410066|FG001|Overall Study|Adverse Event|32|||
44402729|NCT00601172|79410065|FG000|Overall Study|Lack of Efficacy|11|||
44402730|NCT00601172|79410066|FG001|Overall Study|Lack of Efficacy|12|||
44402731|NCT00601172|79410065|FG000|Overall Study|Protocol Violation|2|||
44402732|NCT00601172|79410066|FG001|Overall Study|Protocol Violation|5|||
44402733|NCT00601172|79410065|FG000|Overall Study|Lost to Follow-up|4|||
44402734|NCT00601172|79410066|FG001|Overall Study|Lost to Follow-up|3|||
44402735|NCT00601172|79410065|FG000|Overall Study|Physician Decision|27|||
44402736|NCT00601172|79410066|FG001|Overall Study|Physician Decision|28|||
44402737|NCT00601172|79410065|FG000|Overall Study|Withdrawal by Subject|35|||
44402738|NCT00601172|79410066|FG001|Overall Study|Withdrawal by Subject|27|||
44402739|NCT00601172|79410065|FG000|Overall Study|Did not meet continuation criteria|19|||
44402740|NCT00601172|79410066|FG001|Overall Study|Did not meet continuation criteria|20|||
44402741|NCT00582010|79410075|FG000|Overall Study|Death|0|||
44402742|NCT00582010|79410076|FG001|Overall Study|Death|1|||
44402743|NCT02771795|79410084|FG000|Overall Study|Withdrawal by Subject|47|||
44402744|NCT02771795|79410085|FG001|Overall Study|Withdrawal by Subject|37|||
44402745|NCT02771795|79410084|FG000|Overall Study|Termination by premature discontinuation of study|168|||
44402746|NCT02771795|79410085|FG001|Overall Study|Termination by premature discontinuation of study|185|||
44402747|NCT00580840|79410091|FG000|Run-in|Adverse Event|17|||
44402748|NCT00580840|79410092|FG001|Run-in|Adverse Event|0|||
44402749|NCT00580840|79410093|FG002|Run-in|Adverse Event|0|||
44402750|NCT00580840|79410094|FG003|Run-in|Adverse Event|0|||
44402751|NCT00580840|79410091|FG000|Run-in|Lack of Efficacy|93|||
44402752|NCT00580840|79410092|FG001|Run-in|Lack of Efficacy|0|||
44402753|NCT00580840|79410093|FG002|Run-in|Lack of Efficacy|0|||
44402754|NCT00580840|79410094|FG003|Run-in|Lack of Efficacy|0|||
44402755|NCT00580840|79410091|FG000|Run-in|Loss of Efficacy|1|||
44402756|NCT00580840|79410092|FG001|Run-in|Loss of Efficacy|0|||
44522319|NCT01347866|79530346|FG014|Overall Study|Death|0|||
44522320|NCT01347866|79530347|FG015|Overall Study|Death|1|||
44522321|NCT01347866|79530348|FG016|Overall Study|Death|0|||
44402757|NCT00580840|79410093|FG002|Run-in|Loss of Efficacy|0|||
44402758|NCT00580840|79410094|FG003|Run-in|Loss of Efficacy|0|||
44402759|NCT00580840|79410091|FG000|Run-in|Lost to Follow-up|4|||
44522322|NCT01347866|79530332|FG000|Overall Study|Lost to Follow-up|0|||
44522323|NCT01347866|79530333|FG001|Overall Study|Lost to Follow-up|0|||
44252927|NCT00089297|79091945|FG000|Overall Study|Ineligible|11|||
44402760|NCT00580840|79410092|FG001|Run-in|Lost to Follow-up|0|||
44402761|NCT00580840|79410093|FG002|Run-in|Lost to Follow-up|0|||
44402762|NCT00580840|79410094|FG003|Run-in|Lost to Follow-up|0|||
44522324|NCT01347866|79530334|FG002|Overall Study|Lost to Follow-up|0|||
44522325|NCT01347866|79530335|FG003|Overall Study|Lost to Follow-up|0|||
44402763|NCT00580840|79410091|FG000|Run-in|Withdrawal by Subject|5|||
44402764|NCT00580840|79410092|FG001|Run-in|Withdrawal by Subject|0|||
44522326|NCT01347866|79530336|FG004|Overall Study|Lost to Follow-up|0|||
44522327|NCT01347866|79530337|FG005|Overall Study|Lost to Follow-up|0|||
44402765|NCT00580840|79410093|FG002|Run-in|Withdrawal by Subject|0|||
44402766|NCT00580840|79410094|FG003|Run-in|Withdrawal by Subject|0|||
44402767|NCT00580840|79410091|FG000|Run-in|Other: Per Sponsor Request|2|||
44402768|NCT00580840|79410092|FG001|Run-in|Other: Per Sponsor Request|0|||
44402769|NCT00580840|79410093|FG002|Run-in|Other: Per Sponsor Request|0|||
44402770|NCT00580840|79410094|FG003|Run-in|Other: Per Sponsor Request|0|||
44402771|NCT00580840|79410091|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
44402772|NCT00580840|79410092|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
44402773|NCT00580840|79410093|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
44402774|NCT00580840|79410094|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
44402775|NCT00580840|79410091|FG000|Run-in|Other: Exclusionary Lab Value|1|||
44402776|NCT00580840|79410092|FG001|Run-in|Other: Exclusionary Lab Value|0|||
44402777|NCT00580840|79410093|FG002|Run-in|Other: Exclusionary Lab Value|0|||
44402778|NCT00580840|79410094|FG003|Run-in|Other: Exclusionary Lab Value|0|||
44402779|NCT00580840|79410091|FG000|Double-Blind|Adverse Event|0|||
44402780|NCT00580840|79410092|FG001|Double-Blind|Adverse Event|3|||
44402781|NCT00580840|79410093|FG002|Double-Blind|Adverse Event|4|||
44402782|NCT00580840|79410094|FG003|Double-Blind|Adverse Event|1|||
44402783|NCT00580840|79410091|FG000|Double-Blind|Loss of Efficacy|0|||
44402784|NCT00580840|79410092|FG001|Double-Blind|Loss of Efficacy|1|||
44402785|NCT00580840|79410093|FG002|Double-Blind|Loss of Efficacy|2|||
44402786|NCT00580840|79410094|FG003|Double-Blind|Loss of Efficacy|10|||
44402787|NCT00580840|79410091|FG000|Double-Blind|Lost to Follow-up|0|||
44402788|NCT00580840|79410092|FG001|Double-Blind|Lost to Follow-up|1|||
44147704|NCT02184442|78937010|FG000|Overall Study|Withdrawal by Subject|3|||
44147705|NCT02184442|78937011|FG001|Overall Study|Withdrawal by Subject|11|||
44402789|NCT00580840|79410093|FG002|Double-Blind|Lost to Follow-up|0|||
44402790|NCT00580840|79410094|FG003|Double-Blind|Lost to Follow-up|2|||
44402791|NCT00580840|79410091|FG000|Double-Blind|Withdrawal by Subject|0|||
44402792|NCT00580840|79410092|FG001|Double-Blind|Withdrawal by Subject|1|||
44402793|NCT00580840|79410093|FG002|Double-Blind|Withdrawal by Subject|2|||
44402794|NCT00580840|79410094|FG003|Double-Blind|Withdrawal by Subject|2|||
44402795|NCT00580840|79410091|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
44402796|NCT00580840|79410092|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
44402797|NCT00580840|79410093|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
44402798|NCT00580840|79410094|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
44402799|NCT00580840|79410091|FG000|Double-Blind|Other: Forbidden Medication|0|||
44402800|NCT00580840|79410092|FG001|Double-Blind|Other: Forbidden Medication|0|||
44402801|NCT00580840|79410093|FG002|Double-Blind|Other: Forbidden Medication|1|||
44402802|NCT00580840|79410094|FG003|Double-Blind|Other: Forbidden Medication|0|||
44402803|NCT00879684|79410104|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
44402804|NCT00879684|79410105|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
44402805|NCT00879684|79410106|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
44402806|NCT00879684|79410107|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
44402807|NCT00879684|79410108|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
44402808|NCT00879684|79410109|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
44402809|NCT00879684|79410110|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
44402810|NCT00879684|79410104|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
44402811|NCT00879684|79410105|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
44402812|NCT00879684|79410106|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
44402813|NCT00879684|79410107|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
44402814|NCT00879684|79410108|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
44402815|NCT00879684|79410109|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
44402816|NCT00879684|79410110|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
44402817|NCT00879684|79410104|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
44402818|NCT00879684|79410105|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
44402819|NCT00879684|79410106|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
44522328|NCT01347866|79530338|FG006|Overall Study|Lost to Follow-up|0|||
44522329|NCT01347866|79530339|FG007|Overall Study|Lost to Follow-up|1|||
44522330|NCT01347866|79530340|FG008|Overall Study|Lost to Follow-up|1|||
44522331|NCT01347866|79530341|FG009|Overall Study|Lost to Follow-up|0|||
44402820|NCT00879684|79410107|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
44522332|NCT01347866|79530342|FG010|Overall Study|Lost to Follow-up|0|||
44522333|NCT01347866|79530343|FG011|Overall Study|Lost to Follow-up|0|||
44522334|NCT01347866|79530344|FG012|Overall Study|Lost to Follow-up|0|||
44402821|NCT00879684|79410108|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
44402822|NCT00879684|79410109|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
44402823|NCT00879684|79410110|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
44402824|NCT00879684|79410104|FG000|Stage 1: Dose Escalation|Death|0|||
44402825|NCT00879684|79410105|FG001|Stage 1: Dose Escalation|Death|0|||
44402826|NCT00879684|79410106|FG002|Stage 1: Dose Escalation|Death|1|||
44402827|NCT00879684|79410107|FG003|Stage 1: Dose Escalation|Death|0|||
44402828|NCT00879684|79410108|FG004|Stage 1: Dose Escalation|Death|0|||
44402829|NCT00879684|79410109|FG005|Stage 1: Dose Escalation|Death|0|||
44402830|NCT00879684|79410110|FG006|Stage 1: Dose Escalation|Death|0|||
44522335|NCT01347866|79530345|FG013|Overall Study|Lost to Follow-up|0|||
44522336|NCT01347866|79530346|FG014|Overall Study|Lost to Follow-up|0|||
44522337|NCT01347866|79530347|FG015|Overall Study|Lost to Follow-up|0|||
44522338|NCT01347866|79530348|FG016|Overall Study|Lost to Follow-up|0|||
44522339|NCT01347866|79530332|FG000|Overall Study|Other|3|||
44522340|NCT01347866|79530333|FG001|Overall Study|Other|1|||
44522341|NCT01347866|79530334|FG002|Overall Study|Other|1|||
44522342|NCT01347866|79530335|FG003|Overall Study|Other|4|||
44522343|NCT01347866|79530336|FG004|Overall Study|Other|5|||
44522344|NCT01347866|79530337|FG005|Overall Study|Other|0|||
44522345|NCT01347866|79530338|FG006|Overall Study|Other|5|||
44522346|NCT01347866|79530339|FG007|Overall Study|Other|3|||
44281703|NCT01915914|79244952|FG001|Follow-up Phase|Withdrawal by Subject|0|||
44402831|NCT00879684|79410104|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
44402832|NCT00879684|79410105|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
44281704|NCT01915914|79244953|FG002|Follow-up Phase|Withdrawal by Subject|0|||
44281705|NCT01915914|79244954|FG003|Follow-up Phase|Withdrawal by Subject|1|||
44281706|NCT01915914|79244951|FG000|Follow-up Phase|Physician Decision|0|||
44281707|NCT01915914|79244952|FG001|Follow-up Phase|Physician Decision|0|||
44281708|NCT01915914|79244953|FG002|Follow-up Phase|Physician Decision|0|||
44281709|NCT01915914|79244954|FG003|Follow-up Phase|Physician Decision|1|||
44281710|NCT01919970|79244974|FG000|Overall Study|Withdrawal by Subject|3|||
44281711|NCT01919970|79244975|FG001|Overall Study|Withdrawal by Subject|0|||
44281712|NCT01919814|79244981|FG000|Overall Study|Adverse Event|1|||
44281713|NCT01919814|79244982|FG001|Overall Study|Adverse Event|0|||
44281714|NCT01919814|79244981|FG000|Overall Study|Protocol Violation|1|||
44281715|NCT01919814|79244982|FG001|Overall Study|Protocol Violation|0|||
44281716|NCT01919814|79244981|FG000|Overall Study|Withdrawal by Subject|1|||
44281717|NCT01919814|79244982|FG001|Overall Study|Withdrawal by Subject|0|||
44281718|NCT01968954|79244990|FG000|Overall Study|Adverse Event|6|||
44281719|NCT01968954|79244991|FG001|Overall Study|Adverse Event|3|||
44281720|NCT01968954|79244990|FG000|Overall Study|Death|1|||
44281721|NCT01968954|79244991|FG001|Overall Study|Death|2|||
44281722|NCT01968954|79244990|FG000|Overall Study|Lost to Follow-up|6|||
44281723|NCT01968954|79244991|FG001|Overall Study|Lost to Follow-up|4|||
44281724|NCT01968954|79244990|FG000|Overall Study|Withdrawal by Subject|20|||
44281725|NCT01968954|79244991|FG001|Overall Study|Withdrawal by Subject|23|||
44281726|NCT01968954|79244990|FG000|Overall Study|Other|7|||
44281727|NCT01968954|79244991|FG001|Overall Study|Other|8|||
44281728|NCT01968954|79244990|FG000|Overall Study|Protocol Violation|0|||
44281729|NCT01968954|79244991|FG001|Overall Study|Protocol Violation|1|||
44281730|NCT01968954|79244990|FG000|Overall Study|Did not met inclusion criteria|0|||
44281731|NCT01968954|79244991|FG001|Overall Study|Did not met inclusion criteria|2|||
44281732|NCT01919190|79245000|FG000|Overall Study|Intra-op findings, etc.|3|||
44281733|NCT01919190|79245001|FG001|Overall Study|Intra-op findings, etc.|0|||
44281734|NCT01620060|79245008|FG000|Overall Study|Adverse Event|9|||
44281735|NCT01620060|79245008|FG000|Overall Study|Protocol Violation|1|||
44281736|NCT01620060|79245008|FG000|Overall Study|Withdrawal by Subject|1|||
44281737|NCT01620060|79245008|FG000|Overall Study|Did not comply with Study Produre|1|||
44281738|NCT01620060|79245008|FG000|Overall Study|Family emergency|1|||
44281739|NCT01620060|79245008|FG000|Overall Study|Per Sponsor Decision|2|||
44281740|NCT01914666|79245015|FG000|Treatment Period|Lack of Efficacy|0|||
44281741|NCT01914666|79245016|FG001|Treatment Period|Lack of Efficacy|0|||
44281742|NCT01914666|79245017|FG002|Treatment Period|Lack of Efficacy|2|||
44281743|NCT01914666|79245015|FG000|Treatment Period|Adverse Event|10|||
44281744|NCT01914666|79245016|FG001|Treatment Period|Adverse Event|4|||
44281745|NCT01914666|79245017|FG002|Treatment Period|Adverse Event|2|||
44281746|NCT01914666|79245015|FG000|Treatment Period|Withdrawal by Subject|3|||
44281747|NCT01914666|79245016|FG001|Treatment Period|Withdrawal by Subject|2|||
44281748|NCT01914666|79245017|FG002|Treatment Period|Withdrawal by Subject|2|||
44402833|NCT00879684|79410106|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
44402834|NCT00879684|79410107|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
44402835|NCT00879684|79410108|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
44522347|NCT01347866|79530340|FG008|Overall Study|Other|22|||
44281749|NCT01914666|79245015|FG000|Treatment Period|Physician Decision|0|||
44281750|NCT01914666|79245016|FG001|Treatment Period|Physician Decision|0|||
44281751|NCT01914666|79245017|FG002|Treatment Period|Physician Decision|2|||
44522348|NCT01347866|79530341|FG009|Overall Study|Other|5|||
44522349|NCT01347866|79530342|FG010|Overall Study|Other|0|||
44522350|NCT01347866|79530343|FG011|Overall Study|Other|3|||
44522351|NCT01347866|79530344|FG012|Overall Study|Other|4|||
44281752|NCT01913340|79245025|FG000|Overall Study|Death|2|||
44281753|NCT01913340|79245026|FG001|Overall Study|Death|5|||
44281754|NCT01913340|79245025|FG000|Overall Study|Lost to Follow-up|1|||
44281755|NCT01913340|79245026|FG001|Overall Study|Lost to Follow-up|1|||
44281756|NCT01864200|79245034|FG000|Overall Study|Lost to Follow-up|1|||
44281757|NCT01864200|79245035|FG001|Overall Study|Lost to Follow-up|3|||
44402836|NCT00879684|79410109|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
44522352|NCT01347866|79530345|FG013|Overall Study|Other|4|||
44522353|NCT01347866|79530346|FG014|Overall Study|Other|2|||
44402837|NCT00879684|79410110|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
44402838|NCT00879684|79410104|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
44402839|NCT00879684|79410105|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
44402840|NCT00879684|79410106|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
44402841|NCT00879684|79410107|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
44402842|NCT00879684|79410108|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
44402843|NCT00879684|79410109|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
44402844|NCT00879684|79410110|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
44402845|NCT00879684|79410104|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
44402846|NCT00879684|79410105|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
44402847|NCT00879684|79410106|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
44402848|NCT00879684|79410107|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
44402849|NCT00879684|79410108|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
44402850|NCT00879684|79410109|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
44402851|NCT00879684|79410110|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
44402852|NCT00581776|79410129|FG000|Overall Study|Disease progression or no response|3|||
44402853|NCT00883740|79410133|FG000|First Intervention|Lost to Follow-up|1|||
44402854|NCT00883740|79410134|FG001|First Intervention|Lost to Follow-up|0|||
44402855|NCT00883740|79410133|FG000|First Intervention|No longer willing to participate|2|||
44402856|NCT00883740|79410134|FG001|First Intervention|No longer willing to participate|0|||
44402857|NCT00883740|79410133|FG000|First Intervention|Protocol Violation|3|||
44402858|NCT00883740|79410134|FG001|First Intervention|Protocol Violation|6|||
44402859|NCT00883740|79410133|FG000|First Intervention|Adverse Event|1|||
44402860|NCT00883740|79410134|FG001|First Intervention|Adverse Event|2|||
44402861|NCT00883740|79410133|FG000|Second Intervention|Protocol Violation|1|||
44402862|NCT00883740|79410134|FG001|Second Intervention|Protocol Violation|0|||
44402863|NCT00883740|79410133|FG000|Second Intervention|No longer willing to participate|0|||
44402864|NCT00883740|79410134|FG001|Second Intervention|No longer willing to participate|1|||
44402865|NCT00597012|79410142|FG000|Overall Study|Death|1|||
44402866|NCT00597012|79410143|FG001|Overall Study|Death|1|||
44402867|NCT00597012|79410142|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
44402868|NCT00597012|79410143|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
44402869|NCT00597012|79410142|FG000|Overall Study|Withdrawal by Subject|7|||
44402870|NCT00597012|79410143|FG001|Overall Study|Withdrawal by Subject|4|||
44402871|NCT00597012|79410142|FG000|Overall Study|Ineligible|2|||
44402872|NCT00597012|79410143|FG001|Overall Study|Ineligible|0|||
44402873|NCT00597012|79410142|FG000|Overall Study|Lost to Follow-up|0|||
44402874|NCT00597012|79410143|FG001|Overall Study|Lost to Follow-up|2|||
44402875|NCT00542815|79410154|FG000|Overall Study|Adverse Event|19|||
44402876|NCT00542815|79410155|FG001|Overall Study|Adverse Event|6|||
44402877|NCT00542815|79410156|FG002|Overall Study|Adverse Event|9|||
44402878|NCT00542815|79410154|FG000|Overall Study|Death|10|||
44402879|NCT00542815|79410155|FG001|Overall Study|Death|7|||
44402880|NCT00542815|79410156|FG002|Overall Study|Death|3|||
44402881|NCT00542815|79410154|FG000|Overall Study|Lack of Efficacy|9|||
44402882|NCT00542815|79410155|FG001|Overall Study|Lack of Efficacy|2|||
44402883|NCT00542815|79410156|FG002|Overall Study|Lack of Efficacy|0|||
44402884|NCT00542815|79410154|FG000|Overall Study|Physician Decision|2|||
44402885|NCT00542815|79410155|FG001|Overall Study|Physician Decision|1|||
44402886|NCT00542815|79410156|FG002|Overall Study|Physician Decision|0|||
44402887|NCT00542815|79410154|FG000|Overall Study|Protocol Violation|1|||
44402888|NCT00542815|79410155|FG001|Overall Study|Protocol Violation|1|||
44402889|NCT00542815|79410156|FG002|Overall Study|Protocol Violation|2|||
44402890|NCT00542815|79410154|FG000|Overall Study|Withdrawal by Subject|41|||
44402891|NCT00542815|79410155|FG001|Overall Study|Withdrawal by Subject|5|||
44402892|NCT00542815|79410156|FG002|Overall Study|Withdrawal by Subject|8|||
44402893|NCT00542815|79410154|FG000|Overall Study|Other reasons|24|||
44402894|NCT00542815|79410155|FG001|Overall Study|Other reasons|10|||
44402895|NCT00542815|79410156|FG002|Overall Study|Other reasons|10|||
44402896|NCT00542425|79410169|FG000|Initial 24 Weeks|Administrative reasons|0|||
44402897|NCT00542425|79410170|FG001|Initial 24 Weeks|Administrative reasons|0|||
44402898|NCT00542425|79410171|FG002|Initial 24 Weeks|Administrative reasons|1|||
44402899|NCT00542425|79410172|FG003|Initial 24 Weeks|Administrative reasons|1|||
44402900|NCT00542425|79410173|FG004|Initial 24 Weeks|Administrative reasons|0|||
44402901|NCT00542425|79410169|FG000|Initial 24 Weeks|Adverse Event|0|||
44402902|NCT00542425|79410170|FG001|Initial 24 Weeks|Adverse Event|1|||
44402903|NCT00542425|79410171|FG002|Initial 24 Weeks|Adverse Event|1|||
44402904|NCT00542425|79410172|FG003|Initial 24 Weeks|Adverse Event|3|||
44402905|NCT00542425|79410173|FG004|Initial 24 Weeks|Adverse Event|2|||
44402906|NCT00542425|79410169|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
44402907|NCT00542425|79410170|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
44402908|NCT00542425|79410171|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
44522354|NCT01347866|79530347|FG015|Overall Study|Other|3|||
44522355|NCT01347866|79530348|FG016|Overall Study|Other|0|||
44522356|NCT01347866|79530332|FG000|Overall Study|Subject refused further follow-up|2|||
44402909|NCT00542425|79410172|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
44402910|NCT00542425|79410173|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
44402911|NCT00542425|79410169|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
44402912|NCT00542425|79410170|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
44402913|NCT00542425|79410171|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
44402914|NCT00542425|79410172|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
44402915|NCT00542425|79410173|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
44522357|NCT01347866|79530333|FG001|Overall Study|Subject refused further follow-up|0|||
44522358|NCT01347866|79530334|FG002|Overall Study|Subject refused further follow-up|0|||
44522359|NCT01347866|79530335|FG003|Overall Study|Subject refused further follow-up|2|||
44522360|NCT01347866|79530336|FG004|Overall Study|Subject refused further follow-up|0|||
44522361|NCT01347866|79530337|FG005|Overall Study|Subject refused further follow-up|1|||
44522362|NCT01347866|79530338|FG006|Overall Study|Subject refused further follow-up|0|||
44522363|NCT01347866|79530339|FG007|Overall Study|Subject refused further follow-up|0|||
44522364|NCT01347866|79530340|FG008|Overall Study|Subject refused further follow-up|4|||
44522365|NCT01347866|79530341|FG009|Overall Study|Subject refused further follow-up|1|||
44522366|NCT01347866|79530342|FG010|Overall Study|Subject refused further follow-up|0|||
44402916|NCT00542425|79410169|FG000|Initial 24 Weeks|Non-compliance|0|||
44402917|NCT00542425|79410170|FG001|Initial 24 Weeks|Non-compliance|0|||
44402918|NCT00542425|79410171|FG002|Initial 24 Weeks|Non-compliance|0|||
44402919|NCT00542425|79410172|FG003|Initial 24 Weeks|Non-compliance|1|||
44402920|NCT00542425|79410173|FG004|Initial 24 Weeks|Non-compliance|1|||
44402921|NCT00542425|79410169|FG000|Initial 24 Weeks|Protocol Violation|0|||
44402922|NCT00542425|79410170|FG001|Initial 24 Weeks|Protocol Violation|0|||
44402923|NCT00542425|79410171|FG002|Initial 24 Weeks|Protocol Violation|0|||
44402924|NCT00542425|79410172|FG003|Initial 24 Weeks|Protocol Violation|1|||
44402925|NCT00542425|79410173|FG004|Initial 24 Weeks|Protocol Violation|0|||
44402926|NCT00542425|79410169|FG000|Initial 24 Weeks|Refusal of treatment|2|||
44402927|NCT00542425|79410170|FG001|Initial 24 Weeks|Refusal of treatment|2|||
44402928|NCT00542425|79410171|FG002|Initial 24 Weeks|Refusal of treatment|1|||
44402929|NCT00542425|79410172|FG003|Initial 24 Weeks|Refusal of treatment|4|||
44402930|NCT00542425|79410173|FG004|Initial 24 Weeks|Refusal of treatment|1|||
44402931|NCT00542425|79410169|FG000|Initial 24 Weeks|Other|0|||
44402932|NCT00542425|79410170|FG001|Initial 24 Weeks|Other|2|||
44402933|NCT00542425|79410171|FG002|Initial 24 Weeks|Other|1|||
44402934|NCT00542425|79410172|FG003|Initial 24 Weeks|Other|0|||
44522367|NCT01347866|79530343|FG011|Overall Study|Subject refused further follow-up|0|||
44522368|NCT01347866|79530344|FG012|Overall Study|Subject refused further follow-up|1|||
44402935|NCT00542425|79410173|FG004|Initial 24 Weeks|Other|0|||
44402936|NCT00542425|79410169|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
44402937|NCT00542425|79410170|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
44402938|NCT00542425|79410171|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
44402939|NCT00542425|79410172|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
44402940|NCT00542425|79410173|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
44402941|NCT00542425|79410169|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
44402942|NCT00542425|79410170|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
44402943|NCT00542425|79410171|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
44402944|NCT00542425|79410172|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
44402945|NCT00542425|79410173|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
44402946|NCT00542425|79410169|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
44402947|NCT00542425|79410170|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
44402948|NCT00542425|79410171|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
44402949|NCT00542425|79410172|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
44402950|NCT00542425|79410173|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
44402951|NCT00542425|79410169|FG000|Extended 24 Weeks of Treatment|Other|1|||
44402952|NCT00542425|79410170|FG001|Extended 24 Weeks of Treatment|Other|1|||
44402953|NCT00542425|79410171|FG002|Extended 24 Weeks of Treatment|Other|0|||
44402954|NCT00542425|79410172|FG003|Extended 24 Weeks of Treatment|Other|0|||
44402955|NCT00542425|79410173|FG004|Extended 24 Weeks of Treatment|Other|1|||
44402956|NCT00541099|79410185|FG000|Overall Study|Ineligible|3|||
44402957|NCT00580606|79410191|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
44402958|NCT00580606|79410192|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
44402959|NCT00580606|79410191|FG000|Open Label (OL)|Withdrawal by Subject|4|||
44402960|NCT00580606|79410192|FG001|Open Label (OL)|Withdrawal by Subject|6|||
44402961|NCT00580606|79410191|FG000|Open Label (OL)|Dosing Symptoms|0|||
44402962|NCT00580606|79410192|FG001|Open Label (OL)|Dosing Symptoms|1|||
44402963|NCT00580606|79410191|FG000|Open Label (OL)|Lost to Follow-up|0|||
44402964|NCT00580606|79410192|FG001|Open Label (OL)|Lost to Follow-up|1|||
44402965|NCT00580606|79410191|FG000|Open Label (OL)|Pregnancy|0|||
44402966|NCT00580606|79410192|FG001|Open Label (OL)|Pregnancy|1|||
44402967|NCT00580606|79410191|FG000|Open Label (OL)|Non-compliance|2|||
44402968|NCT00580606|79410192|FG001|Open Label (OL)|Non-compliance|0|||
44402969|NCT00580606|79410191|FG000|Open Label (OL)|Physician Decision|1|||
44402970|NCT00580606|79410192|FG001|Open Label (OL)|Physician Decision|1|||
44402971|NCT00580606|79410191|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
44402972|NCT00580606|79410192|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
44402973|NCT00579982|79410206|FG000|Overall Study|Adverse Event|4|||
44402974|NCT00579982|79410206|FG000|Overall Study|Protocol Violation|4|||
44402975|NCT00596466|79410210|FG000|Overall Study|Lack of Efficacy|5|||
44402976|NCT00596466|79410210|FG000|Overall Study|Adverse Event|4|||
44402977|NCT00596466|79410210|FG000|Overall Study|Withdrawal by Subject|2|||
44402978|NCT00596466|79410210|FG000|Overall Study|Protocol Violation|2|||
44402979|NCT00596466|79410210|FG000|Overall Study|Unpecified|2|||
44402980|NCT00596466|79410210|FG000|Overall Study|Enrolled, not treated|2|||
44402981|NCT00596934|79410214|FG000|Overall Study|Protocol Violation|1|||
44402982|NCT00596934|79410214|FG000|Overall Study|Withdrawal by Subject|1|||
44402983|NCT03911401|79410223|FG000|Overall Study|Adverse Event|1|||
44402984|NCT03911401|79410224|FG001|Overall Study|Adverse Event|2|||
44402985|NCT03911401|79410225|FG002|Overall Study|Adverse Event|5|||
44402986|NCT03911401|79410223|FG000|Overall Study|Lack of Efficacy|1|||
44402987|NCT03911401|79410224|FG001|Overall Study|Lack of Efficacy|1|||
44402988|NCT03911401|79410225|FG002|Overall Study|Lack of Efficacy|8|||
44402989|NCT03911401|79410223|FG000|Overall Study|Physician Decision|0|||
44402990|NCT03911401|79410224|FG001|Overall Study|Physician Decision|0|||
44402991|NCT03911401|79410225|FG002|Overall Study|Physician Decision|1|||
44402992|NCT03911401|79410223|FG000|Overall Study|Withdrawal by Subject|1|||
44402993|NCT03911401|79410224|FG001|Overall Study|Withdrawal by Subject|2|||
44402994|NCT03911401|79410225|FG002|Overall Study|Withdrawal by Subject|0|||
44402995|NCT03911401|79410223|FG000|Overall Study|Withdrawal by parent/guardian|4|||
44402996|NCT03911401|79410224|FG001|Overall Study|Withdrawal by parent/guardian|4|||
44402997|NCT03911401|79410225|FG002|Overall Study|Withdrawal by parent/guardian|11|||
44402998|NCT00579670|79410238|FG000|Overall Study|Death|1|||
44402999|NCT00579670|79410239|FG001|Overall Study|Death|0|||
44403000|NCT00579670|79410240|FG002|Overall Study|Death|0|||
44403001|NCT00579670|79410241|FG003|Overall Study|Death|0|||
44403002|NCT00579670|79410242|FG004|Overall Study|Death|0|||
44403003|NCT00579670|79410238|FG000|Overall Study|Adverse Event|1|||
44403004|NCT00579670|79410239|FG001|Overall Study|Adverse Event|0|||
44403005|NCT00579670|79410240|FG002|Overall Study|Adverse Event|1|||
44403006|NCT00579670|79410241|FG003|Overall Study|Adverse Event|2|||
44403007|NCT00579670|79410242|FG004|Overall Study|Adverse Event|0|||
44403008|NCT00579670|79410238|FG000|Overall Study|Lack of Efficacy|0|||
44403009|NCT00579670|79410239|FG001|Overall Study|Lack of Efficacy|0|||
44403010|NCT00579670|79410240|FG002|Overall Study|Lack of Efficacy|1|||
44403011|NCT00579670|79410241|FG003|Overall Study|Lack of Efficacy|14|||
44403012|NCT00579670|79410242|FG004|Overall Study|Lack of Efficacy|0|||
44403013|NCT00579670|79410238|FG000|Overall Study|Lost to Follow-up|0|||
44403014|NCT00579670|79410239|FG001|Overall Study|Lost to Follow-up|1|||
44403015|NCT00579670|79410240|FG002|Overall Study|Lost to Follow-up|0|||
44403016|NCT00579670|79410241|FG003|Overall Study|Lost to Follow-up|4|||
44403017|NCT00579670|79410242|FG004|Overall Study|Lost to Follow-up|0|||
44403018|NCT00579670|79410238|FG000|Overall Study|Other|0|||
44403019|NCT00579670|79410239|FG001|Overall Study|Other|0|||
44522369|NCT01347866|79530345|FG013|Overall Study|Subject refused further follow-up|3|||
44522370|NCT01347866|79530346|FG014|Overall Study|Subject refused further follow-up|1|||
44522371|NCT01347866|79530347|FG015|Overall Study|Subject refused further follow-up|0|||
44522372|NCT01347866|79530348|FG016|Overall Study|Subject refused further follow-up|2|||
44522373|NCT01347710|79530419|FG000|Overall Study|Withdrawal by Subject|2|||
44522374|NCT01347710|79530419|FG000|Overall Study|Adverse Event|4|||
44522375|NCT01347710|79530419|FG000|Overall Study|Angio or SPECT not completed|18|||
44147706|NCT02155738|78937021|FG000|Overall Study|Missing critical information|1|||
44403020|NCT00579670|79410240|FG002|Overall Study|Other|1|||
44403021|NCT00579670|79410241|FG003|Overall Study|Other|2|||
44403022|NCT00579670|79410242|FG004|Overall Study|Other|0|||
44403023|NCT00579670|79410238|FG000|Overall Study|Withdrawal by Subject|0|||
44403024|NCT00579670|79410239|FG001|Overall Study|Withdrawal by Subject|0|||
44403025|NCT00579670|79410240|FG002|Overall Study|Withdrawal by Subject|1|||
44147707|NCT02155738|78937022|FG001|Overall Study|Missing critical information|0|||
44403026|NCT00579670|79410241|FG003|Overall Study|Withdrawal by Subject|0|||
44403027|NCT00579670|79410242|FG004|Overall Study|Withdrawal by Subject|0|||
44403028|NCT03909295|79410266|FG000|Overall Study|Adverse Event|2|||
44403029|NCT03909295|79410266|FG000|Overall Study|Study terminated by sponsor|50|||
44403030|NCT00599924|79410277|FG000|Overall Study|Lack of Efficacy|3|||
44403031|NCT00599924|79410278|FG001|Overall Study|Lack of Efficacy|5|||
44403032|NCT00599924|79410279|FG002|Overall Study|Lack of Efficacy|1|||
44403033|NCT00599924|79410280|FG003|Overall Study|Lack of Efficacy|2|||
44403034|NCT00599924|79410281|FG004|Overall Study|Lack of Efficacy|3|||
44403035|NCT00599924|79410282|FG005|Overall Study|Lack of Efficacy|2|||
44403036|NCT00599924|79410283|FG006|Overall Study|Lack of Efficacy|0|||
44403037|NCT00599924|79410277|FG000|Overall Study|Adverse Event|0|||
44403038|NCT00599924|79410278|FG001|Overall Study|Adverse Event|0|||
44403039|NCT00599924|79410279|FG002|Overall Study|Adverse Event|0|||
44403040|NCT00599924|79410280|FG003|Overall Study|Adverse Event|2|||
44403041|NCT00599924|79410281|FG004|Overall Study|Adverse Event|0|||
44403042|NCT00599924|79410282|FG005|Overall Study|Adverse Event|0|||
44147708|NCT02155738|78937023|FG002|Overall Study|Missing critical information|0|||
44147709|NCT02155738|78937024|FG003|Overall Study|Missing critical information|1|||
44252928|NCT00089297|79091945|FG000|Overall Study|Secondary malignancy|1|||
44403043|NCT00599924|79410283|FG006|Overall Study|Adverse Event|2|||
44403044|NCT00599924|79410277|FG000|Overall Study|Death|0|||
44403045|NCT00599924|79410278|FG001|Overall Study|Death|0|||
44403046|NCT00599924|79410279|FG002|Overall Study|Death|0|||
44403047|NCT00599924|79410280|FG003|Overall Study|Death|2|||
44403048|NCT00599924|79410281|FG004|Overall Study|Death|0|||
44403049|NCT00599924|79410282|FG005|Overall Study|Death|2|||
44403050|NCT00599924|79410283|FG006|Overall Study|Death|1|||
44403051|NCT00599924|79410277|FG000|Overall Study|Protocol Violation|0|||
44403052|NCT00599924|79410278|FG001|Overall Study|Protocol Violation|0|||
44403053|NCT00599924|79410279|FG002|Overall Study|Protocol Violation|0|||
44403054|NCT00599924|79410280|FG003|Overall Study|Protocol Violation|1|||
44403055|NCT00599924|79410281|FG004|Overall Study|Protocol Violation|0|||
44403056|NCT00599924|79410282|FG005|Overall Study|Protocol Violation|0|||
44403057|NCT00599924|79410283|FG006|Overall Study|Protocol Violation|0|||
44403058|NCT00599924|79410277|FG000|Overall Study|Withdrawal by Subject|0|||
44403059|NCT00599924|79410278|FG001|Overall Study|Withdrawal by Subject|0|||
44403060|NCT00599924|79410279|FG002|Overall Study|Withdrawal by Subject|1|||
44403061|NCT00599924|79410280|FG003|Overall Study|Withdrawal by Subject|0|||
44403062|NCT00599924|79410281|FG004|Overall Study|Withdrawal by Subject|1|||
44403063|NCT00599924|79410282|FG005|Overall Study|Withdrawal by Subject|0|||
44403064|NCT00599924|79410283|FG006|Overall Study|Withdrawal by Subject|0|||
44403065|NCT00599924|79410277|FG000|Overall Study|Other|0|||
44403066|NCT00599924|79410278|FG001|Overall Study|Other|0|||
44403067|NCT00599924|79410279|FG002|Overall Study|Other|0|||
44403068|NCT00599924|79410280|FG003|Overall Study|Other|1|||
44403069|NCT00599924|79410281|FG004|Overall Study|Other|2|||
44403070|NCT00599924|79410282|FG005|Overall Study|Other|0|||
44403071|NCT00599924|79410283|FG006|Overall Study|Other|2|||
44403072|NCT00581542|79410306|FG000|Overall Study|they met an exclusion criteria|2|||
44403073|NCT00581542|79410307|FG001|Overall Study|they met an exclusion criteria|2|||
44403074|NCT00581542|79410306|FG000|Overall Study|Lost to Follow-up|9|||
44403075|NCT00581542|79410307|FG001|Overall Study|Lost to Follow-up|21|||
44403076|NCT03912337|79410317|FG000|Overall Study|Withdrawal of Consent From Study|1|||
44403077|NCT03912337|79410318|FG001|Overall Study|Withdrawal of Consent From Study|0|||
44403078|NCT03912337|79410317|FG000|Overall Study|Lost to Follow-up|1|||
44403079|NCT03912337|79410318|FG001|Overall Study|Lost to Follow-up|1|||
44403080|NCT02121652|79410326|FG000|Overall Study|Lost to Follow-up|2|||
44403081|NCT02121652|79410327|FG001|Overall Study|Lost to Follow-up|1|||
44403082|NCT02121652|79410326|FG000|Overall Study|Death|1|||
44403083|NCT02121652|79410327|FG001|Overall Study|Death|0|||
44403084|NCT02121652|79410326|FG000|Overall Study|Withdrawal by Subject|3|||
44403085|NCT02121652|79410327|FG001|Overall Study|Withdrawal by Subject|3|||
44403086|NCT00595920|79410333|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
44403087|NCT00595764|79410339|FG000|Overall Study|Protocol Violation|24|||
44403088|NCT00595764|79410340|FG001|Overall Study|Protocol Violation|19|||
44403089|NCT00595764|79410339|FG000|Overall Study|Missed Medication >1 week|10|||
44403090|NCT00595764|79410340|FG001|Overall Study|Missed Medication >1 week|17|||
44403091|NCT00595764|79410339|FG000|Overall Study|Missed 3 PM visits|1|||
44403092|NCT00595764|79410340|FG001|Overall Study|Missed 3 PM visits|7|||
44403093|NCT00595764|79410339|FG000|Overall Study|Withdrawal by Subject|4|||
44403094|NCT00595764|79410340|FG001|Overall Study|Withdrawal by Subject|0|||
44403095|NCT00581308|79410360|FG000|Pre Discharge|Lost to Follow-up|1|||
44403096|NCT00581308|79410360|FG000|Pre Discharge|Device Removed|1|||
44403097|NCT00581308|79410360|FG000|Month 1|Lost to Follow-up|3|||
44403098|NCT00581308|79410360|FG000|Month 1|Withdrawal by Subject|2|||
44147710|NCT02181790|78937036|FG000|Overall Study|study terminated|2|||
44403099|NCT00581308|79410360|FG000|Month 1|Device Removed|2|||
44403100|NCT00581308|79410360|FG000|Month 1|Uknown|1|||
44403101|NCT00581308|79410360|FG000|Month 6|Lost to Follow-up|1|||
44403102|NCT00581308|79410360|FG000|Month 6|Withdrawal by Subject|2|||
44403103|NCT00581308|79410360|FG000|Month 12|Death|1|||
44403104|NCT00581308|79410360|FG000|Month 12|Lost to Follow-up|14|||
44403105|NCT00581308|79410360|FG000|Month 12|Withdrawal by Subject|3|||
44403106|NCT00581308|79410360|FG000|Month 12|Device Removed|1|||
44403107|NCT00581308|79410360|FG000|Month 12|Other|1|||
44403108|NCT00877890|79410369|FG000|Overall Study|Adverse Event|6|||
44403109|NCT00877890|79410370|FG001|Overall Study|Adverse Event|6|||
44403110|NCT00877890|79410369|FG000|Overall Study|Lost to Follow-up|5|||
44403111|NCT00877890|79410370|FG001|Overall Study|Lost to Follow-up|5|||
44403112|NCT00877890|79410369|FG000|Overall Study|Protocol Violation|0|||
44403113|NCT00877890|79410370|FG001|Overall Study|Protocol Violation|1|||
44403114|NCT00877890|79410369|FG000|Overall Study|Withdrawal of Consent|6|||
44403115|NCT00877890|79410370|FG001|Overall Study|Withdrawal of Consent|12|||
44403116|NCT00877890|79410369|FG000|Overall Study|Investigator Decision|0|||
44403117|NCT00877890|79410370|FG001|Overall Study|Investigator Decision|2|||
44403118|NCT00877890|79410369|FG000|Overall Study|Loss of Glucose Control|3|||
44403119|NCT00877890|79410370|FG001|Overall Study|Loss of Glucose Control|4|||
44403120|NCT03474679|79410380|FG000|Overall Study|Death|7|||
44403121|NCT03474679|79410380|FG000|Overall Study|Withdrawal by Subject|1|||
44403122|NCT04639219|79410446|FG000|Overall Study|Withdrawal by Subject|8|||
44403123|NCT04639219|79410446|FG000|Overall Study|Lost to Follow-up|6|||
44403124|NCT04639219|79410446|FG000|Overall Study|Death|55|||
44403125|NCT04638153|79410453|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44403126|NCT04638153|79410454|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44403127|NCT04638153|79410455|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44403128|NCT04638153|79410453|FG000|Overall Study|Study terminated by sponsor|4|||
44403129|NCT04638153|79410454|FG001|Overall Study|Study terminated by sponsor|2|||
44403130|NCT04638153|79410455|FG002|Overall Study|Study terminated by sponsor|14|||
44403131|NCT04428333|79410465|FG000|Overall Study|Physician Decision|2|||
44403132|NCT04428333|79410466|FG001|Overall Study|Physician Decision|0|||
44403133|NCT04428333|79410465|FG000|Overall Study|Withdrawal by Subject|0|||
44403134|NCT04428333|79410466|FG001|Overall Study|Withdrawal by Subject|1|||
44403135|NCT04428333|79410465|FG000|Overall Study|In Follow-Up|5|||
44403136|NCT04428333|79410466|FG001|Overall Study|In Follow-Up|10|||
44403137|NCT04428333|79410465|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
44403138|NCT04428333|79410466|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
44403139|NCT04389866|79410474|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
44403140|NCT04389866|79410475|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
44403141|NCT04276415|79410487|FG000|Overall Study|Adverse Event|0|||
44403142|NCT04276415|79410488|FG001|Overall Study|Adverse Event|0|||
44403143|NCT04276415|79410489|FG002|Overall Study|Adverse Event|0|||
44403144|NCT04276415|79410490|FG003|Overall Study|Adverse Event|3|||
44403145|NCT04276415|79410491|FG004|Overall Study|Adverse Event|0|||
44403146|NCT04276415|79410492|FG005|Overall Study|Adverse Event|0|||
44403147|NCT04276415|79410487|FG000|Overall Study|Clinical progression|1|||
44403148|NCT04276415|79410488|FG001|Overall Study|Clinical progression|1|||
44403149|NCT04276415|79410489|FG002|Overall Study|Clinical progression|0|||
44403150|NCT04276415|79410490|FG003|Overall Study|Clinical progression|0|||
44403151|NCT04276415|79410491|FG004|Overall Study|Clinical progression|1|||
44403152|NCT04276415|79410492|FG005|Overall Study|Clinical progression|0|||
44403153|NCT04276415|79410487|FG000|Overall Study|Other|0|||
44403154|NCT04276415|79410488|FG001|Overall Study|Other|0|||
44403155|NCT04276415|79410489|FG002|Overall Study|Other|0|||
44403156|NCT04276415|79410490|FG003|Overall Study|Other|1|||
44522376|NCT01347710|79530419|FG000|Overall Study|issue with vitals prior to dosing|1|||
44522377|NCT01347710|79530419|FG000|Overall Study|Lost to Follow-up|1|||
44522378|NCT01347710|79530419|FG000|Overall Study|Physician Decision|2|||
44403157|NCT04276415|79410491|FG004|Overall Study|Other|0|||
44403158|NCT04276415|79410492|FG005|Overall Study|Other|0|||
44403159|NCT04276415|79410487|FG000|Overall Study|Physician Decision|0|||
44403160|NCT04276415|79410488|FG001|Overall Study|Physician Decision|0|||
44403161|NCT04276415|79410489|FG002|Overall Study|Physician Decision|1|||
44403162|NCT04276415|79410490|FG003|Overall Study|Physician Decision|3|||
44522379|NCT01347710|79530419|FG000|Overall Study|Other|3|||
44522380|NCT03485222|79530429|FG000|Overall Study|Death|0|||
44403163|NCT04276415|79410491|FG004|Overall Study|Physician Decision|2|||
44403164|NCT04276415|79410492|FG005|Overall Study|Physician Decision|0|||
44403165|NCT04276415|79410487|FG000|Overall Study|Progressive disease|3|||
44403166|NCT04276415|79410488|FG001|Overall Study|Progressive disease|3|||
44403167|NCT04276415|79410489|FG002|Overall Study|Progressive disease|4|||
44403168|NCT04276415|79410490|FG003|Overall Study|Progressive disease|5|||
44403169|NCT04276415|79410491|FG004|Overall Study|Progressive disease|1|||
44403170|NCT04276415|79410492|FG005|Overall Study|Progressive disease|2|||
44522381|NCT03485222|79530430|FG001|Overall Study|Death|1|||
44522382|NCT03485222|79530429|FG000|Overall Study|Lost to Follow-up|2|||
44147711|NCT02181790|78937037|FG001|Overall Study|study terminated|0|||
44403171|NCT04276415|79410487|FG000|Overall Study|Withdrawal by patient|0|||
44403172|NCT04276415|79410488|FG001|Overall Study|Withdrawal by patient|0|||
44403173|NCT04276415|79410489|FG002|Overall Study|Withdrawal by patient|0|||
44522383|NCT03485222|79530430|FG001|Overall Study|Lost to Follow-up|1|||
44403174|NCT04276415|79410490|FG003|Overall Study|Withdrawal by patient|1|||
44403175|NCT04276415|79410491|FG004|Overall Study|Withdrawal by patient|2|||
44403176|NCT04276415|79410492|FG005|Overall Study|Withdrawal by patient|0|||
44403177|NCT04146909|79410524|FG000|Overall Study|Withdrawal by Subject|3|||
44281758|NCT01864200|79245034|FG000|Overall Study|Protocol Violation|1|||
44281759|NCT01864200|79245035|FG001|Overall Study|Protocol Violation|0|||
44281760|NCT01912872|79245045|FG000|Overall Study|Lost to Follow-up|2|||
44281761|NCT01912872|79245046|FG001|Overall Study|Lost to Follow-up|3|||
44281762|NCT01912872|79245047|FG002|Overall Study|Lost to Follow-up|5|||
44281763|NCT01912872|79245048|FG003|Overall Study|Lost to Follow-up|5|||
44281764|NCT01912872|79245045|FG000|Overall Study|Other unspecified|3|||
44281765|NCT01912872|79245046|FG001|Overall Study|Other unspecified|1|||
44281766|NCT01912872|79245047|FG002|Overall Study|Other unspecified|3|||
44281767|NCT01912872|79245048|FG003|Overall Study|Other unspecified|0|||
44281768|NCT01912872|79245045|FG000|Overall Study|Informed consent withdrawn|0|||
44281769|NCT01912872|79245046|FG001|Overall Study|Informed consent withdrawn|0|||
44281770|NCT01912872|79245047|FG002|Overall Study|Informed consent withdrawn|1|||
44281771|NCT01912872|79245048|FG003|Overall Study|Informed consent withdrawn|1|||
44281772|NCT01912872|79245045|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
44281773|NCT01912872|79245046|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
44281774|NCT01912872|79245047|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
44281775|NCT01912872|79245048|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
44281776|NCT01912872|79245045|FG000|Overall Study|Protocol Violation|0|||
44281777|NCT01912872|79245046|FG001|Overall Study|Protocol Violation|0|||
44281778|NCT01912872|79245047|FG002|Overall Study|Protocol Violation|1|||
44281779|NCT01912872|79245048|FG003|Overall Study|Protocol Violation|0|||
44281780|NCT01912872|79245045|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44281781|NCT01912872|79245046|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44281782|NCT01912872|79245047|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44281783|NCT01912872|79245048|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
44281784|NCT01912872|79245045|FG000|Overall Study|Withdrawal of study medication|0|||
44281785|NCT01912872|79245046|FG001|Overall Study|Withdrawal of study medication|0|||
44281786|NCT01912872|79245047|FG002|Overall Study|Withdrawal of study medication|0|||
44281787|NCT01912872|79245048|FG003|Overall Study|Withdrawal of study medication|2|||
44281788|NCT01912872|79245045|FG000|Overall Study|Missing|0|||
44281789|NCT01912872|79245046|FG001|Overall Study|Missing|0|||
44281790|NCT01912872|79245047|FG002|Overall Study|Missing|0|||
44281791|NCT01912872|79245048|FG003|Overall Study|Missing|1|||
44281792|NCT01912404|79245061|FG000|Overall Study|Due to personal reasons|1|||
44281793|NCT01912404|79245062|FG001|Overall Study|Due to personal reasons|0|||
44281794|NCT01911780|79245070|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
44281795|NCT01911780|79245071|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
44281796|NCT01911780|79245070|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
44281797|NCT01911780|79245071|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
44281798|NCT01911780|79245070|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
44281799|NCT01911780|79245071|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
44281800|NCT01911780|79245070|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
44403178|NCT04146909|79410524|FG000|Overall Study|Did not qualify after consented|1|||
44403179|NCT04082884|79410530|FG000|Overall Study|Withdrawal by Subject|1|||
44403180|NCT03943550|79410550|FG000|Overall Study|Adverse Event|0|||
44403181|NCT03943550|79410551|FG001|Overall Study|Adverse Event|0|||
44522384|NCT01347554|79530438|FG000|Overall Study|Lack of Efficacy|7|||
44522385|NCT01347554|79530439|FG001|Overall Study|Lack of Efficacy|11|||
44522386|NCT03482882|79530445|FG000|Overall Study|Adverse Event|3|||
44522387|NCT03482882|79530445|FG000|Overall Study|Lost to Follow-up|1|||
44522388|NCT03482882|79530445|FG000|Overall Study|Protocol Violation|2|||
44522389|NCT03482882|79530445|FG000|Overall Study|Not further specified|1|||
44522390|NCT03480932|79530452|FG000|Overall Study|Death|1|||
44522391|NCT03480932|79530453|FG001|Overall Study|Death|1|||
44522392|NCT03480932|79530454|FG002|Overall Study|Death|0|||
44522393|NCT03480932|79530452|FG000|Overall Study|Lost to Follow-up|0|||
44522394|NCT03480932|79530453|FG001|Overall Study|Lost to Follow-up|2|||
44522395|NCT03480932|79530454|FG002|Overall Study|Lost to Follow-up|3|||
44522396|NCT03480932|79530452|FG000|Overall Study|Incarcerated|2|||
44281801|NCT01911780|79245071|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
44281802|NCT01911780|79245070|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
44281803|NCT01911780|79245071|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
44281804|NCT01911780|79245070|FG000|Extension Period (52 Weeks)|Personal reason|1|||
44522397|NCT03480932|79530453|FG001|Overall Study|Incarcerated|2|||
44281805|NCT01911780|79245071|FG001|Extension Period (52 Weeks)|Personal reason|1|||
44522398|NCT03480932|79530454|FG002|Overall Study|Incarcerated|2|||
44281806|NCT01911546|79245081|FG000|Overall Study|Lost to Follow-up|1|||
44281807|NCT01911546|79245081|FG000|Overall Study|Everolimus was discontinued|5|||
44522399|NCT03387020|79530465|FG000|Overall Study|Adverse Event|0|||
44403182|NCT03943550|79410552|FG002|Overall Study|Adverse Event|1|||
44522400|NCT03387020|79530466|FG001|Overall Study|Adverse Event|2|||
44522401|NCT03387020|79530467|FG002|Overall Study|Adverse Event|0|||
44522402|NCT03387020|79530465|FG000|Overall Study|Withdrawal by Subject|2|||
44522403|NCT03387020|79530466|FG001|Overall Study|Withdrawal by Subject|0|||
44522404|NCT03387020|79530467|FG002|Overall Study|Withdrawal by Subject|0|||
44522405|NCT03386474|79530487|FG000|Overall Study|Death|1|||
44522406|NCT03386474|79530488|FG001|Overall Study|Death|0|||
44522407|NCT03386474|79530487|FG000|Overall Study|Adverse Event|0|||
44522408|NCT03386474|79530488|FG001|Overall Study|Adverse Event|1|||
44522409|NCT03405818|79530499|FG000|Overall Study|Withdrawal by Subject|4|||
44522410|NCT03405818|79530499|FG000|Overall Study|Lost to Follow-up|4|||
44522411|NCT03403634|79530503|FG000|Overall Study|Disease progression|3|||
44522412|NCT03403634|79530503|FG000|Overall Study|Did not meet eligibility criteria|4|||
44403183|NCT03943550|79410550|FG000|Overall Study|Lost to Follow-up|0|||
44403184|NCT03943550|79410551|FG001|Overall Study|Lost to Follow-up|0|||
44403185|NCT03943550|79410552|FG002|Overall Study|Lost to Follow-up|1|||
44403186|NCT03943550|79410550|FG000|Overall Study|Progressive Disease|0|||
44403187|NCT03943550|79410551|FG001|Overall Study|Progressive Disease|0|||
44403188|NCT03943550|79410552|FG002|Overall Study|Progressive Disease|2|||
44403189|NCT03943550|79410550|FG000|Overall Study|Participant Moved Out of the Country|0|||
44403190|NCT03943550|79410551|FG001|Overall Study|Participant Moved Out of the Country|1|||
44403191|NCT03943550|79410552|FG002|Overall Study|Participant Moved Out of the Country|0|||
44403192|NCT03759379|79410585|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
44403193|NCT03759379|79410586|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
44403194|NCT03759379|79410585|FG000|Treatment Period|Death|2|||
44403195|NCT03759379|79410586|FG001|Treatment Period|Death|3|||
44403196|NCT03759379|79410585|FG000|Treatment Period|Lost to Follow-up|1|||
44403197|NCT03759379|79410586|FG001|Treatment Period|Lost to Follow-up|0|||
44403198|NCT03759379|79410585|FG000|Treatment Period|Physician Decision|0|||
44403199|NCT03759379|79410586|FG001|Treatment Period|Physician Decision|1|||
44403200|NCT03724396|79410594|FG000|Overall Study|Lost to Follow-up|1|||
44403201|NCT03724396|79410595|FG001|Overall Study|Lost to Follow-up|1|||
44403202|NCT03724396|79410594|FG000|Overall Study|Withdrawal by Subject|1|||
44403203|NCT03724396|79410595|FG001|Overall Study|Withdrawal by Subject|0|||
44403204|NCT03713034|79410603|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
44403205|NCT03713034|79410604|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
44403206|NCT03698019|79410614|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
44403207|NCT03698019|79410615|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
44403208|NCT03698019|79410614|FG000|Step 1: Registration|Withdrawal by Subject|7|||
44403209|NCT03698019|79410615|FG001|Step 1: Registration|Withdrawal by Subject|2|||
44403210|NCT03698019|79410614|FG000|Step 1: Registration|Toxicity|0|||
44403211|NCT03698019|79410615|FG001|Step 1: Registration|Toxicity|1|||
44403212|NCT03698019|79410614|FG000|Step 1: Registration|Disease Progression|0|||
44522413|NCT03403400|79530510|FG000|Overall Study|Lost to Follow-up|1|||
44522414|NCT03403400|79530511|FG001|Overall Study|Lost to Follow-up|0|||
44522415|NCT03403400|79530512|FG002|Overall Study|Lost to Follow-up|1|||
44522416|NCT03403400|79530510|FG000|Overall Study|Hospitalization|1|||
44522417|NCT03403400|79530511|FG001|Overall Study|Hospitalization|0|||
44522418|NCT03403400|79530512|FG002|Overall Study|Hospitalization|0|||
44522419|NCT03403400|79530510|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
44522420|NCT03403400|79530511|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
44522421|NCT03403400|79530512|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
44522422|NCT02863354|79530537|FG000|Year 1|Lost to Follow-up|1|||
44522423|NCT02863354|79530538|FG001|Year 1|Lost to Follow-up|1|||
44522424|NCT02863354|79530537|FG000|Year 1|Withdrawal by Subject|3|||
44522425|NCT02863354|79530538|FG001|Year 1|Withdrawal by Subject|0|||
44522426|NCT02863354|79530537|FG000|Year 1|Death|0|||
44522427|NCT02863354|79530538|FG001|Year 1|Death|1|||
44522428|NCT02863354|79530537|FG000|Year 2|Lost to Follow-up|2|||
44252929|NCT00089297|79091945|FG000|Overall Study|IRB approval not ready|1|||
44252930|NCT00089297|79091945|FG000|Overall Study|Non-compliance|1|||
44252931|NCT00088907|79091987|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
44252932|NCT00088907|79091988|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
44252933|NCT00088907|79091987|FG000|Randomized Study (Step 1)|Adverse Event|14|||
44252934|NCT00088907|79091988|FG001|Randomized Study (Step 1)|Adverse Event|19|||
44252935|NCT00088907|79091987|FG000|Randomized Study (Step 1)|Death|11|||
44252936|NCT00088907|79091988|FG001|Randomized Study (Step 1)|Death|12|||
44403213|NCT03698019|79410615|FG001|Step 1: Registration|Disease Progression|12|||
44522429|NCT02863354|79530538|FG001|Year 2|Lost to Follow-up|2|||
44522430|NCT03480152|79530546|FG000|Phase I|Signed consent. Died before treatment.|1|||
44522431|NCT03480152|79530547|FG001|Phase I|Signed consent. Died before treatment.|0|||
44522432|NCT03480152|79530548|FG002|Phase I|Signed consent. Died before treatment.|0|||
44522433|NCT02859454|79530556|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
44522434|NCT02862730|79530563|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
44522435|NCT02862730|79530564|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
44252937|NCT00088907|79091987|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
44522436|NCT02862730|79530565|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
44522437|NCT02862730|79530566|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
44522438|NCT02862730|79530567|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
44522439|NCT02862730|79530568|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
44522440|NCT02862730|79530569|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
44403214|NCT03698019|79410614|FG000|Step 1: Registration|Co-morbidities|0|||
44403215|NCT03698019|79410615|FG001|Step 1: Registration|Co-morbidities|1|||
44403216|NCT03698019|79410614|FG000|Step 1: Registration|Scheduling Issues|1|||
44403217|NCT03698019|79410615|FG001|Step 1: Registration|Scheduling Issues|0|||
44522441|NCT02862730|79530563|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
44522442|NCT02862730|79530564|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
44522443|NCT02862730|79530565|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
44522444|NCT02862730|79530566|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
44522445|NCT02862730|79530567|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
44147712|NCT02618967|78937053|FG000|Overall Study|Lost to Follow-up|0|||
44147713|NCT02618967|78937054|FG001|Overall Study|Lost to Follow-up|0|||
44147714|NCT02618967|78937055|FG002|Overall Study|Lost to Follow-up|1|||
44403218|NCT03698019|79410614|FG000|Step 1: Registration|Participant Refusal|0|||
44403219|NCT03698019|79410615|FG001|Step 1: Registration|Participant Refusal|1|||
44403220|NCT03698019|79410614|FG000|Step 2: Surgery|Participant Refusal|2|||
44403221|NCT03698019|79410615|FG001|Step 2: Surgery|Participant Refusal|1|||
44403222|NCT03698019|79410614|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
44403223|NCT03698019|79410615|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
44403224|NCT03698019|79410614|FG000|Step 2: Surgery|Metastatic Disease|16|||
44403225|NCT03698019|79410615|FG001|Step 2: Surgery|Metastatic Disease|9|||
44403226|NCT03698019|79410614|FG000|Step 2: Surgery|Residual Disease|2|||
44403227|NCT03698019|79410615|FG001|Step 2: Surgery|Residual Disease|1|||
44403228|NCT03698019|79410614|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
44403229|NCT03698019|79410615|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
44403230|NCT03698019|79410614|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
44403231|NCT03698019|79410615|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
44403232|NCT03698019|79410614|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
44403233|NCT03698019|79410615|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
44522446|NCT02862730|79530568|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
44147715|NCT02618967|78937056|FG003|Overall Study|Lost to Follow-up|0|||
44147716|NCT02618967|78937057|FG004|Overall Study|Lost to Follow-up|2|||
44147717|NCT02618967|78937058|FG005|Overall Study|Lost to Follow-up|0|||
44147718|NCT02618967|78937059|FG006|Overall Study|Lost to Follow-up|0|||
44147719|NCT02618967|78937060|FG007|Overall Study|Lost to Follow-up|0|||
44147720|NCT02618967|78937053|FG000|Overall Study|Withdrawal by Subject|1|||
44147721|NCT02618967|78937054|FG001|Overall Study|Withdrawal by Subject|0|||
44147722|NCT02618967|78937055|FG002|Overall Study|Withdrawal by Subject|0|||
44147723|NCT02618967|78937056|FG003|Overall Study|Withdrawal by Subject|0|||
44147724|NCT02618967|78937057|FG004|Overall Study|Withdrawal by Subject|0|||
44147725|NCT02618967|78937058|FG005|Overall Study|Withdrawal by Subject|0|||
44147726|NCT02618967|78937059|FG006|Overall Study|Withdrawal by Subject|0|||
44147727|NCT02618967|78937060|FG007|Overall Study|Withdrawal by Subject|0|||
44147728|NCT02616783|78937089|FG000|Overall Study|Randomized but Not Treated|1|||
44147729|NCT02616783|78937090|FG001|Overall Study|Randomized but Not Treated|0|||
44147730|NCT02616783|78937089|FG000|Overall Study|Adverse Event|1|||
44147731|NCT02616783|78937090|FG001|Overall Study|Adverse Event|0|||
44147732|NCT02616783|78937089|FG000|Overall Study|Death|1|||
44147733|NCT02616783|78937090|FG001|Overall Study|Death|0|||
44147734|NCT02616783|78937089|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44147735|NCT02616783|78937090|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44147736|NCT02616783|78937089|FG000|Overall Study|Protocol Violation|1|||
44147737|NCT02616783|78937090|FG001|Overall Study|Protocol Violation|1|||
44147738|NCT02616783|78937089|FG000|Overall Study|Withdrew Consent|1|||
44147739|NCT02616783|78937090|FG001|Overall Study|Withdrew Consent|1|||
44522447|NCT02862730|79530569|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
44522448|NCT02862730|79530563|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
44147740|NCT02616393|78937099|FG000|Overall Study|Death|5|||
44147741|NCT02616393|78937100|FG001|Overall Study|Death|12|||
44147742|NCT02616393|78937101|FG002|Overall Study|Death|1|||
44147743|NCT02616393|78937099|FG000|Overall Study|Termination by Sponsor|4|||
44147744|NCT02616393|78937100|FG001|Overall Study|Termination by Sponsor|5|||
44147745|NCT02616393|78937101|FG002|Overall Study|Termination by Sponsor|2|||
44147746|NCT02616393|78937099|FG000|Overall Study|Other|3|||
44147747|NCT02616393|78937100|FG001|Overall Study|Other|0|||
44147748|NCT02616393|78937101|FG002|Overall Study|Other|0|||
44147749|NCT02616393|78937099|FG000|Overall Study|Withdrawal by Subject|1|||
44147750|NCT02616393|78937100|FG001|Overall Study|Withdrawal by Subject|1|||
44147751|NCT02616393|78937101|FG002|Overall Study|Withdrawal by Subject|0|||
44403234|NCT03698019|79410614|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
44403235|NCT03698019|79410615|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
44403236|NCT03698019|79410614|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
44403237|NCT03698019|79410615|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
44403238|NCT03698019|79410614|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
44403239|NCT03698019|79410615|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
44403240|NCT03698019|79410614|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
44403241|NCT03698019|79410615|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
44403242|NCT03698019|79410614|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
44403243|NCT03698019|79410615|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
44403244|NCT03691428|79410625|FG000|Overall Study|Withdrawal by Subject|6|||
44403245|NCT03691428|79410626|FG001|Overall Study|Withdrawal by Subject|8|||
44403246|NCT03623386|79410635|FG000|Overall Study|Protocol Violation|3|||
44403247|NCT03623386|79410636|FG001|Overall Study|Protocol Violation|2|||
44403248|NCT03623386|79410637|FG002|Overall Study|Protocol Violation|0|||
44403249|NCT03623386|79410635|FG000|Overall Study|Physician Decision|1|||
44403250|NCT03623386|79410636|FG001|Overall Study|Physician Decision|1|||
44403251|NCT03623386|79410637|FG002|Overall Study|Physician Decision|0|||
44403252|NCT03623386|79410635|FG000|Overall Study|Lost to Follow-up|0|||
44403253|NCT03623386|79410636|FG001|Overall Study|Lost to Follow-up|2|||
44403254|NCT03623386|79410637|FG002|Overall Study|Lost to Follow-up|0|||
44403255|NCT03623386|79410635|FG000|Overall Study|COVID-19|0|||
44403256|NCT03623386|79410636|FG001|Overall Study|COVID-19|1|||
44403257|NCT03623386|79410637|FG002|Overall Study|COVID-19|0|||
44403258|NCT03476798|79410653|FG000|Overall Study|Death|1|||
44403259|NCT03476798|79410653|FG000|Overall Study|Withdrawal by Subject|2|||
44403260|NCT03476798|79410653|FG000|Overall Study|Protocol Violation|2|||
44403261|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
44403262|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
44403263|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
44403264|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
44403265|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
44403266|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
44403267|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
44403268|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
44403269|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
44403270|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
44403271|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
44403272|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
44403273|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
44403274|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
44403275|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
44403276|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
44403277|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
44403278|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
44403279|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
44403280|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
44403281|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
44403282|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
44403283|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
44403284|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
44403285|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
44403286|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
44403287|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
44403288|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
44403289|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
44403290|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
44403291|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
44403292|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
44403293|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
44403294|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
44403295|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
44403296|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
44252938|NCT00088907|79091988|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
44403297|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
44403298|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
44147752|NCT02616393|78937099|FG000|Overall Study|Lost to Follow-up|0|||
44147753|NCT02616393|78937100|FG001|Overall Study|Lost to Follow-up|2|||
44403299|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
44403300|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
44403301|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
44403302|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
44403303|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
44403304|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
44403305|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
44403306|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
44403307|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
44403308|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
44403309|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
44403310|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
44403311|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
44403312|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
44403313|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
44403314|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
44403315|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
44403316|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
44403317|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
44403318|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
44403319|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
44403320|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
44403321|NCT03395197|79410663|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
44403322|NCT03395197|79410664|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
44403323|NCT03395197|79410665|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
44403324|NCT03395197|79410666|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
44403325|NCT03395197|79410667|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
44403326|NCT03395197|79410668|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
44403327|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Death|0|||
44403328|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Death|0|||
44403329|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Death|0|||
44403330|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Death|0|||
44403331|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Death|1|||
44403332|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Death|4|||
44403333|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
44403334|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
44403335|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
44403336|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
44403337|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
44403338|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
44403339|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
44403340|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
44403341|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
44403342|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
44403343|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
44403344|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
44252939|NCT00088907|79091987|FG000|Randomized Study (Step 1)|complicating disease|3|||
44403345|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
44403346|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
44403347|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
44403348|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
44403349|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
44403350|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
44403351|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
44403352|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
44403353|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
44403354|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
44252940|NCT00088907|79091988|FG001|Randomized Study (Step 1)|complicating disease|1|||
44252941|NCT00088907|79091987|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
44252942|NCT00088907|79091988|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
44252943|NCT00088907|79091987|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
44252944|NCT00088907|79091988|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
44281808|NCT01910298|79245087|FG000|Overall Study|Adverse Event|1|||
44403355|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
44403356|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
44403357|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
44403358|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
44403359|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
44403360|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
44403361|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
44403362|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
44403363|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
44403364|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
44403365|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
44403366|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
44403367|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
44403368|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
44403369|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Other|0|||
44403370|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Other|0|||
44403371|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Other|0|||
44403372|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Other|0|||
44403373|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Other|3|||
44403374|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Other|3|||
44403375|NCT03395197|79410663|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
44403376|NCT03395197|79410664|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
44403377|NCT03395197|79410665|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
44403378|NCT03395197|79410666|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
44403379|NCT03395197|79410667|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
44403380|NCT03395197|79410668|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
44403381|NCT03307967|79410695|FG000|Overall Study|Lost to Follow-up|4|||
44403382|NCT03290300|79410699|FG000|Overall Study|Lost to Follow-up|3|||
44403383|NCT03239470|79410710|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
44403384|NCT03239470|79410711|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
44403385|NCT02938520|79410718|FG000|Overall Study|On-going at the time of analysis|258|||
44403386|NCT02938520|79410719|FG001|Overall Study|On-going at the time of analysis|261|||
44403387|NCT02938520|79410718|FG000|Overall Study|Physician Decision|2|||
44403388|NCT02938520|79410719|FG001|Overall Study|Physician Decision|5|||
44403389|NCT02938520|79410718|FG000|Overall Study|Lost to Follow-up|2|||
44403390|NCT02938520|79410719|FG001|Overall Study|Lost to Follow-up|2|||
44403391|NCT02938520|79410718|FG000|Overall Study|Withdrawal by Subject|7|||
44403392|NCT02938520|79410719|FG001|Overall Study|Withdrawal by Subject|7|||
44403393|NCT02938520|79410718|FG000|Overall Study|Protocol Violation|0|||
44403394|NCT02938520|79410719|FG001|Overall Study|Protocol Violation|1|||
44403395|NCT02938520|79410718|FG000|Overall Study|Lack of Efficacy|5|||
44403396|NCT02938520|79410719|FG001|Overall Study|Lack of Efficacy|3|||
44403397|NCT02938520|79410718|FG000|Overall Study|Adverse Event|9|||
44403398|NCT02938520|79410719|FG001|Overall Study|Adverse Event|4|||
44403399|NCT02918162|79410728|FG000|Overall Study|Withdrawal by Subject|1|||
44403400|NCT02918162|79410728|FG000|Overall Study|Omental Disease|1|||
44403401|NCT02779855|79410735|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
44403402|NCT02779855|79410736|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
44403403|NCT02779855|79410737|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
44403404|NCT02504372|79410757|FG000|Overall Study|Death|136|||
44403405|NCT02504372|79410758|FG001|Overall Study|Death|154|||
44403406|NCT02504372|79410757|FG000|Overall Study|Lost to Follow-up|0|||
44403407|NCT02504372|79410758|FG001|Overall Study|Lost to Follow-up|2|||
44403408|NCT02504372|79410757|FG000|Overall Study|Withdrawal of consent|25|||
44403409|NCT02504372|79410758|FG001|Overall Study|Withdrawal of consent|16|||
44403410|NCT02504372|79410757|FG000|Overall Study|Participants ongoing|429|||
44403411|NCT02504372|79410758|FG001|Overall Study|Participants ongoing|415|||
44403412|NCT02227199|79410767|FG000|Overall Study|Physician Decision|0|||
44403413|NCT02227199|79410768|FG001|Overall Study|Physician Decision|0|||
44403414|NCT02227199|79410769|FG002|Overall Study|Physician Decision|1|||
44147754|NCT02616393|78937101|FG002|Overall Study|Lost to Follow-up|0|||
44147755|NCT02155660|78937129|FG000|Overall Study|Other Reason|8|||
44147756|NCT02155660|78937130|FG001|Overall Study|Other Reason|6|||
44403415|NCT02227199|79410767|FG000|Overall Study|Adverse Event|0|||
44403416|NCT02227199|79410768|FG001|Overall Study|Adverse Event|0|||
44403417|NCT02227199|79410769|FG002|Overall Study|Adverse Event|3|||
44403418|NCT02180867|79410788|FG000|Overall Study|Adverse Event|3|||
44147757|NCT02155660|78937131|FG002|Overall Study|Other Reason|10|||
44147758|NCT02155660|78937132|FG003|Overall Study|Other Reason|10|||
44252945|NCT00088907|79091987|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
44403419|NCT02180867|79410789|FG001|Overall Study|Adverse Event|4|||
44403420|NCT02180867|79410790|FG002|Overall Study|Adverse Event|1|||
44403421|NCT02180867|79410791|FG003|Overall Study|Adverse Event|5|||
44403422|NCT02180867|79410792|FG004|Overall Study|Adverse Event|0|||
44403423|NCT02180867|79410793|FG005|Overall Study|Adverse Event|0|||
44403424|NCT02180867|79410794|FG006|Overall Study|Adverse Event|0|||
44403425|NCT02180867|79410788|FG000|Overall Study|Death|0|||
44403426|NCT02180867|79410789|FG001|Overall Study|Death|0|||
44403427|NCT02180867|79410790|FG002|Overall Study|Death|0|||
44403428|NCT02180867|79410791|FG003|Overall Study|Death|0|||
44403429|NCT02180867|79410792|FG004|Overall Study|Death|1|||
44403430|NCT02180867|79410793|FG005|Overall Study|Death|0|||
44403431|NCT02180867|79410794|FG006|Overall Study|Death|0|||
44403432|NCT02180867|79410788|FG000|Overall Study|Lack of Efficacy|0|||
44403433|NCT02180867|79410789|FG001|Overall Study|Lack of Efficacy|2|||
44403434|NCT02180867|79410790|FG002|Overall Study|Lack of Efficacy|0|||
44403435|NCT02180867|79410791|FG003|Overall Study|Lack of Efficacy|1|||
44403436|NCT02180867|79410792|FG004|Overall Study|Lack of Efficacy|6|||
44403437|NCT02180867|79410793|FG005|Overall Study|Lack of Efficacy|0|||
44403438|NCT02180867|79410794|FG006|Overall Study|Lack of Efficacy|1|||
44403439|NCT02180867|79410788|FG000|Overall Study|Physician Decision|1|||
44403440|NCT02180867|79410789|FG001|Overall Study|Physician Decision|3|||
44403441|NCT02180867|79410790|FG002|Overall Study|Physician Decision|1|||
44403442|NCT02180867|79410791|FG003|Overall Study|Physician Decision|10|||
44403443|NCT02180867|79410792|FG004|Overall Study|Physician Decision|9|||
44403444|NCT02180867|79410793|FG005|Overall Study|Physician Decision|3|||
44403445|NCT02180867|79410794|FG006|Overall Study|Physician Decision|4|||
44403446|NCT02180867|79410788|FG000|Overall Study|Withdrawal by Subject|0|||
44403447|NCT02180867|79410789|FG001|Overall Study|Withdrawal by Subject|0|||
44403448|NCT02180867|79410790|FG002|Overall Study|Withdrawal by Subject|0|||
44403449|NCT02180867|79410791|FG003|Overall Study|Withdrawal by Subject|1|||
44403450|NCT02180867|79410792|FG004|Overall Study|Withdrawal by Subject|1|||
44403451|NCT02180867|79410793|FG005|Overall Study|Withdrawal by Subject|0|||
44403452|NCT02180867|79410794|FG006|Overall Study|Withdrawal by Subject|0|||
44403453|NCT02180867|79410788|FG000|Overall Study|Ineligible|1|||
44403454|NCT02180867|79410789|FG001|Overall Study|Ineligible|2|||
44403455|NCT02180867|79410790|FG002|Overall Study|Ineligible|0|||
44403456|NCT02180867|79410791|FG003|Overall Study|Ineligible|3|||
44403457|NCT02180867|79410792|FG004|Overall Study|Ineligible|5|||
44403458|NCT02180867|79410793|FG005|Overall Study|Ineligible|0|||
44403459|NCT02180867|79410794|FG006|Overall Study|Ineligible|0|||
44403460|NCT02180867|79410788|FG000|Overall Study|Repeat Eligibility Studies|0|||
44403461|NCT02180867|79410789|FG001|Overall Study|Repeat Eligibility Studies|0|||
44403462|NCT02180867|79410790|FG002|Overall Study|Repeat Eligibility Studies|0|||
44403463|NCT02180867|79410791|FG003|Overall Study|Repeat Eligibility Studies|0|||
44403464|NCT02180867|79410792|FG004|Overall Study|Repeat Eligibility Studies|1|||
44403465|NCT02180867|79410793|FG005|Overall Study|Repeat Eligibility Studies|0|||
44403466|NCT02180867|79410794|FG006|Overall Study|Repeat Eligibility Studies|0|||
44403467|NCT02180867|79410788|FG000|Overall Study|Refusal of further protocol therapy|1|||
44403468|NCT02180867|79410789|FG001|Overall Study|Refusal of further protocol therapy|0|||
44403469|NCT02180867|79410790|FG002|Overall Study|Refusal of further protocol therapy|2|||
44403470|NCT02180867|79410791|FG003|Overall Study|Refusal of further protocol therapy|6|||
44403471|NCT02180867|79410792|FG004|Overall Study|Refusal of further protocol therapy|4|||
44403472|NCT02180867|79410793|FG005|Overall Study|Refusal of further protocol therapy|0|||
44403473|NCT02180867|79410794|FG006|Overall Study|Refusal of further protocol therapy|0|||
44403474|NCT02143414|79410824|FG000|Induction|Adverse Event|1|||
44403475|NCT02143414|79410825|FG001|Induction|Adverse Event|2|||
44403476|NCT02143414|79410824|FG000|Induction|Death|1|||
44403477|NCT02143414|79410825|FG001|Induction|Death|2|||
44403478|NCT02143414|79410824|FG000|Induction|Patient refusal|1|||
44403479|NCT02143414|79410825|FG001|Induction|Patient refusal|1|||
44522449|NCT02862730|79530564|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
44522450|NCT02862730|79530565|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
44522451|NCT02862730|79530566|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
44522452|NCT02862730|79530567|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
44522453|NCT02862730|79530568|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
44522454|NCT02862730|79530569|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
44522455|NCT02862730|79530563|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
44522456|NCT02862730|79530564|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
44522457|NCT02862730|79530565|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
44522458|NCT02862730|79530566|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
44522459|NCT02862730|79530567|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
44522460|NCT02862730|79530568|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
44403480|NCT02143414|79410824|FG000|Induction|Refractory|1|||
44403481|NCT02143414|79410825|FG001|Induction|Refractory|0|||
44403482|NCT02143414|79410824|FG000|Induction|Began alternative treatment|1|||
44403483|NCT02143414|79410825|FG001|Induction|Began alternative treatment|0|||
44403484|NCT02143414|79410824|FG000|Induction|Ineligible for postremission|5|||
44403485|NCT02143414|79410825|FG001|Induction|Ineligible for postremission|1|||
44403486|NCT02143414|79410824|FG000|Post-remission|Adverse Event|0|||
44403487|NCT02143414|79410825|FG001|Post-remission|Adverse Event|2|||
44403488|NCT02143414|79410824|FG000|Post-remission|Disease progression/relapse|5|||
44403489|NCT02143414|79410825|FG001|Post-remission|Disease progression/relapse|0|||
44403490|NCT02143414|79410824|FG000|Maintenance|Adverse Event|4|||
44403491|NCT02143414|79410825|FG001|Maintenance|Adverse Event|6|||
44403492|NCT02143414|79410824|FG000|Maintenance|Disease progression/relapse|3|||
44403493|NCT02143414|79410825|FG001|Maintenance|Disease progression/relapse|2|||
44403494|NCT02143414|79410824|FG000|Maintenance|Patient refusal|2|||
44403495|NCT02143414|79410825|FG001|Maintenance|Patient refusal|1|||
44403496|NCT02143414|79410824|FG000|Maintenance|Physician Decision|1|||
44403497|NCT02143414|79410825|FG001|Maintenance|Physician Decision|0|||
44403498|NCT02143414|79410824|FG000|Maintenance|Death|0|||
44403499|NCT02143414|79410825|FG001|Maintenance|Death|1|||
44403500|NCT02143414|79410824|FG000|Maintenance|On protocol treatment|0|||
44403501|NCT02143414|79410825|FG001|Maintenance|On protocol treatment|6|||
44403502|NCT01856192|79410844|FG000|Overall Study|Adverse Event|12|||
44403503|NCT01856192|79410845|FG001|Overall Study|Adverse Event|4|||
44403504|NCT01856192|79410844|FG000|Overall Study|Alternative therapy|0|||
44403505|NCT01856192|79410845|FG001|Overall Study|Alternative therapy|3|||
44403506|NCT01856192|79410844|FG000|Overall Study|Death|3|||
44403507|NCT01856192|79410845|FG001|Overall Study|Death|5|||
44403508|NCT01856192|79410844|FG000|Overall Study|Lack of Efficacy|0|||
44403509|NCT01856192|79410845|FG001|Overall Study|Lack of Efficacy|5|||
44403510|NCT01856192|79410844|FG000|Overall Study|Withdrawal by Subject|1|||
44403511|NCT01856192|79410845|FG001|Overall Study|Withdrawal by Subject|1|||
44403512|NCT01856192|79410844|FG000|Overall Study|Other diseases|1|||
44403513|NCT01856192|79410845|FG001|Overall Study|Other diseases|0|||
44403514|NCT01856192|79410844|FG000|Overall Study|Never started treatment|7|||
44403515|NCT01856192|79410845|FG001|Overall Study|Never started treatment|5|||
44403516|NCT01856192|79410844|FG000|Overall Study|Path ineligible|20|||
44403517|NCT01856192|79410845|FG001|Overall Study|Path ineligible|34|||
44403518|NCT01856192|79410844|FG000|Overall Study|Non-path ineligible|2|||
44403519|NCT01856192|79410845|FG001|Overall Study|Non-path ineligible|2|||
44403520|NCT01856192|79410844|FG000|Overall Study|Physician Decision|1|||
44403521|NCT01856192|79410845|FG001|Overall Study|Physician Decision|1|||
44522461|NCT02862730|79530569|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
44522462|NCT03353792|79530586|FG000|Overall Study|Lost to Follow-up|1|||
44522463|NCT03353792|79530587|FG001|Overall Study|Lost to Follow-up|0|||
44522464|NCT03353792|79530586|FG000|Overall Study|Participant Unable to Manage Device|1|||
44522465|NCT03353792|79530587|FG001|Overall Study|Participant Unable to Manage Device|0|||
44522466|NCT02862574|79530596|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44522467|NCT02862574|79530597|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44522468|NCT02862574|79530598|FG002|Double-Blind Treatment Period|Adverse Event|0|||
44252946|NCT00088907|79091988|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
44252947|NCT00088907|79091987|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
44252948|NCT00088907|79091988|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
44252949|NCT00088907|79091987|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
44252950|NCT00088907|79091988|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
44252951|NCT00088907|79091987|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
44522469|NCT02862574|79530596|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
44522470|NCT02862574|79530597|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
44522471|NCT02862574|79530598|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
44522472|NCT02862574|79530596|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
44522473|NCT02862574|79530597|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
44522474|NCT02862574|79530598|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
44522475|NCT02862106|79530613|FG000|Overall Study|Adverse Event|4|||
44522476|NCT02862106|79530614|FG001|Overall Study|Adverse Event|0|||
44522477|NCT02862106|79530613|FG000|Overall Study|Protocol Violation|16|||
44522478|NCT02862106|79530614|FG001|Overall Study|Protocol Violation|1|||
44522479|NCT02862106|79530613|FG000|Overall Study|Lost to Follow-up|15|||
44522480|NCT02862106|79530614|FG001|Overall Study|Lost to Follow-up|5|||
44522481|NCT02862106|79530613|FG000|Overall Study|Withdrawal by Subject|2|||
44522482|NCT02862106|79530614|FG001|Overall Study|Withdrawal by Subject|0|||
44522483|NCT02862106|79530613|FG000|Overall Study|Subjects moved to other city|1|||
44522484|NCT02862106|79530614|FG001|Overall Study|Subjects moved to other city|0|||
44522485|NCT04157296|79530629|FG000|Overall Study|Withdrawal by Subject|0|||
44522486|NCT04157296|79530630|FG001|Overall Study|Withdrawal by Subject|1|||
44522487|NCT04157296|79530629|FG000|Overall Study|Did not obtain second fMRI.|0|||
44403522|NCT01856192|79410844|FG000|Overall Study|Suspicion of progressive disease|1|||
44403523|NCT01856192|79410845|FG001|Overall Study|Suspicion of progressive disease|0|||
44403524|NCT01856192|79410844|FG000|Overall Study|Non-compliance|1|||
44403525|NCT01856192|79410845|FG001|Overall Study|Non-compliance|0|||
44403526|NCT01812252|79410863|FG000|Overall Study|Persistent Disease|1|||
44403527|NCT01812252|79410864|FG001|Overall Study|Persistent Disease|0|||
44403528|NCT01812252|79410863|FG000|Overall Study|Not transplanted|11|||
44403529|NCT01812252|79410864|FG001|Overall Study|Not transplanted|11|||
44403530|NCT01812252|79410863|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
44403531|NCT01812252|79410864|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
44403532|NCT01812252|79410863|FG000|Overall Study|Withdrawal by Subject|1|||
44403533|NCT01812252|79410864|FG001|Overall Study|Withdrawal by Subject|1|||
44403534|NCT01812252|79410863|FG000|Overall Study|Screen Failure|1|||
44403535|NCT01812252|79410864|FG001|Overall Study|Screen Failure|0|||
44147759|NCT02155660|78937129|FG000|Overall Study|Study-specific withdrawal criteria|0|||
44403536|NCT01708954|79410875|FG000|Step 1|Disease progression|26|||
44522488|NCT04157296|79530630|FG001|Overall Study|Did not obtain second fMRI.|1|||
44147760|NCT02155660|78937130|FG001|Overall Study|Study-specific withdrawal criteria|1|||
44147761|NCT02155660|78937131|FG002|Overall Study|Study-specific withdrawal criteria|1|||
44403537|NCT01708954|79410876|FG001|Step 1|Disease progression|17|||
44403538|NCT01708954|79410877|FG002|Step 1|Disease progression|14|||
44403539|NCT01708954|79410875|FG000|Step 1|Adverse Event|3|||
44403540|NCT01708954|79410876|FG001|Step 1|Adverse Event|11|||
44403541|NCT01708954|79410877|FG002|Step 1|Adverse Event|13|||
44403542|NCT01708954|79410875|FG000|Step 1|Death|3|||
44403543|NCT01708954|79410876|FG001|Step 1|Death|2|||
44403544|NCT01708954|79410877|FG002|Step 1|Death|3|||
44403545|NCT01708954|79410875|FG000|Step 1|Withdrawal by Subject|2|||
44403546|NCT01708954|79410876|FG001|Step 1|Withdrawal by Subject|5|||
44403547|NCT01708954|79410877|FG002|Step 1|Withdrawal by Subject|3|||
44403548|NCT01708954|79410875|FG000|Step 1|Other complicating disease|0|||
44403549|NCT01708954|79410876|FG001|Step 1|Other complicating disease|2|||
44403550|NCT01708954|79410877|FG002|Step 1|Other complicating disease|0|||
44403551|NCT01708954|79410875|FG000|Step 1|Crossed over to Step 2|2|||
44403552|NCT01708954|79410876|FG001|Step 1|Crossed over to Step 2|0|||
44403553|NCT01708954|79410877|FG002|Step 1|Crossed over to Step 2|0|||
44147762|NCT02155660|78937132|FG003|Overall Study|Study-specific withdrawal criteria|1|||
44147763|NCT02155660|78937129|FG000|Overall Study|Severe non-compliance|0|||
44147764|NCT02155660|78937130|FG001|Overall Study|Severe non-compliance|4|||
44147765|NCT02155660|78937131|FG002|Overall Study|Severe non-compliance|0|||
44522489|NCT04157296|79530629|FG000|Overall Study|MRI failed/no second fMRI|0|||
44522490|NCT04157296|79530630|FG001|Overall Study|MRI failed/no second fMRI|1|||
44522491|NCT02859142|79530638|FG000|Overall Study|Adverse Event|1|||
44147766|NCT02155660|78937132|FG003|Overall Study|Severe non-compliance|1|||
44147767|NCT02155660|78937129|FG000|Overall Study|Adverse Event|2|||
44147768|NCT02155660|78937130|FG001|Overall Study|Adverse Event|6|||
44147769|NCT02155660|78937131|FG002|Overall Study|Adverse Event|3|||
44147770|NCT02155660|78937132|FG003|Overall Study|Adverse Event|1|||
44147771|NCT02155660|78937129|FG000|Overall Study|Lost to Follow-up|3|||
44522492|NCT02859142|79530639|FG001|Overall Study|Adverse Event|2|||
44522493|NCT02859142|79530638|FG000|Overall Study|Lost to Follow-up|1|||
44403554|NCT01708954|79410875|FG000|Step 1|Symptomatic deterioration|1|||
44403555|NCT01708954|79410876|FG001|Step 1|Symptomatic deterioration|0|||
44403556|NCT01708954|79410877|FG002|Step 1|Symptomatic deterioration|1|||
44522494|NCT02859142|79530639|FG001|Overall Study|Lost to Follow-up|4|||
44522495|NCT02859142|79530638|FG000|Overall Study|Withdrawal by Subject|2|||
44147772|NCT02155660|78937130|FG001|Overall Study|Lost to Follow-up|6|||
44252952|NCT00088907|79091988|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
44252953|NCT00088829|79091995|FG000|Overall Study|PI left institution and study was close|22|||
44403557|NCT01708954|79410875|FG000|Step 1|Off-treatment reason not submitted|1|||
44403558|NCT01708954|79410876|FG001|Step 1|Off-treatment reason not submitted|1|||
44403559|NCT01708954|79410877|FG002|Step 1|Off-treatment reason not submitted|1|||
44403560|NCT01708954|79410875|FG000|Step 1|Ineligible or never received treatment|4|||
44522496|NCT02859142|79530639|FG001|Overall Study|Withdrawal by Subject|0|||
44403561|NCT01708954|79410876|FG001|Step 1|Ineligible or never received treatment|2|||
44403562|NCT01708954|79410877|FG002|Step 1|Ineligible or never received treatment|8|||
44403563|NCT01708954|79410875|FG000|Step 2|Disease progression|9|||
44403564|NCT01708954|79410876|FG001|Step 2|Disease progression|4|||
44403565|NCT01708954|79410877|FG002|Step 2|Disease progression|0|||
44403566|NCT01708954|79410875|FG000|Step 2|Adverse Event|3|||
44403567|NCT01708954|79410876|FG001|Step 2|Adverse Event|2|||
44403568|NCT01708954|79410877|FG002|Step 2|Adverse Event|0|||
44403569|NCT01708954|79410875|FG000|Step 2|Withdrawal by Subject|1|||
44403570|NCT01708954|79410876|FG001|Step 2|Withdrawal by Subject|1|||
44403571|NCT01708954|79410877|FG002|Step 2|Withdrawal by Subject|0|||
44403572|NCT01386385|79410895|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
44403573|NCT01386385|79410896|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403574|NCT01386385|79410897|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403575|NCT01386385|79410898|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403576|NCT01386385|79410899|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403577|NCT01386385|79410900|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403578|NCT01386385|79410901|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403579|NCT01386385|79410902|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
44403580|NCT01386385|79410895|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
44403581|NCT01386385|79410896|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44403582|NCT01386385|79410897|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44403583|NCT01386385|79410898|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44403584|NCT01386385|79410899|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44403585|NCT01386385|79410900|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44403586|NCT01386385|79410901|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44403587|NCT01386385|79410902|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
44147773|NCT02155660|78937131|FG002|Overall Study|Lost to Follow-up|5|||
44147774|NCT02155660|78937132|FG003|Overall Study|Lost to Follow-up|8|||
44147775|NCT02155660|78937129|FG000|Overall Study|Death|17|||
44147776|NCT02155660|78937130|FG001|Overall Study|Death|19|||
44147777|NCT02155660|78937131|FG002|Overall Study|Death|17|||
44147778|NCT02155660|78937132|FG003|Overall Study|Death|19|||
44147779|NCT02155660|78937129|FG000|Overall Study|Withdrawal by Subject|28|||
44147780|NCT02155660|78937130|FG001|Overall Study|Withdrawal by Subject|31|||
44147781|NCT02155660|78937131|FG002|Overall Study|Withdrawal by Subject|24|||
44147782|NCT02155660|78937132|FG003|Overall Study|Withdrawal by Subject|21|||
44147783|NCT02119936|78937142|FG000|Overall Study|Lost to Follow-up|10|||
44147784|NCT02181634|78937146|FG000|Overall Study|Lack of Efficacy|33|||
44281809|NCT01910298|79245088|FG001|Overall Study|Adverse Event|0|||
44403588|NCT01386385|79410895|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403589|NCT01386385|79410896|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403590|NCT01386385|79410897|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
44403591|NCT01386385|79410898|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403592|NCT01386385|79410899|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403593|NCT01386385|79410900|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403594|NCT01386385|79410901|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403595|NCT01386385|79410902|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
44403596|NCT01386385|79410895|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403597|NCT01386385|79410896|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403598|NCT01386385|79410897|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403599|NCT01386385|79410898|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403600|NCT01386385|79410899|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
44403601|NCT01386385|79410900|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403602|NCT01386385|79410901|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403603|NCT01386385|79410902|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
44403604|NCT01386385|79410895|FG000|Phase II Concurrent CRT|Adverse Event|0|||
44403605|NCT01386385|79410896|FG001|Phase II Concurrent CRT|Adverse Event|0|||
44403606|NCT01386385|79410897|FG002|Phase II Concurrent CRT|Adverse Event|0|||
44403607|NCT01386385|79410898|FG003|Phase II Concurrent CRT|Adverse Event|0|||
44403608|NCT01386385|79410899|FG004|Phase II Concurrent CRT|Adverse Event|0|||
44147785|NCT02181634|78937146|FG000|Overall Study|Adverse Event|17|||
44403609|NCT01386385|79410900|FG005|Phase II Concurrent CRT|Adverse Event|0|||
44403610|NCT01386385|79410901|FG006|Phase II Concurrent CRT|Adverse Event|3|||
44403611|NCT01386385|79410902|FG007|Phase II Concurrent CRT|Adverse Event|3|||
44147786|NCT02181634|78937146|FG000|Overall Study|Physician Decision|8|||
44147787|NCT02181634|78937146|FG000|Overall Study|Withdrawal by Subject|5|||
44147788|NCT02181634|78937146|FG000|Overall Study|Death|2|||
44252954|NCT00088595|79091999|FG000|Overall Study|Adverse Event|11|||
44252955|NCT00088595|79091999|FG000|Overall Study|Withdrawal by Subject|8|||
44252956|NCT00088595|79091999|FG000|Overall Study|Ongoing (After Core)|7|||
44252957|NCT00088595|79091999|FG000|Overall Study|New Cancer Therapy|2|||
44252958|NCT00088205|79092013|FG000|Overall Study|Adverse Event|4|||
44403612|NCT01386385|79410895|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403613|NCT01386385|79410896|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403614|NCT01386385|79410897|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403615|NCT01386385|79410898|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403616|NCT01386385|79410899|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403617|NCT01386385|79410900|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403618|NCT01386385|79410901|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
44403619|NCT01386385|79410902|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
44403620|NCT01386385|79410895|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
44403621|NCT01386385|79410896|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
44403622|NCT01386385|79410897|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
44403623|NCT01386385|79410898|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
44403624|NCT01386385|79410899|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
44403625|NCT01386385|79410900|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
44403626|NCT01386385|79410901|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
44403627|NCT01386385|79410902|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
44403628|NCT01386385|79410895|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44522497|NCT02859142|79530638|FG000|Overall Study|Scheduling difficulties|0|||
44281810|NCT01910298|79245087|FG000|Overall Study|Withdrawal by Subject|2|||
44281811|NCT01910298|79245088|FG001|Overall Study|Withdrawal by Subject|7|||
44281812|NCT01910298|79245087|FG000|Overall Study|Protocol Deviation|0|||
44281813|NCT01910298|79245088|FG001|Overall Study|Protocol Deviation|5|||
44281814|NCT01910298|79245087|FG000|Overall Study|Lost to Follow-up|1|||
44281815|NCT01910298|79245088|FG001|Overall Study|Lost to Follow-up|1|||
44281816|NCT01910298|79245087|FG000|Overall Study|Study Terminated by Sponsor|1|||
44281817|NCT01910298|79245088|FG001|Overall Study|Study Terminated by Sponsor|17|||
44281818|NCT01910298|79245087|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44281819|NCT01910298|79245088|FG001|Overall Study|Other Miscellaneous Reasons|2|||
44281820|NCT01909674|79245096|FG000|Overall Study|Withdrawal by Subject|5|||
44281821|NCT01909674|79245097|FG001|Overall Study|Withdrawal by Subject|2|||
44281822|NCT01908816|79245107|FG000|Overall Study|Subject's no longer requires study drug|0|||
44281823|NCT01908816|79245108|FG001|Overall Study|Subject's no longer requires study drug|0|||
44281824|NCT01908816|79245109|FG002|Overall Study|Subject's no longer requires study drug|0|||
44281825|NCT01908816|79245110|FG003|Overall Study|Subject's no longer requires study drug|1|||
44281826|NCT01908816|79245107|FG000|Overall Study|Protocol deviation|1|||
44281827|NCT01908816|79245108|FG001|Overall Study|Protocol deviation|2|||
44281828|NCT01908816|79245109|FG002|Overall Study|Protocol deviation|1|||
44281829|NCT01908816|79245110|FG003|Overall Study|Protocol deviation|1|||
44281830|NCT01908816|79245107|FG000|Overall Study|Withdrawal by Subject|0|||
44281831|NCT01908816|79245108|FG001|Overall Study|Withdrawal by Subject|4|||
44281832|NCT01908816|79245109|FG002|Overall Study|Withdrawal by Subject|2|||
44281833|NCT01908816|79245110|FG003|Overall Study|Withdrawal by Subject|2|||
44281834|NCT01908816|79245107|FG000|Overall Study|Lost to Follow-up|3|||
44147789|NCT02181634|78937146|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
44147790|NCT02181634|78937146|FG000|Overall Study|Ineligible|1|||
44147791|NCT02181634|78937146|FG000|Overall Study|Max number of dose reduction|1|||
44147792|NCT02181634|78937146|FG000|Overall Study|Symptomatic progression|1|||
44147793|NCT02181634|78937146|FG000|Overall Study|Patient opted to proceed to surgery|1|||
44147794|NCT01595529|78937152|FG000|Overall Study|Adverse Event|2|||
44147795|NCT01595529|78937153|FG001|Overall Study|Adverse Event|0|||
44147796|NCT01595529|78937152|FG000|Overall Study|Subject Non-Compliant|2|||
44147797|NCT01595529|78937153|FG001|Overall Study|Subject Non-Compliant|0|||
44147798|NCT01595529|78937152|FG000|Overall Study|Lost to Follow-up|8|||
44147799|NCT01595529|78937153|FG001|Overall Study|Lost to Follow-up|14|||
44147800|NCT01595529|78937152|FG000|Overall Study|Protocol Violation|1|||
44147801|NCT01595529|78937153|FG001|Overall Study|Protocol Violation|2|||
44147802|NCT01595529|78937152|FG000|Overall Study|Physician Decision|1|||
44147803|NCT01595529|78937153|FG001|Overall Study|Physician Decision|0|||
44147804|NCT01595529|78937152|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
44147805|NCT01595529|78937153|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
44147806|NCT01595529|78937152|FG000|Overall Study|Administrative Decision|1|||
44522498|NCT02859142|79530639|FG001|Overall Study|Scheduling difficulties|3|||
44147807|NCT01595529|78937153|FG001|Overall Study|Administrative Decision|0|||
44147808|NCT01595529|78937152|FG000|Overall Study|Entry Failure/Screening Failure|6|||
44147809|NCT01595529|78937153|FG001|Overall Study|Entry Failure/Screening Failure|1|||
44147810|NCT02615145|78937162|FG000|Overall Study|Did Not Start Treatment|0|||
44403629|NCT01386385|79410896|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44147811|NCT02615145|78937163|FG001|Overall Study|Did Not Start Treatment|0|||
44147812|NCT02615145|78937164|FG002|Overall Study|Did Not Start Treatment|1|||
44281835|NCT01908816|79245108|FG001|Overall Study|Lost to Follow-up|5|||
44522499|NCT03351608|79530650|FG000|Overall Study|Lost to Follow-up|0|||
44147813|NCT02615145|78937165|FG003|Overall Study|Did Not Start Treatment|1|||
44281836|NCT01908816|79245109|FG002|Overall Study|Lost to Follow-up|4|||
44403630|NCT01386385|79410897|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44252959|NCT00088205|79092013|FG000|Overall Study|Progressive Disease|51|||
44403631|NCT01386385|79410898|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44403632|NCT01386385|79410899|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44403633|NCT01386385|79410900|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44403634|NCT01386385|79410901|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
44403635|NCT01386385|79410902|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
44403636|NCT01386385|79410895|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
44403637|NCT01386385|79410896|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
44403638|NCT01386385|79410897|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
44403639|NCT01386385|79410898|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
44403640|NCT01386385|79410899|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
44403641|NCT01386385|79410900|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
44403642|NCT01386385|79410901|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
44403643|NCT01386385|79410902|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
44403644|NCT01275677|79410925|FG000|Overall Study|Not at risk for recurrence.|1|||
44403645|NCT01275677|79410926|FG001|Overall Study|Not at risk for recurrence.|1|||
44403646|NCT01275677|79410925|FG000|Overall Study|No follow-up|26|||
44403647|NCT01275677|79410926|FG001|Overall Study|No follow-up|37|||
44403648|NCT01275677|79410925|FG000|Overall Study|No clinical follow up.|1|||
44403649|NCT01275677|79410926|FG001|Overall Study|No clinical follow up.|4|||
44403650|NCT01251861|79410934|FG000|Overall Study|Disease progression|6|||
44403651|NCT01251861|79410935|FG001|Overall Study|Disease progression|6|||
44403652|NCT01251861|79410934|FG000|Overall Study|Adverse Event|2|||
44403653|NCT01251861|79410935|FG001|Overall Study|Adverse Event|17|||
44403654|NCT01251861|79410934|FG000|Overall Study|Withdrawal by Subject|2|||
44403655|NCT01251861|79410935|FG001|Overall Study|Withdrawal by Subject|2|||
44403656|NCT01251861|79410934|FG000|Overall Study|Alternative therapy|1|||
44403657|NCT01251861|79410935|FG001|Overall Study|Alternative therapy|0|||
44522500|NCT03351608|79530651|FG001|Overall Study|Lost to Follow-up|1|||
44522501|NCT03351608|79530652|FG002|Overall Study|Lost to Follow-up|1|||
44522502|NCT03351608|79530653|FG003|Overall Study|Lost to Follow-up|1|||
44522503|NCT03351608|79530654|FG004|Overall Study|Lost to Follow-up|1|||
44522504|NCT03351608|79530650|FG000|Overall Study|Physician Decision|1|||
44522505|NCT03351608|79530651|FG001|Overall Study|Physician Decision|0|||
44522506|NCT03351608|79530652|FG002|Overall Study|Physician Decision|0|||
44522507|NCT03351608|79530653|FG003|Overall Study|Physician Decision|2|||
44522508|NCT03351608|79530654|FG004|Overall Study|Physician Decision|1|||
44522509|NCT03351608|79530650|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
44522510|NCT03351608|79530651|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
44522511|NCT03351608|79530652|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
44522512|NCT03351608|79530653|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
44522513|NCT03351608|79530654|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
44522514|NCT03351608|79530650|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44522515|NCT03351608|79530651|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44403658|NCT01251861|79410934|FG000|Overall Study|Other complicating disease|0|||
44403659|NCT01251861|79410935|FG001|Overall Study|Other complicating disease|1|||
44403660|NCT01251861|79410934|FG000|Overall Study|Physician Decision|1|||
44403661|NCT01251861|79410935|FG001|Overall Study|Physician Decision|0|||
44403662|NCT01251861|79410934|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
44403663|NCT01251861|79410935|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
44403664|NCT01251861|79410934|FG000|Overall Study|Other|1|||
44403665|NCT01251861|79410935|FG001|Overall Study|Other|0|||
44403666|NCT01251861|79410934|FG000|Overall Study|Never started therapy|4|||
44403667|NCT01251861|79410935|FG001|Overall Study|Never started therapy|1|||
44403668|NCT01251861|79410934|FG000|Overall Study|Potential interaction of drugs|0|||
44403669|NCT01251861|79410935|FG001|Overall Study|Potential interaction of drugs|1|||
44403670|NCT01142388|79410943|FG000|Overall Study|Lack of Efficacy|21|||
44403671|NCT01142388|79410944|FG001|Overall Study|Lack of Efficacy|31|||
44403672|NCT01142388|79410943|FG000|Overall Study|Adverse Event|9|||
44403673|NCT01142388|79410944|FG001|Overall Study|Adverse Event|5|||
44403674|NCT01142388|79410943|FG000|Overall Study|Death|3|||
44403675|NCT01142388|79410944|FG001|Overall Study|Death|2|||
44522516|NCT03351608|79530652|FG002|Overall Study|Withdrawal by parent/guardian|1|||
44252960|NCT00088205|79092013|FG000|Overall Study|Physician Decision|1|||
44403676|NCT01142388|79410943|FG000|Overall Study|Withdrawal by Subject|5|||
44403677|NCT01142388|79410944|FG001|Overall Study|Withdrawal by Subject|3|||
44403678|NCT01142388|79410943|FG000|Overall Study|Alternative therapy|1|||
44403679|NCT01142388|79410944|FG001|Overall Study|Alternative therapy|0|||
44403680|NCT01142388|79410943|FG000|Overall Study|Other complications|0|||
44403681|NCT01142388|79410944|FG001|Overall Study|Other complications|2|||
44522517|NCT03351608|79530653|FG003|Overall Study|Withdrawal by parent/guardian|1|||
44522518|NCT03351608|79530654|FG004|Overall Study|Withdrawal by parent/guardian|0|||
44522519|NCT03351608|79530650|FG000|Overall Study|Other|0|||
44403682|NCT01142388|79410943|FG000|Overall Study|Other|1|||
44403683|NCT01142388|79410944|FG001|Overall Study|Other|1|||
44403684|NCT01142388|79410943|FG000|Overall Study|Never started therapy|7|||
44403685|NCT01142388|79410944|FG001|Overall Study|Never started therapy|3|||
44403686|NCT01134614|79410952|FG000|Overall Study|Still on treatment as of March 2013|21|||
44403687|NCT01134614|79410953|FG001|Overall Study|Still on treatment as of March 2013|13|||
44403688|NCT01134614|79410952|FG000|Overall Study|Progressive disease|60|||
44403689|NCT01134614|79410953|FG001|Overall Study|Progressive disease|54|||
44403690|NCT01134614|79410952|FG000|Overall Study|Adverse Event|26|||
44403691|NCT01134614|79410953|FG001|Overall Study|Adverse Event|39|||
44403692|NCT01134614|79410952|FG000|Overall Study|Death|5|||
44403693|NCT01134614|79410953|FG001|Overall Study|Death|8|||
44403694|NCT01134614|79410952|FG000|Overall Study|Withdrawal by Subject|3|||
44403695|NCT01134614|79410953|FG001|Overall Study|Withdrawal by Subject|2|||
44403696|NCT01134614|79410952|FG000|Overall Study|Alternative therapy|2|||
44403697|NCT01134614|79410953|FG001|Overall Study|Alternative therapy|0|||
44403698|NCT01134614|79410952|FG000|Overall Study|Complicating disease|2|||
44403699|NCT01134614|79410953|FG001|Overall Study|Complicating disease|1|||
44403700|NCT01134614|79410952|FG000|Overall Study|Physician's decision|0|||
44403701|NCT01134614|79410953|FG001|Overall Study|Physician's decision|1|||
44403702|NCT01134614|79410952|FG000|Overall Study|Never started treatment|4|||
44403703|NCT01134614|79410953|FG001|Overall Study|Never started treatment|1|||
44403704|NCT01134614|79410952|FG000|Overall Study|Pt received tx not allowed on study|0|||
44403705|NCT01134614|79410953|FG001|Overall Study|Pt received tx not allowed on study|1|||
44403706|NCT01134614|79410952|FG000|Overall Study|Symptomatic deterioration|0|||
44403707|NCT01134614|79410953|FG001|Overall Study|Symptomatic deterioration|1|||
44403708|NCT01134614|79410952|FG000|Overall Study|Patient in hospice care|0|||
44403709|NCT01134614|79410953|FG001|Overall Study|Patient in hospice care|1|||
44403710|NCT00601900|79410961|FG000|Overall Study|Withdrawal by Subject|0|||
44403711|NCT00601900|79410962|FG001|Overall Study|Withdrawal by Subject|3|||
44403712|NCT03905863|79410970|FG000|Overall Study|Adverse Event|2|||
44403713|NCT03905863|79410971|FG001|Overall Study|Adverse Event|4|||
44403714|NCT03905863|79410970|FG000|Overall Study|Withdrawal by Subject|2|||
44403715|NCT03905863|79410971|FG001|Overall Study|Withdrawal by Subject|2|||
44403716|NCT03905863|79410970|FG000|Overall Study|Physician Decision|0|||
44403717|NCT03905863|79410971|FG001|Overall Study|Physician Decision|3|||
44403718|NCT03905863|79410970|FG000|Overall Study|Lost to Follow-up|1|||
44403719|NCT03905863|79410971|FG001|Overall Study|Lost to Follow-up|0|||
44403720|NCT03905863|79410970|FG000|Overall Study|Protocol Violation|0|||
44403721|NCT03905863|79410971|FG001|Overall Study|Protocol Violation|2|||
44403722|NCT03905863|79410970|FG000|Overall Study|Death|0|||
44403723|NCT03905863|79410971|FG001|Overall Study|Death|1|||
44403724|NCT00539305|79411011|FG000|Overall Study|Adverse Event|1|||
44403725|NCT00539305|79411012|FG001|Overall Study|Adverse Event|0|||
44403726|NCT00539305|79411011|FG000|Overall Study|Substance Use|0|||
44403727|NCT00539305|79411012|FG001|Overall Study|Substance Use|1|||
44403728|NCT00539305|79411011|FG000|Overall Study|Withdrawal by Subject|0|||
44403729|NCT00539305|79411012|FG001|Overall Study|Withdrawal by Subject|1|||
44403730|NCT00877032|79411044|FG000|Overall Study|Did not meet entrance criteria|0|||
44403731|NCT00877032|79411045|FG001|Overall Study|Did not meet entrance criteria|0|||
44403732|NCT00877032|79411046|FG002|Overall Study|Did not meet entrance criteria|0|||
44403733|NCT00877032|79411047|FG003|Overall Study|Did not meet entrance criteria|1|||
44281837|NCT01908816|79245110|FG003|Overall Study|Lost to Follow-up|2|||
44281838|NCT01908816|79245107|FG000|Overall Study|Death|1|||
44281839|NCT01908816|79245108|FG001|Overall Study|Death|0|||
44281840|NCT01908816|79245109|FG002|Overall Study|Death|7|||
44281841|NCT01908816|79245110|FG003|Overall Study|Death|1|||
44281842|NCT01908816|79245107|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44281843|NCT01908816|79245108|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
44281844|NCT01908816|79245109|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
44281845|NCT01908816|79245110|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
44281846|NCT01908816|79245107|FG000|Overall Study|Early termination|87|||
44281847|NCT01908816|79245108|FG001|Overall Study|Early termination|60|||
44281848|NCT01908816|79245109|FG002|Overall Study|Early termination|43|||
44281849|NCT01908816|79245110|FG003|Overall Study|Early termination|28|||
44281850|NCT01908582|79245123|FG000|Period 2|Physician Decision|1|||
44281851|NCT01908582|79245123|FG000|Period 2|Withdrawal by Subject|1|||
44281852|NCT01908426|79245132|FG000|Overall Study|Adverse Event|98|||
44281853|NCT01908426|79245133|FG001|Overall Study|Adverse Event|11|||
44281854|NCT01908426|79245132|FG000|Overall Study|Clinical Deterioration|72|||
44403734|NCT00877032|79411048|FG004|Overall Study|Did not meet entrance criteria|0|||
44403735|NCT00877032|79411049|FG005|Overall Study|Did not meet entrance criteria|0|||
44403736|NCT00877032|79411050|FG006|Overall Study|Did not meet entrance criteria|2|||
44403737|NCT00538681|79411089|FG000|Overall Study|Progressive Disease|7|||
44403738|NCT00538681|79411090|FG001|Overall Study|Progressive Disease|0|||
44403739|NCT00538681|79411091|FG002|Overall Study|Progressive Disease|1|||
44403740|NCT00538681|79411092|FG003|Overall Study|Progressive Disease|0|||
44403741|NCT00538681|79411089|FG000|Overall Study|Sponsor Decision|1|||
44403742|NCT00538681|79411090|FG001|Overall Study|Sponsor Decision|3|||
44403743|NCT00538681|79411091|FG002|Overall Study|Sponsor Decision|8|||
44281855|NCT01908426|79245133|FG001|Overall Study|Clinical Deterioration|38|||
44281856|NCT01908426|79245132|FG000|Overall Study|Lack of Efficacy|3|||
44281857|NCT01908426|79245133|FG001|Overall Study|Lack of Efficacy|0|||
44281858|NCT01908426|79245132|FG000|Overall Study|Lost to Follow-up|0|||
44281859|NCT01908426|79245133|FG001|Overall Study|Lost to Follow-up|1|||
44281860|NCT01908426|79245132|FG000|Overall Study|Physician Decision|3|||
44403744|NCT00538681|79411092|FG003|Overall Study|Sponsor Decision|9|||
44403745|NCT00538681|79411089|FG000|Overall Study|Adverse Event|1|||
44403746|NCT00538681|79411090|FG001|Overall Study|Adverse Event|1|||
44403747|NCT00538681|79411091|FG002|Overall Study|Adverse Event|1|||
44403748|NCT00538681|79411092|FG003|Overall Study|Adverse Event|0|||
44403749|NCT00538681|79411089|FG000|Overall Study|Death|0|||
44403750|NCT00538681|79411090|FG001|Overall Study|Death|0|||
44403751|NCT00538681|79411091|FG002|Overall Study|Death|1|||
44403752|NCT00538681|79411092|FG003|Overall Study|Death|1|||
44403753|NCT00538681|79411089|FG000|Overall Study|Investigator Decision|0|||
44403754|NCT00538681|79411090|FG001|Overall Study|Investigator Decision|0|||
44403755|NCT00538681|79411091|FG002|Overall Study|Investigator Decision|0|||
44403756|NCT00538681|79411092|FG003|Overall Study|Investigator Decision|1|||
44403757|NCT00876018|79411106|FG000|Overall Study|Lost to Follow-up|0|||
44403758|NCT00876018|79411107|FG001|Overall Study|Lost to Follow-up|1|||
44403759|NCT00876018|79411108|FG002|Overall Study|Lost to Follow-up|1|||
44403760|NCT00876018|79411106|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
44403761|NCT00876018|79411107|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
44403762|NCT00876018|79411108|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
44403763|NCT03885934|79411133|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
44403764|NCT03885934|79411134|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
44403765|NCT03885934|79411135|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
44403766|NCT03885934|79411136|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
44403767|NCT03885934|79411137|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
44403768|NCT03885934|79411138|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
44403769|NCT04417894|79411154|FG000|Overall Study|Lost to Follow-up|3|||
44403770|NCT04417894|79411155|FG001|Overall Study|Lost to Follow-up|0|||
44403771|NCT04417894|79411154|FG000|Overall Study|Withdrawal by Subject|7|||
44403772|NCT04417894|79411155|FG001|Overall Study|Withdrawal by Subject|6|||
44522520|NCT03351608|79530651|FG001|Overall Study|Other|1|||
44522521|NCT03351608|79530652|FG002|Overall Study|Other|1|||
44522522|NCT03351608|79530653|FG003|Overall Study|Other|3|||
44522523|NCT03351608|79530654|FG004|Overall Study|Other|0|||
44522524|NCT02857816|79530677|FG000|Overall Study|Screen Failure|33|||
44403773|NCT04417894|79411154|FG000|Overall Study|Lack of Efficacy|3|||
44403774|NCT04417894|79411155|FG001|Overall Study|Lack of Efficacy|1|||
44403775|NCT00875706|79411168|FG000|Overall Study|Withdrawal by Subject|1|||
44403776|NCT00875706|79411169|FG001|Overall Study|Withdrawal by Subject|0|||
44403777|NCT00875706|79411170|FG002|Overall Study|Withdrawal by Subject|0|||
44403778|NCT04399889|79411181|FG000|Overall Study|Death|5|||
44403779|NCT04399889|79411182|FG001|Overall Study|Death|1|||
44403780|NCT04399889|79411183|FG002|Overall Study|Death|1|||
44403781|NCT00837265|79411198|FG000|Pilot Phase|Withdrawal by Subject|0|||
44403782|NCT00837265|79411199|FG001|Pilot Phase|Withdrawal by Subject|2|||
44403783|NCT00837265|79411200|FG002|Pilot Phase|Withdrawal by Subject|3|||
44522525|NCT02857816|79530677|FG000|Overall Study|Withdrawal by Subject|4|||
44522526|NCT02857816|79530677|FG000|Overall Study|Lost to Follow-up|1|||
44522527|NCT02858440|79530682|FG000|Overall Study|Lost to Follow-up|3|||
44403784|NCT00837265|79411201|FG003|Pilot Phase|Withdrawal by Subject|2|||
44281861|NCT01908426|79245133|FG001|Overall Study|Physician Decision|3|||
44403785|NCT00837265|79411202|FG004|Pilot Phase|Withdrawal by Subject|0|||
44403786|NCT00837265|79411203|FG005|Pilot Phase|Withdrawal by Subject|0|||
44403787|NCT00837265|79411204|FG006|Pilot Phase|Withdrawal by Subject|0|||
44403788|NCT00837265|79411198|FG000|Pilot Phase|Decision of the investigator|2|||
44403789|NCT00837265|79411199|FG001|Pilot Phase|Decision of the investigator|1|||
44403790|NCT00837265|79411200|FG002|Pilot Phase|Decision of the investigator|0|||
44403791|NCT00837265|79411201|FG003|Pilot Phase|Decision of the investigator|0|||
44403792|NCT00837265|79411202|FG004|Pilot Phase|Decision of the investigator|0|||
44403793|NCT00837265|79411203|FG005|Pilot Phase|Decision of the investigator|0|||
44403794|NCT00837265|79411204|FG006|Pilot Phase|Decision of the investigator|0|||
44403795|NCT00837265|79411198|FG000|Pilot Phase|Adverse Event|1|||
44403796|NCT00837265|79411199|FG001|Pilot Phase|Adverse Event|0|||
44403797|NCT00837265|79411200|FG002|Pilot Phase|Adverse Event|0|||
44403798|NCT00837265|79411201|FG003|Pilot Phase|Adverse Event|0|||
44403799|NCT00837265|79411202|FG004|Pilot Phase|Adverse Event|0|||
44522528|NCT02858440|79530682|FG000|Overall Study|Protocol Violation|2|||
44403800|NCT00837265|79411203|FG005|Pilot Phase|Adverse Event|0|||
44403801|NCT00837265|79411204|FG006|Pilot Phase|Adverse Event|0|||
44403802|NCT00837265|79411198|FG000|Pilot Phase|Disease progression|0|||
44403803|NCT00837265|79411199|FG001|Pilot Phase|Disease progression|0|||
44403804|NCT00837265|79411200|FG002|Pilot Phase|Disease progression|0|||
44522529|NCT02858440|79530682|FG000|Overall Study|Consent withdrawal|3|||
44403805|NCT00837265|79411201|FG003|Pilot Phase|Disease progression|1|||
44403806|NCT00837265|79411202|FG004|Pilot Phase|Disease progression|0|||
44403807|NCT00837265|79411203|FG005|Pilot Phase|Disease progression|0|||
44403808|NCT00837265|79411204|FG006|Pilot Phase|Disease progression|0|||
44403809|NCT00837265|79411198|FG000|Pilot Phase|Participant left the city|0|||
44403810|NCT00837265|79411199|FG001|Pilot Phase|Participant left the city|0|||
44403811|NCT00837265|79411200|FG002|Pilot Phase|Participant left the city|0|||
44403812|NCT00837265|79411201|FG003|Pilot Phase|Participant left the city|1|||
44403813|NCT00837265|79411202|FG004|Pilot Phase|Participant left the city|0|||
44403814|NCT00837265|79411203|FG005|Pilot Phase|Participant left the city|0|||
44403815|NCT00837265|79411204|FG006|Pilot Phase|Participant left the city|0|||
44403816|NCT00837265|79411198|FG000|Main Phase|Withdrawal by Subject|0|||
44403817|NCT00837265|79411199|FG001|Main Phase|Withdrawal by Subject|0|||
44403818|NCT00837265|79411200|FG002|Main Phase|Withdrawal by Subject|0|||
44403819|NCT00837265|79411201|FG003|Main Phase|Withdrawal by Subject|0|||
44403820|NCT00837265|79411202|FG004|Main Phase|Withdrawal by Subject|4|||
44403821|NCT00837265|79411203|FG005|Main Phase|Withdrawal by Subject|2|||
44403822|NCT00837265|79411204|FG006|Main Phase|Withdrawal by Subject|1|||
44403823|NCT00837265|79411198|FG000|Main Phase|Decision of the investigator|0|||
44403824|NCT00837265|79411199|FG001|Main Phase|Decision of the investigator|0|||
44403825|NCT00837265|79411200|FG002|Main Phase|Decision of the investigator|0|||
44403826|NCT00837265|79411201|FG003|Main Phase|Decision of the investigator|0|||
44403827|NCT00837265|79411202|FG004|Main Phase|Decision of the investigator|0|||
44403828|NCT00837265|79411203|FG005|Main Phase|Decision of the investigator|2|||
44403829|NCT00837265|79411204|FG006|Main Phase|Decision of the investigator|1|||
44403830|NCT00837265|79411198|FG000|Main Phase|Adverse Event|0|||
44403831|NCT00837265|79411199|FG001|Main Phase|Adverse Event|0|||
44403832|NCT00837265|79411200|FG002|Main Phase|Adverse Event|0|||
44403833|NCT00837265|79411201|FG003|Main Phase|Adverse Event|0|||
44403834|NCT00837265|79411202|FG004|Main Phase|Adverse Event|0|||
44403835|NCT00837265|79411203|FG005|Main Phase|Adverse Event|1|||
44403836|NCT00837265|79411204|FG006|Main Phase|Adverse Event|0|||
44403837|NCT00837265|79411198|FG000|Main Phase|Death|0|||
44522530|NCT02858440|79530682|FG000|Overall Study|Migrated/moved from study area|4|||
44147814|NCT02615145|78937162|FG000|Overall Study|Failure to Return|20|||
44403838|NCT00837265|79411199|FG001|Main Phase|Death|0|||
44403839|NCT00837265|79411200|FG002|Main Phase|Death|0|||
44403840|NCT00837265|79411201|FG003|Main Phase|Death|0|||
44403841|NCT00837265|79411202|FG004|Main Phase|Death|2|||
44403842|NCT00837265|79411203|FG005|Main Phase|Death|0|||
44403843|NCT00837265|79411204|FG006|Main Phase|Death|1|||
44403844|NCT00837265|79411198|FG000|Main Phase|Lost to Follow-up|0|||
44403845|NCT00837265|79411199|FG001|Main Phase|Lost to Follow-up|0|||
44403846|NCT00837265|79411200|FG002|Main Phase|Lost to Follow-up|0|||
44403847|NCT00837265|79411201|FG003|Main Phase|Lost to Follow-up|0|||
44403848|NCT00837265|79411202|FG004|Main Phase|Lost to Follow-up|1|||
44403849|NCT00837265|79411203|FG005|Main Phase|Lost to Follow-up|0|||
44403850|NCT00837265|79411204|FG006|Main Phase|Lost to Follow-up|0|||
44403851|NCT00837265|79411198|FG000|Main Phase|Principal investigator resignation|0|||
44403852|NCT00837265|79411199|FG001|Main Phase|Principal investigator resignation|0|||
44403853|NCT00837265|79411200|FG002|Main Phase|Principal investigator resignation|0|||
44403854|NCT00837265|79411201|FG003|Main Phase|Principal investigator resignation|0|||
44403855|NCT00837265|79411202|FG004|Main Phase|Principal investigator resignation|2|||
44403856|NCT00837265|79411203|FG005|Main Phase|Principal investigator resignation|0|||
44403857|NCT00837265|79411204|FG006|Main Phase|Principal investigator resignation|0|||
44403858|NCT00837265|79411198|FG000|Main Phase|Participant's personal reason|0|||
44403859|NCT00837265|79411199|FG001|Main Phase|Participant's personal reason|0|||
44403860|NCT00837265|79411200|FG002|Main Phase|Participant's personal reason|0|||
44403861|NCT00837265|79411201|FG003|Main Phase|Participant's personal reason|0|||
44522531|NCT03382418|79530689|FG000|Overall Study|Withdrawal by Subject|1|||
44522532|NCT03382418|79530690|FG001|Overall Study|Withdrawal by Subject|0|||
44522533|NCT03382418|79530691|FG002|Overall Study|Withdrawal by Subject|0|||
44147815|NCT02615145|78937163|FG001|Overall Study|Failure to Return|10|||
44147816|NCT02615145|78937164|FG002|Overall Study|Failure to Return|7|||
44403862|NCT00837265|79411202|FG004|Main Phase|Participant's personal reason|1|||
44403863|NCT00837265|79411203|FG005|Main Phase|Participant's personal reason|0|||
44403864|NCT00837265|79411204|FG006|Main Phase|Participant's personal reason|0|||
44403865|NCT00594516|79411217|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
44522534|NCT03382418|79530689|FG000|Overall Study|Lost to Follow-up|2|||
44147817|NCT02615145|78937165|FG003|Overall Study|Failure to Return|0|||
44403866|NCT00594516|79411218|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
44403867|NCT00594516|79411219|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
44403868|NCT00594516|79411217|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
44147818|NCT02615145|78937162|FG000|Overall Study|Death|2|||
44403869|NCT00594516|79411218|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
44403870|NCT00594516|79411219|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
44403871|NCT00594516|79411217|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
44403872|NCT00594516|79411218|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
44403873|NCT00594516|79411219|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
44403874|NCT00594516|79411217|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
44403875|NCT00594516|79411218|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
44403876|NCT00594516|79411219|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
44403877|NCT00594516|79411217|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
44403878|NCT00594516|79411218|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
44403879|NCT00594516|79411219|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
44403880|NCT00594516|79411217|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
44403881|NCT00594516|79411218|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
44403882|NCT00594516|79411219|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
44403883|NCT00594516|79411217|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
44403884|NCT00594516|79411218|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
44403885|NCT00594516|79411219|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
44403886|NCT00594516|79411217|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
44403887|NCT00594516|79411218|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
44147819|NCT02615145|78937163|FG001|Overall Study|Death|3|||
44147820|NCT02615145|78937164|FG002|Overall Study|Death|0|||
44147821|NCT02615145|78937165|FG003|Overall Study|Death|0|||
44147822|NCT02615145|78937162|FG000|Overall Study|Other, Not Specified|5|||
44281862|NCT01908426|79245132|FG000|Overall Study|Withdrawal by Subject|11|||
44281863|NCT01908426|79245133|FG001|Overall Study|Withdrawal by Subject|6|||
44281864|NCT01908426|79245132|FG000|Overall Study|Progressive Disease|206|||
44281865|NCT01908426|79245133|FG001|Overall Study|Progressive Disease|152|||
44281866|NCT01908426|79245132|FG000|Overall Study|Protocol Violation|1|||
44281867|NCT01908426|79245133|FG001|Overall Study|Protocol Violation|0|||
44281868|NCT01908426|79245132|FG000|Overall Study|No Study Treatment Given|3|||
44281869|NCT01908426|79245133|FG001|Overall Study|No Study Treatment Given|0|||
44281870|NCT01907100|79245143|FG000|Overall Study|PD based on modified RECIST criteria|31|||
44403888|NCT00594516|79411219|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
44403889|NCT00594516|79411217|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
44403890|NCT00594516|79411218|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
44403891|NCT00594516|79411219|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
44403892|NCT00538291|79411223|FG000|Overall Study|Adverse Event|2|||
44403893|NCT00538291|79411223|FG000|Overall Study|Withdrawal by Subject|1|||
44403894|NCT00594906|79411229|FG000|Overall Study|Physician Decision|1|||
44403895|NCT00594906|79411230|FG001|Overall Study|Physician Decision|0|||
44403896|NCT00594906|79411229|FG000|Overall Study|Physician Decision|0|||
44403897|NCT00594906|79411230|FG001|Overall Study|Physician Decision|1|||
44403898|NCT00594906|79411229|FG000|Overall Study|Death|0|||
44403899|NCT00594906|79411230|FG001|Overall Study|Death|1|||
44403900|NCT00537979|79411238|FG000|Overall Study|Adverse Event|2|||
44403901|NCT00537979|79411239|FG001|Overall Study|Adverse Event|2|||
44403902|NCT00537979|79411238|FG000|Overall Study|Withdrawal by Subject|1|||
44403903|NCT00537979|79411239|FG001|Overall Study|Withdrawal by Subject|4|||
44403904|NCT00537979|79411238|FG000|Overall Study|Lost to Follow-up|1|||
44403905|NCT00537979|79411239|FG001|Overall Study|Lost to Follow-up|4|||
44403906|NCT00537979|79411238|FG000|Overall Study|Lack of Efficacy|0|||
44403907|NCT00537979|79411239|FG001|Overall Study|Lack of Efficacy|1|||
44403908|NCT00537979|79411238|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
44403909|NCT00537979|79411239|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
44403910|NCT00537979|79411238|FG000|Overall Study|Death|0|||
44403911|NCT00537979|79411239|FG001|Overall Study|Death|3|||
44403912|NCT00537979|79411238|FG000|Overall Study|Kidney transplant|0|||
44403913|NCT00537979|79411239|FG001|Overall Study|Kidney transplant|3|||
44522535|NCT03382418|79530690|FG001|Overall Study|Lost to Follow-up|3|||
44522536|NCT03382418|79530691|FG002|Overall Study|Lost to Follow-up|0|||
44522537|NCT02858362|79530703|FG000|Overall Study|Protocol Violation|0|||
44522538|NCT02858362|79530704|FG001|Overall Study|Protocol Violation|1|||
44403914|NCT00537979|79411238|FG000|Overall Study|Heart failure|0|||
44403915|NCT00537979|79411239|FG001|Overall Study|Heart failure|1|||
44403916|NCT00537823|79411248|FG000|Overall Study|Adverse Event|2|||
44522539|NCT02858362|79530705|FG002|Overall Study|Protocol Violation|0|||
44403917|NCT00537823|79411249|FG001|Overall Study|Adverse Event|0|||
44147823|NCT02615145|78937163|FG001|Overall Study|Other, Not Specified|2|||
44403918|NCT00537277|79411256|FG000|Overall Study|Adverse Event|1|||
44403919|NCT00537277|79411256|FG000|Overall Study|Lack of Efficacy|2|||
44403920|NCT00537277|79411256|FG000|Overall Study|Lost to Follow-up|12|||
44403921|NCT00537277|79411256|FG000|Overall Study|Protocol Violation|11|||
44403922|NCT00537277|79411256|FG000|Overall Study|Unclassified|4|||
44522540|NCT02858362|79530703|FG000|Overall Study|Withdrawal by Subject|1|||
44522541|NCT02858362|79530704|FG001|Overall Study|Withdrawal by Subject|0|||
44147824|NCT02615145|78937164|FG002|Overall Study|Other, Not Specified|0|||
44281871|NCT01907100|79245144|FG001|Overall Study|PD based on modified RECIST criteria|32|||
44281872|NCT01907100|79245145|FG002|Overall Study|PD based on modified RECIST criteria|95|||
44281873|NCT01907100|79245146|FG003|Overall Study|PD based on modified RECIST criteria|92|||
44403923|NCT00537277|79411256|FG000|Overall Study|Inability to tolerate trial medication|4|||
44403924|NCT00537277|79411256|FG000|Overall Study|Non-compliance with trial procedures|15|||
44403925|NCT00537199|79411260|FG000|Overall Study|Study Terminated|1|||
44403926|NCT03898063|79411266|FG000|Overall Study|Withdrawal by Subject|10|||
44403927|NCT03898063|79411267|FG001|Overall Study|Withdrawal by Subject|8|||
44403928|NCT00873912|79411275|FG000|Overall Study|Withdrawal by Subject|1|||
44403929|NCT00873912|79411276|FG001|Overall Study|Withdrawal by Subject|0|||
44403930|NCT00873912|79411275|FG000|Overall Study|Lost to Follow-up|2|||
44403931|NCT00873912|79411276|FG001|Overall Study|Lost to Follow-up|0|||
44403932|NCT03823300|79411288|FG000|Overall Study|Withdrawal by Subject|16|||
44403933|NCT03823300|79411289|FG001|Overall Study|Withdrawal by Subject|22|||
44403934|NCT03823300|79411288|FG000|Overall Study|Death|10|||
44403935|NCT03823300|79411289|FG001|Overall Study|Death|14|||
44403936|NCT03823300|79411288|FG000|Overall Study|Adverse Event|3|||
44403937|NCT03823300|79411289|FG001|Overall Study|Adverse Event|5|||
44403938|NCT03823300|79411288|FG000|Overall Study|Physician Decision|1|||
44252961|NCT00088205|79092013|FG000|Overall Study|Death Due to Study Disease|4|||
44252962|NCT00085709|79092107|FG000|Overall Study|Adverse Event|8|||
44252963|NCT00085709|79092108|FG001|Overall Study|Adverse Event|0|||
44252964|NCT00085709|79092107|FG000|Overall Study|Death|8|||
44403939|NCT03823300|79411289|FG001|Overall Study|Physician Decision|7|||
44403940|NCT03823300|79411288|FG000|Overall Study|Lost to Follow-up|1|||
44403941|NCT03823300|79411289|FG001|Overall Study|Lost to Follow-up|3|||
44403942|NCT03823300|79411288|FG000|Overall Study|Protocol Violation|1|||
44403943|NCT03823300|79411289|FG001|Overall Study|Protocol Violation|1|||
44403944|NCT03823300|79411288|FG000|Overall Study|Lack of Efficacy|1|||
44403945|NCT03823300|79411289|FG001|Overall Study|Lack of Efficacy|1|||
44403946|NCT03823300|79411288|FG000|Overall Study|Not Eligible|0|||
44403947|NCT03823300|79411289|FG001|Overall Study|Not Eligible|1|||
44403948|NCT03823300|79411288|FG000|Overall Study|Other|1|||
44403949|NCT03823300|79411289|FG001|Overall Study|Other|0|||
44403950|NCT00537745|79411295|FG000|Overall Study|Did not meet eligibility criteria|2|||
44403951|NCT00537745|79411295|FG000|Overall Study|Withdrawal by Subject|2|||
44403952|NCT00537745|79411295|FG000|Overall Study|Subject unable to provide Interlock info|1|||
44403953|NCT00874848|79411302|FG000|Overall Study|Adverse Event|13|||
44403954|NCT00874848|79411303|FG001|Overall Study|Adverse Event|2|||
44403955|NCT00874848|79411302|FG000|Overall Study|Progressive neoplastic disease|38|||
44403956|NCT00874848|79411303|FG001|Overall Study|Progressive neoplastic disease|18|||
44403957|NCT00874848|79411302|FG000|Overall Study|Withdrawal by Subject|7|||
44403958|NCT00874848|79411303|FG001|Overall Study|Withdrawal by Subject|4|||
44403959|NCT00874848|79411302|FG000|Overall Study|Noncompliance|1|||
44403960|NCT00874848|79411303|FG001|Overall Study|Noncompliance|1|||
44403961|NCT00874848|79411302|FG000|Overall Study|Failure to comply with protocol|0|||
44403962|NCT00874848|79411303|FG001|Overall Study|Failure to comply with protocol|1|||
44403963|NCT00874848|79411302|FG000|Overall Study|Physician Decision|0|||
44403964|NCT00874848|79411303|FG001|Overall Study|Physician Decision|2|||
44403965|NCT00578812|79411311|FG000|Overall Study|Not treated|6|||
44403966|NCT00578812|79411312|FG001|Overall Study|Not treated|7|||
44252965|NCT00085709|79092108|FG001|Overall Study|Death|2|||
44403967|NCT04043806|79411319|FG000|Overall Study|Commercial drug is available for participants|13|||
44403968|NCT04043806|79411319|FG000|Overall Study|Physician Decision|2|||
44403969|NCT04043806|79411319|FG000|Overall Study|Other|12|||
44403970|NCT04043806|79411319|FG000|Overall Study|Adverse Event|2|||
44403971|NCT04043806|79411319|FG000|Overall Study|Lost to Follow-up|6|||
44403972|NCT04043806|79411319|FG000|Overall Study|Other non-compliance|2|||
44403973|NCT04043806|79411319|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
44403974|NCT04043806|79411319|FG000|Overall Study|Never Dosed|1|||
44252966|NCT00085709|79092107|FG000|Overall Study|Refusal unrelated to adverse events|1|||
44403975|NCT00536809|79411324|FG000|Phase II|Adverse Event|1|||
44403976|NCT00536809|79411324|FG000|Phase II|Referred for surgical resection|1|||
44252967|NCT00085709|79092108|FG001|Overall Study|Refusal unrelated to adverse events|2|||
44403977|NCT00536731|79411335|FG000|Overall Study|Adverse Event|3|||
44403978|NCT00536731|79411336|FG001|Overall Study|Adverse Event|2|||
44403979|NCT00536731|79411337|FG002|Overall Study|Adverse Event|3|||
44403980|NCT00536731|79411335|FG000|Overall Study|Withdrawal by Subject|0|||
44403981|NCT00536731|79411336|FG001|Overall Study|Withdrawal by Subject|2|||
44403982|NCT00536731|79411337|FG002|Overall Study|Withdrawal by Subject|0|||
44403983|NCT00536731|79411335|FG000|Overall Study|Intake of prohibited conc. medication|0|||
44403984|NCT00536731|79411336|FG001|Overall Study|Intake of prohibited conc. medication|0|||
44403985|NCT00536731|79411337|FG002|Overall Study|Intake of prohibited conc. medication|1|||
44403986|NCT00536731|79411335|FG000|Overall Study|Safety reasons|0|||
44403987|NCT00536731|79411336|FG001|Overall Study|Safety reasons|0|||
44403988|NCT00536731|79411337|FG002|Overall Study|Safety reasons|1|||
44403989|NCT00536731|79411335|FG000|Overall Study|Other|1|||
44403990|NCT00536731|79411336|FG001|Overall Study|Other|1|||
44403991|NCT00536731|79411337|FG002|Overall Study|Other|0|||
44403992|NCT00536575|79411345|FG000|Overall Study|Withdrawal by Subject|1|||
44403993|NCT00536575|79411345|FG000|Overall Study|Death|1|||
44403994|NCT03214250|79411356|FG000|Overall Study|Death|5|||
44403995|NCT03214250|79411357|FG001|Overall Study|Death|5|||
44403996|NCT03214250|79411358|FG002|Overall Study|Death|7|||
44403997|NCT03214250|79411359|FG003|Overall Study|Death|4|||
44522542|NCT02858362|79530705|FG002|Overall Study|Withdrawal by Subject|0|||
44522543|NCT02858362|79530703|FG000|Overall Study|Early Study Termination|0|||
44522544|NCT02858362|79530704|FG001|Overall Study|Early Study Termination|0|||
44522545|NCT02858362|79530705|FG002|Overall Study|Early Study Termination|3|||
44522546|NCT02858362|79530703|FG000|Overall Study|Lost to Follow-up|1|||
44522547|NCT02858362|79530704|FG001|Overall Study|Lost to Follow-up|0|||
44522548|NCT02858362|79530705|FG002|Overall Study|Lost to Follow-up|0|||
44522549|NCT03350750|79530720|FG000|Overall Study|Death|1|||
44522550|NCT03350750|79530721|FG001|Overall Study|Death|1|||
44522551|NCT03394508|79530731|FG000|Overall Study|Protocol Violation|0|||
44522552|NCT03394508|79530732|FG001|Overall Study|Protocol Violation|3|||
44522553|NCT03394508|79530731|FG000|Overall Study|Lost to Follow-up|1|||
44522554|NCT03394508|79530732|FG001|Overall Study|Lost to Follow-up|0|||
44522555|NCT02856880|79530742|FG000|Overall Study|Withdrawal of consent|1|||
44522556|NCT03393806|79530763|FG000|Overall Study|Physician Decision|1|||
44522557|NCT03393806|79530764|FG001|Overall Study|Physician Decision|0|||
44522558|NCT02856802|79530773|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
44522559|NCT02856802|79530774|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
44522560|NCT02856802|79530773|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
44522561|NCT02856802|79530774|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
44522562|NCT02856802|79530773|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
44522563|NCT02856802|79530774|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
44522564|NCT02856802|79530773|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
44522565|NCT02856802|79530774|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
44522566|NCT02856802|79530773|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
44522567|NCT02856802|79530774|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
44522568|NCT02856802|79530773|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
44522569|NCT02856802|79530774|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
44522570|NCT03380390|79530784|FG000|Overall Study|Adverse Event|3|||
44522571|NCT03350672|79530791|FG000|Overall Study|Withdrawal by Subject|7|||
44522572|NCT03350672|79530792|FG001|Overall Study|Withdrawal by Subject|0|||
44522573|NCT03350672|79530793|FG002|Overall Study|Withdrawal by Subject|0|||
44522574|NCT03392168|79530805|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
44522575|NCT03392168|79530806|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
44522576|NCT03392168|79530807|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
44522577|NCT03392168|79530808|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
44147825|NCT02615145|78937165|FG003|Overall Study|Other, Not Specified|0|||
44147826|NCT02119156|78937194|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
44147827|NCT02119156|78937195|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
44403998|NCT03214250|79411360|FG004|Overall Study|Death|23|||
44403999|NCT03214250|79411361|FG005|Overall Study|Death|23|||
44404000|NCT03214250|79411362|FG006|Overall Study|Death|24|||
44404001|NCT03214250|79411356|FG000|Overall Study|Lost to Follow-up|0|||
44404002|NCT03214250|79411357|FG001|Overall Study|Lost to Follow-up|0|||
44404003|NCT03214250|79411358|FG002|Overall Study|Lost to Follow-up|0|||
44404004|NCT03214250|79411359|FG003|Overall Study|Lost to Follow-up|1|||
44404005|NCT03214250|79411360|FG004|Overall Study|Lost to Follow-up|1|||
44404006|NCT03214250|79411361|FG005|Overall Study|Lost to Follow-up|2|||
44404007|NCT03214250|79411362|FG006|Overall Study|Lost to Follow-up|0|||
44404008|NCT03214250|79411356|FG000|Overall Study|Other|0|||
44404009|NCT03214250|79411357|FG001|Overall Study|Other|0|||
44404010|NCT03214250|79411358|FG002|Overall Study|Other|0|||
44404011|NCT03214250|79411359|FG003|Overall Study|Other|0|||
44404012|NCT03214250|79411360|FG004|Overall Study|Other|1|||
44404013|NCT03214250|79411361|FG005|Overall Study|Other|1|||
44404014|NCT03214250|79411362|FG006|Overall Study|Other|2|||
44404015|NCT03214250|79411356|FG000|Overall Study|Remains on Study|2|||
44404016|NCT03214250|79411357|FG001|Overall Study|Remains on Study|2|||
44404017|NCT03214250|79411358|FG002|Overall Study|Remains on Study|0|||
44404018|NCT03214250|79411359|FG003|Overall Study|Remains on Study|1|||
44404019|NCT03214250|79411360|FG004|Overall Study|Remains on Study|7|||
44404020|NCT03214250|79411361|FG005|Overall Study|Remains on Study|5|||
44404021|NCT03214250|79411362|FG006|Overall Study|Remains on Study|3|||
44404022|NCT03214250|79411356|FG000|Overall Study|Withdrawal by Subject|0|||
44404023|NCT03214250|79411357|FG001|Overall Study|Withdrawal by Subject|0|||
44404024|NCT03214250|79411358|FG002|Overall Study|Withdrawal by Subject|1|||
44404025|NCT03214250|79411359|FG003|Overall Study|Withdrawal by Subject|2|||
44404026|NCT03214250|79411360|FG004|Overall Study|Withdrawal by Subject|5|||
44404027|NCT03214250|79411361|FG005|Overall Study|Withdrawal by Subject|0|||
44404028|NCT03214250|79411362|FG006|Overall Study|Withdrawal by Subject|2|||
44404029|NCT00874770|79411386|FG000|Overall Study|Lack of Efficacy|2|||
44404030|NCT00874770|79411387|FG001|Overall Study|Lack of Efficacy|0|||
44404031|NCT00874770|79411388|FG002|Overall Study|Lack of Efficacy|0|||
44404032|NCT00874770|79411389|FG003|Overall Study|Lack of Efficacy|2|||
44404033|NCT00874770|79411386|FG000|Overall Study|Adverse Event|1|||
44404034|NCT00874770|79411387|FG001|Overall Study|Adverse Event|1|||
44404035|NCT00874770|79411388|FG002|Overall Study|Adverse Event|4|||
44404036|NCT00874770|79411389|FG003|Overall Study|Adverse Event|2|||
44404037|NCT00874770|79411386|FG000|Overall Study|Lost to Follow-up|1|||
44404038|NCT00874770|79411387|FG001|Overall Study|Lost to Follow-up|0|||
44404039|NCT00874770|79411388|FG002|Overall Study|Lost to Follow-up|0|||
44404040|NCT00874770|79411389|FG003|Overall Study|Lost to Follow-up|1|||
44404041|NCT00874770|79411386|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
44404042|NCT00874770|79411387|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
44404043|NCT00874770|79411388|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
44404044|NCT00874770|79411389|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
44404045|NCT00536263|79411412|FG000|Overall Study|Adverse Event|5|||
44404046|NCT00536263|79411413|FG001|Overall Study|Adverse Event|5|||
44404047|NCT00536263|79411414|FG002|Overall Study|Adverse Event|7|||
44404048|NCT00536263|79411412|FG000|Overall Study|Lost to Follow-up|3|||
44404049|NCT00536263|79411413|FG001|Overall Study|Lost to Follow-up|4|||
44522578|NCT03392168|79530805|FG000|Period 2: Cohort 2|Other|0|||
44522579|NCT03392168|79530806|FG001|Period 2: Cohort 2|Other|1|||
44522580|NCT03392168|79530807|FG002|Period 2: Cohort 2|Other|0|||
44522581|NCT03392168|79530808|FG003|Period 2: Cohort 2|Other|0|||
44522582|NCT03391232|79530819|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
44522583|NCT03391232|79530820|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
44522584|NCT03391232|79530819|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
44522585|NCT03391232|79530820|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
44522586|NCT03379376|79530828|FG000|Overall Study|Lost to Follow-up|2|||
44522587|NCT03379376|79530828|FG000|Overall Study|Did not wish to complete follow up|1|||
44404050|NCT00536263|79411414|FG002|Overall Study|Lost to Follow-up|4|||
44404051|NCT00536263|79411412|FG000|Overall Study|Subject withdrew - not treatment related|2|||
44404052|NCT00536263|79411413|FG001|Overall Study|Subject withdrew - not treatment related|0|||
44404053|NCT00536263|79411414|FG002|Overall Study|Subject withdrew - not treatment related|5|||
44522588|NCT03379376|79530828|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
44404054|NCT00536263|79411412|FG000|Overall Study|Subject withdrew - treatment related|0|||
44404055|NCT00536263|79411413|FG001|Overall Study|Subject withdrew - treatment related|3|||
44404056|NCT00536263|79411414|FG002|Overall Study|Subject withdrew - treatment related|2|||
44522589|NCT03379376|79530828|FG000|Overall Study|Death|1|||
44522590|NCT03349034|79530834|FG000|Overall Study|catheters dislodged during transport|2|||
44404057|NCT00536263|79411412|FG000|Overall Study|Noncompliance with protocol|0|||
44404058|NCT00536263|79411413|FG001|Overall Study|Noncompliance with protocol|0|||
44404059|NCT00536263|79411414|FG002|Overall Study|Noncompliance with protocol|1|||
44404060|NCT00536263|79411412|FG000|Overall Study|Did not meet protocol eligibility|1|||
44404061|NCT00536263|79411413|FG001|Overall Study|Did not meet protocol eligibility|2|||
44404062|NCT00536263|79411414|FG002|Overall Study|Did not meet protocol eligibility|2|||
44404063|NCT00578344|79411422|FG000|Overall Study|Insurance problems|1|||
44404064|NCT00578344|79411422|FG000|Overall Study|Graft failure|1|||
44404065|NCT00873366|79411426|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
44404066|NCT00873366|79411426|FG000|Overall Study|Off tamoxifen due to side effects|2|||
44404067|NCT00873366|79411426|FG000|Overall Study|Refused to continue DM-BT testing|3|||
44404068|NCT00536107|79411432|FG000|Overall Study|Death|5|||
44404069|NCT00536107|79411433|FG001|Overall Study|Death|1|||
44404070|NCT00536107|79411432|FG000|Overall Study|Incorrect enrolment|1|||
44404071|NCT00536107|79411433|FG001|Overall Study|Incorrect enrolment|0|||
44404072|NCT00536107|79411432|FG000|Overall Study|Withdrawal by Subject|0|||
44404073|NCT00536107|79411433|FG001|Overall Study|Withdrawal by Subject|1|||
44404074|NCT00536107|79411432|FG000|Overall Study|Study Termination|2|||
44404075|NCT00536107|79411433|FG001|Overall Study|Study Termination|4|||
44404076|NCT00885482|79411453|FG000|Overall Study|Pregnancy|1|||
44404077|NCT00885482|79411453|FG000|Overall Study|Lack of Efficacy|1|||
44404078|NCT00885482|79411453|FG000|Overall Study|Death|1|||
44404079|NCT00885482|79411453|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
44404080|NCT00885170|79411477|FG000|Overall Study|Adverse Event|12|||
44404081|NCT00885170|79411478|FG001|Overall Study|Adverse Event|4|||
44404082|NCT00885170|79411477|FG000|Overall Study|Excessive bone loss|6|||
44404083|NCT00885170|79411478|FG001|Overall Study|Excessive bone loss|3|||
44404084|NCT00885170|79411477|FG000|Overall Study|Lost to Follow-up|2|||
44404085|NCT00885170|79411478|FG001|Overall Study|Lost to Follow-up|1|||
44404086|NCT00885170|79411477|FG000|Overall Study|Physician Decision|2|||
44404087|NCT00885170|79411478|FG001|Overall Study|Physician Decision|1|||
44404088|NCT00885170|79411477|FG000|Overall Study|Protocol Violation|3|||
44404089|NCT00885170|79411478|FG001|Overall Study|Protocol Violation|1|||
44404090|NCT00885170|79411477|FG000|Overall Study|Withdrawal by Subject|13|||
44404091|NCT00885170|79411478|FG001|Overall Study|Withdrawal by Subject|13|||
44404092|NCT00866619|79411505|FG000|Overall Study|Adverse Event|112|||
44404093|NCT00866619|79411506|FG001|Overall Study|Adverse Event|106|||
44404094|NCT00866619|79411507|FG002|Overall Study|Adverse Event|47|||
44404095|NCT00866619|79411508|FG003|Overall Study|Adverse Event|44|||
44404096|NCT00866619|79411505|FG000|Overall Study|Protocol Violation|2|||
44404097|NCT00866619|79411506|FG001|Overall Study|Protocol Violation|39|||
44404098|NCT00866619|79411507|FG002|Overall Study|Protocol Violation|2|||
44404099|NCT00866619|79411508|FG003|Overall Study|Protocol Violation|17|||
44404100|NCT00866619|79411505|FG000|Overall Study|Withdrawal by Subject|587|||
44404101|NCT00866619|79411506|FG001|Overall Study|Withdrawal by Subject|295|||
44404102|NCT00866619|79411507|FG002|Overall Study|Withdrawal by Subject|272|||
44404103|NCT00866619|79411508|FG003|Overall Study|Withdrawal by Subject|144|||
44404104|NCT00866619|79411505|FG000|Overall Study|Lost to Follow-up|1145|||
44404105|NCT00866619|79411506|FG001|Overall Study|Lost to Follow-up|830|||
44404106|NCT00866619|79411507|FG002|Overall Study|Lost to Follow-up|568|||
44522591|NCT03349034|79530835|FG001|Overall Study|catheters dislodged during transport|0|||
44522592|NCT03349034|79530834|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
44522593|NCT03349034|79530835|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
44522594|NCT03349034|79530834|FG000|Overall Study|soft tissue flap used|1|||
44522595|NCT03349034|79530835|FG001|Overall Study|soft tissue flap used|0|||
44522596|NCT03349034|79530834|FG000|Overall Study|Other|0|||
44522597|NCT03349034|79530835|FG001|Overall Study|Other|1|||
44522598|NCT00358215|79530845|FG000|Overall Study|Ineligibility determined|4|||
44522599|NCT00358215|79530846|FG001|Overall Study|Ineligibility determined|3|||
44522600|NCT00358215|79530845|FG000|Overall Study|Adverse Event|83|||
44522601|NCT00358215|79530846|FG001|Overall Study|Adverse Event|65|||
44522602|NCT00358215|79530845|FG000|Overall Study|Withdrawal by Subject|111|||
44522603|NCT00358215|79530846|FG001|Overall Study|Withdrawal by Subject|102|||
44404107|NCT00866619|79411508|FG003|Overall Study|Lost to Follow-up|425|||
44404108|NCT00884390|79411555|FG000|Overall Study|Adverse Event|0|||
44522604|NCT00358215|79530845|FG000|Overall Study|Participant request|65|||
44522605|NCT00358215|79530846|FG001|Overall Study|Participant request|64|||
44522606|NCT00358215|79530845|FG000|Overall Study|Physician Decision|47|||
44522607|NCT00358215|79530846|FG001|Overall Study|Physician Decision|39|||
44404109|NCT00884390|79411556|FG001|Overall Study|Adverse Event|1|||
44404110|NCT00884390|79411555|FG000|Overall Study|Lost to Follow-up|0|||
44404111|NCT00884390|79411556|FG001|Overall Study|Lost to Follow-up|1|||
44404112|NCT00884390|79411555|FG000|Overall Study|Physician Decision|2|||
44404113|NCT00884390|79411556|FG001|Overall Study|Physician Decision|1|||
44522608|NCT00358215|79530845|FG000|Overall Study|Lost to Follow-up|16|||
44404114|NCT00884390|79411555|FG000|Overall Study|Protocol Violation|4|||
44404115|NCT00884390|79411556|FG001|Overall Study|Protocol Violation|1|||
44404116|NCT00884390|79411555|FG000|Overall Study|Withdrawal by Subject|4|||
44404117|NCT00884390|79411556|FG001|Overall Study|Withdrawal by Subject|1|||
44522609|NCT00358215|79530846|FG001|Overall Study|Lost to Follow-up|22|||
44522610|NCT00358215|79530845|FG000|Overall Study|Death|265|||
44522611|NCT00358215|79530846|FG001|Overall Study|Death|281|||
44522612|NCT00358215|79530845|FG000|Overall Study|Protocol Violation|64|||
44522613|NCT00358215|79530846|FG001|Overall Study|Protocol Violation|59|||
44522614|NCT00358215|79530845|FG000|Overall Study|Pregnancy|1|||
44522615|NCT00358215|79530846|FG001|Overall Study|Pregnancy|0|||
44522616|NCT00358215|79530845|FG000|Overall Study|Other|21|||
44522617|NCT00358215|79530846|FG001|Overall Study|Other|14|||
44522618|NCT00358215|79530845|FG000|Overall Study|Did not receive investigational product|2|||
44281874|NCT01907100|79245143|FG000|Overall Study|Withdrawal by Subject|2|||
44281875|NCT01907100|79245144|FG001|Overall Study|Withdrawal by Subject|5|||
44281876|NCT01907100|79245145|FG002|Overall Study|Withdrawal by Subject|10|||
44281877|NCT01907100|79245146|FG003|Overall Study|Withdrawal by Subject|13|||
44281878|NCT01907100|79245143|FG000|Overall Study|Protocol Violation|0|||
44281879|NCT01907100|79245144|FG001|Overall Study|Protocol Violation|0|||
44281880|NCT01907100|79245145|FG002|Overall Study|Protocol Violation|1|||
44281881|NCT01907100|79245146|FG003|Overall Study|Protocol Violation|1|||
44281882|NCT01907100|79245143|FG000|Overall Study|Lost to Follow-up|0|||
44281883|NCT01907100|79245144|FG001|Overall Study|Lost to Follow-up|0|||
44281884|NCT01907100|79245145|FG002|Overall Study|Lost to Follow-up|0|||
44281885|NCT01907100|79245146|FG003|Overall Study|Lost to Follow-up|1|||
44281886|NCT01907100|79245143|FG000|Overall Study|Not treated|2|||
44281887|NCT01907100|79245144|FG001|Overall Study|Not treated|0|||
44281888|NCT01907100|79245145|FG002|Overall Study|Not treated|1|||
44281889|NCT01907100|79245146|FG003|Overall Study|Not treated|2|||
44281890|NCT01907100|79245143|FG000|Overall Study|Other than reasons specified|1|||
44281891|NCT01907100|79245144|FG001|Overall Study|Other than reasons specified|0|||
44281892|NCT01907100|79245145|FG002|Overall Study|Other than reasons specified|10|||
44281893|NCT01907100|79245146|FG003|Overall Study|Other than reasons specified|6|||
44281894|NCT01907100|79245143|FG000|Overall Study|Adverse event (AE)|6|||
44281895|NCT01907100|79245144|FG001|Overall Study|Adverse event (AE)|3|||
44281896|NCT01907100|79245145|FG002|Overall Study|Adverse event (AE)|22|||
44281897|NCT01907100|79245146|FG003|Overall Study|Adverse event (AE)|23|||
44281898|NCT01907100|79245143|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
44281899|NCT01907100|79245144|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
44281900|NCT01907100|79245145|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
44281901|NCT01907100|79245146|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
44281902|NCT01889862|79245154|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
44281903|NCT01889862|79245155|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
44281904|NCT01889862|79245156|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
44281905|NCT01889862|79245157|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
44281906|NCT01889862|79245158|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
44281907|NCT01889862|79245154|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
44281908|NCT01889862|79245155|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
44281909|NCT01889862|79245156|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
44281910|NCT01889862|79245157|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
44281911|NCT01889862|79245158|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
44281912|NCT01889862|79245154|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
44281913|NCT01889862|79245155|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
44281914|NCT01889862|79245156|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
44281915|NCT01889862|79245157|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
44281916|NCT01889862|79245158|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
44281917|NCT01889862|79245154|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
44281918|NCT01889862|79245155|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
44281919|NCT01889862|79245156|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
44281920|NCT01889862|79245157|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
44281921|NCT01889862|79245158|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
44281922|NCT01889862|79245154|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
44281923|NCT01889862|79245155|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
44281924|NCT01889862|79245156|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
44281925|NCT01889862|79245157|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
44281926|NCT01889862|79245158|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
44281927|NCT01889862|79245154|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
44281928|NCT01889862|79245155|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
44281929|NCT01889862|79245156|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
44281930|NCT01889862|79245157|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
44522619|NCT00358215|79530846|FG001|Overall Study|Did not receive investigational product|3|||
44522620|NCT02855164|79530860|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
44404118|NCT00884390|79411555|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
44522621|NCT02855164|79530861|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
44522622|NCT02855164|79530862|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
44522623|NCT02855164|79530863|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
44522624|NCT02855164|79530864|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
44522625|NCT02855164|79530865|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
44522626|NCT02855164|79530866|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
44522627|NCT02855164|79530867|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
44522628|NCT02855164|79530860|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
44522629|NCT02855164|79530861|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
44522630|NCT02855164|79530862|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
44522631|NCT02855164|79530863|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
44522632|NCT02855164|79530864|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
44522633|NCT02855164|79530865|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
44522634|NCT02855164|79530866|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
44522635|NCT02855164|79530867|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
44522636|NCT02855164|79530860|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
44522637|NCT02855164|79530861|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
44522638|NCT02855164|79530862|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
44522639|NCT02855164|79530863|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
44522640|NCT02855164|79530864|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
44522641|NCT02855164|79530865|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
44522642|NCT02855164|79530866|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
44522643|NCT02855164|79530867|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
44522644|NCT02855164|79530860|FG000|Part C (Randomized Set)|Adverse Event|0|||
44522645|NCT02855164|79530861|FG001|Part C (Randomized Set)|Adverse Event|0|||
44522646|NCT02855164|79530862|FG002|Part C (Randomized Set)|Adverse Event|0|||
44522647|NCT02855164|79530863|FG003|Part C (Randomized Set)|Adverse Event|0|||
44522648|NCT02855164|79530864|FG004|Part C (Randomized Set)|Adverse Event|0|||
44522649|NCT02855164|79530865|FG005|Part C (Randomized Set)|Adverse Event|5|||
44522650|NCT02855164|79530866|FG006|Part C (Randomized Set)|Adverse Event|9|||
44522651|NCT02855164|79530867|FG007|Part C (Randomized Set)|Adverse Event|2|||
44522652|NCT02855164|79530860|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
44522653|NCT02855164|79530861|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
44522654|NCT02855164|79530862|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
44522655|NCT02855164|79530863|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
44522656|NCT02855164|79530864|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
44522657|NCT02855164|79530865|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
44522658|NCT02855164|79530866|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
44522659|NCT02855164|79530867|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
44522660|NCT02855164|79530860|FG000|Part C (Randomized Set)|Physician Decision|0|||
44522661|NCT02855164|79530861|FG001|Part C (Randomized Set)|Physician Decision|0|||
44522662|NCT02855164|79530862|FG002|Part C (Randomized Set)|Physician Decision|0|||
44522663|NCT02855164|79530863|FG003|Part C (Randomized Set)|Physician Decision|0|||
44522664|NCT02855164|79530864|FG004|Part C (Randomized Set)|Physician Decision|0|||
44522665|NCT02855164|79530865|FG005|Part C (Randomized Set)|Physician Decision|1|||
44522666|NCT02855164|79530866|FG006|Part C (Randomized Set)|Physician Decision|0|||
44522667|NCT02855164|79530867|FG007|Part C (Randomized Set)|Physician Decision|1|||
44522668|NCT02855164|79530860|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
44522669|NCT02855164|79530861|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
44522670|NCT02855164|79530862|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
44522671|NCT02855164|79530863|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
44522672|NCT02855164|79530864|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
44522673|NCT02855164|79530865|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
44522674|NCT02855164|79530866|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
44522675|NCT02855164|79530867|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
44522676|NCT01002742|79530907|FG000|Overall Study|Determined to be ineligible|0|||
44252968|NCT00085709|79092107|FG000|Overall Study|Progression|3|||
44252969|NCT00085709|79092108|FG001|Overall Study|Progression|4|||
44252970|NCT00085709|79092107|FG000|Overall Study|Not protocol specified|12|||
44252971|NCT00085709|79092108|FG001|Overall Study|Not protocol specified|22|||
44252972|NCT00085709|79092107|FG000|Overall Study|Not eligible|19|||
44252973|NCT00085709|79092108|FG001|Overall Study|Not eligible|19|||
44252974|NCT00085709|79092107|FG000|Overall Study|Withdrawal by Subject|2|||
44252975|NCT00085709|79092108|FG001|Overall Study|Withdrawal by Subject|1|||
44147828|NCT02119156|78937196|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
44252976|NCT00085631|79092143|FG000|Overall Study|Missing Data|4|||
44404119|NCT00884390|79411556|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
44404120|NCT00884390|79411555|FG000|Overall Study|Other|11|||
44404121|NCT00884390|79411556|FG001|Overall Study|Other|1|||
44404122|NCT00872898|79411593|FG000|Part Two - Double Blind|Adverse Event|4|||
44404123|NCT00872898|79411594|FG001|Part Two - Double Blind|Adverse Event|3|||
44404124|NCT00872898|79411593|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
44404125|NCT00872898|79411594|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
44404126|NCT00872898|79411593|FG000|Part Two - Double Blind|Protocol Violation|1|||
44404127|NCT00872898|79411594|FG001|Part Two - Double Blind|Protocol Violation|0|||
44404128|NCT00872898|79411593|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
44404129|NCT00872898|79411594|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
44404130|NCT00872898|79411593|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
44404131|NCT00872898|79411594|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
44404132|NCT00872898|79411593|FG000|Part Two - Double Blind|Other reasons|2|||
44404133|NCT00872898|79411594|FG001|Part Two - Double Blind|Other reasons|0|||
44404134|NCT00884312|79411605|FG000|Overall Study|Non-fatal Progressive Disease|0|||
44404135|NCT00884312|79411606|FG001|Overall Study|Non-fatal Progressive Disease|8|||
44404136|NCT00884312|79411605|FG000|Overall Study|Fatal Progressive Disease|0|||
44404137|NCT00884312|79411606|FG001|Overall Study|Fatal Progressive Disease|1|||
44404138|NCT00884312|79411605|FG000|Overall Study|Non-fatal Adverse Event|1|||
44404139|NCT00884312|79411606|FG001|Overall Study|Non-fatal Adverse Event|0|||
44404140|NCT00884312|79411605|FG000|Overall Study|Fatal Adverse Event|1|||
44404141|NCT00884312|79411606|FG001|Overall Study|Fatal Adverse Event|4|||
44404142|NCT00884312|79411605|FG000|Overall Study|Withdrawal by Subject|0|||
44404143|NCT00884312|79411606|FG001|Overall Study|Withdrawal by Subject|6|||
44404144|NCT00884312|79411605|FG000|Overall Study|Physician Decision|0|||
44404145|NCT00884312|79411606|FG001|Overall Study|Physician Decision|1|||
44404146|NCT00884312|79411605|FG000|Overall Study|Other|0|||
44404147|NCT00884312|79411606|FG001|Overall Study|Other|4|||
44404148|NCT00884312|79411605|FG000|Overall Study|Did Not Receive Study Drug|0|||
44404149|NCT00884312|79411606|FG001|Overall Study|Did Not Receive Study Drug|1|||
44404150|NCT00534313|79411616|FG000|Short-term Period|Adverse Event|1|||
44404151|NCT00534313|79411617|FG001|Short-term Period|Adverse Event|2|||
44404152|NCT00534313|79411618|FG002|Short-term Period|Adverse Event|1|||
44404153|NCT00534313|79411619|FG003|Short-term Period|Adverse Event|3|||
44404154|NCT00534313|79411616|FG000|Short-term Period|Lack of Efficacy|3|||
44404155|NCT00534313|79411617|FG001|Short-term Period|Lack of Efficacy|4|||
44404156|NCT00534313|79411618|FG002|Short-term Period|Lack of Efficacy|0|||
44404157|NCT00534313|79411619|FG003|Short-term Period|Lack of Efficacy|3|||
44404158|NCT00534313|79411616|FG000|Short-term Period|Participant not meeting study criteria|0|||
44404159|NCT00534313|79411617|FG001|Short-term Period|Participant not meeting study criteria|0|||
44404160|NCT00534313|79411618|FG002|Short-term Period|Participant not meeting study criteria|0|||
44404161|NCT00534313|79411619|FG003|Short-term Period|Participant not meeting study criteria|1|||
44404162|NCT00534313|79411616|FG000|Short-term Period|Participant withdrew consent|2|||
44404163|NCT00534313|79411617|FG001|Short-term Period|Participant withdrew consent|0|||
44404164|NCT00534313|79411618|FG002|Short-term Period|Participant withdrew consent|0|||
44404165|NCT00534313|79411619|FG003|Short-term Period|Participant withdrew consent|2|||
44404166|NCT00534313|79411616|FG000|Short-term Period|Pregnancy|0|||
44404167|NCT00534313|79411617|FG001|Short-term Period|Pregnancy|0|||
44404168|NCT00534313|79411618|FG002|Short-term Period|Pregnancy|1|||
44404169|NCT00534313|79411619|FG003|Short-term Period|Pregnancy|0|||
44404170|NCT00534313|79411616|FG000|Long-term Period|Adverse Event|2|||
44404171|NCT00534313|79411617|FG001|Long-term Period|Adverse Event|1|||
44404172|NCT00534313|79411618|FG002|Long-term Period|Adverse Event|0|||
44404173|NCT00534313|79411619|FG003|Long-term Period|Adverse Event|1|||
44404174|NCT00534313|79411616|FG000|Long-term Period|Lack of Efficacy|14|||
44404175|NCT00534313|79411617|FG001|Long-term Period|Lack of Efficacy|10|||
44404176|NCT00534313|79411618|FG002|Long-term Period|Lack of Efficacy|14|||
44404177|NCT00534313|79411619|FG003|Long-term Period|Lack of Efficacy|12|||
44404178|NCT00534313|79411616|FG000|Long-term Period|Lost to Follow-up|1|||
44404179|NCT00534313|79411617|FG001|Long-term Period|Lost to Follow-up|2|||
44404180|NCT00534313|79411618|FG002|Long-term Period|Lost to Follow-up|0|||
44281931|NCT01889862|79245158|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
44404181|NCT00534313|79411619|FG003|Long-term Period|Lost to Follow-up|0|||
44404182|NCT00534313|79411616|FG000|Long-term Period|Withdrawal by Subject|2|||
44404183|NCT00534313|79411617|FG001|Long-term Period|Withdrawal by Subject|2|||
44404184|NCT00534313|79411618|FG002|Long-term Period|Withdrawal by Subject|0|||
44147829|NCT02119156|78937194|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
44404185|NCT00534313|79411619|FG003|Long-term Period|Withdrawal by Subject|0|||
44404186|NCT00534313|79411616|FG000|Long-term Period|No longer meets study criteria|0|||
44404187|NCT00534313|79411617|FG001|Long-term Period|No longer meets study criteria|1|||
44404188|NCT00534313|79411618|FG002|Long-term Period|No longer meets study criteria|0|||
44404189|NCT00534313|79411619|FG003|Long-term Period|No longer meets study criteria|0|||
44404190|NCT00534313|79411616|FG000|Long-term Period|Poor compliance/noncompliance|0|||
44404191|NCT00534313|79411617|FG001|Long-term Period|Poor compliance/noncompliance|1|||
44404192|NCT00534313|79411618|FG002|Long-term Period|Poor compliance/noncompliance|1|||
44404193|NCT00534313|79411619|FG003|Long-term Period|Poor compliance/noncompliance|0|||
44404194|NCT00534313|79411616|FG000|Long-term Period|Administrative reason by sponsor|17|||
44404195|NCT00534313|79411617|FG001|Long-term Period|Administrative reason by sponsor|15|||
44404196|NCT00534313|79411618|FG002|Long-term Period|Administrative reason by sponsor|26|||
44404197|NCT00534313|79411619|FG003|Long-term Period|Administrative reason by sponsor|18|||
44404198|NCT00534313|79411616|FG000|Long-term Period|Other|1|||
44404199|NCT00534313|79411617|FG001|Long-term Period|Other|2|||
44404200|NCT00534313|79411618|FG002|Long-term Period|Other|2|||
44404201|NCT00534313|79411619|FG003|Long-term Period|Other|2|||
44404202|NCT03888391|79411664|FG000|Overall Study|Lost to Follow-up|15|||
44404203|NCT00594204|79411670|FG000|Overall Study|Adverse Event|15|||
44404204|NCT00594204|79411671|FG001|Overall Study|Adverse Event|3|||
44404205|NCT00594204|79411670|FG000|Overall Study|Lost to Follow-up|9|||
44404206|NCT00594204|79411671|FG001|Overall Study|Lost to Follow-up|5|||
44404207|NCT00594204|79411670|FG000|Overall Study|Withdrawal by Subject|23|||
44404208|NCT00594204|79411671|FG001|Overall Study|Withdrawal by Subject|29|||
44404209|NCT00594204|79411670|FG000|Overall Study|Other|4|||
44404210|NCT00594204|79411671|FG001|Overall Study|Other|3|||
44522677|NCT01002742|79530908|FG001|Overall Study|Determined to be ineligible|1|||
44522678|NCT02853760|79530914|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
44522679|NCT02853760|79530915|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
44522680|NCT02853760|79530916|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
44522681|NCT02853760|79530917|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
44522682|NCT02853760|79530918|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
44522683|NCT02853760|79530919|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
44522684|NCT02852434|79530929|FG000|Overall Study|Withdrawal by Subject|0|||
44522685|NCT02852434|79530930|FG001|Overall Study|Withdrawal by Subject|1|||
44522686|NCT02852434|79530929|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
44522687|NCT02852434|79530930|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
44522688|NCT02850016|79530938|FG000|Overall Study|Withdrawal by Subject|1|||
44522689|NCT02850016|79530939|FG001|Overall Study|Withdrawal by Subject|2|||
44522690|NCT02849704|79530947|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
44522691|NCT02849704|79530948|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
44522692|NCT02849704|79530947|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
44522693|NCT02849704|79530948|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
44522694|NCT02849704|79530947|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
44522695|NCT02849704|79530948|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
44522696|NCT03347396|79530969|FG000|Part A (26 Weeks)|Adverse Event|1|||
44522697|NCT03347396|79530970|FG001|Part A (26 Weeks)|Adverse Event|0|||
44522698|NCT03347396|79530969|FG000|Part A (26 Weeks)|Death|0|||
44252977|NCT00085631|79092144|FG001|Overall Study|Missing Data|11|||
44404211|NCT00594204|79411670|FG000|Overall Study|Lack of Efficacy|3|||
44404212|NCT00594204|79411671|FG001|Overall Study|Lack of Efficacy|4|||
44404213|NCT00594204|79411670|FG000|Overall Study|Randomized but not treated|4|||
44522699|NCT03347396|79530970|FG001|Part A (26 Weeks)|Death|1|||
44522700|NCT03347396|79530969|FG000|Part B (149 Weeks)|Adverse Event|1|||
44522701|NCT03347396|79530970|FG001|Part B (149 Weeks)|Adverse Event|1|||
44522702|NCT03347396|79530969|FG000|Part B (149 Weeks)|Death|1|||
44522703|NCT03347396|79530970|FG001|Part B (149 Weeks)|Death|0|||
44522704|NCT03335150|79530981|FG000|Overall Study|Withdrawal by Subject|10|||
44252978|NCT00085631|79092145|FG002|Overall Study|Missing Data|7|||
44252979|NCT00084929|79092161|FG000|Overall Study|ineligible - medical contraindication|1|||
44252980|NCT00084929|79092161|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
44252981|NCT00084929|79092161|FG000|Overall Study|Ineligible - Medical history|6|||
44252982|NCT00084929|79092161|FG000|Overall Study|Withdrawal by Subject|10|||
44252983|NCT00084929|79092161|FG000|Overall Study|Missing/incomplete CTC exam|9|||
44252984|NCT00084929|79092161|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
44252985|NCT00084617|79092219|FG000|Overall Study|Withdrawal by Subject|7|||
44252986|NCT00084617|79092219|FG000|Overall Study|Lack of Efficacy|1|||
44252987|NCT00084617|79092219|FG000|Overall Study|Protocol Violation|1|||
44252988|NCT00083915|79092313|FG000|Overall Study|Death|6|||
44252989|NCT00083915|79092314|FG001|Overall Study|Death|3|||
44252990|NCT00083915|79092313|FG000|Overall Study|Physician Decision|11|||
44252991|NCT00083915|79092314|FG001|Overall Study|Physician Decision|6|||
44252992|NCT00083915|79092313|FG000|Overall Study|Withdrawal by Subject|8|||
44522705|NCT03335150|79530982|FG001|Overall Study|Withdrawal by Subject|4|||
44252993|NCT00083915|79092314|FG001|Overall Study|Withdrawal by Subject|3|||
44252994|NCT00083915|79092313|FG000|Overall Study|disease progression|18|||
44252995|NCT00083915|79092314|FG001|Overall Study|disease progression|23|||
44404214|NCT00594204|79411671|FG001|Overall Study|Randomized but not treated|1|||
44404215|NCT03888235|79411689|FG000|Overall Study|Lost to Follow-up|1|||
44404216|NCT03888235|79411690|FG001|Overall Study|Lost to Follow-up|1|||
44404217|NCT03888235|79411691|FG002|Overall Study|Lost to Follow-up|0|||
44404218|NCT00866307|79411722|FG000|Induction|Adverse Event|5|||
44404219|NCT00866307|79411723|FG001|Induction|Adverse Event|0|||
44404220|NCT00866307|79411724|FG002|Induction|Adverse Event|0|||
44404221|NCT00866307|79411722|FG000|Induction|Death|2|||
44404222|NCT00866307|79411723|FG001|Induction|Death|0|||
44404223|NCT00866307|79411724|FG002|Induction|Death|0|||
44404224|NCT00866307|79411722|FG000|Induction|Physician Decision|5|||
44404225|NCT00866307|79411723|FG001|Induction|Physician Decision|0|||
44404226|NCT00866307|79411724|FG002|Induction|Physician Decision|0|||
44404227|NCT00866307|79411722|FG000|Induction|Progressive Disease|1|||
44404228|NCT00866307|79411723|FG001|Induction|Progressive Disease|0|||
44404229|NCT00866307|79411724|FG002|Induction|Progressive Disease|0|||
44404230|NCT00866307|79411722|FG000|Induction|Identification of Patients with Day 29 M|3|||
44404231|NCT00866307|79411723|FG001|Induction|Identification of Patients with Day 29 M|0|||
44404232|NCT00866307|79411724|FG002|Induction|Identification of Patients with Day 29 M|0|||
44404233|NCT00866307|79411722|FG000|Induction|Inadequate cytognetic samples th|1|||
44404234|NCT00866307|79411723|FG001|Induction|Inadequate cytognetic samples th|0|||
44404235|NCT00866307|79411724|FG002|Induction|Inadequate cytognetic samples th|0|||
44404236|NCT00866307|79411722|FG000|Induction|Improper post-induction consent|2|||
44404237|NCT00866307|79411723|FG001|Induction|Improper post-induction consent|0|||
44404238|NCT00866307|79411724|FG002|Induction|Improper post-induction consent|0|||
44404239|NCT00866307|79411722|FG000|Induction|Study was closed at the time|1|||
44404240|NCT00866307|79411723|FG001|Induction|Study was closed at the time|0|||
44404241|NCT00866307|79411724|FG002|Induction|Study was closed at the time|0|||
44522706|NCT03335150|79530981|FG000|Overall Study|Adverse Event|0|||
44522707|NCT03335150|79530982|FG001|Overall Study|Adverse Event|1|||
44522708|NCT03334448|79530988|FG000|Washout|Personal Reason|0|||
44522709|NCT03334448|79530989|FG001|Washout|Personal Reason|1|||
44522710|NCT03334448|79530990|FG002|Washout|Personal Reason|0|||
44522711|NCT03334448|79530991|FG003|Washout|Personal Reason|0|||
44522712|NCT03334448|79530988|FG000|Washout|Protocol Violation|0|||
44522713|NCT03334448|79530989|FG001|Washout|Protocol Violation|0|||
44522714|NCT03334448|79530990|FG002|Washout|Protocol Violation|0|||
44522715|NCT03334448|79530991|FG003|Washout|Protocol Violation|1|||
44522716|NCT02849080|79530999|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
44522717|NCT02849080|79531000|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
44522718|NCT02849080|79531001|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
44522719|NCT02849080|79531002|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
44147830|NCT02119156|78937195|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
44404242|NCT00866307|79411722|FG000|Consolidation/Maintenance|Adverse Event|0|||
44404243|NCT00866307|79411723|FG001|Consolidation/Maintenance|Adverse Event|0|||
44404244|NCT00866307|79411724|FG002|Consolidation/Maintenance|Adverse Event|8|||
44404245|NCT00866307|79411722|FG000|Consolidation/Maintenance|Death|0|||
44404246|NCT00866307|79411723|FG001|Consolidation/Maintenance|Death|0|||
44404247|NCT00866307|79411724|FG002|Consolidation/Maintenance|Death|1|||
44404248|NCT00866307|79411722|FG000|Consolidation/Maintenance|Physician Decision|0|||
44404249|NCT00866307|79411723|FG001|Consolidation/Maintenance|Physician Decision|3|||
44404250|NCT00866307|79411724|FG002|Consolidation/Maintenance|Physician Decision|2|||
44404251|NCT00866307|79411722|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
44404252|NCT00866307|79411723|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
44404253|NCT00866307|79411724|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
44404254|NCT00866307|79411722|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
44404255|NCT00866307|79411723|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
44404256|NCT00866307|79411724|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
44404257|NCT00866307|79411722|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
44404258|NCT00866307|79411723|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
44404259|NCT00866307|79411724|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
44404260|NCT00866307|79411722|FG000|Consolidation/Maintenance|Therapy error|0|||
44404261|NCT00866307|79411723|FG001|Consolidation/Maintenance|Therapy error|1|||
44404262|NCT00866307|79411724|FG002|Consolidation/Maintenance|Therapy error|0|||
44404263|NCT00866307|79411722|FG000|Consolidation/Maintenance|Non-compliance|0|||
44522720|NCT02849080|79530999|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
44147831|NCT02119156|78937196|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
44404264|NCT00866307|79411723|FG001|Consolidation/Maintenance|Non-compliance|0|||
44404265|NCT00866307|79411724|FG002|Consolidation/Maintenance|Non-compliance|1|||
44404266|NCT00866307|79411722|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
44404267|NCT00866307|79411723|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
44404268|NCT00866307|79411724|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
44522721|NCT02849080|79531000|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
44522722|NCT02849080|79531001|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
44522723|NCT02849080|79531002|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
44522724|NCT02849080|79530999|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
44522725|NCT02849080|79531000|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
44404269|NCT00531427|79411732|FG000|Overall Study|Withdrawal by Subject|7|||
44404270|NCT00531427|79411733|FG001|Overall Study|Withdrawal by Subject|13|||
44404271|NCT00531427|79411732|FG000|Overall Study|Adverse Event|44|||
44404272|NCT00531427|79411733|FG001|Overall Study|Adverse Event|30|||
44404273|NCT00531427|79411732|FG000|Overall Study|Lost to Follow-up|4|||
44404274|NCT00531427|79411733|FG001|Overall Study|Lost to Follow-up|3|||
44404275|NCT00531427|79411732|FG000|Overall Study|Lack of Efficacy|14|||
44404276|NCT00531427|79411733|FG001|Overall Study|Lack of Efficacy|39|||
44404277|NCT00531427|79411732|FG000|Overall Study|Administrative|4|||
44404278|NCT00531427|79411733|FG001|Overall Study|Administrative|9|||
44404279|NCT00871728|79411740|FG000|Overall Study|Adverse Event|1|||
44404280|NCT00871728|79411740|FG000|Overall Study|Protocol Violation|7|||
44404281|NCT00871728|79411740|FG000|Overall Study|Lost to Follow-up|2|||
44404282|NCT00871728|79411740|FG000|Overall Study|Failed to Visit Hospital|4|||
44404283|NCT00871728|79411740|FG000|Overall Study|Participant Non-compliance|1|||
44522726|NCT02849080|79531001|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
44522727|NCT02849080|79531002|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
44522728|NCT02849080|79530999|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
44522729|NCT02849080|79531000|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
44522730|NCT02849080|79531001|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
44252996|NCT00083915|79092313|FG000|Overall Study|Failure to collect|3|||
44252997|NCT00083915|79092314|FG001|Overall Study|Failure to collect|0|||
44404284|NCT00871728|79411740|FG000|Overall Study|Withdrawal of Informed Consent|5|||
44404285|NCT00868998|79411744|FG000|Overall Study|Screen Failure|1|||
44404286|NCT00868998|79411744|FG000|Overall Study|Withdrawal by Subject|1|||
44404287|NCT00868998|79411744|FG000|Overall Study|Progression of disease|2|||
44404288|NCT00868998|79411744|FG000|Overall Study|Death|1|||
44404289|NCT00533845|79411759|FG000|Overall Study|Physician Decision|1|||
44404290|NCT00533845|79411760|FG001|Overall Study|Physician Decision|0|||
44404291|NCT00857649|79411768|FG000|Overall Study|Adverse Event|15|||
44404292|NCT00857649|79411769|FG001|Overall Study|Adverse Event|10|||
44404293|NCT00857649|79411768|FG000|Overall Study|Non-compliance|1|||
44404294|NCT00857649|79411769|FG001|Overall Study|Non-compliance|1|||
44404295|NCT00857649|79411768|FG000|Overall Study|Protocol Violation|2|||
44404296|NCT00857649|79411769|FG001|Overall Study|Protocol Violation|2|||
44404297|NCT00857649|79411768|FG000|Overall Study|Withdrawal of Consent|10|||
44404298|NCT00857649|79411769|FG001|Overall Study|Withdrawal of Consent|7|||
44404299|NCT00857649|79411768|FG000|Overall Study|Nursing Home Placement|2|||
44404300|NCT00857649|79411769|FG001|Overall Study|Nursing Home Placement|9|||
44404301|NCT00857649|79411768|FG000|Overall Study|Other Reasons|1|||
44404302|NCT00857649|79411769|FG001|Overall Study|Other Reasons|3|||
44404303|NCT00857415|79411777|FG000|Overall Study|Image acquisition failure|2|||
44404304|NCT00857415|79411778|FG001|Overall Study|Image acquisition failure|0|||
44404305|NCT00857415|79411777|FG000|Overall Study|Invalid image or not imaged|3|||
44404306|NCT00857415|79411778|FG001|Overall Study|Invalid image or not imaged|0|||
44404307|NCT00857415|79411777|FG000|Overall Study|Subject still living at end of study|110|||
44404308|NCT00857415|79411778|FG001|Overall Study|Subject still living at end of study|0|||
44404309|NCT00857415|79411777|FG000|Overall Study|Deceased with no autopsy|2|||
44404310|NCT00857415|79411778|FG001|Overall Study|Deceased with no autopsy|0|||
44522731|NCT02849080|79531002|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
44522732|NCT02849080|79530999|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
44404311|NCT00532441|79411784|FG000|Overall Study|Death|1|||
44404312|NCT00532441|79411785|FG001|Overall Study|Death|0|||
44404313|NCT00857259|79411806|FG000|Overall Study|Protocol Violation|1|||
44404314|NCT00857259|79411807|FG001|Overall Study|Protocol Violation|0|||
44404315|NCT00857259|79411808|FG002|Overall Study|Protocol Violation|1|||
44404316|NCT00868608|79411821|FG000|Overall Study|Withdrawal by Subject|3|||
44522733|NCT02849080|79531000|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
44522734|NCT02849080|79531001|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
44404317|NCT00868608|79411822|FG001|Overall Study|Withdrawal by Subject|1|||
44404318|NCT00868608|79411823|FG002|Overall Study|Withdrawal by Subject|0|||
44404319|NCT00868608|79411821|FG000|Overall Study|Lost to Follow-up|3|||
44404320|NCT00868608|79411822|FG001|Overall Study|Lost to Follow-up|0|||
44404321|NCT00868608|79411823|FG002|Overall Study|Lost to Follow-up|1|||
44404322|NCT00868608|79411821|FG000|Overall Study|Death|16|||
44404323|NCT00868608|79411822|FG001|Overall Study|Death|2|||
44404324|NCT00868608|79411823|FG002|Overall Study|Death|4|||
44404325|NCT00868608|79411821|FG000|Overall Study|Other - Unspecified|1|||
44404326|NCT00868608|79411822|FG001|Overall Study|Other - Unspecified|0|||
44404327|NCT00868608|79411823|FG002|Overall Study|Other - Unspecified|0|||
44404328|NCT00856635|79411833|FG000|Overall Study|Lost to Follow-up|2|||
44404329|NCT00856635|79411834|FG001|Overall Study|Lost to Follow-up|5|||
44281932|NCT01889862|79245154|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
44281933|NCT01889862|79245155|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
44281934|NCT01889862|79245156|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
44281935|NCT01889862|79245157|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
44281936|NCT01889862|79245158|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
44281937|NCT01889862|79245154|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
44281938|NCT01889862|79245155|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
44281939|NCT01889862|79245156|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
44281940|NCT01889862|79245157|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
44281941|NCT01889862|79245158|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
44281942|NCT01889862|79245154|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
44281943|NCT01889862|79245155|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
44281944|NCT01889862|79245156|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
44281945|NCT01889862|79245157|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
44404330|NCT00856635|79411833|FG000|Overall Study|Pregnancy|1|||
44404331|NCT00856635|79411834|FG001|Overall Study|Pregnancy|0|||
44404332|NCT00856635|79411833|FG000|Overall Study|Withdrawal by Subject|3|||
44404333|NCT00856635|79411834|FG001|Overall Study|Withdrawal by Subject|1|||
44404334|NCT00856635|79411833|FG000|Overall Study|Serious Adverse Event|1|||
44404335|NCT00856635|79411834|FG001|Overall Study|Serious Adverse Event|0|||
44404336|NCT00856635|79411833|FG000|Overall Study|Other|1|||
44404337|NCT00856635|79411834|FG001|Overall Study|Other|0|||
44404338|NCT00856635|79411833|FG000|Overall Study|Discontinued at Randomization|2|||
44404339|NCT00856635|79411834|FG001|Overall Study|Discontinued at Randomization|2|||
44404340|NCT00856557|79411844|FG000|Overall Study|No patients with contextual flags|12|||
44404341|NCT00856557|79411845|FG001|Overall Study|No patients with contextual flags|16|||
44404342|NCT00856323|79411851|FG000|Overall Study|Withdrawal by Subject|2|||
44404343|NCT00856245|79411859|FG000|Overall Study|Was not transplanted|5|||
44404344|NCT00855933|79411865|FG000|Overall Study|Withdrawal by Subject|0|||
44404345|NCT00855933|79411866|FG001|Overall Study|Withdrawal by Subject|1|||
44404346|NCT00871572|79411876|FG000|Overall Study|Adverse Event|0|||
44404347|NCT00871572|79411877|FG001|Overall Study|Adverse Event|2|||
44404348|NCT00871572|79411878|FG002|Overall Study|Adverse Event|0|||
44404349|NCT00871572|79411879|FG003|Overall Study|Adverse Event|3|||
44404350|NCT00871572|79411876|FG000|Overall Study|Investigator Decision|0|||
44522735|NCT02849080|79531002|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
44522736|NCT02849080|79530999|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
44522737|NCT02849080|79531000|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
44522738|NCT02849080|79531001|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
44522739|NCT02849080|79531002|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
44522740|NCT03346070|79531019|FG000|Overall Study|Death|0|||
44522741|NCT03346070|79531020|FG001|Overall Study|Death|0|||
44522742|NCT03346070|79531021|FG002|Overall Study|Death|0|||
44522743|NCT03346070|79531022|FG003|Overall Study|Death|0|||
44147832|NCT02119156|78937194|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
44147833|NCT02119156|78937195|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
44252998|NCT00083915|79092313|FG000|Overall Study|No response|3|||
44252999|NCT00083915|79092314|FG001|Overall Study|No response|1|||
44404351|NCT00871572|79411877|FG001|Overall Study|Investigator Decision|1|||
44404352|NCT00871572|79411878|FG002|Overall Study|Investigator Decision|0|||
44404353|NCT00871572|79411879|FG003|Overall Study|Investigator Decision|1|||
44404354|NCT00871572|79411876|FG000|Overall Study|Lost to Follow-up|0|||
44404355|NCT00871572|79411877|FG001|Overall Study|Lost to Follow-up|1|||
44404356|NCT00871572|79411878|FG002|Overall Study|Lost to Follow-up|0|||
44404357|NCT00871572|79411879|FG003|Overall Study|Lost to Follow-up|1|||
44522744|NCT03346070|79531023|FG004|Overall Study|Death|1|||
44253000|NCT00083915|79092313|FG000|Overall Study|Insurance issues|1|||
44253001|NCT00083915|79092314|FG001|Overall Study|Insurance issues|1|||
44253002|NCT04505722|79092810|FG000|Overall Study|Adverse Event|1|||
44253003|NCT04505722|79092811|FG001|Overall Study|Adverse Event|2|||
44253004|NCT04505722|79092810|FG000|Overall Study|Death|34|||
44253005|NCT04505722|79092811|FG001|Overall Study|Death|63|||
44253006|NCT04505722|79092810|FG000|Overall Study|Lost to Follow-up|271|||
44522745|NCT03346070|79531019|FG000|Overall Study|Lost to Follow-up|0|||
44522746|NCT03346070|79531020|FG001|Overall Study|Lost to Follow-up|1|||
44522747|NCT03346070|79531021|FG002|Overall Study|Lost to Follow-up|2|||
44522748|NCT03346070|79531022|FG003|Overall Study|Lost to Follow-up|0|||
44522749|NCT03346070|79531023|FG004|Overall Study|Lost to Follow-up|0|||
44404358|NCT00871572|79411876|FG000|Overall Study|Protocol Violation|0|||
44404359|NCT00871572|79411877|FG001|Overall Study|Protocol Violation|0|||
44404360|NCT00871572|79411878|FG002|Overall Study|Protocol Violation|1|||
44404361|NCT00871572|79411879|FG003|Overall Study|Protocol Violation|1|||
44404362|NCT00871572|79411876|FG000|Overall Study|Sponsor Decision|1|||
44404363|NCT00871572|79411877|FG001|Overall Study|Sponsor Decision|0|||
44404364|NCT00871572|79411878|FG002|Overall Study|Sponsor Decision|0|||
44404365|NCT00871572|79411879|FG003|Overall Study|Sponsor Decision|0|||
44404366|NCT00871572|79411876|FG000|Overall Study|Withdrawal by Subject|1|||
44404367|NCT00871572|79411877|FG001|Overall Study|Withdrawal by Subject|2|||
44404368|NCT00871572|79411878|FG002|Overall Study|Withdrawal by Subject|3|||
44404369|NCT00871572|79411879|FG003|Overall Study|Withdrawal by Subject|1|||
44404370|NCT03885661|79411891|FG000|Overall Study|Withdrawal by Subject|0|||
44404371|NCT03885661|79411892|FG001|Overall Study|Withdrawal by Subject|1|||
44404372|NCT03885661|79411891|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
44404373|NCT03885661|79411892|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
44404374|NCT00868530|79411898|FG000|Overall Study|Adverse Event|3|||
44404375|NCT00868530|79411898|FG000|Overall Study|Lost to Follow-up|1|||
44404376|NCT00598442|79411905|FG000|Overall Study|Adverse Event|3|||
44404377|NCT00598442|79411906|FG001|Overall Study|Adverse Event|0|||
44404378|NCT00598442|79411907|FG002|Overall Study|Adverse Event|0|||
44404379|NCT00598442|79411905|FG000|Overall Study|Death|19|||
44404380|NCT00598442|79411906|FG001|Overall Study|Death|11|||
44404381|NCT00598442|79411907|FG002|Overall Study|Death|11|||
44404382|NCT00598442|79411905|FG000|Overall Study|Lost to Follow-up|4|||
44404383|NCT00598442|79411906|FG001|Overall Study|Lost to Follow-up|3|||
44404384|NCT00598442|79411907|FG002|Overall Study|Lost to Follow-up|3|||
44404385|NCT00598442|79411905|FG000|Overall Study|Physician Decision|2|||
44404386|NCT00598442|79411906|FG001|Overall Study|Physician Decision|1|||
44404387|NCT00598442|79411907|FG002|Overall Study|Physician Decision|1|||
44404388|NCT00598442|79411905|FG000|Overall Study|Withdrawal by Subject|8|||
44404389|NCT00598442|79411906|FG001|Overall Study|Withdrawal by Subject|16|||
44522750|NCT03346070|79531019|FG000|Overall Study|Physician Decision|0|||
44522751|NCT03346070|79531020|FG001|Overall Study|Physician Decision|0|||
44522752|NCT03346070|79531021|FG002|Overall Study|Physician Decision|0|||
44522753|NCT03346070|79531022|FG003|Overall Study|Physician Decision|1|||
44522754|NCT03346070|79531023|FG004|Overall Study|Physician Decision|1|||
44522755|NCT03346070|79531019|FG000|Overall Study|Withdrawal by Subject|1|||
44147834|NCT02119156|78937196|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
44147835|NCT02119156|78937194|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
44253007|NCT04505722|79092811|FG001|Overall Study|Lost to Follow-up|333|||
44253008|NCT04505722|79092810|FG000|Overall Study|Physician Decision|17|||
44253009|NCT04505722|79092811|FG001|Overall Study|Physician Decision|17|||
44404390|NCT00598442|79411907|FG002|Overall Study|Withdrawal by Subject|6|||
44404391|NCT00598442|79411905|FG000|Overall Study|Noncompliance|0|||
44404392|NCT00598442|79411906|FG001|Overall Study|Noncompliance|2|||
44404393|NCT00598442|79411907|FG002|Overall Study|Noncompliance|1|||
44404394|NCT00598442|79411905|FG000|Overall Study|Relocation|1|||
44404395|NCT00598442|79411906|FG001|Overall Study|Relocation|4|||
44404396|NCT00598442|79411907|FG002|Overall Study|Relocation|0|||
44404397|NCT00598442|79411905|FG000|Overall Study|Renal transplant|0|||
44404398|NCT00598442|79411906|FG001|Overall Study|Renal transplant|0|||
44404399|NCT00598442|79411907|FG002|Overall Study|Renal transplant|1|||
44404400|NCT00598442|79411905|FG000|Overall Study|Site closed by sponsor|5|||
44404401|NCT00598442|79411906|FG001|Overall Study|Site closed by sponsor|2|||
44522756|NCT03346070|79531020|FG001|Overall Study|Withdrawal by Subject|0|||
44522757|NCT03346070|79531021|FG002|Overall Study|Withdrawal by Subject|0|||
44404402|NCT00598442|79411907|FG002|Overall Study|Site closed by sponsor|1|||
44404403|NCT00598442|79411905|FG000|Overall Study|Started dialysis|1|||
44404404|NCT00598442|79411906|FG001|Overall Study|Started dialysis|0|||
44404405|NCT00598442|79411907|FG002|Overall Study|Started dialysis|0|||
44404406|NCT00593814|79411917|FG000|Overall Study|Death|7|||
44404407|NCT00593814|79411918|FG001|Overall Study|Death|0|||
44404408|NCT00593814|79411917|FG000|Overall Study|Withdrawal by Subject|7|||
44404409|NCT00593814|79411918|FG001|Overall Study|Withdrawal by Subject|0|||
44404410|NCT00593814|79411917|FG000|Overall Study|Lost to Follow-up|7|||
44404411|NCT00593814|79411918|FG001|Overall Study|Lost to Follow-up|0|||
44404412|NCT00593814|79411917|FG000|Overall Study|Physician Decision|3|||
44404413|NCT00593814|79411918|FG001|Overall Study|Physician Decision|0|||
44404414|NCT00855309|79411926|FG000|Overall Study|patient never recieved drug|1|||
44404415|NCT00855309|79411927|FG001|Overall Study|patient never recieved drug|0|||
44404416|NCT00532129|79411933|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
44404417|NCT00532129|79411933|FG000|Treatment Period|Physician Decision|15|||
44404418|NCT00532129|79411933|FG000|Treatment Period|Disease progression|3|||
44404419|NCT00532129|79411933|FG000|Treatment Period|Protocol Violation|1|||
44404420|NCT00532129|79411933|FG000|Treatment Period|Other|5|||
44404421|NCT00532129|79411933|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
44404422|NCT00532129|79411933|FG000|Follow-up Period|Disease progression|57|||
44404423|NCT00532129|79411933|FG000|Follow-up Period|Lost to Follow-up|1|||
44404424|NCT00532129|79411933|FG000|Follow-up Period|Other|6|||
44404425|NCT00854607|79411937|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
44404426|NCT00854373|79411950|FG000|Overall Study|Withdrawal by Subject|1|||
44404427|NCT00854373|79411951|FG001|Overall Study|Withdrawal by Subject|3|||
44404428|NCT00854373|79411950|FG000|Overall Study|Forgot to take study drug|1|||
44404429|NCT00854373|79411951|FG001|Overall Study|Forgot to take study drug|1|||
44404430|NCT00853905|79411959|FG000|Overall Study|Lost to Follow-up|1|||
44404431|NCT00853905|79411960|FG001|Overall Study|Lost to Follow-up|3|||
44404432|NCT00853905|79411959|FG000|Overall Study|Withdrawal by Subject|0|||
44404433|NCT00853905|79411960|FG001|Overall Study|Withdrawal by Subject|1|||
44404434|NCT00853905|79411959|FG000|Overall Study|never had surgery|1|||
44404435|NCT00853905|79411960|FG001|Overall Study|never had surgery|0|||
44404436|NCT00868296|79411971|FG000|Overall Study|Adverse Event|0|||
44404437|NCT00868296|79411972|FG001|Overall Study|Adverse Event|2|||
44404438|NCT00868296|79411971|FG000|Overall Study|Withdrawal by Subject|0|||
44404439|NCT00868296|79411972|FG001|Overall Study|Withdrawal by Subject|1|||
44404440|NCT00867360|79411980|FG000|Overall Study|Withdrawal by Subject|1|||
44404441|NCT00867360|79411981|FG001|Overall Study|Withdrawal by Subject|0|||
44404442|NCT00867360|79411980|FG000|Overall Study|Physician Decision|0|||
44404443|NCT00867360|79411981|FG001|Overall Study|Physician Decision|1|||
44404444|NCT00593736|79411992|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
44404445|NCT00593736|79411993|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
44404446|NCT00593736|79411994|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
44404447|NCT00593736|79411995|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
44404448|NCT00593736|79411992|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
44404449|NCT00593736|79411993|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
44404450|NCT00593736|79411994|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
44404451|NCT00593736|79411995|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
44404452|NCT00593736|79411992|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
44404453|NCT00593736|79411993|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
44404454|NCT00593736|79411994|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
44404455|NCT00593736|79411995|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
44404456|NCT00593736|79411992|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
44404457|NCT00593736|79411993|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
44404458|NCT00593736|79411994|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
44404459|NCT00593736|79411995|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
44404460|NCT00593736|79411992|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
44404461|NCT00593736|79411993|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
44404462|NCT00593736|79411994|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
44404463|NCT00593736|79411995|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
44404464|NCT00593736|79411992|FG000|Screening Period and Placebo Run-in|Various|0|||
44404465|NCT00593736|79411993|FG001|Screening Period and Placebo Run-in|Various|0|||
44404466|NCT00593736|79411994|FG002|Screening Period and Placebo Run-in|Various|0|||
44404467|NCT00593736|79411995|FG003|Screening Period and Placebo Run-in|Various|25|||
44404468|NCT00593736|79411992|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
44404469|NCT00593736|79411993|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
44404470|NCT00593736|79411994|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
44404471|NCT00593736|79411995|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
44404472|NCT00593736|79411992|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
44404473|NCT00593736|79411993|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
44404474|NCT00593736|79411994|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
44404475|NCT00593736|79411995|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
44404476|NCT00593736|79411992|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
44404477|NCT00593736|79411993|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
44404478|NCT00593736|79411994|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
44404479|NCT00593736|79411995|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
44404480|NCT00593736|79411992|FG000|Treatment Period and Placebo Run-out|Various|1|||
44404481|NCT00593736|79411993|FG001|Treatment Period and Placebo Run-out|Various|1|||
44404482|NCT00593736|79411994|FG002|Treatment Period and Placebo Run-out|Various|1|||
44404483|NCT00593736|79411995|FG003|Treatment Period and Placebo Run-out|Various|0|||
44404484|NCT00883688|79412005|FG000|Overall Study|Ineligible|2|||
44404485|NCT03883477|79412011|FG000|Overall Study|Death|1|||
44404486|NCT03883477|79412012|FG001|Overall Study|Death|0|||
44404487|NCT03883477|79412011|FG000|Overall Study|Protocol Violation|0|||
44404488|NCT03883477|79412012|FG001|Overall Study|Protocol Violation|1|||
44404489|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Other|4|||
44404490|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Other|0|||
44404491|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
44404492|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
44404493|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
44404494|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
44404495|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
44404496|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
44404497|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
44404498|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
44404499|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
44404500|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
44404501|NCT00853827|79412020|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
44404502|NCT00853827|79412021|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
44404503|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
44404504|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
44404505|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
44404506|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
44404507|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
44404508|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
44404509|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
44404510|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
44404511|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
44404512|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
44404513|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
44404514|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
44404515|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
44404516|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
44404517|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
44404518|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
44404519|NCT00853827|79412020|FG000|Double Blind Period (103 Weeks)|Death|1|||
44404520|NCT00853827|79412021|FG001|Double Blind Period (103 Weeks)|Death|6|||
44404521|NCT00853749|79412029|FG000|Overall Study|Lost to Follow-up|0|||
44404522|NCT00853749|79412030|FG001|Overall Study|Lost to Follow-up|1|||
44404523|NCT00592839|79412039|FG000|Overall Study|Withdrawal by Subject|1|||
44404524|NCT00592839|79412040|FG001|Overall Study|Withdrawal by Subject|1|||
44404525|NCT00592839|79412041|FG002|Overall Study|Withdrawal by Subject|3|||
44522758|NCT03346070|79531022|FG003|Overall Study|Withdrawal by Subject|1|||
44522759|NCT03346070|79531023|FG004|Overall Study|Withdrawal by Subject|0|||
44522760|NCT03346070|79531019|FG000|Overall Study|Study medication not received as planned|2|||
44522761|NCT03346070|79531020|FG001|Overall Study|Study medication not received as planned|3|||
44522762|NCT03346070|79531021|FG002|Overall Study|Study medication not received as planned|2|||
44522763|NCT03346070|79531022|FG003|Overall Study|Study medication not received as planned|3|||
44522764|NCT03346070|79531023|FG004|Overall Study|Study medication not received as planned|2|||
44522765|NCT03346070|79531019|FG000|Overall Study|Screen Failure|0|||
44522766|NCT03346070|79531020|FG001|Overall Study|Screen Failure|0|||
44522767|NCT03346070|79531021|FG002|Overall Study|Screen Failure|0|||
44522768|NCT03346070|79531022|FG003|Overall Study|Screen Failure|1|||
44522769|NCT03346070|79531023|FG004|Overall Study|Screen Failure|1|||
44147836|NCT02119156|78937195|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
44404526|NCT00592839|79412039|FG000|Overall Study|Protocol Violation|1|||
44404527|NCT00592839|79412040|FG001|Overall Study|Protocol Violation|1|||
44404528|NCT00592839|79412041|FG002|Overall Study|Protocol Violation|2|||
44404529|NCT00592839|79412039|FG000|Overall Study|Adverse Event|0|||
44404530|NCT00592839|79412040|FG001|Overall Study|Adverse Event|1|||
44522770|NCT02951780|79531046|FG000|Period 1|Adverse Event|0|||
44522771|NCT02951780|79531047|FG001|Period 1|Adverse Event|0|||
44522772|NCT02951780|79531048|FG002|Period 1|Adverse Event|0|||
44522773|NCT02951780|79531049|FG003|Period 1|Adverse Event|1|||
44522774|NCT02951780|79531050|FG004|Period 1|Adverse Event|0|||
44522775|NCT02951780|79531051|FG005|Period 1|Adverse Event|0|||
44522776|NCT02951780|79531052|FG006|Period 1|Adverse Event|0|||
44522777|NCT02951780|79531053|FG007|Period 1|Adverse Event|0|||
44522778|NCT02951780|79531054|FG008|Period 1|Adverse Event|0|||
44522779|NCT02951780|79531046|FG000|Period 1|Scheduling Conflicts|0|||
44522780|NCT02951780|79531047|FG001|Period 1|Scheduling Conflicts|0|||
44522781|NCT02951780|79531048|FG002|Period 1|Scheduling Conflicts|0|||
44522782|NCT02951780|79531049|FG003|Period 1|Scheduling Conflicts|0|||
44522783|NCT02951780|79531050|FG004|Period 1|Scheduling Conflicts|0|||
44522784|NCT02951780|79531051|FG005|Period 1|Scheduling Conflicts|0|||
44147837|NCT02119156|78937196|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
44522785|NCT02951780|79531052|FG006|Period 1|Scheduling Conflicts|0|||
44522786|NCT02951780|79531053|FG007|Period 1|Scheduling Conflicts|1|||
44522787|NCT02951780|79531054|FG008|Period 1|Scheduling Conflicts|0|||
44522788|NCT02951780|79531046|FG000|Period 2|Scheduling Conflicts|0|||
44522789|NCT02951780|79531047|FG001|Period 2|Scheduling Conflicts|0|||
44522790|NCT02951780|79531048|FG002|Period 2|Scheduling Conflicts|0|||
44147838|NCT02119156|78937194|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
44147839|NCT02119156|78937195|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
44404531|NCT00592839|79412041|FG002|Overall Study|Adverse Event|0|||
44404532|NCT00592839|79412039|FG000|Overall Study|Lost to Follow-up|0|||
44404533|NCT00592839|79412040|FG001|Overall Study|Lost to Follow-up|1|||
44404534|NCT00592839|79412041|FG002|Overall Study|Lost to Follow-up|1|||
44404535|NCT00598832|79412051|FG000|Overall Study|Lack of Efficacy|3|||
44404536|NCT00598832|79412052|FG001|Overall Study|Lack of Efficacy|7|||
44404537|NCT00598832|79412051|FG000|Overall Study|Adverse Event|6|||
44404538|NCT00598832|79412052|FG001|Overall Study|Adverse Event|2|||
44404539|NCT00598832|79412051|FG000|Overall Study|Withdrawal by Subject|25|||
44404540|NCT00598832|79412052|FG001|Overall Study|Withdrawal by Subject|36|||
44404541|NCT00598832|79412051|FG000|Overall Study|Protocol Violation|0|||
44404542|NCT00598832|79412052|FG001|Overall Study|Protocol Violation|2|||
44404543|NCT00598832|79412051|FG000|Overall Study|Lost to Follow-up|24|||
44404544|NCT00598832|79412052|FG001|Overall Study|Lost to Follow-up|29|||
44404545|NCT00598832|79412051|FG000|Overall Study|Pregnancy|2|||
44404546|NCT00598832|79412052|FG001|Overall Study|Pregnancy|2|||
44404547|NCT00598832|79412051|FG000|Overall Study|Physician Decision|1|||
44404548|NCT00598832|79412052|FG001|Overall Study|Physician Decision|4|||
44404549|NCT00598832|79412051|FG000|Overall Study|Non compliance|1|||
44404550|NCT00598832|79412052|FG001|Overall Study|Non compliance|0|||
44404551|NCT00853593|79412058|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
44404552|NCT00853593|79412058|FG000|Overall Study|Model 4396 lead not attempted|29|||
44404553|NCT00853593|79412058|FG000|Overall Study|Implant not attempted|4|||
44404554|NCT00853125|79412079|FG000|Overall Study|Study participant's donor was CMV +|1|||
44404555|NCT00530023|79412086|FG000|Overall Study|Withdrawal by Subject|0|||
44404556|NCT00530023|79412087|FG001|Overall Study|Withdrawal by Subject|1|||
44404557|NCT00529087|79412096|FG000|Overall Study|Adverse Event|10|||
44404558|NCT00529087|79412097|FG001|Overall Study|Adverse Event|13|||
44404559|NCT00529087|79412098|FG002|Overall Study|Adverse Event|4|||
44522791|NCT02951780|79531049|FG003|Period 2|Scheduling Conflicts|0|||
44522792|NCT02951780|79531050|FG004|Period 2|Scheduling Conflicts|0|||
44522793|NCT02951780|79531051|FG005|Period 2|Scheduling Conflicts|0|||
44522794|NCT02951780|79531052|FG006|Period 2|Scheduling Conflicts|0|||
44522795|NCT02951780|79531053|FG007|Period 2|Scheduling Conflicts|1|||
44522796|NCT02951780|79531054|FG008|Period 2|Scheduling Conflicts|0|||
44522797|NCT03334214|79531076|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
44522798|NCT03334214|79531077|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
44522799|NCT03334214|79531076|FG000|Overall Study|Withdrawal by Subject|0|||
44522800|NCT03334214|79531077|FG001|Overall Study|Withdrawal by Subject|1|||
44522801|NCT03334214|79531076|FG000|Overall Study|Other|1|||
44147840|NCT02119156|78937196|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
44147841|NCT02181556|78937211|FG000|Overall Study|Withdrawal by Subject|1|||
44522802|NCT03334214|79531077|FG001|Overall Study|Other|0|||
44522803|NCT02250664|79531087|FG000|Overall Study|Lost to Follow-up|18|||
44522804|NCT02250664|79531088|FG001|Overall Study|Lost to Follow-up|28|||
44522805|NCT02250664|79531089|FG002|Overall Study|Lost to Follow-up|33|||
44522806|NCT02250664|79531087|FG000|Overall Study|Personal Reasons|7|||
44522807|NCT02250664|79531088|FG001|Overall Study|Personal Reasons|8|||
44522808|NCT02250664|79531089|FG002|Overall Study|Personal Reasons|14|||
44404560|NCT00529087|79412096|FG000|Overall Study|Lost to Follow-up|6|||
44404561|NCT00529087|79412097|FG001|Overall Study|Lost to Follow-up|4|||
44404562|NCT00529087|79412098|FG002|Overall Study|Lost to Follow-up|1|||
44404563|NCT00529087|79412096|FG000|Overall Study|Protocol Violation|8|||
44404564|NCT00529087|79412097|FG001|Overall Study|Protocol Violation|7|||
44522809|NCT02250664|79531087|FG000|Overall Study|Adverse Event|6|||
44404565|NCT00529087|79412098|FG002|Overall Study|Protocol Violation|6|||
44404566|NCT00529087|79412096|FG000|Overall Study|Withdrawal by Subject|3|||
44404567|NCT00529087|79412097|FG001|Overall Study|Withdrawal by Subject|3|||
44404568|NCT00529087|79412098|FG002|Overall Study|Withdrawal by Subject|3|||
44404569|NCT00529087|79412096|FG000|Overall Study|Protocol deviation|1|||
44404570|NCT00529087|79412097|FG001|Overall Study|Protocol deviation|1|||
44404571|NCT00529087|79412098|FG002|Overall Study|Protocol deviation|2|||
44404572|NCT00870870|79412133|FG000|Overall Study|Withdrawal by Subject|0|||
44404573|NCT00870870|79412134|FG001|Overall Study|Withdrawal by Subject|1|||
44404574|NCT00870870|79412135|FG002|Overall Study|Withdrawal by Subject|1|||
44404575|NCT00870870|79412136|FG003|Overall Study|Withdrawal by Subject|3|||
44404576|NCT00870870|79412133|FG000|Overall Study|Adverse Event|0|||
44404577|NCT00870870|79412134|FG001|Overall Study|Adverse Event|0|||
44404578|NCT00870870|79412135|FG002|Overall Study|Adverse Event|2|||
44404579|NCT00870870|79412136|FG003|Overall Study|Adverse Event|2|||
44404580|NCT03877237|79412153|FG000|Overall Study|Adverse Event|1|||
44404581|NCT03877237|79412154|FG001|Overall Study|Adverse Event|2|||
44404582|NCT03877237|79412153|FG000|Overall Study|Death|3|||
44404583|NCT03877237|79412154|FG001|Overall Study|Death|2|||
44404584|NCT03877237|79412153|FG000|Overall Study|Physician Decision|1|||
44404585|NCT03877237|79412154|FG001|Overall Study|Physician Decision|0|||
44404586|NCT03877237|79412153|FG000|Overall Study|Withdrawal by Subject|0|||
44404587|NCT03877237|79412154|FG001|Overall Study|Withdrawal by Subject|2|||
44404588|NCT00528931|79412160|FG000|Overall Study|Lost to Follow-up|1|||
44404589|NCT00866814|79412165|FG000|Overall Study|Lost to Follow-up|12|||
44404590|NCT00866814|79412165|FG000|Overall Study|Adverse Event|2|||
44404591|NCT00866814|79412165|FG000|Overall Study|Physician Decision|1|||
44404592|NCT00866814|79412165|FG000|Overall Study|Death|1|||
44404593|NCT00866814|79412165|FG000|Overall Study|No longer wished to participate|1|||
44404594|NCT00866814|79412165|FG000|Overall Study|Unable to meet follow-up requirements|2|||
44404595|NCT00866814|79412165|FG000|Overall Study|Moved to area without study site|1|||
44404596|NCT00871494|79412169|FG000|Overall Study|Protocol Violation|5|||
44404597|NCT00871494|79412169|FG000|Overall Study|Lack of Efficacy|4|||
44404598|NCT00871494|79412169|FG000|Overall Study|Adverse Event|4|||
44404599|NCT00871494|79412169|FG000|Overall Study|Lost to Follow-up|1|||
44404600|NCT00529789|79412173|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
44404601|NCT00529789|79412173|FG000|Study Period II/III|Adverse Event|3|||
44404602|NCT00529789|79412173|FG000|Study Period II/III|Lack of Efficacy|2|||
44404603|NCT00529789|79412173|FG000|Study Period II/III|Withdrawal by Subject|1|||
44404604|NCT00529789|79412173|FG000|Study Period II/III|Protocol Violation|3|||
44404605|NCT00529789|79412173|FG000|Study Period II/III|Physician Decision|3|||
44404606|NCT00529789|79412173|FG000|Study Period II/III|Lost to Follow-up|3|||
44404607|NCT00529789|79412173|FG000|Study Period IV|Parent/Caregiver Decision|1|||
44404608|NCT00529789|79412173|FG000|Study Period IV|Adverse Event|1|||
44404609|NCT00529789|79412173|FG000|Study Period IV|Lack of Efficacy|1|||
44404610|NCT00529789|79412173|FG000|Study Period IV|Lost to Follow-up|3|||
44404611|NCT00577642|79412183|FG000|Overall Study|Clinical Disease Progression|1|||
44404612|NCT00866658|79412189|FG000|Overall Study|Adverse Event|5|||
44404613|NCT00866658|79412190|FG001|Overall Study|Adverse Event|14|||
44404614|NCT00866658|79412189|FG000|Overall Study|Lack of Efficacy|2|||
44404615|NCT00866658|79412190|FG001|Overall Study|Lack of Efficacy|1|||
44404616|NCT00866658|79412189|FG000|Overall Study|Withdrawal by Subject|1|||
44404617|NCT00866658|79412190|FG001|Overall Study|Withdrawal by Subject|0|||
44404618|NCT00866658|79412189|FG000|Overall Study|Protocol Violation|1|||
44404619|NCT00866658|79412190|FG001|Overall Study|Protocol Violation|1|||
44404620|NCT00866658|79412189|FG000|Overall Study|Familial and Personal Reasons|4|||
44404621|NCT00866658|79412190|FG001|Overall Study|Familial and Personal Reasons|5|||
44404622|NCT00597584|79412198|FG000|Overall Study|Adverse Event|4|||
44404623|NCT00597584|79412199|FG001|Overall Study|Adverse Event|2|||
44404624|NCT00597584|79412198|FG000|Overall Study|Death|53|||
44404625|NCT00597584|79412199|FG001|Overall Study|Death|30|||
44404626|NCT00597584|79412198|FG000|Overall Study|Lack of Efficacy|1|||
44404627|NCT00597584|79412199|FG001|Overall Study|Lack of Efficacy|0|||
44404628|NCT00597584|79412198|FG000|Overall Study|Lost to Follow-up|2|||
44281946|NCT01889862|79245158|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
44281947|NCT01889862|79245154|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
44404629|NCT00597584|79412199|FG001|Overall Study|Lost to Follow-up|4|||
44281948|NCT01889862|79245155|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
44404630|NCT00597584|79412198|FG000|Overall Study|Physician Decision|3|||
44404631|NCT00597584|79412199|FG001|Overall Study|Physician Decision|0|||
44404632|NCT00597584|79412198|FG000|Overall Study|Pregnancy|2|||
44404633|NCT00597584|79412199|FG001|Overall Study|Pregnancy|0|||
44404634|NCT00597584|79412198|FG000|Overall Study|Withdrawal by Subject|44|||
44404635|NCT00597584|79412199|FG001|Overall Study|Withdrawal by Subject|12|||
44404636|NCT00597584|79412198|FG000|Overall Study|Discontinued Dialysis|0|||
44404637|NCT00597584|79412199|FG001|Overall Study|Discontinued Dialysis|1|||
44404638|NCT00597584|79412198|FG000|Overall Study|Lost ability to consent|1|||
44404639|NCT00597584|79412199|FG001|Overall Study|Lost ability to consent|1|||
44404640|NCT00597584|79412198|FG000|Overall Study|Never dosed|1|||
44404641|NCT00597584|79412199|FG001|Overall Study|Never dosed|0|||
44404642|NCT00597584|79412198|FG000|Overall Study|Relocation|8|||
44404643|NCT00597584|79412199|FG001|Overall Study|Relocation|6|||
44404644|NCT00597584|79412198|FG000|Overall Study|Renal transplant|9|||
44404645|NCT00597584|79412199|FG001|Overall Study|Renal transplant|7|||
44404646|NCT00529633|79412207|FG000|Overall Study|Withdrawal by Subject|1|||
44404647|NCT00529633|79412208|FG001|Overall Study|Withdrawal by Subject|1|||
44404648|NCT00530335|79412214|FG000|Overall Study|Adverse Event|3|||
44404649|NCT00530335|79412214|FG000|Overall Study|Protocol Violation|1|||
44404650|NCT00530335|79412214|FG000|Overall Study|Withdrawal by Subject|1|||
44404651|NCT00530335|79412214|FG000|Overall Study|Physician Decision|1|||
44404652|NCT00712270|79412221|FG000|Overall Study|Withdrawal by Subject|11|||
44404653|NCT00712270|79412221|FG000|Overall Study|Screen Failure|3|||
44404654|NCT00530257|79412247|FG000|Overall Study|Lost to Follow-up|1|||
44404655|NCT00869778|79412257|FG000|Overall Study|Adverse Event|2|||
44404656|NCT00869778|79412258|FG001|Overall Study|Adverse Event|0|||
44404657|NCT00869778|79412259|FG002|Overall Study|Adverse Event|0|||
44404658|NCT00869778|79412257|FG000|Overall Study|Withdrawal by Subject|3|||
44404659|NCT00869778|79412258|FG001|Overall Study|Withdrawal by Subject|4|||
44404660|NCT00869778|79412259|FG002|Overall Study|Withdrawal by Subject|5|||
44404661|NCT00869778|79412257|FG000|Overall Study|Pregnancy|1|||
44404662|NCT00869778|79412258|FG001|Overall Study|Pregnancy|0|||
44404663|NCT00869778|79412259|FG002|Overall Study|Pregnancy|0|||
44404664|NCT00869778|79412257|FG000|Overall Study|Protocol Violation|5|||
44404665|NCT00869778|79412258|FG001|Overall Study|Protocol Violation|3|||
44404666|NCT00869778|79412259|FG002|Overall Study|Protocol Violation|5|||
44404667|NCT00869778|79412257|FG000|Overall Study|Unblinding|1|||
44404668|NCT00869778|79412258|FG001|Overall Study|Unblinding|0|||
44404669|NCT00869778|79412259|FG002|Overall Study|Unblinding|0|||
44404670|NCT00711958|79412290|FG000|Overall Study|Withdrawal by Subject|6|||
44404671|NCT00711958|79412291|FG001|Overall Study|Withdrawal by Subject|8|||
44404672|NCT00711958|79412290|FG000|Overall Study|Lack of Efficacy|3|||
44404673|NCT00711958|79412291|FG001|Overall Study|Lack of Efficacy|1|||
44404674|NCT00711958|79412290|FG000|Overall Study|Clinical deterioration|1|||
44404675|NCT00711958|79412291|FG001|Overall Study|Clinical deterioration|0|||
44522810|NCT02250664|79531088|FG001|Overall Study|Adverse Event|3|||
44522811|NCT02250664|79531089|FG002|Overall Study|Adverse Event|8|||
44522812|NCT02250664|79531087|FG000|Overall Study|Incarcerated|2|||
44522813|NCT02250664|79531088|FG001|Overall Study|Incarcerated|1|||
44253010|NCT04505722|79092810|FG000|Overall Study|Protocol Violation|0|||
44404676|NCT00711958|79412290|FG000|Overall Study|Adverse Event|9|||
44404677|NCT00711958|79412291|FG001|Overall Study|Adverse Event|7|||
44404678|NCT00711958|79412290|FG000|Overall Study|Protocol Violation|1|||
44404679|NCT00711958|79412291|FG001|Overall Study|Protocol Violation|0|||
44404680|NCT00711958|79412290|FG000|Overall Study|Lost to Follow-up|2|||
44404681|NCT00711958|79412291|FG001|Overall Study|Lost to Follow-up|2|||
44404682|NCT00711958|79412290|FG000|Overall Study|Death|10|||
44404683|NCT00711958|79412291|FG001|Overall Study|Death|5|||
44404684|NCT00711958|79412290|FG000|Overall Study|Progression of disease|1|||
44404685|NCT00711958|79412291|FG001|Overall Study|Progression of disease|0|||
44253011|NCT04505722|79092811|FG001|Overall Study|Protocol Violation|1|||
44404686|NCT00711880|79412299|FG000|Overall Study|Adverse Event|11|||
44404687|NCT00711880|79412300|FG001|Overall Study|Adverse Event|2|||
44404688|NCT00711880|79412299|FG000|Overall Study|Patient non-compliance|1|||
44253012|NCT04505722|79092810|FG000|Overall Study|Withdrawal by Subject|376|||
44253013|NCT04505722|79092811|FG001|Overall Study|Withdrawal by Subject|714|||
44253014|NCT04505722|79092810|FG000|Overall Study|Other|61|||
44253015|NCT04505722|79092811|FG001|Overall Study|Other|98|||
44253016|NCT04505722|79092810|FG000|Overall Study|Still ongoing|21138|||
44253017|NCT04505722|79092811|FG001|Overall Study|Still ongoing|20662|||
44253018|NCT04505722|79092810|FG000|Overall Study|Randomized not vaccinated|276|||
44253019|NCT04505722|79092811|FG001|Overall Study|Randomized not vaccinated|260|||
44253020|NCT04463251|79092824|FG000|Overall Study|Death|1|||
44253021|NCT04463251|79092825|FG001|Overall Study|Death|0|||
44281949|NCT01889862|79245156|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
44253022|NCT04463251|79092826|FG002|Overall Study|Death|1|||
44253023|NCT04463251|79092824|FG000|Overall Study|Adverse Event|0|||
44404689|NCT00711880|79412300|FG001|Overall Study|Patient non-compliance|0|||
44253024|NCT04463251|79092825|FG001|Overall Study|Adverse Event|1|||
44404690|NCT00711880|79412299|FG000|Overall Study|Lack of Efficacy|1|||
44404691|NCT00711880|79412300|FG001|Overall Study|Lack of Efficacy|5|||
44404692|NCT00528775|79412306|FG000|Overall Study|Other not specified|1|||
44404693|NCT00529399|79412313|FG000|Overall Study|Lost to Follow-up|1|||
44404694|NCT00529399|79412314|FG001|Overall Study|Lost to Follow-up|0|||
44404695|NCT00529399|79412315|FG002|Overall Study|Lost to Follow-up|1|||
44404696|NCT00529399|79412313|FG000|Overall Study|Withdrawal by Subject|1|||
44404697|NCT00529399|79412314|FG001|Overall Study|Withdrawal by Subject|0|||
44404698|NCT00529399|79412315|FG002|Overall Study|Withdrawal by Subject|1|||
44404699|NCT00529399|79412313|FG000|Overall Study|Non-compliant|0|||
44522814|NCT02250664|79531089|FG002|Overall Study|Incarcerated|2|||
44281950|NCT01889862|79245157|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
44281951|NCT01889862|79245158|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
44281952|NCT01887912|79245185|FG000|Overall Study|Serious adverse event|400|||
44281953|NCT01887912|79245186|FG001|Overall Study|Serious adverse event|198|||
44281954|NCT01887912|79245185|FG000|Overall Study|Other Adverse Event|34|||
44281955|NCT01887912|79245186|FG001|Overall Study|Other Adverse Event|15|||
44281956|NCT01887912|79245185|FG000|Overall Study|Protocol Violation|67|||
44281957|NCT01887912|79245186|FG001|Overall Study|Protocol Violation|37|||
44281958|NCT01887912|79245185|FG000|Overall Study|Lost to Follow-up|163|||
44281959|NCT01887912|79245186|FG001|Overall Study|Lost to Follow-up|74|||
44281960|NCT01887912|79245185|FG000|Overall Study|Withdrawal by Subject|606|||
44281961|NCT01887912|79245186|FG001|Overall Study|Withdrawal by Subject|349|||
44281962|NCT01887912|79245185|FG000|Overall Study|Other|122|||
44281963|NCT01887912|79245186|FG001|Overall Study|Other|58|||
44281964|NCT01887678|79245194|FG000|Overall Study|Adverse Event|4|||
44281965|NCT01887678|79245195|FG001|Overall Study|Adverse Event|6|||
44281966|NCT01887678|79245194|FG000|Overall Study|Exceeded rescue medication dosage|4|||
44281967|NCT01887678|79245195|FG001|Overall Study|Exceeded rescue medication dosage|5|||
44281968|NCT01887678|79245194|FG000|Overall Study|Withdrawal of consent|3|||
44281969|NCT01887678|79245195|FG001|Overall Study|Withdrawal of consent|4|||
44281970|NCT01887678|79245194|FG000|Overall Study|Lost to Follow-up|4|||
44281971|NCT01887678|79245195|FG001|Overall Study|Lost to Follow-up|2|||
44281972|NCT01887678|79245194|FG000|Overall Study|Deterioration of clinical condition|0|||
44281973|NCT01887678|79245195|FG001|Overall Study|Deterioration of clinical condition|4|||
44281974|NCT01887678|79245194|FG000|Overall Study|Lack of Efficacy|1|||
44281975|NCT01887678|79245195|FG001|Overall Study|Lack of Efficacy|2|||
44281976|NCT01887678|79245194|FG000|Overall Study|Non-compliance|0|||
44281977|NCT01887678|79245195|FG001|Overall Study|Non-compliance|3|||
44281978|NCT01887678|79245194|FG000|Overall Study|Specified|1|||
44281979|NCT01887678|79245195|FG001|Overall Study|Specified|2|||
44281980|NCT01887600|79245203|FG000|Overall Study|Death|39|||
44281981|NCT01887600|79245204|FG001|Overall Study|Death|16|||
44281982|NCT01887600|79245203|FG000|Overall Study|Lack of Efficacy|3|||
44281983|NCT01887600|79245204|FG001|Overall Study|Lack of Efficacy|26|||
44281984|NCT01887600|79245203|FG000|Overall Study|Lost to Follow-up|5|||
44281985|NCT01887600|79245204|FG001|Overall Study|Lost to Follow-up|1|||
44281986|NCT01887600|79245203|FG000|Overall Study|Physician Decision|7|||
44281987|NCT01887600|79245204|FG001|Overall Study|Physician Decision|8|||
44281988|NCT01887600|79245203|FG000|Overall Study|Protocol Deviation|3|||
44404700|NCT00529399|79412314|FG001|Overall Study|Non-compliant|1|||
44404701|NCT00529399|79412315|FG002|Overall Study|Non-compliant|0|||
44404702|NCT00852969|79412325|FG000|Overall Study|Adverse Event|0|||
44404703|NCT00852969|79412326|FG001|Overall Study|Adverse Event|1|||
44404704|NCT00852969|79412325|FG000|Overall Study|Lost to Follow-up|0|||
44404705|NCT00852969|79412326|FG001|Overall Study|Lost to Follow-up|1|||
44404706|NCT03870997|79412338|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
44404707|NCT03870997|79412339|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
44404708|NCT03870997|79412340|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
44404709|NCT03870997|79412341|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
44404710|NCT03870997|79412342|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
44404711|NCT03870997|79412343|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
44404712|NCT00521365|79412352|FG000|Overall Study|Adverse Event|3|||
44404713|NCT00521365|79412352|FG000|Overall Study|Lost to Follow-up|6|||
44404714|NCT00521365|79412352|FG000|Overall Study|Protocol deviation|2|||
44404715|NCT00521365|79412352|FG000|Overall Study|Drug compliance|3|||
44404716|NCT00521365|79412352|FG000|Overall Study|Usage of not allowed drugs|6|||
44404717|NCT00711802|79412364|FG000|Overall Study|Not treated (no further detail)|2|||
44404718|NCT00711802|79412365|FG001|Overall Study|Not treated (no further detail)|1|||
44522815|NCT02250664|79531087|FG000|Overall Study|Withdrawal by Subject|0|||
44404719|NCT00711802|79412366|FG002|Overall Study|Not treated (no further detail)|2|||
44404720|NCT00711802|79412367|FG003|Overall Study|Not treated (no further detail)|0|||
44281989|NCT01887600|79245204|FG001|Overall Study|Protocol Deviation|0|||
44281990|NCT01887600|79245203|FG000|Overall Study|Withdrawal by Subject|58|||
44281991|NCT01887600|79245204|FG001|Overall Study|Withdrawal by Subject|52|||
44281992|NCT01887600|79245203|FG000|Overall Study|Adverse Event|21|||
44281993|NCT01887600|79245204|FG001|Overall Study|Adverse Event|9|||
44404721|NCT00711802|79412368|FG004|Overall Study|Not treated (no further detail)|2|||
44404722|NCT00711802|79412369|FG005|Overall Study|Not treated (no further detail)|0|||
44404723|NCT00711802|79412370|FG006|Overall Study|Not treated (no further detail)|0|||
44522816|NCT02250664|79531088|FG001|Overall Study|Withdrawal by Subject|1|||
44281994|NCT01887600|79245203|FG000|Overall Study|Non-compliance with study drug|3|||
44281995|NCT01887600|79245204|FG001|Overall Study|Non-compliance with study drug|0|||
44281996|NCT01887600|79245203|FG000|Overall Study|Miscellaneous|6|||
44281997|NCT01887600|79245204|FG001|Overall Study|Miscellaneous|2|||
44281998|NCT01887600|79245203|FG000|Overall Study|Progressive Disease|1|||
44281999|NCT01887600|79245204|FG001|Overall Study|Progressive Disease|0|||
44282000|NCT01887288|79245211|FG000|Overall Study|The study was terminated and the PI has|16|||
44404724|NCT00711802|79412371|FG007|Overall Study|Not treated (no further detail)|0|||
44404725|NCT00711802|79412364|FG000|Overall Study|Adverse Event|0|||
44404726|NCT00711802|79412365|FG001|Overall Study|Adverse Event|0|||
44404727|NCT00711802|79412366|FG002|Overall Study|Adverse Event|0|||
44404728|NCT00711802|79412367|FG003|Overall Study|Adverse Event|0|||
44404729|NCT00711802|79412368|FG004|Overall Study|Adverse Event|1|||
44404730|NCT00711802|79412369|FG005|Overall Study|Adverse Event|1|||
44404731|NCT00711802|79412370|FG006|Overall Study|Adverse Event|0|||
44404732|NCT00711802|79412371|FG007|Overall Study|Adverse Event|0|||
44404733|NCT00711802|79412364|FG000|Overall Study|Microbiological failure|0|||
44404734|NCT00711802|79412365|FG001|Overall Study|Microbiological failure|1|||
44522817|NCT02250664|79531089|FG002|Overall Study|Withdrawal by Subject|2|||
44522818|NCT02250664|79531087|FG000|Overall Study|Death|0|||
44522819|NCT02250664|79531088|FG001|Overall Study|Death|1|||
44522820|NCT02250664|79531089|FG002|Overall Study|Death|1|||
44522821|NCT02250664|79531087|FG000|Overall Study|Physician Decision|1|||
44522822|NCT02250664|79531088|FG001|Overall Study|Physician Decision|3|||
44522823|NCT02250664|79531089|FG002|Overall Study|Physician Decision|1|||
44522824|NCT02250664|79531087|FG000|Overall Study|Protocol Violation|1|||
44522825|NCT02250664|79531088|FG001|Overall Study|Protocol Violation|0|||
44522826|NCT02250664|79531089|FG002|Overall Study|Protocol Violation|1|||
44522827|NCT02250664|79531087|FG000|Overall Study|Reason unknown|1|||
44522828|NCT02250664|79531088|FG001|Overall Study|Reason unknown|0|||
44522829|NCT02250664|79531089|FG002|Overall Study|Reason unknown|0|||
44522830|NCT02646982|79531099|FG000|Overall Study|Adverse Event|1|||
44522831|NCT02646982|79531100|FG001|Overall Study|Adverse Event|1|||
44522832|NCT02646982|79531099|FG000|Overall Study|Withdrawal by Subject|2|||
44522833|NCT02646982|79531100|FG001|Overall Study|Withdrawal by Subject|1|||
44522834|NCT02845336|79531108|FG000|Overall Study|Lost to Follow-up|3|||
44253025|NCT04463251|79092826|FG002|Overall Study|Adverse Event|0|||
44253026|NCT04463251|79092824|FG000|Overall Study|Lost to Follow-up|0|||
44253027|NCT04463251|79092825|FG001|Overall Study|Lost to Follow-up|1|||
44253028|NCT04463251|79092826|FG002|Overall Study|Lost to Follow-up|0|||
44253029|NCT04463251|79092824|FG000|Overall Study|Withdrawal by Subject|0|||
44253030|NCT04463251|79092825|FG001|Overall Study|Withdrawal by Subject|2|||
44253031|NCT04463251|79092826|FG002|Overall Study|Withdrawal by Subject|2|||
44253032|NCT04254913|79092839|FG000|Overall Study|Adverse Event|1|||
44253033|NCT04160091|79092851|FG000|Overall Study|Terminated by Sponsor|7|||
44253034|NCT04160091|79092852|FG001|Overall Study|Terminated by Sponsor|3|||
44282001|NCT01887210|79245217|FG000|Overall Study|Withdrawal by Subject|1|||
44282002|NCT01887210|79245218|FG001|Overall Study|Withdrawal by Subject|3|||
44282003|NCT01887210|79245217|FG000|Overall Study|Lost to Follow-up|0|||
44282004|NCT01887210|79245218|FG001|Overall Study|Lost to Follow-up|1|||
44282005|NCT01885182|79245249|FG000|Overall Study|Adverse Event|11|||
44282006|NCT01885182|79245250|FG001|Overall Study|Adverse Event|13|||
44282007|NCT01885182|79245249|FG000|Overall Study|Withdrawal by Subject|13|||
44282008|NCT01885182|79245250|FG001|Overall Study|Withdrawal by Subject|6|||
44282009|NCT01885182|79245249|FG000|Overall Study|Lost to Follow-up|2|||
44282010|NCT01885182|79245250|FG001|Overall Study|Lost to Follow-up|2|||
44282011|NCT01885182|79245249|FG000|Overall Study|Lack of Efficacy|8|||
44253035|NCT04160091|79092853|FG002|Overall Study|Terminated by Sponsor|5|||
44253036|NCT04160091|79092854|FG003|Overall Study|Terminated by Sponsor|2|||
44253037|NCT04160091|79092851|FG000|Overall Study|Noncompliance|0|||
44253038|NCT04160091|79092852|FG001|Overall Study|Noncompliance|0|||
44253039|NCT04160091|79092853|FG002|Overall Study|Noncompliance|0|||
44253040|NCT04160091|79092854|FG003|Overall Study|Noncompliance|1|||
44253041|NCT04160091|79092851|FG000|Overall Study|Withdrawal by Subject|0|||
44253042|NCT04160091|79092852|FG001|Overall Study|Withdrawal by Subject|0|||
44253043|NCT04160091|79092853|FG002|Overall Study|Withdrawal by Subject|0|||
44253044|NCT04160091|79092854|FG003|Overall Study|Withdrawal by Subject|1|||
44253045|NCT04145895|79092866|FG000|Overall Study|Physician Decision|2|||
44282012|NCT01885182|79245250|FG001|Overall Study|Lack of Efficacy|1|||
44404735|NCT00711802|79412366|FG002|Overall Study|Microbiological failure|0|||
44404736|NCT00711802|79412367|FG003|Overall Study|Microbiological failure|0|||
44253046|NCT04145895|79092867|FG001|Overall Study|Physician Decision|0|||
44404737|NCT00711802|79412368|FG004|Overall Study|Microbiological failure|0|||
44522835|NCT02845336|79531109|FG001|Overall Study|Lost to Follow-up|1|||
44522836|NCT02845336|79531108|FG000|Overall Study|Inability to get medication|2|||
44522837|NCT02845336|79531109|FG001|Overall Study|Inability to get medication|0|||
44522838|NCT02844946|79531117|FG000|Overall Study|Lost to Follow-up|7|||
44522839|NCT02844946|79531118|FG001|Overall Study|Lost to Follow-up|0|||
44282013|NCT01885104|79245260|FG000|Overall Study|Withdrawal of Consent|1|||
44282014|NCT01885104|79245261|FG001|Overall Study|Withdrawal of Consent|0|||
44282015|NCT01885104|79245260|FG000|Overall Study|Lost to Follow-up|0|||
44282016|NCT01885104|79245261|FG001|Overall Study|Lost to Follow-up|1|||
44282017|NCT01885104|79245260|FG000|Overall Study|Physician Decision|1|||
44282018|NCT01885104|79245261|FG001|Overall Study|Physician Decision|0|||
44282019|NCT01881750|79245269|FG000|Overall Study|Changes in concomitant therapies|2|||
44282020|NCT01881750|79245270|FG001|Overall Study|Changes in concomitant therapies|3|||
44282021|NCT01881750|79245269|FG000|Overall Study|Lost to Follow-up|0|||
44282022|NCT01881750|79245270|FG001|Overall Study|Lost to Follow-up|1|||
44282023|NCT01906008|79245280|FG000|Overall Study|Lost to Follow-up|2|||
44282024|NCT01906008|79245281|FG001|Overall Study|Lost to Follow-up|0|||
44282025|NCT01906008|79245280|FG000|Overall Study|Oxaliplatin toxicity|2|||
44404738|NCT00711802|79412369|FG005|Overall Study|Microbiological failure|1|||
44404739|NCT00711802|79412370|FG006|Overall Study|Microbiological failure|0|||
44404740|NCT00711802|79412371|FG007|Overall Study|Microbiological failure|0|||
44404741|NCT00711802|79412364|FG000|Overall Study|Protocol Violation|0|||
44404742|NCT00711802|79412365|FG001|Overall Study|Protocol Violation|0|||
44404743|NCT00711802|79412366|FG002|Overall Study|Protocol Violation|0|||
44404744|NCT00711802|79412367|FG003|Overall Study|Protocol Violation|1|||
44404745|NCT00711802|79412368|FG004|Overall Study|Protocol Violation|0|||
44404746|NCT00711802|79412369|FG005|Overall Study|Protocol Violation|0|||
44404747|NCT00711802|79412370|FG006|Overall Study|Protocol Violation|0|||
44404748|NCT00711802|79412371|FG007|Overall Study|Protocol Violation|0|||
44404749|NCT00711802|79412364|FG000|Overall Study|Physician Decision|0|||
44404750|NCT00711802|79412365|FG001|Overall Study|Physician Decision|2|||
44404751|NCT00711802|79412366|FG002|Overall Study|Physician Decision|0|||
44404752|NCT00711802|79412367|FG003|Overall Study|Physician Decision|0|||
44404753|NCT00711802|79412368|FG004|Overall Study|Physician Decision|0|||
44404754|NCT00711802|79412369|FG005|Overall Study|Physician Decision|0|||
44404755|NCT00711802|79412370|FG006|Overall Study|Physician Decision|0|||
44404756|NCT00711802|79412371|FG007|Overall Study|Physician Decision|0|||
44282026|NCT01906008|79245281|FG001|Overall Study|Oxaliplatin toxicity|0|||
44282027|NCT01906008|79245280|FG000|Overall Study|Protocol Violation|0|||
44282028|NCT01906008|79245281|FG001|Overall Study|Protocol Violation|1|||
44282029|NCT01906008|79245280|FG000|Overall Study|Withdrawal by Subject|1|||
44282030|NCT01906008|79245281|FG001|Overall Study|Withdrawal by Subject|5|||
44282031|NCT01906008|79245280|FG000|Overall Study|Did not start study med|3|||
44404757|NCT00711802|79412364|FG000|Overall Study|Withdrawal by Subject|0|||
44404758|NCT00711802|79412365|FG001|Overall Study|Withdrawal by Subject|1|||
44404759|NCT00711802|79412366|FG002|Overall Study|Withdrawal by Subject|0|||
44404760|NCT00711802|79412367|FG003|Overall Study|Withdrawal by Subject|1|||
44404761|NCT00711802|79412368|FG004|Overall Study|Withdrawal by Subject|0|||
44404762|NCT00711802|79412369|FG005|Overall Study|Withdrawal by Subject|0|||
44404763|NCT00711802|79412370|FG006|Overall Study|Withdrawal by Subject|0|||
44404764|NCT00711802|79412371|FG007|Overall Study|Withdrawal by Subject|0|||
44404765|NCT00711802|79412364|FG000|Overall Study|Lost to Follow-up|0|||
44404766|NCT00711802|79412365|FG001|Overall Study|Lost to Follow-up|0|||
44404767|NCT00711802|79412366|FG002|Overall Study|Lost to Follow-up|3|||
44404768|NCT00711802|79412367|FG003|Overall Study|Lost to Follow-up|1|||
44404769|NCT00711802|79412368|FG004|Overall Study|Lost to Follow-up|10|||
44404770|NCT00711802|79412369|FG005|Overall Study|Lost to Follow-up|6|||
44404771|NCT00711802|79412370|FG006|Overall Study|Lost to Follow-up|4|||
44404772|NCT00711802|79412371|FG007|Overall Study|Lost to Follow-up|2|||
44404773|NCT00711802|79412364|FG000|Overall Study|Reason not reported|0|||
44404774|NCT00711802|79412365|FG001|Overall Study|Reason not reported|1|||
44404775|NCT00711802|79412366|FG002|Overall Study|Reason not reported|1|||
44522840|NCT02951156|79531127|FG000|Overall Study|Death|3|||
44522841|NCT02951156|79531128|FG001|Overall Study|Death|8|||
44522842|NCT02951156|79531129|FG002|Overall Study|Death|5|||
44253047|NCT04145895|79092866|FG000|Overall Study|Withdrawal by Subject|0|||
44253048|NCT04145895|79092867|FG001|Overall Study|Withdrawal by Subject|2|||
44253049|NCT04065074|79092894|FG000|Overall Study|Adverse Event|1|||
44253050|NCT04065074|79092894|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
44253051|NCT03793010|79092900|FG000|Overall Study|Withdrawal by Subject|5|||
44253052|NCT03793010|79092901|FG001|Overall Study|Withdrawal by Subject|7|||
44253053|NCT03793010|79092900|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
44253054|NCT03793010|79092901|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
44253055|NCT03793010|79092900|FG000|Overall Study|Lost to Follow-up|1|||
44253056|NCT03793010|79092901|FG001|Overall Study|Lost to Follow-up|2|||
44282032|NCT01906008|79245281|FG001|Overall Study|Did not start study med|4|||
44282033|NCT01906008|79245280|FG000|Overall Study|Oxaliplatin stops|10|||
44282034|NCT01906008|79245281|FG001|Overall Study|Oxaliplatin stops|8|||
44282035|NCT01906008|79245280|FG000|Overall Study|Hospice|1|||
44404776|NCT00711802|79412367|FG003|Overall Study|Reason not reported|0|||
44282036|NCT01906008|79245281|FG001|Overall Study|Hospice|0|||
44404777|NCT00711802|79412368|FG004|Overall Study|Reason not reported|1|||
44522843|NCT02951156|79531127|FG000|Overall Study|Progressive disease|1|||
44404778|NCT00711802|79412369|FG005|Overall Study|Reason not reported|0|||
44404779|NCT00711802|79412370|FG006|Overall Study|Reason not reported|1|||
44404780|NCT00711802|79412371|FG007|Overall Study|Reason not reported|0|||
44404781|NCT00851877|79412392|FG000|Phase I-1|Death|1|||
44404782|NCT00851877|79412393|FG001|Phase I-1|Death|0|||
44404783|NCT00851877|79412394|FG002|Phase I-1|Death|0|||
44404784|NCT00851877|79412392|FG000|Phase II|Withdrawal by Subject|0|||
44404785|NCT00851877|79412393|FG001|Phase II|Withdrawal by Subject|0|||
44404786|NCT00851877|79412394|FG002|Phase II|Withdrawal by Subject|3|||
44404787|NCT00882908|79412405|FG000|Overall Study|Adverse Event|0|||
44404788|NCT00882908|79412406|FG001|Overall Study|Adverse Event|0|||
44404789|NCT00882908|79412407|FG002|Overall Study|Adverse Event|1|||
44404790|NCT00882908|79412408|FG003|Overall Study|Adverse Event|0|||
44404791|NCT00882908|79412409|FG004|Overall Study|Adverse Event|1|||
44404792|NCT00882908|79412405|FG000|Overall Study|Lost to Follow-up|3|||
44404793|NCT00882908|79412406|FG001|Overall Study|Lost to Follow-up|5|||
44404794|NCT00882908|79412407|FG002|Overall Study|Lost to Follow-up|3|||
44404795|NCT00882908|79412408|FG003|Overall Study|Lost to Follow-up|1|||
44404796|NCT00882908|79412409|FG004|Overall Study|Lost to Follow-up|2|||
44404797|NCT00882908|79412405|FG000|Overall Study|Protocol Violation|0|||
44404798|NCT00882908|79412406|FG001|Overall Study|Protocol Violation|1|||
44404799|NCT00882908|79412407|FG002|Overall Study|Protocol Violation|0|||
44404800|NCT00882908|79412408|FG003|Overall Study|Protocol Violation|0|||
44404801|NCT00882908|79412409|FG004|Overall Study|Protocol Violation|0|||
44404802|NCT00882908|79412405|FG000|Overall Study|Withdrawal by Subject|0|||
44404803|NCT00882908|79412406|FG001|Overall Study|Withdrawal by Subject|0|||
44404804|NCT00882908|79412407|FG002|Overall Study|Withdrawal by Subject|3|||
44404805|NCT00882908|79412408|FG003|Overall Study|Withdrawal by Subject|5|||
44404806|NCT00882908|79412409|FG004|Overall Study|Withdrawal by Subject|2|||
44404807|NCT00882908|79412405|FG000|Overall Study|Subject reached a virologic endpoint|0|||
44404808|NCT00882908|79412406|FG001|Overall Study|Subject reached a virologic endpoint|0|||
44404809|NCT00882908|79412407|FG002|Overall Study|Subject reached a virologic endpoint|0|||
44404810|NCT00882908|79412408|FG003|Overall Study|Subject reached a virologic endpoint|0|||
44404811|NCT00882908|79412409|FG004|Overall Study|Subject reached a virologic endpoint|1|||
44404812|NCT00882908|79412405|FG000|Overall Study|Study terminated in error|0|||
44404813|NCT00882908|79412406|FG001|Overall Study|Study terminated in error|0|||
44404814|NCT00882908|79412407|FG002|Overall Study|Study terminated in error|0|||
44404815|NCT00882908|79412408|FG003|Overall Study|Study terminated in error|1|||
44404816|NCT00882908|79412409|FG004|Overall Study|Study terminated in error|0|||
44404817|NCT00851799|79412425|FG000|Overall Study|Death|1|||
44404818|NCT00851799|79412426|FG001|Overall Study|Death|0|||
44404819|NCT00851799|79412427|FG002|Overall Study|Death|1|||
44404820|NCT00851799|79412425|FG000|Overall Study|Lost to Follow-up|5|||
44404821|NCT00851799|79412426|FG001|Overall Study|Lost to Follow-up|3|||
44404822|NCT00851799|79412427|FG002|Overall Study|Lost to Follow-up|10|||
44404823|NCT00851799|79412425|FG000|Overall Study|Not able to get to clinic|8|||
44404824|NCT00851799|79412426|FG001|Overall Study|Not able to get to clinic|5|||
44404825|NCT00851799|79412427|FG002|Overall Study|Not able to get to clinic|9|||
44404826|NCT00851799|79412425|FG000|Overall Study|Not willing to adhere to requirements|1|||
44404827|NCT00851799|79412426|FG001|Overall Study|Not willing to adhere to requirements|2|||
44404828|NCT00851799|79412427|FG002|Overall Study|Not willing to adhere to requirements|2|||
44404829|NCT00851799|79412425|FG000|Overall Study|Withdrew consent prior study completion|1|||
44404830|NCT00851799|79412426|FG001|Overall Study|Withdrew consent prior study completion|2|||
44404831|NCT00851799|79412427|FG002|Overall Study|Withdrew consent prior study completion|1|||
44404832|NCT00851799|79412425|FG000|Overall Study|Severe Debilitation|0|||
44404833|NCT00851799|79412426|FG001|Overall Study|Severe Debilitation|1|||
44404834|NCT00851799|79412427|FG002|Overall Study|Severe Debilitation|0|||
44404835|NCT00851799|79412425|FG000|Overall Study|Completed protocol due to pregnancy|0|||
44404836|NCT00851799|79412426|FG001|Overall Study|Completed protocol due to pregnancy|0|||
44522844|NCT02951156|79531128|FG001|Overall Study|Progressive disease|0|||
44522845|NCT02951156|79531129|FG002|Overall Study|Progressive disease|1|||
44522846|NCT02951156|79531127|FG000|Overall Study|Withdrawal by Subject|0|||
44522847|NCT02951156|79531128|FG001|Overall Study|Withdrawal by Subject|0|||
44522848|NCT02951156|79531129|FG002|Overall Study|Withdrawal by Subject|1|||
44522849|NCT02951156|79531127|FG000|Overall Study|Study terminated by sponsor|0|||
44522850|NCT02951156|79531128|FG001|Overall Study|Study terminated by sponsor|0|||
44404837|NCT00851799|79412427|FG002|Overall Study|Completed protocol due to pregnancy|1|||
44404838|NCT00521053|79412435|FG000|Observation Phase|Disease Progression|55|||
44522851|NCT02951156|79531129|FG002|Overall Study|Study terminated by sponsor|1|||
44522852|NCT02951156|79531127|FG000|Overall Study|Other|5|||
44404839|NCT00521053|79412435|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
44404840|NCT00521053|79412435|FG000|Observation Phase|Death|2|||
44404841|NCT00521053|79412435|FG000|Observation Phase|Adverse Event|1|||
44404842|NCT00521053|79412435|FG000|Observation Phase|Other non-study melanoma treatment|1|||
44522853|NCT02951156|79531128|FG001|Overall Study|Other|1|||
44404843|NCT00521053|79412435|FG000|Observation Phase|Physician Decision|1|||
44522854|NCT02951156|79531129|FG002|Overall Study|Other|2|||
44404844|NCT00853047|79412447|FG000|Core Phase|Participant Request|0|||
44404845|NCT00853047|79412448|FG001|Core Phase|Participant Request|0|||
44404846|NCT00853047|79412449|FG002|Core Phase|Participant Request|0|||
44404847|NCT00853047|79412450|FG003|Core Phase|Participant Request|1|||
44404848|NCT00853047|79412451|FG004|Core Phase|Participant Request|0|||
44404849|NCT00853047|79412452|FG005|Core Phase|Participant Request|0|||
44404850|NCT00853047|79412447|FG000|Open-Label Extension Phase|Participant Request|0|||
44404851|NCT00853047|79412448|FG001|Open-Label Extension Phase|Participant Request|0|||
44404852|NCT00853047|79412449|FG002|Open-Label Extension Phase|Participant Request|0|||
44404853|NCT00853047|79412450|FG003|Open-Label Extension Phase|Participant Request|0|||
44404854|NCT00853047|79412451|FG004|Open-Label Extension Phase|Participant Request|0|||
44404855|NCT00853047|79412452|FG005|Open-Label Extension Phase|Participant Request|7|||
44404856|NCT00853047|79412447|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
44404857|NCT00853047|79412448|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
44404858|NCT00853047|79412449|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
44404859|NCT00853047|79412450|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
44404860|NCT00853047|79412451|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
44404861|NCT00853047|79412452|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
44404862|NCT00853047|79412447|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
44404863|NCT00853047|79412448|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
44404864|NCT00853047|79412449|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
44404865|NCT00853047|79412450|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
44404866|NCT00853047|79412451|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
44404867|NCT00853047|79412452|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
44404868|NCT00853047|79412447|FG000|Open-Label Extension Phase|Investigator Decision|0|||
44404869|NCT00853047|79412448|FG001|Open-Label Extension Phase|Investigator Decision|0|||
44404870|NCT00853047|79412449|FG002|Open-Label Extension Phase|Investigator Decision|0|||
44404871|NCT00853047|79412450|FG003|Open-Label Extension Phase|Investigator Decision|0|||
44404872|NCT00853047|79412451|FG004|Open-Label Extension Phase|Investigator Decision|0|||
44404873|NCT00853047|79412452|FG005|Open-Label Extension Phase|Investigator Decision|1|||
44404874|NCT00853047|79412447|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
44404875|NCT00853047|79412448|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
44404876|NCT00853047|79412449|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
44404877|NCT00853047|79412450|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
44404878|NCT00853047|79412451|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
44404879|NCT00853047|79412452|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
44404880|NCT00520975|79412469|FG000|Overall Study|Disease progression|31|||
44404881|NCT00520975|79412470|FG001|Overall Study|Disease progression|23|||
44404882|NCT00520975|79412469|FG000|Overall Study|Adverse Event|7|||
44404883|NCT00520975|79412470|FG001|Overall Study|Adverse Event|10|||
44404884|NCT00520975|79412469|FG000|Overall Study|Death|0|||
44404885|NCT00520975|79412470|FG001|Overall Study|Death|2|||
44404886|NCT00520975|79412469|FG000|Overall Study|Withdrawal by Subject|3|||
44404887|NCT00520975|79412470|FG001|Overall Study|Withdrawal by Subject|5|||
44404888|NCT00520975|79412469|FG000|Overall Study|Other therapy|2|||
44404889|NCT00520975|79412470|FG001|Overall Study|Other therapy|4|||
44404890|NCT00520975|79412469|FG000|Overall Study|Other reasons|4|||
44404891|NCT00520975|79412470|FG001|Overall Study|Other reasons|2|||
44404892|NCT00520975|79412469|FG000|Overall Study|Not start protocol therapy|1|||
44404893|NCT00520975|79412470|FG001|Overall Study|Not start protocol therapy|2|||
44404894|NCT00851721|79412478|FG000|Overall Study|planned surgery|1|||
44404895|NCT00851721|79412479|FG001|Overall Study|planned surgery|0|||
44404896|NCT00851721|79412478|FG000|Overall Study|Death|1|||
44404897|NCT00851721|79412479|FG001|Overall Study|Death|0|||
44404898|NCT00851721|79412478|FG000|Overall Study|Adverse Event|0|||
44404899|NCT00851721|79412479|FG001|Overall Study|Adverse Event|1|||
44404900|NCT00520741|79412493|FG000|Overall Study|Adverse Event|16|||
44404901|NCT00520741|79412494|FG001|Overall Study|Adverse Event|56|||
44404902|NCT00520741|79412493|FG000|Overall Study|Lack of Efficacy|11|||
44404903|NCT00520741|79412494|FG001|Overall Study|Lack of Efficacy|30|||
44404904|NCT00520741|79412493|FG000|Overall Study|Withdrawal by Subject|0|||
44404905|NCT00520741|79412494|FG001|Overall Study|Withdrawal by Subject|11|||
44404906|NCT00520741|79412493|FG000|Overall Study|Protocol Violation|2|||
44404907|NCT00520741|79412494|FG001|Overall Study|Protocol Violation|15|||
44404908|NCT00520741|79412493|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
44404909|NCT00520741|79412494|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
44404910|NCT00520741|79412493|FG000|Overall Study|Lost to Follow-up|4|||
44404911|NCT00520741|79412494|FG001|Overall Study|Lost to Follow-up|4|||
44404912|NCT00520741|79412493|FG000|Overall Study|Other reasons for premature termination|0|||
44404913|NCT00520741|79412494|FG001|Overall Study|Other reasons for premature termination|6|||
44404914|NCT00882518|79412504|FG000|Overall Study|Adverse Event|9|||
44404915|NCT00882518|79412505|FG001|Overall Study|Adverse Event|18|||
44404916|NCT00882518|79412504|FG000|Overall Study|Withdrawal by Subject|9|||
44404917|NCT00882518|79412505|FG001|Overall Study|Withdrawal by Subject|13|||
44404918|NCT00882518|79412504|FG000|Overall Study|Lack of Efficacy|12|||
44404919|NCT00882518|79412505|FG001|Overall Study|Lack of Efficacy|9|||
44404920|NCT00882518|79412504|FG000|Overall Study|Severe non-compliance to protocol|3|||
44404921|NCT00882518|79412505|FG001|Overall Study|Severe non-compliance to protocol|1|||
44404922|NCT00882518|79412504|FG000|Overall Study|Incorrect enrolment|4|||
44404923|NCT00882518|79412505|FG001|Overall Study|Incorrect enrolment|2|||
44404924|NCT00882518|79412504|FG000|Overall Study|Central lab closure for National day|1|||
44404925|NCT00882518|79412505|FG001|Overall Study|Central lab closure for National day|0|||
44404926|NCT00882518|79412504|FG000|Overall Study|Allocating random number by mistake|0|||
44404927|NCT00882518|79412505|FG001|Overall Study|Allocating random number by mistake|1|||
44404928|NCT00882362|79412522|FG000|Overall Study|Adverse Event|13|||
44404929|NCT00882362|79412523|FG001|Overall Study|Adverse Event|10|||
44404930|NCT00882362|79412522|FG000|Overall Study|Withdrawal by Subject|13|||
44404931|NCT00882362|79412523|FG001|Overall Study|Withdrawal by Subject|10|||
44404932|NCT00882362|79412522|FG000|Overall Study|Lack of Efficacy|3|||
44404933|NCT00882362|79412523|FG001|Overall Study|Lack of Efficacy|0|||
44404934|NCT00882362|79412522|FG000|Overall Study|Protocol Violation|7|||
44404935|NCT00882362|79412523|FG001|Overall Study|Protocol Violation|2|||
44404936|NCT00882362|79412522|FG000|Overall Study|Pregnancy|1|||
44404937|NCT00882362|79412523|FG001|Overall Study|Pregnancy|0|||
44404938|NCT00882362|79412522|FG000|Overall Study|Physician Decision|5|||
44404939|NCT00882362|79412523|FG001|Overall Study|Physician Decision|1|||
44404940|NCT00882362|79412522|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
44404941|NCT00882362|79412523|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
44404942|NCT00882362|79412522|FG000|Overall Study|change of residence or other commitments|5|||
44404943|NCT00882362|79412523|FG001|Overall Study|change of residence or other commitments|0|||
44404944|NCT00851643|79412535|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
44404945|NCT00851643|79412536|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
44404946|NCT00851643|79412537|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
44404947|NCT00851643|79412538|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
44404948|NCT00851643|79412539|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
44404949|NCT00851643|79412540|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
44404950|NCT00851643|79412535|FG000|Base Study (Up to 12 Months)|Other|0|||
44147842|NCT02614131|78937222|FG000|Overall Study|Withdrawal by Subject|1|||
44147843|NCT02614131|78937223|FG001|Overall Study|Withdrawal by Subject|0|||
44147844|NCT02614131|78937224|FG002|Overall Study|Withdrawal by Subject|0|||
44404951|NCT00851643|79412536|FG001|Base Study (Up to 12 Months)|Other|0|||
44404952|NCT00851643|79412537|FG002|Base Study (Up to 12 Months)|Other|0|||
44404953|NCT00851643|79412538|FG003|Base Study (Up to 12 Months)|Other|0|||
44404954|NCT00851643|79412539|FG004|Base Study (Up to 12 Months)|Other|0|||
44404955|NCT00851643|79412540|FG005|Base Study (Up to 12 Months)|Other|1|||
44404956|NCT00851643|79412535|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
44404957|NCT00851643|79412536|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
44404958|NCT00851643|79412537|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
44404959|NCT00851643|79412538|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
44404960|NCT00851643|79412539|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
44404961|NCT00851643|79412540|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
44404962|NCT00851643|79412535|FG000|Extension Study (Up to 36 Months)|Moved|0|||
44404963|NCT00851643|79412536|FG001|Extension Study (Up to 36 Months)|Moved|2|||
44404964|NCT00851643|79412537|FG002|Extension Study (Up to 36 Months)|Moved|1|||
44404965|NCT00851643|79412538|FG003|Extension Study (Up to 36 Months)|Moved|1|||
44404966|NCT00851643|79412539|FG004|Extension Study (Up to 36 Months)|Moved|0|||
44404967|NCT00851643|79412540|FG005|Extension Study (Up to 36 Months)|Moved|1|||
44404968|NCT00529243|79412553|FG000|Overall Study|Adverse Event|1|||
44404969|NCT00529243|79412553|FG000|Overall Study|Death|1|||
44404970|NCT00529243|79412553|FG000|Overall Study|Relocated|1|||
44404971|NCT03728309|79412559|FG000|Overall Study|Randomized but not Treated|0|||
44404972|NCT03728309|79412560|FG001|Overall Study|Randomized but not Treated|1|||
44404973|NCT03728309|79412559|FG000|Overall Study|Adverse Event|0|||
44147845|NCT02614131|78937225|FG003|Overall Study|Withdrawal by Subject|0|||
44404974|NCT03728309|79412560|FG001|Overall Study|Adverse Event|1|||
44404975|NCT03728309|79412559|FG000|Overall Study|Withdrawal by Subject|2|||
44404976|NCT03728309|79412560|FG001|Overall Study|Withdrawal by Subject|8|||
44404977|NCT03728309|79412559|FG000|Overall Study|Lost to Follow-up|9|||
44404978|NCT03728309|79412560|FG001|Overall Study|Lost to Follow-up|10|||
44404979|NCT03728309|79412559|FG000|Overall Study|Protocol Deviation|0|||
44404980|NCT03728309|79412560|FG001|Overall Study|Protocol Deviation|1|||
44404981|NCT03728309|79412559|FG000|Overall Study|Due to COVID|1|||
44404982|NCT03728309|79412560|FG001|Overall Study|Due to COVID|3|||
44404983|NCT03683719|79412577|FG000|Overall Study|Lack of Efficacy|1|||
44404984|NCT03683719|79412578|FG001|Overall Study|Lack of Efficacy|3|||
44404985|NCT03683719|79412579|FG002|Overall Study|Lack of Efficacy|4|||
44404986|NCT03683719|79412580|FG003|Overall Study|Lack of Efficacy|0|||
44404987|NCT03683719|79412581|FG004|Overall Study|Lack of Efficacy|4|||
44404988|NCT03683719|79412577|FG000|Overall Study|Adverse Event|6|||
44404989|NCT03683719|79412578|FG001|Overall Study|Adverse Event|6|||
44404990|NCT03683719|79412579|FG002|Overall Study|Adverse Event|0|||
44404991|NCT03683719|79412580|FG003|Overall Study|Adverse Event|1|||
44404992|NCT03683719|79412581|FG004|Overall Study|Adverse Event|3|||
44404993|NCT03683719|79412577|FG000|Overall Study|Withdrawal by Subject|4|||
44404994|NCT03683719|79412578|FG001|Overall Study|Withdrawal by Subject|4|||
44404995|NCT03683719|79412579|FG002|Overall Study|Withdrawal by Subject|3|||
44404996|NCT03683719|79412580|FG003|Overall Study|Withdrawal by Subject|5|||
44404997|NCT03683719|79412581|FG004|Overall Study|Withdrawal by Subject|5|||
44404998|NCT03683719|79412577|FG000|Overall Study|Lost to Follow-up|1|||
44404999|NCT03683719|79412578|FG001|Overall Study|Lost to Follow-up|0|||
44405000|NCT03683719|79412579|FG002|Overall Study|Lost to Follow-up|0|||
44405001|NCT03683719|79412580|FG003|Overall Study|Lost to Follow-up|1|||
44405002|NCT03683719|79412581|FG004|Overall Study|Lost to Follow-up|1|||
44405003|NCT03683719|79412577|FG000|Overall Study|Other personal reasons|0|||
44405004|NCT03683719|79412578|FG001|Overall Study|Other personal reasons|0|||
44405005|NCT03683719|79412579|FG002|Overall Study|Other personal reasons|1|||
44405006|NCT03683719|79412580|FG003|Overall Study|Other personal reasons|0|||
44405007|NCT03683719|79412581|FG004|Overall Study|Other personal reasons|1|||
44405008|NCT00851253|79412595|FG000|Overall Study|Disease Progression|1|||
44405009|NCT00851253|79412596|FG001|Overall Study|Disease Progression|0|||
44405010|NCT00520351|79412604|FG000|First Intervention|Withdrawal by Subject|1|||
44405011|NCT00520351|79412605|FG001|First Intervention|Withdrawal by Subject|1|||
44405012|NCT00850395|79412615|FG000|Overall Study|Death|1|||
44405013|NCT00850395|79412615|FG000|Overall Study|Adverse Event|1|||
44405014|NCT00850395|79412615|FG000|Overall Study|Insufficient clinical response|3|||
44405015|NCT00850395|79412615|FG000|Overall Study|Other|5|||
44405016|NCT00520039|79412621|FG000|Overall Study|Exclusion criteria met at first visit|7|||
44405017|NCT00520039|79412622|FG001|Overall Study|Exclusion criteria met at first visit|5|||
44405018|NCT00577720|79412634|FG000|Overall Study|Adverse Event|2|||
44405019|NCT00577720|79412635|FG001|Overall Study|Adverse Event|1|||
44405020|NCT00577720|79412636|FG002|Overall Study|Adverse Event|0|||
44405021|NCT00577720|79412637|FG003|Overall Study|Adverse Event|4|||
44405022|NCT00577720|79412634|FG000|Overall Study|Lost to Follow-up|0|||
44405023|NCT00577720|79412635|FG001|Overall Study|Lost to Follow-up|0|||
44405024|NCT00577720|79412636|FG002|Overall Study|Lost to Follow-up|1|||
44405025|NCT00577720|79412637|FG003|Overall Study|Lost to Follow-up|0|||
44405026|NCT00577720|79412634|FG000|Overall Study|Protocol Violation|0|||
44405027|NCT00577720|79412635|FG001|Overall Study|Protocol Violation|0|||
44405028|NCT00577720|79412636|FG002|Overall Study|Protocol Violation|0|||
44405029|NCT00577720|79412637|FG003|Overall Study|Protocol Violation|1|||
44405030|NCT00577720|79412634|FG000|Overall Study|Withdrawal by Subject|2|||
44405031|NCT00577720|79412635|FG001|Overall Study|Withdrawal by Subject|0|||
44405032|NCT00577720|79412636|FG002|Overall Study|Withdrawal by Subject|0|||
44405033|NCT00577720|79412637|FG003|Overall Study|Withdrawal by Subject|2|||
44405034|NCT00519649|79412647|FG000|Overall Study|Withdrawal by Subject|1|||
44405035|NCT00512707|79412665|FG000|Overall Study|Lost to Follow-up|5|||
44405036|NCT00512707|79412666|FG001|Overall Study|Lost to Follow-up|11|||
44405037|NCT00512707|79412665|FG000|Overall Study|Developed skin irritation|2|||
44405038|NCT00512707|79412666|FG001|Overall Study|Developed skin irritation|1|||
44405039|NCT00512707|79412665|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
44405040|NCT00512707|79412666|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
44147846|NCT02614131|78937226|FG004|Overall Study|Withdrawal by Subject|0|||
44147847|NCT02614131|78937227|FG005|Overall Study|Withdrawal by Subject|0|||
44147848|NCT02614131|78937228|FG006|Overall Study|Withdrawal by Subject|0|||
44405041|NCT00512707|79412665|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
44405042|NCT00512707|79412666|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
44405043|NCT03471767|79412674|FG000|Overall Study|Withdrawal by Subject|3|||
44405044|NCT03471767|79412675|FG001|Overall Study|Withdrawal by Subject|1|||
44405045|NCT03471767|79412674|FG000|Overall Study|Adverse Event|1|||
44405046|NCT03471767|79412675|FG001|Overall Study|Adverse Event|0|||
44405047|NCT03471767|79412674|FG000|Overall Study|Lost to Follow-up|1|||
44405048|NCT03471767|79412675|FG001|Overall Study|Lost to Follow-up|0|||
44405049|NCT03471767|79412674|FG000|Overall Study|PI Withdrawal|1|||
44405050|NCT03471767|79412675|FG001|Overall Study|PI Withdrawal|3|||
44405051|NCT00849693|79412685|FG000|Acute Treatment Phase|Adverse Event|12|||
44405052|NCT00849693|79412686|FG001|Acute Treatment Phase|Adverse Event|7|||
44405053|NCT00849693|79412687|FG002|Acute Treatment Phase|Adverse Event|6|||
44405054|NCT00849693|79412688|FG003|Acute Treatment Phase|Adverse Event|4|||
44405055|NCT00849693|79412685|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
44405056|NCT00849693|79412686|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
44405057|NCT00849693|79412687|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
44405058|NCT00849693|79412688|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
44405059|NCT00849693|79412685|FG000|Acute Treatment Phase|Protocol Violation|1|||
44405060|NCT00849693|79412686|FG001|Acute Treatment Phase|Protocol Violation|5|||
44405061|NCT00849693|79412687|FG002|Acute Treatment Phase|Protocol Violation|2|||
44405062|NCT00849693|79412688|FG003|Acute Treatment Phase|Protocol Violation|6|||
44405063|NCT00849693|79412685|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
44405064|NCT00849693|79412686|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
44405065|NCT00849693|79412687|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
44405066|NCT00849693|79412688|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
44405067|NCT00849693|79412685|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
44405068|NCT00849693|79412686|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
44405069|NCT00849693|79412687|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
44405070|NCT00849693|79412688|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
44405071|NCT00849693|79412685|FG000|Acute Treatment Phase|Physician Decision|2|||
44405072|NCT00849693|79412686|FG001|Acute Treatment Phase|Physician Decision|1|||
44405073|NCT00849693|79412687|FG002|Acute Treatment Phase|Physician Decision|2|||
44405074|NCT00849693|79412688|FG003|Acute Treatment Phase|Physician Decision|1|||
44405075|NCT00849693|79412685|FG000|Acute Treatment Phase|Sponsor decision|0|||
44405076|NCT00849693|79412686|FG001|Acute Treatment Phase|Sponsor decision|0|||
44405077|NCT00849693|79412687|FG002|Acute Treatment Phase|Sponsor decision|1|||
44405078|NCT00849693|79412688|FG003|Acute Treatment Phase|Sponsor decision|0|||
44405079|NCT00849693|79412685|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
44405080|NCT00849693|79412686|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
44405081|NCT00849693|79412687|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
44405082|NCT00849693|79412688|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
44405083|NCT00849693|79412685|FG000|Extension Phase|Adverse Event|4|||
44405084|NCT00849693|79412686|FG001|Extension Phase|Adverse Event|6|||
44405085|NCT00849693|79412687|FG002|Extension Phase|Adverse Event|3|||
44405086|NCT00849693|79412688|FG003|Extension Phase|Adverse Event|7|||
44405087|NCT00849693|79412685|FG000|Extension Phase|Lost to Follow-up|7|||
44405088|NCT00849693|79412686|FG001|Extension Phase|Lost to Follow-up|5|||
44405089|NCT00849693|79412687|FG002|Extension Phase|Lost to Follow-up|6|||
44405090|NCT00849693|79412688|FG003|Extension Phase|Lost to Follow-up|6|||
44405091|NCT00849693|79412685|FG000|Extension Phase|Protocol Violation|0|||
44405092|NCT00849693|79412686|FG001|Extension Phase|Protocol Violation|3|||
44405093|NCT00849693|79412687|FG002|Extension Phase|Protocol Violation|2|||
44405094|NCT00849693|79412688|FG003|Extension Phase|Protocol Violation|3|||
44405095|NCT00849693|79412685|FG000|Extension Phase|Withdrawal by Subject|6|||
44405096|NCT00849693|79412686|FG001|Extension Phase|Withdrawal by Subject|9|||
44405097|NCT00849693|79412687|FG002|Extension Phase|Withdrawal by Subject|10|||
44405098|NCT00849693|79412688|FG003|Extension Phase|Withdrawal by Subject|15|||
44405099|NCT00849693|79412685|FG000|Extension Phase|Parent or caregiver decision|9|||
44405100|NCT00849693|79412686|FG001|Extension Phase|Parent or caregiver decision|4|||
44522855|NCT03345914|79531141|FG000|Overall Study|Transition to another study at week 16|80|||
44522856|NCT03345914|79531142|FG001|Overall Study|Transition to another study at week 16|86|||
44522857|NCT03345914|79531143|FG002|Overall Study|Transition to another study at week 16|78|||
44522858|NCT03345914|79531141|FG000|Overall Study|Transition to OLE during follow-up|37|||
44522859|NCT03345914|79531142|FG001|Overall Study|Transition to OLE during follow-up|33|||
44522860|NCT03345914|79531143|FG002|Overall Study|Transition to OLE during follow-up|39|||
44522861|NCT03345914|79531141|FG000|Overall Study|Physician Decision|0|||
44522862|NCT03345914|79531142|FG001|Overall Study|Physician Decision|1|||
44522863|NCT03345914|79531143|FG002|Overall Study|Physician Decision|1|||
44522864|NCT03345914|79531141|FG000|Overall Study|Withdrawal by Subject|5|||
44405101|NCT00849693|79412687|FG002|Extension Phase|Parent or caregiver decision|10|||
44405102|NCT00849693|79412688|FG003|Extension Phase|Parent or caregiver decision|5|||
44405103|NCT00849693|79412685|FG000|Extension Phase|Physician Decision|1|||
44405104|NCT00849693|79412686|FG001|Extension Phase|Physician Decision|1|||
44405105|NCT00849693|79412687|FG002|Extension Phase|Physician Decision|2|||
44405106|NCT00849693|79412688|FG003|Extension Phase|Physician Decision|0|||
44405107|NCT00849693|79412685|FG000|Extension Phase|Sponsor decision|1|||
44522865|NCT03345914|79531142|FG001|Overall Study|Withdrawal by Subject|1|||
44405108|NCT00849693|79412686|FG001|Extension Phase|Sponsor decision|0|||
44405109|NCT00849693|79412687|FG002|Extension Phase|Sponsor decision|0|||
44405110|NCT00849693|79412688|FG003|Extension Phase|Sponsor decision|1|||
44405111|NCT00849693|79412685|FG000|Extension Phase|Lack of Efficacy|2|||
44405112|NCT00849693|79412686|FG001|Extension Phase|Lack of Efficacy|2|||
44405113|NCT00849693|79412687|FG002|Extension Phase|Lack of Efficacy|2|||
44405114|NCT00849693|79412688|FG003|Extension Phase|Lack of Efficacy|1|||
44405115|NCT00527605|79412712|FG000|Overall Study|Adverse Event|3|||
44405116|NCT00527605|79412713|FG001|Overall Study|Adverse Event|0|||
44405117|NCT00527605|79412712|FG000|Overall Study|Withdrawal by Subject|3|||
44405118|NCT00527605|79412713|FG001|Overall Study|Withdrawal by Subject|7|||
44405119|NCT00527605|79412712|FG000|Overall Study|Lost to Follow-up|6|||
44405120|NCT00527605|79412713|FG001|Overall Study|Lost to Follow-up|2|||
44405121|NCT00527605|79412712|FG000|Overall Study|Protocol Violation|1|||
44405122|NCT00527605|79412713|FG001|Overall Study|Protocol Violation|2|||
44405123|NCT00849381|79412719|FG000|Overall Study|Adverse Event|1|||
44405124|NCT00849381|79412719|FG000|Overall Study|Lost to Follow-up|129|||
44405125|NCT00849381|79412719|FG000|Overall Study|Protocol Violation|5|||
44405126|NCT00849381|79412719|FG000|Overall Study|Withdrawal by Subject|6|||
44405127|NCT00849381|79412719|FG000|Overall Study|Other|4|||
44405128|NCT00711412|79412723|FG000|Induction Treatment|Death|2|||
44405129|NCT00711412|79412723|FG000|Induction Treatment|Adverse Event|1|||
44405130|NCT00711412|79412723|FG000|Induction Treatment|Other|1|||
44405131|NCT00711412|79412723|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
44405132|NCT00711412|79412723|FG000|Evaluated for Combination Treatment|Death|1|||
44405133|NCT00711412|79412723|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
44405134|NCT00711412|79412723|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
44405135|NCT00711412|79412723|FG000|Combination Treatment|Progressive Disease|1|||
44405136|NCT00711412|79412723|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
44522866|NCT03345914|79531143|FG002|Overall Study|Withdrawal by Subject|2|||
44522867|NCT03345914|79531141|FG000|Overall Study|Other|1|||
44522868|NCT03345914|79531142|FG001|Overall Study|Other|1|||
44522869|NCT03345914|79531143|FG002|Overall Study|Other|1|||
44405137|NCT00711412|79412723|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
44405138|NCT00711412|79412723|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
44405139|NCT00711412|79412723|FG000|Evaluation for Response and Surgery|Death|1|||
44405140|NCT00711412|79412723|FG000|Survival Follow up Until Death|Other|12|||
44405141|NCT00577408|79412739|FG000|Overall Study|Stopped attending study visits|9|||
44405142|NCT00577408|79412740|FG001|Overall Study|Stopped attending study visits|11|||
44405143|NCT00577408|79412739|FG000|Overall Study|Continued opioid use|3|||
44405144|NCT00577408|79412740|FG001|Overall Study|Continued opioid use|2|||
44405145|NCT00577408|79412739|FG000|Overall Study|Non-compliance with study meds|0|||
44405146|NCT00577408|79412740|FG001|Overall Study|Non-compliance with study meds|3|||
44405147|NCT00577408|79412739|FG000|Overall Study|Refused Oral Naltrexone|0|||
44405148|NCT00577408|79412740|FG001|Overall Study|Refused Oral Naltrexone|1|||
44405149|NCT00577408|79412739|FG000|Overall Study|Moved out of state|0|||
44405150|NCT00577408|79412740|FG001|Overall Study|Moved out of state|1|||
44405151|NCT00577408|79412739|FG000|Overall Study|Scheduling Issues|0|||
44405152|NCT00577408|79412740|FG001|Overall Study|Scheduling Issues|3|||
44405153|NCT00577408|79412739|FG000|Overall Study|Death|0|||
44405154|NCT00577408|79412740|FG001|Overall Study|Death|1|||
44405155|NCT00577408|79412739|FG000|Overall Study|Psychiatric hospitalization|0|||
44405156|NCT00577408|79412740|FG001|Overall Study|Psychiatric hospitalization|1|||
44405157|NCT00713596|79412749|FG000|Overall Study|Study was terminated|2|||
44405158|NCT00713596|79412750|FG001|Overall Study|Study was terminated|3|||
44405159|NCT00713596|79412751|FG002|Overall Study|Study was terminated|2|||
44405160|NCT00880568|79412768|FG000|Overall Study|Disease progression|3|||
44522870|NCT03345914|79531141|FG000|Overall Study|Ongoing|0|||
44522871|NCT03345914|79531142|FG001|Overall Study|Ongoing|0|||
44522872|NCT03345914|79531143|FG002|Overall Study|Ongoing|1|||
44522873|NCT03369704|79531153|FG000|Treatment Epoch|technical problems|1|||
44522874|NCT03369704|79531154|FG001|Treatment Epoch|technical problems|0|||
44522875|NCT03369704|79531153|FG000|Treatment Epoch|Protocol Violation|1|||
44522876|NCT03369704|79531154|FG001|Treatment Epoch|Protocol Violation|0|||
44522877|NCT03369704|79531153|FG000|Treatment Epoch|Lost to Follow-up|0|||
44522878|NCT03369704|79531154|FG001|Treatment Epoch|Lost to Follow-up|1|||
44147849|NCT02614131|78937222|FG000|Overall Study|Adverse Event|0|||
44147850|NCT02614131|78937223|FG001|Overall Study|Adverse Event|0|||
44147851|NCT02614131|78937224|FG002|Overall Study|Adverse Event|0|||
44522879|NCT03369704|79531153|FG000|Treatment Epoch|Lack of Efficacy|0|||
44405161|NCT00880568|79412769|FG001|Overall Study|Disease progression|3|||
44405162|NCT00880568|79412770|FG002|Overall Study|Disease progression|3|||
44405163|NCT00880568|79412771|FG003|Overall Study|Disease progression|1|||
44405164|NCT00880568|79412772|FG004|Overall Study|Disease progression|3|||
44405165|NCT00880568|79412773|FG005|Overall Study|Disease progression|3|||
44405166|NCT00880568|79412774|FG006|Overall Study|Disease progression|5|||
44405167|NCT00880568|79412775|FG007|Overall Study|Disease progression|0|||
44522880|NCT03369704|79531154|FG001|Treatment Epoch|Lack of Efficacy|2|||
44522881|NCT03369704|79531153|FG000|Treatment Epoch|Adverse Event|2|||
44405168|NCT00880568|79412776|FG008|Overall Study|Disease progression|3|||
44405169|NCT00880568|79412768|FG000|Overall Study|Adverse Event|0|||
44522882|NCT03369704|79531154|FG001|Treatment Epoch|Adverse Event|0|||
44522883|NCT03369704|79531153|FG000|Follow-up Epoch|Lost to Follow-up|1|||
44522884|NCT03369704|79531154|FG001|Follow-up Epoch|Lost to Follow-up|0|||
44522885|NCT03366428|79531160|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
44522886|NCT03366428|79531160|FG000|Overall Study|Adverse Event|12|||
44147852|NCT02614131|78937225|FG003|Overall Study|Adverse Event|0|||
44147853|NCT02614131|78937226|FG004|Overall Study|Adverse Event|0|||
44147854|NCT02614131|78937227|FG005|Overall Study|Adverse Event|0|||
44147855|NCT02614131|78937228|FG006|Overall Study|Adverse Event|1|||
44282037|NCT01906008|79245280|FG000|Overall Study|Physician Decision|3|||
44282038|NCT01906008|79245281|FG001|Overall Study|Physician Decision|3|||
44405170|NCT00880568|79412769|FG001|Overall Study|Adverse Event|0|||
44405171|NCT00880568|79412770|FG002|Overall Study|Adverse Event|0|||
44405172|NCT00880568|79412771|FG003|Overall Study|Adverse Event|0|||
44405173|NCT00880568|79412772|FG004|Overall Study|Adverse Event|0|||
44405174|NCT00880568|79412773|FG005|Overall Study|Adverse Event|0|||
44405175|NCT00880568|79412774|FG006|Overall Study|Adverse Event|1|||
44405176|NCT00880568|79412775|FG007|Overall Study|Adverse Event|1|||
44405177|NCT00880568|79412776|FG008|Overall Study|Adverse Event|0|||
44405178|NCT00880568|79412768|FG000|Overall Study|Withdrawal by Subject|0|||
44405179|NCT00880568|79412769|FG001|Overall Study|Withdrawal by Subject|0|||
44405180|NCT00880568|79412770|FG002|Overall Study|Withdrawal by Subject|0|||
44405181|NCT00880568|79412771|FG003|Overall Study|Withdrawal by Subject|0|||
44405182|NCT00880568|79412772|FG004|Overall Study|Withdrawal by Subject|0|||
44405183|NCT00880568|79412773|FG005|Overall Study|Withdrawal by Subject|0|||
44405184|NCT00880568|79412774|FG006|Overall Study|Withdrawal by Subject|0|||
44405185|NCT00880568|79412775|FG007|Overall Study|Withdrawal by Subject|1|||
44405186|NCT00880568|79412776|FG008|Overall Study|Withdrawal by Subject|0|||
44147856|NCT05091307|78937254|FG000|Overall Study|Death|0|||
44405187|NCT00881894|79412803|FG000|Overall Study|Consent withdrawn|0|||
44147857|NCT05091307|78937255|FG001|Overall Study|Death|0|||
44147858|NCT05091307|78937256|FG002|Overall Study|Death|1|||
44147859|NCT05091307|78937257|FG003|Overall Study|Death|0|||
44147860|NCT05091307|78937254|FG000|Overall Study|Lost to Follow-up|33|||
44147861|NCT05091307|78937255|FG001|Overall Study|Lost to Follow-up|33|||
44147862|NCT05091307|78937256|FG002|Overall Study|Lost to Follow-up|2|||
44147863|NCT05091307|78937257|FG003|Overall Study|Lost to Follow-up|0|||
44147864|NCT05091307|78937254|FG000|Overall Study|Physician Decision|1|||
44147865|NCT05091307|78937255|FG001|Overall Study|Physician Decision|0|||
44147866|NCT05091307|78937256|FG002|Overall Study|Physician Decision|0|||
44147867|NCT05091307|78937257|FG003|Overall Study|Physician Decision|0|||
44147868|NCT05091307|78937254|FG000|Overall Study|Protocol Violation|1|||
44147869|NCT05091307|78937255|FG001|Overall Study|Protocol Violation|0|||
44147870|NCT05091307|78937256|FG002|Overall Study|Protocol Violation|0|||
44147871|NCT05091307|78937257|FG003|Overall Study|Protocol Violation|0|||
44147872|NCT05091307|78937254|FG000|Overall Study|Withdrawal by Subject|16|||
44147873|NCT05091307|78937255|FG001|Overall Study|Withdrawal by Subject|16|||
44147874|NCT05091307|78937256|FG002|Overall Study|Withdrawal by Subject|0|||
44147875|NCT05091307|78937257|FG003|Overall Study|Withdrawal by Subject|1|||
44147876|NCT05091307|78937254|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
44147877|NCT05091307|78937255|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
44253057|NCT03793010|79092900|FG000|Overall Study|Patient couldn't sit still for injection|1|||
44253058|NCT03793010|79092901|FG001|Overall Study|Patient couldn't sit still for injection|0|||
44253059|NCT03793010|79092900|FG000|Overall Study|Withdrew to pursue other treatment|1|||
44253060|NCT03793010|79092901|FG001|Overall Study|Withdrew to pursue other treatment|0|||
44253061|NCT03793010|79092900|FG000|Overall Study|Did not meet eligibility criteria|1|||
44253062|NCT03793010|79092901|FG001|Overall Study|Did not meet eligibility criteria|0|||
44253063|NCT03529942|79092950|FG000|Overall Study|Withdrawal by Subject|13|||
44253064|NCT03529942|79092950|FG000|Overall Study|Physician Decision|1|||
44253065|NCT03529942|79092950|FG000|Overall Study|Lost to Follow-up|7|||
44253066|NCT03529942|79092950|FG000|Overall Study|Needle inserted but no drug administered|1|||
44253067|NCT03529942|79092950|FG000|Overall Study|Personal reasons|1|||
44147878|NCT05091307|78937256|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
44147879|NCT05091307|78937257|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
44253068|NCT03484819|79092961|FG000|Overall Study|Death|2|||
44253069|NCT03484819|79092961|FG000|Overall Study|Adverse Event|2|||
44405188|NCT00881894|79412804|FG001|Overall Study|Consent withdrawn|1|||
44147880|NCT05091307|78937254|FG000|Overall Study|Initiated Prohibited Medication|1|||
44405189|NCT00881894|79412803|FG000|Overall Study|Other reasons for premature termination|1|||
44405190|NCT00881894|79412804|FG001|Overall Study|Other reasons for premature termination|2|||
44405191|NCT00711100|79412810|FG000|Overall Study|Lack of Efficacy|5|||
44405192|NCT00711100|79412810|FG000|Overall Study|Withdrawal by Subject|8|||
44405193|NCT00827931|79412828|FG000|Overall Study|Death|3|||
44405194|NCT00827931|79412829|FG001|Overall Study|Death|5|||
44253070|NCT03484819|79092961|FG000|Overall Study|Physician Decision|1|||
44253071|NCT03484819|79092961|FG000|Overall Study|Withdrawal by Subject|2|||
44522887|NCT03366428|79531160|FG000|Overall Study|Clinical progression|2|||
44147881|NCT05091307|78937255|FG001|Overall Study|Initiated Prohibited Medication|0|||
44405195|NCT00827931|79412828|FG000|Overall Study|Adverse Event|1|||
44405196|NCT00827931|79412829|FG001|Overall Study|Adverse Event|0|||
44405197|NCT00827931|79412828|FG000|Overall Study|Lost to Follow-up|1|||
44405198|NCT00827931|79412829|FG001|Overall Study|Lost to Follow-up|0|||
44405199|NCT00827931|79412828|FG000|Overall Study|Withdrawal by Subject|0|||
44405200|NCT00827931|79412829|FG001|Overall Study|Withdrawal by Subject|1|||
44405201|NCT00827931|79412828|FG000|Overall Study|Other|1|||
44405202|NCT00827931|79412829|FG001|Overall Study|Other|0|||
44405203|NCT00526669|79412835|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
44405204|NCT00526669|79412836|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
44405205|NCT00526669|79412835|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
44405206|NCT00526669|79412836|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
44405207|NCT00526669|79412835|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
44405208|NCT00526669|79412836|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
44405209|NCT00526669|79412835|FG000|Combined Treatment Phase|Death|0|||
44405210|NCT00526669|79412836|FG001|Combined Treatment Phase|Death|2|||
44405211|NCT00710866|79412848|FG000|Overall Study|Protocol Violation|5|||
44405212|NCT00710866|79412849|FG001|Overall Study|Protocol Violation|4|||
44405213|NCT00710866|79412848|FG000|Overall Study|Withdrawal by Subject|2|||
44405214|NCT00710866|79412849|FG001|Overall Study|Withdrawal by Subject|1|||
44405215|NCT00710866|79412848|FG000|Overall Study|Lost to Follow-up|1|||
44405216|NCT00710866|79412849|FG001|Overall Study|Lost to Follow-up|0|||
44405217|NCT00710866|79412848|FG000|Overall Study|Failed to meet eligibility|1|||
44522888|NCT03366428|79531160|FG000|Overall Study|Withdrawal by Subject|4|||
44522889|NCT02839876|79531168|FG000|Overall Study|Protocol Violation|10|||
44522890|NCT02839876|79531169|FG001|Overall Study|Protocol Violation|11|||
44522891|NCT03366194|79531175|FG000|Overall Study|Lost to Follow-up|2|||
44522892|NCT02839798|79531180|FG000|Overall Study|Withdrawal by Subject|2|||
44522893|NCT03345836|79531187|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
44522894|NCT03345836|79531188|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
44522895|NCT03345836|79531189|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
44522896|NCT03345836|79531190|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
44522897|NCT03345836|79531191|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
44522898|NCT03345836|79531192|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
44522899|NCT03345836|79531187|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
44522900|NCT03345836|79531188|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
44522901|NCT03345836|79531189|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
44522902|NCT03345836|79531190|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
44522903|NCT03345836|79531191|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
44522904|NCT03345836|79531192|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
44522905|NCT03345836|79531187|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
44522906|NCT03345836|79531188|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
44522907|NCT03345836|79531189|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
44522908|NCT03345836|79531190|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
44522909|NCT03345836|79531191|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
44522910|NCT03345836|79531192|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
44522911|NCT03345836|79531187|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
44522912|NCT03345836|79531188|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
44522913|NCT03345836|79531189|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
44147882|NCT05091307|78937256|FG002|Overall Study|Initiated Prohibited Medication|0|||
44147883|NCT05091307|78937257|FG003|Overall Study|Initiated Prohibited Medication|0|||
44147884|NCT05091307|78937254|FG000|Overall Study|Other|4|||
44147885|NCT05091307|78937255|FG001|Overall Study|Other|4|||
44147886|NCT05091307|78937256|FG002|Overall Study|Other|0|||
44253072|NCT03484819|79092961|FG000|Overall Study|Disease Progression|4|||
44253073|NCT03484819|79092961|FG000|Overall Study|Complicating Condition|1|||
44253074|NCT03382262|79092969|FG000|Overall Study|Physician Decision|0|||
44253075|NCT03382262|79092970|FG001|Overall Study|Physician Decision|0|||
44253076|NCT03382262|79092971|FG002|Overall Study|Physician Decision|1|||
44253077|NCT03382262|79092972|FG003|Overall Study|Physician Decision|0|||
44253078|NCT03382262|79092969|FG000|Overall Study|Withdrawal by Subject|0|||
44405218|NCT00710866|79412849|FG001|Overall Study|Failed to meet eligibility|1|||
44522914|NCT03345836|79531190|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
44147887|NCT05091307|78937257|FG003|Overall Study|Other|0|||
44253079|NCT03382262|79092970|FG001|Overall Study|Withdrawal by Subject|0|||
44253080|NCT03382262|79092971|FG002|Overall Study|Withdrawal by Subject|0|||
44405219|NCT00827775|79412866|FG000|Overall Study|Withdrawal by Subject|0|||
44147888|NCT05091307|78937254|FG000|Overall Study|Randomized but not vaccinated|0|||
44147889|NCT05091307|78937255|FG001|Overall Study|Randomized but not vaccinated|2|||
44253081|NCT03382262|79092972|FG003|Overall Study|Withdrawal by Subject|1|||
44253082|NCT03381274|79092987|FG000|Overall Study|Death|2|||
44405220|NCT00827775|79412867|FG001|Overall Study|Withdrawal by Subject|5|||
44405221|NCT00827541|79412875|FG000|Overall Study|Exitus|1|||
44522915|NCT03345836|79531191|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
44522916|NCT03345836|79531192|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
44522917|NCT03345836|79531187|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
44522918|NCT03345836|79531188|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
44522919|NCT03345836|79531189|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
44522920|NCT03345836|79531190|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
44522921|NCT03345836|79531191|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
44522922|NCT03345836|79531192|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
44522923|NCT03345836|79531187|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
44522924|NCT03345836|79531188|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
44522925|NCT03345836|79531189|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
44522926|NCT03345836|79531190|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
44522927|NCT03345836|79531191|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
44522928|NCT03345836|79531192|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
44147890|NCT05091307|78937256|FG002|Overall Study|Randomized but not vaccinated|0|||
44147891|NCT05091307|78937257|FG003|Overall Study|Randomized but not vaccinated|0|||
44147892|NCT04930965|78937289|FG000|Overall Study|Lost to Follow-up|7|||
44147893|NCT04930965|78937290|FG001|Overall Study|Lost to Follow-up|5|||
44405222|NCT00827541|79412876|FG001|Overall Study|Exitus|8|||
44405223|NCT00827541|79412875|FG000|Overall Study|Other|1|||
44405224|NCT00827541|79412876|FG001|Overall Study|Other|3|||
44405225|NCT00827541|79412875|FG000|Overall Study|Pathogen not susceptible|1|||
44405226|NCT00827541|79412876|FG001|Overall Study|Pathogen not susceptible|0|||
44405227|NCT00827541|79412875|FG000|Overall Study|Lack of effectiveness|1|||
44405228|NCT00827541|79412876|FG001|Overall Study|Lack of effectiveness|0|||
44405229|NCT00518323|79412886|FG000|Overall Study|Lack of Efficacy|14|||
44405230|NCT00518323|79412887|FG001|Overall Study|Lack of Efficacy|2|||
44405231|NCT00518323|79412888|FG002|Overall Study|Lack of Efficacy|4|||
44405232|NCT00518323|79412889|FG003|Overall Study|Lack of Efficacy|20|||
44405233|NCT00518323|79412886|FG000|Overall Study|Withdrawal by Subject|1|||
44405234|NCT00518323|79412887|FG001|Overall Study|Withdrawal by Subject|2|||
44405235|NCT00518323|79412888|FG002|Overall Study|Withdrawal by Subject|4|||
44405236|NCT00518323|79412889|FG003|Overall Study|Withdrawal by Subject|2|||
44405237|NCT00518323|79412886|FG000|Overall Study|Lost to Follow-up|0|||
44405238|NCT00518323|79412887|FG001|Overall Study|Lost to Follow-up|2|||
44405239|NCT00518323|79412888|FG002|Overall Study|Lost to Follow-up|1|||
44522929|NCT03345836|79531187|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
44522930|NCT03345836|79531188|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
44522931|NCT03345836|79531189|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
44522932|NCT03345836|79531190|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
44522933|NCT03345836|79531191|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
44522934|NCT03345836|79531192|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
44147894|NCT04806334|78937296|FG000|Overall Study|Withdrawal by Subject|1|||
44147895|NCT04740931|78937315|FG000|Overall Study|Ongoing in the Study at the Primary Completion Date|360|||
44147896|NCT04740931|78937316|FG001|Overall Study|Ongoing in the Study at the Primary Completion Date|353|||
44147897|NCT04740931|78937315|FG000|Overall Study|Withdrawal by Subject|0|||
44147898|NCT04740931|78937316|FG001|Overall Study|Withdrawal by Subject|4|||
44147899|NCT04740931|78937315|FG000|Overall Study|Death|1|||
44147900|NCT04740931|78937316|FG001|Overall Study|Death|2|||
44147901|NCT04740931|78937315|FG000|Overall Study|Noncompliance with study drug|2|||
44147902|NCT04740931|78937316|FG001|Overall Study|Noncompliance with study drug|0|||
44147903|NCT04740931|78937315|FG000|Overall Study|Reason Not Specified|2|||
44147904|NCT04740931|78937316|FG001|Overall Study|Reason Not Specified|0|||
44147905|NCT04740931|78937315|FG000|Overall Study|Adverse Event|1|||
44147906|NCT04740931|78937316|FG001|Overall Study|Adverse Event|1|||
44147907|NCT04740931|78937315|FG000|Overall Study|Protocol Violation|0|||
44147908|NCT04740931|78937316|FG001|Overall Study|Protocol Violation|1|||
44147909|NCT04740931|78937315|FG000|Overall Study|Physician Decision|0|||
44147910|NCT04740931|78937316|FG001|Overall Study|Physician Decision|1|||
44147911|NCT04740931|78937315|FG000|Overall Study|Lost to Follow-up|0|||
44147912|NCT04740931|78937316|FG001|Overall Study|Lost to Follow-up|1|||
44147913|NCT04681352|78937322|FG000|Overall Study|Lost to Follow-up|2|||
44147914|NCT04681352|78937322|FG000|Overall Study|Withdrawal by Subject|22|||
44147915|NCT04471428|78937328|FG000|Overall Study|Withdrawal by Subject|29|||
44253083|NCT03381274|79092988|FG001|Overall Study|Death|9|||
44253084|NCT03381274|79092989|FG002|Overall Study|Death|3|||
44405240|NCT00518323|79412889|FG003|Overall Study|Lost to Follow-up|3|||
44405241|NCT00518323|79412886|FG000|Overall Study|Adverse Event|1|||
44522935|NCT03345836|79531187|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
44522936|NCT03345836|79531188|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
44147916|NCT04471428|78937329|FG001|Overall Study|Withdrawal by Subject|1|||
44253085|NCT03381274|79092990|FG003|Overall Study|Death|2|||
44405242|NCT00518323|79412887|FG001|Overall Study|Adverse Event|1|||
44405243|NCT00518323|79412888|FG002|Overall Study|Adverse Event|1|||
44405244|NCT00518323|79412889|FG003|Overall Study|Adverse Event|0|||
44405245|NCT00518323|79412886|FG000|Overall Study|Prohibited medication and others|3|||
44405246|NCT00518323|79412887|FG001|Overall Study|Prohibited medication and others|1|||
44405247|NCT00518323|79412888|FG002|Overall Study|Prohibited medication and others|1|||
44405248|NCT00518323|79412889|FG003|Overall Study|Prohibited medication and others|0|||
44405249|NCT00826449|79412901|FG000|Overall Study|Disease Progression|4|||
44405250|NCT00826449|79412901|FG000|Overall Study|Withdrawal by Subject|1|||
44522937|NCT03345836|79531189|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
44522938|NCT03345836|79531190|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
44522939|NCT03345836|79531191|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
44522940|NCT03345836|79531192|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
44522941|NCT03345836|79531187|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
44522942|NCT03345836|79531188|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
44405251|NCT00825825|79412906|FG000|First Medication Period (14 Days)|Adverse Event|1|||
44405252|NCT00825825|79412907|FG001|First Medication Period (14 Days)|Adverse Event|0|||
44405253|NCT00825825|79412908|FG002|First Medication Period (14 Days)|Adverse Event|0|||
44405254|NCT00825825|79412909|FG003|First Medication Period (14 Days)|Adverse Event|0|||
44405255|NCT00825825|79412910|FG004|First Medication Period (14 Days)|Adverse Event|0|||
44405256|NCT00825825|79412911|FG005|First Medication Period (14 Days)|Adverse Event|1|||
44522943|NCT03345836|79531189|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
44522944|NCT03345836|79531190|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
44522945|NCT03345836|79531191|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
44522946|NCT03345836|79531192|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
44522947|NCT03345836|79531187|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
44522948|NCT03345836|79531188|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
44522949|NCT03345836|79531189|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
44522950|NCT03345836|79531190|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
44522951|NCT03345836|79531191|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
44522952|NCT03345836|79531192|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
44522953|NCT03345836|79531187|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
44522954|NCT03345836|79531188|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
44522955|NCT03345836|79531189|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
44522956|NCT03345836|79531190|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
44522957|NCT03345836|79531191|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
44522958|NCT03345836|79531192|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
44282039|NCT01906008|79245280|FG000|Overall Study|Lack of compliance of study med|5|||
44282040|NCT01906008|79245281|FG001|Overall Study|Lack of compliance of study med|3|||
44282041|NCT01906008|79245280|FG000|Overall Study|Adverse Event|0|||
44282042|NCT01906008|79245281|FG001|Overall Study|Adverse Event|3|||
44282043|NCT01863732|79245291|FG000|Overall Study|Adverse Event|2|||
44282044|NCT01863732|79245292|FG001|Overall Study|Adverse Event|0|||
44282045|NCT01863732|79245293|FG002|Overall Study|Adverse Event|3|||
44282046|NCT01863732|79245294|FG003|Overall Study|Adverse Event|3|||
44282047|NCT01863732|79245291|FG000|Overall Study|Lack of Efficacy|1|||
44405257|NCT00825825|79412906|FG000|First Medication Period (14 Days)|Physician Decision|2|||
44405258|NCT00825825|79412907|FG001|First Medication Period (14 Days)|Physician Decision|0|||
44405259|NCT00825825|79412908|FG002|First Medication Period (14 Days)|Physician Decision|1|||
44405260|NCT00825825|79412909|FG003|First Medication Period (14 Days)|Physician Decision|0|||
44405261|NCT00825825|79412910|FG004|First Medication Period (14 Days)|Physician Decision|0|||
44405262|NCT00825825|79412911|FG005|First Medication Period (14 Days)|Physician Decision|1|||
44405263|NCT00825825|79412906|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
44405264|NCT00825825|79412907|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
44405265|NCT00825825|79412908|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
44405266|NCT00825825|79412909|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
44405267|NCT00825825|79412910|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
44405268|NCT00825825|79412911|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
44405269|NCT00825825|79412906|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
44405270|NCT00825825|79412907|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
44405271|NCT00825825|79412908|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
44405272|NCT00825825|79412909|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
44522959|NCT02839330|79531212|FG000|Overall Study|Adverse Event|0|||
44522960|NCT02839330|79531213|FG001|Overall Study|Adverse Event|1|||
44282048|NCT01863732|79245292|FG001|Overall Study|Lack of Efficacy|0|||
44282049|NCT01863732|79245293|FG002|Overall Study|Lack of Efficacy|2|||
44282050|NCT01863732|79245294|FG003|Overall Study|Lack of Efficacy|1|||
44405273|NCT00825825|79412910|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
44405274|NCT00825825|79412911|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
44405275|NCT00825825|79412906|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
44405276|NCT00825825|79412907|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
44405277|NCT00825825|79412908|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
44405278|NCT00825825|79412909|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
44405279|NCT00825825|79412910|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
44405280|NCT00825825|79412911|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
44405281|NCT00825825|79412906|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
44405282|NCT00825825|79412907|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
44405283|NCT00825825|79412908|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
44405284|NCT00825825|79412909|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
44405285|NCT00825825|79412910|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
44405286|NCT00825825|79412911|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
44405287|NCT00825825|79412906|FG000|Third Medication Period (14 Days)|poor data quality|0|||
44405288|NCT00825825|79412907|FG001|Third Medication Period (14 Days)|poor data quality|1|||
44405289|NCT00825825|79412908|FG002|Third Medication Period (14 Days)|poor data quality|0|||
44405290|NCT00825825|79412909|FG003|Third Medication Period (14 Days)|poor data quality|0|||
44405291|NCT00825825|79412910|FG004|Third Medication Period (14 Days)|poor data quality|0|||
44405292|NCT00825825|79412911|FG005|Third Medication Period (14 Days)|poor data quality|0|||
44405293|NCT00710710|79412920|FG000|Overall Study|Consent withdrawn|2|||
44405294|NCT00710710|79412921|FG001|Overall Study|Consent withdrawn|2|||
44405295|NCT00710710|79412920|FG000|Overall Study|Protocol Violation|0|||
44405296|NCT00710710|79412921|FG001|Overall Study|Protocol Violation|1|||
44405297|NCT00710710|79412920|FG000|Overall Study|Adverse Event|3|||
44405298|NCT00710710|79412921|FG001|Overall Study|Adverse Event|3|||
44405299|NCT00710710|79412920|FG000|Overall Study|Progressive disease|40|||
44405300|NCT00710710|79412921|FG001|Overall Study|Progressive disease|38|||
44405301|NCT00880334|79412929|FG000|Randomized Phase|Physician Decision|1|||
44405302|NCT00880334|79412930|FG001|Randomized Phase|Physician Decision|0|||
44405303|NCT00880334|79412929|FG000|Randomized Phase|Withdrawal by Subject|2|||
44405304|NCT00880334|79412930|FG001|Randomized Phase|Withdrawal by Subject|1|||
44405305|NCT00880334|79412929|FG000|Randomized Phase|Inadequate Labs|1|||
44405306|NCT00880334|79412930|FG001|Randomized Phase|Inadequate Labs|1|||
44522961|NCT02839330|79531214|FG002|Overall Study|Adverse Event|2|||
44522962|NCT02839330|79531215|FG003|Overall Study|Adverse Event|2|||
44522963|NCT02839330|79531212|FG000|Overall Study|Death|4|||
44522964|NCT02839330|79531213|FG001|Overall Study|Death|6|||
44522965|NCT02839330|79531214|FG002|Overall Study|Death|1|||
44522966|NCT02839330|79531215|FG003|Overall Study|Death|1|||
44522967|NCT02839330|79531212|FG000|Overall Study|Withdrawal by Subject|27|||
44522968|NCT02839330|79531213|FG001|Overall Study|Withdrawal by Subject|19|||
44522969|NCT02839330|79531214|FG002|Overall Study|Withdrawal by Subject|11|||
44522970|NCT02839330|79531215|FG003|Overall Study|Withdrawal by Subject|13|||
44522971|NCT02839330|79531212|FG000|Overall Study|Lost to Follow-up|22|||
44522972|NCT02839330|79531213|FG001|Overall Study|Lost to Follow-up|27|||
44522973|NCT02839330|79531214|FG002|Overall Study|Lost to Follow-up|29|||
44522974|NCT02839330|79531215|FG003|Overall Study|Lost to Follow-up|25|||
44522975|NCT02839330|79531212|FG000|Overall Study|Administrative Reason|0|||
44522976|NCT02839330|79531213|FG001|Overall Study|Administrative Reason|0|||
44522977|NCT02839330|79531214|FG002|Overall Study|Administrative Reason|0|||
44522978|NCT02839330|79531215|FG003|Overall Study|Administrative Reason|1|||
44522979|NCT02839330|79531212|FG000|Overall Study|Protocol Violation|1|||
44522980|NCT02839330|79531213|FG001|Overall Study|Protocol Violation|2|||
44147917|NCT04471428|78937328|FG000|Overall Study|Physician Decision|0|||
44253086|NCT03381274|79092991|FG004|Overall Study|Death|3|||
44405307|NCT00880334|79412929|FG000|Randomized Phase|Brain Metastasis|0|||
44405308|NCT00880334|79412930|FG001|Randomized Phase|Brain Metastasis|1|||
44405309|NCT00880334|79412929|FG000|Randomized Phase|Crossover Participants|0|||
44522981|NCT02839330|79531214|FG002|Overall Study|Protocol Violation|2|||
44522982|NCT02839330|79531215|FG003|Overall Study|Protocol Violation|3|||
44522983|NCT02839330|79531212|FG000|Overall Study|Other reason, not specified|4|||
44522984|NCT02839330|79531213|FG001|Overall Study|Other reason, not specified|3|||
44522985|NCT02839330|79531214|FG002|Overall Study|Other reason, not specified|3|||
44522986|NCT02839330|79531215|FG003|Overall Study|Other reason, not specified|6|||
44253087|NCT03381274|79092987|FG000|Overall Study|Lost to Follow-up|0|||
44253088|NCT03381274|79092988|FG001|Overall Study|Lost to Follow-up|0|||
44253089|NCT03381274|79092989|FG002|Overall Study|Lost to Follow-up|0|||
44253090|NCT03381274|79092990|FG003|Overall Study|Lost to Follow-up|1|||
44253091|NCT03381274|79092991|FG004|Overall Study|Lost to Follow-up|0|||
44253092|NCT03381274|79092987|FG000|Overall Study|Withdrawal by Subject|2|||
44522987|NCT03363776|79531229|FG000|Overall Study|Progressive disease|2|||
44522988|NCT03363776|79531230|FG001|Overall Study|Progressive disease|3|||
44522989|NCT03363776|79531231|FG002|Overall Study|Progressive disease|1|||
44522990|NCT03363776|79531229|FG000|Overall Study|Study drug toxicity|0|||
44405310|NCT00880334|79412930|FG001|Randomized Phase|Crossover Participants|37|||
44405311|NCT00865566|79412942|FG000|Overall Study|Death|1|||
44405312|NCT00865566|79412943|FG001|Overall Study|Death|11|||
44405313|NCT00865566|79412942|FG000|Overall Study|Lost to Follow-up|314|||
44405314|NCT00865566|79412943|FG001|Overall Study|Lost to Follow-up|315|||
44405315|NCT00865566|79412942|FG000|Overall Study|Withdrawal by Subject|45|||
44405316|NCT00865566|79412943|FG001|Overall Study|Withdrawal by Subject|65|||
44405317|NCT00865566|79412942|FG000|Overall Study|Physician Decision|0|||
44405318|NCT00865566|79412943|FG001|Overall Study|Physician Decision|1|||
44405319|NCT00865566|79412942|FG000|Overall Study|Participant relocated|78|||
44405320|NCT00865566|79412943|FG001|Overall Study|Participant relocated|107|||
44405321|NCT00865566|79412942|FG000|Overall Study|Participant unable to adhere|27|||
44405322|NCT00865566|79412943|FG001|Overall Study|Participant unable to adhere|42|||
44405323|NCT00865566|79412942|FG000|Overall Study|Other; N=245 due to early study closure|154|||
44405324|NCT00865566|79412943|FG001|Overall Study|Other; N=245 due to early study closure|139|||
44405325|NCT00865566|79412942|FG000|Overall Study|HIV infection|5|||
44405326|NCT00865566|79412943|FG001|Overall Study|HIV infection|7|||
44405327|NCT03866473|79412951|FG000|Phase 1|Death|1|||
44405328|NCT03866473|79412952|FG001|Phase 1|Death|0|||
44522991|NCT03363776|79531230|FG001|Overall Study|Study drug toxicity|0|||
44522992|NCT03363776|79531231|FG002|Overall Study|Study drug toxicity|1|||
44522993|NCT03363776|79531229|FG000|Overall Study|Death|1|||
44522994|NCT03363776|79531230|FG001|Overall Study|Death|0|||
44522995|NCT03363776|79531231|FG002|Overall Study|Death|0|||
44522996|NCT03360344|79531242|FG000|Overall Study|Withdrawal by Subject|0|||
44522997|NCT03360344|79531243|FG001|Overall Study|Withdrawal by Subject|1|||
44522998|NCT03360344|79531244|FG002|Overall Study|Withdrawal by Subject|1|||
44522999|NCT02838628|79531254|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
44523000|NCT02838628|79531255|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
44523001|NCT02838628|79531254|FG000|Recurrence Follow-up Period|Adverse Event|1|||
44523002|NCT02838628|79531255|FG001|Recurrence Follow-up Period|Adverse Event|0|||
44523003|NCT02838628|79531254|FG000|Recurrence Follow-up Period|Non-compliance|0|||
44523004|NCT02838628|79531255|FG001|Recurrence Follow-up Period|Non-compliance|1|||
44523005|NCT02838628|79531254|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
44523006|NCT02838628|79531255|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
44523007|NCT02838628|79531254|FG000|Recurrence Follow-up Period|Other un-specified|1|||
44523008|NCT02838628|79531255|FG001|Recurrence Follow-up Period|Other un-specified|1|||
44523009|NCT02835820|79531264|FG000|Overall Study|Baseline Screen Failure|0|||
44523010|NCT02835820|79531265|FG001|Overall Study|Baseline Screen Failure|3|||
44523011|NCT03359174|79531271|FG000|Overall Study|Adverse Event|1|||
44282051|NCT01863732|79245291|FG000|Overall Study|Lost to Follow-up|2|||
44282052|NCT01863732|79245292|FG001|Overall Study|Lost to Follow-up|2|||
44282053|NCT01863732|79245293|FG002|Overall Study|Lost to Follow-up|1|||
44405329|NCT03866473|79412951|FG000|Phase 2|Death|0|||
44405330|NCT03866473|79412952|FG001|Phase 2|Death|2|||
44405331|NCT03866473|79412951|FG000|Phase 2|Dropped|1|||
44405332|NCT03866473|79412952|FG001|Phase 2|Dropped|1|||
44405333|NCT03866473|79412951|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
44282054|NCT01863732|79245294|FG003|Overall Study|Lost to Follow-up|1|||
44282055|NCT01863732|79245291|FG000|Overall Study|Physician Decision|1|||
44282056|NCT01863732|79245292|FG001|Overall Study|Physician Decision|0|||
44282057|NCT01863732|79245293|FG002|Overall Study|Physician Decision|1|||
44282058|NCT01863732|79245294|FG003|Overall Study|Physician Decision|0|||
44282059|NCT01863732|79245291|FG000|Overall Study|Pregnancy|0|||
44282060|NCT01863732|79245292|FG001|Overall Study|Pregnancy|0|||
44282061|NCT01863732|79245293|FG002|Overall Study|Pregnancy|0|||
44282062|NCT01863732|79245294|FG003|Overall Study|Pregnancy|1|||
44523012|NCT02832622|79531275|FG000|Overall Study|MPP not programmed|1259|||
44523013|NCT02832622|79531275|FG000|Overall Study|Withdrawal by Subject|123|||
44523014|NCT02832622|79531275|FG000|Overall Study|Death|119|||
44523015|NCT02832622|79531275|FG000|Overall Study|Unsuccessful CRT implant|93|||
44523016|NCT02832622|79531275|FG000|Overall Study|Lost to Follow-up|45|||
44523017|NCT02832622|79531275|FG000|Overall Study|Patient non-compliance|42|||
44282063|NCT01863732|79245291|FG000|Overall Study|Technical problems|0|||
44282064|NCT01863732|79245292|FG001|Overall Study|Technical problems|1|||
44405334|NCT03866473|79412952|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
44405335|NCT00525499|79412966|FG000|Overall Study|Lost to Follow-up|2|||
44523018|NCT02832622|79531275|FG000|Overall Study|Withdrawal by other reasons|25|||
44523019|NCT02832622|79531275|FG000|Overall Study|System explant|24|||
44523020|NCT02832622|79531275|FG000|Overall Study|Physician Decision|6|||
44523021|NCT00093015|79531282|FG000|Overall Study|Withdrawal by Subject|194|||
44523022|NCT00093015|79531283|FG001|Overall Study|Withdrawal by Subject|171|||
44523023|NCT00093015|79531282|FG000|Overall Study|Lost to Follow-up|96|||
44405336|NCT00525499|79412967|FG001|Overall Study|Lost to Follow-up|4|||
44523024|NCT00093015|79531283|FG001|Overall Study|Lost to Follow-up|108|||
44282065|NCT01863732|79245293|FG002|Overall Study|Technical problems|1|||
44282066|NCT01863732|79245294|FG003|Overall Study|Technical problems|0|||
44523025|NCT00093015|79531282|FG000|Overall Study|Death|375|||
44523026|NCT00093015|79531283|FG001|Overall Study|Death|385|||
44253093|NCT03381274|79092988|FG001|Overall Study|Withdrawal by Subject|1|||
44253094|NCT03381274|79092989|FG002|Overall Study|Withdrawal by Subject|3|||
44253095|NCT03381274|79092990|FG003|Overall Study|Withdrawal by Subject|1|||
44253096|NCT03381274|79092991|FG004|Overall Study|Withdrawal by Subject|0|||
44253097|NCT03381274|79092987|FG000|Overall Study|Other|1|||
44253098|NCT03381274|79092988|FG001|Overall Study|Other|11|||
44253099|NCT03381274|79092989|FG002|Overall Study|Other|0|||
44282067|NCT01863732|79245291|FG000|Overall Study|Subject/guardian decision|6|||
44282068|NCT01863732|79245292|FG001|Overall Study|Subject/guardian decision|9|||
44405337|NCT00525499|79412968|FG002|Overall Study|Lost to Follow-up|1|||
44405338|NCT00525499|79412969|FG003|Overall Study|Lost to Follow-up|4|||
44405339|NCT00525499|79412966|FG000|Overall Study|Adverse Event|0|||
44405340|NCT00525499|79412967|FG001|Overall Study|Adverse Event|1|||
44405341|NCT00525499|79412968|FG002|Overall Study|Adverse Event|0|||
44405342|NCT00525499|79412969|FG003|Overall Study|Adverse Event|1|||
44405343|NCT00525499|79412966|FG000|Overall Study|Withdrawal by Subject|5|||
44405344|NCT00525499|79412967|FG001|Overall Study|Withdrawal by Subject|1|||
44405345|NCT00525499|79412968|FG002|Overall Study|Withdrawal by Subject|5|||
44405346|NCT00525499|79412969|FG003|Overall Study|Withdrawal by Subject|2|||
44405347|NCT00525499|79412966|FG000|Overall Study|Protocol Violation|0|||
44405348|NCT00525499|79412967|FG001|Overall Study|Protocol Violation|1|||
44405349|NCT00525499|79412968|FG002|Overall Study|Protocol Violation|1|||
44405350|NCT00525499|79412969|FG003|Overall Study|Protocol Violation|0|||
44405351|NCT00824655|79412981|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
44405352|NCT00824655|79412982|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
44405353|NCT00824655|79412981|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
44405354|NCT00824655|79412982|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
44405355|NCT00525265|79412992|FG000|Overall Study|Protocol Violation|1|||
44405356|NCT00525265|79412993|FG001|Overall Study|Protocol Violation|0|||
44405357|NCT00880256|79412999|FG000|Overall Study|Lost to Follow-up|28|||
44405358|NCT03865381|79413008|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
44405359|NCT03865381|79413008|FG000|Overall Study|Withdrawal by Subject|2|||
44405360|NCT00865098|79413012|FG000|Overall Study|Progressive disease|1|||
44405361|NCT00880100|79413016|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
44405362|NCT00880100|79413016|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
44405363|NCT00880100|79413016|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
44405364|NCT00518011|79413022|FG000|Overall Study|Death|1|||
44405365|NCT00518011|79413023|FG001|Overall Study|Death|1|||
44405366|NCT00518011|79413022|FG000|Overall Study|Adverse Event|2|||
44147918|NCT04471428|78937329|FG001|Overall Study|Physician Decision|1|||
44147919|NCT04471428|78937328|FG000|Overall Study|Reason Not Specified|0|||
44147920|NCT04471428|78937329|FG001|Overall Study|Reason Not Specified|2|||
44147921|NCT04471428|78937328|FG000|Overall Study|Death|106|||
44147922|NCT04471428|78937329|FG001|Overall Study|Death|114|||
44147923|NCT04471428|78937328|FG000|Overall Study|Ongoing in the study|45|||
44147924|NCT04471428|78937329|FG001|Overall Study|Ongoing in the study|68|||
44282069|NCT01863732|79245293|FG002|Overall Study|Subject/guardian decision|3|||
44282070|NCT01863732|79245294|FG003|Overall Study|Subject/guardian decision|1|||
44282071|NCT01863732|79245291|FG000|Overall Study|Death|1|||
44405367|NCT00518011|79413023|FG001|Overall Study|Adverse Event|3|||
44405368|NCT00518011|79413022|FG000|Overall Study|Disease Progression|2|||
44405369|NCT00518011|79413023|FG001|Overall Study|Disease Progression|2|||
44405370|NCT00518011|79413022|FG000|Overall Study|Other Reasons|3|||
44405371|NCT00518011|79413023|FG001|Overall Study|Other Reasons|2|||
44405372|NCT00518011|79413022|FG000|Overall Study|Withdrawal by Subject|1|||
44282072|NCT01863732|79245292|FG001|Overall Study|Death|0|||
44282073|NCT01863732|79245293|FG002|Overall Study|Death|0|||
44282074|NCT01863732|79245294|FG003|Overall Study|Death|1|||
44282075|NCT01905540|79245307|FG000|Period 3|Other|1|||
44282076|NCT01905540|79245308|FG001|Period 3|Other|0|||
44282077|NCT01905540|79245309|FG002|Period 3|Other|1|||
44282078|NCT01905540|79245310|FG003|Period 3|Other|1|||
44405373|NCT00518011|79413023|FG001|Overall Study|Withdrawal by Subject|0|||
44405374|NCT00865020|79413032|FG000|Overall Study|Withdrawal by Subject|22|||
44405375|NCT00865020|79413033|FG001|Overall Study|Withdrawal by Subject|16|||
44405376|NCT00865020|79413032|FG000|Overall Study|Adverse Event|9|||
44405377|NCT00865020|79413033|FG001|Overall Study|Adverse Event|14|||
44405378|NCT00865020|79413032|FG000|Overall Study|Abnormal test procedure result(s)|6|||
44405379|NCT00865020|79413033|FG001|Overall Study|Abnormal test procedure result(s)|8|||
44147925|NCT04339413|78937347|FG000|Overall Study|Reason Not Specified|2|||
44253100|NCT03381274|79092990|FG003|Overall Study|Other|2|||
44253101|NCT03381274|79092991|FG004|Overall Study|Other|2|||
44147926|NCT04339413|78937348|FG001|Overall Study|Reason Not Specified|7|||
44147927|NCT04339413|78937347|FG000|Overall Study|Study Terminated by Sponsor|30|||
44282079|NCT01904760|79245322|FG000|Overall Study|Protocol Violation|1|||
44282080|NCT01904760|79245323|FG001|Overall Study|Protocol Violation|0|||
44282081|NCT01904604|79245332|FG000|Overall Study|Withdrew before receiving dosing|0|||
44282082|NCT01904604|79245333|FG001|Overall Study|Withdrew before receiving dosing|1|||
44405380|NCT00865020|79413032|FG000|Overall Study|Lost to Follow-up|6|||
44405381|NCT00865020|79413033|FG001|Overall Study|Lost to Follow-up|4|||
44405382|NCT00865020|79413032|FG000|Overall Study|Protocol deviation|4|||
44405383|NCT00865020|79413033|FG001|Overall Study|Protocol deviation|1|||
44405384|NCT00865020|79413032|FG000|Overall Study|Administrative problems|0|||
44405385|NCT00865020|79413033|FG001|Overall Study|Administrative problems|2|||
44405386|NCT00865020|79413032|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44405387|NCT00865020|79413033|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44405388|NCT00865020|79413032|FG000|Overall Study|Death|0|||
44405389|NCT00865020|79413033|FG001|Overall Study|Death|1|||
44405390|NCT00865020|79413032|FG000|Overall Study|Randomized but discontinued|2|||
44405391|NCT00865020|79413033|FG001|Overall Study|Randomized but discontinued|4|||
44405392|NCT00517933|79413041|FG000|Period 1|Death|2|||
44405393|NCT00517933|79413042|FG001|Period 1|Death|1|||
44405394|NCT00517933|79413041|FG000|Period 1|Adverse Event|4|||
44405395|NCT00517933|79413042|FG001|Period 1|Adverse Event|4|||
44405396|NCT00517933|79413041|FG000|Period 1|Lost to Follow-up|2|||
44405397|NCT00517933|79413042|FG001|Period 1|Lost to Follow-up|0|||
44405398|NCT00517933|79413041|FG000|Period 1|Underwent lung transplant|0|||
44405399|NCT00517933|79413042|FG001|Period 1|Underwent lung transplant|1|||
44405400|NCT00517933|79413041|FG000|Period 2|Death|2|||
44405401|NCT00517933|79413042|FG001|Period 2|Death|4|||
44405402|NCT00517933|79413041|FG000|Period 2|Adverse Event|2|||
44405403|NCT00517933|79413042|FG001|Period 2|Adverse Event|4|||
44405404|NCT00517933|79413041|FG000|Period 2|Physician Decision|1|||
44405405|NCT00517933|79413042|FG001|Period 2|Physician Decision|0|||
44405406|NCT00517933|79413041|FG000|Period 2|Withdrawal by Subject|1|||
44405407|NCT00517933|79413042|FG001|Period 2|Withdrawal by Subject|3|||
44405408|NCT00517933|79413041|FG000|Period 2|Underwent lung transplant|0|||
44405409|NCT00517933|79413042|FG001|Period 2|Underwent lung transplant|2|||
44405410|NCT00701038|79413053|FG000|Overall Study|study amended pilot group of patients|4|||
44405411|NCT00701038|79413054|FG001|Overall Study|study amended pilot group of patients|4|||
44405412|NCT00857766|79413062|FG000|Overall Study|Adverse Event|13|||
44405413|NCT00857766|79413063|FG001|Overall Study|Adverse Event|12|||
44405414|NCT00857766|79413062|FG000|Overall Study|Protocol Violation|11|||
44405415|NCT00857766|79413063|FG001|Overall Study|Protocol Violation|11|||
44405416|NCT00857766|79413062|FG000|Overall Study|Lost to Follow-up|1|||
44405417|NCT00857766|79413063|FG001|Overall Study|Lost to Follow-up|0|||
44405418|NCT00857766|79413062|FG000|Overall Study|Investigator Discretion|2|||
44405419|NCT00857766|79413063|FG001|Overall Study|Investigator Discretion|3|||
44405420|NCT00857766|79413062|FG000|Overall Study|Participant Withdrew Consent|4|||
44405421|NCT00857766|79413063|FG001|Overall Study|Participant Withdrew Consent|4|||
44405422|NCT00517699|79413069|FG000|Overall Study|Withdrawal by Subject|1|||
44405423|NCT00517699|79413069|FG000|Overall Study|Lack of Efficacy|1|||
44405424|NCT00517699|79413069|FG000|Overall Study|Administrative error|1|||
44523027|NCT03358238|79531291|FG000|Overall Study|Withdrawal by Subject|0|||
44523028|NCT03358238|79531292|FG001|Overall Study|Withdrawal by Subject|1|||
44523029|NCT03342638|79531304|FG000|Overall Study|Withdrawal by Subject|1|||
44523030|NCT03342638|79531305|FG001|Overall Study|Withdrawal by Subject|0|||
44523031|NCT03342638|79531304|FG000|Overall Study|Physician Decision|0|||
44405425|NCT00517699|79413069|FG000|Overall Study|Study terminated by Sponsor|2|||
44405426|NCT00857454|79413073|FG000|Overall Study|Withdrawal by Subject|2|||
44405427|NCT00857454|79413073|FG000|Overall Study|Lost to Follow-up|1|||
44405428|NCT00857454|79413073|FG000|Overall Study|Adverse Event|2|||
44405429|NCT00857454|79413073|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
44405430|NCT00857454|79413073|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
44405431|NCT00857454|79413073|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
44405432|NCT00525031|79413079|FG000|Overall Study|Disease Progression|1|||
44405433|NCT00525031|79413080|FG001|Overall Study|Disease Progression|1|||
44405434|NCT00524485|79413087|FG000|Overall Study|Withdrawal by Subject|5|||
44405435|NCT00857220|79413091|FG000|Overall Study|Adverse Event|35|||
44405436|NCT00857220|79413091|FG000|Overall Study|Death|1|||
44405437|NCT00857220|79413091|FG000|Overall Study|Lack of Efficacy|11|||
44405438|NCT00857220|79413091|FG000|Overall Study|Lost to Follow-up|30|||
44405439|NCT00857220|79413091|FG000|Overall Study|Physician Decision|4|||
44405440|NCT00857220|79413091|FG000|Overall Study|Protocol Violation|16|||
44523032|NCT03342638|79531305|FG001|Overall Study|Physician Decision|1|||
44523033|NCT03342560|79531311|FG000|Overall Study|Lost to Follow-up|2|||
44523034|NCT03355742|79531328|FG000|Overall Study|Lost to Follow-up|4|||
44405441|NCT00857220|79413091|FG000|Overall Study|Withdrawal by Subject|67|||
44405442|NCT00857220|79413091|FG000|Overall Study|Clinical Hold|6|||
44523035|NCT03355742|79531328|FG000|Overall Study|Withdrawal by Subject|29|||
44405443|NCT00857220|79413091|FG000|Overall Study|Site Closed|5|||
44405444|NCT00857220|79413091|FG000|Overall Study|Miscellaneous|8|||
44405445|NCT00524173|79413097|FG000|Overall Study|Lost to Follow-up|0|||
44405446|NCT00524173|79413098|FG001|Overall Study|Lost to Follow-up|1|||
44405447|NCT00524173|79413097|FG000|Overall Study|Death|1|||
44405448|NCT00524173|79413098|FG001|Overall Study|Death|0|||
44405449|NCT00524173|79413097|FG000|Overall Study|Had not reached endpoint at study close|4|||
44405450|NCT00524173|79413098|FG001|Overall Study|Had not reached endpoint at study close|1|||
44405451|NCT00879710|79413106|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
44405452|NCT00879710|79413107|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
44405453|NCT00879710|79413108|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
44405454|NCT00879710|79413109|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
44405455|NCT00879710|79413106|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
44405456|NCT00879710|79413107|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
44405457|NCT00879710|79413108|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
44405458|NCT00879710|79413109|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
44405459|NCT00597506|79413117|FG000|Overall Study|Subject is being followed for survival|1|||
44405460|NCT00708682|79413130|FG000|Infant Series|Adverse Event|1|||
44405461|NCT00708682|79413130|FG000|Infant Series|Lost to Follow-up|4|||
44405462|NCT00708682|79413130|FG000|Infant Series|Protocol Violation|1|||
44405463|NCT00708682|79413130|FG000|Infant Series|Parent/legal guardian request|6|||
44405464|NCT00708682|79413130|FG000|Infant Series|Failed to return|2|||
44405465|NCT00708682|79413130|FG000|Infant Series|Other|19|||
44405466|NCT00708682|79413130|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
44405467|NCT00708682|79413130|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
44405468|NCT00708682|79413130|FG000|Toddler Dose|Lost to Follow-up|3|||
44405469|NCT00708682|79413130|FG000|Toddler Dose|Failed to Return|4|||
44405470|NCT00712348|79413136|FG000|Overall Study|Withdrawal by Subject|1|||
44405471|NCT00881504|79413140|FG000|Overall Study|Withdrawal by Subject|1|||
44405472|NCT01936831|79413153|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405473|NCT01936831|79413154|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405474|NCT01936831|79413155|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405475|NCT01936831|79413156|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405476|NCT01936831|79413157|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405477|NCT01936831|79413158|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
44405478|NCT01936831|79413159|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405479|NCT01936831|79413160|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405480|NCT01936831|79413161|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
44405481|NCT03863353|79413178|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
44405482|NCT03863353|79413179|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
44405483|NCT00523705|79413187|FG000|Overall Study|No time for study.|0|||
44405484|NCT00523705|79413188|FG001|Overall Study|No time for study.|1|||
44405485|NCT00523549|79413201|FG000|Overall Study|Adverse Event|6|||
44405486|NCT00523549|79413202|FG001|Overall Study|Adverse Event|3|||
44405487|NCT00523549|79413201|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44405488|NCT00523549|79413202|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44405489|NCT00523549|79413201|FG000|Overall Study|Protocol Deviation|3|||
44405490|NCT00523549|79413202|FG001|Overall Study|Protocol Deviation|1|||
44405491|NCT00523549|79413201|FG000|Overall Study|Patient withdrew consent|7|||
44405492|NCT00523549|79413202|FG001|Overall Study|Patient withdrew consent|6|||
44405493|NCT00523549|79413201|FG000|Overall Study|Lost to Follow-up|3|||
44523036|NCT03355742|79531328|FG000|Overall Study|Physician Decision|6|||
44523037|NCT03355742|79531328|FG000|Overall Study|Death|55|||
44523038|NCT03355742|79531328|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
44523039|NCT03341312|79531332|FG000|Period 1|Withdrawal by Subject|0|||
44405494|NCT00523549|79413202|FG001|Overall Study|Lost to Follow-up|5|||
44405495|NCT03504085|79413210|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
44405496|NCT03504085|79413211|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
44405497|NCT03504085|79413210|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
44405498|NCT03504085|79413211|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
44405499|NCT00700102|79413219|FG000|Overall Study|Died|394|||
44405500|NCT00700102|79413220|FG001|Overall Study|Died|385|||
44405501|NCT00700102|79413219|FG000|Overall Study|Lost to Follow-up|8|||
44405502|NCT00700102|79413220|FG001|Overall Study|Lost to Follow-up|10|||
44405503|NCT00595478|79413228|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
44405504|NCT00595478|79413229|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
44405505|NCT00595478|79413228|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
44405506|NCT00595478|79413229|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
44405507|NCT00516295|79413238|FG000|Overall Study|Lack of Efficacy|2|||
44405508|NCT00516295|79413239|FG001|Overall Study|Lack of Efficacy|0|||
44523040|NCT03341312|79531333|FG001|Period 1|Withdrawal by Subject|1|||
44523041|NCT03341312|79531334|FG002|Period 1|Withdrawal by Subject|0|||
44523042|NCT03341312|79531335|FG003|Period 1|Withdrawal by Subject|0|||
44523043|NCT02949908|79531347|FG000|Overall Study|Study termination|2|||
44523044|NCT01358734|79531354|FG000|Overall Study|Adverse Event|4|||
44405509|NCT00516295|79413240|FG002|Overall Study|Lack of Efficacy|0|||
44405510|NCT00516295|79413238|FG000|Overall Study|Ineligible|1|||
44405511|NCT00516295|79413239|FG001|Overall Study|Ineligible|0|||
44405512|NCT00516295|79413240|FG002|Overall Study|Ineligible|0|||
44405513|NCT03861559|79413250|FG000|Overall Study|Adverse Event|0|||
44523045|NCT01358734|79531355|FG001|Overall Study|Adverse Event|7|||
44405514|NCT03861559|79413251|FG001|Overall Study|Adverse Event|2|||
44405515|NCT03861559|79413250|FG000|Overall Study|Treatment failure|0|||
44405516|NCT03861559|79413251|FG001|Overall Study|Treatment failure|2|||
44405517|NCT03861559|79413250|FG000|Overall Study|Noncompliance|1|||
44523046|NCT01358734|79531356|FG002|Overall Study|Adverse Event|3|||
44523047|NCT01358734|79531354|FG000|Overall Study|Lack of Efficacy|0|||
44523048|NCT01358734|79531355|FG001|Overall Study|Lack of Efficacy|1|||
44523049|NCT01358734|79531356|FG002|Overall Study|Lack of Efficacy|3|||
44523050|NCT01358734|79531354|FG000|Overall Study|Withdrawal by Subject|1|||
44523051|NCT01358734|79531355|FG001|Overall Study|Withdrawal by Subject|6|||
44523052|NCT01358734|79531356|FG002|Overall Study|Withdrawal by Subject|3|||
44523053|NCT01358734|79531354|FG000|Overall Study|Death|3|||
44523054|NCT01358734|79531355|FG001|Overall Study|Death|7|||
44523055|NCT01358734|79531356|FG002|Overall Study|Death|2|||
44523056|NCT01358734|79531354|FG000|Overall Study|Progressive Disease|5|||
44523057|NCT01358734|79531355|FG001|Overall Study|Progressive Disease|13|||
44147928|NCT04339413|78937348|FG001|Overall Study|Study Terminated by Sponsor|33|||
44405518|NCT03861559|79413251|FG001|Overall Study|Noncompliance|1|||
44405519|NCT03861559|79413250|FG000|Overall Study|Did not meet eligibility requirements|1|||
44405520|NCT03861559|79413251|FG001|Overall Study|Did not meet eligibility requirements|0|||
44405521|NCT00516139|79413257|FG000|Overall Study|Adverse Event|27|||
44405522|NCT00516139|79413257|FG000|Overall Study|Lost to Follow-up|1|||
44405523|NCT00516139|79413257|FG000|Overall Study|Protocol Violation|1|||
44405524|NCT00516139|79413257|FG000|Overall Study|Withdrawal by Subject|8|||
44523058|NCT01358734|79531356|FG002|Overall Study|Progressive Disease|16|||
44523059|NCT01358734|79531354|FG000|Overall Study|Non-compliance with study drug|0|||
44523060|NCT01358734|79531355|FG001|Overall Study|Non-compliance with study drug|0|||
44523061|NCT01358734|79531356|FG002|Overall Study|Non-compliance with study drug|1|||
44523062|NCT01358734|79531354|FG000|Overall Study|Other|2|||
44523063|NCT01358734|79531355|FG001|Overall Study|Other|5|||
44523064|NCT01358734|79531356|FG002|Overall Study|Other|4|||
44523065|NCT01358734|79531354|FG000|Overall Study|Protocol Violation|0|||
44523066|NCT01358734|79531355|FG001|Overall Study|Protocol Violation|0|||
44523067|NCT01358734|79531356|FG002|Overall Study|Protocol Violation|2|||
44523068|NCT01341652|79531366|FG000|Overall Study|Incorrect Random Assignment|0|||
44523069|NCT01341652|79531367|FG001|Overall Study|Incorrect Random Assignment|1|||
44523070|NCT01341652|79531366|FG000|Overall Study|ineligible; presence metastatic disease|0|||
44523071|NCT01341652|79531367|FG001|Overall Study|ineligible; presence metastatic disease|1|||
44523072|NCT02828644|79531375|FG000|Overall Study|Lost to Follow-up|23|||
44523073|NCT02828644|79531376|FG001|Overall Study|Lost to Follow-up|22|||
44523074|NCT02949362|79531385|FG000|Retrospective Period|Inform consent not signed by participant|4|||
44523075|NCT02949362|79531386|FG001|Retrospective Period|Inform consent not signed by participant|1|||
44523076|NCT02949362|79531387|FG002|Retrospective Period|Inform consent not signed by participant|0|||
44523077|NCT02949362|79531388|FG003|Retrospective Period|Inform consent not signed by participant|0|||
44405525|NCT00516139|79413257|FG000|Overall Study|Lack of Efficacy|1|||
44405526|NCT00515827|79413267|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
44405527|NCT00515827|79413268|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
44405528|NCT00515827|79413267|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
44405529|NCT00515827|79413268|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
44405530|NCT00522457|79413276|FG000|Overall Study|Due to disease progression|16|||
44405531|NCT00522457|79413276|FG000|Overall Study|Adverse Event|2|||
44405532|NCT00856986|79413285|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
44405533|NCT00856986|79413286|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
44405534|NCT00856986|79413287|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
44523078|NCT02949362|79531385|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
44523079|NCT02949362|79531386|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
44523080|NCT02949362|79531387|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
44147929|NCT04339413|78937347|FG000|Overall Study|Progressive Disease|9|||
44405535|NCT00856986|79413288|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
44523081|NCT02949362|79531388|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
44523082|NCT02949362|79531385|FG000|Prospective Period|Other|0|||
44523083|NCT02949362|79531386|FG001|Prospective Period|Other|0|||
44523084|NCT02949362|79531387|FG002|Prospective Period|Other|0|||
44523085|NCT02949362|79531388|FG003|Prospective Period|Other|4|||
44523086|NCT02947022|79531400|FG000|Overall Study|Study Stopped|1|||
44523087|NCT03338972|79531411|FG000|Overall Study|Death|1|||
44523088|NCT03338972|79531412|FG001|Overall Study|Death|1|||
44405536|NCT00856986|79413289|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
44405537|NCT00856986|79413285|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
44405538|NCT00856986|79413286|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
44405539|NCT00856986|79413287|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
44405540|NCT00856986|79413288|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
44405541|NCT00856986|79413289|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
44405542|NCT00856986|79413285|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
44405543|NCT00856986|79413286|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
44405544|NCT00856986|79413287|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
44405545|NCT00856986|79413288|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
44405546|NCT00856986|79413289|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
44405547|NCT00856986|79413285|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
44405548|NCT00856986|79413286|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
44405549|NCT00856986|79413287|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
44405550|NCT00856986|79413288|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
44405551|NCT00856986|79413289|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
44405552|NCT00856986|79413285|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
44405553|NCT00856986|79413286|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
44405554|NCT00856986|79413287|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
44405555|NCT00856986|79413288|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
44405556|NCT00856986|79413289|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
44405557|NCT00856986|79413285|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
44405558|NCT00856986|79413286|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
44405559|NCT00856986|79413287|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
44405560|NCT00856986|79413288|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
44405561|NCT00856986|79413289|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
44405562|NCT00856986|79413285|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
44405563|NCT00856986|79413286|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
44405564|NCT00856986|79413287|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
44405565|NCT00856986|79413288|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
44405566|NCT00856986|79413289|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
44405567|NCT00856986|79413285|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
44405568|NCT00856986|79413286|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
44405569|NCT00856986|79413287|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
44405570|NCT00856986|79413288|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
44405571|NCT00856986|79413289|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
44405572|NCT00856986|79413285|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
44405573|NCT00856986|79413286|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
44405574|NCT00856986|79413287|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
44405575|NCT00856986|79413288|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
44405576|NCT00856986|79413289|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
44405577|NCT00856986|79413285|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
44405578|NCT00856986|79413286|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
44405579|NCT00856986|79413287|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
44405580|NCT00856986|79413288|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
44405581|NCT00856986|79413289|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
44405582|NCT00856986|79413285|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
44405583|NCT00856986|79413286|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
44405584|NCT00856986|79413287|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
44405585|NCT00856986|79413288|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
44405586|NCT00856986|79413289|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
44405587|NCT00856986|79413285|FG000|Main Period, Weeks 0-26|Unclassified|7|||
44405588|NCT00856986|79413286|FG001|Main Period, Weeks 0-26|Unclassified|6|||
44405589|NCT00856986|79413287|FG002|Main Period, Weeks 0-26|Unclassified|7|||
44405590|NCT00856986|79413288|FG003|Main Period, Weeks 0-26|Unclassified|0|||
44405591|NCT00856986|79413289|FG004|Main Period, Weeks 0-26|Unclassified|0|||
44405592|NCT00856986|79413285|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
44523089|NCT03338972|79531413|FG002|Overall Study|Death|0|||
44523090|NCT03338972|79531414|FG003|Overall Study|Death|0|||
44523091|NCT03338972|79531411|FG000|Overall Study|Withdrawal by Subject|1|||
44523092|NCT03338972|79531412|FG001|Overall Study|Withdrawal by Subject|0|||
44523093|NCT03338972|79531413|FG002|Overall Study|Withdrawal by Subject|0|||
44523094|NCT03338972|79531414|FG003|Overall Study|Withdrawal by Subject|0|||
44523095|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
44523096|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
44523097|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
44523098|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
44523099|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
44523100|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
44523101|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
44523102|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
44523103|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
44405593|NCT00856986|79413286|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
44405594|NCT00856986|79413287|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
44405595|NCT00856986|79413288|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
44405596|NCT00856986|79413289|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
44405597|NCT00856986|79413285|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
44405598|NCT00856986|79413286|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
44405599|NCT00856986|79413287|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
44405600|NCT00856986|79413288|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
44405601|NCT00856986|79413289|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
44405602|NCT00856986|79413285|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
44405603|NCT00856986|79413286|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
44405604|NCT00856986|79413287|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
44405605|NCT00856986|79413288|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
44405606|NCT00856986|79413289|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
44405607|NCT00856986|79413285|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
44405608|NCT00856986|79413286|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
44405609|NCT00856986|79413287|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
44405610|NCT00856986|79413288|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
44405611|NCT00856986|79413289|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
44405612|NCT00856986|79413285|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
44405613|NCT00856986|79413286|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
44405614|NCT00856986|79413287|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
44405615|NCT00856986|79413288|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
44405616|NCT00856986|79413289|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
44405617|NCT00856986|79413285|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
44405618|NCT00856986|79413286|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
44405619|NCT00856986|79413287|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
44405620|NCT00856986|79413288|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
44405621|NCT00856986|79413289|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
44405622|NCT00707746|79413303|FG000|Treatment Period|Adverse Event|2|||
44405623|NCT00707746|79413304|FG001|Treatment Period|Adverse Event|4|||
44405624|NCT00707746|79413303|FG000|Treatment Period|Ineligibility|0|||
44405625|NCT00707746|79413304|FG001|Treatment Period|Ineligibility|1|||
44405626|NCT00856908|79413312|FG000|Overall Study|Lost to Follow-up|1|||
44405627|NCT00856908|79413313|FG001|Overall Study|Lost to Follow-up|0|||
44405628|NCT00522379|79413324|FG000|Overall Study|Adverse Event|12|||
44405629|NCT00522379|79413325|FG001|Overall Study|Adverse Event|15|||
44405630|NCT00522379|79413326|FG002|Overall Study|Adverse Event|12|||
44405631|NCT00522379|79413327|FG003|Overall Study|Adverse Event|5|||
44405632|NCT00522379|79413328|FG004|Overall Study|Adverse Event|17|||
44405633|NCT00522379|79413324|FG000|Overall Study|Lack of Efficacy|3|||
44523104|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
44523105|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
44523106|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
44523107|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
44523108|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
44523109|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
44523110|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
44523111|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
44523112|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
44523113|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
44523114|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
44523115|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
44523116|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
44523117|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
44523118|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
44523119|NCT03338816|79531430|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
44523120|NCT03338816|79531431|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
44523121|NCT03338816|79531432|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
44523122|NCT03338816|79531433|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
44523123|NCT03337490|79531445|FG000|Overall Study|Withdrawal by Subject|1|||
44523124|NCT03337490|79531446|FG001|Overall Study|Withdrawal by Subject|0|||
44523125|NCT03337490|79531447|FG002|Overall Study|Withdrawal by Subject|0|||
44523126|NCT03337490|79531445|FG000|Overall Study|Lack of Efficacy|10|||
44405634|NCT00522379|79413325|FG001|Overall Study|Lack of Efficacy|0|||
44405635|NCT00522379|79413326|FG002|Overall Study|Lack of Efficacy|2|||
44523127|NCT03337490|79531446|FG001|Overall Study|Lack of Efficacy|12|||
44405636|NCT00522379|79413327|FG003|Overall Study|Lack of Efficacy|2|||
44405637|NCT00522379|79413328|FG004|Overall Study|Lack of Efficacy|7|||
44405638|NCT00522379|79413324|FG000|Overall Study|Withdrawal by Subject|2|||
44523128|NCT03337490|79531447|FG002|Overall Study|Lack of Efficacy|35|||
44523129|NCT03337490|79531445|FG000|Overall Study|Physician Decision|0|||
44523130|NCT03337490|79531446|FG001|Overall Study|Physician Decision|1|||
44523131|NCT03337490|79531447|FG002|Overall Study|Physician Decision|0|||
44523132|NCT03337490|79531445|FG000|Overall Study|Lost to Follow-up|0|||
44523133|NCT03337490|79531446|FG001|Overall Study|Lost to Follow-up|1|||
44523134|NCT03337490|79531447|FG002|Overall Study|Lost to Follow-up|0|||
44523135|NCT02944448|79531457|FG000|Overall Study|Adverse Event|37|||
44523136|NCT02944448|79531458|FG001|Overall Study|Adverse Event|6|||
44523137|NCT02944448|79531457|FG000|Overall Study|Lack of Efficacy|8|||
44523138|NCT02944448|79531458|FG001|Overall Study|Lack of Efficacy|5|||
44523139|NCT02944448|79531457|FG000|Overall Study|Lost to Follow-up|3|||
44523140|NCT02944448|79531458|FG001|Overall Study|Lost to Follow-up|1|||
44523141|NCT02944448|79531457|FG000|Overall Study|Protocol Violation|25|||
44523142|NCT02944448|79531458|FG001|Overall Study|Protocol Violation|7|||
44253102|NCT03365375|79093018|FG000|Overall Study|Withdrawal by Subject|0|||
44253103|NCT03365375|79093019|FG001|Overall Study|Withdrawal by Subject|1|||
44523143|NCT02944448|79531457|FG000|Overall Study|Withdrawal by Subject|14|||
44523144|NCT02944448|79531458|FG001|Overall Study|Withdrawal by Subject|4|||
44523145|NCT02944448|79531457|FG000|Overall Study|Sponsor did not supply drug in time|0|||
44523146|NCT02944448|79531458|FG001|Overall Study|Sponsor did not supply drug in time|1|||
44523147|NCT02944448|79531457|FG000|Overall Study|Noncompliant with dosing|1|||
44523148|NCT02944448|79531458|FG001|Overall Study|Noncompliant with dosing|0|||
44523149|NCT02944448|79531457|FG000|Overall Study|Abnormal laboratory values|1|||
44523150|NCT02944448|79531458|FG001|Overall Study|Abnormal laboratory values|0|||
44523151|NCT02943668|79531465|FG000|Overall Study|Disease Progression|1|||
44523152|NCT02891408|79531500|FG000|Overall Study|Lost to Follow-up|0|||
44523153|NCT02891408|79531501|FG001|Overall Study|Lost to Follow-up|0|||
44523154|NCT02891408|79531502|FG002|Overall Study|Lost to Follow-up|1|||
44523155|NCT02891408|79531503|FG003|Overall Study|Lost to Follow-up|0|||
44523156|NCT02891408|79531504|FG004|Overall Study|Lost to Follow-up|0|||
44523157|NCT02891408|79531505|FG005|Overall Study|Lost to Follow-up|0|||
44523158|NCT02891408|79531506|FG006|Overall Study|Lost to Follow-up|0|||
44523159|NCT03283670|79531532|FG000|Placebo Gas|Withdrawal by Subject|2|||
44405639|NCT00522379|79413325|FG001|Overall Study|Withdrawal by Subject|3|||
44405640|NCT00522379|79413326|FG002|Overall Study|Withdrawal by Subject|1|||
44405641|NCT00522379|79413327|FG003|Overall Study|Withdrawal by Subject|2|||
44405642|NCT00522379|79413328|FG004|Overall Study|Withdrawal by Subject|0|||
44405643|NCT00522379|79413324|FG000|Overall Study|Protocol Violation|1|||
44405644|NCT00522379|79413325|FG001|Overall Study|Protocol Violation|1|||
44405645|NCT00522379|79413326|FG002|Overall Study|Protocol Violation|2|||
44405646|NCT00522379|79413327|FG003|Overall Study|Protocol Violation|0|||
44405647|NCT00522379|79413328|FG004|Overall Study|Protocol Violation|0|||
44405648|NCT00522379|79413324|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
44405649|NCT00522379|79413325|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
44405650|NCT00522379|79413326|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
44405651|NCT00522379|79413327|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
44405652|NCT00522379|79413328|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
44405653|NCT00522379|79413324|FG000|Overall Study|Lost to Follow-up|1|||
44405654|NCT00522379|79413325|FG001|Overall Study|Lost to Follow-up|0|||
44405655|NCT00522379|79413326|FG002|Overall Study|Lost to Follow-up|4|||
44405656|NCT00522379|79413327|FG003|Overall Study|Lost to Follow-up|2|||
44405657|NCT00522379|79413328|FG004|Overall Study|Lost to Follow-up|2|||
44405658|NCT00522379|79413324|FG000|Overall Study|Randomization error|0|||
44405659|NCT00522379|79413325|FG001|Overall Study|Randomization error|0|||
44405660|NCT00522379|79413326|FG002|Overall Study|Randomization error|0|||
44405661|NCT00522379|79413327|FG003|Overall Study|Randomization error|0|||
44405662|NCT00522379|79413328|FG004|Overall Study|Randomization error|1|||
44405663|NCT00522379|79413324|FG000|Overall Study|Dispensing error|1|||
44405664|NCT00522379|79413325|FG001|Overall Study|Dispensing error|0|||
44405665|NCT00522379|79413326|FG002|Overall Study|Dispensing error|0|||
44405666|NCT00522379|79413327|FG003|Overall Study|Dispensing error|1|||
44405667|NCT00522379|79413328|FG004|Overall Study|Dispensing error|0|||
44405668|NCT00522379|79413324|FG000|Overall Study|Subject Moved|1|||
44405669|NCT00522379|79413325|FG001|Overall Study|Subject Moved|1|||
44405670|NCT00522379|79413326|FG002|Overall Study|Subject Moved|0|||
44405671|NCT00522379|79413327|FG003|Overall Study|Subject Moved|0|||
44523160|NCT03283670|79531532|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
44523161|NCT03283670|79531532|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
44523162|NCT01358578|79531553|FG000|Induction Period|Adverse Event|2|||
44523163|NCT01358578|79531554|FG001|Induction Period|Adverse Event|4|||
44523164|NCT01358578|79531555|FG002|Induction Period|Adverse Event|2|||
44523165|NCT01358578|79531556|FG003|Induction Period|Adverse Event|6|||
44523166|NCT01358578|79531557|FG004|Induction Period|Adverse Event|0|||
44405672|NCT00522379|79413328|FG004|Overall Study|Subject Moved|0|||
44405673|NCT00522379|79413324|FG000|Overall Study|Sponsor Request|0|||
44405674|NCT00522379|79413325|FG001|Overall Study|Sponsor Request|1|||
44405675|NCT00522379|79413326|FG002|Overall Study|Sponsor Request|0|||
44405676|NCT00522379|79413327|FG003|Overall Study|Sponsor Request|0|||
44405677|NCT00522379|79413328|FG004|Overall Study|Sponsor Request|0|||
44405678|NCT00522379|79413324|FG000|Overall Study|Family Problem|0|||
44405679|NCT00522379|79413325|FG001|Overall Study|Family Problem|0|||
44405680|NCT00522379|79413326|FG002|Overall Study|Family Problem|1|||
44405681|NCT00522379|79413327|FG003|Overall Study|Family Problem|0|||
44405682|NCT00522379|79413328|FG004|Overall Study|Family Problem|0|||
44405683|NCT00522379|79413324|FG000|Overall Study|Site Closed|0|||
44405684|NCT00522379|79413325|FG001|Overall Study|Site Closed|0|||
44405685|NCT00522379|79413326|FG002|Overall Study|Site Closed|0|||
44405686|NCT00522379|79413327|FG003|Overall Study|Site Closed|1|||
44405687|NCT00522379|79413328|FG004|Overall Study|Site Closed|0|||
44405688|NCT00522379|79413324|FG000|Overall Study|Subject Withdrawal|0|||
44405689|NCT00522379|79413325|FG001|Overall Study|Subject Withdrawal|0|||
44405690|NCT00522379|79413326|FG002|Overall Study|Subject Withdrawal|0|||
44405691|NCT00522379|79413327|FG003|Overall Study|Subject Withdrawal|1|||
44405692|NCT00522379|79413328|FG004|Overall Study|Subject Withdrawal|0|||
44405693|NCT00856830|79413344|FG000|Irinotecan & Bendamustine|Death|0|||
44405694|NCT00856830|79413345|FG001|Irinotecan & Bendamustine|Death|0|||
44405695|NCT00856830|79413346|FG002|Irinotecan & Bendamustine|Death|0|||
44405696|NCT00856830|79413347|FG003|Irinotecan & Bendamustine|Death|2|||
44405697|NCT00856830|79413344|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
44405698|NCT00856830|79413345|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
44405699|NCT00856830|79413346|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
44405700|NCT00856830|79413347|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
44405701|NCT00522301|79413352|FG000|Overall Study|Withdrawal by Subject|1|||
44405702|NCT00522301|79413352|FG000|Overall Study|Adverse Event|5|||
44405703|NCT00863928|79413358|FG000|Overall Study|Protocol Violation|26|||
44405704|NCT00863928|79413359|FG001|Overall Study|Protocol Violation|0|||
44405705|NCT00863928|79413358|FG000|Overall Study|Withdrawal by Subject|3|||
44405706|NCT00863928|79413359|FG001|Overall Study|Withdrawal by Subject|0|||
44405707|NCT00863928|79413358|FG000|Overall Study|surgery cancellation|4|||
44405708|NCT00863928|79413359|FG001|Overall Study|surgery cancellation|0|||
44405709|NCT00863928|79413358|FG000|Overall Study|medication allergy|3|||
44405710|NCT00863928|79413359|FG001|Overall Study|medication allergy|0|||
44405711|NCT00856518|79413367|FG000|Overall Study|Lost to Follow-up|4|||
44405712|NCT00856518|79413368|FG001|Overall Study|Lost to Follow-up|2|||
44405713|NCT00506389|79413379|FG000|In-treatment Period|Other|3|||
44405714|NCT00506389|79413380|FG001|In-treatment Period|Other|3|||
44405715|NCT00506389|79413381|FG002|In-treatment Period|Other|4|||
44405716|NCT00506389|79413379|FG000|In-treatment Period|Lost to Follow-up|0|||
44405717|NCT00506389|79413380|FG001|In-treatment Period|Lost to Follow-up|0|||
44405718|NCT00506389|79413381|FG002|In-treatment Period|Lost to Follow-up|1|||
44405719|NCT00506389|79413379|FG000|In-treatment Period|Lack of compliance|1|||
44405720|NCT00506389|79413380|FG001|In-treatment Period|Lack of compliance|0|||
44405721|NCT00506389|79413381|FG002|In-treatment Period|Lack of compliance|0|||
44405722|NCT00506389|79413379|FG000|In-treatment Period|Reasons not related to trial|4|||
44405723|NCT00506389|79413380|FG001|In-treatment Period|Reasons not related to trial|1|||
44523167|NCT01358578|79531558|FG005|Induction Period|Adverse Event|0|||
44523168|NCT01358578|79531553|FG000|Induction Period|Lack of Efficacy|0|||
44523169|NCT01358578|79531554|FG001|Induction Period|Lack of Efficacy|0|||
44523170|NCT01358578|79531555|FG002|Induction Period|Lack of Efficacy|9|||
44523171|NCT01358578|79531556|FG003|Induction Period|Lack of Efficacy|1|||
44523172|NCT01358578|79531557|FG004|Induction Period|Lack of Efficacy|0|||
44523173|NCT01358578|79531558|FG005|Induction Period|Lack of Efficacy|0|||
44405724|NCT00506389|79413381|FG002|In-treatment Period|Reasons not related to trial|0|||
44405725|NCT00506389|79413379|FG000|In-treatment Period|Withdrawal by Subject|3|||
44405726|NCT00506389|79413380|FG001|In-treatment Period|Withdrawal by Subject|3|||
44405727|NCT00506389|79413381|FG002|In-treatment Period|Withdrawal by Subject|4|||
44523174|NCT01358578|79531553|FG000|Induction Period|Lost to Follow-up|0|||
44523175|NCT01358578|79531554|FG001|Induction Period|Lost to Follow-up|0|||
44147930|NCT04339413|78937348|FG001|Overall Study|Progressive Disease|6|||
44405728|NCT00506389|79413379|FG000|In-treatment Period|Lack of Efficacy|0|||
44405729|NCT00506389|79413380|FG001|In-treatment Period|Lack of Efficacy|2|||
44405730|NCT00506389|79413381|FG002|In-treatment Period|Lack of Efficacy|0|||
44405731|NCT00506389|79413379|FG000|In-treatment Period|Adverse Event|11|||
44405732|NCT00506389|79413380|FG001|In-treatment Period|Adverse Event|5|||
44405733|NCT00506389|79413381|FG002|In-treatment Period|Adverse Event|2|||
44523176|NCT01358578|79531555|FG002|Induction Period|Lost to Follow-up|1|||
44405734|NCT00506389|79413379|FG000|In-treatment Period|Randomized but not treated|4|||
44405735|NCT00506389|79413380|FG001|In-treatment Period|Randomized but not treated|1|||
44523177|NCT01358578|79531556|FG003|Induction Period|Lost to Follow-up|4|||
44405736|NCT00506389|79413381|FG002|In-treatment Period|Randomized but not treated|1|||
44405737|NCT00871338|79413394|FG000|Prior to Booster|Withdrawal by Subject|1|||
44405738|NCT00871338|79413395|FG001|Prior to Booster|Withdrawal by Subject|3|||
44405739|NCT00871338|79413394|FG000|Prior to Booster|Lost to Follow-up|1|||
44405740|NCT00871338|79413395|FG001|Prior to Booster|Lost to Follow-up|0|||
44405741|NCT00824421|79413404|FG000|Overall Study|Adverse Event|6|||
44405742|NCT00824421|79413405|FG001|Overall Study|Adverse Event|6|||
44405743|NCT00824421|79413406|FG002|Overall Study|Adverse Event|6|||
44405744|NCT00824421|79413404|FG000|Overall Study|Death|0|||
44405745|NCT00824421|79413405|FG001|Overall Study|Death|1|||
44405746|NCT00824421|79413406|FG002|Overall Study|Death|0|||
44405747|NCT00824421|79413404|FG000|Overall Study|Lack of Efficacy|5|||
44405748|NCT00824421|79413405|FG001|Overall Study|Lack of Efficacy|7|||
44405749|NCT00824421|79413406|FG002|Overall Study|Lack of Efficacy|4|||
44405750|NCT00824421|79413404|FG000|Overall Study|Lost to Follow-up|2|||
44405751|NCT00824421|79413405|FG001|Overall Study|Lost to Follow-up|3|||
44405752|NCT00824421|79413406|FG002|Overall Study|Lost to Follow-up|0|||
44405753|NCT00824421|79413404|FG000|Overall Study|Pregnancy|1|||
44405754|NCT00824421|79413405|FG001|Overall Study|Pregnancy|0|||
44405755|NCT00824421|79413406|FG002|Overall Study|Pregnancy|1|||
44405756|NCT00824421|79413404|FG000|Overall Study|Withdrawal by Subject|2|||
44405757|NCT00824421|79413405|FG001|Overall Study|Withdrawal by Subject|3|||
44405758|NCT00824421|79413406|FG002|Overall Study|Withdrawal by Subject|3|||
44405759|NCT00824421|79413404|FG000|Overall Study|Randomized but not Treated|1|||
44405760|NCT00824421|79413405|FG001|Overall Study|Randomized but not Treated|1|||
44405761|NCT00824421|79413406|FG002|Overall Study|Randomized but not Treated|0|||
44405762|NCT00824421|79413404|FG000|Overall Study|Other|0|||
44405763|NCT00824421|79413405|FG001|Overall Study|Other|1|||
44405764|NCT00824421|79413406|FG002|Overall Study|Other|0|||
44405765|NCT00514813|79413420|FG000|Overall Study|Study terminated|14|||
44405766|NCT00514813|79413421|FG001|Overall Study|Study terminated|74|||
44405767|NCT00514813|79413422|FG002|Overall Study|Study terminated|40|||
44405768|NCT00514813|79413423|FG003|Overall Study|Study terminated|2|||
44405769|NCT00514813|79413420|FG000|Overall Study|Adverse Event|0|||
44405770|NCT00514813|79413421|FG001|Overall Study|Adverse Event|2|||
44405771|NCT00514813|79413422|FG002|Overall Study|Adverse Event|2|||
44405772|NCT00514813|79413423|FG003|Overall Study|Adverse Event|0|||
44405773|NCT00514813|79413420|FG000|Overall Study|Protocol Violation|1|||
44405774|NCT00514813|79413421|FG001|Overall Study|Protocol Violation|0|||
44405775|NCT00514813|79413422|FG002|Overall Study|Protocol Violation|0|||
44405776|NCT00514813|79413423|FG003|Overall Study|Protocol Violation|0|||
44405777|NCT00514813|79413420|FG000|Overall Study|Withdrawal by Subject|0|||
44405778|NCT00514813|79413421|FG001|Overall Study|Withdrawal by Subject|1|||
44405779|NCT00514813|79413422|FG002|Overall Study|Withdrawal by Subject|0|||
44523178|NCT01358578|79531557|FG004|Induction Period|Lost to Follow-up|0|||
44523179|NCT01358578|79531558|FG005|Induction Period|Lost to Follow-up|0|||
44523180|NCT01358578|79531553|FG000|Induction Period|Physician Decision|2|||
44523181|NCT01358578|79531554|FG001|Induction Period|Physician Decision|1|||
44523182|NCT01358578|79531555|FG002|Induction Period|Physician Decision|2|||
44523183|NCT01358578|79531556|FG003|Induction Period|Physician Decision|0|||
44253104|NCT03365375|79093018|FG000|Overall Study|Lost to Follow-up|0|||
44405780|NCT00514813|79413423|FG003|Overall Study|Withdrawal by Subject|0|||
44405781|NCT00514813|79413420|FG000|Overall Study|Lack of Efficacy|0|||
44405782|NCT00514813|79413421|FG001|Overall Study|Lack of Efficacy|1|||
44405783|NCT00514813|79413422|FG002|Overall Study|Lack of Efficacy|0|||
44405784|NCT00514813|79413423|FG003|Overall Study|Lack of Efficacy|0|||
44405785|NCT00514813|79413420|FG000|Overall Study|Kidney transplant|0|||
44405786|NCT00514813|79413421|FG001|Overall Study|Kidney transplant|6|||
44405787|NCT00514813|79413422|FG002|Overall Study|Kidney transplant|2|||
44405788|NCT00514813|79413423|FG003|Overall Study|Kidney transplant|0|||
44405789|NCT00514813|79413420|FG000|Overall Study|Death|0|||
44405790|NCT00514813|79413421|FG001|Overall Study|Death|2|||
44405791|NCT00514813|79413422|FG002|Overall Study|Death|3|||
44405792|NCT00514813|79413423|FG003|Overall Study|Death|2|||
44405793|NCT00597116|79413435|FG000|Overall Study|Adverse Event|2|||
44405794|NCT00597116|79413436|FG001|Overall Study|Adverse Event|1|||
44405795|NCT00597116|79413435|FG000|Overall Study|Withdrawal by Subject|0|||
44405796|NCT00597116|79413436|FG001|Overall Study|Withdrawal by Subject|2|||
44405797|NCT00597116|79413435|FG000|Overall Study|Physician Decision|0|||
44405798|NCT00597116|79413436|FG001|Overall Study|Physician Decision|1|||
44523184|NCT01358578|79531557|FG004|Induction Period|Physician Decision|0|||
44523185|NCT01358578|79531558|FG005|Induction Period|Physician Decision|0|||
44523186|NCT01358578|79531553|FG000|Induction Period|Protocol Deviation|3|||
44405799|NCT00597116|79413435|FG000|Overall Study|Death|0|||
44405800|NCT00597116|79413436|FG001|Overall Study|Death|1|||
44405801|NCT00597116|79413435|FG000|Overall Study|Lost to Follow-up|1|||
44523187|NCT01358578|79531554|FG001|Induction Period|Protocol Deviation|5|||
44523188|NCT01358578|79531555|FG002|Induction Period|Protocol Deviation|0|||
44405802|NCT00597116|79413436|FG001|Overall Study|Lost to Follow-up|0|||
44405803|NCT00597116|79413435|FG000|Overall Study|Progressive disease|11|||
44405804|NCT00597116|79413436|FG001|Overall Study|Progressive disease|6|||
44405805|NCT00514735|79413444|FG000|Overall Study|Withdrawal by Subject|13|||
44405806|NCT00514735|79413445|FG001|Overall Study|Withdrawal by Subject|5|||
44405807|NCT00514735|79413444|FG000|Overall Study|Death|1|||
44405808|NCT00514735|79413445|FG001|Overall Study|Death|0|||
44405809|NCT00514735|79413444|FG000|Overall Study|Lost to Follow-up|0|||
44405810|NCT00514735|79413445|FG001|Overall Study|Lost to Follow-up|1|||
44405811|NCT03252587|79413457|FG000|Overall Study|Adverse Event|3|||
44405812|NCT03252587|79413458|FG001|Overall Study|Adverse Event|8|||
44405813|NCT03252587|79413459|FG002|Overall Study|Adverse Event|6|||
44405814|NCT03252587|79413460|FG003|Overall Study|Adverse Event|12|||
44405815|NCT03252587|79413457|FG000|Overall Study|Lack of Efficacy|7|||
44405816|NCT03252587|79413458|FG001|Overall Study|Lack of Efficacy|2|||
44405817|NCT03252587|79413459|FG002|Overall Study|Lack of Efficacy|2|||
44405818|NCT03252587|79413460|FG003|Overall Study|Lack of Efficacy|4|||
44405819|NCT03252587|79413457|FG000|Overall Study|Lost to Follow-up|2|||
44405820|NCT03252587|79413458|FG001|Overall Study|Lost to Follow-up|0|||
44405821|NCT03252587|79413459|FG002|Overall Study|Lost to Follow-up|0|||
44405822|NCT03252587|79413460|FG003|Overall Study|Lost to Follow-up|2|||
44405823|NCT03252587|79413457|FG000|Overall Study|Pregnancy|2|||
44405824|NCT03252587|79413458|FG001|Overall Study|Pregnancy|1|||
44523189|NCT01358578|79531556|FG003|Induction Period|Protocol Deviation|3|||
44523190|NCT01358578|79531557|FG004|Induction Period|Protocol Deviation|0|||
44405825|NCT03252587|79413459|FG002|Overall Study|Pregnancy|0|||
44523191|NCT01358578|79531558|FG005|Induction Period|Protocol Deviation|0|||
44523192|NCT01358578|79531553|FG000|Induction Period|technical problems|0|||
44523193|NCT01358578|79531554|FG001|Induction Period|technical problems|0|||
44523194|NCT01358578|79531555|FG002|Induction Period|technical problems|1|||
44523195|NCT01358578|79531556|FG003|Induction Period|technical problems|1|||
44523196|NCT01358578|79531557|FG004|Induction Period|technical problems|0|||
44523197|NCT01358578|79531558|FG005|Induction Period|technical problems|0|||
44523198|NCT01358578|79531553|FG000|Induction Period|Withdrawal by Subject|5|||
44523199|NCT01358578|79531554|FG001|Induction Period|Withdrawal by Subject|5|||
44523200|NCT01358578|79531555|FG002|Induction Period|Withdrawal by Subject|10|||
44523201|NCT01358578|79531556|FG003|Induction Period|Withdrawal by Subject|6|||
44523202|NCT01358578|79531557|FG004|Induction Period|Withdrawal by Subject|0|||
44523203|NCT01358578|79531558|FG005|Induction Period|Withdrawal by Subject|0|||
44523204|NCT01358578|79531553|FG000|Maintenance Period|Adverse Event|2|||
44523205|NCT01358578|79531554|FG001|Maintenance Period|Adverse Event|7|||
44523206|NCT01358578|79531555|FG002|Maintenance Period|Adverse Event|0|||
44523207|NCT01358578|79531556|FG003|Maintenance Period|Adverse Event|6|||
44523208|NCT01358578|79531557|FG004|Maintenance Period|Adverse Event|4|||
44523209|NCT01358578|79531558|FG005|Maintenance Period|Adverse Event|3|||
44523210|NCT01358578|79531553|FG000|Maintenance Period|Lack of Efficacy|10|||
44523211|NCT01358578|79531554|FG001|Maintenance Period|Lack of Efficacy|2|||
44523212|NCT01358578|79531555|FG002|Maintenance Period|Lack of Efficacy|0|||
44523213|NCT01358578|79531556|FG003|Maintenance Period|Lack of Efficacy|11|||
44405826|NCT03252587|79413460|FG003|Overall Study|Pregnancy|1|||
44405827|NCT03252587|79413457|FG000|Overall Study|Withdrawal by Subject|8|||
44405828|NCT03252587|79413458|FG001|Overall Study|Withdrawal by Subject|4|||
44405829|NCT03252587|79413459|FG002|Overall Study|Withdrawal by Subject|4|||
44405830|NCT03252587|79413460|FG003|Overall Study|Withdrawal by Subject|4|||
44405831|NCT03252587|79413457|FG000|Overall Study|Other Reasons|2|||
44405832|NCT03252587|79413458|FG001|Overall Study|Other Reasons|5|||
44405833|NCT03252587|79413459|FG002|Overall Study|Other Reasons|5|||
44405834|NCT03252587|79413460|FG003|Overall Study|Other Reasons|4|||
44405835|NCT00511147|79413473|FG000|Overall Study|Withdrawal by Subject|1|||
44405836|NCT00511147|79413473|FG000|Overall Study|Disease progression|5|||
44523214|NCT01358578|79531557|FG004|Maintenance Period|Lack of Efficacy|3|||
44405837|NCT00511147|79413473|FG000|Overall Study|Required platelet transfusion|1|||
44405838|NCT00510835|79413480|FG000|Overall Study|Withdrawal by Subject|6|||
44405839|NCT00510835|79413481|FG001|Overall Study|Withdrawal by Subject|2|||
44405840|NCT00510835|79413482|FG002|Overall Study|Withdrawal by Subject|2|||
44405841|NCT00506077|79413492|FG000|Treatment Period 1|Adverse Event|2|||
44523215|NCT01358578|79531558|FG005|Maintenance Period|Lack of Efficacy|0|||
44253105|NCT03365375|79093019|FG001|Overall Study|Lost to Follow-up|4|||
44405842|NCT00506077|79413493|FG001|Treatment Period 1|Adverse Event|1|||
44405843|NCT00506077|79413492|FG000|Treatment Period 1|Lost to Follow-up|0|||
44405844|NCT00506077|79413493|FG001|Treatment Period 1|Lost to Follow-up|2|||
44405845|NCT00506077|79413492|FG000|Treatment Period 1|Withdrawal by Subject|2|||
44523216|NCT01358578|79531553|FG000|Maintenance Period|Lost to Follow-up|4|||
44405846|NCT00506077|79413493|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44405847|NCT00506077|79413492|FG000|Treatment Period 2|Adverse Event|0|||
44405848|NCT00506077|79413493|FG001|Treatment Period 2|Adverse Event|1|||
44405849|NCT00506077|79413492|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44523217|NCT01358578|79531554|FG001|Maintenance Period|Lost to Follow-up|0|||
44523218|NCT01358578|79531555|FG002|Maintenance Period|Lost to Follow-up|0|||
44523219|NCT01358578|79531556|FG003|Maintenance Period|Lost to Follow-up|5|||
44405850|NCT00506077|79413493|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44405851|NCT00505921|79413499|FG000|Overall Study|Ineligible|1|||
44405852|NCT00505921|79413499|FG000|Overall Study|Failed to Mobilize|8|||
44405853|NCT00596960|79413505|FG000|Overall Study|Death|1|||
44405854|NCT00596960|79413506|FG001|Overall Study|Death|2|||
44405855|NCT00596960|79413505|FG000|Overall Study|Lost to Follow-up|6|||
44405856|NCT00596960|79413506|FG001|Overall Study|Lost to Follow-up|5|||
44405857|NCT00596960|79413505|FG000|Overall Study|Withdrawal by Subject|1|||
44253106|NCT03282123|79093025|FG000|Overall Study|Withdrawal by Subject|5|||
44253107|NCT03046446|79093030|FG000|Overall Study|Lack of Efficacy|7|||
44253108|NCT03046446|79093030|FG000|Overall Study|Adverse Event|6|||
44253109|NCT03046446|79093030|FG000|Overall Study|Lost to Follow-up|3|||
44253110|NCT03046446|79093030|FG000|Overall Study|Withdrawal by Subject|14|||
44253111|NCT03046446|79093030|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
44253112|NCT03046446|79093030|FG000|Overall Study|Disease Progression (see caveats)|25|||
44253113|NCT03046446|79093030|FG000|Overall Study|Non OA related knee surgery|1|||
44253114|NCT02762370|79093059|FG000|Overall Study|Protocol Violation|1|||
44253115|NCT02762370|79093060|FG001|Overall Study|Protocol Violation|0|||
44253116|NCT02751580|79093068|FG000|Overall Study|Lost to Follow-up|4|||
44253117|NCT02751580|79093068|FG000|Overall Study|Death|2|||
44253118|NCT02717611|79093072|FG000|Overall Study|Death|13|||
44253119|NCT02717611|79093072|FG000|Overall Study|Withdrawal by Subject|6|||
44253120|NCT02717611|79093072|FG000|Overall Study|Active, not recruiting|40|||
44253121|NCT02717611|79093072|FG000|Overall Study|Complicating disease|1|||
44253122|NCT02513394|79093087|FG000|Overall Study|Withdrawal by Subject|11|||
44253123|NCT02513394|79093088|FG001|Overall Study|Withdrawal by Subject|23|||
44253124|NCT02513394|79093087|FG000|Overall Study|Ineligible|1|||
44253125|NCT02513394|79093088|FG001|Overall Study|Ineligible|0|||
44253126|NCT02284113|79093118|FG000|Overall Study|Adverse Event|1|||
44253127|NCT02284113|79093119|FG001|Overall Study|Adverse Event|0|||
44253128|NCT02284113|79093118|FG000|Overall Study|non-compliance|0|||
44253129|NCT02284113|79093119|FG001|Overall Study|non-compliance|1|||
44253130|NCT02284113|79093118|FG000|Overall Study|Withdrawal by Subject|0|||
44253131|NCT02284113|79093119|FG001|Overall Study|Withdrawal by Subject|1|||
44253132|NCT02284113|79093118|FG000|Overall Study|not provided|0|||
44253133|NCT02284113|79093119|FG001|Overall Study|not provided|1|||
44253134|NCT02284113|79093118|FG000|Overall Study|surgery cancelled|2|||
44253135|NCT02284113|79093119|FG001|Overall Study|surgery cancelled|0|||
44253136|NCT02116972|79093128|FG000|Overall Study|Adverse Event|4|||
44253137|NCT02116972|79093129|FG001|Overall Study|Adverse Event|4|||
44253138|NCT02116972|79093130|FG002|Overall Study|Adverse Event|1|||
44523220|NCT01358578|79531557|FG004|Maintenance Period|Lost to Follow-up|1|||
44523221|NCT01358578|79531558|FG005|Maintenance Period|Lost to Follow-up|1|||
44523222|NCT01358578|79531553|FG000|Maintenance Period|Non-compliance with study treatment|3|||
44523223|NCT01358578|79531554|FG001|Maintenance Period|Non-compliance with study treatment|1|||
44523224|NCT01358578|79531555|FG002|Maintenance Period|Non-compliance with study treatment|0|||
44253139|NCT02116972|79093128|FG000|Overall Study|Withdrawal by Subject|1|||
44253140|NCT02116972|79093129|FG001|Overall Study|Withdrawal by Subject|1|||
44253141|NCT02116972|79093130|FG002|Overall Study|Withdrawal by Subject|5|||
44253142|NCT02116972|79093128|FG000|Overall Study|Protocol Violation|1|||
44253143|NCT02116972|79093129|FG001|Overall Study|Protocol Violation|0|||
44253144|NCT02116972|79093130|FG002|Overall Study|Protocol Violation|1|||
44253145|NCT02116972|79093128|FG000|Overall Study|Lost to Follow-up|4|||
44253146|NCT02116972|79093129|FG001|Overall Study|Lost to Follow-up|3|||
44253147|NCT02116972|79093130|FG002|Overall Study|Lost to Follow-up|1|||
44253148|NCT02116972|79093128|FG000|Overall Study|Lack of Efficacy|6|||
44253149|NCT02116972|79093129|FG001|Overall Study|Lack of Efficacy|6|||
44253150|NCT02116972|79093130|FG002|Overall Study|Lack of Efficacy|5|||
44253151|NCT02116972|79093128|FG000|Overall Study|scheduling conflicts and relocation|3|||
44282083|NCT01904604|79245334|FG002|Overall Study|Withdrew before receiving dosing|0|||
44405858|NCT00596960|79413506|FG001|Overall Study|Withdrawal by Subject|0|||
44405859|NCT00596960|79413505|FG000|Overall Study|Incarcerated|2|||
44405860|NCT00596960|79413506|FG001|Overall Study|Incarcerated|0|||
44405861|NCT00596960|79413505|FG000|Overall Study|Physician Decision|1|||
44523225|NCT01358578|79531556|FG003|Maintenance Period|Non-compliance with study treatment|2|||
44523226|NCT01358578|79531557|FG004|Maintenance Period|Non-compliance with study treatment|1|||
44253152|NCT02116972|79093129|FG001|Overall Study|scheduling conflicts and relocation|3|||
44253153|NCT02116972|79093130|FG002|Overall Study|scheduling conflicts and relocation|6|||
44523227|NCT01358578|79531558|FG005|Maintenance Period|Non-compliance with study treatment|2|||
44523228|NCT01358578|79531553|FG000|Maintenance Period|Physician Decision|0|||
44523229|NCT01358578|79531554|FG001|Maintenance Period|Physician Decision|1|||
44523230|NCT01358578|79531555|FG002|Maintenance Period|Physician Decision|0|||
44253158|NCT02008396|79093146|FG000|Overall Study|Protocol Violation|0|||
44253159|NCT02008396|79093147|FG001|Overall Study|Protocol Violation|1|||
44282084|NCT01904604|79245332|FG000|Overall Study|Non-compliance|1|||
44405862|NCT00596960|79413506|FG001|Overall Study|Physician Decision|0|||
44405863|NCT00596960|79413505|FG000|Overall Study|Protocol Violation|0|||
44405864|NCT00596960|79413506|FG001|Overall Study|Protocol Violation|1|||
44405865|NCT00596960|79413505|FG000|Overall Study|No alcohol use data|0|||
44405866|NCT00596960|79413506|FG001|Overall Study|No alcohol use data|1|||
44405867|NCT00505765|79413515|FG000|Overall Study|Withdrawal by Subject|1|||
44405868|NCT00505765|79413516|FG001|Overall Study|Withdrawal by Subject|0|||
44405869|NCT00505765|79413517|FG002|Overall Study|Withdrawal by Subject|0|||
44405870|NCT00505765|79413515|FG000|Overall Study|Adverse Event|1|||
44405871|NCT00505765|79413516|FG001|Overall Study|Adverse Event|2|||
44405872|NCT00505765|79413517|FG002|Overall Study|Adverse Event|0|||
44405873|NCT00505765|79413515|FG000|Overall Study|Noncompliance|0|||
44405874|NCT00505765|79413516|FG001|Overall Study|Noncompliance|1|||
44405875|NCT00505765|79413517|FG002|Overall Study|Noncompliance|3|||
44405876|NCT00505687|79413525|FG000|Overall Study|Important protocol violation|2|||
44405877|NCT00505687|79413525|FG000|Overall Study|Lack of Efficacy|15|||
44405878|NCT00505687|79413525|FG000|Overall Study|Adverse Event|48|||
44405879|NCT00505687|79413525|FG000|Overall Study|Subject withdrew consent|15|||
44405880|NCT00505687|79413525|FG000|Overall Study|Lost to Follow-up|1|||
44405881|NCT00505687|79413525|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
44405882|NCT00505687|79413525|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
44405883|NCT00505687|79413525|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
44405884|NCT00505687|79413525|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
44405885|NCT00505687|79413525|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
44405886|NCT00505687|79413525|FG000|Overall Study|Other: Disease Progression|1|||
44405887|NCT00505687|79413525|FG000|Overall Study|Other: As Per Sponsor|8|||
44405888|NCT00505375|79413531|FG000|Overall Study|Death|1|||
44405889|NCT00505375|79413532|FG001|Overall Study|Death|0|||
44405890|NCT00505375|79413531|FG000|Overall Study|Withdrawal by Subject|2|||
44405891|NCT00505375|79413532|FG001|Overall Study|Withdrawal by Subject|2|||
44405892|NCT00505375|79413531|FG000|Overall Study|Lost to Follow-up|0|||
44405893|NCT00505375|79413532|FG001|Overall Study|Lost to Follow-up|2|||
44405894|NCT00505375|79413531|FG000|Overall Study|Pregnancy|1|||
44405895|NCT00505375|79413532|FG001|Overall Study|Pregnancy|0|||
44405896|NCT00505375|79413531|FG000|Overall Study|Travel issues|0|||
44405897|NCT00505375|79413532|FG001|Overall Study|Travel issues|1|||
44405898|NCT00594932|79413540|FG000|First 3 Months|Withdrawal by Subject|1|||
44405899|NCT00594932|79413541|FG001|First 3 Months|Withdrawal by Subject|3|||
44405900|NCT00594932|79413540|FG000|Final 3 Months|Withdrawal by Subject|4|||
44405901|NCT00594932|79413541|FG001|Final 3 Months|Withdrawal by Subject|3|||
44405902|NCT00504829|79413550|FG000|Overall Study|Protocol Violation|6|||
44405903|NCT00504829|79413551|FG001|Overall Study|Protocol Violation|4|||
44405904|NCT00504829|79413552|FG002|Overall Study|Protocol Violation|10|||
44405905|NCT00504595|79413564|FG000|Overall Study|Lack of Efficacy|1|||
44405906|NCT00504595|79413565|FG001|Overall Study|Lack of Efficacy|0|||
44405907|NCT00504595|79413566|FG002|Overall Study|Lack of Efficacy|0|||
44405908|NCT00504595|79413567|FG003|Overall Study|Lack of Efficacy|0|||
44405909|NCT00504595|79413564|FG000|Overall Study|Other|0|||
44405910|NCT00504595|79413565|FG001|Overall Study|Other|0|||
44147931|NCT04339413|78937347|FG000|Overall Study|Withdrawal by Subject|9|||
44147932|NCT04339413|78937348|FG001|Overall Study|Withdrawal by Subject|10|||
44147933|NCT04339413|78937347|FG000|Overall Study|Physician Decision|3|||
44147934|NCT04339413|78937348|FG001|Overall Study|Physician Decision|1|||
44147935|NCT04339413|78937347|FG000|Overall Study|Death|2|||
44147936|NCT04339413|78937348|FG001|Overall Study|Death|0|||
44147937|NCT04339413|78937347|FG000|Overall Study|Adverse Event|3|||
44147938|NCT04339413|78937348|FG001|Overall Study|Adverse Event|0|||
44147939|NCT04327999|78937354|FG000|Overall Study|Protocol Violation|1|||
44147940|NCT04145037|78937364|FG000|Overall Study|Study terminated|2|||
44147941|NCT04145037|78937365|FG001|Overall Study|Study terminated|0|||
44147942|NCT04145037|78937364|FG000|Overall Study|Withdrawal by Subject|1|||
44147943|NCT04145037|78937365|FG001|Overall Study|Withdrawal by Subject|0|||
44147944|NCT04145037|78937364|FG000|Overall Study|Lost to Follow-up|1|||
44147945|NCT04145037|78937365|FG001|Overall Study|Lost to Follow-up|0|||
44253160|NCT01904136|79093163|FG000|Overall Study|Physician Decision|0|||
44253161|NCT01904136|79093164|FG001|Overall Study|Physician Decision|0|||
44253162|NCT01904136|79093165|FG002|Overall Study|Physician Decision|0|||
44523231|NCT01358578|79531556|FG003|Maintenance Period|Physician Decision|1|||
44253163|NCT01904136|79093166|FG003|Overall Study|Physician Decision|0|||
44405911|NCT00504595|79413566|FG002|Overall Study|Other|2|||
44405912|NCT00504595|79413567|FG003|Overall Study|Other|0|||
44147946|NCT04097028|78937373|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
44147947|NCT04097028|78937373|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
44253164|NCT01904136|79093167|FG004|Overall Study|Physician Decision|0|||
44405913|NCT00513409|79413579|FG000|Overall Study|Adverse Event|0|||
44405914|NCT00513409|79413580|FG001|Overall Study|Adverse Event|1|||
44405915|NCT00513409|79413579|FG000|Overall Study|Withdrawal by Subject|0|||
44405916|NCT00513409|79413580|FG001|Overall Study|Withdrawal by Subject|2|||
44523232|NCT01358578|79531557|FG004|Maintenance Period|Physician Decision|0|||
44253165|NCT01904136|79093168|FG005|Overall Study|Physician Decision|1|||
44253166|NCT01904136|79093169|FG006|Overall Study|Physician Decision|0|||
44253167|NCT01904136|79093170|FG007|Overall Study|Physician Decision|0|||
44253168|NCT01904136|79093171|FG008|Overall Study|Physician Decision|0|||
44253169|NCT01828099|79093197|FG000|Overall Study|Adverse Event|15|||
44253170|NCT01828099|79093198|FG001|Overall Study|Adverse Event|18|||
44253171|NCT01828099|79093197|FG000|Overall Study|Death|9|||
44253172|NCT01828099|79093198|FG001|Overall Study|Death|11|||
44253173|NCT01828099|79093197|FG000|Overall Study|Lost to Follow-up|2|||
44253174|NCT01828099|79093198|FG001|Overall Study|Lost to Follow-up|0|||
44253175|NCT01828099|79093197|FG000|Overall Study|Non-compliance with study treatment|2|||
44253176|NCT01828099|79093198|FG001|Overall Study|Non-compliance with study treatment|0|||
44523233|NCT01358578|79531558|FG005|Maintenance Period|Physician Decision|0|||
44523234|NCT01358578|79531553|FG000|Maintenance Period|Pregnancy|1|||
44523235|NCT01358578|79531554|FG001|Maintenance Period|Pregnancy|0|||
44523236|NCT01358578|79531555|FG002|Maintenance Period|Pregnancy|0|||
44523237|NCT01358578|79531556|FG003|Maintenance Period|Pregnancy|0|||
44523238|NCT01358578|79531557|FG004|Maintenance Period|Pregnancy|0|||
44523239|NCT01358578|79531558|FG005|Maintenance Period|Pregnancy|0|||
44253177|NCT01828099|79093197|FG000|Overall Study|Physician Decision|7|||
44253178|NCT01828099|79093198|FG001|Overall Study|Physician Decision|11|||
44253179|NCT01828099|79093197|FG000|Overall Study|Progressive disease|51|||
44253180|NCT01828099|79093198|FG001|Overall Study|Progressive disease|94|||
44253181|NCT01828099|79093197|FG000|Overall Study|Protocol Violation|1|||
44253182|NCT01828099|79093198|FG001|Overall Study|Protocol Violation|0|||
44253183|NCT01828099|79093197|FG000|Overall Study|Subject/guardian decision|7|||
44253184|NCT01828099|79093198|FG001|Overall Study|Subject/guardian decision|23|||
44253185|NCT01793610|79093207|FG000|Overall Study|Withdrawal by Subject|1|||
44253186|NCT01793610|79093208|FG001|Overall Study|Withdrawal by Subject|0|||
44253187|NCT01793610|79093209|FG002|Overall Study|Withdrawal by Subject|1|||
44253188|NCT01320085|79093261|FG000|Overall Study|Disease Progression|26|||
44253189|NCT01320085|79093262|FG001|Overall Study|Disease Progression|93|||
44253190|NCT01320085|79093263|FG002|Overall Study|Disease Progression|17|||
44253191|NCT01320085|79093261|FG000|Overall Study|Adverse Event|12|||
44253192|NCT01320085|79093262|FG001|Overall Study|Adverse Event|20|||
44523240|NCT01358578|79531553|FG000|Maintenance Period|Protocol deviation|7|||
44523241|NCT01358578|79531554|FG001|Maintenance Period|Protocol deviation|4|||
44523242|NCT01358578|79531555|FG002|Maintenance Period|Protocol deviation|0|||
44523243|NCT01358578|79531556|FG003|Maintenance Period|Protocol deviation|2|||
44523244|NCT01358578|79531557|FG004|Maintenance Period|Protocol deviation|2|||
44523245|NCT01358578|79531558|FG005|Maintenance Period|Protocol deviation|2|||
44523246|NCT01358578|79531553|FG000|Maintenance Period|Withdrawal by Subject|12|||
44523247|NCT01358578|79531554|FG001|Maintenance Period|Withdrawal by Subject|7|||
44523248|NCT01358578|79531555|FG002|Maintenance Period|Withdrawal by Subject|2|||
44523249|NCT01358578|79531556|FG003|Maintenance Period|Withdrawal by Subject|15|||
44523250|NCT01358578|79531557|FG004|Maintenance Period|Withdrawal by Subject|6|||
44523251|NCT01358578|79531558|FG005|Maintenance Period|Withdrawal by Subject|3|||
44523252|NCT01358578|79531553|FG000|Follow-up Period|Adverse Event|1|||
44523253|NCT01358578|79531554|FG001|Follow-up Period|Adverse Event|1|||
44523254|NCT01358578|79531555|FG002|Follow-up Period|Adverse Event|0|||
44523255|NCT01358578|79531556|FG003|Follow-up Period|Adverse Event|0|||
44523256|NCT01358578|79531557|FG004|Follow-up Period|Adverse Event|0|||
44523257|NCT01358578|79531558|FG005|Follow-up Period|Adverse Event|0|||
44523258|NCT01358578|79531553|FG000|Follow-up Period|Lack of Efficacy|3|||
44523259|NCT01358578|79531554|FG001|Follow-up Period|Lack of Efficacy|0|||
44523260|NCT01358578|79531555|FG002|Follow-up Period|Lack of Efficacy|4|||
44523261|NCT01358578|79531556|FG003|Follow-up Period|Lack of Efficacy|1|||
44523262|NCT01358578|79531557|FG004|Follow-up Period|Lack of Efficacy|0|||
44523263|NCT01358578|79531558|FG005|Follow-up Period|Lack of Efficacy|0|||
44523264|NCT01358578|79531553|FG000|Follow-up Period|Lost to Follow-up|0|||
44523265|NCT01358578|79531554|FG001|Follow-up Period|Lost to Follow-up|1|||
44523266|NCT01358578|79531555|FG002|Follow-up Period|Lost to Follow-up|0|||
44523267|NCT01358578|79531556|FG003|Follow-up Period|Lost to Follow-up|4|||
44523268|NCT01358578|79531557|FG004|Follow-up Period|Lost to Follow-up|0|||
44253193|NCT01320085|79093263|FG002|Overall Study|Adverse Event|5|||
44253194|NCT01320085|79093261|FG000|Overall Study|Withdrawal by Subject|2|||
44253195|NCT01320085|79093262|FG001|Overall Study|Withdrawal by Subject|4|||
44253196|NCT01320085|79093263|FG002|Overall Study|Withdrawal by Subject|1|||
44253197|NCT01320085|79093261|FG000|Overall Study|Protocol Deviation|1|||
44253198|NCT01320085|79093262|FG001|Overall Study|Protocol Deviation|0|||
44253199|NCT01320085|79093263|FG002|Overall Study|Protocol Deviation|1|||
44253200|NCT01320085|79093261|FG000|Overall Study|Administrative problems|0|||
44253201|NCT01320085|79093262|FG001|Overall Study|Administrative problems|0|||
44253202|NCT01320085|79093263|FG002|Overall Study|Administrative problems|1|||
44523269|NCT01358578|79531558|FG005|Follow-up Period|Lost to Follow-up|0|||
44523270|NCT01358578|79531553|FG000|Follow-up Period|non- compliance with study treatment|1|||
44523271|NCT01358578|79531554|FG001|Follow-up Period|non- compliance with study treatment|0|||
44523272|NCT01358578|79531555|FG002|Follow-up Period|non- compliance with study treatment|0|||
44523273|NCT01358578|79531556|FG003|Follow-up Period|non- compliance with study treatment|0|||
44523274|NCT01358578|79531557|FG004|Follow-up Period|non- compliance with study treatment|0|||
44523275|NCT01358578|79531558|FG005|Follow-up Period|non- compliance with study treatment|0|||
44523276|NCT01358578|79531553|FG000|Follow-up Period|Pregnancy|1|||
44523277|NCT01358578|79531554|FG001|Follow-up Period|Pregnancy|0|||
44523278|NCT01358578|79531555|FG002|Follow-up Period|Pregnancy|0|||
44523279|NCT01358578|79531556|FG003|Follow-up Period|Pregnancy|0|||
44523280|NCT01358578|79531557|FG004|Follow-up Period|Pregnancy|0|||
44523281|NCT01358578|79531558|FG005|Follow-up Period|Pregnancy|0|||
44523282|NCT01358578|79531553|FG000|Follow-up Period|Withdrawal by Subject|3|||
44523283|NCT01358578|79531554|FG001|Follow-up Period|Withdrawal by Subject|3|||
44523284|NCT01358578|79531555|FG002|Follow-up Period|Withdrawal by Subject|1|||
44523285|NCT01358578|79531556|FG003|Follow-up Period|Withdrawal by Subject|12|||
44523286|NCT01358578|79531557|FG004|Follow-up Period|Withdrawal by Subject|0|||
44523287|NCT01358578|79531558|FG005|Follow-up Period|Withdrawal by Subject|0|||
44523288|NCT01358578|79531553|FG000|Follow-up Period|Physician Decision|1|||
44523289|NCT01358578|79531554|FG001|Follow-up Period|Physician Decision|1|||
44523290|NCT01358578|79531555|FG002|Follow-up Period|Physician Decision|0|||
44523291|NCT01358578|79531556|FG003|Follow-up Period|Physician Decision|2|||
44523292|NCT01358578|79531557|FG004|Follow-up Period|Physician Decision|0|||
44523293|NCT01358578|79531558|FG005|Follow-up Period|Physician Decision|0|||
44523294|NCT02833948|79531588|FG000|Overall Study|Death|2|||
44523295|NCT02833948|79531589|FG001|Overall Study|Death|3|||
44523296|NCT02833948|79531588|FG000|Overall Study|were not scanned|8|||
44523297|NCT02833948|79531589|FG001|Overall Study|were not scanned|13|||
44523298|NCT02833948|79531588|FG000|Overall Study|scans could not be evaluated|5|||
44523299|NCT02833948|79531589|FG001|Overall Study|scans could not be evaluated|2|||
44523300|NCT02828020|79531602|FG000|Treatment Period|Adverse Event|3|||
44523301|NCT02828020|79531603|FG001|Treatment Period|Adverse Event|1|||
44523302|NCT02828020|79531604|FG002|Treatment Period|Adverse Event|1|||
44523303|NCT02828020|79531602|FG000|Treatment Period|Withdrawal of Consent|10|||
44523304|NCT02828020|79531603|FG001|Treatment Period|Withdrawal of Consent|14|||
44405917|NCT00513409|79413579|FG000|Overall Study|Lost to Follow-up|0|||
44405918|NCT00513409|79413580|FG001|Overall Study|Lost to Follow-up|1|||
44405919|NCT00513409|79413579|FG000|Overall Study|Physician Decision|1|||
44405920|NCT00513409|79413580|FG001|Overall Study|Physician Decision|0|||
44405921|NCT00513409|79413579|FG000|Overall Study|Visit 3 not done|1|||
44405922|NCT00513409|79413580|FG001|Overall Study|Visit 3 not done|2|||
44405923|NCT03150095|79413588|FG000|Overall Study|Death|0|||
44405924|NCT03150095|79413589|FG001|Overall Study|Death|1|||
44405925|NCT03150095|79413588|FG000|Overall Study|Lost to Follow-up|1|||
44405926|NCT03150095|79413589|FG001|Overall Study|Lost to Follow-up|1|||
44405927|NCT03150095|79413588|FG000|Overall Study|Withdrawal by Subject|4|||
44405928|NCT03150095|79413589|FG001|Overall Study|Withdrawal by Subject|0|||
44405929|NCT03150095|79413588|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
44405930|NCT03150095|79413589|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
44253203|NCT01207492|79093284|FG000|Overall Study|Still on study|1|||
44405931|NCT00705016|79413598|FG000|Overall Study|Adverse Event|6|||
44405932|NCT00705016|79413599|FG001|Overall Study|Adverse Event|11|||
44523305|NCT02828020|79531604|FG002|Treatment Period|Withdrawal of Consent|9|||
44523306|NCT02828020|79531602|FG000|Treatment Period|Lost to Follow-up|21|||
44523307|NCT02828020|79531603|FG001|Treatment Period|Lost to Follow-up|24|||
44523308|NCT02828020|79531604|FG002|Treatment Period|Lost to Follow-up|18|||
44523309|NCT02828020|79531602|FG000|Treatment Period|Lack of Qualifying Event|44|||
44523310|NCT02828020|79531603|FG001|Treatment Period|Lack of Qualifying Event|53|||
44253204|NCT01207492|79093284|FG000|Overall Study|Withdrawal by Subject|9|||
44405933|NCT00705016|79413600|FG002|Overall Study|Adverse Event|10|||
44523311|NCT02828020|79531604|FG002|Treatment Period|Lack of Qualifying Event|43|||
44405934|NCT00705016|79413598|FG000|Overall Study|Death|5|||
44405935|NCT00705016|79413599|FG001|Overall Study|Death|7|||
44405936|NCT00705016|79413600|FG002|Overall Study|Death|5|||
44405937|NCT00705016|79413598|FG000|Overall Study|Protocol Violation|0|||
44405938|NCT00705016|79413599|FG001|Overall Study|Protocol Violation|1|||
44405939|NCT00705016|79413600|FG002|Overall Study|Protocol Violation|1|||
44405940|NCT00705016|79413598|FG000|Overall Study|Withdrawal by Subject|4|||
44405941|NCT00705016|79413599|FG001|Overall Study|Withdrawal by Subject|3|||
44405942|NCT00705016|79413600|FG002|Overall Study|Withdrawal by Subject|2|||
44405943|NCT00705016|79413598|FG000|Overall Study|Progressive Disease|33|||
44405944|NCT00705016|79413599|FG001|Overall Study|Progressive Disease|29|||
44405945|NCT00705016|79413600|FG002|Overall Study|Progressive Disease|33|||
44405946|NCT00705016|79413598|FG000|Overall Study|Symptomatic Deterioration|3|||
44405947|NCT00705016|79413599|FG001|Overall Study|Symptomatic Deterioration|1|||
44405948|NCT00705016|79413600|FG002|Overall Study|Symptomatic Deterioration|1|||
44405949|NCT00705016|79413598|FG000|Overall Study|Other|9|||
44405950|NCT00705016|79413599|FG001|Overall Study|Other|6|||
44523312|NCT02828020|79531602|FG000|Treatment Period|Pregnancy|0|||
44523313|NCT02828020|79531603|FG001|Treatment Period|Pregnancy|2|||
44523314|NCT02828020|79531604|FG002|Treatment Period|Pregnancy|0|||
44523315|NCT02828020|79531602|FG000|Treatment Period|Protocol Violation|2|||
44523316|NCT02828020|79531603|FG001|Treatment Period|Protocol Violation|4|||
44523317|NCT02828020|79531604|FG002|Treatment Period|Protocol Violation|7|||
44405951|NCT00705016|79413600|FG002|Overall Study|Other|6|||
44405952|NCT00595868|79413610|FG000|Overall Study|Lost to Follow-up|45|||
44405953|NCT00595868|79413611|FG001|Overall Study|Lost to Follow-up|50|||
44405954|NCT00856284|79413641|FG000|Overall Study|Hyperglycemic rescue|231|||
44405955|NCT00856284|79413642|FG001|Overall Study|Hyperglycemic rescue|201|||
44405956|NCT00856284|79413643|FG002|Overall Study|Hyperglycemic rescue|235|||
44405957|NCT00856284|79413641|FG000|Overall Study|Adverse Event|60|||
44405958|NCT00856284|79413642|FG001|Overall Study|Adverse Event|74|||
44405959|NCT00856284|79413643|FG002|Overall Study|Adverse Event|82|||
44405960|NCT00856284|79413641|FG000|Overall Study|Major protocol deviation|24|||
44405961|NCT00856284|79413642|FG001|Overall Study|Major protocol deviation|16|||
44405962|NCT00856284|79413643|FG002|Overall Study|Major protocol deviation|15|||
44405963|NCT00856284|79413641|FG000|Overall Study|Lost to Follow-up|20|||
44405964|NCT00856284|79413642|FG001|Overall Study|Lost to Follow-up|22|||
44405965|NCT00856284|79413643|FG002|Overall Study|Lost to Follow-up|28|||
44405966|NCT00856284|79413641|FG000|Overall Study|Voluntary withdrawal|48|||
44405967|NCT00856284|79413642|FG001|Overall Study|Voluntary withdrawal|52|||
44405968|NCT00856284|79413643|FG002|Overall Study|Voluntary withdrawal|62|||
44405969|NCT00856284|79413641|FG000|Overall Study|Pregnancy|1|||
44405970|NCT00856284|79413642|FG001|Overall Study|Pregnancy|2|||
44405971|NCT00856284|79413643|FG002|Overall Study|Pregnancy|0|||
44405972|NCT00856284|79413641|FG000|Overall Study|Investigator discretion|9|||
44405973|NCT00856284|79413642|FG001|Overall Study|Investigator discretion|8|||
44405974|NCT00856284|79413643|FG002|Overall Study|Investigator discretion|10|||
44405975|NCT00856284|79413641|FG000|Overall Study|Other|15|||
44405976|NCT00856284|79413642|FG001|Overall Study|Other|17|||
44405977|NCT00856284|79413643|FG002|Overall Study|Other|14|||
44405978|NCT00856284|79413641|FG000|Overall Study|Randomized in error|0|||
44405979|NCT00856284|79413642|FG001|Overall Study|Randomized in error|0|||
44405980|NCT00856284|79413643|FG002|Overall Study|Randomized in error|1|||
44523318|NCT02828020|79531602|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
44405981|NCT00510289|79413651|FG000|Overall Study|Withdrawal by Subject|7|||
44405982|NCT00510289|79413651|FG000|Overall Study|Refused bone marrow biopsy|2|||
44405983|NCT00510289|79413651|FG000|Overall Study|Lost to Follow-up|1|||
44405984|NCT00510289|79413651|FG000|Overall Study|Progressed prior to starting drug|2|||
44405985|NCT00492115|79413658|FG000|Overall Study|Withdrawal by Subject|3|||
44523319|NCT02828020|79531603|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
44523320|NCT02828020|79531604|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
44523321|NCT02828020|79531602|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
44405986|NCT00492115|79413659|FG001|Overall Study|Withdrawal by Subject|4|||
44405987|NCT00856206|79413667|FG000|Overall Study|Protocol Violation|6|||
44405988|NCT00856206|79413668|FG001|Overall Study|Protocol Violation|18|||
44405989|NCT00856206|79413667|FG000|Overall Study|Adverse Event|10|||
44405990|NCT00856206|79413668|FG001|Overall Study|Adverse Event|46|||
44405991|NCT00856206|79413667|FG000|Overall Study|Lack of Efficacy|1|||
44405992|NCT00856206|79413668|FG001|Overall Study|Lack of Efficacy|2|||
44405993|NCT00856206|79413667|FG000|Overall Study|Withdrawal by Subject|15|||
44405994|NCT00856206|79413668|FG001|Overall Study|Withdrawal by Subject|36|||
44405995|NCT00856206|79413667|FG000|Overall Study|Lost to Follow-up|13|||
44523322|NCT02828020|79531603|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
44523323|NCT02828020|79531604|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
44523324|NCT02828020|79531602|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
44405996|NCT00856206|79413668|FG001|Overall Study|Lost to Follow-up|39|||
44405997|NCT00856206|79413667|FG000|Overall Study|Death|2|||
44405998|NCT00856206|79413668|FG001|Overall Study|Death|2|||
44405999|NCT00856206|79413667|FG000|Overall Study|Decision by the Sponsor|4|||
44523325|NCT02828020|79531603|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
44523326|NCT02828020|79531604|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
44523327|NCT02828020|79531602|FG000|Safety Follow-up Period|Protocol Violation|0|||
44523328|NCT02828020|79531603|FG001|Safety Follow-up Period|Protocol Violation|2|||
44523329|NCT02828020|79531604|FG002|Safety Follow-up Period|Protocol Violation|1|||
44523330|NCT02828020|79531602|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
44406000|NCT00856206|79413668|FG001|Overall Study|Decision by the Sponsor|8|||
44406001|NCT00856206|79413667|FG000|Overall Study|Other than specified above|3|||
44406002|NCT00856206|79413668|FG001|Overall Study|Other than specified above|10|||
44406003|NCT00593112|79413676|FG000|Overall Study|Scan Anxiety|3|||
44406004|NCT00593112|79413677|FG001|Overall Study|Scan Anxiety|0|||
44406005|NCT00593112|79413676|FG000|Overall Study|Abnormal Scan|1|||
44406006|NCT00593112|79413677|FG001|Overall Study|Abnormal Scan|0|||
44406007|NCT00593112|79413676|FG000|Overall Study|Unreadable Scan|1|||
44406008|NCT00593112|79413677|FG001|Overall Study|Unreadable Scan|0|||
44406009|NCT00593112|79413676|FG000|Overall Study|Withdrawal by Subject|5|||
44406010|NCT00593112|79413677|FG001|Overall Study|Withdrawal by Subject|0|||
44406011|NCT00491179|79413685|FG000|Overall Study|Adverse Event|5|||
44406012|NCT00491179|79413686|FG001|Overall Study|Adverse Event|1|||
44406013|NCT00491179|79413685|FG000|Overall Study|Withdrawal by Subject|2|||
44406014|NCT00491179|79413686|FG001|Overall Study|Withdrawal by Subject|1|||
44406015|NCT00503581|79413695|FG000|Overall Study|Study closed|3|||
44406016|NCT00503581|79413696|FG001|Overall Study|Study closed|4|||
44406017|NCT00503581|79413697|FG002|Overall Study|Study closed|2|||
44406018|NCT00703534|79413707|FG000|Overall Study|Adverse Event|14|||
44406019|NCT00703534|79413708|FG001|Overall Study|Adverse Event|3|||
44406020|NCT00703534|79413707|FG000|Overall Study|Withdrawal by Subject|8|||
44406021|NCT00703534|79413708|FG001|Overall Study|Withdrawal by Subject|7|||
44406022|NCT00703534|79413707|FG000|Overall Study|Incorrect Enrollment|6|||
44406023|NCT00703534|79413708|FG001|Overall Study|Incorrect Enrollment|6|||
44406024|NCT00703534|79413707|FG000|Overall Study|Lost to Follow-up|1|||
44406025|NCT00703534|79413708|FG001|Overall Study|Lost to Follow-up|4|||
44406026|NCT00703534|79413707|FG000|Overall Study|Severe Non Compliance|1|||
44406027|NCT00703534|79413708|FG001|Overall Study|Severe Non Compliance|5|||
44406028|NCT00503425|79413714|FG000|Overall Study|Participant files lost|6|||
44406029|NCT00503425|79413714|FG000|Overall Study|Adverse Event|5|||
44406030|NCT00503425|79413714|FG000|Overall Study|Lack of Efficacy|25|||
44406031|NCT00503425|79413714|FG000|Overall Study|Withdrawal by Subject|8|||
44406032|NCT00503425|79413714|FG000|Overall Study|Lost to Follow-up|3|||
44406033|NCT00503425|79413714|FG000|Overall Study|Death|3|||
44406034|NCT00503425|79413714|FG000|Overall Study|Missing Data/Unknown|4|||
44406035|NCT00863772|79413722|FG000|Overall Study|Adverse Event|1|||
44406036|NCT00863772|79413723|FG001|Overall Study|Adverse Event|4|||
44406037|NCT00863772|79413724|FG002|Overall Study|Adverse Event|0|||
44406038|NCT00863772|79413722|FG000|Overall Study|Lack of Efficacy|4|||
44406039|NCT00863772|79413723|FG001|Overall Study|Lack of Efficacy|2|||
44406040|NCT00863772|79413724|FG002|Overall Study|Lack of Efficacy|4|||
44406041|NCT00863772|79413722|FG000|Overall Study|Lost to Follow-up|5|||
44406042|NCT00863772|79413723|FG001|Overall Study|Lost to Follow-up|1|||
44406043|NCT00863772|79413724|FG002|Overall Study|Lost to Follow-up|1|||
44406044|NCT00863772|79413722|FG000|Overall Study|Protocol Violation|2|||
44406045|NCT00863772|79413723|FG001|Overall Study|Protocol Violation|0|||
44523331|NCT02828020|79531603|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
44523332|NCT02828020|79531604|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
44523333|NCT02827708|79531623|FG000|Overall Study|Lost to Follow-up|3|||
44523334|NCT02827708|79531624|FG001|Overall Study|Lost to Follow-up|1|||
44523335|NCT02827708|79531623|FG000|Overall Study|Withdrawal by Subject|1|||
44523336|NCT02827708|79531624|FG001|Overall Study|Withdrawal by Subject|2|||
44523337|NCT02827708|79531623|FG000|Overall Study|Death|1|||
44523338|NCT02827708|79531624|FG001|Overall Study|Death|2|||
44523339|NCT03760185|79531630|FG000|Overall Study|Lost to Follow-up|1|||
44253205|NCT01207492|79093284|FG000|Overall Study|Physician Decision|1|||
44406046|NCT00863772|79413724|FG002|Overall Study|Protocol Violation|2|||
44406047|NCT00863772|79413722|FG000|Overall Study|Withdrawal by Subject|4|||
44406048|NCT00863772|79413723|FG001|Overall Study|Withdrawal by Subject|7|||
44406049|NCT00863772|79413724|FG002|Overall Study|Withdrawal by Subject|5|||
44406050|NCT00863772|79413722|FG000|Overall Study|Study terminated by sponsor|44|||
44406051|NCT00863772|79413723|FG001|Overall Study|Study terminated by sponsor|45|||
44523340|NCT03760185|79531631|FG001|Overall Study|Lost to Follow-up|1|||
44523341|NCT02891174|79531641|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
44523342|NCT02891174|79531642|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
44406052|NCT00863772|79413724|FG002|Overall Study|Study terminated by sponsor|36|||
44406053|NCT00863772|79413722|FG000|Overall Study|Entered extension study|6|||
44406054|NCT00863772|79413723|FG001|Overall Study|Entered extension study|4|||
44406055|NCT00863772|79413724|FG002|Overall Study|Entered extension study|9|||
44406056|NCT00863772|79413722|FG000|Overall Study|Other|1|||
44406057|NCT00863772|79413723|FG001|Overall Study|Other|2|||
44523343|NCT02891174|79531641|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
44523344|NCT02891174|79531642|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
44523345|NCT02891174|79531641|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
44523346|NCT02891174|79531642|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
44523347|NCT02891174|79531641|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
44523348|NCT02891174|79531642|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
44523349|NCT02891174|79531641|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
44523350|NCT02891174|79531642|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
44523351|NCT02891174|79531641|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
44523352|NCT02891174|79531642|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
44523353|NCT02891174|79531641|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
44523354|NCT02891174|79531642|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
44406058|NCT00863772|79413724|FG002|Overall Study|Other|4|||
44406059|NCT00863772|79413722|FG000|Overall Study|Randomized but not Treated|1|||
44523355|NCT01751984|79531663|FG000|Overall Study|Adverse Event|5|||
44523356|NCT01751984|79531664|FG001|Overall Study|Adverse Event|3|||
44523357|NCT01751984|79531663|FG000|Overall Study|Withdrawal by Subject|0|||
44253206|NCT01207492|79093284|FG000|Overall Study|Progressive disease|3|||
44406060|NCT00863772|79413723|FG001|Overall Study|Randomized but not Treated|0|||
44406061|NCT00863772|79413724|FG002|Overall Study|Randomized but not Treated|0|||
44523358|NCT01751984|79531664|FG001|Overall Study|Withdrawal by Subject|1|||
44523359|NCT01751984|79531663|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
44523360|NCT01751984|79531664|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
44523361|NCT03330236|79531672|FG000|Overall Study|Death|2|||
44523362|NCT03330236|79531673|FG001|Overall Study|Death|1|||
44523363|NCT03330236|79531672|FG000|Overall Study|Withdrawal by Subject|2|||
44523364|NCT03330236|79531673|FG001|Overall Study|Withdrawal by Subject|4|||
44523365|NCT03330236|79531672|FG000|Overall Study|Lost to Follow-up|0|||
44523366|NCT03330236|79531673|FG001|Overall Study|Lost to Follow-up|2|||
44523367|NCT03330236|79531672|FG000|Overall Study|Physician Decision|2|||
44523368|NCT03330236|79531673|FG001|Overall Study|Physician Decision|0|||
44523369|NCT03330236|79531672|FG000|Overall Study|Protocol Violation|4|||
44523370|NCT03330236|79531673|FG001|Overall Study|Protocol Violation|3|||
44523371|NCT03330236|79531672|FG000|Overall Study|SedLine malfunction/blinding|19|||
44523372|NCT03330236|79531673|FG001|Overall Study|SedLine malfunction/blinding|14|||
44523373|NCT03330236|79531672|FG000|Overall Study|Volatile anesthetics used|11|||
44523374|NCT03330236|79531673|FG001|Overall Study|Volatile anesthetics used|8|||
44523375|NCT03330236|79531672|FG000|Overall Study|Surgery aborted/converted to open|60|||
44523376|NCT03330236|79531673|FG001|Overall Study|Surgery aborted/converted to open|52|||
44523377|NCT03330002|79531679|FG000|Overall Study|Lost to Follow-up|15|||
44523378|NCT03330002|79531679|FG000|Overall Study|Death|7|||
44523379|NCT02948582|79531683|FG000|Washout Period 1|Adverse Event|0|||
44523380|NCT02948582|79531684|FG001|Washout Period 1|Adverse Event|2|||
44523381|NCT02948582|79531685|FG002|Washout Period 1|Adverse Event|0|||
44523382|NCT02948582|79531686|FG003|Washout Period 1|Adverse Event|0|||
44523383|NCT02948582|79531687|FG004|Washout Period 1|Adverse Event|0|||
44523384|NCT02948582|79531688|FG005|Washout Period 1|Adverse Event|0|||
44253207|NCT01207492|79093284|FG000|Overall Study|Toxicity|1|||
44406062|NCT00502801|79413732|FG000|Treatment Period|Withdrawal by Subject|3|||
44523385|NCT02948582|79531683|FG000|Washout Period 1|Protocol Violation|0|||
44523386|NCT02948582|79531684|FG001|Washout Period 1|Protocol Violation|0|||
44523387|NCT02948582|79531685|FG002|Washout Period 1|Protocol Violation|0|||
44523388|NCT02948582|79531686|FG003|Washout Period 1|Protocol Violation|0|||
44523389|NCT02948582|79531687|FG004|Washout Period 1|Protocol Violation|0|||
44523390|NCT02948582|79531688|FG005|Washout Period 1|Protocol Violation|1|||
44523391|NCT02948582|79531683|FG000|Washout Period 2|Adverse Event|0|||
44523392|NCT02948582|79531684|FG001|Washout Period 2|Adverse Event|1|||
44253208|NCT01167140|79093288|FG000|Overall Study|Withdrawal by Subject|1|||
44253209|NCT00402298|79093294|FG000|Overall Study|Withdrawal by Subject|1|||
44523393|NCT02948582|79531685|FG002|Washout Period 2|Adverse Event|0|||
44523394|NCT02948582|79531686|FG003|Washout Period 2|Adverse Event|0|||
44406063|NCT00502801|79413732|FG000|Treatment Period|Adverse Event|7|||
44406064|NCT00502801|79413732|FG000|Treatment Period|Death|14|||
44406065|NCT00502801|79413732|FG000|Treatment Period|OTHER|30|||
44406066|NCT00502801|79413732|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
44406067|NCT00502801|79413732|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
44406068|NCT00502801|79413732|FG000|End of Therapy to Test of Cure|Death|3|||
44406069|NCT00502801|79413732|FG000|End of Therapy to Test of Cure|OTHER|2|||
44406070|NCT00824265|79413738|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
44406071|NCT00824265|79413739|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
44406072|NCT00824265|79413738|FG000|Treatment Phase|Protocol Violation|1|||
44406073|NCT00824265|79413739|FG001|Treatment Phase|Protocol Violation|0|||
44406074|NCT00824265|79413738|FG000|Treatment Phase|Lost to Follow-up|1|||
44406075|NCT00824265|79413739|FG001|Treatment Phase|Lost to Follow-up|1|||
44406076|NCT00824265|79413738|FG000|Treatment Phase|Physician Decision|6|||
44406077|NCT00824265|79413739|FG001|Treatment Phase|Physician Decision|12|||
44406078|NCT00824265|79413738|FG000|Treatment Phase|Withdrawal by Subject|6|||
44406079|NCT00824265|79413739|FG001|Treatment Phase|Withdrawal by Subject|15|||
44523395|NCT02948582|79531687|FG004|Washout Period 2|Adverse Event|0|||
44523396|NCT02948582|79531688|FG005|Washout Period 2|Adverse Event|0|||
44523397|NCT02948582|79531683|FG000|Washout Period 2|personal reasons|0|||
44147948|NCT04097028|78937373|FG000|Overall Study|Disease Progression prior to Surgery|2|||
44406080|NCT00824265|79413738|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
44406081|NCT00824265|79413739|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
44406082|NCT00824265|79413738|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
44406083|NCT00824265|79413739|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
44406084|NCT00855894|79413749|FG000|Overall Study|Death|31|||
44406085|NCT00855894|79413749|FG000|Overall Study|Patient's decision|1|||
44406086|NCT00855894|79413749|FG000|Overall Study|Disease progression|1|||
44406087|NCT00855816|79413755|FG000|Overall Study|Withdrawal by Subject|22|||
44406088|NCT00855816|79413756|FG001|Overall Study|Withdrawal by Subject|15|||
44406089|NCT00855816|79413755|FG000|Overall Study|Lost to Follow-up|3|||
44406090|NCT00855816|79413756|FG001|Overall Study|Lost to Follow-up|5|||
44406091|NCT00855816|79413755|FG000|Overall Study|Death|1|||
44406092|NCT00855816|79413756|FG001|Overall Study|Death|0|||
44406093|NCT00855816|79413755|FG000|Overall Study|Became ineligible|0|||
44406094|NCT00855816|79413756|FG001|Overall Study|Became ineligible|1|||
44406095|NCT00855738|79413762|FG000|Overall Study|Lost to Follow-up|2|||
44406096|NCT00855738|79413762|FG000|Overall Study|Adverse Event|1|||
44406097|NCT00855738|79413762|FG000|Overall Study|Subject Defaulted|1|||
44406098|NCT00855738|79413762|FG000|Overall Study|Death|1|||
44406099|NCT05093790|79413794|FG000|Overall Study|Failure to meet continuation criteria|0|||
44406100|NCT05093790|79413795|FG001|Overall Study|Failure to meet continuation criteria|0|||
44406101|NCT05093790|79413796|FG002|Overall Study|Failure to meet continuation criteria|1|||
44406102|NCT05093790|79413797|FG003|Overall Study|Failure to meet continuation criteria|0|||
44406103|NCT05093790|79413794|FG000|Overall Study|Adverse Event|1|||
44406104|NCT05093790|79413795|FG001|Overall Study|Adverse Event|0|||
44406105|NCT05093790|79413796|FG002|Overall Study|Adverse Event|0|||
44406106|NCT05093790|79413797|FG003|Overall Study|Adverse Event|0|||
44406107|NCT04739306|79413838|FG000|Main Study Period|Adverse Event|6|||
44406108|NCT04739306|79413839|FG001|Main Study Period|Adverse Event|7|||
44406109|NCT04739306|79413838|FG000|Main Study Period|Lost to Follow-up|4|||
44406110|NCT04739306|79413839|FG001|Main Study Period|Lost to Follow-up|6|||
44406111|NCT04739306|79413838|FG000|Main Study Period|Physician Decision|1|||
44406112|NCT04739306|79413839|FG001|Main Study Period|Physician Decision|1|||
44406113|NCT04739306|79413838|FG000|Main Study Period|Withdrawal by Subject|8|||
44406114|NCT04739306|79413839|FG001|Main Study Period|Withdrawal by Subject|6|||
44406115|NCT04739306|79413838|FG000|Main Study Period|Protocol Violation|0|||
44406116|NCT04739306|79413839|FG001|Main Study Period|Protocol Violation|1|||
44406117|NCT04739306|79413838|FG000|Main Study Period|War in Ukraine|1|||
44406118|NCT04739306|79413839|FG001|Main Study Period|War in Ukraine|1|||
44406119|NCT04442490|79413852|FG000|Overall Study|Withdrawal by Subject|18|||
44406120|NCT04442490|79413853|FG001|Overall Study|Withdrawal by Subject|10|||
44406121|NCT04442490|79413852|FG000|Overall Study|Lost to Follow-up|7|||
44406122|NCT04442490|79413853|FG001|Overall Study|Lost to Follow-up|7|||
44406123|NCT04442490|79413852|FG000|Overall Study|Adverse Event|2|||
44406124|NCT04442490|79413853|FG001|Overall Study|Adverse Event|6|||
44406125|NCT04442490|79413852|FG000|Overall Study|Noncompliance|3|||
44523398|NCT02948582|79531684|FG001|Washout Period 2|personal reasons|0|||
44406126|NCT04442490|79413853|FG001|Overall Study|Noncompliance|1|||
44406127|NCT04442490|79413852|FG000|Overall Study|Physician Decision|2|||
44406128|NCT04442490|79413853|FG001|Overall Study|Physician Decision|1|||
44406129|NCT04442490|79413852|FG000|Overall Study|Reason not Specified|2|||
44406130|NCT04442490|79413853|FG001|Overall Study|Reason not Specified|1|||
44406131|NCT04442490|79413852|FG000|Overall Study|Randomized but not Treated|3|||
44523399|NCT02948582|79531685|FG002|Washout Period 2|personal reasons|0|||
44406132|NCT04442490|79413853|FG001|Overall Study|Randomized but not Treated|3|||
44406133|NCT04375761|79413861|FG000|Overall Study|Death|1|||
44406134|NCT04375761|79413862|FG001|Overall Study|Death|2|||
44406135|NCT04375761|79413861|FG000|Overall Study|Lost to Follow-up|203|||
44406136|NCT04375761|79413862|FG001|Overall Study|Lost to Follow-up|380|||
44406137|NCT04375761|79413861|FG000|Overall Study|Withdrawal by Subject|47|||
44406138|NCT04375761|79413862|FG001|Overall Study|Withdrawal by Subject|98|||
44406139|NCT04375761|79413861|FG000|Overall Study|Noncompliance with study procedure|121|||
44406140|NCT04375761|79413862|FG001|Overall Study|Noncompliance with study procedure|251|||
44406141|NCT04375761|79413861|FG000|Overall Study|Reimbursement not enough|1|||
44406142|NCT04375761|79413862|FG001|Overall Study|Reimbursement not enough|2|||
44406143|NCT04375761|79413861|FG000|Overall Study|Unforeseen family circumstances|1|||
44406144|NCT04375761|79413862|FG001|Overall Study|Unforeseen family circumstances|3|||
44406145|NCT04375761|79413861|FG000|Overall Study|Test too painful|1|||
44406146|NCT04375761|79413862|FG001|Overall Study|Test too painful|1|||
44406147|NCT04375761|79413861|FG000|Overall Study|Moved|0|||
44406148|NCT04375761|79413862|FG001|Overall Study|Moved|2|||
44406149|NCT04375761|79413861|FG000|Overall Study|Nonresponsive|0|||
44406150|NCT04375761|79413862|FG001|Overall Study|Nonresponsive|5|||
44406151|NCT04219189|79413871|FG000|Overall Study|Withdrawal by Subject|1|||
44406152|NCT04219189|79413872|FG001|Overall Study|Withdrawal by Subject|2|||
44406153|NCT04219189|79413871|FG000|Overall Study|Protocol Violation|0|||
44406154|NCT04219189|79413872|FG001|Overall Study|Protocol Violation|1|||
44406155|NCT04219189|79413871|FG000|Overall Study|Lost to Follow-up|0|||
44406156|NCT04219189|79413872|FG001|Overall Study|Lost to Follow-up|1|||
44406157|NCT04219189|79413871|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
44406158|NCT04219189|79413872|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
44406159|NCT04209725|79413880|FG000|Overall Study|Adverse Event|1|||
44406160|NCT04164901|79413886|FG000|Overall Study|Withdrawal by Subject|4|||
44406161|NCT04164901|79413887|FG001|Overall Study|Withdrawal by Subject|4|||
44406162|NCT03739762|79413905|FG000|Overall Study|Lost to Follow-up|1|||
44523400|NCT02948582|79531686|FG003|Washout Period 2|personal reasons|1|||
44523401|NCT02948582|79531687|FG004|Washout Period 2|personal reasons|0|||
44523402|NCT02948582|79531688|FG005|Washout Period 2|personal reasons|0|||
44523403|NCT02948582|79531683|FG000|Washout Period 4|Adverse Event|1|||
44406163|NCT03739762|79413906|FG001|Overall Study|Lost to Follow-up|1|||
44406164|NCT03739762|79413905|FG000|Overall Study|Withdrawal by Subject|2|||
44523404|NCT02948582|79531684|FG001|Washout Period 4|Adverse Event|0|||
44523405|NCT02948582|79531685|FG002|Washout Period 4|Adverse Event|1|||
44523406|NCT02948582|79531686|FG003|Washout Period 4|Adverse Event|0|||
44523407|NCT02948582|79531687|FG004|Washout Period 4|Adverse Event|0|||
44523408|NCT02948582|79531688|FG005|Washout Period 4|Adverse Event|0|||
44406165|NCT03739762|79413906|FG001|Overall Study|Withdrawal by Subject|6|||
44406166|NCT03725605|79413912|FG000|Overall Study|Unsuccessful TIL expansion|2|||
44406167|NCT03650387|79413916|FG000|Overall Study|Withdrawal by Subject|13|||
44406168|NCT03650387|79413916|FG000|Overall Study|Lost to Follow-up|12|||
44406169|NCT03650387|79413916|FG000|Overall Study|Adverse Event (Not related)|1|||
44406170|NCT03650387|79413916|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
44406171|NCT03536754|79413942|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
44406172|NCT03536754|79413943|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
44523409|NCT03756285|79531704|FG000|Overall Study|Lost to Follow-up|0|||
44523410|NCT03756285|79531705|FG001|Overall Study|Lost to Follow-up|1|||
44523411|NCT03756285|79531704|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
44523412|NCT03756285|79531705|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
44523413|NCT03756285|79531704|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
44523414|NCT03756285|79531705|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
44523415|NCT02825992|79531712|FG000|Overall Study|Withdrawal by Subject|4|||
44523416|NCT02825992|79531712|FG000|Overall Study|Lost to Follow-up|2|||
44523417|NCT02825992|79531712|FG000|Overall Study|Procedure terminated|2|||
44523418|NCT01339000|79531724|FG000|Overall Study|study closed due to lack of drug supply|1|||
44253210|NCT00402298|79093295|FG001|Overall Study|Withdrawal by Subject|0|||
44253211|NCT04362761|79093481|FG000|Part A (48 Weeks)|Adverse Event|2|||
44406173|NCT03536754|79413944|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
44406174|NCT03536754|79413945|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
44406175|NCT03536754|79413946|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
44406176|NCT03536754|79413942|FG000|Open Label Extension|Other|0|||
44406177|NCT03536754|79413943|FG001|Open Label Extension|Other|0|||
44406178|NCT03536754|79413944|FG002|Open Label Extension|Other|0|||
44406179|NCT03536754|79413945|FG003|Open Label Extension|Other|0|||
44406180|NCT03536754|79413946|FG004|Open Label Extension|Other|1|||
44406181|NCT03436862|79413962|FG000|Overall Study|Adverse Event|4|||
44523419|NCT01339000|79531725|FG001|Overall Study|study closed due to lack of drug supply|0|||
44253212|NCT04362761|79093481|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
44253213|NCT04362761|79093481|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
44406182|NCT03436862|79413962|FG000|Overall Study|Progressive Disease|2|||
44406183|NCT03164616|79413979|FG000|Overall Study|Death|250|||
44406184|NCT03164616|79413980|FG001|Overall Study|Death|264|||
44406185|NCT03164616|79413981|FG002|Overall Study|Death|279|||
44406186|NCT03164616|79413979|FG000|Overall Study|Lost to Follow-up|2|||
44406187|NCT03164616|79413980|FG001|Overall Study|Lost to Follow-up|2|||
44406188|NCT03164616|79413981|FG002|Overall Study|Lost to Follow-up|2|||
44406189|NCT03164616|79413979|FG000|Overall Study|Withdrawal by Subject|6|||
44406190|NCT03164616|79413980|FG001|Overall Study|Withdrawal by Subject|7|||
44406191|NCT03164616|79413981|FG002|Overall Study|Withdrawal by Subject|16|||
44406192|NCT02887248|79414025|FG000|Overall Study|Withdrawal by Subject|1|||
44406193|NCT02887248|79414025|FG000|Overall Study|Adverse Event|1|||
44406194|NCT02887248|79414025|FG000|Overall Study|Progressive Disease|1|||
44406195|NCT02859064|79414029|FG000|Overall Study|Progressive Disease|3|||
44406196|NCT02859064|79414029|FG000|Overall Study|Physician Decision|1|||
44406197|NCT02859064|79414029|FG000|Overall Study|Withdrawal by Subject|1|||
44406198|NCT02859064|79414029|FG000|Overall Study|Death|1|||
44406199|NCT02843074|79414033|FG000|Overall Study|Withdrawal by Subject|5|||
44406200|NCT02843074|79414033|FG000|Overall Study|Progressive disease|1|||
44406201|NCT02843074|79414033|FG000|Overall Study|Physician Decision|1|||
44406202|NCT02843074|79414033|FG000|Overall Study|Lost to Follow-up|1|||
44406203|NCT02843074|79414033|FG000|Overall Study|Death|9|||
44406204|NCT02795156|79414041|FG000|Overall Study|Progressive Disease|22|||
44406205|NCT02795156|79414042|FG001|Overall Study|Progressive Disease|7|||
44406206|NCT02795156|79414043|FG002|Overall Study|Progressive Disease|34|||
44406207|NCT02795156|79414044|FG003|Overall Study|Progressive Disease|7|||
44406208|NCT02795156|79414041|FG000|Overall Study|Adverse Event|13|||
44406209|NCT02795156|79414042|FG001|Overall Study|Adverse Event|2|||
44406210|NCT02795156|79414043|FG002|Overall Study|Adverse Event|3|||
44406211|NCT02795156|79414044|FG003|Overall Study|Adverse Event|2|||
44523420|NCT03755661|79531736|FG000|Overall Study|Lost to Follow-up|1|||
44523421|NCT03755661|79531737|FG001|Overall Study|Lost to Follow-up|0|||
44523422|NCT03752151|79531743|FG000|Overall Study|Withdrawal by Subject|1|||
44523423|NCT03752151|79531743|FG000|Overall Study|Protocol Violation|1|||
44523424|NCT01336634|79531751|FG000|Overall Study|Study closed/terminated|5|||
44523425|NCT01336634|79531752|FG001|Overall Study|Study closed/terminated|6|||
44523426|NCT01336634|79531753|FG002|Overall Study|Study closed/terminated|6|||
44523427|NCT01336634|79531751|FG000|Overall Study|Lost to Follow-up|2|||
44523428|NCT01336634|79531752|FG001|Overall Study|Lost to Follow-up|1|||
44523429|NCT01336634|79531753|FG002|Overall Study|Lost to Follow-up|1|||
44523430|NCT01336634|79531751|FG000|Overall Study|Physician Decision|1|||
44523431|NCT01336634|79531752|FG001|Overall Study|Physician Decision|1|||
44523432|NCT01336634|79531753|FG002|Overall Study|Physician Decision|0|||
44523433|NCT01336634|79531751|FG000|Overall Study|Withdrawal by Subject|6|||
44523434|NCT01336634|79531752|FG001|Overall Study|Withdrawal by Subject|0|||
44523435|NCT01336634|79531753|FG002|Overall Study|Withdrawal by Subject|2|||
44523436|NCT02947100|79531768|FG000|Overall Study|study terminated early|3|||
44523437|NCT02947100|79531768|FG000|Overall Study|did not meet inclusion criteria|1|||
44523438|NCT03329846|79531774|FG000|Overall Study|Disease progression|4|||
44523439|NCT03329846|79531775|FG001|Overall Study|Disease progression|6|||
44523440|NCT03329846|79531774|FG000|Overall Study|Study drug toxicity|1|||
44523441|NCT03329846|79531775|FG001|Overall Study|Study drug toxicity|0|||
44523442|NCT03329846|79531774|FG000|Overall Study|Participant request to discontinue treatment|0|||
44253214|NCT04362761|79093481|FG000|Part A (48 Weeks)|Other|5|||
44253215|NCT04362761|79093481|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
44253216|NCT04362761|79093481|FG000|Part B (86 Weeks)|Other|4|||
44253217|NCT00632749|79093677|FG000|Overall Study|Progressive disease|3|||
44253218|NCT00632749|79093678|FG001|Overall Study|Progressive disease|2|||
44253219|NCT00632749|79093679|FG002|Overall Study|Progressive disease|2|||
44253220|NCT00632749|79093680|FG003|Overall Study|Progressive disease|2|||
44253221|NCT00632749|79093681|FG004|Overall Study|Progressive disease|4|||
44253222|NCT00632749|79093682|FG005|Overall Study|Progressive disease|4|||
44406212|NCT02795156|79414041|FG000|Overall Study|Death|1|||
44406213|NCT02795156|79414042|FG001|Overall Study|Death|1|||
44406214|NCT02795156|79414043|FG002|Overall Study|Death|1|||
44523443|NCT03329846|79531775|FG001|Overall Study|Participant request to discontinue treatment|1|||
44523444|NCT03329846|79531774|FG000|Overall Study|Participant withdrew consent|1|||
44523445|NCT03329846|79531775|FG001|Overall Study|Participant withdrew consent|0|||
44523446|NCT03329846|79531774|FG000|Overall Study|Other reasons|2|||
44523447|NCT03329846|79531775|FG001|Overall Study|Other reasons|2|||
44253223|NCT00632749|79093683|FG006|Overall Study|Progressive disease|3|||
44253224|NCT00632749|79093684|FG007|Overall Study|Progressive disease|2|||
44253225|NCT00632749|79093685|FG008|Overall Study|Progressive disease|3|||
44406215|NCT02795156|79414044|FG003|Overall Study|Death|0|||
44406216|NCT02795156|79414041|FG000|Overall Study|Physician Decision|1|||
44406217|NCT02795156|79414042|FG001|Overall Study|Physician Decision|0|||
44406218|NCT02795156|79414043|FG002|Overall Study|Physician Decision|1|||
44406219|NCT02795156|79414044|FG003|Overall Study|Physician Decision|0|||
44406220|NCT02795156|79414041|FG000|Overall Study|Withdrawal by Subject|2|||
44253226|NCT00632749|79093686|FG009|Overall Study|Progressive disease|2|||
44253227|NCT00632749|79093687|FG010|Overall Study|Progressive disease|4|||
44253228|NCT00632749|79093688|FG011|Overall Study|Progressive disease|3|||
44253229|NCT00632749|79093689|FG012|Overall Study|Progressive disease|2|||
44253230|NCT00632749|79093690|FG013|Overall Study|Progressive disease|4|||
44253231|NCT00632749|79093677|FG000|Overall Study|Other Adverse event|1|||
44253232|NCT00632749|79093678|FG001|Overall Study|Other Adverse event|1|||
44253233|NCT00632749|79093679|FG002|Overall Study|Other Adverse event|1|||
44253234|NCT00632749|79093680|FG003|Overall Study|Other Adverse event|1|||
44253235|NCT00632749|79093681|FG004|Overall Study|Other Adverse event|2|||
44253236|NCT00632749|79093682|FG005|Overall Study|Other Adverse event|4|||
44253237|NCT00632749|79093683|FG006|Overall Study|Other Adverse event|1|||
44253238|NCT00632749|79093684|FG007|Overall Study|Other Adverse event|2|||
44253239|NCT00632749|79093685|FG008|Overall Study|Other Adverse event|2|||
44253240|NCT00632749|79093686|FG009|Overall Study|Other Adverse event|0|||
44523448|NCT03325010|79531783|FG000|Overall Study|Adverse Event|3|||
44523449|NCT03325010|79531784|FG001|Overall Study|Adverse Event|8|||
44523450|NCT03325010|79531783|FG000|Overall Study|Protocol Violation|1|||
44523451|NCT03325010|79531784|FG001|Overall Study|Protocol Violation|8|||
44253241|NCT00632749|79093687|FG010|Overall Study|Other Adverse event|1|||
44406221|NCT02795156|79414042|FG001|Overall Study|Withdrawal by Subject|0|||
44406222|NCT02795156|79414043|FG002|Overall Study|Withdrawal by Subject|3|||
44406223|NCT02795156|79414044|FG003|Overall Study|Withdrawal by Subject|0|||
44406224|NCT02636582|79414073|FG000|Overall Study|Surgical Pathology|1|||
44406225|NCT02636582|79414074|FG001|Overall Study|Surgical Pathology|0|||
44406226|NCT02318784|79414148|FG000|Overall Study|Adverse Event|13|||
44406227|NCT02318784|79414148|FG000|Overall Study|Death|2|||
44406228|NCT02318784|79414148|FG000|Overall Study|Progressive Disease|37|||
44406229|NCT02318784|79414148|FG000|Overall Study|Withdrawal by Subject|10|||
44406230|NCT02195011|79414154|FG000|Overall Study|Adverse Event|4|||
44406231|NCT02195011|79414155|FG001|Overall Study|Adverse Event|0|||
44406232|NCT02195011|79414154|FG000|Overall Study|Progressive Disease|18|||
44406233|NCT02195011|79414155|FG001|Overall Study|Progressive Disease|1|||
44406234|NCT02195011|79414154|FG000|Overall Study|Withdrawal by Subject|3|||
44406235|NCT02195011|79414155|FG001|Overall Study|Withdrawal by Subject|0|||
44406236|NCT02087501|79414161|FG000|Overall Study|Death|7|||
44406237|NCT02087501|79414161|FG000|Overall Study|Open repair of aneurysm|1|||
44406238|NCT02087501|79414161|FG000|Overall Study|Lost to Follow-up|2|||
44406239|NCT01897454|79414167|FG000|Overall Study|Withdrawal by Subject|1|||
44406240|NCT01856023|79414173|FG000|Overall Study|Death|1|||
44406241|NCT01856023|79414174|FG001|Overall Study|Death|2|||
44406242|NCT01856023|79414173|FG000|Overall Study|Adverse Event|2|||
44406243|NCT01856023|79414174|FG001|Overall Study|Adverse Event|1|||
44406244|NCT01856023|79414173|FG000|Overall Study|Lack of Efficacy|5|||
44406245|NCT01856023|79414174|FG001|Overall Study|Lack of Efficacy|5|||
44406246|NCT01856023|79414173|FG000|Overall Study|non compliance, study closure|1|||
44406247|NCT01856023|79414174|FG001|Overall Study|non compliance, study closure|3|||
44406248|NCT01856023|79414173|FG000|Overall Study|Withdrawal by Subject|1|||
44406249|NCT01856023|79414174|FG001|Overall Study|Withdrawal by Subject|1|||
44406250|NCT01364597|79414186|FG000|Overall Study|Adverse Event|4|||
44406251|NCT01364597|79414187|FG001|Overall Study|Adverse Event|5|||
44406252|NCT01364597|79414188|FG002|Overall Study|Adverse Event|16|||
44406253|NCT01364597|79414189|FG003|Overall Study|Adverse Event|7|||
44406254|NCT01364597|79414186|FG000|Overall Study|Lack of Efficacy|4|||
44406255|NCT01364597|79414187|FG001|Overall Study|Lack of Efficacy|4|||
44523452|NCT03325010|79531783|FG000|Overall Study|Withdrawal by Subject|1|||
44523453|NCT03325010|79531784|FG001|Overall Study|Withdrawal by Subject|3|||
44523454|NCT03325010|79531783|FG000|Overall Study|Lost to Follow-up|1|||
44523455|NCT03325010|79531784|FG001|Overall Study|Lost to Follow-up|0|||
44523456|NCT03325010|79531783|FG000|Overall Study|Physician Decision|1|||
44523457|NCT03325010|79531784|FG001|Overall Study|Physician Decision|1|||
44523458|NCT03325010|79531783|FG000|Overall Study|Lack of Efficacy|2|||
44523459|NCT03325010|79531784|FG001|Overall Study|Lack of Efficacy|0|||
44523460|NCT02824432|79531792|FG000|Overall Study|Major Protocol Deviation|1|||
44253242|NCT00632749|79093688|FG011|Overall Study|Other Adverse event|0|||
44253243|NCT00632749|79093689|FG012|Overall Study|Other Adverse event|1|||
44253244|NCT00632749|79093690|FG013|Overall Study|Other Adverse event|0|||
44253245|NCT00632749|79093677|FG000|Overall Study|Refuse to continue medication|0|||
44406256|NCT01364597|79414188|FG002|Overall Study|Lack of Efficacy|23|||
44523461|NCT02824432|79531793|FG001|Overall Study|Major Protocol Deviation|0|||
44253246|NCT00632749|79093678|FG001|Overall Study|Refuse to continue medication|0|||
44253247|NCT00632749|79093679|FG002|Overall Study|Refuse to continue medication|0|||
44253248|NCT00632749|79093680|FG003|Overall Study|Refuse to continue medication|1|||
44406257|NCT01364597|79414189|FG003|Overall Study|Lack of Efficacy|8|||
44406258|NCT01364597|79414186|FG000|Overall Study|Protocol Violation|0|||
44406259|NCT01364597|79414187|FG001|Overall Study|Protocol Violation|0|||
44406260|NCT01364597|79414188|FG002|Overall Study|Protocol Violation|2|||
44406261|NCT01364597|79414189|FG003|Overall Study|Protocol Violation|0|||
44406262|NCT01364597|79414186|FG000|Overall Study|Lost to Follow-up|0|||
44523462|NCT02823964|79531799|FG000|Overall Study|Adverse Event|2|||
44523463|NCT02823964|79531799|FG000|Overall Study|Physician Decision|1|||
44523464|NCT02823964|79531799|FG000|Overall Study|Lack of Efficacy|1|||
44523465|NCT02823964|79531799|FG000|Overall Study|Withdrawal by Subject|1|||
44523466|NCT01338610|79531806|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
44523467|NCT01338610|79531807|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
44523468|NCT01338610|79531808|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
44523469|NCT01338610|79531806|FG000|Overall Study|Protocol Violation|1|||
44523470|NCT01338610|79531807|FG001|Overall Study|Protocol Violation|0|||
44523471|NCT01338610|79531808|FG002|Overall Study|Protocol Violation|1|||
44523472|NCT01338610|79531806|FG000|Overall Study|Adverse Event|3|||
44523473|NCT01338610|79531807|FG001|Overall Study|Adverse Event|0|||
44523474|NCT01338610|79531808|FG002|Overall Study|Adverse Event|0|||
44523475|NCT01355302|79531815|FG000|Phase 1b|Death|4|||
44406263|NCT01364597|79414187|FG001|Overall Study|Lost to Follow-up|0|||
44406264|NCT01364597|79414188|FG002|Overall Study|Lost to Follow-up|5|||
44406265|NCT01364597|79414189|FG003|Overall Study|Lost to Follow-up|3|||
44406266|NCT01364597|79414186|FG000|Overall Study|Withdrawal by Subject|4|||
44406267|NCT01364597|79414187|FG001|Overall Study|Withdrawal by Subject|1|||
44406268|NCT01364597|79414188|FG002|Overall Study|Withdrawal by Subject|18|||
44406269|NCT01364597|79414189|FG003|Overall Study|Withdrawal by Subject|6|||
44406270|NCT01364597|79414186|FG000|Overall Study|Non compliance|1|||
44406271|NCT01364597|79414187|FG001|Overall Study|Non compliance|0|||
44406272|NCT01364597|79414188|FG002|Overall Study|Non compliance|1|||
44406273|NCT01364597|79414189|FG003|Overall Study|Non compliance|0|||
44406274|NCT01364597|79414186|FG000|Overall Study|Lack of compliance|1|||
44406275|NCT01364597|79414187|FG001|Overall Study|Lack of compliance|0|||
44406276|NCT01364597|79414188|FG002|Overall Study|Lack of compliance|0|||
44406277|NCT01364597|79414189|FG003|Overall Study|Lack of compliance|0|||
44406278|NCT01364597|79414186|FG000|Overall Study|End of treatment epilepsy|1|||
44406279|NCT01364597|79414187|FG001|Overall Study|End of treatment epilepsy|0|||
44406280|NCT01364597|79414188|FG002|Overall Study|End of treatment epilepsy|0|||
44406281|NCT01364597|79414189|FG003|Overall Study|End of treatment epilepsy|0|||
44406282|NCT01364597|79414186|FG000|Overall Study|No Seizures|1|||
44406283|NCT01364597|79414187|FG001|Overall Study|No Seizures|0|||
44406284|NCT01364597|79414188|FG002|Overall Study|No Seizures|0|||
44406285|NCT01364597|79414189|FG003|Overall Study|No Seizures|0|||
44406286|NCT01364597|79414186|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
44406287|NCT01364597|79414187|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
44406288|NCT01364597|79414188|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
44406289|NCT01364597|79414189|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
44406290|NCT01364597|79414186|FG000|Overall Study|Cure|1|||
44406291|NCT01364597|79414187|FG001|Overall Study|Cure|0|||
44406292|NCT01364597|79414188|FG002|Overall Study|Cure|0|||
44406293|NCT01364597|79414189|FG003|Overall Study|Cure|0|||
44406294|NCT01364597|79414186|FG000|Overall Study|Patient was moving|0|||
44406295|NCT01364597|79414187|FG001|Overall Study|Patient was moving|1|||
44406296|NCT01364597|79414188|FG002|Overall Study|Patient was moving|0|||
44406297|NCT01364597|79414189|FG003|Overall Study|Patient was moving|0|||
44406298|NCT01364597|79414186|FG000|Overall Study|Seizures resolved|0|||
44406299|NCT01364597|79414187|FG001|Overall Study|Seizures resolved|0|||
44406300|NCT01364597|79414188|FG002|Overall Study|Seizures resolved|1|||
44406301|NCT01364597|79414189|FG003|Overall Study|Seizures resolved|0|||
44406302|NCT01364597|79414186|FG000|Overall Study|Patient became seizure-free after surgery|0|||
44406303|NCT01364597|79414187|FG001|Overall Study|Patient became seizure-free after surgery|0|||
44406304|NCT01364597|79414188|FG002|Overall Study|Patient became seizure-free after surgery|1|||
44406305|NCT01364597|79414189|FG003|Overall Study|Patient became seizure-free after surgery|0|||
44406306|NCT01364597|79414186|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
44406307|NCT01364597|79414187|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
44406308|NCT01364597|79414188|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
44406309|NCT01364597|79414189|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
44406310|NCT01364597|79414186|FG000|Overall Study|Patient cured from Epilepsy|0|||
44406311|NCT01364597|79414187|FG001|Overall Study|Patient cured from Epilepsy|0|||
44523476|NCT01355302|79531816|FG001|Phase 1b|Death|0|||
44523477|NCT01355302|79531817|FG002|Phase 1b|Death|0|||
44523478|NCT01355302|79531815|FG000|Phase 1b|Study terminated by sponsor|2|||
44523479|NCT01355302|79531816|FG001|Phase 1b|Study terminated by sponsor|0|||
44523480|NCT01355302|79531817|FG002|Phase 1b|Study terminated by sponsor|0|||
44406312|NCT01364597|79414188|FG002|Overall Study|Patient cured from Epilepsy|1|||
44406313|NCT01364597|79414189|FG003|Overall Study|Patient cured from Epilepsy|0|||
44406314|NCT01364597|79414186|FG000|Overall Study|Investigator decision|0|||
44406315|NCT01364597|79414187|FG001|Overall Study|Investigator decision|0|||
44406316|NCT01364597|79414188|FG002|Overall Study|Investigator decision|1|||
44406317|NCT01364597|79414189|FG003|Overall Study|Investigator decision|0|||
44406318|NCT01364597|79414186|FG000|Overall Study|Sponsor recommended discontinuation|0|||
44523481|NCT01355068|79531825|FG000|First Intervention Period|Adverse Event|0|||
44406319|NCT01364597|79414187|FG001|Overall Study|Sponsor recommended discontinuation|0|||
44406320|NCT01364597|79414188|FG002|Overall Study|Sponsor recommended discontinuation|0|||
44253249|NCT00632749|79093681|FG004|Overall Study|Refuse to continue medication|0|||
44253250|NCT00632749|79093682|FG005|Overall Study|Refuse to continue medication|0|||
44406321|NCT01364597|79414189|FG003|Overall Study|Sponsor recommended discontinuation|1|||
44406322|NCT01364597|79414186|FG000|Overall Study|Parents went abroad with the patient|0|||
44406323|NCT01364597|79414187|FG001|Overall Study|Parents went abroad with the patient|0|||
44406324|NCT01364597|79414188|FG002|Overall Study|Parents went abroad with the patient|1|||
44406325|NCT01364597|79414189|FG003|Overall Study|Parents went abroad with the patient|0|||
44406326|NCT01364597|79414186|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
44406327|NCT01364597|79414187|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
44406328|NCT01364597|79414188|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
44406329|NCT01364597|79414189|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
44406330|NCT01364597|79414186|FG000|Overall Study|BRV administration dropout|0|||
44406331|NCT01364597|79414187|FG001|Overall Study|BRV administration dropout|0|||
44406332|NCT01364597|79414188|FG002|Overall Study|BRV administration dropout|1|||
44406333|NCT01364597|79414189|FG003|Overall Study|BRV administration dropout|0|||
44406334|NCT01364597|79414186|FG000|Overall Study|Dropout|0|||
44406335|NCT01364597|79414187|FG001|Overall Study|Dropout|0|||
44406336|NCT01364597|79414188|FG002|Overall Study|Dropout|3|||
44406337|NCT01364597|79414189|FG003|Overall Study|Dropout|1|||
44406338|NCT01364597|79414186|FG000|Overall Study|Unreliable subject|0|||
44406339|NCT01364597|79414187|FG001|Overall Study|Unreliable subject|0|||
44406340|NCT01364597|79414188|FG002|Overall Study|Unreliable subject|0|||
44406341|NCT01364597|79414189|FG003|Overall Study|Unreliable subject|1|||
44406342|NCT01364597|79414186|FG000|Overall Study|Other|0|||
44406343|NCT01364597|79414187|FG001|Overall Study|Other|0|||
44406344|NCT01364597|79414188|FG002|Overall Study|Other|0|||
44406345|NCT01364597|79414189|FG003|Overall Study|Other|1|||
44406346|NCT01311648|79414205|FG000|Main Study|Protocol Violation|0|||
44406347|NCT01311648|79414206|FG001|Main Study|Protocol Violation|1|||
44406348|NCT01311648|79414205|FG000|Main Study|Adverse Event|0|||
44406349|NCT01311648|79414206|FG001|Main Study|Adverse Event|1|||
44406350|NCT01311648|79414205|FG000|Main Study|Inhibitor management|0|||
44406351|NCT01311648|79414206|FG001|Main Study|Inhibitor management|17|||
44406352|NCT01311648|79414205|FG000|Main Study|Withdrawal by Subject|0|||
44406353|NCT01311648|79414206|FG001|Main Study|Withdrawal by Subject|2|||
44406354|NCT01311648|79414205|FG000|Extension Study|Physician Decision|0|||
44406355|NCT01311648|79414206|FG001|Extension Study|Physician Decision|1|||
44406356|NCT01311648|79414205|FG000|Extension Study|ITI therapy with marketed product|0|||
44406357|NCT01311648|79414206|FG001|Extension Study|ITI therapy with marketed product|1|||
44406358|NCT01311648|79414205|FG000|Extension Study|Incorrect visit planning|0|||
44406359|NCT01311648|79414206|FG001|Extension Study|Incorrect visit planning|1|||
44406360|NCT01311648|79414205|FG000|Extension Study|Family's decision|0|||
44406361|NCT01311648|79414206|FG001|Extension Study|Family's decision|1|||
44406362|NCT01311648|79414205|FG000|Extension Study|Failure of ITI therapy|0|||
44406363|NCT01311648|79414206|FG001|Extension Study|Failure of ITI therapy|3|||
44406364|NCT01311648|79414205|FG000|Extension Study|Long travel|0|||
44406365|NCT01311648|79414206|FG001|Extension Study|Long travel|1|||
44406366|NCT01311648|79414205|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
44406367|NCT01311648|79414206|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
44406368|NCT01311648|79414205|FG000|Extension Study|Withdrawal by Subject|0|||
44406369|NCT01311648|79414206|FG001|Extension Study|Withdrawal by Subject|1|||
44406370|NCT01311648|79414205|FG000|Extension Study|Inhibitor management|0|||
44406371|NCT01311648|79414206|FG001|Extension Study|Inhibitor management|2|||
44406372|NCT00470704|79414234|FG000|Overall Study|Withdrawal by Subject|4|||
44406373|NCT00470704|79414235|FG001|Overall Study|Withdrawal by Subject|3|||
44406374|NCT00470704|79414234|FG000|Overall Study|Relapse/Progression|37|||
44406375|NCT00470704|79414235|FG001|Overall Study|Relapse/Progression|42|||
44406376|NCT00470704|79414234|FG000|Overall Study|toxicity|0|||
44406377|NCT00470704|79414235|FG001|Overall Study|toxicity|1|||
44253251|NCT00632749|79093683|FG006|Overall Study|Refuse to continue medication|0|||
44253252|NCT00632749|79093684|FG007|Overall Study|Refuse to continue medication|0|||
44253253|NCT00632749|79093685|FG008|Overall Study|Refuse to continue medication|0|||
44253254|NCT00632749|79093686|FG009|Overall Study|Refuse to continue medication|1|||
44406378|NCT00385697|79414246|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
44406379|NCT00385697|79414247|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
44406380|NCT00385697|79414248|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
44406381|NCT00385697|79414249|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
44406382|NCT00385697|79414250|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
44406383|NCT00385697|79414246|FG000|Open-label Segment 1|Lost to Follow-up|1|||
44406384|NCT00385697|79414247|FG001|Open-label Segment 1|Lost to Follow-up|0|||
44406385|NCT00385697|79414248|FG002|Open-label Segment 1|Lost to Follow-up|0|||
44406386|NCT00385697|79414249|FG003|Open-label Segment 1|Lost to Follow-up|0|||
44282085|NCT01904604|79245333|FG001|Overall Study|Non-compliance|0|||
44406387|NCT00385697|79414250|FG004|Open-label Segment 1|Lost to Follow-up|0|||
44406388|NCT00385697|79414246|FG000|Double-blind Segment 2|Adverse Event|0|||
44406389|NCT00385697|79414247|FG001|Double-blind Segment 2|Adverse Event|3|||
44406390|NCT00385697|79414248|FG002|Double-blind Segment 2|Adverse Event|1|||
44406391|NCT00385697|79414249|FG003|Double-blind Segment 2|Adverse Event|0|||
44406392|NCT00385697|79414250|FG004|Double-blind Segment 2|Adverse Event|0|||
44406393|NCT00385697|79414246|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
44406394|NCT00385697|79414247|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
44406395|NCT00385697|79414248|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
44406396|NCT00385697|79414249|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
44406397|NCT00385697|79414250|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
44406398|NCT00385697|79414246|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
44406399|NCT00385697|79414247|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
44406400|NCT00385697|79414248|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
44406401|NCT00385697|79414249|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
44406402|NCT00385697|79414250|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
44406403|NCT00385697|79414246|FG000|Double-blind Segment 2|Other|0|||
44406404|NCT00385697|79414247|FG001|Double-blind Segment 2|Other|2|||
44406405|NCT00385697|79414248|FG002|Double-blind Segment 2|Other|0|||
44406406|NCT00385697|79414249|FG003|Double-blind Segment 2|Other|0|||
44406407|NCT00385697|79414250|FG004|Double-blind Segment 2|Other|0|||
44406408|NCT00490945|79414268|FG000|Overall Study|Adverse Event|0|||
44406409|NCT00490945|79414269|FG001|Overall Study|Adverse Event|1|||
44406410|NCT00490945|79414270|FG002|Overall Study|Adverse Event|0|||
44406411|NCT00490945|79414271|FG003|Overall Study|Adverse Event|0|||
44406412|NCT00490945|79414272|FG004|Overall Study|Adverse Event|0|||
44406413|NCT00879398|79414290|FG000|Overall Study|Visit Stop|399|||
44406414|NCT00879398|79414290|FG000|Overall Study|Lack of Efficacy|64|||
44406415|NCT00879398|79414290|FG000|Overall Study|Adverse Event|41|||
44406416|NCT00879398|79414290|FG000|Overall Study|Other Reasons|171|||
44523482|NCT01355068|79531826|FG001|First Intervention Period|Adverse Event|1|||
44523483|NCT01355068|79531825|FG000|First Intervention Period|Withdrawal by Subject|0|||
44523484|NCT01355068|79531826|FG001|First Intervention Period|Withdrawal by Subject|1|||
44523485|NCT03756129|79531838|FG000|Overall Study|Adverse Event|1|||
44523486|NCT03756129|79531839|FG001|Overall Study|Adverse Event|1|||
44523487|NCT03756129|79531840|FG002|Overall Study|Adverse Event|0|||
44523488|NCT03756129|79531841|FG003|Overall Study|Adverse Event|2|||
44523489|NCT03756129|79531842|FG004|Overall Study|Adverse Event|0|||
44523490|NCT03756129|79531843|FG005|Overall Study|Adverse Event|0|||
44523491|NCT03756129|79531838|FG000|Overall Study|Withdrawal by Subject|2|||
44523492|NCT03756129|79531839|FG001|Overall Study|Withdrawal by Subject|1|||
44523493|NCT03756129|79531840|FG002|Overall Study|Withdrawal by Subject|3|||
44523494|NCT03756129|79531841|FG003|Overall Study|Withdrawal by Subject|1|||
44406417|NCT00696436|79414299|FG000|Overall Study|Adverse Event|7|||
44406418|NCT00696436|79414300|FG001|Overall Study|Adverse Event|9|||
44406419|NCT00696436|79414301|FG002|Overall Study|Adverse Event|8|||
44406420|NCT00696436|79414302|FG003|Overall Study|Adverse Event|6|||
44406421|NCT00696436|79414303|FG004|Overall Study|Adverse Event|4|||
44406422|NCT00696436|79414299|FG000|Overall Study|Protocol Violation|3|||
44406423|NCT00696436|79414300|FG001|Overall Study|Protocol Violation|2|||
44406424|NCT00696436|79414301|FG002|Overall Study|Protocol Violation|2|||
44406425|NCT00696436|79414302|FG003|Overall Study|Protocol Violation|0|||
44406426|NCT00696436|79414303|FG004|Overall Study|Protocol Violation|1|||
44523495|NCT03756129|79531842|FG004|Overall Study|Withdrawal by Subject|1|||
44523496|NCT03756129|79531843|FG005|Overall Study|Withdrawal by Subject|3|||
44406427|NCT00696436|79414299|FG000|Overall Study|Lost to Follow-up|1|||
44523497|NCT03756129|79531838|FG000|Overall Study|Lost to Follow-up|0|||
44523498|NCT03756129|79531839|FG001|Overall Study|Lost to Follow-up|0|||
44523499|NCT03756129|79531840|FG002|Overall Study|Lost to Follow-up|0|||
44523500|NCT03756129|79531841|FG003|Overall Study|Lost to Follow-up|0|||
44523501|NCT03756129|79531842|FG004|Overall Study|Lost to Follow-up|0|||
44523502|NCT03756129|79531843|FG005|Overall Study|Lost to Follow-up|1|||
44523503|NCT03756129|79531838|FG000|Overall Study|Physician Decision|0|||
44406428|NCT00696436|79414300|FG001|Overall Study|Lost to Follow-up|6|||
44406429|NCT00696436|79414301|FG002|Overall Study|Lost to Follow-up|2|||
44406430|NCT00696436|79414302|FG003|Overall Study|Lost to Follow-up|4|||
44406431|NCT00696436|79414303|FG004|Overall Study|Lost to Follow-up|3|||
44406432|NCT00696436|79414299|FG000|Overall Study|Withdrawal by Subject|4|||
44406433|NCT00696436|79414300|FG001|Overall Study|Withdrawal by Subject|11|||
44406434|NCT00696436|79414301|FG002|Overall Study|Withdrawal by Subject|5|||
44406435|NCT00696436|79414302|FG003|Overall Study|Withdrawal by Subject|7|||
44406436|NCT00696436|79414303|FG004|Overall Study|Withdrawal by Subject|1|||
44406437|NCT00696436|79414299|FG000|Overall Study|Lack of Efficacy|3|||
44406438|NCT00696436|79414300|FG001|Overall Study|Lack of Efficacy|1|||
44406439|NCT00696436|79414301|FG002|Overall Study|Lack of Efficacy|5|||
44523504|NCT03756129|79531839|FG001|Overall Study|Physician Decision|0|||
44523505|NCT03756129|79531840|FG002|Overall Study|Physician Decision|0|||
44523506|NCT03756129|79531841|FG003|Overall Study|Physician Decision|0|||
44406440|NCT00696436|79414302|FG003|Overall Study|Lack of Efficacy|2|||
44406441|NCT00696436|79414303|FG004|Overall Study|Lack of Efficacy|4|||
44406442|NCT00696436|79414299|FG000|Overall Study|Participant Unavailability|2|||
44406443|NCT00696436|79414300|FG001|Overall Study|Participant Unavailability|0|||
44406444|NCT00696436|79414301|FG002|Overall Study|Participant Unavailability|2|||
44406445|NCT00696436|79414302|FG003|Overall Study|Participant Unavailability|1|||
44406446|NCT00696436|79414303|FG004|Overall Study|Participant Unavailability|0|||
44406447|NCT00696436|79414299|FG000|Overall Study|Administrative Error|2|||
44406448|NCT00696436|79414300|FG001|Overall Study|Administrative Error|0|||
44406449|NCT00696436|79414301|FG002|Overall Study|Administrative Error|2|||
44406450|NCT00696436|79414302|FG003|Overall Study|Administrative Error|0|||
44406451|NCT00696436|79414303|FG004|Overall Study|Administrative Error|0|||
44406452|NCT00696436|79414299|FG000|Overall Study|Participant Non-compliance|0|||
44406453|NCT00696436|79414300|FG001|Overall Study|Participant Non-compliance|0|||
44406454|NCT00696436|79414301|FG002|Overall Study|Participant Non-compliance|1|||
44406455|NCT00696436|79414302|FG003|Overall Study|Participant Non-compliance|2|||
44406456|NCT00696436|79414303|FG004|Overall Study|Participant Non-compliance|0|||
44406457|NCT00696436|79414299|FG000|Overall Study|Administrative Decision|1|||
44406458|NCT00696436|79414300|FG001|Overall Study|Administrative Decision|0|||
44406459|NCT00696436|79414301|FG002|Overall Study|Administrative Decision|0|||
44406460|NCT00696436|79414302|FG003|Overall Study|Administrative Decision|0|||
44406461|NCT00696436|79414303|FG004|Overall Study|Administrative Decision|0|||
44406462|NCT00696436|79414299|FG000|Overall Study|Missing|0|||
44406463|NCT00696436|79414300|FG001|Overall Study|Missing|1|||
44406464|NCT00696436|79414301|FG002|Overall Study|Missing|1|||
44523507|NCT03756129|79531842|FG004|Overall Study|Physician Decision|0|||
44523508|NCT03756129|79531843|FG005|Overall Study|Physician Decision|1|||
44523509|NCT02822794|79531869|FG000|Overall Study|Withdrew Consent|1|||
44523510|NCT02822794|79531870|FG001|Overall Study|Withdrew Consent|0|||
44523511|NCT01338298|79531885|FG000|Overall Study|Withdrawal by Subject|1|||
44523512|NCT01338298|79531886|FG001|Overall Study|Withdrawal by Subject|1|||
44523513|NCT01338298|79531885|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
44523514|NCT01338298|79531886|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
44523515|NCT01338298|79531885|FG000|Overall Study|Administrative error|0|||
44523516|NCT01338298|79531886|FG001|Overall Study|Administrative error|1|||
44523517|NCT01338298|79531885|FG000|Overall Study|Positive symptom worsening|1|||
44523518|NCT01338298|79531886|FG001|Overall Study|Positive symptom worsening|0|||
44523519|NCT01338298|79531885|FG000|Overall Study|Depressive symptoms and nausea|1|||
44523520|NCT01338298|79531886|FG001|Overall Study|Depressive symptoms and nausea|0|||
44406465|NCT00696436|79414302|FG003|Overall Study|Missing|0|||
44523521|NCT01338298|79531885|FG000|Overall Study|Non-adherence|1|||
44523522|NCT01338298|79531886|FG001|Overall Study|Non-adherence|0|||
44523523|NCT01354132|79531894|FG000|Randomization|Physician Decision|1|||
44523524|NCT01354132|79531895|FG001|Randomization|Physician Decision|0|||
44406466|NCT00696436|79414303|FG004|Overall Study|Missing|0|||
44406467|NCT00878072|79414315|FG000|Overall Study|Withdrew consent|2|||
44406468|NCT00594854|79414343|FG000|Overall Study|Study terminated|7|||
44406469|NCT00594854|79414344|FG001|Overall Study|Study terminated|10|||
44406470|NCT00855582|79414353|FG000|Overall Study|Adverse Event|2|||
44406471|NCT00855582|79414354|FG001|Overall Study|Adverse Event|6|||
44406472|NCT00855582|79414355|FG002|Overall Study|Adverse Event|3|||
44406473|NCT00855582|79414353|FG000|Overall Study|Death|1|||
44406474|NCT00855582|79414354|FG001|Overall Study|Death|0|||
44406475|NCT00855582|79414355|FG002|Overall Study|Death|0|||
44406476|NCT00855582|79414353|FG000|Overall Study|Lack of Efficacy|1|||
44406477|NCT00855582|79414354|FG001|Overall Study|Lack of Efficacy|3|||
44406478|NCT00855582|79414355|FG002|Overall Study|Lack of Efficacy|8|||
44406479|NCT00855582|79414353|FG000|Overall Study|Lost to Follow-up|1|||
44406480|NCT00855582|79414354|FG001|Overall Study|Lost to Follow-up|3|||
44406481|NCT00855582|79414355|FG002|Overall Study|Lost to Follow-up|1|||
44406482|NCT00855582|79414353|FG000|Overall Study|Physician Decision|0|||
44406483|NCT00855582|79414354|FG001|Overall Study|Physician Decision|0|||
44406484|NCT00855582|79414355|FG002|Overall Study|Physician Decision|1|||
44406485|NCT00855582|79414353|FG000|Overall Study|Protocol Violation|6|||
44523525|NCT01354132|79531894|FG000|Randomization|Withdrawal by Subject|0|||
44523526|NCT01354132|79531895|FG001|Randomization|Withdrawal by Subject|1|||
44523527|NCT01354132|79531894|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
44523528|NCT01354132|79531895|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
44406486|NCT00855582|79414354|FG001|Overall Study|Protocol Violation|2|||
44406487|NCT00855582|79414355|FG002|Overall Study|Protocol Violation|6|||
44406488|NCT00855582|79414353|FG000|Overall Study|Entry Criteria Not Met|8|||
44406489|NCT00855582|79414354|FG001|Overall Study|Entry Criteria Not Met|6|||
44406490|NCT00855582|79414355|FG002|Overall Study|Entry Criteria Not Met|3|||
44406491|NCT00855582|79414353|FG000|Overall Study|Withdrawal by Subject|7|||
44406492|NCT00855582|79414354|FG001|Overall Study|Withdrawal by Subject|4|||
44406493|NCT00855582|79414355|FG002|Overall Study|Withdrawal by Subject|8|||
44406494|NCT00854724|79414368|FG000|First Intervention|Withdrawal by Subject|1|||
44523529|NCT01354132|79531894|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
44523530|NCT01354132|79531895|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
44523531|NCT01354132|79531894|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
44523532|NCT01354132|79531895|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
44523533|NCT01353898|79531910|FG000|Overall Study|Study site terminated|0|||
44523534|NCT01353898|79531911|FG001|Overall Study|Study site terminated|0|||
44523535|NCT01353898|79531912|FG002|Overall Study|Study site terminated|0|||
44523536|NCT01353898|79531913|FG003|Overall Study|Study site terminated|0|||
44523537|NCT01353898|79531914|FG004|Overall Study|Study site terminated|0|||
44523538|NCT01353898|79531915|FG005|Overall Study|Study site terminated|1|||
44523539|NCT01372150|79531932|FG000|Overall Study|Lack of Efficacy|3|||
44523540|NCT01372150|79531933|FG001|Overall Study|Lack of Efficacy|0|||
44523541|NCT01372150|79531934|FG002|Overall Study|Lack of Efficacy|1|||
44523542|NCT01372150|79531932|FG000|Overall Study|Lost to Follow-up|4|||
44523543|NCT01372150|79531933|FG001|Overall Study|Lost to Follow-up|5|||
44523544|NCT01372150|79531934|FG002|Overall Study|Lost to Follow-up|6|||
44523545|NCT01372150|79531932|FG000|Overall Study|Protocol Violation|1|||
44523546|NCT01372150|79531933|FG001|Overall Study|Protocol Violation|0|||
44523547|NCT01372150|79531934|FG002|Overall Study|Protocol Violation|3|||
44523548|NCT01372150|79531932|FG000|Overall Study|Withdrawal by Subject|2|||
44523549|NCT01372150|79531933|FG001|Overall Study|Withdrawal by Subject|7|||
44523550|NCT01372150|79531934|FG002|Overall Study|Withdrawal by Subject|2|||
44523551|NCT01372150|79531932|FG000|Overall Study|Other|1|||
44253255|NCT00632749|79093687|FG010|Overall Study|Refuse to continue medication|0|||
44253256|NCT00632749|79093688|FG011|Overall Study|Refuse to continue medication|0|||
44253257|NCT00632749|79093689|FG012|Overall Study|Refuse to continue medication|0|||
44406495|NCT00854724|79414369|FG001|First Intervention|Withdrawal by Subject|1|||
44406496|NCT00854724|79414368|FG000|Washout|Protocol Violation|1|||
44406497|NCT00854724|79414369|FG001|Washout|Protocol Violation|0|||
44406498|NCT00854724|79414368|FG000|Washout|Withdrawal by Subject|0|||
44406499|NCT00854724|79414369|FG001|Washout|Withdrawal by Subject|1|||
44406500|NCT00854724|79414368|FG000|Second Intervention|Protocol Violation|1|||
44406501|NCT00854724|79414369|FG001|Second Intervention|Protocol Violation|0|||
44406502|NCT00854724|79414368|FG000|Second Intervention|Physician Decision|0|||
44406503|NCT00854724|79414369|FG001|Second Intervention|Physician Decision|1|||
44406504|NCT00698932|79414407|FG000|Overall Study|Adverse Event|0|||
44406505|NCT00698932|79414408|FG001|Overall Study|Adverse Event|2|||
44406506|NCT00698932|79414407|FG000|Overall Study|Incorrect enrollment|0|||
44406507|NCT00698932|79414408|FG001|Overall Study|Incorrect enrollment|2|||
44406508|NCT00698932|79414407|FG000|Overall Study|Study specific discontinuation criteria|3|||
44406509|NCT00698932|79414408|FG001|Overall Study|Study specific discontinuation criteria|4|||
44406510|NCT00698932|79414407|FG000|Overall Study|Withdrawal by Subject|11|||
44406511|NCT00698932|79414408|FG001|Overall Study|Withdrawal by Subject|23|||
44406512|NCT00698932|79414407|FG000|Overall Study|Lost to Follow-up|6|||
44406513|NCT00698932|79414408|FG001|Overall Study|Lost to Follow-up|1|||
44406514|NCT00698932|79414407|FG000|Overall Study|Severe non-compliance to protocol|1|||
44406515|NCT00698932|79414408|FG001|Overall Study|Severe non-compliance to protocol|2|||
44406516|NCT00698932|79414407|FG000|Overall Study|Safety reasons|0|||
44406517|NCT00698932|79414408|FG001|Overall Study|Safety reasons|2|||
44406518|NCT00698932|79414407|FG000|Overall Study|Death|1|||
44406519|NCT00698932|79414408|FG001|Overall Study|Death|0|||
44406520|NCT00823719|79414416|FG000|Overall Study|Adverse Event|1|||
44406521|NCT00823719|79414417|FG001|Overall Study|Adverse Event|2|||
44406522|NCT00823719|79414416|FG000|Overall Study|Physician Decision|1|||
44253258|NCT00632749|79093690|FG013|Overall Study|Refuse to continue medication|0|||
44253259|NCT00632749|79093677|FG000|Overall Study|Reason other than those specified above|0|||
44253260|NCT00632749|79093678|FG001|Overall Study|Reason other than those specified above|2|||
44253261|NCT00632749|79093679|FG002|Overall Study|Reason other than those specified above|0|||
44523552|NCT01372150|79531933|FG001|Overall Study|Other|0|||
44523553|NCT01372150|79531934|FG002|Overall Study|Other|2|||
44253262|NCT00632749|79093680|FG003|Overall Study|Reason other than those specified above|0|||
44406523|NCT00823719|79414417|FG001|Overall Study|Physician Decision|4|||
44406524|NCT00823719|79414416|FG000|Overall Study|Withdrawal by Subject|0|||
44406525|NCT00823719|79414417|FG001|Overall Study|Withdrawal by Subject|1|||
44406526|NCT00823719|79414416|FG000|Overall Study|Disease Progression|4|||
44523554|NCT01372150|79531932|FG000|Overall Study|Adverse Event|2|||
44406527|NCT00823719|79414417|FG001|Overall Study|Disease Progression|4|||
44523555|NCT01372150|79531933|FG001|Overall Study|Adverse Event|1|||
44406528|NCT00875420|79414430|FG000|Overall Study|Adverse Event|0|||
44406529|NCT00875420|79414431|FG001|Overall Study|Adverse Event|1|||
44406530|NCT00875420|79414432|FG002|Overall Study|Adverse Event|1|||
44406531|NCT00875420|79414433|FG003|Overall Study|Adverse Event|0|||
44406532|NCT00875420|79414434|FG004|Overall Study|Adverse Event|0|||
44406533|NCT00875420|79414430|FG000|Overall Study|Inability to complete study procedures|1|||
44406534|NCT00875420|79414431|FG001|Overall Study|Inability to complete study procedures|0|||
44406535|NCT00875420|79414432|FG002|Overall Study|Inability to complete study procedures|1|||
44406536|NCT00875420|79414433|FG003|Overall Study|Inability to complete study procedures|1|||
44406537|NCT00875420|79414434|FG004|Overall Study|Inability to complete study procedures|1|||
44406538|NCT00875420|79414430|FG000|Overall Study|Lost to Follow-up|1|||
44406539|NCT00875420|79414431|FG001|Overall Study|Lost to Follow-up|0|||
44406540|NCT00875420|79414432|FG002|Overall Study|Lost to Follow-up|0|||
44523556|NCT01372150|79531934|FG002|Overall Study|Adverse Event|2|||
44523557|NCT01372150|79531932|FG000|Overall Study|Randomized but not treated|0|||
44523558|NCT01372150|79531933|FG001|Overall Study|Randomized but not treated|1|||
44523559|NCT01372150|79531934|FG002|Overall Study|Randomized but not treated|0|||
44523560|NCT03329690|79531947|FG000|Overall Study|Progressive disease per RECIST|85|||
44523561|NCT03329690|79531948|FG001|Overall Study|Progressive disease per RECIST|44|||
44523562|NCT03329690|79531949|FG002|Overall Study|Progressive disease per RECIST|6|||
44523563|NCT03329690|79531950|FG003|Overall Study|Progressive disease per RECIST|16|||
44523564|NCT03329690|79531951|FG004|Overall Study|Progressive disease per RECIST|20|||
44523565|NCT03329690|79531947|FG000|Overall Study|Clinical progression|7|||
44523566|NCT03329690|79531948|FG001|Overall Study|Clinical progression|4|||
44523567|NCT03329690|79531949|FG002|Overall Study|Clinical progression|1|||
44523568|NCT03329690|79531950|FG003|Overall Study|Clinical progression|1|||
44523569|NCT03329690|79531951|FG004|Overall Study|Clinical progression|1|||
44523570|NCT03329690|79531947|FG000|Overall Study|Adverse Event|22|||
44523571|NCT03329690|79531948|FG001|Overall Study|Adverse Event|4|||
44523572|NCT03329690|79531949|FG002|Overall Study|Adverse Event|0|||
44523573|NCT03329690|79531950|FG003|Overall Study|Adverse Event|1|||
44523574|NCT03329690|79531951|FG004|Overall Study|Adverse Event|2|||
44523575|NCT03329690|79531947|FG000|Overall Study|Death|2|||
44523576|NCT03329690|79531948|FG001|Overall Study|Death|0|||
44523577|NCT03329690|79531949|FG002|Overall Study|Death|0|||
44523578|NCT03329690|79531950|FG003|Overall Study|Death|1|||
44523579|NCT03329690|79531951|FG004|Overall Study|Death|0|||
44523580|NCT03329690|79531947|FG000|Overall Study|Withdrawal by Subject|2|||
44523581|NCT03329690|79531948|FG001|Overall Study|Withdrawal by Subject|3|||
44523582|NCT03329690|79531949|FG002|Overall Study|Withdrawal by Subject|0|||
44523583|NCT03329690|79531950|FG003|Overall Study|Withdrawal by Subject|1|||
44523584|NCT03329690|79531951|FG004|Overall Study|Withdrawal by Subject|0|||
44406541|NCT00875420|79414433|FG003|Overall Study|Lost to Follow-up|0|||
44406542|NCT00875420|79414434|FG004|Overall Study|Lost to Follow-up|0|||
44406543|NCT00875420|79414430|FG000|Overall Study|Personal reason|0|||
44406544|NCT00875420|79414431|FG001|Overall Study|Personal reason|0|||
44406545|NCT00875420|79414432|FG002|Overall Study|Personal reason|0|||
44406546|NCT00875420|79414433|FG003|Overall Study|Personal reason|0|||
44406547|NCT00875420|79414434|FG004|Overall Study|Personal reason|1|||
44523585|NCT03329690|79531947|FG000|Overall Study|Physician Decision|1|||
44406548|NCT00875420|79414430|FG000|Overall Study|Prohibited medication|0|||
44523586|NCT03329690|79531948|FG001|Overall Study|Physician Decision|0|||
44523587|NCT03329690|79531949|FG002|Overall Study|Physician Decision|0|||
44523588|NCT03329690|79531950|FG003|Overall Study|Physician Decision|0|||
44523589|NCT03329690|79531951|FG004|Overall Study|Physician Decision|1|||
44523590|NCT03329690|79531947|FG000|Overall Study|Miscellaneous|6|||
44523591|NCT03329690|79531948|FG001|Overall Study|Miscellaneous|0|||
44406549|NCT00875420|79414431|FG001|Overall Study|Prohibited medication|0|||
44406550|NCT00875420|79414432|FG002|Overall Study|Prohibited medication|0|||
44406551|NCT00875420|79414433|FG003|Overall Study|Prohibited medication|1|||
44406552|NCT00875420|79414434|FG004|Overall Study|Prohibited medication|0|||
44406553|NCT00875420|79414430|FG000|Overall Study|Sponsor decision|0|||
44406554|NCT00875420|79414431|FG001|Overall Study|Sponsor decision|1|||
44406555|NCT00875420|79414432|FG002|Overall Study|Sponsor decision|0|||
44406556|NCT00875420|79414433|FG003|Overall Study|Sponsor decision|0|||
44406557|NCT00875420|79414434|FG004|Overall Study|Sponsor decision|0|||
44406558|NCT00875420|79414430|FG000|Overall Study|Withdrawal by Subject|0|||
44406559|NCT00875420|79414431|FG001|Overall Study|Withdrawal by Subject|0|||
44406560|NCT00875420|79414432|FG002|Overall Study|Withdrawal by Subject|1|||
44406561|NCT00875420|79414433|FG003|Overall Study|Withdrawal by Subject|0|||
44406562|NCT00875420|79414434|FG004|Overall Study|Withdrawal by Subject|0|||
44406563|NCT00822237|79414448|FG000|Dose 1 Vaccination|Not vaccinated|3|||
44406564|NCT00822237|79414449|FG001|Dose 1 Vaccination|Not vaccinated|0|||
44406565|NCT00822237|79414448|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
44406566|NCT00822237|79414449|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
44406567|NCT00822237|79414448|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
44406568|NCT00822237|79414449|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
44406569|NCT00822237|79414448|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
44406570|NCT00822237|79414449|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
44406571|NCT00822237|79414448|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
44406572|NCT00822237|79414449|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
44406573|NCT00577096|79414456|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
44406574|NCT00577096|79414457|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
44406575|NCT00577096|79414456|FG000|Short Term Participation|Withdrawal by Subject|3|||
44406576|NCT00577096|79414457|FG001|Short Term Participation|Withdrawal by Subject|5|||
44406577|NCT00577096|79414456|FG000|Short Term Participation|Death|1|||
44406578|NCT00577096|79414457|FG001|Short Term Participation|Death|1|||
44406579|NCT00863304|79414467|FG000|Overall Study|Adverse Event|10|||
44406580|NCT00863304|79414468|FG001|Overall Study|Adverse Event|4|||
44406581|NCT00863304|79414469|FG002|Overall Study|Adverse Event|14|||
44523592|NCT03329690|79531949|FG002|Overall Study|Miscellaneous|0|||
44523593|NCT03329690|79531950|FG003|Overall Study|Miscellaneous|0|||
44523594|NCT03329690|79531951|FG004|Overall Study|Miscellaneous|0|||
44523595|NCT03329690|79531947|FG000|Overall Study|Did not receive treatment|1|||
44523596|NCT03329690|79531948|FG001|Overall Study|Did not receive treatment|0|||
44523597|NCT03329690|79531949|FG002|Overall Study|Did not receive treatment|0|||
44523598|NCT03329690|79531950|FG003|Overall Study|Did not receive treatment|1|||
44523599|NCT03329690|79531951|FG004|Overall Study|Did not receive treatment|0|||
44523600|NCT03328832|79531971|FG000|Overall Study|Lost to Follow-up|0|||
44523601|NCT03328832|79531972|FG001|Overall Study|Lost to Follow-up|1|||
44523602|NCT02820844|79531980|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
44523603|NCT02820844|79531981|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
44523604|NCT02820844|79531982|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
44523605|NCT02820844|79531983|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
44523606|NCT02820844|79531984|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
44523607|NCT02820844|79531985|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
44523608|NCT02820844|79531980|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
44523609|NCT02820844|79531981|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
44523610|NCT02820844|79531982|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
44406582|NCT00863304|79414470|FG003|Overall Study|Adverse Event|16|||
44406583|NCT00863304|79414467|FG000|Overall Study|Lost to Follow-up|1|||
44406584|NCT00863304|79414468|FG001|Overall Study|Lost to Follow-up|5|||
44406585|NCT00863304|79414469|FG002|Overall Study|Lost to Follow-up|4|||
44406586|NCT00863304|79414470|FG003|Overall Study|Lost to Follow-up|2|||
44406587|NCT00863304|79414467|FG000|Overall Study|Lack of Efficacy|57|||
44406588|NCT00863304|79414468|FG001|Overall Study|Lack of Efficacy|26|||
44406589|NCT00863304|79414469|FG002|Overall Study|Lack of Efficacy|30|||
44253263|NCT00632749|79093681|FG004|Overall Study|Reason other than those specified above|1|||
44406590|NCT00863304|79414470|FG003|Overall Study|Lack of Efficacy|28|||
44406591|NCT00863304|79414467|FG000|Overall Study|Withdrawal by Subject|19|||
44406592|NCT00863304|79414468|FG001|Overall Study|Withdrawal by Subject|14|||
44406593|NCT00863304|79414469|FG002|Overall Study|Withdrawal by Subject|20|||
44406594|NCT00863304|79414470|FG003|Overall Study|Withdrawal by Subject|18|||
44406595|NCT00863304|79414467|FG000|Overall Study|Other|1|||
44523611|NCT02820844|79531983|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
44253264|NCT00632749|79093682|FG005|Overall Study|Reason other than those specified above|0|||
44253265|NCT00632749|79093683|FG006|Overall Study|Reason other than those specified above|1|||
44406596|NCT00863304|79414468|FG001|Overall Study|Other|0|||
44406597|NCT00863304|79414469|FG002|Overall Study|Other|0|||
44406598|NCT00863304|79414470|FG003|Overall Study|Other|1|||
44406599|NCT00863304|79414467|FG000|Overall Study|Protocol Violation|2|||
44406600|NCT00863304|79414468|FG001|Overall Study|Protocol Violation|6|||
44406601|NCT00863304|79414469|FG002|Overall Study|Protocol Violation|2|||
44406602|NCT00863304|79414470|FG003|Overall Study|Protocol Violation|0|||
44406603|NCT00863304|79414467|FG000|Overall Study|Randomized, but not Treated|3|||
44406604|NCT00863304|79414468|FG001|Overall Study|Randomized, but not Treated|1|||
44406605|NCT00863304|79414469|FG002|Overall Study|Randomized, but not Treated|4|||
44406606|NCT00863304|79414470|FG003|Overall Study|Randomized, but not Treated|1|||
44406607|NCT00863304|79414467|FG000|Overall Study|Entered extension study|101|||
44406608|NCT00863304|79414468|FG001|Overall Study|Entered extension study|129|||
44406609|NCT00863304|79414469|FG002|Overall Study|Entered extension study|113|||
44406610|NCT00863304|79414470|FG003|Overall Study|Entered extension study|125|||
44406611|NCT00695110|79414482|FG000|Treatment Period 1|Adverse Event|1|||
44406612|NCT00695110|79414482|FG000|Treatment Period 1|Withdrawal by Subject|2|||
44406613|NCT00695110|79414482|FG000|Treatment Period 3|Withdrawal by Subject|1|||
44406614|NCT00695110|79414482|FG000|Treatment Period 4|Adverse Event|1|||
44406615|NCT00594386|79414489|FG000|Overall Study|Major protocol violation|2|||
44406616|NCT00594386|79414489|FG000|Overall Study|Lack of Efficacy|12|||
44406617|NCT00594386|79414489|FG000|Overall Study|Adverse Event|68|||
44406618|NCT00594386|79414489|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
44406619|NCT00594386|79414489|FG000|Overall Study|Subject withdrew consent|35|||
44406620|NCT00594386|79414489|FG000|Overall Study|Study ended per sponsor|115|||
44406621|NCT00594386|79414489|FG000|Overall Study|Lost to Follow-up|6|||
44406622|NCT00594386|79414489|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
44406623|NCT00594386|79414489|FG000|Overall Study|Other: Subject moved to Seattle|1|||
44406624|NCT00594386|79414489|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
44406625|NCT00594386|79414489|FG000|Overall Study|Other: Study terminated per investigator|2|||
44406626|NCT00594386|79414489|FG000|Overall Study|Other: Sponsor closure of study|1|||
44406627|NCT00594386|79414489|FG000|Overall Study|Other: Site terminated participation|1|||
44406628|NCT00594386|79414489|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
44406629|NCT00594386|79414489|FG000|Overall Study|Other: Loss of drivers license|1|||
44406630|NCT00862992|79414496|FG000|Overall Study|Adverse Event|2|||
44406631|NCT00862992|79414497|FG001|Overall Study|Adverse Event|1|||
44406632|NCT00862992|79414498|FG002|Overall Study|Adverse Event|1|||
44406633|NCT00862992|79414496|FG000|Overall Study|Physician Decision|1|||
44406634|NCT00862992|79414497|FG001|Overall Study|Physician Decision|0|||
44406635|NCT00862992|79414498|FG002|Overall Study|Physician Decision|0|||
44406636|NCT00862992|79414496|FG000|Overall Study|Withdrawal by Subject|0|||
44406637|NCT00862992|79414497|FG001|Overall Study|Withdrawal by Subject|0|||
44406638|NCT00862992|79414498|FG002|Overall Study|Withdrawal by Subject|2|||
44406639|NCT00694096|79414506|FG000|Overall Study|Withdrawal by Subject|5|||
44406640|NCT00854100|79414513|FG000|Overall Study|Inability to complete the study visits|0|||
44406641|NCT00854100|79414514|FG001|Overall Study|Inability to complete the study visits|0|||
44406642|NCT00854100|79414515|FG002|Overall Study|Inability to complete the study visits|1|||
44406643|NCT00854100|79414513|FG000|Overall Study|Lost to Follow-up|2|||
44406644|NCT00854100|79414514|FG001|Overall Study|Lost to Follow-up|0|||
44406645|NCT00854100|79414515|FG002|Overall Study|Lost to Follow-up|3|||
44406646|NCT00854100|79414513|FG000|Overall Study|Withdrawal by Subject|3|||
44406647|NCT00854100|79414514|FG001|Overall Study|Withdrawal by Subject|1|||
44406648|NCT00854100|79414515|FG002|Overall Study|Withdrawal by Subject|2|||
44406649|NCT00854100|79414513|FG000|Overall Study|Protocol Violation|2|||
44406650|NCT00854100|79414514|FG001|Overall Study|Protocol Violation|4|||
44406651|NCT00854100|79414515|FG002|Overall Study|Protocol Violation|3|||
44406652|NCT00854100|79414513|FG000|Overall Study|Adverse Event|2|||
44406653|NCT00854100|79414514|FG001|Overall Study|Adverse Event|1|||
44406654|NCT00854100|79414515|FG002|Overall Study|Adverse Event|2|||
44406655|NCT00509899|79414532|FG000|Overall Study|Progressive disease|1|||
44406656|NCT00509899|79414533|FG001|Overall Study|Progressive disease|3|||
44406657|NCT00509899|79414534|FG002|Overall Study|Progressive disease|5|||
44406658|NCT00509899|79414535|FG003|Overall Study|Progressive disease|1|||
44406659|NCT00509899|79414536|FG004|Overall Study|Progressive disease|0|||
44523612|NCT02820844|79531984|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
44253266|NCT00632749|79093684|FG007|Overall Study|Reason other than those specified above|0|||
44253267|NCT00632749|79093685|FG008|Overall Study|Reason other than those specified above|0|||
44253268|NCT00632749|79093686|FG009|Overall Study|Reason other than those specified above|0|||
44253269|NCT00632749|79093687|FG010|Overall Study|Reason other than those specified above|2|||
44253270|NCT00632749|79093688|FG011|Overall Study|Reason other than those specified above|1|||
44406660|NCT00509899|79414537|FG005|Overall Study|Progressive disease|1|||
44406661|NCT00509899|79414538|FG006|Overall Study|Progressive disease|0|||
44406662|NCT00509899|79414539|FG007|Overall Study|Progressive disease|0|||
44406663|NCT00509899|79414532|FG000|Overall Study|Unacceptable Toxicity|1|||
44406664|NCT00509899|79414533|FG001|Overall Study|Unacceptable Toxicity|0|||
44406665|NCT00509899|79414534|FG002|Overall Study|Unacceptable Toxicity|0|||
44406666|NCT00509899|79414535|FG003|Overall Study|Unacceptable Toxicity|2|||
44406667|NCT00509899|79414536|FG004|Overall Study|Unacceptable Toxicity|0|||
44406668|NCT00509899|79414537|FG005|Overall Study|Unacceptable Toxicity|0|||
44406669|NCT00509899|79414538|FG006|Overall Study|Unacceptable Toxicity|0|||
44406670|NCT00509899|79414539|FG007|Overall Study|Unacceptable Toxicity|0|||
44406671|NCT00509899|79414532|FG000|Overall Study|Withdrawal by Subject|6|||
44406672|NCT00509899|79414533|FG001|Overall Study|Withdrawal by Subject|2|||
44406673|NCT00509899|79414534|FG002|Overall Study|Withdrawal by Subject|3|||
44406674|NCT00509899|79414535|FG003|Overall Study|Withdrawal by Subject|0|||
44406675|NCT00509899|79414536|FG004|Overall Study|Withdrawal by Subject|3|||
44406676|NCT00509899|79414537|FG005|Overall Study|Withdrawal by Subject|2|||
44406677|NCT00509899|79414538|FG006|Overall Study|Withdrawal by Subject|0|||
44406678|NCT00509899|79414539|FG007|Overall Study|Withdrawal by Subject|0|||
44406679|NCT00509899|79414532|FG000|Overall Study|Physician Decision|4|||
44406680|NCT00509899|79414533|FG001|Overall Study|Physician Decision|2|||
44406681|NCT00509899|79414534|FG002|Overall Study|Physician Decision|7|||
44406682|NCT00509899|79414535|FG003|Overall Study|Physician Decision|0|||
44406683|NCT00509899|79414536|FG004|Overall Study|Physician Decision|1|||
44406684|NCT00509899|79414537|FG005|Overall Study|Physician Decision|4|||
44406685|NCT00509899|79414538|FG006|Overall Study|Physician Decision|0|||
44406686|NCT00509899|79414539|FG007|Overall Study|Physician Decision|0|||
44406687|NCT00509899|79414532|FG000|Overall Study|Intercurrent Illness|1|||
44406688|NCT00509899|79414533|FG001|Overall Study|Intercurrent Illness|0|||
44406689|NCT00509899|79414534|FG002|Overall Study|Intercurrent Illness|0|||
44406690|NCT00509899|79414535|FG003|Overall Study|Intercurrent Illness|1|||
44406691|NCT00509899|79414536|FG004|Overall Study|Intercurrent Illness|0|||
44406692|NCT00509899|79414537|FG005|Overall Study|Intercurrent Illness|1|||
44406693|NCT00509899|79414538|FG006|Overall Study|Intercurrent Illness|0|||
44406694|NCT00509899|79414539|FG007|Overall Study|Intercurrent Illness|0|||
44406695|NCT00509899|79414532|FG000|Overall Study|Death|2|||
44406696|NCT00509899|79414533|FG001|Overall Study|Death|2|||
44406697|NCT00509899|79414534|FG002|Overall Study|Death|3|||
44406698|NCT00509899|79414535|FG003|Overall Study|Death|0|||
44406699|NCT00509899|79414536|FG004|Overall Study|Death|1|||
44523613|NCT02820844|79531985|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
44523614|NCT02820844|79531980|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
44523615|NCT02820844|79531981|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
44523616|NCT02820844|79531982|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
44523617|NCT02820844|79531983|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
44523618|NCT02820844|79531984|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
44406700|NCT00509899|79414537|FG005|Overall Study|Death|1|||
44406701|NCT00509899|79414538|FG006|Overall Study|Death|1|||
44406702|NCT00509899|79414539|FG007|Overall Study|Death|1|||
44406703|NCT00509899|79414532|FG000|Overall Study|Lack of Efficacy|1|||
44406704|NCT00509899|79414533|FG001|Overall Study|Lack of Efficacy|0|||
44406705|NCT00509899|79414534|FG002|Overall Study|Lack of Efficacy|2|||
44406706|NCT00509899|79414535|FG003|Overall Study|Lack of Efficacy|0|||
44406707|NCT00509899|79414536|FG004|Overall Study|Lack of Efficacy|0|||
44406708|NCT00509899|79414537|FG005|Overall Study|Lack of Efficacy|1|||
44406709|NCT00509899|79414538|FG006|Overall Study|Lack of Efficacy|0|||
44406710|NCT00509899|79414539|FG007|Overall Study|Lack of Efficacy|0|||
44406711|NCT00862836|79414553|FG000|Overall Study|Withdrawal by Subject|1|||
44406712|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
44406713|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
44406714|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
44406715|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Death|28|||
44406716|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Death|0|||
44406717|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Death|0|||
44406718|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
44523619|NCT02820844|79531985|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
44523620|NCT02820844|79531980|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
44523621|NCT02820844|79531981|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
44523622|NCT02820844|79531982|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
44523623|NCT02820844|79531983|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
44253271|NCT00632749|79093689|FG012|Overall Study|Reason other than those specified above|0|||
44253272|NCT00632749|79093690|FG013|Overall Study|Reason other than those specified above|2|||
44253273|NCT00632359|79093751|FG000|Overall Study|Withdrawal by Subject|2|||
44253274|NCT00632203|79093758|FG000|Overall Study|Did not start study treatment|1|||
44253275|NCT00632203|79093759|FG001|Overall Study|Did not start study treatment|0|||
44253276|NCT03830333|79093780|FG000|Overall Study|Death|0|||
44253277|NCT03830333|79093781|FG001|Overall Study|Death|1|||
44253278|NCT03830333|79093780|FG000|Overall Study|Withdrawal by Subject|5|||
44406719|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
44406720|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
44406721|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
44406722|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
44406723|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
44406724|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
44406725|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
44406726|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
44406727|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
44406728|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
44406729|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
44406730|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
44406731|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
44406732|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
44406733|NCT00820755|79414557|FG000|Period 1: Combination Therapy Phase|Other|11|||
44406734|NCT00820755|79414558|FG001|Period 1: Combination Therapy Phase|Other|0|||
44406735|NCT00820755|79414559|FG002|Period 1: Combination Therapy Phase|Other|0|||
44406736|NCT00820755|79414557|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
44406737|NCT00820755|79414558|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
44406738|NCT00820755|79414559|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
44406739|NCT00820599|79414567|FG000|Overall Study|Death|129|||
44406740|NCT00820599|79414567|FG000|Overall Study|Withdrawal by Subject|2|||
44406741|NCT00819741|79414573|FG000|Overall Study|Adverse Event|5|||
44406742|NCT00819741|79414574|FG001|Overall Study|Adverse Event|2|||
44406743|NCT00819741|79414573|FG000|Overall Study|Lack of Efficacy|0|||
44406744|NCT00819741|79414574|FG001|Overall Study|Lack of Efficacy|2|||
44406745|NCT00819741|79414573|FG000|Overall Study|Lost to Follow-up|3|||
44406746|NCT00819741|79414574|FG001|Overall Study|Lost to Follow-up|1|||
44406747|NCT00819741|79414573|FG000|Overall Study|Protocol Violation|3|||
44406748|NCT00819741|79414574|FG001|Overall Study|Protocol Violation|4|||
44406749|NCT00819741|79414573|FG000|Overall Study|Withdrawal by Subject|2|||
44406750|NCT00819741|79414574|FG001|Overall Study|Withdrawal by Subject|2|||
44406751|NCT00819741|79414573|FG000|Overall Study|Unclassified|6|||
44406752|NCT00819741|79414574|FG001|Overall Study|Unclassified|0|||
44406753|NCT00819741|79414573|FG000|Overall Study|Reasons unknown|3|||
44406754|NCT00819741|79414574|FG001|Overall Study|Reasons unknown|3|||
44406755|NCT00862134|79414582|FG000|Overall Study|Death|1|||
44406756|NCT00862134|79414583|FG001|Overall Study|Death|0|||
44406757|NCT00862134|79414582|FG000|Overall Study|Physician Decision|0|||
44406758|NCT00862134|79414583|FG001|Overall Study|Physician Decision|1|||
44406759|NCT00862134|79414582|FG000|Overall Study|Withdrawal by Subject|1|||
44406760|NCT00862134|79414583|FG001|Overall Study|Withdrawal by Subject|2|||
44406761|NCT00862134|79414582|FG000|Overall Study|Sponsor terminated study|5|||
44406762|NCT00862134|79414583|FG001|Overall Study|Sponsor terminated study|7|||
44406763|NCT00862134|79414582|FG000|Overall Study|Adverse Event|2|||
44406764|NCT00862134|79414583|FG001|Overall Study|Adverse Event|2|||
44406765|NCT00862134|79414582|FG000|Overall Study|Withdrew prior to dosing|2|||
44406766|NCT00862134|79414583|FG001|Overall Study|Withdrew prior to dosing|0|||
44406767|NCT00848484|79414591|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
44406768|NCT00848484|79414592|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
44406769|NCT00848484|79414591|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
44406770|NCT00848484|79414592|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
44406771|NCT00848484|79414591|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
44406772|NCT00848484|79414592|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
44406773|NCT00848484|79414591|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
44406774|NCT00848484|79414592|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
44406775|NCT00848484|79414591|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
44406776|NCT00848484|79414592|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
44406777|NCT00509821|79414600|FG000|Study Period 1 (Induction)|Death|0|||
44406778|NCT00509821|79414601|FG001|Study Period 1 (Induction)|Death|1|||
44406779|NCT00509821|79414600|FG000|Study Period 1 (Induction)|Adverse Event|0|||
44406780|NCT00509821|79414601|FG001|Study Period 1 (Induction)|Adverse Event|2|||
44406781|NCT00509821|79414600|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
44406782|NCT00509821|79414601|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
44406783|NCT00508651|79414614|FG000|Overall Study|Lost to Follow-up|3|||
44406784|NCT00508651|79414615|FG001|Overall Study|Lost to Follow-up|1|||
44406785|NCT00508651|79414614|FG000|Overall Study|Withdrawal by Subject|1|||
44406786|NCT00508651|79414615|FG001|Overall Study|Withdrawal by Subject|1|||
44406787|NCT00490555|79414625|FG000|Overall Study|noncompliant with drug administration|0|||
44406788|NCT00490555|79414626|FG001|Overall Study|noncompliant with drug administration|0|||
44523624|NCT02820844|79531984|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
44523625|NCT02820844|79531985|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
44523626|NCT02820844|79531980|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
44406789|NCT00490555|79414627|FG002|Overall Study|noncompliant with drug administration|2|||
44406790|NCT00490555|79414628|FG003|Overall Study|noncompliant with drug administration|0|||
44406791|NCT00501085|79414638|FG000|Overall Study|Lost to Follow-up|195|||
44406792|NCT00501085|79414638|FG000|Overall Study|Withdrawal by Subject|34|||
44406793|NCT00501085|79414638|FG000|Overall Study|Subject Decision|1|||
44406794|NCT00501085|79414638|FG000|Overall Study|Revision Surgery|7|||
44406795|NCT00501085|79414638|FG000|Overall Study|Explantation Surgery|26|||
44406796|NCT00501085|79414638|FG000|Overall Study|Adverse Event|4|||
44406797|NCT00501085|79414638|FG000|Overall Study|Non-Compliance|24|||
44406798|NCT00501085|79414638|FG000|Overall Study|Study closed by sponsor|109|||
44406799|NCT00501085|79414638|FG000|Overall Study|Other loss to follow-up|32|||
44406800|NCT00501007|79414642|FG000|Overall Study|Inclusion criteria not met.|29|||
44406801|NCT00501007|79414643|FG001|Overall Study|Inclusion criteria not met.|25|||
44406802|NCT00873860|79414653|FG000|Overall Study|Lost to Follow-up|1|||
44406803|NCT00873860|79414654|FG001|Overall Study|Lost to Follow-up|0|||
44406804|NCT00873860|79414655|FG002|Overall Study|Lost to Follow-up|0|||
44406805|NCT00873860|79414656|FG003|Overall Study|Lost to Follow-up|1|||
44406806|NCT00873860|79414653|FG000|Overall Study|Withdrawal by Subject|1|||
44406807|NCT00873860|79414654|FG001|Overall Study|Withdrawal by Subject|0|||
44406808|NCT00873860|79414655|FG002|Overall Study|Withdrawal by Subject|2|||
44406809|NCT00873860|79414656|FG003|Overall Study|Withdrawal by Subject|0|||
44406810|NCT00873860|79414653|FG000|Overall Study|Death|1|||
44523627|NCT02820844|79531981|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
44523628|NCT02820844|79531982|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
44523629|NCT02820844|79531983|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
44523630|NCT02820844|79531984|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
44523631|NCT02820844|79531985|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
44523632|NCT02820844|79531980|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
44523633|NCT02820844|79531981|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
44523634|NCT02820844|79531982|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
44523635|NCT02820844|79531983|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
44523636|NCT02820844|79531984|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
44523637|NCT02820844|79531985|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
44523638|NCT02820844|79531980|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
44147949|NCT04097028|78937373|FG000|Overall Study|Adverse Event prior to Surgery|1|||
44147950|NCT03749330|78937392|FG000|Overall Study|Clinicians left work in the CICU|0|||
44147951|NCT03749330|78937393|FG001|Overall Study|Clinicians left work in the CICU|2|||
44147952|NCT03749330|78937394|FG002|Overall Study|Clinicians left work in the CICU|0|||
44147953|NCT03749330|78937395|FG003|Overall Study|Clinicians left work in the CICU|0|||
44147954|NCT03749330|78937396|FG004|Overall Study|Clinicians left work in the CICU|0|||
44147955|NCT03749330|78937397|FG005|Overall Study|Clinicians left work in the CICU|0|||
44147956|NCT03740737|78937419|FG000|Overall Study|Protocol deviation|13|||
44147957|NCT03740737|78937420|FG001|Overall Study|Protocol deviation|0|||
44147958|NCT03740737|78937419|FG000|Overall Study|Adverse Event|2|||
44147959|NCT03740737|78937420|FG001|Overall Study|Adverse Event|0|||
44147960|NCT03740737|78937419|FG000|Overall Study|Lost to Follow-up|1|||
44147961|NCT03740737|78937420|FG001|Overall Study|Lost to Follow-up|0|||
44147962|NCT03740737|78937419|FG000|Overall Study|Randomization failure|1|||
44147963|NCT03740737|78937420|FG001|Overall Study|Randomization failure|0|||
44147964|NCT03740737|78937419|FG000|Overall Study|Participant withdrew consent|1|||
44147965|NCT03740737|78937420|FG001|Overall Study|Participant withdrew consent|0|||
44147966|NCT03740737|78937419|FG000|Overall Study|Participant withdrew from trial|2|||
44147967|NCT03740737|78937420|FG001|Overall Study|Participant withdrew from trial|1|||
44147968|NCT03738618|78937429|FG000|Overall Study|Protocol deviation|23|||
44147969|NCT03738618|78937430|FG001|Overall Study|Protocol deviation|0|||
44147970|NCT03738618|78937429|FG000|Overall Study|Adverse Event|4|||
44147971|NCT03738618|78937430|FG001|Overall Study|Adverse Event|0|||
44147972|NCT03738618|78937429|FG000|Overall Study|Lost to Follow-up|2|||
44147973|NCT03738618|78937430|FG001|Overall Study|Lost to Follow-up|0|||
44147974|NCT03738618|78937429|FG000|Overall Study|Randomization failure|1|||
44147975|NCT03738618|78937430|FG001|Overall Study|Randomization failure|0|||
44147976|NCT03738618|78937429|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
44147977|NCT03738618|78937430|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
44253279|NCT03830333|79093781|FG001|Overall Study|Withdrawal by Subject|1|||
44253280|NCT03830333|79093780|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
44406811|NCT00873860|79414654|FG001|Overall Study|Death|0|||
44406812|NCT00873860|79414655|FG002|Overall Study|Death|0|||
44523639|NCT02820844|79531981|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
44406813|NCT00873860|79414656|FG003|Overall Study|Death|0|||
44406814|NCT00873860|79414653|FG000|Overall Study|Other|1|||
44406815|NCT00873860|79414654|FG001|Overall Study|Other|0|||
44523640|NCT02820844|79531982|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
44523641|NCT02820844|79531983|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
44147978|NCT03738618|78937429|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
44147979|NCT03738618|78937430|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
44147980|NCT03556891|78937438|FG000|Overall Study|Adverse Event|4|||
44147981|NCT03556891|78937438|FG000|Overall Study|MRI Need|3|||
44147982|NCT03556891|78937438|FG000|Overall Study|Device Failure|1|||
44147983|NCT03556891|78937438|FG000|Overall Study|Death|1|||
44406816|NCT00873860|79414655|FG002|Overall Study|Other|1|||
44406817|NCT00873860|79414656|FG003|Overall Study|Other|0|||
44406818|NCT03853291|79414679|FG000|Overall Study|Lost to Follow-up|1|||
44406819|NCT03853291|79414680|FG001|Overall Study|Lost to Follow-up|2|||
44406820|NCT03853291|79414681|FG002|Overall Study|Lost to Follow-up|0|||
44406821|NCT03853291|79414682|FG003|Overall Study|Lost to Follow-up|0|||
44406822|NCT03853291|79414683|FG004|Overall Study|Lost to Follow-up|0|||
44406823|NCT03853291|79414684|FG005|Overall Study|Lost to Follow-up|0|||
44406824|NCT03853291|79414679|FG000|Overall Study|Determined to be ineligible|1|||
44406825|NCT03853291|79414680|FG001|Overall Study|Determined to be ineligible|1|||
44406826|NCT03853291|79414681|FG002|Overall Study|Determined to be ineligible|0|||
44406827|NCT03853291|79414682|FG003|Overall Study|Determined to be ineligible|0|||
44406828|NCT03853291|79414683|FG004|Overall Study|Determined to be ineligible|0|||
44406829|NCT03853291|79414684|FG005|Overall Study|Determined to be ineligible|0|||
44406830|NCT03853213|79414697|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
44406831|NCT03853213|79414698|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
44406832|NCT03853213|79414697|FG000|Overall Study|Other (e.g., too busy)|0|||
44406833|NCT03853213|79414698|FG001|Overall Study|Other (e.g., too busy)|2|||
44406834|NCT02666105|79414724|FG000|Overall Study|Death|1|||
44406835|NCT00819585|79414743|FG000|Core Study|Adverse Event|2|||
44406836|NCT00819585|79414744|FG001|Core Study|Adverse Event|1|||
44406837|NCT00819585|79414745|FG002|Core Study|Adverse Event|1|||
44406838|NCT00819585|79414746|FG003|Core Study|Adverse Event|4|||
44406839|NCT00819585|79414747|FG004|Core Study|Adverse Event|1|||
44406840|NCT00819585|79414748|FG005|Core Study|Adverse Event|0|||
44406841|NCT00819585|79414749|FG006|Core Study|Adverse Event|2|||
44406842|NCT00819585|79414750|FG007|Core Study|Adverse Event|0|||
44406843|NCT00819585|79414751|FG008|Core Study|Adverse Event|0|||
44406844|NCT00819585|79414752|FG009|Core Study|Adverse Event|0|||
44406845|NCT00819585|79414753|FG010|Core Study|Adverse Event|0|||
44406846|NCT00819585|79414743|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
44406847|NCT00819585|79414744|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
44406848|NCT00819585|79414745|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
44406849|NCT00819585|79414746|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
44406850|NCT00819585|79414747|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
44406851|NCT00819585|79414748|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
44523642|NCT02820844|79531984|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
44523643|NCT02820844|79531985|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
44406852|NCT00819585|79414749|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
44406853|NCT00819585|79414750|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
44406854|NCT00819585|79414751|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
44406855|NCT00819585|79414752|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
44406856|NCT00819585|79414753|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
44406857|NCT00819585|79414743|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406858|NCT00819585|79414744|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
44406859|NCT00819585|79414745|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406860|NCT00819585|79414746|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406861|NCT00819585|79414747|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406862|NCT00819585|79414748|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406863|NCT00819585|79414749|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
44406864|NCT00819585|79414750|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406865|NCT00819585|79414751|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406866|NCT00819585|79414752|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406867|NCT00819585|79414753|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
44406868|NCT00819585|79414743|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
44406869|NCT00819585|79414744|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
44406870|NCT00819585|79414745|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
44406871|NCT00819585|79414746|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
44406872|NCT00819585|79414747|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
44523644|NCT02820844|79531980|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44406873|NCT00819585|79414748|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
44406874|NCT00819585|79414749|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
44406875|NCT00819585|79414750|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
44406876|NCT00819585|79414751|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
44523645|NCT02820844|79531981|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44406877|NCT00819585|79414752|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
44406878|NCT00819585|79414753|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
44406879|NCT00819585|79414743|FG000|Core Study|Subject Withdrew Consent|0|||
44406880|NCT00819585|79414744|FG001|Core Study|Subject Withdrew Consent|3|||
44406881|NCT00819585|79414745|FG002|Core Study|Subject Withdrew Consent|2|||
44406882|NCT00819585|79414746|FG003|Core Study|Subject Withdrew Consent|1|||
44406883|NCT00819585|79414747|FG004|Core Study|Subject Withdrew Consent|0|||
44406884|NCT00819585|79414748|FG005|Core Study|Subject Withdrew Consent|0|||
44406885|NCT00819585|79414749|FG006|Core Study|Subject Withdrew Consent|3|||
44523646|NCT02820844|79531982|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
44523647|NCT02820844|79531983|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
44523648|NCT02820844|79531984|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523649|NCT02820844|79531985|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523650|NCT02820844|79531980|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
44523651|NCT02820844|79531981|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
44523652|NCT02820844|79531982|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
44406886|NCT00819585|79414750|FG007|Core Study|Subject Withdrew Consent|0|||
44406887|NCT00819585|79414751|FG008|Core Study|Subject Withdrew Consent|0|||
44406888|NCT00819585|79414752|FG009|Core Study|Subject Withdrew Consent|0|||
44406889|NCT00819585|79414753|FG010|Core Study|Subject Withdrew Consent|0|||
44406890|NCT00819585|79414743|FG000|Core Study|Lost to Follow-up|2|||
44406891|NCT00819585|79414744|FG001|Core Study|Lost to Follow-up|1|||
44406892|NCT00819585|79414745|FG002|Core Study|Lost to Follow-up|2|||
44406893|NCT00819585|79414746|FG003|Core Study|Lost to Follow-up|0|||
44406894|NCT00819585|79414747|FG004|Core Study|Lost to Follow-up|1|||
44406895|NCT00819585|79414748|FG005|Core Study|Lost to Follow-up|1|||
44406896|NCT00819585|79414749|FG006|Core Study|Lost to Follow-up|1|||
44406897|NCT00819585|79414750|FG007|Core Study|Lost to Follow-up|0|||
44406898|NCT00819585|79414751|FG008|Core Study|Lost to Follow-up|0|||
44406899|NCT00819585|79414752|FG009|Core Study|Lost to Follow-up|0|||
44406900|NCT00819585|79414753|FG010|Core Study|Lost to Follow-up|0|||
44406901|NCT00819585|79414743|FG000|Core Study|Administrative Problems|0|||
44406902|NCT00819585|79414744|FG001|Core Study|Administrative Problems|0|||
44406903|NCT00819585|79414745|FG002|Core Study|Administrative Problems|0|||
44406904|NCT00819585|79414746|FG003|Core Study|Administrative Problems|0|||
44406905|NCT00819585|79414747|FG004|Core Study|Administrative Problems|0|||
44523653|NCT02820844|79531983|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
44523654|NCT02820844|79531984|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
44523655|NCT02820844|79531985|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
44523656|NCT02820844|79531980|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523657|NCT02820844|79531981|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523658|NCT02820844|79531982|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523659|NCT02820844|79531983|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523660|NCT02820844|79531984|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
44523661|NCT02820844|79531985|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
44523662|NCT02942576|79532004|FG000|Overall Study|Adverse Event|28|||
44523663|NCT02942576|79532005|FG001|Overall Study|Adverse Event|6|||
44523664|NCT02942576|79532004|FG000|Overall Study|Withdrawal by Subject|7|||
44523665|NCT02942576|79532005|FG001|Overall Study|Withdrawal by Subject|5|||
44523666|NCT02942576|79532004|FG000|Overall Study|Physician Decision|1|||
44523667|NCT02942576|79532005|FG001|Overall Study|Physician Decision|4|||
44523668|NCT02942576|79532004|FG000|Overall Study|Other|10|||
44523669|NCT02942576|79532005|FG001|Overall Study|Other|8|||
44523670|NCT02820298|79532013|FG000|Overall Study|Withdrawal by Subject|0|||
44523671|NCT02820298|79532014|FG001|Overall Study|Withdrawal by Subject|1|||
44523672|NCT02820298|79532013|FG000|Overall Study|Physician Decision|1|||
44523673|NCT02820298|79532014|FG001|Overall Study|Physician Decision|0|||
44523674|NCT02820298|79532013|FG000|Overall Study|Protocol Violation|0|||
44523675|NCT02820298|79532014|FG001|Overall Study|Protocol Violation|1|||
44523676|NCT02819440|79532028|FG000|Overall Study|Adverse Event|3|||
44523677|NCT02819440|79532029|FG001|Overall Study|Adverse Event|1|||
44523678|NCT02819440|79532028|FG000|Overall Study|Lost to Follow-up|1|||
44523679|NCT02819440|79532029|FG001|Overall Study|Lost to Follow-up|3|||
44523680|NCT02819440|79532028|FG000|Overall Study|Withdrawal by Subject|9|||
44523681|NCT02819440|79532029|FG001|Overall Study|Withdrawal by Subject|8|||
44523682|NCT03814720|79532040|FG000|Overall Study|Lost to Follow-up|0|||
44523683|NCT03814720|79532041|FG001|Overall Study|Lost to Follow-up|1|||
44523684|NCT03814720|79532042|FG002|Overall Study|Lost to Follow-up|0|||
44523685|NCT03814720|79532043|FG003|Overall Study|Lost to Follow-up|0|||
44523686|NCT03814720|79532044|FG004|Overall Study|Lost to Follow-up|0|||
44523687|NCT02818036|79532060|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
44406906|NCT00819585|79414748|FG005|Core Study|Administrative Problems|0|||
44406907|NCT00819585|79414749|FG006|Core Study|Administrative Problems|2|||
44523688|NCT02818036|79532061|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
44523689|NCT02818036|79532060|FG000|Overall Study|Withdrawal by Subject|1|||
44523690|NCT02818036|79532061|FG001|Overall Study|Withdrawal by Subject|0|||
44523691|NCT01287741|79532069|FG000|Overall Study|Withdrawal by Subject|35|||
44406908|NCT00819585|79414750|FG007|Core Study|Administrative Problems|0|||
44406909|NCT00819585|79414751|FG008|Core Study|Administrative Problems|0|||
44406910|NCT00819585|79414752|FG009|Core Study|Administrative Problems|0|||
44406911|NCT00819585|79414753|FG010|Core Study|Administrative Problems|0|||
44406912|NCT00819585|79414743|FG000|Core Study|Death|0|||
44406913|NCT00819585|79414744|FG001|Core Study|Death|0|||
44406914|NCT00819585|79414745|FG002|Core Study|Death|0|||
44406915|NCT00819585|79414746|FG003|Core Study|Death|0|||
44406916|NCT00819585|79414747|FG004|Core Study|Death|0|||
44406917|NCT00819585|79414748|FG005|Core Study|Death|0|||
44406918|NCT00819585|79414749|FG006|Core Study|Death|1|||
44406919|NCT00819585|79414750|FG007|Core Study|Death|0|||
44406920|NCT00819585|79414751|FG008|Core Study|Death|0|||
44406921|NCT00819585|79414752|FG009|Core Study|Death|0|||
44406922|NCT00819585|79414753|FG010|Core Study|Death|0|||
44406923|NCT00819585|79414743|FG000|Core Study|Protocol Violation|0|||
44406924|NCT00819585|79414744|FG001|Core Study|Protocol Violation|0|||
44406925|NCT00819585|79414745|FG002|Core Study|Protocol Violation|1|||
44406926|NCT00819585|79414746|FG003|Core Study|Protocol Violation|0|||
44406927|NCT00819585|79414747|FG004|Core Study|Protocol Violation|0|||
44406928|NCT00819585|79414748|FG005|Core Study|Protocol Violation|1|||
44406929|NCT00819585|79414749|FG006|Core Study|Protocol Violation|3|||
44406930|NCT00819585|79414750|FG007|Core Study|Protocol Violation|0|||
44406931|NCT00819585|79414751|FG008|Core Study|Protocol Violation|0|||
44406932|NCT00819585|79414752|FG009|Core Study|Protocol Violation|0|||
44406933|NCT00819585|79414753|FG010|Core Study|Protocol Violation|0|||
44406934|NCT00819585|79414743|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
44406935|NCT00819585|79414744|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
44406936|NCT00819585|79414745|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
44406937|NCT00819585|79414746|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
44406938|NCT00819585|79414747|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
44406939|NCT00819585|79414748|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
44406940|NCT00819585|79414749|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
44406941|NCT00819585|79414750|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
44406942|NCT00819585|79414751|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
44406943|NCT00819585|79414752|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
44406944|NCT00819585|79414753|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
44406945|NCT00819585|79414743|FG000|Extension Study|Subject Withdrew Consent|0|||
44406946|NCT00819585|79414744|FG001|Extension Study|Subject Withdrew Consent|0|||
44406947|NCT00819585|79414745|FG002|Extension Study|Subject Withdrew Consent|0|||
44406948|NCT00819585|79414746|FG003|Extension Study|Subject Withdrew Consent|0|||
44406949|NCT00819585|79414747|FG004|Extension Study|Subject Withdrew Consent|0|||
44406950|NCT00819585|79414748|FG005|Extension Study|Subject Withdrew Consent|0|||
44406951|NCT00819585|79414749|FG006|Extension Study|Subject Withdrew Consent|0|||
44406952|NCT00819585|79414750|FG007|Extension Study|Subject Withdrew Consent|0|||
44406953|NCT00819585|79414751|FG008|Extension Study|Subject Withdrew Consent|3|||
44406954|NCT00819585|79414752|FG009|Extension Study|Subject Withdrew Consent|0|||
44406955|NCT00819585|79414753|FG010|Extension Study|Subject Withdrew Consent|1|||
44406956|NCT00819585|79414743|FG000|Extension Study|Lost to Follow-up|0|||
44406957|NCT00819585|79414744|FG001|Extension Study|Lost to Follow-up|0|||
44406958|NCT00819585|79414745|FG002|Extension Study|Lost to Follow-up|0|||
44406959|NCT00819585|79414746|FG003|Extension Study|Lost to Follow-up|0|||
44406960|NCT00819585|79414747|FG004|Extension Study|Lost to Follow-up|0|||
44406961|NCT00819585|79414748|FG005|Extension Study|Lost to Follow-up|0|||
44406962|NCT00819585|79414749|FG006|Extension Study|Lost to Follow-up|0|||
44406963|NCT00819585|79414750|FG007|Extension Study|Lost to Follow-up|0|||
44406964|NCT00819585|79414751|FG008|Extension Study|Lost to Follow-up|2|||
44406965|NCT00819585|79414752|FG009|Extension Study|Lost to Follow-up|1|||
44406966|NCT00819585|79414753|FG010|Extension Study|Lost to Follow-up|1|||
44406967|NCT00819585|79414743|FG000|Extension Study|Death|0|||
44406968|NCT00819585|79414744|FG001|Extension Study|Death|0|||
44406969|NCT00819585|79414745|FG002|Extension Study|Death|0|||
44406970|NCT00819585|79414746|FG003|Extension Study|Death|0|||
44253281|NCT03830333|79093781|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
44406971|NCT00819585|79414747|FG004|Extension Study|Death|0|||
44406972|NCT00819585|79414748|FG005|Extension Study|Death|0|||
44406973|NCT00819585|79414749|FG006|Extension Study|Death|0|||
44406974|NCT00819585|79414750|FG007|Extension Study|Death|0|||
44406975|NCT00819585|79414751|FG008|Extension Study|Death|2|||
44406976|NCT00819585|79414752|FG009|Extension Study|Death|0|||
44406977|NCT00819585|79414753|FG010|Extension Study|Death|0|||
44147984|NCT03556891|78937438|FG000|Overall Study|Lost to Follow-up|1|||
44406978|NCT00508261|79414785|FG000|Overall Study|Other|0|||
44406979|NCT00508261|79414786|FG001|Overall Study|Other|1|||
44406980|NCT00508261|79414787|FG002|Overall Study|Other|1|||
44406981|NCT00508261|79414788|FG003|Overall Study|Other|0|||
44406982|NCT00508261|79414785|FG000|Overall Study|Serious Adverse Event|0|||
44406983|NCT00508261|79414786|FG001|Overall Study|Serious Adverse Event|1|||
44406984|NCT00508261|79414787|FG002|Overall Study|Serious Adverse Event|0|||
44406985|NCT00508261|79414788|FG003|Overall Study|Serious Adverse Event|0|||
44406986|NCT00508261|79414785|FG000|Overall Study|Withdrawal by Subject|3|||
44406987|NCT00508261|79414786|FG001|Overall Study|Withdrawal by Subject|4|||
44406988|NCT00508261|79414787|FG002|Overall Study|Withdrawal by Subject|4|||
44406989|NCT00508261|79414788|FG003|Overall Study|Withdrawal by Subject|0|||
44406990|NCT00508261|79414785|FG000|Overall Study|Migrated/ moved from study area|0|||
44406991|NCT00508261|79414786|FG001|Overall Study|Migrated/ moved from study area|1|||
44406992|NCT00508261|79414787|FG002|Overall Study|Migrated/ moved from study area|0|||
44406993|NCT00508261|79414788|FG003|Overall Study|Migrated/ moved from study area|0|||
44406994|NCT00508261|79414785|FG000|Overall Study|Lost to Follow-up|0|||
44406995|NCT00508261|79414786|FG001|Overall Study|Lost to Follow-up|1|||
44406996|NCT00508261|79414787|FG002|Overall Study|Lost to Follow-up|1|||
44406997|NCT00508261|79414788|FG003|Overall Study|Lost to Follow-up|1|||
44406998|NCT00819039|79414827|FG000|Overall Study|Physician Decision|1|||
44406999|NCT00819039|79414828|FG001|Overall Study|Physician Decision|0|||
44407000|NCT00819039|79414829|FG002|Overall Study|Physician Decision|1|||
44407001|NCT00819039|79414827|FG000|Overall Study|Protocol Violation|1|||
44407002|NCT00819039|79414828|FG001|Overall Study|Protocol Violation|0|||
44407003|NCT00819039|79414829|FG002|Overall Study|Protocol Violation|0|||
44523692|NCT01287741|79532070|FG001|Overall Study|Withdrawal by Subject|38|||
44523693|NCT01287741|79532069|FG000|Overall Study|Protocol Violation|2|||
44523694|NCT01287741|79532070|FG001|Overall Study|Protocol Violation|0|||
44523695|NCT01287741|79532069|FG000|Overall Study|Physician Decision|15|||
44523696|NCT01287741|79532070|FG001|Overall Study|Physician Decision|23|||
44523697|NCT01287741|79532069|FG000|Overall Study|Non-compliance|8|||
44523698|NCT01287741|79532070|FG001|Overall Study|Non-compliance|6|||
44523699|NCT01287741|79532069|FG000|Overall Study|Lost to Follow-up|10|||
44523700|NCT01287741|79532070|FG001|Overall Study|Lost to Follow-up|8|||
44523701|NCT01287741|79532069|FG000|Overall Study|Death|32|||
44523702|NCT01287741|79532070|FG001|Overall Study|Death|44|||
44523703|NCT01287741|79532069|FG000|Overall Study|Adverse Event|4|||
44523704|NCT01287741|79532070|FG001|Overall Study|Adverse Event|6|||
44523705|NCT01287741|79532069|FG000|Overall Study|Study terminated by Sponsor|307|||
44523706|NCT01287741|79532070|FG001|Overall Study|Study terminated by Sponsor|315|||
44523707|NCT01287741|79532069|FG000|Overall Study|Progressive disease|190|||
44523708|NCT01287741|79532070|FG001|Overall Study|Progressive disease|166|||
44523709|NCT01287741|79532069|FG000|Overall Study|Reason not specified|23|||
44523710|NCT01287741|79532070|FG001|Overall Study|Reason not specified|9|||
44523711|NCT05372315|79532083|FG000|Overall Study|Withdrawal by Subject|1|||
44523712|NCT05372315|79532084|FG001|Overall Study|Withdrawal by Subject|0|||
44253282|NCT00631969|79093867|FG000|Overall Study|Adverse Event|3|||
44407004|NCT00500539|79414839|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
44407005|NCT00500539|79414839|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
44407006|NCT00500539|79414839|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
44407007|NCT00500539|79414839|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
44407008|NCT00500539|79414839|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
44407009|NCT00500539|79414839|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
44407010|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
44407011|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
44407012|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
44407013|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
44407014|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Death|1|||
44407015|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
44407016|NCT00500539|79414839|FG000|Follow-up Period (16 Weeks)|Missing|3|||
44407017|NCT00818883|79414848|FG000|Overall Study|Adverse Event|28|||
44407018|NCT00818883|79414849|FG001|Overall Study|Adverse Event|19|||
44407019|NCT00818883|79414848|FG000|Overall Study|Protocol Violation|2|||
44407020|NCT00818883|79414849|FG001|Overall Study|Protocol Violation|2|||
44407021|NCT00818883|79414848|FG000|Overall Study|Lost to Follow-up|3|||
44407022|NCT00818883|79414849|FG001|Overall Study|Lost to Follow-up|2|||
44407023|NCT00818883|79414848|FG000|Overall Study|Withdrawal by Subject|16|||
44407024|NCT00818883|79414849|FG001|Overall Study|Withdrawal by Subject|14|||
44407025|NCT00818883|79414848|FG000|Overall Study|Lack of Efficacy|0|||
44407026|NCT00818883|79414849|FG001|Overall Study|Lack of Efficacy|2|||
44407027|NCT00818883|79414848|FG000|Overall Study|Other|2|||
44407028|NCT00818883|79414849|FG001|Overall Study|Other|7|||
44523713|NCT04913675|79532104|FG000|Main Study (Up to Week 36)|Death|0|||
44523714|NCT04913675|79532105|FG001|Main Study (Up to Week 36)|Death|2|||
44253283|NCT00631969|79093868|FG001|Overall Study|Adverse Event|1|||
44253284|NCT00631969|79093867|FG000|Overall Study|Lack of Efficacy|2|||
44407029|NCT00508027|79414855|FG000|Dose Level 1|Lost to Follow-up|4|||
44407030|NCT00508027|79414855|FG000|Dose Level 1|Withdrawal by Subject|2|||
44407031|NCT00508027|79414855|FG000|Dose Level 1|Physician Decision|2|||
44523715|NCT04913675|79532106|FG002|Main Study (Up to Week 36)|Death|2|||
44523716|NCT04913675|79532107|FG003|Main Study (Up to Week 36)|Death|0|||
44407032|NCT00508027|79414855|FG000|Dose Level 2|Lost to Follow-up|2|||
44407033|NCT00508027|79414855|FG000|Dose Level 2|Withdrawal by Subject|2|||
44407034|NCT00500149|79414884|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
44407035|NCT00500149|79414885|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
44523717|NCT04913675|79532104|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
44523718|NCT04913675|79532105|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
44407036|NCT00500149|79414884|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
44523719|NCT04913675|79532106|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
44407037|NCT00500149|79414885|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
44407038|NCT00500149|79414884|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
44407039|NCT00500149|79414885|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
44407040|NCT00500149|79414884|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
44407041|NCT00500149|79414885|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
44407042|NCT00500149|79414884|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
44407043|NCT00500149|79414885|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
44407044|NCT00500149|79414884|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
44407045|NCT00500149|79414885|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
44407046|NCT00500149|79414884|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
44407047|NCT00500149|79414885|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
44407048|NCT00489853|79414891|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
44407049|NCT00489853|79414892|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
44407050|NCT00489853|79414893|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
44407051|NCT00489853|79414891|FG000|Wash-out Period 1|Adverse Event|0|||
44407052|NCT00489853|79414892|FG001|Wash-out Period 1|Adverse Event|1|||
44407053|NCT00489853|79414893|FG002|Wash-out Period 1|Adverse Event|1|||
44407054|NCT00489853|79414891|FG000|Wash-out Period 1|Protocol Violation|0|||
44407055|NCT00489853|79414892|FG001|Wash-out Period 1|Protocol Violation|1|||
44407056|NCT00489853|79414893|FG002|Wash-out Period 1|Protocol Violation|1|||
44407057|NCT00489853|79414891|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
44407058|NCT00489853|79414892|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
44407059|NCT00489853|79414893|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
44407060|NCT00489853|79414891|FG000|Wash-out Period 2|Adverse Event|1|||
44407061|NCT00489853|79414892|FG001|Wash-out Period 2|Adverse Event|1|||
44407062|NCT00489853|79414893|FG002|Wash-out Period 2|Adverse Event|0|||
44407063|NCT00489853|79414891|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
44407064|NCT00489853|79414892|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
44407065|NCT00489853|79414893|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
44407066|NCT00489853|79414891|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
44407067|NCT00489853|79414892|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
44407068|NCT00489853|79414893|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
44407069|NCT03686423|79414901|FG000|Overall Study|Withdrawal by Subject|9|||
44407070|NCT03686423|79414901|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
44407071|NCT00499681|79414907|FG000|Overall Study|toxicity|0|||
44407072|NCT00499681|79414908|FG001|Overall Study|toxicity|1|||
44407073|NCT00499681|79414907|FG000|Overall Study|disease progression|0|||
44407074|NCT00499681|79414908|FG001|Overall Study|disease progression|1|||
44407075|NCT00875810|79414919|FG000|Overall Study|Withdrawal by Subject|1|||
44407076|NCT00875810|79414919|FG000|Overall Study|Physician Decision|3|||
44407077|NCT00875810|79414919|FG000|Overall Study|Lost to Follow-up|39|||
44407078|NCT00875810|79414919|FG000|Overall Study|Patient enroled but not implanted|2|||
44407079|NCT00875810|79414919|FG000|Overall Study|Device explanted|1|||
44407080|NCT00499603|79414925|FG000|Overall Study|Adverse Event|0|||
44407081|NCT00499603|79414926|FG001|Overall Study|Adverse Event|1|||
44407082|NCT00810069|79414945|FG000|Lead-in Period I|Adverse Event|43|||
44407083|NCT00810069|79414946|FG001|Lead-in Period I|Adverse Event|0|||
44407084|NCT00810069|79414947|FG002|Lead-in Period I|Adverse Event|0|||
44407085|NCT00810069|79414945|FG000|Lead-in Period I|Lack of Efficacy|1|||
44407086|NCT00810069|79414946|FG001|Lead-in Period I|Lack of Efficacy|0|||
44523720|NCT04913675|79532107|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
44523721|NCT04913675|79532104|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
44523722|NCT04913675|79532105|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
44523723|NCT04913675|79532106|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
44523724|NCT04913675|79532107|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
44523725|NCT04913675|79532104|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
44523726|NCT04913675|79532105|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
44523727|NCT04913675|79532106|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
44523728|NCT04913675|79532107|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
44523729|NCT04913675|79532104|FG000|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
44523730|NCT04913675|79532105|FG001|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
44407087|NCT00810069|79414947|FG002|Lead-in Period I|Lack of Efficacy|0|||
44407088|NCT00810069|79414945|FG000|Lead-in Period I|Lost to Follow-up|19|||
44407089|NCT00810069|79414946|FG001|Lead-in Period I|Lost to Follow-up|0|||
44407090|NCT00810069|79414947|FG002|Lead-in Period I|Lost to Follow-up|0|||
44407091|NCT00810069|79414945|FG000|Lead-in Period I|Physician Decision|1|||
44407092|NCT00810069|79414946|FG001|Lead-in Period I|Physician Decision|0|||
44407093|NCT00810069|79414947|FG002|Lead-in Period I|Physician Decision|0|||
44407094|NCT00810069|79414945|FG000|Lead-in Period I|Protocol Violation|1|||
44407095|NCT00810069|79414946|FG001|Lead-in Period I|Protocol Violation|0|||
44407096|NCT00810069|79414947|FG002|Lead-in Period I|Protocol Violation|0|||
44407097|NCT00810069|79414945|FG000|Lead-in Period I|Withdrawal by Subject|46|||
44407098|NCT00810069|79414946|FG001|Lead-in Period I|Withdrawal by Subject|0|||
44407099|NCT00810069|79414947|FG002|Lead-in Period I|Withdrawal by Subject|0|||
44407100|NCT00810069|79414945|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
44407101|NCT00810069|79414946|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
44407102|NCT00810069|79414947|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
44407103|NCT00810069|79414945|FG000|Lead-in Period I|Randomization criteria not met|158|||
44407104|NCT00810069|79414946|FG001|Lead-in Period I|Randomization criteria not met|0|||
44407105|NCT00810069|79414947|FG002|Lead-in Period I|Randomization criteria not met|0|||
44407106|NCT00810069|79414945|FG000|Double-Blind Period II|Adverse Event|0|||
44407107|NCT00810069|79414946|FG001|Double-Blind Period II|Adverse Event|9|||
44407108|NCT00810069|79414947|FG002|Double-Blind Period II|Adverse Event|8|||
44407109|NCT00810069|79414945|FG000|Double-Blind Period II|Lack of Efficacy|0|||
44407110|NCT00810069|79414946|FG001|Double-Blind Period II|Lack of Efficacy|7|||
44407111|NCT00810069|79414947|FG002|Double-Blind Period II|Lack of Efficacy|12|||
44407112|NCT00810069|79414945|FG000|Double-Blind Period II|Lost to Follow-up|0|||
44523731|NCT04913675|79532106|FG002|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
44523732|NCT04913675|79532107|FG003|Safety Sub-study (Up to Day 29)|Ongoing in this study|80|||
44523733|NCT04913675|79532104|FG000|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
44523734|NCT04913675|79532105|FG001|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
44523735|NCT04913675|79532106|FG002|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
44523736|NCT04913675|79532107|FG003|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|1|||
44523737|NCT04760314|79532124|FG000|Induction Period|Withdrawal by Subject|0|||
44523738|NCT04760314|79532125|FG001|Induction Period|Withdrawal by Subject|1|||
44523739|NCT04760314|79532126|FG002|Induction Period|Withdrawal by Subject|1|||
44523740|NCT04760314|79532127|FG003|Induction Period|Withdrawal by Subject|0|||
44523741|NCT04760314|79532128|FG004|Induction Period|Withdrawal by Subject|0|||
44523742|NCT04760314|79532129|FG005|Induction Period|Withdrawal by Subject|0|||
44523743|NCT04760314|79532130|FG006|Induction Period|Withdrawal by Subject|0|||
44523744|NCT04760314|79532131|FG007|Induction Period|Withdrawal by Subject|0|||
44523745|NCT04760314|79532132|FG008|Induction Period|Withdrawal by Subject|0|||
44523746|NCT04760314|79532133|FG009|Induction Period|Withdrawal by Subject|0|||
44523747|NCT04760314|79532134|FG010|Induction Period|Withdrawal by Subject|0|||
44523748|NCT04760314|79532124|FG000|Induction Period|Adverse Event|0|||
44523749|NCT04760314|79532125|FG001|Induction Period|Adverse Event|0|||
44523750|NCT04760314|79532126|FG002|Induction Period|Adverse Event|2|||
44523751|NCT04760314|79532127|FG003|Induction Period|Adverse Event|0|||
44523752|NCT04760314|79532128|FG004|Induction Period|Adverse Event|0|||
44523753|NCT04760314|79532129|FG005|Induction Period|Adverse Event|0|||
44523754|NCT04760314|79532130|FG006|Induction Period|Adverse Event|0|||
44523755|NCT04760314|79532131|FG007|Induction Period|Adverse Event|0|||
44523756|NCT04760314|79532132|FG008|Induction Period|Adverse Event|0|||
44523757|NCT04760314|79532133|FG009|Induction Period|Adverse Event|0|||
44523758|NCT04760314|79532134|FG010|Induction Period|Adverse Event|0|||
44523759|NCT04760314|79532124|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523760|NCT04760314|79532125|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523761|NCT04760314|79532126|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523762|NCT04760314|79532127|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
44523763|NCT04760314|79532128|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
44523764|NCT04760314|79532129|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
44523765|NCT04760314|79532130|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
44523766|NCT04760314|79532131|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523767|NCT04760314|79532132|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523768|NCT04760314|79532133|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523769|NCT04760314|79532134|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
44523770|NCT04760314|79532124|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523771|NCT04760314|79532125|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523772|NCT04760314|79532126|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523773|NCT04760314|79532127|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
44523774|NCT04760314|79532128|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523775|NCT04760314|79532129|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
44523776|NCT04760314|79532130|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
44523777|NCT04760314|79532131|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523778|NCT04760314|79532132|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523779|NCT04760314|79532133|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523780|NCT04760314|79532134|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
44523781|NCT04760314|79532124|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523782|NCT04760314|79532125|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523783|NCT04760314|79532126|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523784|NCT04760314|79532127|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44407113|NCT00810069|79414946|FG001|Double-Blind Period II|Lost to Follow-up|9|||
44407114|NCT00810069|79414947|FG002|Double-Blind Period II|Lost to Follow-up|9|||
44407115|NCT00810069|79414945|FG000|Double-Blind Period II|Physician Decision|0|||
44407116|NCT00810069|79414946|FG001|Double-Blind Period II|Physician Decision|0|||
44407117|NCT00810069|79414947|FG002|Double-Blind Period II|Physician Decision|1|||
44407118|NCT00810069|79414945|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
44407119|NCT00810069|79414946|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
44407120|NCT00810069|79414947|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
44407121|NCT00810069|79414945|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
44407122|NCT00810069|79414946|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
44407123|NCT00810069|79414947|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
44523785|NCT04760314|79532128|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
44523786|NCT04760314|79532129|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523787|NCT04760314|79532130|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523788|NCT04760314|79532131|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523789|NCT04760314|79532132|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523790|NCT04760314|79532133|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523791|NCT04760314|79532134|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
44523792|NCT04760314|79532124|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
44523793|NCT04760314|79532125|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
44523794|NCT04760314|79532126|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
44523795|NCT04760314|79532127|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
44523796|NCT04760314|79532128|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
44523797|NCT04760314|79532129|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
44523798|NCT04760314|79532130|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
44523799|NCT04760314|79532131|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
44523800|NCT04760314|79532132|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
44407124|NCT00810069|79414945|FG000|Double-Blind Period II|Clinical relapse|0|||
44407125|NCT00810069|79414946|FG001|Double-Blind Period II|Clinical relapse|3|||
44407126|NCT00810069|79414947|FG002|Double-Blind Period II|Clinical relapse|0|||
44407127|NCT00810069|79414945|FG000|Double-Blind Period II|Protocol Violation|0|||
44407128|NCT00810069|79414946|FG001|Double-Blind Period II|Protocol Violation|7|||
44407129|NCT00810069|79414947|FG002|Double-Blind Period II|Protocol Violation|6|||
44407130|NCT00489541|79414958|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
44407131|NCT00489541|79414959|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
44407132|NCT00489541|79414958|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
44407133|NCT00489541|79414959|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
44407134|NCT00489541|79414958|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
44407135|NCT00489541|79414959|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
44407136|NCT00489541|79414958|FG000|12-Month Clinical Follow-up|Death|3|||
44407137|NCT00489541|79414959|FG001|12-Month Clinical Follow-up|Death|2|||
44407138|NCT00489541|79414958|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
44407139|NCT00489541|79414959|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
44407140|NCT00489541|79414958|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
44407141|NCT00489541|79414959|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
44407142|NCT00809835|79414969|FG000|Overall Study|Lost to Follow-up|7|||
44407143|NCT00809835|79414970|FG001|Overall Study|Lost to Follow-up|6|||
44407144|NCT00809835|79414971|FG002|Overall Study|Lost to Follow-up|10|||
44407145|NCT00809835|79414972|FG003|Overall Study|Lost to Follow-up|2|||
44407146|NCT00809835|79414969|FG000|Overall Study|Withdrawal by Subject|1|||
44407147|NCT00809835|79414970|FG001|Overall Study|Withdrawal by Subject|1|||
44523801|NCT04760314|79532133|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
44523802|NCT04760314|79532134|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
44523803|NCT04760314|79532124|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44523804|NCT04760314|79532125|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44523805|NCT04760314|79532126|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44523806|NCT04760314|79532127|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44523807|NCT04760314|79532128|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44523808|NCT04760314|79532129|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44282086|NCT01904604|79245334|FG002|Overall Study|Non-compliance|0|||
44282087|NCT01904604|79245332|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
44523809|NCT04760314|79532130|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44523810|NCT04760314|79532131|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
44523811|NCT04760314|79532132|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44282088|NCT01904604|79245333|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
44282089|NCT01904604|79245334|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
44282090|NCT01904604|79245332|FG000|Overall Study|Patch site reactions|1|||
44282091|NCT01904604|79245333|FG001|Overall Study|Patch site reactions|1|||
44407148|NCT00809835|79414971|FG002|Overall Study|Withdrawal by Subject|1|||
44407149|NCT00809835|79414972|FG003|Overall Study|Withdrawal by Subject|0|||
44407150|NCT00853242|79414989|FG000|Overall Study|Adverse Event|0|||
44407151|NCT00853242|79414990|FG001|Overall Study|Adverse Event|1|||
44407152|NCT00853242|79414991|FG002|Overall Study|Adverse Event|1|||
44407153|NCT00853242|79414992|FG003|Overall Study|Adverse Event|0|||
44407154|NCT00853242|79414993|FG004|Overall Study|Adverse Event|3|||
44407155|NCT00853242|79414994|FG005|Overall Study|Adverse Event|1|||
44407156|NCT00853242|79414995|FG006|Overall Study|Adverse Event|1|||
44407157|NCT00853242|79414989|FG000|Overall Study|Noncompliant|0|||
44407158|NCT00853242|79414990|FG001|Overall Study|Noncompliant|0|||
44407159|NCT00853242|79414991|FG002|Overall Study|Noncompliant|0|||
44407160|NCT00853242|79414992|FG003|Overall Study|Noncompliant|0|||
44407161|NCT00853242|79414993|FG004|Overall Study|Noncompliant|1|||
44407162|NCT00853242|79414994|FG005|Overall Study|Noncompliant|0|||
44407163|NCT00853242|79414995|FG006|Overall Study|Noncompliant|0|||
44407164|NCT00853242|79414989|FG000|Overall Study|Withdrawal by Subject|1|||
44407165|NCT00853242|79414990|FG001|Overall Study|Withdrawal by Subject|2|||
44407166|NCT00853242|79414991|FG002|Overall Study|Withdrawal by Subject|0|||
44407167|NCT00853242|79414992|FG003|Overall Study|Withdrawal by Subject|4|||
44407168|NCT00853242|79414993|FG004|Overall Study|Withdrawal by Subject|0|||
44407169|NCT00853242|79414994|FG005|Overall Study|Withdrawal by Subject|0|||
44407170|NCT00853242|79414995|FG006|Overall Study|Withdrawal by Subject|2|||
44407171|NCT00853242|79414989|FG000|Overall Study|Other|2|||
44407172|NCT00853242|79414990|FG001|Overall Study|Other|0|||
44407173|NCT00853242|79414991|FG002|Overall Study|Other|2|||
44407174|NCT00853242|79414992|FG003|Overall Study|Other|0|||
44407175|NCT00853242|79414993|FG004|Overall Study|Other|0|||
44407176|NCT00853242|79414994|FG005|Overall Study|Other|1|||
44407177|NCT00853242|79414995|FG006|Overall Study|Other|2|||
44407178|NCT00848250|79415019|FG000|Overall Study|surgery was completed without cardiopulm|0|||
44407179|NCT00848250|79415020|FG001|Overall Study|surgery was completed without cardiopulm|1|||
44407180|NCT00809757|79415030|FG000|Overall Study|Adverse Event|2|||
44407181|NCT00809757|79415031|FG001|Overall Study|Adverse Event|3|||
44253285|NCT00631969|79093868|FG001|Overall Study|Lack of Efficacy|8|||
44253286|NCT00631969|79093867|FG000|Overall Study|Lost to Follow-up|2|||
44407182|NCT00809757|79415032|FG002|Overall Study|Adverse Event|3|||
44407183|NCT00809757|79415030|FG000|Overall Study|Lost to Follow-up|0|||
44407184|NCT00809757|79415031|FG001|Overall Study|Lost to Follow-up|0|||
44407185|NCT00809757|79415032|FG002|Overall Study|Lost to Follow-up|1|||
44407186|NCT00809757|79415030|FG000|Overall Study|Protocol Violation|1|||
44407187|NCT00809757|79415031|FG001|Overall Study|Protocol Violation|1|||
44407188|NCT00809757|79415032|FG002|Overall Study|Protocol Violation|1|||
44407189|NCT00809757|79415030|FG000|Overall Study|Withdrawal by Subject|2|||
44407190|NCT00809757|79415031|FG001|Overall Study|Withdrawal by Subject|1|||
44407191|NCT00809757|79415032|FG002|Overall Study|Withdrawal by Subject|3|||
44407192|NCT00809757|79415030|FG000|Overall Study|Subject Uncooperative|1|||
44407193|NCT00809757|79415031|FG001|Overall Study|Subject Uncooperative|0|||
44407194|NCT00809757|79415032|FG002|Overall Study|Subject Uncooperative|2|||
44407195|NCT00809757|79415030|FG000|Overall Study|Noncompliance with Medication|0|||
44407196|NCT00809757|79415031|FG001|Overall Study|Noncompliance with Medication|0|||
44407197|NCT00809757|79415032|FG002|Overall Study|Noncompliance with Medication|1|||
44407198|NCT00594464|79415046|FG000|Overall Study|Withdrawal by Subject|1|||
44407199|NCT00594464|79415046|FG000|Overall Study|Delay in operation|2|||
44407200|NCT00809445|79415059|FG000|1 Month Follow-up|Lost contact|1|||
44407201|NCT00809445|79415060|FG001|1 Month Follow-up|Lost contact|2|||
44407202|NCT00809445|79415061|FG002|1 Month Follow-up|Lost contact|1|||
44407203|NCT00809445|79415059|FG000|1 Month Follow-up|Withdrew consent|1|||
44147985|NCT03556891|78937438|FG000|Overall Study|Missing at random|1|||
44253287|NCT00631969|79093868|FG001|Overall Study|Lost to Follow-up|1|||
44407204|NCT00809445|79415060|FG001|1 Month Follow-up|Withdrew consent|1|||
44407205|NCT00809445|79415061|FG002|1 Month Follow-up|Withdrew consent|1|||
44523812|NCT04760314|79532133|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
44523813|NCT04760314|79532134|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
44253288|NCT00631969|79093867|FG000|Overall Study|Protocol Violation|1|||
44253289|NCT00631969|79093868|FG001|Overall Study|Protocol Violation|1|||
44253290|NCT00631969|79093867|FG000|Overall Study|Consent Withdrawn|5|||
44253291|NCT00631969|79093868|FG001|Overall Study|Consent Withdrawn|7|||
44253292|NCT00631969|79093867|FG000|Overall Study|Noncompliant With Study Medication|0|||
44253293|NCT00631969|79093868|FG001|Overall Study|Noncompliant With Study Medication|1|||
44253294|NCT00631969|79093867|FG000|Overall Study|No Drug Exposure|2|||
44253295|NCT00631969|79093868|FG001|Overall Study|No Drug Exposure|2|||
44407206|NCT00809445|79415059|FG000|1 Month Follow-up|Death|0|||
44407207|NCT00809445|79415060|FG001|1 Month Follow-up|Death|1|||
44407208|NCT00809445|79415061|FG002|1 Month Follow-up|Death|1|||
44407209|NCT00809445|79415059|FG000|1 Month Follow-up|Incarcerated|0|||
44407210|NCT00809445|79415060|FG001|1 Month Follow-up|Incarcerated|0|||
44407211|NCT00809445|79415061|FG002|1 Month Follow-up|Incarcerated|1|||
44407212|NCT00809445|79415059|FG000|6 Month Follow-up|Lost contact|16|||
44407213|NCT00809445|79415060|FG001|6 Month Follow-up|Lost contact|14|||
44407214|NCT00809445|79415061|FG002|6 Month Follow-up|Lost contact|14|||
44253296|NCT00631657|79093904|FG000|6-Month Treatment Period|Adverse Event|47|||
44407215|NCT00809445|79415059|FG000|6 Month Follow-up|Death|2|||
44407216|NCT00809445|79415060|FG001|6 Month Follow-up|Death|1|||
44407217|NCT00809445|79415061|FG002|6 Month Follow-up|Death|1|||
44407218|NCT00809445|79415059|FG000|6 Month Follow-up|Incarcerated|6|||
44407219|NCT00809445|79415060|FG001|6 Month Follow-up|Incarcerated|8|||
44407220|NCT00809445|79415061|FG002|6 Month Follow-up|Incarcerated|8|||
44407221|NCT00809445|79415059|FG000|6 Month Follow-up|Withdrew consent|0|||
44407222|NCT00809445|79415060|FG001|6 Month Follow-up|Withdrew consent|0|||
44407223|NCT00809445|79415061|FG002|6 Month Follow-up|Withdrew consent|1|||
44407224|NCT00593918|79415084|FG000|Overall Study|Withdrawal by Subject|5|||
44407225|NCT00593918|79415085|FG001|Overall Study|Withdrawal by Subject|24|||
44407226|NCT04135196|79415096|FG000|Overall Study|Lost to Follow-up|8|||
44407227|NCT04135196|79415097|FG001|Overall Study|Lost to Follow-up|7|||
44407228|NCT04135196|79415098|FG002|Overall Study|Lost to Follow-up|8|||
44407229|NCT04135196|79415099|FG003|Overall Study|Lost to Follow-up|9|||
44407230|NCT04135196|79415100|FG004|Overall Study|Lost to Follow-up|1|||
44407231|NCT04135196|79415096|FG000|Overall Study|Pregnancy|0|||
44407232|NCT04135196|79415097|FG001|Overall Study|Pregnancy|0|||
44407233|NCT04135196|79415098|FG002|Overall Study|Pregnancy|1|||
44407234|NCT04135196|79415099|FG003|Overall Study|Pregnancy|0|||
44407235|NCT04135196|79415100|FG004|Overall Study|Pregnancy|0|||
44407236|NCT04135196|79415096|FG000|Overall Study|Withdrawal by Subject|0|||
44407237|NCT04135196|79415097|FG001|Overall Study|Withdrawal by Subject|0|||
44407238|NCT04135196|79415098|FG002|Overall Study|Withdrawal by Subject|0|||
44407239|NCT04135196|79415099|FG003|Overall Study|Withdrawal by Subject|0|||
44407240|NCT04135196|79415100|FG004|Overall Study|Withdrawal by Subject|1|||
44407241|NCT00499369|79415117|FG000|Overall Study|Adverse Event|2|||
44407242|NCT00499369|79415118|FG001|Overall Study|Adverse Event|2|||
44407243|NCT00499369|79415119|FG002|Overall Study|Adverse Event|3|||
44407244|NCT00499369|79415120|FG003|Overall Study|Adverse Event|1|||
44407245|NCT00499369|79415121|FG004|Overall Study|Adverse Event|2|||
44407246|NCT00499369|79415117|FG000|Overall Study|Withdrawal by Subject|0|||
44523814|NCT04760314|79532124|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523815|NCT04760314|79532125|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523816|NCT04760314|79532126|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523817|NCT04760314|79532127|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523818|NCT04760314|79532128|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523819|NCT04760314|79532129|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523820|NCT04760314|79532130|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523821|NCT04760314|79532131|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
44523822|NCT04760314|79532132|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
44523823|NCT04760314|79532133|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
44523824|NCT04760314|79532134|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44523825|NCT04760314|79532124|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523826|NCT04760314|79532125|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523827|NCT04760314|79532126|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523828|NCT04760314|79532127|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523829|NCT04760314|79532128|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523830|NCT04760314|79532129|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523831|NCT04760314|79532130|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523832|NCT04760314|79532131|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
44523833|NCT04760314|79532132|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523834|NCT04760314|79532133|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523835|NCT04760314|79532134|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44523836|NCT04760314|79532124|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523837|NCT04760314|79532125|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523838|NCT04760314|79532126|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523839|NCT04760314|79532127|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
44147986|NCT03556891|78937438|FG000|Overall Study|Missing due to COVID|1|||
44407247|NCT00499369|79415118|FG001|Overall Study|Withdrawal by Subject|1|||
44407248|NCT00499369|79415119|FG002|Overall Study|Withdrawal by Subject|1|||
44407249|NCT00499369|79415120|FG003|Overall Study|Withdrawal by Subject|0|||
44407250|NCT00499369|79415121|FG004|Overall Study|Withdrawal by Subject|0|||
44407251|NCT00499369|79415117|FG000|Overall Study|Progression|10|||
44407252|NCT00499369|79415118|FG001|Overall Study|Progression|12|||
44407253|NCT00499369|79415119|FG002|Overall Study|Progression|9|||
44407254|NCT00499369|79415120|FG003|Overall Study|Progression|6|||
44407255|NCT00499369|79415121|FG004|Overall Study|Progression|10|||
44407256|NCT00499369|79415117|FG000|Overall Study|Death|0|||
44407257|NCT00499369|79415118|FG001|Overall Study|Death|1|||
44407258|NCT00499369|79415119|FG002|Overall Study|Death|0|||
44407259|NCT00499369|79415120|FG003|Overall Study|Death|0|||
44407260|NCT00499369|79415121|FG004|Overall Study|Death|0|||
44407261|NCT00499369|79415117|FG000|Overall Study|Not protocol specified|2|||
44407262|NCT00499369|79415118|FG001|Overall Study|Not protocol specified|0|||
44407263|NCT00499369|79415119|FG002|Overall Study|Not protocol specified|3|||
44407264|NCT00499369|79415120|FG003|Overall Study|Not protocol specified|1|||
44523840|NCT04760314|79532128|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523841|NCT04760314|79532129|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523842|NCT04760314|79532130|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523843|NCT04760314|79532131|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523844|NCT04760314|79532132|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
44523845|NCT04760314|79532133|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
44523846|NCT04760314|79532134|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
44523847|NCT04493684|79532177|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
44523848|NCT04493684|79532178|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44253297|NCT00631657|79093905|FG001|6-Month Treatment Period|Adverse Event|0|||
44253298|NCT00631657|79093906|FG002|6-Month Treatment Period|Adverse Event|7|||
44407265|NCT00499369|79415121|FG004|Overall Study|Not protocol specified|0|||
44407266|NCT00499369|79415117|FG000|Overall Study|Ineligible|2|||
44407267|NCT00499369|79415118|FG001|Overall Study|Ineligible|2|||
44407268|NCT00499369|79415119|FG002|Overall Study|Ineligible|1|||
44407269|NCT00499369|79415120|FG003|Overall Study|Ineligible|1|||
44407270|NCT00499369|79415121|FG004|Overall Study|Ineligible|0|||
44407271|NCT00869258|79415133|FG000|Overall Study|Physician Decision|1|||
44407272|NCT00693784|79415137|FG000|Overall Study|Lost to Follow-up|2|||
44407273|NCT00693784|79415137|FG000|Overall Study|Withdrawal by Subject|2|||
44407274|NCT00693706|79415143|FG000|Overall Study|Protocol Violation|0|||
44407275|NCT00693706|79415144|FG001|Overall Study|Protocol Violation|1|||
44407276|NCT00488683|79415153|FG000|Overall Study|Withdrawal by Subject|1|||
44407277|NCT00488683|79415154|FG001|Overall Study|Withdrawal by Subject|2|||
44407278|NCT00488683|79415155|FG002|Overall Study|Withdrawal by Subject|2|||
44407279|NCT00488683|79415153|FG000|Overall Study|Lost to Follow-up|5|||
44407280|NCT00488683|79415154|FG001|Overall Study|Lost to Follow-up|3|||
44407281|NCT00488683|79415155|FG002|Overall Study|Lost to Follow-up|0|||
44407282|NCT00488683|79415153|FG000|Overall Study|Protocol Violation|5|||
44407283|NCT00488683|79415154|FG001|Overall Study|Protocol Violation|1|||
44407284|NCT00488683|79415155|FG002|Overall Study|Protocol Violation|0|||
44407285|NCT00488683|79415153|FG000|Overall Study|Unable to Classify|1|||
44407286|NCT00488683|79415154|FG001|Overall Study|Unable to Classify|0|||
44407287|NCT00488683|79415155|FG002|Overall Study|Unable to Classify|0|||
44253299|NCT00631657|79093904|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
44253300|NCT00631657|79093905|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
44253301|NCT00631657|79093906|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
44253302|NCT00631657|79093904|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
44253303|NCT00631657|79093905|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
44253304|NCT00631657|79093906|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
44253305|NCT00631657|79093904|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
44253306|NCT00631657|79093905|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
44253307|NCT00631657|79093906|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
44253308|NCT00631657|79093904|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
44253309|NCT00631657|79093905|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
44253310|NCT00631657|79093906|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
44253311|NCT00631657|79093904|FG000|6-Month Treatment Period|Other|16|||
44253312|NCT00631657|79093905|FG001|6-Month Treatment Period|Other|0|||
44253313|NCT00631657|79093906|FG002|6-Month Treatment Period|Other|4|||
44253314|NCT00631657|79093904|FG000|6-Month Treatment Period|Not Treated|2|||
44253315|NCT00631657|79093905|FG001|6-Month Treatment Period|Not Treated|0|||
44253316|NCT00631657|79093906|FG002|6-Month Treatment Period|Not Treated|1|||
44253317|NCT00631657|79093904|FG000|7-Day Discontinuation Period|Not Treated|1|||
44253318|NCT00631657|79093905|FG001|7-Day Discontinuation Period|Not Treated|1|||
44253319|NCT00631657|79093906|FG002|7-Day Discontinuation Period|Not Treated|1|||
44253320|NCT00631657|79093904|FG000|7-Day Discontinuation Period|Other|1|||
44253321|NCT00631657|79093905|FG001|7-Day Discontinuation Period|Other|0|||
44253322|NCT00631657|79093906|FG002|7-Day Discontinuation Period|Other|0|||
44253323|NCT00631189|79093944|FG000|Initial Phase|Protocol Violation|347|||
44253324|NCT00631189|79093945|FG001|Initial Phase|Protocol Violation|0|||
44253325|NCT00631189|79093946|FG002|Initial Phase|Protocol Violation|0|||
44253326|NCT00631189|79093947|FG003|Initial Phase|Protocol Violation|0|||
44407288|NCT00693472|79415189|FG000|Part 1|Adverse Event|1|||
44407289|NCT00693472|79415190|FG001|Part 1|Adverse Event|1|||
44407290|NCT00693472|79415191|FG002|Part 1|Adverse Event|0|||
44407291|NCT00693472|79415192|FG003|Part 1|Adverse Event|0|||
44407292|NCT00693472|79415189|FG000|Part 1|Lost to Follow-up|0|||
44407293|NCT00693472|79415190|FG001|Part 1|Lost to Follow-up|1|||
44407294|NCT00693472|79415191|FG002|Part 1|Lost to Follow-up|0|||
44407295|NCT00693472|79415192|FG003|Part 1|Lost to Follow-up|0|||
44407296|NCT00693472|79415189|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
44407297|NCT00693472|79415190|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
44407298|NCT00693472|79415191|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
44407299|NCT00693472|79415192|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
44407300|NCT00693472|79415189|FG000|Part 2|Adverse Event|0|||
44407301|NCT00693472|79415190|FG001|Part 2|Adverse Event|0|||
44407302|NCT00693472|79415191|FG002|Part 2|Adverse Event|1|||
44407303|NCT00693472|79415192|FG003|Part 2|Adverse Event|0|||
44407304|NCT00693472|79415189|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
44407305|NCT00693472|79415190|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
44407306|NCT00693472|79415191|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
44407307|NCT00693472|79415192|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
44407308|NCT00498433|79415205|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
44407309|NCT00498433|79415206|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
44407310|NCT00498433|79415207|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
44407311|NCT00498433|79415205|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
44407312|NCT00498433|79415206|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
44407313|NCT00498433|79415207|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
44407314|NCT00498433|79415205|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
44407315|NCT00498433|79415206|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
44407316|NCT00498433|79415207|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
44407317|NCT00498433|79415205|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
44407318|NCT00498433|79415206|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
44407319|NCT00498433|79415207|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
44407320|NCT00498355|79415224|FG000|Overall Study|Lost to Follow-up|1|||
44253327|NCT00631189|79093944|FG000|Initial Phase|Withdrawal by Subject|4|||
44253328|NCT00631189|79093945|FG001|Initial Phase|Withdrawal by Subject|0|||
44253329|NCT00631189|79093946|FG002|Initial Phase|Withdrawal by Subject|0|||
44253330|NCT00631189|79093947|FG003|Initial Phase|Withdrawal by Subject|0|||
44253331|NCT00631189|79093944|FG000|Treatment Phase|Withdrawal by Subject|0|||
44253332|NCT00631189|79093945|FG001|Treatment Phase|Withdrawal by Subject|2|||
44253333|NCT00631189|79093946|FG002|Treatment Phase|Withdrawal by Subject|1|||
44253334|NCT00631189|79093947|FG003|Treatment Phase|Withdrawal by Subject|1|||
44253335|NCT00631189|79093944|FG000|Treatment Phase|Protocol Violation|0|||
44253336|NCT00631189|79093945|FG001|Treatment Phase|Protocol Violation|1|||
44253337|NCT00631189|79093946|FG002|Treatment Phase|Protocol Violation|6|||
44253338|NCT00631189|79093947|FG003|Treatment Phase|Protocol Violation|2|||
44253339|NCT00631189|79093944|FG000|Treatment Phase|Adverse Event|0|||
44253340|NCT00631189|79093945|FG001|Treatment Phase|Adverse Event|3|||
44253341|NCT00631189|79093946|FG002|Treatment Phase|Adverse Event|2|||
44253342|NCT00631189|79093947|FG003|Treatment Phase|Adverse Event|4|||
44253343|NCT00631189|79093944|FG000|Treatment Phase|Lost to Follow-up|0|||
44253344|NCT00631189|79093945|FG001|Treatment Phase|Lost to Follow-up|1|||
44253345|NCT00631189|79093946|FG002|Treatment Phase|Lost to Follow-up|0|||
44253346|NCT00631189|79093947|FG003|Treatment Phase|Lost to Follow-up|0|||
44253347|NCT00631189|79093944|FG000|Treatment Phase|Pregnancy|0|||
44253348|NCT00631189|79093945|FG001|Treatment Phase|Pregnancy|0|||
44253349|NCT00631189|79093946|FG002|Treatment Phase|Pregnancy|1|||
44253350|NCT00631189|79093947|FG003|Treatment Phase|Pregnancy|0|||
44253351|NCT00631189|79093944|FG000|Treatment Phase|patient did not take pravastatin|0|||
44253352|NCT00631189|79093945|FG001|Treatment Phase|patient did not take pravastatin|0|||
44253353|NCT00631189|79093946|FG002|Treatment Phase|patient did not take pravastatin|1|||
44253354|NCT00631189|79093947|FG003|Treatment Phase|patient did not take pravastatin|0|||
44253355|NCT00630877|79093960|FG000|Overall Study|Adverse Event|11|||
44253356|NCT00630877|79093961|FG001|Overall Study|Adverse Event|8|||
44253357|NCT00630877|79093962|FG002|Overall Study|Adverse Event|7|||
44253358|NCT00630877|79093960|FG000|Overall Study|Withdrawal by Subject|3|||
44253359|NCT00630877|79093961|FG001|Overall Study|Withdrawal by Subject|4|||
44253360|NCT00630877|79093962|FG002|Overall Study|Withdrawal by Subject|0|||
44253361|NCT00630877|79093960|FG000|Overall Study|Lost to Follow-up|2|||
44253362|NCT00630877|79093961|FG001|Overall Study|Lost to Follow-up|0|||
44253363|NCT00630877|79093962|FG002|Overall Study|Lost to Follow-up|0|||
44253364|NCT00630877|79093960|FG000|Overall Study|Noncompliance|2|||
44282092|NCT01904604|79245334|FG002|Overall Study|Patch site reactions|0|||
44282093|NCT01904604|79245332|FG000|Overall Study|Increased syncope|0|||
44282094|NCT01904604|79245333|FG001|Overall Study|Increased syncope|1|||
44282095|NCT01904604|79245334|FG002|Overall Study|Increased syncope|0|||
44282096|NCT01904604|79245332|FG000|Overall Study|Unrelated illness|0|||
44282097|NCT01904604|79245333|FG001|Overall Study|Unrelated illness|1|||
44282098|NCT01904604|79245334|FG002|Overall Study|Unrelated illness|0|||
44282099|NCT01904604|79245332|FG000|Overall Study|Passed Week 52 OFC|1|||
44282100|NCT01904604|79245333|FG001|Overall Study|Passed Week 52 OFC|0|||
44282101|NCT01904604|79245334|FG002|Overall Study|Passed Week 52 OFC|0|||
44282102|NCT01904604|79245332|FG000|Overall Study|Withdrawal by Subject|1|||
44407321|NCT04327271|79415231|FG000|Overall Study|Death|1|||
44407322|NCT04327271|79415232|FG001|Overall Study|Death|0|||
44407323|NCT04327271|79415231|FG000|Overall Study|Withdrawal by Subject|1|||
44407324|NCT04327271|79415232|FG001|Overall Study|Withdrawal by Subject|0|||
44282103|NCT01904604|79245333|FG001|Overall Study|Withdrawal by Subject|2|||
44253365|NCT00630877|79093961|FG001|Overall Study|Noncompliance|3|||
44253366|NCT00630877|79093962|FG002|Overall Study|Noncompliance|1|||
44282104|NCT01904604|79245334|FG002|Overall Study|Withdrawal by Subject|0|||
44282105|NCT01904604|79245332|FG000|Overall Study|Participant Relocated|1|||
44407325|NCT04327271|79415231|FG000|Overall Study|randomization error (data capture)|4|||
44253367|NCT00630877|79093960|FG000|Overall Study|Protocol violation|1|||
44253368|NCT00630877|79093961|FG001|Overall Study|Protocol violation|0|||
44253369|NCT00630877|79093962|FG002|Overall Study|Protocol violation|1|||
44253370|NCT00630877|79093960|FG000|Overall Study|Personal reasons|0|||
44253371|NCT00630877|79093961|FG001|Overall Study|Personal reasons|0|||
44253372|NCT00630877|79093962|FG002|Overall Study|Personal reasons|1|||
44253373|NCT02915783|79093974|FG000|Overall Study|Death|21|||
44253374|NCT02915783|79093974|FG000|Overall Study|Lost to Follow-up|1|||
44253375|NCT02915783|79093974|FG000|Overall Study|Withdrawal by Subject|2|||
44253376|NCT00630331|79093989|FG000|Overall Study|Death|2|||
44253377|NCT00630331|79093990|FG001|Overall Study|Death|1|||
44253378|NCT00630331|79093991|FG002|Overall Study|Death|1|||
44253379|NCT00630331|79093989|FG000|Overall Study|Adverse Event|1|||
44253380|NCT00630331|79093990|FG001|Overall Study|Adverse Event|0|||
44253381|NCT00630331|79093991|FG002|Overall Study|Adverse Event|0|||
44253382|NCT00630331|79093989|FG000|Overall Study|Withdrawal by Subject|12|||
44253383|NCT00630331|79093990|FG001|Overall Study|Withdrawal by Subject|7|||
44407326|NCT04327271|79415232|FG001|Overall Study|randomization error (data capture)|3|||
44407327|NCT00688636|79415249|FG000|Overall Study|Adverse Event|2|||
44407328|NCT00688636|79415250|FG001|Overall Study|Adverse Event|1|||
44407329|NCT00870740|79415262|FG000|Overall Study|Adverse Event|2|||
44407330|NCT00870740|79415263|FG001|Overall Study|Adverse Event|1|||
44407331|NCT00870740|79415264|FG002|Overall Study|Adverse Event|3|||
44407332|NCT00870740|79415265|FG003|Overall Study|Adverse Event|2|||
44407333|NCT00870740|79415266|FG004|Overall Study|Adverse Event|1|||
44407334|NCT00870740|79415267|FG005|Overall Study|Adverse Event|6|||
44407335|NCT00870740|79415262|FG000|Overall Study|Consent Withdrawn|6|||
44407336|NCT00870740|79415263|FG001|Overall Study|Consent Withdrawn|3|||
44407337|NCT00870740|79415264|FG002|Overall Study|Consent Withdrawn|4|||
44407338|NCT00870740|79415265|FG003|Overall Study|Consent Withdrawn|6|||
44407339|NCT00870740|79415266|FG004|Overall Study|Consent Withdrawn|6|||
44407340|NCT00870740|79415267|FG005|Overall Study|Consent Withdrawn|5|||
44407341|NCT00870740|79415262|FG000|Overall Study|Investigator Decision|2|||
44407342|NCT00870740|79415263|FG001|Overall Study|Investigator Decision|0|||
44407343|NCT00870740|79415264|FG002|Overall Study|Investigator Decision|1|||
44407344|NCT00870740|79415265|FG003|Overall Study|Investigator Decision|0|||
44407345|NCT00870740|79415266|FG004|Overall Study|Investigator Decision|0|||
44407346|NCT00870740|79415267|FG005|Overall Study|Investigator Decision|0|||
44407347|NCT00870740|79415262|FG000|Overall Study|Subject Non-compliance|0|||
44407348|NCT00870740|79415263|FG001|Overall Study|Subject Non-compliance|0|||
44407349|NCT00870740|79415264|FG002|Overall Study|Subject Non-compliance|0|||
44407350|NCT00870740|79415265|FG003|Overall Study|Subject Non-compliance|0|||
44407351|NCT00870740|79415266|FG004|Overall Study|Subject Non-compliance|0|||
44407352|NCT00870740|79415267|FG005|Overall Study|Subject Non-compliance|1|||
44407353|NCT00870740|79415262|FG000|Overall Study|Death|0|||
44407354|NCT00870740|79415263|FG001|Overall Study|Death|0|||
44407355|NCT00870740|79415264|FG002|Overall Study|Death|0|||
44407356|NCT00870740|79415265|FG003|Overall Study|Death|0|||
44407357|NCT00870740|79415266|FG004|Overall Study|Death|1|||
44407358|NCT00870740|79415267|FG005|Overall Study|Death|0|||
44407359|NCT00870740|79415262|FG000|Overall Study|Other|2|||
44407360|NCT00870740|79415263|FG001|Overall Study|Other|5|||
44407361|NCT00870740|79415264|FG002|Overall Study|Other|2|||
44407362|NCT00870740|79415265|FG003|Overall Study|Other|4|||
44407363|NCT00870740|79415266|FG004|Overall Study|Other|3|||
44407364|NCT00870740|79415267|FG005|Overall Study|Other|5|||
44407365|NCT00869024|79415294|FG000|Overall Study|Death|2|||
44407366|NCT00869024|79415295|FG001|Overall Study|Death|3|||
44253384|NCT00630331|79093991|FG002|Overall Study|Withdrawal by Subject|5|||
44407367|NCT00869024|79415294|FG000|Overall Study|Lost to Follow-up|0|||
44407368|NCT00869024|79415295|FG001|Overall Study|Lost to Follow-up|1|||
44253385|NCT00630331|79093989|FG000|Overall Study|Lost to Follow-up|175|||
44407369|NCT00869024|79415294|FG000|Overall Study|Protocol Violation|0|||
44253386|NCT00630331|79093990|FG001|Overall Study|Lost to Follow-up|143|||
44253387|NCT00630331|79093991|FG002|Overall Study|Lost to Follow-up|170|||
44253388|NCT00630331|79093989|FG000|Overall Study|Inappropriate enrollment|3|||
44407370|NCT00869024|79415295|FG001|Overall Study|Protocol Violation|1|||
44407371|NCT00506779|79415303|FG000|Overall Study|Withdrawal by Subject|1|||
44407372|NCT00506779|79415304|FG001|Overall Study|Withdrawal by Subject|0|||
44407373|NCT00506779|79415305|FG002|Overall Study|Withdrawal by Subject|1|||
44407374|NCT00506779|79415306|FG003|Overall Study|Withdrawal by Subject|0|||
44407375|NCT00506779|79415303|FG000|Overall Study|Adverse Event|0|||
44407376|NCT00506779|79415304|FG001|Overall Study|Adverse Event|1|||
44407377|NCT00506779|79415305|FG002|Overall Study|Adverse Event|1|||
44253389|NCT00630331|79093990|FG001|Overall Study|Inappropriate enrollment|6|||
44253390|NCT00630331|79093991|FG002|Overall Study|Inappropriate enrollment|3|||
44253391|NCT00630331|79093989|FG000|Overall Study|Unable to classify|9|||
44407378|NCT00506779|79415306|FG003|Overall Study|Adverse Event|1|||
44407379|NCT00488293|79415319|FG000|Overall Study|Lost to Follow-up|28|||
44407380|NCT00488293|79415320|FG001|Overall Study|Lost to Follow-up|25|||
44407381|NCT00488293|79415319|FG000|Overall Study|Withdrawal by Subject|5|||
44407382|NCT00488293|79415320|FG001|Overall Study|Withdrawal by Subject|3|||
44407383|NCT00488293|79415319|FG000|Overall Study|Death|2|||
44407384|NCT00488293|79415320|FG001|Overall Study|Death|1|||
44407385|NCT00488293|79415319|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
44407386|NCT00488293|79415320|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
44407387|NCT00868790|79415326|FG000|Period 1|Adverse Event|1|||
44407388|NCT00868790|79415327|FG001|Period 1|Adverse Event|0|||
44407389|NCT00868790|79415328|FG002|Period 1|Adverse Event|0|||
44407390|NCT00868790|79415329|FG003|Period 1|Adverse Event|0|||
44407391|NCT00868790|79415330|FG004|Period 1|Adverse Event|0|||
44407392|NCT00868790|79415331|FG005|Period 1|Adverse Event|0|||
44407393|NCT00868790|79415332|FG006|Period 1|Adverse Event|0|||
44407394|NCT00868790|79415333|FG007|Period 1|Adverse Event|3|||
44407395|NCT00868790|79415334|FG008|Period 1|Adverse Event|1|||
44407396|NCT00868790|79415335|FG009|Period 1|Adverse Event|0|||
44407397|NCT00868790|79415336|FG010|Period 1|Adverse Event|0|||
44407398|NCT00868790|79415337|FG011|Period 1|Adverse Event|0|||
44407399|NCT00868790|79415338|FG012|Period 1|Adverse Event|0|||
44407400|NCT00868790|79415339|FG013|Period 1|Adverse Event|1|||
44407401|NCT00868790|79415326|FG000|Period 1|Protocol Violation|1|||
44407402|NCT00868790|79415327|FG001|Period 1|Protocol Violation|0|||
44407403|NCT00868790|79415328|FG002|Period 1|Protocol Violation|0|||
44407404|NCT00868790|79415329|FG003|Period 1|Protocol Violation|0|||
44407405|NCT00868790|79415330|FG004|Period 1|Protocol Violation|0|||
44407406|NCT00868790|79415331|FG005|Period 1|Protocol Violation|0|||
44407407|NCT00868790|79415332|FG006|Period 1|Protocol Violation|0|||
44407408|NCT00868790|79415333|FG007|Period 1|Protocol Violation|0|||
44407409|NCT00868790|79415334|FG008|Period 1|Protocol Violation|0|||
44407410|NCT00868790|79415335|FG009|Period 1|Protocol Violation|0|||
44407411|NCT00868790|79415336|FG010|Period 1|Protocol Violation|0|||
44407412|NCT00868790|79415337|FG011|Period 1|Protocol Violation|0|||
44407413|NCT00868790|79415338|FG012|Period 1|Protocol Violation|0|||
44407414|NCT00868790|79415339|FG013|Period 1|Protocol Violation|0|||
44407415|NCT00868790|79415326|FG000|Period 1|Withdrawal by Subject|0|||
44407416|NCT00868790|79415327|FG001|Period 1|Withdrawal by Subject|1|||
44407417|NCT00868790|79415328|FG002|Period 1|Withdrawal by Subject|0|||
44407418|NCT00868790|79415329|FG003|Period 1|Withdrawal by Subject|0|||
44407419|NCT00868790|79415330|FG004|Period 1|Withdrawal by Subject|0|||
44407420|NCT00868790|79415331|FG005|Period 1|Withdrawal by Subject|0|||
44407421|NCT00868790|79415332|FG006|Period 1|Withdrawal by Subject|0|||
44407422|NCT00868790|79415333|FG007|Period 1|Withdrawal by Subject|0|||
44407423|NCT00868790|79415334|FG008|Period 1|Withdrawal by Subject|0|||
44407424|NCT00868790|79415335|FG009|Period 1|Withdrawal by Subject|0|||
44407425|NCT00868790|79415336|FG010|Period 1|Withdrawal by Subject|0|||
44407426|NCT00868790|79415337|FG011|Period 1|Withdrawal by Subject|0|||
44407427|NCT00868790|79415338|FG012|Period 1|Withdrawal by Subject|0|||
44407428|NCT00868790|79415339|FG013|Period 1|Withdrawal by Subject|1|||
44407429|NCT00868790|79415326|FG000|Period 1|Abnormal Triglycerides|0|||
44407430|NCT00868790|79415327|FG001|Period 1|Abnormal Triglycerides|0|||
44407431|NCT00868790|79415328|FG002|Period 1|Abnormal Triglycerides|0|||
44407432|NCT00868790|79415329|FG003|Period 1|Abnormal Triglycerides|0|||
44407433|NCT00868790|79415330|FG004|Period 1|Abnormal Triglycerides|1|||
44407434|NCT00868790|79415331|FG005|Period 1|Abnormal Triglycerides|0|||
44407435|NCT00868790|79415332|FG006|Period 1|Abnormal Triglycerides|0|||
44407436|NCT00868790|79415333|FG007|Period 1|Abnormal Triglycerides|0|||
44407437|NCT00868790|79415334|FG008|Period 1|Abnormal Triglycerides|0|||
44407438|NCT00868790|79415335|FG009|Period 1|Abnormal Triglycerides|0|||
44407439|NCT00868790|79415336|FG010|Period 1|Abnormal Triglycerides|0|||
44407440|NCT00868790|79415337|FG011|Period 1|Abnormal Triglycerides|0|||
44407441|NCT00868790|79415338|FG012|Period 1|Abnormal Triglycerides|0|||
44407442|NCT00868790|79415339|FG013|Period 1|Abnormal Triglycerides|0|||
44407443|NCT00868790|79415326|FG000|Period 1|Lost to Follow-up|0|||
44407444|NCT00868790|79415327|FG001|Period 1|Lost to Follow-up|0|||
44407445|NCT00868790|79415328|FG002|Period 1|Lost to Follow-up|0|||
44407446|NCT00868790|79415329|FG003|Period 1|Lost to Follow-up|0|||
44407447|NCT00868790|79415330|FG004|Period 1|Lost to Follow-up|0|||
44407448|NCT00868790|79415331|FG005|Period 1|Lost to Follow-up|1|||
44407449|NCT00868790|79415332|FG006|Period 1|Lost to Follow-up|0|||
44407450|NCT00868790|79415333|FG007|Period 1|Lost to Follow-up|0|||
44407451|NCT00868790|79415334|FG008|Period 1|Lost to Follow-up|0|||
44407452|NCT00868790|79415335|FG009|Period 1|Lost to Follow-up|0|||
44407453|NCT00868790|79415336|FG010|Period 1|Lost to Follow-up|0|||
44407454|NCT00868790|79415337|FG011|Period 1|Lost to Follow-up|0|||
44407455|NCT00868790|79415338|FG012|Period 1|Lost to Follow-up|0|||
44407456|NCT00868790|79415339|FG013|Period 1|Lost to Follow-up|0|||
44407457|NCT00868790|79415326|FG000|Period 2|Adverse Event|0|||
44407458|NCT00868790|79415327|FG001|Period 2|Adverse Event|0|||
44407459|NCT00868790|79415328|FG002|Period 2|Adverse Event|0|||
44407460|NCT00868790|79415329|FG003|Period 2|Adverse Event|0|||
44407461|NCT00868790|79415330|FG004|Period 2|Adverse Event|0|||
44407462|NCT00868790|79415331|FG005|Period 2|Adverse Event|0|||
44407463|NCT00868790|79415332|FG006|Period 2|Adverse Event|0|||
44407464|NCT00868790|79415333|FG007|Period 2|Adverse Event|0|||
44407465|NCT00868790|79415334|FG008|Period 2|Adverse Event|1|||
44407466|NCT00868790|79415335|FG009|Period 2|Adverse Event|0|||
44407467|NCT00868790|79415336|FG010|Period 2|Adverse Event|0|||
44407468|NCT00868790|79415337|FG011|Period 2|Adverse Event|0|||
44407469|NCT00868790|79415338|FG012|Period 2|Adverse Event|0|||
44407470|NCT00868790|79415339|FG013|Period 2|Adverse Event|0|||
44407471|NCT00868790|79415326|FG000|Period 2|Lost to Follow-up|0|||
44407472|NCT00868790|79415327|FG001|Period 2|Lost to Follow-up|1|||
44407473|NCT00868790|79415328|FG002|Period 2|Lost to Follow-up|0|||
44407474|NCT00868790|79415329|FG003|Period 2|Lost to Follow-up|0|||
44407475|NCT00868790|79415330|FG004|Period 2|Lost to Follow-up|0|||
44407476|NCT00868790|79415331|FG005|Period 2|Lost to Follow-up|1|||
44253392|NCT00630331|79093990|FG001|Overall Study|Unable to classify|4|||
44253393|NCT00630331|79093991|FG002|Overall Study|Unable to classify|3|||
44407477|NCT00868790|79415332|FG006|Period 2|Lost to Follow-up|0|||
44407478|NCT00868790|79415333|FG007|Period 2|Lost to Follow-up|0|||
44407479|NCT00868790|79415334|FG008|Period 2|Lost to Follow-up|0|||
44407480|NCT00868790|79415335|FG009|Period 2|Lost to Follow-up|0|||
44253394|NCT00630331|79093989|FG000|Overall Study|Protocol Violation|4|||
44253395|NCT00630331|79093990|FG001|Overall Study|Protocol Violation|5|||
44253396|NCT00630331|79093991|FG002|Overall Study|Protocol Violation|6|||
44253397|NCT00639509|79094034|FG000|Overall Study|Death|1|||
44147987|NCT03556891|78937438|FG000|Overall Study|Protocol Violation|1|||
44147988|NCT03484923|78937447|FG000|Overall Study|Adverse Event|3|||
44253398|NCT00638963|79094040|FG000|Overall Study|Withdrawal by Subject|1|||
44253399|NCT00638963|79094041|FG001|Overall Study|Withdrawal by Subject|0|||
44253400|NCT00638183|79094047|FG000|Overall Study|Adverse Event|23|||
44253401|NCT00638183|79094047|FG000|Overall Study|Lack of Efficacy|14|||
44253402|NCT00638183|79094047|FG000|Overall Study|Physician Decision|9|||
44253403|NCT00638183|79094047|FG000|Overall Study|Lost to Follow-up|46|||
44253404|NCT00638183|79094047|FG000|Overall Study|Other reason not defined above|27|||
44253405|NCT00638027|79094053|FG000|Overall Study|Adverse Event|0|||
44253406|NCT00638027|79094054|FG001|Overall Study|Adverse Event|2|||
44253407|NCT00636155|79094060|FG000|Overall Study|Adverse Event|8|||
44253408|NCT00636155|79094060|FG000|Overall Study|Lack of Efficacy|1|||
44253409|NCT00636155|79094060|FG000|Overall Study|Withdrawal by Subject|3|||
44253410|NCT00636155|79094060|FG000|Overall Study|Stem cell transplant|1|||
44253411|NCT00636155|79094060|FG000|Overall Study|Physician Decision|5|||
44147989|NCT03484923|78937448|FG001|Overall Study|Adverse Event|3|||
44147990|NCT03484923|78937449|FG002|Overall Study|Adverse Event|5|||
44147991|NCT03484923|78937450|FG003|Overall Study|Adverse Event|11|||
44147992|NCT03484923|78937451|FG004|Overall Study|Adverse Event|1|||
44147993|NCT03484923|78937447|FG000|Overall Study|Death|2|||
44147994|NCT03484923|78937448|FG001|Overall Study|Death|2|||
44147995|NCT03484923|78937449|FG002|Overall Study|Death|3|||
44253412|NCT00634907|79094066|FG000|Overall Study|Withdrawal by Subject|3|||
44253413|NCT00634907|79094067|FG001|Overall Study|Withdrawal by Subject|0|||
44407481|NCT00868790|79415336|FG010|Period 2|Lost to Follow-up|0|||
44407482|NCT00868790|79415337|FG011|Period 2|Lost to Follow-up|0|||
44147996|NCT03484923|78937450|FG003|Overall Study|Death|0|||
44147997|NCT03484923|78937451|FG004|Overall Study|Death|1|||
44147998|NCT03484923|78937447|FG000|Overall Study|Physician Decision|6|||
44253414|NCT00634907|79094066|FG000|Overall Study|Physician Decision|3|||
44253415|NCT00634907|79094067|FG001|Overall Study|Physician Decision|9|||
44253416|NCT00634907|79094066|FG000|Overall Study|Withdrawal by Subject|11|||
44253417|NCT00634907|79094067|FG001|Overall Study|Withdrawal by Subject|8|||
44253418|NCT04740814|79094123|FG000|Overall Study|Adverse Event|3|||
44253419|NCT04740814|79094123|FG000|Overall Study|Protocol Violation|2|||
44253420|NCT04740814|79094123|FG000|Overall Study|Lost to Follow-up|2|||
44253421|NCT04740814|79094123|FG000|Overall Study|Withdrawal by Subject|3|||
44253422|NCT04461600|79094146|FG000|Overall Study|Death|6|||
44253423|NCT04461600|79094147|FG001|Overall Study|Death|5|||
44253424|NCT04461600|79094146|FG000|Overall Study|Withdrawal by Subject|0|||
44253425|NCT04461600|79094147|FG001|Overall Study|Withdrawal by Subject|1|||
44253426|NCT04282148|79094153|FG000|Overall Study|Death|1|||
44147999|NCT03484923|78937448|FG001|Overall Study|Physician Decision|7|||
44148000|NCT03484923|78937449|FG002|Overall Study|Physician Decision|6|||
44253427|NCT04282148|79094153|FG000|Overall Study|Withdrawal by Subject|1|||
44253428|NCT04282148|79094153|FG000|Overall Study|Physician Decision|1|||
44253429|NCT04250714|79094157|FG000|Overall Study|Withdrawal by Subject|14|||
44253430|NCT04250714|79094157|FG000|Overall Study|Lost to Follow-up|11|||
44148001|NCT03484923|78937450|FG003|Overall Study|Physician Decision|3|||
44407483|NCT00868790|79415338|FG012|Period 2|Lost to Follow-up|0|||
44407484|NCT00868790|79415339|FG013|Period 2|Lost to Follow-up|0|||
44407485|NCT00868790|79415326|FG000|Period 2|Withdrawal by Subject|0|||
44407486|NCT00868790|79415327|FG001|Period 2|Withdrawal by Subject|0|||
44407487|NCT00868790|79415328|FG002|Period 2|Withdrawal by Subject|0|||
44407488|NCT00868790|79415329|FG003|Period 2|Withdrawal by Subject|0|||
44407489|NCT00868790|79415330|FG004|Period 2|Withdrawal by Subject|0|||
44407490|NCT00868790|79415331|FG005|Period 2|Withdrawal by Subject|0|||
44407491|NCT00868790|79415332|FG006|Period 2|Withdrawal by Subject|0|||
44407492|NCT00868790|79415333|FG007|Period 2|Withdrawal by Subject|0|||
44407493|NCT00868790|79415334|FG008|Period 2|Withdrawal by Subject|1|||
44407494|NCT00868790|79415335|FG009|Period 2|Withdrawal by Subject|0|||
44407495|NCT00868790|79415336|FG010|Period 2|Withdrawal by Subject|0|||
44253431|NCT04250714|79094157|FG000|Overall Study|End of study due to logistical reasons|2|||
44253432|NCT04250714|79094157|FG000|Overall Study|End of study due to refusing testing COVID|1|||
44253433|NCT04250714|79094157|FG000|Overall Study|Death|1|||
44253434|NCT04250714|79094157|FG000|Overall Study|Withdrawn = unknown reason|2|||
44253435|NCT04250714|79094157|FG000|Overall Study|Consent Ineligible (Does not meet eligibility criteria)|1|||
44253436|NCT04250714|79094157|FG000|Overall Study|Attempt subject|2|||
44253437|NCT04250714|79094157|FG000|Overall Study|Intent Subject|7|||
44253438|NCT04209348|79094165|FG000|Overall Study|Lost to Follow-up|1|||
44253439|NCT04209348|79094166|FG001|Overall Study|Lost to Follow-up|0|||
44253440|NCT03839459|79094192|FG000|Overall Study|Withdrawal by Subject|2|||
44253441|NCT03839459|79094192|FG000|Overall Study|progression of disease|3|||
44253442|NCT03811834|79094196|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
44253443|NCT03251079|79094226|FG000|Overall Study|Withdrawal by Subject|1|||
44253444|NCT03250832|79094240|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
44253445|NCT03250832|79094241|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
44253446|NCT03250832|79094242|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
44253447|NCT03250832|79094243|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
44253448|NCT03250832|79094244|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
44253449|NCT03250832|79094245|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
44253450|NCT03250832|79094246|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
44253451|NCT03250832|79094247|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
44253452|NCT03250832|79094248|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
44253453|NCT03250832|79094249|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
44253454|NCT03250832|79094240|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
44253455|NCT03250832|79094241|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
44253456|NCT03250832|79094242|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
44253457|NCT03250832|79094243|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
44253458|NCT03250832|79094244|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
44253459|NCT03250832|79094245|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
44253460|NCT03250832|79094246|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
44407496|NCT00868790|79415337|FG011|Period 2|Withdrawal by Subject|0|||
44407497|NCT00868790|79415338|FG012|Period 2|Withdrawal by Subject|0|||
44148002|NCT03484923|78937451|FG004|Overall Study|Physician Decision|2|||
44148003|NCT03484923|78937447|FG000|Overall Study|Progressive disease|33|||
44148004|NCT03484923|78937448|FG001|Overall Study|Progressive disease|28|||
44148005|NCT03484923|78937449|FG002|Overall Study|Progressive disease|26|||
44148006|NCT03484923|78937450|FG003|Overall Study|Progressive disease|30|||
44148007|NCT03484923|78937451|FG004|Overall Study|Progressive disease|16|||
44148008|NCT03484923|78937447|FG000|Overall Study|Subject Decision|1|||
44148009|NCT03484923|78937448|FG001|Overall Study|Subject Decision|3|||
44148010|NCT03484923|78937449|FG002|Overall Study|Subject Decision|3|||
44148011|NCT03484923|78937450|FG003|Overall Study|Subject Decision|0|||
44148012|NCT03484923|78937451|FG004|Overall Study|Subject Decision|1|||
44148013|NCT03146650|78937530|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
44407498|NCT00868790|79415339|FG013|Period 2|Withdrawal by Subject|1|||
44407499|NCT00868790|79415326|FG000|Period 3|Adverse Event|0|||
44407500|NCT00868790|79415327|FG001|Period 3|Adverse Event|0|||
44407501|NCT00868790|79415328|FG002|Period 3|Adverse Event|0|||
44407502|NCT00868790|79415329|FG003|Period 3|Adverse Event|0|||
44407503|NCT00868790|79415330|FG004|Period 3|Adverse Event|0|||
44407504|NCT00868790|79415331|FG005|Period 3|Adverse Event|0|||
44407505|NCT00868790|79415332|FG006|Period 3|Adverse Event|0|||
44407506|NCT00868790|79415333|FG007|Period 3|Adverse Event|0|||
44407507|NCT00868790|79415334|FG008|Period 3|Adverse Event|0|||
44407508|NCT00868790|79415335|FG009|Period 3|Adverse Event|1|||
44407509|NCT00868790|79415336|FG010|Period 3|Adverse Event|0|||
44407510|NCT00868790|79415337|FG011|Period 3|Adverse Event|0|||
44407511|NCT00868790|79415338|FG012|Period 3|Adverse Event|0|||
44407512|NCT00868790|79415339|FG013|Period 3|Adverse Event|0|||
44407513|NCT00868790|79415326|FG000|Period 3|Protocol Violation|0|||
44407514|NCT00868790|79415327|FG001|Period 3|Protocol Violation|0|||
44407515|NCT00868790|79415328|FG002|Period 3|Protocol Violation|0|||
44407516|NCT00868790|79415329|FG003|Period 3|Protocol Violation|0|||
44407517|NCT00868790|79415330|FG004|Period 3|Protocol Violation|0|||
44407518|NCT00868790|79415331|FG005|Period 3|Protocol Violation|0|||
44253461|NCT03250832|79094247|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
44407519|NCT00868790|79415332|FG006|Period 3|Protocol Violation|0|||
44407520|NCT00868790|79415333|FG007|Period 3|Protocol Violation|0|||
44407521|NCT00868790|79415334|FG008|Period 3|Protocol Violation|0|||
44407522|NCT00868790|79415335|FG009|Period 3|Protocol Violation|0|||
44407523|NCT00868790|79415336|FG010|Period 3|Protocol Violation|1|||
44407524|NCT00868790|79415337|FG011|Period 3|Protocol Violation|0|||
44407525|NCT00868790|79415338|FG012|Period 3|Protocol Violation|0|||
44407526|NCT00868790|79415339|FG013|Period 3|Protocol Violation|0|||
44407527|NCT00868790|79415326|FG000|Period 3|Study Terminated by Sponsor|0|||
44407528|NCT00868790|79415327|FG001|Period 3|Study Terminated by Sponsor|0|||
44407529|NCT00868790|79415328|FG002|Period 3|Study Terminated by Sponsor|0|||
44407530|NCT00868790|79415329|FG003|Period 3|Study Terminated by Sponsor|1|||
44407531|NCT00868790|79415330|FG004|Period 3|Study Terminated by Sponsor|0|||
44407532|NCT00868790|79415331|FG005|Period 3|Study Terminated by Sponsor|0|||
44407533|NCT00868790|79415332|FG006|Period 3|Study Terminated by Sponsor|0|||
44407534|NCT00868790|79415333|FG007|Period 3|Study Terminated by Sponsor|0|||
44253462|NCT03250832|79094248|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
44253463|NCT03250832|79094249|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
44253464|NCT03250832|79094240|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44253465|NCT03250832|79094241|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44253466|NCT03250832|79094242|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
44253467|NCT03250832|79094243|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44253468|NCT03250832|79094244|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44253469|NCT03250832|79094245|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44253470|NCT03250832|79094246|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44407535|NCT00868790|79415334|FG008|Period 3|Study Terminated by Sponsor|0|||
44407536|NCT00868790|79415335|FG009|Period 3|Study Terminated by Sponsor|0|||
44253471|NCT03250832|79094247|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44253472|NCT03250832|79094248|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44407537|NCT00868790|79415336|FG010|Period 3|Study Terminated by Sponsor|0|||
44407538|NCT00868790|79415337|FG011|Period 3|Study Terminated by Sponsor|0|||
44407539|NCT00868790|79415338|FG012|Period 3|Study Terminated by Sponsor|0|||
44407540|NCT00868790|79415339|FG013|Period 3|Study Terminated by Sponsor|0|||
44253473|NCT03250832|79094249|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
44407541|NCT00868790|79415326|FG000|Period 4|Adverse Event|0|||
44407542|NCT00868790|79415327|FG001|Period 4|Adverse Event|0|||
44407543|NCT00868790|79415328|FG002|Period 4|Adverse Event|0|||
44407544|NCT00868790|79415329|FG003|Period 4|Adverse Event|0|||
44407545|NCT00868790|79415330|FG004|Period 4|Adverse Event|0|||
44407546|NCT00868790|79415331|FG005|Period 4|Adverse Event|0|||
44407547|NCT00868790|79415332|FG006|Period 4|Adverse Event|0|||
44407548|NCT00868790|79415333|FG007|Period 4|Adverse Event|1|||
44407549|NCT00868790|79415334|FG008|Period 4|Adverse Event|0|||
44253474|NCT03250832|79094240|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253475|NCT03250832|79094241|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253476|NCT03250832|79094242|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253477|NCT03250832|79094243|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253478|NCT03250832|79094244|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253479|NCT03250832|79094245|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253480|NCT03250832|79094246|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253481|NCT03250832|79094247|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
44253482|NCT03250832|79094248|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253483|NCT03250832|79094249|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
44253484|NCT03250832|79094240|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253485|NCT03250832|79094241|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253486|NCT03250832|79094242|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253487|NCT03250832|79094243|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253488|NCT03250832|79094244|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253489|NCT03250832|79094245|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253490|NCT03250832|79094246|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253491|NCT03250832|79094247|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
44253492|NCT03250832|79094248|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253493|NCT03250832|79094249|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
44253494|NCT03250832|79094240|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253495|NCT03250832|79094241|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253496|NCT03250832|79094242|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253497|NCT03250832|79094243|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253498|NCT03250832|79094244|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253499|NCT03250832|79094245|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44407550|NCT00868790|79415335|FG009|Period 4|Adverse Event|0|||
44407551|NCT00868790|79415336|FG010|Period 4|Adverse Event|1|||
44407552|NCT00868790|79415337|FG011|Period 4|Adverse Event|0|||
44407553|NCT00868790|79415338|FG012|Period 4|Adverse Event|1|||
44407554|NCT00868790|79415339|FG013|Period 4|Adverse Event|0|||
44407555|NCT00868790|79415326|FG000|Period 4|Lost to Follow-up|0|||
44407556|NCT00868790|79415327|FG001|Period 4|Lost to Follow-up|0|||
44407557|NCT00868790|79415328|FG002|Period 4|Lost to Follow-up|0|||
44407558|NCT00868790|79415329|FG003|Period 4|Lost to Follow-up|0|||
44407559|NCT00868790|79415330|FG004|Period 4|Lost to Follow-up|0|||
44407560|NCT00868790|79415331|FG005|Period 4|Lost to Follow-up|0|||
44407561|NCT00868790|79415332|FG006|Period 4|Lost to Follow-up|0|||
44407562|NCT00868790|79415333|FG007|Period 4|Lost to Follow-up|1|||
44407563|NCT00868790|79415334|FG008|Period 4|Lost to Follow-up|0|||
44407564|NCT00868790|79415335|FG009|Period 4|Lost to Follow-up|0|||
44407565|NCT00868790|79415336|FG010|Period 4|Lost to Follow-up|0|||
44407566|NCT00868790|79415337|FG011|Period 4|Lost to Follow-up|0|||
44253500|NCT03250832|79094246|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253501|NCT03250832|79094247|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
44253502|NCT03250832|79094248|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253503|NCT03250832|79094249|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
44253504|NCT03250832|79094240|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253505|NCT03250832|79094241|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253506|NCT03250832|79094242|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253507|NCT03250832|79094243|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253508|NCT03250832|79094244|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253509|NCT03250832|79094245|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253510|NCT03250832|79094246|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253511|NCT03250832|79094247|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
44253512|NCT03250832|79094248|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253513|NCT03250832|79094249|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
44253514|NCT03250832|79094240|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253515|NCT03250832|79094241|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253516|NCT03250832|79094242|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
44407567|NCT00868790|79415338|FG012|Period 4|Lost to Follow-up|0|||
44407568|NCT00868790|79415339|FG013|Period 4|Lost to Follow-up|0|||
44407569|NCT00868790|79415326|FG000|Period 4|Study Terminated by Sponsor|2|||
44407570|NCT00868790|79415327|FG001|Period 4|Study Terminated by Sponsor|0|||
44253517|NCT03250832|79094243|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
44407571|NCT00868790|79415328|FG002|Period 4|Study Terminated by Sponsor|0|||
44407572|NCT00868790|79415329|FG003|Period 4|Study Terminated by Sponsor|0|||
44407573|NCT00868790|79415330|FG004|Period 4|Study Terminated by Sponsor|0|||
44407574|NCT00868790|79415331|FG005|Period 4|Study Terminated by Sponsor|0|||
44407575|NCT00868790|79415332|FG006|Period 4|Study Terminated by Sponsor|0|||
44407576|NCT00868790|79415333|FG007|Period 4|Study Terminated by Sponsor|1|||
44407577|NCT00868790|79415334|FG008|Period 4|Study Terminated by Sponsor|2|||
44407578|NCT00868790|79415335|FG009|Period 4|Study Terminated by Sponsor|0|||
44407579|NCT00868790|79415336|FG010|Period 4|Study Terminated by Sponsor|2|||
44407580|NCT00868790|79415337|FG011|Period 4|Study Terminated by Sponsor|1|||
44407581|NCT00868790|79415338|FG012|Period 4|Study Terminated by Sponsor|0|||
44407582|NCT00868790|79415339|FG013|Period 4|Study Terminated by Sponsor|1|||
44407583|NCT00868790|79415326|FG000|Period 4|Abnormal ALT/AST|0|||
44407584|NCT00868790|79415327|FG001|Period 4|Abnormal ALT/AST|0|||
44407585|NCT00868790|79415328|FG002|Period 4|Abnormal ALT/AST|1|||
44407586|NCT00868790|79415329|FG003|Period 4|Abnormal ALT/AST|0|||
44407587|NCT00868790|79415330|FG004|Period 4|Abnormal ALT/AST|0|||
44407588|NCT00868790|79415331|FG005|Period 4|Abnormal ALT/AST|0|||
44407589|NCT00868790|79415332|FG006|Period 4|Abnormal ALT/AST|0|||
44407590|NCT00868790|79415333|FG007|Period 4|Abnormal ALT/AST|0|||
44407591|NCT00868790|79415334|FG008|Period 4|Abnormal ALT/AST|0|||
44407592|NCT00868790|79415335|FG009|Period 4|Abnormal ALT/AST|0|||
44407593|NCT00868790|79415336|FG010|Period 4|Abnormal ALT/AST|0|||
44407594|NCT00868790|79415337|FG011|Period 4|Abnormal ALT/AST|0|||
44253518|NCT03250832|79094244|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253519|NCT03250832|79094245|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253520|NCT03250832|79094246|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253521|NCT03250832|79094247|FG007|Part 2A (Up to Approximately 30 Months)|Other|2|||
44253522|NCT03250832|79094248|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253523|NCT03250832|79094249|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
44253524|NCT03250832|79094240|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253525|NCT03250832|79094241|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253526|NCT03250832|79094242|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253527|NCT03250832|79094243|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253528|NCT03250832|79094244|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253529|NCT03250832|79094245|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253530|NCT03250832|79094246|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253531|NCT03250832|79094247|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
44253532|NCT03250832|79094248|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
44253533|NCT03250832|79094249|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
44253534|NCT03250832|79094240|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253535|NCT03250832|79094241|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253536|NCT03250832|79094242|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253537|NCT03250832|79094243|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253538|NCT03250832|79094244|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253539|NCT03250832|79094245|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253540|NCT03250832|79094246|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253541|NCT03250832|79094247|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
44253542|NCT03250832|79094248|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
44253543|NCT03250832|79094249|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
44253544|NCT03250832|79094240|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253545|NCT03250832|79094241|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253546|NCT03250832|79094242|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253547|NCT03250832|79094243|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253548|NCT03250832|79094244|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253549|NCT03250832|79094245|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253550|NCT03250832|79094246|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253551|NCT03250832|79094247|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
44253552|NCT03250832|79094248|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
44253553|NCT03250832|79094249|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
44253554|NCT03250832|79094240|FG000|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253555|NCT03250832|79094241|FG001|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253556|NCT03250832|79094242|FG002|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253557|NCT03250832|79094243|FG003|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253558|NCT03250832|79094244|FG004|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253559|NCT03250832|79094245|FG005|Part 2B (Up to Approximately 29 Months)|Other|0|||
44407595|NCT00868790|79415338|FG012|Period 4|Abnormal ALT/AST|0|||
44407596|NCT00868790|79415339|FG013|Period 4|Abnormal ALT/AST|0|||
44407597|NCT00868790|79415326|FG000|Post-study|Withdrawal by Subject|0|||
44407598|NCT00868790|79415327|FG001|Post-study|Withdrawal by Subject|0|||
44407599|NCT00868790|79415328|FG002|Post-study|Withdrawal by Subject|0|||
44407600|NCT00868790|79415329|FG003|Post-study|Withdrawal by Subject|0|||
44407601|NCT00868790|79415330|FG004|Post-study|Withdrawal by Subject|1|||
44407602|NCT00868790|79415331|FG005|Post-study|Withdrawal by Subject|0|||
44407603|NCT00868790|79415332|FG006|Post-study|Withdrawal by Subject|0|||
44407604|NCT00868790|79415333|FG007|Post-study|Withdrawal by Subject|0|||
44407605|NCT00868790|79415334|FG008|Post-study|Withdrawal by Subject|0|||
44407606|NCT00868790|79415335|FG009|Post-study|Withdrawal by Subject|0|||
44407607|NCT00868790|79415336|FG010|Post-study|Withdrawal by Subject|0|||
44407608|NCT00868790|79415337|FG011|Post-study|Withdrawal by Subject|0|||
44407609|NCT00868790|79415338|FG012|Post-study|Withdrawal by Subject|0|||
44407610|NCT00868790|79415339|FG013|Post-study|Withdrawal by Subject|0|||
44407611|NCT00868790|79415326|FG000|Post-study|Excluded Medication|0|||
44407612|NCT00868790|79415327|FG001|Post-study|Excluded Medication|0|||
44407613|NCT00868790|79415328|FG002|Post-study|Excluded Medication|0|||
44407614|NCT00868790|79415329|FG003|Post-study|Excluded Medication|0|||
44407615|NCT00868790|79415330|FG004|Post-study|Excluded Medication|0|||
44407616|NCT00868790|79415331|FG005|Post-study|Excluded Medication|0|||
44407617|NCT00868790|79415332|FG006|Post-study|Excluded Medication|0|||
44407618|NCT00868790|79415333|FG007|Post-study|Excluded Medication|2|||
44407619|NCT00868790|79415334|FG008|Post-study|Excluded Medication|0|||
44407620|NCT00868790|79415335|FG009|Post-study|Excluded Medication|1|||
44407621|NCT00868790|79415336|FG010|Post-study|Excluded Medication|0|||
44407622|NCT00868790|79415337|FG011|Post-study|Excluded Medication|0|||
44407623|NCT00868790|79415338|FG012|Post-study|Excluded Medication|0|||
44407624|NCT00868790|79415339|FG013|Post-study|Excluded Medication|0|||
44407625|NCT00496483|79415355|FG000|Overall Study|Not dosed|9|||
44407626|NCT00496483|79415355|FG000|Overall Study|Adverse Event|2|||
44407627|NCT00496483|79415355|FG000|Overall Study|Lack of Efficacy|1|||
44407628|NCT03528551|79415365|FG000|Overall Study|Lost to Follow-up|0|||
44407629|NCT03528551|79415366|FG001|Overall Study|Lost to Follow-up|1|||
44407630|NCT03528551|79415367|FG002|Overall Study|Lost to Follow-up|0|||
44407631|NCT03528551|79415365|FG000|Overall Study|Transferred to other arm/group|2|||
44407632|NCT03528551|79415366|FG001|Overall Study|Transferred to other arm/group|3|||
44407633|NCT03528551|79415367|FG002|Overall Study|Transferred to other arm/group|0|||
44407634|NCT03528551|79415365|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44407635|NCT03528551|79415366|FG001|Overall Study|Withdrawal by parent/guardian|5|||
44407636|NCT03528551|79415367|FG002|Overall Study|Withdrawal by parent/guardian|0|||
44407637|NCT03528551|79415365|FG000|Overall Study|Protocol Violation|0|||
44407638|NCT03528551|79415366|FG001|Overall Study|Protocol Violation|3|||
44407639|NCT03528551|79415367|FG002|Overall Study|Protocol Violation|0|||
44407640|NCT03528551|79415365|FG000|Overall Study|Withdrawal by Subject|0|||
44407641|NCT03528551|79415366|FG001|Overall Study|Withdrawal by Subject|7|||
44407642|NCT03528551|79415367|FG002|Overall Study|Withdrawal by Subject|0|||
44407643|NCT00487981|79415376|FG000|Overall Study|Hypothyroidism diagnosis|1|||
44407644|NCT00861744|79415384|FG000|Overall Study|Adverse Event|0|||
44407645|NCT00861744|79415385|FG001|Overall Study|Adverse Event|0|||
44407646|NCT00861744|79415386|FG002|Overall Study|Adverse Event|0|||
44407647|NCT00861744|79415387|FG003|Overall Study|Adverse Event|1|||
44407648|NCT00861744|79415384|FG000|Overall Study|Lost to Follow-up|7|||
44407649|NCT00861744|79415385|FG001|Overall Study|Lost to Follow-up|19|||
44407650|NCT00861744|79415386|FG002|Overall Study|Lost to Follow-up|17|||
44407651|NCT00861744|79415387|FG003|Overall Study|Lost to Follow-up|12|||
44407652|NCT00861744|79415384|FG000|Overall Study|Withdrawal by Subject|10|||
44407653|NCT00861744|79415385|FG001|Overall Study|Withdrawal by Subject|6|||
44407654|NCT00861744|79415386|FG002|Overall Study|Withdrawal by Subject|6|||
44407655|NCT00861744|79415387|FG003|Overall Study|Withdrawal by Subject|19|||
44407656|NCT00861744|79415384|FG000|Overall Study|Protocol Violation|0|||
44407657|NCT00861744|79415385|FG001|Overall Study|Protocol Violation|1|||
44407658|NCT00861744|79415386|FG002|Overall Study|Protocol Violation|0|||
44407659|NCT00861744|79415387|FG003|Overall Study|Protocol Violation|0|||
44407660|NCT00861744|79415384|FG000|Overall Study|Migration from study area|0|||
44253560|NCT03250832|79094246|FG006|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253561|NCT03250832|79094247|FG007|Part 2B (Up to Approximately 29 Months)|Other|0|||
44253562|NCT03250832|79094248|FG008|Part 2B (Up to Approximately 29 Months)|Other|0|||
44407661|NCT00861744|79415385|FG001|Overall Study|Migration from study area|3|||
44407662|NCT00861744|79415386|FG002|Overall Study|Migration from study area|1|||
44407663|NCT00861744|79415387|FG003|Overall Study|Migration from study area|0|||
44407664|NCT00861744|79415384|FG000|Overall Study|Blood draws|0|||
44407665|NCT00861744|79415385|FG001|Overall Study|Blood draws|0|||
44407666|NCT00861744|79415386|FG002|Overall Study|Blood draws|0|||
44407667|NCT00861744|79415387|FG003|Overall Study|Blood draws|1|||
44407668|NCT00603239|79415399|FG000|Overall Study|Adverse Event|4|||
44407669|NCT00603239|79415400|FG001|Overall Study|Adverse Event|1|||
44407670|NCT00603239|79415399|FG000|Overall Study|Entry criteria not met|0|||
44407671|NCT00603239|79415400|FG001|Overall Study|Entry criteria not met|1|||
44407672|NCT00603239|79415399|FG000|Overall Study|Loss of glucose control|3|||
44407673|NCT00603239|79415400|FG001|Overall Study|Loss of glucose control|0|||
44407674|NCT00603239|79415399|FG000|Overall Study|Lost to Follow-up|2|||
44407675|NCT00603239|79415400|FG001|Overall Study|Lost to Follow-up|1|||
44148014|NCT03146650|78937530|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
44407676|NCT00603239|79415399|FG000|Overall Study|Physician Decision|2|||
44407677|NCT00603239|79415400|FG001|Overall Study|Physician Decision|0|||
44407678|NCT00603239|79415399|FG000|Overall Study|Protocol Violation|2|||
44407679|NCT00603239|79415400|FG001|Overall Study|Protocol Violation|0|||
44407680|NCT00603239|79415399|FG000|Overall Study|Subject decision|2|||
44407681|NCT00603239|79415400|FG001|Overall Study|Subject decision|1|||
44407682|NCT00852930|79415409|FG000|Overall Study|Withdrawal by Subject|1|||
44407683|NCT00852930|79415410|FG001|Overall Study|Withdrawal by Subject|1|||
44407684|NCT00852930|79415411|FG002|Overall Study|Withdrawal by Subject|1|||
44407685|NCT00852930|79415409|FG000|Overall Study|Physician Decision|0|||
44407686|NCT00852930|79415410|FG001|Overall Study|Physician Decision|0|||
44407687|NCT00852930|79415411|FG002|Overall Study|Physician Decision|1|||
44407688|NCT00852540|79415422|FG000|Overall Study|Adverse Event|10|||
44407689|NCT00852540|79415423|FG001|Overall Study|Adverse Event|3|||
44407690|NCT00852540|79415422|FG000|Overall Study|Lack of Efficacy|15|||
44407691|NCT00852540|79415423|FG001|Overall Study|Lack of Efficacy|3|||
44407692|NCT00852540|79415422|FG000|Overall Study|Protocol Violation|1|||
44407693|NCT00852540|79415423|FG001|Overall Study|Protocol Violation|2|||
44407694|NCT00852540|79415422|FG000|Overall Study|Lost to Follow-up|2|||
44407695|NCT00852540|79415423|FG001|Overall Study|Lost to Follow-up|3|||
44407696|NCT00852540|79415422|FG000|Overall Study|Investigator Discretion|2|||
44407697|NCT00852540|79415423|FG001|Overall Study|Investigator Discretion|3|||
44407698|NCT00852540|79415422|FG000|Overall Study|Withdrawal by Subject|3|||
44407699|NCT00852540|79415423|FG001|Overall Study|Withdrawal by Subject|1|||
44407700|NCT00852540|79415422|FG000|Overall Study|Did Not Receive Study Drug|3|||
44407701|NCT00852540|79415423|FG001|Overall Study|Did Not Receive Study Drug|3|||
44407702|NCT00861198|79415430|FG000|Overall Study|SpyGlass Failed|5|||
44253563|NCT03250832|79094249|FG009|Part 2B (Up to Approximately 29 Months)|Other|1|||
44253564|NCT03174275|79094278|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
44253565|NCT03174275|79094278|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
44407703|NCT00847704|79415434|FG000|Overall Study|Withdrawal by Subject|1|||
44253566|NCT03174275|79094278|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
44253567|NCT03174275|79094278|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
44253568|NCT03174275|79094278|FG000|Adjuvant Chemotherapy|Progression|1|||
44253569|NCT03174275|79094278|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
44253570|NCT03174275|79094278|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
44253571|NCT03174275|79094278|FG000|Adjuvant Durvalumab|Progression|1|||
44253572|NCT03174275|79094278|FG000|Adjuvant Durvalumab|Adverse Event|3|||
44253573|NCT03174275|79094278|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
44253574|NCT03174275|79094278|FG000|Adjuvant Radiotherapy|Progression|1|||
44253575|NCT03174275|79094278|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
44253576|NCT02817464|79094284|FG000|Overall Study|Lost to Follow-up|1|||
44407704|NCT00860574|79415438|FG000|Overall Study|Death|2|||
44148015|NCT03146650|78937530|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
44148016|NCT03146650|78937530|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
44148017|NCT03146650|78937530|FG000|2 Year Follow-up|Death|11|||
44148018|NCT03146650|78937530|FG000|2 Year Follow-up|Still in follow-up|7|||
44148019|NCT03146650|78937530|FG000|2 Year Follow-up|Lost to Follow-up|1|||
44148020|NCT03091192|78937536|FG000|Overall Study|Study terminated by sponsor|21|||
44148021|NCT03091192|78937537|FG001|Overall Study|Study terminated by sponsor|14|||
44148022|NCT03091192|78937536|FG000|Overall Study|Death|9|||
44148023|NCT03091192|78937537|FG001|Overall Study|Death|13|||
44148024|NCT03091192|78937536|FG000|Overall Study|Withdrawal by Subject|2|||
44148025|NCT03091192|78937537|FG001|Overall Study|Withdrawal by Subject|0|||
44148026|NCT03091192|78937536|FG000|Overall Study|Lost to Follow-up|1|||
44148027|NCT03091192|78937537|FG001|Overall Study|Lost to Follow-up|0|||
44148028|NCT02829723|78937573|FG000|Overall Study|Adverse Event|0|||
44148029|NCT02829723|78937574|FG001|Overall Study|Adverse Event|0|||
44148030|NCT02829723|78937575|FG002|Overall Study|Adverse Event|1|||
44148031|NCT02829723|78937576|FG003|Overall Study|Adverse Event|1|||
44253577|NCT02817464|79094285|FG001|Overall Study|Lost to Follow-up|0|||
44253578|NCT02817464|79094284|FG000|Overall Study|Discontinued early due to personal decision|1|||
44253579|NCT02817464|79094285|FG001|Overall Study|Discontinued early due to personal decision|1|||
44407705|NCT00860574|79415438|FG000|Overall Study|Relapse|1|||
44407706|NCT00496015|79415447|FG000|Overall Study|Other|1|||
44407707|NCT00496015|79415448|FG001|Overall Study|Other|0|||
44407708|NCT00496015|79415449|FG002|Overall Study|Other|0|||
44407709|NCT00496015|79415450|FG003|Overall Study|Other|1|||
44407710|NCT00496015|79415451|FG004|Overall Study|Other|0|||
44407711|NCT00487825|79415473|FG000|Overall Study|Adverse Event|2|||
44148032|NCT02829723|78937577|FG004|Overall Study|Adverse Event|0|||
44148033|NCT02829723|78937578|FG005|Overall Study|Adverse Event|0|||
44148034|NCT02829723|78937579|FG006|Overall Study|Adverse Event|0|||
44148035|NCT02829723|78937580|FG007|Overall Study|Adverse Event|1|||
44407712|NCT00487825|79415474|FG001|Overall Study|Adverse Event|2|||
44407713|NCT00487825|79415473|FG000|Overall Study|Lack of Efficacy|1|||
44407714|NCT00487825|79415474|FG001|Overall Study|Lack of Efficacy|1|||
44407715|NCT00487825|79415473|FG000|Overall Study|Other|3|||
44407716|NCT00487825|79415474|FG001|Overall Study|Other|2|||
44407717|NCT00487747|79415480|FG000|Overall Study|Adverse Event|1|||
44407718|NCT00487747|79415480|FG000|Overall Study|Lost to Follow-up|9|||
44407719|NCT00487747|79415480|FG000|Overall Study|Lack of Efficacy|1|||
44407720|NCT00487435|79415484|FG000|Overall Study|Adverse Event|146|||
44407721|NCT00487435|79415484|FG000|Overall Study|Death|2|||
44407722|NCT00487435|79415484|FG000|Overall Study|Lack of Efficacy|33|||
44407723|NCT00487435|79415484|FG000|Overall Study|Lost to Follow-up|54|||
44407724|NCT00487435|79415484|FG000|Overall Study|Pregnancy|2|||
44407725|NCT00487435|79415484|FG000|Overall Study|Withdrawal by Subject|132|||
44407726|NCT00487435|79415484|FG000|Overall Study|Resolution Of Pain|1|||
44407727|NCT00487435|79415484|FG000|Overall Study|Study Medication Non-Compliant|32|||
44407728|NCT00487435|79415484|FG000|Overall Study|Other|83|||
44407729|NCT00487279|79415490|FG000|Overall Study|Death|1|||
44407730|NCT00487279|79415491|FG001|Overall Study|Death|0|||
44407731|NCT00487279|79415490|FG000|Overall Study|Withdrawal by Subject|0|||
44407732|NCT00487279|79415491|FG001|Overall Study|Withdrawal by Subject|2|||
44407733|NCT00495625|79415497|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
44407734|NCT00847626|79415512|FG000|Overall Study|Adverse Event|10|||
44407735|NCT00847626|79415513|FG001|Overall Study|Adverse Event|10|||
44407736|NCT00847626|79415514|FG002|Overall Study|Adverse Event|6|||
44407737|NCT00847626|79415515|FG003|Overall Study|Adverse Event|19|||
44407738|NCT00847626|79415516|FG004|Overall Study|Adverse Event|11|||
44407739|NCT00847626|79415517|FG005|Overall Study|Adverse Event|22|||
44407740|NCT00847626|79415518|FG006|Overall Study|Adverse Event|4|||
44407741|NCT00847626|79415519|FG007|Overall Study|Adverse Event|6|||
44407742|NCT00847626|79415520|FG008|Overall Study|Adverse Event|3|||
44407743|NCT00847626|79415521|FG009|Overall Study|Adverse Event|6|||
44407744|NCT00847626|79415522|FG010|Overall Study|Adverse Event|6|||
44407745|NCT00847626|79415512|FG000|Overall Study|Protocol Violation|2|||
44407746|NCT00847626|79415513|FG001|Overall Study|Protocol Violation|1|||
44407747|NCT00847626|79415514|FG002|Overall Study|Protocol Violation|2|||
44407748|NCT00847626|79415515|FG003|Overall Study|Protocol Violation|1|||
44407749|NCT00847626|79415516|FG004|Overall Study|Protocol Violation|1|||
44407750|NCT00847626|79415517|FG005|Overall Study|Protocol Violation|1|||
44253580|NCT02752165|79094293|FG000|Overall Study|Withdrawal by Subject|6|||
44148036|NCT02829723|78937581|FG008|Overall Study|Adverse Event|0|||
44148037|NCT02829723|78937582|FG009|Overall Study|Adverse Event|0|||
44148038|NCT02829723|78937583|FG010|Overall Study|Adverse Event|0|||
44148039|NCT02829723|78937584|FG011|Overall Study|Adverse Event|0|||
44148040|NCT02829723|78937585|FG012|Overall Study|Adverse Event|0|||
44253581|NCT02752165|79094294|FG001|Overall Study|Withdrawal by Subject|6|||
44253582|NCT02752165|79094293|FG000|Overall Study|Protocol Violation|6|||
44253583|NCT02752165|79094294|FG001|Overall Study|Protocol Violation|5|||
44253584|NCT02752165|79094293|FG000|Overall Study|Lost to Follow-up|33|||
44253585|NCT02752165|79094294|FG001|Overall Study|Lost to Follow-up|38|||
44253586|NCT02358031|79094303|FG000|Overall Study|Death|226|||
44253587|NCT02358031|79094304|FG001|Overall Study|Death|204|||
44253588|NCT02358031|79094305|FG002|Overall Study|Death|249|||
44407751|NCT00847626|79415518|FG006|Overall Study|Protocol Violation|1|||
44407752|NCT00847626|79415519|FG007|Overall Study|Protocol Violation|1|||
44407753|NCT00847626|79415520|FG008|Overall Study|Protocol Violation|0|||
44407754|NCT00847626|79415521|FG009|Overall Study|Protocol Violation|1|||
44407755|NCT00847626|79415522|FG010|Overall Study|Protocol Violation|1|||
44148041|NCT02829723|78937586|FG013|Overall Study|Adverse Event|0|||
44148042|NCT02829723|78937587|FG014|Overall Study|Adverse Event|1|||
44148043|NCT02829723|78937588|FG015|Overall Study|Adverse Event|1|||
44253589|NCT02358031|79094303|FG000|Overall Study|Lost to Follow-up|0|||
44407756|NCT00847626|79415512|FG000|Overall Study|Lost to Follow-up|0|||
44407757|NCT00847626|79415513|FG001|Overall Study|Lost to Follow-up|1|||
44407758|NCT00847626|79415514|FG002|Overall Study|Lost to Follow-up|1|||
44253590|NCT02358031|79094304|FG001|Overall Study|Lost to Follow-up|1|||
44253591|NCT02358031|79094305|FG002|Overall Study|Lost to Follow-up|1|||
44407759|NCT00847626|79415515|FG003|Overall Study|Lost to Follow-up|1|||
44407760|NCT00847626|79415516|FG004|Overall Study|Lost to Follow-up|0|||
44407761|NCT00847626|79415517|FG005|Overall Study|Lost to Follow-up|3|||
44407762|NCT00847626|79415518|FG006|Overall Study|Lost to Follow-up|1|||
44407763|NCT00847626|79415519|FG007|Overall Study|Lost to Follow-up|3|||
44407764|NCT00847626|79415520|FG008|Overall Study|Lost to Follow-up|1|||
44407765|NCT00847626|79415521|FG009|Overall Study|Lost to Follow-up|0|||
44407766|NCT00847626|79415522|FG010|Overall Study|Lost to Follow-up|1|||
44407767|NCT00847626|79415512|FG000|Overall Study|Withdrawal by Subject|5|||
44407768|NCT00847626|79415513|FG001|Overall Study|Withdrawal by Subject|5|||
44407769|NCT00847626|79415514|FG002|Overall Study|Withdrawal by Subject|3|||
44407770|NCT00847626|79415515|FG003|Overall Study|Withdrawal by Subject|8|||
44407771|NCT00847626|79415516|FG004|Overall Study|Withdrawal by Subject|12|||
44407772|NCT00847626|79415517|FG005|Overall Study|Withdrawal by Subject|9|||
44407773|NCT00847626|79415518|FG006|Overall Study|Withdrawal by Subject|8|||
44407774|NCT00847626|79415519|FG007|Overall Study|Withdrawal by Subject|4|||
44407775|NCT00847626|79415520|FG008|Overall Study|Withdrawal by Subject|4|||
44407776|NCT00847626|79415521|FG009|Overall Study|Withdrawal by Subject|5|||
44407777|NCT00847626|79415522|FG010|Overall Study|Withdrawal by Subject|2|||
44407778|NCT00847626|79415512|FG000|Overall Study|Lack of Efficacy|3|||
44407779|NCT00847626|79415513|FG001|Overall Study|Lack of Efficacy|1|||
44407780|NCT00847626|79415514|FG002|Overall Study|Lack of Efficacy|0|||
44407781|NCT00847626|79415515|FG003|Overall Study|Lack of Efficacy|1|||
44407782|NCT00847626|79415516|FG004|Overall Study|Lack of Efficacy|2|||
44407783|NCT00847626|79415517|FG005|Overall Study|Lack of Efficacy|0|||
44407784|NCT00847626|79415518|FG006|Overall Study|Lack of Efficacy|6|||
44407785|NCT00847626|79415519|FG007|Overall Study|Lack of Efficacy|2|||
44407786|NCT00847626|79415520|FG008|Overall Study|Lack of Efficacy|5|||
44407787|NCT00847626|79415521|FG009|Overall Study|Lack of Efficacy|1|||
44407788|NCT00847626|79415522|FG010|Overall Study|Lack of Efficacy|7|||
44407789|NCT00847626|79415512|FG000|Overall Study|Other|1|||
44407790|NCT00847626|79415513|FG001|Overall Study|Other|5|||
44407791|NCT00847626|79415514|FG002|Overall Study|Other|4|||
44407792|NCT00847626|79415515|FG003|Overall Study|Other|1|||
44407793|NCT00847626|79415516|FG004|Overall Study|Other|2|||
44407794|NCT00847626|79415517|FG005|Overall Study|Other|2|||
44407795|NCT00847626|79415518|FG006|Overall Study|Other|2|||
44407796|NCT00847626|79415519|FG007|Overall Study|Other|3|||
44407797|NCT00847626|79415520|FG008|Overall Study|Other|1|||
44148044|NCT02829723|78937589|FG016|Overall Study|Adverse Event|1|||
44148045|NCT02829723|78937590|FG017|Overall Study|Adverse Event|2|||
44148046|NCT02829723|78937591|FG018|Overall Study|Adverse Event|1|||
44148047|NCT02829723|78937592|FG019|Overall Study|Adverse Event|1|||
44148048|NCT02829723|78937593|FG020|Overall Study|Adverse Event|3|||
44148049|NCT02829723|78937594|FG021|Overall Study|Adverse Event|0|||
44148050|NCT02829723|78937595|FG022|Overall Study|Adverse Event|0|||
44148051|NCT02829723|78937596|FG023|Overall Study|Adverse Event|1|||
44148052|NCT02829723|78937597|FG024|Overall Study|Adverse Event|1|||
44148053|NCT02829723|78937598|FG025|Overall Study|Adverse Event|3|||
44148054|NCT02829723|78937599|FG026|Overall Study|Adverse Event|5|||
44148055|NCT02829723|78937573|FG000|Overall Study|Death|1|||
44148056|NCT02829723|78937574|FG001|Overall Study|Death|0|||
44148057|NCT02829723|78937575|FG002|Overall Study|Death|1|||
44148058|NCT02829723|78937576|FG003|Overall Study|Death|1|||
44148059|NCT02829723|78937577|FG004|Overall Study|Death|0|||
44148060|NCT02829723|78937578|FG005|Overall Study|Death|0|||
44148061|NCT02829723|78937579|FG006|Overall Study|Death|2|||
44148062|NCT02829723|78937580|FG007|Overall Study|Death|0|||
44148063|NCT02829723|78937581|FG008|Overall Study|Death|1|||
44148064|NCT02829723|78937582|FG009|Overall Study|Death|0|||
44148065|NCT02829723|78937583|FG010|Overall Study|Death|0|||
44148066|NCT02829723|78937584|FG011|Overall Study|Death|0|||
44148067|NCT02829723|78937585|FG012|Overall Study|Death|2|||
44148068|NCT02829723|78937586|FG013|Overall Study|Death|1|||
44148069|NCT02829723|78937587|FG014|Overall Study|Death|0|||
44148070|NCT02829723|78937588|FG015|Overall Study|Death|0|||
44148071|NCT02829723|78937589|FG016|Overall Study|Death|0|||
44148072|NCT02829723|78937590|FG017|Overall Study|Death|0|||
44148073|NCT02829723|78937591|FG018|Overall Study|Death|0|||
44148074|NCT02829723|78937592|FG019|Overall Study|Death|0|||
44148075|NCT02829723|78937593|FG020|Overall Study|Death|0|||
44148076|NCT02829723|78937594|FG021|Overall Study|Death|2|||
44148077|NCT02829723|78937595|FG022|Overall Study|Death|0|||
44148078|NCT02829723|78937596|FG023|Overall Study|Death|0|||
44148079|NCT02829723|78937597|FG024|Overall Study|Death|0|||
44148080|NCT02829723|78937598|FG025|Overall Study|Death|1|||
44148081|NCT02829723|78937599|FG026|Overall Study|Death|2|||
44148082|NCT02829723|78937573|FG000|Overall Study|Physician Decision|0|||
44148083|NCT02829723|78937574|FG001|Overall Study|Physician Decision|0|||
44148084|NCT02829723|78937575|FG002|Overall Study|Physician Decision|0|||
44148085|NCT02829723|78937576|FG003|Overall Study|Physician Decision|0|||
44148086|NCT02829723|78937577|FG004|Overall Study|Physician Decision|0|||
44282106|NCT01904604|79245333|FG001|Overall Study|Participant Relocated|1|||
44407798|NCT00847626|79415521|FG009|Overall Study|Other|1|||
44407799|NCT00847626|79415522|FG010|Overall Study|Other|3|||
44407800|NCT00851682|79415551|FG000|Overall Study|screen failure|5|||
44407801|NCT00851682|79415552|FG001|Overall Study|screen failure|0|||
44407802|NCT00860262|79415561|FG000|Overall Study|Adverse Event|9|||
44407803|NCT00860262|79415562|FG001|Overall Study|Adverse Event|6|||
44282107|NCT01904604|79245334|FG002|Overall Study|Participant Relocated|1|||
44282108|NCT01904604|79245332|FG000|Overall Study|Lost to Follow-up|0|||
44407804|NCT00860262|79415563|FG002|Overall Study|Adverse Event|7|||
44407805|NCT00860262|79415561|FG000|Overall Study|Protocol Violation|0|||
44407806|NCT00860262|79415562|FG001|Overall Study|Protocol Violation|1|||
44407807|NCT00860262|79415563|FG002|Overall Study|Protocol Violation|0|||
44407808|NCT00860262|79415561|FG000|Overall Study|Lost to Follow-up|2|||
44407809|NCT00860262|79415562|FG001|Overall Study|Lost to Follow-up|0|||
44407810|NCT00860262|79415563|FG002|Overall Study|Lost to Follow-up|1|||
44407811|NCT00860262|79415561|FG000|Overall Study|Withdrawal by Subject|4|||
44407812|NCT00860262|79415562|FG001|Overall Study|Withdrawal by Subject|8|||
44407813|NCT00860262|79415563|FG002|Overall Study|Withdrawal by Subject|6|||
44407814|NCT00860262|79415561|FG000|Overall Study|Lack of Efficacy|0|||
44407815|NCT00860262|79415562|FG001|Overall Study|Lack of Efficacy|4|||
44407816|NCT00860262|79415563|FG002|Overall Study|Lack of Efficacy|3|||
44407817|NCT00860262|79415561|FG000|Overall Study|Other|5|||
44407818|NCT00860262|79415562|FG001|Overall Study|Other|3|||
44407819|NCT00860262|79415563|FG002|Overall Study|Other|1|||
44407820|NCT00860028|79415575|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
44407821|NCT00860028|79415576|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
44407822|NCT00859638|79415586|FG000|Overall Study|Lost to Follow-up|6|||
44407823|NCT00859638|79415587|FG001|Overall Study|Lost to Follow-up|1|||
44407824|NCT00859638|79415586|FG000|Overall Study|Withdrawal by Subject|3|||
44407825|NCT00859638|79415587|FG001|Overall Study|Withdrawal by Subject|2|||
44148087|NCT02829723|78937578|FG005|Overall Study|Physician Decision|0|||
44148088|NCT02829723|78937579|FG006|Overall Study|Physician Decision|0|||
44148089|NCT02829723|78937580|FG007|Overall Study|Physician Decision|0|||
44148090|NCT02829723|78937581|FG008|Overall Study|Physician Decision|0|||
44148091|NCT02829723|78937582|FG009|Overall Study|Physician Decision|1|||
44253592|NCT02358031|79094303|FG000|Overall Study|Withdrawal by Subject|14|||
44253593|NCT02358031|79094304|FG001|Overall Study|Withdrawal by Subject|12|||
44407826|NCT00859638|79415586|FG000|Overall Study|Ill health|1|||
44407827|NCT00859638|79415587|FG001|Overall Study|Ill health|1|||
44407828|NCT00846846|79415593|FG000|Overall Study|Death|56|||
44407829|NCT00846846|79415593|FG000|Overall Study|Withdrawal by Subject|19|||
44407830|NCT00846768|79415597|FG000|Overall Study|Adverse Event|0|||
44407831|NCT00846768|79415598|FG001|Overall Study|Adverse Event|1|||
44407832|NCT00846768|79415599|FG002|Overall Study|Adverse Event|0|||
44407833|NCT00846768|79415600|FG003|Overall Study|Adverse Event|0|||
44407834|NCT00863798|79415613|FG000|Overall Study|Adverse Event|5|||
44407835|NCT00863798|79415614|FG001|Overall Study|Adverse Event|2|||
44407836|NCT00863798|79415615|FG002|Overall Study|Adverse Event|4|||
44407837|NCT00863798|79415613|FG000|Overall Study|Participant failed to return|2|||
44253594|NCT02358031|79094305|FG002|Overall Study|Withdrawal by Subject|17|||
44253595|NCT02358031|79094303|FG000|Overall Study|Ongoing in Study|61|||
44253596|NCT02358031|79094304|FG001|Overall Study|Ongoing in Study|64|||
44253597|NCT02358031|79094305|FG002|Overall Study|Ongoing in Study|33|||
44253598|NCT02037919|79094315|FG000|Overall Study|Lost to Follow-up|30|||
44253599|NCT02037919|79094316|FG001|Overall Study|Lost to Follow-up|45|||
44253600|NCT01949662|79094324|FG000|Overall Study|Death|9|||
44253601|NCT01949662|79094325|FG001|Overall Study|Death|7|||
44253602|NCT01949662|79094324|FG000|Overall Study|Discharged before an agitation event|8|||
44253603|NCT01949662|79094325|FG001|Overall Study|Discharged before an agitation event|3|||
44253604|NCT01949662|79094324|FG000|Overall Study|Dropped out|1|||
44253605|NCT01949662|79094325|FG001|Overall Study|Dropped out|3|||
44253606|NCT01949662|79094324|FG000|Overall Study|Ineligible|0|||
44253607|NCT01949662|79094325|FG001|Overall Study|Ineligible|1|||
44282109|NCT01904604|79245333|FG001|Overall Study|Lost to Follow-up|0|||
44407838|NCT00863798|79415614|FG001|Overall Study|Participant failed to return|1|||
44407839|NCT00863798|79415615|FG002|Overall Study|Participant failed to return|0|||
44407840|NCT00863798|79415613|FG000|Overall Study|Investigator request|1|||
44407841|NCT00863798|79415614|FG001|Overall Study|Investigator request|2|||
44407842|NCT00863798|79415615|FG002|Overall Study|Investigator request|1|||
44407843|NCT00863798|79415613|FG000|Overall Study|Lack of Efficacy|4|||
44407844|NCT00863798|79415614|FG001|Overall Study|Lack of Efficacy|3|||
44407845|NCT00863798|79415615|FG002|Overall Study|Lack of Efficacy|6|||
44407846|NCT00863798|79415613|FG000|Overall Study|Lost to Follow-up|6|||
44407847|NCT00863798|79415614|FG001|Overall Study|Lost to Follow-up|9|||
44407848|NCT00863798|79415615|FG002|Overall Study|Lost to Follow-up|5|||
44148092|NCT02829723|78937583|FG010|Overall Study|Physician Decision|1|||
44148093|NCT02829723|78937584|FG011|Overall Study|Physician Decision|0|||
44282110|NCT01904604|79245334|FG002|Overall Study|Lost to Follow-up|1|||
44148094|NCT02829723|78937585|FG012|Overall Study|Physician Decision|0|||
44253608|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253609|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253610|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44282111|NCT01904058|79245349|FG000|Overall Study|Adverse Event|2|||
44407849|NCT00863798|79415613|FG000|Overall Study|Other|2|||
44407850|NCT00863798|79415614|FG001|Overall Study|Other|3|||
44407851|NCT00863798|79415615|FG002|Overall Study|Other|1|||
44407852|NCT00863798|79415613|FG000|Overall Study|Protocol Violation|0|||
44407853|NCT00863798|79415614|FG001|Overall Study|Protocol Violation|1|||
44407854|NCT00863798|79415615|FG002|Overall Study|Protocol Violation|1|||
44407855|NCT00863798|79415613|FG000|Overall Study|Withdrawal by Subject|8|||
44407856|NCT00863798|79415614|FG001|Overall Study|Withdrawal by Subject|7|||
44407857|NCT00863798|79415615|FG002|Overall Study|Withdrawal by Subject|4|||
44407858|NCT00863798|79415613|FG000|Overall Study|Randomized not treated|4|||
44407859|NCT00863798|79415614|FG001|Overall Study|Randomized not treated|2|||
44407860|NCT00863798|79415615|FG002|Overall Study|Randomized not treated|3|||
44407861|NCT00859014|79415623|FG000|Overall Study|Death|4|||
44407862|NCT00859014|79415623|FG000|Overall Study|Lost to Follow-up|1|||
44407863|NCT00593606|79415627|FG000|Overall Study|Adverse Event|13|||
44407864|NCT00593606|79415627|FG000|Overall Study|Withdrawal by Subject|1|||
44407865|NCT00593606|79415627|FG000|Overall Study|Protocol Violation|3|||
44407866|NCT00593606|79415627|FG000|Overall Study|Lost to Follow-up|2|||
44407867|NCT00593606|79415627|FG000|Overall Study|Run-In Failure|5|||
44407868|NCT00593606|79415627|FG000|Overall Study|Screen Failure|3|||
44407869|NCT00870584|79415633|FG000|Overall Study|Adverse Event|3|||
44407870|NCT00870584|79415634|FG001|Overall Study|Adverse Event|3|||
44407871|NCT00870584|79415633|FG000|Overall Study|Withdrawal by Subject|6|||
44407872|NCT00870584|79415634|FG001|Overall Study|Withdrawal by Subject|7|||
44407873|NCT00870584|79415633|FG000|Overall Study|Lost to Follow-up|5|||
44407874|NCT00870584|79415634|FG001|Overall Study|Lost to Follow-up|1|||
44407875|NCT00870584|79415633|FG000|Overall Study|Protocol Deviation|2|||
44407876|NCT00870584|79415634|FG001|Overall Study|Protocol Deviation|2|||
44407877|NCT00870194|79415642|FG000|Overall Study|Adverse Event|10|||
44407878|NCT00870194|79415643|FG001|Overall Study|Adverse Event|5|||
44407879|NCT00870194|79415642|FG000|Overall Study|Lack of Efficacy|0|||
44407880|NCT00870194|79415643|FG001|Overall Study|Lack of Efficacy|1|||
44407881|NCT00870194|79415642|FG000|Overall Study|Lost to Follow-up|2|||
44407882|NCT00870194|79415643|FG001|Overall Study|Lost to Follow-up|0|||
44407883|NCT00870194|79415642|FG000|Overall Study|Physician Decision|3|||
44407884|NCT00870194|79415643|FG001|Overall Study|Physician Decision|1|||
44407885|NCT00870194|79415642|FG000|Overall Study|Protocol Violation|3|||
44407886|NCT00870194|79415643|FG001|Overall Study|Protocol Violation|3|||
44407887|NCT00870194|79415642|FG000|Overall Study|Entry Criteria Not Met|1|||
44407888|NCT00870194|79415643|FG001|Overall Study|Entry Criteria Not Met|2|||
44407889|NCT00870194|79415642|FG000|Overall Study|Subject Decision|7|||
44407890|NCT00870194|79415643|FG001|Overall Study|Subject Decision|2|||
44407891|NCT00690430|79415651|FG000|Core Phase|Abnormal Laboratory value|0|||
44407892|NCT00690430|79415652|FG001|Core Phase|Abnormal Laboratory value|1|||
44407893|NCT00690430|79415653|FG002|Core Phase|Abnormal Laboratory value|0|||
44407894|NCT00690430|79415651|FG000|Core Phase|Adverse Event|5|||
44407895|NCT00690430|79415652|FG001|Core Phase|Adverse Event|1|||
44407896|NCT00690430|79415653|FG002|Core Phase|Adverse Event|0|||
44407897|NCT00690430|79415651|FG000|Core Phase|Death|0|||
44407898|NCT00690430|79415652|FG001|Core Phase|Death|2|||
44407899|NCT00690430|79415653|FG002|Core Phase|Death|0|||
44407900|NCT00690430|79415651|FG000|Core Phase|Protocol Violation|1|||
44407901|NCT00690430|79415652|FG001|Core Phase|Protocol Violation|0|||
44407902|NCT00690430|79415653|FG002|Core Phase|Protocol Violation|0|||
44407903|NCT00690430|79415651|FG000|Core Phase|Withdrawal by Subject|3|||
44407904|NCT00690430|79415652|FG001|Core Phase|Withdrawal by Subject|3|||
44407905|NCT00690430|79415653|FG002|Core Phase|Withdrawal by Subject|0|||
44407906|NCT00690430|79415651|FG000|Core Phase|Subject no longer requires study drug|1|||
44407907|NCT00690430|79415652|FG001|Core Phase|Subject no longer requires study drug|0|||
44253611|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
44253612|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
44253613|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253614|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44407908|NCT00690430|79415653|FG002|Core Phase|Subject no longer requires study drug|0|||
44148095|NCT02829723|78937586|FG013|Overall Study|Physician Decision|1|||
44148096|NCT02829723|78937587|FG014|Overall Study|Physician Decision|0|||
44148097|NCT02829723|78937588|FG015|Overall Study|Physician Decision|0|||
44148098|NCT02829723|78937589|FG016|Overall Study|Physician Decision|2|||
44148099|NCT02829723|78937590|FG017|Overall Study|Physician Decision|0|||
44407909|NCT00690430|79415651|FG000|Core Phase|Lack of Efficacy|8|||
44407910|NCT00690430|79415652|FG001|Core Phase|Lack of Efficacy|10|||
44407911|NCT00690430|79415653|FG002|Core Phase|Lack of Efficacy|0|||
44407912|NCT00690430|79415651|FG000|Core Phase|Administrative Problems|0|||
44407913|NCT00690430|79415652|FG001|Core Phase|Administrative Problems|1|||
44407914|NCT00690430|79415653|FG002|Core Phase|Administrative Problems|0|||
44407915|NCT00690430|79415651|FG000|Core Phase|Early Termination|0|||
44148100|NCT02829723|78937591|FG018|Overall Study|Physician Decision|0|||
44407916|NCT00690430|79415652|FG001|Core Phase|Early Termination|5|||
44407917|NCT00690430|79415653|FG002|Core Phase|Early Termination|0|||
44407918|NCT00690430|79415651|FG000|Extension Phase|Lack of Efficacy|3|||
44407919|NCT00690430|79415652|FG001|Extension Phase|Lack of Efficacy|1|||
44407920|NCT00690430|79415653|FG002|Extension Phase|Lack of Efficacy|4|||
44407921|NCT00690430|79415651|FG000|Extension Phase|Abnormal Lab Values|1|||
44407922|NCT00690430|79415652|FG001|Extension Phase|Abnormal Lab Values|0|||
44407923|NCT00690430|79415653|FG002|Extension Phase|Abnormal Lab Values|0|||
44407924|NCT00690430|79415651|FG000|Extension Phase|Abnormal test procedure results|1|||
44407925|NCT00690430|79415652|FG001|Extension Phase|Abnormal test procedure results|0|||
44407926|NCT00690430|79415653|FG002|Extension Phase|Abnormal test procedure results|0|||
44407927|NCT00690430|79415651|FG000|Extension Phase|Administrative Problems|0|||
44407928|NCT00690430|79415652|FG001|Extension Phase|Administrative Problems|1|||
44407929|NCT00690430|79415653|FG002|Extension Phase|Administrative Problems|1|||
44407930|NCT00690430|79415651|FG000|Extension Phase|Adverse Event|2|||
44407931|NCT00690430|79415652|FG001|Extension Phase|Adverse Event|1|||
44407932|NCT00690430|79415653|FG002|Extension Phase|Adverse Event|2|||
44407933|NCT00690430|79415651|FG000|Extension Phase|Death|1|||
44407934|NCT00690430|79415652|FG001|Extension Phase|Death|1|||
44407935|NCT00690430|79415653|FG002|Extension Phase|Death|1|||
44407936|NCT00690430|79415651|FG000|Extension Phase|Withdrawal by Subject|0|||
44407937|NCT00690430|79415652|FG001|Extension Phase|Withdrawal by Subject|0|||
44407938|NCT00690430|79415653|FG002|Extension Phase|Withdrawal by Subject|2|||
44407939|NCT00690430|79415651|FG000|Extension Phase|Early Termination|10|||
44407940|NCT00690430|79415652|FG001|Extension Phase|Early Termination|1|||
44407941|NCT00690430|79415653|FG002|Extension Phase|Early Termination|3|||
44407942|NCT00863330|79415662|FG000|Overall Study|study terminated early due to administra|6|||
44407943|NCT00688324|79415666|FG000|Overall Study|Withdrawal by Subject|2|||
44407944|NCT00688324|79415666|FG000|Overall Study|Physician Decision|5|||
44407945|NCT00688324|79415666|FG000|Overall Study|Lost to Follow-up|1|||
44407946|NCT00862940|79415673|FG000|Overall Study|Adverse Event|15|||
44407947|NCT00862940|79415674|FG001|Overall Study|Adverse Event|12|||
44407948|NCT00862940|79415673|FG000|Overall Study|Lack of Efficacy|1|||
44407949|NCT00862940|79415674|FG001|Overall Study|Lack of Efficacy|3|||
44407950|NCT00862940|79415673|FG000|Overall Study|Protocol Violation|2|||
44407951|NCT00862940|79415674|FG001|Overall Study|Protocol Violation|5|||
44407952|NCT00862940|79415673|FG000|Overall Study|Withdrawal by Subject|4|||
44407953|NCT00862940|79415674|FG001|Overall Study|Withdrawal by Subject|6|||
44407954|NCT00862940|79415673|FG000|Overall Study|Non-compliance|4|||
44407955|NCT00862940|79415674|FG001|Overall Study|Non-compliance|0|||
44407956|NCT00862940|79415673|FG000|Overall Study|Lost to Follow-up|0|||
44407957|NCT00862940|79415674|FG001|Overall Study|Lost to Follow-up|1|||
44407958|NCT00862940|79415673|FG000|Overall Study|Administrative or other reason(s)|4|||
44407959|NCT00862940|79415674|FG001|Overall Study|Administrative or other reason(s)|3|||
44407960|NCT00868166|79415682|FG000|Overall Study|Death|58|||
44407961|NCT00868166|79415683|FG001|Overall Study|Death|65|||
44407962|NCT00868166|79415682|FG000|Overall Study|Withdrawal by Subject|33|||
44253615|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253616|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253617|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
44253618|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44282112|NCT01904058|79245350|FG001|Overall Study|Adverse Event|0|||
44282113|NCT01904058|79245351|FG002|Overall Study|Adverse Event|0|||
44282114|NCT01904058|79245352|FG003|Overall Study|Adverse Event|0|||
44282115|NCT01904058|79245349|FG000|Overall Study|Withdrawal by Subject|1|||
44407963|NCT00868166|79415683|FG001|Overall Study|Withdrawal by Subject|25|||
44253619|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253620|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
44253621|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
44253622|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
44253623|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
44253624|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
44253625|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
44253626|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
44253627|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
44407964|NCT00868166|79415682|FG000|Overall Study|Protocol Violation|1|||
44407965|NCT00868166|79415683|FG001|Overall Study|Protocol Violation|0|||
44407966|NCT00868166|79415682|FG000|Overall Study|Lost to Follow-up|1|||
44407967|NCT00868166|79415683|FG001|Overall Study|Lost to Follow-up|3|||
44407968|NCT00868166|79415682|FG000|Overall Study|Adverse Event|9|||
44407969|NCT00868166|79415683|FG001|Overall Study|Adverse Event|10|||
44407970|NCT00868166|79415682|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
44253628|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
44282116|NCT01904058|79245350|FG001|Overall Study|Withdrawal by Subject|0|||
44407971|NCT00868166|79415683|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
44407972|NCT00868166|79415682|FG000|Overall Study|Non-compliance with IMP|1|||
44407973|NCT00868166|79415683|FG001|Overall Study|Non-compliance with IMP|1|||
44253629|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44253630|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44407974|NCT00858780|79415689|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
44148101|NCT02829723|78937592|FG019|Overall Study|Physician Decision|0|||
44148102|NCT02829723|78937593|FG020|Overall Study|Physician Decision|0|||
44148103|NCT02829723|78937594|FG021|Overall Study|Physician Decision|0|||
44148104|NCT02829723|78937595|FG022|Overall Study|Physician Decision|1|||
44148105|NCT02829723|78937596|FG023|Overall Study|Physician Decision|1|||
44148106|NCT02829723|78937597|FG024|Overall Study|Physician Decision|1|||
44148107|NCT02829723|78937598|FG025|Overall Study|Physician Decision|1|||
44148108|NCT02829723|78937599|FG026|Overall Study|Physician Decision|3|||
44148109|NCT02829723|78937573|FG000|Overall Study|Progressive disease|4|||
44148110|NCT02829723|78937574|FG001|Overall Study|Progressive disease|6|||
44148111|NCT02829723|78937575|FG002|Overall Study|Progressive disease|3|||
44148112|NCT02829723|78937576|FG003|Overall Study|Progressive disease|3|||
44523849|NCT04493684|79532179|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
44523850|NCT04493684|79532180|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523851|NCT04493684|79532181|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523852|NCT04493684|79532182|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
44523853|NCT04493684|79532183|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523854|NCT04493684|79532184|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44407975|NCT00858780|79415690|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
44407976|NCT00858780|79415691|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
44407977|NCT00858780|79415692|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
44407978|NCT00858780|79415693|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
44407979|NCT00858780|79415689|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
44407980|NCT00858780|79415690|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
44523855|NCT04493684|79532185|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523856|NCT04493684|79532186|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523857|NCT04493684|79532187|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523858|NCT04493684|79532188|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523859|NCT04493684|79532189|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523860|NCT04493684|79532190|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523861|NCT04493684|79532191|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523862|NCT04493684|79532192|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523863|NCT04493684|79532193|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
44523864|NCT04493684|79532177|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
44523865|NCT04493684|79532178|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523866|NCT04493684|79532179|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523867|NCT04493684|79532180|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523868|NCT04493684|79532181|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523869|NCT04493684|79532182|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523870|NCT04493684|79532183|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523871|NCT04493684|79532184|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523872|NCT04493684|79532185|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523873|NCT04493684|79532186|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523874|NCT04493684|79532187|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523875|NCT04493684|79532188|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523876|NCT04493684|79532189|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523877|NCT04493684|79532190|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523878|NCT04493684|79532191|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523879|NCT04493684|79532192|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523880|NCT04493684|79532193|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
44523881|NCT04493684|79532177|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523882|NCT04493684|79532178|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523883|NCT04493684|79532179|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523884|NCT04493684|79532180|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523885|NCT04493684|79532181|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523886|NCT04493684|79532182|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523887|NCT04493684|79532183|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
44148113|NCT02829723|78937577|FG004|Overall Study|Progressive disease|3|||
44148114|NCT02829723|78937578|FG005|Overall Study|Progressive disease|5|||
44148115|NCT02829723|78937579|FG006|Overall Study|Progressive disease|4|||
44148116|NCT02829723|78937580|FG007|Overall Study|Progressive disease|6|||
44148117|NCT02829723|78937581|FG008|Overall Study|Progressive disease|8|||
44148118|NCT02829723|78937582|FG009|Overall Study|Progressive disease|4|||
44148119|NCT02829723|78937583|FG010|Overall Study|Progressive disease|9|||
44148120|NCT02829723|78937584|FG011|Overall Study|Progressive disease|0|||
44148121|NCT02829723|78937585|FG012|Overall Study|Progressive disease|3|||
44407981|NCT00858780|79415691|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
44407982|NCT00858780|79415692|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
44407983|NCT00858780|79415693|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
44407984|NCT00858780|79415689|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
44407985|NCT00858780|79415690|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
44407986|NCT00858780|79415691|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
44407987|NCT00858780|79415692|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
44407988|NCT00858780|79415693|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
44407989|NCT00858780|79415689|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
44407990|NCT00858780|79415690|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
44407991|NCT00858780|79415691|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
44407992|NCT00858780|79415692|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
44407993|NCT00858780|79415693|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
44407994|NCT00858780|79415689|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
44407995|NCT00858780|79415690|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
44407996|NCT00858780|79415691|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
44407997|NCT00858780|79415692|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
44407998|NCT00858780|79415693|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
44407999|NCT00858780|79415689|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
44408000|NCT00858780|79415690|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
44408001|NCT00858780|79415691|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
44408002|NCT00858780|79415692|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
44408003|NCT00858780|79415693|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
44408004|NCT00850200|79415703|FG000|Overall Study|Physician Decision|2|||
44408005|NCT00850200|79415703|FG000|Overall Study|Did not recieve treatment|2|||
44408006|NCT00850200|79415703|FG000|Overall Study|Withdrawal by Subject|1|||
44408007|NCT00858234|79415710|FG000|Overall Study|Adverse Event|6|||
44408008|NCT00858234|79415710|FG000|Overall Study|Progressive disease|2|||
44408009|NCT00858234|79415710|FG000|Overall Study|Status unknown|1|||
44408010|NCT00862082|79415716|FG000|Overall Study|Sponsor decision to terminate the study|5|||
44408011|NCT00862082|79415717|FG001|Overall Study|Sponsor decision to terminate the study|0|||
44408012|NCT00862082|79415716|FG000|Overall Study|Withdrawal by Subject|0|||
44408013|NCT00862082|79415717|FG001|Overall Study|Withdrawal by Subject|1|||
44408014|NCT00692770|79415732|FG000|Overall Study|Protocol Violation|2|||
44408015|NCT00692770|79415733|FG001|Overall Study|Protocol Violation|7|||
44408016|NCT00692770|79415732|FG000|Overall Study|Withdrawal by Subject|97|||
44408017|NCT00692770|79415733|FG001|Overall Study|Withdrawal by Subject|36|||
44408018|NCT00692770|79415732|FG000|Overall Study|Adverse Event|136|||
44408019|NCT00692770|79415733|FG001|Overall Study|Adverse Event|41|||
44408020|NCT00692770|79415732|FG000|Overall Study|Death|10|||
44408021|NCT00692770|79415733|FG001|Overall Study|Death|5|||
44408022|NCT00692770|79415732|FG000|Overall Study|Lost to Follow-up|7|||
44408023|NCT00692770|79415733|FG001|Overall Study|Lost to Follow-up|3|||
44408024|NCT00692770|79415732|FG000|Overall Study|Non-compliant with study medication|11|||
44408025|NCT00692770|79415733|FG001|Overall Study|Non-compliant with study medication|5|||
44408026|NCT00692770|79415732|FG000|Overall Study|Progression by clinical judgment|2|||
44408027|NCT00692770|79415733|FG001|Overall Study|Progression by clinical judgment|3|||
44408028|NCT00692770|79415732|FG000|Overall Study|Physician decision not protocol driven|10|||
44408029|NCT00692770|79415733|FG001|Overall Study|Physician decision not protocol driven|14|||
44408030|NCT00692770|79415732|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
44408031|NCT00692770|79415733|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
44408032|NCT00692770|79415732|FG000|Overall Study|Protocol driven decision point|3|||
44408033|NCT00692770|79415733|FG001|Overall Study|Protocol driven decision point|7|||
44408034|NCT00692770|79415732|FG000|Overall Study|Completed all planned assessments|79|||
44408035|NCT00692770|79415733|FG001|Overall Study|Completed all planned assessments|101|||
44408036|NCT00692770|79415732|FG000|Overall Study|Radiological and clinical progression|8|||
44408037|NCT00692770|79415733|FG001|Overall Study|Radiological and clinical progression|8|||
44408038|NCT00692770|79415732|FG000|Overall Study|Clinical endpoint reached|16|||
44408039|NCT00692770|79415733|FG001|Overall Study|Clinical endpoint reached|43|||
44408040|NCT00692770|79415732|FG000|Overall Study|Study terminated by sponsor|2|||
44408041|NCT00692770|79415733|FG001|Overall Study|Study terminated by sponsor|2|||
44408042|NCT00692770|79415732|FG000|Overall Study|Randomized but not treated|3|||
44408043|NCT00692770|79415733|FG001|Overall Study|Randomized but not treated|4|||
44408044|NCT00849108|79415748|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
44408045|NCT00849108|79415749|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
44408046|NCT00849108|79415748|FG000|Cohort 2 Efficacy|Adverse Event|0|||
44408047|NCT00849108|79415749|FG001|Cohort 2 Efficacy|Adverse Event|1|||
44408048|NCT00849108|79415748|FG000|Cohort 2 Efficacy|Other|0|||
44408049|NCT00849108|79415749|FG001|Cohort 2 Efficacy|Other|9|||
44408050|NCT00867308|79415759|FG000|Overall Study|Death|1|||
44408051|NCT00867308|79415760|FG001|Overall Study|Death|0|||
44408052|NCT00867308|79415759|FG000|Overall Study|Adverse Event|1|||
44408053|NCT00867308|79415760|FG001|Overall Study|Adverse Event|4|||
44408054|NCT00867308|79415759|FG000|Overall Study|Lack of Efficacy|6|||
44408055|NCT00867308|79415760|FG001|Overall Study|Lack of Efficacy|12|||
44408056|NCT00867308|79415759|FG000|Overall Study|Withdrawal by Subject|1|||
44408057|NCT00867308|79415760|FG001|Overall Study|Withdrawal by Subject|2|||
44408058|NCT00849186|79415766|FG000|Overall Study|Adverse Event|2|||
44408059|NCT00849186|79415766|FG000|Overall Study|Withdrawal by Subject|1|||
44408060|NCT00849186|79415766|FG000|Overall Study|not treated|6|||
44408061|NCT00849186|79415766|FG000|Overall Study|Other|1|||
44408062|NCT00866918|79415773|FG000|Overall Study|Death|1|||
44408063|NCT00866918|79415774|FG001|Overall Study|Death|5|||
44408064|NCT00866918|79415773|FG000|Overall Study|Lack of Efficacy|1|||
44408065|NCT00866918|79415774|FG001|Overall Study|Lack of Efficacy|1|||
44408066|NCT00866918|79415773|FG000|Overall Study|Physician Decision|10|||
44408067|NCT00866918|79415774|FG001|Overall Study|Physician Decision|2|||
44408068|NCT00866918|79415773|FG000|Overall Study|Ineligible|2|||
44408069|NCT00866918|79415774|FG001|Overall Study|Ineligible|4|||
44408070|NCT00866918|79415773|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
44408071|NCT00866918|79415774|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
44408072|NCT00866918|79415773|FG000|Overall Study|Secondary malignancy|1|||
44408073|NCT00866918|79415774|FG001|Overall Study|Secondary malignancy|0|||
44408074|NCT03158285|79415783|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
44408075|NCT03158285|79415784|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
44408076|NCT03158285|79415785|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
44408077|NCT03158285|79415783|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
44408078|NCT03158285|79415784|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
44408079|NCT03158285|79415785|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
44408080|NCT03158285|79415783|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
44408081|NCT03158285|79415784|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
44408082|NCT03158285|79415785|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
44408083|NCT03158285|79415783|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
44408084|NCT03158285|79415784|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
44408085|NCT03158285|79415785|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
44408086|NCT03158285|79415783|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
44408087|NCT03158285|79415784|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
44408088|NCT03158285|79415785|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
44408089|NCT03158285|79415783|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
44408090|NCT03158285|79415784|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
44253631|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
44253632|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
44253633|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44408091|NCT03158285|79415785|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
44523888|NCT04493684|79532184|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523889|NCT04493684|79532185|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523890|NCT04493684|79532186|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523891|NCT04493684|79532187|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523892|NCT04493684|79532188|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523893|NCT04493684|79532189|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523894|NCT04493684|79532190|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523895|NCT04493684|79532191|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523896|NCT04493684|79532192|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523897|NCT04493684|79532193|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
44523898|NCT04493684|79532177|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
44523899|NCT04493684|79532178|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523900|NCT04493684|79532179|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44408092|NCT03158285|79415783|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
44523901|NCT04493684|79532180|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523902|NCT04493684|79532181|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44253634|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
44408093|NCT03158285|79415784|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
44408094|NCT03158285|79415785|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
44408095|NCT03158285|79415783|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
44408096|NCT03158285|79415784|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
44408097|NCT03158285|79415785|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
44253635|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44408098|NCT03158285|79415783|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
44408099|NCT03158285|79415784|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
44408100|NCT03158285|79415785|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
44253636|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
44253637|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44253638|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44253639|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
44253640|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
44253641|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
44408101|NCT03158285|79415783|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
44408102|NCT03158285|79415784|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
44408103|NCT03158285|79415785|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
44408104|NCT03158285|79415783|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
44408105|NCT03158285|79415784|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
44408106|NCT03158285|79415785|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
44408107|NCT03158285|79415783|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
44408108|NCT03158285|79415784|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
44408109|NCT03158285|79415785|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
44408110|NCT03158285|79415783|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
44408111|NCT03158285|79415784|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
44408112|NCT03158285|79415785|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
44408113|NCT03158285|79415783|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
44408114|NCT03158285|79415784|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
44408115|NCT03158285|79415785|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
44408116|NCT03158285|79415783|FG000|Active Treatment Period: Week 52-100|Death|1|||
44408117|NCT03158285|79415784|FG001|Active Treatment Period: Week 52-100|Death|0|||
44408118|NCT03158285|79415785|FG002|Active Treatment Period: Week 52-100|Death|0|||
44408119|NCT03158285|79415783|FG000|Active Treatment Period: Week 52-100|Other|4|||
44408120|NCT03158285|79415784|FG001|Active Treatment Period: Week 52-100|Other|1|||
44408121|NCT03158285|79415785|FG002|Active Treatment Period: Week 52-100|Other|0|||
44408122|NCT00861692|79415798|FG000|Overall Study|Death|6|||
44408123|NCT00602927|79415804|FG000|Period 1: 13 Days|Protocol Violation|2|||
44408124|NCT00602927|79415805|FG001|Period 1: 13 Days|Protocol Violation|4|||
44408125|NCT00602927|79415804|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
44408126|NCT00602927|79415805|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
44408127|NCT00602927|79415804|FG000|Period 1: 13 Days|Time|1|||
44408128|NCT00602927|79415805|FG001|Period 1: 13 Days|Time|0|||
44408129|NCT00602927|79415804|FG000|Period 1: 13 Days|Claustrophobia|0|||
44408130|NCT00602927|79415805|FG001|Period 1: 13 Days|Claustrophobia|1|||
44408131|NCT00602927|79415804|FG000|Period 2: 14 Days|Protocol Violation|0|||
44408132|NCT00602927|79415805|FG001|Period 2: 14 Days|Protocol Violation|2|||
44408133|NCT00602927|79415804|FG000|Period 3: 13 Days|Protocol Violation|0|||
44408134|NCT00602927|79415805|FG001|Period 3: 13 Days|Protocol Violation|1|||
44408135|NCT00602927|79415804|FG000|Period 3: 13 Days|MRI data quality|2|||
44408136|NCT00602927|79415805|FG001|Period 3: 13 Days|MRI data quality|2|||
44408137|NCT00602537|79415813|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
44408138|NCT00602537|79415814|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
44408139|NCT00602537|79415813|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
44408140|NCT00602537|79415814|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
44408141|NCT00602537|79415813|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
44408142|NCT00602537|79415814|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
44408143|NCT00602537|79415813|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
44408144|NCT00602537|79415814|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
44408145|NCT00602537|79415813|FG000|Follow Up Study Comparison|Adverse Event|1|||
44408146|NCT00602537|79415814|FG001|Follow Up Study Comparison|Adverse Event|0|||
44408147|NCT00602537|79415813|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
44408148|NCT00602537|79415814|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
44253642|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
44253643|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
44253644|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
44408149|NCT00602537|79415813|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
44408150|NCT00602537|79415814|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
44408151|NCT00861614|79415822|FG000|Overall Study|Disease Progression|182|||
44408152|NCT00861614|79415823|FG001|Overall Study|Disease Progression|263|||
44408153|NCT00861614|79415822|FG000|Overall Study|Study Drug Toxicity|79|||
44408154|NCT00861614|79415823|FG001|Overall Study|Study Drug Toxicity|6|||
44408155|NCT00861614|79415822|FG000|Overall Study|Death|32|||
44408156|NCT00861614|79415823|FG001|Overall Study|Death|19|||
44408157|NCT00861614|79415822|FG000|Overall Study|Adverse Event|27|||
44408158|NCT00861614|79415823|FG001|Overall Study|Adverse Event|23|||
44408159|NCT00861614|79415822|FG000|Overall Study|Withdrawal by Subject|34|||
44408160|NCT00861614|79415823|FG001|Overall Study|Withdrawal by Subject|35|||
44523903|NCT04493684|79532182|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44253645|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
44408161|NCT00861614|79415822|FG000|Overall Study|Other|17|||
44408162|NCT00861614|79415823|FG001|Overall Study|Other|22|||
44408163|NCT00485173|79415831|FG000|Overall Study|Death|4|||
44408164|NCT00485173|79415832|FG001|Overall Study|Death|3|||
44408165|NCT00485173|79415831|FG000|Overall Study|Lost to Follow-up|32|||
44408166|NCT00485173|79415832|FG001|Overall Study|Lost to Follow-up|61|||
44408167|NCT00495469|79415845|FG000|Overall Study|Adverse Event|0|||
44408168|NCT00495469|79415846|FG001|Overall Study|Adverse Event|1|||
44408169|NCT00495469|79415847|FG002|Overall Study|Adverse Event|3|||
44408170|NCT00495469|79415848|FG003|Overall Study|Adverse Event|0|||
44408171|NCT00495469|79415849|FG004|Overall Study|Adverse Event|1|||
44408172|NCT00495469|79415850|FG005|Overall Study|Adverse Event|1|||
44408173|NCT00495469|79415851|FG006|Overall Study|Adverse Event|1|||
44408174|NCT00495469|79415845|FG000|Overall Study|Lost to Follow-up|1|||
44408175|NCT00495469|79415846|FG001|Overall Study|Lost to Follow-up|1|||
44408176|NCT00495469|79415847|FG002|Overall Study|Lost to Follow-up|3|||
44408177|NCT00495469|79415848|FG003|Overall Study|Lost to Follow-up|1|||
44408178|NCT00495469|79415849|FG004|Overall Study|Lost to Follow-up|0|||
44408179|NCT00495469|79415850|FG005|Overall Study|Lost to Follow-up|0|||
44408180|NCT00495469|79415851|FG006|Overall Study|Lost to Follow-up|0|||
44408181|NCT00495469|79415845|FG000|Overall Study|Protocol Violation|0|||
44408182|NCT00495469|79415846|FG001|Overall Study|Protocol Violation|0|||
44408183|NCT00495469|79415847|FG002|Overall Study|Protocol Violation|0|||
44408184|NCT00495469|79415848|FG003|Overall Study|Protocol Violation|0|||
44408185|NCT00495469|79415849|FG004|Overall Study|Protocol Violation|1|||
44408186|NCT00495469|79415850|FG005|Overall Study|Protocol Violation|2|||
44408187|NCT00495469|79415851|FG006|Overall Study|Protocol Violation|0|||
44408188|NCT00495469|79415845|FG000|Overall Study|Withdrawal by Subject|5|||
44408189|NCT00495469|79415846|FG001|Overall Study|Withdrawal by Subject|3|||
44408190|NCT00495469|79415847|FG002|Overall Study|Withdrawal by Subject|1|||
44408191|NCT00495469|79415848|FG003|Overall Study|Withdrawal by Subject|3|||
44408192|NCT00495469|79415849|FG004|Overall Study|Withdrawal by Subject|3|||
44408193|NCT00495469|79415850|FG005|Overall Study|Withdrawal by Subject|2|||
44408194|NCT00495469|79415851|FG006|Overall Study|Withdrawal by Subject|3|||
44408195|NCT00495469|79415845|FG000|Overall Study|Lack of Efficacy|0|||
44408196|NCT00495469|79415846|FG001|Overall Study|Lack of Efficacy|0|||
44408197|NCT00495469|79415847|FG002|Overall Study|Lack of Efficacy|0|||
44408198|NCT00495469|79415848|FG003|Overall Study|Lack of Efficacy|0|||
44408199|NCT00495469|79415849|FG004|Overall Study|Lack of Efficacy|0|||
44408200|NCT00495469|79415850|FG005|Overall Study|Lack of Efficacy|0|||
44408201|NCT00495469|79415851|FG006|Overall Study|Lack of Efficacy|1|||
44408202|NCT00495469|79415845|FG000|Overall Study|Liver function test abnormality|0|||
44408203|NCT00495469|79415846|FG001|Overall Study|Liver function test abnormality|1|||
44408204|NCT00495469|79415847|FG002|Overall Study|Liver function test abnormality|0|||
44408205|NCT00495469|79415848|FG003|Overall Study|Liver function test abnormality|0|||
44408206|NCT00495469|79415849|FG004|Overall Study|Liver function test abnormality|0|||
44408207|NCT00495469|79415850|FG005|Overall Study|Liver function test abnormality|0|||
44408208|NCT00495469|79415851|FG006|Overall Study|Liver function test abnormality|0|||
44408209|NCT00495469|79415845|FG000|Overall Study|ST depression at randomisation in ECG|0|||
44408210|NCT00495469|79415846|FG001|Overall Study|ST depression at randomisation in ECG|1|||
44408211|NCT00495469|79415847|FG002|Overall Study|ST depression at randomisation in ECG|0|||
44408212|NCT00495469|79415848|FG003|Overall Study|ST depression at randomisation in ECG|0|||
44408213|NCT00495469|79415849|FG004|Overall Study|ST depression at randomisation in ECG|0|||
44408214|NCT00495469|79415850|FG005|Overall Study|ST depression at randomisation in ECG|0|||
44408215|NCT00495469|79415851|FG006|Overall Study|ST depression at randomisation in ECG|0|||
44408216|NCT00861380|79415881|FG000|Overall Study|Withdrawal Information not recorded|8427|||
44408217|NCT00861380|79415882|FG001|Overall Study|Withdrawal Information not recorded|9112|||
44408218|NCT00861380|79415883|FG002|Overall Study|Withdrawal Information not recorded|8872|||
44408219|NCT00861380|79415884|FG003|Overall Study|Withdrawal Information not recorded|3689|||
44408220|NCT00861380|79415885|FG004|Overall Study|Withdrawal Information not recorded|1812|||
44408221|NCT00861380|79415886|FG005|Overall Study|Withdrawal Information not recorded|6249|||
44408222|NCT00861380|79415887|FG006|Overall Study|Withdrawal Information not recorded|3020|||
44408223|NCT00495391|79415922|FG000|Overall Study|Lack of Efficacy|34|||
44408224|NCT00495391|79415923|FG001|Overall Study|Lack of Efficacy|18|||
44408225|NCT00495391|79415922|FG000|Overall Study|Withdrawal by Subject|2|||
44408226|NCT00495391|79415923|FG001|Overall Study|Withdrawal by Subject|3|||
44408227|NCT00869960|79415929|FG000|Overall Study|Lost to Follow-up|2|||
44408228|NCT00494299|79415935|FG000|Overall Study|Adverse Event|93|||
44408229|NCT00494299|79415936|FG001|Overall Study|Adverse Event|13|||
44523904|NCT04493684|79532183|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44408230|NCT00494299|79415935|FG000|Overall Study|Lost to Follow-up|1|||
44408231|NCT00494299|79415936|FG001|Overall Study|Lost to Follow-up|0|||
44408232|NCT00494299|79415935|FG000|Overall Study|Physician Decision|0|||
44408233|NCT00494299|79415936|FG001|Overall Study|Physician Decision|2|||
44408234|NCT00494299|79415935|FG000|Overall Study|Protocol Violation|1|||
44408235|NCT00494299|79415936|FG001|Overall Study|Protocol Violation|2|||
44408236|NCT00494299|79415935|FG000|Overall Study|Withdrawal by Subject|8|||
44408237|NCT00494299|79415936|FG001|Overall Study|Withdrawal by Subject|3|||
44408238|NCT00494299|79415935|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
44408239|NCT00494299|79415936|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
44408240|NCT00494299|79415935|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
44408241|NCT00494299|79415936|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
44408242|NCT00494299|79415935|FG000|Overall Study|Site Closed by Sponsor|6|||
44408243|NCT00494299|79415936|FG001|Overall Study|Site Closed by Sponsor|0|||
44408244|NCT00494299|79415935|FG000|Overall Study|Protocol Driven Decision Point|11|||
44408245|NCT00494299|79415936|FG001|Overall Study|Protocol Driven Decision Point|22|||
44408246|NCT00593684|79415944|FG000|Overall Study|Death|2|||
44408247|NCT00593684|79415945|FG001|Overall Study|Death|1|||
44408248|NCT02963831|79415955|FG000|Overall Study|Progressive Disease|3|||
44408249|NCT02963831|79415956|FG001|Overall Study|Progressive Disease|3|||
44408250|NCT02963831|79415957|FG002|Overall Study|Progressive Disease|16|||
44408251|NCT02963831|79415958|FG003|Overall Study|Progressive Disease|27|||
44408252|NCT02963831|79415955|FG000|Overall Study|Withdrawal by Subject|1|||
44408253|NCT02963831|79415956|FG001|Overall Study|Withdrawal by Subject|0|||
44408254|NCT02963831|79415957|FG002|Overall Study|Withdrawal by Subject|2|||
44408255|NCT02963831|79415958|FG003|Overall Study|Withdrawal by Subject|4|||
44408256|NCT02963831|79415955|FG000|Overall Study|Adverse Event|0|||
44408257|NCT02963831|79415956|FG001|Overall Study|Adverse Event|1|||
44523905|NCT04493684|79532184|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523906|NCT04493684|79532185|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523907|NCT04493684|79532186|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523908|NCT04493684|79532187|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523909|NCT04493684|79532188|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523910|NCT04493684|79532189|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523911|NCT04493684|79532190|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523912|NCT04493684|79532191|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523913|NCT04493684|79532192|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523914|NCT04493684|79532193|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
44523915|NCT04493684|79532177|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523916|NCT04493684|79532178|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523917|NCT04493684|79532179|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523918|NCT04493684|79532180|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523919|NCT04493684|79532181|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523920|NCT04493684|79532182|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
44523921|NCT04493684|79532183|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523922|NCT04493684|79532184|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523923|NCT04493684|79532185|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523924|NCT04493684|79532186|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523925|NCT04493684|79532187|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523926|NCT04493684|79532188|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44253646|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
44253647|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
44253648|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
44253649|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
44253650|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
44253651|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
44253652|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
44253653|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
44408258|NCT02963831|79415957|FG002|Overall Study|Adverse Event|1|||
44408259|NCT02963831|79415958|FG003|Overall Study|Adverse Event|2|||
44408260|NCT02963831|79415955|FG000|Overall Study|Death|0|||
44408261|NCT02963831|79415956|FG001|Overall Study|Death|0|||
44408262|NCT02963831|79415957|FG002|Overall Study|Death|0|||
44408263|NCT02963831|79415958|FG003|Overall Study|Death|2|||
44408264|NCT00859898|79415973|FG000|Overall Study|Lack of Efficacy|0|||
44408265|NCT00859898|79415974|FG001|Overall Study|Lack of Efficacy|1|||
44408266|NCT00859898|79415975|FG002|Overall Study|Lack of Efficacy|1|||
44408267|NCT00859898|79415973|FG000|Overall Study|Adverse Event|4|||
44408268|NCT00859898|79415974|FG001|Overall Study|Adverse Event|9|||
44408269|NCT00859898|79415975|FG002|Overall Study|Adverse Event|8|||
44408270|NCT00859898|79415973|FG000|Overall Study|Withdrawal by Subject|11|||
44253654|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
44253655|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
44253656|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
44408271|NCT00859898|79415974|FG001|Overall Study|Withdrawal by Subject|8|||
44408272|NCT00859898|79415975|FG002|Overall Study|Withdrawal by Subject|11|||
44408273|NCT00859898|79415973|FG000|Overall Study|Death|0|||
44408274|NCT00859898|79415974|FG001|Overall Study|Death|0|||
44408275|NCT00859898|79415975|FG002|Overall Study|Death|1|||
44408276|NCT00859898|79415973|FG000|Overall Study|Lost to Follow-up|10|||
44408277|NCT00859898|79415974|FG001|Overall Study|Lost to Follow-up|11|||
44408278|NCT00859898|79415975|FG002|Overall Study|Lost to Follow-up|5|||
44253657|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
44253658|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
44408279|NCT00859898|79415973|FG000|Overall Study|poor/non-compliance|2|||
44523927|NCT04493684|79532189|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523928|NCT04493684|79532190|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523929|NCT04493684|79532191|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523930|NCT04493684|79532192|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523931|NCT04493684|79532193|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
44523932|NCT04493684|79532177|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523933|NCT04493684|79532178|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523934|NCT04493684|79532179|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523935|NCT04493684|79532180|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523936|NCT04493684|79532181|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523937|NCT04493684|79532182|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523938|NCT04493684|79532183|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523939|NCT04493684|79532184|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523940|NCT04493684|79532185|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523941|NCT04493684|79532186|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523942|NCT04493684|79532187|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523943|NCT04493684|79532188|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
44523944|NCT04493684|79532189|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523945|NCT04493684|79532190|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523946|NCT04493684|79532191|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523947|NCT04493684|79532192|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523948|NCT04493684|79532193|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
44523949|NCT04493684|79532177|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523950|NCT04493684|79532178|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523951|NCT04493684|79532179|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523952|NCT04493684|79532180|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523953|NCT04493684|79532181|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523954|NCT04493684|79532182|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523955|NCT04493684|79532183|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523956|NCT04493684|79532184|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523957|NCT04493684|79532185|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523958|NCT04493684|79532186|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523959|NCT04493684|79532187|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523960|NCT04493684|79532188|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523961|NCT04493684|79532189|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523962|NCT04493684|79532190|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523963|NCT04493684|79532191|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523964|NCT04493684|79532192|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
44523965|NCT04493684|79532193|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
44523966|NCT04493684|79532177|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523967|NCT04493684|79532178|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523968|NCT04493684|79532179|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523969|NCT04493684|79532180|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523970|NCT04493684|79532181|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523971|NCT04493684|79532182|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523972|NCT04493684|79532183|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523973|NCT04493684|79532184|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523974|NCT04493684|79532185|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523975|NCT04493684|79532186|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523976|NCT04493684|79532187|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523977|NCT04493684|79532188|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523978|NCT04493684|79532189|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44408280|NCT00859898|79415974|FG001|Overall Study|poor/non-compliance|0|||
44408281|NCT00859898|79415975|FG002|Overall Study|poor/non-compliance|0|||
44408282|NCT00859898|79415973|FG000|Overall Study|No longer meets criteria|0|||
44408283|NCT00859898|79415974|FG001|Overall Study|No longer meets criteria|1|||
44408284|NCT00859898|79415975|FG002|Overall Study|No longer meets criteria|0|||
44408285|NCT00859898|79415973|FG000|Overall Study|non-specified|1|||
44408286|NCT00859898|79415974|FG001|Overall Study|non-specified|1|||
44408287|NCT00859898|79415975|FG002|Overall Study|non-specified|1|||
44408288|NCT00859586|79415984|FG000|Overall Study|Donors|4|||
44408289|NCT00494221|79415991|FG000|Overall Study|Death|15|||
44408290|NCT00494221|79415992|FG001|Overall Study|Death|9|||
44408291|NCT00494221|79415993|FG002|Overall Study|Death|14|||
44408292|NCT00494221|79415991|FG000|Overall Study|Withdrawal by Subject|1|||
44408293|NCT00494221|79415992|FG001|Overall Study|Withdrawal by Subject|2|||
44408294|NCT00494221|79415993|FG002|Overall Study|Withdrawal by Subject|0|||
44408295|NCT00857948|79416005|FG000|Overall Study|Withdrawal by Subject|2|||
44408296|NCT00857948|79416006|FG001|Overall Study|Withdrawal by Subject|0|||
44408297|NCT00857948|79416007|FG002|Overall Study|Withdrawal by Subject|0|||
44408298|NCT00857948|79416008|FG003|Overall Study|Withdrawal by Subject|0|||
44408299|NCT00857948|79416005|FG000|Overall Study|Protocol Violation|1|||
44408300|NCT00857948|79416006|FG001|Overall Study|Protocol Violation|0|||
44408301|NCT00857948|79416007|FG002|Overall Study|Protocol Violation|1|||
44408302|NCT00857948|79416008|FG003|Overall Study|Protocol Violation|0|||
44408303|NCT00866606|79416018|FG000|Overall Study|Lost to Follow-up|3|||
44408304|NCT00866606|79416018|FG000|Overall Study|Adverse Event|1|||
44408305|NCT00857792|79416022|FG000|Overall Study|inadequate image quality for analysis|12|||
44408306|NCT00601835|79416028|FG000|Overall Study|Withdrawal by Subject|9|||
44408307|NCT00601835|79416029|FG001|Overall Study|Withdrawal by Subject|6|||
44408308|NCT00601835|79416028|FG000|Overall Study|Physician Decision|1|||
44408309|NCT00601835|79416029|FG001|Overall Study|Physician Decision|0|||
44408310|NCT00601835|79416028|FG000|Overall Study|Lost to Follow-up|37|||
44408311|NCT00601835|79416029|FG001|Overall Study|Lost to Follow-up|5|||
44408312|NCT00601835|79416028|FG000|Overall Study|Adverse Event|1|||
44408313|NCT00601835|79416029|FG001|Overall Study|Adverse Event|1|||
44408314|NCT00601835|79416028|FG000|Overall Study|Relocate|12|||
44408315|NCT00601835|79416029|FG001|Overall Study|Relocate|2|||
44408316|NCT00857246|79416035|FG000|Induction Regimen|Adverse Event|1|||
44408317|NCT00857246|79416035|FG000|Induction Regimen|disease-related complications|1|||
44408318|NCT00857246|79416035|FG000|Induction Regimen|Withdrawal by Subject|1|||
44408319|NCT00857246|79416035|FG000|Surgery (Curative)|disease progression|6|||
44523979|NCT04493684|79532190|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523980|NCT04493684|79532191|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523981|NCT04493684|79532192|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
44523982|NCT04493684|79532193|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
44523983|NCT04289298|79532258|FG000|Overall Study|Lost to Follow-up|5|||
44523984|NCT04289298|79532259|FG001|Overall Study|Lost to Follow-up|0|||
44523985|NCT04289298|79532258|FG000|Overall Study|Withdrawal by Subject|2|||
44523986|NCT04289298|79532259|FG001|Overall Study|Withdrawal by Subject|0|||
44523987|NCT04116710|79532270|FG000|Overall Study|Death|4|||
44523988|NCT04116710|79532271|FG001|Overall Study|Death|6|||
44523989|NCT04116710|79532272|FG002|Overall Study|Death|3|||
44523990|NCT04116710|79532273|FG003|Overall Study|Death|1|||
44523991|NCT04116710|79532270|FG000|Overall Study|Withdrawal by Subject|0|||
44523992|NCT04116710|79532271|FG001|Overall Study|Withdrawal by Subject|0|||
44408320|NCT00857246|79416035|FG000|ChemoRT|Withdrawal by Subject|1|||
44523993|NCT04116710|79532272|FG002|Overall Study|Withdrawal by Subject|0|||
44523994|NCT04116710|79532273|FG003|Overall Study|Withdrawal by Subject|1|||
44523995|NCT02946515|79532312|FG000|Overall Study|Lost to Follow-up|2|||
44523996|NCT02946515|79532313|FG001|Overall Study|Lost to Follow-up|1|||
44523997|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
44523998|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
44523999|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
44148122|NCT02829723|78937586|FG013|Overall Study|Progressive disease|4|||
44253659|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
44253660|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
44408321|NCT00857246|79416035|FG000|ChemoRT|Adverse Event|2|||
44408322|NCT00856856|79416042|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
44408323|NCT00856856|79416042|FG000|4-year Clinical Follow-up|Missed visit|1|||
44408324|NCT00493285|79416057|FG000|Overall Study|Lost to Follow-up|0|||
44408325|NCT00493285|79416058|FG001|Overall Study|Lost to Follow-up|0|||
44408326|NCT00493285|79416059|FG002|Overall Study|Lost to Follow-up|0|||
44408327|NCT00493285|79416060|FG003|Overall Study|Lost to Follow-up|0|||
44524000|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
44408328|NCT00493285|79416061|FG004|Overall Study|Lost to Follow-up|1|||
44408329|NCT00493285|79416062|FG005|Overall Study|Lost to Follow-up|0|||
44524001|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
44524002|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
44524003|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
44524004|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
44524005|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
44524006|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
44524007|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
44524008|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
44524009|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
44524010|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
44524011|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
44524012|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
44524013|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
44524014|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
44524015|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
44524016|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
44524017|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
44524018|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
44524019|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
44524020|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
44524021|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
44524022|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
44524023|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
44524024|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
44524025|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
44524026|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
44524027|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
44524028|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
44524029|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
44524030|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
44524031|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
44524032|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
44524033|NCT02586623|79532322|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
44524034|NCT02586623|79532323|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
44524035|NCT02586623|79532324|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
44524036|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
44524037|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
44524038|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
44524039|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
44524040|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
44524041|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
44524042|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
44524043|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
44524044|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
44524045|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
44524046|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
44524047|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
44148123|NCT02829723|78937587|FG014|Overall Study|Progressive disease|2|||
44148124|NCT02829723|78937588|FG015|Overall Study|Progressive disease|4|||
44148125|NCT02829723|78937589|FG016|Overall Study|Progressive disease|5|||
44148126|NCT02829723|78937590|FG017|Overall Study|Progressive disease|3|||
44148127|NCT02829723|78937591|FG018|Overall Study|Progressive disease|4|||
44148128|NCT02829723|78937592|FG019|Overall Study|Progressive disease|4|||
44148129|NCT02829723|78937593|FG020|Overall Study|Progressive disease|7|||
44408330|NCT00856778|79416076|FG000|Overall Study|Adverse Event|7|||
44408331|NCT00856778|79416076|FG000|Overall Study|Withdrawal by Subject|10|||
44148130|NCT02829723|78937594|FG021|Overall Study|Progressive disease|6|||
44408332|NCT00856778|79416076|FG000|Overall Study|Study deviation|2|||
44148131|NCT02829723|78937595|FG022|Overall Study|Progressive disease|3|||
44148132|NCT02829723|78937596|FG023|Overall Study|Progressive disease|3|||
44148133|NCT02829723|78937597|FG024|Overall Study|Progressive disease|3|||
44148134|NCT02829723|78937598|FG025|Overall Study|Progressive disease|16|||
44148135|NCT02829723|78937599|FG026|Overall Study|Progressive disease|10|||
44148136|NCT02829723|78937573|FG000|Overall Study|Subject/guardian decision|0|||
44408333|NCT00856778|79416076|FG000|Overall Study|Lost to Follow-up|5|||
44408334|NCT00603473|79416080|FG000|Overall Study|Adverse Event|4|||
44408335|NCT00603473|79416080|FG000|Overall Study|Lack of Efficacy|4|||
44408336|NCT00603473|79416080|FG000|Overall Study|Protocol Violation|1|||
44408337|NCT00486889|79416084|FG000|Overall Study|Death|3|||
44408338|NCT00486889|79416084|FG000|Overall Study|Non-compliant|2|||
44408339|NCT00486889|79416084|FG000|Overall Study|Withdrawal by Subject|6|||
44408340|NCT00486811|79416091|FG000|Overall Study|Adverse Event|28|||
44408341|NCT00486811|79416092|FG001|Overall Study|Adverse Event|60|||
44408342|NCT00486811|79416093|FG002|Overall Study|Adverse Event|135|||
44408343|NCT00486811|79416091|FG000|Overall Study|Lack of Efficacy|34|||
44408344|NCT00486811|79416092|FG001|Overall Study|Lack of Efficacy|14|||
44408345|NCT00486811|79416093|FG002|Overall Study|Lack of Efficacy|7|||
44408346|NCT00486811|79416091|FG000|Overall Study|Lost to Follow-up|4|||
44408347|NCT00486811|79416092|FG001|Overall Study|Lost to Follow-up|6|||
44408348|NCT00486811|79416093|FG002|Overall Study|Lost to Follow-up|4|||
44408349|NCT00486811|79416091|FG000|Overall Study|Withdrawal by Subject|33|||
44408350|NCT00486811|79416092|FG001|Overall Study|Withdrawal by Subject|44|||
44408351|NCT00486811|79416093|FG002|Overall Study|Withdrawal by Subject|58|||
44408352|NCT00486811|79416091|FG000|Overall Study|Study drug non-compliant|5|||
44408353|NCT00486811|79416092|FG001|Overall Study|Study drug non-compliant|6|||
44408354|NCT00486811|79416093|FG002|Overall Study|Study drug non-compliant|3|||
44408355|NCT00486811|79416091|FG000|Overall Study|All other|18|||
44408356|NCT00486811|79416092|FG001|Overall Study|All other|11|||
44408357|NCT00486811|79416093|FG002|Overall Study|All other|7|||
44408358|NCT00486265|79416101|FG000|Overall Study|Adverse Event|1|||
44408359|NCT00486265|79416101|FG000|Overall Study|Lack of Efficacy|8|||
44408360|NCT02151604|79416105|FG000|Overall Study|Lost to Follow-up|3|||
44408361|NCT02151604|79416105|FG000|Overall Study|Withdrawal by Subject|2|||
44408362|NCT02151604|79416105|FG000|Overall Study|Physician Decision|3|||
44408363|NCT02151604|79416105|FG000|Overall Study|Death|1|||
44408364|NCT00466921|79416110|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
44408365|NCT00466921|79416110|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
44408366|NCT00466921|79416110|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
44408367|NCT00466921|79416110|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
44408368|NCT00466921|79416110|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
44408369|NCT00466921|79416110|FG000|Follow up for a Minimum of 1 Year|Death|6|||
44408370|NCT00601523|79416116|FG000|Overall Study|Adverse Event|42|||
44408371|NCT00601523|79416117|FG001|Overall Study|Adverse Event|14|||
44408372|NCT00601523|79416116|FG000|Overall Study|Lack of Efficacy|3|||
44408373|NCT00601523|79416117|FG001|Overall Study|Lack of Efficacy|0|||
44408374|NCT00601523|79416116|FG000|Overall Study|Protocol Violation|5|||
44408375|NCT00601523|79416117|FG001|Overall Study|Protocol Violation|1|||
44408376|NCT00601523|79416116|FG000|Overall Study|Lost to Follow-up|0|||
44408377|NCT00601523|79416117|FG001|Overall Study|Lost to Follow-up|1|||
44408378|NCT00601523|79416116|FG000|Overall Study|Withdrawal by Subject|18|||
44408379|NCT00601523|79416117|FG001|Overall Study|Withdrawal by Subject|9|||
44408380|NCT00601523|79416116|FG000|Overall Study|Other|9|||
44524048|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
44524049|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
44524050|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
44524051|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
44524052|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
44524053|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
44524054|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
44524055|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
44524056|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
44524057|NCT02586623|79532322|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
44148137|NCT02829723|78937574|FG001|Overall Study|Subject/guardian decision|1|||
44148138|NCT02829723|78937575|FG002|Overall Study|Subject/guardian decision|0|||
44148139|NCT02829723|78937576|FG003|Overall Study|Subject/guardian decision|1|||
44408381|NCT00601523|79416117|FG001|Overall Study|Other|1|||
44408382|NCT00466687|79416123|FG000|Overall Study|Adverse Event|1|||
44408383|NCT00466687|79416123|FG000|Overall Study|Other complicating illness|3|||
44408384|NCT00466687|79416123|FG000|Overall Study|Withdrawal by Subject|1|||
44408385|NCT00466687|79416123|FG000|Overall Study|Disease progression|29|||
44408386|NCT00465985|79416145|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
44408387|NCT00465985|79416146|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
44408388|NCT00465985|79416145|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
44408389|NCT00465985|79416146|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
44408390|NCT00465985|79416145|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
44408391|NCT00465985|79416146|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
44408392|NCT00465985|79416145|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
44408393|NCT00465985|79416146|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
44408394|NCT00454051|79416157|FG000|Overall Study|Adverse Event|1|||
44408395|NCT00454051|79416158|FG001|Overall Study|Adverse Event|2|||
44408396|NCT00454051|79416157|FG000|Overall Study|Withdrawal by Subject|1|||
44408397|NCT00454051|79416158|FG001|Overall Study|Withdrawal by Subject|0|||
44408398|NCT00454051|79416157|FG000|Overall Study|Protocol Violation|1|||
44253661|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
44408399|NCT00454051|79416158|FG001|Overall Study|Protocol Violation|1|||
44408400|NCT00484939|79416166|FG000|Overall Study|Death|9|||
44408401|NCT00484939|79416167|FG001|Overall Study|Death|13|||
44408402|NCT00484939|79416166|FG000|Overall Study|Adverse Event|22|||
44408403|NCT00484939|79416167|FG001|Overall Study|Adverse Event|12|||
44408404|NCT00484939|79416166|FG000|Overall Study|Patient Withdrew Consent|19|||
44408405|NCT00484939|79416167|FG001|Overall Study|Patient Withdrew Consent|10|||
44408406|NCT00484939|79416166|FG000|Overall Study|Protocol Violation|3|||
44408407|NCT00484939|79416167|FG001|Overall Study|Protocol Violation|3|||
44408408|NCT00484939|79416166|FG000|Overall Study|Lost to Follow-up|0|||
44408409|NCT00484939|79416167|FG001|Overall Study|Lost to Follow-up|3|||
44408410|NCT00484939|79416166|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
44408411|NCT00484939|79416167|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
44408412|NCT00484939|79416166|FG000|Overall Study|Disease progression|67|||
44408413|NCT00484939|79416167|FG001|Overall Study|Disease progression|88|||
44408414|NCT00484939|79416166|FG000|Overall Study|Screen Failure|2|||
44408415|NCT00484939|79416167|FG001|Overall Study|Screen Failure|2|||
44408416|NCT00484939|79416166|FG000|Overall Study|Reason Not Specified|11|||
44408417|NCT00484939|79416167|FG001|Overall Study|Reason Not Specified|6|||
44408418|NCT00453973|79416175|FG000|Overall Study|Adverse Event|4|||
44408419|NCT00453973|79416176|FG001|Overall Study|Adverse Event|9|||
44408420|NCT00453973|79416175|FG000|Overall Study|Withdrawal by Subject|7|||
44408421|NCT00453973|79416176|FG001|Overall Study|Withdrawal by Subject|6|||
44408422|NCT00453973|79416175|FG000|Overall Study|PI Decision|0|||
44408423|NCT00453973|79416176|FG001|Overall Study|PI Decision|2|||
44408424|NCT00453973|79416175|FG000|Overall Study|Relocation|1|||
44408425|NCT00453973|79416176|FG001|Overall Study|Relocation|0|||
44408426|NCT00453973|79416175|FG000|Overall Study|Renal transplant|1|||
44408427|NCT00453973|79416176|FG001|Overall Study|Renal transplant|1|||
44408428|NCT00453973|79416175|FG000|Overall Study|Site closed by sponsor|3|||
44408429|NCT00453973|79416176|FG001|Overall Study|Site closed by sponsor|0|||
44408430|NCT00453973|79416175|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
44408431|NCT00453973|79416176|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
44408432|NCT00465361|79416182|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
44408433|NCT00464815|79416188|FG000|Overall Study|Withdrawal by Subject|6|||
44408434|NCT00464815|79416189|FG001|Overall Study|Withdrawal by Subject|3|||
44408435|NCT00464737|79416198|FG000|Overall Study|Adverse Event|12|||
44408436|NCT00464737|79416199|FG001|Overall Study|Adverse Event|17|||
44408437|NCT00464737|79416200|FG002|Overall Study|Adverse Event|33|||
44408438|NCT00464737|79416198|FG000|Overall Study|Lack of Efficacy|7|||
44408439|NCT00464737|79416199|FG001|Overall Study|Lack of Efficacy|7|||
44408440|NCT00464737|79416200|FG002|Overall Study|Lack of Efficacy|4|||
44408441|NCT00464737|79416198|FG000|Overall Study|Withdrawal by Subject|5|||
44408442|NCT00464737|79416199|FG001|Overall Study|Withdrawal by Subject|3|||
44408443|NCT00464737|79416200|FG002|Overall Study|Withdrawal by Subject|5|||
44408444|NCT00464737|79416198|FG000|Overall Study|Protocol Violation|1|||
44408445|NCT00464737|79416199|FG001|Overall Study|Protocol Violation|1|||
44408446|NCT00464737|79416200|FG002|Overall Study|Protocol Violation|5|||
44408447|NCT00464737|79416198|FG000|Overall Study|Non-compliance|0|||
44408448|NCT00464737|79416199|FG001|Overall Study|Non-compliance|1|||
44524058|NCT02586623|79532323|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
44524059|NCT02586623|79532324|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
44524060|NCT01819831|79532331|FG000|Overall Study|Withdrawal by Subject|1|||
44524061|NCT00078949|79532348|FG000|Overall Study|No treated|4|||
44524062|NCT00078949|79532349|FG001|Overall Study|No treated|5|||
44524063|NCT00078949|79532350|FG002|Overall Study|No treated|3|||
44524064|NCT00078949|79532351|FG003|Overall Study|No treated|3|||
44408449|NCT00464737|79416200|FG002|Overall Study|Non-compliance|1|||
44408450|NCT00464737|79416198|FG000|Overall Study|Lost to Follow-up|5|||
44524065|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
44408451|NCT00464737|79416199|FG001|Overall Study|Lost to Follow-up|2|||
44524066|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
44524067|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
44408452|NCT00464737|79416200|FG002|Overall Study|Lost to Follow-up|5|||
44408453|NCT00464737|79416198|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
44408454|NCT00464737|79416199|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
44408455|NCT00464737|79416200|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
44408456|NCT00464737|79416198|FG000|Overall Study|Other: Subject left town; family illness|1|||
44408457|NCT00464737|79416199|FG001|Overall Study|Other: Subject left town; family illness|0|||
44408458|NCT00464737|79416200|FG002|Overall Study|Other: Subject left town; family illness|0|||
44408459|NCT00464737|79416198|FG000|Overall Study|Other: Study demands too great|0|||
44408460|NCT00464737|79416199|FG001|Overall Study|Other: Study demands too great|1|||
44408461|NCT00464737|79416200|FG002|Overall Study|Other: Study demands too great|0|||
44408462|NCT00464737|79416198|FG000|Overall Study|Other: Personal family reasons|0|||
44408463|NCT00464737|79416199|FG001|Overall Study|Other: Personal family reasons|0|||
44408464|NCT00464737|79416200|FG002|Overall Study|Other: Personal family reasons|1|||
44408465|NCT00464737|79416198|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
44408466|NCT00464737|79416199|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
44408467|NCT00464737|79416200|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
44408468|NCT00453349|79416210|FG000|Randomized|Adverse Event|12|||
44408469|NCT00453349|79416211|FG001|Randomized|Adverse Event|11|||
44408470|NCT00453349|79416210|FG000|Randomized|Lack of Efficacy|2|||
44408471|NCT00453349|79416211|FG001|Randomized|Lack of Efficacy|1|||
44408472|NCT00453349|79416210|FG000|Randomized|Lost to Follow-up|7|||
44408473|NCT00453349|79416211|FG001|Randomized|Lost to Follow-up|5|||
44408474|NCT00453349|79416210|FG000|Randomized|Protocol Violation|1|||
44408475|NCT00453349|79416211|FG001|Randomized|Protocol Violation|1|||
44408476|NCT00453349|79416210|FG000|Randomized|Withdrawal by Subject|3|||
44408477|NCT00453349|79416211|FG001|Randomized|Withdrawal by Subject|5|||
44408478|NCT00453349|79416210|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
44408479|NCT00453349|79416211|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
44408480|NCT00453349|79416210|FG000|Completed Study|Adverse Event|12|||
44408481|NCT00453349|79416211|FG001|Completed Study|Adverse Event|11|||
44408482|NCT00453349|79416210|FG000|Completed Study|Lack of Efficacy|2|||
44408483|NCT00453349|79416211|FG001|Completed Study|Lack of Efficacy|1|||
44408484|NCT00453349|79416210|FG000|Completed Study|Lost to Follow-up|7|||
44408485|NCT00453349|79416211|FG001|Completed Study|Lost to Follow-up|5|||
44408486|NCT00453349|79416210|FG000|Completed Study|Protocol Violation|1|||
44408487|NCT00453349|79416211|FG001|Completed Study|Protocol Violation|1|||
44408488|NCT00453349|79416210|FG000|Completed Study|Withdrawal by Subject|3|||
44408489|NCT00453349|79416211|FG001|Completed Study|Withdrawal by Subject|5|||
44408490|NCT00453349|79416210|FG000|Completed Study|Lost to follow up after study treatment|2|||
44408491|NCT00453349|79416211|FG001|Completed Study|Lost to follow up after study treatment|11|||
44408492|NCT00464269|79416221|FG000|Overall Study|Lack of Efficacy|1|||
44408493|NCT00464269|79416222|FG001|Overall Study|Lack of Efficacy|0|||
44408494|NCT00464269|79416223|FG002|Overall Study|Lack of Efficacy|0|||
44408495|NCT00464269|79416224|FG003|Overall Study|Lack of Efficacy|0|||
44408496|NCT00464269|79416221|FG000|Overall Study|Lost to Follow-up|0|||
44408497|NCT00464269|79416222|FG001|Overall Study|Lost to Follow-up|4|||
44408498|NCT00464269|79416223|FG002|Overall Study|Lost to Follow-up|0|||
44408499|NCT00464269|79416224|FG003|Overall Study|Lost to Follow-up|1|||
44408500|NCT00464269|79416221|FG000|Overall Study|Withdrawal by Subject|0|||
44408501|NCT00464269|79416222|FG001|Overall Study|Withdrawal by Subject|2|||
44408502|NCT00464269|79416223|FG002|Overall Study|Withdrawal by Subject|1|||
44408503|NCT00464269|79416224|FG003|Overall Study|Withdrawal by Subject|1|||
44408504|NCT00464269|79416221|FG000|Overall Study|Other reason|3|||
44408505|NCT00464269|79416222|FG001|Overall Study|Other reason|3|||
44408506|NCT00464269|79416223|FG002|Overall Study|Other reason|1|||
44408507|NCT00464269|79416224|FG003|Overall Study|Other reason|1|||
44408508|NCT00464269|79416221|FG000|Overall Study|AE, serious fatal|0|||
44408509|NCT00464269|79416222|FG001|Overall Study|AE, serious fatal|0|||
44408510|NCT00464269|79416223|FG002|Overall Study|AE, serious fatal|1|||
44408511|NCT00464269|79416224|FG003|Overall Study|AE, serious fatal|1|||
44408512|NCT00464269|79416221|FG000|Overall Study|SAE, non-fatal|0|||
44408513|NCT00464269|79416222|FG001|Overall Study|SAE, non-fatal|0|||
44408514|NCT00464269|79416223|FG002|Overall Study|SAE, non-fatal|0|||
44408515|NCT00464269|79416224|FG003|Overall Study|SAE, non-fatal|1|||
44408516|NCT00464269|79416221|FG000|Overall Study|AE, non-serious non-fatal|2|||
44408517|NCT00464269|79416222|FG001|Overall Study|AE, non-serious non-fatal|8|||
44408518|NCT00464269|79416223|FG002|Overall Study|AE, non-serious non-fatal|3|||
44408519|NCT00464269|79416224|FG003|Overall Study|AE, non-serious non-fatal|4|||
44408520|NCT00464269|79416221|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
44408521|NCT00464269|79416222|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
44148140|NCT02829723|78937577|FG004|Overall Study|Subject/guardian decision|0|||
44148141|NCT02829723|78937578|FG005|Overall Study|Subject/guardian decision|0|||
44148142|NCT02829723|78937579|FG006|Overall Study|Subject/guardian decision|0|||
44408522|NCT00464269|79416223|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
44408523|NCT00464269|79416224|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
44408524|NCT00484315|79416238|FG000|12-Month Clinical Follow-up|Death|6|||
44408525|NCT00484315|79416239|FG001|12-Month Clinical Follow-up|Death|2|||
44408526|NCT00484315|79416238|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
44408527|NCT00484315|79416239|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
44408528|NCT00484315|79416238|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
44408529|NCT00484315|79416239|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
44408530|NCT00484315|79416238|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
44408531|NCT00484315|79416239|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
44408532|NCT00484315|79416238|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
44408533|NCT00484315|79416239|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
44408534|NCT00484315|79416238|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
44408535|NCT00484315|79416239|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
44408536|NCT00484315|79416238|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
44408537|NCT00484315|79416239|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
44408538|NCT00463801|79416245|FG000|Overall Study|Protocol Violation|1|||
44408539|NCT00463801|79416245|FG000|Overall Study|Lack of Efficacy|2|||
44408540|NCT00463801|79416245|FG000|Overall Study|Adverse Event|4|||
44408541|NCT00463801|79416245|FG000|Overall Study|Lost to Follow-up|5|||
44408542|NCT00463801|79416245|FG000|Overall Study|No longer require therapy|1|||
44408543|NCT00463567|79416256|FG000|Overall Study|Adverse Event|29|||
44408544|NCT00463567|79416257|FG001|Overall Study|Adverse Event|26|||
44408545|NCT00463567|79416258|FG002|Overall Study|Adverse Event|17|||
44408546|NCT00463567|79416259|FG003|Overall Study|Adverse Event|46|||
44408547|NCT00463567|79416260|FG004|Overall Study|Adverse Event|10|||
44408548|NCT00463567|79416261|FG005|Overall Study|Adverse Event|10|||
44408549|NCT00463567|79416262|FG006|Overall Study|Adverse Event|4|||
44408550|NCT00463567|79416256|FG000|Overall Study|Withdrawal by Subject|29|||
44408551|NCT00463567|79416257|FG001|Overall Study|Withdrawal by Subject|22|||
44408552|NCT00463567|79416258|FG002|Overall Study|Withdrawal by Subject|20|||
44408553|NCT00463567|79416259|FG003|Overall Study|Withdrawal by Subject|37|||
44408554|NCT00463567|79416260|FG004|Overall Study|Withdrawal by Subject|6|||
44408555|NCT00463567|79416261|FG005|Overall Study|Withdrawal by Subject|5|||
44408556|NCT00463567|79416262|FG006|Overall Study|Withdrawal by Subject|1|||
44408557|NCT00463567|79416256|FG000|Overall Study|Protocol Deviation|13|||
44408558|NCT00463567|79416257|FG001|Overall Study|Protocol Deviation|9|||
44408559|NCT00463567|79416258|FG002|Overall Study|Protocol Deviation|14|||
44408560|NCT00463567|79416259|FG003|Overall Study|Protocol Deviation|11|||
44408561|NCT00463567|79416260|FG004|Overall Study|Protocol Deviation|1|||
44408562|NCT00463567|79416261|FG005|Overall Study|Protocol Deviation|1|||
44408563|NCT00463567|79416262|FG006|Overall Study|Protocol Deviation|2|||
44408564|NCT00463567|79416256|FG000|Overall Study|Lost to Follow-up|12|||
44408565|NCT00463567|79416257|FG001|Overall Study|Lost to Follow-up|6|||
44408566|NCT00463567|79416258|FG002|Overall Study|Lost to Follow-up|13|||
44408567|NCT00463567|79416259|FG003|Overall Study|Lost to Follow-up|8|||
44408568|NCT00463567|79416260|FG004|Overall Study|Lost to Follow-up|1|||
44408569|NCT00463567|79416261|FG005|Overall Study|Lost to Follow-up|1|||
44408570|NCT00463567|79416262|FG006|Overall Study|Lost to Follow-up|1|||
44148143|NCT02829723|78937580|FG007|Overall Study|Subject/guardian decision|1|||
44148144|NCT02829723|78937581|FG008|Overall Study|Subject/guardian decision|0|||
44148145|NCT02829723|78937582|FG009|Overall Study|Subject/guardian decision|0|||
44148146|NCT02829723|78937583|FG010|Overall Study|Subject/guardian decision|0|||
44148147|NCT02829723|78937584|FG011|Overall Study|Subject/guardian decision|0|||
44148148|NCT02829723|78937585|FG012|Overall Study|Subject/guardian decision|0|||
44148149|NCT02829723|78937586|FG013|Overall Study|Subject/guardian decision|0|||
44253662|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
44148150|NCT02829723|78937587|FG014|Overall Study|Subject/guardian decision|1|||
44148151|NCT02829723|78937588|FG015|Overall Study|Subject/guardian decision|0|||
44253663|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
44253664|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
44253665|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253666|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253667|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253668|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253669|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253670|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253671|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44282117|NCT01904058|79245351|FG002|Overall Study|Withdrawal by Subject|1|||
44282118|NCT01904058|79245352|FG003|Overall Study|Withdrawal by Subject|0|||
44408571|NCT00463567|79416256|FG000|Overall Study|Administrative problems|5|||
44282119|NCT01904058|79245349|FG000|Overall Study|Pregnancy|0|||
44408572|NCT00463567|79416257|FG001|Overall Study|Administrative problems|3|||
44408573|NCT00463567|79416258|FG002|Overall Study|Administrative problems|6|||
44408574|NCT00463567|79416259|FG003|Overall Study|Administrative problems|9|||
44408575|NCT00463567|79416260|FG004|Overall Study|Administrative problems|3|||
44408576|NCT00463567|79416261|FG005|Overall Study|Administrative problems|2|||
44408577|NCT00463567|79416262|FG006|Overall Study|Administrative problems|2|||
44408578|NCT00463567|79416256|FG000|Overall Study|Lack of Efficacy|4|||
44408579|NCT00463567|79416257|FG001|Overall Study|Lack of Efficacy|9|||
44408580|NCT00463567|79416258|FG002|Overall Study|Lack of Efficacy|9|||
44408581|NCT00463567|79416259|FG003|Overall Study|Lack of Efficacy|17|||
44408582|NCT00463567|79416260|FG004|Overall Study|Lack of Efficacy|1|||
44408583|NCT00463567|79416261|FG005|Overall Study|Lack of Efficacy|0|||
44408584|NCT00463567|79416262|FG006|Overall Study|Lack of Efficacy|1|||
44408585|NCT00463567|79416256|FG000|Overall Study|Abnormal lab value(s)|1|||
44408586|NCT00463567|79416257|FG001|Overall Study|Abnormal lab value(s)|1|||
44408587|NCT00463567|79416258|FG002|Overall Study|Abnormal lab value(s)|2|||
44408588|NCT00463567|79416259|FG003|Overall Study|Abnormal lab value(s)|1|||
44408589|NCT00463567|79416260|FG004|Overall Study|Abnormal lab value(s)|1|||
44408590|NCT00463567|79416261|FG005|Overall Study|Abnormal lab value(s)|0|||
44408591|NCT00463567|79416262|FG006|Overall Study|Abnormal lab value(s)|0|||
44408592|NCT00463567|79416256|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44408593|NCT00463567|79416257|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44408594|NCT00463567|79416258|FG002|Overall Study|Abnormal test procedure result(s)|6|||
44408595|NCT00463567|79416259|FG003|Overall Study|Abnormal test procedure result(s)|2|||
44408596|NCT00463567|79416260|FG004|Overall Study|Abnormal test procedure result(s)|0|||
44408597|NCT00463567|79416261|FG005|Overall Study|Abnormal test procedure result(s)|2|||
44408598|NCT00463567|79416262|FG006|Overall Study|Abnormal test procedure result(s)|0|||
44408599|NCT00463567|79416256|FG000|Overall Study|Death|1|||
44408600|NCT00463567|79416257|FG001|Overall Study|Death|0|||
44408601|NCT00463567|79416258|FG002|Overall Study|Death|2|||
44408602|NCT00463567|79416259|FG003|Overall Study|Death|0|||
44408603|NCT00463567|79416260|FG004|Overall Study|Death|0|||
44408604|NCT00463567|79416261|FG005|Overall Study|Death|0|||
44408605|NCT00463567|79416262|FG006|Overall Study|Death|0|||
44408606|NCT00484159|79416287|FG000|Overall Study|Lost to Follow-up|1|||
44408607|NCT00484159|79416288|FG001|Overall Study|Lost to Follow-up|1|||
44408608|NCT00484159|79416289|FG002|Overall Study|Lost to Follow-up|0|||
44408609|NCT00462865|79416297|FG000|Overall Study|Adverse Event|1|||
44408610|NCT03839641|79416303|FG000|Overall Study|Withdrawal by Subject|1|||
44408611|NCT03839641|79416304|FG001|Overall Study|Withdrawal by Subject|1|||
44408612|NCT00462709|79416312|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
44408613|NCT00462709|79416312|FG000|Overall Study|Lost to Follow-up|10|||
44408614|NCT00462709|79416312|FG000|Overall Study|Withdrawal by Subject|8|||
44408615|NCT00462709|79416312|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
44408616|NCT00462709|79416312|FG000|Overall Study|Death|2|||
44408617|NCT00462709|79416312|FG000|Overall Study|Logistical reasons|2|||
44408618|NCT00462709|79416312|FG000|Overall Study|Physician Decision|1|||
44408619|NCT00462709|79416312|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
44408620|NCT00461305|79416318|FG000|Treatment|Adverse Event|26|||
44408621|NCT00461305|79416319|FG001|Treatment|Adverse Event|3|||
44408622|NCT00461305|79416318|FG000|Treatment|Lost to Follow-up|4|||
44408623|NCT00461305|79416319|FG001|Treatment|Lost to Follow-up|2|||
44408624|NCT00461305|79416318|FG000|Treatment|Protocol Violation|13|||
44408625|NCT00461305|79416319|FG001|Treatment|Protocol Violation|2|||
44408626|NCT00461305|79416318|FG000|Treatment|Withdrawal by Subject|48|||
44408627|NCT00461305|79416319|FG001|Treatment|Withdrawal by Subject|2|||
44408628|NCT00461305|79416318|FG000|Treatment|Never dispensed|5|||
44408629|NCT00461305|79416319|FG001|Treatment|Never dispensed|0|||
44524068|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
44524069|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
44524070|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
44524071|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
44524072|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
44524073|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
44524074|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
44524075|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
44524076|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
44524077|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
44148152|NCT02829723|78937589|FG016|Overall Study|Subject/guardian decision|1|||
44148153|NCT02829723|78937590|FG017|Overall Study|Subject/guardian decision|0|||
44148154|NCT02829723|78937591|FG018|Overall Study|Subject/guardian decision|1|||
44282120|NCT01904058|79245350|FG001|Overall Study|Pregnancy|0|||
44408630|NCT00461305|79416318|FG000|Treatment|Study drug not taken|1|||
44408631|NCT00461305|79416319|FG001|Treatment|Study drug not taken|0|||
44408632|NCT00461305|79416318|FG000|Treatment|Partially missing diary|2|||
44408633|NCT00461305|79416319|FG001|Treatment|Partially missing diary|0|||
44408634|NCT00461305|79416318|FG000|Treatment|Other (missing drug etc)|2|||
44408635|NCT00461305|79416319|FG001|Treatment|Other (missing drug etc)|0|||
44408636|NCT00461305|79416318|FG000|Continued Treatment|Adverse Event|26|||
44408637|NCT00461305|79416319|FG001|Continued Treatment|Adverse Event|0|||
44408638|NCT00461305|79416318|FG000|Continued Treatment|Lost to Follow-up|4|||
44408639|NCT00461305|79416319|FG001|Continued Treatment|Lost to Follow-up|0|||
44408640|NCT00461305|79416318|FG000|Continued Treatment|Protocol Violation|13|||
44408641|NCT00461305|79416319|FG001|Continued Treatment|Protocol Violation|0|||
44408642|NCT00461305|79416318|FG000|Continued Treatment|Withdrawal by Subject|48|||
44408643|NCT00461305|79416319|FG001|Continued Treatment|Withdrawal by Subject|0|||
44408644|NCT00461305|79416318|FG000|Continued Treatment|Partially missing diary|2|||
44408645|NCT00461305|79416319|FG001|Continued Treatment|Partially missing diary|0|||
44408646|NCT00461305|79416318|FG000|Continued Treatment|Other (missing drug etc)|2|||
44408647|NCT00461305|79416319|FG001|Continued Treatment|Other (missing drug etc)|0|||
44408648|NCT00856544|79416330|FG000|Overall Study|Randomized but not treated|3|||
44408649|NCT00856544|79416331|FG001|Overall Study|Randomized but not treated|0|||
44408650|NCT00856544|79416332|FG002|Overall Study|Randomized but not treated|0|||
44408651|NCT00856544|79416333|FG003|Overall Study|Randomized but not treated|0|||
44408652|NCT00856544|79416330|FG000|Overall Study|Death|0|||
44408653|NCT00856544|79416331|FG001|Overall Study|Death|2|||
44408654|NCT00856544|79416332|FG002|Overall Study|Death|0|||
44408655|NCT00856544|79416333|FG003|Overall Study|Death|0|||
44408656|NCT00856544|79416330|FG000|Overall Study|Adverse Event|20|||
44408657|NCT00856544|79416331|FG001|Overall Study|Adverse Event|29|||
44408658|NCT00856544|79416332|FG002|Overall Study|Adverse Event|2|||
44408659|NCT00856544|79416333|FG003|Overall Study|Adverse Event|3|||
44408660|NCT00856544|79416330|FG000|Overall Study|Lack of Efficacy|16|||
44408661|NCT00856544|79416331|FG001|Overall Study|Lack of Efficacy|12|||
44408662|NCT00856544|79416332|FG002|Overall Study|Lack of Efficacy|3|||
44408663|NCT00856544|79416333|FG003|Overall Study|Lack of Efficacy|3|||
44408664|NCT00856544|79416330|FG000|Overall Study|Other|9|||
44408665|NCT00856544|79416331|FG001|Overall Study|Other|16|||
44408666|NCT00856544|79416332|FG002|Overall Study|Other|1|||
44408667|NCT00856544|79416333|FG003|Overall Study|Other|6|||
44408668|NCT00856544|79416330|FG000|Overall Study|Lost to Follow-up|1|||
44408669|NCT00856544|79416331|FG001|Overall Study|Lost to Follow-up|2|||
44408670|NCT00856544|79416332|FG002|Overall Study|Lost to Follow-up|2|||
44408671|NCT00856544|79416333|FG003|Overall Study|Lost to Follow-up|0|||
44408672|NCT00856544|79416330|FG000|Overall Study|Withdrawal by Subject|8|||
44408673|NCT00856544|79416331|FG001|Overall Study|Withdrawal by Subject|5|||
44408674|NCT00856544|79416332|FG002|Overall Study|Withdrawal by Subject|0|||
44408675|NCT00856544|79416333|FG003|Overall Study|Withdrawal by Subject|1|||
44408676|NCT00856388|79416355|FG000|Overall Study|Other|1|||
44408677|NCT00848354|79416362|FG000|Phase 1|Adverse Event|5|||
44408678|NCT00848354|79416363|FG001|Phase 1|Adverse Event|4|||
44408679|NCT00848354|79416362|FG000|Phase 1|Discontinuation of study by sponsor|2|||
44524078|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
44524079|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
44524080|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
44524081|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
44524082|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
44524083|NCT03739203|79532366|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
44524084|NCT03739203|79532367|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
44524085|NCT03739203|79532368|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
44524086|NCT03739203|79532366|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
44524087|NCT03739203|79532367|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
44524088|NCT03739203|79532368|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
44148155|NCT02829723|78937592|FG019|Overall Study|Subject/guardian decision|0|||
44148156|NCT02829723|78937593|FG020|Overall Study|Subject/guardian decision|1|||
44408680|NCT00848354|79416363|FG001|Phase 1|Discontinuation of study by sponsor|1|||
44408681|NCT00848354|79416362|FG000|Phase 1|Failed to return|0|||
44408682|NCT00848354|79416363|FG001|Phase 1|Failed to return|1|||
44253672|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253673|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44408683|NCT00848354|79416362|FG000|Phase 1|Lost to Follow-up|1|||
44408684|NCT00848354|79416363|FG001|Phase 1|Lost to Follow-up|1|||
44408685|NCT00848354|79416362|FG000|Phase 1|Unspecified Reason|1|||
44408686|NCT00848354|79416363|FG001|Phase 1|Unspecified Reason|1|||
44408687|NCT00848354|79416362|FG000|Phase 1|Protocol Violation|1|||
44408688|NCT00848354|79416363|FG001|Phase 1|Protocol Violation|1|||
44408689|NCT00848354|79416362|FG000|Phase 1|Withdrawal by Subject|2|||
44408690|NCT00848354|79416363|FG001|Phase 1|Withdrawal by Subject|4|||
44408691|NCT00848354|79416362|FG000|Phase 1|Lack of Efficacy|0|||
44408692|NCT00848354|79416363|FG001|Phase 1|Lack of Efficacy|1|||
44408693|NCT00848354|79416362|FG000|Phase 2 Year 1|Adverse Event|7|||
44408694|NCT00848354|79416363|FG001|Phase 2 Year 1|Adverse Event|2|||
44408695|NCT00848354|79416362|FG000|Phase 2 Year 1|Death|1|||
44408696|NCT00848354|79416363|FG001|Phase 2 Year 1|Death|0|||
44408697|NCT00848354|79416362|FG000|Phase 2 Year 1|Failed to Return|1|||
44408698|NCT00848354|79416363|FG001|Phase 2 Year 1|Failed to Return|1|||
44408699|NCT00848354|79416362|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
44408700|NCT00848354|79416363|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
44524089|NCT03739203|79532366|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
44524090|NCT03739203|79532367|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
44524091|NCT03739203|79532368|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
44524092|NCT03739203|79532366|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
44524093|NCT03739203|79532367|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
44524094|NCT03739203|79532368|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
44524095|NCT03739203|79532366|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
44524096|NCT03739203|79532367|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
44524097|NCT03739203|79532368|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
44524098|NCT02942264|79532385|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524099|NCT02942264|79532386|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
44524100|NCT02942264|79532387|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524101|NCT02942264|79532388|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524102|NCT02942264|79532389|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524103|NCT02942264|79532390|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524104|NCT02942264|79532391|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
44524105|NCT02942264|79532392|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524106|NCT02942264|79532393|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
44524107|NCT02942264|79532385|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524108|NCT02942264|79532386|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524109|NCT02942264|79532387|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524110|NCT02942264|79532388|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524111|NCT02942264|79532389|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524112|NCT02942264|79532390|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524113|NCT02942264|79532391|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524114|NCT02942264|79532392|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
44524115|NCT02942264|79532393|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
44524116|NCT03322514|79532420|FG000|Overall Study|Withdrawal by Subject|1|||
44524117|NCT03322514|79532421|FG001|Overall Study|Withdrawal by Subject|1|||
44524118|NCT03325712|79532435|FG000|Overall Study|Protocol Violation|0|||
44524119|NCT03325712|79532436|FG001|Overall Study|Protocol Violation|0|||
44524120|NCT03325712|79532437|FG002|Overall Study|Protocol Violation|0|||
44524121|NCT03325712|79532438|FG003|Overall Study|Protocol Violation|0|||
44524122|NCT03325712|79532439|FG004|Overall Study|Protocol Violation|1|||
44524123|NCT03325712|79532440|FG005|Overall Study|Protocol Violation|0|||
44524124|NCT03325712|79532441|FG006|Overall Study|Protocol Violation|0|||
44524125|NCT03325712|79532442|FG007|Overall Study|Protocol Violation|0|||
44524126|NCT03325712|79532435|FG000|Overall Study|Adverse Event|0|||
44524127|NCT03325712|79532436|FG001|Overall Study|Adverse Event|0|||
44524128|NCT03325712|79532437|FG002|Overall Study|Adverse Event|0|||
44524129|NCT03325712|79532438|FG003|Overall Study|Adverse Event|0|||
44524130|NCT03325712|79532439|FG004|Overall Study|Adverse Event|1|||
44524131|NCT03325712|79532440|FG005|Overall Study|Adverse Event|0|||
44524132|NCT03325712|79532441|FG006|Overall Study|Adverse Event|0|||
44524133|NCT03325712|79532442|FG007|Overall Study|Adverse Event|0|||
44253674|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44408701|NCT00848354|79416362|FG000|Phase 2 Year 1|Unspecified Reason|3|||
44408702|NCT00848354|79416363|FG001|Phase 2 Year 1|Unspecified Reason|0|||
44408703|NCT00848354|79416362|FG000|Phase 2 Year 1|Protocol Violation|4|||
44408704|NCT00848354|79416363|FG001|Phase 2 Year 1|Protocol Violation|1|||
44408705|NCT00848354|79416362|FG000|Phase 2 Year 1|Subject Request|1|||
44408706|NCT00848354|79416363|FG001|Phase 2 Year 1|Subject Request|2|||
44408707|NCT00848354|79416362|FG000|Phase 2 Year 2|Adverse Event|12|||
44408708|NCT00848354|79416363|FG001|Phase 2 Year 2|Adverse Event|2|||
44408709|NCT00848354|79416362|FG000|Phase 2 Year 2|Death|2|||
44408710|NCT00848354|79416363|FG001|Phase 2 Year 2|Death|0|||
44408711|NCT00848354|79416362|FG000|Phase 2 Year 2|Failed to return|3|||
44408712|NCT00848354|79416363|FG001|Phase 2 Year 2|Failed to return|0|||
44408713|NCT00848354|79416362|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
44408714|NCT00848354|79416363|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
44408715|NCT00848354|79416362|FG000|Phase 2 Year 2|Unspecified Reason|1|||
44408716|NCT00848354|79416363|FG001|Phase 2 Year 2|Unspecified Reason|0|||
44408717|NCT00848354|79416362|FG000|Phase 2 Year 2|Protocol Violation|1|||
44408718|NCT00848354|79416363|FG001|Phase 2 Year 2|Protocol Violation|1|||
44408719|NCT00848354|79416362|FG000|Phase 2 Year 2|Subject Request|1|||
44524134|NCT03325556|79532470|FG000|Open-label Period|Lack of Response in OL period|70|||
44524135|NCT03325556|79532471|FG001|Open-label Period|Lack of Response in OL period|0|||
44524136|NCT03325556|79532472|FG002|Open-label Period|Lack of Response in OL period|0|||
44524137|NCT03325556|79532470|FG000|Open-label Period|Adverse Event|27|||
44524138|NCT03325556|79532471|FG001|Open-label Period|Adverse Event|0|||
44282121|NCT01904058|79245351|FG002|Overall Study|Pregnancy|0|||
44408720|NCT00848354|79416363|FG001|Phase 2 Year 2|Subject Request|1|||
44408721|NCT00848354|79416362|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
44408722|NCT00848354|79416363|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
44408723|NCT00848198|79416373|FG000|Overall Study|Incomplete Case Report Forms|15|||
44524139|NCT03325556|79532472|FG002|Open-label Period|Adverse Event|0|||
44524140|NCT03325556|79532470|FG000|Open-label Period|Death|1|||
44524141|NCT03325556|79532471|FG001|Open-label Period|Death|0|||
44524142|NCT03325556|79532472|FG002|Open-label Period|Death|0|||
44524143|NCT03325556|79532470|FG000|Open-label Period|Lost to Follow-up|1|||
44524144|NCT03325556|79532471|FG001|Open-label Period|Lost to Follow-up|0|||
44524145|NCT03325556|79532472|FG002|Open-label Period|Lost to Follow-up|0|||
44524146|NCT03325556|79532470|FG000|Open-label Period|Non-compliance with study drug|5|||
44524147|NCT03325556|79532471|FG001|Open-label Period|Non-compliance with study drug|0|||
44524148|NCT03325556|79532472|FG002|Open-label Period|Non-compliance with study drug|0|||
44524149|NCT03325556|79532470|FG000|Open-label Period|Use of prohibited medication|1|||
44524150|NCT03325556|79532471|FG001|Open-label Period|Use of prohibited medication|0|||
44524151|NCT03325556|79532472|FG002|Open-label Period|Use of prohibited medication|0|||
44524152|NCT03325556|79532470|FG000|Open-label Period|Protocol Violation|4|||
44524153|NCT03325556|79532471|FG001|Open-label Period|Protocol Violation|0|||
44524154|NCT03325556|79532472|FG002|Open-label Period|Protocol Violation|0|||
44524155|NCT03325556|79532470|FG000|Open-label Period|Withdrawal by Subject|17|||
44524156|NCT03325556|79532471|FG001|Open-label Period|Withdrawal by Subject|0|||
44524157|NCT03325556|79532472|FG002|Open-label Period|Withdrawal by Subject|0|||
44524158|NCT03325556|79532470|FG000|Open-label Period|Not otherwise specified|8|||
44524159|NCT03325556|79532471|FG001|Open-label Period|Not otherwise specified|0|||
44524160|NCT03325556|79532472|FG002|Open-label Period|Not otherwise specified|0|||
44524161|NCT03325556|79532470|FG000|Open-label Period|Administrative discont. at study termination|41|||
44524162|NCT03325556|79532471|FG001|Open-label Period|Administrative discont. at study termination|0|||
44524163|NCT03325556|79532472|FG002|Open-label Period|Administrative discont. at study termination|0|||
44524164|NCT03325556|79532470|FG000|Double-blind Period|Relapse|0|||
44524165|NCT03325556|79532471|FG001|Double-blind Period|Relapse|15|||
44524166|NCT03325556|79532472|FG002|Double-blind Period|Relapse|34|||
44524167|NCT03325556|79532470|FG000|Double-blind Period|Adverse Event|0|||
44524168|NCT03325556|79532471|FG001|Double-blind Period|Adverse Event|3|||
44524169|NCT03325556|79532472|FG002|Double-blind Period|Adverse Event|1|||
44524170|NCT03325556|79532470|FG000|Double-blind Period|Noncompliance with study drug|0|||
44524171|NCT03325556|79532471|FG001|Double-blind Period|Noncompliance with study drug|0|||
44524172|NCT03325556|79532472|FG002|Double-blind Period|Noncompliance with study drug|1|||
44524173|NCT03325556|79532470|FG000|Double-blind Period|Use of prohibited medication|0|||
44524174|NCT03325556|79532471|FG001|Double-blind Period|Use of prohibited medication|1|||
44524175|NCT03325556|79532472|FG002|Double-blind Period|Use of prohibited medication|0|||
44524176|NCT03325556|79532470|FG000|Double-blind Period|Physician Decision|0|||
44524177|NCT03325556|79532471|FG001|Double-blind Period|Physician Decision|0|||
44524178|NCT03325556|79532472|FG002|Double-blind Period|Physician Decision|1|||
44524179|NCT03325556|79532470|FG000|Double-blind Period|Withdrawal by Subject|0|||
44524180|NCT03325556|79532471|FG001|Double-blind Period|Withdrawal by Subject|6|||
44524181|NCT03325556|79532472|FG002|Double-blind Period|Withdrawal by Subject|4|||
44524182|NCT03325556|79532470|FG000|Double-blind Period|Not otherwise specified|0|||
44524183|NCT03325556|79532471|FG001|Double-blind Period|Not otherwise specified|1|||
44524184|NCT03325556|79532472|FG002|Double-blind Period|Not otherwise specified|5|||
44524185|NCT03325556|79532470|FG000|Double-blind Period|Administrative discont. at study termination|0|||
44524186|NCT03325556|79532471|FG001|Double-blind Period|Administrative discont. at study termination|35|||
44524187|NCT03325556|79532472|FG002|Double-blind Period|Administrative discont. at study termination|31|||
44524188|NCT03320564|79532479|FG000|Overall Study|Protocol Violation|1|||
44524189|NCT03325166|79532483|FG000|Overall Study|Adverse Event|1|||
44524190|NCT02888756|79532490|FG000|Analytical Treatment Interruption|Physician Decision|10|||
44524191|NCT02888756|79532491|FG001|Analytical Treatment Interruption|Physician Decision|6|||
44524192|NCT02888756|79532492|FG002|Analytical Treatment Interruption|Physician Decision|5|||
44524193|NCT03305666|79532502|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
44524194|NCT03305666|79532503|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
44524195|NCT03304184|79532511|FG000|Overall Study|Withdrawal by Subject|1|||
44524196|NCT03304184|79532512|FG001|Overall Study|Withdrawal by Subject|2|||
44524197|NCT03736785|79532522|FG000|Overall Study|Adverse Event|1|||
44253675|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
44253676|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44524198|NCT03736785|79532523|FG001|Overall Study|Adverse Event|1|||
44524199|NCT03736785|79532524|FG002|Overall Study|Adverse Event|1|||
44524200|NCT03736785|79532522|FG000|Overall Study|Death|1|||
44524201|NCT03736785|79532523|FG001|Overall Study|Death|0|||
44524202|NCT03736785|79532524|FG002|Overall Study|Death|1|||
44253677|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44282122|NCT01904058|79245352|FG003|Overall Study|Pregnancy|1|||
44524203|NCT03736785|79532522|FG000|Overall Study|Lost to Follow-up|0|||
44524204|NCT03736785|79532523|FG001|Overall Study|Lost to Follow-up|2|||
44524205|NCT03736785|79532524|FG002|Overall Study|Lost to Follow-up|3|||
44524206|NCT03736785|79532522|FG000|Overall Study|Non compliance with study drug|1|||
44524207|NCT03736785|79532523|FG001|Overall Study|Non compliance with study drug|1|||
44524208|NCT03736785|79532524|FG002|Overall Study|Non compliance with study drug|0|||
44524209|NCT03736785|79532522|FG000|Overall Study|Physician Decision|0|||
44524210|NCT03736785|79532523|FG001|Overall Study|Physician Decision|1|||
44524211|NCT03736785|79532524|FG002|Overall Study|Physician Decision|1|||
44524212|NCT03736785|79532522|FG000|Overall Study|Protocol Violation|1|||
44524213|NCT03736785|79532523|FG001|Overall Study|Protocol Violation|4|||
44524214|NCT03736785|79532524|FG002|Overall Study|Protocol Violation|3|||
44524215|NCT03736785|79532522|FG000|Overall Study|Sponsor Decision|1|||
44524216|NCT03736785|79532523|FG001|Overall Study|Sponsor Decision|0|||
44524217|NCT03736785|79532524|FG002|Overall Study|Sponsor Decision|0|||
44524218|NCT03736785|79532522|FG000|Overall Study|Unknown/Missing data|3|||
44524219|NCT03736785|79532523|FG001|Overall Study|Unknown/Missing data|2|||
44524220|NCT03736785|79532524|FG002|Overall Study|Unknown/Missing data|1|||
44524221|NCT03736785|79532522|FG000|Overall Study|Withdrawal by Subject|9|||
44524222|NCT03736785|79532523|FG001|Overall Study|Withdrawal by Subject|6|||
44524223|NCT03736785|79532524|FG002|Overall Study|Withdrawal by Subject|4|||
44524224|NCT03734991|79532535|FG000|Overall Study|Adverse Event|4|||
44524225|NCT03734991|79532536|FG001|Overall Study|Adverse Event|0|||
44524226|NCT03734991|79532535|FG000|Overall Study|Lost to Follow-up|4|||
44524227|NCT03734991|79532536|FG001|Overall Study|Lost to Follow-up|0|||
44524228|NCT03734991|79532535|FG000|Overall Study|Physician Decision|0|||
44524229|NCT03734991|79532536|FG001|Overall Study|Physician Decision|1|||
44524230|NCT03734991|79532535|FG000|Overall Study|Pregnancy|1|||
44524231|NCT03734991|79532536|FG001|Overall Study|Pregnancy|0|||
44524232|NCT03734991|79532535|FG000|Overall Study|Withdrawal by Subject|6|||
44524233|NCT03734991|79532536|FG001|Overall Study|Withdrawal by Subject|3|||
44524234|NCT03734991|79532535|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
44408724|NCT00848120|79416381|FG000|Overall Study|Adverse Event|1|||
44408725|NCT00600821|79416387|FG000|Overall Study|Death|45|||
44408726|NCT00600821|79416388|FG001|Overall Study|Death|46|||
44408727|NCT00600821|79416387|FG000|Overall Study|Lost to Follow-up|2|||
44408728|NCT00600821|79416388|FG001|Overall Study|Lost to Follow-up|2|||
44408729|NCT00600821|79416387|FG000|Overall Study|Withdrawal by Subject|1|||
44408730|NCT00600821|79416388|FG001|Overall Study|Withdrawal by Subject|1|||
44408731|NCT00600821|79416387|FG000|Overall Study|Terminated by sponsor|8|||
44408732|NCT00600821|79416388|FG001|Overall Study|Terminated by sponsor|6|||
44408733|NCT00600821|79416387|FG000|Overall Study|Objective progression or relapse|0|||
44408734|NCT00600821|79416388|FG001|Overall Study|Objective progression or relapse|1|||
44408735|NCT00600821|79416387|FG000|Overall Study|Randomized but not treated|0|||
44408736|NCT00600821|79416388|FG001|Overall Study|Randomized but not treated|1|||
44408737|NCT00600821|79416387|FG000|Overall Study|Other|2|||
44408738|NCT00600821|79416388|FG001|Overall Study|Other|3|||
44408739|NCT00592904|79416400|FG000|Overall Study|Adverse Event|15|||
44408740|NCT00592904|79416401|FG001|Overall Study|Adverse Event|25|||
44408741|NCT00592904|79416402|FG002|Overall Study|Adverse Event|13|||
44408742|NCT00592904|79416403|FG003|Overall Study|Adverse Event|5|||
44408743|NCT00592904|79416400|FG000|Overall Study|Protocol Violation|1|||
44408744|NCT00592904|79416401|FG001|Overall Study|Protocol Violation|1|||
44408745|NCT00592904|79416402|FG002|Overall Study|Protocol Violation|0|||
44408746|NCT00592904|79416403|FG003|Overall Study|Protocol Violation|1|||
44408747|NCT00592904|79416400|FG000|Overall Study|Withdrawal by Subject|4|||
44408748|NCT00592904|79416401|FG001|Overall Study|Withdrawal by Subject|16|||
44408749|NCT00592904|79416402|FG002|Overall Study|Withdrawal by Subject|1|||
44408750|NCT00592904|79416403|FG003|Overall Study|Withdrawal by Subject|2|||
44408751|NCT00592904|79416400|FG000|Overall Study|Lack of Efficacy|2|||
44408752|NCT00592904|79416401|FG001|Overall Study|Lack of Efficacy|7|||
44408753|NCT00592904|79416402|FG002|Overall Study|Lack of Efficacy|2|||
44408754|NCT00592904|79416403|FG003|Overall Study|Lack of Efficacy|3|||
44408755|NCT00592904|79416400|FG000|Overall Study|Physician Decision|0|||
44524235|NCT03734991|79532536|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
44524236|NCT03734991|79532535|FG000|Overall Study|Other|2|||
44524237|NCT03734991|79532536|FG001|Overall Study|Other|2|||
44524238|NCT03303092|79532545|FG000|Overall Study|Adverse Event|1|||
44408756|NCT00592904|79416401|FG001|Overall Study|Physician Decision|3|||
44408757|NCT00592904|79416402|FG002|Overall Study|Physician Decision|1|||
44408758|NCT00592904|79416403|FG003|Overall Study|Physician Decision|0|||
44408759|NCT00592904|79416400|FG000|Overall Study|Other|3|||
44408760|NCT00592904|79416401|FG001|Overall Study|Other|3|||
44408761|NCT00592904|79416402|FG002|Overall Study|Other|0|||
44408762|NCT00592904|79416403|FG003|Overall Study|Other|0|||
44524239|NCT03303092|79532546|FG001|Overall Study|Adverse Event|0|||
44524240|NCT03303092|79532547|FG002|Overall Study|Adverse Event|1|||
44524241|NCT03303092|79532545|FG000|Overall Study|Protocol Violation|1|||
44408763|NCT00855920|79416416|FG000|Overall Study|Protocol Violation|0|||
44524242|NCT03303092|79532546|FG001|Overall Study|Protocol Violation|5|||
44524243|NCT03303092|79532547|FG002|Overall Study|Protocol Violation|1|||
44408764|NCT00855920|79416417|FG001|Overall Study|Protocol Violation|0|||
44408765|NCT00855920|79416418|FG002|Overall Study|Protocol Violation|2|||
44408766|NCT00855920|79416416|FG000|Overall Study|Adverse Event|2|||
44408767|NCT00855920|79416417|FG001|Overall Study|Adverse Event|1|||
44408768|NCT00855920|79416418|FG002|Overall Study|Adverse Event|1|||
44408769|NCT00855920|79416416|FG000|Overall Study|Lack of Efficacy|2|||
44408770|NCT00855920|79416417|FG001|Overall Study|Lack of Efficacy|2|||
44408771|NCT00855920|79416418|FG002|Overall Study|Lack of Efficacy|2|||
44408772|NCT00855920|79416416|FG000|Overall Study|Withdrawal by Subject|2|||
44408773|NCT00855920|79416417|FG001|Overall Study|Withdrawal by Subject|3|||
44408774|NCT00855920|79416418|FG002|Overall Study|Withdrawal by Subject|2|||
44408775|NCT00855920|79416416|FG000|Overall Study|Lost to Follow-up|1|||
44408776|NCT00855920|79416417|FG001|Overall Study|Lost to Follow-up|0|||
44408777|NCT00855920|79416418|FG002|Overall Study|Lost to Follow-up|2|||
44408778|NCT00855920|79416416|FG000|Overall Study|Death|0|||
44408779|NCT00855920|79416417|FG001|Overall Study|Death|1|||
44408780|NCT00855920|79416418|FG002|Overall Study|Death|0|||
44408781|NCT00855920|79416416|FG000|Overall Study|Decision by the sponsor|0|||
44148157|NCT02829723|78937594|FG021|Overall Study|Subject/guardian decision|0|||
44148158|NCT02829723|78937595|FG022|Overall Study|Subject/guardian decision|0|||
44148159|NCT02829723|78937596|FG023|Overall Study|Subject/guardian decision|1|||
44148160|NCT02829723|78937597|FG024|Overall Study|Subject/guardian decision|0|||
44148161|NCT02829723|78937598|FG025|Overall Study|Subject/guardian decision|1|||
44148162|NCT02829723|78937599|FG026|Overall Study|Subject/guardian decision|1|||
44148163|NCT02829723|78937573|FG000|Overall Study|Study terminated by sponsor|0|||
44148164|NCT02829723|78937574|FG001|Overall Study|Study terminated by sponsor|0|||
44148165|NCT02829723|78937575|FG002|Overall Study|Study terminated by sponsor|0|||
44148166|NCT02829723|78937576|FG003|Overall Study|Study terminated by sponsor|0|||
44148167|NCT02829723|78937577|FG004|Overall Study|Study terminated by sponsor|0|||
44148168|NCT02829723|78937578|FG005|Overall Study|Study terminated by sponsor|0|||
44148169|NCT02829723|78937579|FG006|Overall Study|Study terminated by sponsor|0|||
44148170|NCT02829723|78937580|FG007|Overall Study|Study terminated by sponsor|0|||
44148171|NCT02829723|78937581|FG008|Overall Study|Study terminated by sponsor|0|||
44148172|NCT02829723|78937582|FG009|Overall Study|Study terminated by sponsor|0|||
44148173|NCT02829723|78937583|FG010|Overall Study|Study terminated by sponsor|0|||
44148174|NCT02829723|78937584|FG011|Overall Study|Study terminated by sponsor|0|||
44148175|NCT02829723|78937585|FG012|Overall Study|Study terminated by sponsor|0|||
44148176|NCT02829723|78937586|FG013|Overall Study|Study terminated by sponsor|0|||
44148177|NCT02829723|78937587|FG014|Overall Study|Study terminated by sponsor|0|||
44148178|NCT02829723|78937588|FG015|Overall Study|Study terminated by sponsor|0|||
44282123|NCT01881126|79245370|FG000|Overall Study|Non-compliance|1|||
44282124|NCT01881126|79245371|FG001|Overall Study|Non-compliance|1|||
44282125|NCT01881126|79245370|FG000|Overall Study|Adverse Event|0|||
44148179|NCT02829723|78937589|FG016|Overall Study|Study terminated by sponsor|0|||
44148180|NCT02829723|78937590|FG017|Overall Study|Study terminated by sponsor|0|||
44148181|NCT02829723|78937591|FG018|Overall Study|Study terminated by sponsor|0|||
44148182|NCT02829723|78937592|FG019|Overall Study|Study terminated by sponsor|0|||
44148183|NCT02829723|78937593|FG020|Overall Study|Study terminated by sponsor|0|||
44148184|NCT02829723|78937594|FG021|Overall Study|Study terminated by sponsor|1|||
44148185|NCT02829723|78937595|FG022|Overall Study|Study terminated by sponsor|0|||
44148186|NCT02829723|78937596|FG023|Overall Study|Study terminated by sponsor|0|||
44148187|NCT02829723|78937597|FG024|Overall Study|Study terminated by sponsor|0|||
44148188|NCT02829723|78937598|FG025|Overall Study|Study terminated by sponsor|0|||
44148189|NCT02829723|78937599|FG026|Overall Study|Study terminated by sponsor|0|||
44148190|NCT02815579|78937718|FG000|Overall Study|Non-payment of loan down-payment|16|||
44148191|NCT02815579|78937719|FG001|Overall Study|Non-payment of loan down-payment|0|||
44148192|NCT02815579|78937718|FG000|Overall Study|Withdrawal by Subject|7|||
44148193|NCT02815579|78937719|FG001|Overall Study|Withdrawal by Subject|1|||
44148194|NCT02815579|78937718|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
44148195|NCT02815579|78937719|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
44282126|NCT01881126|79245371|FG001|Overall Study|Adverse Event|1|||
44282127|NCT01614600|79245377|FG000|Overall Study|Unacceptable fit|1|||
44408782|NCT00855920|79416417|FG001|Overall Study|Decision by the sponsor|1|||
44408783|NCT00855920|79416418|FG002|Overall Study|Decision by the sponsor|1|||
44408784|NCT00855920|79416416|FG000|Overall Study|Other than specified above|1|||
44148196|NCT02815579|78937718|FG000|Overall Study|Lost to Follow-up|7|||
44148197|NCT02815579|78937719|FG001|Overall Study|Lost to Follow-up|4|||
44148198|NCT02815579|78937718|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
44148199|NCT02815579|78937719|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
44282128|NCT01614600|79245377|FG000|Overall Study|Discomfort|1|||
44282129|NCT01614600|79245377|FG000|Overall Study|Unable to remove lens at the end of day|1|||
44408785|NCT00855920|79416417|FG001|Overall Study|Other than specified above|1|||
44408786|NCT00855920|79416418|FG002|Overall Study|Other than specified above|1|||
44408787|NCT00848042|79416429|FG000|Overall Study|Death|1|||
44408788|NCT00848042|79416430|FG001|Overall Study|Death|2|||
44408789|NCT00848042|79416431|FG002|Overall Study|Death|0|||
44408790|NCT00848042|79416429|FG000|Overall Study|Other Therapy|3|||
44408791|NCT00848042|79416430|FG001|Overall Study|Other Therapy|0|||
44408792|NCT00848042|79416431|FG002|Overall Study|Other Therapy|0|||
44408793|NCT00847886|79416441|FG000|Overall Study|Adverse Event|0|||
44408794|NCT00847886|79416442|FG001|Overall Study|Adverse Event|1|||
44408795|NCT00847808|79416448|FG000|Overall Study|Adverse Event|7|||
44408796|NCT00847808|79416448|FG000|Overall Study|Protocol Violation|1|||
44408797|NCT00847808|79416448|FG000|Overall Study|Lost to Follow-up|1|||
44408798|NCT00847808|79416448|FG000|Overall Study|Withdrawal by Subject|4|||
44408799|NCT00847808|79416448|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
44408800|NCT00847808|79416448|FG000|Overall Study|Participant Took Excluded Medication|1|||
44408801|NCT00600353|79416454|FG000|Overall Study|history of malignancy within 5 years|1|||
44408802|NCT00600353|79416455|FG001|Overall Study|history of malignancy within 5 years|0|||
44408803|NCT00600353|79416454|FG000|Overall Study|History of prepartive regimen|0|||
44408804|NCT00600353|79416455|FG001|Overall Study|History of prepartive regimen|1|||
44408805|NCT00691210|79416469|FG000|Overall Study|Progression of Disease|0|||
44408806|NCT00691210|79416470|FG001|Overall Study|Progression of Disease|0|||
44408807|NCT00691210|79416471|FG002|Overall Study|Progression of Disease|0|||
44408808|NCT00691210|79416472|FG003|Overall Study|Progression of Disease|2|||
44408809|NCT00691210|79416473|FG004|Overall Study|Progression of Disease|0|||
44408810|NCT00691210|79416474|FG005|Overall Study|Progression of Disease|0|||
44408811|NCT00691210|79416475|FG006|Overall Study|Progression of Disease|0|||
44408812|NCT00691210|79416476|FG007|Overall Study|Progression of Disease|0|||
44408813|NCT00691210|79416469|FG000|Overall Study|Lack of Efficacy|0|||
44408814|NCT00691210|79416470|FG001|Overall Study|Lack of Efficacy|0|||
44408815|NCT00691210|79416471|FG002|Overall Study|Lack of Efficacy|0|||
44408816|NCT00691210|79416472|FG003|Overall Study|Lack of Efficacy|1|||
44408817|NCT00691210|79416473|FG004|Overall Study|Lack of Efficacy|0|||
44408818|NCT00691210|79416474|FG005|Overall Study|Lack of Efficacy|1|||
44408819|NCT00691210|79416475|FG006|Overall Study|Lack of Efficacy|0|||
44408820|NCT00691210|79416476|FG007|Overall Study|Lack of Efficacy|0|||
44408821|NCT00691132|79416496|FG000|Overall Study|Adverse Event|2|||
44408822|NCT00691132|79416497|FG001|Overall Study|Adverse Event|3|||
44408823|NCT00691132|79416496|FG000|Overall Study|Withdrawal by Subject|10|||
44408824|NCT00691132|79416497|FG001|Overall Study|Withdrawal by Subject|10|||
44408825|NCT00855218|79416519|FG000|Overall Study|Adverse Event|43|||
44408826|NCT00855218|79416520|FG001|Overall Study|Adverse Event|27|||
44408827|NCT00855218|79416519|FG000|Overall Study|Withdrawal by Subject|10|||
44408828|NCT00855218|79416520|FG001|Overall Study|Withdrawal by Subject|6|||
44408829|NCT00855218|79416519|FG000|Overall Study|Physician Decision|18|||
44408830|NCT00855218|79416520|FG001|Overall Study|Physician Decision|11|||
44408831|NCT00855218|79416519|FG000|Overall Study|Lost to Follow-up|0|||
44408832|NCT00855218|79416520|FG001|Overall Study|Lost to Follow-up|1|||
44408833|NCT00855218|79416519|FG000|Overall Study|Protocol Violation|5|||
44524244|NCT03303092|79532545|FG000|Overall Study|Withdrawal by Subject|1|||
44524245|NCT03303092|79532546|FG001|Overall Study|Withdrawal by Subject|1|||
44524246|NCT03303092|79532547|FG002|Overall Study|Withdrawal by Subject|3|||
44524247|NCT03302936|79532557|FG000|Overall Study|Protocol Violation|3|||
44524248|NCT03302936|79532558|FG001|Overall Study|Protocol Violation|4|||
44524249|NCT03733899|79532568|FG000|Period 1|Protocol Violation|0|||
44524250|NCT03733899|79532569|FG001|Period 1|Protocol Violation|0|||
44524251|NCT03733899|79532570|FG002|Period 1|Protocol Violation|0|||
44524252|NCT03733899|79532571|FG003|Period 1|Protocol Violation|0|||
44524253|NCT03733899|79532572|FG004|Period 1|Protocol Violation|0|||
44524254|NCT03733899|79532573|FG005|Period 1|Protocol Violation|1|||
44524255|NCT03733899|79532568|FG000|Period 2|Unscuccessful Treatment|0|||
44524256|NCT03733899|79532569|FG001|Period 2|Unscuccessful Treatment|1|||
44253678|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253679|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44408834|NCT00855218|79416520|FG001|Overall Study|Protocol Violation|9|||
44524257|NCT03733899|79532570|FG002|Period 2|Unscuccessful Treatment|0|||
44524258|NCT03733899|79532571|FG003|Period 2|Unscuccessful Treatment|0|||
44408835|NCT00855218|79416519|FG000|Overall Study|non-compliant with study drug|3|||
44408836|NCT00855218|79416520|FG001|Overall Study|non-compliant with study drug|1|||
44408837|NCT00855218|79416519|FG000|Overall Study|patient convenience|2|||
44408838|NCT00855218|79416520|FG001|Overall Study|patient convenience|0|||
44408839|NCT00855218|79416519|FG000|Overall Study|technical problems|2|||
44408840|NCT00855218|79416520|FG001|Overall Study|technical problems|1|||
44408841|NCT00855218|79416519|FG000|Overall Study|Still treated with study medication|0|||
44408842|NCT00855218|79416520|FG001|Overall Study|Still treated with study medication|1|||
44524259|NCT03733899|79532572|FG004|Period 2|Unscuccessful Treatment|0|||
44524260|NCT03733899|79532573|FG005|Period 2|Unscuccessful Treatment|0|||
44524261|NCT03733899|79532568|FG000|Period 3|Withdrawal by Subject|1|||
44524262|NCT03733899|79532569|FG001|Period 3|Withdrawal by Subject|0|||
44524263|NCT03733899|79532570|FG002|Period 3|Withdrawal by Subject|0|||
44408843|NCT00855218|79416519|FG000|Overall Study|Untreatable disease progression|54|||
44408844|NCT00855218|79416520|FG001|Overall Study|Untreatable disease progression|67|||
44408845|NCT00855218|79416519|FG000|Overall Study|Second malignancy|0|||
44408846|NCT00855218|79416520|FG001|Overall Study|Second malignancy|1|||
44408847|NCT00855218|79416519|FG000|Overall Study|Progression measurement proven|7|||
44408848|NCT00855218|79416520|FG001|Overall Study|Progression measurement proven|15|||
44408849|NCT00855218|79416519|FG000|Overall Study|Clinical endpoint reached|10|||
44408850|NCT00855218|79416520|FG001|Overall Study|Clinical endpoint reached|13|||
44408851|NCT01063348|79416528|FG000|Overall Study|Lost to Follow-up|3|||
44408852|NCT01063348|79416529|FG001|Overall Study|Lost to Follow-up|10|||
44408853|NCT00855062|79416537|FG000|Step1|Early Study Closure|5|||
44408854|NCT00855062|79416538|FG001|Step1|Early Study Closure|7|||
44148200|NCT02815579|78937718|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
44148201|NCT02815579|78937719|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
44148202|NCT02815579|78937718|FG000|Overall Study|Death|5|||
44148203|NCT02815579|78937719|FG001|Overall Study|Death|4|||
44148204|NCT02815579|78937718|FG000|Overall Study|Imprisoned|0|||
44148205|NCT02815579|78937719|FG001|Overall Study|Imprisoned|2|||
44148206|NCT02815579|78937718|FG000|Overall Study|Did not meet enrollment criteria|0|||
44148207|NCT02815579|78937719|FG001|Overall Study|Did not meet enrollment criteria|1|||
44148208|NCT02722616|78937728|FG000|Overall Study|Sponsor closed study after one month|2|||
44148209|NCT02722616|78937729|FG001|Overall Study|Sponsor closed study after one month|0|||
44148210|NCT02722616|78937730|FG002|Overall Study|Sponsor closed study after one month|0|||
44148211|NCT02658487|78937738|FG000|Overall Study|Death|2|||
44148212|NCT02658487|78937738|FG000|Overall Study|Disease progression|10|||
44148213|NCT02658487|78937738|FG000|Overall Study|Alternative therapy|1|||
44148214|NCT02658487|78937738|FG000|Overall Study|Adverse Event|1|||
44148215|NCT02658487|78937738|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
44524264|NCT03733899|79532571|FG003|Period 3|Withdrawal by Subject|0|||
44524265|NCT03733899|79532572|FG004|Period 3|Withdrawal by Subject|0|||
44524266|NCT03733899|79532573|FG005|Period 3|Withdrawal by Subject|0|||
44524267|NCT03727347|79532586|FG000|Overall Study|Withdrawal by Subject|2|||
44524268|NCT03727347|79532586|FG000|Overall Study|Lost to Follow-up|1|||
44148216|NCT02658487|78937738|FG000|Overall Study|Refractory AML|1|||
44148217|NCT02553460|78937752|FG000|Overall Study|Death|3|||
44148218|NCT02553460|78937752|FG000|Overall Study|Withdrawal by Subject|1|||
44148219|NCT02553460|78937752|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
44148220|NCT02553460|78937752|FG000|Overall Study|Relapse or Transplant|14|||
44408855|NCT00855062|79416537|FG000|Step1|Adverse Event|1|||
44408856|NCT00855062|79416538|FG001|Step1|Adverse Event|1|||
44408857|NCT00855062|79416537|FG000|Step1|Protocol Violation|1|||
44408858|NCT00855062|79416538|FG001|Step1|Protocol Violation|0|||
44408859|NCT00855062|79416537|FG000|Step1|Pregnancy|1|||
44408860|NCT00855062|79416538|FG001|Step1|Pregnancy|0|||
44408861|NCT00855062|79416537|FG000|Step1|Withdrawal by Subject|2|||
44408862|NCT00855062|79416538|FG001|Step1|Withdrawal by Subject|3|||
44408863|NCT00855062|79416537|FG000|Step2|Early Study Closure|6|||
44408864|NCT00855062|79416538|FG001|Step2|Early Study Closure|2|||
44408865|NCT00855062|79416537|FG000|Step2|Adverse Event|0|||
44408866|NCT00855062|79416538|FG001|Step2|Adverse Event|3|||
44408867|NCT00855062|79416537|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
44408868|NCT00855062|79416538|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
44408869|NCT00854906|79416544|FG000|Overall Study|One person had no ocular history|1|||
44408870|NCT00854828|79416555|FG000|Overall Study|Death|1|||
44408871|NCT00854828|79416556|FG001|Overall Study|Death|0|||
44408872|NCT00854828|79416557|FG002|Overall Study|Death|0|||
44408873|NCT00854828|79416558|FG003|Overall Study|Death|0|||
44408874|NCT00854828|79416555|FG000|Overall Study|Withdrawal by Subject|1|||
44408875|NCT00854828|79416556|FG001|Overall Study|Withdrawal by Subject|1|||
44408876|NCT00854828|79416557|FG002|Overall Study|Withdrawal by Subject|0|||
44408877|NCT00854828|79416558|FG003|Overall Study|Withdrawal by Subject|9|||
44524269|NCT03915626|79532599|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
44148221|NCT02553460|78937752|FG000|Overall Study|No response to treatment|2|||
44148222|NCT02553460|78937752|FG000|Overall Study|Still on therapy|7|||
44253680|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44408878|NCT00854828|79416555|FG000|Overall Study|Missed 24mo visit|1|||
44408879|NCT00854828|79416556|FG001|Overall Study|Missed 24mo visit|1|||
44524270|NCT03301844|79532611|FG000|Overall Study|suspected colon cancer|1|||
44408880|NCT00854828|79416557|FG002|Overall Study|Missed 24mo visit|8|||
44408881|NCT00854828|79416558|FG003|Overall Study|Missed 24mo visit|8|||
44408882|NCT00847730|79416568|FG000|Overall Study|Multiple interruptions in therapy|8|||
44408883|NCT00600119|79416578|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
44408884|NCT00600119|79416579|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
44408885|NCT00600119|79416580|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
44524271|NCT03301844|79532612|FG001|Overall Study|suspected colon cancer|1|||
44408886|NCT00600119|79416581|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
44408887|NCT00600119|79416582|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
44408888|NCT00600119|79416583|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
44408889|NCT00600119|79416578|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44408890|NCT00600119|79416579|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
44408891|NCT00600119|79416580|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
44408892|NCT00600119|79416581|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44408893|NCT00600119|79416582|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44408894|NCT00600119|79416583|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44408895|NCT00600119|79416578|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
44408896|NCT00600119|79416579|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
44408897|NCT00600119|79416580|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
44408898|NCT00600119|79416581|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
44408899|NCT00600119|79416582|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
44408900|NCT00600119|79416583|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
44408901|NCT00600119|79416578|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
44408902|NCT00600119|79416579|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
44408903|NCT00600119|79416580|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
44408904|NCT00600119|79416581|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
44524272|NCT03313310|79532620|FG000|Phase 2|Lost to Follow-up|4|||
44524273|NCT03313310|79532621|FG001|Phase 2|Lost to Follow-up|0|||
44524274|NCT03313310|79532620|FG000|Phase 3|Lost to Follow-up|0|||
44524275|NCT03313310|79532621|FG001|Phase 3|Lost to Follow-up|1|||
44524276|NCT03313076|79532631|FG000|Overall Study|Withdrawal by Subject|2|||
44524277|NCT03313076|79532632|FG001|Overall Study|Withdrawal by Subject|0|||
44524278|NCT03313076|79532633|FG002|Overall Study|Withdrawal by Subject|0|||
44524279|NCT03313076|79532634|FG003|Overall Study|Withdrawal by Subject|0|||
44524280|NCT03313076|79532631|FG000|Overall Study|Lost to Follow-up|0|||
44524281|NCT03313076|79532632|FG001|Overall Study|Lost to Follow-up|2|||
44524282|NCT03313076|79532633|FG002|Overall Study|Lost to Follow-up|2|||
44524283|NCT03313076|79532634|FG003|Overall Study|Lost to Follow-up|2|||
44524284|NCT02940626|79532652|FG000|Overall Study|Death|40|||
44524285|NCT02940626|79532653|FG001|Overall Study|Death|32|||
44524286|NCT02940626|79532652|FG000|Overall Study|Lost to Follow-up|5|||
44524287|NCT02940626|79532653|FG001|Overall Study|Lost to Follow-up|2|||
44524288|NCT02940626|79532652|FG000|Overall Study|Withdrawal by Subject|1|||
44524289|NCT02940626|79532653|FG001|Overall Study|Withdrawal by Subject|0|||
44524290|NCT02940626|79532652|FG000|Overall Study|Transfer to Hospice Care|1|||
44524291|NCT02940626|79532653|FG001|Overall Study|Transfer to Hospice Care|0|||
44524292|NCT02940626|79532652|FG000|Overall Study|Prohibited Concomitant Medication|0|||
44524293|NCT02940626|79532653|FG001|Overall Study|Prohibited Concomitant Medication|1|||
44524294|NCT03300050|79532666|FG000|Overall Study|Lost to Follow-up|2|||
44524295|NCT03300050|79532667|FG001|Overall Study|Lost to Follow-up|1|||
44524296|NCT03300050|79532668|FG002|Overall Study|Lost to Follow-up|0|||
44524297|NCT03300050|79532669|FG003|Overall Study|Lost to Follow-up|0|||
44524298|NCT03300050|79532670|FG004|Overall Study|Lost to Follow-up|1|||
44524299|NCT03300050|79532666|FG000|Overall Study|Withdrawal by Subject|1|||
44524300|NCT03300050|79532667|FG001|Overall Study|Withdrawal by Subject|1|||
44524301|NCT03300050|79532668|FG002|Overall Study|Withdrawal by Subject|1|||
44524302|NCT03300050|79532669|FG003|Overall Study|Withdrawal by Subject|0|||
44524303|NCT03300050|79532670|FG004|Overall Study|Withdrawal by Subject|0|||
44524304|NCT03300050|79532666|FG000|Overall Study|Death|0|||
44524305|NCT03300050|79532667|FG001|Overall Study|Death|0|||
44524306|NCT03300050|79532668|FG002|Overall Study|Death|1|||
44524307|NCT03300050|79532669|FG003|Overall Study|Death|0|||
44524308|NCT03300050|79532670|FG004|Overall Study|Death|0|||
44524309|NCT03300050|79532666|FG000|Overall Study|Not Eligible at Randomization|0|||
44524310|NCT03300050|79532667|FG001|Overall Study|Not Eligible at Randomization|0|||
44524311|NCT03300050|79532668|FG002|Overall Study|Not Eligible at Randomization|1|||
44524312|NCT03300050|79532669|FG003|Overall Study|Not Eligible at Randomization|1|||
44408905|NCT00600119|79416582|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
44408906|NCT00600119|79416583|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
44524313|NCT03300050|79532670|FG004|Overall Study|Not Eligible at Randomization|0|||
44524314|NCT03725085|79532682|FG000|Overall Study|Lost to Follow-up|2|||
44524315|NCT02940392|79532687|FG000|Overall Study|Lost to Follow-up|3|||
44524316|NCT02940392|79532687|FG000|Overall Study|Retreatment|3|||
44524317|NCT02940392|79532687|FG000|Overall Study|Death|2|||
44524318|NCT03298412|79532700|FG000|Run-in Period|Other, Not Specified|1|||
44408907|NCT00600119|79416578|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
44524319|NCT03298412|79532700|FG000|Run-in Period|Disease Progression|1|||
44524320|NCT03298412|79532700|FG000|Run-in Period|Ineligibility Determined|1|||
44524321|NCT03298412|79532700|FG000|Run-in Period|Decision by Sponsor|6|||
44148223|NCT02553460|78937752|FG000|Overall Study|CAR T cells|1|||
44524322|NCT03297398|79532707|FG000|Overall Study|Sponsor's decision|6|||
44408908|NCT00600119|79416579|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
44408909|NCT00600119|79416580|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
44408910|NCT00600119|79416581|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
44408911|NCT00600119|79416582|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
44408912|NCT00600119|79416583|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
44408913|NCT00600119|79416578|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
44408914|NCT00600119|79416579|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
44408915|NCT00600119|79416580|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
44408916|NCT00600119|79416581|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
44408917|NCT00600119|79416582|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
44408918|NCT00600119|79416583|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
44524323|NCT03297398|79532708|FG001|Overall Study|Sponsor's decision|9|||
44524324|NCT03297398|79532709|FG002|Overall Study|Sponsor's decision|7|||
44524325|NCT03297398|79532707|FG000|Overall Study|Adverse Event|1|||
44524326|NCT03297398|79532708|FG001|Overall Study|Adverse Event|4|||
44524327|NCT03297398|79532709|FG002|Overall Study|Adverse Event|4|||
44524328|NCT03297398|79532707|FG000|Overall Study|Withdrawal by Subject|1|||
44524329|NCT03297398|79532708|FG001|Overall Study|Withdrawal by Subject|2|||
44524330|NCT03297398|79532709|FG002|Overall Study|Withdrawal by Subject|2|||
44524331|NCT03297398|79532707|FG000|Overall Study|Protocol Violation|0|||
44524332|NCT03297398|79532708|FG001|Overall Study|Protocol Violation|2|||
44524333|NCT03297398|79532709|FG002|Overall Study|Protocol Violation|0|||
44524334|NCT03297398|79532707|FG000|Overall Study|Physician Decision|0|||
44524335|NCT03297398|79532708|FG001|Overall Study|Physician Decision|0|||
44524336|NCT03297398|79532709|FG002|Overall Study|Physician Decision|1|||
44524337|NCT03297398|79532707|FG000|Overall Study|Lost to Follow-up|0|||
44524338|NCT03297398|79532708|FG001|Overall Study|Lost to Follow-up|0|||
44524339|NCT03297398|79532709|FG002|Overall Study|Lost to Follow-up|1|||
44524340|NCT03293654|79532720|FG000|Overall Study|Lost to Follow-up|0|||
44524341|NCT03293654|79532721|FG001|Overall Study|Lost to Follow-up|1|||
44524342|NCT03293654|79532722|FG002|Overall Study|Lost to Follow-up|0|||
44524343|NCT03312218|79532732|FG000|Overall Study|Never signed in to access the app|54|||
44524344|NCT03312218|79532733|FG001|Overall Study|Never signed in to access the app|58|||
44524345|NCT03930615|79532741|FG000|Overall Study|Death|9|||
44524346|NCT03930615|79532742|FG001|Overall Study|Death|3|||
44524347|NCT03930615|79532741|FG000|Overall Study|Lost to Follow-up|1|||
44524348|NCT03930615|79532742|FG001|Overall Study|Lost to Follow-up|2|||
44524349|NCT03930615|79532741|FG000|Overall Study|Physician Decision|3|||
44524350|NCT03930615|79532742|FG001|Overall Study|Physician Decision|4|||
44524351|NCT03930615|79532741|FG000|Overall Study|Withdrawal by Subject|13|||
44524352|NCT03930615|79532742|FG001|Overall Study|Withdrawal by Subject|2|||
44524353|NCT03930615|79532741|FG000|Overall Study|Not treated|1|||
44524354|NCT03930615|79532742|FG001|Overall Study|Not treated|1|||
44524355|NCT03292640|79532750|FG000|Overall Study|Withdrawal by Subject|17|||
44524356|NCT03292640|79532751|FG001|Overall Study|Withdrawal by Subject|16|||
44524357|NCT03292640|79532750|FG000|Overall Study|Adverse Event|20|||
44524358|NCT03292640|79532751|FG001|Overall Study|Adverse Event|2|||
44524359|NCT03292640|79532750|FG000|Overall Study|Lost to Follow-up|24|||
44524360|NCT03292640|79532751|FG001|Overall Study|Lost to Follow-up|24|||
44524361|NCT03292406|79532764|FG000|Overall Study|Progressive Disease|6|||
44524362|NCT03292406|79532765|FG001|Overall Study|Progressive Disease|3|||
44524363|NCT03292406|79532766|FG002|Overall Study|Progressive Disease|4|||
44524364|NCT03292406|79532764|FG000|Overall Study|Adverse Event|7|||
44524365|NCT03292406|79532765|FG001|Overall Study|Adverse Event|1|||
44524366|NCT03292406|79532766|FG002|Overall Study|Adverse Event|4|||
44524367|NCT03292406|79532764|FG000|Overall Study|Withdrawal by Subject|0|||
44524368|NCT03292406|79532765|FG001|Overall Study|Withdrawal by Subject|7|||
44524369|NCT03292406|79532766|FG002|Overall Study|Withdrawal by Subject|2|||
44524370|NCT03292406|79532764|FG000|Overall Study|Protocol Violation|0|||
44524371|NCT03292406|79532765|FG001|Overall Study|Protocol Violation|1|||
44524372|NCT03292406|79532766|FG002|Overall Study|Protocol Violation|1|||
44524373|NCT03292406|79532764|FG000|Overall Study|Other|0|||
44524374|NCT03292406|79532765|FG001|Overall Study|Other|1|||
44524375|NCT03292406|79532766|FG002|Overall Study|Other|2|||
44148224|NCT02453282|78937759|FG000|Overall Study|Death|275|||
44148225|NCT02453282|78937760|FG001|Overall Study|Death|277|||
44408919|NCT00600119|79416578|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
44408920|NCT00600119|79416579|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
44524376|NCT03292016|79532803|FG000|Second Washout|Adverse Event|0|||
44524377|NCT03292016|79532804|FG001|Second Washout|Adverse Event|1|||
44524378|NCT03292016|79532805|FG002|Second Washout|Adverse Event|0|||
44524379|NCT03292016|79532806|FG003|Second Washout|Adverse Event|0|||
44524380|NCT03292016|79532807|FG004|Second Washout|Adverse Event|0|||
44524381|NCT03292016|79532808|FG005|Second Washout|Adverse Event|0|||
44524382|NCT03289676|79532818|FG000|Overall Study|Withdrawal by Subject|2|||
44524383|NCT03289676|79532819|FG001|Overall Study|Withdrawal by Subject|0|||
44524384|NCT03289676|79532818|FG000|Overall Study|Protocol Violation|2|||
44524385|NCT03289676|79532819|FG001|Overall Study|Protocol Violation|0|||
44408921|NCT00600119|79416580|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44408922|NCT00600119|79416581|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
44408923|NCT00600119|79416582|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
44408924|NCT00600119|79416583|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
44408925|NCT00600119|79416578|FG000|Double-blind Treatment Period|Other|0|||
44408926|NCT00600119|79416579|FG001|Double-blind Treatment Period|Other|0|||
44408927|NCT00600119|79416580|FG002|Double-blind Treatment Period|Other|0|||
44408928|NCT00600119|79416581|FG003|Double-blind Treatment Period|Other|0|||
44408929|NCT00600119|79416582|FG004|Double-blind Treatment Period|Other|2|||
44408930|NCT00600119|79416583|FG005|Double-blind Treatment Period|Other|1|||
44408931|NCT00600119|79416578|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
44408932|NCT00600119|79416579|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
44408933|NCT00600119|79416580|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
44408934|NCT00600119|79416581|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
44408935|NCT00600119|79416582|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
44408936|NCT00600119|79416583|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
44408937|NCT00600119|79416578|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
44408938|NCT00600119|79416579|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
44408939|NCT00600119|79416580|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
44408940|NCT00600119|79416581|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
44408941|NCT00600119|79416582|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
44408942|NCT00600119|79416583|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
44408943|NCT00600119|79416578|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
44408944|NCT00600119|79416579|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
44408945|NCT00600119|79416580|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
44408946|NCT00600119|79416581|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
44408947|NCT00600119|79416582|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
44408948|NCT00600119|79416583|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
44408949|NCT00600119|79416578|FG000|Double-blind Treatment Period|Physician Decision|2|||
44408950|NCT00600119|79416579|FG001|Double-blind Treatment Period|Physician Decision|0|||
44408951|NCT00600119|79416580|FG002|Double-blind Treatment Period|Physician Decision|0|||
44408952|NCT00600119|79416581|FG003|Double-blind Treatment Period|Physician Decision|0|||
44408953|NCT00600119|79416582|FG004|Double-blind Treatment Period|Physician Decision|0|||
44408954|NCT00600119|79416583|FG005|Double-blind Treatment Period|Physician Decision|0|||
44408955|NCT00600119|79416578|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44408956|NCT00600119|79416579|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
44408957|NCT00600119|79416580|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
44408958|NCT00600119|79416581|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
44408959|NCT00600119|79416582|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
44408960|NCT00600119|79416583|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
44408961|NCT00600119|79416578|FG000|Double-blind Treatment Period|Adverse Event|1|||
44408962|NCT00600119|79416579|FG001|Double-blind Treatment Period|Adverse Event|1|||
44408963|NCT00600119|79416580|FG002|Double-blind Treatment Period|Adverse Event|0|||
44408964|NCT00600119|79416581|FG003|Double-blind Treatment Period|Adverse Event|1|||
44408965|NCT00600119|79416582|FG004|Double-blind Treatment Period|Adverse Event|2|||
44408966|NCT00600119|79416583|FG005|Double-blind Treatment Period|Adverse Event|10|||
44408967|NCT00600119|79416578|FG000|Follow-up Period|Adverse Event|0|||
44408968|NCT00600119|79416579|FG001|Follow-up Period|Adverse Event|0|||
44408969|NCT00600119|79416580|FG002|Follow-up Period|Adverse Event|0|||
44408970|NCT00600119|79416581|FG003|Follow-up Period|Adverse Event|0|||
44408971|NCT00600119|79416582|FG004|Follow-up Period|Adverse Event|0|||
44408972|NCT00600119|79416583|FG005|Follow-up Period|Adverse Event|1|||
44408973|NCT00600119|79416578|FG000|Follow-up Period|Other|1|||
44148226|NCT02453282|78937761|FG002|Overall Study|Death|296|||
44253681|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253682|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253683|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
44253684|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
44253685|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
44253686|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
44253687|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
44253688|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
44253689|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
44253690|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
44253691|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
44408974|NCT00600119|79416579|FG001|Follow-up Period|Other|0|||
44408975|NCT00600119|79416580|FG002|Follow-up Period|Other|0|||
44408976|NCT00600119|79416581|FG003|Follow-up Period|Other|0|||
44408977|NCT00600119|79416582|FG004|Follow-up Period|Other|0|||
44408978|NCT00600119|79416583|FG005|Follow-up Period|Other|0|||
44408979|NCT00866294|79416600|FG000|Overall Study|Adverse Event|12|||
44408980|NCT00866294|79416601|FG001|Overall Study|Adverse Event|13|||
44408981|NCT00866294|79416602|FG002|Overall Study|Adverse Event|9|||
44408982|NCT00866294|79416600|FG000|Overall Study|Lack of Efficacy|7|||
44408983|NCT00866294|79416601|FG001|Overall Study|Lack of Efficacy|1|||
44408984|NCT00866294|79416602|FG002|Overall Study|Lack of Efficacy|0|||
44408985|NCT00866294|79416600|FG000|Overall Study|Protocol Violation|2|||
44408986|NCT00866294|79416601|FG001|Overall Study|Protocol Violation|0|||
44408987|NCT00866294|79416602|FG002|Overall Study|Protocol Violation|0|||
44408988|NCT00866294|79416600|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
44408989|NCT00866294|79416601|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44408990|NCT00866294|79416602|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44408991|NCT00866294|79416600|FG000|Overall Study|Lost to Follow-up|1|||
44408992|NCT00866294|79416601|FG001|Overall Study|Lost to Follow-up|3|||
44408993|NCT00866294|79416602|FG002|Overall Study|Lost to Follow-up|0|||
44408994|NCT00866294|79416600|FG000|Overall Study|Physician Decision|6|||
44408995|NCT00866294|79416601|FG001|Overall Study|Physician Decision|2|||
44408996|NCT00866294|79416602|FG002|Overall Study|Physician Decision|1|||
44408997|NCT00854360|79416622|FG000|Overall Study|Adverse Event|0|||
44408998|NCT00854360|79416623|FG001|Overall Study|Adverse Event|1|||
44408999|NCT00854360|79416624|FG002|Overall Study|Adverse Event|2|||
44409000|NCT00854360|79416625|FG003|Overall Study|Adverse Event|6|||
44409001|NCT00854360|79416622|FG000|Overall Study|Withdrawal by Subject|0|||
44409002|NCT00854360|79416623|FG001|Overall Study|Withdrawal by Subject|0|||
44409003|NCT00854360|79416624|FG002|Overall Study|Withdrawal by Subject|0|||
44409004|NCT00854360|79416625|FG003|Overall Study|Withdrawal by Subject|1|||
44409005|NCT00854360|79416622|FG000|Overall Study|Pregnancy|0|||
44409006|NCT00854360|79416623|FG001|Overall Study|Pregnancy|1|||
44409007|NCT00854360|79416624|FG002|Overall Study|Pregnancy|0|||
44409008|NCT00854360|79416625|FG003|Overall Study|Pregnancy|0|||
44409009|NCT00854360|79416622|FG000|Overall Study|Lack of Efficacy|2|||
44409010|NCT00854360|79416623|FG001|Overall Study|Lack of Efficacy|1|||
44409011|NCT00854360|79416624|FG002|Overall Study|Lack of Efficacy|0|||
44409012|NCT00854360|79416625|FG003|Overall Study|Lack of Efficacy|0|||
44409013|NCT00854360|79416622|FG000|Overall Study|Other|0|||
44409014|NCT00854360|79416623|FG001|Overall Study|Other|0|||
44409015|NCT00854360|79416624|FG002|Overall Study|Other|0|||
44409016|NCT00854360|79416625|FG003|Overall Study|Other|3|||
44409017|NCT00853970|79416637|FG000|Overall Study|Withdrawal by Subject|2|||
44409018|NCT00853970|79416638|FG001|Overall Study|Withdrawal by Subject|1|||
44409019|NCT00853970|79416637|FG000|Overall Study|Cancelled surgery|4|||
44409020|NCT00853970|79416638|FG001|Overall Study|Cancelled surgery|2|||
44409021|NCT00865904|79416666|FG000|Overall Study|Randomized but not Treated|2|||
44409022|NCT00865904|79416667|FG001|Overall Study|Randomized but not Treated|0|||
44409023|NCT00865904|79416668|FG002|Overall Study|Randomized but not Treated|0|||
44409024|NCT00865904|79416669|FG003|Overall Study|Randomized but not Treated|1|||
44524386|NCT03289676|79532818|FG000|Overall Study|Lost to Follow-up|0|||
44524387|NCT03289676|79532819|FG001|Overall Study|Lost to Follow-up|1|||
44524388|NCT03287804|79532835|FG000|Overall Study|Death|1|||
44524389|NCT03287804|79532835|FG000|Overall Study|Physician Decision|2|||
44524390|NCT03287804|79532835|FG000|Overall Study|Progressive disease|8|||
44524391|NCT03286400|79532840|FG000|Overall Study|Death|10|||
44524392|NCT03286400|79532840|FG000|Overall Study|Lost to Follow-up|10|||
44524393|NCT03286400|79532840|FG000|Overall Study|Physician Decision|1|||
44524394|NCT03286400|79532840|FG000|Overall Study|Scheduling difficulty|4|||
44524395|NCT03310970|79532844|FG000|Overall Study|Withdrawal by Subject|0|||
44409025|NCT00865904|79416670|FG004|Overall Study|Randomized but not Treated|1|||
44409026|NCT00599339|79416686|FG000|Overall Study|Adverse Event|79|||
44409027|NCT00599339|79416686|FG000|Overall Study|Withdrawal by Subject|137|||
44409028|NCT00599339|79416686|FG000|Overall Study|Other Reason|179|||
44409029|NCT00599339|79416686|FG000|Overall Study|Lost to Follow-up|221|||
44409030|NCT00599339|79416686|FG000|Overall Study|No valid data consent|36|||
44409031|NCT00599339|79416686|FG000|Overall Study|Study Termination Status Unknown|12|||
44409032|NCT00599027|79416710|FG000|Overall Study|Withdrawal by Subject|1|||
44409033|NCT00599027|79416711|FG001|Overall Study|Withdrawal by Subject|1|||
44409034|NCT00599027|79416710|FG000|Overall Study|Adverse Event|0|||
44409035|NCT00599027|79416711|FG001|Overall Study|Adverse Event|1|||
44409036|NCT00599027|79416710|FG000|Overall Study|Treatment Failure|0|||
44409037|NCT00599027|79416711|FG001|Overall Study|Treatment Failure|1|||
44409038|NCT02881151|79416726|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
44409039|NCT00689728|79416734|FG000|Double-Blind Treatment|Adverse Event|1|||
44409040|NCT00689728|79416735|FG001|Double-Blind Treatment|Adverse Event|0|||
44409041|NCT00689728|79416736|FG002|Double-Blind Treatment|Adverse Event|0|||
44524396|NCT03310970|79532845|FG001|Overall Study|Withdrawal by Subject|1|||
44524397|NCT03285308|79532854|FG000|Overall Study|Adverse Event|3|||
44524398|NCT03285308|79532855|FG001|Overall Study|Adverse Event|7|||
44524399|NCT03285308|79532854|FG000|Overall Study|Withdrawal by Subject|8|||
44524400|NCT03285308|79532855|FG001|Overall Study|Withdrawal by Subject|9|||
44524401|NCT03285308|79532854|FG000|Overall Study|Lost to Follow-up|3|||
44524402|NCT03285308|79532855|FG001|Overall Study|Lost to Follow-up|1|||
44524403|NCT03285308|79532854|FG000|Overall Study|Protocol Deviation|6|||
44524404|NCT03285308|79532855|FG001|Overall Study|Protocol Deviation|5|||
44524405|NCT03285308|79532854|FG000|Overall Study|Reason not Specified|0|||
44524406|NCT03285308|79532855|FG001|Overall Study|Reason not Specified|1|||
44524407|NCT03723915|79532871|FG000|Screening|Failed to meet screening requirements.|2|||
44524408|NCT03723915|79532871|FG000|On Treatment|Failed to meet treatment requirements|2|||
44524409|NCT03281876|79532877|FG000|Overall Study|Adverse Event|4|||
44524410|NCT03281876|79532878|FG001|Overall Study|Adverse Event|15|||
44524411|NCT03281876|79532877|FG000|Overall Study|Lost to Follow-up|1|||
44524412|NCT03281876|79532878|FG001|Overall Study|Lost to Follow-up|4|||
44524413|NCT03281876|79532877|FG000|Overall Study|Withdrawal by Subject|11|||
44524414|NCT03281876|79532878|FG001|Overall Study|Withdrawal by Subject|15|||
44524415|NCT03281876|79532877|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
44524416|NCT03281876|79532878|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44524417|NCT03281876|79532877|FG000|Overall Study|OTHER|5|||
44524418|NCT03281876|79532878|FG001|Overall Study|OTHER|5|||
44524419|NCT03310580|79532887|FG000|Overall Study|Adverse Event|0|||
44524420|NCT03310580|79532888|FG001|Overall Study|Adverse Event|1|||
44524421|NCT03310580|79532889|FG002|Overall Study|Adverse Event|0|||
44524422|NCT03415022|79532912|FG000|Overall Study|Withdrawal by Subject|1|||
44524423|NCT03415022|79532913|FG001|Overall Study|Withdrawal by Subject|2|||
44524424|NCT03415022|79532912|FG000|Overall Study|COVID-19 Suspension|2|||
44524425|NCT03415022|79532913|FG001|Overall Study|COVID-19 Suspension|3|||
44524426|NCT03415022|79532912|FG000|Overall Study|Lost to Follow-up|2|||
44524427|NCT03415022|79532913|FG001|Overall Study|Lost to Follow-up|0|||
44524428|NCT02816398|79532919|FG000|Overall Study|Death|5|||
44524429|NCT02816398|79532919|FG000|Overall Study|Lack of Efficacy|8|||
44409042|NCT00689728|79416734|FG000|Double-Blind Treatment|Protocol Violation|0|||
44409043|NCT00689728|79416735|FG001|Double-Blind Treatment|Protocol Violation|0|||
44409044|NCT00689728|79416736|FG002|Double-Blind Treatment|Protocol Violation|1|||
44409045|NCT00689728|79416734|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
44409046|NCT00689728|79416735|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
44409047|NCT00689728|79416736|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
44409048|NCT00689728|79416734|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
44409049|NCT00689728|79416735|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
44409050|NCT00689728|79416736|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
44409051|NCT00689728|79416734|FG000|Rescue|Adverse Event|0|||
44409052|NCT00689728|79416735|FG001|Rescue|Adverse Event|1|||
44409053|NCT00689728|79416736|FG002|Rescue|Adverse Event|0|||
44409054|NCT00689728|79416734|FG000|Rescue|Withdrawal by Subject|1|||
44409055|NCT00689728|79416735|FG001|Rescue|Withdrawal by Subject|1|||
44409056|NCT00689728|79416736|FG002|Rescue|Withdrawal by Subject|1|||
44409057|NCT00689728|79416734|FG000|Optional Follow-Up|Adverse Event|1|||
44409058|NCT00689728|79416735|FG001|Optional Follow-Up|Adverse Event|0|||
44409059|NCT00689728|79416736|FG002|Optional Follow-Up|Adverse Event|0|||
44524430|NCT02816398|79532919|FG000|Overall Study|Lost to Follow-up|1|||
44524431|NCT02812186|79532925|FG000|Period 1|Post randomization screen failure|5|||
44524432|NCT02812186|79532926|FG001|Period 1|Post randomization screen failure|9|||
44524433|NCT02812186|79532925|FG000|Period 1|nonevaluable data sets|6|||
44524434|NCT02812186|79532926|FG001|Period 1|nonevaluable data sets|6|||
44524435|NCT02811640|79532935|FG000|Overall Study|Technology malfunction|2|||
44524436|NCT03310268|79532942|FG000|Overall Study|(Not specified)|1|||
44524437|NCT03310268|79532943|FG001|Overall Study|(Not specified)|5|||
44524438|NCT03310268|79532944|FG002|Overall Study|(Not specified)|0|||
44524439|NCT02810392|79532954|FG000|Overall Study|Subject too ill to continue|1|||
44524440|NCT02810392|79532955|FG001|Overall Study|Subject too ill to continue|0|||
44524441|NCT02810392|79532954|FG000|Overall Study|COVID 19 research restrictions|0|||
44524442|NCT02810392|79532955|FG001|Overall Study|COVID 19 research restrictions|1|||
44524443|NCT02815540|79532961|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
44409060|NCT00689728|79416734|FG000|Optional Follow-Up|Lack of Efficacy|0|||
44524444|NCT03280550|79532967|FG000|Overall Study|Withdrawal by Subject|2|||
44524445|NCT03280550|79532968|FG001|Overall Study|Withdrawal by Subject|2|||
44524446|NCT03280550|79532967|FG000|Overall Study|Physician Decision|0|||
44524447|NCT03280550|79532968|FG001|Overall Study|Physician Decision|1|||
44524448|NCT03276026|79532976|FG000|Overall Study|Protocol Violation|1|||
44524449|NCT03276026|79532977|FG001|Overall Study|Protocol Violation|0|||
44524450|NCT01589523|79532983|FG000|Overall Study|Withdrawal by Subject|1|||
44409061|NCT00689728|79416735|FG001|Optional Follow-Up|Lack of Efficacy|1|||
44409062|NCT00689728|79416736|FG002|Optional Follow-Up|Lack of Efficacy|1|||
44409063|NCT00689728|79416734|FG000|Optional Follow-Up|Lost to Follow-up|0|||
44524451|NCT03277352|79532989|FG000|Overall Study|Study Terminated By Sponsor|2|||
44524452|NCT03277352|79532989|FG000|Overall Study|Withdrawal by Subject|4|||
44524453|NCT03277352|79532989|FG000|Overall Study|Death|4|||
44524454|NCT03276728|79533002|FG000|Overall Study|Lost to Follow-up|0|||
44524455|NCT03276728|79533003|FG001|Overall Study|Lost to Follow-up|0|||
44524456|NCT03276728|79533004|FG002|Overall Study|Lost to Follow-up|2|||
44524457|NCT03276728|79533005|FG003|Overall Study|Lost to Follow-up|2|||
44524458|NCT03276728|79533006|FG004|Overall Study|Lost to Follow-up|0|||
44524459|NCT03276728|79533007|FG005|Overall Study|Lost to Follow-up|0|||
44524460|NCT03276728|79533008|FG006|Overall Study|Lost to Follow-up|0|||
44524461|NCT03276728|79533009|FG007|Overall Study|Lost to Follow-up|0|||
44524462|NCT03276728|79533002|FG000|Overall Study|Withdrawal by Subject|0|||
44524463|NCT03276728|79533003|FG001|Overall Study|Withdrawal by Subject|0|||
44524464|NCT03276728|79533004|FG002|Overall Study|Withdrawal by Subject|0|||
44524465|NCT03276728|79533005|FG003|Overall Study|Withdrawal by Subject|3|||
44524466|NCT03276728|79533006|FG004|Overall Study|Withdrawal by Subject|0|||
44524467|NCT03276728|79533007|FG005|Overall Study|Withdrawal by Subject|0|||
44524468|NCT03276728|79533008|FG006|Overall Study|Withdrawal by Subject|0|||
44524469|NCT03276728|79533009|FG007|Overall Study|Withdrawal by Subject|0|||
44524470|NCT03276728|79533002|FG000|Overall Study|Decision by sponsor|0|||
44524471|NCT03276728|79533003|FG001|Overall Study|Decision by sponsor|0|||
44524472|NCT03276728|79533004|FG002|Overall Study|Decision by sponsor|0|||
44524473|NCT03276728|79533005|FG003|Overall Study|Decision by sponsor|0|||
44524474|NCT03276728|79533006|FG004|Overall Study|Decision by sponsor|1|||
44524475|NCT03276728|79533007|FG005|Overall Study|Decision by sponsor|0|||
44524476|NCT03276728|79533008|FG006|Overall Study|Decision by sponsor|2|||
44524477|NCT03276728|79533009|FG007|Overall Study|Decision by sponsor|1|||
44524478|NCT03275246|79533029|FG000|Overall Study|Protocol Violation|5|||
44524479|NCT03275246|79533029|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
44524480|NCT02940860|79533035|FG000|Overall Study|Non-serious AE|1|||
44524481|NCT02940860|79533036|FG001|Overall Study|Non-serious AE|2|||
44524482|NCT02940860|79533035|FG000|Overall Study|Serious AE|7|||
44524483|NCT02940860|79533036|FG001|Overall Study|Serious AE|3|||
44524484|NCT02940860|79533035|FG000|Overall Study|Withdrawal by Subject|19|||
44524485|NCT02940860|79533036|FG001|Overall Study|Withdrawal by Subject|9|||
44524486|NCT02940860|79533035|FG000|Overall Study|Lost to Follow-up|13|||
44524487|NCT02940860|79533036|FG001|Overall Study|Lost to Follow-up|7|||
44524488|NCT02940860|79533035|FG000|Overall Study|Physician Decision|5|||
44524489|NCT02940860|79533036|FG001|Overall Study|Physician Decision|3|||
44524490|NCT02940860|79533035|FG000|Overall Study|Sponsor Decision|0|||
44524491|NCT02940860|79533036|FG001|Overall Study|Sponsor Decision|1|||
44524492|NCT02940860|79533035|FG000|Overall Study|Protocol Violation|0|||
44524493|NCT02940860|79533036|FG001|Overall Study|Protocol Violation|2|||
44409064|NCT00689728|79416735|FG001|Optional Follow-Up|Lost to Follow-up|1|||
44409065|NCT00689728|79416736|FG002|Optional Follow-Up|Lost to Follow-up|1|||
44409066|NCT00689728|79416734|FG000|Optional Follow-Up|Protocol Violation|0|||
44409067|NCT00689728|79416735|FG001|Optional Follow-Up|Protocol Violation|0|||
44409068|NCT00689728|79416736|FG002|Optional Follow-Up|Protocol Violation|1|||
44409069|NCT00689728|79416734|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
44409070|NCT00689728|79416735|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
44409071|NCT00689728|79416736|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
44409072|NCT00691054|79416765|FG000|Overall Study|Withdrawal by Subject|1|||
44409073|NCT00598871|79416773|FG000|Overall Study|Adverse Event|0|||
44409074|NCT00598871|79416774|FG001|Overall Study|Adverse Event|1|||
44409075|NCT00690820|79416782|FG000|Period 1|Withdrawal by Subject|0|||
44524494|NCT02940860|79533035|FG000|Overall Study|Death|3|||
44524495|NCT02940860|79533036|FG001|Overall Study|Death|2|||
44524496|NCT02940860|79533035|FG000|Overall Study|Moved, poor venous access, transport|6|||
44524497|NCT02940860|79533036|FG001|Overall Study|Moved, poor venous access, transport|4|||
44524498|NCT02940860|79533035|FG000|Overall Study|Not treated|2|||
44524499|NCT02940860|79533036|FG001|Overall Study|Not treated|2|||
44524500|NCT03309020|79533046|FG000|Overall Study|Death|1|||
44524501|NCT03309020|79533047|FG001|Overall Study|Death|0|||
44524502|NCT03309020|79533046|FG000|Overall Study|Did not undergo surgery|2|||
44524503|NCT03309020|79533047|FG001|Overall Study|Did not undergo surgery|1|||
44524504|NCT02806960|79533055|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
44524505|NCT02806960|79533056|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
44524506|NCT02806960|79533057|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
44524507|NCT02806960|79533058|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
44524508|NCT03718143|79533068|FG000|Overall Study|Death|1|||
44524509|NCT03718143|79533069|FG001|Overall Study|Death|0|||
44409076|NCT00690820|79416783|FG001|Period 1|Withdrawal by Subject|1|||
44409077|NCT00689338|79416789|FG000|Overall Study|Death|65|||
44409078|NCT00689338|79416789|FG000|Overall Study|Adverse Event|13|||
44409079|NCT00689338|79416789|FG000|Overall Study|Insufficient Clinical Response|1|||
44409080|NCT00689338|79416789|FG000|Overall Study|Lack of Efficacy|6|||
44409081|NCT00689338|79416789|FG000|Overall Study|Other|8|||
44409082|NCT00689338|79416789|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
44409083|NCT00689338|79416789|FG000|Overall Study|Lost to Follow-up|5|||
44409084|NCT00689338|79416789|FG000|Overall Study|Withdrawal by Subject|3|||
44409085|NCT00689338|79416789|FG000|Overall Study|Protocol Violation|15|||
44409086|NCT00686998|79416796|FG000|Overall Study|Adverse Event|3|||
44409087|NCT00686998|79416797|FG001|Overall Study|Adverse Event|2|||
44409088|NCT00686998|79416798|FG002|Overall Study|Adverse Event|1|||
44409089|NCT00686998|79416796|FG000|Overall Study|Withdrawal by Subject|2|||
44409090|NCT00686998|79416797|FG001|Overall Study|Withdrawal by Subject|1|||
44409091|NCT00686998|79416798|FG002|Overall Study|Withdrawal by Subject|2|||
44409092|NCT00686998|79416796|FG000|Overall Study|Lack of Efficacy|7|||
44409093|NCT00686998|79416797|FG001|Overall Study|Lack of Efficacy|5|||
44409094|NCT00686998|79416798|FG002|Overall Study|Lack of Efficacy|0|||
44409095|NCT00686998|79416796|FG000|Overall Study|Other|0|||
44409096|NCT00686998|79416797|FG001|Overall Study|Other|0|||
44409097|NCT00686998|79416798|FG002|Overall Study|Other|1|||
44409098|NCT00686998|79416796|FG000|Overall Study|Safety Reasons|1|||
44409099|NCT00686998|79416797|FG001|Overall Study|Safety Reasons|0|||
44524510|NCT03718143|79533070|FG002|Overall Study|Death|0|||
44524511|NCT03718143|79533068|FG000|Overall Study|Progression of Disease|1|||
44524512|NCT03718143|79533069|FG001|Overall Study|Progression of Disease|0|||
44524513|NCT03718143|79533070|FG002|Overall Study|Progression of Disease|0|||
44524514|NCT03718143|79533068|FG000|Overall Study|Withdrawal of Informed Consent|1|||
44409100|NCT00686998|79416798|FG002|Overall Study|Safety Reasons|0|||
44409101|NCT00848718|79416819|FG000|Overall Study|Adverse Event|2|||
44409102|NCT00848718|79416820|FG001|Overall Study|Adverse Event|2|||
44409103|NCT00848718|79416821|FG002|Overall Study|Adverse Event|1|||
44409104|NCT00848718|79416822|FG003|Overall Study|Adverse Event|1|||
44409105|NCT00848718|79416823|FG004|Overall Study|Adverse Event|1|||
44409106|NCT00848718|79416824|FG005|Overall Study|Adverse Event|0|||
44409107|NCT00848718|79416825|FG006|Overall Study|Adverse Event|0|||
44409108|NCT00848718|79416826|FG007|Overall Study|Adverse Event|1|||
44409109|NCT00848718|79416827|FG008|Overall Study|Adverse Event|1|||
44524515|NCT03718143|79533069|FG001|Overall Study|Withdrawal of Informed Consent|2|||
44524516|NCT03718143|79533070|FG002|Overall Study|Withdrawal of Informed Consent|1|||
44524517|NCT03274466|79533080|FG000|Overall Study|Withdrawal by Subject|7|||
44524518|NCT03274466|79533081|FG001|Overall Study|Withdrawal by Subject|3|||
44524519|NCT03274466|79533080|FG000|Overall Study|Protocol Specified Withdrawal|5|||
44524520|NCT03274466|79533081|FG001|Overall Study|Protocol Specified Withdrawal|11|||
44524521|NCT03274466|79533080|FG000|Overall Study|Lost to Follow-up|5|||
44524522|NCT03274466|79533081|FG001|Overall Study|Lost to Follow-up|7|||
44524523|NCT03274466|79533080|FG000|Overall Study|Subject Non-compliance|0|||
44524524|NCT03274466|79533081|FG001|Overall Study|Subject Non-compliance|1|||
44524525|NCT03274466|79533080|FG000|Overall Study|Adverse Event|3|||
44524526|NCT03274466|79533081|FG001|Overall Study|Adverse Event|3|||
44524527|NCT03274466|79533080|FG000|Overall Study|Physician Decision|0|||
44524528|NCT03274466|79533081|FG001|Overall Study|Physician Decision|1|||
44524529|NCT03274466|79533080|FG000|Overall Study|Protocol Violation|3|||
44524530|NCT03274466|79533081|FG001|Overall Study|Protocol Violation|3|||
44524531|NCT02806726|79533087|FG000|Overall Study|Lost to Follow-up|1|||
44524532|NCT02806414|79533092|FG000|Overall Study|Lost to Follow-up|2|||
44524533|NCT02806024|79533098|FG000|Overall Study|Night Delivery|1|||
44524534|NCT02806024|79533099|FG001|Overall Study|Night Delivery|1|||
44524535|NCT02806024|79533098|FG000|Overall Study|DVT during antepartum admission|0|||
44524536|NCT02806024|79533099|FG001|Overall Study|DVT during antepartum admission|1|||
44524537|NCT02805790|79533107|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
44524538|NCT02805790|79533108|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
44524539|NCT02802592|79533114|FG000|Overall Study|Study terminated due to loss of funding|4|||
44524540|NCT02803138|79533119|FG000|Overall Study|Failure to return|38|||
44524541|NCT02803138|79533119|FG000|Overall Study|Insufficient virological response|2|||
44524542|NCT02803138|79533119|FG000|Overall Study|Withdrawn consent|1|||
44148227|NCT02453282|78937759|FG000|Overall Study|Lost to Follow-up|1|||
44409110|NCT00848718|79416828|FG009|Overall Study|Adverse Event|0|||
44409111|NCT00848718|79416829|FG010|Overall Study|Adverse Event|0|||
44524543|NCT02803138|79533119|FG000|Overall Study|Death|1|||
44524544|NCT02803138|79533119|FG000|Overall Study|Other, not specified|28|||
44524545|NCT02801578|79533125|FG000|Overall Study|Adverse Event|2|||
44524546|NCT02799472|79533131|FG000|Overall Study|Withdrawal by Subject|2|||
44524547|NCT02799472|79533132|FG001|Overall Study|Withdrawal by Subject|4|||
44524548|NCT02799472|79533131|FG000|Overall Study|Lack of Efficacy|2|||
44524549|NCT02799472|79533132|FG001|Overall Study|Lack of Efficacy|0|||
44524550|NCT02799472|79533131|FG000|Overall Study|Lost to Follow-up|0|||
44524551|NCT02799472|79533132|FG001|Overall Study|Lost to Follow-up|1|||
44524552|NCT03245450|79533145|FG000|Overall Study|Radiological disease progression|3|||
44524553|NCT03245450|79533146|FG001|Overall Study|Radiological disease progression|3|||
44524554|NCT03245450|79533147|FG002|Overall Study|Radiological disease progression|2|||
44524555|NCT03245450|79533148|FG003|Overall Study|Radiological disease progression|2|||
44524556|NCT03245450|79533149|FG004|Overall Study|Radiological disease progression|7|||
44524557|NCT03245450|79533150|FG005|Overall Study|Radiological disease progression|6|||
44524558|NCT03245450|79533151|FG006|Overall Study|Radiological disease progression|6|||
44524559|NCT03245450|79533145|FG000|Overall Study|Clinical disease progression|0|||
44524560|NCT03245450|79533146|FG001|Overall Study|Clinical disease progression|0|||
44524561|NCT03245450|79533147|FG002|Overall Study|Clinical disease progression|1|||
44524562|NCT03245450|79533148|FG003|Overall Study|Clinical disease progression|0|||
44524563|NCT03245450|79533149|FG004|Overall Study|Clinical disease progression|0|||
44524564|NCT03245450|79533150|FG005|Overall Study|Clinical disease progression|2|||
44524565|NCT03245450|79533151|FG006|Overall Study|Clinical disease progression|0|||
44524566|NCT03245450|79533145|FG000|Overall Study|Other|0|||
44524567|NCT03245450|79533146|FG001|Overall Study|Other|0|||
44524568|NCT03245450|79533147|FG002|Overall Study|Other|0|||
44524569|NCT03245450|79533148|FG003|Overall Study|Other|1|||
44524570|NCT03245450|79533149|FG004|Overall Study|Other|1|||
44524571|NCT03245450|79533150|FG005|Overall Study|Other|1|||
44524572|NCT03245450|79533151|FG006|Overall Study|Other|1|||
44524573|NCT03245450|79533145|FG000|Overall Study|Withdrawal by Subject|0|||
44253692|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
44409112|NCT00848718|79416830|FG011|Overall Study|Adverse Event|0|||
44409113|NCT00848718|79416831|FG012|Overall Study|Adverse Event|2|||
44409114|NCT00848718|79416819|FG000|Overall Study|Lack of Efficacy|0|||
44409115|NCT00848718|79416820|FG001|Overall Study|Lack of Efficacy|0|||
44409116|NCT00848718|79416821|FG002|Overall Study|Lack of Efficacy|1|||
44409117|NCT00848718|79416822|FG003|Overall Study|Lack of Efficacy|0|||
44409118|NCT00848718|79416823|FG004|Overall Study|Lack of Efficacy|0|||
44409119|NCT00848718|79416824|FG005|Overall Study|Lack of Efficacy|0|||
44409120|NCT00848718|79416825|FG006|Overall Study|Lack of Efficacy|1|||
44524574|NCT03245450|79533146|FG001|Overall Study|Withdrawal by Subject|1|||
44524575|NCT03245450|79533147|FG002|Overall Study|Withdrawal by Subject|0|||
44409121|NCT00848718|79416826|FG007|Overall Study|Lack of Efficacy|0|||
44409122|NCT00848718|79416827|FG008|Overall Study|Lack of Efficacy|0|||
44524576|NCT03245450|79533148|FG003|Overall Study|Withdrawal by Subject|0|||
44524577|NCT03245450|79533149|FG004|Overall Study|Withdrawal by Subject|0|||
44524578|NCT03245450|79533150|FG005|Overall Study|Withdrawal by Subject|0|||
44524579|NCT03245450|79533151|FG006|Overall Study|Withdrawal by Subject|0|||
44524580|NCT03245450|79533145|FG000|Overall Study|Adverse Event|0|||
44524581|NCT03245450|79533146|FG001|Overall Study|Adverse Event|0|||
44409123|NCT00848718|79416828|FG009|Overall Study|Lack of Efficacy|0|||
44409124|NCT00848718|79416829|FG010|Overall Study|Lack of Efficacy|0|||
44409125|NCT00848718|79416830|FG011|Overall Study|Lack of Efficacy|0|||
44409126|NCT00848718|79416831|FG012|Overall Study|Lack of Efficacy|0|||
44409127|NCT00848718|79416819|FG000|Overall Study|Physician Decision|0|||
44409128|NCT00848718|79416820|FG001|Overall Study|Physician Decision|1|||
44409129|NCT00848718|79416821|FG002|Overall Study|Physician Decision|0|||
44409130|NCT00848718|79416822|FG003|Overall Study|Physician Decision|0|||
44409131|NCT00848718|79416823|FG004|Overall Study|Physician Decision|1|||
44409132|NCT00848718|79416824|FG005|Overall Study|Physician Decision|1|||
44409133|NCT00848718|79416825|FG006|Overall Study|Physician Decision|0|||
44409134|NCT00848718|79416826|FG007|Overall Study|Physician Decision|0|||
44409135|NCT00848718|79416827|FG008|Overall Study|Physician Decision|1|||
44409136|NCT00848718|79416828|FG009|Overall Study|Physician Decision|2|||
44409137|NCT00848718|79416829|FG010|Overall Study|Physician Decision|0|||
44409138|NCT00848718|79416830|FG011|Overall Study|Physician Decision|0|||
44409139|NCT00848718|79416831|FG012|Overall Study|Physician Decision|1|||
44253693|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
44409140|NCT00848718|79416819|FG000|Overall Study|Progressive disease before treatment|1|||
44409141|NCT00848718|79416820|FG001|Overall Study|Progressive disease before treatment|5|||
44409142|NCT00848718|79416821|FG002|Overall Study|Progressive disease before treatment|1|||
44409143|NCT00848718|79416822|FG003|Overall Study|Progressive disease before treatment|3|||
44409144|NCT00848718|79416823|FG004|Overall Study|Progressive disease before treatment|4|||
44409145|NCT00848718|79416824|FG005|Overall Study|Progressive disease before treatment|4|||
44409146|NCT00848718|79416825|FG006|Overall Study|Progressive disease before treatment|2|||
44409147|NCT00848718|79416826|FG007|Overall Study|Progressive disease before treatment|1|||
44409148|NCT00848718|79416827|FG008|Overall Study|Progressive disease before treatment|2|||
44409149|NCT00848718|79416828|FG009|Overall Study|Progressive disease before treatment|7|||
44409150|NCT00848718|79416829|FG010|Overall Study|Progressive disease before treatment|3|||
44409151|NCT00848718|79416830|FG011|Overall Study|Progressive disease before treatment|6|||
44409152|NCT00848718|79416831|FG012|Overall Study|Progressive disease before treatment|2|||
44409153|NCT00848718|79416819|FG000|Overall Study|Protocol Violation|0|||
44409154|NCT00848718|79416820|FG001|Overall Study|Protocol Violation|1|||
44409155|NCT00848718|79416821|FG002|Overall Study|Protocol Violation|0|||
44409156|NCT00848718|79416822|FG003|Overall Study|Protocol Violation|0|||
44409157|NCT00848718|79416823|FG004|Overall Study|Protocol Violation|0|||
44409158|NCT00848718|79416824|FG005|Overall Study|Protocol Violation|0|||
44409159|NCT00848718|79416825|FG006|Overall Study|Protocol Violation|0|||
44409160|NCT00848718|79416826|FG007|Overall Study|Protocol Violation|1|||
44409161|NCT00848718|79416827|FG008|Overall Study|Protocol Violation|0|||
44409162|NCT00848718|79416828|FG009|Overall Study|Protocol Violation|0|||
44409163|NCT00848718|79416829|FG010|Overall Study|Protocol Violation|0|||
44409164|NCT00848718|79416830|FG011|Overall Study|Protocol Violation|0|||
44409165|NCT00848718|79416831|FG012|Overall Study|Protocol Violation|1|||
44409166|NCT00848718|79416819|FG000|Overall Study|Withdrawal by Subject|1|||
44409167|NCT00848718|79416820|FG001|Overall Study|Withdrawal by Subject|0|||
44409168|NCT00848718|79416821|FG002|Overall Study|Withdrawal by Subject|0|||
44409169|NCT00848718|79416822|FG003|Overall Study|Withdrawal by Subject|1|||
44409170|NCT00848718|79416823|FG004|Overall Study|Withdrawal by Subject|0|||
44409171|NCT00848718|79416824|FG005|Overall Study|Withdrawal by Subject|0|||
44524582|NCT03245450|79533147|FG002|Overall Study|Adverse Event|0|||
44524583|NCT03245450|79533148|FG003|Overall Study|Adverse Event|0|||
44524584|NCT03245450|79533149|FG004|Overall Study|Adverse Event|1|||
44524585|NCT03245450|79533150|FG005|Overall Study|Adverse Event|0|||
44524586|NCT03245450|79533151|FG006|Overall Study|Adverse Event|2|||
44524587|NCT03712917|79533176|FG000|Overall Study|Pregnancy|0|||
44524588|NCT03712917|79533177|FG001|Overall Study|Pregnancy|0|||
44524589|NCT03712917|79533178|FG002|Overall Study|Pregnancy|1|||
44524590|NCT03712917|79533176|FG000|Overall Study|Adverse Event|0|||
44524591|NCT03712917|79533177|FG001|Overall Study|Adverse Event|4|||
44524592|NCT03712917|79533178|FG002|Overall Study|Adverse Event|3|||
44524593|NCT03712917|79533176|FG000|Overall Study|Lost to Follow-up|9|||
44148228|NCT02453282|78937760|FG001|Overall Study|Lost to Follow-up|0|||
44409172|NCT00848718|79416825|FG006|Overall Study|Withdrawal by Subject|0|||
44409173|NCT00848718|79416826|FG007|Overall Study|Withdrawal by Subject|0|||
44409174|NCT00848718|79416827|FG008|Overall Study|Withdrawal by Subject|0|||
44409175|NCT00848718|79416828|FG009|Overall Study|Withdrawal by Subject|0|||
44409176|NCT00848718|79416829|FG010|Overall Study|Withdrawal by Subject|1|||
44409177|NCT00848718|79416830|FG011|Overall Study|Withdrawal by Subject|0|||
44524594|NCT03712917|79533177|FG001|Overall Study|Lost to Follow-up|4|||
44524595|NCT03712917|79533178|FG002|Overall Study|Lost to Follow-up|5|||
44253694|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
44409178|NCT00848718|79416831|FG012|Overall Study|Withdrawal by Subject|0|||
44524596|NCT02748694|79533201|FG000|Overall Study|Voluntary Withdrawal|0|||
44524597|NCT02748694|79533202|FG001|Overall Study|Voluntary Withdrawal|0|||
44524598|NCT02748694|79533203|FG002|Overall Study|Voluntary Withdrawal|0|||
44524599|NCT02748694|79533204|FG003|Overall Study|Voluntary Withdrawal|0|||
44524600|NCT02748694|79533205|FG004|Overall Study|Voluntary Withdrawal|0|||
44524601|NCT02748694|79533206|FG005|Overall Study|Voluntary Withdrawal|0|||
44524602|NCT02748694|79533207|FG006|Overall Study|Voluntary Withdrawal|0|||
44524603|NCT02748694|79533208|FG007|Overall Study|Voluntary Withdrawal|0|||
44524604|NCT02748694|79533209|FG008|Overall Study|Voluntary Withdrawal|0|||
44524605|NCT02748694|79533210|FG009|Overall Study|Voluntary Withdrawal|0|||
44524606|NCT02748694|79533211|FG010|Overall Study|Voluntary Withdrawal|0|||
44524607|NCT02748694|79533212|FG011|Overall Study|Voluntary Withdrawal|0|||
44409179|NCT00848718|79416819|FG000|Overall Study|Progressive disease during treatment|3|||
44409180|NCT00848718|79416820|FG001|Overall Study|Progressive disease during treatment|0|||
44409181|NCT00848718|79416821|FG002|Overall Study|Progressive disease during treatment|3|||
44409182|NCT00848718|79416822|FG003|Overall Study|Progressive disease during treatment|0|||
44409183|NCT00848718|79416823|FG004|Overall Study|Progressive disease during treatment|0|||
44409184|NCT00848718|79416824|FG005|Overall Study|Progressive disease during treatment|0|||
44409185|NCT00848718|79416825|FG006|Overall Study|Progressive disease during treatment|0|||
44409186|NCT00848718|79416826|FG007|Overall Study|Progressive disease during treatment|2|||
44409187|NCT00848718|79416827|FG008|Overall Study|Progressive disease during treatment|0|||
44253695|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
44253696|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
44409188|NCT00848718|79416828|FG009|Overall Study|Progressive disease during treatment|0|||
44409189|NCT00848718|79416829|FG010|Overall Study|Progressive disease during treatment|0|||
44409190|NCT00848718|79416830|FG011|Overall Study|Progressive disease during treatment|0|||
44409191|NCT00848718|79416831|FG012|Overall Study|Progressive disease during treatment|2|||
44409192|NCT00883337|79416868|FG000|Core Treatment Period|Adverse Event|9|||
44409193|NCT00883337|79416869|FG001|Core Treatment Period|Adverse Event|12|||
44409194|NCT00883337|79416870|FG002|Core Treatment Period|Adverse Event|22|||
44409195|NCT00883337|79416868|FG000|Core Treatment Period|Lack of Efficacy|7|||
44409196|NCT00883337|79416869|FG001|Core Treatment Period|Lack of Efficacy|4|||
44409197|NCT00883337|79416870|FG002|Core Treatment Period|Lack of Efficacy|2|||
44409198|NCT00883337|79416868|FG000|Core Treatment Period|Lost to Follow-up|1|||
44409199|NCT00883337|79416869|FG001|Core Treatment Period|Lost to Follow-up|1|||
44409200|NCT00883337|79416870|FG002|Core Treatment Period|Lost to Follow-up|0|||
44409201|NCT00883337|79416868|FG000|Core Treatment Period|Withdrawal by Subject|2|||
44409202|NCT00883337|79416869|FG001|Core Treatment Period|Withdrawal by Subject|2|||
44409203|NCT00883337|79416870|FG002|Core Treatment Period|Withdrawal by Subject|6|||
44409204|NCT00883337|79416868|FG000|Core Treatment Period|Wish to be pregnant|1|||
44409205|NCT00883337|79416869|FG001|Core Treatment Period|Wish to be pregnant|2|||
44409206|NCT00883337|79416870|FG002|Core Treatment Period|Wish to be pregnant|1|||
44409207|NCT00883337|79416868|FG000|Core Treatment Period|Poor compliance to protocol|0|||
44409208|NCT00883337|79416869|FG001|Core Treatment Period|Poor compliance to protocol|0|||
44409209|NCT00883337|79416870|FG002|Core Treatment Period|Poor compliance to protocol|1|||
44409210|NCT00883337|79416868|FG000|Core Treatment Period|Other than above|0|||
44409211|NCT00883337|79416869|FG001|Core Treatment Period|Other than above|1|||
44409212|NCT00883337|79416870|FG002|Core Treatment Period|Other than above|1|||
44409213|NCT00883337|79416868|FG000|Extension Treatment Period|Adverse Event|8|||
44409214|NCT00883337|79416869|FG001|Extension Treatment Period|Adverse Event|5|||
44409215|NCT00883337|79416870|FG002|Extension Treatment Period|Adverse Event|5|||
44409216|NCT00883337|79416868|FG000|Extension Treatment Period|Lack of Efficacy|8|||
44409217|NCT00883337|79416869|FG001|Extension Treatment Period|Lack of Efficacy|8|||
44409218|NCT00883337|79416870|FG002|Extension Treatment Period|Lack of Efficacy|8|||
44409219|NCT00883337|79416868|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
44409220|NCT00883337|79416869|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
44409221|NCT00883337|79416870|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
44409222|NCT00883337|79416868|FG000|Extension Treatment Period|Lost to Follow-up|1|||
44524608|NCT02748694|79533213|FG012|Overall Study|Voluntary Withdrawal|0|||
44524609|NCT02748694|79533214|FG013|Overall Study|Voluntary Withdrawal|0|||
44524610|NCT02748694|79533215|FG014|Overall Study|Voluntary Withdrawal|2|||
44524611|NCT02800642|79533271|FG000|Overall Study|Death|3|||
44524612|NCT02800642|79533271|FG000|Overall Study|Other|10|||
44524613|NCT02800642|79533271|FG000|Overall Study|Physician Decision|2|||
44253697|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
44409223|NCT00883337|79416869|FG001|Extension Treatment Period|Lost to Follow-up|0|||
44409224|NCT00883337|79416870|FG002|Extension Treatment Period|Lost to Follow-up|0|||
44409225|NCT00883337|79416868|FG000|Extension Treatment Period|Other than above|10|||
44524614|NCT02800642|79533271|FG000|Overall Study|Adverse Event|6|||
44524615|NCT02800642|79533271|FG000|Overall Study|Withdrawal by Subject|3|||
44524616|NCT02800642|79533271|FG000|Overall Study|Lost to Follow-up|1|||
44524617|NCT02799784|79533275|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
44524618|NCT02799784|79533276|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
44524619|NCT02799784|79533275|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
44524620|NCT02799784|79533276|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
44524621|NCT02799784|79533275|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
44524622|NCT02799784|79533276|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
44524623|NCT02799784|79533275|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
44524624|NCT02799784|79533276|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
44524625|NCT02799784|79533275|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
44524626|NCT02799784|79533276|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
44524627|NCT02799784|79533275|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
44524628|NCT02799784|79533276|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
44524629|NCT02054806|79533282|FG000|Overall Study|Sponsor Decision|31|||
44524630|NCT02054806|79533282|FG000|Overall Study|Withdrawal by Subject|43|||
44524631|NCT02054806|79533282|FG000|Overall Study|Protocol Violation|2|||
44524632|NCT02054806|79533282|FG000|Overall Study|Lost to Follow-up|10|||
44524633|NCT02054806|79533282|FG000|Overall Study|Death|391|||
44524634|NCT01333072|79533315|FG000|Overall Study|Lost to Follow-up|3|||
44409226|NCT00883337|79416869|FG001|Extension Treatment Period|Other than above|9|||
44409227|NCT00883337|79416870|FG002|Extension Treatment Period|Other than above|5|||
44409228|NCT00838110|79416886|FG000|Overall Study|Death|0|||
44409229|NCT00838110|79416887|FG001|Overall Study|Death|0|||
44524635|NCT01333072|79533316|FG001|Overall Study|Lost to Follow-up|0|||
44524636|NCT01333072|79533315|FG000|Overall Study|Adverse Event|2|||
44524637|NCT01333072|79533316|FG001|Overall Study|Adverse Event|4|||
44524638|NCT01333072|79533315|FG000|Overall Study|Physician Decision|1|||
44524639|NCT01333072|79533316|FG001|Overall Study|Physician Decision|0|||
44524640|NCT01315353|79533325|FG000|Overall Study|Death|2|||
44524641|NCT01315353|79533326|FG001|Overall Study|Death|1|||
44524642|NCT01315353|79533327|FG002|Overall Study|Death|0|||
44524643|NCT01315353|79533325|FG000|Overall Study|Withdrawal by Subject|2|||
44524644|NCT01315353|79533326|FG001|Overall Study|Withdrawal by Subject|6|||
44524645|NCT01315353|79533327|FG002|Overall Study|Withdrawal by Subject|1|||
44524646|NCT01315353|79533325|FG000|Overall Study|Lost to Follow-up|13|||
44524647|NCT01315353|79533326|FG001|Overall Study|Lost to Follow-up|6|||
44524648|NCT01315353|79533327|FG002|Overall Study|Lost to Follow-up|6|||
44524649|NCT01315353|79533325|FG000|Overall Study|Unwilling to adhere to requirements|5|||
44524650|NCT01315353|79533326|FG001|Overall Study|Unwilling to adhere to requirements|5|||
44524651|NCT01315353|79533327|FG002|Overall Study|Unwilling to adhere to requirements|4|||
44524652|NCT01315353|79533325|FG000|Overall Study|Site closing|7|||
44524653|NCT01315353|79533326|FG001|Overall Study|Site closing|4|||
44524654|NCT01315353|79533327|FG002|Overall Study|Site closing|0|||
44524655|NCT01315353|79533325|FG000|Overall Study|Taken off study by site in error|0|||
44524656|NCT01315353|79533326|FG001|Overall Study|Taken off study by site in error|1|||
44524657|NCT01315353|79533327|FG002|Overall Study|Taken off study by site in error|0|||
44524658|NCT01315353|79533325|FG000|Overall Study|Inadvertent randomization/assignment|0|||
44524659|NCT01315353|79533326|FG001|Overall Study|Inadvertent randomization/assignment|0|||
44524660|NCT01315353|79533327|FG002|Overall Study|Inadvertent randomization/assignment|2|||
44524661|NCT03517540|79533339|FG000|Overall Study|Protocol Violation|2|||
44524662|NCT03517540|79533340|FG001|Overall Study|Protocol Violation|0|||
44524663|NCT03517540|79533341|FG002|Overall Study|Protocol Violation|0|||
44524664|NCT03517540|79533342|FG003|Overall Study|Protocol Violation|1|||
44524665|NCT03517540|79533339|FG000|Overall Study|Adverse Event|9|||
44524666|NCT03517540|79533340|FG001|Overall Study|Adverse Event|3|||
44524667|NCT03517540|79533341|FG002|Overall Study|Adverse Event|8|||
44409230|NCT00838110|79416888|FG002|Overall Study|Death|1|||
44409231|NCT00838110|79416889|FG003|Overall Study|Death|2|||
44524668|NCT03517540|79533342|FG003|Overall Study|Adverse Event|1|||
44524669|NCT03517540|79533339|FG000|Overall Study|Withdrawal by Subject|3|||
44524670|NCT03517540|79533340|FG001|Overall Study|Withdrawal by Subject|4|||
44524671|NCT03517540|79533341|FG002|Overall Study|Withdrawal by Subject|1|||
44524672|NCT03517540|79533342|FG003|Overall Study|Withdrawal by Subject|3|||
44524673|NCT02799082|79533354|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
44524674|NCT02799082|79533355|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
44524675|NCT02799082|79533354|FG000|Overall Study|Protocol Violation|0|||
44409232|NCT00838110|79416886|FG000|Overall Study|Adverse Event|11|||
44524676|NCT02799082|79533355|FG001|Overall Study|Protocol Violation|1|||
44524677|NCT03710889|79533361|FG000|Overall Study|Adverse Event|2|||
44524678|NCT03710889|79533361|FG000|Overall Study|Protocol Deviation|1|||
44524679|NCT02797678|79533365|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
44524680|NCT02797678|79533366|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
44524681|NCT02797678|79533367|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
44409233|NCT00838110|79416887|FG001|Overall Study|Adverse Event|10|||
44409234|NCT00838110|79416888|FG002|Overall Study|Adverse Event|8|||
44409235|NCT00838110|79416889|FG003|Overall Study|Adverse Event|7|||
44409236|NCT00838110|79416886|FG000|Overall Study|Withdrawal by Subject|5|||
44409237|NCT00838110|79416887|FG001|Overall Study|Withdrawal by Subject|6|||
44409238|NCT00838110|79416888|FG002|Overall Study|Withdrawal by Subject|3|||
44409239|NCT00838110|79416889|FG003|Overall Study|Withdrawal by Subject|4|||
44409240|NCT00838110|79416886|FG000|Overall Study|Other|3|||
44409241|NCT00838110|79416887|FG001|Overall Study|Other|3|||
44409242|NCT00838110|79416888|FG002|Overall Study|Other|3|||
44409243|NCT00838110|79416889|FG003|Overall Study|Other|2|||
44409244|NCT00838110|79416886|FG000|Overall Study|Protocol Violation|0|||
44409245|NCT00838110|79416887|FG001|Overall Study|Protocol Violation|2|||
44409246|NCT00838110|79416888|FG002|Overall Study|Protocol Violation|1|||
44409247|NCT00838110|79416889|FG003|Overall Study|Protocol Violation|1|||
44409248|NCT00838110|79416886|FG000|Overall Study|Lost to Follow-up|3|||
44409249|NCT00838110|79416887|FG001|Overall Study|Lost to Follow-up|0|||
44409250|NCT00838110|79416888|FG002|Overall Study|Lost to Follow-up|0|||
44409251|NCT00838110|79416889|FG003|Overall Study|Lost to Follow-up|0|||
44409252|NCT00838110|79416886|FG000|Overall Study|Did not meet eligibility criteria|0|||
44409253|NCT00838110|79416887|FG001|Overall Study|Did not meet eligibility criteria|0|||
44524682|NCT02797678|79533368|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
44524683|NCT02797678|79533365|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
44524684|NCT02797678|79533366|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
44409254|NCT00838110|79416888|FG002|Overall Study|Did not meet eligibility criteria|1|||
44409255|NCT00838110|79416889|FG003|Overall Study|Did not meet eligibility criteria|2|||
44409256|NCT00838110|79416886|FG000|Overall Study|Randomized but not treated|0|||
44409257|NCT00838110|79416887|FG001|Overall Study|Randomized but not treated|1|||
44409258|NCT00838110|79416888|FG002|Overall Study|Randomized but not treated|0|||
44409259|NCT00838110|79416889|FG003|Overall Study|Randomized but not treated|0|||
44524685|NCT02797678|79533367|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
44524686|NCT02797678|79533368|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
44524687|NCT02797678|79533365|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
44524688|NCT02797678|79533366|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
44524689|NCT02797678|79533367|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
44524690|NCT02797678|79533368|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
44524691|NCT03308786|79533381|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
44524692|NCT03274076|79533388|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
44524693|NCT03274076|79533389|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
44524694|NCT03274076|79533390|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
44524695|NCT03274076|79533391|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
44524696|NCT03274076|79533388|FG000|24 Weeks Open Label|Adverse Event|0|||
44409260|NCT00837876|79416899|FG000|Overall Study|Death|2|||
44409261|NCT00837876|79416899|FG000|Overall Study|Adverse Event|7|||
44409262|NCT00837876|79416899|FG000|Overall Study|Physician Decision|1|||
44409263|NCT00837876|79416899|FG000|Overall Study|Withdrawal by Subject|3|||
44409264|NCT00837876|79416899|FG000|Overall Study|disease progression|24|||
44409265|NCT00686920|79416905|FG000|Overall Study|Death|45|||
44409266|NCT00686920|79416906|FG001|Overall Study|Death|14|||
44409267|NCT00686920|79416905|FG000|Overall Study|Liver Transplant|23|||
44409268|NCT00686920|79416906|FG001|Overall Study|Liver Transplant|8|||
44409269|NCT00686920|79416905|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
44409270|NCT00686920|79416906|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
44409271|NCT00686920|79416905|FG000|Overall Study|Withdrawal by Subject|23|||
44409272|NCT00686920|79416906|FG001|Overall Study|Withdrawal by Subject|5|||
44409273|NCT00686920|79416905|FG000|Overall Study|Protocol Violation|2|||
44409274|NCT00686920|79416906|FG001|Overall Study|Protocol Violation|1|||
44409275|NCT00686920|79416905|FG000|Overall Study|Adverse Event|10|||
44409276|NCT00686920|79416906|FG001|Overall Study|Adverse Event|2|||
44409277|NCT00686920|79416905|FG000|Overall Study|Personal Reason|0|||
44409278|NCT00686920|79416906|FG001|Overall Study|Personal Reason|1|||
44409279|NCT00686920|79416905|FG000|Overall Study|Lost to Follow-up|15|||
44409280|NCT00686920|79416906|FG001|Overall Study|Lost to Follow-up|3|||
44409281|NCT00686920|79416905|FG000|Overall Study|Moved to Another State|1|||
44409282|NCT00686920|79416906|FG001|Overall Study|Moved to Another State|0|||
44282130|NCT01614600|79245377|FG000|Overall Study|Protocol deviation|1|||
44409283|NCT00686920|79416905|FG000|Overall Study|Transferred to Nursing Home|1|||
44409284|NCT00686920|79416906|FG001|Overall Study|Transferred to Nursing Home|0|||
44409285|NCT00686920|79416905|FG000|Overall Study|Noncompliance|9|||
44409286|NCT00686920|79416906|FG001|Overall Study|Noncompliance|0|||
44409287|NCT00686920|79416905|FG000|Overall Study|Principal Investigator Decision|2|||
44409288|NCT00686920|79416906|FG001|Overall Study|Principal Investigator Decision|0|||
44409289|NCT00845832|79416915|FG000|Treatment Period|Adverse Event|0|||
44409290|NCT00845832|79416916|FG001|Treatment Period|Adverse Event|2|||
44409291|NCT00845832|79416917|FG002|Treatment Period|Adverse Event|0|||
44409292|NCT00845832|79416915|FG000|Treatment Period|Protocol Violation|1|||
44409293|NCT00845832|79416916|FG001|Treatment Period|Protocol Violation|1|||
44409294|NCT00845832|79416917|FG002|Treatment Period|Protocol Violation|0|||
44409295|NCT00845832|79416915|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
44409296|NCT00845832|79416916|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
44409297|NCT00845832|79416917|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
44409298|NCT00845832|79416915|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
44409299|NCT00845832|79416916|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
44409300|NCT00845832|79416917|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
44409301|NCT00591864|79416925|FG000|Overall Study|Incomplete Imaging|5|||
44409302|NCT00885755|79416933|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
44409303|NCT00885755|79416934|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
44409304|NCT00885755|79416935|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
44409305|NCT00885755|79416933|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
44409306|NCT00885755|79416934|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
44409307|NCT00885755|79416935|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
44409308|NCT00885755|79416933|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
44409309|NCT00885755|79416934|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
44409310|NCT00885755|79416935|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
44409311|NCT00885755|79416933|FG000|Part I: Trastuzumab+Taxane|Death|0|||
44409312|NCT00885755|79416934|FG001|Part I: Trastuzumab+Taxane|Death|0|||
44409313|NCT00885755|79416935|FG002|Part I: Trastuzumab+Taxane|Death|1|||
44409314|NCT00885755|79416933|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
44409315|NCT00885755|79416934|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
44409316|NCT00885755|79416935|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
44409317|NCT00837486|79416945|FG000|Blinded-treatment Phase|Physician Decision|1|||
44409318|NCT00837486|79416946|FG001|Blinded-treatment Phase|Physician Decision|0|||
44409319|NCT00837486|79416945|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
44409320|NCT00837486|79416946|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
44409321|NCT00837486|79416945|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
44409322|NCT00837486|79416946|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
44409323|NCT00837486|79416945|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
44409324|NCT00837486|79416946|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
44409325|NCT00845676|79416954|FG000|Overall Study|Virologic breakthrough at week 20|1|||
44409326|NCT00845676|79416954|FG000|Overall Study|Adverse Event|1|||
44409327|NCT00883181|79416959|FG000|Overall Study|Hematological Adverse Event|26|||
44409328|NCT00883181|79416959|FG000|Overall Study|Non-hematological Adverse Event|55|||
44409329|NCT00883181|79416959|FG000|Overall Study|Disease Progression|94|||
44409330|NCT00883181|79416959|FG000|Overall Study|Administrative Reason|24|||
44409331|NCT00883181|79416959|FG000|Overall Study|Withdrawal by Subject|4|||
44409332|NCT00883181|79416959|FG000|Overall Study|Death|31|||
44409333|NCT00883181|79416959|FG000|Overall Study|Other|38|||
44409334|NCT00883181|79416959|FG000|Overall Study|Protocol Deviation|3|||
44409335|NCT00883181|79416959|FG000|Overall Study|Noncompliance|3|||
44409336|NCT00845520|79416979|FG000|Overall Study|Death|1|||
44409337|NCT00845520|79416980|FG001|Overall Study|Death|2|||
44409338|NCT00845520|79416981|FG002|Overall Study|Death|0|||
44524697|NCT03274076|79533389|FG001|24 Weeks Open Label|Adverse Event|0|||
44524698|NCT03274076|79533390|FG002|24 Weeks Open Label|Adverse Event|2|||
44524699|NCT03274076|79533391|FG003|24 Weeks Open Label|Adverse Event|0|||
44524700|NCT03274076|79533388|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
44524701|NCT03274076|79533389|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
44524702|NCT03274076|79533390|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
44524703|NCT03274076|79533391|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
44282131|NCT01880736|79245385|FG000|Overall Study|Adverse Event|0|||
44282132|NCT01880736|79245386|FG001|Overall Study|Adverse Event|0|||
44409339|NCT00845520|79416979|FG000|Overall Study|Lost to Follow-up|1|||
44524704|NCT02797522|79533421|FG000|Overall Study|Study Terminated by Sponsor|0|||
44148229|NCT02453282|78937761|FG002|Overall Study|Lost to Follow-up|2|||
44148230|NCT02453282|78937759|FG000|Overall Study|Withdrawal by Subject|12|||
44148231|NCT02453282|78937760|FG001|Overall Study|Withdrawal by Subject|10|||
44148232|NCT02453282|78937761|FG002|Overall Study|Withdrawal by Subject|11|||
44148233|NCT02453282|78937759|FG000|Overall Study|Participants ongoing at data cut-off|85|||
44148234|NCT02453282|78937760|FG001|Overall Study|Participants ongoing at data cut-off|84|||
44409340|NCT00845520|79416980|FG001|Overall Study|Lost to Follow-up|0|||
44409341|NCT00845520|79416981|FG002|Overall Study|Lost to Follow-up|0|||
44409342|NCT00845520|79416979|FG000|Overall Study|Adverse Event|0|||
44409343|NCT00845520|79416980|FG001|Overall Study|Adverse Event|0|||
44409344|NCT00845520|79416981|FG002|Overall Study|Adverse Event|1|||
44409345|NCT00844896|79416997|FG000|Overall Study|Lost to Follow-up|12|||
44524705|NCT02797522|79533422|FG001|Overall Study|Study Terminated by Sponsor|0|||
44524706|NCT02797522|79533423|FG002|Overall Study|Study Terminated by Sponsor|0|||
44148235|NCT02453282|78937761|FG002|Overall Study|Participants ongoing at data cut-off|62|||
44148236|NCT02453282|78937759|FG000|Overall Study|Other|1|||
44148237|NCT02453282|78937760|FG001|Overall Study|Other|1|||
44148238|NCT02453282|78937761|FG002|Overall Study|Other|1|||
44524707|NCT02797522|79533424|FG003|Overall Study|Study Terminated by Sponsor|0|||
44524708|NCT02797522|79533425|FG004|Overall Study|Study Terminated by Sponsor|0|||
44524709|NCT02797522|79533426|FG005|Overall Study|Study Terminated by Sponsor|0|||
44524710|NCT02797522|79533427|FG006|Overall Study|Study Terminated by Sponsor|0|||
44524711|NCT02797522|79533428|FG007|Overall Study|Study Terminated by Sponsor|4|||
44524712|NCT02797522|79533429|FG008|Overall Study|Study Terminated by Sponsor|2|||
44524713|NCT02797522|79533430|FG009|Overall Study|Study Terminated by Sponsor|4|||
44524714|NCT02797522|79533431|FG010|Overall Study|Study Terminated by Sponsor|1|||
44524715|NCT02659514|79533461|FG000|Overall Study|Adverse Event|3|||
44524716|NCT02659514|79533462|FG001|Overall Study|Adverse Event|12|||
44524717|NCT02659514|79533461|FG000|Overall Study|Disease Progression|23|||
44524718|NCT02659514|79533462|FG001|Overall Study|Disease Progression|13|||
44524719|NCT02659514|79533461|FG000|Overall Study|Withdrawal by Subject|0|||
44524720|NCT02659514|79533462|FG001|Overall Study|Withdrawal by Subject|4|||
44524721|NCT02659514|79533461|FG000|Overall Study|Lost to Follow-up|0|||
44524722|NCT02659514|79533462|FG001|Overall Study|Lost to Follow-up|1|||
44524723|NCT02659514|79533461|FG000|Overall Study|Death|6|||
44524724|NCT02659514|79533462|FG001|Overall Study|Death|1|||
44524725|NCT02659514|79533461|FG000|Overall Study|Reason Unspecified|0|||
44524726|NCT02659514|79533462|FG001|Overall Study|Reason Unspecified|3|||
44148239|NCT02296125|78937773|FG000|Overall Study|Withdrawal by Subject|18|||
44409346|NCT00844896|79416998|FG001|Overall Study|Lost to Follow-up|16|||
44409347|NCT00844896|79416997|FG000|Overall Study|Parents did not have time to complete|0|||
44409348|NCT00844896|79416998|FG001|Overall Study|Parents did not have time to complete|1|||
44409349|NCT00827502|79417005|FG000|Overall Study|randomized but not treated|11|||
44409350|NCT00827502|79417005|FG000|Overall Study|Adverse Event|1|||
44409351|NCT00827502|79417005|FG000|Overall Study|Lost to Follow-up|4|||
44409352|NCT00827502|79417005|FG000|Overall Study|Withdrawal by Subject|5|||
44409353|NCT00837330|79417011|FG000|Overall Study|Lost to Follow-up|1|||
44409354|NCT00837330|79417012|FG001|Overall Study|Lost to Follow-up|3|||
44409355|NCT00837096|79417020|FG000|Overall Study|Physician Decision|1|||
44409356|NCT00837096|79417021|FG001|Overall Study|Physician Decision|1|||
44409357|NCT00837096|79417020|FG000|Overall Study|Not reported|9|||
44409358|NCT00837096|79417021|FG001|Overall Study|Not reported|8|||
44409359|NCT00885677|79417029|FG000|Overall Study|Death|40|||
44409360|NCT00885677|79417030|FG001|Overall Study|Death|34|||
44409361|NCT00885677|79417029|FG000|Overall Study|Lost to Follow-up|15|||
44409362|NCT00885677|79417030|FG001|Overall Study|Lost to Follow-up|13|||
44409363|NCT00885677|79417029|FG000|Overall Study|Protocol Violation|54|||
44409364|NCT00885677|79417030|FG001|Overall Study|Protocol Violation|54|||
44409365|NCT00885677|79417029|FG000|Overall Study|premature study closure|41|||
44409366|NCT00885677|79417030|FG001|Overall Study|premature study closure|44|||
44409367|NCT00885677|79417029|FG000|Overall Study|device/lead revision or replacement|7|||
44409368|NCT00885677|79417030|FG001|Overall Study|device/lead revision or replacement|6|||
44524727|NCT04570670|79533470|FG000|Overall Study|Withdrawal by Subject|1|||
44524728|NCT04570670|79533471|FG001|Overall Study|Withdrawal by Subject|0|||
44524729|NCT02797132|79533477|FG000|Part A (15 Days)|Adverse Event|1|||
44524730|NCT02797132|79533477|FG000|Part B (24 Weeks)|Adverse Event|3|||
44524731|NCT03270644|79533490|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
44524732|NCT03270644|79533490|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
44524733|NCT03269552|79533501|FG000|Overall Study|Adverse Event|2|||
44524734|NCT02796664|79533508|FG000|Overall Study|Withdrawal by Subject|0|||
44524735|NCT02796664|79533509|FG001|Overall Study|Withdrawal by Subject|3|||
44524736|NCT02796664|79533508|FG000|Overall Study|Noncompliance|1|||
44524737|NCT02796664|79533509|FG001|Overall Study|Noncompliance|1|||
44524738|NCT02796664|79533508|FG000|Overall Study|Death|0|||
44524739|NCT02796664|79533509|FG001|Overall Study|Death|1|||
44524740|NCT04233879|79533519|FG000|Overall Study|Death|2|||
44524741|NCT04233879|79533520|FG001|Overall Study|Death|0|||
44148240|NCT02296125|78937774|FG001|Overall Study|Withdrawal by Subject|8|||
44253698|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
44253699|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
44409369|NCT00885677|79417029|FG000|Overall Study|Heart transplantation|1|||
44409370|NCT00885677|79417030|FG001|Overall Study|Heart transplantation|0|||
44409371|NCT00885677|79417029|FG000|Overall Study|Inclusion/exclusion not met|25|||
44524742|NCT04233879|79533519|FG000|Overall Study|Lost to Follow-up|3|||
44524743|NCT04233879|79533520|FG001|Overall Study|Lost to Follow-up|8|||
44524744|NCT04233879|79533519|FG000|Overall Study|Physician Decision|4|||
44524745|NCT04233879|79533520|FG001|Overall Study|Physician Decision|4|||
44148241|NCT02296125|78937775|FG002|Overall Study|Withdrawal by Subject|6|||
44409372|NCT00885677|79417030|FG001|Overall Study|Inclusion/exclusion not met|27|||
44409373|NCT00885365|79417038|FG000|4 Weeks ON Treatment|Adverse Event|2|||
44524746|NCT04233879|79533519|FG000|Overall Study|Withdrawal by Subject|7|||
44524747|NCT04233879|79533520|FG001|Overall Study|Withdrawal by Subject|10|||
44524748|NCT04233879|79533519|FG000|Overall Study|Other|281|||
44524749|NCT04233879|79533520|FG001|Overall Study|Other|279|||
44524750|NCT01370356|79533528|FG000|Overall Study|Death|1|||
44524751|NCT01370356|79533529|FG001|Overall Study|Death|0|||
44524752|NCT01370356|79533528|FG000|Overall Study|Lack of Efficacy|6|||
44409374|NCT00885365|79417039|FG001|4 Weeks ON Treatment|Adverse Event|4|||
44409375|NCT00885365|79417038|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
44409376|NCT00885365|79417039|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
44409377|NCT00885365|79417038|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
44148242|NCT02296125|78937776|FG003|Overall Study|Withdrawal by Subject|2|||
44148243|NCT02296125|78937773|FG000|Overall Study|Adverse Event|41|||
44409378|NCT00885365|79417039|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
44409379|NCT00827112|79417047|FG000|Overall Study|Adverse Event|2|||
44409380|NCT00827112|79417048|FG001|Overall Study|Adverse Event|0|||
44409381|NCT00827112|79417047|FG000|Overall Study|Lack of Efficacy|2|||
44409382|NCT00827112|79417048|FG001|Overall Study|Lack of Efficacy|0|||
44409383|NCT00827112|79417047|FG000|Overall Study|Lost to Follow-up|3|||
44409384|NCT00827112|79417048|FG001|Overall Study|Lost to Follow-up|2|||
44409385|NCT00827112|79417047|FG000|Overall Study|Pregnancy|0|||
44409386|NCT00827112|79417048|FG001|Overall Study|Pregnancy|1|||
44409387|NCT00827112|79417047|FG000|Overall Study|Protocol Violation|0|||
44409388|NCT00827112|79417048|FG001|Overall Study|Protocol Violation|2|||
44409389|NCT00827112|79417047|FG000|Overall Study|Withdrawal by Subject|2|||
44409390|NCT00827112|79417048|FG001|Overall Study|Withdrawal by Subject|1|||
44409391|NCT00827112|79417047|FG000|Overall Study|Randomized but not treated|5|||
44409392|NCT00827112|79417048|FG001|Overall Study|Randomized but not treated|3|||
44409393|NCT00827112|79417047|FG000|Overall Study|Other|1|||
44409394|NCT00827112|79417048|FG001|Overall Study|Other|3|||
44409395|NCT00689104|79417058|FG000|Overall Study|Eligibility criterion not met|5|||
44409396|NCT00689104|79417059|FG001|Overall Study|Eligibility criterion not met|8|||
44409397|NCT00689104|79417060|FG002|Overall Study|Eligibility criterion not met|0|||
44409398|NCT00689104|79417061|FG003|Overall Study|Eligibility criterion not met|4|||
44409399|NCT00689104|79417058|FG000|Overall Study|Adverse Event|13|||
44409400|NCT00689104|79417059|FG001|Overall Study|Adverse Event|25|||
44409401|NCT00689104|79417060|FG002|Overall Study|Adverse Event|16|||
44409402|NCT00689104|79417061|FG003|Overall Study|Adverse Event|24|||
44409403|NCT00689104|79417058|FG000|Overall Study|Lack of Efficacy|5|||
44409404|NCT00689104|79417059|FG001|Overall Study|Lack of Efficacy|6|||
44409405|NCT00689104|79417060|FG002|Overall Study|Lack of Efficacy|2|||
44409406|NCT00689104|79417061|FG003|Overall Study|Lack of Efficacy|3|||
44409407|NCT00689104|79417058|FG000|Overall Study|Withdrawal by Subject|12|||
44409408|NCT00689104|79417059|FG001|Overall Study|Withdrawal by Subject|11|||
44409409|NCT00689104|79417060|FG002|Overall Study|Withdrawal by Subject|18|||
44409410|NCT00689104|79417061|FG003|Overall Study|Withdrawal by Subject|11|||
44409411|NCT00689104|79417058|FG000|Overall Study|Lost to Follow-up|4|||
44409412|NCT00689104|79417059|FG001|Overall Study|Lost to Follow-up|3|||
44409413|NCT00689104|79417060|FG002|Overall Study|Lost to Follow-up|2|||
44409414|NCT00689104|79417061|FG003|Overall Study|Lost to Follow-up|5|||
44409415|NCT00689104|79417058|FG000|Overall Study|Protocol Violation|2|||
44409416|NCT00689104|79417059|FG001|Overall Study|Protocol Violation|3|||
44409417|NCT00689104|79417060|FG002|Overall Study|Protocol Violation|5|||
44409418|NCT00689104|79417061|FG003|Overall Study|Protocol Violation|3|||
44409419|NCT00689104|79417058|FG000|Overall Study|Randomized but never received study drug|2|||
44409420|NCT00689104|79417059|FG001|Overall Study|Randomized but never received study drug|1|||
44409421|NCT00689104|79417060|FG002|Overall Study|Randomized but never received study drug|1|||
44409422|NCT00689104|79417061|FG003|Overall Study|Randomized but never received study drug|0|||
44409423|NCT00689104|79417058|FG000|Overall Study|Physician Decision|1|||
44409424|NCT00689104|79417059|FG001|Overall Study|Physician Decision|0|||
44409425|NCT00689104|79417060|FG002|Overall Study|Physician Decision|0|||
44409426|NCT00689104|79417061|FG003|Overall Study|Physician Decision|0|||
44524753|NCT01370356|79533529|FG001|Overall Study|Lack of Efficacy|28|||
44524754|NCT01370356|79533528|FG000|Overall Study|Lost to Follow-up|76|||
44524755|NCT01370356|79533529|FG001|Overall Study|Lost to Follow-up|81|||
44524756|NCT01370356|79533528|FG000|Overall Study|Withdrawal by Subject|54|||
44148244|NCT02296125|78937774|FG001|Overall Study|Adverse Event|52|||
44409427|NCT00689104|79417058|FG000|Overall Study|Non-compliance with study procedures|0|||
44409428|NCT00689104|79417059|FG001|Overall Study|Non-compliance with study procedures|0|||
44409429|NCT00689104|79417060|FG002|Overall Study|Non-compliance with study procedures|1|||
44409430|NCT00689104|79417061|FG003|Overall Study|Non-compliance with study procedures|0|||
44409431|NCT00689026|79417073|FG000|Overall Study|Withdrawal by Subject|13|||
44409432|NCT00689026|79417074|FG001|Overall Study|Withdrawal by Subject|6|||
44409433|NCT00598559|79417083|FG000|Overall Study|Adverse Event|11|||
44409434|NCT00598559|79417084|FG001|Overall Study|Adverse Event|7|||
44409435|NCT00598559|79417085|FG002|Overall Study|Adverse Event|0|||
44524757|NCT01370356|79533529|FG001|Overall Study|Withdrawal by Subject|59|||
44409436|NCT00598559|79417083|FG000|Overall Study|Withdrawal by Subject|2|||
44409437|NCT00598559|79417084|FG001|Overall Study|Withdrawal by Subject|2|||
44409438|NCT00598559|79417085|FG002|Overall Study|Withdrawal by Subject|0|||
44409439|NCT00598559|79417083|FG000|Overall Study|Protocol Non-compliance|1|||
44253700|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
44409440|NCT00598559|79417084|FG001|Overall Study|Protocol Non-compliance|0|||
44409441|NCT00598559|79417085|FG002|Overall Study|Protocol Non-compliance|0|||
44409442|NCT00598559|79417083|FG000|Overall Study|Early discharge from hospital|9|||
44409443|NCT00598559|79417084|FG001|Overall Study|Early discharge from hospital|12|||
44409444|NCT00598559|79417085|FG002|Overall Study|Early discharge from hospital|3|||
44409445|NCT00598559|79417083|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
44409446|NCT00598559|79417084|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
44409447|NCT00598559|79417085|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
44409448|NCT00686686|79417093|FG000|Overall Study|Non-compliance|1|||
44409449|NCT00686686|79417093|FG000|Overall Study|Adverse Event|2|||
44409450|NCT00686686|79417093|FG000|Overall Study|Lost to Follow-up|3|||
44409451|NCT04160195|79417099|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
44409452|NCT04160195|79417100|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
44409453|NCT00686374|79417108|FG000|Overall Study|Lack of Efficacy|10|||
44409454|NCT00686374|79417108|FG000|Overall Study|Adverse Event|8|||
44409455|NCT00686374|79417108|FG000|Overall Study|Withdrew consent|5|||
44409456|NCT00686374|79417108|FG000|Overall Study|Lost to Follow-up|1|||
44409457|NCT00686374|79417108|FG000|Overall Study|Missing reason|33|||
44409458|NCT00686374|79417108|FG000|Overall Study|Other, not specified|4|||
44409459|NCT00571948|79417114|FG000|Overall Study|Lost to Follow-up|2|||
44409460|NCT00571948|79417115|FG001|Overall Study|Lost to Follow-up|0|||
44409461|NCT00571948|79417114|FG000|Overall Study|Withdrawal by Subject|1|||
44409462|NCT00571948|79417115|FG001|Overall Study|Withdrawal by Subject|2|||
44409463|NCT00571948|79417114|FG000|Overall Study|Protocol Violation|3|||
44409464|NCT00571948|79417115|FG001|Overall Study|Protocol Violation|3|||
44524758|NCT01370356|79533528|FG000|Overall Study|Reason not specified|39|||
44524759|NCT01370356|79533529|FG001|Overall Study|Reason not specified|43|||
44524760|NCT01370356|79533528|FG000|Overall Study|Protocol Violation|3|||
44524761|NCT01370356|79533529|FG001|Overall Study|Protocol Violation|3|||
44524762|NCT01370356|79533528|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
44524763|NCT01370356|79533529|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
44524764|NCT01370356|79533528|FG000|Overall Study|AE Not Related to Study Drug|1|||
44524765|NCT01370356|79533529|FG001|Overall Study|AE Not Related to Study Drug|4|||
44524766|NCT02794870|79533537|FG000|Overall Study|Withdrawal by Subject|2|||
44524767|NCT02794870|79533538|FG001|Overall Study|Withdrawal by Subject|0|||
44524768|NCT01370590|79533546|FG000|Period 1|Adverse Event|8|||
44524769|NCT01370590|79533547|FG001|Period 1|Adverse Event|4|||
44524770|NCT01370590|79533546|FG000|Period 1|Lost to Follow-up|2|||
44253701|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
44524771|NCT01370590|79533547|FG001|Period 1|Lost to Follow-up|2|||
44253702|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
44253703|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253704|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253705|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253706|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253707|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
44253708|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253709|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253710|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253711|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253712|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
44409465|NCT00571948|79417114|FG000|Overall Study|infant refused study meal|3|||
44409466|NCT00571948|79417115|FG001|Overall Study|infant refused study meal|4|||
44409467|NCT00571948|79417114|FG000|Overall Study|Parent were afraid of blood colection|2|||
44524772|NCT01370590|79533546|FG000|Period 1|Protocol Violation|2|||
44524773|NCT01370590|79533547|FG001|Period 1|Protocol Violation|2|||
44409468|NCT00571948|79417115|FG001|Overall Study|Parent were afraid of blood colection|5|||
44409469|NCT00684424|79417121|FG000|Overall Study|Adverse Event|1|||
44409470|NCT00684424|79417121|FG000|Overall Study|Lost to Follow-up|2|||
44409471|NCT00684424|79417121|FG000|Overall Study|Other|2|||
44409472|NCT00685750|79417133|FG000|Overall Study|Tumor sampling failure|0|||
44409473|NCT00685750|79417134|FG001|Overall Study|Tumor sampling failure|0|||
44409474|NCT00685750|79417135|FG002|Overall Study|Tumor sampling failure|1|||
44409475|NCT00685750|79417136|FG003|Overall Study|Tumor sampling failure|0|||
44409476|NCT00685750|79417137|FG004|Overall Study|Tumor sampling failure|0|||
44409477|NCT00685750|79417138|FG005|Overall Study|Tumor sampling failure|0|||
44409478|NCT00685750|79417139|FG006|Overall Study|Tumor sampling failure|0|||
44524774|NCT01370590|79533546|FG000|Period 1|Withdrawal by Subject|4|||
44524775|NCT01370590|79533547|FG001|Period 1|Withdrawal by Subject|2|||
44524776|NCT01370590|79533546|FG000|Period 1|Could not access randomization system|0|||
44524777|NCT01370590|79533547|FG001|Period 1|Could not access randomization system|1|||
44524778|NCT01370590|79533546|FG000|Crossover Washout Period|Adverse Event|1|||
44524779|NCT01370590|79533547|FG001|Crossover Washout Period|Adverse Event|4|||
44524780|NCT01370590|79533546|FG000|Crossover Washout Period|Lost to Follow-up|2|||
44524781|NCT01370590|79533547|FG001|Crossover Washout Period|Lost to Follow-up|0|||
44524782|NCT01370590|79533546|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
44524783|NCT01370590|79533547|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
44148245|NCT02296125|78937775|FG002|Overall Study|Adverse Event|9|||
44148246|NCT02296125|78937776|FG003|Overall Study|Adverse Event|4|||
44148247|NCT02296125|78937773|FG000|Overall Study|Severe non-compliance to protocol|0|||
44148248|NCT02296125|78937774|FG001|Overall Study|Severe non-compliance to protocol|1|||
44148249|NCT02296125|78937775|FG002|Overall Study|Severe non-compliance to protocol|0|||
44148250|NCT02296125|78937776|FG003|Overall Study|Severe non-compliance to protocol|0|||
44148251|NCT02296125|78937773|FG000|Overall Study|Condition under investigation worsened|153|||
44148252|NCT02296125|78937774|FG001|Overall Study|Condition under investigation worsened|199|||
44148253|NCT02296125|78937775|FG002|Overall Study|Condition under investigation worsened|39|||
44148254|NCT02296125|78937776|FG003|Overall Study|Condition under investigation worsened|56|||
44148255|NCT02296125|78937773|FG000|Overall Study|Any reason not specifically recorded|6|||
44148256|NCT02296125|78937774|FG001|Overall Study|Any reason not specifically recorded|4|||
44148257|NCT02296125|78937775|FG002|Overall Study|Any reason not specifically recorded|2|||
44148258|NCT02296125|78937776|FG003|Overall Study|Any reason not specifically recorded|0|||
44148259|NCT02286089|78937791|FG000|Overall Study|Ongoing in Study|1|||
44148260|NCT02286089|78937792|FG001|Overall Study|Ongoing in Study|1|||
44148261|NCT02286089|78937793|FG002|Overall Study|Ongoing in Study|4|||
44148262|NCT02286089|78937794|FG003|Overall Study|Ongoing in Study|10|||
44148263|NCT02286089|78937791|FG000|Overall Study|Withdrawal by Subject|0|||
44148264|NCT02286089|78937792|FG001|Overall Study|Withdrawal by Subject|0|||
44148265|NCT02286089|78937793|FG002|Overall Study|Withdrawal by Subject|2|||
44148266|NCT02286089|78937794|FG003|Overall Study|Withdrawal by Subject|2|||
44148267|NCT02087423|78937807|FG000|Overall Study|Withdrawal by Subject|20|||
44148268|NCT02087423|78937808|FG001|Overall Study|Withdrawal by Subject|20|||
44148269|NCT02087423|78937809|FG002|Overall Study|Withdrawal by Subject|3|||
44148270|NCT02087423|78937807|FG000|Overall Study|Death|68|||
44148271|NCT02087423|78937808|FG001|Overall Study|Death|207|||
44148272|NCT02087423|78937809|FG002|Overall Study|Death|40|||
44148273|NCT02087423|78937807|FG000|Overall Study|Lost to Follow-up|0|||
44148274|NCT02087423|78937808|FG001|Overall Study|Lost to Follow-up|2|||
44148275|NCT02087423|78937809|FG002|Overall Study|Lost to Follow-up|0|||
44148276|NCT02087423|78937807|FG000|Overall Study|Terminated from study at final DCO|23|||
44148277|NCT02087423|78937808|FG001|Overall Study|Terminated from study at final DCO|36|||
44148278|NCT02087423|78937809|FG002|Overall Study|Terminated from study at final DCO|25|||
44148279|NCT01874353|78937821|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
44148280|NCT01874353|78937822|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
44148281|NCT01874353|78937823|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
44148282|NCT01874353|78937824|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
44148283|NCT01874353|78937821|FG000|Overall Study|Lost to Follow-up|2|||
44148284|NCT01874353|78937822|FG001|Overall Study|Lost to Follow-up|2|||
44148285|NCT01874353|78937823|FG002|Overall Study|Lost to Follow-up|2|||
44148286|NCT01874353|78937824|FG003|Overall Study|Lost to Follow-up|0|||
44148287|NCT01874353|78937821|FG000|Overall Study|Death|110|||
44148288|NCT01874353|78937822|FG001|Overall Study|Death|60|||
44148289|NCT01874353|78937823|FG002|Overall Study|Death|13|||
44148290|NCT01874353|78937824|FG003|Overall Study|Death|7|||
44409479|NCT00685750|79417133|FG000|Overall Study|Patient didn't receive the treatment|0|||
44148291|NCT01874353|78937821|FG000|Overall Study|Withdrawal by Subject|13|||
44148292|NCT01874353|78937822|FG001|Overall Study|Withdrawal by Subject|11|||
44148293|NCT01874353|78937823|FG002|Overall Study|Withdrawal by Subject|0|||
44148294|NCT01874353|78937824|FG003|Overall Study|Withdrawal by Subject|0|||
44409480|NCT00685750|79417134|FG001|Overall Study|Patient didn't receive the treatment|0|||
44409481|NCT00685750|79417135|FG002|Overall Study|Patient didn't receive the treatment|0|||
44409482|NCT00685750|79417136|FG003|Overall Study|Patient didn't receive the treatment|0|||
44409483|NCT00685750|79417137|FG004|Overall Study|Patient didn't receive the treatment|0|||
44409484|NCT00685750|79417138|FG005|Overall Study|Patient didn't receive the treatment|0|||
44409485|NCT00685750|79417139|FG006|Overall Study|Patient didn't receive the treatment|1|||
44409486|NCT00685750|79417133|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44409487|NCT00685750|79417134|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44409488|NCT00685750|79417135|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
44409489|NCT00685750|79417136|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
44409490|NCT00685750|79417137|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
44409491|NCT00685750|79417138|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
44409492|NCT00685750|79417139|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
44409493|NCT00576628|79417159|FG000|Overall Study|Adverse Event|11|||
44409494|NCT00576628|79417159|FG000|Overall Study|Death|2|||
44409495|NCT00576628|79417159|FG000|Overall Study|Failure to return|1|||
44409496|NCT00576628|79417159|FG000|Overall Study|Refused Treatment|8|||
44409497|NCT00576628|79417159|FG000|Overall Study|Pregnancy|1|||
44409498|NCT00576628|79417159|FG000|Overall Study|RBC transfusion|1|||
44409499|NCT00576628|79417159|FG000|Overall Study|Progression of Kidney Disease|1|||
44409500|NCT00576628|79417159|FG000|Overall Study|Progression of Renal Failure|1|||
44409501|NCT00576628|79417159|FG000|Overall Study|The patient move into other town|1|||
44409502|NCT00576628|79417159|FG000|Overall Study|Transplantation|1|||
44409503|NCT00576628|79417159|FG000|Overall Study|Dialysis|15|||
44409504|NCT00683878|79417167|FG000|Overall Study|Lack of Efficacy|3|||
44409505|NCT00683878|79417168|FG001|Overall Study|Lack of Efficacy|0|||
44409506|NCT00683878|79417169|FG002|Overall Study|Lack of Efficacy|1|||
44409507|NCT00683878|79417167|FG000|Overall Study|Adverse Event|4|||
44409508|NCT00683878|79417168|FG001|Overall Study|Adverse Event|3|||
44409509|NCT00683878|79417169|FG002|Overall Study|Adverse Event|3|||
44409510|NCT00683878|79417167|FG000|Overall Study|Withdrawal by Subject|9|||
44409511|NCT00683878|79417168|FG001|Overall Study|Withdrawal by Subject|8|||
44409512|NCT00683878|79417169|FG002|Overall Study|Withdrawal by Subject|6|||
44409513|NCT00683878|79417167|FG000|Overall Study|Death|0|||
44409514|NCT00683878|79417168|FG001|Overall Study|Death|1|||
44409515|NCT00683878|79417169|FG002|Overall Study|Death|0|||
44409516|NCT00683878|79417167|FG000|Overall Study|Lost to Follow-up|4|||
44409517|NCT00683878|79417168|FG001|Overall Study|Lost to Follow-up|2|||
44409518|NCT00683878|79417169|FG002|Overall Study|Lost to Follow-up|4|||
44409519|NCT00683878|79417167|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
44409520|NCT00683878|79417168|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
44409521|NCT00683878|79417169|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
44409522|NCT00884741|79417180|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
44409523|NCT00884741|79417181|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
44409524|NCT00884741|79417182|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
44409525|NCT00884741|79417183|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
44409526|NCT00884741|79417180|FG000|Step 1 Registration: Tissue Screening|Death|3|||
44409527|NCT00884741|79417181|FG001|Step 1 Registration: Tissue Screening|Death|0|||
44409528|NCT00884741|79417182|FG002|Step 1 Registration: Tissue Screening|Death|0|||
44409529|NCT00884741|79417183|FG003|Step 1 Registration: Tissue Screening|Death|0|||
44409530|NCT00884741|79417180|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
44409531|NCT00884741|79417181|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
44409532|NCT00884741|79417182|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
44409533|NCT00884741|79417183|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
44409534|NCT00884741|79417180|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
44409535|NCT00884741|79417181|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
44409536|NCT00884741|79417182|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
44409537|NCT00884741|79417183|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
44409538|NCT00884741|79417180|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
44409539|NCT00884741|79417181|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
44409540|NCT00884741|79417182|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
44524784|NCT01370590|79533546|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
44524785|NCT01370590|79533547|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
44409541|NCT00884741|79417183|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
44409542|NCT00884741|79417180|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
44409543|NCT00884741|79417181|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
44409544|NCT00884741|79417182|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
44409545|NCT00884741|79417183|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
44409546|NCT00884741|79417180|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
44524786|NCT01370590|79533546|FG000|Period 2|Adverse Event|0|||
44148295|NCT01802632|78937842|FG000|Overall Study|Death|28|||
44409547|NCT00884741|79417181|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
44524787|NCT01370590|79533547|FG001|Period 2|Adverse Event|1|||
44409548|NCT00884741|79417182|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
44409549|NCT00884741|79417183|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
44409550|NCT00884741|79417180|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
44409551|NCT00884741|79417181|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
44409552|NCT00884741|79417182|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
44409553|NCT00884741|79417183|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
44409554|NCT00884741|79417180|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
44409555|NCT00884741|79417181|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
44409556|NCT00884741|79417182|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
44409557|NCT00884741|79417183|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
44409558|NCT00884741|79417180|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
44409559|NCT00884741|79417181|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
44409560|NCT00884741|79417182|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
44409561|NCT00884741|79417183|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
44409562|NCT00884741|79417180|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
44409563|NCT00884741|79417181|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
44409564|NCT00884741|79417182|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
44409565|NCT00884741|79417183|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
44409566|NCT00884741|79417180|FG000|Randomization|Protocol Violation|0|||
44409567|NCT00884741|79417181|FG001|Randomization|Protocol Violation|0|||
44409568|NCT00884741|79417182|FG002|Randomization|Protocol Violation|8|||
44409569|NCT00884741|79417183|FG003|Randomization|Protocol Violation|8|||
44409570|NCT00880763|79417194|FG000|Extension Period (Part 2)|Adverse Event|0|||
44409571|NCT00880763|79417195|FG001|Extension Period (Part 2)|Adverse Event|0|||
44409572|NCT00880763|79417196|FG002|Extension Period (Part 2)|Adverse Event|1|||
44409573|NCT00880763|79417197|FG003|Extension Period (Part 2)|Adverse Event|1|||
44409574|NCT00880763|79417194|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
44409575|NCT00880763|79417195|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
44409576|NCT00880763|79417196|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
44409577|NCT00880763|79417197|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
44409578|NCT00880763|79417194|FG000|Extension Period (Part 2)|Physician Decision|0|||
44409579|NCT00880763|79417195|FG001|Extension Period (Part 2)|Physician Decision|1|||
44409580|NCT00880763|79417196|FG002|Extension Period (Part 2)|Physician Decision|1|||
44409581|NCT00880763|79417197|FG003|Extension Period (Part 2)|Physician Decision|0|||
44409582|NCT00880763|79417194|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
44409583|NCT00880763|79417195|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
44409584|NCT00880763|79417196|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
44409585|NCT00880763|79417197|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
44409586|NCT00884273|79417209|FG000|Overall Study|Adverse Event|0|||
44409587|NCT00884273|79417210|FG001|Overall Study|Adverse Event|2|||
44409588|NCT00884273|79417209|FG000|Overall Study|Protocol Violation|1|||
44409589|NCT00884273|79417210|FG001|Overall Study|Protocol Violation|3|||
44409590|NCT00884273|79417209|FG000|Overall Study|Practical reasons|1|||
44409591|NCT00884273|79417210|FG001|Overall Study|Practical reasons|0|||
44409592|NCT00884117|79417216|FG000|Overall Study|Adverse Event|2|||
44409593|NCT00884117|79417216|FG000|Overall Study|Withdrawal by Subject|89|||
44409594|NCT00884117|79417216|FG000|Overall Study|Death|3|||
44409595|NCT00884117|79417216|FG000|Overall Study|Lost to Follow-up|143|||
44409596|NCT00884117|79417216|FG000|Overall Study|Other|12|||
44409597|NCT00884039|79417235|FG000|Overall Study|Withdrawal by Subject|0|||
44409598|NCT00884039|79417236|FG001|Overall Study|Withdrawal by Subject|1|||
44409599|NCT00884039|79417235|FG000|Overall Study|Lack of Efficacy|2|||
44409600|NCT00884039|79417236|FG001|Overall Study|Lack of Efficacy|0|||
44409601|NCT00835770|79417244|FG000|Overall Study|MS Relapse|17|||
44409602|NCT00835770|79417245|FG001|Overall Study|MS Relapse|23|||
44409603|NCT00835770|79417244|FG000|Overall Study|MS Progression|14|||
44409604|NCT00835770|79417245|FG001|Overall Study|MS Progression|9|||
44409605|NCT00835770|79417244|FG000|Overall Study|Adverse Event|113|||
44409606|NCT00835770|79417245|FG001|Overall Study|Adverse Event|124|||
44409607|NCT00835770|79417244|FG000|Overall Study|Lost to Follow-up|22|||
44409608|NCT00835770|79417245|FG001|Overall Study|Lost to Follow-up|19|||
44409609|NCT00835770|79417244|FG000|Overall Study|Consent Withdrawn|144|||
44409610|NCT00835770|79417245|FG001|Overall Study|Consent Withdrawn|156|||
44253713|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44524788|NCT01370590|79533546|FG000|Period 2|Withdrawal by Subject|1|||
44253714|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253715|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253716|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253717|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44409611|NCT00835770|79417244|FG000|Overall Study|Investigator Decision|42|||
44409612|NCT00835770|79417245|FG001|Overall Study|Investigator Decision|42|||
44409613|NCT00835770|79417244|FG000|Overall Study|Participant Non-Compliance|11|||
44524789|NCT01370590|79533547|FG001|Period 2|Withdrawal by Subject|1|||
44409614|NCT00835770|79417245|FG001|Overall Study|Participant Non-Compliance|9|||
44409615|NCT00835770|79417244|FG000|Overall Study|Death|4|||
44409616|NCT00835770|79417245|FG001|Overall Study|Death|6|||
44409617|NCT00835770|79417244|FG000|Overall Study|Other|115|||
44409618|NCT00835770|79417245|FG001|Overall Study|Other|104|||
44409619|NCT00835770|79417244|FG000|Overall Study|Other|2|||
44409620|NCT00835770|79417245|FG001|Overall Study|Other|1|||
44409621|NCT00880685|79417257|FG000|Memantine 10mg|Lost to Follow-up|2|||
44409622|NCT00880685|79417257|FG000|Memantine 20mg|Withdrawal by Subject|1|||
44409623|NCT00835380|79417264|FG000|Overall Study|Withdrawal by Subject|2|||
44409624|NCT00880607|79417270|FG000|Overall Study|Physician Decision|2|||
44409625|NCT00880607|79417271|FG001|Overall Study|Physician Decision|2|||
44409626|NCT00880607|79417270|FG000|Overall Study|Protocol Violation|2|||
44409627|NCT00880607|79417271|FG001|Overall Study|Protocol Violation|1|||
44409628|NCT00880607|79417270|FG000|Overall Study|surgery did not extend past L1 level|3|||
44409629|NCT00880607|79417271|FG001|Overall Study|surgery did not extend past L1 level|0|||
44409630|NCT00835068|79417281|FG000|Overall Study|Death|1|||
44409631|NCT00835068|79417282|FG001|Overall Study|Death|0|||
44409632|NCT00835068|79417281|FG000|Overall Study|Adverse Event|0|||
44524790|NCT05200455|79533558|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
44524791|NCT04646109|79533565|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
44524792|NCT04646109|79533566|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
44524793|NCT04502979|79533575|FG000|Overall Study|Lost to Follow-up|1|||
44524794|NCT04502979|79533576|FG001|Overall Study|Lost to Follow-up|3|||
44409633|NCT00835068|79417282|FG001|Overall Study|Adverse Event|1|||
44409634|NCT00835068|79417281|FG000|Overall Study|Other|8|||
44409635|NCT00835068|79417282|FG001|Overall Study|Other|0|||
44409636|NCT00835068|79417281|FG000|Overall Study|Withdrawal by Subject|1|||
44409637|NCT00835068|79417282|FG001|Overall Study|Withdrawal by Subject|0|||
44409638|NCT00834912|79417294|FG000|Treatment Period 1|Adverse Event|0|||
44409639|NCT00834912|79417295|FG001|Treatment Period 1|Adverse Event|1|||
44409640|NCT00834912|79417296|FG002|Treatment Period 1|Adverse Event|0|||
44409641|NCT00834912|79417297|FG003|Treatment Period 1|Adverse Event|1|||
44409642|NCT00834912|79417298|FG004|Treatment Period 1|Adverse Event|0|||
44409643|NCT00834912|79417299|FG005|Treatment Period 1|Adverse Event|0|||
44409644|NCT00834912|79417294|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44409645|NCT00834912|79417295|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44409646|NCT00834912|79417296|FG002|Treatment Period 2|Withdrawal by Subject|1|||
44409647|NCT00834912|79417297|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44409648|NCT00834912|79417298|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44409649|NCT00834912|79417299|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44409650|NCT00883493|79417309|FG000|Overall Study|Adverse Event|11|||
44409651|NCT00883493|79417310|FG001|Overall Study|Adverse Event|12|||
44409652|NCT00883493|79417309|FG000|Overall Study|Lack of Efficacy|4|||
44409653|NCT00883493|79417310|FG001|Overall Study|Lack of Efficacy|3|||
44524795|NCT04502979|79533575|FG000|Overall Study|Withdrawal by Subject|2|||
44524796|NCT04502979|79533576|FG001|Overall Study|Withdrawal by Subject|1|||
44524797|NCT04590027|79533584|FG000|Overall Study|Lost to Follow-up|17|||
44409654|NCT00883493|79417309|FG000|Overall Study|Lost to Follow-up|7|||
44409655|NCT00883493|79417310|FG001|Overall Study|Lost to Follow-up|6|||
44409656|NCT00883493|79417309|FG000|Overall Study|Withdrawal by Subject|11|||
44409657|NCT00883493|79417310|FG001|Overall Study|Withdrawal by Subject|20|||
44409658|NCT00883493|79417309|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
44409659|NCT00883493|79417310|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
44524798|NCT04590027|79533585|FG001|Overall Study|Lost to Follow-up|14|||
44409660|NCT00883493|79417309|FG000|Overall Study|Study specific disc. criteria|2|||
44409661|NCT00883493|79417310|FG001|Overall Study|Study specific disc. criteria|0|||
44524799|NCT04590027|79533584|FG000|Overall Study|Protocol Violation|0|||
44524800|NCT04590027|79533585|FG001|Overall Study|Protocol Violation|3|||
44409662|NCT00883493|79417309|FG000|Overall Study|Other|5|||
44409663|NCT00883493|79417310|FG001|Overall Study|Other|3|||
44409664|NCT04887922|79417325|FG000|1st Randomization|Decided not to have surgery|0|||
44524801|NCT04587453|79533597|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
44524802|NCT04587453|79533598|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
44524803|NCT02793232|79533615|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44524804|NCT02793232|79533616|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44524805|NCT02793232|79533617|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44524806|NCT02793232|79533618|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44409665|NCT04887922|79417326|FG001|1st Randomization|Decided not to have surgery|1|||
44409666|NCT04887922|79417327|FG002|1st Randomization|Decided not to have surgery|0|||
44409667|NCT04887922|79417328|FG003|1st Randomization|Decided not to have surgery|0|||
44409668|NCT04887922|79417329|FG004|1st Randomization|Decided not to have surgery|0|||
44409669|NCT04771403|79417352|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
44409670|NCT04771403|79417353|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
44409671|NCT04771403|79417352|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
44409672|NCT04771403|79417353|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
44409673|NCT04771403|79417352|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
44409674|NCT04771403|79417353|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
44409675|NCT04771403|79417352|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
44409676|NCT04771403|79417353|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
44148296|NCT01802632|78937843|FG001|Overall Study|Death|1|||
44148297|NCT01802632|78937844|FG002|Overall Study|Death|38|||
44148298|NCT01802632|78937845|FG003|Overall Study|Death|0|||
44148299|NCT01802632|78937846|FG004|Overall Study|Death|2|||
44148300|NCT01802632|78937847|FG005|Overall Study|Death|0|||
44148301|NCT01802632|78937842|FG000|Overall Study|Withdrawal by Subject|4|||
44148302|NCT01802632|78937843|FG001|Overall Study|Withdrawal by Subject|2|||
44148303|NCT01802632|78937844|FG002|Overall Study|Withdrawal by Subject|7|||
44148304|NCT01802632|78937845|FG003|Overall Study|Withdrawal by Subject|3|||
44148305|NCT01802632|78937846|FG004|Overall Study|Withdrawal by Subject|0|||
44409677|NCT04771403|79417352|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
44409678|NCT04771403|79417353|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
44409679|NCT04771403|79417352|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
44409680|NCT04771403|79417353|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
44409681|NCT04771403|79417352|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
44409682|NCT04771403|79417353|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
44409683|NCT04771403|79417352|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
44409684|NCT04771403|79417353|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
44409685|NCT04698525|79417362|FG000|Overall Study|Lost to Follow-up|1|||
44409686|NCT04698525|79417363|FG001|Overall Study|Lost to Follow-up|2|||
44409687|NCT04698525|79417362|FG000|Overall Study|Three suffered of Covid-19|2|||
44409688|NCT04698525|79417363|FG001|Overall Study|Three suffered of Covid-19|1|||
44409689|NCT04510675|79417377|FG000|Overall Study|Withdrawal by Subject|5|||
44409690|NCT04228783|79417399|FG000|Overall Study|Adverse Event|1|||
44409691|NCT04228783|79417400|FG001|Overall Study|Adverse Event|0|||
44524807|NCT02793232|79533619|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
44524808|NCT02793232|79533620|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44524809|NCT02793232|79533621|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
44524810|NCT02793232|79533622|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44524811|NCT02793232|79533623|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
44524812|NCT04584645|79533659|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
44524813|NCT04584645|79533660|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
44524814|NCT03695367|79533686|FG000|Overall Study|Missed the Day 28 visit.|1|||
44524815|NCT03695367|79533687|FG001|Overall Study|Missed the Day 28 visit.|0|||
44524816|NCT03695367|79533686|FG000|Overall Study|Lost to Follow-up|0|||
44524817|NCT03695367|79533687|FG001|Overall Study|Lost to Follow-up|1|||
44524818|NCT03695367|79533686|FG000|Overall Study|Withdrawal by Subject|0|||
44524819|NCT03695367|79533687|FG001|Overall Study|Withdrawal by Subject|1|||
44524820|NCT03695367|79533686|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
44524821|NCT03695367|79533687|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
44524822|NCT02794480|79533695|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
44524823|NCT02794480|79533696|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
44148306|NCT01802632|78937847|FG005|Overall Study|Withdrawal by Subject|1|||
44148307|NCT01802632|78937842|FG000|Overall Study|Objective Disease Progression|1|||
44148308|NCT01802632|78937843|FG001|Overall Study|Objective Disease Progression|12|||
44524824|NCT02794480|79533697|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
44524825|NCT02794480|79533698|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
44524826|NCT02794480|79533695|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
44524827|NCT02794480|79533696|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
44253718|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253719|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253720|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253721|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
44253722|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253723|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253724|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
44253725|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253726|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253727|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44148309|NCT01802632|78937844|FG002|Overall Study|Objective Disease Progression|104|||
44148310|NCT01802632|78937845|FG003|Overall Study|Objective Disease Progression|6|||
44148311|NCT01802632|78937846|FG004|Overall Study|Objective Disease Progression|4|||
44148312|NCT01802632|78937847|FG005|Overall Study|Objective Disease Progression|4|||
44409692|NCT04228783|79417401|FG002|Overall Study|Adverse Event|2|||
44409693|NCT04228783|79417402|FG003|Overall Study|Adverse Event|0|||
44409694|NCT04228783|79417403|FG004|Overall Study|Adverse Event|0|||
44409695|NCT04228783|79417404|FG005|Overall Study|Adverse Event|1|||
44409696|NCT04228783|79417399|FG000|Overall Study|Death|0|||
44409697|NCT04228783|79417400|FG001|Overall Study|Death|0|||
44409698|NCT04228783|79417401|FG002|Overall Study|Death|0|||
44409699|NCT04228783|79417402|FG003|Overall Study|Death|0|||
44409700|NCT04228783|79417403|FG004|Overall Study|Death|1|||
44409701|NCT04228783|79417404|FG005|Overall Study|Death|0|||
44409702|NCT04228783|79417399|FG000|Overall Study|Lost to Follow-up|36|||
44409703|NCT04228783|79417400|FG001|Overall Study|Lost to Follow-up|36|||
44409704|NCT04228783|79417401|FG002|Overall Study|Lost to Follow-up|28|||
44409705|NCT04228783|79417402|FG003|Overall Study|Lost to Follow-up|6|||
44409706|NCT04228783|79417403|FG004|Overall Study|Lost to Follow-up|14|||
44409707|NCT04228783|79417404|FG005|Overall Study|Lost to Follow-up|3|||
44409708|NCT04228783|79417399|FG000|Overall Study|Physician Decision|1|||
44409709|NCT04228783|79417400|FG001|Overall Study|Physician Decision|2|||
44409710|NCT04228783|79417401|FG002|Overall Study|Physician Decision|0|||
44409711|NCT04228783|79417402|FG003|Overall Study|Physician Decision|0|||
44409712|NCT04228783|79417403|FG004|Overall Study|Physician Decision|0|||
44409713|NCT04228783|79417404|FG005|Overall Study|Physician Decision|0|||
44409714|NCT04228783|79417399|FG000|Overall Study|Protocol Violation|0|||
44409715|NCT04228783|79417400|FG001|Overall Study|Protocol Violation|0|||
44409716|NCT04228783|79417401|FG002|Overall Study|Protocol Violation|0|||
44409717|NCT04228783|79417402|FG003|Overall Study|Protocol Violation|1|||
44409718|NCT04228783|79417403|FG004|Overall Study|Protocol Violation|0|||
44409719|NCT04228783|79417404|FG005|Overall Study|Protocol Violation|0|||
44409720|NCT04228783|79417399|FG000|Overall Study|Withdrawal by Subject|6|||
44409721|NCT04228783|79417400|FG001|Overall Study|Withdrawal by Subject|10|||
44148313|NCT01802632|78937842|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
44409722|NCT04228783|79417401|FG002|Overall Study|Withdrawal by Subject|19|||
44409723|NCT04228783|79417402|FG003|Overall Study|Withdrawal by Subject|1|||
44409724|NCT04228783|79417403|FG004|Overall Study|Withdrawal by Subject|2|||
44409725|NCT04228783|79417404|FG005|Overall Study|Withdrawal by Subject|0|||
44253728|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253729|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253730|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253731|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253732|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253733|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253734|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253735|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253736|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253737|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
44253738|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
44253739|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
44253740|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
44253741|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
44253742|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
44253743|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44524828|NCT02794480|79533697|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
44524829|NCT02794480|79533698|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
44524830|NCT02794480|79533695|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44524831|NCT02794480|79533696|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44524832|NCT02794480|79533697|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44524833|NCT02794480|79533698|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
44524834|NCT02794480|79533695|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44524835|NCT02794480|79533696|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
44524836|NCT02794480|79533697|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44524837|NCT02794480|79533698|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
44524838|NCT02794480|79533695|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
44409726|NCT04228783|79417399|FG000|Overall Study|Other|4|||
44409727|NCT04228783|79417400|FG001|Overall Study|Other|3|||
44409728|NCT04228783|79417401|FG002|Overall Study|Other|2|||
44409729|NCT04228783|79417402|FG003|Overall Study|Other|1|||
44409730|NCT04228783|79417403|FG004|Overall Study|Other|0|||
44409731|NCT04228783|79417404|FG005|Overall Study|Other|0|||
44409732|NCT03950674|79417420|FG000|Overall Study|Death|3|||
44409733|NCT03950674|79417421|FG001|Overall Study|Death|7|||
44409734|NCT03950674|79417420|FG000|Overall Study|Ongoing in Study|22|||
44409735|NCT03950674|79417421|FG001|Overall Study|Ongoing in Study|8|||
44409736|NCT03702621|79417430|FG000|Overall Study|Physician Decision|6|||
44409737|NCT03702621|79417431|FG001|Overall Study|Physician Decision|6|||
44409738|NCT03577990|79417439|FG000|Overall Study|Lost to Follow-up|4|||
44409739|NCT03577990|79417440|FG001|Overall Study|Lost to Follow-up|6|||
44409740|NCT03577990|79417439|FG000|Overall Study|Withdrawal by Subject|4|||
44409741|NCT03577990|79417440|FG001|Overall Study|Withdrawal by Subject|7|||
44409742|NCT03565497|79417450|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
44409743|NCT03565497|79417451|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
44409744|NCT03565497|79417452|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
44409745|NCT03565497|79417450|FG000|Overall Study|Lost to Follow-up|1|||
44409746|NCT03565497|79417451|FG001|Overall Study|Lost to Follow-up|1|||
44409747|NCT03565497|79417452|FG002|Overall Study|Lost to Follow-up|2|||
44409748|NCT03565497|79417450|FG000|Overall Study|Withdrawal by Subject|1|||
44409749|NCT03565497|79417451|FG001|Overall Study|Withdrawal by Subject|1|||
44409750|NCT03565497|79417452|FG002|Overall Study|Withdrawal by Subject|1|||
44409751|NCT03362931|79417460|FG000|Overall Study|Adverse Event|1|||
44409752|NCT03362931|79417460|FG000|Overall Study|Death|2|||
44409753|NCT03360019|79417467|FG000|Overall Study|Withdrawal by Subject|2|||
44409754|NCT03360019|79417468|FG001|Overall Study|Withdrawal by Subject|0|||
44409755|NCT03360019|79417469|FG002|Overall Study|Withdrawal by Subject|0|||
44409756|NCT03360019|79417467|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
44409757|NCT03360019|79417468|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
44409758|NCT03360019|79417469|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
44409759|NCT03245008|79417486|FG000|Overall Study|Adverse Event|15|||
44253744|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
44253745|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44253746|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44253747|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
44253748|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44253749|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44253750|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44253751|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
44409760|NCT03245008|79417487|FG001|Overall Study|Adverse Event|18|||
44409761|NCT03245008|79417488|FG002|Overall Study|Adverse Event|15|||
44409762|NCT03245008|79417489|FG003|Overall Study|Adverse Event|0|||
44409763|NCT03245008|79417490|FG004|Overall Study|Adverse Event|1|||
44409764|NCT03245008|79417486|FG000|Overall Study|Lack of Efficacy|0|||
44409765|NCT03245008|79417487|FG001|Overall Study|Lack of Efficacy|1|||
44409766|NCT03245008|79417488|FG002|Overall Study|Lack of Efficacy|0|||
44409767|NCT03245008|79417489|FG003|Overall Study|Lack of Efficacy|0|||
44409768|NCT03245008|79417490|FG004|Overall Study|Lack of Efficacy|0|||
44409769|NCT03245008|79417486|FG000|Overall Study|Lost to Follow-up|4|||
44409770|NCT03245008|79417487|FG001|Overall Study|Lost to Follow-up|1|||
44409771|NCT03245008|79417488|FG002|Overall Study|Lost to Follow-up|0|||
44409772|NCT03245008|79417489|FG003|Overall Study|Lost to Follow-up|0|||
44409773|NCT03245008|79417490|FG004|Overall Study|Lost to Follow-up|1|||
44409774|NCT03245008|79417486|FG000|Overall Study|Physician Decision|1|||
44409775|NCT03245008|79417487|FG001|Overall Study|Physician Decision|3|||
44409776|NCT03245008|79417488|FG002|Overall Study|Physician Decision|4|||
44409777|NCT03245008|79417489|FG003|Overall Study|Physician Decision|0|||
44409778|NCT03245008|79417490|FG004|Overall Study|Physician Decision|0|||
44253752|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44282133|NCT01880736|79245387|FG002|Overall Study|Adverse Event|0|||
44409779|NCT03245008|79417486|FG000|Overall Study|Protocol Violation|0|||
44409780|NCT03245008|79417487|FG001|Overall Study|Protocol Violation|1|||
44409781|NCT03245008|79417488|FG002|Overall Study|Protocol Violation|0|||
44409782|NCT03245008|79417489|FG003|Overall Study|Protocol Violation|0|||
44409783|NCT03245008|79417490|FG004|Overall Study|Protocol Violation|0|||
44409784|NCT03245008|79417486|FG000|Overall Study|Withdrawal by Subject|20|||
44524839|NCT02794480|79533696|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44409785|NCT03245008|79417487|FG001|Overall Study|Withdrawal by Subject|19|||
44409786|NCT03245008|79417488|FG002|Overall Study|Withdrawal by Subject|11|||
44409787|NCT03245008|79417489|FG003|Overall Study|Withdrawal by Subject|0|||
44409788|NCT03245008|79417490|FG004|Overall Study|Withdrawal by Subject|0|||
44524840|NCT02794480|79533697|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44409789|NCT03245008|79417486|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
44409790|NCT03245008|79417487|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
44409791|NCT03245008|79417488|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
44409792|NCT03245008|79417489|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
44409793|NCT03245008|79417490|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
44409794|NCT03245008|79417486|FG000|Overall Study|Failure to meet randomization criteria|0|||
44409795|NCT03245008|79417487|FG001|Overall Study|Failure to meet randomization criteria|1|||
44409796|NCT03245008|79417488|FG002|Overall Study|Failure to meet randomization criteria|0|||
44409797|NCT03245008|79417489|FG003|Overall Study|Failure to meet randomization criteria|1|||
44409798|NCT03245008|79417490|FG004|Overall Study|Failure to meet randomization criteria|0|||
44409799|NCT03203473|79417512|FG000|Induction Phase|Never started primary treatment|2|||
44409800|NCT03203473|79417513|FG001|Induction Phase|Never started primary treatment|0|||
44409801|NCT03203473|79417514|FG002|Induction Phase|Never started primary treatment|0|||
44409802|NCT03203473|79417512|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
44409803|NCT03203473|79417513|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
44409804|NCT03203473|79417514|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
44409805|NCT03203473|79417512|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
44409806|NCT03203473|79417513|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
44409807|NCT03203473|79417514|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
44409808|NCT03203473|79417512|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
44409809|NCT03203473|79417513|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
44409810|NCT03203473|79417514|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
44409811|NCT03203473|79417512|FG000|Arm Allocation Phase|started salvage therapy|0|||
44409812|NCT03203473|79417513|FG001|Arm Allocation Phase|started salvage therapy|5|||
44409813|NCT03203473|79417514|FG002|Arm Allocation Phase|started salvage therapy|0|||
44409814|NCT03203473|79417512|FG000|Arm Allocation Phase|Disease progression|0|||
44409815|NCT03203473|79417513|FG001|Arm Allocation Phase|Disease progression|0|||
44409816|NCT03203473|79417514|FG002|Arm Allocation Phase|Disease progression|37|||
44409817|NCT03203473|79417512|FG000|Arm Allocation Phase|Adverse Event|0|||
44409818|NCT03203473|79417513|FG001|Arm Allocation Phase|Adverse Event|0|||
44409819|NCT03203473|79417514|FG002|Arm Allocation Phase|Adverse Event|11|||
44409820|NCT03203473|79417512|FG000|Arm Allocation Phase|Physician Decision|0|||
44409821|NCT03203473|79417513|FG001|Arm Allocation Phase|Physician Decision|0|||
44409822|NCT03203473|79417514|FG002|Arm Allocation Phase|Physician Decision|3|||
44409823|NCT03203473|79417512|FG000|Arm Allocation Phase|Death|0|||
44409824|NCT03203473|79417513|FG001|Arm Allocation Phase|Death|0|||
44409825|NCT03203473|79417514|FG002|Arm Allocation Phase|Death|1|||
44409826|NCT03203473|79417512|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
44409827|NCT03203473|79417513|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
44409828|NCT03203473|79417514|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
44282134|NCT01880736|79245388|FG003|Overall Study|Adverse Event|1|||
44282135|NCT01880736|79245385|FG000|Overall Study|Withdrawal Criteria|1|||
44282136|NCT01880736|79245386|FG001|Overall Study|Withdrawal Criteria|2|||
44282137|NCT01880736|79245387|FG002|Overall Study|Withdrawal Criteria|1|||
44282138|NCT01880736|79245388|FG003|Overall Study|Withdrawal Criteria|5|||
44282139|NCT01880424|79245400|FG000|Overall Study|Adverse Event|7|||
44409829|NCT03203473|79417512|FG000|Arm Allocation Phase|Intercurrent illness|0|||
44409830|NCT03203473|79417513|FG001|Arm Allocation Phase|Intercurrent illness|0|||
44409831|NCT03203473|79417514|FG002|Arm Allocation Phase|Intercurrent illness|1|||
44409832|NCT03203473|79417512|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
44409833|NCT03203473|79417513|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
44409834|NCT03203473|79417514|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
44409835|NCT03158051|79417527|FG000|Overall Study|Lost to Follow-up|41|||
44409836|NCT03158051|79417528|FG001|Overall Study|Lost to Follow-up|47|||
44409837|NCT03158051|79417527|FG000|Overall Study|Physician Decision|6|||
44409838|NCT03158051|79417528|FG001|Overall Study|Physician Decision|7|||
44409839|NCT03158051|79417527|FG000|Overall Study|Withdrawal by Subject|24|||
44409840|NCT03158051|79417528|FG001|Overall Study|Withdrawal by Subject|15|||
44409841|NCT03158051|79417527|FG000|Overall Study|Death|0|||
44409842|NCT03158051|79417528|FG001|Overall Study|Death|1|||
44409843|NCT02600507|79417546|FG000|Overall Study|Adverse Event|3|||
44409844|NCT02600507|79417547|FG001|Overall Study|Adverse Event|15|||
44409845|NCT02600507|79417548|FG002|Overall Study|Adverse Event|5|||
44409846|NCT02600507|79417546|FG000|Overall Study|Lack of Efficacy|3|||
44409847|NCT02600507|79417547|FG001|Overall Study|Lack of Efficacy|8|||
44409848|NCT02600507|79417548|FG002|Overall Study|Lack of Efficacy|5|||
44409849|NCT02600507|79417546|FG000|Overall Study|Lost to Follow-up|3|||
44409850|NCT02600507|79417547|FG001|Overall Study|Lost to Follow-up|5|||
44409851|NCT02600507|79417548|FG002|Overall Study|Lost to Follow-up|2|||
44409852|NCT02600507|79417546|FG000|Overall Study|Protocol Violation|12|||
44409853|NCT02600507|79417547|FG001|Overall Study|Protocol Violation|4|||
44409854|NCT02600507|79417548|FG002|Overall Study|Protocol Violation|4|||
44409855|NCT02600507|79417546|FG000|Overall Study|Physician Decision|1|||
44282140|NCT01880424|79245401|FG001|Overall Study|Adverse Event|6|||
44409856|NCT02600507|79417547|FG001|Overall Study|Physician Decision|0|||
44409857|NCT02600507|79417548|FG002|Overall Study|Physician Decision|1|||
44409858|NCT02600507|79417546|FG000|Overall Study|Withdrawal by Subject|7|||
44409859|NCT02600507|79417547|FG001|Overall Study|Withdrawal by Subject|11|||
44409860|NCT02600507|79417548|FG002|Overall Study|Withdrawal by Subject|7|||
44409861|NCT02600507|79417546|FG000|Overall Study|Other|0|||
44409862|NCT02600507|79417547|FG001|Overall Study|Other|1|||
44409863|NCT02600507|79417548|FG002|Overall Study|Other|1|||
44409864|NCT02578680|79417558|FG000|Overall Study|Death|124|||
44409865|NCT02578680|79417559|FG001|Overall Study|Death|104|||
44409866|NCT02578680|79417558|FG000|Overall Study|Protocol Violation|1|||
44409867|NCT02578680|79417559|FG001|Overall Study|Protocol Violation|1|||
44409868|NCT02578680|79417558|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44409869|NCT02578680|79417559|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44409870|NCT02578680|79417558|FG000|Overall Study|Withdrawal by Subject|8|||
44409871|NCT02578680|79417559|FG001|Overall Study|Withdrawal by Subject|5|||
44409872|NCT02578680|79417558|FG000|Overall Study|Ongoing in Study|276|||
44409873|NCT02578680|79417559|FG001|Overall Study|Ongoing in Study|96|||
44409874|NCT02385266|79417567|FG000|Overall Study|Withdrawal by Subject|1|||
44409875|NCT02385266|79417568|FG001|Overall Study|Withdrawal by Subject|3|||
44409876|NCT02379988|79417574|FG000|Overall Study|Not eligible|1|||
44409877|NCT02006069|79417589|FG000|Overall Study|MPP other programming|239|||
44409878|NCT02006069|79417590|FG001|Overall Study|MPP other programming|0|||
44409879|NCT02006069|79417589|FG000|Overall Study|RV only pacing|0|||
44409880|NCT02006069|79417590|FG001|Overall Study|RV only pacing|3|||
44409881|NCT01985867|79417598|FG000|Overall Study|Lost to Follow-up|3|||
44409882|NCT01985867|79417599|FG001|Overall Study|Lost to Follow-up|4|||
44409883|NCT01985867|79417598|FG000|Overall Study|Adverse Event|3|||
44409884|NCT01985867|79417599|FG001|Overall Study|Adverse Event|2|||
44409885|NCT01985867|79417598|FG000|Overall Study|Lack of Efficacy|1|||
44409886|NCT01985867|79417599|FG001|Overall Study|Lack of Efficacy|0|||
44409887|NCT01367002|79417607|FG000|Overall Study|Withdrawal by Subject|1|||
44409888|NCT01367002|79417608|FG001|Overall Study|Withdrawal by Subject|0|||
44409889|NCT01367002|79417607|FG000|Overall Study|Physician Decision|0|||
44409890|NCT01367002|79417608|FG001|Overall Study|Physician Decision|2|||
44409891|NCT00858273|79417616|FG000|Overall Study|Protocol Violation|3|||
44409892|NCT00858273|79417617|FG001|Overall Study|Protocol Violation|5|||
44409893|NCT00844428|79417648|FG000|Screening Period|Screen Failure|3|||
44409894|NCT00844428|79417648|FG000|Extension Treatment Period|Death|1|||
44409895|NCT00844428|79417648|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
44409896|NCT00834834|79417654|FG000|Overall Study|Withdrawal by Subject|4|||
44409897|NCT00834834|79417655|FG001|Overall Study|Withdrawal by Subject|3|||
44409898|NCT00834366|79417663|FG000|Treatment Period 1|Adverse Event|1|||
44409899|NCT00834366|79417664|FG001|Treatment Period 1|Adverse Event|1|||
44253753|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
44253754|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
44409900|NCT00844194|79417672|FG000|Overall Study|Adverse Event|17|||
44409901|NCT00844194|79417673|FG001|Overall Study|Adverse Event|5|||
44409902|NCT00844194|79417672|FG000|Overall Study|Protocol Violation|1|||
44524841|NCT02794480|79533698|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
44524842|NCT04558125|79533706|FG000|Overall Study|Death|1|||
44524843|NCT02793622|79533712|FG000|Overall Study|Lost to Follow-up|31|||
44524844|NCT02793622|79533713|FG001|Overall Study|Lost to Follow-up|19|||
44524845|NCT02793622|79533712|FG000|Overall Study|Withdrawal by Subject|21|||
44524846|NCT02793622|79533713|FG001|Overall Study|Withdrawal by Subject|17|||
44524847|NCT02793622|79533712|FG000|Overall Study|Adverse Event|0|||
44524848|NCT02793622|79533713|FG001|Overall Study|Adverse Event|1|||
44524849|NCT02793622|79533712|FG000|Overall Study|Protocol Violation|1|||
44524850|NCT02793622|79533713|FG001|Overall Study|Protocol Violation|5|||
44409903|NCT00844194|79417673|FG001|Overall Study|Protocol Violation|1|||
44409904|NCT00844194|79417672|FG000|Overall Study|Lost to Follow-up|1|||
44409905|NCT00844194|79417673|FG001|Overall Study|Lost to Follow-up|1|||
44409906|NCT00844194|79417672|FG000|Overall Study|Withdrawal by Subject|2|||
44524851|NCT04493931|79533726|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
44409907|NCT00844194|79417673|FG001|Overall Study|Withdrawal by Subject|1|||
44409908|NCT00844194|79417672|FG000|Overall Study|Lack of Efficacy|3|||
44524852|NCT04493931|79533727|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
44409909|NCT00844194|79417673|FG001|Overall Study|Lack of Efficacy|0|||
44409910|NCT00844194|79417672|FG000|Overall Study|Other reason (not specified)|1|||
44409911|NCT00844194|79417673|FG001|Overall Study|Other reason (not specified)|0|||
44524853|NCT04493931|79533728|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
44524854|NCT04493931|79533729|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
44409912|NCT00826176|79417685|FG000|Overall Study|Lost to Follow-up|1|||
44409913|NCT00826176|79417686|FG001|Overall Study|Lost to Follow-up|0|||
44409914|NCT00826176|79417685|FG000|Overall Study|Subject Withdrew Consent|3|||
44409915|NCT00826176|79417686|FG001|Overall Study|Subject Withdrew Consent|0|||
44409916|NCT00826176|79417685|FG000|Overall Study|Administrative|9|||
44409917|NCT00826176|79417686|FG001|Overall Study|Administrative|0|||
44409918|NCT00878969|79417695|FG000|Overall Study|Physician Decision|5|||
44409919|NCT00878969|79417696|FG001|Overall Study|Physician Decision|3|||
44524855|NCT04493931|79533730|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
44524856|NCT04493931|79533731|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
44524857|NCT04493931|79533732|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
44524858|NCT04493931|79533726|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
44524859|NCT04493931|79533727|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
44409920|NCT00878969|79417697|FG002|Overall Study|Physician Decision|2|||
44409921|NCT00878969|79417695|FG000|Overall Study|Withdrawal by Subject|1|||
44409922|NCT00878969|79417696|FG001|Overall Study|Withdrawal by Subject|6|||
44409923|NCT00878969|79417697|FG002|Overall Study|Withdrawal by Subject|3|||
44409924|NCT00878969|79417695|FG000|Overall Study|kidney transplant|2|||
44409925|NCT00878969|79417696|FG001|Overall Study|kidney transplant|3|||
44409926|NCT00878969|79417697|FG002|Overall Study|kidney transplant|2|||
44409927|NCT00878969|79417695|FG000|Overall Study|Adverse Event|3|||
44409928|NCT00878969|79417696|FG001|Overall Study|Adverse Event|1|||
44409929|NCT00878969|79417697|FG002|Overall Study|Adverse Event|2|||
44409930|NCT00878969|79417695|FG000|Overall Study|Lost to Follow-up|2|||
44409931|NCT00878969|79417696|FG001|Overall Study|Lost to Follow-up|1|||
44409932|NCT00878969|79417697|FG002|Overall Study|Lost to Follow-up|0|||
44409933|NCT00878969|79417695|FG000|Overall Study|Protocol Violation|2|||
44409934|NCT00878969|79417696|FG001|Overall Study|Protocol Violation|0|||
44409935|NCT00878969|79417697|FG002|Overall Study|Protocol Violation|0|||
44409936|NCT00878969|79417695|FG000|Overall Study|Death|0|||
44409937|NCT00878969|79417696|FG001|Overall Study|Death|0|||
44409938|NCT00878969|79417697|FG002|Overall Study|Death|2|||
44409939|NCT00878969|79417695|FG000|Overall Study|Pregnancy|0|||
44409940|NCT00878969|79417696|FG001|Overall Study|Pregnancy|1|||
44409941|NCT00878969|79417697|FG002|Overall Study|Pregnancy|0|||
44409942|NCT00843726|79417711|FG000|Overall Study|Death|1|||
44409943|NCT00843726|79417712|FG001|Overall Study|Death|0|||
44409944|NCT00843726|79417711|FG000|Overall Study|Withdrawal by Subject|0|||
44409945|NCT00843726|79417712|FG001|Overall Study|Withdrawal by Subject|1|||
44409946|NCT00843492|79417721|FG000|Overall Study|Adverse Event|0|||
44409947|NCT00843492|79417722|FG001|Overall Study|Adverse Event|3|||
44409948|NCT00843492|79417721|FG000|Overall Study|Lost to Follow-up|4|||
44409949|NCT00843492|79417722|FG001|Overall Study|Lost to Follow-up|4|||
44409950|NCT00843492|79417721|FG000|Overall Study|Withdrawal by Subject|0|||
44409951|NCT00843492|79417722|FG001|Overall Study|Withdrawal by Subject|4|||
44409952|NCT00843492|79417721|FG000|Overall Study|Immobilization Stopped|1|||
44409953|NCT00843492|79417722|FG001|Overall Study|Immobilization Stopped|0|||
44409954|NCT00843492|79417721|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
44409955|NCT00843492|79417722|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
44409956|NCT00843492|79417721|FG000|Overall Study|Orthopedic Surgery|0|||
44409957|NCT00843492|79417722|FG001|Overall Study|Orthopedic Surgery|2|||
44409958|NCT00843492|79417721|FG000|Overall Study|Visit Not Performed|1|||
44409959|NCT00843492|79417722|FG001|Overall Study|Visit Not Performed|0|||
44409960|NCT00843492|79417721|FG000|Overall Study|Deep-vein Thrombosis|1|||
44409961|NCT00843492|79417722|FG001|Overall Study|Deep-vein Thrombosis|0|||
44409962|NCT00833976|79417728|FG000|Overall Study|Withdrawal by Subject|5|||
44409963|NCT00833976|79417728|FG000|Overall Study|Lost to Follow-up|4|||
44409964|NCT00833976|79417728|FG000|Overall Study|Did not meet eligibility criteria|41|||
44409965|NCT00833976|79417728|FG000|Overall Study|Physician Decision|1|||
44409966|NCT00833898|79417734|FG000|Overall Study|Withdrawal by Subject|33|||
44409967|NCT00833898|79417735|FG001|Overall Study|Withdrawal by Subject|27|||
44409968|NCT00833898|79417734|FG000|Overall Study|Lost to Follow-up|7|||
44409969|NCT00833898|79417735|FG001|Overall Study|Lost to Follow-up|7|||
44409970|NCT00833898|79417734|FG000|Overall Study|Patient did not receive transplant|0|||
44409971|NCT00833898|79417735|FG001|Overall Study|Patient did not receive transplant|2|||
44409972|NCT00825162|79417744|FG000|Overall Study|Withdrawal by Subject|11|||
44409973|NCT00825162|79417745|FG001|Overall Study|Withdrawal by Subject|13|||
44409974|NCT00825162|79417746|FG002|Overall Study|Withdrawal by Subject|3|||
44524860|NCT04493931|79533728|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
44409975|NCT00825162|79417744|FG000|Overall Study|Lost to Follow-up|9|||
44409976|NCT00825162|79417745|FG001|Overall Study|Lost to Follow-up|6|||
44409977|NCT00825162|79417746|FG002|Overall Study|Lost to Follow-up|3|||
44409978|NCT00825162|79417744|FG000|Overall Study|Physician Decision|2|||
44409979|NCT00825162|79417745|FG001|Overall Study|Physician Decision|0|||
44409980|NCT00825162|79417746|FG002|Overall Study|Physician Decision|0|||
44409981|NCT00825162|79417744|FG000|Overall Study|Move away from the study area|1|||
44409982|NCT00825162|79417745|FG001|Overall Study|Move away from the study area|0|||
44409983|NCT00825162|79417746|FG002|Overall Study|Move away from the study area|0|||
44409984|NCT00825162|79417744|FG000|Overall Study|Unable to attend the study visit|5|||
44409985|NCT00825162|79417745|FG001|Overall Study|Unable to attend the study visit|2|||
44409986|NCT00825162|79417746|FG002|Overall Study|Unable to attend the study visit|0|||
44409987|NCT00824850|79417761|FG000|Overall Study|Withdrawal by Subject|0|||
44409988|NCT00824850|79417762|FG001|Overall Study|Withdrawal by Subject|1|||
44409989|NCT00596687|79417776|FG000|Overall Study|< 24 hours of insulin treatment|8|||
44409990|NCT00596687|79417777|FG001|Overall Study|< 24 hours of insulin treatment|6|||
44409991|NCT00596687|79417776|FG000|Overall Study|continuous insulin infusion during TPN|2|||
44409992|NCT00596687|79417777|FG001|Overall Study|continuous insulin infusion during TPN|1|||
44409993|NCT00596687|79417776|FG000|Overall Study|Withdrawal by Subject|3|||
44409994|NCT00596687|79417777|FG001|Overall Study|Withdrawal by Subject|1|||
44409995|NCT00596687|79417776|FG000|Overall Study|cancelled surgery|1|||
44409996|NCT00596687|79417777|FG001|Overall Study|cancelled surgery|1|||
44409997|NCT00824772|79417783|FG000|Overall Study|Withdrawal by Subject|8|||
44409998|NCT00824616|79417789|FG000|Overall Study|Adverse Event|2|||
44409999|NCT00824616|79417790|FG001|Overall Study|Adverse Event|1|||
44410000|NCT00824616|79417789|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
44410001|NCT00824616|79417790|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
44410002|NCT00824616|79417789|FG000|Overall Study|Hyperglycemia|1|||
44410003|NCT00824616|79417790|FG001|Overall Study|Hyperglycemia|1|||
44410004|NCT00824616|79417789|FG000|Overall Study|Lack of Efficacy|2|||
44410005|NCT00824616|79417790|FG001|Overall Study|Lack of Efficacy|1|||
44410006|NCT00824616|79417789|FG000|Overall Study|Lost to Follow-up|0|||
44410007|NCT00824616|79417790|FG001|Overall Study|Lost to Follow-up|1|||
44410008|NCT00824616|79417789|FG000|Overall Study|Withdrawal by Subject|1|||
44410009|NCT00824616|79417790|FG001|Overall Study|Withdrawal by Subject|1|||
44410010|NCT00824382|79417800|FG000|Overall Study|Adverse Event|4|||
44410011|NCT00824382|79417801|FG001|Overall Study|Adverse Event|1|||
44410012|NCT00824382|79417802|FG002|Overall Study|Adverse Event|1|||
44410013|NCT00824382|79417803|FG003|Overall Study|Adverse Event|4|||
44410014|NCT00824382|79417800|FG000|Overall Study|Protocol Violation|1|||
44410015|NCT00824382|79417801|FG001|Overall Study|Protocol Violation|0|||
44410016|NCT00824382|79417802|FG002|Overall Study|Protocol Violation|0|||
44410017|NCT00824382|79417803|FG003|Overall Study|Protocol Violation|1|||
44410018|NCT00824382|79417800|FG000|Overall Study|Investigator's decision|0|||
44410019|NCT00824382|79417801|FG001|Overall Study|Investigator's decision|1|||
44410020|NCT00824382|79417802|FG002|Overall Study|Investigator's decision|2|||
44410021|NCT00824382|79417803|FG003|Overall Study|Investigator's decision|0|||
44410022|NCT00833040|79417815|FG000|Overall Study|Adverse Event|0|||
44410023|NCT00833040|79417816|FG001|Overall Study|Adverse Event|0|||
44410024|NCT00833040|79417817|FG002|Overall Study|Adverse Event|0|||
44410025|NCT00833040|79417818|FG003|Overall Study|Adverse Event|0|||
44410026|NCT00833040|79417819|FG004|Overall Study|Adverse Event|0|||
44410027|NCT00833040|79417820|FG005|Overall Study|Adverse Event|1|||
44410028|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
44410029|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
44410030|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
44410031|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
44410032|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
44410033|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
44410034|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
44410035|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
44410036|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
44410037|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
44410038|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
44410039|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
44410040|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
44410041|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
44410042|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
44410043|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
44524861|NCT04493931|79533729|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
44524862|NCT04493931|79533730|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
44524863|NCT04493931|79533731|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
44524864|NCT04493931|79533732|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
44524865|NCT04493931|79533726|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
44410044|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
44410045|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
44410046|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
44410047|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
44410048|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
44410049|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
44410050|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
44410051|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
44410052|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
44410053|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
44410054|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
44410055|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
44410056|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
44410057|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
44410058|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
44410059|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
44410060|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
44410061|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
44410062|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
44410063|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
44410064|NCT00843024|79417829|FG000|Single-blind Placebo Run-In Phase|Other|0|||
44410065|NCT00843024|79417830|FG001|Single-blind Placebo Run-In Phase|Other|1|||
44410066|NCT00843024|79417831|FG002|Single-blind Placebo Run-In Phase|Other|0|||
44410067|NCT00843024|79417832|FG003|Single-blind Placebo Run-In Phase|Other|0|||
44410068|NCT00843024|79417833|FG004|Single-blind Placebo Run-In Phase|Other|0|||
44410069|NCT00843024|79417834|FG005|Single-blind Placebo Run-In Phase|Other|0|||
44410070|NCT00843024|79417829|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
44410071|NCT00843024|79417830|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
44410072|NCT00843024|79417831|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
44410073|NCT00843024|79417832|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
44410074|NCT00843024|79417833|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
44410075|NCT00843024|79417834|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
44410076|NCT00843024|79417829|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
44410077|NCT00843024|79417830|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
44410078|NCT00843024|79417831|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
44410079|NCT00843024|79417832|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
44410080|NCT00843024|79417833|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
44410081|NCT00843024|79417834|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
44410082|NCT00843024|79417829|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44410083|NCT00843024|79417830|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44410084|NCT00843024|79417831|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44410085|NCT00843024|79417832|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
44410086|NCT00843024|79417833|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44410087|NCT00843024|79417834|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
44410088|NCT00843024|79417829|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
44410089|NCT00843024|79417830|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
44410090|NCT00843024|79417831|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
44410091|NCT00843024|79417832|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
44410092|NCT00843024|79417833|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
44410093|NCT00843024|79417834|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
44410094|NCT00843024|79417829|FG000|Double-blind Treatment Phase|Physician Decision|0|||
44410095|NCT00843024|79417830|FG001|Double-blind Treatment Phase|Physician Decision|0|||
44410096|NCT00843024|79417831|FG002|Double-blind Treatment Phase|Physician Decision|0|||
44410097|NCT00843024|79417832|FG003|Double-blind Treatment Phase|Physician Decision|3|||
44410098|NCT00843024|79417833|FG004|Double-blind Treatment Phase|Physician Decision|1|||
44410099|NCT00843024|79417834|FG005|Double-blind Treatment Phase|Physician Decision|1|||
44410100|NCT00843024|79417829|FG000|Double-blind Treatment Phase|Adverse Event|0|||
44410101|NCT00843024|79417830|FG001|Double-blind Treatment Phase|Adverse Event|0|||
44410102|NCT00843024|79417831|FG002|Double-blind Treatment Phase|Adverse Event|0|||
44410103|NCT00843024|79417832|FG003|Double-blind Treatment Phase|Adverse Event|0|||
44410104|NCT00843024|79417833|FG004|Double-blind Treatment Phase|Adverse Event|1|||
44410105|NCT00843024|79417834|FG005|Double-blind Treatment Phase|Adverse Event|1|||
44410106|NCT00843024|79417829|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
44410107|NCT00843024|79417830|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
44410108|NCT00843024|79417831|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
44410109|NCT00843024|79417832|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
44410110|NCT00843024|79417833|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
44410111|NCT00843024|79417834|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
44410112|NCT00832650|79417850|FG000|Overall Study|Randomized but not treated|0|||
44410113|NCT00832650|79417851|FG001|Overall Study|Randomized but not treated|0|||
44410114|NCT00832650|79417852|FG002|Overall Study|Randomized but not treated|1|||
44410115|NCT00595517|79417860|FG000|Overall Study|Adverse Event|6|||
44410116|NCT00595517|79417860|FG000|Overall Study|Withdrawal by Subject|4|||
44410117|NCT00595517|79417860|FG000|Overall Study|Protocol Violation|2|||
44410118|NCT00595517|79417860|FG000|Overall Study|Recurrence of ulcer|5|||
44410119|NCT00595517|79417860|FG000|Overall Study|usage of prohibited treatment|1|||
44410120|NCT00595517|79417860|FG000|Overall Study|No intention to attend regularly|1|||
44524866|NCT04493931|79533727|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
44410121|NCT00823836|79417866|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
44410122|NCT00823836|79417867|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
44410123|NCT00823836|79417866|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
44410124|NCT00823836|79417867|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
44410125|NCT00823836|79417866|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
44410126|NCT00823836|79417867|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
44410127|NCT00823836|79417866|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
44410128|NCT00823836|79417867|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
44410129|NCT00823836|79417866|FG000|Long-term Phase|Adverse Event|3|||
44410130|NCT00823836|79417867|FG001|Long-term Phase|Adverse Event|2|||
44410131|NCT00823836|79417866|FG000|Long-term Phase|Physician Decision|1|||
44410132|NCT00823836|79417867|FG001|Long-term Phase|Physician Decision|2|||
44410133|NCT00823836|79417866|FG000|Long-term Phase|Withdrawal by Subject|1|||
44410134|NCT00823836|79417867|FG001|Long-term Phase|Withdrawal by Subject|1|||
44410135|NCT00879437|79417876|FG000|Overall Study|Protocol Violation|0|||
44410136|NCT00879437|79417877|FG001|Overall Study|Protocol Violation|1|||
44410137|NCT00879437|79417876|FG000|Overall Study|Death|1|||
44148314|NCT01802632|78937843|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
44148315|NCT01802632|78937844|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
44410138|NCT00879437|79417877|FG001|Overall Study|Death|0|||
44410139|NCT00877799|79417890|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
44410140|NCT00877799|79417891|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
44410141|NCT00877799|79417892|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
44410142|NCT00877799|79417893|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
44410143|NCT00877799|79417894|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
44410144|NCT00877799|79417890|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
44410145|NCT00877799|79417891|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
44410146|NCT00877799|79417892|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
44410147|NCT00877799|79417893|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
44410148|NCT00877799|79417894|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
44410149|NCT00877799|79417890|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
44410150|NCT00877799|79417891|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
44410151|NCT00877799|79417892|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
44410152|NCT00877799|79417893|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
44410153|NCT00877799|79417894|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
44410154|NCT00877799|79417890|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
44410155|NCT00877799|79417891|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
44410156|NCT00877799|79417892|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
44410157|NCT00877799|79417893|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
44410158|NCT00877799|79417894|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
44410159|NCT00877799|79417890|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
44410160|NCT00877799|79417891|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
44410161|NCT00877799|79417892|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
44410162|NCT00877799|79417893|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
44410163|NCT00877799|79417894|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
44410164|NCT00595127|79417905|FG000|Overall Study|Death|6|||
44410165|NCT00595127|79417905|FG000|Overall Study|Relapsed|3|||
44410166|NCT00595127|79417905|FG000|Overall Study|joined another trial|1|||
44410167|NCT00877487|79417909|FG000|Open-label Treatment Phase|Adverse Event|1|||
44410168|NCT00877487|79417910|FG001|Open-label Treatment Phase|Adverse Event|0|||
44410169|NCT00877487|79417909|FG000|Open-label Treatment Phase|Protocol Violation|3|||
44410170|NCT00877487|79417910|FG001|Open-label Treatment Phase|Protocol Violation|0|||
44410171|NCT00877487|79417909|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
44410172|NCT00877487|79417910|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
44410173|NCT00877487|79417909|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
44410174|NCT00877487|79417910|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
44410175|NCT00877487|79417909|FG000|Open-label Treatment Phase|Out of country for business|1|||
44410176|NCT00877487|79417910|FG001|Open-label Treatment Phase|Out of country for business|0|||
44410177|NCT00877487|79417909|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
44524867|NCT04493931|79533728|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
44524868|NCT04493931|79533729|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
44148316|NCT01802632|78937845|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
44410178|NCT00877487|79417910|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
44410179|NCT00877487|79417909|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
44410180|NCT00877487|79417910|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
44410181|NCT00877487|79417909|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
44410182|NCT00877487|79417910|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
44410183|NCT00877487|79417909|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
44410184|NCT00877487|79417910|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
44410185|NCT00878501|79417919|FG000|Overall Study|Adverse Event|11|||
44410186|NCT00878501|79417920|FG001|Overall Study|Adverse Event|3|||
44410187|NCT00878501|79417921|FG002|Overall Study|Adverse Event|3|||
44524869|NCT04493931|79533730|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
44524870|NCT04493931|79533731|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
44410188|NCT00878501|79417919|FG000|Overall Study|Lack of Efficacy|2|||
44410189|NCT00878501|79417920|FG001|Overall Study|Lack of Efficacy|1|||
44410190|NCT00878501|79417921|FG002|Overall Study|Lack of Efficacy|0|||
44410191|NCT00878501|79417919|FG000|Overall Study|Withdrawal by Subject|2|||
44410192|NCT00878501|79417920|FG001|Overall Study|Withdrawal by Subject|1|||
44410193|NCT00878501|79417921|FG002|Overall Study|Withdrawal by Subject|2|||
44410194|NCT00878501|79417919|FG000|Overall Study|Protocol Violation|0|||
44410195|NCT00878501|79417920|FG001|Overall Study|Protocol Violation|0|||
44410196|NCT00878501|79417921|FG002|Overall Study|Protocol Violation|1|||
44410197|NCT00878501|79417919|FG000|Overall Study|Incorrect enrolment|1|||
44410198|NCT00878501|79417920|FG001|Overall Study|Incorrect enrolment|2|||
44410199|NCT00878501|79417921|FG002|Overall Study|Incorrect enrolment|0|||
44524871|NCT04493931|79533732|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
44524872|NCT04493931|79533726|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
44524873|NCT04493931|79533727|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
44524874|NCT04493931|79533728|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
44524875|NCT04493931|79533729|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
44524876|NCT04493931|79533730|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
44524877|NCT04493931|79533731|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
44524878|NCT04493931|79533732|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
44524879|NCT03437278|79533765|FG000|Overall Study|Adverse Event|0|||
44524880|NCT03437278|79533766|FG001|Overall Study|Adverse Event|0|||
44524881|NCT03437278|79533767|FG002|Overall Study|Adverse Event|1|||
44524882|NCT03437278|79533765|FG000|Overall Study|Progressive disease|1|||
44524883|NCT03437278|79533766|FG001|Overall Study|Progressive disease|0|||
44524884|NCT03437278|79533767|FG002|Overall Study|Progressive disease|0|||
44524885|NCT03437278|79533765|FG000|Overall Study|Physician Decision|1|||
44524886|NCT03437278|79533766|FG001|Overall Study|Physician Decision|0|||
44524887|NCT03437278|79533767|FG002|Overall Study|Physician Decision|1|||
44524888|NCT05935878|79533779|FG000|Overall Study|Death|1|||
44524889|NCT05935878|79533780|FG001|Overall Study|Death|2|||
44524890|NCT05935878|79533779|FG000|Overall Study|Withdrawal by Subject|5|||
44524891|NCT05935878|79533780|FG001|Overall Study|Withdrawal by Subject|5|||
44524892|NCT05935878|79533779|FG000|Overall Study|Revision of implant|1|||
44410200|NCT00878501|79417919|FG000|Overall Study|Intake of prohibited concom. medication|0|||
44410201|NCT00878501|79417920|FG001|Overall Study|Intake of prohibited concom. medication|0|||
44410202|NCT00878501|79417921|FG002|Overall Study|Intake of prohibited concom. medication|1|||
44410203|NCT00878501|79417919|FG000|Overall Study|Mis-randomisation of patient|1|||
44410204|NCT00878501|79417920|FG001|Overall Study|Mis-randomisation of patient|0|||
44410205|NCT00878501|79417921|FG002|Overall Study|Mis-randomisation of patient|0|||
44410206|NCT00878501|79417919|FG000|Overall Study|Administrative|0|||
44410207|NCT00878501|79417920|FG001|Overall Study|Administrative|0|||
44410208|NCT00878501|79417921|FG002|Overall Study|Administrative|1|||
44410209|NCT00882713|79417929|FG000|Overall Study|Adverse Event|2|||
44253755|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
44253756|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
44410210|NCT00882713|79417929|FG000|Overall Study|Death|3|||
44410211|NCT00882713|79417929|FG000|Overall Study|Administrative reasons|4|||
44410212|NCT00882713|79417929|FG000|Overall Study|refused treatment/withdrew consent|4|||
44410213|NCT00882713|79417929|FG000|Overall Study|Blood transfusion|2|||
44410214|NCT00882713|79417929|FG000|Overall Study|Insufficient therapeutic response|3|||
44410215|NCT00882713|79417929|FG000|Overall Study|Failure to return|2|||
44410216|NCT00882713|79417929|FG000|Overall Study|Other - Reasons|2|||
44410217|NCT00809133|79417948|FG000|Overall Study|Progressive disease|2|||
44524893|NCT05935878|79533780|FG001|Overall Study|Revision of implant|1|||
44253757|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
44410218|NCT00809133|79417949|FG001|Overall Study|Progressive disease|5|||
44410219|NCT00809133|79417950|FG002|Overall Study|Progressive disease|5|||
44410220|NCT00809133|79417951|FG003|Overall Study|Progressive disease|3|||
44410221|NCT00809133|79417952|FG004|Overall Study|Progressive disease|4|||
44410222|NCT00809133|79417953|FG005|Overall Study|Progressive disease|1|||
44410223|NCT00809133|79417954|FG006|Overall Study|Progressive disease|3|||
44410224|NCT00809133|79417955|FG007|Overall Study|Progressive disease|3|||
44410225|NCT00809133|79417956|FG008|Overall Study|Progressive disease|3|||
44410226|NCT00809133|79417957|FG009|Overall Study|Progressive disease|9|||
44410227|NCT00809133|79417958|FG010|Overall Study|Progressive disease|5|||
44410228|NCT00809133|79417959|FG011|Overall Study|Progressive disease|7|||
44410229|NCT00809133|79417960|FG012|Overall Study|Progressive disease|5|||
44410230|NCT00809133|79417961|FG013|Overall Study|Progressive disease|4|||
44410231|NCT00809133|79417948|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410232|NCT00809133|79417949|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410233|NCT00809133|79417950|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410234|NCT00809133|79417951|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410235|NCT00809133|79417952|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410236|NCT00809133|79417953|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44410237|NCT00809133|79417954|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44410238|NCT00809133|79417955|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
44410239|NCT00809133|79417956|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410240|NCT00809133|79417957|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410241|NCT00809133|79417958|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410242|NCT00809133|79417959|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410243|NCT00809133|79417960|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44410244|NCT00809133|79417961|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
44410245|NCT00809133|79417948|FG000|Overall Study|Other adverse event|1|||
44410246|NCT00809133|79417949|FG001|Overall Study|Other adverse event|1|||
44410247|NCT00809133|79417950|FG002|Overall Study|Other adverse event|1|||
44410248|NCT00809133|79417951|FG003|Overall Study|Other adverse event|0|||
44410249|NCT00809133|79417952|FG004|Overall Study|Other adverse event|0|||
44410250|NCT00809133|79417953|FG005|Overall Study|Other adverse event|3|||
44410251|NCT00809133|79417954|FG006|Overall Study|Other adverse event|2|||
44410252|NCT00809133|79417955|FG007|Overall Study|Other adverse event|4|||
44410253|NCT00809133|79417956|FG008|Overall Study|Other adverse event|0|||
44410254|NCT00809133|79417957|FG009|Overall Study|Other adverse event|0|||
44410255|NCT00809133|79417958|FG010|Overall Study|Other adverse event|1|||
44410256|NCT00809133|79417959|FG011|Overall Study|Other adverse event|1|||
44410257|NCT00809133|79417960|FG012|Overall Study|Other adverse event|0|||
44410258|NCT00809133|79417961|FG013|Overall Study|Other adverse event|1|||
44410259|NCT00809133|79417948|FG000|Overall Study|Lost to Follow-up|0|||
44410260|NCT00809133|79417949|FG001|Overall Study|Lost to Follow-up|0|||
44410261|NCT00809133|79417950|FG002|Overall Study|Lost to Follow-up|0|||
44410262|NCT00809133|79417951|FG003|Overall Study|Lost to Follow-up|0|||
44410263|NCT00809133|79417952|FG004|Overall Study|Lost to Follow-up|0|||
44410264|NCT00809133|79417953|FG005|Overall Study|Lost to Follow-up|1|||
44410265|NCT00809133|79417954|FG006|Overall Study|Lost to Follow-up|0|||
44410266|NCT00809133|79417955|FG007|Overall Study|Lost to Follow-up|0|||
44410267|NCT00809133|79417956|FG008|Overall Study|Lost to Follow-up|0|||
44410268|NCT00809133|79417957|FG009|Overall Study|Lost to Follow-up|0|||
44410269|NCT00809133|79417958|FG010|Overall Study|Lost to Follow-up|0|||
44410270|NCT00809133|79417959|FG011|Overall Study|Lost to Follow-up|0|||
44410271|NCT00809133|79417960|FG012|Overall Study|Lost to Follow-up|0|||
44410272|NCT00809133|79417961|FG013|Overall Study|Lost to Follow-up|0|||
44410273|NCT00809133|79417948|FG000|Overall Study|Consent withdrawn|0|||
44410274|NCT00809133|79417949|FG001|Overall Study|Consent withdrawn|0|||
44410275|NCT00809133|79417950|FG002|Overall Study|Consent withdrawn|0|||
44410276|NCT00809133|79417951|FG003|Overall Study|Consent withdrawn|0|||
44410277|NCT00809133|79417952|FG004|Overall Study|Consent withdrawn|1|||
44410278|NCT00809133|79417953|FG005|Overall Study|Consent withdrawn|0|||
44410279|NCT00809133|79417954|FG006|Overall Study|Consent withdrawn|0|||
44410280|NCT00809133|79417955|FG007|Overall Study|Consent withdrawn|0|||
44410281|NCT00809133|79417956|FG008|Overall Study|Consent withdrawn|0|||
44410282|NCT00809133|79417957|FG009|Overall Study|Consent withdrawn|0|||
44410283|NCT00809133|79417958|FG010|Overall Study|Consent withdrawn|0|||
44410284|NCT00809133|79417959|FG011|Overall Study|Consent withdrawn|0|||
44410285|NCT00809133|79417960|FG012|Overall Study|Consent withdrawn|0|||
44524894|NCT05935878|79533779|FG000|Overall Study|Mobile bearing dislocation|0|||
44410286|NCT00809133|79417961|FG013|Overall Study|Consent withdrawn|0|||
44410287|NCT00809133|79417948|FG000|Overall Study|Other not mentioned above|0|||
44410288|NCT00809133|79417949|FG001|Overall Study|Other not mentioned above|1|||
44410289|NCT00809133|79417950|FG002|Overall Study|Other not mentioned above|0|||
44410290|NCT00809133|79417951|FG003|Overall Study|Other not mentioned above|0|||
44410291|NCT00809133|79417952|FG004|Overall Study|Other not mentioned above|0|||
44410292|NCT00809133|79417953|FG005|Overall Study|Other not mentioned above|1|||
44410293|NCT00809133|79417954|FG006|Overall Study|Other not mentioned above|0|||
44410294|NCT00809133|79417955|FG007|Overall Study|Other not mentioned above|0|||
44410295|NCT00809133|79417956|FG008|Overall Study|Other not mentioned above|0|||
44410296|NCT00809133|79417957|FG009|Overall Study|Other not mentioned above|0|||
44410297|NCT00809133|79417958|FG010|Overall Study|Other not mentioned above|0|||
44410298|NCT00809133|79417959|FG011|Overall Study|Other not mentioned above|0|||
44410299|NCT00809133|79417960|FG012|Overall Study|Other not mentioned above|0|||
44410300|NCT00809133|79417961|FG013|Overall Study|Other not mentioned above|0|||
44410301|NCT00882557|79418006|FG000|Overall Study|Withdrawal by Subject|1|||
44410302|NCT00882557|79418007|FG001|Overall Study|Withdrawal by Subject|0|||
44410303|NCT00882557|79418006|FG000|Overall Study|Trouble with Vein Access|1|||
44410304|NCT00882557|79418007|FG001|Overall Study|Trouble with Vein Access|0|||
44410305|NCT00882557|79418006|FG000|Overall Study|Randomized Not Treated|0|||
44410306|NCT00882557|79418007|FG001|Overall Study|Randomized Not Treated|1|||
44410307|NCT00808899|79418013|FG000|Overall Study|Death|1|||
44410308|NCT00808899|79418013|FG000|Overall Study|Physician Decision|3|||
44410309|NCT00808665|79418019|FG000|Overall Study|Withdrawal by Subject|1|||
44410310|NCT00808665|79418020|FG001|Overall Study|Withdrawal by Subject|0|||
44410311|NCT00808665|79418019|FG000|Overall Study|only required minimally invasive surgery|1|||
44410312|NCT00808665|79418020|FG001|Overall Study|only required minimally invasive surgery|0|||
44410313|NCT00808665|79418019|FG000|Overall Study|surgery cancelled|1|||
44410314|NCT00808665|79418020|FG001|Overall Study|surgery cancelled|0|||
44410315|NCT00808665|79418019|FG000|Overall Study|required an additional procedure|0|||
44410316|NCT00808665|79418020|FG001|Overall Study|required an additional procedure|1|||
44410317|NCT00808665|79418019|FG000|Overall Study|Physician Decision|3|||
44410318|NCT00808665|79418020|FG001|Overall Study|Physician Decision|1|||
44410319|NCT00808665|79418019|FG000|Overall Study|Medication stopped by resident|0|||
44410320|NCT00808665|79418020|FG001|Overall Study|Medication stopped by resident|1|||
44410321|NCT00808509|79418028|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
44410322|NCT00808509|79418029|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
44410323|NCT00808509|79418028|FG000|Randomized Phase|Reduced methotrexate dose|1|||
44410324|NCT00808509|79418029|FG001|Randomized Phase|Reduced methotrexate dose|2|||
44410325|NCT00808509|79418028|FG000|Randomized Phase|Patient refused rescue therapy|0|||
44410326|NCT00808509|79418029|FG001|Randomized Phase|Patient refused rescue therapy|3|||
44410327|NCT00807885|79418046|FG000|Overall Study|Lost to Follow-up|0|||
44410328|NCT00807885|79418047|FG001|Overall Study|Lost to Follow-up|0|||
44410329|NCT00807885|79418048|FG002|Overall Study|Lost to Follow-up|0|||
44410330|NCT00807885|79418049|FG003|Overall Study|Lost to Follow-up|0|||
44410331|NCT00807885|79418050|FG004|Overall Study|Lost to Follow-up|0|||
44410332|NCT00807885|79418051|FG005|Overall Study|Lost to Follow-up|1|||
44410333|NCT00807885|79418052|FG006|Overall Study|Lost to Follow-up|0|||
44410334|NCT00807885|79418053|FG007|Overall Study|Lost to Follow-up|0|||
44410335|NCT00807885|79418054|FG008|Overall Study|Lost to Follow-up|0|||
44410336|NCT00807573|79418074|FG000|Overall Study|Withdrawal by Subject|1|||
44410337|NCT00807573|79418074|FG000|Overall Study|Adverse Event|1|||
44410338|NCT00842712|79418085|FG000|Safety Run-in Part|Adverse Event|0|||
44410339|NCT00842712|79418086|FG001|Safety Run-in Part|Adverse Event|1|||
44410340|NCT00842712|79418087|FG002|Safety Run-in Part|Adverse Event|0|||
44410341|NCT00842712|79418088|FG003|Safety Run-in Part|Adverse Event|0|||
44410342|NCT00842712|79418089|FG004|Safety Run-in Part|Adverse Event|0|||
44410343|NCT00842712|79418090|FG005|Safety Run-in Part|Adverse Event|0|||
44410344|NCT00842712|79418091|FG006|Safety Run-in Part|Adverse Event|0|||
44410345|NCT00842712|79418085|FG000|Safety Run-in Part|Progressive disease|3|||
44410346|NCT00842712|79418086|FG001|Safety Run-in Part|Progressive disease|1|||
44410347|NCT00842712|79418087|FG002|Safety Run-in Part|Progressive disease|0|||
44410348|NCT00842712|79418088|FG003|Safety Run-in Part|Progressive disease|1|||
44410349|NCT00842712|79418089|FG004|Safety Run-in Part|Progressive disease|0|||
44410350|NCT00842712|79418090|FG005|Safety Run-in Part|Progressive disease|0|||
44410351|NCT00842712|79418091|FG006|Safety Run-in Part|Progressive disease|0|||
44410352|NCT00842712|79418085|FG000|Randomized Part|Randomized but not treated|0|||
44410353|NCT00842712|79418086|FG001|Randomized Part|Randomized but not treated|0|||
44410354|NCT00842712|79418087|FG002|Randomized Part|Randomized but not treated|0|||
44410355|NCT00842712|79418088|FG003|Randomized Part|Randomized but not treated|0|||
44410356|NCT00842712|79418089|FG004|Randomized Part|Randomized but not treated|0|||
44410357|NCT00842712|79418090|FG005|Randomized Part|Randomized but not treated|1|||
44410358|NCT00842712|79418091|FG006|Randomized Part|Randomized but not treated|4|||
44410359|NCT00842712|79418085|FG000|Randomized Part|Ongoing at cut-off date|0|||
44410360|NCT00842712|79418086|FG001|Randomized Part|Ongoing at cut-off date|0|||
44410361|NCT00842712|79418087|FG002|Randomized Part|Ongoing at cut-off date|0|||
44410362|NCT00842712|79418088|FG003|Randomized Part|Ongoing at cut-off date|0|||
44410363|NCT00842712|79418089|FG004|Randomized Part|Ongoing at cut-off date|0|||
44282141|NCT01880424|79245400|FG000|Overall Study|Lack of Efficacy|1|||
44410364|NCT00842712|79418090|FG005|Randomized Part|Ongoing at cut-off date|0|||
44410365|NCT00842712|79418091|FG006|Randomized Part|Ongoing at cut-off date|2|||
44410366|NCT00842244|79418107|FG000|Overall Study|Death|3|||
44410367|NCT00842244|79418107|FG000|Overall Study|Withdrawal by Subject|1|||
44410368|NCT00842244|79418107|FG000|Overall Study|Other|17|||
44410369|NCT00832416|79418118|FG000|Overall Study|Lack of Efficacy|17|||
44410370|NCT00832416|79418119|FG001|Overall Study|Lack of Efficacy|15|||
44410371|NCT00832416|79418120|FG002|Overall Study|Lack of Efficacy|13|||
44410372|NCT00832416|79418121|FG003|Overall Study|Lack of Efficacy|52|||
44410373|NCT00832416|79418118|FG000|Overall Study|Withdrawal by Subject|5|||
44410374|NCT00832416|79418119|FG001|Overall Study|Withdrawal by Subject|7|||
44410375|NCT00832416|79418120|FG002|Overall Study|Withdrawal by Subject|2|||
44410376|NCT00832416|79418121|FG003|Overall Study|Withdrawal by Subject|10|||
44410377|NCT00832416|79418118|FG000|Overall Study|Physician Decision|2|||
44410378|NCT00832416|79418119|FG001|Overall Study|Physician Decision|12|||
44410379|NCT00832416|79418120|FG002|Overall Study|Physician Decision|5|||
44410380|NCT00832416|79418121|FG003|Overall Study|Physician Decision|10|||
44410381|NCT00832416|79418118|FG000|Overall Study|Administrative|0|||
44410382|NCT00832416|79418119|FG001|Overall Study|Administrative|0|||
44410383|NCT00832416|79418120|FG002|Overall Study|Administrative|0|||
44410384|NCT00832416|79418121|FG003|Overall Study|Administrative|1|||
44410385|NCT00832416|79418118|FG000|Overall Study|Adverse Event|21|||
44410386|NCT00832416|79418119|FG001|Overall Study|Adverse Event|19|||
44410387|NCT00832416|79418120|FG002|Overall Study|Adverse Event|41|||
44410388|NCT00832416|79418121|FG003|Overall Study|Adverse Event|10|||
44410389|NCT00832416|79418118|FG000|Overall Study|Death|1|||
44410390|NCT00832416|79418119|FG001|Overall Study|Death|0|||
44410391|NCT00832416|79418120|FG002|Overall Study|Death|0|||
44410392|NCT00832416|79418121|FG003|Overall Study|Death|0|||
44410393|NCT00841776|79418133|FG000|Overall Study|Lack of Efficacy|0|||
44410394|NCT00841776|79418134|FG001|Overall Study|Lack of Efficacy|1|||
44410395|NCT00841776|79418133|FG000|Overall Study|Lost to Follow-up|2|||
44410396|NCT00841776|79418134|FG001|Overall Study|Lost to Follow-up|1|||
44410397|NCT00841776|79418133|FG000|Overall Study|Withdrawal by Subject|0|||
44410398|NCT00841776|79418134|FG001|Overall Study|Withdrawal by Subject|1|||
44410399|NCT00683800|79418142|FG000|Overall Study|Adverse Event|195|||
44410400|NCT00683800|79418143|FG001|Overall Study|Adverse Event|102|||
44410401|NCT00683800|79418142|FG000|Overall Study|Death|0|||
44410402|NCT00683800|79418143|FG001|Overall Study|Death|1|||
44410403|NCT00683800|79418142|FG000|Overall Study|Lost to Follow-up|57|||
44410404|NCT00683800|79418143|FG001|Overall Study|Lost to Follow-up|44|||
44410405|NCT00683800|79418142|FG000|Overall Study|Other|5|||
44410406|NCT00683800|79418143|FG001|Overall Study|Other|2|||
44410407|NCT00683800|79418142|FG000|Overall Study|Protocol Violation|13|||
44410408|NCT00683800|79418143|FG001|Overall Study|Protocol Violation|16|||
44410409|NCT00683800|79418142|FG000|Overall Study|Withdrawal by Subject|66|||
44410410|NCT00683800|79418143|FG001|Overall Study|Withdrawal by Subject|64|||
44410411|NCT00683800|79418142|FG000|Overall Study|Lack of Efficacy|61|||
44410412|NCT00683800|79418143|FG001|Overall Study|Lack of Efficacy|104|||
44410413|NCT00683800|79418142|FG000|Overall Study|Randomized, not treated|35|||
44410414|NCT00683800|79418143|FG001|Overall Study|Randomized, not treated|33|||
44410415|NCT00683644|79418151|FG000|Overall Study|Withdrawal by Subject|4|||
44410416|NCT00683644|79418152|FG001|Overall Study|Withdrawal by Subject|2|||
44410417|NCT00683644|79418151|FG000|Overall Study|Lost to Follow-up|1|||
44410418|NCT00683644|79418152|FG001|Overall Study|Lost to Follow-up|4|||
44410419|NCT00683644|79418151|FG000|Overall Study|Adverse Event|1|||
44410420|NCT00683644|79418152|FG001|Overall Study|Adverse Event|2|||
44410421|NCT00683644|79418151|FG000|Overall Study|Low copper, other health problems,|7|||
44410422|NCT00683644|79418152|FG001|Overall Study|Low copper, other health problems,|6|||
44410423|NCT00685360|79418165|FG000|Overall Study|Lost to Follow-up|0|||
44410424|NCT00685360|79418166|FG001|Overall Study|Lost to Follow-up|1|||
44410425|NCT00685360|79418167|FG002|Overall Study|Lost to Follow-up|2|||
44410426|NCT00685360|79418165|FG000|Overall Study|Adverse Event|4|||
44410427|NCT00685360|79418166|FG001|Overall Study|Adverse Event|6|||
44410428|NCT00685360|79418167|FG002|Overall Study|Adverse Event|4|||
44410429|NCT00685360|79418165|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
44410430|NCT00685360|79418166|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
44410431|NCT00685360|79418167|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
44410432|NCT00685360|79418165|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
44410433|NCT00685360|79418166|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
44410434|NCT00685360|79418167|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
44410435|NCT00685360|79418165|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
44410436|NCT00685360|79418166|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
44410437|NCT00685360|79418167|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
44410438|NCT00685360|79418165|FG000|Overall Study|Protocol Deviation|0|||
44410439|NCT00685360|79418166|FG001|Overall Study|Protocol Deviation|1|||
44410440|NCT00685360|79418167|FG002|Overall Study|Protocol Deviation|1|||
44410441|NCT00684814|79418175|FG000|Washout Period of 7 Days|Adverse Event|1|||
44410442|NCT00684814|79418176|FG001|Washout Period of 7 Days|Adverse Event|2|||
44410443|NCT00684814|79418175|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
44410444|NCT00684814|79418176|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
44410445|NCT00684814|79418175|FG000|Second Intervention|Adverse Event|1|||
44410446|NCT00684814|79418176|FG001|Second Intervention|Adverse Event|0|||
44410447|NCT00576472|79418197|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410448|NCT00576472|79418198|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410449|NCT00576472|79418199|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410450|NCT00576472|79418200|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
44410451|NCT00576472|79418201|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410452|NCT00576472|79418202|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410453|NCT00576472|79418203|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410454|NCT00576472|79418204|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410455|NCT00576472|79418205|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410456|NCT00576472|79418206|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410457|NCT00576472|79418207|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410458|NCT00576472|79418208|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
44148317|NCT01802632|78937846|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
44148318|NCT01802632|78937847|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
44148319|NCT01802632|78937842|FG000|Overall Study|Other (not specified)|0|||
44148320|NCT01802632|78937843|FG001|Overall Study|Other (not specified)|0|||
44148321|NCT01802632|78937844|FG002|Overall Study|Other (not specified)|7|||
44148322|NCT01802632|78937845|FG003|Overall Study|Other (not specified)|1|||
44148323|NCT01802632|78937846|FG004|Overall Study|Other (not specified)|0|||
44148324|NCT01802632|78937847|FG005|Overall Study|Other (not specified)|1|||
44148325|NCT01782131|78937861|FG000|Overall Study|Death|93|||
44148326|NCT01782131|78937862|FG001|Overall Study|Death|96|||
44253758|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
44253759|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
44410459|NCT00576472|79418209|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410460|NCT00576472|79418210|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410461|NCT00576472|79418211|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
44410462|NCT00576472|79418197|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
44410463|NCT00576472|79418198|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
44410464|NCT00576472|79418199|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
44410465|NCT00576472|79418200|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
44410466|NCT00576472|79418201|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
44410467|NCT00576472|79418202|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
44410468|NCT00576472|79418203|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
44410469|NCT00576472|79418204|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
44410470|NCT00576472|79418205|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
44410471|NCT00576472|79418206|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
44410472|NCT00576472|79418207|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
44410473|NCT00576472|79418208|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
44410474|NCT00576472|79418209|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
44410475|NCT00576472|79418210|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
44410476|NCT00576472|79418211|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
44410477|NCT00576472|79418197|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410478|NCT00576472|79418198|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410479|NCT00576472|79418199|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410480|NCT00576472|79418200|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
44410481|NCT00576472|79418201|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410482|NCT00576472|79418202|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410483|NCT00576472|79418203|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410484|NCT00576472|79418204|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410485|NCT00576472|79418205|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410486|NCT00576472|79418206|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410487|NCT00576472|79418207|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410488|NCT00576472|79418208|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410489|NCT00576472|79418209|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410490|NCT00576472|79418210|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410491|NCT00576472|79418211|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
44410492|NCT00576472|79418197|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
44524895|NCT05935878|79533780|FG001|Overall Study|Mobile bearing dislocation|1|||
44148327|NCT01782131|78937861|FG000|Overall Study|Lost to Follow-up|1|||
44148328|NCT01782131|78937862|FG001|Overall Study|Lost to Follow-up|3|||
44253760|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253761|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44524896|NCT05382104|79533805|FG000|Period 2 (2 Days)|Adverse Event|0|||
44524897|NCT05382104|79533806|FG001|Period 2 (2 Days)|Adverse Event|1|||
44524898|NCT05382104|79533807|FG002|Period 2 (2 Days)|Adverse Event|0|||
44524899|NCT05382104|79533808|FG003|Period 2 (2 Days)|Adverse Event|0|||
44524900|NCT05382104|79533809|FG004|Period 2 (2 Days)|Adverse Event|0|||
44524901|NCT05382104|79533810|FG005|Period 2 (2 Days)|Adverse Event|0|||
44524902|NCT05277337|79533820|FG000|Overall Study|Lost to Follow-up|2|||
44524903|NCT05277337|79533821|FG001|Overall Study|Lost to Follow-up|0|||
44524904|NCT05277337|79533820|FG000|Overall Study|Withdrawal by Subject|1|||
44148329|NCT01782131|78937861|FG000|Overall Study|Withdrawal by Subject|10|||
44282142|NCT01880424|79245401|FG001|Overall Study|Lack of Efficacy|4|||
44282143|NCT01880424|79245400|FG000|Overall Study|Lost to Follow-up|3|||
44282144|NCT01880424|79245401|FG001|Overall Study|Lost to Follow-up|2|||
44282145|NCT01880424|79245400|FG000|Overall Study|Protocol Violation|11|||
44282146|NCT01880424|79245401|FG001|Overall Study|Protocol Violation|13|||
44282147|NCT01880424|79245400|FG000|Overall Study|Withdrawal by Subject|10|||
44524905|NCT05277337|79533821|FG001|Overall Study|Withdrawal by Subject|0|||
44148330|NCT01782131|78937862|FG001|Overall Study|Withdrawal by Subject|10|||
44148331|NCT01782131|78937861|FG000|Overall Study|Randomized but not treated|5|||
44148332|NCT01782131|78937862|FG001|Overall Study|Randomized but not treated|5|||
44148333|NCT01782131|78937861|FG000|Overall Study|Reason not provided|0|||
44148334|NCT01782131|78937862|FG001|Overall Study|Reason not provided|1|||
44148335|NCT01903733|78937881|FG000|Overall Study|Death|23|||
44148336|NCT01903733|78937882|FG001|Overall Study|Death|54|||
44148337|NCT01903733|78937883|FG002|Overall Study|Death|30|||
44148338|NCT01903733|78937884|FG003|Overall Study|Death|98|||
44148339|NCT01903733|78937881|FG000|Overall Study|Participant refused further follow-up|35|||
44148340|NCT01903733|78937882|FG001|Overall Study|Participant refused further follow-up|38|||
44148341|NCT01903733|78937883|FG002|Overall Study|Participant refused further follow-up|13|||
44148342|NCT01903733|78937884|FG003|Overall Study|Participant refused further follow-up|9|||
44148343|NCT01903733|78937881|FG000|Overall Study|Lost to Follow-up|18|||
44148344|NCT01903733|78937882|FG001|Overall Study|Lost to Follow-up|19|||
44148345|NCT01903733|78937883|FG002|Overall Study|Lost to Follow-up|6|||
44148346|NCT01903733|78937884|FG003|Overall Study|Lost to Follow-up|9|||
44148347|NCT01903733|78937881|FG000|Overall Study|Other|10|||
44148348|NCT01903733|78937882|FG001|Overall Study|Other|15|||
44148349|NCT01903733|78937883|FG002|Overall Study|Other|12|||
44148350|NCT01903733|78937884|FG003|Overall Study|Other|3|||
44148351|NCT01903733|78937881|FG000|Overall Study|Missing|2|||
44148352|NCT01903733|78937882|FG001|Overall Study|Missing|0|||
44148353|NCT01903733|78937883|FG002|Overall Study|Missing|0|||
44148354|NCT01903733|78937884|FG003|Overall Study|Missing|0|||
44148355|NCT01903733|78937881|FG000|Overall Study|Investigator request|18|||
44148356|NCT01903733|78937882|FG001|Overall Study|Investigator request|0|||
44148357|NCT01903733|78937883|FG002|Overall Study|Investigator request|0|||
44148358|NCT01903733|78937884|FG003|Overall Study|Investigator request|0|||
44148359|NCT01375205|78937906|FG000|Overall Study|Lost to Follow-up|15|||
44148360|NCT01375205|78937907|FG001|Overall Study|Lost to Follow-up|12|||
44148361|NCT01375205|78937906|FG000|Overall Study|Withdrawal by Subject|6|||
44148362|NCT01375205|78937907|FG001|Overall Study|Withdrawal by Subject|1|||
44148363|NCT00700271|78937915|FG000|Overall Study|Adverse Event|4|||
44148364|NCT00700271|78937916|FG001|Overall Study|Adverse Event|6|||
44148365|NCT00700271|78937915|FG000|Overall Study|Protocol Violation|1|||
44148366|NCT00700271|78937916|FG001|Overall Study|Protocol Violation|0|||
44148367|NCT00700271|78937915|FG000|Overall Study|Administrative Reasons|1|||
44148368|NCT00700271|78937916|FG001|Overall Study|Administrative Reasons|0|||
44148369|NCT00700271|78937915|FG000|Overall Study|Withdrawal by Subject|6|||
44148370|NCT00700271|78937916|FG001|Overall Study|Withdrawal by Subject|4|||
44148371|NCT00700271|78937915|FG000|Overall Study|Lost to Follow-up|2|||
44148372|NCT00700271|78937916|FG001|Overall Study|Lost to Follow-up|2|||
44148373|NCT01375049|78937922|FG000|Overall Study|Adverse Event|2|||
44148374|NCT01375049|78937922|FG000|Overall Study|Lost to Follow-up|1|||
44148375|NCT01375049|78937922|FG000|Overall Study|Withdrawal by Subject|2|||
44148376|NCT01375049|78937922|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
44148377|NCT01594749|78937932|FG000|Overall Study|Adverse Event|2|||
44148378|NCT01594749|78937933|FG001|Overall Study|Adverse Event|1|||
44148379|NCT01594749|78937932|FG000|Overall Study|Withdrawal by Subject|2|||
44148380|NCT01594749|78937933|FG001|Overall Study|Withdrawal by Subject|2|||
44148381|NCT01594749|78937932|FG000|Overall Study|Protocol Violation|2|||
44148382|NCT01594749|78937933|FG001|Overall Study|Protocol Violation|0|||
44148383|NCT01594749|78937932|FG000|Overall Study|Physician Decision|1|||
44148384|NCT01594749|78937933|FG001|Overall Study|Physician Decision|1|||
44148385|NCT01594749|78937932|FG000|Overall Study|Non-compliance with Protocol|0|||
44148386|NCT01594749|78937933|FG001|Overall Study|Non-compliance with Protocol|1|||
44148387|NCT01594749|78937932|FG000|Overall Study|Lost to Follow-up|1|||
44148388|NCT01594749|78937933|FG001|Overall Study|Lost to Follow-up|0|||
44148389|NCT01594749|78937932|FG000|Overall Study|Death|9|||
44148390|NCT01594749|78937933|FG001|Overall Study|Death|3|||
44148391|NCT01594749|78937932|FG000|Overall Study|Not Treated|4|||
44148392|NCT01594749|78937933|FG001|Overall Study|Not Treated|10|||
44148393|NCT01594749|78937932|FG000|Overall Study|Lost Source Documentation|1|||
44148394|NCT01594749|78937933|FG001|Overall Study|Lost Source Documentation|0|||
44148395|NCT02179918|78937944|FG000|Overall Study|Death|0|||
44148396|NCT02179918|78937945|FG001|Overall Study|Death|0|||
44282148|NCT01880424|79245401|FG001|Overall Study|Withdrawal by Subject|30|||
44148397|NCT02179918|78937946|FG002|Overall Study|Death|0|||
44148398|NCT02179918|78937947|FG003|Overall Study|Death|1|||
44148399|NCT02179918|78937948|FG004|Overall Study|Death|0|||
44148400|NCT02179918|78937944|FG000|Overall Study|Lost to Follow-up|0|||
44148401|NCT02179918|78937945|FG001|Overall Study|Lost to Follow-up|0|||
44148402|NCT02179918|78937946|FG002|Overall Study|Lost to Follow-up|1|||
44148403|NCT02179918|78937947|FG003|Overall Study|Lost to Follow-up|0|||
44148404|NCT02179918|78937948|FG004|Overall Study|Lost to Follow-up|0|||
44148405|NCT02179918|78937944|FG000|Overall Study|Progressive Disease|4|||
44148406|NCT02179918|78937945|FG001|Overall Study|Progressive Disease|1|||
44148407|NCT02179918|78937946|FG002|Overall Study|Progressive Disease|1|||
44148408|NCT02179918|78937947|FG003|Overall Study|Progressive Disease|2|||
44148409|NCT02179918|78937948|FG004|Overall Study|Progressive Disease|6|||
44253762|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253763|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253764|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253765|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44148410|NCT02179918|78937944|FG000|Overall Study|Other|0|||
44148411|NCT02179918|78937945|FG001|Overall Study|Other|1|||
44148412|NCT02179918|78937946|FG002|Overall Study|Other|0|||
44148413|NCT02179918|78937947|FG003|Overall Study|Other|0|||
44253766|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44524906|NCT05173974|79533828|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
44524907|NCT05173974|79533829|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
44524908|NCT05173974|79533830|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
44524909|NCT05173974|79533831|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
44524910|NCT05173974|79533828|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
44524911|NCT05173974|79533829|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
44148414|NCT02179918|78937948|FG004|Overall Study|Other|1|||
44148415|NCT02179918|78937944|FG000|Overall Study|Subject refused further follow-up|0|||
44148416|NCT02179918|78937945|FG001|Overall Study|Subject refused further follow-up|1|||
44148417|NCT02179918|78937946|FG002|Overall Study|Subject refused further follow-up|0|||
44148418|NCT02179918|78937947|FG003|Overall Study|Subject refused further follow-up|0|||
44148419|NCT02179918|78937948|FG004|Overall Study|Subject refused further follow-up|1|||
44148420|NCT02611479|78937961|FG000|Baseline Enrollment|Exited study|13|||
44148421|NCT02611479|78937961|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
44148422|NCT02611479|78937961|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
44148423|NCT02611479|78937961|FG000|Data Cleaning|No baseline function or pain metrics|2|||
44148424|NCT02153788|78937967|FG000|Overall Study|Physician Decision|2|||
44148425|NCT02153788|78937968|FG001|Overall Study|Physician Decision|1|||
44148426|NCT02153398|78937979|FG000|Overall Study|Withdrawal by Subject|1|||
44148427|NCT02153398|78937980|FG001|Overall Study|Withdrawal by Subject|0|||
44253767|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253768|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44524912|NCT05173974|79533830|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
44524913|NCT05173974|79533831|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
44524914|NCT04718194|79533865|FG000|Overall Study|Withdrawal by Subject|3|||
44524915|NCT04718194|79533866|FG001|Overall Study|Withdrawal by Subject|0|||
44524916|NCT04718194|79533865|FG000|Overall Study|Lost to Follow-up|3|||
44524917|NCT04718194|79533866|FG001|Overall Study|Lost to Follow-up|0|||
44524918|NCT04652453|79533875|FG000|Overall Study|Death|8|||
44524919|NCT04652453|79533876|FG001|Overall Study|Death|2|||
44524920|NCT04652453|79533877|FG002|Overall Study|Death|0|||
44524921|NCT04652453|79533875|FG000|Overall Study|Hospice|5|||
44524922|NCT04652453|79533876|FG001|Overall Study|Hospice|5|||
44524923|NCT04652453|79533877|FG002|Overall Study|Hospice|0|||
44524924|NCT04652453|79533875|FG000|Overall Study|Withdrawal by Subject|2|||
44524925|NCT04652453|79533876|FG001|Overall Study|Withdrawal by Subject|0|||
44524926|NCT04652453|79533877|FG002|Overall Study|Withdrawal by Subject|0|||
44524927|NCT04530136|79533885|FG000|Overall Study|Lost to Follow-up|2|||
44524928|NCT04530136|79533886|FG001|Overall Study|Lost to Follow-up|3|||
44524929|NCT04530136|79533885|FG000|Overall Study|Withdrawal by Subject|1|||
44524930|NCT04530136|79533886|FG001|Overall Study|Withdrawal by Subject|0|||
44524931|NCT04530136|79533885|FG000|Overall Study|Death|0|||
44524932|NCT04530136|79533886|FG001|Overall Study|Death|1|||
44524933|NCT04040439|79533909|FG000|Overall Study|Invalid registration|11|||
44524934|NCT04040439|79533909|FG000|Overall Study|No IC* on publication of study results|2|||
44524935|NCT03814746|79533916|FG000|Overall Study|Participant decision|9|||
44524936|NCT03814746|79533917|FG001|Overall Study|Participant decision|6|||
44524937|NCT03814746|79533918|FG002|Overall Study|Participant decision|15|||
44524938|NCT03814746|79533916|FG000|Overall Study|Physician Decision|2|||
44524939|NCT03814746|79533917|FG001|Overall Study|Physician Decision|2|||
44524940|NCT03814746|79533918|FG002|Overall Study|Physician Decision|4|||
44524941|NCT03814746|79533916|FG000|Overall Study|Death|2|||
44524942|NCT03814746|79533917|FG001|Overall Study|Death|2|||
44148428|NCT02153398|78937981|FG002|Overall Study|Withdrawal by Subject|0|||
44148429|NCT02153398|78937982|FG003|Overall Study|Withdrawal by Subject|0|||
44148430|NCT02153398|78937983|FG004|Overall Study|Withdrawal by Subject|0|||
44253769|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253770|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
44253771|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253772|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253773|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
44253774|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253775|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253776|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
44253777|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
44253778|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
44253779|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
44253780|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253781|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253782|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253783|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253784|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
44253785|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253786|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253787|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253788|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253789|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253790|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253791|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253792|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253793|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
44253794|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253795|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253796|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
44253797|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
44253798|NCT01915498|79094349|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253799|NCT01915498|79094350|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253800|NCT01915498|79094351|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253801|NCT01915498|79094352|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253802|NCT01915498|79094353|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44410493|NCT00576472|79418198|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
44410494|NCT00576472|79418199|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
44410495|NCT00576472|79418200|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
44410496|NCT00576472|79418201|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
44410497|NCT00576472|79418202|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
44410498|NCT00576472|79418203|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
44410499|NCT00576472|79418204|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
44410500|NCT00576472|79418205|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
44410501|NCT00576472|79418206|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
44410502|NCT00576472|79418207|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
44410503|NCT00576472|79418208|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
44410504|NCT00576472|79418209|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
44410505|NCT00576472|79418210|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
44410506|NCT00576472|79418211|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
44410507|NCT00576472|79418197|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410508|NCT00576472|79418198|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410509|NCT00576472|79418199|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410510|NCT00576472|79418200|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
44410511|NCT00576472|79418201|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410512|NCT00576472|79418202|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410513|NCT00576472|79418203|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410514|NCT00576472|79418204|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410515|NCT00576472|79418205|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410516|NCT00576472|79418206|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410517|NCT00576472|79418207|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410518|NCT00576472|79418208|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410519|NCT00576472|79418209|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410520|NCT00576472|79418210|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410521|NCT00576472|79418211|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
44410522|NCT00576472|79418197|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410523|NCT00576472|79418198|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410524|NCT00576472|79418199|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410525|NCT00576472|79418200|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410526|NCT00576472|79418201|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410527|NCT00576472|79418202|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410528|NCT00576472|79418203|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
44410529|NCT00576472|79418204|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410530|NCT00576472|79418205|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410531|NCT00576472|79418206|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410532|NCT00576472|79418207|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410533|NCT00576472|79418208|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410534|NCT00576472|79418209|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410535|NCT00576472|79418210|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410536|NCT00576472|79418211|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
44410537|NCT00576472|79418197|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
44410538|NCT00576472|79418198|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
44410539|NCT00576472|79418199|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
44410540|NCT00576472|79418200|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
44410541|NCT00576472|79418201|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
44410542|NCT00576472|79418202|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
44410543|NCT00576472|79418203|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
44410544|NCT00576472|79418204|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
44410545|NCT00576472|79418205|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
44410546|NCT00576472|79418206|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
44410547|NCT00576472|79418207|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
44410548|NCT00576472|79418208|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
44410549|NCT00576472|79418209|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
44410550|NCT00576472|79418210|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
44410551|NCT00576472|79418211|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
44410552|NCT00576472|79418197|FG000|MPH Cross Over Phase|Physician Decision|0|||
44410553|NCT00576472|79418198|FG001|MPH Cross Over Phase|Physician Decision|0|||
44410554|NCT00576472|79418199|FG002|MPH Cross Over Phase|Physician Decision|0|||
44410555|NCT00576472|79418200|FG003|MPH Cross Over Phase|Physician Decision|0|||
44410556|NCT00576472|79418201|FG004|MPH Cross Over Phase|Physician Decision|0|||
44410557|NCT00576472|79418202|FG005|MPH Cross Over Phase|Physician Decision|0|||
44410558|NCT00576472|79418203|FG006|MPH Cross Over Phase|Physician Decision|4|||
44410559|NCT00576472|79418204|FG007|MPH Cross Over Phase|Physician Decision|0|||
44410560|NCT00576472|79418205|FG008|MPH Cross Over Phase|Physician Decision|0|||
44410561|NCT00576472|79418206|FG009|MPH Cross Over Phase|Physician Decision|0|||
44410562|NCT00576472|79418207|FG010|MPH Cross Over Phase|Physician Decision|0|||
44410563|NCT00576472|79418208|FG011|MPH Cross Over Phase|Physician Decision|0|||
44410564|NCT00576472|79418209|FG012|MPH Cross Over Phase|Physician Decision|0|||
44410565|NCT00576472|79418210|FG013|MPH Cross Over Phase|Physician Decision|0|||
44410566|NCT00576472|79418211|FG014|MPH Cross Over Phase|Physician Decision|0|||
44410567|NCT00576472|79418197|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410568|NCT00576472|79418198|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410569|NCT00576472|79418199|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410570|NCT00576472|79418200|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410571|NCT00576472|79418201|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410572|NCT00576472|79418202|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410573|NCT00576472|79418203|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410574|NCT00576472|79418204|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410575|NCT00576472|79418205|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
44410576|NCT00576472|79418206|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410577|NCT00576472|79418207|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
44410578|NCT00576472|79418208|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
44524943|NCT03814746|79533918|FG002|Overall Study|Death|2|||
44524944|NCT03814746|79533916|FG000|Overall Study|Adverse Event|2|||
44524945|NCT03814746|79533917|FG001|Overall Study|Adverse Event|2|||
44524946|NCT03814746|79533918|FG002|Overall Study|Adverse Event|1|||
44524947|NCT03814746|79533916|FG000|Overall Study|Lost to Follow-up|2|||
44410579|NCT00576472|79418209|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410580|NCT00576472|79418210|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410581|NCT00576472|79418211|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
44410582|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410583|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44524948|NCT03814746|79533917|FG001|Overall Study|Lost to Follow-up|1|||
44524949|NCT03814746|79533918|FG002|Overall Study|Lost to Follow-up|2|||
44524950|NCT03814746|79533916|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44282149|NCT01880424|79245400|FG000|Overall Study|Other|1|||
44410584|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44524951|NCT03814746|79533917|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44410585|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410586|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410587|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410588|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410589|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410590|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410591|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410592|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410593|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410594|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410595|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
44410596|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
44410597|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
44410598|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
44410599|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
44410600|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
44410601|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
44410602|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
44410603|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
44410604|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
44410605|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
44410606|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
44524952|NCT03814746|79533918|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44524953|NCT03814746|79533916|FG000|Overall Study|Pregnancy|0|||
44524954|NCT03814746|79533917|FG001|Overall Study|Pregnancy|1|||
44524955|NCT03814746|79533918|FG002|Overall Study|Pregnancy|1|||
44524956|NCT03814746|79533916|FG000|Overall Study|Protocol Violation|1|||
44524957|NCT03814746|79533917|FG001|Overall Study|Protocol Violation|0|||
44524958|NCT03814746|79533918|FG002|Overall Study|Protocol Violation|0|||
44524959|NCT03752970|79533935|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
44524960|NCT03752970|79533936|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
44524961|NCT03752970|79533937|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
44253803|NCT01915498|79094354|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
44253804|NCT01915498|79094355|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253805|NCT01915498|79094356|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253806|NCT01915498|79094357|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253807|NCT01915498|79094358|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
44253808|NCT01915498|79094359|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253809|NCT01915498|79094360|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253810|NCT01915498|79094361|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253811|NCT01915498|79094362|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
44253812|NCT01915498|79094363|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
44524962|NCT03752970|79533935|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
44524963|NCT03752970|79533936|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
44524964|NCT03752970|79533937|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
44524965|NCT03752970|79533935|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
44524966|NCT03752970|79533936|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
44524967|NCT03752970|79533937|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
44253813|NCT01915498|79094364|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
44253814|NCT01915498|79094365|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
44253815|NCT01915498|79094366|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
44524968|NCT03752970|79533935|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
44524969|NCT03752970|79533936|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
44524970|NCT03752970|79533937|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
44253816|NCT01915498|79094367|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
44253817|NCT01915498|79094349|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253818|NCT01915498|79094350|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253819|NCT01915498|79094351|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253820|NCT01915498|79094352|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253821|NCT01915498|79094353|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253822|NCT01915498|79094354|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253823|NCT01915498|79094355|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253824|NCT01915498|79094356|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253825|NCT01915498|79094357|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253826|NCT01915498|79094358|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44282150|NCT01880424|79245401|FG001|Overall Study|Other|0|||
44253827|NCT01915498|79094359|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253828|NCT01915498|79094360|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253829|NCT01915498|79094361|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253830|NCT01915498|79094362|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253831|NCT01915498|79094363|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253832|NCT01915498|79094364|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253833|NCT01915498|79094365|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253834|NCT01915498|79094366|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
44253835|NCT01915498|79094367|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
44253836|NCT01889238|79094455|FG000|Overall Study|Treatment ongoing|9|||
44253837|NCT01302769|79094461|FG000|Overall Study|Lost to Follow-up|1|||
44253838|NCT01302769|79094462|FG001|Overall Study|Lost to Follow-up|1|||
44410607|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
44410608|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
44410609|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
44410610|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
44410611|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
44410612|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
44410613|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
44410614|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
44410615|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
44410616|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
44410617|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
44410618|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
44410619|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
44410620|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
44410621|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
44410622|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
44410623|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
44410624|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
44410625|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
44410626|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
44410627|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Side effects|0|||
44410628|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Side effects|0|||
44410629|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Side effects|0|||
44410630|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Side effects|0|||
44410631|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Side effects|0|||
44410632|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Side effects|0|||
44410633|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Side effects|0|||
44410634|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Side effects|0|||
44410635|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Side effects|0|||
44410636|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Side effects|0|||
44410637|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Side effects|0|||
44410638|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Side effects|0|||
44410639|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Side effects|0|||
44410640|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Side effects|0|||
44410641|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Side effects|8|||
44410642|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410643|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410644|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410645|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410646|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410647|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410648|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410649|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410650|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410651|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410652|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410653|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410654|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410655|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
44410656|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
44410657|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
44410658|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
44410659|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
44410660|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
44410661|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
44410662|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
44410663|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
44253839|NCT00099437|79094479|FG000|Overall Study|Lost to Follow-up|30|||
44410664|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
44410665|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
44410666|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
44410667|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
44410668|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
44410669|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
44410670|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
44410671|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
44410672|NCT00576472|79418197|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410673|NCT00576472|79418198|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410674|NCT00576472|79418199|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410675|NCT00576472|79418200|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410676|NCT00576472|79418201|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410677|NCT00576472|79418202|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410678|NCT00576472|79418203|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410679|NCT00576472|79418204|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44524971|NCT03752970|79533935|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
44524972|NCT03752970|79533936|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
44410680|NCT00576472|79418205|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410681|NCT00576472|79418206|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410682|NCT00576472|79418207|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410683|NCT00576472|79418208|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410684|NCT00576472|79418209|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410685|NCT00576472|79418210|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
44410686|NCT00576472|79418211|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
44410687|NCT00823212|79418244|FG000|Overall Study|Death|8|||
44410688|NCT00823212|79418245|FG001|Overall Study|Death|10|||
44410689|NCT00823212|79418244|FG000|Overall Study|Withdrawal by Subject|6|||
44410690|NCT00823212|79418245|FG001|Overall Study|Withdrawal by Subject|1|||
44410691|NCT00823212|79418244|FG000|Overall Study|Incarcerated|0|||
44410692|NCT00823212|79418245|FG001|Overall Study|Incarcerated|1|||
44410693|NCT00823212|79418244|FG000|Overall Study|Missed 12-month visit|21|||
44410694|NCT00823212|79418245|FG001|Overall Study|Missed 12-month visit|21|||
44410695|NCT00807495|79418258|FG000|Overall Study|Adverse Event|6|||
44410696|NCT00807495|79418259|FG001|Overall Study|Adverse Event|3|||
44410697|NCT00807495|79418260|FG002|Overall Study|Adverse Event|1|||
44410698|NCT00807495|79418261|FG003|Overall Study|Adverse Event|1|||
44410699|NCT00807495|79418262|FG004|Overall Study|Adverse Event|2|||
44410700|NCT00807495|79418258|FG000|Overall Study|Withdrawal by Patient|2|||
44410701|NCT00807495|79418259|FG001|Overall Study|Withdrawal by Patient|0|||
44410702|NCT00807495|79418260|FG002|Overall Study|Withdrawal by Patient|1|||
44410703|NCT00807495|79418261|FG003|Overall Study|Withdrawal by Patient|0|||
44410704|NCT00807495|79418262|FG004|Overall Study|Withdrawal by Patient|0|||
44410705|NCT00807495|79418258|FG000|Overall Study|Reason Not Specified|0|||
44410706|NCT00807495|79418259|FG001|Overall Study|Reason Not Specified|3|||
44410707|NCT00807495|79418260|FG002|Overall Study|Reason Not Specified|2|||
44410708|NCT00807495|79418261|FG003|Overall Study|Reason Not Specified|0|||
44410709|NCT00807495|79418262|FG004|Overall Study|Reason Not Specified|3|||
44410710|NCT05074433|79418278|FG000|Overall Study|Adverse Event|0|||
44410711|NCT05074433|79418279|FG001|Overall Study|Adverse Event|2|||
44410712|NCT05074433|79418280|FG002|Overall Study|Adverse Event|0|||
44410713|NCT05074433|79418281|FG003|Overall Study|Adverse Event|1|||
44410714|NCT05074433|79418278|FG000|Overall Study|Sponsor Request|0|||
44410715|NCT05074433|79418279|FG001|Overall Study|Sponsor Request|1|||
44410716|NCT05074433|79418280|FG002|Overall Study|Sponsor Request|1|||
44410717|NCT05074433|79418281|FG003|Overall Study|Sponsor Request|0|||
44410718|NCT05074433|79418278|FG000|Overall Study|Death|1|||
44410719|NCT05074433|79418279|FG001|Overall Study|Death|0|||
44410720|NCT05074433|79418280|FG002|Overall Study|Death|0|||
44410721|NCT05074433|79418281|FG003|Overall Study|Death|0|||
44410722|NCT05074433|79418278|FG000|Overall Study|Lost to Follow-up|0|||
44410723|NCT05074433|79418279|FG001|Overall Study|Lost to Follow-up|0|||
44410724|NCT05074433|79418280|FG002|Overall Study|Lost to Follow-up|2|||
44410725|NCT05074433|79418281|FG003|Overall Study|Lost to Follow-up|0|||
44410726|NCT05074433|79418278|FG000|Overall Study|Subject Decision|8|||
44410727|NCT05074433|79418279|FG001|Overall Study|Subject Decision|6|||
44410728|NCT05074433|79418280|FG002|Overall Study|Subject Decision|4|||
44410729|NCT05074433|79418281|FG003|Overall Study|Subject Decision|5|||
44410730|NCT04922021|79418305|FG000|Overall Study|Withdrawal by Subject|4|||
44410731|NCT04922021|79418306|FG001|Overall Study|Withdrawal by Subject|10|||
44410732|NCT04922021|79418305|FG000|Overall Study|Adverse Event|2|||
44410733|NCT04922021|79418306|FG001|Overall Study|Adverse Event|2|||
44410734|NCT04922021|79418305|FG000|Overall Study|Lack of Efficacy|0|||
44410735|NCT04922021|79418306|FG001|Overall Study|Lack of Efficacy|1|||
44410736|NCT04922021|79418305|FG000|Overall Study|Multiple reasons|1|||
44148431|NCT02153398|78937979|FG000|Overall Study|Adverse Event|0|||
44410737|NCT04922021|79418306|FG001|Overall Study|Multiple reasons|0|||
44410738|NCT04233580|79418357|FG000|Overall Study|Adverse Event|3|||
44410739|NCT04233580|79418358|FG001|Overall Study|Adverse Event|3|||
44410740|NCT04233580|79418357|FG000|Overall Study|Withdrawal by Subject|2|||
44410741|NCT04233580|79418358|FG001|Overall Study|Withdrawal by Subject|1|||
44410742|NCT04016805|79418378|FG000|Overall Study|Sponsor's Discretion|30|||
44410743|NCT04016805|79418379|FG001|Overall Study|Sponsor's Discretion|6|||
44410744|NCT04016805|79418380|FG002|Overall Study|Sponsor's Discretion|5|||
44410745|NCT03982199|79418390|FG000|Overall Study|Site terminated by sponsor|14|||
44410746|NCT03982199|79418391|FG001|Overall Study|Site terminated by sponsor|17|||
44410747|NCT03982199|79418390|FG000|Overall Study|Lost to Follow-up|137|||
44524973|NCT03752970|79533937|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
44524974|NCT03681184|79533953|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
44524975|NCT03681184|79533954|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
44524976|NCT03681184|79533953|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
44524977|NCT03681184|79533954|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
44524978|NCT03681184|79533953|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
44524979|NCT03681184|79533954|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
44524980|NCT03317405|79533972|FG000|Overall Study|Withdrawal by Subject|1|||
44524981|NCT03317405|79533973|FG001|Overall Study|Withdrawal by Subject|0|||
44524982|NCT03317405|79533974|FG002|Overall Study|Withdrawal by Subject|0|||
44410748|NCT03982199|79418391|FG001|Overall Study|Lost to Follow-up|142|||
44410749|NCT03982199|79418390|FG000|Overall Study|Physician Decision|38|||
44410750|NCT03982199|79418391|FG001|Overall Study|Physician Decision|33|||
44410751|NCT03982199|79418390|FG000|Overall Study|Withdrawal by Subject|514|||
44410752|NCT03982199|79418391|FG001|Overall Study|Withdrawal by Subject|496|||
44410753|NCT03982199|79418390|FG000|Overall Study|Adverse Event|10|||
44410754|NCT03982199|79418391|FG001|Overall Study|Adverse Event|14|||
44410755|NCT03982199|79418390|FG000|Overall Study|Technical Problems|9|||
44410756|NCT03982199|79418391|FG001|Overall Study|Technical Problems|8|||
44410757|NCT03982199|79418390|FG000|Overall Study|Death|40|||
44410758|NCT03982199|79418391|FG001|Overall Study|Death|40|||
44410759|NCT03982199|79418390|FG000|Overall Study|Study terminated by sponsor|2|||
44410760|NCT03982199|79418391|FG001|Overall Study|Study terminated by sponsor|1|||
44410761|NCT03982199|79418390|FG000|Overall Study|Other|76|||
44410762|NCT03982199|79418391|FG001|Overall Study|Other|81|||
44410763|NCT03982199|79418390|FG000|Overall Study|Ongoing|743|||
44410764|NCT03982199|79418391|FG001|Overall Study|Ongoing|799|||
44410765|NCT03982199|79418390|FG000|Overall Study|Randomized but not vaccinated|18|||
44410766|NCT03982199|79418391|FG001|Overall Study|Randomized but not vaccinated|15|||
44410767|NCT03828448|79418397|FG000|Overall Study|Sponsor's Discretion|34|||
44410768|NCT03580369|79418409|FG000|Overall Study|No treatment due to mis-randomization|1|||
44410769|NCT03580369|79418410|FG001|Overall Study|No treatment due to mis-randomization|0|||
44410770|NCT03580369|79418411|FG002|Overall Study|No treatment due to mis-randomization|0|||
44410771|NCT03580369|79418412|FG003|Overall Study|No treatment due to mis-randomization|0|||
44410772|NCT03580369|79418413|FG004|Overall Study|No treatment due to mis-randomization|3|||
44410773|NCT03580369|79418414|FG005|Overall Study|No treatment due to mis-randomization|0|||
44410774|NCT03580369|79418415|FG006|Overall Study|No treatment due to mis-randomization|0|||
44410775|NCT03580369|79418416|FG007|Overall Study|No treatment due to mis-randomization|0|||
44410776|NCT03580369|79418409|FG000|Overall Study|Reason unknown|0|||
44410777|NCT03580369|79418410|FG001|Overall Study|Reason unknown|0|||
44410778|NCT03580369|79418411|FG002|Overall Study|Reason unknown|1|||
44410779|NCT03580369|79418412|FG003|Overall Study|Reason unknown|0|||
44410780|NCT03580369|79418413|FG004|Overall Study|Reason unknown|0|||
44410781|NCT03580369|79418414|FG005|Overall Study|Reason unknown|0|||
44410782|NCT03580369|79418415|FG006|Overall Study|Reason unknown|0|||
44410783|NCT03580369|79418416|FG007|Overall Study|Reason unknown|0|||
44410784|NCT03580369|79418409|FG000|Overall Study|Technical problems|0|||
44524983|NCT03317405|79533972|FG000|Overall Study|Physician Decision|0|||
44410785|NCT03580369|79418410|FG001|Overall Study|Technical problems|0|||
44410786|NCT03580369|79418411|FG002|Overall Study|Technical problems|0|||
44410787|NCT03580369|79418412|FG003|Overall Study|Technical problems|0|||
44410788|NCT03580369|79418413|FG004|Overall Study|Technical problems|1|||
44410789|NCT03580369|79418414|FG005|Overall Study|Technical problems|0|||
44410790|NCT03580369|79418415|FG006|Overall Study|Technical problems|2|||
44410791|NCT03580369|79418416|FG007|Overall Study|Technical problems|0|||
44524984|NCT03317405|79533973|FG001|Overall Study|Physician Decision|0|||
44148432|NCT02153398|78937980|FG001|Overall Study|Adverse Event|0|||
44410792|NCT03580369|79418409|FG000|Overall Study|Pregnancy|2|||
44410793|NCT03580369|79418410|FG001|Overall Study|Pregnancy|0|||
44410794|NCT03580369|79418411|FG002|Overall Study|Pregnancy|3|||
44410795|NCT03580369|79418412|FG003|Overall Study|Pregnancy|0|||
44410796|NCT03580369|79418413|FG004|Overall Study|Pregnancy|2|||
44410797|NCT03580369|79418414|FG005|Overall Study|Pregnancy|0|||
44410798|NCT03580369|79418415|FG006|Overall Study|Pregnancy|0|||
44410799|NCT03580369|79418416|FG007|Overall Study|Pregnancy|0|||
44410800|NCT03580369|79418409|FG000|Overall Study|Lost to Follow-up|2|||
44410801|NCT03580369|79418410|FG001|Overall Study|Lost to Follow-up|0|||
44410802|NCT03580369|79418411|FG002|Overall Study|Lost to Follow-up|2|||
44410803|NCT03580369|79418412|FG003|Overall Study|Lost to Follow-up|0|||
44410804|NCT03580369|79418413|FG004|Overall Study|Lost to Follow-up|3|||
44410805|NCT03580369|79418414|FG005|Overall Study|Lost to Follow-up|0|||
44410806|NCT03580369|79418415|FG006|Overall Study|Lost to Follow-up|1|||
44410807|NCT03580369|79418416|FG007|Overall Study|Lost to Follow-up|0|||
44410808|NCT03580369|79418409|FG000|Overall Study|Physician Decision|4|||
44410809|NCT03580369|79418410|FG001|Overall Study|Physician Decision|0|||
44410810|NCT03580369|79418411|FG002|Overall Study|Physician Decision|4|||
44410811|NCT03580369|79418412|FG003|Overall Study|Physician Decision|1|||
44410812|NCT03580369|79418413|FG004|Overall Study|Physician Decision|1|||
44410813|NCT03580369|79418414|FG005|Overall Study|Physician Decision|0|||
44410814|NCT03580369|79418415|FG006|Overall Study|Physician Decision|0|||
44410815|NCT03580369|79418416|FG007|Overall Study|Physician Decision|0|||
44410816|NCT03580369|79418409|FG000|Overall Study|Lack of Efficacy|3|||
44410817|NCT03580369|79418410|FG001|Overall Study|Lack of Efficacy|0|||
44410818|NCT03580369|79418411|FG002|Overall Study|Lack of Efficacy|7|||
44410819|NCT03580369|79418412|FG003|Overall Study|Lack of Efficacy|0|||
44410820|NCT03580369|79418413|FG004|Overall Study|Lack of Efficacy|2|||
44410821|NCT03580369|79418414|FG005|Overall Study|Lack of Efficacy|0|||
44410822|NCT03580369|79418415|FG006|Overall Study|Lack of Efficacy|3|||
44410823|NCT03580369|79418416|FG007|Overall Study|Lack of Efficacy|0|||
44410824|NCT03580369|79418409|FG000|Overall Study|Protocol Violation|6|||
44410825|NCT03580369|79418410|FG001|Overall Study|Protocol Violation|0|||
44410826|NCT03580369|79418411|FG002|Overall Study|Protocol Violation|6|||
44410827|NCT03580369|79418412|FG003|Overall Study|Protocol Violation|1|||
44410828|NCT03580369|79418413|FG004|Overall Study|Protocol Violation|8|||
44410829|NCT03580369|79418414|FG005|Overall Study|Protocol Violation|2|||
44410830|NCT03580369|79418415|FG006|Overall Study|Protocol Violation|1|||
44410831|NCT03580369|79418416|FG007|Overall Study|Protocol Violation|0|||
44410832|NCT03580369|79418409|FG000|Overall Study|Adverse Event|7|||
44410833|NCT03580369|79418410|FG001|Overall Study|Adverse Event|0|||
44410834|NCT03580369|79418411|FG002|Overall Study|Adverse Event|14|||
44410835|NCT03580369|79418412|FG003|Overall Study|Adverse Event|1|||
44410836|NCT03580369|79418413|FG004|Overall Study|Adverse Event|6|||
44410837|NCT03580369|79418414|FG005|Overall Study|Adverse Event|0|||
44410838|NCT03580369|79418415|FG006|Overall Study|Adverse Event|1|||
44410839|NCT03580369|79418416|FG007|Overall Study|Adverse Event|0|||
44410840|NCT03580369|79418409|FG000|Overall Study|Withdrawal by Subject|19|||
44410841|NCT03580369|79418410|FG001|Overall Study|Withdrawal by Subject|0|||
44410842|NCT03580369|79418411|FG002|Overall Study|Withdrawal by Subject|17|||
44410843|NCT03580369|79418412|FG003|Overall Study|Withdrawal by Subject|0|||
44410844|NCT03580369|79418413|FG004|Overall Study|Withdrawal by Subject|16|||
44410845|NCT03580369|79418414|FG005|Overall Study|Withdrawal by Subject|1|||
44410846|NCT03580369|79418415|FG006|Overall Study|Withdrawal by Subject|7|||
44410847|NCT03580369|79418416|FG007|Overall Study|Withdrawal by Subject|0|||
44410848|NCT03215810|79418453|FG000|Overall Study|Still responding to nivolumab|1|||
44410849|NCT03215810|79418453|FG000|Overall Study|Insufficient TIL growth|1|||
44410850|NCT03215810|79418453|FG000|Overall Study|Decline in performance status|1|||
44410851|NCT03215810|79418453|FG000|Overall Study|Withdrawal by Subject|1|||
44410852|NCT02634710|79418488|FG000|Overall Study|Death|4|||
44410853|NCT02540993|79418503|FG000|Overall Study|Lost to Follow-up|5|||
44410854|NCT02540993|79418504|FG001|Overall Study|Lost to Follow-up|3|||
44410855|NCT02540993|79418503|FG000|Overall Study|Withdrawal by Subject|4|||
44410856|NCT02540993|79418504|FG001|Overall Study|Withdrawal by Subject|6|||
44410857|NCT02540993|79418503|FG000|Overall Study|GCP violations|33|||
44524985|NCT03317405|79533974|FG002|Overall Study|Physician Decision|1|||
44524986|NCT03317405|79533972|FG000|Overall Study|Surgery Rescheduled|0|||
44410858|NCT02540993|79418504|FG001|Overall Study|GCP violations|27|||
44410859|NCT02449239|79418539|FG000|Induction Phase|Lack of Efficacy|64|||
44410860|NCT02449239|79418539|FG000|Induction Phase|Adverse Event|1|||
44410861|NCT02449239|79418539|FG000|Induction Phase|Lost to Follow-up|1|||
44410862|NCT02449239|79418539|FG000|Induction Phase|Protocol Violation|1|||
44410863|NCT02449239|79418539|FG000|Induction Phase|Physician Decision|1|||
44410864|NCT02449239|79418539|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
44410865|NCT02449239|79418539|FG000|Induction Phase|Withdrawal by Subject|1|||
44410866|NCT02449239|79418539|FG000|Maintenance Month 3|Lack of Efficacy|14|||
44410867|NCT02449239|79418539|FG000|Maintenance Month 6|Lack of Efficacy|10|||
44410868|NCT02449239|79418539|FG000|Maintenance Month 6|Adverse Event|2|||
44410869|NCT02449239|79418539|FG000|Maintenance Month 6|Physician Decision|1|||
44524987|NCT03317405|79533973|FG001|Overall Study|Surgery Rescheduled|1|||
44410870|NCT02449239|79418539|FG000|Maintenance Month 9|Lack of Efficacy|2|||
44410871|NCT02449239|79418539|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
44410872|NCT02449239|79418539|FG000|Maintenance Month 12|Lack of Efficacy|5|||
44410873|NCT02449239|79418539|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
44410874|NCT02449239|79418539|FG000|Maintenance Month 12|Subject moved from area|1|||
44410875|NCT02449239|79418539|FG000|Maintenance Month 15|Lack of Efficacy|1|||
44410876|NCT02449239|79418539|FG000|Maintenance Month 21|Lack of Efficacy|1|||
44410877|NCT02449239|79418539|FG000|Maintenance Month 21|Sponsor decision|1|||
44410878|NCT01292928|79418543|FG000|Overall Study|Death|8|||
44410879|NCT01292928|79418543|FG000|Overall Study|Withdrawal by Subject|8|||
44410880|NCT01292928|79418543|FG000|Overall Study|Lost to Follow-up|6|||
44410881|NCT01292928|79418543|FG000|Overall Study|Physician Decision|2|||
44410882|NCT00581828|79418562|FG000|Overall Study|Protocol Violation|1|||
44410883|NCT00220337|79418611|FG000|Overall Study|Adverse Event|70|||
44410884|NCT00220337|79418611|FG000|Overall Study|Lack of Efficacy|17|||
44410885|NCT00220337|79418611|FG000|Overall Study|Withdrawal by Subject|68|||
44410886|NCT00220337|79418611|FG000|Overall Study|Protocol Violation|2|||
44410887|NCT00220337|79418611|FG000|Overall Study|Lost to Follow-up|5|||
44410888|NCT00220337|79418611|FG000|Overall Study|Other|12|||
44410889|NCT00220337|79418611|FG000|Overall Study|Unsatisfactory compliance|5|||
44410890|NCT00576316|79418615|FG000|Overall Study|Adverse Event|9|||
44410891|NCT00576316|79418615|FG000|Overall Study|Withdrawal by Subject|2|||
44410892|NCT00576316|79418615|FG000|Overall Study|Protocol Violation|9|||
44410893|NCT00823134|79418619|FG000|Overall Study|Invalid measurement|1|||
44410894|NCT00831792|79418624|FG000|Overall Study|Not Eligible|3|||
44410895|NCT00831792|79418624|FG000|Overall Study|Adverse Event|1|||
44410896|NCT00831792|79418624|FG000|Overall Study|Death|1|||
44410897|NCT00831792|79418624|FG000|Overall Study|Lack of Efficacy|1|||
44410898|NCT00575380|79418630|FG000|Overall Study|Withdrawal by Subject|1|||
44410899|NCT00575380|79418631|FG001|Overall Study|Withdrawal by Subject|0|||
44410900|NCT00575380|79418630|FG000|Overall Study|Adverse Event|0|||
44410901|NCT00575380|79418631|FG001|Overall Study|Adverse Event|1|||
44410902|NCT00575380|79418630|FG000|Overall Study|Various|0|||
44410903|NCT00575380|79418631|FG001|Overall Study|Various|2|||
44410904|NCT00840996|79418639|FG000|Overall Study|Withdrawal by Subject|1|||
44410905|NCT00840996|79418640|FG001|Overall Study|Withdrawal by Subject|0|||
44410906|NCT00680914|79418648|FG000|Overall Study|Consent withdrawal|6|||
44410907|NCT00680914|79418649|FG001|Overall Study|Consent withdrawal|3|||
44410908|NCT00680914|79418648|FG000|Overall Study|Lost to Follow-up|4|||
44410909|NCT00680914|79418649|FG001|Overall Study|Lost to Follow-up|0|||
44410910|NCT00680914|79418648|FG000|Overall Study|serious adverse event (SAE)|0|||
44410911|NCT00680914|79418649|FG001|Overall Study|serious adverse event (SAE)|1|||
44410912|NCT00680836|79418657|FG000|Overall Study|Withdrawal by Subject|3|||
44410913|NCT00680836|79418658|FG001|Overall Study|Withdrawal by Subject|0|||
44410914|NCT00680836|79418657|FG000|Overall Study|Lost to Follow-up|3|||
44410915|NCT00680836|79418658|FG001|Overall Study|Lost to Follow-up|1|||
44410916|NCT00680836|79418657|FG000|Overall Study|Physician Decision|2|||
44410917|NCT00680836|79418658|FG001|Overall Study|Physician Decision|1|||
44410918|NCT00679432|79418669|FG000|Overall Study|Adverse Event|5|||
44410919|NCT00679432|79418670|FG001|Overall Study|Adverse Event|6|||
44410920|NCT00679432|79418671|FG002|Overall Study|Adverse Event|10|||
44410921|NCT00679432|79418672|FG003|Overall Study|Adverse Event|7|||
44410922|NCT00679432|79418669|FG000|Overall Study|Protocol Violation|1|||
44410923|NCT00679432|79418670|FG001|Overall Study|Protocol Violation|1|||
44410924|NCT00679432|79418671|FG002|Overall Study|Protocol Violation|2|||
44410925|NCT00679432|79418672|FG003|Overall Study|Protocol Violation|1|||
44410926|NCT00679432|79418669|FG000|Overall Study|Withdrawal by Subject|8|||
44410927|NCT00679432|79418670|FG001|Overall Study|Withdrawal by Subject|11|||
44410928|NCT00679432|79418671|FG002|Overall Study|Withdrawal by Subject|10|||
44410929|NCT00679432|79418672|FG003|Overall Study|Withdrawal by Subject|9|||
44410930|NCT00679432|79418669|FG000|Overall Study|Lost to Follow-up|1|||
44410931|NCT00679432|79418670|FG001|Overall Study|Lost to Follow-up|5|||
44410932|NCT00679432|79418671|FG002|Overall Study|Lost to Follow-up|4|||
44410933|NCT00679432|79418672|FG003|Overall Study|Lost to Follow-up|2|||
44410934|NCT00679432|79418669|FG000|Overall Study|Physician Decision|3|||
44410935|NCT00679432|79418670|FG001|Overall Study|Physician Decision|2|||
44410936|NCT00679432|79418671|FG002|Overall Study|Physician Decision|2|||
44410937|NCT00679432|79418672|FG003|Overall Study|Physician Decision|2|||
44410938|NCT00679432|79418669|FG000|Overall Study|Sponsor decision|1|||
44410939|NCT00679432|79418670|FG001|Overall Study|Sponsor decision|0|||
44410940|NCT00679432|79418671|FG002|Overall Study|Sponsor decision|0|||
44410941|NCT00679432|79418672|FG003|Overall Study|Sponsor decision|0|||
44410942|NCT00679432|79418669|FG000|Overall Study|Lack of Efficacy|13|||
44410943|NCT00679432|79418670|FG001|Overall Study|Lack of Efficacy|9|||
44410944|NCT00679432|79418671|FG002|Overall Study|Lack of Efficacy|14|||
44410945|NCT00679432|79418672|FG003|Overall Study|Lack of Efficacy|8|||
44410946|NCT00679432|79418669|FG000|Overall Study|Infectious colitis, normal histology|5|||
44148433|NCT02153398|78937981|FG002|Overall Study|Adverse Event|1|||
44410947|NCT00679432|79418670|FG001|Overall Study|Infectious colitis, normal histology|4|||
44410948|NCT00679432|79418671|FG002|Overall Study|Infectious colitis, normal histology|8|||
44410949|NCT00679432|79418672|FG003|Overall Study|Infectious colitis, normal histology|3|||
44410950|NCT00679432|79418669|FG000|Overall Study|Randomization error, return to prior Rx|0|||
44410951|NCT00679432|79418670|FG001|Overall Study|Randomization error, return to prior Rx|0|||
44410952|NCT00679432|79418671|FG002|Overall Study|Randomization error, return to prior Rx|3|||
44410953|NCT00679432|79418672|FG003|Overall Study|Randomization error, return to prior Rx|0|||
44410954|NCT00679354|79418682|FG000|Overall Study|Death|3|||
44410955|NCT00679354|79418682|FG000|Overall Study|Lack of Efficacy|22|||
44410956|NCT00679354|79418682|FG000|Overall Study|Physician Decision|4|||
44410957|NCT00679354|79418682|FG000|Overall Study|Ineligible|1|||
44410958|NCT00822900|79418689|FG000|Overall Study|Withdrawal by Subject|14|||
44410959|NCT00822900|79418690|FG001|Overall Study|Withdrawal by Subject|14|||
44410960|NCT00822900|79418689|FG000|Overall Study|Lost to Follow-up|9|||
44410961|NCT00822900|79418690|FG001|Overall Study|Lost to Follow-up|9|||
44410962|NCT00822900|79418689|FG000|Overall Study|Death|83|||
44410963|NCT00822900|79418690|FG001|Overall Study|Death|69|||
44410964|NCT00822900|79418689|FG000|Overall Study|Became a ward of the state|2|||
44410965|NCT00822900|79418690|FG001|Overall Study|Became a ward of the state|1|||
44410966|NCT00682786|79418698|FG000|Overall Study|Withdrawal by Subject|2|||
44410967|NCT00682786|79418699|FG001|Overall Study|Withdrawal by Subject|2|||
44410968|NCT00682786|79418698|FG000|Overall Study|Did not receive irinotecan|0|||
44410969|NCT00682786|79418699|FG001|Overall Study|Did not receive irinotecan|1|||
44410970|NCT00840450|79418711|FG000|Overall Study|Adverse Event|1|||
44410971|NCT00840450|79418711|FG000|Overall Study|Lack of Efficacy|2|||
44410972|NCT00840294|79418717|FG000|Overall Study|Withdrawal by Subject|2|||
44410973|NCT00840294|79418718|FG001|Overall Study|Withdrawal by Subject|1|||
44410974|NCT00840294|79418717|FG000|Overall Study|Protocol Violation|1|||
44410975|NCT00840294|79418718|FG001|Overall Study|Protocol Violation|3|||
44410976|NCT00840294|79418717|FG000|Overall Study|Illness|0|||
44410977|NCT00840294|79418718|FG001|Overall Study|Illness|1|||
44410978|NCT00680368|79418724|FG000|Overall Study|not supervised, not eligible|15|||
44410979|NCT00680056|79418732|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
44410980|NCT00680056|79418733|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
44410981|NCT00680056|79418732|FG000|Second Intervention|Protocol Violation|3|||
44410982|NCT00680056|79418733|FG001|Second Intervention|Protocol Violation|1|||
44410983|NCT00680992|79418743|FG000|Overall Study|Complete Resection (as per protocol)|25|||
44410984|NCT00680992|79418744|FG001|Overall Study|Complete Resection (as per protocol)|121|||
44410985|NCT00680992|79418745|FG002|Overall Study|Complete Resection (as per protocol)|0|||
44410986|NCT00680992|79418743|FG000|Overall Study|Administrative Decision|83|||
44410987|NCT00680992|79418744|FG001|Overall Study|Administrative Decision|42|||
44410988|NCT00680992|79418745|FG002|Overall Study|Administrative Decision|5|||
44410989|NCT00680992|79418743|FG000|Overall Study|End of Trial|32|||
44410990|NCT00680992|79418744|FG001|Overall Study|End of Trial|12|||
44410991|NCT00680992|79418745|FG002|Overall Study|End of Trial|3|||
44410992|NCT00680992|79418743|FG000|Overall Study|Withdrawal by Subject|33|||
44410993|NCT00680992|79418744|FG001|Overall Study|Withdrawal by Subject|11|||
44410994|NCT00680992|79418745|FG002|Overall Study|Withdrawal by Subject|1|||
44410995|NCT00680992|79418743|FG000|Overall Study|Adverse Event|21|||
44410996|NCT00680992|79418744|FG001|Overall Study|Adverse Event|19|||
44410997|NCT00680992|79418745|FG002|Overall Study|Adverse Event|1|||
44410998|NCT00680992|79418743|FG000|Overall Study|Other|19|||
44410999|NCT00680992|79418744|FG001|Overall Study|Other|14|||
44411000|NCT00680992|79418745|FG002|Overall Study|Other|1|||
44411001|NCT00680992|79418743|FG000|Overall Study|Disease Progression|21|||
44411002|NCT00680992|79418744|FG001|Overall Study|Disease Progression|9|||
44411003|NCT00680992|79418745|FG002|Overall Study|Disease Progression|0|||
44411004|NCT00680992|79418743|FG000|Overall Study|Lost to Follow-up|12|||
44411005|NCT00680992|79418744|FG001|Overall Study|Lost to Follow-up|14|||
44411006|NCT00680992|79418745|FG002|Overall Study|Lost to Follow-up|0|||
44411007|NCT00680992|79418743|FG000|Overall Study|Noncompliance|4|||
44411008|NCT00680992|79418744|FG001|Overall Study|Noncompliance|6|||
44411009|NCT00680992|79418745|FG002|Overall Study|Noncompliance|0|||
44411010|NCT00680992|79418743|FG000|Overall Study|Requirement for Alternative Therapy|8|||
44411011|NCT00680992|79418744|FG001|Overall Study|Requirement for Alternative Therapy|2|||
44411012|NCT00680992|79418745|FG002|Overall Study|Requirement for Alternative Therapy|0|||
44411013|NCT00680992|79418743|FG000|Overall Study|Pregnancy|5|||
44411014|NCT00680992|79418744|FG001|Overall Study|Pregnancy|0|||
44411015|NCT00680992|79418745|FG002|Overall Study|Pregnancy|1|||
44411016|NCT00680992|79418743|FG000|Overall Study|Death|5|||
44411017|NCT00680992|79418744|FG001|Overall Study|Death|1|||
44411018|NCT00680992|79418745|FG002|Overall Study|Death|0|||
44411019|NCT00680992|79418743|FG000|Overall Study|Ineligibility Determined|0|||
44411020|NCT00680992|79418744|FG001|Overall Study|Ineligibility Determined|1|||
44411021|NCT00680992|79418745|FG002|Overall Study|Ineligibility Determined|0|||
44411022|NCT00805389|79418759|FG000|Overall Study|Adverse Event|0|||
44411023|NCT00805389|79418760|FG001|Overall Study|Adverse Event|0|||
44411024|NCT00805389|79418761|FG002|Overall Study|Adverse Event|1|||
44411025|NCT00805389|79418762|FG003|Overall Study|Adverse Event|2|||
44411026|NCT00805389|79418763|FG004|Overall Study|Adverse Event|0|||
44411027|NCT00805389|79418759|FG000|Overall Study|Lost to Follow-up|4|||
44411028|NCT00805389|79418760|FG001|Overall Study|Lost to Follow-up|3|||
44411029|NCT00805389|79418761|FG002|Overall Study|Lost to Follow-up|6|||
44524988|NCT03317405|79533974|FG002|Overall Study|Surgery Rescheduled|0|||
44524989|NCT03273907|79533990|FG000|Overall Study|Death|1|||
44524990|NCT03273907|79533990|FG000|Overall Study|Lost to Follow-up|4|||
44524991|NCT03273907|79533990|FG000|Overall Study|Withdrawal by Subject|2|||
44524992|NCT03273907|79533990|FG000|Overall Study|COVID 19|2|||
44411030|NCT00805389|79418762|FG003|Overall Study|Lost to Follow-up|10|||
44411031|NCT00805389|79418763|FG004|Overall Study|Lost to Follow-up|9|||
44411032|NCT00805389|79418759|FG000|Overall Study|Protocol Violation|0|||
44524993|NCT03247972|79533996|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
44524994|NCT03247972|79533996|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
44524995|NCT03103321|79534005|FG000|Overall Study|Protocol Violation|1|||
44524996|NCT03103321|79534006|FG001|Overall Study|Protocol Violation|1|||
44524997|NCT03103321|79534007|FG002|Overall Study|Protocol Violation|1|||
44524998|NCT03103321|79534008|FG003|Overall Study|Protocol Violation|0|||
44524999|NCT02788981|79534020|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
44525000|NCT02788981|79534021|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
44282151|NCT01862874|79245409|FG000|Overall Study|Randomized not treated|1|||
44282152|NCT01862874|79245410|FG001|Overall Study|Randomized not treated|0|||
44282153|NCT01862874|79245409|FG000|Overall Study|Adverse Event|0|||
44282154|NCT01862874|79245410|FG001|Overall Study|Adverse Event|3|||
44411033|NCT00805389|79418760|FG001|Overall Study|Protocol Violation|0|||
44411034|NCT00805389|79418761|FG002|Overall Study|Protocol Violation|1|||
44411035|NCT00805389|79418762|FG003|Overall Study|Protocol Violation|0|||
44411036|NCT00805389|79418763|FG004|Overall Study|Protocol Violation|0|||
44411037|NCT00805389|79418759|FG000|Overall Study|Withdrawal by Subject|3|||
44411038|NCT00805389|79418760|FG001|Overall Study|Withdrawal by Subject|2|||
44411039|NCT00805389|79418761|FG002|Overall Study|Withdrawal by Subject|4|||
44411040|NCT00805389|79418762|FG003|Overall Study|Withdrawal by Subject|5|||
44411041|NCT00805389|79418763|FG004|Overall Study|Withdrawal by Subject|4|||
44411042|NCT00678886|79418787|FG000|Overall Study|Withdrawal by Subject|0|||
44411043|NCT00678886|79418788|FG001|Overall Study|Withdrawal by Subject|0|||
44411044|NCT00678886|79418789|FG002|Overall Study|Withdrawal by Subject|4|||
44411045|NCT00678886|79418790|FG003|Overall Study|Withdrawal by Subject|6|||
44411046|NCT00678886|79418787|FG000|Overall Study|Physician Decision|0|||
44411047|NCT00678886|79418788|FG001|Overall Study|Physician Decision|0|||
44411048|NCT00678886|79418789|FG002|Overall Study|Physician Decision|1|||
44411049|NCT00678886|79418790|FG003|Overall Study|Physician Decision|1|||
44411050|NCT00678886|79418787|FG000|Overall Study|Lost to Follow-up|0|||
44411051|NCT00678886|79418788|FG001|Overall Study|Lost to Follow-up|0|||
44411052|NCT00678886|79418789|FG002|Overall Study|Lost to Follow-up|3|||
44282155|NCT01862874|79245409|FG000|Overall Study|Lost to Follow-up|26|||
44282156|NCT01862874|79245410|FG001|Overall Study|Lost to Follow-up|29|||
44282157|NCT01862874|79245409|FG000|Overall Study|Physician Decision|5|||
44282158|NCT01862874|79245410|FG001|Overall Study|Physician Decision|3|||
44282159|NCT01862874|79245409|FG000|Overall Study|Withdrawn by parent/guardian|1|||
44282160|NCT01862874|79245410|FG001|Overall Study|Withdrawn by parent/guardian|1|||
44282161|NCT01862874|79245409|FG000|Overall Study|Withdrawal by Subject|46|||
44282162|NCT01862874|79245410|FG001|Overall Study|Withdrawal by Subject|40|||
44282163|NCT01862874|79245409|FG000|Overall Study|Death|0|||
44282164|NCT01862874|79245410|FG001|Overall Study|Death|1|||
44282165|NCT01879722|79245426|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44282166|NCT01879722|79245427|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
44282167|NCT01879722|79245428|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
44282168|NCT01879722|79245429|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
44282169|NCT01879722|79245430|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
44282170|NCT01879722|79245431|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
44282171|NCT01879722|79245432|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
44411053|NCT00678886|79418790|FG003|Overall Study|Lost to Follow-up|2|||
44411054|NCT00678886|79418787|FG000|Overall Study|Other|0|||
44411055|NCT00678886|79418788|FG001|Overall Study|Other|0|||
44411056|NCT00678886|79418789|FG002|Overall Study|Other|1|||
44411057|NCT00678886|79418790|FG003|Overall Study|Other|0|||
44411058|NCT00804843|79418801|FG000|Overall Study|Protocol Violation|1|||
44525001|NCT02744612|79534029|FG000|Overall Study|Withdrawal by Subject|0|||
44525002|NCT02744612|79534030|FG001|Overall Study|Withdrawal by Subject|2|||
44282172|NCT01879722|79245433|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
44411059|NCT00804843|79418802|FG001|Overall Study|Protocol Violation|0|||
44411060|NCT00804843|79418801|FG000|Overall Study|Adverse Event|8|||
44411061|NCT00804843|79418802|FG001|Overall Study|Adverse Event|5|||
44411062|NCT00804843|79418801|FG000|Overall Study|Withdrawal by Subject|1|||
44282173|NCT01879722|79245434|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
44282174|NCT01879722|79245435|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
44282175|NCT01879722|79245426|FG000|Overall Study|Voluntary Withdrawal|0|||
44282176|NCT01879722|79245427|FG001|Overall Study|Voluntary Withdrawal|0|||
44411063|NCT00804843|79418802|FG001|Overall Study|Withdrawal by Subject|2|||
44411064|NCT00822120|79418811|FG000|Initial Registration|Adverse Event|1|||
44411065|NCT00822120|79418812|FG001|Initial Registration|Adverse Event|0|||
44411066|NCT00822120|79418813|FG002|Initial Registration|Adverse Event|0|||
44411067|NCT00822120|79418814|FG003|Initial Registration|Adverse Event|0|||
44411068|NCT00822120|79418815|FG004|Initial Registration|Adverse Event|0|||
44411069|NCT00822120|79418816|FG005|Initial Registration|Adverse Event|0|||
44411070|NCT00822120|79418811|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
44253840|NCT00099437|79094480|FG001|Overall Study|Lost to Follow-up|33|||
44411071|NCT00822120|79418812|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
44411072|NCT00822120|79418813|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
44411073|NCT00822120|79418814|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
44411074|NCT00822120|79418815|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
44411075|NCT00822120|79418816|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
44411076|NCT00822120|79418811|FG000|Initial Registration|Reasons not Protocol Specified|2|||
44411077|NCT00822120|79418812|FG001|Initial Registration|Reasons not Protocol Specified|0|||
44411078|NCT00822120|79418813|FG002|Initial Registration|Reasons not Protocol Specified|0|||
44411079|NCT00822120|79418814|FG003|Initial Registration|Reasons not Protocol Specified|0|||
44411080|NCT00822120|79418815|FG004|Initial Registration|Reasons not Protocol Specified|0|||
44411081|NCT00822120|79418816|FG005|Initial Registration|Reasons not Protocol Specified|0|||
44411082|NCT00822120|79418811|FG000|Initial Registration|Ineligible|22|||
44411083|NCT00822120|79418812|FG001|Initial Registration|Ineligible|1|||
44411084|NCT00822120|79418813|FG002|Initial Registration|Ineligible|0|||
44411085|NCT00822120|79418814|FG003|Initial Registration|Ineligible|0|||
44411086|NCT00822120|79418815|FG004|Initial Registration|Ineligible|0|||
44411087|NCT00822120|79418816|FG005|Initial Registration|Ineligible|0|||
44253841|NCT00099437|79094479|FG000|Overall Study|Death|293|||
44253842|NCT00099437|79094480|FG001|Overall Study|Death|261|||
44253843|NCT00099437|79094479|FG000|Overall Study|Withdrawal by Subject|6|||
44253844|NCT00099437|79094480|FG001|Overall Study|Withdrawal by Subject|10|||
44253845|NCT00099437|79094479|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
44253846|NCT00099437|79094480|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
44253847|NCT00634751|79094494|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
44253848|NCT00634751|79094495|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
44525003|NCT02362035|79534036|FG000|Overall Study|Death|67|||
44525004|NCT02362035|79534036|FG000|Overall Study|Lost to Follow-up|3|||
44525005|NCT02362035|79534036|FG000|Overall Study|Adverse Event|1|||
44525006|NCT02362035|79534036|FG000|Overall Study|Physician Decision|1|||
44525007|NCT02362035|79534036|FG000|Overall Study|Subject started another cancer therapy|10|||
44525008|NCT02362035|79534036|FG000|Overall Study|Study terminated by sponsor|45|||
44525009|NCT02362035|79534036|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
44525010|NCT02362035|79534036|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
44525011|NCT02362035|79534036|FG000|Overall Study|Disease progression|11|||
44525012|NCT02362035|79534036|FG000|Overall Study|Withdrawal by Subject|20|||
44525013|NCT01600755|79534048|FG000|Overall Study|Withdrawal by Subject|6|||
44525014|NCT04553913|79534074|FG000|Overall Study|patient's block resolved prior to PACU|1|||
44525015|NCT04553913|79534074|FG000|Overall Study|did not use the device properly|5|||
44525016|NCT04490499|79534079|FG000|Overall Study|Withdrawal by Subject|2|||
44525017|NCT01332994|79534083|FG000|Overall Study|Adverse Event|34|||
44525018|NCT01332994|79534083|FG000|Overall Study|Death|1|||
44411088|NCT00822120|79418811|FG000|PET-directed Therapy|Adverse Event|0|||
44411089|NCT00822120|79418812|FG001|PET-directed Therapy|Adverse Event|0|||
44411090|NCT00822120|79418813|FG002|PET-directed Therapy|Adverse Event|0|||
44411091|NCT00822120|79418814|FG003|PET-directed Therapy|Adverse Event|1|||
44411092|NCT00822120|79418815|FG004|PET-directed Therapy|Adverse Event|0|||
44411093|NCT00822120|79418816|FG005|PET-directed Therapy|Adverse Event|0|||
44411094|NCT00822120|79418811|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
44411095|NCT00822120|79418812|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
44411096|NCT00822120|79418813|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
44411097|NCT00822120|79418814|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
44411098|NCT00822120|79418815|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
44411099|NCT00822120|79418816|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
44411100|NCT00822120|79418811|FG000|PET-directed Therapy|Death|0|||
44411101|NCT00822120|79418812|FG001|PET-directed Therapy|Death|0|||
44411102|NCT00822120|79418813|FG002|PET-directed Therapy|Death|0|||
44411103|NCT00822120|79418814|FG003|PET-directed Therapy|Death|2|||
44411104|NCT00822120|79418815|FG004|PET-directed Therapy|Death|0|||
44411105|NCT00822120|79418816|FG005|PET-directed Therapy|Death|0|||
44411106|NCT00822120|79418811|FG000|PET-directed Therapy|Protocol Violation|0|||
44411107|NCT00822120|79418812|FG001|PET-directed Therapy|Protocol Violation|0|||
44411108|NCT00822120|79418813|FG002|PET-directed Therapy|Protocol Violation|0|||
44411109|NCT00822120|79418814|FG003|PET-directed Therapy|Protocol Violation|6|||
44411110|NCT00822120|79418815|FG004|PET-directed Therapy|Protocol Violation|0|||
44525019|NCT01332994|79534083|FG000|Overall Study|Lack of Efficacy|1|||
44525020|NCT01332994|79534083|FG000|Overall Study|Lost to Follow-up|4|||
44525021|NCT01332994|79534083|FG000|Overall Study|Protocol Violation|6|||
44525022|NCT01332994|79534083|FG000|Overall Study|Withdrawal by Subject|15|||
44525023|NCT01332994|79534083|FG000|Overall Study|Administrative Problem|2|||
44525024|NCT01332994|79534083|FG000|Overall Study|Other|8|||
44525025|NCT03698331|79534089|FG000|Overall Study|Adverse Event|2|||
44525026|NCT03698331|79534090|FG001|Overall Study|Adverse Event|3|||
44525027|NCT03698331|79534089|FG000|Overall Study|Withdrawal by Subject|1|||
44525028|NCT03698331|79534090|FG001|Overall Study|Withdrawal by Subject|1|||
44525029|NCT03698331|79534089|FG000|Overall Study|Lost to Follow-up|0|||
44525030|NCT03698331|79534090|FG001|Overall Study|Lost to Follow-up|2|||
44525031|NCT03698331|79534089|FG000|Overall Study|Non-compliance with study drug|1|||
44525032|NCT03698331|79534090|FG001|Overall Study|Non-compliance with study drug|0|||
44525033|NCT04889625|79534096|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
44525034|NCT04889625|79534097|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
44525035|NCT04889625|79534096|FG000|Period 1|Subject out of window|0|||
44525036|NCT04889625|79534097|FG001|Period 1|Subject out of window|1|||
44525037|NCT04889625|79534096|FG000|Period 1|Wrong add power dispensed|0|||
44525038|NCT04889625|79534097|FG001|Period 1|Wrong add power dispensed|1|||
44525039|NCT04889625|79534096|FG000|Period 1|Discontinued due to fitting guide error|1|||
44525040|NCT04889625|79534097|FG001|Period 1|Discontinued due to fitting guide error|1|||
44525041|NCT04889625|79534096|FG000|Period 2|Test article no longer available|1|||
44525042|NCT04889625|79534097|FG001|Period 2|Test article no longer available|0|||
44525043|NCT04889625|79534096|FG000|Period 2|Incorrect lens dispensed|1|||
44525044|NCT04889625|79534097|FG001|Period 2|Incorrect lens dispensed|0|||
44525045|NCT04889625|79534096|FG000|Period 2|Wrong add power dispensed|0|||
44525046|NCT04889625|79534097|FG001|Period 2|Wrong add power dispensed|1|||
44411111|NCT00822120|79418816|FG005|PET-directed Therapy|Protocol Violation|0|||
44411112|NCT00804687|79418837|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
44411113|NCT00804687|79418838|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
44525047|NCT04883541|79534105|FG000|Overall Study|Not attending regular yoga class|16|||
44525048|NCT04883541|79534106|FG001|Overall Study|Not attending regular yoga class|0|||
44525049|NCT04883541|79534105|FG000|Overall Study|Not attending the pregnancy school|0|||
44525050|NCT04883541|79534106|FG001|Overall Study|Not attending the pregnancy school|9|||
44525051|NCT04882995|79534114|FG000|Overall Study|Withdrawal by Subject|1|||
44525052|NCT04882995|79534115|FG001|Overall Study|Withdrawal by Subject|2|||
44411114|NCT00804687|79418839|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
44411115|NCT00804687|79418840|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
44411116|NCT00804687|79418841|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
44525053|NCT04882995|79534114|FG000|Overall Study|Protocol Violation|4|||
44525054|NCT04882995|79534115|FG001|Overall Study|Protocol Violation|4|||
44525055|NCT04882995|79534114|FG000|Overall Study|Surgery postponed due to COVID|1|||
44525056|NCT04882995|79534115|FG001|Overall Study|Surgery postponed due to COVID|1|||
44525057|NCT04483011|79534123|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
44525058|NCT04483011|79534124|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
44525059|NCT04545567|79534134|FG000|Overall Study|tested positive for SARS-co-V2|1|||
44525060|NCT04545567|79534135|FG001|Overall Study|tested positive for SARS-co-V2|1|||
44525061|NCT04545567|79534134|FG000|Overall Study|Withdrawal by Subject|0|||
44525062|NCT04545567|79534135|FG001|Overall Study|Withdrawal by Subject|1|||
44525063|NCT04534491|79534141|FG000|Overall Study|Not completed end-of-study interview|24|||
44525064|NCT04534491|79534141|FG000|Overall Study|Non-users|70|||
44525065|NCT04534491|79534141|FG000|Overall Study|Non-verifiable users|58|||
44525066|NCT03694821|79534148|FG000|Overall Study|Study terminated|4|||
44525067|NCT03694821|79534149|FG001|Overall Study|Study terminated|8|||
44525068|NCT03694821|79534150|FG002|Overall Study|Study terminated|4|||
44525069|NCT04531527|79534158|FG000|Overall Study|Found to be Ineligible|3|||
44525070|NCT04474197|79534166|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
44525071|NCT04474197|79534167|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
44525072|NCT04474197|79534168|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
44525073|NCT04474197|79534169|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
44525074|NCT02079766|79534186|FG000|Overall Study|Physician Decision|1|||
44525075|NCT02079766|79534187|FG001|Overall Study|Physician Decision|0|||
44525076|NCT02079766|79534186|FG000|Overall Study|Withdrawal by Subject|1|||
44525077|NCT02079766|79534187|FG001|Overall Study|Withdrawal by Subject|0|||
44525078|NCT04841577|79534195|FG000|Overall Study|Adverse Event|5|||
44525079|NCT04841577|79534196|FG001|Overall Study|Adverse Event|10|||
44525080|NCT04841577|79534195|FG000|Overall Study|Lost to Follow-up|8|||
44525081|NCT04841577|79534196|FG001|Overall Study|Lost to Follow-up|7|||
44525082|NCT04841577|79534195|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
44525083|NCT04841577|79534196|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
44525084|NCT04841577|79534195|FG000|Overall Study|Other|0|||
44411117|NCT00804687|79418842|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
44411118|NCT00804687|79418837|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
44411119|NCT00804687|79418838|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
44411120|NCT00804687|79418839|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
44411121|NCT00804687|79418840|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
44411122|NCT00804687|79418841|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
44411123|NCT00804687|79418842|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
44411124|NCT00804687|79418837|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
44411125|NCT00804687|79418838|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
44411126|NCT00804687|79418839|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
44411127|NCT00804687|79418840|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
44411128|NCT00804687|79418841|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
44411129|NCT00804687|79418842|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
44411130|NCT00804687|79418837|FG000|Period 5: Treatment Period|Positive drug test|1|||
44411131|NCT00804687|79418838|FG001|Period 5: Treatment Period|Positive drug test|0|||
44411132|NCT00804687|79418839|FG002|Period 5: Treatment Period|Positive drug test|0|||
44411133|NCT00804687|79418840|FG003|Period 5: Treatment Period|Positive drug test|0|||
44411134|NCT00804687|79418841|FG004|Period 5: Treatment Period|Positive drug test|0|||
44411135|NCT00804687|79418842|FG005|Period 5: Treatment Period|Positive drug test|0|||
44411136|NCT00678652|79418854|FG000|Overall Study|Protocol Violation|2|||
44411137|NCT00678652|79418855|FG001|Overall Study|Protocol Violation|0|||
44411138|NCT00678652|79418856|FG002|Overall Study|Protocol Violation|0|||
44411139|NCT00678652|79418857|FG003|Overall Study|Protocol Violation|0|||
44411140|NCT00678652|79418854|FG000|Overall Study|Pregnancy|0|||
44411141|NCT00678652|79418855|FG001|Overall Study|Pregnancy|0|||
44411142|NCT00678652|79418856|FG002|Overall Study|Pregnancy|1|||
44411143|NCT00678652|79418857|FG003|Overall Study|Pregnancy|0|||
44411144|NCT00678652|79418854|FG000|Overall Study|Relocation|1|||
44411145|NCT00678652|79418855|FG001|Overall Study|Relocation|0|||
44411146|NCT00678652|79418856|FG002|Overall Study|Relocation|0|||
44411147|NCT00678652|79418857|FG003|Overall Study|Relocation|0|||
44525085|NCT04841577|79534196|FG001|Overall Study|Other|1|||
44525086|NCT04529109|79534202|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
44525087|NCT04529109|79534203|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
44525088|NCT04528641|79534215|FG000|Overall Study|Withdrawal by Subject|0|||
44525089|NCT04528641|79534216|FG001|Overall Study|Withdrawal by Subject|0|||
44411148|NCT00840060|79418878|FG000|Overall Study|Withdrawal by Subject|1|||
44411149|NCT00840060|79418879|FG001|Overall Study|Withdrawal by Subject|0|||
44411150|NCT00840060|79418878|FG000|Overall Study|Change in emotional/behavioral status|0|||
44411151|NCT00840060|79418879|FG001|Overall Study|Change in emotional/behavioral status|1|||
44411152|NCT00574912|79418885|FG000|Overall Study|Could not place IV lines.|3|||
44411153|NCT00574912|79418885|FG000|Overall Study|scheduling conflicts|3|||
44411154|NCT00574912|79418885|FG000|Overall Study|Physician Decision|2|||
44411155|NCT00674128|79418899|FG000|Overall Study|Withdrawal by Subject|25|||
44253849|NCT00634751|79094496|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
44253850|NCT00634751|79094497|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
44253851|NCT00634751|79094494|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
44253852|NCT00634751|79094495|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
44253853|NCT00634751|79094496|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
44253854|NCT00634751|79094497|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
44253855|NCT00634751|79094494|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
44253856|NCT00634751|79094495|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
44253857|NCT00634751|79094496|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
44253858|NCT00634751|79094497|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
44411156|NCT00674128|79418900|FG001|Overall Study|Withdrawal by Subject|23|||
44411157|NCT00804141|79418906|FG000|Overall Study|Adverse Event|157|||
44411158|NCT00804141|79418906|FG000|Overall Study|Death|4|||
44411159|NCT00804141|79418906|FG000|Overall Study|Failed to return|96|||
44411160|NCT00804141|79418906|FG000|Overall Study|Investigator request|8|||
44411161|NCT00804141|79418906|FG000|Overall Study|Protocol Violation|85|||
44411162|NCT00804141|79418906|FG000|Overall Study|Withdrawal by Subject|131|||
44411163|NCT00804141|79418906|FG000|Overall Study|Lack of Efficacy|46|||
44411164|NCT00804141|79418906|FG000|Overall Study|Other than specified|30|||
44411165|NCT00804141|79418906|FG000|Overall Study|Enrolled but not treated|6|||
44411166|NCT00677092|79418910|FG000|Overall Study|Adverse Event|1|||
44411167|NCT00677092|79418910|FG000|Overall Study|Lost to Follow-up|1|||
44411168|NCT00677092|79418910|FG000|Overall Study|Withdrawal by Subject|3|||
44411169|NCT00677092|79418910|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
44411170|NCT00677014|79418918|FG000|Overall Study|Lost to Follow-up|20|||
44411171|NCT00677014|79418919|FG001|Overall Study|Lost to Follow-up|12|||
44411172|NCT00677014|79418920|FG002|Overall Study|Lost to Follow-up|24|||
44411173|NCT00677014|79418918|FG000|Overall Study|Death|6|||
44411174|NCT00677014|79418919|FG001|Overall Study|Death|15|||
44411175|NCT00677014|79418920|FG002|Overall Study|Death|7|||
44411176|NCT00677014|79418918|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
44411177|NCT00677014|79418919|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
44411178|NCT00677014|79418920|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
44411179|NCT00839436|79418931|FG000|Overall Study|Developed exclusionary condition|1|||
44411180|NCT00839436|79418932|FG001|Overall Study|Developed exclusionary condition|0|||
44411181|NCT00839436|79418933|FG002|Overall Study|Developed exclusionary condition|0|||
44411182|NCT00839436|79418931|FG000|Overall Study|Withdrawal by Subject|0|||
44411183|NCT00839436|79418932|FG001|Overall Study|Withdrawal by Subject|1|||
44411184|NCT00839436|79418933|FG002|Overall Study|Withdrawal by Subject|0|||
44411185|NCT00839436|79418931|FG000|Overall Study|Study drug no longer available|0|||
44411186|NCT00839436|79418932|FG001|Overall Study|Study drug no longer available|0|||
44411187|NCT00839436|79418933|FG002|Overall Study|Study drug no longer available|1|||
44411188|NCT00675766|79418945|FG000|Overall Study|Lost to Follow-up|6|||
44411189|NCT00675766|79418946|FG001|Overall Study|Lost to Follow-up|5|||
44411190|NCT00675766|79418947|FG002|Overall Study|Lost to Follow-up|21|||
44411191|NCT00675766|79418948|FG003|Overall Study|Lost to Follow-up|26|||
44411192|NCT00673894|79418960|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
44253859|NCT00634049|79094532|FG000|Overall Study|Never received study drug|1|||
44253860|NCT00634049|79094532|FG000|Overall Study|Died prior to receiving study drug|1|||
44253861|NCT00634049|79094532|FG000|Overall Study|Screening failure|1|||
44253862|NCT00632099|79094571|FG000|Overall Study|Lost to Follow-up|3|||
44253863|NCT00632099|79094572|FG001|Overall Study|Lost to Follow-up|3|||
44253864|NCT00632021|79094580|FG000|Overall Study|Withdrawal/death|4|||
44253865|NCT00632021|79094581|FG001|Overall Study|Withdrawal/death|7|||
44253866|NCT00631475|79094588|FG000|Overall Study|Death|18|||
44253867|NCT00631475|79094588|FG000|Overall Study|Adverse Event|14|||
44253868|NCT00631475|79094588|FG000|Overall Study|Withdrew consent|5|||
44411193|NCT00673894|79418961|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
44411194|NCT00673894|79418960|FG000|First Intervention 4 Weeks|Adverse Event|1|||
44411195|NCT00673894|79418961|FG001|First Intervention 4 Weeks|Adverse Event|0|||
44411196|NCT00674986|79418969|FG000|Overall Study|Adverse Event|2|||
44411197|NCT00674986|79418970|FG001|Overall Study|Adverse Event|1|||
44411198|NCT00674986|79418969|FG000|Overall Study|Subject withdrew consent|12|||
44253869|NCT00631475|79094588|FG000|Overall Study|Preparation for lung transplant|8|||
44253870|NCT00631163|79094609|FG000|Number of Participants in Year 1|Adverse Event|12|||
44411199|NCT00674986|79418970|FG001|Overall Study|Subject withdrew consent|19|||
44411200|NCT00674986|79418969|FG000|Overall Study|Lost to Follow-up|25|||
44411201|NCT00674986|79418970|FG001|Overall Study|Lost to Follow-up|53|||
44411202|NCT00674986|79418969|FG000|Overall Study|Other reasons|4|||
44411203|NCT00674986|79418970|FG001|Overall Study|Other reasons|8|||
44411204|NCT00673660|79418977|FG000|Overall Study|Lost to Follow-up|107|||
44411205|NCT00672958|79418988|FG000|Overall Study|Adverse Event|11|||
44411206|NCT00672958|79418989|FG001|Overall Study|Adverse Event|9|||
44411207|NCT00672958|79418988|FG000|Overall Study|Lack of Efficacy|6|||
44411208|NCT00672958|79418989|FG001|Overall Study|Lack of Efficacy|11|||
44411209|NCT00672958|79418988|FG000|Overall Study|Non-compliance with study drug|2|||
44411210|NCT00672958|79418989|FG001|Overall Study|Non-compliance with study drug|3|||
44411211|NCT00672958|79418988|FG000|Overall Study|Protocol deviations|11|||
44411212|NCT00672958|79418989|FG001|Overall Study|Protocol deviations|5|||
44411213|NCT00672958|79418988|FG000|Overall Study|Voluntary withdrawal|12|||
44411214|NCT00672958|79418989|FG001|Overall Study|Voluntary withdrawal|8|||
44411215|NCT00672958|79418988|FG000|Overall Study|Lost to Follow-up|22|||
44411216|NCT00672958|79418989|FG001|Overall Study|Lost to Follow-up|17|||
44411217|NCT00672958|79418988|FG000|Overall Study|Reason not specified|0|||
44411218|NCT00672958|79418989|FG001|Overall Study|Reason not specified|3|||
44411219|NCT00672646|79418998|FG000|Overall Study|Lost to Follow-up|0|||
44411220|NCT00672646|79418999|FG001|Overall Study|Lost to Follow-up|1|||
44411221|NCT00672646|79419000|FG002|Overall Study|Lost to Follow-up|2|||
44411222|NCT00672646|79418998|FG000|Overall Study|Withdrawal by Subject|0|||
44411223|NCT00672646|79418999|FG001|Overall Study|Withdrawal by Subject|0|||
44411224|NCT00672646|79419000|FG002|Overall Study|Withdrawal by Subject|1|||
44253871|NCT00631163|79094609|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
44253872|NCT00631163|79094609|FG000|Number of Participants in Year 1|Death|6|||
44411225|NCT00672490|79419010|FG000|Overall Study|Withdrawal by Subject|8|||
44411226|NCT00672490|79419011|FG001|Overall Study|Withdrawal by Subject|8|||
44411227|NCT00672490|79419010|FG000|Overall Study|Lack of Compliance|2|||
44411228|NCT00672490|79419011|FG001|Overall Study|Lack of Compliance|7|||
44411229|NCT00672490|79419010|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
44411230|NCT00672490|79419011|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
44411231|NCT00672490|79419010|FG000|Overall Study|Adverse Event|5|||
44411232|NCT00672490|79419011|FG001|Overall Study|Adverse Event|8|||
44411233|NCT00672490|79419010|FG000|Overall Study|Violation of Concomitant Medicine|1|||
44411234|NCT00672490|79419011|FG001|Overall Study|Violation of Concomitant Medicine|0|||
44411235|NCT00672490|79419010|FG000|Overall Study|Intolerance|0|||
44411236|NCT00672490|79419011|FG001|Overall Study|Intolerance|2|||
44411237|NCT00672490|79419010|FG000|Overall Study|Lost to Follow-up|1|||
44411238|NCT00672490|79419011|FG001|Overall Study|Lost to Follow-up|5|||
44411239|NCT00672490|79419010|FG000|Overall Study|No reason was provided|6|||
44411240|NCT00672490|79419011|FG001|Overall Study|No reason was provided|2|||
44411241|NCT00670930|79419019|FG000|Overall Study|Adminstrative Problem|0|||
44411242|NCT00670930|79419020|FG001|Overall Study|Adminstrative Problem|1|||
44411243|NCT00670930|79419019|FG000|Overall Study|Lost to Follow-up|1|||
44411244|NCT00670930|79419020|FG001|Overall Study|Lost to Follow-up|0|||
44411245|NCT00670540|79419026|FG000|Overall Study|ineligible|17|||
44411246|NCT00670540|79419026|FG000|Overall Study|not living in France|348|||
44411247|NCT00670540|79419026|FG000|Overall Study|refused to participate|189|||
44411248|NCT00670540|79419026|FG000|Overall Study|controls randomised for no follow up|2770|||
44411249|NCT00670540|79419026|FG000|Overall Study|missing information inclusion criteria|1|||
44411250|NCT00591786|79419040|FG000|Overall Study|Withdrawal of Informed Consent|0|||
44411251|NCT00591786|79419041|FG001|Overall Study|Withdrawal of Informed Consent|0|||
44411252|NCT00591786|79419042|FG002|Overall Study|Withdrawal of Informed Consent|1|||
44411253|NCT00591786|79419043|FG003|Overall Study|Withdrawal of Informed Consent|0|||
44411254|NCT00591786|79419044|FG004|Overall Study|Withdrawal of Informed Consent|0|||
44525090|NCT04528641|79534217|FG002|Overall Study|Withdrawal by Subject|0|||
44148434|NCT02153398|78937982|FG003|Overall Study|Adverse Event|1|||
44253873|NCT00631163|79094609|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
44411255|NCT00591786|79419045|FG005|Overall Study|Withdrawal of Informed Consent|0|||
44411256|NCT00591786|79419046|FG006|Overall Study|Withdrawal of Informed Consent|0|||
44411257|NCT00591786|79419047|FG007|Overall Study|Withdrawal of Informed Consent|0|||
44525091|NCT04528641|79534218|FG003|Overall Study|Withdrawal by Subject|1|||
44148435|NCT02153398|78937983|FG004|Overall Study|Adverse Event|0|||
44411258|NCT00591786|79419048|FG008|Overall Study|Withdrawal of Informed Consent|0|||
44411259|NCT00591786|79419049|FG009|Overall Study|Withdrawal of Informed Consent|0|||
44525092|NCT04528641|79534219|FG004|Overall Study|Withdrawal by Subject|0|||
44148436|NCT02118766|78937997|FG000|Overall Study|Adverse Event|7|||
44411260|NCT00674362|79419073|FG000|Double Blind|Adverse Event|6|||
44411261|NCT00674362|79419074|FG001|Double Blind|Adverse Event|6|||
44411262|NCT00674362|79419073|FG000|Double Blind|Lack of Efficacy|2|||
44411263|NCT00674362|79419074|FG001|Double Blind|Lack of Efficacy|6|||
44411264|NCT00674362|79419073|FG000|Double Blind|Loss of efficacy|0|||
44411265|NCT00674362|79419074|FG001|Double Blind|Loss of efficacy|1|||
44411266|NCT00674362|79419073|FG000|Double Blind|Withdrawal by Subject|4|||
44411267|NCT00674362|79419074|FG001|Double Blind|Withdrawal by Subject|3|||
44411268|NCT00674362|79419073|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
44411269|NCT00674362|79419074|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
44411270|NCT00674362|79419073|FG000|Double Blind|Other: Surgery|0|||
44411271|NCT00674362|79419074|FG001|Double Blind|Other: Surgery|1|||
44411272|NCT00674362|79419073|FG000|Open Label|Adverse Event|1|||
44411273|NCT00674362|79419074|FG001|Open Label|Adverse Event|0|||
44411274|NCT00674362|79419073|FG000|Open Label|Other: Subject moved to extension study|1|||
44411275|NCT00674362|79419074|FG001|Open Label|Other: Subject moved to extension study|0|||
44411276|NCT00820950|79419086|FG000|Overall Study|Scheduling Conflict|0|||
44411277|NCT00820950|79419087|FG001|Overall Study|Scheduling Conflict|0|||
44411278|NCT00820950|79419088|FG002|Overall Study|Scheduling Conflict|0|||
44411279|NCT00820950|79419089|FG003|Overall Study|Scheduling Conflict|0|||
44411280|NCT00820950|79419090|FG004|Overall Study|Scheduling Conflict|0|||
44411281|NCT00820950|79419091|FG005|Overall Study|Scheduling Conflict|0|||
44411282|NCT00820950|79419092|FG006|Overall Study|Scheduling Conflict|1|||
44411283|NCT00820950|79419093|FG007|Overall Study|Scheduling Conflict|1|||
44411284|NCT00820950|79419094|FG008|Overall Study|Scheduling Conflict|0|||
44411285|NCT00820950|79419095|FG009|Overall Study|Scheduling Conflict|0|||
44411286|NCT00820950|79419086|FG000|Overall Study|Protocol Violation|1|||
44411287|NCT00820950|79419087|FG001|Overall Study|Protocol Violation|1|||
44411288|NCT00820950|79419088|FG002|Overall Study|Protocol Violation|0|||
44411289|NCT00820950|79419089|FG003|Overall Study|Protocol Violation|0|||
44411290|NCT00820950|79419090|FG004|Overall Study|Protocol Violation|0|||
44411291|NCT00820950|79419091|FG005|Overall Study|Protocol Violation|0|||
44411292|NCT00820950|79419092|FG006|Overall Study|Protocol Violation|0|||
44411293|NCT00820950|79419093|FG007|Overall Study|Protocol Violation|0|||
44411294|NCT00820950|79419094|FG008|Overall Study|Protocol Violation|0|||
44411295|NCT00820950|79419095|FG009|Overall Study|Protocol Violation|0|||
44411296|NCT00670306|79419135|FG000|Overall Study|Adverse Event|8|||
44411297|NCT00670306|79419135|FG000|Overall Study|Lack of Efficacy|10|||
44411298|NCT00670306|79419135|FG000|Overall Study|Withdrawal by Subject|9|||
44411299|NCT00670306|79419135|FG000|Overall Study|Physician Decision|1|||
44411300|NCT00670306|79419135|FG000|Overall Study|Lost to Follow-up|8|||
44411301|NCT00670306|79419135|FG000|Overall Study|incl/excl criterias did not meet|19|||
44411302|NCT00672256|79419139|FG000|Overall Study|PI dropped, bad data|44|||
44411303|NCT00591630|79419147|FG000|Overall Study|Death|0|||
44411304|NCT00591630|79419148|FG001|Overall Study|Death|0|||
44411305|NCT00591630|79419149|FG002|Overall Study|Death|1|||
44411306|NCT00591630|79419150|FG003|Overall Study|Death|0|||
44411307|NCT00670228|79419162|FG000|Overall Study|Adverse Event|1|||
44411308|NCT00670228|79419163|FG001|Overall Study|Adverse Event|0|||
44411309|NCT00670228|79419162|FG000|Overall Study|Death or MACE|0|||
44525093|NCT04528641|79534220|FG005|Overall Study|Withdrawal by Subject|1|||
44525094|NCT04527471|79534239|FG000|Overall Study|Adverse Event|1|||
44525095|NCT04527471|79534240|FG001|Overall Study|Adverse Event|0|||
44525096|NCT04527471|79534239|FG000|Overall Study|Lost to Follow-up|1|||
44525097|NCT04527471|79534240|FG001|Overall Study|Lost to Follow-up|0|||
44525098|NCT04471935|79534246|FG000|Overall Study|Withdrawal by Subject|1|||
44525099|NCT04471935|79534246|FG000|Overall Study|Deemed ineligible to participate|1|||
44525100|NCT04468347|79534254|FG000|Overall Study|Withdrawal by Subject|0|||
44525101|NCT04468347|79534255|FG001|Overall Study|Withdrawal by Subject|1|||
44525102|NCT04468347|79534256|FG002|Overall Study|Withdrawal by Subject|3|||
44525103|NCT04468347|79534257|FG003|Overall Study|Withdrawal by Subject|3|||
44525104|NCT04468347|79534254|FG000|Overall Study|Lost to Follow-up|0|||
44411310|NCT00670228|79419163|FG001|Overall Study|Death or MACE|1|||
44411311|NCT00670228|79419162|FG000|Overall Study|Not treated|2|||
44411312|NCT00670228|79419163|FG001|Overall Study|Not treated|2|||
44411313|NCT00670228|79419162|FG000|Overall Study|Not meeting the selection criteria|2|||
44411314|NCT00670228|79419163|FG001|Overall Study|Not meeting the selection criteria|0|||
44411315|NCT00570778|79419169|FG000|Overall Study|Protocol deviation|2|||
44411316|NCT00570778|79419170|FG001|Overall Study|Protocol deviation|1|||
44411317|NCT00570778|79419171|FG002|Overall Study|Protocol deviation|2|||
44411318|NCT00570778|79419172|FG003|Overall Study|Protocol deviation|2|||
44411319|NCT00570778|79419169|FG000|Overall Study|Adverse Event|0|||
44411320|NCT00570778|79419170|FG001|Overall Study|Adverse Event|1|||
44411321|NCT00570778|79419171|FG002|Overall Study|Adverse Event|4|||
44411322|NCT00570778|79419172|FG003|Overall Study|Adverse Event|1|||
44411323|NCT00570778|79419169|FG000|Overall Study|Subject withdrew consent|0|||
44525105|NCT04468347|79534255|FG001|Overall Study|Lost to Follow-up|0|||
44525106|NCT04468347|79534256|FG002|Overall Study|Lost to Follow-up|1|||
44525107|NCT04468347|79534257|FG003|Overall Study|Lost to Follow-up|1|||
44525108|NCT04468347|79534254|FG000|Overall Study|Physician Decision|1|||
44411324|NCT00570778|79419170|FG001|Overall Study|Subject withdrew consent|1|||
44411325|NCT00570778|79419171|FG002|Overall Study|Subject withdrew consent|0|||
44411326|NCT00570778|79419172|FG003|Overall Study|Subject withdrew consent|1|||
44411327|NCT00570778|79419169|FG000|Overall Study|Abnormal test procedure|1|||
44411328|NCT00570778|79419170|FG001|Overall Study|Abnormal test procedure|0|||
44411329|NCT00570778|79419171|FG002|Overall Study|Abnormal test procedure|0|||
44411330|NCT00570778|79419172|FG003|Overall Study|Abnormal test procedure|0|||
44411331|NCT00570778|79419169|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44411332|NCT00570778|79419170|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44411333|NCT00570778|79419171|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44411334|NCT00570778|79419172|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
44411335|NCT00570778|79419169|FG000|Overall Study|Lost to Follow-up|0|||
44411336|NCT00570778|79419170|FG001|Overall Study|Lost to Follow-up|0|||
44411337|NCT00570778|79419171|FG002|Overall Study|Lost to Follow-up|1|||
44411338|NCT00570778|79419172|FG003|Overall Study|Lost to Follow-up|0|||
44411339|NCT00570778|79419169|FG000|Overall Study|Subject no longer requires study drug|0|||
44411340|NCT00570778|79419170|FG001|Overall Study|Subject no longer requires study drug|1|||
44411341|NCT00570778|79419171|FG002|Overall Study|Subject no longer requires study drug|0|||
44411342|NCT00570778|79419172|FG003|Overall Study|Subject no longer requires study drug|0|||
44411343|NCT00668746|79419184|FG000|Overall Study|Lost to Follow-up|2|||
44411344|NCT00668746|79419185|FG001|Overall Study|Lost to Follow-up|1|||
44411345|NCT00878189|79419203|FG000|Overall Study|Death|0|||
44411346|NCT00878189|79419204|FG001|Overall Study|Death|1|||
44411347|NCT00878189|79419205|FG002|Overall Study|Death|0|||
44411348|NCT00878189|79419206|FG003|Overall Study|Death|1|||
44411349|NCT00878189|79419207|FG004|Overall Study|Death|0|||
44411350|NCT00878189|79419208|FG005|Overall Study|Death|0|||
44411351|NCT00878189|79419209|FG006|Overall Study|Death|0|||
44411352|NCT00878189|79419210|FG007|Overall Study|Death|0|||
44411353|NCT00878189|79419211|FG008|Overall Study|Death|1|||
44411354|NCT00878189|79419203|FG000|Overall Study|Participant Refused to Follow-up|0|||
44411355|NCT00878189|79419204|FG001|Overall Study|Participant Refused to Follow-up|0|||
44411356|NCT00878189|79419205|FG002|Overall Study|Participant Refused to Follow-up|0|||
44525109|NCT04468347|79534255|FG001|Overall Study|Physician Decision|0|||
44525110|NCT04468347|79534256|FG002|Overall Study|Physician Decision|2|||
44525111|NCT04468347|79534257|FG003|Overall Study|Physician Decision|0|||
44525112|NCT04468347|79534254|FG000|Overall Study|Protocol Violation|1|||
44525113|NCT04468347|79534255|FG001|Overall Study|Protocol Violation|0|||
44525114|NCT04468347|79534256|FG002|Overall Study|Protocol Violation|0|||
44525115|NCT04468347|79534257|FG003|Overall Study|Protocol Violation|0|||
44525116|NCT04822701|79534273|FG000|Overall Study|Not treated|2|||
44525117|NCT04822701|79534274|FG001|Overall Study|Not treated|0|||
44525118|NCT04822701|79534273|FG000|Overall Study|Lost to Follow-up|1|||
44525119|NCT04822701|79534274|FG001|Overall Study|Lost to Follow-up|0|||
44525120|NCT04822701|79534273|FG000|Overall Study|Withdrawal by Subject|1|||
44525121|NCT04822701|79534274|FG001|Overall Study|Withdrawal by Subject|0|||
44525122|NCT04461795|79534280|FG000|Overall Study|Lost to Follow-up|2|||
44525123|NCT04461795|79534280|FG000|Overall Study|Withdrawal by Subject|2|||
44525124|NCT04461795|79534280|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
44525125|NCT04461015|79534287|FG000|Overall Study|IV access lost during the study|0|||
44525126|NCT04461015|79534288|FG001|Overall Study|IV access lost during the study|1|||
44525127|NCT04461015|79534287|FG000|Overall Study|Withdrawal by Subject|0|||
44525128|NCT04461015|79534288|FG001|Overall Study|Withdrawal by Subject|1|||
44525129|NCT04810221|79534294|FG000|Overall Study|Physician Decision|3|||
44525130|NCT03694353|79534298|FG000|Overall Study|Withdrawal by Subject|1|||
44525131|NCT03694353|79534298|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
44525132|NCT04521777|79534302|FG000|Overall Study|Death|2|||
44525133|NCT04521777|79534302|FG000|Overall Study|Withdrawal by Subject|2|||
44525134|NCT03700671|79534308|FG000|Overall Study|Lack of Efficacy|1|||
44525135|NCT03700671|79534309|FG001|Overall Study|Lack of Efficacy|2|||
44525136|NCT04764669|79534321|FG000|Overall Study|Adverse Event|1|||
44525137|NCT04764669|79534322|FG001|Overall Study|Adverse Event|0|||
44525138|NCT04764669|79534323|FG002|Overall Study|Adverse Event|1|||
44525139|NCT04764669|79534324|FG003|Overall Study|Adverse Event|0|||
44525140|NCT04764669|79534321|FG000|Overall Study|Subject Choice|0|||
44148437|NCT02118766|78937998|FG001|Overall Study|Adverse Event|2|||
44148438|NCT02118766|78937997|FG000|Overall Study|Withdrawal by Subject|3|||
44525141|NCT04764669|79534322|FG001|Overall Study|Subject Choice|0|||
44525142|NCT04764669|79534323|FG002|Overall Study|Subject Choice|1|||
44411357|NCT00878189|79419206|FG003|Overall Study|Participant Refused to Follow-up|0|||
44411358|NCT00878189|79419207|FG004|Overall Study|Participant Refused to Follow-up|0|||
44411359|NCT00878189|79419208|FG005|Overall Study|Participant Refused to Follow-up|4|||
44411360|NCT00878189|79419209|FG006|Overall Study|Participant Refused to Follow-up|0|||
44411361|NCT00878189|79419210|FG007|Overall Study|Participant Refused to Follow-up|0|||
44411362|NCT00878189|79419211|FG008|Overall Study|Participant Refused to Follow-up|0|||
44148439|NCT02118766|78937998|FG001|Overall Study|Withdrawal by Subject|6|||
44148440|NCT02118766|78937997|FG000|Overall Study|Lost to Follow-up|5|||
44411363|NCT00878189|79419203|FG000|Overall Study|Other|3|||
44525143|NCT04764669|79534324|FG003|Overall Study|Subject Choice|0|||
44525144|NCT04764669|79534321|FG000|Overall Study|Withdrawal by Subject|2|||
44525145|NCT04764669|79534322|FG001|Overall Study|Withdrawal by Subject|0|||
44525146|NCT04764669|79534323|FG002|Overall Study|Withdrawal by Subject|0|||
44148441|NCT02118766|78937998|FG001|Overall Study|Lost to Follow-up|4|||
44148442|NCT02118766|78937997|FG000|Overall Study|Withdrawal by parent/guardian|12|||
44282177|NCT01879722|79245428|FG002|Overall Study|Voluntary Withdrawal|0|||
44282178|NCT01879722|79245429|FG003|Overall Study|Voluntary Withdrawal|0|||
44525147|NCT04764669|79534324|FG003|Overall Study|Withdrawal by Subject|0|||
44525148|NCT04439253|79534334|FG000|Overall Study|Adverse Event|1|||
44525149|NCT04439253|79534334|FG000|Overall Study|Disease progression|2|||
44525150|NCT04439253|79534334|FG000|Overall Study|Complicating disease|1|||
44525151|NCT04438785|79534340|FG000|Overall Study|change of weight, give up intervention|2|||
44525152|NCT04438785|79534341|FG001|Overall Study|change of weight, give up intervention|10|||
44282179|NCT01879722|79245430|FG004|Overall Study|Voluntary Withdrawal|0|||
44282180|NCT01879722|79245431|FG005|Overall Study|Voluntary Withdrawal|0|||
44282181|NCT01879722|79245432|FG006|Overall Study|Voluntary Withdrawal|0|||
44282182|NCT01879722|79245433|FG007|Overall Study|Voluntary Withdrawal|0|||
44282183|NCT01879722|79245434|FG008|Overall Study|Voluntary Withdrawal|1|||
44282184|NCT01879722|79245435|FG009|Overall Study|Voluntary Withdrawal|0|||
44282185|NCT01879410|79245462|FG000|Overall Study|Adverse Event|9|||
44411364|NCT00878189|79419204|FG001|Overall Study|Other|2|||
44411365|NCT00878189|79419205|FG002|Overall Study|Other|4|||
44411366|NCT00878189|79419206|FG003|Overall Study|Other|7|||
44411367|NCT00878189|79419207|FG004|Overall Study|Other|4|||
44411368|NCT00878189|79419208|FG005|Overall Study|Other|18|||
44411369|NCT00878189|79419209|FG006|Overall Study|Other|15|||
44411370|NCT00878189|79419210|FG007|Overall Study|Other|3|||
44411371|NCT00878189|79419211|FG008|Overall Study|Other|4|||
44411372|NCT00878189|79419203|FG000|Overall Study|Lost to Follow-up|0|||
44411373|NCT00878189|79419204|FG001|Overall Study|Lost to Follow-up|0|||
44411374|NCT00878189|79419205|FG002|Overall Study|Lost to Follow-up|0|||
44411375|NCT00878189|79419206|FG003|Overall Study|Lost to Follow-up|0|||
44411376|NCT00878189|79419207|FG004|Overall Study|Lost to Follow-up|0|||
44411377|NCT00878189|79419208|FG005|Overall Study|Lost to Follow-up|1|||
44411378|NCT00878189|79419209|FG006|Overall Study|Lost to Follow-up|1|||
44411379|NCT00878189|79419210|FG007|Overall Study|Lost to Follow-up|0|||
44411380|NCT00878189|79419211|FG008|Overall Study|Lost to Follow-up|0|||
44411381|NCT00878189|79419203|FG000|Overall Study|Objection Progression or Relapse|0|||
44411382|NCT00878189|79419204|FG001|Overall Study|Objection Progression or Relapse|0|||
44411383|NCT00878189|79419205|FG002|Overall Study|Objection Progression or Relapse|0|||
44411384|NCT00878189|79419206|FG003|Overall Study|Objection Progression or Relapse|0|||
44411385|NCT00878189|79419207|FG004|Overall Study|Objection Progression or Relapse|0|||
44411386|NCT00878189|79419208|FG005|Overall Study|Objection Progression or Relapse|0|||
44411387|NCT00878189|79419209|FG006|Overall Study|Objection Progression or Relapse|0|||
44411388|NCT00878189|79419210|FG007|Overall Study|Objection Progression or Relapse|0|||
44411389|NCT00878189|79419211|FG008|Overall Study|Objection Progression or Relapse|3|||
44411390|NCT00668200|79419245|FG000|Overall Study|Withdrawal by Subject|2|||
44411391|NCT00668200|79419245|FG000|Overall Study|Lost to Follow-up|1|||
44411392|NCT00838578|79419249|FG000|Overall Study|Protocol Violation|2|||
44411393|NCT00829296|79419259|FG000|Overall Study|Adverse Event|5|||
44411394|NCT00829296|79419260|FG001|Overall Study|Adverse Event|4|||
44411395|NCT00881621|79419266|FG000|Overall Study|Physician Decision|34|||
44411396|NCT00818766|79419272|FG000|Overall Study|Could not be Contacted on Day 28|11|||
44411397|NCT00818766|79419273|FG001|Overall Study|Could not be Contacted on Day 28|10|||
44411398|NCT00818766|79419272|FG000|Overall Study|Death|1|||
44411399|NCT00818766|79419273|FG001|Overall Study|Death|0|||
44411400|NCT00818766|79419272|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
44411401|NCT00818766|79419273|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
44411402|NCT00667888|79419281|FG000|Overall Study|Death|1|||
44411403|NCT00667888|79419282|FG001|Overall Study|Death|1|||
44411404|NCT00667888|79419281|FG000|Overall Study|Withdrawal by Subject|6|||
44411405|NCT00667888|79419282|FG001|Overall Study|Withdrawal by Subject|3|||
44411406|NCT00667888|79419281|FG000|Overall Study|Proceed with other treatment|3|||
44411407|NCT00667888|79419282|FG001|Overall Study|Proceed with other treatment|3|||
44411408|NCT00667888|79419281|FG000|Overall Study|Ineligible after SIM|0|||
44411409|NCT00667888|79419282|FG001|Overall Study|Ineligible after SIM|2|||
44411410|NCT00594815|79419288|FG000|Overall Study|Never Treated|3|||
44411411|NCT00594815|79419288|FG000|Overall Study|Withdrawal by Subject|2|||
44411412|NCT00594815|79419288|FG000|Overall Study|Toxicity|4|||
44411413|NCT00820170|79419297|FG000|Overall Study|Adverse Event|0|||
44411414|NCT00820170|79419298|FG001|Overall Study|Adverse Event|0|||
44411415|NCT00820170|79419299|FG002|Overall Study|Adverse Event|0|||
44525153|NCT04741503|79534349|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
44525154|NCT04741503|79534350|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
44525155|NCT04741503|79534351|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
44525156|NCT04741503|79534349|FG000|Initial Enrollment|Overquotas removed|0|||
44525157|NCT04741503|79534350|FG001|Initial Enrollment|Overquotas removed|0|||
44525158|NCT04741503|79534351|FG002|Initial Enrollment|Overquotas removed|186|||
44411416|NCT00820170|79419300|FG003|Overall Study|Adverse Event|0|||
44411417|NCT00820170|79419301|FG004|Overall Study|Adverse Event|2|||
44411418|NCT00820170|79419297|FG000|Overall Study|Progressive Disease|0|||
44411419|NCT00820170|79419298|FG001|Overall Study|Progressive Disease|0|||
44411420|NCT00820170|79419299|FG002|Overall Study|Progressive Disease|0|||
44411421|NCT00820170|79419300|FG003|Overall Study|Progressive Disease|0|||
44411422|NCT00820170|79419301|FG004|Overall Study|Progressive Disease|2|||
44411423|NCT00818454|79419318|FG000|Treatment Period 1|Adverse Event|0|||
44411424|NCT00818454|79419319|FG001|Treatment Period 1|Adverse Event|1|||
44411425|NCT00818454|79419320|FG002|Treatment Period 1|Adverse Event|0|||
44411426|NCT00818454|79419321|FG003|Treatment Period 1|Adverse Event|0|||
44411427|NCT00818454|79419318|FG000|Treatment Period 1|Other|3|||
44411428|NCT00818454|79419319|FG001|Treatment Period 1|Other|0|||
44411429|NCT00818454|79419320|FG002|Treatment Period 1|Other|0|||
44411430|NCT00818454|79419321|FG003|Treatment Period 1|Other|0|||
44411431|NCT00818454|79419318|FG000|Washout Period of 1 Week|Adverse Event|1|||
44411432|NCT00818454|79419319|FG001|Washout Period of 1 Week|Adverse Event|1|||
44411433|NCT00818454|79419320|FG002|Washout Period of 1 Week|Adverse Event|0|||
44411434|NCT00818454|79419321|FG003|Washout Period of 1 Week|Adverse Event|0|||
44411435|NCT00818454|79419318|FG000|Washout Period of 1 Week|Protocol Violation|2|||
44411436|NCT00818454|79419319|FG001|Washout Period of 1 Week|Protocol Violation|0|||
44411437|NCT00818454|79419320|FG002|Washout Period of 1 Week|Protocol Violation|0|||
44411438|NCT00818454|79419321|FG003|Washout Period of 1 Week|Protocol Violation|0|||
44411439|NCT00818454|79419318|FG000|Washout Period of 1 Week|Other|1|||
44411440|NCT00818454|79419319|FG001|Washout Period of 1 Week|Other|2|||
44411441|NCT00818454|79419320|FG002|Washout Period of 1 Week|Other|0|||
44411442|NCT00818454|79419321|FG003|Washout Period of 1 Week|Other|0|||
44411443|NCT00818454|79419318|FG000|Treatment Period 2|Other|2|||
44411444|NCT00818454|79419319|FG001|Treatment Period 2|Other|1|||
44411445|NCT00818454|79419320|FG002|Treatment Period 2|Other|0|||
44411446|NCT00818454|79419321|FG003|Treatment Period 2|Other|0|||
44411447|NCT00818454|79419318|FG000|Treatment Period 3|Adverse Event|0|||
44411448|NCT00818454|79419319|FG001|Treatment Period 3|Adverse Event|0|||
44411449|NCT00818454|79419320|FG002|Treatment Period 3|Adverse Event|0|||
44411450|NCT00818454|79419321|FG003|Treatment Period 3|Adverse Event|1|||
44411451|NCT00828984|79419334|FG000|Overall Study|Adverse Event|2|||
44411452|NCT00828984|79419335|FG001|Overall Study|Adverse Event|3|||
44411453|NCT00828984|79419336|FG002|Overall Study|Adverse Event|0|||
44411454|NCT00828984|79419334|FG000|Overall Study|Lost to Follow-up|5|||
44411455|NCT00828984|79419335|FG001|Overall Study|Lost to Follow-up|3|||
44411456|NCT00828984|79419336|FG002|Overall Study|Lost to Follow-up|1|||
44411457|NCT00828984|79419334|FG000|Overall Study|Withdrawal by Subject|4|||
44411458|NCT00828984|79419335|FG001|Overall Study|Withdrawal by Subject|4|||
44411459|NCT00828984|79419336|FG002|Overall Study|Withdrawal by Subject|4|||
44411460|NCT00828984|79419334|FG000|Overall Study|Ineligable|1|||
44411461|NCT00828984|79419335|FG001|Overall Study|Ineligable|2|||
44411462|NCT00828984|79419336|FG002|Overall Study|Ineligable|0|||
44411463|NCT00828984|79419334|FG000|Overall Study|Medical Contraindication|0|||
44411464|NCT00828984|79419335|FG001|Overall Study|Medical Contraindication|1|||
44411465|NCT00828984|79419336|FG002|Overall Study|Medical Contraindication|0|||
44411466|NCT00828984|79419334|FG000|Overall Study|Noncompliant|1|||
44411467|NCT00828984|79419335|FG001|Overall Study|Noncompliant|2|||
44411468|NCT00828984|79419336|FG002|Overall Study|Noncompliant|3|||
44411469|NCT00828984|79419334|FG000|Overall Study|ConMed|1|||
44411470|NCT00828984|79419335|FG001|Overall Study|ConMed|1|||
44411471|NCT00828984|79419336|FG002|Overall Study|ConMed|1|||
44411472|NCT00828750|79419344|FG000|Overall Study|Lack of Efficacy|3|||
44411473|NCT00828750|79419344|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
44411474|NCT00667810|79419353|FG000|Overall Study|Adverse Event|13|||
44411475|NCT00667810|79419354|FG001|Overall Study|Adverse Event|14|||
44411476|NCT00667810|79419355|FG002|Overall Study|Adverse Event|19|||
44411477|NCT00667810|79419356|FG003|Overall Study|Adverse Event|1|||
44411478|NCT00667810|79419353|FG000|Overall Study|Death|1|||
44411479|NCT00667810|79419354|FG001|Overall Study|Death|1|||
44411480|NCT00667810|79419355|FG002|Overall Study|Death|3|||
44411481|NCT00667810|79419356|FG003|Overall Study|Death|0|||
44411482|NCT00667810|79419353|FG000|Overall Study|Lack of Efficacy|1|||
44411483|NCT00667810|79419354|FG001|Overall Study|Lack of Efficacy|0|||
44411484|NCT00667810|79419355|FG002|Overall Study|Lack of Efficacy|2|||
44411485|NCT00667810|79419356|FG003|Overall Study|Lack of Efficacy|0|||
44411486|NCT00667810|79419353|FG000|Overall Study|Lost to Follow-up|1|||
44411487|NCT00667810|79419354|FG001|Overall Study|Lost to Follow-up|4|||
44411488|NCT00667810|79419355|FG002|Overall Study|Lost to Follow-up|2|||
44411489|NCT00667810|79419356|FG003|Overall Study|Lost to Follow-up|0|||
44411490|NCT00667810|79419353|FG000|Overall Study|Physician Decision|1|||
44411491|NCT00667810|79419354|FG001|Overall Study|Physician Decision|1|||
44411492|NCT00667810|79419355|FG002|Overall Study|Physician Decision|2|||
44411493|NCT00667810|79419356|FG003|Overall Study|Physician Decision|0|||
44411494|NCT00667810|79419353|FG000|Overall Study|Protocol Violation|0|||
44411495|NCT00667810|79419354|FG001|Overall Study|Protocol Violation|2|||
44411496|NCT00667810|79419355|FG002|Overall Study|Protocol Violation|0|||
44411497|NCT00667810|79419356|FG003|Overall Study|Protocol Violation|0|||
44411498|NCT00667810|79419353|FG000|Overall Study|Withdrawal by Subject|14|||
44411499|NCT00667810|79419354|FG001|Overall Study|Withdrawal by Subject|20|||
44411500|NCT00667810|79419355|FG002|Overall Study|Withdrawal by Subject|29|||
44411501|NCT00667810|79419356|FG003|Overall Study|Withdrawal by Subject|1|||
44411502|NCT00667810|79419353|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
44411503|NCT00667810|79419354|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
44411504|NCT00667810|79419355|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
44411505|NCT00667810|79419356|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
44411506|NCT00667810|79419353|FG000|Overall Study|Failed to Return|0|||
44411507|NCT00667810|79419354|FG001|Overall Study|Failed to Return|0|||
44411508|NCT00667810|79419355|FG002|Overall Study|Failed to Return|2|||
44411509|NCT00667810|79419356|FG003|Overall Study|Failed to Return|0|||
44411510|NCT00667810|79419353|FG000|Overall Study|Loss of Caregiver|0|||
44411511|NCT00667810|79419354|FG001|Overall Study|Loss of Caregiver|1|||
44411512|NCT00667810|79419355|FG002|Overall Study|Loss of Caregiver|3|||
44411513|NCT00667810|79419356|FG003|Overall Study|Loss of Caregiver|0|||
44411514|NCT00667810|79419353|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
44411515|NCT00667810|79419354|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
44411516|NCT00667810|79419355|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
44411517|NCT00667810|79419356|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
44411518|NCT00667810|79419353|FG000|Overall Study|Other|6|||
44411519|NCT00667810|79419354|FG001|Overall Study|Other|6|||
44411520|NCT00667810|79419355|FG002|Overall Study|Other|5|||
44411521|NCT00667810|79419356|FG003|Overall Study|Other|0|||
44411522|NCT00819390|79419375|FG000|Overall Study|Lost to Follow-up|1|||
44411523|NCT00819390|79419376|FG001|Overall Study|Lost to Follow-up|1|||
44411524|NCT00819390|79419377|FG002|Overall Study|Lost to Follow-up|0|||
44411525|NCT00819390|79419378|FG003|Overall Study|Lost to Follow-up|0|||
44411526|NCT00819390|79419375|FG000|Overall Study|Withdrawal by Subject|2|||
44411527|NCT00819390|79419376|FG001|Overall Study|Withdrawal by Subject|0|||
44411528|NCT00819390|79419377|FG002|Overall Study|Withdrawal by Subject|0|||
44411529|NCT00819390|79419378|FG003|Overall Study|Withdrawal by Subject|0|||
44411530|NCT00819390|79419375|FG000|Overall Study|Adverse Event|0|||
44411531|NCT00819390|79419376|FG001|Overall Study|Adverse Event|0|||
44411532|NCT00819390|79419377|FG002|Overall Study|Adverse Event|1|||
44411533|NCT00819390|79419378|FG003|Overall Study|Adverse Event|0|||
44411534|NCT00876395|79419393|FG000|Overall Study|Untreated|8|||
44411535|NCT00876395|79419394|FG001|Overall Study|Untreated|1|||
44411536|NCT00876395|79419393|FG000|Overall Study|Adverse Event|63|||
44411537|NCT00876395|79419394|FG001|Overall Study|Adverse Event|11|||
44411538|NCT00876395|79419393|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44411539|NCT00876395|79419394|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44411540|NCT00876395|79419393|FG000|Overall Study|Disease progression|259|||
44411541|NCT00876395|79419394|FG001|Overall Study|Disease progression|162|||
44411542|NCT00876395|79419393|FG000|Overall Study|New cancer therapy|25|||
44411543|NCT00876395|79419394|FG001|Overall Study|New cancer therapy|7|||
44411544|NCT00876395|79419393|FG000|Overall Study|Protocol Violation|5|||
44411545|NCT00876395|79419394|FG001|Overall Study|Protocol Violation|2|||
44411546|NCT00876395|79419393|FG000|Overall Study|Withdrawal by Subject|66|||
44411547|NCT00876395|79419394|FG001|Overall Study|Withdrawal by Subject|33|||
44411548|NCT00876395|79419393|FG000|Overall Study|Lost to Follow-up|2|||
44411549|NCT00876395|79419394|FG001|Overall Study|Lost to Follow-up|0|||
44411550|NCT00876395|79419393|FG000|Overall Study|Administrative problems|39|||
44411551|NCT00876395|79419394|FG001|Overall Study|Administrative problems|23|||
44411552|NCT00876395|79419393|FG000|Overall Study|Death|12|||
44411553|NCT00876395|79419394|FG001|Overall Study|Death|0|||
44411554|NCT00594659|79419408|FG000|Overall Study|Lost to Follow-up|13|||
44411555|NCT00594659|79419409|FG001|Overall Study|Lost to Follow-up|9|||
44253874|NCT00631163|79094609|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
44253875|NCT00631163|79094609|FG000|Number of Participants in Year 1|Administrative problems|6|||
44253876|NCT00631163|79094609|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
44253877|NCT00631163|79094609|FG000|Number of Participants in Year 2|Adverse Event|1|||
44282186|NCT01879410|79245463|FG001|Overall Study|Adverse Event|14|||
44411556|NCT00594659|79419410|FG002|Overall Study|Lost to Follow-up|7|||
44411557|NCT00667732|79419420|FG000|Run -In (8 Weeks)|Adverse Event|4|||
44411558|NCT00667732|79419421|FG001|Run -In (8 Weeks)|Adverse Event|0|||
44411559|NCT00667732|79419422|FG002|Run -In (8 Weeks)|Adverse Event|0|||
44411560|NCT00667732|79419420|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
44411561|NCT00667732|79419421|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
44411562|NCT00667732|79419422|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
44411563|NCT00667732|79419420|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
44411564|NCT00667732|79419421|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
44411565|NCT00667732|79419422|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
44411566|NCT00671788|79419432|FG000|Overall Study|Adverse Event|8|||
44411567|NCT00671788|79419432|FG000|Overall Study|Refused further treatment|3|||
44411568|NCT00671788|79419432|FG000|Overall Study|Ineligible|1|||
44411569|NCT00671788|79419432|FG000|Overall Study|MD Decision|1|||
44411570|NCT00671788|79419432|FG000|Overall Study|Other|1|||
44411571|NCT00875615|79419436|FG000|Overall Study|Withdrawal by Subject|1|||
44411572|NCT00597701|79419442|FG000|Overall Study|Withdrawal by Subject|5|||
44411573|NCT00597701|79419443|FG001|Overall Study|Withdrawal by Subject|5|||
44411574|NCT00597701|79419442|FG000|Overall Study|Death|0|||
44411575|NCT00597701|79419443|FG001|Overall Study|Death|1|||
44411576|NCT00597701|79419442|FG000|Overall Study|Physician Decision|2|||
44411577|NCT00597701|79419443|FG001|Overall Study|Physician Decision|0|||
44411578|NCT00597701|79419442|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
44411579|NCT00597701|79419443|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
44411580|NCT00671554|79419449|FG000|Overall Study|Disease progression|3|||
44411581|NCT00667576|79419459|FG000|Overall Study|Withdrawal by Subject|1|||
44411582|NCT00667576|79419460|FG001|Overall Study|Withdrawal by Subject|0|||
44411583|NCT00667576|79419461|FG002|Overall Study|Withdrawal by Subject|1|||
44411584|NCT00667576|79419462|FG003|Overall Study|Withdrawal by Subject|1|||
44411585|NCT00667576|79419463|FG004|Overall Study|Withdrawal by Subject|1|||
44411586|NCT00667576|79419459|FG000|Overall Study|Adverse Event|1|||
44411587|NCT00667576|79419460|FG001|Overall Study|Adverse Event|1|||
44411588|NCT00667576|79419461|FG002|Overall Study|Adverse Event|0|||
44411589|NCT00667576|79419462|FG003|Overall Study|Adverse Event|0|||
44411590|NCT00667576|79419463|FG004|Overall Study|Adverse Event|0|||
44411591|NCT00667576|79419459|FG000|Overall Study|Lost to Follow-up|0|||
44411592|NCT00667576|79419460|FG001|Overall Study|Lost to Follow-up|0|||
44411593|NCT00667576|79419461|FG002|Overall Study|Lost to Follow-up|1|||
44411594|NCT00667576|79419462|FG003|Overall Study|Lost to Follow-up|0|||
44411595|NCT00667576|79419463|FG004|Overall Study|Lost to Follow-up|0|||
44411596|NCT00667576|79419459|FG000|Overall Study|Protocol Violation|0|||
44411597|NCT00667576|79419460|FG001|Overall Study|Protocol Violation|0|||
44411598|NCT00667576|79419461|FG002|Overall Study|Protocol Violation|0|||
44411599|NCT00667576|79419462|FG003|Overall Study|Protocol Violation|1|||
44411600|NCT00667576|79419463|FG004|Overall Study|Protocol Violation|0|||
44411601|NCT00667576|79419459|FG000|Overall Study|Physician Decision|0|||
44411602|NCT00667576|79419460|FG001|Overall Study|Physician Decision|0|||
44411603|NCT00667576|79419461|FG002|Overall Study|Physician Decision|0|||
44411604|NCT00667576|79419462|FG003|Overall Study|Physician Decision|1|||
44411605|NCT00667576|79419463|FG004|Overall Study|Physician Decision|0|||
44411606|NCT00667576|79419459|FG000|Overall Study|Missed Visit|0|||
44411607|NCT00667576|79419460|FG001|Overall Study|Missed Visit|0|||
44411608|NCT00667576|79419461|FG002|Overall Study|Missed Visit|0|||
44411609|NCT00667576|79419462|FG003|Overall Study|Missed Visit|1|||
44411610|NCT00667576|79419463|FG004|Overall Study|Missed Visit|0|||
44411611|NCT00666718|79419477|FG000|Overall Study|Adverse Event|0|||
44411612|NCT00666718|79419478|FG001|Overall Study|Adverse Event|1|||
44411613|NCT00666718|79419477|FG000|Overall Study|Death|1|||
44411614|NCT00666718|79419478|FG001|Overall Study|Death|0|||
44411615|NCT00666718|79419477|FG000|Overall Study|Lost to Follow-up|1|||
44411616|NCT00666718|79419478|FG001|Overall Study|Lost to Follow-up|0|||
44411617|NCT00666718|79419477|FG000|Overall Study|Entry Criteria Not Met|2|||
44411618|NCT00666718|79419478|FG001|Overall Study|Entry Criteria Not Met|0|||
44411619|NCT00666718|79419477|FG000|Overall Study|Protocol Violation|1|||
44525159|NCT04741503|79534349|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
44148443|NCT02118766|78937998|FG001|Overall Study|Withdrawal by parent/guardian|18|||
44148444|NCT02118766|78937997|FG000|Overall Study|Other|3|||
44148445|NCT02118766|78937998|FG001|Overall Study|Other|1|||
44411620|NCT00666718|79419478|FG001|Overall Study|Protocol Violation|3|||
44411621|NCT00666718|79419477|FG000|Overall Study|Withdrawal by Subject|7|||
44411622|NCT00666718|79419478|FG001|Overall Study|Withdrawal by Subject|12|||
44411623|NCT00666718|79419477|FG000|Overall Study|Physician Decision|0|||
44411624|NCT00666718|79419478|FG001|Overall Study|Physician Decision|2|||
44411625|NCT00667420|79419484|FG000|Overall Study|Adverse Event|2|||
44411626|NCT00667420|79419484|FG000|Overall Study|Lack of Efficacy|5|||
44411627|NCT00667420|79419484|FG000|Overall Study|Physician Decision|1|||
44525160|NCT04741503|79534350|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
44411628|NCT00667420|79419484|FG000|Overall Study|Withdrawal by Subject|2|||
44411629|NCT00853658|79419492|FG000|Overall Study|Death|713|||
44411630|NCT00853658|79419493|FG001|Overall Study|Death|768|||
44411631|NCT00853658|79419494|FG002|Overall Study|Death|753|||
44148446|NCT02614287|78938006|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
44411632|NCT00853658|79419492|FG000|Overall Study|Lost to Follow-up|11|||
44411633|NCT00853658|79419493|FG001|Overall Study|Lost to Follow-up|6|||
44411634|NCT00853658|79419494|FG002|Overall Study|Lost to Follow-up|11|||
44411635|NCT00853658|79419492|FG000|Overall Study|H.A. Request|26|||
44411636|NCT00853658|79419493|FG001|Overall Study|H.A. Request|23|||
44411637|NCT00853658|79419494|FG002|Overall Study|H.A. Request|19|||
44411638|NCT00853658|79419492|FG000|Overall Study|IRB request|0|||
44411639|NCT00853658|79419493|FG001|Overall Study|IRB request|0|||
44411640|NCT00853658|79419494|FG002|Overall Study|IRB request|2|||
44411641|NCT00853658|79419492|FG000|Overall Study|Vital Status known (alive) at study end|2|||
44411642|NCT00853658|79419493|FG001|Overall Study|Vital Status known (alive) at study end|3|||
44411643|NCT00853658|79419494|FG002|Overall Study|Vital Status known (alive) at study end|3|||
44411644|NCT00853658|79419492|FG000|Overall Study|Vital Status unknown at study end|1|||
44411645|NCT00853658|79419493|FG001|Overall Study|Vital Status unknown at study end|1|||
44411646|NCT00853658|79419494|FG002|Overall Study|Vital Status unknown at study end|0|||
44411647|NCT00853658|79419492|FG000|Overall Study|Vital Status at study end N/A|8|||
44411648|NCT00853658|79419493|FG001|Overall Study|Vital Status at study end N/A|10|||
44411649|NCT00853658|79419494|FG002|Overall Study|Vital Status at study end N/A|10|||
44411650|NCT00853658|79419492|FG000|Overall Study|Patient's request|21|||
44411651|NCT00853658|79419493|FG001|Overall Study|Patient's request|17|||
44148447|NCT02614287|78938007|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
44148448|NCT02614287|78938006|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
44148449|NCT02614287|78938007|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
44148450|NCT02614287|78938006|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
44148451|NCT02614287|78938007|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
44148452|NCT02614287|78938006|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
44148453|NCT02614287|78938007|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
44525161|NCT04741503|79534351|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
44525162|NCT04734873|79534360|FG000|Overall Study|Lost to Follow-up|1|||
44525163|NCT04734873|79534361|FG001|Overall Study|Lost to Follow-up|3|||
44525164|NCT04734873|79534362|FG002|Overall Study|Lost to Follow-up|2|||
44525165|NCT04734873|79534360|FG000|Overall Study|Randomized but not dosed|1|||
44525166|NCT04734873|79534361|FG001|Overall Study|Randomized but not dosed|0|||
44525167|NCT04734873|79534362|FG002|Overall Study|Randomized but not dosed|1|||
44525168|NCT04435665|79534374|FG000|Overall Study|Lost to Follow-up|0|||
44525169|NCT04435665|79534375|FG001|Overall Study|Lost to Follow-up|0|||
44525170|NCT04435665|79534376|FG002|Overall Study|Lost to Follow-up|0|||
44525171|NCT04435665|79534377|FG003|Overall Study|Lost to Follow-up|1|||
44525172|NCT04428411|79534387|FG000|Overall Study|Lost to Follow-up|114|||
44148454|NCT02614287|78938006|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
44148455|NCT02614287|78938007|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
44148456|NCT02614287|78938006|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
44148457|NCT02614287|78938007|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
44148458|NCT02614287|78938006|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
44148459|NCT02614287|78938007|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
44148460|NCT02614287|78938006|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
44148461|NCT02614287|78938007|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
44148462|NCT01374971|78938018|FG000|Overall Study|Withdrawal by Subject|1|||
44411652|NCT00853658|79419494|FG002|Overall Study|Patient's request|11|||
44411653|NCT00853658|79419492|FG000|Overall Study|Missing study completion information|5|||
44411654|NCT00853658|79419493|FG001|Overall Study|Missing study completion information|4|||
44411655|NCT00853658|79419494|FG002|Overall Study|Missing study completion information|6|||
44411656|NCT00666562|79419505|FG000|Overall Study|Withdrawal by Subject|0|||
44411657|NCT00666562|79419506|FG001|Overall Study|Withdrawal by Subject|1|||
44411658|NCT00666562|79419507|FG002|Overall Study|Withdrawal by Subject|0|||
44411659|NCT00666562|79419505|FG000|Overall Study|Concomitant Medication|0|||
44411660|NCT00666562|79419506|FG001|Overall Study|Concomitant Medication|1|||
44411661|NCT00666562|79419507|FG002|Overall Study|Concomitant Medication|0|||
44411662|NCT00666328|79419522|FG000|Overall Study|Death|2|||
44411663|NCT00666328|79419522|FG000|Overall Study|Lost to Follow-up|2|||
44411664|NCT00666328|79419522|FG000|Overall Study|No longer met eligibility criteria|1|||
44411665|NCT00853580|79419530|FG000|Overall Study|Lost to Follow-up|3|||
44411666|NCT00853580|79419531|FG001|Overall Study|Lost to Follow-up|5|||
44411667|NCT00853580|79419530|FG000|Overall Study|Protocol Violation|2|||
44411668|NCT00853580|79419531|FG001|Overall Study|Protocol Violation|1|||
44411669|NCT00853580|79419530|FG000|Overall Study|Withdrawal by Subject|2|||
44411670|NCT00853580|79419531|FG001|Overall Study|Withdrawal by Subject|8|||
44411671|NCT00853580|79419530|FG000|Overall Study|Commenced contraindicated therapy|0|||
44411672|NCT00853580|79419531|FG001|Overall Study|Commenced contraindicated therapy|2|||
44148463|NCT02178592|78938024|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
44411673|NCT00865514|79419537|FG000|Overall Study|Infusion cost exceeded funding|2|||
44411674|NCT00865280|79419544|FG000|Overall Study|Withdrawal by Subject|4|||
44411675|NCT00865280|79419545|FG001|Overall Study|Withdrawal by Subject|1|||
44411676|NCT00865280|79419544|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
44411677|NCT00865280|79419545|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
44411678|NCT00865280|79419544|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
44525173|NCT04422561|79534396|FG000|Overall Study|Lost to Follow-up|25|||
44525174|NCT04422561|79534397|FG001|Overall Study|Lost to Follow-up|11|||
44411679|NCT00865280|79419545|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
44411680|NCT00865280|79419544|FG000|Overall Study|Exclusion Condition|1|||
44411681|NCT00865280|79419545|FG001|Overall Study|Exclusion Condition|0|||
44411682|NCT00865280|79419544|FG000|Overall Study|Adverse Event|0|||
44411683|NCT00865280|79419545|FG001|Overall Study|Adverse Event|1|||
44411684|NCT00865124|79419554|FG000|Overall Study|Physician Decision|2|||
44411685|NCT00865124|79419555|FG001|Overall Study|Physician Decision|1|||
44411686|NCT00865124|79419556|FG002|Overall Study|Physician Decision|0|||
44411687|NCT00865124|79419554|FG000|Overall Study|Withdrawn consent|2|||
44411688|NCT00865124|79419555|FG001|Overall Study|Withdrawn consent|0|||
44411689|NCT00865124|79419556|FG002|Overall Study|Withdrawn consent|0|||
44411690|NCT00871715|79419567|FG000|Overall Study|Withdrawal by Subject|6|||
44411691|NCT00871715|79419568|FG001|Overall Study|Withdrawal by Subject|10|||
44411692|NCT00871715|79419569|FG002|Overall Study|Withdrawal by Subject|15|||
44411693|NCT00871715|79419567|FG000|Overall Study|Physician Decision|6|||
44411694|NCT00871715|79419568|FG001|Overall Study|Physician Decision|0|||
44411695|NCT00871715|79419569|FG002|Overall Study|Physician Decision|2|||
44411696|NCT00871715|79419567|FG000|Overall Study|Lost to Follow-up|3|||
44411697|NCT00871715|79419568|FG001|Overall Study|Lost to Follow-up|6|||
44411698|NCT00871715|79419569|FG002|Overall Study|Lost to Follow-up|9|||
44411699|NCT00819234|79419578|FG000|Overall Study|Withdrawal by Subject|8|||
44411700|NCT00819234|79419579|FG001|Overall Study|Withdrawal by Subject|13|||
44411701|NCT00819234|79419580|FG002|Overall Study|Withdrawal by Subject|6|||
44411702|NCT00819234|79419581|FG003|Overall Study|Withdrawal by Subject|3|||
44411703|NCT00819234|79419582|FG004|Overall Study|Withdrawal by Subject|0|||
44411704|NCT00819234|79419583|FG005|Overall Study|Withdrawal by Subject|4|||
44411705|NCT00819234|79419584|FG006|Overall Study|Withdrawal by Subject|4|||
44411706|NCT00819234|79419585|FG007|Overall Study|Withdrawal by Subject|8|||
44411707|NCT00819234|79419586|FG008|Overall Study|Withdrawal by Subject|5|||
44411708|NCT00819234|79419587|FG009|Overall Study|Withdrawal by Subject|3|||
44411709|NCT00819234|79419578|FG000|Overall Study|Adverse Event|0|||
44411710|NCT00819234|79419579|FG001|Overall Study|Adverse Event|0|||
44411711|NCT00819234|79419580|FG002|Overall Study|Adverse Event|1|||
44411712|NCT00819234|79419581|FG003|Overall Study|Adverse Event|0|||
44411713|NCT00819234|79419582|FG004|Overall Study|Adverse Event|0|||
44411714|NCT00819234|79419583|FG005|Overall Study|Adverse Event|2|||
44411715|NCT00819234|79419584|FG006|Overall Study|Adverse Event|0|||
44411716|NCT00819234|79419585|FG007|Overall Study|Adverse Event|0|||
44411717|NCT00819234|79419586|FG008|Overall Study|Adverse Event|0|||
44411718|NCT00819234|79419587|FG009|Overall Study|Adverse Event|0|||
44411719|NCT00819234|79419578|FG000|Overall Study|Physician Decision|0|||
44411720|NCT00819234|79419579|FG001|Overall Study|Physician Decision|0|||
44411721|NCT00819234|79419580|FG002|Overall Study|Physician Decision|0|||
44411722|NCT00819234|79419581|FG003|Overall Study|Physician Decision|1|||
44411723|NCT00819234|79419582|FG004|Overall Study|Physician Decision|0|||
44411724|NCT00819234|79419583|FG005|Overall Study|Physician Decision|0|||
44411725|NCT00819234|79419584|FG006|Overall Study|Physician Decision|0|||
44148464|NCT02178592|78938025|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
44148465|NCT02178592|78938024|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
44148466|NCT02178592|78938025|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
44148467|NCT02178592|78938024|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
44148468|NCT02178592|78938025|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
44282187|NCT01879410|79245462|FG000|Overall Study|Lack of Efficacy|4|||
44411726|NCT00819234|79419585|FG007|Overall Study|Physician Decision|0|||
44411727|NCT00819234|79419586|FG008|Overall Study|Physician Decision|0|||
44411728|NCT00819234|79419587|FG009|Overall Study|Physician Decision|2|||
44411729|NCT00819234|79419578|FG000|Overall Study|Protocol Violation|0|||
44411730|NCT00819234|79419579|FG001|Overall Study|Protocol Violation|0|||
44411731|NCT00819234|79419580|FG002|Overall Study|Protocol Violation|1|||
44411732|NCT00819234|79419581|FG003|Overall Study|Protocol Violation|0|||
44411733|NCT00819234|79419582|FG004|Overall Study|Protocol Violation|0|||
44411734|NCT00819234|79419583|FG005|Overall Study|Protocol Violation|0|||
44411735|NCT00819234|79419584|FG006|Overall Study|Protocol Violation|0|||
44411736|NCT00819234|79419585|FG007|Overall Study|Protocol Violation|0|||
44411737|NCT00819234|79419586|FG008|Overall Study|Protocol Violation|0|||
44411738|NCT00819234|79419587|FG009|Overall Study|Protocol Violation|0|||
44411739|NCT00819234|79419578|FG000|Overall Study|Lost to Follow-up|2|||
44411740|NCT00819234|79419579|FG001|Overall Study|Lost to Follow-up|2|||
44411741|NCT00819234|79419580|FG002|Overall Study|Lost to Follow-up|0|||
44411742|NCT00819234|79419581|FG003|Overall Study|Lost to Follow-up|2|||
44411743|NCT00819234|79419582|FG004|Overall Study|Lost to Follow-up|1|||
44411744|NCT00819234|79419583|FG005|Overall Study|Lost to Follow-up|1|||
44411745|NCT00819234|79419584|FG006|Overall Study|Lost to Follow-up|1|||
44148469|NCT02178592|78938024|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
44411746|NCT00819234|79419585|FG007|Overall Study|Lost to Follow-up|1|||
44411747|NCT00819234|79419586|FG008|Overall Study|Lost to Follow-up|1|||
44411748|NCT00819234|79419587|FG009|Overall Study|Lost to Follow-up|2|||
44411749|NCT00871403|79419645|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
44525175|NCT01369498|79534407|FG000|Overall Study|Lack of Efficacy|9|||
44411750|NCT00871403|79419646|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
44411751|NCT00871403|79419647|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
44411752|NCT00871403|79419645|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
44411753|NCT00871403|79419646|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
44411754|NCT00871403|79419647|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
44411755|NCT00871403|79419645|FG000|Combination Treatment Phase|Adverse Event|0|||
44411756|NCT00871403|79419646|FG001|Combination Treatment Phase|Adverse Event|17|||
44411757|NCT00871403|79419647|FG002|Combination Treatment Phase|Adverse Event|2|||
44411758|NCT00871403|79419645|FG000|Combination Treatment Phase|Disease Progression|0|||
44411759|NCT00871403|79419646|FG001|Combination Treatment Phase|Disease Progression|8|||
44411760|NCT00871403|79419647|FG002|Combination Treatment Phase|Disease Progression|5|||
44411761|NCT00871403|79419645|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
44411762|NCT00871403|79419646|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
44411763|NCT00871403|79419647|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
44411764|NCT00871403|79419645|FG000|Combination Treatment Phase|Physician Decision|0|||
44411765|NCT00871403|79419646|FG001|Combination Treatment Phase|Physician Decision|1|||
44411766|NCT00871403|79419647|FG002|Combination Treatment Phase|Physician Decision|3|||
44411767|NCT00871403|79419645|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
44411768|NCT00871403|79419646|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
44411769|NCT00871403|79419647|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
44411770|NCT00871403|79419645|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
44411771|NCT00871403|79419646|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
44411772|NCT00871403|79419647|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
44411773|NCT00853112|79419661|FG000|Overall Study|Randomized but not treated|0|||
44411774|NCT00853112|79419662|FG001|Overall Study|Randomized but not treated|1|||
44411775|NCT00853112|79419663|FG002|Overall Study|Randomized but not treated|0|||
44411776|NCT00853112|79419664|FG003|Overall Study|Randomized but not treated|2|||
44411777|NCT00853112|79419665|FG004|Overall Study|Randomized but not treated|0|||
44411778|NCT00853112|79419666|FG005|Overall Study|Randomized but not treated|0|||
44411779|NCT00853112|79419667|FG006|Overall Study|Randomized but not treated|1|||
44411780|NCT00460603|79419695|FG000|Phase 1|Death|1|||
44411781|NCT00460603|79419696|FG001|Phase 1|Death|0|||
44411782|NCT00460603|79419697|FG002|Phase 1|Death|0|||
44411783|NCT00460603|79419698|FG003|Phase 1|Death|2|||
44411784|NCT00460603|79419699|FG004|Phase 1|Death|0|||
44411785|NCT00460603|79419700|FG005|Phase 1|Death|0|||
44411786|NCT00460603|79419701|FG006|Phase 1|Death|0|||
44411787|NCT00460603|79419702|FG007|Phase 1|Death|0|||
44411788|NCT00460603|79419703|FG008|Phase 1|Death|1|||
44411789|NCT00460603|79419704|FG009|Phase 1|Death|0|||
44411790|NCT00460603|79419705|FG010|Phase 1|Death|0|||
44411791|NCT00460603|79419706|FG011|Phase 1|Death|0|||
44411792|NCT00460603|79419695|FG000|Phase 1|Adverse Event|3|||
44411793|NCT00460603|79419696|FG001|Phase 1|Adverse Event|1|||
44411794|NCT00460603|79419697|FG002|Phase 1|Adverse Event|1|||
44411795|NCT00460603|79419698|FG003|Phase 1|Adverse Event|2|||
44411796|NCT00460603|79419699|FG004|Phase 1|Adverse Event|0|||
44411797|NCT00460603|79419700|FG005|Phase 1|Adverse Event|0|||
44411798|NCT00460603|79419701|FG006|Phase 1|Adverse Event|3|||
44411799|NCT00460603|79419702|FG007|Phase 1|Adverse Event|0|||
44411800|NCT00460603|79419703|FG008|Phase 1|Adverse Event|4|||
44411801|NCT00460603|79419704|FG009|Phase 1|Adverse Event|0|||
44411802|NCT00460603|79419705|FG010|Phase 1|Adverse Event|0|||
44411803|NCT00460603|79419706|FG011|Phase 1|Adverse Event|0|||
44411804|NCT00460603|79419695|FG000|Phase 1|Lack of Efficacy|1|||
44411805|NCT00460603|79419696|FG001|Phase 1|Lack of Efficacy|0|||
44411806|NCT00460603|79419697|FG002|Phase 1|Lack of Efficacy|1|||
44411807|NCT00460603|79419698|FG003|Phase 1|Lack of Efficacy|2|||
44411808|NCT00460603|79419699|FG004|Phase 1|Lack of Efficacy|2|||
44411809|NCT00460603|79419700|FG005|Phase 1|Lack of Efficacy|2|||
44411810|NCT00460603|79419701|FG006|Phase 1|Lack of Efficacy|2|||
44411811|NCT00460603|79419702|FG007|Phase 1|Lack of Efficacy|2|||
44411812|NCT00460603|79419703|FG008|Phase 1|Lack of Efficacy|11|||
44411813|NCT00460603|79419704|FG009|Phase 1|Lack of Efficacy|0|||
44411814|NCT00460603|79419705|FG010|Phase 1|Lack of Efficacy|0|||
44411815|NCT00460603|79419706|FG011|Phase 1|Lack of Efficacy|0|||
44411816|NCT00460603|79419695|FG000|Phase 1|Withdrawal by Subject|1|||
44411817|NCT00460603|79419696|FG001|Phase 1|Withdrawal by Subject|2|||
44411818|NCT00460603|79419697|FG002|Phase 1|Withdrawal by Subject|1|||
44411819|NCT00460603|79419698|FG003|Phase 1|Withdrawal by Subject|1|||
44411820|NCT00460603|79419699|FG004|Phase 1|Withdrawal by Subject|3|||
44411821|NCT00460603|79419700|FG005|Phase 1|Withdrawal by Subject|0|||
44411822|NCT00460603|79419701|FG006|Phase 1|Withdrawal by Subject|1|||
44411823|NCT00460603|79419702|FG007|Phase 1|Withdrawal by Subject|0|||
44411824|NCT00460603|79419703|FG008|Phase 1|Withdrawal by Subject|2|||
44411825|NCT00460603|79419704|FG009|Phase 1|Withdrawal by Subject|0|||
44411826|NCT00460603|79419705|FG010|Phase 1|Withdrawal by Subject|0|||
44411827|NCT00460603|79419706|FG011|Phase 1|Withdrawal by Subject|0|||
44411828|NCT00460603|79419695|FG000|Phase 1|Other|0|||
44411829|NCT00460603|79419696|FG001|Phase 1|Other|3|||
44411830|NCT00460603|79419697|FG002|Phase 1|Other|1|||
44411831|NCT00460603|79419698|FG003|Phase 1|Other|1|||
44411832|NCT00460603|79419699|FG004|Phase 1|Other|1|||
44148470|NCT02178592|78938025|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
44148471|NCT02178592|78938024|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
44148472|NCT02178592|78938025|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
44411833|NCT00460603|79419700|FG005|Phase 1|Other|2|||
44411834|NCT00460603|79419701|FG006|Phase 1|Other|0|||
44411835|NCT00460603|79419702|FG007|Phase 1|Other|1|||
44411836|NCT00460603|79419703|FG008|Phase 1|Other|0|||
44411837|NCT00460603|79419704|FG009|Phase 1|Other|0|||
44411838|NCT00460603|79419705|FG010|Phase 1|Other|0|||
44411839|NCT00460603|79419706|FG011|Phase 1|Other|0|||
44411840|NCT00460603|79419695|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411841|NCT00460603|79419696|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411842|NCT00460603|79419697|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411843|NCT00460603|79419698|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411844|NCT00460603|79419699|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411845|NCT00460603|79419700|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411846|NCT00460603|79419701|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411847|NCT00460603|79419702|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411848|NCT00460603|79419703|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411849|NCT00460603|79419704|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
44411850|NCT00460603|79419705|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411851|NCT00460603|79419706|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
44411852|NCT00460603|79419695|FG000|Phase 2|Adverse Event|0|||
44411853|NCT00460603|79419696|FG001|Phase 2|Adverse Event|0|||
44411854|NCT00460603|79419697|FG002|Phase 2|Adverse Event|0|||
44411855|NCT00460603|79419698|FG003|Phase 2|Adverse Event|0|||
44411856|NCT00460603|79419699|FG004|Phase 2|Adverse Event|0|||
44411857|NCT00460603|79419700|FG005|Phase 2|Adverse Event|0|||
44411858|NCT00460603|79419701|FG006|Phase 2|Adverse Event|0|||
44411859|NCT00460603|79419702|FG007|Phase 2|Adverse Event|0|||
44411860|NCT00460603|79419703|FG008|Phase 2|Adverse Event|0|||
44411861|NCT00460603|79419704|FG009|Phase 2|Adverse Event|12|||
44411862|NCT00460603|79419705|FG010|Phase 2|Adverse Event|9|||
44411863|NCT00460603|79419706|FG011|Phase 2|Adverse Event|10|||
44411864|NCT00460603|79419695|FG000|Phase 2|Death|0|||
44411865|NCT00460603|79419696|FG001|Phase 2|Death|0|||
44411866|NCT00460603|79419697|FG002|Phase 2|Death|0|||
44411867|NCT00460603|79419698|FG003|Phase 2|Death|0|||
44411868|NCT00460603|79419699|FG004|Phase 2|Death|0|||
44411869|NCT00460603|79419700|FG005|Phase 2|Death|0|||
44411870|NCT00460603|79419701|FG006|Phase 2|Death|0|||
44411871|NCT00460603|79419702|FG007|Phase 2|Death|0|||
44411872|NCT00460603|79419703|FG008|Phase 2|Death|0|||
44411873|NCT00460603|79419704|FG009|Phase 2|Death|4|||
44411874|NCT00460603|79419705|FG010|Phase 2|Death|2|||
44411875|NCT00460603|79419706|FG011|Phase 2|Death|2|||
44148473|NCT02178592|78938024|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
44148474|NCT02178592|78938025|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
44148475|NCT02178592|78938024|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
44148476|NCT02178592|78938025|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
44148477|NCT02178592|78938024|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
44148478|NCT02178592|78938025|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
44148479|NCT02178592|78938024|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
44411876|NCT00460603|79419695|FG000|Phase 2|Protocol Violation|0|||
44411877|NCT00460603|79419696|FG001|Phase 2|Protocol Violation|0|||
44411878|NCT00460603|79419697|FG002|Phase 2|Protocol Violation|0|||
44411879|NCT00460603|79419698|FG003|Phase 2|Protocol Violation|0|||
44411880|NCT00460603|79419699|FG004|Phase 2|Protocol Violation|0|||
44411881|NCT00460603|79419700|FG005|Phase 2|Protocol Violation|0|||
44411882|NCT00460603|79419701|FG006|Phase 2|Protocol Violation|0|||
44411883|NCT00460603|79419702|FG007|Phase 2|Protocol Violation|0|||
44411884|NCT00460603|79419703|FG008|Phase 2|Protocol Violation|0|||
44411885|NCT00460603|79419704|FG009|Phase 2|Protocol Violation|1|||
44411886|NCT00460603|79419705|FG010|Phase 2|Protocol Violation|1|||
44411887|NCT00460603|79419706|FG011|Phase 2|Protocol Violation|0|||
44411888|NCT00460603|79419695|FG000|Phase 2|Lost to Follow-up|0|||
44525176|NCT01369498|79534408|FG001|Overall Study|Lack of Efficacy|9|||
44525177|NCT01369498|79534409|FG002|Overall Study|Lack of Efficacy|1|||
44411889|NCT00460603|79419696|FG001|Phase 2|Lost to Follow-up|0|||
44411890|NCT00460603|79419697|FG002|Phase 2|Lost to Follow-up|0|||
44411891|NCT00460603|79419698|FG003|Phase 2|Lost to Follow-up|0|||
44411892|NCT00460603|79419699|FG004|Phase 2|Lost to Follow-up|0|||
44411893|NCT00460603|79419700|FG005|Phase 2|Lost to Follow-up|0|||
44411894|NCT00460603|79419701|FG006|Phase 2|Lost to Follow-up|0|||
44411895|NCT00460603|79419702|FG007|Phase 2|Lost to Follow-up|0|||
44411896|NCT00460603|79419703|FG008|Phase 2|Lost to Follow-up|0|||
44411897|NCT00460603|79419704|FG009|Phase 2|Lost to Follow-up|1|||
44411898|NCT00460603|79419705|FG010|Phase 2|Lost to Follow-up|0|||
44411899|NCT00460603|79419706|FG011|Phase 2|Lost to Follow-up|0|||
44253878|NCT00631163|79094609|FG000|Number of Participants in Year 2|Protocol Violation|1|||
44253879|NCT00631163|79094609|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
44253880|NCT00631007|79094626|FG000|Overall Study|Adverse Event|0|||
44253881|NCT00631007|79094627|FG001|Overall Study|Adverse Event|2|||
44253882|NCT00631007|79094628|FG002|Overall Study|Adverse Event|0|||
44253883|NCT00631007|79094629|FG003|Overall Study|Adverse Event|2|||
44411900|NCT00460603|79419695|FG000|Phase 2|Other|0|||
44411901|NCT00460603|79419696|FG001|Phase 2|Other|0|||
44411902|NCT00460603|79419697|FG002|Phase 2|Other|0|||
44411903|NCT00460603|79419698|FG003|Phase 2|Other|0|||
44411904|NCT00460603|79419699|FG004|Phase 2|Other|0|||
44411905|NCT00460603|79419700|FG005|Phase 2|Other|0|||
44411906|NCT00460603|79419701|FG006|Phase 2|Other|0|||
44411907|NCT00460603|79419702|FG007|Phase 2|Other|0|||
44411908|NCT00460603|79419703|FG008|Phase 2|Other|0|||
44411909|NCT00460603|79419704|FG009|Phase 2|Other|6|||
44411910|NCT00460603|79419705|FG010|Phase 2|Other|16|||
44411911|NCT00460603|79419706|FG011|Phase 2|Other|7|||
44411912|NCT00460603|79419695|FG000|Phase 2|Objective Progression or Relapse|0|||
44411913|NCT00460603|79419696|FG001|Phase 2|Objective Progression or Relapse|0|||
44411914|NCT00460603|79419697|FG002|Phase 2|Objective Progression or Relapse|0|||
44411915|NCT00460603|79419698|FG003|Phase 2|Objective Progression or Relapse|0|||
44411916|NCT00460603|79419699|FG004|Phase 2|Objective Progression or Relapse|0|||
44411917|NCT00460603|79419700|FG005|Phase 2|Objective Progression or Relapse|0|||
44411918|NCT00460603|79419701|FG006|Phase 2|Objective Progression or Relapse|0|||
44411919|NCT00460603|79419702|FG007|Phase 2|Objective Progression or Relapse|0|||
44411920|NCT00460603|79419703|FG008|Phase 2|Objective Progression or Relapse|0|||
44411921|NCT00460603|79419704|FG009|Phase 2|Objective Progression or Relapse|9|||
44411922|NCT00460603|79419705|FG010|Phase 2|Objective Progression or Relapse|10|||
44411923|NCT00460603|79419706|FG011|Phase 2|Objective Progression or Relapse|17|||
44411924|NCT00460603|79419695|FG000|Phase 2|Global Deterioration of Health Status|0|||
44411925|NCT00460603|79419696|FG001|Phase 2|Global Deterioration of Health Status|0|||
44411926|NCT00460603|79419697|FG002|Phase 2|Global Deterioration of Health Status|0|||
44411927|NCT00460603|79419698|FG003|Phase 2|Global Deterioration of Health Status|0|||
44411928|NCT00460603|79419699|FG004|Phase 2|Global Deterioration of Health Status|0|||
44411929|NCT00460603|79419700|FG005|Phase 2|Global Deterioration of Health Status|0|||
44411930|NCT00460603|79419701|FG006|Phase 2|Global Deterioration of Health Status|0|||
44411931|NCT00460603|79419702|FG007|Phase 2|Global Deterioration of Health Status|0|||
44411932|NCT00460603|79419703|FG008|Phase 2|Global Deterioration of Health Status|0|||
44411933|NCT00460603|79419704|FG009|Phase 2|Global Deterioration of Health Status|0|||
44411934|NCT00460603|79419705|FG010|Phase 2|Global Deterioration of Health Status|1|||
44411935|NCT00460603|79419706|FG011|Phase 2|Global Deterioration of Health Status|0|||
44411936|NCT00460603|79419695|FG000|Phase 2|Withdrawal by Subject|0|||
44411937|NCT00460603|79419696|FG001|Phase 2|Withdrawal by Subject|0|||
44525178|NCT01369498|79534410|FG003|Overall Study|Lack of Efficacy|3|||
44525179|NCT01369498|79534407|FG000|Overall Study|Adverse Event|1|||
44525180|NCT01369498|79534408|FG001|Overall Study|Adverse Event|2|||
44525181|NCT01369498|79534409|FG002|Overall Study|Adverse Event|0|||
44525182|NCT01369498|79534410|FG003|Overall Study|Adverse Event|1|||
44525183|NCT01369498|79534407|FG000|Overall Study|Withdrawal of Consent|0|||
44525184|NCT01369498|79534408|FG001|Overall Study|Withdrawal of Consent|1|||
44525185|NCT01369498|79534409|FG002|Overall Study|Withdrawal of Consent|1|||
44253884|NCT00631007|79094630|FG004|Overall Study|Adverse Event|3|||
44253885|NCT00631007|79094631|FG005|Overall Study|Adverse Event|2|||
44411938|NCT00460603|79419697|FG002|Phase 2|Withdrawal by Subject|0|||
44525186|NCT01369498|79534410|FG003|Overall Study|Withdrawal of Consent|1|||
44525187|NCT01369498|79534407|FG000|Overall Study|Death|0|||
44411939|NCT00460603|79419698|FG003|Phase 2|Withdrawal by Subject|0|||
44411940|NCT00460603|79419699|FG004|Phase 2|Withdrawal by Subject|0|||
44411941|NCT00460603|79419700|FG005|Phase 2|Withdrawal by Subject|0|||
44411942|NCT00460603|79419701|FG006|Phase 2|Withdrawal by Subject|0|||
44411943|NCT00460603|79419702|FG007|Phase 2|Withdrawal by Subject|0|||
44411944|NCT00460603|79419703|FG008|Phase 2|Withdrawal by Subject|0|||
44525188|NCT01369498|79534408|FG001|Overall Study|Death|0|||
44253886|NCT00631007|79094626|FG000|Overall Study|Lost to Follow-up|2|||
44411945|NCT00460603|79419704|FG009|Phase 2|Withdrawal by Subject|5|||
44411946|NCT00460603|79419705|FG010|Phase 2|Withdrawal by Subject|4|||
44411947|NCT00460603|79419706|FG011|Phase 2|Withdrawal by Subject|5|||
44411948|NCT00460603|79419695|FG000|Phase 2|Randomized, but not treated|0|||
44411949|NCT00460603|79419696|FG001|Phase 2|Randomized, but not treated|0|||
44525189|NCT01369498|79534409|FG002|Overall Study|Death|1|||
44282188|NCT01879410|79245463|FG001|Overall Study|Lack of Efficacy|6|||
44282189|NCT01879410|79245462|FG000|Overall Study|Protocol Violation|1|||
44282190|NCT01879410|79245463|FG001|Overall Study|Protocol Violation|7|||
44282191|NCT01879410|79245462|FG000|Overall Study|Lost to Follow-up|2|||
44525190|NCT01369498|79534410|FG003|Overall Study|Death|0|||
44525191|NCT01369498|79534407|FG000|Overall Study|Investigator's Discretion|1|||
44525192|NCT01369498|79534408|FG001|Overall Study|Investigator's Discretion|0|||
44525193|NCT01369498|79534409|FG002|Overall Study|Investigator's Discretion|1|||
44525194|NCT01369498|79534410|FG003|Overall Study|Investigator's Discretion|3|||
44525195|NCT01369498|79534407|FG000|Overall Study|Unknown Reason|1|||
44525196|NCT01369498|79534408|FG001|Overall Study|Unknown Reason|0|||
44525197|NCT01369498|79534409|FG002|Overall Study|Unknown Reason|11|||
44525198|NCT01369498|79534410|FG003|Overall Study|Unknown Reason|6|||
44525199|NCT01369498|79534407|FG000|Overall Study|Disease Progression|0|||
44148480|NCT02178592|78938025|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
44148481|NCT02178592|78938024|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
44148482|NCT02178592|78938025|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
44148483|NCT02178592|78938024|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
44148484|NCT02178592|78938025|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
44148485|NCT02178592|78938024|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
44148486|NCT02178592|78938025|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
44148487|NCT02610777|78938036|FG000|Overall Study|Lost to Follow-up|1|||
44148488|NCT02610777|78938037|FG001|Overall Study|Lost to Follow-up|0|||
44148489|NCT02610777|78938036|FG000|Overall Study|Site Terminated by Sponsor|9|||
44148490|NCT02610777|78938037|FG001|Overall Study|Site Terminated by Sponsor|8|||
44148491|NCT02610777|78938036|FG000|Overall Study|Withdrawal by Subject|2|||
44148492|NCT02610777|78938037|FG001|Overall Study|Withdrawal by Subject|2|||
44148493|NCT02610777|78938036|FG000|Overall Study|Reason not Specified|0|||
44148494|NCT02610777|78938037|FG001|Overall Study|Reason not Specified|1|||
44148495|NCT02610777|78938036|FG000|Overall Study|Death|50|||
44148496|NCT02610777|78938037|FG001|Overall Study|Death|47|||
44148497|NCT01628692|78938051|FG000|Overall Study|Lack of Efficacy|4|||
44148498|NCT01628692|78938052|FG001|Overall Study|Lack of Efficacy|4|||
44148499|NCT01628692|78938053|FG002|Overall Study|Lack of Efficacy|5|||
44148500|NCT01628692|78938054|FG003|Overall Study|Lack of Efficacy|1|||
44148501|NCT01628692|78938055|FG004|Overall Study|Lack of Efficacy|4|||
44148502|NCT01628692|78938056|FG005|Overall Study|Lack of Efficacy|7|||
44148503|NCT01628692|78938051|FG000|Overall Study|Adverse Event|2|||
44148504|NCT01628692|78938052|FG001|Overall Study|Adverse Event|0|||
44148505|NCT01628692|78938053|FG002|Overall Study|Adverse Event|2|||
44148506|NCT01628692|78938054|FG003|Overall Study|Adverse Event|0|||
44148507|NCT01628692|78938055|FG004|Overall Study|Adverse Event|0|||
44148508|NCT01628692|78938056|FG005|Overall Study|Adverse Event|0|||
44148509|NCT01628692|78938051|FG000|Overall Study|Withdrawal by Subject|0|||
44148510|NCT01628692|78938052|FG001|Overall Study|Withdrawal by Subject|1|||
44148511|NCT01628692|78938053|FG002|Overall Study|Withdrawal by Subject|1|||
44148512|NCT01628692|78938054|FG003|Overall Study|Withdrawal by Subject|0|||
44148513|NCT01628692|78938055|FG004|Overall Study|Withdrawal by Subject|0|||
44148514|NCT01628692|78938056|FG005|Overall Study|Withdrawal by Subject|0|||
44148515|NCT01628692|78938051|FG000|Overall Study|Death|0|||
44148516|NCT01628692|78938052|FG001|Overall Study|Death|1|||
44148517|NCT01628692|78938053|FG002|Overall Study|Death|0|||
44148518|NCT01628692|78938054|FG003|Overall Study|Death|0|||
44148519|NCT01628692|78938055|FG004|Overall Study|Death|0|||
44148520|NCT01628692|78938056|FG005|Overall Study|Death|0|||
44148521|NCT01628692|78938051|FG000|Overall Study|Poor compliance/noncompliance|1|||
44148522|NCT01628692|78938052|FG001|Overall Study|Poor compliance/noncompliance|0|||
44148523|NCT01628692|78938053|FG002|Overall Study|Poor compliance/noncompliance|0|||
44148524|NCT01628692|78938054|FG003|Overall Study|Poor compliance/noncompliance|0|||
44148525|NCT01628692|78938055|FG004|Overall Study|Poor compliance/noncompliance|0|||
44148526|NCT01628692|78938056|FG005|Overall Study|Poor compliance/noncompliance|0|||
44148527|NCT01628692|78938051|FG000|Overall Study|Administrative reason by sponsor|0|||
44282192|NCT01879410|79245463|FG001|Overall Study|Lost to Follow-up|1|||
44525200|NCT01369498|79534408|FG001|Overall Study|Disease Progression|0|||
44525201|NCT01369498|79534409|FG002|Overall Study|Disease Progression|0|||
44253887|NCT00631007|79094627|FG001|Overall Study|Lost to Follow-up|1|||
44253888|NCT00631007|79094628|FG002|Overall Study|Lost to Follow-up|2|||
44253889|NCT00631007|79094629|FG003|Overall Study|Lost to Follow-up|4|||
44253890|NCT00631007|79094630|FG004|Overall Study|Lost to Follow-up|5|||
44253891|NCT00631007|79094631|FG005|Overall Study|Lost to Follow-up|3|||
44253892|NCT00631007|79094626|FG000|Overall Study|Physician Decision|1|||
44253893|NCT00631007|79094627|FG001|Overall Study|Physician Decision|0|||
44253894|NCT00631007|79094628|FG002|Overall Study|Physician Decision|1|||
44253895|NCT00631007|79094629|FG003|Overall Study|Physician Decision|0|||
44253896|NCT00631007|79094630|FG004|Overall Study|Physician Decision|0|||
44253897|NCT00631007|79094631|FG005|Overall Study|Physician Decision|2|||
44253898|NCT00631007|79094626|FG000|Overall Study|Persistent Hyperglycemia|2|||
44253899|NCT00631007|79094627|FG001|Overall Study|Persistent Hyperglycemia|2|||
44253900|NCT00631007|79094628|FG002|Overall Study|Persistent Hyperglycemia|5|||
44411950|NCT00460603|79419697|FG002|Phase 2|Randomized, but not treated|0|||
44411951|NCT00460603|79419698|FG003|Phase 2|Randomized, but not treated|0|||
44411952|NCT00460603|79419699|FG004|Phase 2|Randomized, but not treated|0|||
44411953|NCT00460603|79419700|FG005|Phase 2|Randomized, but not treated|0|||
44411954|NCT00460603|79419701|FG006|Phase 2|Randomized, but not treated|0|||
44411955|NCT00460603|79419702|FG007|Phase 2|Randomized, but not treated|0|||
44411956|NCT00460603|79419703|FG008|Phase 2|Randomized, but not treated|0|||
44148528|NCT01628692|78938052|FG001|Overall Study|Administrative reason by sponsor|0|||
44148529|NCT01628692|78938053|FG002|Overall Study|Administrative reason by sponsor|0|||
44411957|NCT00460603|79419704|FG009|Phase 2|Randomized, but not treated|3|||
44411958|NCT00460603|79419705|FG010|Phase 2|Randomized, but not treated|0|||
44411959|NCT00460603|79419706|FG011|Phase 2|Randomized, but not treated|0|||
44411960|NCT00662038|79419732|FG000|Overall Study|Reason not specified|3|||
44411961|NCT00662038|79419732|FG000|Overall Study|Withdrawn consent|22|||
44411962|NCT00662038|79419732|FG000|Overall Study|Withdrawal by Subject|83|||
44411963|NCT00662038|79419732|FG000|Overall Study|Sponsor decision|1|||
44411964|NCT00662038|79419732|FG000|Overall Study|Physician Decision|19|||
44411965|NCT00662038|79419732|FG000|Overall Study|Lung transplantation|44|||
44411966|NCT00662038|79419732|FG000|Overall Study|Lost to Follow-up|1|||
44411967|NCT00662038|79419732|FG000|Overall Study|Death|95|||
44411968|NCT00662038|79419732|FG000|Overall Study|Adverse Event|358|||
44411969|NCT00662038|79419732|FG000|Overall Study|Continued treatment|5|||
44411970|NCT00459979|79419736|FG000|Overall Study|Withdrawal by Subject|1|||
44411971|NCT00459979|79419736|FG000|Overall Study|Protocol Violation|1|||
44411972|NCT00851786|79419742|FG000|Overall Study|Withdrawal by Subject|0|||
44411973|NCT00851786|79419743|FG001|Overall Study|Withdrawal by Subject|1|||
44411974|NCT00851786|79419742|FG000|Overall Study|Protocol Violation|0|||
44411975|NCT00851786|79419743|FG001|Overall Study|Protocol Violation|1|||
44411976|NCT00851786|79419742|FG000|Overall Study|Lost to Follow-up|1|||
44411977|NCT00851786|79419743|FG001|Overall Study|Lost to Follow-up|0|||
44411978|NCT00851786|79419742|FG000|Overall Study|Incarceration|1|||
44411979|NCT00851786|79419743|FG001|Overall Study|Incarceration|0|||
44411980|NCT00851786|79419742|FG000|Overall Study|Site Closure|1|||
44411981|NCT00851786|79419743|FG001|Overall Study|Site Closure|0|||
44411982|NCT00851786|79419742|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
44411983|NCT00851786|79419743|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
44411984|NCT00665626|79419751|FG000|Overall Study|Lack of Efficacy|8|||
44525202|NCT01369498|79534410|FG003|Overall Study|Disease Progression|1|||
44525203|NCT04709835|79534424|FG000|Overall Study|Withdrawal by Subject|0|||
44525204|NCT04709835|79534425|FG001|Overall Study|Withdrawal by Subject|1|||
44525205|NCT04709835|79534426|FG002|Overall Study|Withdrawal by Subject|0|||
44525206|NCT04407507|79534440|FG000|Overall Study|Withdrawal by Subject|0|||
44525207|NCT04407507|79534441|FG001|Overall Study|Withdrawal by Subject|1|||
44148530|NCT01628692|78938054|FG003|Overall Study|Administrative reason by sponsor|0|||
44253901|NCT00631007|79094629|FG003|Overall Study|Persistent Hyperglycemia|1|||
44253902|NCT00631007|79094630|FG004|Overall Study|Persistent Hyperglycemia|2|||
44253903|NCT00631007|79094631|FG005|Overall Study|Persistent Hyperglycemia|5|||
44253904|NCT00631007|79094626|FG000|Overall Study|Withdrawal by Subject|4|||
44148531|NCT01628692|78938055|FG004|Overall Study|Administrative reason by sponsor|0|||
44148532|NCT01628692|78938056|FG005|Overall Study|Administrative reason by sponsor|1|||
44148533|NCT01628692|78938051|FG000|Overall Study|Completed 12 Week only|0|||
44148534|NCT01628692|78938052|FG001|Overall Study|Completed 12 Week only|0|||
44253905|NCT00631007|79094627|FG001|Overall Study|Withdrawal by Subject|5|||
44411985|NCT00665626|79419752|FG001|Overall Study|Lack of Efficacy|5|||
44411986|NCT00665626|79419751|FG000|Overall Study|Lost to Follow-up|0|||
44411987|NCT00665626|79419752|FG001|Overall Study|Lost to Follow-up|2|||
44411988|NCT00665626|79419751|FG000|Overall Study|Withdrawal by Subject|0|||
44411989|NCT00665626|79419752|FG001|Overall Study|Withdrawal by Subject|1|||
44411990|NCT00665626|79419751|FG000|Overall Study|Protocol Violation|0|||
44411991|NCT00665626|79419752|FG001|Overall Study|Protocol Violation|2|||
44411992|NCT00665626|79419751|FG000|Overall Study|Adverse Event|1|||
44148535|NCT01628692|78938053|FG002|Overall Study|Completed 12 Week only|0|||
44253906|NCT00631007|79094628|FG002|Overall Study|Withdrawal by Subject|2|||
44148536|NCT01628692|78938054|FG003|Overall Study|Completed 12 Week only|0|||
44148537|NCT01628692|78938055|FG004|Overall Study|Completed 12 Week only|0|||
44148538|NCT01628692|78938056|FG005|Overall Study|Completed 12 Week only|1|||
44148539|NCT02612727|78938075|FG000|Overall Study|Parent request|4|||
44148540|NCT02612727|78938076|FG001|Overall Study|Parent request|1|||
44148541|NCT02612727|78938075|FG000|Overall Study|Needed treatment incompatible with PT|1|||
44148542|NCT02612727|78938076|FG001|Overall Study|Needed treatment incompatible with PT|1|||
44148543|NCT02612727|78938075|FG000|Overall Study|Direct hyperbilirubinemia|0|||
44148544|NCT02612727|78938076|FG001|Overall Study|Direct hyperbilirubinemia|2|||
44148545|NCT01594827|78938084|FG000|Overall Study|Adverse Event|1|||
44148546|NCT01594827|78938085|FG001|Overall Study|Adverse Event|0|||
44148547|NCT01594827|78938084|FG000|Overall Study|Physician Decision|3|||
44148548|NCT01594827|78938085|FG001|Overall Study|Physician Decision|0|||
44148549|NCT02610231|78938093|FG000|Overall Study|Withdrawal by Subject|27|||
44148550|NCT02610231|78938093|FG000|Overall Study|Adverse Event|20|||
44148551|NCT02610231|78938093|FG000|Overall Study|Death|5|||
44148552|NCT02610231|78938093|FG000|Overall Study|Surgery|2|||
44148553|NCT02610231|78938093|FG000|Overall Study|Physician Decision|1|||
44148554|NCT02610231|78938093|FG000|Overall Study|Non Compliance|2|||
44148555|NCT02610231|78938093|FG000|Overall Study|Other|3|||
44148556|NCT02178358|78938103|FG000|Overall Study|Withdrawal by Subject|0|||
44148557|NCT02178358|78938104|FG001|Overall Study|Withdrawal by Subject|2|||
44148558|NCT02178358|78938105|FG002|Overall Study|Withdrawal by Subject|2|||
44148559|NCT02178358|78938103|FG000|Overall Study|Lost to Follow-up|1|||
44148560|NCT02178358|78938104|FG001|Overall Study|Lost to Follow-up|0|||
44148561|NCT02178358|78938105|FG002|Overall Study|Lost to Follow-up|0|||
44148562|NCT01598896|78938116|FG000|Overall Study|Withdrawal by Subject|0|||
44253907|NCT00631007|79094629|FG003|Overall Study|Withdrawal by Subject|2|||
44282193|NCT01879410|79245462|FG000|Overall Study|Withdrawal by Subject|7|||
44411993|NCT00665626|79419752|FG001|Overall Study|Adverse Event|9|||
44411994|NCT00665626|79419751|FG000|Overall Study|Due to exclusion criteria|0|||
44411995|NCT00665626|79419752|FG001|Overall Study|Due to exclusion criteria|1|||
44411996|NCT00665626|79419751|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
44411997|NCT00665626|79419752|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
44411998|NCT00665626|79419751|FG000|Overall Study|Unably to comply with dosing regimen|0|||
44411999|NCT00665626|79419752|FG001|Overall Study|Unably to comply with dosing regimen|1|||
44412000|NCT00665626|79419751|FG000|Overall Study|Death|1|||
44412001|NCT00665626|79419752|FG001|Overall Study|Death|0|||
44412002|NCT00828672|79419760|FG000|Study Treatment|Lost to Follow-up|1|||
44412003|NCT00828672|79419761|FG001|Study Treatment|Lost to Follow-up|0|||
44412004|NCT00828672|79419760|FG000|Study Treatment|Adverse Event|0|||
44412005|NCT00828672|79419761|FG001|Study Treatment|Adverse Event|1|||
44412006|NCT00828672|79419760|FG000|Study Treatment|Complete response, no surgery|1|||
44412007|NCT00828672|79419761|FG001|Study Treatment|Complete response, no surgery|1|||
44412008|NCT00828672|79419760|FG000|Post-surgery (<30 Days)|No central review materials|0|||
44412009|NCT00828672|79419761|FG001|Post-surgery (<30 Days)|No central review materials|1|||
44412010|NCT00873119|79419769|FG000|Overall Study|Patient request|4|||
44412011|NCT00873119|79419770|FG001|Overall Study|Patient request|2|||
44412012|NCT00873119|79419769|FG000|Overall Study|Adverse Event|8|||
44412013|NCT00873119|79419770|FG001|Overall Study|Adverse Event|0|||
44412014|NCT00873119|79419769|FG000|Overall Study|Progressive disease|26|||
44412015|NCT00873119|79419770|FG001|Overall Study|Progressive disease|18|||
44412016|NCT00873119|79419769|FG000|Overall Study|Death|2|||
44525208|NCT04698993|79534449|FG000|Overall Study|PCR results not accessible|2|||
44525209|NCT04698993|79534450|FG001|Overall Study|PCR results not accessible|7|||
44412017|NCT00873119|79419770|FG001|Overall Study|Death|1|||
44412018|NCT00873119|79419769|FG000|Overall Study|Other|2|||
44412019|NCT00873119|79419770|FG001|Overall Study|Other|5|||
44412020|NCT00873119|79419769|FG000|Overall Study|Not treated|2|||
44412021|NCT00873119|79419770|FG001|Overall Study|Not treated|0|||
44412022|NCT00661726|79419776|FG000|Overall Study|Adverse Event|1|||
44412023|NCT00865046|79419783|FG000|Overall Study|Lost to Follow-up|1|||
44412024|NCT00865046|79419784|FG001|Overall Study|Lost to Follow-up|4|||
44412025|NCT00865046|79419785|FG002|Overall Study|Lost to Follow-up|0|||
44412026|NCT00865046|79419783|FG000|Overall Study|Death|0|||
44525210|NCT04698993|79534449|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
44525211|NCT04698993|79534450|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
44525212|NCT04359771|79534458|FG000|Overall Study|Lack of Efficacy|2|||
44525213|NCT04359771|79534459|FG001|Overall Study|Lack of Efficacy|2|||
44525214|NCT04356573|79534467|FG000|Overall Study|Didn't Qualify|1|||
44525215|NCT04356573|79534468|FG001|Overall Study|Didn't Qualify|0|||
44525216|NCT04352127|79534484|FG000|Overall Study|Unable to obtain readings|4|||
44525217|NCT04352127|79534485|FG001|Overall Study|Unable to obtain readings|1|||
44412027|NCT00865046|79419784|FG001|Overall Study|Death|1|||
44412028|NCT00865046|79419785|FG002|Overall Study|Death|1|||
44412029|NCT00865046|79419783|FG000|Overall Study|Withdrawal by Subject|5|||
44412030|NCT00865046|79419784|FG001|Overall Study|Withdrawal by Subject|0|||
44412031|NCT00865046|79419785|FG002|Overall Study|Withdrawal by Subject|0|||
44412032|NCT00828516|79419793|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
44412033|NCT00665392|79419797|FG000|Overall Study|not treated|1|||
44412034|NCT00851630|79419804|FG000|Overall Study|Death|2|||
44412035|NCT00851630|79419805|FG001|Overall Study|Death|1|||
44412036|NCT00851630|79419804|FG000|Overall Study|Clinical failure|0|||
44412037|NCT00851630|79419805|FG001|Overall Study|Clinical failure|1|||
44412038|NCT00459667|79419814|FG000|Overall Study|Adverse Event|9|||
44412039|NCT00459667|79419815|FG001|Overall Study|Adverse Event|12|||
44412040|NCT00459667|79419816|FG002|Overall Study|Adverse Event|8|||
44412041|NCT00459667|79419814|FG000|Overall Study|Lost to Follow-up|5|||
44412042|NCT00459667|79419815|FG001|Overall Study|Lost to Follow-up|9|||
44412043|NCT00459667|79419816|FG002|Overall Study|Lost to Follow-up|3|||
44412044|NCT00459667|79419814|FG000|Overall Study|Pregnancy|1|||
44412045|NCT00459667|79419815|FG001|Overall Study|Pregnancy|1|||
44412046|NCT00459667|79419816|FG002|Overall Study|Pregnancy|1|||
44412047|NCT00459667|79419814|FG000|Overall Study|Protocol Violation|1|||
44412048|NCT00459667|79419815|FG001|Overall Study|Protocol Violation|0|||
44412049|NCT00459667|79419816|FG002|Overall Study|Protocol Violation|0|||
44412050|NCT00459667|79419814|FG000|Overall Study|Withdrawal by Subject|3|||
44412051|NCT00459667|79419815|FG001|Overall Study|Withdrawal by Subject|5|||
44412052|NCT00459667|79419816|FG002|Overall Study|Withdrawal by Subject|5|||
44412053|NCT00459667|79419814|FG000|Overall Study|Other disease modifying treatment|1|||
44412054|NCT00459667|79419815|FG001|Overall Study|Other disease modifying treatment|2|||
44412055|NCT00459667|79419816|FG002|Overall Study|Other disease modifying treatment|1|||
44412056|NCT00459667|79419814|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
44412057|NCT00459667|79419815|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
44412058|NCT00459667|79419816|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
44412059|NCT00459667|79419814|FG000|Overall Study|No treatment administered|6|||
44412060|NCT00459667|79419815|FG001|Overall Study|No treatment administered|3|||
44412061|NCT00459667|79419816|FG002|Overall Study|No treatment administered|1|||
44412062|NCT00828204|79419826|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
44412063|NCT00828204|79419827|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
44412064|NCT00828204|79419826|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
44412065|NCT00828204|79419827|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
44412066|NCT00828204|79419826|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
44412067|NCT00828204|79419827|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
44412068|NCT00828204|79419826|FG000|Main Study: After Study Restart|Adverse Event|0|||
44412069|NCT00828204|79419827|FG001|Main Study: After Study Restart|Adverse Event|2|||
44412070|NCT00828204|79419826|FG000|Main Study: After Study Restart|Noncompliance|0|||
44412071|NCT00828204|79419827|FG001|Main Study: After Study Restart|Noncompliance|1|||
44412072|NCT00828204|79419826|FG000|Extension Study|Lost to Follow-up|0|||
44412073|NCT00828204|79419827|FG001|Extension Study|Lost to Follow-up|1|||
44412074|NCT00828204|79419826|FG000|Extension Study|Physician Decision|0|||
44412075|NCT00828204|79419827|FG001|Extension Study|Physician Decision|2|||
44412076|NCT00851552|79419834|FG000|Overall Study|Death|2|||
44412077|NCT00851552|79419834|FG000|Overall Study|Adverse Event|1|||
44412078|NCT00851552|79419834|FG000|Overall Study|Disease Progression|4|||
44412079|NCT00459355|79419840|FG000|Overall Study|Subject no longer met inc criteria|20|||
44412080|NCT00459355|79419841|FG001|Overall Study|Subject no longer met inc criteria|18|||
44412081|NCT00459043|79419853|FG000|Overall Study|Withdrawal by Subject|1|||
44412082|NCT00459043|79419854|FG001|Overall Study|Withdrawal by Subject|0|||
44412083|NCT00817206|79419862|FG000|Overall Study|Adverse Event|10|||
44412084|NCT00817206|79419863|FG001|Overall Study|Adverse Event|3|||
44282194|NCT01879410|79245463|FG001|Overall Study|Withdrawal by Subject|8|||
44282195|NCT01879410|79245462|FG000|Overall Study|Randomised in Error|1|||
44282196|NCT01879410|79245463|FG001|Overall Study|Randomised in Error|2|||
44282197|NCT01903434|79245469|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
44282198|NCT01903434|79245470|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
44282199|NCT01903434|79245469|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
44412085|NCT00817206|79419862|FG000|Overall Study|Protocol Violation|0|||
44412086|NCT00817206|79419863|FG001|Overall Study|Protocol Violation|2|||
44412087|NCT00817206|79419862|FG000|Overall Study|Lost to Follow-up|0|||
44412088|NCT00817206|79419863|FG001|Overall Study|Lost to Follow-up|1|||
44412089|NCT00817206|79419862|FG000|Overall Study|Death|2|||
44412090|NCT00817206|79419863|FG001|Overall Study|Death|0|||
44412091|NCT00817206|79419862|FG000|Overall Study|Withdrawal by Subject|7|||
44412092|NCT00817206|79419863|FG001|Overall Study|Withdrawal by Subject|3|||
44412093|NCT00817206|79419862|FG000|Overall Study|Physician Decision|2|||
44412094|NCT00817206|79419863|FG001|Overall Study|Physician Decision|0|||
44412095|NCT00665002|79419869|FG000|Overall Study|Progression/relapse during treatment|11|||
44282200|NCT01903434|79245470|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
44282201|NCT01903356|79245476|FG000|Overall Study|Lost to Follow-up|7|||
44412096|NCT00665002|79419869|FG000|Overall Study|Cytogenetic resistance|1|||
44412097|NCT03847987|79419875|FG000|Overall Study|Lost to Follow-up|1|||
44412098|NCT03847987|79419876|FG001|Overall Study|Lost to Follow-up|0|||
44412099|NCT03847987|79419875|FG000|Overall Study|Adverse Event|2|||
44412100|NCT03847987|79419876|FG001|Overall Study|Adverse Event|0|||
44412101|NCT00660010|79419893|FG000|Overall Study|Withdrawal by Subject|2|||
44412102|NCT00660010|79419893|FG000|Overall Study|Lost to Follow-up|3|||
44412103|NCT00660010|79419893|FG000|Overall Study|Adverse Event|1|||
44412104|NCT00660010|79419893|FG000|Overall Study|Noncompliance with visit schedule|3|||
44412105|NCT00873041|79419900|FG000|Core Study|Adverse Event|2|||
44412106|NCT00873041|79419901|FG001|Core Study|Adverse Event|3|||
44412107|NCT00873041|79419902|FG002|Core Study|Adverse Event|1|||
44412108|NCT00873041|79419900|FG000|Core Study|Withdrawal by Subject|1|||
44412109|NCT00873041|79419901|FG001|Core Study|Withdrawal by Subject|2|||
44412110|NCT00873041|79419902|FG002|Core Study|Withdrawal by Subject|2|||
44412111|NCT00873041|79419900|FG000|Core Study|Lost to Follow-up|3|||
44412112|NCT00873041|79419901|FG001|Core Study|Lost to Follow-up|1|||
44412113|NCT00873041|79419902|FG002|Core Study|Lost to Follow-up|0|||
44412114|NCT00873041|79419900|FG000|Core Study|Abnormal laboratory value|0|||
44525218|NCT04351269|79534494|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
44525219|NCT04351269|79534495|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
44525220|NCT04351269|79534496|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
44525221|NCT04351269|79534494|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
44525222|NCT04351269|79534495|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
44525223|NCT04351269|79534496|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
44412115|NCT00873041|79419901|FG001|Core Study|Abnormal laboratory value|0|||
44412116|NCT00873041|79419902|FG002|Core Study|Abnormal laboratory value|1|||
44412117|NCT00873041|79419900|FG000|Core Study|Protocol deviation|1|||
44412118|NCT00873041|79419901|FG001|Core Study|Protocol deviation|0|||
44412119|NCT00873041|79419902|FG002|Core Study|Protocol deviation|1|||
44412120|NCT00873041|79419900|FG000|Extension Study|Adverse Event|1|||
44412121|NCT00873041|79419901|FG001|Extension Study|Adverse Event|0|||
44412122|NCT00873041|79419902|FG002|Extension Study|Adverse Event|1|||
44412123|NCT00873041|79419900|FG000|Extension Study|Administrative reasons|0|||
44412124|NCT00873041|79419901|FG001|Extension Study|Administrative reasons|0|||
44412125|NCT00873041|79419902|FG002|Extension Study|Administrative reasons|1|||
44412126|NCT00458341|79419919|FG000|Cycle 1|Adverse Event|1|||
44412127|NCT00458341|79419920|FG001|Cycle 1|Adverse Event|0|||
44412128|NCT00816036|79419928|FG000|Overall Study|Death|47|||
44412129|NCT00816036|79419929|FG001|Overall Study|Death|28|||
44412130|NCT00816036|79419928|FG000|Overall Study|Lost to Follow-up|75|||
44412131|NCT00816036|79419929|FG001|Overall Study|Lost to Follow-up|57|||
44412132|NCT00816036|79419928|FG000|Overall Study|Withdrawal by Subject|54|||
44412133|NCT00816036|79419929|FG001|Overall Study|Withdrawal by Subject|23|||
44412134|NCT00664534|79419937|FG000|Overall Study|Adverse Event|2|||
44412135|NCT00664534|79419938|FG001|Overall Study|Adverse Event|3|||
44412136|NCT00664534|79419937|FG000|Overall Study|Lost to Follow-up|6|||
44412137|NCT00664534|79419938|FG001|Overall Study|Lost to Follow-up|10|||
44412138|NCT00664534|79419937|FG000|Overall Study|Protocol Violation|10|||
44412139|NCT00664534|79419938|FG001|Overall Study|Protocol Violation|8|||
44412140|NCT00664534|79419937|FG000|Overall Study|Withdrawal by Subject|7|||
44412141|NCT00664534|79419938|FG001|Overall Study|Withdrawal by Subject|6|||
44412142|NCT00664534|79419937|FG000|Overall Study|Physician Decision|8|||
44412143|NCT00664534|79419938|FG001|Overall Study|Physician Decision|0|||
44412144|NCT00664534|79419937|FG000|Overall Study|Sponsor decision|8|||
44412145|NCT00664534|79419938|FG001|Overall Study|Sponsor decision|6|||
44412146|NCT00594035|79419946|FG000|Overall Study|Lost to Follow-up|1|||
44412147|NCT00594035|79419947|FG001|Overall Study|Lost to Follow-up|1|||
44412148|NCT00594035|79419946|FG000|Overall Study|Withdrawal by Subject|1|||
44412149|NCT00594035|79419947|FG001|Overall Study|Withdrawal by Subject|0|||
44412150|NCT00594035|79419946|FG000|Overall Study|Subject transferred to nursing home|0|||
44412151|NCT00594035|79419947|FG001|Overall Study|Subject transferred to nursing home|1|||
44253908|NCT00631007|79094630|FG004|Overall Study|Withdrawal by Subject|1|||
44412152|NCT00594035|79419946|FG000|Overall Study|Subject couldn't return due to job|0|||
44412153|NCT00594035|79419947|FG001|Overall Study|Subject couldn't return due to job|1|||
44253909|NCT00631007|79094631|FG005|Overall Study|Withdrawal by Subject|3|||
44412154|NCT00570310|79419955|FG000|Overall Study|Adverse Event|1|||
44412155|NCT00570310|79419956|FG001|Overall Study|Adverse Event|2|||
44412156|NCT00570310|79419955|FG000|Overall Study|Lack of Efficacy|1|||
44412157|NCT00570310|79419956|FG001|Overall Study|Lack of Efficacy|4|||
44412158|NCT00664066|79419962|FG000|Overall Study|Study terminated|3|||
44412159|NCT00814710|79419968|FG000|Overall Study|Adverse Event|1|||
44412160|NCT00814710|79419969|FG001|Overall Study|Adverse Event|0|||
44412161|NCT00814710|79419968|FG000|Overall Study|Lost to Follow-up|7|||
44412162|NCT00814710|79419969|FG001|Overall Study|Lost to Follow-up|3|||
44412163|NCT00871169|79419975|FG000|Overall Study|Protocol Violation|1|||
44412164|NCT00871169|79419975|FG000|Overall Study|Patient did not receive study treatment|2|||
44412165|NCT00814632|79419979|FG000|Overall Study|Lack of Efficacy|2|||
44412166|NCT00851318|79419987|FG000|Overall Study|Withdrawal by Subject|7|||
44412167|NCT00851318|79419988|FG001|Overall Study|Withdrawal by Subject|1|||
44282202|NCT01903356|79245476|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
44282203|NCT01903356|79245476|FG000|Overall Study|Violated the dosage and administration|3|||
44282204|NCT01862796|79245483|FG000|Overall Study|Prohibited medications|0|||
44282205|NCT01862796|79245484|FG001|Overall Study|Prohibited medications|0|||
44282206|NCT01862796|79245485|FG002|Overall Study|Prohibited medications|1|||
44412168|NCT00851318|79419989|FG002|Overall Study|Withdrawal by Subject|5|||
44412169|NCT00851318|79419990|FG003|Overall Study|Withdrawal by Subject|3|||
44412170|NCT00851318|79419987|FG000|Overall Study|Adverse Event|13|||
44412171|NCT00851318|79419988|FG001|Overall Study|Adverse Event|2|||
44412172|NCT00851318|79419989|FG002|Overall Study|Adverse Event|9|||
44412173|NCT00851318|79419990|FG003|Overall Study|Adverse Event|12|||
44412174|NCT00851318|79419987|FG000|Overall Study|Pregnancy|0|||
44412175|NCT00851318|79419988|FG001|Overall Study|Pregnancy|0|||
44412176|NCT00851318|79419989|FG002|Overall Study|Pregnancy|1|||
44412177|NCT00851318|79419990|FG003|Overall Study|Pregnancy|1|||
44412178|NCT00851318|79419987|FG000|Overall Study|Lack of Efficacy|8|||
44412179|NCT00851318|79419988|FG001|Overall Study|Lack of Efficacy|2|||
44412180|NCT00851318|79419989|FG002|Overall Study|Lack of Efficacy|4|||
44412181|NCT00851318|79419990|FG003|Overall Study|Lack of Efficacy|2|||
44412182|NCT00851318|79419987|FG000|Overall Study|Non-compliance with Study Procedures|2|||
44412183|NCT00851318|79419988|FG001|Overall Study|Non-compliance with Study Procedures|0|||
44412184|NCT00851318|79419989|FG002|Overall Study|Non-compliance with Study Procedures|1|||
44412185|NCT00851318|79419990|FG003|Overall Study|Non-compliance with Study Procedures|0|||
44412186|NCT00851318|79419987|FG000|Overall Study|Physician Decision|0|||
44412187|NCT00851318|79419988|FG001|Overall Study|Physician Decision|0|||
44412188|NCT00851318|79419989|FG002|Overall Study|Physician Decision|1|||
44412189|NCT00851318|79419990|FG003|Overall Study|Physician Decision|1|||
44412190|NCT00593957|79420003|FG000|Overall Study|Physician Decision|0|||
44282207|NCT01878084|79245493|FG000|Overall Study|Physician Decision|2|||
44282208|NCT01862640|79245502|FG000|Overall Study|Adverse Event|4|||
44282209|NCT01862640|79245503|FG001|Overall Study|Adverse Event|10|||
44282210|NCT01862640|79245504|FG002|Overall Study|Adverse Event|6|||
44282211|NCT01862640|79245505|FG003|Overall Study|Adverse Event|8|||
44282212|NCT01862640|79245502|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
44282213|NCT01862640|79245503|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
44282214|NCT01862640|79245504|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
44412191|NCT00593957|79420004|FG001|Overall Study|Physician Decision|1|||
44412192|NCT00593957|79420005|FG002|Overall Study|Physician Decision|2|||
44412193|NCT00870233|79420027|FG000|Overall Study|Withdrawal by Subject|18|||
44412194|NCT00870233|79420027|FG000|Overall Study|Did not undergo laparotomy|3|||
44412195|NCT00870233|79420027|FG000|Overall Study|Incompatible internet browser|2|||
44412196|NCT00870233|79420027|FG000|Overall Study|Death|1|||
44412197|NCT00851084|79420034|FG000|Overall Study|Randomized but not treated|1|||
44412198|NCT00851084|79420035|FG001|Overall Study|Randomized but not treated|0|||
44412199|NCT00851084|79420034|FG000|Overall Study|Adverse Event|26|||
44412200|NCT00851084|79420035|FG001|Overall Study|Adverse Event|36|||
44412201|NCT00851084|79420034|FG000|Overall Study|Disease progression|52|||
44412202|NCT00851084|79420035|FG001|Overall Study|Disease progression|47|||
44412203|NCT00851084|79420034|FG000|Overall Study|Poor compliance to protocol|1|||
44412204|NCT00851084|79420035|FG001|Overall Study|Poor compliance to protocol|1|||
44412205|NCT00851084|79420034|FG000|Overall Study|Physician Decision|13|||
44412206|NCT00851084|79420035|FG001|Overall Study|Physician Decision|14|||
44412207|NCT00851084|79420034|FG000|Overall Study|Consent withdrawn|0|||
44412208|NCT00851084|79420035|FG001|Overall Study|Consent withdrawn|2|||
44412209|NCT00851084|79420034|FG000|Overall Study|Withdrawal by Subject|11|||
44412210|NCT00851084|79420035|FG001|Overall Study|Withdrawal by Subject|12|||
44253910|NCT00631007|79094626|FG000|Overall Study|Other|2|||
44253911|NCT00631007|79094627|FG001|Overall Study|Other|1|||
44253912|NCT00631007|79094628|FG002|Overall Study|Other|0|||
44253913|NCT00631007|79094629|FG003|Overall Study|Other|0|||
44253914|NCT00631007|79094630|FG004|Overall Study|Other|1|||
44253915|NCT00631007|79094631|FG005|Overall Study|Other|0|||
44253916|NCT00630539|79094649|FG000|Overall Study|Adverse Event|1|||
44253917|NCT00630539|79094650|FG001|Overall Study|Adverse Event|3|||
44253918|NCT00630539|79094651|FG002|Overall Study|Adverse Event|1|||
44253919|NCT00630539|79094652|FG003|Overall Study|Adverse Event|2|||
44412211|NCT00851084|79420034|FG000|Overall Study|Metastatic surgery|6|||
44253920|NCT00630539|79094649|FG000|Overall Study|Withdrawal by Subject|0|||
44253921|NCT00630539|79094650|FG001|Overall Study|Withdrawal by Subject|1|||
44253922|NCT00630539|79094651|FG002|Overall Study|Withdrawal by Subject|0|||
44282215|NCT01862640|79245505|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
44412212|NCT00851084|79420035|FG001|Overall Study|Metastatic surgery|6|||
44412213|NCT00851084|79420034|FG000|Overall Study|Other|7|||
44412214|NCT00851084|79420035|FG001|Overall Study|Other|1|||
44412215|NCT00845858|79420046|FG000|Overall Study|Withdrawal by Subject|5|||
44412216|NCT00845858|79420047|FG001|Overall Study|Withdrawal by Subject|1|||
44412217|NCT00845858|79420048|FG002|Overall Study|Withdrawal by Subject|1|||
44412218|NCT00845858|79420046|FG000|Overall Study|Adverse Event|3|||
44412219|NCT00845858|79420047|FG001|Overall Study|Adverse Event|8|||
44412220|NCT00845858|79420048|FG002|Overall Study|Adverse Event|4|||
44412221|NCT00845858|79420046|FG000|Overall Study|Protocol Violation|0|||
44412222|NCT00845858|79420047|FG001|Overall Study|Protocol Violation|0|||
44412223|NCT00845858|79420048|FG002|Overall Study|Protocol Violation|1|||
44412224|NCT00845858|79420046|FG000|Overall Study|not eligible|0|||
44412225|NCT00845858|79420047|FG001|Overall Study|not eligible|3|||
44412226|NCT00845858|79420048|FG002|Overall Study|not eligible|2|||
44412227|NCT00850538|79420059|FG000|Overall Study|unable/unwilling to complete MRI|13|||
44412228|NCT00850538|79420059|FG000|Overall Study|specimen missed due to scheduling error|14|||
44412229|NCT00850538|79420059|FG000|Overall Study|specimen unusable|7|||
44412230|NCT00850538|79420059|FG000|Overall Study|Withdrawal by Subject|3|||
44412231|NCT00850538|79420059|FG000|Overall Study|radiology error|2|||
44412232|NCT00850538|79420059|FG000|Overall Study|Protocol Violation|2|||
44412233|NCT00850460|79420065|FG000|Overall Study|Lost to Follow-up|4|||
44412234|NCT00850460|79420066|FG001|Overall Study|Lost to Follow-up|4|||
44412235|NCT00661492|79420074|FG000|Overall Study|Adverse Event|16|||
44412236|NCT00661492|79420075|FG001|Overall Study|Adverse Event|13|||
44412237|NCT00661492|79420074|FG000|Overall Study|Disease Progression|44|||
44412238|NCT00661492|79420075|FG001|Overall Study|Disease Progression|14|||
44412239|NCT00661492|79420074|FG000|Overall Study|Patient Request|6|||
44412240|NCT00661492|79420075|FG001|Overall Study|Patient Request|1|||
44412241|NCT00661492|79420074|FG000|Overall Study|Investigator Request|1|||
44412242|NCT00661492|79420075|FG001|Overall Study|Investigator Request|0|||
44412243|NCT00661492|79420074|FG000|Overall Study|Lost to Follow-up|0|||
44412244|NCT00661492|79420075|FG001|Overall Study|Lost to Follow-up|1|||
44412245|NCT00661492|79420074|FG000|Overall Study|Other|1|||
44412246|NCT00661492|79420075|FG001|Overall Study|Other|0|||
44412247|NCT00850070|79420083|FG000|Overall Study|Lack of Efficacy|1|||
44412248|NCT00850070|79420084|FG001|Overall Study|Lack of Efficacy|1|||
44412249|NCT00850070|79420083|FG000|Overall Study|Adverse Event|2|||
44412250|NCT00850070|79420084|FG001|Overall Study|Adverse Event|0|||
44412251|NCT00592358|79420095|FG000|Overall Study|Withdrawal by Subject|2|||
44412252|NCT00592358|79420095|FG000|Overall Study|Adverse Event|1|||
44412253|NCT00592358|79420095|FG000|Overall Study|Lack of Efficacy|2|||
44412254|NCT00592358|79420095|FG000|Overall Study|Inability to swallow pills|1|||
44412255|NCT00814320|79420101|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
44525224|NCT04351269|79534494|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
44525225|NCT04351269|79534495|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
44525226|NCT04351269|79534496|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
44148563|NCT01598896|78938117|FG001|Overall Study|Withdrawal by Subject|1|||
44148564|NCT01598896|78938116|FG000|Overall Study|Lack of Efficacy|0|||
44148565|NCT01598896|78938117|FG001|Overall Study|Lack of Efficacy|1|||
44148566|NCT01598662|78938125|FG000|Overall Study|Lost to Follow-up|10|||
44148567|NCT01598662|78938126|FG001|Overall Study|Lost to Follow-up|17|||
44148568|NCT01598662|78938125|FG000|Overall Study|Physician Decision|1|||
44148569|NCT01598662|78938126|FG001|Overall Study|Physician Decision|2|||
44148570|NCT01598662|78938125|FG000|Overall Study|IUD expelled before month 6|0|||
44148571|NCT01598662|78938126|FG001|Overall Study|IUD expelled before month 6|2|||
44148572|NCT01629706|78938132|FG000|Phase 1 PureVision|Screen Failure|4|||
44148573|NCT01629706|78938132|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
44253923|NCT00630539|79094652|FG003|Overall Study|Withdrawal by Subject|1|||
44253924|NCT00630305|79094730|FG000|Overall Study|Withdrawal by Subject|1|||
44253925|NCT00630305|79094730|FG000|Overall Study|Inability to insert contact lens|1|||
44253926|NCT01926197|79094956|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
44253927|NCT01926197|79094957|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
44253928|NCT01926197|79094956|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
44253929|NCT01926197|79094957|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
44253930|NCT00989963|79094982|FG000|Overall Study|Adverse Event|1|||
44253931|NCT00989963|79094983|FG001|Overall Study|Adverse Event|1|||
44253932|NCT00989963|79094984|FG002|Overall Study|Adverse Event|1|||
44253933|NCT00989573|79095022|FG000|Overall Study|Adverse Event|8|||
44253934|NCT00989573|79095023|FG001|Overall Study|Adverse Event|12|||
44253935|NCT00989573|79095024|FG002|Overall Study|Adverse Event|4|||
44253936|NCT00989573|79095022|FG000|Overall Study|Physician Decision|0|||
44253937|NCT00989573|79095023|FG001|Overall Study|Physician Decision|2|||
44253938|NCT00989573|79095024|FG002|Overall Study|Physician Decision|0|||
44253939|NCT00989573|79095022|FG000|Overall Study|Protocol Violation|1|||
44253940|NCT00989573|79095023|FG001|Overall Study|Protocol Violation|1|||
44253941|NCT00989573|79095024|FG002|Overall Study|Protocol Violation|1|||
44412256|NCT00814320|79420102|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
44412257|NCT00814320|79420101|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
44412258|NCT00814320|79420102|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
44412259|NCT00814320|79420101|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
44412260|NCT00814320|79420102|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
44148574|NCT01629706|78938132|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
44148575|NCT01629706|78938132|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
44148576|NCT01629706|78938132|FG000|Phase 2 Habitual|Screen Failure|6|||
44148577|NCT01629706|78938132|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
44148578|NCT01629706|78938132|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
44148579|NCT01629706|78938132|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
44148580|NCT01629706|78938132|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
44148581|NCT02153086|78938140|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
44412261|NCT00814320|79420101|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
44412262|NCT00814320|79420102|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
44412263|NCT00814320|79420101|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
44412264|NCT00814320|79420102|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
44412265|NCT00814320|79420101|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
44412266|NCT00814320|79420102|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
44412267|NCT00814320|79420101|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
44412268|NCT00814320|79420102|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
44412269|NCT00814320|79420101|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
44412270|NCT00814320|79420102|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
44412271|NCT00814320|79420101|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
44412272|NCT00814320|79420102|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
44412273|NCT00814320|79420101|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
44412274|NCT00814320|79420102|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
44412275|NCT00869999|79420125|FG000|Overall Study|Withdrawal by Subject|1|||
44412276|NCT00869999|79420125|FG000|Overall Study|removed prior to starting therapy|1|||
44412277|NCT00570232|79420129|FG000|Overall Study|Adverse Event|10|||
44412278|NCT00570232|79420129|FG000|Overall Study|discontinued due to medical condition|3|||
44412279|NCT00570232|79420129|FG000|Overall Study|discontinued due to recurrence|8|||
44412280|NCT00570232|79420129|FG000|Overall Study|discontinued due to noncompliance|2|||
44412281|NCT00809328|79420133|FG000|Overall Study|Lack of Efficacy|18|||
44412282|NCT00809328|79420133|FG000|Overall Study|Adverse Event|6|||
44412283|NCT00809328|79420133|FG000|Overall Study|Protocol Violation|3|||
44412284|NCT00809328|79420133|FG000|Overall Study|Withdrawal by Subject|2|||
44412285|NCT00868517|79420140|FG000|Overall Study|Withdrawal by Subject|3|||
44412286|NCT00868517|79420141|FG001|Overall Study|Withdrawal by Subject|3|||
44412287|NCT00868517|79420142|FG002|Overall Study|Withdrawal by Subject|2|||
44412288|NCT00868517|79420140|FG000|Overall Study|Protocol Violation|1|||
44412289|NCT00868517|79420141|FG001|Overall Study|Protocol Violation|1|||
44412290|NCT00868517|79420142|FG002|Overall Study|Protocol Violation|0|||
44412291|NCT00868439|79420152|FG000|Overall Study|Adverse Event|4|||
44412292|NCT00868439|79420153|FG001|Overall Study|Adverse Event|3|||
44412293|NCT00868439|79420152|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
44282216|NCT01862640|79245502|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
44282217|NCT01862640|79245503|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
44412294|NCT00868439|79420153|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
44525227|NCT04351269|79534494|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
44525228|NCT04351269|79534495|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
44525229|NCT04351269|79534496|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
44525230|NCT04351269|79534494|FG000|Overall Study|Lost to Follow-up|1|||
44525231|NCT04351269|79534495|FG001|Overall Study|Lost to Follow-up|3|||
44525232|NCT04351269|79534496|FG002|Overall Study|Lost to Follow-up|0|||
44525233|NCT04348851|79534511|FG000|Post-Test 1|Withdrawal by Subject|0|||
44525234|NCT04348851|79534512|FG001|Post-Test 1|Withdrawal by Subject|1|||
44525235|NCT04348851|79534513|FG002|Post-Test 1|Withdrawal by Subject|0|||
44525236|NCT04348851|79534514|FG003|Post-Test 1|Withdrawal by Subject|0|||
44525237|NCT04348851|79534511|FG000|Post-Test 1|Lost to Follow-up|0|||
44525238|NCT04348851|79534512|FG001|Post-Test 1|Lost to Follow-up|1|||
44525239|NCT04348851|79534513|FG002|Post-Test 1|Lost to Follow-up|0|||
44412295|NCT00868439|79420152|FG000|Overall Study|Death|0|||
44412296|NCT00868439|79420153|FG001|Overall Study|Death|1|||
44412297|NCT00868439|79420152|FG000|Overall Study|Protocol Violation|1|||
44412298|NCT00868439|79420153|FG001|Overall Study|Protocol Violation|1|||
44412299|NCT00868439|79420152|FG000|Overall Study|Physician Decision|1|||
44412300|NCT00868439|79420153|FG001|Overall Study|Physician Decision|0|||
44412301|NCT00868439|79420152|FG000|Overall Study|Withdrawal by Subject|0|||
44525240|NCT04348851|79534514|FG003|Post-Test 1|Lost to Follow-up|0|||
44525241|NCT04348851|79534511|FG000|Post-Test 2|Stroke survivor death|0|||
44525242|NCT04348851|79534512|FG001|Post-Test 2|Stroke survivor death|1|||
44525243|NCT04348851|79534513|FG002|Post-Test 2|Stroke survivor death|0|||
44525244|NCT04348851|79534514|FG003|Post-Test 2|Stroke survivor death|1|||
44412302|NCT00868439|79420153|FG001|Overall Study|Withdrawal by Subject|1|||
44412303|NCT00814164|79420159|FG000|Overall Study|Progression|7|||
44525245|NCT04346199|79534526|FG000|Overall Study|Death|8|||
44525246|NCT04346199|79534527|FG001|Overall Study|Death|9|||
44412304|NCT00814164|79420159|FG000|Overall Study|not stated|7|||
44412305|NCT00814164|79420159|FG000|Overall Study|Death|5|||
44412306|NCT00659230|79420165|FG000|Overall Study|Lost to Follow-up|2|||
44412307|NCT00659230|79420166|FG001|Overall Study|Lost to Follow-up|5|||
44412308|NCT00659230|79420165|FG000|Overall Study|Lost source documentation|5|||
44412309|NCT00659230|79420166|FG001|Overall Study|Lost source documentation|4|||
44412310|NCT00659230|79420165|FG000|Overall Study|Did not return post-randomization|2|||
44412311|NCT00659230|79420166|FG001|Overall Study|Did not return post-randomization|3|||
44412312|NCT00809094|79420174|FG000|Overall Study|Lost to Follow-up|0|||
44412313|NCT00809094|79420175|FG001|Overall Study|Lost to Follow-up|1|||
44412314|NCT00658996|79420181|FG000|First Intervention|Positive slit lamp finding|1|||
44412315|NCT00658996|79420182|FG001|First Intervention|Positive slit lamp finding|0|||
44412316|NCT00658996|79420181|FG000|First Intervention|Lack of lenses|0|||
44412317|NCT00658996|79420182|FG001|First Intervention|Lack of lenses|1|||
44412318|NCT00658996|79420181|FG000|Crossover Period|Physician Decision|1|||
44412319|NCT00658996|79420182|FG001|Crossover Period|Physician Decision|0|||
44148582|NCT02153086|78938140|FG000|Overall Study|Other|2|||
44412320|NCT00658996|79420181|FG000|Crossover Period|Ineligible|1|||
44412321|NCT00658996|79420182|FG001|Crossover Period|Ineligible|1|||
44412322|NCT00658996|79420181|FG000|Second Intervention|Developed a stye on upper lid|1|||
44412323|NCT00658996|79420182|FG001|Second Intervention|Developed a stye on upper lid|0|||
44412324|NCT00658996|79420181|FG000|Second Intervention|Positive slit lamp finding|0|||
44412325|NCT00658996|79420182|FG001|Second Intervention|Positive slit lamp finding|1|||
44412326|NCT00867815|79420188|FG000|Overall Study|Lost to Follow-up|1|||
44412327|NCT00452413|79420195|FG000|Overall Study|Progressive Disease|4|||
44412328|NCT00452413|79420196|FG001|Overall Study|Progressive Disease|11|||
44412329|NCT00452413|79420197|FG002|Overall Study|Progressive Disease|30|||
44412330|NCT00452413|79420195|FG000|Overall Study|Withdrawal by Subject|0|||
44412331|NCT00452413|79420196|FG001|Overall Study|Withdrawal by Subject|1|||
44412332|NCT00452413|79420197|FG002|Overall Study|Withdrawal by Subject|4|||
44412333|NCT00452413|79420195|FG000|Overall Study|Adverse Event|0|||
44412334|NCT00452413|79420196|FG001|Overall Study|Adverse Event|0|||
44412335|NCT00452413|79420197|FG002|Overall Study|Adverse Event|5|||
44412336|NCT00452413|79420195|FG000|Overall Study|Physician Decision|0|||
44412337|NCT00452413|79420196|FG001|Overall Study|Physician Decision|0|||
44412338|NCT00452413|79420197|FG002|Overall Study|Physician Decision|4|||
44412339|NCT00452413|79420195|FG000|Overall Study|Death due to study disease|0|||
44412340|NCT00452413|79420196|FG001|Overall Study|Death due to study disease|0|||
44412341|NCT00452413|79420197|FG002|Overall Study|Death due to study disease|2|||
44412342|NCT00452413|79420195|FG000|Overall Study|Death due to adverse event (AE)|0|||
44412343|NCT00452413|79420196|FG001|Overall Study|Death due to adverse event (AE)|0|||
44412344|NCT00452413|79420197|FG002|Overall Study|Death due to adverse event (AE)|1|||
44412345|NCT00452413|79420195|FG000|Overall Study|On treatment|0|||
44412346|NCT00452413|79420196|FG001|Overall Study|On treatment|0|||
44412347|NCT00452413|79420197|FG002|Overall Study|On treatment|3|||
44412348|NCT00867503|79420206|FG000|Overall Study|Withdrawal by Subject|1|||
44412349|NCT00867113|79420212|FG000|Treatment Period|Adverse Event|15|||
44412350|NCT00867113|79420212|FG000|Treatment Period|Death|2|||
44412351|NCT00867113|79420212|FG000|Treatment Period|Withdrawal by Subject|19|||
44412352|NCT00867113|79420212|FG000|Treatment Period|Lost to Follow-up|3|||
44412353|NCT00867113|79420212|FG000|Treatment Period|Administrative problems|1|||
44412354|NCT00867113|79420212|FG000|Treatment Period|Disease progression/relapse|1|||
44412355|NCT00867113|79420212|FG000|Treatment Period|Protocol Violation|4|||
44412356|NCT00867113|79420212|FG000|Post Treatment After Survival Follow-up|Death|1|||
44412357|NCT00867113|79420212|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
44525247|NCT04346199|79534526|FG000|Overall Study|Lost to Follow-up|0|||
44525248|NCT04346199|79534527|FG001|Overall Study|Lost to Follow-up|1|||
44525249|NCT04346199|79534526|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
44525250|NCT04346199|79534527|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
44525251|NCT04346199|79534526|FG000|Overall Study|Withdrawal by Subject|5|||
44525252|NCT04346199|79534527|FG001|Overall Study|Withdrawal by Subject|1|||
44525253|NCT04345653|79534533|FG000|Overall Study|Withdrawal by Subject|2|||
44525254|NCT04342689|79534540|FG000|Overall Study|Withdrawal by Subject|32|||
44148583|NCT02117050|78938144|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
44148584|NCT02728895|78938151|FG000|Overall Study|Other|1|||
44148585|NCT02728895|78938152|FG001|Overall Study|Other|2|||
44412358|NCT00867113|79420212|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
44412359|NCT00867113|79420212|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
44412360|NCT00451555|79420219|FG000|Overall Study|Protocol Violation|2|||
44412361|NCT00451555|79420220|FG001|Overall Study|Protocol Violation|2|||
44412362|NCT00451555|79420219|FG000|Overall Study|Adverse Event|3|||
44412363|NCT00451555|79420220|FG001|Overall Study|Adverse Event|1|||
44412364|NCT00451555|79420219|FG000|Overall Study|Withdrawal by Subject|6|||
44412365|NCT00451555|79420220|FG001|Overall Study|Withdrawal by Subject|0|||
44412366|NCT00451555|79420219|FG000|Overall Study|Physician Decision|2|||
44412367|NCT00451555|79420220|FG001|Overall Study|Physician Decision|1|||
44412368|NCT00808236|79420237|FG000|Overall Study|Was not resuscitated|50|||
44412369|NCT00808236|79420238|FG001|Overall Study|Was not resuscitated|56|||
44412370|NCT00808236|79420237|FG000|Overall Study|Pre-defined exclusion|13|||
44412371|NCT00808236|79420238|FG001|Overall Study|Pre-defined exclusion|3|||
44412372|NCT00808236|79420237|FG000|Overall Study|Lost to Follow-up|1|||
44412373|NCT00808236|79420238|FG001|Overall Study|Lost to Follow-up|1|||
44412374|NCT00808236|79420237|FG000|Overall Study|Physician Decision|0|||
44412375|NCT00808236|79420238|FG001|Overall Study|Physician Decision|1|||
44412376|NCT00808236|79420237|FG000|Overall Study|Death|18|||
44412377|NCT00808236|79420238|FG001|Overall Study|Death|30|||
44412378|NCT00867035|79420246|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
44412379|NCT00867035|79420247|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
44148586|NCT02728895|78938151|FG000|Overall Study|Withdrawal by Subject|0|||
44148587|NCT02728895|78938152|FG001|Overall Study|Withdrawal by Subject|3|||
44412380|NCT00867035|79420246|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
44412381|NCT00867035|79420247|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
44412382|NCT00663208|79420260|FG000|Treatment Period|Lost to Follow-up|0|||
44412383|NCT00663208|79420261|FG001|Treatment Period|Lost to Follow-up|1|||
44412384|NCT00663208|79420262|FG002|Treatment Period|Lost to Follow-up|0|||
44412385|NCT00663208|79420263|FG003|Treatment Period|Lost to Follow-up|0|||
44412386|NCT00663208|79420264|FG004|Treatment Period|Lost to Follow-up|0|||
44412387|NCT00663208|79420265|FG005|Treatment Period|Lost to Follow-up|0|||
44412388|NCT00663208|79420266|FG006|Treatment Period|Lost to Follow-up|0|||
44412389|NCT00663208|79420260|FG000|Follow-up Period|Lost to Follow-up|2|||
44412390|NCT00663208|79420261|FG001|Follow-up Period|Lost to Follow-up|0|||
44412391|NCT00663208|79420262|FG002|Follow-up Period|Lost to Follow-up|3|||
44412392|NCT00663208|79420263|FG003|Follow-up Period|Lost to Follow-up|2|||
44412393|NCT00663208|79420264|FG004|Follow-up Period|Lost to Follow-up|0|||
44412394|NCT00663208|79420265|FG005|Follow-up Period|Lost to Follow-up|0|||
44412395|NCT00663208|79420266|FG006|Follow-up Period|Lost to Follow-up|0|||
44412396|NCT00663208|79420260|FG000|Follow-up Period|Other reason|1|||
44412397|NCT00663208|79420261|FG001|Follow-up Period|Other reason|0|||
44412398|NCT00663208|79420262|FG002|Follow-up Period|Other reason|0|||
44412399|NCT00663208|79420263|FG003|Follow-up Period|Other reason|0|||
44412400|NCT00663208|79420264|FG004|Follow-up Period|Other reason|0|||
44412401|NCT00663208|79420265|FG005|Follow-up Period|Other reason|0|||
44412402|NCT00663208|79420266|FG006|Follow-up Period|Other reason|1|||
44412403|NCT00810810|79420288|FG000|Overall Study|Withdrawal by Subject|0|||
44412404|NCT00810810|79420289|FG001|Overall Study|Withdrawal by Subject|8|||
44412405|NCT00810810|79420290|FG002|Overall Study|Withdrawal by Subject|10|||
44412406|NCT00810810|79420291|FG003|Overall Study|Withdrawal by Subject|8|||
44412407|NCT00810810|79420288|FG000|Overall Study|Physician Decision|0|||
44412408|NCT00810810|79420289|FG001|Overall Study|Physician Decision|3|||
44412409|NCT00810810|79420290|FG002|Overall Study|Physician Decision|1|||
44412410|NCT00810810|79420291|FG003|Overall Study|Physician Decision|5|||
44412411|NCT00661258|79420303|FG000|Overall Study|Death|1|||
44412412|NCT00661258|79420304|FG001|Overall Study|Death|0|||
44412413|NCT00661258|79420303|FG000|Overall Study|caught by police and in detox center|2|||
44412414|NCT00661258|79420304|FG001|Overall Study|caught by police and in detox center|1|||
44412415|NCT00871871|79420312|FG000|Part I|Adverse Event|0|||
44412416|NCT00871871|79420313|FG001|Part I|Adverse Event|2|||
44412417|NCT00871871|79420314|FG002|Part I|Adverse Event|0|||
44412418|NCT00871871|79420315|FG003|Part I|Adverse Event|0|||
44412419|NCT00871871|79420312|FG000|Part I|Withdrawal by Subject|3|||
44412420|NCT00871871|79420313|FG001|Part I|Withdrawal by Subject|0|||
44412421|NCT00871871|79420314|FG002|Part I|Withdrawal by Subject|0|||
44412422|NCT00871871|79420315|FG003|Part I|Withdrawal by Subject|0|||
44412423|NCT00871871|79420312|FG000|Part I|Laboratory abnormality|0|||
44412424|NCT00871871|79420313|FG001|Part I|Laboratory abnormality|1|||
44253942|NCT00989573|79095022|FG000|Overall Study|Withdrawal by Subject|4|||
44253943|NCT00989573|79095023|FG001|Overall Study|Withdrawal by Subject|7|||
44148588|NCT02606877|78938160|FG000|Overall Study|Adverse Event|3|||
44253944|NCT00989573|79095024|FG002|Overall Study|Withdrawal by Subject|3|||
44253945|NCT04126213|79095098|FG000|Overall Study|Lost to Follow-up|9|||
44412425|NCT00871871|79420314|FG002|Part I|Laboratory abnormality|0|||
44412426|NCT00871871|79420315|FG003|Part I|Laboratory abnormality|0|||
44412427|NCT00871871|79420312|FG000|Part II|Lack of Efficacy|0|||
44412428|NCT00871871|79420313|FG001|Part II|Lack of Efficacy|0|||
44412429|NCT00871871|79420314|FG002|Part II|Lack of Efficacy|1|||
44412430|NCT00871871|79420315|FG003|Part II|Lack of Efficacy|0|||
44412431|NCT00871871|79420312|FG000|Part II|Withdrawal by Subject|0|||
44412432|NCT00871871|79420313|FG001|Part II|Withdrawal by Subject|0|||
44412433|NCT00871871|79420314|FG002|Part II|Withdrawal by Subject|2|||
44412434|NCT00871871|79420315|FG003|Part II|Withdrawal by Subject|1|||
44412435|NCT00871871|79420312|FG000|Part II|Adverse Event|0|||
44412436|NCT00871871|79420313|FG001|Part II|Adverse Event|0|||
44412437|NCT00871871|79420314|FG002|Part II|Adverse Event|1|||
44412438|NCT00871871|79420315|FG003|Part II|Adverse Event|2|||
44412439|NCT00871871|79420312|FG000|Part II|Protocol Violation|0|||
44412440|NCT00871871|79420313|FG001|Part II|Protocol Violation|0|||
44412441|NCT00871871|79420314|FG002|Part II|Protocol Violation|0|||
44412442|NCT00871871|79420315|FG003|Part II|Protocol Violation|1|||
44412443|NCT00849680|79420333|FG000|Overall Study|Adverse Event|0|||
44412444|NCT00849680|79420334|FG001|Overall Study|Adverse Event|0|||
44412445|NCT00849680|79420335|FG002|Overall Study|Adverse Event|0|||
44412446|NCT00849680|79420336|FG003|Overall Study|Adverse Event|0|||
44412447|NCT00849680|79420337|FG004|Overall Study|Adverse Event|0|||
44412448|NCT00849680|79420338|FG005|Overall Study|Adverse Event|0|||
44412449|NCT00849680|79420339|FG006|Overall Study|Adverse Event|2|||
44412450|NCT00849680|79420340|FG007|Overall Study|Adverse Event|0|||
44412451|NCT00849680|79420333|FG000|Overall Study|Lost to Follow-up|7|||
44525255|NCT04342689|79534541|FG001|Overall Study|Withdrawal by Subject|33|||
44525256|NCT04342689|79534540|FG000|Overall Study|Lost to Follow-up|10|||
44525257|NCT04342689|79534541|FG001|Overall Study|Lost to Follow-up|12|||
44525258|NCT04169061|79534549|FG000|Overall Study|Adverse Event|2|||
44525259|NCT04169061|79534549|FG000|Overall Study|Death|1|||
44525260|NCT04169061|79534549|FG000|Overall Study|Withdrawal by Subject|1|||
44525261|NCT04169061|79534549|FG000|Overall Study|Protocol Violation|1|||
44525262|NCT02792218|79534555|FG000|Overall Study|Patient/guardian decision|15|||
44525263|NCT02792218|79534556|FG001|Overall Study|Patient/guardian decision|42|||
44525264|NCT02792218|79534555|FG000|Overall Study|Adverse Event|15|||
44525265|NCT02792218|79534556|FG001|Overall Study|Adverse Event|14|||
44525266|NCT02792218|79534555|FG000|Overall Study|Lost to Follow-up|10|||
44525267|NCT02792218|79534556|FG001|Overall Study|Lost to Follow-up|5|||
44525268|NCT02792218|79534555|FG000|Overall Study|Lack of Efficacy|1|||
44525269|NCT02792218|79534556|FG001|Overall Study|Lack of Efficacy|12|||
44525270|NCT02792218|79534555|FG000|Overall Study|Physician Decision|4|||
44525271|NCT02792218|79534556|FG001|Overall Study|Physician Decision|4|||
44525272|NCT02792218|79534555|FG000|Overall Study|Protocol deviation|3|||
44525273|NCT02792218|79534556|FG001|Overall Study|Protocol deviation|2|||
44525274|NCT02792218|79534555|FG000|Overall Study|New therapy for study indication|0|||
44525275|NCT02792218|79534556|FG001|Overall Study|New therapy for study indication|1|||
44525276|NCT02792218|79534555|FG000|Overall Study|Non-compliance with study treatment|0|||
44525277|NCT02792218|79534556|FG001|Overall Study|Non-compliance with study treatment|1|||
44525278|NCT02792218|79534555|FG000|Overall Study|Pregnancy|1|||
44525279|NCT02792218|79534556|FG001|Overall Study|Pregnancy|0|||
44525280|NCT00153101|79534567|FG000|Overall Study|Lost to Follow-up|14|||
44525281|NCT00153101|79534568|FG001|Overall Study|Lost to Follow-up|14|||
44525282|NCT00153101|79534569|FG002|Overall Study|Lost to Follow-up|12|||
44525283|NCT00153101|79534570|FG003|Overall Study|Lost to Follow-up|5|||
44525284|NCT00153101|79534571|FG004|Overall Study|Lost to Follow-up|5|||
44253946|NCT04126213|79095099|FG001|Overall Study|Lost to Follow-up|1|||
44412452|NCT00849680|79420334|FG001|Overall Study|Lost to Follow-up|3|||
44525285|NCT00153101|79534567|FG000|Overall Study|Withdrawal by Subject|3|||
44525286|NCT00153101|79534568|FG001|Overall Study|Withdrawal by Subject|4|||
44525287|NCT00153101|79534569|FG002|Overall Study|Withdrawal by Subject|3|||
44525288|NCT00153101|79534570|FG003|Overall Study|Withdrawal by Subject|3|||
44525289|NCT00153101|79534571|FG004|Overall Study|Withdrawal by Subject|5|||
44525290|NCT04401579|79534587|FG000|Overall Study|Death|23|||
44525291|NCT04401579|79534588|FG001|Overall Study|Death|36|||
44525292|NCT04401579|79534587|FG000|Overall Study|Lost to Follow-up|40|||
44525293|NCT04401579|79534588|FG001|Overall Study|Lost to Follow-up|41|||
44412453|NCT00849680|79420335|FG002|Overall Study|Lost to Follow-up|12|||
44412454|NCT00849680|79420336|FG003|Overall Study|Lost to Follow-up|11|||
44412455|NCT00849680|79420337|FG004|Overall Study|Lost to Follow-up|8|||
44525294|NCT04401579|79534587|FG000|Overall Study|Withdrawal by Subject|8|||
44525295|NCT04401579|79534588|FG001|Overall Study|Withdrawal by Subject|16|||
44525296|NCT04401579|79534587|FG000|Overall Study|Physician Decision|1|||
44525297|NCT04401579|79534588|FG001|Overall Study|Physician Decision|2|||
44525298|NCT04401579|79534587|FG000|Overall Study|Became ineligible after enrollment|1|||
44525299|NCT04401579|79534588|FG001|Overall Study|Became ineligible after enrollment|1|||
44525300|NCT04401579|79534587|FG000|Overall Study|Enrolled but treatment not administered|7|||
44412456|NCT00849680|79420338|FG005|Overall Study|Lost to Follow-up|11|||
44525301|NCT04401579|79534588|FG001|Overall Study|Enrolled but treatment not administered|9|||
44525302|NCT04401579|79534587|FG000|Overall Study|Adverse Event|2|||
44525303|NCT04401579|79534588|FG001|Overall Study|Adverse Event|1|||
44525304|NCT04401579|79534587|FG000|Overall Study|Scheduling error|1|||
44525305|NCT04401579|79534588|FG001|Overall Study|Scheduling error|2|||
44525306|NCT04401579|79534587|FG000|Overall Study|Transferred to another hospital|1|||
44525307|NCT04401579|79534588|FG001|Overall Study|Transferred to another hospital|2|||
44525308|NCT04161807|79534594|FG000|Overall Study|Withdrawal by Subject|2|||
44525309|NCT04161807|79534594|FG000|Overall Study|Performed only 1 treatment|2|||
44525310|NCT04401423|79534600|FG000|Overall Study|Withdrawal by Subject|3|||
44525311|NCT04401423|79534601|FG001|Overall Study|Withdrawal by Subject|1|||
44525312|NCT04401423|79534600|FG000|Overall Study|Physician Decision|2|||
44525313|NCT04401423|79534601|FG001|Overall Study|Physician Decision|1|||
44525314|NCT04399161|79534612|FG000|Overall Study|Withdrawal by Subject|1|||
44525315|NCT04399161|79534613|FG001|Overall Study|Withdrawal by Subject|0|||
44525316|NCT04399161|79534614|FG002|Overall Study|Withdrawal by Subject|2|||
44525317|NCT04399161|79534612|FG000|Overall Study|Protocol Violation|1|||
44525318|NCT04399161|79534613|FG001|Overall Study|Protocol Violation|2|||
44525319|NCT04399161|79534614|FG002|Overall Study|Protocol Violation|0|||
44525320|NCT02076178|79534624|FG000|Oral Phase|Adverse Event|0|||
44525321|NCT02076178|79534625|FG001|Oral Phase|Adverse Event|7|||
44525322|NCT02076178|79534624|FG000|Oral Phase|Withdrawal by Subject|0|||
44525323|NCT02076178|79534625|FG001|Oral Phase|Withdrawal by Subject|4|||
44525324|NCT02076178|79534624|FG000|Oral Phase|Physician Decision|0|||
44525325|NCT02076178|79534625|FG001|Oral Phase|Physician Decision|1|||
44525326|NCT02076178|79534624|FG000|Injection Phase|Protocol defined stopping criteria|1|||
44253947|NCT04126213|79095100|FG002|Overall Study|Lost to Follow-up|5|||
44253948|NCT04126213|79095101|FG003|Overall Study|Lost to Follow-up|10|||
44253949|NCT04126213|79095102|FG004|Overall Study|Lost to Follow-up|4|||
44525327|NCT02076178|79534625|FG001|Injection Phase|Protocol defined stopping criteria|0|||
44525328|NCT02076178|79534624|FG000|Injection Phase|Withdrawal by Subject|0|||
44525329|NCT02076178|79534625|FG001|Injection Phase|Withdrawal by Subject|3|||
44525330|NCT02076178|79534624|FG000|Injection Phase|Physician Decision|0|||
44525331|NCT02076178|79534625|FG001|Injection Phase|Physician Decision|3|||
44525332|NCT02076178|79534624|FG000|Injection Phase|Lost to Follow-up|0|||
44525333|NCT02076178|79534625|FG001|Injection Phase|Lost to Follow-up|1|||
44525334|NCT00149825|79534635|FG000|Overall Study|Intolerance to medication side effects|1|||
44525335|NCT00149825|79534636|FG001|Overall Study|Intolerance to medication side effects|2|||
44525336|NCT00149825|79534635|FG000|Overall Study|Time commitments|2|||
44525337|NCT00149825|79534636|FG001|Overall Study|Time commitments|1|||
44525338|NCT00149825|79534635|FG000|Overall Study|Not liking insomnia therapy|1|||
44525339|NCT00149825|79534636|FG001|Overall Study|Not liking insomnia therapy|0|||
44525340|NCT00149825|79534635|FG000|Overall Study|Other|1|||
44525341|NCT00149825|79534636|FG001|Overall Study|Other|0|||
44525342|NCT04397757|79534644|FG000|Overall Study|Death|3|||
44525343|NCT04397757|79534645|FG001|Overall Study|Death|11|||
44525344|NCT04397757|79534644|FG000|Overall Study|Withdrawal by Subject|2|||
44525345|NCT04397757|79534645|FG001|Overall Study|Withdrawal by Subject|0|||
44253950|NCT04126213|79095103|FG005|Overall Study|Lost to Follow-up|7|||
44253951|NCT04126213|79095098|FG000|Overall Study|Withdrawal by Subject|3|||
44525346|NCT04397757|79534644|FG000|Overall Study|Lost to Follow-up|4|||
44525347|NCT04397757|79534645|FG001|Overall Study|Lost to Follow-up|3|||
44525348|NCT02792062|79534662|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
44525349|NCT02792062|79534663|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
44525350|NCT02792062|79534664|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
44525351|NCT02792062|79534665|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
44525352|NCT02792062|79534666|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
44525353|NCT02792062|79534667|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
44525354|NCT00196937|79534678|FG000|Overall Study|Serious Adverse Event|1|||
44525355|NCT00196937|79534679|FG001|Overall Study|Serious Adverse Event|0|||
44525356|NCT00196937|79534680|FG002|Overall Study|Serious Adverse Event|0|||
44525357|NCT00196937|79534678|FG000|Overall Study|Non-serious adverse event|1|||
44525358|NCT00196937|79534679|FG001|Overall Study|Non-serious adverse event|1|||
44525359|NCT00196937|79534680|FG002|Overall Study|Non-serious adverse event|1|||
44525360|NCT00196937|79534678|FG000|Overall Study|Withdrawal by Subject|0|||
44525361|NCT00196937|79534679|FG001|Overall Study|Withdrawal by Subject|0|||
44525362|NCT00196937|79534680|FG002|Overall Study|Withdrawal by Subject|2|||
44525363|NCT00196937|79534678|FG000|Overall Study|Lost to Follow-up|4|||
44412457|NCT00849680|79420339|FG006|Overall Study|Lost to Follow-up|12|||
44412458|NCT00849680|79420340|FG007|Overall Study|Lost to Follow-up|5|||
44412459|NCT00849680|79420333|FG000|Overall Study|Subject moved|1|||
44412460|NCT00849680|79420334|FG001|Overall Study|Subject moved|0|||
44412461|NCT00849680|79420335|FG002|Overall Study|Subject moved|3|||
44412462|NCT00849680|79420336|FG003|Overall Study|Subject moved|1|||
44412463|NCT00849680|79420337|FG004|Overall Study|Subject moved|0|||
44412464|NCT00849680|79420338|FG005|Overall Study|Subject moved|2|||
44412465|NCT00849680|79420339|FG006|Overall Study|Subject moved|2|||
44412466|NCT00849680|79420340|FG007|Overall Study|Subject moved|2|||
44412467|NCT00849680|79420333|FG000|Overall Study|Withdrawal by Subject|2|||
44412468|NCT00849680|79420334|FG001|Overall Study|Withdrawal by Subject|0|||
44412469|NCT00849680|79420335|FG002|Overall Study|Withdrawal by Subject|0|||
44412470|NCT00849680|79420336|FG003|Overall Study|Withdrawal by Subject|2|||
44148589|NCT02606877|78938161|FG001|Overall Study|Adverse Event|0|||
44148590|NCT02606877|78938160|FG000|Overall Study|Non-compliance with protocol|0|||
44148591|NCT02606877|78938161|FG001|Overall Study|Non-compliance with protocol|1|||
44148592|NCT02606877|78938160|FG000|Overall Study|Other than listed above|1|||
44412471|NCT00849680|79420337|FG004|Overall Study|Withdrawal by Subject|2|||
44412472|NCT00849680|79420338|FG005|Overall Study|Withdrawal by Subject|2|||
44412473|NCT00849680|79420339|FG006|Overall Study|Withdrawal by Subject|1|||
44412474|NCT00849680|79420340|FG007|Overall Study|Withdrawal by Subject|1|||
44412475|NCT00849680|79420333|FG000|Overall Study|Subject unable to comply with protocol|1|||
44412476|NCT00849680|79420334|FG001|Overall Study|Subject unable to comply with protocol|0|||
44412477|NCT00849680|79420335|FG002|Overall Study|Subject unable to comply with protocol|0|||
44412478|NCT00849680|79420336|FG003|Overall Study|Subject unable to comply with protocol|0|||
44412479|NCT00849680|79420337|FG004|Overall Study|Subject unable to comply with protocol|0|||
44412480|NCT00849680|79420338|FG005|Overall Study|Subject unable to comply with protocol|0|||
44412481|NCT00849680|79420339|FG006|Overall Study|Subject unable to comply with protocol|0|||
44412482|NCT00849680|79420340|FG007|Overall Study|Subject unable to comply with protocol|0|||
44412483|NCT00810342|79420360|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
44412484|NCT00810342|79420361|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
44412485|NCT00810342|79420360|FG000|Month 1 Follow-up|Pregnancy|1|||
44412486|NCT00810342|79420361|FG001|Month 1 Follow-up|Pregnancy|0|||
44412487|NCT00810342|79420360|FG000|6-month Follow-up|Lost to Follow-up|18|||
44412488|NCT00810342|79420361|FG001|6-month Follow-up|Lost to Follow-up|6|||
44412489|NCT00810342|79420360|FG000|6-month Follow-up|Pregnancy|6|||
44412490|NCT00810342|79420361|FG001|6-month Follow-up|Pregnancy|2|||
44412491|NCT00810342|79420360|FG000|12-month Followup|Pregnancy|9|||
44253952|NCT04126213|79095099|FG001|Overall Study|Withdrawal by Subject|2|||
44253953|NCT04126213|79095100|FG002|Overall Study|Withdrawal by Subject|1|||
44412492|NCT00810342|79420361|FG001|12-month Followup|Pregnancy|10|||
44412493|NCT00810342|79420360|FG000|12-month Followup|Lost to Follow-up|3|||
44412494|NCT00810342|79420361|FG001|12-month Followup|Lost to Follow-up|1|||
44412495|NCT00849524|79420369|FG000|Overall Study|Lack of Efficacy|3|||
44525364|NCT00196937|79534679|FG001|Overall Study|Lost to Follow-up|3|||
44525365|NCT00196937|79534680|FG002|Overall Study|Lost to Follow-up|3|||
44525366|NCT00196937|79534678|FG000|Overall Study|Other|3|||
44525367|NCT00196937|79534679|FG001|Overall Study|Other|1|||
44525368|NCT00196937|79534680|FG002|Overall Study|Other|1|||
44525369|NCT04397445|79534689|FG000|Overall Study|Withdrawal by Subject|1|||
44525370|NCT04397445|79534690|FG001|Overall Study|Withdrawal by Subject|0|||
44525371|NCT04397445|79534691|FG002|Overall Study|Withdrawal by Subject|0|||
44412496|NCT00808080|79420373|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
44412497|NCT00866723|79420378|FG000|Overall Study|Withdrawal by Subject|1|||
44412498|NCT00866723|79420378|FG000|Overall Study|Disease Progression|4|||
44412499|NCT00849212|79420382|FG000|Overall Study|Lack of Efficacy|1|||
44412500|NCT00849212|79420382|FG000|Overall Study|Withdrawal by Subject|3|||
44412501|NCT00849212|79420382|FG000|Overall Study|Adverse Event|2|||
44412502|NCT00849212|79420382|FG000|Overall Study|Miscellaneous|1|||
44525372|NCT04397445|79534692|FG003|Overall Study|Withdrawal by Subject|0|||
44253954|NCT04126213|79095101|FG003|Overall Study|Withdrawal by Subject|1|||
44253955|NCT04126213|79095102|FG004|Overall Study|Withdrawal by Subject|1|||
44148593|NCT02606877|78938161|FG001|Overall Study|Other than listed above|0|||
44148594|NCT02606643|78938171|FG000|Overall Study|did not meet inclusion criteria|1|||
44253956|NCT04126213|79095103|FG005|Overall Study|Withdrawal by Subject|1|||
44412503|NCT00810264|79420386|FG000|Overall Study|Lost to Follow-up|191|||
44412504|NCT00810264|79420386|FG000|Overall Study|Withdrawal by subject or physician|721|||
44412505|NCT00810264|79420386|FG000|Overall Study|Death|641|||
44412506|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
44412507|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
44525373|NCT00191945|79534709|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
44412508|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
44412509|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
44412510|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
44412511|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
44412512|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
44412513|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
44412514|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
44412515|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
44412516|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
44412517|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
44412518|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
44412519|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
44412520|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
44412521|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
44412522|NCT00849056|79420396|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
44412523|NCT00849056|79420397|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
44412524|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
44412525|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
44412526|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
44412527|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
44412528|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
44412529|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
44412530|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
44412531|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
44412532|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
44412533|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
44412534|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
44412535|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
44412536|NCT00849056|79420396|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
44412537|NCT00849056|79420397|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
44412538|NCT00837434|79420405|FG000|Overall Study|Physician Decision|3|||
44412539|NCT00837434|79420406|FG001|Overall Study|Physician Decision|0|||
44412540|NCT00837434|79420405|FG000|Overall Study|Lost to Follow-up|1|||
44412541|NCT00837434|79420406|FG001|Overall Study|Lost to Follow-up|1|||
44412542|NCT00837434|79420405|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
44525374|NCT00191945|79534710|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
44525375|NCT00191945|79534709|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
44525376|NCT00191945|79534710|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
44412543|NCT00837434|79420406|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
44412544|NCT00837434|79420405|FG000|Overall Study|Noncompliant|2|||
44412545|NCT00837434|79420406|FG001|Overall Study|Noncompliant|0|||
44412546|NCT00837434|79420405|FG000|Overall Study|Baseline assessments not done in time|1|||
44412547|NCT00837434|79420406|FG001|Overall Study|Baseline assessments not done in time|0|||
44412548|NCT00837434|79420405|FG000|Overall Study|Unable to obtain study drug|1|||
44412549|NCT00837434|79420406|FG001|Overall Study|Unable to obtain study drug|0|||
44412550|NCT00827918|79420415|FG000|Overall Study|Adverse Event|4|||
44412551|NCT00827918|79420416|FG001|Overall Study|Adverse Event|0|||
44412552|NCT00827918|79420417|FG002|Overall Study|Adverse Event|0|||
44412553|NCT00827918|79420415|FG000|Overall Study|Lack of Efficacy|16|||
44412554|NCT00827918|79420416|FG001|Overall Study|Lack of Efficacy|4|||
44412555|NCT00827918|79420417|FG002|Overall Study|Lack of Efficacy|15|||
44412556|NCT00827918|79420415|FG000|Overall Study|Physician Decision|1|||
44412557|NCT00827918|79420416|FG001|Overall Study|Physician Decision|0|||
44412558|NCT00827918|79420417|FG002|Overall Study|Physician Decision|0|||
44525377|NCT00191945|79534709|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
44525378|NCT00191945|79534710|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
44525379|NCT00191945|79534709|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
44525380|NCT00191945|79534710|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
44525381|NCT01369342|79534720|FG000|Overall Study|Withdrawal by Subject|7|||
44525382|NCT01369342|79534721|FG001|Overall Study|Withdrawal by Subject|7|||
44525383|NCT01369342|79534722|FG002|Overall Study|Withdrawal by Subject|2|||
44525384|NCT01369342|79534720|FG000|Overall Study|Lost to Follow-up|5|||
44525385|NCT01369342|79534721|FG001|Overall Study|Lost to Follow-up|2|||
44253957|NCT04126213|79095098|FG000|Overall Study|Other|0|||
44253958|NCT04126213|79095099|FG001|Overall Study|Other|0|||
44253959|NCT04126213|79095100|FG002|Overall Study|Other|2|||
44253960|NCT04126213|79095101|FG003|Overall Study|Other|2|||
44253961|NCT04126213|79095102|FG004|Overall Study|Other|0|||
44253962|NCT04126213|79095103|FG005|Overall Study|Other|1|||
44412559|NCT00827918|79420415|FG000|Overall Study|Pregnancy|0|||
44412560|NCT00827918|79420416|FG001|Overall Study|Pregnancy|1|||
44412561|NCT00827918|79420417|FG002|Overall Study|Pregnancy|0|||
44412562|NCT00827918|79420415|FG000|Overall Study|Progressive Disease|1|||
44412563|NCT00827918|79420416|FG001|Overall Study|Progressive Disease|1|||
44412564|NCT00827918|79420417|FG002|Overall Study|Progressive Disease|0|||
44525386|NCT01369342|79534722|FG002|Overall Study|Lost to Follow-up|1|||
44412565|NCT00827918|79420415|FG000|Overall Study|Protocol Violation|0|||
44412566|NCT00827918|79420416|FG001|Overall Study|Protocol Violation|1|||
44412567|NCT00827918|79420417|FG002|Overall Study|Protocol Violation|0|||
44412568|NCT00827918|79420415|FG000|Overall Study|Withdrawal by Subject|6|||
44412569|NCT00827918|79420416|FG001|Overall Study|Withdrawal by Subject|2|||
44412570|NCT00827918|79420417|FG002|Overall Study|Withdrawal by Subject|6|||
44412571|NCT00813150|79420427|FG000|Treatment Period|Adverse Event|16|||
44412572|NCT00813150|79420428|FG001|Treatment Period|Adverse Event|15|||
44412573|NCT00813150|79420427|FG000|Treatment Period|Death|2|||
44412574|NCT00813150|79420428|FG001|Treatment Period|Death|0|||
44412575|NCT00813150|79420427|FG000|Treatment Period|Progressive disease|1|||
44525387|NCT01369342|79534720|FG000|Overall Study|Not Treated|1|||
44525388|NCT01369342|79534721|FG001|Overall Study|Not Treated|0|||
44525389|NCT01369342|79534722|FG002|Overall Study|Not Treated|0|||
44525390|NCT00191477|79534732|FG000|Overall Study|Tumor Recurrence|49|||
44525391|NCT00191477|79534733|FG001|Overall Study|Tumor Recurrence|48|||
44525392|NCT00191477|79534732|FG000|Overall Study|Death, Study Disease|1|||
44525393|NCT00191477|79534733|FG001|Overall Study|Death, Study Disease|1|||
44525394|NCT00191477|79534732|FG000|Overall Study|Death, Other Cause|3|||
44525395|NCT00191477|79534733|FG001|Overall Study|Death, Other Cause|6|||
44525396|NCT00191477|79534732|FG000|Overall Study|Lost to Follow-up|23|||
44525397|NCT00191477|79534733|FG001|Overall Study|Lost to Follow-up|21|||
44525398|NCT00191477|79534732|FG000|Overall Study|Protocol Violation|1|||
44525399|NCT00191477|79534733|FG001|Overall Study|Protocol Violation|1|||
44525400|NCT00191477|79534732|FG000|Overall Study|Treatment Change|2|||
44525401|NCT00191477|79534733|FG001|Overall Study|Treatment Change|0|||
44525402|NCT00191477|79534732|FG000|Overall Study|Withdrawal by Subject|2|||
44525403|NCT00191477|79534733|FG001|Overall Study|Withdrawal by Subject|0|||
44525404|NCT00191477|79534732|FG000|Overall Study|Other|2|||
44525405|NCT00191477|79534733|FG001|Overall Study|Other|0|||
44525406|NCT00191477|79534732|FG000|Overall Study|Not Eligible|41|||
44525407|NCT00191477|79534733|FG001|Overall Study|Not Eligible|38|||
44525408|NCT00191477|79534732|FG000|Overall Study|Pathological Specimen Lost|1|||
44525409|NCT00191477|79534733|FG001|Overall Study|Pathological Specimen Lost|0|||
44525410|NCT00191477|79534732|FG000|Overall Study|Discontinued Prior to Instillation|13|||
44525411|NCT00191477|79534733|FG001|Overall Study|Discontinued Prior to Instillation|14|||
44412576|NCT00813150|79420428|FG001|Treatment Period|Progressive disease|0|||
44412577|NCT00813150|79420427|FG000|Treatment Period|Complete response|0|||
44412578|NCT00813150|79420428|FG001|Treatment Period|Complete response|1|||
44412579|NCT00813150|79420427|FG000|Treatment Period|Stable disease|1|||
44412580|NCT00813150|79420428|FG001|Treatment Period|Stable disease|2|||
44412581|NCT00813150|79420427|FG000|Treatment Period|Protocol Violation|3|||
44412582|NCT00813150|79420428|FG001|Treatment Period|Protocol Violation|4|||
44412583|NCT00813150|79420427|FG000|Treatment Period|Withdrawal by Subject|5|||
44412584|NCT00813150|79420428|FG001|Treatment Period|Withdrawal by Subject|3|||
44412585|NCT00813150|79420427|FG000|Treatment Period|Non compliance|0|||
44412586|NCT00813150|79420428|FG001|Treatment Period|Non compliance|1|||
44412587|NCT00813150|79420427|FG000|Treatment Period|Reason not specified|3|||
44412588|NCT00813150|79420428|FG001|Treatment Period|Reason not specified|4|||
44412589|NCT00813150|79420427|FG000|Treatment Period|Data not available|1|||
44412590|NCT00813150|79420428|FG001|Treatment Period|Data not available|2|||
44412591|NCT00813150|79420427|FG000|Long Term Follow-up|Death|0|||
44412592|NCT00813150|79420428|FG001|Long Term Follow-up|Death|4|||
44412593|NCT00813150|79420427|FG000|Long Term Follow-up|Other|0|||
44412594|NCT00813150|79420428|FG001|Long Term Follow-up|Other|3|||
44412595|NCT00813150|79420427|FG000|Long Term Follow-up|Lost to Follow-up|2|||
44412596|NCT00813150|79420428|FG001|Long Term Follow-up|Lost to Follow-up|0|||
44412597|NCT00813150|79420427|FG000|Long Term Follow-up|Progression/Relapse|22|||
44525412|NCT04320615|79534741|FG000|Overall Study|Withdrawal by Subject|4|||
44525413|NCT04320615|79534742|FG001|Overall Study|Withdrawal by Subject|10|||
44525414|NCT04320615|79534741|FG000|Overall Study|Physician Decision|2|||
44282218|NCT01862640|79245504|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
44282219|NCT01862640|79245505|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
44412598|NCT00813150|79420428|FG001|Long Term Follow-up|Progression/Relapse|24|||
44412599|NCT00807846|79420436|FG000|Overall Study|Adverse Event|5|||
44525415|NCT04320615|79534742|FG001|Overall Study|Physician Decision|0|||
44525416|NCT04320615|79534741|FG000|Overall Study|Other|2|||
44525417|NCT04320615|79534742|FG001|Overall Study|Other|0|||
44525418|NCT04320615|79534741|FG000|Overall Study|Lost to Follow-up|5|||
44525419|NCT04320615|79534742|FG001|Overall Study|Lost to Follow-up|23|||
44412600|NCT00807846|79420437|FG001|Overall Study|Adverse Event|0|||
44412601|NCT00807846|79420436|FG000|Overall Study|Lack of Efficacy|2|||
44412602|NCT00807846|79420437|FG001|Overall Study|Lack of Efficacy|0|||
44412603|NCT00807846|79420436|FG000|Overall Study|Protocol Violation|2|||
44412604|NCT00807846|79420437|FG001|Overall Study|Protocol Violation|1|||
44412605|NCT00807846|79420436|FG000|Overall Study|Withdrawal by Subject|2|||
44525420|NCT04320615|79534741|FG000|Overall Study|Death|35|||
44525421|NCT04320615|79534742|FG001|Overall Study|Death|71|||
44412606|NCT00807846|79420437|FG001|Overall Study|Withdrawal by Subject|1|||
44412607|NCT00807846|79420436|FG000|Overall Study|Other|1|||
44412608|NCT00807846|79420437|FG001|Overall Study|Other|2|||
44412609|NCT00810108|79420445|FG000|Overall Study|Withdrawal by Subject|1|||
44412610|NCT00810108|79420446|FG001|Overall Study|Withdrawal by Subject|0|||
44412611|NCT00827606|79420453|FG000|Overall Study|Protocol Violation|4|||
44412612|NCT00827606|79420454|FG001|Overall Study|Protocol Violation|3|||
44412613|NCT00827606|79420453|FG000|Overall Study|Lost to Follow-up|3|||
44412614|NCT00827606|79420454|FG001|Overall Study|Lost to Follow-up|1|||
44412615|NCT00827606|79420453|FG000|Overall Study|Withdrawal by Subject|7|||
44412616|NCT00827606|79420454|FG001|Overall Study|Withdrawal by Subject|6|||
44412617|NCT00827606|79420453|FG000|Overall Study|Pregnancy|0|||
44412618|NCT00827606|79420454|FG001|Overall Study|Pregnancy|1|||
44412619|NCT00827606|79420453|FG000|Overall Study|Other|5|||
44412620|NCT00827606|79420454|FG001|Overall Study|Other|13|||
44412621|NCT00827606|79420453|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
44412622|NCT00827606|79420454|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
44412623|NCT00827606|79420453|FG000|Overall Study|Adverse Event|4|||
44412624|NCT00827606|79420454|FG001|Overall Study|Adverse Event|2|||
44412625|NCT00663052|79420468|FG000|Overall Study|Adverse Event|6|||
44412626|NCT00663052|79420469|FG001|Overall Study|Adverse Event|3|||
44412627|NCT00663052|79420468|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
44412628|NCT00663052|79420469|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
44412629|NCT00663052|79420468|FG000|Overall Study|Protocol Violation|1|||
44412630|NCT00663052|79420469|FG001|Overall Study|Protocol Violation|0|||
44412631|NCT00663052|79420468|FG000|Overall Study|Withdrawal by Subject|2|||
44412632|NCT00663052|79420469|FG001|Overall Study|Withdrawal by Subject|5|||
44412633|NCT00663052|79420468|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
44412634|NCT00663052|79420469|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
44412635|NCT00663052|79420468|FG000|Overall Study|Other|0|||
44412636|NCT00663052|79420469|FG001|Overall Study|Other|1|||
44525422|NCT00149747|79534754|FG000|Overall Study|Death|1|||
44525423|NCT00149747|79534755|FG001|Overall Study|Death|0|||
44525424|NCT00149747|79534754|FG000|Overall Study|Withdrawal by Subject|3|||
44525425|NCT00149747|79534755|FG001|Overall Study|Withdrawal by Subject|3|||
44525426|NCT00187889|79534763|FG000|Overall Study|Withdrawal by Subject|6|||
44525427|NCT00187889|79534764|FG001|Overall Study|Withdrawal by Subject|4|||
44525428|NCT00148343|79534773|FG000|Overall Study|Withdrawal by Subject|12|||
44525429|NCT00148343|79534774|FG001|Overall Study|Withdrawal by Subject|7|||
44525430|NCT00148343|79534773|FG000|Overall Study|Physician Decision|3|||
44525431|NCT00148343|79534774|FG001|Overall Study|Physician Decision|4|||
44525432|NCT04150341|79534780|FG000|Overall Study|Physician Decision|0|||
44525433|NCT04150341|79534781|FG001|Overall Study|Physician Decision|0|||
44148595|NCT02606643|78938172|FG001|Overall Study|did not meet inclusion criteria|3|||
44148596|NCT02609607|78938203|FG000|Overall Study|Lost to Follow-up|0|||
44148597|NCT02609607|78938204|FG001|Overall Study|Lost to Follow-up|1|||
44525434|NCT04150341|79534782|FG002|Overall Study|Physician Decision|1|||
44525435|NCT04150341|79534783|FG003|Overall Study|Physician Decision|0|||
44525436|NCT04150341|79534784|FG004|Overall Study|Physician Decision|0|||
44525437|NCT04150341|79534785|FG005|Overall Study|Physician Decision|0|||
44525438|NCT04150341|79534780|FG000|Overall Study|Adverse Event|0|||
44525439|NCT04150341|79534781|FG001|Overall Study|Adverse Event|0|||
44525440|NCT04150341|79534782|FG002|Overall Study|Adverse Event|0|||
44525441|NCT04150341|79534783|FG003|Overall Study|Adverse Event|0|||
44525442|NCT04150341|79534784|FG004|Overall Study|Adverse Event|1|||
44525443|NCT04150341|79534785|FG005|Overall Study|Adverse Event|0|||
44148598|NCT02606253|78938213|FG000|Overall Study|Adverse Event|2|||
44148599|NCT02606253|78938214|FG001|Overall Study|Adverse Event|0|||
44148600|NCT02606253|78938215|FG002|Overall Study|Adverse Event|0|||
44412637|NCT00826748|79420478|FG000|Overall Study|Withdrawal by Subject|0|||
44525444|NCT00148109|79534797|FG000|Overall Study|Lack of Efficacy|10|||
44525445|NCT00148109|79534798|FG001|Overall Study|Lack of Efficacy|18|||
44525446|NCT00148109|79534797|FG000|Overall Study|Adverse Event|0|||
44525447|NCT00148109|79534798|FG001|Overall Study|Adverse Event|2|||
44525448|NCT00148109|79534797|FG000|Overall Study|Withdrawal by Subject|2|||
44525449|NCT00148109|79534798|FG001|Overall Study|Withdrawal by Subject|0|||
44525450|NCT00186485|79534804|FG000|Overall Study|Lost to Follow-up|3|||
44525451|NCT00147251|79534810|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
44525452|NCT00147251|79534811|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
44525453|NCT04390191|79534821|FG000|Overall Study|Withdrawal by Subject|1|||
44525454|NCT04390191|79534822|FG001|Overall Study|Withdrawal by Subject|0|||
44525455|NCT04405076|79534834|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
44525456|NCT04405076|79534835|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
44525457|NCT04405076|79534836|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
44148601|NCT02606253|78938213|FG000|Overall Study|Protocol Violation|2|||
44148602|NCT02606253|78938214|FG001|Overall Study|Protocol Violation|1|||
44412638|NCT00826748|79420479|FG001|Overall Study|Withdrawal by Subject|0|||
44412639|NCT00826748|79420480|FG002|Overall Study|Withdrawal by Subject|2|||
44525458|NCT04405076|79534837|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
44412640|NCT00826748|79420478|FG000|Overall Study|Physician Decision|0|||
44412641|NCT00826748|79420479|FG001|Overall Study|Physician Decision|0|||
44412642|NCT00826748|79420480|FG002|Overall Study|Physician Decision|1|||
44412643|NCT00826748|79420478|FG000|Overall Study|Samples Did Not pass QC|0|||
44412644|NCT00826748|79420479|FG001|Overall Study|Samples Did Not pass QC|0|||
44412645|NCT00826748|79420480|FG002|Overall Study|Samples Did Not pass QC|1|||
44412646|NCT00806988|79420490|FG000|Overall Study|Death|15|||
44412647|NCT00806988|79420491|FG001|Overall Study|Death|16|||
44412648|NCT00806988|79420490|FG000|Overall Study|Withdrawal by Subject|8|||
44412649|NCT00806988|79420491|FG001|Overall Study|Withdrawal by Subject|8|||
44412650|NCT00806988|79420490|FG000|Overall Study|Lost to Follow-up|4|||
44412651|NCT00806988|79420491|FG001|Overall Study|Lost to Follow-up|19|||
44412652|NCT00807144|79420499|FG000|Overall Study|Lost to Follow-up|0|||
44412653|NCT00807144|79420500|FG001|Overall Study|Lost to Follow-up|1|||
44412654|NCT00591006|79420506|FG000|Overall Study|Withdrawal by Subject|0|||
44412655|NCT00591006|79420507|FG001|Overall Study|Withdrawal by Subject|0|||
44412656|NCT00591006|79420508|FG002|Overall Study|Withdrawal by Subject|0|||
44412657|NCT00591006|79420509|FG003|Overall Study|Withdrawal by Subject|0|||
44412658|NCT00591006|79420510|FG004|Overall Study|Withdrawal by Subject|0|||
44412659|NCT00591006|79420511|FG005|Overall Study|Withdrawal by Subject|0|||
44412660|NCT00591006|79420512|FG006|Overall Study|Withdrawal by Subject|0|||
44412661|NCT00591006|79420513|FG007|Overall Study|Withdrawal by Subject|0|||
44412662|NCT00591006|79420514|FG008|Overall Study|Withdrawal by Subject|0|||
44412663|NCT00591006|79420515|FG009|Overall Study|Withdrawal by Subject|0|||
44412664|NCT00591006|79420516|FG010|Overall Study|Withdrawal by Subject|0|||
44412665|NCT00591006|79420517|FG011|Overall Study|Withdrawal by Subject|0|||
44412666|NCT00591006|79420518|FG012|Overall Study|Withdrawal by Subject|0|||
44412667|NCT00591006|79420519|FG013|Overall Study|Withdrawal by Subject|0|||
44412668|NCT00591006|79420520|FG014|Overall Study|Withdrawal by Subject|0|||
44412669|NCT00591006|79420521|FG015|Overall Study|Withdrawal by Subject|1|||
44412670|NCT00591006|79420522|FG016|Overall Study|Withdrawal by Subject|0|||
44412671|NCT00591006|79420523|FG017|Overall Study|Withdrawal by Subject|0|||
44412672|NCT00591006|79420524|FG018|Overall Study|Withdrawal by Subject|0|||
44412673|NCT00591006|79420525|FG019|Overall Study|Withdrawal by Subject|0|||
44412674|NCT00591006|79420526|FG020|Overall Study|Withdrawal by Subject|0|||
44412675|NCT00591006|79420527|FG021|Overall Study|Withdrawal by Subject|0|||
44412676|NCT00591006|79420528|FG022|Overall Study|Withdrawal by Subject|0|||
44412677|NCT00591006|79420529|FG023|Overall Study|Withdrawal by Subject|1|||
44412678|NCT00591006|79420506|FG000|Overall Study|Adverse Event|0|||
44412679|NCT00591006|79420507|FG001|Overall Study|Adverse Event|0|||
44412680|NCT00591006|79420508|FG002|Overall Study|Adverse Event|0|||
44412681|NCT00591006|79420509|FG003|Overall Study|Adverse Event|0|||
44412682|NCT00591006|79420510|FG004|Overall Study|Adverse Event|0|||
44412683|NCT00591006|79420511|FG005|Overall Study|Adverse Event|0|||
44412684|NCT00591006|79420512|FG006|Overall Study|Adverse Event|0|||
44412685|NCT00591006|79420513|FG007|Overall Study|Adverse Event|0|||
44412686|NCT00591006|79420514|FG008|Overall Study|Adverse Event|0|||
44412687|NCT00591006|79420515|FG009|Overall Study|Adverse Event|0|||
44412688|NCT00591006|79420516|FG010|Overall Study|Adverse Event|0|||
44412689|NCT00591006|79420517|FG011|Overall Study|Adverse Event|0|||
44412690|NCT00591006|79420518|FG012|Overall Study|Adverse Event|0|||
44412691|NCT00591006|79420519|FG013|Overall Study|Adverse Event|0|||
44412692|NCT00591006|79420520|FG014|Overall Study|Adverse Event|0|||
44412693|NCT00591006|79420521|FG015|Overall Study|Adverse Event|0|||
44412694|NCT00591006|79420522|FG016|Overall Study|Adverse Event|0|||
44412695|NCT00591006|79420523|FG017|Overall Study|Adverse Event|0|||
44412696|NCT00591006|79420524|FG018|Overall Study|Adverse Event|0|||
44412697|NCT00591006|79420525|FG019|Overall Study|Adverse Event|0|||
44412698|NCT00591006|79420526|FG020|Overall Study|Adverse Event|0|||
44412699|NCT00591006|79420527|FG021|Overall Study|Adverse Event|0|||
44412700|NCT00591006|79420528|FG022|Overall Study|Adverse Event|1|||
44412701|NCT00591006|79420529|FG023|Overall Study|Adverse Event|0|||
44412702|NCT00844844|79420546|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
44412703|NCT00844844|79420546|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
44412704|NCT00844844|79420546|FG000|Extension Treatment Period|Adverse Event|2|||
44412705|NCT00844844|79420546|FG000|Post Treatment Period|Withdrawal by Subject|1|||
44412706|NCT00660790|79420550|FG000|Baseline to 3 Months|Death|1|||
44412707|NCT00660790|79420550|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
44412708|NCT00660790|79420550|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
44412709|NCT00836810|79420556|FG000|Overall Study|New diagnosis|1|||
44148603|NCT02606253|78938215|FG002|Overall Study|Protocol Violation|0|||
44412710|NCT00836810|79420557|FG001|Overall Study|New diagnosis|0|||
44412711|NCT00658684|79420566|FG000|Overall Study|Adverse Event|10|||
44412712|NCT00658684|79420567|FG001|Overall Study|Adverse Event|8|||
44412713|NCT00658684|79420568|FG002|Overall Study|Adverse Event|2|||
44412714|NCT00658684|79420569|FG003|Overall Study|Adverse Event|0|||
44412715|NCT00658684|79420566|FG000|Overall Study|Withdrawal by Subject|6|||
44412716|NCT00658684|79420567|FG001|Overall Study|Withdrawal by Subject|4|||
44412717|NCT00658684|79420568|FG002|Overall Study|Withdrawal by Subject|1|||
44412718|NCT00658684|79420569|FG003|Overall Study|Withdrawal by Subject|1|||
44412719|NCT00658684|79420566|FG000|Overall Study|Lack of Efficacy|1|||
44253963|NCT04126213|79095098|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44253964|NCT04126213|79095099|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
44253965|NCT04126213|79095100|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44253966|NCT04126213|79095101|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44253967|NCT04126213|79095102|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44253968|NCT04126213|79095103|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
44253969|NCT04128319|79095120|FG000|Overall Study|Death|3|||
44412720|NCT00658684|79420567|FG001|Overall Study|Lack of Efficacy|1|||
44412721|NCT00658684|79420568|FG002|Overall Study|Lack of Efficacy|0|||
44412722|NCT00658684|79420569|FG003|Overall Study|Lack of Efficacy|0|||
44412723|NCT00658684|79420566|FG000|Overall Study|Protocol Violation|1|||
44412724|NCT00658684|79420567|FG001|Overall Study|Protocol Violation|1|||
44412725|NCT00658684|79420568|FG002|Overall Study|Protocol Violation|0|||
44412726|NCT00658684|79420569|FG003|Overall Study|Protocol Violation|0|||
44412727|NCT00658684|79420566|FG000|Overall Study|Pregnancy|1|||
44412728|NCT00658684|79420567|FG001|Overall Study|Pregnancy|1|||
44412729|NCT00658684|79420568|FG002|Overall Study|Pregnancy|0|||
44412730|NCT00658684|79420569|FG003|Overall Study|Pregnancy|0|||
44412731|NCT00660400|79420579|FG000|Overall Study|Lack of insurance approval|1|||
44412732|NCT00660400|79420579|FG000|Overall Study|Suboptimal organ function|1|||
44412733|NCT00660400|79420579|FG000|Overall Study|Intracranial hemorrhage|1|||
44412734|NCT00660400|79420579|FG000|Overall Study|Withdrawal by Subject|1|||
44412735|NCT00826514|79420585|FG000|Overall Study|Adverse Event|1|||
44412736|NCT00826514|79420586|FG001|Overall Study|Adverse Event|1|||
44412737|NCT00826514|79420585|FG000|Overall Study|Lack of Efficacy|0|||
44412738|NCT00826514|79420586|FG001|Overall Study|Lack of Efficacy|1|||
44412739|NCT00826514|79420585|FG000|Overall Study|Withdrawal by Subject|2|||
44412740|NCT00826514|79420586|FG001|Overall Study|Withdrawal by Subject|3|||
44412741|NCT00826280|79420595|FG000|Overall Study|Randomized but drug not received|1|||
44412742|NCT00826280|79420596|FG001|Overall Study|Randomized but drug not received|0|||
44412743|NCT00826280|79420597|FG002|Overall Study|Randomized but drug not received|1|||
44412744|NCT00826280|79420595|FG000|Overall Study|Adverse Event|1|||
44412745|NCT00826280|79420596|FG001|Overall Study|Adverse Event|3|||
44412746|NCT00826280|79420597|FG002|Overall Study|Adverse Event|0|||
44412747|NCT00826280|79420595|FG000|Overall Study|Lost to Follow-up|0|||
44412748|NCT00826280|79420596|FG001|Overall Study|Lost to Follow-up|1|||
44412749|NCT00826280|79420597|FG002|Overall Study|Lost to Follow-up|0|||
44412750|NCT00826280|79420595|FG000|Overall Study|Sponsor discontinued subject or study|1|||
44412751|NCT00826280|79420596|FG001|Overall Study|Sponsor discontinued subject or study|0|||
44412752|NCT00826280|79420597|FG002|Overall Study|Sponsor discontinued subject or study|0|||
44412753|NCT00826280|79420595|FG000|Overall Study|Reversible ischemic defect not present|43|||
44412754|NCT00826280|79420596|FG001|Overall Study|Reversible ischemic defect not present|40|||
44412755|NCT00826280|79420597|FG002|Overall Study|Reversible ischemic defect not present|44|||
44412756|NCT00826280|79420595|FG000|Overall Study|Interpretation Failure|1|||
44412757|NCT00826280|79420596|FG001|Overall Study|Interpretation Failure|0|||
44412758|NCT00826280|79420597|FG002|Overall Study|Interpretation Failure|0|||
44412759|NCT00826280|79420595|FG000|Overall Study|Machine Failure|1|||
44412760|NCT00826280|79420596|FG001|Overall Study|Machine Failure|1|||
44412761|NCT00826280|79420597|FG002|Overall Study|Machine Failure|0|||
44412762|NCT00826280|79420595|FG000|Overall Study|One or more non-interpretable scan|0|||
44412763|NCT00826280|79420596|FG001|Overall Study|One or more non-interpretable scan|1|||
44412764|NCT00826280|79420597|FG002|Overall Study|One or more non-interpretable scan|1|||
44412765|NCT00864851|79420608|FG000|Overall Study|Withdrawal by Subject|0|||
44412766|NCT00864851|79420609|FG001|Overall Study|Withdrawal by Subject|1|||
44412767|NCT00864851|79420610|FG002|Overall Study|Withdrawal by Subject|0|||
44412768|NCT00864851|79420608|FG000|Overall Study|Physician Decision|1|||
44412769|NCT00864851|79420609|FG001|Overall Study|Physician Decision|0|||
44412770|NCT00864851|79420610|FG002|Overall Study|Physician Decision|0|||
44412771|NCT00864851|79420608|FG000|Overall Study|Death|1|||
44412772|NCT00864851|79420609|FG001|Overall Study|Death|0|||
44412773|NCT00864851|79420610|FG002|Overall Study|Death|0|||
44412774|NCT00864851|79420608|FG000|Overall Study|Patient uncooperative|1|||
44412775|NCT00864851|79420609|FG001|Overall Study|Patient uncooperative|0|||
44412776|NCT00864851|79420610|FG002|Overall Study|Patient uncooperative|0|||
44253970|NCT05038293|79095166|FG000|Overall Study|device was not operating properly for one subject.|1|||
44412777|NCT00857207|79420622|FG000|Overall Study|Withdrawal by Subject|13|||
44412778|NCT00857207|79420623|FG001|Overall Study|Withdrawal by Subject|0|||
44525459|NCT04405076|79534838|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
44412779|NCT00857207|79420622|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
44412780|NCT00857207|79420623|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
44412781|NCT00857207|79420622|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
44412782|NCT00857207|79420623|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
44412783|NCT00836498|79420632|FG000|Overall Study|Adverse Event|1|||
44412784|NCT00836498|79420633|FG001|Overall Study|Adverse Event|0|||
44412785|NCT00836498|79420632|FG000|Overall Study|Lost to Follow-up|1|||
44412786|NCT00836498|79420633|FG001|Overall Study|Lost to Follow-up|0|||
44412787|NCT00836498|79420632|FG000|Overall Study|Withdrawal by Subject|2|||
44412788|NCT00836498|79420633|FG001|Overall Study|Withdrawal by Subject|1|||
44412789|NCT00856973|79420643|FG000|Overall Study|Adverse Event|5|||
44412790|NCT00856973|79420644|FG001|Overall Study|Adverse Event|5|||
44412791|NCT00856973|79420645|FG002|Overall Study|Adverse Event|3|||
44412792|NCT00856973|79420643|FG000|Overall Study|Lost to Follow-up|6|||
44412793|NCT00856973|79420644|FG001|Overall Study|Lost to Follow-up|3|||
44412794|NCT00856973|79420645|FG002|Overall Study|Lost to Follow-up|5|||
44412795|NCT00856973|79420643|FG000|Overall Study|Physician Decision|0|||
44412796|NCT00856973|79420644|FG001|Overall Study|Physician Decision|3|||
44412797|NCT00856973|79420645|FG002|Overall Study|Physician Decision|1|||
44412798|NCT00856973|79420643|FG000|Overall Study|Protocol Violation|1|||
44412799|NCT00856973|79420644|FG001|Overall Study|Protocol Violation|2|||
44412800|NCT00856973|79420645|FG002|Overall Study|Protocol Violation|1|||
44412801|NCT00856973|79420643|FG000|Overall Study|Withdrawal by Subject|13|||
44412802|NCT00856973|79420644|FG001|Overall Study|Withdrawal by Subject|16|||
44525460|NCT04405076|79534839|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
44525461|NCT04405076|79534840|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
44525462|NCT04405076|79534841|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
44525463|NCT04405076|79534842|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
44525464|NCT04405076|79534834|FG000|Part A (Blinded Phase)|Physician Decision|1|||
44525465|NCT04405076|79534835|FG001|Part A (Blinded Phase)|Physician Decision|2|||
44525466|NCT04405076|79534836|FG002|Part A (Blinded Phase)|Physician Decision|0|||
44525467|NCT04405076|79534837|FG003|Part A (Blinded Phase)|Physician Decision|0|||
44525468|NCT04405076|79534838|FG004|Part A (Blinded Phase)|Physician Decision|0|||
44525469|NCT04405076|79534839|FG005|Part A (Blinded Phase)|Physician Decision|0|||
44525470|NCT04405076|79534840|FG006|Part A (Blinded Phase)|Physician Decision|0|||
44525471|NCT04405076|79534841|FG007|Part A (Blinded Phase)|Physician Decision|0|||
44525472|NCT04405076|79534842|FG008|Part A (Blinded Phase)|Physician Decision|0|||
44525473|NCT04405076|79534834|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
44525474|NCT04405076|79534835|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
44525475|NCT04405076|79534836|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
44525476|NCT04405076|79534837|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
44525477|NCT04405076|79534838|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
44525478|NCT04405076|79534839|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
44525479|NCT04405076|79534840|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
44525480|NCT04405076|79534841|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
44525481|NCT04405076|79534842|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
44525482|NCT04405076|79534834|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
44525483|NCT04405076|79534835|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525484|NCT04405076|79534836|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525485|NCT04405076|79534837|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525486|NCT04405076|79534838|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525487|NCT04405076|79534839|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525488|NCT04405076|79534840|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525489|NCT04405076|79534841|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44525490|NCT04405076|79534842|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
44412803|NCT00856973|79420645|FG002|Overall Study|Withdrawal by Subject|15|||
44412804|NCT00856973|79420643|FG000|Overall Study|Other|11|||
44412805|NCT00856973|79420644|FG001|Overall Study|Other|12|||
44412806|NCT00856973|79420645|FG002|Overall Study|Other|13|||
44412807|NCT00844532|79420657|FG000|Overall Study|Death|16|||
44412808|NCT00844532|79420657|FG000|Overall Study|Withdrawal by Subject|16|||
44525491|NCT04405076|79534834|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
44525492|NCT04405076|79534835|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
44525493|NCT04405076|79534836|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44525494|NCT04405076|79534837|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44525495|NCT04405076|79534838|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44525496|NCT04405076|79534839|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44525497|NCT04405076|79534840|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44525498|NCT04405076|79534841|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44148604|NCT02606253|78938213|FG000|Overall Study|Physician Decision|1|||
44412809|NCT00844532|79420657|FG000|Overall Study|Lost to Follow-up|7|||
44412810|NCT00805194|79420663|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
44412811|NCT00805194|79420664|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
44412812|NCT00805194|79420663|FG000|Overall Study|Worsening or AE of underlying disease|64|||
44525499|NCT04405076|79534842|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
44525500|NCT04405076|79534834|FG000|Part A (Blinded Phase)|Other than Specified|0|||
44525501|NCT04405076|79534835|FG001|Part A (Blinded Phase)|Other than Specified|0|||
44148605|NCT02606253|78938214|FG001|Overall Study|Physician Decision|1|||
44148606|NCT02606253|78938215|FG002|Overall Study|Physician Decision|0|||
44148607|NCT02607735|78938225|FG000|Primary Study|Randomized but Never Treated|1|||
44148608|NCT02607735|78938226|FG001|Primary Study|Randomized but Never Treated|0|||
44148609|NCT02607735|78938227|FG002|Primary Study|Randomized but Never Treated|0|||
44148610|NCT02607735|78938225|FG000|Primary Study|Lost to Follow-up|4|||
44148611|NCT02607735|78938226|FG001|Primary Study|Lost to Follow-up|0|||
44148612|NCT02607735|78938227|FG002|Primary Study|Lost to Follow-up|0|||
44148613|NCT02607735|78938225|FG000|Primary Study|Withdrew Consent|2|||
44148614|NCT02607735|78938226|FG001|Primary Study|Withdrew Consent|0|||
44148615|NCT02607735|78938227|FG002|Primary Study|Withdrew Consent|0|||
44148616|NCT02607735|78938225|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
44148617|NCT02607735|78938226|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
44148618|NCT02607735|78938227|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
44148619|NCT02607735|78938225|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
44148620|NCT02607735|78938226|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
44148621|NCT02607735|78938227|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
44148622|NCT04772313|78938235|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
44148623|NCT04772313|78938235|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
44148624|NCT01668537|78938242|FG000|Overall Study|Request to Discontinue Prematurely|1|||
44148625|NCT01668537|78938243|FG001|Overall Study|Request to Discontinue Prematurely|1|||
44148626|NCT01668537|78938242|FG000|Overall Study|Subject unwilling/unable to comply|5|||
44148627|NCT01668537|78938243|FG001|Overall Study|Subject unwilling/unable to comply|0|||
44148628|NCT01668537|78938242|FG000|Overall Study|Reason Precludes Participation|1|||
44148629|NCT01668537|78938243|FG001|Overall Study|Reason Precludes Participation|0|||
44148630|NCT01668537|78938242|FG000|Overall Study|Lost to Follow-up|13|||
44148631|NCT01668537|78938243|FG001|Overall Study|Lost to Follow-up|6|||
44148632|NCT01668537|78938242|FG000|Overall Study|Other|2|||
44148633|NCT01668537|78938243|FG001|Overall Study|Other|3|||
44148634|NCT01668147|78938249|FG000|Overall Study|Withdrawal by Subject|6|||
44148635|NCT02600559|78938266|FG000|Overall Study|Withdrawal by Subject|3|||
44148636|NCT02600559|78938266|FG000|Overall Study|Lost to Follow-up|20|||
44148637|NCT02601573|78938275|FG000|Overall Study|Lost to Follow-up|0|||
44148638|NCT02601573|78938276|FG001|Overall Study|Lost to Follow-up|3|||
44148639|NCT02601573|78938277|FG002|Overall Study|Lost to Follow-up|1|||
44148640|NCT02601573|78938278|FG003|Overall Study|Lost to Follow-up|0|||
44148641|NCT02601573|78938279|FG004|Overall Study|Lost to Follow-up|2|||
44148642|NCT02601573|78938275|FG000|Overall Study|Withdrawal by Subject|0|||
44148643|NCT02601573|78938276|FG001|Overall Study|Withdrawal by Subject|1|||
44148644|NCT02601573|78938277|FG002|Overall Study|Withdrawal by Subject|0|||
44148645|NCT02601573|78938278|FG003|Overall Study|Withdrawal by Subject|1|||
44148646|NCT02601573|78938279|FG004|Overall Study|Withdrawal by Subject|0|||
44148647|NCT02601027|78938293|FG000|Registration to Surgery|Withdrawal by Subject|20|||
44148648|NCT02601027|78938294|FG001|Registration to Surgery|Withdrawal by Subject|10|||
44148649|NCT02600871|78938302|FG000|Overall Study|Lost to Follow-up|13|||
44148650|NCT02600871|78938303|FG001|Overall Study|Lost to Follow-up|10|||
44148651|NCT02598297|78938312|FG000|Overall Study|Study terminated by Sponsor|21|||
44148652|NCT02598297|78938313|FG001|Overall Study|Study terminated by Sponsor|23|||
44148653|NCT02598297|78938312|FG000|Overall Study|Adverse Event|1|||
44148654|NCT02598297|78938313|FG001|Overall Study|Adverse Event|1|||
44148655|NCT02598297|78938312|FG000|Overall Study|Physician Decision|1|||
44148656|NCT02598297|78938313|FG001|Overall Study|Physician Decision|0|||
44148657|NCT02598297|78938312|FG000|Overall Study|Subject/guardian decision|1|||
44148658|NCT02598297|78938313|FG001|Overall Study|Subject/guardian decision|0|||
44148659|NCT02598297|78938312|FG000|Overall Study|Followed for survival|1|||
44148660|NCT02598297|78938313|FG001|Overall Study|Followed for survival|0|||
44148661|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
44253971|NCT05038293|79095167|FG001|Overall Study|device was not operating properly for one subject.|0|||
44253972|NCT05038293|79095166|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
44148662|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
44253973|NCT05038293|79095167|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
44148663|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
44148664|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
44148665|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
44148666|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
44253974|NCT04753164|79095184|FG000|Overall Study|Adverse Event|0|||
44525502|NCT04405076|79534836|FG002|Part A (Blinded Phase)|Other than Specified|3|||
44148667|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
44148668|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
44148669|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
44525503|NCT04405076|79534837|FG003|Part A (Blinded Phase)|Other than Specified|0|||
44525504|NCT04405076|79534838|FG004|Part A (Blinded Phase)|Other than Specified|0|||
44525505|NCT04405076|79534839|FG005|Part A (Blinded Phase)|Other than Specified|0|||
44253975|NCT04753164|79095185|FG001|Overall Study|Adverse Event|2|||
44412813|NCT00805194|79420664|FG001|Overall Study|Worsening or AE of underlying disease|70|||
44412814|NCT00805194|79420663|FG000|Overall Study|Other AE|84|||
44412815|NCT00805194|79420664|FG001|Overall Study|Other AE|73|||
44412816|NCT00805194|79420663|FG000|Overall Study|Protocol Violation|9|||
44525506|NCT04405076|79534840|FG006|Part A (Blinded Phase)|Other than Specified|0|||
44525507|NCT04405076|79534841|FG007|Part A (Blinded Phase)|Other than Specified|0|||
44525508|NCT04405076|79534842|FG008|Part A (Blinded Phase)|Other than Specified|0|||
44525509|NCT04405076|79534834|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
44525510|NCT04405076|79534835|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
44525511|NCT04405076|79534836|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
44525512|NCT04405076|79534837|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
44525513|NCT04405076|79534838|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
44412817|NCT00805194|79420664|FG001|Overall Study|Protocol Violation|9|||
44412818|NCT00805194|79420663|FG000|Overall Study|Lost to Follow-up|5|||
44412819|NCT00805194|79420664|FG001|Overall Study|Lost to Follow-up|5|||
44412820|NCT00805194|79420663|FG000|Overall Study|Withdrawal by Subject|60|||
44412821|NCT00805194|79420664|FG001|Overall Study|Withdrawal by Subject|42|||
44412822|NCT00805194|79420663|FG000|Overall Study|Not treated|3|||
44412823|NCT00805194|79420664|FG001|Overall Study|Not treated|4|||
44412824|NCT00805194|79420663|FG000|Overall Study|Reasons other than stated above|20|||
44412825|NCT00805194|79420664|FG001|Overall Study|Reasons other than stated above|16|||
44412826|NCT00836186|79420675|FG000|Overall Study|Blood could not be drawn|1|||
44412827|NCT00657046|79420683|FG000|Overall Study|Adverse Event|1|||
44412828|NCT00657046|79420684|FG001|Overall Study|Adverse Event|1|||
44525514|NCT04405076|79534839|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
44525515|NCT04405076|79534840|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
44525516|NCT04405076|79534841|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
44525517|NCT04405076|79534842|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
44525518|NCT04405076|79534834|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44525519|NCT04405076|79534835|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44412829|NCT00657046|79420685|FG002|Overall Study|Adverse Event|0|||
44412830|NCT00657046|79420683|FG000|Overall Study|Protocol Violation|2|||
44412831|NCT00657046|79420684|FG001|Overall Study|Protocol Violation|2|||
44412832|NCT00657046|79420685|FG002|Overall Study|Protocol Violation|0|||
44412833|NCT00657046|79420683|FG000|Overall Study|Withdrawal by Subject|1|||
44412834|NCT00657046|79420684|FG001|Overall Study|Withdrawal by Subject|0|||
44412835|NCT00657046|79420685|FG002|Overall Study|Withdrawal by Subject|0|||
44412836|NCT00657046|79420683|FG000|Overall Study|Death|0|||
44412837|NCT00657046|79420684|FG001|Overall Study|Death|0|||
44412838|NCT00657046|79420685|FG002|Overall Study|Death|1|||
44412839|NCT00657046|79420683|FG000|Overall Study|Surgery|0|||
44412840|NCT00657046|79420684|FG001|Overall Study|Surgery|0|||
44412841|NCT00657046|79420685|FG002|Overall Study|Surgery|1|||
44525520|NCT04405076|79534836|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44525521|NCT04405076|79534837|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44525522|NCT04405076|79534838|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
44525523|NCT04405076|79534839|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44525524|NCT04405076|79534840|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44525525|NCT04405076|79534841|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44412842|NCT00856661|79420695|FG000|Overall Study|Death|15|||
44412843|NCT00856661|79420696|FG001|Overall Study|Death|18|||
44412844|NCT00856661|79420695|FG000|Overall Study|Protocol Violation|2|||
44412845|NCT00856661|79420696|FG001|Overall Study|Protocol Violation|1|||
44412846|NCT00856661|79420695|FG000|Overall Study|Withdrawal by Subject|1|||
44412847|NCT00856661|79420696|FG001|Overall Study|Withdrawal by Subject|2|||
44412848|NCT00856661|79420695|FG000|Overall Study|Lost to Follow-up|1|||
44412849|NCT00856661|79420696|FG001|Overall Study|Lost to Follow-up|3|||
44412850|NCT00856661|79420695|FG000|Overall Study|Physician Judgement|8|||
44412851|NCT00856661|79420696|FG001|Overall Study|Physician Judgement|5|||
44412852|NCT00844376|79420702|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
44412853|NCT00844376|79420703|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
44412854|NCT00658606|79420711|FG000|Overall Study|Adverse Event|2|||
44412855|NCT00658606|79420712|FG001|Overall Study|Adverse Event|1|||
44412856|NCT00658606|79420711|FG000|Overall Study|Lack of Efficacy|6|||
44412857|NCT00658606|79420712|FG001|Overall Study|Lack of Efficacy|3|||
44412858|NCT00658606|79420711|FG000|Overall Study|Lost to Follow-up|1|||
44412859|NCT00658606|79420712|FG001|Overall Study|Lost to Follow-up|0|||
44412860|NCT00658606|79420711|FG000|Overall Study|Withdrawal by Subject|7|||
44412861|NCT00658606|79420712|FG001|Overall Study|Withdrawal by Subject|16|||
44282220|NCT01862640|79245502|FG000|Overall Study|Withdrawal by Subject|2|||
44282221|NCT01862640|79245503|FG001|Overall Study|Withdrawal by Subject|4|||
44282222|NCT01862640|79245504|FG002|Overall Study|Withdrawal by Subject|8|||
44282223|NCT01862640|79245505|FG003|Overall Study|Withdrawal by Subject|5|||
44282224|NCT01862640|79245502|FG000|Overall Study|Protocol Deviation|0|||
44282225|NCT01862640|79245503|FG001|Overall Study|Protocol Deviation|0|||
44282226|NCT01862640|79245504|FG002|Overall Study|Protocol Deviation|1|||
44282227|NCT01862640|79245505|FG003|Overall Study|Protocol Deviation|0|||
44282228|NCT01902966|79245514|FG000|Overall Study|Death|1|||
44282229|NCT01902966|79245514|FG000|Overall Study|Physician Decision|1|||
44282230|NCT01902966|79245514|FG000|Overall Study|Withdrawal by Subject|1|||
44282231|NCT01862484|79245520|FG000|Overall Study|Lack of Efficacy|1|||
44282232|NCT01862484|79245521|FG001|Overall Study|Lack of Efficacy|1|||
44282233|NCT01862484|79245520|FG000|Overall Study|Lost to Follow-up|1|||
44282234|NCT01862484|79245521|FG001|Overall Study|Lost to Follow-up|2|||
44282235|NCT01862484|79245520|FG000|Overall Study|Protocol Violation|0|||
44282236|NCT01862484|79245521|FG001|Overall Study|Protocol Violation|2|||
44282237|NCT01862484|79245520|FG000|Overall Study|Withdrawal by Subject|0|||
44282238|NCT01862484|79245521|FG001|Overall Study|Withdrawal by Subject|3|||
44282239|NCT01902888|79245527|FG000|Overall Study|Study Terminated|3|||
44412862|NCT00658606|79420711|FG000|Overall Study|Lack of Compliance|0|||
44412863|NCT00658606|79420712|FG001|Overall Study|Lack of Compliance|3|||
44412864|NCT00589290|79420718|FG000|Overall Study|Withdrawal by Subject|1|||
44412865|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
44412866|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
44412867|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Death|0|||
44412868|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Death|1|||
44412869|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
44412870|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
44412871|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
44412872|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
44412873|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
44412874|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
44412875|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
44412876|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
44412877|NCT00843518|79420726|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
44412878|NCT00843518|79420727|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
44412879|NCT00843284|79420737|FG000|Overall Study|Adverse Event|39|||
44412880|NCT00843284|79420737|FG000|Overall Study|Lack of Efficacy|5|||
44412881|NCT00843284|79420737|FG000|Overall Study|Lost to Follow-up|11|||
44525526|NCT04405076|79534842|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
44253976|NCT04753164|79095184|FG000|Overall Study|Withdrawal by Subject|9|||
44253977|NCT04753164|79095185|FG001|Overall Study|Withdrawal by Subject|7|||
44253978|NCT04753164|79095184|FG000|Overall Study|Lost to Follow-up|6|||
44253979|NCT04753164|79095185|FG001|Overall Study|Lost to Follow-up|6|||
44253980|NCT04753164|79095184|FG000|Overall Study|Other|12|||
44253981|NCT04753164|79095185|FG001|Overall Study|Other|5|||
44253982|NCT04729101|79095193|FG000|Overall Study|Adverse Event|1|||
44253983|NCT04729101|79095194|FG001|Overall Study|Adverse Event|0|||
44253984|NCT04729101|79095193|FG000|Overall Study|Physician Decision|1|||
44253985|NCT04729101|79095194|FG001|Overall Study|Physician Decision|0|||
44253986|NCT04729101|79095193|FG000|Overall Study|Withdrawal by Subject|1|||
44253987|NCT04729101|79095194|FG001|Overall Study|Withdrawal by Subject|0|||
44253988|NCT04569968|79095220|FG000|Overall Study|Lost to Follow-up|2|||
44253989|NCT04569968|79095221|FG001|Overall Study|Lost to Follow-up|5|||
44253990|NCT04569968|79095220|FG000|Overall Study|Story of head and/or neck surgery|2|||
44253991|NCT04569968|79095221|FG001|Overall Study|Story of head and/or neck surgery|2|||
44253992|NCT04569968|79095220|FG000|Overall Study|Time of stroke onset|8|||
44253993|NCT04569968|79095221|FG001|Overall Study|Time of stroke onset|7|||
44412882|NCT00843284|79420737|FG000|Overall Study|Other|10|||
44412883|NCT00843284|79420737|FG000|Overall Study|Withdrawal by Subject|4|||
44412884|NCT00843284|79420737|FG000|Overall Study|Death|3|||
44412885|NCT00652834|79420754|FG000|Overall Study|Withdrawal by Subject|3|||
44412886|NCT00652834|79420754|FG000|Overall Study|Lost to Follow-up|2|||
44412887|NCT00825812|79420762|FG000|Overall Study|Never entered follow up|0|||
44282240|NCT01862328|79245538|FG000|Overall Study|Progressive Disease|3|||
44282241|NCT01862328|79245539|FG001|Overall Study|Progressive Disease|11|||
44412888|NCT00825812|79420763|FG001|Overall Study|Never entered follow up|0|||
44412889|NCT00825812|79420764|FG002|Overall Study|Never entered follow up|0|||
44412890|NCT00825812|79420765|FG003|Overall Study|Never entered follow up|1|||
44412891|NCT00825812|79420762|FG000|Overall Study|Adverse Event|0|||
44412892|NCT00825812|79420763|FG001|Overall Study|Adverse Event|0|||
44412893|NCT00825812|79420764|FG002|Overall Study|Adverse Event|0|||
44412894|NCT00825812|79420765|FG003|Overall Study|Adverse Event|1|||
44412895|NCT00825812|79420762|FG000|Overall Study|Subject withdrew consent|0|||
44412896|NCT00825812|79420763|FG001|Overall Study|Subject withdrew consent|0|||
44412897|NCT00825812|79420764|FG002|Overall Study|Subject withdrew consent|3|||
44412898|NCT00825812|79420765|FG003|Overall Study|Subject withdrew consent|2|||
44412899|NCT00825812|79420762|FG000|Overall Study|Non-compliance with protocol|0|||
44412900|NCT00825812|79420763|FG001|Overall Study|Non-compliance with protocol|0|||
44412901|NCT00825812|79420764|FG002|Overall Study|Non-compliance with protocol|0|||
44412902|NCT00825812|79420765|FG003|Overall Study|Non-compliance with protocol|1|||
44412903|NCT00825812|79420762|FG000|Overall Study|Administrative|0|||
44412904|NCT00825812|79420763|FG001|Overall Study|Administrative|1|||
44412905|NCT00825812|79420764|FG002|Overall Study|Administrative|3|||
44412906|NCT00825812|79420765|FG003|Overall Study|Administrative|5|||
44412907|NCT00824720|79420778|FG000|Overall Study|failed plug insertion|3|||
44412908|NCT00824720|79420779|FG001|Overall Study|failed plug insertion|1|||
44412909|NCT00824720|79420780|FG002|Overall Study|failed plug insertion|0|||
44412910|NCT00824720|79420778|FG000|Overall Study|Protocol Violation|0|||
44412911|NCT00824720|79420779|FG001|Overall Study|Protocol Violation|0|||
44412912|NCT00824720|79420780|FG002|Overall Study|Protocol Violation|1|||
44412913|NCT03704064|79420790|FG000|Overall Study|Lost to Follow-up|8|||
44412914|NCT03704064|79420791|FG001|Overall Study|Lost to Follow-up|4|||
44412915|NCT03704064|79420790|FG000|Overall Study|Withdrawal by Subject|1|||
44412916|NCT03704064|79420791|FG001|Overall Study|Withdrawal by Subject|1|||
44412917|NCT03704064|79420790|FG000|Overall Study|No longer available for study visits|0|||
44412918|NCT03704064|79420791|FG001|Overall Study|No longer available for study visits|1|||
44412919|NCT03704064|79420790|FG000|Overall Study|Censoring event|1|||
44412920|NCT03704064|79420791|FG001|Overall Study|Censoring event|0|||
44412921|NCT00824564|79420799|FG000|Overall Study|Lost to Follow-up|5|||
44412922|NCT00824564|79420800|FG001|Overall Study|Lost to Follow-up|7|||
44412923|NCT00824564|79420799|FG000|Overall Study|Withdrawal by Subject|1|||
44412924|NCT00824564|79420800|FG001|Overall Study|Withdrawal by Subject|1|||
44412925|NCT00824564|79420799|FG000|Overall Study|Other|1|||
44412926|NCT00824564|79420800|FG001|Overall Study|Other|2|||
44412927|NCT00824564|79420799|FG000|Overall Study|Randomized, but not treated|1|||
44412928|NCT00824564|79420800|FG001|Overall Study|Randomized, but not treated|0|||
44412929|NCT00658528|79420808|FG000|Overall Study|Adverse Event|5|||
44525527|NCT04405076|79534834|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
44525528|NCT04405076|79534835|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
44525529|NCT04405076|79534836|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
44525530|NCT04405076|79534837|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
44525531|NCT04405076|79534838|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
44525532|NCT04405076|79534839|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
44525533|NCT04405076|79534840|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
44525534|NCT04405076|79534841|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
44525535|NCT04405076|79534842|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
44525536|NCT04405076|79534834|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44525537|NCT04405076|79534835|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44525538|NCT04405076|79534836|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44525539|NCT04405076|79534837|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44412930|NCT00658528|79420809|FG001|Overall Study|Adverse Event|7|||
44412931|NCT00658528|79420808|FG000|Overall Study|Lost to Follow-up|14|||
44412932|NCT00658528|79420809|FG001|Overall Study|Lost to Follow-up|22|||
44412933|NCT00658528|79420808|FG000|Overall Study|Withdrawal by Subject|8|||
44412934|NCT00658528|79420809|FG001|Overall Study|Withdrawal by Subject|6|||
44412935|NCT00658528|79420808|FG000|Overall Study|Withdrawal of consent|5|||
44412936|NCT00658528|79420809|FG001|Overall Study|Withdrawal of consent|6|||
44525540|NCT04405076|79534838|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44525541|NCT04405076|79534839|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44412937|NCT00658528|79420808|FG000|Overall Study|Other|8|||
44412938|NCT00658528|79420809|FG001|Overall Study|Other|4|||
44412939|NCT00856583|79420817|FG000|Overall Study|Lack of Efficacy|389|||
44412940|NCT00856583|79420818|FG001|Overall Study|Lack of Efficacy|377|||
44412941|NCT00856583|79420817|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
44412942|NCT00856583|79420818|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
44412943|NCT00856583|79420817|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
44412944|NCT00856583|79420818|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
44525542|NCT04405076|79534840|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
44525543|NCT04405076|79534841|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
44525544|NCT04405076|79534842|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
44525545|NCT04405076|79534834|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44525546|NCT04405076|79534835|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44525547|NCT04405076|79534836|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44525548|NCT04405076|79534837|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44525549|NCT04405076|79534838|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44525550|NCT04405076|79534839|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44525551|NCT04405076|79534840|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
44525552|NCT04405076|79534841|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44253994|NCT04569968|79095220|FG000|Overall Study|Type of strokr|12|||
44253995|NCT04569968|79095221|FG001|Overall Study|Type of strokr|8|||
44412945|NCT00856583|79420817|FG000|Overall Study|Non-compliance|305|||
44253996|NCT04569968|79095220|FG000|Overall Study|Cooperation|8|||
44253997|NCT04569968|79095221|FG001|Overall Study|Cooperation|8|||
44412946|NCT00856583|79420818|FG001|Overall Study|Non-compliance|262|||
44412947|NCT00856583|79420817|FG000|Overall Study|Withdrawal by Subject|1092|||
44412948|NCT00856583|79420818|FG001|Overall Study|Withdrawal by Subject|919|||
44412949|NCT00856583|79420817|FG000|Overall Study|Physician Decision|59|||
44412950|NCT00856583|79420818|FG001|Overall Study|Physician Decision|82|||
44412951|NCT00856583|79420817|FG000|Overall Study|Pregnancy|14|||
44412952|NCT00856583|79420818|FG001|Overall Study|Pregnancy|5|||
44412953|NCT00856583|79420817|FG000|Overall Study|Other|92|||
44412954|NCT00856583|79420818|FG001|Overall Study|Other|104|||
44412955|NCT00856583|79420817|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
44412956|NCT00856583|79420818|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
44412957|NCT00856349|79420824|FG000|Overall Study|Death|418|||
44412958|NCT00856349|79420824|FG000|Overall Study|Withdrawal by Subject|116|||
44412959|NCT00856349|79420824|FG000|Overall Study|Lost to Follow-up|91|||
44412960|NCT00856349|79420824|FG000|Overall Study|Protocol Violation|38|||
44412961|NCT00856349|79420824|FG000|Overall Study|Physician Decision|13|||
44412962|NCT00856349|79420824|FG000|Overall Study|Subject relocation|104|||
44412963|NCT00856349|79420824|FG000|Overall Study|Device explant|33|||
44412964|NCT00856349|79420824|FG000|Overall Study|Site closure|78|||
44412965|NCT00856349|79420824|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
44412966|NCT00803244|79420832|FG000|Overall Study|Adverse Event|1|||
44412967|NCT00803244|79420833|FG001|Overall Study|Adverse Event|2|||
44412968|NCT00803244|79420832|FG000|Overall Study|Withdrawal by Subject|2|||
44412969|NCT00803244|79420833|FG001|Overall Study|Withdrawal by Subject|3|||
44412970|NCT00803244|79420832|FG000|Overall Study|Any other reason not above-mentioned|4|||
44412971|NCT00803244|79420833|FG001|Overall Study|Any other reason not above-mentioned|10|||
44412972|NCT00804570|79420841|FG000|Overall Study|Adverse Event|14|||
44412973|NCT00804570|79420842|FG001|Overall Study|Adverse Event|7|||
44412974|NCT00804570|79420841|FG000|Overall Study|Lack of Efficacy|0|||
44412975|NCT00804570|79420842|FG001|Overall Study|Lack of Efficacy|1|||
44412976|NCT00804570|79420841|FG000|Overall Study|Lost to Follow-up|18|||
44412977|NCT00804570|79420842|FG001|Overall Study|Lost to Follow-up|21|||
44412978|NCT00804570|79420841|FG000|Overall Study|Entry criteria not met|5|||
44412979|NCT00804570|79420842|FG001|Overall Study|Entry criteria not met|5|||
44412980|NCT00804570|79420841|FG000|Overall Study|Protocol Violation|12|||
44412981|NCT00804570|79420842|FG001|Overall Study|Protocol Violation|16|||
44412982|NCT00804570|79420841|FG000|Overall Study|Physician Decision|1|||
44412983|NCT00804570|79420842|FG001|Overall Study|Physician Decision|2|||
44412984|NCT00804570|79420841|FG000|Overall Study|Sponsor decision|1|||
44412985|NCT00804570|79420842|FG001|Overall Study|Sponsor decision|4|||
44412986|NCT00804570|79420841|FG000|Overall Study|Withdrawal by Subject|21|||
44412987|NCT00804570|79420842|FG001|Overall Study|Withdrawal by Subject|38|||
44412988|NCT00824408|79420854|FG000|Run-in Phase|Progressive disease|4|||
44412989|NCT00824408|79420855|FG001|Run-in Phase|Progressive disease|4|||
44412990|NCT00824408|79420856|FG002|Run-in Phase|Progressive disease|0|||
44253998|NCT04569968|79095220|FG000|Overall Study|Age interval|17|||
44412991|NCT00824408|79420857|FG003|Run-in Phase|Progressive disease|0|||
44412992|NCT00824408|79420858|FG004|Run-in Phase|Progressive disease|0|||
44412993|NCT00824408|79420854|FG000|Run-in Phase|Adverse Event|1|||
44412994|NCT00824408|79420855|FG001|Run-in Phase|Adverse Event|1|||
44412995|NCT00824408|79420856|FG002|Run-in Phase|Adverse Event|0|||
44412996|NCT00824408|79420857|FG003|Run-in Phase|Adverse Event|0|||
44525553|NCT04405076|79534842|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
44253999|NCT04569968|79095221|FG001|Overall Study|Age interval|6|||
44412997|NCT00824408|79420858|FG004|Run-in Phase|Adverse Event|0|||
44412998|NCT00824408|79420854|FG000|Run-in Phase|Refused to continue medication|1|||
44412999|NCT00824408|79420855|FG001|Run-in Phase|Refused to continue medication|0|||
44413000|NCT00824408|79420856|FG002|Run-in Phase|Refused to continue medication|0|||
44413001|NCT00824408|79420857|FG003|Run-in Phase|Refused to continue medication|0|||
44413002|NCT00824408|79420858|FG004|Run-in Phase|Refused to continue medication|0|||
44254000|NCT04569968|79095220|FG000|Overall Study|Denial of participation to the study|0|||
44254001|NCT04569968|79095221|FG001|Overall Study|Denial of participation to the study|3|||
44254002|NCT04569968|79095220|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
44254003|NCT04569968|79095221|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
44254004|NCT04569968|79095220|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
44254005|NCT04569968|79095221|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
44254006|NCT04569968|79095220|FG000|Overall Study|Quarantine|1|||
44254007|NCT04569968|79095221|FG001|Overall Study|Quarantine|0|||
44254008|NCT04569968|79095220|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
44254009|NCT04569968|79095221|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
44254010|NCT04569968|79095220|FG000|Overall Study|Repetitive stroke|8|||
44254011|NCT04569968|79095221|FG001|Overall Study|Repetitive stroke|0|||
44254012|NCT04569968|79095220|FG000|Overall Study|Insufficient mastication|1|||
44254013|NCT04569968|79095221|FG001|Overall Study|Insufficient mastication|0|||
44254014|NCT04569968|79095220|FG000|Overall Study|Infection|1|||
44254015|NCT04569968|79095221|FG001|Overall Study|Infection|0|||
44282242|NCT01862328|79245540|FG002|Overall Study|Progressive Disease|5|||
44282243|NCT01862328|79245541|FG003|Overall Study|Progressive Disease|6|||
44282244|NCT01862328|79245542|FG004|Overall Study|Progressive Disease|7|||
44525554|NCT04311177|79534870|FG000|Overall Study|Adverse Event|3|||
44525555|NCT04311177|79534871|FG001|Overall Study|Adverse Event|1|||
44525556|NCT04311177|79534870|FG000|Overall Study|Physician Decision|4|||
44525557|NCT04311177|79534871|FG001|Overall Study|Physician Decision|3|||
44525558|NCT04311177|79534870|FG000|Overall Study|Withdrawal by Subject|1|||
44525559|NCT04311177|79534871|FG001|Overall Study|Withdrawal by Subject|0|||
44525560|NCT03267212|79534877|FG000|First Intervention|Lost to Follow-up|0|||
44525561|NCT03267212|79534878|FG001|First Intervention|Lost to Follow-up|2|||
44525562|NCT03267212|79534877|FG000|First Intervention|Withdrawal by Subject|1|||
44525563|NCT03267212|79534878|FG001|First Intervention|Withdrawal by Subject|1|||
44525564|NCT03267212|79534877|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
44525565|NCT03267212|79534878|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
44525566|NCT04292535|79534898|FG000|Overall Study|Withdrawal by Subject|0|||
44525567|NCT04292535|79534899|FG001|Overall Study|Withdrawal by Subject|0|||
44525568|NCT04292535|79534900|FG002|Overall Study|Withdrawal by Subject|0|||
44282245|NCT01862328|79245543|FG005|Overall Study|Progressive Disease|4|||
44282246|NCT01862328|79245544|FG006|Overall Study|Progressive Disease|3|||
44282247|NCT01862328|79245538|FG000|Overall Study|Adverse Event|0|||
44525569|NCT04292535|79534901|FG003|Overall Study|Withdrawal by Subject|0|||
44525570|NCT04292535|79534902|FG004|Overall Study|Withdrawal by Subject|0|||
44525571|NCT04292535|79534903|FG005|Overall Study|Withdrawal by Subject|0|||
44525572|NCT04292535|79534904|FG006|Overall Study|Withdrawal by Subject|0|||
44525573|NCT04292535|79534905|FG007|Overall Study|Withdrawal by Subject|1|||
44525574|NCT04292535|79534906|FG008|Overall Study|Withdrawal by Subject|0|||
44525575|NCT04292535|79534907|FG009|Overall Study|Withdrawal by Subject|0|||
44525576|NCT04292535|79534908|FG010|Overall Study|Withdrawal by Subject|0|||
44525577|NCT04292535|79534909|FG011|Overall Study|Withdrawal by Subject|0|||
44525578|NCT04292535|79534910|FG012|Overall Study|Withdrawal by Subject|0|||
44525579|NCT04292535|79534911|FG013|Overall Study|Withdrawal by Subject|0|||
44525580|NCT04292535|79534898|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525581|NCT04292535|79534899|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525582|NCT04292535|79534900|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44282248|NCT01862328|79245539|FG001|Overall Study|Adverse Event|4|||
44282249|NCT01862328|79245540|FG002|Overall Study|Adverse Event|0|||
44282250|NCT01862328|79245541|FG003|Overall Study|Adverse Event|1|||
44282251|NCT01862328|79245542|FG004|Overall Study|Adverse Event|0|||
44282252|NCT01862328|79245543|FG005|Overall Study|Adverse Event|2|||
44525583|NCT04292535|79534901|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44282253|NCT01862328|79245544|FG006|Overall Study|Adverse Event|4|||
44282254|NCT01862328|79245538|FG000|Overall Study|Other|0|||
44282255|NCT01862328|79245539|FG001|Overall Study|Other|2|||
44282256|NCT01862328|79245540|FG002|Overall Study|Other|1|||
44525584|NCT04292535|79534902|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44282257|NCT01862328|79245541|FG003|Overall Study|Other|0|||
44282258|NCT01862328|79245542|FG004|Overall Study|Other|4|||
44282259|NCT01862328|79245543|FG005|Overall Study|Other|0|||
44254016|NCT03385304|79095229|FG000|Overall Study|Death|19|||
44254017|NCT03385304|79095230|FG001|Overall Study|Death|7|||
44254018|NCT03385304|79095229|FG000|Overall Study|Lost to Follow-up|17|||
44254019|NCT03385304|79095230|FG001|Overall Study|Lost to Follow-up|14|||
44254020|NCT03385304|79095229|FG000|Overall Study|Withdrawal by Subject|3|||
44254021|NCT03385304|79095230|FG001|Overall Study|Withdrawal by Subject|2|||
44254022|NCT03385304|79095229|FG000|Overall Study|Incarceration|2|||
44254023|NCT03385304|79095230|FG001|Overall Study|Incarceration|3|||
44254024|NCT03325608|79095240|FG000|Overall Study|Lost to Follow-up|47|||
44254025|NCT03325608|79095241|FG001|Overall Study|Lost to Follow-up|47|||
44254026|NCT03325608|79095242|FG002|Overall Study|Lost to Follow-up|41|||
44254027|NCT03325608|79095243|FG003|Overall Study|Lost to Follow-up|41|||
44413003|NCT00824408|79420854|FG000|Run-in Phase|Other reason not defined above|0|||
44413004|NCT00824408|79420855|FG001|Run-in Phase|Other reason not defined above|1|||
44413005|NCT00824408|79420856|FG002|Run-in Phase|Other reason not defined above|0|||
44413006|NCT00824408|79420857|FG003|Run-in Phase|Other reason not defined above|0|||
44413007|NCT00824408|79420858|FG004|Run-in Phase|Other reason not defined above|0|||
44413008|NCT00824408|79420854|FG000|Randomized Phase|Not treated|0|||
44413009|NCT00824408|79420855|FG001|Randomized Phase|Not treated|0|||
44413010|NCT00824408|79420856|FG002|Randomized Phase|Not treated|1|||
44413011|NCT00824408|79420857|FG003|Randomized Phase|Not treated|1|||
44413012|NCT00824408|79420858|FG004|Randomized Phase|Not treated|1|||
44413013|NCT00824408|79420854|FG000|Randomized Phase|Progressive disease|0|||
44413014|NCT00824408|79420855|FG001|Randomized Phase|Progressive disease|0|||
44413015|NCT00824408|79420856|FG002|Randomized Phase|Progressive disease|25|||
44413016|NCT00824408|79420857|FG003|Randomized Phase|Progressive disease|36|||
44413017|NCT00824408|79420858|FG004|Randomized Phase|Progressive disease|34|||
44413018|NCT00824408|79420854|FG000|Randomized Phase|Adverse Event|0|||
44413019|NCT00824408|79420855|FG001|Randomized Phase|Adverse Event|0|||
44413020|NCT00824408|79420856|FG002|Randomized Phase|Adverse Event|4|||
44413021|NCT00824408|79420857|FG003|Randomized Phase|Adverse Event|5|||
44413022|NCT00824408|79420858|FG004|Randomized Phase|Adverse Event|5|||
44413023|NCT00824408|79420854|FG000|Randomized Phase|Refused to continue medication|0|||
44525585|NCT04292535|79534903|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525586|NCT04292535|79534904|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525587|NCT04292535|79534905|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
44525588|NCT04292535|79534906|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525589|NCT04292535|79534907|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525590|NCT04292535|79534908|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525591|NCT04292535|79534909|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
44525592|NCT04292535|79534910|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
44525593|NCT04292535|79534911|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
44525594|NCT04292535|79534898|FG000|Overall Study|Report of Dizziness|0|||
44254028|NCT03325608|79095240|FG000|Overall Study|Death|44|||
44413024|NCT00824408|79420855|FG001|Randomized Phase|Refused to continue medication|0|||
44413025|NCT00824408|79420856|FG002|Randomized Phase|Refused to continue medication|2|||
44413026|NCT00824408|79420857|FG003|Randomized Phase|Refused to continue medication|2|||
44413027|NCT00824408|79420858|FG004|Randomized Phase|Refused to continue medication|2|||
44413028|NCT00824408|79420854|FG000|Randomized Phase|Other reason not defined above|0|||
44413029|NCT00824408|79420855|FG001|Randomized Phase|Other reason not defined above|0|||
44413030|NCT00824408|79420856|FG002|Randomized Phase|Other reason not defined above|4|||
44413031|NCT00824408|79420857|FG003|Randomized Phase|Other reason not defined above|2|||
44413032|NCT00824408|79420858|FG004|Randomized Phase|Other reason not defined above|4|||
44413033|NCT00866333|79420879|FG000|Overall Study|Withdrawal of consent|0|||
44413034|NCT00866333|79420880|FG001|Overall Study|Withdrawal of consent|1|||
44413035|NCT00866333|79420881|FG002|Overall Study|Withdrawal of consent|2|||
44413036|NCT00866333|79420879|FG000|Overall Study|Reason not Specified|3|||
44413037|NCT00866333|79420880|FG001|Overall Study|Reason not Specified|1|||
44413038|NCT00866333|79420881|FG002|Overall Study|Reason not Specified|1|||
44525595|NCT04292535|79534899|FG001|Overall Study|Report of Dizziness|0|||
44525596|NCT04292535|79534900|FG002|Overall Study|Report of Dizziness|0|||
44525597|NCT04292535|79534901|FG003|Overall Study|Report of Dizziness|0|||
44525598|NCT04292535|79534902|FG004|Overall Study|Report of Dizziness|0|||
44525599|NCT04292535|79534903|FG005|Overall Study|Report of Dizziness|0|||
44254029|NCT03325608|79095241|FG001|Overall Study|Death|0|||
44254030|NCT03325608|79095242|FG002|Overall Study|Death|41|||
44254031|NCT03325608|79095243|FG003|Overall Study|Death|0|||
44413039|NCT00866333|79420879|FG000|Overall Study|Study Terminated by Sponsor|2|||
44254032|NCT03325608|79095240|FG000|Overall Study|Death of Care Recipient|0|||
44413040|NCT00866333|79420880|FG001|Overall Study|Study Terminated by Sponsor|5|||
44413041|NCT00866333|79420881|FG002|Overall Study|Study Terminated by Sponsor|9|||
44413042|NCT00834080|79420889|FG000|Overall Study|Adverse Event|7|||
44413043|NCT00834080|79420889|FG000|Overall Study|Lost to Follow-up|7|||
44413044|NCT00834080|79420889|FG000|Overall Study|Withdrawal by Subject|5|||
44413045|NCT00834080|79420889|FG000|Overall Study|Other - Pregnancy|1|||
44413046|NCT00834080|79420889|FG000|Overall Study|Other - False positive tests of the UDS|1|||
44413047|NCT00834080|79420889|FG000|Overall Study|Physician Decision|1|||
44413048|NCT00834080|79420889|FG000|Overall Study|Subject Relocated|1|||
44525600|NCT04292535|79534904|FG006|Overall Study|Report of Dizziness|0|||
44525601|NCT04292535|79534905|FG007|Overall Study|Report of Dizziness|0|||
44525602|NCT04292535|79534906|FG008|Overall Study|Report of Dizziness|0|||
44148670|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
44254033|NCT03325608|79095241|FG001|Overall Study|Death of Care Recipient|44|||
44254034|NCT03325608|79095242|FG002|Overall Study|Death of Care Recipient|0|||
44413049|NCT00823472|79420895|FG000|Overall Study|Physician Decision|24|||
44413050|NCT00823472|79420896|FG001|Overall Study|Physician Decision|28|||
44413051|NCT00856193|79420902|FG000|Period 2|Abnormal test procedure results|0|||
44413052|NCT00856193|79420903|FG001|Period 2|Abnormal test procedure results|1|||
44413053|NCT00856193|79420902|FG000|Period 2|Lost to Follow-up|0|||
44413054|NCT00856193|79420903|FG001|Period 2|Lost to Follow-up|1|||
44413055|NCT00652366|79420914|FG000|Overall Study|Adverse Event|8|||
44413056|NCT00652366|79420915|FG001|Overall Study|Adverse Event|4|||
44413057|NCT00652366|79420916|FG002|Overall Study|Adverse Event|7|||
44413058|NCT00652366|79420917|FG003|Overall Study|Adverse Event|17|||
44413059|NCT00652366|79420918|FG004|Overall Study|Adverse Event|13|||
44413060|NCT00652366|79420914|FG000|Overall Study|Death|5|||
44413061|NCT00652366|79420915|FG001|Overall Study|Death|4|||
44413062|NCT00652366|79420916|FG002|Overall Study|Death|1|||
44413063|NCT00652366|79420917|FG003|Overall Study|Death|8|||
44413064|NCT00652366|79420918|FG004|Overall Study|Death|5|||
44413065|NCT00652366|79420914|FG000|Overall Study|Lack of Efficacy|84|||
44413066|NCT00652366|79420915|FG001|Overall Study|Lack of Efficacy|58|||
44413067|NCT00652366|79420916|FG002|Overall Study|Lack of Efficacy|53|||
44413068|NCT00652366|79420917|FG003|Overall Study|Lack of Efficacy|133|||
44413069|NCT00652366|79420918|FG004|Overall Study|Lack of Efficacy|13|||
44413070|NCT00652366|79420914|FG000|Overall Study|Violation of Selection Criteria|0|||
44413071|NCT00652366|79420915|FG001|Overall Study|Violation of Selection Criteria|0|||
44413072|NCT00652366|79420916|FG002|Overall Study|Violation of Selection Criteria|1|||
44413073|NCT00652366|79420917|FG003|Overall Study|Violation of Selection Criteria|0|||
44413074|NCT00652366|79420918|FG004|Overall Study|Violation of Selection Criteria|0|||
44413075|NCT00652366|79420914|FG000|Overall Study|Protocol Violation|1|||
44413076|NCT00652366|79420915|FG001|Overall Study|Protocol Violation|0|||
44413077|NCT00652366|79420916|FG002|Overall Study|Protocol Violation|0|||
44413078|NCT00652366|79420917|FG003|Overall Study|Protocol Violation|0|||
44413079|NCT00652366|79420918|FG004|Overall Study|Protocol Violation|0|||
44413080|NCT00652366|79420914|FG000|Overall Study|Refused treatment|3|||
44413081|NCT00652366|79420915|FG001|Overall Study|Refused treatment|7|||
44413082|NCT00652366|79420916|FG002|Overall Study|Refused treatment|6|||
44413083|NCT00652366|79420917|FG003|Overall Study|Refused treatment|17|||
44413084|NCT00652366|79420918|FG004|Overall Study|Refused treatment|5|||
44413085|NCT00652366|79420914|FG000|Overall Study|Other|5|||
44413086|NCT00652366|79420915|FG001|Overall Study|Other|2|||
44413087|NCT00652366|79420916|FG002|Overall Study|Other|3|||
44413088|NCT00652366|79420917|FG003|Overall Study|Other|4|||
44413089|NCT00652366|79420918|FG004|Overall Study|Other|0|||
44413090|NCT00841568|79420932|FG000|Overall Study|Adverse Event|1|||
44413091|NCT00841568|79420932|FG000|Overall Study|Death|1|||
44413092|NCT00841568|79420932|FG000|Overall Study|Withdrawal by Subject|2|||
44413093|NCT00841568|79420932|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
44413094|NCT00855959|79420940|FG000|Overall Study|Adverse Event|2|||
44413095|NCT00855959|79420940|FG000|Overall Study|Lost to Follow-up|2|||
44413096|NCT00855959|79420940|FG000|Overall Study|Withdrawal by Subject|3|||
44413097|NCT00855959|79420940|FG000|Overall Study|Pregnancy|1|||
44413098|NCT00855959|79420940|FG000|Overall Study|Incorrect enrolment|1|||
44413099|NCT00841100|79420944|FG000|Phase 1 (28 Days)|Adverse Event|1|||
44413100|NCT00841100|79420944|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
44413101|NCT00651820|79420948|FG000|Overall Study|Lost to Follow-up|2|||
44413102|NCT00866177|79420954|FG000|Overall Study|Withdrawal by Subject|1|||
44525603|NCT04292535|79534907|FG009|Overall Study|Report of Dizziness|0|||
44525604|NCT04292535|79534908|FG010|Overall Study|Report of Dizziness|0|||
44525605|NCT04292535|79534909|FG011|Overall Study|Report of Dizziness|0|||
44254035|NCT03325608|79095243|FG003|Overall Study|Death of Care Recipient|41|||
44413103|NCT00866177|79420954|FG000|Overall Study|Not Treated|151|||
44413104|NCT00833924|79420958|FG000|Overall Study|Death|21|||
44413105|NCT00833924|79420958|FG000|Overall Study|Conversion|2|||
44413106|NCT00833924|79420958|FG000|Overall Study|Lost to Follow-up|2|||
44413107|NCT00833924|79420958|FG000|Overall Study|Withdrawal by Subject|13|||
44413108|NCT00833924|79420958|FG000|Overall Study|In study follow-up|71|||
44413109|NCT00840086|79420962|FG000|Overall Study|Adverse Event|1|||
44413110|NCT00840086|79420962|FG000|Overall Study|Protocol Violation|2|||
44413111|NCT00840086|79420962|FG000|Overall Study|Lost to Follow-up|1|||
44413112|NCT00822926|79420971|FG000|Second Injection Visit|Lost to Follow-up|1|||
44413113|NCT00822926|79420972|FG001|Second Injection Visit|Lost to Follow-up|0|||
44413114|NCT00822926|79420971|FG000|Second Injection Visit|Withdrawal by Subject|0|||
44525606|NCT04292535|79534910|FG012|Overall Study|Report of Dizziness|0|||
44413115|NCT00822926|79420972|FG001|Second Injection Visit|Withdrawal by Subject|1|||
44525607|NCT04292535|79534911|FG013|Overall Study|Report of Dizziness|1|||
44525608|NCT04292535|79534898|FG000|Overall Study|Equipment Failure|0|||
44525609|NCT04292535|79534899|FG001|Overall Study|Equipment Failure|0|||
44525610|NCT04292535|79534900|FG002|Overall Study|Equipment Failure|0|||
44525611|NCT04292535|79534901|FG003|Overall Study|Equipment Failure|0|||
44525612|NCT04292535|79534902|FG004|Overall Study|Equipment Failure|0|||
44525613|NCT04292535|79534903|FG005|Overall Study|Equipment Failure|0|||
44525614|NCT04292535|79534904|FG006|Overall Study|Equipment Failure|0|||
44525615|NCT04292535|79534905|FG007|Overall Study|Equipment Failure|0|||
44525616|NCT04292535|79534906|FG008|Overall Study|Equipment Failure|0|||
44525617|NCT04292535|79534907|FG009|Overall Study|Equipment Failure|0|||
44525618|NCT04292535|79534908|FG010|Overall Study|Equipment Failure|0|||
44525619|NCT04292535|79534909|FG011|Overall Study|Equipment Failure|1|||
44525620|NCT04292535|79534910|FG012|Overall Study|Equipment Failure|0|||
44413116|NCT00822770|79420983|FG000|Overall Study|Not treated|1|||
44413117|NCT00822770|79420984|FG001|Overall Study|Not treated|0|||
44413118|NCT00822770|79420983|FG000|Overall Study|Complication/Incomplete treatment|1|||
44413119|NCT00822770|79420984|FG001|Overall Study|Complication/Incomplete treatment|0|||
44413120|NCT00822770|79420983|FG000|Overall Study|Death|1|||
44413121|NCT00822770|79420984|FG001|Overall Study|Death|1|||
44413122|NCT00822692|79420992|FG000|Overall Study|Lost to Follow-up|17|||
44413123|NCT00822692|79420993|FG001|Overall Study|Lost to Follow-up|25|||
44413124|NCT00806442|79420999|FG000|Overall Study|Lost to Follow-up|3|||
44413125|NCT00806442|79421000|FG001|Overall Study|Lost to Follow-up|2|||
44413126|NCT00806442|79420999|FG000|Overall Study|Withdrawal by Subject|1|||
44413127|NCT00806442|79421000|FG001|Overall Study|Withdrawal by Subject|5|||
44413128|NCT00821678|79421010|FG000|Overall Study|Withdrawal by Subject|8|||
44413129|NCT00821678|79421011|FG001|Overall Study|Withdrawal by Subject|0|||
44413130|NCT00821678|79421010|FG000|Overall Study|Lost to Follow-up|13|||
44413131|NCT00821678|79421011|FG001|Overall Study|Lost to Follow-up|12|||
44413132|NCT00821678|79421010|FG000|Overall Study|Death|0|||
44413133|NCT00821678|79421011|FG001|Overall Study|Death|2|||
44413134|NCT00839852|79421019|FG000|Overall Study|Adverse Event|10|||
44413135|NCT00839852|79421019|FG000|Overall Study|Insufficient Therapeutic Response|3|||
44413136|NCT00839852|79421019|FG000|Overall Study|Protocol Violation|9|||
44413137|NCT00839852|79421019|FG000|Overall Study|Withdrawal of Consent|16|||
44413138|NCT00839852|79421019|FG000|Overall Study|Lost to Follow-up|7|||
44413139|NCT00839852|79421019|FG000|Overall Study|Lack of Compliance While in Jail|1|||
44413140|NCT00839852|79421019|FG000|Overall Study|Pregnancy|1|||
44413141|NCT00833690|79421026|FG000|Overall Study|Withdrawal by Subject|1|||
44413142|NCT00833690|79421027|FG001|Overall Study|Withdrawal by Subject|0|||
44413143|NCT00833690|79421028|FG002|Overall Study|Withdrawal by Subject|0|||
44413144|NCT00833690|79421026|FG000|Overall Study|Discontinued study drug|3|||
44413145|NCT00833690|79421027|FG001|Overall Study|Discontinued study drug|2|||
44413146|NCT00833690|79421028|FG002|Overall Study|Discontinued study drug|0|||
44413147|NCT00820898|79421036|FG000|Overall Study|Inelgible - wrong primary site|1|||
44413148|NCT00865709|79421048|FG000|Treatment|Adverse Event|9|||
44413149|NCT00865709|79421049|FG001|Treatment|Adverse Event|6|||
44413150|NCT00865709|79421048|FG000|Treatment|Withdrawal by Subject|10|||
44413151|NCT00865709|79421049|FG001|Treatment|Withdrawal by Subject|7|||
44413152|NCT00865709|79421048|FG000|Treatment|Physician Decision|3|||
44413153|NCT00865709|79421049|FG001|Treatment|Physician Decision|2|||
44413154|NCT00865709|79421048|FG000|Treatment|Surgery|8|||
44413155|NCT00865709|79421049|FG001|Treatment|Surgery|3|||
44413156|NCT00839306|79421059|FG000|Overall Study|Adverse Event|3|||
44413157|NCT00839306|79421060|FG001|Overall Study|Adverse Event|5|||
44413158|NCT00839306|79421059|FG000|Overall Study|Lost to Follow-up|6|||
44413159|NCT00839306|79421060|FG001|Overall Study|Lost to Follow-up|9|||
44413160|NCT00839306|79421059|FG000|Overall Study|Withdrawal by Subject|5|||
44413161|NCT00839306|79421060|FG001|Overall Study|Withdrawal by Subject|7|||
44413162|NCT00839306|79421059|FG000|Overall Study|Lack of Efficacy|5|||
44413163|NCT00839306|79421060|FG001|Overall Study|Lack of Efficacy|4|||
44413164|NCT00839306|79421059|FG000|Overall Study|Other|6|||
44413165|NCT00839306|79421060|FG001|Overall Study|Other|18|||
44413166|NCT00839072|79421067|FG000|First Intervention Period|Withdrawal by Subject|1|||
44525621|NCT04292535|79534911|FG013|Overall Study|Equipment Failure|0|||
44413167|NCT00839072|79421068|FG001|First Intervention Period|Withdrawal by Subject|0|||
44413168|NCT00839072|79421067|FG000|First Intervention Period|Adverse Event|1|||
44525622|NCT04385199|79534943|FG000|Overall Study|Withdrawal by Subject|1|||
44413169|NCT00839072|79421068|FG001|First Intervention Period|Adverse Event|1|||
44413170|NCT00839072|79421067|FG000|Second Intervention Period|Withdrawal by Subject|1|||
44413171|NCT00839072|79421068|FG001|Second Intervention Period|Withdrawal by Subject|0|||
44413172|NCT00855803|79421074|FG000|Overall Study|Death|2|||
44413173|NCT00855803|79421074|FG000|Overall Study|Lost to Follow-up|2|||
44413174|NCT00855803|79421074|FG000|Overall Study|Technical inability to undergo procedure|2|||
44413175|NCT00855803|79421074|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
44525623|NCT04385199|79534944|FG001|Overall Study|Withdrawal by Subject|0|||
44525624|NCT04284813|79534950|FG000|Overall Study|Withdrawal by Subject|1|||
44525625|NCT03263780|79534954|FG000|Overall Study|Withdrawal by Subject|3|||
44254036|NCT03325608|79095240|FG000|Overall Study|Withdrawal by Subject|44|||
44254037|NCT03325608|79095241|FG001|Overall Study|Withdrawal by Subject|44|||
44254038|NCT03325608|79095242|FG002|Overall Study|Withdrawal by Subject|30|||
44254039|NCT03325608|79095243|FG003|Overall Study|Withdrawal by Subject|30|||
44525626|NCT03263780|79534954|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
44525627|NCT02791438|79534960|FG000|Treatment Period|Adverse Event|1|||
44525628|NCT02791438|79534961|FG001|Treatment Period|Adverse Event|0|||
44525629|NCT02791438|79534960|FG000|Treatment Period|Withdrawal by Subject|0|||
44525630|NCT02791438|79534961|FG001|Treatment Period|Withdrawal by Subject|1|||
44525631|NCT02791438|79534960|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
44525632|NCT02791438|79534961|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
44525633|NCT03712124|79534969|FG000|Overall Study|Protocol Violation|1|||
44525634|NCT03712124|79534970|FG001|Overall Study|Protocol Violation|0|||
44525635|NCT02791516|79534984|FG000|Overall Study|Withdrawal by Subject|1|||
44525636|NCT02791516|79534985|FG001|Overall Study|Withdrawal by Subject|1|||
44525637|NCT03263702|79534993|FG000|Overall Study|Lost to Follow-up|2|||
44525638|NCT03263702|79534994|FG001|Overall Study|Lost to Follow-up|2|||
44525639|NCT03263702|79534993|FG000|Overall Study|Withdrawal by Subject|1|||
44525640|NCT03263702|79534994|FG001|Overall Study|Withdrawal by Subject|2|||
44525641|NCT04130919|79535003|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
44525642|NCT04130919|79535004|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
44525643|NCT04130919|79535005|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
44525644|NCT04130919|79535006|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
44525645|NCT04130919|79535007|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
44525646|NCT04130919|79535008|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
44525647|NCT04130919|79535003|FG000|Blinded Treatment Phase|Adverse Event|0|||
44525648|NCT04130919|79535004|FG001|Blinded Treatment Phase|Adverse Event|0|||
44525649|NCT04130919|79535005|FG002|Blinded Treatment Phase|Adverse Event|1|||
44525650|NCT04130919|79535006|FG003|Blinded Treatment Phase|Adverse Event|0|||
44525651|NCT04130919|79535007|FG004|Blinded Treatment Phase|Adverse Event|0|||
44525652|NCT04130919|79535008|FG005|Blinded Treatment Phase|Adverse Event|0|||
44525653|NCT04130919|79535003|FG000|Blinded Treatment Phase|Disease worsening|0|||
44525654|NCT04130919|79535004|FG001|Blinded Treatment Phase|Disease worsening|0|||
44525655|NCT04130919|79535005|FG002|Blinded Treatment Phase|Disease worsening|1|||
44525656|NCT04130919|79535006|FG003|Blinded Treatment Phase|Disease worsening|0|||
44525657|NCT04130919|79535007|FG004|Blinded Treatment Phase|Disease worsening|0|||
44525658|NCT04130919|79535008|FG005|Blinded Treatment Phase|Disease worsening|0|||
44525659|NCT04130919|79535003|FG000|Blinded Treatment Phase|Investigator's decision|0|||
44525660|NCT04130919|79535004|FG001|Blinded Treatment Phase|Investigator's decision|1|||
44525661|NCT04130919|79535005|FG002|Blinded Treatment Phase|Investigator's decision|0|||
44525662|NCT04130919|79535006|FG003|Blinded Treatment Phase|Investigator's decision|0|||
44525663|NCT04130919|79535007|FG004|Blinded Treatment Phase|Investigator's decision|0|||
44525664|NCT04130919|79535008|FG005|Blinded Treatment Phase|Investigator's decision|0|||
44525665|NCT04130919|79535003|FG000|Blinded Treatment Phase|Withdrew consent|1|||
44525666|NCT04130919|79535004|FG001|Blinded Treatment Phase|Withdrew consent|0|||
44525667|NCT04130919|79535005|FG002|Blinded Treatment Phase|Withdrew consent|0|||
44525668|NCT04130919|79535006|FG003|Blinded Treatment Phase|Withdrew consent|0|||
44525669|NCT04130919|79535007|FG004|Blinded Treatment Phase|Withdrew consent|0|||
44148671|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
44148672|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
44148673|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
44254040|NCT03183141|79095253|FG000|Overall Study|Withdrawal by Subject|2|||
44413176|NCT00855803|79421074|FG000|Overall Study|Withdrawal by Subject|3|||
44525670|NCT04130919|79535008|FG005|Blinded Treatment Phase|Withdrew consent|0|||
44525671|NCT04130919|79535003|FG000|Open-label Treatment Phase|Withdrew consent|0|||
44525672|NCT04130919|79535004|FG001|Open-label Treatment Phase|Withdrew consent|0|||
44525673|NCT04130919|79535005|FG002|Open-label Treatment Phase|Withdrew consent|0|||
44525674|NCT04130919|79535006|FG003|Open-label Treatment Phase|Withdrew consent|1|||
44525675|NCT04130919|79535007|FG004|Open-label Treatment Phase|Withdrew consent|1|||
44525676|NCT04130919|79535008|FG005|Open-label Treatment Phase|Withdrew consent|1|||
44254041|NCT03183141|79095254|FG001|Overall Study|Withdrawal by Subject|4|||
44148674|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
44254042|NCT03183141|79095253|FG000|Overall Study|Death|0|||
44254043|NCT03183141|79095254|FG001|Overall Study|Death|8|||
44254044|NCT02957539|79095263|FG000|Baseline to Week 16|Lost to Follow-up|8|||
44254045|NCT02957539|79095264|FG001|Baseline to Week 16|Lost to Follow-up|10|||
44254046|NCT02957539|79095265|FG002|Baseline to Week 16|Lost to Follow-up|16|||
44254047|NCT02957539|79095263|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
44254048|NCT02957539|79095264|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
44254049|NCT02957539|79095265|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
44254050|NCT02957539|79095263|FG000|Week 16 to 32|Withdrawal by Subject|3|||
44254051|NCT02957539|79095264|FG001|Week 16 to 32|Withdrawal by Subject|3|||
44254052|NCT02957539|79095265|FG002|Week 16 to 32|Withdrawal by Subject|1|||
44282260|NCT01862328|79245544|FG006|Overall Study|Other|1|||
44282261|NCT01862328|79245538|FG000|Overall Study|Withdrawal by Subject|1|||
44413177|NCT00855803|79421074|FG000|Overall Study|Physician Decision|3|||
44413178|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
44413179|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
44282262|NCT01862328|79245539|FG001|Overall Study|Withdrawal by Subject|1|||
44282263|NCT01862328|79245540|FG002|Overall Study|Withdrawal by Subject|0|||
44282264|NCT01862328|79245541|FG003|Overall Study|Withdrawal by Subject|0|||
44148675|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
44254053|NCT02957539|79095263|FG000|Week 16 to 32|Lost to Follow-up|8|||
44254054|NCT02957539|79095264|FG001|Week 16 to 32|Lost to Follow-up|7|||
44254055|NCT02957539|79095265|FG002|Week 16 to 32|Lost to Follow-up|5|||
44282265|NCT01862328|79245542|FG004|Overall Study|Withdrawal by Subject|1|||
44282266|NCT01862328|79245543|FG005|Overall Study|Withdrawal by Subject|1|||
44282267|NCT01862328|79245544|FG006|Overall Study|Withdrawal by Subject|1|||
44282268|NCT01862328|79245538|FG000|Overall Study|Symptomatic Deterioration|0|||
44413180|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
44413181|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
44413182|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
44413183|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
44413184|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
44413185|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
44413186|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
44413187|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
44413188|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
44413189|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
44413190|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
44413191|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
44413192|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
44413193|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
44413194|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Missing|3|||
44413195|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Missing|1|||
44413196|NCT00838916|79421080|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
44413197|NCT00838916|79421081|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
44413198|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
44413199|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
44413200|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
44413201|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
44413202|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
44413203|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
44413204|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
44413205|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
44282269|NCT01862328|79245539|FG001|Overall Study|Symptomatic Deterioration|0|||
44282270|NCT01862328|79245540|FG002|Overall Study|Symptomatic Deterioration|0|||
44282271|NCT01862328|79245541|FG003|Overall Study|Symptomatic Deterioration|0|||
44282272|NCT01862328|79245542|FG004|Overall Study|Symptomatic Deterioration|0|||
44282273|NCT01862328|79245543|FG005|Overall Study|Symptomatic Deterioration|0|||
44282274|NCT01862328|79245544|FG006|Overall Study|Symptomatic Deterioration|1|||
44413206|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
44413207|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
44413208|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
44413209|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
44282275|NCT01862250|79245566|FG000|Overall Study|Adverse Event|4|||
44282276|NCT01860846|79245570|FG000|Overall Study|Lost to Follow-up|33|||
44282277|NCT01901874|79245574|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
44254056|NCT02957539|79095263|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
44413210|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
44413211|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
44413212|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
44413213|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
44413214|NCT00838916|79421080|FG000|Follow-up Period (8 Weeks)|Missing|3|||
44413215|NCT00838916|79421081|FG001|Follow-up Period (8 Weeks)|Missing|0|||
44413216|NCT00838682|79421089|FG000|Overall Study|Lost to Follow-up|21|||
44413217|NCT00838682|79421090|FG001|Overall Study|Lost to Follow-up|14|||
44413218|NCT00838682|79421089|FG000|Overall Study|detection of exclusion criteria|4|||
44413219|NCT00838682|79421090|FG001|Overall Study|detection of exclusion criteria|3|||
44413220|NCT00838682|79421089|FG000|Overall Study|Protocol Violation|0|||
44413221|NCT00838682|79421090|FG001|Overall Study|Protocol Violation|1|||
44413222|NCT00838682|79421089|FG000|Overall Study|Withdrawal by Subject|0|||
44413223|NCT00838682|79421090|FG001|Overall Study|Withdrawal by Subject|1|||
44413224|NCT00820040|79421096|FG000|Overall Study|Death|1|||
44413225|NCT00820040|79421096|FG000|Overall Study|Sponsor terminated study|1|||
44413226|NCT00820040|79421096|FG000|Overall Study|Screen failure|1|||
44413227|NCT00803712|79421102|FG000|Overall Study|Noncompliance|3|||
44413228|NCT00803712|79421103|FG001|Overall Study|Noncompliance|0|||
44413229|NCT00803712|79421102|FG000|Overall Study|Adverse Event|5|||
44413230|NCT00803712|79421103|FG001|Overall Study|Adverse Event|0|||
44413231|NCT00803712|79421102|FG000|Overall Study|Death|8|||
44413232|NCT00803712|79421103|FG001|Overall Study|Death|7|||
44413233|NCT00803712|79421102|FG000|Overall Study|Lost to Follow-up|3|||
44413234|NCT00803712|79421103|FG001|Overall Study|Lost to Follow-up|1|||
44525677|NCT04130919|79535003|FG000|Open-label Treatment Phase|Disease worsening|0|||
44525678|NCT04130919|79535004|FG001|Open-label Treatment Phase|Disease worsening|0|||
44525679|NCT04130919|79535005|FG002|Open-label Treatment Phase|Disease worsening|0|||
44525680|NCT04130919|79535006|FG003|Open-label Treatment Phase|Disease worsening|1|||
44525681|NCT04130919|79535007|FG004|Open-label Treatment Phase|Disease worsening|0|||
44525682|NCT04130919|79535008|FG005|Open-label Treatment Phase|Disease worsening|1|||
44525683|NCT04130919|79535003|FG000|Open-label Treatment Phase|Investigator's decision|0|||
44525684|NCT04130919|79535004|FG001|Open-label Treatment Phase|Investigator's decision|0|||
44525685|NCT04130919|79535005|FG002|Open-label Treatment Phase|Investigator's decision|0|||
44525686|NCT04130919|79535006|FG003|Open-label Treatment Phase|Investigator's decision|1|||
44413235|NCT00803712|79421102|FG000|Overall Study|Withdrawal by Subject|2|||
44413236|NCT00803712|79421103|FG001|Overall Study|Withdrawal by Subject|4|||
44413237|NCT00803712|79421102|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
44413238|NCT00803712|79421103|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
44413239|NCT00803712|79421102|FG000|Overall Study|Protocol criteria (other)|0|||
44413240|NCT00803712|79421103|FG001|Overall Study|Protocol criteria (other)|2|||
44413241|NCT00803712|79421102|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
44525687|NCT04130919|79535007|FG004|Open-label Treatment Phase|Investigator's decision|0|||
44525688|NCT04130919|79535008|FG005|Open-label Treatment Phase|Investigator's decision|0|||
44525689|NCT04130919|79535003|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
44413242|NCT00803712|79421103|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
44413243|NCT00803712|79421102|FG000|Overall Study|Administrative decision|2|||
44413244|NCT00803712|79421103|FG001|Overall Study|Administrative decision|3|||
44413245|NCT00803712|79421102|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
44413246|NCT00803712|79421103|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
44413247|NCT00591344|79421111|FG000|Overall Study|Transportation issues|1|||
44413248|NCT00591344|79421112|FG001|Overall Study|Transportation issues|0|||
44413249|NCT00591344|79421111|FG000|Overall Study|Moved out of state|1|||
44413250|NCT00591344|79421112|FG001|Overall Study|Moved out of state|0|||
44413251|NCT00591344|79421111|FG000|Overall Study|Medical complications|1|||
44413252|NCT00591344|79421112|FG001|Overall Study|Medical complications|3|||
44413253|NCT00591344|79421111|FG000|Overall Study|Underwent DBS|2|||
44413254|NCT00591344|79421112|FG001|Overall Study|Underwent DBS|2|||
44413255|NCT00591344|79421111|FG000|Overall Study|Death|0|||
44413256|NCT00591344|79421112|FG001|Overall Study|Death|1|||
44413257|NCT00591344|79421111|FG000|Overall Study|Lost to Follow-up|0|||
44413258|NCT00591344|79421112|FG001|Overall Study|Lost to Follow-up|1|||
44413259|NCT00591344|79421111|FG000|Overall Study|Did not want to come off medication|0|||
44413260|NCT00591344|79421112|FG001|Overall Study|Did not want to come off medication|1|||
44413261|NCT00803634|79421124|FG000|Overall Study|Withdrew Consent|1|||
44413262|NCT00803634|79421125|FG001|Overall Study|Withdrew Consent|0|||
44413263|NCT00803634|79421124|FG000|Overall Study|Lost to Follow-up|2|||
44413264|NCT00803634|79421125|FG001|Overall Study|Lost to Follow-up|3|||
44413265|NCT00803634|79421124|FG000|Overall Study|Death|3|||
44413266|NCT00803634|79421125|FG001|Overall Study|Death|2|||
44413267|NCT00838526|79421134|FG000|Overall Study|Adverse Event|3|||
44413268|NCT00838526|79421135|FG001|Overall Study|Adverse Event|12|||
44413269|NCT00838526|79421134|FG000|Overall Study|Lost to Follow-up|4|||
44525690|NCT04130919|79535004|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
44525691|NCT04130919|79535005|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
44413270|NCT00838526|79421135|FG001|Overall Study|Lost to Follow-up|12|||
44413271|NCT00838526|79421134|FG000|Overall Study|Withdrawal by Subject|4|||
44413272|NCT00838526|79421135|FG001|Overall Study|Withdrawal by Subject|5|||
44525692|NCT04130919|79535006|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
44525693|NCT04130919|79535007|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
44413273|NCT00838526|79421134|FG000|Overall Study|Lack of Efficacy|2|||
44413274|NCT00838526|79421135|FG001|Overall Study|Lack of Efficacy|3|||
44413275|NCT00838526|79421134|FG000|Overall Study|Other|11|||
44413276|NCT00838526|79421135|FG001|Overall Study|Other|7|||
44525694|NCT04130919|79535008|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
44525695|NCT04130919|79535003|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
44525696|NCT04130919|79535004|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
44525697|NCT04130919|79535005|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
44525698|NCT04130919|79535006|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
44525699|NCT04130919|79535007|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
44525700|NCT04130919|79535008|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
44525701|NCT04128267|79535022|FG000|Overall Study|Withdrawal by Subject|6|||
44525702|NCT04128267|79535022|FG000|Overall Study|Death|2|||
44525703|NCT04128267|79535022|FG000|Overall Study|Disease progression|1|||
44525704|NCT04128267|79535022|FG000|Overall Study|Participant had other medical issues|4|||
44525705|NCT04128267|79535022|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
44525706|NCT03691779|79535026|FG000|Part B (24 Weeks)|Adverse Event|0|||
44525707|NCT03691779|79535027|FG001|Part B (24 Weeks)|Adverse Event|1|||
44525708|NCT03691779|79535026|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
44525709|NCT03691779|79535027|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
44525710|NCT04258995|79535036|FG000|Overall Study|Lost to Follow-up|1|||
44254057|NCT02957539|79095264|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
44413277|NCT00818246|79421154|FG000|Overall Study|Impossible to match pictures|5|||
44413278|NCT00818168|79421158|FG000|Overall Study|Lack of Efficacy|18|||
44413279|NCT00818168|79421158|FG000|Overall Study|Pregnancy|2|||
44254058|NCT02957539|79095265|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
44254059|NCT02957539|79095263|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
44254060|NCT02957539|79095264|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
44254061|NCT02957539|79095265|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
44254062|NCT02690077|79095278|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
44282278|NCT01901874|79245574|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
44413280|NCT00818168|79421158|FG000|Overall Study|Withdrawal by Subject|16|||
44413281|NCT00818168|79421158|FG000|Overall Study|Lost to Follow-up|7|||
44413282|NCT00818168|79421158|FG000|Overall Study|Adverse Event|19|||
44413283|NCT00818168|79421158|FG000|Overall Study|Reason for Non-completion Not reported|6|||
44413284|NCT00818168|79421158|FG000|Overall Study|Participant Moved|2|||
44413285|NCT00817778|79421164|FG000|Overall Study|Adverse Event|1|||
44413286|NCT00817778|79421165|FG001|Overall Study|Adverse Event|0|||
44413287|NCT00817778|79421164|FG000|Overall Study|Withdrawal by Subject|1|||
44413288|NCT00817778|79421165|FG001|Overall Study|Withdrawal by Subject|1|||
44413289|NCT00817778|79421164|FG000|Overall Study|Protocol Violation|0|||
44413290|NCT00817778|79421165|FG001|Overall Study|Protocol Violation|1|||
44413291|NCT00817778|79421164|FG000|Overall Study|Study-specific discontinuation criteria|0|||
44413292|NCT00817778|79421165|FG001|Overall Study|Study-specific discontinuation criteria|1|||
44413293|NCT00817778|79421164|FG000|Overall Study|Poor venous access|1|||
44413294|NCT00817778|79421165|FG001|Overall Study|Poor venous access|0|||
44413295|NCT00813098|79421174|FG000|Overall Study|Adverse Event|2|||
44413296|NCT00813098|79421175|FG001|Overall Study|Adverse Event|4|||
44413297|NCT00813098|79421176|FG002|Overall Study|Adverse Event|1|||
44413298|NCT00813098|79421174|FG000|Overall Study|Withdrawal by Subject|0|||
44413299|NCT00813098|79421175|FG001|Overall Study|Withdrawal by Subject|1|||
44413300|NCT00813098|79421176|FG002|Overall Study|Withdrawal by Subject|0|||
44413301|NCT00813098|79421174|FG000|Overall Study|Inability to complete study procedures|1|||
44413302|NCT00813098|79421175|FG001|Overall Study|Inability to complete study procedures|0|||
44413303|NCT00813098|79421176|FG002|Overall Study|Inability to complete study procedures|0|||
44413304|NCT00813098|79421174|FG000|Overall Study|Lost to Follow-up|0|||
44413305|NCT00813098|79421175|FG001|Overall Study|Lost to Follow-up|1|||
44413306|NCT00813098|79421176|FG002|Overall Study|Lost to Follow-up|0|||
44413307|NCT00813098|79421174|FG000|Overall Study|Protocol Violation|0|||
44413308|NCT00813098|79421175|FG001|Overall Study|Protocol Violation|0|||
44413309|NCT00813098|79421176|FG002|Overall Study|Protocol Violation|1|||
44413310|NCT00813098|79421174|FG000|Overall Study|Principal Investigator decision|0|||
44413311|NCT00813098|79421175|FG001|Overall Study|Principal Investigator decision|1|||
44413312|NCT00813098|79421176|FG002|Overall Study|Principal Investigator decision|0|||
44413313|NCT00813098|79421174|FG000|Overall Study|Withdrew Consent|0|||
44413314|NCT00813098|79421175|FG001|Overall Study|Withdrew Consent|1|||
44413315|NCT00813098|79421176|FG002|Overall Study|Withdrew Consent|0|||
44413316|NCT00796653|79421188|FG000|Overall Study|Adverse Event|19|||
44413317|NCT00796653|79421189|FG001|Overall Study|Adverse Event|16|||
44413318|NCT00796653|79421190|FG002|Overall Study|Adverse Event|16|||
44413319|NCT00796653|79421191|FG003|Overall Study|Adverse Event|16|||
44413320|NCT00796653|79421188|FG000|Overall Study|Lost to Follow-up|2|||
44413321|NCT00796653|79421189|FG001|Overall Study|Lost to Follow-up|1|||
44413322|NCT00796653|79421190|FG002|Overall Study|Lost to Follow-up|2|||
44413323|NCT00796653|79421191|FG003|Overall Study|Lost to Follow-up|3|||
44413324|NCT00796653|79421188|FG000|Overall Study|Withdrawal by Subject|16|||
44413325|NCT00796653|79421189|FG001|Overall Study|Withdrawal by Subject|8|||
44413326|NCT00796653|79421190|FG002|Overall Study|Withdrawal by Subject|8|||
44413327|NCT00796653|79421191|FG003|Overall Study|Withdrawal by Subject|13|||
44413328|NCT00796653|79421188|FG000|Overall Study|Lack of Efficacy|8|||
44413329|NCT00796653|79421189|FG001|Overall Study|Lack of Efficacy|1|||
44413330|NCT00796653|79421190|FG002|Overall Study|Lack of Efficacy|3|||
44525711|NCT04258995|79535037|FG001|Overall Study|Lost to Follow-up|1|||
44525712|NCT04247061|79535043|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
44525713|NCT04247061|79535043|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
44525714|NCT04247061|79535043|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
44525715|NCT04241133|79535049|FG000|Overall Study|COVID19 Precautions|14|||
44525716|NCT04241133|79535050|FG001|Overall Study|COVID19 Precautions|34|||
44525717|NCT04123665|79535058|FG000|Overall Study|Withdrawal by Subject|7|||
44525718|NCT04123665|79535059|FG001|Overall Study|Withdrawal by Subject|0|||
44525719|NCT04123665|79535058|FG000|Overall Study|Lost to Follow-up|1|||
44148676|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
44148677|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
44148678|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
44148679|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
44282279|NCT01901874|79245574|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
44413331|NCT00796653|79421191|FG003|Overall Study|Lack of Efficacy|2|||
44413332|NCT00796653|79421188|FG000|Overall Study|Non compliance with protocol|2|||
44525720|NCT04123665|79535059|FG001|Overall Study|Lost to Follow-up|0|||
44148680|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
44413333|NCT00796653|79421189|FG001|Overall Study|Non compliance with protocol|2|||
44413334|NCT00796653|79421190|FG002|Overall Study|Non compliance with protocol|0|||
44413335|NCT00796653|79421191|FG003|Overall Study|Non compliance with protocol|2|||
44413336|NCT00796653|79421188|FG000|Overall Study|Other reason not described above|4|||
44413337|NCT00796653|79421189|FG001|Overall Study|Other reason not described above|9|||
44413338|NCT00796653|79421190|FG002|Overall Study|Other reason not described above|7|||
44413339|NCT00796653|79421191|FG003|Overall Study|Other reason not described above|4|||
44413340|NCT00806286|79421212|FG000|Overall Study|Adverse Event|5|||
44525721|NCT04232943|79535068|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
44413341|NCT00806286|79421213|FG001|Overall Study|Adverse Event|2|||
44413342|NCT00806286|79421214|FG002|Overall Study|Adverse Event|0|||
44413343|NCT00806286|79421212|FG000|Overall Study|Disease progression|31|||
44413344|NCT00806286|79421213|FG001|Overall Study|Disease progression|38|||
44413345|NCT00806286|79421214|FG002|Overall Study|Disease progression|1|||
44413346|NCT00806286|79421212|FG000|Overall Study|Death|1|||
44413347|NCT00806286|79421213|FG001|Overall Study|Death|6|||
44413348|NCT00806286|79421214|FG002|Overall Study|Death|0|||
44525722|NCT04232943|79535069|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
44525723|NCT04232943|79535070|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
44413349|NCT00806286|79421212|FG000|Overall Study|Lost to Follow-up|0|||
44413350|NCT00806286|79421213|FG001|Overall Study|Lost to Follow-up|1|||
44413351|NCT00806286|79421214|FG002|Overall Study|Lost to Follow-up|0|||
44413352|NCT00806286|79421212|FG000|Overall Study|Withdrawal by Subject|8|||
44413353|NCT00806286|79421213|FG001|Overall Study|Withdrawal by Subject|3|||
44413354|NCT00806286|79421214|FG002|Overall Study|Withdrawal by Subject|1|||
44413355|NCT00806286|79421212|FG000|Overall Study|Physician Decision|2|||
44413356|NCT00806286|79421213|FG001|Overall Study|Physician Decision|2|||
44525724|NCT04232943|79535068|FG000|Overall Study|Withdrawal by Subject|1|||
44525725|NCT04232943|79535069|FG001|Overall Study|Withdrawal by Subject|1|||
44525726|NCT04232943|79535070|FG002|Overall Study|Withdrawal by Subject|0|||
44525727|NCT03694275|79535081|FG000|Overall Study|Adverse Event|0|||
44525728|NCT03694275|79535082|FG001|Overall Study|Adverse Event|1|||
44525729|NCT03694275|79535081|FG000|Overall Study|Reason not Specified|0|||
44525730|NCT03694275|79535082|FG001|Overall Study|Reason not Specified|1|||
44525731|NCT04230213|79535089|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
44525732|NCT04230213|79535090|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
44525733|NCT04230213|79535091|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
44525734|NCT04230213|79535089|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
44525735|NCT04230213|79535090|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
44525736|NCT04230213|79535091|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
44525737|NCT04230213|79535089|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
44525738|NCT04230213|79535090|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
44525739|NCT04230213|79535091|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
44525740|NCT04230213|79535089|FG000|TP2: Week 10 to Week 16|Other|0|||
44525741|NCT04230213|79535090|FG001|TP2: Week 10 to Week 16|Other|2|||
44525742|NCT04230213|79535091|FG002|TP2: Week 10 to Week 16|Other|1|||
44525743|NCT04230213|79535089|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
44525744|NCT04230213|79535090|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
44525745|NCT04230213|79535091|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
44525746|NCT04230213|79535089|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
44148681|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
44413357|NCT00806286|79421214|FG002|Overall Study|Physician Decision|0|||
44413358|NCT00806286|79421212|FG000|Overall Study|Due to a variety of reasons|7|||
44413359|NCT00806286|79421213|FG001|Overall Study|Due to a variety of reasons|2|||
44413360|NCT00806286|79421214|FG002|Overall Study|Due to a variety of reasons|1|||
44413361|NCT00590538|79421222|FG000|Overall Study|Study terminated before completed|2|||
44413362|NCT00796419|79421228|FG000|Overall Study|Death|0|||
44413363|NCT00796419|79421229|FG001|Overall Study|Death|1|||
44413364|NCT00796107|79421235|FG000|Overall Study|Lack of Efficacy|1|||
44413365|NCT00796107|79421235|FG000|Overall Study|Progressive Disease|5|||
44413366|NCT00795951|79421239|FG000|Overall Study|Lost to Follow-up|1|||
44413367|NCT00795951|79421239|FG000|Overall Study|Withdrawal by Subject|1|||
44413368|NCT00795717|79421246|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
44413369|NCT00795717|79421247|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
44413370|NCT00795717|79421246|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
44413371|NCT00795717|79421247|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
44413372|NCT00795717|79421246|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
44525747|NCT04230213|79535090|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
44525748|NCT04230213|79535091|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
44525749|NCT04230213|79535089|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
44148682|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
44148683|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
44148684|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
44282280|NCT01901874|79245574|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
44413373|NCT00795717|79421247|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
44525750|NCT04230213|79535090|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
44525751|NCT04230213|79535091|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
44525752|NCT04230213|79535089|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
44413374|NCT00795717|79421246|FG000|Phase II|too busy|0|||
44148685|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
44413375|NCT00795717|79421247|FG001|Phase II|too busy|1|||
44413376|NCT00805740|79421256|FG000|Overall Study|Death|7|||
44413377|NCT00805740|79421257|FG001|Overall Study|Death|4|||
44413378|NCT00805740|79421256|FG000|Overall Study|Withdrawal by Subject|1|||
44148686|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
44148687|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
44413379|NCT00805740|79421257|FG001|Overall Study|Withdrawal by Subject|0|||
44413380|NCT00805740|79421256|FG000|Overall Study|Lost to Follow-up|1|||
44413381|NCT00805740|79421257|FG001|Overall Study|Lost to Follow-up|0|||
44413382|NCT00805740|79421256|FG000|Overall Study|Randomized, but not treated|2|||
44413383|NCT00805740|79421257|FG001|Overall Study|Randomized, but not treated|0|||
44413384|NCT00795639|79421265|FG000|Overall Study|Death|1|||
44413385|NCT00795639|79421266|FG001|Overall Study|Death|6|||
44413386|NCT00795639|79421265|FG000|Overall Study|Withdrawal by Subject|1|||
44413387|NCT00795639|79421266|FG001|Overall Study|Withdrawal by Subject|3|||
44413388|NCT00795639|79421265|FG000|Overall Study|Pregnancy|1|||
44413389|NCT00795639|79421266|FG001|Overall Study|Pregnancy|0|||
44413390|NCT00795639|79421265|FG000|Overall Study|Adverse Event|5|||
44413391|NCT00795639|79421266|FG001|Overall Study|Adverse Event|2|||
44413392|NCT00795639|79421265|FG000|Overall Study|Other|0|||
44413393|NCT00795639|79421266|FG001|Overall Study|Other|2|||
44413394|NCT00795639|79421265|FG000|Overall Study|Terminated by sponsor|13|||
44413395|NCT00795639|79421266|FG001|Overall Study|Terminated by sponsor|12|||
44413396|NCT00795639|79421265|FG000|Overall Study|Randomized and not treated|0|||
44413397|NCT00795639|79421266|FG001|Overall Study|Randomized and not treated|1|||
44413398|NCT00589602|79421272|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
44413399|NCT00794157|79421281|FG000|Overall Study|Adverse Event|4|||
44413400|NCT00794157|79421282|FG001|Overall Study|Adverse Event|1|||
44413401|NCT00794157|79421283|FG002|Overall Study|Adverse Event|8|||
44413402|NCT00794157|79421281|FG000|Overall Study|Subject withdrew consent|2|||
44413403|NCT00794157|79421282|FG001|Overall Study|Subject withdrew consent|0|||
44413404|NCT00794157|79421283|FG002|Overall Study|Subject withdrew consent|3|||
44413405|NCT00794157|79421281|FG000|Overall Study|Lost to Follow-up|2|||
44413406|NCT00794157|79421282|FG001|Overall Study|Lost to Follow-up|0|||
44413407|NCT00794157|79421283|FG002|Overall Study|Lost to Follow-up|1|||
44413408|NCT00794157|79421281|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44413409|NCT00794157|79421282|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44413410|NCT00794157|79421283|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44413411|NCT00794157|79421281|FG000|Overall Study|Administrative problems|1|||
44413412|NCT00794157|79421282|FG001|Overall Study|Administrative problems|7|||
44413413|NCT00794157|79421283|FG002|Overall Study|Administrative problems|4|||
44413414|NCT00794157|79421281|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44413415|NCT00794157|79421282|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44413416|NCT00794157|79421283|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44413417|NCT00794157|79421281|FG000|Overall Study|Protocol deviation|0|||
44413418|NCT00794157|79421282|FG001|Overall Study|Protocol deviation|1|||
44413419|NCT00794157|79421283|FG002|Overall Study|Protocol deviation|1|||
44413420|NCT00588237|79421291|FG000|Overall Study|Evaluable for toxicity only|3|||
44413421|NCT00588237|79421291|FG000|Overall Study|Patien not treated|1|||
44413422|NCT00790023|79421298|FG000|Overall Study|Adverse Event|2|||
44413423|NCT00790023|79421299|FG001|Overall Study|Adverse Event|1|||
44413424|NCT00790023|79421300|FG002|Overall Study|Adverse Event|4|||
44413425|NCT00790023|79421298|FG000|Overall Study|Protocol Violation|2|||
44413426|NCT00790023|79421299|FG001|Overall Study|Protocol Violation|4|||
44413427|NCT00790023|79421300|FG002|Overall Study|Protocol Violation|2|||
44413428|NCT00790023|79421298|FG000|Overall Study|Withdrawal by Subject|2|||
44413429|NCT00790023|79421299|FG001|Overall Study|Withdrawal by Subject|0|||
44413430|NCT00790023|79421300|FG002|Overall Study|Withdrawal by Subject|6|||
44413431|NCT00790023|79421298|FG000|Overall Study|Lost to Follow-up|0|||
44413432|NCT00790023|79421299|FG001|Overall Study|Lost to Follow-up|0|||
44413433|NCT00790023|79421300|FG002|Overall Study|Lost to Follow-up|1|||
44413434|NCT00790023|79421298|FG000|Overall Study|Other|5|||
44413435|NCT00790023|79421299|FG001|Overall Study|Other|5|||
44413436|NCT00790023|79421300|FG002|Overall Study|Other|8|||
44413437|NCT00588822|79421309|FG000|Overall Study|progression of disease|8|||
44413438|NCT00589914|79421315|FG000|Overall Study|Adverse Event|19|||
44413439|NCT00589914|79421316|FG001|Overall Study|Adverse Event|10|||
44413440|NCT00589914|79421315|FG000|Overall Study|Death|2|||
44413441|NCT00589914|79421316|FG001|Overall Study|Death|0|||
44413442|NCT00589914|79421315|FG000|Overall Study|Lack of Efficacy|40|||
44413443|NCT00589914|79421316|FG001|Overall Study|Lack of Efficacy|43|||
44413444|NCT00589914|79421315|FG000|Overall Study|Lost to Follow-up|11|||
44413445|NCT00589914|79421316|FG001|Overall Study|Lost to Follow-up|18|||
44413446|NCT00589914|79421315|FG000|Overall Study|Pregnancy|1|||
44413447|NCT00589914|79421316|FG001|Overall Study|Pregnancy|0|||
44413448|NCT00589914|79421315|FG000|Overall Study|Withdrawal by Subject|55|||
44413449|NCT00589914|79421316|FG001|Overall Study|Withdrawal by Subject|49|||
44413450|NCT00589914|79421315|FG000|Overall Study|Other|22|||
44413451|NCT00589914|79421316|FG001|Overall Study|Other|17|||
44148688|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
44413452|NCT00789555|79421325|FG000|Overall Study|Protocol Amendment|78|||
44413453|NCT00789555|79421326|FG001|Overall Study|Protocol Amendment|76|||
44413454|NCT00789555|79421327|FG002|Overall Study|Protocol Amendment|80|||
44413455|NCT00789555|79421325|FG000|Overall Study|Adverse Event|17|||
44413456|NCT00789555|79421326|FG001|Overall Study|Adverse Event|7|||
44413457|NCT00789555|79421327|FG002|Overall Study|Adverse Event|10|||
44413458|NCT00789555|79421325|FG000|Overall Study|Lost to Follow-up|9|||
44413459|NCT00789555|79421326|FG001|Overall Study|Lost to Follow-up|10|||
44413460|NCT00789555|79421327|FG002|Overall Study|Lost to Follow-up|18|||
44413461|NCT00789555|79421325|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
44413462|NCT00789555|79421326|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
44413463|NCT00789555|79421327|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
44413464|NCT00789555|79421325|FG000|Overall Study|Treatment failure|11|||
44413465|NCT00789555|79421326|FG001|Overall Study|Treatment failure|8|||
44413466|NCT00789555|79421327|FG002|Overall Study|Treatment failure|12|||
44413467|NCT00789555|79421325|FG000|Overall Study|Protocol Violation|6|||
44413468|NCT00789555|79421326|FG001|Overall Study|Protocol Violation|9|||
44413469|NCT00789555|79421327|FG002|Overall Study|Protocol Violation|13|||
44413470|NCT00451321|79421343|FG000|Overall Study|Lost to Follow-up|3|||
44413471|NCT00451321|79421344|FG001|Overall Study|Lost to Follow-up|3|||
44413472|NCT00451321|79421345|FG002|Overall Study|Lost to Follow-up|1|||
44413473|NCT00451321|79421346|FG003|Overall Study|Lost to Follow-up|3|||
44413474|NCT00451321|79421347|FG004|Overall Study|Lost to Follow-up|0|||
44413475|NCT00451321|79421348|FG005|Overall Study|Lost to Follow-up|1|||
44413476|NCT00451321|79421349|FG006|Overall Study|Lost to Follow-up|0|||
44413477|NCT00451321|79421350|FG007|Overall Study|Lost to Follow-up|0|||
44413478|NCT00451321|79421343|FG000|Overall Study|Withdrawal by Subject|3|||
44254063|NCT02690077|79095279|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
44254064|NCT02690077|79095278|FG000|Overall Study|Withdrawal by Subject|0|||
44254065|NCT02690077|79095279|FG001|Overall Study|Withdrawal by Subject|5|||
44254066|NCT02690077|79095278|FG000|Overall Study|Excluded by IRB|0|||
44254067|NCT02690077|79095279|FG001|Overall Study|Excluded by IRB|2|||
44254068|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Adverse Event|6|||
44254069|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Adverse Event|14|||
44254070|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Death|3|||
44254071|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Death|1|||
44254072|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
44254073|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
44254074|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
44254075|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
44254076|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
44254077|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
44413479|NCT00451321|79421344|FG001|Overall Study|Withdrawal by Subject|1|||
44413480|NCT00451321|79421345|FG002|Overall Study|Withdrawal by Subject|0|||
44413481|NCT00451321|79421346|FG003|Overall Study|Withdrawal by Subject|4|||
44413482|NCT00451321|79421347|FG004|Overall Study|Withdrawal by Subject|0|||
44413483|NCT00451321|79421348|FG005|Overall Study|Withdrawal by Subject|0|||
44413484|NCT00451321|79421349|FG006|Overall Study|Withdrawal by Subject|0|||
44413485|NCT00451321|79421350|FG007|Overall Study|Withdrawal by Subject|0|||
44413486|NCT00451321|79421343|FG000|Overall Study|Study closed/terminated|1|||
44413487|NCT00451321|79421344|FG001|Overall Study|Study closed/terminated|1|||
44413488|NCT00451321|79421345|FG002|Overall Study|Study closed/terminated|17|||
44413489|NCT00451321|79421346|FG003|Overall Study|Study closed/terminated|5|||
44413490|NCT00451321|79421347|FG004|Overall Study|Study closed/terminated|7|||
44525753|NCT04230213|79535090|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
44525754|NCT04230213|79535091|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
44525755|NCT04230213|79535089|FG000|TP3: Week 16 to Week 22|Other|0|||
44525756|NCT04230213|79535090|FG001|TP3: Week 16 to Week 22|Other|1|||
44525757|NCT04230213|79535091|FG002|TP3: Week 16 to Week 22|Other|3|||
44525758|NCT04230213|79535089|FG000|TP4: Week 22 to Week 32|Other|0|||
44525759|NCT04230213|79535090|FG001|TP4: Week 22 to Week 32|Other|5|||
44413491|NCT00451321|79421348|FG005|Overall Study|Study closed/terminated|7|||
44413492|NCT00451321|79421349|FG006|Overall Study|Study closed/terminated|5|||
44413493|NCT00451321|79421350|FG007|Overall Study|Study closed/terminated|3|||
44525760|NCT04230213|79535091|FG002|TP4: Week 22 to Week 32|Other|5|||
44525761|NCT04230213|79535089|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
44254078|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
44254079|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
44282281|NCT01901874|79245574|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
44282282|NCT01901874|79245574|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
44282283|NCT01860534|79245580|FG000|ROP #1|Needed treatment for ROP|0|||
44413494|NCT00451321|79421343|FG000|Overall Study|Sponsor decision to amend protocol|0|||
44413495|NCT00451321|79421344|FG001|Overall Study|Sponsor decision to amend protocol|0|||
44413496|NCT00451321|79421345|FG002|Overall Study|Sponsor decision to amend protocol|0|||
44282284|NCT01860534|79245581|FG001|ROP #1|Needed treatment for ROP|1|||
44413497|NCT00451321|79421346|FG003|Overall Study|Sponsor decision to amend protocol|0|||
44413498|NCT00451321|79421347|FG004|Overall Study|Sponsor decision to amend protocol|0|||
44413499|NCT00451321|79421348|FG005|Overall Study|Sponsor decision to amend protocol|1|||
44413500|NCT00451321|79421349|FG006|Overall Study|Sponsor decision to amend protocol|1|||
44413501|NCT00451321|79421350|FG007|Overall Study|Sponsor decision to amend protocol|3|||
44413502|NCT00802464|79421376|FG000|Month 0 - Month 8|Adverse Event|0|||
44413503|NCT00802464|79421377|FG001|Month 0 - Month 8|Adverse Event|1|||
44413504|NCT00802464|79421378|FG002|Month 0 - Month 8|Adverse Event|1|||
44413505|NCT00802464|79421379|FG003|Month 0 - Month 8|Adverse Event|2|||
44413506|NCT00802464|79421376|FG000|Month 0 - Month 8|Protocol Violation|0|||
44413507|NCT00802464|79421377|FG001|Month 0 - Month 8|Protocol Violation|0|||
44413508|NCT00802464|79421378|FG002|Month 0 - Month 8|Protocol Violation|1|||
44413509|NCT00802464|79421379|FG003|Month 0 - Month 8|Protocol Violation|0|||
44413510|NCT00802464|79421376|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
44413511|NCT00802464|79421377|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
44413512|NCT00802464|79421378|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
44413513|NCT00802464|79421379|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
44413514|NCT00802464|79421376|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
44413515|NCT00802464|79421377|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
44413516|NCT00802464|79421378|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
44413517|NCT00802464|79421379|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
44413518|NCT00802464|79421376|FG000|Month 0 - Month 8|Other|0|||
44413519|NCT00802464|79421377|FG001|Month 0 - Month 8|Other|0|||
44413520|NCT00802464|79421378|FG002|Month 0 - Month 8|Other|1|||
44413521|NCT00802464|79421379|FG003|Month 0 - Month 8|Other|0|||
44413522|NCT00802464|79421376|FG000|Month 8 - Month 14|Adverse Event|0|||
44413523|NCT00802464|79421377|FG001|Month 8 - Month 14|Adverse Event|1|||
44413524|NCT00802464|79421378|FG002|Month 8 - Month 14|Adverse Event|0|||
44413525|NCT00802464|79421379|FG003|Month 8 - Month 14|Adverse Event|0|||
44413526|NCT00802464|79421376|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
44413527|NCT00802464|79421377|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
44413528|NCT00802464|79421378|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
44413529|NCT00802464|79421379|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
44413530|NCT00802464|79421376|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
44413531|NCT00802464|79421377|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
44413532|NCT00802464|79421378|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
44413533|NCT00802464|79421379|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
44413534|NCT00450619|79421393|FG000|Overall Study|refused treatment after randomization|2|||
44413535|NCT00450619|79421394|FG001|Overall Study|refused treatment after randomization|0|||
44413536|NCT00450619|79421393|FG000|Overall Study|did not progress; refused further trmt|1|||
44413537|NCT00450619|79421394|FG001|Overall Study|did not progress; refused further trmt|1|||
44413538|NCT00450619|79421393|FG000|Overall Study|Adverse Event|1|||
44413539|NCT00450619|79421394|FG001|Overall Study|Adverse Event|0|||
44413540|NCT00802074|79421407|FG000|Overall Study|Adverse Event|1|||
44413541|NCT00802074|79421408|FG001|Overall Study|Adverse Event|1|||
44413542|NCT00802074|79421409|FG002|Overall Study|Adverse Event|1|||
44413543|NCT00802074|79421410|FG003|Overall Study|Adverse Event|0|||
44413544|NCT00802074|79421411|FG004|Overall Study|Adverse Event|0|||
44413545|NCT00802074|79421412|FG005|Overall Study|Adverse Event|0|||
44413546|NCT00802074|79421407|FG000|Overall Study|Withdrawal by Subject|1|||
44413547|NCT00802074|79421408|FG001|Overall Study|Withdrawal by Subject|0|||
44413548|NCT00802074|79421409|FG002|Overall Study|Withdrawal by Subject|0|||
44413549|NCT00802074|79421410|FG003|Overall Study|Withdrawal by Subject|0|||
44413550|NCT00802074|79421411|FG004|Overall Study|Withdrawal by Subject|0|||
44413551|NCT00802074|79421412|FG005|Overall Study|Withdrawal by Subject|0|||
44413552|NCT00450385|79421429|FG000|Overall Study|Death|3|||
44413553|NCT00450385|79421429|FG000|Overall Study|Protocol Violation|1|||
44413554|NCT00450385|79421429|FG000|Overall Study|Withdrawal by Subject|2|||
44413555|NCT00450385|79421429|FG000|Overall Study|Lack of Efficacy|2|||
44413556|NCT00450385|79421429|FG000|Overall Study|Adverse Event|1|||
44413557|NCT00450385|79421429|FG000|Overall Study|Physician Decision|1|||
44413558|NCT00450385|79421429|FG000|Overall Study|Other|3|||
44413559|NCT00588354|79421436|FG000|Baseline to 2 Weeks|Adverse Event|1|||
44525762|NCT04230213|79535090|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
44525763|NCT04230213|79535091|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
44525764|NCT04230213|79535089|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
44413560|NCT00588354|79421437|FG001|Baseline to 2 Weeks|Adverse Event|0|||
44413561|NCT00588354|79421436|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
44525765|NCT04230213|79535090|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
44148689|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
44413562|NCT00588354|79421437|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
44413563|NCT00588354|79421436|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
44413564|NCT00588354|79421437|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
44413565|NCT00449761|79421444|FG000|Overall Study|Disease progression|12|||
44413566|NCT00449761|79421444|FG000|Overall Study|Death|5|||
44413567|NCT00449761|79421444|FG000|Overall Study|New cancer therapy|1|||
44413568|NCT00800982|79421451|FG000|Overall Study|Lost to Follow-up|1|||
44413569|NCT00800982|79421452|FG001|Overall Study|Lost to Follow-up|2|||
44413570|NCT00800982|79421451|FG000|Overall Study|Withdrawal by Subject|0|||
44413571|NCT00800982|79421452|FG001|Overall Study|Withdrawal by Subject|1|||
44413572|NCT00800982|79421451|FG000|Overall Study|Patient moved out of state|1|||
44413573|NCT00800982|79421452|FG001|Overall Study|Patient moved out of state|0|||
44413574|NCT00830960|79421464|FG000|Overall Study|Death|5|||
44413575|NCT00830960|79421465|FG001|Overall Study|Death|4|||
44413576|NCT00830960|79421466|FG002|Overall Study|Death|3|||
44413577|NCT00830960|79421467|FG003|Overall Study|Death|2|||
44413578|NCT00830960|79421468|FG004|Overall Study|Death|6|||
44413579|NCT00830960|79421469|FG005|Overall Study|Death|1|||
44413580|NCT00830960|79421464|FG000|Overall Study|Lost to Follow-up|1|||
44413581|NCT00830960|79421465|FG001|Overall Study|Lost to Follow-up|1|||
44413582|NCT00830960|79421466|FG002|Overall Study|Lost to Follow-up|1|||
44413583|NCT00830960|79421467|FG003|Overall Study|Lost to Follow-up|0|||
44413584|NCT00830960|79421468|FG004|Overall Study|Lost to Follow-up|0|||
44413585|NCT00830960|79421469|FG005|Overall Study|Lost to Follow-up|1|||
44413586|NCT00830960|79421464|FG000|Overall Study|Withdrawal by Subject|19|||
44413587|NCT00830960|79421465|FG001|Overall Study|Withdrawal by Subject|19|||
44413588|NCT00830960|79421466|FG002|Overall Study|Withdrawal by Subject|18|||
44413589|NCT00830960|79421467|FG003|Overall Study|Withdrawal by Subject|23|||
44413590|NCT00830960|79421468|FG004|Overall Study|Withdrawal by Subject|16|||
44413591|NCT00830960|79421469|FG005|Overall Study|Withdrawal by Subject|21|||
44413592|NCT00830960|79421464|FG000|Overall Study|Sponsor Decision|1|||
44413593|NCT00830960|79421465|FG001|Overall Study|Sponsor Decision|2|||
44413594|NCT00830960|79421466|FG002|Overall Study|Sponsor Decision|3|||
44413595|NCT00830960|79421467|FG003|Overall Study|Sponsor Decision|4|||
44413596|NCT00830960|79421468|FG004|Overall Study|Sponsor Decision|5|||
44413597|NCT00830960|79421469|FG005|Overall Study|Sponsor Decision|7|||
44413598|NCT00830960|79421464|FG000|Overall Study|No study drug received|7|||
44413599|NCT00830960|79421465|FG001|Overall Study|No study drug received|2|||
44413600|NCT00830960|79421466|FG002|Overall Study|No study drug received|4|||
44413601|NCT00830960|79421467|FG003|Overall Study|No study drug received|3|||
44413602|NCT00830960|79421468|FG004|Overall Study|No study drug received|5|||
44413603|NCT00830960|79421469|FG005|Overall Study|No study drug received|7|||
44413604|NCT00830804|79421506|FG000|Overall Study|Lost to Follow-up|4|||
44413605|NCT00830804|79421506|FG000|Overall Study|Death|1|||
44413606|NCT00830804|79421506|FG000|Overall Study|Unable to get to clinic|7|||
44413607|NCT00830804|79421506|FG000|Overall Study|Consent withdrawn|2|||
44413608|NCT00830804|79421506|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
44413609|NCT00789477|79421516|FG000|Overall Study|Withdrawal by Subject|2|||
44413610|NCT00789477|79421517|FG001|Overall Study|Withdrawal by Subject|1|||
44413611|NCT00789477|79421518|FG002|Overall Study|Withdrawal by Subject|3|||
44413612|NCT00789477|79421519|FG003|Overall Study|Withdrawal by Subject|2|||
44413613|NCT00789477|79421520|FG004|Overall Study|Withdrawal by Subject|3|||
44413614|NCT00789477|79421516|FG000|Overall Study|Protocol Violation|1|||
44413615|NCT00789477|79421517|FG001|Overall Study|Protocol Violation|0|||
44413616|NCT00789477|79421518|FG002|Overall Study|Protocol Violation|0|||
44413617|NCT00789477|79421519|FG003|Overall Study|Protocol Violation|1|||
44413618|NCT00789477|79421520|FG004|Overall Study|Protocol Violation|0|||
44413619|NCT00789477|79421516|FG000|Overall Study|Adverse Event|3|||
44413620|NCT00789477|79421517|FG001|Overall Study|Adverse Event|3|||
44413621|NCT00789477|79421518|FG002|Overall Study|Adverse Event|1|||
44413622|NCT00789477|79421519|FG003|Overall Study|Adverse Event|0|||
44413623|NCT00789477|79421520|FG004|Overall Study|Adverse Event|0|||
44525766|NCT04230213|79535091|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
44525767|NCT04230213|79535089|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
44525768|NCT04230213|79535090|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
44525769|NCT04230213|79535091|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
44525770|NCT04230213|79535089|FG000|Follow up: Week 32 to Week 36|Other|0|||
44254080|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
44413624|NCT00789477|79421516|FG000|Overall Study|Death|1|||
44413625|NCT00789477|79421517|FG001|Overall Study|Death|1|||
44413626|NCT00789477|79421518|FG002|Overall Study|Death|2|||
44413627|NCT00789477|79421519|FG003|Overall Study|Death|2|||
44525771|NCT04230213|79535090|FG001|Follow up: Week 32 to Week 36|Other|1|||
44525772|NCT04230213|79535091|FG002|Follow up: Week 32 to Week 36|Other|1|||
44254081|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
44525773|NCT04222725|79535103|FG000|Overall Study|Adverse Event|0|||
44254082|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Physician Decision|2|||
44254083|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Physician Decision|4|||
44413628|NCT00789477|79421520|FG004|Overall Study|Death|0|||
44413629|NCT00789477|79421516|FG000|Overall Study|Lost to Follow-up|0|||
44413630|NCT00789477|79421517|FG001|Overall Study|Lost to Follow-up|1|||
44413631|NCT00789477|79421518|FG002|Overall Study|Lost to Follow-up|4|||
44413632|NCT00789477|79421519|FG003|Overall Study|Lost to Follow-up|2|||
44413633|NCT00789477|79421520|FG004|Overall Study|Lost to Follow-up|4|||
44413634|NCT00789477|79421516|FG000|Overall Study|Lack of Efficacy|2|||
44413635|NCT00789477|79421517|FG001|Overall Study|Lack of Efficacy|0|||
44413636|NCT00789477|79421518|FG002|Overall Study|Lack of Efficacy|0|||
44525774|NCT04222725|79535104|FG001|Overall Study|Adverse Event|1|||
44413637|NCT00789477|79421519|FG003|Overall Study|Lack of Efficacy|0|||
44413638|NCT00789477|79421520|FG004|Overall Study|Lack of Efficacy|0|||
44413639|NCT00789477|79421516|FG000|Overall Study|Other|2|||
44413640|NCT00789477|79421517|FG001|Overall Study|Other|0|||
44413641|NCT00789477|79421518|FG002|Overall Study|Other|1|||
44413642|NCT00789477|79421519|FG003|Overall Study|Other|3|||
44413643|NCT00789477|79421520|FG004|Overall Study|Other|0|||
44413644|NCT00796614|79421538|FG000|Overall Study|Adverse Event|1|||
44413645|NCT00796614|79421539|FG001|Overall Study|Adverse Event|2|||
44413646|NCT00796614|79421540|FG002|Overall Study|Adverse Event|0|||
44413647|NCT00796614|79421541|FG003|Overall Study|Adverse Event|0|||
44413648|NCT00796614|79421538|FG000|Overall Study|Protocol Violation|0|||
44413649|NCT00796614|79421539|FG001|Overall Study|Protocol Violation|0|||
44413650|NCT00796614|79421540|FG002|Overall Study|Protocol Violation|2|||
44413651|NCT00796614|79421541|FG003|Overall Study|Protocol Violation|0|||
44413652|NCT00796614|79421538|FG000|Overall Study|Lost to Follow-up|2|||
44413653|NCT00796614|79421539|FG001|Overall Study|Lost to Follow-up|2|||
44413654|NCT00796614|79421540|FG002|Overall Study|Lost to Follow-up|1|||
44413655|NCT00796614|79421541|FG003|Overall Study|Lost to Follow-up|0|||
44413656|NCT00796614|79421538|FG000|Overall Study|Withdrawal by Subject|1|||
44413657|NCT00796614|79421539|FG001|Overall Study|Withdrawal by Subject|0|||
44413658|NCT00796614|79421540|FG002|Overall Study|Withdrawal by Subject|0|||
44413659|NCT00796614|79421541|FG003|Overall Study|Withdrawal by Subject|1|||
44413660|NCT00796614|79421538|FG000|Overall Study|Other than stated|1|||
44413661|NCT00796614|79421539|FG001|Overall Study|Other than stated|0|||
44413662|NCT00796614|79421540|FG002|Overall Study|Other than stated|0|||
44413663|NCT00796614|79421541|FG003|Overall Study|Other than stated|0|||
44413664|NCT00448747|79421553|FG000|Overall Study|collapsed veins|1|||
44413665|NCT00448747|79421554|FG001|Overall Study|collapsed veins|0|||
44413666|NCT00830180|79421570|FG000|Overall Study|Adverse Event|6|||
44413667|NCT00830180|79421570|FG000|Overall Study|Death|11|||
44413668|NCT00830180|79421570|FG000|Overall Study|Insufficient clinical response|1|||
44413669|NCT00830180|79421570|FG000|Overall Study|Withdrawal by Subject|5|||
44413670|NCT00830180|79421570|FG000|Overall Study|Progressive disease|2|||
44413671|NCT00830180|79421570|FG000|Overall Study|Other - Unspecified|1|||
44413672|NCT00789321|79421578|FG000|Overall Study|Adverse Event|0|||
44413673|NCT00789321|79421579|FG001|Overall Study|Adverse Event|1|||
44413674|NCT00811928|79421587|FG000|Overall Study|AEs and SAEs Including Death|7|||
44413675|NCT00811928|79421588|FG001|Overall Study|AEs and SAEs Including Death|11|||
44413676|NCT00811928|79421587|FG000|Overall Study|Withdrawal by Subject|18|||
44413677|NCT00811928|79421588|FG001|Overall Study|Withdrawal by Subject|12|||
44413678|NCT00811928|79421587|FG000|Overall Study|Did Not Take Study Drug|3|||
44413679|NCT00811928|79421588|FG001|Overall Study|Did Not Take Study Drug|0|||
44413680|NCT00811928|79421587|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
44413681|NCT00811928|79421588|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
44413682|NCT00811928|79421587|FG000|Overall Study|Investigator Decision|2|||
44413683|NCT00811928|79421588|FG001|Overall Study|Investigator Decision|1|||
44413684|NCT00811928|79421587|FG000|Overall Study|Poor Compliance|2|||
44413685|NCT00811928|79421588|FG001|Overall Study|Poor Compliance|5|||
44413686|NCT00788775|79421596|FG000|Overall Study|Progressive Disease|8|||
44413687|NCT00788775|79421597|FG001|Overall Study|Progressive Disease|6|||
44413688|NCT00788775|79421596|FG000|Overall Study|Withdrawal by Subject|0|||
44413689|NCT00788775|79421597|FG001|Overall Study|Withdrawal by Subject|2|||
44413690|NCT00788775|79421596|FG000|Overall Study|Patient Non-Compliance|1|||
44413691|NCT00788775|79421597|FG001|Overall Study|Patient Non-Compliance|0|||
44413692|NCT00788775|79421596|FG000|Overall Study|Patient's measurable disease resected.|1|||
44413693|NCT00788775|79421597|FG001|Overall Study|Patient's measurable disease resected.|0|||
44413694|NCT00448669|79421605|FG000|Overall Study|Lost to Follow-up|52|||
44413695|NCT00448669|79421606|FG001|Overall Study|Lost to Follow-up|63|||
44413696|NCT00448669|79421605|FG000|Overall Study|Withdrawal by Subject|90|||
44413697|NCT00448669|79421606|FG001|Overall Study|Withdrawal by Subject|74|||
44413698|NCT00448669|79421605|FG000|Overall Study|Relocated|49|||
44413699|NCT00448669|79421606|FG001|Overall Study|Relocated|36|||
44413700|NCT00448669|79421605|FG000|Overall Study|Were withdrawn by investigator|10|||
44413701|NCT00448669|79421606|FG001|Overall Study|Were withdrawn by investigator|6|||
44413702|NCT00448669|79421605|FG000|Overall Study|Death|2|||
44525775|NCT04222725|79535105|FG002|Overall Study|Adverse Event|0|||
44167841|NCT02528357|78961052|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44413703|NCT00448669|79421606|FG001|Overall Study|Death|4|||
44413704|NCT00448669|79421605|FG000|Overall Study|Had other reasons|5|||
44413705|NCT00448669|79421606|FG001|Overall Study|Had other reasons|6|||
44413706|NCT00448669|79421605|FG000|Overall Study|HIV-infected at enrollment|1|||
44413707|NCT00448669|79421606|FG001|Overall Study|HIV-infected at enrollment|2|||
44525776|NCT04222725|79535106|FG003|Overall Study|Adverse Event|0|||
44413708|NCT00448669|79421605|FG000|Overall Study|Never started drug|9|||
44413709|NCT00448669|79421606|FG001|Overall Study|Never started drug|7|||
44413710|NCT00591734|79421614|FG000|Overall Study|Lack of Efficacy|35|||
44413711|NCT00591734|79421614|FG000|Overall Study|Adverse Event|5|||
44413712|NCT00591734|79421614|FG000|Overall Study|Physician Decision|5|||
44413713|NCT00591734|79421614|FG000|Overall Study|Intercurrent Illness|8|||
44413714|NCT00788697|79421618|FG000|Overall Study|No study drug administered|12|||
44413715|NCT00788697|79421618|FG000|Overall Study|Training Patients|74|||
44413716|NCT00788697|79421618|FG000|Overall Study|no truth standard procedure available|5|||
44413717|NCT00788697|79421618|FG000|Overall Study|Technically inadequate truth standard|1|||
44413718|NCT00788697|79421618|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
44413719|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
44413720|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
44413721|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
44413722|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
44413723|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
44413724|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
44413725|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
44413726|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
44413727|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
44413728|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
44413729|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
44413730|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
44413731|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
44413732|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
44413733|NCT00848549|79421632|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
44413734|NCT00848549|79421633|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
44413735|NCT00848549|79421632|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
44413736|NCT00848549|79421633|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
44413737|NCT00848549|79421632|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
44413738|NCT00848549|79421633|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
44413739|NCT00848549|79421632|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
44413740|NCT00848549|79421633|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
44413741|NCT00848549|79421632|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
44413742|NCT00848549|79421633|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
44413743|NCT00848549|79421632|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
44413744|NCT00848549|79421633|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
44413745|NCT00848549|79421632|FG000|E2090-E044-314 (Extension Study)|Other|5|||
44413746|NCT00848549|79421633|FG001|E2090-E044-314 (Extension Study)|Other|6|||
44413747|NCT00788151|79421643|FG000|Overall Study|Other adverse event|0|||
44413748|NCT00788151|79421644|FG001|Overall Study|Other adverse event|2|||
44413749|NCT00788151|79421643|FG000|Overall Study|Protocol Violation|0|||
44413750|NCT00788151|79421644|FG001|Overall Study|Protocol Violation|1|||
44413751|NCT00788151|79421643|FG000|Overall Study|Withdrawal by Subject|13|||
44413752|NCT00788151|79421644|FG001|Overall Study|Withdrawal by Subject|6|||
44413753|NCT00788151|79421643|FG000|Overall Study|Enrolled but not treated|1|||
44413754|NCT00788151|79421644|FG001|Overall Study|Enrolled but not treated|1|||
44413755|NCT00788073|79421652|FG000|STX209 Then Placebo|Adverse Event|1|||
44413756|NCT00788073|79421653|FG001|STX209 Then Placebo|Adverse Event|0|||
44413757|NCT00788073|79421652|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
44413758|NCT00788073|79421653|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
44413759|NCT00788073|79421652|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
44413760|NCT00788073|79421653|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
44413761|NCT00788073|79421652|FG000|STX209 Then Placebo|unable to return due to travel|0|||
44413762|NCT00788073|79421653|FG001|STX209 Then Placebo|unable to return due to travel|1|||
44413763|NCT00788073|79421652|FG000|Placebo Then STX209|Adverse Event|2|||
44413764|NCT00788073|79421653|FG001|Placebo Then STX209|Adverse Event|0|||
44413765|NCT00788073|79421652|FG000|Placebo Then STX209|Protocol Violation|0|||
44413766|NCT00788073|79421653|FG001|Placebo Then STX209|Protocol Violation|1|||
44413767|NCT00848393|79421662|FG000|Overall Study|Protocol Violation|0|||
44413768|NCT00848393|79421663|FG001|Overall Study|Protocol Violation|0|||
44413769|NCT00848393|79421664|FG002|Overall Study|Protocol Violation|1|||
44148690|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
44148691|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
44148692|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
44413770|NCT00848393|79421662|FG000|Overall Study|surgical complications unrelated to stud|0|||
44525777|NCT04213989|79535118|FG000|Overall Study|Withdrawal by Subject|3|||
44525778|NCT04213989|79535119|FG001|Overall Study|Withdrawal by Subject|2|||
44413771|NCT00848393|79421663|FG001|Overall Study|surgical complications unrelated to stud|0|||
44413772|NCT00848393|79421664|FG002|Overall Study|surgical complications unrelated to stud|2|||
44413773|NCT00815516|79421678|FG000|Overall Study|Death|3|||
44413774|NCT00815516|79421679|FG001|Overall Study|Death|1|||
44413775|NCT00815516|79421678|FG000|Overall Study|Physician Decision|1|||
44148693|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
44413776|NCT00815516|79421679|FG001|Overall Study|Physician Decision|0|||
44413777|NCT00787917|79421687|FG000|Blinded Treatment|Adverse Event|1|||
44413778|NCT00787917|79421688|FG001|Blinded Treatment|Adverse Event|0|||
44413779|NCT00787917|79421687|FG000|Blinded Treatment|Lack of Efficacy|1|||
44413780|NCT00787917|79421688|FG001|Blinded Treatment|Lack of Efficacy|0|||
44413781|NCT00787917|79421687|FG000|Blinded Treatment|Administrative problems|3|||
44413782|NCT00787917|79421688|FG001|Blinded Treatment|Administrative problems|2|||
44413783|NCT00787917|79421687|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
44413784|NCT00787917|79421688|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
44413785|NCT00787917|79421687|FG000|Open Label|Administrative problems|3|||
44413786|NCT00787917|79421688|FG001|Open Label|Administrative problems|0|||
44413787|NCT00814892|79421696|FG000|Overall Study|Disease Progression|1|||
44413788|NCT00814892|79421696|FG000|Overall Study|Study Termination|1|||
44413789|NCT00787839|79421700|FG000|Overall Study|Failure to have the OGTT was most common|404|||
44413790|NCT00829244|79421723|FG000|Overall Study|Adverse Event|1|||
44413791|NCT00829244|79421724|FG001|Overall Study|Adverse Event|3|||
44413792|NCT00829244|79421723|FG000|Overall Study|Protocol Violation|1|||
44413793|NCT00829244|79421724|FG001|Overall Study|Protocol Violation|0|||
44413794|NCT00829244|79421723|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
44413795|NCT00829244|79421724|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
44413796|NCT00829244|79421723|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
44413797|NCT00829244|79421724|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
44525779|NCT04213989|79535118|FG000|Overall Study|Physician Decision|1|||
44525780|NCT04213989|79535119|FG001|Overall Study|Physician Decision|0|||
44525781|NCT04213989|79535118|FG000|Overall Study|Lost to Follow-up|0|||
44525782|NCT04213989|79535119|FG001|Overall Study|Lost to Follow-up|4|||
44525783|NCT03242252|79535128|FG000|Overall Study|At the Participant's own Request|18|||
44525784|NCT03242252|79535129|FG001|Overall Study|At the Participant's own Request|10|||
44525785|NCT03242252|79535130|FG002|Overall Study|At the Participant's own Request|15|||
44525786|NCT03242252|79535128|FG000|Overall Study|Adverse Event|8|||
44525787|NCT03242252|79535129|FG001|Overall Study|Adverse Event|6|||
44525788|NCT03242252|79535130|FG002|Overall Study|Adverse Event|9|||
44413798|NCT00829244|79421723|FG000|Overall Study|No fertilization|2|||
44413799|NCT00829244|79421724|FG001|Overall Study|No fertilization|2|||
44413800|NCT00829244|79421723|FG000|Overall Study|All embryos discarded|0|||
44413801|NCT00829244|79421724|FG001|Overall Study|All embryos discarded|3|||
44413802|NCT00829244|79421723|FG000|Overall Study|No embryo cleavage|0|||
44413803|NCT00829244|79421724|FG001|Overall Study|No embryo cleavage|2|||
44413804|NCT00787605|79421732|FG000|Overall Study|Administrative Problems|3|||
44413805|NCT00787605|79421733|FG001|Overall Study|Administrative Problems|0|||
44413806|NCT00787605|79421732|FG000|Overall Study|Adverse Event|14|||
44413807|NCT00787605|79421733|FG001|Overall Study|Adverse Event|25|||
44413808|NCT00787605|79421732|FG000|Overall Study|Lost to Follow-up|3|||
44413809|NCT00787605|79421733|FG001|Overall Study|Lost to Follow-up|6|||
44413810|NCT00787605|79421732|FG000|Overall Study|Protocol Violation|7|||
44413811|NCT00787605|79421733|FG001|Overall Study|Protocol Violation|3|||
44413812|NCT00787605|79421732|FG000|Overall Study|Withdrawal by Subject|6|||
44413813|NCT00787605|79421733|FG001|Overall Study|Withdrawal by Subject|13|||
44413814|NCT00787605|79421732|FG000|Overall Study|Lack of Efficacy|13|||
44413815|NCT00787605|79421733|FG001|Overall Study|Lack of Efficacy|9|||
44413816|NCT00448591|79421739|FG000|Overall Study|Withdrawal by Subject|178|||
44413817|NCT00448591|79421739|FG000|Overall Study|Progressive Disease|1382|||
44413818|NCT00448591|79421739|FG000|Overall Study|Adverse Event|382|||
44413819|NCT00448591|79421739|FG000|Overall Study|Protocol Violation|41|||
44525789|NCT03242252|79535128|FG000|Overall Study|Poor Compliance to Protocol|0|||
44525790|NCT03242252|79535129|FG001|Overall Study|Poor Compliance to Protocol|2|||
44525791|NCT03242252|79535130|FG002|Overall Study|Poor Compliance to Protocol|3|||
44525792|NCT03242252|79535128|FG000|Overall Study|Study Terminated by Sponsor|1|||
44525793|NCT03242252|79535129|FG001|Overall Study|Study Terminated by Sponsor|0|||
44413820|NCT00448591|79421739|FG000|Overall Study|Lost to Follow-up|19|||
44413821|NCT00448591|79421739|FG000|Overall Study|Treatment Regimen Completed|70|||
44413822|NCT00448591|79421739|FG000|Overall Study|Other|154|||
44525794|NCT03242252|79535130|FG002|Overall Study|Study Terminated by Sponsor|0|||
44413823|NCT00448591|79421739|FG000|Overall Study|Termination of Study|70|||
44413824|NCT00651664|79421755|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
44413825|NCT00651664|79421756|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
44413826|NCT00651664|79421757|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
44413827|NCT00651664|79421758|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
44413828|NCT00651664|79421759|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
44413829|NCT00651664|79421760|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
44525795|NCT03242252|79535128|FG000|Overall Study|Reason not Specified|4|||
44525796|NCT03242252|79535129|FG001|Overall Study|Reason not Specified|4|||
44525797|NCT03242252|79535130|FG002|Overall Study|Reason not Specified|1|||
44413830|NCT00651664|79421761|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
44525798|NCT03242252|79535128|FG000|Overall Study|Lost to Follow-up|5|||
44254084|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Pregnancy|2|||
44254085|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Pregnancy|1|||
44254086|NCT02275780|79095287|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
44254087|NCT02275780|79095288|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
44254088|NCT02275780|79095287|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
44254089|NCT02275780|79095288|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
44254090|NCT00545077|79095296|FG000|Overall Study|Treatment not received|5|||
44254091|NCT00545077|79095297|FG001|Overall Study|Treatment not received|1|||
44254092|NCT00545077|79095296|FG000|Overall Study|Disease Progression|131|||
44254093|NCT00545077|79095297|FG001|Overall Study|Disease Progression|98|||
44254094|NCT00545077|79095296|FG000|Overall Study|Withdrawal by Subject|3|||
44254095|NCT00545077|79095297|FG001|Overall Study|Withdrawal by Subject|14|||
44254096|NCT00545077|79095296|FG000|Overall Study|Physician Decision|6|||
44254097|NCT00545077|79095297|FG001|Overall Study|Physician Decision|3|||
44254098|NCT00545077|79095296|FG000|Overall Study|Lost to Follow-up|2|||
44254099|NCT00545077|79095297|FG001|Overall Study|Lost to Follow-up|0|||
44254100|NCT00545077|79095296|FG000|Overall Study|Protocol Violation|1|||
44254101|NCT00545077|79095297|FG001|Overall Study|Protocol Violation|0|||
44254102|NCT00545077|79095296|FG000|Overall Study|Adverse Event|0|||
44254103|NCT00545077|79095297|FG001|Overall Study|Adverse Event|31|||
44254104|NCT00545077|79095296|FG000|Overall Study|Death|0|||
44254105|NCT00545077|79095297|FG001|Overall Study|Death|8|||
44254106|NCT00130533|79095305|FG000|Overall Study|Withdrawal by Subject|33|||
44254107|NCT00130533|79095306|FG001|Overall Study|Withdrawal by Subject|6|||
44254108|NCT00130533|79095305|FG000|Overall Study|Adverse Event|34|||
44254109|NCT00130533|79095306|FG001|Overall Study|Adverse Event|1|||
44254110|NCT00130533|79095305|FG000|Overall Study|Disease relapse|9|||
44254111|NCT00130533|79095306|FG001|Overall Study|Disease relapse|13|||
44254112|NCT00130533|79095305|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
44254113|NCT00130533|79095306|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
44254114|NCT00130533|79095305|FG000|Overall Study|Death|4|||
44254115|NCT00130533|79095306|FG001|Overall Study|Death|2|||
44254116|NCT00130533|79095305|FG000|Overall Study|Protocol Violation|5|||
44254117|NCT00130533|79095306|FG001|Overall Study|Protocol Violation|1|||
44254118|NCT00130533|79095305|FG000|Overall Study|Lost to Follow-up|1|||
44525799|NCT03242252|79535129|FG001|Overall Study|Lost to Follow-up|1|||
44525800|NCT03242252|79535130|FG002|Overall Study|Lost to Follow-up|4|||
44525801|NCT04109391|79535147|FG000|Overall Study|Adverse Event|2|||
44525802|NCT04109391|79535148|FG001|Overall Study|Adverse Event|2|||
44525803|NCT04109391|79535149|FG002|Overall Study|Adverse Event|0|||
44525804|NCT04109391|79535147|FG000|Overall Study|Withdrawal by Subject|2|||
44254119|NCT00130533|79095306|FG001|Overall Study|Lost to Follow-up|1|||
44254120|NCT00130533|79095305|FG000|Overall Study|Sponsor´s decision|2|||
44254121|NCT00130533|79095306|FG001|Overall Study|Sponsor´s decision|0|||
44413831|NCT00651664|79421762|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
44413832|NCT00651664|79421763|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
44413833|NCT00651664|79421764|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
44413834|NCT00651664|79421755|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
44525805|NCT04109391|79535148|FG001|Overall Study|Withdrawal by Subject|0|||
44525806|NCT04109391|79535149|FG002|Overall Study|Withdrawal by Subject|0|||
44525807|NCT04109391|79535147|FG000|Overall Study|Pregnancy|1|||
44525808|NCT04109391|79535148|FG001|Overall Study|Pregnancy|0|||
44525809|NCT04109391|79535149|FG002|Overall Study|Pregnancy|0|||
44525810|NCT04109391|79535147|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
44525811|NCT04109391|79535148|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
44525812|NCT04109391|79535149|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
44525813|NCT04109391|79535147|FG000|Overall Study|Lost to Follow-up|0|||
44525814|NCT04109391|79535148|FG001|Overall Study|Lost to Follow-up|0|||
44525815|NCT04109391|79535149|FG002|Overall Study|Lost to Follow-up|1|||
44525816|NCT04109391|79535147|FG000|Overall Study|Lack of Efficacy|2|||
44254122|NCT00130533|79095305|FG000|Overall Study|Second Primary Malignancy|0|||
44254123|NCT00130533|79095306|FG001|Overall Study|Second Primary Malignancy|1|||
44254124|NCT00130533|79095305|FG000|Overall Study|Other|12|||
44254125|NCT00130533|79095306|FG001|Overall Study|Other|5|||
44254126|NCT00129935|79095314|FG000|Overall Study|Adverse Event|18|||
44254127|NCT00129935|79095315|FG001|Overall Study|Adverse Event|56|||
44254128|NCT00129935|79095314|FG000|Overall Study|Death|1|||
44254129|NCT00129935|79095315|FG001|Overall Study|Death|1|||
44254130|NCT00129935|79095314|FG000|Overall Study|Withdrawal by Subject|7|||
44254131|NCT00129935|79095315|FG001|Overall Study|Withdrawal by Subject|20|||
44413835|NCT00651664|79421756|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
44525817|NCT04109391|79535148|FG001|Overall Study|Lack of Efficacy|2|||
44254132|NCT00129935|79095314|FG000|Overall Study|Protocol Violation|0|||
44254133|NCT00129935|79095315|FG001|Overall Study|Protocol Violation|4|||
44254134|NCT00129935|79095314|FG000|Overall Study|Physician Decision|3|||
44254135|NCT00129935|79095315|FG001|Overall Study|Physician Decision|4|||
44254136|NCT00129935|79095314|FG000|Overall Study|Recurrence|1|||
44254137|NCT00129935|79095315|FG001|Overall Study|Recurrence|3|||
44254138|NCT00129935|79095314|FG000|Overall Study|Second primary|0|||
44413836|NCT00651664|79421757|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
44413837|NCT00651664|79421758|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
44413838|NCT00651664|79421759|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
44413839|NCT00651664|79421760|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
44413840|NCT00651664|79421761|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
44413841|NCT00651664|79421762|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
44413842|NCT00651664|79421763|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
44413843|NCT00651664|79421764|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
44413844|NCT00651664|79421755|FG000|Overall Study|Progressive Disease|3|||
44413845|NCT00651664|79421756|FG001|Overall Study|Progressive Disease|3|||
44413846|NCT00651664|79421757|FG002|Overall Study|Progressive Disease|3|||
44413847|NCT00651664|79421758|FG003|Overall Study|Progressive Disease|12|||
44413848|NCT00651664|79421759|FG004|Overall Study|Progressive Disease|4|||
44413849|NCT00651664|79421760|FG005|Overall Study|Progressive Disease|1|||
44413850|NCT00651664|79421761|FG006|Overall Study|Progressive Disease|3|||
44413851|NCT00651664|79421762|FG007|Overall Study|Progressive Disease|6|||
44413852|NCT00651664|79421763|FG008|Overall Study|Progressive Disease|5|||
44413853|NCT00651664|79421764|FG009|Overall Study|Progressive Disease|5|||
44413854|NCT00651664|79421755|FG000|Overall Study|Patient Declined Further Treatment|0|||
44413855|NCT00651664|79421756|FG001|Overall Study|Patient Declined Further Treatment|0|||
44413856|NCT00651664|79421757|FG002|Overall Study|Patient Declined Further Treatment|0|||
44413857|NCT00651664|79421758|FG003|Overall Study|Patient Declined Further Treatment|1|||
44413858|NCT00651664|79421759|FG004|Overall Study|Patient Declined Further Treatment|1|||
44413859|NCT00651664|79421760|FG005|Overall Study|Patient Declined Further Treatment|1|||
44413860|NCT00651664|79421761|FG006|Overall Study|Patient Declined Further Treatment|0|||
44413861|NCT00651664|79421762|FG007|Overall Study|Patient Declined Further Treatment|0|||
44413862|NCT00651664|79421763|FG008|Overall Study|Patient Declined Further Treatment|0|||
44413863|NCT00651664|79421764|FG009|Overall Study|Patient Declined Further Treatment|1|||
44413864|NCT00651664|79421755|FG000|Overall Study|Symptomatic Deterioration|0|||
44413865|NCT00651664|79421756|FG001|Overall Study|Symptomatic Deterioration|0|||
44413866|NCT00651664|79421757|FG002|Overall Study|Symptomatic Deterioration|0|||
44413867|NCT00651664|79421758|FG003|Overall Study|Symptomatic Deterioration|1|||
44413868|NCT00651664|79421759|FG004|Overall Study|Symptomatic Deterioration|0|||
44413869|NCT00651664|79421760|FG005|Overall Study|Symptomatic Deterioration|0|||
44413870|NCT00651664|79421761|FG006|Overall Study|Symptomatic Deterioration|1|||
44413871|NCT00651664|79421762|FG007|Overall Study|Symptomatic Deterioration|0|||
44413872|NCT00651664|79421763|FG008|Overall Study|Symptomatic Deterioration|1|||
44413873|NCT00651664|79421764|FG009|Overall Study|Symptomatic Deterioration|0|||
44413874|NCT00651664|79421755|FG000|Overall Study|Reason not Specified|0|||
44413875|NCT00651664|79421756|FG001|Overall Study|Reason not Specified|0|||
44413876|NCT00651664|79421757|FG002|Overall Study|Reason not Specified|0|||
44413877|NCT00651664|79421758|FG003|Overall Study|Reason not Specified|0|||
44413878|NCT00651664|79421759|FG004|Overall Study|Reason not Specified|0|||
44413879|NCT00651664|79421760|FG005|Overall Study|Reason not Specified|0|||
44413880|NCT00651664|79421761|FG006|Overall Study|Reason not Specified|1|||
44413881|NCT00651664|79421762|FG007|Overall Study|Reason not Specified|0|||
44413882|NCT00651664|79421763|FG008|Overall Study|Reason not Specified|0|||
44413883|NCT00651664|79421764|FG009|Overall Study|Reason not Specified|0|||
44413884|NCT00787527|79421790|FG000|Overall Study|Toxicity|3|||
44413885|NCT00787137|79421801|FG000|Overall Study|Study Termination|0|||
44413886|NCT00787137|79421802|FG001|Overall Study|Study Termination|0|||
44413887|NCT00787137|79421803|FG002|Overall Study|Study Termination|1|||
44413888|NCT00448435|79421811|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
44413889|NCT00448435|79421812|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
44413890|NCT00448279|79421823|FG000|Overall Study|Lost to Follow-up|2|||
44413891|NCT00448279|79421824|FG001|Overall Study|Lost to Follow-up|2|||
44413892|NCT00448279|79421823|FG000|Overall Study|Adverse Event|1|||
44254139|NCT00129935|79095315|FG001|Overall Study|Second primary|1|||
44254140|NCT00129935|79095314|FG000|Overall Study|Other|3|||
44254141|NCT00129935|79095315|FG001|Overall Study|Other|2|||
44254142|NCT00129935|79095314|FG000|Overall Study|Crossed to the other arm|2|||
44413893|NCT00448279|79421824|FG001|Overall Study|Adverse Event|1|||
44413894|NCT00448279|79421823|FG000|Overall Study|Disease progression|16|||
44413895|NCT00448279|79421824|FG001|Overall Study|Disease progression|18|||
44413896|NCT00448279|79421823|FG000|Overall Study|Withdrawal by Subject|4|||
44254143|NCT00129935|79095315|FG001|Overall Study|Crossed to the other arm|1|||
44254144|NCT00129935|79095314|FG000|Overall Study|Incorrect study treatment|1|||
44413897|NCT00448279|79421824|FG001|Overall Study|Withdrawal by Subject|3|||
44282285|NCT01860534|79245580|FG000|ROP #2|discharged prior to ROP #2|1|||
44413898|NCT00448279|79421823|FG000|Overall Study|Other|6|||
44413899|NCT00448279|79421824|FG001|Overall Study|Other|4|||
44413900|NCT00448279|79421823|FG000|Overall Study|Protocol Violation|0|||
44413901|NCT00448279|79421824|FG001|Overall Study|Protocol Violation|1|||
44413902|NCT00448123|79421832|FG000|Overall Study|Lost to Follow-up|9|||
44413903|NCT00448123|79421833|FG001|Overall Study|Lost to Follow-up|6|||
44413904|NCT00448123|79421832|FG000|Overall Study|Physician Decision|6|||
44413905|NCT00448123|79421833|FG001|Overall Study|Physician Decision|6|||
44413906|NCT00447499|79421842|FG000|Overall Study|Adverse Event|1|||
44413907|NCT00447499|79421842|FG000|Overall Study|Patient Decision|4|||
44413908|NCT00447499|79421842|FG000|Overall Study|Sponsor Decision|1|||
44413909|NCT00447499|79421842|FG000|Overall Study|Physician Decision|1|||
44413910|NCT00800436|79421855|FG000|Overall Study|Withdrawal by Subject|0|||
44413911|NCT00800436|79421856|FG001|Overall Study|Withdrawal by Subject|0|||
44413912|NCT00800436|79421857|FG002|Overall Study|Withdrawal by Subject|1|||
44413913|NCT00800436|79421858|FG003|Overall Study|Withdrawal by Subject|1|||
44413914|NCT00800436|79421859|FG004|Overall Study|Withdrawal by Subject|0|||
44413915|NCT00800436|79421860|FG005|Overall Study|Withdrawal by Subject|0|||
44413916|NCT00800436|79421861|FG006|Overall Study|Withdrawal by Subject|0|||
44413917|NCT00655564|79421877|FG000|Overall Study|Adverse Event|1|||
44413918|NCT00655564|79421877|FG000|Overall Study|Lost to Follow-up|1|||
44413919|NCT00655564|79421877|FG000|Overall Study|Desired Alternate Therapy|1|||
44413920|NCT00447421|79421882|FG000|Overall Study|Lack of Efficacy|1|||
44413921|NCT00447421|79421882|FG000|Overall Study|Adverse Event|3|||
44413922|NCT00447421|79421882|FG000|Overall Study|Sponsor Decision|2|||
44413923|NCT00651118|79421890|FG000|Overall Study|Adverse Event|4|||
44413924|NCT00651118|79421891|FG001|Overall Study|Adverse Event|0|||
44413925|NCT00651118|79421892|FG002|Overall Study|Adverse Event|1|||
44413926|NCT00651118|79421893|FG003|Overall Study|Adverse Event|1|||
44413927|NCT00651118|79421890|FG000|Overall Study|Protocol Violation|2|||
44413928|NCT00651118|79421891|FG001|Overall Study|Protocol Violation|2|||
44413929|NCT00651118|79421892|FG002|Overall Study|Protocol Violation|6|||
44413930|NCT00651118|79421893|FG003|Overall Study|Protocol Violation|2|||
44413931|NCT00651118|79421890|FG000|Overall Study|Lost to Follow-up|2|||
44413932|NCT00651118|79421891|FG001|Overall Study|Lost to Follow-up|0|||
44525818|NCT04109391|79535149|FG002|Overall Study|Lack of Efficacy|3|||
44525819|NCT04106817|79535160|FG000|Overall Study|Lost to Follow-up|1|||
44525820|NCT04106817|79535161|FG001|Overall Study|Lost to Follow-up|0|||
44525821|NCT04106817|79535162|FG002|Overall Study|Lost to Follow-up|0|||
44525822|NCT04097925|79535170|FG000|Overall Study|Withdrawal by Subject|1|||
44525823|NCT04195893|79535174|FG000|Second Intervention|Withdrawal by Subject|1|||
44525824|NCT04195893|79535175|FG001|Second Intervention|Withdrawal by Subject|0|||
44525825|NCT04195581|79535181|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
44525826|NCT04195581|79535181|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
44525827|NCT04195581|79535181|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
44525828|NCT04195581|79535181|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
44525829|NCT04195581|79535181|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
44525830|NCT04195581|79535181|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
44525831|NCT04096365|79535199|FG000|Overall Study|Adverse Event|1|||
44525832|NCT04094883|79535203|FG000|Overall Study|Withdrawal by Subject|1|||
44525833|NCT01368562|79535207|FG000|Overall Study|Adverse Event|1|||
44525834|NCT01368562|79535207|FG000|Overall Study|Disease progression|1|||
44525835|NCT01368562|79535207|FG000|Overall Study|Lost to Follow-up|1|||
44525836|NCT01368562|79535207|FG000|Overall Study|Death|6|||
44525837|NCT01368562|79535207|FG000|Overall Study|Unresponsive to treatment|5|||
44525838|NCT01368562|79535207|FG000|Overall Study|Other|3|||
44525839|NCT01368562|79535207|FG000|Overall Study|Other than specified|2|||
44525840|NCT03242018|79535214|FG000|Overall Study|Adverse Event|7|||
44525841|NCT03242018|79535215|FG001|Overall Study|Adverse Event|7|||
44525842|NCT03242018|79535216|FG002|Overall Study|Adverse Event|6|||
44525843|NCT03242018|79535214|FG000|Overall Study|Lost to Follow-up|2|||
44413933|NCT00651118|79421892|FG002|Overall Study|Lost to Follow-up|1|||
44413934|NCT00651118|79421893|FG003|Overall Study|Lost to Follow-up|2|||
44413935|NCT00651118|79421890|FG000|Overall Study|administrative|1|||
44413936|NCT00651118|79421891|FG001|Overall Study|administrative|4|||
44413937|NCT00651118|79421892|FG002|Overall Study|administrative|2|||
44413938|NCT00651118|79421893|FG003|Overall Study|administrative|1|||
44413939|NCT00651118|79421890|FG000|Overall Study|Withdrawal by Subject|0|||
44413940|NCT00651118|79421891|FG001|Overall Study|Withdrawal by Subject|1|||
44413941|NCT00651118|79421892|FG002|Overall Study|Withdrawal by Subject|1|||
44413942|NCT00651118|79421893|FG003|Overall Study|Withdrawal by Subject|1|||
44413943|NCT00447265|79421906|FG000|Overall Study|Physician Decision|1|||
44413944|NCT00447265|79421907|FG001|Overall Study|Physician Decision|0|||
44413945|NCT00657358|79421911|FG000|Overall Study|Lack of Efficacy|6|||
44413946|NCT00457639|79421916|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
44413947|NCT00457639|79421917|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
44525844|NCT03242018|79535215|FG001|Overall Study|Lost to Follow-up|2|||
44525845|NCT03242018|79535216|FG002|Overall Study|Lost to Follow-up|2|||
44525846|NCT03242018|79535214|FG000|Overall Study|At the Participant's Own Request|5|||
44525847|NCT03242018|79535215|FG001|Overall Study|At the Participant's Own Request|1|||
44525848|NCT03242018|79535216|FG002|Overall Study|At the Participant's Own Request|4|||
44525849|NCT03242018|79535214|FG000|Overall Study|Reason Not Specified|3|||
44525850|NCT03242018|79535215|FG001|Overall Study|Reason Not Specified|4|||
44525851|NCT03242018|79535216|FG002|Overall Study|Reason Not Specified|1|||
44413948|NCT00457639|79421916|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
44413949|NCT00457639|79421917|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
44413950|NCT00457639|79421916|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
44413951|NCT00457639|79421917|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
44413952|NCT00800202|79421925|FG000|Overall Study|Adverse Event|7|||
44413953|NCT00800202|79421926|FG001|Overall Study|Adverse Event|6|||
44413954|NCT00800202|79421925|FG000|Overall Study|Death|1|||
44413955|NCT00800202|79421926|FG001|Overall Study|Death|0|||
44413956|NCT00800202|79421925|FG000|Overall Study|Other|5|||
44413957|NCT00800202|79421926|FG001|Overall Study|Other|0|||
44413958|NCT00800202|79421925|FG000|Overall Study|Disease Progression|54|||
44413959|NCT00800202|79421926|FG001|Overall Study|Disease Progression|18|||
44413960|NCT00655486|79421932|FG000|Overall Study|Adverse Event|10|||
44413961|NCT00655486|79421932|FG000|Overall Study|Lack of Efficacy|8|||
44413962|NCT00655486|79421932|FG000|Overall Study|Withdrawal by Subject|4|||
44413963|NCT00655486|79421932|FG000|Overall Study|Protocol Violation|1|||
44413964|NCT00655486|79421932|FG000|Overall Study|Unsatisfactory compliance|2|||
44413965|NCT00655486|79421932|FG000|Overall Study|Other: Pregnancy|1|||
44413966|NCT00655486|79421932|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
44413967|NCT00655486|79421932|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
44413968|NCT00457249|79421938|FG000|Overall Study|Lost to Follow-up|3|||
44413969|NCT00457249|79421939|FG001|Overall Study|Lost to Follow-up|0|||
44413970|NCT00457249|79421938|FG000|Overall Study|Protocol Violation|4|||
44413971|NCT00457249|79421939|FG001|Overall Study|Protocol Violation|1|||
44413972|NCT00457249|79421938|FG000|Overall Study|Withdrawal by Subject|3|||
44413973|NCT00457249|79421939|FG001|Overall Study|Withdrawal by Subject|1|||
44413974|NCT00457249|79421938|FG000|Overall Study|Serious Adverse Events|2|||
44413975|NCT00457249|79421939|FG001|Overall Study|Serious Adverse Events|0|||
44413976|NCT00457015|79421949|FG000|Overall Study|Left study site against medical advice|0|||
44413977|NCT00457015|79421950|FG001|Overall Study|Left study site against medical advice|1|||
44413978|NCT00654940|79421958|FG000|Period 1|Adverse Event|0|||
44413979|NCT00654940|79421959|FG001|Period 1|Adverse Event|1|||
44413980|NCT00654940|79421958|FG000|Period 1|Intolerable Pain Level|1|||
44413981|NCT00654940|79421959|FG001|Period 1|Intolerable Pain Level|0|||
44413982|NCT00588666|79421971|FG000|Overall Study|Adverse Event|4|||
44413983|NCT00793182|79421986|FG000|Overall Study|Adverse Event|0|||
44413984|NCT00793182|79421987|FG001|Overall Study|Adverse Event|1|||
44413985|NCT00793104|79421993|FG000|Overall Study|Lost to Follow-up|1|||
44413986|NCT00446797|79421999|FG000|Overall Study|Lack of Efficacy|0|||
44413987|NCT00446797|79422000|FG001|Overall Study|Lack of Efficacy|2|||
44413988|NCT00446797|79421999|FG000|Overall Study|Lost to Follow-up|5|||
44413989|NCT00446797|79422000|FG001|Overall Study|Lost to Follow-up|3|||
44413990|NCT00446797|79421999|FG000|Overall Study|Withdrawal by Subject|2|||
44413991|NCT00446797|79422000|FG001|Overall Study|Withdrawal by Subject|2|||
44413992|NCT00446797|79421999|FG000|Overall Study|Protocol Violation|1|||
44413993|NCT00446797|79422000|FG001|Overall Study|Protocol Violation|3|||
44413994|NCT00446797|79421999|FG000|Overall Study|subject entered at another site|0|||
44413995|NCT00446797|79422000|FG001|Overall Study|subject entered at another site|1|||
44413996|NCT00446797|79421999|FG000|Overall Study|did not meet entrance criteria|0|||
44525852|NCT03242018|79535214|FG000|Overall Study|Study Terminated by Sponsor|1|||
44525853|NCT03242018|79535215|FG001|Overall Study|Study Terminated by Sponsor|0|||
44525854|NCT03242018|79535216|FG002|Overall Study|Study Terminated by Sponsor|1|||
44525855|NCT02789176|79535229|FG000|Overall Study|Death|0|||
44525856|NCT02789176|79535230|FG001|Overall Study|Death|0|||
44148694|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
44148695|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
44148696|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
44254145|NCT00129935|79095315|FG001|Overall Study|Incorrect study treatment|0|||
44413997|NCT00446797|79422000|FG001|Overall Study|did not meet entrance criteria|1|||
44413998|NCT00855335|79422011|FG000|Overall Study|Lost to Follow-up|0|||
44413999|NCT00855335|79422012|FG001|Overall Study|Lost to Follow-up|0|||
44414000|NCT00855335|79422013|FG002|Overall Study|Lost to Follow-up|3|||
44414001|NCT00855335|79422014|FG003|Overall Study|Lost to Follow-up|1|||
44414002|NCT00855335|79422015|FG004|Overall Study|Lost to Follow-up|0|||
44414003|NCT00855335|79422011|FG000|Overall Study|Withdrawal by Subject|0|||
44414004|NCT00855335|79422012|FG001|Overall Study|Withdrawal by Subject|0|||
44414005|NCT00855335|79422013|FG002|Overall Study|Withdrawal by Subject|0|||
44414006|NCT00855335|79422014|FG003|Overall Study|Withdrawal by Subject|1|||
44414007|NCT00855335|79422015|FG004|Overall Study|Withdrawal by Subject|0|||
44414008|NCT00855335|79422011|FG000|Overall Study|Adverse Event|2|||
44525857|NCT02789176|79535231|FG002|Overall Study|Death|3|||
44525858|NCT02789176|79535232|FG003|Overall Study|Death|0|||
44148697|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
44148698|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
44148699|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
44414009|NCT00855335|79422012|FG001|Overall Study|Adverse Event|0|||
44414010|NCT00855335|79422013|FG002|Overall Study|Adverse Event|0|||
44414011|NCT00855335|79422014|FG003|Overall Study|Adverse Event|0|||
44414012|NCT00855335|79422015|FG004|Overall Study|Adverse Event|0|||
44414013|NCT00855335|79422011|FG000|Overall Study|Physician Decision|1|||
44414014|NCT00855335|79422012|FG001|Overall Study|Physician Decision|1|||
44414015|NCT00855335|79422013|FG002|Overall Study|Physician Decision|0|||
44414016|NCT00855335|79422014|FG003|Overall Study|Physician Decision|0|||
44254146|NCT01647828|79095330|FG000|Overall Study|Death|3|||
44254147|NCT01647828|79095331|FG001|Overall Study|Death|4|||
44414017|NCT00855335|79422015|FG004|Overall Study|Physician Decision|0|||
44414018|NCT00855335|79422011|FG000|Overall Study|Other|2|||
44414019|NCT00855335|79422012|FG001|Overall Study|Other|1|||
44414020|NCT00855335|79422013|FG002|Overall Study|Other|2|||
44414021|NCT00855335|79422014|FG003|Overall Study|Other|5|||
44414022|NCT00855335|79422015|FG004|Overall Study|Other|1|||
44414023|NCT00799422|79422040|FG000|First Week of Wear|Lost to Follow-up|0|||
44414024|NCT00799422|79422041|FG001|First Week of Wear|Lost to Follow-up|0|||
44414025|NCT00799422|79422042|FG002|First Week of Wear|Lost to Follow-up|1|||
44414026|NCT00799422|79422043|FG003|First Week of Wear|Lost to Follow-up|0|||
44414027|NCT00799422|79422044|FG004|First Week of Wear|Lost to Follow-up|0|||
44414028|NCT00799422|79422045|FG005|First Week of Wear|Lost to Follow-up|0|||
44414029|NCT00799422|79422040|FG000|First Week of Wear|Adverse Event|0|||
44414030|NCT00799422|79422041|FG001|First Week of Wear|Adverse Event|0|||
44414031|NCT00799422|79422042|FG002|First Week of Wear|Adverse Event|0|||
44414032|NCT00799422|79422043|FG003|First Week of Wear|Adverse Event|1|||
44414033|NCT00799422|79422044|FG004|First Week of Wear|Adverse Event|0|||
44414034|NCT00799422|79422045|FG005|First Week of Wear|Adverse Event|0|||
44414035|NCT00593489|79422055|FG000|Allocation|did not attend workshop; allocation not|2|||
44414036|NCT00593489|79422056|FG001|Allocation|did not attend workshop; allocation not|1|||
44414037|NCT00446641|79422066|FG000|Overall Study|Withdrawal by Subject|8|||
44414038|NCT00446641|79422067|FG001|Overall Study|Withdrawal by Subject|3|||
44414039|NCT00446641|79422066|FG000|Overall Study|poor compliance|8|||
44414040|NCT00446641|79422067|FG001|Overall Study|poor compliance|6|||
44414041|NCT00446641|79422066|FG000|Overall Study|Lost to Follow-up|1|||
44414042|NCT00446641|79422067|FG001|Overall Study|Lost to Follow-up|1|||
44414043|NCT00646282|79422075|FG000|Overall Study|Protocol terminated|4|||
44414044|NCT00646282|79422076|FG001|Overall Study|Protocol terminated|4|||
44414045|NCT00792636|79422085|FG000|Overall Study|Protocol Violation|17|||
44414046|NCT00792636|79422086|FG001|Overall Study|Protocol Violation|23|||
44414047|NCT00792636|79422087|FG002|Overall Study|Protocol Violation|20|||
44414048|NCT00792636|79422085|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
44414049|NCT00792636|79422086|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
44414050|NCT00792636|79422087|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
44414051|NCT00792636|79422085|FG000|Overall Study|Lost to Follow-up|13|||
44414052|NCT00792636|79422086|FG001|Overall Study|Lost to Follow-up|19|||
44414053|NCT00792636|79422087|FG002|Overall Study|Lost to Follow-up|14|||
44414054|NCT00792636|79422085|FG000|Overall Study|Withdrew Consent|10|||
44414055|NCT00792636|79422086|FG001|Overall Study|Withdrew Consent|13|||
44414056|NCT00792636|79422087|FG002|Overall Study|Withdrew Consent|9|||
44414057|NCT00792636|79422085|FG000|Overall Study|Lack of Efficacy|3|||
44414058|NCT00792636|79422086|FG001|Overall Study|Lack of Efficacy|4|||
44414059|NCT00792636|79422087|FG002|Overall Study|Lack of Efficacy|13|||
44414060|NCT00792636|79422085|FG000|Overall Study|Adverse Event|4|||
44414061|NCT00792636|79422086|FG001|Overall Study|Adverse Event|2|||
44414062|NCT00792636|79422087|FG002|Overall Study|Adverse Event|3|||
44414063|NCT00792636|79422085|FG000|Overall Study|Investigator Discretion|2|||
44414064|NCT00792636|79422086|FG001|Overall Study|Investigator Discretion|0|||
44414065|NCT00792636|79422087|FG002|Overall Study|Investigator Discretion|2|||
44414066|NCT00446563|79422099|FG000|Overall Study|Adverse Event|4|||
44414067|NCT00446563|79422100|FG001|Overall Study|Adverse Event|3|||
44414068|NCT00446563|79422099|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44414069|NCT00446563|79422100|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44414070|NCT00446563|79422099|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44414071|NCT00446563|79422100|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44414072|NCT00446563|79422099|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44414073|NCT00446563|79422100|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44414074|NCT00446563|79422099|FG000|Overall Study|Withdrawal by Subject|2|||
44414075|NCT00446563|79422100|FG001|Overall Study|Withdrawal by Subject|1|||
44414076|NCT00446563|79422099|FG000|Overall Study|Administrative problems|0|||
44414077|NCT00446563|79422100|FG001|Overall Study|Administrative problems|1|||
44414078|NCT00650806|79422110|FG000|Overall Study|Adverse Event|0|||
44414079|NCT00650806|79422111|FG001|Overall Study|Adverse Event|5|||
44254148|NCT01647828|79095332|FG002|Overall Study|Death|4|||
44414080|NCT00650806|79422112|FG002|Overall Study|Adverse Event|3|||
44414081|NCT00650806|79422113|FG003|Overall Study|Adverse Event|4|||
44414082|NCT00650806|79422110|FG000|Overall Study|Lost to Follow-up|7|||
44414083|NCT00650806|79422111|FG001|Overall Study|Lost to Follow-up|6|||
44414084|NCT00650806|79422112|FG002|Overall Study|Lost to Follow-up|11|||
44414085|NCT00650806|79422113|FG003|Overall Study|Lost to Follow-up|10|||
44414086|NCT00650806|79422110|FG000|Overall Study|Protocol Violation|0|||
44414087|NCT00650806|79422111|FG001|Overall Study|Protocol Violation|0|||
44414088|NCT00650806|79422112|FG002|Overall Study|Protocol Violation|0|||
44414089|NCT00650806|79422113|FG003|Overall Study|Protocol Violation|1|||
44414090|NCT00650806|79422110|FG000|Overall Study|Pregnancy|0|||
44414091|NCT00650806|79422111|FG001|Overall Study|Pregnancy|0|||
44525859|NCT02789176|79535229|FG000|Overall Study|Withdrawal by Subject|0|||
44525860|NCT02789176|79535230|FG001|Overall Study|Withdrawal by Subject|0|||
44525861|NCT02789176|79535231|FG002|Overall Study|Withdrawal by Subject|1|||
44525862|NCT02789176|79535232|FG003|Overall Study|Withdrawal by Subject|0|||
44525863|NCT02789176|79535229|FG000|Overall Study|Lost to Follow-up|8|||
44525864|NCT02789176|79535230|FG001|Overall Study|Lost to Follow-up|2|||
44525865|NCT02789176|79535231|FG002|Overall Study|Lost to Follow-up|6|||
44525866|NCT02789176|79535232|FG003|Overall Study|Lost to Follow-up|1|||
44525867|NCT03259490|79535244|FG000|Period 1|Withdrawal by Subject|0|||
44525868|NCT03259490|79535245|FG001|Period 1|Withdrawal by Subject|1|||
44525869|NCT03259490|79535244|FG000|Period 2|Protocol Violation|1|||
44525870|NCT03259490|79535245|FG001|Period 2|Protocol Violation|0|||
44525871|NCT03259334|79535254|FG000|Overall Study|Adverse Event|3|||
44525872|NCT03259334|79535255|FG001|Overall Study|Adverse Event|8|||
44525873|NCT03259334|79535256|FG002|Overall Study|Adverse Event|5|||
44525874|NCT03259334|79535254|FG000|Overall Study|Withdrawal by Subject|4|||
44525875|NCT03259334|79535255|FG001|Overall Study|Withdrawal by Subject|2|||
44525876|NCT03259334|79535256|FG002|Overall Study|Withdrawal by Subject|4|||
44525877|NCT03259334|79535254|FG000|Overall Study|Physician Decision|1|||
44525878|NCT03259334|79535255|FG001|Overall Study|Physician Decision|0|||
44525879|NCT03259334|79535256|FG002|Overall Study|Physician Decision|0|||
44254149|NCT01647828|79095333|FG003|Overall Study|Death|5|||
44414092|NCT00650806|79422112|FG002|Overall Study|Pregnancy|0|||
44525880|NCT03259334|79535254|FG000|Overall Study|Lost to Follow-up|0|||
44254150|NCT01647828|79095334|FG004|Overall Study|Death|6|||
44525881|NCT03259334|79535255|FG001|Overall Study|Lost to Follow-up|2|||
44254151|NCT01647828|79095335|FG005|Overall Study|Death|3|||
44254152|NCT01647828|79095336|FG006|Overall Study|Death|10|||
44254153|NCT01647828|79095337|FG007|Overall Study|Death|60|||
44254154|NCT01647828|79095338|FG008|Overall Study|Death|71|||
44254155|NCT01647828|79095330|FG000|Overall Study|Withdrawal by Subject|2|||
44414093|NCT00650806|79422113|FG003|Overall Study|Pregnancy|1|||
44254156|NCT01647828|79095331|FG001|Overall Study|Withdrawal by Subject|0|||
44414094|NCT00650806|79422110|FG000|Overall Study|Withdrawal by Subject|7|||
44525882|NCT03259334|79535256|FG002|Overall Study|Lost to Follow-up|1|||
44525883|NCT03259334|79535254|FG000|Overall Study|Protocol Deviation|0|||
44414095|NCT00650806|79422111|FG001|Overall Study|Withdrawal by Subject|5|||
44414096|NCT00650806|79422112|FG002|Overall Study|Withdrawal by Subject|8|||
44414097|NCT00650806|79422113|FG003|Overall Study|Withdrawal by Subject|6|||
44414098|NCT00650806|79422110|FG000|Overall Study|Noncompliance with study drug regimen|1|||
44414099|NCT00650806|79422111|FG001|Overall Study|Noncompliance with study drug regimen|1|||
44414100|NCT00650806|79422112|FG002|Overall Study|Noncompliance with study drug regimen|0|||
44414101|NCT00650806|79422113|FG003|Overall Study|Noncompliance with study drug regimen|0|||
44254157|NCT01647828|79095332|FG002|Overall Study|Withdrawal by Subject|0|||
44414102|NCT00650806|79422110|FG000|Overall Study|Study terminated by sponsor|2|||
44414103|NCT00650806|79422111|FG001|Overall Study|Study terminated by sponsor|3|||
44414104|NCT00650806|79422112|FG002|Overall Study|Study terminated by sponsor|5|||
44414105|NCT00650806|79422113|FG003|Overall Study|Study terminated by sponsor|4|||
44414106|NCT00650806|79422110|FG000|Overall Study|Other|1|||
44414107|NCT00650806|79422111|FG001|Overall Study|Other|1|||
44414108|NCT00650806|79422112|FG002|Overall Study|Other|2|||
44414109|NCT00650806|79422113|FG003|Overall Study|Other|0|||
44414110|NCT00863057|79422129|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
44414111|NCT00863057|79422130|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
44414112|NCT00863057|79422131|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
44414113|NCT00863057|79422132|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
44414114|NCT00863057|79422129|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
44414115|NCT00863057|79422130|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
44414116|NCT00863057|79422131|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
44414117|NCT00863057|79422132|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
44414118|NCT00863057|79422129|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
44414119|NCT00863057|79422130|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
44414120|NCT00863057|79422131|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
44414121|NCT00863057|79422132|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
44414122|NCT00863057|79422129|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
44414123|NCT00863057|79422130|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
44414124|NCT00863057|79422131|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
44414125|NCT00863057|79422132|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
44414126|NCT00829166|79422150|FG000|Overall Study|Death|305|||
44414127|NCT00829166|79422151|FG001|Overall Study|Death|333|||
44414128|NCT00829166|79422150|FG000|Overall Study|Lost to Follow-up|5|||
44414129|NCT00829166|79422151|FG001|Overall Study|Lost to Follow-up|4|||
44414130|NCT00829166|79422150|FG000|Overall Study|Physician's Decision|4|||
44414131|NCT00829166|79422151|FG001|Overall Study|Physician's Decision|3|||
44414132|NCT00829166|79422150|FG000|Overall Study|Subject's Decision|41|||
44414133|NCT00829166|79422151|FG001|Overall Study|Subject's Decision|55|||
44414134|NCT00829166|79422150|FG000|Overall Study|Sponsor's Decision|137|||
44254158|NCT01647828|79095333|FG003|Overall Study|Withdrawal by Subject|1|||
44254159|NCT01647828|79095334|FG004|Overall Study|Withdrawal by Subject|0|||
44254160|NCT01647828|79095335|FG005|Overall Study|Withdrawal by Subject|0|||
44282286|NCT01860534|79245581|FG001|ROP #2|discharged prior to ROP #2|0|||
44414135|NCT00829166|79422151|FG001|Overall Study|Sponsor's Decision|98|||
44414136|NCT00829166|79422150|FG000|Overall Study|Reason Not Specified|3|||
44414137|NCT00829166|79422151|FG001|Overall Study|Reason Not Specified|3|||
44414138|NCT00799266|79422160|FG000|Overall Study|Adverse Event|0|||
44414139|NCT00799266|79422161|FG001|Overall Study|Adverse Event|1|||
44414140|NCT00799266|79422160|FG000|Overall Study|Subject withdrew consent|3|||
44414141|NCT00799266|79422161|FG001|Overall Study|Subject withdrew consent|0|||
44414142|NCT00650104|79422167|FG000|Overall Study|Adverse Event|17|||
44414143|NCT00650104|79422167|FG000|Overall Study|Death|2|||
44414144|NCT00650104|79422167|FG000|Overall Study|Withdrawal by Subject|11|||
44414145|NCT00650104|79422167|FG000|Overall Study|Physician Decision|7|||
44414146|NCT00650104|79422167|FG000|Overall Study|Lost to Follow-up|1|||
44414147|NCT00650104|79422167|FG000|Overall Study|Non-compliance|2|||
44414148|NCT00650104|79422167|FG000|Overall Study|Sponsor Terminated Dosing|1|||
44414149|NCT00654238|79422171|FG000|Overall Study|Screen Failures|4|||
44414150|NCT00862979|79422178|FG000|Overall Study|Adverse Event|6|||
44414151|NCT00862979|79422179|FG001|Overall Study|Adverse Event|3|||
44414152|NCT00862979|79422178|FG000|Overall Study|Protocol Violation|0|||
44414153|NCT00862979|79422179|FG001|Overall Study|Protocol Violation|1|||
44414154|NCT00862979|79422178|FG000|Overall Study|Patient withdrew consent|2|||
44414155|NCT00862979|79422179|FG001|Overall Study|Patient withdrew consent|1|||
44414156|NCT00862979|79422178|FG000|Overall Study|Administrative problems|0|||
44414157|NCT00862979|79422179|FG001|Overall Study|Administrative problems|1|||
44414158|NCT00862979|79422178|FG000|Overall Study|Death|0|||
44254161|NCT01647828|79095336|FG006|Overall Study|Withdrawal by Subject|1|||
44254162|NCT01647828|79095337|FG007|Overall Study|Withdrawal by Subject|0|||
44254163|NCT01647828|79095338|FG008|Overall Study|Withdrawal by Subject|2|||
44414159|NCT00862979|79422179|FG001|Overall Study|Death|1|||
44414160|NCT00483379|79422187|FG000|Treatment Period|Adverse Event|1|||
44414161|NCT00483379|79422188|FG001|Treatment Period|Adverse Event|0|||
44414162|NCT00483379|79422187|FG000|Treatment Period|Withdrawal by Subject|1|||
44414163|NCT00483379|79422188|FG001|Treatment Period|Withdrawal by Subject|0|||
44414164|NCT00446251|79422196|FG000|Overall Study|On-study Transplants|2|||
44414165|NCT00446251|79422196|FG000|Overall Study|Rituximab Infusion Reaction|2|||
44414166|NCT00446251|79422196|FG000|Overall Study|Lost to Follow-up|1|||
44414167|NCT00796224|79422202|FG000|Overall Study|Adverse Event|1|||
44414168|NCT00796224|79422203|FG001|Overall Study|Adverse Event|0|||
44414169|NCT00796224|79422202|FG000|Overall Study|Protocol Violation|0|||
44414170|NCT00796224|79422203|FG001|Overall Study|Protocol Violation|1|||
44414171|NCT00791934|79422211|FG000|Overall Study|Withdrawal by Subject|2|||
44414172|NCT00791934|79422211|FG000|Overall Study|Did not consent for extended follow-up|13|||
44414173|NCT00848081|79422217|FG000|Overall Study|Adverse Event|6|||
44414174|NCT00848081|79422218|FG001|Overall Study|Adverse Event|7|||
44414175|NCT00848081|79422217|FG000|Overall Study|Protocol Violation|8|||
44414176|NCT00848081|79422218|FG001|Overall Study|Protocol Violation|5|||
44414177|NCT00848081|79422217|FG000|Overall Study|Lost to Follow-up|1|||
44414178|NCT00848081|79422218|FG001|Overall Study|Lost to Follow-up|0|||
44414179|NCT00848081|79422217|FG000|Overall Study|Physician Decision|0|||
44414180|NCT00848081|79422218|FG001|Overall Study|Physician Decision|3|||
44414181|NCT00848081|79422217|FG000|Overall Study|Withdrawal by Subject|5|||
44414182|NCT00848081|79422218|FG001|Overall Study|Withdrawal by Subject|3|||
44414183|NCT00654004|79422226|FG000|Overall Study|Lost to Follow-up|1|||
44414184|NCT00654004|79422227|FG001|Overall Study|Lost to Follow-up|0|||
44414185|NCT00791778|79422235|FG000|Double-blind Treatment|Adverse Event|49|||
44414186|NCT00791778|79422236|FG001|Double-blind Treatment|Adverse Event|9|||
44414187|NCT00791778|79422235|FG000|Double-blind Treatment|Physician Decision|6|||
44414188|NCT00791778|79422236|FG001|Double-blind Treatment|Physician Decision|26|||
44414189|NCT00791778|79422235|FG000|Double-blind Treatment|Protocol Violation|0|||
44414190|NCT00791778|79422236|FG001|Double-blind Treatment|Protocol Violation|4|||
44414191|NCT00791778|79422235|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
44414192|NCT00791778|79422236|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
44414193|NCT00791778|79422235|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
44414194|NCT00791778|79422236|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
44414195|NCT00791778|79422235|FG000|Follow-up|Withdrawal by Subject|3|||
44414196|NCT00791778|79422236|FG001|Follow-up|Withdrawal by Subject|0|||
44414197|NCT00791778|79422235|FG000|Follow-up|Lost to Follow-up|2|||
44414198|NCT00791778|79422236|FG001|Follow-up|Lost to Follow-up|1|||
44414199|NCT00798174|79422242|FG000|Overall Study|inability to implant azygos coil|3|||
44414200|NCT00798174|79422243|FG001|Overall Study|inability to implant azygos coil|3|||
44414201|NCT00798174|79422242|FG000|Overall Study|Inability to sedate for DFT testing|1|||
44414202|NCT00798174|79422243|FG001|Overall Study|Inability to sedate for DFT testing|0|||
44414203|NCT00798096|79422247|FG000|Overall Study|Ongoing|2|||
44414204|NCT00795600|79422253|FG000|Overall Study|Adverse Event|1|||
44414205|NCT00795600|79422254|FG001|Overall Study|Adverse Event|1|||
44414206|NCT00795600|79422253|FG000|Overall Study|Protocol Violation|1|||
44525884|NCT03259334|79535255|FG001|Overall Study|Protocol Deviation|3|||
44414207|NCT00795600|79422254|FG001|Overall Study|Protocol Violation|2|||
44414208|NCT00795600|79422253|FG000|Overall Study|Withdrawal by Subject|1|||
44414209|NCT00795600|79422254|FG001|Overall Study|Withdrawal by Subject|0|||
44414210|NCT00795600|79422253|FG000|Overall Study|Unclassified|1|||
44414211|NCT00795600|79422254|FG001|Overall Study|Unclassified|1|||
44414212|NCT00795132|79422260|FG000|Overall Study|Death|1|||
44414213|NCT00795132|79422260|FG000|Overall Study|Relapse|2|||
44414214|NCT00647296|79422276|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
44414215|NCT00647296|79422277|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
44414216|NCT00647296|79422278|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
44525885|NCT03259334|79535256|FG002|Overall Study|Protocol Deviation|2|||
44414217|NCT00647296|79422279|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
44414218|NCT00647296|79422276|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
44414219|NCT00647296|79422277|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
44414220|NCT00647296|79422278|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
44414221|NCT00647296|79422279|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
44414222|NCT00647296|79422276|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
44414223|NCT00647296|79422277|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
44414224|NCT00647296|79422278|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
44414225|NCT00647296|79422279|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
44414226|NCT00647296|79422276|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
44414227|NCT00647296|79422277|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
44414228|NCT00647296|79422278|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
44414229|NCT00647296|79422279|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
44414230|NCT00647296|79422276|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
44414231|NCT00647296|79422277|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
44414232|NCT00647296|79422278|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
44414233|NCT00647296|79422279|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
44414234|NCT00647296|79422276|FG000|Part 2: 4-week Placebo Washout|Death|3|||
44414235|NCT00647296|79422277|FG001|Part 2: 4-week Placebo Washout|Death|0|||
44414236|NCT00647296|79422278|FG002|Part 2: 4-week Placebo Washout|Death|0|||
44414237|NCT00647296|79422279|FG003|Part 2: 4-week Placebo Washout|Death|0|||
44414238|NCT00647296|79422276|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
44414239|NCT00647296|79422277|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
44414240|NCT00647296|79422278|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
44414241|NCT00647296|79422279|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
44414242|NCT00647296|79422276|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
44414243|NCT00647296|79422277|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
44414244|NCT00647296|79422278|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
44414245|NCT00647296|79422279|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
44525886|NCT03259334|79535254|FG000|Overall Study|Lack of Efficacy|2|||
44525887|NCT03259334|79535255|FG001|Overall Study|Lack of Efficacy|0|||
44525888|NCT03259334|79535256|FG002|Overall Study|Lack of Efficacy|1|||
44525889|NCT03259334|79535254|FG000|Overall Study|Randomized but never treated|0|||
44525890|NCT03259334|79535255|FG001|Overall Study|Randomized but never treated|2|||
44525891|NCT03259334|79535256|FG002|Overall Study|Randomized but never treated|0|||
44525892|NCT01331824|79535264|FG000|Overall Study|Adverse Event|2|||
44525893|NCT01331824|79535264|FG000|Overall Study|Death|1|||
44525894|NCT01331824|79535264|FG000|Overall Study|Disease Progression|9|||
44525895|NCT01331824|79535264|FG000|Overall Study|Withdrawal by Subject|1|||
44525896|NCT03258710|79535268|FG000|Overall Study|Adverse Event|1|||
44254164|NCT01647828|79095330|FG000|Overall Study|Study terminated by Sponsor|0|||
44254165|NCT01647828|79095331|FG001|Overall Study|Study terminated by Sponsor|0|||
44254166|NCT01647828|79095332|FG002|Overall Study|Study terminated by Sponsor|0|||
44254167|NCT01647828|79095333|FG003|Overall Study|Study terminated by Sponsor|0|||
44254168|NCT01647828|79095334|FG004|Overall Study|Study terminated by Sponsor|0|||
44254169|NCT01647828|79095335|FG005|Overall Study|Study terminated by Sponsor|0|||
44414246|NCT00647296|79422276|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
44414247|NCT00647296|79422277|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
44414248|NCT00647296|79422278|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
44414249|NCT00647296|79422279|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
44414250|NCT00647296|79422276|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
44414251|NCT00647296|79422277|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
44414252|NCT00647296|79422278|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
44525897|NCT03258710|79535268|FG000|Overall Study|Protocol-defined stopping criteria|1|||
44525898|NCT03258710|79535268|FG000|Overall Study|Physician Decision|1|||
44525899|NCT03240692|79535272|FG000|Overall Study|Physician Decision|1|||
44525900|NCT03240692|79535272|FG000|Overall Study|Withdrawal by Subject|1|||
44525901|NCT03233048|79535276|FG000|Overall Study|Withdrawal by Subject|1|||
44525902|NCT02937740|79535282|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
44254170|NCT01647828|79095336|FG006|Overall Study|Study terminated by Sponsor|1|||
44254171|NCT01647828|79095337|FG007|Overall Study|Study terminated by Sponsor|26|||
44254172|NCT01647828|79095338|FG008|Overall Study|Study terminated by Sponsor|16|||
44254173|NCT01647828|79095330|FG000|Overall Study|Lost to Follow-up|0|||
44254174|NCT01647828|79095331|FG001|Overall Study|Lost to Follow-up|0|||
44254175|NCT01647828|79095332|FG002|Overall Study|Lost to Follow-up|0|||
44254176|NCT01647828|79095333|FG003|Overall Study|Lost to Follow-up|0|||
44254177|NCT01647828|79095334|FG004|Overall Study|Lost to Follow-up|0|||
44525903|NCT02937740|79535283|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
44525904|NCT02937740|79535282|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
44254178|NCT01647828|79095335|FG005|Overall Study|Lost to Follow-up|0|||
44254179|NCT01647828|79095336|FG006|Overall Study|Lost to Follow-up|0|||
44525905|NCT02937740|79535283|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
44414253|NCT00647296|79422279|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
44414254|NCT00647296|79422276|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
44414255|NCT00647296|79422277|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
44414256|NCT00647296|79422278|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
44414257|NCT00647296|79422279|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
44414258|NCT00644878|79422301|FG000|Overall Study|Adverse Event|2|||
44414259|NCT00644878|79422301|FG000|Overall Study|Abnormal laboratory value|3|||
44414260|NCT00644878|79422301|FG000|Overall Study|Protocol deviation|2|||
44414261|NCT00644878|79422301|FG000|Overall Study|Treatment duration completed as per protocol|11|||
44414262|NCT00646906|79422309|FG000|Crossover Period 1|Withdrawal by Subject|1|||
44414263|NCT00646906|79422310|FG001|Crossover Period 1|Withdrawal by Subject|0|||
44414264|NCT00646906|79422311|FG002|Crossover Period 1|Withdrawal by Subject|0|||
44414265|NCT00646906|79422312|FG003|Crossover Period 1|Withdrawal by Subject|0|||
44414266|NCT00646906|79422313|FG004|Crossover Period 1|Withdrawal by Subject|0|||
44414267|NCT00646906|79422314|FG005|Crossover Period 1|Withdrawal by Subject|1|||
44414268|NCT00646906|79422315|FG006|Crossover Period 1|Withdrawal by Subject|0|||
44414269|NCT00646906|79422309|FG000|Crossover Period 2|Withdrawal by Subject|0|||
44414270|NCT00646906|79422310|FG001|Crossover Period 2|Withdrawal by Subject|1|||
44525906|NCT02937740|79535282|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
44525907|NCT02937740|79535283|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
44525908|NCT02937740|79535282|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
44254180|NCT01647828|79095337|FG007|Overall Study|Lost to Follow-up|2|||
44254181|NCT01647828|79095338|FG008|Overall Study|Lost to Follow-up|0|||
44254182|NCT00989261|79095360|FG000|Overall Study|Still in follow up|12|||
44254183|NCT00989261|79095361|FG001|Overall Study|Still in follow up|21|||
44254184|NCT00989261|79095360|FG000|Overall Study|Withdrawal by Subject|0|||
44254185|NCT00989261|79095361|FG001|Overall Study|Withdrawal by Subject|1|||
44254186|NCT00989261|79095360|FG000|Overall Study|Lost to Follow-up|3|||
44254187|NCT00989261|79095361|FG001|Overall Study|Lost to Follow-up|0|||
44254188|NCT00988559|79095380|FG000|Overall Study|Withdrawal by Subject|1|||
44254189|NCT00988559|79095381|FG001|Overall Study|Withdrawal by Subject|1|||
44254190|NCT00988559|79095382|FG002|Overall Study|Withdrawal by Subject|0|||
44254191|NCT00988559|79095383|FG003|Overall Study|Withdrawal by Subject|1|||
44254192|NCT00988559|79095380|FG000|Overall Study|Pregnancy|0|||
44254193|NCT00988559|79095381|FG001|Overall Study|Pregnancy|1|||
44254194|NCT00988559|79095382|FG002|Overall Study|Pregnancy|1|||
44254195|NCT00988559|79095383|FG003|Overall Study|Pregnancy|0|||
44254196|NCT00988559|79095380|FG000|Overall Study|Lost to Follow-up|0|||
44254197|NCT00988559|79095381|FG001|Overall Study|Lost to Follow-up|0|||
44254198|NCT00988559|79095382|FG002|Overall Study|Lost to Follow-up|1|||
44254199|NCT00988559|79095383|FG003|Overall Study|Lost to Follow-up|0|||
44254200|NCT00988169|79095393|FG000|Overall Study|Withdrawal by Subject|1|||
44254201|NCT00988091|79095420|FG000|Double-blind Period|Withdrawal by Subject|15|||
44525909|NCT02937740|79535283|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
44525910|NCT02937740|79535282|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
44525911|NCT02937740|79535283|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
44254202|NCT00988091|79095421|FG001|Double-blind Period|Withdrawal by Subject|13|||
44254203|NCT00988091|79095420|FG000|Double-blind Period|Lost to Follow-up|12|||
44254204|NCT00988091|79095421|FG001|Double-blind Period|Lost to Follow-up|14|||
44254205|NCT00988091|79095420|FG000|Double-blind Period|Other|8|||
44254206|NCT00988091|79095421|FG001|Double-blind Period|Other|8|||
44525912|NCT02937740|79535282|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
44254207|NCT00988091|79095420|FG000|Double-blind Period|Adverse Event|6|||
44254208|NCT00988091|79095421|FG001|Double-blind Period|Adverse Event|9|||
44254209|NCT00988091|79095420|FG000|Double-blind Period|Use of exclusionary medication|2|||
44525913|NCT02937740|79535283|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
44525914|NCT04173741|79535306|FG000|Overall Study|IVC measurement cannot be done|1|||
44525915|NCT04173741|79535307|FG001|Overall Study|IVC measurement cannot be done|1|||
44525916|NCT03231800|79535315|FG000|Overall Study|Lost to Follow-up|0|||
44525917|NCT03231800|79535316|FG001|Overall Study|Lost to Follow-up|2|||
44525918|NCT03231800|79535315|FG000|Overall Study|Protocol Violation|1|||
44525919|NCT03231800|79535316|FG001|Overall Study|Protocol Violation|1|||
44525920|NCT03231800|79535315|FG000|Overall Study|reason not provided|2|||
44525921|NCT03231800|79535316|FG001|Overall Study|reason not provided|0|||
44525922|NCT04085601|79535324|FG000|Overall Study|Lost to Follow-up|1|||
44525923|NCT04085601|79535325|FG001|Overall Study|Lost to Follow-up|0|||
44525924|NCT04085601|79535324|FG000|Overall Study|Death|1|||
44525925|NCT04085601|79535325|FG001|Overall Study|Death|1|||
44525926|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
44525927|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
44525928|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
44525929|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
44525930|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
44525931|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
44525932|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
44525933|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
44525934|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
44525935|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
44525936|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
44148700|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
44525937|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
44525938|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
44525939|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
44525940|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
44525941|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
44525942|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
44525943|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
44525944|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
44525945|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
44525946|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
44525947|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
44525948|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
44525949|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
44525950|NCT03230864|79535334|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
44525951|NCT03230864|79535335|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
44525952|NCT03230864|79535336|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
44525953|NCT03230864|79535337|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
44525954|NCT03230864|79535334|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
44525955|NCT03230864|79535335|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
44525956|NCT03230864|79535336|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
44525957|NCT03230864|79535337|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
44148701|NCT02596893|78938323|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
44525958|NCT03230864|79535334|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44525959|NCT03230864|79535335|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
44525960|NCT03230864|79535336|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
44525961|NCT03230864|79535337|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
44525962|NCT03230864|79535334|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
44525963|NCT03230864|79535335|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
44525964|NCT03230864|79535336|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
44525965|NCT03230864|79535337|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
44525966|NCT04085367|79535349|FG000|Overall Study|Adverse Event|1|||
44525967|NCT04085367|79535350|FG001|Overall Study|Adverse Event|1|||
44525968|NCT04085367|79535349|FG000|Overall Study|Withdrawal by Subject|13|||
44525969|NCT04085367|79535350|FG001|Overall Study|Withdrawal by Subject|4|||
44525970|NCT04085367|79535349|FG000|Overall Study|Lost to Follow-up|3|||
44525971|NCT04085367|79535350|FG001|Overall Study|Lost to Follow-up|1|||
44525972|NCT04085367|79535349|FG000|Overall Study|Other unspecified|2|||
44525973|NCT04085367|79535350|FG001|Overall Study|Other unspecified|1|||
44525974|NCT04085367|79535349|FG000|Overall Study|Status Unknown|1|||
44525975|NCT04085367|79535350|FG001|Overall Study|Status Unknown|1|||
44525976|NCT03228836|79535356|FG000|Overall Study|Adverse Event|3|||
44525977|NCT03228836|79535356|FG000|Overall Study|Withdrawal by Subject|1|||
44525978|NCT03228836|79535356|FG000|Overall Study|Death|1|||
44525979|NCT03228836|79535356|FG000|Overall Study|Physician Decision|1|||
44525980|NCT03228836|79535356|FG000|Overall Study|Disease Progression|7|||
44525981|NCT03228836|79535356|FG000|Overall Study|Other|4|||
44525982|NCT02937350|79535363|FG000|Overall Study|Withdrawal by Subject|0|||
44525983|NCT02937350|79535364|FG001|Overall Study|Withdrawal by Subject|1|||
44525984|NCT02937350|79535365|FG002|Overall Study|Withdrawal by Subject|0|||
44525985|NCT04085289|79535374|FG000|Overall Study|Withdrawal by Subject|0|||
44525986|NCT04085289|79535375|FG001|Overall Study|Withdrawal by Subject|0|||
44525987|NCT04085289|79535376|FG002|Overall Study|Withdrawal by Subject|1|||
44525988|NCT04080297|79535385|FG000|Overall Study|Adverse Event|1|||
44525989|NCT04080297|79535386|FG001|Overall Study|Adverse Event|3|||
44525990|NCT04080297|79535385|FG000|Overall Study|concurrent illness|1|||
44525991|NCT04080297|79535386|FG001|Overall Study|concurrent illness|0|||
44525992|NCT04013529|79535394|FG000|Overall Study|Withdrawal by Subject|1|||
44525993|NCT04013529|79535395|FG001|Overall Study|Withdrawal by Subject|1|||
44525994|NCT04011735|79535404|FG000|Overall Study|Withdrawal by Subject|1|||
44525995|NCT04011735|79535405|FG001|Overall Study|Withdrawal by Subject|0|||
44525996|NCT04011735|79535406|FG002|Overall Study|Withdrawal by Subject|1|||
44525997|NCT04011735|79535404|FG000|Overall Study|Met exclusion criteria after study entry|0|||
44525998|NCT04011735|79535405|FG001|Overall Study|Met exclusion criteria after study entry|1|||
44525999|NCT04011735|79535406|FG002|Overall Study|Met exclusion criteria after study entry|0|||
44526000|NCT04009629|79535418|FG000|Overall Study|Withdrawal by Subject|2|||
44526001|NCT04009629|79535419|FG001|Overall Study|Withdrawal by Subject|0|||
44526002|NCT03694197|79535428|FG000|Overall Study|Adverse Event|9|||
44526003|NCT03694197|79535428|FG000|Overall Study|Protocol became inconvenient to participate|1|||
44526004|NCT03694197|79535428|FG000|Overall Study|Physician Decision|4|||
44526005|NCT03694197|79535428|FG000|Overall Study|Study terminated by sponsor|1350|||
44526006|NCT03694197|79535428|FG000|Overall Study|Participant moved|5|||
44526007|NCT03694197|79535428|FG000|Overall Study|Participant withdrew consent|10|||
44526008|NCT03694197|79535428|FG000|Overall Study|Related to IMP administration|1|||
44526009|NCT03694197|79535428|FG000|Overall Study|Not disclosed|5|||
44526010|NCT04365699|79535435|FG000|Overall Study|Death|2|||
44526011|NCT04365699|79535436|FG001|Overall Study|Death|5|||
44526012|NCT04365699|79535437|FG002|Overall Study|Death|15|||
44526013|NCT04005885|79535445|FG000|First Intervention|Withdrawal by Subject|1|||
44526014|NCT04005885|79535446|FG001|First Intervention|Withdrawal by Subject|1|||
44526015|NCT04005885|79535445|FG000|Second Intervention|Withdrawal by Subject|0|||
44526016|NCT04005885|79535446|FG001|Second Intervention|Withdrawal by Subject|2|||
44526017|NCT04003623|79535459|FG000|Overall Study|Withdrawal by Subject|1|||
44254210|NCT00988091|79095421|FG001|Double-blind Period|Use of exclusionary medication|3|||
44254211|NCT00988091|79095420|FG000|Open-label Period|Adverse Event|4|||
44254212|NCT00988091|79095421|FG001|Open-label Period|Adverse Event|7|||
44254213|NCT00988091|79095420|FG000|Open-label Period|Use of exclusionary medication|1|||
44282287|NCT01901328|79245591|FG000|Overall Study|Lost to Follow-up|1|||
44526018|NCT04003623|79535460|FG001|Overall Study|Withdrawal by Subject|0|||
44526019|NCT04480424|79535468|FG000|Overall Study|Withdrawal by Subject|0|||
44526020|NCT04480424|79535469|FG001|Overall Study|Withdrawal by Subject|2|||
44526021|NCT04480424|79535468|FG000|Overall Study|Lost to Follow-up|3|||
44526022|NCT04480424|79535469|FG001|Overall Study|Lost to Follow-up|3|||
44526023|NCT04480424|79535468|FG000|Overall Study|Death|14|||
44526024|NCT04480424|79535469|FG001|Overall Study|Death|16|||
44526025|NCT04480424|79535468|FG000|Overall Study|Reason not Specified|5|||
44526026|NCT04480424|79535469|FG001|Overall Study|Reason not Specified|5|||
44526027|NCT03256526|79535478|FG000|Overall Study|Adverse Event|1|||
44526028|NCT03256526|79535479|FG001|Overall Study|Adverse Event|0|||
44526029|NCT03256526|79535480|FG002|Overall Study|Adverse Event|1|||
44526030|NCT03256526|79535478|FG000|Overall Study|Lost to Follow-up|1|||
44526031|NCT03256526|79535479|FG001|Overall Study|Lost to Follow-up|0|||
44526032|NCT03256526|79535480|FG002|Overall Study|Lost to Follow-up|2|||
44526033|NCT03255980|79535492|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
44526034|NCT03255980|79535493|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
44526035|NCT03255980|79535494|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
44526036|NCT03255980|79535495|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
44526037|NCT03255980|79535492|FG000|Overall Study|Adverse Event|1|||
44526038|NCT03255980|79535493|FG001|Overall Study|Adverse Event|1|||
44526039|NCT03255980|79535494|FG002|Overall Study|Adverse Event|0|||
44526040|NCT03255980|79535495|FG003|Overall Study|Adverse Event|1|||
44526041|NCT03255980|79535492|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
44526042|NCT03255980|79535493|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
44526043|NCT03255980|79535494|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
44526044|NCT03255980|79535495|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
44526045|NCT03255980|79535492|FG000|Overall Study|Lost to Follow-up|1|||
44526046|NCT03255980|79535493|FG001|Overall Study|Lost to Follow-up|1|||
44526047|NCT03255980|79535494|FG002|Overall Study|Lost to Follow-up|0|||
44526048|NCT03255980|79535495|FG003|Overall Study|Lost to Follow-up|3|||
44526049|NCT03255980|79535492|FG000|Overall Study|Withdrawal by Subject|0|||
44526050|NCT03255980|79535493|FG001|Overall Study|Withdrawal by Subject|1|||
44526051|NCT03255980|79535494|FG002|Overall Study|Withdrawal by Subject|0|||
44526052|NCT03255980|79535495|FG003|Overall Study|Withdrawal by Subject|3|||
44526053|NCT03228212|79535505|FG000|Period 1|Adverse Event|1|||
44526054|NCT03228212|79535506|FG001|Period 1|Adverse Event|0|||
44526055|NCT03228212|79535505|FG000|Period 1|no longer meets eligibility criteria|0|||
44526056|NCT03228212|79535506|FG001|Period 1|no longer meets eligibility criteria|1|||
44526057|NCT03228212|79535505|FG000|Period 2|Lost to Follow-up|1|||
44526058|NCT03228212|79535506|FG001|Period 2|Lost to Follow-up|0|||
44526059|NCT04000815|79535515|FG000|Overall Study|Lost to Follow-up|9|||
44526060|NCT04000815|79535516|FG001|Overall Study|Lost to Follow-up|2|||
44526061|NCT04000815|79535517|FG002|Overall Study|Lost to Follow-up|3|||
44526062|NCT04000815|79535515|FG000|Overall Study|Withdrawal by Subject|4|||
44526063|NCT04000815|79535516|FG001|Overall Study|Withdrawal by Subject|3|||
44526064|NCT04000815|79535517|FG002|Overall Study|Withdrawal by Subject|2|||
44526065|NCT04000815|79535515|FG000|Overall Study|Right ovarian cyst occured|1|||
44526066|NCT04000815|79535516|FG001|Overall Study|Right ovarian cyst occured|0|||
44526067|NCT04000815|79535517|FG002|Overall Study|Right ovarian cyst occured|0|||
44526068|NCT04000815|79535515|FG000|Overall Study|Hypertension occured on follow up|0|||
44526069|NCT04000815|79535516|FG001|Overall Study|Hypertension occured on follow up|0|||
44526070|NCT04000815|79535517|FG002|Overall Study|Hypertension occured on follow up|2|||
44526071|NCT04000581|79535527|FG000|Overall Study|Withdrawal by Subject|0|||
44526072|NCT04000581|79535528|FG001|Overall Study|Withdrawal by Subject|1|||
44526073|NCT03848403|79535534|FG000|Period 2 (Day 8)|Adverse Event|1|||
44526074|NCT03848403|79535535|FG001|Period 2 (Day 8)|Adverse Event|2|||
44526075|NCT03848403|79535536|FG002|Period 2 (Day 8)|Adverse Event|2|||
44526076|NCT03848403|79535534|FG000|Period 2 (Day 8)|Physician Decision|0|||
44526077|NCT03848403|79535535|FG001|Period 2 (Day 8)|Physician Decision|1|||
44526078|NCT03848403|79535536|FG002|Period 2 (Day 8)|Physician Decision|0|||
44148702|NCT02596893|78938324|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
44148703|NCT02596893|78938325|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
44526079|NCT03848403|79535534|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
44526080|NCT03848403|79535535|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
44526081|NCT03848403|79535536|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
44526082|NCT04054011|79535544|FG000|Overall Study|COVID|3|||
44526083|NCT04053465|79535552|FG000|Overall Study|Withdrawal by Subject|4|||
44526084|NCT04053465|79535553|FG001|Overall Study|Withdrawal by Subject|4|||
44526085|NCT00143507|79535561|FG000|Overall Study|Death|572|||
44526086|NCT00143507|79535562|FG001|Overall Study|Death|547|||
44526087|NCT00143507|79535561|FG000|Overall Study|Withdrawal by Subject|114|||
44526088|NCT00143507|79535562|FG001|Overall Study|Withdrawal by Subject|102|||
44526089|NCT00143507|79535561|FG000|Overall Study|Lost to Follow-up|1|||
44526090|NCT00143507|79535562|FG001|Overall Study|Lost to Follow-up|0|||
44526091|NCT00143507|79535561|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
44526092|NCT00143507|79535562|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
44526093|NCT03988803|79535568|FG000|Period 2|Prematurely discontinued from medication|2|||
44526094|NCT03988803|79535568|FG000|Period 2|Adverse Event|1|||
44526095|NCT00181883|79535576|FG000|Overall Study|Lack of Efficacy|2|||
44526096|NCT00181883|79535576|FG000|Overall Study|Treatment Limiting AEs|3|||
44526097|NCT00181883|79535576|FG000|Overall Study|Withdrawal by Subject|4|||
44526098|NCT00181883|79535576|FG000|Overall Study|Lost to Follow-up|1|||
44526099|NCT00180713|79535582|FG000|Overall Study|Withdrawal by Subject|2|||
44148704|NCT02596893|78938326|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
44526100|NCT00180713|79535583|FG001|Overall Study|Withdrawal by Subject|0|||
44526101|NCT00180713|79535582|FG000|Overall Study|Adverse Event|3|||
44526102|NCT00180713|79535583|FG001|Overall Study|Adverse Event|3|||
44526103|NCT03988023|79535591|FG000|Overall Study|Non-compliance|3|||
44526104|NCT03988023|79535592|FG001|Overall Study|Non-compliance|0|||
44526105|NCT03988023|79535591|FG000|Overall Study|Withdrawal by Subject|39|||
44526106|NCT03988023|79535592|FG001|Overall Study|Withdrawal by Subject|37|||
44526107|NCT03988023|79535591|FG000|Overall Study|Adverse Event|0|||
44526108|NCT03988023|79535592|FG001|Overall Study|Adverse Event|2|||
44526109|NCT03988023|79535591|FG000|Overall Study|Physician Decision|0|||
44526110|NCT03988023|79535592|FG001|Overall Study|Physician Decision|1|||
44526111|NCT03988023|79535591|FG000|Overall Study|Lost to Follow-up|5|||
44526112|NCT03988023|79535592|FG001|Overall Study|Lost to Follow-up|8|||
44526113|NCT03988023|79535591|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
44526114|NCT03988023|79535592|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
44526115|NCT03988023|79535591|FG000|Overall Study|Lack of Efficacy|3|||
44526116|NCT03988023|79535592|FG001|Overall Study|Lack of Efficacy|1|||
44526117|NCT03988023|79535591|FG000|Overall Study|COVID-19 pandemic|225|||
44526118|NCT03988023|79535592|FG001|Overall Study|COVID-19 pandemic|227|||
44526119|NCT04052139|79535601|FG000|Overall Study|Lost to Follow-up|2|||
44526120|NCT04052139|79535602|FG001|Overall Study|Lost to Follow-up|0|||
44526121|NCT04052139|79535603|FG002|Overall Study|Lost to Follow-up|0|||
44526122|NCT04052139|79535601|FG000|Overall Study|Withdrawal by Subject|1|||
44526123|NCT04052139|79535602|FG001|Overall Study|Withdrawal by Subject|0|||
44526124|NCT04052139|79535603|FG002|Overall Study|Withdrawal by Subject|0|||
44526125|NCT03984825|79535611|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
44526126|NCT03984825|79535611|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
44526127|NCT03984825|79535611|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
44526128|NCT03981861|79535620|FG000|Overall Study|Withdrawal by Subject|3|||
44526129|NCT01332266|79535629|FG000|Phase 1b|Death|3|||
44526130|NCT01332266|79535630|FG001|Phase 1b|Death|3|||
44526131|NCT01332266|79535631|FG002|Phase 1b|Death|2|||
44526132|NCT01332266|79535632|FG003|Phase 1b|Death|0|||
44254214|NCT00988091|79095421|FG001|Open-label Period|Use of exclusionary medication|1|||
44526133|NCT01332266|79535633|FG004|Phase 1b|Death|0|||
44526134|NCT01332266|79535629|FG000|Phase 1b|Lost to Follow-up|0|||
44526135|NCT01332266|79535630|FG001|Phase 1b|Lost to Follow-up|1|||
44526136|NCT01332266|79535631|FG002|Phase 1b|Lost to Follow-up|0|||
44526137|NCT01332266|79535632|FG003|Phase 1b|Lost to Follow-up|0|||
44526138|NCT01332266|79535633|FG004|Phase 1b|Lost to Follow-up|0|||
44526139|NCT01332266|79535629|FG000|Phase 1b|Withdrawal by Subject|1|||
44526140|NCT01332266|79535630|FG001|Phase 1b|Withdrawal by Subject|1|||
44526141|NCT01332266|79535631|FG002|Phase 1b|Withdrawal by Subject|1|||
44526142|NCT01332266|79535632|FG003|Phase 1b|Withdrawal by Subject|0|||
44526143|NCT01332266|79535633|FG004|Phase 1b|Withdrawal by Subject|0|||
44526144|NCT01332266|79535629|FG000|Phase 2|Death|0|||
44526145|NCT01332266|79535630|FG001|Phase 2|Death|0|||
44526146|NCT01332266|79535631|FG002|Phase 2|Death|0|||
44254215|NCT00988091|79095420|FG000|Open-label Period|Protocol Violation|1|||
44254216|NCT00988091|79095421|FG001|Open-label Period|Protocol Violation|1|||
44254217|NCT00988091|79095420|FG000|Open-label Period|Withdrawal by Subject|10|||
44254218|NCT00988091|79095421|FG001|Open-label Period|Withdrawal by Subject|16|||
44254219|NCT00988091|79095420|FG000|Open-label Period|Lost to Follow-up|3|||
44254220|NCT00988091|79095421|FG001|Open-label Period|Lost to Follow-up|5|||
44526147|NCT01332266|79535632|FG003|Phase 2|Death|33|||
44526148|NCT01332266|79535633|FG004|Phase 2|Death|36|||
44254221|NCT00988091|79095420|FG000|Open-label Period|Other|2|||
44526149|NCT01332266|79535629|FG000|Phase 2|Lost to Follow-up|0|||
44526150|NCT01332266|79535630|FG001|Phase 2|Lost to Follow-up|0|||
44526151|NCT01332266|79535631|FG002|Phase 2|Lost to Follow-up|0|||
44526152|NCT01332266|79535632|FG003|Phase 2|Lost to Follow-up|2|||
44526153|NCT01332266|79535633|FG004|Phase 2|Lost to Follow-up|0|||
44526154|NCT01332266|79535629|FG000|Phase 2|Physician Decision|0|||
44526155|NCT01332266|79535630|FG001|Phase 2|Physician Decision|0|||
44414271|NCT00646906|79422311|FG002|Crossover Period 2|Withdrawal by Subject|2|||
44414272|NCT00646906|79422312|FG003|Crossover Period 2|Withdrawal by Subject|1|||
44414273|NCT00646906|79422313|FG004|Crossover Period 2|Withdrawal by Subject|0|||
44526156|NCT01332266|79535631|FG002|Phase 2|Physician Decision|0|||
44526157|NCT01332266|79535632|FG003|Phase 2|Physician Decision|3|||
44526158|NCT01332266|79535633|FG004|Phase 2|Physician Decision|1|||
44526159|NCT01332266|79535629|FG000|Phase 2|Symptomatic deterioration|0|||
44526160|NCT01332266|79535630|FG001|Phase 2|Symptomatic deterioration|0|||
44526161|NCT01332266|79535631|FG002|Phase 2|Symptomatic deterioration|0|||
44526162|NCT01332266|79535632|FG003|Phase 2|Symptomatic deterioration|0|||
44526163|NCT01332266|79535633|FG004|Phase 2|Symptomatic deterioration|1|||
44526164|NCT01332266|79535629|FG000|Phase 2|Progression Disease|0|||
44526165|NCT01332266|79535630|FG001|Phase 2|Progression Disease|0|||
44526166|NCT01332266|79535631|FG002|Phase 2|Progression Disease|0|||
44526167|NCT01332266|79535632|FG003|Phase 2|Progression Disease|2|||
44526168|NCT01332266|79535633|FG004|Phase 2|Progression Disease|1|||
44526169|NCT01332266|79535629|FG000|Phase 2|Withdrawal by Subject|0|||
44414274|NCT00646906|79422314|FG005|Crossover Period 2|Withdrawal by Subject|0|||
44414275|NCT00646906|79422315|FG006|Crossover Period 2|Withdrawal by Subject|0|||
44414276|NCT00646906|79422309|FG000|Crossover Period 2|Physician Decision|0|||
44414277|NCT00646906|79422310|FG001|Crossover Period 2|Physician Decision|0|||
44414278|NCT00646906|79422311|FG002|Crossover Period 2|Physician Decision|0|||
44414279|NCT00646906|79422312|FG003|Crossover Period 2|Physician Decision|0|||
44414280|NCT00646906|79422313|FG004|Crossover Period 2|Physician Decision|0|||
44414281|NCT00646906|79422314|FG005|Crossover Period 2|Physician Decision|0|||
44414282|NCT00646906|79422315|FG006|Crossover Period 2|Physician Decision|1|||
44414283|NCT00642772|79422328|FG000|Overall Study|Lost to Follow-up|3|||
44414284|NCT00642772|79422328|FG000|Overall Study|Withdrawal by Subject|7|||
44414285|NCT00446095|79422337|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
44414286|NCT00446095|79422338|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
44414287|NCT00446095|79422339|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
44414288|NCT00446095|79422340|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
44414289|NCT00446095|79422341|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
44414290|NCT00446095|79422337|FG000|Phase II (8 Weeks)|Adverse Event|0|||
44414291|NCT00446095|79422338|FG001|Phase II (8 Weeks)|Adverse Event|1|||
44414292|NCT00446095|79422339|FG002|Phase II (8 Weeks)|Adverse Event|1|||
44414293|NCT00446095|79422340|FG003|Phase II (8 Weeks)|Adverse Event|0|||
44414294|NCT00446095|79422341|FG004|Phase II (8 Weeks)|Adverse Event|0|||
44414295|NCT00446095|79422337|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
44414296|NCT00446095|79422338|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
44414297|NCT00446095|79422339|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
44414298|NCT00446095|79422340|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
44414299|NCT00446095|79422341|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
44414300|NCT00446095|79422337|FG000|Phase II (8 Weeks)|Physician Decision|1|||
44526170|NCT01332266|79535630|FG001|Phase 2|Withdrawal by Subject|0|||
44526171|NCT01332266|79535631|FG002|Phase 2|Withdrawal by Subject|0|||
44414301|NCT00446095|79422338|FG001|Phase II (8 Weeks)|Physician Decision|0|||
44414302|NCT00446095|79422339|FG002|Phase II (8 Weeks)|Physician Decision|0|||
44414303|NCT00446095|79422340|FG003|Phase II (8 Weeks)|Physician Decision|0|||
44526172|NCT01332266|79535632|FG003|Phase 2|Withdrawal by Subject|2|||
44526173|NCT01332266|79535633|FG004|Phase 2|Withdrawal by Subject|2|||
44414304|NCT00446095|79422341|FG004|Phase II (8 Weeks)|Physician Decision|0|||
44414305|NCT00446095|79422337|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
44414306|NCT00446095|79422338|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
44414307|NCT00446095|79422339|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
44414308|NCT00446095|79422340|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
44526174|NCT03255824|79535648|FG000|Overall Study|Under-sedation|2|||
44526175|NCT03255824|79535649|FG001|Overall Study|Under-sedation|1|||
44526176|NCT03238352|79535658|FG000|Overall Study|Lost to Follow-up|0|||
44526177|NCT03238352|79535659|FG001|Overall Study|Lost to Follow-up|2|||
44526178|NCT03238352|79535660|FG002|Overall Study|Lost to Follow-up|1|||
44526179|NCT03238352|79535658|FG000|Overall Study|Withdrawal by Subject|0|||
44526180|NCT03238352|79535659|FG001|Overall Study|Withdrawal by Subject|1|||
44526181|NCT03238352|79535660|FG002|Overall Study|Withdrawal by Subject|0|||
44526182|NCT00180479|79535674|FG000|Overall Study|Death|4|||
44526183|NCT00180479|79535675|FG001|Overall Study|Death|2|||
44526184|NCT00180479|79535674|FG000|Overall Study|Lost to Follow-up|9|||
44526185|NCT00180479|79535675|FG001|Overall Study|Lost to Follow-up|7|||
44526186|NCT00180479|79535674|FG000|Overall Study|Withdrawal by Subject|3|||
44526187|NCT00180479|79535675|FG001|Overall Study|Withdrawal by Subject|3|||
44526188|NCT00180479|79535674|FG000|Overall Study|Informed consent not signed|0|||
44526189|NCT00180479|79535675|FG001|Overall Study|Informed consent not signed|1|||
44526190|NCT03224234|79535685|FG000|Main Study|Lost to Follow-up|5|||
44526191|NCT03224234|79535686|FG001|Main Study|Lost to Follow-up|5|||
44526192|NCT02955069|79535700|FG000|Overall Study|Adverse Event|7|||
44526193|NCT02955069|79535701|FG001|Overall Study|Adverse Event|2|||
44526194|NCT02955069|79535700|FG000|Overall Study|Death|7|||
44526195|NCT02955069|79535701|FG001|Overall Study|Death|3|||
44526196|NCT02955069|79535700|FG000|Overall Study|Physician Decision|10|||
44526197|NCT02955069|79535701|FG001|Overall Study|Physician Decision|2|||
44526198|NCT02955069|79535700|FG000|Overall Study|Progressive disease|64|||
44526199|NCT02955069|79535701|FG001|Overall Study|Progressive disease|13|||
44526200|NCT02955069|79535700|FG000|Overall Study|Study terminated by sponsor|4|||
44526201|NCT02955069|79535701|FG001|Overall Study|Study terminated by sponsor|0|||
44526202|NCT02955069|79535700|FG000|Overall Study|Subject/Guardian decision|3|||
44526203|NCT02955069|79535701|FG001|Overall Study|Subject/Guardian decision|1|||
44526204|NCT03254108|79535714|FG000|Overall Study|Adverse Event|0|||
44526205|NCT03254108|79535715|FG001|Overall Study|Adverse Event|2|||
44526206|NCT03254108|79535716|FG002|Overall Study|Adverse Event|0|||
44526207|NCT03254108|79535717|FG003|Overall Study|Adverse Event|1|||
44526208|NCT03254108|79535718|FG004|Overall Study|Adverse Event|1|||
44526209|NCT03254108|79535714|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
44526210|NCT03254108|79535715|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
44526211|NCT03254108|79535716|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
44526212|NCT03254108|79535717|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
44526213|NCT03254108|79535718|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
44526214|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
44526215|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
44526216|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
44526217|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
44526218|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
44526219|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
44526220|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
44526221|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
44526222|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
44526223|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
44526224|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
44526225|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
44526226|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
44526227|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
44414309|NCT00446095|79422341|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
44526228|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
44526229|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
44526230|NCT03773978|79535742|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
44526231|NCT03773978|79535743|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
44526232|NCT03773978|79535742|FG000|DBW Period|Adverse Event|2|||
44526233|NCT03773978|79535743|FG001|DBW Period|Adverse Event|2|||
44526234|NCT03773978|79535742|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
44526235|NCT03773978|79535743|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
44526236|NCT03773978|79535742|FG000|DBW Period|Withdrawal by Subject|2|||
44526237|NCT03773978|79535743|FG001|DBW Period|Withdrawal by Subject|1|||
44526238|NCT03773978|79535742|FG000|DBW Period|Due to epidemic or pandemic|5|||
44526239|NCT03773978|79535743|FG001|DBW Period|Due to epidemic or pandemic|6|||
44526240|NCT03773978|79535742|FG000|DBW Period|Study team decision|1|||
44526241|NCT03773978|79535743|FG001|DBW Period|Study team decision|0|||
44526242|NCT03682107|79535759|FG000|Overall Study|Withdrawal by Subject|0|||
44526243|NCT03682107|79535760|FG001|Overall Study|Withdrawal by Subject|1|||
44526244|NCT03682107|79535761|FG002|Overall Study|Withdrawal by Subject|0|||
44526245|NCT03682107|79535762|FG003|Overall Study|Withdrawal by Subject|0|||
44526246|NCT03682107|79535763|FG004|Overall Study|Withdrawal by Subject|0|||
44526247|NCT03673046|79535777|FG000|Overall Study|Adverse Event|1|||
44526248|NCT03673046|79535778|FG001|Overall Study|Adverse Event|1|||
44526249|NCT03673046|79535777|FG000|Overall Study|Withdrawal by Subject|8|||
44526250|NCT03673046|79535778|FG001|Overall Study|Withdrawal by Subject|2|||
44526251|NCT02956005|79535784|FG000|Overall Study|Not eligible|1|||
44526252|NCT02956005|79535784|FG000|Overall Study|Withdrawal by Subject|3|||
44526253|NCT02956005|79535784|FG000|Overall Study|Physician Decision|12|||
44526254|NCT03253094|79535794|FG000|Overall Study|Adverse Event|2|||
44526255|NCT03253094|79535795|FG001|Overall Study|Adverse Event|0|||
44526256|NCT03253094|79535796|FG002|Overall Study|Adverse Event|0|||
44526257|NCT03253094|79535797|FG003|Overall Study|Adverse Event|0|||
44526258|NCT03253094|79535798|FG004|Overall Study|Adverse Event|0|||
44526259|NCT03253094|79535799|FG005|Overall Study|Adverse Event|0|||
44148705|NCT02592447|78938342|FG000|Overall Study|Lost to Follow-up|1|||
44254222|NCT00988091|79095421|FG001|Open-label Period|Other|3|||
44526260|NCT03253094|79535794|FG000|Overall Study|Lack of Efficacy|0|||
44526261|NCT03253094|79535795|FG001|Overall Study|Lack of Efficacy|0|||
44526262|NCT03253094|79535796|FG002|Overall Study|Lack of Efficacy|2|||
44526263|NCT03253094|79535797|FG003|Overall Study|Lack of Efficacy|1|||
44526264|NCT03253094|79535798|FG004|Overall Study|Lack of Efficacy|2|||
44526265|NCT03253094|79535799|FG005|Overall Study|Lack of Efficacy|1|||
44526266|NCT03253094|79535794|FG000|Overall Study|Lost to Follow-up|0|||
44526267|NCT03253094|79535795|FG001|Overall Study|Lost to Follow-up|0|||
44526268|NCT03253094|79535796|FG002|Overall Study|Lost to Follow-up|1|||
44526269|NCT03253094|79535797|FG003|Overall Study|Lost to Follow-up|1|||
44526270|NCT03253094|79535798|FG004|Overall Study|Lost to Follow-up|0|||
44526271|NCT03253094|79535799|FG005|Overall Study|Lost to Follow-up|1|||
44526272|NCT03253094|79535794|FG000|Overall Study|Physician Decision|1|||
44526273|NCT03253094|79535795|FG001|Overall Study|Physician Decision|0|||
44526274|NCT03253094|79535796|FG002|Overall Study|Physician Decision|0|||
44526275|NCT03253094|79535797|FG003|Overall Study|Physician Decision|1|||
44148706|NCT02592447|78938343|FG001|Overall Study|Lost to Follow-up|0|||
44148707|NCT02592447|78938342|FG000|Overall Study|Ineligible after randomization|1|||
44148708|NCT02592447|78938343|FG001|Overall Study|Ineligible after randomization|0|||
44148709|NCT02592447|78938342|FG000|Overall Study|Withdrawal by Subject|0|||
44148710|NCT02592447|78938343|FG001|Overall Study|Withdrawal by Subject|1|||
44148711|NCT02595723|78938352|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
44148712|NCT02595723|78938353|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
44148713|NCT02595723|78938354|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
44148714|NCT02595723|78938352|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
44148715|NCT02595723|78938353|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
44148716|NCT02595723|78938354|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
44148717|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
44148718|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
44148719|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
44148720|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
44148721|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
44148722|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
44148723|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
44148724|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
44148725|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
44148726|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
44148727|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
44148728|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
44148729|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
44148730|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
44148731|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
44148732|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
44148733|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
44148734|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
44148735|NCT01667679|78938364|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
44148736|NCT01667679|78938365|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
44148737|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
44148738|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
44414310|NCT00446095|79422337|FG000|Phase II (8 Weeks)|Ongoing|0|||
44526276|NCT03253094|79535798|FG004|Overall Study|Physician Decision|0|||
44526277|NCT03253094|79535799|FG005|Overall Study|Physician Decision|2|||
44148739|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
44148740|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
44148741|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
44148742|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
44148743|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
44148744|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
44148745|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
44148746|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
44148747|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
44526278|NCT03253094|79535794|FG000|Overall Study|Withdrawal by Subject|1|||
44526279|NCT03253094|79535795|FG001|Overall Study|Withdrawal by Subject|2|||
44526280|NCT03253094|79535796|FG002|Overall Study|Withdrawal by Subject|1|||
44526281|NCT03253094|79535797|FG003|Overall Study|Withdrawal by Subject|0|||
44526282|NCT03253094|79535798|FG004|Overall Study|Withdrawal by Subject|3|||
44526283|NCT03253094|79535799|FG005|Overall Study|Withdrawal by Subject|0|||
44526284|NCT03253094|79535794|FG000|Overall Study|Other|0|||
44526285|NCT03253094|79535795|FG001|Overall Study|Other|1|||
44526286|NCT03253094|79535796|FG002|Overall Study|Other|2|||
44526287|NCT03253094|79535797|FG003|Overall Study|Other|1|||
44526288|NCT03253094|79535798|FG004|Overall Study|Other|0|||
44526289|NCT03253094|79535799|FG005|Overall Study|Other|0|||
44526290|NCT03654885|79535815|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
44526291|NCT03654885|79535816|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
44526292|NCT03654885|79535815|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
44526293|NCT03654885|79535816|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
44526294|NCT03654885|79535815|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
44526295|NCT03654885|79535816|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
44526296|NCT03654885|79535815|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
44526297|NCT03654885|79535816|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
44526298|NCT03654885|79535815|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
44526299|NCT03654885|79535816|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
44526300|NCT03654885|79535815|FG000|Overall Study|Adverse Event in Study Eye|3|||
44526301|NCT03654885|79535816|FG001|Overall Study|Adverse Event in Study Eye|0|||
44526302|NCT03654885|79535815|FG000|Overall Study|Consent Withdrawn|1|||
44526303|NCT03654885|79535816|FG001|Overall Study|Consent Withdrawn|0|||
44526304|NCT03654885|79535815|FG000|Overall Study|Death|3|||
44526305|NCT03654885|79535816|FG001|Overall Study|Death|1|||
44526306|NCT03654885|79535815|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
44526307|NCT03654885|79535816|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
44526308|NCT03654885|79535815|FG000|Overall Study|Lost to Follow-up|3|||
44526309|NCT03654885|79535816|FG001|Overall Study|Lost to Follow-up|3|||
44526310|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
44526311|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
44526312|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
44526313|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
44526314|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
44526315|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
44526316|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
44526317|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
44526318|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
44526319|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
44526320|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
44526321|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
44526322|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Death|3|||
44526323|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Death|1|||
44526324|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
44526325|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
44526326|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Adverse Event|7|||
44526327|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Adverse Event|8|||
44526328|NCT03236246|79535824|FG000|24-Week Dose Titration Period|Captured as Other|1|||
44526329|NCT03236246|79535825|FG001|24-Week Dose Titration Period|Captured as Other|2|||
44526330|NCT03236246|79535824|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
44526331|NCT03236246|79535825|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
44526332|NCT03236246|79535824|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
44526333|NCT03236246|79535825|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
44526334|NCT03236246|79535824|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
44526335|NCT03236246|79535825|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
44526336|NCT03236246|79535824|FG000|24-Week Dose Maintenance Period|Death|0|||
44526337|NCT03236246|79535825|FG001|24-Week Dose Maintenance Period|Death|1|||
44526338|NCT03236246|79535824|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
44526339|NCT03236246|79535825|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
44526340|NCT02937584|79535831|FG000|Period 1|Adverse Event|1|||
44526341|NCT02937584|79535832|FG001|Period 1|Adverse Event|2|||
44282288|NCT01901328|79245592|FG001|Overall Study|Lost to Follow-up|0|||
44282289|NCT01901328|79245591|FG000|Overall Study|Physician Decision|0|||
44526342|NCT02937584|79535831|FG000|Washout|Adverse Event|0|||
44526343|NCT02937584|79535832|FG001|Washout|Adverse Event|1|||
44282290|NCT01901328|79245592|FG001|Overall Study|Physician Decision|1|||
44526344|NCT00179621|79535841|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
44414311|NCT00446095|79422338|FG001|Phase II (8 Weeks)|Ongoing|0|||
44414312|NCT00446095|79422339|FG002|Phase II (8 Weeks)|Ongoing|1|||
44414313|NCT00446095|79422340|FG003|Phase II (8 Weeks)|Ongoing|0|||
44414314|NCT00446095|79422341|FG004|Phase II (8 Weeks)|Ongoing|0|||
44414315|NCT00446095|79422337|FG000|Phase I (28 Days)|Adverse Event|0|||
44414316|NCT00446095|79422338|FG001|Phase I (28 Days)|Adverse Event|0|||
44414317|NCT00446095|79422339|FG002|Phase I (28 Days)|Adverse Event|0|||
44414318|NCT00446095|79422340|FG003|Phase I (28 Days)|Adverse Event|1|||
44414319|NCT00446095|79422341|FG004|Phase I (28 Days)|Adverse Event|0|||
44414320|NCT00446095|79422337|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
44414321|NCT00446095|79422338|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
44414322|NCT00446095|79422339|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
44414323|NCT00446095|79422340|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
44526345|NCT00179621|79535842|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
44526346|NCT00179621|79535843|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
44526347|NCT00179621|79535844|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
44526348|NCT00179621|79535841|FG000|Double-Blind Period|Adverse Event|2|||
44526349|NCT00179621|79535842|FG001|Double-Blind Period|Adverse Event|7|||
44526350|NCT00179621|79535843|FG002|Double-Blind Period|Adverse Event|4|||
44526351|NCT00179621|79535844|FG003|Double-Blind Period|Adverse Event|0|||
44526352|NCT00179621|79535841|FG000|Double-Blind Period|Withdrawal by Subject|2|||
44526353|NCT00179621|79535842|FG001|Double-Blind Period|Withdrawal by Subject|1|||
44526354|NCT00179621|79535843|FG002|Double-Blind Period|Withdrawal by Subject|3|||
44526355|NCT00179621|79535844|FG003|Double-Blind Period|Withdrawal by Subject|0|||
44526356|NCT00179621|79535841|FG000|Double-Blind Period|Death|0|||
44526357|NCT00179621|79535842|FG001|Double-Blind Period|Death|1|||
44526358|NCT00179621|79535843|FG002|Double-Blind Period|Death|2|||
44526359|NCT00179621|79535844|FG003|Double-Blind Period|Death|0|||
44526360|NCT00179621|79535841|FG000|Double-Blind Period|Protocol Violation|1|||
44526361|NCT00179621|79535842|FG001|Double-Blind Period|Protocol Violation|0|||
44526362|NCT00179621|79535843|FG002|Double-Blind Period|Protocol Violation|0|||
44526363|NCT00179621|79535844|FG003|Double-Blind Period|Protocol Violation|0|||
44526364|NCT00179621|79535841|FG000|Double-Blind Period|Other|0|||
44526365|NCT00179621|79535842|FG001|Double-Blind Period|Other|2|||
44526366|NCT00179621|79535843|FG002|Double-Blind Period|Other|2|||
44526367|NCT00179621|79535844|FG003|Double-Blind Period|Other|0|||
44167842|NCT02528357|78961053|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
44414324|NCT00446095|79422341|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
44414325|NCT00829010|79422357|FG000|Overall Study|Adverse Event|1|||
44414326|NCT00829010|79422358|FG001|Overall Study|Adverse Event|0|||
44414327|NCT00829010|79422359|FG002|Overall Study|Adverse Event|0|||
44414328|NCT00829010|79422360|FG003|Overall Study|Adverse Event|0|||
44414329|NCT00829010|79422361|FG004|Overall Study|Adverse Event|0|||
44414330|NCT00829010|79422357|FG000|Overall Study|Withdrawal by Subject|0|||
44414331|NCT00829010|79422358|FG001|Overall Study|Withdrawal by Subject|1|||
44414332|NCT00829010|79422359|FG002|Overall Study|Withdrawal by Subject|1|||
44414333|NCT00829010|79422360|FG003|Overall Study|Withdrawal by Subject|0|||
44414334|NCT00829010|79422361|FG004|Overall Study|Withdrawal by Subject|2|||
44414335|NCT00829010|79422357|FG000|Overall Study|Lost to Follow-up|1|||
44414336|NCT00829010|79422358|FG001|Overall Study|Lost to Follow-up|0|||
44414337|NCT00829010|79422359|FG002|Overall Study|Lost to Follow-up|2|||
44526368|NCT00179621|79535841|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
44526369|NCT00179621|79535842|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
44414338|NCT00829010|79422360|FG003|Overall Study|Lost to Follow-up|0|||
44526370|NCT00179621|79535843|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
44526371|NCT00179621|79535844|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
44526372|NCT00179621|79535841|FG000|Open-Label Period|Adverse Event|0|||
44148748|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
44282291|NCT01901328|79245591|FG000|Overall Study|Protocol Violation|1|||
44282292|NCT01901328|79245592|FG001|Overall Study|Protocol Violation|1|||
44282293|NCT01901328|79245591|FG000|Overall Study|Study Terminated by Sponsor|19|||
44282294|NCT01901328|79245592|FG001|Overall Study|Study Terminated by Sponsor|16|||
44414339|NCT00829010|79422361|FG004|Overall Study|Lost to Follow-up|0|||
44414340|NCT00829010|79422357|FG000|Overall Study|Fatality|5|||
44414341|NCT00829010|79422358|FG001|Overall Study|Fatality|4|||
44414342|NCT00829010|79422359|FG002|Overall Study|Fatality|0|||
44414343|NCT00829010|79422360|FG003|Overall Study|Fatality|3|||
44414344|NCT00829010|79422361|FG004|Overall Study|Fatality|0|||
44414345|NCT00829010|79422357|FG000|Overall Study|Migrated/Moved from study area|3|||
44414346|NCT00829010|79422358|FG001|Overall Study|Migrated/Moved from study area|4|||
44414347|NCT00829010|79422359|FG002|Overall Study|Migrated/Moved from study area|0|||
44414348|NCT00829010|79422360|FG003|Overall Study|Migrated/Moved from study area|5|||
44414349|NCT00829010|79422361|FG004|Overall Study|Migrated/Moved from study area|0|||
44414350|NCT00644332|79422373|FG000|Overall Study|Adverse Event|11|||
44414351|NCT00644332|79422373|FG000|Overall Study|Withdrawal by Subject|6|||
44414352|NCT00644332|79422373|FG000|Overall Study|Completion Status Unknown|2|||
44414353|NCT00644332|79422373|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
44414354|NCT00644332|79422373|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
44414355|NCT00445939|79422380|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
44414356|NCT00445939|79422381|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
44414357|NCT00445939|79422382|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
44414358|NCT00445939|79422383|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
44414359|NCT00445939|79422380|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
44414360|NCT00445939|79422381|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
44414361|NCT00445939|79422382|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
44414362|NCT00445939|79422383|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
44414363|NCT00482053|79422403|FG000|Inter-treatment Period|Disease progression|1|||
44148749|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
44282295|NCT01901328|79245591|FG000|Overall Study|Withdrawal by Subject|1|||
44282296|NCT01901328|79245592|FG001|Overall Study|Withdrawal by Subject|2|||
44282297|NCT01901328|79245591|FG000|Overall Study|Lack of Efficacy|0|||
44282298|NCT01901328|79245592|FG001|Overall Study|Lack of Efficacy|1|||
44414364|NCT00455923|79422409|FG000|Overall Study|Pregnancy|0|||
44414365|NCT00455923|79422410|FG001|Overall Study|Pregnancy|2|||
44414366|NCT00455923|79422409|FG000|Overall Study|Other|3|||
44254223|NCT02623218|79095711|FG000|Overall Study|Lost to Follow-up|0|||
44254224|NCT02623218|79095712|FG001|Overall Study|Lost to Follow-up|1|||
44254225|NCT02623218|79095713|FG002|Overall Study|Lost to Follow-up|0|||
44254226|NCT02623218|79095714|FG003|Overall Study|Lost to Follow-up|0|||
44414367|NCT00455923|79422410|FG001|Overall Study|Other|1|||
44414368|NCT00642616|79422420|FG000|Overall Study|Adverse Event|2|||
44414369|NCT00642616|79422421|FG001|Overall Study|Adverse Event|0|||
44414370|NCT00642616|79422422|FG002|Overall Study|Adverse Event|1|||
44414371|NCT00642616|79422423|FG003|Overall Study|Adverse Event|0|||
44414372|NCT00642616|79422420|FG000|Overall Study|Study Terminated by Sponsor|7|||
44414373|NCT00642616|79422421|FG001|Overall Study|Study Terminated by Sponsor|6|||
44414374|NCT00642616|79422422|FG002|Overall Study|Study Terminated by Sponsor|4|||
44414375|NCT00642616|79422423|FG003|Overall Study|Study Terminated by Sponsor|5|||
44414376|NCT00642616|79422420|FG000|Overall Study|Withdrawal by Subject|0|||
44414377|NCT00642616|79422421|FG001|Overall Study|Withdrawal by Subject|1|||
44414378|NCT00642616|79422422|FG002|Overall Study|Withdrawal by Subject|1|||
44414379|NCT00642616|79422423|FG003|Overall Study|Withdrawal by Subject|1|||
44414380|NCT00642616|79422420|FG000|Overall Study|Protocol Violation|0|||
44414381|NCT00642616|79422421|FG001|Overall Study|Protocol Violation|0|||
44414382|NCT00642616|79422422|FG002|Overall Study|Protocol Violation|2|||
44414383|NCT00642616|79422423|FG003|Overall Study|Protocol Violation|0|||
44414384|NCT00642616|79422420|FG000|Overall Study|Physician Decision|0|||
44414385|NCT00642616|79422421|FG001|Overall Study|Physician Decision|0|||
44414386|NCT00642616|79422422|FG002|Overall Study|Physician Decision|1|||
44414387|NCT00642616|79422423|FG003|Overall Study|Physician Decision|1|||
44414388|NCT03844945|79422439|FG000|Overall Study|Adverse Event|1|||
44526373|NCT00179621|79535842|FG001|Open-Label Period|Adverse Event|6|||
44526374|NCT00179621|79535843|FG002|Open-Label Period|Adverse Event|5|||
44526375|NCT00179621|79535844|FG003|Open-Label Period|Adverse Event|6|||
44526376|NCT00179621|79535841|FG000|Open-Label Period|Withdrawal by Subject|0|||
44526377|NCT00179621|79535842|FG001|Open-Label Period|Withdrawal by Subject|2|||
44526378|NCT00179621|79535843|FG002|Open-Label Period|Withdrawal by Subject|2|||
44526379|NCT00179621|79535844|FG003|Open-Label Period|Withdrawal by Subject|2|||
44526380|NCT00179621|79535841|FG000|Open-Label Period|Death|0|||
44526381|NCT00179621|79535842|FG001|Open-Label Period|Death|0|||
44526382|NCT00179621|79535843|FG002|Open-Label Period|Death|1|||
44526383|NCT00179621|79535844|FG003|Open-Label Period|Death|2|||
44526384|NCT00179621|79535841|FG000|Open-Label Period|Other|0|||
44526385|NCT00179621|79535842|FG001|Open-Label Period|Other|1|||
44526386|NCT00179621|79535843|FG002|Open-Label Period|Other|1|||
44526387|NCT00179621|79535844|FG003|Open-Label Period|Other|2|||
44526388|NCT00179309|79535855|FG000|Treatment|Toxicity|2|||
44526389|NCT00179309|79535856|FG001|Treatment|Toxicity|3|||
44526390|NCT00179309|79535855|FG000|Treatment|Withdrawal by Subject|1|||
44526391|NCT00179309|79535856|FG001|Treatment|Withdrawal by Subject|2|||
44526392|NCT00179309|79535855|FG000|Treatment|Allergy|1|||
44526393|NCT00179309|79535856|FG001|Treatment|Allergy|0|||
44526394|NCT00178685|79535877|FG000|Overall Study|Death|3|||
44526395|NCT00178685|79535878|FG001|Overall Study|Death|3|||
44526396|NCT00178685|79535879|FG002|Overall Study|Death|6|||
44526397|NCT00178685|79535877|FG000|Overall Study|Lost to Follow-up|100|||
44526398|NCT00178685|79535878|FG001|Overall Study|Lost to Follow-up|187|||
44526399|NCT00178685|79535879|FG002|Overall Study|Lost to Follow-up|183|||
44526400|NCT00178685|79535877|FG000|Overall Study|Withdrawal by Subject|8|||
44526401|NCT00178685|79535878|FG001|Overall Study|Withdrawal by Subject|14|||
44526402|NCT00178685|79535879|FG002|Overall Study|Withdrawal by Subject|7|||
44526403|NCT02933528|79535887|FG000|Overall Study|Lost to Follow-up|2|||
44526404|NCT00177671|79535893|FG000|Overall Study|Withdrawal by Subject|5|||
44148750|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
44282299|NCT01859988|79245605|FG000|Overall Study|Withdrawal by Subject|6|||
44282300|NCT01859988|79245606|FG001|Overall Study|Withdrawal by Subject|3|||
44282301|NCT01859988|79245607|FG002|Overall Study|Withdrawal by Subject|4|||
44414389|NCT03844945|79422440|FG001|Overall Study|Adverse Event|1|||
44148751|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
44254227|NCT02623218|79095715|FG004|Overall Study|Lost to Follow-up|0|||
44526405|NCT00177671|79535894|FG001|Overall Study|Withdrawal by Subject|6|||
44526406|NCT00177671|79535893|FG000|Overall Study|medical complications|2|||
44526407|NCT00177671|79535894|FG001|Overall Study|medical complications|0|||
44526408|NCT00177671|79535893|FG000|Overall Study|Adverse Event|6|||
44526409|NCT00177671|79535894|FG001|Overall Study|Adverse Event|0|||
44526410|NCT00177671|79535893|FG000|Overall Study|Physician Decision|12|||
44526411|NCT00177671|79535894|FG001|Overall Study|Physician Decision|8|||
44526412|NCT02933060|79535902|FG000|Overall Study|Withdrawal by Subject|0|||
44526413|NCT02933060|79535903|FG001|Overall Study|Withdrawal by Subject|1|||
44526414|NCT03235154|79535909|FG000|Overall Study|Withdrawal by Subject|1|||
44526415|NCT03235154|79535909|FG000|Overall Study|Adverse Event|1|||
44526416|NCT03235154|79535909|FG000|Overall Study|Lost to Follow-up|2|||
44526417|NCT03234608|79535917|FG000|Overall Study|Lost to Follow-up|23|||
44526418|NCT03234608|79535918|FG001|Overall Study|Lost to Follow-up|21|||
44526419|NCT03248882|79535929|FG000|Overall Study|Adverse Event|3|||
44526420|NCT03248882|79535930|FG001|Overall Study|Adverse Event|3|||
44148752|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
44254228|NCT02622828|79095740|FG000|Overall Study|participant withdrew|3|||
44254229|NCT02621034|79095876|FG000|Overall Study|Lost to Follow-up|3|||
44254230|NCT02621034|79095877|FG001|Overall Study|Lost to Follow-up|2|||
44254231|NCT02621034|79095878|FG002|Overall Study|Lost to Follow-up|5|||
44254232|NCT02620020|79095940|FG000|Overall Study|Adverse Event|8|||
44254233|NCT02620020|79095941|FG001|Overall Study|Adverse Event|4|||
44526421|NCT03248882|79535931|FG002|Overall Study|Adverse Event|2|||
44254234|NCT02620020|79095942|FG002|Overall Study|Adverse Event|3|||
44526422|NCT03248882|79535932|FG003|Overall Study|Adverse Event|6|||
44526423|NCT03248882|79535933|FG004|Overall Study|Adverse Event|9|||
44526424|NCT03248882|79535929|FG000|Overall Study|Lost to Follow-up|0|||
44414390|NCT03844945|79422441|FG002|Overall Study|Adverse Event|4|||
44414391|NCT03844945|79422442|FG003|Overall Study|Adverse Event|0|||
44414392|NCT03844945|79422439|FG000|Overall Study|Withdrawal by Subject|0|||
44414393|NCT03844945|79422440|FG001|Overall Study|Withdrawal by Subject|0|||
44414394|NCT03844945|79422441|FG002|Overall Study|Withdrawal by Subject|1|||
44414395|NCT03844945|79422442|FG003|Overall Study|Withdrawal by Subject|0|||
44414396|NCT03844945|79422439|FG000|Overall Study|Lack of Efficacy|0|||
44414397|NCT03844945|79422440|FG001|Overall Study|Lack of Efficacy|0|||
44414398|NCT03844945|79422441|FG002|Overall Study|Lack of Efficacy|0|||
44414399|NCT03844945|79422442|FG003|Overall Study|Lack of Efficacy|1|||
44414400|NCT00445549|79422452|FG000|Overall Study|progressive disease|12|||
44414401|NCT00445003|79422459|FG000|Overall Study|Death|1|||
44414402|NCT00445003|79422460|FG001|Overall Study|Death|2|||
44414403|NCT00445003|79422461|FG002|Overall Study|Death|1|||
44414404|NCT00445003|79422459|FG000|Overall Study|Missed Visit|3|||
44414405|NCT00445003|79422460|FG001|Overall Study|Missed Visit|5|||
44414406|NCT00445003|79422461|FG002|Overall Study|Missed Visit|1|||
44414407|NCT00445003|79422459|FG000|Overall Study|Dropped|1|||
44414408|NCT00445003|79422460|FG001|Overall Study|Dropped|3|||
44414409|NCT00445003|79422461|FG002|Overall Study|Dropped|2|||
44148753|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
44148754|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
44148755|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
44148756|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
44148757|NCT01667679|78938364|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
44148758|NCT01667679|78938365|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
44148759|NCT02597049|78938376|FG000|Overall Study|Lost to Follow-up|0|||
44148760|NCT02597049|78938377|FG001|Overall Study|Lost to Follow-up|3|||
44148761|NCT02597049|78938378|FG002|Overall Study|Lost to Follow-up|2|||
44148762|NCT02597049|78938376|FG000|Overall Study|Withdrawal by Subject|2|||
44148763|NCT02597049|78938377|FG001|Overall Study|Withdrawal by Subject|2|||
44148764|NCT02597049|78938378|FG002|Overall Study|Withdrawal by Subject|1|||
44148765|NCT02597049|78938376|FG000|Overall Study|Adverse Event|2|||
44254235|NCT02620020|79095943|FG003|Overall Study|Adverse Event|5|||
44254236|NCT02620020|79095940|FG000|Overall Study|Lost to Follow-up|4|||
44414410|NCT00811070|79422475|FG000|Overall Study|Death|0|||
44414411|NCT00811070|79422476|FG001|Overall Study|Death|0|||
44414412|NCT00811070|79422477|FG002|Overall Study|Death|0|||
44414413|NCT00811070|79422478|FG003|Overall Study|Death|2|||
44414414|NCT00811070|79422479|FG004|Overall Study|Death|5|||
44414415|NCT00811070|79422480|FG005|Overall Study|Death|0|||
44414416|NCT00811070|79422475|FG000|Overall Study|Other|1|||
44414417|NCT00811070|79422476|FG001|Overall Study|Other|0|||
44414418|NCT00811070|79422477|FG002|Overall Study|Other|0|||
44414419|NCT00811070|79422478|FG003|Overall Study|Other|0|||
44148766|NCT02597049|78938377|FG001|Overall Study|Adverse Event|0|||
44148767|NCT02597049|78938378|FG002|Overall Study|Adverse Event|0|||
44148768|NCT02597049|78938376|FG000|Overall Study|Death|2|||
44148769|NCT02597049|78938377|FG001|Overall Study|Death|0|||
44414420|NCT00811070|79422479|FG004|Overall Study|Other|0|||
44414421|NCT00811070|79422480|FG005|Overall Study|Other|0|||
44414422|NCT00811070|79422475|FG000|Overall Study|Withdrawal by Subject|0|||
44414423|NCT00811070|79422476|FG001|Overall Study|Withdrawal by Subject|1|||
44414424|NCT00811070|79422477|FG002|Overall Study|Withdrawal by Subject|0|||
44414425|NCT00811070|79422478|FG003|Overall Study|Withdrawal by Subject|0|||
44414426|NCT00811070|79422479|FG004|Overall Study|Withdrawal by Subject|0|||
44414427|NCT00811070|79422480|FG005|Overall Study|Withdrawal by Subject|0|||
44414428|NCT00811070|79422475|FG000|Overall Study|Physician Decision|0|||
44414429|NCT00811070|79422476|FG001|Overall Study|Physician Decision|0|||
44414430|NCT00811070|79422477|FG002|Overall Study|Physician Decision|0|||
44414431|NCT00811070|79422478|FG003|Overall Study|Physician Decision|0|||
44414432|NCT00811070|79422479|FG004|Overall Study|Physician Decision|0|||
44414433|NCT00811070|79422480|FG005|Overall Study|Physician Decision|1|||
44414434|NCT00642460|79422498|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
44414435|NCT00642460|79422499|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
44414436|NCT00642460|79422500|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
44414437|NCT00642460|79422501|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
44414438|NCT00642460|79422502|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
44414439|NCT00642460|79422503|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
44414440|NCT00642460|79422498|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
44414441|NCT00642460|79422499|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
44414442|NCT00642460|79422500|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
44414443|NCT00642460|79422501|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
44414444|NCT00642460|79422502|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
44414445|NCT00642460|79422503|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
44414446|NCT00642460|79422498|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
44414447|NCT00642460|79422499|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
44414448|NCT00642460|79422500|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
44414449|NCT00642460|79422501|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
44414450|NCT00642460|79422502|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
44414451|NCT00642460|79422503|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
44414452|NCT00642460|79422498|FG000|Part II: Open-Label Up to Week 92|Death|0|||
44414453|NCT00642460|79422499|FG001|Part II: Open-Label Up to Week 92|Death|1|||
44414454|NCT00642460|79422500|FG002|Part II: Open-Label Up to Week 92|Death|0|||
44414455|NCT00642460|79422501|FG003|Part II: Open-Label Up to Week 92|Death|2|||
44414456|NCT00642460|79422502|FG004|Part II: Open-Label Up to Week 92|Death|0|||
44414457|NCT00642460|79422503|FG005|Part II: Open-Label Up to Week 92|Death|0|||
44414458|NCT00642460|79422498|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
44414459|NCT00642460|79422499|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
44414460|NCT00642460|79422500|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
44414461|NCT00642460|79422501|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
44414462|NCT00642460|79422502|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
44414463|NCT00642460|79422503|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
44414464|NCT00642460|79422498|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
44414465|NCT00642460|79422499|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
44414466|NCT00642460|79422500|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
44414467|NCT00642460|79422501|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
44414468|NCT00642460|79422502|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
44414469|NCT00642460|79422503|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
44414470|NCT00642460|79422498|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
44414471|NCT00642460|79422499|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
44414472|NCT00642460|79422500|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
44414473|NCT00642460|79422501|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
44526425|NCT03248882|79535930|FG001|Overall Study|Lost to Follow-up|0|||
44526426|NCT03248882|79535931|FG002|Overall Study|Lost to Follow-up|0|||
44526427|NCT03248882|79535932|FG003|Overall Study|Lost to Follow-up|0|||
44526428|NCT03248882|79535933|FG004|Overall Study|Lost to Follow-up|1|||
44526429|NCT03248882|79535929|FG000|Overall Study|Protocol Violation|2|||
44526430|NCT03248882|79535930|FG001|Overall Study|Protocol Violation|0|||
44526431|NCT03248882|79535931|FG002|Overall Study|Protocol Violation|2|||
44526432|NCT03248882|79535932|FG003|Overall Study|Protocol Violation|0|||
44526433|NCT03248882|79535933|FG004|Overall Study|Protocol Violation|1|||
44254237|NCT02620020|79095941|FG001|Overall Study|Lost to Follow-up|8|||
44526434|NCT03248882|79535929|FG000|Overall Study|Withdrawal by Subject|2|||
44526435|NCT03248882|79535930|FG001|Overall Study|Withdrawal by Subject|2|||
44414474|NCT00642460|79422502|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
44414475|NCT00642460|79422503|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
44414476|NCT00642460|79422498|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
44414477|NCT00642460|79422499|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
44414478|NCT00642460|79422500|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
44414479|NCT00642460|79422501|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
44414480|NCT00642460|79422502|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
44414481|NCT00642460|79422503|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
44414482|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
44414483|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
44414484|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
44414485|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
44414486|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
44414487|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
44414488|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
44414489|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
44414490|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
44414491|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
44414492|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
44414493|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
44414494|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
44414495|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
44414496|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
44414497|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
44414498|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
44414499|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
44414500|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
44414501|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
44414502|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
44414503|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
44414504|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
44414505|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
44414506|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Other|0|||
44414507|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Other|0|||
44414508|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Other|0|||
44414509|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Other|0|||
44414510|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Other|2|||
44414511|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Other|2|||
44414512|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Death|0|||
44414513|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Death|0|||
44414514|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Death|0|||
44414515|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Death|0|||
44414516|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Death|0|||
44414517|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Death|3|||
44414518|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
44414519|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
44414520|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
44526436|NCT03248882|79535931|FG002|Overall Study|Withdrawal by Subject|3|||
44526437|NCT03248882|79535932|FG003|Overall Study|Withdrawal by Subject|4|||
44526438|NCT03248882|79535933|FG004|Overall Study|Withdrawal by Subject|2|||
44526439|NCT03233438|79535947|FG000|Overall Study|Lost to Follow-up|4|||
44526440|NCT03233438|79535948|FG001|Overall Study|Lost to Follow-up|9|||
44526441|NCT03233438|79535947|FG000|Overall Study|Withdrawal by Subject|2|||
44282302|NCT01859988|79245608|FG003|Overall Study|Withdrawal by Subject|3|||
44414521|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
44414522|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
44414523|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
44414524|NCT00642460|79422498|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
44526442|NCT03233438|79535948|FG001|Overall Study|Withdrawal by Subject|1|||
44148770|NCT02597049|78938378|FG002|Overall Study|Death|0|||
44282303|NCT01859988|79245609|FG004|Overall Study|Withdrawal by Subject|2|||
44526443|NCT03233438|79535947|FG000|Overall Study|No recording of dalbavancin|0|||
44526444|NCT03233438|79535948|FG001|Overall Study|No recording of dalbavancin|1|||
44282304|NCT01859988|79245610|FG005|Overall Study|Withdrawal by Subject|2|||
44526445|NCT01368406|79535956|FG000|Overall Study|Lost to Follow-up|8|||
44526446|NCT01368406|79535957|FG001|Overall Study|Lost to Follow-up|4|||
44526447|NCT01368406|79535956|FG000|Overall Study|Withdrawal by Subject|8|||
44526448|NCT01368406|79535957|FG001|Overall Study|Withdrawal by Subject|4|||
44526449|NCT01368406|79535956|FG000|Overall Study|relapse of the disease|3|||
44526450|NCT01368406|79535957|FG001|Overall Study|relapse of the disease|2|||
44526451|NCT01368406|79535956|FG000|Overall Study|started working|2|||
44526452|NCT01368406|79535957|FG001|Overall Study|started working|3|||
44526453|NCT00175877|79535963|FG000|Overall Study|Adverse Event|136|||
44526454|NCT00175877|79535963|FG000|Overall Study|Withdrawal by Subject|141|||
44526455|NCT00175877|79535963|FG000|Overall Study|Lost to Follow-up|9|||
44526456|NCT00175877|79535963|FG000|Overall Study|Lack of Efficacy|26|||
44526457|NCT00175877|79535963|FG000|Overall Study|Protocol Violation|15|||
44526458|NCT00175877|79535963|FG000|Overall Study|Other Reason|20|||
44526459|NCT00175877|79535963|FG000|Overall Study|AE & Other|1|||
44526460|NCT00175877|79535963|FG000|Overall Study|Withdrawal by subject & Other|1|||
44526461|NCT03247556|79535970|FG000|Overall Study|Adverse Event|1|||
44526462|NCT03247556|79535971|FG001|Overall Study|Adverse Event|4|||
44526463|NCT03247556|79535972|FG002|Overall Study|Adverse Event|5|||
44526464|NCT03247556|79535970|FG000|Overall Study|Lost to Follow-up|5|||
44526465|NCT03247556|79535971|FG001|Overall Study|Lost to Follow-up|5|||
44526466|NCT03247556|79535972|FG002|Overall Study|Lost to Follow-up|4|||
44526467|NCT03247556|79535970|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
44526468|NCT03247556|79535971|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
44414525|NCT00642460|79422499|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
44526469|NCT03247556|79535972|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
44148771|NCT02597049|78938376|FG000|Overall Study|Noncompliant with Study Visits|1|||
44148772|NCT02597049|78938377|FG001|Overall Study|Noncompliant with Study Visits|0|||
44148773|NCT02597049|78938378|FG002|Overall Study|Noncompliant with Study Visits|0|||
44148774|NCT02594163|78938388|FG000|Treatment Period|Progressive disease|2|||
44148775|NCT02594163|78938389|FG001|Treatment Period|Progressive disease|3|||
44148776|NCT02594163|78938388|FG000|Treatment Period|Adverse Event|1|||
44148777|NCT02594163|78938389|FG001|Treatment Period|Adverse Event|5|||
44148778|NCT02594163|78938388|FG000|Treatment Period|Physician Decision|1|||
44148779|NCT02594163|78938389|FG001|Treatment Period|Physician Decision|3|||
44148780|NCT02594163|78938388|FG000|Treatment Period|Study termination by sponsor|2|||
44148781|NCT02594163|78938389|FG001|Treatment Period|Study termination by sponsor|1|||
44148782|NCT02594163|78938388|FG000|Treatment Period|Other, Non-AE|1|||
44148783|NCT02594163|78938389|FG001|Treatment Period|Other, Non-AE|0|||
44526470|NCT03247556|79535970|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
44526471|NCT03247556|79535971|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
44148784|NCT02594163|78938388|FG000|Follow-up Period|Withdrawal by Subject|0|||
44148785|NCT02594163|78938389|FG001|Follow-up Period|Withdrawal by Subject|1|||
44148786|NCT02594163|78938388|FG000|Follow-up Period|Study Termination by Sponsor|6|||
44526472|NCT03247556|79535972|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
44526473|NCT03247556|79535970|FG000|Overall Study|Protocol Violation|2|||
44526474|NCT03247556|79535971|FG001|Overall Study|Protocol Violation|0|||
44526475|NCT03247556|79535972|FG002|Overall Study|Protocol Violation|1|||
44148787|NCT02594163|78938389|FG001|Follow-up Period|Study Termination by Sponsor|4|||
44148788|NCT02594163|78938388|FG000|Follow-up Period|Lost to Follow-up|1|||
44148789|NCT02594163|78938389|FG001|Follow-up Period|Lost to Follow-up|0|||
44148790|NCT02594163|78938388|FG000|Follow-up Period|Death|2|||
44148791|NCT02594163|78938389|FG001|Follow-up Period|Death|5|||
44148792|NCT02594163|78938388|FG000|Follow-up Period|Adverse Event|0|||
44148793|NCT02594163|78938389|FG001|Follow-up Period|Adverse Event|1|||
44148794|NCT02594163|78938388|FG000|Follow-up Period|Progressive Disease|2|||
44148795|NCT02594163|78938389|FG001|Follow-up Period|Progressive Disease|0|||
44282305|NCT01859988|79245605|FG000|Overall Study|Lack of Efficacy|1|||
44282306|NCT01859988|79245606|FG001|Overall Study|Lack of Efficacy|1|||
44282307|NCT01859988|79245607|FG002|Overall Study|Lack of Efficacy|5|||
44282308|NCT01859988|79245608|FG003|Overall Study|Lack of Efficacy|0|||
44282309|NCT01859988|79245609|FG004|Overall Study|Lack of Efficacy|7|||
44282310|NCT01859988|79245610|FG005|Overall Study|Lack of Efficacy|9|||
44526476|NCT03247556|79535970|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
44526477|NCT03247556|79535971|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
44526478|NCT03247556|79535972|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
44526479|NCT03216746|79535984|FG000|Overall Study|Lost to Follow-up|6|||
44526480|NCT03216746|79535985|FG001|Overall Study|Lost to Follow-up|8|||
44526481|NCT03216746|79535986|FG002|Overall Study|Lost to Follow-up|5|||
44526482|NCT03216746|79535987|FG003|Overall Study|Lost to Follow-up|6|||
44526483|NCT02787304|79536001|FG000|Overall Study|Adverse Event|9|||
44526484|NCT02787304|79536002|FG001|Overall Study|Adverse Event|3|||
44526485|NCT02787304|79536003|FG002|Overall Study|Adverse Event|8|||
44526486|NCT02787304|79536004|FG003|Overall Study|Adverse Event|1|||
44526487|NCT02787304|79536001|FG000|Overall Study|Withdrawal by Subject|1|||
44526488|NCT02787304|79536002|FG001|Overall Study|Withdrawal by Subject|4|||
44526489|NCT02787304|79536003|FG002|Overall Study|Withdrawal by Subject|0|||
44526490|NCT02787304|79536004|FG003|Overall Study|Withdrawal by Subject|0|||
44526491|NCT02787304|79536001|FG000|Overall Study|Lost to Follow-up|1|||
44526492|NCT02787304|79536002|FG001|Overall Study|Lost to Follow-up|0|||
44526493|NCT02787304|79536003|FG002|Overall Study|Lost to Follow-up|0|||
44526494|NCT02787304|79536004|FG003|Overall Study|Lost to Follow-up|1|||
44526495|NCT02787304|79536001|FG000|Overall Study|Noncompliance with study drug|0|||
44526496|NCT02787304|79536002|FG001|Overall Study|Noncompliance with study drug|0|||
44526497|NCT02787304|79536003|FG002|Overall Study|Noncompliance with study drug|1|||
44526498|NCT02787304|79536004|FG003|Overall Study|Noncompliance with study drug|0|||
44526499|NCT02787304|79536001|FG000|Overall Study|Physician Decision|0|||
44526500|NCT02787304|79536002|FG001|Overall Study|Physician Decision|0|||
44526501|NCT02787304|79536003|FG002|Overall Study|Physician Decision|1|||
44526502|NCT02787304|79536004|FG003|Overall Study|Physician Decision|0|||
44526503|NCT02787304|79536001|FG000|Overall Study|Study terminated by sponsor|25|||
44526504|NCT02787304|79536002|FG001|Overall Study|Study terminated by sponsor|31|||
44526505|NCT02787304|79536003|FG002|Overall Study|Study terminated by sponsor|31|||
44526506|NCT02787304|79536004|FG003|Overall Study|Study terminated by sponsor|32|||
44526507|NCT02932904|79536018|FG000|Overall Study|Reason not Specified|1|||
44526508|NCT02932904|79536019|FG001|Overall Study|Reason not Specified|0|||
44526509|NCT02932904|79536020|FG002|Overall Study|Reason not Specified|2|||
44526510|NCT02932904|79536021|FG003|Overall Study|Reason not Specified|2|||
44526511|NCT02932904|79536018|FG000|Overall Study|Noncompliance with Study Drug|2|||
44526512|NCT02932904|79536019|FG001|Overall Study|Noncompliance with Study Drug|3|||
44526513|NCT02932904|79536020|FG002|Overall Study|Noncompliance with Study Drug|3|||
44526514|NCT02932904|79536021|FG003|Overall Study|Noncompliance with Study Drug|4|||
44526515|NCT02932904|79536018|FG000|Overall Study|Pregnancy|0|||
44526516|NCT02932904|79536019|FG001|Overall Study|Pregnancy|1|||
44526517|NCT02932904|79536020|FG002|Overall Study|Pregnancy|1|||
44526518|NCT02932904|79536021|FG003|Overall Study|Pregnancy|0|||
44526519|NCT02932904|79536018|FG000|Overall Study|Study Termination|0|||
44526520|NCT02932904|79536019|FG001|Overall Study|Study Termination|1|||
44526521|NCT02932904|79536020|FG002|Overall Study|Study Termination|0|||
44526522|NCT02932904|79536021|FG003|Overall Study|Study Termination|0|||
44526523|NCT02932904|79536018|FG000|Overall Study|Voluntary Withdrawal|2|||
44526524|NCT02932904|79536019|FG001|Overall Study|Voluntary Withdrawal|1|||
44526525|NCT02932904|79536020|FG002|Overall Study|Voluntary Withdrawal|4|||
44526526|NCT02932904|79536021|FG003|Overall Study|Voluntary Withdrawal|2|||
44526527|NCT02932904|79536018|FG000|Overall Study|Lost to Follow-up|5|||
44526528|NCT02932904|79536019|FG001|Overall Study|Lost to Follow-up|3|||
44148796|NCT02594163|78938388|FG000|Follow-up Period|Physician Decision|0|||
44526529|NCT02932904|79536020|FG002|Overall Study|Lost to Follow-up|6|||
44526530|NCT02932904|79536021|FG003|Overall Study|Lost to Follow-up|0|||
44526531|NCT02932904|79536018|FG000|Overall Study|Significant Protocol Deviation|2|||
44526532|NCT02932904|79536019|FG001|Overall Study|Significant Protocol Deviation|3|||
44526533|NCT02932904|79536020|FG002|Overall Study|Significant Protocol Deviation|6|||
44526534|NCT02932904|79536021|FG003|Overall Study|Significant Protocol Deviation|1|||
44526535|NCT02932904|79536018|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
44526536|NCT02932904|79536019|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
44526537|NCT02932904|79536020|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
44282311|NCT01859988|79245605|FG000|Overall Study|Physician Decision|1|||
44526538|NCT02932904|79536021|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
44526539|NCT02932904|79536018|FG000|Overall Study|Randomized But Not Treated|1|||
44526540|NCT02932904|79536019|FG001|Overall Study|Randomized But Not Treated|1|||
44526541|NCT02932904|79536020|FG002|Overall Study|Randomized But Not Treated|0|||
44526542|NCT02932904|79536021|FG003|Overall Study|Randomized But Not Treated|2|||
44526543|NCT00688376|79536036|FG000|Double-Blind Phase|Adverse Event|4|||
44526544|NCT00688376|79536037|FG001|Double-Blind Phase|Adverse Event|4|||
44526545|NCT00688376|79536036|FG000|Double-Blind Phase|Protocol Violation|1|||
44526546|NCT00688376|79536037|FG001|Double-Blind Phase|Protocol Violation|2|||
44526547|NCT00688376|79536036|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
44526548|NCT00688376|79536037|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
44526549|NCT00688376|79536036|FG000|Double-Blind Phase|Not treated|0|||
44526550|NCT00688376|79536037|FG001|Double-Blind Phase|Not treated|1|||
44526551|NCT00688376|79536036|FG000|Blinded Extension Phase|Adverse Event|3|||
44526552|NCT00688376|79536037|FG001|Blinded Extension Phase|Adverse Event|4|||
44526553|NCT00688376|79536036|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
44526554|NCT00688376|79536037|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
44526555|NCT00688376|79536036|FG000|Blinded Extension Phase|Physician Decision|1|||
44526556|NCT00688376|79536037|FG001|Blinded Extension Phase|Physician Decision|0|||
44526557|NCT00688376|79536036|FG000|Blinded Extension Phase|Other|1|||
44526558|NCT00688376|79536037|FG001|Blinded Extension Phase|Other|0|||
44526559|NCT03214952|79536045|FG000|Overall Study|Protocol Deviation|45|||
44526560|NCT03214952|79536045|FG000|Overall Study|Case Report Forms Uncollected|13|||
44526561|NCT01367704|79536051|FG000|Overall Study|Lost to Follow-up|47|||
44526562|NCT01367704|79536052|FG001|Overall Study|Lost to Follow-up|161|||
44526563|NCT03214094|79536058|FG000|Overall Study|Case Report Forms Uncollected|14|||
44526564|NCT03214094|79536058|FG000|Overall Study|Protocol Deviation|46|||
44526565|NCT05299359|79536069|FG000|Overall Study|Ongoing in Study|149|||
44526566|NCT05299359|79536069|FG000|Overall Study|Other|1|||
44526567|NCT05069155|79536086|FG000|Overall Study|Withdrawal by Subject|1|||
44526568|NCT05069155|79536087|FG001|Overall Study|Withdrawal by Subject|3|||
44526569|NCT04875533|79536095|FG000|Overall Study|Adverse Event|6|||
44526570|NCT04875533|79536096|FG001|Overall Study|Adverse Event|4|||
44526571|NCT04875533|79536095|FG000|Overall Study|Protocol Violation|4|||
44526572|NCT04875533|79536096|FG001|Overall Study|Protocol Violation|0|||
44526573|NCT04875533|79536095|FG000|Overall Study|Withdrawal by Subject|8|||
44526574|NCT04875533|79536096|FG001|Overall Study|Withdrawal by Subject|5|||
44526575|NCT04875533|79536095|FG000|Overall Study|No longer meets eligibility criteria|1|||
44526576|NCT04875533|79536096|FG001|Overall Study|No longer meets eligibility criteria|0|||
44526577|NCT04875533|79536095|FG000|Overall Study|Other|0|||
44526578|NCT04875533|79536096|FG001|Overall Study|Other|2|||
44526579|NCT04854551|79536106|FG000|Overall Study|Withdrawal by Subject|1|||
44526580|NCT04854551|79536107|FG001|Overall Study|Withdrawal by Subject|1|||
44526581|NCT04672941|79536114|FG000|Overall Study|Investigator decision|1|||
44526582|NCT04672941|79536114|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
44526583|NCT04672941|79536114|FG000|Overall Study|COVID-19 related but no adverse event|1|||
44526584|NCT04672941|79536114|FG000|Overall Study|Adverse Event|2|||
44526585|NCT04672941|79536114|FG000|Overall Study|Lost to Follow-up|2|||
44526586|NCT04599972|79536139|FG000|Overall Study|Withdrawal by Subject|6|||
44526587|NCT04599972|79536140|FG001|Overall Study|Withdrawal by Subject|1|||
44526588|NCT04599972|79536139|FG000|Overall Study|Adverse Event|1|||
44526589|NCT04599972|79536140|FG001|Overall Study|Adverse Event|1|||
44526590|NCT04599972|79536139|FG000|Overall Study|Lost to Follow-up|1|||
44526591|NCT04599972|79536140|FG001|Overall Study|Lost to Follow-up|6|||
44526592|NCT04599972|79536139|FG000|Overall Study|Protocol Violation|1|||
44526593|NCT04599972|79536140|FG001|Overall Study|Protocol Violation|0|||
44526594|NCT04599972|79536139|FG000|Overall Study|Other reason|1|||
44526595|NCT04599972|79536140|FG001|Overall Study|Other reason|0|||
44526596|NCT04599933|79536148|FG000|Overall Study|Adverse Event|4|||
44526597|NCT04599933|79536149|FG001|Overall Study|Adverse Event|1|||
44526598|NCT04599933|79536148|FG000|Overall Study|Withdrawal by Subject|4|||
44526599|NCT04599933|79536149|FG001|Overall Study|Withdrawal by Subject|2|||
44526600|NCT04599933|79536148|FG000|Overall Study|Lost to Follow-up|0|||
44526601|NCT04599933|79536149|FG001|Overall Study|Lost to Follow-up|1|||
44526602|NCT04599933|79536148|FG000|Overall Study|Physician Decision|0|||
44526603|NCT04599933|79536149|FG001|Overall Study|Physician Decision|1|||
44526604|NCT04599933|79536148|FG000|Overall Study|Screen Failure|1|||
44526605|NCT04599933|79536149|FG001|Overall Study|Screen Failure|2|||
44526606|NCT04558918|79536157|FG000|Randomized Treatment Period|Pregnancy|1|||
44414526|NCT00642460|79422500|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
44526607|NCT04558918|79536158|FG001|Randomized Treatment Period|Pregnancy|0|||
44526608|NCT04558918|79536157|FG000|Extension Treatment Period|Pregnancy|1|||
44526609|NCT04558918|79536158|FG001|Extension Treatment Period|Pregnancy|0|||
44526610|NCT04558918|79536157|FG000|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|28|||
44526611|NCT04558918|79536158|FG001|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|14|||
44526612|NCT04498910|79536168|FG000|Overall Study|Lost to Follow-up|0|||
44526613|NCT04498910|79536169|FG001|Overall Study|Lost to Follow-up|1|||
44526614|NCT04498910|79536168|FG000|Overall Study|Withdrawal by Subject|2|||
44526615|NCT04498910|79536169|FG001|Overall Study|Withdrawal by Subject|1|||
44526616|NCT04498910|79536168|FG000|Overall Study|Adverse Event|1|||
44414527|NCT00642460|79422501|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
44414528|NCT00642460|79422502|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
44414529|NCT00642460|79422503|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
44526617|NCT04498910|79536169|FG001|Overall Study|Adverse Event|0|||
44526618|NCT04439344|79536176|FG000|Overall Study|Never started threapy|3|||
44526619|NCT04439344|79536176|FG000|Overall Study|Ineligible|3|||
44526620|NCT04439344|79536176|FG000|Overall Study|Adverse Event|13|||
44526621|NCT04439344|79536176|FG000|Overall Study|Death|2|||
44526622|NCT04439344|79536176|FG000|Overall Study|Disease progression|29|||
44526623|NCT04439344|79536176|FG000|Overall Study|Withdrawal by Subject|2|||
44526624|NCT04439344|79536176|FG000|Overall Study|Alternative therapy|1|||
44526625|NCT04439110|79536180|FG000|Overall Study|Ineligible|2|||
44526626|NCT04439110|79536180|FG000|Overall Study|Adverse Event|4|||
44526627|NCT04439110|79536180|FG000|Overall Study|Death|2|||
44526628|NCT04439110|79536180|FG000|Overall Study|Disease proression|25|||
44526629|NCT04439110|79536180|FG000|Overall Study|Withdrawal by Subject|1|||
44526630|NCT04439110|79536180|FG000|Overall Study|Alternative therapy|1|||
44526631|NCT04439110|79536180|FG000|Overall Study|Other complicating disease|1|||
44526632|NCT04439110|79536180|FG000|Overall Study|Personal reasons|1|||
44526633|NCT04439110|79536180|FG000|Overall Study|Still on treatment|1|||
44526634|NCT04392167|79536184|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
44526635|NCT03738228|79536260|FG000|Overall Study|Never received study treatment|2|||
44526636|NCT03738228|79536261|FG001|Overall Study|Never received study treatment|2|||
44526637|NCT03689894|79536267|FG000|Overall Study|Adverse Event|1|||
44526638|NCT03640754|79536274|FG000|Overall Study|Withdrawal by Subject|1|||
44526639|NCT03640754|79536275|FG001|Overall Study|Withdrawal by Subject|0|||
44526640|NCT03640754|79536274|FG000|Overall Study|Lost to Follow-up|0|||
44526641|NCT03640754|79536275|FG001|Overall Study|Lost to Follow-up|1|||
44526642|NCT03255018|79536296|FG000|Overall Study|Death on study|0|||
44526643|NCT03255018|79536297|FG001|Overall Study|Death on study|5|||
44526644|NCT03255018|79536296|FG000|Overall Study|Withdrawal by Subject|0|||
44526645|NCT03255018|79536297|FG001|Overall Study|Withdrawal by Subject|2|||
44526646|NCT03204188|79536303|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
44526647|NCT03204188|79536303|FG000|Immunotherapy Phase (1 Year)|Death|1|||
44526648|NCT03204188|79536303|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
44526649|NCT03204188|79536303|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
44526650|NCT03000530|79536325|FG000|Overall Study|Adverse Event|0|||
44526651|NCT03000530|79536326|FG001|Overall Study|Adverse Event|0|||
44526652|NCT03000530|79536327|FG002|Overall Study|Adverse Event|2|||
44526653|NCT03000530|79536325|FG000|Overall Study|Lost to Follow-up|0|||
44526654|NCT03000530|79536326|FG001|Overall Study|Lost to Follow-up|3|||
44526655|NCT03000530|79536327|FG002|Overall Study|Lost to Follow-up|1|||
44254238|NCT02620020|79095942|FG002|Overall Study|Lost to Follow-up|1|||
44254239|NCT02620020|79095943|FG003|Overall Study|Lost to Follow-up|4|||
44414530|NCT00814658|79422515|FG000|Overall Study|Lost to Follow-up|0|||
44414531|NCT00814658|79422516|FG001|Overall Study|Lost to Follow-up|1|||
44414532|NCT00814658|79422515|FG000|Overall Study|Physician Decision|1|||
44414533|NCT00814658|79422516|FG001|Overall Study|Physician Decision|0|||
44414534|NCT00814658|79422515|FG000|Overall Study|Adverse Event|3|||
44414535|NCT00814658|79422516|FG001|Overall Study|Adverse Event|3|||
44414536|NCT00642304|79422532|FG000|Overall Study|Adverse Event|1|||
44414537|NCT00642304|79422532|FG000|Overall Study|Death|1|||
44414538|NCT00642304|79422532|FG000|Overall Study|Blood transfusion|2|||
44414539|NCT00642304|79422532|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
44414540|NCT00642304|79422532|FG000|Overall Study|Transplantation|1|||
44414541|NCT00814580|79422538|FG000|Overall Study|Adverse Event|6|||
44414542|NCT00814580|79422539|FG001|Overall Study|Adverse Event|15|||
44414543|NCT00814580|79422538|FG000|Overall Study|Lack of Efficacy|18|||
44254240|NCT02620020|79095940|FG000|Overall Study|Physician Decision|7|||
44414544|NCT00814580|79422539|FG001|Overall Study|Lack of Efficacy|25|||
44414545|NCT00814580|79422538|FG000|Overall Study|Protocol Violation|2|||
44414546|NCT00814580|79422539|FG001|Overall Study|Protocol Violation|0|||
44414547|NCT00814580|79422538|FG000|Overall Study|Withdrawal by Subject|2|||
44526656|NCT03000530|79536325|FG000|Overall Study|Withdrawal by Subject|0|||
44526657|NCT03000530|79536326|FG001|Overall Study|Withdrawal by Subject|2|||
44526658|NCT03000530|79536327|FG002|Overall Study|Withdrawal by Subject|1|||
44526659|NCT02978781|79536341|FG000|Part A|Adverse Event|1|||
44526660|NCT02978781|79536342|FG001|Part A|Adverse Event|1|||
44526661|NCT02978781|79536343|FG002|Part A|Adverse Event|0|||
44414548|NCT00814580|79422539|FG001|Overall Study|Withdrawal by Subject|2|||
44526662|NCT02978781|79536344|FG003|Part A|Adverse Event|0|||
44526663|NCT02978781|79536345|FG004|Part A|Adverse Event|0|||
44254241|NCT02620020|79095941|FG001|Overall Study|Physician Decision|4|||
44414549|NCT00814580|79422538|FG000|Overall Study|Other|1|||
44526664|NCT02978781|79536341|FG000|Part A|Withdrawal by Subject|0|||
44526665|NCT02978781|79536342|FG001|Part A|Withdrawal by Subject|1|||
44526666|NCT02978781|79536343|FG002|Part A|Withdrawal by Subject|0|||
44526667|NCT02978781|79536344|FG003|Part A|Withdrawal by Subject|0|||
44526668|NCT02978781|79536345|FG004|Part A|Withdrawal by Subject|0|||
44526669|NCT02978781|79536341|FG000|Part B|Withdrawal by Subject|0|||
44526670|NCT02978781|79536342|FG001|Part B|Withdrawal by Subject|0|||
44526671|NCT02978781|79536343|FG002|Part B|Withdrawal by Subject|0|||
44526672|NCT02978781|79536344|FG003|Part B|Withdrawal by Subject|1|||
44526673|NCT02978781|79536345|FG004|Part B|Withdrawal by Subject|0|||
44526674|NCT02978781|79536341|FG000|Part C|Adverse Event|0|||
44526675|NCT02978781|79536342|FG001|Part C|Adverse Event|0|||
44526676|NCT02978781|79536343|FG002|Part C|Adverse Event|0|||
44526677|NCT02978781|79536344|FG003|Part C|Adverse Event|0|||
44526678|NCT02978781|79536345|FG004|Part C|Adverse Event|2|||
44526679|NCT02978781|79536341|FG000|Part C|Withdrawal by Subject|0|||
44526680|NCT02978781|79536342|FG001|Part C|Withdrawal by Subject|0|||
44526681|NCT02978781|79536343|FG002|Part C|Withdrawal by Subject|0|||
44526682|NCT02978781|79536344|FG003|Part C|Withdrawal by Subject|0|||
44526683|NCT02978781|79536345|FG004|Part C|Withdrawal by Subject|1|||
44526684|NCT02978781|79536341|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
44526685|NCT02978781|79536342|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
44526686|NCT02978781|79536343|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
44526687|NCT02978781|79536344|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
44526688|NCT02978781|79536345|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
44526689|NCT02549092|79536388|FG000|Treatment Period|Adverse Event|2|||
44526690|NCT02549092|79536389|FG001|Treatment Period|Adverse Event|2|||
44526691|NCT02549092|79536388|FG000|Treatment Period|Withdrawal by Subject|1|||
44526692|NCT02549092|79536389|FG001|Treatment Period|Withdrawal by Subject|3|||
44526693|NCT02549092|79536388|FG000|Treatment Period|Lack of Efficacy|0|||
44526694|NCT02549092|79536389|FG001|Treatment Period|Lack of Efficacy|2|||
44526695|NCT02549092|79536388|FG000|Extension/Transition Period|Adverse Event|1|||
44526696|NCT02549092|79536389|FG001|Extension/Transition Period|Adverse Event|1|||
44526697|NCT02549092|79536388|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
44526698|NCT02549092|79536389|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
44526699|NCT02549092|79536388|FG000|Extension/Transition Period|Other, Not Specified|4|||
44526700|NCT02549092|79536389|FG001|Extension/Transition Period|Other, Not Specified|2|||
44526701|NCT02543281|79536401|FG000|Overall Study|Lost to Follow-up|0|||
44526702|NCT02543281|79536402|FG001|Overall Study|Lost to Follow-up|0|||
44526703|NCT02543281|79536403|FG002|Overall Study|Lost to Follow-up|1|||
44526704|NCT02429791|79536413|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
44526705|NCT02429791|79536414|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
44526706|NCT02429791|79536413|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
44526707|NCT02429791|79536414|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
44526708|NCT02429791|79536413|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
44526709|NCT02429791|79536414|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
44526710|NCT02429791|79536413|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
44526711|NCT02429791|79536414|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
44526712|NCT02429791|79536413|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
44526713|NCT02429791|79536414|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
44526714|NCT02429791|79536413|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
44526715|NCT02429791|79536414|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
44526716|NCT02429791|79536413|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
44526717|NCT02429791|79536414|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
44526718|NCT02429791|79536413|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
44526719|NCT02429791|79536414|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
44526720|NCT02429791|79536413|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
44526721|NCT02429791|79536414|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
44526722|NCT02429791|79536413|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
44526723|NCT02429791|79536414|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
44526724|NCT02429791|79536413|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
44526725|NCT02429791|79536414|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
44526726|NCT02429791|79536413|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
44526727|NCT02429791|79536414|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
44526728|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
44526729|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
44526730|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
44526731|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
44526732|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
44526733|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
44526734|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
44526735|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
44526736|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
44526737|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
44526738|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
44526739|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
44526740|NCT02422797|79536439|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
44526741|NCT02422797|79536440|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
44526742|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
44526743|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
44526744|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
44526745|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
44526746|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
44526747|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
44526748|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
44526749|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
44526750|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
44526751|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
44526752|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
44526753|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
44526754|NCT02422797|79536439|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
44526755|NCT02422797|79536440|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
44526756|NCT02181738|79536460|FG000|Overall Study|Participant Withdrew Consent|2|||
44526757|NCT02181738|79536461|FG001|Overall Study|Participant Withdrew Consent|1|||
44526758|NCT02181738|79536462|FG002|Overall Study|Participant Withdrew Consent|1|||
44526759|NCT02181738|79536463|FG003|Overall Study|Participant Withdrew Consent|1|||
44526760|NCT02181738|79536460|FG000|Overall Study|Lost to Follow-up|1|||
44526761|NCT02181738|79536461|FG001|Overall Study|Lost to Follow-up|2|||
44526762|NCT02181738|79536462|FG002|Overall Study|Lost to Follow-up|1|||
44526763|NCT02181738|79536463|FG003|Overall Study|Lost to Follow-up|1|||
44526764|NCT02181738|79536460|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
44526765|NCT02181738|79536461|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
44526766|NCT02181738|79536462|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
44526767|NCT02181738|79536463|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
44526768|NCT02181738|79536460|FG000|Overall Study|Poor/Non-Compliance|1|||
44526769|NCT02181738|79536461|FG001|Overall Study|Poor/Non-Compliance|0|||
44526770|NCT02181738|79536462|FG002|Overall Study|Poor/Non-Compliance|2|||
44526771|NCT02181738|79536463|FG003|Overall Study|Poor/Non-Compliance|1|||
44526772|NCT02181738|79536460|FG000|Overall Study|Disease Progression|28|||
44526773|NCT02181738|79536461|FG001|Overall Study|Disease Progression|35|||
44526774|NCT02181738|79536462|FG002|Overall Study|Disease Progression|40|||
44526775|NCT02181738|79536463|FG003|Overall Study|Disease Progression|0|||
44526776|NCT02181738|79536460|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
44526777|NCT02181738|79536461|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
44526778|NCT02181738|79536462|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
44148797|NCT02594163|78938389|FG001|Follow-up Period|Physician Decision|1|||
44148798|NCT02712983|78938404|FG000|Treatment Phase|Adverse Event|3|||
44148799|NCT02712983|78938405|FG001|Treatment Phase|Adverse Event|1|||
44148800|NCT02712983|78938406|FG002|Treatment Phase|Adverse Event|1|||
44148801|NCT02712983|78938407|FG003|Treatment Phase|Adverse Event|4|||
44148802|NCT02712983|78938408|FG004|Treatment Phase|Adverse Event|3|||
44148803|NCT02712983|78938409|FG005|Treatment Phase|Adverse Event|0|||
44148804|NCT02712983|78938410|FG006|Treatment Phase|Adverse Event|6|||
44148805|NCT02712983|78938411|FG007|Treatment Phase|Adverse Event|6|||
44148806|NCT02712983|78938412|FG008|Treatment Phase|Adverse Event|1|||
44148807|NCT02712983|78938404|FG000|Treatment Phase|Protocol Deviation|0|||
44148808|NCT02712983|78938405|FG001|Treatment Phase|Protocol Deviation|0|||
44148809|NCT02712983|78938406|FG002|Treatment Phase|Protocol Deviation|0|||
44148810|NCT02712983|78938407|FG003|Treatment Phase|Protocol Deviation|2|||
44148811|NCT02712983|78938408|FG004|Treatment Phase|Protocol Deviation|0|||
44148812|NCT02712983|78938409|FG005|Treatment Phase|Protocol Deviation|0|||
44148813|NCT02712983|78938410|FG006|Treatment Phase|Protocol Deviation|1|||
44526779|NCT02181738|79536463|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
44526780|NCT02181738|79536460|FG000|Overall Study|Study Drug Toxicity|6|||
44526781|NCT02181738|79536461|FG001|Overall Study|Study Drug Toxicity|11|||
44148814|NCT02712983|78938411|FG007|Treatment Phase|Protocol Deviation|0|||
44148815|NCT02712983|78938412|FG008|Treatment Phase|Protocol Deviation|0|||
44148816|NCT02712983|78938404|FG000|Treatment Phase|Technical Problems|0|||
44148817|NCT02712983|78938405|FG001|Treatment Phase|Technical Problems|0|||
44148818|NCT02712983|78938406|FG002|Treatment Phase|Technical Problems|0|||
44526782|NCT02181738|79536462|FG002|Overall Study|Study Drug Toxicity|8|||
44526783|NCT02181738|79536463|FG003|Overall Study|Study Drug Toxicity|1|||
44526784|NCT02181738|79536460|FG000|Overall Study|Other Reasons|14|||
44526785|NCT02181738|79536461|FG001|Overall Study|Other Reasons|16|||
44526786|NCT02181738|79536462|FG002|Overall Study|Other Reasons|28|||
44526787|NCT02181738|79536463|FG003|Overall Study|Other Reasons|0|||
44526788|NCT02181738|79536460|FG000|Overall Study|Maximum Clinical Benefit|3|||
44526789|NCT02181738|79536461|FG001|Overall Study|Maximum Clinical Benefit|0|||
44526790|NCT02181738|79536462|FG002|Overall Study|Maximum Clinical Benefit|1|||
44526791|NCT02181738|79536463|FG003|Overall Study|Maximum Clinical Benefit|0|||
44526792|NCT02181738|79536460|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
44526793|NCT02181738|79536461|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
44526794|NCT02181738|79536462|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
44526795|NCT02181738|79536463|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44526796|NCT02142803|79536482|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
44526797|NCT02142803|79536483|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
44526798|NCT02142803|79536484|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
44526799|NCT02142803|79536485|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
44526800|NCT01844986|79536502|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
44526801|NCT01844986|79536503|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
44526802|NCT01844986|79536502|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
44526803|NCT01844986|79536503|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
44526804|NCT01844986|79536502|FG000|Overall Study (Global Cohort)|Death|55|||
44526805|NCT01844986|79536503|FG001|Overall Study (Global Cohort)|Death|26|||
44526806|NCT01844986|79536502|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
44526807|NCT01844986|79536503|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
44526808|NCT01844986|79536502|FG000|Overall Study (China Cohort)|Death|10|||
44526809|NCT01844986|79536503|FG001|Overall Study (China Cohort)|Death|6|||
44414550|NCT00814580|79422539|FG001|Overall Study|Other|3|||
44414551|NCT00814580|79422538|FG000|Overall Study|Did Not Take Drug|2|||
44414552|NCT00814580|79422539|FG001|Overall Study|Did Not Take Drug|2|||
44414553|NCT00643162|79422559|FG000|Overall Study|Withdrawal by Subject|1|||
44414554|NCT00643162|79422560|FG001|Overall Study|Withdrawal by Subject|1|||
44414555|NCT00643006|79422568|FG000|Overall Study|Lost to Follow-up|5|||
44414556|NCT00643006|79422569|FG001|Overall Study|Lost to Follow-up|4|||
44414557|NCT00814502|79422579|FG000|Overall Study|Adverse Event|1|||
44414558|NCT00814502|79422580|FG001|Overall Study|Adverse Event|0|||
44526810|NCT01367236|79536564|FG000|Overall Study|Withdrawal by Subject|3|||
44526811|NCT01367236|79536565|FG001|Overall Study|Withdrawal by Subject|1|||
44526812|NCT03681951|79536579|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
44526813|NCT03681951|79536580|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526814|NCT03681951|79536581|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526815|NCT03681951|79536582|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526816|NCT03681951|79536583|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526817|NCT03681951|79536584|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526818|NCT03681951|79536585|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526819|NCT03681951|79536586|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
44526820|NCT03681951|79536579|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
44526821|NCT03681951|79536580|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44526822|NCT03681951|79536581|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44526823|NCT03681951|79536582|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44526824|NCT03681951|79536583|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44414559|NCT00814502|79422579|FG000|Overall Study|Withdrawal by Subject|0|||
44414560|NCT00814502|79422580|FG001|Overall Study|Withdrawal by Subject|2|||
44526825|NCT03681951|79536584|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44526826|NCT03681951|79536585|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44526827|NCT03681951|79536586|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
44526828|NCT03681951|79536579|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
44526829|NCT03681951|79536580|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44526830|NCT03681951|79536581|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44526831|NCT03681951|79536582|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44526832|NCT03681951|79536583|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44148819|NCT02712983|78938407|FG003|Treatment Phase|Technical Problems|0|||
44414561|NCT00653224|79422590|FG000|Overall Study|Adverse Event|2|||
44414562|NCT00653224|79422591|FG001|Overall Study|Adverse Event|1|||
44526833|NCT03681951|79536584|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44526834|NCT03681951|79536585|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44414563|NCT00653224|79422590|FG000|Overall Study|Lack of Efficacy|1|||
44414564|NCT00653224|79422591|FG001|Overall Study|Lack of Efficacy|2|||
44526835|NCT03681951|79536586|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
44526836|NCT03681405|79536611|FG000|Overall Study|Found to be ineligible after randomized|1|||
44526837|NCT03681405|79536612|FG001|Overall Study|Found to be ineligible after randomized|0|||
44526838|NCT00174785|79536622|FG000|Overall Study|Adverse Event|293|||
44526839|NCT00174785|79536623|FG001|Overall Study|Adverse Event|191|||
44526840|NCT00174785|79536622|FG000|Overall Study|Protocol Violation|14|||
44526841|NCT00174785|79536623|FG001|Overall Study|Protocol Violation|14|||
44526842|NCT00174785|79536622|FG000|Overall Study|Withdrawal by Subject|173|||
44148820|NCT02712983|78938408|FG004|Treatment Phase|Technical Problems|0|||
44148821|NCT02712983|78938409|FG005|Treatment Phase|Technical Problems|0|||
44148822|NCT02712983|78938410|FG006|Treatment Phase|Technical Problems|1|||
44148823|NCT02712983|78938411|FG007|Treatment Phase|Technical Problems|0|||
44148824|NCT02712983|78938412|FG008|Treatment Phase|Technical Problems|0|||
44414565|NCT00653224|79422590|FG000|Overall Study|Loss of efficacy|1|||
44526843|NCT00174785|79536623|FG001|Overall Study|Withdrawal by Subject|175|||
44526844|NCT00174785|79536622|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
44526845|NCT00174785|79536623|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
44526846|NCT00174785|79536622|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
44526847|NCT00174785|79536623|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
44526848|NCT00174785|79536622|FG000|Overall Study|Other prohibited medication|5|||
44526849|NCT00174785|79536623|FG001|Overall Study|Other prohibited medication|3|||
44526850|NCT00174785|79536622|FG000|Overall Study|Family request|6|||
44526851|NCT00174785|79536623|FG001|Overall Study|Family request|8|||
44526852|NCT00174785|79536622|FG000|Overall Study|Not pre-specified/Not coded|56|||
44526853|NCT00174785|79536623|FG001|Overall Study|Not pre-specified/Not coded|70|||
44526854|NCT03681093|79536632|FG000|Overall Study|Subject decision|0|||
44526855|NCT03681093|79536633|FG001|Overall Study|Subject decision|2|||
44526856|NCT03681093|79536634|FG002|Overall Study|Subject decision|1|||
44526857|NCT00166517|79536644|FG000|Overall Study|Lost to Follow-up|1|||
44526858|NCT00166517|79536645|FG001|Overall Study|Lost to Follow-up|0|||
44526859|NCT00166517|79536644|FG000|Overall Study|Protocol Violation|4|||
44526860|NCT00166517|79536645|FG001|Overall Study|Protocol Violation|1|||
44254242|NCT02620020|79095942|FG002|Overall Study|Physician Decision|3|||
44254243|NCT02620020|79095943|FG003|Overall Study|Physician Decision|4|||
44254244|NCT02620020|79095940|FG000|Overall Study|Protocol Violation|5|||
44414566|NCT00653224|79422591|FG001|Overall Study|Loss of efficacy|0|||
44414567|NCT00653224|79422590|FG000|Overall Study|Lost to Follow-up|1|||
44414568|NCT00653224|79422591|FG001|Overall Study|Lost to Follow-up|0|||
44414569|NCT00653224|79422590|FG000|Overall Study|Other|2|||
44414570|NCT00653224|79422591|FG001|Overall Study|Other|4|||
44414571|NCT00444925|79422600|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
44414572|NCT00444925|79422601|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
44414573|NCT00444925|79422602|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
44414574|NCT00444925|79422600|FG000|Double-blind Treatment Period|Death|2|||
44414575|NCT00444925|79422601|FG001|Double-blind Treatment Period|Death|0|||
44414576|NCT00444925|79422602|FG002|Double-blind Treatment Period|Death|0|||
44414577|NCT00444925|79422600|FG000|Double-blind Treatment Period|Adverse Event|6|||
44414578|NCT00444925|79422601|FG001|Double-blind Treatment Period|Adverse Event|28|||
44414579|NCT00444925|79422602|FG002|Double-blind Treatment Period|Adverse Event|44|||
44414580|NCT00444925|79422600|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
44414581|NCT00444925|79422601|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
44414582|NCT00444925|79422602|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
44414583|NCT00444925|79422600|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
44414584|NCT00444925|79422601|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
44414585|NCT00444925|79422602|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
44414586|NCT00444925|79422600|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
44414587|NCT00444925|79422601|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
44414588|NCT00444925|79422602|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
44414589|NCT00444925|79422600|FG000|Double-blind Treatment Period|Other|7|||
44414590|NCT00444925|79422601|FG001|Double-blind Treatment Period|Other|7|||
44414591|NCT00444925|79422602|FG002|Double-blind Treatment Period|Other|12|||
44414592|NCT00641056|79422612|FG000|Overall Study|Adverse Event|12|||
44414593|NCT00641056|79422613|FG001|Overall Study|Adverse Event|2|||
44526861|NCT00166517|79536644|FG000|Overall Study|Withdrawal by Subject|0|||
44526862|NCT00166517|79536645|FG001|Overall Study|Withdrawal by Subject|1|||
44526863|NCT00166439|79536651|FG000|Overall Study|Ineligible|5|||
44148825|NCT02712983|78938404|FG000|Treatment Phase|Physician Decision|0|||
44414594|NCT00641056|79422612|FG000|Overall Study|Lost to Follow-up|2|||
44526864|NCT00138671|79536657|FG000|Overall Study|Death|0|||
44526865|NCT00138671|79536658|FG001|Overall Study|Death|3|||
44526866|NCT00138671|79536657|FG000|Overall Study|Adverse Event|6|||
44254245|NCT02620020|79095941|FG001|Overall Study|Protocol Violation|2|||
44526867|NCT00138671|79536658|FG001|Overall Study|Adverse Event|3|||
44526868|NCT00138671|79536657|FG000|Overall Study|Lost to Follow-up|1|||
44148826|NCT02712983|78938405|FG001|Treatment Phase|Physician Decision|0|||
44414595|NCT00641056|79422613|FG001|Overall Study|Lost to Follow-up|1|||
44414596|NCT00641056|79422612|FG000|Overall Study|Physician Decision|3|||
44414597|NCT00641056|79422613|FG001|Overall Study|Physician Decision|1|||
44414598|NCT00641056|79422612|FG000|Overall Study|Protocol Violation|2|||
44414599|NCT00641056|79422613|FG001|Overall Study|Protocol Violation|0|||
44414600|NCT00641056|79422612|FG000|Overall Study|Entry Criteria Not Met|3|||
44526869|NCT00138671|79536658|FG001|Overall Study|Lost to Follow-up|2|||
44526870|NCT00138671|79536657|FG000|Overall Study|Withdrawal by Subject|3|||
44526871|NCT00138671|79536658|FG001|Overall Study|Withdrawal by Subject|5|||
44526872|NCT00138671|79536657|FG000|Overall Study|Other|3|||
44526873|NCT00138671|79536658|FG001|Overall Study|Other|3|||
44526874|NCT01367158|79536677|FG000|Overall Study|Withdrew consent|0|||
44526875|NCT01367158|79536678|FG001|Overall Study|Withdrew consent|2|||
44526876|NCT01367158|79536679|FG002|Overall Study|Withdrew consent|1|||
44526877|NCT01367158|79536680|FG003|Overall Study|Withdrew consent|0|||
44526878|NCT01367158|79536681|FG004|Overall Study|Withdrew consent|2|||
44526879|NCT01367158|79536682|FG005|Overall Study|Withdrew consent|0|||
44526880|NCT01367158|79536683|FG006|Overall Study|Withdrew consent|0|||
44526881|NCT01367158|79536684|FG007|Overall Study|Withdrew consent|1|||
44526882|NCT01367158|79536685|FG008|Overall Study|Withdrew consent|0|||
44526883|NCT01367158|79536686|FG009|Overall Study|Withdrew consent|0|||
44526884|NCT01367158|79536687|FG010|Overall Study|Withdrew consent|0|||
44526885|NCT01367158|79536677|FG000|Overall Study|Lost to Follow-up|0|||
44526886|NCT01367158|79536678|FG001|Overall Study|Lost to Follow-up|0|||
44526887|NCT01367158|79536679|FG002|Overall Study|Lost to Follow-up|0|||
44526888|NCT01367158|79536680|FG003|Overall Study|Lost to Follow-up|1|||
44526889|NCT01367158|79536681|FG004|Overall Study|Lost to Follow-up|0|||
44526890|NCT01367158|79536682|FG005|Overall Study|Lost to Follow-up|2|||
44526891|NCT01367158|79536683|FG006|Overall Study|Lost to Follow-up|0|||
44526892|NCT01367158|79536684|FG007|Overall Study|Lost to Follow-up|1|||
44526893|NCT01367158|79536685|FG008|Overall Study|Lost to Follow-up|0|||
44526894|NCT01367158|79536686|FG009|Overall Study|Lost to Follow-up|0|||
44526895|NCT01367158|79536687|FG010|Overall Study|Lost to Follow-up|1|||
44526896|NCT01367158|79536677|FG000|Overall Study|Protocol Violation|0|||
44282312|NCT01859988|79245606|FG001|Overall Study|Physician Decision|3|||
44282313|NCT01859988|79245607|FG002|Overall Study|Physician Decision|1|||
44282314|NCT01859988|79245608|FG003|Overall Study|Physician Decision|3|||
44282315|NCT01859988|79245609|FG004|Overall Study|Physician Decision|4|||
44282316|NCT01859988|79245610|FG005|Overall Study|Physician Decision|1|||
44282317|NCT01859988|79245605|FG000|Overall Study|Adverse Event|2|||
44282318|NCT01859988|79245606|FG001|Overall Study|Adverse Event|1|||
44282319|NCT01859988|79245607|FG002|Overall Study|Adverse Event|3|||
44414601|NCT00641056|79422613|FG001|Overall Study|Entry Criteria Not Met|0|||
44414602|NCT00641056|79422612|FG000|Overall Study|Subject Decision|6|||
44414603|NCT00641056|79422613|FG001|Overall Study|Subject Decision|19|||
44414604|NCT00641056|79422612|FG000|Overall Study|Sponsor Decision|1|||
44526897|NCT01367158|79536678|FG001|Overall Study|Protocol Violation|1|||
44526898|NCT01367158|79536679|FG002|Overall Study|Protocol Violation|0|||
44254246|NCT02620020|79095942|FG002|Overall Study|Protocol Violation|1|||
44254247|NCT02620020|79095943|FG003|Overall Study|Protocol Violation|1|||
44254248|NCT02620020|79095940|FG000|Overall Study|Withdrawal by Subject|20|||
44254249|NCT02620020|79095941|FG001|Overall Study|Withdrawal by Subject|16|||
44254250|NCT02620020|79095942|FG002|Overall Study|Withdrawal by Subject|17|||
44254251|NCT02620020|79095943|FG003|Overall Study|Withdrawal by Subject|12|||
44254252|NCT02620020|79095940|FG000|Overall Study|Death|0|||
44254253|NCT02620020|79095941|FG001|Overall Study|Death|1|||
44254254|NCT02620020|79095942|FG002|Overall Study|Death|0|||
44414605|NCT00641056|79422613|FG001|Overall Study|Sponsor Decision|2|||
44414606|NCT00814346|79422625|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
44526899|NCT01367158|79536680|FG003|Overall Study|Protocol Violation|0|||
44526900|NCT01367158|79536681|FG004|Overall Study|Protocol Violation|0|||
44526901|NCT01367158|79536682|FG005|Overall Study|Protocol Violation|0|||
44526902|NCT01367158|79536683|FG006|Overall Study|Protocol Violation|0|||
44148827|NCT02712983|78938406|FG002|Treatment Phase|Physician Decision|0|||
44414607|NCT00814346|79422626|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
44148828|NCT02712983|78938407|FG003|Treatment Phase|Physician Decision|0|||
44526903|NCT01367158|79536684|FG007|Overall Study|Protocol Violation|0|||
44526904|NCT01367158|79536685|FG008|Overall Study|Protocol Violation|0|||
44254255|NCT02620020|79095943|FG003|Overall Study|Death|0|||
44254256|NCT02549989|79095953|FG000|Overall Study|Adverse Event|4|||
44526905|NCT01367158|79536686|FG009|Overall Study|Protocol Violation|0|||
44526906|NCT01367158|79536687|FG010|Overall Study|Protocol Violation|0|||
44526907|NCT00130637|79536722|FG000|Overall Study|Adverse Event|2|||
44254257|NCT02549989|79095953|FG000|Overall Study|Death|1|||
44282320|NCT01859988|79245608|FG003|Overall Study|Adverse Event|1|||
44282321|NCT01859988|79245609|FG004|Overall Study|Adverse Event|2|||
44526908|NCT00130637|79536722|FG000|Overall Study|Withdrawal by Subject|1|||
44526909|NCT03679767|79536730|FG000|Overall Study|Death|16|||
44526910|NCT03679767|79536731|FG001|Overall Study|Death|11|||
44526911|NCT03679767|79536732|FG002|Overall Study|Death|17|||
44526912|NCT03679767|79536733|FG003|Overall Study|Death|10|||
44526913|NCT03679767|79536730|FG000|Overall Study|Lost to Follow-up|1|||
44526914|NCT03679767|79536731|FG001|Overall Study|Lost to Follow-up|1|||
44526915|NCT03679767|79536732|FG002|Overall Study|Lost to Follow-up|1|||
44526916|NCT03679767|79536733|FG003|Overall Study|Lost to Follow-up|1|||
44526917|NCT03679767|79536730|FG000|Overall Study|Withdrawal by Subject|0|||
44526918|NCT03679767|79536731|FG001|Overall Study|Withdrawal by Subject|0|||
44526919|NCT03679767|79536732|FG002|Overall Study|Withdrawal by Subject|0|||
44526920|NCT03679767|79536733|FG003|Overall Study|Withdrawal by Subject|1|||
44526921|NCT03679767|79536730|FG000|Overall Study|Follow-up Completed|18|||
44526922|NCT03679767|79536731|FG001|Overall Study|Follow-up Completed|11|||
44254258|NCT02549989|79095953|FG000|Overall Study|Lack of Efficacy|19|||
44254259|NCT02549989|79095953|FG000|Overall Study|Withdrawal by Subject|3|||
44254260|NCT00987935|79096112|FG000|Overall Study|Progressive disease|3|||
44254261|NCT00987935|79096113|FG001|Overall Study|Progressive disease|2|||
44254262|NCT00987935|79096114|FG002|Overall Study|Progressive disease|3|||
44254263|NCT00987935|79096115|FG003|Overall Study|Progressive disease|2|||
44254264|NCT00987935|79096116|FG004|Overall Study|Progressive disease|5|||
44254265|NCT00987935|79096117|FG005|Overall Study|Progressive disease|3|||
44254266|NCT00987935|79096118|FG006|Overall Study|Progressive disease|9|||
44254267|NCT00987935|79096119|FG007|Overall Study|Progressive disease|48|||
44254268|NCT00987935|79096120|FG008|Overall Study|Progressive disease|23|||
44254269|NCT00987935|79096112|FG000|Overall Study|Adverse Event|0|||
44254270|NCT00987935|79096113|FG001|Overall Study|Adverse Event|1|||
44254271|NCT00987935|79096114|FG002|Overall Study|Adverse Event|0|||
44254272|NCT00987935|79096115|FG003|Overall Study|Adverse Event|1|||
44254273|NCT00987935|79096116|FG004|Overall Study|Adverse Event|1|||
44254274|NCT00987935|79096117|FG005|Overall Study|Adverse Event|0|||
44254275|NCT00987935|79096118|FG006|Overall Study|Adverse Event|2|||
44254276|NCT00987935|79096119|FG007|Overall Study|Adverse Event|10|||
44254277|NCT00987935|79096120|FG008|Overall Study|Adverse Event|6|||
44254278|NCT00987935|79096112|FG000|Overall Study|Refused to continue taking trial med.|1|||
44254279|NCT00987935|79096113|FG001|Overall Study|Refused to continue taking trial med.|0|||
44254280|NCT00987935|79096114|FG002|Overall Study|Refused to continue taking trial med.|0|||
44254281|NCT00987935|79096115|FG003|Overall Study|Refused to continue taking trial med.|0|||
44254282|NCT00987935|79096116|FG004|Overall Study|Refused to continue taking trial med.|1|||
44254283|NCT00987935|79096117|FG005|Overall Study|Refused to continue taking trial med.|0|||
44254284|NCT00987935|79096118|FG006|Overall Study|Refused to continue taking trial med.|4|||
44254285|NCT00987935|79096119|FG007|Overall Study|Refused to continue taking trial med.|4|||
44254286|NCT00987935|79096120|FG008|Overall Study|Refused to continue taking trial med.|2|||
44254287|NCT00987935|79096112|FG000|Overall Study|Reason other than those specified above|0|||
44254288|NCT00987935|79096113|FG001|Overall Study|Reason other than those specified above|0|||
44414608|NCT00814346|79422625|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
44414609|NCT00814346|79422626|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
44414610|NCT00814346|79422625|FG000|Open Phase (17 Months)|Adverse Event|5|||
44414611|NCT00814346|79422626|FG001|Open Phase (17 Months)|Adverse Event|0|||
44414612|NCT00814346|79422625|FG000|Open Phase (17 Months)|Consent|2|||
44414613|NCT00814346|79422626|FG001|Open Phase (17 Months)|Consent|0|||
44414614|NCT00814346|79422625|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
44414615|NCT00814346|79422626|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
44414616|NCT00814346|79422625|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
44414617|NCT00814346|79422626|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
44414618|NCT00569374|79422645|FG000|Overall Study|Withdrawal by Subject|4|||
44414619|NCT00828464|79422649|FG000|Overall Study|Withdrawal by Subject|1|||
44414620|NCT00810602|79422653|FG000|Overall Study|Withdrawal by Subject|8|||
44414621|NCT00810602|79422654|FG001|Overall Study|Withdrawal by Subject|3|||
44414622|NCT00791700|79422662|FG000|Overall Study|Insufficient clinical response|1|||
44414623|NCT00791700|79422663|FG001|Overall Study|Insufficient clinical response|4|||
44414624|NCT00791700|79422664|FG002|Overall Study|Insufficient clinical response|1|||
44254289|NCT00987935|79096114|FG002|Overall Study|Reason other than those specified above|0|||
44254290|NCT00987935|79096115|FG003|Overall Study|Reason other than those specified above|0|||
44254291|NCT00987935|79096116|FG004|Overall Study|Reason other than those specified above|0|||
44254292|NCT00987935|79096117|FG005|Overall Study|Reason other than those specified above|0|||
44254293|NCT00987935|79096118|FG006|Overall Study|Reason other than those specified above|0|||
44254294|NCT00987935|79096119|FG007|Overall Study|Reason other than those specified above|0|||
44282322|NCT01859988|79245610|FG005|Overall Study|Adverse Event|2|||
44414625|NCT00791700|79422665|FG003|Overall Study|Insufficient clinical response|8|||
44414626|NCT00791700|79422662|FG000|Overall Study|No longer willing to participate|1|||
44526923|NCT03679767|79536732|FG002|Overall Study|Follow-up Completed|11|||
44526924|NCT03679767|79536733|FG003|Overall Study|Follow-up Completed|20|||
44254295|NCT00987935|79096120|FG008|Overall Study|Reason other than those specified above|1|||
44526925|NCT03679767|79536730|FG000|Overall Study|Entered Hospice Care|0|||
44526926|NCT03679767|79536731|FG001|Overall Study|Entered Hospice Care|0|||
44526927|NCT03679767|79536732|FG002|Overall Study|Entered Hospice Care|0|||
44526928|NCT03679767|79536733|FG003|Overall Study|Entered Hospice Care|1|||
44526929|NCT03679767|79536730|FG000|Overall Study|Progressive Disease|0|||
44254296|NCT01597050|79096148|FG000|Overall Study|Withdrawal by Subject|1|||
44254297|NCT01597050|79096149|FG001|Overall Study|Withdrawal by Subject|0|||
44254298|NCT00987623|79096166|FG000|Overall Study|Lost to Follow-up|2|||
44254299|NCT00987623|79096167|FG001|Overall Study|Lost to Follow-up|1|||
44254300|NCT00987623|79096166|FG000|Overall Study|Time/job conflict|2|||
44254301|NCT00987623|79096167|FG001|Overall Study|Time/job conflict|0|||
44254302|NCT00987623|79096166|FG000|Overall Study|Discomfort|1|||
44254303|NCT00987623|79096167|FG001|Overall Study|Discomfort|0|||
44254304|NCT00987623|79096166|FG000|Overall Study|Biomicroscopy|0|||
44254305|NCT00987623|79096167|FG001|Overall Study|Biomicroscopy|1|||
44254306|NCT00987623|79096166|FG000|Overall Study|Influenza|0|||
44254307|NCT00987623|79096167|FG001|Overall Study|Influenza|1|||
44254308|NCT00987467|79096173|FG000|Overall Study|Lost to Follow-up|2|||
44254309|NCT04990440|79096181|FG000|Overall Study|Sponsor's Decision|0|||
44254310|NCT04990440|79096182|FG001|Overall Study|Sponsor's Decision|0|||
44254311|NCT04990440|79096183|FG002|Overall Study|Sponsor's Decision|1|||
44254312|NCT04829747|79096191|FG000|Overall Study|Protocol Violation|1|||
44254313|NCT04258423|79096229|FG000|Overall Study|Study Closure|2|||
44254314|NCT04258423|79096230|FG001|Overall Study|Study Closure|2|||
44254315|NCT04178967|79096238|FG000|Induction Period|Adverse Event|4|||
44254316|NCT04178967|79096239|FG001|Induction Period|Adverse Event|6|||
44254317|NCT04178967|79096240|FG002|Induction Period|Adverse Event|0|||
44254318|NCT04178967|79096241|FG003|Induction Period|Adverse Event|0|||
44254319|NCT04178967|79096242|FG004|Induction Period|Adverse Event|0|||
44254320|NCT04178967|79096243|FG005|Induction Period|Adverse Event|0|||
44254321|NCT04178967|79096244|FG006|Induction Period|Adverse Event|0|||
44254322|NCT04178967|79096245|FG007|Induction Period|Adverse Event|0|||
44254323|NCT04178967|79096246|FG008|Induction Period|Adverse Event|0|||
44254324|NCT04178967|79096247|FG009|Induction Period|Adverse Event|0|||
44254325|NCT04178967|79096248|FG010|Induction Period|Adverse Event|0|||
44254326|NCT04178967|79096238|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
44254327|NCT04178967|79096239|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
44254328|NCT04178967|79096240|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
44254329|NCT04178967|79096241|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
44254330|NCT04178967|79096242|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
44254331|NCT04178967|79096243|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
44254332|NCT04178967|79096244|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
44254333|NCT04178967|79096245|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
44254334|NCT04178967|79096246|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
44254335|NCT04178967|79096247|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
44254336|NCT04178967|79096248|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
44254337|NCT04178967|79096238|FG000|Induction Period|Lack of Efficacy|4|||
44254338|NCT04178967|79096239|FG001|Induction Period|Lack of Efficacy|1|||
44254339|NCT04178967|79096240|FG002|Induction Period|Lack of Efficacy|0|||
44254340|NCT04178967|79096241|FG003|Induction Period|Lack of Efficacy|0|||
44254341|NCT04178967|79096242|FG004|Induction Period|Lack of Efficacy|0|||
44254342|NCT04178967|79096243|FG005|Induction Period|Lack of Efficacy|0|||
44254343|NCT04178967|79096244|FG006|Induction Period|Lack of Efficacy|0|||
44254344|NCT04178967|79096245|FG007|Induction Period|Lack of Efficacy|0|||
44282323|NCT01859988|79245605|FG000|Overall Study|Lost to Follow-up|1|||
44282324|NCT01859988|79245606|FG001|Overall Study|Lost to Follow-up|2|||
44282325|NCT01859988|79245607|FG002|Overall Study|Lost to Follow-up|3|||
44282326|NCT01859988|79245608|FG003|Overall Study|Lost to Follow-up|0|||
44282327|NCT01859988|79245609|FG004|Overall Study|Lost to Follow-up|3|||
44282328|NCT01859988|79245610|FG005|Overall Study|Lost to Follow-up|2|||
44254345|NCT04178967|79096246|FG008|Induction Period|Lack of Efficacy|0|||
44254346|NCT04178967|79096247|FG009|Induction Period|Lack of Efficacy|0|||
44254347|NCT04178967|79096248|FG010|Induction Period|Lack of Efficacy|0|||
44254348|NCT04178967|79096238|FG000|Induction Period|Protocol Violation|0|||
44254349|NCT04178967|79096239|FG001|Induction Period|Protocol Violation|6|||
44254350|NCT04178967|79096240|FG002|Induction Period|Protocol Violation|0|||
44254351|NCT04178967|79096241|FG003|Induction Period|Protocol Violation|0|||
44526930|NCT03679767|79536731|FG001|Overall Study|Progressive Disease|0|||
44254352|NCT04178967|79096242|FG004|Induction Period|Protocol Violation|0|||
44526931|NCT03679767|79536732|FG002|Overall Study|Progressive Disease|0|||
44526932|NCT03679767|79536733|FG003|Overall Study|Progressive Disease|1|||
44254353|NCT04178967|79096243|FG005|Induction Period|Protocol Violation|0|||
44254354|NCT04178967|79096244|FG006|Induction Period|Protocol Violation|0|||
44254355|NCT04178967|79096245|FG007|Induction Period|Protocol Violation|0|||
44282329|NCT01859988|79245605|FG000|Overall Study|Protocol Violation|0|||
44526933|NCT00130247|79536747|FG000|Overall Study|Pregnancy|1|||
44254356|NCT04178967|79096246|FG008|Induction Period|Protocol Violation|0|||
44254357|NCT04178967|79096247|FG009|Induction Period|Protocol Violation|0|||
44254358|NCT04178967|79096248|FG010|Induction Period|Protocol Violation|0|||
44254359|NCT04178967|79096238|FG000|Induction Period|Withdrawal by Subject|6|||
44254360|NCT04178967|79096239|FG001|Induction Period|Withdrawal by Subject|4|||
44254361|NCT04178967|79096240|FG002|Induction Period|Withdrawal by Subject|0|||
44254362|NCT04178967|79096241|FG003|Induction Period|Withdrawal by Subject|0|||
44254363|NCT04178967|79096242|FG004|Induction Period|Withdrawal by Subject|0|||
44254364|NCT04178967|79096243|FG005|Induction Period|Withdrawal by Subject|0|||
44254365|NCT04178967|79096244|FG006|Induction Period|Withdrawal by Subject|0|||
44254366|NCT04178967|79096245|FG007|Induction Period|Withdrawal by Subject|0|||
44254367|NCT04178967|79096246|FG008|Induction Period|Withdrawal by Subject|0|||
44254368|NCT04178967|79096247|FG009|Induction Period|Withdrawal by Subject|0|||
44254369|NCT04178967|79096248|FG010|Induction Period|Withdrawal by Subject|0|||
44254370|NCT04178967|79096238|FG000|Induction Period|Lost to Follow-up|2|||
44254371|NCT04178967|79096239|FG001|Induction Period|Lost to Follow-up|0|||
44254372|NCT04178967|79096240|FG002|Induction Period|Lost to Follow-up|0|||
44254373|NCT04178967|79096241|FG003|Induction Period|Lost to Follow-up|0|||
44254374|NCT04178967|79096242|FG004|Induction Period|Lost to Follow-up|0|||
44254375|NCT04178967|79096243|FG005|Induction Period|Lost to Follow-up|0|||
44254376|NCT04178967|79096244|FG006|Induction Period|Lost to Follow-up|0|||
44254377|NCT04178967|79096245|FG007|Induction Period|Lost to Follow-up|0|||
44254378|NCT04178967|79096246|FG008|Induction Period|Lost to Follow-up|0|||
44254379|NCT04178967|79096247|FG009|Induction Period|Lost to Follow-up|0|||
44254380|NCT04178967|79096248|FG010|Induction Period|Lost to Follow-up|0|||
44254381|NCT04178967|79096238|FG000|Induction Period|Participant Missed Study Visits|0|||
44254382|NCT04178967|79096239|FG001|Induction Period|Participant Missed Study Visits|1|||
44254383|NCT04178967|79096240|FG002|Induction Period|Participant Missed Study Visits|0|||
44254384|NCT04178967|79096241|FG003|Induction Period|Participant Missed Study Visits|0|||
44254385|NCT04178967|79096242|FG004|Induction Period|Participant Missed Study Visits|0|||
44254386|NCT04178967|79096243|FG005|Induction Period|Participant Missed Study Visits|0|||
44254387|NCT04178967|79096244|FG006|Induction Period|Participant Missed Study Visits|0|||
44254388|NCT04178967|79096245|FG007|Induction Period|Participant Missed Study Visits|0|||
44254389|NCT04178967|79096246|FG008|Induction Period|Participant Missed Study Visits|0|||
44254390|NCT04178967|79096247|FG009|Induction Period|Participant Missed Study Visits|0|||
44254391|NCT04178967|79096248|FG010|Induction Period|Participant Missed Study Visits|0|||
44254392|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254393|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254394|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254395|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254396|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254397|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
44254398|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
44254399|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
44254400|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254401|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254402|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
44254403|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254404|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254405|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254406|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254407|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254408|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
44254409|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254410|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254411|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254412|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254413|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
44254414|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254415|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254416|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254417|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
44282330|NCT01859988|79245606|FG001|Overall Study|Protocol Violation|0|||
44254418|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254419|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254420|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44526934|NCT00130247|79536748|FG001|Overall Study|Pregnancy|0|||
44254421|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254422|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254423|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254424|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
44254425|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254426|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254427|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254428|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254429|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254430|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254431|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
44254432|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254433|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254434|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254435|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
44254436|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44414627|NCT00791700|79422663|FG001|Overall Study|No longer willing to participate|1|||
44414628|NCT00791700|79422664|FG002|Overall Study|No longer willing to participate|0|||
44414629|NCT00791700|79422665|FG003|Overall Study|No longer willing to participate|8|||
44414630|NCT00791700|79422662|FG000|Overall Study|Non-compliance with study treatment|0|||
44148829|NCT02712983|78938408|FG004|Treatment Phase|Physician Decision|0|||
44148830|NCT02712983|78938409|FG005|Treatment Phase|Physician Decision|0|||
44148831|NCT02712983|78938410|FG006|Treatment Phase|Physician Decision|0|||
44148832|NCT02712983|78938411|FG007|Treatment Phase|Physician Decision|1|||
44148833|NCT02712983|78938412|FG008|Treatment Phase|Physician Decision|1|||
44148834|NCT02712983|78938404|FG000|Treatment Phase|Subject Decision|2|||
44148835|NCT02712983|78938405|FG001|Treatment Phase|Subject Decision|0|||
44148836|NCT02712983|78938406|FG002|Treatment Phase|Subject Decision|0|||
44148837|NCT02712983|78938407|FG003|Treatment Phase|Subject Decision|2|||
44148838|NCT02712983|78938408|FG004|Treatment Phase|Subject Decision|1|||
44148839|NCT02712983|78938409|FG005|Treatment Phase|Subject Decision|0|||
44148840|NCT02712983|78938410|FG006|Treatment Phase|Subject Decision|1|||
44148841|NCT02712983|78938411|FG007|Treatment Phase|Subject Decision|2|||
44148842|NCT02712983|78938412|FG008|Treatment Phase|Subject Decision|0|||
44148843|NCT02712983|78938404|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44148844|NCT02712983|78938405|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
44148845|NCT02712983|78938406|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44148846|NCT02712983|78938407|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44148847|NCT02712983|78938408|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44148848|NCT02712983|78938409|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44148849|NCT02712983|78938410|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
44148850|NCT02712983|78938411|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
44148851|NCT02712983|78938412|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
44148852|NCT02712983|78938404|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44148853|NCT02712983|78938405|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44526935|NCT00130247|79536747|FG000|Overall Study|Post-randomization exclusion|1|||
44526936|NCT00130247|79536748|FG001|Overall Study|Post-randomization exclusion|2|||
44526937|NCT00130247|79536747|FG000|Overall Study|Not compliant with DOT|0|||
44526938|NCT00130247|79536748|FG001|Overall Study|Not compliant with DOT|2|||
44526939|NCT03678285|79536754|FG000|Overall Study|Adverse Event|2|||
44526940|NCT03678285|79536754|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
44254437|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44254438|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44526941|NCT03678285|79536754|FG000|Overall Study|Dehydrated prior to start of workout|1|||
44526942|NCT04032171|79536760|FG000|Overall Study|Study Termination|1|||
44526943|NCT04032171|79536761|FG001|Overall Study|Study Termination|0|||
44148854|NCT02712983|78938406|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44148855|NCT02712983|78938407|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
44148856|NCT02712983|78938408|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44148857|NCT02712983|78938409|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44526944|NCT00137423|79536769|FG000|Overall Study|Adverse Event|7|||
44526945|NCT00137423|79536770|FG001|Overall Study|Adverse Event|9|||
44526946|NCT00137423|79536769|FG000|Overall Study|consent withdrawn|1|||
44526947|NCT00137423|79536770|FG001|Overall Study|consent withdrawn|1|||
44526948|NCT00137423|79536769|FG000|Overall Study|Lack of Efficacy|31|||
44526949|NCT00137423|79536770|FG001|Overall Study|Lack of Efficacy|33|||
44526950|NCT00137423|79536769|FG000|Overall Study|Death|0|||
44148858|NCT02712983|78938410|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44148859|NCT02712983|78938411|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44148860|NCT02712983|78938412|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
44148861|NCT02712983|78938404|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
44148862|NCT02712983|78938405|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
44148863|NCT02712983|78938406|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
44148864|NCT02712983|78938407|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
44148865|NCT02712983|78938408|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
44148866|NCT02712983|78938409|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
44148867|NCT02712983|78938410|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
44148868|NCT02712983|78938411|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
44148869|NCT02712983|78938412|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
44148870|NCT02596971|78938435|FG000|Overall Study|Death|5|||
44148871|NCT02596971|78938436|FG001|Overall Study|Death|1|||
44148872|NCT02596971|78938437|FG002|Overall Study|Death|5|||
44148873|NCT02596971|78938435|FG000|Overall Study|Withdrawal by Subject|5|||
44148874|NCT02596971|78938436|FG001|Overall Study|Withdrawal by Subject|1|||
44148875|NCT02596971|78938437|FG002|Overall Study|Withdrawal by Subject|4|||
44148876|NCT02593773|78938448|FG000|Overall Study|Voluntary Withdrawal|3|||
44148877|NCT02593773|78938448|FG000|Overall Study|Study Terminated by Sponsor|31|||
44148878|NCT02593773|78938448|FG000|Overall Study|Death|1|||
44148879|NCT02593539|78938452|FG000|Overall Study|Adverse Event|1|||
44148880|NCT00919763|78938461|FG000|Overall Study|Adverse Event|7|||
44148881|NCT00919763|78938462|FG001|Overall Study|Adverse Event|1|||
44148882|NCT00919763|78938461|FG000|Overall Study|Lost to Follow-up|1|||
44148883|NCT00919763|78938462|FG001|Overall Study|Lost to Follow-up|0|||
44148884|NCT00919763|78938461|FG000|Overall Study|Protocol Violation|1|||
44148885|NCT00919763|78938462|FG001|Overall Study|Protocol Violation|1|||
44148886|NCT00919763|78938461|FG000|Overall Study|Withdrawal by Subject|3|||
44148887|NCT00919763|78938462|FG001|Overall Study|Withdrawal by Subject|1|||
44148888|NCT00919763|78938461|FG000|Overall Study|Non-compliance|0|||
44254439|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44254440|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
44254441|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
44526951|NCT00137423|79536770|FG001|Overall Study|Death|1|||
44526952|NCT02786836|79536780|FG000|Overall Study|Death|1|||
44526953|NCT02786836|79536780|FG000|Overall Study|Lack of Efficacy|2|||
44526954|NCT02786836|79536780|FG000|Overall Study|Protocol Violation|3|||
44526955|NCT02786836|79536780|FG000|Overall Study|Withdrawal by Subject|3|||
44526956|NCT02786836|79536780|FG000|Overall Study|Liver Transplantation|2|||
44526957|NCT02786836|79536780|FG000|Overall Study|Device or Pharmacy Issues|3|||
44148889|NCT00919763|78938462|FG001|Overall Study|Non-compliance|1|||
44148890|NCT02593305|78938480|FG000|Post 1|Comparison only group. No intervention.|0|||
44148891|NCT02593305|78938481|FG001|Post 1|Comparison only group. No intervention.|0|||
44148892|NCT02593305|78938482|FG002|Post 1|Comparison only group. No intervention.|10|||
44148893|NCT02593149|78938493|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
44526958|NCT00137267|79536787|FG000|Overall Study|Lost to Follow-up|15|||
44526959|NCT00137267|79536788|FG001|Overall Study|Lost to Follow-up|21|||
44526960|NCT00137111|79536798|FG000|Total Therapy|Death|35|||
44526961|NCT00137111|79536799|FG001|Total Therapy|Death|0|||
44526962|NCT00137111|79536800|FG002|Total Therapy|Death|0|||
44526963|NCT00137111|79536801|FG003|Total Therapy|Death|0|||
44526964|NCT00137111|79536798|FG000|Total Therapy|Non Compliance|5|||
44526965|NCT00137111|79536799|FG001|Total Therapy|Non Compliance|0|||
44526966|NCT00137111|79536800|FG002|Total Therapy|Non Compliance|0|||
44526967|NCT00137111|79536801|FG003|Total Therapy|Non Compliance|0|||
44526968|NCT00136955|79536808|FG000|Overall Study|Adverse Event|8|||
44526969|NCT00136955|79536808|FG000|Overall Study|Lost to Follow-up|1|||
44526970|NCT00136955|79536808|FG000|Overall Study|Withdrawal by Subject|2|||
44526971|NCT00136955|79536808|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
44526972|NCT00135707|79536814|FG000|Overall Study|Lost to Follow-up|94|||
44526973|NCT00135707|79536815|FG001|Overall Study|Lost to Follow-up|89|||
44526974|NCT00135707|79536814|FG000|Overall Study|Withdrawal by Subject|0|||
44526975|NCT00135707|79536815|FG001|Overall Study|Withdrawal by Subject|1|||
44526976|NCT00135707|79536814|FG000|Overall Study|Institutional review board request|1|||
44526977|NCT00135707|79536815|FG001|Overall Study|Institutional review board request|0|||
44526978|NCT00129623|79536827|FG000|Overall Study|Adverse Event|3|||
44526979|NCT00129623|79536828|FG001|Overall Study|Adverse Event|7|||
44526980|NCT00129623|79536827|FG000|Overall Study|Refused Treatment|5|||
44526981|NCT00129623|79536828|FG001|Overall Study|Refused Treatment|3|||
44526982|NCT00129623|79536827|FG000|Overall Study|Failure to Return|1|||
44526983|NCT00129623|79536828|FG001|Overall Study|Failure to Return|1|||
44526984|NCT00129623|79536827|FG000|Overall Study|Relocated job out of state|1|||
44526985|NCT00129623|79536828|FG001|Overall Study|Relocated job out of state|0|||
44148894|NCT02593149|78938494|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
44148895|NCT02593149|78938493|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
44148896|NCT02593149|78938494|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
44148897|NCT02177812|78938509|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
44254442|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44526986|NCT00129623|79536827|FG000|Overall Study|Uncertainty to return|0|||
44526987|NCT00129623|79536828|FG001|Overall Study|Uncertainty to return|1|||
44526988|NCT00129545|79536839|FG000|Overall Study|Death|5|||
44526989|NCT00129545|79536840|FG001|Overall Study|Death|60|||
44526990|NCT00129545|79536841|FG002|Overall Study|Death|44|||
44526991|NCT00129545|79536839|FG000|Overall Study|Withdrawal by Subject|3|||
44526992|NCT00129545|79536840|FG001|Overall Study|Withdrawal by Subject|18|||
44526993|NCT00129545|79536841|FG002|Overall Study|Withdrawal by Subject|44|||
44526994|NCT00129545|79536839|FG000|Overall Study|Lost to Follow-up|2|||
44526995|NCT00129545|79536840|FG001|Overall Study|Lost to Follow-up|22|||
44148898|NCT02177812|78938510|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
44526996|NCT00129545|79536841|FG002|Overall Study|Lost to Follow-up|13|||
44526997|NCT00129545|79536839|FG000|Overall Study|Physician Decision|0|||
44526998|NCT00129545|79536840|FG001|Overall Study|Physician Decision|3|||
44526999|NCT00129545|79536841|FG002|Overall Study|Physician Decision|10|||
44527000|NCT00129545|79536839|FG000|Overall Study|Device not implanted|16|||
44527001|NCT00129545|79536840|FG001|Overall Study|Device not implanted|61|||
44527002|NCT00129545|79536841|FG002|Overall Study|Device not implanted|0|||
44527003|NCT00129467|79536851|FG000|Received Intervention|Death|1|||
44527004|NCT00129467|79536852|FG001|Received Intervention|Death|1|||
44527005|NCT00129467|79536851|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
44527006|NCT00129467|79536852|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
44527007|NCT00129467|79536851|FG000|Received Intervention|Delirium|2|||
44527008|NCT00129467|79536852|FG001|Received Intervention|Delirium|0|||
44527009|NCT00129467|79536851|FG000|Received Intervention|Withdrawal by Subject|1|||
44527010|NCT00129467|79536852|FG001|Received Intervention|Withdrawal by Subject|0|||
44527011|NCT00129467|79536851|FG000|Received Intervention|Nausea|1|||
44527012|NCT00129467|79536852|FG001|Received Intervention|Nausea|0|||
44527013|NCT00129467|79536851|FG000|Received Intervention|Intolerance to citalopram|0|||
44527014|NCT00129467|79536852|FG001|Received Intervention|Intolerance to citalopram|1|||
44527015|NCT00129467|79536851|FG000|Received Intervention|Dizzyness, fatigue|0|||
44527016|NCT00129467|79536852|FG001|Received Intervention|Dizzyness, fatigue|1|||
44527017|NCT00129467|79536851|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
44527018|NCT00129467|79536852|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
44527019|NCT00129467|79536851|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
44527020|NCT00129467|79536852|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
44527021|NCT00129311|79536860|FG000|Overall Study|Withdrawal by Subject|12|||
44527022|NCT00129311|79536861|FG001|Overall Study|Withdrawal by Subject|19|||
44527023|NCT00133991|79536867|FG000|Overall Study|Death|4|||
44527024|NCT02784106|79536873|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
44527025|NCT02784106|79536874|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
44527026|NCT02784106|79536875|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
44527027|NCT02784106|79536876|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
44527028|NCT02784106|79536873|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
44527029|NCT02784106|79536874|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
44527030|NCT02784106|79536875|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
44527031|NCT02784106|79536876|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
44527032|NCT02784106|79536873|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
44527033|NCT02784106|79536874|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
44527034|NCT02784106|79536875|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
44527035|NCT02784106|79536876|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
44527036|NCT02784106|79536873|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
44527037|NCT02784106|79536874|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
44527038|NCT02784106|79536875|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
44527039|NCT02784106|79536876|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
44527040|NCT02784106|79536873|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
44527041|NCT02784106|79536874|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
44527042|NCT02784106|79536875|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
44527043|NCT02784106|79536876|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
44527044|NCT02784106|79536873|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
44527045|NCT02784106|79536874|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
44527046|NCT02784106|79536875|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
44527047|NCT02784106|79536876|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
44527048|NCT02785900|79536887|FG000|Overall Study|Study Termination by Sponsor|64|||
44527049|NCT02785900|79536888|FG001|Overall Study|Study Termination by Sponsor|81|||
44527050|NCT02785900|79536887|FG000|Overall Study|Death|46|||
44527051|NCT02785900|79536888|FG001|Overall Study|Death|32|||
44527052|NCT02785900|79536887|FG000|Overall Study|Withdrawal by Subject|4|||
44527053|NCT02785900|79536888|FG001|Overall Study|Withdrawal by Subject|8|||
44527054|NCT02785900|79536887|FG000|Overall Study|Physician Decision|3|||
44148899|NCT02177812|78938511|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
44148900|NCT02177812|78938512|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
44414631|NCT00791700|79422663|FG001|Overall Study|Non-compliance with study treatment|2|||
44414632|NCT00791700|79422664|FG002|Overall Study|Non-compliance with study treatment|0|||
44527055|NCT02785900|79536888|FG001|Overall Study|Physician Decision|2|||
44282331|NCT01859988|79245607|FG002|Overall Study|Protocol Violation|1|||
44527056|NCT00127205|79536897|FG000|Overall Study|Adverse Event|228|||
44527057|NCT00127205|79536898|FG001|Overall Study|Adverse Event|387|||
44527058|NCT00127205|79536899|FG002|Overall Study|Adverse Event|273|||
44527059|NCT00127205|79536897|FG000|Overall Study|Death|8|||
44527060|NCT00127205|79536898|FG001|Overall Study|Death|6|||
44148901|NCT02177812|78938513|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
44527061|NCT00127205|79536899|FG002|Overall Study|Death|5|||
44527062|NCT00127205|79536897|FG000|Overall Study|Withdrawal by Subject|318|||
44527063|NCT00127205|79536898|FG001|Overall Study|Withdrawal by Subject|310|||
44527064|NCT00127205|79536899|FG002|Overall Study|Withdrawal by Subject|172|||
44527065|NCT00127205|79536897|FG000|Overall Study|Other-non protocol specified|142|||
44527066|NCT00127205|79536898|FG001|Overall Study|Other-non protocol specified|129|||
44527067|NCT00127205|79536899|FG002|Overall Study|Other-non protocol specified|77|||
44527068|NCT00127205|79536897|FG000|Overall Study|Data not reported|6|||
44148902|NCT02177812|78938514|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
44148903|NCT02177812|78938515|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
44148904|NCT02177812|78938516|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
44148905|NCT02177812|78938517|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
44148906|NCT02177812|78938509|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148907|NCT02177812|78938510|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148908|NCT02177812|78938511|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148909|NCT02177812|78938512|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148910|NCT02177812|78938513|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148911|NCT02177812|78938514|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
44148912|NCT02177812|78938515|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
44148913|NCT02177812|78938516|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148914|NCT02177812|78938517|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
44148915|NCT02177812|78938509|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
44148916|NCT02177812|78938510|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
44527069|NCT00127205|79536898|FG001|Overall Study|Data not reported|10|||
44527070|NCT00127205|79536899|FG002|Overall Study|Data not reported|1|||
44527071|NCT00127205|79536897|FG000|Overall Study|Progression|127|||
44527072|NCT00127205|79536898|FG001|Overall Study|Progression|131|||
44527073|NCT00127205|79536899|FG002|Overall Study|Progression|84|||
44527074|NCT02785588|79536909|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
44527075|NCT02785588|79536909|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
44527076|NCT03670641|79536913|FG000|Overall Study|Lost to Follow-up|3|||
44527077|NCT04029519|79536920|FG000|Overall Study|Protocol Violation|1|||
44527078|NCT04029519|79536920|FG000|Overall Study|Withdrawal by Subject|3|||
44527079|NCT04029519|79536920|FG000|Overall Study|Lost to Follow-up|1|||
44527080|NCT03669861|79536924|FG000|Overall Study|Disease Flare|5|||
44527081|NCT03669861|79536924|FG000|Overall Study|Lack of Efficacy|2|||
44527082|NCT00127127|79536932|FG000|Overall Study|Adverse Event|0|||
44527083|NCT00127127|79536933|FG001|Overall Study|Adverse Event|2|||
44527084|NCT00127127|79536934|FG002|Overall Study|Adverse Event|0|||
44527085|NCT00127127|79536935|FG003|Overall Study|Adverse Event|1|||
44527086|NCT00127127|79536932|FG000|Overall Study|Lack of Efficacy|1|||
44527087|NCT00127127|79536933|FG001|Overall Study|Lack of Efficacy|3|||
44527088|NCT00127127|79536934|FG002|Overall Study|Lack of Efficacy|0|||
44148917|NCT02177812|78938511|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
44148918|NCT02177812|78938512|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
44148919|NCT02177812|78938513|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
44148920|NCT02177812|78938514|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
44148921|NCT02177812|78938515|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
44148922|NCT02177812|78938516|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
44148923|NCT02177812|78938517|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
44527089|NCT00127127|79536935|FG003|Overall Study|Lack of Efficacy|2|||
44527090|NCT03669549|79536972|FG000|Overall Study|Adverse Event|4|||
44527091|NCT03669549|79536972|FG000|Overall Study|Withdrawal by Subject|1|||
44527092|NCT03669549|79536972|FG000|Overall Study|Study terminated by the Sponsor|1|||
44527093|NCT00126659|79536983|FG000|Overall Study|Adverse Event|0|||
44527094|NCT00126659|79536984|FG001|Overall Study|Adverse Event|0|||
44527095|NCT00126659|79536985|FG002|Overall Study|Adverse Event|2|||
44527096|NCT03669081|79536993|FG000|Overall Study|Data could not be validated|1|||
44527097|NCT03669081|79536994|FG001|Overall Study|Data could not be validated|1|||
44527098|NCT03667053|79537003|FG000|Overall Study|Withdrawal by Subject|1|||
44527099|NCT03667053|79537004|FG001|Overall Study|Withdrawal by Subject|0|||
44527100|NCT03667053|79537005|FG002|Overall Study|Withdrawal by Subject|0|||
44527101|NCT03631407|79537022|FG000|Overall Study|Withdrawal by Subject|3|||
44527102|NCT03631407|79537023|FG001|Overall Study|Withdrawal by Subject|2|||
44527103|NCT03631407|79537022|FG000|Overall Study|Sponsor Decision|0|||
44527104|NCT03631407|79537023|FG001|Overall Study|Sponsor Decision|2|||
44148924|NCT01626352|78938561|FG000|Overall Study|Disease Progression|3|||
44148925|NCT01626352|78938561|FG000|Overall Study|Intercurrent Illness|2|||
44148926|NCT01626352|78938561|FG000|Overall Study|Death|2|||
44148927|NCT01626352|78938561|FG000|Overall Study|Withdrawal by Subject|1|||
44148928|NCT01626352|78938561|FG000|Overall Study|Non-Compliance|1|||
44148929|NCT01626352|78938561|FG000|Overall Study|Never Treated|1|||
44148930|NCT01626118|78938572|FG000|Overall Study|Lack of Efficacy|1|||
44148931|NCT01626118|78938573|FG001|Overall Study|Lack of Efficacy|0|||
44527105|NCT03631407|79537022|FG000|Overall Study|Death|16|||
44527106|NCT03631407|79537023|FG001|Overall Study|Death|16|||
44527107|NCT03631407|79537022|FG000|Overall Study|Randomized by mistake without study treatment|1|||
44527108|NCT03631407|79537023|FG001|Overall Study|Randomized by mistake without study treatment|0|||
44527109|NCT03630393|79537040|FG000|Overall Study|Death|1|||
44527110|NCT03630393|79537041|FG001|Overall Study|Death|0|||
44148932|NCT01626118|78938574|FG002|Overall Study|Lack of Efficacy|1|||
44148933|NCT01626118|78938575|FG003|Overall Study|Lack of Efficacy|3|||
44148934|NCT01626118|78938572|FG000|Overall Study|Lost to Follow-up|1|||
44148935|NCT01626118|78938573|FG001|Overall Study|Lost to Follow-up|0|||
44148936|NCT01626118|78938574|FG002|Overall Study|Lost to Follow-up|0|||
44148937|NCT01626118|78938575|FG003|Overall Study|Lost to Follow-up|0|||
44148938|NCT01626118|78938572|FG000|Overall Study|Adverse Event|0|||
44148939|NCT01626118|78938573|FG001|Overall Study|Adverse Event|1|||
44148940|NCT01626118|78938574|FG002|Overall Study|Adverse Event|1|||
44148941|NCT01626118|78938575|FG003|Overall Study|Adverse Event|0|||
44527111|NCT03628599|79537058|FG000|Overall Study|Adverse Event|0|||
44527112|NCT03628599|79537059|FG001|Overall Study|Adverse Event|1|||
44527113|NCT03627195|79537085|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
44527114|NCT03627195|79537086|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
44527115|NCT03627195|79537087|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
44527116|NCT03627195|79537088|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
44527117|NCT03627195|79537089|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
44527118|NCT03627195|79537090|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
44527119|NCT00126581|79537106|FG000|Overall Study|Adverse Event|3|||
44527120|NCT00126581|79537107|FG001|Overall Study|Adverse Event|7|||
44527121|NCT00126581|79537106|FG000|Overall Study|Death|3|||
44527122|NCT00126581|79537107|FG001|Overall Study|Death|2|||
44527123|NCT00126581|79537106|FG000|Overall Study|Withdrawal by Subject|1|||
44527124|NCT00126581|79537107|FG001|Overall Study|Withdrawal by Subject|4|||
44527125|NCT00126581|79537106|FG000|Overall Study|Alternative therapy|3|||
44527126|NCT00126581|79537107|FG001|Overall Study|Alternative therapy|3|||
44527127|NCT00126581|79537106|FG000|Overall Study|Other illness/MD discretion|3|||
44527128|NCT00126581|79537107|FG001|Overall Study|Other illness/MD discretion|4|||
44527129|NCT03704584|79537117|FG000|Overall Study|Withdrawal by Subject|1|||
44527130|NCT03704584|79537118|FG001|Overall Study|Withdrawal by Subject|0|||
44527131|NCT03662997|79537128|FG000|Overall Study|Adverse Event|0|||
44527132|NCT03662997|79537129|FG001|Overall Study|Adverse Event|2|||
44527133|NCT03662997|79537130|FG002|Overall Study|Adverse Event|0|||
44527134|NCT03662997|79537131|FG003|Overall Study|Adverse Event|0|||
44527135|NCT03648879|79537143|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
44527136|NCT03647709|79537147|FG000|Overall Study|Lost to Follow-up|5|||
44527137|NCT03647709|79537147|FG000|Overall Study|Physician Decision|6|||
44148942|NCT01626118|78938572|FG000|Overall Study|Investigator Decision|0|||
44148943|NCT01626118|78938573|FG001|Overall Study|Investigator Decision|1|||
44148944|NCT01626118|78938574|FG002|Overall Study|Investigator Decision|0|||
44414633|NCT00791700|79422665|FG003|Overall Study|Non-compliance with study treatment|4|||
44414634|NCT00791700|79422662|FG000|Overall Study|Withdrawn due to pregnancy|0|||
44414635|NCT00791700|79422663|FG001|Overall Study|Withdrawn due to pregnancy|0|||
44414636|NCT00791700|79422664|FG002|Overall Study|Withdrawn due to pregnancy|0|||
44414637|NCT00791700|79422665|FG003|Overall Study|Withdrawn due to pregnancy|1|||
44414638|NCT00791700|79422662|FG000|Overall Study|Other|0|||
44414639|NCT00791700|79422663|FG001|Overall Study|Other|1|||
44527138|NCT03647709|79537147|FG000|Overall Study|Withdrawal by Subject|3|||
44527139|NCT03661983|79537153|FG000|Open Label Stabilization Phase|Adverse Event|5|||
44527140|NCT03661983|79537154|FG001|Open Label Stabilization Phase|Adverse Event|0|||
44527141|NCT03661983|79537155|FG002|Open Label Stabilization Phase|Adverse Event|0|||
44527142|NCT03661983|79537156|FG003|Open Label Stabilization Phase|Adverse Event|0|||
44527143|NCT03661983|79537153|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
44527144|NCT03661983|79537154|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
44527145|NCT03661983|79537155|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
44527146|NCT03661983|79537156|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
44527147|NCT03661983|79537153|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
44527148|NCT03661983|79537154|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
44527149|NCT03661983|79537155|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
44527150|NCT03661983|79537156|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
44148945|NCT01626118|78938575|FG003|Overall Study|Investigator Decision|0|||
44148946|NCT02152384|78938585|FG000|Period 1|Withdrawal by Subject|0|||
44414640|NCT00791700|79422664|FG002|Overall Study|Other|0|||
44414641|NCT00791700|79422665|FG003|Overall Study|Other|1|||
44414642|NCT00791700|79422662|FG000|Overall Study|Death|0|||
44148947|NCT02152384|78938586|FG001|Period 1|Withdrawal by Subject|1|||
44148948|NCT02152384|78938585|FG000|Period 1|Adverse Event|1|||
44148949|NCT02152384|78938586|FG001|Period 1|Adverse Event|1|||
44148950|NCT02177266|78938598|FG000|Overall Study|Adverse Event|0|||
44148951|NCT02177266|78938599|FG001|Overall Study|Adverse Event|1|||
44148952|NCT02177266|78938598|FG000|Overall Study|Withdrawal by Subject|1|||
44148953|NCT02177266|78938599|FG001|Overall Study|Withdrawal by Subject|0|||
44527151|NCT03661983|79537153|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
44527152|NCT03661983|79537154|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
44527153|NCT03661983|79537155|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
44527154|NCT03661983|79537156|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
44527155|NCT03661983|79537153|FG000|Double-blind Randomized Phase|Adverse Event|0|||
44527156|NCT03661983|79537154|FG001|Double-blind Randomized Phase|Adverse Event|1|||
44527157|NCT03661983|79537155|FG002|Double-blind Randomized Phase|Adverse Event|0|||
44527158|NCT03661983|79537156|FG003|Double-blind Randomized Phase|Adverse Event|0|||
44527159|NCT03661983|79537153|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
44527160|NCT03661983|79537154|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
44527161|NCT03661983|79537155|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
44527162|NCT03661983|79537156|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
44527163|NCT03661983|79537153|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
44527164|NCT03661983|79537154|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
44527165|NCT03661983|79537155|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
44527166|NCT03661983|79537156|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
44527167|NCT03661983|79537153|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
44527168|NCT03661983|79537154|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
44527169|NCT03661983|79537155|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
44527170|NCT03661983|79537156|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
44527171|NCT02783170|79537167|FG000|Overall Study|Randomized but not Vaccinated|1|||
44527172|NCT02783170|79537168|FG001|Overall Study|Randomized but not Vaccinated|0|||
44527173|NCT03646305|79537179|FG000|Overall Study|Lost to Follow-up|4|||
44527174|NCT03646305|79537180|FG001|Overall Study|Lost to Follow-up|2|||
44527175|NCT03646305|79537181|FG002|Overall Study|Lost to Follow-up|2|||
44527176|NCT03646305|79537182|FG003|Overall Study|Lost to Follow-up|1|||
44527177|NCT03646305|79537179|FG000|Overall Study|Withdrawal by Subject|1|||
44527178|NCT03646305|79537180|FG001|Overall Study|Withdrawal by Subject|0|||
44527179|NCT03646305|79537181|FG002|Overall Study|Withdrawal by Subject|0|||
44527180|NCT03646305|79537182|FG003|Overall Study|Withdrawal by Subject|1|||
44527181|NCT02782780|79537198|FG000|Overall Study|dropped out after randomization.|7|||
44527182|NCT02782780|79537199|FG001|Overall Study|dropped out after randomization.|5|||
44527183|NCT02782780|79537198|FG000|Overall Study|Protocol Violation|0|||
44527184|NCT02782780|79537199|FG001|Overall Study|Protocol Violation|2|||
44527185|NCT00126503|79537211|FG000|Overall Study|disease progression|23|||
44527186|NCT00126503|79537212|FG001|Overall Study|disease progression|14|||
44527187|NCT00126503|79537211|FG000|Overall Study|Withdrawal by Subject|0|||
44527188|NCT00126503|79537212|FG001|Overall Study|Withdrawal by Subject|1|||
44527189|NCT00126503|79537211|FG000|Overall Study|alternative therapy|1|||
44527190|NCT00126503|79537212|FG001|Overall Study|alternative therapy|1|||
44527191|NCT00126503|79537211|FG000|Overall Study|other complicating disease|4|||
44527192|NCT00126503|79537212|FG001|Overall Study|other complicating disease|1|||
44527193|NCT00126503|79537211|FG000|Overall Study|Death|3|||
44527194|NCT00126503|79537212|FG001|Overall Study|Death|0|||
44527195|NCT00126503|79537211|FG000|Overall Study|Adverse Event|13|||
44527196|NCT00126503|79537212|FG001|Overall Study|Adverse Event|3|||
44148954|NCT02177032|78938609|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
44527197|NCT00126503|79537211|FG000|Overall Study|non-compliant|1|||
44527198|NCT00126503|79537212|FG001|Overall Study|non-compliant|0|||
44148955|NCT02177032|78938610|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
44527199|NCT00126503|79537211|FG000|Overall Study|Physician Decision|2|||
44527200|NCT00126503|79537212|FG001|Overall Study|Physician Decision|1|||
44527201|NCT00126425|79537224|FG000|Overall Study|Withdrawal by Subject|17|||
44527202|NCT00126425|79537225|FG001|Overall Study|Withdrawal by Subject|1|||
44527203|NCT00126425|79537224|FG000|Overall Study|Lost to Follow-up|8|||
44254443|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
44527204|NCT00126425|79537225|FG001|Overall Study|Lost to Follow-up|4|||
44527205|NCT00126425|79537224|FG000|Overall Study|Protocol Violation|9|||
44527206|NCT00126425|79537225|FG001|Overall Study|Protocol Violation|6|||
44527207|NCT00126425|79537224|FG000|Overall Study|Adverse Event|1|||
44527208|NCT00126425|79537225|FG001|Overall Study|Adverse Event|0|||
44527209|NCT00126425|79537224|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
44527210|NCT00126425|79537225|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
44527211|NCT00126425|79537224|FG000|Overall Study|Other|5|||
44527212|NCT00126425|79537225|FG001|Overall Study|Other|0|||
44527213|NCT00126191|79537233|FG000|Overall Study|Physician Decision|0|||
44527214|NCT00126191|79537234|FG001|Overall Study|Physician Decision|1|||
44527215|NCT00126191|79537233|FG000|Overall Study|Death|0|||
44148956|NCT02177032|78938611|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
44148957|NCT02177032|78938612|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
44148958|NCT02177032|78938609|FG000|Overall Study|Lost to Follow-up|0|||
44148959|NCT02177032|78938610|FG001|Overall Study|Lost to Follow-up|2|||
44148960|NCT02177032|78938611|FG002|Overall Study|Lost to Follow-up|0|||
44148961|NCT02177032|78938612|FG003|Overall Study|Lost to Follow-up|0|||
44148962|NCT02177032|78938609|FG000|Overall Study|OTHER|2|||
44148963|NCT02177032|78938610|FG001|Overall Study|OTHER|0|||
44148964|NCT02177032|78938611|FG002|Overall Study|OTHER|1|||
44148965|NCT02177032|78938612|FG003|Overall Study|OTHER|0|||
44148966|NCT02177032|78938609|FG000|Overall Study|Withdrawal by Subject|1|||
44148967|NCT02177032|78938610|FG001|Overall Study|Withdrawal by Subject|0|||
44148968|NCT02177032|78938611|FG002|Overall Study|Withdrawal by Subject|1|||
44148969|NCT02177032|78938612|FG003|Overall Study|Withdrawal by Subject|0|||
44148970|NCT02176642|78938635|FG000|Overall Study|Withdrawal by Subject|0|||
44148971|NCT02176642|78938636|FG001|Overall Study|Withdrawal by Subject|1|||
44148972|NCT02116660|78938644|FG000|Overall Study|Deteriorating renal function|0|||
44148973|NCT02116660|78938645|FG001|Overall Study|Deteriorating renal function|1|||
44148974|NCT02116660|78938644|FG000|Overall Study|Adverse Event|1|||
44148975|NCT02116660|78938645|FG001|Overall Study|Adverse Event|1|||
44148976|NCT02116660|78938644|FG000|Overall Study|Withdrawal by Subject|0|||
44254444|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44527216|NCT00126191|79537234|FG001|Overall Study|Death|1|||
44527217|NCT00124943|79537244|FG000|Phase II|Adverse Event|0|||
44527218|NCT00124943|79537245|FG001|Phase II|Adverse Event|2|||
44527219|NCT00124943|79537246|FG002|Phase II|Adverse Event|0|||
44527220|NCT00124943|79537247|FG003|Phase II|Adverse Event|1|||
44527221|NCT00124943|79537244|FG000|Phase II|Protocol Violation|0|||
44527222|NCT00124943|79537245|FG001|Phase II|Protocol Violation|0|||
44527223|NCT00124943|79537246|FG002|Phase II|Protocol Violation|0|||
44527224|NCT00124943|79537247|FG003|Phase II|Protocol Violation|1|||
44527225|NCT00124943|79537244|FG000|Phase II|Lost to Follow-up|0|||
44527226|NCT00124943|79537245|FG001|Phase II|Lost to Follow-up|0|||
44527227|NCT00124943|79537246|FG002|Phase II|Lost to Follow-up|0|||
44527228|NCT00124943|79537247|FG003|Phase II|Lost to Follow-up|1|||
44527229|NCT00124943|79537244|FG000|Phase II|Withdrawal by Subject|0|||
44527230|NCT00124943|79537245|FG001|Phase II|Withdrawal by Subject|0|||
44527231|NCT00124943|79537246|FG002|Phase II|Withdrawal by Subject|0|||
44527232|NCT00124943|79537247|FG003|Phase II|Withdrawal by Subject|2|||
44527233|NCT00124709|79537259|FG000|Overall Study|Randomized but did not take medication|3|||
44527234|NCT00124709|79537260|FG001|Overall Study|Randomized but did not take medication|1|||
44527235|NCT00124709|79537259|FG000|Overall Study|Adverse Event|3|||
44527236|NCT00124709|79537260|FG001|Overall Study|Adverse Event|0|||
44527237|NCT00124709|79537259|FG000|Overall Study|Lack of Efficacy|5|||
44527238|NCT00124709|79537260|FG001|Overall Study|Lack of Efficacy|10|||
44527239|NCT00124709|79537259|FG000|Overall Study|Protocol Violation|3|||
44527240|NCT00124709|79537260|FG001|Overall Study|Protocol Violation|5|||
44527241|NCT00124709|79537259|FG000|Overall Study|Withdrawal by Subject|127|||
44527242|NCT00124709|79537260|FG001|Overall Study|Withdrawal by Subject|136|||
44527243|NCT00124709|79537259|FG000|Overall Study|Lost to Follow-up|114|||
44527244|NCT00124709|79537260|FG001|Overall Study|Lost to Follow-up|120|||
44148977|NCT02116660|78938645|FG001|Overall Study|Withdrawal by Subject|2|||
44148978|NCT02116660|78938644|FG000|Overall Study|Organization reason|1|||
44148979|NCT02116660|78938645|FG001|Overall Study|Organization reason|0|||
44148980|NCT02589405|78938653|FG000|Overall Study|Adverse Event|3|||
44148981|NCT02589405|78938653|FG000|Overall Study|Withdrawal by Subject|1|||
44148982|NCT02176018|78938659|FG000|Overall Study|Adverse Event|0|||
44148983|NCT02176018|78938660|FG001|Overall Study|Adverse Event|2|||
44148984|NCT02176018|78938659|FG000|Overall Study|Lost to Follow-up|3|||
44148985|NCT02176018|78938660|FG001|Overall Study|Lost to Follow-up|1|||
44148986|NCT02176018|78938659|FG000|Overall Study|Protocol Violation|1|||
44148987|NCT02176018|78938660|FG001|Overall Study|Protocol Violation|1|||
44527245|NCT00108862|79537268|FG000|Overall Study|Death|31|||
44527246|NCT00108862|79537269|FG001|Overall Study|Death|37|||
44527247|NCT00108862|79537268|FG000|Overall Study|Withdrawal by Subject|10|||
44527248|NCT00108862|79537269|FG001|Overall Study|Withdrawal by Subject|6|||
44527249|NCT00108862|79537268|FG000|Overall Study|Lost to Follow-up|27|||
44527250|NCT00108862|79537269|FG001|Overall Study|Lost to Follow-up|19|||
44527251|NCT00564850|79537275|FG000|Overall Study|Protocol Violation|2|||
44527252|NCT00108628|79537281|FG000|Overall Study|Withdrawal by Subject|17|||
44527253|NCT00108628|79537282|FG001|Overall Study|Withdrawal by Subject|9|||
44527254|NCT00108628|79537281|FG000|Overall Study|Lack of Efficacy|2|||
44527255|NCT00108628|79537282|FG001|Overall Study|Lack of Efficacy|1|||
44527256|NCT00108628|79537281|FG000|Overall Study|Death|1|||
44414643|NCT00791700|79422663|FG001|Overall Study|Death|0|||
44414644|NCT00791700|79422664|FG002|Overall Study|Death|0|||
44414645|NCT00791700|79422665|FG003|Overall Study|Death|1|||
44414646|NCT00791700|79422662|FG000|Overall Study|Lost to Follow-up|4|||
44414647|NCT00791700|79422663|FG001|Overall Study|Lost to Follow-up|3|||
44414648|NCT00791700|79422664|FG002|Overall Study|Lost to Follow-up|4|||
44527257|NCT00108628|79537282|FG001|Overall Study|Death|0|||
44527258|NCT02715856|79537290|FG000|Overall Study|Software Issues|12|||
44527259|NCT02715856|79537291|FG001|Overall Study|Software Issues|7|||
44527260|NCT02715856|79537290|FG000|Overall Study|Death|6|||
44527261|NCT02715856|79537291|FG001|Overall Study|Death|5|||
44527262|NCT02715856|79537290|FG000|Overall Study|Non- Compliant|0|||
44527263|NCT02715856|79537291|FG001|Overall Study|Non- Compliant|40|||
44527264|NCT00108160|79537299|FG000|Overall Study|Lost to Follow-up|25|||
44527265|NCT00108160|79537300|FG001|Overall Study|Lost to Follow-up|12|||
44527266|NCT00108160|79537299|FG000|Overall Study|Death|1|||
44527267|NCT00108160|79537300|FG001|Overall Study|Death|2|||
44527268|NCT00108160|79537299|FG000|Overall Study|Withdrawal by Subject|4|||
44527269|NCT00108160|79537300|FG001|Overall Study|Withdrawal by Subject|2|||
44527270|NCT00108160|79537299|FG000|Overall Study|Protocol Violation|9|||
44527271|NCT00108160|79537300|FG001|Overall Study|Protocol Violation|5|||
44527272|NCT01366846|79537312|FG000|Overall Study|Withdrawal by Subject|2|||
44527273|NCT01366846|79537313|FG001|Overall Study|Withdrawal by Subject|0|||
44527274|NCT01366846|79537314|FG002|Overall Study|Withdrawal by Subject|0|||
44527275|NCT01366846|79537315|FG003|Overall Study|Withdrawal by Subject|0|||
44527276|NCT01366846|79537312|FG000|Overall Study|Communication Difficulties|1|||
44527277|NCT01366846|79537313|FG001|Overall Study|Communication Difficulties|4|||
44527278|NCT01366846|79537314|FG002|Overall Study|Communication Difficulties|0|||
44527279|NCT01366846|79537315|FG003|Overall Study|Communication Difficulties|1|||
44148988|NCT02176018|78938659|FG000|Overall Study|Withdrawal by Subject|1|||
44148989|NCT02176018|78938660|FG001|Overall Study|Withdrawal by Subject|2|||
44148990|NCT02116582|78938666|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
44148991|NCT02116582|78938666|FG000|Overall Study|Adverse Event|22|||
44148992|NCT02116582|78938666|FG000|Overall Study|Death|9|||
44148993|NCT02116582|78938666|FG000|Overall Study|Progressive Disease|148|||
44148994|NCT02116582|78938666|FG000|Overall Study|Protocol Violation|3|||
44254445|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44527280|NCT01366846|79537312|FG000|Overall Study|Scheduling Conflicts|0|||
44148995|NCT02116582|78938666|FG000|Overall Study|Withdrawal by Subject|8|||
44148996|NCT02116582|78938666|FG000|Overall Study|Other: Miscellaneous|11|||
44148997|NCT02116582|78938666|FG000|Overall Study|Lost to Follow-up|1|||
44148998|NCT02116582|78938666|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
44414649|NCT00791700|79422665|FG003|Overall Study|Lost to Follow-up|6|||
44414650|NCT00791700|79422662|FG000|Overall Study|Adverse Event|0|||
44527281|NCT01366846|79537313|FG001|Overall Study|Scheduling Conflicts|0|||
44527282|NCT01366846|79537314|FG002|Overall Study|Scheduling Conflicts|1|||
44527283|NCT01366846|79537315|FG003|Overall Study|Scheduling Conflicts|0|||
44527284|NCT00108082|79537331|FG000|Overall Study|Adverse Event|14|||
44527285|NCT00108082|79537332|FG001|Overall Study|Adverse Event|12|||
44527286|NCT00108082|79537333|FG002|Overall Study|Adverse Event|17|||
44527287|NCT00108082|79537331|FG000|Overall Study|Lost to Follow-up|6|||
44527288|NCT00108082|79537332|FG001|Overall Study|Lost to Follow-up|3|||
44527289|NCT00108082|79537333|FG002|Overall Study|Lost to Follow-up|7|||
44527290|NCT00108082|79537331|FG000|Overall Study|Consent Withdrawn|3|||
44527291|NCT00108082|79537332|FG001|Overall Study|Consent Withdrawn|3|||
44527292|NCT00108082|79537333|FG002|Overall Study|Consent Withdrawn|5|||
44527293|NCT00108082|79537331|FG000|Overall Study|Protocol Violation|1|||
44527294|NCT00108082|79537332|FG001|Overall Study|Protocol Violation|2|||
44527295|NCT00108082|79537333|FG002|Overall Study|Protocol Violation|0|||
44527296|NCT00108082|79537331|FG000|Overall Study|Lack of Efficacy|3|||
44527297|NCT00108082|79537332|FG001|Overall Study|Lack of Efficacy|1|||
44527298|NCT00108082|79537333|FG002|Overall Study|Lack of Efficacy|2|||
44527299|NCT00108082|79537331|FG000|Overall Study|Amendment 4: > Month 12|5|||
44527300|NCT00108082|79537332|FG001|Overall Study|Amendment 4: > Month 12|7|||
44527301|NCT00108082|79537333|FG002|Overall Study|Amendment 4: > Month 12|5|||
44527302|NCT00108082|79537331|FG000|Overall Study|Woman of Child-bearing Potential|2|||
44527303|NCT00108082|79537332|FG001|Overall Study|Woman of Child-bearing Potential|0|||
44527304|NCT00108082|79537333|FG002|Overall Study|Woman of Child-bearing Potential|2|||
44414651|NCT00791700|79422663|FG001|Overall Study|Adverse Event|0|||
44414652|NCT00791700|79422664|FG002|Overall Study|Adverse Event|1|||
44414653|NCT00791700|79422665|FG003|Overall Study|Adverse Event|1|||
44527305|NCT00108082|79537331|FG000|Overall Study|Incorrectly Randomized|0|||
44527306|NCT00108082|79537332|FG001|Overall Study|Incorrectly Randomized|0|||
44527307|NCT00108082|79537333|FG002|Overall Study|Incorrectly Randomized|2|||
44527308|NCT00108082|79537331|FG000|Overall Study|Non-compliance|1|||
44527309|NCT00108082|79537332|FG001|Overall Study|Non-compliance|0|||
44527310|NCT00108082|79537333|FG002|Overall Study|Non-compliance|2|||
44527311|NCT00108082|79537331|FG000|Overall Study|Stopped Study Medication|0|||
44527312|NCT00108082|79537332|FG001|Overall Study|Stopped Study Medication|0|||
44527313|NCT00108082|79537333|FG002|Overall Study|Stopped Study Medication|1|||
44527314|NCT00108082|79537331|FG000|Overall Study|Site Closed Study|0|||
44527315|NCT00108082|79537332|FG001|Overall Study|Site Closed Study|2|||
44527316|NCT00108082|79537333|FG002|Overall Study|Site Closed Study|0|||
44527317|NCT00108082|79537331|FG000|Overall Study|Protocol Amendment|0|||
44527318|NCT00108082|79537332|FG001|Overall Study|Protocol Amendment|1|||
44527319|NCT00108082|79537333|FG002|Overall Study|Protocol Amendment|0|||
44527320|NCT00108082|79537331|FG000|Overall Study|Study Medication Not Tapered|0|||
44527321|NCT00108082|79537332|FG001|Overall Study|Study Medication Not Tapered|1|||
44527322|NCT00108082|79537333|FG002|Overall Study|Study Medication Not Tapered|0|||
44527323|NCT00108082|79537331|FG000|Overall Study|Subject Left Site Location|1|||
44527324|NCT00108082|79537332|FG001|Overall Study|Subject Left Site Location|0|||
44527325|NCT00108082|79537333|FG002|Overall Study|Subject Left Site Location|0|||
44527326|NCT00108082|79537331|FG000|Overall Study|Investigator Not at Site|1|||
44527327|NCT00108082|79537332|FG001|Overall Study|Investigator Not at Site|0|||
44527328|NCT00108082|79537333|FG002|Overall Study|Investigator Not at Site|0|||
44527329|NCT00108082|79537331|FG000|Overall Study|Blood Pressure Not Controlled|1|||
44527330|NCT00108082|79537332|FG001|Overall Study|Blood Pressure Not Controlled|0|||
44527331|NCT00108082|79537333|FG002|Overall Study|Blood Pressure Not Controlled|0|||
44527332|NCT00104728|79537345|FG000|Overall Study|screen failures|19|||
44527333|NCT02781844|79537353|FG000|Treatment Period 1|Adverse Event|0|||
44527334|NCT02781844|79537354|FG001|Treatment Period 1|Adverse Event|0|||
44414654|NCT00810368|79422688|FG000|Overall Study|Lost to Follow-up|4|||
44414655|NCT00810368|79422689|FG001|Overall Study|Lost to Follow-up|2|||
44414656|NCT00810368|79422688|FG000|Overall Study|Lack of Efficacy|2|||
44414657|NCT00810368|79422689|FG001|Overall Study|Lack of Efficacy|0|||
44414658|NCT00628108|79422699|FG000|Overall Study|Adverse Event|0|||
44414659|NCT00628108|79422700|FG001|Overall Study|Adverse Event|3|||
44414660|NCT00628108|79422699|FG000|Overall Study|Withdrawal by Subject|1|||
44414661|NCT00628108|79422700|FG001|Overall Study|Withdrawal by Subject|0|||
44414662|NCT00628030|79422708|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
44414663|NCT00628030|79422709|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
44414664|NCT00628030|79422708|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
44414665|NCT00628030|79422709|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
44414666|NCT00628030|79422708|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
44527335|NCT02781844|79537355|FG002|Treatment Period 1|Adverse Event|0|||
44527336|NCT02781844|79537356|FG003|Treatment Period 1|Adverse Event|0|||
44527337|NCT02781844|79537357|FG004|Treatment Period 1|Adverse Event|0|||
44527338|NCT02781844|79537358|FG005|Treatment Period 1|Adverse Event|1|||
44527339|NCT02781844|79537359|FG006|Treatment Period 1|Adverse Event|0|||
44527340|NCT02781844|79537360|FG007|Treatment Period 1|Adverse Event|0|||
44527341|NCT02775916|79537378|FG000|Overall Study|Adverse Event|1|||
44527342|NCT02775916|79537379|FG001|Overall Study|Adverse Event|0|||
44527343|NCT02775916|79537378|FG000|Overall Study|Subject/Guardian Decision|2|||
44527344|NCT02775916|79537379|FG001|Overall Study|Subject/Guardian Decision|0|||
44527345|NCT00122681|79537387|FG000|Overall Study|Adverse Event|20|||
44527346|NCT00122681|79537388|FG001|Overall Study|Adverse Event|16|||
44414667|NCT00628030|79422709|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
44414668|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
44414669|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
44414670|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
44527347|NCT00122681|79537387|FG000|Overall Study|Lost to Follow-up|1080|||
44527348|NCT00122681|79537388|FG001|Overall Study|Lost to Follow-up|1097|||
44527349|NCT00122681|79537387|FG000|Overall Study|Protocol Violation|7|||
44527350|NCT00122681|79537388|FG001|Overall Study|Protocol Violation|10|||
44527351|NCT00122681|79537387|FG000|Overall Study|Withdrawal by Subject|257|||
44527352|NCT00122681|79537388|FG001|Overall Study|Withdrawal by Subject|251|||
44527353|NCT00122681|79537387|FG000|Overall Study|Personal reasons|150|||
44527354|NCT00122681|79537388|FG001|Overall Study|Personal reasons|147|||
44527355|NCT02774278|79537402|FG000|Overall Study|Lack of Efficacy|199|||
44527356|NCT02774278|79537402|FG000|Overall Study|Death|29|||
44527357|NCT02774278|79537402|FG000|Overall Study|Adverse event/intercurrent illness|16|||
44527358|NCT02774278|79537402|FG000|Overall Study|Refused treatment/did not cooperate|9|||
44527359|NCT02774278|79537402|FG000|Overall Study|Administrative reasons|6|||
44527360|NCT02774278|79537402|FG000|Overall Study|Withdrawal by Subject|3|||
44527361|NCT02774278|79537402|FG000|Overall Study|Protocol Violation|2|||
44527362|NCT00122135|79537408|FG000|Overall Study|Withdrawal by Subject|3|||
44527363|NCT00122135|79537409|FG001|Overall Study|Withdrawal by Subject|0|||
44527364|NCT03645057|79537419|FG000|Randomization to Baseline|Lost to Follow-up|1|||
44527365|NCT03645057|79537420|FG001|Randomization to Baseline|Lost to Follow-up|0|||
44527366|NCT03645057|79537421|FG002|Randomization to Baseline|Lost to Follow-up|1|||
44527367|NCT03645057|79537422|FG003|Randomization to Baseline|Lost to Follow-up|0|||
44527368|NCT03645057|79537419|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
44148999|NCT02589639|78938673|FG000|Overall Study|Lost to Follow-up|1|||
44149000|NCT02589639|78938674|FG001|Overall Study|Lost to Follow-up|0|||
44149001|NCT02589639|78938675|FG002|Overall Study|Lost to Follow-up|0|||
44149002|NCT02589639|78938673|FG000|Overall Study|Protocol Violation|1|||
44149003|NCT02589639|78938674|FG001|Overall Study|Protocol Violation|0|||
44149004|NCT02589639|78938675|FG002|Overall Study|Protocol Violation|0|||
44414671|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
44414672|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
44414673|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
44149005|NCT02589639|78938673|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
44149006|NCT02589639|78938674|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
44149007|NCT02589639|78938675|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
44149008|NCT02589639|78938673|FG000|Overall Study|Adverse Event|4|||
44149009|NCT02589639|78938674|FG001|Overall Study|Adverse Event|5|||
44149010|NCT02589639|78938675|FG002|Overall Study|Adverse Event|3|||
44149011|NCT02589639|78938673|FG000|Overall Study|Other reason than specified above|1|||
44149012|NCT02589639|78938674|FG001|Overall Study|Other reason than specified above|2|||
44149013|NCT02589639|78938675|FG002|Overall Study|Other reason than specified above|1|||
44149014|NCT02589639|78938673|FG000|Overall Study|Not Treated|0|||
44149015|NCT02589639|78938674|FG001|Overall Study|Not Treated|3|||
44149016|NCT02589639|78938675|FG002|Overall Study|Not Treated|0|||
44149017|NCT02151682|78938685|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
44414674|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
44414675|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
44414676|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
44414677|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
44414678|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
44414679|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
44414680|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
44414681|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
44414682|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
44414683|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
44414684|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
44414685|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
44414686|NCT00591578|79422718|FG000|Double-Blind Treatment Phase|Other|4|||
44414687|NCT00591578|79422719|FG001|Double-Blind Treatment Phase|Other|9|||
44414688|NCT00591578|79422720|FG002|Double-Blind Treatment Phase|Other|4|||
44527369|NCT03645057|79537420|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
44527370|NCT03645057|79537421|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
44149018|NCT02151682|78938686|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
44149019|NCT02151682|78938687|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
44282332|NCT01859988|79245608|FG003|Overall Study|Protocol Violation|0|||
44414689|NCT00591578|79422718|FG000|Open-Label Extension Phase|Adverse Event|3|||
44527371|NCT03645057|79537422|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
44527372|NCT03645057|79537419|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
44527373|NCT03645057|79537420|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
44527374|NCT03645057|79537421|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
44527375|NCT03645057|79537422|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
44527376|NCT03645057|79537419|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
44527377|NCT03645057|79537420|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
44149020|NCT02151682|78938688|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
44149021|NCT02151682|78938689|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
44527378|NCT03645057|79537421|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
44527379|NCT03645057|79537422|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
44527380|NCT00132041|79537428|FG000|Baseline|Ineligible|6|||
44527381|NCT00132041|79537428|FG000|3 Months Post Ablation|Transplant|1|||
44527382|NCT00132041|79537428|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
44527383|NCT00132041|79537428|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
44527384|NCT00132041|79537428|FG000|6 Months Post Ablation|Death|2|||
44527385|NCT00132041|79537428|FG000|6 Months Post Ablation|Transplant|6|||
44527386|NCT00132041|79537428|FG000|9 Months Post Ablation|Death|1|||
44149022|NCT02151682|78938690|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
44149023|NCT02151682|78938685|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
44149024|NCT02151682|78938686|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
44149025|NCT02151682|78938687|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
44149026|NCT02151682|78938688|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
44149027|NCT02151682|78938689|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
44149028|NCT02151682|78938690|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
44149029|NCT02151682|78938685|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
44149030|NCT02151682|78938686|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
44149031|NCT02151682|78938687|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
44149032|NCT02151682|78938688|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
44527387|NCT00132041|79537428|FG000|9 Months Post Ablation|Transplant|1|||
44527388|NCT00132041|79537428|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
44527389|NCT00132041|79537428|FG000|12 Months Post Ablation|Death|1|||
44149033|NCT02151682|78938689|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
44149034|NCT02151682|78938690|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
44149035|NCT02151682|78938685|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
44149036|NCT02151682|78938686|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
44149037|NCT02151682|78938687|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
44149038|NCT02151682|78938688|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
44149039|NCT02151682|78938689|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
44149040|NCT02151682|78938690|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
44149041|NCT02151682|78938685|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
44149042|NCT02151682|78938686|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
44149043|NCT02151682|78938687|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
44149044|NCT02151682|78938688|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
44149045|NCT02151682|78938689|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
44149046|NCT02151682|78938690|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
44149047|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
44149048|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
44149049|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
44254446|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
44414690|NCT00591578|79422719|FG001|Open-Label Extension Phase|Adverse Event|5|||
44527390|NCT00132041|79537428|FG000|12 Months Post Ablation|Transplant|1|||
44527391|NCT00132041|79537428|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
44527392|NCT00132041|79537428|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
44527393|NCT00132041|79537428|FG000|15 Months Post Ablation|Death|1|||
44527394|NCT00132041|79537428|FG000|15 Months Post Ablation|Transplant|5|||
44527395|NCT00132041|79537428|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
44527396|NCT00132041|79537428|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
44527397|NCT00132041|79537428|FG000|18 Months Post Ablation|Transplant|1|||
44527398|NCT00132041|79537428|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
44149050|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
44149051|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
44149052|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
44149053|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
44254447|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
44254448|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
44527399|NCT00132041|79537428|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
44527400|NCT03643575|79537438|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
44527401|NCT03643575|79537439|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
44527402|NCT03643575|79537440|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
44149054|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
44149055|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
44149056|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
44149057|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
44149058|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
44527403|NCT03643575|79537441|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
44527404|NCT03643575|79537442|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
44527405|NCT03643575|79537443|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
44527406|NCT03643575|79537438|FG000|Washout: 7 Days|Adverse Event|1|||
44527407|NCT03643575|79537439|FG001|Washout: 7 Days|Adverse Event|0|||
44527408|NCT03643575|79537440|FG002|Washout: 7 Days|Adverse Event|0|||
44527409|NCT03643575|79537441|FG003|Washout: 7 Days|Adverse Event|0|||
44527410|NCT03643575|79537442|FG004|Washout: 7 Days|Adverse Event|0|||
44527411|NCT03643575|79537443|FG005|Washout: 7 Days|Adverse Event|0|||
44527412|NCT03643575|79537438|FG000|Washout: 7 Days|Non compliance check in|0|||
44527413|NCT03643575|79537439|FG001|Washout: 7 Days|Non compliance check in|1|||
44527414|NCT03643575|79537440|FG002|Washout: 7 Days|Non compliance check in|0|||
44527415|NCT03643575|79537441|FG003|Washout: 7 Days|Non compliance check in|0|||
44527416|NCT03643575|79537442|FG004|Washout: 7 Days|Non compliance check in|0|||
44527417|NCT03643575|79537443|FG005|Washout: 7 Days|Non compliance check in|0|||
44527418|NCT02768194|79537451|FG000|Period 1|Adverse Event|0|||
44527419|NCT02768194|79537452|FG001|Period 1|Adverse Event|0|||
44527420|NCT02768194|79537453|FG002|Period 1|Adverse Event|0|||
44527421|NCT02768194|79537454|FG003|Period 1|Adverse Event|1|||
44527422|NCT02768194|79537455|FG004|Period 1|Adverse Event|0|||
44527423|NCT02768194|79537456|FG005|Period 1|Adverse Event|0|||
44527424|NCT02768194|79537451|FG000|Period 2|Other (Reason not specified)|1|||
44527425|NCT02768194|79537452|FG001|Period 2|Other (Reason not specified)|0|||
44527426|NCT02768194|79537453|FG002|Period 2|Other (Reason not specified)|0|||
44527427|NCT02768194|79537454|FG003|Period 2|Other (Reason not specified)|0|||
44527428|NCT02768194|79537455|FG004|Period 2|Other (Reason not specified)|0|||
44527429|NCT02768194|79537456|FG005|Period 2|Other (Reason not specified)|0|||
44527430|NCT02768194|79537451|FG000|Period 3|Other (Reason not specified)|0|||
44527431|NCT02768194|79537452|FG001|Period 3|Other (Reason not specified)|1|||
44149059|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
44282333|NCT01859988|79245609|FG004|Overall Study|Protocol Violation|0|||
44527432|NCT02768194|79537453|FG002|Period 3|Other (Reason not specified)|0|||
44527433|NCT02768194|79537454|FG003|Period 3|Other (Reason not specified)|0|||
44527434|NCT02768194|79537455|FG004|Period 3|Other (Reason not specified)|0|||
44282334|NCT01859988|79245610|FG005|Overall Study|Protocol Violation|0|||
44527435|NCT02768194|79537456|FG005|Period 3|Other (Reason not specified)|0|||
44527436|NCT00130793|79537466|FG000|Overall Study|Lost to Follow-up|1|||
44527437|NCT00130793|79537467|FG001|Overall Study|Lost to Follow-up|4|||
44527438|NCT00130793|79537466|FG000|Overall Study|Withdrew consent|2|||
44527439|NCT00130793|79537467|FG001|Overall Study|Withdrew consent|0|||
44527440|NCT03818399|79537474|FG000|Overall Study|Lost to Follow-up|11|||
44527441|NCT03818399|79537474|FG000|Overall Study|Withdrawal by Subject|1|||
44527442|NCT03818399|79537474|FG000|Overall Study|Protocol Violation|2|||
44527443|NCT03642873|79537478|FG000|Third Intervention (1 Day)|Screen failure|0|||
44527444|NCT03642873|79537479|FG001|Third Intervention (1 Day)|Screen failure|0|||
44527445|NCT03642873|79537480|FG002|Third Intervention (1 Day)|Screen failure|0|||
44527446|NCT03642873|79537481|FG003|Third Intervention (1 Day)|Screen failure|0|||
44527447|NCT03642873|79537482|FG004|Third Intervention (1 Day)|Screen failure|1|||
44527448|NCT03642873|79537483|FG005|Third Intervention (1 Day)|Screen failure|0|||
44527449|NCT03818321|79537497|FG000|Overall Study|Withdrawal by Subject|1|||
44527450|NCT03818321|79537498|FG001|Overall Study|Withdrawal by Subject|2|||
44527451|NCT03616977|79537504|FG000|Period 1|Physician Decision|0|||
44527452|NCT03616977|79537505|FG001|Period 1|Physician Decision|1|||
44527453|NCT03616977|79537504|FG000|Period 3|Adverse Event|1|||
44527454|NCT03616977|79537505|FG001|Period 3|Adverse Event|1|||
44527455|NCT02767570|79537514|FG000|Overall Study|Lost to Follow-up|3|||
44527456|NCT02767570|79537515|FG001|Overall Study|Lost to Follow-up|0|||
44527457|NCT02767570|79537514|FG000|Overall Study|COVID shutdown|2|||
44527458|NCT02767570|79537515|FG001|Overall Study|COVID shutdown|5|||
44527459|NCT02767570|79537514|FG000|Overall Study|Increased pain|2|||
44527460|NCT02767570|79537515|FG001|Overall Study|Increased pain|0|||
44527461|NCT02767570|79537514|FG000|Overall Study|Withdrawal by Subject|1|||
44527462|NCT02767570|79537515|FG001|Overall Study|Withdrawal by Subject|3|||
44527463|NCT02767570|79537514|FG000|Overall Study|Unrelated medical issue|1|||
44527464|NCT02767570|79537515|FG001|Overall Study|Unrelated medical issue|1|||
44527465|NCT02767570|79537514|FG000|Overall Study|Received intra-articular injection|0|||
44527466|NCT02767570|79537515|FG001|Overall Study|Received intra-articular injection|1|||
44527467|NCT03816761|79537524|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
44527468|NCT03816761|79537525|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
44527469|NCT03816761|79537526|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
44527470|NCT03816761|79537527|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
44527471|NCT03816761|79537528|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
44527472|NCT03816761|79537529|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
44527473|NCT03816761|79537524|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
44527474|NCT03816761|79537525|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
44527475|NCT03816761|79537526|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
44527476|NCT03816761|79537527|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
44527477|NCT03816761|79537528|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
44527478|NCT03816761|79537529|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
44527479|NCT02770612|79537551|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
44527480|NCT03575871|79537558|FG000|Overall Study|Adverse Event|5|||
44527481|NCT03575871|79537559|FG001|Overall Study|Adverse Event|5|||
44527482|NCT03575871|79537560|FG002|Overall Study|Adverse Event|8|||
44527483|NCT03575871|79537558|FG000|Overall Study|Death|1|||
44527484|NCT03575871|79537559|FG001|Overall Study|Death|0|||
44414691|NCT00591578|79422720|FG002|Open-Label Extension Phase|Adverse Event|0|||
44414692|NCT00591578|79422718|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
44414693|NCT00591578|79422719|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
44414694|NCT00591578|79422720|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
44414695|NCT00591578|79422718|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
44414696|NCT00591578|79422719|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
44414697|NCT00591578|79422720|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
44414698|NCT00591578|79422718|FG000|Open-Label Extension Phase|Other|1|||
44414699|NCT00591578|79422719|FG001|Open-Label Extension Phase|Other|0|||
44414700|NCT00591578|79422720|FG002|Open-Label Extension Phase|Other|0|||
44414701|NCT00797862|79422732|FG000|Overall Study|Adverse Event|86|||
44414702|NCT00797862|79422733|FG001|Overall Study|Adverse Event|44|||
44527485|NCT03575871|79537560|FG002|Overall Study|Death|0|||
44527486|NCT03575871|79537558|FG000|Overall Study|Lack of Efficacy|5|||
44527487|NCT03575871|79537559|FG001|Overall Study|Lack of Efficacy|4|||
44527488|NCT03575871|79537560|FG002|Overall Study|Lack of Efficacy|7|||
44414703|NCT00797862|79422734|FG002|Overall Study|Adverse Event|58|||
44414704|NCT00797862|79422732|FG000|Overall Study|Abnormal Test Procedure Result|0|||
44527489|NCT03575871|79537558|FG000|Overall Study|Lost to Follow-up|1|||
44527490|NCT03575871|79537559|FG001|Overall Study|Lost to Follow-up|1|||
44527491|NCT03575871|79537560|FG002|Overall Study|Lost to Follow-up|1|||
44527492|NCT03575871|79537558|FG000|Overall Study|Protocol Deviation|1|||
44527493|NCT03575871|79537559|FG001|Overall Study|Protocol Deviation|1|||
44527494|NCT03575871|79537560|FG002|Overall Study|Protocol Deviation|1|||
44527495|NCT03575871|79537558|FG000|Overall Study|Withdrawal by Subject|6|||
44527496|NCT03575871|79537559|FG001|Overall Study|Withdrawal by Subject|1|||
44527497|NCT03575871|79537560|FG002|Overall Study|Withdrawal by Subject|9|||
44527498|NCT03575871|79537558|FG000|Overall Study|Other than specified|2|||
44527499|NCT03575871|79537559|FG001|Overall Study|Other than specified|2|||
44527500|NCT03575871|79537560|FG002|Overall Study|Other than specified|0|||
44527501|NCT03642717|79537568|FG000|Overall Study|Lost to Follow-up|2|||
44527502|NCT03642717|79537568|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
44527503|NCT03642717|79537568|FG000|Overall Study|Taken study drug prior to contract date|3|||
44527504|NCT02766478|79537575|FG000|Overall Study|Withdrawal by Subject|1|||
44527505|NCT02766478|79537576|FG001|Overall Study|Withdrawal by Subject|1|||
44527506|NCT02766400|79537584|FG000|Overall Study|Death|1|||
44527507|NCT02766400|79537585|FG001|Overall Study|Death|2|||
44527508|NCT02766400|79537584|FG000|Overall Study|Withdrawal by Subject|1|||
44527509|NCT02766400|79537585|FG001|Overall Study|Withdrawal by Subject|0|||
44527510|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
44527511|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
44527512|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
44527513|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
44527514|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
44527515|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
44527516|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Death|7|||
44527517|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Death|5|||
44527518|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Death|6|||
44527519|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
44527520|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
44527521|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
44527522|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
44527523|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
44527524|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
44527525|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Other|1|||
44527526|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Other|0|||
44527527|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Other|0|||
44527528|NCT00104650|79537594|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
44527529|NCT00104650|79537595|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
44149060|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
44149061|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
44149062|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
44149063|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
44149064|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
44149065|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
44149066|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
44149067|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
44527530|NCT00104650|79537596|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
44527531|NCT00104650|79537594|FG000|Follow-up Period|Physician Decision|1|||
44527532|NCT00104650|79537595|FG001|Follow-up Period|Physician Decision|1|||
44527533|NCT00104650|79537596|FG002|Follow-up Period|Physician Decision|0|||
44527534|NCT00104650|79537594|FG000|Follow-up Period|Adverse Event|1|||
44527535|NCT00104650|79537595|FG001|Follow-up Period|Adverse Event|0|||
44527536|NCT00104650|79537596|FG002|Follow-up Period|Adverse Event|1|||
44527537|NCT00104650|79537594|FG000|Follow-up Period|Withdrawal by Subject|0|||
44527538|NCT00104650|79537595|FG001|Follow-up Period|Withdrawal by Subject|3|||
44527539|NCT00104650|79537596|FG002|Follow-up Period|Withdrawal by Subject|3|||
44527540|NCT00104650|79537594|FG000|Follow-up Period|Death|6|||
44527541|NCT00104650|79537595|FG001|Follow-up Period|Death|6|||
44527542|NCT00104650|79537596|FG002|Follow-up Period|Death|4|||
44527543|NCT00104650|79537594|FG000|Follow-up Period|Disease progression|3|||
44527544|NCT00104650|79537595|FG001|Follow-up Period|Disease progression|1|||
44527545|NCT00104650|79537596|FG002|Follow-up Period|Disease progression|0|||
44527546|NCT00104650|79537594|FG000|Follow-up Period|Lost to Follow-up|0|||
44527547|NCT00104650|79537595|FG001|Follow-up Period|Lost to Follow-up|1|||
44527548|NCT00104650|79537596|FG002|Follow-up Period|Lost to Follow-up|2|||
44527549|NCT00104650|79537594|FG000|Follow-up Period|Other|0|||
44527550|NCT00104650|79537595|FG001|Follow-up Period|Other|1|||
44527551|NCT00104650|79537596|FG002|Follow-up Period|Other|0|||
44527552|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
44527553|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
44527554|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
44527555|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
44527556|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
44527557|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
44527558|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
44527559|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
44527560|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
44527561|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
44527562|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
44527563|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
44527564|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
44527565|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
44527566|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
44414705|NCT00797862|79422733|FG001|Overall Study|Abnormal Test Procedure Result|1|||
44414706|NCT00797862|79422734|FG002|Overall Study|Abnormal Test Procedure Result|1|||
44414707|NCT00797862|79422732|FG000|Overall Study|Lack of Efficacy|1|||
44527567|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
44527568|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
44527569|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
44527570|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
44527571|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
44527572|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
44527573|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
44527574|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
44527575|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
44527576|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
44527577|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
44527578|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
44149068|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
44149069|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
44149070|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
44149071|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
44149072|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
44149073|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
44149074|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
44414708|NCT00797862|79422733|FG001|Overall Study|Lack of Efficacy|7|||
44149075|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
44149076|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
44149077|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
44414709|NCT00797862|79422734|FG002|Overall Study|Lack of Efficacy|6|||
44414710|NCT00797862|79422732|FG000|Overall Study|No longer required study medication|1|||
44527579|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
44149078|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
44149079|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
44149080|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
44149081|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
44149082|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
44149083|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
44149084|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
44149085|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
44149086|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
44149087|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
44149088|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
44149089|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
44149090|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
44527580|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
44527581|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
44527582|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
44527583|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
44527584|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
44527585|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
44527586|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
44527587|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
44527588|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
44527589|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
44527590|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
44527591|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
44527592|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
44527593|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
44527594|NCT03732807|79537611|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44527595|NCT03732807|79537612|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44527596|NCT03732807|79537613|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44527597|NCT03732807|79537614|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44527598|NCT03732807|79537615|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44527599|NCT03732807|79537616|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
44527600|NCT03732807|79537617|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44527601|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
44527602|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
44527603|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
44527604|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
44527605|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
44527606|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
44527607|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
44527608|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
44527609|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
44527610|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
44527611|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
44527612|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
44527613|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
44527614|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
44527615|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
44527616|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
44527617|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
44149091|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
44527618|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
44527619|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
44527620|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
44149092|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
44149093|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
44527621|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
44527622|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
44527623|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
44527624|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
44527625|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
44527626|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
44527627|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
44527628|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
44527629|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
44527630|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
44527631|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
44527632|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
44527633|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
44527634|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
44527635|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
44527636|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
44527637|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
44527638|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
44527639|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
44527640|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
44527641|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
44527642|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
44527643|NCT03732807|79537611|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
44527644|NCT03732807|79537612|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
44527645|NCT03732807|79537613|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
44527646|NCT03732807|79537614|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
44527647|NCT03732807|79537615|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
44527648|NCT03732807|79537616|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
44527649|NCT03732807|79537617|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
44527650|NCT00104416|79537636|FG000|Double-Blind Phase|Adverse Event|2|||
44527651|NCT00104416|79537637|FG001|Double-Blind Phase|Adverse Event|1|||
44527652|NCT00104416|79537638|FG002|Double-Blind Phase|Adverse Event|0|||
44527653|NCT00104416|79537639|FG003|Double-Blind Phase|Adverse Event|0|||
44527654|NCT00104416|79537640|FG004|Double-Blind Phase|Adverse Event|0|||
44527655|NCT00104416|79537636|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44527656|NCT00104416|79537637|FG001|Double-Blind Phase|Lost to Follow-up|1|||
44527657|NCT00104416|79537638|FG002|Double-Blind Phase|Lost to Follow-up|0|||
44527658|NCT00104416|79537639|FG003|Double-Blind Phase|Lost to Follow-up|0|||
44527659|NCT00104416|79537640|FG004|Double-Blind Phase|Lost to Follow-up|0|||
44527660|NCT00104416|79537636|FG000|Double-Blind Phase|Protocol Violation|0|||
44527661|NCT00104416|79537637|FG001|Double-Blind Phase|Protocol Violation|1|||
44527662|NCT00104416|79537638|FG002|Double-Blind Phase|Protocol Violation|0|||
44527663|NCT00104416|79537639|FG003|Double-Blind Phase|Protocol Violation|0|||
44527664|NCT00104416|79537640|FG004|Double-Blind Phase|Protocol Violation|0|||
44527665|NCT00104416|79537636|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
44527666|NCT00104416|79537637|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
44527667|NCT00104416|79537638|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
44527668|NCT00104416|79537639|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44527669|NCT00104416|79537640|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
44527670|NCT00104416|79537636|FG000|Double-Blind Phase|Pregnancy|1|||
44527671|NCT00104416|79537637|FG001|Double-Blind Phase|Pregnancy|0|||
44527672|NCT00104416|79537638|FG002|Double-Blind Phase|Pregnancy|0|||
44527673|NCT00104416|79537639|FG003|Double-Blind Phase|Pregnancy|0|||
44527674|NCT00104416|79537640|FG004|Double-Blind Phase|Pregnancy|0|||
44527675|NCT00104416|79537636|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
44527676|NCT00104416|79537637|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
44527677|NCT00104416|79537638|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
44527678|NCT00104416|79537639|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
44527679|NCT00104416|79537640|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
44527680|NCT00104416|79537636|FG000|Continuation Phase|Adverse Event|0|||
44527681|NCT00104416|79537637|FG001|Continuation Phase|Adverse Event|0|||
44414711|NCT00797862|79422733|FG001|Overall Study|No longer required study medication|0|||
44414712|NCT00797862|79422734|FG002|Overall Study|No longer required study medication|0|||
44527682|NCT00104416|79537638|FG002|Continuation Phase|Adverse Event|2|||
44527683|NCT00104416|79537639|FG003|Continuation Phase|Adverse Event|0|||
44527684|NCT00104416|79537640|FG004|Continuation Phase|Adverse Event|2|||
44527685|NCT00104416|79537636|FG000|Continuation Phase|Lost to Follow-up|0|||
44527686|NCT00104416|79537637|FG001|Continuation Phase|Lost to Follow-up|0|||
44527687|NCT00104416|79537638|FG002|Continuation Phase|Lost to Follow-up|1|||
44527688|NCT00104416|79537639|FG003|Continuation Phase|Lost to Follow-up|0|||
44527689|NCT00104416|79537640|FG004|Continuation Phase|Lost to Follow-up|1|||
44527690|NCT00104416|79537636|FG000|Continuation Phase|Withdrawal by Subject|0|||
44527691|NCT00104416|79537637|FG001|Continuation Phase|Withdrawal by Subject|0|||
44527692|NCT00104416|79537638|FG002|Continuation Phase|Withdrawal by Subject|2|||
44527693|NCT00104416|79537639|FG003|Continuation Phase|Withdrawal by Subject|1|||
44527694|NCT00104416|79537640|FG004|Continuation Phase|Withdrawal by Subject|1|||
44527695|NCT00104416|79537636|FG000|Continuation Phase|Pregnancy|0|||
44527696|NCT00104416|79537637|FG001|Continuation Phase|Pregnancy|0|||
44527697|NCT00104416|79537638|FG002|Continuation Phase|Pregnancy|1|||
44527698|NCT00104416|79537639|FG003|Continuation Phase|Pregnancy|1|||
44527699|NCT00104416|79537640|FG004|Continuation Phase|Pregnancy|0|||
44527700|NCT00104416|79537636|FG000|Continuation Phase|Non-compliance|0|||
44527701|NCT00104416|79537637|FG001|Continuation Phase|Non-compliance|0|||
44527702|NCT00104416|79537638|FG002|Continuation Phase|Non-compliance|0|||
44527703|NCT00104416|79537639|FG003|Continuation Phase|Non-compliance|0|||
44527704|NCT00104416|79537640|FG004|Continuation Phase|Non-compliance|1|||
44527705|NCT03639987|79537654|FG000|Overall Study|Study terminated by sponsor|26|||
44527706|NCT03639987|79537655|FG001|Overall Study|Study terminated by sponsor|25|||
44527707|NCT03639987|79537654|FG000|Overall Study|Lost to Follow-up|0|||
44527708|NCT03639987|79537655|FG001|Overall Study|Lost to Follow-up|1|||
44527709|NCT02766088|79537661|FG000|Overall Study|Sponsor study termination|498|||
44527710|NCT02766088|79537661|FG000|Overall Study|Migrated/moved from the study area|1|||
44527711|NCT02766088|79537661|FG000|Overall Study|Lost to Follow-up|5|||
44527712|NCT02766088|79537661|FG000|Overall Study|Other|1|||
44527713|NCT02766088|79537661|FG000|Overall Study|Death|1|||
44527714|NCT03639675|79537665|FG000|Overall Study|Withdrawal by Subject|1|||
44527715|NCT03635775|79537673|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
44527716|NCT03635775|79537674|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
44527717|NCT03635775|79537675|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
44527718|NCT03635775|79537676|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
44527719|NCT03610581|79537688|FG000|Overall Study|Study terminated by sponsor|2|||
44527720|NCT03610581|79537689|FG001|Overall Study|Study terminated by sponsor|0|||
44527721|NCT03610581|79537688|FG000|Overall Study|Other|0|||
44527722|NCT03610581|79537689|FG001|Overall Study|Other|1|||
44527723|NCT03610581|79537688|FG000|Overall Study|Withdrawal by Subject|1|||
44527724|NCT03610581|79537689|FG001|Overall Study|Withdrawal by Subject|0|||
44527725|NCT03610269|79537695|FG000|Overall Study|Physician Decision|10|||
44527726|NCT03610269|79537695|FG000|Overall Study|Protocol Violation|1|||
44527727|NCT03610269|79537695|FG000|Overall Study|Unable to draw blood|1|||
44527728|NCT03610269|79537695|FG000|Overall Study|Screen fail|4|||
44527729|NCT00121667|79537703|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
44527730|NCT00121667|79537704|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
44527731|NCT00121667|79537705|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
44527732|NCT00121667|79537706|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
44527733|NCT00121667|79537703|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
44527734|NCT00121667|79537704|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
44527735|NCT00121667|79537705|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
44527736|NCT00121667|79537706|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
44527737|NCT00121667|79537703|FG000|Short Term (ST) Period|Adverse Event|5|||
44527738|NCT00121667|79537704|FG001|Short Term (ST) Period|Adverse Event|6|||
44527739|NCT00121667|79537705|FG002|Short Term (ST) Period|Adverse Event|5|||
44527740|NCT00121667|79537706|FG003|Short Term (ST) Period|Adverse Event|3|||
44527741|NCT00121667|79537703|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
44527742|NCT00121667|79537704|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
44527743|NCT00121667|79537705|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
44527744|NCT00121667|79537706|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
44527745|NCT00121667|79537703|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
44527746|NCT00121667|79537704|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
44527747|NCT00121667|79537705|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
44254449|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
44414713|NCT00797862|79422732|FG000|Overall Study|Withdrawal by Subject|14|||
44414714|NCT00797862|79422733|FG001|Overall Study|Withdrawal by Subject|7|||
44414715|NCT00797862|79422734|FG002|Overall Study|Withdrawal by Subject|7|||
44527748|NCT00121667|79537706|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
44527749|NCT00121667|79537703|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
44527750|NCT00121667|79537704|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
44527751|NCT00121667|79537705|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
44527752|NCT00121667|79537706|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
44527753|NCT00121667|79537703|FG000|Short Term (ST) Period|Other Reason|3|||
44527754|NCT00121667|79537704|FG001|Short Term (ST) Period|Other Reason|0|||
44527755|NCT00121667|79537705|FG002|Short Term (ST) Period|Other Reason|0|||
44527756|NCT00121667|79537706|FG003|Short Term (ST) Period|Other Reason|0|||
44527757|NCT00121667|79537703|FG000|Short Term (ST) Period|Death|0|||
44527758|NCT00121667|79537704|FG001|Short Term (ST) Period|Death|0|||
44527759|NCT00121667|79537705|FG002|Short Term (ST) Period|Death|0|||
44527760|NCT00121667|79537706|FG003|Short Term (ST) Period|Death|1|||
44527761|NCT00121667|79537703|FG000|Short Term (ST) Period|Pregnancy|0|||
44527762|NCT00121667|79537704|FG001|Short Term (ST) Period|Pregnancy|0|||
44527763|NCT00121667|79537705|FG002|Short Term (ST) Period|Pregnancy|0|||
44527764|NCT00121667|79537706|FG003|Short Term (ST) Period|Pregnancy|1|||
44527765|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
44527766|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
44527767|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
44527768|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
44527769|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
44527770|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
44527771|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
44254450|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
44527772|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
44527773|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
44527774|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
44527775|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
44527776|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
44527777|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
44527778|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
44527779|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
44527780|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
44527781|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
44527782|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
44527783|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
44527784|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
44527785|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
44527786|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
44527787|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
44527788|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
44527789|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
44149094|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
44527790|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
44527791|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
44527792|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
44527793|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
44527794|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
44527795|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
44527796|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
44527797|NCT00121667|79537703|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
44527798|NCT00121667|79537704|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
44527799|NCT00121667|79537705|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
44527800|NCT00121667|79537706|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
44527801|NCT02954601|79537720|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
44527802|NCT02954601|79537721|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
44527803|NCT02954601|79537722|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
44527804|NCT02954601|79537723|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
44527805|NCT03633903|79537735|FG000|Overall Study|Withdrawal by Subject|1|||
44527806|NCT03633903|79537736|FG001|Overall Study|Withdrawal by Subject|2|||
44527807|NCT03633903|79537735|FG000|Overall Study|Lost to Follow-up|5|||
44527808|NCT03633903|79537736|FG001|Overall Study|Lost to Follow-up|5|||
44527809|NCT03607695|79537742|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
44527810|NCT03607695|79537742|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
44527811|NCT03557775|79537749|FG000|Overall Study|Withdrawal by Subject|1|||
44527812|NCT03557775|79537750|FG001|Overall Study|Withdrawal by Subject|2|||
44527813|NCT03557775|79537751|FG002|Overall Study|Withdrawal by Subject|4|||
44527814|NCT03557775|79537749|FG000|Overall Study|Physician Decision|0|||
44527815|NCT03557775|79537750|FG001|Overall Study|Physician Decision|1|||
44527816|NCT03557775|79537751|FG002|Overall Study|Physician Decision|0|||
44527817|NCT00121199|79537759|FG000|Overall Study|Adverse Event|11|||
44527818|NCT00121199|79537759|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
44527819|NCT00121199|79537759|FG000|Overall Study|Progression/Relapse|1|||
44527820|NCT00121199|79537759|FG000|Overall Study|Death|3|||
44527821|NCT00121199|79537759|FG000|Overall Study|Other - Not Protocol Specified|3|||
44527822|NCT00121199|79537759|FG000|Overall Study|Ineligible|9|||
44527823|NCT00119405|79537763|FG000|Overall Study|Withdrawal by Subject|1|||
44527824|NCT00119015|79537769|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
44527825|NCT00119015|79537770|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
44527826|NCT00119015|79537771|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
44527827|NCT01981850|79537784|FG000|Main Phase Stage 1|Death|2|||
44527828|NCT01981850|79537785|FG001|Main Phase Stage 1|Death|0|||
44527829|NCT01981850|79537786|FG002|Main Phase Stage 1|Death|0|||
44527830|NCT01981850|79537787|FG003|Main Phase Stage 1|Death|0|||
44527831|NCT01981850|79537788|FG004|Main Phase Stage 1|Death|0|||
44527832|NCT01981850|79537789|FG005|Main Phase Stage 1|Death|0|||
44527833|NCT01981850|79537790|FG006|Main Phase Stage 1|Death|0|||
44527834|NCT01981850|79537791|FG007|Main Phase Stage 1|Death|0|||
44527835|NCT01981850|79537792|FG008|Main Phase Stage 1|Death|0|||
44527836|NCT01981850|79537793|FG009|Main Phase Stage 1|Death|0|||
44527837|NCT01981850|79537784|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
44527838|NCT01981850|79537785|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44254451|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
44414716|NCT00797862|79422732|FG000|Overall Study|Lost to Follow-up|11|||
44414717|NCT00797862|79422733|FG001|Overall Study|Lost to Follow-up|0|||
44414718|NCT00797862|79422734|FG002|Overall Study|Lost to Follow-up|5|||
44414719|NCT00797862|79422732|FG000|Overall Study|Administrative Problem|4|||
44527839|NCT01981850|79537786|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527840|NCT01981850|79537787|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527841|NCT01981850|79537788|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527842|NCT01981850|79537789|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527843|NCT01981850|79537790|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527844|NCT01981850|79537791|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527845|NCT01981850|79537792|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527846|NCT01981850|79537793|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
44527847|NCT01981850|79537784|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
44527848|NCT01981850|79537785|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
44527849|NCT01981850|79537786|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
44527850|NCT01981850|79537787|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
44527851|NCT01981850|79537788|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
44527852|NCT01981850|79537789|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
44527853|NCT01981850|79537790|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
44527854|NCT01981850|79537791|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
44527855|NCT01981850|79537792|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
44527856|NCT01981850|79537793|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
44527857|NCT01981850|79537784|FG000|Main Phase Stage 1|Various reasons|0|||
44527858|NCT01981850|79537785|FG001|Main Phase Stage 1|Various reasons|0|||
44414720|NCT00797862|79422733|FG001|Overall Study|Administrative Problem|0|||
44527859|NCT01981850|79537786|FG002|Main Phase Stage 1|Various reasons|2|||
44527860|NCT01981850|79537787|FG003|Main Phase Stage 1|Various reasons|0|||
44527861|NCT01981850|79537788|FG004|Main Phase Stage 1|Various reasons|0|||
44527862|NCT01981850|79537789|FG005|Main Phase Stage 1|Various reasons|0|||
44527863|NCT01981850|79537790|FG006|Main Phase Stage 1|Various reasons|0|||
44527864|NCT01981850|79537791|FG007|Main Phase Stage 1|Various reasons|0|||
44527865|NCT01981850|79537792|FG008|Main Phase Stage 1|Various reasons|0|||
44527866|NCT01981850|79537793|FG009|Main Phase Stage 1|Various reasons|0|||
44527867|NCT01981850|79537784|FG000|Main Phase Stage 2|Adverse Event|0|||
44527868|NCT01981850|79537785|FG001|Main Phase Stage 2|Adverse Event|0|||
44527869|NCT01981850|79537786|FG002|Main Phase Stage 2|Adverse Event|0|||
44527870|NCT01981850|79537787|FG003|Main Phase Stage 2|Adverse Event|0|||
44527871|NCT01981850|79537788|FG004|Main Phase Stage 2|Adverse Event|6|||
44527872|NCT01981850|79537789|FG005|Main Phase Stage 2|Adverse Event|5|||
44527873|NCT01981850|79537790|FG006|Main Phase Stage 2|Adverse Event|7|||
44527874|NCT01981850|79537791|FG007|Main Phase Stage 2|Adverse Event|0|||
44527875|NCT01981850|79537792|FG008|Main Phase Stage 2|Adverse Event|0|||
44527876|NCT01981850|79537793|FG009|Main Phase Stage 2|Adverse Event|0|||
44527877|NCT01981850|79537784|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527878|NCT01981850|79537785|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527879|NCT01981850|79537786|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527880|NCT01981850|79537787|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527881|NCT01981850|79537788|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
44527882|NCT01981850|79537789|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
44527883|NCT01981850|79537790|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
44527884|NCT01981850|79537791|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527885|NCT01981850|79537792|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527886|NCT01981850|79537793|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
44527887|NCT01981850|79537784|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
44527888|NCT01981850|79537785|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
44527889|NCT01981850|79537786|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
44527890|NCT01981850|79537787|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
44527891|NCT01981850|79537788|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
44527892|NCT01981850|79537789|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
44527893|NCT01981850|79537790|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
44527894|NCT01981850|79537791|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
44527895|NCT01981850|79537792|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
44527896|NCT01981850|79537793|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
44527897|NCT01981850|79537784|FG000|Main Phase Stage 2|Various reasons|0|||
44527898|NCT01981850|79537785|FG001|Main Phase Stage 2|Various reasons|0|||
44527899|NCT01981850|79537786|FG002|Main Phase Stage 2|Various reasons|0|||
44527900|NCT01981850|79537787|FG003|Main Phase Stage 2|Various reasons|0|||
44527901|NCT01981850|79537788|FG004|Main Phase Stage 2|Various reasons|2|||
44527902|NCT01981850|79537789|FG005|Main Phase Stage 2|Various reasons|0|||
44527903|NCT01981850|79537790|FG006|Main Phase Stage 2|Various reasons|1|||
44527904|NCT01981850|79537791|FG007|Main Phase Stage 2|Various reasons|0|||
44527905|NCT01981850|79537792|FG008|Main Phase Stage 2|Various reasons|0|||
44527906|NCT01981850|79537793|FG009|Main Phase Stage 2|Various reasons|0|||
44527907|NCT01981850|79537784|FG000|Main Phase Stage 2|Progressive Disease|0|||
44527908|NCT01981850|79537785|FG001|Main Phase Stage 2|Progressive Disease|0|||
44527909|NCT01981850|79537786|FG002|Main Phase Stage 2|Progressive Disease|0|||
44527910|NCT01981850|79537787|FG003|Main Phase Stage 2|Progressive Disease|0|||
44254452|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
44527911|NCT01981850|79537788|FG004|Main Phase Stage 2|Progressive Disease|0|||
44527912|NCT01981850|79537789|FG005|Main Phase Stage 2|Progressive Disease|6|||
44527913|NCT01981850|79537790|FG006|Main Phase Stage 2|Progressive Disease|6|||
44527914|NCT01981850|79537791|FG007|Main Phase Stage 2|Progressive Disease|0|||
44527915|NCT01981850|79537792|FG008|Main Phase Stage 2|Progressive Disease|0|||
44527916|NCT01981850|79537793|FG009|Main Phase Stage 2|Progressive Disease|0|||
44527917|NCT01981850|79537784|FG000|Open Label Extension (OLE)|Adverse Event|0|||
44527918|NCT01981850|79537785|FG001|Open Label Extension (OLE)|Adverse Event|0|||
44527919|NCT01981850|79537786|FG002|Open Label Extension (OLE)|Adverse Event|0|||
44527920|NCT01981850|79537787|FG003|Open Label Extension (OLE)|Adverse Event|0|||
44527921|NCT01981850|79537788|FG004|Open Label Extension (OLE)|Adverse Event|0|||
44527922|NCT01981850|79537789|FG005|Open Label Extension (OLE)|Adverse Event|0|||
44527923|NCT01981850|79537790|FG006|Open Label Extension (OLE)|Adverse Event|0|||
44527924|NCT01981850|79537791|FG007|Open Label Extension (OLE)|Adverse Event|2|||
44527925|NCT01981850|79537792|FG008|Open Label Extension (OLE)|Adverse Event|1|||
44527926|NCT01981850|79537793|FG009|Open Label Extension (OLE)|Adverse Event|8|||
44527927|NCT01981850|79537784|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
44527928|NCT01981850|79537785|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
44527929|NCT01981850|79537786|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
44527930|NCT01981850|79537787|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
44254453|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
44527931|NCT01981850|79537788|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
44527932|NCT01981850|79537789|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
44527933|NCT01981850|79537790|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
44527934|NCT01981850|79537791|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
44527935|NCT01981850|79537792|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
44527936|NCT01981850|79537793|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
44527937|NCT01981850|79537784|FG000|Open Label Extension (OLE)|Various reasons|0|||
44527938|NCT01981850|79537785|FG001|Open Label Extension (OLE)|Various reasons|0|||
44282335|NCT01859988|79245605|FG000|Overall Study|Other than specified above|0|||
44282336|NCT01859988|79245606|FG001|Overall Study|Other than specified above|2|||
44527939|NCT01981850|79537786|FG002|Open Label Extension (OLE)|Various reasons|0|||
44527940|NCT01981850|79537787|FG003|Open Label Extension (OLE)|Various reasons|0|||
44527941|NCT01981850|79537788|FG004|Open Label Extension (OLE)|Various reasons|0|||
44527942|NCT01981850|79537789|FG005|Open Label Extension (OLE)|Various reasons|0|||
44527943|NCT01981850|79537790|FG006|Open Label Extension (OLE)|Various reasons|0|||
44527944|NCT01981850|79537791|FG007|Open Label Extension (OLE)|Various reasons|3|||
44527945|NCT01981850|79537792|FG008|Open Label Extension (OLE)|Various reasons|1|||
44527946|NCT01981850|79537793|FG009|Open Label Extension (OLE)|Various reasons|3|||
44527947|NCT01981850|79537784|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
44527948|NCT01981850|79537785|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
44527949|NCT01981850|79537786|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
44527950|NCT01981850|79537787|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
44527951|NCT01981850|79537788|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
44527952|NCT01981850|79537789|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
44527953|NCT01981850|79537790|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
44527954|NCT01981850|79537791|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
44527955|NCT01981850|79537792|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
44527956|NCT01981850|79537793|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
44527957|NCT01981850|79537784|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527958|NCT01981850|79537785|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527959|NCT01981850|79537786|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527960|NCT01981850|79537787|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527961|NCT01981850|79537788|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527962|NCT01981850|79537789|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527963|NCT01981850|79537790|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527964|NCT01981850|79537791|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527965|NCT01981850|79537792|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
44527966|NCT01981850|79537793|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
44527967|NCT01981850|79537784|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527968|NCT01981850|79537785|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527969|NCT01981850|79537786|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527970|NCT01981850|79537787|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527971|NCT01981850|79537788|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527972|NCT01981850|79537789|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527973|NCT01981850|79537790|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527974|NCT01981850|79537791|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527975|NCT01981850|79537792|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
44527976|NCT01981850|79537793|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
44254454|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
44254455|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
44254456|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
44254457|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
44254458|NCT04178967|79096238|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44254459|NCT04178967|79096239|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44254460|NCT04178967|79096240|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44254461|NCT04178967|79096241|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
44254462|NCT04178967|79096242|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44282337|NCT01859988|79245607|FG002|Overall Study|Other than specified above|11|||
44282338|NCT01859988|79245608|FG003|Overall Study|Other than specified above|3|||
44282339|NCT01859988|79245609|FG004|Overall Study|Other than specified above|5|||
44527977|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
44527978|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
44527979|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
44527980|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
44527981|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
44527982|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
44527983|NCT03557307|79537825|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
44527984|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
44527985|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|Death|3|||
44527986|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
44527987|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
44527988|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
44527989|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
44527990|NCT03557307|79537825|FG000|Period 2: Maintenance Phase|other|3|||
44527991|NCT00118703|79537837|FG000|Overall Study|Protocol Violation|1|||
44527992|NCT00118703|79537838|FG001|Overall Study|Protocol Violation|0|||
44527993|NCT00118703|79537837|FG000|Overall Study|Adverse Event|1|||
44527994|NCT00118703|79537838|FG001|Overall Study|Adverse Event|1|||
44527995|NCT00118703|79537837|FG000|Overall Study|Participant took two different treatment|0|||
44527996|NCT00118703|79537838|FG001|Overall Study|Participant took two different treatment|1|||
44527997|NCT00118703|79537837|FG000|Overall Study|Withdrawal by Subject|2|||
44527998|NCT00118703|79537838|FG001|Overall Study|Withdrawal by Subject|5|||
44527999|NCT00118703|79537837|FG000|Overall Study|Lost to Follow-up|1|||
44528000|NCT00118703|79537838|FG001|Overall Study|Lost to Follow-up|2|||
44528001|NCT00104104|79537846|FG000|Overall Study|Adverse Event|8|||
44528002|NCT00104104|79537847|FG001|Overall Study|Adverse Event|8|||
44528003|NCT00104104|79537846|FG000|Overall Study|Abnormal laboratory value(s)|20|||
44528004|NCT00104104|79537847|FG001|Overall Study|Abnormal laboratory value(s)|14|||
44528005|NCT00104104|79537846|FG000|Overall Study|Lack of Efficacy|0|||
44528006|NCT00104104|79537847|FG001|Overall Study|Lack of Efficacy|3|||
44528007|NCT00104104|79537846|FG000|Overall Study|Condition no longer requires study drug|7|||
44528008|NCT00104104|79537847|FG001|Overall Study|Condition no longer requires study drug|4|||
44528009|NCT00104104|79537846|FG000|Overall Study|Protocol Violation|5|||
44528010|NCT00104104|79537847|FG001|Overall Study|Protocol Violation|2|||
44528011|NCT00104104|79537846|FG000|Overall Study|Withdrawal by Subject|11|||
44528012|NCT00104104|79537847|FG001|Overall Study|Withdrawal by Subject|15|||
44528013|NCT00104104|79537846|FG000|Overall Study|Lost to Follow-up|3|||
44528014|NCT00104104|79537847|FG001|Overall Study|Lost to Follow-up|7|||
44528015|NCT00104104|79537846|FG000|Overall Study|Administrative problems|12|||
44528016|NCT00104104|79537847|FG001|Overall Study|Administrative problems|13|||
44528017|NCT00104104|79537846|FG000|Overall Study|Death|9|||
44528018|NCT00104104|79537847|FG001|Overall Study|Death|6|||
44528019|NCT03557151|79537855|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
44528020|NCT03557151|79537856|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
44528021|NCT03557151|79537855|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
44528022|NCT03557151|79537856|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
44528023|NCT03557151|79537855|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
44149095|NCT02151682|78938685|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
44149096|NCT02151682|78938686|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
44149097|NCT02151682|78938687|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
44149098|NCT02151682|78938688|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
44528024|NCT03557151|79537856|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
44149099|NCT02151682|78938689|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
44528025|NCT00115739|79537864|FG000|Overall Study|Lost to Follow-up|3|||
44528026|NCT01347086|79537880|FG000|Overall Study|failed screening visit|0|||
44528027|NCT01347086|79537881|FG001|Overall Study|failed screening visit|0|||
44254463|NCT04178967|79096243|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
44254464|NCT04178967|79096244|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
44254465|NCT04178967|79096245|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
44254466|NCT04178967|79096246|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44528028|NCT01347086|79537882|FG002|Overall Study|failed screening visit|1|||
44149100|NCT02151682|78938690|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
44149101|NCT02151682|78938685|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
44149102|NCT02151682|78938686|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
44149103|NCT02151682|78938687|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
44149104|NCT02151682|78938688|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
44414721|NCT00797862|79422734|FG002|Overall Study|Administrative Problem|0|||
44414722|NCT00797862|79422732|FG000|Overall Study|Protocol Violation|4|||
44414723|NCT00797862|79422733|FG001|Overall Study|Protocol Violation|6|||
44414724|NCT00797862|79422734|FG002|Overall Study|Protocol Violation|8|||
44149105|NCT02151682|78938689|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
44149106|NCT02151682|78938690|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
44149107|NCT02151682|78938685|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
44149108|NCT02151682|78938686|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
44149109|NCT02151682|78938687|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
44414725|NCT00797862|79422732|FG000|Overall Study|Mis-randomized|3|||
44414726|NCT00797862|79422733|FG001|Overall Study|Mis-randomized|3|||
44414727|NCT00797862|79422734|FG002|Overall Study|Mis-randomized|1|||
44414728|NCT00794820|79422742|FG000|Overall Study|Adverse Event|11|||
44414729|NCT00794820|79422742|FG000|Overall Study|Secondary Malignancies|2|||
44414730|NCT00794820|79422742|FG000|Overall Study|Resistant Disease|2|||
44414731|NCT00794820|79422742|FG000|Overall Study|Ineligible/Screen Failure|1|||
44414732|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
44414733|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
44414734|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
44414735|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
44414736|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
44414737|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
44528029|NCT01347086|79537883|FG003|Overall Study|failed screening visit|0|||
44528030|NCT01347086|79537884|FG004|Overall Study|failed screening visit|0|||
44528031|NCT01347086|79537885|FG005|Overall Study|failed screening visit|0|||
44528032|NCT01347086|79537886|FG006|Overall Study|failed screening visit|1|||
44149110|NCT02151682|78938688|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
44149111|NCT02151682|78938689|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
44149112|NCT02151682|78938690|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
44528033|NCT01347086|79537887|FG007|Overall Study|failed screening visit|1|||
44528034|NCT01347086|79537888|FG008|Overall Study|failed screening visit|0|||
44528035|NCT01347086|79537889|FG009|Overall Study|failed screening visit|1|||
44528036|NCT03605745|79537921|FG000|Overall Study|Study was terminated for business reasons|47|||
44149113|NCT02151682|78938685|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
44149114|NCT02151682|78938686|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
44149115|NCT02151682|78938687|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
44149116|NCT02151682|78938688|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
44149117|NCT02151682|78938689|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
44254467|NCT04178967|79096247|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44528037|NCT03246152|79537925|FG000|Overall Study|Lost to Follow-up|2|||
44528038|NCT03246152|79537925|FG000|Overall Study|Protocol Violation|1|||
44528039|NCT03571581|79537929|FG000|Overall Study|Death|2|||
44528040|NCT03571581|79537929|FG000|Overall Study|Withdrawal by Subject|2|||
44528041|NCT00115349|79537938|FG000|Overall Study|Study closed due to low enrollment.|11|||
44414738|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
44528042|NCT00115349|79537939|FG001|Overall Study|Study closed due to low enrollment.|9|||
44528043|NCT00115037|79537947|FG000|Phase1|Lost to Follow-up|16|||
44528044|NCT00115037|79537948|FG001|Phase1|Lost to Follow-up|23|||
44414739|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
44414740|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
44414741|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
44414742|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
44528045|NCT00115037|79537949|FG002|Phase1|Lost to Follow-up|0|||
44528046|NCT00115037|79537950|FG003|Phase1|Lost to Follow-up|0|||
44528047|NCT00115037|79537951|FG004|Phase1|Lost to Follow-up|0|||
44528048|NCT00115037|79537952|FG005|Phase1|Lost to Follow-up|0|||
44528049|NCT00115037|79537947|FG000|Phase1|Withdrawal by Subject|9|||
44528050|NCT00115037|79537948|FG001|Phase1|Withdrawal by Subject|4|||
44528051|NCT00115037|79537949|FG002|Phase1|Withdrawal by Subject|0|||
44528052|NCT00115037|79537950|FG003|Phase1|Withdrawal by Subject|0|||
44528053|NCT00115037|79537951|FG004|Phase1|Withdrawal by Subject|0|||
44528054|NCT00115037|79537952|FG005|Phase1|Withdrawal by Subject|0|||
44528055|NCT00115037|79537947|FG000|Phase2|Death|0|||
44528056|NCT00115037|79537948|FG001|Phase2|Death|0|||
44528057|NCT00115037|79537949|FG002|Phase2|Death|1|||
44528058|NCT00115037|79537950|FG003|Phase2|Death|0|||
44528059|NCT00115037|79537951|FG004|Phase2|Death|0|||
44528060|NCT00115037|79537952|FG005|Phase2|Death|1|||
44528061|NCT00115037|79537947|FG000|Phase2|Withdrawal by Subject|0|||
44528062|NCT00115037|79537948|FG001|Phase2|Withdrawal by Subject|0|||
44528063|NCT00115037|79537949|FG002|Phase2|Withdrawal by Subject|2|||
44528064|NCT00115037|79537950|FG003|Phase2|Withdrawal by Subject|1|||
44528065|NCT00115037|79537951|FG004|Phase2|Withdrawal by Subject|2|||
44528066|NCT00115037|79537952|FG005|Phase2|Withdrawal by Subject|1|||
44528067|NCT00115037|79537947|FG000|Phase2|Lost to Follow-up|0|||
44528068|NCT00115037|79537948|FG001|Phase2|Lost to Follow-up|0|||
44528069|NCT00115037|79537949|FG002|Phase2|Lost to Follow-up|12|||
44528070|NCT00115037|79537950|FG003|Phase2|Lost to Follow-up|14|||
44528071|NCT00115037|79537951|FG004|Phase2|Lost to Follow-up|4|||
44528072|NCT00115037|79537952|FG005|Phase2|Lost to Follow-up|10|||
44528073|NCT03214640|79537970|FG000|Overall Study|Protocol Violation|1|||
44528074|NCT03214640|79537971|FG001|Overall Study|Protocol Violation|2|||
44528075|NCT03214640|79537972|FG002|Overall Study|Protocol Violation|1|||
44528076|NCT03214640|79537973|FG003|Overall Study|Protocol Violation|4|||
44528077|NCT03214406|79537985|FG000|Overall Study|did not meet enrollment criteria|9|||
44528078|NCT03214406|79537986|FG001|Overall Study|did not meet enrollment criteria|13|||
44414743|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
44414744|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
44414745|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
44414746|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
44528079|NCT03214406|79537985|FG000|Overall Study|Withdrawal by Subject|1|||
44528080|NCT03214406|79537986|FG001|Overall Study|Withdrawal by Subject|0|||
44528081|NCT03214406|79537985|FG000|Overall Study|Lost to Follow-up|0|||
44528082|NCT03214406|79537986|FG001|Overall Study|Lost to Follow-up|2|||
44528083|NCT03213938|79537994|FG000|Overall Study|Lost to Follow-up|4|||
44528084|NCT03213938|79537995|FG001|Overall Study|Lost to Follow-up|3|||
44528085|NCT03213938|79537994|FG000|Overall Study|Lack of Efficacy|1|||
44528086|NCT03213938|79537995|FG001|Overall Study|Lack of Efficacy|0|||
44528087|NCT03213938|79537994|FG000|Overall Study|Decline to participate|5|||
44528088|NCT03213938|79537995|FG001|Overall Study|Decline to participate|4|||
44528089|NCT03213938|79537994|FG000|Overall Study|Without reason|4|||
44528090|NCT03213938|79537995|FG001|Overall Study|Without reason|5|||
44528091|NCT03604497|79538001|FG000|Overall Study|Protocol Violation|52|||
44528092|NCT03213626|79538009|FG000|Overall Study|Adverse Event|1|||
44528093|NCT03213626|79538009|FG000|Overall Study|Progressive Disease|6|||
44528094|NCT03604341|79538015|FG000|Overall Study|Withdrawal by Subject|1|||
44528095|NCT03604341|79538016|FG001|Overall Study|Withdrawal by Subject|1|||
44528096|NCT03604341|79538015|FG000|Overall Study|Adverse Event|1|||
44528097|NCT03604341|79538016|FG001|Overall Study|Adverse Event|0|||
44528098|NCT03604341|79538015|FG000|Overall Study|Protocol Violation|0|||
44528099|NCT03604341|79538016|FG001|Overall Study|Protocol Violation|1|||
44528100|NCT03603639|79538022|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
44528101|NCT03603639|79538023|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
44528102|NCT03603639|79538024|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
44528103|NCT03603639|79538025|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
44149118|NCT02151682|78938690|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
44149119|NCT02151682|78938685|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
44149120|NCT02151682|78938686|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
44149121|NCT02151682|78938687|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
44528104|NCT03603639|79538026|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
44528105|NCT03603639|79538027|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
44528106|NCT03603639|79538022|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
44528107|NCT03603639|79538023|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
44528108|NCT03603639|79538024|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
44528109|NCT03603639|79538025|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
44528110|NCT03603639|79538026|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
44528111|NCT03603639|79538027|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
44528112|NCT00114959|79538037|FG000|Overall Study|Lack of Efficacy|6|||
44528113|NCT00114959|79538037|FG000|Overall Study|Physician Decision|1|||
44528114|NCT00114959|79538037|FG000|Overall Study|Death|1|||
44528115|NCT02778100|79538043|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
44528116|NCT02778100|79538044|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
44528117|NCT00118157|79538052|FG000|Overall Study|Adverse Event|2|||
44528118|NCT00118157|79538052|FG000|Overall Study|Death|8|||
44528119|NCT00118157|79538052|FG000|Overall Study|Withdrawal by Subject|2|||
44528120|NCT02762500|79538059|FG000|Overall Study|Lack of Efficacy|1|||
44528121|NCT02762500|79538060|FG001|Overall Study|Lack of Efficacy|0|||
44528122|NCT02762500|79538059|FG000|Overall Study|Withdrawal by Subject|1|||
44528123|NCT02762500|79538060|FG001|Overall Study|Withdrawal by Subject|1|||
44528124|NCT02762500|79538059|FG000|Overall Study|Adverse Event|0|||
44528125|NCT02762500|79538060|FG001|Overall Study|Adverse Event|2|||
44528126|NCT03552549|79538068|FG000|Overall Study|Disease progression|25|||
44528127|NCT03552549|79538069|FG001|Overall Study|Disease progression|17|||
44528128|NCT03552549|79538068|FG000|Overall Study|Adverse event in first 12 months|12|||
44528129|NCT03552549|79538069|FG001|Overall Study|Adverse event in first 12 months|8|||
44528130|NCT03552549|79538068|FG000|Overall Study|Withdrawal by Subject|7|||
44528131|NCT03552549|79538069|FG001|Overall Study|Withdrawal by Subject|7|||
44528132|NCT03552549|79538068|FG000|Overall Study|Unknown (no reason provided)|4|||
44528133|NCT03552549|79538069|FG001|Overall Study|Unknown (no reason provided)|2|||
44528134|NCT03552549|79538068|FG000|Overall Study|Not in participant's best interest|2|||
44528135|NCT03552549|79538069|FG001|Overall Study|Not in participant's best interest|1|||
44528136|NCT03552549|79538068|FG000|Overall Study|Did not complete study treatment|2|||
44528137|NCT03552549|79538069|FG001|Overall Study|Did not complete study treatment|3|||
44528138|NCT03552549|79538068|FG000|Overall Study|Did not meet eligibility criteria|1|||
44528139|NCT03552549|79538069|FG001|Overall Study|Did not meet eligibility criteria|0|||
44528140|NCT03552549|79538068|FG000|Overall Study|Administrative|0|||
44149122|NCT02151682|78938688|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
44254468|NCT04178967|79096248|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
44414747|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
44414748|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
44414749|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
44414750|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
44528141|NCT03552549|79538069|FG001|Overall Study|Administrative|14|||
44528142|NCT00117845|79538075|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
44528143|NCT02761642|79538079|FG000|Overall Study|Did not Receive Study Treatment|3|||
44528144|NCT02761642|79538079|FG000|Overall Study|Adverse Event|13|||
44528145|NCT02761642|79538079|FG000|Overall Study|Withdrawal by Subject|2|||
44528146|NCT02761642|79538079|FG000|Overall Study|Non-compliant|7|||
44254469|NCT04178967|79096238|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254470|NCT04178967|79096239|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
44528147|NCT02761642|79538079|FG000|Overall Study|Death|3|||
44528148|NCT02761642|79538079|FG000|Overall Study|Lack of Efficacy|20|||
44528149|NCT02761642|79538079|FG000|Overall Study|Physician Decision|1|||
44528150|NCT02761642|79538079|FG000|Overall Study|Reason Unspecified|21|||
44528151|NCT00113555|79538083|FG000|Overall Study|Baseline Failure|59|||
44528152|NCT00113555|79538083|FG000|Overall Study|Permanently Explanted|7|||
44528153|NCT00113555|79538083|FG000|Overall Study|Death|1|||
44414751|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
44414752|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
44414753|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
44414754|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
44414755|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
44414756|NCT00455533|79422748|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
44414757|NCT00455533|79422749|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
44414758|NCT00455533|79422750|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
44528154|NCT00113555|79538083|FG000|Overall Study|Missed Followup|4|||
44528155|NCT00113555|79538083|FG000|Overall Study|Lost to Follow-up|8|||
44528156|NCT03189524|79538091|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
44528157|NCT03189524|79538092|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
44528158|NCT03189524|79538093|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
44528159|NCT03189524|79538091|FG000|Overall Study|Death|2|||
44282340|NCT01859988|79245610|FG005|Overall Study|Other than specified above|3|||
44282341|NCT01859598|79245624|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
44282342|NCT01876446|79245632|FG000|Overall Study|Death|0|||
44528160|NCT03189524|79538092|FG001|Overall Study|Death|2|||
44528161|NCT03189524|79538093|FG002|Overall Study|Death|1|||
44528162|NCT03189524|79538091|FG000|Overall Study|Lost to Follow-up|1|||
44528163|NCT03189524|79538092|FG001|Overall Study|Lost to Follow-up|0|||
44528164|NCT03189524|79538093|FG002|Overall Study|Lost to Follow-up|8|||
44528165|NCT03189524|79538091|FG000|Overall Study|Withdrawal by Subject|1|||
44528166|NCT03189524|79538092|FG001|Overall Study|Withdrawal by Subject|1|||
44528167|NCT03189524|79538093|FG002|Overall Study|Withdrawal by Subject|3|||
44528168|NCT03189524|79538091|FG000|Overall Study|Progressive Disease|0|||
44528169|NCT03189524|79538092|FG001|Overall Study|Progressive Disease|2|||
44528170|NCT03189524|79538093|FG002|Overall Study|Progressive Disease|0|||
44528171|NCT03600909|79538108|FG000|Overall Study|Not treated|0|||
44528172|NCT03600909|79538109|FG001|Overall Study|Not treated|3|||
44282343|NCT01876446|79245633|FG001|Overall Study|Death|1|||
44282344|NCT01876446|79245632|FG000|Overall Study|Withdrawal by Subject|1|||
44528173|NCT03600909|79538110|FG002|Overall Study|Not treated|0|||
44528174|NCT03189446|79538118|FG000|Overall Study|Adverse Event|2|||
44528175|NCT03189446|79538118|FG000|Overall Study|Withdrawal by Subject|2|||
44528176|NCT03189446|79538118|FG000|Overall Study|Physician Decision|1|||
44528177|NCT03212690|79538122|FG000|Overall Study|Protocol Violation|1|||
44528178|NCT03188120|79538126|FG000|Overall Study|Adverse Event|4|||
44528179|NCT03188120|79538126|FG000|Overall Study|Insufficient Effectiveness|8|||
44528180|NCT03188120|79538126|FG000|Overall Study|Improved|12|||
44528181|NCT03188120|79538126|FG000|Overall Study|Lost to Follow-up|7|||
44528182|NCT03188120|79538126|FG000|Overall Study|Other than specified|3|||
44528183|NCT03188120|79538126|FG000|Overall Study|No visit after the first visit|13|||
44528184|NCT02895945|79538132|FG000|Overall Study|Physician Decision|2|||
44528185|NCT02895945|79538133|FG001|Overall Study|Physician Decision|1|||
44528186|NCT02777554|79538141|FG000|Overall Study|Adverse Event|4|||
44528187|NCT02777554|79538142|FG001|Overall Study|Adverse Event|4|||
44528188|NCT02777554|79538143|FG002|Overall Study|Adverse Event|0|||
44528189|NCT02777554|79538144|FG003|Overall Study|Adverse Event|1|||
44528190|NCT02777554|79538145|FG004|Overall Study|Adverse Event|0|||
44528191|NCT02777554|79538146|FG005|Overall Study|Adverse Event|0|||
44528192|NCT02777554|79538141|FG000|Overall Study|Withdrawal by Subject|3|||
44528193|NCT02777554|79538142|FG001|Overall Study|Withdrawal by Subject|1|||
44528194|NCT02777554|79538143|FG002|Overall Study|Withdrawal by Subject|1|||
44528195|NCT02777554|79538144|FG003|Overall Study|Withdrawal by Subject|0|||
44528196|NCT02777554|79538145|FG004|Overall Study|Withdrawal by Subject|0|||
44528197|NCT02777554|79538146|FG005|Overall Study|Withdrawal by Subject|0|||
44528198|NCT02777554|79538141|FG000|Overall Study|Discharged early due to hurricane|22|||
44528199|NCT02777554|79538142|FG001|Overall Study|Discharged early due to hurricane|20|||
44528200|NCT02777554|79538143|FG002|Overall Study|Discharged early due to hurricane|0|||
44528201|NCT02777554|79538144|FG003|Overall Study|Discharged early due to hurricane|0|||
44528202|NCT02777554|79538145|FG004|Overall Study|Discharged early due to hurricane|0|||
44528203|NCT02777554|79538146|FG005|Overall Study|Discharged early due to hurricane|0|||
44528204|NCT02777554|79538141|FG000|Overall Study|Other - Miscellaneous|1|||
44528205|NCT02777554|79538142|FG001|Overall Study|Other - Miscellaneous|0|||
44528206|NCT02777554|79538143|FG002|Overall Study|Other - Miscellaneous|0|||
44528207|NCT02777554|79538144|FG003|Overall Study|Other - Miscellaneous|0|||
44528208|NCT02777554|79538145|FG004|Overall Study|Other - Miscellaneous|0|||
44282345|NCT01876446|79245633|FG001|Overall Study|Withdrawal by Subject|2|||
44282346|NCT01876446|79245632|FG000|Overall Study|Physician Decision|1|||
44528209|NCT02777554|79538146|FG005|Overall Study|Other - Miscellaneous|0|||
44528210|NCT03550209|79538170|FG000|Overall Study|Lost to Follow-up|1|||
44528211|NCT03550209|79538171|FG001|Overall Study|Lost to Follow-up|0|||
44528212|NCT03550209|79538172|FG002|Overall Study|Lost to Follow-up|1|||
44528213|NCT03550209|79538173|FG003|Overall Study|Lost to Follow-up|0|||
44528214|NCT03550209|79538170|FG000|Overall Study|Withdrawal by Subject|0|||
44528215|NCT03550209|79538171|FG001|Overall Study|Withdrawal by Subject|3|||
44528216|NCT03550209|79538172|FG002|Overall Study|Withdrawal by Subject|1|||
44528217|NCT03550209|79538173|FG003|Overall Study|Withdrawal by Subject|2|||
44528218|NCT03550209|79538170|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
44528219|NCT03550209|79538171|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
44149123|NCT02151682|78938689|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
44149124|NCT02151682|78938690|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
44149125|NCT02174848|78938710|FG000|Overall Study|Adverse Event|2|||
44149126|NCT02174848|78938711|FG001|Overall Study|Adverse Event|1|||
44149127|NCT02174848|78938710|FG000|Overall Study|Withdrawal by Subject|3|||
44149128|NCT02174848|78938711|FG001|Overall Study|Withdrawal by Subject|3|||
44149129|NCT02174848|78938710|FG000|Overall Study|Lost to Follow-up|0|||
44149130|NCT02174848|78938711|FG001|Overall Study|Lost to Follow-up|1|||
44149131|NCT02174848|78938710|FG000|Overall Study|Worsening of disease|1|||
44149132|NCT02174848|78938711|FG001|Overall Study|Worsening of disease|1|||
44149133|NCT02174848|78938710|FG000|Overall Study|Unable to comply with study requirements|1|||
44149134|NCT02174848|78938711|FG001|Overall Study|Unable to comply with study requirements|0|||
44414759|NCT00455533|79422748|FG000|Period Two: Randomized Period|Death|0|||
44414760|NCT00455533|79422749|FG001|Period Two: Randomized Period|Death|0|||
44414761|NCT00455533|79422750|FG002|Period Two: Randomized Period|Death|3|||
44414762|NCT00455533|79422748|FG000|Period Two: Randomized Period|Disease Progression|0|||
44414763|NCT00455533|79422749|FG001|Period Two: Randomized Period|Disease Progression|1|||
44414764|NCT00455533|79422750|FG002|Period Two: Randomized Period|Disease Progression|1|||
44414765|NCT00455533|79422748|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
44414766|NCT00455533|79422749|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
44414767|NCT00455533|79422750|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
44414768|NCT00455533|79422748|FG000|Period Two: Randomized Period|Other - need reasons|0|||
44414769|NCT00455533|79422749|FG001|Period Two: Randomized Period|Other - need reasons|1|||
44414770|NCT00455533|79422750|FG002|Period Two: Randomized Period|Other - need reasons|0|||
44414771|NCT00455533|79422748|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
44414772|NCT00455533|79422749|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
44414773|NCT00455533|79422750|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
44528220|NCT03550209|79538172|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
44149135|NCT02151058|78938725|FG000|Overall Study|Withdrawal by Subject|1|||
44149136|NCT02151058|78938726|FG001|Overall Study|Withdrawal by Subject|1|||
44149137|NCT02151058|78938727|FG002|Overall Study|Withdrawal by Subject|3|||
44414774|NCT00455533|79422748|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
44528221|NCT03550209|79538173|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
44528222|NCT03032510|79538185|FG000|Overall Study|Adverse Event|5|||
44528223|NCT03032510|79538186|FG001|Overall Study|Adverse Event|2|||
44528224|NCT03032510|79538185|FG000|Overall Study|Lost to Follow-up|8|||
44528225|NCT03032510|79538186|FG001|Overall Study|Lost to Follow-up|7|||
44528226|NCT03032510|79538185|FG000|Overall Study|Withdrawal by Subject|8|||
44528227|NCT03032510|79538186|FG001|Overall Study|Withdrawal by Subject|7|||
44528228|NCT03032510|79538185|FG000|Overall Study|Subject noncompliance|4|||
44528229|NCT03032510|79538186|FG001|Overall Study|Subject noncompliance|2|||
44528230|NCT03032510|79538185|FG000|Overall Study|Physician Decision|2|||
44528231|NCT03032510|79538186|FG001|Overall Study|Physician Decision|0|||
44528232|NCT03599349|79538196|FG000|Overall Study|Lost to Follow-up|1|||
44528233|NCT03599193|79538206|FG000|Overall Study|Adverse Event|0|||
44528234|NCT03599193|79538207|FG001|Overall Study|Adverse Event|2|||
44528235|NCT03599193|79538206|FG000|Overall Study|Withdrawal by Subject|1|||
44528236|NCT03599193|79538207|FG001|Overall Study|Withdrawal by Subject|0|||
44528237|NCT03599193|79538206|FG000|Overall Study|Protocol Violation|1|||
44528238|NCT03599193|79538207|FG001|Overall Study|Protocol Violation|0|||
44528239|NCT03599193|79538206|FG000|Overall Study|Lost to Follow-up|0|||
44528240|NCT03599193|79538207|FG001|Overall Study|Lost to Follow-up|1|||
44528241|NCT03166124|79538216|FG000|Treatment Period 1|Adverse Event|0|||
44528242|NCT03166124|79538217|FG001|Treatment Period 1|Adverse Event|0|||
44528243|NCT03166124|79538218|FG002|Treatment Period 1|Adverse Event|1|||
44528244|NCT03166124|79538219|FG003|Treatment Period 1|Adverse Event|0|||
44528245|NCT03166124|79538216|FG000|Wash-out Period|Withdrawal by Subject|0|||
44528246|NCT03166124|79538217|FG001|Wash-out Period|Withdrawal by Subject|1|||
44528247|NCT03166124|79538218|FG002|Wash-out Period|Withdrawal by Subject|0|||
44528248|NCT03166124|79538219|FG003|Wash-out Period|Withdrawal by Subject|1|||
44528249|NCT03166124|79538216|FG000|Wash-out Period|Adverse Event|0|||
44528250|NCT03166124|79538217|FG001|Wash-out Period|Adverse Event|1|||
44528251|NCT03166124|79538218|FG002|Wash-out Period|Adverse Event|1|||
44528252|NCT03166124|79538219|FG003|Wash-out Period|Adverse Event|0|||
44528253|NCT03567291|79538230|FG000|Period I|Adverse Event|14|||
44528254|NCT03567291|79538231|FG001|Period I|Adverse Event|0|||
44528255|NCT03567291|79538232|FG002|Period I|Adverse Event|0|||
44528256|NCT03567291|79538233|FG003|Period I|Adverse Event|0|||
44528257|NCT03567291|79538230|FG000|Period I|Protocol Violation|1|||
44528258|NCT03567291|79538231|FG001|Period I|Protocol Violation|0|||
44528259|NCT03567291|79538232|FG002|Period I|Protocol Violation|0|||
44528260|NCT03567291|79538233|FG003|Period I|Protocol Violation|0|||
44528261|NCT03567291|79538230|FG000|Period I|Withdrawal by Subject|23|||
44528262|NCT03567291|79538231|FG001|Period I|Withdrawal by Subject|0|||
44528263|NCT03567291|79538232|FG002|Period I|Withdrawal by Subject|0|||
44528264|NCT03567291|79538233|FG003|Period I|Withdrawal by Subject|0|||
44528265|NCT03567291|79538230|FG000|Period I|Lost to Follow-up|2|||
44528266|NCT03567291|79538231|FG001|Period I|Lost to Follow-up|0|||
44528267|NCT03567291|79538232|FG002|Period I|Lost to Follow-up|0|||
44414775|NCT00455533|79422749|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
44414776|NCT00455533|79422750|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
44254471|NCT04178967|79096240|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
44414777|NCT00627094|79422760|FG000|Overall Study|Adverse Event|8|||
44414778|NCT00627094|79422761|FG001|Overall Study|Adverse Event|7|||
44414779|NCT00627094|79422760|FG000|Overall Study|Lost to Follow-up|1|||
44414780|NCT00627094|79422761|FG001|Overall Study|Lost to Follow-up|0|||
44414781|NCT00627094|79422760|FG000|Overall Study|Withdrawal by Subject|1|||
44414782|NCT00627094|79422761|FG001|Overall Study|Withdrawal by Subject|1|||
44414783|NCT00627094|79422760|FG000|Overall Study|ulcer healed|1|||
44414784|NCT00627094|79422761|FG001|Overall Study|ulcer healed|7|||
44414785|NCT00627094|79422760|FG000|Overall Study|Other reason|1|||
44414786|NCT00627094|79422761|FG001|Overall Study|Other reason|0|||
44414787|NCT00642850|79422769|FG000|Overall Study|Death|7|||
44528268|NCT03567291|79538233|FG003|Period I|Lost to Follow-up|0|||
44528269|NCT03567291|79538230|FG000|Period I|Terminated by sponsor|44|||
44528270|NCT03567291|79538231|FG001|Period I|Terminated by sponsor|0|||
44528271|NCT03567291|79538232|FG002|Period I|Terminated by sponsor|0|||
44528272|NCT03567291|79538233|FG003|Period I|Terminated by sponsor|0|||
44528273|NCT03567291|79538230|FG000|Period I|Missing or unknown|7|||
44414788|NCT00642850|79422769|FG000|Overall Study|Adverse Event|2|||
44414789|NCT00642850|79422769|FG000|Overall Study|Lack of Efficacy|1|||
44414790|NCT00642850|79422769|FG000|Overall Study|Protocol Violation|2|||
44414791|NCT00642850|79422769|FG000|Overall Study|Kidney transplantation|8|||
44414792|NCT00642850|79422769|FG000|Overall Study|Blood transfusion|6|||
44528274|NCT03567291|79538231|FG001|Period I|Missing or unknown|0|||
44528275|NCT03567291|79538232|FG002|Period I|Missing or unknown|0|||
44528276|NCT03567291|79538233|FG003|Period I|Missing or unknown|0|||
44528277|NCT03567291|79538230|FG000|Period II|Adverse Event|0|||
44528278|NCT03567291|79538231|FG001|Period II|Adverse Event|1|||
44528279|NCT03567291|79538232|FG002|Period II|Adverse Event|0|||
44528280|NCT03567291|79538233|FG003|Period II|Adverse Event|0|||
44528281|NCT03567291|79538230|FG000|Period II|Missing or unknown|0|||
44528282|NCT03567291|79538231|FG001|Period II|Missing or unknown|2|||
44528283|NCT03567291|79538232|FG002|Period II|Missing or unknown|1|||
44528284|NCT03567291|79538233|FG003|Period II|Missing or unknown|0|||
44528285|NCT03567291|79538230|FG000|Period III|Adverse Event|0|||
44528286|NCT03567291|79538231|FG001|Period III|Adverse Event|0|||
44528287|NCT03567291|79538232|FG002|Period III|Adverse Event|0|||
44528288|NCT03567291|79538233|FG003|Period III|Adverse Event|4|||
44528289|NCT03567291|79538230|FG000|Period III|Withdrawal by Subject|0|||
44528290|NCT03567291|79538231|FG001|Period III|Withdrawal by Subject|0|||
44528291|NCT03567291|79538232|FG002|Period III|Withdrawal by Subject|0|||
44528292|NCT03567291|79538233|FG003|Period III|Withdrawal by Subject|4|||
44528293|NCT03567291|79538230|FG000|Period III|Lost to Follow-up|0|||
44528294|NCT03567291|79538231|FG001|Period III|Lost to Follow-up|0|||
44528295|NCT03567291|79538232|FG002|Period III|Lost to Follow-up|0|||
44528296|NCT03567291|79538233|FG003|Period III|Lost to Follow-up|1|||
44528297|NCT03567291|79538230|FG000|Period III|Terminated by sponsor|0|||
44528298|NCT03567291|79538231|FG001|Period III|Terminated by sponsor|0|||
44528299|NCT03567291|79538232|FG002|Period III|Terminated by sponsor|0|||
44528300|NCT03567291|79538233|FG003|Period III|Terminated by sponsor|68|||
44528301|NCT03567291|79538230|FG000|Period III|Missing or unknown|0|||
44528302|NCT03567291|79538231|FG001|Period III|Missing or unknown|0|||
44528303|NCT03567291|79538232|FG002|Period III|Missing or unknown|0|||
44528304|NCT03567291|79538233|FG003|Period III|Missing or unknown|8|||
44528305|NCT02777242|79538239|FG000|Overall Study|Other|2|||
44528306|NCT02777242|79538239|FG000|Overall Study|Lost to Follow-up|1|||
44528307|NCT02777242|79538239|FG000|Overall Study|Multiple|1|||
44528308|NCT02777242|79538239|FG000|Overall Study|Sponsor's request|1|||
44528309|NCT02777242|79538239|FG000|Overall Study|Withdrawal by Subject|1|||
44528310|NCT03212144|79538245|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
44528311|NCT03212144|79538246|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
44528312|NCT03212144|79538245|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
44528313|NCT03212144|79538246|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
44528314|NCT03566979|79538256|FG000|Overall Study|Withdrawal by Subject|2|||
44528315|NCT03566979|79538257|FG001|Overall Study|Withdrawal by Subject|0|||
44528316|NCT03566979|79538258|FG002|Overall Study|Withdrawal by Subject|1|||
44528317|NCT03566979|79538259|FG003|Overall Study|Withdrawal by Subject|1|||
44528318|NCT03566979|79538256|FG000|Overall Study|Lost to Follow-up|2|||
44528319|NCT03566979|79538257|FG001|Overall Study|Lost to Follow-up|7|||
44528320|NCT03566979|79538258|FG002|Overall Study|Lost to Follow-up|9|||
44528321|NCT03566979|79538259|FG003|Overall Study|Lost to Follow-up|5|||
44528322|NCT03566979|79538256|FG000|Overall Study|Adverse Event|1|||
44528323|NCT03566979|79538257|FG001|Overall Study|Adverse Event|0|||
44528324|NCT03566979|79538258|FG002|Overall Study|Adverse Event|0|||
44528325|NCT03566979|79538259|FG003|Overall Study|Adverse Event|0|||
44528326|NCT00116831|79538271|FG000|Overall Study|Adverse Event|14|||
44528327|NCT00116831|79538272|FG001|Overall Study|Adverse Event|16|||
44528328|NCT00116831|79538271|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
44414793|NCT00642850|79422769|FG000|Overall Study|Other reasons|7|||
44414794|NCT00455455|79422773|FG000|Washout|Withdrawal by Subject|0|||
44414795|NCT00455455|79422774|FG001|Washout|Withdrawal by Subject|1|||
44414796|NCT00455455|79422773|FG000|Washout|Withdrawal by Subject|1|||
44414797|NCT00455455|79422774|FG001|Washout|Withdrawal by Subject|0|||
44414798|NCT03840811|79422786|FG000|Overall Study|Lost to Follow-up|0|||
44414799|NCT03840811|79422787|FG001|Overall Study|Lost to Follow-up|0|||
44414800|NCT03840811|79422788|FG002|Overall Study|Lost to Follow-up|1|||
44414801|NCT00640510|79422798|FG000|Overall Study|Lack of Efficacy|0|||
44528329|NCT00116831|79538272|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
44414802|NCT00640510|79422799|FG001|Overall Study|Lack of Efficacy|1|||
44414803|NCT00640510|79422798|FG000|Overall Study|Protocol Violation|1|||
44528330|NCT00116831|79538271|FG000|Overall Study|Lost to Follow-up|8|||
44528331|NCT00116831|79538272|FG001|Overall Study|Lost to Follow-up|6|||
44528332|NCT00116831|79538271|FG000|Overall Study|Protocol Violation|3|||
44528333|NCT00116831|79538272|FG001|Overall Study|Protocol Violation|6|||
44528334|NCT00116831|79538271|FG000|Overall Study|Hypoglycaemic events|1|||
44528335|NCT00116831|79538272|FG001|Overall Study|Hypoglycaemic events|0|||
44528336|NCT00116831|79538271|FG000|Overall Study|Low haemoglobin on screening|1|||
44528337|NCT00116831|79538272|FG001|Overall Study|Low haemoglobin on screening|0|||
44528338|NCT00116831|79538271|FG000|Overall Study|Withdrawn investigational product|1|||
44528339|NCT00116831|79538272|FG001|Overall Study|Withdrawn investigational product|0|||
44528340|NCT00116831|79538271|FG000|Overall Study|Withdrawal by Subject|32|||
44528341|NCT00116831|79538272|FG001|Overall Study|Withdrawal by Subject|32|||
44414804|NCT00640510|79422799|FG001|Overall Study|Protocol Violation|0|||
44414805|NCT00640510|79422798|FG000|Overall Study|Physician Decision|0|||
44414806|NCT00640510|79422799|FG001|Overall Study|Physician Decision|1|||
44414807|NCT00813800|79422805|FG000|Overall Study|Screen Failure after Consent|2|||
44414808|NCT00813800|79422805|FG000|Overall Study|Adverse Event|1|||
44414809|NCT00813800|79422805|FG000|Overall Study|Worsening of depression|2|||
44528342|NCT00116831|79538271|FG000|Overall Study|Insufficient therapeutic effect|0|||
44528343|NCT00116831|79538272|FG001|Overall Study|Insufficient therapeutic effect|1|||
44528344|NCT00116831|79538271|FG000|Overall Study|Missing data for participant|1|||
44528345|NCT00116831|79538272|FG001|Overall Study|Missing data for participant|0|||
44528346|NCT02777086|79538280|FG000|Overall Study|Lost to Follow-up|96|||
44528347|NCT02777086|79538281|FG001|Overall Study|Lost to Follow-up|99|||
44528348|NCT03549429|79538289|FG000|Overall Study|Protocol Violation|5|||
44528349|NCT03549429|79538290|FG001|Overall Study|Protocol Violation|3|||
44528350|NCT02784704|79538300|FG000|Overall Study|Adverse Event|4|||
44528351|NCT02784704|79538301|FG001|Overall Study|Adverse Event|2|||
44528352|NCT02784704|79538300|FG000|Overall Study|Lost to Follow-up|6|||
44528353|NCT02784704|79538301|FG001|Overall Study|Lost to Follow-up|4|||
44528354|NCT02784704|79538300|FG000|Overall Study|Withdrawal by Subject|1|||
44528355|NCT02784704|79538301|FG001|Overall Study|Withdrawal by Subject|3|||
44528356|NCT02784704|79538300|FG000|Overall Study|Subject Non Compliance|2|||
44528357|NCT02784704|79538301|FG001|Overall Study|Subject Non Compliance|0|||
44528358|NCT03566823|79538312|FG000|Overall Study|Lack of Efficacy|0|||
44528359|NCT03566823|79538313|FG001|Overall Study|Lack of Efficacy|1|||
44528360|NCT03566823|79538314|FG002|Overall Study|Lack of Efficacy|0|||
44528361|NCT03566823|79538312|FG000|Overall Study|Withdrawal by Subject|1|||
44528362|NCT03566823|79538313|FG001|Overall Study|Withdrawal by Subject|2|||
44528363|NCT03566823|79538314|FG002|Overall Study|Withdrawal by Subject|0|||
44528364|NCT03566823|79538312|FG000|Overall Study|Adverse Event|1|||
44528365|NCT03566823|79538313|FG001|Overall Study|Adverse Event|0|||
44528366|NCT03566823|79538314|FG002|Overall Study|Adverse Event|2|||
44528367|NCT03549117|79538324|FG000|Overall Study|Withdrawal by Subject|1|||
44528368|NCT03549117|79538325|FG001|Overall Study|Withdrawal by Subject|0|||
44528369|NCT03183908|79538333|FG000|Overall Study|Missing Symptom Diary Data|0|||
44528370|NCT03183908|79538334|FG001|Overall Study|Missing Symptom Diary Data|2|||
44528371|NCT03565887|79538346|FG000|Overall Study|Adverse Event|1|||
44528372|NCT03565887|79538347|FG001|Overall Study|Adverse Event|0|||
44528373|NCT03565887|79538346|FG000|Overall Study|Withdrawal by Subject|0|||
44528374|NCT03565887|79538347|FG001|Overall Study|Withdrawal by Subject|2|||
44528375|NCT03183518|79538353|FG000|Overall Study|Other (Not specified)|2|||
44528376|NCT03183518|79538353|FG000|Overall Study|Other (Withdrawal of consent)|1|||
44528377|NCT00116753|79538361|FG000|Overall Study|Adverse Event|16|||
44528378|NCT00116753|79538362|FG001|Overall Study|Adverse Event|10|||
44528379|NCT00116753|79538363|FG002|Overall Study|Adverse Event|7|||
44528380|NCT00116753|79538361|FG000|Overall Study|Withdrawal by Subject|11|||
44528381|NCT00116753|79538362|FG001|Overall Study|Withdrawal by Subject|12|||
44528382|NCT00116753|79538363|FG002|Overall Study|Withdrawal by Subject|8|||
44528383|NCT00116753|79538361|FG000|Overall Study|Lost to Follow-up|0|||
44528384|NCT00116753|79538362|FG001|Overall Study|Lost to Follow-up|2|||
44528385|NCT00116753|79538363|FG002|Overall Study|Lost to Follow-up|1|||
44528386|NCT00116753|79538361|FG000|Overall Study|Protocol Violation|0|||
44414810|NCT00813800|79422805|FG000|Overall Study|Physician Decision|1|||
44414811|NCT00627016|79422811|FG000|Overall Study|Adverse Event|1|||
44414812|NCT00627016|79422812|FG001|Overall Study|Adverse Event|1|||
44414813|NCT00627016|79422811|FG000|Overall Study|Protocol Violation|0|||
44414814|NCT00627016|79422812|FG001|Overall Study|Protocol Violation|2|||
44414815|NCT00627016|79422811|FG000|Overall Study|Lost to Follow-up|0|||
44414816|NCT00627016|79422812|FG001|Overall Study|Lost to Follow-up|1|||
44414817|NCT00627016|79422811|FG000|Overall Study|Withdrawal by Subject|2|||
44414818|NCT00627016|79422812|FG001|Overall Study|Withdrawal by Subject|1|||
44414819|NCT00627016|79422811|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
44414820|NCT00627016|79422812|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
44414821|NCT00627016|79422811|FG000|Overall Study|Lack of Efficacy|1|||
44414822|NCT00627016|79422812|FG001|Overall Study|Lack of Efficacy|0|||
44414823|NCT00627016|79422811|FG000|Overall Study|Placed on Excluded Drugs|1|||
44414824|NCT00627016|79422812|FG001|Overall Study|Placed on Excluded Drugs|0|||
44414825|NCT00627016|79422811|FG000|Overall Study|Pregnancy|1|||
44414826|NCT00627016|79422812|FG001|Overall Study|Pregnancy|0|||
44414827|NCT00794664|79422820|FG000|Treatment Period|Withdrawal by Subject|0|||
44414828|NCT00794664|79422821|FG001|Treatment Period|Withdrawal by Subject|2|||
44414829|NCT00794664|79422820|FG000|Treatment Period|Protocol non-compliance|0|||
44414830|NCT00794664|79422821|FG001|Treatment Period|Protocol non-compliance|1|||
44528387|NCT00116753|79538362|FG001|Overall Study|Protocol Violation|0|||
44528388|NCT00116753|79538363|FG002|Overall Study|Protocol Violation|1|||
44528389|NCT00116753|79538361|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
44528390|NCT00116753|79538362|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
44528391|NCT00116753|79538363|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
44414831|NCT00794664|79422820|FG000|Treatment Period|Other|0|||
44528392|NCT00116753|79538361|FG000|Overall Study|Disease Progression|3|||
44528393|NCT00116753|79538362|FG001|Overall Study|Disease Progression|4|||
44414832|NCT00794664|79422821|FG001|Treatment Period|Other|1|||
44414833|NCT00794664|79422820|FG000|Treatment Period|Adverse Event|1|||
44414834|NCT00794664|79422821|FG001|Treatment Period|Adverse Event|8|||
44414835|NCT00794664|79422820|FG000|Follow-up Period|Other|1|||
44528394|NCT00116753|79538363|FG002|Overall Study|Disease Progression|3|||
44414836|NCT00794664|79422821|FG001|Follow-up Period|Other|2|||
44414837|NCT00794664|79422820|FG000|Follow-up Period|Withdrawal by Subject|0|||
44414838|NCT00794664|79422821|FG001|Follow-up Period|Withdrawal by Subject|2|||
44414839|NCT00794664|79422820|FG000|Follow-up Period|Protocol non-compliance|0|||
44414840|NCT00794664|79422821|FG001|Follow-up Period|Protocol non-compliance|1|||
44414841|NCT00444535|79422827|FG000|Overall Study|Withdrawal by Subject|5|||
44414842|NCT00444535|79422827|FG000|Overall Study|Physician Decision|5|||
44414843|NCT00444535|79422827|FG000|Overall Study|progressive disease|1|||
44414844|NCT00444535|79422827|FG000|Overall Study|Adverse Event|2|||
44528395|NCT00116753|79538361|FG000|Overall Study|Abnormal Echocardiogram|0|||
44528396|NCT00116753|79538362|FG001|Overall Study|Abnormal Echocardiogram|0|||
44528397|NCT00116753|79538363|FG002|Overall Study|Abnormal Echocardiogram|1|||
44528398|NCT00116753|79538361|FG000|Overall Study|Progressive Parkinson's Disease|1|||
44528399|NCT00116753|79538362|FG001|Overall Study|Progressive Parkinson's Disease|0|||
44528400|NCT00116753|79538363|FG002|Overall Study|Progressive Parkinson's Disease|0|||
44528401|NCT00116753|79538361|FG000|Overall Study|Dosing Error|0|||
44528402|NCT00116753|79538362|FG001|Overall Study|Dosing Error|1|||
44528403|NCT00116753|79538363|FG002|Overall Study|Dosing Error|0|||
44528404|NCT00113399|79538373|FG000|Overall Study|Death|1|||
44528405|NCT00113399|79538374|FG001|Overall Study|Death|1|||
44282347|NCT01876446|79245633|FG001|Overall Study|Physician Decision|3|||
44282348|NCT01900626|79245641|FG000|Overall Study|study was closed due to low enrollment|1|||
44282349|NCT01900626|79245642|FG001|Overall Study|study was closed due to low enrollment|1|||
44282350|NCT01900314|79245652|FG000|Overall Study|Lost to Follow-up|1|||
44282351|NCT01900314|79245653|FG001|Overall Study|Lost to Follow-up|0|||
44282352|NCT01900314|79245652|FG000|Overall Study|Protocol Violation|0|||
44282353|NCT01900314|79245653|FG001|Overall Study|Protocol Violation|1|||
44282354|NCT01900314|79245652|FG000|Overall Study|Withdrawal by Subject|3|||
44282355|NCT01900314|79245653|FG001|Overall Study|Withdrawal by Subject|3|||
44282356|NCT01899768|79245660|FG000|Part A|Adverse Event|2|||
44282357|NCT01899768|79245660|FG000|Part A|Withdrawal by Subject|1|||
44282358|NCT01899768|79245660|FG000|Part B|Adverse Event|1|||
44282359|NCT01899768|79245660|FG000|Part B|Withdrawal by Subject|1|||
44282360|NCT01898598|79245670|FG000|Overall Study|Adverse Event|1|||
44282361|NCT01898598|79245671|FG001|Overall Study|Adverse Event|0|||
44282362|NCT01898598|79245670|FG000|Overall Study|Withdrawal by Subject|3|||
44282363|NCT01898598|79245671|FG001|Overall Study|Withdrawal by Subject|0|||
44282364|NCT01898598|79245670|FG000|Overall Study|Lost to Follow-up|0|||
44282365|NCT01898598|79245671|FG001|Overall Study|Lost to Follow-up|1|||
44282366|NCT01898598|79245670|FG000|Overall Study|Other|0|||
44282367|NCT01898598|79245671|FG001|Overall Study|Other|1|||
44282368|NCT01898442|79245680|FG000|Overall Study|Hemolysis/technical problems|1|||
44282369|NCT01898442|79245681|FG001|Overall Study|Hemolysis/technical problems|2|||
44282370|NCT01898442|79245682|FG002|Overall Study|Hemolysis/technical problems|2|||
44282371|NCT01898442|79245680|FG000|Overall Study|Patient vomited pills|0|||
44282372|NCT01898442|79245681|FG001|Overall Study|Patient vomited pills|0|||
44282373|NCT01898442|79245682|FG002|Overall Study|Patient vomited pills|1|||
44414845|NCT00847613|79422835|FG000|Overall Study|Ongoing at cut-off date|250|||
44414846|NCT00847613|79422836|FG001|Overall Study|Ongoing at cut-off date|265|||
44414847|NCT00847613|79422837|FG002|Overall Study|Ongoing at cut-off date|64|||
44414848|NCT00847613|79422838|FG003|Overall Study|Ongoing at cut-off date|64|||
44414849|NCT00847613|79422835|FG000|Overall Study|Death|1|||
44414850|NCT00847613|79422836|FG001|Overall Study|Death|1|||
44414851|NCT00847613|79422837|FG002|Overall Study|Death|0|||
44414852|NCT00847613|79422838|FG003|Overall Study|Death|0|||
44414853|NCT00847613|79422835|FG000|Overall Study|Adverse Event|36|||
44414854|NCT00847613|79422836|FG001|Overall Study|Adverse Event|26|||
44414855|NCT00847613|79422837|FG002|Overall Study|Adverse Event|5|||
44414856|NCT00847613|79422838|FG003|Overall Study|Adverse Event|6|||
44414857|NCT00847613|79422835|FG000|Overall Study|Lack of Efficacy|7|||
44414858|NCT00847613|79422836|FG001|Overall Study|Lack of Efficacy|3|||
44282374|NCT01898286|79245690|FG000|Overall Study|Withdrawal by Subject|1|||
44282375|NCT01898286|79245690|FG000|Overall Study|Protocol Violation|1|||
44282376|NCT01898286|79245690|FG000|Overall Study|Lost to Follow-up|1|||
44414859|NCT00847613|79422837|FG002|Overall Study|Lack of Efficacy|3|||
44414860|NCT00847613|79422838|FG003|Overall Study|Lack of Efficacy|1|||
44414861|NCT00847613|79422835|FG000|Overall Study|Study terminated by Sponsor|1|||
44282377|NCT01898208|79245697|FG000|Overall Study|Positive blood culture|17|||
44282378|NCT01898208|79245698|FG001|Overall Study|Positive blood culture|23|||
44282379|NCT01898208|79245699|FG002|Overall Study|Positive blood culture|15|||
44414862|NCT00847613|79422836|FG001|Overall Study|Study terminated by Sponsor|0|||
44254472|NCT04178967|79096241|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254473|NCT04178967|79096242|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254474|NCT04178967|79096243|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254475|NCT04178967|79096244|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254476|NCT04178967|79096245|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254477|NCT04178967|79096246|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
44254478|NCT04178967|79096247|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
44254479|NCT04178967|79096248|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
44254480|NCT04178967|79096238|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254481|NCT04178967|79096239|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254482|NCT04178967|79096240|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254483|NCT04178967|79096241|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254484|NCT04178967|79096242|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254485|NCT04178967|79096243|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254486|NCT04178967|79096244|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254487|NCT04178967|79096245|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
44254488|NCT04178967|79096246|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
44254489|NCT04178967|79096247|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
44254490|NCT04178967|79096248|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
44254491|NCT04178967|79096238|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254492|NCT04178967|79096239|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254493|NCT04178967|79096240|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44528406|NCT00113399|79538373|FG000|Overall Study|Withdrawal by Subject|1|||
44528407|NCT00113399|79538374|FG001|Overall Study|Withdrawal by Subject|2|||
44414863|NCT00847613|79422837|FG002|Overall Study|Study terminated by Sponsor|2|||
44528408|NCT00113399|79538373|FG000|Overall Study|Complete Response|0|||
44528409|NCT00113399|79538374|FG001|Overall Study|Complete Response|1|||
44528410|NCT00113399|79538373|FG000|Overall Study|Other|0|||
44528411|NCT00113399|79538374|FG001|Overall Study|Other|1|||
44528412|NCT00113087|79538382|FG000|Overall Study|Death or Transplant|14|||
44528413|NCT00113087|79538383|FG001|Overall Study|Death or Transplant|16|||
44528414|NCT00113087|79538382|FG000|Overall Study|Family or MD withdrew subject|10|||
44528415|NCT00113087|79538383|FG001|Overall Study|Family or MD withdrew subject|5|||
44528416|NCT00112463|79538389|FG000|Overall Study|Physician Decision|1|||
44528417|NCT00112463|79538389|FG000|Overall Study|Progression|30|||
44528418|NCT00112463|79538389|FG000|Overall Study|Second Primary|1|||
44414864|NCT00847613|79422838|FG003|Overall Study|Study terminated by Sponsor|1|||
44414865|NCT00847613|79422835|FG000|Overall Study|Lost to Follow-up|5|||
44414866|NCT00847613|79422836|FG001|Overall Study|Lost to Follow-up|0|||
44414867|NCT00847613|79422837|FG002|Overall Study|Lost to Follow-up|0|||
44528419|NCT00112463|79538389|FG000|Overall Study|Toxicity|3|||
44414868|NCT00847613|79422838|FG003|Overall Study|Lost to Follow-up|3|||
44414869|NCT00847613|79422835|FG000|Overall Study|Protocol Violation|6|||
44254494|NCT04178967|79096241|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254495|NCT04178967|79096242|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44528420|NCT00112463|79538389|FG000|Overall Study|Withdrawal by Subject|2|||
44528421|NCT00112463|79538389|FG000|Overall Study|Never started treatment|2|||
44149138|NCT02151058|78938725|FG000|Overall Study|Lost to Follow-up|1|||
44254496|NCT04178967|79096243|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254497|NCT04178967|79096244|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254498|NCT04178967|79096245|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254499|NCT04178967|79096246|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44528422|NCT03548415|79538399|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
44414870|NCT00847613|79422836|FG001|Overall Study|Protocol Violation|6|||
44414871|NCT00847613|79422837|FG002|Overall Study|Protocol Violation|3|||
44414872|NCT00847613|79422838|FG003|Overall Study|Protocol Violation|1|||
44414873|NCT00847613|79422835|FG000|Overall Study|Pregnancy|1|||
44528423|NCT03548415|79538400|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
44528424|NCT03548415|79538401|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
44528425|NCT03548415|79538402|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
44528426|NCT03548415|79538403|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
44528427|NCT00112385|79538419|FG000|Overall Study|Lost to Follow-up|1|||
44528428|NCT00112385|79538420|FG001|Overall Study|Lost to Follow-up|0|||
44528429|NCT00112385|79538419|FG000|Overall Study|Withdrawal by Subject|0|||
44528430|NCT00112385|79538420|FG001|Overall Study|Withdrawal by Subject|1|||
44528431|NCT03548337|79538428|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
44528432|NCT03548337|79538429|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
44528433|NCT03548337|79538428|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
44528434|NCT03548337|79538429|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
44528435|NCT03548337|79538428|FG000|Infant Series|Lost to Follow-up|2|||
44528436|NCT03548337|79538429|FG001|Infant Series|Lost to Follow-up|1|||
44528437|NCT03548337|79538428|FG000|Infant Series|Adverse Event|0|||
44528438|NCT03548337|79538429|FG001|Infant Series|Adverse Event|2|||
44528439|NCT03548337|79538428|FG000|Infant Series|Randomized but Not Vaccinated|1|||
44528440|NCT03548337|79538429|FG001|Infant Series|Randomized but Not Vaccinated|0|||
44528441|NCT03548337|79538428|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
44528442|NCT03548337|79538429|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
44528443|NCT03596151|79538441|FG000|Overall Study|Withdrawal by Subject|1|||
44528444|NCT03547635|79538448|FG000|Overall Study|Adverse Event|5|||
44528445|NCT03547635|79538449|FG001|Overall Study|Adverse Event|2|||
44528446|NCT03547635|79538450|FG002|Overall Study|Adverse Event|3|||
44528447|NCT03547635|79538448|FG000|Overall Study|Lost to Follow-up|1|||
44528448|NCT03547635|79538449|FG001|Overall Study|Lost to Follow-up|3|||
44528449|NCT03547635|79538450|FG002|Overall Study|Lost to Follow-up|4|||
44528450|NCT03547635|79538448|FG000|Overall Study|Withdrawal by Subject|1|||
44528451|NCT03547635|79538449|FG001|Overall Study|Withdrawal by Subject|0|||
44528452|NCT03547635|79538450|FG002|Overall Study|Withdrawal by Subject|0|||
44528453|NCT03547635|79538448|FG000|Overall Study|Withdrawal By PI|0|||
44528454|NCT03547635|79538449|FG001|Overall Study|Withdrawal By PI|1|||
44528455|NCT03547635|79538450|FG002|Overall Study|Withdrawal By PI|0|||
44528456|NCT03547635|79538448|FG000|Overall Study|Withdrawal by Sponsor|0|||
44528457|NCT03547635|79538449|FG001|Overall Study|Withdrawal by Sponsor|0|||
44528458|NCT03547635|79538450|FG002|Overall Study|Withdrawal by Sponsor|1|||
44528459|NCT03547635|79538448|FG000|Overall Study|Errant Randomization before Treatment|0|||
44528460|NCT03547635|79538449|FG001|Overall Study|Errant Randomization before Treatment|1|||
44528461|NCT03547635|79538450|FG002|Overall Study|Errant Randomization before Treatment|0|||
44528462|NCT03547635|79538448|FG000|Overall Study|Withdrawal by Subject|1|||
44149139|NCT02151058|78938726|FG001|Overall Study|Lost to Follow-up|0|||
44149140|NCT02151058|78938727|FG002|Overall Study|Lost to Follow-up|2|||
44149141|NCT02149810|78938737|FG000|Overall Study|Physician Decision|1|||
44254500|NCT04178967|79096247|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
44149142|NCT02149810|78938738|FG001|Overall Study|Physician Decision|2|||
44414874|NCT00847613|79422836|FG001|Overall Study|Pregnancy|1|||
44528463|NCT03547635|79538449|FG001|Overall Study|Withdrawal by Subject|0|||
44528464|NCT03547635|79538450|FG002|Overall Study|Withdrawal by Subject|0|||
44528465|NCT03182738|79538504|FG000|Overall Study|Lost to Follow-up|9|||
44528466|NCT03182738|79538505|FG001|Overall Study|Lost to Follow-up|3|||
44528467|NCT03182738|79538504|FG000|Overall Study|Pregnancy|0|||
44528468|NCT03182738|79538505|FG001|Overall Study|Pregnancy|1|||
44528469|NCT03182738|79538504|FG000|Overall Study|Withdrawal by Subject|0|||
44528470|NCT03182738|79538505|FG001|Overall Study|Withdrawal by Subject|1|||
44528471|NCT03547167|79538513|FG000|Overall Study|Withdrawal by Subject|34|||
44528472|NCT03547167|79538514|FG001|Overall Study|Withdrawal by Subject|12|||
44528473|NCT03547167|79538513|FG000|Overall Study|Screen Failure|0|||
44528474|NCT03547167|79538514|FG001|Overall Study|Screen Failure|1|||
44528475|NCT03547167|79538513|FG000|Overall Study|Lost to Follow-up|59|||
44528476|NCT03547167|79538514|FG001|Overall Study|Lost to Follow-up|15|||
44528477|NCT03547167|79538513|FG000|Overall Study|Death|4|||
44528478|NCT03547167|79538514|FG001|Overall Study|Death|2|||
44528479|NCT03560739|79538528|FG000|Overall Study|Adverse Event|0|||
44528480|NCT03560739|79538529|FG001|Overall Study|Adverse Event|1|||
44528481|NCT03560739|79538530|FG002|Overall Study|Adverse Event|0|||
44528482|NCT03560739|79538531|FG003|Overall Study|Adverse Event|0|||
44528483|NCT00101686|79538551|FG000|Overall Study|Progressive Disease|37|||
44528484|NCT00101686|79538552|FG001|Overall Study|Progressive Disease|28|||
44528485|NCT00101686|79538553|FG002|Overall Study|Progressive Disease|37|||
44528486|NCT00101686|79538554|FG003|Overall Study|Progressive Disease|38|||
44528487|NCT00101686|79538555|FG004|Overall Study|Progressive Disease|28|||
44528488|NCT00101686|79538556|FG005|Overall Study|Progressive Disease|25|||
44528489|NCT00101686|79538557|FG006|Overall Study|Progressive Disease|5|||
44528490|NCT00101686|79538558|FG007|Overall Study|Progressive Disease|7|||
44528491|NCT00101686|79538559|FG008|Overall Study|Progressive Disease|10|||
44528492|NCT00101686|79538560|FG009|Overall Study|Progressive Disease|8|||
44528493|NCT00101686|79538551|FG000|Overall Study|initiation other anti-cancer treatment|4|||
44528494|NCT00101686|79538552|FG001|Overall Study|initiation other anti-cancer treatment|3|||
44528495|NCT00101686|79538553|FG002|Overall Study|initiation other anti-cancer treatment|4|||
44528496|NCT00101686|79538554|FG003|Overall Study|initiation other anti-cancer treatment|3|||
44528497|NCT00101686|79538555|FG004|Overall Study|initiation other anti-cancer treatment|1|||
44528498|NCT00101686|79538556|FG005|Overall Study|initiation other anti-cancer treatment|1|||
44528499|NCT00101686|79538557|FG006|Overall Study|initiation other anti-cancer treatment|2|||
44528500|NCT00101686|79538558|FG007|Overall Study|initiation other anti-cancer treatment|2|||
44528501|NCT00101686|79538559|FG008|Overall Study|initiation other anti-cancer treatment|3|||
44528502|NCT00101686|79538560|FG009|Overall Study|initiation other anti-cancer treatment|3|||
44528503|NCT00101686|79538551|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
44528504|NCT00101686|79538552|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
44528505|NCT00101686|79538553|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
44528506|NCT00101686|79538554|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
44528507|NCT00101686|79538555|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
44528508|NCT00101686|79538556|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
44528509|NCT00101686|79538557|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
44528510|NCT00101686|79538558|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
44528511|NCT00101686|79538559|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
44528512|NCT00101686|79538560|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
44528513|NCT00101686|79538551|FG000|Overall Study|unacceptable toxicity|3|||
44528514|NCT00101686|79538552|FG001|Overall Study|unacceptable toxicity|9|||
44528515|NCT00101686|79538553|FG002|Overall Study|unacceptable toxicity|10|||
44149143|NCT02149810|78938737|FG000|Overall Study|Lost to Follow-up|2|||
44149144|NCT02149810|78938738|FG001|Overall Study|Lost to Follow-up|1|||
44149145|NCT02149810|78938737|FG000|Overall Study|Withdrawal by Subject|5|||
44149146|NCT02149810|78938738|FG001|Overall Study|Withdrawal by Subject|1|||
44149147|NCT02149420|78938747|FG000|Core Study|Administrative problems|0|||
44149148|NCT02149420|78938748|FG001|Core Study|Administrative problems|1|||
44149149|NCT02149420|78938749|FG002|Core Study|Administrative problems|2|||
44149150|NCT02149420|78938747|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
44528516|NCT00101686|79538554|FG003|Overall Study|unacceptable toxicity|6|||
44528517|NCT00101686|79538555|FG004|Overall Study|unacceptable toxicity|16|||
44528518|NCT00101686|79538556|FG005|Overall Study|unacceptable toxicity|10|||
44528519|NCT00101686|79538557|FG006|Overall Study|unacceptable toxicity|4|||
44149151|NCT02149420|78938748|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
44528520|NCT00101686|79538558|FG007|Overall Study|unacceptable toxicity|2|||
44528521|NCT00101686|79538559|FG008|Overall Study|unacceptable toxicity|1|||
44149152|NCT02149420|78938749|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
44149153|NCT02149264|78938762|FG000|Overall Study|Withdrawal by Subject|9|||
44528522|NCT00101686|79538560|FG009|Overall Study|unacceptable toxicity|4|||
44528523|NCT00101686|79538551|FG000|Overall Study|Randomized but did not receive treament|1|||
44528524|NCT00101686|79538552|FG001|Overall Study|Randomized but did not receive treament|6|||
44149154|NCT02149264|78938762|FG000|Overall Study|Adverse Event|7|||
44149155|NCT02149264|78938762|FG000|Overall Study|Physician Decision|3|||
44528525|NCT00101686|79538553|FG002|Overall Study|Randomized but did not receive treament|2|||
44528526|NCT00101686|79538554|FG003|Overall Study|Randomized but did not receive treament|2|||
44528527|NCT00101686|79538555|FG004|Overall Study|Randomized but did not receive treament|2|||
44528528|NCT00101686|79538556|FG005|Overall Study|Randomized but did not receive treament|2|||
44528529|NCT00101686|79538557|FG006|Overall Study|Randomized but did not receive treament|0|||
44528530|NCT00101686|79538558|FG007|Overall Study|Randomized but did not receive treament|1|||
44528531|NCT00101686|79538559|FG008|Overall Study|Randomized but did not receive treament|0|||
44528532|NCT00101686|79538560|FG009|Overall Study|Randomized but did not receive treament|1|||
44528533|NCT00101686|79538551|FG000|Overall Study|intercurrent non-cancer related illness|0|||
44528534|NCT00101686|79538552|FG001|Overall Study|intercurrent non-cancer related illness|0|||
44528535|NCT00101686|79538553|FG002|Overall Study|intercurrent non-cancer related illness|2|||
44528536|NCT00101686|79538554|FG003|Overall Study|intercurrent non-cancer related illness|0|||
44528537|NCT00101686|79538555|FG004|Overall Study|intercurrent non-cancer related illness|1|||
44528538|NCT00101686|79538556|FG005|Overall Study|intercurrent non-cancer related illness|3|||
44528539|NCT00101686|79538557|FG006|Overall Study|intercurrent non-cancer related illness|1|||
44528540|NCT00101686|79538558|FG007|Overall Study|intercurrent non-cancer related illness|0|||
44528541|NCT00101686|79538559|FG008|Overall Study|intercurrent non-cancer related illness|1|||
44528542|NCT00101686|79538560|FG009|Overall Study|intercurrent non-cancer related illness|1|||
44528543|NCT00101686|79538551|FG000|Overall Study|Physician Decision|10|||
44528544|NCT00101686|79538552|FG001|Overall Study|Physician Decision|13|||
44528545|NCT00101686|79538553|FG002|Overall Study|Physician Decision|6|||
44528546|NCT00101686|79538554|FG003|Overall Study|Physician Decision|7|||
44528547|NCT00101686|79538555|FG004|Overall Study|Physician Decision|8|||
44528548|NCT00101686|79538556|FG005|Overall Study|Physician Decision|9|||
44528549|NCT00101686|79538557|FG006|Overall Study|Physician Decision|5|||
44528550|NCT00101686|79538558|FG007|Overall Study|Physician Decision|5|||
44528551|NCT00101686|79538559|FG008|Overall Study|Physician Decision|1|||
44528552|NCT00101686|79538560|FG009|Overall Study|Physician Decision|1|||
44528553|NCT00101686|79538551|FG000|Overall Study|Other|1|||
44528554|NCT00101686|79538552|FG001|Overall Study|Other|4|||
44528555|NCT00101686|79538553|FG002|Overall Study|Other|1|||
44528556|NCT00101686|79538554|FG003|Overall Study|Other|6|||
44528557|NCT00101686|79538555|FG004|Overall Study|Other|2|||
44528558|NCT00101686|79538556|FG005|Overall Study|Other|12|||
44528559|NCT00101686|79538557|FG006|Overall Study|Other|1|||
44528560|NCT00101686|79538558|FG007|Overall Study|Other|5|||
44528561|NCT00101686|79538559|FG008|Overall Study|Other|3|||
44528562|NCT00101686|79538560|FG009|Overall Study|Other|3|||
44528563|NCT00101686|79538551|FG000|Overall Study|Withdrawal by Subject|9|||
44528564|NCT00101686|79538552|FG001|Overall Study|Withdrawal by Subject|8|||
44528565|NCT00101686|79538553|FG002|Overall Study|Withdrawal by Subject|6|||
44528566|NCT00101686|79538554|FG003|Overall Study|Withdrawal by Subject|8|||
44528567|NCT00101686|79538555|FG004|Overall Study|Withdrawal by Subject|8|||
44528568|NCT00101686|79538556|FG005|Overall Study|Withdrawal by Subject|7|||
44528569|NCT00101686|79538557|FG006|Overall Study|Withdrawal by Subject|7|||
44528570|NCT00101686|79538558|FG007|Overall Study|Withdrawal by Subject|7|||
44528571|NCT00101686|79538559|FG008|Overall Study|Withdrawal by Subject|8|||
44528572|NCT00101686|79538560|FG009|Overall Study|Withdrawal by Subject|9|||
44528573|NCT00101452|79538580|FG000|Overall Study|Adverse Event|2|||
44528574|NCT00101452|79538581|FG001|Overall Study|Adverse Event|0|||
44528575|NCT00101452|79538582|FG002|Overall Study|Adverse Event|1|||
44528576|NCT00101452|79538580|FG000|Overall Study|Lost to Follow-up|13|||
44528577|NCT00101452|79538581|FG001|Overall Study|Lost to Follow-up|8|||
44528578|NCT00101452|79538582|FG002|Overall Study|Lost to Follow-up|14|||
44528579|NCT00101452|79538580|FG000|Overall Study|Withdrawal by Subject|10|||
44528580|NCT00101452|79538581|FG001|Overall Study|Withdrawal by Subject|14|||
44528581|NCT00101452|79538582|FG002|Overall Study|Withdrawal by Subject|9|||
44528582|NCT00101452|79538580|FG000|Overall Study|Baseline Fail|2|||
44528583|NCT00101452|79538581|FG001|Overall Study|Baseline Fail|1|||
44528584|NCT00101452|79538582|FG002|Overall Study|Baseline Fail|2|||
44254501|NCT04178967|79096248|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
44254502|NCT04178967|79096238|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44254503|NCT04178967|79096239|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44528585|NCT00101452|79538580|FG000|Overall Study|Physician Decision|0|||
44528586|NCT00101452|79538581|FG001|Overall Study|Physician Decision|3|||
44528587|NCT00101452|79538582|FG002|Overall Study|Physician Decision|2|||
44528588|NCT00101452|79538580|FG000|Overall Study|Protocol Violation|2|||
44528589|NCT00101452|79538581|FG001|Overall Study|Protocol Violation|1|||
44528590|NCT00101452|79538582|FG002|Overall Study|Protocol Violation|3|||
44528591|NCT00101452|79538580|FG000|Overall Study|Other|15|||
44528592|NCT00101452|79538581|FG001|Overall Study|Other|16|||
44528593|NCT00101452|79538582|FG002|Overall Study|Other|12|||
44528594|NCT03546621|79538598|FG000|Overall Study|Withdrawal by Subject|0|||
44528595|NCT03546621|79538599|FG001|Overall Study|Withdrawal by Subject|1|||
44254504|NCT04178967|79096240|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44528596|NCT03546621|79538600|FG002|Overall Study|Withdrawal by Subject|2|||
44528597|NCT03546621|79538601|FG003|Overall Study|Withdrawal by Subject|1|||
44528598|NCT03546621|79538598|FG000|Overall Study|Lost to Follow-up|0|||
44528599|NCT03546621|79538599|FG001|Overall Study|Lost to Follow-up|1|||
44528600|NCT03546621|79538600|FG002|Overall Study|Lost to Follow-up|0|||
44528601|NCT03546621|79538601|FG003|Overall Study|Lost to Follow-up|0|||
44528602|NCT03546621|79538598|FG000|Overall Study|Adverse Event|0|||
44528603|NCT03546621|79538599|FG001|Overall Study|Adverse Event|1|||
44528604|NCT03546621|79538600|FG002|Overall Study|Adverse Event|0|||
44528605|NCT03546621|79538601|FG003|Overall Study|Adverse Event|1|||
44528606|NCT03546621|79538598|FG000|Overall Study|Progressive disease|0|||
44528607|NCT03546621|79538599|FG001|Overall Study|Progressive disease|0|||
44528608|NCT03546621|79538600|FG002|Overall Study|Progressive disease|0|||
44528609|NCT03546621|79538601|FG003|Overall Study|Progressive disease|1|||
44528610|NCT02761330|79538611|FG000|Treatment Week 1|Withdrawal by Subject|0|||
44528611|NCT02761330|79538612|FG001|Treatment Week 1|Withdrawal by Subject|0|||
44528612|NCT02761330|79538613|FG002|Treatment Week 1|Withdrawal by Subject|0|||
44528613|NCT02761330|79538614|FG003|Treatment Week 1|Withdrawal by Subject|1|||
44528614|NCT02761330|79538615|FG004|Treatment Week 1|Withdrawal by Subject|0|||
44528615|NCT02761330|79538616|FG005|Treatment Week 1|Withdrawal by Subject|1|||
44528616|NCT03559257|79538632|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
44528617|NCT03559257|79538633|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
44528618|NCT03559257|79538632|FG000|Double Blind Treatment Period|Protocol Violation|1|||
44528619|NCT03559257|79538633|FG001|Double Blind Treatment Period|Protocol Violation|4|||
44528620|NCT03559257|79538632|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
44528621|NCT03559257|79538633|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
44528622|NCT03559257|79538632|FG000|Double Blind Treatment Period|Adverse Event|0|||
44528623|NCT03559257|79538633|FG001|Double Blind Treatment Period|Adverse Event|1|||
44528624|NCT03559257|79538632|FG000|Double Blind Treatment Period|Screen Failure|0|||
44528625|NCT03559257|79538633|FG001|Double Blind Treatment Period|Screen Failure|1|||
44528626|NCT03559257|79538632|FG000|Open-label Treatment Period|Adverse Event|1|||
44528627|NCT03559257|79538633|FG001|Open-label Treatment Period|Adverse Event|4|||
44528628|NCT03559257|79538632|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
44528629|NCT03559257|79538633|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
44528630|NCT03559257|79538632|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
44528631|NCT03559257|79538633|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
44528632|NCT03559257|79538632|FG000|Open-label Treatment Period|Protocol Violation|2|||
44528633|NCT03559257|79538633|FG001|Open-label Treatment Period|Protocol Violation|0|||
44528634|NCT03559257|79538632|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
44528635|NCT03559257|79538633|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
44528636|NCT03559257|79538632|FG000|Open-label Treatment Period|Physician Decision|0|||
44528637|NCT03559257|79538633|FG001|Open-label Treatment Period|Physician Decision|1|||
44528638|NCT02892513|79538644|FG000|Overall Study|Withdrawal by Subject|0|||
44528639|NCT02892513|79538645|FG001|Overall Study|Withdrawal by Subject|1|||
44528640|NCT03558555|79538653|FG000|Overall Study|Lost to Follow-up|2|||
44528641|NCT03558555|79538654|FG001|Overall Study|Lost to Follow-up|1|||
44528642|NCT03541317|79538662|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
44528643|NCT03541317|79538663|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
44528644|NCT03541317|79538664|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
44528645|NCT03541317|79538665|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
44528646|NCT03541317|79538666|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
44528647|NCT03541317|79538667|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
44528648|NCT03557931|79538682|FG000|Overall Study|Adverse Event|4|||
44528649|NCT03557931|79538683|FG001|Overall Study|Adverse Event|6|||
44528650|NCT03557931|79538684|FG002|Overall Study|Adverse Event|1|||
44528651|NCT03557931|79538682|FG000|Overall Study|Lost to Follow-up|4|||
44254505|NCT04178967|79096241|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44254506|NCT04178967|79096242|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44254507|NCT04178967|79096243|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44254508|NCT04178967|79096244|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44254509|NCT04178967|79096245|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
44254510|NCT04178967|79096246|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
44254511|NCT04178967|79096247|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
44254512|NCT04178967|79096248|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
44254513|NCT04178967|79096238|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44254514|NCT04178967|79096239|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44254515|NCT04178967|79096240|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44282380|NCT01898208|79245697|FG000|Overall Study|Death/comfort care within 24 hours|10|||
44414875|NCT00847613|79422837|FG002|Overall Study|Pregnancy|0|||
44528652|NCT03557931|79538683|FG001|Overall Study|Lost to Follow-up|4|||
44528653|NCT03557931|79538684|FG002|Overall Study|Lost to Follow-up|1|||
44528654|NCT03557931|79538682|FG000|Overall Study|Protocol Violation|1|||
44528655|NCT03557931|79538683|FG001|Overall Study|Protocol Violation|4|||
44528656|NCT03557931|79538684|FG002|Overall Study|Protocol Violation|1|||
44528657|NCT03557931|79538682|FG000|Overall Study|Withdrawal by Subject|14|||
44528658|NCT03557931|79538683|FG001|Overall Study|Withdrawal by Subject|0|||
44528659|NCT03557931|79538684|FG002|Overall Study|Withdrawal by Subject|7|||
44528660|NCT03557931|79538682|FG000|Overall Study|Miscellaneous|8|||
44528661|NCT03557931|79538683|FG001|Overall Study|Miscellaneous|5|||
44528662|NCT03557931|79538684|FG002|Overall Study|Miscellaneous|3|||
44528663|NCT03522675|79538694|FG000|Overall Study|Screen fail|1|||
44528664|NCT03522675|79538694|FG000|Overall Study|Non-reactive to histamine|1|||
44528665|NCT00294047|79538704|FG000|Month 48|Adverse Event|28|||
44528666|NCT00294047|79538705|FG001|Month 48|Adverse Event|13|||
44528667|NCT00294047|79538704|FG000|Month 48|Protocol Violation|4|||
44528668|NCT00294047|79538705|FG001|Month 48|Protocol Violation|4|||
44528669|NCT00294047|79538704|FG000|Month 48|Withdrawal by Subject|111|||
44528670|NCT00294047|79538705|FG001|Month 48|Withdrawal by Subject|115|||
44528671|NCT00294047|79538704|FG000|Month 48|Lost to Follow-up|272|||
44528672|NCT00294047|79538705|FG001|Month 48|Lost to Follow-up|287|||
44528673|NCT00294047|79538704|FG000|Month 48|Other|10|||
44528674|NCT00294047|79538705|FG001|Month 48|Other|14|||
44528675|NCT00294047|79538704|FG000|Month 84|Adverse Event|4|||
44528676|NCT00294047|79538705|FG001|Month 84|Adverse Event|2|||
44528677|NCT00294047|79538704|FG000|Month 84|Protocol Violation|1|||
44528678|NCT00294047|79538705|FG001|Month 84|Protocol Violation|1|||
44528679|NCT00294047|79538704|FG000|Month 84|Withdrawal by Subject|33|||
44528680|NCT00294047|79538705|FG001|Month 84|Withdrawal by Subject|31|||
44149156|NCT02149264|78938762|FG000|Overall Study|Protocol Violation|1|||
44528681|NCT00294047|79538704|FG000|Month 84|Lost to Follow-up|187|||
44528682|NCT00294047|79538705|FG001|Month 84|Lost to Follow-up|190|||
44528683|NCT00294047|79538704|FG000|Month 84|Absent Cervix|2|||
44528684|NCT00294047|79538705|FG001|Month 84|Absent Cervix|0|||
44528685|NCT00294047|79538704|FG000|Month 84|Work related reasons|4|||
44528686|NCT00294047|79538705|FG001|Month 84|Work related reasons|2|||
44528687|NCT00294047|79538704|FG000|Month 84|Center closed, subject did not transfer|1|||
44528688|NCT00294047|79538705|FG001|Month 84|Center closed, subject did not transfer|0|||
44528689|NCT00294047|79538704|FG000|Month 84|Family problems|2|||
44528690|NCT00294047|79538705|FG001|Month 84|Family problems|2|||
44528691|NCT00294047|79538704|FG000|Month 84|Lack of time|3|||
44528692|NCT00294047|79538705|FG001|Month 84|Lack of time|1|||
44528693|NCT00294047|79538704|FG000|Month 84|Personal reason|2|||
44528694|NCT00294047|79538705|FG001|Month 84|Personal reason|4|||
44528695|NCT00294047|79538704|FG000|Month 84|Subject does not want male physician|1|||
44528696|NCT00294047|79538705|FG001|Month 84|Subject does not want male physician|0|||
44528697|NCT00294047|79538704|FG000|Month 84|Transport reimbursement delayed|0|||
44528698|NCT00294047|79538705|FG001|Month 84|Transport reimbursement delayed|1|||
44528699|NCT00294047|79538704|FG000|Month 84|Unable to reach study site|1|||
44528700|NCT00294047|79538705|FG001|Month 84|Unable to reach study site|0|||
44528701|NCT00294047|79538704|FG000|Month 84|Under investigation locally|1|||
44528702|NCT00294047|79538705|FG001|Month 84|Under investigation locally|0|||
44528703|NCT00294047|79538704|FG000|Month 84|Visit missed|0|||
44528704|NCT00294047|79538705|FG001|Month 84|Visit missed|1|||
44528705|NCT00294047|79538704|FG000|Month 84|No consent for Month 84 Follow-up|731|||
44528706|NCT00294047|79538705|FG001|Month 84|No consent for Month 84 Follow-up|754|||
44528707|NCT00293813|79538715|FG000|Overall Study|Physician Decision|0|||
44528708|NCT00293813|79538716|FG001|Overall Study|Physician Decision|1|||
44528709|NCT00293813|79538717|FG002|Overall Study|Physician Decision|0|||
44528710|NCT00293813|79538715|FG000|Overall Study|Adverse Event|3|||
44528711|NCT00293813|79538716|FG001|Overall Study|Adverse Event|1|||
44528712|NCT00293813|79538717|FG002|Overall Study|Adverse Event|1|||
44528713|NCT00293813|79538715|FG000|Overall Study|Withdrawal by Subject|7|||
44528714|NCT00293813|79538716|FG001|Overall Study|Withdrawal by Subject|4|||
44528715|NCT00293813|79538717|FG002|Overall Study|Withdrawal by Subject|4|||
44528716|NCT00293813|79538715|FG000|Overall Study|Lost to Follow-up|3|||
44528717|NCT00293813|79538716|FG001|Overall Study|Lost to Follow-up|2|||
44528718|NCT00293813|79538717|FG002|Overall Study|Lost to Follow-up|3|||
44528719|NCT00293813|79538715|FG000|Overall Study|Noncompliance|0|||
44528720|NCT00293813|79538716|FG001|Overall Study|Noncompliance|1|||
44528721|NCT00293813|79538717|FG002|Overall Study|Noncompliance|0|||
44528722|NCT00293579|79538725|FG000|Overall Study|Withdrawal by Subject|1|||
44528723|NCT00293423|79538732|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
44528724|NCT00293423|79538733|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
44528725|NCT00293423|79538732|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
44528726|NCT00293423|79538733|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
44528727|NCT00293423|79538732|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
44528728|NCT00293423|79538733|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
44528729|NCT00293423|79538732|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
44528730|NCT00293423|79538733|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
44528731|NCT00293423|79538732|FG000|Surgical Resection|processing error during surgical resection|1|||
44528732|NCT00293423|79538733|FG001|Surgical Resection|processing error during surgical resection|0|||
44528733|NCT00293423|79538732|FG000|Surgical Resection|Withdrawal by Subject|4|||
44528734|NCT00293423|79538733|FG001|Surgical Resection|Withdrawal by Subject|0|||
44528735|NCT00293423|79538732|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
44528736|NCT00293423|79538733|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
44528737|NCT03538743|79538748|FG000|Overall Study|Adverse Event|0|||
44528738|NCT03538743|79538749|FG001|Overall Study|Adverse Event|0|||
44528739|NCT03538743|79538750|FG002|Overall Study|Adverse Event|1|||
44528740|NCT03538743|79538751|FG003|Overall Study|Adverse Event|1|||
44528741|NCT03538743|79538752|FG004|Overall Study|Adverse Event|0|||
44528742|NCT03538743|79538753|FG005|Overall Study|Adverse Event|0|||
44528743|NCT03538743|79538754|FG006|Overall Study|Adverse Event|0|||
44528744|NCT03538743|79538755|FG007|Overall Study|Adverse Event|0|||
44528745|NCT03538743|79538756|FG008|Overall Study|Adverse Event|0|||
44528746|NCT03538743|79538748|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
44528747|NCT03538743|79538749|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
44528748|NCT03538743|79538750|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
44528749|NCT03538743|79538751|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
44528750|NCT03538743|79538752|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
44528751|NCT03538743|79538753|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
44528752|NCT03538743|79538754|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
44528753|NCT03538743|79538755|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
44528754|NCT03538743|79538756|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
44528755|NCT03538743|79538748|FG000|Overall Study|Withdrawal by Subject|0|||
44528756|NCT03538743|79538749|FG001|Overall Study|Withdrawal by Subject|0|||
44528757|NCT03538743|79538750|FG002|Overall Study|Withdrawal by Subject|0|||
44528758|NCT03538743|79538751|FG003|Overall Study|Withdrawal by Subject|1|||
44528759|NCT03538743|79538752|FG004|Overall Study|Withdrawal by Subject|0|||
44528760|NCT03538743|79538753|FG005|Overall Study|Withdrawal by Subject|0|||
44528761|NCT03538743|79538754|FG006|Overall Study|Withdrawal by Subject|0|||
44528762|NCT03538743|79538755|FG007|Overall Study|Withdrawal by Subject|0|||
44528763|NCT03538743|79538756|FG008|Overall Study|Withdrawal by Subject|0|||
44528764|NCT03521817|79538786|FG000|Overall Study|Protocol Violation|0|||
44528765|NCT03521817|79538787|FG001|Overall Study|Protocol Violation|1|||
44528766|NCT03538431|79538793|FG000|Overall Study|Physician Decision|0|||
44528767|NCT03538431|79538794|FG001|Overall Study|Physician Decision|1|||
44528768|NCT03538431|79538793|FG000|Overall Study|Withdrawal by Subject|1|||
44528769|NCT03538431|79538794|FG001|Overall Study|Withdrawal by Subject|0|||
44528770|NCT03521193|79538804|FG000|Overall Study|Withdrawal by Subject|8|||
44528771|NCT03521193|79538805|FG001|Overall Study|Withdrawal by Subject|0|||
44528772|NCT03521193|79538804|FG000|Overall Study|non compliant to ASA treatment|8|||
44528773|NCT03521193|79538805|FG001|Overall Study|non compliant to ASA treatment|0|||
44528774|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
44528775|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
44528776|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
44528777|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
44528778|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
44528779|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
44528780|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
44528781|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
44149157|NCT02115256|78938768|FG000|Overall Study|Withdrawal by Subject|0|||
44149158|NCT02115256|78938769|FG001|Overall Study|Withdrawal by Subject|1|||
44149159|NCT02173054|78938778|FG000|Overall Study|lack of compliance|1|||
44149160|NCT02173054|78938779|FG001|Overall Study|lack of compliance|0|||
44149161|NCT02173054|78938780|FG002|Overall Study|lack of compliance|0|||
44149162|NCT02173054|78938778|FG000|Overall Study|Withdrawal by Subject|0|||
44149163|NCT02173054|78938779|FG001|Overall Study|Withdrawal by Subject|0|||
44149164|NCT02173054|78938780|FG002|Overall Study|Withdrawal by Subject|1|||
44149165|NCT02149108|78938825|FG000|Overall Study|Not treated|1|||
44254516|NCT04178967|79096241|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44254517|NCT04178967|79096242|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44149166|NCT02149108|78938826|FG001|Overall Study|Not treated|2|||
44254518|NCT04178967|79096243|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44528782|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
44528783|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
44528784|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
44528785|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
44528786|NCT00293267|79538814|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
44528787|NCT00293267|79538815|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
44414876|NCT00847613|79422838|FG003|Overall Study|Pregnancy|0|||
44414877|NCT00847613|79422835|FG000|Overall Study|Site closure|1|||
44414878|NCT00847613|79422836|FG001|Overall Study|Site closure|0|||
44414879|NCT00847613|79422837|FG002|Overall Study|Site closure|0|||
44414880|NCT00847613|79422838|FG003|Overall Study|Site closure|1|||
44528788|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
44149167|NCT02149108|78938825|FG000|Overall Study|Progressive Disease (PD)|324|||
44149168|NCT02149108|78938826|FG001|Overall Study|Progressive Disease (PD)|318|||
44149169|NCT02149108|78938825|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
44149170|NCT02149108|78938826|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
44149171|NCT02149108|78938825|FG000|Overall Study|Other Adverse Event (AE)|8|||
44149172|NCT02149108|78938826|FG001|Overall Study|Other Adverse Event (AE)|18|||
44149173|NCT02149108|78938825|FG000|Overall Study|Other not defined above|0|||
44149174|NCT02149108|78938826|FG001|Overall Study|Other not defined above|2|||
44149175|NCT02149108|78938825|FG000|Overall Study|Refusal to continue trial medication|15|||
44149176|NCT02149108|78938826|FG001|Overall Study|Refusal to continue trial medication|11|||
44149177|NCT02149108|78938825|FG000|Overall Study|Lost to Follow-up|1|||
44149178|NCT02149108|78938826|FG001|Overall Study|Lost to Follow-up|0|||
44528789|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
44528790|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
44528791|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
44528792|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
44528793|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
44528794|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
44149179|NCT02148952|78938834|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
44149180|NCT02148952|78938835|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
44149181|NCT02148952|78938834|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
44149182|NCT02148952|78938835|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
44149183|NCT02148952|78938834|FG000|Follow-Up|Lost to Follow-up|219|||
44149184|NCT02148952|78938835|FG001|Follow-Up|Lost to Follow-up|231|||
44149185|NCT02148952|78938834|FG000|Follow-Up|Withdrawal by Subject|46|||
44149186|NCT02148952|78938835|FG001|Follow-Up|Withdrawal by Subject|48|||
44149187|NCT02148718|78938849|FG000|Overall Study|Protocol Violation|26|||
44149188|NCT02148718|78938849|FG000|Overall Study|Discontinued Study Prematurely|5|||
44149189|NCT02148250|78938853|FG000|Screening|Withdrawal by Subject|5|||
44149190|NCT02148250|78938854|FG001|Screening|Withdrawal by Subject|0|||
44149191|NCT02147626|78938863|FG000|Overall Study|Lost to Follow-up|4|||
44149192|NCT02147626|78938864|FG001|Overall Study|Lost to Follow-up|4|||
44149193|NCT02147626|78938863|FG000|Overall Study|Pregnancy|1|||
44149194|NCT02147626|78938864|FG001|Overall Study|Pregnancy|2|||
44149195|NCT02147626|78938863|FG000|Overall Study|Withdrawal by Subject|0|||
44149196|NCT02147626|78938864|FG001|Overall Study|Withdrawal by Subject|1|||
44149197|NCT02172664|78938870|FG000|Overall Study|Lost to Follow-up|4|||
44149198|NCT02172664|78938871|FG001|Overall Study|Lost to Follow-up|4|||
44254519|NCT04178967|79096244|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44254520|NCT04178967|79096245|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44528795|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
44528796|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Death|3|||
44528797|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Death|0|||
44414881|NCT00847613|79422835|FG000|Overall Study|Withdrawal by Subject|8|||
44149199|NCT02172664|78938870|FG000|Overall Study|Death|1|||
44149200|NCT02172664|78938871|FG001|Overall Study|Death|1|||
44414882|NCT00847613|79422836|FG001|Overall Study|Withdrawal by Subject|11|||
44414883|NCT00847613|79422837|FG002|Overall Study|Withdrawal by Subject|2|||
44254521|NCT04178967|79096246|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44254522|NCT04178967|79096247|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
44254523|NCT04178967|79096248|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
44254524|NCT04178967|79096238|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44254525|NCT04178967|79096239|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44254526|NCT04178967|79096240|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44254527|NCT04178967|79096241|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44414884|NCT00847613|79422838|FG003|Overall Study|Withdrawal by Subject|2|||
44414885|NCT00847613|79422835|FG000|Overall Study|Participant moved|4|||
44149201|NCT02172664|78938870|FG000|Overall Study|Moved out of area|1|||
44528798|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
44528799|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
44528800|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
44528801|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
44528802|NCT00293267|79538814|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
44528803|NCT00293267|79538815|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
44528804|NCT00293267|79538814|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
44528805|NCT00293267|79538815|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
44528806|NCT00293267|79538814|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
44528807|NCT00293267|79538815|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
44528808|NCT00293267|79538814|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
44528809|NCT00293267|79538815|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
44528810|NCT00293267|79538814|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
44528811|NCT00293267|79538815|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
44149202|NCT02172664|78938871|FG001|Overall Study|Moved out of area|1|||
44254528|NCT04178967|79096242|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44528812|NCT00293267|79538814|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
44528813|NCT00293267|79538815|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
44528814|NCT00293267|79538814|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
44528815|NCT00293267|79538815|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
44528816|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
44528817|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
44528818|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
44528819|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
44528820|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
44528821|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
44528822|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
44528823|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
44528824|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
44528825|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
44528826|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
44528827|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
44528828|NCT00293267|79538814|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
44528829|NCT00293267|79538815|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
44528830|NCT03520959|79538825|FG000|Overall Study|Study terminated by Sponsor|0|||
44528831|NCT03520959|79538826|FG001|Overall Study|Study terminated by Sponsor|1|||
44528832|NCT03537261|79538834|FG000|Overall Study|Lost to Follow-up|4|||
44528833|NCT03537261|79538835|FG001|Overall Study|Lost to Follow-up|5|||
44528834|NCT03537261|79538834|FG000|Overall Study|Withdrawal by Subject|4|||
44528835|NCT03537261|79538835|FG001|Overall Study|Withdrawal by Subject|6|||
44528836|NCT03537261|79538834|FG000|Overall Study|Did not return study questionnaires|0|||
44528837|NCT03537261|79538835|FG001|Overall Study|Did not return study questionnaires|1|||
44528838|NCT03536949|79538843|FG000|Overall Study|Adverse Event|4|||
44528839|NCT03536949|79538844|FG001|Overall Study|Adverse Event|0|||
44528840|NCT03536949|79538843|FG000|Overall Study|Lost to Follow-up|2|||
44528841|NCT03536949|79538844|FG001|Overall Study|Lost to Follow-up|1|||
44528842|NCT03536949|79538843|FG000|Overall Study|Withdrawal by Subject|6|||
44528843|NCT03536949|79538844|FG001|Overall Study|Withdrawal by Subject|0|||
44528844|NCT03536949|79538843|FG000|Overall Study|Non-compliance|2|||
44254529|NCT04178967|79096243|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44254530|NCT04178967|79096244|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44528845|NCT03536949|79538844|FG001|Overall Study|Non-compliance|1|||
44528846|NCT03588741|79538850|FG000|Overall Study|Withdrawal by Subject|1|||
44528847|NCT00111917|79538856|FG000|Overall Study|Withdrawal by Subject|1|||
44414886|NCT00847613|79422836|FG001|Overall Study|Participant moved|1|||
44414887|NCT00847613|79422837|FG002|Overall Study|Participant moved|0|||
44414888|NCT00847613|79422838|FG003|Overall Study|Participant moved|0|||
44414889|NCT00847613|79422835|FG000|Overall Study|Sponsor request|0|||
44414890|NCT00847613|79422836|FG001|Overall Study|Sponsor request|1|||
44414891|NCT00847613|79422837|FG002|Overall Study|Sponsor request|0|||
44414892|NCT00847613|79422838|FG003|Overall Study|Sponsor request|0|||
44414893|NCT00847613|79422835|FG000|Overall Study|Randomized, but not treated|0|||
44414894|NCT00847613|79422836|FG001|Overall Study|Randomized, but not treated|3|||
44414895|NCT00847613|79422837|FG002|Overall Study|Randomized, but not treated|0|||
44414896|NCT00847613|79422838|FG003|Overall Study|Randomized, but not treated|0|||
44414897|NCT00847613|79422835|FG000|Overall Study|Other|1|||
44414898|NCT00847613|79422836|FG001|Overall Study|Other|1|||
44414899|NCT00847613|79422837|FG002|Overall Study|Other|2|||
44414900|NCT00847613|79422838|FG003|Overall Study|Other|0|||
44414901|NCT00794196|79422857|FG000|Overall Study|Lost to Follow-up|5|||
44414902|NCT00794196|79422858|FG001|Overall Study|Lost to Follow-up|23|||
44414903|NCT00807092|79422866|FG000|Overall Study|Adverse Event|0|||
44414904|NCT00807092|79422867|FG001|Overall Study|Adverse Event|1|||
44414905|NCT00807092|79422866|FG000|Overall Study|Protocol Violation|0|||
44414906|NCT00807092|79422867|FG001|Overall Study|Protocol Violation|2|||
44414907|NCT00807092|79422866|FG000|Overall Study|Withdrawal by Subject|1|||
44414908|NCT00807092|79422867|FG001|Overall Study|Withdrawal by Subject|0|||
44414909|NCT00807092|79422866|FG000|Overall Study|CGMS data collection failed|0|||
44414910|NCT00807092|79422867|FG001|Overall Study|CGMS data collection failed|1|||
44414911|NCT00794118|79422873|FG000|Overall Study|Lost to Follow-up|16|||
44414912|NCT00794118|79422873|FG000|Overall Study|Withdrawal by Subject|9|||
44414913|NCT00794118|79422873|FG000|Overall Study|Changed hospital center|2|||
44414914|NCT00640042|79422877|FG000|Enrollment|Did not receive study drug|83|||
44414915|NCT00807014|79422883|FG000|Overall Study|Participant Considered Disease Cured|13|||
44414916|NCT00807014|79422884|FG001|Overall Study|Participant Considered Disease Cured|2|||
44414917|NCT00807014|79422883|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
44414918|NCT00807014|79422884|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
44414919|NCT00807014|79422883|FG000|Overall Study|Protocol Violation|2|||
44414920|NCT00807014|79422884|FG001|Overall Study|Protocol Violation|8|||
44414921|NCT00807014|79422883|FG000|Overall Study|Adverse Event|0|||
44414922|NCT00807014|79422884|FG001|Overall Study|Adverse Event|2|||
44414923|NCT00807014|79422883|FG000|Overall Study|Lost to Follow-up|9|||
44414924|NCT00807014|79422884|FG001|Overall Study|Lost to Follow-up|7|||
44414925|NCT00807014|79422883|FG000|Overall Study|Recovery|1|||
44414926|NCT00807014|79422884|FG001|Overall Study|Recovery|0|||
44414927|NCT00807014|79422883|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
44414928|NCT00807014|79422884|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
44414929|NCT00592631|79422892|FG000|Overall Study|Lost to Follow-up|0|||
44414930|NCT00592631|79422893|FG001|Overall Study|Lost to Follow-up|2|||
44414931|NCT00791388|79422904|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
44414932|NCT00791388|79422905|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
44414933|NCT00791388|79422906|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
44414934|NCT00791388|79422907|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
44414935|NCT00791388|79422908|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
44414936|NCT00791388|79422904|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
44414937|NCT00791388|79422905|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
44414938|NCT00791388|79422906|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
44414939|NCT00791388|79422907|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
44414940|NCT00791388|79422908|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
44414941|NCT00791388|79422904|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
44414942|NCT00791388|79422905|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
44414943|NCT00791388|79422906|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
44414944|NCT00791388|79422907|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
44414945|NCT00791388|79422908|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
44528848|NCT00111917|79538857|FG001|Overall Study|Withdrawal by Subject|1|||
44528849|NCT03520569|79538867|FG000|Overall Study|Withdrawal by Subject|1|||
44528850|NCT00111839|79538880|FG000|Overall Study|Disease Progression|30|||
44528851|NCT00111839|79538881|FG001|Overall Study|Disease Progression|33|||
44414946|NCT00794040|79422922|FG000|Overall Study|Withdrawal by Subject|3|||
44414947|NCT00794040|79422923|FG001|Overall Study|Withdrawal by Subject|4|||
44414948|NCT00794040|79422922|FG000|Overall Study|Physician Decision|0|||
44414949|NCT00794040|79422923|FG001|Overall Study|Physician Decision|1|||
44414950|NCT00813488|79422929|FG000|Titration Period 1|Adverse Event|6|||
44414951|NCT00813488|79422930|FG001|Titration Period 1|Adverse Event|1|||
44414952|NCT00813488|79422929|FG000|Titration Period 1|Lack of Efficacy|9|||
44414953|NCT00813488|79422930|FG001|Titration Period 1|Lack of Efficacy|7|||
44414954|NCT00813488|79422929|FG000|Titration Period 1|Withdrawal by Subject|2|||
44414955|NCT00813488|79422930|FG001|Titration Period 1|Withdrawal by Subject|2|||
44528852|NCT00111839|79538882|FG002|Overall Study|Disease Progression|33|||
44528853|NCT00111839|79538880|FG000|Overall Study|Adverse Event|5|||
44528854|NCT00111839|79538881|FG001|Overall Study|Adverse Event|3|||
44528855|NCT00111839|79538882|FG002|Overall Study|Adverse Event|1|||
44528856|NCT00111839|79538880|FG000|Overall Study|Protocol Violation|2|||
44528857|NCT00111839|79538881|FG001|Overall Study|Protocol Violation|4|||
44528858|NCT00111839|79538882|FG002|Overall Study|Protocol Violation|2|||
44528859|NCT00111839|79538880|FG000|Overall Study|Death|1|||
44528860|NCT00111839|79538881|FG001|Overall Study|Death|1|||
44528861|NCT00111839|79538882|FG002|Overall Study|Death|6|||
44528862|NCT00111839|79538880|FG000|Overall Study|Withdrawal by Subject|2|||
44528863|NCT00111839|79538881|FG001|Overall Study|Withdrawal by Subject|2|||
44528864|NCT00111839|79538882|FG002|Overall Study|Withdrawal by Subject|2|||
44528865|NCT00111839|79538880|FG000|Overall Study|Lost to Follow-up|1|||
44528866|NCT00111839|79538881|FG001|Overall Study|Lost to Follow-up|0|||
44528867|NCT00111839|79538882|FG002|Overall Study|Lost to Follow-up|0|||
44528868|NCT00111839|79538880|FG000|Overall Study|Logistical Constraint|1|||
44528869|NCT00111839|79538881|FG001|Overall Study|Logistical Constraint|0|||
44528870|NCT00111839|79538882|FG002|Overall Study|Logistical Constraint|0|||
44528871|NCT00111839|79538880|FG000|Overall Study|Other|6|||
44528872|NCT00111839|79538881|FG001|Overall Study|Other|3|||
44528873|NCT00111839|79538882|FG002|Overall Study|Other|3|||
44528874|NCT00111839|79538880|FG000|Overall Study|Randomized but Not Treated|0|||
44528875|NCT00111839|79538881|FG001|Overall Study|Randomized but Not Treated|0|||
44528876|NCT00111839|79538882|FG002|Overall Study|Randomized but Not Treated|2|||
44528877|NCT00111761|79538892|FG000|Part 1|Physician Decision|0|||
44528878|NCT00111761|79538893|FG001|Part 1|Physician Decision|1|||
44528879|NCT00111761|79538892|FG000|Part 1|Death|0|||
44528880|NCT00111761|79538893|FG001|Part 1|Death|2|||
44528881|NCT00111761|79538892|FG000|Part 1|Other|0|||
44528882|NCT00111761|79538893|FG001|Part 1|Other|1|||
44528883|NCT00111761|79538892|FG000|Part 1|Withdrawal by Subject|0|||
44528884|NCT00111761|79538893|FG001|Part 1|Withdrawal by Subject|1|||
44528885|NCT00111761|79538892|FG000|Part 2|Adverse Event|1|||
44528886|NCT00111761|79538893|FG001|Part 2|Adverse Event|0|||
44528887|NCT00111761|79538892|FG000|Part 2|Physician Decision|1|||
44528888|NCT00111761|79538893|FG001|Part 2|Physician Decision|0|||
44528889|NCT00111761|79538892|FG000|Part 2|Death|1|||
44528890|NCT00111761|79538893|FG001|Part 2|Death|0|||
44528891|NCT00111761|79538892|FG000|Part 2|Disease progression|3|||
44528892|NCT00111761|79538893|FG001|Part 2|Disease progression|0|||
44528893|NCT00111761|79538892|FG000|Part 2|Protocol-specified criteria|1|||
44528894|NCT00111761|79538893|FG001|Part 2|Protocol-specified criteria|0|||
44528895|NCT00111761|79538892|FG000|Part 2|Other|1|||
44528896|NCT00111761|79538893|FG001|Part 2|Other|0|||
44528897|NCT03519867|79538909|FG000|Overall Study|Adverse Event|1|||
44528898|NCT03519867|79538910|FG001|Overall Study|Adverse Event|1|||
44528899|NCT03519867|79538911|FG002|Overall Study|Adverse Event|0|||
44528900|NCT03519867|79538912|FG003|Overall Study|Adverse Event|0|||
44528901|NCT03519867|79538913|FG004|Overall Study|Adverse Event|0|||
44528902|NCT03519867|79538914|FG005|Overall Study|Adverse Event|0|||
44528903|NCT03519867|79538915|FG006|Overall Study|Adverse Event|0|||
44528904|NCT03519867|79538916|FG007|Overall Study|Adverse Event|0|||
44528905|NCT03519867|79538917|FG008|Overall Study|Adverse Event|0|||
44528906|NCT03519867|79538918|FG009|Overall Study|Adverse Event|0|||
44528907|NCT03519867|79538909|FG000|Overall Study|Protocol Violation|0|||
44528908|NCT03519867|79538910|FG001|Overall Study|Protocol Violation|0|||
44528909|NCT03519867|79538911|FG002|Overall Study|Protocol Violation|0|||
44528910|NCT03519867|79538912|FG003|Overall Study|Protocol Violation|0|||
44528911|NCT03519867|79538913|FG004|Overall Study|Protocol Violation|0|||
44528912|NCT03519867|79538914|FG005|Overall Study|Protocol Violation|1|||
44528913|NCT03519867|79538915|FG006|Overall Study|Protocol Violation|0|||
44528914|NCT03519867|79538916|FG007|Overall Study|Protocol Violation|0|||
44528915|NCT03519867|79538917|FG008|Overall Study|Protocol Violation|0|||
44528916|NCT03519867|79538918|FG009|Overall Study|Protocol Violation|0|||
44528917|NCT03519867|79538909|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528918|NCT03519867|79538910|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528919|NCT03519867|79538911|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528920|NCT03519867|79538912|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528921|NCT03519867|79538913|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528922|NCT03519867|79538914|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528923|NCT03519867|79538915|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
44528924|NCT03519867|79538916|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528925|NCT03519867|79538917|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528926|NCT03519867|79538918|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
44528927|NCT03519867|79538909|FG000|Overall Study|Admin. of other reversal agent|1|||
44528928|NCT03519867|79538910|FG001|Overall Study|Admin. of other reversal agent|1|||
44528929|NCT03519867|79538911|FG002|Overall Study|Admin. of other reversal agent|0|||
44528930|NCT03519867|79538912|FG003|Overall Study|Admin. of other reversal agent|0|||
44528931|NCT03519867|79538913|FG004|Overall Study|Admin. of other reversal agent|0|||
44528932|NCT03519867|79538914|FG005|Overall Study|Admin. of other reversal agent|1|||
44528933|NCT03519867|79538915|FG006|Overall Study|Admin. of other reversal agent|0|||
44528934|NCT03519867|79538916|FG007|Overall Study|Admin. of other reversal agent|0|||
44528935|NCT03519867|79538917|FG008|Overall Study|Admin. of other reversal agent|0|||
44528936|NCT03519867|79538918|FG009|Overall Study|Admin. of other reversal agent|0|||
44528937|NCT03519867|79538909|FG000|Overall Study|Reason not provided|1|||
44528938|NCT03519867|79538910|FG001|Overall Study|Reason not provided|1|||
44528939|NCT03519867|79538911|FG002|Overall Study|Reason not provided|1|||
44528940|NCT03519867|79538912|FG003|Overall Study|Reason not provided|1|||
44528941|NCT03519867|79538913|FG004|Overall Study|Reason not provided|0|||
44528942|NCT03519867|79538914|FG005|Overall Study|Reason not provided|1|||
44528943|NCT03519867|79538915|FG006|Overall Study|Reason not provided|0|||
44528944|NCT03519867|79538916|FG007|Overall Study|Reason not provided|1|||
44528945|NCT03519867|79538917|FG008|Overall Study|Reason not provided|1|||
44528946|NCT03519867|79538918|FG009|Overall Study|Reason not provided|0|||
44528947|NCT03519087|79538942|FG000|Clinic Evaluation|Physician Decision|15|||
44528948|NCT03519087|79538943|FG001|Clinic Evaluation|Physician Decision|18|||
44528949|NCT03519087|79538944|FG002|Clinic Evaluation|Physician Decision|0|||
44528950|NCT03519087|79538945|FG003|Clinic Evaluation|Physician Decision|0|||
44528951|NCT03519087|79538946|FG004|Clinic Evaluation|Physician Decision|0|||
44528952|NCT03519087|79538942|FG000|Clinic Evaluation|Protocol Violation|1|||
44528953|NCT03519087|79538943|FG001|Clinic Evaluation|Protocol Violation|0|||
44528954|NCT03519087|79538944|FG002|Clinic Evaluation|Protocol Violation|0|||
44528955|NCT03519087|79538945|FG003|Clinic Evaluation|Protocol Violation|0|||
44528956|NCT03519087|79538946|FG004|Clinic Evaluation|Protocol Violation|0|||
44528957|NCT03519087|79538942|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
44528958|NCT03519087|79538943|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
44528959|NCT03519087|79538944|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
44528960|NCT03519087|79538945|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
44528961|NCT03519087|79538946|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
44528962|NCT03519087|79538942|FG000|Re-randomization for Treatment|Not appropriate|2|||
44528963|NCT03519087|79538943|FG001|Re-randomization for Treatment|Not appropriate|3|||
44528964|NCT03519087|79538944|FG002|Re-randomization for Treatment|Not appropriate|0|||
44528965|NCT03519087|79538945|FG003|Re-randomization for Treatment|Not appropriate|0|||
44528966|NCT03519087|79538946|FG004|Re-randomization for Treatment|Not appropriate|0|||
44528967|NCT03519087|79538942|FG000|Laboratory Testing|Lost to Follow-up|0|||
44528968|NCT03519087|79538943|FG001|Laboratory Testing|Lost to Follow-up|0|||
44528969|NCT03519087|79538944|FG002|Laboratory Testing|Lost to Follow-up|2|||
44528970|NCT03519087|79538945|FG003|Laboratory Testing|Lost to Follow-up|3|||
44528971|NCT03519087|79538946|FG004|Laboratory Testing|Lost to Follow-up|6|||
44528972|NCT03519087|79538942|FG000|Laboratory Testing|Protocol Violation|0|||
44528973|NCT03519087|79538943|FG001|Laboratory Testing|Protocol Violation|0|||
44528974|NCT03519087|79538944|FG002|Laboratory Testing|Protocol Violation|0|||
44528975|NCT03519087|79538945|FG003|Laboratory Testing|Protocol Violation|1|||
44528976|NCT03519087|79538946|FG004|Laboratory Testing|Protocol Violation|0|||
44528977|NCT02763046|79538965|FG000|Overall Study|Adverse Event|5|||
44528978|NCT02763046|79538966|FG001|Overall Study|Adverse Event|4|||
44528979|NCT02763046|79538967|FG002|Overall Study|Adverse Event|0|||
44528980|NCT02763046|79538965|FG000|Overall Study|Lack of Efficacy|1|||
44528981|NCT02763046|79538966|FG001|Overall Study|Lack of Efficacy|1|||
44528982|NCT02763046|79538967|FG002|Overall Study|Lack of Efficacy|3|||
44528983|NCT02763046|79538965|FG000|Overall Study|Physician Decision|1|||
44528984|NCT02763046|79538966|FG001|Overall Study|Physician Decision|0|||
44528985|NCT02763046|79538967|FG002|Overall Study|Physician Decision|1|||
44528986|NCT02763046|79538965|FG000|Overall Study|Subject/guardian decision|2|||
44528987|NCT02763046|79538966|FG001|Overall Study|Subject/guardian decision|0|||
44528988|NCT02763046|79538967|FG002|Overall Study|Subject/guardian decision|4|||
44528989|NCT03518073|79538984|FG000|Overall Study|Adverse Event|2|||
44528990|NCT03518073|79538985|FG001|Overall Study|Adverse Event|4|||
44528991|NCT03518073|79538986|FG002|Overall Study|Adverse Event|2|||
44528992|NCT03518073|79538984|FG000|Overall Study|Death|2|||
44254531|NCT04178967|79096245|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44528993|NCT03518073|79538985|FG001|Overall Study|Death|1|||
44528994|NCT03518073|79538986|FG002|Overall Study|Death|3|||
44528995|NCT03518073|79538984|FG000|Overall Study|Lost to Follow-up|1|||
44528996|NCT03518073|79538985|FG001|Overall Study|Lost to Follow-up|0|||
44528997|NCT03518073|79538986|FG002|Overall Study|Lost to Follow-up|1|||
44254532|NCT04178967|79096246|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44254533|NCT04178967|79096247|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
44254534|NCT04178967|79096248|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
44528998|NCT03518073|79538984|FG000|Overall Study|Physician Decision|5|||
44528999|NCT03518073|79538985|FG001|Overall Study|Physician Decision|0|||
44529000|NCT03518073|79538986|FG002|Overall Study|Physician Decision|2|||
44529001|NCT03518073|79538984|FG000|Overall Study|Progressive disease|1|||
44529002|NCT03518073|79538985|FG001|Overall Study|Progressive disease|1|||
44529003|NCT03518073|79538986|FG002|Overall Study|Progressive disease|1|||
44529004|NCT03518073|79538984|FG000|Overall Study|Protocol Violation|1|||
44529005|NCT03518073|79538985|FG001|Overall Study|Protocol Violation|0|||
44529006|NCT03518073|79538986|FG002|Overall Study|Protocol Violation|0|||
44529007|NCT03518073|79538984|FG000|Overall Study|Withdrawal by Subject|30|||
44529008|NCT03518073|79538985|FG001|Overall Study|Withdrawal by Subject|34|||
44529009|NCT03518073|79538986|FG002|Overall Study|Withdrawal by Subject|29|||
44529010|NCT03518073|79538984|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
44529011|NCT03518073|79538985|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
44529012|NCT03518073|79538986|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
44529013|NCT03518073|79538984|FG000|Overall Study|Covid-19|1|||
44529014|NCT03518073|79538985|FG001|Overall Study|Covid-19|2|||
44529015|NCT03518073|79538986|FG002|Overall Study|Covid-19|1|||
44529016|NCT02759692|79538996|FG000|Period 1|Test article no longer available|1|||
44529017|NCT02759692|79538997|FG001|Period 1|Test article no longer available|1|||
44529018|NCT02759692|79538996|FG000|Period 1|No longer meets eligibility criteria.|1|||
44529019|NCT02759692|79538997|FG001|Period 1|No longer meets eligibility criteria.|0|||
44529020|NCT02759692|79538996|FG000|Period 1|Miss-Randomized|1|||
44529021|NCT02759692|79538997|FG001|Period 1|Miss-Randomized|1|||
44529022|NCT02759692|79538996|FG000|Period 2|Lost to Follow-up|1|||
44529023|NCT02759692|79538997|FG001|Period 2|Lost to Follow-up|0|||
44529024|NCT02759692|79538996|FG000|Period 2|Test article no longer available|0|||
44529025|NCT02759692|79538997|FG001|Period 2|Test article no longer available|1|||
44529026|NCT03586167|79539005|FG000|Overall Study|Other|1|||
44529027|NCT03586167|79539006|FG001|Overall Study|Other|0|||
44529028|NCT02762578|79539014|FG000|Overall Study|Adverse Event|1|||
44529029|NCT02762578|79539015|FG001|Overall Study|Adverse Event|6|||
44149203|NCT02172040|78938880|FG000|Overall Study|Adverse Event|0|||
44149204|NCT02172040|78938881|FG001|Overall Study|Adverse Event|2|||
44254535|NCT04163900|79096270|FG000|Overall Study|Radiological disease progression|112|||
44254536|NCT04163900|79096271|FG001|Overall Study|Radiological disease progression|127|||
44529030|NCT02762578|79539014|FG000|Overall Study|Protocol Violation|4|||
44529031|NCT02762578|79539015|FG001|Overall Study|Protocol Violation|2|||
44529032|NCT02762578|79539014|FG000|Overall Study|Withdrawal by Subject|4|||
44529033|NCT02762578|79539015|FG001|Overall Study|Withdrawal by Subject|2|||
44529034|NCT02762578|79539014|FG000|Overall Study|Unclassified|6|||
44529035|NCT02762578|79539015|FG001|Overall Study|Unclassified|0|||
44529036|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
44529037|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
44529038|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
44529039|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
44529040|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
44529041|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
44529042|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
44529043|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
44529044|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
44254537|NCT04163900|79096270|FG000|Overall Study|Study closure|98|||
44254538|NCT04163900|79096271|FG001|Overall Study|Study closure|133|||
44529045|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
44529046|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
44529047|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
44529048|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
44529049|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
44529050|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
44529051|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
44529052|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
44529053|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
44529054|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
44529055|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
44529056|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
44529057|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
44529058|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
44529059|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
44529060|NCT03514641|79539025|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
44529061|NCT03514641|79539026|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
44529062|NCT03514641|79539027|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
44529063|NCT03514641|79539028|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
44529064|NCT03514641|79539025|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
44529065|NCT03514641|79539026|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
44529066|NCT03514641|79539027|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
44529067|NCT03514641|79539028|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
44529068|NCT03514641|79539025|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
44529069|NCT03514641|79539026|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
44529070|NCT03514641|79539027|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
44529071|NCT03514641|79539028|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
44529072|NCT03514641|79539025|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
44529073|NCT03514641|79539026|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
44529074|NCT03514641|79539027|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
44529075|NCT03514641|79539028|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
44149205|NCT02172040|78938882|FG002|Overall Study|Adverse Event|0|||
44414956|NCT00813488|79422929|FG000|Titration Period 1|Protocol Violation|4|||
44414957|NCT00813488|79422930|FG001|Titration Period 1|Protocol Violation|3|||
44529076|NCT03514641|79539025|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
44529077|NCT03514641|79539026|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
44529078|NCT03514641|79539027|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
44529079|NCT03514641|79539028|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
44529080|NCT03514641|79539025|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
44529081|NCT03514641|79539026|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
44529082|NCT03514641|79539027|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
44529083|NCT03514641|79539028|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
44529084|NCT00100828|79539040|FG000|Overall Study|Physician Decision|6|||
44529085|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
44529086|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
44529087|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
44529088|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
44529089|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
44529090|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
44529091|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
44529092|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
44529093|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
44529094|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
44529095|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
44529096|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
44529097|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
44529098|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
44414958|NCT00813488|79422929|FG000|Titration Period 1|Non-compliance to study medication|4|||
44414959|NCT00813488|79422930|FG001|Titration Period 1|Non-compliance to study medication|1|||
44414960|NCT00813488|79422929|FG000|Titration Period 1|Non-compliance to study procedures|2|||
44414961|NCT00813488|79422930|FG001|Titration Period 1|Non-compliance to study procedures|2|||
44529099|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
44529100|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
44529101|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
44529102|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
44529103|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
44529104|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
44529105|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
44529106|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
44529107|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
44529108|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
44529109|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
44529110|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
44529111|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
44529112|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
44529113|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
44529114|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
44529115|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
44529116|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
44529117|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
44529118|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
44529119|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
44529120|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
44529121|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
44529122|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
44529123|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
44529124|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
44529125|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
44529126|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
44529127|NCT00100048|79539049|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
44529128|NCT00100048|79539050|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
44529129|NCT00100048|79539051|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
44529130|NCT00100048|79539052|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
44414962|NCT00813488|79422929|FG000|Titration Period 1|Technical Difficulties|0|||
44414963|NCT00813488|79422930|FG001|Titration Period 1|Technical Difficulties|1|||
44414964|NCT00813488|79422929|FG000|Titration Period 2|Adverse Event|2|||
44414965|NCT00813488|79422930|FG001|Titration Period 2|Adverse Event|3|||
44529131|NCT00100048|79539053|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
44529132|NCT00100048|79539054|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
44529133|NCT02757430|79539079|FG000|Overall Study|Physician Decision|6|||
44529134|NCT02757430|79539079|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
44529135|NCT02757430|79539079|FG000|Overall Study|No informed consent|1|||
44414966|NCT00813488|79422929|FG000|Titration Period 2|Lack of Efficacy|8|||
44414967|NCT00813488|79422930|FG001|Titration Period 2|Lack of Efficacy|4|||
44414968|NCT00813488|79422929|FG000|Titration Period 2|Protocol Violation|3|||
44414969|NCT00813488|79422930|FG001|Titration Period 2|Protocol Violation|2|||
44414970|NCT00813488|79422929|FG000|Titration Period 2|Lost to Follow-up|1|||
44414971|NCT00813488|79422930|FG001|Titration Period 2|Lost to Follow-up|0|||
44414972|NCT00813488|79422929|FG000|Titration Period 2|Non-compliance with study procedures|2|||
44414973|NCT00813488|79422930|FG001|Titration Period 2|Non-compliance with study procedures|1|||
44529136|NCT02757430|79539079|FG000|Overall Study|No procedure performed|2|||
44529137|NCT02757352|79539095|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
44529138|NCT02757352|79539096|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529139|NCT02757352|79539097|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
44529140|NCT02757352|79539098|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529141|NCT02757352|79539099|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44149206|NCT02172040|78938883|FG003|Overall Study|Adverse Event|0|||
44149207|NCT02172040|78938880|FG000|Overall Study|Protocol Violation|0|||
44149208|NCT02172040|78938881|FG001|Overall Study|Protocol Violation|1|||
44149209|NCT02172040|78938882|FG002|Overall Study|Protocol Violation|0|||
44149210|NCT02172040|78938883|FG003|Overall Study|Protocol Violation|0|||
44149211|NCT02172040|78938880|FG000|Overall Study|Withdrawal by Subject|0|||
44149212|NCT02172040|78938881|FG001|Overall Study|Withdrawal by Subject|0|||
44149213|NCT02172040|78938882|FG002|Overall Study|Withdrawal by Subject|1|||
44254539|NCT04163900|79096270|FG000|Overall Study|Adverse Event|78|||
44254540|NCT04163900|79096271|FG001|Overall Study|Adverse Event|32|||
44254541|NCT04163900|79096270|FG000|Overall Study|Withdrawal by Subject|37|||
44254542|NCT04163900|79096271|FG001|Overall Study|Withdrawal by Subject|34|||
44254543|NCT04163900|79096270|FG000|Overall Study|Death|29|||
44529142|NCT02757352|79539100|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529143|NCT02757352|79539101|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529144|NCT02757352|79539102|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529145|NCT02757352|79539103|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529146|NCT02757352|79539104|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
44529147|NCT02757352|79539095|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44254544|NCT04163900|79096271|FG001|Overall Study|Death|16|||
44254545|NCT04163900|79096270|FG000|Overall Study|Physician Decision|17|||
44254546|NCT04163900|79096271|FG001|Overall Study|Physician Decision|25|||
44254547|NCT04163900|79096270|FG000|Overall Study|Clinical disease progression|14|||
44254548|NCT04163900|79096271|FG001|Overall Study|Clinical disease progression|13|||
44414974|NCT00813488|79422929|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
44529148|NCT02757352|79539096|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529149|NCT02757352|79539097|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
44529150|NCT02757352|79539098|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529151|NCT02757352|79539099|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529152|NCT02757352|79539100|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529153|NCT02757352|79539101|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529154|NCT02757352|79539102|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529155|NCT02757352|79539103|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44529156|NCT02757352|79539104|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
44149214|NCT02172040|78938883|FG003|Overall Study|Withdrawal by Subject|0|||
44149215|NCT02172040|78938880|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
44149216|NCT02172040|78938881|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
44529157|NCT02757352|79539095|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
44149217|NCT02172040|78938882|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
44414975|NCT00813488|79422930|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
44254549|NCT04163900|79096270|FG000|Overall Study|Protocol Violation|3|||
44254550|NCT04163900|79096271|FG001|Overall Study|Protocol Violation|4|||
44414976|NCT00813488|79422929|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
44529158|NCT02757352|79539096|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
44529159|NCT02757352|79539097|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
44529160|NCT02757352|79539098|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529161|NCT02757352|79539099|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529162|NCT02757352|79539100|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529163|NCT02757352|79539101|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529164|NCT02757352|79539102|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529165|NCT02757352|79539103|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529166|NCT02757352|79539104|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
44529167|NCT02757352|79539095|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529168|NCT02757352|79539096|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
44529169|NCT02757352|79539097|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529170|NCT02757352|79539098|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529171|NCT02757352|79539099|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529172|NCT02757352|79539100|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529173|NCT02757352|79539101|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529174|NCT02757352|79539102|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529175|NCT02757352|79539103|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529176|NCT02757352|79539104|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
44529177|NCT02757352|79539095|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529178|NCT02757352|79539096|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
44529179|NCT02757352|79539097|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529180|NCT02757352|79539098|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529181|NCT02757352|79539099|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529182|NCT02757352|79539100|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529183|NCT02757352|79539101|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529184|NCT02757352|79539102|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529185|NCT02757352|79539103|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529186|NCT02757352|79539104|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529187|NCT02757352|79539095|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
44529188|NCT02757352|79539096|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
44529189|NCT02757352|79539097|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
44529190|NCT02757352|79539098|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529191|NCT02757352|79539099|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529192|NCT02757352|79539100|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529193|NCT02757352|79539101|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529194|NCT02757352|79539102|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529195|NCT02757352|79539103|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529196|NCT02757352|79539104|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529197|NCT02757352|79539095|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
44529198|NCT02757352|79539096|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
44529199|NCT02757352|79539097|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
44529200|NCT02757352|79539098|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529201|NCT02757352|79539099|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529202|NCT02757352|79539100|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529203|NCT02757352|79539101|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529204|NCT02757352|79539102|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529205|NCT02757352|79539103|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529206|NCT02757352|79539104|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
44529207|NCT02757352|79539095|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529208|NCT02757352|79539096|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529209|NCT02757352|79539097|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529210|NCT02757352|79539098|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
44529211|NCT02757352|79539099|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529212|NCT02757352|79539100|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
44529213|NCT02757352|79539101|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529214|NCT02757352|79539102|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529215|NCT02757352|79539103|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529216|NCT02757352|79539104|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
44529217|NCT02757352|79539095|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529218|NCT02757352|79539096|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529219|NCT02757352|79539097|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529220|NCT02757352|79539098|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
44529221|NCT02757352|79539099|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
44529222|NCT02757352|79539100|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
44529223|NCT02757352|79539101|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529224|NCT02757352|79539102|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529225|NCT02757352|79539103|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529226|NCT02757352|79539104|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
44529227|NCT02757352|79539095|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529228|NCT02757352|79539096|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529229|NCT02757352|79539097|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529230|NCT02757352|79539098|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529231|NCT02757352|79539099|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
44529232|NCT02757352|79539100|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529233|NCT02757352|79539101|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529234|NCT02757352|79539102|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529235|NCT02757352|79539103|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44254551|NCT04163900|79096270|FG000|Overall Study|Lost to Follow-up|0|||
44254552|NCT04163900|79096271|FG001|Overall Study|Lost to Follow-up|1|||
44254553|NCT04161495|79096279|FG000|Overall Study|Withdrawal by Subject|3|||
44254554|NCT04161495|79096280|FG001|Overall Study|Withdrawal by Subject|0|||
44529236|NCT02757352|79539104|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
44529237|NCT02757352|79539095|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529238|NCT02757352|79539096|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529239|NCT02757352|79539097|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529240|NCT02757352|79539098|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529241|NCT02757352|79539099|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529242|NCT02757352|79539100|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
44529243|NCT02757352|79539101|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529244|NCT02757352|79539102|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529245|NCT02757352|79539103|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529246|NCT02757352|79539104|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
44529247|NCT02757352|79539095|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529248|NCT02757352|79539096|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529249|NCT02757352|79539097|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529250|NCT02757352|79539098|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
44529251|NCT02757352|79539099|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
44529252|NCT02757352|79539100|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
44529253|NCT02757352|79539101|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529254|NCT02757352|79539102|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529255|NCT02757352|79539103|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529256|NCT02757352|79539104|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
44529257|NCT02757352|79539095|FG000|Follow-Up Period|Adverse Event|0|||
44529258|NCT02757352|79539096|FG001|Follow-Up Period|Adverse Event|0|||
44529259|NCT02757352|79539097|FG002|Follow-Up Period|Adverse Event|0|||
44529260|NCT02757352|79539098|FG003|Follow-Up Period|Adverse Event|0|||
44529261|NCT02757352|79539099|FG004|Follow-Up Period|Adverse Event|0|||
44529262|NCT02757352|79539100|FG005|Follow-Up Period|Adverse Event|0|||
44529263|NCT02757352|79539101|FG006|Follow-Up Period|Adverse Event|1|||
44529264|NCT02757352|79539102|FG007|Follow-Up Period|Adverse Event|0|||
44529265|NCT02757352|79539103|FG008|Follow-Up Period|Adverse Event|2|||
44529266|NCT02757352|79539104|FG009|Follow-Up Period|Adverse Event|0|||
44529267|NCT02757352|79539095|FG000|Follow-Up Period|Lost to Follow-up|0|||
44529268|NCT02757352|79539096|FG001|Follow-Up Period|Lost to Follow-up|0|||
44529269|NCT02757352|79539097|FG002|Follow-Up Period|Lost to Follow-up|0|||
44529270|NCT02757352|79539098|FG003|Follow-Up Period|Lost to Follow-up|0|||
44529271|NCT02757352|79539099|FG004|Follow-Up Period|Lost to Follow-up|0|||
44529272|NCT02757352|79539100|FG005|Follow-Up Period|Lost to Follow-up|0|||
44529273|NCT02757352|79539101|FG006|Follow-Up Period|Lost to Follow-up|0|||
44529274|NCT02757352|79539102|FG007|Follow-Up Period|Lost to Follow-up|0|||
44529275|NCT02757352|79539103|FG008|Follow-Up Period|Lost to Follow-up|1|||
44529276|NCT02757352|79539104|FG009|Follow-Up Period|Lost to Follow-up|0|||
44529277|NCT02757352|79539095|FG000|Follow-Up Period|Lack of Efficacy|0|||
44529278|NCT02757352|79539096|FG001|Follow-Up Period|Lack of Efficacy|0|||
44529279|NCT02757352|79539097|FG002|Follow-Up Period|Lack of Efficacy|0|||
44529280|NCT02757352|79539098|FG003|Follow-Up Period|Lack of Efficacy|0|||
44529281|NCT02757352|79539099|FG004|Follow-Up Period|Lack of Efficacy|0|||
44529282|NCT02757352|79539100|FG005|Follow-Up Period|Lack of Efficacy|0|||
44529283|NCT02757352|79539101|FG006|Follow-Up Period|Lack of Efficacy|0|||
44529284|NCT02757352|79539102|FG007|Follow-Up Period|Lack of Efficacy|0|||
44529285|NCT02757352|79539103|FG008|Follow-Up Period|Lack of Efficacy|1|||
44529286|NCT02757352|79539104|FG009|Follow-Up Period|Lack of Efficacy|1|||
44529287|NCT02757352|79539095|FG000|Follow-Up Period|Withdrawal by Subject|0|||
44529288|NCT02757352|79539096|FG001|Follow-Up Period|Withdrawal by Subject|0|||
44529289|NCT02757352|79539097|FG002|Follow-Up Period|Withdrawal by Subject|0|||
44529290|NCT02757352|79539098|FG003|Follow-Up Period|Withdrawal by Subject|0|||
44529291|NCT02757352|79539099|FG004|Follow-Up Period|Withdrawal by Subject|0|||
44529292|NCT02757352|79539100|FG005|Follow-Up Period|Withdrawal by Subject|0|||
44529293|NCT02757352|79539101|FG006|Follow-Up Period|Withdrawal by Subject|0|||
44529294|NCT02757352|79539102|FG007|Follow-Up Period|Withdrawal by Subject|1|||
44529295|NCT02757352|79539103|FG008|Follow-Up Period|Withdrawal by Subject|6|||
44529296|NCT02757352|79539104|FG009|Follow-Up Period|Withdrawal by Subject|2|||
44529297|NCT04588480|79539137|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
44529298|NCT04588480|79539138|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
44529299|NCT04588480|79539139|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
44529300|NCT04588480|79539137|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
44529301|NCT04588480|79539138|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
44529302|NCT04588480|79539139|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
44529303|NCT02756650|79539146|FG000|Overall Study|Physician Decision|1|||
44529304|NCT02756650|79539146|FG000|Overall Study|Adverse Event|1|||
44529305|NCT00110357|79539152|FG000|Overall Study|Deterioration without progression|2|||
44529306|NCT00110357|79539153|FG001|Overall Study|Deterioration without progression|0|||
44529307|NCT00110357|79539152|FG000|Overall Study|Disease progression/relapse|20|||
44529308|NCT00110357|79539153|FG001|Overall Study|Disease progression/relapse|15|||
44529309|NCT00110357|79539152|FG000|Overall Study|Study Closure|1|||
44529310|NCT00110357|79539153|FG001|Overall Study|Study Closure|0|||
44529311|NCT00110357|79539152|FG000|Overall Study|Study Drug Toxicity|1|||
44529312|NCT00110357|79539153|FG001|Overall Study|Study Drug Toxicity|3|||
44529313|NCT00110357|79539152|FG000|Overall Study|Withdrawal by Subject|3|||
44529314|NCT00110357|79539153|FG001|Overall Study|Withdrawal by Subject|1|||
44529315|NCT02752906|79539188|FG000|Overall Study|Protocol Violation|2|||
44529316|NCT02752906|79539189|FG001|Overall Study|Protocol Violation|1|||
44529317|NCT02752906|79539188|FG000|Overall Study|Withdrawal by Subject|2|||
44529318|NCT02752906|79539189|FG001|Overall Study|Withdrawal by Subject|2|||
44529319|NCT02752906|79539188|FG000|Overall Study|Lost to Follow-up|3|||
44529320|NCT02752906|79539189|FG001|Overall Study|Lost to Follow-up|2|||
44529321|NCT02756338|79539195|FG000|Overall Study|Withdrawn by Investigator|1|||
44529322|NCT02756338|79539195|FG000|Overall Study|Device Replaced with Pacemaker|4|||
44529323|NCT00293033|79539199|FG000|Open-label Titration Period|Adverse Event|10|||
44529324|NCT00293033|79539199|FG000|Open-label Titration Period|Death|3|||
44529325|NCT00293033|79539199|FG000|Open-label Titration Period|Lack of Efficacy|5|||
44529326|NCT00293033|79539199|FG000|Open-label Titration Period|Protocol Violation|2|||
44529327|NCT00293033|79539199|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
44529328|NCT00293033|79539199|FG000|Open-label Titration Period|Noncompliance and other|27|||
44529329|NCT00293033|79539199|FG000|Double-blind Treatment Period|Adverse Event|3|||
44529330|NCT00293033|79539199|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
44529331|NCT00293033|79539199|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
44529332|NCT00293033|79539199|FG000|Double-blind Treatment Period|Noncompliance|4|||
44529333|NCT02756182|79539207|FG000|Overall Study|StudyTechnical Difficulties|4|||
44529334|NCT03823703|79539216|FG000|Overall Study|Sponsor request|0|||
44529335|NCT03823703|79539217|FG001|Overall Study|Sponsor request|3|||
44529336|NCT03823703|79539218|FG002|Overall Study|Sponsor request|4|||
44529337|NCT03823703|79539216|FG000|Overall Study|Adverse Event|3|||
44529338|NCT03823703|79539217|FG001|Overall Study|Adverse Event|1|||
44529339|NCT03823703|79539218|FG002|Overall Study|Adverse Event|0|||
44529340|NCT03823703|79539216|FG000|Overall Study|Withdrawal by Subject|0|||
44529341|NCT03823703|79539217|FG001|Overall Study|Withdrawal by Subject|1|||
44529342|NCT03823703|79539218|FG002|Overall Study|Withdrawal by Subject|0|||
44529343|NCT00109577|79539228|FG000|Overall Study|Withdrawal by Subject|3|||
44529344|NCT00109577|79539229|FG001|Overall Study|Withdrawal by Subject|3|||
44529345|NCT02755090|79539237|FG000|Overall Study|equipment malfunction|1|||
44529346|NCT02755090|79539238|FG001|Overall Study|equipment malfunction|0|||
44529347|NCT00109343|79539247|FG000|Overall Study|Adverse Event|1|||
44529348|NCT00109343|79539248|FG001|Overall Study|Adverse Event|0|||
44529349|NCT00109343|79539249|FG002|Overall Study|Adverse Event|2|||
44529350|NCT00109343|79539247|FG000|Overall Study|Lack of Efficacy|1|||
44529351|NCT00109343|79539248|FG001|Overall Study|Lack of Efficacy|0|||
44529352|NCT00109343|79539249|FG002|Overall Study|Lack of Efficacy|0|||
44529353|NCT00109343|79539247|FG000|Overall Study|Lost to Follow-up|35|||
44529354|NCT00109343|79539248|FG001|Overall Study|Lost to Follow-up|20|||
44529355|NCT00109343|79539249|FG002|Overall Study|Lost to Follow-up|14|||
44529356|NCT00109343|79539247|FG000|Overall Study|Protocol Violation|1|||
44529357|NCT00109343|79539248|FG001|Overall Study|Protocol Violation|2|||
44529358|NCT00109343|79539249|FG002|Overall Study|Protocol Violation|2|||
44529359|NCT00109343|79539247|FG000|Overall Study|Withdrawal by Subject|15|||
44529360|NCT00109343|79539248|FG001|Overall Study|Withdrawal by Subject|11|||
44529361|NCT00109343|79539249|FG002|Overall Study|Withdrawal by Subject|10|||
44529362|NCT00109343|79539247|FG000|Overall Study|Subject Moved|6|||
44529363|NCT00109343|79539248|FG001|Overall Study|Subject Moved|2|||
44414977|NCT00813488|79422930|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
44414978|NCT00813488|79422929|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
44414979|NCT00813488|79422930|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
44414980|NCT00813488|79422929|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
44414981|NCT00813488|79422930|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
44414982|NCT00813488|79422929|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
44414983|NCT00813488|79422930|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
44414984|NCT00813488|79422929|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
44414985|NCT00813488|79422930|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
44414986|NCT00813488|79422929|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
44529364|NCT00109343|79539249|FG002|Overall Study|Subject Moved|1|||
44529365|NCT00109343|79539247|FG000|Overall Study|Other|5|||
44529366|NCT00109343|79539248|FG001|Overall Study|Other|2|||
44529367|NCT00109343|79539249|FG002|Overall Study|Other|1|||
44529368|NCT00108485|79539259|FG000|Overall Study|Withdrawal by Subject|3|||
44529369|NCT00108485|79539260|FG001|Overall Study|Withdrawal by Subject|0|||
44529370|NCT00108485|79539259|FG000|Overall Study|Lost to Follow-up|0|||
44529371|NCT00108485|79539260|FG001|Overall Study|Lost to Follow-up|2|||
44529372|NCT00107783|79539268|FG000|Overall Study|Adverse Event|0|||
44529373|NCT00107783|79539269|FG001|Overall Study|Adverse Event|2|||
44414987|NCT00813488|79422930|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
44414988|NCT00813488|79422929|FG000|Double-blind Treatment Period 2|Other|1|||
44414989|NCT00813488|79422930|FG001|Double-blind Treatment Period 2|Other|0|||
44414990|NCT00813488|79422929|FG000|Open-label Extension|Adverse Event|1|||
44414991|NCT00813488|79422930|FG001|Open-label Extension|Adverse Event|2|||
44414992|NCT00813488|79422929|FG000|Open-label Extension|Lack of Efficacy|3|||
44414993|NCT00813488|79422930|FG001|Open-label Extension|Lack of Efficacy|0|||
44414994|NCT00813488|79422929|FG000|Open-label Extension|Withdrawal by Subject|0|||
44529374|NCT00107783|79539268|FG000|Overall Study|Death|0|||
44529375|NCT00107783|79539269|FG001|Overall Study|Death|1|||
44414995|NCT00813488|79422930|FG001|Open-label Extension|Withdrawal by Subject|2|||
44529376|NCT00107783|79539268|FG000|Overall Study|Withdrawal by Subject|2|||
44529377|NCT00107783|79539269|FG001|Overall Study|Withdrawal by Subject|0|||
44529378|NCT00107783|79539268|FG000|Overall Study|Second hip replacement|1|||
44529379|NCT00107783|79539269|FG001|Overall Study|Second hip replacement|1|||
44529380|NCT00095303|79539277|FG000|Main Study|Lost to Follow-up|91|||
44529381|NCT00095303|79539278|FG001|Main Study|Lost to Follow-up|87|||
44529382|NCT00095303|79539277|FG000|Follow Up Study|Lost to Follow-up|59|||
44529383|NCT00095303|79539278|FG001|Follow Up Study|Lost to Follow-up|58|||
44529384|NCT00105521|79539288|FG000|Overall Study|Other|1|||
44529385|NCT00105521|79539289|FG001|Overall Study|Other|1|||
44529386|NCT00105521|79539290|FG002|Overall Study|Other|2|||
44529387|NCT00105521|79539291|FG003|Overall Study|Other|0|||
44529388|NCT00105521|79539288|FG000|Overall Study|Adverse Event|10|||
44529389|NCT00105521|79539289|FG001|Overall Study|Adverse Event|4|||
44529390|NCT00105521|79539290|FG002|Overall Study|Adverse Event|10|||
44529391|NCT00105521|79539291|FG003|Overall Study|Adverse Event|8|||
44529392|NCT00105521|79539288|FG000|Overall Study|Withdrawal by Subject|1|||
44529393|NCT00105521|79539289|FG001|Overall Study|Withdrawal by Subject|0|||
44529394|NCT00105521|79539290|FG002|Overall Study|Withdrawal by Subject|1|||
44529395|NCT00105521|79539291|FG003|Overall Study|Withdrawal by Subject|4|||
44529396|NCT00105521|79539288|FG000|Overall Study|Lack of Efficacy|0|||
44529397|NCT00105521|79539289|FG001|Overall Study|Lack of Efficacy|0|||
44529398|NCT00105521|79539290|FG002|Overall Study|Lack of Efficacy|0|||
44529399|NCT00105521|79539291|FG003|Overall Study|Lack of Efficacy|1|||
44529400|NCT00105521|79539288|FG000|Overall Study|Protocol Violation|3|||
44529401|NCT00105521|79539289|FG001|Overall Study|Protocol Violation|5|||
44529402|NCT00105521|79539290|FG002|Overall Study|Protocol Violation|4|||
44529403|NCT00105521|79539291|FG003|Overall Study|Protocol Violation|4|||
44529404|NCT00105521|79539288|FG000|Overall Study|Lost to Follow-up|0|||
44529405|NCT00105521|79539289|FG001|Overall Study|Lost to Follow-up|1|||
44529406|NCT00105521|79539290|FG002|Overall Study|Lost to Follow-up|0|||
44529407|NCT00105521|79539291|FG003|Overall Study|Lost to Follow-up|0|||
44529408|NCT00291551|79539301|FG000|Overall Study|Death|7|||
44529409|NCT00291551|79539301|FG000|Overall Study|Withdrawal by Subject|6|||
44529410|NCT02752048|79539330|FG000|Overall Study|Withdrawal by Subject|0|||
44529411|NCT02752048|79539331|FG001|Overall Study|Withdrawal by Subject|0|||
44529412|NCT02752048|79539332|FG002|Overall Study|Withdrawal by Subject|3|||
44529413|NCT00095147|79539347|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
44529414|NCT00095147|79539348|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
44529415|NCT00095147|79539349|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
44529416|NCT00095147|79539350|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
44529417|NCT00095147|79539351|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
44529418|NCT00095147|79539347|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
44529419|NCT00095147|79539348|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
44529420|NCT00095147|79539349|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
44529421|NCT00095147|79539350|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
44529422|NCT00095147|79539351|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
44529423|NCT00095147|79539347|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
44529424|NCT00095147|79539348|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
44529425|NCT00095147|79539349|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
44529426|NCT00095147|79539350|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
44529427|NCT00095147|79539351|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
44529428|NCT00095147|79539347|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
44529429|NCT00095147|79539348|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
44529430|NCT00095147|79539349|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
44529431|NCT00095147|79539350|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
44529432|NCT00095147|79539351|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
44529433|NCT00095147|79539347|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
44529434|NCT00095147|79539348|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
44529435|NCT00095147|79539349|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
44529436|NCT00095147|79539350|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
44529437|NCT00095147|79539351|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
44529438|NCT00095147|79539347|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
44529439|NCT00095147|79539348|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
44529440|NCT00095147|79539349|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
44529441|NCT00095147|79539350|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
44149218|NCT02172040|78938883|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
44529442|NCT00095147|79539351|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
44529443|NCT00095147|79539347|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
44529444|NCT00095147|79539348|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
44529445|NCT00095147|79539349|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
44529446|NCT00095147|79539350|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
44529447|NCT00095147|79539351|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
44529448|NCT00095147|79539347|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
44529449|NCT00095147|79539348|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
44529450|NCT00095147|79539349|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
44529451|NCT00095147|79539350|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
44529452|NCT00095147|79539351|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
44529453|NCT00095147|79539347|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
44529454|NCT00095147|79539348|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
44529455|NCT00095147|79539349|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
44529456|NCT00095147|79539350|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
44529457|NCT00095147|79539351|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
44529458|NCT00095147|79539347|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
44529459|NCT00095147|79539348|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
44529460|NCT00095147|79539349|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
44529461|NCT00095147|79539350|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
44529462|NCT00095147|79539351|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
44529463|NCT00095147|79539347|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
44529464|NCT00095147|79539348|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
44529465|NCT00095147|79539349|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
44529466|NCT00095147|79539350|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
44529467|NCT00095147|79539351|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
44529468|NCT00095147|79539347|FG000|Long-term Extension Period|Death|0|||
44529469|NCT00095147|79539348|FG001|Long-term Extension Period|Death|0|||
44529470|NCT00095147|79539349|FG002|Long-term Extension Period|Death|0|||
44529471|NCT00095147|79539350|FG003|Long-term Extension Period|Death|0|||
44529472|NCT00095147|79539351|FG004|Long-term Extension Period|Death|3|||
44529473|NCT00095147|79539347|FG000|Long-term Extension Period|Adverse Event|0|||
44529474|NCT00095147|79539348|FG001|Long-term Extension Period|Adverse Event|0|||
44529475|NCT00095147|79539349|FG002|Long-term Extension Period|Adverse Event|0|||
44529476|NCT00095147|79539350|FG003|Long-term Extension Period|Adverse Event|0|||
44529477|NCT00095147|79539351|FG004|Long-term Extension Period|Adverse Event|11|||
44529478|NCT00095147|79539347|FG000|Long-term Extension Period|Lack of Efficacy|0|||
44529479|NCT00095147|79539348|FG001|Long-term Extension Period|Lack of Efficacy|0|||
44529480|NCT00095147|79539349|FG002|Long-term Extension Period|Lack of Efficacy|0|||
44529481|NCT00095147|79539350|FG003|Long-term Extension Period|Lack of Efficacy|0|||
44529482|NCT00095147|79539351|FG004|Long-term Extension Period|Lack of Efficacy|9|||
44529483|NCT00095147|79539347|FG000|Long-term Extension Period|Lost to Follow-up|0|||
44529484|NCT00095147|79539348|FG001|Long-term Extension Period|Lost to Follow-up|0|||
44529485|NCT00095147|79539349|FG002|Long-term Extension Period|Lost to Follow-up|0|||
44529486|NCT00095147|79539350|FG003|Long-term Extension Period|Lost to Follow-up|0|||
44529487|NCT00095147|79539351|FG004|Long-term Extension Period|Lost to Follow-up|6|||
44529488|NCT00095147|79539347|FG000|Long-term Extension Period|Withdrawal of consent|0|||
44529489|NCT00095147|79539348|FG001|Long-term Extension Period|Withdrawal of consent|0|||
44529490|NCT00095147|79539349|FG002|Long-term Extension Period|Withdrawal of consent|0|||
44529491|NCT00095147|79539350|FG003|Long-term Extension Period|Withdrawal of consent|0|||
44529492|NCT00095147|79539351|FG004|Long-term Extension Period|Withdrawal of consent|12|||
44529493|NCT00095147|79539347|FG000|Long-term Extension Period|Pregnancy|0|||
44529494|NCT00095147|79539348|FG001|Long-term Extension Period|Pregnancy|0|||
44529495|NCT00095147|79539349|FG002|Long-term Extension Period|Pregnancy|0|||
44529496|NCT00095147|79539350|FG003|Long-term Extension Period|Pregnancy|0|||
44529497|NCT00095147|79539351|FG004|Long-term Extension Period|Pregnancy|1|||
44529498|NCT00095147|79539347|FG000|Long-term Extension Period|No longer meets study criteria|0|||
44529499|NCT00095147|79539348|FG001|Long-term Extension Period|No longer meets study criteria|0|||
44529500|NCT00095147|79539349|FG002|Long-term Extension Period|No longer meets study criteria|0|||
44529501|NCT00095147|79539350|FG003|Long-term Extension Period|No longer meets study criteria|0|||
44529502|NCT00095147|79539351|FG004|Long-term Extension Period|No longer meets study criteria|1|||
44529503|NCT00095147|79539347|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
44529504|NCT00095147|79539348|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
44529505|NCT00095147|79539349|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
44529506|NCT00095147|79539350|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
44529507|NCT00095147|79539351|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
44529508|NCT00095147|79539347|FG000|Long-term Extension Period|Leaving country|0|||
44529509|NCT00095147|79539348|FG001|Long-term Extension Period|Leaving country|0|||
44529510|NCT00095147|79539349|FG002|Long-term Extension Period|Leaving country|0|||
44529511|NCT00095147|79539350|FG003|Long-term Extension Period|Leaving country|0|||
44149219|NCT02172040|78938880|FG000|Overall Study|Family emergency abroad|0|||
44282381|NCT01898208|79245698|FG001|Overall Study|Death/comfort care within 24 hours|9|||
44282382|NCT01898208|79245699|FG002|Overall Study|Death/comfort care within 24 hours|8|||
44529512|NCT00095147|79539351|FG004|Long-term Extension Period|Leaving country|1|||
44529513|NCT02751502|79539369|FG000|Overall Study|Lack of funding|4|||
44529514|NCT02257918|79539376|FG000|Overall Study|Lost to Follow-up|4|||
44529515|NCT02257918|79539377|FG001|Overall Study|Lost to Follow-up|1|||
44529516|NCT02257918|79539378|FG002|Overall Study|Lost to Follow-up|0|||
44529517|NCT02257918|79539376|FG000|Overall Study|Withdrawal by Subject|0|||
44529518|NCT02257918|79539377|FG001|Overall Study|Withdrawal by Subject|0|||
44529519|NCT02257918|79539378|FG002|Overall Study|Withdrawal by Subject|1|||
44529520|NCT02257918|79539376|FG000|Overall Study|Pregnancy|0|||
44529521|NCT02257918|79539377|FG001|Overall Study|Pregnancy|0|||
44529522|NCT02257918|79539378|FG002|Overall Study|Pregnancy|1|||
44529523|NCT02751424|79539395|FG000|Part 2|Adverse Event|0|||
44529524|NCT02751424|79539396|FG001|Part 2|Adverse Event|0|||
44529525|NCT02751424|79539397|FG002|Part 2|Adverse Event|0|||
44529526|NCT02751424|79539398|FG003|Part 2|Adverse Event|0|||
44529527|NCT02751424|79539399|FG004|Part 2|Adverse Event|0|||
44529528|NCT02751424|79539400|FG005|Part 2|Adverse Event|0|||
44529529|NCT02751424|79539401|FG006|Part 2|Adverse Event|0|||
44529530|NCT02751424|79539402|FG007|Part 2|Adverse Event|5|||
44529531|NCT02751424|79539403|FG008|Part 2|Adverse Event|0|||
44529532|NCT00094835|79539433|FG000|Overall Study|Physician Decision|1|||
44529533|NCT00094835|79539434|FG001|Overall Study|Physician Decision|0|||
44529534|NCT00094835|79539435|FG002|Overall Study|Physician Decision|0|||
44529535|NCT00094835|79539436|FG003|Overall Study|Physician Decision|0|||
44529536|NCT00094835|79539437|FG004|Overall Study|Physician Decision|0|||
44529537|NCT00094835|79539438|FG005|Overall Study|Physician Decision|1|||
44529538|NCT00094835|79539439|FG006|Overall Study|Physician Decision|0|||
44529539|NCT00094835|79539433|FG000|Overall Study|Withdrawal by Subject|0|||
44529540|NCT00094835|79539434|FG001|Overall Study|Withdrawal by Subject|0|||
44529541|NCT00094835|79539435|FG002|Overall Study|Withdrawal by Subject|0|||
44529542|NCT00094835|79539436|FG003|Overall Study|Withdrawal by Subject|0|||
44529543|NCT00094835|79539437|FG004|Overall Study|Withdrawal by Subject|0|||
44529544|NCT00094835|79539438|FG005|Overall Study|Withdrawal by Subject|0|||
44529545|NCT00094835|79539439|FG006|Overall Study|Withdrawal by Subject|1|||
44529546|NCT00094835|79539433|FG000|Overall Study|Lost to Follow-up|0|||
44529547|NCT00094835|79539434|FG001|Overall Study|Lost to Follow-up|0|||
44529548|NCT00094835|79539435|FG002|Overall Study|Lost to Follow-up|0|||
44529549|NCT00094835|79539436|FG003|Overall Study|Lost to Follow-up|0|||
44529550|NCT00094835|79539437|FG004|Overall Study|Lost to Follow-up|1|||
44529551|NCT00094835|79539438|FG005|Overall Study|Lost to Follow-up|0|||
44529552|NCT00094835|79539439|FG006|Overall Study|Lost to Follow-up|0|||
44529553|NCT00094835|79539433|FG000|Overall Study|Death|1|||
44529554|NCT00094835|79539434|FG001|Overall Study|Death|0|||
44529555|NCT00094835|79539435|FG002|Overall Study|Death|0|||
44529556|NCT00094835|79539436|FG003|Overall Study|Death|0|||
44529557|NCT00094835|79539437|FG004|Overall Study|Death|1|||
44529558|NCT00094835|79539438|FG005|Overall Study|Death|0|||
44529559|NCT00094835|79539439|FG006|Overall Study|Death|0|||
44529560|NCT00094835|79539433|FG000|Overall Study|Non-compliance|1|||
44529561|NCT00094835|79539434|FG001|Overall Study|Non-compliance|2|||
44529562|NCT00094835|79539435|FG002|Overall Study|Non-compliance|2|||
44529563|NCT00094835|79539436|FG003|Overall Study|Non-compliance|0|||
44529564|NCT00094835|79539437|FG004|Overall Study|Non-compliance|2|||
44529565|NCT00094835|79539438|FG005|Overall Study|Non-compliance|2|||
44529566|NCT00094835|79539439|FG006|Overall Study|Non-compliance|1|||
44529567|NCT00094835|79539433|FG000|Overall Study|Other|1|||
44529568|NCT00094835|79539434|FG001|Overall Study|Other|1|||
44529569|NCT00094835|79539435|FG002|Overall Study|Other|1|||
44254555|NCT04161495|79096279|FG000|Overall Study|Protocol Violation|1|||
44529570|NCT00094835|79539436|FG003|Overall Study|Other|1|||
44529571|NCT00094835|79539437|FG004|Overall Study|Other|0|||
44529572|NCT00094835|79539438|FG005|Overall Study|Other|0|||
44529573|NCT00094835|79539439|FG006|Overall Study|Other|0|||
44529574|NCT00094757|79539463|FG000|Overall Study|Adverse Event|11|||
44529575|NCT00094757|79539464|FG001|Overall Study|Adverse Event|9|||
44529576|NCT00094757|79539465|FG002|Overall Study|Adverse Event|6|||
44529577|NCT00094757|79539463|FG000|Overall Study|Lack of Efficacy|11|||
44529578|NCT00094757|79539464|FG001|Overall Study|Lack of Efficacy|15|||
44529579|NCT00094757|79539465|FG002|Overall Study|Lack of Efficacy|8|||
44529580|NCT00094757|79539463|FG000|Overall Study|Lost to Follow-up|3|||
44529581|NCT00094757|79539464|FG001|Overall Study|Lost to Follow-up|5|||
44529582|NCT00094757|79539465|FG002|Overall Study|Lost to Follow-up|6|||
44529583|NCT00094757|79539463|FG000|Overall Study|Patient Moved|2|||
44529584|NCT00094757|79539464|FG001|Overall Study|Patient Moved|1|||
44529585|NCT00094757|79539465|FG002|Overall Study|Patient Moved|1|||
44529586|NCT00094757|79539463|FG000|Overall Study|Protocol Violation|8|||
44529587|NCT00094757|79539464|FG001|Overall Study|Protocol Violation|5|||
44529588|NCT00094757|79539465|FG002|Overall Study|Protocol Violation|3|||
44529589|NCT00094757|79539463|FG000|Overall Study|Withdrawal by Subject|14|||
44529590|NCT00094757|79539464|FG001|Overall Study|Withdrawal by Subject|21|||
44529591|NCT00094757|79539465|FG002|Overall Study|Withdrawal by Subject|5|||
44149220|NCT02172040|78938881|FG001|Overall Study|Family emergency abroad|0|||
44149221|NCT02172040|78938882|FG002|Overall Study|Family emergency abroad|0|||
44149222|NCT02172040|78938883|FG003|Overall Study|Family emergency abroad|1|||
44149223|NCT02112994|78938909|FG000|Overall Study|Progressive Disease|0|||
44149224|NCT02112994|78938910|FG001|Overall Study|Progressive Disease|0|||
44149225|NCT02112994|78938911|FG002|Overall Study|Progressive Disease|1|||
44149226|NCT02112994|78938909|FG000|Overall Study|Pregnancy|0|||
44149227|NCT02112994|78938910|FG001|Overall Study|Pregnancy|1|||
44149228|NCT02112994|78938911|FG002|Overall Study|Pregnancy|1|||
44149229|NCT02112994|78938909|FG000|Overall Study|Liver Transplant|0|||
44149230|NCT02112994|78938910|FG001|Overall Study|Liver Transplant|1|||
44149231|NCT02112994|78938911|FG002|Overall Study|Liver Transplant|0|||
44149232|NCT02112994|78938909|FG000|Overall Study|Withdrawal by Subject|0|||
44149233|NCT02112994|78938910|FG001|Overall Study|Withdrawal by Subject|0|||
44149234|NCT02112994|78938911|FG002|Overall Study|Withdrawal by Subject|1|||
44149235|NCT02147158|78938929|FG000|Treatment Course 1|Adverse Event|1|||
44149236|NCT02147158|78938930|FG001|Treatment Course 1|Adverse Event|4|||
44149237|NCT02147158|78938931|FG002|Treatment Course 1|Adverse Event|3|||
44149238|NCT02147158|78938932|FG003|Treatment Course 1|Adverse Event|4|||
44149239|NCT02147158|78938933|FG004|Treatment Course 1|Adverse Event|1|||
44149240|NCT02147158|78938934|FG005|Treatment Course 1|Adverse Event|2|||
44149241|NCT02147158|78938929|FG000|Treatment Course 1|Lost to Follow-up|2|||
44149242|NCT02147158|78938930|FG001|Treatment Course 1|Lost to Follow-up|4|||
44149243|NCT02147158|78938931|FG002|Treatment Course 1|Lost to Follow-up|3|||
44149244|NCT02147158|78938932|FG003|Treatment Course 1|Lost to Follow-up|3|||
44149245|NCT02147158|78938933|FG004|Treatment Course 1|Lost to Follow-up|2|||
44149246|NCT02147158|78938934|FG005|Treatment Course 1|Lost to Follow-up|4|||
44149247|NCT02147158|78938929|FG000|Treatment Course 1|Protocol Violation|0|||
44529592|NCT00094757|79539463|FG000|Overall Study|Other|3|||
44529593|NCT00094757|79539464|FG001|Overall Study|Other|3|||
44529594|NCT00094757|79539465|FG002|Overall Study|Other|1|||
44529595|NCT00094757|79539463|FG000|Overall Study|Protocol specified discontinuation|1|||
44149248|NCT02147158|78938930|FG001|Treatment Course 1|Protocol Violation|0|||
44149249|NCT02147158|78938931|FG002|Treatment Course 1|Protocol Violation|1|||
44529596|NCT00094757|79539464|FG001|Overall Study|Protocol specified discontinuation|3|||
44529597|NCT00094757|79539465|FG002|Overall Study|Protocol specified discontinuation|0|||
44149250|NCT02147158|78938932|FG003|Treatment Course 1|Protocol Violation|1|||
44149251|NCT02147158|78938933|FG004|Treatment Course 1|Protocol Violation|0|||
44149252|NCT02147158|78938934|FG005|Treatment Course 1|Protocol Violation|0|||
44149253|NCT02147158|78938929|FG000|Treatment Course 1|Withdrawal of Consent|1|||
44149254|NCT02147158|78938930|FG001|Treatment Course 1|Withdrawal of Consent|1|||
44529598|NCT04378114|79539473|FG000|Overall Study|Withdrawal by Subject|5|||
44529599|NCT00082433|79539482|FG000|Overall Study|Adverse Event|12|||
44529600|NCT00082433|79539483|FG001|Overall Study|Adverse Event|17|||
44529601|NCT00082433|79539482|FG000|Overall Study|Death|8|||
44529602|NCT00082433|79539483|FG001|Overall Study|Death|18|||
44529603|NCT00082433|79539482|FG000|Overall Study|Disease Progression/Relapse|270|||
44529604|NCT00082433|79539483|FG001|Overall Study|Disease Progression/Relapse|388|||
44529605|NCT00082433|79539482|FG000|Overall Study|Physician Decision|50|||
44529606|NCT00082433|79539483|FG001|Overall Study|Physician Decision|61|||
44529607|NCT00082433|79539482|FG000|Overall Study|Lost to Follow-up|1|||
44529608|NCT00082433|79539483|FG001|Overall Study|Lost to Follow-up|2|||
44529609|NCT00082433|79539482|FG000|Overall Study|Study Drug Toxicity|179|||
44529610|NCT00082433|79539483|FG001|Overall Study|Study Drug Toxicity|66|||
44529611|NCT00082433|79539482|FG000|Overall Study|Withdrawal by Subject|55|||
44149255|NCT02147158|78938931|FG002|Treatment Course 1|Withdrawal of Consent|1|||
44149256|NCT02147158|78938932|FG003|Treatment Course 1|Withdrawal of Consent|5|||
44149257|NCT02147158|78938933|FG004|Treatment Course 1|Withdrawal of Consent|3|||
44149258|NCT02147158|78938934|FG005|Treatment Course 1|Withdrawal of Consent|2|||
44149259|NCT02147158|78938929|FG000|Off-Treatment Interval 1|Adverse Event|1|||
44149260|NCT02147158|78938930|FG001|Off-Treatment Interval 1|Adverse Event|0|||
44149261|NCT02147158|78938931|FG002|Off-Treatment Interval 1|Adverse Event|0|||
44149262|NCT02147158|78938932|FG003|Off-Treatment Interval 1|Adverse Event|1|||
44149263|NCT02147158|78938933|FG004|Off-Treatment Interval 1|Adverse Event|0|||
44149264|NCT02147158|78938934|FG005|Off-Treatment Interval 1|Adverse Event|0|||
44149265|NCT02147158|78938929|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
44149266|NCT02147158|78938930|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
44149267|NCT02147158|78938931|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
44149268|NCT02147158|78938932|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
44149269|NCT02147158|78938933|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
44149270|NCT02147158|78938934|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
44149271|NCT02147158|78938929|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
44149272|NCT02147158|78938930|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
44149273|NCT02147158|78938931|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
44149274|NCT02147158|78938932|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
44149275|NCT02147158|78938933|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
44149276|NCT02147158|78938934|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
44149277|NCT02147158|78938929|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
44149278|NCT02147158|78938930|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
44149279|NCT02147158|78938931|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
44149280|NCT02147158|78938932|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
44149281|NCT02147158|78938933|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
44149282|NCT02147158|78938934|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
44149283|NCT02147158|78938929|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
44149284|NCT02147158|78938930|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
44149285|NCT02147158|78938931|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
44149286|NCT02147158|78938932|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
44149287|NCT02147158|78938933|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
44149288|NCT02147158|78938934|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
44149289|NCT02147158|78938929|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
44254556|NCT04161495|79096280|FG001|Overall Study|Protocol Violation|0|||
44254557|NCT04161495|79096279|FG000|Overall Study|Prohibited concomitant medication|3|||
44254558|NCT04161495|79096280|FG001|Overall Study|Prohibited concomitant medication|0|||
44254559|NCT04161495|79096279|FG000|Overall Study|Adverse Event|1|||
44149290|NCT02147158|78938930|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
44149291|NCT02147158|78938931|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
44149292|NCT02147158|78938932|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
44149293|NCT02147158|78938933|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
44529612|NCT00082433|79539483|FG001|Overall Study|Withdrawal by Subject|30|||
44529613|NCT00082433|79539482|FG000|Overall Study|Still On Treatment|2|||
44529614|NCT00082433|79539483|FG001|Overall Study|Still On Treatment|1|||
44529615|NCT00082433|79539482|FG000|Overall Study|Not Treated|12|||
44149294|NCT02147158|78938934|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
44254560|NCT04161495|79096280|FG001|Overall Study|Adverse Event|0|||
44529616|NCT00082433|79539483|FG001|Overall Study|Not Treated|11|||
44529617|NCT00082433|79539482|FG000|Overall Study|Ineligible|2|||
44529618|NCT00082433|79539483|FG001|Overall Study|Ineligible|1|||
44529619|NCT00082433|79539482|FG000|Overall Study|Noncompliance|2|||
44529620|NCT00082433|79539483|FG001|Overall Study|Noncompliance|1|||
44529621|NCT00082433|79539482|FG000|Overall Study|New primary cancer|1|||
44529622|NCT00082433|79539483|FG001|Overall Study|New primary cancer|0|||
44529623|NCT00082433|79539482|FG000|Overall Study|Impending surgery|0|||
44529624|NCT00082433|79539483|FG001|Overall Study|Impending surgery|1|||
44149295|NCT02147158|78938929|FG000|Treatment Course 2|Adverse Event|0|||
44149296|NCT02147158|78938930|FG001|Treatment Course 2|Adverse Event|4|||
44149297|NCT02147158|78938931|FG002|Treatment Course 2|Adverse Event|2|||
44149298|NCT02147158|78938932|FG003|Treatment Course 2|Adverse Event|1|||
44149299|NCT02147158|78938933|FG004|Treatment Course 2|Adverse Event|0|||
44149300|NCT02147158|78938934|FG005|Treatment Course 2|Adverse Event|1|||
44149301|NCT02147158|78938929|FG000|Treatment Course 2|Withdrawal of Consent|0|||
44149302|NCT02147158|78938930|FG001|Treatment Course 2|Withdrawal of Consent|1|||
44149303|NCT02147158|78938931|FG002|Treatment Course 2|Withdrawal of Consent|2|||
44149304|NCT02147158|78938932|FG003|Treatment Course 2|Withdrawal of Consent|3|||
44149305|NCT02147158|78938933|FG004|Treatment Course 2|Withdrawal of Consent|0|||
44149306|NCT02147158|78938934|FG005|Treatment Course 2|Withdrawal of Consent|0|||
44149307|NCT02147158|78938929|FG000|Treatment Course 2|Lost to Follow-up|1|||
44149308|NCT02147158|78938930|FG001|Treatment Course 2|Lost to Follow-up|0|||
44149309|NCT02147158|78938931|FG002|Treatment Course 2|Lost to Follow-up|1|||
44149310|NCT02147158|78938932|FG003|Treatment Course 2|Lost to Follow-up|1|||
44149311|NCT02147158|78938933|FG004|Treatment Course 2|Lost to Follow-up|0|||
44149312|NCT02147158|78938934|FG005|Treatment Course 2|Lost to Follow-up|1|||
44149313|NCT02147158|78938929|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
44149314|NCT02147158|78938930|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
44149315|NCT02147158|78938931|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
44149316|NCT02147158|78938932|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
44149317|NCT02147158|78938933|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
44149318|NCT02147158|78938934|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
44149319|NCT02147158|78938929|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
44149320|NCT02147158|78938930|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
44149321|NCT02147158|78938931|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
44149322|NCT02147158|78938932|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
44149323|NCT02147158|78938933|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
44149324|NCT02147158|78938934|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
44149325|NCT02147158|78938929|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
44149326|NCT02147158|78938930|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
44149327|NCT02147158|78938931|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
44149328|NCT02147158|78938932|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
44149329|NCT02147158|78938933|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
44149330|NCT02147158|78938934|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
44149331|NCT02147158|78938929|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
44149332|NCT02147158|78938930|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
44149333|NCT02147158|78938931|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
44149334|NCT02147158|78938932|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
44149335|NCT02147158|78938933|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
44149336|NCT02147158|78938934|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
44149337|NCT02147158|78938929|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
44149338|NCT02147158|78938930|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
44149339|NCT02147158|78938931|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
44149340|NCT02147158|78938932|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
44149341|NCT02147158|78938933|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
44149342|NCT02147158|78938934|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
44149343|NCT02112448|78938953|FG000|Overall Study|lab values precluding use of ketorolac|2|||
44149344|NCT02112448|78938954|FG001|Overall Study|lab values precluding use of ketorolac|2|||
44149345|NCT02112448|78938953|FG000|Overall Study|Protocol Violation|1|||
44149346|NCT02112448|78938954|FG001|Overall Study|Protocol Violation|2|||
44149347|NCT02112448|78938953|FG000|Overall Study|Physician Decision|4|||
44149348|NCT02112448|78938954|FG001|Overall Study|Physician Decision|6|||
44149349|NCT02112448|78938953|FG000|Overall Study|required heparin so could not use ketoro|1|||
44149350|NCT02112448|78938954|FG001|Overall Study|required heparin so could not use ketoro|0|||
44149351|NCT02171260|78938966|FG000|Overall Study|Death|0|||
44529625|NCT00094445|79539489|FG000|Overall Study|Withdrawal by Subject|3|||
44149352|NCT02171260|78938967|FG001|Overall Study|Death|0|||
44149353|NCT02171260|78938968|FG002|Overall Study|Death|0|||
44149354|NCT02171260|78938969|FG003|Overall Study|Death|1|||
44149355|NCT02171260|78938966|FG000|Overall Study|Physician Decision|1|||
44149356|NCT02171260|78938967|FG001|Overall Study|Physician Decision|0|||
44254561|NCT04161495|79096279|FG000|Overall Study|Other - Unspecified|1|||
44529626|NCT00094445|79539489|FG000|Overall Study|Lost to Follow-up|1|||
44149357|NCT02171260|78938968|FG002|Overall Study|Physician Decision|1|||
44529627|NCT00094445|79539489|FG000|Overall Study|Progressive Disease|2|||
44149358|NCT02171260|78938969|FG003|Overall Study|Physician Decision|0|||
44149359|NCT02171260|78938966|FG000|Overall Study|Withdrawal by Subject|1|||
44149360|NCT02171260|78938967|FG001|Overall Study|Withdrawal by Subject|0|||
44149361|NCT02171260|78938968|FG002|Overall Study|Withdrawal by Subject|0|||
44149362|NCT02171260|78938969|FG003|Overall Study|Withdrawal by Subject|0|||
44149363|NCT02171260|78938966|FG000|Overall Study|Evidence of progressive disease|4|||
44149364|NCT02171260|78938967|FG001|Overall Study|Evidence of progressive disease|6|||
44149365|NCT02171260|78938968|FG002|Overall Study|Evidence of progressive disease|4|||
44149366|NCT02171260|78938969|FG003|Overall Study|Evidence of progressive disease|4|||
44149367|NCT02110732|78938987|FG000|Overall Study|Physician Decision|5|||
44149368|NCT02110732|78938988|FG001|Overall Study|Physician Decision|2|||
44149369|NCT02110732|78938987|FG000|Overall Study|Lost to Follow-up|1|||
44149370|NCT02110732|78938988|FG001|Overall Study|Lost to Follow-up|1|||
44149371|NCT02109562|78938997|FG000|Overall Study|Insufficient clinical response|2|||
44149372|NCT02109562|78938998|FG001|Overall Study|Insufficient clinical response|0|||
44149373|NCT02109562|78938999|FG002|Overall Study|Insufficient clinical response|4|||
44149374|NCT02109562|78938997|FG000|Overall Study|Adverse Event|0|||
44149375|NCT02109562|78938998|FG001|Overall Study|Adverse Event|2|||
44149376|NCT02109562|78938999|FG002|Overall Study|Adverse Event|3|||
44149377|NCT02109562|78938997|FG000|Overall Study|Lost to Follow-up|1|||
44149378|NCT02109562|78938998|FG001|Overall Study|Lost to Follow-up|0|||
44529628|NCT00082355|79539493|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
44529629|NCT00082355|79539493|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
44529630|NCT00082355|79539493|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
44529631|NCT00094055|79539497|FG000|Overall Study|Adverse Event|11|||
44529632|NCT00094055|79539497|FG000|Overall Study|Death|4|||
44529633|NCT00094055|79539497|FG000|Overall Study|Lack of Efficacy|17|||
44529634|NCT00094055|79539497|FG000|Overall Study|Lost to Follow-up|2|||
44529635|NCT00094055|79539497|FG000|Overall Study|progressive disease|2|||
44529636|NCT00094055|79539497|FG000|Overall Study|clinical progression|1|||
44529637|NCT00094055|79539497|FG000|Overall Study|roll-over to another study|14|||
44529638|NCT00094055|79539497|FG000|Overall Study|Withdrawal by Subject|9|||
44529639|NCT00099983|79539503|FG000|Overall Study|Lost to Follow-up|2|||
44149379|NCT02109562|78938999|FG002|Overall Study|Lost to Follow-up|1|||
44149380|NCT02109562|78938997|FG000|Overall Study|Protocol Violation|0|||
44149381|NCT02109562|78938998|FG001|Overall Study|Protocol Violation|3|||
44149382|NCT02109562|78938999|FG002|Overall Study|Protocol Violation|1|||
44149383|NCT02109562|78938997|FG000|Overall Study|Withdrawal by Subject|20|||
44149384|NCT02109562|78938998|FG001|Overall Study|Withdrawal by Subject|25|||
44149385|NCT02109562|78938999|FG002|Overall Study|Withdrawal by Subject|21|||
44149386|NCT02109562|78938997|FG000|Overall Study|Physician Decision|3|||
44149387|NCT02109562|78938998|FG001|Overall Study|Physician Decision|4|||
44149388|NCT02109562|78938999|FG002|Overall Study|Physician Decision|5|||
44254562|NCT04161495|79096280|FG001|Overall Study|Other - Unspecified|0|||
44149389|NCT02109484|78939015|FG000|Overall Study|Lost to Follow-up|0|||
44149390|NCT02109484|78939016|FG001|Overall Study|Lost to Follow-up|0|||
44149391|NCT02109484|78939017|FG002|Overall Study|Lost to Follow-up|0|||
44254563|NCT04161495|79096279|FG000|Overall Study|Death|0|||
44149392|NCT02109484|78939018|FG003|Overall Study|Lost to Follow-up|1|||
44254564|NCT04161495|79096280|FG001|Overall Study|Death|1|||
44254565|NCT04108000|79096309|FG000|Overall Study|Death of patient|1|||
44254566|NCT04108000|79096310|FG001|Overall Study|Death of patient|0|||
44529640|NCT00099983|79539504|FG001|Overall Study|Lost to Follow-up|3|||
44529641|NCT00099983|79539503|FG000|Overall Study|Missing Source Documents|14|||
44149393|NCT02109484|78939019|FG004|Overall Study|Lost to Follow-up|1|||
44149394|NCT02109484|78939020|FG005|Overall Study|Lost to Follow-up|0|||
44529642|NCT00099983|79539504|FG001|Overall Study|Missing Source Documents|15|||
44529643|NCT00099983|79539503|FG000|Overall Study|Withdrawal by Subject|3|||
44529644|NCT00099983|79539504|FG001|Overall Study|Withdrawal by Subject|2|||
44529645|NCT00099983|79539503|FG000|Overall Study|Adverse Event|1|||
44529646|NCT00099983|79539504|FG001|Overall Study|Adverse Event|1|||
44529647|NCT00099983|79539503|FG000|Overall Study|Lack of Efficacy|0|||
44529648|NCT00099983|79539504|FG001|Overall Study|Lack of Efficacy|1|||
44529649|NCT00099983|79539503|FG000|Overall Study|Unable to return for appointments|1|||
44149395|NCT02109484|78939021|FG006|Overall Study|Lost to Follow-up|1|||
44149396|NCT02109484|78939022|FG007|Overall Study|Lost to Follow-up|0|||
44149397|NCT02109484|78939015|FG000|Overall Study|Withdrawal by Subject|0|||
44149398|NCT02109484|78939016|FG001|Overall Study|Withdrawal by Subject|0|||
44149399|NCT02109484|78939017|FG002|Overall Study|Withdrawal by Subject|0|||
44149400|NCT02109484|78939018|FG003|Overall Study|Withdrawal by Subject|0|||
44149401|NCT02109484|78939019|FG004|Overall Study|Withdrawal by Subject|1|||
44149402|NCT02109484|78939020|FG005|Overall Study|Withdrawal by Subject|1|||
44149403|NCT02109484|78939021|FG006|Overall Study|Withdrawal by Subject|1|||
44149404|NCT02109484|78939022|FG007|Overall Study|Withdrawal by Subject|0|||
44149405|NCT02109484|78939015|FG000|Overall Study|Physician Decision|0|||
44149406|NCT02109484|78939016|FG001|Overall Study|Physician Decision|0|||
44149407|NCT02109484|78939017|FG002|Overall Study|Physician Decision|0|||
44149408|NCT02109484|78939018|FG003|Overall Study|Physician Decision|0|||
44149409|NCT02109484|78939019|FG004|Overall Study|Physician Decision|2|||
44149410|NCT02109484|78939020|FG005|Overall Study|Physician Decision|0|||
44149411|NCT02109484|78939021|FG006|Overall Study|Physician Decision|0|||
44149412|NCT02109484|78939022|FG007|Overall Study|Physician Decision|0|||
44149413|NCT02109484|78939015|FG000|Overall Study|Death|0|||
44149414|NCT02109484|78939016|FG001|Overall Study|Death|0|||
44149415|NCT02109484|78939017|FG002|Overall Study|Death|0|||
44149416|NCT02109484|78939018|FG003|Overall Study|Death|0|||
44149417|NCT02109484|78939019|FG004|Overall Study|Death|0|||
44149418|NCT02109484|78939020|FG005|Overall Study|Death|0|||
44149419|NCT02109484|78939021|FG006|Overall Study|Death|0|||
44149420|NCT02109484|78939022|FG007|Overall Study|Death|2|||
44149421|NCT02109484|78939015|FG000|Overall Study|Moved away from study area|0|||
44149422|NCT02109484|78939016|FG001|Overall Study|Moved away from study area|0|||
44149423|NCT02109484|78939017|FG002|Overall Study|Moved away from study area|0|||
44149424|NCT02109484|78939018|FG003|Overall Study|Moved away from study area|0|||
44149425|NCT02109484|78939019|FG004|Overall Study|Moved away from study area|0|||
44149426|NCT02109484|78939020|FG005|Overall Study|Moved away from study area|0|||
44149427|NCT02109484|78939021|FG006|Overall Study|Moved away from study area|1|||
44414996|NCT00813488|79422929|FG000|Open-label Extension|Protocol Violation|1|||
44414997|NCT00813488|79422930|FG001|Open-label Extension|Protocol Violation|2|||
44414998|NCT00813488|79422929|FG000|Open-label Extension|Non-compliance study medication|4|||
44414999|NCT00813488|79422930|FG001|Open-label Extension|Non-compliance study medication|0|||
44415000|NCT00813488|79422929|FG000|Open-label Extension|Non-compliance study procedures|2|||
44415001|NCT00813488|79422930|FG001|Open-label Extension|Non-compliance study procedures|1|||
44415002|NCT00813488|79422929|FG000|Open-label Extension|Other|1|||
44415003|NCT00813488|79422930|FG001|Open-label Extension|Other|0|||
44415004|NCT00797316|79422942|FG000|Overall Study|Administrative problems|1|||
44415005|NCT00797316|79422943|FG001|Overall Study|Administrative problems|0|||
44415006|NCT00797316|79422942|FG000|Overall Study|Adverse Event|5|||
44415007|NCT00797316|79422943|FG001|Overall Study|Adverse Event|3|||
44415008|NCT00797316|79422942|FG000|Overall Study|Lost to Follow-up|4|||
44415009|NCT00797316|79422943|FG001|Overall Study|Lost to Follow-up|8|||
44415010|NCT00797316|79422942|FG000|Overall Study|Protocol Deviation|1|||
44415011|NCT00797316|79422943|FG001|Overall Study|Protocol Deviation|2|||
44415012|NCT00797316|79422942|FG000|Overall Study|Patient withdrew consent|12|||
44415013|NCT00797316|79422943|FG001|Overall Study|Patient withdrew consent|6|||
44415014|NCT00797316|79422942|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44415015|NCT00797316|79422943|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
44415016|NCT00587964|79422949|FG000|Overall Study|Withdrawal by Subject|1|||
44415017|NCT00587964|79422949|FG000|Overall Study|Lost to Follow-up|1|||
44415018|NCT00587964|79422949|FG000|Overall Study|Patient found to be ineligible|1|||
44415019|NCT00587964|79422949|FG000|Overall Study|Patient did not receive intervention|5|||
44415020|NCT00587964|79422949|FG000|Overall Study|Progression of Disease|4|||
44529650|NCT00099983|79539504|FG001|Overall Study|Unable to return for appointments|1|||
44149428|NCT02109484|78939022|FG007|Overall Study|Moved away from study area|1|||
44149429|NCT02105974|78939059|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
44149430|NCT02105974|78939060|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
44149431|NCT02105974|78939061|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
44254567|NCT04108000|79096311|FG002|Overall Study|Death of patient|1|||
44415021|NCT00590954|79422953|FG000|Overall Study|Inevaluable|2|||
44415022|NCT00791076|79422959|FG000|Overall Study|Study was terminated,PI left institution|8|||
44415023|NCT00590720|79422967|FG000|Overall Study|Lost to Follow-up|1|||
44415024|NCT00590720|79422968|FG001|Overall Study|Lost to Follow-up|0|||
44149432|NCT02105974|78939059|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
44149433|NCT02105974|78939060|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
44529651|NCT00099983|79539503|FG000|Overall Study|Moved|1|||
44529652|NCT00099983|79539504|FG001|Overall Study|Moved|0|||
44149434|NCT02105974|78939061|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
44149435|NCT02105974|78939059|FG000|2 Week Run-in Period|Adverse Event|6|||
44149436|NCT02105974|78939060|FG001|2 Week Run-in Period|Adverse Event|0|||
44149437|NCT02105974|78939061|FG002|2 Week Run-in Period|Adverse Event|0|||
44149438|NCT02105974|78939059|FG000|2 Week Run-in Period|Study closed/terminated|1|||
44149439|NCT02105974|78939060|FG001|2 Week Run-in Period|Study closed/terminated|0|||
44149440|NCT02105974|78939061|FG002|2 Week Run-in Period|Study closed/terminated|0|||
44149441|NCT02105974|78939059|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
44149442|NCT02105974|78939060|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
44149443|NCT02105974|78939061|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
44149444|NCT02105974|78939059|FG000|2 Week Run-in Period|Withdrew consent|23|||
44149445|NCT02105974|78939060|FG001|2 Week Run-in Period|Withdrew consent|0|||
44149446|NCT02105974|78939061|FG002|2 Week Run-in Period|Withdrew consent|0|||
44149447|NCT02105974|78939059|FG000|2 Week Run-in Period|Investigator discretion|8|||
44149448|NCT02105974|78939060|FG001|2 Week Run-in Period|Investigator discretion|0|||
44149449|NCT02105974|78939061|FG002|2 Week Run-in Period|Investigator discretion|0|||
44149450|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
44149451|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
44149452|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
44149453|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
44149454|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
44149455|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
44149456|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
44149457|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
44149458|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
44149459|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
44149460|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
44149461|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
44149462|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
44149463|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
44149464|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
44149465|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
44149466|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
44149467|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
44149468|NCT02105974|78939059|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
44149469|NCT02105974|78939060|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
44149470|NCT02105974|78939061|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
44149471|NCT02105662|78939067|FG000|Overall Study|Lost to Follow-up|5|||
44254568|NCT04108000|79096312|FG003|Overall Study|Death of patient|0|||
44254569|NCT04108000|79096309|FG000|Overall Study|Withdrawal by Subject|2|||
44254570|NCT04108000|79096310|FG001|Overall Study|Withdrawal by Subject|2|||
44254571|NCT04108000|79096311|FG002|Overall Study|Withdrawal by Subject|0|||
44254572|NCT04108000|79096312|FG003|Overall Study|Withdrawal by Subject|0|||
44529653|NCT00099983|79539503|FG000|Overall Study|Other psychiatric problem|1|||
44149472|NCT02105662|78939067|FG000|Overall Study|Withdrawal by Subject|1|||
44149473|NCT02143102|78939073|FG000|Overall Study|Lost to Follow-up|11|||
44149474|NCT02143102|78939074|FG001|Overall Study|Lost to Follow-up|0|||
44149475|NCT02143024|78939082|FG000|Overall Study|Lost to Follow-up|1|||
44149476|NCT02143024|78939083|FG001|Overall Study|Lost to Follow-up|1|||
44149477|NCT02143024|78939082|FG000|Overall Study|Withdrawal by Subject|1|||
44254573|NCT04108000|79096309|FG000|Overall Study|Death of surrogate partner|0|||
44529654|NCT00099983|79539504|FG001|Overall Study|Other psychiatric problem|0|||
44529655|NCT00099983|79539503|FG000|Overall Study|Incarcerated|0|||
44529656|NCT00099983|79539504|FG001|Overall Study|Incarcerated|1|||
44529657|NCT00099983|79539503|FG000|Overall Study|Intolerant of burden of visits|0|||
44529658|NCT00099983|79539504|FG001|Overall Study|Intolerant of burden of visits|1|||
44529659|NCT00099983|79539503|FG000|Overall Study|Other issue|1|||
44529660|NCT00099983|79539504|FG001|Overall Study|Other issue|0|||
44529661|NCT00099359|79539513|FG000|Overall Study|Death|11|||
44529662|NCT00099359|79539514|FG001|Overall Study|Death|15|||
44529663|NCT00099359|79539515|FG002|Overall Study|Death|17|||
44529664|NCT00099359|79539513|FG000|Overall Study|Withdrawal by Subject|19|||
44529665|NCT00099359|79539514|FG001|Overall Study|Withdrawal by Subject|19|||
44529666|NCT00099359|79539515|FG002|Overall Study|Withdrawal by Subject|23|||
44149478|NCT02143024|78939083|FG001|Overall Study|Withdrawal by Subject|0|||
44529667|NCT00099359|79539513|FG000|Overall Study|Lost to Follow-up|15|||
44529668|NCT00099359|79539514|FG001|Overall Study|Lost to Follow-up|24|||
44529669|NCT00099359|79539515|FG002|Overall Study|Lost to Follow-up|24|||
44149479|NCT02142712|78939092|FG000|Overall Study|Lost to Follow-up|1|||
44149480|NCT02142712|78939093|FG001|Overall Study|Lost to Follow-up|1|||
44149481|NCT02142712|78939094|FG002|Overall Study|Lost to Follow-up|1|||
44149482|NCT02142712|78939095|FG003|Overall Study|Lost to Follow-up|0|||
44149483|NCT02105272|78939106|FG000|Overall Study|Adverse Event|1|||
44254574|NCT04108000|79096310|FG001|Overall Study|Death of surrogate partner|1|||
44254575|NCT04108000|79096311|FG002|Overall Study|Death of surrogate partner|0|||
44254576|NCT04108000|79096312|FG003|Overall Study|Death of surrogate partner|1|||
44254577|NCT03945266|79096328|FG000|Overall Study|Withdrawal by Subject|1|||
44254578|NCT03945266|79096329|FG001|Overall Study|Withdrawal by Subject|0|||
44254579|NCT03945266|79096328|FG000|Overall Study|Miscarriage|0|||
44254580|NCT03945266|79096329|FG001|Overall Study|Miscarriage|2|||
44254581|NCT03945266|79096328|FG000|Overall Study|Lost to Follow-up|1|||
44254582|NCT03945266|79096329|FG001|Overall Study|Lost to Follow-up|0|||
44254583|NCT03916484|79096343|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
44254584|NCT03916484|79096344|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
44254585|NCT03916484|79096345|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
44254586|NCT03916484|79096346|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
44254587|NCT03916484|79096343|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
44254588|NCT03916484|79096344|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
44254589|NCT03916484|79096345|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
44254590|NCT03916484|79096346|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
44254591|NCT03769311|79096361|FG000|Overall Study|Withdrawal by Subject|1|||
44254592|NCT03738566|79096369|FG000|Initial Study Phase|Withdrawal by Subject|1|||
44254593|NCT03738566|79096370|FG001|Initial Study Phase|Withdrawal by Subject|1|||
44254594|NCT03738566|79096371|FG002|Initial Study Phase|Withdrawal by Subject|2|||
44254595|NCT03738566|79096372|FG003|Initial Study Phase|Withdrawal by Subject|0|||
44415025|NCT00590720|79422967|FG000|Overall Study|Withdrawal by Subject|0|||
44254596|NCT03738566|79096369|FG000|Initial Study Phase|Death|0|||
44254597|NCT03738566|79096370|FG001|Initial Study Phase|Death|1|||
44254598|NCT03738566|79096371|FG002|Initial Study Phase|Death|0|||
44254599|NCT03738566|79096372|FG003|Initial Study Phase|Death|0|||
44254600|NCT03738566|79096369|FG000|Initial Study Phase|Treatment failure|5|||
44254601|NCT03738566|79096370|FG001|Initial Study Phase|Treatment failure|0|||
44282383|NCT01898208|79245697|FG000|Overall Study|Negative Gram Stain|6|||
44415026|NCT00590720|79422968|FG001|Overall Study|Withdrawal by Subject|1|||
44415027|NCT00625378|79422976|FG000|Overall Study|Adverse Event|22|||
44529670|NCT00099359|79539513|FG000|Overall Study|moved out of area|9|||
44529671|NCT00099359|79539514|FG001|Overall Study|moved out of area|7|||
44529672|NCT00099359|79539515|FG002|Overall Study|moved out of area|4|||
44529673|NCT00092495|79539537|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
44529674|NCT00092495|79539538|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
44529675|NCT00092495|79539539|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
44529676|NCT00092495|79539540|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
44529677|NCT00092495|79539541|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
44529678|NCT00092495|79539537|FG000|Base Study Vaccination Period|Extended|0|||
44529679|NCT00092495|79539538|FG001|Base Study Vaccination Period|Extended|0|||
44529680|NCT00092495|79539539|FG002|Base Study Vaccination Period|Extended|0|||
44529681|NCT00092495|79539540|FG003|Base Study Vaccination Period|Extended|1|||
44529682|NCT00092495|79539541|FG004|Base Study Vaccination Period|Extended|0|||
44529683|NCT00092495|79539537|FG000|Base Study Vaccination Period|*Clinical AE|1|||
44529684|NCT00092495|79539538|FG001|Base Study Vaccination Period|*Clinical AE|0|||
44529685|NCT00092495|79539539|FG002|Base Study Vaccination Period|*Clinical AE|1|||
44529686|NCT00092495|79539540|FG003|Base Study Vaccination Period|*Clinical AE|2|||
44529687|NCT00092495|79539541|FG004|Base Study Vaccination Period|*Clinical AE|0|||
44529688|NCT00092495|79539537|FG000|Base Study Vaccination Period|*Other reasons|1|||
44529689|NCT00092495|79539538|FG001|Base Study Vaccination Period|*Other reasons|0|||
44529690|NCT00092495|79539539|FG002|Base Study Vaccination Period|*Other reasons|0|||
44529691|NCT00092495|79539540|FG003|Base Study Vaccination Period|*Other reasons|1|||
44529692|NCT00092495|79539541|FG004|Base Study Vaccination Period|*Other reasons|0|||
44529693|NCT00092495|79539537|FG000|Base Study Vaccination Period|*Pregnancy|0|||
44529694|NCT00092495|79539538|FG001|Base Study Vaccination Period|*Pregnancy|2|||
44529695|NCT00092495|79539539|FG002|Base Study Vaccination Period|*Pregnancy|5|||
44149484|NCT02105272|78939107|FG001|Overall Study|Adverse Event|2|||
44149485|NCT02105272|78939106|FG000|Overall Study|Physician Decision|0|||
44149486|NCT02105272|78939107|FG001|Overall Study|Physician Decision|1|||
44149487|NCT02105272|78939106|FG000|Overall Study|Protocol Violation|2|||
44149488|NCT02105272|78939107|FG001|Overall Study|Protocol Violation|0|||
44149489|NCT02105272|78939106|FG000|Overall Study|Withdrawal by Subject|2|||
44149490|NCT02105272|78939107|FG001|Overall Study|Withdrawal by Subject|0|||
44282384|NCT01898208|79245698|FG001|Overall Study|Negative Gram Stain|9|||
44529696|NCT00092495|79539540|FG003|Base Study Vaccination Period|*Pregnancy|7|||
44529697|NCT00092495|79539541|FG004|Base Study Vaccination Period|*Pregnancy|0|||
44529698|NCT00092495|79539537|FG000|Base Study Vaccination Period|Adverse Event|1|||
44529699|NCT00092495|79539538|FG001|Base Study Vaccination Period|Adverse Event|0|||
44529700|NCT00092495|79539539|FG002|Base Study Vaccination Period|Adverse Event|0|||
44529701|NCT00092495|79539540|FG003|Base Study Vaccination Period|Adverse Event|3|||
44529702|NCT00092495|79539541|FG004|Base Study Vaccination Period|Adverse Event|0|||
44529703|NCT00092495|79539537|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
44529704|NCT00092495|79539538|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
44529705|NCT00092495|79539539|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
44529706|NCT00092495|79539540|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
44529707|NCT00092495|79539541|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
44529708|NCT00092495|79539537|FG000|Base Study Vaccination Period|Moved|3|||
44149491|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
44529709|NCT00092495|79539538|FG001|Base Study Vaccination Period|Moved|1|||
44529710|NCT00092495|79539539|FG002|Base Study Vaccination Period|Moved|2|||
44529711|NCT00092495|79539540|FG003|Base Study Vaccination Period|Moved|2|||
44529712|NCT00092495|79539541|FG004|Base Study Vaccination Period|Moved|0|||
44529713|NCT00092495|79539537|FG000|Base Study Vaccination Period|Other|1|||
44529714|NCT00092495|79539538|FG001|Base Study Vaccination Period|Other|1|||
44529715|NCT00092495|79539539|FG002|Base Study Vaccination Period|Other|0|||
44529716|NCT00092495|79539540|FG003|Base Study Vaccination Period|Other|2|||
44529717|NCT00092495|79539541|FG004|Base Study Vaccination Period|Other|0|||
44149492|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44149493|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44149494|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44149495|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44149496|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
44254602|NCT03738566|79096371|FG002|Initial Study Phase|Treatment failure|0|||
44254603|NCT03738566|79096372|FG003|Initial Study Phase|Treatment failure|0|||
44254604|NCT03738566|79096369|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
44254605|NCT03738566|79096370|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
44254606|NCT03738566|79096371|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
44254607|NCT03738566|79096372|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
44254608|NCT03533751|79096407|FG000|Overall Study|Withdrawal by Subject|12|||
44254609|NCT03533751|79096408|FG001|Overall Study|Withdrawal by Subject|6|||
44254610|NCT03533751|79096409|FG002|Overall Study|Withdrawal by Subject|11|||
44254611|NCT03533751|79096410|FG003|Overall Study|Withdrawal by Subject|9|||
44254612|NCT03533751|79096411|FG004|Overall Study|Withdrawal by Subject|10|||
44254613|NCT03533751|79096407|FG000|Overall Study|Adverse Event|4|||
44254614|NCT03533751|79096408|FG001|Overall Study|Adverse Event|7|||
44254615|NCT03533751|79096409|FG002|Overall Study|Adverse Event|2|||
44254616|NCT03533751|79096410|FG003|Overall Study|Adverse Event|4|||
44254617|NCT03533751|79096411|FG004|Overall Study|Adverse Event|5|||
44254618|NCT03533751|79096407|FG000|Overall Study|Physician Decision|0|||
44254619|NCT03533751|79096408|FG001|Overall Study|Physician Decision|2|||
44254620|NCT03533751|79096409|FG002|Overall Study|Physician Decision|1|||
44254621|NCT03533751|79096410|FG003|Overall Study|Physician Decision|2|||
44254622|NCT03533751|79096411|FG004|Overall Study|Physician Decision|1|||
44254623|NCT03533751|79096407|FG000|Overall Study|Sponsor Decision|0|||
44254624|NCT03533751|79096408|FG001|Overall Study|Sponsor Decision|0|||
44254625|NCT03533751|79096409|FG002|Overall Study|Sponsor Decision|1|||
44254626|NCT03533751|79096410|FG003|Overall Study|Sponsor Decision|1|||
44254627|NCT03533751|79096411|FG004|Overall Study|Sponsor Decision|0|||
44254628|NCT03533751|79096407|FG000|Overall Study|Lost to Follow-up|3|||
44254629|NCT03533751|79096408|FG001|Overall Study|Lost to Follow-up|7|||
44254630|NCT03533751|79096409|FG002|Overall Study|Lost to Follow-up|6|||
44254631|NCT03533751|79096410|FG003|Overall Study|Lost to Follow-up|4|||
44254632|NCT03533751|79096411|FG004|Overall Study|Lost to Follow-up|3|||
44254633|NCT03533751|79096407|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
44254634|NCT03533751|79096408|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
44254635|NCT03533751|79096409|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
44254636|NCT03533751|79096410|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
44254637|NCT03533751|79096411|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
44254638|NCT03533751|79096407|FG000|Overall Study|Other|0|||
44254639|NCT03533751|79096408|FG001|Overall Study|Other|2|||
44254640|NCT03533751|79096409|FG002|Overall Study|Other|1|||
44254641|NCT03533751|79096410|FG003|Overall Study|Other|0|||
44254642|NCT03533751|79096411|FG004|Overall Study|Other|3|||
44254643|NCT04856917|79096430|FG000|Overall Study|Withdrawal by Subject|4|||
44254644|NCT04856917|79096431|FG001|Overall Study|Withdrawal by Subject|3|||
44254645|NCT04856917|79096432|FG002|Overall Study|Withdrawal by Subject|1|||
44254646|NCT04856917|79096430|FG000|Overall Study|Lost to Follow-up|3|||
44529718|NCT00092495|79539537|FG000|Base Study Vaccination Period|Pregnancy|2|||
44254647|NCT04856917|79096431|FG001|Overall Study|Lost to Follow-up|1|||
44254648|NCT04856917|79096432|FG002|Overall Study|Lost to Follow-up|1|||
44254649|NCT04856917|79096430|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
44254650|NCT04856917|79096431|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
44282385|NCT01898208|79245699|FG002|Overall Study|Negative Gram Stain|6|||
44529719|NCT00092495|79539538|FG001|Base Study Vaccination Period|Pregnancy|0|||
44529720|NCT00092495|79539539|FG002|Base Study Vaccination Period|Pregnancy|0|||
44529721|NCT00092495|79539540|FG003|Base Study Vaccination Period|Pregnancy|0|||
44529722|NCT00092495|79539541|FG004|Base Study Vaccination Period|Pregnancy|0|||
44529723|NCT00092495|79539537|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
44529724|NCT00092495|79539538|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
44529725|NCT00092495|79539539|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
44529726|NCT00092495|79539540|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
44529727|NCT00092495|79539541|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
44529728|NCT00092495|79539537|FG000|Base Study Vaccination Period|Protocol Violation|1|||
44529729|NCT00092495|79539538|FG001|Base Study Vaccination Period|Protocol Violation|0|||
44529730|NCT00092495|79539539|FG002|Base Study Vaccination Period|Protocol Violation|0|||
44529731|NCT00092495|79539540|FG003|Base Study Vaccination Period|Protocol Violation|0|||
44529732|NCT00092495|79539541|FG004|Base Study Vaccination Period|Protocol Violation|0|||
44529733|NCT00092495|79539537|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
44529734|NCT00092495|79539538|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
44529735|NCT00092495|79539539|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
44529736|NCT00092495|79539540|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
44529737|NCT00092495|79539541|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
44529738|NCT00092495|79539537|FG000|Base Study Follow-up Period|Extended|0|||
44529739|NCT00092495|79539538|FG001|Base Study Follow-up Period|Extended|0|||
44529740|NCT00092495|79539539|FG002|Base Study Follow-up Period|Extended|1|||
44529741|NCT00092495|79539540|FG003|Base Study Follow-up Period|Extended|2|||
44529742|NCT00092495|79539541|FG004|Base Study Follow-up Period|Extended|0|||
44529743|NCT00092495|79539537|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
44529744|NCT00092495|79539538|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
44529745|NCT00092495|79539539|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
44529746|NCT00092495|79539540|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
44529747|NCT00092495|79539541|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
44529748|NCT00092495|79539537|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
44529749|NCT00092495|79539538|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
44529750|NCT00092495|79539539|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
44149497|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
44149498|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44149499|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44149500|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44149501|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44254651|NCT04856917|79096432|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
44529751|NCT00092495|79539540|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
44529752|NCT00092495|79539541|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
44529753|NCT00092417|79539556|FG000|Overall Study|Lost to Follow-up|2|||
44529754|NCT00092417|79539557|FG001|Overall Study|Lost to Follow-up|0|||
44529755|NCT00092417|79539556|FG000|Overall Study|Withdrawal by Subject|2|||
44254652|NCT04856917|79096430|FG000|Overall Study|Other|1|||
44254653|NCT04856917|79096431|FG001|Overall Study|Other|1|||
44254654|NCT04856917|79096432|FG002|Overall Study|Other|0|||
44529756|NCT00092417|79539557|FG001|Overall Study|Withdrawal by Subject|1|||
44529757|NCT00092417|79539556|FG000|Overall Study|Other|1|||
44529758|NCT00092417|79539557|FG001|Overall Study|Other|0|||
44529759|NCT00091949|79539565|FG000|Overall Study|Withdrawal by Subject|117|||
44529760|NCT00091949|79539566|FG001|Overall Study|Withdrawal by Subject|110|||
44529761|NCT00091949|79539565|FG000|Overall Study|Lost to Follow-up|58|||
44254655|NCT04615247|79096470|FG000|Overall Study|Adverse Event|0|||
44529762|NCT00091949|79539566|FG001|Overall Study|Lost to Follow-up|41|||
44529763|NCT02258542|79539576|FG000|Overall Study|eg. not made to the visit|7|||
44529764|NCT02258542|79539577|FG001|Overall Study|eg. not made to the visit|4|||
44529765|NCT02258542|79539578|FG002|Overall Study|eg. not made to the visit|0|||
44529766|NCT02258542|79539579|FG003|Overall Study|eg. not made to the visit|1|||
44529767|NCT02258542|79539576|FG000|Overall Study|study specific discount. criteria|1|||
44529768|NCT02258542|79539577|FG001|Overall Study|study specific discount. criteria|1|||
44529769|NCT02258542|79539578|FG002|Overall Study|study specific discount. criteria|0|||
44529770|NCT02258542|79539579|FG003|Overall Study|study specific discount. criteria|0|||
44529771|NCT02258542|79539576|FG000|Overall Study|Withdrawal by Subject|20|||
44529772|NCT02258542|79539577|FG001|Overall Study|Withdrawal by Subject|20|||
44529773|NCT02258542|79539578|FG002|Overall Study|Withdrawal by Subject|7|||
44529774|NCT02258542|79539579|FG003|Overall Study|Withdrawal by Subject|1|||
44529775|NCT02258542|79539576|FG000|Overall Study|Lost to Follow-up|5|||
44529776|NCT02258542|79539577|FG001|Overall Study|Lost to Follow-up|12|||
44529777|NCT02258542|79539578|FG002|Overall Study|Lost to Follow-up|1|||
44529778|NCT02258542|79539579|FG003|Overall Study|Lost to Follow-up|2|||
44149502|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
44149503|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
44149504|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44149505|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44149506|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44149507|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44529779|NCT02258542|79539576|FG000|Overall Study|Death|5|||
44529780|NCT02258542|79539577|FG001|Overall Study|Death|4|||
44529781|NCT02258542|79539578|FG002|Overall Study|Death|0|||
44529782|NCT02258542|79539579|FG003|Overall Study|Death|1|||
44529783|NCT02258542|79539576|FG000|Overall Study|Adverse Event|3|||
44529784|NCT02258542|79539577|FG001|Overall Study|Adverse Event|4|||
44529785|NCT02258542|79539578|FG002|Overall Study|Adverse Event|0|||
44529786|NCT02258542|79539579|FG003|Overall Study|Adverse Event|0|||
44529787|NCT02258542|79539576|FG000|Overall Study|Protocol Violation|1|||
44529788|NCT02258542|79539577|FG001|Overall Study|Protocol Violation|2|||
44529789|NCT02258542|79539578|FG002|Overall Study|Protocol Violation|0|||
44529790|NCT02258542|79539579|FG003|Overall Study|Protocol Violation|0|||
44529791|NCT02258542|79539576|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44529792|NCT02258542|79539577|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
44529793|NCT02258542|79539578|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
44529794|NCT02258542|79539579|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
44529795|NCT00091793|79539609|FG000|Overall Study|Adverse Event|1|||
44529796|NCT00091793|79539610|FG001|Overall Study|Adverse Event|2|||
44529797|NCT00091793|79539609|FG000|Overall Study|Withdrawal by Subject|10|||
44529798|NCT00091793|79539610|FG001|Overall Study|Withdrawal by Subject|15|||
44149508|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
44149509|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Other|14|||
44149510|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Other|0|||
44149511|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Other|0|||
44149512|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Other|0|||
44149513|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Other|0|||
44149514|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Other|0|||
44149515|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
44149516|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
44149517|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
44149518|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
44149519|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
44149520|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
44149521|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
44529799|NCT00091793|79539609|FG000|Overall Study|Ineligibility determined|2|||
44529800|NCT00091793|79539610|FG001|Overall Study|Ineligibility determined|0|||
44529801|NCT00091793|79539609|FG000|Overall Study|Lost to Follow-up|7|||
44529802|NCT00091793|79539610|FG001|Overall Study|Lost to Follow-up|5|||
44529803|NCT00091793|79539609|FG000|Overall Study|Noncompliance|2|||
44529804|NCT00091793|79539610|FG001|Overall Study|Noncompliance|0|||
44529805|NCT00091793|79539609|FG000|Overall Study|Other|2|||
44529806|NCT00091793|79539610|FG001|Overall Study|Other|0|||
44149522|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44149523|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44149524|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44149525|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44149526|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
44149527|NCT02141854|78939118|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
44149528|NCT02141854|78939119|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44149529|NCT02141854|78939120|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44149530|NCT02141854|78939121|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44149531|NCT02141854|78939122|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44149532|NCT02141854|78939123|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
44149533|NCT02141854|78939118|FG000|Treatment Period|Protocol Violation|0|||
44149534|NCT02141854|78939119|FG001|Treatment Period|Protocol Violation|1|||
44149535|NCT02141854|78939120|FG002|Treatment Period|Protocol Violation|0|||
44149536|NCT02141854|78939121|FG003|Treatment Period|Protocol Violation|2|||
44149537|NCT02141854|78939122|FG004|Treatment Period|Protocol Violation|2|||
44149538|NCT02141854|78939123|FG005|Treatment Period|Protocol Violation|1|||
44149539|NCT02141854|78939118|FG000|Treatment Period|Noncompliance|0|||
44149540|NCT02141854|78939119|FG001|Treatment Period|Noncompliance|0|||
44149541|NCT02141854|78939120|FG002|Treatment Period|Noncompliance|0|||
44149542|NCT02141854|78939121|FG003|Treatment Period|Noncompliance|1|||
44149543|NCT02141854|78939122|FG004|Treatment Period|Noncompliance|0|||
44149544|NCT02141854|78939123|FG005|Treatment Period|Noncompliance|0|||
44149545|NCT02141854|78939118|FG000|Treatment Period|Lack of Efficacy|0|||
44149546|NCT02141854|78939119|FG001|Treatment Period|Lack of Efficacy|0|||
44149547|NCT02141854|78939120|FG002|Treatment Period|Lack of Efficacy|0|||
44149548|NCT02141854|78939121|FG003|Treatment Period|Lack of Efficacy|1|||
44149549|NCT02141854|78939122|FG004|Treatment Period|Lack of Efficacy|1|||
44149550|NCT02141854|78939123|FG005|Treatment Period|Lack of Efficacy|7|||
44149551|NCT02141854|78939118|FG000|Treatment Period|Pregnancy|0|||
44149552|NCT02141854|78939119|FG001|Treatment Period|Pregnancy|1|||
44149553|NCT02141854|78939120|FG002|Treatment Period|Pregnancy|0|||
44529807|NCT00098813|79539616|FG000|Overall Study|Death|8|||
44149554|NCT02141854|78939121|FG003|Treatment Period|Pregnancy|0|||
44149555|NCT02141854|78939122|FG004|Treatment Period|Pregnancy|0|||
44149556|NCT02141854|78939123|FG005|Treatment Period|Pregnancy|0|||
44149557|NCT02141854|78939118|FG000|Treatment Period|Other|0|||
44149558|NCT02141854|78939119|FG001|Treatment Period|Other|1|||
44149559|NCT02141854|78939120|FG002|Treatment Period|Other|2|||
44149560|NCT02141854|78939121|FG003|Treatment Period|Other|0|||
44149561|NCT02141854|78939122|FG004|Treatment Period|Other|1|||
44149562|NCT02141854|78939123|FG005|Treatment Period|Other|2|||
44149563|NCT02141854|78939118|FG000|Treatment Period|Adverse Event|0|||
44149564|NCT02141854|78939119|FG001|Treatment Period|Adverse Event|2|||
44149565|NCT02141854|78939120|FG002|Treatment Period|Adverse Event|2|||
44149566|NCT02141854|78939121|FG003|Treatment Period|Adverse Event|0|||
44149567|NCT02141854|78939122|FG004|Treatment Period|Adverse Event|2|||
44149568|NCT02141854|78939123|FG005|Treatment Period|Adverse Event|2|||
44149569|NCT02141854|78939118|FG000|Treatment Period|Withdrawal by Subject|0|||
44149570|NCT02141854|78939119|FG001|Treatment Period|Withdrawal by Subject|2|||
44149571|NCT02141854|78939120|FG002|Treatment Period|Withdrawal by Subject|3|||
44149572|NCT02141854|78939121|FG003|Treatment Period|Withdrawal by Subject|3|||
44149573|NCT02141854|78939122|FG004|Treatment Period|Withdrawal by Subject|4|||
44149574|NCT02141854|78939123|FG005|Treatment Period|Withdrawal by Subject|7|||
44149575|NCT02141854|78939118|FG000|Treatment Period|Disease progression|0|||
44149576|NCT02141854|78939119|FG001|Treatment Period|Disease progression|2|||
44149577|NCT02141854|78939120|FG002|Treatment Period|Disease progression|1|||
44254656|NCT04615247|79096471|FG001|Overall Study|Adverse Event|2|||
44529808|NCT00098813|79539616|FG000|Overall Study|Protocol Violation|1|||
44529809|NCT00098813|79539616|FG000|Overall Study|Withdrawal by Subject|7|||
44529810|NCT00098813|79539616|FG000|Overall Study|Progression of Disease|1|||
44529811|NCT00098813|79539616|FG000|Overall Study|Other complicating disease|1|||
44529812|NCT00098813|79539616|FG000|Overall Study|Reversal of RAI resistance|1|||
44529813|NCT00090857|79539622|FG000|Overall Study|Lost to Follow-up|0|||
44529814|NCT00090857|79539623|FG001|Overall Study|Lost to Follow-up|1|||
44529815|NCT00090857|79539622|FG000|Overall Study|Withdrawal by Subject|2|||
44149578|NCT02141854|78939121|FG003|Treatment Period|Disease progression|3|||
44149579|NCT02141854|78939122|FG004|Treatment Period|Disease progression|0|||
44149580|NCT02141854|78939123|FG005|Treatment Period|Disease progression|18|||
44149581|NCT02141854|78939118|FG000|Treatment Period|Lost to Follow-up|0|||
44149582|NCT02141854|78939119|FG001|Treatment Period|Lost to Follow-up|1|||
44149583|NCT02141854|78939120|FG002|Treatment Period|Lost to Follow-up|1|||
44415028|NCT00625378|79422977|FG001|Overall Study|Adverse Event|0|||
44149584|NCT02141854|78939121|FG003|Treatment Period|Lost to Follow-up|1|||
44149585|NCT02141854|78939122|FG004|Treatment Period|Lost to Follow-up|0|||
44149586|NCT02141854|78939123|FG005|Treatment Period|Lost to Follow-up|1|||
44149587|NCT02587221|78939137|FG000|Overall Study|Adverse Event|3|||
44149588|NCT02587221|78939138|FG001|Overall Study|Adverse Event|3|||
44149589|NCT02587221|78939137|FG000|Overall Study|Death|33|||
44149590|NCT02587221|78939138|FG001|Overall Study|Death|34|||
44149591|NCT02587221|78939137|FG000|Overall Study|Withdrawal by Subject|66|||
44149592|NCT02587221|78939138|FG001|Overall Study|Withdrawal by Subject|61|||
44149593|NCT02587221|78939137|FG000|Overall Study|Lost to Follow-up|21|||
44149594|NCT02587221|78939138|FG001|Overall Study|Lost to Follow-up|19|||
44149595|NCT02587221|78939137|FG000|Overall Study|Protocol Violation|6|||
44149596|NCT02587221|78939138|FG001|Overall Study|Protocol Violation|5|||
44149597|NCT02587221|78939137|FG000|Overall Study|Other Reason or Unspecified|2|||
44149598|NCT02587221|78939138|FG001|Overall Study|Other Reason or Unspecified|1|||
44149599|NCT02141620|78939144|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
44149600|NCT02141620|78939145|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
44149601|NCT02106910|78939153|FG000|Overall Study|Lost to Follow-up|1|||
44149602|NCT02106910|78939154|FG001|Overall Study|Lost to Follow-up|1|||
44149603|NCT01664949|78939163|FG000|Overall Study|Adverse Event|11|||
44149604|NCT01664949|78939164|FG001|Overall Study|Adverse Event|12|||
44149605|NCT01664949|78939163|FG000|Overall Study|Lack of Efficacy|1|||
44149606|NCT01664949|78939164|FG001|Overall Study|Lack of Efficacy|1|||
44149607|NCT01664949|78939163|FG000|Overall Study|Lost to Follow-up|1|||
44149608|NCT01664949|78939164|FG001|Overall Study|Lost to Follow-up|2|||
44149609|NCT01664949|78939163|FG000|Overall Study|Personal Reasons|3|||
44149610|NCT01664949|78939164|FG001|Overall Study|Personal Reasons|4|||
44529816|NCT00090857|79539623|FG001|Overall Study|Withdrawal by Subject|0|||
44529817|NCT00090857|79539622|FG000|Overall Study|Adverse Event|2|||
44529818|NCT00090857|79539623|FG001|Overall Study|Adverse Event|2|||
44529819|NCT00090779|79539635|FG000|Step 1|Withdrawal by Subject|4|||
44149611|NCT01664949|78939163|FG000|Overall Study|Protocol Violation|5|||
44149612|NCT01664949|78939164|FG001|Overall Study|Protocol Violation|5|||
44149613|NCT01664949|78939163|FG000|Overall Study|Other Miscellaneous Reasons|3|||
44149614|NCT01664949|78939164|FG001|Overall Study|Other Miscellaneous Reasons|1|||
44529820|NCT00090779|79539636|FG001|Step 1|Withdrawal by Subject|2|||
44529821|NCT00090779|79539635|FG000|Step 1|Lost to Follow-up|3|||
44529822|NCT00090779|79539636|FG001|Step 1|Lost to Follow-up|2|||
44529823|NCT00090779|79539635|FG000|Step 1|Death|0|||
44529824|NCT00090779|79539636|FG001|Step 1|Death|2|||
44529825|NCT00090779|79539635|FG000|Step 1|Physician Decision|1|||
44529826|NCT00090779|79539636|FG001|Step 1|Physician Decision|0|||
44529827|NCT00090779|79539635|FG000|Step 1|Pregnancy|1|||
44529828|NCT00090779|79539636|FG001|Step 1|Pregnancy|0|||
44149615|NCT02587143|78939172|FG000|Overall Study|Adverse Event|1|||
44149616|NCT02587143|78939173|FG001|Overall Study|Adverse Event|0|||
44149617|NCT02106832|78939183|FG000|Overall Study|Adverse Event|1|||
44149618|NCT02106832|78939184|FG001|Overall Study|Adverse Event|2|||
44149619|NCT02106832|78939185|FG002|Overall Study|Adverse Event|3|||
44149620|NCT02106832|78939186|FG003|Overall Study|Adverse Event|0|||
44149621|NCT02106832|78939183|FG000|Overall Study|Death|4|||
44149622|NCT02106832|78939184|FG001|Overall Study|Death|4|||
44149623|NCT02106832|78939185|FG002|Overall Study|Death|1|||
44529829|NCT00090779|79539635|FG000|Step 1|Non-compliance to study requirements|0|||
44529830|NCT00090779|79539636|FG001|Step 1|Non-compliance to study requirements|1|||
44529831|NCT00090779|79539635|FG000|Step 1|Subject relocated|2|||
44529832|NCT00090779|79539636|FG001|Step 1|Subject relocated|8|||
44415029|NCT00625378|79422976|FG000|Overall Study|Withdrawal by Subject|16|||
44415030|NCT00625378|79422977|FG001|Overall Study|Withdrawal by Subject|0|||
44415031|NCT00625378|79422976|FG000|Overall Study|Death|38|||
44415032|NCT00625378|79422977|FG001|Overall Study|Death|0|||
44415033|NCT00625378|79422976|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
44415034|NCT00625378|79422977|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
44415035|NCT00625378|79422976|FG000|Overall Study|Lost to Follow-up|17|||
44415036|NCT00625378|79422977|FG001|Overall Study|Lost to Follow-up|0|||
44415037|NCT00625378|79422976|FG000|Overall Study|Non-compliant with study medication|3|||
44529833|NCT00090779|79539635|FG000|Step 2|Off study per study closure|6|||
44149624|NCT02106832|78939186|FG003|Overall Study|Death|4|||
44149625|NCT02106832|78939183|FG000|Overall Study|Deterioration of general conditions|0|||
44149626|NCT02106832|78939184|FG001|Overall Study|Deterioration of general conditions|0|||
44149627|NCT02106832|78939185|FG002|Overall Study|Deterioration of general conditions|1|||
44149628|NCT02106832|78939186|FG003|Overall Study|Deterioration of general conditions|0|||
44149629|NCT02106832|78939183|FG000|Overall Study|Lost to Follow-up|0|||
44149630|NCT02106832|78939184|FG001|Overall Study|Lost to Follow-up|1|||
44149631|NCT02106832|78939185|FG002|Overall Study|Lost to Follow-up|1|||
44149632|NCT02106832|78939186|FG003|Overall Study|Lost to Follow-up|3|||
44149633|NCT02106832|78939183|FG000|Overall Study|Physician Decision|1|||
44149634|NCT02106832|78939184|FG001|Overall Study|Physician Decision|0|||
44149635|NCT02106832|78939185|FG002|Overall Study|Physician Decision|0|||
44149636|NCT02106832|78939186|FG003|Overall Study|Physician Decision|0|||
44149637|NCT02106832|78939183|FG000|Overall Study|Protocol Violation|0|||
44149638|NCT02106832|78939184|FG001|Overall Study|Protocol Violation|0|||
44149639|NCT02106832|78939185|FG002|Overall Study|Protocol Violation|0|||
44149640|NCT02106832|78939186|FG003|Overall Study|Protocol Violation|1|||
44149641|NCT02106832|78939183|FG000|Overall Study|Withdrawal by Subject|17|||
44529834|NCT00090779|79539636|FG001|Step 2|Off study per study closure|16|||
44529835|NCT00090779|79539635|FG000|Step 2|Subject relocated|0|||
44529836|NCT00090779|79539636|FG001|Step 2|Subject relocated|1|||
44529837|NCT00090779|79539635|FG000|Step 2|Non-compliance to study requirements|0|||
44529838|NCT00090779|79539636|FG001|Step 2|Non-compliance to study requirements|1|||
44529839|NCT00090779|79539635|FG000|Step 3|Initiation of ART and off extended study|3|||
44529840|NCT00090779|79539636|FG001|Step 3|Initiation of ART and off extended study|2|||
44149642|NCT02106832|78939184|FG001|Overall Study|Withdrawal by Subject|17|||
44415038|NCT00625378|79422977|FG001|Overall Study|Non-compliant with study medication|0|||
44415039|NCT00625378|79422976|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
44149643|NCT02106832|78939185|FG002|Overall Study|Withdrawal by Subject|10|||
44415040|NCT00625378|79422977|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
44149644|NCT02106832|78939186|FG003|Overall Study|Withdrawal by Subject|7|||
44149645|NCT02106832|78939183|FG000|Overall Study|Technical problems|0|||
44149646|NCT02106832|78939184|FG001|Overall Study|Technical problems|1|||
44149647|NCT02106832|78939185|FG002|Overall Study|Technical problems|0|||
44149648|NCT02106832|78939186|FG003|Overall Study|Technical problems|0|||
44149649|NCT02106442|78939198|FG000|Overall Study|Case Report Forms Uncollected|7|||
44149650|NCT02106442|78939198|FG000|Overall Study|Protocol Deviation|30|||
44149651|NCT02105116|78939202|FG000|Overall Study|not eligible for step 2 of trial|5|||
44149652|NCT02105116|78939202|FG000|Overall Study|Death|1|||
44149653|NCT02104804|78939208|FG000|Overall Study|Did not take study medication|0|||
44149654|NCT02104804|78939209|FG001|Overall Study|Did not take study medication|1|||
44149655|NCT02104804|78939208|FG000|Overall Study|Study specific discontinuation criteria|6|||
44149656|NCT02104804|78939209|FG001|Overall Study|Study specific discontinuation criteria|1|||
44149657|NCT02104804|78939208|FG000|Overall Study|Other listed|2|||
44149658|NCT02104804|78939209|FG001|Overall Study|Other listed|1|||
44149659|NCT02104804|78939208|FG000|Overall Study|Protocol Violation|0|||
44149660|NCT02104804|78939209|FG001|Overall Study|Protocol Violation|1|||
44149661|NCT02104804|78939208|FG000|Overall Study|Adverse Event|4|||
44149662|NCT02104804|78939209|FG001|Overall Study|Adverse Event|3|||
44149663|NCT02104804|78939208|FG000|Overall Study|Withdrawal by Subject|4|||
44149664|NCT02104804|78939209|FG001|Overall Study|Withdrawal by Subject|12|||
44254657|NCT04615247|79096470|FG000|Overall Study|Withdrawal by Subject|1|||
44254658|NCT04615247|79096471|FG001|Overall Study|Withdrawal by Subject|1|||
44254659|NCT04552132|79096492|FG000|Overall Study|Lost to Follow-up|4|||
44149665|NCT02075008|78939215|FG000|Overall Study|Technical problems|1|||
44149666|NCT02075008|78939215|FG000|Overall Study|Pregnancy|1|||
44254660|NCT04552132|79096493|FG001|Overall Study|Lost to Follow-up|3|||
44149667|NCT02075008|78939215|FG000|Overall Study|Physician Decision|1|||
44149668|NCT02075008|78939215|FG000|Overall Study|Lost to Follow-up|1|||
44149669|NCT02075008|78939215|FG000|Overall Study|Lack of Efficacy|1|||
44149670|NCT02075008|78939215|FG000|Overall Study|Death|1|||
44149671|NCT02075008|78939215|FG000|Overall Study|Adverse Event|5|||
44149672|NCT02075008|78939215|FG000|Overall Study|Withdrawal by Subject|6|||
44149673|NCT02075008|78939215|FG000|Overall Study|Study terminated by Sponsor|159|||
44149674|NCT01666119|78939246|FG000|Overall Study|Adverse Event|6|||
44149675|NCT01666119|78939246|FG000|Overall Study|Withdrawal by Subject|16|||
44149676|NCT01666119|78939246|FG000|Overall Study|Lost to Follow-up|7|||
44149677|NCT01666119|78939246|FG000|Overall Study|non compliance with study medication, pa|18|||
44149678|NCT01666119|78939246|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
44149679|NCT05128773|78939250|FG000|Overall Study|Sponsor decision to terminate study|3|||
44149680|NCT01665807|78939258|FG000|Overall Study|Withdrawal by Subject|2|||
44149681|NCT01665807|78939259|FG001|Overall Study|Withdrawal by Subject|0|||
44149682|NCT01665807|78939260|FG002|Overall Study|Withdrawal by Subject|1|||
44149683|NCT02584959|78939271|FG000|Period 1|Withdrawn from study|3|||
44149684|NCT02584959|78939272|FG001|Period 1|Withdrawn from study|4|||
44149685|NCT02584959|78939273|FG002|Period 1|Withdrawn from study|0|||
44149686|NCT02584959|78939271|FG000|Period 2|Withdrawn from study|6|||
44149687|NCT02584959|78939272|FG001|Period 2|Withdrawn from study|1|||
44149688|NCT02584959|78939273|FG002|Period 2|Withdrawn from study|2|||
44149689|NCT02584257|78939290|FG000|Period 1|Withdrawal by Subject|0|||
44149690|NCT02584257|78939291|FG001|Period 1|Withdrawal by Subject|0|||
44149691|NCT02584257|78939292|FG002|Period 1|Withdrawal by Subject|0|||
44149692|NCT02584257|78939293|FG003|Period 1|Withdrawal by Subject|0|||
44149693|NCT02584257|78939294|FG004|Period 1|Withdrawal by Subject|0|||
44149694|NCT02584257|78939295|FG005|Period 1|Withdrawal by Subject|0|||
44149695|NCT02584257|78939296|FG006|Period 1|Withdrawal by Subject|1|||
44149696|NCT02584257|78939297|FG007|Period 1|Withdrawal by Subject|0|||
44254661|NCT04552132|79096492|FG000|Overall Study|Protocol Violation|1|||
44415041|NCT00625378|79422976|FG000|Overall Study|Medical decision|1|||
44149697|NCT02584257|78939298|FG008|Period 1|Withdrawal by Subject|0|||
44149698|NCT02584257|78939290|FG000|Period 2|Physician Decision|1|||
44149699|NCT02584257|78939291|FG001|Period 2|Physician Decision|0|||
44149700|NCT02584257|78939292|FG002|Period 2|Physician Decision|0|||
44149701|NCT02584257|78939293|FG003|Period 2|Physician Decision|0|||
44149702|NCT02584257|78939294|FG004|Period 2|Physician Decision|0|||
44149703|NCT02584257|78939295|FG005|Period 2|Physician Decision|0|||
44149704|NCT02584257|78939296|FG006|Period 2|Physician Decision|0|||
44149705|NCT02584257|78939297|FG007|Period 2|Physician Decision|0|||
44149706|NCT02584257|78939298|FG008|Period 2|Physician Decision|0|||
44149707|NCT02584257|78939290|FG000|Period 2|Adverse Event|0|||
44149708|NCT02584257|78939291|FG001|Period 2|Adverse Event|1|||
44149709|NCT02584257|78939292|FG002|Period 2|Adverse Event|0|||
44149710|NCT02584257|78939293|FG003|Period 2|Adverse Event|0|||
44149711|NCT02584257|78939294|FG004|Period 2|Adverse Event|0|||
44149712|NCT02584257|78939295|FG005|Period 2|Adverse Event|0|||
44149713|NCT02584257|78939296|FG006|Period 2|Adverse Event|0|||
44149714|NCT02584257|78939297|FG007|Period 2|Adverse Event|0|||
44149715|NCT02584257|78939298|FG008|Period 2|Adverse Event|0|||
44149716|NCT02583711|78939313|FG000|Overall Study|Withdrawal by Subject|0|||
44149717|NCT02583711|78939314|FG001|Overall Study|Withdrawal by Subject|10|||
44149718|NCT02583711|78939315|FG002|Overall Study|Withdrawal by Subject|0|||
44149719|NCT02583477|78939327|FG000|Overall Study|Adverse Event|0|||
44149720|NCT02583477|78939328|FG001|Overall Study|Adverse Event|2|||
44149721|NCT02583477|78939327|FG000|Overall Study|Death|1|||
44149722|NCT02583477|78939328|FG001|Overall Study|Death|16|||
44149723|NCT02583477|78939327|FG000|Overall Study|Study terminated|2|||
44149724|NCT02583477|78939328|FG001|Overall Study|Study terminated|2|||
44149725|NCT02583399|78939335|FG000|Overall Study|Able to be discharged|3|||
44149726|NCT02583399|78939335|FG000|Overall Study|Wanted to use a restricted medication|3|||
44149727|NCT02580591|78939343|FG000|Overall Study|Adverse Event|0|||
44149728|NCT02580591|78939344|FG001|Overall Study|Adverse Event|1|||
44149729|NCT02580591|78939345|FG002|Overall Study|Adverse Event|2|||
44149730|NCT02580591|78939346|FG003|Overall Study|Adverse Event|5|||
44149731|NCT02580591|78939343|FG000|Overall Study|Protocol Violation|3|||
44149732|NCT02580591|78939344|FG001|Overall Study|Protocol Violation|2|||
44149733|NCT02580591|78939345|FG002|Overall Study|Protocol Violation|1|||
44149734|NCT02580591|78939346|FG003|Overall Study|Protocol Violation|1|||
44149735|NCT02580591|78939343|FG000|Overall Study|Lost to Follow-up|5|||
44149736|NCT02580591|78939344|FG001|Overall Study|Lost to Follow-up|3|||
44149737|NCT02580591|78939345|FG002|Overall Study|Lost to Follow-up|3|||
44149738|NCT02580591|78939346|FG003|Overall Study|Lost to Follow-up|1|||
44149739|NCT02580591|78939343|FG000|Overall Study|Withdrawal by Subject|6|||
44149740|NCT02580591|78939344|FG001|Overall Study|Withdrawal by Subject|1|||
44149741|NCT02580591|78939345|FG002|Overall Study|Withdrawal by Subject|2|||
44149742|NCT02580591|78939346|FG003|Overall Study|Withdrawal by Subject|3|||
44149743|NCT02580591|78939343|FG000|Overall Study|Not treated|1|||
44149744|NCT02580591|78939344|FG001|Overall Study|Not treated|1|||
44149745|NCT02580591|78939345|FG002|Overall Study|Not treated|0|||
44149746|NCT02580591|78939346|FG003|Overall Study|Not treated|0|||
44149747|NCT02580591|78939343|FG000|Overall Study|Other than specified|3|||
44149748|NCT02580591|78939344|FG001|Overall Study|Other than specified|2|||
44149749|NCT02580591|78939345|FG002|Overall Study|Other than specified|5|||
44149750|NCT02580591|78939346|FG003|Overall Study|Other than specified|2|||
44149751|NCT02580357|78939359|FG000|Overall Study|Lost to Follow-up|2|||
44149752|NCT02580357|78939360|FG001|Overall Study|Lost to Follow-up|0|||
44149753|NCT02580357|78939361|FG002|Overall Study|Lost to Follow-up|0|||
44415042|NCT00625378|79422977|FG001|Overall Study|Medical decision|0|||
44149754|NCT02580357|78939359|FG000|Overall Study|Protocol Violation|1|||
44149755|NCT02580357|78939360|FG001|Overall Study|Protocol Violation|0|||
44149756|NCT02580357|78939361|FG002|Overall Study|Protocol Violation|0|||
44149757|NCT01664091|78939369|FG000|Overall Study|Death|1|||
44149758|NCT01664091|78939369|FG000|Overall Study|Disease Progression|2|||
44415043|NCT00625378|79422976|FG000|Overall Study|Multiple toxicities|1|||
44529841|NCT00090779|79539635|FG000|Step 3|Off extended study due to study closure|4|||
44529842|NCT00090779|79539636|FG001|Step 3|Off extended study due to study closure|3|||
44529843|NCT00098345|79539642|FG000|Overall Study|Adverse Event|7|||
44529844|NCT00098345|79539642|FG000|Overall Study|Withdrawal by Subject|2|||
44529845|NCT00098345|79539642|FG000|Overall Study|progression|4|||
44529846|NCT02224456|79539646|FG000|Overall Study|Lack of Efficacy|1|||
44529847|NCT02224456|79539646|FG000|Overall Study|Lost to Follow-up|15|||
44529848|NCT02224456|79539646|FG000|Overall Study|Withdrawal by Subject|9|||
44529849|NCT02224456|79539646|FG000|Overall Study|Physician Decision|3|||
44149759|NCT01664091|78939369|FG000|Overall Study|Lost to Follow-up|2|||
44149760|NCT01664091|78939369|FG000|Overall Study|Withdrawal by Subject|1|||
44149761|NCT02577315|78939376|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44149762|NCT02577315|78939377|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
44149763|NCT02711345|78939393|FG000|Overall Study|Adverse Event|0|||
44149764|NCT02711345|78939394|FG001|Overall Study|Adverse Event|0|||
44149765|NCT02711345|78939395|FG002|Overall Study|Adverse Event|0|||
44149766|NCT02711345|78939396|FG003|Overall Study|Adverse Event|1|||
44149767|NCT02711345|78939397|FG004|Overall Study|Adverse Event|1|||
44149768|NCT02711345|78939398|FG005|Overall Study|Adverse Event|2|||
44149769|NCT02711345|78939399|FG006|Overall Study|Adverse Event|1|||
44149770|NCT02711345|78939400|FG007|Overall Study|Adverse Event|0|||
44149771|NCT02711345|78939401|FG008|Overall Study|Adverse Event|0|||
44529850|NCT02224456|79539646|FG000|Overall Study|Death|2|||
44529851|NCT02224456|79539646|FG000|Overall Study|Pregnancy|4|||
44529852|NCT02224456|79539646|FG000|Overall Study|Protocol Violation|1|||
44149772|NCT02711345|78939402|FG009|Overall Study|Adverse Event|2|||
44149773|NCT02711345|78939393|FG000|Overall Study|Physician Decision|0|||
44149774|NCT02711345|78939394|FG001|Overall Study|Physician Decision|0|||
44149775|NCT02711345|78939395|FG002|Overall Study|Physician Decision|1|||
44149776|NCT02711345|78939396|FG003|Overall Study|Physician Decision|0|||
44149777|NCT02711345|78939397|FG004|Overall Study|Physician Decision|0|||
44149778|NCT02711345|78939398|FG005|Overall Study|Physician Decision|0|||
44149779|NCT02711345|78939399|FG006|Overall Study|Physician Decision|0|||
44149780|NCT02711345|78939400|FG007|Overall Study|Physician Decision|0|||
44149781|NCT02711345|78939401|FG008|Overall Study|Physician Decision|1|||
44149782|NCT02711345|78939402|FG009|Overall Study|Physician Decision|0|||
44149783|NCT02711345|78939393|FG000|Overall Study|Progressive disease|1|||
44529853|NCT02224456|79539646|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
44529854|NCT00097721|79539652|FG000|Overall Study|Adverse Event|8|||
44529855|NCT00097721|79539653|FG001|Overall Study|Adverse Event|1|||
44529856|NCT00097721|79539652|FG000|Overall Study|Withdrawal by Subject|6|||
44529857|NCT00097721|79539653|FG001|Overall Study|Withdrawal by Subject|1|||
44529858|NCT00097721|79539652|FG000|Overall Study|Progressive Disease|55|||
44529859|NCT00097721|79539653|FG001|Overall Study|Progressive Disease|27|||
44529860|NCT00097721|79539652|FG000|Overall Study|Physician Decision|1|||
44529861|NCT00097721|79539653|FG001|Overall Study|Physician Decision|3|||
44529862|NCT00097721|79539652|FG000|Overall Study|Reason not given|1|||
44529863|NCT00097721|79539653|FG001|Overall Study|Reason not given|1|||
44529864|NCT03553498|79539661|FG000|Overall Study|Missing primary outcome|1|||
44529865|NCT03553498|79539662|FG001|Overall Study|Missing primary outcome|2|||
44149784|NCT02711345|78939394|FG001|Overall Study|Progressive disease|3|||
44149785|NCT02711345|78939395|FG002|Overall Study|Progressive disease|5|||
44149786|NCT02711345|78939396|FG003|Overall Study|Progressive disease|3|||
44529866|NCT00096941|79539668|FG000|Overall Study|disease progression|3|||
44149787|NCT02711345|78939397|FG004|Overall Study|Progressive disease|7|||
44529867|NCT00096785|79539674|FG000|Overall Study|Lost to Follow-up|1|||
44529868|NCT00096785|79539675|FG001|Overall Study|Lost to Follow-up|0|||
44529869|NCT00096785|79539674|FG000|Overall Study|Withdrawal by Subject|0|||
44529870|NCT00096785|79539675|FG001|Overall Study|Withdrawal by Subject|1|||
44529871|NCT00096785|79539674|FG000|Overall Study|Relocated|1|||
44529872|NCT00096785|79539675|FG001|Overall Study|Relocated|0|||
44529873|NCT03285178|79539710|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
44529874|NCT03285178|79539711|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
44529875|NCT03285178|79539712|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
44149788|NCT02711345|78939398|FG005|Overall Study|Progressive disease|2|||
44149789|NCT02711345|78939399|FG006|Overall Study|Progressive disease|8|||
44149790|NCT02711345|78939400|FG007|Overall Study|Progressive disease|4|||
44149791|NCT02711345|78939401|FG008|Overall Study|Progressive disease|5|||
44149792|NCT02711345|78939402|FG009|Overall Study|Progressive disease|6|||
44149793|NCT02711345|78939393|FG000|Overall Study|Subject/guardian decision|0|||
44149794|NCT02711345|78939394|FG001|Overall Study|Subject/guardian decision|0|||
44149795|NCT02711345|78939395|FG002|Overall Study|Subject/guardian decision|0|||
44149796|NCT02711345|78939396|FG003|Overall Study|Subject/guardian decision|0|||
44149797|NCT02711345|78939397|FG004|Overall Study|Subject/guardian decision|0|||
44149798|NCT02711345|78939398|FG005|Overall Study|Subject/guardian decision|2|||
44149799|NCT02711345|78939399|FG006|Overall Study|Subject/guardian decision|3|||
44149800|NCT02711345|78939400|FG007|Overall Study|Subject/guardian decision|1|||
44149801|NCT02711345|78939401|FG008|Overall Study|Subject/guardian decision|0|||
44149802|NCT02711345|78939402|FG009|Overall Study|Subject/guardian decision|4|||
44149803|NCT02711345|78939393|FG000|Overall Study|Death|1|||
44149804|NCT02711345|78939394|FG001|Overall Study|Death|0|||
44149805|NCT02711345|78939395|FG002|Overall Study|Death|0|||
44149806|NCT02711345|78939396|FG003|Overall Study|Death|0|||
44254662|NCT04552132|79096493|FG001|Overall Study|Protocol Violation|0|||
44529876|NCT03285178|79539713|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
44149807|NCT02711345|78939397|FG004|Overall Study|Death|0|||
44149808|NCT02711345|78939398|FG005|Overall Study|Death|0|||
44149809|NCT02711345|78939399|FG006|Overall Study|Death|0|||
44149810|NCT02711345|78939400|FG007|Overall Study|Death|1|||
44149811|NCT02711345|78939401|FG008|Overall Study|Death|0|||
44529877|NCT03285178|79539714|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
44529878|NCT03285178|79539715|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
44529879|NCT03285178|79539716|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
44529880|NCT03285178|79539710|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
44529881|NCT03285178|79539711|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
44529882|NCT03285178|79539712|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
44529883|NCT03285178|79539713|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
44149812|NCT02711345|78939402|FG009|Overall Study|Death|0|||
44149813|NCT02581995|78939439|FG000|Overall Study|Unspecified other|3|||
44149814|NCT02581995|78939439|FG000|Overall Study|Adverse Event|6|||
44149815|NCT02581995|78939439|FG000|Overall Study|Lost to Follow-up|5|||
44149816|NCT02581995|78939439|FG000|Overall Study|Withdrawal by participant|12|||
44282386|NCT01898208|79245697|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
44282387|NCT01898208|79245698|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
44282388|NCT01898208|79245699|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
44282389|NCT01898208|79245697|FG000|Overall Study|System/Technical Error|1|||
44149817|NCT02581995|78939439|FG000|Overall Study|Physician Decision|1|||
44149818|NCT02581995|78939439|FG000|Overall Study|Death|4|||
44149819|NCT02577003|78939445|FG000|Overall Study|Adverse Event|2|||
44149820|NCT02577003|78939446|FG001|Overall Study|Adverse Event|4|||
44149821|NCT02577003|78939445|FG000|Overall Study|Withdrawal by Subject|0|||
44149822|NCT02577003|78939446|FG001|Overall Study|Withdrawal by Subject|1|||
44149823|NCT02446899|78939454|FG000|Overall Study|Adverse Event|4|||
44149824|NCT02446899|78939455|FG001|Overall Study|Adverse Event|7|||
44149825|NCT02446899|78939454|FG000|Overall Study|Condition Under Investigation Worsened|1|||
44149826|NCT02446899|78939455|FG001|Overall Study|Condition Under Investigation Worsened|4|||
44149827|NCT02446899|78939454|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
44149828|NCT02446899|78939455|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
44149829|NCT02446899|78939454|FG000|Overall Study|Lack of Efficacy|2|||
44149830|NCT02446899|78939455|FG001|Overall Study|Lack of Efficacy|8|||
44149831|NCT02446899|78939454|FG000|Overall Study|Lost to Follow-up|1|||
44149832|NCT02446899|78939455|FG001|Overall Study|Lost to Follow-up|3|||
44149833|NCT02446899|78939454|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
44149834|NCT02446899|78939455|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
44149835|NCT02446899|78939454|FG000|Overall Study|Withdrawal by Subject|11|||
44149836|NCT02446899|78939455|FG001|Overall Study|Withdrawal by Subject|19|||
44149837|NCT02446899|78939454|FG000|Overall Study|Miscellaneous|5|||
44529884|NCT03285178|79539714|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
44282390|NCT01898208|79245698|FG001|Overall Study|System/Technical Error|2|||
44282391|NCT01898208|79245699|FG002|Overall Study|System/Technical Error|3|||
44529885|NCT03285178|79539715|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
44529886|NCT03285178|79539716|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
44282392|NCT01898208|79245697|FG000|Overall Study|Lost to Follow-up|3|||
44282393|NCT01898208|79245698|FG001|Overall Study|Lost to Follow-up|1|||
44282394|NCT01898208|79245699|FG002|Overall Study|Lost to Follow-up|1|||
44282395|NCT01898130|79245707|FG000|Treatment|Withdrawal by Subject|2|||
44149838|NCT02446899|78939455|FG001|Overall Study|Miscellaneous|4|||
44149839|NCT02446899|78939454|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
44149840|NCT02446899|78939455|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
44149841|NCT02709785|78939464|FG000|Overall Study|Withdrawal by Subject|1|||
44149842|NCT02709785|78939465|FG001|Overall Study|Withdrawal by Subject|2|||
44149843|NCT02709785|78939466|FG002|Overall Study|Withdrawal by Subject|1|||
44282396|NCT01898130|79245707|FG000|Treatment|Progressive Disease|4|||
44529887|NCT03285178|79539710|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
44529888|NCT03285178|79539711|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
44529889|NCT03285178|79539712|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
44529890|NCT03285178|79539713|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
44529891|NCT03285178|79539714|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
44529892|NCT03285178|79539715|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
44529893|NCT03285178|79539716|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
44529894|NCT03285178|79539710|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
44529895|NCT03285178|79539711|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
44529896|NCT03285178|79539712|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
44529897|NCT03285178|79539713|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
44529898|NCT03285178|79539714|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
44529899|NCT03285178|79539715|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
44529900|NCT03285178|79539716|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
44529901|NCT03285178|79539710|FG000|Single-Blind Run-In Period|Physician Decision|2|||
44529902|NCT03285178|79539711|FG001|Single-Blind Run-In Period|Physician Decision|0|||
44529903|NCT03285178|79539712|FG002|Single-Blind Run-In Period|Physician Decision|0|||
44529904|NCT03285178|79539713|FG003|Single-Blind Run-In Period|Physician Decision|0|||
44529905|NCT03285178|79539714|FG004|Single-Blind Run-In Period|Physician Decision|0|||
44529906|NCT03285178|79539715|FG005|Single-Blind Run-In Period|Physician Decision|0|||
44529907|NCT03285178|79539716|FG006|Single-Blind Run-In Period|Physician Decision|0|||
44529908|NCT03285178|79539710|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
44529909|NCT03285178|79539711|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
44529910|NCT03285178|79539712|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
44529911|NCT03285178|79539713|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
44529912|NCT03285178|79539714|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
44529913|NCT03285178|79539715|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
44529914|NCT03285178|79539716|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
44529915|NCT03285178|79539710|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44529916|NCT03285178|79539711|FG001|Double-Blind Treatment Period|Adverse Event|0|||
44529917|NCT03285178|79539712|FG002|Double-Blind Treatment Period|Adverse Event|0|||
44529918|NCT03285178|79539713|FG003|Double-Blind Treatment Period|Adverse Event|0|||
44529919|NCT03285178|79539714|FG004|Double-Blind Treatment Period|Adverse Event|0|||
44529920|NCT03285178|79539715|FG005|Double-Blind Treatment Period|Adverse Event|0|||
44529921|NCT03285178|79539716|FG006|Double-Blind Treatment Period|Adverse Event|2|||
44529922|NCT03285178|79539710|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44529923|NCT03285178|79539711|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
44529924|NCT03285178|79539712|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
44529925|NCT03285178|79539713|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
44529926|NCT03285178|79539714|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
44529927|NCT03285178|79539715|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
44529928|NCT03285178|79539716|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
44529929|NCT03285178|79539710|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44529930|NCT03285178|79539711|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44529931|NCT03285178|79539712|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44529932|NCT03285178|79539713|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44529933|NCT03285178|79539714|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44529934|NCT03285178|79539715|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44529935|NCT03285178|79539716|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44529936|NCT03285178|79539710|FG000|Double-Blind Treatment Period|COVID-19|0|||
44529937|NCT03285178|79539711|FG001|Double-Blind Treatment Period|COVID-19|0|||
44529938|NCT03285178|79539712|FG002|Double-Blind Treatment Period|COVID-19|1|||
44529939|NCT03285178|79539713|FG003|Double-Blind Treatment Period|COVID-19|0|||
44529940|NCT03285178|79539714|FG004|Double-Blind Treatment Period|COVID-19|0|||
44529941|NCT03285178|79539715|FG005|Double-Blind Treatment Period|COVID-19|0|||
44529942|NCT03285178|79539716|FG006|Double-Blind Treatment Period|COVID-19|0|||
44529943|NCT00090545|79539740|FG000|Overall Study|Disease progression on study|21|||
44529944|NCT00090545|79539741|FG001|Overall Study|Disease progression on study|17|||
44149844|NCT02356887|78939474|FG000|Overall Study|poor compliance|2|||
44149845|NCT01604265|78939486|FG000|Overall Study|Adverse Event|1|||
44529945|NCT00090545|79539740|FG000|Overall Study|Refused further treatment|1|||
44529946|NCT00090545|79539741|FG001|Overall Study|Refused further treatment|4|||
44254663|NCT04421456|79096502|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
44529947|NCT00090545|79539740|FG000|Overall Study|Death|0|||
44254664|NCT04421456|79096503|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
44254665|NCT04421456|79096504|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
44254666|NCT04421456|79096502|FG000|Randomized Treatment Period|Adverse Event|0|||
44529948|NCT00090545|79539741|FG001|Overall Study|Death|1|||
44529949|NCT00090545|79539740|FG000|Overall Study|Adverse Event|0|||
44529950|NCT00090545|79539741|FG001|Overall Study|Adverse Event|2|||
44529951|NCT03249376|79539751|FG000|Overall Study|Adverse Event|11|||
44529952|NCT03249376|79539752|FG001|Overall Study|Adverse Event|5|||
44529953|NCT03249376|79539751|FG000|Overall Study|Lack of Efficacy|2|||
44529954|NCT03249376|79539752|FG001|Overall Study|Lack of Efficacy|4|||
44529955|NCT03249376|79539751|FG000|Overall Study|Protocol Violation|3|||
44529956|NCT03249376|79539752|FG001|Overall Study|Protocol Violation|2|||
44529957|NCT03249376|79539751|FG000|Overall Study|Physician Decision|0|||
44529958|NCT03249376|79539752|FG001|Overall Study|Physician Decision|2|||
44529959|NCT03249376|79539751|FG000|Overall Study|Withdrawal by Subject|3|||
44529960|NCT03249376|79539752|FG001|Overall Study|Withdrawal by Subject|9|||
44282397|NCT01898130|79245707|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
44282398|NCT01876368|79245713|FG000|Overall Study|Adverse Event|2|||
44282399|NCT01876368|79245714|FG001|Overall Study|Adverse Event|5|||
44282400|NCT01876368|79245713|FG000|Overall Study|Lack of Efficacy|1|||
44282401|NCT01876368|79245714|FG001|Overall Study|Lack of Efficacy|0|||
44282402|NCT01876368|79245713|FG000|Overall Study|Lost to Follow-up|0|||
44282403|NCT01876368|79245714|FG001|Overall Study|Lost to Follow-up|1|||
44282404|NCT01876368|79245713|FG000|Overall Study|Non-compliance with study treatment|0|||
44282405|NCT01876368|79245714|FG001|Overall Study|Non-compliance with study treatment|1|||
44282406|NCT01876368|79245713|FG000|Overall Study|Physician Decision|0|||
44282407|NCT01876368|79245714|FG001|Overall Study|Physician Decision|2|||
44282408|NCT01876368|79245713|FG000|Overall Study|Protocol deviation|3|||
44282409|NCT01876368|79245714|FG001|Overall Study|Protocol deviation|3|||
44282410|NCT01876368|79245713|FG000|Overall Study|Subject/guardian decision|3|||
44282411|NCT01876368|79245714|FG001|Overall Study|Subject/guardian decision|1|||
44282412|NCT01874340|79245724|FG000|Overall Study|Study terminated by Sponsor|6|||
44282413|NCT01874340|79245725|FG001|Overall Study|Study terminated by Sponsor|8|||
44282414|NCT01874340|79245726|FG002|Overall Study|Study terminated by Sponsor|8|||
44282415|NCT01874340|79245727|FG003|Overall Study|Study terminated by Sponsor|4|||
44282416|NCT01874340|79245724|FG000|Overall Study|Withdrawal by Subject|0|||
44282417|NCT01874340|79245725|FG001|Overall Study|Withdrawal by Subject|0|||
44282418|NCT01874340|79245726|FG002|Overall Study|Withdrawal by Subject|0|||
44282419|NCT01874340|79245727|FG003|Overall Study|Withdrawal by Subject|1|||
44282420|NCT01897896|79245739|FG000|Overall Study|Death|1|||
44282421|NCT01897896|79245740|FG001|Overall Study|Death|0|||
44282422|NCT01897896|79245739|FG000|Overall Study|Adverse Event|11|||
44529961|NCT03249376|79539751|FG000|Overall Study|LTFU|2|||
44529962|NCT03249376|79539752|FG001|Overall Study|LTFU|1|||
44529963|NCT00070109|79539763|FG000|Overall Study|Death|1|||
44529964|NCT00070109|79539764|FG001|Overall Study|Death|1|||
44529965|NCT00070109|79539765|FG002|Overall Study|Death|0|||
44529966|NCT00070109|79539766|FG003|Overall Study|Death|0|||
44529967|NCT00070109|79539767|FG004|Overall Study|Death|1|||
44529968|NCT00070109|79539763|FG000|Overall Study|Lack of Efficacy|6|||
44529969|NCT00070109|79539764|FG001|Overall Study|Lack of Efficacy|4|||
44529970|NCT00070109|79539765|FG002|Overall Study|Lack of Efficacy|5|||
44529971|NCT00070109|79539766|FG003|Overall Study|Lack of Efficacy|15|||
44529972|NCT00070109|79539767|FG004|Overall Study|Lack of Efficacy|5|||
44529973|NCT00070109|79539763|FG000|Overall Study|Physician Decision|1|||
44529974|NCT00070109|79539764|FG001|Overall Study|Physician Decision|0|||
44529975|NCT00070109|79539765|FG002|Overall Study|Physician Decision|0|||
44529976|NCT00070109|79539766|FG003|Overall Study|Physician Decision|0|||
44529977|NCT00070109|79539767|FG004|Overall Study|Physician Decision|0|||
44529978|NCT00070109|79539763|FG000|Overall Study|Withdrawal by Subject|0|||
44529979|NCT00070109|79539764|FG001|Overall Study|Withdrawal by Subject|1|||
44529980|NCT00070109|79539765|FG002|Overall Study|Withdrawal by Subject|1|||
44529981|NCT00070109|79539766|FG003|Overall Study|Withdrawal by Subject|0|||
44529982|NCT00070109|79539767|FG004|Overall Study|Withdrawal by Subject|0|||
44529983|NCT00070109|79539763|FG000|Overall Study|Adverse Event|0|||
44529984|NCT00070109|79539764|FG001|Overall Study|Adverse Event|0|||
44529985|NCT00070109|79539765|FG002|Overall Study|Adverse Event|2|||
44529986|NCT00070109|79539766|FG003|Overall Study|Adverse Event|4|||
44149846|NCT01604265|78939487|FG001|Overall Study|Adverse Event|0|||
44282423|NCT01897896|79245740|FG001|Overall Study|Adverse Event|1|||
44282424|NCT01897896|79245739|FG000|Overall Study|Lost to Follow-up|1|||
44282425|NCT01897896|79245740|FG001|Overall Study|Lost to Follow-up|0|||
44282426|NCT01897896|79245739|FG000|Overall Study|Non-compliance with study drug dosing|1|||
44282427|NCT01897896|79245740|FG001|Overall Study|Non-compliance with study drug dosing|1|||
44282428|NCT01897896|79245739|FG000|Overall Study|Withdrawal by Subject|7|||
44282429|NCT01897896|79245740|FG001|Overall Study|Withdrawal by Subject|1|||
44282430|NCT01897896|79245739|FG000|Overall Study|Require drug that interfere with study|1|||
44529987|NCT00070109|79539767|FG004|Overall Study|Adverse Event|2|||
44529988|NCT00070109|79539763|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
44529989|NCT00070109|79539764|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
44529990|NCT00070109|79539765|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
44529991|NCT00070109|79539766|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
44529992|NCT00070109|79539767|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
44529993|NCT00090233|79539788|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
44529994|NCT00090233|79539789|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
44529995|NCT00090233|79539788|FG000|Overall Study|Adverse Event|214|||
44282431|NCT01897896|79245740|FG001|Overall Study|Require drug that interfere with study|4|||
44282432|NCT01897896|79245739|FG000|Overall Study|Protocol Violation|1|||
44282433|NCT01897896|79245740|FG001|Overall Study|Protocol Violation|1|||
44282434|NCT01897896|79245739|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
44282435|NCT01897896|79245740|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
44282436|NCT01897896|79245739|FG000|Overall Study|Caregiver can no longer participate|0|||
44282437|NCT01897896|79245740|FG001|Overall Study|Caregiver can no longer participate|2|||
44282438|NCT01897896|79245739|FG000|Overall Study|Other than specified|2|||
44282439|NCT01897896|79245740|FG001|Overall Study|Other than specified|1|||
44282440|NCT01858194|79245750|FG000|Overall Study|Total Artificial Heart Implant|0|||
44282441|NCT01858194|79245751|FG001|Overall Study|Total Artificial Heart Implant|1|||
44282442|NCT01858194|79245750|FG000|Overall Study|Lost to Follow-up|0|||
44282443|NCT01858194|79245751|FG001|Overall Study|Lost to Follow-up|1|||
44282444|NCT01873950|79245759|FG000|Period 5|Withdrawal by Subject|0|||
44282445|NCT01873950|79245760|FG001|Period 5|Withdrawal by Subject|0|||
44282446|NCT01873950|79245761|FG002|Period 5|Withdrawal by Subject|0|||
44282447|NCT01873950|79245762|FG003|Period 5|Withdrawal by Subject|1|||
44282448|NCT01873950|79245763|FG004|Period 5|Withdrawal by Subject|0|||
44282449|NCT01857102|79245777|FG000|Period 1|No longer meets Eligibility Criteria|0|||
44282450|NCT01857102|79245778|FG001|Period 1|No longer meets Eligibility Criteria|2|||
44149847|NCT01604265|78939486|FG000|Overall Study|Withdrawal by Subject|1|||
44149848|NCT01604265|78939487|FG001|Overall Study|Withdrawal by Subject|0|||
44149849|NCT01664247|78939495|FG000|Overall Study|Adverse Event|5|||
44149850|NCT01664247|78939496|FG001|Overall Study|Adverse Event|3|||
44149851|NCT01664247|78939495|FG000|Overall Study|Protocol Violation|3|||
44149852|NCT01664247|78939496|FG001|Overall Study|Protocol Violation|5|||
44149853|NCT01664247|78939495|FG000|Overall Study|Withdrawal Criteria|1|||
44149854|NCT01664247|78939496|FG001|Overall Study|Withdrawal Criteria|4|||
44149855|NCT01664247|78939495|FG000|Overall Study|Unclassified|5|||
44149856|NCT01664247|78939496|FG001|Overall Study|Unclassified|29|||
44149857|NCT03191903|78939520|FG000|Overall Study|Withdrawal by Subject|6|||
44149858|NCT03191903|78939521|FG001|Overall Study|Withdrawal by Subject|5|||
44529996|NCT00090233|79539789|FG001|Overall Study|Adverse Event|198|||
44149859|NCT03191903|78939522|FG002|Overall Study|Withdrawal by Subject|4|||
44149860|NCT03191903|78939520|FG000|Overall Study|Adverse Event|1|||
44149861|NCT03191903|78939521|FG001|Overall Study|Adverse Event|0|||
44149862|NCT03191903|78939522|FG002|Overall Study|Adverse Event|0|||
44149863|NCT02576145|78939537|FG000|Overall Study|Adverse Event|1|||
44149864|NCT02576145|78939538|FG001|Overall Study|Adverse Event|0|||
44149865|NCT02576145|78939537|FG000|Overall Study|Withdrawal by Subject|1|||
44149866|NCT02576145|78939538|FG001|Overall Study|Withdrawal by Subject|0|||
44149867|NCT02576145|78939537|FG000|Overall Study|Acute rejection|1|||
44149868|NCT02576145|78939538|FG001|Overall Study|Acute rejection|0|||
44149869|NCT02576145|78939537|FG000|Overall Study|Tetanus Titers Decreased|0|||
44149870|NCT02576145|78939538|FG001|Overall Study|Tetanus Titers Decreased|1|||
44149871|NCT02576067|78939583|FG000|Overall Study|Death|0|||
44149872|NCT02576067|78939584|FG001|Overall Study|Death|1|||
44149873|NCT02576067|78939583|FG000|Overall Study|Lack of Efficacy|1|||
44149874|NCT02576067|78939584|FG001|Overall Study|Lack of Efficacy|0|||
44149875|NCT02576067|78939583|FG000|Overall Study|Lost to Follow-up|11|||
44149876|NCT02576067|78939584|FG001|Overall Study|Lost to Follow-up|0|||
44149877|NCT02576067|78939583|FG000|Overall Study|Withdrawal by Subject|11|||
44149878|NCT02576067|78939584|FG001|Overall Study|Withdrawal by Subject|2|||
44149879|NCT02576067|78939583|FG000|Overall Study|study closure of main CIRT trial)|0|||
44149880|NCT02576067|78939584|FG001|Overall Study|study closure of main CIRT trial)|8|||
44529997|NCT00090233|79539788|FG000|Overall Study|Lost to Follow-up|68|||
44529998|NCT00090233|79539789|FG001|Overall Study|Lost to Follow-up|95|||
44529999|NCT00090233|79539788|FG000|Overall Study|Protocol Violation|960|||
44530000|NCT00090233|79539789|FG001|Overall Study|Protocol Violation|1022|||
44530001|NCT00090233|79539788|FG000|Overall Study|Withdrawal by Subject|182|||
44149881|NCT02576067|78939583|FG000|Overall Study|not randomized, failed run-in|7|||
44149882|NCT02576067|78939584|FG001|Overall Study|not randomized, failed run-in|0|||
44282451|NCT01857102|79245777|FG000|Period 1|Lost to Follow-up|0|||
44282452|NCT01857102|79245778|FG001|Period 1|Lost to Follow-up|3|||
44282453|NCT01857102|79245777|FG000|Period 1|Unsatisfactory Lens Fit|1|||
44282454|NCT01857102|79245778|FG001|Period 1|Unsatisfactory Lens Fit|0|||
44282455|NCT01857102|79245777|FG000|Period 1|Unsatisfactory Visual Response|1|||
44282456|NCT01857102|79245778|FG001|Period 1|Unsatisfactory Visual Response|0|||
44530002|NCT00090233|79539789|FG001|Overall Study|Withdrawal by Subject|211|||
44149883|NCT02576067|78939583|FG000|Overall Study|screen failure/ re-enrolled|0|||
44149884|NCT02576067|78939584|FG001|Overall Study|screen failure/ re-enrolled|25|||
44149885|NCT02576067|78939583|FG000|Overall Study|Physician Decision|4|||
44530003|NCT00090233|79539788|FG000|Overall Study|Moved|203|||
44530004|NCT00090233|79539789|FG001|Overall Study|Moved|189|||
44530005|NCT00090233|79539788|FG000|Overall Study|Other|1211|||
44530006|NCT00090233|79539789|FG001|Overall Study|Other|1160|||
44530007|NCT00090233|79539788|FG000|Overall Study|Data not available at data cut-off point|1552|||
44530008|NCT00090233|79539789|FG001|Overall Study|Data not available at data cut-off point|1563|||
44530009|NCT00069953|79539799|FG000|Overall Study|Protocol Violation|2|||
44530010|NCT02750800|79539809|FG000|Overall Study|Adverse Event|18|||
44530011|NCT02750800|79539809|FG000|Overall Study|Lost to Follow-up|12|||
44530012|NCT02750800|79539809|FG000|Overall Study|Investigator decision|53|||
44530013|NCT02750800|79539809|FG000|Overall Study|Patient request|12|||
44530014|NCT02750800|79539809|FG000|Overall Study|Other, not specified|3|||
44530015|NCT01329562|79539829|FG000|Overall Study|Protocol Violation|5|||
44530016|NCT01329562|79539830|FG001|Overall Study|Protocol Violation|3|||
44530017|NCT01329562|79539829|FG000|Overall Study|Lost to Follow-up|1|||
44530018|NCT01329562|79539830|FG001|Overall Study|Lost to Follow-up|1|||
44530019|NCT01329562|79539829|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
44530020|NCT01329562|79539830|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
44530021|NCT01329562|79539829|FG000|Overall Study|Physician Decision|0|||
44530022|NCT01329562|79539830|FG001|Overall Study|Physician Decision|1|||
44530023|NCT00069641|79539841|FG000|Overall Study|Death|1|||
44530024|NCT00069641|79539842|FG001|Overall Study|Death|0|||
44530025|NCT00069641|79539843|FG002|Overall Study|Death|1|||
44530026|NCT03653026|79539854|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
44530027|NCT03653026|79539855|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
44530028|NCT03653026|79539856|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
44530029|NCT03653026|79539857|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
44530030|NCT03653026|79539854|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
44530031|NCT03653026|79539855|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
44530032|NCT03653026|79539856|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44530033|NCT03653026|79539857|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
44530034|NCT03653026|79539854|FG000|Part 1: Placebo-controlled Period|Other|0|||
44530035|NCT03653026|79539855|FG001|Part 1: Placebo-controlled Period|Other|3|||
44530036|NCT03653026|79539856|FG002|Part 1: Placebo-controlled Period|Other|0|||
44530037|NCT03653026|79539857|FG003|Part 1: Placebo-controlled Period|Other|0|||
44149886|NCT02576067|78939584|FG001|Overall Study|Physician Decision|0|||
44530038|NCT03653026|79539854|FG000|Part 2: Open-label Extension|Adverse Event|0|||
44530039|NCT03653026|79539855|FG001|Part 2: Open-label Extension|Adverse Event|0|||
44530040|NCT03653026|79539856|FG002|Part 2: Open-label Extension|Adverse Event|1|||
44530041|NCT03653026|79539857|FG003|Part 2: Open-label Extension|Adverse Event|1|||
44530042|NCT03653026|79539854|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
44530043|NCT03653026|79539855|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
44530044|NCT03653026|79539856|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
44530045|NCT03653026|79539857|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
44530046|NCT03653026|79539854|FG000|Part 2: Open-label Extension|Other|0|||
44530047|NCT03653026|79539855|FG001|Part 2: Open-label Extension|Other|0|||
44530048|NCT03653026|79539856|FG002|Part 2: Open-label Extension|Other|1|||
44530049|NCT03653026|79539857|FG003|Part 2: Open-label Extension|Other|2|||
44530050|NCT01329328|79539868|FG000|Overall Study|Withdrawal by Subject|2|||
44530051|NCT01329328|79539869|FG001|Overall Study|Withdrawal by Subject|4|||
44530052|NCT01329328|79539870|FG002|Overall Study|Withdrawal by Subject|3|||
44530053|NCT01337986|79539880|FG000|Overall Study|Adverse Event|2|||
44530054|NCT01337986|79539881|FG001|Overall Study|Adverse Event|2|||
44530055|NCT01337986|79539880|FG000|Overall Study|Lost to Follow-up|1|||
44530056|NCT01337986|79539881|FG001|Overall Study|Lost to Follow-up|0|||
44530057|NCT01337986|79539880|FG000|Overall Study|Protocol Violation|0|||
44530058|NCT01337986|79539881|FG001|Overall Study|Protocol Violation|3|||
44530059|NCT01337674|79539905|FG000|Treatment Period 1|Adverse Event|0|||
44530060|NCT01337674|79539906|FG001|Treatment Period 1|Adverse Event|1|||
44149887|NCT02575911|78939590|FG000|Overall Study|Lost to Follow-up|1|||
44530061|NCT01337674|79539907|FG002|Treatment Period 1|Adverse Event|0|||
44149888|NCT02575833|78939604|FG000|Overall Study|Withdrawal by Subject|0|||
44149889|NCT02575833|78939605|FG001|Overall Study|Withdrawal by Subject|1|||
44254667|NCT04421456|79096503|FG001|Randomized Treatment Period|Adverse Event|1|||
44254668|NCT04421456|79096504|FG002|Randomized Treatment Period|Adverse Event|0|||
44254669|NCT04421456|79096502|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
44254670|NCT04421456|79096503|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
44254671|NCT04421456|79096504|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
44254672|NCT04421456|79096502|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
44254673|NCT04421456|79096503|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
44254674|NCT04421456|79096504|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
44254675|NCT04421456|79096502|FG000|Randomized Treatment Period|Participant non-compliance|1|||
44254676|NCT04421456|79096503|FG001|Randomized Treatment Period|Participant non-compliance|1|||
44415044|NCT00625378|79422977|FG001|Overall Study|Multiple toxicities|0|||
44530062|NCT01337674|79539908|FG003|Treatment Period 1|Adverse Event|0|||
44530063|NCT01337674|79539905|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
44530064|NCT01337674|79539906|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
44530065|NCT01337674|79539907|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
44530066|NCT01337674|79539908|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
44530067|NCT01337674|79539905|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44530068|NCT01337674|79539906|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44530069|NCT01337674|79539907|FG002|Treatment Period 2|Withdrawal by Subject|1|||
44530070|NCT01337674|79539908|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44530071|NCT02750410|79539923|FG000|Double-Blind Treatment Period|Adverse Event|2|||
44530072|NCT02750410|79539924|FG001|Double-Blind Treatment Period|Adverse Event|2|||
44530073|NCT02750410|79539923|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44530074|NCT02750410|79539924|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44530075|NCT02750410|79539923|FG000|Open-Label Extension Period|Adverse Event|5|||
44530076|NCT02750410|79539924|FG001|Open-Label Extension Period|Adverse Event|3|||
44530077|NCT02750410|79539923|FG000|Open-Label Extension Period|Protocol Violation|0|||
44530078|NCT02750410|79539924|FG001|Open-Label Extension Period|Protocol Violation|1|||
44530079|NCT02750410|79539923|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
44530080|NCT02750410|79539924|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
44530081|NCT02750332|79539934|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44530082|NCT02750332|79539935|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44530083|NCT01337596|79539950|FG000|Overall Study|Withdrawal by Subject|0|||
44530084|NCT01337596|79539951|FG001|Overall Study|Withdrawal by Subject|0|||
44530085|NCT01337596|79539952|FG002|Overall Study|Withdrawal by Subject|0|||
44530086|NCT01337596|79539953|FG003|Overall Study|Withdrawal by Subject|0|||
44415045|NCT00625378|79422976|FG000|Overall Study|New cancer|1|||
44530087|NCT01337596|79539954|FG004|Overall Study|Withdrawal by Subject|2|||
44530088|NCT01337596|79539955|FG005|Overall Study|Withdrawal by Subject|0|||
44530089|NCT01337596|79539956|FG006|Overall Study|Withdrawal by Subject|0|||
44530090|NCT01337596|79539957|FG007|Overall Study|Withdrawal by Subject|0|||
44530091|NCT01337596|79539958|FG008|Overall Study|Withdrawal by Subject|0|||
44530092|NCT00069095|79539987|FG000|Primary Treatment Phase|Ongoing|0|||
44530093|NCT00069095|79539988|FG001|Primary Treatment Phase|Ongoing|0|||
44530094|NCT00069095|79539989|FG002|Primary Treatment Phase|Ongoing|5|||
44530095|NCT00069095|79539990|FG003|Primary Treatment Phase|Ongoing|7|||
44530096|NCT00069095|79539991|FG004|Primary Treatment Phase|Ongoing|7|||
44530097|NCT00069095|79539992|FG005|Primary Treatment Phase|Ongoing|4|||
44530098|NCT00069095|79539987|FG000|Primary Treatment Phase|Admin/Other|29|||
44530099|NCT00069095|79539988|FG001|Primary Treatment Phase|Admin/Other|38|||
44530100|NCT00069095|79539989|FG002|Primary Treatment Phase|Admin/Other|31|||
44530101|NCT00069095|79539990|FG003|Primary Treatment Phase|Admin/Other|45|||
44530102|NCT00069095|79539991|FG004|Primary Treatment Phase|Admin/Other|48|||
44530103|NCT00069095|79539992|FG005|Primary Treatment Phase|Admin/Other|42|||
44530104|NCT00069095|79539987|FG000|Primary Treatment Phase|Adverse Event|99|||
44530105|NCT00069095|79539988|FG001|Primary Treatment Phase|Adverse Event|92|||
44530106|NCT00069095|79539989|FG002|Primary Treatment Phase|Adverse Event|71|||
44254677|NCT04421456|79096504|FG002|Randomized Treatment Period|Participant non-compliance|2|||
44254678|NCT04421456|79096502|FG000|Randomized Treatment Period|Other|0|||
44254679|NCT04421456|79096503|FG001|Randomized Treatment Period|Other|1|||
44530107|NCT00069095|79539990|FG003|Primary Treatment Phase|Adverse Event|72|||
44530108|NCT00069095|79539991|FG004|Primary Treatment Phase|Adverse Event|109|||
44530109|NCT00069095|79539992|FG005|Primary Treatment Phase|Adverse Event|101|||
44254680|NCT04421456|79096504|FG002|Randomized Treatment Period|Other|3|||
44254681|NCT04341363|79096513|FG000|Overall Study|Adverse Event|1|||
44254682|NCT04341363|79096513|FG000|Overall Study|Withdrawal by Subject|1|||
44254683|NCT04268303|79096524|FG000|Overall Study|Lost to Follow-up|1|||
44254684|NCT04268303|79096525|FG001|Overall Study|Lost to Follow-up|1|||
44254685|NCT04268303|79096526|FG002|Overall Study|Lost to Follow-up|2|||
44254686|NCT04268303|79096524|FG000|Overall Study|Withdrawal by Subject|0|||
44254687|NCT04268303|79096525|FG001|Overall Study|Withdrawal by Subject|1|||
44254688|NCT04268303|79096526|FG002|Overall Study|Withdrawal by Subject|1|||
44254689|NCT04268303|79096524|FG000|Overall Study|Adverse Event|2|||
44254690|NCT04268303|79096525|FG001|Overall Study|Adverse Event|0|||
44254691|NCT04268303|79096526|FG002|Overall Study|Adverse Event|0|||
44254692|NCT04092452|79096570|FG000|Overall Study|Adverse Event|1|||
44254693|NCT04092452|79096571|FG001|Overall Study|Adverse Event|3|||
44254694|NCT04092452|79096572|FG002|Overall Study|Adverse Event|3|||
44254695|NCT04092452|79096573|FG003|Overall Study|Adverse Event|7|||
44254696|NCT04092452|79096570|FG000|Overall Study|Lack of Efficacy|1|||
44530110|NCT00069095|79539987|FG000|Primary Treatment Phase|Death|14|||
44254697|NCT04092452|79096571|FG001|Overall Study|Lack of Efficacy|1|||
44254698|NCT04092452|79096572|FG002|Overall Study|Lack of Efficacy|1|||
44415046|NCT00625378|79422977|FG001|Overall Study|New cancer|0|||
44415047|NCT00625378|79422976|FG000|Overall Study|PTA program|2|||
44530111|NCT00069095|79539988|FG001|Primary Treatment Phase|Death|8|||
44530112|NCT00069095|79539989|FG002|Primary Treatment Phase|Death|2|||
44530113|NCT00069095|79539990|FG003|Primary Treatment Phase|Death|5|||
44530114|NCT00069095|79539991|FG004|Primary Treatment Phase|Death|8|||
44530115|NCT00069095|79539992|FG005|Primary Treatment Phase|Death|8|||
44530116|NCT00069095|79539987|FG000|Primary Treatment Phase|Failure to return|5|||
44530117|NCT00069095|79539988|FG001|Primary Treatment Phase|Failure to return|5|||
44530118|NCT00069095|79539989|FG002|Primary Treatment Phase|Failure to return|0|||
44530119|NCT00069095|79539990|FG003|Primary Treatment Phase|Failure to return|0|||
44530120|NCT00069095|79539991|FG004|Primary Treatment Phase|Failure to return|0|||
44530121|NCT00069095|79539992|FG005|Primary Treatment Phase|Failure to return|2|||
44530122|NCT00069095|79539987|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
44530123|NCT00069095|79539988|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
44530124|NCT00069095|79539989|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
44530125|NCT00069095|79539990|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
44530126|NCT00069095|79539991|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
44530127|NCT00069095|79539992|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
44530128|NCT00069095|79539987|FG000|Primary Treatment Phase|Refused treatment|15|||
44530129|NCT00069095|79539988|FG001|Primary Treatment Phase|Refused treatment|26|||
44530130|NCT00069095|79539989|FG002|Primary Treatment Phase|Refused treatment|17|||
44254699|NCT04092452|79096573|FG003|Overall Study|Lack of Efficacy|0|||
44415048|NCT00625378|79422977|FG001|Overall Study|PTA program|0|||
44415049|NCT00625378|79422976|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
44415050|NCT00625378|79422977|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
44415051|NCT00625378|79422976|FG000|Overall Study|Sponsor decision|1|||
44415052|NCT00625378|79422977|FG001|Overall Study|Sponsor decision|0|||
44530131|NCT00069095|79539990|FG003|Primary Treatment Phase|Refused treatment|31|||
44530132|NCT00069095|79539991|FG004|Primary Treatment Phase|Refused treatment|24|||
44530133|NCT00069095|79539992|FG005|Primary Treatment Phase|Refused treatment|27|||
44530134|NCT00069095|79539987|FG000|Primary Treatment Phase|Withdrew|2|||
44415053|NCT00625378|79422976|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
44415054|NCT00625378|79422977|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
44415055|NCT00625378|79422976|FG000|Overall Study|Switch to commercial drug|6|||
44530135|NCT00069095|79539988|FG001|Primary Treatment Phase|Withdrew|3|||
44530136|NCT00069095|79539989|FG002|Primary Treatment Phase|Withdrew|8|||
44530137|NCT00069095|79539990|FG003|Primary Treatment Phase|Withdrew|2|||
44254700|NCT04092452|79096570|FG000|Overall Study|Lost to Follow-up|4|||
44254701|NCT04092452|79096571|FG001|Overall Study|Lost to Follow-up|3|||
44530138|NCT00069095|79539991|FG004|Primary Treatment Phase|Withdrew|4|||
44530139|NCT00069095|79539992|FG005|Primary Treatment Phase|Withdrew|9|||
44530140|NCT00069095|79539987|FG000|Primary Treatment Phase|Other Violation|0|||
44530141|NCT00069095|79539988|FG001|Primary Treatment Phase|Other Violation|1|||
44254702|NCT04092452|79096572|FG002|Overall Study|Lost to Follow-up|5|||
44254703|NCT04092452|79096573|FG003|Overall Study|Lost to Follow-up|1|||
44254704|NCT04092452|79096570|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44254705|NCT04092452|79096571|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44254706|NCT04092452|79096572|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44254707|NCT04092452|79096573|FG003|Overall Study|Non-Compliance With Study Drug|1|||
44254708|NCT04092452|79096570|FG000|Overall Study|Physician Decision|1|||
44530142|NCT00069095|79539989|FG002|Primary Treatment Phase|Other Violation|1|||
44530143|NCT00069095|79539990|FG003|Primary Treatment Phase|Other Violation|1|||
44254709|NCT04092452|79096571|FG001|Overall Study|Physician Decision|0|||
44254710|NCT04092452|79096572|FG002|Overall Study|Physician Decision|1|||
44254711|NCT04092452|79096573|FG003|Overall Study|Physician Decision|0|||
44254712|NCT04092452|79096570|FG000|Overall Study|Pregnancy|2|||
44530144|NCT00069095|79539991|FG004|Primary Treatment Phase|Other Violation|0|||
44530145|NCT00069095|79539992|FG005|Primary Treatment Phase|Other Violation|1|||
44254713|NCT04092452|79096571|FG001|Overall Study|Pregnancy|0|||
44530146|NCT00069095|79539987|FG000|Primary Treatment Phase|Violation criteria|0|||
44530147|NCT00069095|79539988|FG001|Primary Treatment Phase|Violation criteria|2|||
44530148|NCT00069095|79539989|FG002|Primary Treatment Phase|Violation criteria|4|||
44530149|NCT00069095|79539990|FG003|Primary Treatment Phase|Violation criteria|3|||
44530150|NCT00069095|79539991|FG004|Primary Treatment Phase|Violation criteria|1|||
44530151|NCT00069095|79539992|FG005|Primary Treatment Phase|Violation criteria|5|||
44530152|NCT00069095|79539987|FG000|Post-study Treatment Phase|Missing reason|1|||
44530153|NCT00069095|79539988|FG001|Post-study Treatment Phase|Missing reason|3|||
44530154|NCT00069095|79539989|FG002|Post-study Treatment Phase|Missing reason|12|||
44530155|NCT00069095|79539990|FG003|Post-study Treatment Phase|Missing reason|8|||
44530156|NCT00069095|79539991|FG004|Post-study Treatment Phase|Missing reason|18|||
44530157|NCT00069095|79539992|FG005|Post-study Treatment Phase|Missing reason|17|||
44530158|NCT00069095|79539987|FG000|Post-study Treatment Phase|Adverse Event|2|||
44530159|NCT00069095|79539988|FG001|Post-study Treatment Phase|Adverse Event|3|||
44530160|NCT00069095|79539989|FG002|Post-study Treatment Phase|Adverse Event|1|||
44530161|NCT00069095|79539990|FG003|Post-study Treatment Phase|Adverse Event|0|||
44530162|NCT00069095|79539991|FG004|Post-study Treatment Phase|Adverse Event|5|||
44530163|NCT00069095|79539992|FG005|Post-study Treatment Phase|Adverse Event|1|||
44530164|NCT00069095|79539987|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
44530165|NCT00069095|79539988|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
44530166|NCT00069095|79539989|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
44530167|NCT00069095|79539990|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
44530168|NCT00069095|79539991|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
44530169|NCT00069095|79539992|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
44530170|NCT00069095|79539987|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
44530171|NCT00069095|79539988|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
44530172|NCT00069095|79539989|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
44530173|NCT00069095|79539990|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
44530174|NCT00069095|79539991|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
44530175|NCT00069095|79539992|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
44530176|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
44530177|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
44530178|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
44530179|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
44530180|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
44530181|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
44530182|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant had complete response|1|||
44530183|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant had complete response|1|||
44530184|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant had complete response|0|||
44530185|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant had complete response|0|||
44530186|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant had complete response|0|||
44530187|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant had complete response|0|||
44530188|NCT00069095|79539987|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
44530189|NCT00069095|79539988|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
44530190|NCT00069095|79539989|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
44530191|NCT00069095|79539990|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
44530192|NCT00069095|79539991|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
44530193|NCT00069095|79539992|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
44530194|NCT00069095|79539987|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
44530195|NCT00069095|79539988|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
44530196|NCT00069095|79539989|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
44530197|NCT00069095|79539990|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
44530198|NCT00069095|79539991|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
44530199|NCT00069095|79539992|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
44530200|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
44530201|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
44530202|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
44530203|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
44530204|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
44530205|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
44530206|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
44530207|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
44530208|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
44149890|NCT02575833|78939604|FG000|Overall Study|Lost to Follow-up|1|||
44149891|NCT02575833|78939605|FG001|Overall Study|Lost to Follow-up|0|||
44149892|NCT02709083|78939611|FG000|Overall Study|Original PI left institution|7|||
44530209|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
44530210|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
44530211|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
44530212|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
44530213|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
44530214|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
44530215|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
44530216|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
44530217|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
44530218|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
44530219|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
44530220|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
44149893|NCT02709005|78939617|FG000|Overall Study|Lost to Follow-up|1|||
44149894|NCT02709005|78939618|FG001|Overall Study|Lost to Follow-up|1|||
44149895|NCT02709005|78939617|FG000|Overall Study|Withdrawal by Subject|3|||
44149896|NCT02709005|78939618|FG001|Overall Study|Withdrawal by Subject|0|||
44149897|NCT02573883|78939626|FG000|Six Month Follow Up|Lost to Follow-up|1|||
44530221|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
44530222|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
44530223|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
44530224|NCT00069095|79539987|FG000|Post-study Treatment Phase|Surgery|0|||
44530225|NCT00069095|79539988|FG001|Post-study Treatment Phase|Surgery|0|||
44530226|NCT00069095|79539989|FG002|Post-study Treatment Phase|Surgery|0|||
44530227|NCT00069095|79539990|FG003|Post-study Treatment Phase|Surgery|1|||
44530228|NCT00069095|79539991|FG004|Post-study Treatment Phase|Surgery|1|||
44530229|NCT00069095|79539992|FG005|Post-study Treatment Phase|Surgery|0|||
44530230|NCT00069095|79539987|FG000|Post-study Treatment Phase|Death|0|||
44530231|NCT00069095|79539988|FG001|Post-study Treatment Phase|Death|0|||
44530232|NCT00069095|79539989|FG002|Post-study Treatment Phase|Death|0|||
44530233|NCT00069095|79539990|FG003|Post-study Treatment Phase|Death|0|||
44530234|NCT00069095|79539991|FG004|Post-study Treatment Phase|Death|1|||
44530235|NCT00069095|79539992|FG005|Post-study Treatment Phase|Death|0|||
44530236|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
44530237|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
44530238|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
44530239|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
44530240|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
44530241|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
44530242|NCT00069095|79539987|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
44530243|NCT00069095|79539988|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
44530244|NCT00069095|79539989|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
44530245|NCT00069095|79539990|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
44530246|NCT00069095|79539991|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
44530247|NCT00069095|79539992|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
44530248|NCT00069095|79539987|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
44530249|NCT00069095|79539988|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
44530250|NCT00069095|79539989|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
44530251|NCT00069095|79539990|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
44530252|NCT00069095|79539991|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
44530253|NCT00069095|79539992|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
44530254|NCT00069095|79539987|FG000|Post-study Treatment Phase|Investigator decision|0|||
44530255|NCT00069095|79539988|FG001|Post-study Treatment Phase|Investigator decision|0|||
44530256|NCT00069095|79539989|FG002|Post-study Treatment Phase|Investigator decision|0|||
44530257|NCT00069095|79539990|FG003|Post-study Treatment Phase|Investigator decision|0|||
44530258|NCT00069095|79539991|FG004|Post-study Treatment Phase|Investigator decision|0|||
44530259|NCT00069095|79539992|FG005|Post-study Treatment Phase|Investigator decision|1|||
44530260|NCT00069095|79539987|FG000|Follow-up Phase|Death|174|||
44530261|NCT00069095|79539988|FG001|Follow-up Phase|Death|206|||
44530262|NCT00069095|79539989|FG002|Follow-up Phase|Death|120|||
44530263|NCT00069095|79539990|FG003|Follow-up Phase|Death|112|||
44530264|NCT00069095|79539991|FG004|Follow-up Phase|Death|92|||
44530265|NCT00069095|79539992|FG005|Follow-up Phase|Death|101|||
44530266|NCT00086411|79540008|FG000|Overall Study|Lost to Follow-up|11|||
44530267|NCT00086411|79540009|FG001|Overall Study|Lost to Follow-up|11|||
44415056|NCT00625378|79422977|FG001|Overall Study|Switch to commercial drug|1|||
44530268|NCT00086411|79540010|FG002|Overall Study|Lost to Follow-up|13|||
44530269|NCT00086411|79540011|FG003|Overall Study|Lost to Follow-up|12|||
44530270|NCT00068237|79540022|FG000|Overall Study|Ineligible|3|||
44530271|NCT00068237|79540022|FG000|Overall Study|No protocol treatment received|2|||
44530272|NCT00055601|79540028|FG000|Overall Study|Protocol Violation|1|||
44530273|NCT00055601|79540029|FG001|Overall Study|Protocol Violation|1|||
44530274|NCT00055601|79540028|FG000|Overall Study|No protocol treatment received|1|||
44530275|NCT00055601|79540029|FG001|Overall Study|No protocol treatment received|1|||
44530276|NCT03806231|79540037|FG000|Overall Study|Physician Decision|1|||
44530277|NCT03806231|79540038|FG001|Overall Study|Physician Decision|0|||
44530278|NCT03806231|79540037|FG000|Overall Study|Withdrawal by Subject|1|||
44530279|NCT03806231|79540038|FG001|Overall Study|Withdrawal by Subject|0|||
44530280|NCT00054275|79540044|FG000|Overall Study|Withdrawal by Subject|4|||
44530281|NCT00054275|79540044|FG000|Overall Study|Adverse Event|5|||
44530282|NCT00054275|79540044|FG000|Overall Study|Progressive disease in cycle 1|1|||
44530283|NCT00054275|79540044|FG000|Overall Study|Physician Decision|1|||
44530284|NCT00053417|79540052|FG000|Overall Study|Adverse Event|1|||
44530285|NCT00053417|79540053|FG001|Overall Study|Adverse Event|0|||
44530286|NCT00053417|79540054|FG002|Overall Study|Adverse Event|1|||
44530287|NCT00053417|79540055|FG003|Overall Study|Adverse Event|5|||
44530288|NCT00053417|79540052|FG000|Overall Study|Non-Compliance|0|||
44530289|NCT00053417|79540053|FG001|Overall Study|Non-Compliance|0|||
44530290|NCT00053417|79540054|FG002|Overall Study|Non-Compliance|0|||
44530291|NCT00053417|79540055|FG003|Overall Study|Non-Compliance|1|||
44530292|NCT00053417|79540052|FG000|Overall Study|Withdrawal by Subject|0|||
44530293|NCT00053417|79540053|FG001|Overall Study|Withdrawal by Subject|1|||
44530294|NCT00053417|79540054|FG002|Overall Study|Withdrawal by Subject|0|||
44530295|NCT00053417|79540055|FG003|Overall Study|Withdrawal by Subject|0|||
44530296|NCT00053417|79540052|FG000|Overall Study|Lost to Follow-up|1|||
44530297|NCT00053417|79540053|FG001|Overall Study|Lost to Follow-up|1|||
44530298|NCT00053417|79540054|FG002|Overall Study|Lost to Follow-up|0|||
44530299|NCT00053417|79540055|FG003|Overall Study|Lost to Follow-up|0|||
44530300|NCT00052715|79540065|FG000|Overall Study|wrong histology|1|||
44149898|NCT02573883|78939627|FG001|Six Month Follow Up|Lost to Follow-up|0|||
44149899|NCT02573883|78939628|FG002|Six Month Follow Up|Lost to Follow-up|0|||
44149900|NCT02573883|78939629|FG003|Six Month Follow Up|Lost to Follow-up|0|||
44254714|NCT04092452|79096572|FG002|Overall Study|Pregnancy|0|||
44530301|NCT00051311|79540071|FG000|Overall Study|Starting new study|0|||
44530302|NCT00051311|79540072|FG001|Overall Study|Starting new study|1|||
44149901|NCT02573883|78939626|FG000|One Year Follow Up|Lost to Follow-up|2|||
44530303|NCT00051311|79540071|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
44530304|NCT00051311|79540072|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
44530305|NCT00051311|79540071|FG000|Overall Study|Death of recipient|8|||
44149902|NCT02573883|78939627|FG001|One Year Follow Up|Lost to Follow-up|1|||
44254715|NCT04092452|79096573|FG003|Overall Study|Pregnancy|0|||
44530306|NCT00051311|79540072|FG001|Overall Study|Death of recipient|8|||
44149903|NCT02573883|78939628|FG002|One Year Follow Up|Lost to Follow-up|0|||
44530307|NCT00051311|79540071|FG000|Overall Study|Recipient taken off study|4|||
44530308|NCT00051311|79540072|FG001|Overall Study|Recipient taken off study|4|||
44530309|NCT00049673|79540078|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
44530310|NCT00049673|79540079|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
44530311|NCT00049127|79540090|FG000|Overall Study|Withdrawal by Subject|0|||
44530312|NCT00049127|79540091|FG001|Overall Study|Withdrawal by Subject|0|||
44530313|NCT00049127|79540092|FG002|Overall Study|Withdrawal by Subject|1|||
44530314|NCT00049127|79540093|FG003|Overall Study|Withdrawal by Subject|0|||
44530315|NCT00049127|79540094|FG004|Overall Study|Withdrawal by Subject|0|||
44530316|NCT00066365|79540108|FG000|Overall Study|Adverse Event|1|||
44149904|NCT02573883|78939629|FG003|One Year Follow Up|Lost to Follow-up|0|||
44149905|NCT02575365|78939644|FG000|Overall Study|Lost to Follow-up|4|||
44149906|NCT02707991|78939650|FG000|Overall Study|Protocol Violation|1|||
44149907|NCT02707991|78939651|FG001|Overall Study|Protocol Violation|0|||
44149908|NCT02707991|78939650|FG000|Overall Study|Became ineligible|0|||
44149909|NCT02707991|78939651|FG001|Overall Study|Became ineligible|1|||
44254716|NCT04092452|79096570|FG000|Overall Study|Protocol Deviation|1|||
44254717|NCT04092452|79096571|FG001|Overall Study|Protocol Deviation|0|||
44254718|NCT04092452|79096572|FG002|Overall Study|Protocol Deviation|0|||
44254719|NCT04092452|79096573|FG003|Overall Study|Protocol Deviation|0|||
44254720|NCT04092452|79096570|FG000|Overall Study|Withdrawal by Subject|3|||
44149910|NCT02707757|78939659|FG000|Overall Study|Protocol Violation|3|||
44530317|NCT00066365|79540109|FG001|Overall Study|Adverse Event|0|||
44149911|NCT02707757|78939660|FG001|Overall Study|Protocol Violation|2|||
44149912|NCT02707757|78939659|FG000|Overall Study|Withdrawal by Subject|2|||
44149913|NCT02707757|78939660|FG001|Overall Study|Withdrawal by Subject|0|||
44149914|NCT02707757|78939659|FG000|Overall Study|Death|0|||
44149915|NCT02707757|78939660|FG001|Overall Study|Death|1|||
44149916|NCT02707757|78939659|FG000|Overall Study|Adverse Event|6|||
44149917|NCT02707757|78939660|FG001|Overall Study|Adverse Event|4|||
44149918|NCT02707757|78939659|FG000|Overall Study|Renal transplant/elective operation|1|||
44149919|NCT02707757|78939660|FG001|Overall Study|Renal transplant/elective operation|5|||
44149920|NCT02572401|78939670|FG000|Overall Study|Lost to Follow-up|5|||
44530318|NCT00066365|79540108|FG000|Overall Study|Lack of Efficacy|15|||
44149921|NCT02572401|78939671|FG001|Overall Study|Lost to Follow-up|8|||
44149922|NCT02572401|78939672|FG002|Overall Study|Lost to Follow-up|9|||
44149923|NCT02572401|78939673|FG003|Overall Study|Lost to Follow-up|9|||
44149924|NCT02572401|78939670|FG000|Overall Study|Death|0|||
44149925|NCT02572401|78939671|FG001|Overall Study|Death|0|||
44149926|NCT02572401|78939672|FG002|Overall Study|Death|0|||
44149927|NCT02572401|78939673|FG003|Overall Study|Death|1|||
44149928|NCT02431325|78939685|FG000|Overall Study|Adverse Event|3|||
44149929|NCT02431325|78939686|FG001|Overall Study|Adverse Event|0|||
44149930|NCT02431325|78939685|FG000|Overall Study|Lost to Follow-up|0|||
44149931|NCT02431325|78939686|FG001|Overall Study|Lost to Follow-up|1|||
44149932|NCT02431325|78939685|FG000|Overall Study|Withdrawal by Subject|1|||
44149933|NCT02431325|78939686|FG001|Overall Study|Withdrawal by Subject|2|||
44149934|NCT02431325|78939685|FG000|Overall Study|Declined to take study medication|1|||
44149935|NCT02431325|78939686|FG001|Overall Study|Declined to take study medication|0|||
44149936|NCT02431325|78939685|FG000|Overall Study|Withdrew before starting study medication|1|||
44149937|NCT02431325|78939686|FG001|Overall Study|Withdrew before starting study medication|0|||
44149938|NCT02431325|78939685|FG000|Overall Study|Placebo shortage|2|||
44149939|NCT02431325|78939686|FG001|Overall Study|Placebo shortage|0|||
44149940|NCT02103478|78939699|FG000|Overall Study|Adverse Event|0|||
44530319|NCT00066365|79540109|FG001|Overall Study|Lack of Efficacy|12|||
44530320|NCT00066365|79540108|FG000|Overall Study|Physician Decision|1|||
44530321|NCT00066365|79540109|FG001|Overall Study|Physician Decision|0|||
44530322|NCT00066365|79540108|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
44530323|NCT00066365|79540109|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
44530324|NCT00066365|79540108|FG000|Overall Study|Ineligible|4|||
44530325|NCT00066365|79540109|FG001|Overall Study|Ineligible|2|||
44530326|NCT00048581|79540119|FG000|Double-Blind Period|Adverse Event|9|||
44530327|NCT00048581|79540120|FG001|Double-Blind Period|Adverse Event|5|||
44530328|NCT00048581|79540121|FG002|Double-Blind Period|Adverse Event|0|||
44530329|NCT00048581|79540119|FG000|Double-Blind Period|Lack of Efficacy|14|||
44530330|NCT00048581|79540120|FG001|Double-Blind Period|Lack of Efficacy|27|||
44530331|NCT00048581|79540121|FG002|Double-Blind Period|Lack of Efficacy|0|||
44530332|NCT00048581|79540119|FG000|Double-Blind Period|Lost to Follow-up|5|||
44530333|NCT00048581|79540120|FG001|Double-Blind Period|Lost to Follow-up|0|||
44530334|NCT00048581|79540121|FG002|Double-Blind Period|Lost to Follow-up|0|||
44530335|NCT00048581|79540119|FG000|Double-Blind Period|Withdrawal by Subject|5|||
44415057|NCT00625378|79422976|FG000|Overall Study|Missing|2|||
44530336|NCT00048581|79540120|FG001|Double-Blind Period|Withdrawal by Subject|2|||
44530337|NCT00048581|79540121|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44530338|NCT00048581|79540119|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
44530339|NCT00048581|79540120|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
44149941|NCT02103478|78939700|FG001|Overall Study|Adverse Event|0|||
44149942|NCT02103478|78939701|FG002|Overall Study|Adverse Event|1|||
44149943|NCT02103478|78939702|FG003|Overall Study|Adverse Event|1|||
44149944|NCT02103478|78939703|FG004|Overall Study|Adverse Event|2|||
44149945|NCT02103478|78939704|FG005|Overall Study|Adverse Event|1|||
44530340|NCT00048581|79540121|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
44530341|NCT00048581|79540119|FG000|Double-Blind Period|Investigator Decision|1|||
44530342|NCT00048581|79540120|FG001|Double-Blind Period|Investigator Decision|0|||
44530343|NCT00048581|79540121|FG002|Double-Blind Period|Investigator Decision|0|||
44530344|NCT00048581|79540119|FG000|Open-Label Period|Death|0|||
44530345|NCT00048581|79540120|FG001|Open-Label Period|Death|0|||
44530346|NCT00048581|79540121|FG002|Open-Label Period|Death|4|||
44530347|NCT00048581|79540119|FG000|Open-Label Period|Adverse Event|0|||
44530348|NCT00048581|79540120|FG001|Open-Label Period|Adverse Event|0|||
44530349|NCT00048581|79540121|FG002|Open-Label Period|Adverse Event|37|||
44530350|NCT00048581|79540119|FG000|Open-Label Period|Lack of Efficacy|0|||
44530351|NCT00048581|79540120|FG001|Open-Label Period|Lack of Efficacy|0|||
44530352|NCT00048581|79540121|FG002|Open-Label Period|Lack of Efficacy|69|||
44530353|NCT00048581|79540119|FG000|Open-Label Period|Lost to Follow-up|0|||
44530354|NCT00048581|79540120|FG001|Open-Label Period|Lost to Follow-up|0|||
44530355|NCT00048581|79540121|FG002|Open-Label Period|Lost to Follow-up|14|||
44530356|NCT00048581|79540119|FG000|Open-Label Period|Withdrawal by Subject|0|||
44530357|NCT00048581|79540120|FG001|Open-Label Period|Withdrawal by Subject|0|||
44530358|NCT00048581|79540121|FG002|Open-Label Period|Withdrawal by Subject|20|||
44530359|NCT00048581|79540119|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
44530360|NCT00048581|79540120|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
44530361|NCT00048581|79540121|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
44530362|NCT00048581|79540119|FG000|Open-Label Period|Poor/Non-compliance|0|||
44530363|NCT00048581|79540120|FG001|Open-Label Period|Poor/Non-compliance|0|||
44530364|NCT00048581|79540121|FG002|Open-Label Period|Poor/Non-compliance|5|||
44530365|NCT00048581|79540119|FG000|Open-Label Period|Pregnancy|0|||
44530366|NCT00048581|79540120|FG001|Open-Label Period|Pregnancy|0|||
44530367|NCT00048581|79540121|FG002|Open-Label Period|Pregnancy|7|||
44530368|NCT00048581|79540119|FG000|Open-Label Period|Study Site Closure|0|||
44149946|NCT02103478|78939705|FG006|Overall Study|Adverse Event|0|||
44530369|NCT00048581|79540120|FG001|Open-Label Period|Study Site Closure|0|||
44530370|NCT00048581|79540121|FG002|Open-Label Period|Study Site Closure|2|||
44530371|NCT00048581|79540119|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
44530372|NCT00048581|79540120|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
44530373|NCT00048581|79540121|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
44530374|NCT00048581|79540119|FG000|Open-Label Period|Problem With Transportation To Site|0|||
44530375|NCT00048581|79540120|FG001|Open-Label Period|Problem With Transportation To Site|0|||
44530376|NCT00048581|79540121|FG002|Open-Label Period|Problem With Transportation To Site|1|||
44530377|NCT00048581|79540119|FG000|Open-Label Period|Primary Investigator Retired|0|||
44530378|NCT00048581|79540120|FG001|Open-Label Period|Primary Investigator Retired|0|||
44530379|NCT00048581|79540121|FG002|Open-Label Period|Primary Investigator Retired|2|||
44530380|NCT00048581|79540119|FG000|Open-Label Period|Study Ended By Sponsor|0|||
44149947|NCT02103478|78939706|FG007|Overall Study|Adverse Event|0|||
44149948|NCT02103478|78939707|FG008|Overall Study|Adverse Event|0|||
44149949|NCT02103478|78939699|FG000|Overall Study|Death|2|||
44149950|NCT02103478|78939700|FG001|Overall Study|Death|2|||
44149951|NCT02103478|78939701|FG002|Overall Study|Death|1|||
44149952|NCT02103478|78939702|FG003|Overall Study|Death|1|||
44149953|NCT02103478|78939703|FG004|Overall Study|Death|5|||
44149954|NCT02103478|78939704|FG005|Overall Study|Death|15|||
44530381|NCT00048581|79540120|FG001|Open-Label Period|Study Ended By Sponsor|0|||
44530382|NCT00048581|79540121|FG002|Open-Label Period|Study Ended By Sponsor|1|||
44149955|NCT02103478|78939705|FG006|Overall Study|Death|14|||
44530383|NCT00048347|79540134|FG000|Overall Study|Screen failure|2|||
44530384|NCT00065507|79540140|FG000|Overall Study|Death|16|||
44149956|NCT02103478|78939706|FG007|Overall Study|Death|10|||
44530385|NCT00065507|79540141|FG001|Overall Study|Death|17|||
44530386|NCT00065507|79540140|FG000|Overall Study|Adverse Event|4|||
44149957|NCT02103478|78939707|FG008|Overall Study|Death|11|||
44149958|NCT02103478|78939699|FG000|Overall Study|Progressive Disease|2|||
44530387|NCT00065507|79540141|FG001|Overall Study|Adverse Event|3|||
44149959|NCT02103478|78939700|FG001|Overall Study|Progressive Disease|1|||
44530388|NCT00065507|79540140|FG000|Overall Study|Lack of Efficacy|0|||
44530389|NCT00065507|79540141|FG001|Overall Study|Lack of Efficacy|6|||
44149960|NCT02103478|78939701|FG002|Overall Study|Progressive Disease|2|||
44149961|NCT02103478|78939702|FG003|Overall Study|Progressive Disease|0|||
44149962|NCT02103478|78939703|FG004|Overall Study|Progressive Disease|9|||
44149963|NCT02103478|78939704|FG005|Overall Study|Progressive Disease|1|||
44149964|NCT02103478|78939705|FG006|Overall Study|Progressive Disease|2|||
44149965|NCT02103478|78939706|FG007|Overall Study|Progressive Disease|0|||
44149966|NCT02103478|78939707|FG008|Overall Study|Progressive Disease|1|||
44149967|NCT02103478|78939699|FG000|Overall Study|Withdrawal by Subject|2|||
44149968|NCT02103478|78939700|FG001|Overall Study|Withdrawal by Subject|0|||
44149969|NCT02103478|78939701|FG002|Overall Study|Withdrawal by Subject|0|||
44149970|NCT02103478|78939702|FG003|Overall Study|Withdrawal by Subject|4|||
44149971|NCT02103478|78939703|FG004|Overall Study|Withdrawal by Subject|0|||
44149972|NCT02103478|78939704|FG005|Overall Study|Withdrawal by Subject|0|||
44149973|NCT02103478|78939705|FG006|Overall Study|Withdrawal by Subject|1|||
44149974|NCT02103478|78939706|FG007|Overall Study|Withdrawal by Subject|1|||
44149975|NCT02103478|78939707|FG008|Overall Study|Withdrawal by Subject|0|||
44149976|NCT02103478|78939699|FG000|Overall Study|Lost to Follow-up|0|||
44149977|NCT02103478|78939700|FG001|Overall Study|Lost to Follow-up|0|||
44149978|NCT02103478|78939701|FG002|Overall Study|Lost to Follow-up|0|||
44149979|NCT02103478|78939702|FG003|Overall Study|Lost to Follow-up|0|||
44149980|NCT02103478|78939703|FG004|Overall Study|Lost to Follow-up|0|||
44149981|NCT02103478|78939704|FG005|Overall Study|Lost to Follow-up|0|||
44149982|NCT02103478|78939705|FG006|Overall Study|Lost to Follow-up|0|||
44149983|NCT02103478|78939706|FG007|Overall Study|Lost to Follow-up|1|||
44149984|NCT02103478|78939707|FG008|Overall Study|Lost to Follow-up|0|||
44149985|NCT02103478|78939699|FG000|Overall Study|Other|1|||
44149986|NCT02103478|78939700|FG001|Overall Study|Other|3|||
44149987|NCT02103478|78939701|FG002|Overall Study|Other|2|||
44149988|NCT02103478|78939702|FG003|Overall Study|Other|0|||
44149989|NCT02103478|78939703|FG004|Overall Study|Other|3|||
44149990|NCT02103478|78939704|FG005|Overall Study|Other|8|||
44149991|NCT02103478|78939705|FG006|Overall Study|Other|8|||
44149992|NCT02103478|78939706|FG007|Overall Study|Other|4|||
44149993|NCT02103478|78939707|FG008|Overall Study|Other|2|||
44149994|NCT02102464|78939739|FG000|Randomized Study|Withdrawal by Subject|0|||
44149995|NCT02102464|78939740|FG001|Randomized Study|Withdrawal by Subject|1|||
44149996|NCT02102464|78939741|FG002|Randomized Study|Withdrawal by Subject|0|||
44149997|NCT02707601|78939752|FG000|Overall Study|Death|0|||
44149998|NCT02707601|78939753|FG001|Overall Study|Death|1|||
44149999|NCT02707601|78939752|FG000|Overall Study|Lack of Efficacy|0|||
44150000|NCT02707601|78939753|FG001|Overall Study|Lack of Efficacy|1|||
44150001|NCT02707601|78939752|FG000|Overall Study|Investigator's Discretion|1|||
44150002|NCT02707601|78939753|FG001|Overall Study|Investigator's Discretion|0|||
44150003|NCT02707601|78939752|FG000|Overall Study|Withdrew Consent|0|||
44150004|NCT02707601|78939753|FG001|Overall Study|Withdrew Consent|1|||
44530390|NCT00065507|79540140|FG000|Overall Study|Poor/Non-compliance|3|||
44530391|NCT00065507|79540141|FG001|Overall Study|Poor/Non-compliance|2|||
44530392|NCT00065507|79540140|FG000|Overall Study|Lost to Follow-up|3|||
44530393|NCT00065507|79540141|FG001|Overall Study|Lost to Follow-up|0|||
44530394|NCT00065507|79540140|FG000|Overall Study|Subject Withdrew Consent|2|||
44530395|NCT00065507|79540141|FG001|Overall Study|Subject Withdrew Consent|1|||
44530396|NCT00065507|79540140|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
44530397|NCT00065507|79540141|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
44530398|NCT00065429|79540158|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
44530399|NCT00065429|79540159|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
44530400|NCT00065429|79540160|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
44530401|NCT00065429|79540161|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
44530402|NCT00065429|79540162|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
44530403|NCT00065429|79540163|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
44530404|NCT00065429|79540164|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
44530405|NCT00065429|79540158|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
44530406|NCT00065429|79540159|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
44530407|NCT00065429|79540160|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
44530408|NCT00065429|79540161|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
44150005|NCT02707601|78939752|FG000|Overall Study|Lost to Follow-up|1|||
44150006|NCT02707601|78939753|FG001|Overall Study|Lost to Follow-up|1|||
44150007|NCT02707601|78939752|FG000|Overall Study|Participants Randomized but Not Treated|2|||
44150008|NCT02707601|78939753|FG001|Overall Study|Participants Randomized but Not Treated|0|||
44150009|NCT02707055|78939765|FG000|Phase 1|Withdrawal by Subject|1|||
44150010|NCT02707055|78939766|FG001|Phase 1|Withdrawal by Subject|2|||
44150011|NCT02707055|78939765|FG000|Phase 1|Physician Decision|0|||
44150012|NCT02707055|78939766|FG001|Phase 1|Physician Decision|1|||
44150013|NCT02707055|78939765|FG000|Phase 2|Adverse Event|1|||
44150014|NCT02707055|78939766|FG001|Phase 2|Adverse Event|2|||
44150015|NCT02073682|78939774|FG000|Overall Study|Low Creatinine Clearance|1|||
44282457|NCT01857102|79245777|FG000|Period 1|Physician Decision|1|||
44530409|NCT00065429|79540162|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
44530410|NCT00065429|79540163|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
44530411|NCT00065429|79540164|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
44530412|NCT00065429|79540158|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
44530413|NCT00065429|79540159|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
44530414|NCT00065429|79540160|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
44530415|NCT00065429|79540161|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
44530416|NCT00065429|79540162|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
44530417|NCT00065429|79540163|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
44530418|NCT00065429|79540164|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
44530419|NCT00065429|79540158|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
44530420|NCT00065429|79540159|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
44530421|NCT00065429|79540160|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
44530422|NCT00065429|79540161|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
44530423|NCT00065429|79540162|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
44530424|NCT00065429|79540163|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
44530425|NCT00065429|79540164|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
44530426|NCT00065429|79540158|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
44530427|NCT00065429|79540159|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
44530428|NCT00065429|79540160|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
44530429|NCT00065429|79540161|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
44530430|NCT00065429|79540162|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
44530431|NCT00065429|79540163|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
44530432|NCT00065429|79540164|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
44530433|NCT00065429|79540158|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
44530434|NCT00065429|79540159|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
44530435|NCT00065429|79540160|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
44530436|NCT00065429|79540161|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
44530437|NCT00065429|79540162|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
44530438|NCT00065429|79540163|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
44530439|NCT00065429|79540164|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
44530440|NCT00065429|79540158|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
44530441|NCT00065429|79540159|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
44530442|NCT00065429|79540160|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
44530443|NCT00065429|79540161|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
44530444|NCT00065429|79540162|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
44254721|NCT04092452|79096571|FG001|Overall Study|Withdrawal by Subject|10|||
44254722|NCT04092452|79096572|FG002|Overall Study|Withdrawal by Subject|3|||
44254723|NCT04092452|79096573|FG003|Overall Study|Withdrawal by Subject|5|||
44254724|NCT04092452|79096570|FG000|Overall Study|Other|0|||
44530445|NCT00065429|79540163|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
44254725|NCT04092452|79096571|FG001|Overall Study|Other|0|||
44530446|NCT00065429|79540164|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
44530447|NCT00048035|79540181|FG000|Core Period|Early Withdrawals|4|||
44530448|NCT00048035|79540182|FG001|Core Period|Early Withdrawals|2|||
44530449|NCT00048035|79540183|FG002|Core Period|Early Withdrawals|1|||
44530450|NCT00048035|79540184|FG003|Core Period|Early Withdrawals|1|||
44530451|NCT00048035|79540185|FG004|Core Period|Early Withdrawals|1|||
44530452|NCT00048035|79540186|FG005|Core Period|Early Withdrawals|1|||
44530453|NCT00048035|79540187|FG006|Core Period|Early Withdrawals|0|||
44530454|NCT00048035|79540188|FG007|Core Period|Early Withdrawals|0|||
44530455|NCT00048035|79540181|FG000|Extension Year 1|Early Withdrawals|0|||
44530456|NCT00048035|79540182|FG001|Extension Year 1|Early Withdrawals|0|||
44530457|NCT00048035|79540183|FG002|Extension Year 1|Early Withdrawals|0|||
44530458|NCT00048035|79540184|FG003|Extension Year 1|Early Withdrawals|0|||
44530459|NCT00048035|79540185|FG004|Extension Year 1|Early Withdrawals|0|||
44254726|NCT04092452|79096572|FG002|Overall Study|Other|1|||
44530460|NCT00048035|79540186|FG005|Extension Year 1|Early Withdrawals|0|||
44254727|NCT04092452|79096573|FG003|Overall Study|Other|2|||
44254728|NCT04029116|79096588|FG000|Overall Study|Adverse Event|0|||
44530461|NCT00048035|79540187|FG006|Extension Year 1|Early Withdrawals|11|||
44530462|NCT00048035|79540188|FG007|Extension Year 1|Early Withdrawals|11|||
44150016|NCT02073682|78939775|FG001|Overall Study|Low Creatinine Clearance|2|||
44150017|NCT02073682|78939774|FG000|Overall Study|Death|86|||
44150018|NCT02073682|78939775|FG001|Overall Study|Death|100|||
44150019|NCT02073682|78939774|FG000|Overall Study|Cancer Cured|10|||
44150020|NCT02073682|78939775|FG001|Overall Study|Cancer Cured|15|||
44150021|NCT02073682|78939774|FG000|Overall Study|ID: Patient Noncompliance|1|||
44150022|NCT02073682|78939775|FG001|Overall Study|ID: Patient Noncompliance|2|||
44150023|NCT02073682|78939774|FG000|Overall Study|ID: Palliative Treatment Only|10|||
44150024|NCT02073682|78939775|FG001|Overall Study|ID: Palliative Treatment Only|7|||
44150025|NCT02073682|78939774|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
44150026|NCT02073682|78939775|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
44150027|NCT02073682|78939774|FG000|Overall Study|Platelet Count <50,000/mL|1|||
44150028|NCT02073682|78939775|FG001|Overall Study|Platelet Count <50,000/mL|2|||
44150029|NCT02073682|78939774|FG000|Overall Study|Surgery/Medical Procedure|3|||
44150030|NCT02073682|78939775|FG001|Overall Study|Surgery/Medical Procedure|1|||
44150031|NCT02073682|78939774|FG000|Overall Study|Withdrawal by Subject|6|||
44150032|NCT02073682|78939775|FG001|Overall Study|Withdrawal by Subject|8|||
44150033|NCT02073682|78939774|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
44150034|NCT02073682|78939775|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
44150035|NCT02073682|78939774|FG000|Overall Study|Cancer Progression|53|||
44150036|NCT02073682|78939775|FG001|Overall Study|Cancer Progression|33|||
44150037|NCT02073682|78939774|FG000|Overall Study|Protocol Violation|1|||
44150038|NCT02073682|78939775|FG001|Overall Study|Protocol Violation|0|||
44150039|NCT02073682|78939774|FG000|Overall Study|Adverse Event|79|||
44150040|NCT02073682|78939775|FG001|Overall Study|Adverse Event|62|||
44150041|NCT02073682|78939774|FG000|Overall Study|No reason provided|11|||
44150042|NCT02073682|78939775|FG001|Overall Study|No reason provided|9|||
44150043|NCT02073682|78939774|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
44150044|NCT02073682|78939775|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
44150045|NCT02073682|78939774|FG000|Overall Study|Lost to Follow-up|1|||
44150046|NCT02073682|78939775|FG001|Overall Study|Lost to Follow-up|1|||
44150047|NCT02073682|78939774|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
44150048|NCT02073682|78939775|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
44150049|NCT02072980|78939781|FG000|Period 2, Second Wear|Adverse Event|0|||
44150050|NCT02072980|78939782|FG001|Period 2, Second Wear|Adverse Event|1|||
44150051|NCT02706899|78939790|FG000|Overall Study|Withdrawal by Subject|1|||
44150052|NCT02706899|78939791|FG001|Overall Study|Withdrawal by Subject|0|||
44150053|NCT02706899|78939790|FG000|Overall Study|Death|8|||
44150054|NCT02706899|78939791|FG001|Overall Study|Death|0|||
44150055|NCT02706899|78939790|FG000|Overall Study|Study Termination by Sponsor|4|||
44150056|NCT02706899|78939791|FG001|Overall Study|Study Termination by Sponsor|6|||
44150057|NCT02072824|78939800|FG000|Overall Study|Insufficient clinical response|1|||
44150058|NCT02072824|78939801|FG001|Overall Study|Insufficient clinical response|0|||
44150059|NCT02072824|78939802|FG002|Overall Study|Insufficient clinical response|1|||
44150060|NCT02072824|78939800|FG000|Overall Study|No longer willing to participate|1|||
44150061|NCT02072824|78939801|FG001|Overall Study|No longer willing to participate|0|||
44150062|NCT02072824|78939802|FG002|Overall Study|No longer willing to participate|1|||
44150063|NCT02072824|78939800|FG000|Overall Study|Medication error|0|||
44150064|NCT02072824|78939801|FG001|Overall Study|Medication error|1|||
44150065|NCT02072824|78939802|FG002|Overall Study|Medication error|0|||
44150066|NCT02072824|78939800|FG000|Overall Study|Adverse Event|0|||
44150067|NCT02072824|78939801|FG001|Overall Study|Adverse Event|0|||
44150068|NCT02072824|78939802|FG002|Overall Study|Adverse Event|1|||
44150069|NCT02072668|78939810|FG000|Second Intervention|Lost to Follow-up|1|||
44150070|NCT02072668|78939811|FG001|Second Intervention|Lost to Follow-up|0|||
44150071|NCT02140762|78939821|FG000|Overall Study|Adverse Event|1|||
44150072|NCT02140762|78939822|FG001|Overall Study|Adverse Event|1|||
44150073|NCT02140762|78939821|FG000|Overall Study|Lost to Follow-up|9|||
44254729|NCT04029116|79096589|FG001|Overall Study|Adverse Event|2|||
44254730|NCT04029116|79096588|FG000|Overall Study|Lost to Follow-up|3|||
44254731|NCT04029116|79096589|FG001|Overall Study|Lost to Follow-up|5|||
44254732|NCT04029116|79096588|FG000|Overall Study|Physician Decision|2|||
44415058|NCT00625378|79422977|FG001|Overall Study|Missing|0|||
44415059|NCT00625378|79422976|FG000|Overall Study|End of treatment not available|2|||
44150074|NCT02140762|78939822|FG001|Overall Study|Lost to Follow-up|5|||
44150075|NCT02140762|78939821|FG000|Overall Study|Protocol Violation|1|||
44150076|NCT02140762|78939822|FG001|Overall Study|Protocol Violation|1|||
44150077|NCT02140762|78939821|FG000|Overall Study|Withdrawal by Subject|6|||
44150078|NCT02140762|78939822|FG001|Overall Study|Withdrawal by Subject|4|||
44150079|NCT02140762|78939821|FG000|Overall Study|Other|0|||
44150080|NCT02140762|78939822|FG001|Overall Study|Other|1|||
44150081|NCT02101294|78939833|FG000|Overall Study|Withdrawal by Subject|5|||
44150082|NCT02101294|78939833|FG000|Overall Study|Lost to Follow-up|6|||
44150083|NCT01598506|78939840|FG000|Overall Study|Withdrawal by Subject|2|||
44254733|NCT04029116|79096589|FG001|Overall Study|Physician Decision|0|||
44254734|NCT04029116|79096588|FG000|Overall Study|Pregnancy|1|||
44254735|NCT04029116|79096589|FG001|Overall Study|Pregnancy|2|||
44530463|NCT00048035|79540181|FG000|Extension Year 2|Early Withdrawals|0|||
44530464|NCT00048035|79540182|FG001|Extension Year 2|Early Withdrawals|0|||
44530465|NCT00048035|79540183|FG002|Extension Year 2|Early Withdrawals|0|||
44530466|NCT00048035|79540184|FG003|Extension Year 2|Early Withdrawals|0|||
44530467|NCT00048035|79540185|FG004|Extension Year 2|Early Withdrawals|0|||
44530468|NCT00048035|79540186|FG005|Extension Year 2|Early Withdrawals|0|||
44530469|NCT00048035|79540187|FG006|Extension Year 2|Early Withdrawals|3|||
44530470|NCT00048035|79540188|FG007|Extension Year 2|Early Withdrawals|3|||
44530471|NCT00047879|79540205|FG000|Overall Study|Progressive disease|4|||
44530472|NCT00047879|79540206|FG001|Overall Study|Progressive disease|3|||
44530473|NCT00064337|79540212|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
44530474|NCT00064337|79540212|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
44530475|NCT00064337|79540212|FG000|PBSCC or Induction/PBSCC|Progression|3|||
44530476|NCT00064337|79540212|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
44530477|NCT00064337|79540212|FG000|PBSCC or Induction/PBSCC|Death|2|||
44530478|NCT00064337|79540212|FG000|Transplant|Adverse Event|9|||
44530479|NCT00064337|79540212|FG000|Transplant|Not protocol-specified|5|||
44530480|NCT00064337|79540212|FG000|Transplant|Death|3|||
44530481|NCT00064337|79540212|FG000|Transplant|Patient Refusal|2|||
44530482|NCT00064337|79540212|FG000|Transplant|Progression|2|||
44530483|NCT00064337|79540212|FG000|Maintenance|Adverse Event|3|||
44530484|NCT00064337|79540212|FG000|Maintenance|Progression|2|||
44530485|NCT00064337|79540212|FG000|Maintenance|On treatment at time of analysis|2|||
44530486|NCT00064337|79540212|FG000|Maintenance|Not protocol-specified|2|||
44150084|NCT02140060|78939851|FG000|Overall Study|Adverse Event|0|||
44150085|NCT02140060|78939852|FG001|Overall Study|Adverse Event|0|||
44150086|NCT02140060|78939853|FG002|Overall Study|Adverse Event|0|||
44150087|NCT02140060|78939854|FG003|Overall Study|Adverse Event|1|||
44150088|NCT02140060|78939855|FG004|Overall Study|Adverse Event|1|||
44150089|NCT02140060|78939856|FG005|Overall Study|Adverse Event|1|||
44150090|NCT02140060|78939851|FG000|Overall Study|Lack of Efficacy|0|||
44150091|NCT02140060|78939852|FG001|Overall Study|Lack of Efficacy|0|||
44150092|NCT02140060|78939853|FG002|Overall Study|Lack of Efficacy|0|||
44150093|NCT02140060|78939854|FG003|Overall Study|Lack of Efficacy|1|||
44150094|NCT02140060|78939855|FG004|Overall Study|Lack of Efficacy|0|||
44150095|NCT02140060|78939856|FG005|Overall Study|Lack of Efficacy|0|||
44150096|NCT02139982|78939881|FG000|Overall Study|Lack of Efficacy|0|||
44150097|NCT02139982|78939882|FG001|Overall Study|Lack of Efficacy|1|||
44150098|NCT02139982|78939883|FG002|Overall Study|Lack of Efficacy|0|||
44150099|NCT02139982|78939884|FG003|Overall Study|Lack of Efficacy|1|||
44150100|NCT02139982|78939885|FG004|Overall Study|Lack of Efficacy|0|||
44150101|NCT02139982|78939886|FG005|Overall Study|Lack of Efficacy|0|||
44150102|NCT02139982|78939887|FG006|Overall Study|Lack of Efficacy|0|||
44150103|NCT02139982|78939888|FG007|Overall Study|Lack of Efficacy|0|||
44150104|NCT02139982|78939889|FG008|Overall Study|Lack of Efficacy|0|||
44530487|NCT00064337|79540212|FG000|Maintenance|Death|1|||
44150105|NCT02139982|78939890|FG009|Overall Study|Lack of Efficacy|0|||
44150106|NCT02139826|78939912|FG000|Overall Study|Adverse Event|1|||
44150107|NCT02139592|78939922|FG000|Overall Study|Case Report Forms Uncollected|8|||
44530488|NCT00064259|79540219|FG000|Overall Study|Adverse Event|1|||
44530489|NCT00064259|79540220|FG001|Overall Study|Adverse Event|0|||
44530490|NCT00064259|79540221|FG002|Overall Study|Adverse Event|0|||
44150108|NCT02139280|78939928|FG000|Overall Study|No longer eligible|2|||
44150109|NCT02139280|78939929|FG001|Overall Study|No longer eligible|0|||
44530491|NCT00064259|79540222|FG003|Overall Study|Adverse Event|1|||
44530492|NCT00044213|79540231|FG000|Overall Study|Withdrawal by Subject|50|||
44530493|NCT00044213|79540232|FG001|Overall Study|Withdrawal by Subject|65|||
44530494|NCT00044213|79540233|FG002|Overall Study|Withdrawal by Subject|91|||
44530495|NCT00044213|79540234|FG003|Overall Study|Withdrawal by Subject|83|||
44530496|NCT00044213|79540231|FG000|Overall Study|Death|42|||
44530497|NCT00044213|79540232|FG001|Overall Study|Death|42|||
44530498|NCT00044213|79540233|FG002|Overall Study|Death|42|||
44530499|NCT00044213|79540234|FG003|Overall Study|Death|49|||
44530500|NCT00044213|79540231|FG000|Overall Study|Lost to Follow-up|8|||
44530501|NCT00044213|79540232|FG001|Overall Study|Lost to Follow-up|5|||
44150110|NCT02072434|78939937|FG000|Overall Study|Protocol Violation|10|||
44150111|NCT02072434|78939938|FG001|Overall Study|Protocol Violation|9|||
44150112|NCT02072434|78939937|FG000|Overall Study|Physician Decision|5|||
44150113|NCT02072434|78939938|FG001|Overall Study|Physician Decision|10|||
44150114|NCT02072434|78939937|FG000|Overall Study|Adverse event, serious fatal|1|||
44150115|NCT02072434|78939938|FG001|Overall Study|Adverse event, serious fatal|6|||
44150116|NCT02072434|78939937|FG000|Overall Study|Adverse Event|7|||
44150117|NCT02072434|78939938|FG001|Overall Study|Adverse Event|6|||
44150118|NCT02072434|78939937|FG000|Overall Study|Withdrawal by Subject|17|||
44150119|NCT02072434|78939938|FG001|Overall Study|Withdrawal by Subject|29|||
44150120|NCT02072434|78939937|FG000|Overall Study|Other|14|||
44150121|NCT02072434|78939938|FG001|Overall Study|Other|29|||
44150122|NCT02072434|78939937|FG000|Overall Study|Lost to Follow-up|0|||
44150123|NCT02072434|78939938|FG001|Overall Study|Lost to Follow-up|1|||
44150124|NCT02101060|78939946|FG000|Overall Study|Adverse Event|1|||
44150125|NCT02101060|78939947|FG001|Overall Study|Adverse Event|0|||
44150126|NCT02101060|78939946|FG000|Overall Study|Withdrawal by Subject|1|||
44150127|NCT02101060|78939947|FG001|Overall Study|Withdrawal by Subject|1|||
44150128|NCT02101060|78939946|FG000|Overall Study|Lost to Follow-up|3|||
44150129|NCT02101060|78939947|FG001|Overall Study|Lost to Follow-up|3|||
44150130|NCT02139124|78939958|FG000|Overall Study|Adverse Event|2|||
44150131|NCT02139124|78939959|FG001|Overall Study|Adverse Event|0|||
44254736|NCT04029116|79096588|FG000|Overall Study|Withdrawal by Subject|4|||
44150132|NCT02139124|78939960|FG002|Overall Study|Adverse Event|1|||
44254737|NCT04029116|79096589|FG001|Overall Study|Withdrawal by Subject|6|||
44150133|NCT02139124|78939961|FG003|Overall Study|Adverse Event|2|||
44150134|NCT02139124|78939962|FG004|Overall Study|Adverse Event|5|||
44150135|NCT02139124|78939958|FG000|Overall Study|Withdrawal by Subject|2|||
44150136|NCT02139124|78939959|FG001|Overall Study|Withdrawal by Subject|2|||
44254738|NCT04029116|79096588|FG000|Overall Study|Other|2|||
44530502|NCT00044213|79540233|FG002|Overall Study|Lost to Follow-up|5|||
44530503|NCT00044213|79540234|FG003|Overall Study|Lost to Follow-up|4|||
44530504|NCT00064025|79540244|FG000|Overall Study|Ineligible|4|||
44530505|NCT00064025|79540244|FG000|Overall Study|Inevaluable|3|||
44530506|NCT00043979|79540252|FG000|Period 1|recipient with progressive disease|7|||
44530507|NCT00043979|79540253|FG001|Period 1|recipient with progressive disease|4|||
44530508|NCT00043979|79540254|FG002|Period 1|recipient with progressive disease|3|||
44530509|NCT00039377|79540271|FG000|Initial Registration|Adverse Event|2|||
44530510|NCT00039377|79540272|FG001|Initial Registration|Adverse Event|0|||
44150137|NCT02139124|78939960|FG002|Overall Study|Withdrawal by Subject|2|||
44150138|NCT02139124|78939961|FG003|Overall Study|Withdrawal by Subject|2|||
44150139|NCT02139124|78939962|FG004|Overall Study|Withdrawal by Subject|3|||
44150140|NCT02139124|78939958|FG000|Overall Study|Protocol Violation|0|||
44150141|NCT02139124|78939959|FG001|Overall Study|Protocol Violation|0|||
44150142|NCT02139124|78939960|FG002|Overall Study|Protocol Violation|0|||
44150143|NCT02139124|78939961|FG003|Overall Study|Protocol Violation|1|||
44150144|NCT02139124|78939962|FG004|Overall Study|Protocol Violation|1|||
44150145|NCT02139124|78939958|FG000|Overall Study|non-compliant|1|||
44150146|NCT02139124|78939959|FG001|Overall Study|non-compliant|0|||
44150147|NCT02139124|78939960|FG002|Overall Study|non-compliant|0|||
44150148|NCT02139124|78939961|FG003|Overall Study|non-compliant|2|||
44150149|NCT02139124|78939962|FG004|Overall Study|non-compliant|0|||
44150150|NCT02139124|78939958|FG000|Overall Study|incarceration|0|||
44150151|NCT02139124|78939959|FG001|Overall Study|incarceration|0|||
44150152|NCT02139124|78939960|FG002|Overall Study|incarceration|1|||
44150153|NCT02139124|78939961|FG003|Overall Study|incarceration|0|||
44150154|NCT02139124|78939962|FG004|Overall Study|incarceration|0|||
44150155|NCT02139124|78939958|FG000|Overall Study|subject moved|1|||
44150156|NCT02139124|78939959|FG001|Overall Study|subject moved|0|||
44150157|NCT02139124|78939960|FG002|Overall Study|subject moved|0|||
44150158|NCT02139124|78939961|FG003|Overall Study|subject moved|0|||
44150159|NCT02139124|78939962|FG004|Overall Study|subject moved|0|||
44150160|NCT02139124|78939958|FG000|Overall Study|Lost to Follow-up|3|||
44150161|NCT02139124|78939959|FG001|Overall Study|Lost to Follow-up|2|||
44150162|NCT02139124|78939960|FG002|Overall Study|Lost to Follow-up|0|||
44150163|NCT02139124|78939961|FG003|Overall Study|Lost to Follow-up|5|||
44150164|NCT02139124|78939962|FG004|Overall Study|Lost to Follow-up|4|||
44150165|NCT02139046|78939979|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
44150166|NCT02139046|78939980|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
44150167|NCT02139046|78939981|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
44150168|NCT02139046|78939982|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
44150169|NCT02139046|78939983|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
44150170|NCT02139046|78939979|FG000|Overall Study|Major Protocol Deviation|9|||
44150171|NCT02139046|78939980|FG001|Overall Study|Major Protocol Deviation|10|||
44150172|NCT02139046|78939981|FG002|Overall Study|Major Protocol Deviation|16|||
44150173|NCT02139046|78939982|FG003|Overall Study|Major Protocol Deviation|12|||
44150174|NCT02139046|78939983|FG004|Overall Study|Major Protocol Deviation|6|||
44150175|NCT02139046|78939979|FG000|Overall Study|Lost to Follow-up|13|||
44150176|NCT02139046|78939980|FG001|Overall Study|Lost to Follow-up|16|||
44150177|NCT02139046|78939981|FG002|Overall Study|Lost to Follow-up|16|||
44150178|NCT02139046|78939982|FG003|Overall Study|Lost to Follow-up|18|||
44150179|NCT02139046|78939983|FG004|Overall Study|Lost to Follow-up|13|||
44150180|NCT02139046|78939979|FG000|Overall Study|Voluntary Withdrawal|20|||
44150181|NCT02139046|78939980|FG001|Overall Study|Voluntary Withdrawal|8|||
44150182|NCT02139046|78939981|FG002|Overall Study|Voluntary Withdrawal|10|||
44150183|NCT02139046|78939982|FG003|Overall Study|Voluntary Withdrawal|15|||
44150184|NCT02139046|78939983|FG004|Overall Study|Voluntary Withdrawal|16|||
44150185|NCT02139046|78939979|FG000|Overall Study|Lack of Efficacy|0|||
44150186|NCT02139046|78939980|FG001|Overall Study|Lack of Efficacy|1|||
44150187|NCT02139046|78939981|FG002|Overall Study|Lack of Efficacy|2|||
44150188|NCT02139046|78939982|FG003|Overall Study|Lack of Efficacy|1|||
44150189|NCT02139046|78939983|FG004|Overall Study|Lack of Efficacy|2|||
44150190|NCT02139046|78939979|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
44150191|NCT02139046|78939980|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
44150192|NCT02139046|78939981|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
44150193|NCT02139046|78939982|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
44530511|NCT00039377|79540273|FG002|Initial Registration|Adverse Event|0|||
44530512|NCT00039377|79540274|FG003|Initial Registration|Adverse Event|0|||
44150194|NCT02139046|78939983|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
44150195|NCT02139046|78939979|FG000|Overall Study|Other Miscellaneous Reasons|10|||
44150196|NCT02139046|78939980|FG001|Overall Study|Other Miscellaneous Reasons|9|||
44150197|NCT02139046|78939981|FG002|Overall Study|Other Miscellaneous Reasons|4|||
44150198|NCT02139046|78939982|FG003|Overall Study|Other Miscellaneous Reasons|9|||
44150199|NCT02139046|78939983|FG004|Overall Study|Other Miscellaneous Reasons|12|||
44150200|NCT02138890|78939997|FG000|Overall Study|Adverse Event|1|||
44150201|NCT02138890|78939998|FG001|Overall Study|Adverse Event|0|||
44150202|NCT02100670|78940009|FG000|Overall Study|Adverse Event|10|||
44150203|NCT02100670|78940010|FG001|Overall Study|Adverse Event|3|||
44150204|NCT02100670|78940011|FG002|Overall Study|Adverse Event|3|||
44150205|NCT02100670|78940012|FG003|Overall Study|Adverse Event|0|||
44150206|NCT02100670|78940009|FG000|Overall Study|Lost to Follow-up|1|||
44150207|NCT02100670|78940010|FG001|Overall Study|Lost to Follow-up|0|||
44150208|NCT02100670|78940011|FG002|Overall Study|Lost to Follow-up|0|||
44150209|NCT02100670|78940012|FG003|Overall Study|Lost to Follow-up|0|||
44150210|NCT02100670|78940009|FG000|Overall Study|Protocol Violation|0|||
44150211|NCT02100670|78940010|FG001|Overall Study|Protocol Violation|1|||
44150212|NCT02100670|78940011|FG002|Overall Study|Protocol Violation|0|||
44254739|NCT04029116|79096589|FG001|Overall Study|Other|1|||
44254740|NCT03734029|79096620|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
44254741|NCT03734029|79096621|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
44254742|NCT03734029|79096620|FG000|Overall Study|Adverse Event|60|||
44254743|NCT03734029|79096621|FG001|Overall Study|Adverse Event|14|||
44530513|NCT00039377|79540271|FG000|Initial Registration|Relapsed|6|||
44150213|NCT02100670|78940012|FG003|Overall Study|Protocol Violation|1|||
44150214|NCT02100670|78940009|FG000|Overall Study|Withdrawal of Consent|0|||
44150215|NCT02100670|78940010|FG001|Overall Study|Withdrawal of Consent|1|||
44150216|NCT02100670|78940011|FG002|Overall Study|Withdrawal of Consent|1|||
44150217|NCT02100670|78940012|FG003|Overall Study|Withdrawal of Consent|0|||
44150218|NCT02100670|78940009|FG000|Overall Study|No swelling no pain|1|||
44150219|NCT02100670|78940010|FG001|Overall Study|No swelling no pain|0|||
44150220|NCT02100670|78940011|FG002|Overall Study|No swelling no pain|0|||
44150221|NCT02100670|78940012|FG003|Overall Study|No swelling no pain|0|||
44150222|NCT02100670|78940009|FG000|Overall Study|Poor Efficacy|0|||
44150223|NCT02100670|78940010|FG001|Overall Study|Poor Efficacy|1|||
44150224|NCT02100670|78940011|FG002|Overall Study|Poor Efficacy|0|||
44150225|NCT02100670|78940012|FG003|Overall Study|Poor Efficacy|0|||
44150226|NCT02100670|78940009|FG000|Overall Study|Physician Decision|0|||
44150227|NCT02100670|78940010|FG001|Overall Study|Physician Decision|1|||
44150228|NCT02100670|78940011|FG002|Overall Study|Physician Decision|0|||
44150229|NCT02100670|78940012|FG003|Overall Study|Physician Decision|0|||
44150230|NCT02100670|78940009|FG000|Overall Study|Withdrawal by Subject|1|||
44150231|NCT02100670|78940010|FG001|Overall Study|Withdrawal by Subject|0|||
44150232|NCT02100670|78940011|FG002|Overall Study|Withdrawal by Subject|0|||
44150233|NCT02100670|78940012|FG003|Overall Study|Withdrawal by Subject|0|||
44150234|NCT02070484|78940031|FG000|Overall Study|Withdrawal by Subject|1|||
44150235|NCT02070484|78940032|FG001|Overall Study|Withdrawal by Subject|0|||
44150236|NCT02100514|78940040|FG000|Treatment Period|Adverse Event|0|||
44150237|NCT02100514|78940041|FG001|Treatment Period|Adverse Event|5|||
44150238|NCT02100514|78940042|FG002|Treatment Period|Adverse Event|0|||
44150239|NCT02100514|78940043|FG003|Treatment Period|Adverse Event|0|||
44150240|NCT02100514|78940044|FG004|Treatment Period|Adverse Event|0|||
44150241|NCT02100514|78940040|FG000|Treatment Period|Death|2|||
44150242|NCT02100514|78940041|FG001|Treatment Period|Death|2|||
44150243|NCT02100514|78940042|FG002|Treatment Period|Death|0|||
44150244|NCT02100514|78940043|FG003|Treatment Period|Death|0|||
44150245|NCT02100514|78940044|FG004|Treatment Period|Death|0|||
44150246|NCT02100514|78940040|FG000|Treatment Period|Lost to Follow-up|5|||
44254744|NCT03734029|79096620|FG000|Overall Study|Withdrawal by Subject|12|||
44530514|NCT00039377|79540272|FG001|Initial Registration|Relapsed|0|||
44530515|NCT00039377|79540273|FG002|Initial Registration|Relapsed|0|||
44530516|NCT00039377|79540274|FG003|Initial Registration|Relapsed|0|||
44530517|NCT00039377|79540271|FG000|Initial Registration|Received non-protocol therapy|11|||
44530518|NCT00039377|79540272|FG001|Initial Registration|Received non-protocol therapy|0|||
44530519|NCT00039377|79540273|FG002|Initial Registration|Received non-protocol therapy|0|||
44530520|NCT00039377|79540274|FG003|Initial Registration|Received non-protocol therapy|0|||
44530521|NCT00039377|79540271|FG000|Initial Registration|Withdrawal by Subject|3|||
44530522|NCT00039377|79540272|FG001|Initial Registration|Withdrawal by Subject|0|||
44530523|NCT00039377|79540273|FG002|Initial Registration|Withdrawal by Subject|0|||
44150247|NCT02100514|78940041|FG001|Treatment Period|Lost to Follow-up|17|||
44150248|NCT02100514|78940042|FG002|Treatment Period|Lost to Follow-up|0|||
44150249|NCT02100514|78940043|FG003|Treatment Period|Lost to Follow-up|0|||
44150250|NCT02100514|78940044|FG004|Treatment Period|Lost to Follow-up|0|||
44150251|NCT02100514|78940040|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
44150252|NCT02100514|78940041|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
44150253|NCT02100514|78940042|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
44150254|NCT02100514|78940043|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
44150255|NCT02100514|78940044|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
44254745|NCT03734029|79096621|FG001|Overall Study|Withdrawal by Subject|11|||
44530524|NCT00039377|79540274|FG003|Initial Registration|Withdrawal by Subject|0|||
44530525|NCT00154102|79540284|FG000|Overall Study|investigational study phase ongoing|7|||
44530526|NCT00154102|79540285|FG001|Overall Study|investigational study phase ongoing|2|||
44530527|NCT03687502|79540308|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
44530528|NCT03687502|79540308|FG000|Overall Study|Lumason not available|1|||
44530529|NCT03654976|79540316|FG000|Overall Study|Withdrawal by Subject|12|||
44530530|NCT03654976|79540317|FG001|Overall Study|Withdrawal by Subject|11|||
44530531|NCT03654976|79540316|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
44530532|NCT03654976|79540317|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
44530533|NCT03654976|79540316|FG000|Overall Study|Adverse Event|5|||
44530534|NCT03654976|79540317|FG001|Overall Study|Adverse Event|0|||
44530535|NCT03654976|79540316|FG000|Overall Study|Lost to Follow-up|2|||
44530536|NCT03654976|79540317|FG001|Overall Study|Lost to Follow-up|0|||
44530537|NCT03654976|79540316|FG000|Overall Study|Lack of Efficacy|0|||
44530538|NCT03654976|79540317|FG001|Overall Study|Lack of Efficacy|1|||
44530539|NCT00035555|79540326|FG000|Overall Study|Adverse Event|5|||
44530540|NCT00035555|79540327|FG001|Overall Study|Adverse Event|8|||
44530541|NCT00035555|79540328|FG002|Overall Study|Adverse Event|9|||
44530542|NCT00035555|79540326|FG000|Overall Study|Allograft loss|1|||
44530543|NCT00035555|79540327|FG001|Overall Study|Allograft loss|1|||
44150256|NCT02100514|78940040|FG000|Treatment Period|Protocol Violation|1|||
44530544|NCT00035555|79540328|FG002|Overall Study|Allograft loss|2|||
44530545|NCT00035555|79540326|FG000|Overall Study|Death|0|||
44530546|NCT00035555|79540327|FG001|Overall Study|Death|0|||
44150257|NCT02100514|78940041|FG001|Treatment Period|Protocol Violation|1|||
44150258|NCT02100514|78940042|FG002|Treatment Period|Protocol Violation|0|||
44530547|NCT00035555|79540328|FG002|Overall Study|Death|2|||
44530548|NCT00035555|79540326|FG000|Overall Study|Lost to Follow-up|0|||
44530549|NCT00035555|79540327|FG001|Overall Study|Lost to Follow-up|0|||
44530550|NCT00035555|79540328|FG002|Overall Study|Lost to Follow-up|1|||
44530551|NCT00035555|79540326|FG000|Overall Study|Noncompliance|0|||
44530552|NCT00035555|79540327|FG001|Overall Study|Noncompliance|1|||
44530553|NCT00035555|79540328|FG002|Overall Study|Noncompliance|1|||
44530554|NCT00035555|79540326|FG000|Overall Study|Prohibited medication|1|||
44530555|NCT00035555|79540327|FG001|Overall Study|Prohibited medication|1|||
44530556|NCT00035555|79540328|FG002|Overall Study|Prohibited medication|0|||
44530557|NCT00035555|79540326|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
44530558|NCT00035555|79540327|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
44530559|NCT00035555|79540328|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
44530560|NCT00035555|79540326|FG000|Overall Study|Withdrawal by Subject|2|||
44530561|NCT00035555|79540327|FG001|Overall Study|Withdrawal by Subject|0|||
44530562|NCT00035555|79540328|FG002|Overall Study|Withdrawal by Subject|2|||
44530563|NCT00035555|79540326|FG000|Overall Study|Investigator deemed not a good candidate|0|||
44530564|NCT00035555|79540327|FG001|Overall Study|Investigator deemed not a good candidate|0|||
44530565|NCT00035555|79540328|FG002|Overall Study|Investigator deemed not a good candidate|1|||
44530566|NCT00035555|79540326|FG000|Overall Study|Received cyclosporin in error|0|||
44530567|NCT00035555|79540327|FG001|Overall Study|Received cyclosporin in error|0|||
44530568|NCT00035555|79540328|FG002|Overall Study|Received cyclosporin in error|1|||
44530569|NCT03894046|79540340|FG000|Overall Study|Protocol Violation|1|||
44530570|NCT03894046|79540341|FG001|Overall Study|Protocol Violation|0|||
44530571|NCT03894046|79540342|FG002|Overall Study|Protocol Violation|0|||
44530572|NCT03894046|79540340|FG000|Overall Study|Adverse Event|0|||
44530573|NCT03894046|79540341|FG001|Overall Study|Adverse Event|1|||
44530574|NCT03894046|79540342|FG002|Overall Study|Adverse Event|0|||
44530575|NCT03894046|79540340|FG000|Overall Study|Withdrawal by Subject|2|||
44530576|NCT03894046|79540341|FG001|Overall Study|Withdrawal by Subject|3|||
44530577|NCT03894046|79540342|FG002|Overall Study|Withdrawal by Subject|1|||
44530578|NCT03894046|79540340|FG000|Overall Study|Death|15|||
44530579|NCT03894046|79540341|FG001|Overall Study|Death|21|||
44530580|NCT03894046|79540342|FG002|Overall Study|Death|4|||
44530581|NCT03894046|79540340|FG000|Overall Study|No growth of ABC|2|||
44530582|NCT03894046|79540341|FG001|Overall Study|No growth of ABC|1|||
44530583|NCT03894046|79540342|FG002|Overall Study|No growth of ABC|0|||
44530584|NCT03894046|79540340|FG000|Overall Study|Physician Decision|1|||
44530585|NCT03894046|79540341|FG001|Overall Study|Physician Decision|1|||
44530586|NCT03894046|79540342|FG002|Overall Study|Physician Decision|1|||
44530587|NCT03894046|79540340|FG000|Overall Study|Prohibited concomitant medication|1|||
44530588|NCT03894046|79540341|FG001|Overall Study|Prohibited concomitant medication|0|||
44530589|NCT03894046|79540342|FG002|Overall Study|Prohibited concomitant medication|0|||
44530590|NCT03894046|79540340|FG000|Overall Study|Transferred to other arm/group|1|||
44530591|NCT03894046|79540341|FG001|Overall Study|Transferred to other arm/group|1|||
44530592|NCT03894046|79540342|FG002|Overall Study|Transferred to other arm/group|0|||
44530593|NCT00033371|79540351|FG000|Overall Study|Adverse Event|1|||
44530594|NCT00033371|79540352|FG001|Overall Study|Adverse Event|5|||
44530595|NCT00033371|79540351|FG000|Overall Study|Lost to Follow-up|2|||
44530596|NCT00033371|79540352|FG001|Overall Study|Lost to Follow-up|1|||
44530597|NCT00033371|79540351|FG000|Overall Study|Withdrawal by Subject|3|||
44530598|NCT00033371|79540352|FG001|Overall Study|Withdrawal by Subject|3|||
44530599|NCT00033371|79540351|FG000|Overall Study|Disease Progression|0|||
44150259|NCT02100514|78940043|FG003|Treatment Period|Protocol Violation|0|||
44150260|NCT02100514|78940044|FG004|Treatment Period|Protocol Violation|0|||
44530600|NCT00033371|79540352|FG001|Overall Study|Disease Progression|1|||
44530601|NCT00081731|79540364|FG000|Overall Study|scientific integrity issue|8|||
44530602|NCT00081731|79540365|FG001|Overall Study|scientific integrity issue|8|||
44530603|NCT00079937|79540373|FG000|Overall Study|Adverse Event|2|||
44530604|NCT00079937|79540374|FG001|Overall Study|Adverse Event|1|||
44530605|NCT00079937|79540373|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44530606|NCT00079937|79540374|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44530607|NCT00079937|79540373|FG000|Overall Study|Subject no longer requires study drug|3|||
44150261|NCT02100514|78940040|FG000|Treatment Period|Withdrawal by Subject|12|||
44150262|NCT02100514|78940041|FG001|Treatment Period|Withdrawal by Subject|37|||
44150263|NCT02100514|78940042|FG002|Treatment Period|Withdrawal by Subject|0|||
44150264|NCT02100514|78940043|FG003|Treatment Period|Withdrawal by Subject|0|||
44150265|NCT02100514|78940044|FG004|Treatment Period|Withdrawal by Subject|0|||
44150266|NCT02100514|78940040|FG000|Treatment Period|Other|9|||
44150267|NCT02100514|78940041|FG001|Treatment Period|Other|11|||
44530608|NCT00079937|79540374|FG001|Overall Study|Subject no longer requires study drug|0|||
44530609|NCT00079937|79540373|FG000|Overall Study|Protocol Violation|8|||
44150268|NCT02100514|78940042|FG002|Treatment Period|Other|0|||
44150269|NCT02100514|78940043|FG003|Treatment Period|Other|0|||
44150270|NCT02100514|78940044|FG004|Treatment Period|Other|0|||
44150271|NCT02100514|78940040|FG000|Extension Period|Withdrew consent|0|||
44150272|NCT02100514|78940041|FG001|Extension Period|Withdrew consent|0|||
44150273|NCT02100514|78940042|FG002|Extension Period|Withdrew consent|2|||
44150274|NCT02100514|78940043|FG003|Extension Period|Withdrew consent|0|||
44150275|NCT02100514|78940044|FG004|Extension Period|Withdrew consent|0|||
44150276|NCT02069392|78940060|FG000|Overall Study|Withdrawal by Subject|4|||
44150277|NCT02069392|78940061|FG001|Overall Study|Withdrawal by Subject|2|||
44150278|NCT02047318|78940069|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
44150279|NCT02047318|78940069|FG000|Core Study Period|Adverse Event|1|||
44150280|NCT02047318|78940069|FG000|Core Study Period|Withdrawal by caregiver|3|||
44150281|NCT02047318|78940069|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
44150282|NCT02100124|78940087|FG000|Overall Study|Lost to Follow-up|5|||
44150283|NCT02100124|78940088|FG001|Overall Study|Lost to Follow-up|11|||
44150284|NCT02100124|78940089|FG002|Overall Study|Lost to Follow-up|3|||
44150285|NCT02100124|78940087|FG000|Overall Study|Withdrawal by Subject|1|||
44150286|NCT02100124|78940088|FG001|Overall Study|Withdrawal by Subject|0|||
44150287|NCT02100124|78940089|FG002|Overall Study|Withdrawal by Subject|0|||
44150288|NCT02068768|78940097|FG000|Overall Study|Lost to Follow-up|5|||
44150289|NCT02068768|78940097|FG000|Overall Study|Early Termination by Sponsor|2|||
44150290|NCT02046616|78940101|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
44150291|NCT02046616|78940101|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
44150292|NCT02046616|78940101|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
44150293|NCT02046616|78940101|FG000|24-Week Treatment Period|Physician Decision|3|||
44150294|NCT02046616|78940101|FG000|24-Week Treatment Period|Other|1|||
44530610|NCT00079937|79540374|FG001|Overall Study|Protocol Violation|6|||
44530611|NCT00079937|79540373|FG000|Overall Study|Withdrawal by Subject|21|||
44530612|NCT00079937|79540374|FG001|Overall Study|Withdrawal by Subject|7|||
44530613|NCT00079937|79540373|FG000|Overall Study|Lost to Follow-up|12|||
44530614|NCT00079937|79540374|FG001|Overall Study|Lost to Follow-up|5|||
44530615|NCT00079937|79540373|FG000|Overall Study|Administrative problems|22|||
44530616|NCT00079937|79540374|FG001|Overall Study|Administrative problems|11|||
44530617|NCT00909610|79540382|FG000|Period: First Intervention|Adverse Event|0|||
44530618|NCT00909610|79540383|FG001|Period: First Intervention|Adverse Event|1|||
44530619|NCT00909610|79540382|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
44530620|NCT00909610|79540383|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
44530621|NCT00909610|79540382|FG000|Period: Second Intervention|Adverse Event|1|||
44150295|NCT02046616|78940101|FG000|8-Week FU Period|Lost to Follow-up|1|||
44150296|NCT02099344|78940107|FG000|Overall Study|Physician Decision|1|||
44150297|NCT02099344|78940108|FG001|Overall Study|Physician Decision|0|||
44150298|NCT02068222|78940116|FG000|Overall Study|Lost to Follow-up|1|||
44150299|NCT02099110|78940125|FG000|Overall Study|Protocol Violation|2|||
44150300|NCT02099110|78940126|FG001|Overall Study|Protocol Violation|1|||
44150301|NCT02099110|78940127|FG002|Overall Study|Protocol Violation|0|||
44254746|NCT03734029|79096620|FG000|Overall Study|Clinical progression by investigator|10|||
44282458|NCT01857102|79245778|FG001|Period 1|Physician Decision|0|||
44150302|NCT02099110|78940128|FG003|Overall Study|Protocol Violation|3|||
44530622|NCT00909610|79540383|FG001|Period: Second Intervention|Adverse Event|0|||
44530623|NCT03126110|79540405|FG000|Phase 1|Death|2|||
44530624|NCT03126110|79540406|FG001|Phase 1|Death|2|||
44530625|NCT03126110|79540407|FG002|Phase 1|Death|4|||
44530626|NCT03126110|79540408|FG003|Phase 1|Death|3|||
44150303|NCT02099110|78940129|FG004|Overall Study|Protocol Violation|1|||
44150304|NCT02099110|78940125|FG000|Overall Study|Participant moved|1|||
44150305|NCT02099110|78940126|FG001|Overall Study|Participant moved|1|||
44150306|NCT02099110|78940127|FG002|Overall Study|Participant moved|1|||
44530627|NCT03126110|79540409|FG004|Phase 1|Death|4|||
44530628|NCT03126110|79540410|FG005|Phase 1|Death|4|||
44150307|NCT02099110|78940128|FG003|Overall Study|Participant moved|0|||
44150308|NCT02099110|78940129|FG004|Overall Study|Participant moved|2|||
44150309|NCT02099110|78940125|FG000|Overall Study|Withdrawal by Subject|7|||
44150310|NCT02099110|78940126|FG001|Overall Study|Withdrawal by Subject|11|||
44150311|NCT02099110|78940127|FG002|Overall Study|Withdrawal by Subject|13|||
44150312|NCT02099110|78940128|FG003|Overall Study|Withdrawal by Subject|9|||
44150313|NCT02099110|78940129|FG004|Overall Study|Withdrawal by Subject|13|||
44150314|NCT02099110|78940125|FG000|Overall Study|Adverse Event|3|||
44150315|NCT02099110|78940126|FG001|Overall Study|Adverse Event|5|||
44150316|NCT02099110|78940127|FG002|Overall Study|Adverse Event|2|||
44150317|NCT02099110|78940128|FG003|Overall Study|Adverse Event|3|||
44150318|NCT02099110|78940129|FG004|Overall Study|Adverse Event|2|||
44150319|NCT02099110|78940125|FG000|Overall Study|Lost to Follow-up|6|||
44150320|NCT02099110|78940126|FG001|Overall Study|Lost to Follow-up|12|||
44150321|NCT02099110|78940127|FG002|Overall Study|Lost to Follow-up|11|||
44150322|NCT02099110|78940128|FG003|Overall Study|Lost to Follow-up|5|||
44150323|NCT02099110|78940129|FG004|Overall Study|Lost to Follow-up|6|||
44150324|NCT02099110|78940125|FG000|Overall Study|Death|0|||
44150325|NCT02099110|78940126|FG001|Overall Study|Death|1|||
44530629|NCT03126110|79540411|FG006|Phase 1|Death|3|||
44530630|NCT03126110|79540412|FG007|Phase 1|Death|4|||
44150326|NCT02099110|78940127|FG002|Overall Study|Death|0|||
44150327|NCT02099110|78940128|FG003|Overall Study|Death|0|||
44150328|NCT02099110|78940129|FG004|Overall Study|Death|0|||
44150329|NCT02099110|78940125|FG000|Overall Study|Screen failure|0|||
44150330|NCT02099110|78940126|FG001|Overall Study|Screen failure|0|||
44254747|NCT03734029|79096621|FG001|Overall Study|Clinical progression by investigator|8|||
44530631|NCT03126110|79540413|FG008|Phase 1|Death|5|||
44530632|NCT03126110|79540414|FG009|Phase 1|Death|2|||
44150331|NCT02099110|78940127|FG002|Overall Study|Screen failure|0|||
44530633|NCT03126110|79540415|FG010|Phase 1|Death|6|||
44530634|NCT03126110|79540416|FG011|Phase 1|Death|0|||
44530635|NCT03126110|79540417|FG012|Phase 1|Death|0|||
44530636|NCT03126110|79540418|FG013|Phase 1|Death|0|||
44530637|NCT03126110|79540419|FG014|Phase 1|Death|0|||
44530638|NCT03126110|79540420|FG015|Phase 1|Death|0|||
44530639|NCT03126110|79540421|FG016|Phase 1|Death|0|||
44530640|NCT03126110|79540405|FG000|Phase 1|Lost to Follow-up|0|||
44530641|NCT03126110|79540406|FG001|Phase 1|Lost to Follow-up|1|||
44530642|NCT03126110|79540407|FG002|Phase 1|Lost to Follow-up|0|||
44530643|NCT03126110|79540408|FG003|Phase 1|Lost to Follow-up|0|||
44150332|NCT02099110|78940128|FG003|Overall Study|Screen failure|0|||
44150333|NCT02099110|78940129|FG004|Overall Study|Screen failure|1|||
44150334|NCT02099110|78940125|FG000|Overall Study|Non-compliance with study drug|2|||
44150335|NCT02099110|78940126|FG001|Overall Study|Non-compliance with study drug|0|||
44150336|NCT02099110|78940127|FG002|Overall Study|Non-compliance with study drug|0|||
44150337|NCT02099110|78940128|FG003|Overall Study|Non-compliance with study drug|0|||
44150338|NCT02099110|78940129|FG004|Overall Study|Non-compliance with study drug|1|||
44150339|NCT02099110|78940125|FG000|Overall Study|Physician Decision|3|||
44150340|NCT02099110|78940126|FG001|Overall Study|Physician Decision|0|||
44150341|NCT02099110|78940127|FG002|Overall Study|Physician Decision|1|||
44150342|NCT02099110|78940128|FG003|Overall Study|Physician Decision|2|||
44150343|NCT02099110|78940129|FG004|Overall Study|Physician Decision|1|||
44150344|NCT02098876|78940143|FG000|Overall Study|Withdrawal by Subject|5|||
44150345|NCT02098876|78940144|FG001|Overall Study|Withdrawal by Subject|5|||
44150346|NCT01624090|78940154|FG000|Overall Study|DLT, taken off therapy|0|||
44150347|NCT01624090|78940155|FG001|Overall Study|DLT, taken off therapy|1|||
44150348|NCT01624090|78940156|FG002|Overall Study|DLT, taken off therapy|0|||
44150349|NCT01624090|78940157|FG003|Overall Study|DLT, taken off therapy|0|||
44150350|NCT01624090|78940154|FG000|Overall Study|Withdrew prior to treatment|0|||
44150351|NCT01624090|78940155|FG001|Overall Study|Withdrew prior to treatment|1|||
44150352|NCT01624090|78940156|FG002|Overall Study|Withdrew prior to treatment|0|||
44150353|NCT01624090|78940157|FG003|Overall Study|Withdrew prior to treatment|0|||
44150354|NCT01624090|78940154|FG000|Overall Study|Died on study|0|||
44150355|NCT01624090|78940155|FG001|Overall Study|Died on study|0|||
44150356|NCT01624090|78940156|FG002|Overall Study|Died on study|2|||
44150357|NCT01624090|78940157|FG003|Overall Study|Died on study|0|||
44150358|NCT01624090|78940154|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
44530644|NCT03126110|79540409|FG004|Phase 1|Lost to Follow-up|0|||
44530645|NCT03126110|79540410|FG005|Phase 1|Lost to Follow-up|0|||
44530646|NCT03126110|79540411|FG006|Phase 1|Lost to Follow-up|0|||
44530647|NCT03126110|79540412|FG007|Phase 1|Lost to Follow-up|0|||
44530648|NCT03126110|79540413|FG008|Phase 1|Lost to Follow-up|1|||
44530649|NCT03126110|79540414|FG009|Phase 1|Lost to Follow-up|0|||
44530650|NCT03126110|79540415|FG010|Phase 1|Lost to Follow-up|0|||
44530651|NCT03126110|79540416|FG011|Phase 1|Lost to Follow-up|0|||
44530652|NCT03126110|79540417|FG012|Phase 1|Lost to Follow-up|0|||
44530653|NCT03126110|79540418|FG013|Phase 1|Lost to Follow-up|0|||
44530654|NCT03126110|79540419|FG014|Phase 1|Lost to Follow-up|0|||
44415060|NCT00625378|79422977|FG001|Overall Study|End of treatment not available|0|||
44530655|NCT03126110|79540420|FG015|Phase 1|Lost to Follow-up|0|||
44530656|NCT03126110|79540421|FG016|Phase 1|Lost to Follow-up|0|||
44530657|NCT03126110|79540405|FG000|Phase 1|Withdrawal by Subject|1|||
44530658|NCT03126110|79540406|FG001|Phase 1|Withdrawal by Subject|0|||
44530659|NCT03126110|79540407|FG002|Phase 1|Withdrawal by Subject|0|||
44530660|NCT03126110|79540408|FG003|Phase 1|Withdrawal by Subject|1|||
44530661|NCT03126110|79540409|FG004|Phase 1|Withdrawal by Subject|1|||
44530662|NCT03126110|79540410|FG005|Phase 1|Withdrawal by Subject|0|||
44530663|NCT03126110|79540411|FG006|Phase 1|Withdrawal by Subject|0|||
44530664|NCT03126110|79540412|FG007|Phase 1|Withdrawal by Subject|0|||
44530665|NCT03126110|79540413|FG008|Phase 1|Withdrawal by Subject|2|||
44530666|NCT03126110|79540414|FG009|Phase 1|Withdrawal by Subject|1|||
44530667|NCT03126110|79540415|FG010|Phase 1|Withdrawal by Subject|0|||
44530668|NCT03126110|79540416|FG011|Phase 1|Withdrawal by Subject|0|||
44530669|NCT03126110|79540417|FG012|Phase 1|Withdrawal by Subject|0|||
44530670|NCT03126110|79540418|FG013|Phase 1|Withdrawal by Subject|0|||
44530671|NCT03126110|79540419|FG014|Phase 1|Withdrawal by Subject|0|||
44530672|NCT03126110|79540420|FG015|Phase 1|Withdrawal by Subject|0|||
44530673|NCT03126110|79540421|FG016|Phase 1|Withdrawal by Subject|0|||
44530674|NCT03126110|79540405|FG000|Phase 1|Safety follow-up no longer necessary|1|||
44530675|NCT03126110|79540406|FG001|Phase 1|Safety follow-up no longer necessary|0|||
44530676|NCT03126110|79540407|FG002|Phase 1|Safety follow-up no longer necessary|0|||
44530677|NCT03126110|79540408|FG003|Phase 1|Safety follow-up no longer necessary|0|||
44150359|NCT01624090|78940155|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
44150360|NCT01624090|78940156|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
44415061|NCT00625378|79422976|FG000|Overall Study|Never treated|2|||
44530678|NCT03126110|79540409|FG004|Phase 1|Safety follow-up no longer necessary|0|||
44150361|NCT01624090|78940157|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
44530679|NCT03126110|79540410|FG005|Phase 1|Safety follow-up no longer necessary|0|||
44530680|NCT03126110|79540411|FG006|Phase 1|Safety follow-up no longer necessary|0|||
44530681|NCT03126110|79540412|FG007|Phase 1|Safety follow-up no longer necessary|0|||
44530682|NCT03126110|79540413|FG008|Phase 1|Safety follow-up no longer necessary|0|||
44530683|NCT03126110|79540414|FG009|Phase 1|Safety follow-up no longer necessary|0|||
44530684|NCT03126110|79540415|FG010|Phase 1|Safety follow-up no longer necessary|0|||
44530685|NCT03126110|79540416|FG011|Phase 1|Safety follow-up no longer necessary|0|||
44530686|NCT03126110|79540417|FG012|Phase 1|Safety follow-up no longer necessary|0|||
44530687|NCT03126110|79540418|FG013|Phase 1|Safety follow-up no longer necessary|0|||
44530688|NCT03126110|79540419|FG014|Phase 1|Safety follow-up no longer necessary|0|||
44530689|NCT03126110|79540420|FG015|Phase 1|Safety follow-up no longer necessary|0|||
44150362|NCT01624090|78940154|FG000|Overall Study|Dose escalated|0|||
44150363|NCT01624090|78940155|FG001|Overall Study|Dose escalated|0|||
44150364|NCT01624090|78940156|FG002|Overall Study|Dose escalated|3|||
44150365|NCT01624090|78940157|FG003|Overall Study|Dose escalated|0|||
44150366|NCT02571777|78940172|FG000|Overall Study|Subject/guardian decision|34|||
44254748|NCT03734029|79096620|FG000|Overall Study|Death|5|||
44254749|NCT03734029|79096621|FG001|Overall Study|Death|2|||
44530690|NCT03126110|79540421|FG016|Phase 1|Safety follow-up no longer necessary|0|||
44530691|NCT03126110|79540405|FG000|Phase 1|Survival follow-up no longer necessary|0|||
44530692|NCT03126110|79540406|FG001|Phase 1|Survival follow-up no longer necessary|0|||
44530693|NCT03126110|79540407|FG002|Phase 1|Survival follow-up no longer necessary|1|||
44150367|NCT02571777|78940173|FG001|Overall Study|Subject/guardian decision|26|||
44254750|NCT03734029|79096620|FG000|Overall Study|Physician Decision|4|||
44254751|NCT03734029|79096621|FG001|Overall Study|Physician Decision|3|||
44254752|NCT03734029|79096620|FG000|Overall Study|Other|2|||
44254753|NCT03734029|79096621|FG001|Overall Study|Other|0|||
44415062|NCT00625378|79422977|FG001|Overall Study|Never treated|0|||
44150368|NCT02571777|78940174|FG002|Overall Study|Subject/guardian decision|26|||
44254754|NCT03734029|79096620|FG000|Overall Study|Lost to Follow-up|0|||
44530694|NCT03126110|79540408|FG003|Phase 1|Survival follow-up no longer necessary|0|||
44530695|NCT03126110|79540409|FG004|Phase 1|Survival follow-up no longer necessary|0|||
44530696|NCT03126110|79540410|FG005|Phase 1|Survival follow-up no longer necessary|0|||
44530697|NCT03126110|79540411|FG006|Phase 1|Survival follow-up no longer necessary|0|||
44530698|NCT03126110|79540412|FG007|Phase 1|Survival follow-up no longer necessary|0|||
44530699|NCT03126110|79540413|FG008|Phase 1|Survival follow-up no longer necessary|0|||
44530700|NCT03126110|79540414|FG009|Phase 1|Survival follow-up no longer necessary|0|||
44530701|NCT03126110|79540415|FG010|Phase 1|Survival follow-up no longer necessary|0|||
44530702|NCT03126110|79540416|FG011|Phase 1|Survival follow-up no longer necessary|0|||
44530703|NCT03126110|79540417|FG012|Phase 1|Survival follow-up no longer necessary|0|||
44530704|NCT03126110|79540418|FG013|Phase 1|Survival follow-up no longer necessary|0|||
44530705|NCT03126110|79540419|FG014|Phase 1|Survival follow-up no longer necessary|0|||
44530706|NCT03126110|79540420|FG015|Phase 1|Survival follow-up no longer necessary|0|||
44530707|NCT03126110|79540421|FG016|Phase 1|Survival follow-up no longer necessary|0|||
44530708|NCT03126110|79540405|FG000|Phase 2|Study terminated by the sponsor|0|||
44530709|NCT03126110|79540406|FG001|Phase 2|Study terminated by the sponsor|0|||
44530710|NCT03126110|79540407|FG002|Phase 2|Study terminated by the sponsor|0|||
44530711|NCT03126110|79540408|FG003|Phase 2|Study terminated by the sponsor|0|||
44530712|NCT03126110|79540409|FG004|Phase 2|Study terminated by the sponsor|0|||
44530713|NCT03126110|79540410|FG005|Phase 2|Study terminated by the sponsor|0|||
44530714|NCT03126110|79540411|FG006|Phase 2|Study terminated by the sponsor|0|||
44530715|NCT03126110|79540412|FG007|Phase 2|Study terminated by the sponsor|0|||
44530716|NCT03126110|79540413|FG008|Phase 2|Study terminated by the sponsor|0|||
44530717|NCT03126110|79540414|FG009|Phase 2|Study terminated by the sponsor|0|||
44530718|NCT03126110|79540415|FG010|Phase 2|Study terminated by the sponsor|0|||
44530719|NCT03126110|79540416|FG011|Phase 2|Study terminated by the sponsor|0|||
44530720|NCT03126110|79540417|FG012|Phase 2|Study terminated by the sponsor|0|||
44150369|NCT02571777|78940175|FG003|Overall Study|Subject/guardian decision|25|||
44150370|NCT02571777|78940176|FG004|Overall Study|Subject/guardian decision|27|||
44150371|NCT02571777|78940172|FG000|Overall Study|Protocol Deviation|2|||
44150372|NCT02571777|78940173|FG001|Overall Study|Protocol Deviation|3|||
44150373|NCT02571777|78940174|FG002|Overall Study|Protocol Deviation|4|||
44150374|NCT02571777|78940175|FG003|Overall Study|Protocol Deviation|8|||
44150375|NCT02571777|78940176|FG004|Overall Study|Protocol Deviation|4|||
44150376|NCT02571777|78940172|FG000|Overall Study|Death|1|||
44150377|NCT02571777|78940173|FG001|Overall Study|Death|1|||
44150378|NCT02571777|78940174|FG002|Overall Study|Death|4|||
44150379|NCT02571777|78940175|FG003|Overall Study|Death|0|||
44150380|NCT02571777|78940176|FG004|Overall Study|Death|0|||
44150381|NCT02571777|78940172|FG000|Overall Study|Lost to Follow-up|1|||
44150382|NCT02571777|78940173|FG001|Overall Study|Lost to Follow-up|1|||
44150383|NCT02571777|78940174|FG002|Overall Study|Lost to Follow-up|2|||
44150384|NCT02571777|78940175|FG003|Overall Study|Lost to Follow-up|0|||
44150385|NCT02571777|78940176|FG004|Overall Study|Lost to Follow-up|1|||
44150386|NCT02571777|78940172|FG000|Overall Study|Physician Decision|1|||
44150387|NCT02571777|78940173|FG001|Overall Study|Physician Decision|7|||
44150388|NCT02571777|78940174|FG002|Overall Study|Physician Decision|5|||
44150389|NCT02571777|78940175|FG003|Overall Study|Physician Decision|2|||
44150390|NCT02571777|78940176|FG004|Overall Study|Physician Decision|4|||
44150391|NCT02571777|78940172|FG000|Overall Study|Pregnancy|0|||
44150392|NCT02571777|78940173|FG001|Overall Study|Pregnancy|0|||
44150393|NCT02571777|78940174|FG002|Overall Study|Pregnancy|0|||
44530721|NCT03126110|79540418|FG013|Phase 2|Study terminated by the sponsor|4|||
44530722|NCT03126110|79540419|FG014|Phase 2|Study terminated by the sponsor|0|||
44530723|NCT03126110|79540420|FG015|Phase 2|Study terminated by the sponsor|0|||
44530724|NCT03126110|79540421|FG016|Phase 2|Study terminated by the sponsor|0|||
44530725|NCT03126110|79540405|FG000|Phase 2|Withdrawal by Subject|0|||
44150394|NCT02571777|78940175|FG003|Overall Study|Pregnancy|2|||
44150395|NCT02571777|78940176|FG004|Overall Study|Pregnancy|0|||
44150396|NCT02571075|78940190|FG000|Overall Study|Lost to Follow-up|20|||
44150397|NCT02571075|78940191|FG001|Overall Study|Lost to Follow-up|24|||
44150398|NCT02705105|78940205|FG000|Treatment|Objective Disease Progression|1|||
44530726|NCT03126110|79540406|FG001|Phase 2|Withdrawal by Subject|0|||
44530727|NCT03126110|79540407|FG002|Phase 2|Withdrawal by Subject|0|||
44530728|NCT03126110|79540408|FG003|Phase 2|Withdrawal by Subject|0|||
44530729|NCT03126110|79540409|FG004|Phase 2|Withdrawal by Subject|0|||
44530730|NCT03126110|79540410|FG005|Phase 2|Withdrawal by Subject|0|||
44150399|NCT02705105|78940206|FG001|Treatment|Objective Disease Progression|50|||
44150400|NCT02705105|78940205|FG000|Treatment|Withdrawal by Subject|3|||
44530731|NCT03126110|79540411|FG006|Phase 2|Withdrawal by Subject|0|||
44530732|NCT03126110|79540412|FG007|Phase 2|Withdrawal by Subject|0|||
44530733|NCT03126110|79540413|FG008|Phase 2|Withdrawal by Subject|0|||
44530734|NCT03126110|79540414|FG009|Phase 2|Withdrawal by Subject|0|||
44530735|NCT03126110|79540415|FG010|Phase 2|Withdrawal by Subject|0|||
44530736|NCT03126110|79540416|FG011|Phase 2|Withdrawal by Subject|1|||
44150401|NCT02705105|78940206|FG001|Treatment|Withdrawal by Subject|5|||
44150402|NCT02705105|78940205|FG000|Treatment|Adverse Event|0|||
44150403|NCT02705105|78940206|FG001|Treatment|Adverse Event|17|||
44150404|NCT02705105|78940205|FG000|Treatment|Clinical Disease Progression|0|||
44150405|NCT02705105|78940206|FG001|Treatment|Clinical Disease Progression|32|||
44150406|NCT02705105|78940205|FG000|Treatment|Physician Decision|0|||
44150407|NCT02705105|78940206|FG001|Treatment|Physician Decision|3|||
44150408|NCT02705105|78940205|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
44150409|NCT02705105|78940206|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
44150410|NCT02705105|78940205|FG000|Follow-Up|Death|3|||
44150411|NCT02705105|78940206|FG001|Follow-Up|Death|68|||
44150412|NCT02705105|78940205|FG000|Follow-Up|Withdrawal by Subject|1|||
44150413|NCT02705105|78940206|FG001|Follow-Up|Withdrawal by Subject|14|||
44150414|NCT02705105|78940205|FG000|Follow-Up|Study Terminated|0|||
44150415|NCT02705105|78940206|FG001|Follow-Up|Study Terminated|26|||
44150416|NCT02705105|78940205|FG000|Follow-Up|Discontinued per Amendment 3|0|||
44150417|NCT02705105|78940206|FG001|Follow-Up|Discontinued per Amendment 3|2|||
44150418|NCT02097472|78940232|FG000|Received Vaccination 2|Adverse Event|0|||
44150419|NCT02097472|78940233|FG001|Received Vaccination 2|Adverse Event|0|||
44150420|NCT02097472|78940234|FG002|Received Vaccination 2|Adverse Event|0|||
44150421|NCT02097472|78940235|FG003|Received Vaccination 2|Adverse Event|0|||
44150422|NCT02097472|78940236|FG004|Received Vaccination 2|Adverse Event|0|||
44150423|NCT02097472|78940237|FG005|Received Vaccination 2|Adverse Event|0|||
44150424|NCT02097472|78940238|FG006|Received Vaccination 2|Adverse Event|1|||
44150425|NCT02097472|78940239|FG007|Received Vaccination 2|Adverse Event|0|||
44150426|NCT01623310|78940323|FG000|Overall Study|Adverse Event|21|||
44150427|NCT01623310|78940323|FG000|Overall Study|Lost to Follow-up|18|||
44150428|NCT01623310|78940323|FG000|Overall Study|Lack of Efficacy|6|||
44150429|NCT01623310|78940323|FG000|Overall Study|Protocol Violation|6|||
44150430|NCT01623310|78940323|FG000|Overall Study|Withdrawal by Subject|25|||
44150431|NCT01623310|78940323|FG000|Overall Study|Became potentially child-bearing|1|||
44150432|NCT01623310|78940323|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
44150433|NCT01623310|78940323|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
44150434|NCT02046226|78940327|FG000|Overall Study|Lost to Follow-up|7|||
44150435|NCT02046148|78940334|FG000|Overall Study|Lost to Follow-up|1|||
44150436|NCT02046148|78940335|FG001|Overall Study|Lost to Follow-up|1|||
44150437|NCT02046148|78940334|FG000|Overall Study|Withdrawal by Subject|0|||
44150438|NCT02046148|78940335|FG001|Overall Study|Withdrawal by Subject|2|||
44150439|NCT02097238|78940341|FG000|Overall Study|Death|1|||
44150440|NCT02097238|78940341|FG000|Overall Study|Physician Decision|1|||
44150441|NCT02097238|78940341|FG000|Overall Study|Progressive Disease|17|||
44150442|NCT02704091|78940348|FG000|Overall Study|Adverse Event|4|||
44150443|NCT02704091|78940349|FG001|Overall Study|Adverse Event|3|||
44282459|NCT01857102|79245777|FG000|Period 2|Lens Discomfort|1|||
44530737|NCT03126110|79540417|FG012|Phase 2|Withdrawal by Subject|3|||
44530738|NCT03126110|79540418|FG013|Phase 2|Withdrawal by Subject|3|||
44530739|NCT03126110|79540419|FG014|Phase 2|Withdrawal by Subject|2|||
44530740|NCT03126110|79540420|FG015|Phase 2|Withdrawal by Subject|1|||
44530741|NCT03126110|79540421|FG016|Phase 2|Withdrawal by Subject|0|||
44530742|NCT03126110|79540405|FG000|Phase 2|Lost to Follow-up|0|||
44530743|NCT03126110|79540406|FG001|Phase 2|Lost to Follow-up|0|||
44530744|NCT03126110|79540407|FG002|Phase 2|Lost to Follow-up|0|||
44150444|NCT02704091|78940348|FG000|Overall Study|Protocol Violation|5|||
44530745|NCT03126110|79540408|FG003|Phase 2|Lost to Follow-up|0|||
44530746|NCT03126110|79540409|FG004|Phase 2|Lost to Follow-up|0|||
44530747|NCT03126110|79540410|FG005|Phase 2|Lost to Follow-up|0|||
44530748|NCT03126110|79540411|FG006|Phase 2|Lost to Follow-up|0|||
44150445|NCT02704091|78940349|FG001|Overall Study|Protocol Violation|3|||
44150446|NCT02704091|78940348|FG000|Overall Study|Consent withdrawn|4|||
44150447|NCT02704091|78940349|FG001|Overall Study|Consent withdrawn|4|||
44150448|NCT02704091|78940348|FG000|Overall Study|Lost to Follow-up|13|||
44150449|NCT02704091|78940349|FG001|Overall Study|Lost to Follow-up|5|||
44150450|NCT02704091|78940348|FG000|Overall Study|Other|2|||
44150451|NCT02704091|78940349|FG001|Overall Study|Other|8|||
44530749|NCT03126110|79540412|FG007|Phase 2|Lost to Follow-up|0|||
44530750|NCT03126110|79540413|FG008|Phase 2|Lost to Follow-up|0|||
44150452|NCT02702609|78940357|FG000|Overall Study|Lost to Follow-up|8|||
44150453|NCT02702609|78940358|FG001|Overall Study|Lost to Follow-up|4|||
44150454|NCT02702609|78940357|FG000|Overall Study|Physician Decision|1|||
44150455|NCT02702609|78940358|FG001|Overall Study|Physician Decision|0|||
44530751|NCT03126110|79540414|FG009|Phase 2|Lost to Follow-up|0|||
44530752|NCT03126110|79540415|FG010|Phase 2|Lost to Follow-up|0|||
44150456|NCT02046070|78940367|FG000|Overall Study|Progressive Disease|18|||
44150457|NCT02046070|78940368|FG001|Overall Study|Progressive Disease|11|||
44150458|NCT02046070|78940369|FG002|Overall Study|Progressive Disease|40|||
44150459|NCT02046070|78940367|FG000|Overall Study|Adverse Event|8|||
44150460|NCT02046070|78940368|FG001|Overall Study|Adverse Event|10|||
44150461|NCT02046070|78940369|FG002|Overall Study|Adverse Event|17|||
44150462|NCT02046070|78940367|FG000|Overall Study|Withdrawal by Subject|1|||
44150463|NCT02046070|78940368|FG001|Overall Study|Withdrawal by Subject|2|||
44150464|NCT02046070|78940369|FG002|Overall Study|Withdrawal by Subject|6|||
44150465|NCT02046070|78940367|FG000|Overall Study|Study Terminated by Sponsor|1|||
44150466|NCT02046070|78940368|FG001|Overall Study|Study Terminated by Sponsor|1|||
44150467|NCT02046070|78940369|FG002|Overall Study|Study Terminated by Sponsor|1|||
44150468|NCT02046070|78940367|FG000|Overall Study|Reason not Specified|4|||
44150469|NCT02046070|78940368|FG001|Overall Study|Reason not Specified|4|||
44150470|NCT02046070|78940369|FG002|Overall Study|Reason not Specified|6|||
44150471|NCT01663857|78940381|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
44150472|NCT01663857|78940382|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
44150473|NCT01663857|78940383|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
44150474|NCT01663857|78940384|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
44150475|NCT01663857|78940381|FG000|Overall Study|Lost to Follow-up|0|||
44150476|NCT01663857|78940382|FG001|Overall Study|Lost to Follow-up|0|||
44150477|NCT01663857|78940383|FG002|Overall Study|Lost to Follow-up|3|||
44150478|NCT01663857|78940384|FG003|Overall Study|Lost to Follow-up|1|||
44150479|NCT02094898|78940400|FG000|Overall Study|Clinical Worsening|2|||
44150480|NCT02094898|78940400|FG000|Overall Study|Adverse Event|2|||
44150481|NCT02094898|78940400|FG000|Overall Study|Lack of Efficacy|1|||
44150482|NCT02045836|78940408|FG000|Overall Study|Adverse Event|4|||
44150483|NCT02045836|78940409|FG001|Overall Study|Adverse Event|4|||
44150484|NCT02045836|78940408|FG000|Overall Study|Withdrawal by Subject|1|||
44150485|NCT02045836|78940409|FG001|Overall Study|Withdrawal by Subject|1|||
44150486|NCT02045836|78940408|FG000|Overall Study|Lost to Follow-up|4|||
44150487|NCT02045836|78940409|FG001|Overall Study|Lost to Follow-up|7|||
44150488|NCT02045836|78940408|FG000|Overall Study|Migrated from study area|0|||
44150489|NCT02045836|78940409|FG001|Overall Study|Migrated from study area|2|||
44150490|NCT02569437|78940418|FG000|Overall Study|Lost to Follow-up|12|||
44150491|NCT02569437|78940419|FG001|Overall Study|Lost to Follow-up|14|||
44530753|NCT03126110|79540416|FG011|Phase 2|Lost to Follow-up|1|||
44530754|NCT03126110|79540417|FG012|Phase 2|Lost to Follow-up|1|||
44530755|NCT03126110|79540418|FG013|Phase 2|Lost to Follow-up|1|||
44530756|NCT03126110|79540419|FG014|Phase 2|Lost to Follow-up|2|||
44530757|NCT03126110|79540420|FG015|Phase 2|Lost to Follow-up|0|||
44530758|NCT03126110|79540421|FG016|Phase 2|Lost to Follow-up|0|||
44530759|NCT03126110|79540405|FG000|Phase 2|Death|0|||
44530760|NCT03126110|79540406|FG001|Phase 2|Death|0|||
44530761|NCT03126110|79540407|FG002|Phase 2|Death|0|||
44150492|NCT02045212|78940427|FG000|Overall Study|Adverse Event|0|||
44150493|NCT02045212|78940428|FG001|Overall Study|Adverse Event|1|||
44415063|NCT00806624|79422986|FG000|Overall Study|Adverse Event|2|||
44530762|NCT03126110|79540408|FG003|Phase 2|Death|0|||
44150494|NCT02045212|78940427|FG000|Overall Study|Withdrawal by Subject|1|||
44150495|NCT02045212|78940428|FG001|Overall Study|Withdrawal by Subject|0|||
44150496|NCT02045212|78940427|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
44150497|NCT02045212|78940428|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
44150498|NCT02044822|78940438|FG000|Overall Study|Study Terminated by Sponsor|77|||
44150499|NCT02044822|78940438|FG000|Overall Study|Investigator's Discretion|10|||
44150500|NCT02044822|78940438|FG000|Overall Study|Withdrew Consent|3|||
44150501|NCT02044822|78940438|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
44150502|NCT02044822|78940438|FG000|Overall Study|Lost to Follow-up|1|||
44530763|NCT03126110|79540409|FG004|Phase 2|Death|0|||
44530764|NCT03126110|79540410|FG005|Phase 2|Death|0|||
44530765|NCT03126110|79540411|FG006|Phase 2|Death|0|||
44530766|NCT03126110|79540412|FG007|Phase 2|Death|0|||
44530767|NCT03126110|79540413|FG008|Phase 2|Death|0|||
44530768|NCT03126110|79540414|FG009|Phase 2|Death|0|||
44530769|NCT03126110|79540415|FG010|Phase 2|Death|0|||
44530770|NCT03126110|79540416|FG011|Phase 2|Death|6|||
44530771|NCT03126110|79540417|FG012|Phase 2|Death|12|||
44530772|NCT03126110|79540418|FG013|Phase 2|Death|25|||
44530773|NCT03126110|79540419|FG014|Phase 2|Death|11|||
44530774|NCT03126110|79540420|FG015|Phase 2|Death|3|||
44530775|NCT03126110|79540421|FG016|Phase 2|Death|2|||
44530776|NCT03126110|79540405|FG000|Phase 2|Progressive Disease|0|||
44530777|NCT03126110|79540406|FG001|Phase 2|Progressive Disease|0|||
44530778|NCT03126110|79540407|FG002|Phase 2|Progressive Disease|0|||
44530779|NCT03126110|79540408|FG003|Phase 2|Progressive Disease|0|||
44530780|NCT03126110|79540409|FG004|Phase 2|Progressive Disease|0|||
44530781|NCT03126110|79540410|FG005|Phase 2|Progressive Disease|0|||
44530782|NCT03126110|79540411|FG006|Phase 2|Progressive Disease|0|||
44530783|NCT03126110|79540412|FG007|Phase 2|Progressive Disease|0|||
44530784|NCT03126110|79540413|FG008|Phase 2|Progressive Disease|0|||
44530785|NCT03126110|79540414|FG009|Phase 2|Progressive Disease|0|||
44530786|NCT03126110|79540415|FG010|Phase 2|Progressive Disease|0|||
44530787|NCT03126110|79540416|FG011|Phase 2|Progressive Disease|0|||
44530788|NCT03126110|79540417|FG012|Phase 2|Progressive Disease|0|||
44530789|NCT03126110|79540418|FG013|Phase 2|Progressive Disease|1|||
44530790|NCT03126110|79540419|FG014|Phase 2|Progressive Disease|0|||
44530791|NCT03126110|79540420|FG015|Phase 2|Progressive Disease|0|||
44530792|NCT03126110|79540421|FG016|Phase 2|Progressive Disease|0|||
44530793|NCT03126110|79540405|FG000|Phase 2|Started new treatment|0|||
44530794|NCT03126110|79540406|FG001|Phase 2|Started new treatment|0|||
44530795|NCT03126110|79540407|FG002|Phase 2|Started new treatment|0|||
44530796|NCT03126110|79540408|FG003|Phase 2|Started new treatment|0|||
44530797|NCT03126110|79540409|FG004|Phase 2|Started new treatment|0|||
44530798|NCT03126110|79540410|FG005|Phase 2|Started new treatment|0|||
44530799|NCT03126110|79540411|FG006|Phase 2|Started new treatment|0|||
44530800|NCT03126110|79540412|FG007|Phase 2|Started new treatment|0|||
44530801|NCT03126110|79540413|FG008|Phase 2|Started new treatment|0|||
44530802|NCT03126110|79540414|FG009|Phase 2|Started new treatment|0|||
44530803|NCT03126110|79540415|FG010|Phase 2|Started new treatment|0|||
44530804|NCT03126110|79540416|FG011|Phase 2|Started new treatment|0|||
44530805|NCT03126110|79540417|FG012|Phase 2|Started new treatment|0|||
44530806|NCT03126110|79540418|FG013|Phase 2|Started new treatment|0|||
44530807|NCT03126110|79540419|FG014|Phase 2|Started new treatment|1|||
44150503|NCT02044510|78940444|FG000|Overall Study|Adverse Event|1|||
44150504|NCT02044510|78940445|FG001|Overall Study|Adverse Event|2|||
44530808|NCT03126110|79540420|FG015|Phase 2|Started new treatment|0|||
44530809|NCT03126110|79540421|FG016|Phase 2|Started new treatment|0|||
44530810|NCT00905164|79540471|FG000|Period 1|Protocol Violation|0|||
44530811|NCT00905164|79540472|FG001|Period 1|Protocol Violation|1|||
44530812|NCT03181958|79540479|FG000|Overall Study|Lost to Follow-up|17|||
44530813|NCT03181958|79540480|FG001|Overall Study|Lost to Follow-up|21|||
44530814|NCT03181958|79540481|FG002|Overall Study|Lost to Follow-up|15|||
44530815|NCT03165110|79540489|FG000|Overall Study|Anroid phone software incompatibility|1|||
44530816|NCT00079781|79540496|FG000|Pre-implant Period|Withdrawal by Subject|2|||
44530817|NCT00079781|79540497|FG001|Pre-implant Period|Withdrawal by Subject|0|||
44530818|NCT00079781|79540498|FG002|Pre-implant Period|Withdrawal by Subject|0|||
44530819|NCT00079781|79540496|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
44530820|NCT00079781|79540497|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
44530821|NCT00079781|79540498|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
44530822|NCT00079781|79540496|FG000|Follow-up Period|Withdrawal by Subject|3|||
44530823|NCT00079781|79540497|FG001|Follow-up Period|Withdrawal by Subject|0|||
44530824|NCT00079781|79540498|FG002|Follow-up Period|Withdrawal by Subject|1|||
44530825|NCT00079781|79540496|FG000|Follow-up Period|Lost to Follow-up|1|||
44530826|NCT00079781|79540497|FG001|Follow-up Period|Lost to Follow-up|0|||
44530827|NCT00079781|79540498|FG002|Follow-up Period|Lost to Follow-up|0|||
44530828|NCT00079781|79540496|FG000|Follow-up Period|Death|0|||
44530829|NCT00079781|79540497|FG001|Follow-up Period|Death|0|||
44530830|NCT00079781|79540498|FG002|Follow-up Period|Death|1|||
44530831|NCT03176966|79540506|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
44530832|NCT03176966|79540507|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
44530833|NCT03176966|79540506|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
44530834|NCT03176966|79540507|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
44150505|NCT02067676|78940457|FG000|Overall Study|Withdrawal by Subject|1|||
44150506|NCT02067676|78940458|FG001|Overall Study|Withdrawal by Subject|0|||
44150507|NCT02067676|78940459|FG002|Overall Study|Withdrawal by Subject|0|||
44150508|NCT02067676|78940460|FG003|Overall Study|Withdrawal by Subject|0|||
44150509|NCT02067676|78940461|FG004|Overall Study|Withdrawal by Subject|0|||
44150510|NCT02067676|78940462|FG005|Overall Study|Withdrawal by Subject|0|||
44150511|NCT01623154|78940481|FG000|Overall Study|Did not drink Pranactin Citric|4|||
44150512|NCT03174431|78940489|FG000|Overall Study|Withdrawal by Subject|14|||
44150513|NCT03174431|78940490|FG001|Overall Study|Withdrawal by Subject|11|||
44150514|NCT03174431|78940489|FG000|Overall Study|alternative treatment|2|||
44150515|NCT03174431|78940490|FG001|Overall Study|alternative treatment|0|||
44150516|NCT03174431|78940489|FG000|Overall Study|Lost to Follow-up|1|||
44150517|NCT03174431|78940490|FG001|Overall Study|Lost to Follow-up|5|||
44150518|NCT00702689|78940496|FG000|Overall Study|Withdrawal by Subject|4|||
44150519|NCT00702689|78940496|FG000|Overall Study|Recurrent malignancy|1|||
44150520|NCT00702689|78940496|FG000|Overall Study|Adverse Event|1|||
44150521|NCT02065570|78940502|FG000|Induction Study|Adverse Event|5|||
44150522|NCT02065570|78940503|FG001|Induction Study|Adverse Event|12|||
44150523|NCT02065570|78940504|FG002|Induction Study|Adverse Event|0|||
44530835|NCT03176966|79540506|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
44530836|NCT03176966|79540507|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
44530837|NCT03176966|79540506|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
44282460|NCT01857102|79245778|FG001|Period 2|Lens Discomfort|0|||
44282461|NCT01857102|79245777|FG000|Period 2|Unsatisfactory Lens Fit|1|||
44530838|NCT03176966|79540507|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
44150524|NCT02065570|78940505|FG003|Induction Study|Adverse Event|0|||
44150525|NCT02065570|78940502|FG000|Induction Study|Withdrawal by Subject|2|||
44282462|NCT01857102|79245778|FG001|Period 2|Unsatisfactory Lens Fit|0|||
44530839|NCT03176966|79540506|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
44530840|NCT03176966|79540507|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
44530841|NCT03176966|79540506|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
44530842|NCT03176966|79540507|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
44530843|NCT03176966|79540506|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
44530844|NCT03176966|79540507|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
44530845|NCT03175562|79540513|FG000|Overall Study|Adverse Event|1|||
44530846|NCT03175562|79540513|FG000|Overall Study|Lost to Follow-up|3|||
44530847|NCT03175562|79540513|FG000|Overall Study|Withdrawal by Subject|7|||
44530848|NCT03175562|79540513|FG000|Overall Study|Other (Not Specified)|5|||
44530849|NCT00079391|79540520|FG000|Overall Study|Withdrawal by Subject|1|||
44530850|NCT03209570|79540528|FG000|Overall Study|Death|1|||
44530851|NCT03209570|79540529|FG001|Overall Study|Death|0|||
44530852|NCT03209570|79540528|FG000|Overall Study|Incomplete Data|8|||
44530853|NCT03209570|79540529|FG001|Overall Study|Incomplete Data|10|||
44530854|NCT03209570|79540528|FG000|Overall Study|Protocol Violation|1|||
44530855|NCT03209570|79540529|FG001|Overall Study|Protocol Violation|0|||
44530856|NCT03209570|79540528|FG000|Overall Study|Withdrawal by Subject|0|||
44530857|NCT03209570|79540529|FG001|Overall Study|Withdrawal by Subject|3|||
44530858|NCT03209492|79540535|FG000|Overall Study|Case Report Forms Uncollected|5|||
44530859|NCT03208244|79540539|FG000|Overall Study|Death|1|||
44530860|NCT03175172|79540543|FG000|Overall Study|Death|3|||
44530861|NCT03175172|79540543|FG000|Overall Study|Withdrawal by Subject|3|||
44530862|NCT03175172|79540543|FG000|Overall Study|Lost to Follow-up|1|||
44150526|NCT02065570|78940503|FG001|Induction Study|Withdrawal by Subject|3|||
44150527|NCT02065570|78940504|FG002|Induction Study|Withdrawal by Subject|0|||
44150528|NCT02065570|78940505|FG003|Induction Study|Withdrawal by Subject|0|||
44415064|NCT00806624|79422987|FG001|Overall Study|Adverse Event|8|||
44150529|NCT02065570|78940502|FG000|Induction Study|Lost to Follow-up|1|||
44150530|NCT02065570|78940503|FG001|Induction Study|Lost to Follow-up|1|||
44530863|NCT03175172|79540543|FG000|Overall Study|Study Terminated by Sponsor|3|||
44530864|NCT03172364|79540549|FG000|Overall Study|Adverse Event|1|||
44530865|NCT03172364|79540550|FG001|Overall Study|Adverse Event|1|||
44530866|NCT03172364|79540549|FG000|Overall Study|Protocol Violation|1|||
44530867|NCT03172364|79540550|FG001|Overall Study|Protocol Violation|0|||
44530868|NCT00078767|79540558|FG000|Overall Study|Withdrawal by Subject|1|||
44530869|NCT00078767|79540559|FG001|Overall Study|Withdrawal by Subject|1|||
44530870|NCT03208088|79540565|FG000|Period 2|Withdrawal by Subject|0|||
44530871|NCT03208088|79540566|FG001|Period 2|Withdrawal by Subject|0|||
44530872|NCT03208088|79540567|FG002|Period 2|Withdrawal by Subject|0|||
44530873|NCT03208088|79540568|FG003|Period 2|Withdrawal by Subject|0|||
44530874|NCT03208088|79540569|FG004|Period 2|Withdrawal by Subject|0|||
44530875|NCT03208088|79540570|FG005|Period 2|Withdrawal by Subject|0|||
44530876|NCT03208088|79540571|FG006|Period 2|Withdrawal by Subject|0|||
44530877|NCT03208088|79540572|FG007|Period 2|Withdrawal by Subject|0|||
44530878|NCT03208088|79540573|FG008|Period 2|Withdrawal by Subject|1|||
44530879|NCT03208088|79540574|FG009|Period 2|Withdrawal by Subject|0|||
44530880|NCT03208088|79540565|FG000|Period 3|Unsatisfactory Test Article|0|||
44530881|NCT03208088|79540566|FG001|Period 3|Unsatisfactory Test Article|0|||
44530882|NCT03208088|79540567|FG002|Period 3|Unsatisfactory Test Article|0|||
44530883|NCT03208088|79540568|FG003|Period 3|Unsatisfactory Test Article|1|||
44530884|NCT03208088|79540569|FG004|Period 3|Unsatisfactory Test Article|0|||
44530885|NCT03208088|79540570|FG005|Period 3|Unsatisfactory Test Article|0|||
44530886|NCT03208088|79540571|FG006|Period 3|Unsatisfactory Test Article|0|||
44530887|NCT03208088|79540572|FG007|Period 3|Unsatisfactory Test Article|0|||
44530888|NCT03208088|79540573|FG008|Period 3|Unsatisfactory Test Article|0|||
44530889|NCT03208088|79540574|FG009|Period 3|Unsatisfactory Test Article|0|||
44530890|NCT03208088|79540565|FG000|Period 4|Unsatisfactory Test Article|0|||
44530891|NCT03208088|79540566|FG001|Period 4|Unsatisfactory Test Article|0|||
44530892|NCT03208088|79540567|FG002|Period 4|Unsatisfactory Test Article|0|||
44530893|NCT03208088|79540568|FG003|Period 4|Unsatisfactory Test Article|1|||
44530894|NCT03208088|79540569|FG004|Period 4|Unsatisfactory Test Article|0|||
44150531|NCT02065570|78940504|FG002|Induction Study|Lost to Follow-up|0|||
44150532|NCT02065570|78940505|FG003|Induction Study|Lost to Follow-up|0|||
44150533|NCT02065570|78940502|FG000|Induction Study|Other, Not Specified|6|||
44150534|NCT02065570|78940503|FG001|Induction Study|Other, Not Specified|5|||
44150535|NCT02065570|78940504|FG002|Induction Study|Other, Not Specified|0|||
44150536|NCT02065570|78940505|FG003|Induction Study|Other, Not Specified|0|||
44150537|NCT02065570|78940502|FG000|Maintenance Study|Adverse Event|0|||
44150538|NCT02065570|78940503|FG001|Maintenance Study|Adverse Event|0|||
44150539|NCT02065570|78940504|FG002|Maintenance Study|Adverse Event|8|||
44150540|NCT02065570|78940505|FG003|Maintenance Study|Adverse Event|8|||
44150541|NCT02065570|78940502|FG000|Maintenance Study|Withdrawal by Subject|0|||
44150542|NCT02065570|78940503|FG001|Maintenance Study|Withdrawal by Subject|0|||
44150543|NCT02065570|78940504|FG002|Maintenance Study|Withdrawal by Subject|1|||
44150544|NCT02065570|78940505|FG003|Maintenance Study|Withdrawal by Subject|4|||
44150545|NCT02065570|78940502|FG000|Maintenance Study|Lost to Follow-up|0|||
44150546|NCT02065570|78940503|FG001|Maintenance Study|Lost to Follow-up|0|||
44150547|NCT02065570|78940504|FG002|Maintenance Study|Lost to Follow-up|2|||
44150548|NCT02065570|78940505|FG003|Maintenance Study|Lost to Follow-up|2|||
44150549|NCT02065570|78940502|FG000|Maintenance Study|Other, Not Specified|0|||
44150550|NCT02065570|78940503|FG001|Maintenance Study|Other, Not Specified|0|||
44150551|NCT02065570|78940504|FG002|Maintenance Study|Other, Not Specified|11|||
44150552|NCT02065570|78940505|FG003|Maintenance Study|Other, Not Specified|5|||
44150553|NCT02566005|78940518|FG000|Overall Study|vaginal bleeding|0|||
44530895|NCT03208088|79540570|FG005|Period 4|Unsatisfactory Test Article|0|||
44530896|NCT03208088|79540571|FG006|Period 4|Unsatisfactory Test Article|0|||
44150554|NCT02566005|78940519|FG001|Overall Study|vaginal bleeding|1|||
44150555|NCT02566005|78940518|FG000|Overall Study|received foley|8|||
44150556|NCT02566005|78940519|FG001|Overall Study|received foley|0|||
44530897|NCT03208088|79540572|FG007|Period 4|Unsatisfactory Test Article|0|||
44530898|NCT03208088|79540573|FG008|Period 4|Unsatisfactory Test Article|0|||
44530899|NCT03208088|79540574|FG009|Period 4|Unsatisfactory Test Article|0|||
44530900|NCT00078377|79540589|FG000|Overall Study|Adverse Event|2|||
44530901|NCT00078377|79540590|FG001|Overall Study|Adverse Event|5|||
44530902|NCT00078377|79540591|FG002|Overall Study|Adverse Event|1|||
44530903|NCT00078377|79540589|FG000|Overall Study|Lack of Efficacy|2|||
44530904|NCT00078377|79540590|FG001|Overall Study|Lack of Efficacy|0|||
44530905|NCT00078377|79540591|FG002|Overall Study|Lack of Efficacy|2|||
44530906|NCT00078377|79540589|FG000|Overall Study|Lost to Follow-up|0|||
44150557|NCT02566005|78940518|FG000|Overall Study|did not receive foley|0|||
44150558|NCT02566005|78940519|FG001|Overall Study|did not receive foley|1|||
44150559|NCT02566005|78940518|FG000|Overall Study|labor after randomization|0|||
44150560|NCT02566005|78940519|FG001|Overall Study|labor after randomization|4|||
44150561|NCT02065336|78940537|FG000|Extension Phase|Study Terminated by Sponsor|0|||
44150562|NCT02065336|78940538|FG001|Extension Phase|Study Terminated by Sponsor|0|||
44150563|NCT02065336|78940539|FG002|Extension Phase|Study Terminated by Sponsor|0|||
44150564|NCT02065336|78940540|FG003|Extension Phase|Study Terminated by Sponsor|0|||
44150565|NCT02065336|78940541|FG004|Extension Phase|Study Terminated by Sponsor|0|||
44150566|NCT02065336|78940542|FG005|Extension Phase|Study Terminated by Sponsor|0|||
44530907|NCT00078377|79540590|FG001|Overall Study|Lost to Follow-up|1|||
44530908|NCT00078377|79540591|FG002|Overall Study|Lost to Follow-up|1|||
44530909|NCT00078377|79540589|FG000|Overall Study|Physician Decision|2|||
44530910|NCT00078377|79540590|FG001|Overall Study|Physician Decision|0|||
44530911|NCT00078377|79540591|FG002|Overall Study|Physician Decision|0|||
44530912|NCT00078377|79540589|FG000|Overall Study|Withdrawal by Subject|3|||
44530913|NCT00078377|79540590|FG001|Overall Study|Withdrawal by Subject|4|||
44150567|NCT02065336|78940543|FG006|Extension Phase|Study Terminated by Sponsor|0|||
44150568|NCT02065336|78940544|FG007|Extension Phase|Study Terminated by Sponsor|0|||
44530914|NCT00078377|79540591|FG002|Overall Study|Withdrawal by Subject|4|||
44150569|NCT02065336|78940545|FG008|Extension Phase|Study Terminated by Sponsor|2|||
44530915|NCT00078377|79540589|FG000|Overall Study|Miscellaneous|2|||
44530916|NCT00078377|79540590|FG001|Overall Study|Miscellaneous|6|||
44530917|NCT00078377|79540591|FG002|Overall Study|Miscellaneous|1|||
44530918|NCT00886600|79540604|FG000|Double-blind Monotherapy|Adverse Event|1|||
44530919|NCT00886600|79540605|FG001|Double-blind Monotherapy|Adverse Event|1|||
44530920|NCT00886600|79540606|FG002|Double-blind Monotherapy|Adverse Event|1|||
44530921|NCT00886600|79540607|FG003|Double-blind Monotherapy|Adverse Event|1|||
44530922|NCT00886600|79540604|FG000|Double-blind Monotherapy|Protocol Violation|0|||
44530923|NCT00886600|79540605|FG001|Double-blind Monotherapy|Protocol Violation|0|||
44530924|NCT00886600|79540606|FG002|Double-blind Monotherapy|Protocol Violation|0|||
44530925|NCT00886600|79540607|FG003|Double-blind Monotherapy|Protocol Violation|1|||
44530926|NCT00886600|79540604|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
44530927|NCT00886600|79540605|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
44530928|NCT00886600|79540606|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
44530929|NCT00886600|79540607|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
44530930|NCT00886600|79540604|FG000|Combination Therapy Period|Adverse Event|0|||
44530931|NCT00886600|79540605|FG001|Combination Therapy Period|Adverse Event|0|||
44530932|NCT00886600|79540606|FG002|Combination Therapy Period|Adverse Event|1|||
44530933|NCT00886600|79540607|FG003|Combination Therapy Period|Adverse Event|0|||
44530934|NCT00886600|79540604|FG000|Combination Therapy Period|Protocol Violation|0|||
44530935|NCT00886600|79540605|FG001|Combination Therapy Period|Protocol Violation|0|||
44530936|NCT00886600|79540606|FG002|Combination Therapy Period|Protocol Violation|1|||
44530937|NCT00886600|79540607|FG003|Combination Therapy Period|Protocol Violation|0|||
44530938|NCT03172130|79540615|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
44530939|NCT03172130|79540616|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
44530940|NCT00870688|79540632|FG000|Overall Study|Lost to Follow-up|2|||
44530941|NCT00870688|79540632|FG000|Overall Study|Death, Unrelated|1|||
44530942|NCT00870688|79540632|FG000|Overall Study|Granules in the Stools|1|||
44530943|NCT00869128|79540635|FG000|Overall Study|lack of Compliance|6|||
44530944|NCT00869128|79540636|FG001|Overall Study|lack of Compliance|6|||
44530945|NCT00077675|79540642|FG000|Overall Study|Adverse Event|1|||
44530946|NCT00077675|79540643|FG001|Overall Study|Adverse Event|2|||
44530947|NCT00077675|79540642|FG000|Overall Study|Lost to Follow-up|6|||
44530948|NCT00077675|79540643|FG001|Overall Study|Lost to Follow-up|3|||
44530949|NCT00077675|79540642|FG000|Overall Study|Withdrawal by Subject|1|||
44530950|NCT00077675|79540643|FG001|Overall Study|Withdrawal by Subject|0|||
44530951|NCT00077675|79540642|FG000|Overall Study|Other|0|||
44530952|NCT00077675|79540643|FG001|Overall Study|Other|1|||
44530953|NCT00077675|79540642|FG000|Overall Study|Never received study treatment|3|||
44530954|NCT00077675|79540643|FG001|Overall Study|Never received study treatment|3|||
44530955|NCT02576444|79540660|FG000|Overall Study|Death|1|||
44530956|NCT02576444|79540661|FG001|Overall Study|Death|1|||
44530957|NCT02576444|79540662|FG002|Overall Study|Death|0|||
44530958|NCT02576444|79540663|FG003|Overall Study|Death|0|||
44530959|NCT02576444|79540660|FG000|Overall Study|Withdrawal by Subject|0|||
44530960|NCT02576444|79540661|FG001|Overall Study|Withdrawal by Subject|0|||
44530961|NCT02576444|79540662|FG002|Overall Study|Withdrawal by Subject|2|||
44530962|NCT02576444|79540663|FG003|Overall Study|Withdrawal by Subject|0|||
44282463|NCT01872078|79245790|FG000|Overall Study|Adverse Event|0|||
44530963|NCT02576444|79540660|FG000|Overall Study|Adverse Event|0|||
44530964|NCT02576444|79540661|FG001|Overall Study|Adverse Event|0|||
44530965|NCT02576444|79540662|FG002|Overall Study|Adverse Event|1|||
44530966|NCT02576444|79540663|FG003|Overall Study|Adverse Event|0|||
44530967|NCT02576444|79540660|FG000|Overall Study|Physician Decision|0|||
44530968|NCT02576444|79540661|FG001|Overall Study|Physician Decision|0|||
44530969|NCT02576444|79540662|FG002|Overall Study|Physician Decision|1|||
44530970|NCT02576444|79540663|FG003|Overall Study|Physician Decision|0|||
44282464|NCT01872078|79245791|FG001|Overall Study|Adverse Event|0|||
44530971|NCT00850174|79540674|FG000|Washout: One Week|Withdrawal by Subject|0|||
44530972|NCT00850174|79540675|FG001|Washout: One Week|Withdrawal by Subject|2|||
44530973|NCT00850174|79540674|FG000|Second Intervention|Withdrawal by Subject|1|||
44530974|NCT00850174|79540675|FG001|Second Intervention|Withdrawal by Subject|0|||
44530975|NCT00077207|79540686|FG000|Overall Study|Adverse Event|5|||
44530976|NCT00077207|79540686|FG000|Overall Study|Lack of Efficacy|12|||
44530977|NCT00077207|79540686|FG000|Overall Study|Physician Decision|6|||
44530978|NCT00077207|79540686|FG000|Overall Study|Withdrawal by Subject|6|||
44530979|NCT00077207|79540686|FG000|Overall Study|Ineligible|1|||
44530980|NCT03206918|79540691|FG000|Overall Study|Death|11|||
44530981|NCT03206918|79540691|FG000|Overall Study|Withdrawal by Subject|5|||
44530982|NCT03206918|79540691|FG000|Overall Study|Study terminated by sponsor|12|||
44530983|NCT03206918|79540691|FG000|Overall Study|Lost to Follow-up|3|||
44150570|NCT02065336|78940546|FG009|Extension Phase|Study Terminated by Sponsor|8|||
44150571|NCT02701985|78940579|FG000|Overall Study|Withdrawal by Subject|1|||
44150572|NCT02701985|78940580|FG001|Overall Study|Withdrawal by Subject|1|||
44150573|NCT02701985|78940579|FG000|Overall Study|Lost to Follow-up|1|||
44150574|NCT02701985|78940580|FG001|Overall Study|Lost to Follow-up|0|||
44150575|NCT02701985|78940579|FG000|Overall Study|Death|1|||
44150576|NCT02701985|78940580|FG001|Overall Study|Death|0|||
44150577|NCT02701985|78940579|FG000|Overall Study|Adverse Event|0|||
44150578|NCT02701985|78940580|FG001|Overall Study|Adverse Event|5|||
44150579|NCT02064868|78940589|FG000|Overall Study|Lost to Follow-up|14|||
44150580|NCT02064868|78940590|FG001|Overall Study|Lost to Follow-up|8|||
44150581|NCT02064868|78940589|FG000|Overall Study|Physician Decision|1|||
44150582|NCT02064868|78940590|FG001|Overall Study|Physician Decision|0|||
44150583|NCT02064868|78940589|FG000|Overall Study|Withdrawal by Subject|14|||
44150584|NCT02064868|78940590|FG001|Overall Study|Withdrawal by Subject|3|||
44150585|NCT02064868|78940589|FG000|Overall Study|Technical Problems or Missing|5|||
44150586|NCT02064868|78940590|FG001|Overall Study|Technical Problems or Missing|2|||
44150587|NCT02064166|78940598|FG000|Overall Study|Adverse Event|1|||
44150588|NCT02064166|78940599|FG001|Overall Study|Adverse Event|0|||
44150589|NCT02565615|78940632|FG000|Overall Study|Death|0|||
44150590|NCT02565615|78940633|FG001|Overall Study|Death|1|||
44150591|NCT02565615|78940634|FG002|Overall Study|Death|0|||
44150592|NCT02565615|78940635|FG003|Overall Study|Death|0|||
44150593|NCT02565615|78940636|FG004|Overall Study|Death|4|||
44150594|NCT02565615|78940632|FG000|Overall Study|Not willing to participate in study|2|||
44150595|NCT02565615|78940633|FG001|Overall Study|Not willing to participate in study|21|||
44150596|NCT02565615|78940634|FG002|Overall Study|Not willing to participate in study|0|||
44150597|NCT02565615|78940635|FG003|Overall Study|Not willing to participate in study|1|||
44150598|NCT02565615|78940636|FG004|Overall Study|Not willing to participate in study|169|||
44150599|NCT02565615|78940632|FG000|Overall Study|Lost to Follow-up|0|||
44150600|NCT02565615|78940633|FG001|Overall Study|Lost to Follow-up|4|||
44150601|NCT02565615|78940634|FG002|Overall Study|Lost to Follow-up|0|||
44150602|NCT02565615|78940635|FG003|Overall Study|Lost to Follow-up|1|||
44150603|NCT02565615|78940636|FG004|Overall Study|Lost to Follow-up|765|||
44150604|NCT02565615|78940632|FG000|Overall Study|Not meeting eligibility criteria|0|||
44150605|NCT02565615|78940633|FG001|Overall Study|Not meeting eligibility criteria|7|||
44150606|NCT02565615|78940634|FG002|Overall Study|Not meeting eligibility criteria|0|||
44150607|NCT02565615|78940635|FG003|Overall Study|Not meeting eligibility criteria|0|||
44150608|NCT02565615|78940636|FG004|Overall Study|Not meeting eligibility criteria|25|||
44150609|NCT02565615|78940632|FG000|Overall Study|Reason not defined|0|||
44150610|NCT02565615|78940633|FG001|Overall Study|Reason not defined|2|||
44150611|NCT02565615|78940634|FG002|Overall Study|Reason not defined|0|||
44282465|NCT01872078|79245792|FG002|Overall Study|Adverse Event|1|||
44530984|NCT03206918|79540691|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
44530985|NCT03206216|79540698|FG000|Overall Study|Withdrawal by Subject|0|||
44150612|NCT02565615|78940635|FG003|Overall Study|Reason not defined|1|||
44150613|NCT02565615|78940636|FG004|Overall Study|Reason not defined|62|||
44150614|NCT02565615|78940632|FG000|Overall Study|Adverse Event|1|||
44150615|NCT02565615|78940633|FG001|Overall Study|Adverse Event|1|||
44150616|NCT02565615|78940634|FG002|Overall Study|Adverse Event|0|||
44150617|NCT02565615|78940635|FG003|Overall Study|Adverse Event|0|||
44150618|NCT02565615|78940636|FG004|Overall Study|Adverse Event|9|||
44150619|NCT02565615|78940632|FG000|Overall Study|Untreated|0|||
44150620|NCT02565615|78940633|FG001|Overall Study|Untreated|0|||
44150621|NCT02565615|78940634|FG002|Overall Study|Untreated|0|||
44530986|NCT03206216|79540699|FG001|Overall Study|Withdrawal by Subject|1|||
44530987|NCT03169244|79540707|FG000|Overall Study|Lost to Follow-up|1|||
44530988|NCT03169244|79540708|FG001|Overall Study|Lost to Follow-up|2|||
44530989|NCT03169244|79540707|FG000|Overall Study|Adverse Event|1|||
44530990|NCT03169244|79540708|FG001|Overall Study|Adverse Event|0|||
44530991|NCT03169244|79540707|FG000|Overall Study|Withdrawal by Subject|2|||
44530992|NCT03169244|79540708|FG001|Overall Study|Withdrawal by Subject|2|||
44530993|NCT03169244|79540707|FG000|Overall Study|Physician Decision|1|||
44530994|NCT03169244|79540708|FG001|Overall Study|Physician Decision|0|||
44530995|NCT02486042|79540716|FG000|Overall Study|Physician Decision|1|||
44530996|NCT02486042|79540717|FG001|Overall Study|Physician Decision|7|||
44530997|NCT02486042|79540716|FG000|Overall Study|Hospital transfer|2|||
44530998|NCT02486042|79540717|FG001|Overall Study|Hospital transfer|2|||
44530999|NCT02486042|79540716|FG000|Overall Study|Withdrawal by Subject|0|||
44531000|NCT02486042|79540717|FG001|Overall Study|Withdrawal by Subject|2|||
44531001|NCT00057941|79540725|FG000|Overall Study|Death|1|||
44531002|NCT00057941|79540726|FG001|Overall Study|Death|2|||
44531003|NCT00057941|79540725|FG000|Overall Study|Adverse Event|7|||
44531004|NCT00057941|79540726|FG001|Overall Study|Adverse Event|9|||
44531005|NCT00057941|79540725|FG000|Overall Study|Lack of Efficacy|54|||
44531006|NCT00057941|79540726|FG001|Overall Study|Lack of Efficacy|53|||
44531007|NCT00057941|79540725|FG000|Overall Study|Withdrawal by Subject|6|||
44531008|NCT00057941|79540726|FG001|Overall Study|Withdrawal by Subject|1|||
44531009|NCT00057941|79540725|FG000|Overall Study|still on treatment|3|||
44531010|NCT00057941|79540726|FG001|Overall Study|still on treatment|1|||
44531011|NCT00057941|79540725|FG000|Overall Study|insurance, symptomatic deterioration|1|||
44531012|NCT00057941|79540726|FG001|Overall Study|insurance, symptomatic deterioration|3|||
44254755|NCT03734029|79096621|FG001|Overall Study|Lost to Follow-up|1|||
44254756|NCT03734029|79096620|FG000|Overall Study|Randomized, but not treated|2|||
44254757|NCT03734029|79096621|FG001|Overall Study|Randomized, but not treated|12|||
44254758|NCT03724032|79096630|FG000|Overall Study|Physician Decision|1|||
44531013|NCT00057941|79540725|FG000|Overall Study|Ineligible|2|||
44531014|NCT00057941|79540726|FG001|Overall Study|Ineligible|5|||
44531015|NCT00075881|79540741|FG000|Overall Study|Lack of Efficacy|18|||
44531016|NCT00075881|79540741|FG000|Overall Study|Adverse Event|7|||
44531017|NCT00075881|79540741|FG000|Overall Study|Death|1|||
44531018|NCT00075881|79540741|FG000|Overall Study|Withdrawal by Subject|2|||
44531019|NCT00075881|79540741|FG000|Overall Study|Protocol Violation|4|||
44150622|NCT02565615|78940635|FG003|Overall Study|Untreated|0|||
44150623|NCT02565615|78940636|FG004|Overall Study|Untreated|567|||
44150624|NCT02701361|78940651|FG000|Overall Study|Lost to Follow-up|5|||
44150625|NCT02701361|78940652|FG001|Overall Study|Lost to Follow-up|2|||
44150626|NCT02701361|78940653|FG002|Overall Study|Lost to Follow-up|1|||
44150627|NCT02701361|78940651|FG000|Overall Study|Withdrawal by Subject|4|||
44150628|NCT02701361|78940652|FG001|Overall Study|Withdrawal by Subject|0|||
44415065|NCT00806624|79422988|FG002|Overall Study|Adverse Event|0|||
44415066|NCT00806624|79422986|FG000|Overall Study|Death|0|||
44531020|NCT00075881|79540741|FG000|Overall Study|other complicating disease|3|||
44150629|NCT02701361|78940653|FG002|Overall Study|Withdrawal by Subject|0|||
44531021|NCT00075881|79540741|FG000|Overall Study|other|4|||
44531022|NCT00075881|79540741|FG000|Overall Study|missing data|2|||
44531023|NCT00075881|79540741|FG000|Overall Study|Ineligible|1|||
44531024|NCT00075881|79540741|FG000|Overall Study|never start protocol therapy|1|||
44531025|NCT00838630|79540749|FG000|First Intervention|Adverse Event|1|||
44531026|NCT00838630|79540750|FG001|First Intervention|Adverse Event|0|||
44531027|NCT00838630|79540749|FG000|Washout: 7 Days|Protocol Violation|1|||
44531028|NCT00838630|79540750|FG001|Washout: 7 Days|Protocol Violation|0|||
44531029|NCT02996474|79540754|FG000|Overall Study|Physician Decision|5|||
44150630|NCT02701361|78940651|FG000|Overall Study|timed out in rehab center|0|||
44150631|NCT02701361|78940652|FG001|Overall Study|timed out in rehab center|1|||
44531030|NCT03667924|79540761|FG000|Baseline Completed|Lost to Follow-up|0|||
44531031|NCT03667924|79540762|FG001|Baseline Completed|Lost to Follow-up|2|||
44531032|NCT03667924|79540763|FG002|Baseline Completed|Lost to Follow-up|0|||
44531033|NCT03667924|79540761|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
44531034|NCT03667924|79540762|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
44531035|NCT03667924|79540763|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
44531036|NCT03667924|79540761|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
44531037|NCT03667924|79540762|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
44531038|NCT03667924|79540763|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
44531039|NCT03667924|79540761|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
44531040|NCT03667924|79540762|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
44531041|NCT03667924|79540763|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
44531042|NCT03667924|79540761|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
44531043|NCT03667924|79540762|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
44531044|NCT03667924|79540763|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
44531045|NCT03667924|79540761|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
44531046|NCT03667924|79540762|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
44531047|NCT03667924|79540763|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
44531048|NCT03667924|79540761|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
44531049|NCT03667924|79540762|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
44531050|NCT03667924|79540763|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
44531051|NCT03205046|79540775|FG000|Overall Study|Death|10|||
44531052|NCT03205046|79540776|FG001|Overall Study|Death|6|||
44531053|NCT03205046|79540775|FG000|Overall Study|Withdrawal by Subject|1|||
44531054|NCT03205046|79540776|FG001|Overall Study|Withdrawal by Subject|2|||
44531055|NCT03205046|79540775|FG000|Overall Study|Lost to Follow-up|0|||
44531056|NCT03205046|79540776|FG001|Overall Study|Lost to Follow-up|1|||
44531057|NCT03205046|79540775|FG000|Overall Study|Study terminated by sponsor|2|||
44531058|NCT03205046|79540776|FG001|Overall Study|Study terminated by sponsor|1|||
44531059|NCT02339090|79540784|FG000|Overall Study|Adverse Event|1|||
44531060|NCT02339090|79540785|FG001|Overall Study|Adverse Event|0|||
44531061|NCT02339090|79540784|FG000|Overall Study|Lost to Follow-up|0|||
44531062|NCT02339090|79540785|FG001|Overall Study|Lost to Follow-up|1|||
44531063|NCT02339090|79540784|FG000|Overall Study|Non-compliance With Study Drug|0|||
44531064|NCT02339090|79540785|FG001|Overall Study|Non-compliance With Study Drug|1|||
44531065|NCT02339090|79540784|FG000|Overall Study|Withdrawal by Subject|2|||
44531066|NCT02339090|79540785|FG001|Overall Study|Withdrawal by Subject|1|||
44531067|NCT02339090|79540784|FG000|Overall Study|Poor Growth|3|||
44531068|NCT02339090|79540785|FG001|Overall Study|Poor Growth|0|||
44531069|NCT02339090|79540784|FG000|Overall Study|Randomized but not treated|0|||
44531070|NCT02339090|79540785|FG001|Overall Study|Randomized but not treated|2|||
44531071|NCT03331562|79540804|FG000|Overall Study|Adverse Event|2|||
44531072|NCT03331562|79540805|FG001|Overall Study|Adverse Event|0|||
44531073|NCT03331562|79540804|FG000|Overall Study|Death|1|||
44531074|NCT03331562|79540805|FG001|Overall Study|Death|0|||
44531075|NCT02038634|79540817|FG000|Overall Study|Lost to Follow-up|0|||
44531076|NCT02038634|79540818|FG001|Overall Study|Lost to Follow-up|1|||
44531077|NCT00836056|79540826|FG000|First Intervention|Adverse Event|1|||
44531078|NCT00836056|79540827|FG001|First Intervention|Adverse Event|0|||
44531079|NCT03200912|79540834|FG000|Overall Study|Adverse Event|3|||
44531080|NCT03200912|79540835|FG001|Overall Study|Adverse Event|0|||
44531081|NCT03200912|79540836|FG002|Overall Study|Adverse Event|0|||
44531082|NCT03200912|79540834|FG000|Overall Study|Withdrawal by Subject|1|||
44254759|NCT03724032|79096631|FG001|Overall Study|Physician Decision|0|||
44254760|NCT03724032|79096632|FG002|Overall Study|Physician Decision|0|||
44254761|NCT03724032|79096630|FG000|Overall Study|Protocol Violation|2|||
44531083|NCT03200912|79540835|FG001|Overall Study|Withdrawal by Subject|2|||
44254762|NCT03724032|79096631|FG001|Overall Study|Protocol Violation|2|||
44254763|NCT03724032|79096632|FG002|Overall Study|Protocol Violation|1|||
44531084|NCT03200912|79540836|FG002|Overall Study|Withdrawal by Subject|4|||
44531085|NCT03200912|79540834|FG000|Overall Study|Non-compliance with study drug|0|||
44254764|NCT03657797|79096653|FG000|Overall Study|Lost to Follow-up|0|||
44254765|NCT03657797|79096654|FG001|Overall Study|Lost to Follow-up|1|||
44531086|NCT03200912|79540835|FG001|Overall Study|Non-compliance with study drug|1|||
44531087|NCT03200912|79540836|FG002|Overall Study|Non-compliance with study drug|0|||
44531088|NCT00835666|79540846|FG000|Washout|Protocol Violation|1|||
44531089|NCT00835666|79540847|FG001|Washout|Protocol Violation|0|||
44531090|NCT00835666|79540846|FG000|Washout|Withdrawal by Subject|1|||
44531091|NCT00835666|79540847|FG001|Washout|Withdrawal by Subject|0|||
44531092|NCT03200366|79540861|FG000|Patient Navigation Intervention Given|Death|0|||
44531093|NCT03200366|79540862|FG001|Patient Navigation Intervention Given|Death|2|||
44531094|NCT03200366|79540863|FG002|Patient Navigation Intervention Given|Death|0|||
44531095|NCT03200366|79540861|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
44531096|NCT03200366|79540862|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
44531097|NCT03200366|79540863|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
44531098|NCT03200366|79540861|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
44531099|NCT03200366|79540862|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
44531100|NCT03200366|79540863|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
44531101|NCT03200366|79540861|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
44531102|NCT03200366|79540862|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
44531103|NCT03200366|79540863|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
44531104|NCT03200366|79540861|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
44531105|NCT03200366|79540862|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
44531106|NCT03200366|79540863|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
44150632|NCT02701361|78940653|FG002|Overall Study|timed out in rehab center|0|||
44150633|NCT02701361|78940651|FG000|Overall Study|incarceration|0|||
44150634|NCT02701361|78940652|FG001|Overall Study|incarceration|0|||
44150635|NCT02701361|78940653|FG002|Overall Study|incarceration|1|||
44150636|NCT01662999|78940678|FG000|Period 3|Withdrawal by Subject|0|||
44150637|NCT01662999|78940679|FG001|Period 3|Withdrawal by Subject|1|||
44150638|NCT01662999|78940680|FG002|Period 3|Withdrawal by Subject|0|||
44150639|NCT01662999|78940681|FG003|Period 3|Withdrawal by Subject|0|||
44150640|NCT01662999|78940682|FG004|Period 3|Withdrawal by Subject|0|||
44150641|NCT01662999|78940683|FG005|Period 3|Withdrawal by Subject|0|||
44150642|NCT02565381|78940716|FG000|Overall Study|Lost to Follow-up|1|||
44150643|NCT02565381|78940717|FG001|Overall Study|Lost to Follow-up|0|||
44150644|NCT02565381|78940718|FG002|Overall Study|Lost to Follow-up|1|||
44150645|NCT02063854|78940733|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
44150646|NCT02063854|78940734|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
44150647|NCT02063854|78940735|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
44531107|NCT03200366|79540861|FG000|6 Month Post-Baseline Interview|Death|1|||
44531108|NCT03200366|79540862|FG001|6 Month Post-Baseline Interview|Death|1|||
44531109|NCT03200366|79540863|FG002|6 Month Post-Baseline Interview|Death|1|||
44531110|NCT03200366|79540861|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
44531111|NCT03200366|79540862|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
44254766|NCT03657797|79096655|FG002|Overall Study|Lost to Follow-up|1|||
44254767|NCT03657797|79096656|FG003|Overall Study|Lost to Follow-up|0|||
44254768|NCT03657797|79096653|FG000|Overall Study|Physician Decision|0|||
44150648|NCT02063854|78940736|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
44150649|NCT02063854|78940737|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
44150650|NCT02063854|78940738|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
44531112|NCT03200366|79540863|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
44531113|NCT03200366|79540861|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
44531114|NCT03200366|79540862|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
44531115|NCT03200366|79540863|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
44531116|NCT03200366|79540861|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
44531117|NCT03200366|79540862|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
44531118|NCT03200366|79540863|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
44531119|NCT03200366|79540861|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
44254769|NCT03657797|79096654|FG001|Overall Study|Physician Decision|1|||
44254770|NCT03657797|79096655|FG002|Overall Study|Physician Decision|0|||
44254771|NCT03657797|79096656|FG003|Overall Study|Physician Decision|0|||
44254772|NCT03657797|79096653|FG000|Overall Study|Withdrawal by Subject|0|||
44254773|NCT03657797|79096654|FG001|Overall Study|Withdrawal by Subject|1|||
44254774|NCT03657797|79096655|FG002|Overall Study|Withdrawal by Subject|2|||
44254775|NCT03657797|79096656|FG003|Overall Study|Withdrawal by Subject|0|||
44254776|NCT03657797|79096653|FG000|Overall Study|Adverse Event|0|||
44254777|NCT03657797|79096654|FG001|Overall Study|Adverse Event|0|||
44254778|NCT03657797|79096655|FG002|Overall Study|Adverse Event|2|||
44254779|NCT03657797|79096656|FG003|Overall Study|Adverse Event|0|||
44254780|NCT03551938|79096672|FG000|3-Month Follow Up|Lost to Follow-up|39|||
44254781|NCT03551938|79096673|FG001|3-Month Follow Up|Lost to Follow-up|38|||
44254782|NCT03551938|79096672|FG000|6-Month Follow Up|Lost to Follow-up|46|||
44254783|NCT03551938|79096673|FG001|6-Month Follow Up|Lost to Follow-up|42|||
44254784|NCT03551938|79096672|FG000|9-Month Follow Up|Lost to Follow-up|44|||
44254785|NCT03551938|79096673|FG001|9-Month Follow Up|Lost to Follow-up|43|||
44254786|NCT03525600|79096682|FG000|Overall Study|Adverse Event|9|||
44254787|NCT03525600|79096683|FG001|Overall Study|Adverse Event|6|||
44254788|NCT03525600|79096684|FG002|Overall Study|Adverse Event|5|||
44254789|NCT03525600|79096685|FG003|Overall Study|Adverse Event|3|||
44415067|NCT00806624|79422987|FG001|Overall Study|Death|1|||
44254790|NCT03525600|79096682|FG000|Overall Study|Lost to Follow-up|2|||
44254791|NCT03525600|79096683|FG001|Overall Study|Lost to Follow-up|4|||
44254792|NCT03525600|79096684|FG002|Overall Study|Lost to Follow-up|4|||
44254793|NCT03525600|79096685|FG003|Overall Study|Lost to Follow-up|0|||
44254794|NCT03525600|79096682|FG000|Overall Study|Physician Decision|1|||
44254795|NCT03525600|79096683|FG001|Overall Study|Physician Decision|0|||
44254796|NCT03525600|79096684|FG002|Overall Study|Physician Decision|2|||
44254797|NCT03525600|79096685|FG003|Overall Study|Physician Decision|0|||
44415068|NCT00806624|79422988|FG002|Overall Study|Death|1|||
44531120|NCT03200366|79540862|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
44531121|NCT03200366|79540863|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
44531122|NCT03200366|79540861|FG000|9 Month Post-Baseline Interview|Death|1|||
44531123|NCT03200366|79540862|FG001|9 Month Post-Baseline Interview|Death|1|||
44531124|NCT03200366|79540863|FG002|9 Month Post-Baseline Interview|Death|1|||
44531125|NCT03200366|79540861|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
44531126|NCT03200366|79540862|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
44254798|NCT03525600|79096682|FG000|Overall Study|Consent withdrawal|36|||
44150651|NCT02063854|78940739|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
44150652|NCT02063854|78940733|FG000|Overall Study|Major Protocol Deviation|0|||
44150653|NCT02063854|78940734|FG001|Overall Study|Major Protocol Deviation|0|||
44150654|NCT02063854|78940735|FG002|Overall Study|Major Protocol Deviation|3|||
44150655|NCT02063854|78940736|FG003|Overall Study|Major Protocol Deviation|0|||
44150656|NCT02063854|78940737|FG004|Overall Study|Major Protocol Deviation|0|||
44150657|NCT02063854|78940738|FG005|Overall Study|Major Protocol Deviation|0|||
44150658|NCT02063854|78940739|FG006|Overall Study|Major Protocol Deviation|0|||
44150659|NCT02063854|78940733|FG000|Overall Study|Voluntary Withdrawal|2|||
44150660|NCT02063854|78940734|FG001|Overall Study|Voluntary Withdrawal|0|||
44150661|NCT02063854|78940735|FG002|Overall Study|Voluntary Withdrawal|8|||
44150662|NCT02063854|78940736|FG003|Overall Study|Voluntary Withdrawal|1|||
44150663|NCT02063854|78940737|FG004|Overall Study|Voluntary Withdrawal|3|||
44150664|NCT02063854|78940738|FG005|Overall Study|Voluntary Withdrawal|6|||
44150665|NCT02063854|78940739|FG006|Overall Study|Voluntary Withdrawal|1|||
44150666|NCT02063854|78940733|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
44254799|NCT03525600|79096683|FG001|Overall Study|Consent withdrawal|20|||
44254800|NCT03525600|79096684|FG002|Overall Study|Consent withdrawal|6|||
44254801|NCT03525600|79096685|FG003|Overall Study|Consent withdrawal|13|||
44254802|NCT03525600|79096682|FG000|Overall Study|Death|7|||
44254803|NCT03525600|79096683|FG001|Overall Study|Death|6|||
44254804|NCT03525600|79096684|FG002|Overall Study|Death|4|||
44531127|NCT03200366|79540863|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
44150667|NCT02063854|78940734|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
44150668|NCT02063854|78940735|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
44254805|NCT03525600|79096685|FG003|Overall Study|Death|3|||
44254806|NCT03525600|79096682|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
44254807|NCT03525600|79096683|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
44254808|NCT03525600|79096684|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
44254809|NCT03525600|79096685|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
44254810|NCT03525600|79096682|FG000|Overall Study|Other|0|||
44254811|NCT03525600|79096683|FG001|Overall Study|Other|1|||
44254812|NCT03525600|79096684|FG002|Overall Study|Other|0|||
44254813|NCT03525600|79096685|FG003|Overall Study|Other|0|||
44254814|NCT03472040|79096702|FG000|Overall Study|Physician Decision|0|||
44254815|NCT03472040|79096703|FG001|Overall Study|Physician Decision|3|||
44254816|NCT03472040|79096702|FG000|Overall Study|Withdrawal by Subject|10|||
44254817|NCT03472040|79096703|FG001|Overall Study|Withdrawal by Subject|23|||
44254818|NCT03472040|79096702|FG000|Overall Study|Perceived Lack of Efficacy|29|||
44254819|NCT03472040|79096703|FG001|Overall Study|Perceived Lack of Efficacy|30|||
44254820|NCT03472040|79096702|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
44254821|NCT03472040|79096703|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
44254822|NCT03472040|79096702|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
44254823|NCT03472040|79096703|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
44254824|NCT03472040|79096702|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
44254825|NCT03472040|79096703|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
44531128|NCT03200366|79540861|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
44531129|NCT03200366|79540862|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
44531130|NCT03200366|79540863|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
44531131|NCT03200366|79540861|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
44282466|NCT01872078|79245793|FG003|Overall Study|Adverse Event|0|||
44282467|NCT01872078|79245790|FG000|Overall Study|Dose administration non-compliance|0|||
44282468|NCT01872078|79245791|FG001|Overall Study|Dose administration non-compliance|0|||
44282469|NCT01872078|79245792|FG002|Overall Study|Dose administration non-compliance|0|||
44282470|NCT01872078|79245793|FG003|Overall Study|Dose administration non-compliance|1|||
44282471|NCT01872078|79245790|FG000|Overall Study|Protocol Violation|0|||
44282472|NCT01872078|79245791|FG001|Overall Study|Protocol Violation|0|||
44282473|NCT01872078|79245792|FG002|Overall Study|Protocol Violation|1|||
44282474|NCT01872078|79245793|FG003|Overall Study|Protocol Violation|0|||
44282475|NCT01872078|79245790|FG000|Overall Study|Withdrawal by Subject|0|||
44282476|NCT01872078|79245791|FG001|Overall Study|Withdrawal by Subject|0|||
44282477|NCT01872078|79245792|FG002|Overall Study|Withdrawal by Subject|1|||
44282478|NCT01872078|79245793|FG003|Overall Study|Withdrawal by Subject|0|||
44282479|NCT01872078|79245790|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
44282480|NCT01872078|79245791|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
44282481|NCT01872078|79245792|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
44282482|NCT01872078|79245793|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
44282483|NCT01896726|79245803|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
44282484|NCT01896726|79245803|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
44282485|NCT01856790|79245810|FG000|Closed Loop Control|Withdrawal by Subject|2|||
44282486|NCT01856790|79245810|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
44282487|NCT01856322|79245824|FG000|Overall Study|off study due to lack of accrual|0|||
44531132|NCT03200366|79540862|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
44531133|NCT03200366|79540863|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
44531134|NCT00835354|79540875|FG000|First Intervention|Adverse Event|0|||
44531135|NCT00835354|79540876|FG001|First Intervention|Adverse Event|1|||
44531136|NCT00835042|79540907|FG000|First Intervention|Withdrawal by Subject|3|||
44282488|NCT01856322|79245825|FG001|Overall Study|off study due to lack of accrual|0|||
44282489|NCT01856322|79245826|FG002|Overall Study|off study due to lack of accrual|3|||
44254826|NCT03472040|79096702|FG000|Overall Study|Subject Non-compliance|2|||
44282490|NCT01896102|79245833|FG000|Overall Study|Death|1|||
44254827|NCT03472040|79096703|FG001|Overall Study|Subject Non-compliance|5|||
44254828|NCT03472040|79096702|FG000|Overall Study|Discontinuation due to Rash|0|||
44254829|NCT03472040|79096703|FG001|Overall Study|Discontinuation due to Rash|1|||
44531137|NCT00835042|79540908|FG001|First Intervention|Withdrawal by Subject|0|||
44531138|NCT00835042|79540907|FG000|First Intervention|Adverse Event|1|||
44531139|NCT00835042|79540908|FG001|First Intervention|Adverse Event|2|||
44531140|NCT00835042|79540907|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
44531141|NCT00835042|79540908|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
44531142|NCT00834418|79540945|FG000|Overall Study|Adverse Event|0|||
44531143|NCT00834418|79540946|FG001|Overall Study|Adverse Event|2|||
44531144|NCT00834340|79540952|FG000|Washout|Adverse Event|1|||
44531145|NCT00834340|79540953|FG001|Washout|Adverse Event|0|||
44531146|NCT00834340|79540952|FG000|Washout|Withdrawal by Subject|1|||
44531147|NCT00834340|79540953|FG001|Washout|Withdrawal by Subject|0|||
44531148|NCT00151996|79540959|FG000|Overall Study|Adverse Event|3|||
44531149|NCT00151996|79540960|FG001|Overall Study|Adverse Event|2|||
44531150|NCT00151996|79540959|FG000|Overall Study|Withdrawal by Subject|1|||
44531151|NCT00151996|79540960|FG001|Overall Study|Withdrawal by Subject|1|||
44531152|NCT00151996|79540959|FG000|Overall Study|Protocol Violation|1|||
44150669|NCT02063854|78940736|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
44150670|NCT02063854|78940737|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
44150671|NCT02063854|78940738|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
44150672|NCT02063854|78940739|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
44150673|NCT02063854|78940733|FG000|Overall Study|Reason Not Specified|1|||
44150674|NCT02063854|78940734|FG001|Overall Study|Reason Not Specified|0|||
44150675|NCT02063854|78940735|FG002|Overall Study|Reason Not Specified|0|||
44150676|NCT02063854|78940736|FG003|Overall Study|Reason Not Specified|0|||
44150677|NCT02063854|78940737|FG004|Overall Study|Reason Not Specified|0|||
44150678|NCT02063854|78940738|FG005|Overall Study|Reason Not Specified|0|||
44150679|NCT02063854|78940739|FG006|Overall Study|Reason Not Specified|0|||
44150680|NCT02063854|78940733|FG000|Overall Study|Did Not Receive Study Drug|0|||
44150681|NCT02063854|78940734|FG001|Overall Study|Did Not Receive Study Drug|0|||
44150682|NCT02063854|78940735|FG002|Overall Study|Did Not Receive Study Drug|0|||
44150683|NCT02063854|78940736|FG003|Overall Study|Did Not Receive Study Drug|0|||
44150684|NCT02063854|78940737|FG004|Overall Study|Did Not Receive Study Drug|0|||
44150685|NCT02063854|78940738|FG005|Overall Study|Did Not Receive Study Drug|1|||
44150686|NCT02063854|78940739|FG006|Overall Study|Did Not Receive Study Drug|0|||
44150687|NCT02063698|78940759|FG000|Overall Study|did not complete booklet for days 2-8|1|||
44150688|NCT02063698|78940760|FG001|Overall Study|did not complete booklet for days 2-8|2|||
44150689|NCT02062450|78940768|FG000|Overall Study|No follow-up visit|124|||
44150690|NCT02561247|78940776|FG000|Overall Study|Protocol Violation|1|||
44150691|NCT02561247|78940776|FG000|Overall Study|Withdrawal by Subject|1|||
44150692|NCT02561247|78940776|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
44254830|NCT03472040|79096702|FG000|Overall Study|Subsequent Ineligibility|0|||
44254831|NCT03472040|79096703|FG001|Overall Study|Subsequent Ineligibility|2|||
44254832|NCT03472040|79096702|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
44254833|NCT03472040|79096703|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
44254834|NCT03323385|79096721|FG000|Overall Study|Withdrawal by Subject|1|||
44254835|NCT03323385|79096722|FG001|Overall Study|Withdrawal by Subject|2|||
44150693|NCT02061592|78940782|FG000|Period 1|Withdrawal by Subject|1|||
44254836|NCT03323385|79096721|FG000|Overall Study|Noncompliance|0|||
44254837|NCT03323385|79096722|FG001|Overall Study|Noncompliance|1|||
44254838|NCT03161483|79096732|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
44282491|NCT01896102|79245833|FG000|Overall Study|Participant to receive allogenic transplant|2|||
44531153|NCT00151996|79540960|FG001|Overall Study|Protocol Violation|2|||
44531154|NCT00151996|79540959|FG000|Overall Study|Sponsor's decision|0|||
44150694|NCT02061592|78940783|FG001|Period 1|Withdrawal by Subject|0|||
44150695|NCT02061592|78940782|FG000|Period 1|Protocol Violation|1|||
44150696|NCT02061592|78940783|FG001|Period 1|Protocol Violation|0|||
44150697|NCT02061592|78940782|FG000|Period 2|Lost to Follow-up|0|||
44531155|NCT00151996|79540960|FG001|Overall Study|Sponsor's decision|2|||
44150698|NCT02061592|78940783|FG001|Period 2|Lost to Follow-up|1|||
44531156|NCT00830206|79540968|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
44531157|NCT00830206|79540969|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
44531158|NCT00829504|79540975|FG000|First Intervention|Adverse Event|1|||
44531159|NCT00829504|79540976|FG001|First Intervention|Adverse Event|0|||
44531160|NCT00829504|79540975|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
44531161|NCT00829504|79540976|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44531162|NCT00829504|79540975|FG000|Second Intervention|Physician Decision|1|||
44531163|NCT00829504|79540976|FG001|Second Intervention|Physician Decision|0|||
44531164|NCT00829426|79540982|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
44531165|NCT00829426|79540983|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
44531166|NCT00152464|79540989|FG000|Overall Study|Adverse Event|3|||
44531167|NCT00152464|79540990|FG001|Overall Study|Adverse Event|6|||
44531168|NCT00152464|79540989|FG000|Overall Study|Lost to Follow-up|8|||
44531169|NCT00152464|79540990|FG001|Overall Study|Lost to Follow-up|4|||
44531170|NCT00152464|79540989|FG000|Overall Study|Protocol Violation|3|||
44531171|NCT00152464|79540990|FG001|Overall Study|Protocol Violation|1|||
44531172|NCT00152464|79540989|FG000|Overall Study|Withdrawal by Subject|21|||
44531173|NCT00152464|79540990|FG001|Overall Study|Withdrawal by Subject|22|||
44531174|NCT00152464|79540989|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
44531175|NCT00152464|79540990|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
44531176|NCT00152464|79540989|FG000|Overall Study|Eczema deterioration|0|||
44531177|NCT00152464|79540990|FG001|Overall Study|Eczema deterioration|1|||
44531178|NCT00152464|79540989|FG000|Overall Study|Parent decision|1|||
44531179|NCT00152464|79540990|FG001|Overall Study|Parent decision|1|||
44531180|NCT00152464|79540989|FG000|Overall Study|Investigator decision|1|||
44531181|NCT00152464|79540990|FG001|Overall Study|Investigator decision|0|||
44531182|NCT00152464|79540989|FG000|Overall Study|Lack of Efficacy|1|||
44531183|NCT00152464|79540990|FG001|Overall Study|Lack of Efficacy|0|||
44531184|NCT00152464|79540989|FG000|Overall Study|Eczema poorly controlled|1|||
44531185|NCT00152464|79540990|FG001|Overall Study|Eczema poorly controlled|0|||
44531186|NCT00152464|79540989|FG000|Overall Study|Patient relocated|1|||
44531187|NCT00152464|79540990|FG001|Overall Study|Patient relocated|0|||
44531188|NCT00674440|79540996|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
44531189|NCT00674440|79540996|FG000|Overall Study|did not have surgery, so unevaluable|7|||
44531190|NCT00674440|79540996|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
44531191|NCT02742766|79541020|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531192|NCT02742766|79541021|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531193|NCT02742766|79541022|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531194|NCT02742766|79541023|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531195|NCT02742766|79541024|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531196|NCT02742766|79541025|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531197|NCT02742766|79541026|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531198|NCT02742766|79541027|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531199|NCT02742766|79541028|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531200|NCT02742766|79541029|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531201|NCT02742766|79541030|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531202|NCT02742766|79541031|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531203|NCT02742766|79541032|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531204|NCT02742766|79541033|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
44531205|NCT02742766|79541034|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531206|NCT02742766|79541035|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531207|NCT02742766|79541036|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531208|NCT02742766|79541037|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531209|NCT02742766|79541038|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
44531210|NCT02742766|79541020|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531211|NCT02742766|79541021|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531212|NCT02742766|79541022|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531213|NCT02742766|79541023|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531214|NCT02742766|79541024|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
44150699|NCT01663623|78940793|FG000|Overall Study|Adverse Event|3|||
44150700|NCT01663623|78940794|FG001|Overall Study|Adverse Event|7|||
44282492|NCT01871532|79245840|FG000|Overall Study|Withdrawal by Subject|1|||
44282493|NCT01871532|79245841|FG001|Overall Study|Withdrawal by Subject|2|||
44531215|NCT02742766|79541025|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531216|NCT02742766|79541026|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531217|NCT02742766|79541027|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531218|NCT02742766|79541028|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531219|NCT02742766|79541029|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531220|NCT02742766|79541030|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531221|NCT02742766|79541031|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531222|NCT02742766|79541032|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
44531223|NCT02742766|79541033|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
44531224|NCT02742766|79541034|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531225|NCT02742766|79541035|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
44531226|NCT02742766|79541036|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531227|NCT02742766|79541037|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531228|NCT02742766|79541038|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
44531229|NCT01468922|79541116|FG000|Overall Study|Screening failure|0|||
44531230|NCT01468922|79541117|FG001|Overall Study|Screening failure|0|||
44531231|NCT01468922|79541118|FG002|Overall Study|Screening failure|0|||
44531232|NCT01468922|79541119|FG003|Overall Study|Screening failure|0|||
44531233|NCT01468922|79541120|FG004|Overall Study|Screening failure|0|||
44531234|NCT01468922|79541121|FG005|Overall Study|Screening failure|0|||
44531235|NCT01468922|79541122|FG006|Overall Study|Screening failure|0|||
44531236|NCT01468922|79541123|FG007|Overall Study|Screening failure|0|||
44531237|NCT01468922|79541124|FG008|Overall Study|Screening failure|1|||
44531238|NCT01468922|79541116|FG000|Overall Study|Per patient choice|1|||
44531239|NCT01468922|79541117|FG001|Overall Study|Per patient choice|0|||
44531240|NCT01468922|79541118|FG002|Overall Study|Per patient choice|0|||
44531241|NCT01468922|79541119|FG003|Overall Study|Per patient choice|0|||
44531242|NCT01468922|79541120|FG004|Overall Study|Per patient choice|0|||
44531243|NCT01468922|79541121|FG005|Overall Study|Per patient choice|0|||
44531244|NCT01468922|79541122|FG006|Overall Study|Per patient choice|0|||
44531245|NCT01468922|79541123|FG007|Overall Study|Per patient choice|0|||
44531246|NCT01468922|79541124|FG008|Overall Study|Per patient choice|0|||
44531247|NCT01468922|79541116|FG000|Overall Study|Switched to alternative treatment|1|||
44531248|NCT01468922|79541117|FG001|Overall Study|Switched to alternative treatment|0|||
44531249|NCT01468922|79541118|FG002|Overall Study|Switched to alternative treatment|0|||
44150701|NCT01663623|78940793|FG000|Overall Study|Lack of Efficacy|5|||
44150702|NCT01663623|78940794|FG001|Overall Study|Lack of Efficacy|6|||
44150703|NCT01663623|78940793|FG000|Overall Study|Protocol Violation|0|||
44150704|NCT01663623|78940794|FG001|Overall Study|Protocol Violation|1|||
44150705|NCT01663623|78940793|FG000|Overall Study|Other-Study closed/terminated|1|||
44150706|NCT01663623|78940794|FG001|Overall Study|Other-Study closed/terminated|1|||
44150707|NCT01663623|78940793|FG000|Overall Study|Physician Decision|1|||
44150708|NCT01663623|78940794|FG001|Overall Study|Physician Decision|4|||
44150709|NCT01663623|78940793|FG000|Overall Study|Withdrawal by Subject|2|||
44150710|NCT01663623|78940794|FG001|Overall Study|Withdrawal by Subject|1|||
44150711|NCT02042950|78940800|FG000|Overall Study|Progressive Disease|4|||
44150712|NCT02042404|78940804|FG000|Overall Study|Death|1|||
44150713|NCT02042404|78940805|FG001|Overall Study|Death|0|||
44150714|NCT02042404|78940804|FG000|Overall Study|Unrelated Adverse Event|3|||
44254839|NCT03161483|79096733|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
44254840|NCT03161483|79096734|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
44531250|NCT01468922|79541119|FG003|Overall Study|Switched to alternative treatment|0|||
44531251|NCT01468922|79541120|FG004|Overall Study|Switched to alternative treatment|1|||
44531252|NCT01468922|79541121|FG005|Overall Study|Switched to alternative treatment|0|||
44150715|NCT02042404|78940805|FG001|Overall Study|Unrelated Adverse Event|0|||
44150716|NCT02042404|78940804|FG000|Overall Study|Inability to meet time requirements|1|||
44531253|NCT01468922|79541122|FG006|Overall Study|Switched to alternative treatment|0|||
44150717|NCT02042404|78940805|FG001|Overall Study|Inability to meet time requirements|0|||
44150718|NCT02042014|78940812|FG000|Overall Study|Adverse Event|1|||
44150719|NCT02042014|78940812|FG000|Overall Study|Physician Decision|7|||
44150720|NCT02041702|78940818|FG000|Overall Study|Lost to Follow-up|1|||
44531254|NCT01468922|79541123|FG007|Overall Study|Switched to alternative treatment|0|||
44531255|NCT01468922|79541124|FG008|Overall Study|Switched to alternative treatment|0|||
44531256|NCT01468922|79541116|FG000|Overall Study|Enrolled on new protocol|0|||
44531257|NCT01468922|79541117|FG001|Overall Study|Enrolled on new protocol|0|||
44531258|NCT01468922|79541118|FG002|Overall Study|Enrolled on new protocol|0|||
44150721|NCT02041702|78940819|FG001|Overall Study|Lost to Follow-up|6|||
44150722|NCT02041702|78940818|FG000|Overall Study|Death|4|||
44150723|NCT02041702|78940819|FG001|Overall Study|Death|0|||
44150724|NCT02041702|78940818|FG000|Overall Study|Withdrawal by Subject|4|||
44150725|NCT02041702|78940819|FG001|Overall Study|Withdrawal by Subject|3|||
44150726|NCT02041702|78940818|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
44150727|NCT02041702|78940819|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
44150728|NCT02041702|78940818|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
44150729|NCT02041702|78940819|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
44150730|NCT02565147|78940827|FG000|Overall Study|Withdrawal by Subject|5|||
44150731|NCT02565147|78940828|FG001|Overall Study|Withdrawal by Subject|1|||
44150732|NCT02565147|78940827|FG000|Overall Study|Lost to Follow-up|0|||
44150733|NCT02565147|78940828|FG001|Overall Study|Lost to Follow-up|1|||
44150734|NCT02565147|78940827|FG000|Overall Study|Death|1|||
44150735|NCT02565147|78940828|FG001|Overall Study|Death|1|||
44150736|NCT02061280|78940836|FG000|Overall Study|Protocol Violation|12|||
44150737|NCT02061280|78940837|FG001|Overall Study|Protocol Violation|8|||
44150738|NCT02061280|78940836|FG000|Overall Study|moved out of state|0|||
44254841|NCT03161483|79096735|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
44254842|NCT03161483|79096732|FG000|Treatment Period|Death|1|||
44254843|NCT03161483|79096733|FG001|Treatment Period|Death|0|||
44254844|NCT03161483|79096734|FG002|Treatment Period|Death|0|||
44254845|NCT03161483|79096735|FG003|Treatment Period|Death|0|||
44254846|NCT03161483|79096732|FG000|Treatment Period|Adverse Event|5|||
44254847|NCT03161483|79096733|FG001|Treatment Period|Adverse Event|2|||
44254848|NCT03161483|79096734|FG002|Treatment Period|Adverse Event|1|||
44254849|NCT03161483|79096735|FG003|Treatment Period|Adverse Event|11|||
44254850|NCT03161483|79096732|FG000|Treatment Period|Pregnancy|1|||
44254851|NCT03161483|79096733|FG001|Treatment Period|Pregnancy|0|||
44254852|NCT03161483|79096734|FG002|Treatment Period|Pregnancy|0|||
44254853|NCT03161483|79096735|FG003|Treatment Period|Pregnancy|0|||
44254854|NCT03161483|79096732|FG000|Treatment Period|Lack of Efficacy|0|||
44254855|NCT03161483|79096733|FG001|Treatment Period|Lack of Efficacy|0|||
44254856|NCT03161483|79096734|FG002|Treatment Period|Lack of Efficacy|0|||
44254857|NCT03161483|79096735|FG003|Treatment Period|Lack of Efficacy|1|||
44254858|NCT03161483|79096732|FG000|Treatment Period|Withdrawal by Subject|2|||
44254859|NCT03161483|79096733|FG001|Treatment Period|Withdrawal by Subject|5|||
44254860|NCT03161483|79096734|FG002|Treatment Period|Withdrawal by Subject|2|||
44254861|NCT03161483|79096735|FG003|Treatment Period|Withdrawal by Subject|6|||
44254862|NCT03161483|79096732|FG000|Treatment Period|Lost to Follow-up|0|||
44254863|NCT03161483|79096733|FG001|Treatment Period|Lost to Follow-up|0|||
44254864|NCT03161483|79096734|FG002|Treatment Period|Lost to Follow-up|0|||
44254865|NCT03161483|79096735|FG003|Treatment Period|Lost to Follow-up|1|||
44531259|NCT01468922|79541119|FG003|Overall Study|Enrolled on new protocol|0|||
44531260|NCT01468922|79541120|FG004|Overall Study|Enrolled on new protocol|1|||
44531261|NCT01468922|79541121|FG005|Overall Study|Enrolled on new protocol|0|||
44531262|NCT01468922|79541122|FG006|Overall Study|Enrolled on new protocol|0|||
44531263|NCT01468922|79541123|FG007|Overall Study|Enrolled on new protocol|0|||
44531264|NCT01468922|79541124|FG008|Overall Study|Enrolled on new protocol|0|||
44531265|NCT01468922|79541116|FG000|Overall Study|Adverse Event|0|||
44531266|NCT01468922|79541117|FG001|Overall Study|Adverse Event|0|||
44531267|NCT01468922|79541118|FG002|Overall Study|Adverse Event|0|||
44254866|NCT03161483|79096732|FG000|Treatment Period|Protocol Violation|0|||
44254867|NCT03161483|79096733|FG001|Treatment Period|Protocol Violation|0|||
44531268|NCT01468922|79541119|FG003|Overall Study|Adverse Event|0|||
44531269|NCT01468922|79541120|FG004|Overall Study|Adverse Event|0|||
44150739|NCT02061280|78940837|FG001|Overall Study|moved out of state|1|||
44150740|NCT02061280|78940836|FG000|Overall Study|Withdrawal by Subject|1|||
44150741|NCT02061280|78940837|FG001|Overall Study|Withdrawal by Subject|2|||
44150742|NCT02061280|78940836|FG000|Overall Study|Lost to Follow-up|5|||
44254868|NCT03161483|79096734|FG002|Treatment Period|Protocol Violation|0|||
44531270|NCT01468922|79541121|FG005|Overall Study|Adverse Event|0|||
44415069|NCT00806624|79422986|FG000|Overall Study|Lost to Follow-up|1|||
44415070|NCT00806624|79422987|FG001|Overall Study|Lost to Follow-up|0|||
44531271|NCT01468922|79541122|FG006|Overall Study|Adverse Event|0|||
44531272|NCT01468922|79541123|FG007|Overall Study|Adverse Event|1|||
44531273|NCT01468922|79541124|FG008|Overall Study|Adverse Event|0|||
44531274|NCT01468922|79541116|FG000|Overall Study|Infection of blood|0|||
44531275|NCT01468922|79541117|FG001|Overall Study|Infection of blood|0|||
44531276|NCT01468922|79541118|FG002|Overall Study|Infection of blood|0|||
44531277|NCT01468922|79541119|FG003|Overall Study|Infection of blood|0|||
44531278|NCT01468922|79541120|FG004|Overall Study|Infection of blood|0|||
44531279|NCT01468922|79541121|FG005|Overall Study|Infection of blood|0|||
44531280|NCT01468922|79541122|FG006|Overall Study|Infection of blood|0|||
44531281|NCT01468922|79541123|FG007|Overall Study|Infection of blood|1|||
44531282|NCT01468922|79541124|FG008|Overall Study|Infection of blood|0|||
44150743|NCT02061280|78940837|FG001|Overall Study|Lost to Follow-up|1|||
44150744|NCT02061202|78940848|FG000|Overall Study|Lost to Follow-up|1|||
44150745|NCT02061202|78940849|FG001|Overall Study|Lost to Follow-up|1|||
44150746|NCT02059408|78940858|FG000|Overall Study|Did not get tested|0|||
44150747|NCT02059408|78940859|FG001|Overall Study|Did not get tested|330|||
44150748|NCT02059408|78940860|FG002|Overall Study|Did not get tested|358|||
44150749|NCT01625338|78940873|FG000|Overall Study|Enrolled but not Treated|0|||
44150750|NCT01625338|78940874|FG001|Overall Study|Enrolled but not Treated|0|||
44150751|NCT01625338|78940875|FG002|Overall Study|Enrolled but not Treated|1|||
44150752|NCT01625338|78940873|FG000|Overall Study|Efficacy Failure|27|||
44150753|NCT01625338|78940874|FG001|Overall Study|Efficacy Failure|39|||
44150754|NCT01625338|78940875|FG002|Overall Study|Efficacy Failure|31|||
44415071|NCT00806624|79422988|FG002|Overall Study|Lost to Follow-up|1|||
44415072|NCT00806624|79422986|FG000|Overall Study|Withdrawal by Subject|6|||
44150755|NCT01625338|78940873|FG000|Overall Study|Lost to Follow-up|3|||
44150756|NCT01625338|78940874|FG001|Overall Study|Lost to Follow-up|3|||
44150757|NCT01625338|78940875|FG002|Overall Study|Lost to Follow-up|2|||
44150758|NCT01625338|78940873|FG000|Overall Study|Investigator Decision|0|||
44531283|NCT01468922|79541116|FG000|Overall Study|Patient choice - surgery|0|||
44531284|NCT01468922|79541117|FG001|Overall Study|Patient choice - surgery|0|||
44531285|NCT01468922|79541118|FG002|Overall Study|Patient choice - surgery|0|||
44531286|NCT01468922|79541119|FG003|Overall Study|Patient choice - surgery|0|||
44531287|NCT01468922|79541120|FG004|Overall Study|Patient choice - surgery|0|||
44531288|NCT01468922|79541121|FG005|Overall Study|Patient choice - surgery|0|||
44531289|NCT01468922|79541122|FG006|Overall Study|Patient choice - surgery|0|||
44531290|NCT01468922|79541123|FG007|Overall Study|Patient choice - surgery|1|||
44531291|NCT01468922|79541124|FG008|Overall Study|Patient choice - surgery|0|||
44531292|NCT01468922|79541116|FG000|Overall Study|Refused further treatment|0|||
44531293|NCT01468922|79541117|FG001|Overall Study|Refused further treatment|0|||
44531294|NCT01468922|79541118|FG002|Overall Study|Refused further treatment|0|||
44531295|NCT01468922|79541119|FG003|Overall Study|Refused further treatment|0|||
44531296|NCT01468922|79541120|FG004|Overall Study|Refused further treatment|0|||
44531297|NCT01468922|79541121|FG005|Overall Study|Refused further treatment|0|||
44531298|NCT01468922|79541122|FG006|Overall Study|Refused further treatment|0|||
44531299|NCT01468922|79541123|FG007|Overall Study|Refused further treatment|1|||
44531300|NCT01468922|79541124|FG008|Overall Study|Refused further treatment|0|||
44531301|NCT01381094|79541147|FG000|Overall Study|Adverse Event|1|||
44531302|NCT01381094|79541148|FG001|Overall Study|Adverse Event|2|||
44531303|NCT01381094|79541149|FG002|Overall Study|Adverse Event|0|||
44531304|NCT01381094|79541150|FG003|Overall Study|Adverse Event|1|||
44531305|NCT01381094|79541151|FG004|Overall Study|Adverse Event|0|||
44531306|NCT01381094|79541147|FG000|Overall Study|Lost to Follow-up|0|||
44531307|NCT01381094|79541148|FG001|Overall Study|Lost to Follow-up|0|||
44254869|NCT03161483|79096735|FG003|Treatment Period|Protocol Violation|1|||
44254870|NCT03161483|79096732|FG000|Treatment Period|Other reasons|1|||
44254871|NCT03161483|79096733|FG001|Treatment Period|Other reasons|1|||
44254872|NCT03161483|79096734|FG002|Treatment Period|Other reasons|0|||
44254873|NCT03161483|79096735|FG003|Treatment Period|Other reasons|0|||
44254874|NCT03132636|79096749|FG000|Overall Study|Adverse Event|1|||
44254875|NCT03132636|79096750|FG001|Overall Study|Adverse Event|2|||
44254876|NCT03132636|79096749|FG000|Overall Study|Death|4|||
44254877|NCT03132636|79096750|FG001|Overall Study|Death|7|||
44254878|NCT03132636|79096749|FG000|Overall Study|Lost to Follow-up|2|||
44254879|NCT03132636|79096750|FG001|Overall Study|Lost to Follow-up|2|||
44254880|NCT03132636|79096749|FG000|Overall Study|Protocol Violation|1|||
44254881|NCT03132636|79096750|FG001|Overall Study|Protocol Violation|1|||
44254882|NCT03132636|79096749|FG000|Overall Study|Participant Decision|1|||
44254883|NCT03132636|79096750|FG001|Overall Study|Participant Decision|9|||
44254884|NCT03132636|79096749|FG000|Overall Study|Sponsor Decision|0|||
44254885|NCT03132636|79096750|FG001|Overall Study|Sponsor Decision|1|||
44531308|NCT01381094|79541149|FG002|Overall Study|Lost to Follow-up|0|||
44531309|NCT01381094|79541150|FG003|Overall Study|Lost to Follow-up|0|||
44254886|NCT03132636|79096749|FG000|Overall Study|Progressive disease|32|||
44254887|NCT03132636|79096750|FG001|Overall Study|Progressive disease|36|||
44254888|NCT03132636|79096749|FG000|Overall Study|Withdrawal of consent|2|||
44282494|NCT01855074|79245847|FG000|Overall Study|Adverse Event|1|||
44254889|NCT03132636|79096750|FG001|Overall Study|Withdrawal of consent|5|||
44254890|NCT03132636|79096749|FG000|Overall Study|Study ongoing|9|||
44282495|NCT01855074|79245847|FG000|Overall Study|Lost to Follow-up|4|||
44531310|NCT01381094|79541151|FG004|Overall Study|Lost to Follow-up|1|||
44531311|NCT01381094|79541147|FG000|Overall Study|Withdrawal of informed consent|0|||
44531312|NCT01381094|79541148|FG001|Overall Study|Withdrawal of informed consent|1|||
44531313|NCT01381094|79541149|FG002|Overall Study|Withdrawal of informed consent|0|||
44531314|NCT01381094|79541150|FG003|Overall Study|Withdrawal of informed consent|0|||
44531315|NCT01381094|79541151|FG004|Overall Study|Withdrawal of informed consent|0|||
44415073|NCT00806624|79422987|FG001|Overall Study|Withdrawal by Subject|3|||
44531316|NCT01381094|79541147|FG000|Overall Study|Participant given Aranesp injection|1|||
44150759|NCT01625338|78940874|FG001|Overall Study|Investigator Decision|2|||
44150760|NCT01625338|78940875|FG002|Overall Study|Investigator Decision|1|||
44150761|NCT01625338|78940873|FG000|Overall Study|Subject Withdrew Consent|1|||
44150762|NCT01625338|78940874|FG001|Overall Study|Subject Withdrew Consent|0|||
44150763|NCT01625338|78940875|FG002|Overall Study|Subject Withdrew Consent|2|||
44150764|NCT01625338|78940873|FG000|Overall Study|Adverse Event|1|||
44150765|NCT01625338|78940874|FG001|Overall Study|Adverse Event|0|||
44150766|NCT01625338|78940875|FG002|Overall Study|Adverse Event|1|||
44150767|NCT01625338|78940873|FG000|Overall Study|Study Discontinued by Sponsor|0|||
44150768|NCT01625338|78940874|FG001|Overall Study|Study Discontinued by Sponsor|0|||
44150769|NCT01625338|78940875|FG002|Overall Study|Study Discontinued by Sponsor|1|||
44150770|NCT02560623|78940887|FG000|Overall Study|Unable to swallow sponge|0|||
44150771|NCT02560623|78940888|FG001|Overall Study|Unable to swallow sponge|1|||
44150772|NCT02560623|78940889|FG002|Overall Study|Unable to swallow sponge|0|||
44150773|NCT02560623|78940890|FG003|Overall Study|Unable to swallow sponge|0|||
44150774|NCT02560623|78940887|FG000|Overall Study|Intervention prior to sponge administration|0|||
44150775|NCT02560623|78940888|FG001|Overall Study|Intervention prior to sponge administration|1|||
44150776|NCT02560623|78940889|FG002|Overall Study|Intervention prior to sponge administration|0|||
44150777|NCT02560623|78940890|FG003|Overall Study|Intervention prior to sponge administration|0|||
44150778|NCT02560389|78940903|FG000|Overall Study|Lost to Follow-up|1|||
44150779|NCT02560389|78940904|FG001|Overall Study|Lost to Follow-up|2|||
44150780|NCT02560389|78940905|FG002|Overall Study|Lost to Follow-up|2|||
44150781|NCT02560389|78940903|FG000|Overall Study|Tested positive for illicit substance|0|||
44150782|NCT02560389|78940904|FG001|Overall Study|Tested positive for illicit substance|1|||
44150783|NCT02560389|78940905|FG002|Overall Study|Tested positive for illicit substance|0|||
44150784|NCT02564211|78940913|FG000|Overall Study|Adverse Event|4|||
44150785|NCT02093026|78940917|FG000|Overall Study|Adverse Event|26|||
44150786|NCT02093026|78940917|FG000|Overall Study|Death|10|||
44150787|NCT02093026|78940917|FG000|Overall Study|Other|157|||
44150788|NCT02040844|78940925|FG000|Overall Study|Adverse Event|0|||
44150789|NCT02040844|78940926|FG001|Overall Study|Adverse Event|0|||
44150790|NCT02040844|78940927|FG002|Overall Study|Adverse Event|1|||
44150791|NCT02040844|78940925|FG000|Overall Study|Withdrawal by Subject|16|||
44150792|NCT02040844|78940926|FG001|Overall Study|Withdrawal by Subject|22|||
44150793|NCT02040844|78940927|FG002|Overall Study|Withdrawal by Subject|25|||
44150794|NCT02040844|78940925|FG000|Overall Study|Lost to Follow-up|12|||
44150795|NCT02040844|78940926|FG001|Overall Study|Lost to Follow-up|9|||
44150796|NCT02040844|78940927|FG002|Overall Study|Lost to Follow-up|13|||
44150797|NCT02040844|78940925|FG000|Overall Study|Missing|13|||
44150798|NCT02040844|78940926|FG001|Overall Study|Missing|3|||
44150799|NCT02040844|78940927|FG002|Overall Study|Missing|2|||
44150800|NCT02040844|78940925|FG000|Overall Study|Non-specified|8|||
44150801|NCT02040844|78940926|FG001|Overall Study|Non-specified|2|||
44150802|NCT02040844|78940927|FG002|Overall Study|Non-specified|5|||
44150803|NCT02040844|78940925|FG000|Overall Study|Concomitant medication|1|||
44150804|NCT02040844|78940926|FG001|Overall Study|Concomitant medication|3|||
44150805|NCT02040844|78940927|FG002|Overall Study|Concomitant medication|1|||
44254891|NCT03132636|79096750|FG001|Overall Study|Study ongoing|10|||
44254892|NCT03132636|79096749|FG000|Overall Study|Other|1|||
44254893|NCT03132636|79096750|FG001|Overall Study|Other|2|||
44254894|NCT02906202|79096756|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
44254895|NCT02869789|79096764|FG000|Overall Study|Disease progression|184|||
44254896|NCT02869789|79096765|FG001|Overall Study|Disease progression|109|||
44150806|NCT02059174|78940935|FG000|Period 1|Withdrawal by Subject|0|||
44150807|NCT02059174|78940936|FG001|Period 1|Withdrawal by Subject|2|||
44254897|NCT02869789|79096766|FG002|Overall Study|Disease progression|260|||
44531317|NCT01381094|79541148|FG001|Overall Study|Participant given Aranesp injection|0|||
44150808|NCT02059174|78940935|FG000|Period 2|Withdrawal by Subject|0|||
44150809|NCT02059174|78940936|FG001|Period 2|Withdrawal by Subject|2|||
44150810|NCT02059174|78940935|FG000|Period 2|Protocol Violation|1|||
44150811|NCT02059174|78940936|FG001|Period 2|Protocol Violation|0|||
44150812|NCT02059174|78940935|FG000|Period 3|Physician Decision|1|||
44150813|NCT02059174|78940936|FG001|Period 3|Physician Decision|0|||
44150814|NCT02092324|78940944|FG000|Overall Study|Adverse Event|1|||
44150815|NCT02092324|78940944|FG000|Overall Study|Lack of Efficacy|6|||
44150816|NCT02092324|78940944|FG000|Overall Study|Proceed to Transplant|3|||
44150817|NCT02092324|78940944|FG000|Overall Study|Physician Decision|7|||
44254898|NCT02869789|79096767|FG003|Overall Study|Disease progression|19|||
44150818|NCT02092324|78940944|FG000|Overall Study|Misdiagnosis|2|||
44150819|NCT02040766|78940956|FG000|Overall Study|Adverse Event|1|||
44150820|NCT02040766|78940957|FG001|Overall Study|Adverse Event|1|||
44150821|NCT02040766|78940958|FG002|Overall Study|Adverse Event|1|||
44254899|NCT02869789|79096764|FG000|Overall Study|Study drug toxicity|90|||
44254900|NCT02869789|79096765|FG001|Overall Study|Study drug toxicity|32|||
44254901|NCT02869789|79096766|FG002|Overall Study|Study drug toxicity|55|||
44254902|NCT02869789|79096767|FG003|Overall Study|Study drug toxicity|14|||
44254903|NCT02869789|79096764|FG000|Overall Study|Death|7|||
44254904|NCT02869789|79096765|FG001|Overall Study|Death|3|||
44254905|NCT02869789|79096766|FG002|Overall Study|Death|5|||
44254906|NCT02869789|79096767|FG003|Overall Study|Death|1|||
44254907|NCT02869789|79096764|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
44254908|NCT02869789|79096765|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
44254909|NCT02869789|79096766|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
44254910|NCT02869789|79096767|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
44254911|NCT02869789|79096764|FG000|Overall Study|Participant request to discontinue study treatment|10|||
44254912|NCT02869789|79096765|FG001|Overall Study|Participant request to discontinue study treatment|5|||
44254913|NCT02869789|79096766|FG002|Overall Study|Participant request to discontinue study treatment|5|||
44254914|NCT02869789|79096767|FG003|Overall Study|Participant request to discontinue study treatment|3|||
44254915|NCT02869789|79096764|FG000|Overall Study|Withdrawal by Subject|5|||
44254916|NCT02869789|79096765|FG001|Overall Study|Withdrawal by Subject|2|||
44254917|NCT02869789|79096766|FG002|Overall Study|Withdrawal by Subject|7|||
44254918|NCT02869789|79096767|FG003|Overall Study|Withdrawal by Subject|2|||
44254919|NCT02869789|79096764|FG000|Overall Study|Lost to Follow-up|0|||
44254920|NCT02869789|79096765|FG001|Overall Study|Lost to Follow-up|0|||
44254921|NCT02869789|79096766|FG002|Overall Study|Lost to Follow-up|2|||
44254922|NCT02869789|79096767|FG003|Overall Study|Lost to Follow-up|0|||
44254923|NCT02869789|79096764|FG000|Overall Study|Maximum clinical benefit|5|||
44254924|NCT02869789|79096765|FG001|Overall Study|Maximum clinical benefit|2|||
44254925|NCT02869789|79096766|FG002|Overall Study|Maximum clinical benefit|1|||
44254926|NCT02869789|79096767|FG003|Overall Study|Maximum clinical benefit|0|||
44254927|NCT02869789|79096764|FG000|Overall Study|Poor/Non-compliance|0|||
44254928|NCT02869789|79096765|FG001|Overall Study|Poor/Non-compliance|2|||
44254929|NCT02869789|79096766|FG002|Overall Study|Poor/Non-compliance|1|||
44254930|NCT02869789|79096767|FG003|Overall Study|Poor/Non-compliance|0|||
44254931|NCT02869789|79096764|FG000|Overall Study|Participant no longer meets study criteria|0|||
44254932|NCT02869789|79096765|FG001|Overall Study|Participant no longer meets study criteria|1|||
44254933|NCT02869789|79096766|FG002|Overall Study|Participant no longer meets study criteria|1|||
44254934|NCT02869789|79096767|FG003|Overall Study|Participant no longer meets study criteria|0|||
44254935|NCT02869789|79096764|FG000|Overall Study|Administrative reason by sponsor|0|||
44254936|NCT02869789|79096765|FG001|Overall Study|Administrative reason by sponsor|0|||
44254937|NCT02869789|79096766|FG002|Overall Study|Administrative reason by sponsor|1|||
44254938|NCT02869789|79096767|FG003|Overall Study|Administrative reason by sponsor|0|||
44254939|NCT02869789|79096764|FG000|Overall Study|Other reasons|4|||
44254940|NCT02869789|79096765|FG001|Overall Study|Other reasons|8|||
44254941|NCT02869789|79096766|FG002|Overall Study|Other reasons|6|||
44254942|NCT02869789|79096767|FG003|Overall Study|Other reasons|0|||
44254943|NCT02760485|79096788|FG000|Phase 1|Death|3|||
44254944|NCT02760485|79096789|FG001|Phase 1|Death|6|||
44254945|NCT02760485|79096790|FG002|Phase 1|Death|0|||
44254946|NCT02760485|79096788|FG000|Phase 1|Withdrawal by Subject|2|||
44254947|NCT02760485|79096789|FG001|Phase 1|Withdrawal by Subject|0|||
44254948|NCT02760485|79096790|FG002|Phase 1|Withdrawal by Subject|0|||
44254949|NCT02760485|79096788|FG000|Phase 1|Progressive Disease|1|||
44254950|NCT02760485|79096789|FG001|Phase 1|Progressive Disease|0|||
44254951|NCT02760485|79096790|FG002|Phase 1|Progressive Disease|0|||
44150822|NCT02040766|78940959|FG003|Overall Study|Adverse Event|0|||
44282496|NCT01855074|79245847|FG000|Overall Study|Withdrawal by Subject|8|||
44282497|NCT01855074|79245847|FG000|Overall Study|Started but not treated|1|||
44282498|NCT01871142|79245851|FG000|Overall Study|Adverse Event|1|||
44282499|NCT01895322|79245865|FG000|Overall Study|Adverse Event|1|||
44282500|NCT01895322|79245865|FG000|Overall Study|Withdrawal by Subject|2|||
44282501|NCT01895322|79245865|FG000|Overall Study|Protocol Violation|10|||
44282502|NCT01894776|79245870|FG000|Overall Study|Withdrawal by Subject|1|||
44531318|NCT01381094|79541149|FG002|Overall Study|Participant given Aranesp injection|0|||
44531319|NCT01381094|79541150|FG003|Overall Study|Participant given Aranesp injection|0|||
44531320|NCT01381094|79541151|FG004|Overall Study|Participant given Aranesp injection|0|||
44531321|NCT03197558|79541163|FG000|Overall Study|Tubes not placed|1|||
44531322|NCT03197324|79541169|FG000|Overall Study|Adverse Event|0|||
44531323|NCT03197324|79541170|FG001|Overall Study|Adverse Event|1|||
44531324|NCT03162614|79541182|FG000|Overall Study|Lost to Follow-up|2|||
44531325|NCT03162614|79541183|FG001|Overall Study|Lost to Follow-up|1|||
44531326|NCT03162614|79541184|FG002|Overall Study|Lost to Follow-up|1|||
44531327|NCT03162614|79541185|FG003|Overall Study|Lost to Follow-up|1|||
44150823|NCT02040766|78940960|FG004|Overall Study|Adverse Event|2|||
44150824|NCT02040766|78940956|FG000|Overall Study|Withdrawal by Subject|4|||
44150825|NCT02040766|78940957|FG001|Overall Study|Withdrawal by Subject|3|||
44150826|NCT02040766|78940958|FG002|Overall Study|Withdrawal by Subject|2|||
44150827|NCT02040766|78940959|FG003|Overall Study|Withdrawal by Subject|3|||
44150828|NCT02040766|78940960|FG004|Overall Study|Withdrawal by Subject|2|||
44150829|NCT02040766|78940956|FG000|Overall Study|Non-compliance|0|||
44150830|NCT02040766|78940957|FG001|Overall Study|Non-compliance|1|||
44150831|NCT02040766|78940958|FG002|Overall Study|Non-compliance|0|||
44150832|NCT02040766|78940959|FG003|Overall Study|Non-compliance|0|||
44150833|NCT02040766|78940960|FG004|Overall Study|Non-compliance|0|||
44150834|NCT02040766|78940956|FG000|Overall Study|Protocol Violation|2|||
44150835|NCT02040766|78940957|FG001|Overall Study|Protocol Violation|1|||
44150836|NCT02040766|78940958|FG002|Overall Study|Protocol Violation|2|||
44150837|NCT02040766|78940959|FG003|Overall Study|Protocol Violation|3|||
44150838|NCT02040766|78940960|FG004|Overall Study|Protocol Violation|0|||
44150839|NCT02040766|78940956|FG000|Overall Study|Lost to Follow-up|4|||
44150840|NCT02040766|78940957|FG001|Overall Study|Lost to Follow-up|1|||
44150841|NCT02040766|78940958|FG002|Overall Study|Lost to Follow-up|3|||
44150842|NCT02040766|78940959|FG003|Overall Study|Lost to Follow-up|1|||
44150843|NCT02040766|78940960|FG004|Overall Study|Lost to Follow-up|4|||
44150844|NCT02040766|78940956|FG000|Overall Study|Not reported|1|||
44150845|NCT02040766|78940957|FG001|Overall Study|Not reported|0|||
44150846|NCT02040766|78940958|FG002|Overall Study|Not reported|0|||
44150847|NCT02040766|78940959|FG003|Overall Study|Not reported|0|||
44150848|NCT02040766|78940960|FG004|Overall Study|Not reported|0|||
44150849|NCT02040766|78940956|FG000|Overall Study|Lack of Efficacy|6|||
44150850|NCT02040766|78940957|FG001|Overall Study|Lack of Efficacy|3|||
44254952|NCT02760485|79096788|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
44254953|NCT02760485|79096789|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
44254954|NCT02760485|79096790|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
44254955|NCT02760485|79096788|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
44254956|NCT02760485|79096789|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
44254957|NCT02760485|79096790|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
44254958|NCT02760485|79096788|FG000|Phase 2|Death|0|||
44254959|NCT02760485|79096789|FG001|Phase 2|Death|0|||
44254960|NCT02760485|79096790|FG002|Phase 2|Death|12|||
44254961|NCT02760485|79096788|FG000|Phase 2|Withdrawal by Subject|0|||
44254962|NCT02760485|79096789|FG001|Phase 2|Withdrawal by Subject|0|||
44254963|NCT02760485|79096790|FG002|Phase 2|Withdrawal by Subject|3|||
44254964|NCT02760485|79096788|FG000|Phase 2|Progressive Disease|0|||
44282503|NCT01894620|79245876|FG000|Overall Study|Withdrawal by Subject|0|||
44531328|NCT03162614|79541186|FG004|Overall Study|Lost to Follow-up|2|||
44531329|NCT03162614|79541187|FG005|Overall Study|Lost to Follow-up|0|||
44531330|NCT03162614|79541182|FG000|Overall Study|Protocol Violation|0|||
44531331|NCT03162614|79541183|FG001|Overall Study|Protocol Violation|1|||
44282504|NCT01894620|79245877|FG001|Overall Study|Withdrawal by Subject|1|||
44531332|NCT03162614|79541184|FG002|Overall Study|Protocol Violation|0|||
44531333|NCT03162614|79541185|FG003|Overall Study|Protocol Violation|1|||
44282505|NCT01854918|79245887|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
44531334|NCT03162614|79541186|FG004|Overall Study|Protocol Violation|0|||
44150851|NCT02040766|78940958|FG002|Overall Study|Lack of Efficacy|4|||
44150852|NCT02040766|78940959|FG003|Overall Study|Lack of Efficacy|6|||
44150853|NCT02040766|78940960|FG004|Overall Study|Lack of Efficacy|5|||
44150854|NCT02040532|78940973|FG000|Overall Study|Lost to Follow-up|1|||
44150855|NCT02040532|78940973|FG000|Overall Study|Physician Decision|4|||
44150856|NCT02040532|78940973|FG000|Overall Study|Adverse Event|4|||
44150857|NCT02040532|78940973|FG000|Overall Study|Withdrawal by Subject|3|||
44150858|NCT02039908|78940977|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
44150859|NCT02039908|78940978|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
44254965|NCT02760485|79096789|FG001|Phase 2|Progressive Disease|0|||
44150860|NCT02039908|78940979|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
44150861|NCT02039908|78940980|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
44150862|NCT02039908|78940977|FG000|Phase 1-Summer|Protocol Violation|6|||
44150863|NCT02039908|78940978|FG001|Phase 1-Summer|Protocol Violation|0|||
44150864|NCT02039908|78940979|FG002|Phase 1-Summer|Protocol Violation|0|||
44150865|NCT02039908|78940980|FG003|Phase 1-Summer|Protocol Violation|0|||
44150866|NCT02039908|78940977|FG000|Phase 2-School Year|Lost to Follow-up|0|||
44150867|NCT02039908|78940978|FG001|Phase 2-School Year|Lost to Follow-up|0|||
44150868|NCT02039908|78940979|FG002|Phase 2-School Year|Lost to Follow-up|1|||
44150869|NCT02039908|78940980|FG003|Phase 2-School Year|Lost to Follow-up|3|||
44150870|NCT02039908|78940977|FG000|Phase 2-School Year|Protocol Violation|0|||
44150871|NCT02039908|78940978|FG001|Phase 2-School Year|Protocol Violation|0|||
44150872|NCT02039908|78940979|FG002|Phase 2-School Year|Protocol Violation|3|||
44150873|NCT02039908|78940980|FG003|Phase 2-School Year|Protocol Violation|0|||
44150874|NCT02039908|78940977|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
44150875|NCT02039908|78940978|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
44150876|NCT02039908|78940979|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
44150877|NCT02039908|78940980|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
44150878|NCT02058940|78940988|FG000|Overall Study|Discharged from Critical Care Unit|1|||
44150879|NCT02058628|78940994|FG000|Overall Study|Adverse Event|1|||
44150880|NCT02058628|78940995|FG001|Overall Study|Adverse Event|0|||
44150881|NCT02058628|78940994|FG000|Overall Study|Withdrawal by Subject|2|||
44150882|NCT02058628|78940995|FG001|Overall Study|Withdrawal by Subject|2|||
44150883|NCT02058628|78940994|FG000|Overall Study|Lost to Follow-up|2|||
44150884|NCT02058628|78940995|FG001|Overall Study|Lost to Follow-up|4|||
44150885|NCT02058628|78940994|FG000|Overall Study|Not in time schedule|0|||
44150886|NCT02058628|78940995|FG001|Overall Study|Not in time schedule|1|||
44150887|NCT02058628|78940994|FG000|Overall Study|The visit date was not in timeline|0|||
44150888|NCT02058628|78940995|FG001|Overall Study|The visit date was not in timeline|1|||
44150889|NCT02058628|78940994|FG000|Overall Study|A lot of time for study for participant|1|||
44150890|NCT02058628|78940995|FG001|Overall Study|A lot of time for study for participant|0|||
44150891|NCT02058628|78940994|FG000|Overall Study|Non compliance|1|||
44150892|NCT02058628|78940995|FG001|Overall Study|Non compliance|0|||
44150893|NCT02058160|78941006|FG000|Overall Study|Randomized but not treated|2|||
44150894|NCT02058160|78941007|FG001|Overall Study|Randomized but not treated|4|||
44150895|NCT02058160|78941006|FG000|Overall Study|Poor compliance to protocol|4|||
44150896|NCT02058160|78941007|FG001|Overall Study|Poor compliance to protocol|1|||
44150897|NCT02058160|78941006|FG000|Overall Study|Adverse Event|12|||
44150898|NCT02058160|78941007|FG001|Overall Study|Adverse Event|3|||
44150899|NCT02058160|78941006|FG000|Overall Study|Lost to Follow-up|1|||
44150900|NCT02058160|78941007|FG001|Overall Study|Lost to Follow-up|0|||
44150901|NCT02058160|78941006|FG000|Overall Study|Other than specified above|12|||
44150902|NCT02058160|78941007|FG001|Overall Study|Other than specified above|6|||
44150903|NCT02090764|78941015|FG000|Overall Study|Adverse Event|1|||
44150904|NCT02090764|78941016|FG001|Overall Study|Adverse Event|3|||
44150905|NCT02090764|78941015|FG000|Overall Study|Lack of Efficacy|0|||
44150906|NCT02090764|78941016|FG001|Overall Study|Lack of Efficacy|13|||
44150907|NCT02090764|78941015|FG000|Overall Study|Withdrawal by Subject|2|||
44150908|NCT02090764|78941016|FG001|Overall Study|Withdrawal by Subject|1|||
44150909|NCT02090764|78941015|FG000|Overall Study|Intercurrent illness and other|1|||
44150910|NCT02090764|78941016|FG001|Overall Study|Intercurrent illness and other|1|||
44150911|NCT02090764|78941015|FG000|Overall Study|Lost to Follow-up|2|||
44150912|NCT02090764|78941016|FG001|Overall Study|Lost to Follow-up|2|||
44150913|NCT02057692|78941026|FG000|Overall Study|Adverse Event|1|||
44150914|NCT02057692|78941027|FG001|Overall Study|Adverse Event|0|||
44254966|NCT02760485|79096790|FG002|Phase 2|Progressive Disease|1|||
44150915|NCT02057692|78941028|FG002|Overall Study|Adverse Event|0|||
44150916|NCT02057692|78941029|FG003|Overall Study|Adverse Event|0|||
44150917|NCT02057692|78941026|FG000|Overall Study|Lost to Follow-up|0|||
44254967|NCT02760485|79096788|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
44150918|NCT02057692|78941027|FG001|Overall Study|Lost to Follow-up|0|||
44150919|NCT02057692|78941028|FG002|Overall Study|Lost to Follow-up|0|||
44150920|NCT02057692|78941029|FG003|Overall Study|Lost to Follow-up|1|||
44150921|NCT02038036|78941047|FG000|Core Study|Adverse Event|7|||
44150922|NCT02038036|78941048|FG001|Core Study|Adverse Event|7|||
44150923|NCT02038036|78941047|FG000|Core Study|Death|1|||
44150924|NCT02038036|78941048|FG001|Core Study|Death|1|||
44150925|NCT02038036|78941047|FG000|Core Study|Disease progression|2|||
44150926|NCT02038036|78941048|FG001|Core Study|Disease progression|2|||
44150927|NCT02038036|78941047|FG000|Core Study|Lost to Follow-up|0|||
44150928|NCT02038036|78941048|FG001|Core Study|Lost to Follow-up|1|||
44150929|NCT02038036|78941047|FG000|Core Study|Physician Decision|2|||
44150930|NCT02038036|78941048|FG001|Core Study|Physician Decision|1|||
44150931|NCT02038036|78941047|FG000|Core Study|Subject/guardian decision|0|||
44150932|NCT02038036|78941048|FG001|Core Study|Subject/guardian decision|1|||
44254968|NCT02760485|79096789|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
44415074|NCT00806624|79422988|FG002|Overall Study|Withdrawal by Subject|3|||
44531335|NCT03162614|79541187|FG005|Overall Study|Protocol Violation|0|||
44531336|NCT03162614|79541182|FG000|Overall Study|Withdrawal by Subject|2|||
44531337|NCT03162614|79541183|FG001|Overall Study|Withdrawal by Subject|1|||
44531338|NCT03162614|79541184|FG002|Overall Study|Withdrawal by Subject|1|||
44531339|NCT03162614|79541185|FG003|Overall Study|Withdrawal by Subject|1|||
44531340|NCT03162614|79541186|FG004|Overall Study|Withdrawal by Subject|0|||
44531341|NCT03162614|79541187|FG005|Overall Study|Withdrawal by Subject|0|||
44531342|NCT03162614|79541182|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
44531343|NCT03162614|79541183|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
44531344|NCT03162614|79541184|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
44531345|NCT03162614|79541185|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
44150933|NCT02038036|78941047|FG000|Core Study|Withdrawal by Subject|3|||
44150934|NCT02038036|78941048|FG001|Core Study|Withdrawal by Subject|1|||
44282506|NCT01854918|79245888|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
44282507|NCT01854918|79245887|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
44282508|NCT01854918|79245888|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
44282509|NCT01854918|79245887|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
44282510|NCT01854918|79245888|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
44282511|NCT01854918|79245887|FG000|SOC-controlled Period (Year 1)|Death|5|||
44282512|NCT01854918|79245888|FG001|SOC-controlled Period (Year 1)|Death|5|||
44282513|NCT01854918|79245887|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
44282514|NCT01854918|79245888|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
44282515|NCT01854918|79245887|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
44282516|NCT01854918|79245888|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
44282517|NCT01854918|79245887|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
44282518|NCT01854918|79245888|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
44282519|NCT01854918|79245887|FG000|All-IP Period (Years 2 and 3)|Death|5|||
44282520|NCT01854918|79245888|FG001|All-IP Period (Years 2 and 3)|Death|16|||
44282521|NCT01894230|79245903|FG000|Overall Study|Lost to Follow-up|2|||
44282522|NCT01894230|79245904|FG001|Overall Study|Lost to Follow-up|2|||
44282523|NCT01894230|79245903|FG000|Overall Study|Withdrawal by Subject|4|||
44282524|NCT01894230|79245904|FG001|Overall Study|Withdrawal by Subject|4|||
44282525|NCT01894230|79245903|FG000|Overall Study|Non-adherent|0|||
44282526|NCT01894230|79245904|FG001|Overall Study|Non-adherent|1|||
44254969|NCT02760485|79096790|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
44254970|NCT02634333|79096825|FG000|Overall Study|Completed out of Window|3|||
44282527|NCT01894230|79245903|FG000|Overall Study|Death|1|||
44415075|NCT00806624|79422986|FG000|Overall Study|discontinued before start of treatment|0|||
44254971|NCT02634333|79096826|FG001|Overall Study|Completed out of Window|2|||
44254972|NCT02634333|79096825|FG000|Overall Study|Missed Visit|5|||
44254973|NCT02634333|79096826|FG001|Overall Study|Missed Visit|2|||
44254974|NCT02634333|79096825|FG000|Overall Study|Lost to Follow-up|12|||
44254975|NCT02634333|79096826|FG001|Overall Study|Lost to Follow-up|7|||
44531346|NCT03162614|79541186|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
44531347|NCT03162614|79541187|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
44254976|NCT02634333|79096825|FG000|Overall Study|Withdrawal by Subject|9|||
44282528|NCT01894230|79245904|FG001|Overall Study|Death|0|||
44531348|NCT03160898|79541205|FG000|Overall Study|Adverse Event|4|||
44254977|NCT02634333|79096826|FG001|Overall Study|Withdrawal by Subject|13|||
44282529|NCT01894152|79245910|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
44282530|NCT01854528|79245916|FG000|Overall Study|Adverse Event|0|||
44282531|NCT01854528|79245917|FG001|Overall Study|Adverse Event|4|||
44150935|NCT02038036|78941047|FG000|Crossover Period|Withdrawal by Subject|0|||
44254978|NCT02634333|79096825|FG000|Overall Study|Death|11|||
44150936|NCT02038036|78941048|FG001|Crossover Period|Withdrawal by Subject|3|||
44150937|NCT02038036|78941047|FG000|Crossover Period|Adverse Event|0|||
44150938|NCT02038036|78941048|FG001|Crossover Period|Adverse Event|9|||
44150939|NCT02038036|78941047|FG000|Crossover Period|Death|0|||
44150940|NCT02038036|78941048|FG001|Crossover Period|Death|2|||
44150941|NCT02038036|78941047|FG000|Crossover Period|Disease progression|0|||
44150942|NCT02038036|78941048|FG001|Crossover Period|Disease progression|3|||
44150943|NCT02038036|78941047|FG000|Crossover Period|Lost to Follow-up|0|||
44150944|NCT02038036|78941048|FG001|Crossover Period|Lost to Follow-up|1|||
44150945|NCT02038036|78941047|FG000|Crossover Period|Physician Decision|0|||
44150946|NCT02038036|78941048|FG001|Crossover Period|Physician Decision|2|||
44150947|NCT02037568|78941059|FG000|Overall Study|Withdrawal by Subject|17|||
44150948|NCT02037568|78941060|FG001|Overall Study|Withdrawal by Subject|24|||
44150949|NCT02037568|78941059|FG000|Overall Study|Lost to Follow-up|16|||
44150950|NCT02037568|78941060|FG001|Overall Study|Lost to Follow-up|13|||
44150951|NCT02037568|78941059|FG000|Overall Study|Screen Failure|3|||
44150952|NCT02037568|78941060|FG001|Overall Study|Screen Failure|1|||
44150953|NCT02037568|78941059|FG000|Overall Study|Patient did not receive transplant|0|||
44150954|NCT02037568|78941060|FG001|Overall Study|Patient did not receive transplant|1|||
44150955|NCT02088034|78941069|FG000|Overall Study|Lost to Follow-up|1|||
44150956|NCT02088034|78941070|FG001|Overall Study|Lost to Follow-up|1|||
44150957|NCT02088034|78941071|FG002|Overall Study|Lost to Follow-up|0|||
44150958|NCT02088034|78941069|FG000|Overall Study|Pregnancy|2|||
44150959|NCT02088034|78941070|FG001|Overall Study|Pregnancy|1|||
44150960|NCT02088034|78941071|FG002|Overall Study|Pregnancy|2|||
44150961|NCT02037256|78941081|FG000|Overall Study|Protocol Violation|0|||
44150962|NCT02037256|78941082|FG001|Overall Study|Protocol Violation|1|||
44150963|NCT02037256|78941081|FG000|Overall Study|Withdrawn prior to Velcade|0|||
44150964|NCT02037256|78941082|FG001|Overall Study|Withdrawn prior to Velcade|2|||
44282532|NCT01854528|79245916|FG000|Overall Study|Withdrawal by Subject|0|||
44282533|NCT01854528|79245917|FG001|Overall Study|Withdrawal by Subject|2|||
44282534|NCT01854528|79245916|FG000|Overall Study|Virologic Failure|0|||
44282535|NCT01854528|79245917|FG001|Overall Study|Virologic Failure|9|||
44282536|NCT01853982|79245925|FG000|Overall Study|Withdrawal by Subject|1|||
44282537|NCT01853982|79245926|FG001|Overall Study|Withdrawal by Subject|0|||
44282538|NCT01853982|79245925|FG000|Overall Study|Death|1|||
44282539|NCT01853982|79245926|FG001|Overall Study|Death|0|||
44282540|NCT01853982|79245925|FG000|Overall Study|Lost to Follow-up|0|||
44282541|NCT01853982|79245926|FG001|Overall Study|Lost to Follow-up|1|||
44282542|NCT01853280|79245934|FG000|Overall Study|Lack of Efficacy|2|||
44282543|NCT01853280|79245935|FG001|Overall Study|Lack of Efficacy|2|||
44282544|NCT01853280|79245934|FG000|Overall Study|Lost to Follow-up|0|||
44282545|NCT01853280|79245935|FG001|Overall Study|Lost to Follow-up|1|||
44282546|NCT01853280|79245934|FG000|Overall Study|Physician Decision|0|||
44282547|NCT01853280|79245935|FG001|Overall Study|Physician Decision|1|||
44282548|NCT01853280|79245934|FG000|Overall Study|Withdrawal by Subject|0|||
44282549|NCT01853280|79245935|FG001|Overall Study|Withdrawal by Subject|1|||
44282550|NCT01853280|79245934|FG000|Overall Study|Ineligible|0|||
44282551|NCT01853280|79245935|FG001|Overall Study|Ineligible|1|||
44282552|NCT01892436|79245945|FG000|Overall Study|Withdrawal by Subject|8|||
44282553|NCT01892436|79245946|FG001|Overall Study|Withdrawal by Subject|15|||
44282554|NCT01892436|79245947|FG002|Overall Study|Withdrawal by Subject|4|||
44282555|NCT01892436|79245948|FG003|Overall Study|Withdrawal by Subject|4|||
44254979|NCT02634333|79096826|FG001|Overall Study|Death|8|||
44254980|NCT02515630|79096835|FG000|Overall Study|Withdrawal by Subject|5|||
44254981|NCT02515630|79096835|FG000|Overall Study|Adverse Event|4|||
44254982|NCT02515630|79096835|FG000|Overall Study|Physician Decision|4|||
44254983|NCT02515630|79096835|FG000|Overall Study|Death|2|||
44254984|NCT02515630|79096835|FG000|Overall Study|Disease Progression|1|||
44254985|NCT02450331|79096844|FG000|Overall Study|Death|162|||
44254986|NCT02450331|79096845|FG001|Overall Study|Death|171|||
44254987|NCT02450331|79096844|FG000|Overall Study|Lost to Follow-up|14|||
44254988|NCT02450331|79096845|FG001|Overall Study|Lost to Follow-up|12|||
44254989|NCT02450331|79096844|FG000|Overall Study|Withdrawal by Subject|55|||
44254990|NCT02450331|79096845|FG001|Overall Study|Withdrawal by Subject|44|||
44254991|NCT02450331|79096844|FG000|Overall Study|Non-specified other|1|||
44254992|NCT02450331|79096845|FG001|Overall Study|Non-specified other|1|||
44254993|NCT02335944|79096862|FG000|Treatment Phase|Progressive Disease|2|||
44282556|NCT01892436|79245945|FG000|Overall Study|Death|1|||
44282557|NCT01892436|79245946|FG001|Overall Study|Death|1|||
44282558|NCT01892436|79245947|FG002|Overall Study|Death|0|||
44150965|NCT02035696|78941094|FG000|Overall Study|Lost to Follow-up|0|||
44150966|NCT02035696|78941095|FG001|Overall Study|Lost to Follow-up|3|||
44150967|NCT02035696|78941096|FG002|Overall Study|Lost to Follow-up|1|||
44150968|NCT02035696|78941097|FG003|Overall Study|Lost to Follow-up|2|||
44150969|NCT02035696|78941094|FG000|Overall Study|Withdrawal by Subject|3|||
44254994|NCT02335944|79096863|FG001|Treatment Phase|Progressive Disease|5|||
44254995|NCT02335944|79096864|FG002|Treatment Phase|Progressive Disease|2|||
44282559|NCT01892436|79245948|FG003|Overall Study|Death|0|||
44150970|NCT02035696|78941095|FG001|Overall Study|Withdrawal by Subject|0|||
44150971|NCT02035696|78941096|FG002|Overall Study|Withdrawal by Subject|2|||
44150972|NCT02035696|78941097|FG003|Overall Study|Withdrawal by Subject|1|||
44150973|NCT02057458|78941111|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
44150974|NCT02057458|78941112|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
44150975|NCT02057458|78941113|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
44150976|NCT02057458|78941111|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
44150977|NCT02057458|78941112|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
44150978|NCT02057458|78941113|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
44150979|NCT02057458|78941111|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
44150980|NCT02057458|78941112|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
44150981|NCT02057458|78941113|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
44150982|NCT02057068|78941145|FG000|Overall Study|Withdrawal by Subject|2|||
44150983|NCT02057068|78941146|FG001|Overall Study|Withdrawal by Subject|2|||
44150984|NCT02057068|78941145|FG000|Overall Study|Caregiver (CG) Health|0|||
44150985|NCT02057068|78941146|FG001|Overall Study|Caregiver (CG) Health|2|||
44150986|NCT02057068|78941145|FG000|Overall Study|Carepartner (CP) Health|4|||
44150987|NCT02057068|78941146|FG001|Overall Study|Carepartner (CP) Health|2|||
44150988|NCT02057068|78941145|FG000|Overall Study|Lost to Follow-up|2|||
44150989|NCT02057068|78941146|FG001|Overall Study|Lost to Follow-up|2|||
44150990|NCT02056834|78941154|FG000|Overall Study|Lost to Follow-up|7|||
44150991|NCT02087176|78941159|FG000|Overall Study|Withdrawal by Subject|1|||
44150992|NCT02087176|78941159|FG000|Overall Study|Death|10|||
44150993|NCT02087176|78941159|FG000|Overall Study|Censored|19|||
44150994|NCT02087176|78941159|FG000|Overall Study|Study Terminated by Sponsor|2|||
44150995|NCT02056288|78941165|FG000|In-Hospital Data|Surgery cancelled|1|||
44150996|NCT02056288|78941166|FG001|In-Hospital Data|Surgery cancelled|0|||
44150997|NCT02056288|78941165|FG000|In-Hospital Data|Protocol Violation|3|||
44150998|NCT02056288|78941166|FG001|In-Hospital Data|Protocol Violation|0|||
44150999|NCT02056288|78941165|FG000|In-Hospital Data|Physician Decision|1|||
44151000|NCT02056288|78941166|FG001|In-Hospital Data|Physician Decision|0|||
44151001|NCT02056288|78941165|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
44151002|NCT02056288|78941166|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
44151003|NCT02086162|78941174|FG000|Overall Study|Withdrawal by Subject|4|||
44151004|NCT02086162|78941175|FG001|Overall Study|Withdrawal by Subject|4|||
44151005|NCT02086162|78941174|FG000|Overall Study|moved|1|||
44151006|NCT02086162|78941175|FG001|Overall Study|moved|1|||
44151007|NCT02086162|78941174|FG000|Overall Study|Lost to Follow-up|4|||
44151008|NCT02086162|78941175|FG001|Overall Study|Lost to Follow-up|2|||
44151009|NCT02086162|78941174|FG000|Overall Study|Death|1|||
44151010|NCT02086162|78941175|FG001|Overall Study|Death|0|||
44151011|NCT02700815|78941189|FG000|Overall Study|Adverse Event|0|||
44151012|NCT02700815|78941190|FG001|Overall Study|Adverse Event|6|||
44151013|NCT02700815|78941191|FG002|Overall Study|Adverse Event|2|||
44151014|NCT02700815|78941192|FG003|Overall Study|Adverse Event|3|||
44151015|NCT02700815|78941189|FG000|Overall Study|Lack of Efficacy|0|||
44151016|NCT02700815|78941190|FG001|Overall Study|Lack of Efficacy|0|||
44151017|NCT02700815|78941191|FG002|Overall Study|Lack of Efficacy|1|||
44151018|NCT02700815|78941192|FG003|Overall Study|Lack of Efficacy|2|||
44151019|NCT02700815|78941189|FG000|Overall Study|Lost to Follow-up|1|||
44151020|NCT02700815|78941190|FG001|Overall Study|Lost to Follow-up|0|||
44151021|NCT02700815|78941191|FG002|Overall Study|Lost to Follow-up|0|||
44151022|NCT02700815|78941192|FG003|Overall Study|Lost to Follow-up|1|||
44151023|NCT02700815|78941189|FG000|Overall Study|Refusal to continue medication|0|||
44254996|NCT02335944|79096865|FG003|Treatment Phase|Progressive Disease|11|||
44531349|NCT03160898|79541206|FG001|Overall Study|Adverse Event|8|||
44531350|NCT03160898|79541207|FG002|Overall Study|Adverse Event|7|||
44531351|NCT03160898|79541208|FG003|Overall Study|Adverse Event|10|||
44531352|NCT03160898|79541205|FG000|Overall Study|Death|1|||
44531353|NCT03160898|79541206|FG001|Overall Study|Death|0|||
44531354|NCT03160898|79541207|FG002|Overall Study|Death|0|||
44531355|NCT03160898|79541208|FG003|Overall Study|Death|1|||
44531356|NCT03160898|79541205|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
44531357|NCT03160898|79541206|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
44531358|NCT03160898|79541207|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
44531359|NCT03160898|79541208|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
44254997|NCT02335944|79096866|FG004|Treatment Phase|Progressive Disease|4|||
44254998|NCT02335944|79096867|FG005|Treatment Phase|Progressive Disease|25|||
44531360|NCT03160898|79541205|FG000|Overall Study|Lost to Follow-up|1|||
44151024|NCT02700815|78941190|FG001|Overall Study|Refusal to continue medication|1|||
44151025|NCT02700815|78941191|FG002|Overall Study|Refusal to continue medication|0|||
44151026|NCT02700815|78941192|FG003|Overall Study|Refusal to continue medication|1|||
44151027|NCT02700815|78941189|FG000|Overall Study|Withdrawal by Subject|0|||
44151028|NCT02700815|78941190|FG001|Overall Study|Withdrawal by Subject|0|||
44151029|NCT02700815|78941191|FG002|Overall Study|Withdrawal by Subject|1|||
44151030|NCT02700815|78941192|FG003|Overall Study|Withdrawal by Subject|0|||
44151031|NCT00708305|78941202|FG000|Period 1|Protocol Violation|1|||
44151032|NCT00708305|78941203|FG001|Period 1|Protocol Violation|0|||
44151033|NCT00708305|78941204|FG002|Period 1|Protocol Violation|1|||
44151034|NCT00708305|78941205|FG003|Period 1|Protocol Violation|0|||
44151035|NCT00708305|78941202|FG000|Period 1|Other Reason|0|||
44151036|NCT00708305|78941203|FG001|Period 1|Other Reason|0|||
44151037|NCT00708305|78941204|FG002|Period 1|Other Reason|0|||
44151038|NCT00708305|78941205|FG003|Period 1|Other Reason|2|||
44151039|NCT00708305|78941202|FG000|Period 2|Lost to Follow-up|0|||
44151040|NCT00708305|78941203|FG001|Period 2|Lost to Follow-up|1|||
44151041|NCT00708305|78941204|FG002|Period 2|Lost to Follow-up|0|||
44151042|NCT00708305|78941205|FG003|Period 2|Lost to Follow-up|0|||
44151043|NCT00708305|78941202|FG000|Period 2|Protocol Violation|0|||
44151044|NCT00708305|78941203|FG001|Period 2|Protocol Violation|1|||
44151045|NCT00708305|78941204|FG002|Period 2|Protocol Violation|0|||
44151046|NCT00708305|78941205|FG003|Period 2|Protocol Violation|0|||
44151047|NCT00708305|78941202|FG000|Period 2|Other Reason|1|||
44151048|NCT00708305|78941203|FG001|Period 2|Other Reason|0|||
44151049|NCT00708305|78941204|FG002|Period 2|Other Reason|0|||
44151050|NCT00708305|78941205|FG003|Period 2|Other Reason|1|||
44151051|NCT00708305|78941202|FG000|Period 3|Protocol Violation|0|||
44151052|NCT00708305|78941203|FG001|Period 3|Protocol Violation|2|||
44151053|NCT00708305|78941204|FG002|Period 3|Protocol Violation|0|||
44151054|NCT00708305|78941205|FG003|Period 3|Protocol Violation|0|||
44151055|NCT00708305|78941202|FG000|Period 3|Other Reason|1|||
44151056|NCT00708305|78941203|FG001|Period 3|Other Reason|0|||
44151057|NCT00708305|78941204|FG002|Period 3|Other Reason|0|||
44151058|NCT00708305|78941205|FG003|Period 3|Other Reason|0|||
44151059|NCT02055976|78941227|FG000|Overall Study|Other|0|||
44151060|NCT02055976|78941228|FG001|Overall Study|Other|0|||
44151061|NCT02055976|78941229|FG002|Overall Study|Other|1|||
44151062|NCT02055976|78941230|FG003|Overall Study|Other|0|||
44151063|NCT02055976|78941231|FG004|Overall Study|Other|0|||
44151064|NCT02055976|78941232|FG005|Overall Study|Other|0|||
44151065|NCT02055976|78941233|FG006|Overall Study|Other|0|||
44151066|NCT02055976|78941234|FG007|Overall Study|Other|0|||
44282560|NCT01892436|79245945|FG000|Overall Study|Physician Decision|2|||
44282561|NCT01892436|79245946|FG001|Overall Study|Physician Decision|1|||
44282562|NCT01892436|79245947|FG002|Overall Study|Physician Decision|0|||
44282563|NCT01892436|79245948|FG003|Overall Study|Physician Decision|1|||
44282564|NCT01892436|79245945|FG000|Overall Study|Pregnancy|0|||
44415076|NCT00806624|79422987|FG001|Overall Study|discontinued before start of treatment|0|||
44151067|NCT02055976|78941235|FG008|Overall Study|Other|0|||
44151068|NCT02055976|78941227|FG000|Overall Study|Adverse Event|0|||
44151069|NCT02055976|78941228|FG001|Overall Study|Adverse Event|0|||
44151070|NCT02055976|78941229|FG002|Overall Study|Adverse Event|0|||
44151071|NCT02055976|78941230|FG003|Overall Study|Adverse Event|0|||
44151072|NCT02055976|78941231|FG004|Overall Study|Adverse Event|0|||
44151073|NCT02055976|78941232|FG005|Overall Study|Adverse Event|1|||
44151074|NCT02055976|78941233|FG006|Overall Study|Adverse Event|1|||
44151075|NCT02055976|78941234|FG007|Overall Study|Adverse Event|0|||
44151076|NCT02055976|78941235|FG008|Overall Study|Adverse Event|0|||
44151077|NCT02055976|78941227|FG000|Overall Study|Does not meet entrance criteria|0|||
44151078|NCT02055976|78941228|FG001|Overall Study|Does not meet entrance criteria|0|||
44151079|NCT02055976|78941229|FG002|Overall Study|Does not meet entrance criteria|0|||
44151080|NCT02055976|78941230|FG003|Overall Study|Does not meet entrance criteria|0|||
44151081|NCT02055976|78941231|FG004|Overall Study|Does not meet entrance criteria|0|||
44151082|NCT02055976|78941232|FG005|Overall Study|Does not meet entrance criteria|0|||
44151083|NCT02055976|78941233|FG006|Overall Study|Does not meet entrance criteria|1|||
44151084|NCT02055976|78941234|FG007|Overall Study|Does not meet entrance criteria|0|||
44151085|NCT02055976|78941235|FG008|Overall Study|Does not meet entrance criteria|0|||
44151086|NCT02055976|78941227|FG000|Overall Study|Lost to Follow-up|0|||
44151087|NCT02055976|78941228|FG001|Overall Study|Lost to Follow-up|0|||
44151088|NCT02055976|78941229|FG002|Overall Study|Lost to Follow-up|0|||
44151089|NCT02055976|78941230|FG003|Overall Study|Lost to Follow-up|1|||
44151090|NCT02055976|78941231|FG004|Overall Study|Lost to Follow-up|0|||
44282565|NCT01892436|79245946|FG001|Overall Study|Pregnancy|2|||
44151091|NCT02055976|78941232|FG005|Overall Study|Lost to Follow-up|0|||
44151092|NCT02055976|78941233|FG006|Overall Study|Lost to Follow-up|0|||
44151093|NCT02055976|78941234|FG007|Overall Study|Lost to Follow-up|0|||
44151094|NCT02055976|78941235|FG008|Overall Study|Lost to Follow-up|0|||
44151095|NCT02055898|78941264|FG000|First Intervention (5 Days)|Physician Decision|2|||
44151096|NCT02055898|78941265|FG001|First Intervention (5 Days)|Physician Decision|0|||
44151097|NCT02055898|78941264|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
44151098|NCT02055898|78941265|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
44151099|NCT02564055|78941277|FG000|Overall Study|Adverse Event|1|||
44151100|NCT02564055|78941278|FG001|Overall Study|Adverse Event|0|||
44151101|NCT02564055|78941279|FG002|Overall Study|Adverse Event|4|||
44151102|NCT02564055|78941280|FG003|Overall Study|Adverse Event|1|||
44151103|NCT02564055|78941281|FG004|Overall Study|Adverse Event|4|||
44151104|NCT02564055|78941282|FG005|Overall Study|Adverse Event|1|||
44151105|NCT02564055|78941277|FG000|Overall Study|Protocol Violation|1|||
44151106|NCT02564055|78941278|FG001|Overall Study|Protocol Violation|0|||
44151107|NCT02564055|78941279|FG002|Overall Study|Protocol Violation|0|||
44151108|NCT02564055|78941280|FG003|Overall Study|Protocol Violation|0|||
44151109|NCT02564055|78941281|FG004|Overall Study|Protocol Violation|0|||
44151110|NCT02564055|78941282|FG005|Overall Study|Protocol Violation|0|||
44151111|NCT02564055|78941277|FG000|Overall Study|Reached stopping criteria|0|||
44151112|NCT02564055|78941278|FG001|Overall Study|Reached stopping criteria|0|||
44151113|NCT02564055|78941279|FG002|Overall Study|Reached stopping criteria|0|||
44151114|NCT02564055|78941280|FG003|Overall Study|Reached stopping criteria|0|||
44151115|NCT02564055|78941281|FG004|Overall Study|Reached stopping criteria|0|||
44282566|NCT01892436|79245947|FG002|Overall Study|Pregnancy|1|||
44282567|NCT01892436|79245948|FG003|Overall Study|Pregnancy|0|||
44282568|NCT01892436|79245945|FG000|Overall Study|Technical problems|2|||
44282569|NCT01892436|79245946|FG001|Overall Study|Technical problems|1|||
44282570|NCT01892436|79245947|FG002|Overall Study|Technical problems|1|||
44282571|NCT01892436|79245948|FG003|Overall Study|Technical problems|1|||
44282572|NCT01892436|79245945|FG000|Overall Study|Lack of Efficacy|1|||
44282573|NCT01892436|79245946|FG001|Overall Study|Lack of Efficacy|2|||
44282574|NCT01892436|79245947|FG002|Overall Study|Lack of Efficacy|2|||
44282575|NCT01892436|79245948|FG003|Overall Study|Lack of Efficacy|2|||
44282576|NCT01892436|79245945|FG000|Overall Study|Lost to Follow-up|1|||
44282577|NCT01892436|79245946|FG001|Overall Study|Lost to Follow-up|1|||
44531361|NCT03160898|79541206|FG001|Overall Study|Lost to Follow-up|1|||
44531362|NCT03160898|79541207|FG002|Overall Study|Lost to Follow-up|1|||
44151116|NCT02564055|78941282|FG005|Overall Study|Reached stopping criteria|1|||
44531363|NCT03160898|79541208|FG003|Overall Study|Lost to Follow-up|2|||
44531364|NCT03160898|79541205|FG000|Overall Study|Physician Decision|1|||
44531365|NCT03160898|79541206|FG001|Overall Study|Physician Decision|0|||
44531366|NCT03160898|79541207|FG002|Overall Study|Physician Decision|0|||
44531367|NCT03160898|79541208|FG003|Overall Study|Physician Decision|1|||
44531368|NCT03160898|79541205|FG000|Overall Study|Progressive Disease|4|||
44531369|NCT03160898|79541206|FG001|Overall Study|Progressive Disease|1|||
44531370|NCT03160898|79541207|FG002|Overall Study|Progressive Disease|2|||
44531371|NCT03160898|79541208|FG003|Overall Study|Progressive Disease|1|||
44531372|NCT03160898|79541205|FG000|Overall Study|Protocol Violation|1|||
44531373|NCT03160898|79541206|FG001|Overall Study|Protocol Violation|0|||
44531374|NCT03160898|79541207|FG002|Overall Study|Protocol Violation|2|||
44531375|NCT03160898|79541208|FG003|Overall Study|Protocol Violation|0|||
44531376|NCT03160898|79541205|FG000|Overall Study|Sponsor Discretion|2|||
44151117|NCT02564055|78941277|FG000|Overall Study|Lost to Follow-up|0|||
44282578|NCT01892436|79245947|FG002|Overall Study|Lost to Follow-up|1|||
44282579|NCT01892436|79245948|FG003|Overall Study|Lost to Follow-up|3|||
44531377|NCT03160898|79541206|FG001|Overall Study|Sponsor Discretion|0|||
44151118|NCT02564055|78941278|FG001|Overall Study|Lost to Follow-up|1|||
44151119|NCT02564055|78941279|FG002|Overall Study|Lost to Follow-up|4|||
44531378|NCT03160898|79541207|FG002|Overall Study|Sponsor Discretion|0|||
44151120|NCT02564055|78941280|FG003|Overall Study|Lost to Follow-up|2|||
44151121|NCT02564055|78941281|FG004|Overall Study|Lost to Follow-up|1|||
44151122|NCT02564055|78941282|FG005|Overall Study|Lost to Follow-up|0|||
44151123|NCT02564055|78941277|FG000|Overall Study|Physician Decision|0|||
44151124|NCT02564055|78941278|FG001|Overall Study|Physician Decision|0|||
44151125|NCT02564055|78941279|FG002|Overall Study|Physician Decision|1|||
44151126|NCT02564055|78941280|FG003|Overall Study|Physician Decision|0|||
44151127|NCT02564055|78941281|FG004|Overall Study|Physician Decision|0|||
44151128|NCT02564055|78941282|FG005|Overall Study|Physician Decision|0|||
44151129|NCT02564055|78941277|FG000|Overall Study|Withdrawal by Subject|4|||
44151130|NCT02564055|78941278|FG001|Overall Study|Withdrawal by Subject|4|||
44151131|NCT02564055|78941279|FG002|Overall Study|Withdrawal by Subject|3|||
44151132|NCT02564055|78941280|FG003|Overall Study|Withdrawal by Subject|3|||
44151133|NCT02564055|78941281|FG004|Overall Study|Withdrawal by Subject|10|||
44151134|NCT02564055|78941282|FG005|Overall Study|Withdrawal by Subject|10|||
44151135|NCT02563899|78941300|FG000|Overall Study|Protocol Violation|1|||
44151136|NCT02563899|78941301|FG001|Overall Study|Protocol Violation|0|||
44151137|NCT02563899|78941302|FG002|Overall Study|Protocol Violation|0|||
44151138|NCT02563899|78941303|FG003|Overall Study|Protocol Violation|0|||
44151139|NCT02563899|78941300|FG000|Overall Study|Withdrawal by Subject|0|||
44151140|NCT02563899|78941301|FG001|Overall Study|Withdrawal by Subject|0|||
44151141|NCT02563899|78941302|FG002|Overall Study|Withdrawal by Subject|1|||
44151142|NCT02563899|78941303|FG003|Overall Study|Withdrawal by Subject|0|||
44151143|NCT02699099|78941317|FG000|Overall Study|Adverse Event|1|||
44531379|NCT03160898|79541208|FG003|Overall Study|Sponsor Discretion|0|||
44531380|NCT03160898|79541205|FG000|Overall Study|Withdrawal by Subject|1|||
44531381|NCT03160898|79541206|FG001|Overall Study|Withdrawal by Subject|3|||
44531382|NCT03160898|79541207|FG002|Overall Study|Withdrawal by Subject|2|||
44151144|NCT02699099|78941318|FG001|Overall Study|Adverse Event|0|||
44151145|NCT02699099|78941319|FG002|Overall Study|Adverse Event|2|||
44151146|NCT02699099|78941317|FG000|Overall Study|Lost to Follow-up|0|||
44151147|NCT02699099|78941318|FG001|Overall Study|Lost to Follow-up|1|||
44151148|NCT02699099|78941319|FG002|Overall Study|Lost to Follow-up|0|||
44151149|NCT02699099|78941317|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
44151150|NCT02699099|78941318|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
44151151|NCT02699099|78941319|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
44151152|NCT02698865|78941331|FG000|Overall Study|Other|11|||
44151153|NCT02698865|78941332|FG001|Overall Study|Other|11|||
44151154|NCT02698865|78941331|FG000|Overall Study|Withdrawal by Subject|20|||
44151155|NCT02698865|78941332|FG001|Overall Study|Withdrawal by Subject|16|||
44151156|NCT02698865|78941331|FG000|Overall Study|Physician Decision|0|||
44151157|NCT02698865|78941332|FG001|Overall Study|Physician Decision|4|||
44151158|NCT02698865|78941331|FG000|Overall Study|Lost to Follow-up|4|||
44151159|NCT02698865|78941332|FG001|Overall Study|Lost to Follow-up|2|||
44151160|NCT02698787|78941340|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
44151161|NCT02698787|78941341|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
44151162|NCT02698475|78941348|FG000|Main Study Period|Lack of Efficacy|1|||
44151163|NCT02698475|78941348|FG000|Main Study Period|Protocol Violation|2|||
44151164|NCT02698475|78941348|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
44151165|NCT02698475|78941348|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
44151166|NCT02698475|78941348|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
44151167|NCT02698475|78941348|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
44151168|NCT02698475|78941348|FG000|Long-Term Extension Period|Other|1|||
44151169|NCT02559687|78941355|FG000|Overall Study|Death|112|||
44151170|NCT02559687|78941355|FG000|Overall Study|Sponsor Decision|5|||
44151171|NCT02559687|78941355|FG000|Overall Study|Withdrawal by Subject|4|||
44151172|NCT04294719|78941369|FG000|Overall Study|Withdrawal by Subject|1|||
44151173|NCT02703311|78941377|FG000|Overall Study|Death|5|||
44151174|NCT02703311|78941377|FG000|Overall Study|Withdrawal by Subject|3|||
44151175|NCT02697617|78941381|FG000|Overall Study|Withdrawal by Subject|0|||
44531383|NCT03160898|79541208|FG003|Overall Study|Withdrawal by Subject|1|||
44531384|NCT03160898|79541205|FG000|Overall Study|Other|2|||
44531385|NCT03160898|79541206|FG001|Overall Study|Other|0|||
44531386|NCT03160898|79541207|FG002|Overall Study|Other|2|||
44151176|NCT02697617|78941382|FG001|Overall Study|Withdrawal by Subject|2|||
44151177|NCT02697617|78941381|FG000|Overall Study|Pregnancy|1|||
44254999|NCT02335944|79096868|FG006|Treatment Phase|Progressive Disease|2|||
44255000|NCT02335944|79096869|FG007|Treatment Phase|Progressive Disease|30|||
44255001|NCT02335944|79096870|FG008|Treatment Phase|Progressive Disease|27|||
44531387|NCT03160898|79541208|FG003|Overall Study|Other|2|||
44531388|NCT03193736|79541219|FG000|Overall Study|Death|2|||
44151178|NCT02697617|78941382|FG001|Overall Study|Pregnancy|0|||
44151179|NCT02698241|78941392|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
44531389|NCT03193736|79541219|FG000|Overall Study|Withdrawal by Subject|1|||
44151180|NCT02698241|78941392|FG000|Overall Study|Screening not met|7|||
44151181|NCT02698241|78941392|FG000|Overall Study|Withdrawal by Subject|7|||
44531390|NCT03193736|79541219|FG000|Overall Study|Lost to Follow-up|1|||
44151182|NCT02698241|78941392|FG000|Overall Study|Physician Decision|2|||
44151183|NCT02698241|78941392|FG000|Overall Study|Subject underwent system modification|2|||
44151184|NCT02698241|78941392|FG000|Overall Study|Lost to Follow-up|3|||
44151185|NCT02698241|78941392|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
44151186|NCT02698241|78941392|FG000|Overall Study|geographic and licensing issue|1|||
44151187|NCT02698241|78941392|FG000|Overall Study|Death|2|||
44151188|NCT01663233|78941398|FG000|Overall Study|Withdrawal by Subject|3|||
44151189|NCT01663233|78941399|FG001|Overall Study|Withdrawal by Subject|2|||
44151190|NCT01663233|78941398|FG000|Overall Study|Protocol Deviation|1|||
44151191|NCT01663233|78941399|FG001|Overall Study|Protocol Deviation|4|||
44151192|NCT01663233|78941398|FG000|Overall Study|Lost to Follow-up|0|||
44151193|NCT01663233|78941399|FG001|Overall Study|Lost to Follow-up|1|||
44151194|NCT02556255|78941418|FG000|Overall Study|Lost to Follow-up|4|||
44151195|NCT02556801|78941426|FG000|Overall Study|Lost to Follow-up|1|||
44151196|NCT02556801|78941427|FG001|Overall Study|Lost to Follow-up|0|||
44151197|NCT02556801|78941428|FG002|Overall Study|Lost to Follow-up|2|||
44151198|NCT02556801|78941429|FG003|Overall Study|Lost to Follow-up|0|||
44151199|NCT02556801|78941426|FG000|Overall Study|Withdrawal by Subject|1|||
44151200|NCT02556801|78941427|FG001|Overall Study|Withdrawal by Subject|1|||
44151201|NCT02556801|78941428|FG002|Overall Study|Withdrawal by Subject|1|||
44151202|NCT02556801|78941429|FG003|Overall Study|Withdrawal by Subject|0|||
44151203|NCT02556801|78941426|FG000|Overall Study|Protocol Violation|0|||
44151204|NCT02556801|78941427|FG001|Overall Study|Protocol Violation|3|||
44151205|NCT02556801|78941428|FG002|Overall Study|Protocol Violation|1|||
44151206|NCT02556801|78941429|FG003|Overall Study|Protocol Violation|1|||
44151207|NCT02556801|78941426|FG000|Overall Study|Adverse Event|0|||
44151208|NCT02556801|78941427|FG001|Overall Study|Adverse Event|2|||
44151209|NCT02556801|78941428|FG002|Overall Study|Adverse Event|0|||
44151210|NCT02556801|78941429|FG003|Overall Study|Adverse Event|3|||
44151211|NCT02556801|78941426|FG000|Overall Study|Pregnancy|0|||
44151212|NCT02556801|78941427|FG001|Overall Study|Pregnancy|1|||
44151213|NCT02556801|78941428|FG002|Overall Study|Pregnancy|0|||
44151214|NCT02556801|78941429|FG003|Overall Study|Pregnancy|0|||
44151215|NCT02556801|78941426|FG000|Overall Study|Personal reasons patient|0|||
44151216|NCT02556801|78941427|FG001|Overall Study|Personal reasons patient|0|||
44151217|NCT02556801|78941428|FG002|Overall Study|Personal reasons patient|0|||
44151218|NCT02556801|78941429|FG003|Overall Study|Personal reasons patient|1|||
44151219|NCT02556177|78941441|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
44151220|NCT02556177|78941442|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
44151221|NCT02554929|78941450|FG000|Overall Study|Lost to Follow-up|4|||
44151222|NCT02554929|78941451|FG001|Overall Study|Lost to Follow-up|4|||
44151223|NCT02554929|78941450|FG000|Overall Study|Withdrawal by Subject|2|||
44151224|NCT02554929|78941451|FG001|Overall Study|Withdrawal by Subject|8|||
44151225|NCT02697773|78941469|FG000|Overall Study|Adverse Event|2|||
44151226|NCT02697773|78941470|FG001|Overall Study|Adverse Event|1|||
44151227|NCT02697773|78941471|FG002|Overall Study|Adverse Event|2|||
44151228|NCT02697773|78941469|FG000|Overall Study|Death|0|||
44151229|NCT02697773|78941470|FG001|Overall Study|Death|0|||
44151230|NCT02697773|78941471|FG002|Overall Study|Death|2|||
44151231|NCT02697773|78941469|FG000|Overall Study|Lack of Efficacy|4|||
44151232|NCT02697773|78941470|FG001|Overall Study|Lack of Efficacy|6|||
44151233|NCT02697773|78941471|FG002|Overall Study|Lack of Efficacy|6|||
44151234|NCT02697773|78941469|FG000|Overall Study|Lost to Follow-up|5|||
44151235|NCT02697773|78941470|FG001|Overall Study|Lost to Follow-up|5|||
44151236|NCT02697773|78941471|FG002|Overall Study|Lost to Follow-up|7|||
44151237|NCT02697773|78941469|FG000|Overall Study|Other|15|||
44151238|NCT02697773|78941470|FG001|Overall Study|Other|11|||
44151239|NCT02697773|78941471|FG002|Overall Study|Other|10|||
44151240|NCT02697773|78941469|FG000|Overall Study|Protocol Violation|1|||
44151241|NCT02697773|78941470|FG001|Overall Study|Protocol Violation|1|||
44151242|NCT02697773|78941471|FG002|Overall Study|Protocol Violation|0|||
44415077|NCT00806624|79422988|FG002|Overall Study|discontinued before start of treatment|1|||
44415078|NCT00806546|79422996|FG000|Overall Study|Enrolled, not treated|35|||
44255002|NCT02335944|79096871|FG009|Treatment Phase|Progressive Disease|0|||
44255003|NCT02335944|79096862|FG000|Treatment Phase|Adverse Event|2|||
44415079|NCT00806546|79422996|FG000|Overall Study|Lost to Follow-up|32|||
44151243|NCT02697773|78941469|FG000|Overall Study|Withdrawal by Subject|10|||
44151244|NCT02697773|78941470|FG001|Overall Study|Withdrawal by Subject|13|||
44151245|NCT02697773|78941471|FG002|Overall Study|Withdrawal by Subject|13|||
44151246|NCT02697773|78941469|FG000|Overall Study|Randomized but not treated|1|||
44151247|NCT02697773|78941470|FG001|Overall Study|Randomized but not treated|1|||
44415080|NCT00806546|79422996|FG000|Overall Study|Adverse Event|74|||
44151248|NCT02697773|78941471|FG002|Overall Study|Randomized but not treated|0|||
44151249|NCT02693171|78941479|FG000|Overall Study|Adverse Event|1|||
44151250|NCT02693171|78941479|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
44151251|NCT02692703|78941483|FG000|Overall Study|Lost to Follow-up|1|||
44415081|NCT00806546|79422996|FG000|Overall Study|Withdrawal by Subject|75|||
44151252|NCT02692703|78941483|FG000|Overall Study|Other|1|||
44151253|NCT02692235|78941489|FG000|Overall Study|Withdrawal by Subject|2|||
44151254|NCT02692235|78941490|FG001|Overall Study|Withdrawal by Subject|1|||
44151255|NCT02692235|78941489|FG000|Overall Study|Adverse Event|1|||
44151256|NCT02692235|78941490|FG001|Overall Study|Adverse Event|2|||
44151257|NCT02552121|78941504|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
44151258|NCT02552121|78941505|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151259|NCT02552121|78941506|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151260|NCT02552121|78941507|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151261|NCT02552121|78941508|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151262|NCT02552121|78941509|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151263|NCT02552121|78941510|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151264|NCT02552121|78941511|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
44151265|NCT02552121|78941504|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
44151266|NCT02552121|78941505|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151267|NCT02552121|78941506|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151268|NCT02552121|78941507|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151269|NCT02552121|78941508|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151270|NCT02552121|78941509|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151271|NCT02552121|78941510|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151272|NCT02552121|78941511|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
44151273|NCT02552121|78941504|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151274|NCT02552121|78941505|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
44151275|NCT02552121|78941506|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151276|NCT02552121|78941507|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151277|NCT02552121|78941508|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151278|NCT02552121|78941509|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151279|NCT02552121|78941510|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151280|NCT02552121|78941511|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
44151281|NCT02552121|78941504|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151282|NCT02552121|78941505|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
44151283|NCT02552121|78941506|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151284|NCT02552121|78941507|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151285|NCT02552121|78941508|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151286|NCT02552121|78941509|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151287|NCT02552121|78941510|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151288|NCT02552121|78941511|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
44151289|NCT02552121|78941504|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151290|NCT02552121|78941505|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
44151291|NCT02552121|78941506|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151292|NCT02552121|78941507|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151293|NCT02552121|78941508|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151294|NCT02552121|78941509|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151295|NCT02552121|78941510|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151296|NCT02552121|78941511|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
44151297|NCT02552121|78941504|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44151298|NCT02552121|78941505|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
44151299|NCT02552121|78941506|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44151300|NCT02552121|78941507|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44151301|NCT02552121|78941508|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44255004|NCT02335944|79096863|FG001|Treatment Phase|Adverse Event|0|||
44531391|NCT03193736|79541219|FG000|Overall Study|implant not received|1|||
44531392|NCT03192488|79541227|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
44531393|NCT03192488|79541228|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
44531394|NCT03192488|79541229|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
44531395|NCT03192488|79541230|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
44531396|NCT03192488|79541231|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
44531397|NCT03192488|79541232|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
44531398|NCT03192488|79541227|FG000|Third Intervention (d1)|Adverse Event|0|||
44531399|NCT03192488|79541228|FG001|Third Intervention (d1)|Adverse Event|0|||
44255005|NCT02335944|79096864|FG002|Treatment Phase|Adverse Event|0|||
44255006|NCT02335944|79096865|FG003|Treatment Phase|Adverse Event|2|||
44531400|NCT03192488|79541229|FG002|Third Intervention (d1)|Adverse Event|0|||
44531401|NCT03192488|79541230|FG003|Third Intervention (d1)|Adverse Event|0|||
44151302|NCT02552121|78941509|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44151303|NCT02552121|78941510|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44151304|NCT02552121|78941511|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
44151305|NCT02552121|78941504|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
44151306|NCT02552121|78941505|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
44151307|NCT02552121|78941506|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
44151308|NCT02552121|78941507|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
44151309|NCT02552121|78941508|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
44151310|NCT02552121|78941509|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
44151311|NCT02552121|78941510|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
44531402|NCT03192488|79541231|FG004|Third Intervention (d1)|Adverse Event|1|||
44531403|NCT03192488|79541232|FG005|Third Intervention (d1)|Adverse Event|0|||
44531404|NCT01642004|79541248|FG000|Randomization|Adverse Event unrelated to study drug|1|||
44531405|NCT01642004|79541249|FG001|Randomization|Adverse Event unrelated to study drug|0|||
44531406|NCT01642004|79541248|FG000|Randomization|Participant withdrew consent|1|||
44531407|NCT01642004|79541249|FG001|Randomization|Participant withdrew consent|6|||
44531408|NCT01642004|79541248|FG000|Randomization|No longer meets study criteria|2|||
44531409|NCT01642004|79541249|FG001|Randomization|No longer meets study criteria|2|||
44531410|NCT01642004|79541248|FG000|Treatment|Disease progression|95|||
44151312|NCT02552121|78941511|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
44151313|NCT02552121|78941504|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
44151314|NCT02552121|78941505|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
44151315|NCT02552121|78941506|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
44151316|NCT02552121|78941507|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
44151317|NCT02552121|78941508|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
44151318|NCT02552121|78941509|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
44151319|NCT02552121|78941510|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
44151320|NCT02552121|78941511|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
44151321|NCT02552121|78941504|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
44151322|NCT02552121|78941505|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
44151323|NCT02552121|78941506|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
44151324|NCT02552121|78941507|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
44151325|NCT02552121|78941508|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
44151326|NCT02552121|78941509|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
44151327|NCT02552121|78941510|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
44151328|NCT02552121|78941511|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
44151329|NCT02552121|78941504|FG000|Part 2: Cohort Expansion|Death|0|||
44151330|NCT02552121|78941505|FG001|Part 2: Cohort Expansion|Death|0|||
44151331|NCT02552121|78941506|FG002|Part 2: Cohort Expansion|Death|1|||
44151332|NCT02552121|78941507|FG003|Part 2: Cohort Expansion|Death|0|||
44151333|NCT02552121|78941508|FG004|Part 2: Cohort Expansion|Death|0|||
44151334|NCT02552121|78941509|FG005|Part 2: Cohort Expansion|Death|0|||
44151335|NCT02552121|78941510|FG006|Part 2: Cohort Expansion|Death|0|||
44151336|NCT02552121|78941511|FG007|Part 2: Cohort Expansion|Death|0|||
44151337|NCT02552355|78941556|FG000|Overall Study|Adverse Event|0|||
44151338|NCT02552355|78941557|FG001|Overall Study|Adverse Event|2|||
44151339|NCT02552355|78941558|FG002|Overall Study|Adverse Event|2|||
44151340|NCT02552355|78941559|FG003|Overall Study|Adverse Event|0|||
44151341|NCT02552355|78941556|FG000|Overall Study|Withdrawal by Subject|0|||
44151342|NCT02552355|78941557|FG001|Overall Study|Withdrawal by Subject|0|||
44151343|NCT02552355|78941558|FG002|Overall Study|Withdrawal by Subject|0|||
44151344|NCT02552355|78941559|FG003|Overall Study|Withdrawal by Subject|1|||
44151345|NCT02551731|78941569|FG000|Overall Study|Withdrawal by Subject|2|||
44151346|NCT02542605|78941573|FG000|Part B: Challenge Phase|Sponsor decision|1|||
44151347|NCT02542605|78941574|FG001|Part B: Challenge Phase|Sponsor decision|0|||
44255007|NCT02335944|79096866|FG004|Treatment Phase|Adverse Event|1|||
44151348|NCT02542605|78941575|FG002|Part B: Challenge Phase|Sponsor decision|0|||
44151349|NCT02542605|78941573|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
44151350|NCT02542605|78941574|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
44151351|NCT02542605|78941575|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
44255008|NCT02335944|79096867|FG005|Treatment Phase|Adverse Event|15|||
44151352|NCT02550873|78941586|FG000|Randomized Double Blind|Adverse Event|3|||
44255009|NCT02335944|79096868|FG006|Treatment Phase|Adverse Event|0|||
44255010|NCT02335944|79096869|FG007|Treatment Phase|Adverse Event|5|||
44255011|NCT02335944|79096870|FG008|Treatment Phase|Adverse Event|7|||
44255012|NCT02335944|79096871|FG009|Treatment Phase|Adverse Event|0|||
44151353|NCT02550873|78941587|FG001|Randomized Double Blind|Adverse Event|1|||
44151354|NCT02550873|78941588|FG002|Randomized Double Blind|Adverse Event|0|||
44151355|NCT02550873|78941586|FG000|Randomized Double Blind|Disease progression|1|||
44151356|NCT02550873|78941587|FG001|Randomized Double Blind|Disease progression|1|||
44151357|NCT02550873|78941588|FG002|Randomized Double Blind|Disease progression|0|||
44151358|NCT02550873|78941586|FG000|Open Label Extension|Study ongoing|0|||
44151359|NCT02550873|78941587|FG001|Open Label Extension|Study ongoing|0|||
44255013|NCT02335944|79096862|FG000|Treatment Phase|Physician Decision|0|||
44255014|NCT02335944|79096863|FG001|Treatment Phase|Physician Decision|0|||
44151360|NCT02550873|78941588|FG002|Open Label Extension|Study ongoing|111|||
44151361|NCT02550795|78941626|FG000|Overall Study|Physician Decision|0|||
44151362|NCT02550795|78941627|FG001|Overall Study|Physician Decision|1|||
44151363|NCT02550795|78941628|FG002|Overall Study|Physician Decision|0|||
44151364|NCT02541903|78941636|FG000|Overall Study|Death|1|||
44151365|NCT02541669|78941645|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
44151366|NCT02541669|78941646|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
44151367|NCT02541669|78941647|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
44151368|NCT02541669|78941648|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
44151369|NCT02541669|78941649|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
44151370|NCT02549859|78941660|FG000|Long-term 60 Hz DBS|Study Closed|1|||
44151371|NCT02688647|78941670|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
44151372|NCT02688647|78941671|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
44282580|NCT01892436|79245945|FG000|Overall Study|non-compliance with treatment|1|||
44282581|NCT01892436|79245946|FG001|Overall Study|non-compliance with treatment|0|||
44282582|NCT01892436|79245947|FG002|Overall Study|non-compliance with treatment|0|||
44282583|NCT01892436|79245948|FG003|Overall Study|non-compliance with treatment|0|||
44282584|NCT01892436|79245945|FG000|Overall Study|Adverse Event|7|||
44282585|NCT01892436|79245946|FG001|Overall Study|Adverse Event|6|||
44151373|NCT02688647|78941670|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
44151374|NCT02688647|78941671|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
44151375|NCT02688647|78941670|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
44151376|NCT02688647|78941671|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
44151377|NCT02688647|78941670|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
44151378|NCT02688647|78941671|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
44151379|NCT02688647|78941670|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
44151380|NCT02688647|78941671|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
44151381|NCT02688647|78941670|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
44151382|NCT02688647|78941671|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
44151383|NCT02688647|78941670|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
44255015|NCT02335944|79096864|FG002|Treatment Phase|Physician Decision|0|||
44255016|NCT02335944|79096865|FG003|Treatment Phase|Physician Decision|1|||
44255017|NCT02335944|79096866|FG004|Treatment Phase|Physician Decision|0|||
44255018|NCT02335944|79096867|FG005|Treatment Phase|Physician Decision|6|||
44255019|NCT02335944|79096868|FG006|Treatment Phase|Physician Decision|1|||
44255020|NCT02335944|79096869|FG007|Treatment Phase|Physician Decision|2|||
44255021|NCT02335944|79096870|FG008|Treatment Phase|Physician Decision|1|||
44255022|NCT02335944|79096871|FG009|Treatment Phase|Physician Decision|0|||
44282586|NCT01892436|79245947|FG002|Overall Study|Adverse Event|2|||
44255023|NCT02335944|79096862|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
44255024|NCT02335944|79096863|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
44255025|NCT02335944|79096864|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
44255026|NCT02335944|79096865|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
44255027|NCT02335944|79096866|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
44151384|NCT02688647|78941671|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
44255028|NCT02335944|79096867|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
44255029|NCT02335944|79096868|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
44255030|NCT02335944|79096869|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
44255031|NCT02335944|79096870|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
44255032|NCT02335944|79096871|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
44255033|NCT02335944|79096862|FG000|Treatment Phase|Subject/Guardian Decision|0|||
44255034|NCT02335944|79096863|FG001|Treatment Phase|Subject/Guardian Decision|0|||
44255035|NCT02335944|79096864|FG002|Treatment Phase|Subject/Guardian Decision|1|||
44255036|NCT02335944|79096865|FG003|Treatment Phase|Subject/Guardian Decision|0|||
44255037|NCT02335944|79096866|FG004|Treatment Phase|Subject/Guardian Decision|0|||
44255038|NCT02335944|79096867|FG005|Treatment Phase|Subject/Guardian Decision|1|||
44255039|NCT02335944|79096868|FG006|Treatment Phase|Subject/Guardian Decision|0|||
44255040|NCT02335944|79096869|FG007|Treatment Phase|Subject/Guardian Decision|4|||
44255041|NCT02335944|79096870|FG008|Treatment Phase|Subject/Guardian Decision|0|||
44255042|NCT02335944|79096871|FG009|Treatment Phase|Subject/Guardian Decision|0|||
44282587|NCT01892436|79245948|FG003|Overall Study|Adverse Event|3|||
44282588|NCT01853046|79245960|FG000|Overall Study|Withdrawal by Subject|1|||
44255043|NCT02335944|79096862|FG000|Post-treatment Follow-up|Progressive Disease|0|||
44282589|NCT01853046|79245961|FG001|Overall Study|Withdrawal by Subject|1|||
44255044|NCT02335944|79096863|FG001|Post-treatment Follow-up|Progressive Disease|0|||
44151385|NCT02687711|78941689|FG000|Overall Study|Adverse Event|89|||
44151386|NCT02687711|78941689|FG000|Overall Study|Lack of Efficacy|70|||
44282590|NCT01853046|79245960|FG000|Overall Study|Adverse Event|4|||
44282591|NCT01853046|79245961|FG001|Overall Study|Adverse Event|2|||
44282592|NCT01853046|79245960|FG000|Overall Study|Disease progression|13|||
44282593|NCT01853046|79245961|FG001|Overall Study|Disease progression|3|||
44282594|NCT01891890|79245971|FG000|Overall Study|Lost to Follow-up|0|||
44282595|NCT01891890|79245972|FG001|Overall Study|Lost to Follow-up|0|||
44282596|NCT01891890|79245973|FG002|Overall Study|Lost to Follow-up|1|||
44531411|NCT01642004|79541249|FG001|Treatment|Disease progression|79|||
44282597|NCT01891890|79245971|FG000|Overall Study|Study ended before endpoint reached|7|||
44531412|NCT01642004|79541248|FG000|Treatment|Study drug toxicity|10|||
44282598|NCT01891890|79245972|FG001|Overall Study|Study ended before endpoint reached|3|||
44282599|NCT01891890|79245973|FG002|Overall Study|Study ended before endpoint reached|6|||
44282600|NCT01852812|79245984|FG000|Overall Study|Adverse Event|0|||
44282601|NCT01852812|79245985|FG001|Overall Study|Adverse Event|0|||
44282602|NCT01852812|79245986|FG002|Overall Study|Adverse Event|1|||
44282603|NCT01852812|79245984|FG000|Overall Study|Non-compliance With Study Drug|0|||
44282604|NCT01852812|79245985|FG001|Overall Study|Non-compliance With Study Drug|1|||
44282605|NCT01852812|79245986|FG002|Overall Study|Non-compliance With Study Drug|0|||
44282606|NCT01869348|79245996|FG000|Overall Study|Withdrawal by Subject|1|||
44282607|NCT01869348|79245997|FG001|Overall Study|Withdrawal by Subject|1|||
44282608|NCT01869192|79246005|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
44282609|NCT01869192|79246006|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
44282610|NCT01869192|79246005|FG000|Postoperative Chemotherapy|Physician Decision|0|||
44282611|NCT01869192|79246006|FG001|Postoperative Chemotherapy|Physician Decision|2|||
44282612|NCT01868646|79246014|FG000|Overall Study|Do not meet inclusion criteria|3|||
44282613|NCT01868646|79246015|FG001|Overall Study|Do not meet inclusion criteria|5|||
44531413|NCT01642004|79541249|FG001|Treatment|Study drug toxicity|13|||
44531414|NCT01642004|79541248|FG000|Treatment|Death|1|||
44531415|NCT01642004|79541249|FG001|Treatment|Death|1|||
44531416|NCT01642004|79541248|FG000|Treatment|Adverse event unrelated to study drug|9|||
44531417|NCT01642004|79541249|FG001|Treatment|Adverse event unrelated to study drug|13|||
44531418|NCT01642004|79541248|FG000|Treatment|Maximum clinical benefit|1|||
44531419|NCT01642004|79541249|FG001|Treatment|Maximum clinical benefit|9|||
44151387|NCT02687711|78941689|FG000|Overall Study|Lost to Follow-up|20|||
44282614|NCT01852110|79246023|FG000|Overall Study|Adverse Event|12|||
44282615|NCT01852110|79246024|FG001|Overall Study|Adverse Event|5|||
44282616|NCT01852110|79246025|FG002|Overall Study|Adverse Event|0|||
44282617|NCT01852110|79246026|FG003|Overall Study|Adverse Event|0|||
44282618|NCT01852110|79246027|FG004|Overall Study|Adverse Event|0|||
44531420|NCT01642004|79541248|FG000|Treatment|Poor/non-compliance|1|||
44531421|NCT01642004|79541249|FG001|Treatment|Poor/non-compliance|0|||
44151388|NCT02687711|78941689|FG000|Overall Study|Consent withdrawn|15|||
44151389|NCT02687711|78941689|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
44151390|NCT02687711|78941689|FG000|Overall Study|Too expensive|4|||
44151391|NCT02687711|78941689|FG000|Overall Study|Participant moved abroad|1|||
44151392|NCT02687711|78941689|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
44151393|NCT02687711|78941689|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
44151394|NCT02687711|78941689|FG000|Overall Study|Disliked taste|1|||
44151395|NCT02687711|78941689|FG000|Overall Study|Low mood|1|||
44151396|NCT02687711|78941689|FG000|Overall Study|Side effects|1|||
44151397|NCT02687711|78941689|FG000|Overall Study|Change of Hospital|1|||
44151398|NCT02687711|78941689|FG000|Overall Study|Liver Encephalopathy|1|||
44151399|NCT02687711|78941689|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
44151400|NCT02687711|78941689|FG000|Overall Study|Withdrawn due to intake interruption|1|||
44151401|NCT02687711|78941689|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
44151402|NCT02687711|78941689|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
44151403|NCT02687711|78941689|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
44151404|NCT01662063|78941695|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
44151405|NCT01662063|78941696|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
44151406|NCT01662063|78941697|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
44151407|NCT01662063|78941695|FG000|Overall Study|Lack of Efficacy|1|||
44151408|NCT01662063|78941696|FG001|Overall Study|Lack of Efficacy|6|||
44151409|NCT01662063|78941697|FG002|Overall Study|Lack of Efficacy|0|||
44151410|NCT01662063|78941695|FG000|Overall Study|Lost to Follow-up|0|||
44151411|NCT01662063|78941696|FG001|Overall Study|Lost to Follow-up|4|||
44151412|NCT01662063|78941697|FG002|Overall Study|Lost to Follow-up|0|||
44151413|NCT01662063|78941695|FG000|Overall Study|Protocol Violation|1|||
44151414|NCT01662063|78941696|FG001|Overall Study|Protocol Violation|0|||
44151415|NCT01662063|78941697|FG002|Overall Study|Protocol Violation|0|||
44151416|NCT01662063|78941695|FG000|Overall Study|Withdrawal by Subject|2|||
44151417|NCT01662063|78941696|FG001|Overall Study|Withdrawal by Subject|4|||
44151418|NCT01662063|78941697|FG002|Overall Study|Withdrawal by Subject|1|||
44151419|NCT01662063|78941695|FG000|Overall Study|Physician Decision|0|||
44151420|NCT01662063|78941696|FG001|Overall Study|Physician Decision|2|||
44151421|NCT01662063|78941697|FG002|Overall Study|Physician Decision|0|||
44531422|NCT01642004|79541248|FG000|Treatment|No longer meets study criteria|1|||
44531423|NCT01642004|79541249|FG001|Treatment|No longer meets study criteria|2|||
44531424|NCT01642004|79541248|FG000|Treatment|Other reasons|2|||
44531425|NCT01642004|79541249|FG001|Treatment|Other reasons|0|||
44531426|NCT01642004|79541248|FG000|Treatment|Not reported|0|||
44531427|NCT01642004|79541249|FG001|Treatment|Not reported|3|||
44531428|NCT01642004|79541248|FG000|Treatment|Participant request to discontinue study treatment|6|||
44531429|NCT01642004|79541249|FG001|Treatment|Participant request to discontinue study treatment|4|||
44531430|NCT01642004|79541248|FG000|Treatment|Participant withdrew consent|5|||
44531431|NCT01642004|79541249|FG001|Treatment|Participant withdrew consent|5|||
44531432|NCT00042289|79541305|FG000|Overall Study|Lost to Follow-up|3|||
44531433|NCT00042289|79541306|FG001|Overall Study|Lost to Follow-up|0|||
44531434|NCT00042289|79541307|FG002|Overall Study|Lost to Follow-up|0|||
44531435|NCT00042289|79541308|FG003|Overall Study|Lost to Follow-up|1|||
44531436|NCT00042289|79541309|FG004|Overall Study|Lost to Follow-up|3|||
44531437|NCT00042289|79541310|FG005|Overall Study|Lost to Follow-up|3|||
44531438|NCT00042289|79541311|FG006|Overall Study|Lost to Follow-up|6|||
44531439|NCT00042289|79541312|FG007|Overall Study|Lost to Follow-up|1|||
44531440|NCT00042289|79541313|FG008|Overall Study|Lost to Follow-up|1|||
44531441|NCT00042289|79541314|FG009|Overall Study|Lost to Follow-up|0|||
44531442|NCT00042289|79541315|FG010|Overall Study|Lost to Follow-up|0|||
44531443|NCT00042289|79541316|FG011|Overall Study|Lost to Follow-up|0|||
44531444|NCT00042289|79541317|FG012|Overall Study|Lost to Follow-up|0|||
44531445|NCT00042289|79541318|FG013|Overall Study|Lost to Follow-up|0|||
44531446|NCT00042289|79541319|FG014|Overall Study|Lost to Follow-up|0|||
44531447|NCT00042289|79541320|FG015|Overall Study|Lost to Follow-up|1|||
44531448|NCT00042289|79541321|FG016|Overall Study|Lost to Follow-up|1|||
44531449|NCT00042289|79541322|FG017|Overall Study|Lost to Follow-up|0|||
44151422|NCT01662063|78941695|FG000|Overall Study|Other|0|||
44151423|NCT01662063|78941696|FG001|Overall Study|Other|1|||
44151424|NCT01662063|78941697|FG002|Overall Study|Other|0|||
44151425|NCT02548455|78941705|FG000|Overall Study|Withdrawal by Subject|27|||
44531450|NCT00042289|79541323|FG018|Overall Study|Lost to Follow-up|3|||
44531451|NCT00042289|79541324|FG019|Overall Study|Lost to Follow-up|2|||
44531452|NCT00042289|79541325|FG020|Overall Study|Lost to Follow-up|0|||
44531453|NCT00042289|79541326|FG021|Overall Study|Lost to Follow-up|0|||
44531454|NCT00042289|79541327|FG022|Overall Study|Lost to Follow-up|0|||
44151426|NCT02548455|78941705|FG000|Overall Study|Death|26|||
44151427|NCT02548455|78941705|FG000|Overall Study|Lost to Follow-up|14|||
44531455|NCT00042289|79541328|FG023|Overall Study|Lost to Follow-up|0|||
44531456|NCT00042289|79541329|FG024|Overall Study|Lost to Follow-up|0|||
44151428|NCT02548455|78941705|FG000|Overall Study|Visit not completed|173|||
44282619|NCT01852110|79246028|FG005|Overall Study|Adverse Event|0|||
44282620|NCT01852110|79246023|FG000|Overall Study|Lost to Follow-up|1|||
44282621|NCT01852110|79246024|FG001|Overall Study|Lost to Follow-up|3|||
44415082|NCT00806546|79422996|FG000|Overall Study|Protocol Violation|49|||
44415083|NCT00806546|79422996|FG000|Overall Study|Various|42|||
44415084|NCT00624832|79423004|FG000|Overall Study|Adverse Event|0|||
44415085|NCT00624832|79423005|FG001|Overall Study|Adverse Event|1|||
44415086|NCT00624832|79423006|FG002|Overall Study|Adverse Event|0|||
44415087|NCT00624832|79423007|FG003|Overall Study|Adverse Event|1|||
44415088|NCT00624832|79423004|FG000|Overall Study|Abnormal Laboratory Value|2|||
44531457|NCT00042289|79541330|FG025|Overall Study|Lost to Follow-up|0|||
44151429|NCT02691455|78941711|FG000|Overall Study|Withdrawal by Subject|1|||
44151430|NCT02691455|78941712|FG001|Overall Study|Withdrawal by Subject|2|||
44151431|NCT02691455|78941711|FG000|Overall Study|Lost to Follow-up|15|||
44151432|NCT02691455|78941712|FG001|Overall Study|Lost to Follow-up|15|||
44151433|NCT02534883|78941720|FG000|Overall Study|Early Termination|8|||
44151434|NCT02534883|78941721|FG001|Overall Study|Early Termination|3|||
44151435|NCT02685995|78941729|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
44151436|NCT02685995|78941730|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
44151437|NCT02548143|78941738|FG000|Overall Study|Adverse Event|1|||
44151438|NCT02548143|78941739|FG001|Overall Study|Adverse Event|0|||
44151439|NCT02548143|78941738|FG000|Overall Study|Withdrawal by Subject|0|||
44151440|NCT02548143|78941739|FG001|Overall Study|Withdrawal by Subject|1|||
44282622|NCT01852110|79246025|FG002|Overall Study|Lost to Follow-up|0|||
44282623|NCT01852110|79246026|FG003|Overall Study|Lost to Follow-up|0|||
44282624|NCT01852110|79246027|FG004|Overall Study|Lost to Follow-up|0|||
44151441|NCT02547441|78941747|FG000|Double-Blind Study Period|Adverse Event|4|||
44151442|NCT02547441|78941748|FG001|Double-Blind Study Period|Adverse Event|9|||
44151443|NCT02547441|78941747|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
44151444|NCT02547441|78941748|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
44151445|NCT02547441|78941747|FG000|Double-Blind Study Period|Physician Decision|1|||
44151446|NCT02547441|78941748|FG001|Double-Blind Study Period|Physician Decision|0|||
44151447|NCT02547441|78941747|FG000|Double-Blind Study Period|Protocol Violation|1|||
44151448|NCT02547441|78941748|FG001|Double-Blind Study Period|Protocol Violation|2|||
44151449|NCT02547441|78941747|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
44151450|NCT02547441|78941748|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
44151451|NCT02547441|78941747|FG000|Double-Blind Study Period|Sponsor Decision|1|||
44151452|NCT02547441|78941748|FG001|Double-Blind Study Period|Sponsor Decision|0|||
44151453|NCT02547441|78941747|FG000|Open-Label Study Period|Adverse Event|10|||
44151454|NCT02547441|78941748|FG001|Open-Label Study Period|Adverse Event|11|||
44151455|NCT02547441|78941747|FG000|Open-Label Study Period|Lack of Efficacy|3|||
44151456|NCT02547441|78941748|FG001|Open-Label Study Period|Lack of Efficacy|2|||
44151457|NCT02547441|78941747|FG000|Open-Label Study Period|Lost to Follow-up|7|||
44151458|NCT02547441|78941748|FG001|Open-Label Study Period|Lost to Follow-up|8|||
44151459|NCT02547441|78941747|FG000|Open-Label Study Period|Physician Decision|1|||
44151460|NCT02547441|78941748|FG001|Open-Label Study Period|Physician Decision|0|||
44151461|NCT02547441|78941747|FG000|Open-Label Study Period|Protocol Violation|2|||
44151462|NCT02547441|78941748|FG001|Open-Label Study Period|Protocol Violation|0|||
44255045|NCT02335944|79096864|FG002|Post-treatment Follow-up|Progressive Disease|0|||
44255046|NCT02335944|79096865|FG003|Post-treatment Follow-up|Progressive Disease|1|||
44255047|NCT02335944|79096866|FG004|Post-treatment Follow-up|Progressive Disease|0|||
44255048|NCT02335944|79096867|FG005|Post-treatment Follow-up|Progressive Disease|9|||
44255049|NCT02335944|79096868|FG006|Post-treatment Follow-up|Progressive Disease|0|||
44531458|NCT00042289|79541331|FG026|Overall Study|Lost to Follow-up|2|||
44531459|NCT00042289|79541332|FG027|Overall Study|Lost to Follow-up|2|||
44531460|NCT00042289|79541333|FG028|Overall Study|Lost to Follow-up|2|||
44531461|NCT00042289|79541334|FG029|Overall Study|Lost to Follow-up|0|||
44531462|NCT00042289|79541335|FG030|Overall Study|Lost to Follow-up|0|||
44531463|NCT00042289|79541336|FG031|Overall Study|Lost to Follow-up|2|||
44531464|NCT00042289|79541337|FG032|Overall Study|Lost to Follow-up|1|||
44151463|NCT02547441|78941747|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
44255050|NCT02335944|79096869|FG007|Post-treatment Follow-up|Progressive Disease|2|||
44415089|NCT00624832|79423005|FG001|Overall Study|Abnormal Laboratory Value|0|||
44255051|NCT02335944|79096870|FG008|Post-treatment Follow-up|Progressive Disease|3|||
44255052|NCT02335944|79096871|FG009|Post-treatment Follow-up|Progressive Disease|0|||
44531465|NCT00042289|79541338|FG033|Overall Study|Lost to Follow-up|1|||
44531466|NCT00042289|79541339|FG034|Overall Study|Lost to Follow-up|1|||
44282625|NCT01852110|79246028|FG005|Overall Study|Lost to Follow-up|0|||
44282626|NCT01852110|79246023|FG000|Overall Study|Non-compliance with Study Drug|2|||
44531467|NCT00042289|79541340|FG035|Overall Study|Lost to Follow-up|2|||
44151464|NCT02547441|78941748|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
44151465|NCT02547441|78941747|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
44151466|NCT02547441|78941748|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
44415090|NCT00624832|79423006|FG002|Overall Study|Abnormal Laboratory Value|0|||
44282627|NCT01852110|79246024|FG001|Overall Study|Non-compliance with Study Drug|1|||
44282628|NCT01852110|79246025|FG002|Overall Study|Non-compliance with Study Drug|0|||
44282629|NCT01852110|79246026|FG003|Overall Study|Non-compliance with Study Drug|0|||
44282630|NCT01852110|79246027|FG004|Overall Study|Non-compliance with Study Drug|0|||
44282631|NCT01852110|79246028|FG005|Overall Study|Non-compliance with Study Drug|0|||
44282632|NCT01852110|79246023|FG000|Overall Study|Physician Decision|1|||
44282633|NCT01852110|79246024|FG001|Overall Study|Physician Decision|0|||
44282634|NCT01852110|79246025|FG002|Overall Study|Physician Decision|0|||
44282635|NCT01852110|79246026|FG003|Overall Study|Physician Decision|0|||
44282636|NCT01852110|79246027|FG004|Overall Study|Physician Decision|0|||
44282637|NCT01852110|79246028|FG005|Overall Study|Physician Decision|0|||
44282638|NCT01852110|79246023|FG000|Overall Study|Protocol Violation|0|||
44282639|NCT01852110|79246024|FG001|Overall Study|Protocol Violation|1|||
44282640|NCT01852110|79246025|FG002|Overall Study|Protocol Violation|0|||
44282641|NCT01852110|79246026|FG003|Overall Study|Protocol Violation|0|||
44282642|NCT01852110|79246027|FG004|Overall Study|Protocol Violation|0|||
44282643|NCT01852110|79246028|FG005|Overall Study|Protocol Violation|0|||
44282644|NCT01852110|79246023|FG000|Overall Study|Study Terminated by Sponsor|30|||
44282645|NCT01852110|79246024|FG001|Overall Study|Study Terminated by Sponsor|32|||
44282646|NCT01852110|79246025|FG002|Overall Study|Study Terminated by Sponsor|0|||
44282647|NCT01852110|79246026|FG003|Overall Study|Study Terminated by Sponsor|0|||
44282648|NCT01852110|79246027|FG004|Overall Study|Study Terminated by Sponsor|0|||
44282649|NCT01852110|79246028|FG005|Overall Study|Study Terminated by Sponsor|0|||
44282650|NCT01852110|79246023|FG000|Overall Study|Withdrawal by Subject|4|||
44282651|NCT01852110|79246024|FG001|Overall Study|Withdrawal by Subject|4|||
44282652|NCT01852110|79246025|FG002|Overall Study|Withdrawal by Subject|0|||
44282653|NCT01852110|79246026|FG003|Overall Study|Withdrawal by Subject|0|||
44282654|NCT01852110|79246027|FG004|Overall Study|Withdrawal by Subject|0|||
44282655|NCT01852110|79246028|FG005|Overall Study|Withdrawal by Subject|0|||
44282656|NCT01851720|79246044|FG000|Overall Study|Lost to Follow-up|0|||
44282657|NCT01851720|79246045|FG001|Overall Study|Lost to Follow-up|1|||
44282658|NCT01851330|79246054|FG000|Overall Study|Lack of Efficacy|10|||
44282659|NCT01851330|79246055|FG001|Overall Study|Lack of Efficacy|9|||
44282660|NCT01851330|79246056|FG002|Overall Study|Lack of Efficacy|2|||
44282661|NCT01851330|79246054|FG000|Overall Study|Lost to Follow-up|1|||
44282662|NCT01851330|79246055|FG001|Overall Study|Lost to Follow-up|6|||
44282663|NCT01851330|79246056|FG002|Overall Study|Lost to Follow-up|9|||
44531468|NCT00042289|79541341|FG036|Overall Study|Lost to Follow-up|1|||
44531469|NCT00042289|79541342|FG037|Overall Study|Lost to Follow-up|1|||
44531470|NCT00042289|79541343|FG038|Overall Study|Lost to Follow-up|0|||
44531471|NCT00042289|79541344|FG039|Overall Study|Lost to Follow-up|5|||
44531472|NCT00042289|79541345|FG040|Overall Study|Lost to Follow-up|0|||
44531473|NCT00042289|79541346|FG041|Overall Study|Lost to Follow-up|2|||
44531474|NCT00042289|79541347|FG042|Overall Study|Lost to Follow-up|2|||
44531475|NCT00042289|79541348|FG043|Overall Study|Lost to Follow-up|0|||
44531476|NCT00042289|79541349|FG044|Overall Study|Lost to Follow-up|0|||
44531477|NCT00042289|79541350|FG045|Overall Study|Lost to Follow-up|1|||
44531478|NCT00042289|79541351|FG046|Overall Study|Lost to Follow-up|0|||
44531479|NCT00042289|79541305|FG000|Overall Study|Other reason|0|||
44531480|NCT00042289|79541306|FG001|Overall Study|Other reason|0|||
44531481|NCT00042289|79541307|FG002|Overall Study|Other reason|0|||
44531482|NCT00042289|79541308|FG003|Overall Study|Other reason|2|||
44531483|NCT00042289|79541309|FG004|Overall Study|Other reason|0|||
44255053|NCT02335944|79096862|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255054|NCT02335944|79096863|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255055|NCT02335944|79096864|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255056|NCT02335944|79096865|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255057|NCT02335944|79096866|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255058|NCT02335944|79096867|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
44255059|NCT02335944|79096868|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255060|NCT02335944|79096869|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255061|NCT02335944|79096870|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44255062|NCT02335944|79096871|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
44282664|NCT01851330|79246054|FG000|Overall Study|Withdrew Consent|2|||
44282665|NCT01851330|79246055|FG001|Overall Study|Withdrew Consent|1|||
44282666|NCT01851330|79246056|FG002|Overall Study|Withdrew Consent|0|||
44282667|NCT01851330|79246054|FG000|Overall Study|Investigator's Discretion|0|||
44282668|NCT01851330|79246055|FG001|Overall Study|Investigator's Discretion|0|||
44282669|NCT01851330|79246056|FG002|Overall Study|Investigator's Discretion|1|||
44282670|NCT01868022|79246073|FG000|Overall Study|Withdrawal by Subject|0|||
44531484|NCT00042289|79541310|FG005|Overall Study|Other reason|0|||
44531485|NCT00042289|79541311|FG006|Overall Study|Other reason|0|||
44531486|NCT00042289|79541312|FG007|Overall Study|Other reason|0|||
44282671|NCT01868022|79246074|FG001|Overall Study|Withdrawal by Subject|0|||
44282672|NCT01868022|79246075|FG002|Overall Study|Withdrawal by Subject|1|||
44531487|NCT00042289|79541313|FG008|Overall Study|Other reason|0|||
44531488|NCT00042289|79541314|FG009|Overall Study|Other reason|0|||
44151467|NCT02540265|78941758|FG000|Overall Study|Lost to Follow-up|0|||
44151468|NCT02540265|78941759|FG001|Overall Study|Lost to Follow-up|0|||
44151469|NCT02540265|78941760|FG002|Overall Study|Lost to Follow-up|1|||
44151470|NCT02547363|78941770|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
44151471|NCT02547363|78941771|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
44151472|NCT02547363|78941770|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
44151473|NCT02547363|78941771|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
44151474|NCT02547363|78941770|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
44151475|NCT02547363|78941771|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
44151476|NCT02547363|78941770|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
44151477|NCT02547363|78941771|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
44531489|NCT00042289|79541315|FG010|Overall Study|Other reason|0|||
44531490|NCT00042289|79541316|FG011|Overall Study|Other reason|0|||
44531491|NCT00042289|79541317|FG012|Overall Study|Other reason|0|||
44531492|NCT00042289|79541318|FG013|Overall Study|Other reason|0|||
44531493|NCT00042289|79541319|FG014|Overall Study|Other reason|0|||
44151478|NCT02547363|78941770|FG000|12-month Follow-up|Withdrawal by Subject|4|||
44151479|NCT02547363|78941771|FG001|12-month Follow-up|Withdrawal by Subject|3|||
44151480|NCT02547363|78941770|FG000|12-month Follow-up|Lost to Follow-up|4|||
44151481|NCT02547363|78941771|FG001|12-month Follow-up|Lost to Follow-up|1|||
44151482|NCT02547363|78941770|FG000|12-month Follow-up|Lack of Efficacy|1|||
44151483|NCT02547363|78941771|FG001|12-month Follow-up|Lack of Efficacy|1|||
44151484|NCT02547363|78941770|FG000|12-month Follow-up|Other|1|||
44151485|NCT02547363|78941771|FG001|12-month Follow-up|Other|0|||
44151486|NCT02539797|78941779|FG000|Overall Study|Lost to Follow-up|0|||
44282673|NCT01868022|79246076|FG003|Overall Study|Withdrawal by Subject|1|||
44531494|NCT00042289|79541320|FG015|Overall Study|Other reason|0|||
44531495|NCT00042289|79541321|FG016|Overall Study|Other reason|0|||
44531496|NCT00042289|79541322|FG017|Overall Study|Other reason|0|||
44151487|NCT02539797|78941780|FG001|Overall Study|Lost to Follow-up|1|||
44151488|NCT02539797|78941781|FG002|Overall Study|Lost to Follow-up|0|||
44151489|NCT02684357|78941792|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
44151490|NCT02684357|78941793|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
44151491|NCT02684357|78941794|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
44151492|NCT02684357|78941795|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
44151493|NCT02684357|78941796|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
44151494|NCT02684357|78941797|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
44151495|NCT02684357|78941792|FG000|Part A|Lost to Follow-up|0|||
44151496|NCT02684357|78941793|FG001|Part A|Lost to Follow-up|2|||
44151497|NCT02684357|78941794|FG002|Part A|Lost to Follow-up|2|||
44151498|NCT02684357|78941795|FG003|Part A|Lost to Follow-up|0|||
44151499|NCT02684357|78941796|FG004|Part A|Lost to Follow-up|0|||
44151500|NCT02684357|78941797|FG005|Part A|Lost to Follow-up|0|||
44151501|NCT02684357|78941792|FG000|Part A|Withdrawal by Subject|3|||
44151502|NCT02684357|78941793|FG001|Part A|Withdrawal by Subject|0|||
44151503|NCT02684357|78941794|FG002|Part A|Withdrawal by Subject|0|||
44151504|NCT02684357|78941795|FG003|Part A|Withdrawal by Subject|0|||
44255063|NCT02335944|79096862|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255064|NCT02335944|79096863|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255065|NCT02335944|79096864|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255066|NCT02335944|79096865|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
44531497|NCT00042289|79541323|FG018|Overall Study|Other reason|1|||
44531498|NCT00042289|79541324|FG019|Overall Study|Other reason|0|||
44151505|NCT02684357|78941796|FG004|Part A|Withdrawal by Subject|0|||
44151506|NCT02684357|78941797|FG005|Part A|Withdrawal by Subject|0|||
44151507|NCT02684357|78941792|FG000|Part A|Other|0|||
44151508|NCT02684357|78941793|FG001|Part A|Other|1|||
44255067|NCT02335944|79096866|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
44151509|NCT02684357|78941794|FG002|Part A|Other|0|||
44151510|NCT02684357|78941795|FG003|Part A|Other|0|||
44151511|NCT02684357|78941796|FG004|Part A|Other|0|||
44255068|NCT02335944|79096867|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255069|NCT02335944|79096868|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255070|NCT02335944|79096869|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
44255071|NCT02335944|79096870|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255072|NCT02335944|79096871|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
44255073|NCT02335944|79096862|FG000|Post-treatment Follow-up|Adverse Event|0|||
44255074|NCT02335944|79096863|FG001|Post-treatment Follow-up|Adverse Event|0|||
44282674|NCT01868022|79246077|FG004|Overall Study|Withdrawal by Subject|0|||
44151512|NCT02684357|78941797|FG005|Part A|Other|0|||
44255075|NCT02335944|79096864|FG002|Post-treatment Follow-up|Adverse Event|0|||
44282675|NCT01868022|79246078|FG005|Overall Study|Withdrawal by Subject|0|||
44531499|NCT00042289|79541325|FG020|Overall Study|Other reason|0|||
44151513|NCT02684357|78941792|FG000|Part B|Adverse Event (Other)|0|||
44151514|NCT02684357|78941793|FG001|Part B|Adverse Event (Other)|0|||
44255076|NCT02335944|79096865|FG003|Post-treatment Follow-up|Adverse Event|0|||
44531500|NCT00042289|79541326|FG021|Overall Study|Other reason|0|||
44151515|NCT02684357|78941794|FG002|Part B|Adverse Event (Other)|0|||
44151516|NCT02684357|78941795|FG003|Part B|Adverse Event (Other)|1|||
44151517|NCT02684357|78941796|FG004|Part B|Adverse Event (Other)|1|||
44151518|NCT02684357|78941797|FG005|Part B|Adverse Event (Other)|1|||
44151519|NCT02684357|78941792|FG000|Part B|Lost to Follow-up|0|||
44151520|NCT02684357|78941793|FG001|Part B|Lost to Follow-up|0|||
44151521|NCT02684357|78941794|FG002|Part B|Lost to Follow-up|0|||
44151522|NCT02684357|78941795|FG003|Part B|Lost to Follow-up|1|||
44151523|NCT02684357|78941796|FG004|Part B|Lost to Follow-up|1|||
44151524|NCT02684357|78941797|FG005|Part B|Lost to Follow-up|7|||
44151525|NCT02684357|78941792|FG000|Part B|Withdrawal by Subject|0|||
44151526|NCT02684357|78941793|FG001|Part B|Withdrawal by Subject|0|||
44151527|NCT02684357|78941794|FG002|Part B|Withdrawal by Subject|0|||
44151528|NCT02684357|78941795|FG003|Part B|Withdrawal by Subject|0|||
44151529|NCT02684357|78941796|FG004|Part B|Withdrawal by Subject|2|||
44151530|NCT02684357|78941797|FG005|Part B|Withdrawal by Subject|4|||
44151531|NCT02684357|78941792|FG000|Part B|Other|0|||
44151532|NCT02684357|78941793|FG001|Part B|Other|0|||
44151533|NCT02684357|78941794|FG002|Part B|Other|0|||
44151534|NCT02684357|78941795|FG003|Part B|Other|1|||
44151535|NCT02684357|78941796|FG004|Part B|Other|0|||
44151536|NCT02684357|78941797|FG005|Part B|Other|1|||
44151537|NCT02684279|78941810|FG000|Overall Study|Adverse Event|87|||
44151538|NCT02684279|78941810|FG000|Overall Study|Lack of Efficacy|4|||
44151539|NCT02684279|78941810|FG000|Overall Study|Lost to Follow-up|61|||
44151540|NCT02684279|78941810|FG000|Overall Study|Protocol Violation|6|||
44151541|NCT02684279|78941810|FG000|Overall Study|Pregnancy|8|||
44151542|NCT02684279|78941810|FG000|Overall Study|Withdrawal by Subject|92|||
44151543|NCT02684279|78941810|FG000|Overall Study|non-compliance with study drug|9|||
44151544|NCT02684279|78941810|FG000|Overall Study|non compliance with study visits|2|||
44151545|NCT02684279|78941810|FG000|Overall Study|subject to have surgery|1|||
44151546|NCT02684279|78941810|FG000|Overall Study|family emergency|1|||
44151547|NCT02684279|78941810|FG000|Overall Study|Site closures|7|||
44151548|NCT02684279|78941810|FG000|Overall Study|Physician Decision|1|||
44151549|NCT02534493|78941814|FG000|Overall Study|Lost to Follow-up|1|||
44151550|NCT02534493|78941814|FG000|Overall Study|Withdrawal by Subject|1|||
44151551|NCT02547129|78941822|FG000|Overall Study|Difficulty with ongoing infection|1|||
44151552|NCT02547129|78941823|FG001|Overall Study|Difficulty with ongoing infection|0|||
44151553|NCT02546193|78941831|FG000|Overall Study|Withdrawal by Subject|2|||
44151554|NCT02546193|78941832|FG001|Overall Study|Withdrawal by Subject|0|||
44151555|NCT02546193|78941833|FG002|Overall Study|Withdrawal by Subject|1|||
44151556|NCT02546193|78941834|FG003|Overall Study|Withdrawal by Subject|0|||
44151557|NCT02546193|78941831|FG000|Overall Study|Not eligible at time of induction|4|||
44151558|NCT02546193|78941832|FG001|Overall Study|Not eligible at time of induction|6|||
44151559|NCT02546193|78941833|FG002|Overall Study|Not eligible at time of induction|1|||
44151560|NCT02546193|78941834|FG003|Overall Study|Not eligible at time of induction|0|||
44151561|NCT02538471|78941840|FG000|Overall Study|Progression of disease|2|||
44151562|NCT01661595|78941848|FG000|Phase 1: Week 0-4|Adverse Event|1|||
44151563|NCT01661595|78941849|FG001|Phase 1: Week 0-4|Adverse Event|0|||
44151564|NCT01661595|78941850|FG002|Phase 1: Week 0-4|Adverse Event|0|||
44151565|NCT01661595|78941851|FG003|Phase 1: Week 0-4|Adverse Event|0|||
44151566|NCT01661595|78941848|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
44151567|NCT01661595|78941849|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
44151568|NCT01661595|78941850|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
44151569|NCT01661595|78941851|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
44151570|NCT02213133|78941871|FG000|Overall Study|Participant discontinued study therapy|2|||
44151571|NCT02213133|78941872|FG001|Overall Study|Participant discontinued study therapy|0|||
44151572|NCT02213133|78941873|FG002|Overall Study|Participant discontinued study therapy|0|||
44151573|NCT02213133|78941871|FG000|Overall Study|Participant withdrew informed consent|2|||
44151574|NCT02213133|78941872|FG001|Overall Study|Participant withdrew informed consent|1|||
44151575|NCT02213133|78941873|FG002|Overall Study|Participant withdrew informed consent|2|||
44255077|NCT02335944|79096866|FG004|Post-treatment Follow-up|Adverse Event|0|||
44255078|NCT02335944|79096867|FG005|Post-treatment Follow-up|Adverse Event|1|||
44151576|NCT02213133|78941871|FG000|Overall Study|Disease progression|11|||
44151577|NCT02213133|78941872|FG001|Overall Study|Disease progression|2|||
44151578|NCT02213133|78941873|FG002|Overall Study|Disease progression|0|||
44151579|NCT02213133|78941871|FG000|Overall Study|Adverse Event (AE)|1|||
44151580|NCT02213133|78941872|FG001|Overall Study|Adverse Event (AE)|0|||
44151581|NCT02213133|78941873|FG002|Overall Study|Adverse Event (AE)|0|||
44151582|NCT02213133|78941871|FG000|Overall Study|Death|16|||
44151583|NCT02213133|78941872|FG001|Overall Study|Death|2|||
44255079|NCT02335944|79096868|FG006|Post-treatment Follow-up|Adverse Event|0|||
44255080|NCT02335944|79096869|FG007|Post-treatment Follow-up|Adverse Event|0|||
44151584|NCT02213133|78941873|FG002|Overall Study|Death|1|||
44151585|NCT02213133|78941871|FG000|Overall Study|Other|5|||
44151586|NCT02213133|78941872|FG001|Overall Study|Other|0|||
44151587|NCT02213133|78941873|FG002|Overall Study|Other|0|||
44151588|NCT02684981|78941885|FG000|Overall Study|Permanently discontinued the treatment|157|||
44151589|NCT02684981|78941886|FG001|Overall Study|Permanently discontinued the treatment|161|||
44151590|NCT02684981|78941887|FG002|Overall Study|Permanently discontinued the treatment|110|||
44151591|NCT02684981|78941885|FG000|Overall Study|Other|83|||
44151592|NCT02684981|78941886|FG001|Overall Study|Other|49|||
44151593|NCT02684981|78941887|FG002|Overall Study|Other|17|||
44151594|NCT02146833|78941901|FG000|Overall Study|Death|10|||
44151595|NCT02146833|78941901|FG000|Overall Study|No longer consented to study treatment|1|||
44151596|NCT02690207|78941905|FG000|Overall Study|Lost to Follow-up|48|||
44151597|NCT02690207|78941905|FG000|Overall Study|Withdrawal by Subject|46|||
44151598|NCT02690207|78941905|FG000|Overall Study|Protocol Violation|2|||
44151599|NCT02690207|78941905|FG000|Overall Study|Serious adverse event|110|||
44151600|NCT02690207|78941905|FG000|Overall Study|Non-serious Adverse Event|18|||
44151601|NCT02690207|78941905|FG000|Overall Study|Migrated/moved from study area|5|||
44151602|NCT02690207|78941905|FG000|Overall Study|Suspected HZ Episode|1|||
44151603|NCT02690207|78941905|FG000|Overall Study|Other reasons for withdrawal|23|||
44151604|NCT02689349|78941911|FG000|Overall Study|Not implanted|4|||
44151605|NCT02689349|78941912|FG001|Overall Study|Not implanted|0|||
44151606|NCT02689349|78941911|FG000|Overall Study|Withdrawal by Subject|9|||
44151607|NCT02689349|78941912|FG001|Overall Study|Withdrawal by Subject|0|||
44151608|NCT02679287|78941923|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
44151609|NCT02679287|78941924|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
44151610|NCT02679287|78941923|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
44151611|NCT02679287|78941924|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
44151612|NCT02679287|78941923|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
44151613|NCT02679287|78941924|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
44151614|NCT02679287|78941923|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
44151615|NCT02679287|78941924|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
44151616|NCT02679287|78941923|FG000|Period 2|Work/Scheduling Conflict|1|||
44151617|NCT02679287|78941924|FG001|Period 2|Work/Scheduling Conflict|0|||
44151618|NCT02679287|78941923|FG000|Period 2|Disliked Mobile System|2|||
44151619|NCT02679287|78941924|FG001|Period 2|Disliked Mobile System|0|||
44151620|NCT02679287|78941923|FG000|Period 3|Work/Scheduling Conflict|0|||
44151621|NCT02679287|78941924|FG001|Period 3|Work/Scheduling Conflict|1|||
44151622|NCT02544633|78941940|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
44151623|NCT02544633|78941941|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
44151624|NCT02544633|78941942|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
44151625|NCT02544633|78941943|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
44151626|NCT02544633|78941940|FG000|Treatment Period|Adverse Event|7|||
44151627|NCT02544633|78941941|FG001|Treatment Period|Adverse Event|4|||
44151628|NCT02544633|78941942|FG002|Treatment Period|Adverse Event|0|||
44282676|NCT01868022|79246079|FG006|Overall Study|Withdrawal by Subject|0|||
44282677|NCT01868022|79246080|FG007|Overall Study|Withdrawal by Subject|1|||
44282678|NCT01868022|79246081|FG008|Overall Study|Withdrawal by Subject|0|||
44282679|NCT01868022|79246073|FG000|Overall Study|Adverse Event|0|||
44282680|NCT01868022|79246074|FG001|Overall Study|Adverse Event|0|||
44282681|NCT01868022|79246075|FG002|Overall Study|Adverse Event|0|||
44282682|NCT01868022|79246076|FG003|Overall Study|Adverse Event|0|||
44282683|NCT01868022|79246077|FG004|Overall Study|Adverse Event|2|||
44282684|NCT01868022|79246078|FG005|Overall Study|Adverse Event|0|||
44282685|NCT01868022|79246079|FG006|Overall Study|Adverse Event|0|||
44282686|NCT01868022|79246080|FG007|Overall Study|Adverse Event|2|||
44282687|NCT01868022|79246081|FG008|Overall Study|Adverse Event|2|||
44282688|NCT01868022|79246073|FG000|Overall Study|Physician Decision|0|||
44282689|NCT01868022|79246074|FG001|Overall Study|Physician Decision|0|||
44415091|NCT00624832|79423007|FG003|Overall Study|Abnormal Laboratory Value|0|||
44415092|NCT00633880|79423019|FG000|Open Label Titration|Lack of Efficacy|1|||
44415093|NCT00633880|79423020|FG001|Open Label Titration|Lack of Efficacy|0|||
44415094|NCT00633880|79423021|FG002|Open Label Titration|Lack of Efficacy|0|||
44531501|NCT00042289|79541327|FG022|Overall Study|Other reason|0|||
44531502|NCT00042289|79541328|FG023|Overall Study|Other reason|1|||
44531503|NCT00042289|79541329|FG024|Overall Study|Other reason|0|||
44531504|NCT00042289|79541330|FG025|Overall Study|Other reason|0|||
44531505|NCT00042289|79541331|FG026|Overall Study|Other reason|1|||
44151629|NCT02544633|78941943|FG003|Treatment Period|Adverse Event|5|||
44151630|NCT02544633|78941940|FG000|Treatment Period|Lack of Efficacy|17|||
44151631|NCT02544633|78941941|FG001|Treatment Period|Lack of Efficacy|11|||
44151632|NCT02544633|78941942|FG002|Treatment Period|Lack of Efficacy|5|||
44151633|NCT02544633|78941943|FG003|Treatment Period|Lack of Efficacy|5|||
44151634|NCT02544633|78941940|FG000|Treatment Period|Global Deterioration of Health|3|||
44151635|NCT02544633|78941941|FG001|Treatment Period|Global Deterioration of Health|3|||
44151636|NCT02544633|78941942|FG002|Treatment Period|Global Deterioration of Health|0|||
44151637|NCT02544633|78941943|FG003|Treatment Period|Global Deterioration of Health|1|||
44282690|NCT01868022|79246075|FG002|Overall Study|Physician Decision|0|||
44282691|NCT01868022|79246076|FG003|Overall Study|Physician Decision|0|||
44415095|NCT00633880|79423019|FG000|Open Label Titration|Adverse Event|13|||
44531506|NCT00042289|79541332|FG027|Overall Study|Other reason|0|||
44151638|NCT02544633|78941940|FG000|Treatment Period|Withdrawal by Subject|1|||
44151639|NCT02544633|78941941|FG001|Treatment Period|Withdrawal by Subject|0|||
44151640|NCT02544633|78941942|FG002|Treatment Period|Withdrawal by Subject|0|||
44151641|NCT02544633|78941943|FG003|Treatment Period|Withdrawal by Subject|0|||
44151642|NCT02544633|78941940|FG000|Treatment Period|Lost to Follow-up|0|||
44151643|NCT02544633|78941941|FG001|Treatment Period|Lost to Follow-up|1|||
44151644|NCT02544633|78941942|FG002|Treatment Period|Lost to Follow-up|0|||
44282692|NCT01868022|79246077|FG004|Overall Study|Physician Decision|0|||
44282693|NCT01868022|79246078|FG005|Overall Study|Physician Decision|1|||
44282694|NCT01868022|79246079|FG006|Overall Study|Physician Decision|0|||
44282695|NCT01868022|79246080|FG007|Overall Study|Physician Decision|2|||
44282696|NCT01868022|79246081|FG008|Overall Study|Physician Decision|0|||
44282697|NCT01868022|79246073|FG000|Overall Study|Study closed/terminated|0|||
44282698|NCT01868022|79246074|FG001|Overall Study|Study closed/terminated|0|||
44282699|NCT01868022|79246075|FG002|Overall Study|Study closed/terminated|0|||
44282700|NCT01868022|79246076|FG003|Overall Study|Study closed/terminated|0|||
44282701|NCT01868022|79246077|FG004|Overall Study|Study closed/terminated|0|||
44282702|NCT01868022|79246078|FG005|Overall Study|Study closed/terminated|0|||
44282703|NCT01868022|79246079|FG006|Overall Study|Study closed/terminated|0|||
44415096|NCT00633880|79423020|FG001|Open Label Titration|Adverse Event|0|||
44415097|NCT00633880|79423021|FG002|Open Label Titration|Adverse Event|0|||
44415098|NCT00633880|79423019|FG000|Open Label Titration|Treatment Failure|55|||
44151645|NCT02544633|78941943|FG003|Treatment Period|Lost to Follow-up|0|||
44151646|NCT02544633|78941940|FG000|Treatment Period|Death|0|||
44151647|NCT02544633|78941941|FG001|Treatment Period|Death|0|||
44151648|NCT02544633|78941942|FG002|Treatment Period|Death|1|||
44255081|NCT02335944|79096870|FG008|Post-treatment Follow-up|Adverse Event|0|||
44255082|NCT02335944|79096871|FG009|Post-treatment Follow-up|Adverse Event|0|||
44255083|NCT02335944|79096862|FG000|Post-treatment Follow-up|Death|0|||
44255084|NCT02335944|79096863|FG001|Post-treatment Follow-up|Death|0|||
44255085|NCT02335944|79096864|FG002|Post-treatment Follow-up|Death|0|||
44255086|NCT02335944|79096865|FG003|Post-treatment Follow-up|Death|1|||
44255087|NCT02335944|79096866|FG004|Post-treatment Follow-up|Death|0|||
44255088|NCT02335944|79096867|FG005|Post-treatment Follow-up|Death|1|||
44255089|NCT02335944|79096868|FG006|Post-treatment Follow-up|Death|0|||
44255090|NCT02335944|79096869|FG007|Post-treatment Follow-up|Death|0|||
44255091|NCT02335944|79096870|FG008|Post-treatment Follow-up|Death|0|||
44255092|NCT02335944|79096871|FG009|Post-treatment Follow-up|Death|0|||
44255093|NCT02335944|79096862|FG000|Post-treatment Follow-up|Physician Decision|1|||
44255094|NCT02335944|79096863|FG001|Post-treatment Follow-up|Physician Decision|0|||
44255095|NCT02335944|79096864|FG002|Post-treatment Follow-up|Physician Decision|0|||
44255096|NCT02335944|79096865|FG003|Post-treatment Follow-up|Physician Decision|0|||
44255097|NCT02335944|79096866|FG004|Post-treatment Follow-up|Physician Decision|0|||
44255098|NCT02335944|79096867|FG005|Post-treatment Follow-up|Physician Decision|0|||
44255099|NCT02335944|79096868|FG006|Post-treatment Follow-up|Physician Decision|0|||
44255100|NCT02335944|79096869|FG007|Post-treatment Follow-up|Physician Decision|1|||
44255101|NCT02335944|79096870|FG008|Post-treatment Follow-up|Physician Decision|0|||
44255102|NCT02335944|79096871|FG009|Post-treatment Follow-up|Physician Decision|0|||
44255105|NCT02200445|79096957|FG000|Overall Study|Lack of Efficacy|1|||
44255106|NCT02200445|79096958|FG001|Overall Study|Lack of Efficacy|2|||
44255107|NCT02200445|79096959|FG002|Overall Study|Lack of Efficacy|2|||
44255108|NCT02200445|79096957|FG000|Overall Study|Adverse Event|0|||
44255109|NCT02200445|79096958|FG001|Overall Study|Adverse Event|2|||
44255110|NCT02200445|79096959|FG002|Overall Study|Adverse Event|0|||
44255111|NCT02058693|79096969|FG000|Phase 1|Withdrawal by Subject|3|||
44255112|NCT02058693|79096970|FG001|Phase 1|Withdrawal by Subject|2|||
44255113|NCT02058693|79096969|FG000|Phase 1|Adverse Event|0|||
44255114|NCT02058693|79096970|FG001|Phase 1|Adverse Event|1|||
44255115|NCT02058693|79096969|FG000|Phase 1|Lack of Efficacy|1|||
44255116|NCT02058693|79096970|FG001|Phase 1|Lack of Efficacy|0|||
44255117|NCT02058693|79096969|FG000|Phase 1|Physician Decision|1|||
44255118|NCT02058693|79096970|FG001|Phase 1|Physician Decision|1|||
44282704|NCT01868022|79246080|FG007|Overall Study|Study closed/terminated|1|||
44282705|NCT01868022|79246081|FG008|Overall Study|Study closed/terminated|0|||
44282706|NCT01868022|79246073|FG000|Overall Study|Ongoing|0|||
44282707|NCT01868022|79246074|FG001|Overall Study|Ongoing|0|||
44282708|NCT01868022|79246075|FG002|Overall Study|Ongoing|0|||
44282709|NCT01868022|79246076|FG003|Overall Study|Ongoing|0|||
44282710|NCT01868022|79246077|FG004|Overall Study|Ongoing|0|||
44282711|NCT01868022|79246078|FG005|Overall Study|Ongoing|0|||
44282712|NCT01868022|79246079|FG006|Overall Study|Ongoing|0|||
44282713|NCT01868022|79246080|FG007|Overall Study|Ongoing|3|||
44282714|NCT01868022|79246081|FG008|Overall Study|Ongoing|0|||
44282715|NCT01850004|79246107|FG000|Overall Study|Poor/Non-compliance|1|||
44282716|NCT01850004|79246107|FG000|Overall Study|Participant Withdrew Consent|9|||
44282717|NCT01850004|79246107|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
44282718|NCT01850004|79246107|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
44282719|NCT01850004|79246107|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
44282720|NCT01850004|79246107|FG000|Overall Study|Other Reasons|2|||
44282721|NCT01850004|79246107|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
44282722|NCT01850004|79246107|FG000|Overall Study|Maximum Clinical Benefit|4|||
44282723|NCT01867710|79246115|FG000|Overall Study|Death|25|||
44282724|NCT01867710|79246116|FG001|Overall Study|Death|15|||
44282725|NCT01867710|79246117|FG002|Overall Study|Death|27|||
44282726|NCT01867710|79246118|FG003|Overall Study|Death|20|||
44282727|NCT01867710|79246115|FG000|Overall Study|Lost to Follow-up|3|||
44282728|NCT01867710|79246116|FG001|Overall Study|Lost to Follow-up|4|||
44282729|NCT01867710|79246117|FG002|Overall Study|Lost to Follow-up|3|||
44282730|NCT01867710|79246118|FG003|Overall Study|Lost to Follow-up|2|||
44282731|NCT01867710|79246115|FG000|Overall Study|Withdrawal of consent|2|||
44282732|NCT01867710|79246116|FG001|Overall Study|Withdrawal of consent|5|||
44282733|NCT01867710|79246117|FG002|Overall Study|Withdrawal of consent|1|||
44282734|NCT01867710|79246118|FG003|Overall Study|Withdrawal of consent|2|||
44282735|NCT01867710|79246115|FG000|Overall Study|Study Terminated by Sponsor|9|||
44282736|NCT01867710|79246116|FG001|Overall Study|Study Terminated by Sponsor|13|||
44282737|NCT01867710|79246117|FG002|Overall Study|Study Terminated by Sponsor|8|||
44282738|NCT01867710|79246118|FG003|Overall Study|Study Terminated by Sponsor|16|||
44282739|NCT01867710|79246115|FG000|Overall Study|Biochemical progression|0|||
44282740|NCT01867710|79246116|FG001|Overall Study|Biochemical progression|1|||
44282741|NCT01867710|79246117|FG002|Overall Study|Biochemical progression|0|||
44282742|NCT01867710|79246118|FG003|Overall Study|Biochemical progression|0|||
44282743|NCT01867710|79246115|FG000|Overall Study|Clinical progression|0|||
44282744|NCT01867710|79246116|FG001|Overall Study|Clinical progression|0|||
44282745|NCT01867710|79246117|FG002|Overall Study|Clinical progression|1|||
44282746|NCT01867710|79246118|FG003|Overall Study|Clinical progression|0|||
44415099|NCT00633880|79423020|FG001|Open Label Titration|Treatment Failure|0|||
44415100|NCT00633880|79423021|FG002|Open Label Titration|Treatment Failure|0|||
44415101|NCT00633880|79423019|FG000|Open Label Titration|Protocol Violation|6|||
44531507|NCT00042289|79541333|FG028|Overall Study|Other reason|3|||
44531508|NCT00042289|79541334|FG029|Overall Study|Other reason|0|||
44531509|NCT00042289|79541335|FG030|Overall Study|Other reason|0|||
44531510|NCT00042289|79541336|FG031|Overall Study|Other reason|1|||
44531511|NCT00042289|79541337|FG032|Overall Study|Other reason|0|||
44531512|NCT00042289|79541338|FG033|Overall Study|Other reason|1|||
44531513|NCT00042289|79541339|FG034|Overall Study|Other reason|0|||
44531514|NCT00042289|79541340|FG035|Overall Study|Other reason|2|||
44531515|NCT00042289|79541341|FG036|Overall Study|Other reason|0|||
44531516|NCT00042289|79541342|FG037|Overall Study|Other reason|0|||
44531517|NCT00042289|79541343|FG038|Overall Study|Other reason|0|||
44531518|NCT00042289|79541344|FG039|Overall Study|Other reason|0|||
44531519|NCT00042289|79541345|FG040|Overall Study|Other reason|0|||
44531520|NCT00042289|79541346|FG041|Overall Study|Other reason|0|||
44531521|NCT00042289|79541347|FG042|Overall Study|Other reason|0|||
44531522|NCT00042289|79541348|FG043|Overall Study|Other reason|1|||
44151649|NCT02544633|78941943|FG003|Treatment Period|Death|0|||
44255119|NCT02058693|79096969|FG000|Phase 2|Withdrawal by Subject|0|||
44282747|NCT01867710|79246115|FG000|Overall Study|Disease progression|1|||
44282748|NCT01867710|79246116|FG001|Overall Study|Disease progression|0|||
44282749|NCT01867710|79246117|FG002|Overall Study|Disease progression|0|||
44282750|NCT01867710|79246118|FG003|Overall Study|Disease progression|0|||
44282751|NCT01867710|79246115|FG000|Overall Study|Patient decision|0|||
44531523|NCT00042289|79541349|FG044|Overall Study|Other reason|0|||
44255120|NCT02058693|79096970|FG001|Phase 2|Withdrawal by Subject|2|||
44531524|NCT00042289|79541350|FG045|Overall Study|Other reason|0|||
44151650|NCT02544633|78941940|FG000|Treatment Period|Non-compliance|0|||
44151651|NCT02544633|78941941|FG001|Treatment Period|Non-compliance|0|||
44151652|NCT02544633|78941942|FG002|Treatment Period|Non-compliance|1|||
44151653|NCT02544633|78941943|FG003|Treatment Period|Non-compliance|0|||
44151654|NCT02544633|78941940|FG000|Treatment Period|Clinical Disease Progression|0|||
44151655|NCT02544633|78941941|FG001|Treatment Period|Clinical Disease Progression|0|||
44151656|NCT02544633|78941942|FG002|Treatment Period|Clinical Disease Progression|0|||
44151657|NCT02544633|78941943|FG003|Treatment Period|Clinical Disease Progression|1|||
44151658|NCT02544633|78941940|FG000|Survival Follow-up Period|Death|12|||
44151659|NCT02544633|78941941|FG001|Survival Follow-up Period|Death|14|||
44151660|NCT02544633|78941942|FG002|Survival Follow-up Period|Death|3|||
44151661|NCT02544633|78941943|FG003|Survival Follow-up Period|Death|9|||
44151662|NCT02544633|78941940|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
44151663|NCT02544633|78941941|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
44151664|NCT02544633|78941942|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
44151665|NCT02544633|78941943|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
44151666|NCT02544633|78941940|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
44282752|NCT01867710|79246116|FG001|Overall Study|Patient decision|0|||
44282753|NCT01867710|79246117|FG002|Overall Study|Patient decision|0|||
44151667|NCT02544633|78941941|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
44151668|NCT02544633|78941942|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
44151669|NCT02544633|78941943|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
44151670|NCT02544633|78941940|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
44151671|NCT02544633|78941941|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
44151672|NCT02544633|78941942|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
44151673|NCT02544633|78941943|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
44151674|NCT02678351|78941965|FG000|Overall Study|Withdrawal by Subject|1|||
44151675|NCT02683187|78941969|FG000|Overall Study|Failed IV access|3|||
44151676|NCT02683187|78941969|FG000|Overall Study|Withdrawal by Subject|5|||
44151677|NCT02683109|78941979|FG000|Overall Study|Adverse Event|1|||
44151678|NCT02683109|78941980|FG001|Overall Study|Adverse Event|0|||
44151679|NCT02544321|78941989|FG000|Overall Study|Withdrawal by Subject|1|||
44151680|NCT02544321|78941990|FG001|Overall Study|Withdrawal by Subject|2|||
44151681|NCT02544321|78941989|FG000|Overall Study|Adverse Event|1|||
44255121|NCT02039856|79096980|FG000|Overall Study|Death|5|||
44255122|NCT02039856|79096981|FG001|Overall Study|Death|3|||
44255123|NCT02039856|79096980|FG000|Overall Study|Partial survey completion|61|||
44255124|NCT02039856|79096981|FG001|Overall Study|Partial survey completion|26|||
44255125|NCT02039856|79096980|FG000|Overall Study|Lost to Follow-up|388|||
44255126|NCT02039856|79096981|FG001|Overall Study|Lost to Follow-up|206|||
44255127|NCT02039856|79096980|FG000|Overall Study|Withdrawal by Subject|1573|||
44255128|NCT02039856|79096981|FG001|Overall Study|Withdrawal by Subject|618|||
44531525|NCT00042289|79541351|FG046|Overall Study|Other reason|0|||
44531526|NCT00042289|79541305|FG000|Overall Study|Severe debilitation, unable to continue|0|||
44531527|NCT00042289|79541306|FG001|Overall Study|Severe debilitation, unable to continue|0|||
44531528|NCT00042289|79541307|FG002|Overall Study|Severe debilitation, unable to continue|0|||
44531529|NCT00042289|79541308|FG003|Overall Study|Severe debilitation, unable to continue|0|||
44531530|NCT00042289|79541309|FG004|Overall Study|Severe debilitation, unable to continue|0|||
44531531|NCT00042289|79541310|FG005|Overall Study|Severe debilitation, unable to continue|0|||
44531532|NCT00042289|79541311|FG006|Overall Study|Severe debilitation, unable to continue|0|||
44531533|NCT00042289|79541312|FG007|Overall Study|Severe debilitation, unable to continue|0|||
44531534|NCT00042289|79541313|FG008|Overall Study|Severe debilitation, unable to continue|0|||
44531535|NCT00042289|79541314|FG009|Overall Study|Severe debilitation, unable to continue|0|||
44531536|NCT00042289|79541315|FG010|Overall Study|Severe debilitation, unable to continue|0|||
44531537|NCT00042289|79541316|FG011|Overall Study|Severe debilitation, unable to continue|0|||
44531538|NCT00042289|79541317|FG012|Overall Study|Severe debilitation, unable to continue|0|||
44531539|NCT00042289|79541318|FG013|Overall Study|Severe debilitation, unable to continue|0|||
44531540|NCT00042289|79541319|FG014|Overall Study|Severe debilitation, unable to continue|0|||
44531541|NCT00042289|79541320|FG015|Overall Study|Severe debilitation, unable to continue|0|||
44531542|NCT00042289|79541321|FG016|Overall Study|Severe debilitation, unable to continue|0|||
44531543|NCT00042289|79541322|FG017|Overall Study|Severe debilitation, unable to continue|0|||
44531544|NCT00042289|79541323|FG018|Overall Study|Severe debilitation, unable to continue|0|||
44531545|NCT00042289|79541324|FG019|Overall Study|Severe debilitation, unable to continue|0|||
44531546|NCT00042289|79541325|FG020|Overall Study|Severe debilitation, unable to continue|0|||
44151682|NCT02544321|78941990|FG001|Overall Study|Adverse Event|1|||
44151683|NCT02544321|78941989|FG000|Overall Study|Protocol Violation|0|||
44151684|NCT02544321|78941990|FG001|Overall Study|Protocol Violation|1|||
44151685|NCT02533401|78942005|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
44151686|NCT02533401|78942005|FG000|Overall Study|Death|5|||
44255129|NCT01796392|79096991|FG000|Overall Study|Withdrawal by Subject|2|||
44255130|NCT01796392|79096992|FG001|Overall Study|Withdrawal by Subject|0|||
44255131|NCT01796392|79096991|FG000|Overall Study|Death|5|||
44282754|NCT01867710|79246118|FG003|Overall Study|Patient decision|1|||
44282755|NCT01867710|79246115|FG000|Overall Study|Patient to follow subsequent treatment|0|||
44282756|NCT01867710|79246116|FG001|Overall Study|Patient to follow subsequent treatment|1|||
44282757|NCT01867710|79246117|FG002|Overall Study|Patient to follow subsequent treatment|0|||
44531547|NCT00042289|79541326|FG021|Overall Study|Severe debilitation, unable to continue|1|||
44531548|NCT00042289|79541327|FG022|Overall Study|Severe debilitation, unable to continue|0|||
44531549|NCT00042289|79541328|FG023|Overall Study|Severe debilitation, unable to continue|1|||
44531550|NCT00042289|79541329|FG024|Overall Study|Severe debilitation, unable to continue|0|||
44282758|NCT01867710|79246118|FG003|Overall Study|Patient to follow subsequent treatment|0|||
44282759|NCT01867710|79246115|FG000|Overall Study|Progressive disease|1|||
44282760|NCT01867710|79246116|FG001|Overall Study|Progressive disease|0|||
44282761|NCT01867710|79246117|FG002|Overall Study|Progressive disease|0|||
44282762|NCT01867710|79246118|FG003|Overall Study|Progressive disease|0|||
44282763|NCT01867710|79246115|FG000|Overall Study|Protocol Violation|0|||
44282764|NCT01867710|79246116|FG001|Overall Study|Protocol Violation|0|||
44282765|NCT01867710|79246117|FG002|Overall Study|Protocol Violation|0|||
44282766|NCT01867710|79246118|FG003|Overall Study|Protocol Violation|1|||
44282767|NCT01867710|79246115|FG000|Overall Study|PSA-progression|0|||
44282768|NCT01867710|79246116|FG001|Overall Study|PSA-progression|1|||
44282769|NCT01867710|79246117|FG002|Overall Study|PSA-progression|0|||
44282770|NCT01867710|79246118|FG003|Overall Study|PSA-progression|0|||
44282771|NCT01867710|79246115|FG000|Overall Study|Study medication no longer effective|0|||
44282772|NCT01867710|79246116|FG001|Overall Study|Study medication no longer effective|1|||
44282773|NCT01867710|79246117|FG002|Overall Study|Study medication no longer effective|0|||
44282774|NCT01867710|79246118|FG003|Overall Study|Study medication no longer effective|0|||
44282775|NCT01849848|79246128|FG000|Overall Study|Physician Decision|1|||
44282776|NCT01849848|79246128|FG000|Overall Study|Progression of the primary disease|3|||
44282777|NCT01849458|79246132|FG000|Overall Study|Lost to Follow-up|4|||
44282778|NCT01832766|79246136|FG000|Washout|Lost to Follow-up|0|||
44282779|NCT01832766|79246137|FG001|Washout|Lost to Follow-up|1|||
44282780|NCT01832532|79246145|FG000|Overall Study|Withdrawal by Subject|5|||
44282781|NCT01832532|79246146|FG001|Overall Study|Withdrawal by Subject|2|||
44282782|NCT01848990|79246155|FG000|Overall Study|Adverse Event|6|||
44282783|NCT01848990|79246156|FG001|Overall Study|Adverse Event|2|||
44282784|NCT01848990|79246157|FG002|Overall Study|Adverse Event|0|||
44282785|NCT01848990|79246155|FG000|Overall Study|Lost to Follow-up|6|||
44282786|NCT01848990|79246156|FG001|Overall Study|Lost to Follow-up|2|||
44282787|NCT01848990|79246157|FG002|Overall Study|Lost to Follow-up|2|||
44282788|NCT01848990|79246155|FG000|Overall Study|Protocol Violation|1|||
44282789|NCT01848990|79246156|FG001|Overall Study|Protocol Violation|1|||
44282790|NCT01848990|79246157|FG002|Overall Study|Protocol Violation|0|||
44282791|NCT01848990|79246155|FG000|Overall Study|Withdrawal by Subject|29|||
44282792|NCT01848990|79246156|FG001|Overall Study|Withdrawal by Subject|10|||
44282793|NCT01848990|79246157|FG002|Overall Study|Withdrawal by Subject|11|||
44282794|NCT01848990|79246155|FG000|Overall Study|Physician Decision|1|||
44531551|NCT00042289|79541330|FG025|Overall Study|Severe debilitation, unable to continue|0|||
44531552|NCT00042289|79541331|FG026|Overall Study|Severe debilitation, unable to continue|0|||
44282795|NCT01848990|79246156|FG001|Overall Study|Physician Decision|1|||
44282796|NCT01848990|79246157|FG002|Overall Study|Physician Decision|0|||
44282797|NCT01848990|79246155|FG000|Overall Study|Non Compliance|1|||
44282798|NCT01848990|79246156|FG001|Overall Study|Non Compliance|0|||
44282799|NCT01848990|79246157|FG002|Overall Study|Non Compliance|0|||
44282800|NCT01848990|79246155|FG000|Overall Study|Death|1|||
44282801|NCT01848990|79246156|FG001|Overall Study|Death|0|||
44282802|NCT01848990|79246157|FG002|Overall Study|Death|1|||
44151687|NCT02533401|78942005|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
44282803|NCT01848990|79246155|FG000|Overall Study|Other|1|||
44282804|NCT01848990|79246156|FG001|Overall Study|Other|4|||
44531553|NCT00042289|79541332|FG027|Overall Study|Severe debilitation, unable to continue|1|||
44282805|NCT01848990|79246157|FG002|Overall Study|Other|2|||
44531554|NCT00042289|79541333|FG028|Overall Study|Severe debilitation, unable to continue|0|||
44531555|NCT00042289|79541334|FG029|Overall Study|Severe debilitation, unable to continue|0|||
44282806|NCT01867086|79246169|FG000|Overall Study|Disease Progression|1|||
44282807|NCT01831596|79246173|FG000|Overall Study|Other|8|||
44282808|NCT01848834|79246182|FG000|Overall Study|Adverse Event|3|||
44282809|NCT01848834|79246183|FG001|Overall Study|Adverse Event|11|||
44282810|NCT01848834|79246184|FG002|Overall Study|Adverse Event|3|||
44282811|NCT01848834|79246185|FG003|Overall Study|Adverse Event|5|||
44282812|NCT01848834|79246186|FG004|Overall Study|Adverse Event|9|||
44282813|NCT01848834|79246182|FG000|Overall Study|Death|2|||
44282814|NCT01848834|79246183|FG001|Overall Study|Death|11|||
44282815|NCT01848834|79246184|FG002|Overall Study|Death|1|||
44282816|NCT01848834|79246185|FG003|Overall Study|Death|8|||
44151688|NCT02533401|78942005|FG000|Overall Study|Lost to Follow-up|1|||
44151689|NCT02533401|78942005|FG000|Overall Study|Violation of Selection Criteria|1|||
44151690|NCT02536833|78942013|FG000|Overall Study|Discontinued Before Treatment|0|||
44282817|NCT01848834|79246186|FG004|Overall Study|Death|27|||
44151691|NCT02536833|78942014|FG001|Overall Study|Discontinued Before Treatment|0|||
44151692|NCT02536833|78942015|FG002|Overall Study|Discontinued Before Treatment|1|||
44151693|NCT02536833|78942016|FG003|Overall Study|Discontinued Before Treatment|2|||
44151694|NCT02536833|78942013|FG000|Overall Study|Adverse Event|1|||
44151695|NCT02536833|78942014|FG001|Overall Study|Adverse Event|3|||
44151696|NCT02536833|78942015|FG002|Overall Study|Adverse Event|4|||
44151697|NCT02536833|78942016|FG003|Overall Study|Adverse Event|1|||
44151698|NCT02536833|78942013|FG000|Overall Study|Lost to Follow-up|2|||
44151699|NCT02536833|78942014|FG001|Overall Study|Lost to Follow-up|1|||
44151700|NCT02536833|78942015|FG002|Overall Study|Lost to Follow-up|2|||
44151701|NCT02536833|78942016|FG003|Overall Study|Lost to Follow-up|2|||
44282818|NCT01848834|79246182|FG000|Overall Study|Excluded Medication|5|||
44282819|NCT01848834|79246183|FG001|Overall Study|Excluded Medication|4|||
44282820|NCT01848834|79246184|FG002|Overall Study|Excluded Medication|3|||
44282821|NCT01848834|79246185|FG003|Overall Study|Excluded Medication|6|||
44282822|NCT01848834|79246186|FG004|Overall Study|Excluded Medication|6|||
44282823|NCT01848834|79246182|FG000|Overall Study|Lost to Follow-up|5|||
44282824|NCT01848834|79246183|FG001|Overall Study|Lost to Follow-up|5|||
44282825|NCT01848834|79246184|FG002|Overall Study|Lost to Follow-up|3|||
44415102|NCT00633880|79423020|FG001|Open Label Titration|Protocol Violation|0|||
44415103|NCT00633880|79423021|FG002|Open Label Titration|Protocol Violation|0|||
44415104|NCT00633880|79423019|FG000|Open Label Titration|Physician Decision|1|||
44151702|NCT02536833|78942013|FG000|Overall Study|Physician Decision|0|||
44151703|NCT02536833|78942014|FG001|Overall Study|Physician Decision|0|||
44255132|NCT01796392|79096992|FG001|Overall Study|Death|1|||
44255133|NCT01796392|79096991|FG000|Overall Study|Excluded for medical reasons|1|||
44255134|NCT01796392|79096992|FG001|Overall Study|Excluded for medical reasons|2|||
44255135|NCT01796392|79096991|FG000|Overall Study|Lost to Follow-up|1|||
44255136|NCT01796392|79096992|FG001|Overall Study|Lost to Follow-up|0|||
44255137|NCT01571635|79097003|FG000|Overall Study|Adverse Event|3|||
44255138|NCT01571635|79097004|FG001|Overall Study|Adverse Event|0|||
44255139|NCT01571635|79097005|FG002|Overall Study|Adverse Event|2|||
44255140|NCT01571635|79097006|FG003|Overall Study|Adverse Event|3|||
44255141|NCT01571635|79097007|FG004|Overall Study|Adverse Event|5|||
44255142|NCT01571635|79097003|FG000|Overall Study|Other reasons|2|||
44255143|NCT01571635|79097004|FG001|Overall Study|Other reasons|1|||
44255144|NCT01571635|79097005|FG002|Overall Study|Other reasons|2|||
44255145|NCT01571635|79097006|FG003|Overall Study|Other reasons|2|||
44255146|NCT01571635|79097007|FG004|Overall Study|Other reasons|1|||
44255147|NCT01571635|79097003|FG000|Overall Study|Study terminated by sponsor|0|||
44282826|NCT01848834|79246185|FG003|Overall Study|Lost to Follow-up|0|||
44282827|NCT01848834|79246186|FG004|Overall Study|Lost to Follow-up|3|||
44151704|NCT02536833|78942015|FG002|Overall Study|Physician Decision|0|||
44151705|NCT02536833|78942016|FG003|Overall Study|Physician Decision|1|||
44255148|NCT01571635|79097004|FG001|Overall Study|Study terminated by sponsor|4|||
44255149|NCT01571635|79097005|FG002|Overall Study|Study terminated by sponsor|1|||
44255150|NCT01571635|79097006|FG003|Overall Study|Study terminated by sponsor|3|||
44255151|NCT01571635|79097007|FG004|Overall Study|Study terminated by sponsor|1|||
44282828|NCT01848834|79246182|FG000|Overall Study|Physician Decision|1|||
44282829|NCT01848834|79246183|FG001|Overall Study|Physician Decision|3|||
44282830|NCT01848834|79246184|FG002|Overall Study|Physician Decision|4|||
44282831|NCT01848834|79246185|FG003|Overall Study|Physician Decision|0|||
44282832|NCT01848834|79246186|FG004|Overall Study|Physician Decision|11|||
44531556|NCT00042289|79541335|FG030|Overall Study|Severe debilitation, unable to continue|0|||
44531557|NCT00042289|79541336|FG031|Overall Study|Severe debilitation, unable to continue|1|||
44531558|NCT00042289|79541337|FG032|Overall Study|Severe debilitation, unable to continue|1|||
44531559|NCT00042289|79541338|FG033|Overall Study|Severe debilitation, unable to continue|0|||
44531560|NCT00042289|79541339|FG034|Overall Study|Severe debilitation, unable to continue|0|||
44282833|NCT01848834|79246182|FG000|Overall Study|Protocol Violation|0|||
44282834|NCT01848834|79246183|FG001|Overall Study|Protocol Violation|0|||
44282835|NCT01848834|79246184|FG002|Overall Study|Protocol Violation|0|||
44282836|NCT01848834|79246185|FG003|Overall Study|Protocol Violation|0|||
44282837|NCT01848834|79246186|FG004|Overall Study|Protocol Violation|1|||
44282838|NCT01848834|79246182|FG000|Overall Study|Sponsor Decision|1|||
44282839|NCT01848834|79246183|FG001|Overall Study|Sponsor Decision|1|||
44282840|NCT01848834|79246184|FG002|Overall Study|Sponsor Decision|0|||
44282841|NCT01848834|79246185|FG003|Overall Study|Sponsor Decision|1|||
44282842|NCT01848834|79246186|FG004|Overall Study|Sponsor Decision|1|||
44282843|NCT01848834|79246182|FG000|Overall Study|Withdrawal by Subject|2|||
44282844|NCT01848834|79246183|FG001|Overall Study|Withdrawal by Subject|13|||
44282845|NCT01848834|79246184|FG002|Overall Study|Withdrawal by Subject|10|||
44282846|NCT01848834|79246185|FG003|Overall Study|Withdrawal by Subject|6|||
44282847|NCT01848834|79246186|FG004|Overall Study|Withdrawal by Subject|36|||
44282848|NCT01867008|79246202|FG000|Overall Study|Withdrawal by Subject|1|||
44282849|NCT01848756|79246206|FG000|Overall Study|Adverse Event|1|||
44282850|NCT01848756|79246206|FG000|Overall Study|Withdrawal by Subject|1|||
44282851|NCT01848756|79246206|FG000|Overall Study|Enrolled in Error|1|||
44282852|NCT01830972|79246213|FG000|Part II|Withdrawal by Subject|2|||
44282853|NCT01830972|79246214|FG001|Part II|Withdrawal by Subject|2|||
44282854|NCT01830972|79246213|FG000|Part III|Withdrawal by Subject|1|||
44282855|NCT01830972|79246214|FG001|Part III|Withdrawal by Subject|0|||
44282856|NCT01830972|79246213|FG000|Part III|Noncompliance|1|||
44282857|NCT01830972|79246214|FG001|Part III|Noncompliance|0|||
44282858|NCT01830972|79246213|FG000|Part IV|Withdrawal by Subject|2|||
44282859|NCT01830972|79246214|FG001|Part IV|Withdrawal by Subject|1|||
44282860|NCT01830972|79246213|FG000|Part IV|Non-Compliance|1|||
44282861|NCT01830972|79246214|FG001|Part IV|Non-Compliance|0|||
44282862|NCT01848288|79246230|FG000|Overall Study|Death|1|||
44282863|NCT01848288|79246230|FG000|Overall Study|Protocol Violation|1|||
44282864|NCT01848288|79246230|FG000|Overall Study|Withdrawal by Subject|1|||
44282865|NCT01848210|79246237|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
44282866|NCT01848210|79246238|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
44282867|NCT01848210|79246237|FG000|Overall Study|Lost to Follow-up|24|||
44282868|NCT01848210|79246238|FG001|Overall Study|Lost to Follow-up|12|||
44282869|NCT01848210|79246237|FG000|Overall Study|Protocol Violation|3|||
44282870|NCT01848210|79246238|FG001|Overall Study|Protocol Violation|5|||
44531561|NCT00042289|79541340|FG035|Overall Study|Severe debilitation, unable to continue|0|||
44531562|NCT00042289|79541341|FG036|Overall Study|Severe debilitation, unable to continue|0|||
44531563|NCT00042289|79541342|FG037|Overall Study|Severe debilitation, unable to continue|0|||
44531564|NCT00042289|79541343|FG038|Overall Study|Severe debilitation, unable to continue|0|||
44531565|NCT00042289|79541344|FG039|Overall Study|Severe debilitation, unable to continue|0|||
44531566|NCT00042289|79541345|FG040|Overall Study|Severe debilitation, unable to continue|0|||
44531567|NCT00042289|79541346|FG041|Overall Study|Severe debilitation, unable to continue|0|||
44531568|NCT00042289|79541347|FG042|Overall Study|Severe debilitation, unable to continue|0|||
44531569|NCT00042289|79541348|FG043|Overall Study|Severe debilitation, unable to continue|0|||
44531570|NCT00042289|79541349|FG044|Overall Study|Severe debilitation, unable to continue|0|||
44531571|NCT00042289|79541350|FG045|Overall Study|Severe debilitation, unable to continue|0|||
44531572|NCT00042289|79541351|FG046|Overall Study|Severe debilitation, unable to continue|0|||
44531573|NCT00042289|79541305|FG000|Overall Study|Site closed|0|||
44531574|NCT00042289|79541306|FG001|Overall Study|Site closed|0|||
44531575|NCT00042289|79541307|FG002|Overall Study|Site closed|0|||
44531576|NCT00042289|79541308|FG003|Overall Study|Site closed|0|||
44531577|NCT00042289|79541309|FG004|Overall Study|Site closed|0|||
44531578|NCT00042289|79541310|FG005|Overall Study|Site closed|0|||
44531579|NCT00042289|79541311|FG006|Overall Study|Site closed|0|||
44531580|NCT00042289|79541312|FG007|Overall Study|Site closed|0|||
44531581|NCT00042289|79541313|FG008|Overall Study|Site closed|0|||
44531582|NCT00042289|79541314|FG009|Overall Study|Site closed|0|||
44531583|NCT00042289|79541315|FG010|Overall Study|Site closed|0|||
44282871|NCT01848210|79246237|FG000|Overall Study|Use of Forbidden Drugs|9|||
44282872|NCT01848210|79246238|FG001|Overall Study|Use of Forbidden Drugs|10|||
44282873|NCT01848210|79246237|FG000|Overall Study|Impedition Condition|5|||
44282874|NCT01848210|79246238|FG001|Overall Study|Impedition Condition|9|||
44282875|NCT01848210|79246237|FG000|Overall Study|Adverse Event|7|||
44282876|NCT01848210|79246238|FG001|Overall Study|Adverse Event|9|||
44282877|NCT01848210|79246237|FG000|Overall Study|Discontinuation Criterion|5|||
44151706|NCT02536833|78942013|FG000|Overall Study|Site Terminated by Sponsor|2|||
44151707|NCT02536833|78942014|FG001|Overall Study|Site Terminated by Sponsor|2|||
44151708|NCT02536833|78942015|FG002|Overall Study|Site Terminated by Sponsor|2|||
44151709|NCT02536833|78942016|FG003|Overall Study|Site Terminated by Sponsor|2|||
44151710|NCT02536833|78942013|FG000|Overall Study|Subject Non-Compliance|0|||
44151711|NCT02536833|78942014|FG001|Overall Study|Subject Non-Compliance|1|||
44151712|NCT02536833|78942015|FG002|Overall Study|Subject Non-Compliance|1|||
44151713|NCT02536833|78942016|FG003|Overall Study|Subject Non-Compliance|0|||
44255152|NCT01571635|79097003|FG000|Overall Study|Withdrew consent|1|||
44255153|NCT01571635|79097004|FG001|Overall Study|Withdrew consent|1|||
44255154|NCT01571635|79097005|FG002|Overall Study|Withdrew consent|2|||
44255155|NCT01571635|79097006|FG003|Overall Study|Withdrew consent|3|||
44255156|NCT01571635|79097007|FG004|Overall Study|Withdrew consent|0|||
44255157|NCT01571635|79097003|FG000|Overall Study|Lack of Efficacy|0|||
44255158|NCT01571635|79097004|FG001|Overall Study|Lack of Efficacy|2|||
44255159|NCT01571635|79097005|FG002|Overall Study|Lack of Efficacy|0|||
44255160|NCT01571635|79097006|FG003|Overall Study|Lack of Efficacy|1|||
44255161|NCT01571635|79097007|FG004|Overall Study|Lack of Efficacy|2|||
44255162|NCT01248715|79097021|FG000|Overall Study|Not influenza positive|501|||
44255163|NCT01248715|79097022|FG001|Overall Study|Not influenza positive|510|||
44255164|NCT00812214|79097074|FG000|Overall Study|Lost to Follow-up|3|||
44255165|NCT00812214|79097075|FG001|Overall Study|Lost to Follow-up|1|||
44255166|NCT00217425|79097082|FG000|Overall Study|Never started treatment|2|||
44255167|NCT00217425|79097082|FG000|Overall Study|Patient ineligible|5|||
44255168|NCT00217425|79097082|FG000|Overall Study|Lack of Efficacy|13|||
44255169|NCT00217425|79097082|FG000|Overall Study|Adverse Event|8|||
44255170|NCT00217425|79097082|FG000|Overall Study|Withdrawal by Subject|4|||
44255171|NCT00217425|79097082|FG000|Overall Study|Other complicating disease|1|||
44255172|NCT00217425|79097082|FG000|Overall Study|Other|4|||
44255173|NCT03208231|79097101|FG000|Overall Study|Death|1|||
44255174|NCT03208231|79097102|FG001|Overall Study|Death|2|||
44255175|NCT03208231|79097101|FG000|Overall Study|Moved and unable to get to clinic|1|||
44255176|NCT03208231|79097102|FG001|Overall Study|Moved and unable to get to clinic|0|||
44255177|NCT03208231|79097101|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
44255178|NCT03208231|79097102|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
44255179|NCT03102242|79097121|FG000|Overall Study|Adverse Event|2|||
44255180|NCT03097328|79097125|FG000|Overall Study|Still on Therapy|2|||
44255181|NCT03097328|79097125|FG000|Overall Study|Progressive Disease|29|||
44255182|NCT03097328|79097125|FG000|Overall Study|Adverse Event|4|||
44255183|NCT03097328|79097125|FG000|Overall Study|Withdrawal by Subject|1|||
44255184|NCT03097328|79097125|FG000|Overall Study|Physician Decision|1|||
44255185|NCT03097328|79097125|FG000|Overall Study|Patient Decision|1|||
44255186|NCT03097328|79097125|FG000|Overall Study|Ineligible for Study Drug|1|||
44255187|NCT03033602|79097131|FG000|Overall Study|Withdrawal by Subject|11|||
44255188|NCT03033602|79097132|FG001|Overall Study|Withdrawal by Subject|21|||
44255189|NCT03033602|79097131|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
44255190|NCT03033602|79097132|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
44255191|NCT02994784|79097143|FG000|6 Months Follow-up|Lost to Follow-up|3|||
44255192|NCT02948829|79097147|FG000|Overall Study|Lost to Follow-up|2|||
44151714|NCT02536833|78942013|FG000|Overall Study|Withdrawal by Subject|4|||
44151715|NCT02536833|78942014|FG001|Overall Study|Withdrawal by Subject|3|||
44151716|NCT02536833|78942015|FG002|Overall Study|Withdrawal by Subject|5|||
44151717|NCT02536833|78942016|FG003|Overall Study|Withdrawal by Subject|11|||
44151718|NCT02680847|78942030|FG000|Overall Study|Other|2|||
44151719|NCT02680847|78942031|FG001|Overall Study|Other|0|||
44151720|NCT02680847|78942032|FG002|Overall Study|Other|0|||
44151721|NCT02680847|78942030|FG000|Overall Study|No longer met eligibility criteria|2|||
44151722|NCT02680847|78942031|FG001|Overall Study|No longer met eligibility criteria|2|||
44151723|NCT02680847|78942032|FG002|Overall Study|No longer met eligibility criteria|0|||
44151724|NCT02680847|78942030|FG000|Overall Study|Unwilling to participate in study|1|||
44255193|NCT02948829|79097147|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
44255194|NCT02948829|79097147|FG000|Overall Study|Pregnancy|1|||
44415105|NCT00633880|79423020|FG001|Open Label Titration|Physician Decision|0|||
44415106|NCT00633880|79423021|FG002|Open Label Titration|Physician Decision|0|||
44415107|NCT00633880|79423019|FG000|Open Label Titration|Withdrawal by Subject|4|||
44415108|NCT00633880|79423020|FG001|Open Label Titration|Withdrawal by Subject|0|||
44255195|NCT02948829|79097147|FG000|Overall Study|Other: Reason not Specified|8|||
44255196|NCT02617446|79097178|FG000|Overall Study|Withdrawal by Subject|0|||
44255197|NCT02617446|79097179|FG001|Overall Study|Withdrawal by Subject|2|||
44255198|NCT02617446|79097180|FG002|Overall Study|Withdrawal by Subject|0|||
44255199|NCT02617446|79097178|FG000|Overall Study|Adverse Event|1|||
44415109|NCT00633880|79423021|FG002|Open Label Titration|Withdrawal by Subject|0|||
44151725|NCT02680847|78942031|FG001|Overall Study|Unwilling to participate in study|1|||
44151726|NCT02680847|78942032|FG002|Overall Study|Unwilling to participate in study|0|||
44151727|NCT02680847|78942030|FG000|Overall Study|Lack of Efficacy|0|||
44151728|NCT02680847|78942031|FG001|Overall Study|Lack of Efficacy|0|||
44415110|NCT00590564|79423028|FG000|Overall Study|Withdrawal by Subject|4|||
44415111|NCT00590564|79423028|FG000|Overall Study|Lost to Follow-up|6|||
44415112|NCT00590564|79423028|FG000|Overall Study|Protocol Violation|1|||
44415113|NCT00590564|79423028|FG000|Overall Study|Patient Found to be Ineligible|1|||
44415114|NCT00590564|79423028|FG000|Overall Study|Patient Non-compliance|6|||
44415115|NCT00631696|79423034|FG000|Overall Study|Entered, not randomized to treatment|1|||
44415116|NCT00631696|79423035|FG001|Overall Study|Entered, not randomized to treatment|1|||
44415117|NCT00631696|79423034|FG000|Overall Study|Discontinued after database release date|1|||
44415118|NCT00631696|79423035|FG001|Overall Study|Discontinued after database release date|0|||
44415119|NCT00631696|79423034|FG000|Overall Study|Follow up after database release date|1|||
44415120|NCT00631696|79423035|FG001|Overall Study|Follow up after database release date|0|||
44415121|NCT00631696|79423034|FG000|Overall Study|Lost to Follow-up|7|||
44415122|NCT00631696|79423035|FG001|Overall Study|Lost to Follow-up|10|||
44415123|NCT00631696|79423034|FG000|Overall Study|Withdrawal by Subject|2|||
44415124|NCT00631696|79423035|FG001|Overall Study|Withdrawal by Subject|9|||
44415125|NCT00631696|79423034|FG000|Overall Study|Other|8|||
44415126|NCT00631696|79423035|FG001|Overall Study|Other|8|||
44415127|NCT00631696|79423034|FG000|Overall Study|Protocol Violation|9|||
44151729|NCT02680847|78942032|FG002|Overall Study|Lack of Efficacy|2|||
44151730|NCT02680847|78942030|FG000|Overall Study|Adverse Event|0|||
44151731|NCT02680847|78942031|FG001|Overall Study|Adverse Event|0|||
44151732|NCT02680847|78942032|FG002|Overall Study|Adverse Event|1|||
44151733|NCT02532855|78942042|FG000|Overall Study|Lost to Follow-up|4|||
44151734|NCT02532855|78942043|FG001|Overall Study|Lost to Follow-up|3|||
44151735|NCT02532855|78942042|FG000|Overall Study|Withdrawal by Subject|4|||
44151736|NCT02532855|78942043|FG001|Overall Study|Withdrawal by Subject|8|||
44151737|NCT02530125|78942049|FG000|Completed Treatment|Early termination of study|1|||
44151738|NCT02530125|78942049|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
44151739|NCT01661205|78942053|FG000|Overall Study|Physician Decision|2|||
44151740|NCT02055820|78942067|FG000|Phase I: Dose-Finding|Death|1|||
44282878|NCT01848210|79246238|FG001|Overall Study|Discontinuation Criterion|7|||
44282879|NCT01848210|79246237|FG000|Overall Study|Hypesensitivity|1|||
44282880|NCT01848210|79246238|FG001|Overall Study|Hypesensitivity|0|||
44151741|NCT02055820|78942068|FG001|Phase I: Dose-Finding|Death|0|||
44151742|NCT02055820|78942069|FG002|Phase I: Dose-Finding|Death|1|||
44151743|NCT02055820|78942070|FG003|Phase I: Dose-Finding|Death|2|||
44151744|NCT02055820|78942071|FG004|Phase I: Dose-Finding|Death|0|||
44151745|NCT02055820|78942072|FG005|Phase I: Dose-Finding|Death|1|||
44151746|NCT02055820|78942073|FG006|Phase I: Dose-Finding|Death|1|||
44151747|NCT02055820|78942074|FG007|Phase I: Dose-Finding|Death|0|||
44151748|NCT02055820|78942075|FG008|Phase I: Dose-Finding|Death|0|||
44151749|NCT02055820|78942076|FG009|Phase I: Dose-Finding|Death|0|||
44151750|NCT02055820|78942067|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44151751|NCT02055820|78942068|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44151752|NCT02055820|78942069|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44282881|NCT01848210|79246237|FG000|Overall Study|Hepatic Function Alteration|4|||
44282882|NCT01848210|79246238|FG001|Overall Study|Hepatic Function Alteration|0|||
44282883|NCT01848210|79246237|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
44282884|NCT01848210|79246238|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
44282885|NCT01848210|79246237|FG000|Overall Study|Administrative|1|||
44282886|NCT01848210|79246238|FG001|Overall Study|Administrative|0|||
44282887|NCT01830816|79246247|FG000|Overall Study|Progressive Disease|12|||
44282888|NCT01830816|79246248|FG001|Overall Study|Progressive Disease|7|||
44282889|NCT01830816|79246249|FG002|Overall Study|Progressive Disease|7|||
44282890|NCT01830816|79246247|FG000|Overall Study|Adverse Event|3|||
44282891|NCT01830816|79246248|FG001|Overall Study|Adverse Event|4|||
44282892|NCT01830816|79246249|FG002|Overall Study|Adverse Event|0|||
44282893|NCT01830816|79246247|FG000|Overall Study|Study Terminated by Sponsor|1|||
44282894|NCT01830816|79246248|FG001|Overall Study|Study Terminated by Sponsor|1|||
44282895|NCT01830816|79246249|FG002|Overall Study|Study Terminated by Sponsor|0|||
44282896|NCT01830816|79246247|FG000|Overall Study|Withdrawal by Subject|1|||
44151753|NCT02055820|78942070|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44151754|NCT02055820|78942071|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44151755|NCT02055820|78942072|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
44151756|NCT02055820|78942073|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44282897|NCT01830816|79246248|FG001|Overall Study|Withdrawal by Subject|1|||
44282898|NCT01830816|79246249|FG002|Overall Study|Withdrawal by Subject|0|||
44282899|NCT01830816|79246247|FG000|Overall Study|Lost to Follow-up|0|||
44415128|NCT00631696|79423035|FG001|Overall Study|Protocol Violation|9|||
44415129|NCT00631696|79423034|FG000|Overall Study|Study terminated by sponsor|3|||
44415130|NCT00631696|79423035|FG001|Overall Study|Study terminated by sponsor|3|||
44415131|NCT00631696|79423034|FG000|Overall Study|Adverse Event|5|||
44151757|NCT02055820|78942074|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44151758|NCT02055820|78942075|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44151759|NCT02055820|78942076|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
44282900|NCT01830816|79246248|FG001|Overall Study|Lost to Follow-up|1|||
44151760|NCT02055820|78942067|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151761|NCT02055820|78942068|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151762|NCT02055820|78942069|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151763|NCT02055820|78942070|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
44151764|NCT02055820|78942071|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151765|NCT02055820|78942072|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151766|NCT02055820|78942073|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
44151767|NCT02055820|78942074|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151768|NCT02055820|78942075|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151769|NCT02055820|78942076|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
44151770|NCT02055820|78942067|FG000|Phase II: Expansion|Death|0|||
44151771|NCT02055820|78942068|FG001|Phase II: Expansion|Death|0|||
44151772|NCT02055820|78942069|FG002|Phase II: Expansion|Death|0|||
44151773|NCT02055820|78942070|FG003|Phase II: Expansion|Death|0|||
44151774|NCT02055820|78942071|FG004|Phase II: Expansion|Death|33|||
44151775|NCT02055820|78942072|FG005|Phase II: Expansion|Death|0|||
44151776|NCT02055820|78942073|FG006|Phase II: Expansion|Death|0|||
44151777|NCT02055820|78942074|FG007|Phase II: Expansion|Death|0|||
44151778|NCT02055820|78942075|FG008|Phase II: Expansion|Death|0|||
44151779|NCT02055820|78942076|FG009|Phase II: Expansion|Death|0|||
44151780|NCT02055820|78942067|FG000|Phase II: Expansion|Lost to Follow-up|0|||
44151781|NCT02055820|78942068|FG001|Phase II: Expansion|Lost to Follow-up|0|||
44151782|NCT02055820|78942069|FG002|Phase II: Expansion|Lost to Follow-up|0|||
44151783|NCT02055820|78942070|FG003|Phase II: Expansion|Lost to Follow-up|0|||
44151784|NCT02055820|78942071|FG004|Phase II: Expansion|Lost to Follow-up|4|||
44151785|NCT02055820|78942072|FG005|Phase II: Expansion|Lost to Follow-up|0|||
44151786|NCT02055820|78942073|FG006|Phase II: Expansion|Lost to Follow-up|0|||
44151787|NCT02055820|78942074|FG007|Phase II: Expansion|Lost to Follow-up|0|||
44151788|NCT02055820|78942075|FG008|Phase II: Expansion|Lost to Follow-up|0|||
44151789|NCT02055820|78942076|FG009|Phase II: Expansion|Lost to Follow-up|0|||
44151790|NCT02055820|78942067|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
44151791|NCT02055820|78942068|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
44151792|NCT02055820|78942069|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
44151793|NCT02055820|78942070|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
44151794|NCT02055820|78942071|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
44151795|NCT02055820|78942072|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
44151796|NCT02055820|78942073|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
44151797|NCT02055820|78942074|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
44151798|NCT02055820|78942075|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
44151799|NCT02055820|78942076|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
44151800|NCT02055352|78942120|FG000|Overall Study|Adverse Event|0|||
44151801|NCT02055352|78942121|FG001|Overall Study|Adverse Event|1|||
44151802|NCT02055352|78942120|FG000|Overall Study|Non-eligible|0|||
44151803|NCT02055352|78942121|FG001|Overall Study|Non-eligible|1|||
44151804|NCT02055352|78942120|FG000|Overall Study|Poor compliance|1|||
44151805|NCT02055352|78942121|FG001|Overall Study|Poor compliance|1|||
44151806|NCT02055352|78942120|FG000|Overall Study|Death|1|||
44151807|NCT02055352|78942121|FG001|Overall Study|Death|2|||
44415132|NCT00631696|79423035|FG001|Overall Study|Adverse Event|0|||
44415133|NCT00631540|79423041|FG000|Overall Study|Withdrawal by Subject|5|||
44415134|NCT00631540|79423041|FG000|Overall Study|Death|4|||
44531584|NCT00042289|79541316|FG011|Overall Study|Site closed|0|||
44531585|NCT00042289|79541317|FG012|Overall Study|Site closed|0|||
44531586|NCT00042289|79541318|FG013|Overall Study|Site closed|0|||
44531587|NCT00042289|79541319|FG014|Overall Study|Site closed|0|||
44531588|NCT00042289|79541320|FG015|Overall Study|Site closed|0|||
44531589|NCT00042289|79541321|FG016|Overall Study|Site closed|0|||
44531590|NCT00042289|79541322|FG017|Overall Study|Site closed|0|||
44531591|NCT00042289|79541323|FG018|Overall Study|Site closed|0|||
44531592|NCT00042289|79541324|FG019|Overall Study|Site closed|0|||
44531593|NCT00042289|79541325|FG020|Overall Study|Site closed|0|||
44151808|NCT02055352|78942120|FG000|Overall Study|Patient decision|1|||
44151809|NCT02055352|78942121|FG001|Overall Study|Patient decision|1|||
44151810|NCT02055352|78942120|FG000|Overall Study|Use of prohibited treatment|0|||
44151811|NCT02055352|78942121|FG001|Overall Study|Use of prohibited treatment|3|||
44151812|NCT02055352|78942120|FG000|Overall Study|AE, study drug would be detrimental|1|||
44255200|NCT02617446|79097179|FG001|Overall Study|Adverse Event|0|||
44255201|NCT02617446|79097180|FG002|Overall Study|Adverse Event|5|||
44255202|NCT02617446|79097178|FG000|Overall Study|Lost to Follow-up|3|||
44255203|NCT02617446|79097179|FG001|Overall Study|Lost to Follow-up|0|||
44255204|NCT02617446|79097180|FG002|Overall Study|Lost to Follow-up|0|||
44415135|NCT00631540|79423041|FG000|Overall Study|Lost to Follow-up|2|||
44415136|NCT00631540|79423041|FG000|Overall Study|Core Lab Data Unavailable|3|||
44151813|NCT02055352|78942121|FG001|Overall Study|AE, study drug would be detrimental|3|||
44151814|NCT02055352|78942120|FG000|Overall Study|Withdrawal of informed consent|1|||
44151815|NCT02055352|78942121|FG001|Overall Study|Withdrawal of informed consent|0|||
44151816|NCT02055352|78942120|FG000|Overall Study|Reason unknown|1|||
44151817|NCT02055352|78942121|FG001|Overall Study|Reason unknown|5|||
44151818|NCT02034916|78942129|FG000|Overall Study|Death|39|||
44531594|NCT00042289|79541326|FG021|Overall Study|Site closed|0|||
44151819|NCT02034916|78942130|FG001|Overall Study|Death|28|||
44151820|NCT02034916|78942129|FG000|Overall Study|Withdrawal by Subject|2|||
44151821|NCT02034916|78942130|FG001|Overall Study|Withdrawal by Subject|1|||
44151822|NCT02034916|78942129|FG000|Overall Study|Lost to Follow-up|4|||
44151823|NCT02034916|78942130|FG001|Overall Study|Lost to Follow-up|1|||
44151824|NCT02034916|78942129|FG000|Overall Study|Study terminated by sponsor|4|||
44255205|NCT02617446|79097178|FG000|Overall Study|Death|0|||
44282901|NCT01830816|79246249|FG002|Overall Study|Lost to Follow-up|0|||
44282902|NCT01830816|79246247|FG000|Overall Study|Symptomatic Deterioration|1|||
44282903|NCT01830816|79246248|FG001|Overall Study|Symptomatic Deterioration|0|||
44282904|NCT01830816|79246249|FG002|Overall Study|Symptomatic Deterioration|0|||
44282905|NCT01830816|79246247|FG000|Overall Study|Reason not Specified|2|||
44282906|NCT01830816|79246248|FG001|Overall Study|Reason not Specified|0|||
44282907|NCT01830816|79246249|FG002|Overall Study|Reason not Specified|0|||
44282908|NCT01846416|79246263|FG000|Treatment Phase|Death|2|||
44282909|NCT01846416|79246264|FG001|Treatment Phase|Death|9|||
44282910|NCT01846416|79246265|FG002|Treatment Phase|Death|1|||
44282911|NCT01846416|79246263|FG000|Treatment Phase|Withdrawal by Subject|2|||
44282912|NCT01846416|79246264|FG001|Treatment Phase|Withdrawal by Subject|4|||
44282913|NCT01846416|79246265|FG002|Treatment Phase|Withdrawal by Subject|2|||
44282914|NCT01846416|79246263|FG000|Treatment Phase|Other|1|||
44282915|NCT01846416|79246264|FG001|Treatment Phase|Other|5|||
44255206|NCT02617446|79097179|FG001|Overall Study|Death|0|||
44255207|NCT02617446|79097180|FG002|Overall Study|Death|2|||
44255208|NCT02549170|79097194|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
44255209|NCT02549170|79097195|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
44255210|NCT02549170|79097196|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
44255211|NCT02549170|79097197|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
44255212|NCT02549170|79097198|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
44282916|NCT01846416|79246265|FG002|Treatment Phase|Other|1|||
44282917|NCT01846416|79246263|FG000|Treatment Phase|Physician Decision|1|||
44415137|NCT00630916|79423045|FG000|Overall Study|Death|110|||
44415138|NCT00630916|79423045|FG000|Overall Study|Explant|8|||
44531595|NCT00042289|79541327|FG022|Overall Study|Site closed|0|||
44531596|NCT00042289|79541328|FG023|Overall Study|Site closed|0|||
44531597|NCT00042289|79541329|FG024|Overall Study|Site closed|0|||
44531598|NCT00042289|79541330|FG025|Overall Study|Site closed|0|||
44531599|NCT00042289|79541331|FG026|Overall Study|Site closed|0|||
44531600|NCT00042289|79541332|FG027|Overall Study|Site closed|0|||
44531601|NCT00042289|79541333|FG028|Overall Study|Site closed|0|||
44531602|NCT00042289|79541334|FG029|Overall Study|Site closed|0|||
44531603|NCT00042289|79541335|FG030|Overall Study|Site closed|0|||
44531604|NCT00042289|79541336|FG031|Overall Study|Site closed|3|||
44531605|NCT00042289|79541337|FG032|Overall Study|Site closed|0|||
44531606|NCT00042289|79541338|FG033|Overall Study|Site closed|0|||
44531607|NCT00042289|79541339|FG034|Overall Study|Site closed|0|||
44151825|NCT02034916|78942130|FG001|Overall Study|Study terminated by sponsor|5|||
44151826|NCT01374425|78942139|FG000|Overall Study|Radiographic Disease Progression|86|||
44151827|NCT01374425|78942140|FG001|Overall Study|Radiographic Disease Progression|81|||
44151828|NCT01374425|78942139|FG000|Overall Study|Clinical Disease Progression|9|||
44151829|NCT01374425|78942140|FG001|Overall Study|Clinical Disease Progression|6|||
44151830|NCT01374425|78942139|FG000|Overall Study|Adverse Event|29|||
44151831|NCT01374425|78942140|FG001|Overall Study|Adverse Event|18|||
44151832|NCT01374425|78942139|FG000|Overall Study|Death (Progression of Disease)|1|||
44151833|NCT01374425|78942140|FG001|Overall Study|Death (Progression of Disease)|0|||
44151834|NCT01374425|78942139|FG000|Overall Study|Death (Adverse Event)|2|||
44531608|NCT00042289|79541340|FG035|Overall Study|Site closed|0|||
44531609|NCT00042289|79541341|FG036|Overall Study|Site closed|1|||
44531610|NCT00042289|79541342|FG037|Overall Study|Site closed|0|||
44531611|NCT00042289|79541343|FG038|Overall Study|Site closed|0|||
44531612|NCT00042289|79541344|FG039|Overall Study|Site closed|0|||
44531613|NCT00042289|79541345|FG040|Overall Study|Site closed|0|||
44531614|NCT00042289|79541346|FG041|Overall Study|Site closed|0|||
44531615|NCT00042289|79541347|FG042|Overall Study|Site closed|1|||
44151835|NCT01374425|78942140|FG001|Overall Study|Death (Adverse Event)|4|||
44151836|NCT01374425|78942139|FG000|Overall Study|Withdrawal by Subject|6|||
44151837|NCT01374425|78942140|FG001|Overall Study|Withdrawal by Subject|7|||
44151838|NCT01374425|78942139|FG000|Overall Study|Refused Treatment|10|||
44151839|NCT01374425|78942140|FG001|Overall Study|Refused Treatment|24|||
44151840|NCT01374425|78942139|FG000|Overall Study|Protocol Violation|2|||
44151841|NCT01374425|78942140|FG001|Overall Study|Protocol Violation|3|||
44151842|NCT01374425|78942139|FG000|Overall Study|Sponsor Decision|0|||
44151843|NCT01374425|78942140|FG001|Overall Study|Sponsor Decision|1|||
44151844|NCT01374425|78942139|FG000|Overall Study|Lost to Follow-up|2|||
44151845|NCT01374425|78942140|FG001|Overall Study|Lost to Follow-up|1|||
44151846|NCT01374425|78942139|FG000|Overall Study|Other|41|||
44151847|NCT01374425|78942140|FG001|Overall Study|Other|43|||
44531616|NCT00042289|79541348|FG043|Overall Study|Site closed|0|||
44531617|NCT00042289|79541349|FG044|Overall Study|Site closed|0|||
44151848|NCT02085460|78942170|FG000|Overall Study|Adverse Event|2|||
44255213|NCT02549170|79097194|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
44255214|NCT02549170|79097195|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
44255215|NCT02549170|79097196|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
44255216|NCT02549170|79097197|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
44255217|NCT02549170|79097198|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
44255218|NCT02549170|79097194|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
44255219|NCT02549170|79097195|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
44255220|NCT02549170|79097196|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
44255221|NCT02549170|79097197|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
44255222|NCT02549170|79097198|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
44255223|NCT02410902|79097215|FG000|Overall Study|Adverse Event|2|||
44255224|NCT02410902|79097216|FG001|Overall Study|Adverse Event|3|||
44255225|NCT02410902|79097215|FG000|Overall Study|Lost to Follow-up|4|||
44255226|NCT02410902|79097216|FG001|Overall Study|Lost to Follow-up|1|||
44255227|NCT02410902|79097215|FG000|Overall Study|Protocol Violation|1|||
44255228|NCT02410902|79097216|FG001|Overall Study|Protocol Violation|4|||
44255229|NCT02410902|79097215|FG000|Overall Study|Withdrawal by Subject|6|||
44255230|NCT02410902|79097216|FG001|Overall Study|Withdrawal by Subject|8|||
44255231|NCT02410902|79097215|FG000|Overall Study|Non-Compliance|8|||
44255232|NCT02410902|79097216|FG001|Overall Study|Non-Compliance|2|||
44255233|NCT02101736|79097226|FG000|Overall Study|Protocol Violation|3|||
44255234|NCT02101736|79097227|FG001|Overall Study|Protocol Violation|0|||
44255235|NCT02101736|79097226|FG000|Overall Study|Withdrawal by Subject|1|||
44415139|NCT00630916|79423045|FG000|Overall Study|Lost to Follow-up|5|||
44415140|NCT00630916|79423045|FG000|Overall Study|Withdrawal by Subject|30|||
44415141|NCT00630916|79423045|FG000|Overall Study|Protocol Violation|7|||
44255236|NCT02101736|79097227|FG001|Overall Study|Withdrawal by Subject|1|||
44255237|NCT01918397|79097239|FG000|Overall Study|Never started treatment|2|||
44255238|NCT01918397|79097240|FG001|Overall Study|Never started treatment|1|||
44255239|NCT01918397|79097241|FG002|Overall Study|Never started treatment|0|||
44255240|NCT01918397|79097242|FG003|Overall Study|Never started treatment|0|||
44255241|NCT01918397|79097239|FG000|Overall Study|Adverse Event|1|||
44255242|NCT01918397|79097240|FG001|Overall Study|Adverse Event|1|||
44255243|NCT01918397|79097241|FG002|Overall Study|Adverse Event|1|||
44255244|NCT01918397|79097242|FG003|Overall Study|Adverse Event|0|||
44255245|NCT01918397|79097239|FG000|Overall Study|Lack of compliance|2|||
44255246|NCT01918397|79097240|FG001|Overall Study|Lack of compliance|2|||
44255247|NCT01918397|79097241|FG002|Overall Study|Lack of compliance|3|||
44255248|NCT01918397|79097242|FG003|Overall Study|Lack of compliance|0|||
44255249|NCT01918397|79097239|FG000|Overall Study|Pregnancy|0|||
44255250|NCT01918397|79097240|FG001|Overall Study|Pregnancy|1|||
44255251|NCT01918397|79097241|FG002|Overall Study|Pregnancy|0|||
44255252|NCT01918397|79097242|FG003|Overall Study|Pregnancy|0|||
44255253|NCT01918397|79097239|FG000|Overall Study|Rifampin susceptible|0|||
44255254|NCT01918397|79097240|FG001|Overall Study|Rifampin susceptible|0|||
44255255|NCT01918397|79097241|FG002|Overall Study|Rifampin susceptible|0|||
44255256|NCT01918397|79097242|FG003|Overall Study|Rifampin susceptible|2|||
44255257|NCT01918397|79097239|FG000|Overall Study|Treatment failure|0|||
44255258|NCT01918397|79097240|FG001|Overall Study|Treatment failure|0|||
44255259|NCT01918397|79097241|FG002|Overall Study|Treatment failure|0|||
44255260|NCT01918397|79097242|FG003|Overall Study|Treatment failure|1|||
44255261|NCT01918397|79097239|FG000|Overall Study|Withdrawal by Subject|3|||
44255262|NCT01918397|79097240|FG001|Overall Study|Withdrawal by Subject|2|||
44255263|NCT01918397|79097241|FG002|Overall Study|Withdrawal by Subject|1|||
44255264|NCT01918397|79097242|FG003|Overall Study|Withdrawal by Subject|1|||
44255265|NCT01918397|79097239|FG000|Overall Study|XDR at baseline|0|||
44255266|NCT01918397|79097240|FG001|Overall Study|XDR at baseline|0|||
44255267|NCT01918397|79097241|FG002|Overall Study|XDR at baseline|1|||
44255268|NCT01918397|79097242|FG003|Overall Study|XDR at baseline|0|||
44255269|NCT01918397|79097239|FG000|Overall Study|Lost to Follow-up|2|||
44255270|NCT01918397|79097240|FG001|Overall Study|Lost to Follow-up|1|||
44255271|NCT01918397|79097241|FG002|Overall Study|Lost to Follow-up|1|||
44255272|NCT01918397|79097242|FG003|Overall Study|Lost to Follow-up|1|||
44255273|NCT01918397|79097239|FG000|Overall Study|Increased QTc|1|||
44255274|NCT01918397|79097240|FG001|Overall Study|Increased QTc|0|||
44255275|NCT01918397|79097241|FG002|Overall Study|Increased QTc|0|||
44255276|NCT01918397|79097242|FG003|Overall Study|Increased QTc|1|||
44255277|NCT01918397|79097239|FG000|Overall Study|Death|0|||
44255278|NCT01918397|79097240|FG001|Overall Study|Death|0|||
44255279|NCT01918397|79097241|FG002|Overall Study|Death|1|||
44415142|NCT00630916|79423045|FG000|Overall Study|Physician Decision|47|||
44255280|NCT01918397|79097242|FG003|Overall Study|Death|0|||
44255281|NCT01918397|79097239|FG000|Overall Study|Involved in another investigative trial|0|||
44255282|NCT01918397|79097240|FG001|Overall Study|Involved in another investigative trial|0|||
44255283|NCT01918397|79097241|FG002|Overall Study|Involved in another investigative trial|0|||
44255284|NCT01918397|79097242|FG003|Overall Study|Involved in another investigative trial|1|||
44255285|NCT00986921|79097276|FG000|Overall Study|Physician Decision|1|||
44255286|NCT00986921|79097277|FG001|Overall Study|Physician Decision|0|||
44255287|NCT01596972|79097288|FG000|Overall Study|Physician Decision|1|||
44255288|NCT01596972|79097289|FG001|Overall Study|Physician Decision|9|||
44255289|NCT01596972|79097288|FG000|Overall Study|Lost to Follow-up|0|||
44255290|NCT01596972|79097289|FG001|Overall Study|Lost to Follow-up|4|||
44255291|NCT01596972|79097288|FG000|Overall Study|Withdrawal by Subject|0|||
44255292|NCT01596972|79097289|FG001|Overall Study|Withdrawal by Subject|1|||
44255293|NCT00985751|79097390|FG000|Overall Study|Adverse Event|0|||
44255294|NCT00985751|79097391|FG001|Overall Study|Adverse Event|0|||
44255295|NCT00985751|79097392|FG002|Overall Study|Adverse Event|0|||
44255296|NCT00985751|79097393|FG003|Overall Study|Adverse Event|0|||
44255297|NCT00985751|79097394|FG004|Overall Study|Adverse Event|1|||
44255298|NCT01596582|79097439|FG000|Overall Study|Deemed ineligible after study visit|3|||
44255299|NCT01596582|79097440|FG001|Overall Study|Deemed ineligible after study visit|6|||
44255300|NCT01596582|79097439|FG000|Overall Study|Missing all outcome data|1|||
44255301|NCT01596582|79097440|FG001|Overall Study|Missing all outcome data|1|||
44255302|NCT01596504|79097456|FG000|Overall Study|Participant's Private Reason|0|||
44255303|NCT01596504|79097457|FG001|Overall Study|Participant's Private Reason|1|||
44255304|NCT01596504|79097458|FG002|Overall Study|Participant's Private Reason|0|||
44255305|NCT01596504|79097456|FG000|Overall Study|Adverse Event|1|||
44255306|NCT01596504|79097457|FG001|Overall Study|Adverse Event|2|||
44255307|NCT01596504|79097458|FG002|Overall Study|Adverse Event|1|||
44255308|NCT01596504|79097456|FG000|Overall Study|Withdrawal by Subject|1|||
44255309|NCT01596504|79097457|FG001|Overall Study|Withdrawal by Subject|0|||
44255310|NCT01596504|79097458|FG002|Overall Study|Withdrawal by Subject|0|||
44255311|NCT02616900|79097513|FG000|Overall Study|Lack of Efficacy|7|||
44255312|NCT02616900|79097513|FG000|Overall Study|Lost to Follow-up|2|||
44255313|NCT02616900|79097513|FG000|Overall Study|Protocol Violation|5|||
44255314|NCT02616900|79097513|FG000|Overall Study|Withdrawal by Subject|3|||
44255315|NCT02616900|79097513|FG000|Overall Study|Incomplete data|6|||
44255316|NCT00985673|79097625|FG000|Overall Study|Lost to Follow-up|6|||
44255317|NCT00985673|79097626|FG001|Overall Study|Lost to Follow-up|7|||
44255318|NCT00985673|79097627|FG002|Overall Study|Lost to Follow-up|6|||
44255319|NCT00985673|79097628|FG003|Overall Study|Lost to Follow-up|10|||
44255320|NCT00985673|79097629|FG004|Overall Study|Lost to Follow-up|5|||
44255321|NCT00985673|79097630|FG005|Overall Study|Lost to Follow-up|3|||
44255322|NCT00985673|79097625|FG000|Overall Study|Withdrawal by Subject|0|||
44255323|NCT00985673|79097626|FG001|Overall Study|Withdrawal by Subject|4|||
44255324|NCT00985673|79097627|FG002|Overall Study|Withdrawal by Subject|5|||
44255325|NCT00985673|79097628|FG003|Overall Study|Withdrawal by Subject|2|||
44255326|NCT00985673|79097629|FG004|Overall Study|Withdrawal by Subject|2|||
44255327|NCT00985673|79097630|FG005|Overall Study|Withdrawal by Subject|3|||
44255328|NCT00985673|79097625|FG000|Overall Study|Other|1|||
44255329|NCT00985673|79097626|FG001|Overall Study|Other|0|||
44255330|NCT00985673|79097627|FG002|Overall Study|Other|1|||
44255331|NCT00985673|79097628|FG003|Overall Study|Other|0|||
44255332|NCT00985673|79097629|FG004|Overall Study|Other|1|||
44255333|NCT00985673|79097630|FG005|Overall Study|Other|0|||
44255334|NCT00985439|79097676|FG000|Overall Study|Adverse Event|0|||
44255335|NCT00985439|79097677|FG001|Overall Study|Adverse Event|0|||
44255336|NCT00985439|79097678|FG002|Overall Study|Adverse Event|1|||
44255337|NCT00985439|79097679|FG003|Overall Study|Adverse Event|0|||
44255338|NCT02618928|79097689|FG000|Overall Study|Failure to Return|28|||
44255339|NCT02618928|79097689|FG000|Overall Study|Insufficient Virological Response|1|||
44255340|NCT02618928|79097689|FG000|Overall Study|Withdrawal by Subject|2|||
44255341|NCT02618928|79097689|FG000|Overall Study|Death|3|||
44255342|NCT02618928|79097689|FG000|Overall Study|Other|11|||
44255343|NCT02618928|79097689|FG000|Overall Study|Missing|6|||
44255344|NCT02618928|79097689|FG000|Overall Study|Treatment Never Started|7|||
44255345|NCT00983957|79097700|FG000|Overall Study|Adverse Event|1|||
44255346|NCT00983957|79097700|FG000|Overall Study|Personal Reasons|1|||
44255347|NCT00981149|79097754|FG000|Overall Study|Lost to Follow-up|1|||
44255348|NCT00981149|79097755|FG001|Overall Study|Lost to Follow-up|2|||
44255349|NCT00981149|79097754|FG000|Overall Study|Withdrawal by Subject|1|||
44255350|NCT00981149|79097755|FG001|Overall Study|Withdrawal by Subject|1|||
44255351|NCT01595646|79097813|FG000|Overall Study|Withdrawal by Subject|1|||
44255352|NCT01595646|79097814|FG001|Overall Study|Withdrawal by Subject|0|||
44255353|NCT01595646|79097815|FG002|Overall Study|Withdrawal by Subject|0|||
44255354|NCT00981461|79097843|FG000|Overall Study|Lost to Follow-up|5|||
44255355|NCT00981461|79097844|FG001|Overall Study|Lost to Follow-up|2|||
44255356|NCT02618616|79097861|FG000|Overall Study|Lack of Efficacy|4|||
44255357|NCT02618616|79097862|FG001|Overall Study|Lack of Efficacy|0|||
44255358|NCT02618616|79097861|FG000|Overall Study|Pregnancy|0|||
44255359|NCT02618616|79097862|FG001|Overall Study|Pregnancy|1|||
44255360|NCT02618616|79097861|FG000|Overall Study|Adverse Event|8|||
44255361|NCT02618616|79097862|FG001|Overall Study|Adverse Event|0|||
44255362|NCT02618616|79097861|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
44255363|NCT02618616|79097862|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
44531618|NCT00042289|79541350|FG045|Overall Study|Site closed|0|||
44531619|NCT00042289|79541351|FG046|Overall Study|Site closed|0|||
44531620|NCT00042289|79541305|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
44531621|NCT00042289|79541306|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
44151849|NCT02085460|78942171|FG001|Overall Study|Adverse Event|2|||
44151850|NCT02085460|78942172|FG002|Overall Study|Adverse Event|1|||
44151851|NCT02085460|78942170|FG000|Overall Study|Physician Decision|1|||
44151852|NCT02085460|78942171|FG001|Overall Study|Physician Decision|1|||
44151853|NCT02085460|78942172|FG002|Overall Study|Physician Decision|2|||
44151854|NCT02085460|78942170|FG000|Overall Study|Withdrawal by Subject|11|||
44531622|NCT00042289|79541307|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
44531623|NCT00042289|79541308|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
44531624|NCT00042289|79541309|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
44531625|NCT00042289|79541310|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
44531626|NCT00042289|79541311|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
44531627|NCT00042289|79541312|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
44531628|NCT00042289|79541313|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
44531629|NCT00042289|79541314|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
44531630|NCT00042289|79541315|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
44531631|NCT00042289|79541316|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
44151855|NCT02085460|78942171|FG001|Overall Study|Withdrawal by Subject|5|||
44151856|NCT02085460|78942172|FG002|Overall Study|Withdrawal by Subject|7|||
44151857|NCT02084134|78942182|FG000|Overall Study|Protocol Violation|4|||
44151858|NCT02084134|78942183|FG001|Overall Study|Protocol Violation|2|||
44151859|NCT02084134|78942182|FG000|Overall Study|Death|0|||
44151860|NCT02084134|78942183|FG001|Overall Study|Death|1|||
44151861|NCT02034058|78942189|FG000|Overall Study|Death|3|||
44151862|NCT01374269|78942195|FG000|Overall Study|Withdrawal by Subject|4|||
44151863|NCT01374269|78942196|FG001|Overall Study|Withdrawal by Subject|0|||
44151864|NCT01374269|78942195|FG000|Overall Study|Lost to Follow-up|1|||
44151865|NCT01374269|78942196|FG001|Overall Study|Lost to Follow-up|3|||
44151866|NCT01374269|78942195|FG000|Overall Study|closed research|1|||
44151867|NCT01374269|78942196|FG001|Overall Study|closed research|2|||
44151868|NCT02679755|78942204|FG000|Overall Study|Death|0|||
44151869|NCT02679755|78942205|FG001|Overall Study|Death|3|||
44151870|NCT02679755|78942204|FG000|Overall Study|Global deterioration of health status|1|||
44255364|NCT02618616|79097861|FG000|Overall Study|Consent withdrawn by subject|8|||
44255365|NCT02618616|79097862|FG001|Overall Study|Consent withdrawn by subject|5|||
44255366|NCT02618616|79097861|FG000|Overall Study|Lost to Follow-up|0|||
44255367|NCT02618616|79097862|FG001|Overall Study|Lost to Follow-up|1|||
44255368|NCT02618382|79097941|FG000|Overall Study|Physician Decision|1|||
44255369|NCT02618382|79097941|FG000|Overall Study|Withdrawal by Subject|1|||
44255370|NCT02618382|79097941|FG000|Overall Study|Protocol Violation|1|||
44255371|NCT00980057|79097985|FG000|Overall Study|Death|13|||
44255372|NCT00980057|79097986|FG001|Overall Study|Death|3|||
44255373|NCT00980057|79097985|FG000|Overall Study|Adverse Event|0|||
44255374|NCT00980057|79097986|FG001|Overall Study|Adverse Event|1|||
44255375|NCT00980057|79097985|FG000|Overall Study|Physician Decision|4|||
44255376|NCT00980057|79097986|FG001|Overall Study|Physician Decision|0|||
44151871|NCT02679755|78942205|FG001|Overall Study|Global deterioration of health status|8|||
44151872|NCT02679755|78942204|FG000|Overall Study|Lost to Follow-up|1|||
44151873|NCT02679755|78942205|FG001|Overall Study|Lost to Follow-up|0|||
44255377|NCT00980057|79097985|FG000|Overall Study|Lost to Follow-up|1|||
44255378|NCT00980057|79097986|FG001|Overall Study|Lost to Follow-up|0|||
44255379|NCT00980057|79097985|FG000|Overall Study|Withdrawal by Subject|1|||
44255380|NCT00980057|79097986|FG001|Overall Study|Withdrawal by Subject|1|||
44151874|NCT02679755|78942204|FG000|Overall Study|Objective progression or relapse|24|||
44151875|NCT02679755|78942205|FG001|Overall Study|Objective progression or relapse|83|||
44151876|NCT02679755|78942204|FG000|Overall Study|Not defined|0|||
44151877|NCT02679755|78942205|FG001|Overall Study|Not defined|2|||
44151878|NCT02679755|78942204|FG000|Overall Study|Withdrawal by participant|6|||
44255381|NCT04126733|79098107|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
44255382|NCT04126733|79098107|FG000|Treatment Period|Adverse Event|8|||
44255383|NCT04126733|79098107|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
44255384|NCT04126733|79098107|FG000|Treatment Period|Physician Decision|5|||
44255385|NCT04126733|79098107|FG000|Treatment Period|Death|1|||
44255386|NCT04126733|79098107|FG000|Treatment Period|Other Reasons|2|||
44255387|NCT04126733|79098107|FG000|Active Follow-up Period|Death|13|||
44255388|NCT04126733|79098107|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
44255389|NCT04126733|79098107|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
44255390|NCT04126733|79098107|FG000|Active Follow-up Period|Other Reasons|1|||
44255391|NCT04126733|79098107|FG000|Long-term Follow-up Period|Death|22|||
44255392|NCT04126733|79098107|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
44255393|NCT04126733|79098107|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
44255394|NCT00988247|79098142|FG000|Overall Study|Adverse Event|17|||
44531632|NCT00042289|79541317|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
44531633|NCT00042289|79541318|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
44531634|NCT00042289|79541319|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
44531635|NCT00042289|79541320|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
44151879|NCT02679755|78942205|FG001|Overall Study|Withdrawal by participant|3|||
44151880|NCT02679755|78942204|FG000|Overall Study|Adverse Event|1|||
44151881|NCT02679755|78942205|FG001|Overall Study|Adverse Event|4|||
44151882|NCT02679755|78942204|FG000|Overall Study|Adverse events not related to study drug|1|||
44151883|NCT02679755|78942205|FG001|Overall Study|Adverse events not related to study drug|2|||
44151884|NCT02675075|78942216|FG000|Overall Study|Lost to Follow-up|3|||
44255395|NCT00988247|79098143|FG001|Overall Study|Adverse Event|3|||
44255396|NCT00988247|79098142|FG000|Overall Study|Withdrawal by Subject|44|||
44255397|NCT00988247|79098143|FG001|Overall Study|Withdrawal by Subject|13|||
44255398|NCT00988247|79098142|FG000|Overall Study|Pregnancy|1|||
44255399|NCT00988247|79098143|FG001|Overall Study|Pregnancy|2|||
44255400|NCT00988247|79098142|FG000|Overall Study|Lost to Follow-up|11|||
44255401|NCT00988247|79098143|FG001|Overall Study|Lost to Follow-up|2|||
44255402|NCT00988247|79098142|FG000|Overall Study|Protocol Violation|4|||
44255403|NCT00988247|79098143|FG001|Overall Study|Protocol Violation|5|||
44255404|NCT00988247|79098142|FG000|Overall Study|Sponsor requested withdrawal|3|||
44255405|NCT00988247|79098143|FG001|Overall Study|Sponsor requested withdrawal|1|||
44255406|NCT00988247|79098142|FG000|Overall Study|Other|3|||
44255407|NCT00988247|79098143|FG001|Overall Study|Other|0|||
44255408|NCT00984659|79098153|FG000|2-week Run-in Period|Adverse Event|8|||
44255409|NCT00984659|79098154|FG001|2-week Run-in Period|Adverse Event|0|||
44255410|NCT00984659|79098155|FG002|2-week Run-in Period|Adverse Event|0|||
44531636|NCT00042289|79541321|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
44531637|NCT00042289|79541322|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
44531638|NCT00042289|79541323|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
44151885|NCT02675075|78942217|FG001|Overall Study|Lost to Follow-up|0|||
44151886|NCT02673515|78942227|FG000|Overall Study|Lack of motivation|2|||
44255411|NCT00984659|79098156|FG003|2-week Run-in Period|Adverse Event|0|||
44255412|NCT00984659|79098153|FG000|2-week Run-in Period|Protocol Violation|5|||
44255413|NCT00984659|79098154|FG001|2-week Run-in Period|Protocol Violation|0|||
44255414|NCT00984659|79098155|FG002|2-week Run-in Period|Protocol Violation|0|||
44151887|NCT02673515|78942228|FG001|Overall Study|Lack of motivation|1|||
44255415|NCT00984659|79098156|FG003|2-week Run-in Period|Protocol Violation|0|||
44255416|NCT00984659|79098153|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
44151888|NCT02667275|78942236|FG000|Overall Study|Protocol Violation|11|||
44151889|NCT02667275|78942237|FG001|Overall Study|Protocol Violation|7|||
44151890|NCT02667275|78942236|FG000|Overall Study|Lost to Follow-up|0|||
44151891|NCT02667275|78942237|FG001|Overall Study|Lost to Follow-up|2|||
44151892|NCT02667275|78942236|FG000|Overall Study|Withdrawal by Subject|0|||
44151893|NCT02667275|78942237|FG001|Overall Study|Withdrawal by Subject|5|||
44151894|NCT02667275|78942236|FG000|Overall Study|Discontinued early without completing|0|||
44151895|NCT02667275|78942237|FG001|Overall Study|Discontinued early without completing|1|||
44151896|NCT02672423|78942246|FG000|Period 1|Adverse Event|0|||
44151897|NCT02672423|78942247|FG001|Period 1|Adverse Event|0|||
44151898|NCT02672423|78942248|FG002|Period 1|Adverse Event|0|||
44151899|NCT02672423|78942249|FG003|Period 1|Adverse Event|0|||
44151900|NCT02672423|78942250|FG004|Period 1|Adverse Event|1|||
44151901|NCT02672423|78942251|FG005|Period 1|Adverse Event|0|||
44151902|NCT02672423|78942252|FG006|Period 1|Adverse Event|0|||
44151903|NCT02672423|78942253|FG007|Period 1|Adverse Event|0|||
44255417|NCT00984659|79098154|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
44255418|NCT00984659|79098155|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
44255419|NCT00984659|79098156|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
44255420|NCT00984659|79098153|FG000|2-week Run-in Period|Lost to Follow-up|3|||
44151904|NCT02672423|78942254|FG008|Period 1|Adverse Event|0|||
44151905|NCT02672423|78942255|FG009|Period 1|Adverse Event|0|||
44151906|NCT02672423|78942246|FG000|Period 2|Withdrawal by Subject|0|||
44151907|NCT02672423|78942247|FG001|Period 2|Withdrawal by Subject|0|||
44151908|NCT02672423|78942248|FG002|Period 2|Withdrawal by Subject|1|||
44151909|NCT02672423|78942249|FG003|Period 2|Withdrawal by Subject|0|||
44151910|NCT02672423|78942250|FG004|Period 2|Withdrawal by Subject|0|||
44151911|NCT02672423|78942251|FG005|Period 2|Withdrawal by Subject|0|||
44151912|NCT02672423|78942252|FG006|Period 2|Withdrawal by Subject|0|||
44151913|NCT02672423|78942253|FG007|Period 2|Withdrawal by Subject|0|||
44151914|NCT02672423|78942254|FG008|Period 2|Withdrawal by Subject|0|||
44151915|NCT02672423|78942255|FG009|Period 2|Withdrawal by Subject|0|||
44151916|NCT02672423|78942246|FG000|Period 3|Withdrawal by Subject|0|||
44151917|NCT02672423|78942247|FG001|Period 3|Withdrawal by Subject|0|||
44151918|NCT02672423|78942248|FG002|Period 3|Withdrawal by Subject|0|||
44151919|NCT02672423|78942249|FG003|Period 3|Withdrawal by Subject|0|||
44151920|NCT02672423|78942250|FG004|Period 3|Withdrawal by Subject|0|||
44151921|NCT02672423|78942251|FG005|Period 3|Withdrawal by Subject|0|||
44151922|NCT02672423|78942252|FG006|Period 3|Withdrawal by Subject|0|||
44255421|NCT00984659|79098154|FG001|2-week Run-in Period|Lost to Follow-up|0|||
44255422|NCT00984659|79098155|FG002|2-week Run-in Period|Lost to Follow-up|0|||
44531639|NCT00042289|79541324|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
44531640|NCT00042289|79541325|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
44151923|NCT02672423|78942253|FG007|Period 3|Withdrawal by Subject|1|||
44151924|NCT02672423|78942254|FG008|Period 3|Withdrawal by Subject|0|||
44151925|NCT02672423|78942255|FG009|Period 3|Withdrawal by Subject|0|||
44151926|NCT02672423|78942246|FG000|Period 3|Physician Decision|0|||
44151927|NCT02672423|78942247|FG001|Period 3|Physician Decision|0|||
44151928|NCT02672423|78942248|FG002|Period 3|Physician Decision|0|||
44151929|NCT02672423|78942249|FG003|Period 3|Physician Decision|0|||
44151930|NCT02672423|78942250|FG004|Period 3|Physician Decision|0|||
44255423|NCT00984659|79098156|FG003|2-week Run-in Period|Lost to Follow-up|0|||
44255424|NCT00984659|79098153|FG000|2-week Run-in Period|Physician Decision|10|||
44531641|NCT00042289|79541326|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
44531642|NCT00042289|79541327|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
44531643|NCT00042289|79541328|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
44531644|NCT00042289|79541329|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
44531645|NCT00042289|79541330|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
44531646|NCT00042289|79541331|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
44531647|NCT00042289|79541332|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
44151931|NCT02672423|78942251|FG005|Period 3|Physician Decision|1|||
44151932|NCT02672423|78942252|FG006|Period 3|Physician Decision|0|||
44151933|NCT02672423|78942253|FG007|Period 3|Physician Decision|0|||
44151934|NCT02672423|78942254|FG008|Period 3|Physician Decision|0|||
44151935|NCT02672423|78942255|FG009|Period 3|Physician Decision|0|||
44151936|NCT02670551|78942279|FG000|Overall Study|Adverse Event|4|||
44151937|NCT02670551|78942280|FG001|Overall Study|Adverse Event|7|||
44151938|NCT02670551|78942281|FG002|Overall Study|Adverse Event|9|||
44151939|NCT02670551|78942279|FG000|Overall Study|Lack of Efficacy|2|||
44151940|NCT02670551|78942280|FG001|Overall Study|Lack of Efficacy|0|||
44151941|NCT02670551|78942281|FG002|Overall Study|Lack of Efficacy|3|||
44151942|NCT02670551|78942279|FG000|Overall Study|Withdrawal of Consent|6|||
44151943|NCT02670551|78942280|FG001|Overall Study|Withdrawal of Consent|3|||
44151944|NCT02670551|78942281|FG002|Overall Study|Withdrawal of Consent|8|||
44151945|NCT02670551|78942279|FG000|Overall Study|Lost to Follow-up|5|||
44151946|NCT02670551|78942280|FG001|Overall Study|Lost to Follow-up|7|||
44151947|NCT02670551|78942281|FG002|Overall Study|Lost to Follow-up|6|||
44151948|NCT02670551|78942279|FG000|Overall Study|Protocol Violation|1|||
44151949|NCT02670551|78942280|FG001|Overall Study|Protocol Violation|0|||
44151950|NCT02670551|78942281|FG002|Overall Study|Protocol Violation|0|||
44255425|NCT00984659|79098154|FG001|2-week Run-in Period|Physician Decision|0|||
44151951|NCT02670551|78942279|FG000|Overall Study|Noncompliance with study drug|3|||
44151952|NCT02670551|78942280|FG001|Overall Study|Noncompliance with study drug|3|||
44255426|NCT00984659|79098155|FG002|2-week Run-in Period|Physician Decision|0|||
44255427|NCT00984659|79098156|FG003|2-week Run-in Period|Physician Decision|0|||
44255428|NCT00984659|79098153|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
44255429|NCT00984659|79098154|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44255430|NCT00984659|79098155|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44255431|NCT00984659|79098156|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
44255432|NCT00984659|79098153|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
44255433|NCT00984659|79098154|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
44255434|NCT00984659|79098155|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
44531648|NCT00042289|79541333|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
44531649|NCT00042289|79541334|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
44531650|NCT00042289|79541335|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
44531651|NCT00042289|79541336|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
44531652|NCT00042289|79541337|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
44531653|NCT00042289|79541338|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
44151953|NCT02670551|78942281|FG002|Overall Study|Noncompliance with study drug|2|||
44151954|NCT02670551|78942279|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44151955|NCT02670551|78942280|FG001|Overall Study|Other Miscellaneous Reasons|3|||
44151956|NCT02670551|78942281|FG002|Overall Study|Other Miscellaneous Reasons|3|||
44151957|NCT02670551|78942279|FG000|Overall Study|Did Not Receive Treatment|5|||
44151958|NCT02670551|78942280|FG001|Overall Study|Did Not Receive Treatment|3|||
44151959|NCT02670551|78942281|FG002|Overall Study|Did Not Receive Treatment|0|||
44151960|NCT02670473|78942289|FG000|Overall Study|Withdrawal by Subject|1|||
44151961|NCT02667119|78942304|FG000|Overall Study|Lost to Follow-up|3|||
44151962|NCT02667119|78942305|FG001|Overall Study|Lost to Follow-up|0|||
44151963|NCT02670083|78942313|FG000|Overall Study|Adverse Event|16|||
44151964|NCT02670083|78942314|FG001|Overall Study|Adverse Event|13|||
44151965|NCT02670083|78942313|FG000|Overall Study|Death|4|||
44151966|NCT02670083|78942314|FG001|Overall Study|Death|6|||
44151967|NCT02670083|78942313|FG000|Overall Study|Lost to Follow-up|2|||
44151968|NCT02670083|78942314|FG001|Overall Study|Lost to Follow-up|2|||
44151969|NCT02670083|78942313|FG000|Overall Study|Multiple Reasons|9|||
44151970|NCT02670083|78942314|FG001|Overall Study|Multiple Reasons|9|||
44151971|NCT02670083|78942313|FG000|Overall Study|Physician Decision|0|||
44151972|NCT02670083|78942314|FG001|Overall Study|Physician Decision|2|||
44151973|NCT02670083|78942313|FG000|Overall Study|Study Terminated By Sponsor|257|||
44151974|NCT02670083|78942314|FG001|Overall Study|Study Terminated By Sponsor|254|||
44151975|NCT02670083|78942313|FG000|Overall Study|Symptomatic Deterioration|0|||
44151976|NCT02670083|78942314|FG001|Overall Study|Symptomatic Deterioration|2|||
44151977|NCT02670083|78942313|FG000|Overall Study|Withdrawal by Subject|32|||
44151978|NCT02670083|78942314|FG001|Overall Study|Withdrawal by Subject|31|||
44151979|NCT02670083|78942313|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44151980|NCT02670083|78942314|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44151981|NCT02669849|78942324|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
44151982|NCT02669849|78942325|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
44151983|NCT02669849|78942326|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
44151984|NCT02669849|78942324|FG000|Overall Study|Lost to Follow-up|1|||
44151985|NCT02669849|78942325|FG001|Overall Study|Lost to Follow-up|0|||
44151986|NCT02669849|78942326|FG002|Overall Study|Lost to Follow-up|3|||
44151987|NCT02669849|78942324|FG000|Overall Study|Death|1|||
44151988|NCT02669849|78942325|FG001|Overall Study|Death|1|||
44151989|NCT02669849|78942326|FG002|Overall Study|Death|2|||
44151990|NCT02669849|78942324|FG000|Overall Study|Study terminated by sponsor|16|||
44151991|NCT02669849|78942325|FG001|Overall Study|Study terminated by sponsor|1|||
44151992|NCT02669849|78942326|FG002|Overall Study|Study terminated by sponsor|14|||
44151993|NCT02669849|78942324|FG000|Overall Study|Other|0|||
44151994|NCT02669849|78942325|FG001|Overall Study|Other|0|||
44151995|NCT02669849|78942326|FG002|Overall Study|Other|2|||
44151996|NCT03625895|78942334|FG000|Overall Study|Protocol Violation|585|||
44151997|NCT02663687|78942343|FG000|Overall Study|Adverse Event|1|||
44151998|NCT02663687|78942344|FG001|Overall Study|Adverse Event|0|||
44151999|NCT02663687|78942345|FG002|Overall Study|Adverse Event|0|||
44152000|NCT02663687|78942346|FG003|Overall Study|Adverse Event|0|||
44152001|NCT02663687|78942347|FG004|Overall Study|Adverse Event|0|||
44152002|NCT02663687|78942343|FG000|Overall Study|Other|1|||
44152003|NCT02663687|78942344|FG001|Overall Study|Other|0|||
44152004|NCT02663687|78942345|FG002|Overall Study|Other|1|||
44152005|NCT02663687|78942346|FG003|Overall Study|Other|0|||
44152006|NCT02663687|78942347|FG004|Overall Study|Other|0|||
44152007|NCT02663453|78942378|FG000|Overall Study|Death|4|||
44152008|NCT02663453|78942379|FG001|Overall Study|Death|4|||
44152009|NCT02663453|78942378|FG000|Overall Study|Withdrawal by Subject|1|||
44152010|NCT02663453|78942379|FG001|Overall Study|Withdrawal by Subject|0|||
44152011|NCT02055118|78942388|FG000|Overall Study|Withdrawal by Subject|0|||
44152012|NCT02055118|78942389|FG001|Overall Study|Withdrawal by Subject|2|||
44152013|NCT02055118|78942390|FG002|Overall Study|Withdrawal by Subject|0|||
44152014|NCT02084056|78942401|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
44152015|NCT02084056|78942402|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44152016|NCT02084056|78942403|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44152017|NCT02084056|78942404|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
44152018|NCT02084056|78942401|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
44152019|NCT02084056|78942402|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
44152020|NCT02084056|78942403|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
44152021|NCT02084056|78942404|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
44152022|NCT01625182|78942416|FG000|Overall Study|Administrative problems|1|||
44152023|NCT01625182|78942417|FG001|Overall Study|Administrative problems|0|||
44152024|NCT01625182|78942416|FG000|Overall Study|Protocol deviation|0|||
44255435|NCT00984659|79098156|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
44255436|NCT00984659|79098153|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
44255437|NCT00984659|79098154|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
44415143|NCT00630916|79423045|FG000|Overall Study|Lack of Efficacy|3|||
44415144|NCT00630292|79423049|FG000|Overall Study|Withdrawal by Subject|1|||
44531654|NCT00042289|79541339|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
44531655|NCT00042289|79541340|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
44531656|NCT00042289|79541341|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
44531657|NCT00042289|79541342|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
44531658|NCT00042289|79541343|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
44531659|NCT00042289|79541344|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
44531660|NCT00042289|79541345|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
44255438|NCT00984659|79098155|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
44255439|NCT00984659|79098156|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
44255440|NCT00984659|79098153|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
44255441|NCT00984659|79098154|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
44255442|NCT00984659|79098155|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
44255443|NCT00984659|79098156|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
44255444|NCT00984659|79098153|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
44152025|NCT01625182|78942417|FG001|Overall Study|Protocol deviation|2|||
44152026|NCT01625182|78942416|FG000|Overall Study|Adverse Event|2|||
44152027|NCT01625182|78942417|FG001|Overall Study|Adverse Event|0|||
44255445|NCT00984659|79098154|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
44255446|NCT00984659|79098155|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
44255447|NCT00984659|79098156|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
44255448|NCT00984659|79098153|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
44255449|NCT00984659|79098154|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
44255450|NCT00984659|79098155|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
44255451|NCT00984659|79098156|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
44255452|NCT00984659|79098153|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44152028|NCT01625182|78942416|FG000|Overall Study|Withdrawal by Subject|5|||
44255453|NCT00984659|79098154|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
44415145|NCT00626548|79423055|FG000|Overall Study|Adverse Event|164|||
44152029|NCT01625182|78942417|FG001|Overall Study|Withdrawal by Subject|1|||
44531661|NCT00042289|79541346|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
44531662|NCT00042289|79541347|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
44531663|NCT00042289|79541348|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
44531664|NCT00042289|79541349|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
44531665|NCT00042289|79541350|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
44531666|NCT00042289|79541351|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
44531667|NCT00042289|79541305|FG000|Overall Study|Protocol Violation|0|||
44531668|NCT00042289|79541306|FG001|Overall Study|Protocol Violation|0|||
44255454|NCT00984659|79098155|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
44255455|NCT00984659|79098156|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
44255456|NCT00982319|79098165|FG000|Overall Study|Surgery date change|1|||
44255457|NCT00982319|79098166|FG001|Overall Study|Surgery date change|0|||
44255458|NCT00982319|79098165|FG000|Overall Study|Preop values out of acceptable range|1|||
44255459|NCT00982319|79098166|FG001|Overall Study|Preop values out of acceptable range|1|||
44255460|NCT00982319|79098165|FG000|Overall Study|Pregnancy|0|||
44255461|NCT00982319|79098166|FG001|Overall Study|Pregnancy|1|||
44255462|NCT02612064|79098178|FG000|Overall Study|Withdrawal by Subject|1|||
44255463|NCT02612064|79098179|FG001|Overall Study|Withdrawal by Subject|1|||
44255464|NCT02612064|79098178|FG000|Overall Study|Other|0|||
44415146|NCT00626548|79423056|FG001|Overall Study|Adverse Event|44|||
44415147|NCT00626548|79423055|FG000|Overall Study|Withdrawal by Subject|42|||
44415148|NCT00626548|79423056|FG001|Overall Study|Withdrawal by Subject|46|||
44415149|NCT00626548|79423055|FG000|Overall Study|Protocol Violation|4|||
44415150|NCT00626548|79423056|FG001|Overall Study|Protocol Violation|11|||
44415151|NCT00626548|79423055|FG000|Overall Study|Lost to Follow-up|2|||
44152030|NCT01625182|78942416|FG000|Overall Study|Lack of Efficacy|12|||
44152031|NCT01625182|78942417|FG001|Overall Study|Lack of Efficacy|8|||
44152032|NCT02661815|78942428|FG000|Overall Study|Withdrawal by Subject|1|||
44152033|NCT02661815|78942429|FG001|Overall Study|Withdrawal by Subject|0|||
44152034|NCT02661815|78942430|FG002|Overall Study|Withdrawal by Subject|0|||
44152035|NCT02661815|78942431|FG003|Overall Study|Withdrawal by Subject|0|||
44152036|NCT02053792|78942447|FG000|Overall Study|Physician Decision|0|||
44152037|NCT02053792|78942448|FG001|Overall Study|Physician Decision|1|||
44152038|NCT02053792|78942447|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
44152039|NCT02053792|78942448|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
44152040|NCT02053792|78942447|FG000|Overall Study|Lack of Efficacy|1|||
44152041|NCT02053792|78942448|FG001|Overall Study|Lack of Efficacy|0|||
44152042|NCT02053792|78942447|FG000|Overall Study|Adverse Event|1|||
44152043|NCT02053792|78942448|FG001|Overall Study|Adverse Event|0|||
44152044|NCT02053792|78942447|FG000|Overall Study|Withdrawal by Subject|2|||
44152045|NCT02053792|78942448|FG001|Overall Study|Withdrawal by Subject|2|||
44152046|NCT02053792|78942447|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
44152047|NCT02053792|78942448|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
44152048|NCT02053792|78942447|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
44152049|NCT02053792|78942448|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
44152050|NCT02082340|78942456|FG000|Overall Study|Lost to Follow-up|1|||
44152051|NCT02082340|78942457|FG001|Overall Study|Lost to Follow-up|1|||
44152052|NCT02053246|78942463|FG000|Overall Study|Withdrawal by Subject|3|||
44255465|NCT02612064|79098179|FG001|Overall Study|Other|2|||
44531669|NCT00042289|79541307|FG002|Overall Study|Protocol Violation|0|||
44531670|NCT00042289|79541308|FG003|Overall Study|Protocol Violation|0|||
44531671|NCT00042289|79541309|FG004|Overall Study|Protocol Violation|0|||
44255466|NCT02614560|79098198|FG000|Overall Study|Death|6|||
44152053|NCT02053246|78942463|FG000|Overall Study|Physician Decision|1|||
44152054|NCT02053168|78942467|FG000|Overall Study|Withdrawal by Subject|1|||
44152055|NCT02053168|78942467|FG000|Overall Study|Physician Decision|1|||
44152056|NCT02053168|78942467|FG000|Overall Study|Lost to Follow-up|1|||
44255467|NCT02614560|79098199|FG001|Overall Study|Death|2|||
44255468|NCT01669122|79098216|FG000|Period I|Lost to Follow-up|1|||
44255469|NCT01669122|79098216|FG000|Washout Period II|Protocol Violation|2|||
44255470|NCT02611752|79098249|FG000|Overall Study|Adverse Event|0|||
44255471|NCT02611752|79098250|FG001|Overall Study|Adverse Event|1|||
44255472|NCT02611362|79098271|FG000|Overall Study|Withdrawal by Subject|7|||
44255473|NCT02611362|79098272|FG001|Overall Study|Withdrawal by Subject|2|||
44255474|NCT02611362|79098271|FG000|Overall Study|Lost to Follow-up|2|||
44255475|NCT02611362|79098272|FG001|Overall Study|Lost to Follow-up|4|||
44255476|NCT01594476|79098292|FG000|Overall Study|Protocol Violation|1|||
44255477|NCT01594476|79098293|FG001|Overall Study|Protocol Violation|3|||
44255478|NCT01668966|79098307|FG000|Overall Study|Withdrawal by Subject|1|||
44255479|NCT01668966|79098307|FG000|Overall Study|Death|1|||
44255480|NCT01668966|79098307|FG000|Overall Study|Not treated|2|||
44255481|NCT02609724|79098314|FG000|Overall Study|Death|2|||
44255482|NCT02609724|79098315|FG001|Overall Study|Death|0|||
44255483|NCT02609724|79098316|FG002|Overall Study|Death|1|||
44255484|NCT02609724|79098314|FG000|Overall Study|Withdrawal by Subject|1|||
44255485|NCT02609724|79098315|FG001|Overall Study|Withdrawal by Subject|2|||
44255486|NCT02609724|79098316|FG002|Overall Study|Withdrawal by Subject|3|||
44282918|NCT01846416|79246264|FG001|Treatment Phase|Physician Decision|2|||
44282919|NCT01846416|79246265|FG002|Treatment Phase|Physician Decision|0|||
44282920|NCT01846416|79246263|FG000|Treatment Phase|Adverse Event|3|||
44282921|NCT01846416|79246264|FG001|Treatment Phase|Adverse Event|4|||
44152057|NCT02052466|78942471|FG000|Overall Study|Withdrawal by Subject|1|||
44152058|NCT02052466|78942471|FG000|Overall Study|Acromial fracture|1|||
44152059|NCT02032888|78942478|FG000|Treatment Period|Poor compliance/noncompliance|1|||
44152060|NCT02032888|78942479|FG001|Treatment Period|Poor compliance/noncompliance|1|||
44152061|NCT02032888|78942480|FG002|Treatment Period|Poor compliance/noncompliance|0|||
44152062|NCT02032888|78942478|FG000|Treatment Period|Other|1|||
44152063|NCT02032888|78942479|FG001|Treatment Period|Other|1|||
44152064|NCT02032888|78942480|FG002|Treatment Period|Other|0|||
44152065|NCT02032888|78942478|FG000|Follow-up Period|Lost to Follow-up|1|||
44152066|NCT02032888|78942479|FG001|Follow-up Period|Lost to Follow-up|1|||
44152067|NCT02032888|78942480|FG002|Follow-up Period|Lost to Follow-up|0|||
44152068|NCT02032888|78942478|FG000|Follow-up Period|Death|1|||
44152069|NCT02032888|78942479|FG001|Follow-up Period|Death|1|||
44152070|NCT02032888|78942480|FG002|Follow-up Period|Death|0|||
44152071|NCT02032888|78942478|FG000|Follow-up Period|Other|1|||
44152072|NCT02032888|78942479|FG001|Follow-up Period|Other|0|||
44152073|NCT02032888|78942480|FG002|Follow-up Period|Other|0|||
44152074|NCT02082262|78942497|FG000|Overall Study|Withdrawal by Subject|3|||
44152075|NCT02082262|78942497|FG000|Overall Study|Adverse Event|48|||
44152076|NCT04697069|78942503|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
44152077|NCT04697069|78942504|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
44152078|NCT04697069|78942503|FG000|Overall Study|Study termination|2|||
44152079|NCT04697069|78942504|FG001|Overall Study|Study termination|1|||
44152080|NCT02082184|78942512|FG000|Overall Study|Adverse Event|1|||
44152081|NCT02082184|78942513|FG001|Overall Study|Adverse Event|0|||
44152082|NCT02082184|78942512|FG000|Overall Study|Medical diagnosis|1|||
44152083|NCT02082184|78942513|FG001|Overall Study|Medical diagnosis|2|||
44152084|NCT02082184|78942512|FG000|Overall Study|Device associated symptoms|5|||
44152085|NCT02082184|78942513|FG001|Overall Study|Device associated symptoms|0|||
44152086|NCT02082184|78942512|FG000|Overall Study|Withdrawal by Subject|3|||
44152087|NCT02082184|78942513|FG001|Overall Study|Withdrawal by Subject|2|||
44152088|NCT02082184|78942512|FG000|Overall Study|Protocol Violation|0|||
44282922|NCT01846416|79246265|FG002|Treatment Phase|Adverse Event|0|||
44282923|NCT01846416|79246263|FG000|Treatment Phase|Non-compliance|0|||
44282924|NCT01846416|79246264|FG001|Treatment Phase|Non-compliance|2|||
44415152|NCT00626548|79423056|FG001|Overall Study|Lost to Follow-up|2|||
44282925|NCT01846416|79246265|FG002|Treatment Phase|Non-compliance|0|||
44152089|NCT02082184|78942513|FG001|Overall Study|Protocol Violation|6|||
44282926|NCT01846416|79246263|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
44282927|NCT01846416|79246264|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
44282928|NCT01846416|79246265|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
44282929|NCT01846416|79246263|FG000|Treatment Phase|Progressive Disease|21|||
44282930|NCT01846416|79246264|FG001|Treatment Phase|Progressive Disease|63|||
44282931|NCT01846416|79246265|FG002|Treatment Phase|Progressive Disease|9|||
44282932|NCT01846416|79246263|FG000|Survival Follow-up|Death|21|||
44415153|NCT00626548|79423055|FG000|Overall Study|Other termination reason|493|||
44152090|NCT02082184|78942512|FG000|Overall Study|Lost to Follow-up|0|||
44152091|NCT02082184|78942513|FG001|Overall Study|Lost to Follow-up|2|||
44152092|NCT02082184|78942512|FG000|Overall Study|Subject non-compliance|0|||
44152093|NCT02082184|78942513|FG001|Overall Study|Subject non-compliance|1|||
44152094|NCT01624870|78942519|FG000|Overall Study|Death|19|||
44152095|NCT01624870|78942519|FG000|Overall Study|Withdrawal by Subject|1|||
44255487|NCT02609724|79098314|FG000|Overall Study|Illness|2|||
44255488|NCT02609724|79098315|FG001|Overall Study|Illness|1|||
44255489|NCT02609724|79098316|FG002|Overall Study|Illness|0|||
44255490|NCT02610816|79098345|FG000|Phase 1|Withdrawal by Subject|2|||
44255491|NCT02610816|79098346|FG001|Phase 1|Withdrawal by Subject|6|||
44255492|NCT02610816|79098347|FG002|Phase 1|Withdrawal by Subject|0|||
44255493|NCT02610816|79098348|FG003|Phase 1|Withdrawal by Subject|0|||
44255494|NCT02610816|79098345|FG000|Phase 1|Lost to Follow-up|2|||
44255495|NCT02610816|79098346|FG001|Phase 1|Lost to Follow-up|1|||
44255496|NCT02610816|79098347|FG002|Phase 1|Lost to Follow-up|0|||
44255497|NCT02610816|79098348|FG003|Phase 1|Lost to Follow-up|0|||
44255498|NCT02610816|79098345|FG000|Phase 1|Physician Decision|0|||
44255499|NCT02610816|79098346|FG001|Phase 1|Physician Decision|1|||
44255500|NCT02610816|79098347|FG002|Phase 1|Physician Decision|0|||
44255501|NCT02610816|79098348|FG003|Phase 1|Physician Decision|0|||
44255502|NCT02610816|79098345|FG000|Phase 2|Withdrawal by Subject|0|||
44255503|NCT02610816|79098346|FG001|Phase 2|Withdrawal by Subject|0|||
44152096|NCT01624870|78942519|FG000|Overall Study|CoreValve not implanted|6|||
44255504|NCT02610816|79098347|FG002|Phase 2|Withdrawal by Subject|9|||
44255505|NCT02610816|79098348|FG003|Phase 2|Withdrawal by Subject|3|||
44255506|NCT02610816|79098345|FG000|Phase 2|Lost to Follow-up|0|||
44152097|NCT01624870|78942519|FG000|Overall Study|Lost to follow up|1|||
44152098|NCT02031640|78942530|FG000|Screening Period|Adverse Event|1|||
44152099|NCT02031640|78942531|FG001|Screening Period|Adverse Event|0|||
44152100|NCT02031640|78942532|FG002|Screening Period|Adverse Event|0|||
44152101|NCT02031640|78942533|FG003|Screening Period|Adverse Event|0|||
44152102|NCT02031640|78942534|FG004|Screening Period|Adverse Event|0|||
44152103|NCT02031640|78942535|FG005|Screening Period|Adverse Event|0|||
44152104|NCT02031640|78942530|FG000|Screening Period|Withdrawal by Subject|29|||
44152105|NCT02031640|78942531|FG001|Screening Period|Withdrawal by Subject|0|||
44152106|NCT02031640|78942532|FG002|Screening Period|Withdrawal by Subject|0|||
44152107|NCT02031640|78942533|FG003|Screening Period|Withdrawal by Subject|0|||
44152108|NCT02031640|78942534|FG004|Screening Period|Withdrawal by Subject|0|||
44415154|NCT00626548|79423056|FG001|Overall Study|Other termination reason|613|||
44415155|NCT00847379|79423065|FG000|Overall Study|Study terminated by Sponsor|59|||
44415156|NCT00847379|79423066|FG001|Overall Study|Study terminated by Sponsor|57|||
44415157|NCT00847379|79423067|FG002|Overall Study|Study terminated by Sponsor|57|||
44415158|NCT00847301|79423077|FG000|Overall Study|Adverse Event|35|||
44415159|NCT00847301|79423077|FG000|Overall Study|Switch to other anticoagulants|16|||
44415160|NCT00847301|79423077|FG000|Overall Study|Lost to Follow-up|1|||
44415161|NCT00847301|79423077|FG000|Overall Study|No prescription after hospital discharge|1|||
44415162|NCT00847301|79423077|FG000|Overall Study|Other reason not defined above|1|||
44415163|NCT00624520|79423083|FG000|Overall Study|Withdrawal by Subject|12|||
44415164|NCT00624520|79423084|FG001|Overall Study|Withdrawal by Subject|7|||
44415165|NCT00624520|79423083|FG000|Overall Study|Death|0|||
44415166|NCT00624520|79423084|FG001|Overall Study|Death|1|||
44531672|NCT00042289|79541310|FG005|Overall Study|Protocol Violation|1|||
44531673|NCT00042289|79541311|FG006|Overall Study|Protocol Violation|0|||
44531674|NCT00042289|79541312|FG007|Overall Study|Protocol Violation|1|||
44152109|NCT02031640|78942535|FG005|Screening Period|Withdrawal by Subject|0|||
44152110|NCT02031640|78942530|FG000|Screening Period|Inclusion criteria not met|312|||
44152111|NCT02031640|78942531|FG001|Screening Period|Inclusion criteria not met|0|||
44152112|NCT02031640|78942532|FG002|Screening Period|Inclusion criteria not met|0|||
44152113|NCT02031640|78942533|FG003|Screening Period|Inclusion criteria not met|0|||
44152114|NCT02031640|78942534|FG004|Screening Period|Inclusion criteria not met|0|||
44152115|NCT02031640|78942535|FG005|Screening Period|Inclusion criteria not met|0|||
44152116|NCT02031640|78942530|FG000|Screening Period|Exclusion criteria met|30|||
44152117|NCT02031640|78942531|FG001|Screening Period|Exclusion criteria met|0|||
44152118|NCT02031640|78942532|FG002|Screening Period|Exclusion criteria met|0|||
44152119|NCT02031640|78942533|FG003|Screening Period|Exclusion criteria met|0|||
44152120|NCT02031640|78942534|FG004|Screening Period|Exclusion criteria met|0|||
44152121|NCT02031640|78942535|FG005|Screening Period|Exclusion criteria met|0|||
44152122|NCT02031640|78942530|FG000|Screening Period|Lost to Follow-up|14|||
44152123|NCT02031640|78942531|FG001|Screening Period|Lost to Follow-up|0|||
44152124|NCT02031640|78942532|FG002|Screening Period|Lost to Follow-up|0|||
44152125|NCT02031640|78942533|FG003|Screening Period|Lost to Follow-up|0|||
44152126|NCT02031640|78942534|FG004|Screening Period|Lost to Follow-up|0|||
44152127|NCT02031640|78942535|FG005|Screening Period|Lost to Follow-up|0|||
44152128|NCT02031640|78942530|FG000|Screening Period|Enrollment closed|26|||
44152129|NCT02031640|78942531|FG001|Screening Period|Enrollment closed|0|||
44152130|NCT02031640|78942532|FG002|Screening Period|Enrollment closed|0|||
44152131|NCT02031640|78942533|FG003|Screening Period|Enrollment closed|0|||
44531675|NCT00042289|79541313|FG008|Overall Study|Protocol Violation|0|||
44531676|NCT00042289|79541314|FG009|Overall Study|Protocol Violation|0|||
44531677|NCT00042289|79541315|FG010|Overall Study|Protocol Violation|0|||
44531678|NCT00042289|79541316|FG011|Overall Study|Protocol Violation|0|||
44531679|NCT00042289|79541317|FG012|Overall Study|Protocol Violation|0|||
44152132|NCT02031640|78942534|FG004|Screening Period|Enrollment closed|0|||
44152133|NCT02031640|78942535|FG005|Screening Period|Enrollment closed|0|||
44152134|NCT02031640|78942530|FG000|Run-In Period|Adverse Event|4|||
44152135|NCT02031640|78942531|FG001|Run-In Period|Adverse Event|0|||
44152136|NCT02031640|78942532|FG002|Run-In Period|Adverse Event|0|||
44152137|NCT02031640|78942533|FG003|Run-In Period|Adverse Event|0|||
44152138|NCT02031640|78942534|FG004|Run-In Period|Adverse Event|0|||
44152139|NCT02031640|78942535|FG005|Run-In Period|Adverse Event|0|||
44152140|NCT02031640|78942530|FG000|Run-In Period|Withdrawal by Subject|17|||
44152141|NCT02031640|78942531|FG001|Run-In Period|Withdrawal by Subject|0|||
44152142|NCT02031640|78942532|FG002|Run-In Period|Withdrawal by Subject|0|||
44152143|NCT02031640|78942533|FG003|Run-In Period|Withdrawal by Subject|0|||
44152144|NCT02031640|78942534|FG004|Run-In Period|Withdrawal by Subject|0|||
44152145|NCT02031640|78942535|FG005|Run-In Period|Withdrawal by Subject|0|||
44152146|NCT02031640|78942530|FG000|Run-In Period|Inclusion criteria not met|38|||
44282933|NCT01846416|79246264|FG001|Survival Follow-up|Death|62|||
44415167|NCT00847145|79423098|FG000|Overall Study|AE or Death|0|||
44531680|NCT00042289|79541318|FG013|Overall Study|Protocol Violation|0|||
44282934|NCT01846416|79246265|FG002|Survival Follow-up|Death|9|||
44415168|NCT00847145|79423099|FG001|Overall Study|AE or Death|1|||
44531681|NCT00042289|79541319|FG014|Overall Study|Protocol Violation|0|||
44282935|NCT01846416|79246263|FG000|Survival Follow-up|Lost to Follow-up|0|||
44282936|NCT01846416|79246264|FG001|Survival Follow-up|Lost to Follow-up|2|||
44282937|NCT01846416|79246265|FG002|Survival Follow-up|Lost to Follow-up|2|||
44282938|NCT01846416|79246263|FG000|Survival Follow-up|Withdrawal by Subject|2|||
44415169|NCT00847145|79423100|FG002|Overall Study|AE or Death|1|||
44415170|NCT00847145|79423101|FG003|Overall Study|AE or Death|0|||
44415171|NCT00847145|79423102|FG004|Overall Study|AE or Death|0|||
44415172|NCT00847145|79423103|FG005|Overall Study|AE or Death|0|||
44415173|NCT00847145|79423104|FG006|Overall Study|AE or Death|0|||
44415174|NCT00847145|79423105|FG007|Overall Study|AE or Death|0|||
44415175|NCT00847145|79423098|FG000|Overall Study|Withdrawal by Subject|3|||
44415176|NCT00847145|79423099|FG001|Overall Study|Withdrawal by Subject|4|||
44415177|NCT00847145|79423100|FG002|Overall Study|Withdrawal by Subject|6|||
44415178|NCT00847145|79423101|FG003|Overall Study|Withdrawal by Subject|1|||
44415179|NCT00847145|79423102|FG004|Overall Study|Withdrawal by Subject|0|||
44415180|NCT00847145|79423103|FG005|Overall Study|Withdrawal by Subject|0|||
44415181|NCT00847145|79423104|FG006|Overall Study|Withdrawal by Subject|1|||
44415182|NCT00847145|79423105|FG007|Overall Study|Withdrawal by Subject|1|||
44415183|NCT00847145|79423098|FG000|Overall Study|Lost to Follow-up|3|||
44415184|NCT00847145|79423099|FG001|Overall Study|Lost to Follow-up|1|||
44415185|NCT00847145|79423100|FG002|Overall Study|Lost to Follow-up|1|||
44531682|NCT00042289|79541320|FG015|Overall Study|Protocol Violation|0|||
44531683|NCT00042289|79541321|FG016|Overall Study|Protocol Violation|0|||
44531684|NCT00042289|79541322|FG017|Overall Study|Protocol Violation|0|||
44531685|NCT00042289|79541323|FG018|Overall Study|Protocol Violation|0|||
44531686|NCT00042289|79541324|FG019|Overall Study|Protocol Violation|0|||
44531687|NCT00042289|79541325|FG020|Overall Study|Protocol Violation|0|||
44531688|NCT00042289|79541326|FG021|Overall Study|Protocol Violation|0|||
44531689|NCT00042289|79541327|FG022|Overall Study|Protocol Violation|0|||
44282939|NCT01846416|79246264|FG001|Survival Follow-up|Withdrawal by Subject|7|||
44282940|NCT01846416|79246265|FG002|Survival Follow-up|Withdrawal by Subject|0|||
44282941|NCT01846416|79246263|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
44282942|NCT01846416|79246264|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
44282943|NCT01846416|79246265|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
44282944|NCT01846416|79246263|FG000|Survival Follow-up|Other|3|||
44282945|NCT01846416|79246264|FG001|Survival Follow-up|Other|1|||
44282946|NCT01846416|79246265|FG002|Survival Follow-up|Other|1|||
44282947|NCT01865448|79246276|FG000|Overall Study|Adverse Event|1|||
44282948|NCT01865448|79246277|FG001|Overall Study|Adverse Event|1|||
44282949|NCT01865448|79246276|FG000|Overall Study|Pregnancy|0|||
44282950|NCT01865448|79246277|FG001|Overall Study|Pregnancy|1|||
44282951|NCT01865448|79246276|FG000|Overall Study|dropout unrelated to study|1|||
44282952|NCT01865448|79246277|FG001|Overall Study|dropout unrelated to study|1|||
44282953|NCT01804140|79246284|FG000|Overall Study|No sampling or biopsy procedures done|114|||
44282954|NCT01846104|79246288|FG000|Overall Study|Withdrawal by Subject|1|||
44282955|NCT01803282|79246304|FG000|Overall Study|Progressive Disease|4|||
44282956|NCT01803282|79246305|FG001|Overall Study|Progressive Disease|3|||
44282957|NCT01803282|79246306|FG002|Overall Study|Progressive Disease|6|||
44282958|NCT01803282|79246307|FG003|Overall Study|Progressive Disease|22|||
44282959|NCT01803282|79246308|FG004|Overall Study|Progressive Disease|5|||
44282960|NCT01803282|79246309|FG005|Overall Study|Progressive Disease|8|||
44282961|NCT01803282|79246310|FG006|Overall Study|Progressive Disease|23|||
44282962|NCT01803282|79246311|FG007|Overall Study|Progressive Disease|24|||
44282963|NCT01803282|79246312|FG008|Overall Study|Progressive Disease|3|||
44282964|NCT01803282|79246313|FG009|Overall Study|Progressive Disease|29|||
44282965|NCT01803282|79246314|FG010|Overall Study|Progressive Disease|6|||
44282966|NCT01803282|79246315|FG011|Overall Study|Progressive Disease|11|||
44282967|NCT01803282|79246304|FG000|Overall Study|Death|0|||
44415186|NCT00847145|79423101|FG003|Overall Study|Lost to Follow-up|0|||
44415187|NCT00847145|79423102|FG004|Overall Study|Lost to Follow-up|4|||
44415188|NCT00847145|79423103|FG005|Overall Study|Lost to Follow-up|4|||
44415189|NCT00847145|79423104|FG006|Overall Study|Lost to Follow-up|8|||
44415190|NCT00847145|79423105|FG007|Overall Study|Lost to Follow-up|2|||
44415191|NCT00847145|79423098|FG000|Overall Study|Inappropriate enrollment|0|||
44415192|NCT00847145|79423099|FG001|Overall Study|Inappropriate enrollment|0|||
44415193|NCT00847145|79423100|FG002|Overall Study|Inappropriate enrollment|0|||
44531690|NCT00042289|79541328|FG023|Overall Study|Protocol Violation|1|||
44531691|NCT00042289|79541329|FG024|Overall Study|Protocol Violation|1|||
44531692|NCT00042289|79541330|FG025|Overall Study|Protocol Violation|0|||
44282968|NCT01803282|79246305|FG001|Overall Study|Death|0|||
44282969|NCT01803282|79246306|FG002|Overall Study|Death|0|||
44282970|NCT01803282|79246307|FG003|Overall Study|Death|0|||
44282971|NCT01803282|79246308|FG004|Overall Study|Death|2|||
44415194|NCT00847145|79423101|FG003|Overall Study|Inappropriate enrollment|0|||
44282972|NCT01803282|79246309|FG005|Overall Study|Death|1|||
44415195|NCT00847145|79423102|FG004|Overall Study|Inappropriate enrollment|1|||
44282973|NCT01803282|79246310|FG006|Overall Study|Death|1|||
44531693|NCT00042289|79541331|FG026|Overall Study|Protocol Violation|2|||
44531694|NCT00042289|79541332|FG027|Overall Study|Protocol Violation|0|||
44531695|NCT00042289|79541333|FG028|Overall Study|Protocol Violation|0|||
44152147|NCT02031640|78942531|FG001|Run-In Period|Inclusion criteria not met|0|||
44152148|NCT02031640|78942532|FG002|Run-In Period|Inclusion criteria not met|0|||
44152149|NCT02031640|78942533|FG003|Run-In Period|Inclusion criteria not met|0|||
44152150|NCT02031640|78942534|FG004|Run-In Period|Inclusion criteria not met|0|||
44152151|NCT02031640|78942535|FG005|Run-In Period|Inclusion criteria not met|0|||
44152152|NCT02031640|78942530|FG000|Run-In Period|Exclusion criteria met|8|||
44282974|NCT01803282|79246311|FG007|Overall Study|Death|5|||
44282975|NCT01803282|79246312|FG008|Overall Study|Death|1|||
44282976|NCT01803282|79246313|FG009|Overall Study|Death|1|||
44282977|NCT01803282|79246314|FG010|Overall Study|Death|0|||
44282978|NCT01803282|79246315|FG011|Overall Study|Death|0|||
44282979|NCT01803282|79246304|FG000|Overall Study|Withdrew Consent|0|||
44282980|NCT01803282|79246305|FG001|Overall Study|Withdrew Consent|0|||
44282981|NCT01803282|79246306|FG002|Overall Study|Withdrew Consent|0|||
44282982|NCT01803282|79246307|FG003|Overall Study|Withdrew Consent|6|||
44282983|NCT01803282|79246308|FG004|Overall Study|Withdrew Consent|1|||
44282984|NCT01803282|79246309|FG005|Overall Study|Withdrew Consent|0|||
44282985|NCT01803282|79246310|FG006|Overall Study|Withdrew Consent|8|||
44282986|NCT01803282|79246311|FG007|Overall Study|Withdrew Consent|3|||
44282987|NCT01803282|79246312|FG008|Overall Study|Withdrew Consent|1|||
44152153|NCT02031640|78942531|FG001|Run-In Period|Exclusion criteria met|0|||
44282988|NCT01803282|79246313|FG009|Overall Study|Withdrew Consent|5|||
44282989|NCT01803282|79246314|FG010|Overall Study|Withdrew Consent|0|||
44282990|NCT01803282|79246315|FG011|Overall Study|Withdrew Consent|1|||
44282991|NCT01803282|79246304|FG000|Overall Study|Investigator's Discretion|0|||
44282992|NCT01803282|79246305|FG001|Overall Study|Investigator's Discretion|0|||
44282993|NCT01803282|79246306|FG002|Overall Study|Investigator's Discretion|0|||
44282994|NCT01803282|79246307|FG003|Overall Study|Investigator's Discretion|7|||
44282995|NCT01803282|79246308|FG004|Overall Study|Investigator's Discretion|2|||
44282996|NCT01803282|79246309|FG005|Overall Study|Investigator's Discretion|1|||
44282997|NCT01803282|79246310|FG006|Overall Study|Investigator's Discretion|7|||
44282998|NCT01803282|79246311|FG007|Overall Study|Investigator's Discretion|10|||
44282999|NCT01803282|79246312|FG008|Overall Study|Investigator's Discretion|6|||
44283000|NCT01803282|79246313|FG009|Overall Study|Investigator's Discretion|7|||
44283001|NCT01803282|79246314|FG010|Overall Study|Investigator's Discretion|1|||
44283002|NCT01803282|79246315|FG011|Overall Study|Investigator's Discretion|0|||
44283003|NCT01803282|79246304|FG000|Overall Study|Adverse Event|0|||
44283004|NCT01803282|79246305|FG001|Overall Study|Adverse Event|0|||
44283005|NCT01803282|79246306|FG002|Overall Study|Adverse Event|0|||
44283006|NCT01803282|79246307|FG003|Overall Study|Adverse Event|0|||
44283007|NCT01803282|79246308|FG004|Overall Study|Adverse Event|0|||
44283008|NCT01803282|79246309|FG005|Overall Study|Adverse Event|0|||
44283009|NCT01803282|79246310|FG006|Overall Study|Adverse Event|1|||
44152154|NCT02031640|78942532|FG002|Run-In Period|Exclusion criteria met|0|||
44152155|NCT02031640|78942533|FG003|Run-In Period|Exclusion criteria met|0|||
44152156|NCT02031640|78942534|FG004|Run-In Period|Exclusion criteria met|0|||
44415196|NCT00847145|79423103|FG005|Overall Study|Inappropriate enrollment|0|||
44415197|NCT00847145|79423104|FG006|Overall Study|Inappropriate enrollment|0|||
44531696|NCT00042289|79541334|FG029|Overall Study|Protocol Violation|0|||
44531697|NCT00042289|79541335|FG030|Overall Study|Protocol Violation|1|||
44531698|NCT00042289|79541336|FG031|Overall Study|Protocol Violation|0|||
44531699|NCT00042289|79541337|FG032|Overall Study|Protocol Violation|0|||
44531700|NCT00042289|79541338|FG033|Overall Study|Protocol Violation|0|||
44531701|NCT00042289|79541339|FG034|Overall Study|Protocol Violation|0|||
44531702|NCT00042289|79541340|FG035|Overall Study|Protocol Violation|0|||
44531703|NCT00042289|79541341|FG036|Overall Study|Protocol Violation|0|||
44531704|NCT00042289|79541342|FG037|Overall Study|Protocol Violation|0|||
44283010|NCT01803282|79246311|FG007|Overall Study|Adverse Event|2|||
44283011|NCT01803282|79246312|FG008|Overall Study|Adverse Event|0|||
44283012|NCT01803282|79246313|FG009|Overall Study|Adverse Event|1|||
44283013|NCT01803282|79246314|FG010|Overall Study|Adverse Event|0|||
44283014|NCT01803282|79246315|FG011|Overall Study|Adverse Event|3|||
44283015|NCT01803282|79246304|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44415198|NCT00847145|79423105|FG007|Overall Study|Inappropriate enrollment|0|||
44531705|NCT00042289|79541343|FG038|Overall Study|Protocol Violation|0|||
44531706|NCT00042289|79541344|FG039|Overall Study|Protocol Violation|0|||
44152157|NCT02031640|78942535|FG005|Run-In Period|Exclusion criteria met|0|||
44152158|NCT02031640|78942530|FG000|Run-In Period|Randomization criteria not met|85|||
44152159|NCT02031640|78942531|FG001|Run-In Period|Randomization criteria not met|0|||
44415199|NCT00847145|79423098|FG000|Overall Study|Protocol Violation|0|||
44283016|NCT01803282|79246305|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44283017|NCT01803282|79246306|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44283018|NCT01803282|79246307|FG003|Overall Study|Non-Compliance with Study Drug|1|||
44283019|NCT01803282|79246308|FG004|Overall Study|Non-Compliance with Study Drug|0|||
44283020|NCT01803282|79246309|FG005|Overall Study|Non-Compliance with Study Drug|0|||
44531707|NCT00042289|79541345|FG040|Overall Study|Protocol Violation|0|||
44531708|NCT00042289|79541346|FG041|Overall Study|Protocol Violation|1|||
44152160|NCT02031640|78942532|FG002|Run-In Period|Randomization criteria not met|0|||
44152161|NCT02031640|78942533|FG003|Run-In Period|Randomization criteria not met|0|||
44152162|NCT02031640|78942534|FG004|Run-In Period|Randomization criteria not met|0|||
44531709|NCT00042289|79541347|FG042|Overall Study|Protocol Violation|1|||
44531710|NCT00042289|79541348|FG043|Overall Study|Protocol Violation|1|||
44531711|NCT00042289|79541349|FG044|Overall Study|Protocol Violation|0|||
44531712|NCT00042289|79541350|FG045|Overall Study|Protocol Violation|0|||
44531713|NCT00042289|79541351|FG046|Overall Study|Protocol Violation|0|||
44531714|NCT00042289|79541305|FG000|Overall Study|Withdrawal by Subject|4|||
44531715|NCT00042289|79541306|FG001|Overall Study|Withdrawal by Subject|1|||
44531716|NCT00042289|79541307|FG002|Overall Study|Withdrawal by Subject|0|||
44152163|NCT02031640|78942535|FG005|Run-In Period|Randomization criteria not met|0|||
44152164|NCT02031640|78942530|FG000|Run-In Period|Various administrative reasons|17|||
44152165|NCT02031640|78942531|FG001|Run-In Period|Various administrative reasons|0|||
44152166|NCT02031640|78942532|FG002|Run-In Period|Various administrative reasons|0|||
44152167|NCT02031640|78942533|FG003|Run-In Period|Various administrative reasons|0|||
44152168|NCT02031640|78942534|FG004|Run-In Period|Various administrative reasons|0|||
44152169|NCT02031640|78942535|FG005|Run-In Period|Various administrative reasons|0|||
44531717|NCT00042289|79541308|FG003|Overall Study|Withdrawal by Subject|2|||
44531718|NCT00042289|79541309|FG004|Overall Study|Withdrawal by Subject|0|||
44531719|NCT00042289|79541310|FG005|Overall Study|Withdrawal by Subject|2|||
44531720|NCT00042289|79541311|FG006|Overall Study|Withdrawal by Subject|0|||
44531721|NCT00042289|79541312|FG007|Overall Study|Withdrawal by Subject|0|||
44531722|NCT00042289|79541313|FG008|Overall Study|Withdrawal by Subject|0|||
44531723|NCT00042289|79541314|FG009|Overall Study|Withdrawal by Subject|1|||
44531724|NCT00042289|79541315|FG010|Overall Study|Withdrawal by Subject|0|||
44531725|NCT00042289|79541316|FG011|Overall Study|Withdrawal by Subject|0|||
44531726|NCT00042289|79541317|FG012|Overall Study|Withdrawal by Subject|2|||
44531727|NCT00042289|79541318|FG013|Overall Study|Withdrawal by Subject|0|||
44531728|NCT00042289|79541319|FG014|Overall Study|Withdrawal by Subject|0|||
44531729|NCT00042289|79541320|FG015|Overall Study|Withdrawal by Subject|0|||
44531730|NCT00042289|79541321|FG016|Overall Study|Withdrawal by Subject|0|||
44255507|NCT02610816|79098346|FG001|Phase 2|Lost to Follow-up|0|||
44255508|NCT02610816|79098347|FG002|Phase 2|Lost to Follow-up|2|||
44255509|NCT02610816|79098348|FG003|Phase 2|Lost to Follow-up|0|||
44255510|NCT02610816|79098345|FG000|Phase 2|Physician Decision|0|||
44255511|NCT02610816|79098346|FG001|Phase 2|Physician Decision|0|||
44255512|NCT02610816|79098347|FG002|Phase 2|Physician Decision|0|||
44255513|NCT02610816|79098348|FG003|Phase 2|Physician Decision|2|||
44255514|NCT02610816|79098345|FG000|Phase 2|Pregnancy|0|||
44531731|NCT00042289|79541322|FG017|Overall Study|Withdrawal by Subject|0|||
44531732|NCT00042289|79541323|FG018|Overall Study|Withdrawal by Subject|0|||
44152170|NCT02031640|78942530|FG000|Double-blind Treatment Period|Protocol deviation|0|||
44152171|NCT02031640|78942531|FG001|Double-blind Treatment Period|Protocol deviation|2|||
44255515|NCT02610816|79098346|FG001|Phase 2|Pregnancy|0|||
44255516|NCT02610816|79098347|FG002|Phase 2|Pregnancy|0|||
44152172|NCT02031640|78942532|FG002|Double-blind Treatment Period|Protocol deviation|0|||
44152173|NCT02031640|78942533|FG003|Double-blind Treatment Period|Protocol deviation|1|||
44152174|NCT02031640|78942534|FG004|Double-blind Treatment Period|Protocol deviation|3|||
44152175|NCT02031640|78942535|FG005|Double-blind Treatment Period|Protocol deviation|1|||
44152176|NCT02031640|78942530|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
44152177|NCT02031640|78942531|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
44152178|NCT02031640|78942532|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
44152179|NCT02031640|78942533|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
44152180|NCT02031640|78942534|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
44152181|NCT02031640|78942535|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
44152182|NCT02031640|78942530|FG000|Double-blind Treatment Period|Non-compliance|0|||
44152183|NCT02031640|78942531|FG001|Double-blind Treatment Period|Non-compliance|1|||
44152184|NCT02031640|78942532|FG002|Double-blind Treatment Period|Non-compliance|0|||
44152185|NCT02031640|78942533|FG003|Double-blind Treatment Period|Non-compliance|1|||
44152186|NCT02031640|78942534|FG004|Double-blind Treatment Period|Non-compliance|1|||
44152187|NCT02031640|78942535|FG005|Double-blind Treatment Period|Non-compliance|0|||
44152188|NCT02031640|78942530|FG000|Double-blind Treatment Period|Adverse Event|0|||
44152189|NCT02031640|78942531|FG001|Double-blind Treatment Period|Adverse Event|0|||
44152190|NCT02031640|78942532|FG002|Double-blind Treatment Period|Adverse Event|0|||
44152191|NCT02031640|78942533|FG003|Double-blind Treatment Period|Adverse Event|2|||
44152192|NCT02031640|78942534|FG004|Double-blind Treatment Period|Adverse Event|0|||
44152193|NCT02031640|78942535|FG005|Double-blind Treatment Period|Adverse Event|0|||
44152194|NCT02031640|78942530|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
44152195|NCT02031640|78942531|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
44152196|NCT02031640|78942532|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
44152197|NCT02031640|78942533|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
44152198|NCT02031640|78942534|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
44152199|NCT02031640|78942535|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
44152200|NCT02031640|78942530|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44152201|NCT02031640|78942531|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
44152202|NCT02031640|78942532|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
44152203|NCT02031640|78942533|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
44152204|NCT02031640|78942534|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
44152205|NCT02031640|78942535|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
44152206|NCT02370173|78942556|FG000|Overall Study|Protocol Violation|1|||
44152207|NCT02370173|78942557|FG001|Overall Study|Protocol Violation|1|||
44152208|NCT02370173|78942556|FG000|Overall Study|Withdrawal by Subject|2|||
44152209|NCT02370173|78942557|FG001|Overall Study|Withdrawal by Subject|2|||
44531733|NCT00042289|79541324|FG019|Overall Study|Withdrawal by Subject|0|||
44531734|NCT00042289|79541325|FG020|Overall Study|Withdrawal by Subject|0|||
44531735|NCT00042289|79541326|FG021|Overall Study|Withdrawal by Subject|1|||
44531736|NCT00042289|79541327|FG022|Overall Study|Withdrawal by Subject|1|||
44531737|NCT00042289|79541328|FG023|Overall Study|Withdrawal by Subject|1|||
44531738|NCT00042289|79541329|FG024|Overall Study|Withdrawal by Subject|0|||
44531739|NCT00042289|79541330|FG025|Overall Study|Withdrawal by Subject|0|||
44531740|NCT00042289|79541331|FG026|Overall Study|Withdrawal by Subject|1|||
44531741|NCT00042289|79541332|FG027|Overall Study|Withdrawal by Subject|0|||
44531742|NCT00042289|79541333|FG028|Overall Study|Withdrawal by Subject|2|||
44531743|NCT00042289|79541334|FG029|Overall Study|Withdrawal by Subject|0|||
44152210|NCT02660489|78942567|FG000|Overall Study|Lost to Follow-up|1|||
44152211|NCT02660489|78942568|FG001|Overall Study|Lost to Follow-up|1|||
44152212|NCT02660489|78942567|FG000|Overall Study|Adverse Event|1|||
44283021|NCT01803282|79246310|FG006|Overall Study|Non-Compliance with Study Drug|0|||
44283022|NCT01803282|79246311|FG007|Overall Study|Non-Compliance with Study Drug|0|||
44152213|NCT02660489|78942568|FG001|Overall Study|Adverse Event|3|||
44152214|NCT02660489|78942567|FG000|Overall Study|no rhinovirus infection|4|||
44152215|NCT02660489|78942568|FG001|Overall Study|no rhinovirus infection|4|||
44152216|NCT02052310|78942576|FG000|Overall Study|Death|64|||
44152217|NCT02052310|78942577|FG001|Overall Study|Death|54|||
44152218|NCT02052310|78942576|FG000|Overall Study|Withdrawal by Subject|37|||
44152219|NCT02052310|78942577|FG001|Overall Study|Withdrawal by Subject|49|||
44152220|NCT02052310|78942576|FG000|Overall Study|Other than specified|32|||
44152221|NCT02052310|78942577|FG001|Overall Study|Other than specified|29|||
44152222|NCT02052310|78942576|FG000|Overall Study|Adverse Event|29|||
44152223|NCT02052310|78942577|FG001|Overall Study|Adverse Event|22|||
44152224|NCT02052310|78942576|FG000|Overall Study|Kidney Transplant|23|||
44152225|NCT02052310|78942577|FG001|Overall Study|Kidney Transplant|29|||
44152226|NCT02052310|78942576|FG000|Overall Study|Physician Decision|14|||
44531744|NCT00042289|79541335|FG030|Overall Study|Withdrawal by Subject|0|||
44531745|NCT00042289|79541336|FG031|Overall Study|Withdrawal by Subject|1|||
44152227|NCT02052310|78942577|FG001|Overall Study|Physician Decision|7|||
44152228|NCT02052310|78942576|FG000|Overall Study|Lack of Efficacy|6|||
44152229|NCT02052310|78942577|FG001|Overall Study|Lack of Efficacy|1|||
44152230|NCT02052310|78942576|FG000|Overall Study|Site Terminated by Sponsor|5|||
44152231|NCT02052310|78942577|FG001|Overall Study|Site Terminated by Sponsor|13|||
44152232|NCT02052310|78942576|FG000|Overall Study|Lost to Follow-up|4|||
44152233|NCT02052310|78942577|FG001|Overall Study|Lost to Follow-up|2|||
44152234|NCT02052310|78942576|FG000|Overall Study|Protocol Violation|1|||
44152235|NCT02052310|78942577|FG001|Overall Study|Protocol Violation|6|||
44152236|NCT02051764|78942585|FG000|Overall Study|Study terminated by sponsor|0|||
44152237|NCT02051764|78942586|FG001|Overall Study|Study terminated by sponsor|7|||
44152238|NCT02051296|78942594|FG000|Overall Study|Lost to Follow-up|1|||
44152239|NCT02051296|78942595|FG001|Overall Study|Lost to Follow-up|2|||
44531746|NCT00042289|79541337|FG032|Overall Study|Withdrawal by Subject|2|||
44531747|NCT00042289|79541338|FG033|Overall Study|Withdrawal by Subject|1|||
44531748|NCT00042289|79541339|FG034|Overall Study|Withdrawal by Subject|0|||
44531749|NCT00042289|79541340|FG035|Overall Study|Withdrawal by Subject|0|||
44531750|NCT00042289|79541341|FG036|Overall Study|Withdrawal by Subject|0|||
44531751|NCT00042289|79541342|FG037|Overall Study|Withdrawal by Subject|1|||
44531752|NCT00042289|79541343|FG038|Overall Study|Withdrawal by Subject|0|||
44531753|NCT00042289|79541344|FG039|Overall Study|Withdrawal by Subject|0|||
44531754|NCT00042289|79541345|FG040|Overall Study|Withdrawal by Subject|0|||
44531755|NCT00042289|79541346|FG041|Overall Study|Withdrawal by Subject|0|||
44531756|NCT00042289|79541347|FG042|Overall Study|Withdrawal by Subject|1|||
44531757|NCT00042289|79541348|FG043|Overall Study|Withdrawal by Subject|0|||
44531758|NCT00042289|79541349|FG044|Overall Study|Withdrawal by Subject|0|||
44531759|NCT00042289|79541350|FG045|Overall Study|Withdrawal by Subject|0|||
44531760|NCT00042289|79541351|FG046|Overall Study|Withdrawal by Subject|0|||
44531761|NCT02886728|79541523|FG000|Overall Study|Withdrew Consent|31|||
44531762|NCT02886728|79541524|FG001|Overall Study|Withdrew Consent|13|||
44531763|NCT02886728|79541525|FG002|Overall Study|Withdrew Consent|11|||
44531764|NCT02886728|79541526|FG003|Overall Study|Withdrew Consent|47|||
44531765|NCT02886728|79541523|FG000|Overall Study|Lost to Follow-up|12|||
44531766|NCT02886728|79541524|FG001|Overall Study|Lost to Follow-up|6|||
44531767|NCT02886728|79541525|FG002|Overall Study|Lost to Follow-up|13|||
44531768|NCT02886728|79541526|FG003|Overall Study|Lost to Follow-up|12|||
44531769|NCT02886728|79541523|FG000|Overall Study|Adverse Event|13|||
44152240|NCT02051296|78942594|FG000|Overall Study|withdraw prior to treatment|7|||
44531770|NCT02886728|79541524|FG001|Overall Study|Adverse Event|5|||
44531771|NCT02886728|79541525|FG002|Overall Study|Adverse Event|5|||
44531772|NCT02886728|79541526|FG003|Overall Study|Adverse Event|11|||
44152241|NCT02051296|78942595|FG001|Overall Study|withdraw prior to treatment|7|||
44152242|NCT02050048|78942603|FG000|Overall Study|Lost to Follow-up|0|||
44152243|NCT02050048|78942604|FG001|Overall Study|Lost to Follow-up|1|||
44255517|NCT02610816|79098348|FG003|Phase 2|Pregnancy|1|||
44255518|NCT01896505|79098364|FG000|Overall Study|Adverse Event|1|||
44255519|NCT01896505|79098365|FG001|Overall Study|Adverse Event|0|||
44255520|NCT01896505|79098366|FG002|Overall Study|Adverse Event|2|||
44255521|NCT01896505|79098367|FG003|Overall Study|Adverse Event|1|||
44255522|NCT01896505|79098368|FG004|Overall Study|Adverse Event|1|||
44255523|NCT01896505|79098369|FG005|Overall Study|Adverse Event|0|||
44255524|NCT01896505|79098364|FG000|Overall Study|Physician Decision|1|||
44255525|NCT01896505|79098365|FG001|Overall Study|Physician Decision|3|||
44255526|NCT01896505|79098366|FG002|Overall Study|Physician Decision|2|||
44255527|NCT01896505|79098367|FG003|Overall Study|Physician Decision|0|||
44255528|NCT01896505|79098368|FG004|Overall Study|Physician Decision|0|||
44152244|NCT02050048|78942603|FG000|Overall Study|Death|1|||
44152245|NCT02050048|78942604|FG001|Overall Study|Death|0|||
44152246|NCT02050048|78942603|FG000|Overall Study|Ineligible after ERCP|4|||
44152247|NCT02050048|78942604|FG001|Overall Study|Ineligible after ERCP|1|||
44255529|NCT01896505|79098369|FG005|Overall Study|Physician Decision|1|||
44152248|NCT02049814|78942612|FG000|Overall Study|Reason not Specified|4|||
44152249|NCT02049814|78942613|FG001|Overall Study|Reason not Specified|3|||
44152250|NCT02049814|78942612|FG000|Overall Study|Pregnancy|1|||
44152251|NCT02049814|78942613|FG001|Overall Study|Pregnancy|0|||
44152252|NCT02049814|78942612|FG000|Overall Study|Lost to Follow-up|2|||
44152253|NCT02049814|78942613|FG001|Overall Study|Lost to Follow-up|3|||
44152254|NCT02049814|78942612|FG000|Overall Study|Serious Protocol Violation|5|||
44152255|NCT02049814|78942613|FG001|Overall Study|Serious Protocol Violation|7|||
44152256|NCT02049814|78942612|FG000|Overall Study|Study Termination|0|||
44152257|NCT02049814|78942613|FG001|Overall Study|Study Termination|1|||
44152258|NCT02049814|78942612|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
44152259|NCT02049814|78942613|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
44152260|NCT02049814|78942612|FG000|Overall Study|Voluntary withdrawal|9|||
44152261|NCT02049814|78942613|FG001|Overall Study|Voluntary withdrawal|8|||
44152262|NCT02079844|78942631|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
44152263|NCT02079844|78942632|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
44152264|NCT02079844|78942633|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
44152265|NCT02079844|78942631|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
44152266|NCT02079844|78942632|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
44152267|NCT02079844|78942633|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
44152268|NCT02048722|78942653|FG000|2 Cycles of Treatment|Adverse Event|2|||
44152269|NCT02048722|78942653|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
44152270|NCT02048722|78942653|FG000|2 Cycles of Treatment|Progressive Disease|2|||
44152271|NCT02048722|78942653|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
44152272|NCT02048722|78942653|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
44152273|NCT02048722|78942653|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
44152274|NCT02030002|78942657|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
44152275|NCT02030002|78942657|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
44152276|NCT02030002|78942657|FG000|Follow-up|Lost to Follow-up|2|||
44152277|NCT02079610|78942665|FG000|Overall Study|Withdrawal by Subject|1|||
44152278|NCT02079610|78942666|FG001|Overall Study|Withdrawal by Subject|1|||
44152279|NCT02079532|78942672|FG000|Overall Study|Adverse Event|7|||
44152280|NCT02079532|78942672|FG000|Overall Study|Additional or changed therapy|2|||
44152281|NCT02079532|78942672|FG000|Overall Study|Lack of Efficacy|9|||
44152282|NCT02079532|78942672|FG000|Overall Study|Protocol Violation|3|||
44152283|NCT02079532|78942672|FG000|Overall Study|Withdrawal by Subject|1|||
44152284|NCT02079532|78942672|FG000|Overall Study|Administrative problems|1|||
44152285|NCT02079532|78942672|FG000|Overall Study|Inclusion into ReFIRST|3|||
44152286|NCT02079532|78942672|FG000|Overall Study|Other|3|||
44152287|NCT02357849|78942689|FG000|Overall Study|Withdrawal by Subject|2|||
44152288|NCT02357849|78942690|FG001|Overall Study|Withdrawal by Subject|3|||
44152289|NCT02709889|78942734|FG000|Overall Study|Withdrawal by Subject|11|||
44152290|NCT02709889|78942735|FG001|Overall Study|Withdrawal by Subject|10|||
44152291|NCT02709889|78942736|FG002|Overall Study|Withdrawal by Subject|2|||
44152292|NCT02709889|78942737|FG003|Overall Study|Withdrawal by Subject|12|||
44152293|NCT02709889|78942734|FG000|Overall Study|Death|25|||
44152294|NCT02709889|78942735|FG001|Overall Study|Death|38|||
44152295|NCT02709889|78942736|FG002|Overall Study|Death|4|||
44152296|NCT02709889|78942737|FG003|Overall Study|Death|44|||
44152297|NCT02709889|78942734|FG000|Overall Study|Physician Decision|1|||
44152298|NCT02709889|78942735|FG001|Overall Study|Physician Decision|2|||
44152299|NCT02709889|78942736|FG002|Overall Study|Physician Decision|3|||
44152300|NCT02709889|78942737|FG003|Overall Study|Physician Decision|5|||
44152301|NCT02709889|78942734|FG000|Overall Study|Lost to Follow-up|2|||
44152302|NCT02709889|78942735|FG001|Overall Study|Lost to Follow-up|0|||
44152303|NCT02709889|78942736|FG002|Overall Study|Lost to Follow-up|0|||
44152304|NCT02709889|78942737|FG003|Overall Study|Lost to Follow-up|4|||
44152305|NCT02709889|78942734|FG000|Overall Study|Study Terminated by Sponsor|4|||
44152306|NCT02709889|78942735|FG001|Overall Study|Study Terminated by Sponsor|6|||
44152307|NCT02709889|78942736|FG002|Overall Study|Study Terminated by Sponsor|2|||
44152308|NCT02709889|78942737|FG003|Overall Study|Study Terminated by Sponsor|17|||
44152309|NCT02709889|78942734|FG000|Overall Study|Other, Not Specified|0|||
44255530|NCT01896505|79098364|FG000|Overall Study|Withdrawal by Subject|1|||
44255531|NCT01896505|79098365|FG001|Overall Study|Withdrawal by Subject|0|||
44255532|NCT01896505|79098366|FG002|Overall Study|Withdrawal by Subject|3|||
44255533|NCT01896505|79098367|FG003|Overall Study|Withdrawal by Subject|1|||
44255534|NCT01896505|79098368|FG004|Overall Study|Withdrawal by Subject|0|||
44255535|NCT01896505|79098369|FG005|Overall Study|Withdrawal by Subject|0|||
44255536|NCT01896505|79098364|FG000|Overall Study|Disease Progression|7|||
44255537|NCT01896505|79098365|FG001|Overall Study|Disease Progression|5|||
44255538|NCT01896505|79098366|FG002|Overall Study|Disease Progression|8|||
44255539|NCT01896505|79098367|FG003|Overall Study|Disease Progression|4|||
44255540|NCT01896505|79098368|FG004|Overall Study|Disease Progression|4|||
44255541|NCT01896505|79098369|FG005|Overall Study|Disease Progression|4|||
44255542|NCT01896505|79098364|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
44415200|NCT00847145|79423099|FG001|Overall Study|Protocol Violation|0|||
44152310|NCT02709889|78942735|FG001|Overall Study|Other, Not Specified|1|||
44283023|NCT01803282|79246312|FG008|Overall Study|Non-Compliance with Study Drug|0|||
44152311|NCT02709889|78942736|FG002|Overall Study|Other, Not Specified|1|||
44152312|NCT02709889|78942737|FG003|Overall Study|Other, Not Specified|6|||
44283024|NCT01803282|79246313|FG009|Overall Study|Non-Compliance with Study Drug|0|||
44283025|NCT01803282|79246314|FG010|Overall Study|Non-Compliance with Study Drug|0|||
44283026|NCT01803282|79246315|FG011|Overall Study|Non-Compliance with Study Drug|0|||
44283027|NCT01803282|79246304|FG000|Overall Study|Unknown Reason|0|||
44283028|NCT01803282|79246305|FG001|Overall Study|Unknown Reason|0|||
44283029|NCT01803282|79246306|FG002|Overall Study|Unknown Reason|0|||
44283030|NCT01803282|79246307|FG003|Overall Study|Unknown Reason|0|||
44283031|NCT01803282|79246308|FG004|Overall Study|Unknown Reason|0|||
44283032|NCT01803282|79246309|FG005|Overall Study|Unknown Reason|0|||
44283033|NCT01803282|79246310|FG006|Overall Study|Unknown Reason|0|||
44283034|NCT01803282|79246311|FG007|Overall Study|Unknown Reason|1|||
44283035|NCT01803282|79246312|FG008|Overall Study|Unknown Reason|0|||
44283036|NCT01803282|79246313|FG009|Overall Study|Unknown Reason|0|||
44283037|NCT01803282|79246314|FG010|Overall Study|Unknown Reason|0|||
44283038|NCT01803282|79246315|FG011|Overall Study|Unknown Reason|0|||
44283039|NCT01803282|79246304|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
44283040|NCT01803282|79246305|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
44283041|NCT01803282|79246306|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
44283042|NCT01803282|79246307|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
44283043|NCT01803282|79246308|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
44283044|NCT01803282|79246309|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
44283045|NCT01803282|79246310|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
44283046|NCT01803282|79246311|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
44283047|NCT01803282|79246312|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
44283048|NCT01803282|79246313|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
44283049|NCT01803282|79246314|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
44283050|NCT01803282|79246315|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
44283051|NCT01803282|79246304|FG000|Overall Study|Enrolled but Never Treated|0|||
44283052|NCT01803282|79246305|FG001|Overall Study|Enrolled but Never Treated|0|||
44283053|NCT01803282|79246306|FG002|Overall Study|Enrolled but Never Treated|0|||
44283054|NCT01803282|79246307|FG003|Overall Study|Enrolled but Never Treated|0|||
44152313|NCT02711995|78942782|FG000|Washout (90 Days)|Conflicting medication|1|||
44283055|NCT01803282|79246308|FG004|Overall Study|Enrolled but Never Treated|1|||
44283056|NCT01803282|79246309|FG005|Overall Study|Enrolled but Never Treated|0|||
44152314|NCT02514239|78942820|FG000|Overall Study|Refused to continue trial medication|0|||
44152315|NCT02514239|78942821|FG001|Overall Study|Refused to continue trial medication|0|||
44152316|NCT02514239|78942822|FG002|Overall Study|Refused to continue trial medication|0|||
44152317|NCT02514239|78942823|FG003|Overall Study|Refused to continue trial medication|0|||
44152318|NCT02514239|78942824|FG004|Overall Study|Refused to continue trial medication|0|||
44152319|NCT02514239|78942825|FG005|Overall Study|Refused to continue trial medication|0|||
44152320|NCT02514239|78942826|FG006|Overall Study|Refused to continue trial medication|0|||
44152321|NCT02514239|78942827|FG007|Overall Study|Refused to continue trial medication|0|||
44152322|NCT02514239|78942828|FG008|Overall Study|Refused to continue trial medication|0|||
44255543|NCT01896505|79098365|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
44283057|NCT01803282|79246310|FG006|Overall Study|Enrolled but Never Treated|1|||
44283058|NCT01803282|79246311|FG007|Overall Study|Enrolled but Never Treated|1|||
44415201|NCT00847145|79423100|FG002|Overall Study|Protocol Violation|3|||
44531773|NCT02886728|79541523|FG000|Overall Study|Investigator's Discretion|11|||
44531774|NCT02886728|79541524|FG001|Overall Study|Investigator's Discretion|7|||
44531775|NCT02886728|79541525|FG002|Overall Study|Investigator's Discretion|5|||
44531776|NCT02886728|79541526|FG003|Overall Study|Investigator's Discretion|11|||
44531777|NCT02886728|79541523|FG000|Overall Study|Death|3|||
44531778|NCT02886728|79541524|FG001|Overall Study|Death|1|||
44531779|NCT02886728|79541525|FG002|Overall Study|Death|0|||
44531780|NCT02886728|79541526|FG003|Overall Study|Death|0|||
44255544|NCT01896505|79098366|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
44531781|NCT02886728|79541523|FG000|Overall Study|Protocol Violation|0|||
44152323|NCT02514239|78942829|FG009|Overall Study|Refused to continue trial medication|1|||
44255545|NCT01896505|79098367|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
44255546|NCT01896505|79098368|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
44255547|NCT01896505|79098369|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
44255548|NCT01896505|79098364|FG000|Overall Study|Intercurrent illness|0|||
44255549|NCT01896505|79098365|FG001|Overall Study|Intercurrent illness|1|||
44255550|NCT01896505|79098366|FG002|Overall Study|Intercurrent illness|0|||
44255551|NCT01896505|79098367|FG003|Overall Study|Intercurrent illness|0|||
44283059|NCT01803282|79246312|FG008|Overall Study|Enrolled but Never Treated|0|||
44283060|NCT01803282|79246313|FG009|Overall Study|Enrolled but Never Treated|1|||
44283061|NCT01803282|79246314|FG010|Overall Study|Enrolled but Never Treated|0|||
44283062|NCT01803282|79246315|FG011|Overall Study|Enrolled but Never Treated|0|||
44283063|NCT01844778|79246344|FG000|Overall Study|Protocol deviation|0|||
44283064|NCT01844778|79246345|FG001|Overall Study|Protocol deviation|1|||
44283065|NCT01844778|79246346|FG002|Overall Study|Protocol deviation|2|||
44283066|NCT01844778|79246344|FG000|Overall Study|Withdrawal by Subject|2|||
44283067|NCT01844778|79246345|FG001|Overall Study|Withdrawal by Subject|0|||
44283068|NCT01844778|79246346|FG002|Overall Study|Withdrawal by Subject|0|||
44283069|NCT01844778|79246344|FG000|Overall Study|Adverse Event|0|||
44283070|NCT01844778|79246345|FG001|Overall Study|Adverse Event|2|||
44283071|NCT01844778|79246346|FG002|Overall Study|Adverse Event|2|||
44283072|NCT01802580|79246360|FG000|Overall Study|Physician Decision|1|||
44415202|NCT00847145|79423101|FG003|Overall Study|Protocol Violation|0|||
44415203|NCT00847145|79423102|FG004|Overall Study|Protocol Violation|1|||
44415204|NCT00847145|79423103|FG005|Overall Study|Protocol Violation|0|||
44415205|NCT00847145|79423104|FG006|Overall Study|Protocol Violation|0|||
44415206|NCT00847145|79423105|FG007|Overall Study|Protocol Violation|1|||
44415207|NCT00846521|79423132|FG000|Overall Study|Withdrawal by Subject|5|||
44415208|NCT00846521|79423132|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
44152324|NCT02514239|78942820|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152325|NCT02514239|78942821|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152326|NCT02514239|78942822|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152327|NCT02514239|78942823|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152328|NCT02514239|78942824|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152329|NCT02514239|78942825|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152330|NCT02514239|78942826|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152331|NCT02514239|78942827|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
44152332|NCT02514239|78942828|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
44152333|NCT02514239|78942829|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
44415209|NCT00846521|79423132|FG000|Overall Study|Protocol Violation|1|||
44415210|NCT00862823|79423136|FG000|First Intervention|Withdrawal by Subject|1|||
44415211|NCT00862823|79423137|FG001|First Intervention|Withdrawal by Subject|1|||
44415212|NCT00790842|79423145|FG000|Dose Level 1|Adverse Event|1|||
44415213|NCT00790842|79423146|FG001|Dose Level 1|Adverse Event|0|||
44415214|NCT00790842|79423147|FG002|Dose Level 1|Adverse Event|0|||
44415215|NCT00790842|79423148|FG003|Dose Level 1|Adverse Event|2|||
44415216|NCT00790842|79423149|FG004|Dose Level 1|Adverse Event|0|||
44415217|NCT00790842|79423150|FG005|Dose Level 1|Adverse Event|0|||
44152334|NCT02514239|78942820|FG000|Overall Study|Not treated|0|||
44152335|NCT02514239|78942821|FG001|Overall Study|Not treated|1|||
44152336|NCT02514239|78942822|FG002|Overall Study|Not treated|0|||
44255552|NCT01896505|79098368|FG004|Overall Study|Intercurrent illness|0|||
44255553|NCT01896505|79098369|FG005|Overall Study|Intercurrent illness|0|||
44255554|NCT01896505|79098364|FG000|Overall Study|Death|0|||
44255555|NCT01896505|79098365|FG001|Overall Study|Death|0|||
44255556|NCT01896505|79098366|FG002|Overall Study|Death|1|||
44255557|NCT01896505|79098367|FG003|Overall Study|Death|1|||
44255558|NCT01896505|79098368|FG004|Overall Study|Death|0|||
44255559|NCT01896505|79098369|FG005|Overall Study|Death|1|||
44255560|NCT02612610|79098490|FG000|Overall Study|Withdrawal by Subject|1|||
44255561|NCT02612610|79098491|FG001|Overall Study|Withdrawal by Subject|1|||
44255562|NCT02612610|79098492|FG002|Overall Study|Withdrawal by Subject|0|||
44255563|NCT02612610|79098493|FG003|Overall Study|Withdrawal by Subject|2|||
44255564|NCT02612610|79098490|FG000|Overall Study|Adverse Event|2|||
44255565|NCT02612610|79098491|FG001|Overall Study|Adverse Event|2|||
44255566|NCT02612610|79098492|FG002|Overall Study|Adverse Event|3|||
44255567|NCT02612610|79098493|FG003|Overall Study|Adverse Event|10|||
44255568|NCT02612610|79098490|FG000|Overall Study|Lost to Follow-up|0|||
44255569|NCT02612610|79098491|FG001|Overall Study|Lost to Follow-up|1|||
44255570|NCT02612610|79098492|FG002|Overall Study|Lost to Follow-up|0|||
44255571|NCT02612610|79098493|FG003|Overall Study|Lost to Follow-up|0|||
44255572|NCT02612610|79098490|FG000|Overall Study|Protocol Violation|0|||
44255573|NCT02612610|79098491|FG001|Overall Study|Protocol Violation|1|||
44255574|NCT02612610|79098492|FG002|Overall Study|Protocol Violation|1|||
44255575|NCT02612610|79098493|FG003|Overall Study|Protocol Violation|0|||
44255576|NCT02612610|79098490|FG000|Overall Study|Lack of Efficacy|1|||
44255577|NCT02612610|79098491|FG001|Overall Study|Lack of Efficacy|2|||
44255578|NCT02612610|79098492|FG002|Overall Study|Lack of Efficacy|0|||
44255579|NCT02612610|79098493|FG003|Overall Study|Lack of Efficacy|1|||
44283073|NCT01802580|79246361|FG001|Overall Study|Physician Decision|0|||
44152337|NCT02514239|78942823|FG003|Overall Study|Not treated|0|||
44152338|NCT02514239|78942824|FG004|Overall Study|Not treated|0|||
44152339|NCT02514239|78942825|FG005|Overall Study|Not treated|0|||
44152340|NCT02514239|78942826|FG006|Overall Study|Not treated|0|||
44152341|NCT02514239|78942827|FG007|Overall Study|Not treated|0|||
44152342|NCT02514239|78942828|FG008|Overall Study|Not treated|0|||
44152343|NCT02514239|78942829|FG009|Overall Study|Not treated|0|||
44152344|NCT02514239|78942820|FG000|Overall Study|Other Adverse Events|2|||
44152345|NCT02514239|78942821|FG001|Overall Study|Other Adverse Events|0|||
44152346|NCT02514239|78942822|FG002|Overall Study|Other Adverse Events|0|||
44152347|NCT02514239|78942823|FG003|Overall Study|Other Adverse Events|1|||
44152348|NCT02514239|78942824|FG004|Overall Study|Other Adverse Events|0|||
44152349|NCT02514239|78942825|FG005|Overall Study|Other Adverse Events|1|||
44152350|NCT02514239|78942826|FG006|Overall Study|Other Adverse Events|0|||
44152351|NCT02514239|78942827|FG007|Overall Study|Other Adverse Events|1|||
44152352|NCT02514239|78942828|FG008|Overall Study|Other Adverse Events|2|||
44152353|NCT02514239|78942829|FG009|Overall Study|Other Adverse Events|0|||
44152354|NCT02514239|78942820|FG000|Overall Study|Progressive disease|3|||
44152355|NCT02514239|78942821|FG001|Overall Study|Progressive disease|3|||
44152356|NCT02514239|78942822|FG002|Overall Study|Progressive disease|2|||
44152357|NCT02514239|78942823|FG003|Overall Study|Progressive disease|2|||
44152358|NCT02514239|78942824|FG004|Overall Study|Progressive disease|3|||
44152359|NCT02514239|78942825|FG005|Overall Study|Progressive disease|3|||
44152360|NCT02514239|78942826|FG006|Overall Study|Progressive disease|4|||
44152361|NCT02514239|78942827|FG007|Overall Study|Progressive disease|2|||
44152362|NCT02514239|78942828|FG008|Overall Study|Progressive disease|5|||
44152363|NCT02514239|78942829|FG009|Overall Study|Progressive disease|0|||
44152364|NCT02709109|78942873|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
44152365|NCT02709109|78942874|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
44152366|NCT02709109|78942875|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
44152367|NCT02709109|78942876|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
44152368|NCT02709109|78942873|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
44152369|NCT02709109|78942874|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
44152370|NCT02709109|78942875|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
44152371|NCT02709109|78942876|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
44152372|NCT02709109|78942873|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
44152373|NCT02709109|78942874|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
44283074|NCT01802580|79246360|FG000|Overall Study|Protocol Violation|2|||
44283075|NCT01802580|79246361|FG001|Overall Study|Protocol Violation|0|||
44283076|NCT01802580|79246360|FG000|Overall Study|Withdrawal by Subject|5|||
44283077|NCT01802580|79246361|FG001|Overall Study|Withdrawal by Subject|6|||
44283078|NCT01802580|79246360|FG000|Overall Study|Other|1|||
44283079|NCT01802580|79246361|FG001|Overall Study|Other|3|||
44283080|NCT01802580|79246360|FG000|Overall Study|Lack of Efficacy|0|||
44283081|NCT01802580|79246361|FG001|Overall Study|Lack of Efficacy|2|||
44283082|NCT01611090|79246369|FG000|Randomized Period|Lost to Follow-up|8|||
44283083|NCT01611090|79246370|FG001|Randomized Period|Lost to Follow-up|3|||
44283084|NCT01611090|79246371|FG002|Randomized Period|Lost to Follow-up|0|||
44531782|NCT02886728|79541524|FG001|Overall Study|Protocol Violation|0|||
44531783|NCT02886728|79541525|FG002|Overall Study|Protocol Violation|0|||
44531784|NCT02886728|79541526|FG003|Overall Study|Protocol Violation|4|||
44531785|NCT02886728|79541523|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44531786|NCT02886728|79541524|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44531787|NCT02886728|79541525|FG002|Overall Study|Non-Compliance with Study Drug|1|||
44531788|NCT02886728|79541526|FG003|Overall Study|Non-Compliance with Study Drug|0|||
44531789|NCT02886728|79541523|FG000|Overall Study|Pregnancy|0|||
44531790|NCT02886728|79541524|FG001|Overall Study|Pregnancy|0|||
44531791|NCT02886728|79541525|FG002|Overall Study|Pregnancy|1|||
44531792|NCT02886728|79541526|FG003|Overall Study|Pregnancy|0|||
44283085|NCT01611090|79246369|FG000|Randomized Period|Withdrawal by Subject|22|||
44283086|NCT01611090|79246370|FG001|Randomized Period|Withdrawal by Subject|26|||
44531793|NCT02886728|79541523|FG000|Overall Study|Randomized but Not Dosed|1|||
44531794|NCT02886728|79541524|FG001|Overall Study|Randomized but Not Dosed|0|||
44283087|NCT01611090|79246371|FG002|Randomized Period|Withdrawal by Subject|0|||
44283088|NCT01611090|79246369|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
44283089|NCT01611090|79246370|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
44152374|NCT02709109|78942875|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
44283090|NCT01611090|79246371|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
44152375|NCT02709109|78942876|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
44152376|NCT02709109|78942873|FG000|Washout Period (28 Days)|Other|2|||
44152377|NCT02709109|78942874|FG001|Washout Period (28 Days)|Other|2|||
44152378|NCT02709109|78942875|FG002|Washout Period (28 Days)|Other|3|||
44152379|NCT02709109|78942876|FG003|Washout Period (28 Days)|Other|0|||
44283091|NCT01611090|79246369|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
44415218|NCT00790842|79423151|FG006|Dose Level 1|Adverse Event|0|||
44152380|NCT02709109|78942873|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
44152381|NCT02709109|78942874|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
44152382|NCT02709109|78942875|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
44283092|NCT01611090|79246370|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
44415219|NCT00790842|79423152|FG007|Dose Level 1|Adverse Event|1|||
44415220|NCT00790842|79423153|FG008|Dose Level 1|Adverse Event|0|||
44415221|NCT00790842|79423154|FG009|Dose Level 1|Adverse Event|0|||
44415222|NCT00790842|79423155|FG010|Dose Level 1|Adverse Event|0|||
44531795|NCT02886728|79541525|FG002|Overall Study|Randomized but Not Dosed|0|||
44531796|NCT02886728|79541526|FG003|Overall Study|Randomized but Not Dosed|2|||
44531797|NCT00039871|79541536|FG000|Overall Study|Adverse Event|165|||
44531798|NCT00039871|79541536|FG000|Overall Study|Lost to Follow-up|18|||
44531799|NCT00039871|79541536|FG000|Overall Study|Protocol Violation|24|||
44531800|NCT00039871|79541536|FG000|Overall Study|Withdrawal by Subject|97|||
44531801|NCT00039871|79541536|FG000|Overall Study|Did not meet eligibility criteria|11|||
44531802|NCT00039871|79541536|FG000|Overall Study|Administrative|1|||
44531803|NCT00039871|79541536|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
44531804|NCT00039871|79541536|FG000|Overall Study|Never entered follow-up|7|||
44531805|NCT00015457|79541540|FG000|First Intervention|Adverse Event|0|||
44531806|NCT00015457|79541541|FG001|First Intervention|Adverse Event|2|||
44415223|NCT00790842|79423145|FG000|Dose Level 1|Physician Decision|1|||
44415224|NCT00790842|79423146|FG001|Dose Level 1|Physician Decision|0|||
44415225|NCT00790842|79423147|FG002|Dose Level 1|Physician Decision|0|||
44415226|NCT00790842|79423148|FG003|Dose Level 1|Physician Decision|0|||
44415227|NCT00790842|79423149|FG004|Dose Level 1|Physician Decision|0|||
44415228|NCT00790842|79423150|FG005|Dose Level 1|Physician Decision|0|||
44415229|NCT00790842|79423151|FG006|Dose Level 1|Physician Decision|0|||
44415230|NCT00790842|79423152|FG007|Dose Level 1|Physician Decision|1|||
44415231|NCT00790842|79423153|FG008|Dose Level 1|Physician Decision|0|||
44415232|NCT00790842|79423154|FG009|Dose Level 1|Physician Decision|0|||
44415233|NCT00790842|79423155|FG010|Dose Level 1|Physician Decision|0|||
44415234|NCT00790842|79423145|FG000|Dose Level 1|Withdrawal by Subject|1|||
44415235|NCT00790842|79423146|FG001|Dose Level 1|Withdrawal by Subject|0|||
44415236|NCT00790842|79423147|FG002|Dose Level 1|Withdrawal by Subject|0|||
44415237|NCT00790842|79423148|FG003|Dose Level 1|Withdrawal by Subject|0|||
44415238|NCT00790842|79423149|FG004|Dose Level 1|Withdrawal by Subject|0|||
44415239|NCT00790842|79423150|FG005|Dose Level 1|Withdrawal by Subject|0|||
44415240|NCT00790842|79423151|FG006|Dose Level 1|Withdrawal by Subject|0|||
44415241|NCT00790842|79423152|FG007|Dose Level 1|Withdrawal by Subject|0|||
44415242|NCT00790842|79423153|FG008|Dose Level 1|Withdrawal by Subject|0|||
44415243|NCT00790842|79423154|FG009|Dose Level 1|Withdrawal by Subject|0|||
44415244|NCT00790842|79423155|FG010|Dose Level 1|Withdrawal by Subject|0|||
44415245|NCT00790842|79423145|FG000|Dose Level 2|Death|0|||
44415246|NCT00790842|79423146|FG001|Dose Level 2|Death|1|||
44415247|NCT00790842|79423147|FG002|Dose Level 2|Death|0|||
44415248|NCT00790842|79423148|FG003|Dose Level 2|Death|0|||
44415249|NCT00790842|79423149|FG004|Dose Level 2|Death|1|||
44415250|NCT00790842|79423150|FG005|Dose Level 2|Death|0|||
44415251|NCT00790842|79423151|FG006|Dose Level 2|Death|0|||
44415252|NCT00790842|79423152|FG007|Dose Level 2|Death|0|||
44415253|NCT00790842|79423153|FG008|Dose Level 2|Death|0|||
44415254|NCT00790842|79423154|FG009|Dose Level 2|Death|0|||
44415255|NCT00790842|79423155|FG010|Dose Level 2|Death|0|||
44415256|NCT00790842|79423145|FG000|Dose Level 2|Physician Decision|0|||
44415257|NCT00790842|79423146|FG001|Dose Level 2|Physician Decision|1|||
44415258|NCT00790842|79423147|FG002|Dose Level 2|Physician Decision|0|||
44415259|NCT00790842|79423148|FG003|Dose Level 2|Physician Decision|0|||
44415260|NCT00790842|79423149|FG004|Dose Level 2|Physician Decision|0|||
44415261|NCT00790842|79423150|FG005|Dose Level 2|Physician Decision|0|||
44415262|NCT00790842|79423151|FG006|Dose Level 2|Physician Decision|0|||
44415263|NCT00790842|79423152|FG007|Dose Level 2|Physician Decision|0|||
44415264|NCT00790842|79423153|FG008|Dose Level 2|Physician Decision|0|||
44415265|NCT00790842|79423154|FG009|Dose Level 2|Physician Decision|0|||
44415266|NCT00790842|79423155|FG010|Dose Level 2|Physician Decision|0|||
44531807|NCT00015457|79541540|FG000|First Intervention|Lack of Efficacy|0|||
44531808|NCT00015457|79541541|FG001|First Intervention|Lack of Efficacy|1|||
44531809|NCT00015457|79541540|FG000|Second Intervention|Withdrawal by Subject|1|||
44531810|NCT00015457|79541541|FG001|Second Intervention|Withdrawal by Subject|0|||
44531811|NCT03191630|79541554|FG000|Overall Study|Lost to Follow-up|7|||
44152383|NCT02709109|78942876|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
44415267|NCT00790842|79423145|FG000|Dose Level 2|Withdrawal by Subject|0|||
44415268|NCT00790842|79423146|FG001|Dose Level 2|Withdrawal by Subject|1|||
44415269|NCT00790842|79423147|FG002|Dose Level 2|Withdrawal by Subject|0|||
44415270|NCT00790842|79423148|FG003|Dose Level 2|Withdrawal by Subject|0|||
44415271|NCT00790842|79423149|FG004|Dose Level 2|Withdrawal by Subject|0|||
44415272|NCT00790842|79423150|FG005|Dose Level 2|Withdrawal by Subject|0|||
44152384|NCT02709109|78942873|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
44152385|NCT02709109|78942874|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
44152386|NCT02709109|78942875|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
44152387|NCT02709109|78942876|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
44152388|NCT02709109|78942873|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
44152389|NCT02709109|78942874|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
44152390|NCT02709109|78942875|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
44152391|NCT02709109|78942876|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
44152392|NCT02709109|78942873|FG000|Treatment Period 2 (28 Days)|Other|0|||
44152393|NCT02709109|78942874|FG001|Treatment Period 2 (28 Days)|Other|0|||
44152394|NCT02709109|78942875|FG002|Treatment Period 2 (28 Days)|Other|1|||
44152395|NCT02709109|78942876|FG003|Treatment Period 2 (28 Days)|Other|0|||
44152396|NCT04289051|78942891|FG000|Overall Study|Lost to Follow-up|0|||
44152397|NCT04289051|78942892|FG001|Overall Study|Lost to Follow-up|0|||
44152398|NCT04289051|78942893|FG002|Overall Study|Lost to Follow-up|2|||
44283093|NCT01611090|79246371|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
44283094|NCT01844700|79246380|FG000|Overall Study|Lack of Efficacy|1|||
44283095|NCT01844700|79246381|FG001|Overall Study|Lack of Efficacy|0|||
44283096|NCT01844700|79246380|FG000|Overall Study|refused medication switch|1|||
44415273|NCT00790842|79423151|FG006|Dose Level 2|Withdrawal by Subject|0|||
44415274|NCT00790842|79423152|FG007|Dose Level 2|Withdrawal by Subject|0|||
44415275|NCT00790842|79423153|FG008|Dose Level 2|Withdrawal by Subject|0|||
44415276|NCT00790842|79423154|FG009|Dose Level 2|Withdrawal by Subject|0|||
44415277|NCT00790842|79423155|FG010|Dose Level 2|Withdrawal by Subject|0|||
44415278|NCT00790842|79423145|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415279|NCT00790842|79423146|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415280|NCT00790842|79423147|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415281|NCT00790842|79423148|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415282|NCT00790842|79423149|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415283|NCT00790842|79423150|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415284|NCT00790842|79423151|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415285|NCT00790842|79423152|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415286|NCT00790842|79423153|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
44415287|NCT00790842|79423154|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415288|NCT00790842|79423155|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
44415289|NCT00790842|79423145|FG000|Dose Level 3|Adverse Event|0|||
44415290|NCT00790842|79423146|FG001|Dose Level 3|Adverse Event|0|||
44415291|NCT00790842|79423147|FG002|Dose Level 3|Adverse Event|1|||
44415292|NCT00790842|79423148|FG003|Dose Level 3|Adverse Event|0|||
44415293|NCT00790842|79423149|FG004|Dose Level 3|Adverse Event|0|||
44415294|NCT00790842|79423150|FG005|Dose Level 3|Adverse Event|0|||
44415295|NCT00790842|79423151|FG006|Dose Level 3|Adverse Event|0|||
44415296|NCT00790842|79423152|FG007|Dose Level 3|Adverse Event|0|||
44415297|NCT00790842|79423153|FG008|Dose Level 3|Adverse Event|0|||
44415298|NCT00790842|79423154|FG009|Dose Level 3|Adverse Event|0|||
44415299|NCT00790842|79423155|FG010|Dose Level 3|Adverse Event|0|||
44415300|NCT00790842|79423145|FG000|Dose Level 3|Withdrawal by Subject|0|||
44415301|NCT00790842|79423146|FG001|Dose Level 3|Withdrawal by Subject|0|||
44415302|NCT00790842|79423147|FG002|Dose Level 3|Withdrawal by Subject|3|||
44415303|NCT00790842|79423148|FG003|Dose Level 3|Withdrawal by Subject|0|||
44415304|NCT00790842|79423149|FG004|Dose Level 3|Withdrawal by Subject|0|||
44415305|NCT00790842|79423150|FG005|Dose Level 3|Withdrawal by Subject|0|||
44283097|NCT01844700|79246381|FG001|Overall Study|refused medication switch|0|||
44283098|NCT01844700|79246380|FG000|Overall Study|Withdrawal by Subject|1|||
44283099|NCT01844700|79246381|FG001|Overall Study|Withdrawal by Subject|0|||
44283100|NCT01844700|79246380|FG000|Overall Study|stopped taking meds|0|||
44283101|NCT01844700|79246381|FG001|Overall Study|stopped taking meds|1|||
44283102|NCT01844076|79246391|FG000|Overall Study|Adverse Event|1|||
44283103|NCT01844076|79246392|FG001|Overall Study|Adverse Event|0|||
44283104|NCT01844076|79246393|FG002|Overall Study|Adverse Event|0|||
44283105|NCT01844076|79246394|FG003|Overall Study|Adverse Event|0|||
44283106|NCT01844076|79246391|FG000|Overall Study|Withdrawal by Subject|1|||
44283107|NCT01844076|79246392|FG001|Overall Study|Withdrawal by Subject|0|||
44283108|NCT01844076|79246393|FG002|Overall Study|Withdrawal by Subject|0|||
44283109|NCT01844076|79246394|FG003|Overall Study|Withdrawal by Subject|0|||
44283110|NCT01826604|79246406|FG000|Overall Study|Lost to Follow-up|8|||
44283111|NCT01826604|79246407|FG001|Overall Study|Lost to Follow-up|9|||
44152399|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
44152400|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
44283112|NCT01843842|79246415|FG000|Overall Study|Do not meet inclusion criteria|1|||
44283113|NCT01843842|79246416|FG001|Overall Study|Do not meet inclusion criteria|1|||
44283114|NCT01826448|79246424|FG000|Overall Study|Adverse Event|1|||
44283115|NCT01826448|79246425|FG001|Overall Study|Adverse Event|3|||
44283116|NCT01826448|79246424|FG000|Overall Study|Disease progression|2|||
44283117|NCT01826448|79246425|FG001|Overall Study|Disease progression|4|||
44283118|NCT01826448|79246424|FG000|Overall Study|Withdrawal by Subject|1|||
44283119|NCT01826448|79246425|FG001|Overall Study|Withdrawal by Subject|0|||
44283120|NCT01826448|79246424|FG000|Overall Study|Physician Decision|0|||
44283121|NCT01826448|79246425|FG001|Overall Study|Physician Decision|1|||
44283122|NCT01826448|79246424|FG000|Overall Study|2 active cancers|0|||
44283123|NCT01826448|79246425|FG001|Overall Study|2 active cancers|1|||
44283124|NCT01826370|79246431|FG000|Overall Study|Protocol Violation|6|||
44283125|NCT01826370|79246431|FG000|Overall Study|Lost to Follow-up|12|||
44283126|NCT01826370|79246431|FG000|Overall Study|Other reason not defined above|2|||
44283127|NCT01826214|79246437|FG000|Overall Study|Adverse Event|7|||
44283128|NCT01826214|79246438|FG001|Overall Study|Adverse Event|6|||
44283129|NCT01826214|79246437|FG000|Overall Study|Death|3|||
44283130|NCT01826214|79246438|FG001|Overall Study|Death|1|||
44283131|NCT01826214|79246437|FG000|Overall Study|Lost to Follow-up|1|||
44283132|NCT01826214|79246438|FG001|Overall Study|Lost to Follow-up|0|||
44283133|NCT01826214|79246437|FG000|Overall Study|Physician Decision|0|||
44531812|NCT03191630|79541555|FG001|Overall Study|Lost to Follow-up|7|||
44531813|NCT03191552|79541566|FG000|Overall Study|Lost to Follow-up|1|||
44531814|NCT03191552|79541567|FG001|Overall Study|Lost to Follow-up|0|||
44531815|NCT03191552|79541568|FG002|Overall Study|Lost to Follow-up|0|||
44531816|NCT03191552|79541566|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
44283134|NCT01826214|79246438|FG001|Overall Study|Physician Decision|2|||
44283135|NCT01826214|79246437|FG000|Overall Study|Progressive disease|22|||
44283136|NCT01826214|79246438|FG001|Overall Study|Progressive disease|21|||
44283137|NCT01826214|79246437|FG000|Overall Study|Study terminated by Sponsor|0|||
44283138|NCT01826214|79246438|FG001|Overall Study|Study terminated by Sponsor|1|||
44283139|NCT01826214|79246437|FG000|Overall Study|Subject/guardian decision|2|||
44283140|NCT01826214|79246438|FG001|Overall Study|Subject/guardian decision|3|||
44283141|NCT01843062|79246446|FG000|Overall Study|Protocol Violation|1|||
44283142|NCT01843062|79246447|FG001|Overall Study|Protocol Violation|0|||
44283143|NCT01843062|79246446|FG000|Overall Study|New treatment following progression|2|||
44283144|NCT01843062|79246447|FG001|Overall Study|New treatment following progression|0|||
44283145|NCT01843062|79246446|FG000|Overall Study|Pregnancy|1|||
44283146|NCT01843062|79246447|FG001|Overall Study|Pregnancy|0|||
44283147|NCT01843062|79246446|FG000|Overall Study|Adverse Event|2|||
44283148|NCT01843062|79246447|FG001|Overall Study|Adverse Event|0|||
44283149|NCT01843062|79246446|FG000|Overall Study|Incorrect randomisation|1|||
44283150|NCT01843062|79246447|FG001|Overall Study|Incorrect randomisation|0|||
44283151|NCT01843062|79246446|FG000|Overall Study|Withdrawal by Subject|12|||
44283152|NCT01843062|79246447|FG001|Overall Study|Withdrawal by Subject|3|||
44531817|NCT03191552|79541567|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
44531818|NCT03191552|79541568|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
44531819|NCT03191396|79541582|FG000|Overall Study|Lost to Follow-up|0|||
44531820|NCT03191396|79541583|FG001|Overall Study|Lost to Follow-up|3|||
44283153|NCT01843062|79246446|FG000|Overall Study|Death|1|||
44283154|NCT01843062|79246447|FG001|Overall Study|Death|2|||
44531821|NCT03191396|79541582|FG000|Overall Study|Withdrawal by Subject|3|||
44283155|NCT01843062|79246446|FG000|Overall Study|Lost to Follow-up|2|||
44283156|NCT01843062|79246447|FG001|Overall Study|Lost to Follow-up|4|||
44283157|NCT01842438|79246455|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
44531822|NCT03191396|79541583|FG001|Overall Study|Withdrawal by Subject|2|||
44283158|NCT01842438|79246456|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
44283159|NCT01842438|79246455|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
44283160|NCT01842438|79246456|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
44283161|NCT01842438|79246455|FG000|T2: 6month Follow-up|Death|0|||
44283162|NCT01842438|79246456|FG001|T2: 6month Follow-up|Death|1|||
44283163|NCT01799226|79246468|FG000|Overall Study|Withdrawal by Subject|1|||
44283164|NCT01799226|79246469|FG001|Overall Study|Withdrawal by Subject|0|||
44283165|NCT01799226|79246468|FG000|Overall Study|Disqualified at Day 14|1|||
44283166|NCT01799226|79246469|FG001|Overall Study|Disqualified at Day 14|0|||
44283167|NCT01825200|79246477|FG000|Overall Study|Lost to Follow-up|5|||
44283168|NCT01825200|79246478|FG001|Overall Study|Lost to Follow-up|6|||
44283169|NCT01825200|79246477|FG000|Overall Study|Withdrawal by Subject|0|||
44283170|NCT01825200|79246478|FG001|Overall Study|Withdrawal by Subject|1|||
44283171|NCT01824576|79246484|FG000|Overall Study|Device deficiency|2|||
44283172|NCT01824498|79246494|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
44283173|NCT01824498|79246495|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
44531823|NCT00007345|79541591|FG000|Overall Study|Refused further treatment|0|||
44531824|NCT00007345|79541592|FG001|Overall Study|Refused further treatment|7|||
44531825|NCT00007345|79541591|FG000|Overall Study|Switched to alternative treatment|0|||
44283174|NCT01824498|79246496|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
44283175|NCT01824498|79246497|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
44283176|NCT01824498|79246498|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
44283177|NCT01824498|79246499|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
44283178|NCT01798134|79246507|FG000|Overall Study|Lost to Follow-up|1|||
44283179|NCT01798134|79246507|FG000|Overall Study|Withdrawal by Subject|3|||
44283180|NCT01798134|79246507|FG000|Overall Study|Death|2|||
44283181|NCT01798134|79246507|FG000|Overall Study|Adverse Event|3|||
44283182|NCT01798134|79246507|FG000|Overall Study|Physician Decision|3|||
44283183|NCT01798134|79246507|FG000|Overall Study|Liver transplant/surgery|4|||
44283184|NCT01798056|79246513|FG000|Overall Study|Serious Adverse Event|13|||
44283185|NCT01798056|79246514|FG001|Overall Study|Serious Adverse Event|12|||
44283186|NCT01798056|79246513|FG000|Overall Study|Withdrawal by Subject|12|||
44283187|NCT01798056|79246514|FG001|Overall Study|Withdrawal by Subject|9|||
44283188|NCT01798056|79246513|FG000|Overall Study|Migrated/moved from study area|1|||
44283189|NCT01798056|79246514|FG001|Overall Study|Migrated/moved from study area|1|||
44283190|NCT01798056|79246513|FG000|Overall Study|Lost to Follow-up|1|||
44283191|NCT01798056|79246514|FG001|Overall Study|Lost to Follow-up|1|||
44283192|NCT01798056|79246513|FG000|Overall Study|Other|0|||
44283193|NCT01798056|79246514|FG001|Overall Study|Other|2|||
44283194|NCT01824342|79246524|FG000|Overall Study|Withdrawal by Subject|0|||
44283195|NCT01824342|79246525|FG001|Overall Study|Withdrawal by Subject|3|||
44283196|NCT01824342|79246524|FG000|Overall Study|Adverse Event|1|||
44283197|NCT01824342|79246525|FG001|Overall Study|Adverse Event|1|||
44283198|NCT01824342|79246524|FG000|Overall Study|Disease Progression|1|||
44283199|NCT01824342|79246525|FG001|Overall Study|Disease Progression|1|||
44283200|NCT01824342|79246524|FG000|Overall Study|Physician Decision|5|||
44283201|NCT01824342|79246525|FG001|Overall Study|Physician Decision|0|||
44283202|NCT01824342|79246524|FG000|Overall Study|Death|2|||
44283203|NCT01824342|79246525|FG001|Overall Study|Death|0|||
44531826|NCT00007345|79541592|FG001|Overall Study|Switched to alternative treatment|3|||
44531827|NCT00007345|79541591|FG000|Overall Study|Intercurrent illness|1|||
44531828|NCT00007345|79541592|FG001|Overall Study|Intercurrent illness|0|||
44531829|NCT00007345|79541591|FG000|Overall Study|Death on study|1|||
44531830|NCT00007345|79541592|FG001|Overall Study|Death on study|1|||
44531831|NCT03405662|79541600|FG000|Overall Study|COVID-19 restriction|1|||
44531832|NCT03405662|79541601|FG001|Overall Study|COVID-19 restriction|0|||
44531833|NCT03405662|79541600|FG000|Overall Study|unblinding|0|||
44531834|NCT03405662|79541601|FG001|Overall Study|unblinding|1|||
44531835|NCT03405662|79541600|FG000|Overall Study|placement in memory care facility|0|||
44531836|NCT03405662|79541601|FG001|Overall Study|placement in memory care facility|2|||
44531837|NCT00031447|79541609|FG000|Overall Study|Lost to Follow-up|0|||
44531838|NCT00031447|79541610|FG001|Overall Study|Lost to Follow-up|1|||
44531839|NCT00031447|79541609|FG000|Overall Study|Non-compliant|1|||
44531840|NCT00031447|79541610|FG001|Overall Study|Non-compliant|1|||
44283204|NCT01841970|79246531|FG000|Overall Study|Withdrawal by Subject|1|||
44283205|NCT01841970|79246531|FG000|Overall Study|Physician Decision|2|||
44531841|NCT00031447|79541609|FG000|Overall Study|Re-activation of Disease|2|||
44283206|NCT01841970|79246531|FG000|Overall Study|Lost to Follow-up|8|||
44283207|NCT01823328|79246540|FG000|Overall Study|Withdrawal by Subject|8|||
44283208|NCT01823328|79246541|FG001|Overall Study|Withdrawal by Subject|6|||
44531842|NCT00031447|79541610|FG001|Overall Study|Re-activation of Disease|1|||
44531843|NCT00031447|79541609|FG000|Overall Study|Disruption of blinded study drug supply|7|||
44531844|NCT00031447|79541610|FG001|Overall Study|Disruption of blinded study drug supply|4|||
44531845|NCT00006409|79541622|FG000|Baseline|Protocol Violation|48|||
44283209|NCT01840410|79246549|FG000|Overall Study|Physician Decision|1|||
44283210|NCT01840410|79246550|FG001|Overall Study|Physician Decision|2|||
44283211|NCT01840410|79246549|FG000|Overall Study|Pregnancy|1|||
44283212|NCT01840410|79246550|FG001|Overall Study|Pregnancy|0|||
44283213|NCT01840410|79246549|FG000|Overall Study|Protocol deviation|1|||
44283214|NCT01840410|79246550|FG001|Overall Study|Protocol deviation|0|||
44283215|NCT01840410|79246549|FG000|Overall Study|Lost to Follow-up|1|||
44283216|NCT01840410|79246550|FG001|Overall Study|Lost to Follow-up|0|||
44283217|NCT01840410|79246549|FG000|Overall Study|Withdrawal by Subject|2|||
44283218|NCT01840410|79246550|FG001|Overall Study|Withdrawal by Subject|1|||
44283219|NCT01840410|79246549|FG000|Overall Study|Adverse Event|1|||
44283220|NCT01840410|79246550|FG001|Overall Study|Adverse Event|1|||
44283221|NCT01797432|79246558|FG000|Overall Study|Lost to Follow-up|1|||
44283222|NCT01797432|79246558|FG000|Overall Study|Adverse Event|1|||
44531846|NCT00006409|79541623|FG001|Baseline|Protocol Violation|70|||
44531847|NCT00006409|79541624|FG002|Baseline|Protocol Violation|0|||
44531848|NCT00006409|79541625|FG003|Baseline|Protocol Violation|0|||
44531849|NCT00006409|79541626|FG004|Baseline|Protocol Violation|0|||
44531850|NCT00006409|79541627|FG005|Baseline|Protocol Violation|0|||
44531851|NCT00006409|79541622|FG000|Post-2 Year Intervention|Protocol Violation|0|||
44531852|NCT00006409|79541623|FG001|Post-2 Year Intervention|Protocol Violation|0|||
44531853|NCT00006409|79541624|FG002|Post-2 Year Intervention|Protocol Violation|251|||
44531854|NCT00006409|79541625|FG003|Post-2 Year Intervention|Protocol Violation|168|||
44531855|NCT00006409|79541626|FG004|Post-2 Year Intervention|Protocol Violation|0|||
44531856|NCT00006409|79541627|FG005|Post-2 Year Intervention|Protocol Violation|0|||
44531857|NCT00006409|79541622|FG000|Post-3 Year Intervention|Protocol Violation|0|||
44531858|NCT00006409|79541623|FG001|Post-3 Year Intervention|Protocol Violation|0|||
44531859|NCT00006409|79541624|FG002|Post-3 Year Intervention|Protocol Violation|0|||
44531860|NCT00006409|79541625|FG003|Post-3 Year Intervention|Protocol Violation|0|||
44531861|NCT00006409|79541626|FG004|Post-3 Year Intervention|Protocol Violation|62|||
44531862|NCT00006409|79541627|FG005|Post-3 Year Intervention|Protocol Violation|62|||
44531863|NCT00006289|79541643|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
44531864|NCT00006289|79541644|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
44531865|NCT00006289|79541643|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
44531866|NCT00006289|79541644|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
44531867|NCT00005947|79541662|FG000|Overall Study|Death|54|||
44531868|NCT00005947|79541663|FG001|Overall Study|Death|40|||
44531869|NCT00005947|79541662|FG000|Overall Study|Patient Refused to Continue|2|||
44531870|NCT00005947|79541663|FG001|Overall Study|Patient Refused to Continue|1|||
44531871|NCT00005947|79541662|FG000|Overall Study|Site Closure|1|||
44531872|NCT00005947|79541663|FG001|Overall Study|Site Closure|0|||
44531873|NCT00005047|79541675|FG000|Overall Study|Withdrawal by Subject|12|||
44531874|NCT00005047|79541676|FG001|Overall Study|Withdrawal by Subject|0|||
44531875|NCT00005047|79541677|FG002|Overall Study|Withdrawal by Subject|0|||
44531876|NCT00005047|79541678|FG003|Overall Study|Withdrawal by Subject|0|||
44531877|NCT00005047|79541675|FG000|Overall Study|Adverse Event|5|||
44531878|NCT00005047|79541676|FG001|Overall Study|Adverse Event|0|||
44531879|NCT00005047|79541677|FG002|Overall Study|Adverse Event|0|||
44531880|NCT00005047|79541678|FG003|Overall Study|Adverse Event|0|||
44531881|NCT00005047|79541675|FG000|Overall Study|Lost to Follow-up|1|||
44531882|NCT00005047|79541676|FG001|Overall Study|Lost to Follow-up|0|||
44531883|NCT00005047|79541677|FG002|Overall Study|Lost to Follow-up|0|||
44531884|NCT00005047|79541678|FG003|Overall Study|Lost to Follow-up|0|||
44531885|NCT00005047|79541675|FG000|Overall Study|Lack of Efficacy|1|||
44152401|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
44152402|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
44152403|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
44152404|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
44152405|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
44152406|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
44152407|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
44152408|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
44283223|NCT01797432|79246558|FG000|Overall Study|Withdrawal by Subject|1|||
44283224|NCT01797432|79246558|FG000|Overall Study|lived too far from study site|1|||
44283225|NCT01797120|79246564|FG000|Overall Study|Disesae progression|37|||
44283226|NCT01797120|79246565|FG001|Overall Study|Disesae progression|49|||
44283227|NCT01797120|79246564|FG000|Overall Study|Adverse Event|13|||
44283228|NCT01797120|79246565|FG001|Overall Study|Adverse Event|5|||
44283229|NCT01797120|79246564|FG000|Overall Study|Withdrawal by Subject|6|||
44152409|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
44152410|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
44283230|NCT01797120|79246565|FG001|Overall Study|Withdrawal by Subject|6|||
44283231|NCT01797120|79246564|FG000|Overall Study|Symptomatic progression|2|||
44283232|NCT01797120|79246565|FG001|Overall Study|Symptomatic progression|1|||
44531886|NCT00005047|79541676|FG001|Overall Study|Lack of Efficacy|0|||
44531887|NCT00005047|79541677|FG002|Overall Study|Lack of Efficacy|0|||
44531888|NCT00005047|79541678|FG003|Overall Study|Lack of Efficacy|0|||
44531889|NCT00003901|79541688|FG000|Overall Study|Adverse Event|1|||
44531890|NCT00003901|79541688|FG000|Overall Study|Withdrawal by Subject|1|||
44531891|NCT00003901|79541688|FG000|Overall Study|Ineligible|6|||
44531892|NCT00003901|79541688|FG000|Overall Study|CT Scan not within protocol requirement|2|||
44152411|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
44152412|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
44152413|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
44152414|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
44152415|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
44152416|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
44255580|NCT02612610|79098490|FG000|Overall Study|Physician Decision|0|||
44255581|NCT02612610|79098491|FG001|Overall Study|Physician Decision|1|||
44255582|NCT02612610|79098492|FG002|Overall Study|Physician Decision|0|||
44283233|NCT01797120|79246564|FG000|Overall Study|Non-compliance|1|||
44283234|NCT01797120|79246565|FG001|Overall Study|Non-compliance|0|||
44283235|NCT01797120|79246564|FG000|Overall Study|Physician Decision|3|||
44283236|NCT01797120|79246565|FG001|Overall Study|Physician Decision|0|||
44283237|NCT01797120|79246564|FG000|Overall Study|still on treatment|2|||
44283238|NCT01797120|79246565|FG001|Overall Study|still on treatment|4|||
44283239|NCT01797120|79246564|FG000|Overall Study|never start protocol therapy|2|||
44283240|NCT01797120|79246565|FG001|Overall Study|never start protocol therapy|0|||
44283241|NCT01796964|79246573|FG000|Overall Study|Adverse Event|1|||
44283242|NCT01796964|79246574|FG001|Overall Study|Adverse Event|1|||
44283243|NCT01796964|79246573|FG000|Overall Study|Death|1|||
44283244|NCT01796964|79246574|FG001|Overall Study|Death|0|||
44283245|NCT01796964|79246573|FG000|Overall Study|Protocol Violation|0|||
44283246|NCT01796964|79246574|FG001|Overall Study|Protocol Violation|1|||
44283247|NCT01796964|79246573|FG000|Overall Study|Withdrawal by Subject|1|||
44283248|NCT01796964|79246574|FG001|Overall Study|Withdrawal by Subject|1|||
44283249|NCT01838694|79246583|FG000|Overall Study|Adverse Event|0|||
44283250|NCT01838694|79246584|FG001|Overall Study|Adverse Event|1|||
44283251|NCT01795638|79246595|FG000|Overall Study|Death|0|||
44283252|NCT01795638|79246596|FG001|Overall Study|Death|3|||
44283253|NCT01795638|79246595|FG000|Overall Study|transferred to quaternary hospital|2|||
44283254|NCT01795638|79246596|FG001|Overall Study|transferred to quaternary hospital|3|||
44255583|NCT02612610|79098493|FG003|Overall Study|Physician Decision|0|||
44255584|NCT02612610|79098490|FG000|Overall Study|Noncompliance|1|||
44255585|NCT02612610|79098491|FG001|Overall Study|Noncompliance|0|||
44255586|NCT02612610|79098492|FG002|Overall Study|Noncompliance|0|||
44255587|NCT02612610|79098493|FG003|Overall Study|Noncompliance|0|||
44255588|NCT02612610|79098490|FG000|Overall Study|Cough Improvement|0|||
44255589|NCT02612610|79098491|FG001|Overall Study|Cough Improvement|0|||
44255590|NCT02612610|79098492|FG002|Overall Study|Cough Improvement|1|||
44255591|NCT02612610|79098493|FG003|Overall Study|Cough Improvement|0|||
44255592|NCT02610192|79098706|FG000|Overall Study|Received other treatment|8|||
44255593|NCT02610192|79098706|FG000|Overall Study|Physician Decision|1|||
44255594|NCT02609178|79098834|FG000|First Crown|Withdrawal by Subject|0|||
44255595|NCT02609178|79098835|FG001|First Crown|Withdrawal by Subject|0|||
44255596|NCT02609178|79098836|FG002|First Crown|Withdrawal by Subject|1|||
44255597|NCT02609178|79098837|FG003|First Crown|Withdrawal by Subject|1|||
44255598|NCT02609178|79098838|FG004|First Crown|Withdrawal by Subject|0|||
44255599|NCT02609178|79098839|FG005|First Crown|Withdrawal by Subject|0|||
44255600|NCT02607228|79099063|FG000|Overall Study|Progressive Disease|4|||
44283255|NCT01795638|79246595|FG000|Overall Study|Protocol Violation|3|||
44283256|NCT01795638|79246596|FG001|Overall Study|Protocol Violation|0|||
44283257|NCT01795638|79246595|FG000|Overall Study|discharged from hospital|7|||
44283258|NCT01795638|79246596|FG001|Overall Study|discharged from hospital|5|||
44283259|NCT01795638|79246595|FG000|Overall Study|Withdrawal by Subject|1|||
44283260|NCT01795638|79246596|FG001|Overall Study|Withdrawal by Subject|0|||
44283261|NCT01794780|79246610|FG000|Overall Study|Adverse Event|0|||
44283262|NCT01794780|79246611|FG001|Overall Study|Adverse Event|1|||
44283263|NCT01794780|79246612|FG002|Overall Study|Adverse Event|2|||
44283264|NCT01794780|79246613|FG003|Overall Study|Adverse Event|0|||
44283265|NCT01794780|79246614|FG004|Overall Study|Adverse Event|0|||
44283266|NCT01794780|79246615|FG005|Overall Study|Adverse Event|0|||
44283267|NCT01794780|79246616|FG006|Overall Study|Adverse Event|0|||
44283268|NCT01794780|79246617|FG007|Overall Study|Adverse Event|0|||
44283269|NCT01794780|79246610|FG000|Overall Study|Death|0|||
44283270|NCT01794780|79246611|FG001|Overall Study|Death|2|||
44283271|NCT01794780|79246612|FG002|Overall Study|Death|14|||
44283272|NCT01794780|79246613|FG003|Overall Study|Death|1|||
44283273|NCT01794780|79246614|FG004|Overall Study|Death|0|||
44283274|NCT01794780|79246615|FG005|Overall Study|Death|9|||
44283275|NCT01794780|79246616|FG006|Overall Study|Death|4|||
44415306|NCT00790842|79423151|FG006|Dose Level 3|Withdrawal by Subject|0|||
44415307|NCT00790842|79423152|FG007|Dose Level 3|Withdrawal by Subject|0|||
44415308|NCT00790842|79423153|FG008|Dose Level 3|Withdrawal by Subject|0|||
44415309|NCT00790842|79423154|FG009|Dose Level 3|Withdrawal by Subject|2|||
44415310|NCT00790842|79423155|FG010|Dose Level 3|Withdrawal by Subject|0|||
44415311|NCT00790842|79423145|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415312|NCT00790842|79423146|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415313|NCT00790842|79423147|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415314|NCT00790842|79423148|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415315|NCT00790842|79423149|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415316|NCT00790842|79423150|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
44415317|NCT00790842|79423151|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415318|NCT00790842|79423152|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415319|NCT00790842|79423153|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415320|NCT00790842|79423154|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44415321|NCT00790842|79423155|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
44531893|NCT00003901|79541688|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
44531894|NCT00003901|79541688|FG000|Overall Study|Medical problems|6|||
44531895|NCT00003895|79541697|FG000|Overall Study|Adverse Event|4|||
44531896|NCT00003895|79541698|FG001|Overall Study|Adverse Event|0|||
44531897|NCT00003895|79541697|FG000|Overall Study|Lack of Efficacy|1|||
44531898|NCT00003895|79541698|FG001|Overall Study|Lack of Efficacy|1|||
44531899|NCT00003895|79541697|FG000|Overall Study|Patient Vacation|2|||
44531900|NCT00003895|79541698|FG001|Overall Study|Patient Vacation|0|||
44283276|NCT01794780|79246617|FG007|Overall Study|Death|0|||
44415322|NCT00790842|79423145|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415323|NCT00790842|79423146|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44531901|NCT00003895|79541697|FG000|Overall Study|Withdrawal by Subject|0|||
44531902|NCT00003895|79541698|FG001|Overall Study|Withdrawal by Subject|3|||
44283277|NCT01794780|79246610|FG000|Overall Study|Lost to Follow-up|10|||
44283278|NCT01794780|79246611|FG001|Overall Study|Lost to Follow-up|64|||
44283279|NCT01794780|79246612|FG002|Overall Study|Lost to Follow-up|165|||
44283280|NCT01794780|79246613|FG003|Overall Study|Lost to Follow-up|53|||
44415324|NCT00790842|79423147|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
44415325|NCT00790842|79423148|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415326|NCT00790842|79423149|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415327|NCT00790842|79423150|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415328|NCT00790842|79423151|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415329|NCT00790842|79423152|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415330|NCT00790842|79423153|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415331|NCT00790842|79423154|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415332|NCT00790842|79423155|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
44415333|NCT00790842|79423145|FG000|Dose Level 4|Adverse Event|0|||
44415334|NCT00790842|79423146|FG001|Dose Level 4|Adverse Event|0|||
44152417|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
44152418|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
44152419|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
44152420|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
44152421|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
44152422|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
44152423|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
44152424|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
44152425|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
44152426|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
44152427|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
44152428|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
44152429|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
44152430|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
44152431|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
44152432|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
44415335|NCT00790842|79423147|FG002|Dose Level 4|Adverse Event|0|||
44415336|NCT00790842|79423148|FG003|Dose Level 4|Adverse Event|0|||
44415337|NCT00790842|79423149|FG004|Dose Level 4|Adverse Event|0|||
44415338|NCT00790842|79423150|FG005|Dose Level 4|Adverse Event|0|||
44415339|NCT00790842|79423151|FG006|Dose Level 4|Adverse Event|1|||
44415340|NCT00790842|79423152|FG007|Dose Level 4|Adverse Event|0|||
44415341|NCT00790842|79423153|FG008|Dose Level 4|Adverse Event|0|||
44415342|NCT00790842|79423154|FG009|Dose Level 4|Adverse Event|0|||
44415343|NCT00790842|79423155|FG010|Dose Level 4|Adverse Event|0|||
44531903|NCT03800173|79541709|FG000|Overall Study|Lost to Follow-up|0|||
44531904|NCT03800173|79541710|FG001|Overall Study|Lost to Follow-up|0|||
44531905|NCT03800173|79541711|FG002|Overall Study|Lost to Follow-up|0|||
44152433|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
44531906|NCT03800173|79541712|FG003|Overall Study|Lost to Follow-up|0|||
44531907|NCT03800173|79541713|FG004|Overall Study|Lost to Follow-up|1|||
44531908|NCT00003631|79541732|FG000|Overall Study|Patient not treated|1|||
44531909|NCT00003631|79541733|FG001|Overall Study|Patient not treated|0|||
44531910|NCT00003631|79541734|FG002|Overall Study|Patient not treated|1|||
44152434|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
44531911|NCT00003631|79541732|FG000|Overall Study|Protocol Violation|1|||
44531912|NCT00003631|79541733|FG001|Overall Study|Protocol Violation|0|||
44152435|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
44152436|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
44152437|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
44152438|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
44415344|NCT00790842|79423145|FG000|Dose Level 4|Physician Decision|0|||
44415345|NCT00790842|79423146|FG001|Dose Level 4|Physician Decision|0|||
44415346|NCT00790842|79423147|FG002|Dose Level 4|Physician Decision|0|||
44531913|NCT00003631|79541734|FG002|Overall Study|Protocol Violation|0|||
44531914|NCT00003631|79541732|FG000|Overall Study|Adverse Event|1|||
44152439|NCT02709655|78942901|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
44415347|NCT00790842|79423148|FG003|Dose Level 4|Physician Decision|0|||
44415348|NCT00790842|79423149|FG004|Dose Level 4|Physician Decision|0|||
44415349|NCT00790842|79423150|FG005|Dose Level 4|Physician Decision|0|||
44531915|NCT00003631|79541733|FG001|Overall Study|Adverse Event|1|||
44531916|NCT00003631|79541734|FG002|Overall Study|Adverse Event|5|||
44531917|NCT00003631|79541732|FG000|Overall Study|Death|0|||
44531918|NCT00003631|79541733|FG001|Overall Study|Death|0|||
44531919|NCT00003631|79541734|FG002|Overall Study|Death|1|||
44531920|NCT00003631|79541732|FG000|Overall Study|Evaluable for toxicity only|0|||
44531921|NCT00003631|79541733|FG001|Overall Study|Evaluable for toxicity only|0|||
44531922|NCT00003631|79541734|FG002|Overall Study|Evaluable for toxicity only|2|||
44531923|NCT00003535|79541742|FG000|Overall Study|Not evaluable|5|||
44531924|NCT00003511|79541746|FG000|Overall Study|Not evaluable|4|||
44531925|NCT00003499|79541750|FG000|Overall Study|Not evaluable|8|||
44531926|NCT00003487|79541754|FG000|Overall Study|Not evaluable|2|||
44531927|NCT00003475|79541758|FG000|Overall Study|Not evaluable|13|||
44531928|NCT00003457|79541763|FG000|Overall Study|Not evaluable|9|||
44415350|NCT00790842|79423151|FG006|Dose Level 4|Physician Decision|1|||
44152440|NCT02709655|78942902|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
44152441|NCT02709655|78942903|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
44152442|NCT02709655|78942904|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
44152443|NCT02709655|78942905|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
44152444|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
44152445|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
44152446|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
44152447|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
44152448|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
44152449|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
44152450|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
44152451|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
44152452|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
44152453|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
44152454|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
44152455|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
44152456|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
44152457|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
44152458|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
44152459|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
44152460|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
44152461|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
44152462|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
44152463|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
44152464|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
44152465|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
44152466|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
44152467|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
44152468|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
44152469|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
44152470|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
44152471|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
44152472|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
44152473|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
44152474|NCT02709655|78942901|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
44152475|NCT02709655|78942902|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
44152476|NCT02709655|78942903|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
44152477|NCT02709655|78942904|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
44152478|NCT02709655|78942905|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
44152479|NCT02708485|78942919|FG000|Overall Study|Withdrawal by Subject|3|||
44152480|NCT02708485|78942920|FG001|Overall Study|Withdrawal by Subject|2|||
44152481|NCT02709577|78942932|FG000|Overall Study|non-accommodating anatomy|0|||
44152482|NCT02709577|78942933|FG001|Overall Study|non-accommodating anatomy|1|||
44152483|NCT02709577|78942934|FG002|Overall Study|non-accommodating anatomy|0|||
44152484|NCT02709577|78942935|FG003|Overall Study|non-accommodating anatomy|0|||
44152485|NCT02709577|78942932|FG000|Overall Study|procedural complication|0|||
44152486|NCT02709577|78942933|FG001|Overall Study|procedural complication|1|||
44152487|NCT02709577|78942934|FG002|Overall Study|procedural complication|0|||
44152488|NCT02709577|78942935|FG003|Overall Study|procedural complication|0|||
44152489|NCT02709577|78942932|FG000|Overall Study|Withdrawal by Subject|2|||
44152490|NCT02709577|78942933|FG001|Overall Study|Withdrawal by Subject|3|||
44152491|NCT02709577|78942934|FG002|Overall Study|Withdrawal by Subject|2|||
44152492|NCT02709577|78942935|FG003|Overall Study|Withdrawal by Subject|0|||
44152493|NCT02078752|78942956|FG000|Overall Study|Death|0|||
44152494|NCT02078752|78942957|FG001|Overall Study|Death|3|||
44152495|NCT02078752|78942958|FG002|Overall Study|Death|0|||
44152496|NCT02078752|78942959|FG003|Overall Study|Death|0|||
44152497|NCT02078752|78942960|FG004|Overall Study|Death|0|||
44152498|NCT02078752|78942961|FG005|Overall Study|Death|1|||
44255601|NCT02607228|79099064|FG001|Overall Study|Progressive Disease|3|||
44255602|NCT02607228|79099065|FG002|Overall Study|Progressive Disease|1|||
44255603|NCT02607228|79099066|FG003|Overall Study|Progressive Disease|5|||
44255604|NCT02607228|79099067|FG004|Overall Study|Progressive Disease|4|||
44255605|NCT02607228|79099068|FG005|Overall Study|Progressive Disease|3|||
44255606|NCT02607228|79099069|FG006|Overall Study|Progressive Disease|1|||
44152499|NCT02078752|78942962|FG006|Overall Study|Death|0|||
44152500|NCT02078752|78942963|FG007|Overall Study|Death|1|||
44152501|NCT02078752|78942964|FG008|Overall Study|Death|0|||
44152502|NCT02078752|78942965|FG009|Overall Study|Death|4|||
44152503|NCT02078752|78942956|FG000|Overall Study|Lost to Follow-up|1|||
44152504|NCT02078752|78942957|FG001|Overall Study|Lost to Follow-up|0|||
44152505|NCT02078752|78942958|FG002|Overall Study|Lost to Follow-up|0|||
44152506|NCT02078752|78942959|FG003|Overall Study|Lost to Follow-up|1|||
44152507|NCT02078752|78942960|FG004|Overall Study|Lost to Follow-up|0|||
44152508|NCT02078752|78942961|FG005|Overall Study|Lost to Follow-up|0|||
44152509|NCT02078752|78942962|FG006|Overall Study|Lost to Follow-up|0|||
44152510|NCT02078752|78942963|FG007|Overall Study|Lost to Follow-up|0|||
44152511|NCT02078752|78942964|FG008|Overall Study|Lost to Follow-up|0|||
44283281|NCT01794780|79246614|FG004|Overall Study|Lost to Follow-up|2|||
44283282|NCT01794780|79246615|FG005|Overall Study|Lost to Follow-up|99|||
44152512|NCT02078752|78942965|FG009|Overall Study|Lost to Follow-up|0|||
44152513|NCT02078752|78942956|FG000|Overall Study|Withdrawal by Subject|1|||
44152514|NCT02078752|78942957|FG001|Overall Study|Withdrawal by Subject|1|||
44152515|NCT02078752|78942958|FG002|Overall Study|Withdrawal by Subject|1|||
44152516|NCT02078752|78942959|FG003|Overall Study|Withdrawal by Subject|1|||
44152517|NCT02078752|78942960|FG004|Overall Study|Withdrawal by Subject|0|||
44152518|NCT02078752|78942961|FG005|Overall Study|Withdrawal by Subject|3|||
44152519|NCT02078752|78942962|FG006|Overall Study|Withdrawal by Subject|2|||
44152520|NCT02078752|78942963|FG007|Overall Study|Withdrawal by Subject|1|||
44152521|NCT02078752|78942964|FG008|Overall Study|Withdrawal by Subject|0|||
44152522|NCT02078752|78942965|FG009|Overall Study|Withdrawal by Subject|1|||
44152523|NCT02078752|78942956|FG000|Overall Study|Other|0|||
44152524|NCT02078752|78942957|FG001|Overall Study|Other|3|||
44152525|NCT02078752|78942958|FG002|Overall Study|Other|0|||
44152526|NCT02078752|78942959|FG003|Overall Study|Other|0|||
44152527|NCT02078752|78942960|FG004|Overall Study|Other|1|||
44152528|NCT02078752|78942961|FG005|Overall Study|Other|0|||
44152529|NCT02078752|78942962|FG006|Overall Study|Other|0|||
44152530|NCT02078752|78942963|FG007|Overall Study|Other|1|||
44152531|NCT02078752|78942964|FG008|Overall Study|Other|0|||
44152532|NCT02078752|78942965|FG009|Overall Study|Other|0|||
44152533|NCT02078752|78942956|FG000|Overall Study|Study terminated by sponsor|0|||
44152534|NCT02078752|78942957|FG001|Overall Study|Study terminated by sponsor|0|||
44152535|NCT02078752|78942958|FG002|Overall Study|Study terminated by sponsor|0|||
44152536|NCT02078752|78942959|FG003|Overall Study|Study terminated by sponsor|0|||
44152537|NCT02078752|78942960|FG004|Overall Study|Study terminated by sponsor|0|||
44152538|NCT02078752|78942961|FG005|Overall Study|Study terminated by sponsor|0|||
44152539|NCT02078752|78942962|FG006|Overall Study|Study terminated by sponsor|0|||
44152540|NCT02078752|78942963|FG007|Overall Study|Study terminated by sponsor|0|||
44152541|NCT02078752|78942964|FG008|Overall Study|Study terminated by sponsor|0|||
44152542|NCT02078752|78942965|FG009|Overall Study|Study terminated by sponsor|5|||
44152543|NCT02022748|78942998|FG000|Overall Study|Adverse Event|1|||
44283283|NCT01794780|79246616|FG006|Overall Study|Lost to Follow-up|30|||
44283284|NCT01794780|79246617|FG007|Overall Study|Lost to Follow-up|5|||
44283285|NCT01794780|79246610|FG000|Overall Study|Withdrew informed consent|7|||
44531929|NCT00030901|79541769|FG000|Initial Registration|Ineligible|167|||
44531930|NCT00030901|79541770|FG001|Initial Registration|Ineligible|0|||
44531931|NCT00030901|79541771|FG002|Initial Registration|Ineligible|0|||
44531932|NCT00030901|79541769|FG000|Randomization|Adverse Event|0|||
44531933|NCT00030901|79541770|FG001|Randomization|Adverse Event|11|||
44531934|NCT00030901|79541771|FG002|Randomization|Adverse Event|7|||
44531935|NCT00030901|79541769|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
44531936|NCT00030901|79541770|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
44531937|NCT00030901|79541771|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
44531938|NCT00030901|79541769|FG000|Randomization|Progression/Relapse|0|||
44152544|NCT02022748|78942999|FG001|Overall Study|Adverse Event|1|||
44152545|NCT02022748|78943000|FG002|Overall Study|Adverse Event|0|||
44152546|NCT02022748|78942998|FG000|Overall Study|Withdrawal by Subject|0|||
44152547|NCT02022748|78942999|FG001|Overall Study|Withdrawal by Subject|1|||
44152548|NCT02022748|78943000|FG002|Overall Study|Withdrawal by Subject|0|||
44152549|NCT02022670|78943011|FG000|Overall Study|Adverse Event|1|||
44152550|NCT02022670|78943012|FG001|Overall Study|Adverse Event|0|||
44152551|NCT02022670|78943013|FG002|Overall Study|Adverse Event|1|||
44152552|NCT02076334|78943026|FG000|Overall Study|Protocol Violation|1|||
44531939|NCT00030901|79541770|FG001|Randomization|Progression/Relapse|22|||
44531940|NCT00030901|79541771|FG002|Randomization|Progression/Relapse|21|||
44531941|NCT00030901|79541769|FG000|Randomization|Death|0|||
44152553|NCT02076334|78943027|FG001|Overall Study|Protocol Violation|0|||
44152554|NCT02076334|78943028|FG002|Overall Study|Protocol Violation|0|||
44152555|NCT02076334|78943029|FG003|Overall Study|Protocol Violation|0|||
44152556|NCT02076334|78943026|FG000|Overall Study|Lost to Follow-up|0|||
44152557|NCT02076334|78943027|FG001|Overall Study|Lost to Follow-up|1|||
44152558|NCT02076334|78943028|FG002|Overall Study|Lost to Follow-up|1|||
44152559|NCT02076334|78943029|FG003|Overall Study|Lost to Follow-up|0|||
44152560|NCT02076334|78943026|FG000|Overall Study|muscle soreness|0|||
44152561|NCT02076334|78943027|FG001|Overall Study|muscle soreness|0|||
44152562|NCT02076334|78943028|FG002|Overall Study|muscle soreness|0|||
44152563|NCT02076334|78943029|FG003|Overall Study|muscle soreness|1|||
44283286|NCT01794780|79246611|FG001|Overall Study|Withdrew informed consent|17|||
44152564|NCT02021812|78943039|FG000|Overall Study|Death|8|||
44152565|NCT02021812|78943039|FG000|Overall Study|Withdrawal by Subject|3|||
44152566|NCT02021812|78943039|FG000|Overall Study|Lost to Follow-up|2|||
44152567|NCT02021812|78943039|FG000|Overall Study|Refuse to return, COVD 19|2|||
44152568|NCT02021656|78943043|FG000|Overall Study|Adverse Event|1|||
44152569|NCT02021656|78943043|FG000|Overall Study|Lack of Efficacy|2|||
44152570|NCT02021656|78943043|FG000|Overall Study|Lost to Follow-up|1|||
44152571|NCT02021656|78943043|FG000|Overall Study|Withdrew Consent|2|||
44152572|NCT02076022|78943053|FG000|Overall Study|Withdrawal by Subject|2|||
44152573|NCT02076022|78943054|FG001|Overall Study|Withdrawal by Subject|0|||
44152574|NCT02075632|78943062|FG000|Overall Study|Adverse Event|1|||
44152575|NCT02075632|78943063|FG001|Overall Study|Adverse Event|1|||
44283287|NCT01794780|79246612|FG002|Overall Study|Withdrew informed consent|36|||
44283288|NCT01794780|79246613|FG003|Overall Study|Withdrew informed consent|9|||
44283289|NCT01794780|79246614|FG004|Overall Study|Withdrew informed consent|0|||
44283290|NCT01794780|79246615|FG005|Overall Study|Withdrew informed consent|48|||
44283291|NCT01794780|79246616|FG006|Overall Study|Withdrew informed consent|4|||
44283292|NCT01794780|79246617|FG007|Overall Study|Withdrew informed consent|3|||
44283293|NCT01794780|79246610|FG000|Overall Study|Other|0|||
44283294|NCT01794780|79246611|FG001|Overall Study|Other|12|||
44283295|NCT01794780|79246612|FG002|Overall Study|Other|25|||
44283296|NCT01794780|79246613|FG003|Overall Study|Other|20|||
44283297|NCT01794780|79246614|FG004|Overall Study|Other|1|||
44283298|NCT01794780|79246615|FG005|Overall Study|Other|24|||
44283299|NCT01794780|79246616|FG006|Overall Study|Other|4|||
44283300|NCT01794780|79246617|FG007|Overall Study|Other|1|||
44283301|NCT01838616|79246644|FG000|Titration Period|Adverse Event|18|||
44283302|NCT01838616|79246645|FG001|Titration Period|Adverse Event|48|||
44283303|NCT01838616|79246644|FG000|Titration Period|Lack of Efficacy|5|||
44283304|NCT01838616|79246645|FG001|Titration Period|Lack of Efficacy|12|||
44283305|NCT01838616|79246644|FG000|Titration Period|Withdrawal by Subject|5|||
44283306|NCT01838616|79246645|FG001|Titration Period|Withdrawal by Subject|5|||
44283307|NCT01838616|79246644|FG000|Titration Period|Technical problems|1|||
44283308|NCT01838616|79246645|FG001|Titration Period|Technical problems|0|||
44283309|NCT01838616|79246644|FG000|Titration Period|Other|1|||
44283310|NCT01838616|79246645|FG001|Titration Period|Other|0|||
44283311|NCT01838616|79246644|FG000|Titration Period|Protocol Violation|0|||
44283312|NCT01838616|79246645|FG001|Titration Period|Protocol Violation|1|||
44283313|NCT01838616|79246644|FG000|Continuation Period|Lack of Efficacy|3|||
44283314|NCT01838616|79246645|FG001|Continuation Period|Lack of Efficacy|5|||
44283315|NCT01838616|79246644|FG000|Continuation Period|Adverse Event|8|||
44283316|NCT01838616|79246645|FG001|Continuation Period|Adverse Event|4|||
44283317|NCT01838616|79246644|FG000|Continuation Period|Protocol Violation|2|||
44283318|NCT01838616|79246645|FG001|Continuation Period|Protocol Violation|0|||
44283319|NCT01838616|79246644|FG000|Continuation Period|Lost to Follow-up|1|||
44283320|NCT01838616|79246645|FG001|Continuation Period|Lost to Follow-up|0|||
44283321|NCT01838616|79246644|FG000|Continuation Period|Withdrawal by Subject|0|||
44283322|NCT01838616|79246645|FG001|Continuation Period|Withdrawal by Subject|4|||
44283323|NCT01838616|79246644|FG000|Continuation Period|Technical problems|0|||
44283324|NCT01838616|79246645|FG001|Continuation Period|Technical problems|1|||
44152576|NCT02075632|78943062|FG000|Overall Study|Lost to Follow-up|0|||
44283325|NCT01838616|79246644|FG000|Pick-up Arm|Lack of Efficacy|4|||
44283326|NCT01838616|79246645|FG001|Pick-up Arm|Lack of Efficacy|0|||
44283327|NCT01838616|79246644|FG000|Pick-up Arm|Adverse Event|9|||
44283328|NCT01838616|79246645|FG001|Pick-up Arm|Adverse Event|0|||
44283329|NCT01838616|79246644|FG000|Pick-up Arm|Withdrawal by Subject|1|||
44283330|NCT01838616|79246645|FG001|Pick-up Arm|Withdrawal by Subject|0|||
44283331|NCT01838616|79246644|FG000|Pick-up Arm|Technical problems|1|||
44283332|NCT01838616|79246645|FG001|Pick-up Arm|Technical problems|0|||
44283333|NCT01611792|79246658|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
44283334|NCT01611792|79246659|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
44283335|NCT01611792|79246658|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
44283336|NCT01611792|79246659|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
44283337|NCT01820364|79246666|FG000|Part I: LGX818|Death|1|||
44283338|NCT01820364|79246667|FG001|Part I: LGX818|Death|0|||
44152577|NCT02075632|78943063|FG001|Overall Study|Lost to Follow-up|3|||
44283339|NCT01820364|79246666|FG000|Part I: LGX818|Administrative Problems|3|||
44283340|NCT01820364|79246667|FG001|Part I: LGX818|Administrative Problems|0|||
44283341|NCT01820364|79246666|FG000|Part I: LGX818|Adverse Event|6|||
44283342|NCT01820364|79246667|FG001|Part I: LGX818|Adverse Event|0|||
44283343|NCT01820364|79246666|FG000|Part I: LGX818|Disease Progression|4|||
44283344|NCT01820364|79246667|FG001|Part I: LGX818|Disease Progression|0|||
44152578|NCT02075632|78943062|FG000|Overall Study|Withdrawal by Subject|0|||
44152579|NCT02075632|78943063|FG001|Overall Study|Withdrawal by Subject|1|||
44152580|NCT02075554|78943069|FG000|Overall Study|Lost to Follow-up|7|||
44283345|NCT01820364|79246666|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
44152581|NCT02075554|78943069|FG000|Overall Study|Withdrawal by Subject|5|||
44283346|NCT01820364|79246667|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
44283347|NCT01819506|79246675|FG000|Overall Study|Physician Decision|5|||
44152582|NCT02075554|78943069|FG000|Overall Study|Physician Decision|3|||
44531942|NCT00030901|79541770|FG001|Randomization|Death|1|||
44531943|NCT00030901|79541771|FG002|Randomization|Death|3|||
44531944|NCT00030901|79541769|FG000|Randomization|Other|0|||
44531945|NCT00030901|79541770|FG001|Randomization|Other|36|||
44531946|NCT00030901|79541771|FG002|Randomization|Other|33|||
44531947|NCT00030901|79541769|FG000|Randomization|Ineligible|0|||
44531948|NCT00030901|79541770|FG001|Randomization|Ineligible|15|||
44531949|NCT00030901|79541771|FG002|Randomization|Ineligible|14|||
44531950|NCT00003199|79541777|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
44531951|NCT00003199|79541777|FG000|Overall Study|Lack of insurance clearance|2|||
44531952|NCT00003199|79541777|FG000|Overall Study|Screen fail|15|||
44531953|NCT00030823|79541781|FG000|Overall Study|Withdrawal by Subject|1|||
44531954|NCT00001849|79541785|FG000|Overall Study|Death|4|||
44531955|NCT00001849|79541785|FG000|Overall Study|Lost to Follow-up|2|||
44531956|NCT00001849|79541785|FG000|Overall Study|Withdrawal by Subject|2|||
44531957|NCT00001849|79541785|FG000|Overall Study|tumor remained occult|6|||
44531958|NCT01342952|79541802|FG000|Overall Study|Adverse Event|0|||
44531959|NCT01342952|79541803|FG001|Overall Study|Adverse Event|5|||
44531960|NCT01342952|79541804|FG002|Overall Study|Adverse Event|1|||
44531961|NCT01342952|79541805|FG003|Overall Study|Adverse Event|0|||
44531962|NCT01342952|79541802|FG000|Overall Study|Lost to Follow-up|0|||
44531963|NCT01342952|79541803|FG001|Overall Study|Lost to Follow-up|2|||
44531964|NCT01342952|79541804|FG002|Overall Study|Lost to Follow-up|0|||
44531965|NCT01342952|79541805|FG003|Overall Study|Lost to Follow-up|0|||
44531966|NCT01342952|79541802|FG000|Overall Study|Withdrawal by Subject|1|||
44531967|NCT01342952|79541803|FG001|Overall Study|Withdrawal by Subject|1|||
44531968|NCT01342952|79541804|FG002|Overall Study|Withdrawal by Subject|0|||
44531969|NCT01342952|79541805|FG003|Overall Study|Withdrawal by Subject|0|||
44531970|NCT01342952|79541802|FG000|Overall Study|Physician Decision|3|||
44531971|NCT01342952|79541803|FG001|Overall Study|Physician Decision|3|||
44531972|NCT01342952|79541804|FG002|Overall Study|Physician Decision|1|||
44531973|NCT01342952|79541805|FG003|Overall Study|Physician Decision|0|||
44531974|NCT02886884|79541832|FG000|Follow-up|Withdrawal by Subject|0|||
44531975|NCT02886884|79541833|FG001|Follow-up|Withdrawal by Subject|0|||
44152583|NCT02075476|78943075|FG000|Overall Study|Death|2|||
44152584|NCT02075476|78943076|FG001|Overall Study|Death|2|||
44152585|NCT02075476|78943075|FG000|Overall Study|Lost to Follow-up|1|||
44152586|NCT02075476|78943076|FG001|Overall Study|Lost to Follow-up|3|||
44152587|NCT02075320|78943082|FG000|Overall Study|Withdrawal by Subject|2|||
44152588|NCT02708095|78943089|FG000|Overall Study|Adverse Event|4|||
44152589|NCT02708095|78943090|FG001|Overall Study|Adverse Event|10|||
44152590|NCT02708095|78943091|FG002|Overall Study|Adverse Event|11|||
44152591|NCT02708095|78943089|FG000|Overall Study|Lack of Efficacy|9|||
44152592|NCT02708095|78943090|FG001|Overall Study|Lack of Efficacy|3|||
44152593|NCT02708095|78943091|FG002|Overall Study|Lack of Efficacy|0|||
44152594|NCT02708095|78943089|FG000|Overall Study|Lost to Follow-up|2|||
44255607|NCT02607228|79099063|FG000|Overall Study|Adverse Event|1|||
44255608|NCT02607228|79099064|FG001|Overall Study|Adverse Event|0|||
44531976|NCT02886884|79541834|FG002|Follow-up|Withdrawal by Subject|0|||
44531977|NCT02886884|79541835|FG003|Follow-up|Withdrawal by Subject|1|||
44531978|NCT01240694|79541854|FG000|Overall Study|Adverse Event|9|||
44531979|NCT01240694|79541854|FG000|Overall Study|Lack of Efficacy|6|||
44531980|NCT01240694|79541854|FG000|Overall Study|Withdrawal by Subject|6|||
44531981|NCT01240694|79541854|FG000|Overall Study|Protocol Violation|2|||
44531982|NCT01240694|79541854|FG000|Overall Study|Lost to Follow-up|2|||
44531983|NCT01240694|79541854|FG000|Overall Study|Other than specified|3|||
44531984|NCT01240694|79541854|FG000|Overall Study|Withdrawn due to early study termination|107|||
44531985|NCT03162224|79541861|FG000|Overall Study|Death|4|||
44255609|NCT02607228|79099065|FG002|Overall Study|Adverse Event|1|||
44255610|NCT02607228|79099066|FG003|Overall Study|Adverse Event|0|||
44255611|NCT02607228|79099067|FG004|Overall Study|Adverse Event|1|||
44255612|NCT02607228|79099068|FG005|Overall Study|Adverse Event|1|||
44255613|NCT02607228|79099069|FG006|Overall Study|Adverse Event|1|||
44255614|NCT02607228|79099063|FG000|Overall Study|Investigator's Discretion|0|||
44255615|NCT02607228|79099064|FG001|Overall Study|Investigator's Discretion|0|||
44255616|NCT02607228|79099065|FG002|Overall Study|Investigator's Discretion|1|||
44255617|NCT02607228|79099066|FG003|Overall Study|Investigator's Discretion|0|||
44255618|NCT02607228|79099067|FG004|Overall Study|Investigator's Discretion|0|||
44255619|NCT02607228|79099068|FG005|Overall Study|Investigator's Discretion|1|||
44531986|NCT03162224|79541862|FG001|Overall Study|Death|5|||
44531987|NCT03162224|79541863|FG002|Overall Study|Death|8|||
44531988|NCT03162224|79541861|FG000|Overall Study|Withdrawal by Subject|1|||
44152595|NCT02708095|78943090|FG001|Overall Study|Lost to Follow-up|0|||
44255620|NCT02607228|79099069|FG006|Overall Study|Investigator's Discretion|0|||
44531989|NCT03162224|79541862|FG001|Overall Study|Withdrawal by Subject|0|||
44255621|NCT02607228|79099063|FG000|Overall Study|Withdrew Consent|0|||
44152596|NCT02708095|78943091|FG002|Overall Study|Lost to Follow-up|0|||
44152597|NCT02708095|78943089|FG000|Overall Study|Physician Decision|2|||
44531990|NCT03162224|79541863|FG002|Overall Study|Withdrawal by Subject|1|||
44152598|NCT02708095|78943090|FG001|Overall Study|Physician Decision|3|||
44152599|NCT02708095|78943091|FG002|Overall Study|Physician Decision|2|||
44152600|NCT02708095|78943089|FG000|Overall Study|Protocol Violation|0|||
44152601|NCT02708095|78943090|FG001|Overall Study|Protocol Violation|0|||
44152602|NCT02708095|78943091|FG002|Overall Study|Protocol Violation|1|||
44152603|NCT02708095|78943089|FG000|Overall Study|Withdrawal by Subject|5|||
44152604|NCT02708095|78943090|FG001|Overall Study|Withdrawal by Subject|3|||
44152605|NCT02708095|78943091|FG002|Overall Study|Withdrawal by Subject|4|||
44152606|NCT02707861|78943103|FG000|Overall Study|Went onto commercial drug|30|||
44152607|NCT02707861|78943104|FG001|Overall Study|Went onto commercial drug|23|||
44152608|NCT02707861|78943103|FG000|Overall Study|Adverse Event|2|||
44152609|NCT02707861|78943104|FG001|Overall Study|Adverse Event|3|||
44152610|NCT02707861|78943103|FG000|Overall Study|Death|5|||
44152611|NCT02707861|78943104|FG001|Overall Study|Death|2|||
44152612|NCT02707861|78943103|FG000|Overall Study|Lack of Efficacy|0|||
44152613|NCT02707861|78943104|FG001|Overall Study|Lack of Efficacy|2|||
44152614|NCT02707861|78943103|FG000|Overall Study|Physician Decision|1|||
44152615|NCT02707861|78943104|FG001|Overall Study|Physician Decision|4|||
44152616|NCT02707861|78943103|FG000|Overall Study|Withdrawal by Subject|2|||
44152617|NCT02707861|78943104|FG001|Overall Study|Withdrawal by Subject|1|||
44152618|NCT02707861|78943103|FG000|Overall Study|Lost to Follow-up|1|||
44152619|NCT02707861|78943104|FG001|Overall Study|Lost to Follow-up|3|||
44152620|NCT02027428|78943112|FG000|Induction|Never treated|7|||
44152621|NCT02027428|78943113|FG001|Induction|Never treated|0|||
44152622|NCT02027428|78943114|FG002|Induction|Never treated|0|||
44152623|NCT02027428|78943112|FG000|Induction|Progressive disease|77|||
44152624|NCT02027428|78943113|FG001|Induction|Progressive disease|0|||
44152625|NCT02027428|78943114|FG002|Induction|Progressive disease|0|||
44152626|NCT02027428|78943112|FG000|Induction|Adverse Event|51|||
44152627|NCT02027428|78943113|FG001|Induction|Adverse Event|0|||
44152628|NCT02027428|78943114|FG002|Induction|Adverse Event|0|||
44152629|NCT02027428|78943112|FG000|Induction|Withdrawal by Subject|22|||
44531991|NCT03162224|79541861|FG000|Overall Study|Lost to Follow-up|0|||
44531992|NCT03162224|79541862|FG001|Overall Study|Lost to Follow-up|1|||
44531993|NCT03162224|79541863|FG002|Overall Study|Lost to Follow-up|0|||
44531994|NCT03162224|79541861|FG000|Overall Study|Other|6|||
44531995|NCT03162224|79541862|FG001|Overall Study|Other|2|||
44531996|NCT03162224|79541863|FG002|Overall Study|Other|1|||
44531997|NCT02886338|79541902|FG000|Overall Study|Withdrawal by Subject|1|||
44531998|NCT00004124|79541908|FG000|Overall Study|Received no protocol therapy|12|||
44531999|NCT00004124|79541909|FG001|Overall Study|Received no protocol therapy|20|||
44532000|NCT00383552|79541919|FG000|Overall Study|Adverse Event|7|||
44532001|NCT00383552|79541920|FG001|Overall Study|Adverse Event|6|||
44532002|NCT00383552|79541921|FG002|Overall Study|Adverse Event|9|||
44532003|NCT00383552|79541922|FG003|Overall Study|Adverse Event|6|||
44532004|NCT00383552|79541919|FG000|Overall Study|Lack of Efficacy|4|||
44532005|NCT00383552|79541920|FG001|Overall Study|Lack of Efficacy|13|||
44532006|NCT00383552|79541921|FG002|Overall Study|Lack of Efficacy|29|||
44532007|NCT00383552|79541922|FG003|Overall Study|Lack of Efficacy|42|||
44532008|NCT00383552|79541919|FG000|Overall Study|Lost to Follow-up|0|||
44532009|NCT00383552|79541920|FG001|Overall Study|Lost to Follow-up|1|||
44532010|NCT00383552|79541921|FG002|Overall Study|Lost to Follow-up|5|||
44532011|NCT00383552|79541922|FG003|Overall Study|Lost to Follow-up|1|||
44532012|NCT00383552|79541919|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
44152630|NCT02027428|78943113|FG001|Induction|Withdrawal by Subject|0|||
44152631|NCT02027428|78943114|FG002|Induction|Withdrawal by Subject|0|||
44532013|NCT00383552|79541920|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
44532014|NCT00383552|79541921|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
44532015|NCT00383552|79541922|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
44532016|NCT00383552|79541919|FG000|Overall Study|Did not wish to continue (related)|1|||
44532017|NCT00383552|79541920|FG001|Overall Study|Did not wish to continue (related)|0|||
44532018|NCT00383552|79541921|FG002|Overall Study|Did not wish to continue (related)|2|||
44532019|NCT00383552|79541922|FG003|Overall Study|Did not wish to continue (related)|3|||
44532020|NCT00383552|79541919|FG000|Overall Study|Noncompliance with the protocol|11|||
44152632|NCT02027428|78943112|FG000|Induction|Death|21|||
44152633|NCT02027428|78943113|FG001|Induction|Death|0|||
44532021|NCT00383552|79541920|FG001|Overall Study|Noncompliance with the protocol|6|||
44532022|NCT00383552|79541921|FG002|Overall Study|Noncompliance with the protocol|8|||
44152634|NCT02027428|78943114|FG002|Induction|Death|0|||
44152635|NCT02027428|78943112|FG000|Induction|Symptomatic deterioration|16|||
44532023|NCT00383552|79541922|FG003|Overall Study|Noncompliance with the protocol|10|||
44532024|NCT00383552|79541919|FG000|Overall Study|Did not meet protocol eligibility|8|||
44532025|NCT00383552|79541920|FG001|Overall Study|Did not meet protocol eligibility|6|||
44152636|NCT02027428|78943113|FG001|Induction|Symptomatic deterioration|0|||
44152637|NCT02027428|78943114|FG002|Induction|Symptomatic deterioration|0|||
44152638|NCT02027428|78943112|FG000|Induction|Study terminated by sponsor|12|||
44152639|NCT02027428|78943113|FG001|Induction|Study terminated by sponsor|0|||
44152640|NCT02027428|78943114|FG002|Induction|Study terminated by sponsor|0|||
44152641|NCT02027428|78943112|FG000|Induction|Protocol Violation|1|||
44152642|NCT02027428|78943113|FG001|Induction|Protocol Violation|0|||
44532026|NCT00383552|79541921|FG002|Overall Study|Did not meet protocol eligibility|2|||
44532027|NCT00383552|79541922|FG003|Overall Study|Did not meet protocol eligibility|3|||
44532028|NCT00383552|79541919|FG000|Overall Study|Administrative|1|||
44532029|NCT00383552|79541920|FG001|Overall Study|Administrative|0|||
44532030|NCT00383552|79541921|FG002|Overall Study|Administrative|1|||
44532031|NCT00383552|79541922|FG003|Overall Study|Administrative|1|||
44532032|NCT03158012|79541939|FG000|Overall Study|Withdrawal by Subject|0|||
44532033|NCT03158012|79541940|FG001|Overall Study|Withdrawal by Subject|1|||
44532034|NCT01776424|79541949|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
44532035|NCT01776424|79541950|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
44532036|NCT01776424|79541951|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
44532037|NCT01776424|79541949|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
44532038|NCT01776424|79541950|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
44532039|NCT01776424|79541951|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
44532040|NCT01776424|79541949|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
44532041|NCT01776424|79541950|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
44532042|NCT01776424|79541951|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
44532043|NCT01776424|79541949|FG000|LTOLE Part (Open Label)|Refused|5|||
44532044|NCT01776424|79541950|FG001|LTOLE Part (Open Label)|Refused|2|||
44532045|NCT01776424|79541951|FG002|LTOLE Part (Open Label)|Refused|11|||
44532046|NCT01776424|79541949|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
44532047|NCT01776424|79541950|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
44532048|NCT01776424|79541951|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
44532049|NCT03799627|79541977|FG000|Overall Study|Adverse Event|1|||
44532050|NCT03799627|79541978|FG001|Overall Study|Adverse Event|2|||
44532051|NCT03799627|79541979|FG002|Overall Study|Adverse Event|0|||
44532052|NCT03799627|79541980|FG003|Overall Study|Adverse Event|0|||
44532053|NCT03799627|79541981|FG004|Overall Study|Adverse Event|2|||
44532054|NCT03799627|79541982|FG005|Overall Study|Adverse Event|5|||
44152643|NCT02027428|78943114|FG002|Induction|Protocol Violation|0|||
44152644|NCT02027428|78943112|FG000|Induction|Miscellaneous|14|||
44152645|NCT02027428|78943113|FG001|Induction|Miscellaneous|0|||
44152646|NCT02027428|78943114|FG002|Induction|Miscellaneous|0|||
44152647|NCT02027428|78943112|FG000|Induction|Induction Treatment Ongoing|4|||
44283348|NCT01819506|79246676|FG001|Overall Study|Physician Decision|2|||
44283349|NCT01819506|79246675|FG000|Overall Study|Withdrawal by Subject|3|||
44283350|NCT01819506|79246676|FG001|Overall Study|Withdrawal by Subject|3|||
44283351|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
44283352|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
44283353|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Death|1|||
44283354|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Death|2|||
44283355|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
44283356|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
44283357|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
44283358|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
44283359|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
44283360|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
44283361|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
44283362|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
44283363|NCT01794000|79246684|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
44283364|NCT01794000|79246685|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
44283365|NCT01794000|79246684|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
44283366|NCT01794000|79246685|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
44283367|NCT01609296|79246692|FG000|Overall Study|Death|253|||
44283368|NCT01609296|79246692|FG000|Overall Study|Withdrawal by Subject|151|||
44283369|NCT01609296|79246692|FG000|Overall Study|Lost to Follow-up|21|||
44532055|NCT03799627|79541983|FG006|Overall Study|Adverse Event|0|||
44532056|NCT03799627|79541984|FG007|Overall Study|Adverse Event|2|||
44532057|NCT03799627|79541985|FG008|Overall Study|Adverse Event|0|||
44532058|NCT03799627|79541977|FG000|Overall Study|Physician Decision|2|||
44532059|NCT03799627|79541978|FG001|Overall Study|Physician Decision|2|||
44532060|NCT03799627|79541979|FG002|Overall Study|Physician Decision|0|||
44532061|NCT03799627|79541980|FG003|Overall Study|Physician Decision|0|||
44532062|NCT03799627|79541981|FG004|Overall Study|Physician Decision|2|||
44152648|NCT02027428|78943113|FG001|Induction|Induction Treatment Ongoing|0|||
44152649|NCT02027428|78943114|FG002|Induction|Induction Treatment Ongoing|0|||
44152650|NCT02027428|78943112|FG000|Maintenance|Death|0|||
44152651|NCT02027428|78943113|FG001|Maintenance|Death|3|||
44152652|NCT02027428|78943114|FG002|Maintenance|Death|2|||
44152653|NCT02027428|78943112|FG000|Maintenance|Adverse Event|0|||
44152654|NCT02027428|78943113|FG001|Maintenance|Adverse Event|21|||
44152655|NCT02027428|78943114|FG002|Maintenance|Adverse Event|1|||
44152656|NCT02027428|78943112|FG000|Maintenance|Progressive disease|0|||
44152657|NCT02027428|78943113|FG001|Maintenance|Progressive disease|84|||
44152658|NCT02027428|78943114|FG002|Maintenance|Progressive disease|47|||
44152659|NCT02027428|78943112|FG000|Maintenance|Symptomatic deterioration|0|||
44152660|NCT02027428|78943113|FG001|Maintenance|Symptomatic deterioration|4|||
44152661|NCT02027428|78943114|FG002|Maintenance|Symptomatic deterioration|1|||
44152662|NCT02027428|78943112|FG000|Maintenance|Withdrawal by Subject|0|||
44152663|NCT02027428|78943113|FG001|Maintenance|Withdrawal by Subject|6|||
44152664|NCT02027428|78943114|FG002|Maintenance|Withdrawal by Subject|5|||
44152665|NCT02027428|78943112|FG000|Maintenance|Protocol Violation|0|||
44152666|NCT02027428|78943113|FG001|Maintenance|Protocol Violation|0|||
44415351|NCT00790842|79423152|FG007|Dose Level 4|Physician Decision|0|||
44415352|NCT00790842|79423153|FG008|Dose Level 4|Physician Decision|0|||
44152667|NCT02027428|78943114|FG002|Maintenance|Protocol Violation|1|||
44152668|NCT02027428|78943112|FG000|Maintenance|Other|0|||
44152669|NCT02027428|78943113|FG001|Maintenance|Other|6|||
44152670|NCT02027428|78943114|FG002|Maintenance|Other|3|||
44152671|NCT02027428|78943112|FG000|Survival Follow-up|Death|0|||
44152672|NCT02027428|78943113|FG001|Survival Follow-up|Death|78|||
44152673|NCT02027428|78943114|FG002|Survival Follow-up|Death|45|||
44152674|NCT02027428|78943112|FG000|Survival Follow-up|Lost to Follow-up|0|||
44152675|NCT02027428|78943113|FG001|Survival Follow-up|Lost to Follow-up|1|||
44152676|NCT02027428|78943114|FG002|Survival Follow-up|Lost to Follow-up|1|||
44152677|NCT01995136|78943137|FG000|Overall Study|Change in residence|1|||
44152678|NCT01994902|78943141|FG000|Test Period 1|Withdrawal by Subject|3|||
44152679|NCT01994902|78943142|FG001|Test Period 1|Withdrawal by Subject|0|||
44152680|NCT01994902|78943141|FG000|Test Period 1|device deficiency with adverse event|0|||
44152681|NCT01994902|78943142|FG001|Test Period 1|device deficiency with adverse event|1|||
44152682|NCT01994902|78943141|FG000|Test Period 1|Adverse Event|2|||
44152683|NCT01994902|78943142|FG001|Test Period 1|Adverse Event|1|||
44152684|NCT01994902|78943141|FG000|Test Period 1|Lack of Efficacy|0|||
44415353|NCT00790842|79423154|FG009|Dose Level 4|Physician Decision|0|||
44415354|NCT00790842|79423155|FG010|Dose Level 4|Physician Decision|1|||
44415355|NCT00790842|79423145|FG000|Dose Level 4|Withdrawal by Subject|0|||
44415356|NCT00790842|79423146|FG001|Dose Level 4|Withdrawal by Subject|0|||
44152685|NCT01994902|78943142|FG001|Test Period 1|Lack of Efficacy|1|||
44152686|NCT01994902|78943141|FG000|Test Period 1|bag too small|1|||
44152687|NCT01994902|78943142|FG001|Test Period 1|bag too small|0|||
44152688|NCT01994902|78943141|FG000|Test Period 2|Withdrawal by Subject|0|||
44152689|NCT01994902|78943142|FG001|Test Period 2|Withdrawal by Subject|2|||
44152690|NCT01994902|78943141|FG000|Test Period 2|Lack of Efficacy|0|||
44152691|NCT01994902|78943142|FG001|Test Period 2|Lack of Efficacy|1|||
44152692|NCT01994902|78943141|FG000|Test Period 2|Other|0|||
44415357|NCT00790842|79423147|FG002|Dose Level 4|Withdrawal by Subject|0|||
44415358|NCT00790842|79423148|FG003|Dose Level 4|Withdrawal by Subject|0|||
44415359|NCT00790842|79423149|FG004|Dose Level 4|Withdrawal by Subject|0|||
44415360|NCT00790842|79423150|FG005|Dose Level 4|Withdrawal by Subject|0|||
44415361|NCT00790842|79423151|FG006|Dose Level 4|Withdrawal by Subject|0|||
44532063|NCT03799627|79541982|FG005|Overall Study|Physician Decision|2|||
44532064|NCT03799627|79541983|FG006|Overall Study|Physician Decision|0|||
44532065|NCT03799627|79541984|FG007|Overall Study|Physician Decision|0|||
44532066|NCT03799627|79541985|FG008|Overall Study|Physician Decision|0|||
44532067|NCT03799627|79541977|FG000|Overall Study|Withdrawal by Subject|1|||
44532068|NCT03799627|79541978|FG001|Overall Study|Withdrawal by Subject|1|||
44532069|NCT03799627|79541979|FG002|Overall Study|Withdrawal by Subject|0|||
44532070|NCT03799627|79541980|FG003|Overall Study|Withdrawal by Subject|2|||
44152693|NCT01994902|78943142|FG001|Test Period 2|Other|3|||
44152694|NCT02026258|78943150|FG000|Randomized|Did not start treatment|2|||
44152695|NCT02026258|78943151|FG001|Randomized|Did not start treatment|1|||
44152696|NCT02026258|78943150|FG000|Randomized|Change in treatment plan|1|||
44415362|NCT00790842|79423152|FG007|Dose Level 4|Withdrawal by Subject|0|||
44415363|NCT00790842|79423153|FG008|Dose Level 4|Withdrawal by Subject|0|||
44532071|NCT03799627|79541981|FG004|Overall Study|Withdrawal by Subject|0|||
44152697|NCT02026258|78943151|FG001|Randomized|Change in treatment plan|0|||
44152698|NCT02026258|78943150|FG000|Randomized|Presence of periodontal disease|1|||
44152699|NCT02026258|78943151|FG001|Randomized|Presence of periodontal disease|1|||
44152700|NCT02026258|78943150|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
44152701|NCT02026258|78943151|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
44152702|NCT02026258|78943150|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
44152703|NCT02026258|78943151|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
44152704|NCT01994590|78943158|FG000|Overall Study|Adverse Event|1|||
44415364|NCT00790842|79423154|FG009|Dose Level 4|Withdrawal by Subject|0|||
44415365|NCT00790842|79423155|FG010|Dose Level 4|Withdrawal by Subject|1|||
44415366|NCT00790842|79423145|FG000|Expansion Cohort|Adverse Event|0|||
44415367|NCT00790842|79423146|FG001|Expansion Cohort|Adverse Event|0|||
44415368|NCT00790842|79423147|FG002|Expansion Cohort|Adverse Event|0|||
44415369|NCT00790842|79423148|FG003|Expansion Cohort|Adverse Event|0|||
44415370|NCT00790842|79423149|FG004|Expansion Cohort|Adverse Event|0|||
44415371|NCT00790842|79423150|FG005|Expansion Cohort|Adverse Event|0|||
44415372|NCT00790842|79423151|FG006|Expansion Cohort|Adverse Event|1|||
44415373|NCT00790842|79423152|FG007|Expansion Cohort|Adverse Event|0|||
44415374|NCT00790842|79423153|FG008|Expansion Cohort|Adverse Event|0|||
44415375|NCT00790842|79423154|FG009|Expansion Cohort|Adverse Event|0|||
44415376|NCT00790842|79423155|FG010|Expansion Cohort|Adverse Event|0|||
44415377|NCT00790842|79423145|FG000|Expansion Cohort|Death|0|||
44152705|NCT01994590|78943158|FG000|Overall Study|Trial Terminated|1|||
44152706|NCT02019550|78943164|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
44152707|NCT02019550|78943165|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
44152708|NCT02019472|78943176|FG000|Overall Study|Adverse Event|14|||
44152709|NCT02019472|78943177|FG001|Overall Study|Adverse Event|23|||
44152710|NCT02019472|78943178|FG002|Overall Study|Adverse Event|17|||
44152711|NCT02019472|78943176|FG000|Overall Study|Death|0|||
44152712|NCT02019472|78943177|FG001|Overall Study|Death|1|||
44152713|NCT02019472|78943178|FG002|Overall Study|Death|1|||
44152714|NCT02019472|78943176|FG000|Overall Study|Lack of Efficacy|7|||
44152715|NCT02019472|78943177|FG001|Overall Study|Lack of Efficacy|4|||
44152716|NCT02019472|78943178|FG002|Overall Study|Lack of Efficacy|4|||
44152717|NCT02019472|78943176|FG000|Overall Study|Lost to Follow-up|0|||
44152718|NCT02019472|78943177|FG001|Overall Study|Lost to Follow-up|2|||
44152719|NCT02019472|78943178|FG002|Overall Study|Lost to Follow-up|1|||
44152720|NCT02019472|78943176|FG000|Overall Study|Physician Decision|1|||
44152721|NCT02019472|78943177|FG001|Overall Study|Physician Decision|2|||
44152722|NCT02019472|78943178|FG002|Overall Study|Physician Decision|0|||
44415378|NCT00790842|79423146|FG001|Expansion Cohort|Death|0|||
44415379|NCT00790842|79423147|FG002|Expansion Cohort|Death|2|||
44415380|NCT00790842|79423148|FG003|Expansion Cohort|Death|0|||
44415381|NCT00790842|79423149|FG004|Expansion Cohort|Death|0|||
44415382|NCT00790842|79423150|FG005|Expansion Cohort|Death|0|||
44532072|NCT03799627|79541982|FG005|Overall Study|Withdrawal by Subject|3|||
44532073|NCT03799627|79541983|FG006|Overall Study|Withdrawal by Subject|0|||
44532074|NCT03799627|79541984|FG007|Overall Study|Withdrawal by Subject|0|||
44532075|NCT03799627|79541985|FG008|Overall Study|Withdrawal by Subject|0|||
44532076|NCT03799627|79541977|FG000|Overall Study|Lack of Efficacy|0|||
44532077|NCT03799627|79541978|FG001|Overall Study|Lack of Efficacy|0|||
44532078|NCT03799627|79541979|FG002|Overall Study|Lack of Efficacy|0|||
44532079|NCT03799627|79541980|FG003|Overall Study|Lack of Efficacy|1|||
44532080|NCT03799627|79541981|FG004|Overall Study|Lack of Efficacy|0|||
44532081|NCT03799627|79541982|FG005|Overall Study|Lack of Efficacy|0|||
44532082|NCT03799627|79541983|FG006|Overall Study|Lack of Efficacy|0|||
44415383|NCT00790842|79423151|FG006|Expansion Cohort|Death|0|||
44415384|NCT00790842|79423152|FG007|Expansion Cohort|Death|0|||
44532083|NCT03799627|79541984|FG007|Overall Study|Lack of Efficacy|0|||
44532084|NCT03799627|79541985|FG008|Overall Study|Lack of Efficacy|0|||
44152723|NCT02019472|78943176|FG000|Overall Study|Pregnancy|1|||
44152724|NCT02019472|78943177|FG001|Overall Study|Pregnancy|2|||
44152725|NCT02019472|78943178|FG002|Overall Study|Pregnancy|2|||
44152726|NCT02019472|78943176|FG000|Overall Study|Withdrawal by Subject|11|||
44152727|NCT02019472|78943177|FG001|Overall Study|Withdrawal by Subject|10|||
44255622|NCT02607228|79099064|FG001|Overall Study|Withdrew Consent|1|||
44415385|NCT00790842|79423153|FG008|Expansion Cohort|Death|0|||
44415386|NCT00790842|79423154|FG009|Expansion Cohort|Death|0|||
44415387|NCT00790842|79423155|FG010|Expansion Cohort|Death|0|||
44152728|NCT02019472|78943178|FG002|Overall Study|Withdrawal by Subject|11|||
44152729|NCT02019472|78943176|FG000|Overall Study|Other|3|||
44152730|NCT02019472|78943177|FG001|Overall Study|Other|8|||
44152731|NCT02019472|78943178|FG002|Overall Study|Other|6|||
44152732|NCT02705755|78943190|FG000|Part A (6 Days)|Adverse Event|1|||
44152733|NCT02705755|78943191|FG001|Part A (6 Days)|Adverse Event|0|||
44152734|NCT02705755|78943192|FG002|Part A (6 Days)|Adverse Event|0|||
44152735|NCT02705755|78943193|FG003|Part A (6 Days)|Adverse Event|0|||
44152736|NCT02705755|78943190|FG000|Part A (6 Days)|Physician Decision|3|||
44152737|NCT02705755|78943191|FG001|Part A (6 Days)|Physician Decision|0|||
44152738|NCT02705755|78943192|FG002|Part A (6 Days)|Physician Decision|0|||
44152739|NCT02705755|78943193|FG003|Part A (6 Days)|Physician Decision|0|||
44152740|NCT02705755|78943190|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
44152741|NCT02705755|78943191|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
44152742|NCT02705755|78943192|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
44152743|NCT02705755|78943193|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
44152744|NCT02705755|78943190|FG000|Part C (20 Weeks)|Physician Decision|0|||
44152745|NCT02705755|78943191|FG001|Part C (20 Weeks)|Physician Decision|0|||
44152746|NCT02705755|78943192|FG002|Part C (20 Weeks)|Physician Decision|0|||
44152747|NCT02705755|78943193|FG003|Part C (20 Weeks)|Physician Decision|2|||
44152748|NCT02705755|78943190|FG000|Part C (20 Weeks)|Adverse Event|0|||
44152749|NCT02705755|78943191|FG001|Part C (20 Weeks)|Adverse Event|0|||
44152750|NCT02705755|78943192|FG002|Part C (20 Weeks)|Adverse Event|0|||
44152751|NCT02705755|78943193|FG003|Part C (20 Weeks)|Adverse Event|6|||
44152752|NCT02705755|78943190|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
44152753|NCT02705755|78943191|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
44152754|NCT02705755|78943192|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
44152755|NCT02705755|78943193|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
44532085|NCT03799627|79541977|FG000|Overall Study|Lost to Follow-up|0|||
44532086|NCT03799627|79541978|FG001|Overall Study|Lost to Follow-up|0|||
44532087|NCT03799627|79541979|FG002|Overall Study|Lost to Follow-up|0|||
44532088|NCT03799627|79541980|FG003|Overall Study|Lost to Follow-up|0|||
44532089|NCT03799627|79541981|FG004|Overall Study|Lost to Follow-up|0|||
44532090|NCT03799627|79541982|FG005|Overall Study|Lost to Follow-up|0|||
44532091|NCT03799627|79541983|FG006|Overall Study|Lost to Follow-up|1|||
44532092|NCT03799627|79541984|FG007|Overall Study|Lost to Follow-up|0|||
44532093|NCT03799627|79541985|FG008|Overall Study|Lost to Follow-up|1|||
44532094|NCT03799627|79541977|FG000|Overall Study|Death|0|||
44532095|NCT03799627|79541978|FG001|Overall Study|Death|0|||
44532096|NCT03799627|79541979|FG002|Overall Study|Death|0|||
44532097|NCT03799627|79541980|FG003|Overall Study|Death|1|||
44152756|NCT02024932|78943226|FG000|Overall Study|Adverse Event|2|||
44152757|NCT02024932|78943227|FG001|Overall Study|Adverse Event|3|||
44152758|NCT02024932|78943228|FG002|Overall Study|Adverse Event|0|||
44152759|NCT02024932|78943229|FG003|Overall Study|Adverse Event|0|||
44532098|NCT03799627|79541981|FG004|Overall Study|Death|0|||
44152760|NCT02024932|78943230|FG004|Overall Study|Adverse Event|2|||
44532099|NCT03799627|79541982|FG005|Overall Study|Death|0|||
44532100|NCT03799627|79541983|FG006|Overall Study|Death|0|||
44532101|NCT03799627|79541984|FG007|Overall Study|Death|0|||
44152761|NCT02024932|78943231|FG005|Overall Study|Adverse Event|0|||
44152762|NCT02024932|78943226|FG000|Overall Study|Abnormal laboratory value|0|||
44152763|NCT02024932|78943227|FG001|Overall Study|Abnormal laboratory value|0|||
44152764|NCT02024932|78943228|FG002|Overall Study|Abnormal laboratory value|0|||
44532102|NCT03799627|79541985|FG008|Overall Study|Death|0|||
44532103|NCT03799627|79541977|FG000|Overall Study|Study Drug Put on Hold|1|||
44152765|NCT02024932|78943229|FG003|Overall Study|Abnormal laboratory value|2|||
44152766|NCT02024932|78943230|FG004|Overall Study|Abnormal laboratory value|0|||
44152767|NCT02024932|78943231|FG005|Overall Study|Abnormal laboratory value|0|||
44152768|NCT01993888|78943262|FG000|Overall Study|Death|1|||
44152769|NCT01993888|78943263|FG001|Overall Study|Death|1|||
44152770|NCT01993888|78943262|FG000|Overall Study|Lost to Follow-up|1|||
44152771|NCT01993888|78943263|FG001|Overall Study|Lost to Follow-up|1|||
44152772|NCT01993888|78943262|FG000|Overall Study|Withdrawal by Subject|0|||
44152773|NCT01993888|78943263|FG001|Overall Study|Withdrawal by Subject|1|||
44152774|NCT02024698|78943269|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
44152775|NCT02024698|78943270|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
44415388|NCT00790842|79423145|FG000|Expansion Cohort|Physician Decision|0|||
44415389|NCT00790842|79423146|FG001|Expansion Cohort|Physician Decision|0|||
44415390|NCT00790842|79423147|FG002|Expansion Cohort|Physician Decision|1|||
44532104|NCT03799627|79541978|FG001|Overall Study|Study Drug Put on Hold|0|||
44152776|NCT02018458|78943276|FG000|Overall Study|Death|4|||
44415391|NCT00790842|79423148|FG003|Expansion Cohort|Physician Decision|0|||
44415392|NCT00790842|79423149|FG004|Expansion Cohort|Physician Decision|0|||
44415393|NCT00790842|79423150|FG005|Expansion Cohort|Physician Decision|0|||
44415394|NCT00790842|79423151|FG006|Expansion Cohort|Physician Decision|0|||
44415395|NCT00790842|79423152|FG007|Expansion Cohort|Physician Decision|0|||
44415396|NCT00790842|79423153|FG008|Expansion Cohort|Physician Decision|0|||
44415397|NCT00790842|79423154|FG009|Expansion Cohort|Physician Decision|0|||
44415398|NCT00790842|79423155|FG010|Expansion Cohort|Physician Decision|0|||
44532105|NCT03799627|79541979|FG002|Overall Study|Study Drug Put on Hold|0|||
44532106|NCT03799627|79541980|FG003|Overall Study|Study Drug Put on Hold|0|||
44532107|NCT03799627|79541981|FG004|Overall Study|Study Drug Put on Hold|0|||
44532108|NCT03799627|79541982|FG005|Overall Study|Study Drug Put on Hold|0|||
44415399|NCT00790842|79423145|FG000|Expansion Cohort|Withdrawal by Subject|0|||
44415400|NCT00790842|79423146|FG001|Expansion Cohort|Withdrawal by Subject|0|||
44415401|NCT00790842|79423147|FG002|Expansion Cohort|Withdrawal by Subject|3|||
44415402|NCT00790842|79423148|FG003|Expansion Cohort|Withdrawal by Subject|0|||
44415403|NCT00790842|79423149|FG004|Expansion Cohort|Withdrawal by Subject|0|||
44415404|NCT00790842|79423150|FG005|Expansion Cohort|Withdrawal by Subject|0|||
44415405|NCT00790842|79423151|FG006|Expansion Cohort|Withdrawal by Subject|0|||
44415406|NCT00790842|79423152|FG007|Expansion Cohort|Withdrawal by Subject|0|||
44415407|NCT00790842|79423153|FG008|Expansion Cohort|Withdrawal by Subject|0|||
44415408|NCT00790842|79423154|FG009|Expansion Cohort|Withdrawal by Subject|0|||
44415409|NCT00790842|79423155|FG010|Expansion Cohort|Withdrawal by Subject|0|||
44415410|NCT00790842|79423145|FG000|Expansion Cohort|Study Closure|0|||
44415411|NCT00790842|79423146|FG001|Expansion Cohort|Study Closure|0|||
44532109|NCT03799627|79541983|FG006|Overall Study|Study Drug Put on Hold|0|||
44532110|NCT03799627|79541984|FG007|Overall Study|Study Drug Put on Hold|0|||
44532111|NCT03799627|79541985|FG008|Overall Study|Study Drug Put on Hold|0|||
44532112|NCT03799627|79541977|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
44532113|NCT03799627|79541978|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
44532114|NCT03799627|79541979|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
44532115|NCT03799627|79541980|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
44532116|NCT03799627|79541981|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
44152777|NCT02017522|78943280|FG000|Overall Study|Withdrawal by Subject|1|||
44152778|NCT02017444|78943287|FG000|Overall Study|Physician Decision|1|||
44255623|NCT02607228|79099065|FG002|Overall Study|Withdrew Consent|0|||
44255624|NCT02607228|79099066|FG003|Overall Study|Withdrew Consent|0|||
44255625|NCT02607228|79099067|FG004|Overall Study|Withdrew Consent|0|||
44415412|NCT00790842|79423147|FG002|Expansion Cohort|Study Closure|1|||
44415413|NCT00790842|79423148|FG003|Expansion Cohort|Study Closure|0|||
44415414|NCT00790842|79423149|FG004|Expansion Cohort|Study Closure|0|||
44415415|NCT00790842|79423150|FG005|Expansion Cohort|Study Closure|0|||
44532117|NCT03799627|79541982|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
44532118|NCT03799627|79541983|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
44152779|NCT02017444|78943288|FG001|Overall Study|Physician Decision|0|||
44152780|NCT02017444|78943287|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
44152781|NCT02017444|78943288|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
44152782|NCT01993186|78943296|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
44152783|NCT01993186|78943297|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
44152784|NCT01993186|78943296|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
44152785|NCT01993186|78943297|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
44152786|NCT01993186|78943296|FG000|Open-Label Extension Period|Other, Not Specified|0|||
44152787|NCT01993186|78943297|FG001|Open-Label Extension Period|Other, Not Specified|1|||
44152788|NCT01993186|78943296|FG000|Open-Label Extension Period|Adverse Event|1|||
44283370|NCT01609296|79246692|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
44283371|NCT01609296|79246692|FG000|Overall Study|missed visit but known to be alive|28|||
44283372|NCT01609218|79246700|FG000|Period 1|Adverse Event|3|||
44283373|NCT01609218|79246701|FG001|Period 1|Adverse Event|5|||
44415416|NCT00790842|79423151|FG006|Expansion Cohort|Study Closure|0|||
44415417|NCT00790842|79423152|FG007|Expansion Cohort|Study Closure|0|||
44415418|NCT00790842|79423153|FG008|Expansion Cohort|Study Closure|0|||
44415419|NCT00790842|79423154|FG009|Expansion Cohort|Study Closure|0|||
44415420|NCT00790842|79423155|FG010|Expansion Cohort|Study Closure|0|||
44415421|NCT00574288|79423210|FG000|Overall Study|Adverse Event|2|||
44283374|NCT01609218|79246700|FG000|Period 1|Sponsor Decision|0|||
44283375|NCT01609218|79246701|FG001|Period 1|Sponsor Decision|1|||
44283376|NCT01609218|79246700|FG000|Period 2|Adverse Event|1|||
44283377|NCT01609218|79246701|FG001|Period 2|Adverse Event|0|||
44283378|NCT01609062|79246709|FG000|Extension Phase|Terminated by Sponsor|14|||
44283379|NCT01609062|79246710|FG001|Extension Phase|Terminated by Sponsor|9|||
44283380|NCT01609062|79246709|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
44283381|NCT01609062|79246710|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
44283382|NCT01609062|79246709|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
44283383|NCT01609062|79246710|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
44283384|NCT01819272|79246723|FG000|Overall Study|Adverse Event|1|||
44283385|NCT01819272|79246724|FG001|Overall Study|Adverse Event|0|||
44283386|NCT01819272|79246725|FG002|Overall Study|Adverse Event|0|||
44283387|NCT01819272|79246726|FG003|Overall Study|Adverse Event|2|||
44283388|NCT01819272|79246727|FG004|Overall Study|Adverse Event|0|||
44283389|NCT01819272|79246728|FG005|Overall Study|Adverse Event|0|||
44283390|NCT01819272|79246723|FG000|Overall Study|Lost to Follow-up|3|||
44283391|NCT01819272|79246724|FG001|Overall Study|Lost to Follow-up|0|||
44283392|NCT01819272|79246725|FG002|Overall Study|Lost to Follow-up|1|||
44283393|NCT01819272|79246726|FG003|Overall Study|Lost to Follow-up|0|||
44283394|NCT01819272|79246727|FG004|Overall Study|Lost to Follow-up|0|||
44283395|NCT01819272|79246728|FG005|Overall Study|Lost to Follow-up|3|||
44283396|NCT01819272|79246723|FG000|Overall Study|Protocol Violation|0|||
44283397|NCT01819272|79246724|FG001|Overall Study|Protocol Violation|0|||
44283398|NCT01819272|79246725|FG002|Overall Study|Protocol Violation|0|||
44283399|NCT01819272|79246726|FG003|Overall Study|Protocol Violation|1|||
44283400|NCT01819272|79246727|FG004|Overall Study|Protocol Violation|2|||
44283401|NCT01819272|79246728|FG005|Overall Study|Protocol Violation|3|||
44283402|NCT01819272|79246723|FG000|Overall Study|Physician Decision|0|||
44283403|NCT01819272|79246724|FG001|Overall Study|Physician Decision|1|||
44283404|NCT01819272|79246725|FG002|Overall Study|Physician Decision|0|||
44283405|NCT01819272|79246726|FG003|Overall Study|Physician Decision|0|||
44283406|NCT01819272|79246727|FG004|Overall Study|Physician Decision|0|||
44283407|NCT01819272|79246728|FG005|Overall Study|Physician Decision|0|||
44283408|NCT01819272|79246723|FG000|Overall Study|Withdrawal of Consent|0|||
44283409|NCT01819272|79246724|FG001|Overall Study|Withdrawal of Consent|1|||
44283410|NCT01819272|79246725|FG002|Overall Study|Withdrawal of Consent|2|||
44283411|NCT01819272|79246726|FG003|Overall Study|Withdrawal of Consent|1|||
44283412|NCT01819272|79246727|FG004|Overall Study|Withdrawal of Consent|0|||
44283413|NCT01819272|79246728|FG005|Overall Study|Withdrawal of Consent|1|||
44283414|NCT01819272|79246723|FG000|Overall Study|Loss of Glucose Control|2|||
44283415|NCT01819272|79246724|FG001|Overall Study|Loss of Glucose Control|1|||
44283416|NCT01819272|79246725|FG002|Overall Study|Loss of Glucose Control|0|||
44283417|NCT01819272|79246726|FG003|Overall Study|Loss of Glucose Control|1|||
44415422|NCT00574288|79423211|FG001|Overall Study|Adverse Event|0|||
44415423|NCT00574288|79423212|FG002|Overall Study|Adverse Event|0|||
44152789|NCT01993186|78943297|FG001|Open-Label Extension Period|Adverse Event|0|||
44283418|NCT01819272|79246727|FG004|Overall Study|Loss of Glucose Control|2|||
44283419|NCT01819272|79246728|FG005|Overall Study|Loss of Glucose Control|0|||
44283420|NCT01819194|79246742|FG000|Overall Study|Loss of study articles|2|||
44283421|NCT01611558|79246746|FG000|Induction Phase|Study drug toxicity|15|||
44283422|NCT01611558|79246746|FG000|Induction Phase|Disease progression|18|||
44532119|NCT03799627|79541984|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
44532120|NCT03799627|79541985|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
44532121|NCT03799627|79541977|FG000|Overall Study|Kidney Transplantation|1|||
44532122|NCT03799627|79541978|FG001|Overall Study|Kidney Transplantation|0|||
44532123|NCT03799627|79541979|FG002|Overall Study|Kidney Transplantation|0|||
44532124|NCT03799627|79541980|FG003|Overall Study|Kidney Transplantation|1|||
44532125|NCT03799627|79541981|FG004|Overall Study|Kidney Transplantation|1|||
44532126|NCT03799627|79541982|FG005|Overall Study|Kidney Transplantation|0|||
44532127|NCT03799627|79541983|FG006|Overall Study|Kidney Transplantation|0|||
44152790|NCT01993186|78943296|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
44152791|NCT01993186|78943297|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
44152792|NCT01993186|78943296|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
44152793|NCT01993186|78943297|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
44152794|NCT01993186|78943296|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
44152795|NCT01993186|78943297|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
44152796|NCT02016898|78943306|FG000|Overall Study|Death|1|||
44152797|NCT02016898|78943307|FG001|Overall Study|Death|1|||
44152798|NCT02016898|78943306|FG000|Overall Study|Lost to Follow-up|4|||
44532128|NCT03799627|79541984|FG007|Overall Study|Kidney Transplantation|0|||
44532129|NCT03799627|79541985|FG008|Overall Study|Kidney Transplantation|0|||
44532130|NCT03799627|79541977|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
44532131|NCT03799627|79541978|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
44152799|NCT02016898|78943307|FG001|Overall Study|Lost to Follow-up|4|||
44152800|NCT01993030|78943315|FG000|Overall Study|Adverse Event|0|||
44152801|NCT01993030|78943316|FG001|Overall Study|Adverse Event|4|||
44152802|NCT01992094|78943325|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
44152803|NCT01992094|78943326|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
44532132|NCT03799627|79541979|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
44152804|NCT01992094|78943327|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
44152805|NCT01992094|78943325|FG000|Overall Study|Adverse Event|1|||
44152806|NCT01992094|78943326|FG001|Overall Study|Adverse Event|0|||
44152807|NCT01992094|78943327|FG002|Overall Study|Adverse Event|0|||
44152808|NCT01992094|78943325|FG000|Overall Study|Death|5|||
44152809|NCT01992094|78943326|FG001|Overall Study|Death|5|||
44152810|NCT01992094|78943327|FG002|Overall Study|Death|2|||
44152811|NCT01992094|78943325|FG000|Overall Study|Lost to Follow-up|26|||
44152812|NCT01992094|78943326|FG001|Overall Study|Lost to Follow-up|9|||
44152813|NCT01992094|78943327|FG002|Overall Study|Lost to Follow-up|13|||
44152814|NCT01992094|78943325|FG000|Overall Study|OTHER|4|||
44152815|NCT01992094|78943326|FG001|Overall Study|OTHER|0|||
44152816|NCT01992094|78943327|FG002|Overall Study|OTHER|0|||
44152817|NCT01992094|78943325|FG000|Overall Study|Protocol Violation|1|||
44152818|NCT01992094|78943326|FG001|Overall Study|Protocol Violation|0|||
44152819|NCT01992094|78943327|FG002|Overall Study|Protocol Violation|1|||
44152820|NCT01992094|78943325|FG000|Overall Study|Withdrawal by Subject|7|||
44152821|NCT01992094|78943326|FG001|Overall Study|Withdrawal by Subject|3|||
44152822|NCT01992094|78943327|FG002|Overall Study|Withdrawal by Subject|4|||
44152823|NCT02706691|78943351|FG000|Overall Study|Adverse Event|1|||
44152824|NCT01991470|78943356|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
44152825|NCT01991470|78943356|FG000|Enlite 1 Period|Adverse Event|1|||
44152826|NCT01991470|78943356|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
44152827|NCT01991470|78943356|FG000|Enlite 3 Period|Lost to Follow-up|1|||
44152828|NCT01991470|78943356|FG000|Enlite 3 Period|Physician Decision|2|||
44152829|NCT01991470|78943356|FG000|Enlite 3 Period|Physician Decision|8|||
44152830|NCT01991470|78943356|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
44152831|NCT01991314|78943370|FG000|Overall Study|Adverse Event|5|||
44152832|NCT01991314|78943371|FG001|Overall Study|Adverse Event|1|||
44152833|NCT01991314|78943370|FG000|Overall Study|Lost to Follow-up|6|||
44152834|NCT01991314|78943371|FG001|Overall Study|Lost to Follow-up|10|||
44152835|NCT01990768|78943380|FG000|Intervention Started|Found to be ineligible|14|||
44152836|NCT01990768|78943381|FG001|Intervention Started|Found to be ineligible|13|||
44532133|NCT03799627|79541980|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
44532134|NCT03799627|79541981|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
44532135|NCT03799627|79541982|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
44532136|NCT03799627|79541983|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
44152837|NCT01990768|78943382|FG002|Intervention Started|Found to be ineligible|11|||
44255626|NCT02607228|79099068|FG005|Overall Study|Withdrew Consent|1|||
44255627|NCT02607228|79099069|FG006|Overall Study|Withdrew Consent|0|||
44255628|NCT02607228|79099063|FG000|Overall Study|Study Terminated by Sponsor|0|||
44255629|NCT02607228|79099064|FG001|Overall Study|Study Terminated by Sponsor|0|||
44255630|NCT02607228|79099065|FG002|Overall Study|Study Terminated by Sponsor|0|||
44532137|NCT03799627|79541984|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
44532138|NCT03799627|79541985|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
44532139|NCT03799627|79541977|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532140|NCT03799627|79541978|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
44532141|NCT03799627|79541979|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532142|NCT03799627|79541980|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44152838|NCT01990768|78943380|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
44152839|NCT01990768|78943381|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
44152840|NCT01990768|78943382|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
44152841|NCT01990768|78943380|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
44152842|NCT01990768|78943381|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
44152843|NCT01990768|78943382|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
44152844|NCT01990768|78943380|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
44152845|NCT01990768|78943381|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
44152846|NCT01990768|78943382|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
44152847|NCT01990768|78943380|FG000|Intervention Started|Patient care priority|1|||
44152848|NCT01990768|78943381|FG001|Intervention Started|Patient care priority|2|||
44152849|NCT01990768|78943382|FG002|Intervention Started|Patient care priority|3|||
44152850|NCT01990768|78943380|FG000|Intervention Started|IV lost|2|||
44255631|NCT02607228|79099066|FG003|Overall Study|Study Terminated by Sponsor|1|||
44255632|NCT02607228|79099067|FG004|Overall Study|Study Terminated by Sponsor|0|||
44415424|NCT00574288|79423213|FG003|Overall Study|Adverse Event|0|||
44152851|NCT01990768|78943381|FG001|Intervention Started|IV lost|2|||
44152852|NCT01990768|78943382|FG002|Intervention Started|IV lost|2|||
44283423|NCT01611558|79246746|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
44283424|NCT01611558|79246746|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
44283425|NCT01611558|79246746|FG000|Induction Phase|Death|1|||
44283426|NCT01611558|79246746|FG000|Maintenance Phase|Withdrawal by Subject|1|||
44283427|NCT01611558|79246746|FG000|Maintenance Phase|Elevated Uric acid|1|||
44283428|NCT01818726|79246753|FG000|Overall Study|Administrative reasons|5|||
44283429|NCT01818726|79246754|FG001|Overall Study|Administrative reasons|1|||
44283430|NCT01818726|79246753|FG000|Overall Study|Withdrawal by Subject|0|||
44283431|NCT01818726|79246754|FG001|Overall Study|Withdrawal by Subject|1|||
44283432|NCT01818726|79246753|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
44283433|NCT01818726|79246754|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
44283434|NCT01818336|79246760|FG000|Overall Study|Declined retest visit|0|||
44532143|NCT03799627|79541981|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532144|NCT03799627|79541982|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532145|NCT03799627|79541983|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532146|NCT03799627|79541984|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532147|NCT03799627|79541985|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
44532148|NCT03799627|79541977|FG000|Overall Study|Met Exclusion Criteria|0|||
44532149|NCT03799627|79541978|FG001|Overall Study|Met Exclusion Criteria|0|||
44283435|NCT01818336|79246761|FG001|Overall Study|Declined retest visit|11|||
44283436|NCT01818336|79246760|FG000|Overall Study|Lost to Follow-up|0|||
44283437|NCT01818336|79246761|FG001|Overall Study|Lost to Follow-up|1|||
44283438|NCT01818258|79246769|FG000|Overall Study|Death|3|||
44283439|NCT01818258|79246770|FG001|Overall Study|Death|0|||
44283440|NCT01818258|79246769|FG000|Overall Study|Withdrawal by Subject|0|||
44283441|NCT01818258|79246770|FG001|Overall Study|Withdrawal by Subject|1|||
44283442|NCT01818258|79246769|FG000|Overall Study|Lost to Follow-up|0|||
44283443|NCT01818258|79246770|FG001|Overall Study|Lost to Follow-up|1|||
44283444|NCT01818258|79246769|FG000|Overall Study|Unable to Travel to Clinic|0|||
44283445|NCT01818258|79246770|FG001|Overall Study|Unable to Travel to Clinic|1|||
44283446|NCT01817790|79246779|FG000|Overall Study|Adverse Event|0|||
44283447|NCT01817790|79246780|FG001|Overall Study|Adverse Event|2|||
44283448|NCT01817790|79246779|FG000|Overall Study|Lost to Follow-up|0|||
44283449|NCT01817790|79246780|FG001|Overall Study|Lost to Follow-up|1|||
44283450|NCT01817790|79246779|FG000|Overall Study|Protocol Violation|2|||
44283451|NCT01817790|79246780|FG001|Overall Study|Protocol Violation|1|||
44283452|NCT01817790|79246779|FG000|Overall Study|Withdrawal by Subject|1|||
44283453|NCT01817790|79246780|FG001|Overall Study|Withdrawal by Subject|3|||
44283454|NCT01817790|79246779|FG000|Overall Study|Other: Could not attend appointment|1|||
44283455|NCT01817790|79246780|FG001|Overall Study|Other: Could not attend appointment|1|||
44532150|NCT03799627|79541979|FG002|Overall Study|Met Exclusion Criteria|0|||
44532151|NCT03799627|79541980|FG003|Overall Study|Met Exclusion Criteria|1|||
44532152|NCT03799627|79541981|FG004|Overall Study|Met Exclusion Criteria|0|||
44532153|NCT03799627|79541982|FG005|Overall Study|Met Exclusion Criteria|0|||
44532154|NCT03799627|79541983|FG006|Overall Study|Met Exclusion Criteria|0|||
44532155|NCT03799627|79541984|FG007|Overall Study|Met Exclusion Criteria|0|||
44532156|NCT03799627|79541985|FG008|Overall Study|Met Exclusion Criteria|0|||
44532157|NCT03799627|79541977|FG000|Overall Study|Investigational Product Noncompliance|0|||
44532158|NCT03799627|79541978|FG001|Overall Study|Investigational Product Noncompliance|0|||
44532159|NCT03799627|79541979|FG002|Overall Study|Investigational Product Noncompliance|0|||
44532160|NCT03799627|79541980|FG003|Overall Study|Investigational Product Noncompliance|1|||
44532161|NCT03799627|79541981|FG004|Overall Study|Investigational Product Noncompliance|0|||
44152853|NCT01990768|78943380|FG000|Intervention Started|Required CPR|1|||
44152854|NCT01990768|78943381|FG001|Intervention Started|Required CPR|1|||
44152855|NCT01990768|78943382|FG002|Intervention Started|Required CPR|0|||
44152856|NCT01990768|78943380|FG000|Intervention Started|Seizure or hx of seizure|0|||
44152857|NCT01990768|78943381|FG001|Intervention Started|Seizure or hx of seizure|0|||
44152858|NCT01990768|78943382|FG002|Intervention Started|Seizure or hx of seizure|2|||
44152859|NCT01990768|78943380|FG000|Intervention Started|Discovered to be pregnant|0|||
44283456|NCT01793688|79246788|FG000|Overall Study|Protocol Violation|2|||
44283457|NCT01793142|79246792|FG000|Overall Study|Randomized not treated|7|||
44283458|NCT01792830|79246807|FG000|Overall Study|Withdrawal by Subject|22|||
44283459|NCT01792830|79246808|FG001|Overall Study|Withdrawal by Subject|0|||
44283460|NCT01792830|79246809|FG002|Overall Study|Withdrawal by Subject|0|||
44532162|NCT03799627|79541982|FG005|Overall Study|Investigational Product Noncompliance|0|||
44532163|NCT03799627|79541983|FG006|Overall Study|Investigational Product Noncompliance|0|||
44152860|NCT01990768|78943381|FG001|Intervention Started|Discovered to be pregnant|1|||
44152861|NCT01990768|78943382|FG002|Intervention Started|Discovered to be pregnant|0|||
44152862|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
44152863|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
44152864|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
44152865|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
44152866|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
44152867|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
44152868|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
44152869|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
44255633|NCT02607228|79099068|FG005|Overall Study|Study Terminated by Sponsor|0|||
44255634|NCT02607228|79099069|FG006|Overall Study|Study Terminated by Sponsor|0|||
44283461|NCT01792830|79246810|FG003|Overall Study|Withdrawal by Subject|2|||
44283462|NCT01792830|79246811|FG004|Overall Study|Withdrawal by Subject|1|||
44532164|NCT03799627|79541984|FG007|Overall Study|Investigational Product Noncompliance|0|||
44532165|NCT03799627|79541985|FG008|Overall Study|Investigational Product Noncompliance|0|||
44532166|NCT03799627|79541977|FG000|Overall Study|Participant Relocation|0|||
44532167|NCT03799627|79541978|FG001|Overall Study|Participant Relocation|0|||
44532168|NCT03799627|79541979|FG002|Overall Study|Participant Relocation|0|||
44532169|NCT03799627|79541980|FG003|Overall Study|Participant Relocation|1|||
44532170|NCT03799627|79541981|FG004|Overall Study|Participant Relocation|0|||
44532171|NCT03799627|79541982|FG005|Overall Study|Participant Relocation|1|||
44532172|NCT03799627|79541983|FG006|Overall Study|Participant Relocation|0|||
44152870|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
44255635|NCT01668654|79099111|FG000|Overall Study|Study Closed/Terminated|3|||
44255636|NCT01668654|79099111|FG000|Overall Study|Withdrawal by Subject|1|||
44255637|NCT02608476|79099205|FG000|Overall Study|Withdrawal by Subject|30|||
44255638|NCT02608476|79099206|FG001|Overall Study|Withdrawal by Subject|37|||
44255639|NCT02608476|79099205|FG000|Overall Study|Lost to Follow-up|24|||
44255640|NCT02608476|79099206|FG001|Overall Study|Lost to Follow-up|24|||
44255641|NCT02608476|79099205|FG000|Overall Study|Adverse Event|2|||
44255642|NCT02608476|79099206|FG001|Overall Study|Adverse Event|8|||
44152871|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
44255643|NCT02608476|79099205|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
44255644|NCT02608476|79099206|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
44532173|NCT03799627|79541984|FG007|Overall Study|Participant Relocation|0|||
44532174|NCT03799627|79541985|FG008|Overall Study|Participant Relocation|0|||
44152872|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
44152873|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
44152874|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Death|3|||
44152875|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Death|1|||
44152876|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Death|1|||
44152877|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Discharged|2|||
44152878|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Discharged|1|||
44152879|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Discharged|0|||
44152880|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
44152881|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
44152882|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
44152883|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
44152884|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
44152885|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
44152886|NCT01990768|78943380|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
44152887|NCT01990768|78943381|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
44152888|NCT01990768|78943382|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
44152889|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
44152890|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
44532175|NCT03799627|79541977|FG000|Overall Study|Eurofin Issue|0|||
44532176|NCT03799627|79541978|FG001|Overall Study|Eurofin Issue|0|||
44532177|NCT03799627|79541979|FG002|Overall Study|Eurofin Issue|0|||
44532178|NCT03799627|79541980|FG003|Overall Study|Eurofin Issue|0|||
44532179|NCT03799627|79541981|FG004|Overall Study|Eurofin Issue|1|||
44532180|NCT03799627|79541982|FG005|Overall Study|Eurofin Issue|0|||
44532181|NCT03799627|79541983|FG006|Overall Study|Eurofin Issue|0|||
44532182|NCT03799627|79541984|FG007|Overall Study|Eurofin Issue|0|||
44532183|NCT03799627|79541985|FG008|Overall Study|Eurofin Issue|0|||
44532184|NCT03799627|79541977|FG000|Overall Study|Noncompliance with Site Instructions|0|||
44532185|NCT03799627|79541978|FG001|Overall Study|Noncompliance with Site Instructions|0|||
44532186|NCT03799627|79541979|FG002|Overall Study|Noncompliance with Site Instructions|0|||
44532187|NCT03799627|79541980|FG003|Overall Study|Noncompliance with Site Instructions|0|||
44532188|NCT03799627|79541981|FG004|Overall Study|Noncompliance with Site Instructions|1|||
44532189|NCT03799627|79541982|FG005|Overall Study|Noncompliance with Site Instructions|0|||
44532190|NCT03799627|79541983|FG006|Overall Study|Noncompliance with Site Instructions|0|||
44152891|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
44152892|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
44152893|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
44415425|NCT00574288|79423214|FG004|Overall Study|Adverse Event|1|||
44152894|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
44152895|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
44152896|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
44152897|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
44152898|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
44152899|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
44152900|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
44152901|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
44152902|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
44152903|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
44152904|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
44152905|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
44152906|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
44152907|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
44532191|NCT03799627|79541984|FG007|Overall Study|Noncompliance with Site Instructions|0|||
44532192|NCT03799627|79541985|FG008|Overall Study|Noncompliance with Site Instructions|0|||
44532193|NCT03799627|79541977|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532194|NCT03799627|79541978|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532195|NCT03799627|79541979|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532196|NCT03799627|79541980|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532197|NCT03799627|79541981|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
44532198|NCT03799627|79541982|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532199|NCT03799627|79541983|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532200|NCT03799627|79541984|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532201|NCT03799627|79541985|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
44532202|NCT03799627|79541977|FG000|Overall Study|Changes In Hemoglobin Values|1|||
44532203|NCT03799627|79541978|FG001|Overall Study|Changes In Hemoglobin Values|2|||
44532204|NCT03799627|79541979|FG002|Overall Study|Changes In Hemoglobin Values|1|||
44532205|NCT03799627|79541980|FG003|Overall Study|Changes In Hemoglobin Values|0|||
44532206|NCT03799627|79541981|FG004|Overall Study|Changes In Hemoglobin Values|0|||
44532207|NCT03799627|79541982|FG005|Overall Study|Changes In Hemoglobin Values|2|||
44532208|NCT03799627|79541983|FG006|Overall Study|Changes In Hemoglobin Values|1|||
44532209|NCT03799627|79541984|FG007|Overall Study|Changes In Hemoglobin Values|0|||
44532210|NCT03799627|79541985|FG008|Overall Study|Changes In Hemoglobin Values|1|||
44532211|NCT00756574|79542026|FG000|Overall Study|Withdrawal by Subject|9|||
44532212|NCT00756574|79542027|FG001|Overall Study|Withdrawal by Subject|7|||
44532213|NCT00756574|79542026|FG000|Overall Study|Lost to Follow-up|4|||
44532214|NCT00756574|79542027|FG001|Overall Study|Lost to Follow-up|4|||
44532215|NCT02743780|79542036|FG000|Part 3 (7 Days)|Adverse Event|0|||
44532216|NCT02743780|79542037|FG001|Part 3 (7 Days)|Adverse Event|0|||
44532217|NCT02743780|79542038|FG002|Part 3 (7 Days)|Adverse Event|1|||
44532218|NCT02743780|79542039|FG003|Part 3 (7 Days)|Adverse Event|0|||
44532219|NCT02743780|79542040|FG004|Part 3 (7 Days)|Adverse Event|0|||
44532220|NCT02880956|79542064|FG000|Overall Study|Adverse Event|3|||
44532221|NCT02880956|79542065|FG001|Overall Study|Adverse Event|6|||
44532222|NCT02880956|79542066|FG002|Overall Study|Adverse Event|5|||
44532223|NCT02880956|79542067|FG003|Overall Study|Adverse Event|4|||
44532224|NCT02880956|79542064|FG000|Overall Study|Withdrawal by Subject|9|||
44532225|NCT02880956|79542065|FG001|Overall Study|Withdrawal by Subject|4|||
44532226|NCT02880956|79542066|FG002|Overall Study|Withdrawal by Subject|6|||
44532227|NCT02880956|79542067|FG003|Overall Study|Withdrawal by Subject|11|||
44532228|NCT02880956|79542064|FG000|Overall Study|Lost to Follow-up|0|||
44532229|NCT02880956|79542065|FG001|Overall Study|Lost to Follow-up|1|||
44532230|NCT02880956|79542066|FG002|Overall Study|Lost to Follow-up|0|||
44532231|NCT02880956|79542067|FG003|Overall Study|Lost to Follow-up|0|||
44532232|NCT02880956|79542064|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
44532233|NCT02880956|79542065|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
44532234|NCT02880956|79542066|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
44532235|NCT02880956|79542067|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
44532236|NCT02880956|79542064|FG000|Overall Study|Other, Not Specified|4|||
44532237|NCT02880956|79542065|FG001|Overall Study|Other, Not Specified|2|||
44532238|NCT02880956|79542066|FG002|Overall Study|Other, Not Specified|0|||
44532239|NCT02880956|79542067|FG003|Overall Study|Other, Not Specified|3|||
44532240|NCT01352416|79542084|FG000|Overall Study|Physician Decision|1|||
44152908|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
44152909|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
44152910|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
44152911|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
44152912|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
44152913|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
44152914|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
44152915|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
44152916|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
44152917|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
44152918|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
44152919|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
44152920|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
44152921|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
44152922|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
44152923|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
44152924|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
44152925|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
44152926|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
44152927|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
44152928|NCT01990768|78943380|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
44152929|NCT01990768|78943381|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
44152930|NCT01990768|78943382|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
44152931|NCT01990768|78943380|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
44152932|NCT01990768|78943381|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
44152933|NCT01990768|78943382|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
44152934|NCT01990768|78943380|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
44152935|NCT01990768|78943381|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
44152936|NCT01990768|78943382|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
44152937|NCT01990768|78943380|FG000|6-Month Follow-up|No contact information|5|||
44152938|NCT01990768|78943381|FG001|6-Month Follow-up|No contact information|6|||
44152939|NCT01990768|78943382|FG002|6-Month Follow-up|No contact information|5|||
44152940|NCT01990768|78943380|FG000|6-Month Follow-up|Homeless|4|||
44152941|NCT01990768|78943381|FG001|6-Month Follow-up|Homeless|3|||
44152942|NCT01990768|78943382|FG002|6-Month Follow-up|Homeless|6|||
44152943|NCT01990768|78943380|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
44152944|NCT01990768|78943381|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
44152945|NCT01990768|78943382|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
44152946|NCT01990768|78943380|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
44152947|NCT01990768|78943381|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
44152948|NCT01990768|78943382|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
44152949|NCT01990768|78943380|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
44152950|NCT01990768|78943381|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
44152951|NCT01990768|78943382|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
44152952|NCT01990612|78943393|FG000|Overall Study|Lost to Follow-up|2|||
44152953|NCT01990612|78943394|FG001|Overall Study|Lost to Follow-up|1|||
44152954|NCT01990612|78943393|FG000|Overall Study|Withdrawal by Subject|5|||
44152955|NCT01990612|78943394|FG001|Overall Study|Withdrawal by Subject|2|||
44152956|NCT01990534|78943400|FG000|Overall Study|Death|22|||
44152957|NCT01990534|78943400|FG000|Overall Study|Progressive disease|3|||
44152958|NCT01990534|78943400|FG000|Overall Study|Protocol Violation|1|||
44152959|NCT01990534|78943400|FG000|Overall Study|Withdrawal of Informed Consent|2|||
44152960|NCT01990534|78943400|FG000|Overall Study|Symptomatic Deterioration|1|||
44152961|NCT01990534|78943400|FG000|Overall Study|Withdrawal by Subject|3|||
44152962|NCT01990534|78943400|FG000|Overall Study|Reason not Specified|2|||
44152963|NCT01990534|78943400|FG000|Overall Study|Lost to Follow-up|1|||
44152964|NCT01967134|78943407|FG000|Overall Study|Lost to Follow-up|0|||
44152965|NCT01967134|78943408|FG001|Overall Study|Lost to Follow-up|1|||
44152966|NCT01967134|78943409|FG002|Overall Study|Lost to Follow-up|0|||
44152967|NCT01966432|78943420|FG000|Overall Study|Lost to Follow-up|3|||
44152968|NCT01966432|78943421|FG001|Overall Study|Lost to Follow-up|2|||
44152969|NCT01966432|78943422|FG002|Overall Study|Lost to Follow-up|5|||
44152970|NCT01966432|78943420|FG000|Overall Study|Withdrawal by Subject|1|||
44152971|NCT01966432|78943421|FG001|Overall Study|Withdrawal by Subject|3|||
44152972|NCT01966432|78943422|FG002|Overall Study|Withdrawal by Subject|0|||
44152973|NCT01966432|78943420|FG000|Overall Study|Subject Incarcerated|0|||
44152974|NCT01966432|78943421|FG001|Overall Study|Subject Incarcerated|0|||
44152975|NCT01966432|78943422|FG002|Overall Study|Subject Incarcerated|1|||
44152976|NCT01966432|78943420|FG000|Overall Study|SBIRT program ended|1|||
44152977|NCT01966432|78943421|FG001|Overall Study|SBIRT program ended|8|||
44152978|NCT01966432|78943422|FG002|Overall Study|SBIRT program ended|20|||
44152979|NCT02702401|78943434|FG000|Overall Study|Death|242|||
44152980|NCT02702401|78943435|FG001|Overall Study|Death|125|||
44152981|NCT02702401|78943434|FG000|Overall Study|Withdrawal by Subject|15|||
44152982|NCT02702401|78943435|FG001|Overall Study|Withdrawal by Subject|5|||
44152983|NCT02702401|78943434|FG000|Overall Study|Sponsor Decision|19|||
44152984|NCT02702401|78943435|FG001|Overall Study|Sponsor Decision|3|||
44152985|NCT02702401|78943434|FG000|Overall Study|Physician Decision|1|||
44152986|NCT02702401|78943435|FG001|Overall Study|Physician Decision|2|||
44532241|NCT01352416|79542085|FG001|Overall Study|Physician Decision|2|||
44532242|NCT01352416|79542086|FG002|Overall Study|Physician Decision|2|||
44532243|NCT01352416|79542087|FG003|Overall Study|Physician Decision|1|||
44532244|NCT00439738|79542099|FG000|Overall Study|Withdrawal by Subject|16|||
44532245|NCT00439738|79542100|FG001|Overall Study|Withdrawal by Subject|13|||
44532246|NCT00439738|79542099|FG000|Overall Study|Adverse Event|6|||
44532247|NCT00439738|79542100|FG001|Overall Study|Adverse Event|4|||
44532248|NCT00439738|79542099|FG000|Overall Study|Lost to Follow-up|5|||
44532249|NCT00439738|79542100|FG001|Overall Study|Lost to Follow-up|6|||
44532250|NCT00439738|79542099|FG000|Overall Study|Protocol Violation|6|||
44532251|NCT00439738|79542100|FG001|Overall Study|Protocol Violation|3|||
44532252|NCT00439738|79542099|FG000|Overall Study|Lack of Efficacy|2|||
44532253|NCT00439738|79542100|FG001|Overall Study|Lack of Efficacy|2|||
44152987|NCT02702401|78943434|FG000|Overall Study|Lost to Follow-up|1|||
44152988|NCT02702401|78943435|FG001|Overall Study|Lost to Follow-up|0|||
44152989|NCT02703337|78943442|FG000|Period One (Part A)|Withdrawal by Subject|0|||
44152990|NCT02703337|78943443|FG001|Period One (Part A)|Withdrawal by Subject|0|||
44152991|NCT02703337|78943444|FG002|Period One (Part A)|Withdrawal by Subject|0|||
44152992|NCT02703337|78943445|FG003|Period One (Part A)|Withdrawal by Subject|0|||
44532254|NCT00439738|79542099|FG000|Overall Study|Abnormal Lab Values|1|||
44532255|NCT00439738|79542100|FG001|Overall Study|Abnormal Lab Values|0|||
44152993|NCT02703337|78943446|FG004|Period One (Part A)|Withdrawal by Subject|1|||
44152994|NCT02703337|78943447|FG005|Period One (Part A)|Withdrawal by Subject|0|||
44152995|NCT02703337|78943448|FG006|Period One (Part A)|Withdrawal by Subject|0|||
44152996|NCT02703337|78943449|FG007|Period One (Part A)|Withdrawal by Subject|0|||
44152997|NCT01680497|78943467|FG000|Overall Study|Lost to Follow-up|2|||
44152998|NCT01680341|78943473|FG000|Overall Study|Adverse Event|3|||
44152999|NCT01680341|78943474|FG001|Overall Study|Adverse Event|2|||
44153000|NCT01680341|78943473|FG000|Overall Study|Unclassified|18|||
44153001|NCT01680341|78943474|FG001|Overall Study|Unclassified|15|||
44153002|NCT01679405|78943482|FG000|Overall Study|Death|2|||
44153003|NCT01679405|78943483|FG001|Overall Study|Death|5|||
44153004|NCT01603355|78943489|FG000|Overall Study|Lack of Efficacy|2|||
44153005|NCT02703259|78943495|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
44153006|NCT02703259|78943496|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
44153007|NCT02703259|78943495|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
44153008|NCT02703259|78943496|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
44153009|NCT02703259|78943495|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
44153010|NCT02703259|78943496|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
44153011|NCT00701701|78943504|FG000|Overall Study|Withdrawal by Subject|0|||
44153012|NCT00701701|78943505|FG001|Overall Study|Withdrawal by Subject|1|||
44153013|NCT00701701|78943504|FG000|Overall Study|Adverse Event|0|||
44153014|NCT00701701|78943505|FG001|Overall Study|Adverse Event|1|||
44153015|NCT01989754|78943514|FG000|Overall Study|Withdrawal by Subject|10|||
44153016|NCT01989754|78943515|FG001|Overall Study|Withdrawal by Subject|14|||
44153017|NCT01989754|78943514|FG000|Overall Study|Lost to Follow-up|28|||
44153018|NCT01989754|78943515|FG001|Overall Study|Lost to Follow-up|20|||
44532256|NCT00338104|79542107|FG000|Overall Study|Protocol Violation|2|||
44532257|NCT00338104|79542108|FG001|Overall Study|Protocol Violation|1|||
44532258|NCT00338104|79542109|FG002|Overall Study|Protocol Violation|3|||
44532259|NCT05593913|79542114|FG000|Overall Study|Insufficient image quality|39|||
44532260|NCT05166603|79542144|FG000|Overall Study|Withdrawal by Subject|68|||
44532261|NCT05166603|79542145|FG001|Overall Study|Withdrawal by Subject|0|||
44532262|NCT05049122|79542151|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
44532263|NCT05049122|79542151|FG000|Overall Study|Participant moved|1|||
44532264|NCT05049122|79542151|FG000|Overall Study|At the direction of the doctor|1|||
44532265|NCT04969263|79542159|FG000|Overall Study|Death|1|||
44532266|NCT04969263|79542159|FG000|Overall Study|Lost to Follow-up|2|||
44532267|NCT04969263|79542159|FG000|Overall Study|Withdrawal by Subject|5|||
44532268|NCT04969263|79542159|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
44532269|NCT04964063|79542163|FG000|Overall Study|Adverse Event|4|||
44532270|NCT04964063|79542163|FG000|Overall Study|Lost to Follow-up|47|||
44532271|NCT04964063|79542163|FG000|Overall Study|Withdrawal by Subject|5|||
44532272|NCT04964063|79542163|FG000|Overall Study|Baseline Tasks Expired|41|||
44532273|NCT04964063|79542163|FG000|Overall Study|Participant withdrawn in error|1|||
44532274|NCT04744831|79542170|FG000|Overall Study|Progressive Disease|31|||
44532275|NCT04744831|79542171|FG001|Overall Study|Progressive Disease|27|||
44532276|NCT04744831|79542172|FG002|Overall Study|Progressive Disease|25|||
44532277|NCT04744831|79542170|FG000|Overall Study|Adverse Event|3|||
44532278|NCT04744831|79542171|FG001|Overall Study|Adverse Event|3|||
44153019|NCT01989754|78943514|FG000|Overall Study|Closed Site|1|||
44153020|NCT01989754|78943515|FG001|Overall Study|Closed Site|1|||
44153021|NCT01619878|78943521|FG000|6 Week Follow-up Phase|Adverse Event|1|||
44153022|NCT01619878|78943521|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
44153023|NCT01619878|78943521|FG000|Follow-up at 12 Months of Age|Death|2|||
44153024|NCT02015104|78943527|FG000|Overall Study|Withdrew consent after first dose drug|1|||
44153025|NCT02015104|78943528|FG001|Overall Study|Withdrew consent after first dose drug|0|||
44153026|NCT02015104|78943527|FG000|Overall Study|Withdrew consent prior to treatment|0|||
44532279|NCT04744831|79542172|FG002|Overall Study|Adverse Event|3|||
44532280|NCT04744831|79542170|FG000|Overall Study|Clinical Progression|3|||
44283463|NCT01792830|79246812|FG005|Overall Study|Withdrawal by Subject|1|||
44153027|NCT02015104|78943528|FG001|Overall Study|Withdrew consent prior to treatment|1|||
44153028|NCT01619800|78943539|FG000|Overall Study|study terminated|2|||
44153029|NCT01619800|78943540|FG001|Overall Study|study terminated|0|||
44153030|NCT01989208|78943548|FG000|200 mg (7 Days)|Protocol Violation|0|||
44153031|NCT01989208|78943549|FG001|200 mg (7 Days)|Protocol Violation|1|||
44153032|NCT01619410|78943569|FG000|Overall Study|Lost to Follow-up|7|||
44153033|NCT01619410|78943570|FG001|Overall Study|Lost to Follow-up|4|||
44153034|NCT01966042|78943576|FG000|Overall Study|Death|2|||
44153035|NCT02014480|78943580|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
44153036|NCT02014480|78943581|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
44153037|NCT02014480|78943582|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
44153038|NCT02014480|78943583|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
44153039|NCT02014480|78943584|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
44153040|NCT02014480|78943585|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
44153041|NCT02014480|78943580|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44153042|NCT02014480|78943581|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44153043|NCT02014480|78943582|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44153044|NCT02014480|78943583|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
44153045|NCT02014480|78943584|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
44153046|NCT02014480|78943585|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
44153047|NCT02014480|78943580|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44153048|NCT02014480|78943581|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44153049|NCT02014480|78943582|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
44153050|NCT02014480|78943583|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44153051|NCT02014480|78943584|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44153052|NCT02014480|78943585|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
44153053|NCT02014480|78943580|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
44153054|NCT02014480|78943581|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
44153055|NCT02014480|78943582|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
44153056|NCT02014480|78943583|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
44153057|NCT02014480|78943584|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44415426|NCT00574288|79423215|FG005|Overall Study|Adverse Event|0|||
44415427|NCT00574288|79423216|FG006|Overall Study|Adverse Event|0|||
44415428|NCT00574288|79423210|FG000|Overall Study|Death|0|||
44532281|NCT04744831|79542171|FG001|Overall Study|Clinical Progression|2|||
44532282|NCT04744831|79542172|FG002|Overall Study|Clinical Progression|5|||
44532283|NCT04744831|79542170|FG000|Overall Study|Other|0|||
44532284|NCT04744831|79542171|FG001|Overall Study|Other|2|||
44532285|NCT04744831|79542172|FG002|Overall Study|Other|1|||
44532286|NCT04744831|79542170|FG000|Overall Study|Death|0|||
44532287|NCT04744831|79542171|FG001|Overall Study|Death|2|||
44532288|NCT04744831|79542172|FG002|Overall Study|Death|1|||
44153058|NCT02014480|78943585|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
44153059|NCT02014480|78943580|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44153060|NCT02014480|78943581|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
44153061|NCT02014480|78943582|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44153062|NCT02014480|78943583|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44153063|NCT02014480|78943584|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44153064|NCT02014480|78943585|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
44153065|NCT02014480|78943580|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
44153066|NCT02014480|78943581|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
44153067|NCT02014480|78943582|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
44532289|NCT04642079|79542183|FG000|Overall Study|Lost to Follow-up|2|||
44532290|NCT04642079|79542184|FG001|Overall Study|Lost to Follow-up|5|||
44532291|NCT04642079|79542185|FG002|Overall Study|Lost to Follow-up|2|||
44153068|NCT02014480|78943583|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
44153069|NCT02014480|78943584|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
44153070|NCT02014480|78943585|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
44153071|NCT02014480|78943580|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44153072|NCT02014480|78943581|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44153073|NCT02014480|78943582|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44153074|NCT02014480|78943583|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44153075|NCT02014480|78943584|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
44153076|NCT02014480|78943585|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
44153077|NCT01261247|78943593|FG000|Overall Study|Ineligible|2|||
44415429|NCT00574288|79423211|FG001|Overall Study|Death|0|||
44415430|NCT00574288|79423212|FG002|Overall Study|Death|0|||
44415431|NCT00574288|79423213|FG003|Overall Study|Death|0|||
44415432|NCT00574288|79423214|FG004|Overall Study|Death|0|||
44415433|NCT00574288|79423215|FG005|Overall Study|Death|25|||
44415434|NCT00574288|79423216|FG006|Overall Study|Death|21|||
44415435|NCT00574288|79423210|FG000|Overall Study|Lost to Follow-up|0|||
44415436|NCT00574288|79423211|FG001|Overall Study|Lost to Follow-up|0|||
44415437|NCT00574288|79423212|FG002|Overall Study|Lost to Follow-up|0|||
44415438|NCT00574288|79423213|FG003|Overall Study|Lost to Follow-up|0|||
44415439|NCT00574288|79423214|FG004|Overall Study|Lost to Follow-up|0|||
44415440|NCT00574288|79423215|FG005|Overall Study|Lost to Follow-up|1|||
44415441|NCT00574288|79423216|FG006|Overall Study|Lost to Follow-up|2|||
44532292|NCT04642079|79542186|FG003|Overall Study|Lost to Follow-up|0|||
44532293|NCT04642079|79542183|FG000|Overall Study|Withdrawal by Subject|0|||
44532294|NCT04642079|79542184|FG001|Overall Study|Withdrawal by Subject|4|||
44532295|NCT04642079|79542185|FG002|Overall Study|Withdrawal by Subject|1|||
44532296|NCT04642079|79542186|FG003|Overall Study|Withdrawal by Subject|2|||
44532297|NCT04642079|79542183|FG000|Overall Study|Other|0|||
44532298|NCT04642079|79542184|FG001|Overall Study|Other|0|||
44532299|NCT04642079|79542185|FG002|Overall Study|Other|0|||
44532300|NCT04642079|79542186|FG003|Overall Study|Other|1|||
44153078|NCT01677767|78943597|FG000|Overall Study|Adverse Event|1|||
44283464|NCT01792830|79246813|FG006|Overall Study|Withdrawal by Subject|1|||
44415442|NCT00574288|79423210|FG000|Overall Study|Study Terminated By Sponsor|0|||
44532301|NCT04642079|79542183|FG000|Overall Study|No longer met eligibility criteria|1|||
44532302|NCT04642079|79542184|FG001|Overall Study|No longer met eligibility criteria|0|||
44153079|NCT01677767|78943597|FG000|Overall Study|Death|4|||
44153080|NCT01677767|78943597|FG000|Overall Study|Protocol Violation|4|||
44153081|NCT01677767|78943597|FG000|Overall Study|Withdrawal by Subject|10|||
44153082|NCT01677767|78943597|FG000|Overall Study|Non-compliance by the participants|3|||
44532303|NCT04642079|79542185|FG002|Overall Study|No longer met eligibility criteria|1|||
44532304|NCT04642079|79542186|FG003|Overall Study|No longer met eligibility criteria|1|||
44532305|NCT04232124|79542231|FG000|Overall Study|Lost to Follow-up|3|||
44532306|NCT03529110|79542241|FG000|Overall Study|Progressive Disease|66|||
44532307|NCT03529110|79542242|FG001|Overall Study|Progressive Disease|158|||
44532308|NCT03529110|79542241|FG000|Overall Study|Clinical Progression|4|||
44532309|NCT03529110|79542242|FG001|Overall Study|Clinical Progression|12|||
44532310|NCT03529110|79542241|FG000|Overall Study|Adverse Event|35|||
44532311|NCT03529110|79542242|FG001|Overall Study|Adverse Event|17|||
44532312|NCT03529110|79542241|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
44153083|NCT01603277|78943618|FG000|Overall Study|Adverse Event|1|||
44532313|NCT03529110|79542242|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
44532314|NCT03529110|79542241|FG000|Overall Study|Lack of Efficacy|3|||
44532315|NCT03529110|79542242|FG001|Overall Study|Lack of Efficacy|3|||
44532316|NCT03529110|79542241|FG000|Overall Study|Physician Decision|2|||
44532317|NCT03529110|79542242|FG001|Overall Study|Physician Decision|8|||
44532318|NCT03529110|79542241|FG000|Overall Study|Miscellaneous|2|||
44532319|NCT03529110|79542242|FG001|Overall Study|Miscellaneous|5|||
44532320|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
44532321|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
44532322|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
44532323|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
44532324|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
44532325|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
44532326|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
44532327|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
44532328|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
44532329|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
44532330|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
44532331|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
44532332|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
44532333|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
44532334|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
44532335|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
44532336|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
44153084|NCT01603277|78943619|FG001|Overall Study|Adverse Event|2|||
44153085|NCT01603277|78943618|FG000|Overall Study|Physician Decision|0|||
44153086|NCT01603277|78943619|FG001|Overall Study|Physician Decision|1|||
44153087|NCT01603277|78943618|FG000|Overall Study|Protocol Violation|6|||
44153088|NCT01603277|78943619|FG001|Overall Study|Protocol Violation|10|||
44153089|NCT01603277|78943618|FG000|Overall Study|Withdrawal by Subject|5|||
44153090|NCT01603277|78943619|FG001|Overall Study|Withdrawal by Subject|4|||
44153091|NCT01603277|78943618|FG000|Overall Study|Non-Compliance|2|||
44153092|NCT01603277|78943619|FG001|Overall Study|Non-Compliance|1|||
44153093|NCT01678313|78943627|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
44153094|NCT01678313|78943628|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
44153095|NCT01678313|78943627|FG000|Completed the 3-month Therapy|Physician Decision|3|||
44283465|NCT01792830|79246814|FG007|Overall Study|Withdrawal by Subject|1|||
44532337|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
44532338|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
44532339|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
44532340|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
44153096|NCT01678313|78943628|FG001|Completed the 3-month Therapy|Physician Decision|4|||
44153097|NCT01678313|78943627|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
44153098|NCT01678313|78943628|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
44153099|NCT01678313|78943627|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
44153100|NCT01678313|78943628|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
44153101|NCT01603121|78943634|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
44153102|NCT01603121|78943635|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
44532341|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
44532342|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
44532343|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
44532344|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
44532345|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
44153103|NCT01603043|78943643|FG000|Overall Study|Study Futility|7|||
44153104|NCT01603043|78943644|FG001|Overall Study|Study Futility|3|||
44153105|NCT02014402|78943654|FG000|Overall Study|Adverse Event|1|||
44153106|NCT02014402|78943655|FG001|Overall Study|Adverse Event|0|||
44153107|NCT02014402|78943656|FG002|Overall Study|Adverse Event|0|||
44153108|NCT02014402|78943657|FG003|Overall Study|Adverse Event|0|||
44153109|NCT02014402|78943654|FG000|Overall Study|Withdrawal by Subject|1|||
44153110|NCT02014402|78943655|FG001|Overall Study|Withdrawal by Subject|2|||
44153111|NCT02014402|78943656|FG002|Overall Study|Withdrawal by Subject|2|||
44153112|NCT02014402|78943657|FG003|Overall Study|Withdrawal by Subject|1|||
44153113|NCT02014402|78943654|FG000|Overall Study|Subject did not have transportation|0|||
44153114|NCT02014402|78943655|FG001|Overall Study|Subject did not have transportation|1|||
44153115|NCT02014402|78943656|FG002|Overall Study|Subject did not have transportation|0|||
44153116|NCT02014402|78943657|FG003|Overall Study|Subject did not have transportation|0|||
44153117|NCT02014402|78943654|FG000|Overall Study|Lost to Follow-up|0|||
44153118|NCT02014402|78943655|FG001|Overall Study|Lost to Follow-up|0|||
44153119|NCT02014402|78943656|FG002|Overall Study|Lost to Follow-up|1|||
44153120|NCT02014402|78943657|FG003|Overall Study|Lost to Follow-up|2|||
44153121|NCT01988662|78943676|FG000|Overall Study|Subject/guardian decision|1|||
44153122|NCT01988662|78943677|FG001|Overall Study|Subject/guardian decision|1|||
44153123|NCT01988662|78943676|FG000|Overall Study|Adverse Event|3|||
44153124|NCT01988662|78943677|FG001|Overall Study|Adverse Event|1|||
44153125|NCT02839343|78943686|FG000|Overall Study|Withdrawal by Subject|3|||
44153126|NCT02839343|78943687|FG001|Overall Study|Withdrawal by Subject|1|||
44153127|NCT02839343|78943686|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
44153128|NCT02839343|78943687|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
44153129|NCT02839343|78943686|FG000|Overall Study|Adverse Event|1|||
44153130|NCT02839343|78943687|FG001|Overall Study|Adverse Event|0|||
44153131|NCT01965652|78943716|FG000|Overall Study|Adverse Event|40|||
44153132|NCT01965652|78943717|FG001|Overall Study|Adverse Event|37|||
44153133|NCT01965652|78943716|FG000|Overall Study|Withdrawal by Subject|62|||
44153134|NCT01965652|78943717|FG001|Overall Study|Withdrawal by Subject|69|||
44153135|NCT01965652|78943716|FG000|Overall Study|Lost to Follow-up|53|||
44153136|NCT01965652|78943717|FG001|Overall Study|Lost to Follow-up|40|||
44153137|NCT01965652|78943716|FG000|Overall Study|Protocol Violation|34|||
44153138|NCT01965652|78943717|FG001|Overall Study|Protocol Violation|38|||
44153139|NCT01965652|78943716|FG000|Overall Study|Death|3|||
44153140|NCT01965652|78943717|FG001|Overall Study|Death|4|||
44153141|NCT01965652|78943716|FG000|Overall Study|Other - Miscellaneous|18|||
44153142|NCT01965652|78943717|FG001|Overall Study|Other - Miscellaneous|21|||
44153143|NCT01965652|78943716|FG000|Overall Study|Pregnancy|0|||
44153144|NCT01965652|78943717|FG001|Overall Study|Pregnancy|1|||
44153145|NCT01602965|78943725|FG000|Overall Study|Lost to Follow-up|4|||
44153146|NCT01602965|78943726|FG001|Overall Study|Lost to Follow-up|2|||
44153147|NCT01987960|78943734|FG000|Period 1|Adverse Event|24|||
44153148|NCT01987960|78943735|FG001|Period 1|Adverse Event|0|||
44153149|NCT01987960|78943736|FG002|Period 1|Adverse Event|0|||
44532346|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
44532347|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
44532348|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
44532349|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
44532350|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
44532351|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
44532352|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
44532353|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
44153150|NCT01987960|78943737|FG003|Period 1|Adverse Event|0|||
44153151|NCT01987960|78943734|FG000|Period 1|Lack of Efficacy|4|||
44153152|NCT01987960|78943735|FG001|Period 1|Lack of Efficacy|0|||
44153153|NCT01987960|78943736|FG002|Period 1|Lack of Efficacy|0|||
44153154|NCT01987960|78943737|FG003|Period 1|Lack of Efficacy|0|||
44153155|NCT01987960|78943734|FG000|Period 1|Non-compliance with IMP|6|||
44153156|NCT01987960|78943735|FG001|Period 1|Non-compliance with IMP|0|||
44153157|NCT01987960|78943736|FG002|Period 1|Non-compliance with IMP|0|||
44153158|NCT01987960|78943737|FG003|Period 1|Non-compliance with IMP|0|||
44153159|NCT01987960|78943734|FG000|Period 1|Protocol Violation|12|||
44153160|NCT01987960|78943735|FG001|Period 1|Protocol Violation|0|||
44532354|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
44153161|NCT01987960|78943736|FG002|Period 1|Protocol Violation|0|||
44153162|NCT01987960|78943737|FG003|Period 1|Protocol Violation|0|||
44153163|NCT01987960|78943734|FG000|Period 1|Withdrawal by Subject|21|||
44153164|NCT01987960|78943735|FG001|Period 1|Withdrawal by Subject|0|||
44153165|NCT01987960|78943736|FG002|Period 1|Withdrawal by Subject|0|||
44153166|NCT01987960|78943737|FG003|Period 1|Withdrawal by Subject|0|||
44153167|NCT01987960|78943734|FG000|Period 1|Lost to Follow-up|40|||
44153168|NCT01987960|78943735|FG001|Period 1|Lost to Follow-up|0|||
44153169|NCT01987960|78943736|FG002|Period 1|Lost to Follow-up|0|||
44153170|NCT01987960|78943737|FG003|Period 1|Lost to Follow-up|0|||
44153171|NCT01987960|78943734|FG000|Period 1|administrative or other reason|75|||
44153172|NCT01987960|78943735|FG001|Period 1|administrative or other reason|0|||
44153173|NCT01987960|78943736|FG002|Period 1|administrative or other reason|0|||
44153174|NCT01987960|78943737|FG003|Period 1|administrative or other reason|0|||
44153175|NCT01987960|78943734|FG000|Period 1|Withdrawal of consent before treatment|4|||
44153176|NCT01987960|78943735|FG001|Period 1|Withdrawal of consent before treatment|0|||
44153177|NCT01987960|78943736|FG002|Period 1|Withdrawal of consent before treatment|0|||
44153178|NCT01987960|78943737|FG003|Period 1|Withdrawal of consent before treatment|0|||
44153179|NCT01987960|78943734|FG000|Period 2|Adverse Event|0|||
44153180|NCT01987960|78943735|FG001|Period 2|Adverse Event|0|||
44153181|NCT01987960|78943736|FG002|Period 2|Adverse Event|1|||
44153182|NCT01987960|78943737|FG003|Period 2|Adverse Event|0|||
44153183|NCT01987960|78943734|FG000|Period 2|Withdrawal by Subject|0|||
44153184|NCT01987960|78943735|FG001|Period 2|Withdrawal by Subject|0|||
44153185|NCT01987960|78943736|FG002|Period 2|Withdrawal by Subject|1|||
44153186|NCT01987960|78943737|FG003|Period 2|Withdrawal by Subject|0|||
44153187|NCT01987960|78943734|FG000|Period 2|Administrative or other reason|0|||
44153188|NCT01987960|78943735|FG001|Period 2|Administrative or other reason|5|||
44415443|NCT00574288|79423211|FG001|Overall Study|Study Terminated By Sponsor|0|||
44415444|NCT00574288|79423212|FG002|Overall Study|Study Terminated By Sponsor|0|||
44415445|NCT00574288|79423213|FG003|Overall Study|Study Terminated By Sponsor|0|||
44415446|NCT00574288|79423214|FG004|Overall Study|Study Terminated By Sponsor|0|||
44415447|NCT00574288|79423215|FG005|Overall Study|Study Terminated By Sponsor|0|||
44415448|NCT00574288|79423216|FG006|Overall Study|Study Terminated By Sponsor|5|||
44415449|NCT00574288|79423210|FG000|Overall Study|Progressive Disease|17|||
44415450|NCT00574288|79423211|FG001|Overall Study|Progressive Disease|2|||
44153189|NCT01987960|78943736|FG002|Period 2|Administrative or other reason|7|||
44153190|NCT01987960|78943737|FG003|Period 2|Administrative or other reason|0|||
44532355|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
44532356|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
44532357|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
44532358|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
44532359|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
44532360|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
44532361|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
44153191|NCT01987960|78943734|FG000|Period 3|Adverse Event|0|||
44153192|NCT01987960|78943735|FG001|Period 3|Adverse Event|0|||
44153193|NCT01987960|78943736|FG002|Period 3|Adverse Event|0|||
44153194|NCT01987960|78943737|FG003|Period 3|Adverse Event|7|||
44153195|NCT01987960|78943734|FG000|Period 3|Non-compliance with IMP|0|||
44153196|NCT01987960|78943735|FG001|Period 3|Non-compliance with IMP|0|||
44415451|NCT00574288|79423212|FG002|Overall Study|Progressive Disease|3|||
44153197|NCT01987960|78943736|FG002|Period 3|Non-compliance with IMP|0|||
44153198|NCT01987960|78943737|FG003|Period 3|Non-compliance with IMP|1|||
44153199|NCT01987960|78943734|FG000|Period 3|Protocol Violation|0|||
44153200|NCT01987960|78943735|FG001|Period 3|Protocol Violation|0|||
44153201|NCT01987960|78943736|FG002|Period 3|Protocol Violation|0|||
44153202|NCT01987960|78943737|FG003|Period 3|Protocol Violation|6|||
44532362|NCT03524092|79542252|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
44532363|NCT03524092|79542253|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
44532364|NCT03524092|79542254|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
44532365|NCT03524092|79542255|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
44532366|NCT03524092|79542256|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
44415452|NCT00574288|79423213|FG003|Overall Study|Progressive Disease|2|||
44532367|NCT03524092|79542257|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
44532368|NCT03524092|79542252|FG000|Loss of Response Rescue Period|Adverse Event|0|||
44532369|NCT03524092|79542253|FG001|Loss of Response Rescue Period|Adverse Event|0|||
44532370|NCT03524092|79542254|FG002|Loss of Response Rescue Period|Adverse Event|0|||
44532371|NCT03524092|79542255|FG003|Loss of Response Rescue Period|Adverse Event|2|||
44532372|NCT03524092|79542256|FG004|Loss of Response Rescue Period|Adverse Event|0|||
44532373|NCT03524092|79542257|FG005|Loss of Response Rescue Period|Adverse Event|0|||
44532374|NCT03524092|79542252|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
44532375|NCT03524092|79542253|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
44532376|NCT03524092|79542254|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
44532377|NCT03524092|79542255|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
44532378|NCT03524092|79542256|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
44532379|NCT03524092|79542257|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
44532380|NCT03524092|79542252|FG000|Loss of Response Rescue Period|Pregnancy|0|||
44532381|NCT03524092|79542253|FG001|Loss of Response Rescue Period|Pregnancy|0|||
44532382|NCT03524092|79542254|FG002|Loss of Response Rescue Period|Pregnancy|0|||
44532383|NCT03524092|79542255|FG003|Loss of Response Rescue Period|Pregnancy|1|||
44532384|NCT03524092|79542256|FG004|Loss of Response Rescue Period|Pregnancy|0|||
44532385|NCT03524092|79542257|FG005|Loss of Response Rescue Period|Pregnancy|0|||
44532386|NCT03524092|79542252|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
44532387|NCT03524092|79542253|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
44532388|NCT03524092|79542254|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
44532389|NCT03524092|79542255|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
44532390|NCT03524092|79542256|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
44532391|NCT03524092|79542257|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
44532392|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
44532393|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
44415453|NCT00574288|79423214|FG004|Overall Study|Progressive Disease|1|||
44415454|NCT00574288|79423215|FG005|Overall Study|Progressive Disease|0|||
44415455|NCT00574288|79423216|FG006|Overall Study|Progressive Disease|0|||
44532394|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
44532395|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
44532396|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
44532397|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
44532398|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
44532399|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
44532400|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
44532401|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
44532402|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
44532403|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
44532404|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
44532405|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
44532406|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
44532407|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
44532408|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
44532409|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
44532410|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
44532411|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
44532412|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
44532413|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
44532414|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
44532415|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
44532416|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
44532417|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
44532418|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
44532419|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
44532420|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
44532421|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
44532422|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
44532423|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
44532424|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
44532425|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
44532426|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
44532427|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
44532428|NCT03524092|79542252|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
44532429|NCT03524092|79542253|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
44532430|NCT03524092|79542254|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
44532431|NCT03524092|79542255|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
44532432|NCT03524092|79542256|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
44532433|NCT03524092|79542257|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
44532434|NCT03524092|79542252|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
44532435|NCT03524092|79542253|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
44153203|NCT01987960|78943734|FG000|Period 3|Withdrawal by Subject|0|||
44153204|NCT01987960|78943735|FG001|Period 3|Withdrawal by Subject|0|||
44153205|NCT01987960|78943736|FG002|Period 3|Withdrawal by Subject|0|||
44153206|NCT01987960|78943737|FG003|Period 3|Withdrawal by Subject|9|||
44153207|NCT01987960|78943734|FG000|Period 3|Lost to Follow-up|0|||
44153208|NCT01987960|78943735|FG001|Period 3|Lost to Follow-up|0|||
44153209|NCT01987960|78943736|FG002|Period 3|Lost to Follow-up|0|||
44415456|NCT00574288|79423210|FG000|Overall Study|Other|1|||
44532436|NCT03524092|79542254|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
44532437|NCT03524092|79542255|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
44153210|NCT01987960|78943737|FG003|Period 3|Lost to Follow-up|5|||
44153211|NCT01987960|78943734|FG000|Period 3|Administrative or other reason|0|||
44532438|NCT03524092|79542256|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
44532439|NCT03524092|79542257|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
44532440|NCT03524092|79542252|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
44532441|NCT03524092|79542253|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
44532442|NCT03524092|79542254|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
44532443|NCT03524092|79542255|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
44532444|NCT03524092|79542256|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
44532445|NCT03524092|79542257|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
44532446|NCT03524092|79542252|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
44532447|NCT03524092|79542253|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
44532448|NCT03524092|79542254|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
44532449|NCT03524092|79542255|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
44532450|NCT03524092|79542256|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
44532451|NCT03524092|79542257|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
44532452|NCT03524092|79542252|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
44532453|NCT03524092|79542253|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
44532454|NCT03524092|79542254|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
44532455|NCT03524092|79542255|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
44153212|NCT01987960|78943735|FG001|Period 3|Administrative or other reason|0|||
44153213|NCT01987960|78943736|FG002|Period 3|Administrative or other reason|0|||
44153214|NCT01987960|78943737|FG003|Period 3|Administrative or other reason|43|||
44153215|NCT02013778|78943747|FG000|Overall Study|Death|4|||
44153216|NCT02013778|78943747|FG000|Overall Study|Withdrawal by Subject|1|||
44153217|NCT02013778|78943747|FG000|Overall Study|Physician Decision|1|||
44153218|NCT02013778|78943747|FG000|Overall Study|Adverse Event|1|||
44153219|NCT02013622|78943751|FG000|Overall Study|Lost to Follow-up|10|||
44153220|NCT02013622|78943751|FG000|Overall Study|Adverse Event|3|||
44153221|NCT02013622|78943751|FG000|Overall Study|Met Withdrawal Criteria|3|||
44153222|NCT02013622|78943751|FG000|Overall Study|Withdrawal by Subject|6|||
44153223|NCT02013622|78943751|FG000|Overall Study|Protocol Deviation|1|||
44153224|NCT02013622|78943751|FG000|Overall Study|Lack of Efficacy|1|||
44153225|NCT01987102|78943757|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
44153226|NCT01987102|78943758|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
44153227|NCT01987102|78943757|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
44153228|NCT01987102|78943758|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
44153229|NCT01987102|78943757|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
44153230|NCT01987102|78943758|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
44415457|NCT00574288|79423211|FG001|Overall Study|Other|1|||
44415458|NCT00574288|79423212|FG002|Overall Study|Other|0|||
44415459|NCT00574288|79423213|FG003|Overall Study|Other|0|||
44153231|NCT01987102|78943757|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
44153232|NCT01987102|78943758|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
44153233|NCT01987102|78943757|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
44153234|NCT01987102|78943758|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
44153235|NCT01987102|78943757|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
44153236|NCT01987102|78943758|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
44153237|NCT02013544|78943767|FG000|Overall Study|Adverse Event|5|||
44153238|NCT02013544|78943768|FG001|Overall Study|Adverse Event|5|||
44153239|NCT02013544|78943767|FG000|Overall Study|Lost to Follow-up|2|||
44153240|NCT02013544|78943768|FG001|Overall Study|Lost to Follow-up|3|||
44153241|NCT02013544|78943767|FG000|Overall Study|Withdrawal by Subject|2|||
44153242|NCT02013544|78943768|FG001|Overall Study|Withdrawal by Subject|8|||
44153243|NCT02013544|78943767|FG000|Overall Study|Physician Decision|0|||
44415460|NCT00574288|79423214|FG004|Overall Study|Other|0|||
44415461|NCT00574288|79423215|FG005|Overall Study|Other|0|||
44415462|NCT00574288|79423216|FG006|Overall Study|Other|0|||
44532456|NCT03524092|79542256|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
44532457|NCT03524092|79542257|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
44532458|NCT03518086|79542270|FG000|Overall Study|Adverse Event|23|||
44532459|NCT03518086|79542271|FG001|Overall Study|Adverse Event|15|||
44532460|NCT03518086|79542272|FG002|Overall Study|Adverse Event|0|||
44532461|NCT03518086|79542273|FG003|Overall Study|Adverse Event|0|||
44532462|NCT03518086|79542270|FG000|Overall Study|Withdrawal by Subject|8|||
44532463|NCT03518086|79542271|FG001|Overall Study|Withdrawal by Subject|5|||
44532464|NCT03518086|79542272|FG002|Overall Study|Withdrawal by Subject|0|||
44283466|NCT01792830|79246815|FG008|Overall Study|Withdrawal by Subject|7|||
44283467|NCT01792830|79246816|FG009|Overall Study|Withdrawal by Subject|0|||
44532465|NCT03518086|79542273|FG003|Overall Study|Withdrawal by Subject|0|||
44532466|NCT03518086|79542270|FG000|Overall Study|Lack of Efficacy|5|||
44532467|NCT03518086|79542271|FG001|Overall Study|Lack of Efficacy|5|||
44532468|NCT03518086|79542272|FG002|Overall Study|Lack of Efficacy|0|||
44532469|NCT03518086|79542273|FG003|Overall Study|Lack of Efficacy|0|||
44532470|NCT03518086|79542270|FG000|Overall Study|Protocol Violation|1|||
44532471|NCT03518086|79542271|FG001|Overall Study|Protocol Violation|5|||
44532472|NCT03518086|79542272|FG002|Overall Study|Protocol Violation|0|||
44532473|NCT03518086|79542273|FG003|Overall Study|Protocol Violation|0|||
44532474|NCT03518086|79542270|FG000|Overall Study|Lost to Follow-up|0|||
44532475|NCT03518086|79542271|FG001|Overall Study|Lost to Follow-up|3|||
44532476|NCT03518086|79542272|FG002|Overall Study|Lost to Follow-up|0|||
44532477|NCT03518086|79542273|FG003|Overall Study|Lost to Follow-up|0|||
44532478|NCT03518086|79542270|FG000|Overall Study|Insufficient Diary Data|0|||
44532479|NCT03518086|79542271|FG001|Overall Study|Insufficient Diary Data|2|||
44153244|NCT02013544|78943768|FG001|Overall Study|Physician Decision|1|||
44153245|NCT02013544|78943767|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
44153246|NCT02013544|78943768|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
44153247|NCT02013388|78943782|FG000|Overall Study|work emergency|1|||
44153248|NCT02013388|78943783|FG001|Overall Study|work emergency|0|||
44153249|NCT02013388|78943784|FG002|Overall Study|work emergency|0|||
44415463|NCT00790452|79423244|FG000|Overall Study|Drug supply issue|1|||
44415464|NCT00790452|79423245|FG001|Overall Study|Drug supply issue|0|||
44415465|NCT00626392|79423257|FG000|Run-in Period|Adverse Event|0|||
44532480|NCT03518086|79542272|FG002|Overall Study|Insufficient Diary Data|0|||
44532481|NCT03518086|79542273|FG003|Overall Study|Insufficient Diary Data|0|||
44532482|NCT03518086|79542270|FG000|Overall Study|Non- compliance to Protocol|0|||
44532483|NCT03518086|79542271|FG001|Overall Study|Non- compliance to Protocol|1|||
44153250|NCT02013388|78943785|FG003|Overall Study|work emergency|0|||
44153251|NCT02013388|78943786|FG004|Overall Study|work emergency|1|||
44153252|NCT02013388|78943787|FG005|Overall Study|work emergency|0|||
44153253|NCT02013388|78943788|FG006|Overall Study|work emergency|0|||
44153254|NCT02013388|78943789|FG007|Overall Study|work emergency|0|||
44153255|NCT02012686|78943813|FG000|Overall Study|muscle contraction|0|||
44153256|NCT02012686|78943814|FG001|Overall Study|muscle contraction|1|||
44153257|NCT02012686|78943813|FG000|Overall Study|electrocardiography monitoring noise|0|||
44153258|NCT02012686|78943814|FG001|Overall Study|electrocardiography monitoring noise|1|||
44153259|NCT02012452|78943822|FG000|Overall Study|Lost to Follow-up|2|||
44153260|NCT02012452|78943823|FG001|Overall Study|Lost to Follow-up|1|||
44153261|NCT02012452|78943822|FG000|Overall Study|Withdrawal by Subject|4|||
44153262|NCT02012452|78943823|FG001|Overall Study|Withdrawal by Subject|0|||
44153263|NCT01676909|78943831|FG000|Overall Study|Withdrawal by Subject|3|||
44153264|NCT01676909|78943832|FG001|Overall Study|Withdrawal by Subject|5|||
44153265|NCT01676909|78943831|FG000|Overall Study|Lost to Follow-up|15|||
44153266|NCT01676909|78943832|FG001|Overall Study|Lost to Follow-up|9|||
44153267|NCT02012296|78943843|FG000|Overall Study|Lack of Efficacy|0|||
44153268|NCT02012296|78943844|FG001|Overall Study|Lack of Efficacy|0|||
44532484|NCT03518086|79542272|FG002|Overall Study|Non- compliance to Protocol|0|||
44532485|NCT03518086|79542273|FG003|Overall Study|Non- compliance to Protocol|0|||
44153269|NCT02012296|78943845|FG002|Overall Study|Lack of Efficacy|15|||
44153270|NCT02012296|78943843|FG000|Overall Study|Adverse Event|0|||
44153271|NCT02012296|78943844|FG001|Overall Study|Adverse Event|0|||
44153272|NCT02012296|78943845|FG002|Overall Study|Adverse Event|2|||
44153273|NCT02012296|78943843|FG000|Overall Study|Early study closure|0|||
44153274|NCT02012296|78943844|FG001|Overall Study|Early study closure|0|||
44153275|NCT02012296|78943845|FG002|Overall Study|Early study closure|5|||
44153276|NCT02012296|78943843|FG000|Overall Study|Protocol Violation|0|||
44153277|NCT02012296|78943844|FG001|Overall Study|Protocol Violation|1|||
44153278|NCT02012296|78943845|FG002|Overall Study|Protocol Violation|0|||
44153279|NCT02012218|78943862|FG000|Overall Study|Withdrawal by Subject|1|||
44153280|NCT02012218|78943863|FG001|Overall Study|Withdrawal by Subject|0|||
44153281|NCT02012218|78943864|FG002|Overall Study|Withdrawal by Subject|1|||
44153282|NCT02012218|78943865|FG003|Overall Study|Withdrawal by Subject|1|||
44153283|NCT02012218|78943866|FG004|Overall Study|Withdrawal by Subject|1|||
44153284|NCT02012218|78943862|FG000|Overall Study|Adverse Event|1|||
44153285|NCT02012218|78943863|FG001|Overall Study|Adverse Event|0|||
44153286|NCT02012218|78943864|FG002|Overall Study|Adverse Event|0|||
44153287|NCT02012218|78943865|FG003|Overall Study|Adverse Event|1|||
44153288|NCT02012218|78943866|FG004|Overall Study|Adverse Event|0|||
44153289|NCT02012218|78943862|FG000|Overall Study|Lost to Follow-up|0|||
44153290|NCT02012218|78943863|FG001|Overall Study|Lost to Follow-up|1|||
44153291|NCT02012218|78943864|FG002|Overall Study|Lost to Follow-up|1|||
44153292|NCT02012218|78943865|FG003|Overall Study|Lost to Follow-up|0|||
44153293|NCT02012218|78943866|FG004|Overall Study|Lost to Follow-up|0|||
44153294|NCT02012218|78943862|FG000|Overall Study|Protocol Specified|1|||
44153295|NCT02012218|78943863|FG001|Overall Study|Protocol Specified|0|||
44153296|NCT02012218|78943864|FG002|Overall Study|Protocol Specified|0|||
44153297|NCT02012218|78943865|FG003|Overall Study|Protocol Specified|0|||
44153298|NCT02012218|78943866|FG004|Overall Study|Protocol Specified|0|||
44153299|NCT02012218|78943862|FG000|Overall Study|Protocol Deviation|1|||
44153300|NCT02012218|78943863|FG001|Overall Study|Protocol Deviation|0|||
44153301|NCT02012218|78943864|FG002|Overall Study|Protocol Deviation|0|||
44153302|NCT02012218|78943865|FG003|Overall Study|Protocol Deviation|0|||
44153303|NCT02012218|78943866|FG004|Overall Study|Protocol Deviation|0|||
44153304|NCT01965262|78943878|FG000|Second Intervention (7 Days)|Discontinued|0|||
44153305|NCT01965262|78943879|FG001|Second Intervention (7 Days)|Discontinued|1|||
44153306|NCT01965262|78943878|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
44153307|NCT01965262|78943879|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
44153308|NCT01965262|78943878|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
44153309|NCT01965262|78943879|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
44153310|NCT01677377|78943888|FG000|Overall Study|Protocol Violation|1|||
44153311|NCT01677377|78943889|FG001|Overall Study|Protocol Violation|0|||
44153312|NCT01677377|78943890|FG002|Overall Study|Protocol Violation|0|||
44153313|NCT01677377|78943888|FG000|Overall Study|Lost to Follow-up|0|||
44153314|NCT01677377|78943889|FG001|Overall Study|Lost to Follow-up|1|||
44153315|NCT01677377|78943890|FG002|Overall Study|Lost to Follow-up|1|||
44153316|NCT01677377|78943888|FG000|Overall Study|Withdrawal by Subject|0|||
44153317|NCT01677377|78943889|FG001|Overall Study|Withdrawal by Subject|0|||
44153318|NCT01677377|78943890|FG002|Overall Study|Withdrawal by Subject|3|||
44153319|NCT01677377|78943888|FG000|Overall Study|Lack of Efficacy|0|||
44153320|NCT01677377|78943889|FG001|Overall Study|Lack of Efficacy|0|||
44153321|NCT01677377|78943890|FG002|Overall Study|Lack of Efficacy|1|||
44153322|NCT01677377|78943888|FG000|Overall Study|Pregnancy|0|||
44153323|NCT01677377|78943889|FG001|Overall Study|Pregnancy|0|||
44153324|NCT01677377|78943890|FG002|Overall Study|Pregnancy|1|||
44153325|NCT01964950|78943900|FG000|Overall Study|Protocol Violation|25|||
44153326|NCT01964716|78943909|FG000|Overall Study|Withdrawal by Subject|2|||
44153327|NCT01964716|78943910|FG001|Overall Study|Withdrawal by Subject|3|||
44153328|NCT01964716|78943909|FG000|Overall Study|Lost to Follow-up|1|||
44153329|NCT01964716|78943910|FG001|Overall Study|Lost to Follow-up|2|||
44153330|NCT01964716|78943909|FG000|Overall Study|No longer met eligibility criteria|1|||
44153331|NCT01964716|78943910|FG001|Overall Study|No longer met eligibility criteria|1|||
44153332|NCT01964716|78943909|FG000|Overall Study|Death|1|||
44153333|NCT01964716|78943910|FG001|Overall Study|Death|0|||
44153334|NCT01964560|78943924|FG000|Overall Study|Adverse Event|23|||
44153335|NCT01964560|78943924|FG000|Overall Study|Lack of Efficacy|46|||
44153336|NCT01964560|78943924|FG000|Overall Study|Protocol deviation|2|||
44153337|NCT01964560|78943924|FG000|Overall Study|Lost to Follow-up|4|||
44153338|NCT01964560|78943924|FG000|Overall Study|Withdrawal by Subject|64|||
44153339|NCT01964560|78943924|FG000|Overall Study|Surgery-hemispherotomy|1|||
44153340|NCT01964560|78943924|FG000|Overall Study|Surgery|1|||
44153341|NCT01964560|78943924|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
44153342|NCT01964560|78943924|FG000|Overall Study|Patient and Investigator choice|1|||
44153343|NCT01964560|78943924|FG000|Overall Study|Patient was prescribed CBD|1|||
44153344|NCT01964560|78943924|FG000|Overall Study|Participant moved to another country|1|||
44153345|NCT02659943|78943935|FG000|Overall Study|Switched to alternative treatment|1|||
44153346|NCT02659943|78943936|FG001|Overall Study|Switched to alternative treatment|1|||
44153347|NCT02659943|78943937|FG002|Overall Study|Switched to alternative treatment|0|||
44153348|NCT02659943|78943938|FG003|Overall Study|Switched to alternative treatment|2|||
44153349|NCT02659943|78943939|FG004|Overall Study|Switched to alternative treatment|1|||
44153350|NCT02659943|78943940|FG005|Overall Study|Switched to alternative treatment|0|||
44153351|NCT02659943|78943941|FG006|Overall Study|Switched to alternative treatment|1|||
44153352|NCT02659943|78943935|FG000|Overall Study|Disease progression on study|0|||
44153353|NCT02659943|78943936|FG001|Overall Study|Disease progression on study|1|||
44153354|NCT02659943|78943937|FG002|Overall Study|Disease progression on study|1|||
44153355|NCT02659943|78943938|FG003|Overall Study|Disease progression on study|1|||
44153356|NCT02659943|78943939|FG004|Overall Study|Disease progression on study|1|||
44153357|NCT02659943|78943940|FG005|Overall Study|Disease progression on study|4|||
44153358|NCT02659943|78943941|FG006|Overall Study|Disease progression on study|0|||
44153359|NCT02659943|78943935|FG000|Overall Study|Patient's condition per principal investigator|0|||
44153360|NCT02659943|78943936|FG001|Overall Study|Patient's condition per principal investigator|0|||
44153361|NCT02659943|78943937|FG002|Overall Study|Patient's condition per principal investigator|0|||
44153362|NCT02659943|78943938|FG003|Overall Study|Patient's condition per principal investigator|0|||
44153363|NCT02659943|78943939|FG004|Overall Study|Patient's condition per principal investigator|0|||
44415466|NCT00626392|79423258|FG001|Run-in Period|Adverse Event|0|||
44415467|NCT00626392|79423259|FG002|Run-in Period|Adverse Event|1|||
44415468|NCT00626392|79423260|FG003|Run-in Period|Adverse Event|0|||
44532486|NCT03518086|79542270|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
44532487|NCT03518086|79542271|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
44532488|NCT03518086|79542272|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
44532489|NCT03518086|79542273|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
44153364|NCT02659943|78943940|FG005|Overall Study|Patient's condition per principal investigator|1|||
44415469|NCT00626392|79423261|FG004|Run-in Period|Adverse Event|1|||
44532490|NCT03518086|79542270|FG000|Overall Study|Site Terminated by Sponsor|0|||
44153365|NCT02659943|78943941|FG006|Overall Study|Patient's condition per principal investigator|0|||
44153366|NCT02659943|78943935|FG000|Overall Study|Ineligible|0|||
44153367|NCT02659943|78943936|FG001|Overall Study|Ineligible|0|||
44153368|NCT02659943|78943937|FG002|Overall Study|Ineligible|0|||
44153369|NCT02659943|78943938|FG003|Overall Study|Ineligible|0|||
44153370|NCT02659943|78943939|FG004|Overall Study|Ineligible|0|||
44532491|NCT03518086|79542271|FG001|Overall Study|Site Terminated by Sponsor|1|||
44532492|NCT03518086|79542272|FG002|Overall Study|Site Terminated by Sponsor|0|||
44532493|NCT03518086|79542273|FG003|Overall Study|Site Terminated by Sponsor|0|||
44532494|NCT03358472|79542283|FG000|Overall Study|Death|6|||
44532495|NCT03358472|79542284|FG001|Overall Study|Death|3|||
44532496|NCT03358472|79542285|FG002|Overall Study|Death|10|||
44532497|NCT03358472|79542283|FG000|Overall Study|Physician Decision|0|||
44532498|NCT03358472|79542284|FG001|Overall Study|Physician Decision|1|||
44153371|NCT02659943|78943940|FG005|Overall Study|Ineligible|0|||
44153372|NCT02659943|78943941|FG006|Overall Study|Ineligible|1|||
44153373|NCT02659943|78943935|FG000|Overall Study|No longer meets eligibility|0|||
44153374|NCT02659943|78943936|FG001|Overall Study|No longer meets eligibility|0|||
44153375|NCT02659943|78943937|FG002|Overall Study|No longer meets eligibility|0|||
44153376|NCT02659943|78943938|FG003|Overall Study|No longer meets eligibility|0|||
44153377|NCT02659943|78943939|FG004|Overall Study|No longer meets eligibility|0|||
44153378|NCT02659943|78943940|FG005|Overall Study|No longer meets eligibility|0|||
44415470|NCT00626392|79423262|FG005|Run-in Period|Adverse Event|0|||
44153379|NCT02659943|78943941|FG006|Overall Study|No longer meets eligibility|1|||
44153380|NCT02659943|78943935|FG000|Overall Study|No treatment, per protocol|0|||
44415471|NCT00626392|79423257|FG000|Run-in Period|Withdrawal by Subject|0|||
44532499|NCT03358472|79542285|FG002|Overall Study|Physician Decision|0|||
44532500|NCT03358472|79542283|FG000|Overall Study|Withdrawal by Subject|0|||
44153381|NCT02659943|78943936|FG001|Overall Study|No treatment, per protocol|0|||
44153382|NCT02659943|78943937|FG002|Overall Study|No treatment, per protocol|0|||
44153383|NCT02659943|78943938|FG003|Overall Study|No treatment, per protocol|0|||
44153384|NCT02659943|78943939|FG004|Overall Study|No treatment, per protocol|0|||
44153385|NCT02659943|78943940|FG005|Overall Study|No treatment, per protocol|0|||
44153386|NCT02659943|78943941|FG006|Overall Study|No treatment, per protocol|3|||
44153387|NCT01677299|78943966|FG000|Overall Study|Adverse Event|0|||
44153388|NCT01677299|78943967|FG001|Overall Study|Adverse Event|2|||
44153389|NCT01677299|78943968|FG002|Overall Study|Adverse Event|1|||
44153390|NCT01677299|78943969|FG003|Overall Study|Adverse Event|0|||
44153391|NCT01677299|78943966|FG000|Overall Study|Withdrawal by Subject|0|||
44153392|NCT01677299|78943967|FG001|Overall Study|Withdrawal by Subject|1|||
44153393|NCT01677299|78943968|FG002|Overall Study|Withdrawal by Subject|0|||
44153394|NCT01677299|78943969|FG003|Overall Study|Withdrawal by Subject|1|||
44153395|NCT01964326|78943983|FG000|Overall Study|Adverse Event|48|||
44153396|NCT01964326|78943983|FG000|Overall Study|Death|2|||
44153397|NCT01964326|78943983|FG000|Overall Study|Protocol Violation|4|||
44153398|NCT01964326|78943983|FG000|Overall Study|Lost to Follow-up|88|||
44153399|NCT01964326|78943983|FG000|Overall Study|Withdrawal by Subject|87|||
44153400|NCT01964326|78943983|FG000|Overall Study|Pregnancy|1|||
44153401|NCT01964326|78943983|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
44153402|NCT01964326|78943983|FG000|Overall Study|Physician Decision|55|||
44153403|NCT01964326|78943983|FG000|Overall Study|Investigator Discretion|1|||
44153404|NCT01964326|78943983|FG000|Overall Study|Other|9|||
44153405|NCT01964326|78943983|FG000|Overall Study|Did not meet eligibility criteria|1|||
44153406|NCT02699749|78944001|FG000|Overall Study|Other|0|||
44153407|NCT02699749|78944002|FG001|Overall Study|Other|0|||
44153408|NCT02699749|78944003|FG002|Overall Study|Other|2|||
44153409|NCT02699749|78944004|FG003|Overall Study|Other|0|||
44153410|NCT02699749|78944005|FG004|Overall Study|Other|0|||
44153411|NCT02699749|78944006|FG005|Overall Study|Other|1|||
44153412|NCT02699749|78944007|FG006|Overall Study|Other|1|||
44153413|NCT02699749|78944008|FG007|Overall Study|Other|0|||
44153414|NCT02699749|78944009|FG008|Overall Study|Other|0|||
44153415|NCT02699749|78944010|FG009|Overall Study|Other|0|||
44153416|NCT02699749|78944011|FG010|Overall Study|Other|1|||
44153417|NCT02699749|78944012|FG011|Overall Study|Other|0|||
44153418|NCT02699749|78944013|FG012|Overall Study|Other|0|||
44153419|NCT02699749|78944014|FG013|Overall Study|Other|0|||
44153420|NCT02699749|78944001|FG000|Overall Study|Progressive Disease|3|||
44153421|NCT02699749|78944002|FG001|Overall Study|Progressive Disease|3|||
44153422|NCT02699749|78944003|FG002|Overall Study|Progressive Disease|14|||
44153423|NCT02699749|78944004|FG003|Overall Study|Progressive Disease|3|||
44153424|NCT02699749|78944005|FG004|Overall Study|Progressive Disease|3|||
44153425|NCT02699749|78944006|FG005|Overall Study|Progressive Disease|7|||
44153426|NCT02699749|78944007|FG006|Overall Study|Progressive Disease|5|||
44153427|NCT02699749|78944008|FG007|Overall Study|Progressive Disease|5|||
44153428|NCT02699749|78944009|FG008|Overall Study|Progressive Disease|6|||
44153429|NCT02699749|78944010|FG009|Overall Study|Progressive Disease|6|||
44153430|NCT02699749|78944011|FG010|Overall Study|Progressive Disease|5|||
44153431|NCT02699749|78944012|FG011|Overall Study|Progressive Disease|4|||
44153432|NCT02699749|78944013|FG012|Overall Study|Progressive Disease|3|||
44153433|NCT02699749|78944014|FG013|Overall Study|Progressive Disease|5|||
44153434|NCT02699749|78944001|FG000|Overall Study|Death|0|||
44153435|NCT02699749|78944002|FG001|Overall Study|Death|0|||
44153436|NCT02699749|78944003|FG002|Overall Study|Death|0|||
44153437|NCT02699749|78944004|FG003|Overall Study|Death|0|||
44153438|NCT02699749|78944005|FG004|Overall Study|Death|0|||
44153439|NCT02699749|78944006|FG005|Overall Study|Death|0|||
44153440|NCT02699749|78944007|FG006|Overall Study|Death|0|||
44153441|NCT02699749|78944008|FG007|Overall Study|Death|0|||
44153442|NCT02699749|78944009|FG008|Overall Study|Death|0|||
44153443|NCT02699749|78944010|FG009|Overall Study|Death|0|||
44255645|NCT02608476|79099205|FG000|Overall Study|Noncompliance with treatment|1|||
44153444|NCT02699749|78944011|FG010|Overall Study|Death|0|||
44153445|NCT02699749|78944012|FG011|Overall Study|Death|0|||
44153446|NCT02699749|78944013|FG012|Overall Study|Death|0|||
44153447|NCT02699749|78944014|FG013|Overall Study|Death|1|||
44153448|NCT02699749|78944001|FG000|Overall Study|Lost to Follow-up|0|||
44153449|NCT02699749|78944002|FG001|Overall Study|Lost to Follow-up|0|||
44153450|NCT02699749|78944003|FG002|Overall Study|Lost to Follow-up|0|||
44153451|NCT02699749|78944004|FG003|Overall Study|Lost to Follow-up|0|||
44153452|NCT02699749|78944005|FG004|Overall Study|Lost to Follow-up|0|||
44153453|NCT02699749|78944006|FG005|Overall Study|Lost to Follow-up|1|||
44153454|NCT02699749|78944007|FG006|Overall Study|Lost to Follow-up|0|||
44153455|NCT02699749|78944008|FG007|Overall Study|Lost to Follow-up|1|||
44153456|NCT02699749|78944009|FG008|Overall Study|Lost to Follow-up|0|||
44153457|NCT02699749|78944010|FG009|Overall Study|Lost to Follow-up|0|||
44153458|NCT02699749|78944011|FG010|Overall Study|Lost to Follow-up|0|||
44153459|NCT02699749|78944012|FG011|Overall Study|Lost to Follow-up|0|||
44153460|NCT02699749|78944013|FG012|Overall Study|Lost to Follow-up|0|||
44153461|NCT02699749|78944014|FG013|Overall Study|Lost to Follow-up|0|||
44153462|NCT02699593|78944044|FG000|Period 1|Unsatisfactory Visual Response|0|||
44153463|NCT02699593|78944045|FG001|Period 1|Unsatisfactory Visual Response|1|||
44153464|NCT02699593|78944044|FG000|Period 1|Torn Contact Len|4|||
44153465|NCT02699593|78944045|FG001|Period 1|Torn Contact Len|3|||
44153466|NCT02699593|78944044|FG000|Period 1|Protocol Violation|0|||
44153467|NCT02699593|78944045|FG001|Period 1|Protocol Violation|1|||
44153468|NCT02699593|78944044|FG000|Period 1|Withdrawal by Subject|0|||
44532501|NCT03358472|79542284|FG001|Overall Study|Withdrawal by Subject|0|||
44532502|NCT03358472|79542285|FG002|Overall Study|Withdrawal by Subject|1|||
44532503|NCT03358472|79542283|FG000|Overall Study|On-going at clinical cut off date|9|||
44532504|NCT03358472|79542284|FG001|Overall Study|On-going at clinical cut off date|6|||
44153469|NCT02699593|78944045|FG001|Period 1|Withdrawal by Subject|1|||
44153470|NCT02699593|78944044|FG000|Period 1|Adverse Event|1|||
44153471|NCT02699593|78944045|FG001|Period 1|Adverse Event|1|||
44153472|NCT02699593|78944044|FG000|Period 2|Adverse Event|1|||
44153473|NCT02699593|78944045|FG001|Period 2|Adverse Event|1|||
44153474|NCT02699593|78944044|FG000|Period 2|Lost Contact Lens|0|||
44153475|NCT02699593|78944045|FG001|Period 2|Lost Contact Lens|1|||
44153476|NCT02699593|78944044|FG000|Period 2|Torn Contact Lens|1|||
44153477|NCT02699593|78944045|FG001|Period 2|Torn Contact Lens|0|||
44153478|NCT00708097|78944051|FG000|Period 1|Protocol Violation|0|||
44153479|NCT00708097|78944052|FG001|Period 1|Protocol Violation|1|||
44153480|NCT00708097|78944053|FG002|Period 1|Protocol Violation|0|||
44153481|NCT00708097|78944054|FG003|Period 1|Protocol Violation|2|||
44153482|NCT00708097|78944055|FG004|Period 1|Protocol Violation|0|||
44153483|NCT00708097|78944051|FG000|Period 1|Other Reason|0|||
44153484|NCT00708097|78944052|FG001|Period 1|Other Reason|0|||
44153485|NCT00708097|78944053|FG002|Period 1|Other Reason|0|||
44153486|NCT00708097|78944054|FG003|Period 1|Other Reason|0|||
44153487|NCT00708097|78944055|FG004|Period 1|Other Reason|1|||
44153488|NCT00708097|78944051|FG000|Period 2|Protocol Violation|0|||
44153489|NCT00708097|78944052|FG001|Period 2|Protocol Violation|1|||
44153490|NCT00708097|78944053|FG002|Period 2|Protocol Violation|1|||
44153491|NCT00708097|78944054|FG003|Period 2|Protocol Violation|1|||
44153492|NCT00708097|78944055|FG004|Period 2|Protocol Violation|0|||
44153493|NCT02659631|78944082|FG000|Overall Study|Lost to Follow-up|0|||
44153494|NCT02659631|78944083|FG001|Overall Study|Lost to Follow-up|0|||
44153495|NCT02659631|78944084|FG002|Overall Study|Lost to Follow-up|2|||
44153496|NCT02659631|78944085|FG003|Overall Study|Lost to Follow-up|0|||
44153497|NCT02659631|78944086|FG004|Overall Study|Lost to Follow-up|0|||
44153498|NCT02659631|78944087|FG005|Overall Study|Lost to Follow-up|1|||
44153499|NCT02659631|78944088|FG006|Overall Study|Lost to Follow-up|0|||
44153500|NCT02659631|78944089|FG007|Overall Study|Lost to Follow-up|0|||
44153501|NCT02659631|78944090|FG008|Overall Study|Lost to Follow-up|0|||
44153502|NCT02659631|78944091|FG009|Overall Study|Lost to Follow-up|0|||
44153503|NCT02659631|78944082|FG000|Overall Study|Withdrawal prior to treatment|0|||
44153504|NCT02659631|78944083|FG001|Overall Study|Withdrawal prior to treatment|0|||
44153505|NCT02659631|78944084|FG002|Overall Study|Withdrawal prior to treatment|0|||
44532505|NCT03358472|79542285|FG002|Overall Study|On-going at clinical cut off date|5|||
44153506|NCT02659631|78944085|FG003|Overall Study|Withdrawal prior to treatment|0|||
44153507|NCT02659631|78944086|FG004|Overall Study|Withdrawal prior to treatment|1|||
44153508|NCT02659631|78944087|FG005|Overall Study|Withdrawal prior to treatment|0|||
44153509|NCT02659631|78944088|FG006|Overall Study|Withdrawal prior to treatment|0|||
44153510|NCT02659631|78944089|FG007|Overall Study|Withdrawal prior to treatment|0|||
44153511|NCT02659631|78944090|FG008|Overall Study|Withdrawal prior to treatment|0|||
44153512|NCT02659631|78944091|FG009|Overall Study|Withdrawal prior to treatment|0|||
44153513|NCT02659631|78944082|FG000|Overall Study|Participant refused further follow-up|0|||
44153514|NCT02659631|78944083|FG001|Overall Study|Participant refused further follow-up|0|||
44153515|NCT02659631|78944084|FG002|Overall Study|Participant refused further follow-up|0|||
44153516|NCT02659631|78944085|FG003|Overall Study|Participant refused further follow-up|1|||
44153517|NCT02659631|78944086|FG004|Overall Study|Participant refused further follow-up|0|||
44153518|NCT02659631|78944087|FG005|Overall Study|Participant refused further follow-up|0|||
44153519|NCT02659631|78944088|FG006|Overall Study|Participant refused further follow-up|0|||
44532506|NCT03099382|79542310|FG000|Overall Study|Protocol Violation|2|||
44532507|NCT03099382|79542311|FG001|Overall Study|Protocol Violation|3|||
44153520|NCT02659631|78944089|FG007|Overall Study|Participant refused further follow-up|0|||
44153521|NCT02659631|78944090|FG008|Overall Study|Participant refused further follow-up|1|||
44153522|NCT02659631|78944091|FG009|Overall Study|Participant refused further follow-up|0|||
44153523|NCT02659631|78944082|FG000|Overall Study|Death (follow-up phase)|1|||
44153524|NCT02659631|78944083|FG001|Overall Study|Death (follow-up phase)|2|||
44153525|NCT02659631|78944084|FG002|Overall Study|Death (follow-up phase)|1|||
44153526|NCT02659631|78944085|FG003|Overall Study|Death (follow-up phase)|1|||
44153527|NCT02659631|78944086|FG004|Overall Study|Death (follow-up phase)|3|||
44153528|NCT02659631|78944087|FG005|Overall Study|Death (follow-up phase)|2|||
44153529|NCT02659631|78944088|FG006|Overall Study|Death (follow-up phase)|0|||
44153530|NCT02659631|78944089|FG007|Overall Study|Death (follow-up phase)|3|||
44153531|NCT02659631|78944090|FG008|Overall Study|Death (follow-up phase)|1|||
44153532|NCT02659631|78944091|FG009|Overall Study|Death (follow-up phase)|0|||
44153533|NCT02659631|78944082|FG000|Overall Study|Death (treatment phase)|0|||
44153534|NCT02659631|78944083|FG001|Overall Study|Death (treatment phase)|0|||
44153535|NCT02659631|78944084|FG002|Overall Study|Death (treatment phase)|0|||
44153536|NCT02659631|78944085|FG003|Overall Study|Death (treatment phase)|0|||
44153537|NCT02659631|78944086|FG004|Overall Study|Death (treatment phase)|1|||
44153538|NCT02659631|78944087|FG005|Overall Study|Death (treatment phase)|0|||
44153539|NCT02659631|78944088|FG006|Overall Study|Death (treatment phase)|1|||
44153540|NCT02659631|78944089|FG007|Overall Study|Death (treatment phase)|0|||
44153541|NCT02659631|78944090|FG008|Overall Study|Death (treatment phase)|0|||
44153542|NCT02659631|78944091|FG009|Overall Study|Death (treatment phase)|0|||
44153543|NCT02699125|78944115|FG000|Placebo|Lost to Follow-up|2|||
44153544|NCT02699125|78944116|FG001|Placebo|Lost to Follow-up|0|||
44153545|NCT02699125|78944115|FG000|Placebo|Protocol Violation|1|||
44153546|NCT02699125|78944116|FG001|Placebo|Protocol Violation|0|||
44153547|NCT02699125|78944115|FG000|Placebo|Withdrawal by Subject|0|||
44153548|NCT02699125|78944116|FG001|Placebo|Withdrawal by Subject|4|||
44153549|NCT02699125|78944115|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
44153550|NCT02699125|78944116|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
44283468|NCT01792830|79246817|FG010|Overall Study|Withdrawal by Subject|2|||
44283469|NCT01792830|79246807|FG000|Overall Study|Death|3|||
44283470|NCT01792830|79246808|FG001|Overall Study|Death|0|||
44283471|NCT01792830|79246809|FG002|Overall Study|Death|0|||
44283472|NCT01792830|79246810|FG003|Overall Study|Death|1|||
44283473|NCT01792830|79246811|FG004|Overall Study|Death|0|||
44283474|NCT01792830|79246812|FG005|Overall Study|Death|0|||
44283475|NCT01792830|79246813|FG006|Overall Study|Death|1|||
44283476|NCT01792830|79246814|FG007|Overall Study|Death|0|||
44283477|NCT01792830|79246815|FG008|Overall Study|Death|1|||
44283478|NCT01792830|79246816|FG009|Overall Study|Death|0|||
44283479|NCT01792830|79246817|FG010|Overall Study|Death|1|||
44283480|NCT01792830|79246807|FG000|Overall Study|Adverse Event|0|||
44283481|NCT01792830|79246808|FG001|Overall Study|Adverse Event|0|||
44283482|NCT01792830|79246809|FG002|Overall Study|Adverse Event|0|||
44283483|NCT01792830|79246810|FG003|Overall Study|Adverse Event|0|||
44283484|NCT01792830|79246811|FG004|Overall Study|Adverse Event|0|||
44283485|NCT01792830|79246812|FG005|Overall Study|Adverse Event|0|||
44283486|NCT01792830|79246813|FG006|Overall Study|Adverse Event|0|||
44283487|NCT01792830|79246814|FG007|Overall Study|Adverse Event|0|||
44283488|NCT01792830|79246815|FG008|Overall Study|Adverse Event|1|||
44153551|NCT02698891|78944126|FG000|Overall Study|Withdrawal by Subject|2|||
44153552|NCT02698891|78944126|FG000|Overall Study|deemed ineligible|1|||
44153553|NCT02698891|78944126|FG000|Overall Study|Adverse Event|9|||
44153554|NCT02698423|78944132|FG000|Overall Study|Lost to Follow-up|19|||
44153555|NCT02698423|78944133|FG001|Overall Study|Lost to Follow-up|24|||
44283489|NCT01792830|79246816|FG009|Overall Study|Adverse Event|0|||
44283490|NCT01792830|79246817|FG010|Overall Study|Adverse Event|0|||
44153556|NCT02700997|78944141|FG000|Overall Study|Did not undergo CT imaging|1|||
44153557|NCT02700997|78944141|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
44153558|NCT02658149|78944147|FG000|Overall Study|Physician Decision|1|||
44153559|NCT02658149|78944148|FG001|Overall Study|Physician Decision|0|||
44153560|NCT02698189|78944156|FG000|Overall Study|Physician Decision|3|||
44153561|NCT02698189|78944157|FG001|Overall Study|Physician Decision|0|||
44153562|NCT02698189|78944156|FG000|Overall Study|Progressive disease|0|||
44153563|NCT02698189|78944157|FG001|Overall Study|Progressive disease|5|||
44153564|NCT02698189|78944156|FG000|Overall Study|Study terminated by sponsor|0|||
44153565|NCT02698189|78944157|FG001|Overall Study|Study terminated by sponsor|1|||
44153566|NCT02702011|78944169|FG000|Overall Study|Withdrawal by Subject|0|||
44153567|NCT02702011|78944170|FG001|Overall Study|Withdrawal by Subject|1|||
44153568|NCT02702011|78944171|FG002|Overall Study|Withdrawal by Subject|0|||
44153569|NCT02702011|78944172|FG003|Overall Study|Withdrawal by Subject|0|||
44153570|NCT02657369|78944182|FG000|Overall Study|Death|27|||
44153571|NCT02657369|78944182|FG000|Overall Study|Study terminated by sponsor|7|||
44153572|NCT02701777|78944190|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
44283491|NCT01792518|79246849|FG000|Overall Study|Adverse Event|3|||
44153573|NCT02701777|78944191|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
44153574|NCT02701777|78944192|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
44153575|NCT02701777|78944193|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
44153576|NCT02701777|78944190|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
44153577|NCT02701777|78944191|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
44153578|NCT02701777|78944192|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
44153579|NCT02701777|78944193|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
44153580|NCT04604015|78944207|FG000|Overall Study|Incomplete Data Collection|33|||
44153581|NCT01675661|78944223|FG000|Overall Study|Lost to Follow-up|22|||
44153582|NCT01675661|78944224|FG001|Overall Study|Lost to Follow-up|23|||
44153583|NCT01675661|78944223|FG000|Overall Study|Practical problems|9|||
44153584|NCT01675661|78944224|FG001|Overall Study|Practical problems|5|||
44153585|NCT01675661|78944223|FG000|Overall Study|Moved away|5|||
44153586|NCT01675661|78944224|FG001|Overall Study|Moved away|6|||
44153587|NCT01675661|78944223|FG000|Overall Study|Withdrawal by Subject|3|||
44153588|NCT01675661|78944224|FG001|Overall Study|Withdrawal by Subject|7|||
44153589|NCT01675661|78944223|FG000|Overall Study|Physician Decision|0|||
44153590|NCT01675661|78944224|FG001|Overall Study|Physician Decision|2|||
44153591|NCT01675661|78944223|FG000|Overall Study|Death|0|||
44153592|NCT01675661|78944224|FG001|Overall Study|Death|1|||
44153593|NCT01675661|78944223|FG000|Overall Study|Other reason|1|||
44153594|NCT01675661|78944224|FG001|Overall Study|Other reason|2|||
44153595|NCT01602341|78944232|FG000|Overall Study|Adverse Event|0|||
44153596|NCT01602341|78944233|FG001|Overall Study|Adverse Event|1|||
44153597|NCT02700919|78944246|FG000|Overall Study|Physician Decision|1|||
44153598|NCT02700919|78944247|FG001|Overall Study|Physician Decision|0|||
44153599|NCT02700919|78944248|FG002|Overall Study|Physician Decision|0|||
44153600|NCT02700919|78944246|FG000|Overall Study|Protocol Violation|1|||
44153601|NCT02700919|78944247|FG001|Overall Study|Protocol Violation|0|||
44153602|NCT02700919|78944248|FG002|Overall Study|Protocol Violation|0|||
44153603|NCT02700919|78944246|FG000|Overall Study|Adverse Event|1|||
44153604|NCT02700919|78944247|FG001|Overall Study|Adverse Event|3|||
44153605|NCT02700919|78944248|FG002|Overall Study|Adverse Event|1|||
44153606|NCT02700919|78944246|FG000|Overall Study|Withdrawal by Subject|5|||
44532508|NCT02939287|79542320|FG000|Overall Study|met exclusion criteria|1|||
44283492|NCT01792518|79246850|FG001|Overall Study|Adverse Event|4|||
44283493|NCT01792518|79246849|FG000|Overall Study|Protocol Violation|0|||
44532509|NCT02939287|79542321|FG001|Overall Study|met exclusion criteria|1|||
44532510|NCT02939287|79542322|FG002|Overall Study|met exclusion criteria|1|||
44532511|NCT02939287|79542320|FG000|Overall Study|Did not complete survey|2|||
44532512|NCT02939287|79542321|FG001|Overall Study|Did not complete survey|2|||
44532513|NCT02939287|79542322|FG002|Overall Study|Did not complete survey|0|||
44532514|NCT02939287|79542320|FG000|Overall Study|Withdrawal by Subject|1|||
44532515|NCT02939287|79542321|FG001|Overall Study|Withdrawal by Subject|1|||
44153607|NCT02700919|78944247|FG001|Overall Study|Withdrawal by Subject|8|||
44153608|NCT02700919|78944248|FG002|Overall Study|Withdrawal by Subject|2|||
44153609|NCT02700919|78944246|FG000|Overall Study|Lost to Follow-up|2|||
44153610|NCT02700919|78944247|FG001|Overall Study|Lost to Follow-up|0|||
44153611|NCT02700919|78944248|FG002|Overall Study|Lost to Follow-up|0|||
44153612|NCT02700919|78944246|FG000|Overall Study|Other|2|||
44283494|NCT01792518|79246850|FG001|Overall Study|Protocol Violation|1|||
44283495|NCT01792518|79246849|FG000|Overall Study|Lost to Follow-up|3|||
44283496|NCT01792518|79246850|FG001|Overall Study|Lost to Follow-up|1|||
44283497|NCT01792518|79246849|FG000|Overall Study|Withdrawal by Subject|2|||
44415472|NCT00626392|79423258|FG001|Run-in Period|Withdrawal by Subject|1|||
44532516|NCT02939287|79542322|FG002|Overall Study|Withdrawal by Subject|0|||
44532517|NCT02771275|79542347|FG000|Overall Study|Reoperation|3|||
44532518|NCT02771275|79542347|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
44532519|NCT02564900|79542375|FG000|Dose Escalation|Progressive disease per RECIST|2|||
44532520|NCT02564900|79542376|FG001|Dose Escalation|Progressive disease per RECIST|3|||
44532521|NCT02564900|79542377|FG002|Dose Escalation|Progressive disease per RECIST|3|||
44532522|NCT02564900|79542378|FG003|Dose Escalation|Progressive disease per RECIST|3|||
44532523|NCT02564900|79542379|FG004|Dose Escalation|Progressive disease per RECIST|3|||
44532524|NCT02564900|79542380|FG005|Dose Escalation|Progressive disease per RECIST|1|||
44532525|NCT02564900|79542381|FG006|Dose Escalation|Progressive disease per RECIST|0|||
44532526|NCT02564900|79542382|FG007|Dose Escalation|Progressive disease per RECIST|0|||
44283498|NCT01792518|79246850|FG001|Overall Study|Withdrawal by Subject|0|||
44532527|NCT02564900|79542383|FG008|Dose Escalation|Progressive disease per RECIST|0|||
44532528|NCT02564900|79542384|FG009|Dose Escalation|Progressive disease per RECIST|0|||
44532529|NCT02564900|79542385|FG010|Dose Escalation|Progressive disease per RECIST|0|||
44532530|NCT02564900|79542386|FG011|Dose Escalation|Progressive disease per RECIST|0|||
44153613|NCT02700919|78944247|FG001|Overall Study|Other|1|||
44153614|NCT02700919|78944248|FG002|Overall Study|Other|1|||
44153615|NCT01986010|78944273|FG000|Overall Study|Adverse Event|0|||
44153616|NCT01986010|78944274|FG001|Overall Study|Adverse Event|1|||
44153617|NCT01986010|78944275|FG002|Overall Study|Adverse Event|0|||
44153618|NCT01986010|78944276|FG003|Overall Study|Adverse Event|0|||
44283499|NCT01792518|79246849|FG000|Overall Study|Other Reason|0|||
44283500|NCT01792518|79246850|FG001|Overall Study|Other Reason|1|||
44283501|NCT01792284|79246856|FG000|Lead-in Period|Adverse Event|15|||
44283502|NCT01792284|79246857|FG001|Lead-in Period|Adverse Event|0|||
44153619|NCT01986010|78944277|FG004|Overall Study|Adverse Event|0|||
44153620|NCT01986010|78944278|FG005|Overall Study|Adverse Event|0|||
44153621|NCT01986010|78944279|FG006|Overall Study|Adverse Event|0|||
44153622|NCT01986010|78944280|FG007|Overall Study|Adverse Event|0|||
44153623|NCT01986010|78944281|FG008|Overall Study|Adverse Event|0|||
44153624|NCT01986010|78944282|FG009|Overall Study|Adverse Event|0|||
44153625|NCT01986010|78944283|FG010|Overall Study|Adverse Event|0|||
44153626|NCT01986010|78944284|FG011|Overall Study|Adverse Event|0|||
44153627|NCT01986010|78944285|FG012|Overall Study|Adverse Event|0|||
44153628|NCT01986010|78944286|FG013|Overall Study|Adverse Event|0|||
44153629|NCT01986010|78944287|FG014|Overall Study|Adverse Event|0|||
44153630|NCT01986010|78944288|FG015|Overall Study|Adverse Event|1|||
44153631|NCT01986010|78944289|FG016|Overall Study|Adverse Event|0|||
44153632|NCT01986010|78944273|FG000|Overall Study|Lost to Follow-up|2|||
44153633|NCT01986010|78944274|FG001|Overall Study|Lost to Follow-up|1|||
44153634|NCT01986010|78944275|FG002|Overall Study|Lost to Follow-up|2|||
44153635|NCT01986010|78944276|FG003|Overall Study|Lost to Follow-up|2|||
44153636|NCT01986010|78944277|FG004|Overall Study|Lost to Follow-up|2|||
44153637|NCT01986010|78944278|FG005|Overall Study|Lost to Follow-up|2|||
44153638|NCT01986010|78944279|FG006|Overall Study|Lost to Follow-up|0|||
44153639|NCT01986010|78944280|FG007|Overall Study|Lost to Follow-up|0|||
44153640|NCT01986010|78944281|FG008|Overall Study|Lost to Follow-up|4|||
44153641|NCT01986010|78944282|FG009|Overall Study|Lost to Follow-up|2|||
44153642|NCT01986010|78944283|FG010|Overall Study|Lost to Follow-up|0|||
44153643|NCT01986010|78944284|FG011|Overall Study|Lost to Follow-up|1|||
44153644|NCT01986010|78944285|FG012|Overall Study|Lost to Follow-up|1|||
44153645|NCT01986010|78944286|FG013|Overall Study|Lost to Follow-up|1|||
44153646|NCT01986010|78944287|FG014|Overall Study|Lost to Follow-up|2|||
44153647|NCT01986010|78944288|FG015|Overall Study|Lost to Follow-up|0|||
44153648|NCT01986010|78944289|FG016|Overall Study|Lost to Follow-up|0|||
44153649|NCT01986010|78944273|FG000|Overall Study|Physician Decision|0|||
44153650|NCT01986010|78944274|FG001|Overall Study|Physician Decision|0|||
44153651|NCT01986010|78944275|FG002|Overall Study|Physician Decision|0|||
44153652|NCT01986010|78944276|FG003|Overall Study|Physician Decision|0|||
44153653|NCT01986010|78944277|FG004|Overall Study|Physician Decision|0|||
44153654|NCT01986010|78944278|FG005|Overall Study|Physician Decision|0|||
44153655|NCT01986010|78944279|FG006|Overall Study|Physician Decision|0|||
44153656|NCT01986010|78944280|FG007|Overall Study|Physician Decision|0|||
44153657|NCT01986010|78944281|FG008|Overall Study|Physician Decision|0|||
44153658|NCT01986010|78944282|FG009|Overall Study|Physician Decision|0|||
44283503|NCT01792284|79246858|FG002|Lead-in Period|Adverse Event|0|||
44283504|NCT01792284|79246856|FG000|Lead-in Period|Lost to Follow-up|2|||
44283505|NCT01792284|79246857|FG001|Lead-in Period|Lost to Follow-up|0|||
44283506|NCT01792284|79246858|FG002|Lead-in Period|Lost to Follow-up|0|||
44283507|NCT01792284|79246856|FG000|Lead-in Period|Protocol Violation|1|||
44283508|NCT01792284|79246857|FG001|Lead-in Period|Protocol Violation|0|||
44283509|NCT01792284|79246858|FG002|Lead-in Period|Protocol Violation|0|||
44283510|NCT01792284|79246856|FG000|Lead-in Period|Withdrawal by Subject|10|||
44283511|NCT01792284|79246857|FG001|Lead-in Period|Withdrawal by Subject|0|||
44283512|NCT01792284|79246858|FG002|Lead-in Period|Withdrawal by Subject|0|||
44283513|NCT01792284|79246856|FG000|Lead-in Period|Physician Decision|1|||
44153659|NCT01986010|78944283|FG010|Overall Study|Physician Decision|0|||
44153660|NCT01986010|78944284|FG011|Overall Study|Physician Decision|0|||
44153661|NCT01986010|78944285|FG012|Overall Study|Physician Decision|0|||
44153662|NCT01986010|78944286|FG013|Overall Study|Physician Decision|0|||
44153663|NCT01986010|78944287|FG014|Overall Study|Physician Decision|1|||
44153664|NCT01986010|78944288|FG015|Overall Study|Physician Decision|0|||
44153665|NCT01986010|78944289|FG016|Overall Study|Physician Decision|0|||
44153666|NCT01986010|78944273|FG000|Overall Study|Withdrawal by Subject|2|||
44153667|NCT01986010|78944274|FG001|Overall Study|Withdrawal by Subject|2|||
44283514|NCT01792284|79246857|FG001|Lead-in Period|Physician Decision|0|||
44153668|NCT01986010|78944275|FG002|Overall Study|Withdrawal by Subject|3|||
44153669|NCT01986010|78944276|FG003|Overall Study|Withdrawal by Subject|0|||
44153670|NCT01986010|78944277|FG004|Overall Study|Withdrawal by Subject|2|||
44153671|NCT01986010|78944278|FG005|Overall Study|Withdrawal by Subject|4|||
44153672|NCT01986010|78944279|FG006|Overall Study|Withdrawal by Subject|0|||
44153673|NCT01986010|78944280|FG007|Overall Study|Withdrawal by Subject|0|||
44153674|NCT01986010|78944281|FG008|Overall Study|Withdrawal by Subject|0|||
44153675|NCT01986010|78944282|FG009|Overall Study|Withdrawal by Subject|0|||
44153676|NCT01986010|78944283|FG010|Overall Study|Withdrawal by Subject|0|||
44153677|NCT01986010|78944284|FG011|Overall Study|Withdrawal by Subject|2|||
44153678|NCT01986010|78944285|FG012|Overall Study|Withdrawal by Subject|0|||
44153679|NCT01986010|78944286|FG013|Overall Study|Withdrawal by Subject|1|||
44153680|NCT01986010|78944287|FG014|Overall Study|Withdrawal by Subject|2|||
44153681|NCT01986010|78944288|FG015|Overall Study|Withdrawal by Subject|0|||
44153682|NCT01986010|78944289|FG016|Overall Study|Withdrawal by Subject|0|||
44153683|NCT01986010|78944273|FG000|Overall Study|Status Not Recorded|2|||
44153684|NCT01986010|78944274|FG001|Overall Study|Status Not Recorded|4|||
44153685|NCT01986010|78944275|FG002|Overall Study|Status Not Recorded|2|||
44153686|NCT01986010|78944276|FG003|Overall Study|Status Not Recorded|0|||
44153687|NCT01986010|78944277|FG004|Overall Study|Status Not Recorded|1|||
44153688|NCT01986010|78944278|FG005|Overall Study|Status Not Recorded|2|||
44153689|NCT01986010|78944279|FG006|Overall Study|Status Not Recorded|0|||
44153690|NCT01986010|78944280|FG007|Overall Study|Status Not Recorded|0|||
44153691|NCT01986010|78944281|FG008|Overall Study|Status Not Recorded|2|||
44153692|NCT01986010|78944282|FG009|Overall Study|Status Not Recorded|1|||
44153693|NCT01986010|78944283|FG010|Overall Study|Status Not Recorded|7|||
44153694|NCT01986010|78944284|FG011|Overall Study|Status Not Recorded|7|||
44153695|NCT01986010|78944285|FG012|Overall Study|Status Not Recorded|9|||
44153696|NCT01986010|78944286|FG013|Overall Study|Status Not Recorded|9|||
44153697|NCT01986010|78944287|FG014|Overall Study|Status Not Recorded|5|||
44153698|NCT01986010|78944288|FG015|Overall Study|Status Not Recorded|10|||
44153699|NCT01986010|78944289|FG016|Overall Study|Status Not Recorded|4|||
44153700|NCT01963780|78944335|FG000|Overall Study|Death|7|||
44153701|NCT02009878|78944342|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
44153702|NCT02009878|78944343|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
44153703|NCT02009878|78944344|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
44283515|NCT01792284|79246858|FG002|Lead-in Period|Physician Decision|0|||
44283516|NCT01792284|79246856|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
44283517|NCT01792284|79246857|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
44283518|NCT01792284|79246858|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
44283519|NCT01792284|79246856|FG000|Randomization Period 1|Withdrawal by Subject|0|||
44283520|NCT01792284|79246857|FG001|Randomization Period 1|Withdrawal by Subject|1|||
44283521|NCT01792284|79246858|FG002|Randomization Period 1|Withdrawal by Subject|1|||
44283522|NCT01792284|79246856|FG000|Randomization Period 1|Physician Decision|0|||
44283523|NCT01792284|79246857|FG001|Randomization Period 1|Physician Decision|1|||
44283524|NCT01792284|79246858|FG002|Randomization Period 1|Physician Decision|1|||
44283525|NCT01792284|79246856|FG000|Randomization Period 1|Adverse Event|0|||
44283526|NCT01792284|79246857|FG001|Randomization Period 1|Adverse Event|0|||
44283527|NCT01792284|79246858|FG002|Randomization Period 1|Adverse Event|2|||
44283528|NCT01792284|79246856|FG000|Randomization Period 1|Lost to Follow-up|0|||
44283529|NCT01792284|79246857|FG001|Randomization Period 1|Lost to Follow-up|0|||
44283530|NCT01792284|79246858|FG002|Randomization Period 1|Lost to Follow-up|1|||
44283531|NCT01792284|79246856|FG000|Randomization Period 2|Protocol Violation|0|||
44283532|NCT01792284|79246857|FG001|Randomization Period 2|Protocol Violation|1|||
44283533|NCT01792284|79246858|FG002|Randomization Period 2|Protocol Violation|0|||
44283534|NCT01792284|79246856|FG000|Randomization Period 2|Withdrawal by Subject|0|||
44283535|NCT01792284|79246857|FG001|Randomization Period 2|Withdrawal by Subject|2|||
44283536|NCT01792284|79246858|FG002|Randomization Period 2|Withdrawal by Subject|0|||
44283537|NCT01791894|79246866|FG000|Overall Study|Adverse Event|1|||
44283538|NCT01837680|79246873|FG000|Overall Study|Lost to Follow-up|2|||
44283539|NCT01837680|79246874|FG001|Overall Study|Lost to Follow-up|2|||
44283540|NCT01837680|79246873|FG000|Overall Study|lack of insurance|0|||
44283541|NCT01837680|79246874|FG001|Overall Study|lack of insurance|2|||
44283542|NCT01837680|79246873|FG000|Overall Study|allergic reaction|6|||
44283543|NCT01837680|79246874|FG001|Overall Study|allergic reaction|0|||
44283544|NCT01837680|79246873|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
44283545|NCT01837680|79246874|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
44153704|NCT02009722|78944354|FG000|Overall Study|Protocol Violation|1|||
44283546|NCT01836276|79246882|FG000|Overall Study|Lost to Follow-up|28|||
44283547|NCT01836276|79246883|FG001|Overall Study|Lost to Follow-up|51|||
44153705|NCT02009722|78944355|FG001|Overall Study|Protocol Violation|2|||
44153706|NCT02009722|78944354|FG000|Overall Study|Did not receive intervention|0|||
44153707|NCT02009722|78944355|FG001|Overall Study|Did not receive intervention|1|||
44153708|NCT02655419|78944363|FG000|Overall Study|Enrolled but not treated|1|||
44153709|NCT02655419|78944364|FG001|Overall Study|Enrolled but not treated|5|||
44153710|NCT02655419|78944363|FG000|Overall Study|Withdrawal by Subject|4|||
44153711|NCT02655419|78944364|FG001|Overall Study|Withdrawal by Subject|1|||
44153712|NCT02655419|78944363|FG000|Overall Study|Other|0|||
44153713|NCT02655419|78944364|FG001|Overall Study|Other|1|||
44153714|NCT01962922|78944376|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
44153715|NCT01962922|78944377|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
44153716|NCT01962922|78944376|FG000|PK Portion Day 7|non-compliance|1|||
44283548|NCT01790568|79246889|FG000|Overall Study|Progression prior to transplant|0|||
44283549|NCT01790568|79246890|FG001|Overall Study|Progression prior to transplant|1|||
44283550|NCT01610076|79246896|FG000|Overall Study|Technical issue with video|0|||
44283551|NCT01610076|79246897|FG001|Overall Study|Technical issue with video|1|||
44283552|NCT01610076|79246896|FG000|Overall Study|Lost to Follow-up|3|||
44283553|NCT01610076|79246897|FG001|Overall Study|Lost to Follow-up|4|||
44283554|NCT01836198|79246906|FG000|Part A, Period 2|Protocol Violation|0|||
44283555|NCT01836198|79246907|FG001|Part A, Period 2|Protocol Violation|1|||
44283556|NCT01836198|79246908|FG002|Part A, Period 2|Protocol Violation|0|||
44283557|NCT01816074|79246928|FG000|Phase 1|Time commitment issues|0|||
44283558|NCT01816074|79246929|FG001|Phase 1|Time commitment issues|0|||
44283559|NCT01816074|79246930|FG002|Phase 1|Time commitment issues|1|||
44283560|NCT01816074|79246931|FG003|Phase 1|Time commitment issues|0|||
44283561|NCT01816074|79246928|FG000|Phase 2|Time commitment Issues|0|||
44283562|NCT01816074|79246929|FG001|Phase 2|Time commitment Issues|2|||
44283563|NCT01816074|79246930|FG002|Phase 2|Time commitment Issues|0|||
44283564|NCT01816074|79246931|FG003|Phase 2|Time commitment Issues|0|||
44283565|NCT01816074|79246928|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
44283566|NCT01816074|79246929|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
44283567|NCT01816074|79246930|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
44283568|NCT01816074|79246931|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
44283569|NCT01816074|79246928|FG000|Phase 2|Physician Decision|0|||
44283570|NCT01816074|79246929|FG001|Phase 2|Physician Decision|0|||
44283571|NCT01816074|79246930|FG002|Phase 2|Physician Decision|0|||
44283572|NCT01816074|79246931|FG003|Phase 2|Physician Decision|1|||
44283573|NCT01816074|79246928|FG000|Phase 2|Withdrawal by Subject|1|||
44283574|NCT01816074|79246929|FG001|Phase 2|Withdrawal by Subject|0|||
44283575|NCT01816074|79246930|FG002|Phase 2|Withdrawal by Subject|0|||
44283576|NCT01816074|79246931|FG003|Phase 2|Withdrawal by Subject|0|||
44283577|NCT01815918|79246957|FG000|Overall Study|Patient samples not analyzable|3|||
44283578|NCT01815918|79246958|FG001|Overall Study|Patient samples not analyzable|4|||
44283579|NCT01815918|79246957|FG000|Overall Study|Lack of Efficacy|15|||
44283580|NCT01815918|79246958|FG001|Overall Study|Lack of Efficacy|15|||
44532531|NCT02564900|79542387|FG012|Dose Escalation|Progressive disease per RECIST|0|||
44532532|NCT02564900|79542388|FG013|Dose Escalation|Progressive disease per RECIST|0|||
44532533|NCT02564900|79542389|FG014|Dose Escalation|Progressive disease per RECIST|0|||
44532534|NCT02564900|79542375|FG000|Dose Escalation|Ongoing|1|||
44532535|NCT02564900|79542376|FG001|Dose Escalation|Ongoing|0|||
44532536|NCT02564900|79542377|FG002|Dose Escalation|Ongoing|0|||
44532537|NCT02564900|79542378|FG003|Dose Escalation|Ongoing|2|||
44153717|NCT01962922|78944377|FG001|PK Portion Day 7|non-compliance|0|||
44153718|NCT01962922|78944376|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
44283581|NCT01789476|79246970|FG000|Overall Study|Lack of Efficacy|6|||
44283582|NCT01789476|79246971|FG001|Overall Study|Lack of Efficacy|2|||
44283583|NCT01789476|79246970|FG000|Overall Study|Adverse Event|1|||
44283584|NCT01789476|79246971|FG001|Overall Study|Adverse Event|0|||
44283585|NCT01789476|79246970|FG000|Overall Study|Unable to get IV access|1|||
44283586|NCT01789476|79246971|FG001|Overall Study|Unable to get IV access|0|||
44283587|NCT01789320|79246977|FG000|Overall Study|Re-enrolled into study|1|||
44283588|NCT01789320|79246977|FG000|Overall Study|Lost to Follow-up|1|||
44283589|NCT01815840|79246983|FG000|Overall Study|Missing|1|||
44283590|NCT01815840|79246984|FG001|Overall Study|Missing|0|||
44283591|NCT01815840|79246983|FG000|Overall Study|Withdrew Consent|31|||
44283592|NCT01815840|79246984|FG001|Overall Study|Withdrew Consent|30|||
44283593|NCT01815840|79246983|FG000|Overall Study|Administrative/Other|1|||
44283594|NCT01815840|79246984|FG001|Overall Study|Administrative/Other|3|||
44283595|NCT01815840|79246983|FG000|Overall Study|Adverse Event|10|||
44283596|NCT01815840|79246984|FG001|Overall Study|Adverse Event|16|||
44283597|NCT01815840|79246983|FG000|Overall Study|Death|2|||
44283598|NCT01815840|79246984|FG001|Overall Study|Death|2|||
44283599|NCT01815840|79246983|FG000|Overall Study|Disease progression|3|||
44283600|NCT01815840|79246984|FG001|Overall Study|Disease progression|2|||
44283601|NCT01815840|79246983|FG000|Overall Study|Investigators Decision|2|||
44532538|NCT02564900|79542379|FG004|Dose Escalation|Ongoing|2|||
44532539|NCT02564900|79542380|FG005|Dose Escalation|Ongoing|2|||
44532540|NCT02564900|79542381|FG006|Dose Escalation|Ongoing|0|||
44532541|NCT02564900|79542382|FG007|Dose Escalation|Ongoing|0|||
44153719|NCT01962922|78944377|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
44153720|NCT01962922|78944376|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
44283602|NCT01815840|79246984|FG001|Overall Study|Investigators Decision|3|||
44283603|NCT01815840|79246983|FG000|Overall Study|Lost to Follow-up|3|||
44532542|NCT02564900|79542383|FG008|Dose Escalation|Ongoing|0|||
44153721|NCT01962922|78944377|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
44153722|NCT01984684|78944385|FG000|Overall Study|Lost to Follow-up|25|||
44153723|NCT01984684|78944386|FG001|Overall Study|Lost to Follow-up|24|||
44153724|NCT01984684|78944385|FG000|Overall Study|Adverse Event|8|||
44153725|NCT01984684|78944386|FG001|Overall Study|Adverse Event|12|||
44153726|NCT01984684|78944385|FG000|Overall Study|Withdrawal by Subject|9|||
44532543|NCT02564900|79542384|FG009|Dose Escalation|Ongoing|0|||
44153727|NCT01984684|78944386|FG001|Overall Study|Withdrawal by Subject|9|||
44153728|NCT01984684|78944385|FG000|Overall Study|Lack of Efficacy|3|||
44153729|NCT01984684|78944386|FG001|Overall Study|Lack of Efficacy|6|||
44153730|NCT01984684|78944385|FG000|Overall Study|Physician Decision|4|||
44153731|NCT01984684|78944386|FG001|Overall Study|Physician Decision|2|||
44153732|NCT01984684|78944385|FG000|Overall Study|Protocol Violation|4|||
44153733|NCT01984684|78944386|FG001|Overall Study|Protocol Violation|2|||
44153734|NCT01984684|78944385|FG000|Overall Study|Death|0|||
44153735|NCT01984684|78944386|FG001|Overall Study|Death|1|||
44153736|NCT01984684|78944385|FG000|Overall Study|Noncompliance with study drug|2|||
44153737|NCT01984684|78944386|FG001|Overall Study|Noncompliance with study drug|1|||
44153738|NCT01984684|78944385|FG000|Overall Study|Subject incarcerated|1|||
44153739|NCT01984684|78944386|FG001|Overall Study|Subject incarcerated|0|||
44153740|NCT01984684|78944385|FG000|Overall Study|Study drug not available at site|1|||
44153741|NCT01984684|78944386|FG001|Overall Study|Study drug not available at site|1|||
44153742|NCT01984684|78944385|FG000|Overall Study|Subject had inadequate IV access|0|||
44153743|NCT01984684|78944386|FG001|Overall Study|Subject had inadequate IV access|1|||
44153744|NCT02694523|78944394|FG000|Part A|Adverse Event|7|||
44153745|NCT02694523|78944395|FG001|Part A|Adverse Event|3|||
44153746|NCT02694523|78944396|FG002|Part A|Adverse Event|0|||
44153747|NCT02694523|78944397|FG003|Part A|Adverse Event|0|||
44153748|NCT02694523|78944398|FG004|Part A|Adverse Event|0|||
44153749|NCT02694523|78944399|FG005|Part A|Adverse Event|0|||
44153750|NCT02694523|78944400|FG006|Part A|Adverse Event|0|||
44153751|NCT02694523|78944394|FG000|Part A|Protocol Violation|1|||
44153752|NCT02694523|78944395|FG001|Part A|Protocol Violation|0|||
44153753|NCT02694523|78944396|FG002|Part A|Protocol Violation|0|||
44153754|NCT02694523|78944397|FG003|Part A|Protocol Violation|0|||
44153755|NCT02694523|78944398|FG004|Part A|Protocol Violation|0|||
44153756|NCT02694523|78944399|FG005|Part A|Protocol Violation|0|||
44153757|NCT02694523|78944400|FG006|Part A|Protocol Violation|0|||
44153758|NCT02694523|78944394|FG000|Part A|Lost to Follow-up|1|||
44153759|NCT02694523|78944395|FG001|Part A|Lost to Follow-up|2|||
44153760|NCT02694523|78944396|FG002|Part A|Lost to Follow-up|0|||
44153761|NCT02694523|78944397|FG003|Part A|Lost to Follow-up|0|||
44153762|NCT02694523|78944398|FG004|Part A|Lost to Follow-up|0|||
44153763|NCT02694523|78944399|FG005|Part A|Lost to Follow-up|0|||
44153764|NCT02694523|78944400|FG006|Part A|Lost to Follow-up|0|||
44153765|NCT02694523|78944394|FG000|Part A|Withdrawal by Subject|3|||
44153766|NCT02694523|78944395|FG001|Part A|Withdrawal by Subject|1|||
44532544|NCT02564900|79542385|FG010|Dose Escalation|Ongoing|0|||
44532545|NCT02564900|79542386|FG011|Dose Escalation|Ongoing|0|||
44532546|NCT02564900|79542387|FG012|Dose Escalation|Ongoing|0|||
44532547|NCT02564900|79542388|FG013|Dose Escalation|Ongoing|0|||
44532548|NCT02564900|79542389|FG014|Dose Escalation|Ongoing|0|||
44532549|NCT02564900|79542375|FG000|Dose Escalation|Adverse Event|0|||
44532550|NCT02564900|79542376|FG001|Dose Escalation|Adverse Event|0|||
44532551|NCT02564900|79542377|FG002|Dose Escalation|Adverse Event|0|||
44532552|NCT02564900|79542378|FG003|Dose Escalation|Adverse Event|1|||
44153767|NCT02694523|78944396|FG002|Part A|Withdrawal by Subject|0|||
44153768|NCT02694523|78944397|FG003|Part A|Withdrawal by Subject|0|||
44153769|NCT02694523|78944398|FG004|Part A|Withdrawal by Subject|0|||
44153770|NCT02694523|78944399|FG005|Part A|Withdrawal by Subject|0|||
44153771|NCT02694523|78944400|FG006|Part A|Withdrawal by Subject|0|||
44153772|NCT02694523|78944394|FG000|Part A|Other|1|||
44532553|NCT02564900|79542379|FG004|Dose Escalation|Adverse Event|1|||
44532554|NCT02564900|79542380|FG005|Dose Escalation|Adverse Event|3|||
44532555|NCT02564900|79542381|FG006|Dose Escalation|Adverse Event|0|||
44153773|NCT02694523|78944395|FG001|Part A|Other|1|||
44153774|NCT02694523|78944396|FG002|Part A|Other|0|||
44153775|NCT02694523|78944397|FG003|Part A|Other|0|||
44153776|NCT02694523|78944398|FG004|Part A|Other|0|||
44153777|NCT02694523|78944399|FG005|Part A|Other|0|||
44153778|NCT02694523|78944400|FG006|Part A|Other|0|||
44153779|NCT02694523|78944394|FG000|Part B|Adverse Event|0|||
44153780|NCT02694523|78944395|FG001|Part B|Adverse Event|0|||
44153781|NCT02694523|78944396|FG002|Part B|Adverse Event|7|||
44153782|NCT02694523|78944397|FG003|Part B|Adverse Event|1|||
44153783|NCT02694523|78944398|FG004|Part B|Adverse Event|1|||
44153784|NCT02694523|78944399|FG005|Part B|Adverse Event|2|||
44153785|NCT02694523|78944400|FG006|Part B|Adverse Event|0|||
44153786|NCT02694523|78944394|FG000|Part B|Protocol Violation|0|||
44153787|NCT02694523|78944395|FG001|Part B|Protocol Violation|0|||
44153788|NCT02694523|78944396|FG002|Part B|Protocol Violation|1|||
44153789|NCT02694523|78944397|FG003|Part B|Protocol Violation|0|||
44153790|NCT02694523|78944398|FG004|Part B|Protocol Violation|0|||
44153791|NCT02694523|78944399|FG005|Part B|Protocol Violation|0|||
44153792|NCT02694523|78944400|FG006|Part B|Protocol Violation|0|||
44153793|NCT02694523|78944394|FG000|Part B|Lost to Follow-up|0|||
44153794|NCT02694523|78944395|FG001|Part B|Lost to Follow-up|0|||
44153795|NCT02694523|78944396|FG002|Part B|Lost to Follow-up|2|||
44153796|NCT02694523|78944397|FG003|Part B|Lost to Follow-up|3|||
44153797|NCT02694523|78944398|FG004|Part B|Lost to Follow-up|2|||
44153798|NCT02694523|78944399|FG005|Part B|Lost to Follow-up|0|||
44153799|NCT02694523|78944400|FG006|Part B|Lost to Follow-up|1|||
44153800|NCT02694523|78944394|FG000|Part B|Withdrawal by Subject|0|||
44153801|NCT02694523|78944395|FG001|Part B|Withdrawal by Subject|0|||
44153802|NCT02694523|78944396|FG002|Part B|Withdrawal by Subject|9|||
44153803|NCT02694523|78944397|FG003|Part B|Withdrawal by Subject|0|||
44153804|NCT02694523|78944398|FG004|Part B|Withdrawal by Subject|1|||
44153805|NCT02694523|78944399|FG005|Part B|Withdrawal by Subject|3|||
44153806|NCT02694523|78944400|FG006|Part B|Withdrawal by Subject|0|||
44153807|NCT02694523|78944394|FG000|Part B|Other|0|||
44153808|NCT02694523|78944395|FG001|Part B|Other|0|||
44153809|NCT02694523|78944396|FG002|Part B|Other|1|||
44283604|NCT01815840|79246984|FG001|Overall Study|Lost to Follow-up|6|||
44283605|NCT01815840|79246983|FG000|Overall Study|Refused Treatment|5|||
44283606|NCT01815840|79246984|FG001|Overall Study|Refused Treatment|1|||
44283607|NCT01815840|79246983|FG000|Overall Study|Sponsor Termination Treatment|1|||
44283608|NCT01815840|79246984|FG001|Overall Study|Sponsor Termination Treatment|0|||
44283609|NCT01774110|79246990|FG000|Overall Study|Lost to Follow-up|7|||
44283610|NCT01788228|79246997|FG000|Overall Study|Migrated/moved from study area|1|||
44283611|NCT01788228|79246998|FG001|Overall Study|Migrated/moved from study area|0|||
44283612|NCT01607346|79247007|FG000|Overall Study|Adverse Event|3|||
44283613|NCT01787838|79247011|FG000|Overall Study|refused|1413|||
44283614|NCT01787760|79247018|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
44283615|NCT01787760|79247019|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
44283616|NCT01787760|79247020|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
44283617|NCT01787760|79247018|FG000|Overall Study|Decompensated on left exotropia|0|||
44283618|NCT01787760|79247019|FG001|Overall Study|Decompensated on left exotropia|0|||
44283619|NCT01787760|79247020|FG002|Overall Study|Decompensated on left exotropia|1|||
44153810|NCT02694523|78944397|FG003|Part B|Other|0|||
44153811|NCT02694523|78944398|FG004|Part B|Other|0|||
44153812|NCT02694523|78944399|FG005|Part B|Other|0|||
44153813|NCT02694523|78944400|FG006|Part B|Other|1|||
44153814|NCT01353703|78944414|FG000|Overall Study|Migrated/moved from study area|1|||
44153815|NCT01353703|78944415|FG001|Overall Study|Migrated/moved from study area|0|||
44255646|NCT02608476|79099206|FG001|Overall Study|Noncompliance with treatment|5|||
44255647|NCT02608476|79099205|FG000|Overall Study|Lack of Efficacy|3|||
44255648|NCT02608476|79099206|FG001|Overall Study|Lack of Efficacy|1|||
44255649|NCT02608476|79099205|FG000|Overall Study|Other|0|||
44255650|NCT02608476|79099206|FG001|Overall Study|Other|1|||
44255651|NCT02608476|79099205|FG000|Overall Study|Physician Decision|1|||
44255652|NCT02608476|79099206|FG001|Overall Study|Physician Decision|0|||
44255653|NCT02608476|79099205|FG000|Overall Study|Pregnancy|0|||
44255654|NCT02608476|79099206|FG001|Overall Study|Pregnancy|1|||
44255655|NCT02608476|79099205|FG000|Overall Study|Progressive disease|1|||
44255656|NCT02608476|79099206|FG001|Overall Study|Progressive disease|0|||
44255657|NCT02607306|79099335|FG000|Overall Study|Adverse Event|8|||
44255658|NCT02607306|79099336|FG001|Overall Study|Adverse Event|6|||
44255659|NCT02607306|79099337|FG002|Overall Study|Adverse Event|6|||
44255660|NCT02607306|79099335|FG000|Overall Study|Unclassified|1|||
44255661|NCT02607306|79099336|FG001|Overall Study|Unclassified|4|||
44255662|NCT02607306|79099337|FG002|Overall Study|Unclassified|0|||
44255663|NCT02607306|79099335|FG000|Overall Study|Withdrawal by Subject|8|||
44255664|NCT02607306|79099336|FG001|Overall Study|Withdrawal by Subject|10|||
44153816|NCT02009332|78944429|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
44153817|NCT02009332|78944430|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
44153818|NCT02009332|78944431|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
44153819|NCT02009332|78944432|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
44153820|NCT02009332|78944433|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
44153821|NCT02009332|78944434|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
44153822|NCT02009332|78944429|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
44153823|NCT02009332|78944430|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
44255665|NCT02607306|79099337|FG002|Overall Study|Withdrawal by Subject|2|||
44255666|NCT02607306|79099335|FG000|Overall Study|Lack of Efficacy|0|||
44153824|NCT02009332|78944431|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
44153825|NCT02009332|78944432|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
44415473|NCT00626392|79423259|FG002|Run-in Period|Withdrawal by Subject|1|||
44415474|NCT00626392|79423260|FG003|Run-in Period|Withdrawal by Subject|1|||
44532556|NCT02564900|79542382|FG007|Dose Escalation|Adverse Event|0|||
44532557|NCT02564900|79542383|FG008|Dose Escalation|Adverse Event|0|||
44532558|NCT02564900|79542384|FG009|Dose Escalation|Adverse Event|0|||
44532559|NCT02564900|79542385|FG010|Dose Escalation|Adverse Event|0|||
44532560|NCT02564900|79542386|FG011|Dose Escalation|Adverse Event|0|||
44532561|NCT02564900|79542387|FG012|Dose Escalation|Adverse Event|0|||
44532562|NCT02564900|79542388|FG013|Dose Escalation|Adverse Event|0|||
44532563|NCT02564900|79542389|FG014|Dose Escalation|Adverse Event|0|||
44532564|NCT02564900|79542375|FG000|Dose Expansion|Progressive disease per RECIST|0|||
44532565|NCT02564900|79542376|FG001|Dose Expansion|Progressive disease per RECIST|0|||
44532566|NCT02564900|79542377|FG002|Dose Expansion|Progressive disease per RECIST|0|||
44532567|NCT02564900|79542378|FG003|Dose Expansion|Progressive disease per RECIST|0|||
44532568|NCT02564900|79542379|FG004|Dose Expansion|Progressive disease per RECIST|0|||
44532569|NCT02564900|79542380|FG005|Dose Expansion|Progressive disease per RECIST|0|||
44532570|NCT02564900|79542381|FG006|Dose Expansion|Progressive disease per RECIST|19|||
44153826|NCT02009332|78944433|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
44153827|NCT02009332|78944434|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
44283620|NCT01787760|79247018|FG000|Overall Study|Dryness|0|||
44283621|NCT01787760|79247019|FG001|Overall Study|Dryness|1|||
44283622|NCT01787760|79247020|FG002|Overall Study|Dryness|0|||
44283623|NCT01787760|79247018|FG000|Overall Study|Relocation|1|||
44283624|NCT01787760|79247019|FG001|Overall Study|Relocation|1|||
44283625|NCT01787760|79247020|FG002|Overall Study|Relocation|0|||
44283626|NCT01787760|79247018|FG000|Overall Study|Lens discomfort|3|||
44283627|NCT01787760|79247019|FG001|Overall Study|Lens discomfort|0|||
44283628|NCT01787760|79247020|FG002|Overall Study|Lens discomfort|0|||
44283629|NCT01787760|79247018|FG000|Overall Study|Lens handling difficulty|1|||
44283630|NCT01787760|79247019|FG001|Overall Study|Lens handling difficulty|2|||
44283631|NCT01787760|79247020|FG002|Overall Study|Lens handling difficulty|0|||
44283632|NCT01787760|79247018|FG000|Overall Study|Protocol Violation|6|||
44283633|NCT01787760|79247019|FG001|Overall Study|Protocol Violation|0|||
44283634|NCT01787760|79247020|FG002|Overall Study|Protocol Violation|1|||
44283635|NCT01787760|79247018|FG000|Overall Study|Withdrawal by Subject|5|||
44283636|NCT01787760|79247019|FG001|Overall Study|Withdrawal by Subject|1|||
44283637|NCT01787760|79247020|FG002|Overall Study|Withdrawal by Subject|2|||
44283638|NCT01787760|79247018|FG000|Overall Study|Lost to Follow-up|1|||
44283639|NCT01787760|79247019|FG001|Overall Study|Lost to Follow-up|0|||
44283640|NCT01787760|79247020|FG002|Overall Study|Lost to Follow-up|1|||
44283641|NCT01787760|79247018|FG000|Overall Study|Stroke|1|||
44283642|NCT01787760|79247019|FG001|Overall Study|Stroke|0|||
44283643|NCT01787760|79247020|FG002|Overall Study|Stroke|0|||
44283644|NCT01787760|79247018|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
44283645|NCT01787760|79247019|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
44283646|NCT01787760|79247020|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
44283647|NCT01787760|79247018|FG000|Overall Study|Unsatisfactory physiological response|2|||
44283648|NCT01787760|79247019|FG001|Overall Study|Unsatisfactory physiological response|4|||
44283649|NCT01787760|79247020|FG002|Overall Study|Unsatisfactory physiological response|0|||
44283650|NCT01787760|79247018|FG000|Overall Study|Unsatisfactory visual response|1|||
44283651|NCT01787760|79247019|FG001|Overall Study|Unsatisfactory visual response|1|||
44283652|NCT01787760|79247020|FG002|Overall Study|Unsatisfactory visual response|0|||
44283653|NCT01787760|79247018|FG000|Overall Study|Near vision blur|1|||
44283654|NCT01787760|79247019|FG001|Overall Study|Near vision blur|0|||
44283655|NCT01787760|79247020|FG002|Overall Study|Near vision blur|0|||
44283656|NCT01815138|79247031|FG000|Overall Study|Withdrawal by Subject|0|||
44283657|NCT01815138|79247032|FG001|Overall Study|Withdrawal by Subject|1|||
44283658|NCT01815138|79247031|FG000|Overall Study|Physician Decision|8|||
44283659|NCT01815138|79247032|FG001|Overall Study|Physician Decision|5|||
44283660|NCT01606800|79247040|FG000|Overall Study|Adverse Event|3|||
44283661|NCT01606800|79247041|FG001|Overall Study|Adverse Event|1|||
44283662|NCT01606800|79247040|FG000|Overall Study|Participant withdrew consent|0|||
44283663|NCT01606800|79247041|FG001|Overall Study|Participant withdrew consent|1|||
44283664|NCT01606800|79247040|FG000|Overall Study|Missing completion status|2|||
44283665|NCT01606800|79247041|FG001|Overall Study|Missing completion status|0|||
44532571|NCT02564900|79542382|FG007|Dose Expansion|Progressive disease per RECIST|17|||
44532572|NCT02564900|79542383|FG008|Dose Expansion|Progressive disease per RECIST|8|||
44532573|NCT02564900|79542384|FG009|Dose Expansion|Progressive disease per RECIST|16|||
44532574|NCT02564900|79542385|FG010|Dose Expansion|Progressive disease per RECIST|13|||
44283666|NCT01772550|79247050|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
44283667|NCT01772550|79247051|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
44283668|NCT01772550|79247052|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
44283669|NCT01772550|79247050|FG000|Overall Study|Adverse Event|0|||
44153828|NCT02009332|78944429|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
44153829|NCT02009332|78944430|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
44153830|NCT02009332|78944431|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
44153831|NCT02009332|78944432|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
44153832|NCT02009332|78944433|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
44153833|NCT02009332|78944434|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
44153834|NCT01984294|78944451|FG000|Overall Study|Randomized but Never Treated|0|||
44153835|NCT01984294|78944452|FG001|Overall Study|Randomized but Never Treated|0|||
44153836|NCT01984294|78944453|FG002|Overall Study|Randomized but Never Treated|1|||
44153837|NCT01984294|78944451|FG000|Overall Study|Lack of Efficacy|4|||
44153838|NCT01984294|78944452|FG001|Overall Study|Lack of Efficacy|2|||
44153839|NCT01984294|78944453|FG002|Overall Study|Lack of Efficacy|6|||
44153840|NCT01984294|78944451|FG000|Overall Study|Adverse Event|0|||
44153841|NCT01984294|78944452|FG001|Overall Study|Adverse Event|1|||
44153842|NCT01984294|78944453|FG002|Overall Study|Adverse Event|0|||
44153843|NCT01962298|78944466|FG000|Overall Study|Protocol Violation|1|||
44153844|NCT01962298|78944467|FG001|Overall Study|Protocol Violation|0|||
44153845|NCT01962298|78944468|FG002|Overall Study|Protocol Violation|1|||
44153846|NCT01962298|78944469|FG003|Overall Study|Protocol Violation|1|||
44153847|NCT01962298|78944470|FG004|Overall Study|Protocol Violation|0|||
44153848|NCT01962298|78944466|FG000|Overall Study|Data quality insufficient|2|||
44153849|NCT01962298|78944467|FG001|Overall Study|Data quality insufficient|0|||
44153850|NCT01962298|78944468|FG002|Overall Study|Data quality insufficient|3|||
44153851|NCT01962298|78944469|FG003|Overall Study|Data quality insufficient|1|||
44153852|NCT01962298|78944470|FG004|Overall Study|Data quality insufficient|4|||
44153853|NCT01962298|78944466|FG000|Overall Study|Insufficient data|0|||
44153854|NCT01962298|78944467|FG001|Overall Study|Insufficient data|2|||
44153855|NCT01962298|78944468|FG002|Overall Study|Insufficient data|1|||
44532575|NCT02564900|79542386|FG011|Dose Expansion|Progressive disease per RECIST|19|||
44532576|NCT02564900|79542387|FG012|Dose Expansion|Progressive disease per RECIST|10|||
44532577|NCT02564900|79542388|FG013|Dose Expansion|Progressive disease per RECIST|13|||
44532578|NCT02564900|79542389|FG014|Dose Expansion|Progressive disease per RECIST|11|||
44532579|NCT02564900|79542375|FG000|Dose Expansion|Clinical progression|0|||
44532580|NCT02564900|79542376|FG001|Dose Expansion|Clinical progression|0|||
44532581|NCT02564900|79542377|FG002|Dose Expansion|Clinical progression|0|||
44532582|NCT02564900|79542378|FG003|Dose Expansion|Clinical progression|0|||
44532583|NCT02564900|79542379|FG004|Dose Expansion|Clinical progression|0|||
44532584|NCT02564900|79542380|FG005|Dose Expansion|Clinical progression|0|||
44532585|NCT02564900|79542381|FG006|Dose Expansion|Clinical progression|5|||
44532586|NCT02564900|79542382|FG007|Dose Expansion|Clinical progression|12|||
44532587|NCT02564900|79542383|FG008|Dose Expansion|Clinical progression|0|||
44532588|NCT02564900|79542384|FG009|Dose Expansion|Clinical progression|3|||
44532589|NCT02564900|79542385|FG010|Dose Expansion|Clinical progression|2|||
44532590|NCT02564900|79542386|FG011|Dose Expansion|Clinical progression|0|||
44532591|NCT02564900|79542387|FG012|Dose Expansion|Clinical progression|1|||
44532592|NCT02564900|79542388|FG013|Dose Expansion|Clinical progression|3|||
44532593|NCT02564900|79542389|FG014|Dose Expansion|Clinical progression|1|||
44532594|NCT02564900|79542375|FG000|Dose Expansion|Adverse Event|0|||
44153856|NCT01962298|78944469|FG003|Overall Study|Insufficient data|0|||
44153857|NCT01962298|78944470|FG004|Overall Study|Insufficient data|1|||
44153858|NCT01962298|78944466|FG000|Overall Study|Incorrect data recorded|0|||
44532595|NCT02564900|79542376|FG001|Dose Expansion|Adverse Event|0|||
44153859|NCT01962298|78944467|FG001|Overall Study|Incorrect data recorded|1|||
44153860|NCT01962298|78944468|FG002|Overall Study|Incorrect data recorded|0|||
44255667|NCT02607306|79099336|FG001|Overall Study|Lack of Efficacy|1|||
44532596|NCT02564900|79542377|FG002|Dose Expansion|Adverse Event|0|||
44532597|NCT02564900|79542378|FG003|Dose Expansion|Adverse Event|0|||
44532598|NCT02564900|79542379|FG004|Dose Expansion|Adverse Event|0|||
44532599|NCT02564900|79542380|FG005|Dose Expansion|Adverse Event|0|||
44532600|NCT02564900|79542381|FG006|Dose Expansion|Adverse Event|9|||
44532601|NCT02564900|79542382|FG007|Dose Expansion|Adverse Event|22|||
44532602|NCT02564900|79542383|FG008|Dose Expansion|Adverse Event|0|||
44532603|NCT02564900|79542384|FG009|Dose Expansion|Adverse Event|11|||
44532604|NCT02564900|79542385|FG010|Dose Expansion|Adverse Event|0|||
44532605|NCT02564900|79542386|FG011|Dose Expansion|Adverse Event|5|||
44532606|NCT02564900|79542387|FG012|Dose Expansion|Adverse Event|2|||
44532607|NCT02564900|79542388|FG013|Dose Expansion|Adverse Event|2|||
44532608|NCT02564900|79542389|FG014|Dose Expansion|Adverse Event|1|||
44532609|NCT02564900|79542375|FG000|Dose Expansion|Ongoing|0|||
44532610|NCT02564900|79542376|FG001|Dose Expansion|Ongoing|0|||
44532611|NCT02564900|79542377|FG002|Dose Expansion|Ongoing|0|||
44532612|NCT02564900|79542378|FG003|Dose Expansion|Ongoing|0|||
44532613|NCT02564900|79542379|FG004|Dose Expansion|Ongoing|0|||
44532614|NCT02564900|79542380|FG005|Dose Expansion|Ongoing|0|||
44532615|NCT02564900|79542381|FG006|Dose Expansion|Ongoing|9|||
44532616|NCT02564900|79542382|FG007|Dose Expansion|Ongoing|10|||
44532617|NCT02564900|79542383|FG008|Dose Expansion|Ongoing|11|||
44532618|NCT02564900|79542384|FG009|Dose Expansion|Ongoing|3|||
44532619|NCT02564900|79542385|FG010|Dose Expansion|Ongoing|0|||
44532620|NCT02564900|79542386|FG011|Dose Expansion|Ongoing|0|||
44532621|NCT02564900|79542387|FG012|Dose Expansion|Ongoing|4|||
44532622|NCT02564900|79542388|FG013|Dose Expansion|Ongoing|0|||
44532623|NCT02564900|79542389|FG014|Dose Expansion|Ongoing|6|||
44532624|NCT02564900|79542375|FG000|Dose Expansion|Death|0|||
44532625|NCT02564900|79542376|FG001|Dose Expansion|Death|0|||
44532626|NCT02564900|79542377|FG002|Dose Expansion|Death|0|||
44532627|NCT02564900|79542378|FG003|Dose Expansion|Death|0|||
44532628|NCT02564900|79542379|FG004|Dose Expansion|Death|0|||
44532629|NCT02564900|79542380|FG005|Dose Expansion|Death|0|||
44532630|NCT02564900|79542381|FG006|Dose Expansion|Death|1|||
44532631|NCT02564900|79542382|FG007|Dose Expansion|Death|0|||
44532632|NCT02564900|79542383|FG008|Dose Expansion|Death|0|||
44532633|NCT02564900|79542384|FG009|Dose Expansion|Death|0|||
44532634|NCT02564900|79542385|FG010|Dose Expansion|Death|1|||
44532635|NCT02564900|79542386|FG011|Dose Expansion|Death|0|||
44532636|NCT02564900|79542387|FG012|Dose Expansion|Death|1|||
44532637|NCT02564900|79542388|FG013|Dose Expansion|Death|1|||
44532638|NCT02564900|79542389|FG014|Dose Expansion|Death|0|||
44532639|NCT02564900|79542375|FG000|Dose Expansion|Withdrawal by Subject|0|||
44532640|NCT02564900|79542376|FG001|Dose Expansion|Withdrawal by Subject|0|||
44532641|NCT02564900|79542377|FG002|Dose Expansion|Withdrawal by Subject|0|||
44532642|NCT02564900|79542378|FG003|Dose Expansion|Withdrawal by Subject|0|||
44532643|NCT02564900|79542379|FG004|Dose Expansion|Withdrawal by Subject|0|||
44532644|NCT02564900|79542380|FG005|Dose Expansion|Withdrawal by Subject|0|||
44532645|NCT02564900|79542381|FG006|Dose Expansion|Withdrawal by Subject|4|||
44153861|NCT01962298|78944469|FG003|Overall Study|Incorrect data recorded|0|||
44153862|NCT01962298|78944470|FG004|Overall Study|Incorrect data recorded|0|||
44153863|NCT01962298|78944466|FG000|Overall Study|Physician Decision|0|||
44153864|NCT01962298|78944467|FG001|Overall Study|Physician Decision|1|||
44153865|NCT01962298|78944468|FG002|Overall Study|Physician Decision|0|||
44153866|NCT01962298|78944469|FG003|Overall Study|Physician Decision|0|||
44153867|NCT01962298|78944470|FG004|Overall Study|Physician Decision|1|||
44153868|NCT02693743|78944484|FG000|Overall Study|Physician Decision|1|||
44153869|NCT02693743|78944485|FG001|Overall Study|Physician Decision|0|||
44153870|NCT02655887|78944491|FG000|Overall Study|Lost to Follow-up|3|||
44153871|NCT02655887|78944491|FG000|Overall Study|Death|4|||
44153872|NCT02655887|78944491|FG000|Overall Study|Withdrawal by Subject|3|||
44153873|NCT02655887|78944491|FG000|Overall Study|Missed 12-month follow-up visit|4|||
44153874|NCT02008318|78944497|FG000|Overall Study|Adverse Event|4|||
44153875|NCT02008318|78944498|FG001|Overall Study|Adverse Event|0|||
44153876|NCT02008318|78944497|FG000|Overall Study|Physician Decision|2|||
44153877|NCT02008318|78944498|FG001|Overall Study|Physician Decision|0|||
44153878|NCT02008318|78944497|FG000|Overall Study|Progressive Disease|2|||
44153879|NCT02008318|78944498|FG001|Overall Study|Progressive Disease|0|||
44153880|NCT02008318|78944497|FG000|Overall Study|Protocol Violation|1|||
44153881|NCT02008318|78944498|FG001|Overall Study|Protocol Violation|1|||
44153882|NCT02008318|78944497|FG000|Overall Study|Withdrawal by Subject|3|||
44153883|NCT02008318|78944498|FG001|Overall Study|Withdrawal by Subject|0|||
44153884|NCT01982812|78944509|FG000|Overall Study|Death|1|||
44153885|NCT01982812|78944510|FG001|Overall Study|Death|5|||
44153886|NCT01982812|78944509|FG000|Overall Study|Adverse Event|0|||
44153887|NCT01982812|78944510|FG001|Overall Study|Adverse Event|5|||
44153888|NCT02007070|78944516|FG000|Overall Study|Adverse Event|4|||
44153889|NCT02007070|78944516|FG000|Overall Study|Clinical Progression|4|||
44153890|NCT02007070|78944516|FG000|Overall Study|Death|1|||
44153891|NCT02007070|78944516|FG000|Overall Study|Protocol Violation|2|||
44153892|NCT02007070|78944516|FG000|Overall Study|Physician Decision|1|||
44153893|NCT02007070|78944516|FG000|Overall Study|Progressive Disease|21|||
44153894|NCT02006758|78944520|FG000|Overall Study|Protocol Violation|1|||
44153895|NCT02006758|78944520|FG000|Overall Study|Death|1|||
44153896|NCT02006758|78944520|FG000|Overall Study|Lost to Follow-up|4|||
44153897|NCT02006758|78944520|FG000|Overall Study|Withdrawal by Subject|4|||
44153898|NCT02006758|78944520|FG000|Overall Study|Procedurally excluded|1|||
44153899|NCT02006758|78944520|FG000|Overall Study|Other|2|||
44153900|NCT01960816|78944525|FG000|Overall Study|Lost to Follow-up|1|||
44153901|NCT01602419|78944529|FG000|Overall Study|Not treated with Wilate|9|||
44153902|NCT01602419|78944529|FG000|Overall Study|Adverse Drug Reaction|4|||
44532646|NCT02564900|79542382|FG007|Dose Expansion|Withdrawal by Subject|0|||
44532647|NCT02564900|79542383|FG008|Dose Expansion|Withdrawal by Subject|0|||
44532648|NCT02564900|79542384|FG009|Dose Expansion|Withdrawal by Subject|0|||
44532649|NCT02564900|79542385|FG010|Dose Expansion|Withdrawal by Subject|1|||
44532650|NCT02564900|79542386|FG011|Dose Expansion|Withdrawal by Subject|0|||
44532651|NCT02564900|79542387|FG012|Dose Expansion|Withdrawal by Subject|0|||
44532652|NCT02564900|79542388|FG013|Dose Expansion|Withdrawal by Subject|1|||
44532653|NCT02564900|79542389|FG014|Dose Expansion|Withdrawal by Subject|1|||
44532654|NCT02564900|79542375|FG000|Dose Expansion|Other|0|||
44532655|NCT02564900|79542376|FG001|Dose Expansion|Other|0|||
44532656|NCT02564900|79542377|FG002|Dose Expansion|Other|0|||
44532657|NCT02564900|79542378|FG003|Dose Expansion|Other|0|||
44532658|NCT02564900|79542379|FG004|Dose Expansion|Other|0|||
44532659|NCT02564900|79542380|FG005|Dose Expansion|Other|0|||
44532660|NCT02564900|79542381|FG006|Dose Expansion|Other|1|||
44532661|NCT02564900|79542382|FG007|Dose Expansion|Other|0|||
44283670|NCT01772550|79247051|FG001|Overall Study|Adverse Event|0|||
44283671|NCT01772550|79247052|FG002|Overall Study|Adverse Event|1|||
44283672|NCT01787292|79247060|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
44283673|NCT01787292|79247061|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
44532662|NCT02564900|79542383|FG008|Dose Expansion|Other|1|||
44532663|NCT02564900|79542384|FG009|Dose Expansion|Other|0|||
44532664|NCT02564900|79542385|FG010|Dose Expansion|Other|0|||
44532665|NCT02564900|79542386|FG011|Dose Expansion|Other|0|||
44532666|NCT02564900|79542387|FG012|Dose Expansion|Other|0|||
44153903|NCT01602419|78944529|FG000|Overall Study|Insurance issues|3|||
44532667|NCT02564900|79542388|FG013|Dose Expansion|Other|0|||
44532668|NCT02564900|79542389|FG014|Dose Expansion|Other|1|||
44532669|NCT02564900|79542375|FG000|Dose Expansion|Did not receive treatment|0|||
44532670|NCT02564900|79542376|FG001|Dose Expansion|Did not receive treatment|0|||
44532671|NCT02564900|79542377|FG002|Dose Expansion|Did not receive treatment|0|||
44283674|NCT01787292|79247060|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
44283675|NCT01787292|79247061|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
44283676|NCT01814748|79247074|FG000|Overall Study|Lost to Follow-up|1|||
44283677|NCT01814748|79247075|FG001|Overall Study|Lost to Follow-up|2|||
44283678|NCT01814748|79247074|FG000|Overall Study|Study site terminated by sponsor|1|||
44283679|NCT01814748|79247075|FG001|Overall Study|Study site terminated by sponsor|1|||
44283680|NCT01814748|79247074|FG000|Overall Study|Withdrawal by Subject|6|||
44283681|NCT01814748|79247075|FG001|Overall Study|Withdrawal by Subject|4|||
44283682|NCT01814670|79247081|FG000|Overall Study|Protocol Violation|12|||
44283683|NCT01814046|79247087|FG000|Drug Administration|Death due to complications of RSV|1|||
44283684|NCT01814046|79247088|FG001|Drug Administration|Death due to complications of RSV|0|||
44415475|NCT00626392|79423261|FG004|Run-in Period|Withdrawal by Subject|3|||
44415476|NCT00626392|79423262|FG005|Run-in Period|Withdrawal by Subject|1|||
44415477|NCT00626392|79423257|FG000|Run-in Period|Noncompliance|1|||
44415478|NCT00626392|79423258|FG001|Run-in Period|Noncompliance|0|||
44415479|NCT00626392|79423259|FG002|Run-in Period|Noncompliance|1|||
44415480|NCT00626392|79423260|FG003|Run-in Period|Noncompliance|0|||
44415481|NCT00626392|79423261|FG004|Run-in Period|Noncompliance|0|||
44415482|NCT00626392|79423262|FG005|Run-in Period|Noncompliance|0|||
44415483|NCT00626392|79423257|FG000|Coadministration Period|Adverse Event|3|||
44415484|NCT00626392|79423258|FG001|Coadministration Period|Adverse Event|1|||
44415485|NCT00626392|79423259|FG002|Coadministration Period|Adverse Event|7|||
44415486|NCT00626392|79423260|FG003|Coadministration Period|Adverse Event|4|||
44415487|NCT00626392|79423261|FG004|Coadministration Period|Adverse Event|3|||
44415488|NCT00626392|79423262|FG005|Coadministration Period|Adverse Event|4|||
44415489|NCT00626392|79423257|FG000|Coadministration Period|Withdrawal by Subject|1|||
44415490|NCT00626392|79423258|FG001|Coadministration Period|Withdrawal by Subject|1|||
44415491|NCT00626392|79423259|FG002|Coadministration Period|Withdrawal by Subject|0|||
44415492|NCT00626392|79423260|FG003|Coadministration Period|Withdrawal by Subject|1|||
44415493|NCT00626392|79423261|FG004|Coadministration Period|Withdrawal by Subject|0|||
44532672|NCT02564900|79542378|FG003|Dose Expansion|Did not receive treatment|0|||
44532673|NCT02564900|79542379|FG004|Dose Expansion|Did not receive treatment|0|||
44532674|NCT02564900|79542380|FG005|Dose Expansion|Did not receive treatment|0|||
44532675|NCT02564900|79542381|FG006|Dose Expansion|Did not receive treatment|1|||
44532676|NCT02564900|79542382|FG007|Dose Expansion|Did not receive treatment|1|||
44532677|NCT02564900|79542383|FG008|Dose Expansion|Did not receive treatment|0|||
44532678|NCT02564900|79542384|FG009|Dose Expansion|Did not receive treatment|0|||
44153904|NCT01602419|78944529|FG000|Overall Study|Changed treatment centre|1|||
44415494|NCT00626392|79423262|FG005|Coadministration Period|Withdrawal by Subject|1|||
44283685|NCT01814046|79247089|FG002|Drug Administration|Death due to complications of RSV|0|||
44415495|NCT00626392|79423257|FG000|Coadministration Period|Protocol Violation|0|||
44415496|NCT00626392|79423258|FG001|Coadministration Period|Protocol Violation|1|||
44415497|NCT00626392|79423259|FG002|Coadministration Period|Protocol Violation|0|||
44415498|NCT00626392|79423260|FG003|Coadministration Period|Protocol Violation|1|||
44415499|NCT00626392|79423261|FG004|Coadministration Period|Protocol Violation|1|||
44415500|NCT00626392|79423262|FG005|Coadministration Period|Protocol Violation|0|||
44415501|NCT00626392|79423257|FG000|Coadministration Period|Other|0|||
44415502|NCT00626392|79423258|FG001|Coadministration Period|Other|2|||
44415503|NCT00626392|79423259|FG002|Coadministration Period|Other|3|||
44532679|NCT02564900|79542385|FG010|Dose Expansion|Did not receive treatment|0|||
44532680|NCT02564900|79542386|FG011|Dose Expansion|Did not receive treatment|0|||
44532681|NCT02564900|79542387|FG012|Dose Expansion|Did not receive treatment|0|||
44532682|NCT02564900|79542388|FG013|Dose Expansion|Did not receive treatment|0|||
44532683|NCT02564900|79542389|FG014|Dose Expansion|Did not receive treatment|1|||
44532684|NCT02470091|79542432|FG000|Overall Study|Withdrawal by Subject|1|||
44532685|NCT02470091|79542433|FG001|Overall Study|Withdrawal by Subject|0|||
44532686|NCT02470091|79542432|FG000|Overall Study|Ineligible|0|||
44532687|NCT02470091|79542433|FG001|Overall Study|Ineligible|2|||
44532688|NCT02451943|79542443|FG000|Overall Study|On Treatment|4|||
44532689|NCT02451943|79542444|FG001|Overall Study|On Treatment|4|||
44532690|NCT02451943|79542443|FG000|Overall Study|Withdrawal by Subject|13|||
44532691|NCT02451943|79542444|FG001|Overall Study|Withdrawal by Subject|16|||
44532692|NCT02451943|79542443|FG000|Overall Study|Lost to Follow-up|3|||
44532693|NCT02451943|79542444|FG001|Overall Study|Lost to Follow-up|4|||
44532694|NCT02432196|79542450|FG000|Overall Study|Exit - did not receive study device|1|||
44532695|NCT02432196|79542450|FG000|Overall Study|Death|2|||
44532696|NCT02432196|79542450|FG000|Overall Study|Reoperation|3|||
44532697|NCT02163733|79542469|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
44532698|NCT02163733|79542470|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
44532699|NCT02163733|79542471|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
44532700|NCT02163733|79542469|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
44532701|NCT02163733|79542470|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
44532702|NCT02163733|79542471|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
44532703|NCT01391832|79542489|FG000|Overall Study|Withdrawal by Subject|21|||
44532704|NCT01391832|79542490|FG001|Overall Study|Withdrawal by Subject|22|||
44532705|NCT01391832|79542489|FG000|Overall Study|Lost to Follow-up|0|||
44532706|NCT01391832|79542490|FG001|Overall Study|Lost to Follow-up|1|||
44532707|NCT05590000|79542496|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
44532708|NCT05333965|79542504|FG000|First Intervention|Adverse Event|0|||
44532709|NCT05333965|79542505|FG001|First Intervention|Adverse Event|1|||
44532710|NCT05333965|79542504|FG000|First Intervention|Withdrawal by Subject|0|||
44415504|NCT00626392|79423260|FG003|Coadministration Period|Other|1|||
44153905|NCT01602419|78944529|FG000|Overall Study|Treatment centre closed|1|||
44415505|NCT00626392|79423261|FG004|Coadministration Period|Other|1|||
44415506|NCT00626392|79423262|FG005|Coadministration Period|Other|1|||
44532711|NCT05333965|79542505|FG001|First Intervention|Withdrawal by Subject|1|||
44532712|NCT05109702|79542522|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
44532713|NCT05109702|79542523|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
44532714|NCT05109702|79542524|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
44283686|NCT01813890|79247099|FG000|Overall Study|Adverse Event|0|||
44283687|NCT01813890|79247100|FG001|Overall Study|Adverse Event|3|||
44283688|NCT01813890|79247101|FG002|Overall Study|Adverse Event|4|||
44283689|NCT01813890|79247099|FG000|Overall Study|Lack of Efficacy|9|||
44283690|NCT01813890|79247100|FG001|Overall Study|Lack of Efficacy|1|||
44283691|NCT01813890|79247101|FG002|Overall Study|Lack of Efficacy|2|||
44283692|NCT01772316|79247109|FG000|Overall Study|Serious adverse event|1|||
44283693|NCT01772316|79247109|FG000|Overall Study|Inform consent withdrawn|1|||
44283694|NCT01772316|79247109|FG000|Overall Study|Withdrawn by sponsor decision|5|||
44283695|NCT01813422|79247115|FG000|Overall Study|Withdrawal by Subject|14|||
44283696|NCT01813422|79247116|FG001|Overall Study|Withdrawal by Subject|8|||
44283697|NCT01813422|79247115|FG000|Overall Study|Death|2|||
44283698|NCT01813422|79247116|FG001|Overall Study|Death|3|||
44283699|NCT01813422|79247115|FG000|Overall Study|Sponsor Decision|2|||
44283700|NCT01813422|79247116|FG001|Overall Study|Sponsor Decision|1|||
44283701|NCT01813422|79247115|FG000|Overall Study|Lost to Follow-up|2|||
44283702|NCT01813422|79247116|FG001|Overall Study|Lost to Follow-up|4|||
44283703|NCT01786668|79247126|FG000|Overall Study|Adverse Event|0|||
44532715|NCT05109702|79542522|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
44532716|NCT05109702|79542523|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
44283704|NCT01786668|79247127|FG001|Overall Study|Adverse Event|1|||
44283705|NCT01786668|79247128|FG002|Overall Study|Adverse Event|1|||
44283706|NCT01786668|79247129|FG003|Overall Study|Adverse Event|2|||
44283707|NCT01786668|79247126|FG000|Overall Study|Withdrawal by Subject|0|||
44532717|NCT05109702|79542524|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
44532718|NCT05109702|79542522|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
44532719|NCT05109702|79542523|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
44532720|NCT05109702|79542524|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
44532721|NCT05109702|79542522|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
44532722|NCT05109702|79542523|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
44532723|NCT05109702|79542524|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
44532724|NCT05109702|79542522|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
44532725|NCT05109702|79542523|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
44532726|NCT05109702|79542524|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
44532727|NCT04699461|79542537|FG000|Overall Study|Withdrawal by Subject|1|||
44532728|NCT04699461|79542538|FG001|Overall Study|Withdrawal by Subject|0|||
44532729|NCT04699461|79542537|FG000|Overall Study|Study termination by sponsor|2|||
44532730|NCT04699461|79542538|FG001|Overall Study|Study termination by sponsor|1|||
44532731|NCT04699461|79542537|FG000|Overall Study|Death|1|||
44532732|NCT04699461|79542538|FG001|Overall Study|Death|0|||
44532733|NCT04699461|79542537|FG000|Overall Study|Radiographic progression|0|||
44532734|NCT04699461|79542538|FG001|Overall Study|Radiographic progression|1|||
44532735|NCT04399551|79542544|FG000|Overall Study|Adverse Event|15|||
44532736|NCT04399551|79542544|FG000|Overall Study|Withdrawal by Subject|6|||
44532737|NCT04399551|79542544|FG000|Overall Study|Physician Decision|3|||
44283708|NCT01786668|79247127|FG001|Overall Study|Withdrawal by Subject|0|||
44283709|NCT01786668|79247128|FG002|Overall Study|Withdrawal by Subject|3|||
44283710|NCT01786668|79247129|FG003|Overall Study|Withdrawal by Subject|1|||
44532738|NCT04399551|79542544|FG000|Overall Study|Lost to Follow-up|2|||
44532739|NCT04399551|79542544|FG000|Overall Study|Protocol Deviation|2|||
44532740|NCT04343235|79542575|FG000|Overall Study|Lost to Follow-up|3|||
44532741|NCT04343235|79542576|FG001|Overall Study|Lost to Follow-up|2|||
44532742|NCT04338321|79542584|FG000|Overall Study|Adverse Event|4|||
44283711|NCT01786668|79247126|FG000|Overall Study|Pregnancy|0|||
44283712|NCT01786668|79247127|FG001|Overall Study|Pregnancy|0|||
44283713|NCT01786668|79247128|FG002|Overall Study|Pregnancy|0|||
44283714|NCT01786668|79247129|FG003|Overall Study|Pregnancy|1|||
44153906|NCT01602419|78944529|FG000|Overall Study|Withdrawal by Subject|5|||
44153907|NCT01602419|78944529|FG000|Overall Study|Lost to Follow-up|6|||
44153908|NCT01981954|78944574|FG000|Titration Period|Protocol Deviation|1|||
44153909|NCT01981954|78944574|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
44153910|NCT02693119|78944580|FG000|Open-Label Period|Withdrawal by Subject|0|||
44532743|NCT04338321|79542585|FG001|Overall Study|Adverse Event|10|||
44532744|NCT04338321|79542584|FG000|Overall Study|Death|1|||
44532745|NCT04338321|79542585|FG001|Overall Study|Death|1|||
44532746|NCT04338321|79542584|FG000|Overall Study|Lost to Follow-up|4|||
44532747|NCT04338321|79542585|FG001|Overall Study|Lost to Follow-up|9|||
44532748|NCT04338321|79542584|FG000|Overall Study|Withdrawal by Subject|45|||
44532749|NCT04338321|79542585|FG001|Overall Study|Withdrawal by Subject|69|||
44532750|NCT04338321|79542584|FG000|Overall Study|Physician Decision|5|||
44532751|NCT04338321|79542585|FG001|Overall Study|Physician Decision|9|||
44532752|NCT04338321|79542584|FG000|Overall Study|Other|3|||
44532753|NCT04338321|79542585|FG001|Overall Study|Other|10|||
44532754|NCT04303780|79542593|FG000|Overall Study|Death|104|||
44532755|NCT04303780|79542594|FG001|Overall Study|Death|85|||
44532756|NCT04303780|79542593|FG000|Overall Study|Lost to Follow-up|5|||
44532757|NCT04303780|79542594|FG001|Overall Study|Lost to Follow-up|2|||
44532758|NCT04303780|79542593|FG000|Overall Study|Withdrawal by Subject|12|||
44532759|NCT04303780|79542594|FG001|Overall Study|Withdrawal by Subject|39|||
44532760|NCT04303780|79542593|FG000|Overall Study|Ongoing in study|50|||
44532761|NCT04303780|79542594|FG001|Overall Study|Ongoing in study|45|||
44532762|NCT04068181|79542605|FG000|Overall Study|Withdrawal by Subject|2|||
44532763|NCT04068181|79542606|FG001|Overall Study|Withdrawal by Subject|0|||
44532764|NCT04068181|79542607|FG002|Overall Study|Withdrawal by Subject|0|||
44532765|NCT04068181|79542608|FG003|Overall Study|Withdrawal by Subject|0|||
44532766|NCT04068181|79542605|FG000|Overall Study|Lost to Follow-up|1|||
44532767|NCT04068181|79542606|FG001|Overall Study|Lost to Follow-up|0|||
44532768|NCT04068181|79542607|FG002|Overall Study|Lost to Follow-up|0|||
44532769|NCT04068181|79542608|FG003|Overall Study|Lost to Follow-up|0|||
44532770|NCT04068181|79542605|FG000|Overall Study|Death|8|||
44532771|NCT04068181|79542606|FG001|Overall Study|Death|8|||
44532772|NCT04068181|79542607|FG002|Overall Study|Death|4|||
44532773|NCT04068181|79542608|FG003|Overall Study|Death|2|||
44532774|NCT04068181|79542605|FG000|Overall Study|Continuing Study|16|||
44532775|NCT04068181|79542606|FG001|Overall Study|Continuing Study|7|||
44532776|NCT04068181|79542607|FG002|Overall Study|Continuing Study|11|||
44532777|NCT04068181|79542608|FG003|Overall Study|Continuing Study|13|||
44532778|NCT03910673|79542637|FG000|Overall Study|Adverse Event|0|||
44532779|NCT03910673|79542638|FG001|Overall Study|Adverse Event|0|||
44532780|NCT03910673|79542639|FG002|Overall Study|Adverse Event|0|||
44532781|NCT03910673|79542640|FG003|Overall Study|Adverse Event|2|||
44532782|NCT03910673|79542641|FG004|Overall Study|Adverse Event|0|||
44532783|NCT03781167|79542651|FG000|Overall Study|Adverse Event|23|||
44532784|NCT03781167|79542652|FG001|Overall Study|Adverse Event|25|||
44532785|NCT03781167|79542651|FG000|Overall Study|Withdrew consent|16|||
44532786|NCT03781167|79542652|FG001|Overall Study|Withdrew consent|12|||
44532787|NCT03781167|79542651|FG000|Overall Study|Lost to Follow-up|0|||
44532788|NCT03781167|79542652|FG001|Overall Study|Lost to Follow-up|1|||
44153911|NCT02693119|78944581|FG001|Open-Label Period|Withdrawal by Subject|1|||
44283715|NCT01786668|79247126|FG000|Overall Study|Lost to Follow-up|1|||
44283716|NCT01786668|79247127|FG001|Overall Study|Lost to Follow-up|0|||
44283717|NCT01786668|79247128|FG002|Overall Study|Lost to Follow-up|1|||
44283718|NCT01786668|79247129|FG003|Overall Study|Lost to Follow-up|0|||
44283719|NCT01786512|79247150|FG000|Overall Study|Lost to Follow-up|0|||
44283720|NCT01786512|79247151|FG001|Overall Study|Lost to Follow-up|0|||
44283721|NCT01786512|79247152|FG002|Overall Study|Lost to Follow-up|0|||
44283722|NCT01786512|79247153|FG003|Overall Study|Lost to Follow-up|0|||
44283723|NCT01786512|79247154|FG004|Overall Study|Lost to Follow-up|0|||
44532789|NCT03781167|79542651|FG000|Overall Study|Lack of Efficacy|4|||
44153912|NCT05641311|78944619|FG000|Dosing Period 1|Adverse Event|1|||
44153913|NCT05641311|78944620|FG001|Dosing Period 1|Adverse Event|0|||
44153914|NCT05502289|78944633|FG000|Period 1|Out Of Window|1|||
44532790|NCT03781167|79542652|FG001|Overall Study|Lack of Efficacy|5|||
44532791|NCT03781167|79542651|FG000|Overall Study|Difficulty with drug delivery system|2|||
44532792|NCT03781167|79542652|FG001|Overall Study|Difficulty with drug delivery system|3|||
44532793|NCT03781167|79542651|FG000|Overall Study|Other, not specified|2|||
44532794|NCT03781167|79542652|FG001|Overall Study|Other, not specified|2|||
44532795|NCT03689712|79542700|FG000|Overall Study|Adverse Event|1|||
44532796|NCT03689712|79542701|FG001|Overall Study|Adverse Event|0|||
44532797|NCT03689712|79542700|FG000|Overall Study|Death|20|||
44153915|NCT05502289|78944634|FG001|Period 1|Out Of Window|0|||
44153916|NCT04934722|78944646|FG000|Overall Study|Death|4|||
44283724|NCT01786512|79247155|FG005|Overall Study|Lost to Follow-up|0|||
44283725|NCT01786512|79247156|FG006|Overall Study|Lost to Follow-up|0|||
44532798|NCT03689712|79542701|FG001|Overall Study|Death|10|||
44532799|NCT03689712|79542700|FG000|Overall Study|Lost to Follow-up|6|||
44532800|NCT03689712|79542701|FG001|Overall Study|Lost to Follow-up|6|||
44153917|NCT04934722|78944647|FG001|Overall Study|Death|3|||
44153918|NCT04934722|78944646|FG000|Overall Study|Participants Ongoing|88|||
44153919|NCT04934722|78944647|FG001|Overall Study|Participants Ongoing|91|||
44283726|NCT01786512|79247157|FG007|Overall Study|Lost to Follow-up|0|||
44283727|NCT01786512|79247158|FG008|Overall Study|Lost to Follow-up|0|||
44283728|NCT01786512|79247159|FG009|Overall Study|Lost to Follow-up|1|||
44283729|NCT01786512|79247160|FG010|Overall Study|Lost to Follow-up|0|||
44153920|NCT04778592|78944655|FG000|Overall Study|Adverse Event|1|||
44153921|NCT04778592|78944656|FG001|Overall Study|Adverse Event|2|||
44153922|NCT04778592|78944655|FG000|Overall Study|Withdrawal by Subject|1|||
44153923|NCT04778592|78944656|FG001|Overall Study|Withdrawal by Subject|2|||
44153924|NCT04688671|78944664|FG000|Overall Study|Adverse Event|3|||
44153925|NCT04688671|78944665|FG001|Overall Study|Adverse Event|1|||
44153926|NCT04688671|78944664|FG000|Overall Study|Withdrawal by Subject|3|||
44153927|NCT04688671|78944665|FG001|Overall Study|Withdrawal by Subject|1|||
44153928|NCT04688671|78944664|FG000|Overall Study|Lack of Efficacy|1|||
44283730|NCT01786512|79247150|FG000|Overall Study|Decision by sponsor|0|||
44283731|NCT01786512|79247151|FG001|Overall Study|Decision by sponsor|0|||
44283732|NCT01786512|79247152|FG002|Overall Study|Decision by sponsor|0|||
44283733|NCT01786512|79247153|FG003|Overall Study|Decision by sponsor|0|||
44283734|NCT01786512|79247154|FG004|Overall Study|Decision by sponsor|0|||
44283735|NCT01786512|79247155|FG005|Overall Study|Decision by sponsor|0|||
44153929|NCT04688671|78944665|FG001|Overall Study|Lack of Efficacy|1|||
44153930|NCT04688671|78944664|FG000|Overall Study|Protocol Violation|1|||
44153931|NCT04688671|78944665|FG001|Overall Study|Protocol Violation|0|||
44283736|NCT01786512|79247156|FG006|Overall Study|Decision by sponsor|0|||
44283737|NCT01786512|79247157|FG007|Overall Study|Decision by sponsor|0|||
44283738|NCT01786512|79247158|FG008|Overall Study|Decision by sponsor|0|||
44283739|NCT01786512|79247159|FG009|Overall Study|Decision by sponsor|0|||
44532801|NCT03689712|79542700|FG000|Overall Study|Other|1|||
44532802|NCT03689712|79542701|FG001|Overall Study|Other|0|||
44532803|NCT03689712|79542700|FG000|Overall Study|Patient Non-Compliance|0|||
44532804|NCT03689712|79542701|FG001|Overall Study|Patient Non-Compliance|1|||
44532805|NCT03689712|79542700|FG000|Overall Study|Withdrawal by Subject|20|||
44153932|NCT04688671|78944664|FG000|Overall Study|Lost to Follow-up|0|||
44153933|NCT04688671|78944665|FG001|Overall Study|Lost to Follow-up|1|||
44153934|NCT04668209|78944673|FG000|Overall Study|Withdrawal by Subject|2|||
44153935|NCT04668209|78944674|FG001|Overall Study|Withdrawal by Subject|2|||
44153936|NCT04668209|78944673|FG000|Overall Study|Lost to Follow-up|3|||
44153937|NCT04668209|78944674|FG001|Overall Study|Lost to Follow-up|4|||
44153938|NCT04668209|78944673|FG000|Overall Study|Subject Expired|2|||
44153939|NCT04668209|78944674|FG001|Overall Study|Subject Expired|0|||
44153940|NCT04668209|78944673|FG000|Overall Study|Withdrawn from study|0|||
44153941|NCT04668209|78944674|FG001|Overall Study|Withdrawn from study|1|||
44153942|NCT04668209|78944673|FG000|Overall Study|Adverse Event|0|||
44153943|NCT04668209|78944674|FG001|Overall Study|Adverse Event|1|||
44153944|NCT04456998|78944684|FG000|Overall Study|Adverse Event|0|||
44532806|NCT03689712|79542701|FG001|Overall Study|Withdrawal by Subject|4|||
44532807|NCT03689712|79542700|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
44532808|NCT03689712|79542701|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
44153945|NCT04456998|78944685|FG001|Overall Study|Adverse Event|4|||
44153946|NCT04456998|78944684|FG000|Overall Study|Protocol Deviation|0|||
44153947|NCT04456998|78944685|FG001|Overall Study|Protocol Deviation|1|||
44153948|NCT04456998|78944684|FG000|Overall Study|Withdrawal by Subject|0|||
44153949|NCT04456998|78944685|FG001|Overall Study|Withdrawal by Subject|1|||
44283740|NCT01786512|79247160|FG010|Overall Study|Decision by sponsor|2|||
44283741|NCT01786512|79247150|FG000|Overall Study|Withdrawal by Subject|0|||
44283742|NCT01786512|79247151|FG001|Overall Study|Withdrawal by Subject|1|||
44283743|NCT01786512|79247152|FG002|Overall Study|Withdrawal by Subject|0|||
44283744|NCT01786512|79247153|FG003|Overall Study|Withdrawal by Subject|0|||
44283745|NCT01786512|79247154|FG004|Overall Study|Withdrawal by Subject|0|||
44532809|NCT03689712|79542700|FG000|Overall Study|Randomized but not Treated|13|||
44532810|NCT03689712|79542701|FG001|Overall Study|Randomized but not Treated|7|||
44532811|NCT03689712|79542700|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
44532812|NCT03689712|79542701|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
44532813|NCT03679624|79542709|FG000|Overall Study|Adverse Event|1|||
44532814|NCT03679624|79542710|FG001|Overall Study|Adverse Event|0|||
44153950|NCT04251221|78944714|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
44153951|NCT04251221|78944715|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
44153952|NCT04203238|78944723|FG000|Overall Study|Withdrawal by Subject|1|||
44153953|NCT04203238|78944724|FG001|Overall Study|Withdrawal by Subject|1|||
44153954|NCT04203238|78944723|FG000|Overall Study|Covid-19|3|||
44153955|NCT04203238|78944724|FG001|Overall Study|Covid-19|0|||
44153956|NCT04055844|78944762|FG000|Overall Study|Adverse Event|12|||
44153957|NCT04055844|78944762|FG000|Overall Study|Poor Performance|1|||
44153958|NCT04055844|78944762|FG000|Overall Study|Death|1|||
44153959|NCT03905655|78944784|FG000|Overall Study|Adverse Event|1|||
44153960|NCT03905655|78944785|FG001|Overall Study|Adverse Event|0|||
44153961|NCT03905655|78944786|FG002|Overall Study|Adverse Event|1|||
44532815|NCT03602586|79542716|FG000|Overall Study|Withdrawal by Subject|3|||
44532816|NCT03399552|79542729|FG000|Overall Study|No evidence of disease|1|||
44532817|NCT03399552|79542729|FG000|Overall Study|Unevaluable|1|||
44532818|NCT03312231|79542764|FG000|Overall Study|Lost to Follow-up|2|||
44532819|NCT03312231|79542765|FG001|Overall Study|Lost to Follow-up|6|||
44532820|NCT03312231|79542766|FG002|Overall Study|Lost to Follow-up|1|||
44532821|NCT03312231|79542767|FG003|Overall Study|Lost to Follow-up|3|||
44532822|NCT03312231|79542768|FG004|Overall Study|Lost to Follow-up|1|||
44532823|NCT03312231|79542764|FG000|Overall Study|Withdrawal by Subject|0|||
44532824|NCT03312231|79542765|FG001|Overall Study|Withdrawal by Subject|3|||
44532825|NCT03312231|79542766|FG002|Overall Study|Withdrawal by Subject|1|||
44532826|NCT03312231|79542767|FG003|Overall Study|Withdrawal by Subject|0|||
44532827|NCT03312231|79542768|FG004|Overall Study|Withdrawal by Subject|0|||
44532828|NCT03312231|79542764|FG000|Overall Study|Death|0|||
44532829|NCT03312231|79542765|FG001|Overall Study|Death|1|||
44532830|NCT03312231|79542766|FG002|Overall Study|Death|1|||
44532831|NCT03312231|79542767|FG003|Overall Study|Death|0|||
44532832|NCT03312231|79542768|FG004|Overall Study|Death|0|||
44532833|NCT03312231|79542764|FG000|Overall Study|Study Vaccination not Received|1|||
44532834|NCT03312231|79542765|FG001|Overall Study|Study Vaccination not Received|1|||
44532835|NCT03312231|79542766|FG002|Overall Study|Study Vaccination not Received|1|||
44532836|NCT03312231|79542767|FG003|Overall Study|Study Vaccination not Received|0|||
44532837|NCT03312231|79542768|FG004|Overall Study|Study Vaccination not Received|0|||
44532838|NCT03294590|79542782|FG000|Overall Study|Lost to Follow-up|105|||
44532839|NCT03294590|79542783|FG001|Overall Study|Lost to Follow-up|107|||
44532840|NCT03292731|79542794|FG000|Overall Study|Protocol Violation|4|||
44532841|NCT03292731|79542795|FG001|Overall Study|Protocol Violation|11|||
44532842|NCT03292731|79542796|FG002|Overall Study|Protocol Violation|1|||
44532843|NCT03277313|79542821|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
44532844|NCT03277313|79542822|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
44532845|NCT03277313|79542821|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
44532846|NCT03277313|79542822|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
44532847|NCT03277313|79542821|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
44532848|NCT03277313|79542822|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
44532849|NCT03277313|79542821|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
44532850|NCT03277313|79542822|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
44153962|NCT03905655|78944787|FG003|Overall Study|Adverse Event|1|||
44153963|NCT03761849|78944803|FG000|Overall Study|transferred to OpenLabelExtension|35|||
44153964|NCT03761849|78944804|FG001|Overall Study|transferred to OpenLabelExtension|34|||
44153965|NCT03761849|78944805|FG002|Overall Study|transferred to OpenLabelExtension|36|||
44153966|NCT03761849|78944806|FG003|Overall Study|transferred to OpenLabelExtension|0|||
44153967|NCT03761849|78944807|FG004|Overall Study|transferred to OpenLabelExtension|0|||
44153968|NCT03761849|78944808|FG005|Overall Study|transferred to OpenLabelExtension|0|||
44153969|NCT03761849|78944803|FG000|Overall Study|Adverse Event|1|||
44153970|NCT03761849|78944804|FG001|Overall Study|Adverse Event|0|||
44153971|NCT03761849|78944805|FG002|Overall Study|Adverse Event|0|||
44532851|NCT03277313|79542821|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
44153972|NCT03761849|78944806|FG003|Overall Study|Adverse Event|0|||
44153973|NCT03761849|78944807|FG004|Overall Study|Adverse Event|2|||
44255668|NCT02607306|79099337|FG002|Overall Study|Lack of Efficacy|1|||
44532852|NCT03277313|79542822|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
44532853|NCT03206073|79542834|FG000|Overall Study|Participant Noncompliance|0|||
44532854|NCT03206073|79542835|FG001|Overall Study|Participant Noncompliance|1|||
44532855|NCT03206073|79542836|FG002|Overall Study|Participant Noncompliance|0|||
44532856|NCT03206073|79542837|FG003|Overall Study|Participant Noncompliance|0|||
44532857|NCT03206073|79542834|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
44532858|NCT03206073|79542835|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
44532859|NCT03206073|79542836|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
44532860|NCT03206073|79542837|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
44532861|NCT03206073|79542834|FG000|Overall Study|Death|0|||
44532862|NCT03206073|79542835|FG001|Overall Study|Death|0|||
44532863|NCT03206073|79542836|FG002|Overall Study|Death|1|||
44532864|NCT03206073|79542837|FG003|Overall Study|Death|0|||
44532865|NCT03206073|79542834|FG000|Overall Study|Taken off active treatment|0|||
44153974|NCT03761849|78944808|FG005|Overall Study|Adverse Event|3|||
44153975|NCT03761849|78944803|FG000|Overall Study|Withdrawal by Subject|0|||
44153976|NCT03761849|78944804|FG001|Overall Study|Withdrawal by Subject|0|||
44153977|NCT03761849|78944805|FG002|Overall Study|Withdrawal by Subject|0|||
44153978|NCT03761849|78944806|FG003|Overall Study|Withdrawal by Subject|41|||
44153979|NCT03761849|78944807|FG004|Overall Study|Withdrawal by Subject|43|||
44153980|NCT03761849|78944808|FG005|Overall Study|Withdrawal by Subject|35|||
44153981|NCT03761849|78944803|FG000|Overall Study|Lost to Follow-up|0|||
44153982|NCT03761849|78944804|FG001|Overall Study|Lost to Follow-up|1|||
44153983|NCT03761849|78944805|FG002|Overall Study|Lost to Follow-up|0|||
44153984|NCT03761849|78944806|FG003|Overall Study|Lost to Follow-up|2|||
44153985|NCT03761849|78944807|FG004|Overall Study|Lost to Follow-up|4|||
44153986|NCT03761849|78944808|FG005|Overall Study|Lost to Follow-up|5|||
44153987|NCT03761849|78944803|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
44153988|NCT03761849|78944804|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
44153989|NCT03761849|78944805|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
44153990|NCT03761849|78944806|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
44532866|NCT03206073|79542835|FG001|Overall Study|Taken off active treatment|0|||
44532867|NCT03206073|79542836|FG002|Overall Study|Taken off active treatment|3|||
44532868|NCT03206073|79542837|FG003|Overall Study|Taken off active treatment|0|||
44532869|NCT03193801|79542847|FG000|Overall Study|Physician Decision|2|||
44532870|NCT03193801|79542847|FG000|Overall Study|Withdrawal by Subject|1|||
44532871|NCT02973997|79542853|FG000|Overall Study|Withdrawal by Subject|4|||
44532872|NCT02973997|79542854|FG001|Overall Study|Withdrawal by Subject|0|||
44532873|NCT02973997|79542853|FG000|Overall Study|Adverse Event|4|||
44532874|NCT02973997|79542854|FG001|Overall Study|Adverse Event|1|||
44532875|NCT02973997|79542853|FG000|Overall Study|Disease Progression|11|||
44532876|NCT02973997|79542854|FG001|Overall Study|Disease Progression|20|||
44532877|NCT02973997|79542853|FG000|Overall Study|Alternative Therapy|3|||
44532878|NCT02973997|79542854|FG001|Overall Study|Alternative Therapy|0|||
44153991|NCT03761849|78944807|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
44283746|NCT01786512|79247155|FG005|Overall Study|Withdrawal by Subject|0|||
44283747|NCT01786512|79247156|FG006|Overall Study|Withdrawal by Subject|1|||
44283748|NCT01786512|79247157|FG007|Overall Study|Withdrawal by Subject|0|||
44283749|NCT01786512|79247158|FG008|Overall Study|Withdrawal by Subject|0|||
44283750|NCT01786512|79247159|FG009|Overall Study|Withdrawal by Subject|3|||
44283751|NCT01786512|79247160|FG010|Overall Study|Withdrawal by Subject|7|||
44283752|NCT01786512|79247150|FG000|Overall Study|Death|0|||
44532879|NCT02973997|79542853|FG000|Overall Study|Other complicating disease|0|||
44532880|NCT02973997|79542854|FG001|Overall Study|Other complicating disease|1|||
44532881|NCT02973997|79542853|FG000|Overall Study|Death|0|||
44532882|NCT02973997|79542854|FG001|Overall Study|Death|1|||
44532883|NCT02941926|79542862|FG000|Core Phase|Progressive disease|1109|||
44532884|NCT02941926|79542862|FG000|Core Phase|Adverse Event|504|||
44532885|NCT02941926|79542862|FG000|Core Phase|Subject/guardian decision|127|||
44153992|NCT03761849|78944808|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
44153993|NCT03761849|78944803|FG000|Overall Study|Physician Decision|0|||
44283753|NCT01786512|79247151|FG001|Overall Study|Death|0|||
44283754|NCT01786512|79247152|FG002|Overall Study|Death|0|||
44283755|NCT01786512|79247153|FG003|Overall Study|Death|0|||
44283756|NCT01786512|79247154|FG004|Overall Study|Death|0|||
44283757|NCT01786512|79247155|FG005|Overall Study|Death|0|||
44532886|NCT02941926|79542862|FG000|Core Phase|Physician Decision|112|||
44532887|NCT02941926|79542862|FG000|Core Phase|Death|46|||
44532888|NCT02941926|79542862|FG000|Core Phase|Protocol deviation|34|||
44532889|NCT02941926|79542862|FG000|Core Phase|Lost to Follow-up|8|||
44532890|NCT02941926|79542862|FG000|Core Phase|Technical problems|5|||
44153994|NCT03761849|78944804|FG001|Overall Study|Physician Decision|0|||
44153995|NCT03761849|78944805|FG002|Overall Study|Physician Decision|0|||
44153996|NCT03761849|78944806|FG003|Overall Study|Physician Decision|1|||
44153997|NCT03761849|78944807|FG004|Overall Study|Physician Decision|4|||
44153998|NCT03761849|78944808|FG005|Overall Study|Physician Decision|4|||
44283758|NCT01786512|79247156|FG006|Overall Study|Death|0|||
44283759|NCT01786512|79247157|FG007|Overall Study|Death|0|||
44283760|NCT01786512|79247158|FG008|Overall Study|Death|4|||
44283761|NCT01786512|79247159|FG009|Overall Study|Death|1|||
44283762|NCT01786512|79247160|FG010|Overall Study|Death|3|||
44283763|NCT01772160|79247192|FG000|Overall Study|Death|3|||
44283764|NCT01772160|79247192|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
44283765|NCT01772160|79247192|FG000|Overall Study|Consent withdrawal|3|||
44283766|NCT01772160|79247192|FG000|Overall Study|Migrated / moved from the study area|4|||
44283767|NCT01772160|79247192|FG000|Overall Study|Lost to Follow-up|30|||
44283768|NCT01772160|79247192|FG000|Overall Study|Other|5|||
44283769|NCT01770912|79247198|FG000|Overall Study|Lost to Follow-up|2|||
44283770|NCT01770912|79247199|FG001|Overall Study|Lost to Follow-up|0|||
44283771|NCT01811706|79247205|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
44283772|NCT01811706|79247206|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
44283773|NCT01811472|79247217|FG000|Overall Study|Adverse Event|1|||
44283774|NCT01811472|79247218|FG001|Overall Study|Adverse Event|0|||
44283775|NCT01811472|79247219|FG002|Overall Study|Adverse Event|4|||
44283776|NCT01811472|79247217|FG000|Overall Study|Lost to Follow-up|0|||
44283777|NCT01811472|79247218|FG001|Overall Study|Lost to Follow-up|0|||
44283778|NCT01811472|79247219|FG002|Overall Study|Lost to Follow-up|1|||
44283779|NCT01811472|79247217|FG000|Overall Study|Subject/guardian decision|1|||
44283780|NCT01811472|79247218|FG001|Overall Study|Subject/guardian decision|0|||
44283781|NCT01811472|79247219|FG002|Overall Study|Subject/guardian decision|0|||
44283782|NCT01811238|79247228|FG000|Overall Study|Withdrawal by Subject|42|||
44283783|NCT01811238|79247228|FG000|Overall Study|Adverse Event|25|||
44283784|NCT01811238|79247228|FG000|Overall Study|Protocol Violation|4|||
44283785|NCT01811238|79247228|FG000|Overall Study|Lack of Efficacy|4|||
44283786|NCT01811238|79247228|FG000|Overall Study|subject refused study medication|6|||
44283787|NCT01769508|79247233|FG000|Overall Study|Death|3|||
44283788|NCT01769508|79247233|FG000|Overall Study|Withdrawal by Subject|1|||
44283789|NCT01769508|79247233|FG000|Overall Study|Adverse Event|1|||
44283790|NCT01769508|79247233|FG000|Overall Study|Lost to Follow-up|1|||
44283791|NCT01810380|79247240|FG000|Overall Study|Randomised not treated|2|||
44283792|NCT01810380|79247241|FG001|Overall Study|Randomised not treated|1|||
44283793|NCT01810380|79247242|FG002|Overall Study|Randomised not treated|1|||
44283794|NCT01810380|79247240|FG000|Overall Study|Adverse Event|11|||
44283795|NCT01810380|79247241|FG001|Overall Study|Adverse Event|14|||
44283796|NCT01810380|79247242|FG002|Overall Study|Adverse Event|4|||
44283797|NCT01810380|79247240|FG000|Overall Study|Lack of Efficacy|24|||
44283798|NCT01810380|79247241|FG001|Overall Study|Lack of Efficacy|10|||
44283799|NCT01810380|79247242|FG002|Overall Study|Lack of Efficacy|11|||
44283800|NCT01810380|79247240|FG000|Overall Study|Protocol Violation|1|||
44283801|NCT01810380|79247241|FG001|Overall Study|Protocol Violation|0|||
44283802|NCT01810380|79247242|FG002|Overall Study|Protocol Violation|1|||
44283803|NCT01810380|79247240|FG000|Overall Study|Withdrawal by Subject|6|||
44283804|NCT01810380|79247241|FG001|Overall Study|Withdrawal by Subject|0|||
44283805|NCT01810380|79247242|FG002|Overall Study|Withdrawal by Subject|6|||
44283806|NCT01810380|79247240|FG000|Overall Study|Administrative or other reasons|11|||
44283807|NCT01810380|79247241|FG001|Overall Study|Administrative or other reasons|13|||
44153999|NCT03761849|78944803|FG000|Overall Study|Death|0|||
44283808|NCT01810380|79247242|FG002|Overall Study|Administrative or other reasons|9|||
44283809|NCT01769196|79247252|FG000|Overall Study|Adverse Event|24|||
44283810|NCT01769196|79247253|FG001|Overall Study|Adverse Event|20|||
44283811|NCT01769196|79247252|FG000|Overall Study|Death|21|||
44283812|NCT01769196|79247253|FG001|Overall Study|Death|26|||
44283813|NCT01769196|79247252|FG000|Overall Study|Investigator Discretion|7|||
44283814|NCT01769196|79247253|FG001|Overall Study|Investigator Discretion|3|||
44283815|NCT01769196|79247252|FG000|Overall Study|Lack of Efficacy|3|||
44283816|NCT01769196|79247253|FG001|Overall Study|Lack of Efficacy|2|||
44283817|NCT01769196|79247252|FG000|Overall Study|Progressive disease|11|||
44283818|NCT01769196|79247253|FG001|Overall Study|Progressive disease|6|||
44283819|NCT01769196|79247252|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
44415507|NCT00624286|79423270|FG000|Overall Study|Protocol Deviation|7|||
44154000|NCT03761849|78944804|FG001|Overall Study|Death|0|||
44283820|NCT01769196|79247253|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
44154001|NCT03761849|78944805|FG002|Overall Study|Death|0|||
44154002|NCT03761849|78944806|FG003|Overall Study|Death|1|||
44283821|NCT01769196|79247252|FG000|Overall Study|Protocol Violation|0|||
44283822|NCT01769196|79247253|FG001|Overall Study|Protocol Violation|3|||
44283823|NCT01769196|79247252|FG000|Overall Study|Study terminated by sponsor|160|||
44283824|NCT01769196|79247253|FG001|Overall Study|Study terminated by sponsor|161|||
44154003|NCT03761849|78944807|FG004|Overall Study|Death|1|||
44283825|NCT01769196|79247252|FG000|Overall Study|Participant never dosed with study drug|1|||
44154004|NCT03761849|78944808|FG005|Overall Study|Death|3|||
44154005|NCT03761849|78944803|FG000|Overall Study|Protocol Violation|0|||
44154006|NCT03761849|78944804|FG001|Overall Study|Protocol Violation|0|||
44154007|NCT03761849|78944805|FG002|Overall Study|Protocol Violation|0|||
44154008|NCT03761849|78944806|FG003|Overall Study|Protocol Violation|2|||
44154009|NCT03761849|78944807|FG004|Overall Study|Protocol Violation|2|||
44154010|NCT03761849|78944808|FG005|Overall Study|Protocol Violation|1|||
44154011|NCT03761849|78944803|FG000|Overall Study|Participant could not come to site|0|||
44154012|NCT03761849|78944804|FG001|Overall Study|Participant could not come to site|0|||
44154013|NCT03761849|78944805|FG002|Overall Study|Participant could not come to site|0|||
44154014|NCT03761849|78944806|FG003|Overall Study|Participant could not come to site|0|||
44154015|NCT03761849|78944807|FG004|Overall Study|Participant could not come to site|1|||
44154016|NCT03761849|78944808|FG005|Overall Study|Participant could not come to site|0|||
44154017|NCT03761849|78944803|FG000|Overall Study|SF- safety Finding|0|||
44283826|NCT01769196|79247253|FG001|Overall Study|Participant never dosed with study drug|0|||
44283827|NCT01769196|79247252|FG000|Overall Study|Withdrew consent|36|||
44154018|NCT03761849|78944804|FG001|Overall Study|SF- safety Finding|0|||
44154019|NCT03761849|78944805|FG002|Overall Study|SF- safety Finding|0|||
44154020|NCT03761849|78944806|FG003|Overall Study|SF- safety Finding|0|||
44154021|NCT03761849|78944807|FG004|Overall Study|SF- safety Finding|0|||
44154022|NCT03761849|78944808|FG005|Overall Study|SF- safety Finding|1|||
44154023|NCT03761849|78944803|FG000|Overall Study|Patient did not attend visit|0|||
44154024|NCT03761849|78944804|FG001|Overall Study|Patient did not attend visit|0|||
44154025|NCT03761849|78944805|FG002|Overall Study|Patient did not attend visit|0|||
44154026|NCT03761849|78944806|FG003|Overall Study|Patient did not attend visit|0|||
44154027|NCT03761849|78944807|FG004|Overall Study|Patient did not attend visit|0|||
44154028|NCT03761849|78944808|FG005|Overall Study|Patient did not attend visit|1|||
44154029|NCT03698994|78944822|FG000|Overall Study|Adverse Event|2|||
44154030|NCT03698994|78944822|FG000|Overall Study|Death|1|||
44154031|NCT03698994|78944822|FG000|Overall Study|Physician Decision|1|||
44154032|NCT03698994|78944822|FG000|Overall Study|Withdrawal by Subject|3|||
44154033|NCT03698994|78944822|FG000|Overall Study|Progressive Disease|12|||
44154034|NCT03555149|78944847|FG000|Overall Study|Death|18|||
44154035|NCT03555149|78944848|FG001|Overall Study|Death|15|||
44154036|NCT03555149|78944849|FG002|Overall Study|Death|15|||
44154037|NCT03555149|78944850|FG003|Overall Study|Death|4|||
44154038|NCT03555149|78944851|FG004|Overall Study|Death|4|||
44154039|NCT03555149|78944852|FG005|Overall Study|Death|11|||
44154040|NCT03555149|78944853|FG006|Overall Study|Death|12|||
44154041|NCT03555149|78944854|FG007|Overall Study|Death|1|||
44154042|NCT03555149|78944847|FG000|Overall Study|Lost to Follow-up|1|||
44154043|NCT03555149|78944848|FG001|Overall Study|Lost to Follow-up|0|||
44154044|NCT03555149|78944849|FG002|Overall Study|Lost to Follow-up|0|||
44154045|NCT03555149|78944850|FG003|Overall Study|Lost to Follow-up|0|||
44283828|NCT01769196|79247253|FG001|Overall Study|Withdrew consent|40|||
44283829|NCT01810302|79247261|FG000|Overall Study|Death|1|||
44283830|NCT01810302|79247262|FG001|Overall Study|Death|0|||
44283831|NCT01810302|79247261|FG000|Overall Study|Physician Decision|0|||
44283832|NCT01810302|79247262|FG001|Overall Study|Physician Decision|1|||
44283833|NCT01783938|79247270|FG000|Overall Study|Disease Progression|18|||
44154046|NCT03555149|78944851|FG004|Overall Study|Lost to Follow-up|0|||
44283834|NCT01783938|79247271|FG001|Overall Study|Disease Progression|41|||
44283835|NCT01783938|79247270|FG000|Overall Study|Study Drug Toxicity|27|||
44283836|NCT01783938|79247271|FG001|Overall Study|Study Drug Toxicity|14|||
44283837|NCT01783938|79247270|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
44415508|NCT00624286|79423271|FG001|Overall Study|Protocol Deviation|9|||
44154047|NCT03555149|78944852|FG005|Overall Study|Lost to Follow-up|1|||
44283838|NCT01783938|79247271|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
44415509|NCT00624286|79423270|FG000|Overall Study|Adverse Event|6|||
44415510|NCT00624286|79423271|FG001|Overall Study|Adverse Event|3|||
44154048|NCT03555149|78944853|FG006|Overall Study|Lost to Follow-up|0|||
44154049|NCT03555149|78944854|FG007|Overall Study|Lost to Follow-up|0|||
44283839|NCT01783938|79247270|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
44415511|NCT00624286|79423270|FG000|Overall Study|Withdrawal by Subject|5|||
44154050|NCT03555149|78944847|FG000|Overall Study|Physician Decision|1|||
44154051|NCT03555149|78944848|FG001|Overall Study|Physician Decision|0|||
44154052|NCT03555149|78944849|FG002|Overall Study|Physician Decision|0|||
44154053|NCT03555149|78944850|FG003|Overall Study|Physician Decision|0|||
44154054|NCT03555149|78944851|FG004|Overall Study|Physician Decision|0|||
44154055|NCT03555149|78944852|FG005|Overall Study|Physician Decision|0|||
44415512|NCT00624286|79423271|FG001|Overall Study|Withdrawal by Subject|4|||
44283840|NCT01783938|79247271|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
44283841|NCT01783938|79247270|FG000|Overall Study|Participant Withdrew Consent|2|||
44283842|NCT01783938|79247271|FG001|Overall Study|Participant Withdrew Consent|0|||
44283843|NCT01783938|79247270|FG000|Overall Study|Maximum Clinical Benefit|1|||
44283844|NCT01783938|79247271|FG001|Overall Study|Maximum Clinical Benefit|0|||
44283845|NCT01783938|79247270|FG000|Overall Study|Other Reasons|3|||
44283846|NCT01783938|79247271|FG001|Overall Study|Other Reasons|1|||
44283847|NCT01768572|79247280|FG000|Overall Study|Adverse Event|7|||
44283848|NCT01768572|79247281|FG001|Overall Study|Adverse Event|8|||
44283849|NCT01768572|79247282|FG002|Overall Study|Adverse Event|4|||
44283850|NCT01768572|79247280|FG000|Overall Study|Lack of Efficacy|1|||
44283851|NCT01768572|79247281|FG001|Overall Study|Lack of Efficacy|3|||
44283852|NCT01768572|79247282|FG002|Overall Study|Lack of Efficacy|1|||
44283853|NCT01768572|79247280|FG000|Overall Study|Other, Not due to an adverse event|1|||
44283854|NCT01768572|79247281|FG001|Overall Study|Other, Not due to an adverse event|1|||
44283855|NCT01768572|79247282|FG002|Overall Study|Other, Not due to an adverse event|1|||
44283856|NCT01783548|79247292|FG000|Overall Study|Adverse Event|8|||
44283857|NCT01783548|79247293|FG001|Overall Study|Adverse Event|4|||
44283858|NCT01783548|79247292|FG000|Overall Study|Withdrawal by Subject|11|||
44283859|NCT01783548|79247293|FG001|Overall Study|Withdrawal by Subject|8|||
44283860|NCT01783548|79247292|FG000|Overall Study|Non-compliance|4|||
44283861|NCT01783548|79247293|FG001|Overall Study|Non-compliance|0|||
44283862|NCT01783548|79247292|FG000|Overall Study|Protocol Violation|2|||
44283863|NCT01783548|79247293|FG001|Overall Study|Protocol Violation|2|||
44283864|NCT01783548|79247292|FG000|Overall Study|Lost to Follow-up|8|||
44283865|NCT01783548|79247293|FG001|Overall Study|Lost to Follow-up|3|||
44283866|NCT01783548|79247292|FG000|Overall Study|Lack of Efficacy|1|||
44283867|NCT01783548|79247293|FG001|Overall Study|Lack of Efficacy|1|||
44283868|NCT01809210|79247306|FG000|Overall Study|Withdrawal by Subject|0|||
44283869|NCT01809210|79247307|FG001|Overall Study|Withdrawal by Subject|0|||
44283870|NCT01809210|79247308|FG002|Overall Study|Withdrawal by Subject|1|||
44283871|NCT01809210|79247309|FG003|Overall Study|Withdrawal by Subject|1|||
44283872|NCT01809210|79247310|FG004|Overall Study|Withdrawal by Subject|1|||
44283873|NCT01809210|79247311|FG005|Overall Study|Withdrawal by Subject|0|||
44415513|NCT00624286|79423270|FG000|Overall Study|Lost to Follow-up|3|||
44283874|NCT01809210|79247312|FG006|Overall Study|Withdrawal by Subject|4|||
44283875|NCT01809210|79247306|FG000|Overall Study|Death|1|||
44283876|NCT01809210|79247307|FG001|Overall Study|Death|1|||
44283877|NCT01809210|79247308|FG002|Overall Study|Death|2|||
44283878|NCT01809210|79247309|FG003|Overall Study|Death|0|||
44283879|NCT01809210|79247310|FG004|Overall Study|Death|1|||
44283880|NCT01809210|79247311|FG005|Overall Study|Death|3|||
44283881|NCT01809210|79247312|FG006|Overall Study|Death|1|||
44283882|NCT01809132|79247331|FG000|Overall Study|Withdrawal by Subject|0|||
44283883|NCT01809132|79247332|FG001|Overall Study|Withdrawal by Subject|0|||
44283884|NCT01809132|79247333|FG002|Overall Study|Withdrawal by Subject|1|||
44283885|NCT01808508|79247344|FG000|Overall Study|Lost to Follow-up|1|||
44283886|NCT01808508|79247345|FG001|Overall Study|Lost to Follow-up|0|||
44283887|NCT01808508|79247346|FG002|Overall Study|Lost to Follow-up|0|||
44415514|NCT00624286|79423271|FG001|Overall Study|Lost to Follow-up|2|||
44415515|NCT00624286|79423270|FG000|Overall Study|Administrative problems|3|||
44283888|NCT01766778|79247356|FG000|Overall Study|Adverse Event|4|||
44283889|NCT01766778|79247357|FG001|Overall Study|Adverse Event|4|||
44283890|NCT01766778|79247356|FG000|Overall Study|Withdrawal by Subject|1|||
44415516|NCT00624286|79423271|FG001|Overall Study|Administrative problems|0|||
44415517|NCT00624286|79423270|FG000|Overall Study|Lack of Efficacy|1|||
44154056|NCT03555149|78944853|FG006|Overall Study|Physician Decision|0|||
44154057|NCT03555149|78944854|FG007|Overall Study|Physician Decision|0|||
44154058|NCT03555149|78944847|FG000|Overall Study|Study Terminated By Sponsor|1|||
44154059|NCT03555149|78944848|FG001|Overall Study|Study Terminated By Sponsor|0|||
44154060|NCT03555149|78944849|FG002|Overall Study|Study Terminated By Sponsor|0|||
44154061|NCT03555149|78944850|FG003|Overall Study|Study Terminated By Sponsor|0|||
44154062|NCT03555149|78944851|FG004|Overall Study|Study Terminated By Sponsor|0|||
44154063|NCT03555149|78944852|FG005|Overall Study|Study Terminated By Sponsor|2|||
44154064|NCT03555149|78944853|FG006|Overall Study|Study Terminated By Sponsor|3|||
44154065|NCT03555149|78944854|FG007|Overall Study|Study Terminated By Sponsor|1|||
44154066|NCT03555149|78944847|FG000|Overall Study|Withdrawal by Subject|3|||
44154067|NCT03555149|78944848|FG001|Overall Study|Withdrawal by Subject|0|||
44154068|NCT03555149|78944849|FG002|Overall Study|Withdrawal by Subject|0|||
44154069|NCT03555149|78944850|FG003|Overall Study|Withdrawal by Subject|2|||
44154070|NCT03555149|78944851|FG004|Overall Study|Withdrawal by Subject|0|||
44154071|NCT03555149|78944852|FG005|Overall Study|Withdrawal by Subject|1|||
44154072|NCT03555149|78944853|FG006|Overall Study|Withdrawal by Subject|0|||
44154073|NCT03555149|78944854|FG007|Overall Study|Withdrawal by Subject|0|||
44154074|NCT03515811|78944874|FG000|Overall Study|Lost to Follow-up|2|||
44154075|NCT03515811|78944875|FG001|Overall Study|Lost to Follow-up|1|||
44154076|NCT03515811|78944874|FG000|Overall Study|Protocol Violation|1|||
44154077|NCT03515811|78944875|FG001|Overall Study|Protocol Violation|1|||
44154078|NCT03515811|78944874|FG000|Overall Study|Death|1|||
44154079|NCT03515811|78944875|FG001|Overall Study|Death|1|||
44154080|NCT03515811|78944874|FG000|Overall Study|Withdrawal by Subject|0|||
44154081|NCT03515811|78944875|FG001|Overall Study|Withdrawal by Subject|2|||
44154082|NCT03515811|78944874|FG000|Overall Study|Technical Problems|1|||
44154083|NCT03515811|78944875|FG001|Overall Study|Technical Problems|0|||
44154084|NCT03515811|78944874|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
44154085|NCT03515811|78944875|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
44154086|NCT03515811|78944874|FG000|Overall Study|COVID-19|0|||
44154087|NCT03515811|78944875|FG001|Overall Study|COVID-19|1|||
44154088|NCT02975934|78944943|FG000|Treatment Phase|Ongoing at data-analysis|33|||
44154089|NCT02975934|78944944|FG001|Treatment Phase|Ongoing at data-analysis|5|||
44154090|NCT02975934|78944943|FG000|Treatment Phase|Discontinued prior to study drug|0|||
44154091|NCT02975934|78944944|FG001|Treatment Phase|Discontinued prior to study drug|5|||
44154092|NCT02975934|78944943|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
44154093|NCT02975934|78944944|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
44154094|NCT02847598|78944958|FG000|Overall Study|Adverse Event|0|||
44154095|NCT02847598|78944959|FG001|Overall Study|Adverse Event|0|||
44154096|NCT02847598|78944960|FG002|Overall Study|Adverse Event|0|||
44154097|NCT02847598|78944961|FG003|Overall Study|Adverse Event|0|||
44154098|NCT02847598|78944962|FG004|Overall Study|Adverse Event|0|||
44154099|NCT02847598|78944963|FG005|Overall Study|Adverse Event|0|||
44154100|NCT02847598|78944964|FG006|Overall Study|Adverse Event|0|||
44154101|NCT02847598|78944965|FG007|Overall Study|Adverse Event|1|||
44154102|NCT02847598|78944958|FG000|Overall Study|Consent withdrawn|2|||
44154103|NCT02847598|78944959|FG001|Overall Study|Consent withdrawn|0|||
44154104|NCT02847598|78944960|FG002|Overall Study|Consent withdrawn|0|||
44154105|NCT02847598|78944961|FG003|Overall Study|Consent withdrawn|4|||
44154106|NCT02847598|78944962|FG004|Overall Study|Consent withdrawn|3|||
44283891|NCT01766778|79247357|FG001|Overall Study|Withdrawal by Subject|0|||
44283892|NCT01808196|79247363|FG000|Overall Study|Lost to Follow-up|1|||
44154107|NCT02847598|78944963|FG005|Overall Study|Consent withdrawn|2|||
44154108|NCT02847598|78944964|FG006|Overall Study|Consent withdrawn|1|||
44154109|NCT02847598|78944965|FG007|Overall Study|Consent withdrawn|3|||
44283893|NCT01808118|79247367|FG000|Period 1|Adverse Event|15|||
44154110|NCT02847598|78944958|FG000|Overall Study|Death|3|||
44154111|NCT02847598|78944959|FG001|Overall Study|Death|0|||
44154112|NCT02847598|78944960|FG002|Overall Study|Death|0|||
44154113|NCT02847598|78944961|FG003|Overall Study|Death|0|||
44154114|NCT02847598|78944962|FG004|Overall Study|Death|0|||
44283894|NCT01808118|79247368|FG001|Period 1|Adverse Event|0|||
44154115|NCT02847598|78944963|FG005|Overall Study|Death|0|||
44154116|NCT02847598|78944964|FG006|Overall Study|Death|0|||
44154117|NCT02847598|78944965|FG007|Overall Study|Death|0|||
44283895|NCT01808118|79247369|FG002|Period 1|Adverse Event|0|||
44154118|NCT02847598|78944958|FG000|Overall Study|Lost to Follow-up|0|||
44154119|NCT02847598|78944959|FG001|Overall Study|Lost to Follow-up|0|||
44154120|NCT02847598|78944960|FG002|Overall Study|Lost to Follow-up|0|||
44154121|NCT02847598|78944961|FG003|Overall Study|Lost to Follow-up|0|||
44154122|NCT02847598|78944962|FG004|Overall Study|Lost to Follow-up|0|||
44283896|NCT01808118|79247367|FG000|Period 1|Withdrew consent|24|||
44283897|NCT01808118|79247368|FG001|Period 1|Withdrew consent|0|||
44283898|NCT01808118|79247369|FG002|Period 1|Withdrew consent|0|||
44283899|NCT01808118|79247367|FG000|Period 1|Lost to Follow-up|9|||
44283900|NCT01808118|79247368|FG001|Period 1|Lost to Follow-up|0|||
44283901|NCT01808118|79247369|FG002|Period 1|Lost to Follow-up|0|||
44283902|NCT01808118|79247367|FG000|Period 1|Did not meet criteria for remission|303|||
44283903|NCT01808118|79247368|FG001|Period 1|Did not meet criteria for remission|0|||
44283904|NCT01808118|79247369|FG002|Period 1|Did not meet criteria for remission|0|||
44283905|NCT01808118|79247367|FG000|Period 1|Enrolled in error|7|||
44283906|NCT01808118|79247368|FG001|Period 1|Enrolled in error|0|||
44283907|NCT01808118|79247369|FG002|Period 1|Enrolled in error|0|||
44283908|NCT01808118|79247367|FG000|Period 1|Did not meet inclusion criteria|3|||
44283909|NCT01808118|79247368|FG001|Period 1|Did not meet inclusion criteria|0|||
44283910|NCT01808118|79247369|FG002|Period 1|Did not meet inclusion criteria|0|||
44283911|NCT01808118|79247367|FG000|Period 1|Non-conformance with inclusion criteria|3|||
44283912|NCT01808118|79247368|FG001|Period 1|Non-conformance with inclusion criteria|0|||
44283913|NCT01808118|79247369|FG002|Period 1|Non-conformance with inclusion criteria|0|||
44283914|NCT01808118|79247367|FG000|Period 1|Investigator decision: site closure|2|||
44283915|NCT01808118|79247368|FG001|Period 1|Investigator decision: site closure|0|||
44283916|NCT01808118|79247369|FG002|Period 1|Investigator decision: site closure|0|||
44283917|NCT01808118|79247367|FG000|Period 1|Non-compliance per sponsor|1|||
44283918|NCT01808118|79247368|FG001|Period 1|Non-compliance per sponsor|0|||
44283919|NCT01808118|79247369|FG002|Period 1|Non-compliance per sponsor|0|||
44283920|NCT01808118|79247367|FG000|Period 1|Lack of Efficacy|1|||
44283921|NCT01808118|79247368|FG001|Period 1|Lack of Efficacy|0|||
44283922|NCT01808118|79247369|FG002|Period 1|Lack of Efficacy|0|||
44283923|NCT01808118|79247367|FG000|Period 2|Adverse Event|0|||
44532891|NCT02941926|79542862|FG000|Extension Phase|Physician Decision|155|||
44532892|NCT02941926|79542862|FG000|Extension Phase|Progressive disease|115|||
44532893|NCT02941926|79542862|FG000|Extension Phase|Adverse Event|13|||
44532894|NCT02941926|79542862|FG000|Extension Phase|Subject/Guardian decision|12|||
44532895|NCT02941926|79542862|FG000|Extension Phase|Death|6|||
44532896|NCT02846415|79542873|FG000|Overall Study|Lost to Follow-up|2|||
44532897|NCT02846415|79542874|FG001|Overall Study|Lost to Follow-up|0|||
44532898|NCT02846415|79542873|FG000|Overall Study|Withdrawal by Subject|1|||
44532899|NCT02846415|79542874|FG001|Overall Study|Withdrawal by Subject|1|||
44532900|NCT02485639|79542888|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
44154123|NCT02847598|78944963|FG005|Overall Study|Lost to Follow-up|1|||
44154124|NCT02847598|78944964|FG006|Overall Study|Lost to Follow-up|1|||
44154125|NCT02847598|78944965|FG007|Overall Study|Lost to Follow-up|0|||
44283924|NCT01808118|79247368|FG001|Period 2|Adverse Event|4|||
44283925|NCT01808118|79247369|FG002|Period 2|Adverse Event|0|||
44283926|NCT01808118|79247367|FG000|Period 2|Withdrew consent|0|||
44283927|NCT01808118|79247368|FG001|Period 2|Withdrew consent|7|||
44283928|NCT01808118|79247369|FG002|Period 2|Withdrew consent|6|||
44283929|NCT01808118|79247367|FG000|Period 2|Lost to Follow-up|0|||
44283930|NCT01808118|79247368|FG001|Period 2|Lost to Follow-up|0|||
44283931|NCT01808118|79247369|FG002|Period 2|Lost to Follow-up|2|||
44283932|NCT01808118|79247367|FG000|Period 2|Investigator no longer conducting trials|0|||
44283933|NCT01808118|79247368|FG001|Period 2|Investigator no longer conducting trials|1|||
44283934|NCT01808118|79247369|FG002|Period 2|Investigator no longer conducting trials|0|||
44283935|NCT01808118|79247367|FG000|Period 2|Switched to other therapy|0|||
44283936|NCT01808118|79247368|FG001|Period 2|Switched to other therapy|1|||
44283937|NCT01808118|79247369|FG002|Period 2|Switched to other therapy|0|||
44283938|NCT01807650|79247383|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
44532901|NCT02485639|79542888|FG000|Overall Study|Early termination|4|||
44532902|NCT02485639|79542888|FG000|Overall Study|Withdrawal by Subject|4|||
44532903|NCT02418949|79542896|FG000|Overall Study|Withdrawal by Subject|1|||
44283939|NCT01807650|79247383|FG000|Overall Study|Adverse Event|5|||
44283940|NCT01807650|79247383|FG000|Overall Study|Other|2|||
44283941|NCT01782690|79247424|FG000|Overall Study|Not reported|7|||
44283942|NCT01782690|79247424|FG000|Overall Study|Toxicity of gemcitabine|1|||
44283943|NCT01782690|79247424|FG000|Overall Study|Toxicity of erlotinib|1|||
44283944|NCT01782690|79247424|FG000|Overall Study|Lost to Follow-up|31|||
44283945|NCT01782690|79247424|FG000|Overall Study|Withdrawal of informed consent|2|||
44154126|NCT02834975|78944989|FG000|Overall Study|Physician Decision|2|||
44532904|NCT02418949|79542897|FG001|Overall Study|Withdrawal by Subject|0|||
44532905|NCT02418949|79542898|FG002|Overall Study|Withdrawal by Subject|1|||
44532906|NCT02418949|79542899|FG003|Overall Study|Withdrawal by Subject|1|||
44532907|NCT02418949|79542896|FG000|Overall Study|Lost to Follow-up|1|||
44532908|NCT02418949|79542897|FG001|Overall Study|Lost to Follow-up|0|||
44532909|NCT02418949|79542898|FG002|Overall Study|Lost to Follow-up|1|||
44532910|NCT02418949|79542899|FG003|Overall Study|Lost to Follow-up|0|||
44532911|NCT02418949|79542896|FG000|Overall Study|Physician Decision|1|||
44532912|NCT02418949|79542897|FG001|Overall Study|Physician Decision|1|||
44532913|NCT02418949|79542898|FG002|Overall Study|Physician Decision|1|||
44154127|NCT02834975|78944989|FG000|Overall Study|Adverse Event|1|||
44154128|NCT02834975|78944989|FG000|Overall Study|Withdrawal by Subject|1|||
44154129|NCT02834975|78944989|FG000|Overall Study|Lack of Efficacy|1|||
44154130|NCT02684123|78945012|FG000|Phase 1|Lack of Efficacy|5|||
44154131|NCT02684123|78945013|FG001|Phase 1|Lack of Efficacy|0|||
44154132|NCT02684123|78945012|FG000|Phase 1|Adverse Event|3|||
44283946|NCT01782690|79247424|FG000|Overall Study|Absent rash|9|||
44283947|NCT01782690|79247424|FG000|Overall Study|Physician Decision|13|||
44283948|NCT01782690|79247424|FG000|Overall Study|Patient's wish|21|||
44283949|NCT01782690|79247424|FG000|Overall Study|Tumor progression|74|||
44283950|NCT01782690|79247424|FG000|Overall Study|Death|133|||
44283951|NCT01782690|79247424|FG000|Overall Study|Study completion unknown|7|||
44283952|NCT01782378|79247430|FG000|First Series|Lost to Follow-up|7|||
44283953|NCT01782378|79247431|FG001|First Series|Lost to Follow-up|8|||
44283954|NCT01782378|79247430|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
44283955|NCT01782378|79247431|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
44283956|NCT01782378|79247430|FG000|Second Series|Lost to Follow-up|8|||
44283957|NCT01782378|79247431|FG001|Second Series|Lost to Follow-up|7|||
44283958|NCT01782378|79247430|FG000|Second Series|Did not choose to complete S2 Optional|18|||
44283959|NCT01782378|79247431|FG001|Second Series|Did not choose to complete S2 Optional|0|||
44283960|NCT01766310|79247439|FG000|Overall Study|Lost to Follow-up|1|||
44283961|NCT01766310|79247440|FG001|Overall Study|Lost to Follow-up|3|||
44283962|NCT01765920|79247448|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
44283963|NCT01765920|79247449|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
44283964|NCT01765920|79247448|FG000|Overall Study|Patient code disclosure|0|||
44283965|NCT01765920|79247449|FG001|Overall Study|Patient code disclosure|1|||
44283966|NCT01782222|79247458|FG000|Overall Study|Adverse Event|4|||
44283967|NCT01782222|79247459|FG001|Overall Study|Adverse Event|5|||
44283968|NCT01782222|79247460|FG002|Overall Study|Adverse Event|3|||
44283969|NCT01782222|79247458|FG000|Overall Study|Lack of Efficacy|2|||
44283970|NCT01782222|79247459|FG001|Overall Study|Lack of Efficacy|1|||
44283971|NCT01782222|79247460|FG002|Overall Study|Lack of Efficacy|0|||
44283972|NCT01782222|79247458|FG000|Overall Study|Protocol Violation|1|||
44532914|NCT02418949|79542899|FG003|Overall Study|Physician Decision|0|||
44532915|NCT02383433|79542909|FG000|Overall Study|Disease progression|2|||
44532916|NCT02336074|79542924|FG000|Overall Study|Adverse Event|0|||
44532917|NCT02336074|79542925|FG001|Overall Study|Adverse Event|2|||
44532918|NCT02229825|79542952|FG000|Overall Study|Personal Reasons|0|||
44532919|NCT02229825|79542953|FG001|Overall Study|Personal Reasons|1|||
44532920|NCT02229825|79542952|FG000|Overall Study|Refused continuing medication|7|||
44532921|NCT02229825|79542953|FG001|Overall Study|Refused continuing medication|6|||
44532922|NCT02229825|79542952|FG000|Overall Study|Lost to Follow-up|1|||
44283973|NCT01782222|79247459|FG001|Overall Study|Protocol Violation|0|||
44283974|NCT01782222|79247460|FG002|Overall Study|Protocol Violation|0|||
44283975|NCT01782222|79247458|FG000|Overall Study|Withdrawal by Subject|1|||
44532923|NCT02229825|79542953|FG001|Overall Study|Lost to Follow-up|2|||
44532924|NCT02229825|79542952|FG000|Overall Study|Protocol Violation|1|||
44154133|NCT02684123|78945013|FG001|Phase 1|Adverse Event|0|||
44532925|NCT02229825|79542953|FG001|Overall Study|Protocol Violation|1|||
44283976|NCT01782222|79247459|FG001|Overall Study|Withdrawal by Subject|4|||
44283977|NCT01782222|79247460|FG002|Overall Study|Withdrawal by Subject|1|||
44283978|NCT01782222|79247458|FG000|Overall Study|Moved to other state|0|||
44532926|NCT02229825|79542952|FG000|Overall Study|Lack of Efficacy|4|||
44154134|NCT02684123|78945012|FG000|Phase 1|Lost to Follow-up|0|||
44154135|NCT02684123|78945013|FG001|Phase 1|Lost to Follow-up|1|||
44154136|NCT02684123|78945012|FG000|Phase 2|Lack of Efficacy|1|||
44154137|NCT02684123|78945013|FG001|Phase 2|Lack of Efficacy|8|||
44154138|NCT02576574|78945034|FG000|Overall Study|still ongoing|65|||
44154139|NCT02576574|78945035|FG001|Overall Study|still ongoing|66|||
44154140|NCT02576574|78945036|FG002|Overall Study|still ongoing|73|||
44154141|NCT02576574|78945034|FG000|Overall Study|Randomized, not treated|5|||
44154142|NCT02576574|78945035|FG001|Overall Study|Randomized, not treated|4|||
44154143|NCT02576574|78945036|FG002|Overall Study|Randomized, not treated|26|||
44154144|NCT02203331|78945106|FG000|Overall Study|Pregnancy|1|||
44154145|NCT02203331|78945107|FG001|Overall Study|Pregnancy|0|||
44154146|NCT02203331|78945108|FG002|Overall Study|Pregnancy|0|||
44154147|NCT02203331|78945109|FG003|Overall Study|Pregnancy|0|||
44154148|NCT02203331|78945110|FG004|Overall Study|Pregnancy|2|||
44154149|NCT02203331|78945111|FG005|Overall Study|Pregnancy|0|||
44154150|NCT02203331|78945106|FG000|Overall Study|Withdrawal by Subject|1|||
44154151|NCT02203331|78945107|FG001|Overall Study|Withdrawal by Subject|0|||
44154152|NCT02203331|78945108|FG002|Overall Study|Withdrawal by Subject|1|||
44154153|NCT02203331|78945109|FG003|Overall Study|Withdrawal by Subject|0|||
44154154|NCT02203331|78945110|FG004|Overall Study|Withdrawal by Subject|0|||
44283979|NCT01782222|79247459|FG001|Overall Study|Moved to other state|1|||
44283980|NCT01782222|79247460|FG002|Overall Study|Moved to other state|0|||
44283981|NCT01781832|79247468|FG000|Overall Study|Withdrawal by Subject|1|||
44283982|NCT01807182|79247472|FG000|Overall Study|Death|1|||
44283983|NCT01807182|79247472|FG000|Overall Study|New therapy|1|||
44283984|NCT01807182|79247472|FG000|Overall Study|Moved to hospice care|1|||
44283985|NCT01806714|79247478|FG000|Overall Study|No functioning phone number|200|||
44283986|NCT01806714|79247479|FG001|Overall Study|No functioning phone number|170|||
44283987|NCT01765764|79247488|FG000|Treatment Period|Adverse Event|1|||
44283988|NCT01765764|79247489|FG001|Treatment Period|Adverse Event|2|||
44283989|NCT01765764|79247490|FG002|Treatment Period|Adverse Event|1|||
44283990|NCT01765764|79247488|FG000|Treatment Period|Lost to Follow-up|0|||
44283991|NCT01765764|79247489|FG001|Treatment Period|Lost to Follow-up|3|||
44283992|NCT01765764|79247490|FG002|Treatment Period|Lost to Follow-up|2|||
44283993|NCT01765764|79247488|FG000|Treatment Period|Personal Reasons|1|||
44283994|NCT01765764|79247489|FG001|Treatment Period|Personal Reasons|2|||
44283995|NCT01765764|79247490|FG002|Treatment Period|Personal Reasons|1|||
44283996|NCT01765764|79247488|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
44283997|NCT01765764|79247489|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
44283998|NCT01765764|79247490|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
44283999|NCT01806168|79247501|FG000|Overall Study|Adverse Event|1|||
44154155|NCT02203331|78945111|FG005|Overall Study|Withdrawal by Subject|3|||
44284000|NCT01806168|79247502|FG001|Overall Study|Adverse Event|0|||
44284001|NCT01806168|79247503|FG002|Overall Study|Adverse Event|0|||
44284002|NCT01806168|79247501|FG000|Overall Study|Withdrawal by Subject|0|||
44284003|NCT01806168|79247502|FG001|Overall Study|Withdrawal by Subject|1|||
44284004|NCT01806168|79247503|FG002|Overall Study|Withdrawal by Subject|2|||
44284005|NCT01806168|79247501|FG000|Overall Study|Protocol Violation|0|||
44532927|NCT02229825|79542953|FG001|Overall Study|Lack of Efficacy|10|||
44532928|NCT02229825|79542952|FG000|Overall Study|Adverse Event|11|||
44532929|NCT02229825|79542953|FG001|Overall Study|Adverse Event|9|||
44532930|NCT02229825|79542952|FG000|Overall Study|Not treated|0|||
44532931|NCT02229825|79542953|FG001|Overall Study|Not treated|1|||
44532932|NCT02112916|79542974|FG000|Overall Study|Adverse Event|6|||
44532933|NCT02112916|79542975|FG001|Overall Study|Adverse Event|9|||
44532934|NCT02112916|79542976|FG002|Overall Study|Adverse Event|3|||
44284006|NCT01806168|79247502|FG001|Overall Study|Protocol Violation|0|||
44284007|NCT01806168|79247503|FG002|Overall Study|Protocol Violation|1|||
44154156|NCT02203331|78945106|FG000|Overall Study|Adverse Event|4|||
44154157|NCT02203331|78945107|FG001|Overall Study|Adverse Event|8|||
44154158|NCT02203331|78945108|FG002|Overall Study|Adverse Event|3|||
44154159|NCT02203331|78945109|FG003|Overall Study|Adverse Event|4|||
44532935|NCT02112916|79542977|FG003|Overall Study|Adverse Event|2|||
44284008|NCT01804842|79247517|FG000|Overall Study|Adverse Event|1|||
44284009|NCT01804842|79247518|FG001|Overall Study|Adverse Event|1|||
44284010|NCT01804842|79247519|FG002|Overall Study|Adverse Event|0|||
44284011|NCT01804842|79247517|FG000|Overall Study|Lost to Follow-up|1|||
44284012|NCT01804842|79247518|FG001|Overall Study|Lost to Follow-up|0|||
44284013|NCT01804842|79247519|FG002|Overall Study|Lost to Follow-up|0|||
44284014|NCT01804842|79247517|FG000|Overall Study|Non-Compliance|1|||
44532936|NCT02112916|79542974|FG000|Overall Study|Death|9|||
44532937|NCT02112916|79542975|FG001|Overall Study|Death|9|||
44532938|NCT02112916|79542976|FG002|Overall Study|Death|3|||
44532939|NCT02112916|79542977|FG003|Overall Study|Death|4|||
44154160|NCT02203331|78945110|FG004|Overall Study|Adverse Event|3|||
44154161|NCT02203331|78945111|FG005|Overall Study|Adverse Event|3|||
44154162|NCT02203331|78945106|FG000|Overall Study|Other Reasons|1|||
44154163|NCT02203331|78945107|FG001|Overall Study|Other Reasons|2|||
44154164|NCT02203331|78945108|FG002|Overall Study|Other Reasons|0|||
44154165|NCT02203331|78945109|FG003|Overall Study|Other Reasons|2|||
44154166|NCT02203331|78945110|FG004|Overall Study|Other Reasons|0|||
44154167|NCT02203331|78945111|FG005|Overall Study|Other Reasons|0|||
44154168|NCT02203331|78945106|FG000|Overall Study|Lack of Efficacy|0|||
44154169|NCT02203331|78945107|FG001|Overall Study|Lack of Efficacy|2|||
44154170|NCT02203331|78945108|FG002|Overall Study|Lack of Efficacy|1|||
44154171|NCT02203331|78945109|FG003|Overall Study|Lack of Efficacy|0|||
44154172|NCT02203331|78945110|FG004|Overall Study|Lack of Efficacy|0|||
44154173|NCT02203331|78945111|FG005|Overall Study|Lack of Efficacy|1|||
44154174|NCT02203331|78945106|FG000|Overall Study|Protocol Violation|0|||
44154175|NCT02203331|78945107|FG001|Overall Study|Protocol Violation|2|||
44154176|NCT02203331|78945108|FG002|Overall Study|Protocol Violation|0|||
44154177|NCT02203331|78945109|FG003|Overall Study|Protocol Violation|1|||
44154178|NCT02203331|78945110|FG004|Overall Study|Protocol Violation|1|||
44154179|NCT02203331|78945111|FG005|Overall Study|Protocol Violation|0|||
44154180|NCT02203331|78945106|FG000|Overall Study|Lost to Follow-up|0|||
44154181|NCT02203331|78945107|FG001|Overall Study|Lost to Follow-up|0|||
44154182|NCT02203331|78945108|FG002|Overall Study|Lost to Follow-up|0|||
44154183|NCT02203331|78945109|FG003|Overall Study|Lost to Follow-up|0|||
44154184|NCT02203331|78945110|FG004|Overall Study|Lost to Follow-up|1|||
44154185|NCT02203331|78945111|FG005|Overall Study|Lost to Follow-up|0|||
44154186|NCT02170025|78945140|FG000|Overall Study|Adverse Event|2|||
44154187|NCT02170025|78945141|FG001|Overall Study|Adverse Event|0|||
44154188|NCT02164578|78945149|FG000|Treatment Period|Withdrawal by Subject|3|||
44154189|NCT02164578|78945150|FG001|Treatment Period|Withdrawal by Subject|3|||
44154190|NCT02164578|78945149|FG000|Treatment Period|Adverse Event|13|||
44154191|NCT02164578|78945150|FG001|Treatment Period|Adverse Event|6|||
44154192|NCT02164578|78945149|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
44154193|NCT02164578|78945150|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
44154194|NCT02164578|78945149|FG000|Treatment Period|Protocol Violation|0|||
44154195|NCT02164578|78945150|FG001|Treatment Period|Protocol Violation|2|||
44154196|NCT02164578|78945149|FG000|Extension Period|Withdrawal by Subject|2|||
44154197|NCT02164578|78945150|FG001|Extension Period|Withdrawal by Subject|0|||
44532940|NCT02112916|79542974|FG000|Overall Study|Lost to Follow-up|1|||
44532941|NCT02112916|79542975|FG001|Overall Study|Lost to Follow-up|0|||
44532942|NCT02112916|79542976|FG002|Overall Study|Lost to Follow-up|0|||
44532943|NCT02112916|79542977|FG003|Overall Study|Lost to Follow-up|0|||
44532944|NCT02112916|79542974|FG000|Overall Study|Physician Decision|94|||
44532945|NCT02112916|79542975|FG001|Overall Study|Physician Decision|72|||
44532946|NCT02112916|79542976|FG002|Overall Study|Physician Decision|24|||
44532947|NCT02112916|79542977|FG003|Overall Study|Physician Decision|15|||
44532948|NCT02112916|79542974|FG000|Overall Study|Withdrawal by Subject|5|||
44532949|NCT02112916|79542975|FG001|Overall Study|Withdrawal by Subject|3|||
44532950|NCT02112916|79542976|FG002|Overall Study|Withdrawal by Subject|1|||
44532951|NCT02112916|79542977|FG003|Overall Study|Withdrawal by Subject|1|||
44532952|NCT02112916|79542974|FG000|Overall Study|Ineligible|4|||
44532953|NCT02112916|79542975|FG001|Overall Study|Ineligible|8|||
44532954|NCT02112916|79542976|FG002|Overall Study|Ineligible|3|||
44532955|NCT02112916|79542977|FG003|Overall Study|Ineligible|8|||
44532956|NCT02112916|79542974|FG000|Overall Study|Inevaluable|6|||
44154198|NCT02164578|78945149|FG000|Extension Period|Adverse Event|4|||
44154199|NCT02164578|78945150|FG001|Extension Period|Adverse Event|0|||
44154200|NCT02164578|78945149|FG000|Extension Period|Expiry of study medication|1|||
44154201|NCT02164578|78945150|FG001|Extension Period|Expiry of study medication|0|||
44154202|NCT02164578|78945149|FG000|Extension Period|Protocol Violation|0|||
44532957|NCT02112916|79542975|FG001|Overall Study|Inevaluable|4|||
44532958|NCT02112916|79542976|FG002|Overall Study|Inevaluable|5|||
44532959|NCT02112916|79542977|FG003|Overall Study|Inevaluable|5|||
44154203|NCT02164578|78945150|FG001|Extension Period|Protocol Violation|1|||
44154204|NCT02107703|78945158|FG000|Overall Study|Withdrawal by Subject|46|||
44532960|NCT02112916|79542974|FG000|Overall Study|Refusal of further protocol therapy|19|||
44532961|NCT02112916|79542975|FG001|Overall Study|Refusal of further protocol therapy|16|||
44415518|NCT00624286|79423271|FG001|Overall Study|Lack of Efficacy|6|||
44415519|NCT00624286|79423270|FG000|Overall Study|Not stated|0|||
44415520|NCT00624286|79423271|FG001|Overall Study|Not stated|1|||
44415521|NCT00624286|79423270|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44532962|NCT02112916|79542976|FG002|Overall Study|Refusal of further protocol therapy|1|||
44532963|NCT02112916|79542977|FG003|Overall Study|Refusal of further protocol therapy|7|||
44532964|NCT02112916|79542974|FG000|Overall Study|Development of SMN|1|||
44532965|NCT02112916|79542975|FG001|Overall Study|Development of SMN|0|||
44532966|NCT02112916|79542976|FG002|Overall Study|Development of SMN|0|||
44532967|NCT02112916|79542977|FG003|Overall Study|Development of SMN|1|||
44532968|NCT02112916|79542974|FG000|Overall Study|Relapse/Progression|10|||
44532969|NCT02112916|79542975|FG001|Overall Study|Relapse/Progression|18|||
44532970|NCT02112916|79542976|FG002|Overall Study|Relapse/Progression|15|||
44154205|NCT02107703|78945159|FG001|Overall Study|Withdrawal by Subject|21|||
44532971|NCT02112916|79542977|FG003|Overall Study|Relapse/Progression|2|||
44532972|NCT02112916|79542974|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
44154206|NCT02107703|78945158|FG000|Overall Study|Lost to Follow-up|20|||
44255669|NCT02607306|79099335|FG000|Overall Study|Protocol Violation|4|||
44532973|NCT02112916|79542975|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
44415522|NCT00624286|79423271|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44415523|NCT00624286|79423270|FG000|Overall Study|Death|0|||
44415524|NCT00624286|79423271|FG001|Overall Study|Death|1|||
44415525|NCT00624052|79423281|FG000|Overall Study|Adverse Event|7|||
44415526|NCT00624052|79423282|FG001|Overall Study|Adverse Event|6|||
44415527|NCT00624052|79423283|FG002|Overall Study|Adverse Event|0|||
44415528|NCT00624052|79423284|FG003|Overall Study|Adverse Event|3|||
44415529|NCT00624052|79423281|FG000|Overall Study|Lack of Efficacy|1|||
44415530|NCT00624052|79423282|FG001|Overall Study|Lack of Efficacy|1|||
44154207|NCT02107703|78945159|FG001|Overall Study|Lost to Follow-up|9|||
44154208|NCT02107703|78945158|FG000|Overall Study|On study treatment/follow up|48|||
44154209|NCT02107703|78945159|FG001|Overall Study|On study treatment/follow up|5|||
44532974|NCT02112916|79542976|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
44415531|NCT00624052|79423283|FG002|Overall Study|Lack of Efficacy|0|||
44415532|NCT00624052|79423284|FG003|Overall Study|Lack of Efficacy|0|||
44415533|NCT00624052|79423281|FG000|Overall Study|Lost to Follow-up|2|||
44415534|NCT00624052|79423282|FG001|Overall Study|Lost to Follow-up|3|||
44415535|NCT00624052|79423283|FG002|Overall Study|Lost to Follow-up|1|||
44415536|NCT00624052|79423284|FG003|Overall Study|Lost to Follow-up|0|||
44415537|NCT00624052|79423281|FG000|Overall Study|Non compliant with the protocol|2|||
44415538|NCT00624052|79423282|FG001|Overall Study|Non compliant with the protocol|1|||
44532975|NCT02112916|79542977|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
44532976|NCT02112916|79542974|FG000|Overall Study|Still on Therapy|44|||
44532977|NCT02112916|79542975|FG001|Overall Study|Still on Therapy|47|||
44532978|NCT02112916|79542976|FG002|Overall Study|Still on Therapy|3|||
44532979|NCT02112916|79542977|FG003|Overall Study|Still on Therapy|2|||
44532980|NCT02112916|79542974|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
44532981|NCT02112916|79542975|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
44532982|NCT02112916|79542976|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
44532983|NCT02112916|79542977|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
44532984|NCT02112916|79542974|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
44532985|NCT02112916|79542975|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
44284015|NCT01804842|79247518|FG001|Overall Study|Non-Compliance|1|||
44284016|NCT01804842|79247519|FG002|Overall Study|Non-Compliance|0|||
44284017|NCT01804842|79247517|FG000|Overall Study|Personal Reason|0|||
44284018|NCT01804842|79247518|FG001|Overall Study|Personal Reason|0|||
44284019|NCT01804842|79247519|FG002|Overall Study|Personal Reason|1|||
44284020|NCT01781286|79247527|FG000|Overall Study|Lost to Follow-up|0|||
44284021|NCT01781286|79247528|FG001|Overall Study|Lost to Follow-up|0|||
44284022|NCT01781286|79247529|FG002|Overall Study|Lost to Follow-up|0|||
44284023|NCT01781286|79247530|FG003|Overall Study|Lost to Follow-up|0|||
44284024|NCT01781286|79247531|FG004|Overall Study|Lost to Follow-up|0|||
44284025|NCT01781286|79247532|FG005|Overall Study|Lost to Follow-up|1|||
44284026|NCT01781286|79247527|FG000|Overall Study|Time Constraints|2|||
44284027|NCT01781286|79247528|FG001|Overall Study|Time Constraints|0|||
44284028|NCT01781286|79247529|FG002|Overall Study|Time Constraints|2|||
44415539|NCT00624052|79423283|FG002|Overall Study|Non compliant with the protocol|1|||
44415540|NCT00624052|79423284|FG003|Overall Study|Non compliant with the protocol|1|||
44284029|NCT01781286|79247530|FG003|Overall Study|Time Constraints|0|||
44284030|NCT01781286|79247531|FG004|Overall Study|Time Constraints|0|||
44284031|NCT01781286|79247532|FG005|Overall Study|Time Constraints|0|||
44284032|NCT01781286|79247527|FG000|Overall Study|Noncompliance|0|||
44415541|NCT00624052|79423281|FG000|Overall Study|Consent withdrawn|3|||
44284033|NCT01781286|79247528|FG001|Overall Study|Noncompliance|0|||
44284034|NCT01781286|79247529|FG002|Overall Study|Noncompliance|0|||
44532986|NCT02112916|79542976|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
44284035|NCT01781286|79247530|FG003|Overall Study|Noncompliance|1|||
44284036|NCT01781286|79247531|FG004|Overall Study|Noncompliance|0|||
44284037|NCT01781286|79247532|FG005|Overall Study|Noncompliance|0|||
44284038|NCT01780974|79247544|FG000|Overall Study|Death|1|||
44284039|NCT01780974|79247545|FG001|Overall Study|Death|0|||
44284040|NCT01780974|79247544|FG000|Overall Study|Adverse Event|1|||
44284041|NCT01780974|79247545|FG001|Overall Study|Adverse Event|3|||
44284042|NCT01780662|79247554|FG000|Overall Study|Adverse Event|1|||
44284043|NCT01780662|79247555|FG001|Overall Study|Adverse Event|0|||
44284044|NCT01780662|79247556|FG002|Overall Study|Adverse Event|2|||
44284045|NCT01780662|79247554|FG000|Overall Study|Physician Decision|0|||
44284046|NCT01780662|79247555|FG001|Overall Study|Physician Decision|5|||
44284047|NCT01780662|79247556|FG002|Overall Study|Physician Decision|7|||
44284048|NCT01780662|79247554|FG000|Overall Study|Protocol Violation|0|||
44284049|NCT01780662|79247555|FG001|Overall Study|Protocol Violation|1|||
44284050|NCT01780662|79247556|FG002|Overall Study|Protocol Violation|0|||
44284051|NCT01780662|79247554|FG000|Overall Study|Ineligible|0|||
44284052|NCT01780662|79247555|FG001|Overall Study|Ineligible|0|||
44284053|NCT01780662|79247556|FG002|Overall Study|Ineligible|1|||
44284054|NCT01780584|79247568|FG000|Overall Study|Death|1|||
44284055|NCT01780584|79247569|FG001|Overall Study|Death|0|||
44284056|NCT01780584|79247570|FG002|Overall Study|Death|1|||
44284057|NCT01780584|79247568|FG000|Overall Study|Adverse Event|0|||
44284058|NCT01780584|79247569|FG001|Overall Study|Adverse Event|1|||
44284059|NCT01780584|79247570|FG002|Overall Study|Adverse Event|0|||
44284060|NCT01780584|79247568|FG000|Overall Study|Protocol Violation|0|||
44284061|NCT01780584|79247569|FG001|Overall Study|Protocol Violation|0|||
44284062|NCT01780584|79247570|FG002|Overall Study|Protocol Violation|1|||
44284063|NCT01780506|79247580|FG000|Double-Blind Phase|Randomized but not Treated|3|||
44284064|NCT01780506|79247581|FG001|Double-Blind Phase|Randomized but not Treated|2|||
44284065|NCT01780506|79247580|FG000|Double-Blind Phase|Adverse Event|4|||
44284066|NCT01780506|79247581|FG001|Double-Blind Phase|Adverse Event|14|||
44284067|NCT01780506|79247580|FG000|Double-Blind Phase|Death|1|||
44284068|NCT01780506|79247581|FG001|Double-Blind Phase|Death|2|||
44284069|NCT01780506|79247580|FG000|Double-Blind Phase|Pregnancy|2|||
44284070|NCT01780506|79247581|FG001|Double-Blind Phase|Pregnancy|1|||
44532987|NCT02112916|79542977|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
44532988|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
44532989|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
44532990|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
44532991|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
44532992|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
44532993|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
44532994|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
44532995|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
44532996|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
44255670|NCT02607306|79099336|FG001|Overall Study|Protocol Violation|2|||
44255671|NCT02607306|79099337|FG002|Overall Study|Protocol Violation|1|||
44255672|NCT01495689|79099386|FG000|Overall Study|Death|0|||
44255673|NCT01495689|79099387|FG001|Overall Study|Death|1|||
44255674|NCT01495689|79099386|FG000|Overall Study|Withdrawal by Subject|3|||
44255675|NCT01495689|79099387|FG001|Overall Study|Withdrawal by Subject|0|||
44255676|NCT01495689|79099386|FG000|Overall Study|Lost to Follow-up|7|||
44255677|NCT01495689|79099387|FG001|Overall Study|Lost to Follow-up|6|||
44255678|NCT02603952|79099660|FG000|Overall Study|Withdrawal by Subject|1|||
44255679|NCT02603952|79099661|FG001|Overall Study|Withdrawal by Subject|0|||
44255680|NCT02603952|79099662|FG002|Overall Study|Withdrawal by Subject|0|||
44255681|NCT02603952|79099663|FG003|Overall Study|Withdrawal by Subject|0|||
44255682|NCT02603952|79099660|FG000|Overall Study|Received oseltamivir by error|0|||
44255683|NCT02603952|79099661|FG001|Overall Study|Received oseltamivir by error|0|||
44284071|NCT01780506|79247580|FG000|Double-Blind Phase|Lack of Efficacy|1|||
44284072|NCT01780506|79247581|FG001|Double-Blind Phase|Lack of Efficacy|1|||
44284073|NCT01780506|79247580|FG000|Double-Blind Phase|Investigator's Discretion|5|||
44284074|NCT01780506|79247581|FG001|Double-Blind Phase|Investigator's Discretion|2|||
44284075|NCT01780506|79247580|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
44284076|NCT01780506|79247581|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
44284077|NCT01780506|79247580|FG000|Double-Blind Phase|Protocol Violation|4|||
44284078|NCT01780506|79247581|FG001|Double-Blind Phase|Protocol Violation|3|||
44284079|NCT01780506|79247580|FG000|Double-Blind Phase|Withdrew Consent|23|||
44255684|NCT02603952|79099662|FG002|Overall Study|Received oseltamivir by error|0|||
44255685|NCT02603952|79099663|FG003|Overall Study|Received oseltamivir by error|1|||
44255686|NCT02603172|79100177|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44284080|NCT01780506|79247581|FG001|Double-Blind Phase|Withdrew Consent|24|||
44284081|NCT01780506|79247580|FG000|Double-Blind Phase|Lost to Follow-up|23|||
44532997|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
44532998|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
44532999|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
44533000|NCT02057718|79542994|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
44533001|NCT02057718|79542995|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
44533002|NCT02057718|79542994|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
44533003|NCT02057718|79542995|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
44533004|NCT02057718|79542994|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
44533005|NCT02057718|79542995|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
44533006|NCT02057718|79542994|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
44533007|NCT02057718|79542995|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
44533008|NCT02057718|79542994|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
44284082|NCT01780506|79247581|FG001|Double-Blind Phase|Lost to Follow-up|26|||
44284083|NCT01780506|79247580|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
44284084|NCT01780506|79247581|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
44533009|NCT02057718|79542995|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
44533010|NCT01750281|79543004|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
44533011|NCT01750281|79543005|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
44533012|NCT01750281|79543006|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
44533013|NCT01750281|79543004|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
44533014|NCT01750281|79543005|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
44533015|NCT01750281|79543006|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
44533016|NCT01750281|79543004|FG000|Overall Study|Did not receive treatment|0|||
44533017|NCT01750281|79543005|FG001|Overall Study|Did not receive treatment|1|||
44533018|NCT01750281|79543006|FG002|Overall Study|Did not receive treatment|0|||
44533019|NCT01205061|79543016|FG000|Overall Study|Adverse Event|4|||
44533020|NCT01205061|79543016|FG000|Overall Study|Withdrawal by Subject|11|||
44533021|NCT01205061|79543016|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
44533022|NCT01205061|79543016|FG000|Overall Study|Lost to Follow-up|9|||
44533023|NCT01205061|79543016|FG000|Overall Study|Other|1|||
44533024|NCT01108237|79543024|FG000|Overall Study|No alignment data|2|||
44533025|NCT01108237|79543025|FG001|Overall Study|No alignment data|15|||
44533026|NCT01108237|79543024|FG000|Overall Study|Did not meet criteria for analysis|7|||
44533027|NCT01108237|79543025|FG001|Overall Study|Did not meet criteria for analysis|0|||
44533028|NCT00736450|79543054|FG000|Overall Study|Not ABC gene eligible|19|||
44533029|NCT00736450|79543054|FG000|Overall Study|Withdrawal by Subject|5|||
44533030|NCT00736450|79543054|FG000|Overall Study|Physician Decision|1|||
44533031|NCT00571662|79543075|FG000|Overall Study|Withdrawal by Subject|2|||
44284085|NCT01779648|79247591|FG000|Overall Study|Protocol Violation|1|||
44533032|NCT00571662|79543075|FG000|Overall Study|psychiatric instability|1|||
44284086|NCT01779648|79247592|FG001|Overall Study|Protocol Violation|0|||
44284087|NCT01762800|79247600|FG000|Overall Study|Adverse Event|8|||
44284088|NCT01762800|79247601|FG001|Overall Study|Adverse Event|13|||
44284089|NCT01762800|79247600|FG000|Overall Study|Lack of Efficacy|3|||
44284090|NCT01762800|79247601|FG001|Overall Study|Lack of Efficacy|2|||
44284091|NCT01762800|79247600|FG000|Overall Study|Study Closed/Terminated|0|||
44284092|NCT01762800|79247601|FG001|Overall Study|Study Closed/Terminated|1|||
44284093|NCT01762800|79247600|FG000|Overall Study|Physician Decision|1|||
44284094|NCT01762800|79247601|FG001|Overall Study|Physician Decision|1|||
44284095|NCT01762800|79247600|FG000|Overall Study|Withdrawal by Subject|7|||
44284096|NCT01762800|79247601|FG001|Overall Study|Withdrawal by Subject|4|||
44284097|NCT01597596|79247615|FG000|Overall Study|Study terminated by sponsor|1|||
44284098|NCT01597596|79247616|FG001|Overall Study|Study terminated by sponsor|0|||
44284099|NCT01597596|79247615|FG000|Overall Study|Physician Decision|0|||
44284100|NCT01597596|79247616|FG001|Overall Study|Physician Decision|1|||
44284101|NCT01778556|79247624|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
44284102|NCT01778556|79247625|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
44284103|NCT01778556|79247624|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
44284104|NCT01778556|79247625|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
44284105|NCT01778556|79247624|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
44284106|NCT01778556|79247625|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
44284107|NCT01778556|79247624|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
44284108|NCT01778556|79247625|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
44284109|NCT01761162|79247634|FG000|Overall Study|Withdrawal by Subject|3|||
44284110|NCT01778010|79247638|FG000|Overall Study|Withdrawal by Subject|2|||
44284111|NCT01778010|79247638|FG000|Overall Study|abnormal ECG before meds|1|||
44284112|NCT01778010|79247638|FG000|Overall Study|Arrested|1|||
44284113|NCT01778010|79247638|FG000|Overall Study|rash while on placebo|1|||
44284114|NCT01777932|79247655|FG000|Overall Study|Disease progression|136|||
44284115|NCT01777932|79247655|FG000|Overall Study|Death|3|||
44284116|NCT01777932|79247655|FG000|Overall Study|Adverse Event|34|||
44284117|NCT01777932|79247655|FG000|Overall Study|Lost to Follow-up|3|||
44284118|NCT01777932|79247655|FG000|Overall Study|Investigator decision|10|||
44284119|NCT01777932|79247655|FG000|Overall Study|Reimbursement limit|9|||
44284120|NCT01777932|79247655|FG000|Overall Study|Patient refused further treatment|10|||
44284121|NCT01777854|79247659|FG000|Overall Study|Physician Decision|3|||
44284122|NCT01777854|79247660|FG001|Overall Study|Physician Decision|3|||
44284123|NCT01777776|79247668|FG000|Overall Study|Adverse Event|2|||
44284124|NCT01777776|79247669|FG001|Overall Study|Adverse Event|4|||
44284125|NCT01777776|79247670|FG002|Overall Study|Adverse Event|0|||
44284126|NCT01777776|79247671|FG003|Overall Study|Adverse Event|0|||
44284127|NCT01777776|79247668|FG000|Overall Study|Disease Progression|4|||
44284128|NCT01777776|79247669|FG001|Overall Study|Disease Progression|8|||
44284129|NCT01777776|79247670|FG002|Overall Study|Disease Progression|6|||
44284130|NCT01777776|79247671|FG003|Overall Study|Disease Progression|3|||
44533033|NCT00571662|79543075|FG000|Overall Study|Adverse Event|5|||
44533034|NCT04500769|79543098|FG000|Overall Study|Withdrawal by Subject|5|||
44533035|NCT04446377|79543104|FG000|Overall Study|Withdrawal by Subject|6|||
44533036|NCT04446377|79543105|FG001|Overall Study|Withdrawal by Subject|1|||
44533037|NCT04446377|79543104|FG000|Overall Study|Physician Decision|1|||
44533038|NCT04446377|79543105|FG001|Overall Study|Physician Decision|1|||
44533039|NCT04446377|79543104|FG000|Overall Study|Lost to Follow-up|0|||
44284131|NCT01777776|79247668|FG000|Overall Study|Withdrawal by Subject|0|||
44284132|NCT01777776|79247669|FG001|Overall Study|Withdrawal by Subject|0|||
44284133|NCT01777776|79247670|FG002|Overall Study|Withdrawal by Subject|0|||
44284134|NCT01777776|79247671|FG003|Overall Study|Withdrawal by Subject|1|||
44284135|NCT01777620|79247692|FG000|Overall Study|Subject Withdrawal|1|||
44284136|NCT01777620|79247693|FG001|Overall Study|Subject Withdrawal|0|||
44284137|NCT01777542|79247699|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
44284138|NCT01777542|79247700|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
44284139|NCT01736124|79247709|FG000|Post-intervention Assessment|Death|2|||
44533040|NCT04446377|79543105|FG001|Overall Study|Lost to Follow-up|2|||
44533041|NCT04446377|79543104|FG000|Overall Study|Not eligible|0|||
44533042|NCT04446377|79543105|FG001|Overall Study|Not eligible|1|||
44284140|NCT01736124|79247710|FG001|Post-intervention Assessment|Death|2|||
44284141|NCT01736124|79247709|FG000|Post-intervention Assessment|lost computer access|1|||
44284142|NCT01736124|79247710|FG001|Post-intervention Assessment|lost computer access|1|||
44284143|NCT01736124|79247709|FG000|Post-intervention Assessment|Moved away|3|||
44284144|NCT01736124|79247710|FG001|Post-intervention Assessment|Moved away|1|||
44284145|NCT01736124|79247709|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
44284146|NCT01736124|79247710|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
44284147|NCT01736124|79247709|FG000|Post-intervention Assessment|Illness|3|||
44284148|NCT01736124|79247710|FG001|Post-intervention Assessment|Illness|2|||
44533043|NCT04398368|79543115|FG000|Overall Study|Withdrawal by Subject|2|||
44533044|NCT04275297|79543121|FG000|Overall Study|Lost to Follow-up|1|||
44533045|NCT04275297|79543122|FG001|Overall Study|Lost to Follow-up|1|||
44533046|NCT04247282|79543132|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
44533047|NCT04247282|79543133|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
44533048|NCT04247282|79543134|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
44533049|NCT04247282|79543135|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
44533050|NCT04247282|79543132|FG000|Overall Study|Refused further treatment|0|||
44533051|NCT04247282|79543133|FG001|Overall Study|Refused further treatment|1|||
44533052|NCT04247282|79543134|FG002|Overall Study|Refused further treatment|0|||
44533053|NCT04247282|79543135|FG003|Overall Study|Refused further treatment|0|||
44533054|NCT04224688|79543146|FG000|Overall Study|Withdrawal by Subject|1|||
44533055|NCT04224688|79543147|FG001|Overall Study|Withdrawal by Subject|3|||
44533056|NCT04224688|79543146|FG000|Overall Study|Lack of Efficacy|1|||
44533057|NCT04224688|79543147|FG001|Overall Study|Lack of Efficacy|1|||
44154240|NCT01823198|78945228|FG000|Overall Study|Physician Decision|0|||
44154241|NCT01823198|78945229|FG001|Overall Study|Physician Decision|1|||
44154242|NCT01823198|78945230|FG002|Overall Study|Physician Decision|0|||
44154243|NCT01823198|78945231|FG003|Overall Study|Physician Decision|0|||
44154244|NCT01823198|78945232|FG004|Overall Study|Physician Decision|0|||
44154245|NCT01823198|78945233|FG005|Overall Study|Physician Decision|3|||
44154246|NCT01823198|78945234|FG006|Overall Study|Physician Decision|3|||
44154247|NCT01761292|78945252|FG000|Part 1|Adverse Event|1|||
44154248|NCT01761292|78945252|FG000|Part 1|not receiving treatment in Part 1|1|||
44154249|NCT01761292|78945252|FG000|Extension 1|Withdrawal by Subject|1|||
44284149|NCT01736124|79247709|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
44533058|NCT04224688|79543146|FG000|Overall Study|Adverse event, not fatal|0|||
44533059|NCT04224688|79543147|FG001|Overall Study|Adverse event, not fatal|2|||
44533060|NCT04224688|79543146|FG000|Overall Study|COVID-19|0|||
44533061|NCT04224688|79543147|FG001|Overall Study|COVID-19|1|||
44533062|NCT04200456|79543155|FG000|Overall Study|Physician Decision|0|||
44533063|NCT04200456|79543156|FG001|Overall Study|Physician Decision|1|||
44533064|NCT04200456|79543155|FG000|Overall Study|Withdrawal by Subject|2|||
44533065|NCT04200456|79543156|FG001|Overall Study|Withdrawal by Subject|2|||
44154250|NCT01725113|78945263|FG000|Overall Study|Kidney Transplant|1|||
44284150|NCT01736124|79247710|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
44284151|NCT01736124|79247709|FG000|Post-intervention Assessment|Temporarily away|3|||
44284152|NCT01736124|79247710|FG001|Post-intervention Assessment|Temporarily away|1|||
44284153|NCT01736124|79247709|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
44284154|NCT01736124|79247710|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
44284155|NCT01736124|79247709|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
44284156|NCT01736124|79247710|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
44284157|NCT01736124|79247709|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
44284158|NCT01736124|79247710|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
44284159|NCT01736124|79247709|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
44284160|NCT01736124|79247710|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
44284161|NCT01736124|79247709|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
44284162|NCT01736124|79247710|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
44284163|NCT01736124|79247709|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
44284164|NCT01736124|79247710|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
44284165|NCT01736124|79247709|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
44284166|NCT01736124|79247710|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
44284167|NCT01736124|79247709|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
44284168|NCT01736124|79247710|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
44284169|NCT01736124|79247709|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
44284170|NCT01736124|79247710|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
44284171|NCT01759446|79247723|FG000|Overall Study|Protocol Violation|1|||
44284172|NCT01759446|79247724|FG001|Overall Study|Protocol Violation|0|||
44284173|NCT01759446|79247725|FG002|Overall Study|Protocol Violation|1|||
44284174|NCT01759446|79247726|FG003|Overall Study|Protocol Violation|0|||
44284175|NCT01759446|79247727|FG004|Overall Study|Protocol Violation|0|||
44284176|NCT01759446|79247723|FG000|Overall Study|Withdrawal by Subject|0|||
44284177|NCT01759446|79247724|FG001|Overall Study|Withdrawal by Subject|1|||
44284178|NCT01759446|79247725|FG002|Overall Study|Withdrawal by Subject|0|||
44284179|NCT01759446|79247726|FG003|Overall Study|Withdrawal by Subject|1|||
44284180|NCT01759446|79247727|FG004|Overall Study|Withdrawal by Subject|0|||
44284181|NCT01777308|79247741|FG000|Overall Study|Withdrawal by Subject|5|||
44154251|NCT01725113|78945264|FG001|Overall Study|Kidney Transplant|1|||
44154252|NCT01725113|78945263|FG000|Overall Study|Withdrawal by Subject|0|||
44154253|NCT01725113|78945264|FG001|Overall Study|Withdrawal by Subject|1|||
44154254|NCT01580293|78945277|FG000|Part A_Main Trial|Adverse Event|0|||
44154255|NCT01580293|78945278|FG001|Part A_Main Trial|Adverse Event|2|||
44284182|NCT01777308|79247742|FG001|Overall Study|Withdrawal by Subject|1|||
44284183|NCT01777308|79247741|FG000|Overall Study|Migrated/moved from study area|1|||
44284184|NCT01777308|79247742|FG001|Overall Study|Migrated/moved from study area|0|||
44284185|NCT01777308|79247741|FG000|Overall Study|Lost to Follow-up|7|||
44154256|NCT01580293|78945279|FG002|Part A_Main Trial|Adverse Event|0|||
44284186|NCT01777308|79247742|FG001|Overall Study|Lost to Follow-up|2|||
44284187|NCT01777308|79247741|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
44284188|NCT01777308|79247742|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
44284189|NCT01759368|79247751|FG000|Overall Study|Lost to Follow-up|1|||
44284190|NCT01759368|79247752|FG001|Overall Study|Lost to Follow-up|0|||
44284191|NCT01777152|79247762|FG000|Overall Study|Withdrawal by Subject|22|||
44284192|NCT01777152|79247763|FG001|Overall Study|Withdrawal by Subject|16|||
44284193|NCT01777152|79247762|FG000|Overall Study|Lost to Follow-up|3|||
44284194|NCT01777152|79247763|FG001|Overall Study|Lost to Follow-up|5|||
44284195|NCT01777152|79247762|FG000|Overall Study|Death|68|||
44284196|NCT01777152|79247763|FG001|Overall Study|Death|89|||
44284197|NCT01777152|79247762|FG000|Overall Study|Not eligible, no study drug received|1|||
44284198|NCT01777152|79247763|FG001|Overall Study|Not eligible, no study drug received|0|||
44284199|NCT01777152|79247762|FG000|Overall Study|Change of diagnosis|1|||
44284200|NCT01777152|79247763|FG001|Overall Study|Change of diagnosis|0|||
44284201|NCT01759290|79247770|FG000|Overall Study|Subjects withdrawn consent|5|||
44284202|NCT01759290|79247770|FG000|Overall Study|Physician Decision|2|||
44284203|NCT01759290|79247770|FG000|Overall Study|Death|17|||
44284204|NCT01759290|79247770|FG000|Overall Study|Lost to Follow-up|53|||
44284205|NCT01759290|79247770|FG000|Overall Study|Unknown reason|4|||
44284206|NCT01758900|79247776|FG000|Overall Study|difficulty for further intubation|7|||
44284207|NCT01758900|79247777|FG001|Overall Study|difficulty for further intubation|8|||
44284208|NCT01757184|79247785|FG000|Double-blind Period|Adverse Event|1|||
44284209|NCT01757184|79247786|FG001|Double-blind Period|Adverse Event|0|||
44284210|NCT01757184|79247787|FG002|Double-blind Period|Adverse Event|0|||
44284211|NCT01757184|79247788|FG003|Double-blind Period|Adverse Event|0|||
44284212|NCT01757184|79247785|FG000|Open-label Period|Lost to Follow-up|0|||
44284213|NCT01757184|79247786|FG001|Open-label Period|Lost to Follow-up|0|||
44284214|NCT01757184|79247787|FG002|Open-label Period|Lost to Follow-up|2|||
44284215|NCT01757184|79247788|FG003|Open-label Period|Lost to Follow-up|0|||
44284216|NCT01757184|79247785|FG000|Open-label Period|Withdrawal by Subject|0|||
44284217|NCT01757184|79247786|FG001|Open-label Period|Withdrawal by Subject|0|||
44284218|NCT01757184|79247787|FG002|Open-label Period|Withdrawal by Subject|1|||
44415542|NCT00624052|79423282|FG001|Overall Study|Consent withdrawn|1|||
44415543|NCT00624052|79423283|FG002|Overall Study|Consent withdrawn|1|||
44415544|NCT00624052|79423284|FG003|Overall Study|Consent withdrawn|0|||
44415545|NCT00624052|79423281|FG000|Overall Study|Changed job/ran out if meds|0|||
44415546|NCT00624052|79423282|FG001|Overall Study|Changed job/ran out if meds|2|||
44415547|NCT00624052|79423283|FG002|Overall Study|Changed job/ran out if meds|0|||
44415548|NCT00624052|79423284|FG003|Overall Study|Changed job/ran out if meds|0|||
44415549|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
44415550|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
44415551|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
44415552|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
44533066|NCT04200456|79543155|FG000|Overall Study|Lack of Efficacy|1|||
44533067|NCT04200456|79543156|FG001|Overall Study|Lack of Efficacy|1|||
44533068|NCT04200456|79543155|FG000|Overall Study|Adverse event, non-fatal|0|||
44533069|NCT04200456|79543156|FG001|Overall Study|Adverse event, non-fatal|1|||
44533070|NCT04200456|79543155|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
44533071|NCT04200456|79543156|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
44533072|NCT03766685|79543166|FG000|Overall Study|Lost to Follow-up|1|||
44533073|NCT03766685|79543167|FG001|Overall Study|Lost to Follow-up|1|||
44533074|NCT03766685|79543168|FG002|Overall Study|Lost to Follow-up|0|||
44533075|NCT03766685|79543169|FG003|Overall Study|Lost to Follow-up|0|||
44255687|NCT02603172|79100178|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44255688|NCT02603172|79100179|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
44255689|NCT02603172|79100180|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44255690|NCT02603172|79100181|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44255691|NCT02603172|79100182|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44255692|NCT02603172|79100183|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44255693|NCT02603172|79100184|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
44255694|NCT02605824|79100305|FG000|Overall Study|Physician Decision|1|||
44255695|NCT02605824|79100306|FG001|Overall Study|Physician Decision|0|||
44255696|NCT02605122|79100436|FG000|Overall Study|Withdrawal by Subject|4|||
44255697|NCT02605122|79100437|FG001|Overall Study|Withdrawal by Subject|1|||
44255698|NCT02605122|79100436|FG000|Overall Study|Lost to Follow-up|1|||
44255699|NCT02605122|79100437|FG001|Overall Study|Lost to Follow-up|1|||
44284219|NCT01757184|79247788|FG003|Open-label Period|Withdrawal by Subject|1|||
44284220|NCT01757184|79247785|FG000|Open-label Period|Discontinued by Sponsor|0|||
44284221|NCT01757184|79247786|FG001|Open-label Period|Discontinued by Sponsor|0|||
44284222|NCT01757184|79247787|FG002|Open-label Period|Discontinued by Sponsor|1|||
44284223|NCT01757184|79247788|FG003|Open-label Period|Discontinued by Sponsor|2|||
44284224|NCT01775904|79247802|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
44284225|NCT01775904|79247802|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
44415553|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
44284226|NCT01775670|79247814|FG000|Overall Study|Lost to Follow-up|1|||
44284227|NCT01775670|79247815|FG001|Overall Study|Lost to Follow-up|1|||
44284228|NCT01775124|79247823|FG000|Core Period|Disease Progression|0|||
44284229|NCT01775124|79247824|FG001|Core Period|Disease Progression|1|||
44284230|NCT01775124|79247823|FG000|Core Period|Physician Decision|1|||
44284231|NCT01775124|79247824|FG001|Core Period|Physician Decision|1|||
44284232|NCT01775124|79247823|FG000|Core Period|Death|0|||
44284233|NCT01775124|79247824|FG001|Core Period|Death|1|||
44284234|NCT01775124|79247823|FG000|Core Period|Administrative problems|1|||
44284235|NCT01775124|79247824|FG001|Core Period|Administrative problems|0|||
44284236|NCT01775124|79247823|FG000|Core Period|Withdrawal by Subject|4|||
44284237|NCT01775124|79247824|FG001|Core Period|Withdrawal by Subject|2|||
44284238|NCT01775124|79247823|FG000|Core Period|Adverse Event|5|||
44284239|NCT01775124|79247824|FG001|Core Period|Adverse Event|5|||
44284240|NCT01775124|79247823|FG000|Extension Period|Adverse Event|3|||
44284241|NCT01775124|79247824|FG001|Extension Period|Adverse Event|2|||
44284242|NCT01775124|79247823|FG000|Extension Period|Physician Decision|0|||
44284243|NCT01775124|79247824|FG001|Extension Period|Physician Decision|2|||
44284244|NCT01775124|79247823|FG000|Extension Period|Administrative problems|0|||
44284245|NCT01775124|79247824|FG001|Extension Period|Administrative problems|1|||
44284246|NCT01775124|79247823|FG000|Extension Period|Lost to Follow-up|0|||
44284247|NCT01775124|79247824|FG001|Extension Period|Lost to Follow-up|1|||
44284248|NCT01775124|79247823|FG000|Extension Period|Withdrawal by Subject|9|||
44284249|NCT01775124|79247824|FG001|Extension Period|Withdrawal by Subject|12|||
44284250|NCT01733316|79247831|FG000|RP103 Phase|Non-compliance|1|||
44284251|NCT01733316|79247831|FG000|Long Term Extension Phase|Adverse Event|1|||
44284252|NCT01733316|79247831|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
44284253|NCT01733316|79247831|FG000|Long Term Extension Phase|Sponsor Decision|2|||
44284254|NCT01732926|79247844|FG000|Overall Study|Study Terminated by Sponsor|168|||
44284255|NCT01732926|79247845|FG001|Overall Study|Study Terminated by Sponsor|80|||
44284256|NCT01732926|79247844|FG000|Overall Study|Withdrawal by Subject|46|||
44284257|NCT01732926|79247845|FG001|Overall Study|Withdrawal by Subject|8|||
44284258|NCT01732926|79247844|FG000|Overall Study|Physician Decision|24|||
44284259|NCT01732926|79247845|FG001|Overall Study|Physician Decision|11|||
44284260|NCT01732926|79247844|FG000|Overall Study|Other Reason|21|||
44284261|NCT01732926|79247845|FG001|Overall Study|Other Reason|4|||
44284262|NCT01732926|79247844|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
44284263|NCT01732926|79247845|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
44284264|NCT01732926|79247844|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
44284265|NCT01732926|79247845|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
44284266|NCT01755858|79247853|FG000|Overall Study|Adverse Event|1|||
44284267|NCT01755858|79247854|FG001|Overall Study|Adverse Event|1|||
44284268|NCT01732770|79247864|FG000|Overall Study|Lost to Follow-up|2|||
44284269|NCT01732770|79247865|FG001|Overall Study|Lost to Follow-up|3|||
44284270|NCT01732770|79247864|FG000|Overall Study|Withdrawal by Subject|5|||
44284271|NCT01732770|79247865|FG001|Overall Study|Withdrawal by Subject|3|||
44284272|NCT01732770|79247864|FG000|Overall Study|Decision by Sponsor|2|||
44284273|NCT01732770|79247865|FG001|Overall Study|Decision by Sponsor|2|||
44284274|NCT01732770|79247864|FG000|Overall Study|Death|1|||
44284275|NCT01732770|79247865|FG001|Overall Study|Death|0|||
44284276|NCT01732692|79247873|FG000|Overall Study|Adverse Event|0|||
44284277|NCT01732692|79247874|FG001|Overall Study|Adverse Event|1|||
44284278|NCT01774968|79247882|FG000|Overall Study|Adverse Event|4|||
44284279|NCT01774968|79247883|FG001|Overall Study|Adverse Event|4|||
44284280|NCT01774968|79247882|FG000|Overall Study|Death|0|||
44284281|NCT01774968|79247883|FG001|Overall Study|Death|1|||
44284282|NCT01774968|79247882|FG000|Overall Study|Lost to Follow-up|1|||
44284283|NCT01774968|79247883|FG001|Overall Study|Lost to Follow-up|3|||
44284284|NCT01774968|79247882|FG000|Overall Study|Physician Decision|5|||
44284285|NCT01774968|79247883|FG001|Overall Study|Physician Decision|1|||
44284286|NCT01774968|79247882|FG000|Overall Study|Protocol Violation|14|||
44284287|NCT01774968|79247883|FG001|Overall Study|Protocol Violation|13|||
44284288|NCT01774968|79247882|FG000|Overall Study|Sponsor Decision|0|||
44284289|NCT01774968|79247883|FG001|Overall Study|Sponsor Decision|2|||
44284290|NCT01774968|79247882|FG000|Overall Study|Withdrawal by Subject|6|||
44284291|NCT01774968|79247883|FG001|Overall Study|Withdrawal by Subject|11|||
44284292|NCT01774344|79247891|FG000|Overall Study|Withdrawal by Subject|3|||
44284293|NCT01774344|79247892|FG001|Overall Study|Withdrawal by Subject|10|||
44284294|NCT01774344|79247891|FG000|Overall Study|Protocol Violation|0|||
44255700|NCT01454102|79100488|FG000|Overall Study|Continuing in the treatment period|0|||
44255701|NCT01454102|79100489|FG001|Overall Study|Continuing in the treatment period|0|||
44255702|NCT01454102|79100490|FG002|Overall Study|Continuing in the treatment period|0|||
44255703|NCT01454102|79100491|FG003|Overall Study|Continuing in the treatment period|0|||
44255704|NCT01454102|79100492|FG004|Overall Study|Continuing in the treatment period|3|||
44255705|NCT01454102|79100493|FG005|Overall Study|Continuing in the treatment period|3|||
44255706|NCT01454102|79100494|FG006|Overall Study|Continuing in the treatment period|2|||
44255707|NCT01454102|79100495|FG007|Overall Study|Continuing in the treatment period|0|||
44284295|NCT01774344|79247892|FG001|Overall Study|Protocol Violation|1|||
44415554|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
44533076|NCT03766685|79543166|FG000|Overall Study|Adverse Event, not fatal|0|||
44533077|NCT03766685|79543167|FG001|Overall Study|Adverse Event, not fatal|1|||
44533078|NCT03766685|79543168|FG002|Overall Study|Adverse Event, not fatal|0|||
44533079|NCT03766685|79543169|FG003|Overall Study|Adverse Event, not fatal|1|||
44533080|NCT03766685|79543166|FG000|Overall Study|Withdrawal by Subject|0|||
44533081|NCT03766685|79543167|FG001|Overall Study|Withdrawal by Subject|2|||
44533082|NCT03766685|79543168|FG002|Overall Study|Withdrawal by Subject|0|||
44533083|NCT03766685|79543169|FG003|Overall Study|Withdrawal by Subject|0|||
44533084|NCT03766685|79543166|FG000|Overall Study|Protocol Violation|0|||
44533085|NCT03766685|79543167|FG001|Overall Study|Protocol Violation|1|||
44154257|NCT01580293|78945277|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
44154258|NCT01580293|78945278|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
44154259|NCT01580293|78945279|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
44154260|NCT01580293|78945277|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
44154261|NCT01580293|78945278|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
44154262|NCT01580293|78945279|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
44154263|NCT01580293|78945277|FG000|Part A_Extension|Adverse Event|0|||
44154264|NCT01580293|78945278|FG001|Part A_Extension|Adverse Event|2|||
44154265|NCT01580293|78945279|FG002|Part A_Extension|Adverse Event|0|||
44154266|NCT01580293|78945277|FG000|Part A_Extension|Withdrawal by Subject|0|||
44154267|NCT01580293|78945278|FG001|Part A_Extension|Withdrawal by Subject|3|||
44154268|NCT01580293|78945279|FG002|Part A_Extension|Withdrawal by Subject|0|||
44154269|NCT01580293|78945277|FG000|Part A_Extension|Lost to Follow-up|0|||
44154270|NCT01580293|78945278|FG001|Part A_Extension|Lost to Follow-up|1|||
44154271|NCT01580293|78945279|FG002|Part A_Extension|Lost to Follow-up|0|||
44154272|NCT01580293|78945277|FG000|Part A_Extension|Other Reason|0|||
44154273|NCT01580293|78945278|FG001|Part A_Extension|Other Reason|1|||
44154274|NCT01580293|78945279|FG002|Part A_Extension|Other Reason|0|||
44154275|NCT01580293|78945277|FG000|Part A_Extension|Completed Japan only|0|||
44154276|NCT01580293|78945278|FG001|Part A_Extension|Completed Japan only|5|||
44533086|NCT03766685|79543168|FG002|Overall Study|Protocol Violation|0|||
44255708|NCT01454102|79100496|FG008|Overall Study|Continuing in the treatment period|1|||
44255709|NCT01454102|79100497|FG009|Overall Study|Continuing in the treatment period|0|||
44255710|NCT01454102|79100498|FG010|Overall Study|Continuing in the treatment period|0|||
44255711|NCT01454102|79100499|FG011|Overall Study|Continuing in the treatment period|4|||
44255712|NCT01454102|79100500|FG012|Overall Study|Continuing in the treatment period|7|||
44284296|NCT01774344|79247891|FG000|Overall Study|Lost to Follow-up|4|||
44284297|NCT01774344|79247892|FG001|Overall Study|Lost to Follow-up|10|||
44284298|NCT01774344|79247891|FG000|Overall Study|End of survival follow-up not available|2|||
44284299|NCT01774344|79247892|FG001|Overall Study|End of survival follow-up not available|2|||
44284300|NCT01774344|79247891|FG000|Overall Study|Data collection finished|4|||
44284301|NCT01774344|79247892|FG001|Overall Study|Data collection finished|14|||
44284302|NCT01774344|79247891|FG000|Overall Study|Other|0|||
44284303|NCT01774344|79247892|FG001|Overall Study|Other|1|||
44284304|NCT01774344|79247891|FG000|Overall Study|Did not enter Survival Follow up|49|||
44284305|NCT01774344|79247892|FG001|Overall Study|Did not enter Survival Follow up|83|||
44284306|NCT01732536|79247900|FG000|Overall Study|Withdrawal by Subject|1|||
44284307|NCT01732536|79247901|FG001|Overall Study|Withdrawal by Subject|1|||
44284308|NCT01755702|79247910|FG000|Wash Out Period I|Other Reason|3|||
44284309|NCT01755702|79247910|FG000|Washout Period II|Other Reason|5|||
44284310|NCT01732458|79247924|FG000|Overall Study|Lost to Follow-up|0|||
44284311|NCT01732458|79247925|FG001|Overall Study|Lost to Follow-up|2|||
44284312|NCT01732458|79247926|FG002|Overall Study|Lost to Follow-up|0|||
44284313|NCT01732458|79247927|FG003|Overall Study|Lost to Follow-up|0|||
44284314|NCT01732458|79247924|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44284315|NCT01732458|79247925|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44284316|NCT01732458|79247926|FG002|Overall Study|Non-Compliance With Study Drug|1|||
44284317|NCT01732458|79247927|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44284318|NCT01732458|79247924|FG000|Overall Study|Physician Decision|1|||
44284319|NCT01732458|79247925|FG001|Overall Study|Physician Decision|2|||
44284320|NCT01732458|79247926|FG002|Overall Study|Physician Decision|2|||
44284321|NCT01732458|79247927|FG003|Overall Study|Physician Decision|0|||
44284322|NCT01732458|79247924|FG000|Overall Study|Protocol Violation|2|||
44284323|NCT01732458|79247925|FG001|Overall Study|Protocol Violation|0|||
44284324|NCT01732458|79247926|FG002|Overall Study|Protocol Violation|0|||
44284325|NCT01732458|79247927|FG003|Overall Study|Protocol Violation|2|||
44284326|NCT01732458|79247924|FG000|Overall Study|Screen Failure|0|||
44284327|NCT01732458|79247925|FG001|Overall Study|Screen Failure|1|||
44284328|NCT01732458|79247926|FG002|Overall Study|Screen Failure|0|||
44284329|NCT01732458|79247927|FG003|Overall Study|Screen Failure|0|||
44284330|NCT01731990|79247951|FG000|Overall Study|Adverse Event|1|||
44284331|NCT01731990|79247952|FG001|Overall Study|Adverse Event|5|||
44284332|NCT01731990|79247951|FG000|Overall Study|Withdrawal by Subject|1|||
44284333|NCT01731990|79247952|FG001|Overall Study|Withdrawal by Subject|1|||
44284334|NCT01731990|79247951|FG000|Overall Study|Protocol deviation|1|||
44284335|NCT01731990|79247952|FG001|Overall Study|Protocol deviation|2|||
44284336|NCT01731990|79247951|FG000|Overall Study|Death|1|||
44284337|NCT01731990|79247952|FG001|Overall Study|Death|0|||
44284338|NCT01708902|79247965|FG000|Overall Study|Adverse Event|3|||
44284339|NCT01708902|79247966|FG001|Overall Study|Adverse Event|4|||
44284340|NCT01708902|79247967|FG002|Overall Study|Adverse Event|9|||
44284341|NCT01708902|79247968|FG003|Overall Study|Adverse Event|2|||
44284342|NCT01708902|79247969|FG004|Overall Study|Adverse Event|7|||
44284343|NCT01708902|79247970|FG005|Overall Study|Adverse Event|3|||
44284344|NCT01708902|79247971|FG006|Overall Study|Adverse Event|5|||
44284345|NCT01708902|79247965|FG000|Overall Study|Lack of Efficacy|3|||
44284346|NCT01708902|79247966|FG001|Overall Study|Lack of Efficacy|1|||
44284347|NCT01708902|79247967|FG002|Overall Study|Lack of Efficacy|0|||
44284348|NCT01708902|79247968|FG003|Overall Study|Lack of Efficacy|0|||
44284349|NCT01708902|79247969|FG004|Overall Study|Lack of Efficacy|0|||
44284350|NCT01708902|79247970|FG005|Overall Study|Lack of Efficacy|1|||
44284351|NCT01708902|79247971|FG006|Overall Study|Lack of Efficacy|0|||
44284352|NCT01708902|79247965|FG000|Overall Study|Non compliance with protocol|0|||
44284353|NCT01708902|79247966|FG001|Overall Study|Non compliance with protocol|2|||
44533087|NCT03766685|79543169|FG003|Overall Study|Protocol Violation|0|||
44533088|NCT03766685|79543166|FG000|Overall Study|Non-compliance|0|||
44533089|NCT03766685|79543167|FG001|Overall Study|Non-compliance|2|||
44284354|NCT01708902|79247967|FG002|Overall Study|Non compliance with protocol|1|||
44533090|NCT03766685|79543168|FG002|Overall Study|Non-compliance|0|||
44533091|NCT03766685|79543169|FG003|Overall Study|Non-compliance|0|||
44533092|NCT03654274|79543183|FG000|Overall Study|Adverse Event|19|||
44284355|NCT01708902|79247968|FG003|Overall Study|Non compliance with protocol|3|||
44284356|NCT01708902|79247969|FG004|Overall Study|Non compliance with protocol|0|||
44284357|NCT01708902|79247970|FG005|Overall Study|Non compliance with protocol|0|||
44284358|NCT01708902|79247971|FG006|Overall Study|Non compliance with protocol|0|||
44284359|NCT01708902|79247965|FG000|Overall Study|Lost to Follow-up|2|||
44284360|NCT01708902|79247966|FG001|Overall Study|Lost to Follow-up|1|||
44284361|NCT01708902|79247967|FG002|Overall Study|Lost to Follow-up|2|||
44284362|NCT01708902|79247968|FG003|Overall Study|Lost to Follow-up|2|||
44533093|NCT03654274|79543184|FG001|Overall Study|Adverse Event|23|||
44284363|NCT01708902|79247969|FG004|Overall Study|Lost to Follow-up|0|||
44284364|NCT01708902|79247970|FG005|Overall Study|Lost to Follow-up|0|||
44284365|NCT01708902|79247971|FG006|Overall Study|Lost to Follow-up|1|||
44533094|NCT03654274|79543185|FG002|Overall Study|Adverse Event|24|||
44533095|NCT03654274|79543183|FG000|Overall Study|Protocol Deviation|0|||
44533096|NCT03654274|79543184|FG001|Overall Study|Protocol Deviation|2|||
44533097|NCT03654274|79543185|FG002|Overall Study|Protocol Deviation|0|||
44533098|NCT03654274|79543183|FG000|Overall Study|Lost to Follow-up|8|||
44533099|NCT03654274|79543184|FG001|Overall Study|Lost to Follow-up|6|||
44533100|NCT03654274|79543185|FG002|Overall Study|Lost to Follow-up|5|||
44533101|NCT03654274|79543183|FG000|Overall Study|Withdrawal by Subject|46|||
44533102|NCT03654274|79543184|FG001|Overall Study|Withdrawal by Subject|25|||
44533103|NCT03654274|79543185|FG002|Overall Study|Withdrawal by Subject|33|||
44533104|NCT03654274|79543183|FG000|Overall Study|Lack of Efficacy|4|||
44533105|NCT03654274|79543184|FG001|Overall Study|Lack of Efficacy|5|||
44533106|NCT03654274|79543185|FG002|Overall Study|Lack of Efficacy|7|||
44533107|NCT03654274|79543183|FG000|Overall Study|Pregnancy|2|||
44533108|NCT03654274|79543184|FG001|Overall Study|Pregnancy|2|||
44533109|NCT03654274|79543185|FG002|Overall Study|Pregnancy|1|||
44533110|NCT03654274|79543183|FG000|Overall Study|Other|27|||
44533111|NCT03654274|79543184|FG001|Overall Study|Other|29|||
44533112|NCT03654274|79543185|FG002|Overall Study|Other|32|||
44533113|NCT03654274|79543183|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
44533114|NCT03654274|79543184|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
44533115|NCT03654274|79543185|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
44533116|NCT03533686|79543203|FG000|Overall Study|Withdrawal by Subject|1|||
44533117|NCT03533686|79543204|FG001|Overall Study|Withdrawal by Subject|0|||
44533118|NCT03533686|79543205|FG002|Overall Study|Withdrawal by Subject|0|||
44533119|NCT03533686|79543206|FG003|Overall Study|Withdrawal by Subject|3|||
44533120|NCT03533686|79543207|FG004|Overall Study|Withdrawal by Subject|5|||
44255713|NCT01454102|79100501|FG013|Overall Study|Continuing in the treatment period|4|||
44255714|NCT01454102|79100502|FG014|Overall Study|Continuing in the treatment period|3|||
44255715|NCT01454102|79100503|FG015|Overall Study|Continuing in the treatment period|1|||
44255716|NCT02602080|79100597|FG000|Overall Study|Protocol Violation|6|||
44255717|NCT02602080|79100598|FG001|Overall Study|Protocol Violation|1|||
44255718|NCT02602080|79100599|FG002|Overall Study|Protocol Violation|3|||
44255719|NCT02604342|79100683|FG000|Overall Study|Death|32|||
44255720|NCT02604342|79100684|FG001|Overall Study|Death|16|||
44255721|NCT02604342|79100683|FG000|Overall Study|Progression of disease|1|||
44255722|NCT02604342|79100684|FG001|Overall Study|Progression of disease|0|||
44255723|NCT02604342|79100683|FG000|Overall Study|Withdrawal by Subject|5|||
44255724|NCT02604342|79100684|FG001|Overall Study|Withdrawal by Subject|6|||
44255725|NCT02604342|79100683|FG000|Overall Study|Other|1|||
44255726|NCT02604342|79100684|FG001|Overall Study|Other|0|||
44255727|NCT02604342|79100683|FG000|Overall Study|Study Termination by Sponsor|1|||
44255728|NCT02604342|79100684|FG001|Overall Study|Study Termination by Sponsor|0|||
44255729|NCT02604342|79100683|FG000|Overall Study|Lost to Follow-up|1|||
44255730|NCT02604342|79100684|FG001|Overall Study|Lost to Follow-up|1|||
44255731|NCT02604342|79100683|FG000|Overall Study|Physician Decision|2|||
44255732|NCT02604342|79100684|FG001|Overall Study|Physician Decision|0|||
44255733|NCT02604264|79100713|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
44255734|NCT02604264|79100714|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
44255735|NCT02601300|79100751|FG000|Induction Phase|Lack of Efficacy|2|||
44255736|NCT02601300|79100751|FG000|Induction Phase|Protocol Violation|1|||
44255737|NCT02601300|79100751|FG000|Extension Phase|Withdrawal by Subject|3|||
44255738|NCT02601300|79100751|FG000|Extension Phase|Adverse Event|4|||
44255739|NCT02601300|79100751|FG000|Extension Phase|Lack of Efficacy|10|||
44255740|NCT01471340|79100790|FG000|Overall Study|Death|5|||
44255741|NCT01471340|79100791|FG001|Overall Study|Death|4|||
44255742|NCT01471340|79100790|FG000|Overall Study|Lost to Follow-up|0|||
44255743|NCT01471340|79100791|FG001|Overall Study|Lost to Follow-up|1|||
44255744|NCT01471340|79100790|FG000|Overall Study|Investigational site closure|0|||
44255745|NCT01471340|79100791|FG001|Overall Study|Investigational site closure|1|||
44255746|NCT01471340|79100790|FG000|Overall Study|Invalid informed consent|1|||
44255747|NCT01471340|79100791|FG001|Overall Study|Invalid informed consent|0|||
44255748|NCT01492400|79100813|FG000|Overall Study|Miscellaneous Reasons|2|||
44255749|NCT01492400|79100814|FG001|Overall Study|Miscellaneous Reasons|3|||
44255750|NCT01492400|79100813|FG000|Overall Study|Personal Reasons|0|||
44255751|NCT01492400|79100814|FG001|Overall Study|Personal Reasons|5|||
44255752|NCT01492400|79100813|FG000|Overall Study|Lost to Follow-up|3|||
44255753|NCT01492400|79100814|FG001|Overall Study|Lost to Follow-up|1|||
44533121|NCT03533686|79543208|FG005|Overall Study|Withdrawal by Subject|1|||
44255754|NCT01492400|79100813|FG000|Overall Study|Pregnancy|0|||
44255755|NCT01492400|79100814|FG001|Overall Study|Pregnancy|1|||
44255756|NCT01492400|79100813|FG000|Overall Study|Lack of Efficacy|1|||
44255757|NCT01492400|79100814|FG001|Overall Study|Lack of Efficacy|1|||
44533122|NCT03533686|79543203|FG000|Overall Study|Lost to Follow-up|0|||
44533123|NCT03533686|79543204|FG001|Overall Study|Lost to Follow-up|1|||
44255758|NCT01492400|79100813|FG000|Overall Study|Adverse Event|10|||
44533124|NCT03533686|79543205|FG002|Overall Study|Lost to Follow-up|0|||
44533125|NCT03533686|79543206|FG003|Overall Study|Lost to Follow-up|0|||
44533126|NCT03533686|79543207|FG004|Overall Study|Lost to Follow-up|2|||
44533127|NCT03533686|79543208|FG005|Overall Study|Lost to Follow-up|0|||
44533128|NCT03533686|79543203|FG000|Overall Study|Screen Failure|0|||
44533129|NCT03533686|79543204|FG001|Overall Study|Screen Failure|0|||
44533130|NCT03533686|79543205|FG002|Overall Study|Screen Failure|0|||
44533131|NCT03533686|79543206|FG003|Overall Study|Screen Failure|2|||
44533132|NCT03533686|79543207|FG004|Overall Study|Screen Failure|0|||
44533133|NCT03533686|79543208|FG005|Overall Study|Screen Failure|0|||
44533134|NCT03154359|79543266|FG000|Overall Study|Adverse Event|1|||
44533135|NCT03154359|79543266|FG000|Overall Study|Lack of Efficacy|2|||
44533136|NCT03154359|79543266|FG000|Overall Study|Lost to Follow-up|3|||
44533137|NCT03154359|79543266|FG000|Overall Study|Physician Decision|3|||
44533138|NCT03154359|79543266|FG000|Overall Study|Protocol Violation|4|||
44533139|NCT03154359|79543266|FG000|Overall Study|Withdrawal by Subject|5|||
44533140|NCT03154359|79543266|FG000|Overall Study|Disruption of study due to COVID-19|4|||
44533141|NCT03135834|79543285|FG000|Stage 1|Adverse Event|1|||
44533142|NCT03135834|79543286|FG001|Stage 1|Adverse Event|2|||
44533143|NCT03135834|79543287|FG002|Stage 1|Adverse Event|2|||
44533144|NCT03135834|79543288|FG003|Stage 1|Adverse Event|1|||
44533145|NCT03135834|79543285|FG000|Stage 1|Death|1|||
44533146|NCT03135834|79543286|FG001|Stage 1|Death|0|||
44533147|NCT03135834|79543287|FG002|Stage 1|Death|0|||
44533148|NCT03135834|79543288|FG003|Stage 1|Death|0|||
44533149|NCT03135834|79543285|FG000|Stage 1|Lost to Follow-up|17|||
44533150|NCT03135834|79543286|FG001|Stage 1|Lost to Follow-up|24|||
44533151|NCT03135834|79543287|FG002|Stage 1|Lost to Follow-up|21|||
44533152|NCT03135834|79543288|FG003|Stage 1|Lost to Follow-up|38|||
44533153|NCT03135834|79543285|FG000|Stage 1|No longer met eligibility criteria|1|||
44533154|NCT03135834|79543286|FG001|Stage 1|No longer met eligibility criteria|6|||
44533155|NCT03135834|79543287|FG002|Stage 1|No longer met eligibility criteria|2|||
44533156|NCT03135834|79543288|FG003|Stage 1|No longer met eligibility criteria|5|||
44533157|NCT03135834|79543285|FG000|Stage 1|Other|0|||
44533158|NCT03135834|79543286|FG001|Stage 1|Other|2|||
44533159|NCT03135834|79543287|FG002|Stage 1|Other|1|||
44533160|NCT03135834|79543288|FG003|Stage 1|Other|0|||
44533161|NCT03135834|79543285|FG000|Stage 1|Physician Decision|0|||
44533162|NCT03135834|79543286|FG001|Stage 1|Physician Decision|1|||
44533163|NCT03135834|79543287|FG002|Stage 1|Physician Decision|0|||
44533164|NCT03135834|79543288|FG003|Stage 1|Physician Decision|0|||
44533165|NCT03135834|79543285|FG000|Stage 1|Pregnancy|0|||
44533166|NCT03135834|79543286|FG001|Stage 1|Pregnancy|4|||
44533167|NCT03135834|79543287|FG002|Stage 1|Pregnancy|2|||
44533168|NCT03135834|79543288|FG003|Stage 1|Pregnancy|4|||
44533169|NCT03135834|79543285|FG000|Stage 1|Protocol Violation|1|||
44533170|NCT03135834|79543286|FG001|Stage 1|Protocol Violation|1|||
44533171|NCT03135834|79543287|FG002|Stage 1|Protocol Violation|2|||
44533172|NCT03135834|79543288|FG003|Stage 1|Protocol Violation|1|||
44533173|NCT03135834|79543285|FG000|Stage 1|Withdrawal by parent/guardian|2|||
44533174|NCT03135834|79543286|FG001|Stage 1|Withdrawal by parent/guardian|10|||
44533175|NCT03135834|79543287|FG002|Stage 1|Withdrawal by parent/guardian|2|||
44533176|NCT03135834|79543288|FG003|Stage 1|Withdrawal by parent/guardian|1|||
44533177|NCT03135834|79543285|FG000|Stage 1|Withdrawal by Subject|16|||
44533178|NCT03135834|79543286|FG001|Stage 1|Withdrawal by Subject|22|||
44533179|NCT03135834|79543287|FG002|Stage 1|Withdrawal by Subject|7|||
44533180|NCT03135834|79543288|FG003|Stage 1|Withdrawal by Subject|10|||
44533181|NCT03135834|79543285|FG000|Stage 1|Randomized but not Vaccinated|0|||
44533182|NCT03135834|79543286|FG001|Stage 1|Randomized but not Vaccinated|3|||
44533183|NCT03135834|79543287|FG002|Stage 1|Randomized but not Vaccinated|1|||
44533184|NCT03135834|79543288|FG003|Stage 1|Randomized but not Vaccinated|6|||
44533185|NCT03135834|79543285|FG000|Stage 2|Lost to Follow-up|0|||
44154277|NCT01580293|78945279|FG002|Part A_Extension|Completed Japan only|0|||
44154278|NCT01580293|78945277|FG000|Part B|Withdrawal by Subject|0|||
44154279|NCT01580293|78945278|FG001|Part B|Withdrawal by Subject|0|||
44154280|NCT01580293|78945279|FG002|Part B|Withdrawal by Subject|1|||
44533186|NCT03135834|79543286|FG001|Stage 2|Lost to Follow-up|1|||
44533187|NCT03135834|79543287|FG002|Stage 2|Lost to Follow-up|0|||
44533188|NCT03135834|79543288|FG003|Stage 2|Lost to Follow-up|0|||
44533189|NCT03135834|79543285|FG000|Stage 2|Withdrawal by Subject|0|||
44533190|NCT03135834|79543286|FG001|Stage 2|Withdrawal by Subject|1|||
44533191|NCT03135834|79543287|FG002|Stage 2|Withdrawal by Subject|0|||
44154281|NCT01580293|78945277|FG000|Part B|Other reason|0|||
44284366|NCT01708902|79247965|FG000|Overall Study|Refused to continue trial medication|8|||
44533192|NCT03135834|79543288|FG003|Stage 2|Withdrawal by Subject|0|||
44533193|NCT03135834|79543285|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
44533194|NCT03135834|79543286|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
44533195|NCT03135834|79543287|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
44284367|NCT01708902|79247966|FG001|Overall Study|Refused to continue trial medication|0|||
44533196|NCT03135834|79543288|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
44533197|NCT03135834|79543285|FG000|Stage 2|Did not receive Booster Vaccination|1|||
44533198|NCT03135834|79543286|FG001|Stage 2|Did not receive Booster Vaccination|1|||
44533199|NCT03135834|79543287|FG002|Stage 2|Did not receive Booster Vaccination|0|||
44533200|NCT03135834|79543288|FG003|Stage 2|Did not receive Booster Vaccination|0|||
44533201|NCT03130777|79543321|FG000|Overall Study|Death|0|||
44533202|NCT03130777|79543322|FG001|Overall Study|Death|1|||
44533203|NCT03130777|79543321|FG000|Overall Study|Did not meet eligibility criteria|1|||
44533204|NCT03130777|79543322|FG001|Overall Study|Did not meet eligibility criteria|0|||
44533205|NCT02207725|79543363|FG000|Overall Study|Did Not Receive Treatment|0|||
44533206|NCT02207725|79543364|FG001|Overall Study|Did Not Receive Treatment|1|||
44533207|NCT02207725|79543365|FG002|Overall Study|Did Not Receive Treatment|1|||
44533208|NCT02207725|79543366|FG003|Overall Study|Did Not Receive Treatment|1|||
44533209|NCT00968799|79543400|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
44533210|NCT02883452|79543410|FG000|Overall Study|Withdrawal by Subject|1|||
44533211|NCT02883452|79543411|FG001|Overall Study|Withdrawal by Subject|1|||
44533212|NCT02883452|79543412|FG002|Overall Study|Withdrawal by Subject|3|||
44533213|NCT02883452|79543413|FG003|Overall Study|Withdrawal by Subject|0|||
44533214|NCT02883452|79543414|FG004|Overall Study|Withdrawal by Subject|2|||
44533215|NCT02883452|79543415|FG005|Overall Study|Withdrawal by Subject|5|||
44533216|NCT02883452|79543410|FG000|Overall Study|Disease progression|1|||
44533217|NCT02883452|79543411|FG001|Overall Study|Disease progression|0|||
44533218|NCT02883452|79543412|FG002|Overall Study|Disease progression|0|||
44533219|NCT02883452|79543413|FG003|Overall Study|Disease progression|1|||
44533220|NCT02883452|79543414|FG004|Overall Study|Disease progression|4|||
44533221|NCT02883452|79543415|FG005|Overall Study|Disease progression|5|||
44533222|NCT02883452|79543410|FG000|Overall Study|Adverse Event|2|||
44533223|NCT02883452|79543411|FG001|Overall Study|Adverse Event|1|||
44533224|NCT02883452|79543412|FG002|Overall Study|Adverse Event|1|||
44533225|NCT02883452|79543413|FG003|Overall Study|Adverse Event|1|||
44533226|NCT02883452|79543414|FG004|Overall Study|Adverse Event|1|||
44533227|NCT02883452|79543415|FG005|Overall Study|Adverse Event|3|||
44533228|NCT02883452|79543410|FG000|Overall Study|Physician Decision|0|||
44533229|NCT02883452|79543411|FG001|Overall Study|Physician Decision|0|||
44533230|NCT02883452|79543412|FG002|Overall Study|Physician Decision|0|||
44284368|NCT01708902|79247967|FG002|Overall Study|Refused to continue trial medication|4|||
44533231|NCT02883452|79543413|FG003|Overall Study|Physician Decision|0|||
44533232|NCT02883452|79543414|FG004|Overall Study|Physician Decision|4|||
44533233|NCT02883452|79543415|FG005|Overall Study|Physician Decision|1|||
44154282|NCT01580293|78945278|FG001|Part B|Other reason|0|||
44533234|NCT02883452|79543410|FG000|Overall Study|Death|1|||
44533235|NCT02883452|79543411|FG001|Overall Study|Death|0|||
44533236|NCT02883452|79543412|FG002|Overall Study|Death|1|||
44533237|NCT02883452|79543413|FG003|Overall Study|Death|0|||
44533238|NCT02883452|79543414|FG004|Overall Study|Death|0|||
44533239|NCT02883452|79543415|FG005|Overall Study|Death|0|||
44533240|NCT02883452|79543410|FG000|Overall Study|Other|0|||
44533241|NCT02883452|79543411|FG001|Overall Study|Other|0|||
44533242|NCT02883452|79543412|FG002|Overall Study|Other|0|||
44533243|NCT02883452|79543413|FG003|Overall Study|Other|0|||
44533244|NCT02883452|79543414|FG004|Overall Study|Other|0|||
44533245|NCT02883452|79543415|FG005|Overall Study|Other|1|||
44533246|NCT00151372|79543432|FG000|Overall Study|Death|12|||
44533247|NCT00151372|79543433|FG001|Overall Study|Death|11|||
44533248|NCT00151372|79543432|FG000|Overall Study|Lost to Follow-up|5|||
44533249|NCT00151372|79543433|FG001|Overall Study|Lost to Follow-up|5|||
44533250|NCT00151372|79543432|FG000|Overall Study|Too sick medically to continue|5|||
44533251|NCT00151372|79543433|FG001|Overall Study|Too sick medically to continue|6|||
44533252|NCT00151372|79543432|FG000|Overall Study|Withdrawal by Subject|7|||
44533253|NCT00151372|79543433|FG001|Overall Study|Withdrawal by Subject|7|||
44533254|NCT02603809|79543445|FG000|Overall Study|Withdrawal by Subject|4|||
44533255|NCT02603809|79543446|FG001|Overall Study|Withdrawal by Subject|1|||
44533256|NCT02603809|79543447|FG002|Overall Study|Withdrawal by Subject|2|||
44533257|NCT02603809|79543448|FG003|Overall Study|Withdrawal by Subject|3|||
44533258|NCT02603809|79543449|FG004|Overall Study|Withdrawal by Subject|3|||
44533259|NCT02603809|79543450|FG005|Overall Study|Withdrawal by Subject|4|||
44533260|NCT02603809|79543445|FG000|Overall Study|Lost to Follow-up|2|||
44533261|NCT02603809|79543446|FG001|Overall Study|Lost to Follow-up|3|||
44533262|NCT02603809|79543447|FG002|Overall Study|Lost to Follow-up|1|||
44533263|NCT02603809|79543448|FG003|Overall Study|Lost to Follow-up|4|||
44533264|NCT02603809|79543449|FG004|Overall Study|Lost to Follow-up|2|||
44533265|NCT02603809|79543450|FG005|Overall Study|Lost to Follow-up|2|||
44533266|NCT02603809|79543445|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
44533267|NCT02603809|79543446|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
44533268|NCT02603809|79543447|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
44533269|NCT02603809|79543448|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
44533270|NCT02603809|79543449|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
44533271|NCT02603809|79543450|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
44533272|NCT02603809|79543445|FG000|Overall Study|Physician Decision|0|||
44533273|NCT02603809|79543446|FG001|Overall Study|Physician Decision|0|||
44533274|NCT02603809|79543447|FG002|Overall Study|Physician Decision|0|||
44533275|NCT02603809|79543448|FG003|Overall Study|Physician Decision|1|||
44533276|NCT02603809|79543449|FG004|Overall Study|Physician Decision|2|||
44533277|NCT02603809|79543450|FG005|Overall Study|Physician Decision|1|||
44533278|NCT02603809|79543445|FG000|Overall Study|Adverse Event|3|||
44533279|NCT02603809|79543446|FG001|Overall Study|Adverse Event|0|||
44255759|NCT01492400|79100814|FG001|Overall Study|Adverse Event|5|||
44533280|NCT02603809|79543447|FG002|Overall Study|Adverse Event|2|||
44533281|NCT02603809|79543448|FG003|Overall Study|Adverse Event|2|||
44533282|NCT02603809|79543449|FG004|Overall Study|Adverse Event|1|||
44533283|NCT02603809|79543450|FG005|Overall Study|Adverse Event|1|||
44533284|NCT02603809|79543445|FG000|Overall Study|Lack of Efficacy|0|||
44533285|NCT02603809|79543446|FG001|Overall Study|Lack of Efficacy|1|||
44533286|NCT02603809|79543447|FG002|Overall Study|Lack of Efficacy|0|||
44533287|NCT02603809|79543448|FG003|Overall Study|Lack of Efficacy|0|||
44533288|NCT02603809|79543449|FG004|Overall Study|Lack of Efficacy|0|||
44533289|NCT02603809|79543450|FG005|Overall Study|Lack of Efficacy|1|||
44533290|NCT02741596|79543481|FG000|Overall Study|Adverse Event|1|||
44255760|NCT02596854|79100939|FG000|Overall Study|Withdrawn|8|||
44533291|NCT02741596|79543482|FG001|Overall Study|Adverse Event|5|||
44533292|NCT02741596|79543481|FG000|Overall Study|Lost to Follow-up|1|||
44533293|NCT02741596|79543482|FG001|Overall Study|Lost to Follow-up|1|||
44533294|NCT02741596|79543481|FG000|Overall Study|Physician Decision|2|||
44284369|NCT01708902|79247968|FG003|Overall Study|Refused to continue trial medication|2|||
44533295|NCT02741596|79543482|FG001|Overall Study|Physician Decision|1|||
44533296|NCT02741596|79543481|FG000|Overall Study|Pregnancy|3|||
44533297|NCT02741596|79543482|FG001|Overall Study|Pregnancy|1|||
44533298|NCT02741596|79543481|FG000|Overall Study|Other (Unspecified)|0|||
44533299|NCT02741596|79543482|FG001|Overall Study|Other (Unspecified)|3|||
44533300|NCT02741596|79543481|FG000|Overall Study|Subject withdrawn-Other|17|||
44533301|NCT02741596|79543482|FG001|Overall Study|Subject withdrawn-Other|4|||
44533302|NCT02741596|79543481|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
44533303|NCT02741596|79543482|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
44533304|NCT03147248|79543494|FG000|Overall Study|Adverse Event|0|||
44533305|NCT03147248|79543495|FG001|Overall Study|Adverse Event|2|||
44533306|NCT03147248|79543496|FG002|Overall Study|Adverse Event|2|||
44533307|NCT03147248|79543497|FG003|Overall Study|Adverse Event|2|||
44533308|NCT03147248|79543498|FG004|Overall Study|Adverse Event|6|||
44533309|NCT03147248|79543499|FG005|Overall Study|Adverse Event|11|||
44533310|NCT03147248|79543494|FG000|Overall Study|Disease progression|1|||
44533311|NCT03147248|79543495|FG001|Overall Study|Disease progression|0|||
44154283|NCT01580293|78945279|FG002|Part B|Other reason|1|||
44154284|NCT01960348|78945332|FG000|Overall Study|Adverse event, not serious|2|||
44154285|NCT01960348|78945333|FG001|Overall Study|Adverse event, not serious|2|||
44284370|NCT01708902|79247969|FG004|Overall Study|Refused to continue trial medication|8|||
44533312|NCT03147248|79543496|FG002|Overall Study|Disease progression|0|||
44533313|NCT03147248|79543497|FG003|Overall Study|Disease progression|0|||
44533314|NCT03147248|79543498|FG004|Overall Study|Disease progression|0|||
44533315|NCT03147248|79543499|FG005|Overall Study|Disease progression|2|||
44533316|NCT03147248|79543494|FG000|Overall Study|Withdrawal by Subject|0|||
44533317|NCT03147248|79543495|FG001|Overall Study|Withdrawal by Subject|0|||
44533318|NCT03147248|79543496|FG002|Overall Study|Withdrawal by Subject|0|||
44533319|NCT03147248|79543497|FG003|Overall Study|Withdrawal by Subject|0|||
44533320|NCT03147248|79543498|FG004|Overall Study|Withdrawal by Subject|12|||
44533321|NCT03147248|79543499|FG005|Overall Study|Withdrawal by Subject|9|||
44533322|NCT03147248|79543494|FG000|Overall Study|Protocol Violation|0|||
44533323|NCT03147248|79543495|FG001|Overall Study|Protocol Violation|0|||
44533324|NCT03147248|79543496|FG002|Overall Study|Protocol Violation|0|||
44533325|NCT03147248|79543497|FG003|Overall Study|Protocol Violation|0|||
44533326|NCT03147248|79543498|FG004|Overall Study|Protocol Violation|2|||
44284371|NCT01708902|79247970|FG005|Overall Study|Refused to continue trial medication|1|||
44284372|NCT01708902|79247971|FG006|Overall Study|Refused to continue trial medication|1|||
44284373|NCT01708902|79247965|FG000|Overall Study|Other Reason|1|||
44284374|NCT01708902|79247966|FG001|Overall Study|Other Reason|0|||
44284375|NCT01708902|79247967|FG002|Overall Study|Other Reason|1|||
44284376|NCT01708902|79247968|FG003|Overall Study|Other Reason|1|||
44284377|NCT01708902|79247969|FG004|Overall Study|Other Reason|1|||
44284378|NCT01708902|79247970|FG005|Overall Study|Other Reason|2|||
44284379|NCT01708902|79247971|FG006|Overall Study|Other Reason|0|||
44284380|NCT01755546|79247990|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
44284381|NCT01755546|79247990|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
44284382|NCT01755546|79247990|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
44284383|NCT01755546|79247990|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
44284384|NCT01755546|79247990|FG000|Titration Phase|Adverse Event|11|||
44284385|NCT01755546|79247990|FG000|Titration Phase|Lack of Efficacy|18|||
44284386|NCT01755546|79247990|FG000|Titration Phase|Protocol Violation|9|||
44284387|NCT01755546|79247990|FG000|Titration Phase|Lost to Follow-up|2|||
44284388|NCT01755546|79247990|FG000|Titration Phase|Other and Continuing|22|||
44284389|NCT01755546|79247990|FG000|Titration Phase|Withdrawal by Subject|8|||
44284390|NCT01755546|79247990|FG000|Long Term Treatment|Adverse Event|12|||
44284391|NCT01755546|79247990|FG000|Long Term Treatment|Lack of Efficacy|6|||
44284392|NCT01755546|79247990|FG000|Long Term Treatment|Protocol Violation|10|||
44284393|NCT01755546|79247990|FG000|Long Term Treatment|Withdrawal by Subject|35|||
44533327|NCT03147248|79543499|FG005|Overall Study|Protocol Violation|0|||
44533328|NCT03147248|79543494|FG000|Overall Study|Lost to Follow-up|0|||
44533329|NCT03147248|79543495|FG001|Overall Study|Lost to Follow-up|0|||
44533330|NCT03147248|79543496|FG002|Overall Study|Lost to Follow-up|0|||
44533331|NCT03147248|79543497|FG003|Overall Study|Lost to Follow-up|0|||
44533332|NCT03147248|79543498|FG004|Overall Study|Lost to Follow-up|2|||
44154286|NCT01960348|78945332|FG000|Overall Study|Adverse event, serious fatal|6|||
44284394|NCT01755546|79247990|FG000|Long Term Treatment|Lost to Follow-up|17|||
44284395|NCT01755546|79247990|FG000|Long Term Treatment|other and ongoing|41|||
44284396|NCT01755234|79247996|FG000|Overall Study|Lost to Follow-up|11|||
44284397|NCT01755234|79247997|FG001|Overall Study|Lost to Follow-up|6|||
44533333|NCT03147248|79543499|FG005|Overall Study|Lost to Follow-up|0|||
44533334|NCT03147248|79543494|FG000|Overall Study|Pregnancy|0|||
44284398|NCT01755234|79247996|FG000|Overall Study|Change in surgical case|2|||
44284399|NCT01755234|79247997|FG001|Overall Study|Change in surgical case|1|||
44284400|NCT01755234|79247996|FG000|Overall Study|case cancelled|1|||
44284401|NCT01755234|79247997|FG001|Overall Study|case cancelled|0|||
44284402|NCT01755234|79247996|FG000|Overall Study|Withdrawal by Subject|0|||
44284403|NCT01755234|79247997|FG001|Overall Study|Withdrawal by Subject|1|||
44284404|NCT01755234|79247996|FG000|Overall Study|unblinded|1|||
44284405|NCT01755234|79247997|FG001|Overall Study|unblinded|0|||
44284406|NCT01731912|79248003|FG000|Overall Study|noncompliance|2|||
44284407|NCT01731678|79248007|FG000|Overall Study|Withdrawal by Subject|3|||
44284408|NCT01731678|79248007|FG000|Overall Study|Did not meet inclusion criteria|1|||
44284409|NCT01731678|79248007|FG000|Overall Study|RMT too high, making TMS difficult|3|||
44284410|NCT01731600|79248013|FG000|Overall Study|Adverse Event|2|||
44284411|NCT01731600|79248014|FG001|Overall Study|Adverse Event|0|||
44284412|NCT01731600|79248013|FG000|Overall Study|Withdrawal criteria|1|||
44284413|NCT01731600|79248014|FG001|Overall Study|Withdrawal criteria|0|||
44284414|NCT01731600|79248013|FG000|Overall Study|Other reasons|3|||
44533335|NCT03147248|79543495|FG001|Overall Study|Pregnancy|0|||
44533336|NCT03147248|79543496|FG002|Overall Study|Pregnancy|0|||
44533337|NCT03147248|79543497|FG003|Overall Study|Pregnancy|0|||
44533338|NCT03147248|79543498|FG004|Overall Study|Pregnancy|1|||
44533339|NCT03147248|79543499|FG005|Overall Study|Pregnancy|0|||
44533340|NCT03147248|79543494|FG000|Overall Study|Death|0|||
44533341|NCT03147248|79543495|FG001|Overall Study|Death|0|||
44533342|NCT03147248|79543496|FG002|Overall Study|Death|0|||
44533343|NCT03147248|79543497|FG003|Overall Study|Death|0|||
44533344|NCT03147248|79543498|FG004|Overall Study|Death|0|||
44533345|NCT03147248|79543499|FG005|Overall Study|Death|4|||
44533346|NCT03147248|79543494|FG000|Overall Study|Physician Decision|0|||
44154287|NCT01960348|78945333|FG001|Overall Study|Adverse event, serious fatal|5|||
44255761|NCT02592876|79101076|FG000|Overall Study|Withdrawal by Subject|3|||
44255762|NCT02592876|79101077|FG001|Overall Study|Withdrawal by Subject|3|||
44255763|NCT02592876|79101076|FG000|Overall Study|Study Termination by Sponsor|32|||
44255764|NCT02592876|79101077|FG001|Overall Study|Study Termination by Sponsor|27|||
44255765|NCT02592876|79101076|FG000|Overall Study|Lost to Follow-up|0|||
44255766|NCT02592876|79101077|FG001|Overall Study|Lost to Follow-up|1|||
44255767|NCT02592876|79101076|FG000|Overall Study|Death|6|||
44255768|NCT02592876|79101077|FG001|Overall Study|Death|9|||
44255769|NCT01492088|79101094|FG000|Overall Study|Withdrawal by Patient|0|||
44255770|NCT01492088|79101095|FG001|Overall Study|Withdrawal by Patient|2|||
44255771|NCT01492088|79101096|FG002|Overall Study|Withdrawal by Patient|0|||
44255772|NCT01492088|79101094|FG000|Overall Study|Death|1|||
44255773|NCT01492088|79101095|FG001|Overall Study|Death|6|||
44255774|NCT01492088|79101096|FG002|Overall Study|Death|2|||
44255775|NCT01492088|79101094|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
44255776|NCT01492088|79101095|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
44255777|NCT01492088|79101096|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
44255778|NCT01492088|79101094|FG000|Overall Study|Alive at Last Follow-up|0|||
44255779|NCT01492088|79101095|FG001|Overall Study|Alive at Last Follow-up|6|||
44255780|NCT01492088|79101096|FG002|Overall Study|Alive at Last Follow-up|11|||
44255781|NCT02592798|79101338|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
44255782|NCT02592798|79101339|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
44255783|NCT02592798|79101338|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
44255784|NCT02592798|79101339|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
44255785|NCT02592798|79101338|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
44255786|NCT02592798|79101339|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
44255787|NCT02592798|79101338|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
44255788|NCT02592798|79101339|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
44255789|NCT02592798|79101338|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
44255790|NCT02592798|79101339|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
44255791|NCT02592798|79101338|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
44255792|NCT02592798|79101339|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
44284415|NCT01731600|79248014|FG001|Overall Study|Other reasons|0|||
44533347|NCT03147248|79543495|FG001|Overall Study|Physician Decision|0|||
44533348|NCT03147248|79543496|FG002|Overall Study|Physician Decision|0|||
44533349|NCT03147248|79543497|FG003|Overall Study|Physician Decision|0|||
44255793|NCT02592798|79101338|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
44284416|NCT01730586|79248024|FG000|Overall Study|Progressive Disease|2|||
44284417|NCT01730586|79248024|FG000|Overall Study|Inadequate Trial|8|||
44284418|NCT01730586|79248024|FG000|Overall Study|Adverse Event|2|||
44284419|NCT01730586|79248024|FG000|Overall Study|Hospice|1|||
44533350|NCT03147248|79543498|FG004|Overall Study|Physician Decision|2|||
44255794|NCT02592798|79101339|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
44255795|NCT02592798|79101338|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
44255796|NCT02592798|79101339|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
44533351|NCT03147248|79543499|FG005|Overall Study|Physician Decision|4|||
44533352|NCT03147248|79543494|FG000|Overall Study|Prolonged Dosing Interval|0|||
44533353|NCT03147248|79543495|FG001|Overall Study|Prolonged Dosing Interval|0|||
44533354|NCT03147248|79543496|FG002|Overall Study|Prolonged Dosing Interval|0|||
44533355|NCT03147248|79543497|FG003|Overall Study|Prolonged Dosing Interval|0|||
44154288|NCT01960348|78945332|FG000|Overall Study|Adverse event, serious non-fatal|0|||
44154289|NCT01960348|78945333|FG001|Overall Study|Adverse event, serious non-fatal|3|||
44533356|NCT03147248|79543498|FG004|Overall Study|Prolonged Dosing Interval|1|||
44533357|NCT03147248|79543499|FG005|Overall Study|Prolonged Dosing Interval|1|||
44533358|NCT03796039|79543515|FG000|Overall Study|Death|2|||
44533359|NCT03796039|79543516|FG001|Overall Study|Death|1|||
44533360|NCT03796039|79543515|FG000|Overall Study|Withdrawal by Subject|7|||
44533361|NCT03796039|79543516|FG001|Overall Study|Withdrawal by Subject|4|||
44533362|NCT03151304|79543522|FG000|Overall Study|Termination of study by Sponsor|23|||
44533363|NCT03151304|79543522|FG000|Overall Study|missing|3|||
44533364|NCT03151304|79543522|FG000|Overall Study|Withdrawal by Subject|8|||
44533365|NCT03151304|79543522|FG000|Overall Study|multiple reasons|30|||
44533366|NCT03152552|79543531|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
44533367|NCT03152552|79543532|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
44154290|NCT01960348|78945332|FG000|Overall Study|Withdrawal by Subject|1|||
44154291|NCT01960348|78945333|FG001|Overall Study|Withdrawal by Subject|11|||
44154292|NCT01960348|78945332|FG000|Overall Study|Physician Decision|0|||
44533368|NCT03152552|79543533|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
44533369|NCT03152552|79543534|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
44533370|NCT03152552|79543535|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
44533371|NCT03152552|79543531|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
44533372|NCT03152552|79543532|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
44533373|NCT03152552|79543533|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
44533374|NCT03152552|79543534|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
44533375|NCT03152552|79543535|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
44533376|NCT03152552|79543531|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
44533377|NCT03152552|79543532|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
44533378|NCT03152552|79543533|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
44533379|NCT03152552|79543534|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
44533380|NCT03152552|79543535|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
44533381|NCT03152552|79543531|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44533382|NCT03152552|79543532|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44533383|NCT03152552|79543533|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
44533384|NCT03152552|79543534|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44533385|NCT03152552|79543535|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44533386|NCT03152552|79543531|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
44154293|NCT01960348|78945333|FG001|Overall Study|Physician Decision|1|||
44154294|NCT01960348|78945332|FG000|Overall Study|Protocol Violation|1|||
44154295|NCT01960348|78945333|FG001|Overall Study|Protocol Violation|0|||
44154296|NCT02653625|78945339|FG000|Overall Study|Adverse Event|1|||
44154297|NCT02653625|78945339|FG000|Overall Study|Non-compliance with Study Drug|1|||
44154298|NCT02653625|78945339|FG000|Overall Study|Protocol Violation|1|||
44154299|NCT02653625|78945339|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
44154300|NCT01981096|78945345|FG000|Overall Study|Parent illness|1|||
44154301|NCT01981096|78945346|FG001|Overall Study|Parent illness|0|||
44154302|NCT01981096|78945345|FG000|Overall Study|Withdrawal by Subject|0|||
44154303|NCT01981096|78945346|FG001|Overall Study|Withdrawal by Subject|1|||
44533387|NCT03152552|79543532|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
44533388|NCT03152552|79543533|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
44154304|NCT01981096|78945345|FG000|Overall Study|Lost to Follow-up|2|||
44533389|NCT03152552|79543534|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
44154305|NCT01981096|78945346|FG001|Overall Study|Lost to Follow-up|0|||
44154306|NCT02652767|78945352|FG000|Overall Study|Death|2|||
44154307|NCT02652767|78945352|FG000|Overall Study|Lost to Follow-up|1|||
44154308|NCT02652767|78945352|FG000|Overall Study|Withdrawal by Subject|1|||
44284420|NCT01707030|79248032|FG000|Overall Study|Death|1|||
44284421|NCT01707030|79248033|FG001|Overall Study|Death|1|||
44284422|NCT01707030|79248032|FG000|Overall Study|Withdrawal by Subject|2|||
44284423|NCT01707030|79248033|FG001|Overall Study|Withdrawal by Subject|3|||
44284424|NCT01707030|79248032|FG000|Overall Study|Lost to Follow-up|8|||
44284425|NCT01707030|79248033|FG001|Overall Study|Lost to Follow-up|13|||
44284426|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
44284427|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
44284428|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
44284429|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
44284430|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
44284431|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
44284432|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
44284433|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
44284434|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
44284435|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
44284436|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
44284437|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
44284438|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
44284439|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
44284440|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
44284441|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
44284442|NCT01755156|79248045|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
44284443|NCT01755156|79248046|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
44284444|NCT01755156|79248045|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
44284445|NCT01755156|79248046|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
44284446|NCT01755156|79248045|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
44284447|NCT01755156|79248046|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
44284448|NCT01754922|79248058|FG000|Overall Study|Adverse Event|0|||
44284449|NCT01754922|79248059|FG001|Overall Study|Adverse Event|1|||
44284450|NCT01754766|79248069|FG000|Overall Study|Personal reasons|1|||
44284451|NCT01754766|79248070|FG001|Overall Study|Personal reasons|1|||
44284452|NCT01754766|79248071|FG002|Overall Study|Personal reasons|0|||
44284453|NCT01754376|79248079|FG000|Overall Study|Adverse Event|1|||
44284454|NCT01754376|79248079|FG000|Overall Study|Lack of Efficacy|2|||
44284455|NCT01605396|79248086|FG000|Overall Study|Adverse Event|5|||
44284456|NCT01605396|79248087|FG001|Overall Study|Adverse Event|3|||
44284457|NCT01605396|79248086|FG000|Overall Study|Lost to Follow-up|1|||
44284458|NCT01605396|79248087|FG001|Overall Study|Lost to Follow-up|0|||
44284459|NCT01605396|79248086|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44284460|NCT01605396|79248087|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44284461|NCT01605396|79248086|FG000|Overall Study|Physician Decision|2|||
44284462|NCT01605396|79248087|FG001|Overall Study|Physician Decision|2|||
44284463|NCT01605396|79248086|FG000|Overall Study|Progressive Disease|23|||
44284464|NCT01605396|79248087|FG001|Overall Study|Progressive Disease|27|||
44284465|NCT01605396|79248086|FG000|Overall Study|Withdrawal by Subject|4|||
44284466|NCT01605396|79248087|FG001|Overall Study|Withdrawal by Subject|2|||
44284467|NCT01605396|79248086|FG000|Overall Study|Transfer Off Study|4|||
44284468|NCT01605396|79248087|FG001|Overall Study|Transfer Off Study|5|||
44284469|NCT01730118|79248100|FG000|Dose Escalation|Death on study|5|||
44284470|NCT01730118|79248101|FG001|Dose Escalation|Death on study|7|||
44284471|NCT01730118|79248102|FG002|Dose Escalation|Death on study|2|||
44284472|NCT01730118|79248103|FG003|Dose Escalation|Death on study|6|||
44415555|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
44415556|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
44415557|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
44415558|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
44415559|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
44415560|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
44415561|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
44415562|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
44255797|NCT02592798|79101338|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
44255798|NCT02592798|79101339|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
44255799|NCT02592798|79101338|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
44255800|NCT02592798|79101339|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
44255801|NCT02592798|79101338|FG000|Transition From DB2 to OLE|Other reasons|1|||
44255802|NCT02592798|79101339|FG001|Transition From DB2 to OLE|Other reasons|0|||
44255803|NCT02592798|79101338|FG000|Open Label Period (OLE)|Other reasons|0|||
44255804|NCT02592798|79101339|FG001|Open Label Period (OLE)|Other reasons|2|||
44255805|NCT02592798|79101338|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
44255806|NCT02592798|79101339|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
44255807|NCT02592798|79101338|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
44255808|NCT02592798|79101339|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
44255809|NCT02592798|79101338|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
44284473|NCT01730118|79248104|FG004|Dose Escalation|Death on study|0|||
44284474|NCT01730118|79248105|FG005|Dose Escalation|Death on study|0|||
44284475|NCT01730118|79248106|FG006|Dose Escalation|Death on study|0|||
44284476|NCT01730118|79248100|FG000|Dose Escalation|Died before treatment|0|||
44284477|NCT01730118|79248101|FG001|Dose Escalation|Died before treatment|0|||
44284478|NCT01730118|79248102|FG002|Dose Escalation|Died before treatment|0|||
44284479|NCT01730118|79248103|FG003|Dose Escalation|Died before treatment|0|||
44284480|NCT01730118|79248104|FG004|Dose Escalation|Died before treatment|0|||
44284481|NCT01730118|79248105|FG005|Dose Escalation|Died before treatment|0|||
44284482|NCT01730118|79248106|FG006|Dose Escalation|Died before treatment|1|||
44284483|NCT01730118|79248100|FG000|Dose Escalation|Chose to start a different treatment|1|||
44284484|NCT01730118|79248101|FG001|Dose Escalation|Chose to start a different treatment|0|||
44284485|NCT01730118|79248102|FG002|Dose Escalation|Chose to start a different treatment|0|||
44284486|NCT01730118|79248103|FG003|Dose Escalation|Chose to start a different treatment|0|||
44284487|NCT01730118|79248104|FG004|Dose Escalation|Chose to start a different treatment|0|||
44284488|NCT01730118|79248105|FG005|Dose Escalation|Chose to start a different treatment|0|||
44284489|NCT01730118|79248106|FG006|Dose Escalation|Chose to start a different treatment|0|||
44284490|NCT01730118|79248100|FG000|Dose Escalation|Withdrawal by Subject|0|||
44284491|NCT01730118|79248101|FG001|Dose Escalation|Withdrawal by Subject|0|||
44284492|NCT01730118|79248102|FG002|Dose Escalation|Withdrawal by Subject|1|||
44284493|NCT01730118|79248103|FG003|Dose Escalation|Withdrawal by Subject|0|||
44284494|NCT01730118|79248104|FG004|Dose Escalation|Withdrawal by Subject|0|||
44284495|NCT01730118|79248105|FG005|Dose Escalation|Withdrawal by Subject|0|||
44284496|NCT01730118|79248106|FG006|Dose Escalation|Withdrawal by Subject|0|||
44284497|NCT01730118|79248100|FG000|Dose Escalation|Disease progression prior to treatment|0|||
44284498|NCT01730118|79248101|FG001|Dose Escalation|Disease progression prior to treatment|0|||
44284499|NCT01730118|79248102|FG002|Dose Escalation|Disease progression prior to treatment|0|||
44284500|NCT01730118|79248103|FG003|Dose Escalation|Disease progression prior to treatment|0|||
44284501|NCT01730118|79248104|FG004|Dose Escalation|Disease progression prior to treatment|0|||
44284502|NCT01730118|79248105|FG005|Dose Escalation|Disease progression prior to treatment|0|||
44284503|NCT01730118|79248106|FG006|Dose Escalation|Disease progression prior to treatment|1|||
44284504|NCT01730118|79248100|FG000|Dose Expansion|Death|0|||
44284505|NCT01730118|79248101|FG001|Dose Expansion|Death|0|||
44284506|NCT01730118|79248102|FG002|Dose Expansion|Death|0|||
44284507|NCT01730118|79248103|FG003|Dose Expansion|Death|0|||
44284508|NCT01730118|79248104|FG004|Dose Expansion|Death|1|||
44284509|NCT01730118|79248105|FG005|Dose Expansion|Death|0|||
44284510|NCT01730118|79248106|FG006|Dose Expansion|Death|0|||
44284511|NCT01730118|79248100|FG000|Dose Expansion|Other medical condition|0|||
44284512|NCT01730118|79248101|FG001|Dose Expansion|Other medical condition|0|||
44284513|NCT01730118|79248102|FG002|Dose Expansion|Other medical condition|0|||
44284514|NCT01730118|79248103|FG003|Dose Expansion|Other medical condition|0|||
44284515|NCT01730118|79248104|FG004|Dose Expansion|Other medical condition|1|||
44284516|NCT01730118|79248105|FG005|Dose Expansion|Other medical condition|0|||
44284517|NCT01730118|79248106|FG006|Dose Expansion|Other medical condition|0|||
44284518|NCT01730118|79248100|FG000|Dose Expansion|Withdrawal by Subject|0|||
44284519|NCT01730118|79248101|FG001|Dose Expansion|Withdrawal by Subject|0|||
44284520|NCT01730118|79248102|FG002|Dose Expansion|Withdrawal by Subject|0|||
44284521|NCT01730118|79248103|FG003|Dose Expansion|Withdrawal by Subject|0|||
44284522|NCT01730118|79248104|FG004|Dose Expansion|Withdrawal by Subject|1|||
44284523|NCT01730118|79248105|FG005|Dose Expansion|Withdrawal by Subject|0|||
44284524|NCT01730118|79248106|FG006|Dose Expansion|Withdrawal by Subject|0|||
44284525|NCT01730118|79248100|FG000|Dose Expansion|Disease progression|0|||
44284526|NCT01730118|79248101|FG001|Dose Expansion|Disease progression|0|||
44284527|NCT01730118|79248102|FG002|Dose Expansion|Disease progression|0|||
44284528|NCT01730118|79248103|FG003|Dose Expansion|Disease progression|0|||
44284529|NCT01730118|79248104|FG004|Dose Expansion|Disease progression|0|||
44284530|NCT01730118|79248105|FG005|Dose Expansion|Disease progression|1|||
44284531|NCT01730118|79248106|FG006|Dose Expansion|Disease progression|0|||
44284532|NCT01730118|79248100|FG000|Dose Expansion|Inability to return|0|||
44284533|NCT01730118|79248101|FG001|Dose Expansion|Inability to return|0|||
44284534|NCT01730118|79248102|FG002|Dose Expansion|Inability to return|0|||
44284535|NCT01730118|79248103|FG003|Dose Expansion|Inability to return|0|||
44284536|NCT01730118|79248104|FG004|Dose Expansion|Inability to return|0|||
44284537|NCT01730118|79248105|FG005|Dose Expansion|Inability to return|1|||
44284538|NCT01730118|79248106|FG006|Dose Expansion|Inability to return|0|||
44284539|NCT01730118|79248100|FG000|Dose Expansion|Physician Decision|0|||
44284540|NCT01730118|79248101|FG001|Dose Expansion|Physician Decision|0|||
44284541|NCT01730118|79248102|FG002|Dose Expansion|Physician Decision|0|||
44284542|NCT01730118|79248103|FG003|Dose Expansion|Physician Decision|0|||
44284543|NCT01730118|79248104|FG004|Dose Expansion|Physician Decision|0|||
44284544|NCT01730118|79248105|FG005|Dose Expansion|Physician Decision|1|||
44284545|NCT01730118|79248106|FG006|Dose Expansion|Physician Decision|0|||
44284546|NCT01730040|79248130|FG000|Overall Study|Randomized but not treated|0|||
44284547|NCT01730040|79248131|FG001|Overall Study|Randomized but not treated|0|||
44284548|NCT01730040|79248132|FG002|Overall Study|Randomized but not treated|0|||
44284549|NCT01730040|79248133|FG003|Overall Study|Randomized but not treated|0|||
44284550|NCT01730040|79248134|FG004|Overall Study|Randomized but not treated|0|||
44284551|NCT01730040|79248135|FG005|Overall Study|Randomized but not treated|1|||
44284552|NCT01730040|79248136|FG006|Overall Study|Randomized but not treated|0|||
44284553|NCT01730040|79248130|FG000|Overall Study|Subject moved|0|||
44284554|NCT01730040|79248131|FG001|Overall Study|Subject moved|0|||
44284555|NCT01730040|79248132|FG002|Overall Study|Subject moved|1|||
44284556|NCT01730040|79248133|FG003|Overall Study|Subject moved|0|||
44284557|NCT01730040|79248134|FG004|Overall Study|Subject moved|0|||
44284558|NCT01730040|79248135|FG005|Overall Study|Subject moved|0|||
44284559|NCT01730040|79248136|FG006|Overall Study|Subject moved|1|||
44284560|NCT01730040|79248130|FG000|Overall Study|Physician Decision|0|||
44284561|NCT01730040|79248131|FG001|Overall Study|Physician Decision|0|||
44284562|NCT01730040|79248132|FG002|Overall Study|Physician Decision|0|||
44284563|NCT01730040|79248133|FG003|Overall Study|Physician Decision|0|||
44284564|NCT01730040|79248134|FG004|Overall Study|Physician Decision|0|||
44284565|NCT01730040|79248135|FG005|Overall Study|Physician Decision|1|||
44284566|NCT01730040|79248136|FG006|Overall Study|Physician Decision|1|||
44284567|NCT01730040|79248130|FG000|Overall Study|Other than specified|7|||
44284568|NCT01730040|79248131|FG001|Overall Study|Other than specified|8|||
44284569|NCT01730040|79248132|FG002|Overall Study|Other than specified|5|||
44284570|NCT01730040|79248133|FG003|Overall Study|Other than specified|5|||
44284571|NCT01730040|79248134|FG004|Overall Study|Other than specified|5|||
44284572|NCT01730040|79248135|FG005|Overall Study|Other than specified|4|||
44284573|NCT01730040|79248136|FG006|Overall Study|Other than specified|4|||
44284574|NCT01730040|79248130|FG000|Overall Study|Adverse Event|4|||
44284575|NCT01730040|79248131|FG001|Overall Study|Adverse Event|3|||
44284576|NCT01730040|79248132|FG002|Overall Study|Adverse Event|5|||
44284577|NCT01730040|79248133|FG003|Overall Study|Adverse Event|3|||
44284578|NCT01730040|79248134|FG004|Overall Study|Adverse Event|1|||
44284579|NCT01730040|79248135|FG005|Overall Study|Adverse Event|1|||
44284580|NCT01730040|79248136|FG006|Overall Study|Adverse Event|2|||
44284581|NCT01730040|79248130|FG000|Overall Study|Poor compliance to protocol|2|||
44284582|NCT01730040|79248131|FG001|Overall Study|Poor compliance to protocol|4|||
44284583|NCT01730040|79248132|FG002|Overall Study|Poor compliance to protocol|0|||
44284584|NCT01730040|79248133|FG003|Overall Study|Poor compliance to protocol|0|||
44284585|NCT01730040|79248134|FG004|Overall Study|Poor compliance to protocol|0|||
44284586|NCT01730040|79248135|FG005|Overall Study|Poor compliance to protocol|0|||
44284587|NCT01730040|79248136|FG006|Overall Study|Poor compliance to protocol|1|||
44284588|NCT01706328|79248154|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
44284589|NCT01706328|79248155|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44284590|NCT01706328|79248156|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44284591|NCT01706328|79248154|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
44284592|NCT01706328|79248155|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44284593|NCT01706328|79248156|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44284594|NCT01706328|79248154|FG000|2-week Run-in Period|Physician Decision|4|||
44533390|NCT03152552|79543535|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
44533391|NCT03152552|79543531|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
44533392|NCT03152552|79543532|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
44533393|NCT03152552|79543533|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
44533394|NCT03152552|79543534|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
44533395|NCT03152552|79543535|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
44533396|NCT03152552|79543531|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
44255810|NCT02592798|79101339|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
44255811|NCT02592798|79101338|FG000|Open Label Period (OLE)|Adverse Event|0|||
44255812|NCT02592798|79101339|FG001|Open Label Period (OLE)|Adverse Event|1|||
44255813|NCT00081653|79101379|FG000|Overall Study|Adverse Event|23|||
44255814|NCT00081653|79101380|FG001|Overall Study|Adverse Event|17|||
44255815|NCT00081653|79101379|FG000|Overall Study|Lost to Follow-up|2|||
44255816|NCT00081653|79101380|FG001|Overall Study|Lost to Follow-up|4|||
44255817|NCT00081653|79101379|FG000|Overall Study|Refused Treatment|18|||
44255818|NCT00081653|79101380|FG001|Overall Study|Refused Treatment|14|||
44255819|NCT00081653|79101379|FG000|Overall Study|Low bone mineral density|1|||
44255820|NCT00081653|79101380|FG001|Overall Study|Low bone mineral density|0|||
44255821|NCT00081653|79101379|FG000|Overall Study|Bone loss|2|||
44255822|NCT00081653|79101380|FG001|Overall Study|Bone loss|0|||
44255823|NCT00081653|79101379|FG000|Overall Study|Participant leaving country|1|||
44255824|NCT00081653|79101380|FG001|Overall Study|Participant leaving country|0|||
44255825|NCT00081653|79101379|FG000|Overall Study|Loss of bone mass|0|||
44255826|NCT00081653|79101380|FG001|Overall Study|Loss of bone mass|2|||
44255827|NCT02596620|79101441|FG000|Overall Study|Lost to Follow-up|1|||
44284595|NCT01706328|79248155|FG001|2-week Run-in Period|Physician Decision|0|||
44284596|NCT01706328|79248156|FG002|2-week Run-in Period|Physician Decision|0|||
44284597|NCT01706328|79248154|FG000|2-week Run-in Period|Adverse Event|4|||
44284598|NCT01706328|79248155|FG001|2-week Run-in Period|Adverse Event|0|||
44284599|NCT01706328|79248156|FG002|2-week Run-in Period|Adverse Event|0|||
44284600|NCT01706328|79248154|FG000|2-week Run-in Period|Lost to Follow-up|2|||
44284601|NCT01706328|79248155|FG001|2-week Run-in Period|Lost to Follow-up|0|||
44284602|NCT01706328|79248156|FG002|2-week Run-in Period|Lost to Follow-up|0|||
44284603|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
44284604|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
44284605|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
44284606|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
44284607|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
44284608|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
44284609|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
44284610|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
44284611|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
44284612|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
44284613|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
44284614|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
44284615|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
44284616|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
44284617|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
44284618|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
44284619|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
44284620|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
44284621|NCT01706328|79248154|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44284622|NCT01706328|79248155|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
44284623|NCT01706328|79248156|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
44284624|NCT01753518|79248164|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
44284625|NCT01753518|79248165|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
44284626|NCT01753518|79248164|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
44284627|NCT01753518|79248165|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
44284628|NCT01753518|79248164|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
44284629|NCT01753518|79248165|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
44284630|NCT01753518|79248164|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
44284631|NCT01753518|79248165|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
44284632|NCT01706250|79248171|FG000|Overall Study|Lost to Follow-up|2|||
44284633|NCT01729728|79248183|FG000|Overall Study|Adverse Event|0|||
44284634|NCT01729728|79248184|FG001|Overall Study|Adverse Event|6|||
44284635|NCT01729728|79248185|FG002|Overall Study|Adverse Event|0|||
44284636|NCT01729728|79248183|FG000|Overall Study|Protocol Violation|1|||
44284637|NCT01729728|79248184|FG001|Overall Study|Protocol Violation|0|||
44284638|NCT01729728|79248185|FG002|Overall Study|Protocol Violation|1|||
44284639|NCT01729026|79248318|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
44284640|NCT01729026|79248319|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
44284641|NCT01729026|79248318|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
44284642|NCT01729026|79248319|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
44284643|NCT01728792|79248333|FG000|Overall Study|Withdrawal of Consent|1|||
44284644|NCT01728792|79248334|FG001|Overall Study|Withdrawal of Consent|1|||
44284645|NCT01728792|79248335|FG002|Overall Study|Withdrawal of Consent|0|||
44284646|NCT01728792|79248336|FG003|Overall Study|Withdrawal of Consent|1|||
44284647|NCT01728792|79248337|FG004|Overall Study|Withdrawal of Consent|0|||
44284648|NCT01728792|79248333|FG000|Overall Study|Lost to Follow-up|2|||
44284649|NCT01728792|79248334|FG001|Overall Study|Lost to Follow-up|1|||
44284650|NCT01728792|79248335|FG002|Overall Study|Lost to Follow-up|4|||
44284651|NCT01728792|79248336|FG003|Overall Study|Lost to Follow-up|2|||
44284652|NCT01728792|79248337|FG004|Overall Study|Lost to Follow-up|0|||
44154309|NCT01980940|78945366|FG000|Overall Study|Protocol Violation|0|||
44154310|NCT01980940|78945367|FG001|Overall Study|Protocol Violation|0|||
44154311|NCT01980940|78945368|FG002|Overall Study|Protocol Violation|0|||
44154312|NCT01980940|78945369|FG003|Overall Study|Protocol Violation|0|||
44284653|NCT01752036|79248349|FG000|Overall Study|Death|2|||
44284654|NCT01728324|79248357|FG000|Termination of DBV|Adverse Event|14|||
44284655|NCT01728324|79248358|FG001|Termination of DBV|Adverse Event|13|||
44284656|NCT01728324|79248359|FG002|Termination of DBV|Adverse Event|4|||
44284657|NCT01728324|79248357|FG000|Termination of DBV|Lack of Efficacy|14|||
44154313|NCT01980940|78945370|FG004|Overall Study|Protocol Violation|0|||
44154314|NCT01980940|78945371|FG005|Overall Study|Protocol Violation|2|||
44284658|NCT01728324|79248358|FG001|Termination of DBV|Lack of Efficacy|12|||
44284659|NCT01728324|79248359|FG002|Termination of DBV|Lack of Efficacy|8|||
44284660|NCT01728324|79248357|FG000|Termination of DBV|Withdrawal by Subject|9|||
44284661|NCT01728324|79248358|FG001|Termination of DBV|Withdrawal by Subject|6|||
44284662|NCT01728324|79248359|FG002|Termination of DBV|Withdrawal by Subject|2|||
44154315|NCT01980940|78945372|FG006|Overall Study|Protocol Violation|0|||
44154316|NCT01980940|78945373|FG007|Overall Study|Protocol Violation|0|||
44154317|NCT02699983|78945399|FG000|Overall Study|Withdrawal by Subject|1|||
44154318|NCT02699983|78945400|FG001|Overall Study|Withdrawal by Subject|0|||
44154319|NCT01960114|78945412|FG000|Overall Study|Adverse Event|1|||
44154320|NCT01960114|78945413|FG001|Overall Study|Adverse Event|0|||
44154321|NCT01960114|78945412|FG000|Overall Study|Could not swallow study medication|0|||
44154322|NCT01960114|78945413|FG001|Overall Study|Could not swallow study medication|1|||
44154323|NCT02005276|78945423|FG000|Overall Study|No longer interested|5|||
44154324|NCT02005276|78945424|FG001|Overall Study|No longer interested|2|||
44154325|NCT02005276|78945425|FG002|Overall Study|No longer interested|3|||
44154326|NCT02005276|78945426|FG003|Overall Study|No longer interested|3|||
44154327|NCT01980706|78945441|FG000|Overall Study|Withdrawal by Subject|9|||
44154328|NCT01980706|78945442|FG001|Overall Study|Withdrawal by Subject|6|||
44154329|NCT01980706|78945443|FG002|Overall Study|Withdrawal by Subject|2|||
44154330|NCT01980706|78945441|FG000|Overall Study|Adverse Event|1|||
44154331|NCT01980706|78945442|FG001|Overall Study|Adverse Event|2|||
44154332|NCT01980706|78945443|FG002|Overall Study|Adverse Event|5|||
44284663|NCT01728324|79248357|FG000|Termination of DBV|Other than stated|1|||
44284664|NCT01728324|79248358|FG001|Termination of DBV|Other than stated|3|||
44284665|NCT01728324|79248359|FG002|Termination of DBV|Other than stated|0|||
44284666|NCT01728324|79248357|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
44284667|NCT01728324|79248358|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
44284668|NCT01728324|79248359|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
44284669|NCT01728324|79248357|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
44284670|NCT01728324|79248358|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
44284671|NCT01728324|79248359|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
44284672|NCT01728324|79248357|FG000|Termination of FDV|Adverse Event|14|||
44284673|NCT01728324|79248358|FG001|Termination of FDV|Adverse Event|13|||
44284674|NCT01728324|79248359|FG002|Termination of FDV|Adverse Event|4|||
44284675|NCT01728324|79248357|FG000|Termination of FDV|Lack of Efficacy|14|||
44284676|NCT01728324|79248358|FG001|Termination of FDV|Lack of Efficacy|12|||
44284677|NCT01728324|79248359|FG002|Termination of FDV|Lack of Efficacy|8|||
44284678|NCT01728324|79248357|FG000|Termination of FDV|Withdrawal by Subject|9|||
44284679|NCT01728324|79248358|FG001|Termination of FDV|Withdrawal by Subject|6|||
44284680|NCT01728324|79248359|FG002|Termination of FDV|Withdrawal by Subject|2|||
44284681|NCT01728324|79248357|FG000|Termination of FDV|Other than stated|1|||
44284682|NCT01728324|79248358|FG001|Termination of FDV|Other than stated|3|||
44284683|NCT01728324|79248359|FG002|Termination of FDV|Other than stated|0|||
44284684|NCT01728324|79248357|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
44284685|NCT01728324|79248358|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
44284686|NCT01728324|79248359|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
44284687|NCT01728324|79248357|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
44284688|NCT01728324|79248358|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
44284689|NCT01728324|79248359|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
44284690|NCT01728324|79248357|FG000|Termination of RBV|Adverse Event|15|||
44284691|NCT01728324|79248358|FG001|Termination of RBV|Adverse Event|16|||
44284692|NCT01728324|79248359|FG002|Termination of RBV|Adverse Event|5|||
44284693|NCT01728324|79248357|FG000|Termination of RBV|Lack of Efficacy|14|||
44284694|NCT01728324|79248358|FG001|Termination of RBV|Lack of Efficacy|11|||
44284695|NCT01728324|79248359|FG002|Termination of RBV|Lack of Efficacy|7|||
44284696|NCT01728324|79248357|FG000|Termination of RBV|Withdrawal by Subject|9|||
44284697|NCT01728324|79248358|FG001|Termination of RBV|Withdrawal by Subject|5|||
44284698|NCT01728324|79248359|FG002|Termination of RBV|Withdrawal by Subject|2|||
44284699|NCT01728324|79248357|FG000|Termination of RBV|Other than stated|1|||
44284700|NCT01728324|79248358|FG001|Termination of RBV|Other than stated|3|||
44284701|NCT01728324|79248359|FG002|Termination of RBV|Other than stated|1|||
44284702|NCT01728324|79248357|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
44284703|NCT01728324|79248358|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
44284704|NCT01728324|79248359|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
44284705|NCT01728324|79248357|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
44284706|NCT01728324|79248358|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
44284707|NCT01728324|79248359|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
44284708|NCT01728246|79248371|FG000|Overall Study|Participant needed rescue medication|1|||
44154333|NCT01980706|78945441|FG000|Overall Study|Lost to Follow-up|3|||
44154334|NCT01980706|78945442|FG001|Overall Study|Lost to Follow-up|4|||
44154335|NCT01980706|78945443|FG002|Overall Study|Lost to Follow-up|3|||
44154336|NCT01980706|78945441|FG000|Overall Study|miscellaneous|4|||
44284709|NCT01728246|79248372|FG001|Overall Study|Participant needed rescue medication|5|||
44284710|NCT01728246|79248371|FG000|Overall Study|Protocol Violation|1|||
44284711|NCT01728246|79248372|FG001|Overall Study|Protocol Violation|0|||
44284712|NCT01728246|79248371|FG000|Overall Study|Withdrawal by Subject|2|||
44284713|NCT01728246|79248372|FG001|Overall Study|Withdrawal by Subject|3|||
44284714|NCT01728246|79248371|FG000|Overall Study|Lost to Follow-up|23|||
44284715|NCT01728246|79248372|FG001|Overall Study|Lost to Follow-up|22|||
44284716|NCT01728246|79248371|FG000|Overall Study|Lack of Efficacy|1|||
44284717|NCT01728246|79248372|FG001|Overall Study|Lack of Efficacy|1|||
44284718|NCT01728246|79248371|FG000|Overall Study|Adverse Event|8|||
44284719|NCT01728246|79248372|FG001|Overall Study|Adverse Event|5|||
44284720|NCT01705236|79248378|FG000|Overall Study|Lost to Follow-up|1|||
44284721|NCT01705236|79248378|FG000|Overall Study|Administrative problems|2|||
44284722|NCT01705236|79248378|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
44284723|NCT01705236|79248378|FG000|Overall Study|Protocol Violation|3|||
44284724|NCT01705236|79248378|FG000|Overall Study|Abnormal test procedure result(s)|4|||
44284725|NCT01705236|79248378|FG000|Overall Study|Abnormal laboratory value(s)|4|||
44284726|NCT01705236|79248378|FG000|Overall Study|Withdrawal by Subject|5|||
44284727|NCT01705236|79248378|FG000|Overall Study|Adverse Event|5|||
44284728|NCT01705080|79248385|FG000|Overall Study|Missed visit|10|||
44284729|NCT01705080|79248386|FG001|Overall Study|Missed visit|4|||
44284730|NCT01705080|79248387|FG002|Overall Study|Missed visit|1|||
44284731|NCT01705080|79248385|FG000|Overall Study|Death|4|||
44284732|NCT01705080|79248386|FG001|Overall Study|Death|4|||
44284733|NCT01705080|79248387|FG002|Overall Study|Death|6|||
44284734|NCT01705080|79248385|FG000|Overall Study|Withdrawal by Subject|61|||
44284735|NCT01705080|79248386|FG001|Overall Study|Withdrawal by Subject|44|||
44284736|NCT01705080|79248387|FG002|Overall Study|Withdrawal by Subject|9|||
44284737|NCT01704846|79248397|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44284738|NCT01704846|79248398|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44284739|NCT01751802|79248406|FG000|Overall Study|Adverse Event|4|||
44284740|NCT01751802|79248407|FG001|Overall Study|Adverse Event|2|||
44284741|NCT01704456|79248421|FG000|Overall Study|Lost to Follow-up|8|||
44284742|NCT01704456|79248422|FG001|Overall Study|Lost to Follow-up|14|||
44284743|NCT01703988|79248432|FG000|Overall Study|Investigator Judgment|0|||
44284744|NCT01703988|79248433|FG001|Overall Study|Investigator Judgment|0|||
44284745|NCT01703988|79248434|FG002|Overall Study|Investigator Judgment|0|||
44284746|NCT01703988|79248435|FG003|Overall Study|Investigator Judgment|1|||
44284747|NCT01703832|79248448|FG000|Overall Study|Withdrawal by Subject|1|||
44284748|NCT01703832|79248449|FG001|Overall Study|Withdrawal by Subject|0|||
44284749|NCT01703286|79248455|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
44284750|NCT01703286|79248456|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
44284751|NCT01703286|79248457|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
44284752|NCT01703286|79248458|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
44284753|NCT01703286|79248459|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
44284754|NCT01703286|79248460|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
44284755|NCT01703286|79248455|FG000|Period 2 Including Washout|Adverse Event|0|||
44284756|NCT01703286|79248456|FG001|Period 2 Including Washout|Adverse Event|0|||
44284757|NCT01703286|79248457|FG002|Period 2 Including Washout|Adverse Event|0|||
44284758|NCT01703286|79248458|FG003|Period 2 Including Washout|Adverse Event|1|||
44284759|NCT01703286|79248459|FG004|Period 2 Including Washout|Adverse Event|0|||
44284760|NCT01703286|79248460|FG005|Period 2 Including Washout|Adverse Event|0|||
44284761|NCT01703208|79248473|FG000|Overall Study|Death|61|||
44284762|NCT01703208|79248474|FG001|Overall Study|Death|48|||
44284763|NCT01703208|79248473|FG000|Overall Study|Lack of Efficacy|1|||
44284764|NCT01703208|79248474|FG001|Overall Study|Lack of Efficacy|2|||
44284765|NCT01703208|79248473|FG000|Overall Study|Lost to Follow-up|68|||
44284766|NCT01703208|79248474|FG001|Overall Study|Lost to Follow-up|62|||
44284767|NCT01703208|79248473|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44284768|NCT01703208|79248474|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44284769|NCT01703208|79248473|FG000|Overall Study|Excluded Medication|1|||
44284770|NCT01703208|79248474|FG001|Overall Study|Excluded Medication|2|||
44284771|NCT01703208|79248473|FG000|Overall Study|Site Discontinued Study Participation|23|||
44284772|NCT01703208|79248474|FG001|Overall Study|Site Discontinued Study Participation|27|||
44284773|NCT01703208|79248473|FG000|Overall Study|Physician Decision|11|||
44284774|NCT01703208|79248474|FG001|Overall Study|Physician Decision|13|||
44284775|NCT01703208|79248473|FG000|Overall Study|Progressive disease|2|||
44284776|NCT01703208|79248474|FG001|Overall Study|Progressive disease|2|||
44284777|NCT01703208|79248473|FG000|Overall Study|Protocol Violation|1|||
44284778|NCT01703208|79248474|FG001|Overall Study|Protocol Violation|1|||
44284779|NCT01703208|79248473|FG000|Overall Study|Study Terminated by Sponsor|1710|||
44284780|NCT01703208|79248474|FG001|Overall Study|Study Terminated by Sponsor|1716|||
44284781|NCT01703208|79248473|FG000|Overall Study|Withdrawal by Subject|205|||
44284782|NCT01703208|79248474|FG001|Overall Study|Withdrawal by Subject|209|||
44284783|NCT01703208|79248473|FG000|Overall Study|Adverse Event|14|||
44284784|NCT01703208|79248474|FG001|Overall Study|Adverse Event|19|||
44284785|NCT01703208|79248473|FG000|Overall Study|Technical Problems|0|||
44284786|NCT01703208|79248474|FG001|Overall Study|Technical Problems|1|||
44284787|NCT01703208|79248473|FG000|Overall Study|Protocol Deviation|2|||
44284788|NCT01703208|79248474|FG001|Overall Study|Protocol Deviation|0|||
44284789|NCT01727700|79248483|FG000|Overall Study|Adverse Event|0|||
44284790|NCT01727700|79248484|FG001|Overall Study|Adverse Event|7|||
44284791|NCT01727700|79248485|FG002|Overall Study|Adverse Event|1|||
44284792|NCT01727700|79248483|FG000|Overall Study|Particpant withdrew consent|0|||
44284793|NCT01727700|79248484|FG001|Overall Study|Particpant withdrew consent|3|||
44284794|NCT01727700|79248485|FG002|Overall Study|Particpant withdrew consent|1|||
44284795|NCT01727700|79248483|FG000|Overall Study|Protocol Violation|2|||
44284796|NCT01727700|79248484|FG001|Overall Study|Protocol Violation|0|||
44284797|NCT01727700|79248485|FG002|Overall Study|Protocol Violation|0|||
44284798|NCT01727154|79248493|FG000|Overall Study|Death|17|||
44284799|NCT01727154|79248493|FG000|Overall Study|Withdrawal by Subject|14|||
44284800|NCT01727154|79248493|FG000|Overall Study|Subject Withdrew Consent|18|||
44284801|NCT01727154|79248493|FG000|Overall Study|Study Terminated|6|||
44284802|NCT01727154|79248493|FG000|Overall Study|No Discontinuation Documentation|4|||
44284803|NCT01725750|79248499|FG000|Overall Study|Adverse Event|1|||
44284804|NCT01725750|79248500|FG001|Overall Study|Adverse Event|0|||
44284805|NCT01725750|79248499|FG000|Overall Study|Lost to Follow-up|1|||
44284806|NCT01725750|79248500|FG001|Overall Study|Lost to Follow-up|1|||
44284807|NCT01725750|79248499|FG000|Overall Study|Withdrawal by Subject|0|||
44284808|NCT01725750|79248500|FG001|Overall Study|Withdrawal by Subject|9|||
44284809|NCT01725282|79248512|FG000|Overall Study|Adverse Event|1|||
44284810|NCT01725282|79248513|FG001|Overall Study|Adverse Event|3|||
44284811|NCT01725282|79248514|FG002|Overall Study|Adverse Event|6|||
44284812|NCT01725282|79248515|FG003|Overall Study|Adverse Event|4|||
44284813|NCT01725282|79248512|FG000|Overall Study|Exacerbation of Target Disease|1|||
44284814|NCT01725282|79248513|FG001|Overall Study|Exacerbation of Target Disease|0|||
44284815|NCT01725282|79248514|FG002|Overall Study|Exacerbation of Target Disease|0|||
44284816|NCT01725282|79248515|FG003|Overall Study|Exacerbation of Target Disease|1|||
44284817|NCT01725282|79248512|FG000|Overall Study|Met Exclusion Criteria|0|||
44284818|NCT01725282|79248513|FG001|Overall Study|Met Exclusion Criteria|0|||
44284819|NCT01725282|79248514|FG002|Overall Study|Met Exclusion Criteria|1|||
44284820|NCT01725282|79248515|FG003|Overall Study|Met Exclusion Criteria|0|||
44284821|NCT01725282|79248512|FG000|Overall Study|Study Site Withdrawal|0|||
44284822|NCT01725282|79248513|FG001|Overall Study|Study Site Withdrawal|1|||
44284823|NCT01725282|79248514|FG002|Overall Study|Study Site Withdrawal|0|||
44284824|NCT01725282|79248515|FG003|Overall Study|Study Site Withdrawal|0|||
44284825|NCT01725282|79248512|FG000|Overall Study|Withdrawal by Subject|0|||
44284826|NCT01725282|79248513|FG001|Overall Study|Withdrawal by Subject|0|||
44284827|NCT01725282|79248514|FG002|Overall Study|Withdrawal by Subject|1|||
44415563|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
44415564|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
44415565|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
44415566|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
44415567|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
44415568|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
44415569|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
44415570|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
44415571|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
44415572|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
44415573|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
44415574|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
44415575|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
44415576|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
44415577|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
44415578|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
44415579|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
44154337|NCT01980706|78945442|FG001|Overall Study|miscellaneous|5|||
44154338|NCT01980706|78945443|FG002|Overall Study|miscellaneous|3|||
44284828|NCT01725282|79248515|FG003|Overall Study|Withdrawal by Subject|1|||
44284829|NCT01725282|79248512|FG000|Overall Study|Lack of Efficacy|0|||
44284830|NCT01725282|79248513|FG001|Overall Study|Lack of Efficacy|1|||
44284831|NCT01725282|79248514|FG002|Overall Study|Lack of Efficacy|0|||
44284832|NCT01725282|79248515|FG003|Overall Study|Lack of Efficacy|1|||
44284833|NCT01725126|79248531|FG000|Overall Study|Protocol Violation|0|||
44415580|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
44415581|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
44154339|NCT02692417|78945453|FG000|Overall Study|Withdrawal by Subject|5|||
44284834|NCT01725126|79248532|FG001|Overall Study|Protocol Violation|1|||
44284835|NCT01725126|79248533|FG002|Overall Study|Protocol Violation|0|||
44284836|NCT01725126|79248534|FG003|Overall Study|Protocol Violation|0|||
44284837|NCT01725126|79248535|FG004|Overall Study|Protocol Violation|0|||
44284838|NCT01725126|79248536|FG005|Overall Study|Protocol Violation|0|||
44284839|NCT01725126|79248531|FG000|Overall Study|Withdrawal by Subject|0|||
44284840|NCT01725126|79248532|FG001|Overall Study|Withdrawal by Subject|0|||
44284841|NCT01725126|79248533|FG002|Overall Study|Withdrawal by Subject|0|||
44284842|NCT01725126|79248534|FG003|Overall Study|Withdrawal by Subject|1|||
44284843|NCT01725126|79248535|FG004|Overall Study|Withdrawal by Subject|0|||
44284844|NCT01725126|79248536|FG005|Overall Study|Withdrawal by Subject|0|||
44284845|NCT01751724|79248561|FG000|Overall Study|extubated bef.start assigned treatment|1|||
44284846|NCT01751724|79248562|FG001|Overall Study|extubated bef.start assigned treatment|0|||
44284847|NCT01751724|79248561|FG000|Overall Study|withdrawn by parent|0|||
44284848|NCT01751724|79248562|FG001|Overall Study|withdrawn by parent|2|||
44284849|NCT01751646|79248570|FG000|Overall Study|Lost to Follow-up|5|||
44284850|NCT01751646|79248571|FG001|Overall Study|Lost to Follow-up|1|||
44284851|NCT01751646|79248570|FG000|Overall Study|Withdrawal by Subject|0|||
44284852|NCT01751646|79248571|FG001|Overall Study|Withdrawal by Subject|4|||
44284853|NCT01751646|79248570|FG000|Overall Study|Starting hormone therapy|1|||
44284854|NCT01751646|79248571|FG001|Overall Study|Starting hormone therapy|0|||
44284855|NCT01751646|79248570|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
44284856|NCT01751646|79248571|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
44284857|NCT01751646|79248570|FG000|Overall Study|Inadvertent enrollment|1|||
44284858|NCT01751646|79248571|FG001|Overall Study|Inadvertent enrollment|1|||
44284859|NCT01751646|79248570|FG000|Overall Study|Moved out of the area|1|||
44284860|NCT01751646|79248571|FG001|Overall Study|Moved out of the area|5|||
44284861|NCT01751646|79248570|FG000|Overall Study|Inability to attend required visits|0|||
44284862|NCT01751646|79248571|FG001|Overall Study|Inability to attend required visits|1|||
44284863|NCT01751646|79248570|FG000|Overall Study|Off study due to multiple obligations|0|||
44415582|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
44415583|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
44415584|NCT00785577|79423303|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
44415585|NCT00785577|79423304|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
44284864|NCT01751646|79248571|FG001|Overall Study|Off study due to multiple obligations|1|||
44284865|NCT01751646|79248570|FG000|Overall Study|Fails to comply with study requirements|0|||
44284866|NCT01751646|79248571|FG001|Overall Study|Fails to comply with study requirements|1|||
44284867|NCT01751646|79248570|FG000|Overall Study|Childcare issues|1|||
44284868|NCT01751646|79248571|FG001|Overall Study|Childcare issues|1|||
44284869|NCT01751568|79248584|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
44284870|NCT01751568|79248585|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
44284871|NCT01751568|79248586|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
44284872|NCT01751412|79248594|FG000|Overall Study|Disease Progression Before Treatment|1|||
44284873|NCT01751178|79248601|FG000|Overall Study|Adverse Event|2|||
44284874|NCT01751178|79248602|FG001|Overall Study|Adverse Event|0|||
44284875|NCT01751178|79248603|FG002|Overall Study|Adverse Event|0|||
44284876|NCT01751178|79248601|FG000|Overall Study|Other Reason (unknown)|1|||
44284877|NCT01751178|79248602|FG001|Overall Study|Other Reason (unknown)|0|||
44284878|NCT01751178|79248603|FG002|Overall Study|Other Reason (unknown)|2|||
44284879|NCT01606254|79248619|FG000|Overall Study|Withdrawal by Subject|1|||
44284880|NCT01606254|79248620|FG001|Overall Study|Withdrawal by Subject|3|||
44284881|NCT01606254|79248621|FG002|Overall Study|Withdrawal by Subject|0|||
44284882|NCT01606254|79248622|FG003|Overall Study|Withdrawal by Subject|2|||
44284883|NCT01606254|79248619|FG000|Overall Study|Adverse Event|1|||
44284884|NCT01606254|79248620|FG001|Overall Study|Adverse Event|1|||
44284885|NCT01606254|79248621|FG002|Overall Study|Adverse Event|0|||
44284886|NCT01606254|79248622|FG003|Overall Study|Adverse Event|1|||
44284887|NCT01750242|79248632|FG000|Overall Study|Unreadable Images|3|||
44284888|NCT01723254|79248645|FG000|Overall Study|Conflict with work schedule|0|||
44284889|NCT01723254|79248646|FG001|Overall Study|Conflict with work schedule|0|||
44284890|NCT01723254|79248647|FG002|Overall Study|Conflict with work schedule|0|||
44415586|NCT00785577|79423305|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
44415587|NCT00785577|79423306|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
44255828|NCT02596620|79101442|FG001|Overall Study|Lost to Follow-up|1|||
44255829|NCT02596230|79101598|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
44255830|NCT02596230|79101599|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
44255831|NCT02596230|79101600|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
44255832|NCT02596230|79101601|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
44255833|NCT02596230|79101602|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
44255834|NCT02596230|79101598|FG000|Objective 2, One Year|Lost to Follow-up|0|||
44255835|NCT02596230|79101599|FG001|Objective 2, One Year|Lost to Follow-up|41|||
44255836|NCT02596230|79101600|FG002|Objective 2, One Year|Lost to Follow-up|41|||
44255837|NCT02596230|79101601|FG003|Objective 2, One Year|Lost to Follow-up|32|||
44255838|NCT02596230|79101602|FG004|Objective 2, One Year|Lost to Follow-up|46|||
44255839|NCT02596230|79101598|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
44255840|NCT02596230|79101599|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
44284891|NCT01723254|79248648|FG003|Overall Study|Conflict with work schedule|0|||
44284892|NCT01723254|79248649|FG004|Overall Study|Conflict with work schedule|0|||
44284893|NCT01723254|79248650|FG005|Overall Study|Conflict with work schedule|0|||
44284894|NCT01723254|79248651|FG006|Overall Study|Conflict with work schedule|0|||
44284895|NCT01723254|79248652|FG007|Overall Study|Conflict with work schedule|1|||
44284896|NCT01723254|79248645|FG000|Overall Study|Personal issues|0|||
44284897|NCT01723254|79248646|FG001|Overall Study|Personal issues|0|||
44284898|NCT01723254|79248647|FG002|Overall Study|Personal issues|0|||
44284899|NCT01723254|79248648|FG003|Overall Study|Personal issues|0|||
44284900|NCT01723254|79248649|FG004|Overall Study|Personal issues|0|||
44284901|NCT01723254|79248650|FG005|Overall Study|Personal issues|1|||
44284902|NCT01723254|79248651|FG006|Overall Study|Personal issues|0|||
44284903|NCT01723254|79248652|FG007|Overall Study|Personal issues|0|||
44284904|NCT01723254|79248645|FG000|Overall Study|No longer have time to participate|0|||
44284905|NCT01723254|79248646|FG001|Overall Study|No longer have time to participate|0|||
44284906|NCT01723254|79248647|FG002|Overall Study|No longer have time to participate|0|||
44284907|NCT01723254|79248648|FG003|Overall Study|No longer have time to participate|1|||
44284908|NCT01723254|79248649|FG004|Overall Study|No longer have time to participate|0|||
44284909|NCT01723254|79248650|FG005|Overall Study|No longer have time to participate|0|||
44284910|NCT01723254|79248651|FG006|Overall Study|No longer have time to participate|0|||
44284911|NCT01723254|79248652|FG007|Overall Study|No longer have time to participate|0|||
44284912|NCT01723254|79248645|FG000|Overall Study|Move/Left to another country/city|0|||
44284913|NCT01723254|79248646|FG001|Overall Study|Move/Left to another country/city|0|||
44284914|NCT01723254|79248647|FG002|Overall Study|Move/Left to another country/city|2|||
44284915|NCT01723254|79248648|FG003|Overall Study|Move/Left to another country/city|1|||
44284916|NCT01723254|79248649|FG004|Overall Study|Move/Left to another country/city|1|||
44284917|NCT01723254|79248650|FG005|Overall Study|Move/Left to another country/city|0|||
44284918|NCT01723254|79248651|FG006|Overall Study|Move/Left to another country/city|0|||
44284919|NCT01723254|79248652|FG007|Overall Study|Move/Left to another country/city|0|||
44284920|NCT01723254|79248645|FG000|Overall Study|Protocol Violation|0|||
44284921|NCT01723254|79248646|FG001|Overall Study|Protocol Violation|1|||
44284922|NCT01723254|79248647|FG002|Overall Study|Protocol Violation|0|||
44284923|NCT01723254|79248648|FG003|Overall Study|Protocol Violation|0|||
44284924|NCT01723254|79248649|FG004|Overall Study|Protocol Violation|0|||
44284925|NCT01723254|79248650|FG005|Overall Study|Protocol Violation|0|||
44284926|NCT01723254|79248651|FG006|Overall Study|Protocol Violation|0|||
44284927|NCT01723254|79248652|FG007|Overall Study|Protocol Violation|0|||
44284928|NCT01723254|79248645|FG000|Overall Study|Withdrawal by Subject|1|||
44284929|NCT01723254|79248646|FG001|Overall Study|Withdrawal by Subject|2|||
44284930|NCT01723254|79248647|FG002|Overall Study|Withdrawal by Subject|1|||
44284931|NCT01723254|79248648|FG003|Overall Study|Withdrawal by Subject|0|||
44284932|NCT01723254|79248649|FG004|Overall Study|Withdrawal by Subject|1|||
44284933|NCT01723254|79248650|FG005|Overall Study|Withdrawal by Subject|1|||
44284934|NCT01723254|79248651|FG006|Overall Study|Withdrawal by Subject|1|||
44284935|NCT01723254|79248652|FG007|Overall Study|Withdrawal by Subject|2|||
44284936|NCT01722162|79248672|FG000|Overall Study|Withdrawal by Subject|1|||
44284937|NCT01722162|79248673|FG001|Overall Study|Withdrawal by Subject|1|||
44284938|NCT01722162|79248672|FG000|Overall Study|Found ineligible|1|||
44284939|NCT01722162|79248673|FG001|Overall Study|Found ineligible|0|||
44284940|NCT01722162|79248672|FG000|Overall Study|Unrelated to study adverse event|2|||
44284941|NCT01722162|79248673|FG001|Overall Study|Unrelated to study adverse event|2|||
44284942|NCT01722162|79248672|FG000|Overall Study|Adverse Event|1|||
44284943|NCT01722162|79248673|FG001|Overall Study|Adverse Event|1|||
44284944|NCT01722162|79248672|FG000|Overall Study|Insurance denial post enrollment|0|||
44284945|NCT01722162|79248673|FG001|Overall Study|Insurance denial post enrollment|1|||
44284946|NCT01722162|79248672|FG000|Overall Study|Noncompliance|0|||
44284947|NCT01722162|79248673|FG001|Overall Study|Noncompliance|1|||
44284948|NCT01721772|79248681|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
44284949|NCT01721772|79248682|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
44284950|NCT01721772|79248681|FG000|Pre-Treatment|Poor/non-compliance|0|||
44284951|NCT01721772|79248682|FG001|Pre-Treatment|Poor/non-compliance|1|||
44284952|NCT01721772|79248681|FG000|Pre-Treatment|Participant withdrew consent|0|||
44284953|NCT01721772|79248682|FG001|Pre-Treatment|Participant withdrew consent|1|||
44284954|NCT01721772|79248681|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
44284955|NCT01721772|79248682|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
44284956|NCT01721772|79248681|FG000|Treatment|Disease progression|119|||
44284957|NCT01721772|79248682|FG001|Treatment|Disease progression|168|||
44284958|NCT01721772|79248681|FG000|Treatment|Study drug toxicity|19|||
44284959|NCT01721772|79248682|FG001|Treatment|Study drug toxicity|10|||
44284960|NCT01721772|79248681|FG000|Treatment|Adverse event unrelated to study drug|7|||
44284961|NCT01721772|79248682|FG001|Treatment|Adverse event unrelated to study drug|7|||
44284962|NCT01721772|79248681|FG000|Treatment|Maximum clinical benefit|16|||
44284963|NCT01721772|79248682|FG001|Treatment|Maximum clinical benefit|4|||
44284964|NCT01721772|79248681|FG000|Treatment|Other|19|||
44284965|NCT01721772|79248682|FG001|Treatment|Other|2|||
44284966|NCT01721772|79248681|FG000|Treatment|Participant withdrew consent|2|||
44284967|NCT01721772|79248682|FG001|Treatment|Participant withdrew consent|5|||
44284968|NCT01721772|79248681|FG000|Treatment|Participant request to discontinue study treatment|21|||
44284969|NCT01721772|79248682|FG001|Treatment|Participant request to discontinue study treatment|8|||
44284970|NCT01721772|79248681|FG000|Treatment|Death|1|||
44284971|NCT01721772|79248682|FG001|Treatment|Death|0|||
44284972|NCT01721772|79248681|FG000|Treatment|Not reported|1|||
44284973|NCT01721772|79248682|FG001|Treatment|Not reported|0|||
44284974|NCT01721772|79248681|FG000|Treatment|Poor/non-compliance|1|||
44284975|NCT01721772|79248682|FG001|Treatment|Poor/non-compliance|0|||
44284976|NCT01721772|79248681|FG000|Treatment|Lost to Follow-up|0|||
44284977|NCT01721772|79248682|FG001|Treatment|Lost to Follow-up|1|||
44284978|NCT01702428|79248692|FG000|Overall Study|Adverse Event|2|||
44284979|NCT01702428|79248693|FG001|Overall Study|Adverse Event|0|||
44284980|NCT01702428|79248694|FG002|Overall Study|Adverse Event|0|||
44284981|NCT01702428|79248695|FG003|Overall Study|Adverse Event|0|||
44284982|NCT01702428|79248692|FG000|Overall Study|Lost to Follow-up|33|||
44284983|NCT01702428|79248693|FG001|Overall Study|Lost to Follow-up|41|||
44284984|NCT01702428|79248694|FG002|Overall Study|Lost to Follow-up|37|||
44284985|NCT01702428|79248695|FG003|Overall Study|Lost to Follow-up|44|||
44284986|NCT01702428|79248692|FG000|Overall Study|Parents cannot assist to site|1|||
44284987|NCT01702428|79248693|FG001|Overall Study|Parents cannot assist to site|0|||
44284988|NCT01702428|79248694|FG002|Overall Study|Parents cannot assist to site|1|||
44284989|NCT01702428|79248695|FG003|Overall Study|Parents cannot assist to site|0|||
44284990|NCT01702428|79248692|FG000|Overall Study|Lost Coverage|0|||
44284991|NCT01702428|79248693|FG001|Overall Study|Lost Coverage|0|||
44284992|NCT01702428|79248694|FG002|Overall Study|Lost Coverage|0|||
44284993|NCT01702428|79248695|FG003|Overall Study|Lost Coverage|1|||
44284994|NCT01702428|79248692|FG000|Overall Study|Lost Health Plan|3|||
44284995|NCT01702428|79248693|FG001|Overall Study|Lost Health Plan|5|||
44284996|NCT01702428|79248694|FG002|Overall Study|Lost Health Plan|0|||
44284997|NCT01702428|79248695|FG003|Overall Study|Lost Health Plan|2|||
44284998|NCT01702428|79248692|FG000|Overall Study|Mother transferred care|0|||
44284999|NCT01702428|79248693|FG001|Overall Study|Mother transferred care|1|||
44285000|NCT01702428|79248694|FG002|Overall Study|Mother transferred care|0|||
44285001|NCT01702428|79248695|FG003|Overall Study|Mother transferred care|0|||
44285002|NCT01702428|79248692|FG000|Overall Study|Parents too busy|1|||
44285003|NCT01702428|79248693|FG001|Overall Study|Parents too busy|0|||
44285004|NCT01702428|79248694|FG002|Overall Study|Parents too busy|0|||
44285005|NCT01702428|79248695|FG003|Overall Study|Parents too busy|0|||
44285006|NCT01702428|79248692|FG000|Overall Study|Protocol Violation|3|||
44285007|NCT01702428|79248693|FG001|Overall Study|Protocol Violation|0|||
44285008|NCT01702428|79248694|FG002|Overall Study|Protocol Violation|1|||
44285009|NCT01702428|79248695|FG003|Overall Study|Protocol Violation|0|||
44285010|NCT01702428|79248692|FG000|Overall Study|Withdrawal by Subject|21|||
44285011|NCT01702428|79248693|FG001|Overall Study|Withdrawal by Subject|23|||
44285012|NCT01702428|79248694|FG002|Overall Study|Withdrawal by Subject|14|||
44285013|NCT01702428|79248695|FG003|Overall Study|Withdrawal by Subject|10|||
44285014|NCT01701258|79248716|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
44285015|NCT01701258|79248717|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
44285016|NCT01701258|79248718|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
44285017|NCT01701258|79248719|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
44285018|NCT01701258|79248720|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
44285019|NCT01701258|79248721|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
44285020|NCT01701258|79248722|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
44285021|NCT01701258|79248723|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
44285022|NCT01701258|79248724|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
44285023|NCT01701258|79248725|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
44415588|NCT00785577|79423307|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
44285024|NCT01701258|79248726|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
44285025|NCT01701258|79248727|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
44285026|NCT01701258|79248728|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
44285027|NCT01701258|79248716|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
44285028|NCT01701258|79248717|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
44285029|NCT01701258|79248718|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
44285030|NCT01701258|79248719|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
44285031|NCT01701258|79248720|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
44285032|NCT01701258|79248721|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
44285033|NCT01701258|79248722|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
44285034|NCT01701258|79248723|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
44285035|NCT01701258|79248724|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
44285036|NCT01701258|79248725|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
44285037|NCT01701258|79248726|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
44285038|NCT01701258|79248727|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
44285039|NCT01701258|79248728|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
44285040|NCT01701258|79248716|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
44285041|NCT01701258|79248717|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
44285042|NCT01701258|79248718|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
44285043|NCT01701258|79248719|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
44285044|NCT01701258|79248720|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
44285045|NCT01701258|79248721|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
44285046|NCT01701258|79248722|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
44285047|NCT01701258|79248723|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
44285048|NCT01701258|79248724|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
44285049|NCT01701258|79248725|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
44285050|NCT01701258|79248726|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
44285051|NCT01701258|79248727|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
44285052|NCT01701258|79248728|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
44285053|NCT01701258|79248716|FG000|Assessment and Scheduling|Investigator Terminated|2|||
44285054|NCT01701258|79248717|FG001|Assessment and Scheduling|Investigator Terminated|0|||
44285055|NCT01701258|79248718|FG002|Assessment and Scheduling|Investigator Terminated|0|||
44285056|NCT01701258|79248719|FG003|Assessment and Scheduling|Investigator Terminated|0|||
44285057|NCT01701258|79248720|FG004|Assessment and Scheduling|Investigator Terminated|0|||
44285058|NCT01701258|79248721|FG005|Assessment and Scheduling|Investigator Terminated|0|||
44285059|NCT01701258|79248722|FG006|Assessment and Scheduling|Investigator Terminated|0|||
44285060|NCT01701258|79248723|FG007|Assessment and Scheduling|Investigator Terminated|0|||
44285061|NCT01701258|79248724|FG008|Assessment and Scheduling|Investigator Terminated|0|||
44285062|NCT01701258|79248725|FG009|Assessment and Scheduling|Investigator Terminated|0|||
44285063|NCT01701258|79248726|FG010|Assessment and Scheduling|Investigator Terminated|0|||
44285064|NCT01701258|79248727|FG011|Assessment and Scheduling|Investigator Terminated|0|||
44285065|NCT01701258|79248728|FG012|Assessment and Scheduling|Investigator Terminated|0|||
44285066|NCT01700946|79248758|FG000|Overall Study|Lost to Follow-up|1|||
44285067|NCT01700946|79248759|FG001|Overall Study|Lost to Follow-up|0|||
44285068|NCT01700946|79248758|FG000|Overall Study|Physician Decision|7|||
44285069|NCT01700946|79248759|FG001|Overall Study|Physician Decision|12|||
44285070|NCT01700946|79248758|FG000|Overall Study|Withdrawal by Subject|0|||
44285071|NCT01700946|79248759|FG001|Overall Study|Withdrawal by Subject|2|||
44285072|NCT01700946|79248758|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
44285073|NCT01700946|79248759|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
44285074|NCT01700946|79248758|FG000|Overall Study|Relapse|2|||
44285075|NCT01700946|79248759|FG001|Overall Study|Relapse|1|||
44285076|NCT01700946|79248758|FG000|Overall Study|Unacceptable toxicity|1|||
44285077|NCT01700946|79248759|FG001|Overall Study|Unacceptable toxicity|0|||
44285078|NCT01748994|79248771|FG000|Overall Study|Lost to Follow-up|8|||
44285079|NCT01748994|79248772|FG001|Overall Study|Lost to Follow-up|6|||
44285080|NCT01721070|79248778|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
44285081|NCT01748760|79248787|FG000|Overall Study|Withdrawal by Subject|1|||
44285082|NCT01748760|79248788|FG001|Overall Study|Withdrawal by Subject|1|||
44285083|NCT01748760|79248787|FG000|Overall Study|Lost to Follow-up|5|||
44285084|NCT01748760|79248788|FG001|Overall Study|Lost to Follow-up|1|||
44285085|NCT01748292|79248796|FG000|Overall Study|Adverse Event|2|||
44285086|NCT01748292|79248797|FG001|Overall Study|Adverse Event|4|||
44285087|NCT01748292|79248796|FG000|Overall Study|Lost to Follow-up|0|||
44285088|NCT01748292|79248797|FG001|Overall Study|Lost to Follow-up|3|||
44285089|NCT01748292|79248796|FG000|Overall Study|Death|0|||
44285090|NCT01748292|79248797|FG001|Overall Study|Death|3|||
44285091|NCT01748292|79248796|FG000|Overall Study|Withdrawal by Subject|0|||
44285092|NCT01748292|79248797|FG001|Overall Study|Withdrawal by Subject|2|||
44285093|NCT01720602|79248803|FG000|Overall Study|Adverse Event|3|||
44285094|NCT01720602|79248803|FG000|Overall Study|Progressive disease on therapy|2|||
44285095|NCT01746732|79248807|FG000|Lead-In Period|Withdrawal by Subject|1|||
44285096|NCT01746732|79248808|FG001|Lead-In Period|Withdrawal by Subject|0|||
44285097|NCT01746732|79248809|FG002|Lead-In Period|Withdrawal by Subject|0|||
44285098|NCT01746732|79248807|FG000|Period 1|Physician Decision|0|||
44285099|NCT01746732|79248808|FG001|Period 1|Physician Decision|1|||
44285100|NCT01746732|79248809|FG002|Period 1|Physician Decision|0|||
44285101|NCT01746732|79248807|FG000|Period 2|Withdrawal by Subject|0|||
44285102|NCT01746732|79248808|FG001|Period 2|Withdrawal by Subject|0|||
44285103|NCT01746732|79248809|FG002|Period 2|Withdrawal by Subject|2|||
44285104|NCT01746732|79248807|FG000|Period 2|Adverse Event|0|||
44285105|NCT01746732|79248808|FG001|Period 2|Adverse Event|0|||
44285106|NCT01746732|79248809|FG002|Period 2|Adverse Event|1|||
44285107|NCT01746732|79248807|FG000|Period 2|Lost to Follow-up|0|||
44285108|NCT01746732|79248808|FG001|Period 2|Lost to Follow-up|0|||
44285109|NCT01746732|79248809|FG002|Period 2|Lost to Follow-up|1|||
44285110|NCT01720524|79248819|FG000|Part A|Insufficient Clinical Response|2|||
44285111|NCT01720524|79248820|FG001|Part A|Insufficient Clinical Response|4|||
44285112|NCT01720524|79248819|FG000|Part A|Adverse Event|2|||
44285113|NCT01720524|79248820|FG001|Part A|Adverse Event|2|||
44285114|NCT01720524|79248819|FG000|Part A|Death|2|||
44285115|NCT01720524|79248820|FG001|Part A|Death|1|||
44285116|NCT01720524|79248819|FG000|Part A|Lost to Follow-up|0|||
44285117|NCT01720524|79248820|FG001|Part A|Lost to Follow-up|1|||
44285118|NCT01720524|79248819|FG000|Part A|Missed 28 day follow-up visit|1|||
44285119|NCT01720524|79248820|FG001|Part A|Missed 28 day follow-up visit|1|||
44285120|NCT01720524|79248819|FG000|Part A|Withdrawal by Subject|0|||
44285121|NCT01720524|79248820|FG001|Part A|Withdrawal by Subject|1|||
44285122|NCT01720524|79248819|FG000|Part A|Other|0|||
44285123|NCT01720524|79248820|FG001|Part A|Other|1|||
44285124|NCT01720524|79248819|FG000|Part A|Lost to Follow-up|0|||
44285125|NCT01720524|79248820|FG001|Part A|Lost to Follow-up|1|||
44285126|NCT01720524|79248819|FG000|Part B|No longer willing to participate in study|1|||
44285127|NCT01720524|79248820|FG001|Part B|No longer willing to participate in study|4|||
44285128|NCT01720524|79248819|FG000|Part B|Other|2|||
44285129|NCT01720524|79248820|FG001|Part B|Other|0|||
44285130|NCT01720524|79248819|FG000|Part B|Lost to Follow-up|2|||
44285131|NCT01720524|79248820|FG001|Part B|Lost to Follow-up|3|||
44285132|NCT01720524|79248819|FG000|Part B|Death|0|||
44285133|NCT01720524|79248820|FG001|Part B|Death|2|||
44285134|NCT01720446|79248832|FG000|Overall Study|Lost to Follow-up|12|||
44285135|NCT01720446|79248833|FG001|Overall Study|Lost to Follow-up|6|||
44285136|NCT01720446|79248834|FG002|Overall Study|Lost to Follow-up|16|||
44285137|NCT01720446|79248835|FG003|Overall Study|Lost to Follow-up|16|||
44285138|NCT01720446|79248832|FG000|Overall Study|Withdrawal by Subject|2|||
44285139|NCT01720446|79248833|FG001|Overall Study|Withdrawal by Subject|5|||
44285140|NCT01720446|79248834|FG002|Overall Study|Withdrawal by Subject|4|||
44285141|NCT01720446|79248835|FG003|Overall Study|Withdrawal by Subject|4|||
44285142|NCT01746108|79248851|FG000|Overall Study|Migrated /moved from study area|0|||
44285143|NCT01746108|79248852|FG001|Overall Study|Migrated /moved from study area|1|||
44285144|NCT01746108|79248853|FG002|Overall Study|Migrated /moved from study area|0|||
44285145|NCT01746108|79248851|FG000|Overall Study|Adverse event, non-fatal|0|||
44285146|NCT01746108|79248852|FG001|Overall Study|Adverse event, non-fatal|1|||
44285147|NCT01746108|79248853|FG002|Overall Study|Adverse event, non-fatal|0|||
44285148|NCT01746108|79248851|FG000|Overall Study|Withdrawal by Subject|0|||
44285149|NCT01746108|79248852|FG001|Overall Study|Withdrawal by Subject|1|||
44285150|NCT01746108|79248853|FG002|Overall Study|Withdrawal by Subject|0|||
44285151|NCT01746108|79248851|FG000|Overall Study|Lost to Follow-up|0|||
44285152|NCT01746108|79248852|FG001|Overall Study|Lost to Follow-up|1|||
44285153|NCT01746108|79248853|FG002|Overall Study|Lost to Follow-up|0|||
44285154|NCT01717638|79248882|FG000|Overall Study|Lost to Follow-up|0|||
44285155|NCT01717638|79248883|FG001|Overall Study|Lost to Follow-up|0|||
44285156|NCT01717638|79248884|FG002|Overall Study|Lost to Follow-up|0|||
44285157|NCT01717638|79248885|FG003|Overall Study|Lost to Follow-up|0|||
44285158|NCT01717638|79248886|FG004|Overall Study|Lost to Follow-up|0|||
44285159|NCT01717638|79248887|FG005|Overall Study|Lost to Follow-up|1|||
44285160|NCT01717638|79248888|FG006|Overall Study|Lost to Follow-up|0|||
44285161|NCT01717638|79248889|FG007|Overall Study|Lost to Follow-up|0|||
44285162|NCT01717638|79248890|FG008|Overall Study|Lost to Follow-up|0|||
44285163|NCT01717638|79248891|FG009|Overall Study|Lost to Follow-up|0|||
44285164|NCT01717638|79248892|FG010|Overall Study|Lost to Follow-up|0|||
44285165|NCT01717638|79248893|FG011|Overall Study|Lost to Follow-up|0|||
44285166|NCT01717638|79248894|FG012|Overall Study|Lost to Follow-up|0|||
44285167|NCT01717638|79248882|FG000|Overall Study|Father in hospital|0|||
44285168|NCT01717638|79248883|FG001|Overall Study|Father in hospital|0|||
44285169|NCT01717638|79248884|FG002|Overall Study|Father in hospital|0|||
44285170|NCT01717638|79248885|FG003|Overall Study|Father in hospital|0|||
44285171|NCT01717638|79248886|FG004|Overall Study|Father in hospital|0|||
44285172|NCT01717638|79248887|FG005|Overall Study|Father in hospital|0|||
44533397|NCT03152552|79543532|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
44533398|NCT03152552|79543533|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
44533399|NCT03152552|79543534|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
44533400|NCT03152552|79543535|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
44533401|NCT03151226|79543548|FG000|Overall Study|Withdrawal by Subject|2|||
44533402|NCT03151226|79543548|FG000|Overall Study|not wear device correctly|1|||
44533403|NCT03151148|79543554|FG000|Overall Study|Lost to Follow-up|1|||
44533404|NCT03151148|79543555|FG001|Overall Study|Lost to Follow-up|0|||
44533405|NCT03151148|79543554|FG000|Overall Study|Withdrawal by Subject|1|||
44533406|NCT03151148|79543555|FG001|Overall Study|Withdrawal by Subject|0|||
44533407|NCT02741518|79543564|FG000|Overall Study|Withdrawal by Subject|1|||
44285173|NCT01717638|79248888|FG006|Overall Study|Father in hospital|0|||
44285174|NCT01717638|79248889|FG007|Overall Study|Father in hospital|0|||
44285175|NCT01717638|79248890|FG008|Overall Study|Father in hospital|0|||
44285176|NCT01717638|79248891|FG009|Overall Study|Father in hospital|0|||
44533408|NCT02741518|79543565|FG001|Overall Study|Withdrawal by Subject|1|||
44285177|NCT01717638|79248892|FG010|Overall Study|Father in hospital|0|||
44285178|NCT01717638|79248893|FG011|Overall Study|Father in hospital|0|||
44285179|NCT01717638|79248894|FG012|Overall Study|Father in hospital|1|||
44285180|NCT01717638|79248882|FG000|Overall Study|Withdrawal by Subject|0|||
44285181|NCT01717638|79248883|FG001|Overall Study|Withdrawal by Subject|1|||
44285182|NCT01717638|79248884|FG002|Overall Study|Withdrawal by Subject|1|||
44285183|NCT01717638|79248885|FG003|Overall Study|Withdrawal by Subject|0|||
44285184|NCT01717638|79248886|FG004|Overall Study|Withdrawal by Subject|1|||
44285185|NCT01717638|79248887|FG005|Overall Study|Withdrawal by Subject|0|||
44285186|NCT01717638|79248888|FG006|Overall Study|Withdrawal by Subject|2|||
44285187|NCT01717638|79248889|FG007|Overall Study|Withdrawal by Subject|1|||
44285188|NCT01717638|79248890|FG008|Overall Study|Withdrawal by Subject|2|||
44285189|NCT01717638|79248891|FG009|Overall Study|Withdrawal by Subject|1|||
44285190|NCT01717638|79248892|FG010|Overall Study|Withdrawal by Subject|0|||
44285191|NCT01717638|79248893|FG011|Overall Study|Withdrawal by Subject|0|||
44285192|NCT01717638|79248894|FG012|Overall Study|Withdrawal by Subject|18|||
44285193|NCT01745094|79248932|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
44285194|NCT01745094|79248933|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
44285195|NCT01745094|79248934|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
44285196|NCT01745094|79248935|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
44285197|NCT01745094|79248932|FG000|Overall Study|Adverse Event|0|||
44285198|NCT01745094|79248933|FG001|Overall Study|Adverse Event|0|||
44285199|NCT01745094|79248934|FG002|Overall Study|Adverse Event|3|||
44285200|NCT01745094|79248935|FG003|Overall Study|Adverse Event|0|||
44285201|NCT01745094|79248932|FG000|Overall Study|Withdrawal by Subject|2|||
44285202|NCT01745094|79248933|FG001|Overall Study|Withdrawal by Subject|0|||
44285203|NCT01745094|79248934|FG002|Overall Study|Withdrawal by Subject|1|||
44285204|NCT01745094|79248935|FG003|Overall Study|Withdrawal by Subject|2|||
44285205|NCT01745094|79248932|FG000|Overall Study|Protocol Violation|1|||
44285206|NCT01745094|79248933|FG001|Overall Study|Protocol Violation|0|||
44285207|NCT01745094|79248934|FG002|Overall Study|Protocol Violation|3|||
44285208|NCT01745094|79248935|FG003|Overall Study|Protocol Violation|1|||
44285209|NCT01745094|79248932|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
44285210|NCT01745094|79248933|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
44285211|NCT01745094|79248934|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
44285212|NCT01745094|79248935|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
44285213|NCT01745094|79248932|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
44285214|NCT01745094|79248933|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
44285215|NCT01745094|79248934|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
44285216|NCT01745094|79248935|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
44285217|NCT01745094|79248932|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
44285218|NCT01745094|79248933|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
44285219|NCT01745094|79248934|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
44285220|NCT01745094|79248935|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
44285221|NCT01697748|79248950|FG000|Overall Study|ineligible skin incision|1|||
44285222|NCT01697748|79248951|FG001|Overall Study|ineligible skin incision|2|||
44285223|NCT01697748|79248950|FG000|Overall Study|ineligible uterine incision|4|||
44285224|NCT01697748|79248951|FG001|Overall Study|ineligible uterine incision|1|||
44285225|NCT01697748|79248950|FG000|Overall Study|Lost to Follow-up|53|||
44415589|NCT00785577|79423303|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
44415590|NCT00785577|79423304|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
44415591|NCT00785577|79423305|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
44415592|NCT00785577|79423306|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
44415593|NCT00785577|79423307|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
44415594|NCT00785577|79423303|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
44415595|NCT00785577|79423304|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
44415596|NCT00785577|79423305|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
44415597|NCT00785577|79423306|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
44255841|NCT02596230|79101600|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
44255842|NCT02596230|79101601|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
44255843|NCT02596230|79101602|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
44255844|NCT02596230|79101598|FG000|Objective 2, One Year|Adverse drug reaction|0|||
44255845|NCT02596230|79101599|FG001|Objective 2, One Year|Adverse drug reaction|1|||
44255846|NCT02596230|79101600|FG002|Objective 2, One Year|Adverse drug reaction|0|||
44255847|NCT02596230|79101601|FG003|Objective 2, One Year|Adverse drug reaction|0|||
44255848|NCT02596230|79101602|FG004|Objective 2, One Year|Adverse drug reaction|0|||
44255849|NCT02596230|79101598|FG000|Objective 2, One Year|Death|0|||
44255850|NCT02596230|79101599|FG001|Objective 2, One Year|Death|12|||
44255851|NCT02596230|79101600|FG002|Objective 2, One Year|Death|41|||
44255852|NCT02596230|79101601|FG003|Objective 2, One Year|Death|21|||
44255853|NCT02596230|79101602|FG004|Objective 2, One Year|Death|30|||
44255854|NCT02596230|79101598|FG000|Objective 2, One Year|Other|0|||
44255855|NCT02596230|79101599|FG001|Objective 2, One Year|Other|3|||
44255856|NCT02596230|79101600|FG002|Objective 2, One Year|Other|2|||
44285226|NCT01697748|79248951|FG001|Overall Study|Lost to Follow-up|65|||
44255857|NCT02596230|79101601|FG003|Objective 2, One Year|Other|0|||
44285227|NCT01717326|79248977|FG000|Overall Study|Death|0|||
44285228|NCT01717326|79248978|FG001|Overall Study|Death|0|||
44285229|NCT01717326|79248979|FG002|Overall Study|Death|0|||
44285230|NCT01717326|79248980|FG003|Overall Study|Death|0|||
44285231|NCT01717326|79248981|FG004|Overall Study|Death|0|||
44285232|NCT01717326|79248982|FG005|Overall Study|Death|0|||
44285233|NCT01717326|79248983|FG006|Overall Study|Death|0|||
44285234|NCT01717326|79248984|FG007|Overall Study|Death|0|||
44285235|NCT01717326|79248985|FG008|Overall Study|Death|0|||
44285236|NCT01717326|79248986|FG009|Overall Study|Death|0|||
44285237|NCT01717326|79248987|FG010|Overall Study|Death|1|||
44285238|NCT01717326|79248988|FG011|Overall Study|Death|0|||
44285239|NCT01717326|79248989|FG012|Overall Study|Death|0|||
44285240|NCT01717326|79248990|FG013|Overall Study|Death|0|||
44285241|NCT01717326|79248991|FG014|Overall Study|Death|0|||
44285242|NCT01717326|79248992|FG015|Overall Study|Death|0|||
44285243|NCT01717326|79248993|FG016|Overall Study|Death|0|||
44285244|NCT01717326|79248994|FG017|Overall Study|Death|0|||
44285245|NCT01717326|79248995|FG018|Overall Study|Death|0|||
44285246|NCT01717326|79248996|FG019|Overall Study|Death|0|||
44285247|NCT01717326|79248977|FG000|Overall Study|Lost to Follow-up|3|||
44285248|NCT01717326|79248978|FG001|Overall Study|Lost to Follow-up|0|||
44285249|NCT01717326|79248979|FG002|Overall Study|Lost to Follow-up|0|||
44285250|NCT01717326|79248980|FG003|Overall Study|Lost to Follow-up|2|||
44285251|NCT01717326|79248981|FG004|Overall Study|Lost to Follow-up|1|||
44285252|NCT01717326|79248982|FG005|Overall Study|Lost to Follow-up|0|||
44285253|NCT01717326|79248983|FG006|Overall Study|Lost to Follow-up|1|||
44285254|NCT01717326|79248984|FG007|Overall Study|Lost to Follow-up|0|||
44285255|NCT01717326|79248985|FG008|Overall Study|Lost to Follow-up|0|||
44285256|NCT01717326|79248986|FG009|Overall Study|Lost to Follow-up|0|||
44285257|NCT01717326|79248987|FG010|Overall Study|Lost to Follow-up|1|||
44285258|NCT01717326|79248988|FG011|Overall Study|Lost to Follow-up|0|||
44285259|NCT01717326|79248989|FG012|Overall Study|Lost to Follow-up|0|||
44285260|NCT01717326|79248990|FG013|Overall Study|Lost to Follow-up|0|||
44285261|NCT01717326|79248991|FG014|Overall Study|Lost to Follow-up|0|||
44285262|NCT01717326|79248992|FG015|Overall Study|Lost to Follow-up|2|||
44285263|NCT01717326|79248993|FG016|Overall Study|Lost to Follow-up|1|||
44285264|NCT01717326|79248994|FG017|Overall Study|Lost to Follow-up|0|||
44285265|NCT01717326|79248995|FG018|Overall Study|Lost to Follow-up|2|||
44285266|NCT01717326|79248996|FG019|Overall Study|Lost to Follow-up|3|||
44285267|NCT01717326|79248977|FG000|Overall Study|Physician Decision|0|||
44285268|NCT01717326|79248978|FG001|Overall Study|Physician Decision|0|||
44285269|NCT01717326|79248979|FG002|Overall Study|Physician Decision|0|||
44285270|NCT01717326|79248980|FG003|Overall Study|Physician Decision|0|||
44285271|NCT01717326|79248981|FG004|Overall Study|Physician Decision|0|||
44285272|NCT01717326|79248982|FG005|Overall Study|Physician Decision|0|||
44285273|NCT01717326|79248983|FG006|Overall Study|Physician Decision|0|||
44285274|NCT01717326|79248984|FG007|Overall Study|Physician Decision|0|||
44285275|NCT01717326|79248985|FG008|Overall Study|Physician Decision|0|||
44285276|NCT01717326|79248986|FG009|Overall Study|Physician Decision|1|||
44285277|NCT01717326|79248987|FG010|Overall Study|Physician Decision|0|||
44285278|NCT01717326|79248988|FG011|Overall Study|Physician Decision|0|||
44285279|NCT01717326|79248989|FG012|Overall Study|Physician Decision|0|||
44285280|NCT01717326|79248990|FG013|Overall Study|Physician Decision|0|||
44285281|NCT01717326|79248991|FG014|Overall Study|Physician Decision|0|||
44285282|NCT01717326|79248992|FG015|Overall Study|Physician Decision|0|||
44285283|NCT01717326|79248993|FG016|Overall Study|Physician Decision|0|||
44285284|NCT01717326|79248994|FG017|Overall Study|Physician Decision|0|||
44285285|NCT01717326|79248995|FG018|Overall Study|Physician Decision|0|||
44285286|NCT01717326|79248996|FG019|Overall Study|Physician Decision|0|||
44285287|NCT01717326|79248977|FG000|Overall Study|Protocol Violation|0|||
44285288|NCT01717326|79248978|FG001|Overall Study|Protocol Violation|0|||
44415598|NCT00785577|79423307|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
44415599|NCT00789828|79423331|FG000|Core Period (48 Weeks)|Administrative problems|0|||
44415600|NCT00789828|79423332|FG001|Core Period (48 Weeks)|Administrative problems|1|||
44415601|NCT00789828|79423331|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
44415602|NCT00789828|79423332|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
44285289|NCT01717326|79248979|FG002|Overall Study|Protocol Violation|0|||
44285290|NCT01717326|79248980|FG003|Overall Study|Protocol Violation|0|||
44285291|NCT01717326|79248981|FG004|Overall Study|Protocol Violation|1|||
44285292|NCT01717326|79248982|FG005|Overall Study|Protocol Violation|0|||
44285293|NCT01717326|79248983|FG006|Overall Study|Protocol Violation|0|||
44285294|NCT01717326|79248984|FG007|Overall Study|Protocol Violation|0|||
44285295|NCT01717326|79248985|FG008|Overall Study|Protocol Violation|0|||
44285296|NCT01717326|79248986|FG009|Overall Study|Protocol Violation|0|||
44285297|NCT01717326|79248987|FG010|Overall Study|Protocol Violation|0|||
44285298|NCT01717326|79248988|FG011|Overall Study|Protocol Violation|0|||
44285299|NCT01717326|79248989|FG012|Overall Study|Protocol Violation|0|||
44285300|NCT01717326|79248990|FG013|Overall Study|Protocol Violation|0|||
44285301|NCT01717326|79248991|FG014|Overall Study|Protocol Violation|0|||
44285302|NCT01717326|79248992|FG015|Overall Study|Protocol Violation|0|||
44285303|NCT01717326|79248993|FG016|Overall Study|Protocol Violation|0|||
44285304|NCT01717326|79248994|FG017|Overall Study|Protocol Violation|0|||
44285305|NCT01717326|79248995|FG018|Overall Study|Protocol Violation|0|||
44285306|NCT01717326|79248996|FG019|Overall Study|Protocol Violation|0|||
44285307|NCT01717326|79248977|FG000|Overall Study|Withdrawal by Subject|0|||
44285308|NCT01717326|79248978|FG001|Overall Study|Withdrawal by Subject|1|||
44285309|NCT01717326|79248979|FG002|Overall Study|Withdrawal by Subject|0|||
44285310|NCT01717326|79248980|FG003|Overall Study|Withdrawal by Subject|0|||
44285311|NCT01717326|79248981|FG004|Overall Study|Withdrawal by Subject|0|||
44285312|NCT01717326|79248982|FG005|Overall Study|Withdrawal by Subject|0|||
44285313|NCT01717326|79248983|FG006|Overall Study|Withdrawal by Subject|0|||
44285314|NCT01717326|79248984|FG007|Overall Study|Withdrawal by Subject|0|||
44285315|NCT01717326|79248985|FG008|Overall Study|Withdrawal by Subject|0|||
44285316|NCT01717326|79248986|FG009|Overall Study|Withdrawal by Subject|1|||
44285317|NCT01717326|79248987|FG010|Overall Study|Withdrawal by Subject|0|||
44285318|NCT01717326|79248988|FG011|Overall Study|Withdrawal by Subject|0|||
44285319|NCT01717326|79248989|FG012|Overall Study|Withdrawal by Subject|1|||
44285320|NCT01717326|79248990|FG013|Overall Study|Withdrawal by Subject|0|||
44285321|NCT01717326|79248991|FG014|Overall Study|Withdrawal by Subject|0|||
44285322|NCT01717326|79248992|FG015|Overall Study|Withdrawal by Subject|1|||
44285323|NCT01717326|79248993|FG016|Overall Study|Withdrawal by Subject|0|||
44285324|NCT01717326|79248994|FG017|Overall Study|Withdrawal by Subject|0|||
44154340|NCT02692417|78945454|FG001|Overall Study|Withdrawal by Subject|1|||
44154341|NCT02692417|78945453|FG000|Overall Study|Adverse Event|1|||
44154342|NCT02692417|78945454|FG001|Overall Study|Adverse Event|0|||
44154343|NCT02004886|78945464|FG000|Overall Study|Adverse Event|0|||
44154344|NCT02004886|78945465|FG001|Overall Study|Adverse Event|1|||
44154345|NCT02004886|78945466|FG002|Overall Study|Adverse Event|0|||
44154346|NCT02004886|78945467|FG003|Overall Study|Adverse Event|0|||
44285325|NCT01717326|79248995|FG018|Overall Study|Withdrawal by Subject|2|||
44285326|NCT01717326|79248996|FG019|Overall Study|Withdrawal by Subject|3|||
44285327|NCT01697592|79249048|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
44285328|NCT01697592|79249049|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285329|NCT01697592|79249050|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285330|NCT01697592|79249051|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285331|NCT01697592|79249052|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285332|NCT01697592|79249053|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285333|NCT01697592|79249054|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44533409|NCT03145766|79543576|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
44533410|NCT03145766|79543577|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
44533411|NCT03145766|79543578|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
44533412|NCT03145766|79543579|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
44533413|NCT03145766|79543580|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
44533414|NCT03145766|79543576|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
44533415|NCT03145766|79543577|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
44533416|NCT03145766|79543578|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
44533417|NCT03145766|79543579|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
44533418|NCT03145766|79543580|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
44533419|NCT03145766|79543576|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
44533420|NCT03145766|79543577|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
44154347|NCT02004886|78945464|FG000|Overall Study|Unable to attend future visits|1|||
44154348|NCT02004886|78945465|FG001|Overall Study|Unable to attend future visits|0|||
44285334|NCT01697592|79249055|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285335|NCT01697592|79249056|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285336|NCT01697592|79249057|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
44285337|NCT01697592|79249048|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285338|NCT01697592|79249049|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285339|NCT01697592|79249050|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285340|NCT01697592|79249051|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285341|NCT01697592|79249052|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285342|NCT01697592|79249053|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
44285343|NCT01697592|79249054|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285344|NCT01697592|79249055|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285345|NCT01697592|79249056|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285346|NCT01697592|79249057|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
44285347|NCT01697592|79249048|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
44285348|NCT01697592|79249049|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285349|NCT01697592|79249050|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285350|NCT01697592|79249051|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285351|NCT01697592|79249052|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285352|NCT01697592|79249053|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285353|NCT01697592|79249054|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285354|NCT01697592|79249055|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285355|NCT01697592|79249056|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285356|NCT01697592|79249057|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
44285357|NCT01697592|79249048|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
44285358|NCT01697592|79249049|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
44285359|NCT01697592|79249050|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44285360|NCT01697592|79249051|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44285361|NCT01697592|79249052|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44285362|NCT01697592|79249053|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44533421|NCT03145766|79543578|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
44533422|NCT03145766|79543579|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
44533423|NCT03145766|79543580|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
44533424|NCT03145766|79543576|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
44533425|NCT03145766|79543577|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
44533426|NCT03145766|79543578|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
44533427|NCT03145766|79543579|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
44533428|NCT03145766|79543580|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
44533429|NCT03145766|79543576|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
44533430|NCT03145766|79543577|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
44285363|NCT01697592|79249054|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
44285364|NCT01697592|79249055|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44285365|NCT01697592|79249056|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
44285366|NCT01697592|79249057|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
44285367|NCT01697592|79249048|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
44285368|NCT01697592|79249049|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
44285369|NCT01697592|79249050|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
44285370|NCT01697592|79249051|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
44285371|NCT01697592|79249052|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
44285372|NCT01697592|79249053|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
44285373|NCT01697592|79249054|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
44533431|NCT03145766|79543578|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
44533432|NCT03145766|79543579|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
44533433|NCT03145766|79543580|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
44533434|NCT03145766|79543576|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
44533435|NCT03145766|79543577|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
44533436|NCT03145766|79543578|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
44533437|NCT03145766|79543579|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
44533438|NCT03145766|79543580|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
44533439|NCT03145766|79543576|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
44533440|NCT03145766|79543577|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
44533441|NCT03145766|79543578|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
44533442|NCT03145766|79543579|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
44533443|NCT03145766|79543580|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
44533444|NCT03145064|79543593|FG000|Overall Study|Death|24|||
44533445|NCT03145064|79543593|FG000|Overall Study|Lost to Follow-up|3|||
44533446|NCT03145064|79543593|FG000|Overall Study|Withdrawal by Subject|6|||
44285374|NCT01697592|79249055|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
44285375|NCT01697592|79249056|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
44285376|NCT01697592|79249057|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
44285377|NCT01697592|79249048|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
44285378|NCT01697592|79249049|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285379|NCT01697592|79249050|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285380|NCT01697592|79249051|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
44285381|NCT01697592|79249052|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285382|NCT01697592|79249053|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285383|NCT01697592|79249054|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285384|NCT01697592|79249055|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285385|NCT01697592|79249056|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285386|NCT01697592|79249057|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
44285387|NCT01697592|79249048|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
44285388|NCT01697592|79249049|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285389|NCT01697592|79249050|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285390|NCT01697592|79249051|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285391|NCT01697592|79249052|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285392|NCT01697592|79249053|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
44285393|NCT01697592|79249054|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285394|NCT01697592|79249055|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
44285395|NCT01697592|79249056|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285396|NCT01697592|79249057|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
44285397|NCT01697592|79249048|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
44285398|NCT01697592|79249049|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
44285399|NCT01697592|79249050|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
44285400|NCT01697592|79249051|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
44285401|NCT01697592|79249052|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
44285402|NCT01697592|79249053|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
44285403|NCT01697592|79249054|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
44285404|NCT01697592|79249055|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
44285405|NCT01697592|79249056|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
44285406|NCT01697592|79249057|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
44415603|NCT00789828|79423331|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
44255858|NCT02596230|79101602|FG004|Objective 2, One Year|Other|0|||
44255859|NCT01667562|79101651|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
44255860|NCT01667562|79101652|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
44255861|NCT01667562|79101651|FG000|Erlotinib Phase|Lost to Follow-up|0|||
44255862|NCT01667562|79101652|FG001|Erlotinib Phase|Lost to Follow-up|1|||
44255863|NCT01667562|79101651|FG000|Erlotinib Phase|Adverse Event|0|||
44255864|NCT01667562|79101652|FG001|Erlotinib Phase|Adverse Event|1|||
44255865|NCT01667562|79101651|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
44255866|NCT01667562|79101652|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
44255867|NCT02595528|79101689|FG000|Overall Study|Withdrawal by Subject|1|||
44255868|NCT02595528|79101690|FG001|Overall Study|Withdrawal by Subject|2|||
44255869|NCT02595528|79101691|FG002|Overall Study|Withdrawal by Subject|1|||
44255870|NCT02595528|79101692|FG003|Overall Study|Withdrawal by Subject|3|||
44255871|NCT02595528|79101689|FG000|Overall Study|Lost to Follow-up|1|||
44255872|NCT02595528|79101690|FG001|Overall Study|Lost to Follow-up|1|||
44255873|NCT02595528|79101691|FG002|Overall Study|Lost to Follow-up|0|||
44255874|NCT02595528|79101692|FG003|Overall Study|Lost to Follow-up|1|||
44255875|NCT02595450|79101720|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
44255876|NCT02595450|79101720|FG000|Overall Study|Enrolled, but not treated|8|||
44255877|NCT02592018|79101724|FG000|Overall Study|Adverse Event|1|||
44255878|NCT02592018|79101724|FG000|Overall Study|Lost to Follow-up|1|||
44255879|NCT02591238|79101732|FG000|Overall Study|Pregnancy|1|||
44255880|NCT02591238|79101733|FG001|Overall Study|Pregnancy|0|||
44255881|NCT02591238|79101734|FG002|Overall Study|Pregnancy|0|||
44255882|NCT02591238|79101735|FG003|Overall Study|Pregnancy|0|||
44255883|NCT02591238|79101732|FG000|Overall Study|Withdrawal by Subject|0|||
44255884|NCT02591238|79101733|FG001|Overall Study|Withdrawal by Subject|0|||
44255885|NCT02591238|79101734|FG002|Overall Study|Withdrawal by Subject|0|||
44255886|NCT02591238|79101735|FG003|Overall Study|Withdrawal by Subject|1|||
44255887|NCT02591238|79101732|FG000|Overall Study|influenza|0|||
44255888|NCT02591238|79101733|FG001|Overall Study|influenza|0|||
44255889|NCT02591238|79101734|FG002|Overall Study|influenza|0|||
44255890|NCT02591238|79101735|FG003|Overall Study|influenza|1|||
44255891|NCT02591238|79101732|FG000|Overall Study|personal circumstances|0|||
44255892|NCT02591238|79101733|FG001|Overall Study|personal circumstances|0|||
44255893|NCT02591238|79101734|FG002|Overall Study|personal circumstances|0|||
44255894|NCT02591238|79101735|FG003|Overall Study|personal circumstances|1|||
44255895|NCT02591238|79101732|FG000|Overall Study|personal circumstances|0|||
44255896|NCT02591238|79101733|FG001|Overall Study|personal circumstances|1|||
44255897|NCT02591238|79101734|FG002|Overall Study|personal circumstances|0|||
44255898|NCT02591238|79101735|FG003|Overall Study|personal circumstances|0|||
44255899|NCT02597946|79101817|FG000|Overall Study|Withdrawal by Subject|1|||
44255900|NCT02597946|79101817|FG000|Overall Study|Progressive disease|16|||
44285407|NCT01744782|79249093|FG000|Overall Study|Death|1|||
44285408|NCT01744392|79249097|FG000|Overall Study|Physician Decision|1|||
44285409|NCT01604850|79249104|FG000|Overall Study|Enrolled but never treated|0|||
44285410|NCT01604850|79249105|FG001|Overall Study|Enrolled but never treated|1|||
44285411|NCT01604850|79249104|FG000|Overall Study|Efficacy Failure|50|||
44285412|NCT01604850|79249105|FG001|Overall Study|Efficacy Failure|29|||
44285413|NCT01604850|79249104|FG000|Overall Study|Lost to Follow-up|1|||
44285414|NCT01604850|79249105|FG001|Overall Study|Lost to Follow-up|0|||
44285415|NCT01604850|79249104|FG000|Overall Study|Subject withdrew consent|1|||
44285416|NCT01604850|79249105|FG001|Overall Study|Subject withdrew consent|0|||
44285417|NCT01742286|79249118|FG000|Escalation Phase|Administrative problems|1|||
44285418|NCT01742286|79249119|FG001|Escalation Phase|Administrative problems|1|||
44285419|NCT01742286|79249120|FG002|Escalation Phase|Administrative problems|0|||
44285420|NCT01742286|79249121|FG003|Escalation Phase|Administrative problems|0|||
44285421|NCT01742286|79249122|FG004|Escalation Phase|Administrative problems|0|||
44285422|NCT01742286|79249123|FG005|Escalation Phase|Administrative problems|0|||
44285423|NCT01742286|79249124|FG006|Escalation Phase|Administrative problems|2|||
44285424|NCT01742286|79249118|FG000|Escalation Phase|Adverse Event|0|||
44285425|NCT01742286|79249119|FG001|Escalation Phase|Adverse Event|1|||
44285426|NCT01742286|79249120|FG002|Escalation Phase|Adverse Event|2|||
44285427|NCT01742286|79249121|FG003|Escalation Phase|Adverse Event|0|||
44285428|NCT01742286|79249122|FG004|Escalation Phase|Adverse Event|0|||
44285429|NCT01742286|79249123|FG005|Escalation Phase|Adverse Event|1|||
44285430|NCT01742286|79249124|FG006|Escalation Phase|Adverse Event|0|||
44285431|NCT01742286|79249118|FG000|Escalation Phase|Disease progression|3|||
44285432|NCT01742286|79249119|FG001|Escalation Phase|Disease progression|7|||
44285433|NCT01742286|79249120|FG002|Escalation Phase|Disease progression|4|||
44285434|NCT01742286|79249121|FG003|Escalation Phase|Disease progression|1|||
44285435|NCT01742286|79249122|FG004|Escalation Phase|Disease progression|4|||
44285436|NCT01742286|79249123|FG005|Escalation Phase|Disease progression|3|||
44285437|NCT01742286|79249124|FG006|Escalation Phase|Disease progression|2|||
44285438|NCT01742286|79249118|FG000|Escalation Phase|Death|0|||
44285439|NCT01742286|79249119|FG001|Escalation Phase|Death|0|||
44285440|NCT01742286|79249120|FG002|Escalation Phase|Death|0|||
44285441|NCT01742286|79249121|FG003|Escalation Phase|Death|0|||
44285442|NCT01742286|79249122|FG004|Escalation Phase|Death|0|||
44285443|NCT01742286|79249123|FG005|Escalation Phase|Death|1|||
44285444|NCT01742286|79249124|FG006|Escalation Phase|Death|0|||
44285445|NCT01742286|79249118|FG000|Escalation Phase|Physician Decision|0|||
44285446|NCT01742286|79249119|FG001|Escalation Phase|Physician Decision|3|||
44285447|NCT01742286|79249120|FG002|Escalation Phase|Physician Decision|0|||
44285448|NCT01742286|79249121|FG003|Escalation Phase|Physician Decision|1|||
44285449|NCT01742286|79249122|FG004|Escalation Phase|Physician Decision|0|||
44285450|NCT01742286|79249123|FG005|Escalation Phase|Physician Decision|0|||
44285451|NCT01742286|79249124|FG006|Escalation Phase|Physician Decision|2|||
44285452|NCT01742286|79249118|FG000|Escalation Phase|Subject/guardian decision|1|||
44285453|NCT01742286|79249119|FG001|Escalation Phase|Subject/guardian decision|0|||
44285454|NCT01742286|79249120|FG002|Escalation Phase|Subject/guardian decision|0|||
44285455|NCT01742286|79249121|FG003|Escalation Phase|Subject/guardian decision|0|||
44285456|NCT01742286|79249122|FG004|Escalation Phase|Subject/guardian decision|0|||
44285457|NCT01742286|79249123|FG005|Escalation Phase|Subject/guardian decision|0|||
44285458|NCT01742286|79249124|FG006|Escalation Phase|Subject/guardian decision|0|||
44285459|NCT01742286|79249118|FG000|Expansion Phase|Administrative problems|0|||
44285460|NCT01742286|79249119|FG001|Expansion Phase|Administrative problems|0|||
44285461|NCT01742286|79249120|FG002|Expansion Phase|Administrative problems|0|||
44285462|NCT01742286|79249121|FG003|Expansion Phase|Administrative problems|0|||
44285463|NCT01742286|79249122|FG004|Expansion Phase|Administrative problems|0|||
44285464|NCT01742286|79249123|FG005|Expansion Phase|Administrative problems|0|||
44285465|NCT01742286|79249124|FG006|Expansion Phase|Administrative problems|5|||
44285466|NCT01742286|79249118|FG000|Expansion Phase|Physician Decision|0|||
44285467|NCT01742286|79249119|FG001|Expansion Phase|Physician Decision|0|||
44285468|NCT01742286|79249120|FG002|Expansion Phase|Physician Decision|4|||
44415604|NCT00789828|79423332|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
44415605|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
44285469|NCT01742286|79249121|FG003|Expansion Phase|Physician Decision|0|||
44285470|NCT01742286|79249122|FG004|Expansion Phase|Physician Decision|0|||
44285471|NCT01742286|79249123|FG005|Expansion Phase|Physician Decision|0|||
44285472|NCT01742286|79249124|FG006|Expansion Phase|Physician Decision|9|||
44285473|NCT01742286|79249118|FG000|Expansion Phase|Adverse Event|0|||
44285474|NCT01742286|79249119|FG001|Expansion Phase|Adverse Event|0|||
44285475|NCT01742286|79249120|FG002|Expansion Phase|Adverse Event|0|||
44285476|NCT01742286|79249121|FG003|Expansion Phase|Adverse Event|0|||
44285477|NCT01742286|79249122|FG004|Expansion Phase|Adverse Event|0|||
44285478|NCT01742286|79249123|FG005|Expansion Phase|Adverse Event|0|||
44285479|NCT01742286|79249124|FG006|Expansion Phase|Adverse Event|6|||
44285480|NCT01742286|79249118|FG000|Expansion Phase|Disease progression|0|||
44285481|NCT01742286|79249119|FG001|Expansion Phase|Disease progression|0|||
44285482|NCT01742286|79249120|FG002|Expansion Phase|Disease progression|3|||
44285483|NCT01742286|79249121|FG003|Expansion Phase|Disease progression|0|||
44415606|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
44154349|NCT02004886|78945466|FG002|Overall Study|Unable to attend future visits|0|||
44154350|NCT02004886|78945467|FG003|Overall Study|Unable to attend future visits|0|||
44154351|NCT01959880|78945481|FG000|Overall Study|Withdrawal by Subject|11|||
44154352|NCT01959880|78945482|FG001|Overall Study|Withdrawal by Subject|13|||
44285484|NCT01742286|79249122|FG004|Expansion Phase|Disease progression|0|||
44285485|NCT01742286|79249123|FG005|Expansion Phase|Disease progression|0|||
44285486|NCT01742286|79249124|FG006|Expansion Phase|Disease progression|15|||
44285487|NCT01742286|79249118|FG000|Expansion Phase|Withdrawal by Subject|0|||
44285488|NCT01742286|79249119|FG001|Expansion Phase|Withdrawal by Subject|0|||
44285489|NCT01742286|79249120|FG002|Expansion Phase|Withdrawal by Subject|0|||
44285490|NCT01742286|79249121|FG003|Expansion Phase|Withdrawal by Subject|0|||
44285491|NCT01742286|79249122|FG004|Expansion Phase|Withdrawal by Subject|0|||
44285492|NCT01742286|79249123|FG005|Expansion Phase|Withdrawal by Subject|0|||
44285493|NCT01742286|79249124|FG006|Expansion Phase|Withdrawal by Subject|1|||
44285494|NCT01697358|79249149|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
44285495|NCT01697358|79249150|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
44285496|NCT01697358|79249149|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
44285497|NCT01697358|79249150|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
44285498|NCT01697358|79249149|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
44285499|NCT01697358|79249150|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
44285500|NCT01697358|79249149|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
44285501|NCT01697358|79249150|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
44285502|NCT01697358|79249149|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
44285503|NCT01697358|79249150|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
44285504|NCT01697358|79249149|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
44285505|NCT01697358|79249150|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
44285506|NCT01697358|79249149|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
44285507|NCT01697358|79249150|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
44285508|NCT01697358|79249149|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
44285509|NCT01697358|79249150|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
44285510|NCT01697358|79249149|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
44285511|NCT01697358|79249150|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
44285512|NCT01697358|79249149|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
44285513|NCT01697358|79249150|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
44285514|NCT01716234|79249163|FG000|Overall Study|Protocol Violation|0|||
44285515|NCT01716234|79249164|FG001|Overall Study|Protocol Violation|0|||
44285516|NCT01716234|79249165|FG002|Overall Study|Protocol Violation|0|||
44285517|NCT01716234|79249166|FG003|Overall Study|Protocol Violation|1|||
44285518|NCT01716234|79249167|FG004|Overall Study|Protocol Violation|1|||
44285519|NCT01716234|79249168|FG005|Overall Study|Protocol Violation|1|||
44285520|NCT01716234|79249169|FG006|Overall Study|Protocol Violation|0|||
44285521|NCT01716234|79249163|FG000|Overall Study|Lack of Efficacy|0|||
44285522|NCT01716234|79249164|FG001|Overall Study|Lack of Efficacy|0|||
44285523|NCT01716234|79249165|FG002|Overall Study|Lack of Efficacy|0|||
44285524|NCT01716234|79249166|FG003|Overall Study|Lack of Efficacy|1|||
44285525|NCT01716234|79249167|FG004|Overall Study|Lack of Efficacy|0|||
44285526|NCT01716234|79249168|FG005|Overall Study|Lack of Efficacy|0|||
44285527|NCT01716234|79249169|FG006|Overall Study|Lack of Efficacy|0|||
44285528|NCT01716234|79249163|FG000|Overall Study|Did not meet protocol eligibility|0|||
44285529|NCT01716234|79249164|FG001|Overall Study|Did not meet protocol eligibility|0|||
44285530|NCT01716234|79249165|FG002|Overall Study|Did not meet protocol eligibility|1|||
44285531|NCT01716234|79249166|FG003|Overall Study|Did not meet protocol eligibility|0|||
44285532|NCT01716234|79249167|FG004|Overall Study|Did not meet protocol eligibility|0|||
44285533|NCT01716234|79249168|FG005|Overall Study|Did not meet protocol eligibility|4|||
44285534|NCT01716234|79249169|FG006|Overall Study|Did not meet protocol eligibility|0|||
44285535|NCT01716234|79249163|FG000|Overall Study|Adverse Event|7|||
44285536|NCT01716234|79249164|FG001|Overall Study|Adverse Event|10|||
44285537|NCT01716234|79249165|FG002|Overall Study|Adverse Event|2|||
44285538|NCT01716234|79249166|FG003|Overall Study|Adverse Event|8|||
44154353|NCT01959880|78945483|FG002|Overall Study|Withdrawal by Subject|8|||
44285539|NCT01716234|79249167|FG004|Overall Study|Adverse Event|3|||
44285540|NCT01716234|79249168|FG005|Overall Study|Adverse Event|6|||
44285541|NCT01716234|79249169|FG006|Overall Study|Adverse Event|0|||
44285542|NCT01716234|79249163|FG000|Overall Study|Withdrawal by Subject|3|||
44285543|NCT01716234|79249164|FG001|Overall Study|Withdrawal by Subject|0|||
44285544|NCT01716234|79249165|FG002|Overall Study|Withdrawal by Subject|2|||
44285545|NCT01716234|79249166|FG003|Overall Study|Withdrawal by Subject|2|||
44285546|NCT01716234|79249167|FG004|Overall Study|Withdrawal by Subject|1|||
44285547|NCT01716234|79249168|FG005|Overall Study|Withdrawal by Subject|3|||
44285548|NCT01716234|79249169|FG006|Overall Study|Withdrawal by Subject|0|||
44285549|NCT01716156|79249188|FG000|Overall Study|Protocol Violation|1|||
44285550|NCT01716156|79249189|FG001|Overall Study|Protocol Violation|0|||
44285551|NCT01716156|79249190|FG002|Overall Study|Protocol Violation|0|||
44285552|NCT01716156|79249188|FG000|Overall Study|Withdrawal by Subject|0|||
44285553|NCT01716156|79249189|FG001|Overall Study|Withdrawal by Subject|1|||
44285554|NCT01716156|79249190|FG002|Overall Study|Withdrawal by Subject|2|||
44285555|NCT01716156|79249188|FG000|Overall Study|Lost to Follow-up|1|||
44285556|NCT01716156|79249189|FG001|Overall Study|Lost to Follow-up|0|||
44285557|NCT01716156|79249190|FG002|Overall Study|Lost to Follow-up|0|||
44285558|NCT01739790|79249204|FG000|Overall Study|Early Trial Termination|2|||
44285559|NCT01739790|79249205|FG001|Overall Study|Early Trial Termination|4|||
44285560|NCT01696032|79249215|FG000|Overall Study|Withdrawal by Subject|0|||
44285561|NCT01696032|79249216|FG001|Overall Study|Withdrawal by Subject|0|||
44285562|NCT01696032|79249217|FG002|Overall Study|Withdrawal by Subject|1|||
44285563|NCT01696032|79249218|FG003|Overall Study|Withdrawal by Subject|2|||
44285564|NCT01696032|79249215|FG000|Overall Study|Death|14|||
44285565|NCT01696032|79249216|FG001|Overall Study|Death|4|||
44285566|NCT01696032|79249217|FG002|Overall Study|Death|43|||
44285567|NCT01696032|79249218|FG003|Overall Study|Death|18|||
44285568|NCT01696032|79249215|FG000|Overall Study|Lost to Follow-up|0|||
44285569|NCT01696032|79249216|FG001|Overall Study|Lost to Follow-up|1|||
44285570|NCT01696032|79249217|FG002|Overall Study|Lost to Follow-up|0|||
44285571|NCT01696032|79249218|FG003|Overall Study|Lost to Follow-up|0|||
44285572|NCT01696032|79249215|FG000|Overall Study|Database lock|0|||
44285573|NCT01696032|79249216|FG001|Overall Study|Database lock|1|||
44285574|NCT01696032|79249217|FG002|Overall Study|Database lock|7|||
44285575|NCT01696032|79249218|FG003|Overall Study|Database lock|2|||
44285576|NCT01695954|79249234|FG000|Overall Study|Withdrawal by Subject|4|||
44285577|NCT01695954|79249235|FG001|Overall Study|Withdrawal by Subject|0|||
44285578|NCT01695954|79249234|FG000|Overall Study|Adverse Event|0|||
44285579|NCT01695954|79249235|FG001|Overall Study|Adverse Event|2|||
44285580|NCT01694706|79249243|FG000|Overall Study|Adverse Event|0|||
44285581|NCT01694706|79249244|FG001|Overall Study|Adverse Event|1|||
44285582|NCT01694706|79249245|FG002|Overall Study|Adverse Event|0|||
44285583|NCT01694706|79249243|FG000|Overall Study|other reason not defined above|1|||
44285584|NCT01694706|79249244|FG001|Overall Study|other reason not defined above|0|||
44285585|NCT01694706|79249245|FG002|Overall Study|other reason not defined above|0|||
44285586|NCT01693692|79249257|FG000|Overall Study|Withdrawal by Subject|12|||
44285587|NCT01693692|79249258|FG001|Overall Study|Withdrawal by Subject|10|||
44285588|NCT01693692|79249259|FG002|Overall Study|Withdrawal by Subject|11|||
44285589|NCT01693692|79249257|FG000|Overall Study|Adverse Event|7|||
44285590|NCT01693692|79249258|FG001|Overall Study|Adverse Event|14|||
44285591|NCT01693692|79249259|FG002|Overall Study|Adverse Event|9|||
44285592|NCT01693692|79249257|FG000|Overall Study|Physician Decision|0|||
44285593|NCT01693692|79249258|FG001|Overall Study|Physician Decision|0|||
44285594|NCT01693692|79249259|FG002|Overall Study|Physician Decision|1|||
44285595|NCT01693692|79249257|FG000|Overall Study|Protocol Violation|5|||
44285596|NCT01693692|79249258|FG001|Overall Study|Protocol Violation|4|||
44285597|NCT01693692|79249259|FG002|Overall Study|Protocol Violation|6|||
44285598|NCT01693692|79249257|FG000|Overall Study|Lost to Follow-up|2|||
44285599|NCT01693692|79249258|FG001|Overall Study|Lost to Follow-up|2|||
44285600|NCT01693692|79249259|FG002|Overall Study|Lost to Follow-up|3|||
44285601|NCT01693692|79249257|FG000|Overall Study|Other|4|||
44285602|NCT01693692|79249258|FG001|Overall Study|Other|4|||
44285603|NCT01693692|79249259|FG002|Overall Study|Other|6|||
44285604|NCT01693614|79249270|FG000|Overall Study|Adverse Event|7|||
44285605|NCT01693614|79249271|FG001|Overall Study|Adverse Event|11|||
44285606|NCT01693614|79249272|FG002|Overall Study|Adverse Event|5|||
44285607|NCT01693614|79249270|FG000|Overall Study|Disease progression|11|||
44285608|NCT01693614|79249271|FG001|Overall Study|Disease progression|8|||
44285609|NCT01693614|79249272|FG002|Overall Study|Disease progression|7|||
44285610|NCT01693614|79249270|FG000|Overall Study|Protocol Violation|5|||
44415607|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
44154354|NCT01959880|78945484|FG003|Overall Study|Withdrawal by Subject|7|||
44285611|NCT01693614|79249271|FG001|Overall Study|Protocol Violation|2|||
44285612|NCT01693614|79249272|FG002|Overall Study|Protocol Violation|1|||
44285613|NCT01693614|79249270|FG000|Overall Study|Death|1|||
44285614|NCT01693614|79249271|FG001|Overall Study|Death|0|||
44285615|NCT01693614|79249272|FG002|Overall Study|Death|0|||
44285616|NCT01693614|79249270|FG000|Overall Study|Physician Decision|1|||
44285617|NCT01693614|79249271|FG001|Overall Study|Physician Decision|1|||
44285618|NCT01693614|79249272|FG002|Overall Study|Physician Decision|4|||
44285619|NCT01693614|79249270|FG000|Overall Study|Withdrawal by subject/guardian|0|||
44285620|NCT01693614|79249271|FG001|Overall Study|Withdrawal by subject/guardian|0|||
44285621|NCT01693614|79249272|FG002|Overall Study|Withdrawal by subject/guardian|2|||
44285622|NCT01693614|79249270|FG000|Overall Study|Withdrawal by Subject|1|||
44285623|NCT01693614|79249271|FG001|Overall Study|Withdrawal by Subject|0|||
44285624|NCT01693614|79249272|FG002|Overall Study|Withdrawal by Subject|5|||
44285625|NCT01715298|79249283|FG000|Overall Study|Lost to Follow-up|0|||
44285626|NCT01715298|79249284|FG001|Overall Study|Lost to Follow-up|2|||
44285627|NCT01715298|79249283|FG000|Overall Study|Patient/guardian decision|7|||
44285628|NCT01715298|79249284|FG001|Overall Study|Patient/guardian decision|9|||
44285629|NCT01713582|79249311|FG000|Overall Study|Disease progression|3|||
44285630|NCT01713582|79249312|FG001|Overall Study|Disease progression|3|||
44285631|NCT01713582|79249313|FG002|Overall Study|Disease progression|3|||
44285632|NCT01713582|79249314|FG003|Overall Study|Disease progression|2|||
44285633|NCT01713582|79249315|FG004|Overall Study|Disease progression|3|||
44285634|NCT01713582|79249316|FG005|Overall Study|Disease progression|3|||
44285635|NCT01713582|79249317|FG006|Overall Study|Disease progression|3|||
44285636|NCT01713582|79249318|FG007|Overall Study|Disease progression|3|||
44285637|NCT01713582|79249319|FG008|Overall Study|Disease progression|3|||
44285638|NCT01713582|79249320|FG009|Overall Study|Disease progression|11|||
44285639|NCT01713582|79249321|FG010|Overall Study|Disease progression|10|||
44285640|NCT01713582|79249322|FG011|Overall Study|Disease progression|5|||
44285641|NCT01713582|79249323|FG012|Overall Study|Disease progression|3|||
44285642|NCT01713582|79249324|FG013|Overall Study|Disease progression|3|||
44285643|NCT01713582|79249325|FG014|Overall Study|Disease progression|6|||
44285644|NCT01713582|79249326|FG015|Overall Study|Disease progression|6|||
44285645|NCT01713582|79249327|FG016|Overall Study|Disease progression|5|||
44285646|NCT01713582|79249328|FG017|Overall Study|Disease progression|2|||
44415608|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
44415609|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
44533447|NCT03145064|79543593|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
44533448|NCT03145064|79543593|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
44285647|NCT01713582|79249329|FG018|Overall Study|Disease progression|3|||
44285648|NCT01713582|79249330|FG019|Overall Study|Disease progression|5|||
44285649|NCT01713582|79249331|FG020|Overall Study|Disease progression|15|||
44285650|NCT01713582|79249311|FG000|Overall Study|Death|0|||
44285651|NCT01713582|79249312|FG001|Overall Study|Death|0|||
44285652|NCT01713582|79249313|FG002|Overall Study|Death|0|||
44285653|NCT01713582|79249314|FG003|Overall Study|Death|1|||
44285654|NCT01713582|79249315|FG004|Overall Study|Death|1|||
44285655|NCT01713582|79249316|FG005|Overall Study|Death|3|||
44285656|NCT01713582|79249317|FG006|Overall Study|Death|3|||
44285657|NCT01713582|79249318|FG007|Overall Study|Death|2|||
44285658|NCT01713582|79249319|FG008|Overall Study|Death|3|||
44285659|NCT01713582|79249320|FG009|Overall Study|Death|4|||
44285660|NCT01713582|79249321|FG010|Overall Study|Death|3|||
44285661|NCT01713582|79249322|FG011|Overall Study|Death|0|||
44285662|NCT01713582|79249323|FG012|Overall Study|Death|0|||
44285663|NCT01713582|79249324|FG013|Overall Study|Death|0|||
44285664|NCT01713582|79249325|FG014|Overall Study|Death|0|||
44285665|NCT01713582|79249326|FG015|Overall Study|Death|0|||
44285666|NCT01713582|79249327|FG016|Overall Study|Death|0|||
44285667|NCT01713582|79249328|FG017|Overall Study|Death|0|||
44285668|NCT01713582|79249329|FG018|Overall Study|Death|0|||
44285669|NCT01713582|79249330|FG019|Overall Study|Death|0|||
44285670|NCT01713582|79249331|FG020|Overall Study|Death|0|||
44285671|NCT01713582|79249311|FG000|Overall Study|Adverse event-related|0|||
44285672|NCT01713582|79249312|FG001|Overall Study|Adverse event-related|0|||
44285673|NCT01713582|79249313|FG002|Overall Study|Adverse event-related|0|||
44285674|NCT01713582|79249314|FG003|Overall Study|Adverse event-related|0|||
44285675|NCT01713582|79249315|FG004|Overall Study|Adverse event-related|0|||
44285676|NCT01713582|79249316|FG005|Overall Study|Adverse event-related|0|||
44285677|NCT01713582|79249317|FG006|Overall Study|Adverse event-related|0|||
44285678|NCT01713582|79249318|FG007|Overall Study|Adverse event-related|0|||
44285679|NCT01713582|79249319|FG008|Overall Study|Adverse event-related|0|||
44285680|NCT01713582|79249320|FG009|Overall Study|Adverse event-related|1|||
44285681|NCT01713582|79249321|FG010|Overall Study|Adverse event-related|1|||
44285682|NCT01713582|79249322|FG011|Overall Study|Adverse event-related|0|||
44285683|NCT01713582|79249323|FG012|Overall Study|Adverse event-related|0|||
44285684|NCT01713582|79249324|FG013|Overall Study|Adverse event-related|0|||
44285685|NCT01713582|79249325|FG014|Overall Study|Adverse event-related|0|||
44285686|NCT01713582|79249326|FG015|Overall Study|Adverse event-related|0|||
44285687|NCT01713582|79249327|FG016|Overall Study|Adverse event-related|0|||
44285688|NCT01713582|79249328|FG017|Overall Study|Adverse event-related|0|||
44285689|NCT01713582|79249329|FG018|Overall Study|Adverse event-related|1|||
44285690|NCT01713582|79249330|FG019|Overall Study|Adverse event-related|0|||
44285691|NCT01713582|79249331|FG020|Overall Study|Adverse event-related|0|||
44285692|NCT01713582|79249311|FG000|Overall Study|Adverse event-unrelated|0|||
44285693|NCT01713582|79249312|FG001|Overall Study|Adverse event-unrelated|0|||
44285694|NCT01713582|79249313|FG002|Overall Study|Adverse event-unrelated|0|||
44285695|NCT01713582|79249314|FG003|Overall Study|Adverse event-unrelated|0|||
44285696|NCT01713582|79249315|FG004|Overall Study|Adverse event-unrelated|0|||
44285697|NCT01713582|79249316|FG005|Overall Study|Adverse event-unrelated|1|||
44285698|NCT01713582|79249317|FG006|Overall Study|Adverse event-unrelated|1|||
44285699|NCT01713582|79249318|FG007|Overall Study|Adverse event-unrelated|1|||
44285700|NCT01713582|79249319|FG008|Overall Study|Adverse event-unrelated|0|||
44285701|NCT01713582|79249320|FG009|Overall Study|Adverse event-unrelated|0|||
44285702|NCT01713582|79249321|FG010|Overall Study|Adverse event-unrelated|0|||
44285703|NCT01713582|79249322|FG011|Overall Study|Adverse event-unrelated|0|||
44285704|NCT01713582|79249323|FG012|Overall Study|Adverse event-unrelated|0|||
44285705|NCT01713582|79249324|FG013|Overall Study|Adverse event-unrelated|1|||
44285706|NCT01713582|79249325|FG014|Overall Study|Adverse event-unrelated|1|||
44285707|NCT01713582|79249326|FG015|Overall Study|Adverse event-unrelated|0|||
44285708|NCT01713582|79249327|FG016|Overall Study|Adverse event-unrelated|0|||
44285709|NCT01713582|79249328|FG017|Overall Study|Adverse event-unrelated|0|||
44285710|NCT01713582|79249329|FG018|Overall Study|Adverse event-unrelated|0|||
44285711|NCT01713582|79249330|FG019|Overall Study|Adverse event-unrelated|0|||
44285712|NCT01713582|79249331|FG020|Overall Study|Adverse event-unrelated|0|||
44285713|NCT01713582|79249311|FG000|Overall Study|Withdrawal of consent|0|||
44285714|NCT01713582|79249312|FG001|Overall Study|Withdrawal of consent|0|||
44285715|NCT01713582|79249313|FG002|Overall Study|Withdrawal of consent|1|||
44285716|NCT01713582|79249314|FG003|Overall Study|Withdrawal of consent|0|||
44285717|NCT01713582|79249315|FG004|Overall Study|Withdrawal of consent|0|||
44285718|NCT01713582|79249316|FG005|Overall Study|Withdrawal of consent|1|||
44285719|NCT01713582|79249317|FG006|Overall Study|Withdrawal of consent|0|||
44285720|NCT01713582|79249318|FG007|Overall Study|Withdrawal of consent|0|||
44285721|NCT01713582|79249319|FG008|Overall Study|Withdrawal of consent|0|||
44285722|NCT01713582|79249320|FG009|Overall Study|Withdrawal of consent|1|||
44285723|NCT01713582|79249321|FG010|Overall Study|Withdrawal of consent|0|||
44285724|NCT01713582|79249322|FG011|Overall Study|Withdrawal of consent|0|||
44285725|NCT01713582|79249323|FG012|Overall Study|Withdrawal of consent|0|||
44285726|NCT01713582|79249324|FG013|Overall Study|Withdrawal of consent|0|||
44285727|NCT01713582|79249325|FG014|Overall Study|Withdrawal of consent|0|||
44285728|NCT01713582|79249326|FG015|Overall Study|Withdrawal of consent|0|||
44285729|NCT01713582|79249327|FG016|Overall Study|Withdrawal of consent|0|||
44285730|NCT01713582|79249328|FG017|Overall Study|Withdrawal of consent|0|||
44285731|NCT01713582|79249329|FG018|Overall Study|Withdrawal of consent|1|||
44285732|NCT01713582|79249330|FG019|Overall Study|Withdrawal of consent|0|||
44285733|NCT01713582|79249331|FG020|Overall Study|Withdrawal of consent|0|||
44285734|NCT01713582|79249311|FG000|Overall Study|Lack of Efficacy|0|||
44285735|NCT01713582|79249312|FG001|Overall Study|Lack of Efficacy|0|||
44285736|NCT01713582|79249313|FG002|Overall Study|Lack of Efficacy|0|||
44285737|NCT01713582|79249314|FG003|Overall Study|Lack of Efficacy|0|||
44285738|NCT01713582|79249315|FG004|Overall Study|Lack of Efficacy|0|||
44285739|NCT01713582|79249316|FG005|Overall Study|Lack of Efficacy|0|||
44285740|NCT01713582|79249317|FG006|Overall Study|Lack of Efficacy|0|||
44285741|NCT01713582|79249318|FG007|Overall Study|Lack of Efficacy|0|||
44285742|NCT01713582|79249319|FG008|Overall Study|Lack of Efficacy|0|||
44285743|NCT01713582|79249320|FG009|Overall Study|Lack of Efficacy|1|||
44285744|NCT01713582|79249321|FG010|Overall Study|Lack of Efficacy|2|||
44285745|NCT01713582|79249322|FG011|Overall Study|Lack of Efficacy|0|||
44285746|NCT01713582|79249323|FG012|Overall Study|Lack of Efficacy|0|||
44285747|NCT01713582|79249324|FG013|Overall Study|Lack of Efficacy|0|||
44285748|NCT01713582|79249325|FG014|Overall Study|Lack of Efficacy|0|||
44285749|NCT01713582|79249326|FG015|Overall Study|Lack of Efficacy|0|||
44285750|NCT01713582|79249327|FG016|Overall Study|Lack of Efficacy|0|||
44285751|NCT01713582|79249328|FG017|Overall Study|Lack of Efficacy|0|||
44285752|NCT01713582|79249329|FG018|Overall Study|Lack of Efficacy|0|||
44285753|NCT01713582|79249330|FG019|Overall Study|Lack of Efficacy|0|||
44285754|NCT01713582|79249331|FG020|Overall Study|Lack of Efficacy|0|||
44285755|NCT01713582|79249311|FG000|Overall Study|Withdrawal by Subject|0|||
44285756|NCT01713582|79249312|FG001|Overall Study|Withdrawal by Subject|0|||
44285757|NCT01713582|79249313|FG002|Overall Study|Withdrawal by Subject|0|||
44285758|NCT01713582|79249314|FG003|Overall Study|Withdrawal by Subject|0|||
44285759|NCT01713582|79249315|FG004|Overall Study|Withdrawal by Subject|0|||
44285760|NCT01713582|79249316|FG005|Overall Study|Withdrawal by Subject|0|||
44285761|NCT01713582|79249317|FG006|Overall Study|Withdrawal by Subject|0|||
44285762|NCT01713582|79249318|FG007|Overall Study|Withdrawal by Subject|0|||
44285763|NCT01713582|79249319|FG008|Overall Study|Withdrawal by Subject|0|||
44285764|NCT01713582|79249320|FG009|Overall Study|Withdrawal by Subject|0|||
44285765|NCT01713582|79249321|FG010|Overall Study|Withdrawal by Subject|0|||
44285766|NCT01713582|79249322|FG011|Overall Study|Withdrawal by Subject|0|||
44285767|NCT01713582|79249323|FG012|Overall Study|Withdrawal by Subject|0|||
44285768|NCT01713582|79249324|FG013|Overall Study|Withdrawal by Subject|0|||
44285769|NCT01713582|79249325|FG014|Overall Study|Withdrawal by Subject|0|||
44285770|NCT01713582|79249326|FG015|Overall Study|Withdrawal by Subject|0|||
44533449|NCT03787615|79543618|FG000|Overall Study|Withdrawal by Subject|2|||
44285771|NCT01713582|79249327|FG016|Overall Study|Withdrawal by Subject|0|||
44285772|NCT01713582|79249328|FG017|Overall Study|Withdrawal by Subject|1|||
44285773|NCT01713582|79249329|FG018|Overall Study|Withdrawal by Subject|0|||
44285774|NCT01713582|79249330|FG019|Overall Study|Withdrawal by Subject|0|||
44285775|NCT01713582|79249331|FG020|Overall Study|Withdrawal by Subject|0|||
44285776|NCT01713582|79249311|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
44285777|NCT01713582|79249312|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
44154355|NCT01959880|78945481|FG000|Overall Study|Death|1|||
44154356|NCT01959880|78945482|FG001|Overall Study|Death|10|||
44154357|NCT01959880|78945483|FG002|Overall Study|Death|1|||
44154358|NCT01959880|78945484|FG003|Overall Study|Death|2|||
44285778|NCT01713582|79249313|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
44285779|NCT01713582|79249314|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
44285780|NCT01713582|79249315|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
44285781|NCT01713582|79249316|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
44285782|NCT01713582|79249317|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
44285783|NCT01713582|79249318|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
44285784|NCT01713582|79249319|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
44285785|NCT01713582|79249320|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
44285786|NCT01713582|79249321|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
44285787|NCT01713582|79249322|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
44285788|NCT01713582|79249323|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
44285789|NCT01713582|79249324|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
44285790|NCT01713582|79249325|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
44285791|NCT01713582|79249326|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
44285792|NCT01713582|79249327|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
44285793|NCT01713582|79249328|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
44285794|NCT01713582|79249329|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
44285795|NCT01713582|79249330|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
44285796|NCT01713582|79249331|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
44285797|NCT01713582|79249311|FG000|Overall Study|Disease progression and adverse event|0|||
44285798|NCT01713582|79249312|FG001|Overall Study|Disease progression and adverse event|0|||
44285799|NCT01713582|79249313|FG002|Overall Study|Disease progression and adverse event|0|||
44285800|NCT01713582|79249314|FG003|Overall Study|Disease progression and adverse event|0|||
44285801|NCT01713582|79249315|FG004|Overall Study|Disease progression and adverse event|0|||
44285802|NCT01713582|79249316|FG005|Overall Study|Disease progression and adverse event|0|||
44285803|NCT01713582|79249317|FG006|Overall Study|Disease progression and adverse event|0|||
44285804|NCT01713582|79249318|FG007|Overall Study|Disease progression and adverse event|0|||
44285805|NCT01713582|79249319|FG008|Overall Study|Disease progression and adverse event|0|||
44285806|NCT01713582|79249320|FG009|Overall Study|Disease progression and adverse event|0|||
44285807|NCT01713582|79249321|FG010|Overall Study|Disease progression and adverse event|0|||
44285808|NCT01713582|79249322|FG011|Overall Study|Disease progression and adverse event|0|||
44285809|NCT01713582|79249323|FG012|Overall Study|Disease progression and adverse event|0|||
44285810|NCT01713582|79249324|FG013|Overall Study|Disease progression and adverse event|0|||
44285811|NCT01713582|79249325|FG014|Overall Study|Disease progression and adverse event|0|||
44285812|NCT01713582|79249326|FG015|Overall Study|Disease progression and adverse event|0|||
44285813|NCT01713582|79249327|FG016|Overall Study|Disease progression and adverse event|1|||
44285814|NCT01713582|79249328|FG017|Overall Study|Disease progression and adverse event|0|||
44285815|NCT01713582|79249329|FG018|Overall Study|Disease progression and adverse event|0|||
44285816|NCT01713582|79249330|FG019|Overall Study|Disease progression and adverse event|0|||
44285817|NCT01713582|79249331|FG020|Overall Study|Disease progression and adverse event|0|||
44285818|NCT01739400|79249391|FG000|Overall Study|Physician Decision|3|||
44285819|NCT01739400|79249392|FG001|Overall Study|Physician Decision|0|||
44285820|NCT01739400|79249391|FG000|Overall Study|Lost to Follow-up|2|||
44285821|NCT01739400|79249392|FG001|Overall Study|Lost to Follow-up|0|||
44285822|NCT01739400|79249391|FG000|Overall Study|Death|5|||
44285823|NCT01739400|79249392|FG001|Overall Study|Death|2|||
44285824|NCT01739400|79249391|FG000|Overall Study|Withdrawal by Subject|7|||
44285825|NCT01739400|79249392|FG001|Overall Study|Withdrawal by Subject|7|||
44285826|NCT01713348|79249401|FG000|Overall Study|Withdrawal by Subject|3|||
44285827|NCT01713348|79249402|FG001|Overall Study|Withdrawal by Subject|2|||
44285828|NCT01713348|79249403|FG002|Overall Study|Withdrawal by Subject|2|||
44285829|NCT01713348|79249404|FG003|Overall Study|Withdrawal by Subject|0|||
44533450|NCT03787615|79543618|FG000|Overall Study|Lost to Follow-up|2|||
44285830|NCT01713348|79249401|FG000|Overall Study|Lost to Follow-up|1|||
44533451|NCT03784963|79543627|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
44533452|NCT03784963|79543628|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
44533453|NCT03784963|79543629|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
44285831|NCT01713348|79249402|FG001|Overall Study|Lost to Follow-up|0|||
44285832|NCT01713348|79249403|FG002|Overall Study|Lost to Follow-up|0|||
44285833|NCT01713348|79249404|FG003|Overall Study|Lost to Follow-up|0|||
44285834|NCT01737996|79249417|FG000|Overall Study|Adverse Event|0|||
44285835|NCT01737996|79249418|FG001|Overall Study|Adverse Event|1|||
44285836|NCT01737996|79249419|FG002|Overall Study|Adverse Event|1|||
44285837|NCT01737996|79249417|FG000|Overall Study|Withdrawal by Subject|0|||
44285838|NCT01737996|79249418|FG001|Overall Study|Withdrawal by Subject|0|||
44285839|NCT01737996|79249419|FG002|Overall Study|Withdrawal by Subject|1|||
44285840|NCT01713036|79249427|FG000|Overall Study|Death|1|||
44285841|NCT01712334|79249437|FG000|Treatment Period 1|Randomized in Error|0|||
44285842|NCT01712334|79249438|FG001|Treatment Period 1|Randomized in Error|2|||
44285843|NCT01712256|79249444|FG000|Overall Study|Lost to Follow-up|1|||
44285844|NCT01712178|79249450|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
44285845|NCT01712178|79249451|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
44285846|NCT01712178|79249450|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
44285847|NCT01712178|79249451|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
44285848|NCT01712178|79249450|FG000|Overall Study|Lost to Follow-up|0|||
44285849|NCT01712178|79249451|FG001|Overall Study|Lost to Follow-up|1|||
44285850|NCT01693068|79249459|FG000|Randomization Period|On-study|2|||
44285851|NCT01693068|79249460|FG001|Randomization Period|On-study|5|||
44285852|NCT01693068|79249461|FG002|Randomization Period|On-study|0|||
44285853|NCT01693068|79249459|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
44285854|NCT01693068|79249460|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
44285855|NCT01693068|79249461|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
44285856|NCT01691898|79249475|FG000|Overall Study|Death|34|||
44285857|NCT01691898|79249476|FG001|Overall Study|Death|32|||
44285858|NCT01691898|79249477|FG002|Overall Study|Death|6|||
44285859|NCT01691898|79249478|FG003|Overall Study|Death|3|||
44285860|NCT01691898|79249479|FG004|Overall Study|Death|8|||
44285861|NCT01691898|79249480|FG005|Overall Study|Death|31|||
44285862|NCT01691898|79249475|FG000|Overall Study|Adverse Event|0|||
44285863|NCT01691898|79249476|FG001|Overall Study|Adverse Event|1|||
44285864|NCT01691898|79249477|FG002|Overall Study|Adverse Event|0|||
44285865|NCT01691898|79249478|FG003|Overall Study|Adverse Event|1|||
44285866|NCT01691898|79249479|FG004|Overall Study|Adverse Event|1|||
44285867|NCT01691898|79249480|FG005|Overall Study|Adverse Event|0|||
44285868|NCT01691898|79249475|FG000|Overall Study|Progression of Disease|1|||
44285869|NCT01691898|79249476|FG001|Overall Study|Progression of Disease|2|||
44285870|NCT01691898|79249477|FG002|Overall Study|Progression of Disease|1|||
44285871|NCT01691898|79249478|FG003|Overall Study|Progression of Disease|0|||
44285872|NCT01691898|79249479|FG004|Overall Study|Progression of Disease|0|||
44285873|NCT01691898|79249480|FG005|Overall Study|Progression of Disease|1|||
44285874|NCT01691898|79249475|FG000|Overall Study|Lost to Follow-up|3|||
44285875|NCT01691898|79249476|FG001|Overall Study|Lost to Follow-up|1|||
44285876|NCT01691898|79249477|FG002|Overall Study|Lost to Follow-up|0|||
44285877|NCT01691898|79249478|FG003|Overall Study|Lost to Follow-up|0|||
44285878|NCT01691898|79249479|FG004|Overall Study|Lost to Follow-up|1|||
44285879|NCT01691898|79249480|FG005|Overall Study|Lost to Follow-up|0|||
44285880|NCT01691898|79249475|FG000|Overall Study|Withdrawal by Subject|9|||
44285881|NCT01691898|79249476|FG001|Overall Study|Withdrawal by Subject|8|||
44285882|NCT01691898|79249477|FG002|Overall Study|Withdrawal by Subject|2|||
44285883|NCT01691898|79249478|FG003|Overall Study|Withdrawal by Subject|1|||
44285884|NCT01691898|79249479|FG004|Overall Study|Withdrawal by Subject|3|||
44285885|NCT01691898|79249480|FG005|Overall Study|Withdrawal by Subject|3|||
44285886|NCT01691898|79249475|FG000|Overall Study|Non-Compliance|0|||
44285887|NCT01691898|79249476|FG001|Overall Study|Non-Compliance|0|||
44415610|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
44415611|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
44533454|NCT03784963|79543630|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
44533455|NCT03787303|79543640|FG000|Overall Study|Death|1|||
44533456|NCT03787303|79543640|FG000|Overall Study|Premature Termination of Study|1|||
44533457|NCT04170296|79543646|FG000|Overall Study|Adverse Event|1|||
44533458|NCT04170296|79543647|FG001|Overall Study|Adverse Event|0|||
44533459|NCT04170296|79543646|FG000|Overall Study|Withdrawal by Subject|3|||
44533460|NCT04170296|79543647|FG001|Overall Study|Withdrawal by Subject|2|||
44533461|NCT04170296|79543646|FG000|Overall Study|Lost to Follow-up|4|||
44533462|NCT04170296|79543647|FG001|Overall Study|Lost to Follow-up|2|||
44285888|NCT01691898|79249477|FG002|Overall Study|Non-Compliance|0|||
44285889|NCT01691898|79249478|FG003|Overall Study|Non-Compliance|0|||
44285890|NCT01691898|79249479|FG004|Overall Study|Non-Compliance|1|||
44285891|NCT01691898|79249480|FG005|Overall Study|Non-Compliance|0|||
44285892|NCT01691820|79249514|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
44285893|NCT01691820|79249515|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
44285894|NCT01691820|79249514|FG000|Overall Study|Migrated/moved from study area|7|||
44285895|NCT01691820|79249515|FG001|Overall Study|Migrated/moved from study area|4|||
44285896|NCT01691820|79249514|FG000|Overall Study|Lost to Follow-up|6|||
44285897|NCT01691820|79249515|FG001|Overall Study|Lost to Follow-up|17|||
44285898|NCT01691820|79249514|FG000|Overall Study|Other (unspecified)|4|||
44285899|NCT01691820|79249515|FG001|Overall Study|Other (unspecified)|1|||
44285900|NCT01711866|79249525|FG000|Overall Study|Noncompliant|3|||
44285901|NCT01711866|79249525|FG000|Overall Study|Withdrawal by Subject|3|||
44285902|NCT01711866|79249525|FG000|Overall Study|Adverse Event|2|||
44285903|NCT01737762|79249531|FG000|Overall Study|Adverse Event|2|||
44285904|NCT01737762|79249532|FG001|Overall Study|Adverse Event|2|||
44285905|NCT01737762|79249531|FG000|Overall Study|Lost to Follow-up|1|||
44285906|NCT01737762|79249532|FG001|Overall Study|Lost to Follow-up|0|||
44285907|NCT01737762|79249531|FG000|Overall Study|Withdrawal by Subject|2|||
44285908|NCT01737762|79249532|FG001|Overall Study|Withdrawal by Subject|2|||
44285909|NCT01737762|79249531|FG000|Overall Study|Progressive disease|1|||
44285910|NCT01737762|79249532|FG001|Overall Study|Progressive disease|2|||
44285911|NCT01737762|79249531|FG000|Overall Study|Physician Decision|1|||
44285912|NCT01737762|79249532|FG001|Overall Study|Physician Decision|1|||
44285913|NCT01737762|79249531|FG000|Overall Study|Moved from area|2|||
44285914|NCT01737762|79249532|FG001|Overall Study|Moved from area|1|||
44285915|NCT01737762|79249531|FG000|Overall Study|Trial termination|11|||
44285916|NCT01737762|79249532|FG001|Overall Study|Trial termination|9|||
44285917|NCT01691508|79249540|FG000|Overall Study|Adverse Event|3|||
44285918|NCT01691508|79249541|FG001|Overall Study|Adverse Event|3|||
44285919|NCT01691508|79249540|FG000|Overall Study|Withdrawal by Subject|1|||
44285920|NCT01691508|79249541|FG001|Overall Study|Withdrawal by Subject|0|||
44285921|NCT01682460|79249547|FG000|Overall Study|Withdrawal by Subject|2|||
44285922|NCT01682460|79249547|FG000|Overall Study|Did not meet inclusion criteria|2|||
44285923|NCT01691430|79249553|FG000|Overall Study|Death|17|||
44285924|NCT01691430|79249554|FG001|Overall Study|Death|16|||
44285925|NCT01691430|79249553|FG000|Overall Study|Withdrawal by Subject|5|||
44285926|NCT01691430|79249554|FG001|Overall Study|Withdrawal by Subject|1|||
44285927|NCT01691430|79249553|FG000|Overall Study|Lost to Follow-up|0|||
44285928|NCT01691430|79249554|FG001|Overall Study|Lost to Follow-up|3|||
44285929|NCT01709838|79249560|FG000|Overall Study|Withdrawal by Subject|21|||
44285930|NCT01709838|79249560|FG000|Overall Study|Lost to Follow-up|16|||
44285931|NCT01709838|79249560|FG000|Overall Study|Pregnancy|10|||
44285932|NCT01709838|79249560|FG000|Overall Study|Subject/guardian decision|8|||
44285933|NCT01709838|79249560|FG000|Overall Study|Adverse Event|4|||
44285934|NCT01709838|79249560|FG000|Overall Study|Physician Decision|4|||
44285935|NCT01709838|79249560|FG000|Overall Study|Death|3|||
44285936|NCT01709838|79249560|FG000|Overall Study|Protocol Violation|1|||
44285937|NCT01682226|79249566|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
44285938|NCT01682226|79249566|FG000|Overall Study|Participants did not receive treatment|2|||
44285939|NCT01682226|79249566|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
44285940|NCT04167618|79249572|FG000|Overall Study|Trial terminated by sponsor|1|||
44285941|NCT04167618|79249573|FG001|Overall Study|Trial terminated by sponsor|1|||
44285942|NCT01688466|79249581|FG000|Overall Study|Withdrawal by Subject|2|||
44285943|NCT01688466|79249582|FG001|Overall Study|Withdrawal by Subject|1|||
44285944|NCT01688466|79249581|FG000|Overall Study|Death|0|||
44285945|NCT01688466|79249582|FG001|Overall Study|Death|1|||
44285946|NCT01688466|79249581|FG000|Overall Study|Adverse Event|0|||
44285947|NCT01688466|79249582|FG001|Overall Study|Adverse Event|4|||
44285948|NCT01688466|79249581|FG000|Overall Study|Not evaluable|0|||
44285949|NCT01688466|79249582|FG001|Overall Study|Not evaluable|1|||
44285950|NCT01682148|79249590|FG000|Overall Study|Withdrawal by Subject|2|||
44285951|NCT01682148|79249591|FG001|Overall Study|Withdrawal by Subject|0|||
44285952|NCT01682148|79249590|FG000|Overall Study|Lost to Follow-up|1|||
44285953|NCT01682148|79249591|FG001|Overall Study|Lost to Follow-up|2|||
44285954|NCT01682148|79249590|FG000|Overall Study|Protocol Violation|1|||
44285955|NCT01682148|79249591|FG001|Overall Study|Protocol Violation|1|||
44285956|NCT01681992|79249605|FG000|Overall Study|Adverse Event|3|||
44285957|NCT01681992|79249606|FG001|Overall Study|Adverse Event|2|||
44285958|NCT01681992|79249607|FG002|Overall Study|Adverse Event|3|||
44285959|NCT01681992|79249605|FG000|Overall Study|Lost to Follow-up|36|||
44285960|NCT01681992|79249606|FG001|Overall Study|Lost to Follow-up|38|||
44285961|NCT01681992|79249607|FG002|Overall Study|Lost to Follow-up|53|||
44285962|NCT01681992|79249605|FG000|Overall Study|As Per Sponsor Decision|0|||
44285963|NCT01681992|79249606|FG001|Overall Study|As Per Sponsor Decision|0|||
44285964|NCT01681992|79249607|FG002|Overall Study|As Per Sponsor Decision|1|||
44285965|NCT01681992|79249605|FG000|Overall Study|Protocol Violation|0|||
44285966|NCT01681992|79249606|FG001|Overall Study|Protocol Violation|0|||
44285967|NCT01681992|79249607|FG002|Overall Study|Protocol Violation|1|||
44285968|NCT01681992|79249605|FG000|Overall Study|Withdrawal by Subject|27|||
44285969|NCT01681992|79249606|FG001|Overall Study|Withdrawal by Subject|30|||
44285970|NCT01681992|79249607|FG002|Overall Study|Withdrawal by Subject|25|||
44285971|NCT01737840|79249617|FG000|Overall Study|Diagnosed with an other pathology|2|||
44285972|NCT01737840|79249618|FG001|Overall Study|Diagnosed with an other pathology|2|||
44285973|NCT01687998|79249628|FG000|Overall Study|Withdrawal by Subject|49|||
44285974|NCT01687998|79249629|FG001|Overall Study|Withdrawal by Subject|51|||
44285975|NCT01687998|79249628|FG000|Overall Study|Known to be Alive at Study End|54|||
44285976|NCT01687998|79249629|FG001|Overall Study|Known to be Alive at Study End|62|||
44285977|NCT01687998|79249628|FG000|Overall Study|Lost to Follow-up|9|||
44285978|NCT01687998|79249629|FG001|Overall Study|Lost to Follow-up|7|||
44285979|NCT01681836|79249635|FG000|Second Intervention|Withdrawal by Subject|0|||
44285980|NCT01681836|79249636|FG001|Second Intervention|Withdrawal by Subject|1|||
44285981|NCT01681368|79249642|FG000|Overall Study|Refused further treatment|1|||
44285982|NCT01681368|79249642|FG000|Overall Study|Refused further follow up|1|||
44285983|NCT01681212|79249646|FG000|Overall Study|No longer met study criteria|5|||
44285984|NCT01681212|79249646|FG000|Overall Study|Administrative reason by sponsor|1|||
44285985|NCT01687296|79249652|FG000|Overall Study|Lack of Efficacy|1|||
44285986|NCT01687296|79249653|FG001|Overall Study|Lack of Efficacy|1|||
44285987|NCT01687296|79249652|FG000|Overall Study|Protocol Violation|0|||
44285988|NCT01687296|79249653|FG001|Overall Study|Protocol Violation|1|||
44285989|NCT01687296|79249652|FG000|Overall Study|Withdrawal by Subject|6|||
44285990|NCT01687296|79249653|FG001|Overall Study|Withdrawal by Subject|3|||
44285991|NCT01568892|79249674|FG000|Open-label Phase|Adverse Event|2|||
44285992|NCT01568892|79249675|FG001|Open-label Phase|Adverse Event|0|||
44285993|NCT01568892|79249674|FG000|Open-label Phase|Lack of Efficacy|4|||
44285994|NCT01568892|79249675|FG001|Open-label Phase|Lack of Efficacy|2|||
44285995|NCT01568892|79249674|FG000|Open-label Phase|Lost to Follow-up|0|||
44285996|NCT01568892|79249675|FG001|Open-label Phase|Lost to Follow-up|1|||
44285997|NCT01568112|79249686|FG000|Overall Study|Randomized But Not Treated|0|||
44285998|NCT01568112|79249687|FG001|Overall Study|Randomized But Not Treated|1|||
44285999|NCT01568112|79249688|FG002|Overall Study|Randomized But Not Treated|0|||
44286000|NCT01568112|79249689|FG003|Overall Study|Randomized But Not Treated|0|||
44286001|NCT01568112|79249686|FG000|Overall Study|Withdrew due to Adverse Event|2|||
44286002|NCT01568112|79249687|FG001|Overall Study|Withdrew due to Adverse Event|4|||
44286003|NCT01568112|79249688|FG002|Overall Study|Withdrew due to Adverse Event|6|||
44286004|NCT01568112|79249689|FG003|Overall Study|Withdrew due to Adverse Event|3|||
44286005|NCT01568112|79249686|FG000|Overall Study|Lost to Follow-up|0|||
44286006|NCT01568112|79249687|FG001|Overall Study|Lost to Follow-up|0|||
44286007|NCT01568112|79249688|FG002|Overall Study|Lost to Follow-up|0|||
44286008|NCT01568112|79249689|FG003|Overall Study|Lost to Follow-up|1|||
44286009|NCT01568112|79249686|FG000|Overall Study|Withdrawal by Subject|2|||
44286010|NCT01568112|79249687|FG001|Overall Study|Withdrawal by Subject|3|||
44286011|NCT01568112|79249688|FG002|Overall Study|Withdrawal by Subject|0|||
44286012|NCT01568112|79249689|FG003|Overall Study|Withdrawal by Subject|7|||
44286013|NCT01568112|79249686|FG000|Overall Study|Withdrawal by Physician|1|||
44533463|NCT03141788|79543683|FG000|Overall Study|Lost to Follow-up|1|||
44533464|NCT03141788|79543683|FG000|Overall Study|Protocol Violation|3|||
44286014|NCT01568112|79249687|FG001|Overall Study|Withdrawal by Physician|0|||
44286015|NCT01568112|79249688|FG002|Overall Study|Withdrawal by Physician|1|||
44286016|NCT01568112|79249689|FG003|Overall Study|Withdrawal by Physician|1|||
44286017|NCT01568034|79249700|FG000|Overall Study|Withdrawal by Subject|1|||
44286018|NCT01568034|79249701|FG001|Overall Study|Withdrawal by Subject|0|||
44286019|NCT01568034|79249702|FG002|Overall Study|Withdrawal by Subject|0|||
44286020|NCT01568034|79249703|FG003|Overall Study|Withdrawal by Subject|0|||
44286021|NCT01687218|79249719|FG000|Overall Study|Withdrawal by Subject|2|||
44286022|NCT01687218|79249720|FG001|Overall Study|Withdrawal by Subject|3|||
44286023|NCT01687218|79249721|FG002|Overall Study|Withdrawal by Subject|0|||
44286024|NCT01687218|79249722|FG003|Overall Study|Withdrawal by Subject|1|||
44286025|NCT01687218|79249723|FG004|Overall Study|Withdrawal by Subject|1|||
44286026|NCT01687218|79249724|FG005|Overall Study|Withdrawal by Subject|0|||
44286027|NCT01687218|79249719|FG000|Overall Study|Relocated, no follow-up planned|1|||
44286028|NCT01687218|79249720|FG001|Overall Study|Relocated, no follow-up planned|0|||
44286029|NCT01687218|79249721|FG002|Overall Study|Relocated, no follow-up planned|1|||
44286030|NCT01687218|79249722|FG003|Overall Study|Relocated, no follow-up planned|1|||
44286031|NCT01687218|79249723|FG004|Overall Study|Relocated, no follow-up planned|0|||
44286032|NCT01687218|79249724|FG005|Overall Study|Relocated, no follow-up planned|0|||
44286033|NCT01686828|79249736|FG000|Overall Study|Physician Decision|1|||
44286034|NCT01686828|79249737|FG001|Overall Study|Physician Decision|0|||
44286035|NCT01686828|79249738|FG002|Overall Study|Physician Decision|0|||
44286036|NCT01686828|79249739|FG003|Overall Study|Physician Decision|0|||
44286037|NCT01686828|79249736|FG000|Overall Study|New Job|0|||
44286038|NCT01686828|79249737|FG001|Overall Study|New Job|1|||
44286039|NCT01686828|79249738|FG002|Overall Study|New Job|0|||
44286040|NCT01686828|79249739|FG003|Overall Study|New Job|0|||
44286041|NCT01686828|79249736|FG000|Overall Study|Weight Loss|0|||
44286042|NCT01686828|79249737|FG001|Overall Study|Weight Loss|0|||
44286043|NCT01686828|79249738|FG002|Overall Study|Weight Loss|1|||
44286044|NCT01686828|79249739|FG003|Overall Study|Weight Loss|0|||
44286045|NCT01686438|79249756|FG000|Overall Study|Lost to Follow-up|8|||
44286046|NCT01686438|79249757|FG001|Overall Study|Lost to Follow-up|9|||
44286047|NCT01686438|79249758|FG002|Overall Study|Lost to Follow-up|10|||
44286048|NCT01686438|79249756|FG000|Overall Study|Adverse Event|0|||
44533465|NCT03141788|79543683|FG000|Overall Study|Withdrawal by Subject|4|||
44286049|NCT01686438|79249757|FG001|Overall Study|Adverse Event|0|||
44286050|NCT01686438|79249758|FG002|Overall Study|Adverse Event|1|||
44286051|NCT01686438|79249756|FG000|Overall Study|Protocol Violation|0|||
44286052|NCT01686438|79249757|FG001|Overall Study|Protocol Violation|0|||
44286053|NCT01686438|79249758|FG002|Overall Study|Protocol Violation|1|||
44286054|NCT01686438|79249756|FG000|Overall Study|Withdrawal by Subject|0|||
44286055|NCT01686438|79249757|FG001|Overall Study|Withdrawal by Subject|0|||
44286056|NCT01686438|79249758|FG002|Overall Study|Withdrawal by Subject|1|||
44286057|NCT01593696|79249772|FG000|Dose Escalation|Progressive Disease|2|||
44286058|NCT01593696|79249773|FG001|Dose Escalation|Progressive Disease|0|||
44286059|NCT01593696|79249774|FG002|Dose Escalation|Progressive Disease|0|||
44286060|NCT01593696|79249775|FG003|Dose Escalation|Progressive Disease|0|||
44286061|NCT01593696|79249772|FG000|Dose Expansion|Fungal infection|0|||
44286062|NCT01593696|79249773|FG001|Dose Expansion|Fungal infection|0|||
44286063|NCT01593696|79249774|FG002|Dose Expansion|Fungal infection|1|||
44286064|NCT01593696|79249775|FG003|Dose Expansion|Fungal infection|0|||
44286065|NCT01592760|79249788|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
44286066|NCT01592760|79249789|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
44286067|NCT01592760|79249790|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
44286068|NCT01696188|79249803|FG000|Overall Study|Protocol Violation|1|||
44286069|NCT01696188|79249804|FG001|Overall Study|Protocol Violation|1|||
44286070|NCT01603602|79249813|FG000|Overall Study|Adverse Event|1|||
44286071|NCT01603602|79249814|FG001|Overall Study|Adverse Event|0|||
44286072|NCT01603602|79249815|FG002|Overall Study|Adverse Event|0|||
44286073|NCT01603602|79249813|FG000|Overall Study|Personal Reasons|1|||
44286074|NCT01603602|79249814|FG001|Overall Study|Personal Reasons|0|||
44286075|NCT01603602|79249815|FG002|Overall Study|Personal Reasons|1|||
44286076|NCT01684878|79249827|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
44286077|NCT01684878|79249828|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
44286078|NCT01684878|79249829|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
44286079|NCT01684878|79249830|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
44286080|NCT01684878|79249827|FG000|Part 1: Safety Run in Phase|Death|15|||
44286081|NCT01684878|79249828|FG001|Part 1: Safety Run in Phase|Death|20|||
44286082|NCT01684878|79249829|FG002|Part 1: Safety Run in Phase|Death|0|||
44286083|NCT01684878|79249830|FG003|Part 1: Safety Run in Phase|Death|0|||
44286084|NCT01684878|79249827|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
44286085|NCT01684878|79249828|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
44286086|NCT01684878|79249829|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
44286087|NCT01684878|79249830|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
44286088|NCT01684878|79249827|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
44286089|NCT01684878|79249828|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
44286090|NCT01684878|79249829|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
44286091|NCT01684878|79249830|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
44286092|NCT01684878|79249827|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
44286093|NCT01684878|79249828|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
44286094|NCT01684878|79249829|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
44286095|NCT01684878|79249830|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
44286096|NCT01684878|79249827|FG000|Part 2: Randomized Phase|Death|0|||
44286097|NCT01684878|79249828|FG001|Part 2: Randomized Phase|Death|0|||
44286098|NCT01684878|79249829|FG002|Part 2: Randomized Phase|Death|62|||
44286099|NCT01684878|79249830|FG003|Part 2: Randomized Phase|Death|68|||
44286100|NCT01684878|79249827|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
44286101|NCT01684878|79249828|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
44286102|NCT01684878|79249829|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
44286103|NCT01684878|79249830|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
44286104|NCT01684878|79249827|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
44286105|NCT01684878|79249828|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
44286106|NCT01684878|79249829|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
44286107|NCT01684878|79249830|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
44286108|NCT01684722|79249844|FG000|Overall Study|Lost to Follow-up|78|||
44415612|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
44154359|NCT01959880|78945481|FG000|Overall Study|Lost to Follow-up|95|||
44154360|NCT01959880|78945482|FG001|Overall Study|Lost to Follow-up|18|||
44286109|NCT01684722|79249845|FG001|Overall Study|Lost to Follow-up|56|||
44286110|NCT01684722|79249846|FG002|Overall Study|Lost to Follow-up|75|||
44286111|NCT01684722|79249847|FG003|Overall Study|Lost to Follow-up|89|||
44286112|NCT01684722|79249844|FG000|Overall Study|Death|19|||
44286113|NCT01684722|79249845|FG001|Overall Study|Death|21|||
44286114|NCT01684722|79249846|FG002|Overall Study|Death|19|||
44286115|NCT01684722|79249847|FG003|Overall Study|Death|21|||
44286116|NCT01592292|79249864|FG000|Overall Study|Follow-up loss|3|||
44286117|NCT01592292|79249865|FG001|Overall Study|Follow-up loss|3|||
44286118|NCT01592292|79249866|FG002|Overall Study|Follow-up loss|1|||
44286119|NCT01592292|79249867|FG003|Overall Study|Follow-up loss|0|||
44286120|NCT01592292|79249864|FG000|Overall Study|Withdrew consent|2|||
44286121|NCT01592292|79249865|FG001|Overall Study|Withdrew consent|1|||
44286122|NCT01592292|79249866|FG002|Overall Study|Withdrew consent|0|||
44286123|NCT01592292|79249867|FG003|Overall Study|Withdrew consent|0|||
44286124|NCT01592292|79249864|FG000|Overall Study|Other|1|||
44286125|NCT01592292|79249865|FG001|Overall Study|Other|1|||
44286126|NCT01592292|79249866|FG002|Overall Study|Other|2|||
44286127|NCT01592292|79249867|FG003|Overall Study|Other|1|||
44286128|NCT01590888|79249876|FG000|Overall Study|Adverse Event|3|||
44286129|NCT01590888|79249877|FG001|Overall Study|Adverse Event|0|||
44286130|NCT01590888|79249878|FG002|Overall Study|Adverse Event|1|||
44286131|NCT01590888|79249876|FG000|Overall Study|Lost to Follow-up|1|||
44286132|NCT01590888|79249877|FG001|Overall Study|Lost to Follow-up|0|||
44286133|NCT01590888|79249878|FG002|Overall Study|Lost to Follow-up|0|||
44286134|NCT01565928|79249886|FG000|Overall Study|Adverse Event|3|||
44286135|NCT01565928|79249886|FG000|Overall Study|Other|3|||
44286136|NCT01565928|79249886|FG000|Overall Study|Progressive Disease|13|||
44286137|NCT01565928|79249886|FG000|Overall Study|Withdrawal by Subject|1|||
44286138|NCT01565928|79249886|FG000|Overall Study|Death|2|||
44286139|NCT01565850|79249895|FG000|Overall Study|Adverse Event|0|||
44286140|NCT01565850|79249896|FG001|Overall Study|Adverse Event|1|||
44286141|NCT01565850|79249895|FG000|Overall Study|Lost to Follow-up|12|||
44286142|NCT01565850|79249896|FG001|Overall Study|Lost to Follow-up|4|||
44286143|NCT01565850|79249895|FG000|Overall Study|Investigator's Discretion|2|||
44286144|NCT01565850|79249896|FG001|Overall Study|Investigator's Discretion|1|||
44286145|NCT01565850|79249895|FG000|Overall Study|Participant noncompliance|2|||
44286146|NCT01565850|79249896|FG001|Overall Study|Participant noncompliance|0|||
44286147|NCT01565850|79249895|FG000|Overall Study|Withdrew Consent|4|||
44286148|NCT01565850|79249896|FG001|Overall Study|Withdrew Consent|2|||
44286149|NCT01565694|79249902|FG000|Dose-Titration Period|Adverse Event|4|||
44286150|NCT01565694|79249902|FG000|Dose-Titration Period|Protocol Violation|10|||
44286151|NCT01565694|79249902|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
44286152|NCT01543152|79249911|FG000|Overall Study|Withdrawal by Subject|0|||
44286153|NCT01543152|79249912|FG001|Overall Study|Withdrawal by Subject|2|||
44286154|NCT01543152|79249913|FG002|Overall Study|Withdrawal by Subject|0|||
44286155|NCT01543152|79249914|FG003|Overall Study|Withdrawal by Subject|0|||
44286156|NCT01543152|79249915|FG004|Overall Study|Withdrawal by Subject|0|||
44286157|NCT01590810|79249932|FG000|Overall Study|Physician Decision|0|||
44286158|NCT01590810|79249933|FG001|Overall Study|Physician Decision|1|||
44286159|NCT01590810|79249934|FG002|Overall Study|Physician Decision|1|||
44286160|NCT01590810|79249935|FG003|Overall Study|Physician Decision|0|||
44286161|NCT01590810|79249936|FG004|Overall Study|Physician Decision|0|||
44286162|NCT01542528|79249971|FG000|Overall Study|Lost to Follow-up|2|||
44286163|NCT01542528|79249972|FG001|Overall Study|Lost to Follow-up|1|||
44286164|NCT01542528|79249971|FG000|Overall Study|Physician Decision|1|||
44286165|NCT01542528|79249972|FG001|Overall Study|Physician Decision|0|||
44286166|NCT01542528|79249971|FG000|Overall Study|Withdrawal by Subject|9|||
44286167|NCT01542528|79249972|FG001|Overall Study|Withdrawal by Subject|6|||
44286168|NCT01565148|79249982|FG000|Overall Study|Withdrawal by Subject|1|||
44286169|NCT01565148|79249983|FG001|Overall Study|Withdrawal by Subject|1|||
44286170|NCT01565148|79249984|FG002|Overall Study|Withdrawal by Subject|1|||
44286171|NCT01565148|79249985|FG003|Overall Study|Withdrawal by Subject|2|||
44286172|NCT01565148|79249982|FG000|Overall Study|Lost to Follow-up|4|||
44286173|NCT01565148|79249983|FG001|Overall Study|Lost to Follow-up|4|||
44286174|NCT01565148|79249984|FG002|Overall Study|Lost to Follow-up|0|||
44286175|NCT01565148|79249985|FG003|Overall Study|Lost to Follow-up|3|||
44286176|NCT01565148|79249982|FG000|Overall Study|Rescue Therapy|8|||
44286177|NCT01565148|79249983|FG001|Overall Study|Rescue Therapy|5|||
44286178|NCT01565148|79249984|FG002|Overall Study|Rescue Therapy|5|||
44286179|NCT01565148|79249985|FG003|Overall Study|Rescue Therapy|8|||
44286180|NCT01565148|79249982|FG000|Overall Study|Death|0|||
44286181|NCT01565148|79249983|FG001|Overall Study|Death|0|||
44286182|NCT01565148|79249984|FG002|Overall Study|Death|1|||
44286183|NCT01565148|79249985|FG003|Overall Study|Death|0|||
44286184|NCT01565148|79249982|FG000|Overall Study|Physician Decision|2|||
44154361|NCT01959880|78945483|FG002|Overall Study|Lost to Follow-up|15|||
44286185|NCT01565148|79249983|FG001|Overall Study|Physician Decision|5|||
44286186|NCT01565148|79249984|FG002|Overall Study|Physician Decision|0|||
44286187|NCT01565148|79249985|FG003|Overall Study|Physician Decision|0|||
44286188|NCT01564758|79249999|FG000|Overall Study|Death|8|||
44286189|NCT01564758|79249999|FG000|Overall Study|Adverse Event|3|||
44286190|NCT01564758|79249999|FG000|Overall Study|Other|3|||
44286191|NCT01541826|79250006|FG000|Overall Study|Lost to Follow-up|2|||
44286192|NCT01541826|79250007|FG001|Overall Study|Lost to Follow-up|3|||
44286193|NCT01541826|79250008|FG002|Overall Study|Lost to Follow-up|0|||
44286194|NCT01541826|79250006|FG000|Overall Study|Withdrawal by Subject|2|||
44286195|NCT01541826|79250007|FG001|Overall Study|Withdrawal by Subject|0|||
44286196|NCT01541826|79250008|FG002|Overall Study|Withdrawal by Subject|0|||
44286197|NCT01541748|79250016|FG000|Overall Study|Lost to Follow-up|17|||
44286198|NCT01541748|79250016|FG000|Overall Study|Moved out of state|1|||
44286199|NCT01541748|79250016|FG000|Overall Study|Withdrawal by Subject|7|||
44286200|NCT01541748|79250016|FG000|Overall Study|Screen failure|5|||
44286201|NCT01541748|79250016|FG000|Overall Study|Did not receive study device|1|||
44286202|NCT01589094|79250029|FG000|Overall Study|Did not receive treatment|2|||
44286203|NCT01563978|79250035|FG000|Overall Study|Physician Decision|1|||
44286204|NCT01563978|79250036|FG001|Overall Study|Physician Decision|0|||
44286205|NCT01563978|79250035|FG000|Overall Study|Lost to Follow-up|1|||
44286206|NCT01563978|79250036|FG001|Overall Study|Lost to Follow-up|0|||
44286207|NCT01563978|79250035|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
44286208|NCT01563978|79250036|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
44286209|NCT01563978|79250035|FG000|Overall Study|Adverse Event|1|||
44286210|NCT01563978|79250036|FG001|Overall Study|Adverse Event|2|||
44286211|NCT01563354|79250045|FG000|Core Phase|Adverse Event|5|||
44286212|NCT01563354|79250046|FG001|Core Phase|Adverse Event|15|||
44286213|NCT01563354|79250047|FG002|Core Phase|Adverse Event|13|||
44286214|NCT01563354|79250045|FG000|Core Phase|Withdrawal by Subject|1|||
44286215|NCT01563354|79250046|FG001|Core Phase|Withdrawal by Subject|0|||
44286216|NCT01563354|79250047|FG002|Core Phase|Withdrawal by Subject|3|||
44286217|NCT01563354|79250045|FG000|Core Phase|Lost to Follow-up|1|||
44286218|NCT01563354|79250046|FG001|Core Phase|Lost to Follow-up|0|||
44286219|NCT01563354|79250047|FG002|Core Phase|Lost to Follow-up|0|||
44286220|NCT01563354|79250045|FG000|Core Phase|Death|1|||
44286221|NCT01563354|79250046|FG001|Core Phase|Death|5|||
44286222|NCT01563354|79250047|FG002|Core Phase|Death|2|||
44286223|NCT01563354|79250045|FG000|Core Phase|Diseasse progression|18|||
44286224|NCT01563354|79250046|FG001|Core Phase|Diseasse progression|7|||
44286225|NCT01563354|79250047|FG002|Core Phase|Diseasse progression|8|||
44286226|NCT01563354|79250045|FG000|Core Phase|Protocol deviation|2|||
44286227|NCT01563354|79250046|FG001|Core Phase|Protocol deviation|0|||
44286228|NCT01563354|79250047|FG002|Core Phase|Protocol deviation|0|||
44286229|NCT01563354|79250045|FG000|Core Phase|PI decision - did not enter extension|0|||
44286230|NCT01563354|79250046|FG001|Core Phase|PI decision - did not enter extension|1|||
44286231|NCT01563354|79250047|FG002|Core Phase|PI decision - did not enter extension|0|||
44286232|NCT01563354|79250045|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
44286233|NCT01563354|79250046|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
44286234|NCT01563354|79250047|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
44286235|NCT01563354|79250045|FG000|Extension Phase|Adverse Event|0|||
44286236|NCT01563354|79250046|FG001|Extension Phase|Adverse Event|3|||
44286237|NCT01563354|79250047|FG002|Extension Phase|Adverse Event|2|||
44286238|NCT01563354|79250045|FG000|Extension Phase|Withdrawal by Subject|0|||
44286239|NCT01563354|79250046|FG001|Extension Phase|Withdrawal by Subject|1|||
44286240|NCT01563354|79250047|FG002|Extension Phase|Withdrawal by Subject|0|||
44286241|NCT01563354|79250045|FG000|Extension Phase|Administration problems|3|||
44286242|NCT01563354|79250046|FG001|Extension Phase|Administration problems|2|||
44286243|NCT01563354|79250047|FG002|Extension Phase|Administration problems|3|||
44286244|NCT01563354|79250045|FG000|Extension Phase|Disease progression|9|||
44286245|NCT01563354|79250046|FG001|Extension Phase|Disease progression|8|||
44286246|NCT01563354|79250047|FG002|Extension Phase|Disease progression|10|||
44286247|NCT01588548|79250061|FG000|Overall Study|Withdrawal by Subject|0|||
44286248|NCT01588548|79250062|FG001|Overall Study|Withdrawal by Subject|1|||
44286249|NCT01588548|79250063|FG002|Overall Study|Withdrawal by Subject|1|||
44286250|NCT01588548|79250064|FG003|Overall Study|Withdrawal by Subject|1|||
44286251|NCT01588548|79250065|FG004|Overall Study|Withdrawal by Subject|2|||
44286252|NCT01588548|79250066|FG005|Overall Study|Withdrawal by Subject|3|||
44286253|NCT01588548|79250061|FG000|Overall Study|Adverse Event|0|||
44286254|NCT01588548|79250062|FG001|Overall Study|Adverse Event|0|||
44286255|NCT01588548|79250063|FG002|Overall Study|Adverse Event|1|||
44286256|NCT01588548|79250064|FG003|Overall Study|Adverse Event|2|||
44286257|NCT01588548|79250065|FG004|Overall Study|Adverse Event|1|||
44286258|NCT01588548|79250066|FG005|Overall Study|Adverse Event|0|||
44286259|NCT01588548|79250061|FG000|Overall Study|Condition Under Investigation Worsened|3|||
44286260|NCT01588548|79250062|FG001|Overall Study|Condition Under Investigation Worsened|6|||
44286261|NCT01588548|79250063|FG002|Overall Study|Condition Under Investigation Worsened|4|||
44286262|NCT01588548|79250064|FG003|Overall Study|Condition Under Investigation Worsened|4|||
44286263|NCT01588548|79250065|FG004|Overall Study|Condition Under Investigation Worsened|3|||
44286264|NCT01588548|79250066|FG005|Overall Study|Condition Under Investigation Worsened|3|||
44286265|NCT01587924|79250084|FG000|Overall Study|Adverse Event|0|||
44286266|NCT01587924|79250085|FG001|Overall Study|Adverse Event|2|||
44286267|NCT01587924|79250086|FG002|Overall Study|Adverse Event|0|||
44286268|NCT01587924|79250087|FG003|Overall Study|Adverse Event|0|||
44286269|NCT01587924|79250084|FG000|Overall Study|Protocol Violation|2|||
44286270|NCT01587924|79250085|FG001|Overall Study|Protocol Violation|1|||
44286271|NCT01587924|79250086|FG002|Overall Study|Protocol Violation|2|||
44286272|NCT01587924|79250087|FG003|Overall Study|Protocol Violation|1|||
44286273|NCT01587924|79250084|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
44533466|NCT03781375|79543692|FG000|Double-blind Phase|Adverse Event|0|||
44286274|NCT01587924|79250085|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
44533467|NCT03781375|79543693|FG001|Double-blind Phase|Adverse Event|1|||
44286275|NCT01587924|79250086|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
44286276|NCT01587924|79250087|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
44286277|NCT01587924|79250084|FG000|Overall Study|Withdrawal by Subject|0|||
44286278|NCT01587924|79250085|FG001|Overall Study|Withdrawal by Subject|1|||
44286279|NCT01587924|79250086|FG002|Overall Study|Withdrawal by Subject|1|||
44286280|NCT01587924|79250087|FG003|Overall Study|Withdrawal by Subject|0|||
44286281|NCT01539642|79250099|FG000|Overall Study|Lack of Efficacy|20|||
44286282|NCT01539642|79250100|FG001|Overall Study|Lack of Efficacy|18|||
44286283|NCT01539642|79250099|FG000|Overall Study|Patient ready for early discharge|8|||
44286284|NCT01539642|79250100|FG001|Overall Study|Patient ready for early discharge|7|||
44286285|NCT01539642|79250099|FG000|Overall Study|Adverse Event|6|||
44286286|NCT01539642|79250100|FG001|Overall Study|Adverse Event|4|||
44286287|NCT01539642|79250099|FG000|Overall Study|Withdrawal by Subject|2|||
44286288|NCT01539642|79250100|FG001|Overall Study|Withdrawal by Subject|2|||
44286289|NCT01586364|79250106|FG000|Overall Study|Withdrawal by Subject|40|||
44286290|NCT01586364|79250106|FG000|Overall Study|Adverse Event|37|||
44286291|NCT01586364|79250106|FG000|Overall Study|Lost to Follow-up|17|||
44286292|NCT01586364|79250106|FG000|Overall Study|Protocol Violation|16|||
44286293|NCT01586364|79250106|FG000|Overall Study|Lack of Efficacy|1|||
44286294|NCT01586364|79250106|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
44286295|NCT01586364|79250106|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
44286296|NCT01586364|79250106|FG000|Overall Study|Other-Site closure due to PI illness|1|||
44286297|NCT01586364|79250106|FG000|Overall Study|Other-PI discretion, site closing|2|||
44286298|NCT01586364|79250106|FG000|Overall Study|Other-Not specified|1|||
44286299|NCT01538628|79250112|FG000|Overall Study|Withdrawal by Subject|1|||
44286300|NCT01538628|79250113|FG001|Overall Study|Withdrawal by Subject|1|||
44286301|NCT01538628|79250112|FG000|Overall Study|Lost to Follow-up|0|||
44286302|NCT01538628|79250113|FG001|Overall Study|Lost to Follow-up|1|||
44286303|NCT01538472|79250120|FG000|Overall Study|Disease Progression|3|||
44286304|NCT01538472|79250120|FG000|Overall Study|Death|1|||
44286305|NCT01562028|79250126|FG000|Overall Study|Withdrawal by Subject|1|||
44286306|NCT01562028|79250127|FG001|Overall Study|Withdrawal by Subject|1|||
44286307|NCT01562028|79250126|FG000|Overall Study|Lost to Follow-up|2|||
44286308|NCT01562028|79250127|FG001|Overall Study|Lost to Follow-up|1|||
44286309|NCT01585584|79250133|FG000|Overall Study|Lack of Efficacy|1|||
44286310|NCT01585584|79250133|FG000|Overall Study|Withdrawal by Subject|1|||
44286311|NCT01585584|79250133|FG000|Overall Study|Physician Decision|2|||
44286312|NCT01561560|79250137|FG000|First Two Weeks of Wear|Time/job conflict|0|||
44286313|NCT01561560|79250138|FG001|First Two Weeks of Wear|Time/job conflict|1|||
44286314|NCT01561560|79250137|FG000|First Two Weeks of Wear|Adverse Event|0|||
44286315|NCT01561560|79250138|FG001|First Two Weeks of Wear|Adverse Event|1|||
44286316|NCT01561560|79250137|FG000|Second Two Weeks of Wear|Adverse Event|0|||
44286317|NCT01561560|79250138|FG001|Second Two Weeks of Wear|Adverse Event|1|||
44286318|NCT01537068|79250146|FG000|Overall Study|Lost to Follow-up|2|||
44286319|NCT01537068|79250147|FG001|Overall Study|Lost to Follow-up|1|||
44286320|NCT01537068|79250146|FG000|Overall Study|Adverse Event|0|||
44286321|NCT01537068|79250147|FG001|Overall Study|Adverse Event|1|||
44286322|NCT01537068|79250146|FG000|Overall Study|Withdrawal by Subject|1|||
44286323|NCT01537068|79250147|FG001|Overall Study|Withdrawal by Subject|1|||
44286324|NCT01537068|79250146|FG000|Overall Study|Lack of Efficacy|1|||
44286325|NCT01537068|79250147|FG001|Overall Study|Lack of Efficacy|0|||
44286326|NCT01585428|79250155|FG000|Overall Study|Death during treatment|1|||
44286327|NCT01585428|79250156|FG001|Overall Study|Death during treatment|0|||
44286328|NCT01585272|79250163|FG000|Overall Study|Adverse Event|22|||
44286329|NCT01585272|79250163|FG000|Overall Study|Protocol Violation|7|||
44286330|NCT01585272|79250163|FG000|Overall Study|Withdrawal by Subject|10|||
44286331|NCT01560780|79250169|FG000|Overall Study|Death|2|||
44255901|NCT02597946|79101817|FG000|Overall Study|Other than above|1|||
44255902|NCT02597712|79101823|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
44255903|NCT02597712|79101824|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
44255904|NCT02597712|79101823|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
44255905|NCT02597712|79101824|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
44255906|NCT02597712|79101823|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
44255907|NCT02597712|79101824|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
44255908|NCT02597478|79101832|FG000|Overall Study|Withdrawal by Subject|2|||
44255909|NCT02597478|79101833|FG001|Overall Study|Withdrawal by Subject|0|||
44255910|NCT02597478|79101832|FG000|Overall Study|Change of opioid dose|1|||
44255911|NCT02597478|79101833|FG001|Overall Study|Change of opioid dose|0|||
44255912|NCT02597478|79101832|FG000|Overall Study|Insufficient exertional dyspnea|0|||
44286332|NCT01560780|79250170|FG001|Overall Study|Death|1|||
44286333|NCT01560780|79250169|FG000|Overall Study|Patient Preference|11|||
44286334|NCT01560780|79250170|FG001|Overall Study|Patient Preference|11|||
44286335|NCT01585038|79250178|FG000|Overall Study|Adverse Event|2|||
44286336|NCT01585038|79250179|FG001|Overall Study|Adverse Event|2|||
44286337|NCT01560234|79250193|FG000|Overall Study|Lost to Follow-up|3|||
44286338|NCT01560234|79250194|FG001|Overall Study|Lost to Follow-up|0|||
44286339|NCT01560234|79250195|FG002|Overall Study|Lost to Follow-up|1|||
44286340|NCT01560234|79250196|FG003|Overall Study|Lost to Follow-up|0|||
44286341|NCT01560234|79250197|FG004|Overall Study|Lost to Follow-up|0|||
44286342|NCT01560234|79250198|FG005|Overall Study|Lost to Follow-up|2|||
44286343|NCT01560234|79250199|FG006|Overall Study|Lost to Follow-up|0|||
44286344|NCT01560234|79250200|FG007|Overall Study|Lost to Follow-up|2|||
44286345|NCT01559844|79250218|FG000|Overall Study|Consent Withdrawn|7|||
44286346|NCT01559844|79250218|FG000|Overall Study|Death|5|||
44286347|NCT01559844|79250218|FG000|Overall Study|Efficacy Failure|10|||
44286348|NCT01559844|79250218|FG000|Overall Study|No Longer A Transplant Candidate|3|||
44286349|NCT01584648|79250224|FG000|Overall Study|Death|136|||
44286350|NCT01584648|79250225|FG001|Overall Study|Death|146|||
44286351|NCT01584648|79250224|FG000|Overall Study|Lost to Follow-up|9|||
44286352|NCT01584648|79250225|FG001|Overall Study|Lost to Follow-up|9|||
44286353|NCT01584648|79250224|FG000|Overall Study|Investigator discretion|3|||
44286354|NCT01584648|79250225|FG001|Overall Study|Investigator discretion|2|||
44286355|NCT01584648|79250224|FG000|Overall Study|Withdrew consent|13|||
44286356|NCT01584648|79250225|FG001|Overall Study|Withdrew consent|4|||
44286357|NCT01584648|79250224|FG000|Overall Study|Study closed/terminated|50|||
44286358|NCT01584648|79250225|FG001|Overall Study|Study closed/terminated|23|||
44286359|NCT01584648|79250224|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
44286360|NCT01584648|79250225|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
44286361|NCT01559454|79250236|FG000|Overall Study|Lost to Follow-up|3|||
44286362|NCT01559454|79250237|FG001|Overall Study|Lost to Follow-up|2|||
44286363|NCT01559454|79250236|FG000|Overall Study|Withdrawal by Subject|0|||
44286364|NCT01559454|79250237|FG001|Overall Study|Withdrawal by Subject|1|||
44286365|NCT01559454|79250236|FG000|Overall Study|Physician Decision|0|||
44286366|NCT01559454|79250237|FG001|Overall Study|Physician Decision|1|||
44286367|NCT01559454|79250236|FG000|Overall Study|Protocol Violation|0|||
44286368|NCT01559454|79250237|FG001|Overall Study|Protocol Violation|1|||
44286369|NCT01559454|79250236|FG000|Overall Study|Lack of Efficacy|0|||
44286370|NCT01559454|79250237|FG001|Overall Study|Lack of Efficacy|1|||
44286371|NCT01584024|79250243|FG000|Overall Study|Lost to Follow-up|10|||
44286372|NCT01584024|79250243|FG000|Overall Study|Withdrawal by Subject|3|||
44286373|NCT01583166|79250250|FG000|Overall Study|Withdrawal by Subject|4|||
44286374|NCT01583166|79250251|FG001|Overall Study|Withdrawal by Subject|6|||
44286375|NCT01535274|79250259|FG000|Overall Study|Determined to be ineligible|0|||
44286376|NCT01535274|79250260|FG001|Overall Study|Determined to be ineligible|1|||
44286377|NCT01535274|79250259|FG000|Overall Study|Misallocated to propofol intervention|0|||
44286378|NCT01535274|79250260|FG001|Overall Study|Misallocated to propofol intervention|1|||
44286379|NCT01558752|79250270|FG000|Overall Study|Physician Decision|2|||
44286380|NCT01558752|79250271|FG001|Overall Study|Physician Decision|0|||
44286381|NCT01582854|79250279|FG000|Overall Study|Death|8|||
44286382|NCT01582854|79250280|FG001|Overall Study|Death|5|||
44286383|NCT01582854|79250279|FG000|Overall Study|Adverse Event|2|||
44286384|NCT01582854|79250280|FG001|Overall Study|Adverse Event|3|||
44286385|NCT01582854|79250279|FG000|Overall Study|Withdrawal by Participant|8|||
44286386|NCT01582854|79250280|FG001|Overall Study|Withdrawal by Participant|11|||
44286387|NCT01582854|79250279|FG000|Overall Study|Lost to Follow-up|1|||
44286388|NCT01582854|79250280|FG001|Overall Study|Lost to Follow-up|2|||
44286389|NCT01582854|79250279|FG000|Overall Study|Physician Decision|0|||
44286390|NCT01582854|79250280|FG001|Overall Study|Physician Decision|1|||
44286391|NCT01582854|79250279|FG000|Overall Study|Recurrent Stroke|13|||
44286392|NCT01582854|79250280|FG001|Overall Study|Recurrent Stroke|8|||
44286393|NCT01582854|79250279|FG000|Overall Study|Disallowed Concomitant Medication|3|||
44286394|NCT01582854|79250280|FG001|Overall Study|Disallowed Concomitant Medication|2|||
44286395|NCT01582854|79250279|FG000|Overall Study|Carotid or Neurosurgery|0|||
44286396|NCT01582854|79250280|FG001|Overall Study|Carotid or Neurosurgery|1|||
44286397|NCT01582854|79250279|FG000|Overall Study|General Anaesthesia|0|||
44286398|NCT01582854|79250280|FG001|Overall Study|General Anaesthesia|1|||
44286399|NCT01582854|79250279|FG000|Overall Study|Other Miscellaneous Reason|1|||
44286400|NCT01582854|79250280|FG001|Overall Study|Other Miscellaneous Reason|0|||
44286401|NCT01582308|79250286|FG000|Period 1|Withdrawal by Subject|0|||
44286402|NCT01582308|79250287|FG001|Period 1|Withdrawal by Subject|0|||
44286403|NCT01582308|79250288|FG002|Period 1|Withdrawal by Subject|0|||
44286404|NCT01582308|79250289|FG003|Period 1|Withdrawal by Subject|0|||
44286405|NCT01582308|79250290|FG004|Period 1|Withdrawal by Subject|0|||
44286406|NCT01582308|79250291|FG005|Period 1|Withdrawal by Subject|0|||
44286407|NCT01582308|79250292|FG006|Period 1|Withdrawal by Subject|1|||
44154362|NCT01959880|78945484|FG003|Overall Study|Lost to Follow-up|8|||
44286408|NCT01582308|79250293|FG007|Period 1|Withdrawal by Subject|0|||
44286409|NCT01582308|79250294|FG008|Period 1|Withdrawal by Subject|0|||
44286410|NCT01582308|79250295|FG009|Period 1|Withdrawal by Subject|0|||
44286411|NCT01582308|79250286|FG000|10-day Washout Following Period 1|Physician Decision|0|||
44286412|NCT01582308|79250287|FG001|10-day Washout Following Period 1|Physician Decision|0|||
44286413|NCT01582308|79250288|FG002|10-day Washout Following Period 1|Physician Decision|0|||
44286414|NCT01582308|79250289|FG003|10-day Washout Following Period 1|Physician Decision|0|||
44286415|NCT01582308|79250290|FG004|10-day Washout Following Period 1|Physician Decision|1|||
44286416|NCT01582308|79250291|FG005|10-day Washout Following Period 1|Physician Decision|0|||
44286417|NCT01582308|79250292|FG006|10-day Washout Following Period 1|Physician Decision|0|||
44286418|NCT01582308|79250293|FG007|10-day Washout Following Period 1|Physician Decision|0|||
44286419|NCT01582308|79250294|FG008|10-day Washout Following Period 1|Physician Decision|0|||
44286420|NCT01582308|79250295|FG009|10-day Washout Following Period 1|Physician Decision|0|||
44286421|NCT01582308|79250286|FG000|Period 4|Physician Decision|1|||
44286422|NCT01582308|79250287|FG001|Period 4|Physician Decision|0|||
44286423|NCT01582308|79250288|FG002|Period 4|Physician Decision|0|||
44286424|NCT01582308|79250289|FG003|Period 4|Physician Decision|0|||
44286425|NCT01582308|79250290|FG004|Period 4|Physician Decision|0|||
44286426|NCT01582308|79250291|FG005|Period 4|Physician Decision|1|||
44286427|NCT01582308|79250292|FG006|Period 4|Physician Decision|0|||
44286428|NCT01582308|79250293|FG007|Period 4|Physician Decision|0|||
44286429|NCT01582308|79250294|FG008|Period 4|Physician Decision|0|||
44286430|NCT01582308|79250295|FG009|Period 4|Physician Decision|1|||
44286431|NCT01558674|79250310|FG000|Part 1|Study Terminated by Sponsor|10|||
44286432|NCT01558674|79250311|FG001|Part 1|Study Terminated by Sponsor|0|||
44286433|NCT01558674|79250310|FG000|Part 1|Withdrawal by Subject|1|||
44286434|NCT01558674|79250311|FG001|Part 1|Withdrawal by Subject|0|||
44286435|NCT01558596|79250332|FG000|Overall Study|Withdrawal by Subject|1|||
44286436|NCT01558596|79250333|FG001|Overall Study|Withdrawal by Subject|0|||
44286437|NCT01558596|79250332|FG000|Overall Study|surgery elsewhere or cancelled|1|||
44286438|NCT01558596|79250333|FG001|Overall Study|surgery elsewhere or cancelled|1|||
44286439|NCT01558596|79250332|FG000|Overall Study|Protocol Violation|1|||
44286440|NCT01558596|79250333|FG001|Overall Study|Protocol Violation|0|||
44286441|NCT01535040|79250341|FG000|Overall Study|Physician Decision|0|||
44286442|NCT01535040|79250342|FG001|Overall Study|Physician Decision|1|||
44286443|NCT01535040|79250341|FG000|Overall Study|Withdrawal by Subject|13|||
44286444|NCT01535040|79250342|FG001|Overall Study|Withdrawal by Subject|10|||
44286445|NCT01535040|79250341|FG000|Overall Study|Never Started|9|||
44286446|NCT01535040|79250342|FG001|Overall Study|Never Started|4|||
44286447|NCT01535040|79250341|FG000|Overall Study|Toxicity|7|||
44286448|NCT01535040|79250342|FG001|Overall Study|Toxicity|5|||
44286449|NCT01535040|79250341|FG000|Overall Study|Multiple Reasons|1|||
44286450|NCT01535040|79250342|FG001|Overall Study|Multiple Reasons|1|||
44286451|NCT01534962|79250352|FG000|Overall Study|Randomized but did not start treatment|2|||
44286452|NCT01534962|79250353|FG001|Overall Study|Randomized but did not start treatment|0|||
44286453|NCT01534962|79250354|FG002|Overall Study|Randomized but did not start treatment|0|||
44286454|NCT01534962|79250355|FG003|Overall Study|Randomized but did not start treatment|1|||
44286455|NCT01534962|79250352|FG000|Overall Study|Discontinued at AF recurrence|35|||
44286456|NCT01534962|79250353|FG001|Overall Study|Discontinued at AF recurrence|26|||
44286457|NCT01534962|79250354|FG002|Overall Study|Discontinued at AF recurrence|24|||
44286458|NCT01534962|79250355|FG003|Overall Study|Discontinued at AF recurrence|31|||
44286459|NCT01582152|79250367|FG000|Overall Study|Disease Progression|4|||
44286460|NCT01582152|79250368|FG001|Overall Study|Disease Progression|5|||
44286461|NCT01582152|79250367|FG000|Overall Study|Adverse Event|2|||
44286462|NCT01582152|79250368|FG001|Overall Study|Adverse Event|1|||
44286463|NCT01581684|79250384|FG000|Overall Study|Other reason not defined|0|||
44286464|NCT01581684|79250385|FG001|Overall Study|Other reason not defined|0|||
44286465|NCT01581684|79250386|FG002|Overall Study|Other reason not defined|0|||
44286466|NCT01581684|79250387|FG003|Overall Study|Other reason not defined|0|||
44286467|NCT01581684|79250388|FG004|Overall Study|Other reason not defined|0|||
44286468|NCT01581684|79250389|FG005|Overall Study|Other reason not defined|0|||
44286469|NCT01581684|79250390|FG006|Overall Study|Other reason not defined|0|||
44286470|NCT01581684|79250391|FG007|Overall Study|Other reason not defined|0|||
44286471|NCT01581684|79250392|FG008|Overall Study|Other reason not defined|1|||
44286472|NCT01581684|79250393|FG009|Overall Study|Other reason not defined|0|||
44286473|NCT01557582|79250426|FG000|Overall Study|Protocol Violation|4|||
44286474|NCT01557582|79250426|FG000|Overall Study|Operator error|2|||
44286475|NCT01557504|79250432|FG000|Overall Study|Physician Decision|1|||
44286476|NCT01557504|79250433|FG001|Overall Study|Physician Decision|0|||
44286477|NCT01557348|79250447|FG000|Overall Study|Adverse Event|6|||
44286478|NCT01557348|79250448|FG001|Overall Study|Adverse Event|16|||
44286479|NCT01557348|79250447|FG000|Overall Study|Infusion reaction event|5|||
44286480|NCT01557348|79250448|FG001|Overall Study|Infusion reaction event|5|||
44286481|NCT01557348|79250447|FG000|Overall Study|Death|7|||
44286482|NCT01557348|79250448|FG001|Overall Study|Death|4|||
44286483|NCT01557348|79250447|FG000|Overall Study|Insufficient Therapeutic Response|13|||
44286484|NCT01557348|79250448|FG001|Overall Study|Insufficient Therapeutic Response|28|||
44286485|NCT01557348|79250447|FG000|Overall Study|Withdrawal by Subject|5|||
44286486|NCT01557348|79250448|FG001|Overall Study|Withdrawal by Subject|4|||
44286487|NCT01557348|79250447|FG000|Overall Study|Lost to Follow-up|26|||
44286488|NCT01557348|79250448|FG001|Overall Study|Lost to Follow-up|22|||
44286489|NCT01557348|79250447|FG000|Overall Study|Administrative|18|||
44286490|NCT01557348|79250448|FG001|Overall Study|Administrative|11|||
44286491|NCT01580670|79250455|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
44286492|NCT01580670|79250455|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
44286493|NCT01534260|79250461|FG000|Overall Study|Adverse Event|1|||
44286494|NCT01534260|79250462|FG001|Overall Study|Adverse Event|8|||
44286495|NCT01534260|79250461|FG000|Overall Study|Death|2|||
44286496|NCT01534260|79250462|FG001|Overall Study|Death|0|||
44286497|NCT01534260|79250461|FG000|Overall Study|Lack of Efficacy|1|||
44286498|NCT01534260|79250462|FG001|Overall Study|Lack of Efficacy|1|||
44286499|NCT01534260|79250461|FG000|Overall Study|Withdrawal by Subject|1|||
44286500|NCT01534260|79250462|FG001|Overall Study|Withdrawal by Subject|3|||
44286501|NCT01534260|79250461|FG000|Overall Study|Disease Progression|8|||
44286502|NCT01534260|79250462|FG001|Overall Study|Disease Progression|6|||
44286503|NCT01534260|79250461|FG000|Overall Study|Physician Decision|3|||
44286504|NCT01534260|79250462|FG001|Overall Study|Physician Decision|1|||
44286505|NCT01534260|79250461|FG000|Overall Study|No treatment, per protocol|0|||
44286506|NCT01534260|79250462|FG001|Overall Study|No treatment, per protocol|1|||
44286507|NCT01534182|79250470|FG000|Overall Study|Administrative problems|1|||
44286508|NCT01534182|79250471|FG001|Overall Study|Administrative problems|0|||
44286509|NCT01534182|79250470|FG000|Overall Study|Withdrawal by Subject|4|||
44286510|NCT01534182|79250471|FG001|Overall Study|Withdrawal by Subject|7|||
44286511|NCT01534182|79250470|FG000|Overall Study|Adverse Event|7|||
44286512|NCT01534182|79250471|FG001|Overall Study|Adverse Event|3|||
44286513|NCT01579812|79250478|FG000|Overall Study|Ineligible after treatment start|40|||
44286514|NCT01579812|79250478|FG000|Overall Study|Patient choice|3|||
44286515|NCT01579812|79250478|FG000|Overall Study|Noncompliance|3|||
44286516|NCT01579812|79250478|FG000|Overall Study|Withdrawal by Subject|6|||
44286517|NCT01533714|79250491|FG000|Overall Study|Adverse Event|0|||
44286518|NCT01533714|79250492|FG001|Overall Study|Adverse Event|1|||
44286519|NCT01533714|79250493|FG002|Overall Study|Adverse Event|2|||
44286520|NCT01533714|79250494|FG003|Overall Study|Adverse Event|2|||
44286521|NCT01533714|79250495|FG004|Overall Study|Adverse Event|2|||
44286522|NCT01533714|79250496|FG005|Overall Study|Adverse Event|1|||
44286523|NCT01533714|79250491|FG000|Overall Study|Lack of Efficacy|0|||
44286524|NCT01533714|79250492|FG001|Overall Study|Lack of Efficacy|0|||
44286525|NCT01533714|79250493|FG002|Overall Study|Lack of Efficacy|0|||
44286526|NCT01533714|79250494|FG003|Overall Study|Lack of Efficacy|0|||
44286527|NCT01533714|79250495|FG004|Overall Study|Lack of Efficacy|0|||
44286528|NCT01533714|79250496|FG005|Overall Study|Lack of Efficacy|1|||
44286529|NCT01533714|79250491|FG000|Overall Study|Withdrawal by Subject|0|||
44286530|NCT01533714|79250492|FG001|Overall Study|Withdrawal by Subject|1|||
44415613|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|Death|1|||
44415614|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|Death|0|||
44415615|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
44415616|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
44415617|NCT00789828|79423331|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
44415618|NCT00789828|79423332|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
44415619|NCT00790296|79423343|FG000|Overall Study|Did not meet study eligibility criteria|1|||
44415620|NCT00790296|79423344|FG001|Overall Study|Did not meet study eligibility criteria|1|||
44415621|NCT00790296|79423343|FG000|Overall Study|Adverse Event|0|||
44415622|NCT00790296|79423344|FG001|Overall Study|Adverse Event|1|||
44415623|NCT00623194|79423350|FG000|Overall Study|Lack of Efficacy|1|||
44415624|NCT00623194|79423350|FG000|Overall Study|Protocol Violation|3|||
44415625|NCT00623194|79423350|FG000|Overall Study|Unclassified|1|||
44415626|NCT00784368|79423357|FG000|Overall Study|Physician Decision|0|||
44415627|NCT00784368|79423358|FG001|Overall Study|Physician Decision|0|||
44415628|NCT00784368|79423359|FG002|Overall Study|Physician Decision|6|||
44415629|NCT00784368|79423357|FG000|Overall Study|Lack of Efficacy|2|||
44415630|NCT00784368|79423358|FG001|Overall Study|Lack of Efficacy|0|||
44415631|NCT00784368|79423359|FG002|Overall Study|Lack of Efficacy|1|||
44415632|NCT00784368|79423357|FG000|Overall Study|Adverse Event|6|||
44415633|NCT00784368|79423358|FG001|Overall Study|Adverse Event|9|||
44415634|NCT00784368|79423359|FG002|Overall Study|Adverse Event|2|||
44415635|NCT00784368|79423357|FG000|Overall Study|Diagnosis of fever|0|||
44415636|NCT00784368|79423358|FG001|Overall Study|Diagnosis of fever|0|||
44415637|NCT00784368|79423359|FG002|Overall Study|Diagnosis of fever|1|||
44154363|NCT01959880|78945481|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
44154364|NCT01959880|78945482|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
44415638|NCT00784368|79423357|FG000|Overall Study|Worsening of complications|0|||
44286531|NCT01533714|79250493|FG002|Overall Study|Withdrawal by Subject|0|||
44286532|NCT01533714|79250494|FG003|Overall Study|Withdrawal by Subject|1|||
44286533|NCT01533714|79250495|FG004|Overall Study|Withdrawal by Subject|1|||
44286534|NCT01533714|79250496|FG005|Overall Study|Withdrawal by Subject|0|||
44415639|NCT00784368|79423358|FG001|Overall Study|Worsening of complications|0|||
44415640|NCT00784368|79423359|FG002|Overall Study|Worsening of complications|1|||
44154365|NCT01959880|78945483|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
44286535|NCT01533714|79250491|FG000|Overall Study|Exclusion criteria|0|||
44286536|NCT01533714|79250492|FG001|Overall Study|Exclusion criteria|1|||
44286537|NCT01533714|79250493|FG002|Overall Study|Exclusion criteria|0|||
44286538|NCT01533714|79250494|FG003|Overall Study|Exclusion criteria|0|||
44286539|NCT01533714|79250495|FG004|Overall Study|Exclusion criteria|0|||
44286540|NCT01533714|79250496|FG005|Overall Study|Exclusion criteria|0|||
44286541|NCT01533714|79250491|FG000|Overall Study|Positive for purified protein derivative|0|||
44286542|NCT01533714|79250492|FG001|Overall Study|Positive for purified protein derivative|0|||
44286543|NCT01533714|79250493|FG002|Overall Study|Positive for purified protein derivative|1|||
44286544|NCT01533714|79250494|FG003|Overall Study|Positive for purified protein derivative|0|||
44286545|NCT01533714|79250495|FG004|Overall Study|Positive for purified protein derivative|1|||
44286546|NCT01533714|79250496|FG005|Overall Study|Positive for purified protein derivative|0|||
44286547|NCT01533714|79250491|FG000|Overall Study|Withdrawal criteria|0|||
44286548|NCT01533714|79250492|FG001|Overall Study|Withdrawal criteria|0|||
44286549|NCT01533714|79250493|FG002|Overall Study|Withdrawal criteria|1|||
44286550|NCT01533714|79250494|FG003|Overall Study|Withdrawal criteria|0|||
44286551|NCT01533714|79250495|FG004|Overall Study|Withdrawal criteria|3|||
44286552|NCT01533714|79250496|FG005|Overall Study|Withdrawal criteria|1|||
44286553|NCT01533714|79250491|FG000|Overall Study|Ineligibility reason|0|||
44286554|NCT01533714|79250492|FG001|Overall Study|Ineligibility reason|0|||
44286555|NCT01533714|79250493|FG002|Overall Study|Ineligibility reason|0|||
44286556|NCT01533714|79250494|FG003|Overall Study|Ineligibility reason|1|||
44286557|NCT01533714|79250495|FG004|Overall Study|Ineligibility reason|0|||
44286558|NCT01533714|79250496|FG005|Overall Study|Ineligibility reason|0|||
44286559|NCT01533246|79250510|FG000|Overall Study|Adverse Event|1|||
44286560|NCT01533246|79250510|FG000|Overall Study|Withdrawal by Subject|1|||
44286561|NCT01579578|79250516|FG000|Overall Study|Death|4|||
44286562|NCT01579578|79250517|FG001|Overall Study|Death|1|||
44286563|NCT01579578|79250516|FG000|Overall Study|Lost to Follow-up|1|||
44286564|NCT01579578|79250517|FG001|Overall Study|Lost to Follow-up|1|||
44286565|NCT01579578|79250516|FG000|Overall Study|Withdrawal by Subject|2|||
44286566|NCT01579578|79250517|FG001|Overall Study|Withdrawal by Subject|1|||
44286567|NCT01579578|79250516|FG000|Overall Study|Eligibility criteria|3|||
44286568|NCT01579578|79250517|FG001|Overall Study|Eligibility criteria|9|||
44286569|NCT01579578|79250516|FG000|Overall Study|Ongoing|3|||
44286570|NCT01579578|79250517|FG001|Overall Study|Ongoing|0|||
44286571|NCT01578486|79250523|FG000|Overall Study|Physician Decision|3|||
44286572|NCT01578486|79250523|FG000|Overall Study|Withdrawal by Subject|2|||
44286573|NCT01532934|79250529|FG000|Overall Study|Lost to Follow-up|11|||
44286574|NCT01532934|79250530|FG001|Overall Study|Lost to Follow-up|11|||
44286575|NCT01532934|79250529|FG000|Overall Study|In controlled environment|3|||
44286576|NCT01532934|79250530|FG001|Overall Study|In controlled environment|2|||
44286577|NCT01555164|79250540|FG000|Overall Study|Adverse Event|5|||
44286578|NCT01555164|79250541|FG001|Overall Study|Adverse Event|7|||
44286579|NCT01555164|79250540|FG000|Overall Study|Hyperglycemia|0|||
44286580|NCT01555164|79250541|FG001|Overall Study|Hyperglycemia|1|||
44286581|NCT01555164|79250540|FG000|Overall Study|Investigator's Discretion|2|||
44286582|NCT01555164|79250541|FG001|Overall Study|Investigator's Discretion|2|||
44286583|NCT01555164|79250540|FG000|Overall Study|Lost to Follow-up|4|||
44286584|NCT01555164|79250541|FG001|Overall Study|Lost to Follow-up|3|||
44286585|NCT01555164|79250540|FG000|Overall Study|Protocol Violation|9|||
44286586|NCT01555164|79250541|FG001|Overall Study|Protocol Violation|5|||
44286587|NCT01555164|79250540|FG000|Overall Study|Subject Non-compliance|14|||
44286588|NCT01555164|79250541|FG001|Overall Study|Subject Non-compliance|6|||
44286589|NCT01555164|79250540|FG000|Overall Study|Subject Withdrew Consent|6|||
44286590|NCT01555164|79250541|FG001|Overall Study|Subject Withdrew Consent|11|||
44286591|NCT01578330|79250547|FG000|Overall Study|Adverse Event|2|||
44286592|NCT01578330|79250547|FG000|Overall Study|Protocol Violation|5|||
44286593|NCT01577160|79250551|FG000|Overall Study|Adverse Event|9|||
44286594|NCT01577160|79250551|FG000|Overall Study|Lack of Efficacy|15|||
44286595|NCT01577160|79250551|FG000|Overall Study|Lost to Follow-up|40|||
44286596|NCT01577160|79250551|FG000|Overall Study|Withdrawal by Subject|18|||
44286597|NCT01577160|79250551|FG000|Overall Study|Subject Uncooperative|7|||
44286598|NCT01577160|79250551|FG000|Overall Study|Other|9|||
44415641|NCT00784368|79423357|FG000|Overall Study|Worsening of symptoms|0|||
44415642|NCT00784368|79423358|FG001|Overall Study|Worsening of symptoms|1|||
44286599|NCT01554618|79250557|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
44286600|NCT01554618|79250558|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
44286601|NCT01554618|79250557|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
44286602|NCT01554618|79250558|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
44286603|NCT01554618|79250557|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
44286604|NCT01554618|79250558|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
44415643|NCT00784368|79423359|FG002|Overall Study|Worsening of symptoms|0|||
44415644|NCT00784368|79423357|FG000|Overall Study|Withdrawal of informed consent|0|||
44286605|NCT01554618|79250557|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
44286606|NCT01554618|79250558|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
44286607|NCT01554618|79250557|FG000|Open-Label Extension Period|Physician Decision|0|||
44286608|NCT01554618|79250558|FG001|Open-Label Extension Period|Physician Decision|1|||
44286609|NCT01554618|79250557|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
44286610|NCT01554618|79250558|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
44286611|NCT01531998|79250568|FG000|Overall Study|Withdrawal by Subject|3|||
44286612|NCT01576146|79250572|FG000|Extension Period 1|Adverse Event|2|||
44286613|NCT01576146|79250572|FG000|Extension Period 1|Death|2|||
44286614|NCT01576146|79250572|FG000|Extension Period 1|Physician Decision|2|||
44286615|NCT01576146|79250572|FG000|Extension Period 1|Withdrawal by Subject|1|||
44286616|NCT01576146|79250572|FG000|Extension Period 1|Lost to Follow-up|1|||
44286617|NCT01576146|79250572|FG000|Extension Period 1|Parathyroidectomy|1|||
44286618|NCT01576146|79250572|FG000|Extension Period 1|Renal Transplant|1|||
44286619|NCT01576146|79250572|FG000|Extension Period 2|Sponsor Decision|13|||
44286620|NCT01576146|79250572|FG000|Extension Period 2|Death|1|||
44286621|NCT01576146|79250572|FG000|Extension Period 2|Adverse Event|1|||
44286622|NCT01576146|79250572|FG000|Extension Period 2|Renal Transplant|1|||
44286623|NCT01576146|79250572|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
44415645|NCT00784368|79423358|FG001|Overall Study|Withdrawal of informed consent|1|||
44415646|NCT00784368|79423359|FG002|Overall Study|Withdrawal of informed consent|0|||
44415647|NCT00622726|79423372|FG000|March, 2008 to August, 2010|Death|5|||
44415648|NCT00622726|79423373|FG001|March, 2008 to August, 2010|Death|2|||
44415649|NCT00622726|79423372|FG000|August, 2010 to April, 2013|Death|1|||
44415650|NCT00622726|79423373|FG001|August, 2010 to April, 2013|Death|5|||
44415651|NCT00623428|79423385|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
44415652|NCT00623428|79423386|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
44415653|NCT00623428|79423385|FG000|Treatment Period|Death|0|||
44415654|NCT00623428|79423386|FG001|Treatment Period|Death|1|||
44415655|NCT00623428|79423385|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
44415656|NCT00623428|79423386|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
44415657|NCT00623428|79423385|FG000|Treatment Period|Insufficient therapeutic response|0|||
44415658|NCT00623428|79423386|FG001|Treatment Period|Insufficient therapeutic response|2|||
44415659|NCT00623428|79423385|FG000|Treatment Period|Other|0|||
44415660|NCT00623428|79423386|FG001|Treatment Period|Other|1|||
44415661|NCT00623428|79423385|FG000|Treatment Period|Withdrawal by Subject|0|||
44415662|NCT00623428|79423386|FG001|Treatment Period|Withdrawal by Subject|1|||
44415663|NCT00623428|79423385|FG000|Follow-up Period|Relapse post-treatment|11|||
44415664|NCT00623428|79423386|FG001|Follow-up Period|Relapse post-treatment|3|||
44415665|NCT00623428|79423385|FG000|Follow-up Period|Failure to return|10|||
44415666|NCT00623428|79423386|FG001|Follow-up Period|Failure to return|2|||
44415667|NCT00623428|79423385|FG000|Follow-up Period|Patient withdrew consent|5|||
44415668|NCT00623428|79423386|FG001|Follow-up Period|Patient withdrew consent|4|||
44415669|NCT00623428|79423385|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
44415670|NCT00623428|79423386|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
44415671|NCT00623428|79423385|FG000|Follow-up Period|Did not cooperate|0|||
44415672|NCT00623428|79423386|FG001|Follow-up Period|Did not cooperate|3|||
44415673|NCT00623428|79423385|FG000|Follow-up Period|Reason not specified|1|||
44154366|NCT01959880|78945484|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
44154367|NCT01959880|78945481|FG000|Overall Study|Study completed early-FDA approved|1003|||
44154368|NCT01959880|78945482|FG001|Overall Study|Study completed early-FDA approved|311|||
44154369|NCT01959880|78945483|FG002|Overall Study|Study completed early-FDA approved|179|||
44154370|NCT01959880|78945484|FG003|Overall Study|Study completed early-FDA approved|152|||
44154371|NCT01980628|78945494|FG000|Overall Study|Adverse Event|12|||
44154372|NCT01980628|78945494|FG000|Overall Study|Physician Decision|5|||
44154373|NCT01980628|78945494|FG000|Overall Study|Withdrawal by Subject|4|||
44154374|NCT01980628|78945494|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
44154375|NCT01979614|78945501|FG000|Overall Study|Adverse Event|1|||
44154376|NCT01979614|78945502|FG001|Overall Study|Adverse Event|1|||
44154377|NCT02654717|78945510|FG000|Overall Study|Adverse Event|2|||
44154378|NCT02654717|78945511|FG001|Overall Study|Adverse Event|2|||
44154379|NCT02654717|78945510|FG000|Overall Study|Protocol Violation|1|||
44154380|NCT02654717|78945511|FG001|Overall Study|Protocol Violation|2|||
44154381|NCT02654717|78945510|FG000|Overall Study|Withdrawal by Subject|0|||
44154382|NCT02654717|78945511|FG001|Overall Study|Withdrawal by Subject|1|||
44154383|NCT02654717|78945510|FG000|Overall Study|Non-permitted medication|3|||
44154384|NCT02654717|78945511|FG001|Overall Study|Non-permitted medication|0|||
44286624|NCT01553916|79250576|FG000|Overall Study|Withdrawal by Subject|2|||
44286625|NCT01553916|79250576|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
44415674|NCT00623428|79423386|FG001|Follow-up Period|Reason not specified|1|||
44415675|NCT00623428|79423385|FG000|Follow-up Period|Death|0|||
44415676|NCT00623428|79423386|FG001|Follow-up Period|Death|1|||
44415677|NCT00784134|79423394|FG000|Overall Study|Lost to Follow-up|3|||
44286626|NCT01553136|79250582|FG000|Overall Study|Adverse Event|3|||
44286627|NCT01553136|79250583|FG001|Overall Study|Adverse Event|2|||
44286628|NCT01553136|79250582|FG000|Overall Study|Withdrawal by Subject|2|||
44286629|NCT01553136|79250583|FG001|Overall Study|Withdrawal by Subject|3|||
44286630|NCT01553136|79250582|FG000|Overall Study|Lost to Follow-up|4|||
44286631|NCT01553136|79250583|FG001|Overall Study|Lost to Follow-up|10|||
44286632|NCT01553136|79250582|FG000|Overall Study|Physician Decision|2|||
44286633|NCT01553136|79250583|FG001|Overall Study|Physician Decision|3|||
44286634|NCT01553136|79250582|FG000|Overall Study|Scheduling Difficulties|5|||
44286635|NCT01553136|79250583|FG001|Overall Study|Scheduling Difficulties|4|||
44286636|NCT01552902|79250592|FG000|Overall Study|Adverse Event|1|||
44286637|NCT01552902|79250593|FG001|Overall Study|Adverse Event|15|||
44286638|NCT01552902|79250594|FG002|Overall Study|Adverse Event|14|||
44286639|NCT01552902|79250592|FG000|Overall Study|Protocol Violation|3|||
44286640|NCT01552902|79250593|FG001|Overall Study|Protocol Violation|3|||
44286641|NCT01552902|79250594|FG002|Overall Study|Protocol Violation|3|||
44286642|NCT01552902|79250592|FG000|Overall Study|Lack of Efficacy|4|||
44286643|NCT01552902|79250593|FG001|Overall Study|Lack of Efficacy|3|||
44286644|NCT01552902|79250594|FG002|Overall Study|Lack of Efficacy|1|||
44286645|NCT01552902|79250592|FG000|Overall Study|Withdrawal by Subject|1|||
44286646|NCT01552902|79250593|FG001|Overall Study|Withdrawal by Subject|9|||
44286647|NCT01552902|79250594|FG002|Overall Study|Withdrawal by Subject|6|||
44286648|NCT01552902|79250592|FG000|Overall Study|Lost to Follow-up|1|||
44286649|NCT01552902|79250593|FG001|Overall Study|Lost to Follow-up|3|||
44286650|NCT01552902|79250594|FG002|Overall Study|Lost to Follow-up|6|||
44286651|NCT01552902|79250592|FG000|Overall Study|Other|3|||
44286652|NCT01552902|79250593|FG001|Overall Study|Other|4|||
44286653|NCT01552902|79250594|FG002|Overall Study|Other|3|||
44286654|NCT01529346|79250620|FG000|Overall Study|Lost to Follow-up|2|||
44286655|NCT01529346|79250621|FG001|Overall Study|Lost to Follow-up|0|||
44286656|NCT01529346|79250622|FG002|Overall Study|Lost to Follow-up|1|||
44286657|NCT01529346|79250623|FG003|Overall Study|Lost to Follow-up|0|||
44286658|NCT01529346|79250624|FG004|Overall Study|Lost to Follow-up|0|||
44286659|NCT01529346|79250620|FG000|Overall Study|Other|0|||
44286660|NCT01529346|79250621|FG001|Overall Study|Other|1|||
44286661|NCT01529346|79250622|FG002|Overall Study|Other|1|||
44286662|NCT01529346|79250623|FG003|Overall Study|Other|0|||
44286663|NCT01529346|79250624|FG004|Overall Study|Other|0|||
44286664|NCT01529268|79250648|FG000|Overall Study|Lost to Follow-up|9|||
44286665|NCT01529268|79250649|FG001|Overall Study|Lost to Follow-up|3|||
44286666|NCT01529268|79250648|FG000|Overall Study|Moved|3|||
44286667|NCT01529268|79250649|FG001|Overall Study|Moved|0|||
44286668|NCT01529112|79250657|FG000|Overall Study|Adverse Event|2|||
44286669|NCT01529112|79250658|FG001|Overall Study|Adverse Event|0|||
44286670|NCT01529112|79250657|FG000|Overall Study|Death|59|||
44286671|NCT01529112|79250658|FG001|Overall Study|Death|38|||
44286672|NCT01529112|79250657|FG000|Overall Study|Protocol Violation|1|||
44286673|NCT01529112|79250658|FG001|Overall Study|Protocol Violation|0|||
44286674|NCT01529112|79250657|FG000|Overall Study|Withdrawal by Subject|7|||
44286675|NCT01529112|79250658|FG001|Overall Study|Withdrawal by Subject|3|||
44286676|NCT01551420|79250666|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
44286677|NCT01551420|79250667|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
44286678|NCT01551420|79250666|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
44286679|NCT01551420|79250667|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
44286680|NCT01551420|79250666|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
44286681|NCT01551420|79250667|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
44286682|NCT01551420|79250666|FG000|Screened for Part B Eligibility|Declined participation|8|||
44286683|NCT01551420|79250667|FG001|Screened for Part B Eligibility|Declined participation|1|||
44286684|NCT01551420|79250666|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
44286685|NCT01551420|79250667|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
44286686|NCT01551420|79250666|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
44286687|NCT01551420|79250667|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
44286688|NCT01551420|79250666|FG000|Home Use (Part B)|Withdrawal by staff|0|||
44286689|NCT01551420|79250667|FG001|Home Use (Part B)|Withdrawal by staff|1|||
44286690|NCT01575054|79250675|FG000|Overall Study|Other Reasons|5|||
44286691|NCT01575054|79250676|FG001|Overall Study|Other Reasons|3|||
44286692|NCT01575054|79250675|FG000|Overall Study|Protocol Violation|2|||
44286693|NCT01575054|79250676|FG001|Overall Study|Protocol Violation|1|||
44286694|NCT01575054|79250675|FG000|Overall Study|Personal Reasons|10|||
44286695|NCT01575054|79250676|FG001|Overall Study|Personal Reasons|11|||
44286696|NCT01575054|79250675|FG000|Overall Study|Lost to Follow-up|3|||
44286697|NCT01575054|79250676|FG001|Overall Study|Lost to Follow-up|3|||
44286698|NCT01575054|79250675|FG000|Overall Study|Adverse Event|9|||
44286699|NCT01575054|79250676|FG001|Overall Study|Adverse Event|8|||
44286700|NCT01528254|79250684|FG000|Overall Study|Administrative problems|96|||
44286701|NCT01528254|79250685|FG001|Overall Study|Administrative problems|94|||
44286702|NCT01528254|79250684|FG000|Overall Study|Adverse Event|28|||
44286703|NCT01528254|79250685|FG001|Overall Study|Adverse Event|44|||
44286704|NCT01528254|79250684|FG000|Overall Study|Lost to Follow-up|17|||
44286705|NCT01528254|79250685|FG001|Overall Study|Lost to Follow-up|24|||
44286706|NCT01528254|79250684|FG000|Overall Study|Death|13|||
44286707|NCT01528254|79250685|FG001|Overall Study|Death|9|||
44286708|NCT01528254|79250684|FG000|Overall Study|Protocol deviation|9|||
44286709|NCT01528254|79250685|FG001|Overall Study|Protocol deviation|19|||
44286710|NCT01528254|79250684|FG000|Overall Study|New therapy for study indication|8|||
44286711|NCT01528254|79250685|FG001|Overall Study|New therapy for study indication|6|||
44286712|NCT01528254|79250684|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
44286713|NCT01528254|79250685|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
44286714|NCT01528254|79250684|FG000|Overall Study|Withdrawal by Subject|5|||
44286715|NCT01528254|79250685|FG001|Overall Study|Withdrawal by Subject|4|||
44286716|NCT01528254|79250684|FG000|Overall Study|Abnormal laboratory value(s)|3|||
44286717|NCT01528254|79250685|FG001|Overall Study|Abnormal laboratory value(s)|7|||
44286718|NCT01528254|79250684|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44286719|NCT01528254|79250685|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44286720|NCT01528254|79250684|FG000|Overall Study|No longer requires study drug|1|||
44286721|NCT01528254|79250685|FG001|Overall Study|No longer requires study drug|1|||
44286722|NCT01574352|79250694|FG000|Overall Study|Withdrawal by Subject|6|||
44286723|NCT01574352|79250695|FG001|Overall Study|Withdrawal by Subject|13|||
44286724|NCT01574352|79250694|FG000|Overall Study|Injury in non-camp related sport|1|||
44286725|NCT01574352|79250695|FG001|Overall Study|Injury in non-camp related sport|0|||
44286726|NCT01527006|79250703|FG000|Core Study|Adverse Event|0|||
44286727|NCT01527006|79250704|FG001|Core Study|Adverse Event|2|||
44286728|NCT01527006|79250703|FG000|Core Study|Lost to Follow-up|0|||
44286729|NCT01527006|79250704|FG001|Core Study|Lost to Follow-up|1|||
44286730|NCT01527006|79250703|FG000|Core Study|Subject Choice|1|||
44286731|NCT01527006|79250704|FG001|Core Study|Subject Choice|0|||
44286732|NCT01527006|79250703|FG000|Core Study|Inadequate Therapeutic Effect|1|||
44286733|NCT01527006|79250704|FG001|Core Study|Inadequate Therapeutic Effect|0|||
44286734|NCT01527006|79250703|FG000|Core Study|Withdrawal by Subject|0|||
44286735|NCT01527006|79250704|FG001|Core Study|Withdrawal by Subject|1|||
44286736|NCT01527006|79250703|FG000|Core Study|Other|0|||
44286737|NCT01527006|79250704|FG001|Core Study|Other|2|||
44286738|NCT01527006|79250703|FG000|Extension Phase|Adverse Event|4|||
44286739|NCT01527006|79250704|FG001|Extension Phase|Adverse Event|2|||
44286740|NCT01527006|79250703|FG000|Extension Phase|Lost to Follow-up|0|||
44286741|NCT01527006|79250704|FG001|Extension Phase|Lost to Follow-up|1|||
44286742|NCT01527006|79250703|FG000|Extension Phase|Subject Choice|1|||
44286743|NCT01527006|79250704|FG001|Extension Phase|Subject Choice|1|||
44286744|NCT01527006|79250703|FG000|Extension Phase|Inadequate therapeutic effect|1|||
44286745|NCT01527006|79250704|FG001|Extension Phase|Inadequate therapeutic effect|1|||
44286746|NCT01527006|79250703|FG000|Extension Phase|Other|0|||
44286747|NCT01527006|79250704|FG001|Extension Phase|Other|3|||
44286748|NCT01526928|79250722|FG000|Overall Study|Progressive Disease|35|||
44286749|NCT01526928|79250723|FG001|Overall Study|Progressive Disease|17|||
44286750|NCT01526928|79250724|FG002|Overall Study|Progressive Disease|150|||
44286751|NCT01526928|79250725|FG003|Overall Study|Progressive Disease|182|||
44286752|NCT01526928|79250726|FG004|Overall Study|Progressive Disease|76|||
44286753|NCT01526928|79250727|FG005|Overall Study|Progressive Disease|4|||
44286754|NCT01526928|79250722|FG000|Overall Study|Adverse Event|2|||
44286755|NCT01526928|79250723|FG001|Overall Study|Adverse Event|1|||
44286756|NCT01526928|79250724|FG002|Overall Study|Adverse Event|29|||
44286757|NCT01526928|79250725|FG003|Overall Study|Adverse Event|40|||
44286758|NCT01526928|79250726|FG004|Overall Study|Adverse Event|13|||
44286759|NCT01526928|79250727|FG005|Overall Study|Adverse Event|2|||
44286760|NCT01526928|79250722|FG000|Overall Study|Death|0|||
44286761|NCT01526928|79250723|FG001|Overall Study|Death|0|||
44286762|NCT01526928|79250724|FG002|Overall Study|Death|3|||
44286763|NCT01526928|79250725|FG003|Overall Study|Death|0|||
44286764|NCT01526928|79250726|FG004|Overall Study|Death|0|||
44286765|NCT01526928|79250727|FG005|Overall Study|Death|0|||
44286766|NCT01526928|79250722|FG000|Overall Study|Withdrawal by Subject|1|||
44286767|NCT01526928|79250723|FG001|Overall Study|Withdrawal by Subject|0|||
44286768|NCT01526928|79250724|FG002|Overall Study|Withdrawal by Subject|13|||
44286769|NCT01526928|79250725|FG003|Overall Study|Withdrawal by Subject|11|||
44533468|NCT03781375|79543692|FG000|Double-blind Phase|Lack of Response|6|||
44286770|NCT01526928|79250726|FG004|Overall Study|Withdrawal by Subject|3|||
44286771|NCT01526928|79250727|FG005|Overall Study|Withdrawal by Subject|0|||
44286772|NCT01526928|79250722|FG000|Overall Study|Physician Decision|0|||
44286773|NCT01526928|79250723|FG001|Overall Study|Physician Decision|0|||
44286774|NCT01526928|79250724|FG002|Overall Study|Physician Decision|2|||
44286775|NCT01526928|79250725|FG003|Overall Study|Physician Decision|5|||
44286776|NCT01526928|79250726|FG004|Overall Study|Physician Decision|0|||
44286777|NCT01526928|79250727|FG005|Overall Study|Physician Decision|0|||
44286778|NCT01526928|79250722|FG000|Overall Study|Other Reason|0|||
44286779|NCT01526928|79250723|FG001|Overall Study|Other Reason|1|||
44286780|NCT01526928|79250724|FG002|Overall Study|Other Reason|11|||
44286781|NCT01526928|79250725|FG003|Overall Study|Other Reason|4|||
44286782|NCT01526928|79250726|FG004|Overall Study|Other Reason|1|||
44286783|NCT01526928|79250727|FG005|Overall Study|Other Reason|0|||
44286784|NCT01526928|79250722|FG000|Overall Study|Lost to Follow-up|0|||
44286785|NCT01526928|79250723|FG001|Overall Study|Lost to Follow-up|0|||
44286786|NCT01526928|79250724|FG002|Overall Study|Lost to Follow-up|0|||
44286787|NCT01526928|79250725|FG003|Overall Study|Lost to Follow-up|1|||
44286788|NCT01526928|79250726|FG004|Overall Study|Lost to Follow-up|0|||
44286789|NCT01526928|79250727|FG005|Overall Study|Lost to Follow-up|0|||
44286790|NCT01526928|79250722|FG000|Overall Study|Protocol Deviation|0|||
44286791|NCT01526928|79250723|FG001|Overall Study|Protocol Deviation|0|||
44286792|NCT01526928|79250724|FG002|Overall Study|Protocol Deviation|0|||
44286793|NCT01526928|79250725|FG003|Overall Study|Protocol Deviation|2|||
44286794|NCT01526928|79250726|FG004|Overall Study|Protocol Deviation|0|||
44286795|NCT01526928|79250727|FG005|Overall Study|Protocol Deviation|0|||
44286796|NCT01526928|79250722|FG000|Overall Study|Missing|0|||
44286797|NCT01526928|79250723|FG001|Overall Study|Missing|0|||
44286798|NCT01526928|79250724|FG002|Overall Study|Missing|1|||
44286799|NCT01526928|79250725|FG003|Overall Study|Missing|0|||
44286800|NCT01526928|79250726|FG004|Overall Study|Missing|2|||
44286801|NCT01526928|79250727|FG005|Overall Study|Missing|0|||
44286802|NCT01549860|79250785|FG000|Overall Study|Withdrawal by Subject|1|||
44286803|NCT01549860|79250786|FG001|Overall Study|Withdrawal by Subject|0|||
44286804|NCT01549860|79250785|FG000|Overall Study|Physician Decision|1|||
44286805|NCT01549860|79250786|FG001|Overall Study|Physician Decision|1|||
44286806|NCT01549392|79250794|FG000|Overall Study|Withdrawal by Subject|1|||
44286807|NCT01549392|79250795|FG001|Overall Study|Withdrawal by Subject|0|||
44286808|NCT01526148|79250803|FG000|Overall Study|Adverse Event|6|||
44286809|NCT01526148|79250804|FG001|Overall Study|Adverse Event|5|||
44286810|NCT01526148|79250803|FG000|Overall Study|Lost to Follow-up|3|||
44286811|NCT01526148|79250804|FG001|Overall Study|Lost to Follow-up|6|||
44286812|NCT01526148|79250803|FG000|Overall Study|Withdrawal by Subject|2|||
44286813|NCT01526148|79250804|FG001|Overall Study|Withdrawal by Subject|0|||
44286814|NCT01526148|79250803|FG000|Overall Study|Unstable Medical Condition|1|||
44286815|NCT01526148|79250804|FG001|Overall Study|Unstable Medical Condition|0|||
44286816|NCT01526148|79250803|FG000|Overall Study|Unable to discontinue concomitant med|1|||
44286817|NCT01526148|79250804|FG001|Overall Study|Unable to discontinue concomitant med|0|||
44286818|NCT01526148|79250803|FG000|Overall Study|Moved out of state|1|||
44286819|NCT01526148|79250804|FG001|Overall Study|Moved out of state|0|||
44286820|NCT01526148|79250803|FG000|Overall Study|Incarcerated|0|||
44286821|NCT01526148|79250804|FG001|Overall Study|Incarcerated|2|||
44286822|NCT01572948|79250812|FG000|Overall Study|Lost to Follow-up|1|||
44286823|NCT01572948|79250813|FG001|Overall Study|Lost to Follow-up|0|||
44286824|NCT01572948|79250812|FG000|Overall Study|unable to contact|0|||
44286825|NCT01572948|79250813|FG001|Overall Study|unable to contact|1|||
44286826|NCT01525602|79250831|FG000|Overall Study|Adverse Event|1|||
44255913|NCT02597478|79101833|FG001|Overall Study|Insufficient exertional dyspnea|1|||
44255914|NCT01471028|79101928|FG000|VTI-208|Adverse Event|39|||
44255915|NCT01471028|79101929|FG001|VTI-208|Adverse Event|41|||
44255916|NCT01471028|79101928|FG000|VTI-208|Withdrawal by Subject|0|||
44255917|NCT01471028|79101929|FG001|VTI-208|Withdrawal by Subject|2|||
44255918|NCT01471028|79101928|FG000|VTI-208|Lost to Follow-up|1|||
44255919|NCT01471028|79101929|FG001|VTI-208|Lost to Follow-up|1|||
44255920|NCT01471028|79101928|FG000|VTI-208E|Death|7|||
44255921|NCT01471028|79101929|FG001|VTI-208E|Death|10|||
44255922|NCT01471028|79101928|FG000|VTI-208E|Withdrawal by Subject|1|||
44255923|NCT01471028|79101929|FG001|VTI-208E|Withdrawal by Subject|0|||
44255924|NCT01471028|79101928|FG000|VTI-208E|Lost to Follow-up|0|||
44255925|NCT01471028|79101929|FG001|VTI-208E|Lost to Follow-up|2|||
44255926|NCT01491854|79101943|FG000|Overall Study|mainly due to premature termination|93|||
44255927|NCT01491854|79101943|FG000|Overall Study|Death|1|||
44255928|NCT01491854|79101943|FG000|Overall Study|Withdrawal by Subject|3|||
44255929|NCT01491854|79101943|FG000|Overall Study|Lost to Follow-up|33|||
44255930|NCT01470248|79101951|FG000|Overall Study|Withdrawal by Subject|1|||
44255931|NCT01490918|79101971|FG000|Overall Study|Lost to Follow-up|2|||
44255932|NCT01490918|79101972|FG001|Overall Study|Lost to Follow-up|1|||
44255933|NCT01490918|79101973|FG002|Overall Study|Lost to Follow-up|0|||
44255934|NCT01490918|79101971|FG000|Overall Study|Withdrawal by Subject|7|||
44255935|NCT01490918|79101972|FG001|Overall Study|Withdrawal by Subject|8|||
44255936|NCT01490918|79101973|FG002|Overall Study|Withdrawal by Subject|3|||
44255937|NCT01490918|79101971|FG000|Overall Study|Adverse Event|0|||
44255938|NCT01490918|79101972|FG001|Overall Study|Adverse Event|0|||
44255939|NCT01490918|79101973|FG002|Overall Study|Adverse Event|1|||
44255940|NCT01490918|79101971|FG000|Overall Study|other cause|4|||
44255941|NCT01490918|79101972|FG001|Overall Study|other cause|5|||
44286827|NCT01525602|79250832|FG001|Overall Study|Adverse Event|0|||
44286828|NCT01525602|79250833|FG002|Overall Study|Adverse Event|1|||
44286829|NCT01525602|79250834|FG003|Overall Study|Adverse Event|1|||
44286830|NCT01525602|79250835|FG004|Overall Study|Adverse Event|3|||
44286831|NCT01525602|79250836|FG005|Overall Study|Adverse Event|3|||
44286832|NCT01525602|79250837|FG006|Overall Study|Adverse Event|0|||
44286833|NCT01525602|79250838|FG007|Overall Study|Adverse Event|1|||
44286834|NCT01525602|79250831|FG000|Overall Study|Disease progression|6|||
44286835|NCT01525602|79250832|FG001|Overall Study|Disease progression|3|||
44286836|NCT01525602|79250833|FG002|Overall Study|Disease progression|2|||
44286837|NCT01525602|79250834|FG003|Overall Study|Disease progression|5|||
44286838|NCT01525602|79250835|FG004|Overall Study|Disease progression|22|||
44286839|NCT01525602|79250836|FG005|Overall Study|Disease progression|2|||
44286840|NCT01525602|79250837|FG006|Overall Study|Disease progression|3|||
44286841|NCT01525602|79250838|FG007|Overall Study|Disease progression|3|||
44286842|NCT01525602|79250831|FG000|Overall Study|Clinical progression|2|||
44286843|NCT01525602|79250832|FG001|Overall Study|Clinical progression|0|||
44286844|NCT01525602|79250833|FG002|Overall Study|Clinical progression|0|||
44286845|NCT01525602|79250834|FG003|Overall Study|Clinical progression|0|||
44286846|NCT01525602|79250835|FG004|Overall Study|Clinical progression|0|||
44286847|NCT01525602|79250836|FG005|Overall Study|Clinical progression|0|||
44286848|NCT01525602|79250837|FG006|Overall Study|Clinical progression|1|||
44286849|NCT01525602|79250838|FG007|Overall Study|Clinical progression|1|||
44286850|NCT01525602|79250831|FG000|Overall Study|Non-compliance|0|||
44286851|NCT01525602|79250832|FG001|Overall Study|Non-compliance|0|||
44286852|NCT01525602|79250833|FG002|Overall Study|Non-compliance|0|||
44286853|NCT01525602|79250834|FG003|Overall Study|Non-compliance|0|||
44286854|NCT01525602|79250835|FG004|Overall Study|Non-compliance|1|||
44286855|NCT01525602|79250836|FG005|Overall Study|Non-compliance|0|||
44286856|NCT01525602|79250837|FG006|Overall Study|Non-compliance|0|||
44415678|NCT00784134|79423395|FG001|Overall Study|Lost to Follow-up|6|||
44286857|NCT01525602|79250838|FG007|Overall Study|Non-compliance|0|||
44286858|NCT01525602|79250831|FG000|Overall Study|Withdrawal by Subject|0|||
44286859|NCT01525602|79250832|FG001|Overall Study|Withdrawal by Subject|0|||
44286860|NCT01525602|79250833|FG002|Overall Study|Withdrawal by Subject|0|||
44286861|NCT01525602|79250834|FG003|Overall Study|Withdrawal by Subject|0|||
44286862|NCT01525602|79250835|FG004|Overall Study|Withdrawal by Subject|3|||
44286863|NCT01525602|79250836|FG005|Overall Study|Withdrawal by Subject|1|||
44286864|NCT01525602|79250837|FG006|Overall Study|Withdrawal by Subject|0|||
44286865|NCT01525602|79250838|FG007|Overall Study|Withdrawal by Subject|1|||
44286866|NCT01525602|79250831|FG000|Overall Study|Physician Decision|0|||
44286867|NCT01525602|79250832|FG001|Overall Study|Physician Decision|0|||
44286868|NCT01525602|79250833|FG002|Overall Study|Physician Decision|0|||
44286869|NCT01525602|79250834|FG003|Overall Study|Physician Decision|0|||
44286870|NCT01525602|79250835|FG004|Overall Study|Physician Decision|3|||
44286871|NCT01525602|79250836|FG005|Overall Study|Physician Decision|0|||
44286872|NCT01525602|79250837|FG006|Overall Study|Physician Decision|1|||
44286873|NCT01525602|79250838|FG007|Overall Study|Physician Decision|0|||
44286874|NCT01525602|79250831|FG000|Overall Study|Death|0|||
44286875|NCT01525602|79250832|FG001|Overall Study|Death|0|||
44286876|NCT01525602|79250833|FG002|Overall Study|Death|0|||
44286877|NCT01525602|79250834|FG003|Overall Study|Death|0|||
44286878|NCT01525602|79250835|FG004|Overall Study|Death|1|||
44286879|NCT01525602|79250836|FG005|Overall Study|Death|1|||
44286880|NCT01525602|79250837|FG006|Overall Study|Death|0|||
44286881|NCT01525602|79250838|FG007|Overall Study|Death|0|||
44286882|NCT01525602|79250831|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
44286883|NCT01525602|79250832|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
44286884|NCT01525602|79250833|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
44286885|NCT01525602|79250834|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
44255942|NCT01490918|79101973|FG002|Overall Study|other cause|8|||
44255943|NCT01490840|79102005|FG000|Phase 1|Lost to Follow-up|1|||
44255944|NCT01490840|79102006|FG001|Phase 1|Lost to Follow-up|0|||
44255945|NCT01490840|79102005|FG000|Phase 1|Adverse Event|2|||
44255946|NCT01490840|79102006|FG001|Phase 1|Adverse Event|1|||
44255947|NCT01490840|79102005|FG000|Phase 1|Withdrawal by Subject|6|||
44255948|NCT01490840|79102006|FG001|Phase 1|Withdrawal by Subject|5|||
44255949|NCT01490840|79102005|FG000|Phase 1|Visit 6a omitted|1|||
44255950|NCT01490840|79102006|FG001|Phase 1|Visit 6a omitted|0|||
44255951|NCT01490840|79102005|FG000|Phase 2|Withdrawal by Subject|4|||
44255952|NCT01490840|79102006|FG001|Phase 2|Withdrawal by Subject|3|||
44255953|NCT01490840|79102005|FG000|Phase 2|Permanent interruption of fingolimod|0|||
44255954|NCT01490840|79102006|FG001|Phase 2|Permanent interruption of fingolimod|1|||
44255955|NCT01490840|79102005|FG000|Phase 2|Lost to Follow-up|1|||
44255956|NCT01490840|79102006|FG001|Phase 2|Lost to Follow-up|1|||
44255957|NCT01490840|79102005|FG000|Phase 2|Adverse Event|1|||
44255958|NCT01490840|79102006|FG001|Phase 2|Adverse Event|1|||
44255959|NCT01490450|79102038|FG000|Period 1|Lack of Efficacy|2|||
44255960|NCT01490450|79102039|FG001|Period 1|Lack of Efficacy|0|||
44255961|NCT01490450|79102040|FG002|Period 1|Lack of Efficacy|3|||
44255962|NCT01490450|79102041|FG003|Period 1|Lack of Efficacy|0|||
44255963|NCT01490450|79102038|FG000|Period 1|Adverse Event|0|||
44286886|NCT01525602|79250835|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
44286887|NCT01525602|79250836|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
44286888|NCT01525602|79250837|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
44286889|NCT01525602|79250838|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
44286890|NCT01549002|79250865|FG000|Overall Study|Excessive pain|0|||
44286891|NCT01549002|79250866|FG001|Overall Study|Excessive pain|2|||
44286892|NCT01549002|79250865|FG000|Overall Study|Moderate sedation required|0|||
44286893|NCT01549002|79250866|FG001|Overall Study|Moderate sedation required|2|||
44286894|NCT01548768|79250876|FG000|Overall Study|Withdrawal by Subject|0|||
44286895|NCT01548768|79250877|FG001|Overall Study|Withdrawal by Subject|2|||
44286896|NCT01548768|79250878|FG002|Overall Study|Withdrawal by Subject|1|||
44286897|NCT01548768|79250879|FG003|Overall Study|Withdrawal by Subject|0|||
44286898|NCT01548768|79250876|FG000|Overall Study|Physician Decision|1|||
44286899|NCT01548768|79250877|FG001|Overall Study|Physician Decision|0|||
44286900|NCT01548768|79250878|FG002|Overall Study|Physician Decision|0|||
44286901|NCT01548768|79250879|FG003|Overall Study|Physician Decision|0|||
44286902|NCT01548768|79250876|FG000|Overall Study|Adverse Event|0|||
44286903|NCT01548768|79250877|FG001|Overall Study|Adverse Event|0|||
44286904|NCT01548768|79250878|FG002|Overall Study|Adverse Event|0|||
44286905|NCT01548768|79250879|FG003|Overall Study|Adverse Event|1|||
44286906|NCT01548768|79250876|FG000|Overall Study|Non-Compliance|0|||
44286907|NCT01548768|79250877|FG001|Overall Study|Non-Compliance|0|||
44286908|NCT01548768|79250878|FG002|Overall Study|Non-Compliance|0|||
44286909|NCT01548768|79250879|FG003|Overall Study|Non-Compliance|3|||
44286910|NCT01572792|79250896|FG000|Lead-in Study|Lost to Follow-up|5|||
44286911|NCT01572792|79250897|FG001|Lead-in Study|Lost to Follow-up|9|||
44286912|NCT01572792|79250898|FG002|Lead-in Study|Lost to Follow-up|4|||
44286913|NCT01572792|79250899|FG003|Lead-in Study|Lost to Follow-up|2|||
44286914|NCT01572792|79250900|FG004|Lead-in Study|Lost to Follow-up|4|||
44286915|NCT01572792|79250896|FG000|Lead-in Study|Withdrawal by Subject|22|||
44533469|NCT03781375|79543693|FG001|Double-blind Phase|Lack of Response|2|||
44533470|NCT03781375|79543692|FG000|Double-blind Phase|Other|1|||
44533471|NCT03781375|79543693|FG001|Double-blind Phase|Other|3|||
44286916|NCT01572792|79250897|FG001|Lead-in Study|Withdrawal by Subject|11|||
44286917|NCT01572792|79250898|FG002|Lead-in Study|Withdrawal by Subject|12|||
44286918|NCT01572792|79250899|FG003|Lead-in Study|Withdrawal by Subject|24|||
44286919|NCT01572792|79250900|FG004|Lead-in Study|Withdrawal by Subject|11|||
44286920|NCT01572792|79250896|FG000|Lead-in Study|Protocol Violation|19|||
44286921|NCT01572792|79250897|FG001|Lead-in Study|Protocol Violation|10|||
44286922|NCT01572792|79250898|FG002|Lead-in Study|Protocol Violation|12|||
44286923|NCT01572792|79250899|FG003|Lead-in Study|Protocol Violation|13|||
44286924|NCT01572792|79250900|FG004|Lead-in Study|Protocol Violation|21|||
44286925|NCT01572792|79250896|FG000|Lead-in Study|Lack of Efficacy|20|||
44286926|NCT01572792|79250897|FG001|Lead-in Study|Lack of Efficacy|5|||
44286927|NCT01572792|79250898|FG002|Lead-in Study|Lack of Efficacy|4|||
44286928|NCT01572792|79250899|FG003|Lead-in Study|Lack of Efficacy|8|||
44286929|NCT01572792|79250900|FG004|Lead-in Study|Lack of Efficacy|10|||
44286930|NCT01572792|79250896|FG000|Lead-in Study|Adverse Event|21|||
44286931|NCT01572792|79250897|FG001|Lead-in Study|Adverse Event|21|||
44286932|NCT01572792|79250898|FG002|Lead-in Study|Adverse Event|22|||
44286933|NCT01572792|79250899|FG003|Lead-in Study|Adverse Event|16|||
44286934|NCT01572792|79250900|FG004|Lead-in Study|Adverse Event|14|||
44286935|NCT01572792|79250896|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
44286936|NCT01572792|79250897|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
44286937|NCT01572792|79250898|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
44286938|NCT01572792|79250899|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
44286939|NCT01572792|79250900|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
44286940|NCT01572792|79250896|FG000|Extension Study|Lost to Follow-up|6|||
44286941|NCT01572792|79250897|FG001|Extension Study|Lost to Follow-up|2|||
44286942|NCT01572792|79250898|FG002|Extension Study|Lost to Follow-up|0|||
44286943|NCT01572792|79250899|FG003|Extension Study|Lost to Follow-up|3|||
44286944|NCT01572792|79250900|FG004|Extension Study|Lost to Follow-up|3|||
44286945|NCT01572792|79250896|FG000|Extension Study|Withdrawal by Subject|7|||
44286946|NCT01572792|79250897|FG001|Extension Study|Withdrawal by Subject|6|||
44286947|NCT01572792|79250898|FG002|Extension Study|Withdrawal by Subject|11|||
44286948|NCT01572792|79250899|FG003|Extension Study|Withdrawal by Subject|8|||
44286949|NCT01572792|79250900|FG004|Extension Study|Withdrawal by Subject|14|||
44286950|NCT01572792|79250896|FG000|Extension Study|Protocol Violation|0|||
44286951|NCT01572792|79250897|FG001|Extension Study|Protocol Violation|4|||
44286952|NCT01572792|79250898|FG002|Extension Study|Protocol Violation|3|||
44286953|NCT01572792|79250899|FG003|Extension Study|Protocol Violation|4|||
44286954|NCT01572792|79250900|FG004|Extension Study|Protocol Violation|3|||
44286955|NCT01572792|79250896|FG000|Extension Study|Lack of Efficacy|2|||
44533472|NCT03781375|79543692|FG000|Open-label Phase|Protocol Issues|0|||
44533473|NCT03781375|79543693|FG001|Open-label Phase|Protocol Issues|1|||
44286956|NCT01572792|79250897|FG001|Extension Study|Lack of Efficacy|3|||
44286957|NCT01572792|79250898|FG002|Extension Study|Lack of Efficacy|3|||
44286958|NCT01572792|79250899|FG003|Extension Study|Lack of Efficacy|2|||
44286959|NCT01572792|79250900|FG004|Extension Study|Lack of Efficacy|2|||
44286960|NCT01572792|79250896|FG000|Extension Study|Adverse Event|7|||
44286961|NCT01572792|79250897|FG001|Extension Study|Adverse Event|6|||
44286962|NCT01572792|79250898|FG002|Extension Study|Adverse Event|5|||
44286963|NCT01572792|79250899|FG003|Extension Study|Adverse Event|6|||
44286964|NCT01572792|79250900|FG004|Extension Study|Adverse Event|4|||
44286965|NCT01572792|79250896|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
44286966|NCT01572792|79250897|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
44286967|NCT01572792|79250898|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
44286968|NCT01572792|79250899|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
44286969|NCT01572792|79250900|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
44286970|NCT01547598|79250915|FG000|Overall Study|Withdrew consent|1|||
44286971|NCT01547598|79250916|FG001|Overall Study|Withdrew consent|1|||
44286972|NCT01547598|79250915|FG000|Overall Study|Lost to Follow-up|1|||
44286973|NCT01547598|79250916|FG001|Overall Study|Lost to Follow-up|1|||
44286974|NCT01547598|79250915|FG000|Overall Study|Adverse Event|1|||
44286975|NCT01547598|79250916|FG001|Overall Study|Adverse Event|1|||
44286976|NCT01547598|79250915|FG000|Overall Study|Protocol Violation|1|||
44286977|NCT01547598|79250916|FG001|Overall Study|Protocol Violation|1|||
44286978|NCT01547598|79250915|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44286979|NCT01547598|79250916|FG001|Overall Study|Other Miscellaneous Reasons|1|||
44286980|NCT01547286|79250923|FG000|Overall Study|Did not meet all eligibility criteria|1|||
44286981|NCT01547286|79250923|FG000|Overall Study|Physician Decision|1|||
44286982|NCT01547130|79250930|FG000|Overall Study|Lost to Follow-up|9|||
44286983|NCT01547130|79250931|FG001|Overall Study|Lost to Follow-up|5|||
44286984|NCT01524978|79250956|FG000|Overall Study|Other|16|||
44286985|NCT01524978|79250957|FG001|Overall Study|Other|2|||
44286986|NCT01524978|79250958|FG002|Overall Study|Other|1|||
44286987|NCT01524978|79250959|FG003|Overall Study|Other|2|||
44286988|NCT01524978|79250960|FG004|Overall Study|Other|1|||
44286989|NCT01524978|79250961|FG005|Overall Study|Other|3|||
44286990|NCT01524978|79250962|FG006|Overall Study|Other|17|||
44286991|NCT01524978|79250963|FG007|Overall Study|Other|1|||
44286992|NCT01524978|79250964|FG008|Overall Study|Other|2|||
44286993|NCT01524978|79250965|FG009|Overall Study|Other|2|||
44286994|NCT01524978|79250966|FG010|Overall Study|Other|5|||
44286995|NCT01524978|79250956|FG000|Overall Study|Withdrawal by Subject|12|||
44286996|NCT01524978|79250957|FG001|Overall Study|Withdrawal by Subject|0|||
44286997|NCT01524978|79250958|FG002|Overall Study|Withdrawal by Subject|1|||
44286998|NCT01524978|79250959|FG003|Overall Study|Withdrawal by Subject|1|||
44286999|NCT01524978|79250960|FG004|Overall Study|Withdrawal by Subject|3|||
44287000|NCT01524978|79250961|FG005|Overall Study|Withdrawal by Subject|1|||
44287001|NCT01524978|79250962|FG006|Overall Study|Withdrawal by Subject|6|||
44287002|NCT01524978|79250963|FG007|Overall Study|Withdrawal by Subject|2|||
44287003|NCT01524978|79250964|FG008|Overall Study|Withdrawal by Subject|4|||
44287004|NCT01524978|79250965|FG009|Overall Study|Withdrawal by Subject|0|||
44287005|NCT01524978|79250966|FG010|Overall Study|Withdrawal by Subject|5|||
44287006|NCT01524978|79250956|FG000|Overall Study|Lost to Follow-up|0|||
44287007|NCT01524978|79250957|FG001|Overall Study|Lost to Follow-up|0|||
44287008|NCT01524978|79250958|FG002|Overall Study|Lost to Follow-up|3|||
44287009|NCT01524978|79250959|FG003|Overall Study|Lost to Follow-up|0|||
44287010|NCT01524978|79250960|FG004|Overall Study|Lost to Follow-up|1|||
44287011|NCT01524978|79250961|FG005|Overall Study|Lost to Follow-up|1|||
44287012|NCT01524978|79250962|FG006|Overall Study|Lost to Follow-up|2|||
44287013|NCT01524978|79250963|FG007|Overall Study|Lost to Follow-up|0|||
44287014|NCT01524978|79250964|FG008|Overall Study|Lost to Follow-up|1|||
44287015|NCT01524978|79250965|FG009|Overall Study|Lost to Follow-up|1|||
44255964|NCT01490450|79102039|FG001|Period 1|Adverse Event|0|||
44255965|NCT01490450|79102040|FG002|Period 1|Adverse Event|0|||
44255966|NCT01490450|79102041|FG003|Period 1|Adverse Event|5|||
44255967|NCT01490450|79102038|FG000|Period 1|Request to discontinue treatment|1|||
44255968|NCT01490450|79102039|FG001|Period 1|Request to discontinue treatment|0|||
44255969|NCT01490450|79102040|FG002|Period 1|Request to discontinue treatment|0|||
44255970|NCT01490450|79102041|FG003|Period 1|Request to discontinue treatment|0|||
44255971|NCT01490450|79102038|FG000|Period 1|Withdrawal by Subject|0|||
44255972|NCT01490450|79102039|FG001|Period 1|Withdrawal by Subject|0|||
44255973|NCT01490450|79102040|FG002|Period 1|Withdrawal by Subject|0|||
44255974|NCT01490450|79102041|FG003|Period 1|Withdrawal by Subject|3|||
44255975|NCT01490450|79102038|FG000|Period 1|No longer met study criteria|0|||
44255976|NCT01490450|79102039|FG001|Period 1|No longer met study criteria|1|||
44255977|NCT01490450|79102040|FG002|Period 1|No longer met study criteria|1|||
44255978|NCT01490450|79102041|FG003|Period 1|No longer met study criteria|0|||
44255979|NCT01490450|79102038|FG000|Period 2|Lack of Efficacy|0|||
44255980|NCT01490450|79102039|FG001|Period 2|Lack of Efficacy|0|||
44255981|NCT01490450|79102040|FG002|Period 2|Lack of Efficacy|0|||
44255982|NCT01490450|79102041|FG003|Period 2|Lack of Efficacy|1|||
44255983|NCT01490450|79102038|FG000|Period 2|Adverse Event|1|||
44255984|NCT01490450|79102039|FG001|Period 2|Adverse Event|1|||
44255985|NCT01490450|79102040|FG002|Period 2|Adverse Event|0|||
44287016|NCT01524978|79250966|FG010|Overall Study|Lost to Follow-up|1|||
44287017|NCT01524978|79250956|FG000|Overall Study|Death|34|||
44415679|NCT00776100|79423403|FG000|Overall Study|Disease Progression|1|||
44415680|NCT00776100|79423404|FG001|Overall Study|Disease Progression|0|||
44415681|NCT00783432|79423412|FG000|Overall Study|Adverse Event|22|||
44415682|NCT00783432|79423413|FG001|Overall Study|Adverse Event|17|||
44415683|NCT00783432|79423412|FG000|Overall Study|Lack of Efficacy|20|||
44415684|NCT00783432|79423413|FG001|Overall Study|Lack of Efficacy|21|||
44415685|NCT00783432|79423412|FG000|Overall Study|Lost to Follow-up|11|||
44415686|NCT00783432|79423413|FG001|Overall Study|Lost to Follow-up|6|||
44533474|NCT03781375|79543692|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
44533475|NCT03781375|79543693|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
44533476|NCT03781375|79543692|FG000|Open-label Phase|Other|2|||
44533477|NCT03781375|79543693|FG001|Open-label Phase|Other|2|||
44533478|NCT03779503|79543700|FG000|First Intervention|Adverse Event|0|||
44533479|NCT03779503|79543701|FG001|First Intervention|Adverse Event|1|||
44533480|NCT03779503|79543700|FG000|First Intervention|Withdrawal by Subject|1|||
44533481|NCT03779503|79543701|FG001|First Intervention|Withdrawal by Subject|0|||
44533482|NCT03150056|79543713|FG000|Overall Study|Withdrawal by Subject|0|||
44533483|NCT03150056|79543714|FG001|Overall Study|Withdrawal by Subject|0|||
44533484|NCT03150056|79543715|FG002|Overall Study|Withdrawal by Subject|0|||
44533485|NCT03150056|79543716|FG003|Overall Study|Withdrawal by Subject|0|||
44533486|NCT03150056|79543717|FG004|Overall Study|Withdrawal by Subject|0|||
44533487|NCT03150056|79543718|FG005|Overall Study|Withdrawal by Subject|2|||
44533488|NCT03150056|79543713|FG000|Overall Study|Study terminated by Sponsor|1|||
44533489|NCT03150056|79543714|FG001|Overall Study|Study terminated by Sponsor|3|||
44533490|NCT03150056|79543715|FG002|Overall Study|Study terminated by Sponsor|1|||
44533491|NCT03150056|79543716|FG003|Overall Study|Study terminated by Sponsor|1|||
44533492|NCT03150056|79543717|FG004|Overall Study|Study terminated by Sponsor|5|||
44533493|NCT03150056|79543718|FG005|Overall Study|Study terminated by Sponsor|6|||
44533494|NCT03150056|79543713|FG000|Overall Study|Death|9|||
44533495|NCT03150056|79543714|FG001|Overall Study|Death|2|||
44533496|NCT03150056|79543715|FG002|Overall Study|Death|2|||
44533497|NCT03150056|79543716|FG003|Overall Study|Death|7|||
44533498|NCT03150056|79543717|FG004|Overall Study|Death|8|||
44533499|NCT03150056|79543718|FG005|Overall Study|Death|10|||
44533500|NCT02640664|79543738|FG000|Epoch 1|Withdrawal of informed consent|1|||
44533501|NCT02640664|79543739|FG001|Epoch 1|Withdrawal of informed consent|0|||
44533502|NCT02640664|79543740|FG002|Epoch 1|Withdrawal of informed consent|0|||
44533503|NCT02640664|79543738|FG000|Epoch 1|Death|0|||
44533504|NCT02640664|79543739|FG001|Epoch 1|Death|0|||
44533505|NCT02640664|79543740|FG002|Epoch 1|Death|1|||
44533506|NCT02640664|79543738|FG000|Epoch 2|Withdrawal of informed consent|3|||
44287018|NCT01524978|79250957|FG001|Overall Study|Death|2|||
44287019|NCT01524978|79250958|FG002|Overall Study|Death|5|||
44287020|NCT01524978|79250959|FG003|Overall Study|Death|24|||
44287021|NCT01524978|79250960|FG004|Overall Study|Death|4|||
44287022|NCT01524978|79250961|FG005|Overall Study|Death|4|||
44287023|NCT01524978|79250962|FG006|Overall Study|Death|1|||
44287024|NCT01524978|79250963|FG007|Overall Study|Death|9|||
44287025|NCT01524978|79250964|FG008|Overall Study|Death|5|||
44287026|NCT01524978|79250965|FG009|Overall Study|Death|6|||
44415687|NCT00783432|79423412|FG000|Overall Study|Withdrawal by Subject|23|||
44415688|NCT00783432|79423413|FG001|Overall Study|Withdrawal by Subject|20|||
44415689|NCT00783432|79423412|FG000|Overall Study|subject moved|3|||
44415690|NCT00783432|79423413|FG001|Overall Study|subject moved|5|||
44415691|NCT00783432|79423412|FG000|Overall Study|Protocol Violation|6|||
44415692|NCT00783432|79423413|FG001|Overall Study|Protocol Violation|9|||
44415693|NCT00783198|79423422|FG000|Overall Study|Adverse Event|15|||
44415694|NCT00783198|79423423|FG001|Overall Study|Adverse Event|19|||
44415695|NCT00783198|79423424|FG002|Overall Study|Adverse Event|3|||
44415696|NCT00783198|79423422|FG000|Overall Study|Lost to Follow-up|11|||
44415697|NCT00783198|79423423|FG001|Overall Study|Lost to Follow-up|1|||
44415698|NCT00783198|79423424|FG002|Overall Study|Lost to Follow-up|7|||
44415699|NCT00783198|79423422|FG000|Overall Study|Withdrawal by Subject|22|||
44415700|NCT00783198|79423423|FG001|Overall Study|Withdrawal by Subject|14|||
44415701|NCT00783198|79423424|FG002|Overall Study|Withdrawal by Subject|20|||
44415702|NCT00783198|79423422|FG000|Overall Study|Noncompliance with protocol|7|||
44415703|NCT00783198|79423423|FG001|Overall Study|Noncompliance with protocol|7|||
44415704|NCT00783198|79423424|FG002|Overall Study|Noncompliance with protocol|10|||
44533507|NCT02640664|79543739|FG001|Epoch 2|Withdrawal of informed consent|4|||
44287027|NCT01524978|79250966|FG010|Overall Study|Death|17|||
44415705|NCT00783198|79423422|FG000|Overall Study|Did not meet protocol eligibility|0|||
44415706|NCT00783198|79423423|FG001|Overall Study|Did not meet protocol eligibility|1|||
44415707|NCT00783198|79423424|FG002|Overall Study|Did not meet protocol eligibility|0|||
44533508|NCT02640664|79543740|FG002|Epoch 2|Withdrawal of informed consent|2|||
44533509|NCT02640664|79543738|FG000|Epoch 2|Subject/guardian decision|0|||
44533510|NCT02640664|79543739|FG001|Epoch 2|Subject/guardian decision|2|||
44533511|NCT02640664|79543740|FG002|Epoch 2|Subject/guardian decision|2|||
44287028|NCT01524900|79250986|FG000|Overall Study|Lost to Follow-up|3|||
44287029|NCT01524900|79250987|FG001|Overall Study|Lost to Follow-up|12|||
44287030|NCT01524900|79250988|FG002|Overall Study|Lost to Follow-up|1|||
44287031|NCT01524900|79250989|FG003|Overall Study|Lost to Follow-up|0|||
44287032|NCT01524900|79250990|FG004|Overall Study|Lost to Follow-up|0|||
44287033|NCT01524900|79250986|FG000|Overall Study|Other reason than stated above|1|||
44287034|NCT01524900|79250987|FG001|Overall Study|Other reason than stated above|1|||
44287035|NCT01524900|79250988|FG002|Overall Study|Other reason than stated above|0|||
44287036|NCT01524900|79250989|FG003|Overall Study|Other reason than stated above|0|||
44287037|NCT01524900|79250990|FG004|Overall Study|Other reason than stated above|0|||
44287038|NCT01524900|79250986|FG000|Overall Study|No reason documented|2|||
44287039|NCT01524900|79250987|FG001|Overall Study|No reason documented|1|||
44287040|NCT01524900|79250988|FG002|Overall Study|No reason documented|0|||
44287041|NCT01524900|79250989|FG003|Overall Study|No reason documented|1|||
44287042|NCT01524900|79250990|FG004|Overall Study|No reason documented|0|||
44287043|NCT01524198|79251005|FG000|Overall Study|Protocol Violation|8|||
44287044|NCT01524198|79251006|FG001|Overall Study|Protocol Violation|6|||
44287045|NCT01524198|79251005|FG000|Overall Study|Withdrawal by Subject|15|||
44287046|NCT01524198|79251006|FG001|Overall Study|Withdrawal by Subject|10|||
44287047|NCT01523886|79251014|FG000|Overall Study|surgery cancelled|0|||
44287048|NCT01523886|79251015|FG001|Overall Study|surgery cancelled|1|||
44287049|NCT01546038|79251027|FG000|Overall Study|Death|15|||
44287050|NCT01546038|79251028|FG001|Overall Study|Death|6|||
44287051|NCT01546038|79251029|FG002|Overall Study|Death|4|||
44287052|NCT01546038|79251030|FG003|Overall Study|Death|2|||
44287053|NCT01546038|79251031|FG004|Overall Study|Death|9|||
44287054|NCT01546038|79251032|FG005|Overall Study|Death|3|||
44287055|NCT01546038|79251033|FG006|Overall Study|Death|46|||
44287056|NCT01546038|79251034|FG007|Overall Study|Death|76|||
44287057|NCT01546038|79251035|FG008|Overall Study|Death|39|||
44287058|NCT01546038|79251027|FG000|Overall Study|Lost to Follow-up|0|||
44287059|NCT01546038|79251028|FG001|Overall Study|Lost to Follow-up|0|||
44287060|NCT01546038|79251029|FG002|Overall Study|Lost to Follow-up|0|||
44287061|NCT01546038|79251030|FG003|Overall Study|Lost to Follow-up|0|||
44287062|NCT01546038|79251031|FG004|Overall Study|Lost to Follow-up|1|||
44287063|NCT01546038|79251032|FG005|Overall Study|Lost to Follow-up|0|||
44287064|NCT01546038|79251033|FG006|Overall Study|Lost to Follow-up|2|||
44287065|NCT01546038|79251034|FG007|Overall Study|Lost to Follow-up|1|||
44287066|NCT01546038|79251035|FG008|Overall Study|Lost to Follow-up|0|||
44287067|NCT01546038|79251027|FG000|Overall Study|Withdrawal by Subject|1|||
44287068|NCT01546038|79251028|FG001|Overall Study|Withdrawal by Subject|0|||
44287069|NCT01546038|79251029|FG002|Overall Study|Withdrawal by Subject|0|||
44287070|NCT01546038|79251030|FG003|Overall Study|Withdrawal by Subject|1|||
44287071|NCT01546038|79251031|FG004|Overall Study|Withdrawal by Subject|0|||
44287072|NCT01546038|79251032|FG005|Overall Study|Withdrawal by Subject|1|||
44154393|NCT02696785|78945530|FG000|Blinded Treatment Period|Adverse Event|0|||
44287073|NCT01546038|79251033|FG006|Overall Study|Withdrawal by Subject|3|||
44287074|NCT01546038|79251034|FG007|Overall Study|Withdrawal by Subject|3|||
44287075|NCT01546038|79251035|FG008|Overall Study|Withdrawal by Subject|1|||
44287076|NCT01546038|79251027|FG000|Overall Study|: Randomized, not treated|0|||
44287077|NCT01546038|79251028|FG001|Overall Study|: Randomized, not treated|0|||
44287078|NCT01546038|79251029|FG002|Overall Study|: Randomized, not treated|0|||
44287079|NCT01546038|79251030|FG003|Overall Study|: Randomized, not treated|0|||
44287080|NCT01546038|79251031|FG004|Overall Study|: Randomized, not treated|0|||
44287081|NCT01546038|79251032|FG005|Overall Study|: Randomized, not treated|0|||
44287082|NCT01546038|79251033|FG006|Overall Study|: Randomized, not treated|2|||
44287083|NCT01546038|79251034|FG007|Overall Study|: Randomized, not treated|4|||
44287084|NCT01546038|79251035|FG008|Overall Study|: Randomized, not treated|3|||
44287085|NCT01571232|79251087|FG000|Overall Study|Lost to Follow-up|0|||
44287086|NCT01571232|79251088|FG001|Overall Study|Lost to Follow-up|1|||
44287087|NCT01571232|79251087|FG000|Overall Study|Withdrawal by Subject|1|||
44287088|NCT01571232|79251088|FG001|Overall Study|Withdrawal by Subject|0|||
44287089|NCT01544478|79251095|FG000|Overall Study|Adverse Event|1|||
44287090|NCT01544478|79251095|FG000|Overall Study|Death|1|||
44287091|NCT01544478|79251095|FG000|Overall Study|Lost to Follow-up|48|||
44287092|NCT01544478|79251095|FG000|Overall Study|Physician Decision|15|||
44287093|NCT01544478|79251095|FG000|Overall Study|Pregnancy|1|||
44287094|NCT01544478|79251095|FG000|Overall Study|Withdrawal by Subject|52|||
44287095|NCT01522950|79251102|FG000|Overall Study|Withdrawal by Subject|3|||
44287096|NCT01522950|79251103|FG001|Overall Study|Withdrawal by Subject|2|||
44287097|NCT01522950|79251104|FG002|Overall Study|Withdrawal by Subject|1|||
44287098|NCT01522950|79251102|FG000|Overall Study|Adverse Event|3|||
44287099|NCT01522950|79251103|FG001|Overall Study|Adverse Event|1|||
44287100|NCT01522950|79251104|FG002|Overall Study|Adverse Event|1|||
44287101|NCT01522950|79251102|FG000|Overall Study|Protocol Violation|0|||
44287102|NCT01522950|79251103|FG001|Overall Study|Protocol Violation|0|||
44287103|NCT01522950|79251104|FG002|Overall Study|Protocol Violation|2|||
44287104|NCT01522950|79251102|FG000|Overall Study|Death|0|||
44287105|NCT01522950|79251103|FG001|Overall Study|Death|1|||
44287106|NCT01522950|79251104|FG002|Overall Study|Death|1|||
44287107|NCT01522950|79251102|FG000|Overall Study|Study Medication Sensitivity|0|||
44287108|NCT01522950|79251103|FG001|Overall Study|Study Medication Sensitivity|1|||
44287109|NCT01522950|79251104|FG002|Overall Study|Study Medication Sensitivity|0|||
44287110|NCT01522404|79251114|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
44287111|NCT01522404|79251115|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
44287112|NCT01522404|79251114|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
44287113|NCT01522404|79251115|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
44287114|NCT01522404|79251114|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
44533512|NCT02640664|79543738|FG000|Epoch 2|Lost to Follow-up|3|||
44533513|NCT02640664|79543739|FG001|Epoch 2|Lost to Follow-up|4|||
44533514|NCT02640664|79543740|FG002|Epoch 2|Lost to Follow-up|1|||
44533515|NCT02640664|79543738|FG000|Epoch 2|Death|0|||
44287115|NCT01522404|79251115|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
44287116|NCT01570686|79251131|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44287117|NCT01570686|79251132|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44287118|NCT01570686|79251131|FG000|Overall Study|Administrative problems|0|||
44287119|NCT01570686|79251132|FG001|Overall Study|Administrative problems|1|||
44287120|NCT01570686|79251131|FG000|Overall Study|Adverse Event|8|||
44287121|NCT01570686|79251132|FG001|Overall Study|Adverse Event|6|||
44287122|NCT01570686|79251131|FG000|Overall Study|Lost to Follow-up|4|||
44287123|NCT01570686|79251132|FG001|Overall Study|Lost to Follow-up|3|||
44287124|NCT01570686|79251131|FG000|Overall Study|Protocol Deviation|3|||
44287125|NCT01570686|79251132|FG001|Overall Study|Protocol Deviation|0|||
44287126|NCT01570686|79251131|FG000|Overall Study|Withdrawal by Subject|4|||
44287127|NCT01570686|79251132|FG001|Overall Study|Withdrawal by Subject|4|||
44287128|NCT01570686|79251131|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44287129|NCT01570686|79251132|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44287130|NCT01522248|79251140|FG000|Overall Study|Lost to Follow-up|1|||
44287131|NCT01522248|79251141|FG001|Overall Study|Lost to Follow-up|0|||
44287132|NCT01543776|79251154|FG000|Overall Study|Withdrawal by Subject|2|||
44287133|NCT01543776|79251155|FG001|Overall Study|Withdrawal by Subject|2|||
44287134|NCT01518192|79251164|FG000|Overall Study|Lost to Follow-up|29|||
44287135|NCT01518192|79251165|FG001|Overall Study|Lost to Follow-up|26|||
44287136|NCT01518192|79251166|FG002|Overall Study|Lost to Follow-up|35|||
44287137|NCT01517802|79251180|FG000|Overall Study|Death|1|||
44287138|NCT01520922|79251186|FG000|Treatment Phase|Physician Decision|2|||
44287139|NCT01520922|79251187|FG001|Treatment Phase|Physician Decision|1|||
44287140|NCT01520922|79251186|FG000|Treatment Phase|Progression|0|||
44287141|NCT01520922|79251187|FG001|Treatment Phase|Progression|2|||
44287142|NCT01520922|79251186|FG000|Treatment Phase|Adverse Event|3|||
44287143|NCT01520922|79251187|FG001|Treatment Phase|Adverse Event|5|||
44287144|NCT01520922|79251186|FG000|Follow up|Lost to Follow-up|0|||
44287145|NCT01520922|79251187|FG001|Follow up|Lost to Follow-up|1|||
44287146|NCT01520922|79251186|FG000|Survival Follow-up|Withdrawal by Subject|1|||
44287147|NCT01520922|79251187|FG001|Survival Follow-up|Withdrawal by Subject|0|||
44287148|NCT01569438|79251195|FG000|Overall Study|Lack of Efficacy|1|||
44287149|NCT01569438|79251196|FG001|Overall Study|Lack of Efficacy|2|||
44287150|NCT01569438|79251195|FG000|Overall Study|Withdrawal by Subject|0|||
44287151|NCT01569438|79251196|FG001|Overall Study|Withdrawal by Subject|3|||
44287152|NCT01569438|79251195|FG000|Overall Study|Adverse Event|2|||
44287153|NCT01569438|79251196|FG001|Overall Study|Adverse Event|15|||
44287154|NCT01569438|79251195|FG000|Overall Study|Protocol Violation|2|||
44287155|NCT01569438|79251196|FG001|Overall Study|Protocol Violation|0|||
44287156|NCT01569438|79251195|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
44287157|NCT01569438|79251196|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
44287158|NCT01569438|79251195|FG000|Overall Study|Sponsor/Physician decision|1|||
44287159|NCT01569438|79251196|FG001|Overall Study|Sponsor/Physician decision|1|||
44533516|NCT02640664|79543739|FG001|Epoch 2|Death|0|||
44533517|NCT02640664|79543740|FG002|Epoch 2|Death|1|||
44533518|NCT00812006|79543752|FG000|Overall Study|Lost to Follow-up|0|||
44533519|NCT00812006|79543753|FG001|Overall Study|Lost to Follow-up|0|||
44533520|NCT00812006|79543754|FG002|Overall Study|Lost to Follow-up|2|||
44287160|NCT01569438|79251195|FG000|Overall Study|Unable to adhere to study schedule|0|||
44287161|NCT01569438|79251196|FG001|Overall Study|Unable to adhere to study schedule|1|||
44287162|NCT01517412|79251204|FG000|Overall Study|Adverse Event|10|||
44287163|NCT01517412|79251205|FG001|Overall Study|Adverse Event|11|||
44287164|NCT01517412|79251204|FG000|Overall Study|Lack of Efficacy|10|||
44287165|NCT01517412|79251205|FG001|Overall Study|Lack of Efficacy|5|||
44287166|NCT01517412|79251204|FG000|Overall Study|Poor compliance to protocol|8|||
44415708|NCT00783198|79423422|FG000|Overall Study|Administrative|2|||
44533521|NCT00812006|79543752|FG000|Overall Study|Physician Decision|0|||
44533522|NCT00812006|79543753|FG001|Overall Study|Physician Decision|0|||
44287167|NCT01517412|79251205|FG001|Overall Study|Poor compliance to protocol|3|||
44287168|NCT01517412|79251204|FG000|Overall Study|Other than specified above|8|||
44287169|NCT01517412|79251205|FG001|Overall Study|Other than specified above|5|||
44287170|NCT01517178|79251211|FG000|Period 1|Adverse Event|1|||
44287171|NCT01517178|79251212|FG001|Period 1|Adverse Event|2|||
44287172|NCT01517178|79251211|FG000|Period 1|Lack of Efficacy|0|||
44287173|NCT01517178|79251212|FG001|Period 1|Lack of Efficacy|1|||
44287174|NCT01517178|79251211|FG000|Period 1|E.g. study termination|3|||
44287175|NCT01517178|79251212|FG001|Period 1|E.g. study termination|1|||
44287176|NCT01517178|79251211|FG000|Period 1|Withdrawal by Subject|0|||
44287177|NCT01517178|79251212|FG001|Period 1|Withdrawal by Subject|1|||
44287178|NCT01517178|79251211|FG000|Period 2|Adverse Event|1|||
44287179|NCT01517178|79251212|FG001|Period 2|Adverse Event|0|||
44287180|NCT01517178|79251211|FG000|Period 2|Withdrawal by Subject|3|||
44287181|NCT01517178|79251212|FG001|Period 2|Withdrawal by Subject|0|||
44287182|NCT01517178|79251211|FG000|Period 2|E.g. study termination|2|||
44287183|NCT01517178|79251212|FG001|Period 2|E.g. study termination|2|||
44287184|NCT01489956|79251220|FG000|Overall Study|Lost to Follow-up|1|||
44287185|NCT01489956|79251221|FG001|Overall Study|Lost to Follow-up|0|||
44287186|NCT01489956|79251222|FG002|Overall Study|Lost to Follow-up|0|||
44287187|NCT01489956|79251220|FG000|Overall Study|Withdrawal by Subject|0|||
44287188|NCT01489956|79251221|FG001|Overall Study|Withdrawal by Subject|0|||
44287189|NCT01489956|79251222|FG002|Overall Study|Withdrawal by Subject|1|||
44287190|NCT01516008|79251233|FG000|Overall Study|Adverse Event|0|||
44287191|NCT01516008|79251234|FG001|Overall Study|Adverse Event|2|||
44287192|NCT01516008|79251235|FG002|Overall Study|Adverse Event|7|||
44287193|NCT01516008|79251233|FG000|Overall Study|Lack of Efficacy|44|||
44287194|NCT01516008|79251234|FG001|Overall Study|Lack of Efficacy|14|||
44287195|NCT01516008|79251235|FG002|Overall Study|Lack of Efficacy|10|||
44287196|NCT01516008|79251233|FG000|Overall Study|Protocol Violation|1|||
44287197|NCT01516008|79251234|FG001|Overall Study|Protocol Violation|0|||
44287198|NCT01516008|79251235|FG002|Overall Study|Protocol Violation|0|||
44287199|NCT01516008|79251233|FG000|Overall Study|Reason not specified|0|||
44287200|NCT01516008|79251234|FG001|Overall Study|Reason not specified|0|||
44287201|NCT01516008|79251235|FG002|Overall Study|Reason not specified|1|||
44287202|NCT01489254|79251246|FG000|Double-blind Part|Adverse Event|7|||
44287203|NCT01489254|79251247|FG001|Double-blind Part|Adverse Event|2|||
44287204|NCT01489254|79251248|FG002|Double-blind Part|Adverse Event|2|||
44287205|NCT01489254|79251249|FG003|Double-blind Part|Adverse Event|0|||
44287206|NCT01489254|79251246|FG000|Double-blind Part|Pregnancy|1|||
44287207|NCT01489254|79251247|FG001|Double-blind Part|Pregnancy|3|||
44287208|NCT01489254|79251248|FG002|Double-blind Part|Pregnancy|0|||
44287209|NCT01489254|79251249|FG003|Double-blind Part|Pregnancy|0|||
44287210|NCT01489254|79251246|FG000|Double-blind Part|Withdrawal by Subject|12|||
44287211|NCT01489254|79251247|FG001|Double-blind Part|Withdrawal by Subject|20|||
44287212|NCT01489254|79251248|FG002|Double-blind Part|Withdrawal by Subject|1|||
44287213|NCT01489254|79251249|FG003|Double-blind Part|Withdrawal by Subject|0|||
44287214|NCT01489254|79251246|FG000|Double-blind Part|Lost to Follow-up|1|||
44287215|NCT01489254|79251247|FG001|Double-blind Part|Lost to Follow-up|2|||
44287216|NCT01489254|79251248|FG002|Double-blind Part|Lost to Follow-up|0|||
44287217|NCT01489254|79251249|FG003|Double-blind Part|Lost to Follow-up|0|||
44287218|NCT01489254|79251246|FG000|Double-blind Part|Other reasons for not completing study|4|||
44287219|NCT01489254|79251247|FG001|Double-blind Part|Other reasons for not completing study|6|||
44287220|NCT01489254|79251248|FG002|Double-blind Part|Other reasons for not completing study|0|||
44287221|NCT01489254|79251249|FG003|Double-blind Part|Other reasons for not completing study|0|||
44287222|NCT01489254|79251246|FG000|Open-label Extension Part|Adverse Event|0|||
44287223|NCT01489254|79251247|FG001|Open-label Extension Part|Adverse Event|0|||
44287224|NCT01489254|79251248|FG002|Open-label Extension Part|Adverse Event|0|||
44287225|NCT01489254|79251249|FG003|Open-label Extension Part|Adverse Event|10|||
44287226|NCT01489254|79251246|FG000|Open-label Extension Part|Pregnancy|0|||
44287227|NCT01489254|79251247|FG001|Open-label Extension Part|Pregnancy|0|||
44287228|NCT01489254|79251248|FG002|Open-label Extension Part|Pregnancy|0|||
44287229|NCT01489254|79251249|FG003|Open-label Extension Part|Pregnancy|3|||
44287230|NCT01489254|79251246|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
44287231|NCT01489254|79251247|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
44287232|NCT01489254|79251248|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
44415709|NCT00783198|79423423|FG001|Overall Study|Administrative|1|||
44415710|NCT00783198|79423424|FG002|Overall Study|Administrative|2|||
44415711|NCT00789360|79423434|FG000|Overall Study|Protocol Violation|3|||
44415712|NCT00789360|79423435|FG001|Overall Study|Protocol Violation|1|||
44287233|NCT01489254|79251249|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
44287234|NCT01489254|79251246|FG000|Open-label Extension Part|Protocol Violation|0|||
44287235|NCT01489254|79251247|FG001|Open-label Extension Part|Protocol Violation|0|||
44287236|NCT01489254|79251248|FG002|Open-label Extension Part|Protocol Violation|0|||
44287237|NCT01489254|79251249|FG003|Open-label Extension Part|Protocol Violation|1|||
44287238|NCT01489254|79251246|FG000|Open-label Extension Part|Lost to Follow-up|0|||
44287239|NCT01489254|79251247|FG001|Open-label Extension Part|Lost to Follow-up|0|||
44287240|NCT01489254|79251248|FG002|Open-label Extension Part|Lost to Follow-up|0|||
44287241|NCT01489254|79251249|FG003|Open-label Extension Part|Lost to Follow-up|9|||
44287242|NCT01489254|79251246|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
44287243|NCT01489254|79251247|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
44287244|NCT01489254|79251248|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
44287245|NCT01489254|79251249|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
44287246|NCT01489020|79251264|FG000|Overall Study|Withdrawal by Subject|1|||
44287247|NCT01489020|79251265|FG001|Overall Study|Withdrawal by Subject|0|||
44287248|NCT01489020|79251266|FG002|Overall Study|Withdrawal by Subject|0|||
44287249|NCT01489020|79251267|FG003|Overall Study|Withdrawal by Subject|0|||
44287250|NCT01489020|79251268|FG004|Overall Study|Withdrawal by Subject|0|||
44287251|NCT01489020|79251269|FG005|Overall Study|Withdrawal by Subject|0|||
44287252|NCT01489020|79251264|FG000|Overall Study|Adverse Event|0|||
44287253|NCT01489020|79251265|FG001|Overall Study|Adverse Event|0|||
44287254|NCT01489020|79251266|FG002|Overall Study|Adverse Event|3|||
44287255|NCT01489020|79251267|FG003|Overall Study|Adverse Event|0|||
44287256|NCT01489020|79251268|FG004|Overall Study|Adverse Event|3|||
44287257|NCT01489020|79251269|FG005|Overall Study|Adverse Event|0|||
44287258|NCT01489020|79251264|FG000|Overall Study|Concomitant disease|0|||
44287259|NCT01489020|79251265|FG001|Overall Study|Concomitant disease|0|||
44287260|NCT01489020|79251266|FG002|Overall Study|Concomitant disease|0|||
44287261|NCT01489020|79251267|FG003|Overall Study|Concomitant disease|0|||
44287262|NCT01489020|79251268|FG004|Overall Study|Concomitant disease|3|||
44287263|NCT01489020|79251269|FG005|Overall Study|Concomitant disease|0|||
44287264|NCT01514760|79251289|FG000|Overall Study|Lost to Follow-up|2|||
44287265|NCT01514682|79251295|FG000|Overall Study|Withdrawal by Subject|2|||
44287266|NCT01514682|79251296|FG001|Overall Study|Withdrawal by Subject|3|||
44287267|NCT01514682|79251295|FG000|Overall Study|Physician Decision|4|||
44287268|NCT01514682|79251296|FG001|Overall Study|Physician Decision|3|||
44287269|NCT01514448|79251304|FG000|Overall Study|Death|7|||
44287270|NCT01514448|79251305|FG001|Overall Study|Death|8|||
44287271|NCT01514448|79251304|FG000|Overall Study|Withdrawal by Subject|2|||
44287272|NCT01514448|79251305|FG001|Overall Study|Withdrawal by Subject|0|||
44287273|NCT01514448|79251304|FG000|Overall Study|Lost to Follow-up|2|||
44287274|NCT01514448|79251305|FG001|Overall Study|Lost to Follow-up|0|||
44287275|NCT01514448|79251304|FG000|Overall Study|New Cancer Therapy|1|||
44287276|NCT01514448|79251305|FG001|Overall Study|New Cancer Therapy|0|||
44287277|NCT01514370|79251314|FG000|Overall Study|Protocol Violation|2|||
44287278|NCT01514370|79251315|FG001|Overall Study|Protocol Violation|3|||
44287279|NCT01514370|79251314|FG000|Overall Study|Lost to Follow-up|0|||
44287280|NCT01514370|79251315|FG001|Overall Study|Lost to Follow-up|2|||
44287281|NCT01514370|79251314|FG000|Overall Study|Withdrawal by Subject|2|||
44287282|NCT01514370|79251315|FG001|Overall Study|Withdrawal by Subject|1|||
44287283|NCT01514370|79251314|FG000|Overall Study|Adverse Event|1|||
44287284|NCT01514370|79251315|FG001|Overall Study|Adverse Event|3|||
44287285|NCT01514370|79251314|FG000|Overall Study|Other|6|||
44287286|NCT01514370|79251315|FG001|Overall Study|Other|7|||
44287287|NCT01519674|79251325|FG000|Overall Study|Adverse Event|3|||
44287288|NCT01519674|79251326|FG001|Overall Study|Adverse Event|3|||
44287289|NCT01519674|79251327|FG002|Overall Study|Adverse Event|0|||
44287290|NCT01519674|79251325|FG000|Overall Study|Lack of Efficacy|1|||
44287291|NCT01519674|79251326|FG001|Overall Study|Lack of Efficacy|1|||
44287292|NCT01519674|79251327|FG002|Overall Study|Lack of Efficacy|1|||
44287293|NCT01519674|79251325|FG000|Overall Study|Protocol Violation|0|||
44287294|NCT01519674|79251326|FG001|Overall Study|Protocol Violation|3|||
44287295|NCT01519674|79251327|FG002|Overall Study|Protocol Violation|1|||
44287296|NCT01519674|79251325|FG000|Overall Study|Withdrawal Criteria|7|||
44415713|NCT00782496|79423444|FG000|Overall Study|Lost to Follow-up|14|||
44415714|NCT00782496|79423445|FG001|Overall Study|Lost to Follow-up|15|||
44415715|NCT00782418|79423452|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
44415716|NCT00782418|79423453|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
44533523|NCT00812006|79543754|FG002|Overall Study|Physician Decision|1|||
44287297|NCT01519674|79251326|FG001|Overall Study|Withdrawal Criteria|2|||
44287298|NCT01519674|79251327|FG002|Overall Study|Withdrawal Criteria|7|||
44415717|NCT00782418|79423454|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
44415718|NCT00782418|79423455|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
44287299|NCT01519674|79251325|FG000|Overall Study|Unsclassified|10|||
44287300|NCT01519674|79251326|FG001|Overall Study|Unsclassified|4|||
44287301|NCT01519674|79251327|FG002|Overall Study|Unsclassified|3|||
44287302|NCT01519518|79251337|FG000|Overall Study|Consent not available|7|||
44287303|NCT01519518|79251338|FG001|Overall Study|Consent not available|10|||
44287304|NCT01519206|79251344|FG000|Overall Study|Lost to Follow-up|3|||
44287305|NCT01519206|79251344|FG000|Overall Study|Missed Visit|2|||
44287306|NCT01518972|79251357|FG000|Overall Study|Lost to Follow-up|2|||
44415719|NCT00782418|79423456|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
44287307|NCT01518972|79251358|FG001|Overall Study|Lost to Follow-up|1|||
44287308|NCT01518972|79251357|FG000|Overall Study|Withdrawal by Subject|1|||
44287309|NCT01518972|79251358|FG001|Overall Study|Withdrawal by Subject|0|||
44287310|NCT01518972|79251357|FG000|Overall Study|Moved from area|1|||
44287311|NCT01518972|79251358|FG001|Overall Study|Moved from area|0|||
44287312|NCT01518972|79251357|FG000|Overall Study|Transportation problems|1|||
44287313|NCT01518972|79251358|FG001|Overall Study|Transportation problems|0|||
44287314|NCT01518972|79251357|FG000|Overall Study|Exclusionary medical condition|1|||
44287315|NCT01518972|79251358|FG001|Overall Study|Exclusionary medical condition|0|||
44287316|NCT01518972|79251357|FG000|Overall Study|Missed safety visits|0|||
44287317|NCT01518972|79251358|FG001|Overall Study|Missed safety visits|1|||
44287318|NCT01518972|79251357|FG000|Overall Study|Exclusionary medication|0|||
44287319|NCT01518972|79251358|FG001|Overall Study|Exclusionary medication|1|||
44287320|NCT01518972|79251357|FG000|Overall Study|Declined medication starting on day 12|0|||
44287321|NCT01518972|79251358|FG001|Overall Study|Declined medication starting on day 12|1|||
44287322|NCT01514136|79251366|FG000|Test Period 1; Test A|Protocol Violation|1|||
44287323|NCT01514136|79251367|FG001|Test Period 1; Test A|Protocol Violation|0|||
44287324|NCT01514136|79251368|FG002|Test Period 1; Test A|Protocol Violation|0|||
44287325|NCT01514136|79251369|FG003|Test Period 1; Test A|Protocol Violation|0|||
44287326|NCT01514136|79251370|FG004|Test Period 1; Test A|Protocol Violation|0|||
44287327|NCT01514136|79251371|FG005|Test Period 1; Test A|Protocol Violation|0|||
44287328|NCT01514136|79251372|FG006|Test Period 1; Test A|Protocol Violation|0|||
44287329|NCT01514136|79251373|FG007|Test Period 1; Test A|Protocol Violation|0|||
44287330|NCT01514136|79251366|FG000|Test Period 1; Test A|Break from study holiday|2|||
44287331|NCT01514136|79251367|FG001|Test Period 1; Test A|Break from study holiday|0|||
44287332|NCT01514136|79251368|FG002|Test Period 1; Test A|Break from study holiday|0|||
44287333|NCT01514136|79251369|FG003|Test Period 1; Test A|Break from study holiday|0|||
44287334|NCT01514136|79251370|FG004|Test Period 1; Test A|Break from study holiday|0|||
44287335|NCT01514136|79251371|FG005|Test Period 1; Test A|Break from study holiday|0|||
44287336|NCT01514136|79251372|FG006|Test Period 1; Test A|Break from study holiday|0|||
44287337|NCT01514136|79251373|FG007|Test Period 1; Test A|Break from study holiday|0|||
44287338|NCT01514136|79251366|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
44287339|NCT01514136|79251367|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
44287340|NCT01514136|79251368|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
44287341|NCT01514136|79251369|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
44287342|NCT01514136|79251370|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
44287343|NCT01514136|79251371|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
44287344|NCT01514136|79251372|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
44287345|NCT01514136|79251373|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
44287346|NCT01514136|79251366|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287347|NCT01514136|79251367|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287348|NCT01514136|79251368|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287349|NCT01514136|79251369|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
44287350|NCT01514136|79251370|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287351|NCT01514136|79251371|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287352|NCT01514136|79251372|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287353|NCT01514136|79251373|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
44287354|NCT01514136|79251366|FG000|Test Period 2; Test A*|Adverse Event|0|||
44287355|NCT01514136|79251367|FG001|Test Period 2; Test A*|Adverse Event|0|||
44287356|NCT01514136|79251368|FG002|Test Period 2; Test A*|Adverse Event|0|||
44287357|NCT01514136|79251369|FG003|Test Period 2; Test A*|Adverse Event|0|||
44287358|NCT01514136|79251370|FG004|Test Period 2; Test A*|Adverse Event|1|||
44287359|NCT01514136|79251371|FG005|Test Period 2; Test A*|Adverse Event|0|||
44287360|NCT01514136|79251372|FG006|Test Period 2; Test A*|Adverse Event|0|||
44287361|NCT01514136|79251373|FG007|Test Period 2; Test A*|Adverse Event|0|||
44287362|NCT01514136|79251366|FG000|Test Period 2; Test A*|Holiday|0|||
44287363|NCT01514136|79251367|FG001|Test Period 2; Test A*|Holiday|0|||
44287364|NCT01514136|79251368|FG002|Test Period 2; Test A*|Holiday|0|||
44287365|NCT01514136|79251369|FG003|Test Period 2; Test A*|Holiday|0|||
44287366|NCT01514136|79251370|FG004|Test Period 2; Test A*|Holiday|1|||
44287367|NCT01514136|79251371|FG005|Test Period 2; Test A*|Holiday|0|||
44287368|NCT01514136|79251372|FG006|Test Period 2; Test A*|Holiday|0|||
44287369|NCT01514136|79251373|FG007|Test Period 2; Test A*|Holiday|0|||
44415720|NCT00782418|79423457|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
44415721|NCT00782418|79423458|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
44415722|NCT00782418|79423452|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
44415723|NCT00782418|79423453|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
44415724|NCT00782418|79423454|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
44287370|NCT01514136|79251366|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
44287371|NCT01514136|79251367|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
44287372|NCT01514136|79251368|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
44287373|NCT01514136|79251369|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
44287374|NCT01514136|79251370|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
44415725|NCT00782418|79423455|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
44287375|NCT01514136|79251371|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
44287376|NCT01514136|79251372|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
44287377|NCT01514136|79251373|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
44287378|NCT01514136|79251366|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287379|NCT01514136|79251367|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287380|NCT01514136|79251368|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287381|NCT01514136|79251369|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287382|NCT01514136|79251370|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287383|NCT01514136|79251371|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287384|NCT01514136|79251372|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
44287385|NCT01514136|79251373|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
44287386|NCT01514136|79251366|FG000|Test Period 2; Test C*|holiday|0|||
44287387|NCT01514136|79251367|FG001|Test Period 2; Test C*|holiday|0|||
44287388|NCT01514136|79251368|FG002|Test Period 2; Test C*|holiday|0|||
44287389|NCT01514136|79251369|FG003|Test Period 2; Test C*|holiday|0|||
44287390|NCT01514136|79251370|FG004|Test Period 2; Test C*|holiday|0|||
44287391|NCT01514136|79251371|FG005|Test Period 2; Test C*|holiday|0|||
44287392|NCT01514136|79251372|FG006|Test Period 2; Test C*|holiday|1|||
44287393|NCT01514136|79251373|FG007|Test Period 2; Test C*|holiday|0|||
44287394|NCT01514136|79251366|FG000|Test Period 2; Test C*|Protocol Violation|0|||
44287395|NCT01514136|79251367|FG001|Test Period 2; Test C*|Protocol Violation|0|||
44287396|NCT01514136|79251368|FG002|Test Period 2; Test C*|Protocol Violation|0|||
44287397|NCT01514136|79251369|FG003|Test Period 2; Test C*|Protocol Violation|0|||
44287398|NCT01514136|79251370|FG004|Test Period 2; Test C*|Protocol Violation|0|||
44287399|NCT01514136|79251371|FG005|Test Period 2; Test C*|Protocol Violation|0|||
44287400|NCT01514136|79251372|FG006|Test Period 2; Test C*|Protocol Violation|1|||
44287401|NCT01514136|79251373|FG007|Test Period 2; Test C*|Protocol Violation|0|||
44287402|NCT01513590|79251401|FG000|Overall Study|Adverse Event|2|||
44287403|NCT01513590|79251402|FG001|Overall Study|Adverse Event|3|||
44287404|NCT01513590|79251401|FG000|Overall Study|Withdrawal Criteria|3|||
44287405|NCT01513590|79251402|FG001|Overall Study|Withdrawal Criteria|0|||
44287406|NCT01513590|79251401|FG000|Overall Study|Unclassified|5|||
44287407|NCT01513590|79251402|FG001|Overall Study|Unclassified|10|||
44287408|NCT01512264|79251412|FG000|Overall Study|Lost to Follow-up|0|||
44287409|NCT01512264|79251413|FG001|Overall Study|Lost to Follow-up|0|||
44287410|NCT01512264|79251414|FG002|Overall Study|Lost to Follow-up|0|||
44287411|NCT01512264|79251415|FG003|Overall Study|Lost to Follow-up|1|||
44287412|NCT01512108|79251427|FG000|Overall Study|Adverse Event|9|||
44287413|NCT01512108|79251428|FG001|Overall Study|Adverse Event|4|||
44287414|NCT01512108|79251427|FG000|Overall Study|Protocol Violation|1|||
44287415|NCT01512108|79251428|FG001|Overall Study|Protocol Violation|2|||
44287416|NCT01512108|79251427|FG000|Overall Study|Withdrawal Criteria|1|||
44287417|NCT01512108|79251428|FG001|Overall Study|Withdrawal Criteria|0|||
44287418|NCT01512108|79251427|FG000|Overall Study|Unclassified|11|||
44287419|NCT01512108|79251428|FG001|Overall Study|Unclassified|3|||
44287420|NCT01486758|79251436|FG000|Overall Study|Lost to Follow-up|0|||
44287421|NCT01486758|79251437|FG001|Overall Study|Lost to Follow-up|1|||
44287422|NCT01463982|79251448|FG000|Overall Study|Withdrawal by Subject|0|||
44287423|NCT01463982|79251449|FG001|Overall Study|Withdrawal by Subject|1|||
44287424|NCT01463982|79251450|FG002|Overall Study|Withdrawal by Subject|1|||
44287425|NCT01463982|79251451|FG003|Overall Study|Withdrawal by Subject|0|||
44287426|NCT01463982|79251448|FG000|Overall Study|Treatment delay over 5 week|0|||
44287427|NCT01463982|79251449|FG001|Overall Study|Treatment delay over 5 week|0|||
44287428|NCT01463982|79251450|FG002|Overall Study|Treatment delay over 5 week|1|||
44287429|NCT01463982|79251451|FG003|Overall Study|Treatment delay over 5 week|0|||
44287430|NCT01486446|79251463|FG000|Overall Study|Adverse Event|1|||
44287431|NCT01486446|79251464|FG001|Overall Study|Adverse Event|0|||
44287432|NCT01485354|79251470|FG000|Overall Study|Withdrawal by Subject|5|||
44287433|NCT01510158|79251477|FG000|Overall Study|Adverse Event|7|||
44287434|NCT01510158|79251478|FG001|Overall Study|Adverse Event|8|||
44287435|NCT01510158|79251479|FG002|Overall Study|Adverse Event|5|||
44533524|NCT00812006|79543752|FG000|Overall Study|Withdrawal by Subject|2|||
44533525|NCT00812006|79543753|FG001|Overall Study|Withdrawal by Subject|1|||
44533526|NCT00812006|79543754|FG002|Overall Study|Withdrawal by Subject|1|||
44415726|NCT00782418|79423456|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
44533527|NCT00812006|79543752|FG000|Overall Study|Lack of Qualifying Event|4|||
44287436|NCT01510158|79251477|FG000|Overall Study|Gout flare|1|||
44287437|NCT01510158|79251478|FG001|Overall Study|Gout flare|0|||
44287438|NCT01510158|79251479|FG002|Overall Study|Gout flare|0|||
44415727|NCT00782418|79423457|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
44533528|NCT00812006|79543753|FG001|Overall Study|Lack of Qualifying Event|2|||
44287439|NCT01510158|79251477|FG000|Overall Study|Protocol Violation|17|||
44287440|NCT01510158|79251478|FG001|Overall Study|Protocol Violation|16|||
44287441|NCT01510158|79251479|FG002|Overall Study|Protocol Violation|24|||
44287442|NCT01510158|79251477|FG000|Overall Study|Sponsor terminated study.|2|||
44287443|NCT01510158|79251478|FG001|Overall Study|Sponsor terminated study.|0|||
44287444|NCT01510158|79251479|FG002|Overall Study|Sponsor terminated study.|2|||
44287445|NCT01510158|79251477|FG000|Overall Study|Lost to Follow-up|13|||
44287446|NCT01510158|79251478|FG001|Overall Study|Lost to Follow-up|16|||
44287447|NCT01510158|79251479|FG002|Overall Study|Lost to Follow-up|9|||
44287448|NCT01510158|79251477|FG000|Overall Study|Withdrawal by Subject|10|||
44287449|NCT01510158|79251478|FG001|Overall Study|Withdrawal by Subject|13|||
44287450|NCT01510158|79251479|FG002|Overall Study|Withdrawal by Subject|10|||
44287451|NCT01510158|79251477|FG000|Overall Study|Death|1|||
44287452|NCT01510158|79251478|FG001|Overall Study|Death|0|||
44287453|NCT01510158|79251479|FG002|Overall Study|Death|0|||
44287454|NCT01485120|79251496|FG000|Overall Study|Withdrawal by Subject|2|||
44287455|NCT01484496|79251503|FG000|Period 1|Protocol Violation|3|||
44287456|NCT01484496|79251504|FG001|Period 1|Protocol Violation|4|||
44287457|NCT01484496|79251505|FG002|Period 1|Protocol Violation|0|||
44287458|NCT01484496|79251506|FG003|Period 1|Protocol Violation|0|||
44287459|NCT01484496|79251503|FG000|Period 1|Physician Decision|5|||
44287460|NCT01484496|79251504|FG001|Period 1|Physician Decision|1|||
44287461|NCT01484496|79251505|FG002|Period 1|Physician Decision|0|||
44287462|NCT01484496|79251506|FG003|Period 1|Physician Decision|0|||
44287463|NCT01484496|79251503|FG000|Period 1|Lack of Efficacy|10|||
44287464|NCT01484496|79251504|FG001|Period 1|Lack of Efficacy|15|||
44287465|NCT01484496|79251505|FG002|Period 1|Lack of Efficacy|0|||
44287466|NCT01484496|79251506|FG003|Period 1|Lack of Efficacy|0|||
44287467|NCT01484496|79251503|FG000|Period 1|Adverse Event|25|||
44287468|NCT01484496|79251504|FG001|Period 1|Adverse Event|40|||
44287469|NCT01484496|79251505|FG002|Period 1|Adverse Event|0|||
44287470|NCT01484496|79251506|FG003|Period 1|Adverse Event|0|||
44287471|NCT01484496|79251503|FG000|Period 1|Withdrawal by Subject|15|||
44287472|NCT01484496|79251504|FG001|Period 1|Withdrawal by Subject|12|||
44287473|NCT01484496|79251505|FG002|Period 1|Withdrawal by Subject|0|||
44287474|NCT01484496|79251506|FG003|Period 1|Withdrawal by Subject|0|||
44287475|NCT01484496|79251503|FG000|Period 1|Lost to Follow-up|2|||
44287476|NCT01484496|79251504|FG001|Period 1|Lost to Follow-up|6|||
44287477|NCT01484496|79251505|FG002|Period 1|Lost to Follow-up|0|||
44287478|NCT01484496|79251506|FG003|Period 1|Lost to Follow-up|0|||
44287479|NCT01484496|79251503|FG000|Period 1|Positive Pregnancy|1|||
44287480|NCT01484496|79251504|FG001|Period 1|Positive Pregnancy|6|||
44287481|NCT01484496|79251505|FG002|Period 1|Positive Pregnancy|0|||
44287482|NCT01484496|79251506|FG003|Period 1|Positive Pregnancy|0|||
44287483|NCT01484496|79251503|FG000|Period 1|Treatment Failure|3|||
44287484|NCT01484496|79251504|FG001|Period 1|Treatment Failure|6|||
44287485|NCT01484496|79251505|FG002|Period 1|Treatment Failure|0|||
44287486|NCT01484496|79251506|FG003|Period 1|Treatment Failure|0|||
44287487|NCT01484496|79251503|FG000|Period 1|Lack of Compliance|2|||
44287488|NCT01484496|79251504|FG001|Period 1|Lack of Compliance|1|||
44287489|NCT01484496|79251505|FG002|Period 1|Lack of Compliance|0|||
44287490|NCT01484496|79251506|FG003|Period 1|Lack of Compliance|0|||
44287491|NCT01484496|79251503|FG000|Period 1|Unable to Visit Site|0|||
44287492|NCT01484496|79251504|FG001|Period 1|Unable to Visit Site|2|||
44287493|NCT01484496|79251505|FG002|Period 1|Unable to Visit Site|0|||
44287494|NCT01484496|79251506|FG003|Period 1|Unable to Visit Site|0|||
44287495|NCT01484496|79251503|FG000|Period 2|Lack of Efficacy|0|||
44287496|NCT01484496|79251504|FG001|Period 2|Lack of Efficacy|0|||
44287497|NCT01484496|79251505|FG002|Period 2|Lack of Efficacy|1|||
44287498|NCT01484496|79251506|FG003|Period 2|Lack of Efficacy|3|||
44287499|NCT01484496|79251503|FG000|Period 2|Adverse Event|0|||
44287500|NCT01484496|79251504|FG001|Period 2|Adverse Event|0|||
44287501|NCT01484496|79251505|FG002|Period 2|Adverse Event|5|||
44287502|NCT01484496|79251506|FG003|Period 2|Adverse Event|13|||
44287503|NCT01484496|79251503|FG000|Period 2|Other|0|||
44287504|NCT01484496|79251504|FG001|Period 2|Other|0|||
44287505|NCT01484496|79251505|FG002|Period 2|Other|9|||
44287506|NCT01484496|79251506|FG003|Period 2|Other|6|||
44287507|NCT01509846|79251519|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
44287508|NCT01509846|79251520|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
44287509|NCT01509846|79251521|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
44287510|NCT01509846|79251522|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
44287511|NCT01509846|79251523|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
44287512|NCT01509846|79251519|FG000|Received Vaccination 2|Illness|0|||
44415728|NCT00782418|79423458|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
44415729|NCT00782340|79423475|FG000|Open Label Titration|Adverse Event|12|||
44415730|NCT00782340|79423476|FG001|Open Label Titration|Adverse Event|0|||
44287513|NCT01509846|79251520|FG001|Received Vaccination 2|Illness|0|||
44287514|NCT01509846|79251521|FG002|Received Vaccination 2|Illness|0|||
44287515|NCT01509846|79251522|FG003|Received Vaccination 2|Illness|0|||
44415731|NCT00782340|79423477|FG002|Open Label Titration|Adverse Event|0|||
44287516|NCT01509846|79251523|FG004|Received Vaccination 2|Illness|1|||
44415732|NCT00782340|79423475|FG000|Open Label Titration|Treatment failure|50|||
44287517|NCT01509846|79251519|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
44287518|NCT01509846|79251520|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
44287519|NCT01509846|79251521|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
44287520|NCT01509846|79251522|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
44287521|NCT01509846|79251523|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
44287522|NCT01509846|79251519|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
44287523|NCT01509846|79251520|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
44287524|NCT01509846|79251521|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
44287525|NCT01509846|79251522|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
44287526|NCT01509846|79251523|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
44287527|NCT01509846|79251519|FG000|Received Vaccination 3|Pregnancy|0|||
44287528|NCT01509846|79251520|FG001|Received Vaccination 3|Pregnancy|0|||
44287529|NCT01509846|79251521|FG002|Received Vaccination 3|Pregnancy|0|||
44287530|NCT01509846|79251522|FG003|Received Vaccination 3|Pregnancy|1|||
44287531|NCT01509846|79251523|FG004|Received Vaccination 3|Pregnancy|0|||
44287532|NCT01509846|79251519|FG000|Received Vaccination 3|Lost to Follow-up|0|||
44287533|NCT01509846|79251520|FG001|Received Vaccination 3|Lost to Follow-up|0|||
44287534|NCT01509846|79251521|FG002|Received Vaccination 3|Lost to Follow-up|1|||
44287535|NCT01509846|79251522|FG003|Received Vaccination 3|Lost to Follow-up|0|||
44287536|NCT01509846|79251523|FG004|Received Vaccination 3|Lost to Follow-up|0|||
44287537|NCT01462344|79251544|FG000|Overall Study|Withdrawal by Subject|245|||
44287538|NCT01462344|79251545|FG001|Overall Study|Withdrawal by Subject|226|||
44287539|NCT01462344|79251544|FG000|Overall Study|Adverse Event|24|||
44287540|NCT01462344|79251545|FG001|Overall Study|Adverse Event|23|||
44287541|NCT01462344|79251544|FG000|Overall Study|Asthma Exacerbation|34|||
44287542|NCT01462344|79251545|FG001|Overall Study|Asthma Exacerbation|35|||
44287543|NCT01462344|79251544|FG000|Overall Study|Lack of Efficacy|5|||
44287544|NCT01462344|79251545|FG001|Overall Study|Lack of Efficacy|6|||
44287545|NCT01462344|79251544|FG000|Overall Study|Protocol Violation|68|||
44287546|NCT01462344|79251545|FG001|Overall Study|Protocol Violation|53|||
44287547|NCT01462344|79251544|FG000|Overall Study|Lost to Follow-up|7|||
44287548|NCT01462344|79251545|FG001|Overall Study|Lost to Follow-up|7|||
44287549|NCT01484028|79251551|FG000|Period 1|Lost to Follow-up|0|||
44287550|NCT01484028|79251552|FG001|Period 1|Lost to Follow-up|1|||
44533529|NCT00812006|79543754|FG002|Overall Study|Lack of Qualifying Event|2|||
44533530|NCT04988308|79543788|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
44287551|NCT01484028|79251553|FG002|Period 1|Lost to Follow-up|0|||
44287552|NCT01484028|79251554|FG003|Period 1|Lost to Follow-up|0|||
44287553|NCT01484028|79251551|FG000|Period 1|Non-Compliance to Protocol|0|||
44287554|NCT01484028|79251552|FG001|Period 1|Non-Compliance to Protocol|1|||
44287555|NCT01484028|79251553|FG002|Period 1|Non-Compliance to Protocol|0|||
44287556|NCT01484028|79251554|FG003|Period 1|Non-Compliance to Protocol|1|||
44287557|NCT01484028|79251551|FG000|Period 1|Lens Discomfort|0|||
44287558|NCT01484028|79251552|FG001|Period 1|Lens Discomfort|1|||
44287559|NCT01484028|79251553|FG002|Period 1|Lens Discomfort|0|||
44287560|NCT01484028|79251554|FG003|Period 1|Lens Discomfort|0|||
44287561|NCT01462266|79251564|FG000|Overall Study|Adverse Event|7|||
44287562|NCT01462266|79251565|FG001|Overall Study|Adverse Event|6|||
44287563|NCT01462266|79251564|FG000|Overall Study|Death|2|||
44287564|NCT01462266|79251565|FG001|Overall Study|Death|1|||
44287565|NCT01462266|79251564|FG000|Overall Study|Lack of Efficacy|0|||
44287566|NCT01462266|79251565|FG001|Overall Study|Lack of Efficacy|2|||
44287567|NCT01462266|79251564|FG000|Overall Study|Lost to Follow-up|4|||
44287568|NCT01462266|79251565|FG001|Overall Study|Lost to Follow-up|3|||
44287569|NCT01462266|79251564|FG000|Overall Study|Non-compliance with study drug|3|||
44287570|NCT01462266|79251565|FG001|Overall Study|Non-compliance with study drug|0|||
44287571|NCT01462266|79251564|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
44287572|NCT01462266|79251565|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
44287573|NCT01462266|79251564|FG000|Overall Study|Physician Decision|2|||
44287574|NCT01462266|79251565|FG001|Overall Study|Physician Decision|5|||
44287575|NCT01462266|79251564|FG000|Overall Study|Protocol Violation|1|||
44287576|NCT01462266|79251565|FG001|Overall Study|Protocol Violation|3|||
44287577|NCT01462266|79251564|FG000|Overall Study|Withdrawal by Subject|7|||
44287578|NCT01462266|79251565|FG001|Overall Study|Withdrawal by Subject|2|||
44287579|NCT01462266|79251564|FG000|Overall Study|Screen failure|1|||
44287580|NCT01462266|79251565|FG001|Overall Study|Screen failure|1|||
44287581|NCT01508910|79251574|FG000|Treatment|Death|2|||
44287582|NCT01508910|79251575|FG001|Treatment|Death|3|||
44287583|NCT01508910|79251576|FG002|Treatment|Death|2|||
44287584|NCT01508910|79251577|FG003|Treatment|Death|0|||
44287585|NCT01508910|79251574|FG000|Treatment|Lost to Follow-up|0|||
44533531|NCT04988308|79543789|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
44287586|NCT01508910|79251575|FG001|Treatment|Lost to Follow-up|0|||
44287587|NCT01508910|79251576|FG002|Treatment|Lost to Follow-up|2|||
44287588|NCT01508910|79251577|FG003|Treatment|Lost to Follow-up|1|||
44287589|NCT01508910|79251574|FG000|Treatment|Withdrawal by Subject|0|||
44287590|NCT01508910|79251575|FG001|Treatment|Withdrawal by Subject|1|||
44287591|NCT01508910|79251576|FG002|Treatment|Withdrawal by Subject|6|||
44287592|NCT01508910|79251577|FG003|Treatment|Withdrawal by Subject|1|||
44287593|NCT01508910|79251574|FG000|Treatment|Sponsor Decision|0|||
44287594|NCT01508910|79251575|FG001|Treatment|Sponsor Decision|0|||
44287595|NCT01508910|79251576|FG002|Treatment|Sponsor Decision|0|||
44287596|NCT01508910|79251577|FG003|Treatment|Sponsor Decision|1|||
44287597|NCT01462110|79251591|FG000|Overall Study|Adverse Event|1|||
44287598|NCT01462110|79251592|FG001|Overall Study|Adverse Event|0|||
44287599|NCT01508676|79251600|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
44287600|NCT01508676|79251601|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
44287601|NCT01508676|79251600|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
44287602|NCT01508676|79251601|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
44287603|NCT01508676|79251600|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
44287604|NCT01508676|79251601|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
44287605|NCT01508676|79251600|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
44287606|NCT01508676|79251601|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
44287607|NCT01508676|79251600|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
44287608|NCT01508676|79251601|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
44287609|NCT01508130|79251610|FG000|Overall Study|Adverse Event|81|||
44287610|NCT01508130|79251611|FG001|Overall Study|Adverse Event|28|||
44287611|NCT01508130|79251610|FG000|Overall Study|Death|3|||
44287612|NCT01508130|79251611|FG001|Overall Study|Death|1|||
44287613|NCT01508130|79251610|FG000|Overall Study|Protocol Violation|2|||
44287614|NCT01508130|79251611|FG001|Overall Study|Protocol Violation|0|||
44287615|NCT01508130|79251610|FG000|Overall Study|Lost to Follow-up|25|||
44287616|NCT01508130|79251611|FG001|Overall Study|Lost to Follow-up|2|||
44287617|NCT01508130|79251610|FG000|Overall Study|Withdrawal by Subject|3|||
44287618|NCT01508130|79251611|FG001|Overall Study|Withdrawal by Subject|3|||
44287619|NCT01508130|79251610|FG000|Overall Study|Subject's substantial non-compliance|25|||
44287620|NCT01508130|79251611|FG001|Overall Study|Subject's substantial non-compliance|9|||
44287621|NCT01508130|79251610|FG000|Overall Study|Insufficient therapeutic response|74|||
44287622|NCT01508130|79251611|FG001|Overall Study|Insufficient therapeutic response|23|||
44287623|NCT01508130|79251610|FG000|Overall Study|Administrative|14|||
44287624|NCT01508130|79251611|FG001|Overall Study|Administrative|3|||
44287625|NCT01482312|79251619|FG000|Period 1, 90 Minutes of Wear|Other|1|||
44287626|NCT01482312|79251620|FG001|Period 1, 90 Minutes of Wear|Other|0|||
44287627|NCT01482312|79251621|FG002|Period 1, 90 Minutes of Wear|Other|0|||
44287628|NCT01482312|79251619|FG000|Period 2, 90 Minutes of Wear|Other|1|||
44287629|NCT01482312|79251620|FG001|Period 2, 90 Minutes of Wear|Other|0|||
44287630|NCT01482312|79251621|FG002|Period 2, 90 Minutes of Wear|Other|0|||
44287631|NCT01461096|79251631|FG000|Overall Study|Death|3|||
44287632|NCT01461096|79251632|FG001|Overall Study|Death|6|||
44287633|NCT01461096|79251631|FG000|Overall Study|Severe debilitation, unable to continue|1|||
44287634|NCT01461096|79251632|FG001|Overall Study|Severe debilitation, unable to continue|1|||
44287635|NCT01461096|79251631|FG000|Overall Study|Subj not able to get to clinic|15|||
44287636|NCT01461096|79251632|FG001|Overall Study|Subj not able to get to clinic|13|||
44287637|NCT01461096|79251631|FG000|Overall Study|Site is closing|27|||
44287638|NCT01461096|79251632|FG001|Overall Study|Site is closing|30|||
44287639|NCT01461096|79251631|FG000|Overall Study|Withdrawal by Subject|5|||
44287640|NCT01461096|79251632|FG001|Overall Study|Withdrawal by Subject|3|||
44287641|NCT01461096|79251631|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
44287642|NCT01461096|79251632|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
44287643|NCT01461096|79251631|FG000|Overall Study|Lost to Follow-up|8|||
44287644|NCT01461096|79251632|FG001|Overall Study|Lost to Follow-up|4|||
44287645|NCT01507896|79251639|FG000|Overall Study|Withdrawal by Subject|1|||
44287646|NCT01507896|79251639|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
44287647|NCT01507662|79251654|FG000|Overall Study|Death|26|||
44287648|NCT01507662|79251655|FG001|Overall Study|Death|18|||
44287649|NCT01507662|79251654|FG000|Overall Study|Withdrawal by Subject|290|||
44287650|NCT01507662|79251655|FG001|Overall Study|Withdrawal by Subject|287|||
44287651|NCT01507662|79251654|FG000|Overall Study|Lost to Follow-up|498|||
44287652|NCT01507662|79251655|FG001|Overall Study|Lost to Follow-up|523|||
44533532|NCT04988308|79543790|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
44533533|NCT04988308|79543791|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
44533534|NCT04988308|79543792|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
44533535|NCT04988308|79543793|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
44533536|NCT04988308|79543788|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
44533537|NCT04988308|79543789|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
44533538|NCT04988308|79543790|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
44533539|NCT04988308|79543791|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
44533540|NCT04988308|79543792|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
44533541|NCT04988308|79543793|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
44533542|NCT04988308|79543788|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
44287653|NCT01507662|79251654|FG000|Overall Study|Proxy interview done|2|||
44287654|NCT01507662|79251655|FG001|Overall Study|Proxy interview done|3|||
44287655|NCT01506960|79251661|FG000|Overall Study|Did not meet angiographic criteria|47|||
44287656|NCT01480674|79251667|FG000|Overall Study|Death|23|||
44287657|NCT01480674|79251667|FG000|Overall Study|Lost to Follow-up|2|||
44287658|NCT01480674|79251667|FG000|Overall Study|visit not done|10|||
44287659|NCT01506882|79251673|FG000|Overall Study|Lack of Efficacy|4|||
44287660|NCT01506882|79251674|FG001|Overall Study|Lack of Efficacy|3|||
44533543|NCT04988308|79543789|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
44533544|NCT04988308|79543790|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
44533545|NCT04988308|79543791|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
44533546|NCT04988308|79543792|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
44533547|NCT04988308|79543793|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
44533548|NCT04988308|79543788|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
44533549|NCT04988308|79543789|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
44533550|NCT04988308|79543790|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
44533551|NCT04988308|79543791|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
44533552|NCT04988308|79543792|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
44533553|NCT04988308|79543793|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
44287661|NCT01506882|79251673|FG000|Overall Study|Lost to Follow-up|1|||
44287662|NCT01506882|79251674|FG001|Overall Study|Lost to Follow-up|0|||
44415733|NCT00782340|79423476|FG001|Open Label Titration|Treatment failure|0|||
44415734|NCT00782340|79423477|FG002|Open Label Titration|Treatment failure|0|||
44415735|NCT00782340|79423475|FG000|Open Label Titration|Protocol Violation|5|||
44415736|NCT00782340|79423476|FG001|Open Label Titration|Protocol Violation|0|||
44415737|NCT00782340|79423477|FG002|Open Label Titration|Protocol Violation|0|||
44415738|NCT00782340|79423475|FG000|Open Label Titration|Withdrawal by Subject|5|||
44415739|NCT00782340|79423476|FG001|Open Label Titration|Withdrawal by Subject|0|||
44533554|NCT04988308|79543788|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
44533555|NCT04988308|79543789|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
44533556|NCT04988308|79543790|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
44533557|NCT04988308|79543791|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
44287663|NCT01506882|79251673|FG000|Overall Study|Withdrawal by Subject|9|||
44287664|NCT01506882|79251674|FG001|Overall Study|Withdrawal by Subject|3|||
44287665|NCT01506882|79251673|FG000|Overall Study|SAE, non-fatal|2|||
44415740|NCT00782340|79423477|FG002|Open Label Titration|Withdrawal by Subject|0|||
44415741|NCT00782340|79423475|FG000|Open Label Titration|Enrollment capped|16|||
44415742|NCT00782340|79423476|FG001|Open Label Titration|Enrollment capped|0|||
44415743|NCT00782340|79423477|FG002|Open Label Titration|Enrollment capped|0|||
44415744|NCT00782340|79423475|FG000|Open Label Titration|Did not meet responder criteria|2|||
44415745|NCT00782340|79423476|FG001|Open Label Titration|Did not meet responder criteria|0|||
44415746|NCT00782340|79423477|FG002|Open Label Titration|Did not meet responder criteria|0|||
44415747|NCT00782340|79423475|FG000|Open Label Titration|Lost to Follow-up|5|||
44415748|NCT00782340|79423476|FG001|Open Label Titration|Lost to Follow-up|0|||
44415749|NCT00782340|79423477|FG002|Open Label Titration|Lost to Follow-up|0|||
44415750|NCT00782340|79423475|FG000|Open Label Titration|Randomized in error|6|||
44415751|NCT00782340|79423476|FG001|Open Label Titration|Randomized in error|0|||
44415752|NCT00782340|79423477|FG002|Open Label Titration|Randomized in error|0|||
44415753|NCT00774852|79423486|FG000|Overall Study|Adverse Event|9|||
44415754|NCT00774852|79423487|FG001|Overall Study|Adverse Event|6|||
44415755|NCT00774852|79423486|FG000|Overall Study|Death|2|||
44415756|NCT00774852|79423487|FG001|Overall Study|Death|1|||
44415757|NCT00774852|79423486|FG000|Overall Study|Lack of Efficacy|3|||
44415758|NCT00774852|79423487|FG001|Overall Study|Lack of Efficacy|7|||
44415759|NCT00774852|79423486|FG000|Overall Study|Lost to Follow-up|9|||
44415760|NCT00774852|79423487|FG001|Overall Study|Lost to Follow-up|5|||
44415761|NCT00774852|79423486|FG000|Overall Study|Physician Decision|2|||
44415762|NCT00774852|79423487|FG001|Overall Study|Physician Decision|6|||
44415763|NCT00774852|79423486|FG000|Overall Study|Pregnancy|1|||
44415764|NCT00774852|79423487|FG001|Overall Study|Pregnancy|2|||
44415765|NCT00774852|79423486|FG000|Overall Study|Withdrawal by Subject|2|||
44415766|NCT00774852|79423487|FG001|Overall Study|Withdrawal by Subject|2|||
44415767|NCT00774852|79423486|FG000|Overall Study|Non-responder|15|||
44415768|NCT00774852|79423487|FG001|Overall Study|Non-responder|11|||
44415769|NCT00774852|79423486|FG000|Overall Study|Subject non-compliance|0|||
44415770|NCT00774852|79423487|FG001|Overall Study|Subject non-compliance|1|||
44415771|NCT00774852|79423486|FG000|Overall Study|Protocol Violation|1|||
44415772|NCT00774852|79423487|FG001|Overall Study|Protocol Violation|0|||
44415773|NCT00774852|79423486|FG000|Overall Study|Subject received prohibited medication|1|||
44533558|NCT04988308|79543792|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
44415774|NCT00774852|79423487|FG001|Overall Study|Subject received prohibited medication|0|||
44415775|NCT00774306|79423507|FG000|Overall Study|Adverse Event|3|||
44415776|NCT00774306|79423508|FG001|Overall Study|Adverse Event|0|||
44287666|NCT01506882|79251674|FG001|Overall Study|SAE, non-fatal|0|||
44415777|NCT00774306|79423509|FG002|Overall Study|Adverse Event|0|||
44415778|NCT00774306|79423510|FG003|Overall Study|Adverse Event|0|||
44415779|NCT00774306|79423507|FG000|Overall Study|Protocol Violation|2|||
44415780|NCT00774306|79423508|FG001|Overall Study|Protocol Violation|0|||
44415781|NCT00774306|79423509|FG002|Overall Study|Protocol Violation|3|||
44415782|NCT00774306|79423510|FG003|Overall Study|Protocol Violation|0|||
44415783|NCT00774306|79423507|FG000|Overall Study|Withdrawal by Subject|6|||
44287667|NCT01506882|79251673|FG000|Overall Study|AE, non-serious non-fatal|3|||
44287668|NCT01506882|79251674|FG001|Overall Study|AE, non-serious non-fatal|1|||
44287669|NCT01506882|79251673|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
44287670|NCT01506882|79251674|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
44287671|NCT01506882|79251673|FG000|Overall Study|Other Reason|2|||
44287672|NCT01506882|79251674|FG001|Overall Study|Other Reason|0|||
44287673|NCT01506726|79251684|FG000|Overall Study|Adverse Event|1|||
44287674|NCT01506726|79251685|FG001|Overall Study|Adverse Event|2|||
44287675|NCT01505868|79251696|FG000|Overall Study|Withdrawal by Subject|1|||
44287676|NCT01505868|79251697|FG001|Overall Study|Withdrawal by Subject|0|||
44287677|NCT01505868|79251698|FG002|Overall Study|Withdrawal by Subject|0|||
44287678|NCT01505868|79251699|FG003|Overall Study|Withdrawal by Subject|0|||
44287679|NCT01505868|79251700|FG004|Overall Study|Withdrawal by Subject|0|||
44287680|NCT01505634|79251715|FG000|Overall Study|Withdrawal by Subject|2|||
44287681|NCT01505634|79251716|FG001|Overall Study|Withdrawal by Subject|5|||
44287682|NCT01505634|79251717|FG002|Overall Study|Withdrawal by Subject|1|||
44287683|NCT01505634|79251715|FG000|Overall Study|Physician Decision|1|||
44287684|NCT01505634|79251716|FG001|Overall Study|Physician Decision|1|||
44287685|NCT01505634|79251717|FG002|Overall Study|Physician Decision|0|||
44287686|NCT01505634|79251715|FG000|Overall Study|Adverse Event|1|||
44287687|NCT01505634|79251716|FG001|Overall Study|Adverse Event|0|||
44287688|NCT01505634|79251717|FG002|Overall Study|Adverse Event|0|||
44287689|NCT01505634|79251715|FG000|Overall Study|Insufficient supply of drug at site|1|||
44287690|NCT01505634|79251716|FG001|Overall Study|Insufficient supply of drug at site|0|||
44287691|NCT01505634|79251717|FG002|Overall Study|Insufficient supply of drug at site|0|||
44287692|NCT01505634|79251715|FG000|Overall Study|Protocol Violation|2|||
44287693|NCT01505634|79251716|FG001|Overall Study|Protocol Violation|0|||
44287694|NCT01505634|79251717|FG002|Overall Study|Protocol Violation|0|||
44287695|NCT01505634|79251715|FG000|Overall Study|Lost to Follow-up|1|||
44154394|NCT02696785|78945531|FG001|Blinded Treatment Period|Adverse Event|1|||
44154395|NCT02696785|78945532|FG002|Blinded Treatment Period|Adverse Event|3|||
44154396|NCT02696785|78945533|FG003|Blinded Treatment Period|Adverse Event|0|||
44154397|NCT02696785|78945530|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
44154398|NCT02696785|78945531|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
44154399|NCT02696785|78945532|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
44154400|NCT02696785|78945533|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
44287696|NCT01505634|79251716|FG001|Overall Study|Lost to Follow-up|4|||
44287697|NCT01505634|79251717|FG002|Overall Study|Lost to Follow-up|4|||
44287698|NCT01505634|79251715|FG000|Overall Study|Death|1|||
44287699|NCT01505634|79251716|FG001|Overall Study|Death|0|||
44287700|NCT01505634|79251717|FG002|Overall Study|Death|0|||
44287701|NCT01505634|79251715|FG000|Overall Study|In a conflict zone|0|||
44287702|NCT01505634|79251716|FG001|Overall Study|In a conflict zone|0|||
44287703|NCT01505634|79251717|FG002|Overall Study|In a conflict zone|1|||
44287704|NCT01460628|79251725|FG000|Overall Study|Adverse Event|3|||
44287705|NCT01460628|79251725|FG000|Overall Study|Withdrawal by Subject|2|||
44287706|NCT01480596|79251731|FG000|Overall Study|Adverse Event|3|||
44287707|NCT01480596|79251732|FG001|Overall Study|Adverse Event|0|||
44287708|NCT01480596|79251731|FG000|Overall Study|MG exacerbation or change in medication|2|||
44287709|NCT01480596|79251732|FG001|Overall Study|MG exacerbation or change in medication|2|||
44287710|NCT01480284|79251740|FG000|Overall Study|Withdrawal by Subject|2|||
44287711|NCT01480284|79251741|FG001|Overall Study|Withdrawal by Subject|0|||
44287712|NCT01480284|79251740|FG000|Overall Study|Adverse Event|1|||
44287713|NCT01480284|79251741|FG001|Overall Study|Adverse Event|0|||
44287714|NCT01480284|79251740|FG000|Overall Study|Study closed/terminated|3|||
44287715|NCT01480284|79251741|FG001|Overall Study|Study closed/terminated|0|||
44287716|NCT01480284|79251740|FG000|Overall Study|Lost to Follow-up|1|||
44287717|NCT01480284|79251741|FG001|Overall Study|Lost to Follow-up|0|||
44287718|NCT01480284|79251740|FG000|Overall Study|Physician Decision|1|||
44287719|NCT01480284|79251741|FG001|Overall Study|Physician Decision|0|||
44287720|NCT01459614|79251749|FG000|Overall Study|Adverse Event|1|||
44287721|NCT01459614|79251750|FG001|Overall Study|Adverse Event|0|||
44287722|NCT01458522|79251758|FG000|Overall Study|Withdrawal by Subject|2|||
44287723|NCT01458522|79251759|FG001|Overall Study|Withdrawal by Subject|2|||
44287724|NCT01458522|79251758|FG000|Overall Study|Physician Decision|1|||
44287725|NCT01458522|79251759|FG001|Overall Study|Physician Decision|9|||
44287726|NCT01505010|79251773|FG000|Overall Study|Protocol Violation|0|||
44154401|NCT02696785|78945530|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
44154402|NCT02696785|78945531|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
44154403|NCT02696785|78945532|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
44287727|NCT01505010|79251774|FG001|Overall Study|Protocol Violation|1|||
44287728|NCT01505010|79251773|FG000|Overall Study|Lost to Follow-up|0|||
44287729|NCT01505010|79251774|FG001|Overall Study|Lost to Follow-up|1|||
44287730|NCT01458210|79251780|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
44287731|NCT01458210|79251780|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
44287732|NCT01458210|79251780|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
44287733|NCT01458210|79251780|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
44287734|NCT01478958|79251790|FG000|Overall Study|Withdrawal by Subject|1|||
44287735|NCT01478958|79251791|FG001|Overall Study|Withdrawal by Subject|1|||
44287736|NCT01478958|79251792|FG002|Overall Study|Withdrawal by Subject|1|||
44287737|NCT01478958|79251790|FG000|Overall Study|Weight loss|1|||
44287738|NCT01478958|79251791|FG001|Overall Study|Weight loss|0|||
44287739|NCT01478958|79251792|FG002|Overall Study|Weight loss|0|||
44287740|NCT01478958|79251790|FG000|Overall Study|Re-located|0|||
44287741|NCT01478958|79251791|FG001|Overall Study|Re-located|1|||
44287742|NCT01478958|79251792|FG002|Overall Study|Re-located|0|||
44287743|NCT01478958|79251790|FG000|Overall Study|Unable to comply|0|||
44287744|NCT01478958|79251791|FG001|Overall Study|Unable to comply|0|||
44287745|NCT01478958|79251792|FG002|Overall Study|Unable to comply|2|||
44287746|NCT01458132|79251802|FG000|Overall Study|Other|15|||
44287747|NCT01458132|79251803|FG001|Overall Study|Other|3|||
44287748|NCT05220254|79251813|FG000|Overall Study|Withdrawal by Subject|4|||
44287749|NCT05220254|79251813|FG000|Overall Study|Removed due to ineligibility|1|||
44287750|NCT05220254|79251813|FG000|Overall Study|Lost to Follow-up|7|||
44287751|NCT05178121|79251817|FG000|Overall Study|Other|4|||
44287752|NCT05178121|79251817|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
44287753|NCT05110690|79251822|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
44287754|NCT05110690|79251822|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
44287755|NCT05110690|79251822|FG000|Completion of Intervention|Lost to Follow-up|1|||
44287756|NCT05110690|79251822|FG000|Completion of Intervention|Death|1|||
44287757|NCT05110690|79251822|FG000|Completion of Intervention|Withdrawal by Subject|2|||
44287758|NCT04842604|79251837|FG000|Overall Study|Death|1|||
44287759|NCT04842604|79251838|FG001|Overall Study|Death|0|||
44287760|NCT04842604|79251837|FG000|Overall Study|Other|4|||
44287761|NCT04842604|79251838|FG001|Overall Study|Other|4|||
44287762|NCT04842604|79251837|FG000|Overall Study|Randomized but not treated|1|||
44287763|NCT04842604|79251838|FG001|Overall Study|Randomized but not treated|0|||
44287764|NCT04508621|79251855|FG000|Overall Study|Adverse Event|39|||
44287765|NCT04508621|79251856|FG001|Overall Study|Adverse Event|16|||
44287766|NCT04508621|79251855|FG000|Overall Study|Lack of Efficacy|2|||
44287767|NCT04508621|79251856|FG001|Overall Study|Lack of Efficacy|8|||
44287768|NCT04508621|79251855|FG000|Overall Study|Physician Decision|0|||
44287769|NCT04508621|79251856|FG001|Overall Study|Physician Decision|1|||
44287770|NCT04508621|79251855|FG000|Overall Study|Withdrawal by Subject|10|||
44287771|NCT04508621|79251856|FG001|Overall Study|Withdrawal by Subject|14|||
44287772|NCT04508621|79251855|FG000|Overall Study|Lost to Follow-up|12|||
44287773|NCT04508621|79251856|FG001|Overall Study|Lost to Follow-up|9|||
44287774|NCT04508621|79251855|FG000|Overall Study|COVID-19 related crisis|3|||
44287775|NCT04508621|79251856|FG001|Overall Study|COVID-19 related crisis|0|||
44287776|NCT04508621|79251855|FG000|Overall Study|Subject non-compliance|1|||
44287777|NCT04508621|79251856|FG001|Overall Study|Subject non-compliance|0|||
44287778|NCT04416204|79251864|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
44287779|NCT04416204|79251865|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
44287780|NCT04416204|79251866|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
44287781|NCT04416204|79251867|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
44287782|NCT04158648|79251877|FG000|Overall Study|Ongoing in the Study|69|||
44287783|NCT04158648|79251877|FG000|Overall Study|Withdrawal by Subject|4|||
44287784|NCT04107935|79251886|FG000|Overall Study|Death|1|||
44287785|NCT04107935|79251887|FG001|Overall Study|Death|0|||
44287786|NCT03923491|79251914|FG000|Overall Study|Lost to Follow-up|5|||
44287787|NCT03923491|79251915|FG001|Overall Study|Lost to Follow-up|8|||
44287788|NCT03923491|79251914|FG000|Overall Study|Withdrawal by Subject|4|||
44287789|NCT03923491|79251915|FG001|Overall Study|Withdrawal by Subject|6|||
44287790|NCT03923426|79251921|FG000|Overall Study|Other|19|||
44287791|NCT03923426|79251921|FG000|Overall Study|Lost to Follow-up|16|||
44287792|NCT03923426|79251921|FG000|Overall Study|Death|107|||
44287793|NCT03923426|79251921|FG000|Overall Study|Incomplete response to question|13|||
44287794|NCT03896152|79251927|FG000|Overall Study|Patient/guardian decision|1|||
44287795|NCT03896152|79251928|FG001|Overall Study|Patient/guardian decision|1|||
44287796|NCT03896152|79251927|FG000|Overall Study|Adverse Event|0|||
44415784|NCT00774306|79423508|FG001|Overall Study|Withdrawal by Subject|1|||
44415785|NCT00774306|79423509|FG002|Overall Study|Withdrawal by Subject|1|||
44415786|NCT00774306|79423510|FG003|Overall Study|Withdrawal by Subject|0|||
44415787|NCT00774306|79423507|FG000|Overall Study|Lost to Follow-up|6|||
44415788|NCT00774306|79423508|FG001|Overall Study|Lost to Follow-up|0|||
44415789|NCT00774306|79423509|FG002|Overall Study|Lost to Follow-up|4|||
44287797|NCT03896152|79251928|FG001|Overall Study|Adverse Event|1|||
44287798|NCT03896152|79251927|FG000|Overall Study|Physician Decision|1|||
44287799|NCT03896152|79251928|FG001|Overall Study|Physician Decision|0|||
44287800|NCT03896152|79251927|FG000|Overall Study|Technical problems|1|||
44287801|NCT03896152|79251928|FG001|Overall Study|Technical problems|0|||
44287802|NCT03794583|79251973|FG000|Overall Study|Death|8|||
44287803|NCT03794583|79251973|FG000|Overall Study|Study Terminated by Sponsor|24|||
44415790|NCT00774306|79423510|FG003|Overall Study|Lost to Follow-up|5|||
44415791|NCT00774306|79423507|FG000|Overall Study|Death|1|||
44415792|NCT00774306|79423508|FG001|Overall Study|Death|1|||
44287804|NCT03794583|79251973|FG000|Overall Study|Withdrawal by Subject|9|||
44287805|NCT03759366|79251977|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
44287806|NCT03759366|79251977|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
44287807|NCT03695237|79251992|FG000|Overall Study|Discontinued to Restart Puberty|1|||
44287808|NCT03695237|79251993|FG001|Overall Study|Discontinued to Restart Puberty|0|||
44287809|NCT03584373|79252002|FG000|Overall Study|Lost to Follow-up|7|||
44287810|NCT03584373|79252003|FG001|Overall Study|Lost to Follow-up|8|||
44287811|NCT03386929|79252016|FG000|Overall Study|Death|0|||
44287812|NCT03386929|79252017|FG001|Overall Study|Death|0|||
44287813|NCT03386929|79252018|FG002|Overall Study|Death|1|||
44287814|NCT03386929|79252016|FG000|Overall Study|Withdrawal by Subject|0|||
44287815|NCT03386929|79252017|FG001|Overall Study|Withdrawal by Subject|1|||
44287816|NCT03386929|79252018|FG002|Overall Study|Withdrawal by Subject|0|||
44287817|NCT03386929|79252016|FG000|Overall Study|Physician Decision|0|||
44287818|NCT03386929|79252017|FG001|Overall Study|Physician Decision|0|||
44287819|NCT03386929|79252018|FG002|Overall Study|Physician Decision|1|||
44287820|NCT03386929|79252016|FG000|Overall Study|Progression|4|||
44287821|NCT03386929|79252017|FG001|Overall Study|Progression|4|||
44287822|NCT03386929|79252018|FG002|Overall Study|Progression|0|||
44287823|NCT03386929|79252016|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
44287824|NCT03386929|79252017|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
44287825|NCT03386929|79252018|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
44287826|NCT03386929|79252016|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
44287827|NCT03386929|79252017|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
44287828|NCT03386929|79252018|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
44287829|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
44287830|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
44287831|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
44287832|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
44287833|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
44287834|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
44287835|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
44287836|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
44287837|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
44287838|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
44287839|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
44287840|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
44287841|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
44287842|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
44287843|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
44287844|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
44287845|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
44287846|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
44287847|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
44287848|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
44287849|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
44287850|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
44287851|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
44287852|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
44287853|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
44287854|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
44287855|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
44287856|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
44287857|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
44287858|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
44287859|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
44287860|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
44287861|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
44287862|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
44533559|NCT04988308|79543793|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
44533560|NCT04988308|79543788|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
44154404|NCT02696785|78945533|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
44287863|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
44287864|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
44287865|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
44533561|NCT04988308|79543789|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
44154405|NCT02696785|78945530|FG000|Blinded Treatment Period|Screen Failure|1|||
44287866|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
44287867|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
44287868|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
44287869|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
44287870|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
44287871|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
44287872|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
44287873|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287874|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287875|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
44287876|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287877|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287878|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
44287879|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287880|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287881|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287882|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44287883|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
44415793|NCT00774306|79423509|FG002|Overall Study|Death|0|||
44415794|NCT00774306|79423510|FG003|Overall Study|Death|0|||
44415795|NCT00781326|79423520|FG000|Phase I|Adverse Event|1|||
44415796|NCT00781326|79423520|FG000|Phase I|Withdrawal by Subject|1|||
44415797|NCT00781326|79423520|FG000|Phase I|Physician Decision|2|||
44415798|NCT00787800|79423526|FG000|Overall Study|Withdrawal by Subject|3|||
44533562|NCT04988308|79543790|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
44533563|NCT04988308|79543791|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
44533564|NCT04988308|79543792|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
44533565|NCT04988308|79543793|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
44533566|NCT04988308|79543788|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
44533567|NCT04988308|79543789|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
44533568|NCT04988308|79543790|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
44533569|NCT04988308|79543791|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
44533570|NCT04988308|79543792|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
44533571|NCT04988308|79543793|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
44533572|NCT04988308|79543788|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44533573|NCT04988308|79543789|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44533574|NCT04988308|79543790|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44533575|NCT04988308|79543791|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
44533576|NCT04988308|79543792|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
44533577|NCT04988308|79543793|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
44533578|NCT04988308|79543788|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
44533579|NCT04988308|79543789|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
44154406|NCT02696785|78945531|FG001|Blinded Treatment Period|Screen Failure|0|||
44287884|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
44287885|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287886|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287887|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44415799|NCT00787800|79423527|FG001|Overall Study|Withdrawal by Subject|5|||
44415800|NCT00787800|79423526|FG000|Overall Study|Death|0|||
44287888|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287889|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287890|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287891|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287892|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44415801|NCT00787800|79423527|FG001|Overall Study|Death|2|||
44415802|NCT00773838|79423534|FG000|Overall Study|Adverse Event|29|||
44415803|NCT00773838|79423534|FG000|Overall Study|Lost to Follow-up|1|||
44415804|NCT00773838|79423534|FG000|Overall Study|Physician Decision|8|||
44415805|NCT00773838|79423534|FG000|Overall Study|Progressive Disease|82|||
44415806|NCT00773838|79423534|FG000|Overall Study|Protocol Violation|2|||
44415807|NCT00773838|79423534|FG000|Overall Study|Withdrawal by Subject|21|||
44154407|NCT02696785|78945532|FG002|Blinded Treatment Period|Screen Failure|0|||
44154408|NCT02696785|78945533|FG003|Blinded Treatment Period|Screen Failure|0|||
44415808|NCT00787644|79423540|FG000|Overall Study|Lost to Follow-up|1|||
44415809|NCT00787644|79423541|FG001|Overall Study|Lost to Follow-up|1|||
44415810|NCT00787644|79423540|FG000|Overall Study|Withdrawal by Subject|1|||
44533580|NCT04988308|79543790|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
44154409|NCT02696785|78945530|FG000|Washout Period|Withdrawal by Subject|0|||
44287893|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287894|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
44287895|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287896|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287897|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
44287898|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287899|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287900|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287901|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287902|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287903|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287904|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287905|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
44287906|NCT02914561|79252060|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
44287907|NCT02914561|79252061|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
44287908|NCT02914561|79252062|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
44287909|NCT02914561|79252063|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
44287910|NCT02914561|79252064|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
44287911|NCT02914561|79252065|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
44287912|NCT02914561|79252066|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
44287913|NCT02914561|79252067|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
44287914|NCT02914561|79252068|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
44287915|NCT02914561|79252069|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
44287916|NCT02914561|79252070|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
44287917|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
44287918|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
44287919|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
44287920|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
44287921|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
44287922|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
44287923|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
44287924|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
44287925|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
44287926|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
44287927|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
44287928|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
44287929|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
44287930|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
44287931|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
44287932|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
44287933|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
44287934|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
44287935|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
44287936|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
44287937|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
44287938|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
44287939|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
44287940|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
44287941|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
44287942|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
44287943|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
44287944|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
44287945|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
44287946|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
44287947|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
44287948|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
44287949|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
44287950|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287951|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287952|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287953|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287954|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287955|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287956|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
44287957|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287958|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
44287959|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
44287960|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
44287961|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287962|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287963|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287964|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287965|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287966|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287967|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
44287968|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
44287969|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
44287970|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
44287971|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
44287972|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287973|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287974|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287975|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287976|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287977|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287978|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
44287979|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287980|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
44287981|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287982|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
44287983|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287984|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287985|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287986|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287987|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287988|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287989|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287990|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287991|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
44287992|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44287993|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
44533581|NCT04988308|79543791|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
44533582|NCT04988308|79543792|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
44533583|NCT04988308|79543793|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
44533584|NCT04737109|79543806|FG000|Study Treatment|Disease Progression|5|||
44533585|NCT04737109|79543807|FG001|Study Treatment|Disease Progression|0|||
44533586|NCT04737109|79543808|FG002|Study Treatment|Disease Progression|0|||
44533587|NCT04737109|79543809|FG003|Study Treatment|Disease Progression|0|||
44533588|NCT04737109|79543806|FG000|Study Treatment|Death on study|1|||
44533589|NCT04737109|79543807|FG001|Study Treatment|Death on study|0|||
44533590|NCT04737109|79543808|FG002|Study Treatment|Death on study|0|||
44287994|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44287995|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44287996|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44287997|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44287998|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44287999|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44288000|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
44288001|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44288002|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44288003|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44288004|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
44288005|NCT02914561|79252060|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288006|NCT02914561|79252061|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288007|NCT02914561|79252062|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288008|NCT02914561|79252063|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288009|NCT02914561|79252064|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44415811|NCT00787644|79423541|FG001|Overall Study|Withdrawal by Subject|1|||
44533591|NCT04737109|79543809|FG003|Study Treatment|Death on study|0|||
44533592|NCT04582669|79543827|FG000|Overall Study|Subject missed appointment(s).|1|||
44288010|NCT02914561|79252065|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288011|NCT02914561|79252066|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288012|NCT02914561|79252067|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
44288013|NCT02914561|79252068|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
44288014|NCT02914561|79252069|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
44288015|NCT02914561|79252070|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
44288016|NCT02840799|79252100|FG000|Phase 1|Physician Decision|1|||
44288017|NCT02840799|79252101|FG001|Phase 1|Physician Decision|3|||
44288018|NCT02840799|79252100|FG000|Phase 1|Withdrawal by Subject|4|||
44288019|NCT02840799|79252101|FG001|Phase 1|Withdrawal by Subject|0|||
44288020|NCT02840799|79252100|FG000|Phase 2 (Crossover)|Adverse Event|0|||
44288021|NCT02840799|79252101|FG001|Phase 2 (Crossover)|Adverse Event|1|||
44288022|NCT02840799|79252100|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
44288023|NCT02840799|79252101|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
44288024|NCT02400255|79252127|FG000|Overall Study|Relapse|4|||
44288025|NCT02400255|79252128|FG001|Overall Study|Relapse|1|||
44288026|NCT02400255|79252129|FG002|Overall Study|Relapse|1|||
44288027|NCT02400255|79252130|FG003|Overall Study|Relapse|2|||
44288028|NCT02400255|79252127|FG000|Overall Study|Adverse Event|6|||
44288029|NCT02400255|79252128|FG001|Overall Study|Adverse Event|3|||
44288030|NCT02400255|79252129|FG002|Overall Study|Adverse Event|0|||
44288031|NCT02400255|79252130|FG003|Overall Study|Adverse Event|0|||
44288032|NCT02400255|79252127|FG000|Overall Study|Physician Decision|6|||
44288033|NCT02400255|79252128|FG001|Overall Study|Physician Decision|0|||
44288034|NCT02400255|79252129|FG002|Overall Study|Physician Decision|0|||
44288035|NCT02400255|79252130|FG003|Overall Study|Physician Decision|0|||
44288036|NCT02400255|79252127|FG000|Overall Study|Loss of insurance|1|||
44288037|NCT02400255|79252128|FG001|Overall Study|Loss of insurance|0|||
44288038|NCT02400255|79252129|FG002|Overall Study|Loss of insurance|0|||
44288039|NCT02400255|79252130|FG003|Overall Study|Loss of insurance|0|||
44288040|NCT01868438|79252138|FG000|First Intervention|Withdrawal by Subject|5|||
44288041|NCT01868438|79252139|FG001|First Intervention|Withdrawal by Subject|1|||
44288042|NCT01868438|79252138|FG000|First Intervention|Lost to Follow-up|2|||
44288043|NCT01868438|79252139|FG001|First Intervention|Lost to Follow-up|3|||
44288044|NCT01868438|79252138|FG000|First Intervention|Meeting the non-redosing criteria|0|||
44288045|NCT01868438|79252139|FG001|First Intervention|Meeting the non-redosing criteria|1|||
44288046|NCT01868438|79252138|FG000|Second Intervention|Adverse Event|3|||
44288047|NCT01868438|79252139|FG001|Second Intervention|Adverse Event|3|||
44288048|NCT01208662|79252148|FG000|Induction and Consolidation|Disease Progression|23|||
44288049|NCT01208662|79252149|FG001|Induction and Consolidation|Disease Progression|13|||
44288050|NCT01208662|79252150|FG002|Induction and Consolidation|Disease Progression|0|||
44288051|NCT01208662|79252148|FG000|Induction and Consolidation|Adverse Event|16|||
44288052|NCT01208662|79252149|FG001|Induction and Consolidation|Adverse Event|18|||
44288053|NCT01208662|79252150|FG002|Induction and Consolidation|Adverse Event|2|||
44288054|NCT01208662|79252148|FG000|Induction and Consolidation|MD or Participant Decision|16|||
44288055|NCT01208662|79252149|FG001|Induction and Consolidation|MD or Participant Decision|34|||
44288056|NCT01208662|79252150|FG002|Induction and Consolidation|MD or Participant Decision|4|||
44288057|NCT01208662|79252148|FG000|Induction and Consolidation|Death|1|||
44288058|NCT01208662|79252149|FG001|Induction and Consolidation|Death|3|||
44288059|NCT01208662|79252150|FG002|Induction and Consolidation|Death|1|||
44288060|NCT01208662|79252148|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
44288061|NCT01208662|79252149|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
44288062|NCT01208662|79252150|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
44288063|NCT01208662|79252148|FG000|Maintenance|Disease Progression|156|||
44288064|NCT01208662|79252149|FG001|Maintenance|Disease Progression|102|||
44288065|NCT01208662|79252150|FG002|Maintenance|Disease Progression|0|||
44288066|NCT01208662|79252148|FG000|Maintenance|Adverse Event|12|||
44288067|NCT01208662|79252149|FG001|Maintenance|Adverse Event|28|||
44288068|NCT01208662|79252150|FG002|Maintenance|Adverse Event|0|||
44288069|NCT01208662|79252148|FG000|Maintenance|MD or Participant Decision|24|||
44288070|NCT01208662|79252149|FG001|Maintenance|MD or Participant Decision|36|||
44288071|NCT01208662|79252150|FG002|Maintenance|MD or Participant Decision|0|||
44288072|NCT01208662|79252148|FG000|Maintenance|Death|0|||
44154410|NCT02696785|78945531|FG001|Washout Period|Withdrawal by Subject|1|||
44288073|NCT01208662|79252149|FG001|Maintenance|Death|3|||
44288074|NCT01208662|79252150|FG002|Maintenance|Death|0|||
44288075|NCT01208662|79252148|FG000|Maintenance|Discontinued for other reasons|21|||
44288076|NCT01208662|79252149|FG001|Maintenance|Discontinued for other reasons|31|||
44288077|NCT01208662|79252150|FG002|Maintenance|Discontinued for other reasons|0|||
44288078|NCT01208662|79252148|FG000|Maintenance|Still on Treatment|78|||
44288079|NCT01208662|79252149|FG001|Maintenance|Still on Treatment|89|||
44415812|NCT00787566|79423550|FG000|Overall Study|AE related to chemotherapy|0|||
44415813|NCT00787566|79423551|FG001|Overall Study|AE related to chemotherapy|1|||
44415814|NCT00787566|79423552|FG002|Overall Study|AE related to chemotherapy|0|||
44415815|NCT00787254|79423562|FG000|Overall Study|Adverse Event|24|||
44154411|NCT02696785|78945532|FG002|Washout Period|Withdrawal by Subject|0|||
44288080|NCT01208662|79252150|FG002|Maintenance|Still on Treatment|0|||
44288081|NCT01457352|79252159|FG000|Period 1|Adverse Event|2|||
44288082|NCT01457352|79252160|FG001|Period 1|Adverse Event|0|||
44288083|NCT01457352|79252159|FG000|Period 1|Withdrawal by Subject|2|||
44288084|NCT01457352|79252160|FG001|Period 1|Withdrawal by Subject|0|||
44288085|NCT01457352|79252159|FG000|Period 1|Physician Decision|2|||
44288086|NCT01457352|79252160|FG001|Period 1|Physician Decision|0|||
44533593|NCT04582669|79543828|FG001|Overall Study|Subject missed appointment(s).|0|||
44533594|NCT04582669|79543829|FG002|Overall Study|Subject missed appointment(s).|1|||
44533595|NCT04582669|79543830|FG003|Overall Study|Subject missed appointment(s).|2|||
44533596|NCT04582669|79543827|FG000|Overall Study|Protocol Violation|0|||
44533597|NCT04582669|79543828|FG001|Overall Study|Protocol Violation|1|||
44533598|NCT04582669|79543829|FG002|Overall Study|Protocol Violation|1|||
44533599|NCT04582669|79543830|FG003|Overall Study|Protocol Violation|0|||
44533600|NCT04560309|79543842|FG000|Overall Study|Meet drop out criteria|1|||
44533601|NCT04560309|79543843|FG001|Overall Study|Meet drop out criteria|1|||
44533602|NCT04535986|79543851|FG000|Overall Study|Death|4|||
44533603|NCT04535986|79543852|FG001|Overall Study|Death|5|||
44533604|NCT04535986|79543851|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
44533605|NCT04535986|79543852|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
44533606|NCT04535986|79543851|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
44288087|NCT01457352|79252159|FG000|Period 1|MS related disease progression|1|||
44288088|NCT01457352|79252160|FG001|Period 1|MS related disease progression|0|||
44288089|NCT01457352|79252159|FG000|Period 1|Withdrawn|1|||
44288090|NCT01457352|79252160|FG001|Period 1|Withdrawn|0|||
44288091|NCT01457352|79252159|FG000|Period 1|withdrew per sponsor|1|||
44288092|NCT01457352|79252160|FG001|Period 1|withdrew per sponsor|0|||
44288093|NCT01457352|79252159|FG000|Period 1|Protocol Violation|4|||
44288094|NCT01457352|79252160|FG001|Period 1|Protocol Violation|0|||
44288095|NCT01457352|79252159|FG000|Period 1|Did not meet eligibility criteria|3|||
44288096|NCT01457352|79252160|FG001|Period 1|Did not meet eligibility criteria|0|||
44288097|NCT01457352|79252159|FG000|Period 2|Withdrawal by Subject|23|||
44288098|NCT01457352|79252160|FG001|Period 2|Withdrawal by Subject|0|||
44288099|NCT01457352|79252159|FG000|Period 2|Adverse Event|22|||
44288100|NCT01457352|79252160|FG001|Period 2|Adverse Event|0|||
44288101|NCT01457352|79252159|FG000|Period 2|no analysis|10|||
44288102|NCT01457352|79252160|FG001|Period 2|no analysis|0|||
44288103|NCT01457352|79252159|FG000|Period 2|Lack of Efficacy|8|||
44533607|NCT04535986|79543852|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
44533608|NCT04535986|79543851|FG000|Overall Study|Adverse Event|10|||
44533609|NCT04535986|79543852|FG001|Overall Study|Adverse Event|1|||
44533610|NCT04535986|79543851|FG000|Overall Study|Lack of Efficacy|3|||
44288104|NCT01457352|79252160|FG001|Period 2|Lack of Efficacy|0|||
44288105|NCT01457352|79252159|FG000|Period 2|Protocol Violation|4|||
44288106|NCT01457352|79252160|FG001|Period 2|Protocol Violation|0|||
44288107|NCT01457352|79252159|FG000|Period 2|Sponsor's withdrawal|7|||
44288108|NCT01457352|79252160|FG001|Period 2|Sponsor's withdrawal|0|||
44288109|NCT01457352|79252159|FG000|Period 2|Lost to Follow-up|1|||
44288110|NCT01457352|79252160|FG001|Period 2|Lost to Follow-up|0|||
44288111|NCT01457352|79252159|FG000|Period 2|dose change|1|||
44288112|NCT01457352|79252160|FG001|Period 2|dose change|0|||
44288113|NCT01457352|79252159|FG000|Period 2|Physician Decision|1|||
44288114|NCT01457352|79252160|FG001|Period 2|Physician Decision|0|||
44288115|NCT01457352|79252159|FG000|Period 2|Did not meet eligibility criteria|3|||
44288116|NCT01457352|79252160|FG001|Period 2|Did not meet eligibility criteria|0|||
44288117|NCT01457352|79252159|FG000|Period 3|Adverse Event|1|||
44288118|NCT01457352|79252160|FG001|Period 3|Adverse Event|1|||
44288119|NCT01457352|79252159|FG000|Period 3|Withdrawal by Subject|0|||
44288120|NCT01457352|79252160|FG001|Period 3|Withdrawal by Subject|2|||
44288121|NCT01457352|79252159|FG000|Period 3|incorrect treatment|0|||
44288122|NCT01457352|79252160|FG001|Period 3|incorrect treatment|1|||
44288123|NCT01457352|79252159|FG000|Period 3|Sponsor's withdrawal|0|||
44288124|NCT01457352|79252160|FG001|Period 3|Sponsor's withdrawal|1|||
44288125|NCT01457118|79252174|FG000|Overall Study|Adverse Event|1|||
44288126|NCT01457118|79252175|FG001|Overall Study|Adverse Event|0|||
44288127|NCT01457118|79252176|FG002|Overall Study|Adverse Event|0|||
44288128|NCT01457118|79252177|FG003|Overall Study|Adverse Event|1|||
44533611|NCT04535986|79543852|FG001|Overall Study|Lack of Efficacy|2|||
44154412|NCT02696785|78945533|FG003|Washout Period|Withdrawal by Subject|0|||
44288129|NCT01457118|79252174|FG000|Overall Study|Clinical Progression|0|||
44288130|NCT01457118|79252175|FG001|Overall Study|Clinical Progression|1|||
44533612|NCT04535986|79543851|FG000|Overall Study|Investigator discretion|3|||
44533613|NCT04535986|79543852|FG001|Overall Study|Investigator discretion|0|||
44533614|NCT04535986|79543851|FG000|Overall Study|Withdrawal by Subject|32|||
44288131|NCT01457118|79252176|FG002|Overall Study|Clinical Progression|0|||
44288132|NCT01457118|79252177|FG003|Overall Study|Clinical Progression|1|||
44288133|NCT01457118|79252174|FG000|Overall Study|Physician Decision|2|||
44288134|NCT01457118|79252175|FG001|Overall Study|Physician Decision|0|||
44288135|NCT01457118|79252176|FG002|Overall Study|Physician Decision|0|||
44533615|NCT04535986|79543852|FG001|Overall Study|Withdrawal by Subject|14|||
44288136|NCT01457118|79252177|FG003|Overall Study|Physician Decision|0|||
44288137|NCT01457118|79252174|FG000|Overall Study|Progressive Disease by RECIST|12|||
44288138|NCT01457118|79252175|FG001|Overall Study|Progressive Disease by RECIST|3|||
44288139|NCT01457118|79252176|FG002|Overall Study|Progressive Disease by RECIST|1|||
44288140|NCT01457118|79252177|FG003|Overall Study|Progressive Disease by RECIST|0|||
44288141|NCT01457118|79252174|FG000|Overall Study|Withdrawal by Subject|5|||
44288142|NCT01457118|79252175|FG001|Overall Study|Withdrawal by Subject|0|||
44288143|NCT01457118|79252176|FG002|Overall Study|Withdrawal by Subject|0|||
44288144|NCT01457118|79252177|FG003|Overall Study|Withdrawal by Subject|0|||
44288145|NCT01456962|79252189|FG000|Overall Study|Lost to Follow-up|2|||
44288146|NCT01456962|79252190|FG001|Overall Study|Lost to Follow-up|1|||
44288147|NCT01501110|79252198|FG000|Overall Study|Death|0|||
44288148|NCT01501110|79252199|FG001|Overall Study|Death|1|||
44288149|NCT01500720|79252207|FG000|Overall Study|Randomized But Not Treated|1|||
44288150|NCT01500720|79252208|FG001|Overall Study|Randomized But Not Treated|1|||
44288151|NCT01500720|79252207|FG000|Overall Study|Other|4|||
44288152|NCT01500720|79252208|FG001|Overall Study|Other|8|||
44288153|NCT01500252|79252216|FG000|Overall Study|Death|4|||
44288154|NCT01500252|79252217|FG001|Overall Study|Death|2|||
44288155|NCT01500252|79252216|FG000|Overall Study|Lost to Follow-up|5|||
44288156|NCT01500252|79252217|FG001|Overall Study|Lost to Follow-up|4|||
44288157|NCT01476696|79252224|FG000|Overall Study|Sponsor decision|2|||
44288158|NCT01476696|79252225|FG001|Overall Study|Sponsor decision|1|||
44288159|NCT01476696|79252226|FG002|Overall Study|Sponsor decision|0|||
44288160|NCT01476696|79252224|FG000|Overall Study|Withdrawal by Subject|1|||
44288161|NCT01476696|79252225|FG001|Overall Study|Withdrawal by Subject|0|||
44288162|NCT01476696|79252226|FG002|Overall Study|Withdrawal by Subject|0|||
44288163|NCT01500096|79252243|FG000|Overall Study|Lost to Follow-up|1|||
44288164|NCT01500096|79252244|FG001|Overall Study|Lost to Follow-up|0|||
44288165|NCT01500096|79252245|FG002|Overall Study|Lost to Follow-up|0|||
44288166|NCT01500096|79252246|FG003|Overall Study|Lost to Follow-up|2|||
44288167|NCT01455012|79252258|FG000|Overall Study|Adverse Event|0|||
44288168|NCT01455012|79252259|FG001|Overall Study|Adverse Event|2|||
44288169|NCT01455012|79252258|FG000|Overall Study|Lack of Efficacy|6|||
44288170|NCT01455012|79252259|FG001|Overall Study|Lack of Efficacy|1|||
44288171|NCT01455012|79252258|FG000|Overall Study|Withdrawal by Subject|3|||
44288172|NCT01455012|79252259|FG001|Overall Study|Withdrawal by Subject|1|||
44288173|NCT01455012|79252258|FG000|Overall Study|Unknown reason|2|||
44288174|NCT01455012|79252259|FG001|Overall Study|Unknown reason|0|||
44288175|NCT01454778|79252265|FG000|Overall Study|Lost to Follow-up|2|||
44288176|NCT01454778|79252265|FG000|Overall Study|Death|1|||
44288177|NCT01454076|79252274|FG000|Overall Study|Other|2|||
44533616|NCT04535986|79543851|FG000|Overall Study|Lost to Follow-up|5|||
44533617|NCT04535986|79543852|FG001|Overall Study|Lost to Follow-up|3|||
44533618|NCT04535986|79543851|FG000|Overall Study|Other|7|||
44533619|NCT04535986|79543852|FG001|Overall Study|Other|3|||
44533620|NCT04187196|79543862|FG000|Overall Study|Screen Failure|2|||
44533621|NCT04187196|79543863|FG001|Overall Study|Screen Failure|0|||
44533622|NCT04091971|79543869|FG000|Overall Study|Withdrawal by Subject|1|||
44154413|NCT02696785|78945530|FG000|Washout Period|Lack of Efficacy|0|||
44154414|NCT02696785|78945531|FG001|Washout Period|Lack of Efficacy|1|||
44154415|NCT02696785|78945532|FG002|Washout Period|Lack of Efficacy|0|||
44154416|NCT02696785|78945533|FG003|Washout Period|Lack of Efficacy|0|||
44154417|NCT02696785|78945530|FG000|Extended Treatment Period|Adverse Event|2|||
44154418|NCT02696785|78945531|FG001|Extended Treatment Period|Adverse Event|3|||
44288178|NCT01454076|79252275|FG001|Overall Study|Other|0|||
44288179|NCT01454076|79252276|FG002|Overall Study|Other|0|||
44288180|NCT01454076|79252277|FG003|Overall Study|Other|1|||
44288181|NCT01454076|79252278|FG004|Overall Study|Other|2|||
44288182|NCT01454076|79252274|FG000|Overall Study|Withdrawal by Subject|3|||
44288183|NCT01454076|79252275|FG001|Overall Study|Withdrawal by Subject|4|||
44288184|NCT01454076|79252276|FG002|Overall Study|Withdrawal by Subject|2|||
44533623|NCT04091971|79543869|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
44154419|NCT02696785|78945532|FG002|Extended Treatment Period|Adverse Event|2|||
44154420|NCT02696785|78945533|FG003|Extended Treatment Period|Adverse Event|1|||
44154421|NCT02696785|78945530|FG000|Extended Treatment Period|Lack of Efficacy|0|||
44154422|NCT02696785|78945531|FG001|Extended Treatment Period|Lack of Efficacy|1|||
44288185|NCT01454076|79252277|FG003|Overall Study|Withdrawal by Subject|1|||
44154423|NCT02696785|78945532|FG002|Extended Treatment Period|Lack of Efficacy|0|||
44154424|NCT02696785|78945533|FG003|Extended Treatment Period|Lack of Efficacy|0|||
44154425|NCT02696785|78945530|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
44154426|NCT02696785|78945531|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
44288186|NCT01454076|79252278|FG004|Overall Study|Withdrawal by Subject|2|||
44288187|NCT01454076|79252274|FG000|Overall Study|Adverse Event|8|||
44288188|NCT01454076|79252275|FG001|Overall Study|Adverse Event|2|||
44288189|NCT01454076|79252276|FG002|Overall Study|Adverse Event|7|||
44288190|NCT01454076|79252277|FG003|Overall Study|Adverse Event|0|||
44288191|NCT01454076|79252278|FG004|Overall Study|Adverse Event|2|||
44288192|NCT01453998|79252302|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
44288193|NCT01453998|79252303|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
44288194|NCT01453998|79252304|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
44288195|NCT01453374|79252315|FG000|Overall Study|Adverse Event|7|||
44288196|NCT01453374|79252315|FG000|Overall Study|Lack of Efficacy|1|||
44288197|NCT01453374|79252315|FG000|Overall Study|Lost to Follow-up|3|||
44288198|NCT01453374|79252315|FG000|Overall Study|Withdrawal by Subject|5|||
44288199|NCT01453374|79252315|FG000|Overall Study|Incarcerated|2|||
44288200|NCT01453296|79252321|FG000|Treatment Period 1|Adverse Event|0|||
44288201|NCT01453296|79252322|FG001|Treatment Period 1|Adverse Event|1|||
44288202|NCT01453296|79252321|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
44288203|NCT01453296|79252322|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
44288204|NCT01453296|79252321|FG000|Treatment Period 2|Adverse Event|1|||
44288205|NCT01453296|79252322|FG001|Treatment Period 2|Adverse Event|0|||
44288206|NCT01453296|79252321|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44288207|NCT01453296|79252322|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44288208|NCT01453140|79252328|FG000|Overall Study|Adverse Event|3|||
44288209|NCT01499940|79252336|FG000|Overall Study|Study was withdrawn before completion.|9|||
44288210|NCT01499160|79252340|FG000|Overall Study|Adverse Event|1|||
44288211|NCT01499160|79252340|FG000|Overall Study|Withdrawal by Subject|1|||
44288212|NCT01498692|79252345|FG000|Overall Study|Death|4|||
44288213|NCT01498692|79252345|FG000|Overall Study|Withdrawal by Subject|1|||
44288214|NCT01498692|79252345|FG000|Overall Study|Missed 12-month visit|3|||
44288215|NCT01498068|79252351|FG000|Overall Study|Withdrawal by Subject|1|||
44288216|NCT01498068|79252352|FG001|Overall Study|Withdrawal by Subject|1|||
44288217|NCT01497366|79252360|FG000|Overall Study|Virologic failure|2|||
44288218|NCT01497366|79252361|FG001|Overall Study|Virologic failure|50|||
44288219|NCT01497366|79252360|FG000|Overall Study|Lost to Follow-up|11|||
44288220|NCT01497366|79252361|FG001|Overall Study|Lost to Follow-up|10|||
44288221|NCT01497366|79252360|FG000|Overall Study|Withdrawal by Subject|6|||
44288222|NCT01497366|79252361|FG001|Overall Study|Withdrawal by Subject|6|||
44288223|NCT01497366|79252360|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
44288224|NCT01497366|79252361|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
44288225|NCT01497366|79252360|FG000|Overall Study|Other|5|||
44288226|NCT01497366|79252361|FG001|Overall Study|Other|0|||
44288227|NCT01497366|79252360|FG000|Overall Study|Death|1|||
44288228|NCT01497366|79252361|FG001|Overall Study|Death|1|||
44288229|NCT01497366|79252360|FG000|Overall Study|Randomized but not treated|7|||
44288230|NCT01497366|79252361|FG001|Overall Study|Randomized but not treated|21|||
44288231|NCT01475838|79252370|FG000|Randomized Phase|Randomized but Not Treated|0|||
44288232|NCT01475838|79252371|FG001|Randomized Phase|Randomized but Not Treated|5|||
44288233|NCT01475838|79252370|FG000|Randomized Phase|Adverse Event|6|||
44288234|NCT01475838|79252371|FG001|Randomized Phase|Adverse Event|1|||
44288235|NCT01475838|79252370|FG000|Randomized Phase|Pregnancy|0|||
44288236|NCT01475838|79252371|FG001|Randomized Phase|Pregnancy|1|||
44288237|NCT01475838|79252370|FG000|Randomized Phase|Investigators Discretion|1|||
44288238|NCT01475838|79252371|FG001|Randomized Phase|Investigators Discretion|2|||
44288239|NCT01475838|79252370|FG000|Randomized Phase|Withdrew Consent|10|||
44288240|NCT01475838|79252371|FG001|Randomized Phase|Withdrew Consent|14|||
44288241|NCT01475838|79252370|FG000|Randomized Phase|Lost to Follow-up|3|||
44288242|NCT01475838|79252371|FG001|Randomized Phase|Lost to Follow-up|4|||
44288243|NCT01475838|79252370|FG000|Randomized Phase|Participant Noncompliance|1|||
44288244|NCT01475838|79252371|FG001|Randomized Phase|Participant Noncompliance|5|||
44288245|NCT01475838|79252370|FG000|Randomized Phase|Protocol Violation|9|||
44288246|NCT01475838|79252371|FG001|Randomized Phase|Protocol Violation|4|||
44288247|NCT01475838|79252370|FG000|Extension Phase|Participant Noncompliance|1|||
44288248|NCT01475838|79252371|FG001|Extension Phase|Participant Noncompliance|0|||
44288249|NCT01451814|79252380|FG000|Overall Study|Withdrawal by Subject|1|||
44288250|NCT01451814|79252381|FG001|Overall Study|Withdrawal by Subject|1|||
44288251|NCT01451814|79252380|FG000|Overall Study|Lost to Follow-up|5|||
44288252|NCT01451814|79252381|FG001|Overall Study|Lost to Follow-up|4|||
44288253|NCT01475370|79252390|FG000|Overall Study|Exacerbation of primary disease|2|||
44288254|NCT01475370|79252391|FG001|Overall Study|Exacerbation of primary disease|2|||
44288255|NCT01475370|79252392|FG002|Overall Study|Exacerbation of primary disease|2|||
44288256|NCT01475370|79252390|FG000|Overall Study|Study drug administration difficult|0|||
44288257|NCT01475370|79252391|FG001|Overall Study|Study drug administration difficult|1|||
44288258|NCT01475370|79252392|FG002|Overall Study|Study drug administration difficult|1|||
44288259|NCT01475370|79252390|FG000|Overall Study|Other than specified|1|||
44288260|NCT01475370|79252391|FG001|Overall Study|Other than specified|0|||
44288261|NCT01475370|79252392|FG002|Overall Study|Other than specified|0|||
44288262|NCT01496430|79252403|FG000|Overall Study|Adverse Event|0|||
44288263|NCT01496430|79252404|FG001|Overall Study|Adverse Event|0|||
44288264|NCT01496430|79252405|FG002|Overall Study|Adverse Event|1|||
44288265|NCT01496430|79252403|FG000|Overall Study|Major Protocol Deviation|0|||
44288266|NCT01496430|79252404|FG001|Overall Study|Major Protocol Deviation|0|||
44288267|NCT01496430|79252405|FG002|Overall Study|Major Protocol Deviation|1|||
44288268|NCT01496430|79252403|FG000|Overall Study|Lost to Follow-up|2|||
44288269|NCT01496430|79252404|FG001|Overall Study|Lost to Follow-up|3|||
44288270|NCT01496430|79252405|FG002|Overall Study|Lost to Follow-up|1|||
44288271|NCT01496430|79252403|FG000|Overall Study|Voluntary Withdrawal|2|||
44288272|NCT01496430|79252404|FG001|Overall Study|Voluntary Withdrawal|1|||
44288273|NCT01496430|79252405|FG002|Overall Study|Voluntary Withdrawal|6|||
44288274|NCT01496430|79252403|FG000|Overall Study|Principal Investigator Discretion|0|||
44288275|NCT01496430|79252404|FG001|Overall Study|Principal Investigator Discretion|1|||
44288276|NCT01496430|79252405|FG002|Overall Study|Principal Investigator Discretion|1|||
44288277|NCT01496430|79252403|FG000|Overall Study|Other|2|||
44288278|NCT01496430|79252404|FG001|Overall Study|Other|0|||
44288279|NCT01496430|79252405|FG002|Overall Study|Other|0|||
44288280|NCT01451424|79252417|FG000|Overall Study|Withdrawal by Subject|1|||
44288281|NCT01451424|79252418|FG001|Overall Study|Withdrawal by Subject|1|||
44288282|NCT01451424|79252419|FG002|Overall Study|Withdrawal by Subject|0|||
44288283|NCT01451424|79252420|FG003|Overall Study|Withdrawal by Subject|2|||
44288284|NCT01451424|79252417|FG000|Overall Study|Lost to Follow-up|0|||
44288285|NCT01451424|79252418|FG001|Overall Study|Lost to Follow-up|1|||
44288286|NCT01451424|79252419|FG002|Overall Study|Lost to Follow-up|0|||
44288287|NCT01451424|79252420|FG003|Overall Study|Lost to Follow-up|1|||
44288288|NCT01451424|79252417|FG000|Overall Study|Physician Decision|0|||
44288289|NCT01451424|79252418|FG001|Overall Study|Physician Decision|0|||
44288290|NCT01451424|79252419|FG002|Overall Study|Physician Decision|1|||
44288291|NCT01451424|79252420|FG003|Overall Study|Physician Decision|1|||
44288292|NCT01451424|79252417|FG000|Overall Study|Adverse Event|0|||
44288293|NCT01451424|79252418|FG001|Overall Study|Adverse Event|0|||
44288294|NCT01451424|79252419|FG002|Overall Study|Adverse Event|0|||
44288295|NCT01451424|79252420|FG003|Overall Study|Adverse Event|1|||
44288296|NCT01475214|79252438|FG000|Overall Study|Lost to Follow-up|1|||
44288297|NCT01475214|79252439|FG001|Overall Study|Lost to Follow-up|0|||
44288298|NCT01475214|79252440|FG002|Overall Study|Lost to Follow-up|1|||
44288299|NCT01475214|79252438|FG000|Overall Study|Physician Decision|2|||
44288300|NCT01475214|79252439|FG001|Overall Study|Physician Decision|0|||
44288301|NCT01475214|79252440|FG002|Overall Study|Physician Decision|0|||
44288302|NCT01475214|79252438|FG000|Overall Study|Withdrawal by Subject|2|||
44288303|NCT01475214|79252439|FG001|Overall Study|Withdrawal by Subject|4|||
44288304|NCT01475214|79252440|FG002|Overall Study|Withdrawal by Subject|1|||
44288305|NCT01496274|79252451|FG000|Overall Study|Protocol Violation|0|||
44288306|NCT01496274|79252452|FG001|Overall Study|Protocol Violation|1|||
44288307|NCT01496274|79252451|FG000|Overall Study|Adverse Event|1|||
44288308|NCT01496274|79252452|FG001|Overall Study|Adverse Event|1|||
44288309|NCT01496274|79252451|FG000|Overall Study|Withdrawal by Subject|2|||
44288310|NCT01496274|79252452|FG001|Overall Study|Withdrawal by Subject|0|||
44288311|NCT01496274|79252451|FG000|Overall Study|Lost to Follow-up|0|||
44288312|NCT01496274|79252452|FG001|Overall Study|Lost to Follow-up|3|||
44288313|NCT01475136|79252477|FG000|Overall Study|Sponsor Decision|0|||
44288314|NCT01475136|79252478|FG001|Overall Study|Sponsor Decision|1|||
44288315|NCT01475136|79252479|FG002|Overall Study|Sponsor Decision|0|||
44288316|NCT01475136|79252480|FG003|Overall Study|Sponsor Decision|0|||
44288317|NCT01475136|79252477|FG000|Overall Study|Entry Criteria Not Met|0|||
44288318|NCT01475136|79252478|FG001|Overall Study|Entry Criteria Not Met|2|||
44288319|NCT01475136|79252479|FG002|Overall Study|Entry Criteria Not Met|3|||
44288320|NCT01475136|79252480|FG003|Overall Study|Entry Criteria Not Met|1|||
44288321|NCT01475136|79252477|FG000|Overall Study|Withdrawal by Subject|0|||
44288322|NCT01475136|79252478|FG001|Overall Study|Withdrawal by Subject|0|||
44288323|NCT01475136|79252479|FG002|Overall Study|Withdrawal by Subject|0|||
44288324|NCT01475136|79252480|FG003|Overall Study|Withdrawal by Subject|2|||
44288325|NCT01475136|79252477|FG000|Overall Study|Adverse Event|1|||
44288326|NCT01475136|79252478|FG001|Overall Study|Adverse Event|0|||
44288327|NCT01475136|79252479|FG002|Overall Study|Adverse Event|0|||
44288328|NCT01475136|79252480|FG003|Overall Study|Adverse Event|1|||
44288329|NCT01475136|79252477|FG000|Overall Study|Death|0|||
44288330|NCT01475136|79252478|FG001|Overall Study|Death|0|||
44288331|NCT01475136|79252479|FG002|Overall Study|Death|0|||
44288332|NCT01475136|79252480|FG003|Overall Study|Death|1|||
44288333|NCT01474746|79252492|FG000|Overall Study|Lost to Follow-up|1|||
44288334|NCT01474746|79252493|FG001|Overall Study|Lost to Follow-up|1|||
44288335|NCT01474746|79252492|FG000|Overall Study|Withdrawal by Subject|2|||
44255986|NCT01490450|79102041|FG003|Period 2|Adverse Event|1|||
44255987|NCT01490450|79102038|FG000|Period 2|Withdrawal by Subject|1|||
44255988|NCT01490450|79102039|FG001|Period 2|Withdrawal by Subject|0|||
44255989|NCT01490450|79102040|FG002|Period 2|Withdrawal by Subject|0|||
44255990|NCT01490450|79102041|FG003|Period 2|Withdrawal by Subject|0|||
44255991|NCT01490450|79102038|FG000|Period 2|Lost to Follow-up|0|||
44255992|NCT01490450|79102039|FG001|Period 2|Lost to Follow-up|0|||
44255993|NCT01490450|79102040|FG002|Period 2|Lost to Follow-up|0|||
44255994|NCT01490450|79102041|FG003|Period 2|Lost to Follow-up|2|||
44255995|NCT01469546|79102085|FG000|Received 5 mg Dose|Adverse Event|13|||
44255996|NCT01469546|79102085|FG000|Received 5 mg Dose|Death|2|||
44288336|NCT01474746|79252493|FG001|Overall Study|Withdrawal by Subject|1|||
44288337|NCT01450800|79252501|FG000|Overall Study|Protocol Violation|1|||
44288338|NCT01450800|79252502|FG001|Overall Study|Protocol Violation|3|||
44288339|NCT01474512|79252513|FG000|Induction Period|Adverse Event|6|||
44288340|NCT01474512|79252514|FG001|Induction Period|Adverse Event|10|||
44288341|NCT01474512|79252515|FG002|Induction Period|Adverse Event|10|||
44288342|NCT01474512|79252516|FG003|Induction Period|Adverse Event|0|||
44288343|NCT01474512|79252517|FG004|Induction Period|Adverse Event|0|||
44288344|NCT01474512|79252518|FG005|Induction Period|Adverse Event|0|||
44288345|NCT01474512|79252519|FG006|Induction Period|Adverse Event|0|||
44288346|NCT01474512|79252520|FG007|Induction Period|Adverse Event|0|||
44288347|NCT01474512|79252521|FG008|Induction Period|Adverse Event|0|||
44288348|NCT01474512|79252522|FG009|Induction Period|Adverse Event|0|||
44288349|NCT01474512|79252523|FG010|Induction Period|Adverse Event|0|||
44288350|NCT01474512|79252524|FG011|Induction Period|Adverse Event|0|||
44288351|NCT01474512|79252525|FG012|Induction Period|Adverse Event|0|||
44288352|NCT01474512|79252526|FG013|Induction Period|Adverse Event|0|||
44288353|NCT01474512|79252527|FG014|Induction Period|Adverse Event|0|||
44288354|NCT01474512|79252528|FG015|Induction Period|Adverse Event|0|||
44288355|NCT01474512|79252529|FG016|Induction Period|Adverse Event|0|||
44288356|NCT01474512|79252530|FG017|Induction Period|Adverse Event|0|||
44288357|NCT01474512|79252513|FG000|Induction Period|Lack of Efficacy|7|||
44288358|NCT01474512|79252514|FG001|Induction Period|Lack of Efficacy|1|||
44288359|NCT01474512|79252515|FG002|Induction Period|Lack of Efficacy|0|||
44288360|NCT01474512|79252516|FG003|Induction Period|Lack of Efficacy|0|||
44288361|NCT01474512|79252517|FG004|Induction Period|Lack of Efficacy|0|||
44288362|NCT01474512|79252518|FG005|Induction Period|Lack of Efficacy|0|||
44288363|NCT01474512|79252519|FG006|Induction Period|Lack of Efficacy|0|||
44288364|NCT01474512|79252520|FG007|Induction Period|Lack of Efficacy|0|||
44288365|NCT01474512|79252521|FG008|Induction Period|Lack of Efficacy|0|||
44288366|NCT01474512|79252522|FG009|Induction Period|Lack of Efficacy|0|||
44288367|NCT01474512|79252523|FG010|Induction Period|Lack of Efficacy|0|||
44288368|NCT01474512|79252524|FG011|Induction Period|Lack of Efficacy|0|||
44288369|NCT01474512|79252525|FG012|Induction Period|Lack of Efficacy|0|||
44288370|NCT01474512|79252526|FG013|Induction Period|Lack of Efficacy|0|||
44288371|NCT01474512|79252527|FG014|Induction Period|Lack of Efficacy|0|||
44288372|NCT01474512|79252528|FG015|Induction Period|Lack of Efficacy|0|||
44288373|NCT01474512|79252529|FG016|Induction Period|Lack of Efficacy|0|||
44288374|NCT01474512|79252530|FG017|Induction Period|Lack of Efficacy|0|||
44288375|NCT01474512|79252513|FG000|Induction Period|Withdrawal by Subject|6|||
44288376|NCT01474512|79252514|FG001|Induction Period|Withdrawal by Subject|6|||
44288377|NCT01474512|79252515|FG002|Induction Period|Withdrawal by Subject|5|||
44288378|NCT01474512|79252516|FG003|Induction Period|Withdrawal by Subject|0|||
44288379|NCT01474512|79252517|FG004|Induction Period|Withdrawal by Subject|0|||
44288380|NCT01474512|79252518|FG005|Induction Period|Withdrawal by Subject|0|||
44288381|NCT01474512|79252519|FG006|Induction Period|Withdrawal by Subject|0|||
44288382|NCT01474512|79252520|FG007|Induction Period|Withdrawal by Subject|0|||
44288383|NCT01474512|79252521|FG008|Induction Period|Withdrawal by Subject|0|||
44288384|NCT01474512|79252522|FG009|Induction Period|Withdrawal by Subject|0|||
44288385|NCT01474512|79252523|FG010|Induction Period|Withdrawal by Subject|0|||
44288386|NCT01474512|79252524|FG011|Induction Period|Withdrawal by Subject|0|||
44288387|NCT01474512|79252525|FG012|Induction Period|Withdrawal by Subject|0|||
44288388|NCT01474512|79252526|FG013|Induction Period|Withdrawal by Subject|0|||
44288389|NCT01474512|79252527|FG014|Induction Period|Withdrawal by Subject|0|||
44288390|NCT01474512|79252528|FG015|Induction Period|Withdrawal by Subject|0|||
44288391|NCT01474512|79252529|FG016|Induction Period|Withdrawal by Subject|0|||
44288392|NCT01474512|79252530|FG017|Induction Period|Withdrawal by Subject|0|||
44288393|NCT01474512|79252513|FG000|Induction Period|Protocol Violation|3|||
44415816|NCT00787254|79423563|FG001|Overall Study|Adverse Event|23|||
44288394|NCT01474512|79252514|FG001|Induction Period|Protocol Violation|6|||
44288395|NCT01474512|79252515|FG002|Induction Period|Protocol Violation|0|||
44288396|NCT01474512|79252516|FG003|Induction Period|Protocol Violation|0|||
44288397|NCT01474512|79252517|FG004|Induction Period|Protocol Violation|0|||
44288398|NCT01474512|79252518|FG005|Induction Period|Protocol Violation|0|||
44288399|NCT01474512|79252519|FG006|Induction Period|Protocol Violation|0|||
44288400|NCT01474512|79252520|FG007|Induction Period|Protocol Violation|0|||
44288401|NCT01474512|79252521|FG008|Induction Period|Protocol Violation|0|||
44288402|NCT01474512|79252522|FG009|Induction Period|Protocol Violation|0|||
44415817|NCT00787254|79423562|FG000|Overall Study|Protocol Violation|26|||
44415818|NCT00787254|79423563|FG001|Overall Study|Protocol Violation|23|||
44415819|NCT00787254|79423562|FG000|Overall Study|Withdrawal by Subject|16|||
44288403|NCT01474512|79252523|FG010|Induction Period|Protocol Violation|0|||
44288404|NCT01474512|79252524|FG011|Induction Period|Protocol Violation|0|||
44288405|NCT01474512|79252525|FG012|Induction Period|Protocol Violation|0|||
44288406|NCT01474512|79252526|FG013|Induction Period|Protocol Violation|0|||
44288407|NCT01474512|79252527|FG014|Induction Period|Protocol Violation|0|||
44288408|NCT01474512|79252528|FG015|Induction Period|Protocol Violation|0|||
44288409|NCT01474512|79252529|FG016|Induction Period|Protocol Violation|0|||
44288410|NCT01474512|79252530|FG017|Induction Period|Protocol Violation|0|||
44288411|NCT01474512|79252513|FG000|Induction Period|Sponsor Decision|1|||
44288412|NCT01474512|79252514|FG001|Induction Period|Sponsor Decision|1|||
44288413|NCT01474512|79252515|FG002|Induction Period|Sponsor Decision|1|||
44288414|NCT01474512|79252516|FG003|Induction Period|Sponsor Decision|0|||
44288415|NCT01474512|79252517|FG004|Induction Period|Sponsor Decision|0|||
44288416|NCT01474512|79252518|FG005|Induction Period|Sponsor Decision|0|||
44288417|NCT01474512|79252519|FG006|Induction Period|Sponsor Decision|0|||
44288418|NCT01474512|79252520|FG007|Induction Period|Sponsor Decision|0|||
44288419|NCT01474512|79252521|FG008|Induction Period|Sponsor Decision|0|||
44288420|NCT01474512|79252522|FG009|Induction Period|Sponsor Decision|0|||
44288421|NCT01474512|79252523|FG010|Induction Period|Sponsor Decision|0|||
44288422|NCT01474512|79252524|FG011|Induction Period|Sponsor Decision|0|||
44288423|NCT01474512|79252525|FG012|Induction Period|Sponsor Decision|0|||
44288424|NCT01474512|79252526|FG013|Induction Period|Sponsor Decision|0|||
44288425|NCT01474512|79252527|FG014|Induction Period|Sponsor Decision|0|||
44288426|NCT01474512|79252528|FG015|Induction Period|Sponsor Decision|0|||
44288427|NCT01474512|79252529|FG016|Induction Period|Sponsor Decision|0|||
44288428|NCT01474512|79252530|FG017|Induction Period|Sponsor Decision|0|||
44288429|NCT01474512|79252513|FG000|Induction Period|Lost to Follow-up|1|||
44288430|NCT01474512|79252514|FG001|Induction Period|Lost to Follow-up|0|||
44288431|NCT01474512|79252515|FG002|Induction Period|Lost to Follow-up|2|||
44288432|NCT01474512|79252516|FG003|Induction Period|Lost to Follow-up|0|||
44288433|NCT01474512|79252517|FG004|Induction Period|Lost to Follow-up|0|||
44288434|NCT01474512|79252518|FG005|Induction Period|Lost to Follow-up|0|||
44288435|NCT01474512|79252519|FG006|Induction Period|Lost to Follow-up|0|||
44288436|NCT01474512|79252520|FG007|Induction Period|Lost to Follow-up|0|||
44288437|NCT01474512|79252521|FG008|Induction Period|Lost to Follow-up|0|||
44288438|NCT01474512|79252522|FG009|Induction Period|Lost to Follow-up|0|||
44288439|NCT01474512|79252523|FG010|Induction Period|Lost to Follow-up|0|||
44288440|NCT01474512|79252524|FG011|Induction Period|Lost to Follow-up|0|||
44288441|NCT01474512|79252525|FG012|Induction Period|Lost to Follow-up|0|||
44288442|NCT01474512|79252526|FG013|Induction Period|Lost to Follow-up|0|||
44288443|NCT01474512|79252527|FG014|Induction Period|Lost to Follow-up|0|||
44288444|NCT01474512|79252528|FG015|Induction Period|Lost to Follow-up|0|||
44288445|NCT01474512|79252529|FG016|Induction Period|Lost to Follow-up|0|||
44288446|NCT01474512|79252530|FG017|Induction Period|Lost to Follow-up|0|||
44288447|NCT01474512|79252513|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288448|NCT01474512|79252514|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288449|NCT01474512|79252515|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288450|NCT01474512|79252516|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
44288451|NCT01474512|79252517|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
44288452|NCT01474512|79252518|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
44288453|NCT01474512|79252519|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
44288454|NCT01474512|79252520|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288455|NCT01474512|79252521|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288456|NCT01474512|79252522|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288457|NCT01474512|79252523|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288458|NCT01474512|79252524|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288459|NCT01474512|79252525|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288460|NCT01474512|79252526|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288461|NCT01474512|79252527|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288462|NCT01474512|79252528|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288463|NCT01474512|79252529|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288464|NCT01474512|79252530|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
44288465|NCT01474512|79252513|FG000|Maintenance Period|Adverse Event|0|||
44288466|NCT01474512|79252514|FG001|Maintenance Period|Adverse Event|0|||
44288467|NCT01474512|79252515|FG002|Maintenance Period|Adverse Event|0|||
44288468|NCT01474512|79252516|FG003|Maintenance Period|Adverse Event|4|||
44288469|NCT01474512|79252517|FG004|Maintenance Period|Adverse Event|2|||
44288470|NCT01474512|79252518|FG005|Maintenance Period|Adverse Event|7|||
44288471|NCT01474512|79252519|FG006|Maintenance Period|Adverse Event|0|||
44288472|NCT01474512|79252520|FG007|Maintenance Period|Adverse Event|19|||
44288473|NCT01474512|79252521|FG008|Maintenance Period|Adverse Event|1|||
44288474|NCT01474512|79252522|FG009|Maintenance Period|Adverse Event|3|||
44288475|NCT01474512|79252523|FG010|Maintenance Period|Adverse Event|0|||
44288476|NCT01474512|79252524|FG011|Maintenance Period|Adverse Event|0|||
44288477|NCT01474512|79252525|FG012|Maintenance Period|Adverse Event|0|||
44288478|NCT01474512|79252526|FG013|Maintenance Period|Adverse Event|0|||
44288479|NCT01474512|79252527|FG014|Maintenance Period|Adverse Event|0|||
44288480|NCT01474512|79252528|FG015|Maintenance Period|Adverse Event|0|||
44288481|NCT01474512|79252529|FG016|Maintenance Period|Adverse Event|0|||
44288482|NCT01474512|79252530|FG017|Maintenance Period|Adverse Event|0|||
44288483|NCT01474512|79252513|FG000|Maintenance Period|Withdrawal by Subject|0|||
44288484|NCT01474512|79252514|FG001|Maintenance Period|Withdrawal by Subject|0|||
44288485|NCT01474512|79252515|FG002|Maintenance Period|Withdrawal by Subject|0|||
44288486|NCT01474512|79252516|FG003|Maintenance Period|Withdrawal by Subject|6|||
44288487|NCT01474512|79252517|FG004|Maintenance Period|Withdrawal by Subject|2|||
44288488|NCT01474512|79252518|FG005|Maintenance Period|Withdrawal by Subject|3|||
44288489|NCT01474512|79252519|FG006|Maintenance Period|Withdrawal by Subject|1|||
44288490|NCT01474512|79252520|FG007|Maintenance Period|Withdrawal by Subject|6|||
44288491|NCT01474512|79252521|FG008|Maintenance Period|Withdrawal by Subject|3|||
44288492|NCT01474512|79252522|FG009|Maintenance Period|Withdrawal by Subject|1|||
44288493|NCT01474512|79252523|FG010|Maintenance Period|Withdrawal by Subject|0|||
44288494|NCT01474512|79252524|FG011|Maintenance Period|Withdrawal by Subject|0|||
44288495|NCT01474512|79252525|FG012|Maintenance Period|Withdrawal by Subject|0|||
44288496|NCT01474512|79252526|FG013|Maintenance Period|Withdrawal by Subject|0|||
44288497|NCT01474512|79252527|FG014|Maintenance Period|Withdrawal by Subject|0|||
44288498|NCT01474512|79252528|FG015|Maintenance Period|Withdrawal by Subject|0|||
44288499|NCT01474512|79252529|FG016|Maintenance Period|Withdrawal by Subject|0|||
44288500|NCT01474512|79252530|FG017|Maintenance Period|Withdrawal by Subject|0|||
44288501|NCT01474512|79252513|FG000|Maintenance Period|Lost to Follow-up|0|||
44288502|NCT01474512|79252514|FG001|Maintenance Period|Lost to Follow-up|0|||
44288503|NCT01474512|79252515|FG002|Maintenance Period|Lost to Follow-up|0|||
44288504|NCT01474512|79252516|FG003|Maintenance Period|Lost to Follow-up|3|||
44288505|NCT01474512|79252517|FG004|Maintenance Period|Lost to Follow-up|3|||
44288506|NCT01474512|79252518|FG005|Maintenance Period|Lost to Follow-up|0|||
44288507|NCT01474512|79252519|FG006|Maintenance Period|Lost to Follow-up|0|||
44288508|NCT01474512|79252520|FG007|Maintenance Period|Lost to Follow-up|2|||
44288509|NCT01474512|79252521|FG008|Maintenance Period|Lost to Follow-up|1|||
44288510|NCT01474512|79252522|FG009|Maintenance Period|Lost to Follow-up|1|||
44288511|NCT01474512|79252523|FG010|Maintenance Period|Lost to Follow-up|0|||
44288512|NCT01474512|79252524|FG011|Maintenance Period|Lost to Follow-up|0|||
44288513|NCT01474512|79252525|FG012|Maintenance Period|Lost to Follow-up|0|||
44288514|NCT01474512|79252526|FG013|Maintenance Period|Lost to Follow-up|0|||
44288515|NCT01474512|79252527|FG014|Maintenance Period|Lost to Follow-up|0|||
44288516|NCT01474512|79252528|FG015|Maintenance Period|Lost to Follow-up|0|||
44288517|NCT01474512|79252529|FG016|Maintenance Period|Lost to Follow-up|0|||
44288518|NCT01474512|79252530|FG017|Maintenance Period|Lost to Follow-up|0|||
44288519|NCT01474512|79252513|FG000|Maintenance Period|Death|0|||
44288520|NCT01474512|79252514|FG001|Maintenance Period|Death|0|||
44288521|NCT01474512|79252515|FG002|Maintenance Period|Death|0|||
44288522|NCT01474512|79252516|FG003|Maintenance Period|Death|0|||
44288523|NCT01474512|79252517|FG004|Maintenance Period|Death|0|||
44288524|NCT01474512|79252518|FG005|Maintenance Period|Death|2|||
44288525|NCT01474512|79252519|FG006|Maintenance Period|Death|0|||
44288526|NCT01474512|79252520|FG007|Maintenance Period|Death|0|||
44288527|NCT01474512|79252521|FG008|Maintenance Period|Death|0|||
44288528|NCT01474512|79252522|FG009|Maintenance Period|Death|0|||
44288529|NCT01474512|79252523|FG010|Maintenance Period|Death|0|||
44288530|NCT01474512|79252524|FG011|Maintenance Period|Death|0|||
44288531|NCT01474512|79252525|FG012|Maintenance Period|Death|0|||
44288532|NCT01474512|79252526|FG013|Maintenance Period|Death|0|||
44288533|NCT01474512|79252527|FG014|Maintenance Period|Death|0|||
44288534|NCT01474512|79252528|FG015|Maintenance Period|Death|0|||
44415820|NCT00787254|79423563|FG001|Overall Study|Withdrawal by Subject|11|||
44415821|NCT00787254|79423562|FG000|Overall Study|Lack of Efficacy|4|||
44415822|NCT00787254|79423563|FG001|Overall Study|Lack of Efficacy|15|||
44415823|NCT00787254|79423562|FG000|Overall Study|NSAIDs discontinuation|1|||
44415824|NCT00787254|79423563|FG001|Overall Study|NSAIDs discontinuation|2|||
44415825|NCT00787254|79423562|FG000|Overall Study|Institution closed|1|||
44415826|NCT00787254|79423563|FG001|Overall Study|Institution closed|0|||
44288535|NCT01474512|79252529|FG016|Maintenance Period|Death|0|||
44288536|NCT01474512|79252530|FG017|Maintenance Period|Death|0|||
44288537|NCT01474512|79252513|FG000|Maintenance Period|Physician Decision|0|||
44288538|NCT01474512|79252514|FG001|Maintenance Period|Physician Decision|0|||
44288539|NCT01474512|79252515|FG002|Maintenance Period|Physician Decision|0|||
44288540|NCT01474512|79252516|FG003|Maintenance Period|Physician Decision|0|||
44288541|NCT01474512|79252517|FG004|Maintenance Period|Physician Decision|0|||
44288542|NCT01474512|79252518|FG005|Maintenance Period|Physician Decision|1|||
44288543|NCT01474512|79252519|FG006|Maintenance Period|Physician Decision|0|||
44288544|NCT01474512|79252520|FG007|Maintenance Period|Physician Decision|2|||
44288545|NCT01474512|79252521|FG008|Maintenance Period|Physician Decision|0|||
44288546|NCT01474512|79252522|FG009|Maintenance Period|Physician Decision|0|||
44288547|NCT01474512|79252523|FG010|Maintenance Period|Physician Decision|0|||
44288548|NCT01474512|79252524|FG011|Maintenance Period|Physician Decision|0|||
44288549|NCT01474512|79252525|FG012|Maintenance Period|Physician Decision|0|||
44288550|NCT01474512|79252526|FG013|Maintenance Period|Physician Decision|0|||
44288551|NCT01474512|79252527|FG014|Maintenance Period|Physician Decision|0|||
44415827|NCT00787254|79423562|FG000|Overall Study|Physician Decision|4|||
44288552|NCT01474512|79252528|FG015|Maintenance Period|Physician Decision|0|||
44288553|NCT01474512|79252529|FG016|Maintenance Period|Physician Decision|0|||
44288554|NCT01474512|79252530|FG017|Maintenance Period|Physician Decision|0|||
44288555|NCT01474512|79252513|FG000|Maintenance Period|Clinical Relapse|0|||
44288556|NCT01474512|79252514|FG001|Maintenance Period|Clinical Relapse|0|||
44288557|NCT01474512|79252515|FG002|Maintenance Period|Clinical Relapse|0|||
44288558|NCT01474512|79252516|FG003|Maintenance Period|Clinical Relapse|1|||
44288559|NCT01474512|79252517|FG004|Maintenance Period|Clinical Relapse|0|||
44288560|NCT01474512|79252518|FG005|Maintenance Period|Clinical Relapse|0|||
44288561|NCT01474512|79252519|FG006|Maintenance Period|Clinical Relapse|0|||
44288562|NCT01474512|79252520|FG007|Maintenance Period|Clinical Relapse|0|||
44288563|NCT01474512|79252521|FG008|Maintenance Period|Clinical Relapse|0|||
44288564|NCT01474512|79252522|FG009|Maintenance Period|Clinical Relapse|0|||
44288565|NCT01474512|79252523|FG010|Maintenance Period|Clinical Relapse|0|||
44288566|NCT01474512|79252524|FG011|Maintenance Period|Clinical Relapse|0|||
44288567|NCT01474512|79252525|FG012|Maintenance Period|Clinical Relapse|0|||
44288568|NCT01474512|79252526|FG013|Maintenance Period|Clinical Relapse|0|||
44288569|NCT01474512|79252527|FG014|Maintenance Period|Clinical Relapse|0|||
44288570|NCT01474512|79252528|FG015|Maintenance Period|Clinical Relapse|0|||
44288571|NCT01474512|79252529|FG016|Maintenance Period|Clinical Relapse|0|||
44288572|NCT01474512|79252530|FG017|Maintenance Period|Clinical Relapse|0|||
44288573|NCT01474512|79252513|FG000|Maintenance Period|Lack of Efficacy|0|||
44288574|NCT01474512|79252514|FG001|Maintenance Period|Lack of Efficacy|0|||
44288575|NCT01474512|79252515|FG002|Maintenance Period|Lack of Efficacy|0|||
44288576|NCT01474512|79252516|FG003|Maintenance Period|Lack of Efficacy|1|||
44288577|NCT01474512|79252517|FG004|Maintenance Period|Lack of Efficacy|0|||
44288578|NCT01474512|79252518|FG005|Maintenance Period|Lack of Efficacy|0|||
44288579|NCT01474512|79252519|FG006|Maintenance Period|Lack of Efficacy|0|||
44288580|NCT01474512|79252520|FG007|Maintenance Period|Lack of Efficacy|11|||
44288581|NCT01474512|79252521|FG008|Maintenance Period|Lack of Efficacy|11|||
44288582|NCT01474512|79252522|FG009|Maintenance Period|Lack of Efficacy|12|||
44288583|NCT01474512|79252523|FG010|Maintenance Period|Lack of Efficacy|0|||
44288584|NCT01474512|79252524|FG011|Maintenance Period|Lack of Efficacy|0|||
44288585|NCT01474512|79252525|FG012|Maintenance Period|Lack of Efficacy|0|||
44288586|NCT01474512|79252526|FG013|Maintenance Period|Lack of Efficacy|0|||
44288587|NCT01474512|79252527|FG014|Maintenance Period|Lack of Efficacy|0|||
44288588|NCT01474512|79252528|FG015|Maintenance Period|Lack of Efficacy|0|||
44288589|NCT01474512|79252529|FG016|Maintenance Period|Lack of Efficacy|0|||
44288590|NCT01474512|79252530|FG017|Maintenance Period|Lack of Efficacy|0|||
44288591|NCT01474512|79252513|FG000|Maintenance Period|Protocol Violation|0|||
44288592|NCT01474512|79252514|FG001|Maintenance Period|Protocol Violation|0|||
44288593|NCT01474512|79252515|FG002|Maintenance Period|Protocol Violation|0|||
44288594|NCT01474512|79252516|FG003|Maintenance Period|Protocol Violation|1|||
44288595|NCT01474512|79252517|FG004|Maintenance Period|Protocol Violation|0|||
44288596|NCT01474512|79252518|FG005|Maintenance Period|Protocol Violation|0|||
44288597|NCT01474512|79252519|FG006|Maintenance Period|Protocol Violation|0|||
44288598|NCT01474512|79252520|FG007|Maintenance Period|Protocol Violation|1|||
44288599|NCT01474512|79252521|FG008|Maintenance Period|Protocol Violation|0|||
44288600|NCT01474512|79252522|FG009|Maintenance Period|Protocol Violation|1|||
44288601|NCT01474512|79252523|FG010|Maintenance Period|Protocol Violation|0|||
44288602|NCT01474512|79252524|FG011|Maintenance Period|Protocol Violation|0|||
44288603|NCT01474512|79252525|FG012|Maintenance Period|Protocol Violation|0|||
44288604|NCT01474512|79252526|FG013|Maintenance Period|Protocol Violation|0|||
44288605|NCT01474512|79252527|FG014|Maintenance Period|Protocol Violation|0|||
44288606|NCT01474512|79252528|FG015|Maintenance Period|Protocol Violation|0|||
44288607|NCT01474512|79252529|FG016|Maintenance Period|Protocol Violation|0|||
44288608|NCT01474512|79252530|FG017|Maintenance Period|Protocol Violation|0|||
44288609|NCT01474512|79252513|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
44288610|NCT01474512|79252514|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
44288611|NCT01474512|79252515|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
44288612|NCT01474512|79252516|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
44288613|NCT01474512|79252517|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
44288614|NCT01474512|79252518|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
44288615|NCT01474512|79252519|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
44288616|NCT01474512|79252520|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
44288617|NCT01474512|79252521|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
44288618|NCT01474512|79252522|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
44288619|NCT01474512|79252523|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
44288620|NCT01474512|79252524|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
44288621|NCT01474512|79252525|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
44288622|NCT01474512|79252526|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
44288623|NCT01474512|79252527|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
44288624|NCT01474512|79252528|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
44288625|NCT01474512|79252529|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
44288626|NCT01474512|79252530|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
44288627|NCT01474512|79252513|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
44288628|NCT01474512|79252514|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
44288629|NCT01474512|79252515|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
44288630|NCT01474512|79252516|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
44288631|NCT01474512|79252517|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
44288632|NCT01474512|79252518|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
44288633|NCT01474512|79252519|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
44288634|NCT01474512|79252520|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
44288635|NCT01474512|79252521|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
44288636|NCT01474512|79252522|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
44288637|NCT01474512|79252523|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
44288638|NCT01474512|79252524|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
44288639|NCT01474512|79252525|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
44288640|NCT01474512|79252526|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
44288641|NCT01474512|79252527|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
44288642|NCT01474512|79252528|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
44288643|NCT01474512|79252529|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
44288644|NCT01474512|79252530|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
44288645|NCT01474512|79252513|FG000|Long-Term Extension Period|Adverse Event|0|||
44288646|NCT01474512|79252514|FG001|Long-Term Extension Period|Adverse Event|0|||
44288647|NCT01474512|79252515|FG002|Long-Term Extension Period|Adverse Event|0|||
44288648|NCT01474512|79252516|FG003|Long-Term Extension Period|Adverse Event|0|||
44288649|NCT01474512|79252517|FG004|Long-Term Extension Period|Adverse Event|0|||
44288650|NCT01474512|79252518|FG005|Long-Term Extension Period|Adverse Event|0|||
44288651|NCT01474512|79252519|FG006|Long-Term Extension Period|Adverse Event|0|||
44288652|NCT01474512|79252520|FG007|Long-Term Extension Period|Adverse Event|0|||
44288653|NCT01474512|79252521|FG008|Long-Term Extension Period|Adverse Event|0|||
44288654|NCT01474512|79252522|FG009|Long-Term Extension Period|Adverse Event|0|||
44288655|NCT01474512|79252523|FG010|Long-Term Extension Period|Adverse Event|0|||
44288656|NCT01474512|79252524|FG011|Long-Term Extension Period|Adverse Event|1|||
44288657|NCT01474512|79252525|FG012|Long-Term Extension Period|Adverse Event|57|||
44288658|NCT01474512|79252526|FG013|Long-Term Extension Period|Adverse Event|58|||
44288659|NCT01474512|79252527|FG014|Long-Term Extension Period|Adverse Event|0|||
44288660|NCT01474512|79252528|FG015|Long-Term Extension Period|Adverse Event|0|||
44288661|NCT01474512|79252529|FG016|Long-Term Extension Period|Adverse Event|0|||
44288662|NCT01474512|79252530|FG017|Long-Term Extension Period|Adverse Event|0|||
44288663|NCT01474512|79252513|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
44288664|NCT01474512|79252514|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
44288665|NCT01474512|79252515|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
44288666|NCT01474512|79252516|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
44288667|NCT01474512|79252517|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
44288668|NCT01474512|79252518|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
44288669|NCT01474512|79252519|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
44288670|NCT01474512|79252520|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
44288671|NCT01474512|79252521|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
44288672|NCT01474512|79252522|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
44288673|NCT01474512|79252523|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
44288674|NCT01474512|79252524|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
44288675|NCT01474512|79252525|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
44288676|NCT01474512|79252526|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
44288677|NCT01474512|79252527|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
44288678|NCT01474512|79252528|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
44288679|NCT01474512|79252529|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
44288680|NCT01474512|79252530|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
44288681|NCT01474512|79252513|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
44288682|NCT01474512|79252514|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
44288683|NCT01474512|79252515|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
44288684|NCT01474512|79252516|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
44288685|NCT01474512|79252517|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
44415828|NCT00787254|79423563|FG001|Overall Study|Physician Decision|8|||
44415829|NCT00625846|79423573|FG000|Overall Study|Withdrawal by Subject|2|||
44415830|NCT00625846|79423574|FG001|Overall Study|Withdrawal by Subject|0|||
44415831|NCT00625846|79423575|FG002|Overall Study|Withdrawal by Subject|1|||
44415832|NCT00625846|79423576|FG003|Overall Study|Withdrawal by Subject|2|||
44415833|NCT00773292|79423590|FG000|Treatment 48 Weeks|Adverse Event|1|||
44288686|NCT01474512|79252518|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
44288687|NCT01474512|79252519|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
44288688|NCT01474512|79252520|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
44288689|NCT01474512|79252521|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
44288690|NCT01474512|79252522|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
44288691|NCT01474512|79252523|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
44415834|NCT00773292|79423590|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
44288692|NCT01474512|79252524|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
44288693|NCT01474512|79252525|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
44288694|NCT01474512|79252526|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
44288695|NCT01474512|79252527|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
44288696|NCT01474512|79252528|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
44288697|NCT01474512|79252529|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
44288698|NCT01474512|79252530|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
44288699|NCT01474512|79252513|FG000|Long-Term Extension Period|Physician Decision|0|||
44288700|NCT01474512|79252514|FG001|Long-Term Extension Period|Physician Decision|0|||
44288701|NCT01474512|79252515|FG002|Long-Term Extension Period|Physician Decision|0|||
44288702|NCT01474512|79252516|FG003|Long-Term Extension Period|Physician Decision|0|||
44288703|NCT01474512|79252517|FG004|Long-Term Extension Period|Physician Decision|0|||
44288704|NCT01474512|79252518|FG005|Long-Term Extension Period|Physician Decision|0|||
44288705|NCT01474512|79252519|FG006|Long-Term Extension Period|Physician Decision|0|||
44288706|NCT01474512|79252520|FG007|Long-Term Extension Period|Physician Decision|0|||
44288707|NCT01474512|79252521|FG008|Long-Term Extension Period|Physician Decision|0|||
44288708|NCT01474512|79252522|FG009|Long-Term Extension Period|Physician Decision|0|||
44288709|NCT01474512|79252523|FG010|Long-Term Extension Period|Physician Decision|0|||
44288710|NCT01474512|79252524|FG011|Long-Term Extension Period|Physician Decision|0|||
44288711|NCT01474512|79252525|FG012|Long-Term Extension Period|Physician Decision|21|||
44288712|NCT01474512|79252526|FG013|Long-Term Extension Period|Physician Decision|21|||
44288713|NCT01474512|79252527|FG014|Long-Term Extension Period|Physician Decision|0|||
44288714|NCT01474512|79252528|FG015|Long-Term Extension Period|Physician Decision|0|||
44288715|NCT01474512|79252529|FG016|Long-Term Extension Period|Physician Decision|0|||
44288716|NCT01474512|79252530|FG017|Long-Term Extension Period|Physician Decision|0|||
44288717|NCT01474512|79252513|FG000|Long-Term Extension Period|Clinical Relapse|0|||
44288718|NCT01474512|79252514|FG001|Long-Term Extension Period|Clinical Relapse|0|||
44288719|NCT01474512|79252515|FG002|Long-Term Extension Period|Clinical Relapse|0|||
44288720|NCT01474512|79252516|FG003|Long-Term Extension Period|Clinical Relapse|0|||
44288721|NCT01474512|79252517|FG004|Long-Term Extension Period|Clinical Relapse|0|||
44288722|NCT01474512|79252518|FG005|Long-Term Extension Period|Clinical Relapse|0|||
44288723|NCT01474512|79252519|FG006|Long-Term Extension Period|Clinical Relapse|0|||
44288724|NCT01474512|79252520|FG007|Long-Term Extension Period|Clinical Relapse|0|||
44288725|NCT01474512|79252521|FG008|Long-Term Extension Period|Clinical Relapse|0|||
44288726|NCT01474512|79252522|FG009|Long-Term Extension Period|Clinical Relapse|0|||
44288727|NCT01474512|79252523|FG010|Long-Term Extension Period|Clinical Relapse|0|||
44288728|NCT01474512|79252524|FG011|Long-Term Extension Period|Clinical Relapse|0|||
44288729|NCT01474512|79252525|FG012|Long-Term Extension Period|Clinical Relapse|9|||
44288730|NCT01474512|79252526|FG013|Long-Term Extension Period|Clinical Relapse|9|||
44288731|NCT01474512|79252527|FG014|Long-Term Extension Period|Clinical Relapse|0|||
44288732|NCT01474512|79252528|FG015|Long-Term Extension Period|Clinical Relapse|0|||
44288733|NCT01474512|79252529|FG016|Long-Term Extension Period|Clinical Relapse|0|||
44288734|NCT01474512|79252530|FG017|Long-Term Extension Period|Clinical Relapse|0|||
44415835|NCT00786864|79423596|FG000|Overall Study|Lost to Follow-up|0|||
44415836|NCT00786864|79423597|FG001|Overall Study|Lost to Follow-up|1|||
44415837|NCT00786864|79423596|FG000|Overall Study|Sustained serious back injury|1|||
44415838|NCT00786864|79423597|FG001|Overall Study|Sustained serious back injury|0|||
44415839|NCT00621322|79423609|FG000|Overall Study|Lost to Follow-up|0|||
44415840|NCT00621322|79423610|FG001|Overall Study|Lost to Follow-up|0|||
44415841|NCT00621322|79423611|FG002|Overall Study|Lost to Follow-up|0|||
44415842|NCT00621322|79423612|FG003|Overall Study|Lost to Follow-up|0|||
44415843|NCT00621322|79423613|FG004|Overall Study|Lost to Follow-up|1|||
44415844|NCT00621322|79423614|FG005|Overall Study|Lost to Follow-up|0|||
44415845|NCT00621322|79423609|FG000|Overall Study|Physician Decision|0|||
44415846|NCT00621322|79423610|FG001|Overall Study|Physician Decision|0|||
44415847|NCT00621322|79423611|FG002|Overall Study|Physician Decision|1|||
44288735|NCT01474512|79252513|FG000|Long-Term Extension Period|Death|0|||
44288736|NCT01474512|79252514|FG001|Long-Term Extension Period|Death|0|||
44288737|NCT01474512|79252515|FG002|Long-Term Extension Period|Death|0|||
44288738|NCT01474512|79252516|FG003|Long-Term Extension Period|Death|0|||
44288739|NCT01474512|79252517|FG004|Long-Term Extension Period|Death|0|||
44288740|NCT01474512|79252518|FG005|Long-Term Extension Period|Death|0|||
44288741|NCT01474512|79252519|FG006|Long-Term Extension Period|Death|0|||
44288742|NCT01474512|79252520|FG007|Long-Term Extension Period|Death|0|||
44288743|NCT01474512|79252521|FG008|Long-Term Extension Period|Death|0|||
44288744|NCT01474512|79252522|FG009|Long-Term Extension Period|Death|0|||
44288745|NCT01474512|79252523|FG010|Long-Term Extension Period|Death|0|||
44288746|NCT01474512|79252524|FG011|Long-Term Extension Period|Death|0|||
44288747|NCT01474512|79252525|FG012|Long-Term Extension Period|Death|9|||
44288748|NCT01474512|79252526|FG013|Long-Term Extension Period|Death|9|||
44415848|NCT00621322|79423612|FG003|Overall Study|Physician Decision|1|||
44288749|NCT01474512|79252527|FG014|Long-Term Extension Period|Death|0|||
44415849|NCT00621322|79423613|FG004|Overall Study|Physician Decision|0|||
44415850|NCT00621322|79423614|FG005|Overall Study|Physician Decision|0|||
44288750|NCT01474512|79252528|FG015|Long-Term Extension Period|Death|0|||
44288751|NCT01474512|79252529|FG016|Long-Term Extension Period|Death|0|||
44288752|NCT01474512|79252530|FG017|Long-Term Extension Period|Death|0|||
44288753|NCT01474512|79252513|FG000|Long-Term Extension Period|Sponsor Decision|0|||
44288754|NCT01474512|79252514|FG001|Long-Term Extension Period|Sponsor Decision|0|||
44288755|NCT01474512|79252515|FG002|Long-Term Extension Period|Sponsor Decision|0|||
44288756|NCT01474512|79252516|FG003|Long-Term Extension Period|Sponsor Decision|0|||
44288757|NCT01474512|79252517|FG004|Long-Term Extension Period|Sponsor Decision|0|||
44288758|NCT01474512|79252518|FG005|Long-Term Extension Period|Sponsor Decision|0|||
44288759|NCT01474512|79252519|FG006|Long-Term Extension Period|Sponsor Decision|0|||
44288760|NCT01474512|79252520|FG007|Long-Term Extension Period|Sponsor Decision|0|||
44288761|NCT01474512|79252521|FG008|Long-Term Extension Period|Sponsor Decision|0|||
44288762|NCT01474512|79252522|FG009|Long-Term Extension Period|Sponsor Decision|0|||
44288763|NCT01474512|79252523|FG010|Long-Term Extension Period|Sponsor Decision|0|||
44288764|NCT01474512|79252524|FG011|Long-Term Extension Period|Sponsor Decision|0|||
44288765|NCT01474512|79252525|FG012|Long-Term Extension Period|Sponsor Decision|6|||
44288766|NCT01474512|79252526|FG013|Long-Term Extension Period|Sponsor Decision|6|||
44288767|NCT01474512|79252527|FG014|Long-Term Extension Period|Sponsor Decision|0|||
44288768|NCT01474512|79252528|FG015|Long-Term Extension Period|Sponsor Decision|0|||
44288769|NCT01474512|79252529|FG016|Long-Term Extension Period|Sponsor Decision|0|||
44288770|NCT01474512|79252530|FG017|Long-Term Extension Period|Sponsor Decision|0|||
44288771|NCT01474512|79252513|FG000|Long-Term Extension Period|Protocol Violation|0|||
44288772|NCT01474512|79252514|FG001|Long-Term Extension Period|Protocol Violation|0|||
44288773|NCT01474512|79252515|FG002|Long-Term Extension Period|Protocol Violation|0|||
44288774|NCT01474512|79252516|FG003|Long-Term Extension Period|Protocol Violation|0|||
44288775|NCT01474512|79252517|FG004|Long-Term Extension Period|Protocol Violation|0|||
44288776|NCT01474512|79252518|FG005|Long-Term Extension Period|Protocol Violation|0|||
44288777|NCT01474512|79252519|FG006|Long-Term Extension Period|Protocol Violation|0|||
44288778|NCT01474512|79252520|FG007|Long-Term Extension Period|Protocol Violation|0|||
44288779|NCT01474512|79252521|FG008|Long-Term Extension Period|Protocol Violation|0|||
44288780|NCT01474512|79252522|FG009|Long-Term Extension Period|Protocol Violation|0|||
44288781|NCT01474512|79252523|FG010|Long-Term Extension Period|Protocol Violation|0|||
44288782|NCT01474512|79252524|FG011|Long-Term Extension Period|Protocol Violation|0|||
44288783|NCT01474512|79252525|FG012|Long-Term Extension Period|Protocol Violation|5|||
44288784|NCT01474512|79252526|FG013|Long-Term Extension Period|Protocol Violation|5|||
44288785|NCT01474512|79252527|FG014|Long-Term Extension Period|Protocol Violation|0|||
44288786|NCT01474512|79252528|FG015|Long-Term Extension Period|Protocol Violation|0|||
44288787|NCT01474512|79252529|FG016|Long-Term Extension Period|Protocol Violation|0|||
44288788|NCT01474512|79252530|FG017|Long-Term Extension Period|Protocol Violation|0|||
44288789|NCT01474512|79252513|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288790|NCT01474512|79252514|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288791|NCT01474512|79252515|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288792|NCT01474512|79252516|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288793|NCT01474512|79252517|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288794|NCT01474512|79252518|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288795|NCT01474512|79252519|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288796|NCT01474512|79252520|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288797|NCT01474512|79252521|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288798|NCT01474512|79252522|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288799|NCT01474512|79252523|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288800|NCT01474512|79252524|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288801|NCT01474512|79252525|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
44288802|NCT01474512|79252526|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
44288803|NCT01474512|79252527|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288804|NCT01474512|79252528|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288805|NCT01474512|79252529|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288806|NCT01474512|79252530|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
44288807|NCT01474512|79252513|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288808|NCT01474512|79252514|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44533624|NCT04091971|79543869|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
44288809|NCT01474512|79252515|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288810|NCT01474512|79252516|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288811|NCT01474512|79252517|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288812|NCT01474512|79252518|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288813|NCT01474512|79252519|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288814|NCT01474512|79252520|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288815|NCT01474512|79252521|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44533625|NCT03902613|79543898|FG000|Overall Study|Physician Decision|1|||
44288816|NCT01474512|79252522|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288817|NCT01474512|79252523|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288818|NCT01474512|79252524|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
44288819|NCT01474512|79252525|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288820|NCT01474512|79252526|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288821|NCT01474512|79252527|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288822|NCT01474512|79252528|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288823|NCT01474512|79252529|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288824|NCT01474512|79252530|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
44288825|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
44288826|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
44288827|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
44288828|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
44288829|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
44288830|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
44288831|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
44288832|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
44288833|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
44288834|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
44288835|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
44288836|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
44288837|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
44288838|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
44288839|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
44288840|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
44288841|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
44288842|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
44288843|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288844|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288845|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288846|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288847|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288848|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288849|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288850|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288851|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288852|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288853|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288854|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288855|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288856|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
44288857|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
44288858|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
44288859|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
44288860|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
44288861|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288862|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288863|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288864|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288865|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288866|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288867|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288868|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288869|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288870|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288871|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288872|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288873|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288874|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
44288875|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
44288876|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
44288877|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
44288878|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
44288879|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288880|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288881|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288882|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288883|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288884|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288885|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288886|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44415851|NCT00621322|79423609|FG000|Overall Study|Withdrawal by Subject|0|||
44154427|NCT02696785|78945532|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
44154428|NCT02696785|78945533|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
44154429|NCT02696785|78945530|FG000|Follow-up Period|Adverse Event|0|||
44154430|NCT02696785|78945531|FG001|Follow-up Period|Adverse Event|0|||
44154431|NCT02696785|78945532|FG002|Follow-up Period|Adverse Event|8|||
44154432|NCT02696785|78945533|FG003|Follow-up Period|Adverse Event|2|||
44154433|NCT02696785|78945530|FG000|Follow-up Period|Lost to Follow-up|0|||
44288887|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288888|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288889|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288890|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288891|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288892|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288893|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288894|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
44288895|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
44288896|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
44288897|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
44288898|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
44288899|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
44288900|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
44288901|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
44288902|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
44288903|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
44288904|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
44288905|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
44288906|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
44288907|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
44288908|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
44288909|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
44288910|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
44288911|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
44288912|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
44288913|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
44288914|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
44288915|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288916|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288917|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288918|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288919|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288920|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288921|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288922|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288923|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288924|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288925|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288926|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288927|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288928|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288929|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288930|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
44288931|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
44288932|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
44288933|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
44288934|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
44288935|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
44288936|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
44288937|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
44288938|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
44288939|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
44288940|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
44288941|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
44288942|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
44415852|NCT00621322|79423610|FG001|Overall Study|Withdrawal by Subject|0|||
44288943|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
44288944|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
44288945|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
44415853|NCT00621322|79423611|FG002|Overall Study|Withdrawal by Subject|0|||
44288946|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
44288947|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
44288948|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
44288949|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
44288950|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
44288951|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288952|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288953|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288954|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288955|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288956|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288957|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288958|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288959|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288960|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288961|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288962|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288963|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288964|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288965|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
44288966|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288967|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
44288968|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
44288969|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288970|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288971|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288972|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288973|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288974|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288975|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288976|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288977|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288978|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288979|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288980|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288981|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288982|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288983|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
44288984|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288985|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
44288986|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
44288987|NCT01474512|79252513|FG000|Post-Treatment Follow-Up|Death|0|||
44288988|NCT01474512|79252514|FG001|Post-Treatment Follow-Up|Death|0|||
44288989|NCT01474512|79252515|FG002|Post-Treatment Follow-Up|Death|0|||
44288990|NCT01474512|79252516|FG003|Post-Treatment Follow-Up|Death|0|||
44288991|NCT01474512|79252517|FG004|Post-Treatment Follow-Up|Death|0|||
44288992|NCT01474512|79252518|FG005|Post-Treatment Follow-Up|Death|0|||
44288993|NCT01474512|79252519|FG006|Post-Treatment Follow-Up|Death|0|||
44288994|NCT01474512|79252520|FG007|Post-Treatment Follow-Up|Death|0|||
44288995|NCT01474512|79252521|FG008|Post-Treatment Follow-Up|Death|0|||
44288996|NCT01474512|79252522|FG009|Post-Treatment Follow-Up|Death|0|||
44288997|NCT01474512|79252523|FG010|Post-Treatment Follow-Up|Death|0|||
44288998|NCT01474512|79252524|FG011|Post-Treatment Follow-Up|Death|0|||
44288999|NCT01474512|79252525|FG012|Post-Treatment Follow-Up|Death|0|||
44289000|NCT01474512|79252526|FG013|Post-Treatment Follow-Up|Death|0|||
44289001|NCT01474512|79252527|FG014|Post-Treatment Follow-Up|Death|0|||
44289002|NCT01474512|79252528|FG015|Post-Treatment Follow-Up|Death|0|||
44289003|NCT01474512|79252529|FG016|Post-Treatment Follow-Up|Death|1|||
44289004|NCT01474512|79252530|FG017|Post-Treatment Follow-Up|Death|0|||
44289005|NCT01474434|79252564|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
44289006|NCT01474434|79252565|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
44289007|NCT01474434|79252566|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
44289008|NCT01474434|79252567|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
44289009|NCT01474434|79252564|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
44289010|NCT01474434|79252565|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
44289011|NCT01474434|79252566|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
44289012|NCT01474434|79252567|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
44289013|NCT01474434|79252564|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
44289014|NCT01474434|79252565|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
44289015|NCT01474434|79252566|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
44289016|NCT01474434|79252567|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
44289017|NCT01473732|79252583|FG000|Overall Study|Adverse Event|1|||
44289018|NCT01473732|79252584|FG001|Overall Study|Adverse Event|0|||
44289019|NCT01473732|79252583|FG000|Overall Study|Death|1|||
44289020|NCT01473732|79252584|FG001|Overall Study|Death|0|||
44289021|NCT01450098|79252592|FG000|Period 3|Protocol Violation|0|||
44289022|NCT01450098|79252593|FG001|Period 3|Protocol Violation|1|||
44289023|NCT01450098|79252592|FG000|Period 3|Withdrawal by Subject|0|||
44289024|NCT01450098|79252593|FG001|Period 3|Withdrawal by Subject|2|||
44289025|NCT01449708|79252608|FG000|Overall Study|Protocol Violation|0|||
44289026|NCT01449708|79252609|FG001|Overall Study|Protocol Violation|1|||
44289027|NCT01449708|79252608|FG000|Overall Study|surgical complication|1|||
44289028|NCT01449708|79252609|FG001|Overall Study|surgical complication|2|||
44289029|NCT01449708|79252608|FG000|Overall Study|respiratory failure|1|||
44289030|NCT01449708|79252609|FG001|Overall Study|respiratory failure|0|||
44289031|NCT01449630|79252627|FG000|Period 1|Physician Decision|1|||
44289032|NCT01449630|79252628|FG001|Period 1|Physician Decision|0|||
44289033|NCT01449630|79252629|FG002|Period 1|Physician Decision|0|||
44289034|NCT01449630|79252630|FG003|Period 1|Physician Decision|1|||
44154434|NCT02696785|78945531|FG001|Follow-up Period|Lost to Follow-up|0|||
44154435|NCT02696785|78945532|FG002|Follow-up Period|Lost to Follow-up|0|||
44154436|NCT02696785|78945533|FG003|Follow-up Period|Lost to Follow-up|1|||
44154437|NCT02696785|78945530|FG000|Follow-up Period|Lack of Efficacy|0|||
44154438|NCT02696785|78945531|FG001|Follow-up Period|Lack of Efficacy|0|||
44154439|NCT02696785|78945532|FG002|Follow-up Period|Lack of Efficacy|0|||
44289035|NCT01449630|79252631|FG004|Period 1|Physician Decision|0|||
44289036|NCT01449630|79252632|FG005|Period 1|Physician Decision|0|||
44289037|NCT01449630|79252633|FG006|Period 1|Physician Decision|0|||
44289038|NCT01449630|79252634|FG007|Period 1|Physician Decision|0|||
44289039|NCT01449630|79252635|FG008|Period 1|Physician Decision|0|||
44289040|NCT01449630|79252627|FG000|Period 1|Sponsor Decision|0|||
44289041|NCT01449630|79252628|FG001|Period 1|Sponsor Decision|0|||
44289042|NCT01449630|79252629|FG002|Period 1|Sponsor Decision|0|||
44289043|NCT01449630|79252630|FG003|Period 1|Sponsor Decision|0|||
44289044|NCT01449630|79252631|FG004|Period 1|Sponsor Decision|0|||
44289045|NCT01449630|79252632|FG005|Period 1|Sponsor Decision|1|||
44289046|NCT01449630|79252633|FG006|Period 1|Sponsor Decision|0|||
44289047|NCT01449630|79252634|FG007|Period 1|Sponsor Decision|0|||
44289048|NCT01449630|79252635|FG008|Period 1|Sponsor Decision|0|||
44289049|NCT01449630|79252627|FG000|Period 2|Sponsor Decision|0|||
44289050|NCT01449630|79252628|FG001|Period 2|Sponsor Decision|0|||
44289051|NCT01449630|79252629|FG002|Period 2|Sponsor Decision|0|||
44289052|NCT01449630|79252630|FG003|Period 2|Sponsor Decision|0|||
44289053|NCT01449630|79252631|FG004|Period 2|Sponsor Decision|0|||
44289054|NCT01449630|79252632|FG005|Period 2|Sponsor Decision|0|||
44289055|NCT01449630|79252633|FG006|Period 2|Sponsor Decision|1|||
44289056|NCT01449630|79252634|FG007|Period 2|Sponsor Decision|0|||
44289057|NCT01449630|79252635|FG008|Period 2|Sponsor Decision|0|||
44289058|NCT01493778|79252657|FG000|Overall Study|Withdrawal by Subject|8|||
44289059|NCT01473420|79252672|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
44289060|NCT01473420|79252673|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
44289061|NCT01473420|79252672|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
44289062|NCT01473420|79252673|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
44289063|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
44289064|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
44289065|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
44289066|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
44289067|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
44415854|NCT00621322|79423612|FG003|Overall Study|Withdrawal by Subject|1|||
44415855|NCT00621322|79423613|FG004|Overall Study|Withdrawal by Subject|0|||
44415856|NCT00621322|79423614|FG005|Overall Study|Withdrawal by Subject|2|||
44415857|NCT00621322|79423609|FG000|Overall Study|Migrated/moved from study area|1|||
44289068|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
44289069|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
44289070|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
44415858|NCT00621322|79423610|FG001|Overall Study|Migrated/moved from study area|0|||
44415859|NCT00621322|79423611|FG002|Overall Study|Migrated/moved from study area|1|||
44415860|NCT00621322|79423612|FG003|Overall Study|Migrated/moved from study area|1|||
44154440|NCT02696785|78945533|FG003|Follow-up Period|Lack of Efficacy|1|||
44154441|NCT02696785|78945530|FG000|Follow-up Period|Withdrawal by Subject|1|||
44289071|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
44289072|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
44415861|NCT00621322|79423613|FG004|Overall Study|Migrated/moved from study area|0|||
44289073|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
44289074|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
44289075|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
44289076|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
44289077|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
44289078|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
44289079|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
44289080|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
44289081|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
44289082|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
44289083|NCT01473420|79252672|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
44289084|NCT01473420|79252673|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
44289085|NCT01492686|79252687|FG000|Double-blind Phase|Adverse Event|0|||
44289086|NCT01492686|79252688|FG001|Double-blind Phase|Adverse Event|2|||
44289087|NCT01492686|79252687|FG000|Double-blind Phase|Physician Decision|0|||
44289088|NCT01492686|79252688|FG001|Double-blind Phase|Physician Decision|1|||
44289089|NCT01492686|79252687|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44289090|NCT01492686|79252688|FG001|Double-blind Phase|Withdrawal by Subject|2|||
44289091|NCT01492686|79252687|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
44289092|NCT01492686|79252688|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
44289093|NCT01492686|79252687|FG000|Open-label Phase|Adverse Event|1|||
44289094|NCT01492686|79252688|FG001|Open-label Phase|Adverse Event|2|||
44289095|NCT01492686|79252687|FG000|Open-label Phase|Physician Decision|1|||
44289096|NCT01492686|79252688|FG001|Open-label Phase|Physician Decision|0|||
44289097|NCT01492686|79252687|FG000|Open-label Phase|Withdrawal by Subject|6|||
44289098|NCT01492686|79252688|FG001|Open-label Phase|Withdrawal by Subject|7|||
44289099|NCT01492686|79252687|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
44289100|NCT01492686|79252688|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
44289101|NCT01449006|79252698|FG000|Overall Study|Lost to Follow-up|1|||
44289102|NCT01449006|79252699|FG001|Overall Study|Lost to Follow-up|0|||
44289103|NCT01449006|79252698|FG000|Overall Study|Withdrawal by Subject|1|||
44289104|NCT01449006|79252699|FG001|Overall Study|Withdrawal by Subject|0|||
44289105|NCT01449006|79252698|FG000|Overall Study|Protocol Violation|1|||
44289106|NCT01449006|79252699|FG001|Overall Study|Protocol Violation|0|||
44289107|NCT01448850|79252707|FG000|Overall Study|Death|3|||
44289108|NCT01448850|79252708|FG001|Overall Study|Death|6|||
44289109|NCT01448850|79252707|FG000|Overall Study|Withdrawal by Subject|13|||
44289110|NCT01448850|79252708|FG001|Overall Study|Withdrawal by Subject|21|||
44289111|NCT01448850|79252707|FG000|Overall Study|Lost to Follow-up|3|||
44289112|NCT01448850|79252708|FG001|Overall Study|Lost to Follow-up|1|||
44289113|NCT01448850|79252707|FG000|Overall Study|Other|15|||
44289114|NCT01448850|79252708|FG001|Overall Study|Other|12|||
44289115|NCT01491672|79252718|FG000|Overall Study|Lost to Follow-up|0|||
44289116|NCT01491672|79252719|FG001|Overall Study|Lost to Follow-up|4|||
44289117|NCT01491672|79252720|FG002|Overall Study|Lost to Follow-up|1|||
44289118|NCT01491672|79252718|FG000|Overall Study|Withdrawal by Subject|6|||
44289119|NCT01491672|79252719|FG001|Overall Study|Withdrawal by Subject|7|||
44289120|NCT01491672|79252720|FG002|Overall Study|Withdrawal by Subject|0|||
44289121|NCT01491672|79252718|FG000|Overall Study|Adverse Event|8|||
44289122|NCT01491672|79252719|FG001|Overall Study|Adverse Event|10|||
44289123|NCT01491672|79252720|FG002|Overall Study|Adverse Event|4|||
44289124|NCT01491672|79252718|FG000|Overall Study|Disease progression|42|||
44289125|NCT01491672|79252719|FG001|Overall Study|Disease progression|34|||
44289126|NCT01491672|79252720|FG002|Overall Study|Disease progression|6|||
44289127|NCT01491672|79252718|FG000|Overall Study|Protocol deviation|0|||
44289128|NCT01491672|79252719|FG001|Overall Study|Protocol deviation|1|||
44289129|NCT01491672|79252720|FG002|Overall Study|Protocol deviation|0|||
44289130|NCT01491672|79252718|FG000|Overall Study|Death|0|||
44289131|NCT01491672|79252719|FG001|Overall Study|Death|4|||
44289132|NCT01491672|79252720|FG002|Overall Study|Death|0|||
44289133|NCT01447446|79252736|FG000|Overall Study|Death|6|||
44289134|NCT01447446|79252737|FG001|Overall Study|Death|3|||
44289135|NCT01447446|79252738|FG002|Overall Study|Death|2|||
44289136|NCT01447446|79252739|FG003|Overall Study|Death|1|||
44289137|NCT01447446|79252740|FG004|Overall Study|Death|7|||
44289138|NCT01447446|79252741|FG005|Overall Study|Death|0|||
44289139|NCT01447446|79252736|FG000|Overall Study|Adverse Event|3|||
44415862|NCT00621322|79423614|FG005|Overall Study|Migrated/moved from study area|2|||
44415863|NCT00853385|79423633|FG000|Overall Study|Death|0|||
44289140|NCT01447446|79252737|FG001|Overall Study|Adverse Event|0|||
44289141|NCT01447446|79252738|FG002|Overall Study|Adverse Event|1|||
44289142|NCT01447446|79252739|FG003|Overall Study|Adverse Event|0|||
44415864|NCT00853385|79423634|FG001|Overall Study|Death|0|||
44415865|NCT00853385|79423635|FG002|Overall Study|Death|0|||
44415866|NCT00853385|79423636|FG003|Overall Study|Death|0|||
44289143|NCT01447446|79252740|FG004|Overall Study|Adverse Event|2|||
44289144|NCT01447446|79252741|FG005|Overall Study|Adverse Event|0|||
44289145|NCT01447446|79252736|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
44289146|NCT01447446|79252737|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
44415867|NCT00853385|79423637|FG004|Overall Study|Death|1|||
44415868|NCT00853385|79423633|FG000|Overall Study|Adverse Event|24|||
44289147|NCT01447446|79252738|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
44289148|NCT01447446|79252739|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
44289149|NCT01447446|79252740|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
44415869|NCT00853385|79423634|FG001|Overall Study|Adverse Event|24|||
44415870|NCT00853385|79423635|FG002|Overall Study|Adverse Event|2|||
44289150|NCT01447446|79252741|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
44289151|NCT01447446|79252736|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
44289152|NCT01447446|79252737|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
44289153|NCT01447446|79252738|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
44289154|NCT01447446|79252739|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
44289155|NCT01447446|79252740|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
44289156|NCT01447446|79252741|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
44289157|NCT01447446|79252736|FG000|Overall Study|Administrative/Other|34|||
44289158|NCT01447446|79252737|FG001|Overall Study|Administrative/Other|9|||
44289159|NCT01447446|79252738|FG002|Overall Study|Administrative/Other|10|||
44289160|NCT01447446|79252739|FG003|Overall Study|Administrative/Other|2|||
44289161|NCT01447446|79252740|FG004|Overall Study|Administrative/Other|33|||
44289162|NCT01447446|79252741|FG005|Overall Study|Administrative/Other|4|||
44289163|NCT01447446|79252736|FG000|Overall Study|SVR12 Assessment|13|||
44289164|NCT01447446|79252737|FG001|Overall Study|SVR12 Assessment|1|||
44289165|NCT01447446|79252738|FG002|Overall Study|SVR12 Assessment|2|||
44289166|NCT01447446|79252739|FG003|Overall Study|SVR12 Assessment|1|||
44289167|NCT01447446|79252740|FG004|Overall Study|SVR12 Assessment|5|||
44289168|NCT01447446|79252741|FG005|Overall Study|SVR12 Assessment|5|||
44289169|NCT01447446|79252736|FG000|Overall Study|New Treatment Started|8|||
44289170|NCT01447446|79252737|FG001|Overall Study|New Treatment Started|2|||
44289171|NCT01447446|79252738|FG002|Overall Study|New Treatment Started|1|||
44289172|NCT01447446|79252739|FG003|Overall Study|New Treatment Started|0|||
44289173|NCT01447446|79252740|FG004|Overall Study|New Treatment Started|2|||
44289174|NCT01447446|79252741|FG005|Overall Study|New Treatment Started|0|||
44289175|NCT01447446|79252736|FG000|Overall Study|Reason not Specified|1|||
44289176|NCT01447446|79252737|FG001|Overall Study|Reason not Specified|1|||
44289177|NCT01447446|79252738|FG002|Overall Study|Reason not Specified|1|||
44289178|NCT01447446|79252739|FG003|Overall Study|Reason not Specified|1|||
44289179|NCT01447446|79252740|FG004|Overall Study|Reason not Specified|1|||
44289180|NCT01447446|79252741|FG005|Overall Study|Reason not Specified|0|||
44289181|NCT01490814|79252763|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
44289182|NCT01490814|79252764|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
44289183|NCT01490814|79252763|FG000|Overall Study|Physician Decision|1|||
44289184|NCT01490814|79252764|FG001|Overall Study|Physician Decision|0|||
44289185|NCT01490814|79252763|FG000|Overall Study|Withdrawal by Subject|0|||
44289186|NCT01490814|79252764|FG001|Overall Study|Withdrawal by Subject|5|||
44289187|NCT01471782|79252776|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
44289188|NCT01471782|79252777|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
44289189|NCT01471782|79252778|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
44289190|NCT01471782|79252779|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
44289191|NCT01471782|79252780|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
44289192|NCT01471782|79252781|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
44289193|NCT01471782|79252776|FG000|Overall Study|Lack of Efficacy|1|||
44289194|NCT01471782|79252777|FG001|Overall Study|Lack of Efficacy|2|||
44289195|NCT01471782|79252778|FG002|Overall Study|Lack of Efficacy|1|||
44289196|NCT01471782|79252779|FG003|Overall Study|Lack of Efficacy|1|||
44289197|NCT01471782|79252780|FG004|Overall Study|Lack of Efficacy|5|||
44289198|NCT01471782|79252781|FG005|Overall Study|Lack of Efficacy|18|||
44289199|NCT01471782|79252776|FG000|Overall Study|Adverse Event|1|||
44289200|NCT01471782|79252777|FG001|Overall Study|Adverse Event|1|||
44289201|NCT01471782|79252778|FG002|Overall Study|Adverse Event|2|||
44289202|NCT01471782|79252779|FG003|Overall Study|Adverse Event|2|||
44289203|NCT01471782|79252780|FG004|Overall Study|Adverse Event|3|||
44289204|NCT01471782|79252781|FG005|Overall Study|Adverse Event|1|||
44289205|NCT01471782|79252776|FG000|Overall Study|Other|0|||
44289206|NCT01471782|79252777|FG001|Overall Study|Other|0|||
44289207|NCT01471782|79252778|FG002|Overall Study|Other|1|||
44289208|NCT01471782|79252779|FG003|Overall Study|Other|1|||
44289209|NCT01471782|79252780|FG004|Overall Study|Other|6|||
44289210|NCT01471782|79252781|FG005|Overall Study|Other|5|||
44289211|NCT01471782|79252776|FG000|Overall Study|Change of Chemotherapy|1|||
44289212|NCT01471782|79252777|FG001|Overall Study|Change of Chemotherapy|1|||
44289213|NCT01471782|79252778|FG002|Overall Study|Change of Chemotherapy|0|||
44289214|NCT01471782|79252779|FG003|Overall Study|Change of Chemotherapy|0|||
44289215|NCT01471782|79252780|FG004|Overall Study|Change of Chemotherapy|1|||
44415871|NCT00853385|79423636|FG003|Overall Study|Adverse Event|5|||
44289216|NCT01471782|79252781|FG005|Overall Study|Change of Chemotherapy|4|||
44289217|NCT01471782|79252776|FG000|Overall Study|Disease Relapse|0|||
44289218|NCT01471782|79252777|FG001|Overall Study|Disease Relapse|0|||
44289219|NCT01471782|79252778|FG002|Overall Study|Disease Relapse|0|||
44289220|NCT01471782|79252779|FG003|Overall Study|Disease Relapse|1|||
44289221|NCT01471782|79252780|FG004|Overall Study|Disease Relapse|2|||
44289222|NCT01471782|79252781|FG005|Overall Study|Disease Relapse|1|||
44289223|NCT01471782|79252776|FG000|Overall Study|Physician Decision|0|||
44289224|NCT01471782|79252777|FG001|Overall Study|Physician Decision|0|||
44289225|NCT01471782|79252778|FG002|Overall Study|Physician Decision|0|||
44289226|NCT01471782|79252779|FG003|Overall Study|Physician Decision|0|||
44289227|NCT01471782|79252780|FG004|Overall Study|Physician Decision|3|||
44289228|NCT01471782|79252781|FG005|Overall Study|Physician Decision|8|||
44289229|NCT01471782|79252776|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44289230|NCT01471782|79252777|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44289231|NCT01471782|79252778|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44289232|NCT01471782|79252779|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
44289233|NCT01471782|79252780|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
44289234|NCT01471782|79252781|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
44289235|NCT01471782|79252776|FG000|Overall Study|Death|0|||
44289236|NCT01471782|79252777|FG001|Overall Study|Death|0|||
44289237|NCT01471782|79252778|FG002|Overall Study|Death|0|||
44289238|NCT01471782|79252779|FG003|Overall Study|Death|0|||
44289239|NCT01471782|79252780|FG004|Overall Study|Death|0|||
44289240|NCT01471782|79252781|FG005|Overall Study|Death|1|||
44289241|NCT01490580|79252808|FG000|Overall Study|Parents withdrew consent|0|||
44289242|NCT01490580|79252809|FG001|Overall Study|Parents withdrew consent|2|||
44289243|NCT01490190|79252819|FG000|Overall Study|Withdrawal by Subject|9|||
44289244|NCT01490190|79252819|FG000|Overall Study|Adverse Event|17|||
44289245|NCT01490190|79252819|FG000|Overall Study|Protocol Violation|5|||
44289246|NCT01490190|79252819|FG000|Overall Study|Lost to Follow-up|13|||
44415872|NCT00853385|79423637|FG004|Overall Study|Adverse Event|22|||
44415873|NCT00853385|79423633|FG000|Overall Study|Lack of Efficacy|6|||
44415874|NCT00853385|79423634|FG001|Overall Study|Lack of Efficacy|7|||
44415875|NCT00853385|79423635|FG002|Overall Study|Lack of Efficacy|3|||
44415876|NCT00853385|79423636|FG003|Overall Study|Lack of Efficacy|3|||
44415877|NCT00853385|79423637|FG004|Overall Study|Lack of Efficacy|6|||
44415878|NCT00853385|79423633|FG000|Overall Study|Lost to Follow-up|2|||
44415879|NCT00853385|79423634|FG001|Overall Study|Lost to Follow-up|1|||
44415880|NCT00853385|79423635|FG002|Overall Study|Lost to Follow-up|0|||
44415881|NCT00853385|79423636|FG003|Overall Study|Lost to Follow-up|0|||
44415882|NCT00853385|79423637|FG004|Overall Study|Lost to Follow-up|0|||
44415883|NCT00853385|79423633|FG000|Overall Study|Withdrawal by Subject|4|||
44415884|NCT00853385|79423634|FG001|Overall Study|Withdrawal by Subject|2|||
44415885|NCT00853385|79423635|FG002|Overall Study|Withdrawal by Subject|0|||
44415886|NCT00853385|79423636|FG003|Overall Study|Withdrawal by Subject|1|||
44415887|NCT00853385|79423637|FG004|Overall Study|Withdrawal by Subject|1|||
44415888|NCT00853385|79423633|FG000|Overall Study|Other|18|||
44415889|NCT00853385|79423634|FG001|Overall Study|Other|9|||
44415890|NCT00853385|79423635|FG002|Overall Study|Other|4|||
44415891|NCT00853385|79423636|FG003|Overall Study|Other|4|||
44415892|NCT00853385|79423637|FG004|Overall Study|Other|12|||
44415893|NCT00622336|79423659|FG000|Treatment Phase|Progression of Disease|181|||
44415894|NCT00622336|79423659|FG000|Treatment Phase|Adverse Event|46|||
44415895|NCT00622336|79423659|FG000|Treatment Phase|Other|40|||
44415896|NCT00622336|79423659|FG000|Treatment Phase|Death|14|||
44415897|NCT00622336|79423659|FG000|Treatment Phase|Lack of therapeutic effect|13|||
44415898|NCT00622336|79423659|FG000|Treatment Phase|Withdrawal by Subject|13|||
44415899|NCT00622336|79423659|FG000|Treatment Phase|Lost to Follow-up|2|||
44415900|NCT00622336|79423659|FG000|Extension Phase|Adverse Event|2|||
44415901|NCT00622336|79423659|FG000|Extension Phase|Progressive Disease|6|||
44415902|NCT00622336|79423659|FG000|Extension Phase|Lack of therapeutic effect|2|||
44415903|NCT00622336|79423659|FG000|Extension Phase|Withdrawal by Subject|1|||
44289247|NCT01490190|79252819|FG000|Overall Study|Relocation|1|||
44289248|NCT01490190|79252819|FG000|Overall Study|Inconvenience|1|||
44289249|NCT01490190|79252819|FG000|Overall Study|Ring expulsion|2|||
44289250|NCT01446042|79252826|FG000|Overall Study|Withdrawal by Subject|12|||
44289251|NCT01446042|79252827|FG001|Overall Study|Withdrawal by Subject|2|||
44289252|NCT01446042|79252828|FG002|Overall Study|Withdrawal by Subject|4|||
44289253|NCT01446042|79252826|FG000|Overall Study|Adverse Event|1|||
44289254|NCT01446042|79252827|FG001|Overall Study|Adverse Event|0|||
44415904|NCT00622336|79423659|FG000|Extension Phase|Lost to Follow-up|1|||
44415905|NCT00622336|79423659|FG000|Extension Phase|Other|9|||
44289255|NCT01446042|79252828|FG002|Overall Study|Adverse Event|4|||
44289256|NCT01446042|79252826|FG000|Overall Study|Lost to Follow-up|5|||
44289257|NCT01446042|79252827|FG001|Overall Study|Lost to Follow-up|0|||
44289258|NCT01446042|79252828|FG002|Overall Study|Lost to Follow-up|0|||
44415906|NCT00779766|79423667|FG000|Month 24|Serious Adverse Event|2|||
44415907|NCT00779766|79423668|FG001|Month 24|Serious Adverse Event|3|||
44289259|NCT01446042|79252826|FG000|Overall Study|Other reasons|2|||
44289260|NCT01446042|79252827|FG001|Overall Study|Other reasons|1|||
44289261|NCT01446042|79252828|FG002|Overall Study|Other reasons|1|||
44415908|NCT00779766|79423667|FG000|Month 24|Adverse Event|3|||
44415909|NCT00779766|79423668|FG001|Month 24|Adverse Event|3|||
44415910|NCT00779766|79423667|FG000|Month 24|Protocol Violation|3|||
44415911|NCT00779766|79423668|FG001|Month 24|Protocol Violation|1|||
44415912|NCT00779766|79423667|FG000|Month 24|Withdrawal by Subject|159|||
44415913|NCT00779766|79423668|FG001|Month 24|Withdrawal by Subject|127|||
44415914|NCT00779766|79423667|FG000|Month 24|Migrated/moved from study area|138|||
44415915|NCT00779766|79423668|FG001|Month 24|Migrated/moved from study area|162|||
44415916|NCT00779766|79423667|FG000|Month 24|Lost to Follow-up|9|||
44415917|NCT00779766|79423668|FG001|Month 24|Lost to Follow-up|9|||
44415918|NCT00779766|79423667|FG000|Month 24|Other|18|||
44415919|NCT00779766|79423668|FG001|Month 24|Other|27|||
44415920|NCT00779766|79423667|FG000|Month 48|Withdrawal by Subject|68|||
44415921|NCT00779766|79423668|FG001|Month 48|Withdrawal by Subject|63|||
44415922|NCT00779766|79423667|FG000|Month 48|Migrated/moved from study area|76|||
44415923|NCT00779766|79423668|FG001|Month 48|Migrated/moved from study area|75|||
44415924|NCT00779766|79423667|FG000|Month 48|Lost to Follow-up|29|||
44415925|NCT00779766|79423668|FG001|Month 48|Lost to Follow-up|30|||
44415926|NCT00779766|79423667|FG000|Month 48|Other|1|||
44415927|NCT00779766|79423668|FG001|Month 48|Other|0|||
44415928|NCT00779766|79423667|FG000|Month 72|Withdrawal by Subject|55|||
44415929|NCT00779766|79423668|FG001|Month 72|Withdrawal by Subject|71|||
44415930|NCT00779766|79423667|FG000|Month 72|Migrated/moved from study area|124|||
44415931|NCT00779766|79423668|FG001|Month 72|Migrated/moved from study area|109|||
44415932|NCT00779766|79423667|FG000|Month 72|Lost to Follow-up|6|||
44415933|NCT00779766|79423668|FG001|Month 72|Lost to Follow-up|8|||
44415934|NCT00779766|79423667|FG000|Month 72|Other|0|||
44415935|NCT00779766|79423668|FG001|Month 72|Other|1|||
44415936|NCT00846365|79423678|FG000|Overall Study|Adverse Event|20|||
44415937|NCT00846365|79423679|FG001|Overall Study|Adverse Event|30|||
44415938|NCT00846365|79423680|FG002|Overall Study|Adverse Event|11|||
44415939|NCT00846365|79423678|FG000|Overall Study|Protocol Violation|5|||
44415940|NCT00846365|79423679|FG001|Overall Study|Protocol Violation|4|||
44415941|NCT00846365|79423680|FG002|Overall Study|Protocol Violation|0|||
44415942|NCT00846365|79423678|FG000|Overall Study|Lost to Follow-up|8|||
44415943|NCT00846365|79423679|FG001|Overall Study|Lost to Follow-up|2|||
44415944|NCT00846365|79423680|FG002|Overall Study|Lost to Follow-up|5|||
44415945|NCT00846365|79423678|FG000|Overall Study|Withdrawal by Subject|11|||
44154442|NCT02696785|78945531|FG001|Follow-up Period|Withdrawal by Subject|0|||
44289262|NCT01445886|79252836|FG000|Overall Study|Lost to Follow-up|2|||
44289263|NCT01445886|79252836|FG000|Overall Study|Protocol Violation|3|||
44289264|NCT01470612|79252844|FG000|Overall Study|Adverse Event|20|||
44289265|NCT01470612|79252845|FG001|Overall Study|Adverse Event|80|||
44289266|NCT01470612|79252844|FG000|Overall Study|Death|0|||
44289267|NCT01470612|79252845|FG001|Overall Study|Death|1|||
44289268|NCT01470612|79252844|FG000|Overall Study|Lack of Efficacy|20|||
44289269|NCT01470612|79252845|FG001|Overall Study|Lack of Efficacy|326|||
44289270|NCT01470612|79252844|FG000|Overall Study|Lost to Follow-up|2|||
44289271|NCT01470612|79252845|FG001|Overall Study|Lost to Follow-up|5|||
44289272|NCT01470612|79252844|FG000|Overall Study|Did not meet entrance criteria|0|||
44289273|NCT01470612|79252845|FG001|Overall Study|Did not meet entrance criteria|1|||
44289274|NCT01470612|79252844|FG000|Overall Study|Pregnancy|2|||
44289275|NCT01470612|79252845|FG001|Overall Study|Pregnancy|10|||
44289276|NCT01470612|79252844|FG000|Overall Study|Protocol Violation|2|||
44289277|NCT01470612|79252845|FG001|Overall Study|Protocol Violation|7|||
44289278|NCT01470612|79252844|FG000|Overall Study|Withdrawal by Subject|24|||
44289279|NCT01470612|79252845|FG001|Overall Study|Withdrawal by Subject|79|||
44289280|NCT01470612|79252844|FG000|Overall Study|Other|14|||
44289281|NCT01470612|79252845|FG001|Overall Study|Other|156|||
44289282|NCT01445730|79252851|FG000|Overall Study|Adverse Event|1|||
44289283|NCT01445730|79252851|FG000|Overall Study|For the advice of a dentist|1|||
44289284|NCT01445730|79252851|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
44154443|NCT02696785|78945532|FG002|Follow-up Period|Withdrawal by Subject|5|||
44289285|NCT01445652|79252857|FG000|Overall Study|Not comfortable in lenses|5|||
44289286|NCT01445652|79252858|FG001|Overall Study|Not comfortable in lenses|0|||
44289287|NCT01445652|79252857|FG000|Overall Study|Failed to attend scheduled visit|2|||
44415946|NCT00846365|79423679|FG001|Overall Study|Withdrawal by Subject|11|||
44415947|NCT00846365|79423680|FG002|Overall Study|Withdrawal by Subject|9|||
44154444|NCT02696785|78945533|FG003|Follow-up Period|Withdrawal by Subject|4|||
44415948|NCT00846365|79423678|FG000|Overall Study|Pregnancy|1|||
44415949|NCT00846365|79423679|FG001|Overall Study|Pregnancy|0|||
44415950|NCT00846365|79423680|FG002|Overall Study|Pregnancy|0|||
44415951|NCT00846365|79423678|FG000|Overall Study|Lack of Efficacy|1|||
44415952|NCT00846365|79423679|FG001|Overall Study|Lack of Efficacy|1|||
44415953|NCT00846365|79423680|FG002|Overall Study|Lack of Efficacy|2|||
44289288|NCT01445652|79252858|FG001|Overall Study|Failed to attend scheduled visit|3|||
44289289|NCT01445652|79252857|FG000|Overall Study|Failed teach session|2|||
44289290|NCT01445652|79252858|FG001|Overall Study|Failed teach session|0|||
44289291|NCT01445652|79252857|FG000|Overall Study|Adverse Event|1|||
44289292|NCT01445652|79252858|FG001|Overall Study|Adverse Event|0|||
44289293|NCT01470144|79252864|FG000|Overall Study|Adverse Event|2|||
44289294|NCT01470144|79252864|FG000|Overall Study|Death|1|||
44289295|NCT01470144|79252864|FG000|Overall Study|Lung transplant|6|||
44289296|NCT01470144|79252864|FG000|Overall Study|Patient's and investigator's decision|1|||
44289297|NCT01443858|79252871|FG000|Overall Study|Withdrawal by Subject|9|||
44289298|NCT01443858|79252872|FG001|Overall Study|Withdrawal by Subject|8|||
44289299|NCT01443858|79252873|FG002|Overall Study|Withdrawal by Subject|5|||
44289300|NCT01443858|79252871|FG000|Overall Study|Lack of Efficacy|1|||
44289301|NCT01443858|79252872|FG001|Overall Study|Lack of Efficacy|0|||
44289302|NCT01443858|79252873|FG002|Overall Study|Lack of Efficacy|0|||
44289303|NCT01443858|79252871|FG000|Overall Study|Lost to Follow-up|5|||
44289304|NCT01443858|79252872|FG001|Overall Study|Lost to Follow-up|5|||
44289305|NCT01443858|79252873|FG002|Overall Study|Lost to Follow-up|2|||
44289306|NCT01443078|79252881|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
44289307|NCT01443078|79252881|FG000|Overall Study|Withdrawal by Subject|1|||
44289308|NCT01443078|79252881|FG000|Overall Study|Patient had brain mets|1|||
44289309|NCT01439880|79252887|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
44289310|NCT01439880|79252888|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
44289311|NCT01439880|79252887|FG000|SOC-controlled Period (Year 1)|Death|2|||
44289312|NCT01439880|79252888|FG001|SOC-controlled Period (Year 1)|Death|1|||
44289313|NCT01439880|79252887|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
44289314|NCT01439880|79252888|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
44289315|NCT01439880|79252887|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
44289316|NCT01439880|79252888|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
44289317|NCT01439880|79252887|FG000|SOC-controlled Period (Year 1)|Other|8|||
44289318|NCT01439880|79252888|FG001|SOC-controlled Period (Year 1)|Other|13|||
44289319|NCT01439880|79252887|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
44289320|NCT01439880|79252888|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
44289321|NCT01439880|79252887|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
44289322|NCT01439880|79252888|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
44289323|NCT01439880|79252887|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
44289324|NCT01439880|79252888|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
44289325|NCT01439880|79252887|FG000|All-IP Period (Years 2 to 5)|Death|3|||
44289326|NCT01439880|79252888|FG001|All-IP Period (Years 2 to 5)|Death|13|||
44289327|NCT01439880|79252887|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
44289328|NCT01439880|79252888|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
44289329|NCT01439880|79252887|FG000|All-IP Period (Years 2 to 5)|Other|14|||
44289330|NCT01439880|79252888|FG001|All-IP Period (Years 2 to 5)|Other|31|||
44289331|NCT01439880|79252887|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
44289332|NCT01439880|79252888|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
44289333|NCT01469364|79252905|FG000|Overall Study|Adverse Event|1|||
44289334|NCT01469364|79252905|FG000|Overall Study|Withdrawal by Subject|1|||
44289335|NCT01439724|79252911|FG000|Overall Study|missing consultation|9|||
44289336|NCT01439724|79252912|FG001|Overall Study|missing consultation|8|||
44289337|NCT01439568|79252920|FG000|Overall Study|Lost to Follow-up|1|||
44289338|NCT01439568|79252921|FG001|Overall Study|Lost to Follow-up|0|||
44289339|NCT01439568|79252920|FG000|Overall Study|Withdrawal by Subject|2|||
44289340|NCT01439568|79252921|FG001|Overall Study|Withdrawal by Subject|2|||
44289341|NCT01469052|79252933|FG000|Overall Study|Adverse Event|2|||
44289342|NCT01469052|79252934|FG001|Overall Study|Adverse Event|3|||
44289343|NCT01469052|79252935|FG002|Overall Study|Adverse Event|0|||
44289344|NCT01469052|79252936|FG003|Overall Study|Adverse Event|2|||
44289345|NCT01469052|79252937|FG004|Overall Study|Adverse Event|0|||
44289346|NCT01469052|79252938|FG005|Overall Study|Adverse Event|1|||
44289347|NCT01469052|79252933|FG000|Overall Study|Progressive disease|3|||
44289348|NCT01469052|79252934|FG001|Overall Study|Progressive disease|0|||
44289349|NCT01469052|79252935|FG002|Overall Study|Progressive disease|5|||
44289350|NCT01469052|79252936|FG003|Overall Study|Progressive disease|3|||
44154445|NCT02004262|78945567|FG000|Overall Study|Death|67|||
44154446|NCT02004262|78945568|FG001|Overall Study|Death|64|||
44154447|NCT02004262|78945569|FG002|Overall Study|Death|66|||
44289351|NCT01469052|79252937|FG004|Overall Study|Progressive disease|7|||
44289352|NCT01469052|79252938|FG005|Overall Study|Progressive disease|2|||
44289353|NCT01469052|79252933|FG000|Overall Study|Lack of Efficacy|0|||
44289354|NCT01469052|79252934|FG001|Overall Study|Lack of Efficacy|0|||
44289355|NCT01469052|79252935|FG002|Overall Study|Lack of Efficacy|0|||
44289356|NCT01469052|79252936|FG003|Overall Study|Lack of Efficacy|0|||
44289357|NCT01469052|79252937|FG004|Overall Study|Lack of Efficacy|0|||
44154448|NCT02004262|78945570|FG003|Overall Study|Death|28|||
44289358|NCT01469052|79252938|FG005|Overall Study|Lack of Efficacy|2|||
44289359|NCT01469052|79252933|FG000|Overall Study|Moved to rollover protocol|1|||
44289360|NCT01469052|79252934|FG001|Overall Study|Moved to rollover protocol|0|||
44289361|NCT01469052|79252935|FG002|Overall Study|Moved to rollover protocol|1|||
44289362|NCT01469052|79252936|FG003|Overall Study|Moved to rollover protocol|0|||
44289363|NCT01469052|79252937|FG004|Overall Study|Moved to rollover protocol|0|||
44289364|NCT01469052|79252938|FG005|Overall Study|Moved to rollover protocol|1|||
44289365|NCT01469052|79252933|FG000|Overall Study|Other|0|||
44289366|NCT01469052|79252934|FG001|Overall Study|Other|1|||
44289367|NCT01469052|79252935|FG002|Overall Study|Other|0|||
44289368|NCT01469052|79252936|FG003|Overall Study|Other|0|||
44289369|NCT01469052|79252937|FG004|Overall Study|Other|1|||
44289370|NCT01469052|79252938|FG005|Overall Study|Other|0|||
44289371|NCT01468818|79252950|FG000|Overall Study|Death during treatment|2|||
44289372|NCT01442376|79252957|FG000|Overall Study|Adverse Event|0|||
44289373|NCT01442376|79252958|FG001|Overall Study|Adverse Event|3|||
44289374|NCT01442376|79252959|FG002|Overall Study|Adverse Event|2|||
44289375|NCT01442376|79252957|FG000|Overall Study|Death|0|||
44289376|NCT01442376|79252958|FG001|Overall Study|Death|1|||
44289377|NCT01442376|79252959|FG002|Overall Study|Death|1|||
44289378|NCT01442376|79252957|FG000|Overall Study|Withdrawal of consent|0|||
44289379|NCT01442376|79252958|FG001|Overall Study|Withdrawal of consent|0|||
44289380|NCT01442376|79252959|FG002|Overall Study|Withdrawal of consent|1|||
44289381|NCT01442376|79252957|FG000|Overall Study|Patients not treated|2|||
44289382|NCT01442376|79252958|FG001|Overall Study|Patients not treated|3|||
44289383|NCT01442376|79252959|FG002|Overall Study|Patients not treated|1|||
44289384|NCT01442376|79252957|FG000|Overall Study|Not eligible for subsequent cycles|1|||
44289385|NCT01442376|79252958|FG001|Overall Study|Not eligible for subsequent cycles|2|||
44289386|NCT01442376|79252959|FG002|Overall Study|Not eligible for subsequent cycles|0|||
44289387|NCT01442064|79252973|FG000|Overall Study|Adverse Event|2|||
44289388|NCT01442064|79252974|FG001|Overall Study|Adverse Event|2|||
44289389|NCT01442064|79252975|FG002|Overall Study|Adverse Event|2|||
44289390|NCT01442064|79252976|FG003|Overall Study|Adverse Event|1|||
44289391|NCT01442064|79252977|FG004|Overall Study|Adverse Event|2|||
44289392|NCT01442064|79252978|FG005|Overall Study|Adverse Event|0|||
44289393|NCT01442064|79252973|FG000|Overall Study|Death|0|||
44289394|NCT01442064|79252974|FG001|Overall Study|Death|1|||
44289395|NCT01442064|79252975|FG002|Overall Study|Death|3|||
44289396|NCT01442064|79252976|FG003|Overall Study|Death|3|||
44289397|NCT01442064|79252977|FG004|Overall Study|Death|1|||
44289398|NCT01442064|79252978|FG005|Overall Study|Death|3|||
44289399|NCT01442064|79252973|FG000|Overall Study|Lost to Follow-up|5|||
44289400|NCT01442064|79252974|FG001|Overall Study|Lost to Follow-up|5|||
44289401|NCT01442064|79252975|FG002|Overall Study|Lost to Follow-up|1|||
44289402|NCT01442064|79252976|FG003|Overall Study|Lost to Follow-up|1|||
44289403|NCT01442064|79252977|FG004|Overall Study|Lost to Follow-up|3|||
44289404|NCT01442064|79252978|FG005|Overall Study|Lost to Follow-up|3|||
44289405|NCT01442064|79252973|FG000|Overall Study|Physician Decision|1|||
44289406|NCT01442064|79252974|FG001|Overall Study|Physician Decision|1|||
44289407|NCT01442064|79252975|FG002|Overall Study|Physician Decision|2|||
44289408|NCT01442064|79252976|FG003|Overall Study|Physician Decision|3|||
44289409|NCT01442064|79252977|FG004|Overall Study|Physician Decision|3|||
44289410|NCT01442064|79252978|FG005|Overall Study|Physician Decision|1|||
44289411|NCT01442064|79252973|FG000|Overall Study|Withdrawal by Subject|6|||
44289412|NCT01442064|79252974|FG001|Overall Study|Withdrawal by Subject|3|||
44289413|NCT01442064|79252975|FG002|Overall Study|Withdrawal by Subject|2|||
44289414|NCT01442064|79252976|FG003|Overall Study|Withdrawal by Subject|2|||
44289415|NCT01442064|79252977|FG004|Overall Study|Withdrawal by Subject|2|||
44289416|NCT01442064|79252978|FG005|Overall Study|Withdrawal by Subject|1|||
44289417|NCT01442064|79252973|FG000|Overall Study|Sponsor decision|82|||
44289418|NCT01442064|79252974|FG001|Overall Study|Sponsor decision|88|||
44289419|NCT01442064|79252975|FG002|Overall Study|Sponsor decision|92|||
44289420|NCT01442064|79252976|FG003|Overall Study|Sponsor decision|88|||
44289421|NCT01442064|79252977|FG004|Overall Study|Sponsor decision|95|||
44289422|NCT01442064|79252978|FG005|Overall Study|Sponsor decision|87|||
44289423|NCT01442064|79252973|FG000|Overall Study|Subject non-compliance|0|||
44289424|NCT01442064|79252974|FG001|Overall Study|Subject non-compliance|0|||
44289425|NCT01442064|79252975|FG002|Overall Study|Subject non-compliance|0|||
44415954|NCT00846365|79423678|FG000|Overall Study|Other|9|||
44415955|NCT00846365|79423679|FG001|Overall Study|Other|1|||
44415956|NCT00846365|79423680|FG002|Overall Study|Other|6|||
44415957|NCT00779142|79423688|FG000|Overall Study|Screen Failures|3|||
44415958|NCT00622180|79423693|FG000|Overall Study|Lost to Follow-up|1|||
44415959|NCT00622180|79423694|FG001|Overall Study|Lost to Follow-up|2|||
44289426|NCT01442064|79252976|FG003|Overall Study|Subject non-compliance|0|||
44289427|NCT01442064|79252977|FG004|Overall Study|Subject non-compliance|0|||
44289428|NCT01442064|79252978|FG005|Overall Study|Subject non-compliance|2|||
44289429|NCT01442064|79252973|FG000|Overall Study|Condition mandated other intervention|1|||
44289430|NCT01442064|79252974|FG001|Overall Study|Condition mandated other intervention|1|||
44289431|NCT01442064|79252975|FG002|Overall Study|Condition mandated other intervention|2|||
44289432|NCT01442064|79252976|FG003|Overall Study|Condition mandated other intervention|0|||
44289433|NCT01442064|79252977|FG004|Overall Study|Condition mandated other intervention|0|||
44289434|NCT01442064|79252978|FG005|Overall Study|Condition mandated other intervention|2|||
44289435|NCT01467960|79253001|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
44289436|NCT01467960|79253002|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
44289437|NCT01467960|79253003|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
44289438|NCT01467960|79253004|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
44289439|NCT01467960|79253005|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
44289440|NCT01467960|79253006|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
44289441|NCT01441596|79253023|FG000|Overall Study|Other reason not defined below|0|||
44289442|NCT01441596|79253024|FG001|Overall Study|Other reason not defined below|2|||
44289443|NCT01441596|79253025|FG002|Overall Study|Other reason not defined below|1|||
44289444|NCT01441596|79253023|FG000|Overall Study|Withdrawal by Subject|4|||
44289445|NCT01441596|79253024|FG001|Overall Study|Withdrawal by Subject|0|||
44289446|NCT01441596|79253025|FG002|Overall Study|Withdrawal by Subject|2|||
44289447|NCT01441596|79253023|FG000|Overall Study|Not treated|0|||
44289448|NCT01441596|79253024|FG001|Overall Study|Not treated|1|||
44289449|NCT01441596|79253025|FG002|Overall Study|Not treated|1|||
44289450|NCT01441440|79253036|FG000|Overall Study|Death|1|||
44289451|NCT01441440|79253037|FG001|Overall Study|Death|0|||
44289452|NCT01441440|79253038|FG002|Overall Study|Death|1|||
44289453|NCT01441440|79253036|FG000|Overall Study|Adverse Event|2|||
44289454|NCT01441440|79253037|FG001|Overall Study|Adverse Event|9|||
44289455|NCT01441440|79253038|FG002|Overall Study|Adverse Event|9|||
44289456|NCT01441440|79253036|FG000|Overall Study|Lost to Follow-up|0|||
44289457|NCT01441440|79253037|FG001|Overall Study|Lost to Follow-up|2|||
44289458|NCT01441440|79253038|FG002|Overall Study|Lost to Follow-up|1|||
44289459|NCT01441440|79253036|FG000|Overall Study|Withdrawal by Subject|11|||
44289460|NCT01441440|79253037|FG001|Overall Study|Withdrawal by Subject|9|||
44289461|NCT01441440|79253038|FG002|Overall Study|Withdrawal by Subject|9|||
44289462|NCT01441440|79253036|FG000|Overall Study|Pregnancy|1|||
44415960|NCT00773136|79423700|FG000|Overall Study|Physician Decision|2|||
44415961|NCT00853307|79423707|FG000|Overall Study|Adverse Event|1|||
44415962|NCT00853307|79423708|FG001|Overall Study|Adverse Event|2|||
44415963|NCT00853307|79423707|FG000|Overall Study|Withdrawal by Subject|1|||
44415964|NCT00853307|79423708|FG001|Overall Study|Withdrawal by Subject|2|||
44415965|NCT00853307|79423707|FG000|Overall Study|Reason Not Specified|0|||
44415966|NCT00853307|79423708|FG001|Overall Study|Reason Not Specified|1|||
44415967|NCT00778830|79423716|FG000|Overall Study|Ongoing at data cut-off|0|||
44415968|NCT00778830|79423717|FG001|Overall Study|Ongoing at data cut-off|1|||
44415969|NCT00772668|79423723|FG000|Overall Study|Physician Decision|3|||
44415970|NCT00786474|79423730|FG000|Overall Study|Death|5|||
44415971|NCT00786474|79423731|FG001|Overall Study|Death|4|||
44415972|NCT00786474|79423730|FG000|Overall Study|Withdrawal by Subject|23|||
44415973|NCT00786474|79423731|FG001|Overall Study|Withdrawal by Subject|31|||
44415974|NCT00786474|79423730|FG000|Overall Study|Lost to Follow-up|3|||
44415975|NCT00786474|79423731|FG001|Overall Study|Lost to Follow-up|3|||
44415976|NCT00786474|79423730|FG000|Overall Study|Physician Decision|2|||
44415977|NCT00786474|79423731|FG001|Overall Study|Physician Decision|1|||
44415978|NCT00786474|79423730|FG000|Overall Study|Other|4|||
44415979|NCT00786474|79423731|FG001|Overall Study|Other|4|||
44415980|NCT00784875|79423741|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
44415981|NCT00784875|79423742|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
44415982|NCT00784875|79423743|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
44415983|NCT00784875|79423744|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
44415984|NCT00784875|79423741|FG000|Period A - Baseline|Adverse Event|0|||
44415985|NCT00784875|79423742|FG001|Period A - Baseline|Adverse Event|0|||
44415986|NCT00784875|79423743|FG002|Period A - Baseline|Adverse Event|0|||
44415987|NCT00784875|79423744|FG003|Period A - Baseline|Adverse Event|8|||
44415988|NCT00784875|79423741|FG000|Period A - Baseline|Protocol Violation|0|||
44415989|NCT00784875|79423742|FG001|Period A - Baseline|Protocol Violation|0|||
44415990|NCT00784875|79423743|FG002|Period A - Baseline|Protocol Violation|0|||
44415991|NCT00784875|79423744|FG003|Period A - Baseline|Protocol Violation|25|||
44415992|NCT00784875|79423741|FG000|Period A - Baseline|Withdrawal by Subject|0|||
44415993|NCT00784875|79423742|FG001|Period A - Baseline|Withdrawal by Subject|0|||
44415994|NCT00784875|79423743|FG002|Period A - Baseline|Withdrawal by Subject|0|||
44154449|NCT02004262|78945571|FG004|Overall Study|Death|29|||
44289463|NCT01441440|79253037|FG001|Overall Study|Pregnancy|0|||
44289464|NCT01441440|79253038|FG002|Overall Study|Pregnancy|0|||
44289465|NCT01441440|79253036|FG000|Overall Study|Lack of Efficacy|1|||
44289466|NCT01441440|79253037|FG001|Overall Study|Lack of Efficacy|0|||
44415995|NCT00784875|79423744|FG003|Period A - Baseline|Withdrawal by Subject|27|||
44415996|NCT00784875|79423741|FG000|Period A - Baseline|Physician Decision|0|||
44415997|NCT00784875|79423742|FG001|Period A - Baseline|Physician Decision|0|||
44415998|NCT00784875|79423743|FG002|Period A - Baseline|Physician Decision|0|||
44415999|NCT00784875|79423744|FG003|Period A - Baseline|Physician Decision|2|||
44416000|NCT00784875|79423741|FG000|Period A - Baseline|Sponsor Decision|0|||
44416001|NCT00784875|79423742|FG001|Period A - Baseline|Sponsor Decision|0|||
44289467|NCT01441440|79253038|FG002|Overall Study|Lack of Efficacy|1|||
44289468|NCT01441440|79253036|FG000|Overall Study|Moving|0|||
44289469|NCT01441440|79253037|FG001|Overall Study|Moving|1|||
44289470|NCT01441440|79253038|FG002|Overall Study|Moving|1|||
44289471|NCT01441440|79253036|FG000|Overall Study|Work-related matter|0|||
44289472|NCT01441440|79253037|FG001|Overall Study|Work-related matter|1|||
44289473|NCT01441440|79253038|FG002|Overall Study|Work-related matter|0|||
44289474|NCT01441440|79253036|FG000|Overall Study|Difficllty in keeping the schedule|1|||
44289475|NCT01441440|79253037|FG001|Overall Study|Difficllty in keeping the schedule|1|||
44289476|NCT01441440|79253038|FG002|Overall Study|Difficllty in keeping the schedule|0|||
44289477|NCT01438476|79253048|FG000|Overall Study|Protocol Violation|1|||
44416002|NCT00784875|79423743|FG002|Period A - Baseline|Sponsor Decision|0|||
44416003|NCT00784875|79423744|FG003|Period A - Baseline|Sponsor Decision|113|||
44416004|NCT00784875|79423741|FG000|Period A - Baseline|Lost to Follow-up|0|||
44416005|NCT00784875|79423742|FG001|Period A - Baseline|Lost to Follow-up|0|||
44416006|NCT00784875|79423743|FG002|Period A - Baseline|Lost to Follow-up|0|||
44416007|NCT00784875|79423744|FG003|Period A - Baseline|Lost to Follow-up|2|||
44416008|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
44416009|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
44416010|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
44416011|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
44416012|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
44416013|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
44416014|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
44416015|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
44416016|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
44416017|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
44416018|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
44416019|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
44416020|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
44416021|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
44416022|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
44416023|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
44416024|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
44416025|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
44416026|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
44416027|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
44416028|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
44416029|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
44416030|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
44416031|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
44416032|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
44416033|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
44416034|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
44416035|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
44416036|NCT00784875|79423741|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
44416037|NCT00784875|79423742|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
44289478|NCT01438476|79253049|FG001|Overall Study|Protocol Violation|0|||
44289479|NCT01438476|79253048|FG000|Overall Study|Withdrawal by Subject|1|||
44289480|NCT01438476|79253049|FG001|Overall Study|Withdrawal by Subject|0|||
44289481|NCT01438476|79253048|FG000|Overall Study|No Surgery- Disease|8|||
44289482|NCT01438476|79253049|FG001|Overall Study|No Surgery- Disease|10|||
44289483|NCT01438476|79253048|FG000|Overall Study|Communication barrier|0|||
44289484|NCT01438476|79253049|FG001|Overall Study|Communication barrier|1|||
44289485|NCT01467570|79253057|FG000|Overall Study|Lost to Follow-up|8|||
44289486|NCT01467570|79253058|FG001|Overall Study|Lost to Follow-up|9|||
44289487|NCT01437540|79253068|FG000|Overall Study|Not listed below|7|||
44289488|NCT01437540|79253069|FG001|Overall Study|Not listed below|6|||
44289489|NCT01437540|79253068|FG000|Overall Study|COPD exacerbation|13|||
44289490|NCT01437540|79253069|FG001|Overall Study|COPD exacerbation|3|||
44289491|NCT01437540|79253068|FG000|Overall Study|Lost to Follow-up|3|||
44289492|NCT01437540|79253069|FG001|Overall Study|Lost to Follow-up|5|||
44289493|NCT01437540|79253068|FG000|Overall Study|Lack of Efficacy|23|||
44289494|NCT01437540|79253069|FG001|Overall Study|Lack of Efficacy|11|||
44289495|NCT01437540|79253068|FG000|Overall Study|Protocol Violation|24|||
44289496|NCT01437540|79253069|FG001|Overall Study|Protocol Violation|12|||
44289497|NCT01437540|79253068|FG000|Overall Study|Adverse Event|26|||
44289498|NCT01437540|79253069|FG001|Overall Study|Adverse Event|13|||
44289499|NCT01437540|79253068|FG000|Overall Study|Withdrawal by Subject|31|||
44289500|NCT01437540|79253069|FG001|Overall Study|Withdrawal by Subject|15|||
44416038|NCT00784875|79423743|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
44416039|NCT00784875|79423744|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
44416040|NCT00784875|79423741|FG000|Period C|Adverse Event|1|||
44289501|NCT01440972|79253077|FG000|Overall Study|Withdrawal by Subject|3|||
44289502|NCT01440972|79253078|FG001|Overall Study|Withdrawal by Subject|2|||
44289503|NCT01420536|79253086|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
44289504|NCT01420536|79253087|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
44289505|NCT01420068|79253097|FG000|Overall Study|Administrative problems|1|||
44289506|NCT01420068|79253098|FG001|Overall Study|Administrative problems|3|||
44289507|NCT01420068|79253097|FG000|Overall Study|Withdrawal by Subject|1|||
44289508|NCT01420068|79253098|FG001|Overall Study|Withdrawal by Subject|2|||
44289509|NCT01467492|79253106|FG000|Overall Study|Withdrawal by Subject|6|||
44289510|NCT01467492|79253107|FG001|Overall Study|Withdrawal by Subject|4|||
44289511|NCT01467492|79253106|FG000|Overall Study|Study Terminated by Sponsor|6|||
44289512|NCT01467492|79253107|FG001|Overall Study|Study Terminated by Sponsor|4|||
44289513|NCT01467492|79253106|FG000|Overall Study|Adverse Event|4|||
44289514|NCT01467492|79253107|FG001|Overall Study|Adverse Event|3|||
44289515|NCT01467492|79253106|FG000|Overall Study|Lost to Follow-up|3|||
44289516|NCT01467492|79253107|FG001|Overall Study|Lost to Follow-up|2|||
44289517|NCT01467492|79253106|FG000|Overall Study|Undefined|2|||
44289518|NCT01467492|79253107|FG001|Overall Study|Undefined|0|||
44289519|NCT01467492|79253106|FG000|Overall Study|Enrolled But Not Treated|1|||
44289520|NCT01467492|79253107|FG001|Overall Study|Enrolled But Not Treated|0|||
44289521|NCT01466790|79253122|FG000|Overall Study|Adverse Event|1|||
44289522|NCT01466790|79253123|FG001|Overall Study|Adverse Event|0|||
44289523|NCT01466790|79253124|FG002|Overall Study|Adverse Event|0|||
44289524|NCT01466790|79253125|FG003|Overall Study|Adverse Event|0|||
44289525|NCT01466790|79253126|FG004|Overall Study|Adverse Event|2|||
44289526|NCT01466790|79253127|FG005|Overall Study|Adverse Event|0|||
44289527|NCT01466790|79253128|FG006|Overall Study|Adverse Event|0|||
44289528|NCT01466790|79253129|FG007|Overall Study|Adverse Event|0|||
44289529|NCT01466790|79253122|FG000|Overall Study|Lost to Follow-up|2|||
44289530|NCT01466790|79253123|FG001|Overall Study|Lost to Follow-up|0|||
44289531|NCT01466790|79253124|FG002|Overall Study|Lost to Follow-up|0|||
44289532|NCT01466790|79253125|FG003|Overall Study|Lost to Follow-up|0|||
44289533|NCT01466790|79253126|FG004|Overall Study|Lost to Follow-up|0|||
44289534|NCT01466790|79253127|FG005|Overall Study|Lost to Follow-up|0|||
44289535|NCT01466790|79253128|FG006|Overall Study|Lost to Follow-up|0|||
44289536|NCT01466790|79253129|FG007|Overall Study|Lost to Follow-up|0|||
44289537|NCT01466790|79253122|FG000|Overall Study|Withdrawal by Subject|1|||
44289538|NCT01466790|79253123|FG001|Overall Study|Withdrawal by Subject|1|||
44289539|NCT01466790|79253124|FG002|Overall Study|Withdrawal by Subject|0|||
44289540|NCT01466790|79253125|FG003|Overall Study|Withdrawal by Subject|0|||
44289541|NCT01466790|79253126|FG004|Overall Study|Withdrawal by Subject|1|||
44289542|NCT01466790|79253127|FG005|Overall Study|Withdrawal by Subject|0|||
44289543|NCT01466790|79253128|FG006|Overall Study|Withdrawal by Subject|1|||
44289544|NCT01466790|79253129|FG007|Overall Study|Withdrawal by Subject|1|||
44289545|NCT01418352|79253147|FG000|Overall Study|Lost to Follow-up|2|||
44289546|NCT01418352|79253148|FG001|Overall Study|Lost to Follow-up|0|||
44289547|NCT01418352|79253149|FG002|Overall Study|Lost to Follow-up|0|||
44289548|NCT01418352|79253150|FG003|Overall Study|Lost to Follow-up|0|||
44289549|NCT01418352|79253147|FG000|Overall Study|Adverse Event|0|||
44289550|NCT01418352|79253148|FG001|Overall Study|Adverse Event|1|||
44289551|NCT01418352|79253149|FG002|Overall Study|Adverse Event|0|||
44289552|NCT01418352|79253150|FG003|Overall Study|Adverse Event|0|||
44289553|NCT01418352|79253147|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
44289554|NCT01418352|79253148|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
44289555|NCT01418352|79253149|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
44289556|NCT01418352|79253150|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
44289557|NCT01418352|79253147|FG000|Overall Study|Subject Withdrew Consent|0|||
44289558|NCT01418352|79253148|FG001|Overall Study|Subject Withdrew Consent|1|||
44289559|NCT01418352|79253149|FG002|Overall Study|Subject Withdrew Consent|2|||
44289560|NCT01418352|79253150|FG003|Overall Study|Subject Withdrew Consent|1|||
44289561|NCT01418352|79253147|FG000|Overall Study|Protocol Deviation|0|||
44289562|NCT01418352|79253148|FG001|Overall Study|Protocol Deviation|0|||
44289563|NCT01418352|79253149|FG002|Overall Study|Protocol Deviation|1|||
44289564|NCT01418352|79253150|FG003|Overall Study|Protocol Deviation|0|||
44289565|NCT01418352|79253147|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
44289566|NCT01418352|79253148|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
44289567|NCT01418352|79253149|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
44289568|NCT01418352|79253150|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
44416041|NCT00784875|79423742|FG001|Period C|Adverse Event|0|||
44289569|NCT01436370|79253168|FG000|Overall Study|Lost to Follow-up|0|||
44289570|NCT01436370|79253169|FG001|Overall Study|Lost to Follow-up|0|||
44289571|NCT01436370|79253170|FG002|Overall Study|Lost to Follow-up|0|||
44289572|NCT01436370|79253171|FG003|Overall Study|Lost to Follow-up|0|||
44289573|NCT01436370|79253172|FG004|Overall Study|Lost to Follow-up|1|||
44289574|NCT01436370|79253173|FG005|Overall Study|Lost to Follow-up|0|||
44289575|NCT01436370|79253174|FG006|Overall Study|Lost to Follow-up|0|||
44289576|NCT01436370|79253175|FG007|Overall Study|Lost to Follow-up|0|||
44289577|NCT01465464|79253203|FG000|Overall Study|Adverse Event|96|||
44416042|NCT00784875|79423743|FG002|Period C|Adverse Event|4|||
44289578|NCT01465464|79253204|FG001|Overall Study|Adverse Event|49|||
44289579|NCT01465464|79253203|FG000|Overall Study|Lack of Efficacy|139|||
44154450|NCT02004262|78945572|FG005|Overall Study|Death|22|||
44154451|NCT02004262|78945567|FG000|Overall Study|Withdrawal by Subject|1|||
44154452|NCT02004262|78945568|FG001|Overall Study|Withdrawal by Subject|0|||
44154453|NCT02004262|78945569|FG002|Overall Study|Withdrawal by Subject|4|||
44154454|NCT02004262|78945570|FG003|Overall Study|Withdrawal by Subject|0|||
44154455|NCT02004262|78945571|FG004|Overall Study|Withdrawal by Subject|1|||
44289580|NCT01465464|79253204|FG001|Overall Study|Lack of Efficacy|190|||
44416043|NCT00784875|79423744|FG003|Period C|Adverse Event|2|||
44416044|NCT00784875|79423741|FG000|Period C|Protocol Violation|0|||
44416045|NCT00784875|79423742|FG001|Period C|Protocol Violation|0|||
44416046|NCT00784875|79423743|FG002|Period C|Protocol Violation|1|||
44289581|NCT01465464|79253203|FG000|Overall Study|Physician Decision|13|||
44289582|NCT01465464|79253204|FG001|Overall Study|Physician Decision|5|||
44289583|NCT01465464|79253203|FG000|Overall Study|Protocol Violation|1|||
44289584|NCT01465464|79253204|FG001|Overall Study|Protocol Violation|1|||
44289585|NCT01465464|79253203|FG000|Overall Study|Withdrawal by Subject|46|||
44289586|NCT01465464|79253204|FG001|Overall Study|Withdrawal by Subject|30|||
44289587|NCT01465464|79253203|FG000|Overall Study|Other|9|||
44289588|NCT01465464|79253204|FG001|Overall Study|Other|3|||
44154456|NCT02004262|78945572|FG005|Overall Study|Withdrawal by Subject|3|||
44154457|NCT02004262|78945567|FG000|Overall Study|Lost to Follow-up|1|||
44154458|NCT02004262|78945568|FG001|Overall Study|Lost to Follow-up|1|||
44154459|NCT02004262|78945569|FG002|Overall Study|Lost to Follow-up|0|||
44154460|NCT02004262|78945570|FG003|Overall Study|Lost to Follow-up|0|||
44154461|NCT02004262|78945571|FG004|Overall Study|Lost to Follow-up|0|||
44154462|NCT02004262|78945572|FG005|Overall Study|Lost to Follow-up|0|||
44154463|NCT02004262|78945567|FG000|Overall Study|Study Terminated by Sponsor|4|||
44289589|NCT01465464|79253203|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
44289590|NCT01465464|79253204|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
44289591|NCT01417104|79253212|FG000|Overall Study|Withdrawal by Subject|5|||
44289592|NCT01417104|79253213|FG001|Overall Study|Withdrawal by Subject|1|||
44289593|NCT01417104|79253212|FG000|Overall Study|Failure to make contact|0|||
44289594|NCT01417104|79253213|FG001|Overall Study|Failure to make contact|1|||
44289595|NCT01417104|79253212|FG000|Overall Study|Adverse Event|1|||
44289596|NCT01417104|79253213|FG001|Overall Study|Adverse Event|0|||
44289597|NCT01465386|79253219|FG000|Overall Study|Lack of Efficacy|3|||
44289598|NCT01465386|79253219|FG000|Overall Study|Adverse Event|1|||
44289599|NCT01465230|79253223|FG000|Overall Study|Withdrawal by Subject|2|||
44289600|NCT01435356|79253229|FG000|Overall Study|Adverse Event|2|||
44289601|NCT01435356|79253230|FG001|Overall Study|Adverse Event|0|||
44289602|NCT01435356|79253229|FG000|Overall Study|Disease progression/recurrence|17|||
44289603|NCT01435356|79253230|FG001|Overall Study|Disease progression/recurrence|10|||
44289604|NCT01435356|79253229|FG000|Overall Study|Protocol Violation|0|||
44289605|NCT01435356|79253230|FG001|Overall Study|Protocol Violation|1|||
44289606|NCT01435356|79253229|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
44289607|NCT01435356|79253230|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
44289608|NCT01435356|79253229|FG000|Overall Study|Withdrawal by Subject|1|||
44289609|NCT01435356|79253230|FG001|Overall Study|Withdrawal by Subject|1|||
44289610|NCT01435356|79253229|FG000|Overall Study|Facial palsy|1|||
44289611|NCT01435356|79253230|FG001|Overall Study|Facial palsy|0|||
44289612|NCT01435356|79253229|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
44289613|NCT01435356|79253230|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
44289614|NCT01435356|79253229|FG000|Overall Study|Physician Decision|1|||
44289615|NCT01435356|79253230|FG001|Overall Study|Physician Decision|0|||
44289616|NCT01435356|79253229|FG000|Overall Study|Patient decision|3|||
44289617|NCT01435356|79253230|FG001|Overall Study|Patient decision|0|||
44289618|NCT01435356|79253229|FG000|Overall Study|Patient moved to another city|1|||
44289619|NCT01435356|79253230|FG001|Overall Study|Patient moved to another city|1|||
44416047|NCT00784875|79423744|FG003|Period C|Protocol Violation|2|||
44154464|NCT02004262|78945568|FG001|Overall Study|Study Terminated by Sponsor|3|||
44154465|NCT02004262|78945569|FG002|Overall Study|Study Terminated by Sponsor|2|||
44154466|NCT02004262|78945570|FG003|Overall Study|Study Terminated by Sponsor|1|||
44154467|NCT02004262|78945571|FG004|Overall Study|Study Terminated by Sponsor|1|||
44154468|NCT02004262|78945572|FG005|Overall Study|Study Terminated by Sponsor|5|||
44154469|NCT01675427|78945586|FG000|Overall Study|Withdrawal by Subject|7|||
44154470|NCT01675427|78945586|FG000|Overall Study|Participant Refused Sample Collection|18|||
44154471|NCT01675427|78945586|FG000|Overall Study|Sample not Collected by Mistake|2|||
44289620|NCT01435122|79253236|FG000|Overall Study|Early withdrawal due to toxicity|8|||
44289621|NCT01434810|79253251|FG000|Overall Study|Did not receive treatment|11|||
44289622|NCT01434810|79253252|FG001|Overall Study|Did not receive treatment|3|||
44289623|NCT01434810|79253251|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
44289624|NCT01434810|79253252|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
44289625|NCT01393626|79253262|FG000|Overall Study|Adverse Event|2|||
44416048|NCT00784875|79423741|FG000|Period C|Lack of Efficacy|0|||
44416049|NCT00784875|79423742|FG001|Period C|Lack of Efficacy|0|||
44289626|NCT01393626|79253263|FG001|Overall Study|Adverse Event|1|||
44289627|NCT01393626|79253264|FG002|Overall Study|Adverse Event|5|||
44289628|NCT01393626|79253265|FG003|Overall Study|Adverse Event|0|||
44289629|NCT01393626|79253262|FG000|Overall Study|Did not meet entrance criteria|1|||
44289630|NCT01393626|79253263|FG001|Overall Study|Did not meet entrance criteria|0|||
44289631|NCT01393626|79253264|FG002|Overall Study|Did not meet entrance criteria|0|||
44289632|NCT01393626|79253265|FG003|Overall Study|Did not meet entrance criteria|0|||
44289633|NCT01393626|79253262|FG000|Overall Study|Lack of Efficacy|6|||
44289634|NCT01393626|79253263|FG001|Overall Study|Lack of Efficacy|6|||
44289635|NCT01393626|79253264|FG002|Overall Study|Lack of Efficacy|4|||
44289636|NCT01393626|79253265|FG003|Overall Study|Lack of Efficacy|1|||
44289637|NCT01393626|79253262|FG000|Overall Study|Lost to Follow-up|1|||
44289638|NCT01393626|79253263|FG001|Overall Study|Lost to Follow-up|1|||
44289639|NCT01393626|79253264|FG002|Overall Study|Lost to Follow-up|1|||
44289640|NCT01393626|79253265|FG003|Overall Study|Lost to Follow-up|0|||
44289641|NCT01393626|79253262|FG000|Overall Study|Withdrawal by Subject|6|||
44289642|NCT01393626|79253263|FG001|Overall Study|Withdrawal by Subject|4|||
44289643|NCT01393626|79253264|FG002|Overall Study|Withdrawal by Subject|0|||
44289644|NCT01393626|79253265|FG003|Overall Study|Withdrawal by Subject|0|||
44289645|NCT01393626|79253262|FG000|Overall Study|Other|1|||
44289646|NCT01393626|79253263|FG001|Overall Study|Other|0|||
44289647|NCT01393626|79253264|FG002|Overall Study|Other|0|||
44289648|NCT01393626|79253265|FG003|Overall Study|Other|0|||
44289649|NCT01393626|79253262|FG000|Overall Study|Protocol Violation|1|||
44289650|NCT01393626|79253263|FG001|Overall Study|Protocol Violation|0|||
44289651|NCT01393626|79253264|FG002|Overall Study|Protocol Violation|2|||
44289652|NCT01393626|79253265|FG003|Overall Study|Protocol Violation|0|||
44289653|NCT01434654|79253284|FG000|Overall Study|Withdrawal by Subject|1|||
44289654|NCT01434654|79253285|FG001|Overall Study|Withdrawal by Subject|0|||
44289655|NCT01434654|79253284|FG000|Overall Study|Lost to Follow-up|1|||
44289656|NCT01434654|79253285|FG001|Overall Study|Lost to Follow-up|0|||
44289657|NCT01393158|79253295|FG000|Overall Study|Adverse Event|1|||
44289658|NCT01393158|79253296|FG001|Overall Study|Adverse Event|0|||
44289659|NCT01413360|79253308|FG000|Overall Study|Lost to Follow-up|2|||
44289660|NCT01413360|79253308|FG000|Overall Study|Adverse Event|1|||
44289661|NCT01413204|79253315|FG000|Overall Study|Adverse Event|1|||
44289662|NCT01413204|79253316|FG001|Overall Study|Adverse Event|2|||
44289663|NCT01413204|79253317|FG002|Overall Study|Adverse Event|2|||
44289664|NCT01413204|79253315|FG000|Overall Study|Physician Decision|3|||
44289665|NCT01413204|79253316|FG001|Overall Study|Physician Decision|0|||
44289666|NCT01413204|79253317|FG002|Overall Study|Physician Decision|2|||
44289667|NCT01413204|79253315|FG000|Overall Study|Withdrawal by Subject|1|||
44289668|NCT01413204|79253316|FG001|Overall Study|Withdrawal by Subject|4|||
44289669|NCT01413204|79253317|FG002|Overall Study|Withdrawal by Subject|4|||
44289670|NCT01413204|79253315|FG000|Overall Study|Clearly not eligible for the study|0|||
44289671|NCT01413204|79253316|FG001|Overall Study|Clearly not eligible for the study|0|||
44289672|NCT01413204|79253317|FG002|Overall Study|Clearly not eligible for the study|1|||
44289673|NCT01413204|79253315|FG000|Overall Study|Fasting plasma glucose level increased|1|||
44289674|NCT01413204|79253316|FG001|Overall Study|Fasting plasma glucose level increased|0|||
44289675|NCT01413204|79253317|FG002|Overall Study|Fasting plasma glucose level increased|10|||
44289676|NCT01392378|79253330|FG000|Infant Series|Adverse Event|0|||
44289677|NCT01392378|79253331|FG001|Infant Series|Adverse Event|0|||
44289678|NCT01392378|79253332|FG002|Infant Series|Adverse Event|0|||
44289679|NCT01392378|79253333|FG003|Infant Series|Adverse Event|1|||
44289680|NCT01392378|79253334|FG004|Infant Series|Adverse Event|0|||
44289681|NCT01392378|79253330|FG000|Infant Series|Lost to Follow-up|0|||
44289682|NCT01392378|79253331|FG001|Infant Series|Lost to Follow-up|0|||
44289683|NCT01392378|79253332|FG002|Infant Series|Lost to Follow-up|0|||
44289684|NCT01392378|79253333|FG003|Infant Series|Lost to Follow-up|1|||
44289685|NCT01392378|79253334|FG004|Infant Series|Lost to Follow-up|0|||
44289686|NCT01392378|79253330|FG000|Infant Series|Protocol Violation|0|||
44289687|NCT01392378|79253331|FG001|Infant Series|Protocol Violation|1|||
44289688|NCT01392378|79253332|FG002|Infant Series|Protocol Violation|0|||
44289689|NCT01392378|79253333|FG003|Infant Series|Protocol Violation|0|||
44289690|NCT01392378|79253334|FG004|Infant Series|Protocol Violation|0|||
44289691|NCT01392378|79253330|FG000|Infant Series|Withdrawal by Parent|4|||
44416050|NCT00784875|79423743|FG002|Period C|Lack of Efficacy|1|||
44289692|NCT01392378|79253331|FG001|Infant Series|Withdrawal by Parent|1|||
44289693|NCT01392378|79253332|FG002|Infant Series|Withdrawal by Parent|0|||
44289694|NCT01392378|79253333|FG003|Infant Series|Withdrawal by Parent|0|||
44289695|NCT01392378|79253334|FG004|Infant Series|Withdrawal by Parent|0|||
44289696|NCT01392378|79253330|FG000|After Infant Series|Lost to Follow-up|0|||
44289697|NCT01392378|79253331|FG001|After Infant Series|Lost to Follow-up|0|||
44289698|NCT01392378|79253332|FG002|After Infant Series|Lost to Follow-up|1|||
44289699|NCT01392378|79253333|FG003|After Infant Series|Lost to Follow-up|0|||
44289700|NCT01392378|79253334|FG004|After Infant Series|Lost to Follow-up|0|||
44289701|NCT01392378|79253330|FG000|After Infant Series|Withdrawal by Parent|0|||
44289702|NCT01392378|79253331|FG001|After Infant Series|Withdrawal by Parent|1|||
44289703|NCT01392378|79253332|FG002|After Infant Series|Withdrawal by Parent|1|||
44289704|NCT01392378|79253333|FG003|After Infant Series|Withdrawal by Parent|0|||
44289705|NCT01392378|79253334|FG004|After Infant Series|Withdrawal by Parent|1|||
44289706|NCT01392378|79253330|FG000|Toddler Dose|Lost to Follow-up|0|||
44289707|NCT01392378|79253331|FG001|Toddler Dose|Lost to Follow-up|0|||
44289708|NCT01392378|79253332|FG002|Toddler Dose|Lost to Follow-up|0|||
44289709|NCT01392378|79253333|FG003|Toddler Dose|Lost to Follow-up|1|||
44289710|NCT01392378|79253334|FG004|Toddler Dose|Lost to Follow-up|0|||
44289711|NCT01392378|79253330|FG000|Toddler Dose|Withdrawal by Parent|0|||
44289712|NCT01392378|79253331|FG001|Toddler Dose|Withdrawal by Parent|1|||
44289713|NCT01392378|79253332|FG002|Toddler Dose|Withdrawal by Parent|0|||
44289714|NCT01392378|79253333|FG003|Toddler Dose|Withdrawal by Parent|1|||
44289715|NCT01392378|79253334|FG004|Toddler Dose|Withdrawal by Parent|1|||
44289716|NCT01412424|79253356|FG000|Core Treatment Period|Treatment Failure|24|||
44289717|NCT01412424|79253356|FG000|Core Treatment Period|Adverse Event|21|||
44289718|NCT01412424|79253356|FG000|Core Treatment Period|Patient Request|5|||
44289719|NCT01412424|79253356|FG000|Core Treatment Period|Lost to Follow-up|2|||
44289720|NCT01412424|79253356|FG000|Core Treatment Period|Sponsor Request|1|||
44289721|NCT01412424|79253356|FG000|Extension Treatment Period|Adverse Event|2|||
44289722|NCT01412424|79253356|FG000|Extension Treatment Period|Treatment Failure|2|||
44289723|NCT01412424|79253356|FG000|Extension Treatment Period|Patient Request|2|||
44289724|NCT01433250|79253368|FG000|Overall Study|Protocol Violation|0|||
44416051|NCT00784875|79423744|FG003|Period C|Lack of Efficacy|0|||
44416052|NCT00784875|79423741|FG000|Period C|Withdrawal by Subject|1|||
44416053|NCT00784875|79423742|FG001|Period C|Withdrawal by Subject|1|||
44416054|NCT00784875|79423743|FG002|Period C|Withdrawal by Subject|2|||
44416055|NCT00784875|79423744|FG003|Period C|Withdrawal by Subject|0|||
44416056|NCT00784875|79423741|FG000|Period C|Physician Decision|0|||
44416057|NCT00784875|79423742|FG001|Period C|Physician Decision|0|||
44416058|NCT00784875|79423743|FG002|Period C|Physician Decision|1|||
44416059|NCT00784875|79423744|FG003|Period C|Physician Decision|1|||
44416060|NCT00784875|79423741|FG000|Period C|Sponsor Decision|5|||
44416061|NCT00784875|79423742|FG001|Period C|Sponsor Decision|5|||
44416062|NCT00784875|79423743|FG002|Period C|Sponsor Decision|4|||
44416063|NCT00784875|79423744|FG003|Period C|Sponsor Decision|2|||
44416064|NCT00784875|79423741|FG000|Period D|Adverse Event|0|||
44416065|NCT00784875|79423742|FG001|Period D|Adverse Event|2|||
44416066|NCT00784875|79423743|FG002|Period D|Adverse Event|2|||
44416067|NCT00784875|79423744|FG003|Period D|Adverse Event|0|||
44416068|NCT00784875|79423741|FG000|Period D|Protocol Violation|1|||
44416069|NCT00784875|79423742|FG001|Period D|Protocol Violation|0|||
44416070|NCT00784875|79423743|FG002|Period D|Protocol Violation|0|||
44416071|NCT00784875|79423744|FG003|Period D|Protocol Violation|0|||
44416072|NCT00784875|79423741|FG000|Period D|Withdrawal by Subject|2|||
44416073|NCT00784875|79423742|FG001|Period D|Withdrawal by Subject|0|||
44416074|NCT00784875|79423743|FG002|Period D|Withdrawal by Subject|2|||
44416075|NCT00784875|79423744|FG003|Period D|Withdrawal by Subject|0|||
44416076|NCT00784875|79423741|FG000|Period D|Physician Decision|0|||
44416077|NCT00784875|79423742|FG001|Period D|Physician Decision|1|||
44416078|NCT00784875|79423743|FG002|Period D|Physician Decision|0|||
44154472|NCT01675427|78945586|FG000|Overall Study|Lost to Follow-up|5|||
44154473|NCT01675427|78945586|FG000|Overall Study|Other|2|||
44289725|NCT01433250|79253369|FG001|Overall Study|Protocol Violation|1|||
44289726|NCT01433250|79253368|FG000|Overall Study|Withdrawal by Subject|3|||
44289727|NCT01433250|79253369|FG001|Overall Study|Withdrawal by Subject|2|||
44289728|NCT01433172|79253378|FG000|Overall Study|Withdrawal by Subject|0|||
44416079|NCT00784875|79423744|FG003|Period D|Physician Decision|0|||
44416080|NCT00784875|79423741|FG000|Period D|Sponsor Decision|1|||
44154474|NCT01978912|78945624|FG000|Overall Study|Adverse Event|0|||
44154475|NCT01978912|78945625|FG001|Overall Study|Adverse Event|1|||
44154476|NCT01978912|78945626|FG002|Overall Study|Adverse Event|0|||
44289729|NCT01433172|79253379|FG001|Overall Study|Withdrawal by Subject|1|||
44289730|NCT01433172|79253380|FG002|Overall Study|Withdrawal by Subject|0|||
44289731|NCT01433172|79253378|FG000|Overall Study|Disease Progression|0|||
44289732|NCT01433172|79253379|FG001|Overall Study|Disease Progression|0|||
44289733|NCT01433172|79253380|FG002|Overall Study|Disease Progression|1|||
44416081|NCT00784875|79423742|FG001|Period D|Sponsor Decision|1|||
44289734|NCT01433172|79253378|FG000|Overall Study|Death|0|||
44416082|NCT00784875|79423743|FG002|Period D|Sponsor Decision|1|||
44416083|NCT00784875|79423744|FG003|Period D|Sponsor Decision|0|||
44154477|NCT01978912|78945627|FG003|Overall Study|Adverse Event|0|||
44289735|NCT01433172|79253379|FG001|Overall Study|Death|2|||
44416084|NCT00784875|79423741|FG000|Period D|Lost to Follow-up|1|||
44416085|NCT00784875|79423742|FG001|Period D|Lost to Follow-up|0|||
44416086|NCT00784875|79423743|FG002|Period D|Lost to Follow-up|1|||
44416087|NCT00784875|79423744|FG003|Period D|Lost to Follow-up|1|||
44416088|NCT00592553|79423770|FG000|Overall Study|Protocol Noncompliance|1|||
44416089|NCT00592553|79423771|FG001|Overall Study|Protocol Noncompliance|0|||
44289736|NCT01433172|79253380|FG002|Overall Study|Death|0|||
44289737|NCT01432938|79253388|FG000|First Intervention|Protocol Violation|1|||
44289738|NCT01432938|79253389|FG001|First Intervention|Protocol Violation|0|||
44289739|NCT01432938|79253388|FG000|First Intervention|Physician Decision|1|||
44289740|NCT01432938|79253389|FG001|First Intervention|Physician Decision|0|||
44289741|NCT01432938|79253388|FG000|Second Intervention|Adverse Event|1|||
44289742|NCT01432938|79253389|FG001|Second Intervention|Adverse Event|0|||
44289743|NCT01392300|79253398|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
44289744|NCT01392300|79253399|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
44289745|NCT01392300|79253400|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
44289746|NCT01392300|79253398|FG000|Main Period (MP)|Withdrawal by Subject|5|||
44289747|NCT01392300|79253399|FG001|Main Period (MP)|Withdrawal by Subject|1|||
44289748|NCT01392300|79253400|FG002|Main Period (MP)|Withdrawal by Subject|0|||
44289749|NCT01392300|79253398|FG000|Main Period (MP)|Lost to Follow-up|3|||
44289750|NCT01392300|79253399|FG001|Main Period (MP)|Lost to Follow-up|3|||
44416090|NCT00592553|79423772|FG002|Overall Study|Protocol Noncompliance|0|||
44416091|NCT00853229|79423782|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
44416092|NCT00853229|79423783|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
44416093|NCT00853151|79423795|FG000|Overall Study|Adverse Event|1|||
44416094|NCT00853151|79423796|FG001|Overall Study|Adverse Event|4|||
44416095|NCT00853151|79423797|FG002|Overall Study|Adverse Event|2|||
44416096|NCT00853151|79423798|FG003|Overall Study|Adverse Event|0|||
44416097|NCT00853151|79423795|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
44416098|NCT00853151|79423796|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44416099|NCT00853151|79423797|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44416100|NCT00853151|79423798|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
44416101|NCT00853151|79423795|FG000|Overall Study|Lost to Follow-up|2|||
44416102|NCT00853151|79423796|FG001|Overall Study|Lost to Follow-up|0|||
44416103|NCT00853151|79423797|FG002|Overall Study|Lost to Follow-up|3|||
44416104|NCT00853151|79423798|FG003|Overall Study|Lost to Follow-up|0|||
44416105|NCT00853151|79423795|FG000|Overall Study|Death|1|||
44416106|NCT00853151|79423796|FG001|Overall Study|Death|0|||
44416107|NCT00853151|79423797|FG002|Overall Study|Death|0|||
44416108|NCT00853151|79423798|FG003|Overall Study|Death|1|||
44416109|NCT00853151|79423795|FG000|Overall Study|Protocol Violation|0|||
44416110|NCT00853151|79423796|FG001|Overall Study|Protocol Violation|0|||
44416111|NCT00853151|79423797|FG002|Overall Study|Protocol Violation|0|||
44416112|NCT00853151|79423798|FG003|Overall Study|Protocol Violation|1|||
44416113|NCT00853151|79423795|FG000|Overall Study|Withdrawal by Subject|5|||
44416114|NCT00853151|79423796|FG001|Overall Study|Withdrawal by Subject|4|||
44416115|NCT00853151|79423797|FG002|Overall Study|Withdrawal by Subject|2|||
44416116|NCT00853151|79423798|FG003|Overall Study|Withdrawal by Subject|1|||
44416117|NCT00853151|79423795|FG000|Overall Study|Physician Decision|0|||
44416118|NCT00853151|79423796|FG001|Overall Study|Physician Decision|2|||
44416119|NCT00853151|79423797|FG002|Overall Study|Physician Decision|1|||
44416120|NCT00853151|79423798|FG003|Overall Study|Physician Decision|0|||
44416121|NCT00853151|79423795|FG000|Overall Study|Sponsor Decision|0|||
44416122|NCT00853151|79423796|FG001|Overall Study|Sponsor Decision|3|||
44533626|NCT03299842|79543946|FG000|Overall Study|Caregiver withdrew consent|2|||
44533627|NCT03299842|79543946|FG000|Overall Study|Child would not keep the watch on|3|||
44533628|NCT03237611|79543950|FG000|Overall Study|Withdrawal by Subject|1|||
44533629|NCT03237611|79543950|FG000|Overall Study|Ineligible|1|||
44533630|NCT03104374|79543957|FG000|Overall Study|Adverse Event|7|||
44533631|NCT03104374|79543958|FG001|Overall Study|Adverse Event|6|||
44533632|NCT03104374|79543959|FG002|Overall Study|Adverse Event|12|||
44154478|NCT01978912|78945624|FG000|Overall Study|Lost to Follow-up|1|||
44154479|NCT01978912|78945625|FG001|Overall Study|Lost to Follow-up|1|||
44289751|NCT01392300|79253400|FG002|Main Period (MP)|Lost to Follow-up|0|||
44416123|NCT00853151|79423797|FG002|Overall Study|Sponsor Decision|0|||
44416124|NCT00853151|79423798|FG003|Overall Study|Sponsor Decision|0|||
44416125|NCT00853073|79423813|FG000|Overall Study|Withdrawal by Subject|3|||
44416126|NCT00853073|79423814|FG001|Overall Study|Withdrawal by Subject|2|||
44416127|NCT00846053|79423822|FG000|Overall Study|Physician Decision|3|||
44533633|NCT03104374|79543960|FG003|Overall Study|Adverse Event|15|||
44533634|NCT03104374|79543957|FG000|Overall Study|Withdrawal by Subject|18|||
44154480|NCT01978912|78945626|FG002|Overall Study|Lost to Follow-up|0|||
44154481|NCT01978912|78945627|FG003|Overall Study|Lost to Follow-up|1|||
44289752|NCT01392300|79253398|FG000|Main Period (MP)|Non-compliance|1|||
44416128|NCT00846053|79423823|FG001|Overall Study|Physician Decision|0|||
44416129|NCT00845897|79423834|FG000|Overall Study|Lost to Follow-up|1|||
44416130|NCT00845897|79423835|FG001|Overall Study|Lost to Follow-up|1|||
44416131|NCT00845897|79423836|FG002|Overall Study|Lost to Follow-up|0|||
44416132|NCT00845897|79423834|FG000|Overall Study|Withdrawal by Subject|0|||
44533635|NCT03104374|79543958|FG001|Overall Study|Withdrawal by Subject|10|||
44154482|NCT01978912|78945624|FG000|Overall Study|Withdrawal by Subject|1|||
44289753|NCT01392300|79253399|FG001|Main Period (MP)|Non-compliance|0|||
44416133|NCT00845897|79423835|FG001|Overall Study|Withdrawal by Subject|3|||
44533636|NCT03104374|79543959|FG002|Overall Study|Withdrawal by Subject|10|||
44533637|NCT03104374|79543960|FG003|Overall Study|Withdrawal by Subject|17|||
44533638|NCT03104374|79543957|FG000|Overall Study|Lost to Follow-up|4|||
44533639|NCT03104374|79543958|FG001|Overall Study|Lost to Follow-up|4|||
44533640|NCT03104374|79543959|FG002|Overall Study|Lost to Follow-up|6|||
44533641|NCT03104374|79543960|FG003|Overall Study|Lost to Follow-up|8|||
44154483|NCT01978912|78945625|FG001|Overall Study|Withdrawal by Subject|0|||
44154484|NCT01978912|78945626|FG002|Overall Study|Withdrawal by Subject|2|||
44289754|NCT01392300|79253400|FG002|Main Period (MP)|Non-compliance|0|||
44289755|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
44289756|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
44289757|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
44289758|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
44289759|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
44289760|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
44289761|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
44289762|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
44289763|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
44289764|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Death|0|||
44289765|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Death|0|||
44289766|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Death|4|||
44289767|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
44289768|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
44289769|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
44289770|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
44289771|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
44289772|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
44289773|NCT01392300|79253398|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
44289774|NCT01392300|79253399|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
44289775|NCT01392300|79253400|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
44289776|NCT01432626|79253407|FG000|Overall Study|LV function recovered|2|||
44289777|NCT01432626|79253407|FG000|Overall Study|Withdrawal by Subject|2|||
44289778|NCT01432626|79253407|FG000|Overall Study|Only 1 image competed|2|||
44289779|NCT01432626|79253407|FG000|Overall Study|Imaging agent not available|1|||
44289780|NCT01410474|79253413|FG000|Overall Study|Withdrawal by Subject|0|||
44289781|NCT01410474|79253414|FG001|Overall Study|Withdrawal by Subject|1|||
44154485|NCT01978912|78945627|FG003|Overall Study|Withdrawal by Subject|2|||
44154486|NCT01978912|78945624|FG000|Overall Study|Lumbar Surgery|1|||
44154487|NCT01978912|78945625|FG001|Overall Study|Lumbar Surgery|0|||
44154488|NCT01978912|78945626|FG002|Overall Study|Lumbar Surgery|1|||
44289782|NCT01391130|79253429|FG000|Overall Study|Withdrawal by Subject|3|||
44289783|NCT01391130|79253430|FG001|Overall Study|Withdrawal by Subject|2|||
44289784|NCT01391130|79253429|FG000|Overall Study|Physician Decision|2|||
44289785|NCT01391130|79253430|FG001|Overall Study|Physician Decision|3|||
44289786|NCT01391130|79253429|FG000|Overall Study|Did not Receive Drug|1|||
44416134|NCT00845897|79423836|FG002|Overall Study|Withdrawal by Subject|2|||
44289787|NCT01391130|79253430|FG001|Overall Study|Did not Receive Drug|1|||
44289788|NCT01410240|79253439|FG000|Overall Study|Physician Decision|0|||
44289789|NCT01410240|79253440|FG001|Overall Study|Physician Decision|0|||
44289790|NCT01410240|79253441|FG002|Overall Study|Physician Decision|1|||
44289791|NCT01410240|79253439|FG000|Overall Study|Missed week 6 assessments|1|||
44289792|NCT01410240|79253440|FG001|Overall Study|Missed week 6 assessments|1|||
44289793|NCT01410240|79253441|FG002|Overall Study|Missed week 6 assessments|1|||
44289794|NCT01409928|79253450|FG000|Overall Study|Physician Decision|12|||
44289795|NCT01431534|79253457|FG000|Treatment Phase|Adverse Event|0|||
44289796|NCT01431534|79253458|FG001|Treatment Phase|Adverse Event|0|||
44289797|NCT01431534|79253459|FG002|Treatment Phase|Adverse Event|1|||
44289798|NCT01431534|79253457|FG000|Treatment Phase|Progressive Disease|4|||
44289799|NCT01431534|79253458|FG001|Treatment Phase|Progressive Disease|3|||
44289800|NCT01431534|79253459|FG002|Treatment Phase|Progressive Disease|10|||
44289801|NCT01409382|79253469|FG000|Overall Study|Lost to Follow-up|1|||
44289802|NCT01409382|79253470|FG001|Overall Study|Lost to Follow-up|1|||
44289803|NCT01409382|79253469|FG000|Overall Study|Protocol Violation|0|||
44416135|NCT00845897|79423834|FG000|Overall Study|Ulcer did not heal|1|||
44533642|NCT03104374|79543957|FG000|Overall Study|Lack of Efficacy|6|||
44154489|NCT01978912|78945627|FG003|Overall Study|Lumbar Surgery|0|||
44289804|NCT01409382|79253470|FG001|Overall Study|Protocol Violation|3|||
44289805|NCT01409382|79253469|FG000|Overall Study|Multiple pregnancy|2|||
44289806|NCT01409382|79253470|FG001|Overall Study|Multiple pregnancy|4|||
44289807|NCT01409382|79253469|FG000|Overall Study|Still pregnant when study ended|13|||
44289808|NCT01409382|79253470|FG001|Overall Study|Still pregnant when study ended|2|||
44416136|NCT00845897|79423835|FG001|Overall Study|Ulcer did not heal|0|||
44416137|NCT00845897|79423836|FG002|Overall Study|Ulcer did not heal|1|||
44533643|NCT03104374|79543958|FG001|Overall Study|Lack of Efficacy|7|||
44533644|NCT03104374|79543959|FG002|Overall Study|Lack of Efficacy|12|||
44289809|NCT01409382|79253469|FG000|Overall Study|Did not manage to get pregnant|64|||
44289810|NCT01409382|79253470|FG001|Overall Study|Did not manage to get pregnant|70|||
44289811|NCT01409382|79253469|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
44289812|NCT01409382|79253470|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
44289813|NCT01408914|79253483|FG000|Overall Study|Could not complete tx in protocol period|5|||
44289814|NCT01408914|79253484|FG001|Overall Study|Could not complete tx in protocol period|5|||
44289815|NCT01408914|79253485|FG002|Overall Study|Could not complete tx in protocol period|6|||
44289816|NCT01408914|79253483|FG000|Overall Study|Lost to Follow-up|4|||
44289817|NCT01408914|79253484|FG001|Overall Study|Lost to Follow-up|1|||
44289818|NCT01408914|79253485|FG002|Overall Study|Lost to Follow-up|2|||
44289819|NCT01408914|79253483|FG000|Overall Study|Physician Decision|1|||
44289820|NCT01408914|79253484|FG001|Overall Study|Physician Decision|1|||
44289821|NCT01408914|79253485|FG002|Overall Study|Physician Decision|0|||
44289822|NCT01408914|79253483|FG000|Overall Study|Withdrawal by Subject|1|||
44289823|NCT01408914|79253484|FG001|Overall Study|Withdrawal by Subject|0|||
44289824|NCT01408914|79253485|FG002|Overall Study|Withdrawal by Subject|1|||
44289825|NCT01408914|79253483|FG000|Overall Study|Moved out of study jurisdiction|1|||
44289826|NCT01408914|79253484|FG001|Overall Study|Moved out of study jurisdiction|1|||
44289827|NCT01408914|79253485|FG002|Overall Study|Moved out of study jurisdiction|0|||
44289828|NCT01408914|79253483|FG000|Overall Study|Late exclusion|0|||
44289829|NCT01408914|79253484|FG001|Overall Study|Late exclusion|3|||
44289830|NCT01408914|79253485|FG002|Overall Study|Late exclusion|3|||
44289831|NCT01408914|79253483|FG000|Overall Study|Change in local TB/HIV norms|0|||
44289832|NCT01408914|79253484|FG001|Overall Study|Change in local TB/HIV norms|1|||
44289833|NCT01408914|79253485|FG002|Overall Study|Change in local TB/HIV norms|1|||
44289834|NCT01431144|79253495|FG000|Overall Study|Implant mobility and removal|2|||
44289835|NCT01431144|79253496|FG001|Overall Study|Implant mobility and removal|0|||
44289836|NCT01430754|79253505|FG000|Run-In Phase|Circadian Period Ineligible|24|||
44289837|NCT01430754|79253506|FG001|Run-In Phase|Circadian Period Ineligible|0|||
44289838|NCT01430754|79253505|FG000|Run-In Phase|Protocol Violation|6|||
44289839|NCT01430754|79253506|FG001|Run-In Phase|Protocol Violation|0|||
44289840|NCT01430754|79253505|FG000|Run-In Phase|Adverse Event|2|||
44289841|NCT01430754|79253506|FG001|Run-In Phase|Adverse Event|0|||
44289842|NCT01430754|79253505|FG000|Run-In Phase|Other|2|||
44289843|NCT01430754|79253506|FG001|Run-In Phase|Other|0|||
44289844|NCT01430754|79253505|FG000|Run-In Phase|Withdrawal by Subject|2|||
44289845|NCT01430754|79253506|FG001|Run-In Phase|Withdrawal by Subject|0|||
44289846|NCT01430754|79253505|FG000|Run-In Phase|Lost to Follow-up|1|||
44289847|NCT01430754|79253506|FG001|Run-In Phase|Lost to Follow-up|0|||
44289848|NCT01390428|79253520|FG000|Overall Study|Elective Surgery|0|||
44289849|NCT01390428|79253521|FG001|Overall Study|Elective Surgery|0|||
44289850|NCT01390428|79253522|FG002|Overall Study|Elective Surgery|0|||
44289851|NCT01390428|79253523|FG003|Overall Study|Elective Surgery|0|||
44289852|NCT01390428|79253524|FG004|Overall Study|Elective Surgery|1|||
44289853|NCT01390428|79253525|FG005|Overall Study|Elective Surgery|0|||
44289854|NCT01390428|79253520|FG000|Overall Study|Withdrawal by Subject|0|||
44289855|NCT01390428|79253521|FG001|Overall Study|Withdrawal by Subject|0|||
44289856|NCT01390428|79253522|FG002|Overall Study|Withdrawal by Subject|1|||
44289857|NCT01390428|79253523|FG003|Overall Study|Withdrawal by Subject|0|||
44289858|NCT01390428|79253524|FG004|Overall Study|Withdrawal by Subject|0|||
44289859|NCT01390428|79253525|FG005|Overall Study|Withdrawal by Subject|0|||
44289860|NCT01430130|79253539|FG000|Overall Study|Lost to Follow-up|1|||
44289861|NCT01430130|79253539|FG000|Overall Study|Infection on Control Side of Incision|1|||
44289862|NCT01407354|79253545|FG000|First Intervention|Withdrawal by Subject|0|||
44289863|NCT01407354|79253546|FG001|First Intervention|Withdrawal by Subject|2|||
44289864|NCT01407354|79253545|FG000|First Intervention|Adverse Event|1|||
44289865|NCT01407354|79253546|FG001|First Intervention|Adverse Event|0|||
44289866|NCT01407354|79253545|FG000|First Intervention|Physician Decision|1|||
44289867|NCT01407354|79253546|FG001|First Intervention|Physician Decision|0|||
44289868|NCT01407276|79253561|FG000|Overall Study|Withdrawal by Subject|0|||
44289869|NCT01407276|79253562|FG001|Overall Study|Withdrawal by Subject|0|||
44289870|NCT01407276|79253563|FG002|Overall Study|Withdrawal by Subject|0|||
44289871|NCT01407276|79253564|FG003|Overall Study|Withdrawal by Subject|0|||
44533645|NCT03104374|79543960|FG003|Overall Study|Lack of Efficacy|6|||
44533646|NCT03104374|79543957|FG000|Overall Study|Other|2|||
44289872|NCT01407276|79253565|FG004|Overall Study|Withdrawal by Subject|0|||
44289873|NCT01407276|79253566|FG005|Overall Study|Withdrawal by Subject|0|||
44289874|NCT01407276|79253567|FG006|Overall Study|Withdrawal by Subject|0|||
44289875|NCT01407276|79253568|FG007|Overall Study|Withdrawal by Subject|1|||
44289876|NCT01390272|79253595|FG000|Overall Study|Death|3|||
44289877|NCT01390272|79253596|FG001|Overall Study|Death|2|||
44289878|NCT01390272|79253595|FG000|Overall Study|Withdrawal by Subject|9|||
44289879|NCT01390272|79253596|FG001|Overall Study|Withdrawal by Subject|5|||
44289880|NCT01390272|79253595|FG000|Overall Study|Patient moved, no longer eligible|5|||
44289881|NCT01390272|79253596|FG001|Overall Study|Patient moved, no longer eligible|8|||
44289882|NCT01429584|79253604|FG000|Overall Study|Withdrawal by Subject|1|||
44289883|NCT01429584|79253605|FG001|Overall Study|Withdrawal by Subject|0|||
44289884|NCT01429584|79253604|FG000|Overall Study|Protocol Violation|0|||
44289885|NCT01429584|79253605|FG001|Overall Study|Protocol Violation|1|||
44289886|NCT01406652|79253613|FG000|Overall Study|Lost-to-follow-up|3|||
44289887|NCT01406652|79253614|FG001|Overall Study|Lost-to-follow-up|4|||
44289888|NCT01406652|79253613|FG000|Overall Study|Withdrawal by Subject|2|||
44289889|NCT01406652|79253614|FG001|Overall Study|Withdrawal by Subject|2|||
44289890|NCT01406652|79253613|FG000|Overall Study|Insufficient follow-up|5|||
44289891|NCT01406652|79253614|FG001|Overall Study|Insufficient follow-up|4|||
44289892|NCT01406652|79253613|FG000|Overall Study|Infection not sure|10|||
44289893|NCT01406652|79253614|FG001|Overall Study|Infection not sure|10|||
44289894|NCT01406574|79253622|FG000|Overall Study|Adverse Event|0|||
44289895|NCT01406574|79253623|FG001|Overall Study|Adverse Event|0|||
44289896|NCT01406574|79253624|FG002|Overall Study|Adverse Event|1|||
44289897|NCT01406574|79253625|FG003|Overall Study|Adverse Event|3|||
44289898|NCT01406574|79253622|FG000|Overall Study|Physician Decision|0|||
44289899|NCT01406574|79253623|FG001|Overall Study|Physician Decision|0|||
44289900|NCT01406574|79253624|FG002|Overall Study|Physician Decision|0|||
44289901|NCT01406574|79253625|FG003|Overall Study|Physician Decision|1|||
44289902|NCT01406574|79253622|FG000|Overall Study|Withdrawal by Subject|0|||
44289903|NCT01406574|79253623|FG001|Overall Study|Withdrawal by Subject|1|||
44289904|NCT01406574|79253624|FG002|Overall Study|Withdrawal by Subject|0|||
44289905|NCT01406574|79253625|FG003|Overall Study|Withdrawal by Subject|0|||
44289906|NCT01406574|79253622|FG000|Overall Study|Definite progression of primary disease|1|||
44289907|NCT01406574|79253623|FG001|Overall Study|Definite progression of primary disease|0|||
44289908|NCT01406574|79253624|FG002|Overall Study|Definite progression of primary disease|0|||
44289909|NCT01406574|79253625|FG003|Overall Study|Definite progression of primary disease|0|||
44289910|NCT01405950|79253638|FG000|Overall Study|Withdrawal by Subject|1|||
44289911|NCT01405950|79253639|FG001|Overall Study|Withdrawal by Subject|0|||
44289912|NCT01405950|79253640|FG002|Overall Study|Withdrawal by Subject|0|||
44289913|NCT01405950|79253641|FG003|Overall Study|Withdrawal by Subject|0|||
44289914|NCT01405560|79253649|FG000|Overall Study|Physician Decision|1|||
44289915|NCT01428882|79253655|FG000|Overall Study|Lack of Efficacy|2|||
44289916|NCT01428882|79253656|FG001|Overall Study|Lack of Efficacy|7|||
44289917|NCT01428882|79253655|FG000|Overall Study|Protocol Violation|4|||
44289918|NCT01428882|79253656|FG001|Overall Study|Protocol Violation|3|||
44289919|NCT01428258|79253664|FG000|Intervention 1|Withdrawal by Subject|2|||
44289920|NCT01428258|79253665|FG001|Intervention 1|Withdrawal by Subject|0|||
44289921|NCT01389882|79253681|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
44289922|NCT01389882|79253682|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
44289923|NCT01389882|79253681|FG000|Overall Study|Withdrawal by Subject|0|||
44289924|NCT01389882|79253682|FG001|Overall Study|Withdrawal by Subject|1|||
44289925|NCT01442688|79253690|FG000|First Intervention|Withdrawal by Subject|1|||
44289926|NCT01442688|79253691|FG001|First Intervention|Withdrawal by Subject|0|||
44289927|NCT01442688|79253690|FG000|First Intervention|subject incarcerated|1|||
44289928|NCT01442688|79253691|FG001|First Intervention|subject incarcerated|0|||
44289929|NCT01442688|79253690|FG000|Second Intervention|Adverse Event|1|||
44289930|NCT01442688|79253691|FG001|Second Intervention|Adverse Event|0|||
44289931|NCT01466166|79253697|FG000|Overall Study|Death|1|||
44289932|NCT01466166|79253697|FG000|Overall Study|Lost to Follow-up|7|||
44289933|NCT01466166|79253697|FG000|Overall Study|Infusion Reaction (IR)|27|||
44289934|NCT01466166|79253697|FG000|Overall Study|Adverse Event (Other than IR)|11|||
44289935|NCT01466166|79253697|FG000|Overall Study|Elevated Serum Uric Acid|78|||
44289936|NCT01466166|79253697|FG000|Overall Study|Withdrawal by Subject|13|||
44289937|NCT01466166|79253697|FG000|Overall Study|Sponsor Decision|4|||
44289938|NCT01466166|79253697|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
44289939|NCT01466166|79253697|FG000|Overall Study|Other|20|||
44289940|NCT01426854|79253703|FG000|Overall Study|Adverse Event|1|||
44289941|NCT01426854|79253704|FG001|Overall Study|Adverse Event|5|||
44289942|NCT01426854|79253703|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
44289943|NCT01426854|79253704|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
44289944|NCT01426854|79253703|FG000|Overall Study|Lost to Follow-up|3|||
44289945|NCT01426854|79253704|FG001|Overall Study|Lost to Follow-up|0|||
44289946|NCT01426854|79253703|FG000|Overall Study|Noncompliance|0|||
44416138|NCT00845897|79423834|FG000|Overall Study|Too ill to participate|0|||
44416139|NCT00845897|79423835|FG001|Overall Study|Too ill to participate|1|||
44289947|NCT01426854|79253704|FG001|Overall Study|Noncompliance|1|||
44289948|NCT01426854|79253703|FG000|Overall Study|Treatment Failure|0|||
44289949|NCT01426854|79253704|FG001|Overall Study|Treatment Failure|16|||
44289950|NCT01426854|79253703|FG000|Overall Study|Protocol Deviation|0|||
44289951|NCT01426854|79253704|FG001|Overall Study|Protocol Deviation|1|||
44289952|NCT01426854|79253703|FG000|Overall Study|Other|3|||
44289953|NCT01426854|79253704|FG001|Overall Study|Other|2|||
44289954|NCT01426386|79253716|FG000|Overall Study|Adverse Event|0|||
44289955|NCT01426386|79253717|FG001|Overall Study|Adverse Event|1|||
44289956|NCT01426386|79253718|FG002|Overall Study|Adverse Event|0|||
44416140|NCT00845897|79423836|FG002|Overall Study|Too ill to participate|0|||
44289957|NCT01426386|79253719|FG003|Overall Study|Adverse Event|0|||
44289958|NCT01426386|79253720|FG004|Overall Study|Adverse Event|0|||
44289959|NCT01426386|79253721|FG005|Overall Study|Adverse Event|0|||
44289960|NCT01426386|79253716|FG000|Overall Study|Did not attend scheduled visit|1|||
44289961|NCT01426386|79253717|FG001|Overall Study|Did not attend scheduled visit|4|||
44289962|NCT01426386|79253718|FG002|Overall Study|Did not attend scheduled visit|0|||
44289963|NCT01426386|79253719|FG003|Overall Study|Did not attend scheduled visit|0|||
44289964|NCT01426386|79253720|FG004|Overall Study|Did not attend scheduled visit|2|||
44289965|NCT01426386|79253721|FG005|Overall Study|Did not attend scheduled visit|1|||
44289966|NCT01426386|79253716|FG000|Overall Study|Poor response|2|||
44289967|NCT01426386|79253717|FG001|Overall Study|Poor response|1|||
44289968|NCT01426386|79253718|FG002|Overall Study|Poor response|2|||
44289969|NCT01426386|79253719|FG003|Overall Study|Poor response|0|||
44289970|NCT01426386|79253720|FG004|Overall Study|Poor response|1|||
44289971|NCT01426386|79253721|FG005|Overall Study|Poor response|0|||
44289972|NCT01426386|79253716|FG000|Overall Study|Personal reasons|0|||
44289973|NCT01426386|79253717|FG001|Overall Study|Personal reasons|0|||
44289974|NCT01426386|79253718|FG002|Overall Study|Personal reasons|0|||
44289975|NCT01426386|79253719|FG003|Overall Study|Personal reasons|0|||
44289976|NCT01426386|79253720|FG004|Overall Study|Personal reasons|1|||
44289977|NCT01426386|79253721|FG005|Overall Study|Personal reasons|0|||
44289978|NCT01404234|79253735|FG000|Overall Study|Withdrawal by Subject|2|||
44289979|NCT01403610|79253743|FG000|Overall Study|Withdrawal by Subject|2|||
44289980|NCT01403610|79253744|FG001|Overall Study|Withdrawal by Subject|0|||
44289981|NCT01403610|79253745|FG002|Overall Study|Withdrawal by Subject|0|||
44289982|NCT01403610|79253746|FG003|Overall Study|Withdrawal by Subject|0|||
44289983|NCT01403610|79253743|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
44289984|NCT01403610|79253744|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
44289985|NCT01403610|79253745|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
44289986|NCT01403610|79253746|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
44289987|NCT01403064|79253760|FG000|Overall Study|Death|0|||
44289988|NCT01403064|79253761|FG001|Overall Study|Death|0|||
44289989|NCT01403064|79253762|FG002|Overall Study|Death|1|||
44289990|NCT01403064|79253763|FG003|Overall Study|Death|1|||
44289991|NCT01403064|79253760|FG000|Overall Study|Withdrawal by Subject|0|||
44289992|NCT01403064|79253761|FG001|Overall Study|Withdrawal by Subject|0|||
44289993|NCT01403064|79253762|FG002|Overall Study|Withdrawal by Subject|1|||
44289994|NCT01403064|79253763|FG003|Overall Study|Withdrawal by Subject|1|||
44289995|NCT01403064|79253760|FG000|Overall Study|Other|1|||
44289996|NCT01403064|79253761|FG001|Overall Study|Other|0|||
44289997|NCT01403064|79253762|FG002|Overall Study|Other|2|||
44289998|NCT01403064|79253763|FG003|Overall Study|Other|1|||
44289999|NCT01402986|79253782|FG000|Overall Study|Withdrawal by Subject|7|||
44290000|NCT01402986|79253783|FG001|Overall Study|Withdrawal by Subject|10|||
44290001|NCT01402986|79253784|FG002|Overall Study|Withdrawal by Subject|7|||
44290002|NCT01402986|79253785|FG003|Overall Study|Withdrawal by Subject|13|||
44290003|NCT01402986|79253782|FG000|Overall Study|Death|0|||
44290004|NCT01402986|79253783|FG001|Overall Study|Death|0|||
44290005|NCT01402986|79253784|FG002|Overall Study|Death|0|||
44290006|NCT01402986|79253785|FG003|Overall Study|Death|2|||
44290007|NCT01402986|79253782|FG000|Overall Study|Lost to Follow-up|0|||
44290008|NCT01402986|79253783|FG001|Overall Study|Lost to Follow-up|0|||
44290009|NCT01402986|79253784|FG002|Overall Study|Lost to Follow-up|0|||
44416141|NCT00862277|79423847|FG000|Overall Study|Protocol Violation|1|||
44154490|NCT01978912|78945624|FG000|Overall Study|Intradiscal Steroid Injection|0|||
44154491|NCT01978912|78945625|FG001|Overall Study|Intradiscal Steroid Injection|1|||
44154492|NCT01978912|78945626|FG002|Overall Study|Intradiscal Steroid Injection|0|||
44154493|NCT01978912|78945627|FG003|Overall Study|Intradiscal Steroid Injection|0|||
44154494|NCT01977898|78945639|FG000|Overall Study|Non functioning catheter|1|||
44154495|NCT01977898|78945640|FG001|Overall Study|Non functioning catheter|1|||
44154496|NCT02003638|78945648|FG000|Overall Study|Withdrawal by Subject|1|||
44154497|NCT02003638|78945649|FG001|Overall Study|Withdrawal by Subject|0|||
44290010|NCT01402986|79253785|FG003|Overall Study|Lost to Follow-up|1|||
44290011|NCT01402986|79253782|FG000|Overall Study|Other|2|||
44290012|NCT01402986|79253783|FG001|Overall Study|Other|5|||
44290013|NCT01402986|79253784|FG002|Overall Study|Other|1|||
44290014|NCT01402986|79253785|FG003|Overall Study|Other|6|||
44290015|NCT01402908|79253797|FG000|Overall Study|Withdrawal by Subject|30|||
44290016|NCT01402908|79253798|FG001|Overall Study|Withdrawal by Subject|17|||
44290017|NCT01402908|79253797|FG000|Overall Study|Lost to Follow-up|3|||
44290018|NCT01402908|79253798|FG001|Overall Study|Lost to Follow-up|1|||
44290019|NCT01402908|79253797|FG000|Overall Study|Physician Decision|1|||
44290020|NCT01402908|79253798|FG001|Overall Study|Physician Decision|0|||
44290021|NCT01389258|79253804|FG000|Overall Study|Lost to Follow-up|5|||
44290022|NCT01389102|79253814|FG000|Overall Study|Adverse Event|1|||
44290023|NCT01389102|79253815|FG001|Overall Study|Adverse Event|3|||
44290024|NCT01389102|79253816|FG002|Overall Study|Adverse Event|2|||
44290025|NCT01389102|79253817|FG003|Overall Study|Adverse Event|2|||
44290026|NCT01389102|79253818|FG004|Overall Study|Adverse Event|2|||
44290027|NCT01389102|79253819|FG005|Overall Study|Adverse Event|2|||
44290028|NCT01389102|79253814|FG000|Overall Study|Hurricane Katrina|4|||
44290029|NCT01389102|79253815|FG001|Overall Study|Hurricane Katrina|2|||
44290030|NCT01389102|79253816|FG002|Overall Study|Hurricane Katrina|3|||
44290031|NCT01389102|79253817|FG003|Overall Study|Hurricane Katrina|0|||
44290032|NCT01389102|79253818|FG004|Overall Study|Hurricane Katrina|3|||
44290033|NCT01389102|79253819|FG005|Overall Study|Hurricane Katrina|1|||
44290034|NCT01389102|79253814|FG000|Overall Study|Lost to Follow-up|4|||
44290035|NCT01389102|79253815|FG001|Overall Study|Lost to Follow-up|1|||
44290036|NCT01389102|79253816|FG002|Overall Study|Lost to Follow-up|1|||
44290037|NCT01389102|79253817|FG003|Overall Study|Lost to Follow-up|2|||
44290038|NCT01389102|79253818|FG004|Overall Study|Lost to Follow-up|4|||
44290039|NCT01389102|79253819|FG005|Overall Study|Lost to Follow-up|1|||
44290040|NCT01389102|79253814|FG000|Overall Study|Protocol Violation|0|||
44290041|NCT01389102|79253815|FG001|Overall Study|Protocol Violation|0|||
44290042|NCT01389102|79253816|FG002|Overall Study|Protocol Violation|3|||
44290043|NCT01389102|79253817|FG003|Overall Study|Protocol Violation|0|||
44290044|NCT01389102|79253818|FG004|Overall Study|Protocol Violation|1|||
44290045|NCT01389102|79253819|FG005|Overall Study|Protocol Violation|1|||
44290046|NCT01389102|79253814|FG000|Overall Study|Withdrawal by Subject|7|||
44290047|NCT01389102|79253815|FG001|Overall Study|Withdrawal by Subject|4|||
44290048|NCT01389102|79253816|FG002|Overall Study|Withdrawal by Subject|9|||
44290049|NCT01389102|79253817|FG003|Overall Study|Withdrawal by Subject|2|||
44290050|NCT01389102|79253818|FG004|Overall Study|Withdrawal by Subject|3|||
44290051|NCT01389102|79253819|FG005|Overall Study|Withdrawal by Subject|3|||
44290052|NCT01389102|79253814|FG000|Overall Study|Subject Traveling Out of Country|0|||
44290053|NCT01389102|79253815|FG001|Overall Study|Subject Traveling Out of Country|0|||
44290054|NCT01389102|79253816|FG002|Overall Study|Subject Traveling Out of Country|0|||
44290055|NCT01389102|79253817|FG003|Overall Study|Subject Traveling Out of Country|1|||
44290056|NCT01389102|79253818|FG004|Overall Study|Subject Traveling Out of Country|0|||
44290057|NCT01389102|79253819|FG005|Overall Study|Subject Traveling Out of Country|0|||
44290058|NCT01389102|79253814|FG000|Overall Study|Subject Moved|2|||
44290059|NCT01389102|79253815|FG001|Overall Study|Subject Moved|0|||
44290060|NCT01389102|79253816|FG002|Overall Study|Subject Moved|1|||
44290061|NCT01389102|79253817|FG003|Overall Study|Subject Moved|0|||
44290062|NCT01389102|79253818|FG004|Overall Study|Subject Moved|0|||
44290063|NCT01389102|79253819|FG005|Overall Study|Subject Moved|0|||
44290064|NCT01389102|79253814|FG000|Overall Study|Unavailable due to husband's illness|0|||
44290065|NCT01389102|79253815|FG001|Overall Study|Unavailable due to husband's illness|1|||
44290066|NCT01389102|79253816|FG002|Overall Study|Unavailable due to husband's illness|0|||
44290067|NCT01389102|79253817|FG003|Overall Study|Unavailable due to husband's illness|0|||
44290068|NCT01389102|79253818|FG004|Overall Study|Unavailable due to husband's illness|0|||
44290069|NCT01389102|79253819|FG005|Overall Study|Unavailable due to husband's illness|0|||
44290070|NCT01389102|79253814|FG000|Overall Study|Investigator Judgement|0|||
44290071|NCT01389102|79253815|FG001|Overall Study|Investigator Judgement|1|||
44290072|NCT01389102|79253816|FG002|Overall Study|Investigator Judgement|0|||
44290073|NCT01389102|79253817|FG003|Overall Study|Investigator Judgement|0|||
44290074|NCT01389102|79253818|FG004|Overall Study|Investigator Judgement|0|||
44290075|NCT01389102|79253819|FG005|Overall Study|Investigator Judgement|0|||
44290076|NCT01402284|79253839|FG000|Overall Study|Withdrawal consent|2|||
44290077|NCT01402284|79253839|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
44290078|NCT01402284|79253839|FG000|Overall Study|Physician Decision|1|||
44290079|NCT01402284|79253839|FG000|Overall Study|Disease progression on study|10|||
44290080|NCT01388790|79253843|FG000|Overall Study|Ongoing at data cut-off date|8|||
44290081|NCT01388478|79253847|FG000|Overall Study|Adverse Event|4|||
44290082|NCT01388478|79253847|FG000|Overall Study|Withdrawal by Subject|1|||
44290083|NCT01424670|79253853|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
44290084|NCT01424670|79253854|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
44290085|NCT01424670|79253853|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
44290086|NCT01424670|79253854|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
44290087|NCT01424670|79253853|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
44290088|NCT01424670|79253854|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
44154498|NCT02696317|78945655|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
44154499|NCT02696317|78945656|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
44290089|NCT01424670|79253853|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
44290090|NCT01424670|79253854|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
44290091|NCT01424670|79253853|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
44290092|NCT01424670|79253854|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
44290093|NCT01424670|79253853|FG000|Continuation Period|Adverse Event|13|||
44290094|NCT01424670|79253854|FG001|Continuation Period|Adverse Event|5|||
44290095|NCT01424670|79253853|FG000|Continuation Period|Lost to Follow-up|2|||
44290096|NCT01424670|79253854|FG001|Continuation Period|Lost to Follow-up|0|||
44290097|NCT01424670|79253853|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
44290098|NCT01424670|79253854|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
44290099|NCT01424670|79253853|FG000|Continuation Period|Physician Decision|5|||
44290100|NCT01424670|79253854|FG001|Continuation Period|Physician Decision|4|||
44290101|NCT01424670|79253853|FG000|Continuation Period|Withdrawal by Subject|13|||
44290102|NCT01424670|79253854|FG001|Continuation Period|Withdrawal by Subject|4|||
44290103|NCT01424514|79253862|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
44290104|NCT01424514|79253863|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
44290105|NCT01424514|79253862|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
44290106|NCT01424514|79253863|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
44290107|NCT01400958|79253876|FG000|Overall Study|Physician Decision|0|||
44290108|NCT01400958|79253877|FG001|Overall Study|Physician Decision|1|||
44290109|NCT01400958|79253876|FG000|Overall Study|Withdrawal by Subject|0|||
44290110|NCT01400958|79253877|FG001|Overall Study|Withdrawal by Subject|1|||
44290111|NCT01400958|79253876|FG000|Overall Study|Adverse Event|1|||
44290112|NCT01400958|79253877|FG001|Overall Study|Adverse Event|0|||
44290113|NCT01388166|79253883|FG000|Overall Study|Adverse Event|16|||
44290114|NCT01388166|79253883|FG000|Overall Study|Lost to Follow-up|30|||
44290115|NCT01388166|79253883|FG000|Overall Study|Others than specified above|13|||
44290116|NCT01400412|79253889|FG000|Overall Study|Lost to Follow-up|4|||
44290117|NCT01400412|79253890|FG001|Overall Study|Lost to Follow-up|7|||
44290118|NCT01400412|79253889|FG000|Overall Study|Withdrawal by Subject|3|||
44290119|NCT01400412|79253890|FG001|Overall Study|Withdrawal by Subject|4|||
44290120|NCT01400412|79253889|FG000|Overall Study|Unable to complete|3|||
44290121|NCT01400412|79253890|FG001|Overall Study|Unable to complete|3|||
44290122|NCT01400412|79253889|FG000|Overall Study|Never started study treatment|0|||
44290123|NCT01400412|79253890|FG001|Overall Study|Never started study treatment|3|||
44290124|NCT01422876|79253908|FG000|Week 24|Lost to Follow-up|1|||
44290125|NCT01422876|79253909|FG001|Week 24|Lost to Follow-up|1|||
44290126|NCT01422876|79253910|FG002|Week 24|Lost to Follow-up|2|||
44290127|NCT01422876|79253911|FG003|Week 24|Lost to Follow-up|4|||
44290128|NCT01422876|79253912|FG004|Week 24|Lost to Follow-up|2|||
44290129|NCT01422876|79253913|FG005|Week 24|Lost to Follow-up|0|||
44290130|NCT01422876|79253914|FG006|Week 24|Lost to Follow-up|1|||
44290131|NCT01422876|79253915|FG007|Week 24|Lost to Follow-up|3|||
44290132|NCT01422876|79253916|FG008|Week 24|Lost to Follow-up|3|||
44290133|NCT01422876|79253917|FG009|Week 24|Lost to Follow-up|4|||
44290134|NCT01422876|79253908|FG000|Week 24|Consent withdrawn|5|||
44290135|NCT01422876|79253909|FG001|Week 24|Consent withdrawn|1|||
44290136|NCT01422876|79253910|FG002|Week 24|Consent withdrawn|3|||
44290137|NCT01422876|79253911|FG003|Week 24|Consent withdrawn|4|||
44290138|NCT01422876|79253912|FG004|Week 24|Consent withdrawn|5|||
44290139|NCT01422876|79253913|FG005|Week 24|Consent withdrawn|6|||
44290140|NCT01422876|79253914|FG006|Week 24|Consent withdrawn|5|||
44416142|NCT00862277|79423848|FG001|Overall Study|Protocol Violation|2|||
44416143|NCT00862277|79423849|FG002|Overall Study|Protocol Violation|5|||
44416144|NCT00852995|79423862|FG000|Overall Study|Adverse Event|1|||
44416145|NCT00852995|79423863|FG001|Overall Study|Adverse Event|0|||
44416146|NCT00852995|79423864|FG002|Overall Study|Adverse Event|4|||
44416147|NCT00852995|79423865|FG003|Overall Study|Adverse Event|0|||
44416148|NCT00852995|79423866|FG004|Overall Study|Adverse Event|0|||
44416149|NCT00852995|79423862|FG000|Overall Study|Lost to Follow-up|0|||
44416150|NCT00852995|79423863|FG001|Overall Study|Lost to Follow-up|1|||
44416151|NCT00852995|79423864|FG002|Overall Study|Lost to Follow-up|1|||
44416152|NCT00852995|79423865|FG003|Overall Study|Lost to Follow-up|0|||
44416153|NCT00852995|79423866|FG004|Overall Study|Lost to Follow-up|0|||
44416154|NCT00852995|79423862|FG000|Overall Study|Withdrawal by Subject|4|||
44416155|NCT00852995|79423863|FG001|Overall Study|Withdrawal by Subject|0|||
44416156|NCT00852995|79423864|FG002|Overall Study|Withdrawal by Subject|0|||
44416157|NCT00852995|79423865|FG003|Overall Study|Withdrawal by Subject|1|||
44154500|NCT02696317|78945655|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
44154501|NCT02696317|78945656|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
44290141|NCT01422876|79253915|FG007|Week 24|Consent withdrawn|4|||
44290142|NCT01422876|79253916|FG008|Week 24|Consent withdrawn|3|||
44290143|NCT01422876|79253917|FG009|Week 24|Consent withdrawn|6|||
44290144|NCT01422876|79253908|FG000|Week 24|Death|0|||
44290145|NCT01422876|79253909|FG001|Week 24|Death|1|||
44290146|NCT01422876|79253910|FG002|Week 24|Death|0|||
44290147|NCT01422876|79253911|FG003|Week 24|Death|0|||
44290148|NCT01422876|79253912|FG004|Week 24|Death|0|||
44290149|NCT01422876|79253913|FG005|Week 24|Death|0|||
44290150|NCT01422876|79253914|FG006|Week 24|Death|0|||
44290151|NCT01422876|79253915|FG007|Week 24|Death|0|||
44290152|NCT01422876|79253916|FG008|Week 24|Death|0|||
44290153|NCT01422876|79253917|FG009|Week 24|Death|0|||
44290154|NCT01422876|79253908|FG000|Week 52|Lost to Follow-up|3|||
44290155|NCT01422876|79253909|FG001|Week 52|Lost to Follow-up|5|||
44290156|NCT01422876|79253910|FG002|Week 52|Lost to Follow-up|7|||
44290157|NCT01422876|79253911|FG003|Week 52|Lost to Follow-up|5|||
44416158|NCT00852995|79423866|FG004|Overall Study|Withdrawal by Subject|2|||
44416159|NCT00852995|79423862|FG000|Overall Study|Non-Compliance|0|||
44416160|NCT00852995|79423863|FG001|Overall Study|Non-Compliance|0|||
44290158|NCT01422876|79253912|FG004|Week 52|Lost to Follow-up|8|||
44290159|NCT01422876|79253913|FG005|Week 52|Lost to Follow-up|5|||
44290160|NCT01422876|79253914|FG006|Week 52|Lost to Follow-up|5|||
44290161|NCT01422876|79253915|FG007|Week 52|Lost to Follow-up|8|||
44290162|NCT01422876|79253916|FG008|Week 52|Lost to Follow-up|7|||
44290163|NCT01422876|79253917|FG009|Week 52|Lost to Follow-up|8|||
44416161|NCT00852995|79423864|FG002|Overall Study|Non-Compliance|0|||
44416162|NCT00852995|79423865|FG003|Overall Study|Non-Compliance|2|||
44416163|NCT00852995|79423866|FG004|Overall Study|Non-Compliance|0|||
44416164|NCT00852995|79423862|FG000|Overall Study|Progressive Disease|1|||
44416165|NCT00852995|79423863|FG001|Overall Study|Progressive Disease|0|||
44416166|NCT00852995|79423864|FG002|Overall Study|Progressive Disease|0|||
44416167|NCT00852995|79423865|FG003|Overall Study|Progressive Disease|2|||
44416168|NCT00852995|79423866|FG004|Overall Study|Progressive Disease|1|||
44416169|NCT00852995|79423862|FG000|Overall Study|Physician Decision|1|||
44416170|NCT00852995|79423863|FG001|Overall Study|Physician Decision|0|||
44416171|NCT00852995|79423864|FG002|Overall Study|Physician Decision|0|||
44416172|NCT00852995|79423865|FG003|Overall Study|Physician Decision|0|||
44416173|NCT00852995|79423866|FG004|Overall Study|Physician Decision|0|||
44416174|NCT00852995|79423862|FG000|Overall Study|Protocol Violation|0|||
44416175|NCT00852995|79423863|FG001|Overall Study|Protocol Violation|0|||
44416176|NCT00852995|79423864|FG002|Overall Study|Protocol Violation|0|||
44416177|NCT00852995|79423865|FG003|Overall Study|Protocol Violation|0|||
44416178|NCT00852995|79423866|FG004|Overall Study|Protocol Violation|1|||
44416179|NCT00852995|79423862|FG000|Overall Study|Moved Out of Area|1|||
44416180|NCT00852995|79423863|FG001|Overall Study|Moved Out of Area|0|||
44416181|NCT00852995|79423864|FG002|Overall Study|Moved Out of Area|0|||
44416182|NCT00852995|79423865|FG003|Overall Study|Moved Out of Area|0|||
44416183|NCT00852995|79423866|FG004|Overall Study|Moved Out of Area|0|||
44416184|NCT00592319|79423885|FG000|Overall Study|Lost to Follow-up|0|||
44416185|NCT00592319|79423886|FG001|Overall Study|Lost to Follow-up|3|||
44416186|NCT00862121|79423896|FG000|Overall Study|Adverse Event|1|||
44416187|NCT00862121|79423897|FG001|Overall Study|Adverse Event|2|||
44416188|NCT00862121|79423896|FG000|Overall Study|Lack of Efficacy|0|||
44416189|NCT00862121|79423897|FG001|Overall Study|Lack of Efficacy|3|||
44416190|NCT00862121|79423896|FG000|Overall Study|Protocol Violation|0|||
44416191|NCT00862121|79423897|FG001|Overall Study|Protocol Violation|1|||
44416192|NCT00862121|79423896|FG000|Overall Study|Exclusion criterion violation|0|||
44416193|NCT00862121|79423897|FG001|Overall Study|Exclusion criterion violation|1|||
44416194|NCT00862121|79423896|FG000|Overall Study|Incorrect randomisation|0|||
44416195|NCT00862121|79423897|FG001|Overall Study|Incorrect randomisation|1|||
44416196|NCT00784719|79423910|FG000|Overall Study|Adverse Event|0|||
44416197|NCT00784719|79423911|FG001|Overall Study|Adverse Event|2|||
44416198|NCT00784719|79423912|FG002|Overall Study|Adverse Event|0|||
44416199|NCT00784719|79423913|FG003|Overall Study|Adverse Event|0|||
44416200|NCT00784719|79423914|FG004|Overall Study|Adverse Event|1|||
44416201|NCT00784719|79423915|FG005|Overall Study|Adverse Event|1|||
44290164|NCT01422876|79253908|FG000|Week 52|Consent withdrawn|9|||
44290165|NCT01422876|79253909|FG001|Week 52|Consent withdrawn|4|||
44290166|NCT01422876|79253910|FG002|Week 52|Consent withdrawn|6|||
44290167|NCT01422876|79253911|FG003|Week 52|Consent withdrawn|12|||
44290168|NCT01422876|79253912|FG004|Week 52|Consent withdrawn|7|||
44290169|NCT01422876|79253913|FG005|Week 52|Consent withdrawn|12|||
44290170|NCT01422876|79253914|FG006|Week 52|Consent withdrawn|10|||
44290171|NCT01422876|79253915|FG007|Week 52|Consent withdrawn|12|||
44290172|NCT01422876|79253916|FG008|Week 52|Consent withdrawn|13|||
44290173|NCT01422876|79253917|FG009|Week 52|Consent withdrawn|9|||
44290174|NCT01422876|79253908|FG000|Week 52|Death|0|||
44290175|NCT01422876|79253909|FG001|Week 52|Death|1|||
44290176|NCT01422876|79253910|FG002|Week 52|Death|0|||
44290177|NCT01422876|79253911|FG003|Week 52|Death|1|||
44290178|NCT01422876|79253912|FG004|Week 52|Death|0|||
44290179|NCT01422876|79253913|FG005|Week 52|Death|0|||
44290180|NCT01422876|79253914|FG006|Week 52|Death|1|||
44290181|NCT01422876|79253915|FG007|Week 52|Death|3|||
44290182|NCT01422876|79253916|FG008|Week 52|Death|1|||
44290183|NCT01422876|79253917|FG009|Week 52|Death|0|||
44416202|NCT00784719|79423916|FG006|Overall Study|Adverse Event|1|||
44416203|NCT00784719|79423910|FG000|Overall Study|Lost to Follow-up|0|||
44416204|NCT00784719|79423911|FG001|Overall Study|Lost to Follow-up|0|||
44416205|NCT00784719|79423912|FG002|Overall Study|Lost to Follow-up|0|||
44416206|NCT00784719|79423913|FG003|Overall Study|Lost to Follow-up|0|||
44416207|NCT00784719|79423914|FG004|Overall Study|Lost to Follow-up|1|||
44416208|NCT00784719|79423915|FG005|Overall Study|Lost to Follow-up|1|||
44416209|NCT00784719|79423916|FG006|Overall Study|Lost to Follow-up|0|||
44416210|NCT00784719|79423910|FG000|Overall Study|Other|2|||
44416211|NCT00784719|79423911|FG001|Overall Study|Other|1|||
44416212|NCT00784719|79423912|FG002|Overall Study|Other|1|||
44416213|NCT00784719|79423913|FG003|Overall Study|Other|0|||
44416214|NCT00784719|79423914|FG004|Overall Study|Other|2|||
44416215|NCT00784719|79423915|FG005|Overall Study|Other|1|||
44416216|NCT00784719|79423916|FG006|Overall Study|Other|3|||
44416217|NCT00784719|79423910|FG000|Overall Study|Withdrawal by Subject|1|||
44416218|NCT00784719|79423911|FG001|Overall Study|Withdrawal by Subject|0|||
44416219|NCT00784719|79423912|FG002|Overall Study|Withdrawal by Subject|0|||
44416220|NCT00784719|79423913|FG003|Overall Study|Withdrawal by Subject|0|||
44416221|NCT00784719|79423914|FG004|Overall Study|Withdrawal by Subject|2|||
44416222|NCT00784719|79423915|FG005|Overall Study|Withdrawal by Subject|0|||
44416223|NCT00784719|79423916|FG006|Overall Study|Withdrawal by Subject|1|||
44416224|NCT00852917|79423936|FG000|Overall Study|Adverse Event|13|||
44416225|NCT00852917|79423937|FG001|Overall Study|Adverse Event|20|||
44416226|NCT00852917|79423938|FG002|Overall Study|Adverse Event|35|||
44416227|NCT00852917|79423939|FG003|Overall Study|Adverse Event|17|||
44416228|NCT00852917|79423936|FG000|Overall Study|Lack of Efficacy|21|||
44416229|NCT00852917|79423937|FG001|Overall Study|Lack of Efficacy|11|||
44416230|NCT00852917|79423938|FG002|Overall Study|Lack of Efficacy|11|||
44416231|NCT00852917|79423939|FG003|Overall Study|Lack of Efficacy|47|||
44416232|NCT00852917|79423936|FG000|Overall Study|Withdrawal by Subject|4|||
44416233|NCT00852917|79423937|FG001|Overall Study|Withdrawal by Subject|8|||
44416234|NCT00852917|79423938|FG002|Overall Study|Withdrawal by Subject|10|||
44416235|NCT00852917|79423939|FG003|Overall Study|Withdrawal by Subject|9|||
44416236|NCT00852917|79423936|FG000|Overall Study|Physician Decision|6|||
44533647|NCT03104374|79543958|FG001|Overall Study|Other|2|||
44533648|NCT03104374|79543959|FG002|Overall Study|Other|4|||
44533649|NCT03104374|79543960|FG003|Overall Study|Other|7|||
44533650|NCT03043313|79543993|FG000|Overall Study|Withdrawal by Subject|4|||
44533651|NCT03043313|79543994|FG001|Overall Study|Withdrawal by Subject|1|||
44533652|NCT03043313|79543995|FG002|Overall Study|Withdrawal by Subject|1|||
44533653|NCT03043313|79543993|FG000|Overall Study|Lost to Follow-up|1|||
44533654|NCT03043313|79543994|FG001|Overall Study|Lost to Follow-up|0|||
44533655|NCT03043313|79543995|FG002|Overall Study|Lost to Follow-up|0|||
44533656|NCT03043313|79543993|FG000|Overall Study|Death|26|||
44154502|NCT01959412|78945664|FG000|Overall Study|Protocol deviation|1|||
44154503|NCT01959412|78945665|FG001|Overall Study|Protocol deviation|1|||
44154504|NCT01959412|78945666|FG002|Overall Study|Protocol deviation|0|||
44154505|NCT01959412|78945667|FG003|Overall Study|Protocol deviation|1|||
44154506|NCT01959412|78945668|FG004|Overall Study|Protocol deviation|3|||
44154507|NCT01959412|78945669|FG005|Overall Study|Protocol deviation|0|||
44154508|NCT01959412|78945664|FG000|Overall Study|Adverse Event|0|||
44154509|NCT01959412|78945665|FG001|Overall Study|Adverse Event|0|||
44154510|NCT01959412|78945666|FG002|Overall Study|Adverse Event|0|||
44154511|NCT01959412|78945667|FG003|Overall Study|Adverse Event|1|||
44154512|NCT01959412|78945668|FG004|Overall Study|Adverse Event|0|||
44154513|NCT01959412|78945669|FG005|Overall Study|Adverse Event|0|||
44154514|NCT01977820|78945685|FG000|Overall Study|Sponsor terminated the study|1|||
44154515|NCT01977820|78945686|FG001|Overall Study|Sponsor terminated the study|1|||
44154516|NCT02003014|78945692|FG000|Overall Study|Case report forms uncollected|9|||
44154517|NCT02003014|78945692|FG000|Overall Study|Treatment started after contract period|1|||
44154518|NCT02003014|78945692|FG000|Overall Study|Patient did not visit the study site|5|||
44154519|NCT02003014|78945692|FG000|Overall Study|Investigator's transfer|4|||
44154520|NCT01977352|78945698|FG000|Overall Study|Lost to Follow-up|1|||
44154521|NCT01977352|78945699|FG001|Overall Study|Lost to Follow-up|2|||
44533657|NCT03043313|79543994|FG001|Overall Study|Death|13|||
44154522|NCT02001688|78945708|FG000|Overall Study|Withdrawal by Subject|0|||
44533658|NCT03043313|79543995|FG002|Overall Study|Death|8|||
44533659|NCT03043313|79543993|FG000|Overall Study|On Treatment|7|||
44533660|NCT03043313|79543994|FG001|Overall Study|On Treatment|12|||
44154523|NCT02001688|78945709|FG001|Overall Study|Withdrawal by Subject|0|||
44154524|NCT02001688|78945710|FG002|Overall Study|Withdrawal by Subject|1|||
44533661|NCT03043313|79543995|FG002|Overall Study|On Treatment|11|||
44154525|NCT02001688|78945708|FG000|Overall Study|Adverse Event|0|||
44154526|NCT02001688|78945709|FG001|Overall Study|Adverse Event|1|||
44154527|NCT02001688|78945710|FG002|Overall Study|Adverse Event|0|||
44416237|NCT00852917|79423937|FG001|Overall Study|Physician Decision|7|||
44416238|NCT00852917|79423938|FG002|Overall Study|Physician Decision|2|||
44416239|NCT00852917|79423939|FG003|Overall Study|Physician Decision|19|||
44416240|NCT00852917|79423936|FG000|Overall Study|Death|0|||
44416241|NCT00852917|79423937|FG001|Overall Study|Death|0|||
44533662|NCT03043313|79543993|FG000|Overall Study|In follow up|7|||
44416242|NCT00852917|79423938|FG002|Overall Study|Death|0|||
44416243|NCT00852917|79423939|FG003|Overall Study|Death|1|||
44416244|NCT00845429|79423952|FG000|Overall Study|Protocol Violation|5|||
44416245|NCT00845429|79423953|FG001|Overall Study|Protocol Violation|4|||
44416246|NCT00845429|79423954|FG002|Overall Study|Protocol Violation|7|||
44416247|NCT00845429|79423952|FG000|Overall Study|Lost to Follow-up|7|||
44416248|NCT00845429|79423953|FG001|Overall Study|Lost to Follow-up|9|||
44416249|NCT00845429|79423954|FG002|Overall Study|Lost to Follow-up|10|||
44416250|NCT00845429|79423952|FG000|Overall Study|Withdrawal by Subject|2|||
44416251|NCT00845429|79423953|FG001|Overall Study|Withdrawal by Subject|2|||
44416252|NCT00845429|79423954|FG002|Overall Study|Withdrawal by Subject|2|||
44416253|NCT00845429|79423952|FG000|Overall Study|Serious adverse event|0|||
44416254|NCT00845429|79423953|FG001|Overall Study|Serious adverse event|0|||
44416255|NCT00845429|79423954|FG002|Overall Study|Serious adverse event|1|||
44416256|NCT00593333|79423964|FG000|Overall Study|Lost to Follow-up|10|||
44416257|NCT00593333|79423965|FG001|Overall Study|Lost to Follow-up|11|||
44416258|NCT00844883|79423971|FG000|Overall Study|Bridged to liver transplant|3|||
44416259|NCT00844883|79423971|FG000|Overall Study|Bridged to resection|1|||
44416260|NCT00851903|79423975|FG000|Overall Study|Withdrawal by Subject|2|||
44416261|NCT00587457|79423982|FG000|Overall Study|Adverse Event|1|||
44416262|NCT00587457|79423983|FG001|Overall Study|Adverse Event|2|||
44416263|NCT00587457|79423984|FG002|Overall Study|Adverse Event|1|||
44416264|NCT00587457|79423982|FG000|Overall Study|Disease progression|2|||
44416265|NCT00587457|79423983|FG001|Overall Study|Disease progression|0|||
44416266|NCT00587457|79423984|FG002|Overall Study|Disease progression|2|||
44416267|NCT00587457|79423982|FG000|Overall Study|Initiation of alternative therapy|0|||
44416268|NCT00587457|79423983|FG001|Overall Study|Initiation of alternative therapy|1|||
44416269|NCT00587457|79423984|FG002|Overall Study|Initiation of alternative therapy|0|||
44416270|NCT00587457|79423982|FG000|Overall Study|Undefined|0|||
44416271|NCT00587457|79423983|FG001|Overall Study|Undefined|0|||
44416272|NCT00587457|79423984|FG002|Overall Study|Undefined|1|||
44416273|NCT00587457|79423982|FG000|Overall Study|Development of neutralizing Abs|0|||
44416274|NCT00587457|79423983|FG001|Overall Study|Development of neutralizing Abs|0|||
44416275|NCT00587457|79423984|FG002|Overall Study|Development of neutralizing Abs|1|||
44416276|NCT00851747|79423995|FG000|Overall Study|Physician Decision|6|||
44416277|NCT00851747|79423996|FG001|Overall Study|Physician Decision|6|||
44416278|NCT00851747|79423997|FG002|Overall Study|Physician Decision|6|||
44416279|NCT00767325|79424004|FG000|Overall Study|Lack of Efficacy|2|||
44416280|NCT00767325|79424004|FG000|Overall Study|Adverse Event|7|||
44416281|NCT00767325|79424004|FG000|Overall Study|Lost to Follow-up|3|||
44416282|NCT00767325|79424004|FG000|Overall Study|No longer met study criteria|2|||
44416283|NCT00767325|79424004|FG000|Overall Study|Missed visit due to family reasons|1|||
44416284|NCT00851591|79424010|FG000|Overall Study|Withdrawal by Subject|2|||
44416285|NCT00851591|79424011|FG001|Overall Study|Withdrawal by Subject|0|||
44416286|NCT00861341|79424017|FG000|Overall Study|Withdrawal by Subject|2|||
44416287|NCT00766467|79424023|FG000|Overall Study|Withdrawal by Subject|7|||
44416288|NCT00766467|79424024|FG001|Overall Study|Withdrawal by Subject|2|||
44416289|NCT00766467|79424023|FG000|Overall Study|Adverse Event|1|||
44416290|NCT00766467|79424024|FG001|Overall Study|Adverse Event|1|||
44416291|NCT00766467|79424023|FG000|Overall Study|Protocol Violation|2|||
44533663|NCT03043313|79543994|FG001|Overall Study|In follow up|15|||
44154528|NCT02001064|78945721|FG000|Overall Study|Withdrawal by Subject|2|||
44154529|NCT02001064|78945722|FG001|Overall Study|Withdrawal by Subject|1|||
44154530|NCT02000752|78945730|FG000|Overall Study|Dystocic delivery|19|||
44154531|NCT02000752|78945731|FG001|Overall Study|Dystocic delivery|8|||
44154532|NCT02000752|78945730|FG000|Overall Study|Shift Changes|12|||
44154533|NCT02000752|78945731|FG001|Overall Study|Shift Changes|5|||
44154534|NCT02000440|78945737|FG000|Overall Study|Adverse Event|3|||
44154535|NCT02000440|78945737|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
44154536|NCT02687815|78945743|FG000|Overall Study|Lost to Follow-up|2|||
44290184|NCT01422720|79253935|FG000|Overall Study|Adverse Event|16|||
44290185|NCT01422720|79253935|FG000|Overall Study|Lack of Efficacy|1|||
44290186|NCT01422720|79253935|FG000|Overall Study|Withdrawal by Subject|4|||
44290187|NCT01422720|79253935|FG000|Overall Study|Ineligibility|1|||
44290188|NCT01387932|79253945|FG000|Randomized and Treated|Physician Decision|3|||
44290189|NCT01387932|79253946|FG001|Randomized and Treated|Physician Decision|2|||
44290190|NCT01387932|79253945|FG000|Randomized and Treated|Withdrawal by Subject|4|||
44416292|NCT00766467|79424024|FG001|Overall Study|Protocol Violation|4|||
44416293|NCT00766467|79424023|FG000|Overall Study|Tumor Progression on Study|0|||
44416294|NCT00766467|79424024|FG001|Overall Study|Tumor Progression on Study|1|||
44416295|NCT00766467|79424023|FG000|Overall Study|Physician Decision|1|||
44416296|NCT00766467|79424024|FG001|Overall Study|Physician Decision|0|||
44416297|NCT00850499|79424032|FG000|Overall Study|Adverse Event|3|||
44416298|NCT00850499|79424033|FG001|Overall Study|Adverse Event|1|||
44416299|NCT00850499|79424032|FG000|Overall Study|Lack of Efficacy|0|||
44416300|NCT00850499|79424033|FG001|Overall Study|Lack of Efficacy|1|||
44416301|NCT00860951|79424039|FG000|Overall Study|Withdrawal by Subject|2|||
44416302|NCT00860951|79424039|FG000|Overall Study|Lost to Follow-up|5|||
44290191|NCT01387932|79253946|FG001|Randomized and Treated|Withdrawal by Subject|2|||
44290192|NCT01387932|79253945|FG000|Survival Follow-up|Liver Transplant|24|||
44290193|NCT01387932|79253946|FG001|Survival Follow-up|Liver Transplant|28|||
44290194|NCT01387932|79253945|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
44290195|NCT01387932|79253946|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
44290196|NCT01387932|79253945|FG000|Survival Follow-up|Withdrawal by Subject|2|||
44290197|NCT01387932|79253946|FG001|Survival Follow-up|Withdrawal by Subject|4|||
44290198|NCT01387932|79253945|FG000|Survival Follow-up|Lost to Follow-up|6|||
44290199|NCT01387932|79253946|FG001|Survival Follow-up|Lost to Follow-up|5|||
44290200|NCT01422408|79253954|FG000|Overall Study|Adverse Event|1|||
44290201|NCT01422408|79253954|FG000|Overall Study|Withdrawal by Subject|3|||
44290202|NCT01399788|79253958|FG000|First Intervention Period|Adverse Event|1|||
44290203|NCT01399788|79253959|FG001|First Intervention Period|Adverse Event|0|||
44290204|NCT01387542|79253965|FG000|Overall Study|Adverse Event|3|||
44290205|NCT01387542|79253965|FG000|Overall Study|Withdrawal by Subject|1|||
44290206|NCT01387542|79253965|FG000|Overall Study|Changed diagnosis|1|||
44290207|NCT01387542|79253965|FG000|Overall Study|Insufficient response|1|||
44290208|NCT01387542|79253965|FG000|Overall Study|Non-compliant|1|||
44290209|NCT01387542|79253965|FG000|Overall Study|Lost to Follow-up|1|||
44290210|NCT01387230|79253972|FG000|Overall Study|Adverse Event|0|||
44290211|NCT01387230|79253973|FG001|Overall Study|Adverse Event|1|||
44290212|NCT01387230|79253974|FG002|Overall Study|Adverse Event|3|||
44290213|NCT01387230|79253972|FG000|Overall Study|Lack of Efficacy|8|||
44290214|NCT01387230|79253973|FG001|Overall Study|Lack of Efficacy|5|||
44290215|NCT01387230|79253974|FG002|Overall Study|Lack of Efficacy|4|||
44290216|NCT01387230|79253972|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
44290217|NCT01387230|79253973|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
44290218|NCT01387230|79253974|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
44290219|NCT01387230|79253972|FG000|Overall Study|Lost to Follow-up|0|||
44290220|NCT01387230|79253973|FG001|Overall Study|Lost to Follow-up|0|||
44290221|NCT01387230|79253974|FG002|Overall Study|Lost to Follow-up|1|||
44290222|NCT01387230|79253972|FG000|Overall Study|Withdrawal by Subject|4|||
44290223|NCT01387230|79253973|FG001|Overall Study|Withdrawal by Subject|1|||
44290224|NCT01387230|79253974|FG002|Overall Study|Withdrawal by Subject|0|||
44290225|NCT01387074|79253982|FG000|Overall Study|Lost to Follow-up|7|||
44290226|NCT01387074|79253982|FG000|Overall Study|Lack of Efficacy|1|||
44290227|NCT01386606|79253990|FG000|Overall Study|Adverse Event|0|||
44290228|NCT01386606|79253991|FG001|Overall Study|Adverse Event|1|||
44290229|NCT01386606|79253992|FG002|Overall Study|Adverse Event|0|||
44290230|NCT01386606|79253993|FG003|Overall Study|Adverse Event|0|||
44290231|NCT01386606|79253990|FG000|Overall Study|Withdrawal by Subject|0|||
44290232|NCT01386606|79253991|FG001|Overall Study|Withdrawal by Subject|1|||
44290233|NCT01386606|79253992|FG002|Overall Study|Withdrawal by Subject|1|||
44290234|NCT01386606|79253993|FG003|Overall Study|Withdrawal by Subject|0|||
44290235|NCT01386606|79253990|FG000|Overall Study|Protocol Violation|1|||
44290236|NCT01386606|79253991|FG001|Overall Study|Protocol Violation|0|||
44290237|NCT01386606|79253992|FG002|Overall Study|Protocol Violation|1|||
44290238|NCT01386606|79253993|FG003|Overall Study|Protocol Violation|1|||
44290239|NCT01386606|79253990|FG000|Overall Study|Lost to Follow-up|2|||
44290240|NCT01386606|79253991|FG001|Overall Study|Lost to Follow-up|0|||
44290241|NCT01386606|79253992|FG002|Overall Study|Lost to Follow-up|0|||
44290242|NCT01386606|79253993|FG003|Overall Study|Lost to Follow-up|0|||
44290243|NCT01386606|79253990|FG000|Overall Study|Subject incarcerated|0|||
44290244|NCT01386606|79253991|FG001|Overall Study|Subject incarcerated|1|||
44290245|NCT01386606|79253992|FG002|Overall Study|Subject incarcerated|0|||
44290246|NCT01386606|79253993|FG003|Overall Study|Subject incarcerated|0|||
44290247|NCT01386606|79253990|FG000|Overall Study|Unable to draw PK|1|||
44290248|NCT01386606|79253991|FG001|Overall Study|Unable to draw PK|0|||
44290249|NCT01386606|79253992|FG002|Overall Study|Unable to draw PK|0|||
44290250|NCT01386606|79253993|FG003|Overall Study|Unable to draw PK|0|||
44290251|NCT01386606|79253990|FG000|Overall Study|T levels too high|0|||
44290252|NCT01386606|79253991|FG001|Overall Study|T levels too high|1|||
44290253|NCT01386606|79253992|FG002|Overall Study|T levels too high|1|||
44290254|NCT01386606|79253993|FG003|Overall Study|T levels too high|0|||
44290255|NCT01385748|79254010|FG000|Overall Study|Withdrawal by Subject|7|||
44290256|NCT01385748|79254011|FG001|Overall Study|Withdrawal by Subject|4|||
44290257|NCT01385748|79254012|FG002|Overall Study|Withdrawal by Subject|5|||
44290258|NCT01385748|79254010|FG000|Overall Study|Noncompliance|3|||
44290259|NCT01385748|79254011|FG001|Overall Study|Noncompliance|1|||
44290260|NCT01385748|79254012|FG002|Overall Study|Noncompliance|6|||
44290261|NCT01385748|79254010|FG000|Overall Study|Other|1|||
44290262|NCT01385748|79254011|FG001|Overall Study|Other|7|||
44290263|NCT01385748|79254012|FG002|Overall Study|Other|1|||
44290264|NCT01385748|79254010|FG000|Overall Study|Adverse Event|4|||
44290265|NCT01385748|79254011|FG001|Overall Study|Adverse Event|2|||
44416303|NCT00844805|79424057|FG000|Treatment Phase|Adverse Event|5|||
44290266|NCT01385748|79254012|FG002|Overall Study|Adverse Event|1|||
44290267|NCT01397448|79254027|FG000|Overall Study|Adverse Event|4|||
44290268|NCT01397448|79254028|FG001|Overall Study|Adverse Event|4|||
44290269|NCT01397448|79254029|FG002|Overall Study|Adverse Event|6|||
44290270|NCT01397448|79254027|FG000|Overall Study|Withdrawal by Subject|4|||
44290271|NCT01397448|79254028|FG001|Overall Study|Withdrawal by Subject|4|||
44290272|NCT01397448|79254029|FG002|Overall Study|Withdrawal by Subject|3|||
44290273|NCT01397448|79254027|FG000|Overall Study|Lack of Efficacy|2|||
44290274|NCT01397448|79254028|FG001|Overall Study|Lack of Efficacy|0|||
44290275|NCT01397448|79254029|FG002|Overall Study|Lack of Efficacy|5|||
44290276|NCT01397448|79254027|FG000|Overall Study|Other|8|||
44290277|NCT01397448|79254028|FG001|Overall Study|Other|7|||
44290278|NCT01397448|79254029|FG002|Overall Study|Other|4|||
44290279|NCT01385202|79254037|FG000|Overall Study|Lost to Follow-up|6|||
44290280|NCT01385202|79254037|FG000|Overall Study|Not Eligible|11|||
44290281|NCT01385202|79254037|FG000|Overall Study|Withdrawn|1|||
44290282|NCT01384734|79254048|FG000|Overall Study|Adverse Event|0|||
44290283|NCT01384734|79254049|FG001|Overall Study|Adverse Event|3|||
44290284|NCT01384734|79254050|FG002|Overall Study|Adverse Event|0|||
44290285|NCT01384734|79254051|FG003|Overall Study|Adverse Event|2|||
44290286|NCT01384734|79254052|FG004|Overall Study|Adverse Event|7|||
44290287|NCT01384734|79254048|FG000|Overall Study|Death|1|||
44290288|NCT01384734|79254049|FG001|Overall Study|Death|0|||
44290289|NCT01384734|79254050|FG002|Overall Study|Death|1|||
44290290|NCT01384734|79254051|FG003|Overall Study|Death|0|||
44290291|NCT01384734|79254052|FG004|Overall Study|Death|0|||
44290292|NCT01384734|79254048|FG000|Overall Study|Continuation criteria not met|0|||
44290293|NCT01384734|79254049|FG001|Overall Study|Continuation criteria not met|0|||
44290294|NCT01384734|79254050|FG002|Overall Study|Continuation criteria not met|1|||
44290295|NCT01384734|79254051|FG003|Overall Study|Continuation criteria not met|1|||
44416304|NCT00844805|79424058|FG001|Treatment Phase|Adverse Event|1|||
44416305|NCT00844805|79424059|FG002|Treatment Phase|Adverse Event|0|||
44290296|NCT01384734|79254052|FG004|Overall Study|Continuation criteria not met|0|||
44290297|NCT01384734|79254048|FG000|Overall Study|Lack of Efficacy|3|||
44290298|NCT01384734|79254049|FG001|Overall Study|Lack of Efficacy|7|||
44290299|NCT01384734|79254050|FG002|Overall Study|Lack of Efficacy|4|||
44290300|NCT01384734|79254051|FG003|Overall Study|Lack of Efficacy|4|||
44290301|NCT01384734|79254052|FG004|Overall Study|Lack of Efficacy|2|||
44290302|NCT01384734|79254048|FG000|Overall Study|Lost to Follow-up|5|||
44290303|NCT01384734|79254049|FG001|Overall Study|Lost to Follow-up|3|||
44290304|NCT01384734|79254050|FG002|Overall Study|Lost to Follow-up|3|||
44290305|NCT01384734|79254051|FG003|Overall Study|Lost to Follow-up|8|||
44290306|NCT01384734|79254052|FG004|Overall Study|Lost to Follow-up|5|||
44290307|NCT01384734|79254048|FG000|Overall Study|Non-compliance with study drug|1|||
44290308|NCT01384734|79254049|FG001|Overall Study|Non-compliance with study drug|2|||
44290309|NCT01384734|79254050|FG002|Overall Study|Non-compliance with study drug|6|||
44290310|NCT01384734|79254051|FG003|Overall Study|Non-compliance with study drug|0|||
44290311|NCT01384734|79254052|FG004|Overall Study|Non-compliance with study drug|2|||
44290312|NCT01384734|79254048|FG000|Overall Study|Pregnancy|0|||
44290313|NCT01384734|79254049|FG001|Overall Study|Pregnancy|1|||
44290314|NCT01384734|79254050|FG002|Overall Study|Pregnancy|0|||
44290315|NCT01384734|79254051|FG003|Overall Study|Pregnancy|0|||
44290316|NCT01384734|79254052|FG004|Overall Study|Pregnancy|1|||
44290317|NCT01384734|79254048|FG000|Overall Study|Sponsor terminated|0|||
44290318|NCT01384734|79254049|FG001|Overall Study|Sponsor terminated|0|||
44290319|NCT01384734|79254050|FG002|Overall Study|Sponsor terminated|0|||
44290320|NCT01384734|79254051|FG003|Overall Study|Sponsor terminated|0|||
44290321|NCT01384734|79254052|FG004|Overall Study|Sponsor terminated|1|||
44290322|NCT01384734|79254048|FG000|Overall Study|Withdrawal by Subject|5|||
44290323|NCT01384734|79254049|FG001|Overall Study|Withdrawal by Subject|5|||
44290324|NCT01384734|79254050|FG002|Overall Study|Withdrawal by Subject|6|||
44290325|NCT01384734|79254051|FG003|Overall Study|Withdrawal by Subject|7|||
44290326|NCT01384734|79254052|FG004|Overall Study|Withdrawal by Subject|9|||
44290327|NCT01384734|79254048|FG000|Overall Study|Investigator relocating|0|||
44290328|NCT01384734|79254049|FG001|Overall Study|Investigator relocating|2|||
44290329|NCT01384734|79254050|FG002|Overall Study|Investigator relocating|0|||
44290330|NCT01384734|79254051|FG003|Overall Study|Investigator relocating|3|||
44290331|NCT01384734|79254052|FG004|Overall Study|Investigator relocating|1|||
44290332|NCT01384734|79254048|FG000|Overall Study|Unable to come back for visit|1|||
44290333|NCT01384734|79254049|FG001|Overall Study|Unable to come back for visit|0|||
44290334|NCT01384734|79254050|FG002|Overall Study|Unable to come back for visit|1|||
44290335|NCT01384734|79254051|FG003|Overall Study|Unable to come back for visit|1|||
44290336|NCT01384734|79254052|FG004|Overall Study|Unable to come back for visit|0|||
44290337|NCT01384734|79254048|FG000|Overall Study|Prison|0|||
44290338|NCT01384734|79254049|FG001|Overall Study|Prison|0|||
44290339|NCT01384734|79254050|FG002|Overall Study|Prison|1|||
44416306|NCT00844805|79424060|FG003|Treatment Phase|Adverse Event|0|||
44416307|NCT00844805|79424057|FG000|Treatment Phase|Withdrawal by Subject|3|||
44290340|NCT01384734|79254051|FG003|Overall Study|Prison|0|||
44416308|NCT00844805|79424058|FG001|Treatment Phase|Withdrawal by Subject|4|||
44290341|NCT01384734|79254052|FG004|Overall Study|Prison|0|||
44290342|NCT01384734|79254048|FG000|Overall Study|As per Exclusion criteria|0|||
44290343|NCT01384734|79254049|FG001|Overall Study|As per Exclusion criteria|1|||
44290344|NCT01384734|79254050|FG002|Overall Study|As per Exclusion criteria|0|||
44290345|NCT01384734|79254051|FG003|Overall Study|As per Exclusion criteria|0|||
44290346|NCT01384734|79254052|FG004|Overall Study|As per Exclusion criteria|0|||
44290347|NCT01384734|79254048|FG000|Overall Study|Missed End of treatment visit|0|||
44290348|NCT01384734|79254049|FG001|Overall Study|Missed End of treatment visit|0|||
44290349|NCT01384734|79254050|FG002|Overall Study|Missed End of treatment visit|0|||
44290350|NCT01384734|79254051|FG003|Overall Study|Missed End of treatment visit|1|||
44290351|NCT01384734|79254052|FG004|Overall Study|Missed End of treatment visit|0|||
44290352|NCT01384734|79254048|FG000|Overall Study|Adhesion problem|0|||
44290353|NCT01384734|79254049|FG001|Overall Study|Adhesion problem|0|||
44290354|NCT01384734|79254050|FG002|Overall Study|Adhesion problem|0|||
44290355|NCT01384734|79254051|FG003|Overall Study|Adhesion problem|1|||
44290356|NCT01384734|79254052|FG004|Overall Study|Adhesion problem|0|||
44290357|NCT01384734|79254048|FG000|Overall Study|Early termination|0|||
44290358|NCT01384734|79254049|FG001|Overall Study|Early termination|0|||
44290359|NCT01384734|79254050|FG002|Overall Study|Early termination|0|||
44290360|NCT01384734|79254051|FG003|Overall Study|Early termination|0|||
44290361|NCT01384734|79254052|FG004|Overall Study|Early termination|1|||
44290362|NCT01384734|79254048|FG000|Overall Study|Physician Decision|1|||
44290363|NCT01384734|79254049|FG001|Overall Study|Physician Decision|0|||
44290364|NCT01384734|79254050|FG002|Overall Study|Physician Decision|0|||
44290365|NCT01384734|79254051|FG003|Overall Study|Physician Decision|0|||
44290366|NCT01384734|79254052|FG004|Overall Study|Physician Decision|0|||
44290367|NCT01396512|79254063|FG000|Overall Study|Withdrawal by Subject|0|||
44290368|NCT01396512|79254064|FG001|Overall Study|Withdrawal by Subject|1|||
44290369|NCT01396434|79254073|FG000|Overall Study|Lost to Follow-up|1|||
44290370|NCT01396434|79254074|FG001|Overall Study|Lost to Follow-up|0|||
44290371|NCT01396434|79254075|FG002|Overall Study|Lost to Follow-up|0|||
44290372|NCT01396434|79254073|FG000|Overall Study|Other|10|||
44290373|NCT01396434|79254074|FG001|Overall Study|Other|0|||
44290374|NCT01396434|79254075|FG002|Overall Study|Other|0|||
44290375|NCT01383954|79254083|FG000|Overall Study|Lack of Efficacy|2|||
44290376|NCT01383954|79254083|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
44290377|NCT01383954|79254083|FG000|Overall Study|Adverse Event|1|||
44290378|NCT01383954|79254083|FG000|Overall Study|Reason Not Specified|9|||
44290379|NCT01383486|79254087|FG000|Overall Study|Lost to Follow-up|10|||
44290380|NCT01383486|79254087|FG000|Overall Study|Incomplete information for analysis|2|||
44290381|NCT01383486|79254087|FG000|Overall Study|Did not take any product|6|||
44290382|NCT01383174|79254094|FG000|3 Month Assessment|Death|0|||
44290383|NCT01383174|79254095|FG001|3 Month Assessment|Death|1|||
44290384|NCT01383174|79254094|FG000|3 Month Assessment|Lost to Follow-up|2|||
44290385|NCT01383174|79254095|FG001|3 Month Assessment|Lost to Follow-up|0|||
44290386|NCT01383174|79254094|FG000|3 Month Assessment|Refused to complete|4|||
44290387|NCT01383174|79254095|FG001|3 Month Assessment|Refused to complete|0|||
44290388|NCT01383174|79254094|FG000|6 Month Assessment|Lost to Follow-up|1|||
44290389|NCT01383174|79254095|FG001|6 Month Assessment|Lost to Follow-up|1|||
44290390|NCT01383174|79254094|FG000|6 Month Assessment|Refused to complete|4|||
44290391|NCT01383174|79254095|FG001|6 Month Assessment|Refused to complete|0|||
44290392|NCT01396278|79254106|FG000|Overall Study|Adverse Event|0|||
44290393|NCT01396278|79254107|FG001|Overall Study|Adverse Event|0|||
44290394|NCT01396278|79254108|FG002|Overall Study|Adverse Event|0|||
44290395|NCT01396278|79254109|FG003|Overall Study|Adverse Event|2|||
44290396|NCT01396278|79254110|FG004|Overall Study|Adverse Event|0|||
44290397|NCT01396278|79254106|FG000|Overall Study|Withdraw due to trial termination|2|||
44290398|NCT01396278|79254107|FG001|Overall Study|Withdraw due to trial termination|1|||
44290399|NCT01396278|79254108|FG002|Overall Study|Withdraw due to trial termination|1|||
44290400|NCT01396278|79254109|FG003|Overall Study|Withdraw due to trial termination|0|||
44290401|NCT01396278|79254110|FG004|Overall Study|Withdraw due to trial termination|2|||
44290402|NCT01383096|79254125|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
44290403|NCT01383096|79254126|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
44290404|NCT01383096|79254127|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
44290405|NCT01383096|79254125|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
44290406|NCT01383096|79254126|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
44290407|NCT01383096|79254127|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
44290408|NCT01383096|79254125|FG000|Third Intervention (8 Days)|Elevated AST|0|||
44290409|NCT01383096|79254126|FG001|Third Intervention (8 Days)|Elevated AST|1|||
44290410|NCT01383096|79254127|FG002|Third Intervention (8 Days)|Elevated AST|0|||
44290411|NCT01383096|79254125|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
44290412|NCT01383096|79254126|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
44290413|NCT01383096|79254127|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
44290414|NCT01383096|79254125|FG000|Third Intervention (8 Days)|Adverse Event|1|||
44290415|NCT01383096|79254126|FG001|Third Intervention (8 Days)|Adverse Event|0|||
44290416|NCT01383096|79254127|FG002|Third Intervention (8 Days)|Adverse Event|0|||
44290417|NCT01383096|79254125|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
44290418|NCT01383096|79254126|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
44290419|NCT01383096|79254127|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
44290420|NCT01383096|79254125|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
44290421|NCT01383096|79254126|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
44290422|NCT01383096|79254127|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
44290423|NCT01383096|79254125|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
44290424|NCT01383096|79254126|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
44290425|NCT01383096|79254127|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
44290426|NCT01383096|79254125|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
44290427|NCT01383096|79254126|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
44290428|NCT01383096|79254127|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
44290429|NCT01383096|79254125|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
44290430|NCT01383096|79254126|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
44290431|NCT01383096|79254127|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
44290432|NCT01383096|79254125|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
44290433|NCT01383096|79254126|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
44290434|NCT01383096|79254127|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
44290435|NCT01383018|79254168|FG000|Overall Study|Adverse Event|14|||
44290436|NCT01383018|79254168|FG000|Overall Study|Death|10|||
44290437|NCT01383018|79254168|FG000|Overall Study|Lost to Follow-up|5|||
44290438|NCT01383018|79254168|FG000|Overall Study|Physician Decision|5|||
44290439|NCT01383018|79254168|FG000|Overall Study|Withdrawal by Subject|9|||
44290440|NCT01383018|79254168|FG000|Overall Study|Subject not implanted|76|||
44290441|NCT01383018|79254168|FG000|Overall Study|Missed Visit|247|||
44290442|NCT01383018|79254168|FG000|Overall Study|Site closed early-not compliance related|7|||
44290443|NCT01383018|79254168|FG000|Overall Study|Patient moved away from site|1|||
44290444|NCT01383018|79254168|FG000|Overall Study|Subject Incarcerated|1|||
44290445|NCT01382940|79254182|FG000|Overall Study|Adverse Event|19|||
44290446|NCT01382940|79254182|FG000|Overall Study|Lost to Follow-up|4|||
44290447|NCT01382940|79254182|FG000|Overall Study|Physician Decision|7|||
44290448|NCT01382940|79254182|FG000|Overall Study|Withdrawal by Subject|23|||
44290449|NCT01382940|79254182|FG000|Overall Study|Protocol Violation|20|||
44290450|NCT01381926|79254188|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
44290451|NCT01381926|79254189|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
44290452|NCT01381926|79254188|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
44290453|NCT01381926|79254189|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
44290454|NCT01395888|79254199|FG000|2-week Run-in Period|Adverse Event|2|||
44290455|NCT01395888|79254200|FG001|2-week Run-in Period|Adverse Event|0|||
44290456|NCT01395888|79254201|FG002|2-week Run-in Period|Adverse Event|0|||
44290457|NCT01395888|79254199|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
44290458|NCT01395888|79254200|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
44290459|NCT01395888|79254201|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
44290460|NCT01395888|79254199|FG000|2-week Run-in Period|Lost to Follow-up|1|||
44290461|NCT01395888|79254200|FG001|2-week Run-in Period|Lost to Follow-up|0|||
44290462|NCT01395888|79254201|FG002|2-week Run-in Period|Lost to Follow-up|0|||
44290463|NCT01395888|79254199|FG000|2-week Run-in Period|Protocol Violation|2|||
44290464|NCT01395888|79254200|FG001|2-week Run-in Period|Protocol Violation|0|||
44290465|NCT01395888|79254201|FG002|2-week Run-in Period|Protocol Violation|0|||
44290466|NCT01395888|79254199|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
44290467|NCT01395888|79254200|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44290468|NCT01395888|79254201|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44290469|NCT01395888|79254199|FG000|Treatment Period (TP)|Adverse Event|0|||
44290470|NCT01395888|79254200|FG001|Treatment Period (TP)|Adverse Event|7|||
44290471|NCT01395888|79254201|FG002|Treatment Period (TP)|Adverse Event|6|||
44290472|NCT01395888|79254199|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
44290473|NCT01395888|79254200|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
44290474|NCT01395888|79254201|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
44290475|NCT01395888|79254199|FG000|Treatment Period (TP)|Protocol Violation|0|||
44290476|NCT01395888|79254200|FG001|Treatment Period (TP)|Protocol Violation|1|||
44290477|NCT01395888|79254201|FG002|Treatment Period (TP)|Protocol Violation|5|||
44290478|NCT01395888|79254199|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
44290479|NCT01395888|79254200|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
44290480|NCT01395888|79254201|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
44290481|NCT01395888|79254199|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
44290482|NCT01395888|79254200|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
44290483|NCT01395888|79254201|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
44290484|NCT01395810|79254211|FG000|Overall Study|Adverse Event|0|||
44290485|NCT01395810|79254212|FG001|Overall Study|Adverse Event|1|||
44290486|NCT01395810|79254213|FG002|Overall Study|Adverse Event|0|||
44416309|NCT00844805|79424059|FG002|Treatment Phase|Withdrawal by Subject|0|||
44290487|NCT01395810|79254214|FG003|Overall Study|Adverse Event|0|||
44290488|NCT01395810|79254211|FG000|Overall Study|Lack of Efficacy|0|||
44290489|NCT01395810|79254212|FG001|Overall Study|Lack of Efficacy|1|||
44290490|NCT01395810|79254213|FG002|Overall Study|Lack of Efficacy|0|||
44290491|NCT01395810|79254214|FG003|Overall Study|Lack of Efficacy|0|||
44290492|NCT01395810|79254211|FG000|Overall Study|Withdrawal criteria|0|||
44290493|NCT01395810|79254212|FG001|Overall Study|Withdrawal criteria|2|||
44290494|NCT01395810|79254213|FG002|Overall Study|Withdrawal criteria|0|||
44290495|NCT01395810|79254214|FG003|Overall Study|Withdrawal criteria|0|||
44290496|NCT01395810|79254211|FG000|Overall Study|Unclassified|2|||
44290497|NCT01395810|79254212|FG001|Overall Study|Unclassified|0|||
44290498|NCT01395810|79254213|FG002|Overall Study|Unclassified|0|||
44290499|NCT01395810|79254214|FG003|Overall Study|Unclassified|0|||
44290500|NCT01381692|79254227|FG000|Overall Study|Adverse Event|1|||
44290501|NCT01381692|79254228|FG001|Overall Study|Adverse Event|0|||
44290502|NCT01381692|79254229|FG002|Overall Study|Adverse Event|0|||
44290503|NCT01381692|79254230|FG003|Overall Study|Adverse Event|0|||
44290504|NCT01381692|79254231|FG004|Overall Study|Adverse Event|0|||
44290505|NCT01381692|79254232|FG005|Overall Study|Adverse Event|0|||
44290506|NCT01395030|79254240|FG000|Overall Study|Did not complete FCH PET/CT|7|||
44290507|NCT01381068|79254248|FG000|Overall Study|Death|1|||
44290508|NCT01381068|79254249|FG001|Overall Study|Death|0|||
44290509|NCT01394952|79254257|FG000|Overall Study|Lost to Follow-up|0|||
44290510|NCT01394952|79254258|FG001|Overall Study|Lost to Follow-up|5|||
44290511|NCT01394952|79254257|FG000|Overall Study|Withdrawal by Subject|10|||
44290512|NCT01394952|79254258|FG001|Overall Study|Withdrawal by Subject|5|||
44290513|NCT01394952|79254257|FG000|Overall Study|Physician Decision|2|||
44290514|NCT01394952|79254258|FG001|Overall Study|Physician Decision|0|||
44290515|NCT01394952|79254257|FG000|Overall Study|Sponsor Decision|5|||
44290516|NCT01394952|79254258|FG001|Overall Study|Sponsor Decision|7|||
44290517|NCT01394718|79254266|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
44290518|NCT01394718|79254267|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
44290519|NCT01394250|79254275|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
44290520|NCT01394250|79254276|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
44290521|NCT01394250|79254275|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
44290522|NCT01394250|79254276|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
44290523|NCT01380990|79254284|FG000|Overall Study|Treatment Failure|1|||
44290524|NCT01380990|79254285|FG001|Overall Study|Treatment Failure|0|||
44290525|NCT01380990|79254284|FG000|Overall Study|Death|0|||
44290526|NCT01380990|79254285|FG001|Overall Study|Death|1|||
44290527|NCT01380834|79254297|FG000|Overall Study|Physician Decision|1|||
44290528|NCT01380834|79254298|FG001|Overall Study|Physician Decision|0|||
44290529|NCT00214422|79254307|FG000|Overall Study|Physician Decision|2|||
44290530|NCT00214422|79254308|FG001|Overall Study|Physician Decision|0|||
44290531|NCT00214422|79254309|FG002|Overall Study|Physician Decision|0|||
44290532|NCT00214422|79254307|FG000|Overall Study|Developed esophageal ca|1|||
44290533|NCT00214422|79254308|FG001|Overall Study|Developed esophageal ca|0|||
44290534|NCT00214422|79254309|FG002|Overall Study|Developed esophageal ca|0|||
44290535|NCT00214422|79254307|FG000|Overall Study|Pt taken off study|1|||
44290536|NCT00214422|79254308|FG001|Overall Study|Pt taken off study|1|||
44290537|NCT00214422|79254309|FG002|Overall Study|Pt taken off study|0|||
44290538|NCT00214422|79254307|FG000|Overall Study|Disease progression on study|1|||
44290539|NCT00214422|79254308|FG001|Overall Study|Disease progression on study|0|||
44290540|NCT00214422|79254309|FG002|Overall Study|Disease progression on study|0|||
44290541|NCT00214422|79254307|FG000|Overall Study|Unable to make a radiation treatment|0|||
44290542|NCT00214422|79254308|FG001|Overall Study|Unable to make a radiation treatment|0|||
44290543|NCT00214422|79254309|FG002|Overall Study|Unable to make a radiation treatment|1|||
44290544|NCT00218634|79254323|FG000|Overall Study|Lost to Follow-up|8|||
44290545|NCT00218634|79254324|FG001|Overall Study|Lost to Follow-up|15|||
44290546|NCT00217620|79254333|FG000|Overall Study|Adverse Event|2|||
44290547|NCT00217620|79254333|FG000|Overall Study|Progression|31|||
44290548|NCT00217620|79254333|FG000|Overall Study|Not Protocol Specified|4|||
44290549|NCT00217620|79254333|FG000|Overall Study|Ineligible|13|||
44290550|NCT00217620|79254333|FG000|Overall Study|Never received treatment|1|||
44290551|NCT00217464|79254341|FG000|Overall Study|Progression|15|||
44290552|NCT00217464|79254341|FG000|Overall Study|Other|2|||
44290553|NCT00214500|79254345|FG000|Treatment Period|Adverse Event|1|||
44290554|NCT00214500|79254345|FG000|Extension Period|Withdrawal by Subject|2|||
44290555|NCT00211536|79254354|FG000|Overall Study|Withdrawal by Subject|2|||
44290556|NCT00211536|79254355|FG001|Overall Study|Withdrawal by Subject|2|||
44290557|NCT00211536|79254354|FG000|Overall Study|Physician Decision|0|||
44290558|NCT00211536|79254355|FG001|Overall Study|Physician Decision|5|||
44290559|NCT00211536|79254354|FG000|Overall Study|Adverse Event|2|||
44290560|NCT00211536|79254355|FG001|Overall Study|Adverse Event|0|||
44290561|NCT03192462|79254407|FG000|Overall Study|Death|13|||
44290562|NCT03192462|79254408|FG001|Overall Study|Death|11|||
44290563|NCT03192462|79254409|FG002|Overall Study|Death|9|||
44290564|NCT03192462|79254407|FG000|Overall Study|Lost to Follow-up|0|||
44290565|NCT03192462|79254408|FG001|Overall Study|Lost to Follow-up|1|||
44290566|NCT03192462|79254409|FG002|Overall Study|Lost to Follow-up|0|||
44290567|NCT03192462|79254407|FG000|Overall Study|On follow up|0|||
44290568|NCT03192462|79254408|FG001|Overall Study|On follow up|0|||
44290569|NCT03192462|79254409|FG002|Overall Study|On follow up|3|||
44290570|NCT03589326|79254419|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
44290571|NCT03589326|79254420|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
44290572|NCT03589326|79254419|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
44290573|NCT03589326|79254420|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
44290574|NCT03589326|79254419|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
44290575|NCT03589326|79254420|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
44290576|NCT03589326|79254419|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
44290577|NCT03589326|79254420|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
44290578|NCT03589326|79254419|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
44290579|NCT03589326|79254420|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
44290580|NCT03028740|79254441|FG000|Overall Study|Did not Receive Study Drug|4|||
44290581|NCT03028740|79254442|FG001|Overall Study|Did not Receive Study Drug|5|||
44290582|NCT03028740|79254441|FG000|Overall Study|Adverse Event|8|||
44533664|NCT03043313|79543995|FG002|Overall Study|In follow up|11|||
44533665|NCT02834780|79544015|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
44533666|NCT02834780|79544016|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
44533667|NCT02834780|79544017|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
44290583|NCT03028740|79254442|FG001|Overall Study|Adverse Event|26|||
44290584|NCT03028740|79254441|FG000|Overall Study|Lack of Efficacy|0|||
44290585|NCT03028740|79254442|FG001|Overall Study|Lack of Efficacy|1|||
44290586|NCT03028740|79254441|FG000|Overall Study|Withdrawal by Subject|48|||
44290587|NCT03028740|79254442|FG001|Overall Study|Withdrawal by Subject|101|||
44290588|NCT03028740|79254441|FG000|Overall Study|Lost to Follow-up|30|||
44290589|NCT03028740|79254442|FG001|Overall Study|Lost to Follow-up|54|||
44290590|NCT03028740|79254441|FG000|Overall Study|Physician Decision|4|||
44290591|NCT03028740|79254442|FG001|Overall Study|Physician Decision|11|||
44290592|NCT03028740|79254441|FG000|Overall Study|Protocol Violation|4|||
44290593|NCT03028740|79254442|FG001|Overall Study|Protocol Violation|8|||
44290594|NCT03028740|79254441|FG000|Overall Study|Non-compliance with Study Drug|0|||
44290595|NCT03028740|79254442|FG001|Overall Study|Non-compliance with Study Drug|2|||
44290596|NCT03028740|79254441|FG000|Overall Study|Study Terminated by Sponsor|467|||
44290597|NCT03028740|79254442|FG001|Overall Study|Study Terminated by Sponsor|917|||
44290598|NCT03028740|79254441|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
44290599|NCT03028740|79254442|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
44290600|NCT03028740|79254441|FG000|Overall Study|Reason not Specified|1|||
44290601|NCT03028740|79254442|FG001|Overall Study|Reason not Specified|5|||
44290602|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
44416310|NCT00844805|79424060|FG003|Treatment Phase|Withdrawal by Subject|0|||
44533668|NCT02834780|79544018|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
44533669|NCT02834780|79544019|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
44533670|NCT02834780|79544020|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
44533671|NCT02834780|79544021|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
44154537|NCT02687815|78945744|FG001|Overall Study|Lost to Follow-up|4|||
44154538|NCT02687815|78945743|FG000|Overall Study|Withdrawal by Subject|2|||
44290603|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
44290604|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
44416311|NCT00844805|79424057|FG000|Treatment Phase|Noncompliance With Protocol|1|||
44416312|NCT00844805|79424058|FG001|Treatment Phase|Noncompliance With Protocol|0|||
44416313|NCT00844805|79424059|FG002|Treatment Phase|Noncompliance With Protocol|0|||
44416314|NCT00844805|79424060|FG003|Treatment Phase|Noncompliance With Protocol|0|||
44416315|NCT00844805|79424057|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
44416316|NCT00844805|79424058|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
44416317|NCT00844805|79424059|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
44416318|NCT00844805|79424060|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
44416319|NCT00844805|79424057|FG000|Follow-Up Phase|Adverse Event|0|||
44154539|NCT02687815|78945744|FG001|Overall Study|Withdrawal by Subject|4|||
44154540|NCT01959334|78945752|FG000|Second Dose|Adverse Event|1|||
44290605|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
44290606|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
44290607|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
44290608|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
44290609|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
44290610|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
44290611|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
44290612|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
44290613|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
44290614|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
44290615|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
44290616|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
44290617|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
44290618|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
44290619|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
44290620|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
44290621|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
44290622|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
44290623|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
44290624|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
44290625|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
44290626|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
44290627|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Other|1|||
44290628|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Other|0|||
44290629|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Other|0|||
44290630|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Other|0|||
44290631|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Other|1|||
44290632|NCT02980692|79254465|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
44290633|NCT02980692|79254466|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
44290634|NCT02980692|79254467|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
44290635|NCT02980692|79254468|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
44290636|NCT02980692|79254469|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
44290637|NCT02980692|79254465|FG000|Double-blind Follow-up Period|Adverse Event|0|||
44290638|NCT02980692|79254466|FG001|Double-blind Follow-up Period|Adverse Event|0|||
44290639|NCT02980692|79254467|FG002|Double-blind Follow-up Period|Adverse Event|0|||
44290640|NCT02980692|79254468|FG003|Double-blind Follow-up Period|Adverse Event|1|||
44290641|NCT02980692|79254469|FG004|Double-blind Follow-up Period|Adverse Event|1|||
44290642|NCT02980692|79254465|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
44290643|NCT02980692|79254466|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
44290644|NCT02980692|79254467|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
44290645|NCT02980692|79254468|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
44290646|NCT02980692|79254469|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
44290647|NCT02980692|79254465|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
44290648|NCT02980692|79254466|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
44290649|NCT02980692|79254467|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
44290650|NCT02980692|79254468|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
44290651|NCT02980692|79254469|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
44290652|NCT02980692|79254465|FG000|Double-blind Follow-up Period|Pregnancy|0|||
44290653|NCT02980692|79254466|FG001|Double-blind Follow-up Period|Pregnancy|0|||
44290654|NCT02980692|79254467|FG002|Double-blind Follow-up Period|Pregnancy|1|||
44290655|NCT02980692|79254468|FG003|Double-blind Follow-up Period|Pregnancy|1|||
44290656|NCT02980692|79254469|FG004|Double-blind Follow-up Period|Pregnancy|0|||
44290657|NCT02980692|79254465|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
44290658|NCT02980692|79254466|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
44416320|NCT00844805|79424058|FG001|Follow-Up Phase|Adverse Event|0|||
44533672|NCT02834780|79544022|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
44533673|NCT02834780|79544023|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
44533674|NCT02834780|79544024|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
44533675|NCT02834780|79544025|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
44533676|NCT02834780|79544026|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
44533677|NCT02834780|79544027|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
44533678|NCT02834780|79544015|FG000|Overall Study|Withdrawal by Subject|0|||
44533679|NCT02834780|79544016|FG001|Overall Study|Withdrawal by Subject|0|||
44533680|NCT02834780|79544017|FG002|Overall Study|Withdrawal by Subject|1|||
44533681|NCT02834780|79544018|FG003|Overall Study|Withdrawal by Subject|0|||
44533682|NCT02834780|79544019|FG004|Overall Study|Withdrawal by Subject|0|||
44154541|NCT01959334|78945753|FG001|Second Dose|Adverse Event|0|||
44290659|NCT02980692|79254467|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
44290660|NCT02980692|79254468|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
44290661|NCT02980692|79254469|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
44290662|NCT02980692|79254465|FG000|Double-blind Follow-up Period|Other|0|||
44290663|NCT02980692|79254466|FG001|Double-blind Follow-up Period|Other|0|||
44290664|NCT02980692|79254467|FG002|Double-blind Follow-up Period|Other|1|||
44290665|NCT02980692|79254468|FG003|Double-blind Follow-up Period|Other|1|||
44290666|NCT02980692|79254469|FG004|Double-blind Follow-up Period|Other|3|||
44290667|NCT04439279|79254732|FG000|Overall Study|Adverse Event|7|||
44290668|NCT04439279|79254732|FG000|Overall Study|Death|4|||
44290669|NCT04439279|79254732|FG000|Overall Study|Disease progression|17|||
44290670|NCT04439279|79254732|FG000|Overall Study|Complicating disease|3|||
44290671|NCT04439279|79254732|FG000|Overall Study|Withdrawal by Subject|2|||
44290672|NCT04439279|79254732|FG000|Overall Study|Ineligible|1|||
44290673|NCT04439279|79254732|FG000|Overall Study|Treatment still ongoing|1|||
44290674|NCT04123548|79254762|FG000|Overall Study|Withdrawal by Subject|1|||
44290675|NCT04123548|79254762|FG000|Overall Study|Lost to Follow-up|8|||
44290676|NCT04123548|79254762|FG000|Overall Study|Death|4|||
44290677|NCT04123548|79254762|FG000|Overall Study|Reason Not Specified|1|||
44290678|NCT04022733|79254768|FG000|Overall Study|conversion to open surgery|3|||
44290679|NCT04022733|79254769|FG001|Overall Study|conversion to open surgery|2|||
44290680|NCT04022733|79254768|FG000|Overall Study|bradycardia|0|||
44290681|NCT04022733|79254769|FG001|Overall Study|bradycardia|1|||
44290682|NCT03593915|79254798|FG000|Overall Study|Adverse Event|0|||
44290683|NCT03593915|79254799|FG001|Overall Study|Adverse Event|0|||
44290684|NCT03593915|79254800|FG002|Overall Study|Adverse Event|0|||
44290685|NCT03593915|79254801|FG003|Overall Study|Adverse Event|1|||
44290686|NCT03593915|79254802|FG004|Overall Study|Adverse Event|0|||
44290687|NCT03593915|79254803|FG005|Overall Study|Adverse Event|0|||
44290688|NCT03593915|79254798|FG000|Overall Study|Physician Decision|0|||
44290689|NCT03593915|79254799|FG001|Overall Study|Physician Decision|0|||
44290690|NCT03593915|79254800|FG002|Overall Study|Physician Decision|0|||
44290691|NCT03593915|79254801|FG003|Overall Study|Physician Decision|0|||
44290692|NCT03593915|79254802|FG004|Overall Study|Physician Decision|0|||
44290693|NCT03593915|79254803|FG005|Overall Study|Physician Decision|1|||
44533683|NCT02834780|79544020|FG005|Overall Study|Withdrawal by Subject|0|||
44533684|NCT02834780|79544021|FG006|Overall Study|Withdrawal by Subject|0|||
44290696|NCT03336333|79254839|FG000|Overall Study|Remained on study at time of data cut-off|202|||
44290697|NCT03336333|79254840|FG001|Overall Study|Remained on study at time of data cut-off|219|||
44290698|NCT03336333|79254841|FG002|Overall Study|Remained on study at time of data cut-off|102|||
44290699|NCT03336333|79254839|FG000|Overall Study|Death|14|||
44290700|NCT03336333|79254840|FG001|Overall Study|Death|16|||
44290701|NCT03336333|79254841|FG002|Overall Study|Death|8|||
44290702|NCT03336333|79254839|FG000|Overall Study|Withdrawal by Subject|16|||
44290703|NCT03336333|79254840|FG001|Overall Study|Withdrawal by Subject|5|||
44290704|NCT03336333|79254841|FG002|Overall Study|Withdrawal by Subject|1|||
44290705|NCT03336333|79254839|FG000|Overall Study|Physician Decision|5|||
44290706|NCT03336333|79254840|FG001|Overall Study|Physician Decision|1|||
44290707|NCT03336333|79254841|FG002|Overall Study|Physician Decision|0|||
44290708|NCT03336333|79254839|FG000|Overall Study|Lost to Follow-up|1|||
44290709|NCT03336333|79254840|FG001|Overall Study|Lost to Follow-up|0|||
44290710|NCT03336333|79254841|FG002|Overall Study|Lost to Follow-up|0|||
44290711|NCT03240874|79254852|FG000|Overall Study|Lost to Follow-up|0|||
44290712|NCT03240874|79254853|FG001|Overall Study|Lost to Follow-up|2|||
44290713|NCT03240874|79254854|FG002|Overall Study|Lost to Follow-up|4|||
44290714|NCT03240874|79254855|FG003|Overall Study|Lost to Follow-up|1|||
44290715|NCT03083665|79254866|FG000|Double-Blind Period|Adverse Event|5|||
44290716|NCT03083665|79254867|FG001|Double-Blind Period|Adverse Event|4|||
44290717|NCT03083665|79254868|FG002|Double-Blind Period|Adverse Event|5|||
44290718|NCT03083665|79254869|FG003|Double-Blind Period|Adverse Event|0|||
44290719|NCT03083665|79254870|FG004|Double-Blind Period|Adverse Event|0|||
44290720|NCT03083665|79254871|FG005|Double-Blind Period|Adverse Event|0|||
44290721|NCT03083665|79254866|FG000|Double-Blind Period|Lack of Efficacy|0|||
44290722|NCT03083665|79254867|FG001|Double-Blind Period|Lack of Efficacy|0|||
44290723|NCT03083665|79254868|FG002|Double-Blind Period|Lack of Efficacy|1|||
44533685|NCT02834780|79544022|FG007|Overall Study|Withdrawal by Subject|0|||
44290724|NCT03083665|79254869|FG003|Double-Blind Period|Lack of Efficacy|0|||
44290725|NCT03083665|79254870|FG004|Double-Blind Period|Lack of Efficacy|0|||
44290726|NCT03083665|79254871|FG005|Double-Blind Period|Lack of Efficacy|0|||
44290727|NCT03083665|79254866|FG000|Double-Blind Period|Protocol Violation|1|||
44290728|NCT03083665|79254867|FG001|Double-Blind Period|Protocol Violation|0|||
44290729|NCT03083665|79254868|FG002|Double-Blind Period|Protocol Violation|1|||
44290730|NCT03083665|79254869|FG003|Double-Blind Period|Protocol Violation|0|||
44290731|NCT03083665|79254870|FG004|Double-Blind Period|Protocol Violation|0|||
44290732|NCT03083665|79254871|FG005|Double-Blind Period|Protocol Violation|0|||
44290733|NCT03083665|79254866|FG000|Double-Blind Period|Lost to Follow-up|1|||
44290734|NCT03083665|79254867|FG001|Double-Blind Period|Lost to Follow-up|0|||
44290735|NCT03083665|79254868|FG002|Double-Blind Period|Lost to Follow-up|1|||
44290736|NCT03083665|79254869|FG003|Double-Blind Period|Lost to Follow-up|0|||
44290737|NCT03083665|79254870|FG004|Double-Blind Period|Lost to Follow-up|0|||
44290738|NCT03083665|79254871|FG005|Double-Blind Period|Lost to Follow-up|0|||
44290739|NCT03083665|79254866|FG000|Double-Blind Period|Withdrawal by Subject|3|||
44290740|NCT03083665|79254867|FG001|Double-Blind Period|Withdrawal by Subject|0|||
44290741|NCT03083665|79254868|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44290742|NCT03083665|79254869|FG003|Double-Blind Period|Withdrawal by Subject|0|||
44290743|NCT03083665|79254870|FG004|Double-Blind Period|Withdrawal by Subject|0|||
44290744|NCT03083665|79254871|FG005|Double-Blind Period|Withdrawal by Subject|0|||
44290745|NCT03083665|79254866|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
44290746|NCT03083665|79254867|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
44290747|NCT03083665|79254868|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
44290748|NCT03083665|79254869|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
44290749|NCT03083665|79254870|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
44290750|NCT03083665|79254871|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
44290751|NCT03083665|79254866|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
44290752|NCT03083665|79254867|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
44290753|NCT03083665|79254868|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
44290754|NCT03083665|79254869|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
44290755|NCT03083665|79254870|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
44290756|NCT03083665|79254871|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
44290757|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
44290758|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
44290759|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
44290760|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
44290761|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
44290762|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
44290763|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
44290764|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
44290765|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
44290766|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
44290767|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
44290768|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
44290769|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
44290770|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
44290771|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
44290772|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
44416321|NCT00844805|79424059|FG002|Follow-Up Phase|Adverse Event|1|||
44416322|NCT00844805|79424060|FG003|Follow-Up Phase|Adverse Event|0|||
44416323|NCT00844805|79424057|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
44416324|NCT00844805|79424058|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
44416325|NCT00844805|79424059|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
44416326|NCT00844805|79424060|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
44416327|NCT00844805|79424057|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
44416328|NCT00844805|79424058|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
44416329|NCT00844805|79424059|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
44416330|NCT00844805|79424060|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
44416331|NCT00844805|79424057|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
44290773|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
44290774|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
44290775|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
44290776|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
44290777|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
44290778|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
44290779|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
44290780|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
44290781|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
44290782|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
44290783|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
44290784|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
44416332|NCT00844805|79424058|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
44416333|NCT00844805|79424059|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
44416334|NCT00844805|79424060|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
44416335|NCT00844805|79424057|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
44290785|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
44290786|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
44290787|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
44290788|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
44290789|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
44290790|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
44290791|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
44290792|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
44290793|NCT03083665|79254866|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
44290794|NCT03083665|79254867|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
44290795|NCT03083665|79254868|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
44290796|NCT03083665|79254869|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
44290797|NCT03083665|79254870|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
44290798|NCT03083665|79254871|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
44290799|NCT03045276|79254892|FG000|Intervention Phase|Withdrawal by Subject|7|||
44290800|NCT03045276|79254893|FG001|Intervention Phase|Withdrawal by Subject|2|||
44290801|NCT03045276|79254894|FG002|Intervention Phase|Withdrawal by Subject|3|||
44290802|NCT03045276|79254895|FG003|Intervention Phase|Withdrawal by Subject|7|||
44290803|NCT03045276|79254892|FG000|Intervention Phase|Developed exclusionary criteria|3|||
44290804|NCT03045276|79254893|FG001|Intervention Phase|Developed exclusionary criteria|3|||
44290805|NCT03045276|79254894|FG002|Intervention Phase|Developed exclusionary criteria|0|||
44290806|NCT03045276|79254895|FG003|Intervention Phase|Developed exclusionary criteria|0|||
44290807|NCT03045276|79254892|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
44290808|NCT03045276|79254893|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
44290809|NCT03045276|79254894|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
44290810|NCT03045276|79254895|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
44290811|NCT03045276|79254892|FG000|Follow-Up Phase|Lost to Follow-up|0|||
44290812|NCT03045276|79254893|FG001|Follow-Up Phase|Lost to Follow-up|1|||
44290813|NCT03045276|79254894|FG002|Follow-Up Phase|Lost to Follow-up|0|||
44290814|NCT03045276|79254895|FG003|Follow-Up Phase|Lost to Follow-up|1|||
44290815|NCT03045276|79254892|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
44290816|NCT03045276|79254893|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
44290817|NCT03045276|79254894|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
44290818|NCT03045276|79254895|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
44290819|NCT02819518|79254927|FG000|Overall Study|Death|9|||
44290820|NCT02819518|79254928|FG001|Overall Study|Death|11|||
44290821|NCT02819518|79254929|FG002|Overall Study|Death|9|||
44290822|NCT02819518|79254930|FG003|Overall Study|Death|447|||
44290823|NCT02819518|79254931|FG004|Overall Study|Death|233|||
44290824|NCT02819518|79254927|FG000|Overall Study|Withdrawal by Subject|0|||
44290825|NCT02819518|79254928|FG001|Overall Study|Withdrawal by Subject|0|||
44290826|NCT02819518|79254929|FG002|Overall Study|Withdrawal by Subject|0|||
44290827|NCT02819518|79254930|FG003|Overall Study|Withdrawal by Subject|21|||
44290828|NCT02819518|79254931|FG004|Overall Study|Withdrawal by Subject|6|||
44290829|NCT02819518|79254927|FG000|Overall Study|Ongoing in Study|2|||
44290830|NCT02819518|79254928|FG001|Overall Study|Ongoing in Study|3|||
44290831|NCT02819518|79254929|FG002|Overall Study|Ongoing in Study|1|||
44290832|NCT02819518|79254930|FG003|Overall Study|Ongoing in Study|98|||
44290833|NCT02819518|79254931|FG004|Overall Study|Ongoing in Study|42|||
44290834|NCT02661022|79254947|FG000|Overall Study|Withdrawal by Subject|3|||
44290835|NCT02661022|79254948|FG001|Overall Study|Withdrawal by Subject|0|||
44290836|NCT02661022|79254947|FG000|Overall Study|Adverse Event|1|||
44290837|NCT02661022|79254948|FG001|Overall Study|Adverse Event|1|||
44290838|NCT02661022|79254947|FG000|Overall Study|Physician Decision|1|||
44290839|NCT02661022|79254948|FG001|Overall Study|Physician Decision|0|||
44290840|NCT02661022|79254947|FG000|Overall Study|Progressive Disease|2|||
44290841|NCT02661022|79254948|FG001|Overall Study|Progressive Disease|1|||
44290842|NCT02475681|79254959|FG000|Overall Study|Death|16|||
44290843|NCT02475681|79254960|FG001|Overall Study|Death|6|||
44290844|NCT02475681|79254961|FG002|Overall Study|Death|9|||
44290845|NCT02475681|79254959|FG000|Overall Study|Physician Decision|0|||
44290846|NCT02475681|79254960|FG001|Overall Study|Physician Decision|3|||
44290847|NCT02475681|79254961|FG002|Overall Study|Physician Decision|1|||
44290848|NCT02475681|79254959|FG000|Overall Study|Withdrawal by Subject|12|||
44290849|NCT02475681|79254960|FG001|Overall Study|Withdrawal by Subject|6|||
44290850|NCT02475681|79254961|FG002|Overall Study|Withdrawal by Subject|9|||
44290851|NCT02475681|79254959|FG000|Overall Study|Lost to Follow-up|2|||
44290852|NCT02475681|79254960|FG001|Overall Study|Lost to Follow-up|1|||
44290853|NCT02475681|79254961|FG002|Overall Study|Lost to Follow-up|3|||
44290854|NCT02475681|79254959|FG000|Overall Study|Ongoing in Study|0|||
44290855|NCT02475681|79254960|FG001|Overall Study|Ongoing in Study|163|||
44290856|NCT02475681|79254961|FG002|Overall Study|Ongoing in Study|157|||
44290857|NCT02475681|79254959|FG000|Overall Study|Reasons other than above listed|2|||
44290858|NCT02475681|79254960|FG001|Overall Study|Reasons other than above listed|0|||
44290859|NCT02475681|79254961|FG002|Overall Study|Reasons other than above listed|0|||
44290860|NCT01901562|79254986|FG000|Overall Study|Protocol Violation|5|||
44290861|NCT01901562|79254986|FG000|Overall Study|Excluded intraoperatively|4|||
44290862|NCT00819247|79254993|FG000|Overall Study|Adverse Event|0|||
44290863|NCT00819247|79254994|FG001|Overall Study|Adverse Event|5|||
44290864|NCT00819247|79254995|FG002|Overall Study|Adverse Event|3|||
44290865|NCT00819247|79254993|FG000|Overall Study|Insufficient testosterone response|5|||
44290866|NCT00819247|79254994|FG001|Overall Study|Insufficient testosterone response|8|||
44290867|NCT00819247|79254995|FG002|Overall Study|Insufficient testosterone response|10|||
44290868|NCT00819247|79254993|FG000|Overall Study|Withdrawal by Subject|1|||
44290869|NCT00819247|79254994|FG001|Overall Study|Withdrawal by Subject|0|||
44290870|NCT00819247|79254995|FG002|Overall Study|Withdrawal by Subject|0|||
44290871|NCT00819247|79254993|FG000|Overall Study|Protocol Violation|1|||
44290872|NCT00819247|79254994|FG001|Overall Study|Protocol Violation|0|||
44290873|NCT00819247|79254995|FG002|Overall Study|Protocol Violation|1|||
44290874|NCT00819247|79254993|FG000|Overall Study|Mistakenly withdrawn|0|||
44290875|NCT00819247|79254994|FG001|Overall Study|Mistakenly withdrawn|1|||
44290876|NCT00819247|79254995|FG002|Overall Study|Mistakenly withdrawn|0|||
44290877|NCT00819247|79254993|FG000|Overall Study|Bad prostate-specific antigen response|3|||
44290878|NCT00819247|79254994|FG001|Overall Study|Bad prostate-specific antigen response|2|||
44290879|NCT00819247|79254995|FG002|Overall Study|Bad prostate-specific antigen response|0|||
44290880|NCT00819247|79254993|FG000|Overall Study|Other|1|||
44290881|NCT00819247|79254994|FG001|Overall Study|Other|0|||
44290882|NCT00819247|79254995|FG002|Overall Study|Other|0|||
44290883|NCT00716976|79255005|FG000|Overall Study|Adverse Event|2|||
44290884|NCT00716976|79255006|FG001|Overall Study|Adverse Event|0|||
44290885|NCT00716976|79255005|FG000|Overall Study|Death|1|||
44290886|NCT00716976|79255006|FG001|Overall Study|Death|0|||
44290887|NCT00716976|79255005|FG000|Overall Study|Physician Decision|2|||
44290888|NCT00716976|79255006|FG001|Overall Study|Physician Decision|2|||
44290889|NCT00716976|79255005|FG000|Overall Study|Withdrawal by Subject|5|||
44290890|NCT00716976|79255006|FG001|Overall Study|Withdrawal by Subject|1|||
44290891|NCT00716976|79255005|FG000|Overall Study|Premature discontinuation cisplatin|5|||
44290892|NCT00716976|79255006|FG001|Overall Study|Premature discontinuation cisplatin|4|||
44290893|NCT00716976|79255005|FG000|Overall Study|Radiation during protocol|1|||
44290894|NCT00716976|79255006|FG001|Overall Study|Radiation during protocol|0|||
44290895|NCT00716976|79255005|FG000|Overall Study|Ineligibles|4|||
44290896|NCT00716976|79255006|FG001|Overall Study|Ineligibles|2|||
44290897|NCT00089778|79255128|FG000|Overall Study|Protocol Violation|0|||
44290898|NCT00089778|79255129|FG001|Overall Study|Protocol Violation|0|||
44290899|NCT00089778|79255130|FG002|Overall Study|Protocol Violation|1|||
44290900|NCT00089544|79255142|FG000|Overall Study|Ineligible|1|||
44290901|NCT00089544|79255143|FG001|Overall Study|Ineligible|0|||
44290902|NCT00089076|79255149|FG000|Overall Study|Alternate Therapy|1|||
44290903|NCT00089076|79255149|FG000|Overall Study|Withdrawal by Subject|2|||
44290904|NCT00089076|79255149|FG000|Overall Study|Progression|7|||
44290905|NCT00088374|79255153|FG000|Overall Study|patient did not receive any 17AAG|1|||
44290906|NCT00088374|79255153|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
44290907|NCT00087594|79255159|FG000|Overall Study|Adverse Event|2|||
44290908|NCT00087594|79255160|FG001|Overall Study|Adverse Event|3|||
44290909|NCT00087594|79255159|FG000|Overall Study|Lost to Follow-up|0|||
44290910|NCT00087594|79255160|FG001|Overall Study|Lost to Follow-up|2|||
44290911|NCT00087594|79255159|FG000|Overall Study|Withdrawal by Subject|4|||
44290912|NCT00087594|79255160|FG001|Overall Study|Withdrawal by Subject|2|||
44290913|NCT00087594|79255159|FG000|Overall Study|Lack of Efficacy|2|||
44290914|NCT00087594|79255160|FG001|Overall Study|Lack of Efficacy|5|||
44290915|NCT00087516|79255169|FG000|Overall Study|Adverse Event|10|||
44290916|NCT00087516|79255170|FG001|Overall Study|Adverse Event|10|||
44290917|NCT00087516|79255171|FG002|Overall Study|Adverse Event|3|||
44416336|NCT00844805|79424058|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
44416337|NCT00844805|79424059|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
44416338|NCT00844805|79424060|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
44416339|NCT00765999|79424071|FG000|Overall Study|Adverse Event|203|||
44290918|NCT00087516|79255172|FG003|Overall Study|Adverse Event|6|||
44290919|NCT00087516|79255169|FG000|Overall Study|Lack of Efficacy|82|||
44290920|NCT00087516|79255170|FG001|Overall Study|Lack of Efficacy|80|||
44290921|NCT00087516|79255171|FG002|Overall Study|Lack of Efficacy|39|||
44290922|NCT00087516|79255172|FG003|Overall Study|Lack of Efficacy|29|||
44290923|NCT00087516|79255169|FG000|Overall Study|Lost to Follow-up|8|||
44290924|NCT00087516|79255170|FG001|Overall Study|Lost to Follow-up|6|||
44290925|NCT00087516|79255171|FG002|Overall Study|Lost to Follow-up|5|||
44290926|NCT00087516|79255172|FG003|Overall Study|Lost to Follow-up|5|||
44290927|NCT00087516|79255169|FG000|Overall Study|Protocol Violation|4|||
44290928|NCT00087516|79255170|FG001|Overall Study|Protocol Violation|8|||
44290929|NCT00087516|79255171|FG002|Overall Study|Protocol Violation|3|||
44290930|NCT00087516|79255172|FG003|Overall Study|Protocol Violation|6|||
44290931|NCT00087516|79255169|FG000|Overall Study|Withdrawal by Subject|16|||
44290932|NCT00087516|79255170|FG001|Overall Study|Withdrawal by Subject|27|||
44290933|NCT00087516|79255171|FG002|Overall Study|Withdrawal by Subject|11|||
44290934|NCT00087516|79255172|FG003|Overall Study|Withdrawal by Subject|12|||
44290935|NCT00087516|79255169|FG000|Overall Study|Site terminated|0|||
44290936|NCT00087516|79255170|FG001|Overall Study|Site terminated|2|||
44290937|NCT00087516|79255171|FG002|Overall Study|Site terminated|1|||
44290938|NCT00087516|79255172|FG003|Overall Study|Site terminated|0|||
44290939|NCT00087516|79255169|FG000|Overall Study|Protocol specified discontinuation|35|||
44290940|NCT00087516|79255170|FG001|Overall Study|Protocol specified discontinuation|33|||
44290941|NCT00087516|79255171|FG002|Overall Study|Protocol specified discontinuation|33|||
44290942|NCT00087516|79255172|FG003|Overall Study|Protocol specified discontinuation|26|||
44290943|NCT00087516|79255169|FG000|Overall Study|Patient moved|3|||
44290944|NCT00087516|79255170|FG001|Overall Study|Patient moved|2|||
44290945|NCT00087516|79255171|FG002|Overall Study|Patient moved|1|||
44290946|NCT00087516|79255172|FG003|Overall Study|Patient moved|0|||
44290947|NCT00087516|79255169|FG000|Overall Study|Patient was non-compliant|3|||
44290948|NCT00087516|79255170|FG001|Overall Study|Patient was non-compliant|1|||
44290949|NCT00087516|79255171|FG002|Overall Study|Patient was non-compliant|0|||
44290950|NCT00087516|79255172|FG003|Overall Study|Patient was non-compliant|0|||
44290951|NCT00087516|79255169|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
44290952|NCT00087516|79255170|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
44290953|NCT00087516|79255171|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
44290954|NCT00087516|79255172|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
44290955|NCT00087516|79255169|FG000|Overall Study|Other|0|||
44290956|NCT00087516|79255170|FG001|Overall Study|Other|0|||
44290957|NCT00087516|79255171|FG002|Overall Study|Other|1|||
44290958|NCT00087516|79255172|FG003|Overall Study|Other|0|||
44290959|NCT00087126|79255186|FG000|Overall Study|Ineligible - second primary|1|||
44290960|NCT00087126|79255186|FG000|Overall Study|Never treated|1|||
44290961|NCT03490734|79255199|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
44290962|NCT03490734|79255200|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
44290963|NCT03490734|79255201|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
44290964|NCT03490734|79255202|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
44290965|NCT03490734|79255199|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
44290966|NCT03490734|79255200|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
44290967|NCT03490734|79255201|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
44290968|NCT03490734|79255202|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
44290969|NCT03490734|79255199|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
44290970|NCT03490734|79255200|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
44290971|NCT03490734|79255201|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
44290972|NCT03490734|79255202|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
44290973|NCT03490734|79255199|FG000|Post-intervention Scan Visit|Adverse Event|2|||
44290974|NCT03490734|79255200|FG001|Post-intervention Scan Visit|Adverse Event|0|||
44290975|NCT03490734|79255201|FG002|Post-intervention Scan Visit|Adverse Event|0|||
44290976|NCT03490734|79255202|FG003|Post-intervention Scan Visit|Adverse Event|0|||
44290977|NCT03490734|79255199|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
44290978|NCT03490734|79255200|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
44290979|NCT03490734|79255201|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
44290980|NCT03490734|79255202|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
44290981|NCT03490734|79255199|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
44290982|NCT03490734|79255200|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
44290983|NCT03490734|79255201|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
44290984|NCT03490734|79255202|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
44290985|NCT00086346|79255213|FG000|Randomization|Did not receive test article|4|||
44290986|NCT00086346|79255214|FG001|Randomization|Did not receive test article|4|||
44290987|NCT00086346|79255213|FG000|Patients Dosed With Test Article|Adverse Event|94|||
44290988|NCT00086346|79255214|FG001|Patients Dosed With Test Article|Adverse Event|11|||
44290989|NCT00086346|79255213|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
44290990|NCT00086346|79255214|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
44290991|NCT00086346|79255213|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
44290992|NCT00086346|79255214|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
44290993|NCT00086346|79255213|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
44290994|NCT00086346|79255214|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
44290995|NCT00086346|79255213|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
44290996|NCT00086346|79255214|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
44290997|NCT00086346|79255213|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
44533686|NCT02834780|79544023|FG008|Overall Study|Withdrawal by Subject|0|||
44533687|NCT02834780|79544024|FG009|Overall Study|Withdrawal by Subject|0|||
44290998|NCT00086346|79255214|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
44290999|NCT00085566|79255223|FG000|Overall Study|Adverse Event|0|||
44291000|NCT00085566|79255224|FG001|Overall Study|Adverse Event|0|||
44533688|NCT02834780|79544025|FG010|Overall Study|Withdrawal by Subject|1|||
44291001|NCT00085566|79255225|FG002|Overall Study|Adverse Event|10|||
44291002|NCT00085566|79255223|FG000|Overall Study|Patient Not treated|0|||
44291003|NCT00085566|79255224|FG001|Overall Study|Patient Not treated|0|||
44291004|NCT00085566|79255225|FG002|Overall Study|Patient Not treated|3|||
44291005|NCT00085566|79255223|FG000|Overall Study|Clinical progression|0|||
44291006|NCT00085566|79255224|FG001|Overall Study|Clinical progression|0|||
44291007|NCT00085566|79255225|FG002|Overall Study|Clinical progression|1|||
44291008|NCT00085098|79255235|FG000|Overall Study|Withdrawal by Subject|0|||
44291009|NCT00085098|79255236|FG001|Overall Study|Withdrawal by Subject|1|||
44291010|NCT00085098|79255235|FG000|Overall Study|Ineligible|1|||
44291011|NCT00085098|79255236|FG001|Overall Study|Ineligible|1|||
44291012|NCT00084864|79255249|FG000|Overall Study|Adverse Event|1|||
44291013|NCT00084864|79255250|FG001|Overall Study|Adverse Event|0|||
44291014|NCT00084864|79255251|FG002|Overall Study|Adverse Event|0|||
44291015|NCT00084864|79255252|FG003|Overall Study|Adverse Event|0|||
44291016|NCT00084318|79255264|FG000|Overall Study|Withdrawal by Subject|5|||
44291017|NCT00084318|79255265|FG001|Overall Study|Withdrawal by Subject|2|||
44291018|NCT00084318|79255264|FG000|Overall Study|Protocol Violation|15|||
44291019|NCT00084318|79255265|FG001|Overall Study|Protocol Violation|11|||
44291020|NCT00084318|79255264|FG000|Overall Study|No protocol treatment|2|||
44291021|NCT00084318|79255265|FG001|Overall Study|No protocol treatment|0|||
44291022|NCT00084084|79255273|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
44291023|NCT00084084|79255273|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
44291024|NCT00083616|79255278|FG000|Overall Study|Disease Progression|16|||
44291025|NCT00083616|79255278|FG000|Overall Study|Lost to Follow-up|1|||
44291026|NCT00083616|79255278|FG000|Overall Study|Physician Decision|2|||
44291027|NCT00083616|79255278|FG000|Overall Study|Withdrawal by Subject|3|||
44291028|NCT00083616|79255278|FG000|Overall Study|Ineligibility determined|2|||
44291029|NCT00083616|79255278|FG000|Overall Study|Non-compliance|1|||
44291030|NCT00083616|79255278|FG000|Overall Study|Other|6|||
44291031|NCT00083226|79255282|FG000|Overall Study|Lack of Efficacy|19|||
44291032|NCT00083226|79255282|FG000|Overall Study|Adverse Event|9|||
44291033|NCT00083226|79255282|FG000|Overall Study|Death|4|||
44291034|NCT00083226|79255282|FG000|Overall Study|Withdrawal by Subject|4|||
44291035|NCT00083226|79255282|FG000|Overall Study|Other|2|||
44291036|NCT00083226|79255282|FG000|Overall Study|ineligible or not receiving treatment|4|||
44291037|NCT00082758|79255289|FG000|Overall Study|Adverse Event|0|||
44291038|NCT00082758|79255290|FG001|Overall Study|Adverse Event|2|||
44291039|NCT00082758|79255291|FG002|Overall Study|Adverse Event|0|||
44291040|NCT00082758|79255289|FG000|Overall Study|Lack of Efficacy|12|||
44291041|NCT00082758|79255290|FG001|Overall Study|Lack of Efficacy|13|||
44291042|NCT00082758|79255291|FG002|Overall Study|Lack of Efficacy|0|||
44291043|NCT00082758|79255289|FG000|Overall Study|Physician Decision|0|||
44291044|NCT00082758|79255290|FG001|Overall Study|Physician Decision|1|||
44291045|NCT00082758|79255291|FG002|Overall Study|Physician Decision|0|||
44291046|NCT00082758|79255289|FG000|Overall Study|Withdrawal by Subject|3|||
44291047|NCT00082758|79255290|FG001|Overall Study|Withdrawal by Subject|0|||
44291048|NCT00082758|79255291|FG002|Overall Study|Withdrawal by Subject|0|||
44291049|NCT00082758|79255289|FG000|Overall Study|Protocol Violation|0|||
44291050|NCT00082758|79255290|FG001|Overall Study|Protocol Violation|1|||
44291051|NCT00082758|79255291|FG002|Overall Study|Protocol Violation|0|||
44291052|NCT00088452|79255302|FG000|Overall Study|Did not receive intervention|1|||
44291053|NCT00088452|79255303|FG001|Overall Study|Did not receive intervention|0|||
44291054|NCT00088452|79255304|FG002|Overall Study|Did not receive intervention|1|||
44291055|NCT03406104|79255332|FG000|Overall Study|Lost to Follow-up|2|||
44291056|NCT03406104|79255332|FG000|Overall Study|Withdrawal by Subject|2|||
44291057|NCT03406104|79255332|FG000|Overall Study|due to Covid patient did not want to travel|1|||
44291058|NCT03406104|79255332|FG000|Overall Study|Death|2|||
44291059|NCT04686084|79255401|FG000|Overall Study|Lost to Follow-up|1|||
44291060|NCT04685538|79255408|FG000|Overall Study|Adverse Event|0|||
44291061|NCT04685538|79255409|FG001|Overall Study|Adverse Event|1|||
44291062|NCT04685538|79255408|FG000|Overall Study|Lost to Follow-up|0|||
44291063|NCT04685538|79255409|FG001|Overall Study|Lost to Follow-up|2|||
44291064|NCT04213326|79255421|FG000|Overall Study|Consent withdrawn|51|||
44291065|NCT04213326|79255422|FG001|Overall Study|Consent withdrawn|241|||
44291066|NCT04213326|79255421|FG000|Overall Study|Lost to Follow-up|50|||
44291067|NCT04213326|79255422|FG001|Overall Study|Lost to Follow-up|902|||
44533689|NCT02834780|79544026|FG011|Overall Study|Withdrawal by Subject|0|||
44533690|NCT02834780|79544027|FG012|Overall Study|Withdrawal by Subject|0|||
44291068|NCT04213326|79255421|FG000|Overall Study|Protocol Violation|3|||
44291069|NCT04213326|79255422|FG001|Overall Study|Protocol Violation|25|||
44291070|NCT04213326|79255421|FG000|Overall Study|Participant eligibility changed|106|||
44291071|NCT04213326|79255422|FG001|Overall Study|Participant eligibility changed|19|||
44533691|NCT02834780|79544015|FG000|Overall Study|Adverse Event|0|||
44533692|NCT02834780|79544016|FG001|Overall Study|Adverse Event|0|||
44291072|NCT04213326|79255421|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
44291073|NCT04213326|79255422|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
44291074|NCT04213326|79255421|FG000|Overall Study|Incomplete study visit|0|||
44291075|NCT04213326|79255422|FG001|Overall Study|Incomplete study visit|367|||
44291076|NCT01625286|79255435|FG000|Overall Study|Adverse Event|0|||
44291077|NCT01625286|79255436|FG001|Overall Study|Adverse Event|0|||
44291078|NCT01625286|79255437|FG002|Overall Study|Adverse Event|0|||
44291079|NCT01625286|79255438|FG003|Overall Study|Adverse Event|0|||
44291080|NCT01625286|79255439|FG004|Overall Study|Adverse Event|1|||
44291081|NCT01625286|79255440|FG005|Overall Study|Adverse Event|2|||
44291082|NCT01625286|79255441|FG006|Overall Study|Adverse Event|1|||
44291083|NCT01625286|79255435|FG000|Overall Study|Death|0|||
44291084|NCT01625286|79255436|FG001|Overall Study|Death|0|||
44291085|NCT01625286|79255437|FG002|Overall Study|Death|1|||
44291086|NCT01625286|79255438|FG003|Overall Study|Death|1|||
44291087|NCT01625286|79255439|FG004|Overall Study|Death|0|||
44291088|NCT01625286|79255440|FG005|Overall Study|Death|11|||
44291089|NCT01625286|79255441|FG006|Overall Study|Death|16|||
44291090|NCT01625286|79255435|FG000|Overall Study|Withdrawal by Subject|0|||
44291091|NCT01625286|79255436|FG001|Overall Study|Withdrawal by Subject|1|||
44291092|NCT01625286|79255437|FG002|Overall Study|Withdrawal by Subject|0|||
44291093|NCT01625286|79255438|FG003|Overall Study|Withdrawal by Subject|1|||
44291094|NCT01625286|79255439|FG004|Overall Study|Withdrawal by Subject|0|||
44291095|NCT01625286|79255440|FG005|Overall Study|Withdrawal by Subject|0|||
44291096|NCT01625286|79255441|FG006|Overall Study|Withdrawal by Subject|1|||
44291097|NCT01625286|79255435|FG000|Overall Study|Any reason not specifically recorded|0|||
44291098|NCT01625286|79255436|FG001|Overall Study|Any reason not specifically recorded|0|||
44291099|NCT01625286|79255437|FG002|Overall Study|Any reason not specifically recorded|0|||
44291100|NCT01625286|79255438|FG003|Overall Study|Any reason not specifically recorded|0|||
44291101|NCT01625286|79255439|FG004|Overall Study|Any reason not specifically recorded|0|||
44291102|NCT01625286|79255440|FG005|Overall Study|Any reason not specifically recorded|1|||
44291103|NCT01625286|79255441|FG006|Overall Study|Any reason not specifically recorded|0|||
44291104|NCT01625286|79255435|FG000|Overall Study|Progressive disease|6|||
44291105|NCT01625286|79255436|FG001|Overall Study|Progressive disease|3|||
44291106|NCT01625286|79255437|FG002|Overall Study|Progressive disease|4|||
44291107|NCT01625286|79255438|FG003|Overall Study|Progressive disease|5|||
44291108|NCT01625286|79255439|FG004|Overall Study|Progressive disease|5|||
44291109|NCT01625286|79255440|FG005|Overall Study|Progressive disease|0|||
44291110|NCT01625286|79255441|FG006|Overall Study|Progressive disease|0|||
44291111|NCT01625286|79255435|FG000|Overall Study|Lost to Follow-up|0|||
44291112|NCT01625286|79255436|FG001|Overall Study|Lost to Follow-up|0|||
44291113|NCT01625286|79255437|FG002|Overall Study|Lost to Follow-up|0|||
44291114|NCT01625286|79255438|FG003|Overall Study|Lost to Follow-up|0|||
44291115|NCT01625286|79255439|FG004|Overall Study|Lost to Follow-up|0|||
44291116|NCT01625286|79255440|FG005|Overall Study|Lost to Follow-up|0|||
44291117|NCT01625286|79255441|FG006|Overall Study|Lost to Follow-up|1|||
44291118|NCT04083222|79255486|FG000|Overall Study|Voluntary Withdrawal|0|||
44291119|NCT04083222|79255487|FG001|Overall Study|Voluntary Withdrawal|1|||
44291120|NCT04083222|79255486|FG000|Overall Study|Reason not Specified|0|||
44291121|NCT04083222|79255487|FG001|Overall Study|Reason not Specified|1|||
44291122|NCT03286842|79255493|FG000|Overall Study|Patients rolled over to another study|80|||
44291123|NCT03037476|79255501|FG000|Overall Study|Lost to Follow-up|63|||
44291124|NCT03037476|79255502|FG001|Overall Study|Lost to Follow-up|46|||
44291125|NCT00639678|79255517|FG000|Overall Study|Withdrawal by Subject|3|||
44291126|NCT00639678|79255518|FG001|Overall Study|Withdrawal by Subject|0|||
44291127|NCT00639678|79255519|FG002|Overall Study|Withdrawal by Subject|4|||
44291128|NCT00639678|79255520|FG003|Overall Study|Withdrawal by Subject|0|||
44291129|NCT00639678|79255517|FG000|Overall Study|Lost to Follow-up|1|||
44291130|NCT00639678|79255518|FG001|Overall Study|Lost to Follow-up|0|||
44291131|NCT00639678|79255519|FG002|Overall Study|Lost to Follow-up|6|||
44291132|NCT00639678|79255520|FG003|Overall Study|Lost to Follow-up|0|||
44291133|NCT00639678|79255517|FG000|Overall Study|Adverse Event|0|||
44291134|NCT00639678|79255518|FG001|Overall Study|Adverse Event|1|||
44291135|NCT00639678|79255519|FG002|Overall Study|Adverse Event|0|||
44291136|NCT00639678|79255520|FG003|Overall Study|Adverse Event|0|||
44291137|NCT00639678|79255517|FG000|Overall Study|Lack of Compliance|0|||
44291138|NCT00639678|79255518|FG001|Overall Study|Lack of Compliance|0|||
44291139|NCT00639678|79255519|FG002|Overall Study|Lack of Compliance|1|||
44291140|NCT00639678|79255520|FG003|Overall Study|Lack of Compliance|0|||
44291141|NCT00638508|79255545|FG000|Overall Study|Physician Decision|5|||
44291142|NCT00638508|79255546|FG001|Overall Study|Physician Decision|2|||
44291143|NCT00637806|79255559|FG000|Double-blind Phase|Study Discontinued|2|||
44291144|NCT00637806|79255560|FG001|Double-blind Phase|Study Discontinued|0|||
44291145|NCT00637806|79255561|FG002|Double-blind Phase|Study Discontinued|1|||
44533693|NCT02834780|79544017|FG002|Overall Study|Adverse Event|0|||
44291146|NCT00637806|79255562|FG003|Double-blind Phase|Study Discontinued|0|||
44291147|NCT00637806|79255559|FG000|Extension Phase|Study Discontinued|0|||
44291148|NCT00637806|79255560|FG001|Extension Phase|Study Discontinued|0|||
44533694|NCT02834780|79544018|FG003|Overall Study|Adverse Event|0|||
44291149|NCT00637806|79255561|FG002|Extension Phase|Study Discontinued|0|||
44291150|NCT00637806|79255562|FG003|Extension Phase|Study Discontinued|1|||
44291151|NCT00637728|79255573|FG000|Double-blind Phase|Adverse Event|1|||
44291152|NCT00637728|79255574|FG001|Double-blind Phase|Adverse Event|0|||
44291153|NCT00637728|79255575|FG002|Double-blind Phase|Adverse Event|0|||
44291154|NCT00637728|79255573|FG000|Double-blind Phase|Non-compliance|2|||
44291155|NCT00637728|79255574|FG001|Double-blind Phase|Non-compliance|0|||
44291156|NCT00637728|79255575|FG002|Double-blind Phase|Non-compliance|0|||
44291157|NCT00637728|79255573|FG000|Double-blind Phase|Study Discontinued|1|||
44291158|NCT00637728|79255574|FG001|Double-blind Phase|Study Discontinued|1|||
44291159|NCT00637728|79255575|FG002|Double-blind Phase|Study Discontinued|0|||
44291160|NCT00637572|79255584|FG000|Overall Study|Adverse Event|1|||
44291161|NCT00637572|79255585|FG001|Overall Study|Adverse Event|2|||
44291162|NCT00637572|79255584|FG000|Overall Study|Death|0|||
44291163|NCT00637572|79255585|FG001|Overall Study|Death|1|||
44291164|NCT00637572|79255584|FG000|Overall Study|Lost to Follow-up|0|||
44291165|NCT00637572|79255585|FG001|Overall Study|Lost to Follow-up|1|||
44291166|NCT00637572|79255584|FG000|Overall Study|Physician Decision|1|||
44291167|NCT00637572|79255585|FG001|Overall Study|Physician Decision|1|||
44291168|NCT00637572|79255584|FG000|Overall Study|Withdrawal by Subject|0|||
44291169|NCT00637572|79255585|FG001|Overall Study|Withdrawal by Subject|2|||
44291170|NCT00637572|79255584|FG000|Overall Study|Illicit Drug Use|1|||
44291171|NCT00637572|79255585|FG001|Overall Study|Illicit Drug Use|0|||
44291172|NCT00637416|79255593|FG000|Overall Study|Lost to Follow-up|1|||
44291173|NCT00637416|79255594|FG001|Overall Study|Lost to Follow-up|1|||
44291174|NCT00637416|79255593|FG000|Overall Study|Unable to take study drug|0|||
44291175|NCT00637416|79255594|FG001|Overall Study|Unable to take study drug|1|||
44291176|NCT00636792|79255600|FG000|Overall Study|Adverse Event|16|||
44291177|NCT00636792|79255600|FG000|Overall Study|Physician Decision|7|||
44291178|NCT00636792|79255600|FG000|Overall Study|Progressive Disease|4|||
44291179|NCT00636792|79255600|FG000|Overall Study|Withdrawal by Subject|3|||
44291180|NCT00636792|79255600|FG000|Overall Study|Other|3|||
44291181|NCT00636636|79255632|FG000|Overall Study|Other reason|4|||
44291182|NCT00636636|79255633|FG001|Overall Study|Other reason|6|||
44291183|NCT00636636|79255632|FG000|Overall Study|Adverse Event|19|||
44291184|NCT00636636|79255633|FG001|Overall Study|Adverse Event|8|||
44291185|NCT00636636|79255632|FG000|Overall Study|Lack of Efficacy|7|||
44291186|NCT00636636|79255633|FG001|Overall Study|Lack of Efficacy|12|||
44291187|NCT00636636|79255632|FG000|Overall Study|Protocol Violation|2|||
44291188|NCT00636636|79255633|FG001|Overall Study|Protocol Violation|2|||
44291189|NCT00636636|79255632|FG000|Overall Study|Lost to Follow-up|0|||
44291190|NCT00636636|79255633|FG001|Overall Study|Lost to Follow-up|1|||
44291191|NCT00636636|79255632|FG000|Overall Study|Death|0|||
44291192|NCT00636636|79255633|FG001|Overall Study|Death|1|||
44291193|NCT00636636|79255632|FG000|Overall Study|Withdrawal by Subject|4|||
44291194|NCT00636636|79255633|FG001|Overall Study|Withdrawal by Subject|9|||
44291195|NCT00635778|79255646|FG000|Overall Study|Adverse Event|1|||
44291196|NCT00635778|79255647|FG001|Overall Study|Adverse Event|0|||
44291197|NCT00635778|79255648|FG002|Overall Study|Adverse Event|0|||
44291198|NCT00635778|79255649|FG003|Overall Study|Adverse Event|3|||
44291199|NCT00635778|79255650|FG004|Overall Study|Adverse Event|3|||
44291200|NCT00635778|79255651|FG005|Overall Study|Adverse Event|6|||
44291201|NCT00635778|79255652|FG006|Overall Study|Adverse Event|1|||
44291202|NCT00635778|79255646|FG000|Overall Study|Withdrawal by Subject|0|||
44291203|NCT00635778|79255647|FG001|Overall Study|Withdrawal by Subject|0|||
44291204|NCT00635778|79255648|FG002|Overall Study|Withdrawal by Subject|0|||
44291205|NCT00635778|79255649|FG003|Overall Study|Withdrawal by Subject|1|||
44291206|NCT00635778|79255650|FG004|Overall Study|Withdrawal by Subject|0|||
44291207|NCT00635778|79255651|FG005|Overall Study|Withdrawal by Subject|1|||
44416340|NCT00765999|79424071|FG000|Overall Study|Insufficient Therapeutic Response|100|||
44416341|NCT00765999|79424071|FG000|Overall Study|Protocol Violation|95|||
44416342|NCT00765999|79424071|FG000|Overall Study|Consent Withdrawn|202|||
44416343|NCT00765999|79424071|FG000|Overall Study|Lost to Follow-up|131|||
44533695|NCT02834780|79544019|FG004|Overall Study|Adverse Event|1|||
44533696|NCT02834780|79544020|FG005|Overall Study|Adverse Event|0|||
44291208|NCT00635778|79255652|FG006|Overall Study|Withdrawal by Subject|1|||
44291209|NCT00635778|79255646|FG000|Overall Study|Progressive disease|0|||
44291210|NCT00635778|79255647|FG001|Overall Study|Progressive disease|3|||
44416344|NCT00765999|79424071|FG000|Overall Study|Study Terminated by Sponsor|2|||
44533697|NCT02834780|79544021|FG006|Overall Study|Adverse Event|1|||
44416345|NCT00765999|79424071|FG000|Overall Study|Other Miscellaneous Reasons|51|||
44533698|NCT02834780|79544022|FG007|Overall Study|Adverse Event|1|||
44291211|NCT00635778|79255648|FG002|Overall Study|Progressive disease|3|||
44291212|NCT00635778|79255649|FG003|Overall Study|Progressive disease|4|||
44291213|NCT00635778|79255650|FG004|Overall Study|Progressive disease|5|||
44291214|NCT00635778|79255651|FG005|Overall Study|Progressive disease|14|||
44416346|NCT00765843|79424080|FG000|Overall Study|Lost to Follow-up|1|||
44291215|NCT00635778|79255652|FG006|Overall Study|Progressive disease|4|||
44291216|NCT00634920|79255672|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
44291217|NCT00634920|79255673|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
44533699|NCT02834780|79544023|FG008|Overall Study|Adverse Event|0|||
44416347|NCT00765843|79424081|FG001|Overall Study|Lost to Follow-up|3|||
44291218|NCT00634920|79255674|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
44291219|NCT00634920|79255672|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
44291220|NCT00634920|79255673|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
44291221|NCT00634920|79255674|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
44291222|NCT00634920|79255672|FG000|Period 1 - Pre-Randomization|Rejections|0|||
44291223|NCT00634920|79255673|FG001|Period 1 - Pre-Randomization|Rejections|0|||
44291224|NCT00634920|79255674|FG002|Period 1 - Pre-Randomization|Rejections|55|||
44291225|NCT00634920|79255672|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
44291226|NCT00634920|79255673|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
44291227|NCT00634920|79255674|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
44291228|NCT00634920|79255672|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
44291229|NCT00634920|79255673|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
44291230|NCT00634920|79255674|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
44291231|NCT00634920|79255672|FG000|Period 1 - Pre-Randomization|Other issues|0|||
44291232|NCT00634920|79255673|FG001|Period 1 - Pre-Randomization|Other issues|0|||
44291233|NCT00634920|79255674|FG002|Period 1 - Pre-Randomization|Other issues|6|||
44291234|NCT00634920|79255672|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
44291235|NCT00634920|79255673|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
44291236|NCT00634920|79255674|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
44291237|NCT00634920|79255672|FG000|Period 2 - Post-Randomization|Rejection|11|||
44291238|NCT00634920|79255673|FG001|Period 2 - Post-Randomization|Rejection|5|||
44291239|NCT00634920|79255674|FG002|Period 2 - Post-Randomization|Rejection|0|||
44291240|NCT00634920|79255672|FG000|Period 2 - Post-Randomization|Death|2|||
44291241|NCT00634920|79255673|FG001|Period 2 - Post-Randomization|Death|5|||
44291242|NCT00634920|79255674|FG002|Period 2 - Post-Randomization|Death|0|||
44291243|NCT00634920|79255672|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
44291244|NCT00634920|79255673|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
44291245|NCT00634920|79255674|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
44291246|NCT00634920|79255672|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
44291247|NCT00634920|79255673|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
44291248|NCT00634920|79255674|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
44291249|NCT00634842|79255682|FG000|Overall Study|Adverse Event|2|||
44291250|NCT00634842|79255683|FG001|Overall Study|Adverse Event|3|||
44291251|NCT00634842|79255682|FG000|Overall Study|Protocol Violation|8|||
44291252|NCT00634842|79255683|FG001|Overall Study|Protocol Violation|4|||
44291253|NCT00634842|79255682|FG000|Overall Study|Move to another state|1|||
44291254|NCT00634842|79255683|FG001|Overall Study|Move to another state|0|||
44291255|NCT00634842|79255682|FG000|Overall Study|Inclusion criteria were not met|1|||
44291256|NCT00634842|79255683|FG001|Overall Study|Inclusion criteria were not met|0|||
44291257|NCT00634842|79255682|FG000|Overall Study|Lost to Follow-up|1|||
44291258|NCT00634842|79255683|FG001|Overall Study|Lost to Follow-up|2|||
44291259|NCT00634842|79255682|FG000|Overall Study|Physician Decision|1|||
44291260|NCT00634842|79255683|FG001|Overall Study|Physician Decision|0|||
44291261|NCT00634842|79255682|FG000|Overall Study|Withdrawal by Subject|1|||
44291262|NCT00634842|79255683|FG001|Overall Study|Withdrawal by Subject|3|||
44291263|NCT00634842|79255682|FG000|Overall Study|Lack of time and intolerance to drug|0|||
44291264|NCT00634842|79255683|FG001|Overall Study|Lack of time and intolerance to drug|1|||
44291265|NCT00634842|79255682|FG000|Overall Study|Discontinued due to injection|0|||
44291266|NCT00634842|79255683|FG001|Overall Study|Discontinued due to injection|2|||
44291267|NCT00634842|79255682|FG000|Overall Study|No need of study drug to treat diabetes|0|||
44291268|NCT00634842|79255683|FG001|Overall Study|No need of study drug to treat diabetes|1|||
44291269|NCT00634842|79255682|FG000|Overall Study|No wish to keep taking Avandia|0|||
44291270|NCT00634842|79255683|FG001|Overall Study|No wish to keep taking Avandia|1|||
44291271|NCT00634842|79255682|FG000|Overall Study|Subject off study drug for too long|0|||
44291272|NCT00634842|79255683|FG001|Overall Study|Subject off study drug for too long|1|||
44533700|NCT02834780|79544024|FG009|Overall Study|Adverse Event|2|||
44154542|NCT01959334|78945752|FG000|Third Dose|Adverse Event|0|||
44291273|NCT00633984|79255691|FG000|Overall Study|Lost to Follow-up|0|||
44291274|NCT00633984|79255692|FG001|Overall Study|Lost to Follow-up|6|||
44291275|NCT00633984|79255691|FG000|Overall Study|Withdrawal by Subject|8|||
44291276|NCT00633984|79255692|FG001|Overall Study|Withdrawal by Subject|7|||
44291277|NCT00633984|79255691|FG000|Overall Study|Hospitalized|1|||
44291278|NCT00633984|79255692|FG001|Overall Study|Hospitalized|0|||
44291279|NCT01921218|79255720|FG000|Overall Study|Death|2|||
44291280|NCT01921218|79255721|FG001|Overall Study|Death|1|||
44291281|NCT01921218|79255720|FG000|Overall Study|Withdrawal by Subject|0|||
44291282|NCT01921218|79255721|FG001|Overall Study|Withdrawal by Subject|2|||
44533701|NCT02834780|79544025|FG010|Overall Study|Adverse Event|0|||
44154543|NCT01959334|78945753|FG001|Third Dose|Adverse Event|1|||
44291283|NCT01921218|79255720|FG000|Overall Study|Kidney transplant|1|||
44291284|NCT01921218|79255721|FG001|Overall Study|Kidney transplant|1|||
44291285|NCT00633750|79255727|FG000|Overall Study|Adverse Event|2|||
44291286|NCT00633750|79255727|FG000|Overall Study|Withdrawal by Subject|3|||
44291287|NCT00633360|79255735|FG000|Overall Study|Lost to Follow-up|1|||
44291288|NCT00633360|79255736|FG001|Overall Study|Lost to Follow-up|1|||
44291289|NCT00633360|79255735|FG000|Overall Study|Adverse Event|3|||
44291290|NCT00633360|79255736|FG001|Overall Study|Adverse Event|1|||
44291291|NCT00633360|79255735|FG000|Overall Study|Protocol Violation|0|||
44291292|NCT00633360|79255736|FG001|Overall Study|Protocol Violation|1|||
44291293|NCT00633126|79255744|FG000|Overall Study|Did not receive full dose|1|||
44291294|NCT00989664|79255748|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
44291295|NCT00989664|79255748|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
44291296|NCT00989664|79255748|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
44291297|NCT00989664|79255748|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
44291298|NCT00989664|79255748|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
44291299|NCT00989664|79255748|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
44291300|NCT00989664|79255748|FG000|Long-Term Follow-Up|Death|3|||
44291301|NCT00632736|79255754|FG000|Overall Study|Adverse Event|104|||
44291302|NCT00632736|79255754|FG000|Overall Study|Lost to Follow-up|15|||
44291303|NCT00632736|79255754|FG000|Overall Study|Protocol Violation|14|||
44291304|NCT00632736|79255754|FG000|Overall Study|Withdrawal by Subject|99|||
44291305|NCT00632736|79255754|FG000|Overall Study|Lack of Efficacy|5|||
44291306|NCT00632736|79255754|FG000|Overall Study|Sponsor terminated study|5|||
44291307|NCT00632736|79255754|FG000|Overall Study|Non-compliance|10|||
44291308|NCT00632736|79255754|FG000|Overall Study|Other|16|||
44291309|NCT00989196|79255758|FG000|Treatment Period|Lost to Follow-up|1|||
44291310|NCT00989196|79255759|FG001|Treatment Period|Lost to Follow-up|0|||
44291311|NCT00632502|79255767|FG000|Overall Study|Adverse Event|0|||
44291312|NCT00632502|79255768|FG001|Overall Study|Adverse Event|1|||
44291313|NCT00632502|79255767|FG000|Overall Study|Randomized not treated|3|||
44291314|NCT00632502|79255768|FG001|Overall Study|Randomized not treated|0|||
44291315|NCT00632424|79255778|FG000|Overall Study|Disease Progression|17|||
44291316|NCT00632424|79255778|FG000|Overall Study|Study Drug Toxicity|1|||
44291317|NCT00631488|79255795|FG000|Overall Study|Adverse Event|1|||
44291318|NCT00631488|79255796|FG001|Overall Study|Adverse Event|0|||
44291319|NCT00631488|79255797|FG002|Overall Study|Adverse Event|0|||
44291320|NCT00631488|79255795|FG000|Overall Study|Lost to Follow-up|2|||
44291321|NCT00631488|79255796|FG001|Overall Study|Lost to Follow-up|2|||
44291322|NCT00631488|79255797|FG002|Overall Study|Lost to Follow-up|0|||
44291323|NCT00631488|79255795|FG000|Overall Study|Physician Decision|1|||
44291324|NCT00631488|79255796|FG001|Overall Study|Physician Decision|0|||
44291325|NCT00631488|79255797|FG002|Overall Study|Physician Decision|1|||
44291326|NCT00631488|79255795|FG000|Overall Study|Protocol Violation|0|||
44291327|NCT00631488|79255796|FG001|Overall Study|Protocol Violation|0|||
44291328|NCT00631488|79255797|FG002|Overall Study|Protocol Violation|1|||
44291329|NCT00988884|79255807|FG000|Overall Study|Adverse Event|0|||
44291330|NCT00988884|79255808|FG001|Overall Study|Adverse Event|1|||
44291331|NCT00988884|79255807|FG000|Overall Study|Lost to Follow-up|20|||
44291332|NCT00988884|79255808|FG001|Overall Study|Lost to Follow-up|16|||
44291333|NCT00988884|79255807|FG000|Overall Study|Protocol Violation|0|||
44291334|NCT00988884|79255808|FG001|Overall Study|Protocol Violation|1|||
44291335|NCT00988884|79255807|FG000|Overall Study|Withdrawal by Subject|15|||
44291336|NCT00988884|79255808|FG001|Overall Study|Withdrawal by Subject|18|||
44291337|NCT00631020|79255814|FG000|Overall Study|Lost to Follow-up|7|||
44291338|NCT00631020|79255814|FG000|Overall Study|Incarcerated|1|||
44291339|NCT00987402|79255820|FG000|Overall Study|Insufficient data entry|86|||
44291340|NCT00987402|79255821|FG001|Overall Study|Insufficient data entry|98|||
44291341|NCT00630864|79255827|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
44291342|NCT00630864|79255827|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
44291343|NCT00630786|79255834|FG000|Overall Study|Physician Decision|0|||
44291344|NCT00630786|79255835|FG001|Overall Study|Physician Decision|0|||
44291345|NCT00630786|79255836|FG002|Overall Study|Physician Decision|1|||
44291346|NCT00630786|79255834|FG000|Overall Study|Withdrawal by Subject|0|||
44291347|NCT00630786|79255835|FG001|Overall Study|Withdrawal by Subject|1|||
44291348|NCT00630786|79255836|FG002|Overall Study|Withdrawal by Subject|1|||
44291349|NCT00630786|79255834|FG000|Overall Study|Lost to Follow-up|0|||
44291350|NCT00630786|79255835|FG001|Overall Study|Lost to Follow-up|1|||
44291351|NCT00630786|79255836|FG002|Overall Study|Lost to Follow-up|0|||
44291352|NCT00630786|79255834|FG000|Overall Study|Other|1|||
44291353|NCT00630786|79255835|FG001|Overall Study|Other|0|||
44291354|NCT00630786|79255836|FG002|Overall Study|Other|0|||
44291355|NCT00630396|79255842|FG000|Overall Study|Death|4|||
44291356|NCT00630396|79255842|FG000|Overall Study|Lost to Follow-up|3|||
44291357|NCT00985686|79255850|FG000|Overall Study|Lost to Follow-up|1|||
44291358|NCT00985686|79255851|FG001|Overall Study|Lost to Follow-up|1|||
44291359|NCT00985686|79255852|FG002|Overall Study|Lost to Follow-up|0|||
44291360|NCT00985686|79255853|FG003|Overall Study|Lost to Follow-up|2|||
44291361|NCT03098394|79255863|FG000|Overall Study|Pregnancy|0|||
44291362|NCT03098394|79255864|FG001|Overall Study|Pregnancy|1|||
44291363|NCT00984594|79255875|FG000|Overall Study|Lost to Follow-up|1|||
44291364|NCT00984594|79255876|FG001|Overall Study|Lost to Follow-up|0|||
44291365|NCT00984594|79255875|FG000|Overall Study|Withdrawal by Subject|0|||
44291366|NCT00984594|79255876|FG001|Overall Study|Withdrawal by Subject|1|||
44291367|NCT00984204|79255884|FG000|Overall Study|Death|1|||
44291368|NCT00984204|79255884|FG000|Overall Study|Lost to Follow-up|4|||
44291369|NCT00984204|79255884|FG000|Overall Study|Lack of Efficacy|10|||
44291370|NCT00983892|79255890|FG000|Overall Study|Withdrawal by Subject|10|||
44291371|NCT00983892|79255891|FG001|Overall Study|Withdrawal by Subject|12|||
44291372|NCT00983580|79255899|FG000|Overall Study|Cancel Prior to treatment|1|||
44291373|NCT00983580|79255900|FG001|Overall Study|Cancel Prior to treatment|3|||
44291374|NCT00983580|79255899|FG000|Overall Study|Protocol Violation|1|||
44291375|NCT00983580|79255900|FG001|Overall Study|Protocol Violation|1|||
44291376|NCT00983580|79255899|FG000|Overall Study|Ineligible|3|||
44291377|NCT00983580|79255900|FG001|Overall Study|Ineligible|0|||
44291378|NCT00982878|79255907|FG000|Overall Study|Physician Decision|1|||
44291379|NCT00982488|79255916|FG000|Overall Study|Administrative reason by sponsor|81|||
44291380|NCT00982488|79255917|FG001|Overall Study|Administrative reason by sponsor|3|||
44291381|NCT00982488|79255918|FG002|Overall Study|Administrative reason by sponsor|11|||
44291382|NCT00982488|79255919|FG003|Overall Study|Administrative reason by sponsor|0|||
44291383|NCT00982488|79255920|FG004|Overall Study|Administrative reason by sponsor|0|||
44291384|NCT00982488|79255916|FG000|Overall Study|Adverse event unrelated to study drug|5|||
44291385|NCT00982488|79255917|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44291386|NCT00982488|79255918|FG002|Overall Study|Adverse event unrelated to study drug|0|||
44291387|NCT00982488|79255919|FG003|Overall Study|Adverse event unrelated to study drug|0|||
44291388|NCT00982488|79255920|FG004|Overall Study|Adverse event unrelated to study drug|0|||
44291389|NCT00982488|79255916|FG000|Overall Study|Death|11|||
44291390|NCT00982488|79255917|FG001|Overall Study|Death|0|||
44291391|NCT00982488|79255918|FG002|Overall Study|Death|2|||
44291392|NCT00982488|79255919|FG003|Overall Study|Death|0|||
44291393|NCT00982488|79255920|FG004|Overall Study|Death|0|||
44291394|NCT00982488|79255916|FG000|Overall Study|Disease progression|30|||
44291395|NCT00982488|79255917|FG001|Overall Study|Disease progression|5|||
44291396|NCT00982488|79255918|FG002|Overall Study|Disease progression|10|||
44291397|NCT00982488|79255919|FG003|Overall Study|Disease progression|1|||
44291398|NCT00982488|79255920|FG004|Overall Study|Disease progression|1|||
44291399|NCT00982488|79255916|FG000|Overall Study|Lost to Follow-up|1|||
44291400|NCT00982488|79255917|FG001|Overall Study|Lost to Follow-up|0|||
44291401|NCT00982488|79255918|FG002|Overall Study|Lost to Follow-up|0|||
44291402|NCT00982488|79255919|FG003|Overall Study|Lost to Follow-up|0|||
44291403|NCT00982488|79255920|FG004|Overall Study|Lost to Follow-up|0|||
44291404|NCT00982488|79255916|FG000|Overall Study|Maximum clinical benefit|1|||
44291405|NCT00982488|79255917|FG001|Overall Study|Maximum clinical benefit|1|||
44291406|NCT00982488|79255918|FG002|Overall Study|Maximum clinical benefit|1|||
44291407|NCT00982488|79255919|FG003|Overall Study|Maximum clinical benefit|0|||
44291408|NCT00982488|79255920|FG004|Overall Study|Maximum clinical benefit|0|||
44291409|NCT00982488|79255916|FG000|Overall Study|Other|15|||
44291410|NCT00982488|79255917|FG001|Overall Study|Other|1|||
44291411|NCT00982488|79255918|FG002|Overall Study|Other|3|||
44291412|NCT00982488|79255919|FG003|Overall Study|Other|1|||
44291413|NCT00982488|79255920|FG004|Overall Study|Other|0|||
44291414|NCT00982488|79255916|FG000|Overall Study|Poor compliance/noncompliance|0|||
44291415|NCT00982488|79255917|FG001|Overall Study|Poor compliance/noncompliance|1|||
44291416|NCT00982488|79255918|FG002|Overall Study|Poor compliance/noncompliance|0|||
44291417|NCT00982488|79255919|FG003|Overall Study|Poor compliance/noncompliance|0|||
44291418|NCT00982488|79255920|FG004|Overall Study|Poor compliance/noncompliance|0|||
44291419|NCT00982488|79255916|FG000|Overall Study|Stem cell transplant|2|||
44291420|NCT00982488|79255917|FG001|Overall Study|Stem cell transplant|0|||
44291421|NCT00982488|79255918|FG002|Overall Study|Stem cell transplant|0|||
44416348|NCT00765843|79424082|FG002|Overall Study|Lost to Follow-up|2|||
44416349|NCT00765843|79424080|FG000|Overall Study|did not return to receive intervention|0|||
44533702|NCT02834780|79544026|FG011|Overall Study|Adverse Event|3|||
44533703|NCT02834780|79544027|FG012|Overall Study|Adverse Event|2|||
44291422|NCT00982488|79255919|FG003|Overall Study|Stem cell transplant|1|||
44291423|NCT00982488|79255920|FG004|Overall Study|Stem cell transplant|0|||
44291424|NCT00982488|79255916|FG000|Overall Study|Study drug toxicity|34|||
44291425|NCT00982488|79255917|FG001|Overall Study|Study drug toxicity|1|||
44291426|NCT00982488|79255918|FG002|Overall Study|Study drug toxicity|6|||
44291427|NCT00982488|79255919|FG003|Overall Study|Study drug toxicity|0|||
44416350|NCT00765843|79424081|FG001|Overall Study|did not return to receive intervention|1|||
44416351|NCT00765843|79424082|FG002|Overall Study|did not return to receive intervention|0|||
44291428|NCT00982488|79255920|FG004|Overall Study|Study drug toxicity|0|||
44291429|NCT00982488|79255916|FG000|Overall Study|Withdrawal by Subject|5|||
44291430|NCT00982488|79255917|FG001|Overall Study|Withdrawal by Subject|1|||
44291431|NCT00982488|79255918|FG002|Overall Study|Withdrawal by Subject|1|||
44291432|NCT00982488|79255919|FG003|Overall Study|Withdrawal by Subject|0|||
44291433|NCT00982488|79255920|FG004|Overall Study|Withdrawal by Subject|0|||
44291434|NCT00982410|79255934|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
44291435|NCT00982410|79255935|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
44291436|NCT00982410|79255934|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
44291437|NCT00982410|79255935|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
44291438|NCT00982410|79255934|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
44291439|NCT00982410|79255935|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
44291440|NCT00982410|79255934|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
44291441|NCT00982410|79255935|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
44291442|NCT00982410|79255934|FG000|6-month Follow-up Assessment|participant no transportation|1|||
44291443|NCT00982410|79255935|FG001|6-month Follow-up Assessment|participant no transportation|0|||
44291444|NCT00982410|79255934|FG000|6-month Follow-up Assessment|incarceration|0|||
44291445|NCT00982410|79255935|FG001|6-month Follow-up Assessment|incarceration|2|||
44291446|NCT00982410|79255934|FG000|6-month Follow-up Assessment|patent surgery|0|||
44291447|NCT00982410|79255935|FG001|6-month Follow-up Assessment|patent surgery|1|||
44291448|NCT00982410|79255934|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
44291449|NCT00982410|79255935|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
44291450|NCT00982410|79255934|FG000|12-month Follow-up Assessment|Death|0|||
44291451|NCT00982410|79255935|FG001|12-month Follow-up Assessment|Death|2|||
44291452|NCT00982410|79255934|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
44291453|NCT00982410|79255935|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
44291454|NCT00982410|79255934|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
44291455|NCT00982410|79255935|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
44291456|NCT00982410|79255934|FG000|12-month Follow-up Assessment|incarceration|2|||
44291457|NCT00982410|79255935|FG001|12-month Follow-up Assessment|incarceration|1|||
44291458|NCT00982410|79255934|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
44291459|NCT00982410|79255935|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
44291460|NCT00982020|79255944|FG000|Overall Study|Adverse Event|19|||
44291461|NCT00982020|79255945|FG001|Overall Study|Adverse Event|15|||
44291462|NCT00982020|79255944|FG000|Overall Study|Withdrawal by Subject|11|||
44291463|NCT00982020|79255945|FG001|Overall Study|Withdrawal by Subject|14|||
44291464|NCT00982020|79255944|FG000|Overall Study|Lost to Follow-up|5|||
44291465|NCT00982020|79255945|FG001|Overall Study|Lost to Follow-up|11|||
44291466|NCT00982020|79255944|FG000|Overall Study|Lack of Efficacy|10|||
44291467|NCT00982020|79255945|FG001|Overall Study|Lack of Efficacy|4|||
44291468|NCT00982020|79255944|FG000|Overall Study|Parent/Caregiver Decision|5|||
44291469|NCT00982020|79255945|FG001|Overall Study|Parent/Caregiver Decision|5|||
44291470|NCT00982020|79255944|FG000|Overall Study|Treatment Non-compliance|3|||
44291471|NCT00982020|79255945|FG001|Overall Study|Treatment Non-compliance|6|||
44291472|NCT00982020|79255944|FG000|Overall Study|Physician Decision|2|||
44291473|NCT00982020|79255945|FG001|Overall Study|Physician Decision|5|||
44291474|NCT00982020|79255944|FG000|Overall Study|Entry Criteria Not Met|2|||
44291475|NCT00982020|79255945|FG001|Overall Study|Entry Criteria Not Met|1|||
44291476|NCT00982020|79255944|FG000|Overall Study|Protocol Violation|0|||
44291477|NCT00982020|79255945|FG001|Overall Study|Protocol Violation|2|||
44291478|NCT00982020|79255944|FG000|Overall Study|Clinical Relapse|0|||
44291479|NCT00982020|79255945|FG001|Overall Study|Clinical Relapse|1|||
44291480|NCT00981084|79255958|FG000|Post Intervention (Data Analysis)|poor effort|1|||
44291481|NCT00981084|79255959|FG001|Post Intervention (Data Analysis)|poor effort|1|||
44291482|NCT00981084|79255958|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
44291483|NCT00981084|79255959|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
44291484|NCT00980148|79255969|FG000|Overall Study|Discharged from facility|89|||
44291485|NCT00980148|79255970|FG001|Overall Study|Discharged from facility|96|||
44291486|NCT00980148|79255969|FG000|Overall Study|Received other antichlamydia treatment|20|||
44291487|NCT00980148|79255970|FG001|Overall Study|Received other antichlamydia treatment|14|||
44291488|NCT00980148|79255969|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
44291489|NCT00980148|79255970|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
44291490|NCT00980148|79255969|FG000|Overall Study|Various other reasons|8|||
44291491|NCT00980148|79255970|FG001|Overall Study|Various other reasons|9|||
44291492|NCT04553406|79256007|FG000|Overall Study|Study Discontinuation|0|||
44291493|NCT04553406|79256008|FG001|Overall Study|Study Discontinuation|1|||
44291494|NCT04129944|79256018|FG000|Overall Study|Death|0|||
44291495|NCT04129944|79256019|FG001|Overall Study|Death|0|||
44291496|NCT04129944|79256020|FG002|Overall Study|Death|0|||
44291497|NCT04129944|79256021|FG003|Overall Study|Death|1|||
44291498|NCT04129944|79256018|FG000|Overall Study|Lost to Follow-up|1|||
44291499|NCT04129944|79256019|FG001|Overall Study|Lost to Follow-up|0|||
44291500|NCT04129944|79256020|FG002|Overall Study|Lost to Follow-up|0|||
44291501|NCT04129944|79256021|FG003|Overall Study|Lost to Follow-up|0|||
44291502|NCT04129944|79256018|FG000|Overall Study|Withdrawal by Subject|1|||
44291503|NCT04129944|79256019|FG001|Overall Study|Withdrawal by Subject|0|||
44291504|NCT04129944|79256020|FG002|Overall Study|Withdrawal by Subject|1|||
44291505|NCT04129944|79256021|FG003|Overall Study|Withdrawal by Subject|2|||
44291506|NCT03829332|79256085|FG000|Overall Study|Death|145|||
44291507|NCT03829332|79256086|FG001|Overall Study|Death|135|||
44291508|NCT03829332|79256085|FG000|Overall Study|Withdrawal by Subject|10|||
44291509|NCT03829332|79256086|FG001|Overall Study|Withdrawal by Subject|4|||
44291510|NCT03829332|79256085|FG000|Overall Study|Ongoing in Study|154|||
44291511|NCT03829332|79256086|FG001|Overall Study|Ongoing in Study|175|||
44291512|NCT02914314|79256106|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
44291513|NCT02914314|79256107|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
44291514|NCT02914314|79256108|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
44291515|NCT02914314|79256109|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
44291516|NCT02914314|79256106|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
44291517|NCT02914314|79256107|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
44291518|NCT02914314|79256108|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
44291519|NCT02914314|79256109|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
44291520|NCT02914314|79256106|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
44291521|NCT02914314|79256107|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
44291522|NCT02914314|79256108|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
44291523|NCT02914314|79256109|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
44291524|NCT02914314|79256106|FG000|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
44291525|NCT02914314|79256107|FG001|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
44291526|NCT02914314|79256108|FG002|Extension Phase (Up to 32 Weeks)|Participant choice|1|||
44291527|NCT02914314|79256109|FG003|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
44291528|NCT02914314|79256106|FG000|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
44291529|NCT02914314|79256107|FG001|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
44291530|NCT02914314|79256108|FG002|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|1|||
44291531|NCT02914314|79256109|FG003|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
44291532|NCT01899144|79257694|FG000|Treatment Period 2|Other|1|||
44291533|NCT01899144|79257694|FG000|Treatment Period 3|Other|2|||
44291534|NCT01899144|79257694|FG000|Treatment Period 5|Other|1|||
44291535|NCT03821844|79258284|FG000|Overall Study|Death|37|||
44291536|NCT03821844|79258285|FG001|Overall Study|Death|31|||
44291537|NCT03821844|79258284|FG000|Overall Study|Discharged|10|||
44291538|NCT03821844|79258285|FG001|Overall Study|Discharged|14|||
44291539|NCT03821844|79258284|FG000|Overall Study|Not present in facility at followup|2|||
44291540|NCT03821844|79258285|FG001|Overall Study|Not present in facility at followup|3|||
44291541|NCT01796106|79259736|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
44291542|NCT01796106|79259737|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
44291543|NCT01168219|79260916|FG000|Overall Study|off study before starting treatment|2|||
44291544|NCT01168219|79260916|FG000|Overall Study|withdrew before transplant|1|||
44291545|NCT01168219|79260916|FG000|Overall Study|ineligible due to CML|2|||
44291546|NCT01115803|79260927|FG000|Overall Study|Withdrawal by Subject|0|||
44291547|NCT01115803|79260928|FG001|Overall Study|Withdrawal by Subject|0|||
44291548|NCT01115803|79260929|FG002|Overall Study|Withdrawal by Subject|0|||
44291549|NCT01115803|79260930|FG003|Overall Study|Withdrawal by Subject|0|||
44291550|NCT01115803|79260931|FG004|Overall Study|Withdrawal by Subject|0|||
44291551|NCT01115803|79260932|FG005|Overall Study|Withdrawal by Subject|0|||
44291552|NCT01115803|79260933|FG006|Overall Study|Withdrawal by Subject|1|||
44291553|NCT01115803|79260927|FG000|Overall Study|Lost to Follow-up|0|||
44416352|NCT00765843|79424080|FG000|Overall Study|Adverse Event|0|||
44416353|NCT00765843|79424081|FG001|Overall Study|Adverse Event|0|||
44533704|NCT02834780|79544015|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
44533705|NCT02834780|79544016|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
44533706|NCT02834780|79544017|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
44533707|NCT02834780|79544018|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
44533708|NCT02834780|79544019|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
44533709|NCT02834780|79544020|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
44533710|NCT02834780|79544021|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
44533711|NCT02834780|79544022|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
44291554|NCT01115803|79260928|FG001|Overall Study|Lost to Follow-up|0|||
44291555|NCT01115803|79260929|FG002|Overall Study|Lost to Follow-up|1|||
44291556|NCT01115803|79260930|FG003|Overall Study|Lost to Follow-up|0|||
44416354|NCT00765843|79424082|FG002|Overall Study|Adverse Event|1|||
44533712|NCT02834780|79544023|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
44533713|NCT02834780|79544024|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
44416355|NCT00765063|79424090|FG000|Overall Study|Lack of Efficacy|5|||
44291557|NCT01115803|79260931|FG004|Overall Study|Lost to Follow-up|0|||
44291558|NCT01115803|79260932|FG005|Overall Study|Lost to Follow-up|0|||
44291559|NCT01115803|79260933|FG006|Overall Study|Lost to Follow-up|0|||
44291560|NCT01115803|79260927|FG000|Overall Study|Progressive Disease during Cycle1|0|||
44291561|NCT01115803|79260928|FG001|Overall Study|Progressive Disease during Cycle1|0|||
44291562|NCT01115803|79260929|FG002|Overall Study|Progressive Disease during Cycle1|0|||
44291563|NCT01115803|79260930|FG003|Overall Study|Progressive Disease during Cycle1|0|||
44291564|NCT01115803|79260931|FG004|Overall Study|Progressive Disease during Cycle1|0|||
44291565|NCT01115803|79260932|FG005|Overall Study|Progressive Disease during Cycle1|0|||
44291566|NCT01115803|79260933|FG006|Overall Study|Progressive Disease during Cycle1|1|||
44291567|NCT01115569|79260954|FG000|Conversion/Titration Phase|Adverse Event|59|||
44291568|NCT01115569|79260955|FG001|Conversion/Titration Phase|Adverse Event|0|||
44291569|NCT01115569|79260954|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
44291570|NCT01115569|79260955|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
44291571|NCT01115569|79260954|FG000|Conversion/Titration Phase|Physician Decision|5|||
44291572|NCT01115569|79260955|FG001|Conversion/Titration Phase|Physician Decision|0|||
44291573|NCT01115569|79260954|FG000|Conversion/Titration Phase|Protocol Violation|68|||
44291574|NCT01115569|79260955|FG001|Conversion/Titration Phase|Protocol Violation|0|||
44416356|NCT00765063|79424090|FG000|Overall Study|Withdrawal by Subject|1|||
44416357|NCT00765063|79424090|FG000|Overall Study|Other|16|||
44416358|NCT00765063|79424090|FG000|Overall Study|Protocol Violation|6|||
44416359|NCT00765063|79424090|FG000|Overall Study|Adverse Event|4|||
44416360|NCT00764751|79424096|FG000|Overall Study|Adverse Event|1|||
44416361|NCT00764751|79424097|FG001|Overall Study|Adverse Event|1|||
44416362|NCT00764751|79424096|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
44416363|NCT00764751|79424097|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
44416364|NCT00764673|79424108|FG000|Overall Study|Death|1|||
44416365|NCT00764673|79424108|FG000|Overall Study|Lost to Follow-up|3|||
44416366|NCT00764673|79424108|FG000|Overall Study|Withdrawal by Subject|6|||
44416367|NCT00764673|79424108|FG000|Overall Study|Revision of Device|2|||
44416368|NCT00764517|79424114|FG000|Overall Study|Adverse Event|9|||
44416369|NCT00764517|79424115|FG001|Overall Study|Adverse Event|3|||
44416370|NCT00764517|79424114|FG000|Overall Study|Death|3|||
44416371|NCT00764517|79424115|FG001|Overall Study|Death|11|||
44416372|NCT00764517|79424114|FG000|Overall Study|Physician Decision|3|||
44416373|NCT00764517|79424115|FG001|Overall Study|Physician Decision|0|||
44416374|NCT00764361|79424123|FG000|Overall Study|Withdrawal by Subject|2|||
44416375|NCT00764361|79424124|FG001|Overall Study|Withdrawal by Subject|3|||
44416376|NCT00764361|79424123|FG000|Overall Study|Adverse Event|0|||
44416377|NCT00764361|79424124|FG001|Overall Study|Adverse Event|1|||
44416378|NCT00763971|79424133|FG000|Overall Study|Adverse Event|5|||
44416379|NCT00763971|79424134|FG001|Overall Study|Adverse Event|2|||
44416380|NCT00763971|79424135|FG002|Overall Study|Adverse Event|4|||
44416381|NCT00763971|79424133|FG000|Overall Study|Protocol Violation|3|||
44416382|NCT00763971|79424134|FG001|Overall Study|Protocol Violation|3|||
44416383|NCT00763971|79424135|FG002|Overall Study|Protocol Violation|2|||
44416384|NCT00763971|79424133|FG000|Overall Study|Withdrawal by Subject|4|||
44416385|NCT00763971|79424134|FG001|Overall Study|Withdrawal by Subject|5|||
44416386|NCT00763971|79424135|FG002|Overall Study|Withdrawal by Subject|5|||
44416387|NCT00763971|79424133|FG000|Overall Study|Lost to Follow-up|0|||
44416388|NCT00763971|79424134|FG001|Overall Study|Lost to Follow-up|1|||
44416389|NCT00763971|79424135|FG002|Overall Study|Lost to Follow-up|0|||
44416390|NCT00763971|79424133|FG000|Overall Study|Lack of Efficacy|11|||
44416391|NCT00763971|79424134|FG001|Overall Study|Lack of Efficacy|22|||
44416392|NCT00763971|79424135|FG002|Overall Study|Lack of Efficacy|54|||
44416393|NCT00763971|79424133|FG000|Overall Study|Unable to swallow capsule|2|||
44416394|NCT00763971|79424134|FG001|Overall Study|Unable to swallow capsule|1|||
44416395|NCT00763971|79424135|FG002|Overall Study|Unable to swallow capsule|1|||
44416396|NCT00763971|79424133|FG000|Overall Study|Personal reason|3|||
44416397|NCT00763971|79424134|FG001|Overall Study|Personal reason|0|||
44416398|NCT00763971|79424135|FG002|Overall Study|Personal reason|0|||
44416399|NCT00763971|79424133|FG000|Overall Study|Exclusion criteria met|1|||
44533714|NCT02834780|79544025|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
44154544|NCT02687581|78945763|FG000|Overall Study|Withdrawal by Subject|1|||
44154545|NCT02687581|78945764|FG001|Overall Study|Withdrawal by Subject|0|||
44154546|NCT02687581|78945765|FG002|Overall Study|Withdrawal by Subject|0|||
44291575|NCT01115569|79260954|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
44291576|NCT01115569|79260955|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
44416400|NCT00763971|79424134|FG001|Overall Study|Exclusion criteria met|0|||
44416401|NCT00763971|79424135|FG002|Overall Study|Exclusion criteria met|0|||
44416402|NCT00763971|79424133|FG000|Overall Study|Sponsor decision|1|||
44416403|NCT00763971|79424134|FG001|Overall Study|Sponsor decision|0|||
44416404|NCT00763971|79424135|FG002|Overall Study|Sponsor decision|0|||
44416405|NCT00763971|79424133|FG000|Overall Study|Due to holiday season|2|||
44416406|NCT00763971|79424134|FG001|Overall Study|Due to holiday season|0|||
44416407|NCT00763971|79424135|FG002|Overall Study|Due to holiday season|1|||
44416408|NCT00763971|79424133|FG000|Overall Study|Randomization error|0|||
44416409|NCT00763971|79424134|FG001|Overall Study|Randomization error|0|||
44154547|NCT02687581|78945766|FG003|Overall Study|Withdrawal by Subject|1|||
44291577|NCT01115569|79260954|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
44291578|NCT01115569|79260955|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
44291579|NCT01115569|79260954|FG000|Maintenance Phase|Adverse Event|0|||
44291580|NCT01115569|79260955|FG001|Maintenance Phase|Adverse Event|43|||
44291581|NCT01115569|79260954|FG000|Maintenance Phase|Lost to Follow-up|0|||
44291582|NCT01115569|79260955|FG001|Maintenance Phase|Lost to Follow-up|8|||
44291583|NCT01115569|79260954|FG000|Maintenance Phase|Physician Decision|0|||
44291584|NCT01115569|79260955|FG001|Maintenance Phase|Physician Decision|3|||
44291585|NCT01115569|79260954|FG000|Maintenance Phase|Protocol Violation|0|||
44291586|NCT01115569|79260955|FG001|Maintenance Phase|Protocol Violation|9|||
44291587|NCT01115569|79260954|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44291588|NCT01115569|79260955|FG001|Maintenance Phase|Withdrawal by Subject|27|||
44291589|NCT01115569|79260954|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
44291590|NCT01115569|79260955|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
44291591|NCT01115569|79260954|FG000|Maintenance Phase|Administrative|0|||
44291592|NCT01115569|79260955|FG001|Maintenance Phase|Administrative|1|||
44291593|NCT01107886|79260962|FG000|Overall Study|Lost to Follow-up|15|||
44291594|NCT01107886|79260963|FG001|Overall Study|Lost to Follow-up|13|||
44291595|NCT01107886|79260962|FG000|Overall Study|Withdrawal by Subject|180|||
44291596|NCT01107886|79260963|FG001|Overall Study|Withdrawal by Subject|196|||
44291597|NCT01107886|79260962|FG000|Overall Study|Administrative withdrawal of consent|7|||
44291598|NCT01107886|79260963|FG001|Overall Study|Administrative withdrawal of consent|5|||
44291599|NCT01107457|79260974|FG000|Part A|Adverse Event|1|||
44291600|NCT01107457|79260975|FG001|Part A|Adverse Event|2|||
44291601|NCT01107457|79260976|FG002|Part A|Adverse Event|1|||
44291602|NCT01107457|79260977|FG003|Part A|Adverse Event|0|||
44291603|NCT01107457|79260978|FG004|Part A|Adverse Event|0|||
44416410|NCT00763971|79424135|FG002|Overall Study|Randomization error|1|||
44291604|NCT01107457|79260979|FG005|Part A|Adverse Event|0|||
44291605|NCT01107457|79260974|FG000|Part A|Withdrawal by Subject|3|||
44291606|NCT01107457|79260975|FG001|Part A|Withdrawal by Subject|3|||
44291607|NCT01107457|79260976|FG002|Part A|Withdrawal by Subject|0|||
44291608|NCT01107457|79260977|FG003|Part A|Withdrawal by Subject|3|||
44291609|NCT01107457|79260978|FG004|Part A|Withdrawal by Subject|1|||
44291610|NCT01107457|79260979|FG005|Part A|Withdrawal by Subject|0|||
44291611|NCT01107457|79260974|FG000|Part A|Lost to Follow-up|0|||
44291612|NCT01107457|79260975|FG001|Part A|Lost to Follow-up|1|||
44291613|NCT01107457|79260976|FG002|Part A|Lost to Follow-up|0|||
44291614|NCT01107457|79260977|FG003|Part A|Lost to Follow-up|0|||
44291615|NCT01107457|79260978|FG004|Part A|Lost to Follow-up|0|||
44291616|NCT01107457|79260979|FG005|Part A|Lost to Follow-up|0|||
44291617|NCT01107457|79260974|FG000|Part A|Lack of Efficacy|1|||
44291618|NCT01107457|79260975|FG001|Part A|Lack of Efficacy|0|||
44291619|NCT01107457|79260976|FG002|Part A|Lack of Efficacy|0|||
44291620|NCT01107457|79260977|FG003|Part A|Lack of Efficacy|0|||
44291621|NCT01107457|79260978|FG004|Part A|Lack of Efficacy|0|||
44291622|NCT01107457|79260979|FG005|Part A|Lack of Efficacy|0|||
44291623|NCT01107457|79260974|FG000|Part A|Protocol Violation|0|||
44291624|NCT01107457|79260975|FG001|Part A|Protocol Violation|1|||
44291625|NCT01107457|79260976|FG002|Part A|Protocol Violation|0|||
44291626|NCT01107457|79260977|FG003|Part A|Protocol Violation|0|||
44291627|NCT01107457|79260978|FG004|Part A|Protocol Violation|0|||
44291628|NCT01107457|79260979|FG005|Part A|Protocol Violation|0|||
44291629|NCT01107457|79260974|FG000|Part B and C|Adverse Event|0|||
44291630|NCT01107457|79260975|FG001|Part B and C|Adverse Event|0|||
44291631|NCT01107457|79260976|FG002|Part B and C|Adverse Event|0|||
44291632|NCT01107457|79260977|FG003|Part B and C|Adverse Event|0|||
44291633|NCT01107457|79260978|FG004|Part B and C|Adverse Event|0|||
44291634|NCT01107457|79260979|FG005|Part B and C|Adverse Event|12|||
44291635|NCT01107457|79260974|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
44291636|NCT01107457|79260975|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
44291637|NCT01107457|79260976|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
44291638|NCT01107457|79260977|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
44291639|NCT01107457|79260978|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
44291640|NCT01107457|79260979|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
44291641|NCT01107457|79260974|FG000|Part B and C|Physician Decision|0|||
44416411|NCT00763971|79424133|FG000|Overall Study|Medical monitor decision|0|||
44291642|NCT01107457|79260975|FG001|Part B and C|Physician Decision|0|||
44291643|NCT01107457|79260976|FG002|Part B and C|Physician Decision|0|||
44291644|NCT01107457|79260977|FG003|Part B and C|Physician Decision|0|||
44291645|NCT01107457|79260978|FG004|Part B and C|Physician Decision|0|||
44533715|NCT02834780|79544026|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
44291646|NCT01107457|79260979|FG005|Part B and C|Physician Decision|3|||
44291647|NCT01107457|79260974|FG000|Part B and C|Lack of Efficacy|0|||
44291648|NCT01107457|79260975|FG001|Part B and C|Lack of Efficacy|0|||
44291649|NCT01107457|79260976|FG002|Part B and C|Lack of Efficacy|0|||
44291650|NCT01107457|79260977|FG003|Part B and C|Lack of Efficacy|0|||
44291651|NCT01107457|79260978|FG004|Part B and C|Lack of Efficacy|0|||
44291652|NCT01107457|79260979|FG005|Part B and C|Lack of Efficacy|7|||
44291653|NCT01107457|79260974|FG000|Part B and C|Lost to Follow-up|0|||
44291654|NCT01107457|79260975|FG001|Part B and C|Lost to Follow-up|0|||
44291655|NCT01107457|79260976|FG002|Part B and C|Lost to Follow-up|0|||
44291656|NCT01107457|79260977|FG003|Part B and C|Lost to Follow-up|0|||
44291657|NCT01107457|79260978|FG004|Part B and C|Lost to Follow-up|0|||
44291658|NCT01107457|79260979|FG005|Part B and C|Lost to Follow-up|10|||
44291659|NCT01107457|79260974|FG000|Part B and C|Protocol Violation|0|||
44291660|NCT01107457|79260975|FG001|Part B and C|Protocol Violation|0|||
44291661|NCT01107457|79260976|FG002|Part B and C|Protocol Violation|0|||
44291662|NCT01107457|79260977|FG003|Part B and C|Protocol Violation|0|||
44291663|NCT01107457|79260978|FG004|Part B and C|Protocol Violation|0|||
44291664|NCT01107457|79260979|FG005|Part B and C|Protocol Violation|1|||
44291665|NCT01107457|79260974|FG000|Part B and C|Sponsor Decision|0|||
44291666|NCT01107457|79260975|FG001|Part B and C|Sponsor Decision|0|||
44291667|NCT01107457|79260976|FG002|Part B and C|Sponsor Decision|0|||
44291668|NCT01107457|79260977|FG003|Part B and C|Sponsor Decision|0|||
44291669|NCT01107457|79260978|FG004|Part B and C|Sponsor Decision|0|||
44291670|NCT01107457|79260979|FG005|Part B and C|Sponsor Decision|66|||
44291671|NCT01107457|79260974|FG000|Part B and C|Withdrawal by Subject|0|||
44291672|NCT01107457|79260975|FG001|Part B and C|Withdrawal by Subject|0|||
44291673|NCT01107457|79260976|FG002|Part B and C|Withdrawal by Subject|0|||
44291674|NCT01107457|79260977|FG003|Part B and C|Withdrawal by Subject|0|||
44291675|NCT01107457|79260978|FG004|Part B and C|Withdrawal by Subject|0|||
44291676|NCT01107457|79260979|FG005|Part B and C|Withdrawal by Subject|16|||
44291677|NCT01107457|79260974|FG000|Part B and C|Clinical Relapse|0|||
44291678|NCT01107457|79260975|FG001|Part B and C|Clinical Relapse|0|||
44291679|NCT01107457|79260976|FG002|Part B and C|Clinical Relapse|0|||
44291680|NCT01107457|79260977|FG003|Part B and C|Clinical Relapse|0|||
44291681|NCT01107457|79260978|FG004|Part B and C|Clinical Relapse|0|||
44291682|NCT01107457|79260979|FG005|Part B and C|Clinical Relapse|4|||
44291683|NCT04545385|79261009|FG000|Overall Study|Withdrawal by Subject|2|||
44291684|NCT04545385|79261010|FG001|Overall Study|Withdrawal by Subject|0|||
44291685|NCT04545385|79261009|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
44291686|NCT04545385|79261010|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
44291687|NCT04545385|79261009|FG000|Overall Study|Study termination|10|||
44291688|NCT04545385|79261010|FG001|Overall Study|Study termination|10|||
44291689|NCT04545385|79261009|FG000|Overall Study|Sponsor decision|2|||
44291690|NCT04545385|79261010|FG001|Overall Study|Sponsor decision|2|||
44291691|NCT04545385|79261009|FG000|Overall Study|Other than specified|1|||
44291692|NCT04545385|79261010|FG001|Overall Study|Other than specified|0|||
44291693|NCT03783026|79261025|FG000|Treatment Phase|Adverse Event|15|||
44291694|NCT03783026|79261025|FG000|Treatment Phase|Lack of Efficacy|11|||
44291695|NCT03783026|79261025|FG000|Treatment Phase|Withdrawal by Subject|6|||
44291696|NCT03783026|79261025|FG000|Treatment Phase|Lost to Follow-up|2|||
44291697|NCT03783026|79261025|FG000|Treatment Phase|Protocol Deviation|8|||
44291698|NCT03783026|79261025|FG000|Treatment Phase|Did Not Receive Treatment|1|||
44291699|NCT03783026|79261025|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
44291700|NCT03635112|79261032|FG000|Overall Study|Adverse Event|5|||
44291701|NCT03635112|79261033|FG001|Overall Study|Adverse Event|9|||
44291702|NCT03635112|79261034|FG002|Overall Study|Adverse Event|14|||
44291703|NCT03635112|79261032|FG000|Overall Study|Lost to Follow-up|1|||
44291704|NCT03635112|79261033|FG001|Overall Study|Lost to Follow-up|0|||
44291705|NCT03635112|79261034|FG002|Overall Study|Lost to Follow-up|1|||
44291706|NCT03635112|79261032|FG000|Overall Study|Physician Decision|5|||
44291707|NCT03635112|79261033|FG001|Overall Study|Physician Decision|7|||
44291708|NCT03635112|79261034|FG002|Overall Study|Physician Decision|5|||
44291709|NCT03635112|79261032|FG000|Overall Study|Protocol Violation|0|||
44291710|NCT03635112|79261033|FG001|Overall Study|Protocol Violation|0|||
44291711|NCT03635112|79261034|FG002|Overall Study|Protocol Violation|1|||
44291712|NCT03635112|79261032|FG000|Overall Study|Study Terminated by Sponsor|11|||
44291713|NCT03635112|79261033|FG001|Overall Study|Study Terminated by Sponsor|17|||
44291714|NCT03635112|79261034|FG002|Overall Study|Study Terminated by Sponsor|21|||
44291715|NCT03635112|79261032|FG000|Overall Study|Withdrawal by Subject|4|||
44291716|NCT03635112|79261033|FG001|Overall Study|Withdrawal by Subject|9|||
44291717|NCT03635112|79261034|FG002|Overall Study|Withdrawal by Subject|7|||
44291718|NCT03635112|79261032|FG000|Overall Study|Miscellaneous|0|||
44291719|NCT03635112|79261033|FG001|Overall Study|Miscellaneous|0|||
44291720|NCT03635112|79261034|FG002|Overall Study|Miscellaneous|1|||
44291721|NCT03588728|79261047|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
44291722|NCT03588728|79261048|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
44291723|NCT03588728|79261049|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
44291724|NCT03588728|79261050|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
44291725|NCT03588728|79261047|FG000|Overall Study|Lab shut down due to COVID-19|0|||
44291726|NCT03588728|79261048|FG001|Overall Study|Lab shut down due to COVID-19|0|||
44291727|NCT03588728|79261049|FG002|Overall Study|Lab shut down due to COVID-19|0|||
44291728|NCT03588728|79261050|FG003|Overall Study|Lab shut down due to COVID-19|1|||
44291729|NCT03588728|79261047|FG000|Overall Study|multiple technical issues|1|||
44291730|NCT03588728|79261048|FG001|Overall Study|multiple technical issues|0|||
44291731|NCT03588728|79261049|FG002|Overall Study|multiple technical issues|0|||
44291732|NCT03588728|79261050|FG003|Overall Study|multiple technical issues|0|||
44291733|NCT03588728|79261047|FG000|Overall Study|Hospitalized for COVID|1|||
44291734|NCT03588728|79261048|FG001|Overall Study|Hospitalized for COVID|0|||
44291735|NCT03588728|79261049|FG002|Overall Study|Hospitalized for COVID|0|||
44291736|NCT03588728|79261050|FG003|Overall Study|Hospitalized for COVID|0|||
44291737|NCT03588728|79261047|FG000|Overall Study|Schedule change unable to attend sessions|1|||
44291738|NCT03588728|79261048|FG001|Overall Study|Schedule change unable to attend sessions|0|||
44291739|NCT03588728|79261049|FG002|Overall Study|Schedule change unable to attend sessions|0|||
44291740|NCT03588728|79261050|FG003|Overall Study|Schedule change unable to attend sessions|0|||
44291741|NCT02987543|79261072|FG000|Overall Study|Ongoing study at data cut off|49|||
44291742|NCT02987543|79261073|FG001|Overall Study|Ongoing study at data cut off|21|||
44291743|NCT02987543|79261074|FG002|Overall Study|Ongoing study at data cut off|19|||
44291744|NCT02987543|79261075|FG003|Overall Study|Ongoing study at data cut off|12|||
44291745|NCT02987543|79261072|FG000|Overall Study|Death|88|||
44291746|NCT02987543|79261073|FG001|Overall Study|Death|54|||
44291747|NCT02987543|79261074|FG002|Overall Study|Death|67|||
44291748|NCT02987543|79261075|FG003|Overall Study|Death|28|||
44291749|NCT02987543|79261072|FG000|Overall Study|Lost to Follow-up|3|||
44291750|NCT02987543|79261073|FG001|Overall Study|Lost to Follow-up|0|||
44291751|NCT02987543|79261074|FG002|Overall Study|Lost to Follow-up|1|||
44291752|NCT02987543|79261075|FG003|Overall Study|Lost to Follow-up|0|||
44291753|NCT02987543|79261072|FG000|Overall Study|Screen failure|0|||
44291754|NCT02987543|79261073|FG001|Overall Study|Screen failure|0|||
44291755|NCT02987543|79261074|FG002|Overall Study|Screen failure|0|||
44291756|NCT02987543|79261075|FG003|Overall Study|Screen failure|1|||
44291757|NCT02987543|79261072|FG000|Overall Study|Withdrawal by Subject|21|||
44291758|NCT02987543|79261073|FG001|Overall Study|Withdrawal by Subject|7|||
44291759|NCT02987543|79261074|FG002|Overall Study|Withdrawal by Subject|7|||
44291760|NCT02987543|79261075|FG003|Overall Study|Withdrawal by Subject|6|||
44291761|NCT02987543|79261072|FG000|Overall Study|Study terminated by sponsor|1|||
44291762|NCT02987543|79261073|FG001|Overall Study|Study terminated by sponsor|0|||
44291763|NCT02987543|79261074|FG002|Overall Study|Study terminated by sponsor|0|||
44291764|NCT02987543|79261075|FG003|Overall Study|Study terminated by sponsor|0|||
44291765|NCT02987543|79261072|FG000|Overall Study|Investigator decision|0|||
44291766|NCT02987543|79261073|FG001|Overall Study|Investigator decision|1|||
44291767|NCT02987543|79261074|FG002|Overall Study|Investigator decision|0|||
44291768|NCT02987543|79261075|FG003|Overall Study|Investigator decision|0|||
44291769|NCT02987543|79261072|FG000|Overall Study|Disease progression|0|||
44291770|NCT02987543|79261073|FG001|Overall Study|Disease progression|0|||
44291771|NCT02987543|79261074|FG002|Overall Study|Disease progression|0|||
44291772|NCT02987543|79261075|FG003|Overall Study|Disease progression|1|||
44291773|NCT02983045|79261091|FG000|Overall Study|Withdrawal by Subject|0|||
44291774|NCT02983045|79261092|FG001|Overall Study|Withdrawal by Subject|1|||
44416412|NCT00763971|79424134|FG001|Overall Study|Medical monitor decision|0|||
44416413|NCT00763971|79424135|FG002|Overall Study|Medical monitor decision|1|||
44416414|NCT00763971|79424133|FG000|Overall Study|Moved to another country|0|||
44416415|NCT00763971|79424134|FG001|Overall Study|Moved to another country|1|||
44416416|NCT00763971|79424135|FG002|Overall Study|Moved to another country|0|||
44416417|NCT00763971|79424133|FG000|Overall Study|Subject wanted dose reduction|0|||
44416418|NCT00763971|79424134|FG001|Overall Study|Subject wanted dose reduction|1|||
44416419|NCT00763971|79424135|FG002|Overall Study|Subject wanted dose reduction|0|||
44416420|NCT00763971|79424133|FG000|Overall Study|Lack of availability|0|||
44416421|NCT00763971|79424134|FG001|Overall Study|Lack of availability|1|||
44416422|NCT00763971|79424135|FG002|Overall Study|Lack of availability|0|||
44416423|NCT00763971|79424133|FG000|Overall Study|Performed final visit on phone|0|||
44416424|NCT00763971|79424134|FG001|Overall Study|Performed final visit on phone|1|||
44416425|NCT00763971|79424135|FG002|Overall Study|Performed final visit on phone|0|||
44416426|NCT00763971|79424133|FG000|Overall Study|Participation in 489-326 required|1|||
44416427|NCT00763971|79424134|FG001|Overall Study|Participation in 489-326 required|0|||
44416428|NCT00763971|79424135|FG002|Overall Study|Participation in 489-326 required|0|||
44416429|NCT00763815|79424145|FG000|Overall Study|Adverse Event|14|||
44416430|NCT00763815|79424146|FG001|Overall Study|Adverse Event|29|||
44291775|NCT02983045|79261093|FG002|Overall Study|Withdrawal by Subject|0|||
44291776|NCT02983045|79261094|FG003|Overall Study|Withdrawal by Subject|5|||
44291777|NCT02983045|79261095|FG004|Overall Study|Withdrawal by Subject|0|||
44416431|NCT00763815|79424145|FG000|Overall Study|Lack of Efficacy|10|||
44416432|NCT00763815|79424146|FG001|Overall Study|Lack of Efficacy|11|||
44291778|NCT02983045|79261096|FG005|Overall Study|Withdrawal by Subject|72|||
44291779|NCT02983045|79261097|FG006|Overall Study|Withdrawal by Subject|0|||
44291780|NCT02983045|79261098|FG007|Overall Study|Withdrawal by Subject|0|||
44291781|NCT02983045|79261099|FG008|Overall Study|Withdrawal by Subject|0|||
44416433|NCT00763815|79424145|FG000|Overall Study|Poor Compliance to Protocol|6|||
44416434|NCT00763815|79424146|FG001|Overall Study|Poor Compliance to Protocol|6|||
44291782|NCT02983045|79261100|FG009|Overall Study|Withdrawal by Subject|2|||
44291783|NCT02983045|79261091|FG000|Overall Study|Lost to Follow-up|0|||
44291784|NCT02983045|79261092|FG001|Overall Study|Lost to Follow-up|0|||
44291785|NCT02983045|79261093|FG002|Overall Study|Lost to Follow-up|0|||
44291786|NCT02983045|79261094|FG003|Overall Study|Lost to Follow-up|0|||
44291787|NCT02983045|79261095|FG004|Overall Study|Lost to Follow-up|0|||
44291788|NCT02983045|79261096|FG005|Overall Study|Lost to Follow-up|10|||
44291789|NCT02983045|79261097|FG006|Overall Study|Lost to Follow-up|0|||
44291790|NCT02983045|79261098|FG007|Overall Study|Lost to Follow-up|0|||
44291791|NCT02983045|79261099|FG008|Overall Study|Lost to Follow-up|0|||
44291792|NCT02983045|79261100|FG009|Overall Study|Lost to Follow-up|0|||
44291793|NCT02564263|79261124|FG000|Overall Study|Adverse Event|31|||
44291794|NCT02564263|79261125|FG001|Overall Study|Adverse Event|29|||
44291795|NCT02564263|79261124|FG000|Overall Study|Death|270|||
44291796|NCT02564263|79261125|FG001|Overall Study|Death|262|||
44291797|NCT02564263|79261124|FG000|Overall Study|Withdrawal by Subject|4|||
44291798|NCT02564263|79261125|FG001|Overall Study|Withdrawal by Subject|19|||
44291799|NCT02564263|79261124|FG000|Overall Study|Sponsor's decision|9|||
44291800|NCT02564263|79261125|FG001|Overall Study|Sponsor's decision|4|||
44291801|NCT02379819|79261132|FG000|Overall Study|Withdrawal by Subject|10|||
44291802|NCT02379819|79261132|FG000|Overall Study|Death|2|||
44291803|NCT02379819|79261132|FG000|Overall Study|Lack of Efficacy|1|||
44291804|NCT02379819|79261132|FG000|Overall Study|Lost to Follow-up|1|||
44291805|NCT02368886|79261140|FG000|Overall Study|Cancel|1|||
44291806|NCT02368886|79261141|FG001|Overall Study|Cancel|1|||
44291807|NCT02368886|79261142|FG002|Overall Study|Cancel|1|||
44291808|NCT02368886|79261143|FG003|Overall Study|Cancel|3|||
44291809|NCT02368886|79261140|FG000|Overall Study|Ineligible|0|||
44291810|NCT02368886|79261141|FG001|Overall Study|Ineligible|0|||
44291811|NCT02368886|79261142|FG002|Overall Study|Ineligible|0|||
44291812|NCT02368886|79261143|FG003|Overall Study|Ineligible|1|||
44291813|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
44291814|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
44291815|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
44291816|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
44291817|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
44291818|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
44291819|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
44291820|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
44291821|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
44291822|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
44291823|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
44291824|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
44291825|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
44291826|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
44291827|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
44291828|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
44291829|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
44291830|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
44291831|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
44291832|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
44291833|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
44291834|NCT02227238|79261157|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
44291835|NCT02227238|79261158|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
44291836|NCT02227238|79261159|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
44291837|NCT02227238|79261157|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
44291838|NCT02227238|79261158|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
44291839|NCT02227238|79261159|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
44291840|NCT02227238|79261157|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
44291841|NCT02227238|79261158|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
44291842|NCT02227238|79261159|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
44291843|NCT02227238|79261157|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
44291844|NCT02227238|79261158|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
44291845|NCT02227238|79261159|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
44291846|NCT02227238|79261157|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
44291847|NCT02227238|79261158|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
44291848|NCT02227238|79261159|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
44291849|NCT02227238|79261157|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
44291850|NCT02227238|79261158|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
44291851|NCT02227238|79261159|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
44291852|NCT02227238|79261157|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
44291853|NCT02227238|79261158|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
44291854|NCT02227238|79261159|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
44291855|NCT02126969|79261180|FG000|Overall Study|Withdrawal by Subject|1|||
44291856|NCT02126969|79261181|FG001|Overall Study|Withdrawal by Subject|2|||
44291857|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
44291858|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
44291859|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
44291860|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
44291861|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
44291862|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
44291863|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
44291864|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
44291865|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
44291866|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
44291867|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
44291868|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
44291869|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
44291870|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
44291871|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
44291872|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
44291873|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
44291874|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
44291875|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
44291876|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
44291877|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
44291878|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
44291879|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
44291880|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
44291881|NCT01715285|79261189|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
44291882|NCT01715285|79261190|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
44291883|NCT01715285|79261191|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
44291884|NCT01715285|79261189|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
44291885|NCT01715285|79261190|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
44291886|NCT01715285|79261191|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
44291887|NCT01715285|79261189|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
44291888|NCT01715285|79261190|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
44291889|NCT01715285|79261191|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
44291890|NCT01715285|79261189|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
44291891|NCT01715285|79261190|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
44291892|NCT01715285|79261191|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
44291893|NCT01715285|79261189|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
44291894|NCT01715285|79261190|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
44291895|NCT01715285|79261191|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
44291896|NCT01715285|79261189|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
44291897|NCT01715285|79261190|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
44291898|NCT01715285|79261191|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
44291899|NCT01250496|79261200|FG000|Overall Study|Study terminated|124|||
44291900|NCT01250496|79261201|FG001|Overall Study|Study terminated|124|||
44291901|NCT01105975|79261217|FG000|Overall Study|Adverse Event|2|||
44291902|NCT01105975|79261218|FG001|Overall Study|Adverse Event|1|||
44291903|NCT01105975|79261219|FG002|Overall Study|Adverse Event|5|||
44291904|NCT01105975|79261220|FG003|Overall Study|Adverse Event|1|||
44291905|NCT01105975|79261221|FG004|Overall Study|Adverse Event|0|||
44291906|NCT01105975|79261222|FG005|Overall Study|Adverse Event|1|||
44291907|NCT01105975|79261223|FG006|Overall Study|Adverse Event|2|||
44291908|NCT01105975|79261224|FG007|Overall Study|Adverse Event|4|||
44291909|NCT01105975|79261225|FG008|Overall Study|Adverse Event|1|||
44291910|NCT01105975|79261226|FG009|Overall Study|Adverse Event|4|||
44291911|NCT01105975|79261217|FG000|Overall Study|Withdrawal by Subject|2|||
44291912|NCT01105975|79261218|FG001|Overall Study|Withdrawal by Subject|2|||
44291913|NCT01105975|79261219|FG002|Overall Study|Withdrawal by Subject|2|||
44291914|NCT01105975|79261220|FG003|Overall Study|Withdrawal by Subject|0|||
44291915|NCT01105975|79261221|FG004|Overall Study|Withdrawal by Subject|4|||
44291916|NCT01105975|79261222|FG005|Overall Study|Withdrawal by Subject|1|||
44291917|NCT01105975|79261223|FG006|Overall Study|Withdrawal by Subject|2|||
44291918|NCT01105975|79261224|FG007|Overall Study|Withdrawal by Subject|1|||
44416435|NCT00763815|79424145|FG000|Overall Study|Lost to Follow-up|2|||
44416436|NCT00763815|79424146|FG001|Overall Study|Lost to Follow-up|4|||
44416437|NCT00763815|79424145|FG000|Overall Study|Early Termination|1|||
44416438|NCT00763815|79424146|FG001|Overall Study|Early Termination|0|||
44416439|NCT00763815|79424145|FG000|Overall Study|Familial and Personal Reasons|9|||
44291919|NCT01105975|79261225|FG008|Overall Study|Withdrawal by Subject|0|||
44291920|NCT01105975|79261226|FG009|Overall Study|Withdrawal by Subject|3|||
44291921|NCT01105975|79261217|FG000|Overall Study|Lost to Follow-up|1|||
44291922|NCT01105975|79261218|FG001|Overall Study|Lost to Follow-up|0|||
44291923|NCT01105975|79261219|FG002|Overall Study|Lost to Follow-up|0|||
44291924|NCT01105975|79261220|FG003|Overall Study|Lost to Follow-up|1|||
44291925|NCT01105975|79261221|FG004|Overall Study|Lost to Follow-up|1|||
44291926|NCT01105975|79261222|FG005|Overall Study|Lost to Follow-up|0|||
44291927|NCT01105975|79261223|FG006|Overall Study|Lost to Follow-up|0|||
44291928|NCT01105975|79261224|FG007|Overall Study|Lost to Follow-up|0|||
44291929|NCT01105975|79261225|FG008|Overall Study|Lost to Follow-up|1|||
44291930|NCT01105975|79261226|FG009|Overall Study|Lost to Follow-up|0|||
44291931|NCT01105975|79261217|FG000|Overall Study|Physician Decision|0|||
44291932|NCT01105975|79261218|FG001|Overall Study|Physician Decision|0|||
44291933|NCT01105975|79261219|FG002|Overall Study|Physician Decision|0|||
44533716|NCT02834780|79544027|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
44533717|NCT02834780|79544015|FG000|Overall Study|Other|1|||
44291934|NCT01105975|79261220|FG003|Overall Study|Physician Decision|0|||
44291935|NCT01105975|79261221|FG004|Overall Study|Physician Decision|0|||
44291936|NCT01105975|79261222|FG005|Overall Study|Physician Decision|0|||
44291937|NCT01105975|79261223|FG006|Overall Study|Physician Decision|2|||
44291938|NCT01105975|79261224|FG007|Overall Study|Physician Decision|0|||
44291939|NCT01105975|79261225|FG008|Overall Study|Physician Decision|0|||
44291940|NCT01105975|79261226|FG009|Overall Study|Physician Decision|0|||
44291941|NCT01105975|79261217|FG000|Overall Study|Protocol Violation|0|||
44291942|NCT01105975|79261218|FG001|Overall Study|Protocol Violation|2|||
44291943|NCT01105975|79261219|FG002|Overall Study|Protocol Violation|2|||
44291944|NCT01105975|79261220|FG003|Overall Study|Protocol Violation|0|||
44291945|NCT01105975|79261221|FG004|Overall Study|Protocol Violation|1|||
44291946|NCT01105975|79261222|FG005|Overall Study|Protocol Violation|1|||
44291947|NCT01105975|79261223|FG006|Overall Study|Protocol Violation|1|||
44291948|NCT01105975|79261224|FG007|Overall Study|Protocol Violation|1|||
44291949|NCT01105975|79261225|FG008|Overall Study|Protocol Violation|2|||
44291950|NCT01105975|79261226|FG009|Overall Study|Protocol Violation|2|||
44291951|NCT01105975|79261217|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44291952|NCT01105975|79261218|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44291953|NCT01105975|79261219|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
44291954|NCT01105975|79261220|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44291955|NCT01105975|79261221|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44291956|NCT01105975|79261222|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
44533718|NCT02834780|79544016|FG001|Overall Study|Other|0|||
44533719|NCT02834780|79544017|FG002|Overall Study|Other|1|||
44533720|NCT02834780|79544018|FG003|Overall Study|Other|2|||
44533721|NCT02834780|79544019|FG004|Overall Study|Other|0|||
44533722|NCT02834780|79544020|FG005|Overall Study|Other|0|||
44533723|NCT02834780|79544021|FG006|Overall Study|Other|0|||
44533724|NCT02834780|79544022|FG007|Overall Study|Other|0|||
44533725|NCT02834780|79544023|FG008|Overall Study|Other|0|||
44291957|NCT01105975|79261223|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
44291958|NCT01105975|79261224|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
44291959|NCT01105975|79261225|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
44291960|NCT01105975|79261226|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44291961|NCT00831623|79261267|FG000|Overall Study|Withdrawal by Subject|9|||
44291962|NCT00831623|79261267|FG000|Overall Study|Lost to Follow-up|1|||
44291963|NCT00831623|79261267|FG000|Overall Study|Not 2 years post-treatment|12|||
44291964|NCT00079417|79261271|FG000|Overall Study|Physician Decision|2|||
44291965|NCT00079417|79261271|FG000|Overall Study|Ineligible|7|||
44291966|NCT04627038|79265990|FG000|Overall Study|Adverse Event|36|||
44291967|NCT04627038|79265991|FG001|Overall Study|Adverse Event|8|||
44291968|NCT04627038|79265990|FG000|Overall Study|Lost to Follow-up|1|||
44533726|NCT02834780|79544024|FG009|Overall Study|Other|0|||
44533727|NCT02834780|79544025|FG010|Overall Study|Other|0|||
44533728|NCT02834780|79544026|FG011|Overall Study|Other|0|||
44533729|NCT02834780|79544027|FG012|Overall Study|Other|1|||
44533730|NCT02829957|79544063|FG000|Overall Study|Lost to Follow-up|2|||
44533731|NCT02829957|79544064|FG001|Overall Study|Lost to Follow-up|1|||
44291969|NCT04627038|79265991|FG001|Overall Study|Lost to Follow-up|0|||
44291970|NCT04627038|79265990|FG000|Overall Study|Physician Decision|0|||
44291971|NCT04627038|79265991|FG001|Overall Study|Physician Decision|1|||
44291972|NCT04627038|79265990|FG000|Overall Study|Protocol Violation|3|||
44291973|NCT04627038|79265991|FG001|Overall Study|Protocol Violation|1|||
44291974|NCT04627038|79265990|FG000|Overall Study|Withdrawal by Subject|13|||
44291975|NCT04627038|79265991|FG001|Overall Study|Withdrawal by Subject|3|||
44291976|NCT04627038|79265990|FG000|Overall Study|Non-compliance with study drug|0|||
44291977|NCT04627038|79265991|FG001|Overall Study|Non-compliance with study drug|1|||
44291978|NCT04627038|79265990|FG000|Overall Study|Prohibited Concomitant Medication|1|||
44533732|NCT01984346|79544083|FG000|Overall Study|Physician Decision|4|||
44533733|NCT01984346|79544084|FG001|Overall Study|Physician Decision|2|||
44291979|NCT04627038|79265991|FG001|Overall Study|Prohibited Concomitant Medication|0|||
44291980|NCT05483686|79266205|FG000|Overall Study|Lost to Follow-up|5|||
44291981|NCT05483686|79266206|FG001|Overall Study|Lost to Follow-up|7|||
44291982|NCT05292755|79266214|FG000|Overall Study|Lost to Follow-up|5|||
44291983|NCT05292755|79266215|FG001|Overall Study|Lost to Follow-up|9|||
44291984|NCT04590781|79266229|FG000|Overall Study|Death|0|||
44291985|NCT04590781|79266230|FG001|Overall Study|Death|2|||
44291986|NCT04590781|79266229|FG000|Overall Study|Withdrawal by Subject|2|||
44291987|NCT04590781|79266230|FG001|Overall Study|Withdrawal by Subject|0|||
44291988|NCT04248868|79266237|FG000|Overall Study|Death|1|||
44291989|NCT04248868|79266237|FG000|Overall Study|Lost to Follow-up|3|||
44291990|NCT04248868|79266237|FG000|Overall Study|Protocol Violation|2|||
44291991|NCT04211831|79266244|FG000|Overall Study|Withdrawal by Subject|4|||
44291992|NCT04211831|79266245|FG001|Overall Study|Withdrawal by Subject|1|||
44291993|NCT04211831|79266246|FG002|Overall Study|Withdrawal by Subject|1|||
44291994|NCT04211831|79266244|FG000|Overall Study|Protocol Violation|0|||
44291995|NCT04211831|79266245|FG001|Overall Study|Protocol Violation|0|||
44291996|NCT04211831|79266246|FG002|Overall Study|Protocol Violation|1|||
44291997|NCT04211831|79266244|FG000|Overall Study|Adverse Event|0|||
44291998|NCT04211831|79266245|FG001|Overall Study|Adverse Event|1|||
44291999|NCT04211831|79266246|FG002|Overall Study|Adverse Event|0|||
44292000|NCT04211831|79266244|FG000|Overall Study|Lack of Efficacy|0|||
44292001|NCT04211831|79266245|FG001|Overall Study|Lack of Efficacy|0|||
44292002|NCT04211831|79266246|FG002|Overall Study|Lack of Efficacy|1|||
44292003|NCT04211831|79266244|FG000|Overall Study|Lost to Follow-up|0|||
44292004|NCT04211831|79266245|FG001|Overall Study|Lost to Follow-up|0|||
44292005|NCT04211831|79266246|FG002|Overall Study|Lost to Follow-up|2|||
44292006|NCT04211831|79266244|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
44292007|NCT04211831|79266245|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
44292008|NCT04211831|79266246|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
44292009|NCT04211831|79266244|FG000|Overall Study|Other|0|||
44292010|NCT04211831|79266245|FG001|Overall Study|Other|1|||
44292011|NCT04211831|79266246|FG002|Overall Study|Other|0|||
44292012|NCT04067518|79266304|FG000|Overall Study|Adverse Event|1|||
44292013|NCT04067518|79266305|FG001|Overall Study|Adverse Event|3|||
44292014|NCT04067518|79266304|FG000|Overall Study|Screen failures|0|||
44292015|NCT04067518|79266305|FG001|Overall Study|Screen failures|1|||
44292016|NCT04067518|79266304|FG000|Overall Study|Enrolled but not treated|0|||
44292017|NCT04067518|79266305|FG001|Overall Study|Enrolled but not treated|1|||
44292018|NCT03912233|79266346|FG000|Overall Study|Adverse Event|1|||
44292019|NCT03912233|79266347|FG001|Overall Study|Adverse Event|0|||
44292020|NCT03912233|79266348|FG002|Overall Study|Adverse Event|0|||
44292021|NCT03912233|79266349|FG003|Overall Study|Adverse Event|0|||
44292022|NCT03912233|79266350|FG004|Overall Study|Adverse Event|0|||
44292023|NCT03912233|79266351|FG005|Overall Study|Adverse Event|0|||
44292024|NCT03912233|79266346|FG000|Overall Study|Physician Decision|1|||
44292025|NCT03912233|79266347|FG001|Overall Study|Physician Decision|0|||
44292026|NCT03912233|79266348|FG002|Overall Study|Physician Decision|0|||
44292027|NCT03912233|79266349|FG003|Overall Study|Physician Decision|0|||
44292028|NCT03912233|79266350|FG004|Overall Study|Physician Decision|0|||
44292029|NCT03912233|79266351|FG005|Overall Study|Physician Decision|0|||
44292030|NCT03912233|79266346|FG000|Overall Study|Other|0|||
44292031|NCT03912233|79266347|FG001|Overall Study|Other|0|||
44292032|NCT03912233|79266348|FG002|Overall Study|Other|0|||
44292033|NCT03912233|79266349|FG003|Overall Study|Other|0|||
44292034|NCT03912233|79266350|FG004|Overall Study|Other|7|||
44292035|NCT03912233|79266351|FG005|Overall Study|Other|12|||
44292036|NCT03546062|79266394|FG000|Overall Study|Adverse Event|6|||
44292037|NCT03546062|79266395|FG001|Overall Study|Adverse Event|5|||
44292038|NCT03546062|79266396|FG002|Overall Study|Adverse Event|8|||
44292039|NCT03539952|79266406|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
44292040|NCT03539952|79266407|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
44292041|NCT03539952|79266406|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
44292042|NCT03539952|79266407|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
44292043|NCT03539952|79266406|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
44292044|NCT03539952|79266407|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
44292045|NCT03539952|79266406|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
44292046|NCT03539952|79266407|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
44292047|NCT03539952|79266406|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
44292048|NCT03539952|79266407|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
44292049|NCT03539952|79266406|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
44292050|NCT03539952|79266407|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
44292051|NCT03539952|79266406|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
44292052|NCT03539952|79266407|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
44292053|NCT02929108|79266439|FG000|Overall Study|Hospice patient death|100|||
44292054|NCT02929108|79266440|FG001|Overall Study|Hospice patient death|64|||
44292055|NCT02929108|79266441|FG002|Overall Study|Hospice patient death|28|||
44292056|NCT02929108|79266442|FG003|Overall Study|Hospice patient death|46|||
44292057|NCT02929108|79266443|FG004|Overall Study|Hospice patient death|55|||
44292058|NCT02929108|79266444|FG005|Overall Study|Hospice patient death|28|||
44292059|NCT02929108|79266445|FG006|Overall Study|Hospice patient death|78|||
44292060|NCT02661295|79266453|FG000|Overall Study|Death|1|||
44292061|NCT02661295|79266453|FG000|Overall Study|Transferred Out|1|||
44292062|NCT02661295|79266453|FG000|Overall Study|Kidney Transplant|1|||
44292063|NCT02661295|79266453|FG000|Overall Study|Withdrawn due to side effects|8|||
44292064|NCT02661295|79266453|FG000|Overall Study|Withdrawn due to access type|1|||
44292065|NCT02661295|79266453|FG000|Overall Study|Withdrawn due to allergies|1|||
44292066|NCT02661295|79266453|FG000|Overall Study|Withdrawn due to non-compliance|1|||
44292067|NCT02661295|79266453|FG000|Overall Study|Withdrawal by Subject|3|||
44292068|NCT02661295|79266453|FG000|Overall Study|Failed screening|2|||
44292069|NCT02412748|79266459|FG000|Overall Study|Lost to Follow-up|38|||
44292070|NCT02412748|79266460|FG001|Overall Study|Lost to Follow-up|39|||
44292071|NCT01844726|79266485|FG000|Overall Study|Withdrawal by Subject|0|||
44292072|NCT01844726|79266486|FG001|Overall Study|Withdrawal by Subject|1|||
44292073|NCT01844726|79266485|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
44292074|NCT01844726|79266486|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
44292075|NCT04980391|79269705|FG000|Overall Study|Death|0|||
44292076|NCT04980391|79269706|FG001|Overall Study|Death|0|||
44292077|NCT04980391|79269707|FG002|Overall Study|Death|1|||
44292078|NCT04980391|79269708|FG003|Overall Study|Death|1|||
44292079|NCT04980391|79269705|FG000|Overall Study|Lost to Follow-up|3|||
44292080|NCT04980391|79269706|FG001|Overall Study|Lost to Follow-up|3|||
44292081|NCT04980391|79269707|FG002|Overall Study|Lost to Follow-up|2|||
44292082|NCT04980391|79269708|FG003|Overall Study|Lost to Follow-up|3|||
44292083|NCT04980391|79269705|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
44292084|NCT04980391|79269706|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
44292085|NCT04980391|79269707|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
44292086|NCT04980391|79269708|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
44292087|NCT04980391|79269705|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44292088|NCT04980391|79269706|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44292089|NCT04980391|79269707|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
44292090|NCT04980391|79269708|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44292091|NCT04980391|79269705|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
44292092|NCT04980391|79269706|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
44292093|NCT04980391|79269707|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
44292094|NCT04980391|79269708|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
44292095|NCT04939428|79269723|FG000|Overall Study|Death|0|||
44416440|NCT00763815|79424146|FG001|Overall Study|Familial and Personal Reasons|16|||
44416441|NCT00763815|79424145|FG000|Overall Study|Physician Decision|1|||
44416442|NCT00763815|79424146|FG001|Overall Study|Physician Decision|0|||
44416443|NCT00763815|79424145|FG000|Overall Study|Withdrawal by Subject|7|||
44416444|NCT00763815|79424146|FG001|Overall Study|Withdrawal by Subject|12|||
44416445|NCT00763815|79424145|FG000|Overall Study|Protocol Violation|2|||
44416446|NCT00763815|79424146|FG001|Overall Study|Protocol Violation|5|||
44416447|NCT00763815|79424145|FG000|Overall Study|Sponsor's Decision|0|||
44292096|NCT04939428|79269724|FG001|Overall Study|Death|1|||
44292097|NCT04939428|79269725|FG002|Overall Study|Death|0|||
44292098|NCT04939428|79269723|FG000|Overall Study|Lost to Follow-up|0|||
44292099|NCT04939428|79269724|FG001|Overall Study|Lost to Follow-up|5|||
44292100|NCT04939428|79269725|FG002|Overall Study|Lost to Follow-up|0|||
44292101|NCT04939428|79269723|FG000|Overall Study|Physician Decision|1|||
44292102|NCT04939428|79269724|FG001|Overall Study|Physician Decision|0|||
44292103|NCT04939428|79269725|FG002|Overall Study|Physician Decision|0|||
44292104|NCT04939428|79269723|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
44416448|NCT00763815|79424146|FG001|Overall Study|Sponsor's Decision|1|||
44416449|NCT00763269|79424154|FG000|Overall Study|Lost to Follow-up|12|||
44416450|NCT00763269|79424155|FG001|Overall Study|Lost to Follow-up|13|||
44292105|NCT04939428|79269724|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44292106|NCT04939428|79269725|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44292107|NCT04939428|79269723|FG000|Overall Study|Withdrawal by Subject|10|||
44292108|NCT04939428|79269724|FG001|Overall Study|Withdrawal by Subject|11|||
44292109|NCT04939428|79269725|FG002|Overall Study|Withdrawal by Subject|0|||
44292110|NCT04939428|79269723|FG000|Overall Study|Unkown|6|||
44292111|NCT04939428|79269724|FG001|Overall Study|Unkown|3|||
44292112|NCT04939428|79269725|FG002|Overall Study|Unkown|0|||
44292113|NCT04939428|79269723|FG000|Overall Study|Discotinued per protocol|0|||
44292114|NCT04939428|79269724|FG001|Overall Study|Discotinued per protocol|0|||
44416451|NCT00763035|79424161|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
44416452|NCT00763035|79424162|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
44292115|NCT04939428|79269725|FG002|Overall Study|Discotinued per protocol|902|||
44292116|NCT04805671|79269733|FG000|Overall Study|Death|2|||
44292117|NCT04805671|79269734|FG001|Overall Study|Death|7|||
44292118|NCT04805671|79269733|FG000|Overall Study|Lost to Follow-up|1|||
44292119|NCT04805671|79269734|FG001|Overall Study|Lost to Follow-up|0|||
44292120|NCT04805671|79269733|FG000|Overall Study|Withdrawal by Subject|9|||
44292121|NCT04805671|79269734|FG001|Overall Study|Withdrawal by Subject|7|||
44292122|NCT04805671|79269733|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
44292123|NCT04805671|79269734|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
44292124|NCT04779489|79269740|FG000|Overall Study|Physician Decision|1|||
44292125|NCT04533438|79269758|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
44292126|NCT04533438|79269759|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
44292127|NCT04469465|79269769|FG000|Overall Study|Adverse Event|2|||
44292128|NCT04469465|79269770|FG001|Overall Study|Adverse Event|1|||
44292129|NCT04469465|79269769|FG000|Overall Study|Ongoing treatment|7|||
44292130|NCT04469465|79269770|FG001|Overall Study|Ongoing treatment|4|||
44292131|NCT04469465|79269769|FG000|Overall Study|Withdrawal by Subject|0|||
44292132|NCT04469465|79269770|FG001|Overall Study|Withdrawal by Subject|1|||
44292133|NCT04431453|79269784|FG000|Overall Study|Withdrew Consent|0|||
44292134|NCT04431453|79269785|FG001|Overall Study|Withdrew Consent|1|||
44292135|NCT04431453|79269786|FG002|Overall Study|Withdrew Consent|0|||
44292136|NCT04431453|79269787|FG003|Overall Study|Withdrew Consent|2|||
44292137|NCT04431453|79269788|FG004|Overall Study|Withdrew Consent|0|||
44292138|NCT04431453|79269789|FG005|Overall Study|Withdrew Consent|0|||
44292139|NCT04431453|79269790|FG006|Overall Study|Withdrew Consent|0|||
44292140|NCT04431453|79269791|FG007|Overall Study|Withdrew Consent|0|||
44292141|NCT04431453|79269784|FG000|Overall Study|Death|1|||
44292142|NCT04431453|79269785|FG001|Overall Study|Death|0|||
44292143|NCT04431453|79269786|FG002|Overall Study|Death|0|||
44292144|NCT04431453|79269787|FG003|Overall Study|Death|0|||
44292145|NCT04431453|79269788|FG004|Overall Study|Death|0|||
44292146|NCT04431453|79269789|FG005|Overall Study|Death|0|||
44292147|NCT04431453|79269790|FG006|Overall Study|Death|0|||
44292148|NCT04431453|79269791|FG007|Overall Study|Death|1|||
44292149|NCT04431453|79269784|FG000|Overall Study|Lost to Follow-up|0|||
44292150|NCT04431453|79269785|FG001|Overall Study|Lost to Follow-up|0|||
44292151|NCT04431453|79269786|FG002|Overall Study|Lost to Follow-up|1|||
44292152|NCT04431453|79269787|FG003|Overall Study|Lost to Follow-up|1|||
44292153|NCT04431453|79269788|FG004|Overall Study|Lost to Follow-up|0|||
44292154|NCT04431453|79269789|FG005|Overall Study|Lost to Follow-up|0|||
44292155|NCT04431453|79269790|FG006|Overall Study|Lost to Follow-up|0|||
44292156|NCT04431453|79269791|FG007|Overall Study|Lost to Follow-up|0|||
44292157|NCT04431453|79269784|FG000|Overall Study|Enrolled but Never Treated|0|||
44292158|NCT04431453|79269785|FG001|Overall Study|Enrolled but Never Treated|0|||
44292159|NCT04431453|79269786|FG002|Overall Study|Enrolled but Never Treated|0|||
44292160|NCT04431453|79269787|FG003|Overall Study|Enrolled but Never Treated|0|||
44292161|NCT04431453|79269788|FG004|Overall Study|Enrolled but Never Treated|1|||
44292162|NCT04431453|79269789|FG005|Overall Study|Enrolled but Never Treated|0|||
44292163|NCT04431453|79269790|FG006|Overall Study|Enrolled but Never Treated|0|||
44292164|NCT04431453|79269791|FG007|Overall Study|Enrolled but Never Treated|0|||
44292165|NCT04403763|79269822|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
44292166|NCT04403763|79269823|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
44292167|NCT04403763|79269824|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
44292168|NCT04403763|79269825|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
44292169|NCT04403763|79269826|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
44292170|NCT04403763|79269827|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
44292171|NCT04403763|79269828|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
44292172|NCT04403763|79269822|FG000|Stage 1|Early termination due to PK tube failure|0|||
44292173|NCT04403763|79269823|FG001|Stage 1|Early termination due to PK tube failure|0|||
44292174|NCT04403763|79269824|FG002|Stage 1|Early termination due to PK tube failure|1|||
44292175|NCT04403763|79269825|FG003|Stage 1|Early termination due to PK tube failure|0|||
44292176|NCT04403763|79269826|FG004|Stage 1|Early termination due to PK tube failure|0|||
44292177|NCT04403763|79269827|FG005|Stage 1|Early termination due to PK tube failure|0|||
44292178|NCT04403763|79269828|FG006|Stage 1|Early termination due to PK tube failure|0|||
44292179|NCT04403763|79269822|FG000|Stage 2A|Adverse Event|0|||
44292180|NCT04403763|79269823|FG001|Stage 2A|Adverse Event|0|||
44292181|NCT04403763|79269824|FG002|Stage 2A|Adverse Event|0|||
44292182|NCT04403763|79269825|FG003|Stage 2A|Adverse Event|0|||
44292183|NCT04403763|79269826|FG004|Stage 2A|Adverse Event|0|||
44292184|NCT04403763|79269827|FG005|Stage 2A|Adverse Event|0|||
44292185|NCT04403763|79269828|FG006|Stage 2A|Adverse Event|1|||
44292186|NCT04323436|79269853|FG000|Overall Study|Adverse Event|7|||
44292187|NCT04323436|79269854|FG001|Overall Study|Adverse Event|0|||
44292188|NCT04323436|79269855|FG002|Overall Study|Adverse Event|0|||
44292189|NCT04323436|79269853|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
44292190|NCT04323436|79269854|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
44292191|NCT04323436|79269855|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
44292192|NCT04323436|79269853|FG000|Overall Study|Death|1|||
44292193|NCT04323436|79269854|FG001|Overall Study|Death|0|||
44292194|NCT04323436|79269855|FG002|Overall Study|Death|0|||
44292195|NCT04323436|79269853|FG000|Overall Study|Physician Decision|2|||
44292196|NCT04323436|79269854|FG001|Overall Study|Physician Decision|0|||
44292197|NCT04323436|79269855|FG002|Overall Study|Physician Decision|0|||
44292198|NCT04323436|79269853|FG000|Overall Study|Progressive disease|10|||
44292199|NCT04323436|79269854|FG001|Overall Study|Progressive disease|0|||
44292200|NCT04323436|79269855|FG002|Overall Study|Progressive disease|0|||
44292201|NCT04323436|79269853|FG000|Overall Study|Subject decision|3|||
44292202|NCT04323436|79269854|FG001|Overall Study|Subject decision|0|||
44292203|NCT04323436|79269855|FG002|Overall Study|Subject decision|0|||
44292204|NCT04098068|79269876|FG000|Overall Study|Disease Progression|7|||
44292205|NCT04098068|79269876|FG000|Overall Study|Withdrawal by Subject|2|||
44292206|NCT04098068|79269876|FG000|Overall Study|New Cancer Diagnosis|1|||
44292207|NCT04084314|79269880|FG000|Overall Study|Subject/guardian decision|91|||
44292208|NCT04084314|79269880|FG000|Overall Study|Adverse Event|24|||
44292209|NCT04084314|79269880|FG000|Overall Study|Lost to Follow-up|19|||
44292210|NCT04084314|79269880|FG000|Overall Study|New therapy for study indication|9|||
44292211|NCT04084314|79269880|FG000|Overall Study|Pregnancy|9|||
44292212|NCT04084314|79269880|FG000|Overall Study|Withdrawal of informed consent|8|||
44292213|NCT04084314|79269880|FG000|Overall Study|Physician Decision|4|||
44292214|NCT04084314|79269880|FG000|Overall Study|Protocol Deviation|3|||
44292215|NCT04059484|79269886|FG000|Overall Study|Adverse Event|2|||
44292216|NCT04059484|79269887|FG001|Overall Study|Adverse Event|5|||
44292217|NCT04059484|79269886|FG000|Overall Study|Withdrawal by Subject|5|||
44292218|NCT04059484|79269887|FG001|Overall Study|Withdrawal by Subject|3|||
44292219|NCT04059484|79269886|FG000|Overall Study|Progressive disease|112|||
44533734|NCT01984346|79544083|FG000|Overall Study|Withdrawal by Subject|2|||
44292220|NCT04059484|79269887|FG001|Overall Study|Progressive disease|112|||
44292221|NCT04059484|79269886|FG000|Overall Study|Other|8|||
44292222|NCT04059484|79269887|FG001|Overall Study|Other|3|||
44292223|NCT04059484|79269886|FG000|Overall Study|Ongoing|20|||
44533735|NCT01984346|79544084|FG001|Overall Study|Withdrawal by Subject|2|||
44533736|NCT01984346|79544083|FG000|Overall Study|Enrollment Closed|8|||
44533737|NCT01984346|79544084|FG001|Overall Study|Enrollment Closed|1|||
44533738|NCT01984346|79544083|FG000|Overall Study|Insurance Coverage|1|||
44533739|NCT01984346|79544084|FG001|Overall Study|Insurance Coverage|0|||
44533740|NCT01984346|79544083|FG000|Overall Study|Intra-operative Exclusion|2|||
44533741|NCT01984346|79544084|FG001|Overall Study|Intra-operative Exclusion|0|||
44533742|NCT03772327|79544122|FG000|Overall Study|Lost to Follow-up|3|||
44533743|NCT03772327|79544123|FG001|Overall Study|Lost to Follow-up|4|||
44533744|NCT03772327|79544122|FG000|Overall Study|Withdrawal by Subject|2|||
44533745|NCT03772327|79544123|FG001|Overall Study|Withdrawal by Subject|3|||
44533746|NCT04364763|79544166|FG000|Overall Study|Death|1|||
44533747|NCT04364763|79544167|FG001|Overall Study|Death|2|||
44533748|NCT04364763|79544166|FG000|Overall Study|Lost to Follow-up|1|||
44533749|NCT04364763|79544167|FG001|Overall Study|Lost to Follow-up|0|||
44533750|NCT04247815|79544184|FG000|Overall Study|Adverse Event|1|||
44533751|NCT04247815|79544185|FG001|Overall Study|Adverse Event|0|||
44533752|NCT04247815|79544184|FG000|Overall Study|Withdrawal by Subject|1|||
44533753|NCT04247815|79544185|FG001|Overall Study|Withdrawal by Subject|0|||
44533754|NCT04247815|79544184|FG000|Overall Study|Protocol Violation|0|||
44533755|NCT04247815|79544185|FG001|Overall Study|Protocol Violation|1|||
44533756|NCT03432819|79544220|FG000|Overall Study|Lost to Follow-up|2|||
44533757|NCT03432819|79544221|FG001|Overall Study|Lost to Follow-up|2|||
44292224|NCT04059484|79269887|FG001|Overall Study|Ongoing|20|||
44533758|NCT03432819|79544220|FG000|Overall Study|Withdrawal by Subject|5|||
44533759|NCT03432819|79544221|FG001|Overall Study|Withdrawal by Subject|3|||
44533760|NCT03272347|79544249|FG000|Overall Study|Death|0|||
44533761|NCT03272347|79544250|FG001|Overall Study|Death|0|||
44533762|NCT03272347|79544251|FG002|Overall Study|Death|0|||
44533763|NCT03272347|79544252|FG003|Overall Study|Death|1|||
44533764|NCT03272347|79544249|FG000|Overall Study|Lost to Follow-up|1|||
44533765|NCT03272347|79544250|FG001|Overall Study|Lost to Follow-up|3|||
44533766|NCT03272347|79544251|FG002|Overall Study|Lost to Follow-up|5|||
44292225|NCT03907969|79269907|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
44292226|NCT03907969|79269908|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
44292227|NCT03907969|79269909|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
44292228|NCT03907969|79269910|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
44533767|NCT03272347|79544252|FG003|Overall Study|Lost to Follow-up|1|||
44533768|NCT03272347|79544249|FG000|Overall Study|Physician Decision|4|||
44416453|NCT00763035|79424161|FG000|First Intervention|Adverse Event|0|||
44416454|NCT00763035|79424162|FG001|First Intervention|Adverse Event|1|||
44416455|NCT00763035|79424161|FG000|Second Intervention|Adverse Event|1|||
44416456|NCT00763035|79424162|FG001|Second Intervention|Adverse Event|0|||
44416457|NCT00763035|79424161|FG000|Second Intervention|Physician Decision|2|||
44416458|NCT00763035|79424162|FG001|Second Intervention|Physician Decision|0|||
44416459|NCT00844649|79424170|FG000|Overall Study|Progressive Disease|196|||
44416460|NCT00844649|79424171|FG001|Overall Study|Progressive Disease|245|||
44416461|NCT00844649|79424170|FG000|Overall Study|Adverse Event|128|||
44416462|NCT00844649|79424171|FG001|Overall Study|Adverse Event|73|||
44416463|NCT00844649|79424170|FG000|Overall Study|Physician Decision|25|||
44416464|NCT00844649|79424171|FG001|Overall Study|Physician Decision|18|||
44416465|NCT00844649|79424170|FG000|Overall Study|Protocol Violation|10|||
44416466|NCT00844649|79424171|FG001|Overall Study|Protocol Violation|6|||
44416467|NCT00844649|79424170|FG000|Overall Study|Withdrawal by Subject|28|||
44416468|NCT00844649|79424171|FG001|Overall Study|Withdrawal by Subject|39|||
44416469|NCT00844649|79424170|FG000|Overall Study|Other|7|||
44416470|NCT00844649|79424171|FG001|Overall Study|Other|10|||
44416471|NCT00844649|79424170|FG000|Overall Study|Withdrew prior to starting treatment|11|||
44416472|NCT00844649|79424171|FG001|Overall Study|Withdrew prior to starting treatment|27|||
44416473|NCT00762723|79424182|FG000|Overall Study|Study Terminated slow enrollement|5|||
44416474|NCT00762723|79424183|FG001|Overall Study|Study Terminated slow enrollement|5|||
44416475|NCT00762723|79424184|FG002|Overall Study|Study Terminated slow enrollement|3|||
44416476|NCT00850343|79424196|FG000|Overall Study|Withdrawal by Subject|11|||
44416477|NCT00850343|79424197|FG001|Overall Study|Withdrawal by Subject|0|||
44416478|NCT00850343|79424198|FG002|Overall Study|Withdrawal by Subject|3|||
44416479|NCT00850343|79424199|FG003|Overall Study|Withdrawal by Subject|2|||
44416480|NCT00850343|79424196|FG000|Overall Study|Adverse Event|15|||
44416481|NCT00850343|79424197|FG001|Overall Study|Adverse Event|2|||
44416482|NCT00850343|79424198|FG002|Overall Study|Adverse Event|6|||
44416483|NCT00850343|79424199|FG003|Overall Study|Adverse Event|6|||
44416484|NCT00850343|79424196|FG000|Overall Study|Pregnancy|0|||
44416485|NCT00850343|79424197|FG001|Overall Study|Pregnancy|0|||
44416486|NCT00850343|79424198|FG002|Overall Study|Pregnancy|0|||
44416487|NCT00850343|79424199|FG003|Overall Study|Pregnancy|1|||
44416488|NCT00850343|79424196|FG000|Overall Study|Lack of Efficacy|17|||
44416489|NCT00850343|79424197|FG001|Overall Study|Lack of Efficacy|0|||
44416490|NCT00850343|79424198|FG002|Overall Study|Lack of Efficacy|3|||
44416491|NCT00850343|79424199|FG003|Overall Study|Lack of Efficacy|2|||
44416492|NCT00850343|79424196|FG000|Overall Study|Non-compliance with Study Procedures|1|||
44416493|NCT00850343|79424197|FG001|Overall Study|Non-compliance with Study Procedures|0|||
44416494|NCT00850343|79424198|FG002|Overall Study|Non-compliance with Study Procedures|1|||
44416495|NCT00850343|79424199|FG003|Overall Study|Non-compliance with Study Procedures|1|||
44416496|NCT00850343|79424196|FG000|Overall Study|Physician Decision|2|||
44416497|NCT00850343|79424197|FG001|Overall Study|Physician Decision|1|||
44416498|NCT00850343|79424198|FG002|Overall Study|Physician Decision|1|||
44416499|NCT00850343|79424199|FG003|Overall Study|Physician Decision|1|||
44416500|NCT00849875|79424212|FG000|Overall Study|Death|28|||
44416501|NCT00849875|79424212|FG000|Overall Study|Ongoing (unknown completion status)|11|||
44416502|NCT00849875|79424212|FG000|Overall Study|Others|6|||
44416503|NCT00849875|79424212|FG000|Overall Study|Lost to Follow-up|2|||
44416504|NCT00844415|79424223|FG000|Overall Study|Withdrawal by Subject|1|||
44533769|NCT03272347|79544250|FG001|Overall Study|Physician Decision|2|||
44533770|NCT03272347|79544251|FG002|Overall Study|Physician Decision|5|||
44533771|NCT03272347|79544252|FG003|Overall Study|Physician Decision|4|||
44533772|NCT03272347|79544249|FG000|Overall Study|Screen Failure|1|||
44533773|NCT03272347|79544250|FG001|Overall Study|Screen Failure|0|||
44533774|NCT03272347|79544251|FG002|Overall Study|Screen Failure|0|||
44533775|NCT03272347|79544252|FG003|Overall Study|Screen Failure|0|||
44533776|NCT03272347|79544249|FG000|Overall Study|Withdrawal by Subject|5|||
44533777|NCT03272347|79544250|FG001|Overall Study|Withdrawal by Subject|1|||
44416505|NCT00843635|79424231|FG000|Overall Study|Adverse Event|2|||
44416506|NCT00843635|79424232|FG001|Overall Study|Adverse Event|2|||
44416507|NCT00843635|79424233|FG002|Overall Study|Adverse Event|0|||
44416508|NCT00843167|79424247|FG000|Treatment Period|Adverse Event|1|||
44416509|NCT00843167|79424248|FG001|Treatment Period|Adverse Event|5|||
44533778|NCT03272347|79544251|FG002|Overall Study|Withdrawal by Subject|2|||
44416510|NCT00843167|79424247|FG000|Treatment Period|Withdrawal by Subject|2|||
44416511|NCT00843167|79424248|FG001|Treatment Period|Withdrawal by Subject|3|||
44416512|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
44154548|NCT02687581|78945763|FG000|Overall Study|Lost to Follow-up|2|||
44416513|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
44416514|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
44533779|NCT03272347|79544252|FG003|Overall Study|Withdrawal by Subject|1|||
44533780|NCT03259568|79544274|FG000|Overall Study|Participant performance was low|3|||
44416515|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
44292229|NCT03907969|79269911|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
44292230|NCT03907969|79269912|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
44292231|NCT03907969|79269913|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
44292232|NCT03907969|79269914|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
44292233|NCT03907969|79269915|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
44292234|NCT03907969|79269916|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
44292235|NCT03907969|79269917|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
44292236|NCT03907969|79269907|FG000|Monotherapy Part A|Progressive Disease|0|||
44292237|NCT03907969|79269908|FG001|Monotherapy Part A|Progressive Disease|1|||
44292238|NCT03907969|79269909|FG002|Monotherapy Part A|Progressive Disease|0|||
44292239|NCT03907969|79269910|FG003|Monotherapy Part A|Progressive Disease|0|||
44292240|NCT03907969|79269911|FG004|Monotherapy Part A|Progressive Disease|0|||
44292241|NCT03907969|79269912|FG005|Monotherapy Part A|Progressive Disease|1|||
44292242|NCT03907969|79269913|FG006|Monotherapy Part A|Progressive Disease|2|||
44292243|NCT03907969|79269914|FG007|Monotherapy Part A|Progressive Disease|0|||
44292244|NCT03907969|79269915|FG008|Monotherapy Part A|Progressive Disease|0|||
44292245|NCT03907969|79269916|FG009|Monotherapy Part A|Progressive Disease|0|||
44292246|NCT03907969|79269917|FG010|Monotherapy Part A|Progressive Disease|0|||
44292247|NCT03907969|79269907|FG000|Monotherapy Part A|Death|0|||
44292248|NCT03907969|79269908|FG001|Monotherapy Part A|Death|0|||
44292249|NCT03907969|79269909|FG002|Monotherapy Part A|Death|1|||
44292250|NCT03907969|79269910|FG003|Monotherapy Part A|Death|1|||
44292251|NCT03907969|79269911|FG004|Monotherapy Part A|Death|0|||
44292252|NCT03907969|79269912|FG005|Monotherapy Part A|Death|1|||
44292253|NCT03907969|79269913|FG006|Monotherapy Part A|Death|0|||
44292254|NCT03907969|79269914|FG007|Monotherapy Part A|Death|0|||
44292255|NCT03907969|79269915|FG008|Monotherapy Part A|Death|0|||
44292256|NCT03907969|79269916|FG009|Monotherapy Part A|Death|0|||
44292257|NCT03907969|79269917|FG010|Monotherapy Part A|Death|0|||
44292258|NCT03907969|79269907|FG000|Combination Therapy Part A|Adverse Event|0|||
44292259|NCT03907969|79269908|FG001|Combination Therapy Part A|Adverse Event|0|||
44292260|NCT03907969|79269909|FG002|Combination Therapy Part A|Adverse Event|0|||
44292261|NCT03907969|79269910|FG003|Combination Therapy Part A|Adverse Event|0|||
44292262|NCT03907969|79269911|FG004|Combination Therapy Part A|Adverse Event|0|||
44292263|NCT03907969|79269912|FG005|Combination Therapy Part A|Adverse Event|0|||
44292264|NCT03907969|79269913|FG006|Combination Therapy Part A|Adverse Event|0|||
44292265|NCT03907969|79269914|FG007|Combination Therapy Part A|Adverse Event|0|||
44292266|NCT03907969|79269915|FG008|Combination Therapy Part A|Adverse Event|0|||
44292267|NCT03907969|79269916|FG009|Combination Therapy Part A|Adverse Event|1|||
44292268|NCT03907969|79269917|FG010|Combination Therapy Part A|Adverse Event|1|||
44292269|NCT03907969|79269907|FG000|Combination Therapy Part A|Progressive disease|0|||
44292270|NCT03907969|79269908|FG001|Combination Therapy Part A|Progressive disease|0|||
44292271|NCT03907969|79269909|FG002|Combination Therapy Part A|Progressive disease|0|||
44292272|NCT03907969|79269910|FG003|Combination Therapy Part A|Progressive disease|0|||
44292273|NCT03907969|79269911|FG004|Combination Therapy Part A|Progressive disease|0|||
44292274|NCT03907969|79269912|FG005|Combination Therapy Part A|Progressive disease|0|||
44533781|NCT03167723|79544286|FG000|Overall Study|Protocol Violation|4|||
44533782|NCT03167723|79544287|FG001|Overall Study|Protocol Violation|6|||
44533783|NCT03103152|79544299|FG000|Overall Study|Physician Decision|5|||
44533784|NCT03103152|79544300|FG001|Overall Study|Physician Decision|2|||
44533785|NCT03103152|79544301|FG002|Overall Study|Physician Decision|6|||
44533786|NCT03103152|79544302|FG003|Overall Study|Physician Decision|3|||
44533787|NCT03103152|79544303|FG004|Overall Study|Physician Decision|3|||
44533788|NCT03103152|79544304|FG005|Overall Study|Physician Decision|1|||
44533789|NCT03103152|79544299|FG000|Overall Study|Protocol Violation|2|||
44533790|NCT03103152|79544300|FG001|Overall Study|Protocol Violation|2|||
44292275|NCT03907969|79269913|FG006|Combination Therapy Part A|Progressive disease|0|||
44292276|NCT03907969|79269914|FG007|Combination Therapy Part A|Progressive disease|1|||
44292277|NCT03907969|79269915|FG008|Combination Therapy Part A|Progressive disease|0|||
44292278|NCT03907969|79269916|FG009|Combination Therapy Part A|Progressive disease|2|||
44292279|NCT03907969|79269917|FG010|Combination Therapy Part A|Progressive disease|3|||
44292280|NCT03907969|79269907|FG000|Combination Therapy Part A|Death|0|||
44292281|NCT03907969|79269908|FG001|Combination Therapy Part A|Death|0|||
44292282|NCT03907969|79269909|FG002|Combination Therapy Part A|Death|0|||
44292283|NCT03907969|79269910|FG003|Combination Therapy Part A|Death|0|||
44292284|NCT03907969|79269911|FG004|Combination Therapy Part A|Death|0|||
44292285|NCT03907969|79269912|FG005|Combination Therapy Part A|Death|0|||
44533791|NCT03103152|79544301|FG002|Overall Study|Protocol Violation|1|||
44533792|NCT03103152|79544302|FG003|Overall Study|Protocol Violation|2|||
44533793|NCT03103152|79544303|FG004|Overall Study|Protocol Violation|1|||
44292286|NCT03907969|79269913|FG006|Combination Therapy Part A|Death|0|||
44292287|NCT03907969|79269914|FG007|Combination Therapy Part A|Death|0|||
44292288|NCT03907969|79269915|FG008|Combination Therapy Part A|Death|1|||
44292289|NCT03907969|79269916|FG009|Combination Therapy Part A|Death|0|||
44292290|NCT03907969|79269917|FG010|Combination Therapy Part A|Death|1|||
44533794|NCT03103152|79544304|FG005|Overall Study|Protocol Violation|1|||
44533795|NCT03103152|79544299|FG000|Overall Study|Inter-current illness|0|||
44533796|NCT03103152|79544300|FG001|Overall Study|Inter-current illness|0|||
44292291|NCT03907969|79269907|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
44292292|NCT03907969|79269908|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
44292293|NCT03907969|79269909|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
44292294|NCT03907969|79269910|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
44292295|NCT03907969|79269911|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
44292296|NCT03907969|79269912|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
44292297|NCT03907969|79269913|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
44292298|NCT03907969|79269914|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
44292299|NCT03907969|79269915|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
44292300|NCT03907969|79269916|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
44292301|NCT03907969|79269917|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
44292302|NCT03907969|79269907|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
44292303|NCT03907969|79269908|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
44292304|NCT03907969|79269909|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
44292305|NCT03907969|79269910|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
44292306|NCT03907969|79269911|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
44292307|NCT03907969|79269912|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
44292308|NCT03907969|79269913|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
44292309|NCT03907969|79269914|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
44292310|NCT03907969|79269915|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
44292311|NCT03907969|79269916|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
44292312|NCT03907969|79269917|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
44292313|NCT03907969|79269907|FG000|Combination Therapy Part A|Physician Decision|0|||
44292314|NCT03907969|79269908|FG001|Combination Therapy Part A|Physician Decision|0|||
44292315|NCT03907969|79269909|FG002|Combination Therapy Part A|Physician Decision|0|||
44292316|NCT03907969|79269910|FG003|Combination Therapy Part A|Physician Decision|0|||
44292317|NCT03907969|79269911|FG004|Combination Therapy Part A|Physician Decision|0|||
44292318|NCT03907969|79269912|FG005|Combination Therapy Part A|Physician Decision|0|||
44292319|NCT03907969|79269913|FG006|Combination Therapy Part A|Physician Decision|0|||
44292320|NCT03907969|79269914|FG007|Combination Therapy Part A|Physician Decision|1|||
44292321|NCT03907969|79269915|FG008|Combination Therapy Part A|Physician Decision|0|||
44292322|NCT03907969|79269916|FG009|Combination Therapy Part A|Physician Decision|0|||
44292323|NCT03907969|79269917|FG010|Combination Therapy Part A|Physician Decision|1|||
44292324|NCT03898180|79269950|FG000|Overall Study|Ongoing in Study|133|||
44292325|NCT03898180|79269951|FG001|Overall Study|Ongoing in Study|134|||
44292326|NCT03898180|79269950|FG000|Overall Study|Withdrawal by Subject|3|||
44292327|NCT03898180|79269951|FG001|Overall Study|Withdrawal by Subject|2|||
44292328|NCT03898180|79269950|FG000|Overall Study|Death|109|||
44292329|NCT03898180|79269951|FG001|Overall Study|Death|106|||
44292330|NCT03684694|79269988|FG000|Phase 1|Withdrawal by Subject|1|||
44292331|NCT03684694|79269989|FG001|Phase 1|Withdrawal by Subject|0|||
44292332|NCT03684694|79269990|FG002|Phase 1|Withdrawal by Subject|0|||
44292333|NCT03684694|79269991|FG003|Phase 1|Withdrawal by Subject|0|||
44292334|NCT03684694|79269992|FG004|Phase 1|Withdrawal by Subject|0|||
44292335|NCT03684694|79269993|FG005|Phase 1|Withdrawal by Subject|0|||
44292336|NCT03684694|79269988|FG000|Phase 1|Investigator/Sponsor Decision|12|||
44292337|NCT03684694|79269989|FG001|Phase 1|Investigator/Sponsor Decision|2|||
44292338|NCT03684694|79269990|FG002|Phase 1|Investigator/Sponsor Decision|1|||
44292339|NCT03684694|79269991|FG003|Phase 1|Investigator/Sponsor Decision|0|||
44292340|NCT03684694|79269992|FG004|Phase 1|Investigator/Sponsor Decision|0|||
44292341|NCT03684694|79269993|FG005|Phase 1|Investigator/Sponsor Decision|0|||
44292342|NCT03684694|79269988|FG000|Phase 1|Death|24|||
44292343|NCT03684694|79269989|FG001|Phase 1|Death|0|||
44292344|NCT03684694|79269990|FG002|Phase 1|Death|3|||
44292345|NCT03684694|79269991|FG003|Phase 1|Death|0|||
44292346|NCT03684694|79269992|FG004|Phase 1|Death|0|||
44292347|NCT03684694|79269993|FG005|Phase 1|Death|0|||
44416516|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
44416517|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
44416518|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
44416519|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
44416520|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
44416521|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
44292348|NCT03684694|79269988|FG000|Phase 1|Lost to Follow-up|0|||
44292349|NCT03684694|79269989|FG001|Phase 1|Lost to Follow-up|0|||
44292350|NCT03684694|79269990|FG002|Phase 1|Lost to Follow-up|1|||
44416522|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
44292351|NCT03684694|79269991|FG003|Phase 1|Lost to Follow-up|0|||
44292352|NCT03684694|79269992|FG004|Phase 1|Lost to Follow-up|0|||
44292353|NCT03684694|79269993|FG005|Phase 1|Lost to Follow-up|0|||
44292354|NCT03684694|79269988|FG000|Phase 1|Miscellaneous|0|||
44292355|NCT03684694|79269989|FG001|Phase 1|Miscellaneous|1|||
44292356|NCT03684694|79269990|FG002|Phase 1|Miscellaneous|0|||
44292357|NCT03684694|79269991|FG003|Phase 1|Miscellaneous|0|||
44292358|NCT03684694|79269992|FG004|Phase 1|Miscellaneous|0|||
44292359|NCT03684694|79269993|FG005|Phase 1|Miscellaneous|0|||
44292360|NCT03684694|79269988|FG000|Phase 2|Withdrawal by Subject|0|||
44292361|NCT03684694|79269989|FG001|Phase 2|Withdrawal by Subject|0|||
44292362|NCT03684694|79269990|FG002|Phase 2|Withdrawal by Subject|0|||
44292363|NCT03684694|79269991|FG003|Phase 2|Withdrawal by Subject|0|||
44292364|NCT03684694|79269992|FG004|Phase 2|Withdrawal by Subject|0|||
44292365|NCT03684694|79269993|FG005|Phase 2|Withdrawal by Subject|1|||
44292366|NCT03684694|79269988|FG000|Phase 2|Investigator/Sponsor Decision|0|||
44292367|NCT03684694|79269989|FG001|Phase 2|Investigator/Sponsor Decision|0|||
44292368|NCT03684694|79269990|FG002|Phase 2|Investigator/Sponsor Decision|0|||
44292369|NCT03684694|79269991|FG003|Phase 2|Investigator/Sponsor Decision|17|||
44292370|NCT03684694|79269992|FG004|Phase 2|Investigator/Sponsor Decision|16|||
44292371|NCT03684694|79269993|FG005|Phase 2|Investigator/Sponsor Decision|6|||
44292372|NCT03684694|79269988|FG000|Phase 2|Death|0|||
44292373|NCT03684694|79269989|FG001|Phase 2|Death|0|||
44292374|NCT03684694|79269990|FG002|Phase 2|Death|0|||
44292375|NCT03684694|79269991|FG003|Phase 2|Death|28|||
44292376|NCT03684694|79269992|FG004|Phase 2|Death|14|||
44292377|NCT03684694|79269993|FG005|Phase 2|Death|3|||
44292378|NCT03684694|79269988|FG000|Phase 2|Lost to Follow-up|0|||
44292379|NCT03684694|79269989|FG001|Phase 2|Lost to Follow-up|0|||
44292380|NCT03684694|79269990|FG002|Phase 2|Lost to Follow-up|0|||
44292381|NCT03684694|79269991|FG003|Phase 2|Lost to Follow-up|1|||
44292382|NCT03684694|79269992|FG004|Phase 2|Lost to Follow-up|0|||
44292383|NCT03684694|79269993|FG005|Phase 2|Lost to Follow-up|0|||
44292384|NCT03684694|79269988|FG000|Phase 2|Miscellaneous|0|||
44292385|NCT03684694|79269989|FG001|Phase 2|Miscellaneous|0|||
44292386|NCT03684694|79269990|FG002|Phase 2|Miscellaneous|0|||
44292387|NCT03684694|79269991|FG003|Phase 2|Miscellaneous|3|||
44292388|NCT03684694|79269992|FG004|Phase 2|Miscellaneous|0|||
44292389|NCT03684694|79269993|FG005|Phase 2|Miscellaneous|0|||
44292390|NCT03345420|79270012|FG000|Overall Study|Withdrawal by Subject|1|||
44292391|NCT03283761|79270017|FG000|Study Treatment|Patient Non-Compliance|1|||
44292392|NCT03283761|79270017|FG000|Study Treatment|Alternative Cancer Therapy|7|||
44292393|NCT03283761|79270017|FG000|Study Treatment|Disease progression|21|||
44292394|NCT03283761|79270017|FG000|Study Treatment|Adverse Event|3|||
44292395|NCT03283761|79270017|FG000|Study Treatment|Withdrawal by Subject|4|||
44292396|NCT03283761|79270017|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
44292397|NCT03283761|79270017|FG000|Study Treatment|Symptomatic Deterioration|1|||
44292398|NCT03283761|79270017|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
44292399|NCT03283761|79270017|FG000|Follow up|Lost to Follow-up|1|||
44292400|NCT03283761|79270017|FG000|Follow up|Symptomatic Deterioration|1|||
44292401|NCT03283761|79270017|FG000|Follow up|Death|29|||
44292402|NCT03283761|79270017|FG000|Follow up|study terminated|4|||
44292403|NCT03283761|79270017|FG000|Follow up|Primary Investigator Withdrawal|1|||
44292404|NCT03283761|79270017|FG000|Follow up|Switched to alternative therapy|1|||
44292405|NCT03283761|79270017|FG000|Follow up|Subject is now in Hospice|1|||
44292406|NCT03258723|79270021|FG000|Overall Study|COVID Interruption of study|54|||
44292407|NCT03258723|79270021|FG000|Overall Study|Lost to Follow-up|8|||
44292408|NCT03230916|79270036|FG000|Overall Study|Withdrawal by Subject|0|||
44292409|NCT03230916|79270037|FG001|Overall Study|Withdrawal by Subject|0|||
44292410|NCT03230916|79270038|FG002|Overall Study|Withdrawal by Subject|0|||
44292411|NCT03230916|79270039|FG003|Overall Study|Withdrawal by Subject|0|||
44292412|NCT03230916|79270040|FG004|Overall Study|Withdrawal by Subject|0|||
44292413|NCT03230916|79270041|FG005|Overall Study|Withdrawal by Subject|1|||
44292414|NCT03230916|79270042|FG006|Overall Study|Withdrawal by Subject|0|||
44292415|NCT03230916|79270043|FG007|Overall Study|Withdrawal by Subject|0|||
44292416|NCT03230916|79270044|FG008|Overall Study|Withdrawal by Subject|0|||
44292417|NCT03230916|79270045|FG009|Overall Study|Withdrawal by Subject|0|||
44292418|NCT03230916|79270046|FG010|Overall Study|Withdrawal by Subject|0|||
44292419|NCT03173248|79270089|FG000|Overall Study|Death|28|||
44292420|NCT03173248|79270090|FG001|Overall Study|Death|46|||
44292421|NCT03173248|79270089|FG000|Overall Study|Lost to Follow-up|0|||
44292422|NCT03173248|79270090|FG001|Overall Study|Lost to Follow-up|1|||
44292423|NCT03173248|79270089|FG000|Overall Study|Withdrawal by Subject|6|||
44292424|NCT03173248|79270090|FG001|Overall Study|Withdrawal by Subject|4|||
44292425|NCT03173248|79270089|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
44292426|NCT03173248|79270090|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
44292427|NCT03068130|79270113|FG000|Overall Study|Adverse Event|19|||
44292428|NCT03068130|79270113|FG000|Overall Study|Death|14|||
44292429|NCT03068130|79270113|FG000|Overall Study|Lost to Follow-up|4|||
44292430|NCT03068130|79270113|FG000|Overall Study|Withdrawal by Subject|26|||
44292431|NCT03068130|79270113|FG000|Overall Study|Administrative Reasons|3|||
44154549|NCT02687581|78945764|FG001|Overall Study|Lost to Follow-up|2|||
44292432|NCT03068130|79270113|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
44292433|NCT03068130|79270113|FG000|Overall Study|Study terminated by sponsor|194|||
44292434|NCT03015129|79270119|FG000|Overall Study|Death|2|||
44292435|NCT03015129|79270120|FG001|Overall Study|Death|2|||
44292436|NCT03015129|79270119|FG000|Overall Study|Lost to Follow-up|0|||
44416523|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
44416524|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
44416525|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
44416526|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
44416527|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
44416528|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
44416529|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
44416530|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
44416531|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
44416532|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
44416533|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
44416534|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
44416535|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
44416536|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
44416537|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
44416538|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
44416539|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
44416540|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
44416541|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
44416542|NCT00849017|79424261|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
44416543|NCT00849017|79424262|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
44416544|NCT00849017|79424263|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
44416545|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
44416546|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
44416547|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
44416548|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
44533797|NCT03103152|79544301|FG002|Overall Study|Inter-current illness|1|||
44533798|NCT03103152|79544302|FG003|Overall Study|Inter-current illness|0|||
44292437|NCT03015129|79270120|FG001|Overall Study|Lost to Follow-up|1|||
44292438|NCT03015129|79270119|FG000|Overall Study|Progression of disease|38|||
44292439|NCT03015129|79270120|FG001|Overall Study|Progression of disease|33|||
44292440|NCT03015129|79270119|FG000|Overall Study|Adverse Event|0|||
44292441|NCT03015129|79270120|FG001|Overall Study|Adverse Event|4|||
44292442|NCT02879448|79270128|FG000|Overall Study|No implant attempt|17|||
44292443|NCT02879448|79270129|FG001|Overall Study|No implant attempt|28|||
44292444|NCT02879448|79270128|FG000|Overall Study|Withdrawal by Subject|20|||
44292445|NCT02879448|79270129|FG001|Overall Study|Withdrawal by Subject|46|||
44292446|NCT02879448|79270128|FG000|Overall Study|Death|63|||
44292447|NCT02879448|79270129|FG001|Overall Study|Death|85|||
44292448|NCT02879448|79270128|FG000|Overall Study|Lost to Follow-up|3|||
44292449|NCT02879448|79270129|FG001|Overall Study|Lost to Follow-up|4|||
44292450|NCT02879448|79270128|FG000|Overall Study|Missing visit|34|||
44292451|NCT02879448|79270129|FG001|Overall Study|Missing visit|39|||
44292452|NCT02879448|79270128|FG000|Overall Study|Pending evaluation|1|||
44292453|NCT02879448|79270129|FG001|Overall Study|Pending evaluation|0|||
44292454|NCT02859337|79270138|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
44292455|NCT02859337|79270139|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
44292456|NCT02859337|79270140|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
44292457|NCT02859337|79270138|FG000|Overall Study|Withdrawal by Subject|3|||
44292458|NCT02859337|79270139|FG001|Overall Study|Withdrawal by Subject|1|||
44292459|NCT02859337|79270140|FG002|Overall Study|Withdrawal by Subject|0|||
44292460|NCT02859337|79270138|FG000|Overall Study|Lost to Follow-up|1|||
44292461|NCT02859337|79270139|FG001|Overall Study|Lost to Follow-up|0|||
44292462|NCT02859337|79270140|FG002|Overall Study|Lost to Follow-up|0|||
44292463|NCT02657356|79270161|FG000|Overall Study|Death|1|||
44292464|NCT02657356|79270162|FG001|Overall Study|Death|0|||
44416549|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
44416550|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
44416551|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
44292465|NCT02657356|79270161|FG000|Overall Study|Withdrawal by Subject|5|||
44292466|NCT02657356|79270162|FG001|Overall Study|Withdrawal by Subject|6|||
44292467|NCT02657356|79270161|FG000|Overall Study|Terminated by Sponsor|8|||
44292468|NCT02657356|79270162|FG001|Overall Study|Terminated by Sponsor|5|||
44292469|NCT02657356|79270161|FG000|Overall Study|Rolled over to EAP study|6|||
44292470|NCT02657356|79270162|FG001|Overall Study|Rolled over to EAP study|4|||
44416552|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
44416553|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
44416554|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
44533799|NCT03103152|79544303|FG004|Overall Study|Inter-current illness|0|||
44292471|NCT02562235|79270168|FG000|Overall Study|Adverse Event|3|||
44292472|NCT02467270|79270189|FG000|Overall Study|Participants Never Treated|0|||
44292473|NCT02467270|79270190|FG001|Overall Study|Participants Never Treated|1|||
44292474|NCT02467270|79270191|FG002|Overall Study|Participants Never Treated|0|||
44292475|NCT02467270|79270189|FG000|Overall Study|Ongoing|50|||
44292476|NCT02467270|79270190|FG001|Overall Study|Ongoing|41|||
44292477|NCT02467270|79270191|FG002|Overall Study|Ongoing|43|||
44292478|NCT02467270|79270189|FG000|Overall Study|Adverse Event|16|||
44292479|NCT02467270|79270190|FG001|Overall Study|Adverse Event|15|||
44292480|NCT02467270|79270191|FG002|Overall Study|Adverse Event|14|||
44292481|NCT02467270|79270189|FG000|Overall Study|Progressive Disease|7|||
44292482|NCT02467270|79270190|FG001|Overall Study|Progressive Disease|7|||
44292483|NCT02467270|79270191|FG002|Overall Study|Progressive Disease|4|||
44292484|NCT02467270|79270189|FG000|Overall Study|Death|2|||
44292485|NCT02467270|79270190|FG001|Overall Study|Death|0|||
44292486|NCT02467270|79270191|FG002|Overall Study|Death|2|||
44292487|NCT02467270|79270189|FG000|Overall Study|Lack of Efficacy|12|||
44292488|NCT02467270|79270190|FG001|Overall Study|Lack of Efficacy|18|||
44292489|NCT02467270|79270191|FG002|Overall Study|Lack of Efficacy|23|||
44292490|NCT02467270|79270189|FG000|Overall Study|Non-compliance With Study Drug|0|||
44292491|NCT02467270|79270190|FG001|Overall Study|Non-compliance With Study Drug|2|||
44292492|NCT02467270|79270191|FG002|Overall Study|Non-compliance With Study Drug|1|||
44292493|NCT02467270|79270189|FG000|Overall Study|Lost to Follow-up|2|||
44292494|NCT02467270|79270190|FG001|Overall Study|Lost to Follow-up|1|||
44292495|NCT02467270|79270191|FG002|Overall Study|Lost to Follow-up|0|||
44292496|NCT02467270|79270189|FG000|Overall Study|Pregnancy|0|||
44292497|NCT02467270|79270190|FG001|Overall Study|Pregnancy|1|||
44292498|NCT02467270|79270191|FG002|Overall Study|Pregnancy|0|||
44292499|NCT02467270|79270189|FG000|Overall Study|Physician Decision|0|||
44292500|NCT02467270|79270190|FG001|Overall Study|Physician Decision|4|||
44292501|NCT02467270|79270191|FG002|Overall Study|Physician Decision|1|||
44292502|NCT02467270|79270189|FG000|Overall Study|Withdrawal by Subject|4|||
44292503|NCT02467270|79270190|FG001|Overall Study|Withdrawal by Subject|3|||
44292504|NCT02467270|79270191|FG002|Overall Study|Withdrawal by Subject|5|||
44292505|NCT02467270|79270189|FG000|Overall Study|Reason not Specified|1|||
44292506|NCT02467270|79270190|FG001|Overall Study|Reason not Specified|2|||
44292507|NCT02467270|79270191|FG002|Overall Study|Reason not Specified|1|||
44292508|NCT01981551|79270199|FG000|Overall Study|Refused further treatment|8|||
44292509|NCT01981551|79270199|FG000|Overall Study|Adverse Event|1|||
44292510|NCT01796197|79270203|FG000|Overall Study|Lost to Follow-up|1|||
44292511|NCT01796197|79270203|FG000|Overall Study|Lack of Efficacy|1|||
44292512|NCT01772472|79270209|FG000|Overall Study|Death|56|||
44292513|NCT01772472|79270210|FG001|Overall Study|Death|42|||
44292514|NCT01772472|79270209|FG000|Overall Study|Physician Decision|1|||
44292515|NCT01772472|79270210|FG001|Overall Study|Physician Decision|3|||
44292516|NCT01772472|79270209|FG000|Overall Study|Other|5|||
44292517|NCT01772472|79270210|FG001|Overall Study|Other|5|||
44292518|NCT01772472|79270209|FG000|Overall Study|Lost to Follow-up|12|||
44292519|NCT01772472|79270210|FG001|Overall Study|Lost to Follow-up|8|||
44292520|NCT01772472|79270209|FG000|Overall Study|Withdrawal by Subject|72|||
44292521|NCT01772472|79270210|FG001|Overall Study|Withdrawal by Subject|50|||
44292522|NCT01772472|79270209|FG000|Overall Study|Ongoing|597|||
44292523|NCT01772472|79270210|FG001|Overall Study|Ongoing|635|||
44292524|NCT01525082|79270216|FG000|Overall Study|Death|1|||
44292525|NCT00770809|79270226|FG000|Overall Study|Adverse Event|9|||
44292526|NCT00770809|79270227|FG001|Overall Study|Adverse Event|1|||
44292527|NCT00770809|79270228|FG002|Overall Study|Adverse Event|12|||
44292528|NCT00770809|79270226|FG000|Overall Study|Death|1|||
44292529|NCT00770809|79270227|FG001|Overall Study|Death|0|||
44292530|NCT00770809|79270228|FG002|Overall Study|Death|0|||
44292531|NCT00770809|79270226|FG000|Overall Study|Withdrawal by Subject|3|||
44154550|NCT02687581|78945765|FG002|Overall Study|Lost to Follow-up|0|||
44154551|NCT02687581|78945766|FG003|Overall Study|Lost to Follow-up|0|||
44292532|NCT00770809|79270227|FG001|Overall Study|Withdrawal by Subject|3|||
44292533|NCT00770809|79270228|FG002|Overall Study|Withdrawal by Subject|7|||
44292534|NCT00770809|79270226|FG000|Overall Study|Progression|2|||
44292535|NCT00770809|79270227|FG001|Overall Study|Progression|2|||
44292536|NCT00770809|79270228|FG002|Overall Study|Progression|0|||
44292537|NCT00770809|79270226|FG000|Overall Study|Complicating illness|0|||
44292538|NCT00770809|79270227|FG001|Overall Study|Complicating illness|0|||
44292539|NCT00770809|79270228|FG002|Overall Study|Complicating illness|1|||
44154552|NCT02687581|78945763|FG000|Overall Study|the device is too small for the patient.|1|||
44154553|NCT02687581|78945764|FG001|Overall Study|the device is too small for the patient.|0|||
44154554|NCT02687581|78945765|FG002|Overall Study|the device is too small for the patient.|0|||
44292540|NCT00770809|79270226|FG000|Overall Study|Other Medical Reasons|2|||
44292541|NCT00770809|79270227|FG001|Overall Study|Other Medical Reasons|4|||
44292542|NCT00770809|79270228|FG002|Overall Study|Other Medical Reasons|3|||
44292543|NCT00104676|79270251|FG000|Overall Study|Death|3|||
44292544|NCT00104676|79270252|FG001|Overall Study|Death|2|||
44292545|NCT00104676|79270251|FG000|Overall Study|Withdrawal by Subject|0|||
44292546|NCT00104676|79270252|FG001|Overall Study|Withdrawal by Subject|2|||
44292547|NCT00104676|79270251|FG000|Overall Study|treatment interruption|4|||
44292548|NCT00104676|79270252|FG001|Overall Study|treatment interruption|10|||
44292549|NCT05131451|79272004|FG000|Overall Study|Protocol Violation|1|||
44292550|NCT05131451|79272005|FG001|Overall Study|Protocol Violation|0|||
44292551|NCT05108922|79272013|FG000|Overall Study|Adverse Event|0|||
44292552|NCT05108922|79272014|FG001|Overall Study|Adverse Event|1|||
44292553|NCT05108922|79272013|FG000|Overall Study|Physician Decision|1|||
44292554|NCT05108922|79272014|FG001|Overall Study|Physician Decision|1|||
44292555|NCT05108922|79272013|FG000|Overall Study|Screen Failure|1|||
44292556|NCT05108922|79272014|FG001|Overall Study|Screen Failure|1|||
44292557|NCT05108922|79272013|FG000|Overall Study|Withdrawal by Subject|7|||
44292558|NCT05108922|79272014|FG001|Overall Study|Withdrawal by Subject|4|||
44292559|NCT04874636|79272030|FG000|Overall Study|Adverse Event|17|||
44292560|NCT04874636|79272031|FG001|Overall Study|Adverse Event|7|||
44292561|NCT04874636|79272030|FG000|Overall Study|Lost to Follow-up|1|||
44292562|NCT04874636|79272031|FG001|Overall Study|Lost to Follow-up|0|||
44292563|NCT04874636|79272030|FG000|Overall Study|Non-Compliance with Study Drug|2|||
44292564|NCT04874636|79272031|FG001|Overall Study|Non-Compliance with Study Drug|0|||
44292565|NCT04874636|79272030|FG000|Overall Study|Physician Decision|1|||
44292566|NCT04874636|79272031|FG001|Overall Study|Physician Decision|0|||
44292567|NCT04874636|79272030|FG000|Overall Study|Withdrawal by Subject|6|||
44292568|NCT04874636|79272031|FG001|Overall Study|Withdrawal by Subject|5|||
44292569|NCT04707157|79272047|FG000|Overall Study|Adverse Event|12|||
44292570|NCT04707157|79272048|FG001|Overall Study|Adverse Event|3|||
44292571|NCT04707157|79272047|FG000|Overall Study|Lost to Follow-up|2|||
44292572|NCT04707157|79272048|FG001|Overall Study|Lost to Follow-up|0|||
44292573|NCT04707157|79272047|FG000|Overall Study|Sponsor's decision|1|||
44292574|NCT04707157|79272048|FG001|Overall Study|Sponsor's decision|0|||
44292575|NCT04707157|79272047|FG000|Overall Study|Physician Decision|8|||
44292576|NCT04707157|79272048|FG001|Overall Study|Physician Decision|5|||
44292577|NCT04707157|79272047|FG000|Overall Study|Protocol Deviation|1|||
44292578|NCT04707157|79272048|FG001|Overall Study|Protocol Deviation|0|||
44292579|NCT04707157|79272047|FG000|Overall Study|Withdrawal by Subject|1|||
44292580|NCT04707157|79272048|FG001|Overall Study|Withdrawal by Subject|1|||
44292581|NCT04700449|79272057|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
44292582|NCT04700449|79272058|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
44292583|NCT04700449|79272059|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
44292584|NCT04700449|79272060|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
44292585|NCT04700449|79272057|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
44292586|NCT04700449|79272058|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
44416555|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
44416556|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
44416557|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
44416558|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
44416559|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
44416560|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
44416561|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
44416562|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
44416563|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
44416564|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
44416565|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
44416566|NCT00849017|79424261|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
44416567|NCT00849017|79424262|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
44416568|NCT00849017|79424263|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
44416569|NCT00842543|79424279|FG000|Overall Study|Withdrawal by Subject|2|||
44416570|NCT00842543|79424280|FG001|Overall Study|Withdrawal by Subject|0|||
44416571|NCT00842543|79424281|FG002|Overall Study|Withdrawal by Subject|3|||
44416572|NCT00842543|79424282|FG003|Overall Study|Withdrawal by Subject|4|||
44416573|NCT00785928|79424301|FG000|Treatment Phase|Adverse Event|1|||
44416574|NCT00785928|79424302|FG001|Treatment Phase|Adverse Event|1|||
44416575|NCT00785928|79424303|FG002|Treatment Phase|Adverse Event|2|||
44416576|NCT00785928|79424304|FG003|Treatment Phase|Adverse Event|0|||
44416577|NCT00785928|79424305|FG004|Treatment Phase|Adverse Event|0|||
44416578|NCT00785928|79424306|FG005|Treatment Phase|Adverse Event|0|||
44416579|NCT00785928|79424307|FG006|Treatment Phase|Adverse Event|2|||
44292587|NCT04700449|79272059|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
44292588|NCT04700449|79272060|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
44292589|NCT04700449|79272057|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
44292590|NCT04700449|79272058|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
44416580|NCT00785928|79424301|FG000|Treatment Phase|Inadequate Response|0|||
44416581|NCT00785928|79424302|FG001|Treatment Phase|Inadequate Response|1|||
44533800|NCT03103152|79544304|FG005|Overall Study|Inter-current illness|0|||
44533801|NCT03103152|79544299|FG000|Overall Study|Death|0|||
44533802|NCT03103152|79544300|FG001|Overall Study|Death|1|||
44533803|NCT03103152|79544301|FG002|Overall Study|Death|0|||
44292591|NCT04700449|79272059|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
44292592|NCT04700449|79272060|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
44292593|NCT04700449|79272057|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
44292594|NCT04700449|79272058|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
44292595|NCT04700449|79272059|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
44292596|NCT04700449|79272060|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
44292597|NCT04700449|79272057|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
44292598|NCT04700449|79272058|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
44292599|NCT04700449|79272059|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
44292600|NCT04700449|79272060|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
44292601|NCT04700449|79272057|FG000|Stage 1: Double-Blind Period|Other|0|||
44292602|NCT04700449|79272058|FG001|Stage 1: Double-Blind Period|Other|0|||
44292603|NCT04700449|79272059|FG002|Stage 1: Double-Blind Period|Other|1|||
44292604|NCT04700449|79272060|FG003|Stage 1: Double-Blind Period|Other|0|||
44292605|NCT04700449|79272057|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
44292606|NCT04700449|79272058|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
44292607|NCT04700449|79272059|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
44292608|NCT04700449|79272060|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
44416582|NCT00785928|79424303|FG002|Treatment Phase|Inadequate Response|0|||
44416583|NCT00785928|79424304|FG003|Treatment Phase|Inadequate Response|0|||
44416584|NCT00785928|79424305|FG004|Treatment Phase|Inadequate Response|0|||
44416585|NCT00785928|79424306|FG005|Treatment Phase|Inadequate Response|0|||
44416586|NCT00785928|79424307|FG006|Treatment Phase|Inadequate Response|0|||
44416587|NCT00785928|79424301|FG000|Treatment Phase|Lack of Efficacy|0|||
44416588|NCT00785928|79424302|FG001|Treatment Phase|Lack of Efficacy|1|||
44416589|NCT00785928|79424303|FG002|Treatment Phase|Lack of Efficacy|1|||
44416590|NCT00785928|79424304|FG003|Treatment Phase|Lack of Efficacy|0|||
44416591|NCT00785928|79424305|FG004|Treatment Phase|Lack of Efficacy|0|||
44416592|NCT00785928|79424306|FG005|Treatment Phase|Lack of Efficacy|0|||
44416593|NCT00785928|79424307|FG006|Treatment Phase|Lack of Efficacy|0|||
44416594|NCT00785928|79424301|FG000|Treatment Phase|Physician Decision|0|||
44416595|NCT00785928|79424302|FG001|Treatment Phase|Physician Decision|0|||
44416596|NCT00785928|79424303|FG002|Treatment Phase|Physician Decision|0|||
44416597|NCT00785928|79424304|FG003|Treatment Phase|Physician Decision|0|||
44416598|NCT00785928|79424305|FG004|Treatment Phase|Physician Decision|1|||
44416599|NCT00785928|79424306|FG005|Treatment Phase|Physician Decision|0|||
44416600|NCT00785928|79424307|FG006|Treatment Phase|Physician Decision|0|||
44416601|NCT00785928|79424301|FG000|Treatment Phase|Sponsor Decision|1|||
44416602|NCT00785928|79424302|FG001|Treatment Phase|Sponsor Decision|0|||
44416603|NCT00785928|79424303|FG002|Treatment Phase|Sponsor Decision|0|||
44416604|NCT00785928|79424304|FG003|Treatment Phase|Sponsor Decision|0|||
44416605|NCT00785928|79424305|FG004|Treatment Phase|Sponsor Decision|0|||
44154555|NCT02687581|78945766|FG003|Overall Study|the device is too small for the patient.|0|||
44154556|NCT01977040|78945776|FG000|Overall Study|Vasa previa not confirmed|2|||
44154557|NCT01958476|78945786|FG000|Overall Study|Parent requested exclusion from analysis|1|||
44154558|NCT01958476|78945787|FG001|Overall Study|Parent requested exclusion from analysis|0|||
44154559|NCT02695537|78945823|FG000|Overall Study|Adverse Event|3|||
44154560|NCT02695537|78945823|FG000|Overall Study|Lack of Efficacy|28|||
44154561|NCT02695537|78945823|FG000|Overall Study|Withdrawal by Subject|4|||
44154562|NCT02695537|78945823|FG000|Overall Study|Protocol Violation|3|||
44154563|NCT02691247|78945830|FG000|Overall Study|Withdrawal by Subject|1|||
44154564|NCT02691247|78945831|FG001|Overall Study|Withdrawal by Subject|2|||
44154565|NCT02691247|78945832|FG002|Overall Study|Withdrawal by Subject|2|||
44154566|NCT02691247|78945830|FG000|Overall Study|Lost to Follow-up|2|||
44154567|NCT02691247|78945831|FG001|Overall Study|Lost to Follow-up|0|||
44154568|NCT02691247|78945832|FG002|Overall Study|Lost to Follow-up|1|||
44292609|NCT04700449|79272057|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
44292610|NCT04700449|79272058|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
44416606|NCT00785928|79424306|FG005|Treatment Phase|Sponsor Decision|0|||
44416607|NCT00785928|79424307|FG006|Treatment Phase|Sponsor Decision|1|||
44416608|NCT00785928|79424301|FG000|Treatment Phase|Withdrawal by Subject|1|||
44416609|NCT00785928|79424302|FG001|Treatment Phase|Withdrawal by Subject|2|||
44292611|NCT04700449|79272059|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
44292612|NCT04700449|79272060|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
44292613|NCT04700449|79272057|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
44292614|NCT04700449|79272058|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
44292615|NCT04700449|79272059|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
44292616|NCT04700449|79272060|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
44292617|NCT04700449|79272057|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
44416610|NCT00785928|79424303|FG002|Treatment Phase|Withdrawal by Subject|0|||
44154569|NCT01362491|78945843|FG000|Overall Study|Ineligible|1|||
44154570|NCT01362491|78945844|FG001|Overall Study|Ineligible|0|||
44154571|NCT01362491|78945845|FG002|Overall Study|Ineligible|0|||
44416611|NCT00785928|79424304|FG003|Treatment Phase|Withdrawal by Subject|0|||
44416612|NCT00785928|79424305|FG004|Treatment Phase|Withdrawal by Subject|1|||
44154572|NCT02687191|78945860|FG000|Overall Study|Death|0|||
44292618|NCT04700449|79272058|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
44292619|NCT04700449|79272059|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
44292620|NCT04700449|79272060|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
44292621|NCT04700449|79272057|FG000|Stage 2 Sub-study 1|Other|1|||
44292622|NCT04700449|79272058|FG001|Stage 2 Sub-study 1|Other|2|||
44292623|NCT04700449|79272059|FG002|Stage 2 Sub-study 1|Other|0|||
44292624|NCT04700449|79272060|FG003|Stage 2 Sub-study 1|Other|0|||
44292625|NCT04700449|79272057|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
44292626|NCT04700449|79272058|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
44292627|NCT04700449|79272059|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
44416613|NCT00785928|79424306|FG005|Treatment Phase|Withdrawal by Subject|0|||
44416614|NCT00785928|79424307|FG006|Treatment Phase|Withdrawal by Subject|0|||
44416615|NCT00842309|79424347|FG000|Overall Study|Withdrawal by Subject|3|||
44416616|NCT00842309|79424348|FG001|Overall Study|Withdrawal by Subject|1|||
44416617|NCT00842153|79424356|FG000|Overall Study|Adverse Event|0|||
44416618|NCT00842153|79424357|FG001|Overall Study|Adverse Event|1|||
44416619|NCT00842153|79424356|FG000|Overall Study|Lost to Follow-up|1|||
44416620|NCT00842153|79424357|FG001|Overall Study|Lost to Follow-up|2|||
44416621|NCT00762411|79424365|FG000|Initial Treatment|Death|7|||
44416622|NCT00762411|79424366|FG001|Initial Treatment|Death|6|||
44416623|NCT00762411|79424365|FG000|Initial Treatment|Adverse Event|132|||
44416624|NCT00762411|79424366|FG001|Initial Treatment|Adverse Event|40|||
44416625|NCT00762411|79424365|FG000|Initial Treatment|Protocol Violation|4|||
44416626|NCT00762411|79424366|FG001|Initial Treatment|Protocol Violation|1|||
44533804|NCT03103152|79544302|FG003|Overall Study|Death|0|||
44533805|NCT03103152|79544303|FG004|Overall Study|Death|0|||
44533806|NCT03103152|79544304|FG005|Overall Study|Death|0|||
44533807|NCT03103152|79544299|FG000|Overall Study|Adverse Event|0|||
44533808|NCT03103152|79544300|FG001|Overall Study|Adverse Event|0|||
44533809|NCT03103152|79544301|FG002|Overall Study|Adverse Event|1|||
44533810|NCT03103152|79544302|FG003|Overall Study|Adverse Event|0|||
44533811|NCT03103152|79544303|FG004|Overall Study|Adverse Event|0|||
44533812|NCT03103152|79544304|FG005|Overall Study|Adverse Event|1|||
44533813|NCT03103152|79544299|FG000|Overall Study|Withdrawal by Subject|1|||
44533814|NCT03103152|79544300|FG001|Overall Study|Withdrawal by Subject|0|||
44533815|NCT03103152|79544301|FG002|Overall Study|Withdrawal by Subject|1|||
44533816|NCT03103152|79544302|FG003|Overall Study|Withdrawal by Subject|1|||
44533817|NCT03103152|79544303|FG004|Overall Study|Withdrawal by Subject|1|||
44533818|NCT03103152|79544304|FG005|Overall Study|Withdrawal by Subject|1|||
44533819|NCT03103152|79544299|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
44533820|NCT03103152|79544300|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
44533821|NCT03103152|79544301|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
44533822|NCT03103152|79544302|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
44533823|NCT03103152|79544303|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
44533824|NCT03103152|79544304|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
44533825|NCT03103152|79544299|FG000|Overall Study|Unacceptable side effects|0|||
44533826|NCT03103152|79544300|FG001|Overall Study|Unacceptable side effects|0|||
44533827|NCT03103152|79544301|FG002|Overall Study|Unacceptable side effects|0|||
44533828|NCT03103152|79544302|FG003|Overall Study|Unacceptable side effects|0|||
44533829|NCT03103152|79544303|FG004|Overall Study|Unacceptable side effects|0|||
44533830|NCT03103152|79544304|FG005|Overall Study|Unacceptable side effects|1|||
44533831|NCT03103152|79544299|FG000|Overall Study|Lost to Follow-up|0|||
44533832|NCT03103152|79544300|FG001|Overall Study|Lost to Follow-up|1|||
44533833|NCT03103152|79544301|FG002|Overall Study|Lost to Follow-up|0|||
44533834|NCT03103152|79544302|FG003|Overall Study|Lost to Follow-up|1|||
44533835|NCT03103152|79544303|FG004|Overall Study|Lost to Follow-up|0|||
44533836|NCT03103152|79544304|FG005|Overall Study|Lost to Follow-up|1|||
44533837|NCT03103152|79544299|FG000|Overall Study|Testicular pain|0|||
44533838|NCT03103152|79544300|FG001|Overall Study|Testicular pain|0|||
44533839|NCT03103152|79544301|FG002|Overall Study|Testicular pain|0|||
44533840|NCT03103152|79544302|FG003|Overall Study|Testicular pain|1|||
44533841|NCT03103152|79544303|FG004|Overall Study|Testicular pain|0|||
44533842|NCT03103152|79544304|FG005|Overall Study|Testicular pain|0|||
44416627|NCT00762411|79424365|FG000|Initial Treatment|Withdrawal by Subject|65|||
44533843|NCT03033901|79544318|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
44533844|NCT03033901|79544318|FG000|Overall Study|Refused PSG|23|||
44533845|NCT03033901|79544318|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
44533846|NCT03033901|79544318|FG000|Overall Study|Missing Oximetry Data|3|||
44533847|NCT02315196|79544361|FG000|Overall Study|Withdrew consent|9|||
44292628|NCT04700449|79272060|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
44533848|NCT02059005|79544367|FG000|Overall Study|Death|1|||
44154573|NCT02687191|78945861|FG001|Overall Study|Death|1|||
44292629|NCT04700449|79272057|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
44292630|NCT04700449|79272058|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
44416628|NCT00762411|79424366|FG001|Initial Treatment|Withdrawal by Subject|52|||
44533849|NCT02059005|79544368|FG001|Overall Study|Death|3|||
44533850|NCT02059005|79544367|FG000|Overall Study|Lost to Follow-up|19|||
44533851|NCT02059005|79544368|FG001|Overall Study|Lost to Follow-up|19|||
44292631|NCT04700449|79272059|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
44292632|NCT04700449|79272060|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
44292633|NCT04700449|79272057|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
44292634|NCT04700449|79272058|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
44292635|NCT04700449|79272059|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
44292636|NCT04700449|79272060|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
44292637|NCT04700449|79272057|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
44292638|NCT04700449|79272058|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
44292639|NCT04700449|79272059|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
44292640|NCT04700449|79272060|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
44292641|NCT04700449|79272057|FG000|Stage 2 Sub-study 2|Other|0|||
44292642|NCT04700449|79272058|FG001|Stage 2 Sub-study 2|Other|0|||
44292643|NCT04700449|79272059|FG002|Stage 2 Sub-study 2|Other|0|||
44292644|NCT04700449|79272060|FG003|Stage 2 Sub-study 2|Other|5|||
44292645|NCT04667377|79272084|FG000|Dose Escalation Period|Other not specified below|3|||
44292646|NCT04667377|79272085|FG001|Dose Escalation Period|Other not specified below|3|||
44533852|NCT02059005|79544367|FG000|Overall Study|Incarceration|0|||
44533853|NCT02059005|79544368|FG001|Overall Study|Incarceration|1|||
44533854|NCT02059005|79544367|FG000|Overall Study|Inpatient|0|||
44255997|NCT01469546|79102085|FG000|Received 5 mg Dose|Protocol Violation|2|||
44255998|NCT01469546|79102085|FG000|Received 5 mg Dose|Progressive Disease|3|||
44255999|NCT01469546|79102085|FG000|Received 5 mg Dose|Physician Decision|3|||
44256000|NCT00081497|79102091|FG000|Overall Study|Adverse Event|2|||
44256001|NCT00081497|79102092|FG001|Overall Study|Adverse Event|0|||
44256002|NCT00081497|79102091|FG000|Overall Study|Death|0|||
44256003|NCT00081497|79102092|FG001|Overall Study|Death|1|||
44256004|NCT00081497|79102091|FG000|Overall Study|Withdrawal by Subject|1|||
44256005|NCT00081497|79102092|FG001|Overall Study|Withdrawal by Subject|0|||
44256006|NCT00081497|79102091|FG000|Overall Study|Non-compliance|0|||
44256007|NCT00081497|79102092|FG001|Overall Study|Non-compliance|1|||
44256008|NCT00081263|79102106|FG000|Overall Study|clerical error|1|||
44256009|NCT00081263|79102107|FG001|Overall Study|clerical error|0|||
44256010|NCT00081263|79102106|FG000|Overall Study|wrong cell type|7|||
44256011|NCT00081263|79102107|FG001|Overall Study|wrong cell type|5|||
44256012|NCT00081263|79102106|FG000|Overall Study|improper pre-protocol therapy|0|||
44256013|NCT00081263|79102107|FG001|Overall Study|improper pre-protocol therapy|1|||
44256014|NCT00081263|79102106|FG000|Overall Study|Inadequate pathology|0|||
44256015|NCT00081263|79102107|FG001|Overall Study|Inadequate pathology|1|||
44256016|NCT00081263|79102106|FG000|Overall Study|Never treated|4|||
44256017|NCT00081263|79102107|FG001|Overall Study|Never treated|5|||
44256018|NCT00081263|79102106|FG000|Overall Study|Inadequate data|5|||
44256019|NCT00081263|79102107|FG001|Overall Study|Inadequate data|10|||
44256020|NCT01490294|79102117|FG000|Overall Study|Prematurely discontinuation|4|||
44256021|NCT01490294|79102118|FG001|Overall Study|Prematurely discontinuation|0|||
44256022|NCT01490294|79102119|FG002|Overall Study|Prematurely discontinuation|1|||
44256023|NCT01490294|79102120|FG003|Overall Study|Prematurely discontinuation|1|||
44256024|NCT01490294|79102117|FG000|Overall Study|Adverse Event|1|||
44256025|NCT01490294|79102118|FG001|Overall Study|Adverse Event|0|||
44256026|NCT01490294|79102119|FG002|Overall Study|Adverse Event|0|||
44256027|NCT01490294|79102120|FG003|Overall Study|Adverse Event|0|||
44256028|NCT00080483|79102147|FG000|Overall Study|Lost to Follow-up|1|||
44256029|NCT00080483|79102148|FG001|Overall Study|Lost to Follow-up|1|||
44256030|NCT00080483|79102147|FG000|Overall Study|Physician Decision|1|||
44256031|NCT00080483|79102148|FG001|Overall Study|Physician Decision|1|||
44256032|NCT00089141|79102169|FG000|Overall Study|Termination of trial|18|||
44256033|NCT00089141|79102170|FG001|Overall Study|Termination of trial|24|||
44256034|NCT02588664|79102216|FG000|Overall Study|Death|56|||
44256035|NCT02588664|79102217|FG001|Overall Study|Death|55|||
44256036|NCT02588664|79102216|FG000|Overall Study|Lost to Follow-up|1305|||
44256037|NCT02588664|79102217|FG001|Overall Study|Lost to Follow-up|990|||
44256038|NCT00083759|79102280|FG000|Overall Study|Adverse Event|5|||
44256039|NCT00083759|79102281|FG001|Overall Study|Adverse Event|3|||
44256040|NCT00083759|79102280|FG000|Overall Study|Lost to Follow-up|1|||
44256041|NCT00083759|79102281|FG001|Overall Study|Lost to Follow-up|0|||
44256042|NCT00083759|79102280|FG000|Overall Study|Death|1|||
44256043|NCT00083759|79102281|FG001|Overall Study|Death|1|||
44256044|NCT00083759|79102280|FG000|Overall Study|Inadequate Therapeutic Response|32|||
44256045|NCT00083759|79102281|FG001|Overall Study|Inadequate Therapeutic Response|35|||
44256046|NCT00083759|79102280|FG000|Overall Study|Subject Withdrew Consent|2|||
44256047|NCT00083759|79102281|FG001|Overall Study|Subject Withdrew Consent|2|||
44256048|NCT00083759|79102280|FG000|Overall Study|Non-Compliance|1|||
44256049|NCT00083759|79102281|FG001|Overall Study|Non-Compliance|0|||
44256050|NCT00083759|79102280|FG000|Overall Study|Sponsor's Discretion|28|||
44256051|NCT00083759|79102281|FG001|Overall Study|Sponsor's Discretion|29|||
44292647|NCT04667377|79272086|FG002|Dose Escalation Period|Other not specified below|2|||
44292648|NCT04667377|79272087|FG003|Dose Escalation Period|Other not specified below|1|||
44292649|NCT04667377|79272088|FG004|Dose Escalation Period|Other not specified below|3|||
44533855|NCT02059005|79544368|FG001|Overall Study|Inpatient|1|||
44533856|NCT01393821|79544378|FG000|Overall Study|Cancel|1|||
44292650|NCT04667377|79272084|FG000|Dose Escalation Period|Protocol Violation|2|||
44292651|NCT04667377|79272085|FG001|Dose Escalation Period|Protocol Violation|2|||
44292652|NCT04667377|79272086|FG002|Dose Escalation Period|Protocol Violation|0|||
44292653|NCT04667377|79272087|FG003|Dose Escalation Period|Protocol Violation|2|||
44292654|NCT04667377|79272088|FG004|Dose Escalation Period|Protocol Violation|1|||
44292655|NCT04667377|79272084|FG000|Dose Escalation Period|Burden of study procedures|2|||
44292656|NCT04667377|79272085|FG001|Dose Escalation Period|Burden of study procedures|1|||
44292657|NCT04667377|79272086|FG002|Dose Escalation Period|Burden of study procedures|1|||
44292658|NCT04667377|79272087|FG003|Dose Escalation Period|Burden of study procedures|1|||
44292659|NCT04667377|79272088|FG004|Dose Escalation Period|Burden of study procedures|5|||
44292660|NCT04667377|79272084|FG000|Dose Escalation Period|Change of residence|0|||
44292661|NCT04667377|79272085|FG001|Dose Escalation Period|Change of residence|0|||
44292662|NCT04667377|79272086|FG002|Dose Escalation Period|Change of residence|1|||
44292663|NCT04667377|79272087|FG003|Dose Escalation Period|Change of residence|0|||
44292664|NCT04667377|79272088|FG004|Dose Escalation Period|Change of residence|0|||
44292665|NCT04667377|79272084|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
44292666|NCT04667377|79272085|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
44292667|NCT04667377|79272086|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
44292668|NCT04667377|79272087|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
44292669|NCT04667377|79272088|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
44292670|NCT04667377|79272084|FG000|Dose Escalation Period|Adverse Event|9|||
44292671|NCT04667377|79272085|FG001|Dose Escalation Period|Adverse Event|10|||
44292672|NCT04667377|79272086|FG002|Dose Escalation Period|Adverse Event|12|||
44292673|NCT04667377|79272087|FG003|Dose Escalation Period|Adverse Event|17|||
44292674|NCT04667377|79272088|FG004|Dose Escalation Period|Adverse Event|3|||
44292675|NCT04667377|79272084|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
44292676|NCT04667377|79272085|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
44292677|NCT04667377|79272086|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
44292678|NCT04667377|79272087|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
44292679|NCT04667377|79272088|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
44292680|NCT04667377|79272084|FG000|Dose Escalation Period|Not treated|1|||
44292681|NCT04667377|79272085|FG001|Dose Escalation Period|Not treated|0|||
44292682|NCT04667377|79272086|FG002|Dose Escalation Period|Not treated|0|||
44292683|NCT04667377|79272087|FG003|Dose Escalation Period|Not treated|0|||
44292684|NCT04667377|79272088|FG004|Dose Escalation Period|Not treated|0|||
44292685|NCT04667377|79272084|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
44292686|NCT04667377|79272085|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
44292687|NCT04667377|79272086|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
44292688|NCT04667377|79272087|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
44292689|NCT04667377|79272088|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
44292690|NCT04667377|79272084|FG000|Dose Escalation Period|Lost to Follow-up|0|||
44292691|NCT04667377|79272085|FG001|Dose Escalation Period|Lost to Follow-up|1|||
44292692|NCT04667377|79272086|FG002|Dose Escalation Period|Lost to Follow-up|0|||
44292693|NCT04667377|79272087|FG003|Dose Escalation Period|Lost to Follow-up|0|||
44292694|NCT04667377|79272088|FG004|Dose Escalation Period|Lost to Follow-up|0|||
44292695|NCT04667377|79272084|FG000|Maintenance Period|Perceived lack of efficacy|0|||
44292696|NCT04667377|79272085|FG001|Maintenance Period|Perceived lack of efficacy|2|||
44416629|NCT00762411|79424365|FG000|Initial Treatment|Physician Decision|1|||
44416630|NCT00762411|79424366|FG001|Initial Treatment|Physician Decision|0|||
44416631|NCT00762411|79424365|FG000|Initial Treatment|Sponsor Decision|293|||
44416632|NCT00762411|79424366|FG001|Initial Treatment|Sponsor Decision|401|||
44416633|NCT00762411|79424365|FG000|Initial Treatment|Lost to Follow-up|5|||
44416634|NCT00762411|79424366|FG001|Initial Treatment|Lost to Follow-up|0|||
44416635|NCT00762411|79424365|FG000|Initial Treatment|Caregiver Decision|21|||
44416636|NCT00762411|79424366|FG001|Initial Treatment|Caregiver Decision|16|||
44416637|NCT00762411|79424365|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
44416638|NCT00762411|79424366|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
44416639|NCT00762411|79424365|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
44416640|NCT00762411|79424366|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
44533857|NCT01393821|79544379|FG001|Overall Study|Cancel|1|||
44533858|NCT01393821|79544378|FG000|Overall Study|not evaluable for primary endpoint|4|||
44533859|NCT01393821|79544379|FG001|Overall Study|not evaluable for primary endpoint|2|||
44416641|NCT00762411|79424365|FG000|Delayed Start|Adverse Event|0|||
44416642|NCT00762411|79424366|FG001|Delayed Start|Adverse Event|4|||
44416643|NCT00762411|79424365|FG000|Delayed Start|Protocol Violation|0|||
44416644|NCT00762411|79424366|FG001|Delayed Start|Protocol Violation|1|||
44416645|NCT00762411|79424365|FG000|Delayed Start|Sponsor Decision|16|||
44416646|NCT00762411|79424366|FG001|Delayed Start|Sponsor Decision|20|||
44533860|NCT00496873|79544391|FG000|Overall Study|Ineligible|2|||
44292697|NCT04667377|79272086|FG002|Maintenance Period|Perceived lack of efficacy|1|||
44292698|NCT04667377|79272087|FG003|Maintenance Period|Perceived lack of efficacy|0|||
44292699|NCT04667377|79272088|FG004|Maintenance Period|Perceived lack of efficacy|1|||
44533861|NCT00496873|79544391|FG000|Overall Study|Death|2|||
44292700|NCT04667377|79272084|FG000|Maintenance Period|Adverse Event|2|||
44292701|NCT04667377|79272085|FG001|Maintenance Period|Adverse Event|8|||
44292702|NCT04667377|79272086|FG002|Maintenance Period|Adverse Event|5|||
44292703|NCT04667377|79272087|FG003|Maintenance Period|Adverse Event|4|||
44292704|NCT04667377|79272088|FG004|Maintenance Period|Adverse Event|1|||
44292705|NCT04667377|79272084|FG000|Maintenance Period|Adverse event: COVID infection|0|||
44292706|NCT04667377|79272085|FG001|Maintenance Period|Adverse event: COVID infection|1|||
44292707|NCT04667377|79272086|FG002|Maintenance Period|Adverse event: COVID infection|0|||
44292708|NCT04667377|79272087|FG003|Maintenance Period|Adverse event: COVID infection|0|||
44292709|NCT04667377|79272088|FG004|Maintenance Period|Adverse event: COVID infection|0|||
44292710|NCT04667377|79272084|FG000|Maintenance Period|COVID-related|0|||
44292711|NCT04667377|79272085|FG001|Maintenance Period|COVID-related|0|||
44292712|NCT04667377|79272086|FG002|Maintenance Period|COVID-related|1|||
44292713|NCT04667377|79272087|FG003|Maintenance Period|COVID-related|1|||
44292714|NCT04667377|79272088|FG004|Maintenance Period|COVID-related|0|||
44292715|NCT04667377|79272084|FG000|Maintenance Period|Protocol Violation|1|||
44292716|NCT04667377|79272085|FG001|Maintenance Period|Protocol Violation|0|||
44292717|NCT04667377|79272086|FG002|Maintenance Period|Protocol Violation|0|||
44292718|NCT04667377|79272087|FG003|Maintenance Period|Protocol Violation|0|||
44154574|NCT02687191|78945862|FG002|Overall Study|Death|1|||
44292719|NCT04667377|79272088|FG004|Maintenance Period|Protocol Violation|1|||
44292720|NCT04667377|79272084|FG000|Maintenance Period|Burden of study procedures|1|||
44292721|NCT04667377|79272085|FG001|Maintenance Period|Burden of study procedures|2|||
44292722|NCT04667377|79272086|FG002|Maintenance Period|Burden of study procedures|0|||
44292723|NCT04667377|79272087|FG003|Maintenance Period|Burden of study procedures|1|||
44292724|NCT04667377|79272088|FG004|Maintenance Period|Burden of study procedures|0|||
44292725|NCT04667377|79272084|FG000|Maintenance Period|Change of residence|0|||
44292726|NCT04667377|79272085|FG001|Maintenance Period|Change of residence|1|||
44292727|NCT04667377|79272086|FG002|Maintenance Period|Change of residence|0|||
44292728|NCT04667377|79272087|FG003|Maintenance Period|Change of residence|0|||
44292729|NCT04667377|79272088|FG004|Maintenance Period|Change of residence|1|||
44292730|NCT04667377|79272084|FG000|Maintenance Period|Missing|1|||
44292731|NCT04667377|79272085|FG001|Maintenance Period|Missing|0|||
44292732|NCT04667377|79272086|FG002|Maintenance Period|Missing|0|||
44292733|NCT04667377|79272087|FG003|Maintenance Period|Missing|0|||
44292734|NCT04667377|79272088|FG004|Maintenance Period|Missing|0|||
44292735|NCT04667377|79272084|FG000|Maintenance Period|Other than listed above|2|||
44292736|NCT04667377|79272085|FG001|Maintenance Period|Other than listed above|0|||
44292737|NCT04667377|79272086|FG002|Maintenance Period|Other than listed above|3|||
44292738|NCT04667377|79272087|FG003|Maintenance Period|Other than listed above|2|||
44292739|NCT04667377|79272088|FG004|Maintenance Period|Other than listed above|6|||
44292740|NCT04667377|79272084|FG000|Maintenance Period|Withdrawal by Subject|0|||
44292741|NCT04667377|79272085|FG001|Maintenance Period|Withdrawal by Subject|1|||
44292742|NCT04667377|79272086|FG002|Maintenance Period|Withdrawal by Subject|0|||
44292743|NCT04667377|79272087|FG003|Maintenance Period|Withdrawal by Subject|0|||
44292744|NCT04667377|79272088|FG004|Maintenance Period|Withdrawal by Subject|0|||
44292745|NCT04667377|79272084|FG000|Maintenance Period|Lost to Follow-up|1|||
44292746|NCT04667377|79272085|FG001|Maintenance Period|Lost to Follow-up|0|||
44292747|NCT04667377|79272086|FG002|Maintenance Period|Lost to Follow-up|1|||
44292748|NCT04667377|79272087|FG003|Maintenance Period|Lost to Follow-up|0|||
44292749|NCT04667377|79272088|FG004|Maintenance Period|Lost to Follow-up|1|||
44416647|NCT00762411|79424365|FG000|Delayed Start|Caregiver Decision|1|||
44292750|NCT04537923|79272108|FG000|Overall Study|Adverse Event|2|||
44292751|NCT04537923|79272109|FG001|Overall Study|Adverse Event|1|||
44292752|NCT04537923|79272110|FG002|Overall Study|Adverse Event|2|||
44292753|NCT04537923|79272111|FG003|Overall Study|Adverse Event|4|||
44292754|NCT04537923|79272108|FG000|Overall Study|Death|3|||
44292755|NCT04537923|79272109|FG001|Overall Study|Death|3|||
44292756|NCT04537923|79272110|FG002|Overall Study|Death|1|||
44292757|NCT04537923|79272111|FG003|Overall Study|Death|11|||
44292758|NCT04537923|79272108|FG000|Overall Study|Lost to Follow-up|1|||
44292759|NCT04537923|79272109|FG001|Overall Study|Lost to Follow-up|2|||
44292760|NCT04537923|79272110|FG002|Overall Study|Lost to Follow-up|1|||
44292761|NCT04537923|79272111|FG003|Overall Study|Lost to Follow-up|6|||
44416648|NCT00762411|79424366|FG001|Delayed Start|Caregiver Decision|1|||
44292762|NCT04537923|79272108|FG000|Overall Study|Physician Decision|1|||
44292763|NCT04537923|79272109|FG001|Overall Study|Physician Decision|0|||
44292764|NCT04537923|79272110|FG002|Overall Study|Physician Decision|2|||
44154575|NCT02687191|78945863|FG003|Overall Study|Death|0|||
44154576|NCT02687191|78945864|FG004|Overall Study|Death|1|||
44154577|NCT02687191|78945865|FG005|Overall Study|Death|1|||
44154578|NCT02687191|78945860|FG000|Overall Study|Withdrawal by Subject|0|||
44154579|NCT02687191|78945861|FG001|Overall Study|Withdrawal by Subject|0|||
44292765|NCT04537923|79272111|FG003|Overall Study|Physician Decision|5|||
44416649|NCT00762411|79424365|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
44154580|NCT02687191|78945862|FG002|Overall Study|Withdrawal by Subject|0|||
44154581|NCT02687191|78945863|FG003|Overall Study|Withdrawal by Subject|1|||
44256052|NCT00083759|79102280|FG000|Overall Study|Other|14|||
44256053|NCT00083759|79102281|FG001|Overall Study|Other|13|||
44256054|NCT00089609|79102407|FG000|Overall Study|Withdrawal by Subject|3|||
44256055|NCT00089609|79102408|FG001|Overall Study|Withdrawal by Subject|1|||
44256056|NCT02440581|79102549|FG000|Overall Study|Death|0|||
44256057|NCT02440581|79102550|FG001|Overall Study|Death|0|||
44256058|NCT02440581|79102551|FG002|Overall Study|Death|7|||
44256059|NCT02440581|79102552|FG003|Overall Study|Death|5|||
44256060|NCT02440581|79102549|FG000|Overall Study|Transplanted|1|||
44256061|NCT02440581|79102550|FG001|Overall Study|Transplanted|0|||
44256062|NCT02440581|79102551|FG002|Overall Study|Transplanted|3|||
44256063|NCT02440581|79102552|FG003|Overall Study|Transplanted|2|||
44256064|NCT02440581|79102549|FG000|Overall Study|Withdrawal by Subject|4|||
44256065|NCT02440581|79102550|FG001|Overall Study|Withdrawal by Subject|11|||
44256066|NCT02440581|79102551|FG002|Overall Study|Withdrawal by Subject|3|||
44256067|NCT02440581|79102552|FG003|Overall Study|Withdrawal by Subject|7|||
44256068|NCT01359150|79102564|FG000|Overall Study|Lack of Efficacy|1|||
44256069|NCT01359150|79102565|FG001|Overall Study|Lack of Efficacy|1|||
44256070|NCT01359150|79102564|FG000|Overall Study|Withdrawal by Subject|1|||
44256071|NCT01359150|79102565|FG001|Overall Study|Withdrawal by Subject|1|||
44256072|NCT01359150|79102564|FG000|Overall Study|Adverse Event|4|||
44256073|NCT01359150|79102565|FG001|Overall Study|Adverse Event|3|||
44292766|NCT04537923|79272108|FG000|Overall Study|Pregnancy|1|||
44292767|NCT04537923|79272109|FG001|Overall Study|Pregnancy|0|||
44292768|NCT04537923|79272110|FG002|Overall Study|Pregnancy|0|||
44292769|NCT04537923|79272111|FG003|Overall Study|Pregnancy|0|||
44292770|NCT04537923|79272108|FG000|Overall Study|Withdrawal by Subject|4|||
44292771|NCT04537923|79272109|FG001|Overall Study|Withdrawal by Subject|4|||
44292772|NCT04537923|79272110|FG002|Overall Study|Withdrawal by Subject|4|||
44292773|NCT04537923|79272111|FG003|Overall Study|Withdrawal by Subject|58|||
44292774|NCT04537923|79272108|FG000|Overall Study|Missed study visits|2|||
44292775|NCT04537923|79272109|FG001|Overall Study|Missed study visits|0|||
44292776|NCT04537923|79272110|FG002|Overall Study|Missed study visits|0|||
44292777|NCT04537923|79272111|FG003|Overall Study|Missed study visits|3|||
44292778|NCT04537923|79272108|FG000|Overall Study|Sponsor's decision|0|||
44292779|NCT04537923|79272109|FG001|Overall Study|Sponsor's decision|0|||
44292780|NCT04537923|79272110|FG002|Overall Study|Sponsor's decision|1|||
44292781|NCT04537923|79272111|FG003|Overall Study|Sponsor's decision|1|||
44292782|NCT04537923|79272108|FG000|Overall Study|Safety reasons|1|||
44292783|NCT04537923|79272109|FG001|Overall Study|Safety reasons|0|||
44292784|NCT04537923|79272110|FG002|Overall Study|Safety reasons|0|||
44292785|NCT04537923|79272111|FG003|Overall Study|Safety reasons|0|||
44292786|NCT04160468|79272134|FG000|Overall Study|Lost to Follow-up|19|||
44292787|NCT04160468|79272135|FG001|Overall Study|Lost to Follow-up|4|||
44292788|NCT04160468|79272134|FG000|Overall Study|Randomized but not dosed|6|||
44292789|NCT04160468|79272135|FG001|Overall Study|Randomized but not dosed|0|||
44292790|NCT04160468|79272134|FG000|Overall Study|Withdrawal by Subject|4|||
44292791|NCT04160468|79272135|FG001|Overall Study|Withdrawal by Subject|1|||
44292792|NCT04160468|79272134|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
44292793|NCT04160468|79272135|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
44292794|NCT04160468|79272134|FG000|Overall Study|Participant incarcerated|1|||
44292795|NCT04160468|79272135|FG001|Overall Study|Participant incarcerated|0|||
44292796|NCT03761056|79272154|FG000|Overall Study|Still on Study|34|||
44292797|NCT03761056|79272154|FG000|Overall Study|Death|6|||
44292798|NCT03761056|79272154|FG000|Overall Study|Investigator Decision|1|||
44292799|NCT03761056|79272154|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
44292800|NCT03276572|79272176|FG000|Overall Study|In follow-up|0|||
44292801|NCT03276572|79272177|FG001|Overall Study|In follow-up|0|||
44292802|NCT03276572|79272178|FG002|Overall Study|In follow-up|0|||
44292803|NCT03276572|79272179|FG003|Overall Study|In follow-up|0|||
44416650|NCT00762411|79424366|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
44416651|NCT00762411|79424365|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
44292804|NCT03276572|79272180|FG004|Overall Study|In follow-up|0|||
44416652|NCT00762411|79424366|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
44416653|NCT00762411|79424365|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
44416654|NCT00762411|79424366|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
44256074|NCT01359150|79102564|FG000|Overall Study|Other|1|||
44256075|NCT01359150|79102565|FG001|Overall Study|Other|0|||
44256076|NCT01469000|79102626|FG000|Overall Study|Withdrawal by Subject|16|||
44256077|NCT01469000|79102627|FG001|Overall Study|Withdrawal by Subject|3|||
44292805|NCT03276572|79272181|FG005|Overall Study|In follow-up|1|||
44256078|NCT01469000|79102626|FG000|Overall Study|Sponsor Decision|4|||
44256079|NCT01469000|79102627|FG001|Overall Study|Sponsor Decision|1|||
44256080|NCT01490060|79102640|FG000|Cycle 1|Change of Treatment|0|||
44256081|NCT01490060|79102641|FG001|Cycle 1|Change of Treatment|1|||
44292806|NCT03276572|79272182|FG006|Overall Study|In follow-up|1|||
44292807|NCT03276572|79272176|FG000|Overall Study|Lost to Follow-up|0|||
44292808|NCT03276572|79272177|FG001|Overall Study|Lost to Follow-up|0|||
44292809|NCT03276572|79272178|FG002|Overall Study|Lost to Follow-up|0|||
44292810|NCT03276572|79272179|FG003|Overall Study|Lost to Follow-up|0|||
44292811|NCT03276572|79272180|FG004|Overall Study|Lost to Follow-up|0|||
44292812|NCT03276572|79272181|FG005|Overall Study|Lost to Follow-up|0|||
44292813|NCT03276572|79272182|FG006|Overall Study|Lost to Follow-up|1|||
44292814|NCT02840877|79272208|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
44292815|NCT02840877|79272208|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
44292816|NCT02840877|79272208|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
44292817|NCT02840877|79272208|FG000|Baseline to 12 Weeks|Death|1|||
44292818|NCT02840877|79272208|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
44292819|NCT02840877|79272208|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
44292820|NCT02840877|79272208|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
44292821|NCT02840877|79272208|FG000|12 Weeks to 6 Months|Treatment failure|1|||
44292822|NCT02840877|79272208|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
44292823|NCT02840877|79272208|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
44292824|NCT02840877|79272208|FG000|12 Weeks to 6 Months|Death|1|||
44292825|NCT02840877|79272208|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
44292826|NCT02840877|79272208|FG000|6 Months to 18 Months|Treatment failure|7|||
44292827|NCT02840877|79272208|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
44292828|NCT02840877|79272208|FG000|6 Months to 18 Months|Moved/transferred out|6|||
44292829|NCT02840877|79272208|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
44292830|NCT02840877|79272208|FG000|6 Months to 18 Months|Death|4|||
44292831|NCT02840877|79272208|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
44292832|NCT02840877|79272208|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
44292833|NCT02840877|79272208|FG000|6 Months to 18 Months|Still in study.|14|||
44292834|NCT02694185|79272214|FG000|Overall Study|Withdrawal by Subject|45|||
44292835|NCT02694185|79272215|FG001|Overall Study|Withdrawal by Subject|0|||
44292836|NCT02684903|79272223|FG000|Overall Study|COVID-19 shutdown of lab|4|||
44292837|NCT02684903|79272224|FG001|Overall Study|COVID-19 shutdown of lab|6|||
44292838|NCT02684903|79272223|FG000|Overall Study|Lost to Follow-up|31|||
44292839|NCT02684903|79272224|FG001|Overall Study|Lost to Follow-up|41|||
44292840|NCT02621424|79272239|FG000|Overall Study|Withdrawal by Subject|1|||
44292841|NCT02621424|79272240|FG001|Overall Study|Withdrawal by Subject|2|||
44292842|NCT02616185|79272255|FG000|Overall Study|Death|0|||
44292843|NCT02616185|79272256|FG001|Overall Study|Death|0|||
44292844|NCT02616185|79272257|FG002|Overall Study|Death|0|||
44292845|NCT02616185|79272258|FG003|Overall Study|Death|1|||
44292846|NCT02616185|79272259|FG004|Overall Study|Death|2|||
44292847|NCT02616185|79272260|FG005|Overall Study|Death|0|||
44292848|NCT02616185|79272261|FG006|Overall Study|Death|0|||
44292849|NCT02616185|79272262|FG007|Overall Study|Death|2|||
44292850|NCT02616185|79272263|FG008|Overall Study|Death|1|||
44292851|NCT02616185|79272255|FG000|Overall Study|Study terminated by sponsor|0|||
44292852|NCT02616185|79272256|FG001|Overall Study|Study terminated by sponsor|0|||
44292853|NCT02616185|79272257|FG002|Overall Study|Study terminated by sponsor|1|||
44292854|NCT02616185|79272258|FG003|Overall Study|Study terminated by sponsor|0|||
44292855|NCT02616185|79272259|FG004|Overall Study|Study terminated by sponsor|0|||
44292856|NCT02616185|79272260|FG005|Overall Study|Study terminated by sponsor|0|||
44292857|NCT02616185|79272261|FG006|Overall Study|Study terminated by sponsor|5|||
44292858|NCT02616185|79272262|FG007|Overall Study|Study terminated by sponsor|2|||
44292859|NCT02616185|79272263|FG008|Overall Study|Study terminated by sponsor|0|||
44533862|NCT00496873|79544391|FG000|Overall Study|Withdrawal by Subject|3|||
44533863|NCT00492778|79544397|FG000|Overall Study|Ineligible by Pathology Review|8|||
44533864|NCT00492778|79544398|FG001|Overall Study|Ineligible by Pathology Review|1|||
44533865|NCT03775681|79544432|FG000|Overall Study|Physician Decision|3|||
44533866|NCT03774823|79544438|FG000|Overall Study|Withdrawal by Subject|1|||
44533867|NCT03774823|79544439|FG001|Overall Study|Withdrawal by Subject|1|||
44533868|NCT03149042|79544445|FG000|Overall Study|Invasive FFR not performed|21|||
44533869|NCT03149042|79544445|FG000|Overall Study|Poor CT Image Quality|1|||
44533870|NCT03149042|79544445|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
44533871|NCT03496012|79544453|FG000|Overall Study|Withdrawal by Subject|2|||
44533872|NCT03496012|79544454|FG001|Overall Study|Withdrawal by Subject|0|||
44533873|NCT03496012|79544455|FG002|Overall Study|Withdrawal by Subject|2|||
44533874|NCT03496012|79544453|FG000|Overall Study|Adverse Event|0|||
44533875|NCT03496012|79544454|FG001|Overall Study|Adverse Event|0|||
44533876|NCT03496012|79544455|FG002|Overall Study|Adverse Event|1|||
44533877|NCT03496012|79544453|FG000|Overall Study|Reason Not Specified|2|||
44533878|NCT03496012|79544454|FG001|Overall Study|Reason Not Specified|0|||
44533879|NCT03496012|79544455|FG002|Overall Study|Reason Not Specified|1|||
44292860|NCT02616185|79272255|FG000|Overall Study|Participant refused further follow-up|1|||
44292861|NCT02616185|79272256|FG001|Overall Study|Participant refused further follow-up|1|||
44292862|NCT02616185|79272257|FG002|Overall Study|Participant refused further follow-up|2|||
44533880|NCT03774433|79544463|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
44533881|NCT05061992|79544478|FG000|Overall Study|Excess bowel movements|1|||
44533882|NCT05061992|79544479|FG001|Overall Study|Excess bowel movements|0|||
44292863|NCT02616185|79272258|FG003|Overall Study|Participant refused further follow-up|3|||
44292864|NCT02616185|79272259|FG004|Overall Study|Participant refused further follow-up|4|||
44292865|NCT02616185|79272260|FG005|Overall Study|Participant refused further follow-up|0|||
44292866|NCT02616185|79272261|FG006|Overall Study|Participant refused further follow-up|3|||
44292867|NCT02616185|79272262|FG007|Overall Study|Participant refused further follow-up|4|||
44292868|NCT02616185|79272263|FG008|Overall Study|Participant refused further follow-up|3|||
44292869|NCT02616185|79272255|FG000|Overall Study|Not reported|0|||
44292870|NCT02616185|79272256|FG001|Overall Study|Not reported|0|||
44292871|NCT02616185|79272257|FG002|Overall Study|Not reported|0|||
44292872|NCT02616185|79272258|FG003|Overall Study|Not reported|1|||
44292873|NCT02616185|79272259|FG004|Overall Study|Not reported|3|||
44292874|NCT02616185|79272260|FG005|Overall Study|Not reported|1|||
44292875|NCT02616185|79272261|FG006|Overall Study|Not reported|0|||
44292876|NCT02616185|79272262|FG007|Overall Study|Not reported|5|||
44292877|NCT02616185|79272263|FG008|Overall Study|Not reported|2|||
44292878|NCT01967888|79272329|FG000|Overall Study|Lost to Follow-up|6|||
44292879|NCT01967888|79272330|FG001|Overall Study|Lost to Follow-up|4|||
44292880|NCT01967888|79272329|FG000|Overall Study|Withdrawal by Subject|1|||
44292881|NCT01967888|79272330|FG001|Overall Study|Withdrawal by Subject|1|||
44292882|NCT01967888|79272329|FG000|Overall Study|Did Not Have Transplant|1|||
44292883|NCT01967888|79272330|FG001|Overall Study|Did Not Have Transplant|0|||
44292884|NCT01967888|79272329|FG000|Overall Study|Research visit not done, data recorded|1|||
44292885|NCT01967888|79272330|FG001|Overall Study|Research visit not done, data recorded|0|||
44292886|NCT01967888|79272329|FG000|Overall Study|Subject excluded after randomization|1|||
44292887|NCT01967888|79272330|FG001|Overall Study|Subject excluded after randomization|0|||
44292888|NCT01967888|79272329|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
44292889|NCT01967888|79272330|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
44292890|NCT01967888|79272329|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
44292891|NCT01967888|79272330|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
44292892|NCT00653068|79272353|FG000|Overall Study|Death|9|||
44292893|NCT00653068|79272353|FG000|Overall Study|Lack of Efficacy|34|||
44292894|NCT00653068|79272353|FG000|Overall Study|Physician Decision|4|||
44292895|NCT00653068|79272353|FG000|Overall Study|Withdrawal by Subject|1|||
44292896|NCT00653068|79272353|FG000|Overall Study|Ineligible|2|||
44292897|NCT00414648|79272362|FG000|Overall Study|Adverse Event|5|||
44292898|NCT00414648|79272363|FG001|Overall Study|Adverse Event|5|||
44292899|NCT00414648|79272362|FG000|Overall Study|Death|0|||
44292900|NCT00414648|79272363|FG001|Overall Study|Death|1|||
44292901|NCT00414648|79272362|FG000|Overall Study|Lack of Efficacy|0|||
44292902|NCT00414648|79272363|FG001|Overall Study|Lack of Efficacy|2|||
44292903|NCT00414648|79272362|FG000|Overall Study|Withdrawal by Subject|0|||
44292904|NCT00414648|79272363|FG001|Overall Study|Withdrawal by Subject|1|||
44292905|NCT02538666|79272968|FG000|Pre-Treatment|Disease progression|1|||
44292906|NCT02538666|79272969|FG001|Pre-Treatment|Disease progression|0|||
44292907|NCT02538666|79272970|FG002|Pre-Treatment|Disease progression|0|||
44292908|NCT02538666|79272968|FG000|Pre-Treatment|no longer meets study criteria|1|||
44292909|NCT02538666|79272969|FG001|Pre-Treatment|no longer meets study criteria|0|||
44292910|NCT02538666|79272970|FG002|Pre-Treatment|no longer meets study criteria|0|||
44292911|NCT02538666|79272968|FG000|Pre-Treatment|Withdrew Consent|0|||
44292912|NCT02538666|79272969|FG001|Pre-Treatment|Withdrew Consent|1|||
44292913|NCT02538666|79272970|FG002|Pre-Treatment|Withdrew Consent|1|||
44292914|NCT02538666|79272968|FG000|Treatment|Disease progression|270|||
44292915|NCT02538666|79272969|FG001|Treatment|Disease progression|227|||
44292916|NCT02538666|79272970|FG002|Treatment|Disease progression|165|||
44292917|NCT02538666|79272968|FG000|Treatment|Study drug toxicity|1|||
44292918|NCT02538666|79272969|FG001|Treatment|Study drug toxicity|29|||
44292919|NCT02538666|79272970|FG002|Treatment|Study drug toxicity|92|||
44292920|NCT02538666|79272968|FG000|Treatment|Death|0|||
44292921|NCT02538666|79272969|FG001|Treatment|Death|2|||
44292922|NCT02538666|79272970|FG002|Treatment|Death|3|||
44292923|NCT02538666|79272968|FG000|Treatment|Adverse event unrelated to study drug|8|||
44292924|NCT02538666|79272969|FG001|Treatment|Adverse event unrelated to study drug|10|||
44292925|NCT02538666|79272970|FG002|Treatment|Adverse event unrelated to study drug|15|||
44292926|NCT02538666|79272968|FG000|Treatment|Participant request to discontinue study treatment|3|||
44292927|NCT02538666|79272969|FG001|Treatment|Participant request to discontinue study treatment|6|||
44292928|NCT02538666|79272970|FG002|Treatment|Participant request to discontinue study treatment|11|||
44292929|NCT02538666|79272968|FG000|Treatment|Participant withdrew consent|2|||
44292930|NCT02538666|79272969|FG001|Treatment|Participant withdrew consent|5|||
44292931|NCT02538666|79272970|FG002|Treatment|Participant withdrew consent|3|||
44292932|NCT02538666|79272968|FG000|Treatment|Lost to Follow-up|0|||
44292933|NCT02538666|79272969|FG001|Treatment|Lost to Follow-up|1|||
44292934|NCT02538666|79272970|FG002|Treatment|Lost to Follow-up|1|||
44292935|NCT02538666|79272968|FG000|Treatment|Maximum clinical benefit|4|||
44292936|NCT02538666|79272969|FG001|Treatment|Maximum clinical benefit|3|||
44292937|NCT02538666|79272970|FG002|Treatment|Maximum clinical benefit|4|||
44292938|NCT02538666|79272968|FG000|Treatment|Poor/non-compliance|0|||
44292939|NCT02538666|79272969|FG001|Treatment|Poor/non-compliance|1|||
44292940|NCT02538666|79272970|FG002|Treatment|Poor/non-compliance|0|||
44292941|NCT02538666|79272968|FG000|Treatment|Participant no longer meets study criteria|0|||
44292942|NCT02538666|79272969|FG001|Treatment|Participant no longer meets study criteria|2|||
44292943|NCT02538666|79272970|FG002|Treatment|Participant no longer meets study criteria|0|||
44292944|NCT02538666|79272968|FG000|Treatment|Administrative reason by sponsor|0|||
44292945|NCT02538666|79272969|FG001|Treatment|Administrative reason by sponsor|0|||
44292946|NCT02538666|79272970|FG002|Treatment|Administrative reason by sponsor|1|||
44292947|NCT02538666|79272968|FG000|Treatment|Other reasons|8|||
44292948|NCT02538666|79272969|FG001|Treatment|Other reasons|15|||
44292949|NCT02538666|79272970|FG002|Treatment|Other reasons|5|||
44292950|NCT02538666|79272968|FG000|Treatment|Not reported|2|||
44292951|NCT02538666|79272969|FG001|Treatment|Not reported|2|||
44292952|NCT02538666|79272970|FG002|Treatment|Not reported|2|||
44292953|NCT02407236|79273024|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
44292954|NCT02407236|79273025|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
44292955|NCT02407236|79273026|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
44292956|NCT02407236|79273027|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
44292957|NCT02407236|79273028|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
44292958|NCT02407236|79273029|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
44292959|NCT02407236|79273030|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
44292960|NCT02407236|79273031|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
44292961|NCT02407236|79273032|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
44292962|NCT02407236|79273033|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
44292963|NCT02407236|79273034|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
44292964|NCT02407236|79273035|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
44292965|NCT02407236|79273036|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
44292966|NCT02407236|79273024|FG000|Induction Study (8 Weeks)|Death|0|||
44292967|NCT02407236|79273025|FG001|Induction Study (8 Weeks)|Death|0|||
44292968|NCT02407236|79273026|FG002|Induction Study (8 Weeks)|Death|1|||
44292969|NCT02407236|79273027|FG003|Induction Study (8 Weeks)|Death|0|||
44292970|NCT02407236|79273028|FG004|Induction Study (8 Weeks)|Death|0|||
44292971|NCT02407236|79273029|FG005|Induction Study (8 Weeks)|Death|0|||
44292972|NCT02407236|79273030|FG006|Induction Study (8 Weeks)|Death|0|||
44292973|NCT02407236|79273031|FG007|Induction Study (8 Weeks)|Death|0|||
44292974|NCT02407236|79273032|FG008|Induction Study (8 Weeks)|Death|0|||
44292975|NCT02407236|79273033|FG009|Induction Study (8 Weeks)|Death|0|||
44292976|NCT02407236|79273034|FG010|Induction Study (8 Weeks)|Death|0|||
44292977|NCT02407236|79273035|FG011|Induction Study (8 Weeks)|Death|0|||
44292978|NCT02407236|79273036|FG012|Induction Study (8 Weeks)|Death|0|||
44292979|NCT02407236|79273024|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
44292980|NCT02407236|79273025|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
44292981|NCT02407236|79273026|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
44292982|NCT02407236|79273027|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292983|NCT02407236|79273028|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292984|NCT02407236|79273029|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292985|NCT02407236|79273030|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292986|NCT02407236|79273031|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292987|NCT02407236|79273032|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292988|NCT02407236|79273033|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292989|NCT02407236|79273034|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292990|NCT02407236|79273035|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292991|NCT02407236|79273036|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
44292992|NCT02407236|79273024|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44292993|NCT02407236|79273025|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44292994|NCT02407236|79273026|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
44292995|NCT02407236|79273027|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44292996|NCT02407236|79273028|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44292997|NCT02407236|79273029|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44292998|NCT02407236|79273030|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44292999|NCT02407236|79273031|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44293000|NCT02407236|79273032|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44293001|NCT02407236|79273033|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44293002|NCT02407236|79273034|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44293003|NCT02407236|79273035|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44293004|NCT02407236|79273036|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
44293005|NCT02407236|79273024|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
44293006|NCT02407236|79273025|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
44416655|NCT00762411|79424365|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
44416656|NCT00762411|79424366|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
44293007|NCT02407236|79273026|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
44293008|NCT02407236|79273027|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
44293009|NCT02407236|79273028|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
44293010|NCT02407236|79273029|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
44293011|NCT02407236|79273030|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
44256082|NCT01490060|79102642|FG002|Cycle 1|Change of Treatment|1|||
44256083|NCT01490060|79102643|FG003|Cycle 1|Change of Treatment|1|||
44256084|NCT01490060|79102640|FG000|Cycle 1|Insurance Denied|0|||
44256085|NCT01490060|79102641|FG001|Cycle 1|Insurance Denied|0|||
44256086|NCT01490060|79102642|FG002|Cycle 1|Insurance Denied|2|||
44256087|NCT01490060|79102643|FG003|Cycle 1|Insurance Denied|0|||
44256088|NCT01490060|79102640|FG000|Cycle 1|Withdrawal by Subject|0|||
44256089|NCT01490060|79102641|FG001|Cycle 1|Withdrawal by Subject|0|||
44256090|NCT01490060|79102642|FG002|Cycle 1|Withdrawal by Subject|0|||
44256091|NCT01490060|79102643|FG003|Cycle 1|Withdrawal by Subject|1|||
44256092|NCT01490060|79102640|FG000|Cycle 1|Treatment at Another Facility|0|||
44256093|NCT01490060|79102641|FG001|Cycle 1|Treatment at Another Facility|0|||
44256094|NCT01490060|79102642|FG002|Cycle 1|Treatment at Another Facility|0|||
44256095|NCT01490060|79102643|FG003|Cycle 1|Treatment at Another Facility|1|||
44256096|NCT01490060|79102640|FG000|Cycle 2|Change of Treatment|1|||
44256097|NCT01490060|79102641|FG001|Cycle 2|Change of Treatment|1|||
44256098|NCT01490060|79102642|FG002|Cycle 2|Change of Treatment|0|||
44256099|NCT01490060|79102643|FG003|Cycle 2|Change of Treatment|0|||
44256100|NCT01490060|79102640|FG000|Cycle 2|Non-Compliance|0|||
44256101|NCT01490060|79102641|FG001|Cycle 2|Non-Compliance|0|||
44256102|NCT01490060|79102642|FG002|Cycle 2|Non-Compliance|1|||
44256103|NCT01490060|79102643|FG003|Cycle 2|Non-Compliance|0|||
44256104|NCT01490060|79102640|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
44256105|NCT01490060|79102641|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
44256106|NCT01490060|79102642|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
44256107|NCT01490060|79102643|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
44256108|NCT01452152|79102695|FG000|Overall Study|Study termination by sponsor|5|||
44256109|NCT01452152|79102696|FG001|Overall Study|Study termination by sponsor|0|||
44256110|NCT01452152|79102697|FG002|Overall Study|Study termination by sponsor|4|||
44256111|NCT01451762|79102708|FG000|Overall Study|Lost to Follow-up|3|||
44256112|NCT01451762|79102709|FG001|Overall Study|Lost to Follow-up|6|||
44256113|NCT01451762|79102710|FG002|Overall Study|Lost to Follow-up|6|||
44256114|NCT01468844|79102745|FG000|Overall Study|Adverse Event|1|||
44256115|NCT01468844|79102746|FG001|Overall Study|Adverse Event|0|||
44256116|NCT01468844|79102745|FG000|Overall Study|Withdrawal by Subject|1|||
44256117|NCT01468844|79102746|FG001|Overall Study|Withdrawal by Subject|0|||
44256118|NCT01451606|79102770|FG000|Overall Study|Withdrawal by Subject|4|||
44256119|NCT01451606|79102771|FG001|Overall Study|Withdrawal by Subject|3|||
44256120|NCT00473343|79102826|FG000|Overall Study|Adverse Event|9|||
44256121|NCT00473343|79102826|FG000|Overall Study|Lost to Follow-up|8|||
44256122|NCT00473343|79102826|FG000|Overall Study|Treatment failure|27|||
44256123|NCT00473343|79102826|FG000|Overall Study|Withdrew consent|3|||
44256124|NCT00473343|79102826|FG000|Overall Study|Other un-specified reason|3|||
44256125|NCT02587962|79103283|FG000|Overall Study|Adverse Event|0|||
44256126|NCT02587962|79103284|FG001|Overall Study|Adverse Event|0|||
44256127|NCT02587962|79103285|FG002|Overall Study|Adverse Event|1|||
44256128|NCT02587962|79103286|FG003|Overall Study|Adverse Event|0|||
44256129|NCT02587962|79103287|FG004|Overall Study|Adverse Event|0|||
44256130|NCT02587962|79103283|FG000|Overall Study|Withdrawal by Subject|0|||
44256131|NCT02587962|79103284|FG001|Overall Study|Withdrawal by Subject|0|||
44256132|NCT02587962|79103285|FG002|Overall Study|Withdrawal by Subject|1|||
44256133|NCT02587962|79103286|FG003|Overall Study|Withdrawal by Subject|1|||
44256134|NCT02587962|79103287|FG004|Overall Study|Withdrawal by Subject|4|||
44256135|NCT02587962|79103283|FG000|Overall Study|Radiological progression|2|||
44256136|NCT02587962|79103284|FG001|Overall Study|Radiological progression|2|||
44256137|NCT02587962|79103285|FG002|Overall Study|Radiological progression|2|||
44256138|NCT02587962|79103286|FG003|Overall Study|Radiological progression|5|||
44256139|NCT02587962|79103287|FG004|Overall Study|Radiological progression|10|||
44256140|NCT02587962|79103283|FG000|Overall Study|Clinical progression|0|||
44256141|NCT02587962|79103284|FG001|Overall Study|Clinical progression|1|||
44256142|NCT02587962|79103285|FG002|Overall Study|Clinical progression|2|||
44256143|NCT02587962|79103286|FG003|Overall Study|Clinical progression|0|||
44256144|NCT02587962|79103287|FG004|Overall Study|Clinical progression|1|||
44256145|NCT01440374|79103432|FG000|Part 1: Open-label Phase|Adverse Event|5|||
44256146|NCT01440374|79103433|FG001|Part 1: Open-label Phase|Adverse Event|0|||
44256147|NCT01440374|79103434|FG002|Part 1: Open-label Phase|Adverse Event|0|||
44256148|NCT01440374|79103435|FG003|Part 1: Open-label Phase|Adverse Event|0|||
44256149|NCT01440374|79103432|FG000|Part 1: Open-label Phase|Physician Decision|1|||
44256150|NCT01440374|79103433|FG001|Part 1: Open-label Phase|Physician Decision|0|||
44256151|NCT01440374|79103434|FG002|Part 1: Open-label Phase|Physician Decision|0|||
44256152|NCT01440374|79103435|FG003|Part 1: Open-label Phase|Physician Decision|0|||
44256153|NCT01440374|79103432|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
44293012|NCT02407236|79273031|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
44293013|NCT02407236|79273032|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
44293014|NCT02407236|79273033|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
44293015|NCT02407236|79273034|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
44293016|NCT02407236|79273035|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
44293017|NCT02407236|79273036|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
44293018|NCT02407236|79273024|FG000|Induction Study (8 Weeks)|Other|2|||
44293019|NCT02407236|79273025|FG001|Induction Study (8 Weeks)|Other|1|||
44293020|NCT02407236|79273026|FG002|Induction Study (8 Weeks)|Other|5|||
44293021|NCT02407236|79273027|FG003|Induction Study (8 Weeks)|Other|0|||
44293022|NCT02407236|79273028|FG004|Induction Study (8 Weeks)|Other|0|||
44293023|NCT02407236|79273029|FG005|Induction Study (8 Weeks)|Other|0|||
44293024|NCT02407236|79273030|FG006|Induction Study (8 Weeks)|Other|0|||
44293025|NCT02407236|79273031|FG007|Induction Study (8 Weeks)|Other|0|||
44293026|NCT02407236|79273032|FG008|Induction Study (8 Weeks)|Other|0|||
44293027|NCT02407236|79273033|FG009|Induction Study (8 Weeks)|Other|0|||
44293028|NCT02407236|79273034|FG010|Induction Study (8 Weeks)|Other|0|||
44293029|NCT02407236|79273035|FG011|Induction Study (8 Weeks)|Other|0|||
44293030|NCT02407236|79273036|FG012|Induction Study (8 Weeks)|Other|0|||
44293031|NCT02407236|79273024|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293032|NCT02407236|79273025|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293033|NCT02407236|79273026|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293034|NCT02407236|79273027|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
44293035|NCT02407236|79273028|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
44293036|NCT02407236|79273029|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
44293037|NCT02407236|79273030|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
44293038|NCT02407236|79273031|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
44293039|NCT02407236|79273032|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293040|NCT02407236|79273033|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293041|NCT02407236|79273034|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293042|NCT02407236|79273035|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293043|NCT02407236|79273036|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
44293044|NCT02407236|79273024|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293045|NCT02407236|79273025|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293046|NCT02407236|79273026|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293047|NCT02407236|79273027|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
44293048|NCT02407236|79273028|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
44293049|NCT02407236|79273029|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
44293050|NCT02407236|79273030|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
44293051|NCT02407236|79273031|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
44293052|NCT02407236|79273032|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293053|NCT02407236|79273033|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293054|NCT02407236|79273034|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293055|NCT02407236|79273035|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293056|NCT02407236|79273036|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
44293057|NCT02407236|79273024|FG000|Maintenance Study (44 Weeks)|Other|0|||
44293058|NCT02407236|79273025|FG001|Maintenance Study (44 Weeks)|Other|0|||
44293059|NCT02407236|79273026|FG002|Maintenance Study (44 Weeks)|Other|0|||
44293060|NCT02407236|79273027|FG003|Maintenance Study (44 Weeks)|Other|5|||
44293061|NCT02407236|79273028|FG004|Maintenance Study (44 Weeks)|Other|7|||
44293062|NCT02407236|79273029|FG005|Maintenance Study (44 Weeks)|Other|8|||
44293063|NCT02407236|79273030|FG006|Maintenance Study (44 Weeks)|Other|4|||
44293064|NCT02407236|79273031|FG007|Maintenance Study (44 Weeks)|Other|6|||
44293065|NCT02407236|79273032|FG008|Maintenance Study (44 Weeks)|Other|0|||
44293066|NCT02407236|79273033|FG009|Maintenance Study (44 Weeks)|Other|0|||
44293067|NCT02407236|79273034|FG010|Maintenance Study (44 Weeks)|Other|0|||
44293068|NCT02407236|79273035|FG011|Maintenance Study (44 Weeks)|Other|0|||
44293069|NCT02407236|79273036|FG012|Maintenance Study (44 Weeks)|Other|0|||
44293070|NCT02407236|79273024|FG000|Maintenance Study (44 Weeks)|Death|0|||
44293071|NCT02407236|79273025|FG001|Maintenance Study (44 Weeks)|Death|0|||
44293072|NCT02407236|79273026|FG002|Maintenance Study (44 Weeks)|Death|0|||
44293073|NCT02407236|79273027|FG003|Maintenance Study (44 Weeks)|Death|0|||
44293074|NCT02407236|79273028|FG004|Maintenance Study (44 Weeks)|Death|0|||
44293075|NCT02407236|79273029|FG005|Maintenance Study (44 Weeks)|Death|0|||
44293076|NCT02407236|79273030|FG006|Maintenance Study (44 Weeks)|Death|0|||
44293077|NCT02407236|79273031|FG007|Maintenance Study (44 Weeks)|Death|1|||
44293078|NCT02407236|79273032|FG008|Maintenance Study (44 Weeks)|Death|0|||
44293079|NCT02407236|79273033|FG009|Maintenance Study (44 Weeks)|Death|0|||
44293080|NCT02407236|79273034|FG010|Maintenance Study (44 Weeks)|Death|0|||
44293081|NCT02407236|79273035|FG011|Maintenance Study (44 Weeks)|Death|0|||
44293082|NCT02407236|79273036|FG012|Maintenance Study (44 Weeks)|Death|0|||
44293083|NCT02407236|79273024|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293084|NCT02407236|79273025|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293085|NCT02407236|79273026|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293086|NCT02407236|79273027|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293087|NCT02407236|79273028|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293088|NCT02407236|79273029|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293089|NCT02407236|79273030|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293090|NCT02407236|79273031|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
44293091|NCT02407236|79273032|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
44293092|NCT02407236|79273033|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
44293093|NCT02407236|79273034|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
44293094|NCT02407236|79273035|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
44293095|NCT02407236|79273036|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
44293096|NCT02407236|79273024|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293097|NCT02407236|79273025|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293098|NCT02407236|79273026|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293099|NCT02407236|79273027|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293100|NCT02407236|79273028|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293101|NCT02407236|79273029|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293102|NCT02407236|79273030|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293103|NCT02407236|79273031|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293104|NCT02407236|79273032|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293105|NCT02407236|79273033|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293106|NCT02407236|79273034|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
44293107|NCT02407236|79273035|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293108|NCT02407236|79273036|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
44293109|NCT02407236|79273024|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293110|NCT02407236|79273025|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293111|NCT02407236|79273026|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293112|NCT02407236|79273027|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293113|NCT02407236|79273028|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293114|NCT02407236|79273029|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293115|NCT02407236|79273030|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293116|NCT02407236|79273031|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
44293117|NCT02407236|79273032|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
44293118|NCT02407236|79273033|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
44293119|NCT02407236|79273034|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
44293120|NCT02407236|79273035|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
44293121|NCT02407236|79273036|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
44293122|NCT02407236|79273024|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
44293123|NCT02407236|79273025|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
44293124|NCT02407236|79273026|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
44293125|NCT02407236|79273027|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
44293126|NCT02407236|79273028|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
44293127|NCT02407236|79273029|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
44293128|NCT02407236|79273030|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
44293129|NCT02407236|79273031|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
44293130|NCT02407236|79273032|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
44293131|NCT02407236|79273033|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
44293132|NCT02407236|79273034|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
44293133|NCT02407236|79273035|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
44293134|NCT02407236|79273036|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
44293135|NCT01893138|79273064|FG000|Double-Blind Period|Withdrawal by Subject|1|||
44293136|NCT01893138|79273065|FG001|Double-Blind Period|Withdrawal by Subject|1|||
44293137|NCT01893138|79273064|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
44293138|NCT01893138|79273065|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
44293139|NCT01893138|79273064|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
44416657|NCT00762411|79424365|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
44416658|NCT00762411|79424366|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
44416659|NCT00762411|79424365|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
44416660|NCT00762411|79424366|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
44533883|NCT05061992|79544478|FG000|Overall Study|Complications of Medical Care|1|||
44533884|NCT05061992|79544479|FG001|Overall Study|Complications of Medical Care|0|||
44533885|NCT05061992|79544478|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
44533886|NCT05061992|79544479|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
44533887|NCT05061992|79544478|FG000|Overall Study|Withdrawal by Subject|0|||
44533888|NCT05061992|79544479|FG001|Overall Study|Withdrawal by Subject|1|||
44293140|NCT01893138|79273065|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
44416661|NCT00761865|79424378|FG000|Overall Study|Lost to Follow-up|8|||
44293141|NCT01893138|79273064|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
44416662|NCT00761865|79424379|FG001|Overall Study|Lost to Follow-up|7|||
44416663|NCT00841763|79424387|FG000|Overall Study|Withdrawal by Subject|60|||
44416664|NCT00841763|79424388|FG001|Overall Study|Withdrawal by Subject|17|||
44416665|NCT00841763|79424389|FG002|Overall Study|Withdrawal by Subject|4|||
44416666|NCT00841763|79424390|FG003|Overall Study|Withdrawal by Subject|1|||
44416667|NCT00841763|79424387|FG000|Overall Study|Adverse Event|9|||
44416668|NCT00841763|79424388|FG001|Overall Study|Adverse Event|10|||
44416669|NCT00841763|79424389|FG002|Overall Study|Adverse Event|3|||
44416670|NCT00841763|79424390|FG003|Overall Study|Adverse Event|2|||
44416671|NCT00841763|79424387|FG000|Overall Study|Lost to Follow-up|63|||
44416672|NCT00841763|79424388|FG001|Overall Study|Lost to Follow-up|25|||
44416673|NCT00841763|79424389|FG002|Overall Study|Lost to Follow-up|0|||
44416674|NCT00841763|79424390|FG003|Overall Study|Lost to Follow-up|0|||
44416675|NCT00841763|79424387|FG000|Overall Study|Protocol Violation|20|||
44416676|NCT00841763|79424388|FG001|Overall Study|Protocol Violation|3|||
44416677|NCT00841763|79424389|FG002|Overall Study|Protocol Violation|1|||
44416678|NCT00841763|79424390|FG003|Overall Study|Protocol Violation|0|||
44416679|NCT00841763|79424387|FG000|Overall Study|Administrative Reasons|3|||
44416680|NCT00841763|79424388|FG001|Overall Study|Administrative Reasons|1|||
44416681|NCT00841763|79424389|FG002|Overall Study|Administrative Reasons|0|||
44416682|NCT00841763|79424390|FG003|Overall Study|Administrative Reasons|0|||
44416683|NCT00841763|79424387|FG000|Overall Study|Unable to Classify|7|||
44416684|NCT00841763|79424388|FG001|Overall Study|Unable to Classify|1|||
44416685|NCT00841763|79424389|FG002|Overall Study|Unable to Classify|0|||
44416686|NCT00841763|79424390|FG003|Overall Study|Unable to Classify|0|||
44416687|NCT00838331|79424435|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
44416688|NCT00785538|79424443|FG000|Treatment Period|Adverse Event|1|||
44416689|NCT00785538|79424444|FG001|Treatment Period|Adverse Event|2|||
44416690|NCT00785538|79424445|FG002|Treatment Period|Adverse Event|2|||
44416691|NCT00785538|79424446|FG003|Treatment Period|Adverse Event|0|||
44293142|NCT01893138|79273065|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
44293143|NCT01893138|79273064|FG000|Open Label - Unblinded Period|Adverse Event|1|||
44293144|NCT01893138|79273065|FG001|Open Label - Unblinded Period|Adverse Event|0|||
44293145|NCT04309500|79273077|FG000|Overall Study|Lost to Follow-up|1|||
44293146|NCT04309500|79273078|FG001|Overall Study|Lost to Follow-up|0|||
44293147|NCT04309500|79273079|FG002|Overall Study|Lost to Follow-up|0|||
44293148|NCT04309500|79273080|FG003|Overall Study|Lost to Follow-up|0|||
44293149|NCT03671304|79274415|FG000|Overall Study|study terminated|7|||
44154582|NCT02687191|78945864|FG004|Overall Study|Withdrawal by Subject|0|||
44154583|NCT02687191|78945865|FG005|Overall Study|Withdrawal by Subject|0|||
44154584|NCT02687035|78945879|FG000|Overall Study|Withdrawal by Subject|1|||
44154585|NCT02687035|78945879|FG000|Overall Study|Death|87|||
44154586|NCT02687035|78945879|FG000|Overall Study|Lost to Follow-up|1|||
44293150|NCT03447990|79274426|FG000|Overall Study|Withdrawal by Subject|0|||
44293151|NCT03447990|79274427|FG001|Overall Study|Withdrawal by Subject|0|||
44416692|NCT00785538|79424443|FG000|Treatment Period|Withdrawal by Subject|0|||
44256154|NCT01440374|79103433|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
44256155|NCT01440374|79103434|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
44256156|NCT01440374|79103435|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
44256157|NCT01440374|79103432|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
44256158|NCT01440374|79103433|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
44256159|NCT01440374|79103434|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
44256160|NCT01440374|79103435|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
44256161|NCT01440374|79103432|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
44256162|NCT01440374|79103433|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
44256163|NCT01440374|79103434|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
44256164|NCT01440374|79103435|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
44256165|NCT01440374|79103432|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
44256166|NCT01440374|79103433|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
44256167|NCT01440374|79103434|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
44256168|NCT01440374|79103435|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
44256169|NCT01440374|79103432|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
44256170|NCT01440374|79103433|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
44256171|NCT01440374|79103434|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
44256172|NCT01440374|79103435|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
44416693|NCT00785538|79424444|FG001|Treatment Period|Withdrawal by Subject|0|||
44416694|NCT00785538|79424445|FG002|Treatment Period|Withdrawal by Subject|0|||
44256173|NCT01440374|79103432|FG000|Part 2; Double-blind Phase|Not treated|0|||
44293152|NCT03447990|79274428|FG002|Overall Study|Withdrawal by Subject|0|||
44416695|NCT00785538|79424446|FG003|Treatment Period|Withdrawal by Subject|1|||
44416696|NCT00860405|79424459|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
44416697|NCT00860405|79424460|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
44416698|NCT00838097|79424466|FG000|Overall Study|Ineligibility determined|6|||
44154587|NCT02687035|78945879|FG000|Overall Study|Missed Visit|87|||
44293153|NCT03447990|79274429|FG003|Overall Study|Withdrawal by Subject|0|||
44293154|NCT03447990|79274430|FG004|Overall Study|Withdrawal by Subject|0|||
44293155|NCT03447990|79274431|FG005|Overall Study|Withdrawal by Subject|0|||
44293156|NCT03447990|79274432|FG006|Overall Study|Withdrawal by Subject|1|||
44293157|NCT01376778|79274484|FG000|Overall Study|Lost to Follow-up|3|||
44293158|NCT01376778|79274485|FG001|Overall Study|Lost to Follow-up|2|||
44293159|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
44293160|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
44293161|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
44293162|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
44293163|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
44293164|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
44293165|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
44293166|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
44293167|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
44293168|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
44293169|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
44293170|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
44293171|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
44293172|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
44293173|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
44293174|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
44293175|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
44293176|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
44533889|NCT04814823|79544494|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
44533890|NCT04762160|79544511|FG000|Overall Study|Study terminated early due to business reasons|5|||
44533891|NCT04625972|79544517|FG000|Overall Study|Death|3|||
44533892|NCT04625972|79544518|FG001|Overall Study|Death|2|||
44533893|NCT04625972|79544517|FG000|Overall Study|Lost to Follow-up|82|||
44533894|NCT04625972|79544518|FG001|Overall Study|Lost to Follow-up|38|||
44533895|NCT04625972|79544517|FG000|Overall Study|Physician Decision|2|||
44533896|NCT04625972|79544518|FG001|Overall Study|Physician Decision|0|||
44533897|NCT04625972|79544517|FG000|Overall Study|Protocol Violation|0|||
44533898|NCT04625972|79544518|FG001|Overall Study|Protocol Violation|1|||
44293177|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
44293178|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
44293179|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
44293180|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
44293181|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
44293182|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
44293183|NCT01074294|79274494|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
44293184|NCT01074294|79274495|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
44293185|NCT01074294|79274496|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
44293186|NCT01074294|79274497|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
44293187|NCT01074294|79274494|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
44293188|NCT01074294|79274495|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
44293189|NCT01074294|79274496|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
44293190|NCT01074294|79274497|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
44293191|NCT01074294|79274494|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
44293192|NCT01074294|79274495|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
44293193|NCT01074294|79274496|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
44533899|NCT04625972|79544517|FG000|Overall Study|Withdrawal by Subject|37|||
44533900|NCT04625972|79544518|FG001|Overall Study|Withdrawal by Subject|24|||
44256174|NCT01440374|79103433|FG001|Part 2; Double-blind Phase|Not treated|0|||
44256175|NCT01440374|79103434|FG002|Part 2; Double-blind Phase|Not treated|1|||
44256176|NCT01440374|79103435|FG003|Part 2; Double-blind Phase|Not treated|0|||
44256177|NCT01440374|79103432|FG000|Part 3: Extension|Withdrawal by Subject|0|||
44256178|NCT01440374|79103433|FG001|Part 3: Extension|Withdrawal by Subject|0|||
44256179|NCT01440374|79103434|FG002|Part 3: Extension|Withdrawal by Subject|0|||
44256180|NCT01440374|79103435|FG003|Part 3: Extension|Withdrawal by Subject|5|||
44256181|NCT01440374|79103432|FG000|Part 3: Extension|Adverse Event|0|||
44256182|NCT01440374|79103433|FG001|Part 3: Extension|Adverse Event|0|||
44256183|NCT01440374|79103434|FG002|Part 3: Extension|Adverse Event|0|||
44256184|NCT01440374|79103435|FG003|Part 3: Extension|Adverse Event|13|||
44256185|NCT01440374|79103432|FG000|Part 3: Extension|Physician Decision|0|||
44256186|NCT01440374|79103433|FG001|Part 3: Extension|Physician Decision|0|||
44256187|NCT01440374|79103434|FG002|Part 3: Extension|Physician Decision|0|||
44256188|NCT01440374|79103435|FG003|Part 3: Extension|Physician Decision|14|||
44293194|NCT01074294|79274497|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
44533901|NCT04625972|79544517|FG000|Overall Study|Not specified elsewhere|8|||
44533902|NCT04625972|79544518|FG001|Overall Study|Not specified elsewhere|6|||
44256189|NCT01666782|79103583|FG000|Overall Study|Received 2 doses of vaccine|0|||
44256190|NCT01666782|79103584|FG001|Overall Study|Received 2 doses of vaccine|1|||
44256191|NCT01666782|79103583|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
44256192|NCT01666782|79103584|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
44256193|NCT01439360|79103600|FG000|Overall Study|Adverse Event|4|||
44256194|NCT01439360|79103601|FG001|Overall Study|Adverse Event|16|||
44256195|NCT01439360|79103600|FG000|Overall Study|Lost to Follow-up|43|||
44256196|NCT01439360|79103601|FG001|Overall Study|Lost to Follow-up|58|||
44256197|NCT01439360|79103600|FG000|Overall Study|Others|10|||
44293195|NCT01074294|79274494|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
44293196|NCT01074294|79274495|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
44293197|NCT01074294|79274496|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
44293198|NCT01074294|79274497|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
44293199|NCT01074294|79274494|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
44293200|NCT01074294|79274495|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
44293201|NCT01074294|79274496|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
44293202|NCT01074294|79274497|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
44293203|NCT01074294|79274494|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
44293204|NCT01074294|79274495|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
44293205|NCT01074294|79274496|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
44293206|NCT01074294|79274497|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
44293207|NCT01074294|79274494|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
44293208|NCT01074294|79274495|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
44293209|NCT01074294|79274496|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
44293210|NCT01074294|79274497|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
44293211|NCT04753437|79275437|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
44293212|NCT04753437|79275438|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
44293213|NCT04753437|79275437|FG000|Overall Study|Liver Function Test Abnormalities|2|||
44293214|NCT04753437|79275438|FG001|Overall Study|Liver Function Test Abnormalities|4|||
44293215|NCT04605094|79275446|FG000|Overall Study|Adverse Event|2|||
44293216|NCT04605094|79275447|FG001|Overall Study|Adverse Event|2|||
44293217|NCT04605094|79275446|FG000|Overall Study|Lost to Follow-up|1|||
44293218|NCT04605094|79275447|FG001|Overall Study|Lost to Follow-up|4|||
44293219|NCT04605094|79275446|FG000|Overall Study|Physician Decision|2|||
44293220|NCT04605094|79275447|FG001|Overall Study|Physician Decision|2|||
44293221|NCT04605094|79275446|FG000|Overall Study|Study terminated by Sponsor|31|||
44293222|NCT04605094|79275447|FG001|Overall Study|Study terminated by Sponsor|33|||
44293223|NCT04605094|79275446|FG000|Overall Study|Withdrawal by Subject|22|||
44293224|NCT04605094|79275447|FG001|Overall Study|Withdrawal by Subject|19|||
44293225|NCT04605094|79275446|FG000|Overall Study|Other|1|||
44154588|NCT02687035|78945879|FG000|Overall Study|Did not receive Study Device|8|||
44293226|NCT04605094|79275447|FG001|Overall Study|Other|1|||
44293227|NCT04526210|79275456|FG000|Overall Study|Sponsor decision|7|||
44293228|NCT04526210|79275457|FG001|Overall Study|Sponsor decision|5|||
44293229|NCT04526210|79275456|FG000|Overall Study|Withdrawal by Subject|3|||
44293230|NCT04526210|79275457|FG001|Overall Study|Withdrawal by Subject|2|||
44293231|NCT04149964|79275475|FG000|Overall Study|Lost to Follow-up|19|||
44293232|NCT04149964|79275476|FG001|Overall Study|Lost to Follow-up|18|||
44293233|NCT03842969|79275502|FG000|Overall Study|Participant declined follow-up visit|0|||
44293234|NCT03842969|79275503|FG001|Overall Study|Participant declined follow-up visit|1|||
44293235|NCT03842969|79275504|FG002|Overall Study|Participant declined follow-up visit|0|||
44293236|NCT03842969|79275502|FG000|Overall Study|Sponsor's decision|12|||
44293237|NCT03842969|79275503|FG001|Overall Study|Sponsor's decision|99|||
44293238|NCT03842969|79275504|FG002|Overall Study|Sponsor's decision|61|||
44293239|NCT03842969|79275502|FG000|Overall Study|Pregnancy|0|||
44293240|NCT03842969|79275503|FG001|Overall Study|Pregnancy|0|||
44293241|NCT03842969|79275504|FG002|Overall Study|Pregnancy|1|||
44293242|NCT03842969|79275502|FG000|Overall Study|Death|1|||
44293243|NCT03842969|79275503|FG001|Overall Study|Death|0|||
44293244|NCT03842969|79275504|FG002|Overall Study|Death|1|||
44293245|NCT03842969|79275502|FG000|Overall Study|Withdrawal by Subject|3|||
44154589|NCT02691013|78945885|FG000|Overall Study|Withdrawal by Subject|3|||
44293246|NCT03842969|79275503|FG001|Overall Study|Withdrawal by Subject|30|||
44154590|NCT02691013|78945886|FG001|Overall Study|Withdrawal by Subject|0|||
44293247|NCT03842969|79275504|FG002|Overall Study|Withdrawal by Subject|18|||
44293248|NCT03842969|79275502|FG000|Overall Study|Protocol Violation|1|||
44293249|NCT03842969|79275503|FG001|Overall Study|Protocol Violation|1|||
44154591|NCT02690701|78945896|FG000|Treatment Period 1|Adverse Event|2|||
44154592|NCT02690701|78945897|FG001|Treatment Period 1|Adverse Event|2|||
44256198|NCT01439360|79103601|FG001|Overall Study|Others|5|||
44256199|NCT01439360|79103600|FG000|Overall Study|Protocol Violation|1|||
44256200|NCT01439360|79103601|FG001|Overall Study|Protocol Violation|0|||
44293250|NCT03842969|79275504|FG002|Overall Study|Protocol Violation|0|||
44293251|NCT03842969|79275502|FG000|Overall Study|Physician Decision|0|||
44293252|NCT03842969|79275503|FG001|Overall Study|Physician Decision|3|||
44293253|NCT03842969|79275504|FG002|Overall Study|Physician Decision|0|||
44293254|NCT03842969|79275502|FG000|Overall Study|Lost to Follow-up|0|||
44293255|NCT03842969|79275503|FG001|Overall Study|Lost to Follow-up|2|||
44293256|NCT03842969|79275504|FG002|Overall Study|Lost to Follow-up|0|||
44293257|NCT03842969|79275502|FG000|Overall Study|Adverse Event|0|||
44293258|NCT03842969|79275503|FG001|Overall Study|Adverse Event|2|||
44293259|NCT03842969|79275504|FG002|Overall Study|Adverse Event|0|||
44293260|NCT02764541|79275533|FG000|Overall Study|Withdrawal by Subject|0|||
44293261|NCT02764541|79275534|FG001|Overall Study|Withdrawal by Subject|0|||
44293262|NCT02764541|79275535|FG002|Overall Study|Withdrawal by Subject|0|||
44293263|NCT02764541|79275536|FG003|Overall Study|Withdrawal by Subject|0|||
44293264|NCT02764541|79275537|FG004|Overall Study|Withdrawal by Subject|1|||
44293265|NCT02764541|79275538|FG005|Overall Study|Withdrawal by Subject|1|||
44293266|NCT02764541|79275539|FG006|Overall Study|Withdrawal by Subject|0|||
44293267|NCT02764541|79275540|FG007|Overall Study|Withdrawal by Subject|1|||
44293268|NCT02764541|79275533|FG000|Overall Study|Adverse Event|1|||
44293269|NCT02764541|79275534|FG001|Overall Study|Adverse Event|0|||
44293270|NCT02764541|79275535|FG002|Overall Study|Adverse Event|0|||
44293271|NCT02764541|79275536|FG003|Overall Study|Adverse Event|0|||
44293272|NCT02764541|79275537|FG004|Overall Study|Adverse Event|0|||
44293273|NCT02764541|79275538|FG005|Overall Study|Adverse Event|0|||
44293274|NCT02764541|79275539|FG006|Overall Study|Adverse Event|1|||
44293275|NCT02764541|79275540|FG007|Overall Study|Adverse Event|0|||
44293276|NCT02764541|79275533|FG000|Overall Study|Metastasis|1|||
44293277|NCT02764541|79275534|FG001|Overall Study|Metastasis|0|||
44293278|NCT02764541|79275535|FG002|Overall Study|Metastasis|0|||
44293279|NCT02764541|79275536|FG003|Overall Study|Metastasis|0|||
44293280|NCT02764541|79275537|FG004|Overall Study|Metastasis|0|||
44293281|NCT02764541|79275538|FG005|Overall Study|Metastasis|0|||
44293282|NCT02764541|79275539|FG006|Overall Study|Metastasis|0|||
44293283|NCT02764541|79275540|FG007|Overall Study|Metastasis|0|||
44293284|NCT02764541|79275533|FG000|Overall Study|Disease progression|1|||
44293285|NCT02764541|79275534|FG001|Overall Study|Disease progression|1|||
44293286|NCT02764541|79275535|FG002|Overall Study|Disease progression|0|||
44293287|NCT02764541|79275536|FG003|Overall Study|Disease progression|0|||
44293288|NCT02764541|79275537|FG004|Overall Study|Disease progression|0|||
44293289|NCT02764541|79275538|FG005|Overall Study|Disease progression|0|||
44293290|NCT02764541|79275539|FG006|Overall Study|Disease progression|0|||
44293291|NCT02764541|79275540|FG007|Overall Study|Disease progression|1|||
44293292|NCT02764541|79275533|FG000|Overall Study|Protocol Violation|0|||
44293293|NCT02764541|79275534|FG001|Overall Study|Protocol Violation|0|||
44293294|NCT02764541|79275535|FG002|Overall Study|Protocol Violation|0|||
44293295|NCT02764541|79275536|FG003|Overall Study|Protocol Violation|1|||
44293296|NCT02764541|79275537|FG004|Overall Study|Protocol Violation|0|||
44293297|NCT02764541|79275538|FG005|Overall Study|Protocol Violation|1|||
44293298|NCT02764541|79275539|FG006|Overall Study|Protocol Violation|0|||
44293299|NCT02764541|79275540|FG007|Overall Study|Protocol Violation|0|||
44293300|NCT02764541|79275533|FG000|Overall Study|Physician Decision|0|||
44293301|NCT02764541|79275534|FG001|Overall Study|Physician Decision|0|||
44293302|NCT02764541|79275535|FG002|Overall Study|Physician Decision|0|||
44293303|NCT02764541|79275536|FG003|Overall Study|Physician Decision|1|||
44293304|NCT02764541|79275537|FG004|Overall Study|Physician Decision|0|||
44293305|NCT02764541|79275538|FG005|Overall Study|Physician Decision|0|||
44293306|NCT02764541|79275539|FG006|Overall Study|Physician Decision|0|||
44154593|NCT02690701|78945896|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44293307|NCT02764541|79275540|FG007|Overall Study|Physician Decision|1|||
44293308|NCT02764541|79275533|FG000|Overall Study|Three Cycles completed before surgery|0|||
44293309|NCT02764541|79275534|FG001|Overall Study|Three Cycles completed before surgery|0|||
44293310|NCT02764541|79275535|FG002|Overall Study|Three Cycles completed before surgery|0|||
44293311|NCT02764541|79275536|FG003|Overall Study|Three Cycles completed before surgery|1|||
44293312|NCT02764541|79275537|FG004|Overall Study|Three Cycles completed before surgery|0|||
44293313|NCT02764541|79275538|FG005|Overall Study|Three Cycles completed before surgery|0|||
44154594|NCT02690701|78945897|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44154595|NCT02690701|78945896|FG000|Treatment Period 2|Adverse Event|2|||
44293314|NCT02764541|79275539|FG006|Overall Study|Three Cycles completed before surgery|0|||
44293315|NCT02764541|79275540|FG007|Overall Study|Three Cycles completed before surgery|0|||
44293316|NCT02764541|79275533|FG000|Overall Study|Patient Compliance|0|||
44293317|NCT02764541|79275534|FG001|Overall Study|Patient Compliance|0|||
44293318|NCT02764541|79275535|FG002|Overall Study|Patient Compliance|1|||
44293319|NCT02764541|79275536|FG003|Overall Study|Patient Compliance|0|||
44293320|NCT02764541|79275537|FG004|Overall Study|Patient Compliance|0|||
44293321|NCT02764541|79275538|FG005|Overall Study|Patient Compliance|0|||
44154596|NCT02690701|78945897|FG001|Treatment Period 2|Adverse Event|0|||
44293322|NCT02764541|79275539|FG006|Overall Study|Patient Compliance|0|||
44293323|NCT02764541|79275540|FG007|Overall Study|Patient Compliance|0|||
44293324|NCT02764541|79275533|FG000|Overall Study|Death|0|||
44293325|NCT02764541|79275534|FG001|Overall Study|Death|0|||
44293326|NCT02764541|79275535|FG002|Overall Study|Death|0|||
44293327|NCT02764541|79275536|FG003|Overall Study|Death|0|||
44293328|NCT02764541|79275537|FG004|Overall Study|Death|0|||
44293329|NCT02764541|79275538|FG005|Overall Study|Death|0|||
44293330|NCT02764541|79275539|FG006|Overall Study|Death|1|||
44293331|NCT02764541|79275540|FG007|Overall Study|Death|0|||
44293332|NCT02764541|79275533|FG000|Overall Study|Insurance reasons|0|||
44293333|NCT02764541|79275534|FG001|Overall Study|Insurance reasons|0|||
44293334|NCT02764541|79275535|FG002|Overall Study|Insurance reasons|0|||
44293335|NCT02764541|79275536|FG003|Overall Study|Insurance reasons|0|||
44293336|NCT02764541|79275537|FG004|Overall Study|Insurance reasons|0|||
44293337|NCT02764541|79275538|FG005|Overall Study|Insurance reasons|0|||
44293338|NCT02764541|79275539|FG006|Overall Study|Insurance reasons|1|||
44293339|NCT02764541|79275540|FG007|Overall Study|Insurance reasons|0|||
44293340|NCT02587065|79275560|FG000|Overall Study|Adverse Event|14|||
44293341|NCT02587065|79275560|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
44293342|NCT02587065|79275560|FG000|Overall Study|Non-adherence to the Protocol|3|||
44293343|NCT02587065|79275560|FG000|Overall Study|Discontinuation of Study Medication|2|||
44293344|NCT02587065|79275560|FG000|Overall Study|Reason not Specified|3|||
44293345|NCT02544503|79275570|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
44293346|NCT02544503|79275571|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
44293347|NCT02544503|79275570|FG000|Overall Study|Lost to Follow-up|9|||
44293348|NCT02544503|79275571|FG001|Overall Study|Lost to Follow-up|0|||
44293349|NCT02544503|79275570|FG000|Overall Study|Withdrawal by Subject|1|||
44293350|NCT02544503|79275571|FG001|Overall Study|Withdrawal by Subject|0|||
44293351|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
44293352|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
44293353|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Adverse Event|57|||
44293354|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Adverse Event|49|||
44293355|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
44293356|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
44293357|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Site closure|3|||
44293358|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Site closure|2|||
44293359|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
44293360|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
44293361|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Physician Decision|48|||
44293362|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Physician Decision|38|||
44293363|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
44293364|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
44293365|NCT01705977|79275579|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
44293366|NCT01705977|79275580|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
44293367|NCT01705977|79275579|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
44293368|NCT01705977|79275580|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
44293369|NCT01705977|79275579|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
44293370|NCT01705977|79275580|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
44293371|NCT01705977|79275579|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
44293372|NCT01705977|79275580|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
44293373|NCT01705977|79275579|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
44293374|NCT01705977|79275580|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
44293375|NCT01474889|79275589|FG000|Overall Study|Physician Decision|1|||
44293376|NCT01474889|79275590|FG001|Overall Study|Physician Decision|0|||
44293377|NCT01474889|79275591|FG002|Overall Study|Physician Decision|0|||
44293378|NCT01474889|79275589|FG000|Overall Study|Did not meet inclusion|1|||
44293379|NCT01474889|79275590|FG001|Overall Study|Did not meet inclusion|0|||
44293380|NCT01474889|79275591|FG002|Overall Study|Did not meet inclusion|0|||
44293381|NCT01474889|79275589|FG000|Overall Study|Withdrawal by Subject|0|||
44293382|NCT01474889|79275590|FG001|Overall Study|Withdrawal by Subject|1|||
44293383|NCT01474889|79275591|FG002|Overall Study|Withdrawal by Subject|0|||
44293384|NCT01231906|79275599|FG000|Overall Study|Lack of Efficacy|75|||
44293385|NCT01231906|79275600|FG001|Overall Study|Lack of Efficacy|68|||
44293386|NCT01231906|79275599|FG000|Overall Study|Lost to Follow-up|1|||
44293387|NCT01231906|79275600|FG001|Overall Study|Lost to Follow-up|0|||
44293388|NCT01231906|79275599|FG000|Overall Study|Physician Decision|34|||
44293389|NCT01231906|79275600|FG001|Overall Study|Physician Decision|24|||
44293390|NCT01231906|79275599|FG000|Overall Study|Withdrawal by Subject|0|||
44293391|NCT01231906|79275600|FG001|Overall Study|Withdrawal by Subject|4|||
44293392|NCT01231906|79275599|FG000|Overall Study|Ineligible|10|||
44293393|NCT01231906|79275600|FG001|Overall Study|Ineligible|3|||
44293394|NCT01231906|79275599|FG000|Overall Study|No treatment|1|||
44293395|NCT01231906|79275600|FG001|Overall Study|No treatment|2|||
44293396|NCT00724048|79275610|FG000|Overall Study|Adverse Event|1|||
44293397|NCT00724048|79275611|FG001|Overall Study|Adverse Event|1|||
44416699|NCT00838097|79424466|FG000|Overall Study|Adverse Event|2|||
44293398|NCT00724048|79275612|FG002|Overall Study|Adverse Event|1|||
44533903|NCT04482647|79544524|FG000|Overall Study|Time constraints|2|||
44293399|NCT00724048|79275613|FG003|Overall Study|Adverse Event|0|||
44293400|NCT00724048|79275610|FG000|Overall Study|Lost to Follow-up|0|||
44293401|NCT00724048|79275611|FG001|Overall Study|Lost to Follow-up|1|||
44293402|NCT00724048|79275612|FG002|Overall Study|Lost to Follow-up|0|||
44293403|NCT00724048|79275613|FG003|Overall Study|Lost to Follow-up|0|||
44293404|NCT00724048|79275610|FG000|Overall Study|Withdrawal by Subject|1|||
44293405|NCT00724048|79275611|FG001|Overall Study|Withdrawal by Subject|2|||
44293406|NCT00724048|79275612|FG002|Overall Study|Withdrawal by Subject|1|||
44293407|NCT00724048|79275613|FG003|Overall Study|Withdrawal by Subject|2|||
44293408|NCT00724048|79275610|FG000|Overall Study|Investigator decision|0|||
44293409|NCT00724048|79275611|FG001|Overall Study|Investigator decision|0|||
44293410|NCT00724048|79275612|FG002|Overall Study|Investigator decision|1|||
44293411|NCT00724048|79275613|FG003|Overall Study|Investigator decision|0|||
44293412|NCT00724048|79275610|FG000|Overall Study|Did not tolerate study drug|0|||
44293413|NCT00724048|79275611|FG001|Overall Study|Did not tolerate study drug|0|||
44293414|NCT00724048|79275612|FG002|Overall Study|Did not tolerate study drug|0|||
44293415|NCT00724048|79275613|FG003|Overall Study|Did not tolerate study drug|1|||
44293416|NCT00724048|79275610|FG000|Overall Study|Other than specified|1|||
44293417|NCT00724048|79275611|FG001|Overall Study|Other than specified|1|||
44293418|NCT00724048|79275612|FG002|Overall Study|Other than specified|0|||
44293419|NCT00724048|79275613|FG003|Overall Study|Other than specified|0|||
44293435|NCT00160680|79275642|FG000|Overall Study|Adverse Event|0|||
44293436|NCT00160680|79275643|FG001|Overall Study|Adverse Event|1|||
44293437|NCT00160680|79275642|FG000|Overall Study|Lack of Efficacy|2|||
44293438|NCT00160680|79275643|FG001|Overall Study|Lack of Efficacy|1|||
44293439|NCT00160680|79275642|FG000|Overall Study|Lost to Follow-up|3|||
44293440|NCT00160680|79275643|FG001|Overall Study|Lost to Follow-up|2|||
44293441|NCT00160680|79275642|FG000|Overall Study|Withdrawal by Subject|4|||
44293442|NCT00160680|79275643|FG001|Overall Study|Withdrawal by Subject|9|||
44293443|NCT03671148|79276498|FG000|Overall Study|Adverse Event|3|||
44293444|NCT03671148|79276499|FG001|Overall Study|Adverse Event|2|||
44293445|NCT03671148|79276498|FG000|Overall Study|Withdrawal by Subject|8|||
44293446|NCT03671148|79276499|FG001|Overall Study|Withdrawal by Subject|2|||
44293447|NCT03671148|79276498|FG000|Overall Study|Lost to Follow-up|1|||
44293448|NCT03671148|79276499|FG001|Overall Study|Lost to Follow-up|2|||
44293449|NCT03671148|79276498|FG000|Overall Study|Lack of Efficacy|7|||
44293450|NCT03671148|79276499|FG001|Overall Study|Lack of Efficacy|2|||
44293451|NCT03671148|79276498|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
44293452|NCT03671148|79276499|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
44293453|NCT03671148|79276498|FG000|Overall Study|Other|1|||
44293454|NCT03671148|79276499|FG001|Overall Study|Other|0|||
44293455|NCT03671148|79276498|FG000|Overall Study|Incomplete Randomization Visit|1|||
44293456|NCT03671148|79276499|FG001|Overall Study|Incomplete Randomization Visit|0|||
44293457|NCT01430442|79276513|FG000|Overall Study|Subject Withdrew Consent|3|||
44293458|NCT01430442|79276514|FG001|Overall Study|Subject Withdrew Consent|0|||
44293459|NCT01430442|79276515|FG002|Overall Study|Subject Withdrew Consent|1|||
44293460|NCT01430442|79276516|FG003|Overall Study|Subject Withdrew Consent|0|||
44293461|NCT01430442|79276517|FG004|Overall Study|Subject Withdrew Consent|2|||
44293462|NCT01430442|79276518|FG005|Overall Study|Subject Withdrew Consent|1|||
44293463|NCT01430442|79276519|FG006|Overall Study|Subject Withdrew Consent|5|||
44293464|NCT01430442|79276520|FG007|Overall Study|Subject Withdrew Consent|2|||
44293465|NCT01430442|79276513|FG000|Overall Study|Lost to Follow-up|2|||
44293466|NCT01430442|79276514|FG001|Overall Study|Lost to Follow-up|0|||
44293467|NCT01430442|79276515|FG002|Overall Study|Lost to Follow-up|1|||
44293468|NCT01430442|79276516|FG003|Overall Study|Lost to Follow-up|2|||
44293469|NCT01430442|79276517|FG004|Overall Study|Lost to Follow-up|2|||
44293470|NCT01430442|79276518|FG005|Overall Study|Lost to Follow-up|1|||
44293471|NCT01430442|79276519|FG006|Overall Study|Lost to Follow-up|5|||
44293472|NCT01430442|79276520|FG007|Overall Study|Lost to Follow-up|1|||
44293473|NCT01430442|79276513|FG000|Overall Study|Pregnancy|1|||
44293474|NCT01430442|79276514|FG001|Overall Study|Pregnancy|0|||
44293475|NCT01430442|79276515|FG002|Overall Study|Pregnancy|0|||
44293476|NCT01430442|79276516|FG003|Overall Study|Pregnancy|0|||
44293477|NCT01430442|79276517|FG004|Overall Study|Pregnancy|0|||
44293478|NCT01430442|79276518|FG005|Overall Study|Pregnancy|1|||
44293479|NCT01430442|79276519|FG006|Overall Study|Pregnancy|0|||
44293480|NCT01430442|79276520|FG007|Overall Study|Pregnancy|0|||
44293481|NCT01430442|79276513|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
44293482|NCT01430442|79276514|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
44293483|NCT01430442|79276515|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
44293484|NCT01430442|79276516|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
44293485|NCT01430442|79276517|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
44293486|NCT01430442|79276518|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
44293487|NCT01430442|79276519|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
44293488|NCT01430442|79276520|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
44293489|NCT01420926|79276540|FG000|Overall Study|Adverse Event|6|||
44293490|NCT01420926|79276541|FG001|Overall Study|Adverse Event|4|||
44293491|NCT01420926|79276540|FG000|Overall Study|Death|18|||
44293492|NCT01420926|79276541|FG001|Overall Study|Death|17|||
44293493|NCT01420926|79276540|FG000|Overall Study|Withdrawal by Subject|11|||
44293494|NCT01420926|79276541|FG001|Overall Study|Withdrawal by Subject|17|||
44293495|NCT01420926|79276540|FG000|Overall Study|Non-protocol treatment|17|||
44293496|NCT01420926|79276541|FG001|Overall Study|Non-protocol treatment|20|||
44293497|NCT01420926|79276540|FG000|Overall Study|Physician Decision|8|||
44293498|NCT01420926|79276541|FG001|Overall Study|Physician Decision|5|||
44293499|NCT04303572|79277097|FG000|Overall Study|Study closed due to poor enrollment|1|||
44293500|NCT03551730|79277120|FG000|Overall Study|Adverse Event|1|||
44293501|NCT03551730|79277121|FG001|Overall Study|Adverse Event|0|||
44293502|NCT03551730|79277122|FG002|Overall Study|Adverse Event|0|||
44293503|NCT03551730|79277123|FG003|Overall Study|Adverse Event|0|||
44293504|NCT02534844|79277135|FG000|Part B|Withdrawal by Subject|0|||
44293505|NCT02534844|79277136|FG001|Part B|Withdrawal by Subject|0|||
44293506|NCT02534844|79277137|FG002|Part B|Withdrawal by Subject|0|||
44293507|NCT02534844|79277138|FG003|Part B|Withdrawal by Subject|0|||
44293508|NCT02534844|79277139|FG004|Part B|Withdrawal by Subject|2|||
44293509|NCT02534844|79277140|FG005|Part B|Withdrawal by Subject|1|||
44293510|NCT01818492|79277157|FG000|Overall Study|Adverse Event|2|||
44293511|NCT01818492|79277157|FG000|Overall Study|Death|3|||
44293512|NCT01818492|79277157|FG000|Overall Study|Withdrawal by Subject|1|||
44293513|NCT01818492|79277157|FG000|Overall Study|Additional therapy when not allowed PP|4|||
44293514|NCT01239030|79277167|FG000|Double Blind|Adverse Event|0|||
44293515|NCT01239030|79277168|FG001|Double Blind|Adverse Event|1|||
44293516|NCT01239030|79277169|FG002|Double Blind|Adverse Event|0|||
44293517|NCT01239030|79277170|FG003|Double Blind|Adverse Event|2|||
44293518|NCT01239030|79277171|FG004|Double Blind|Adverse Event|0|||
44293519|NCT01239030|79277167|FG000|Double Blind|Withdrawal by Subject|0|||
44293520|NCT01239030|79277168|FG001|Double Blind|Withdrawal by Subject|1|||
44293521|NCT01239030|79277169|FG002|Double Blind|Withdrawal by Subject|1|||
44293522|NCT01239030|79277170|FG003|Double Blind|Withdrawal by Subject|0|||
44293523|NCT01239030|79277171|FG004|Double Blind|Withdrawal by Subject|1|||
44293524|NCT01239030|79277167|FG000|Double Blind|Lost to Follow-up|1|||
44293525|NCT01239030|79277168|FG001|Double Blind|Lost to Follow-up|1|||
44293526|NCT01239030|79277169|FG002|Double Blind|Lost to Follow-up|0|||
44293527|NCT01239030|79277170|FG003|Double Blind|Lost to Follow-up|0|||
44293528|NCT01239030|79277171|FG004|Double Blind|Lost to Follow-up|0|||
44293529|NCT01239030|79277167|FG000|Double Blind|Physician Decision|0|||
44293530|NCT01239030|79277168|FG001|Double Blind|Physician Decision|1|||
44293531|NCT01239030|79277169|FG002|Double Blind|Physician Decision|0|||
44293532|NCT01239030|79277170|FG003|Double Blind|Physician Decision|0|||
44293533|NCT01239030|79277171|FG004|Double Blind|Physician Decision|0|||
44533904|NCT04482647|79544524|FG000|Overall Study|Health issues|1|||
44293534|NCT01239030|79277167|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
44293535|NCT01239030|79277168|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
44293536|NCT01239030|79277169|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
44293537|NCT01239030|79277170|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
44533905|NCT04482647|79544524|FG000|Overall Study|Death in the family|1|||
44533906|NCT04482647|79544524|FG000|Overall Study|Disliked the intervention|1|||
44293538|NCT01239030|79277171|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
44293539|NCT01239030|79277167|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
44293540|NCT01239030|79277168|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
44293541|NCT01239030|79277169|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
44293542|NCT01239030|79277170|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
44293543|NCT01239030|79277171|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
44293544|NCT01239030|79277167|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
44293545|NCT01239030|79277168|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
44533907|NCT04482647|79544524|FG000|Overall Study|No reasons specified|7|||
44293546|NCT01239030|79277169|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
44293547|NCT01239030|79277170|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
44533908|NCT04429503|79544531|FG000|Overall Study|Non-compliance with protocol by the subject|1|||
44293548|NCT01239030|79277171|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
44293549|NCT01239030|79277167|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
44293550|NCT01239030|79277168|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
44293551|NCT01239030|79277169|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
44293552|NCT01239030|79277170|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
44293553|NCT01239030|79277171|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
44293554|NCT01086540|79277186|FG000|Overall Study|Death|3|||
44293555|NCT01086540|79277187|FG001|Overall Study|Death|1|||
44293556|NCT01086540|79277186|FG000|Overall Study|Physician Decision|2|||
44293557|NCT01086540|79277187|FG001|Overall Study|Physician Decision|1|||
44293558|NCT01086540|79277186|FG000|Overall Study|Addition of new therapy for PAH|1|||
44293559|NCT01086540|79277187|FG001|Overall Study|Addition of new therapy for PAH|0|||
44293560|NCT04567524|79280458|FG000|Overall Study|Adverse Event|1|||
44293561|NCT04567524|79280459|FG001|Overall Study|Adverse Event|1|||
44293562|NCT04567524|79280460|FG002|Overall Study|Adverse Event|0|||
44293563|NCT04567524|79280461|FG003|Overall Study|Adverse Event|0|||
44293564|NCT04567524|79280458|FG000|Overall Study|Withdrawal by Subject|2|||
44293565|NCT04567524|79280459|FG001|Overall Study|Withdrawal by Subject|0|||
44293566|NCT04567524|79280460|FG002|Overall Study|Withdrawal by Subject|0|||
44293567|NCT04567524|79280461|FG003|Overall Study|Withdrawal by Subject|1|||
44293568|NCT03370302|79280497|FG000|Dose Escalation Phase|Other|0|||
44293569|NCT03370302|79280498|FG001|Dose Escalation Phase|Other|1|||
44293570|NCT03370302|79280499|FG002|Dose Escalation Phase|Other|1|||
44293571|NCT03370302|79280500|FG003|Dose Escalation Phase|Other|0|||
44293572|NCT03370302|79280501|FG004|Dose Escalation Phase|Other|0|||
44293573|NCT03370302|79280502|FG005|Dose Escalation Phase|Other|0|||
44293574|NCT03370302|79280497|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
44293575|NCT03370302|79280498|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
44293576|NCT03370302|79280499|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
44293577|NCT03370302|79280500|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44293578|NCT03370302|79280501|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
44293579|NCT03370302|79280502|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
44293580|NCT03370302|79280497|FG000|Dose Escalation Phase|Adverse Event|1|||
44293581|NCT03370302|79280498|FG001|Dose Escalation Phase|Adverse Event|0|||
44293582|NCT03370302|79280499|FG002|Dose Escalation Phase|Adverse Event|2|||
44293583|NCT03370302|79280500|FG003|Dose Escalation Phase|Adverse Event|0|||
44293584|NCT03370302|79280501|FG004|Dose Escalation Phase|Adverse Event|0|||
44293585|NCT03370302|79280502|FG005|Dose Escalation Phase|Adverse Event|0|||
44293586|NCT03370302|79280497|FG000|Dose Escalation Phase|Progressive Disease|2|||
44293587|NCT03370302|79280498|FG001|Dose Escalation Phase|Progressive Disease|4|||
44293588|NCT03370302|79280499|FG002|Dose Escalation Phase|Progressive Disease|2|||
44293589|NCT03370302|79280500|FG003|Dose Escalation Phase|Progressive Disease|0|||
44293590|NCT03370302|79280501|FG004|Dose Escalation Phase|Progressive Disease|3|||
44293591|NCT03370302|79280502|FG005|Dose Escalation Phase|Progressive Disease|1|||
44293592|NCT03370302|79280497|FG000|Dose Expansion Phase|Progressive Disease|0|||
44293593|NCT03370302|79280498|FG001|Dose Expansion Phase|Progressive Disease|0|||
44293594|NCT03370302|79280499|FG002|Dose Expansion Phase|Progressive Disease|0|||
44293595|NCT03370302|79280500|FG003|Dose Expansion Phase|Progressive Disease|6|||
44293596|NCT03370302|79280501|FG004|Dose Expansion Phase|Progressive Disease|0|||
44293597|NCT03370302|79280502|FG005|Dose Expansion Phase|Progressive Disease|0|||
44293598|NCT03327324|79280526|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44256201|NCT01439360|79103600|FG000|Overall Study|Withdrawal by Subject|140|||
44256202|NCT01439360|79103601|FG001|Overall Study|Withdrawal by Subject|129|||
44256203|NCT01439204|79103778|FG000|Overall Study|Withdrawal by Subject|0|||
44256204|NCT01439204|79103779|FG001|Overall Study|Withdrawal by Subject|1|||
44256205|NCT01439204|79103778|FG000|Overall Study|Lost to Follow-up|0|||
44256206|NCT01439204|79103779|FG001|Overall Study|Lost to Follow-up|2|||
44256207|NCT01439204|79103778|FG000|Overall Study|No longer meets study criteria|1|||
44256208|NCT01439204|79103779|FG001|Overall Study|No longer meets study criteria|0|||
44256209|NCT01439204|79103778|FG000|Overall Study|poor/non-compliance|3|||
44256210|NCT01439204|79103779|FG001|Overall Study|poor/non-compliance|0|||
44256211|NCT01439126|79103825|FG000|Overall Study|Adverse Event|2|||
44256212|NCT01439126|79103826|FG001|Overall Study|Adverse Event|0|||
44256213|NCT01439126|79103825|FG000|Overall Study|Withdrawal by Subject|5|||
44256214|NCT01439126|79103826|FG001|Overall Study|Withdrawal by Subject|21|||
44256215|NCT01439126|79103825|FG000|Overall Study|Protocol Violation|6|||
44256216|NCT01439126|79103826|FG001|Overall Study|Protocol Violation|4|||
44256217|NCT01439126|79103825|FG000|Overall Study|Lost to Follow-up|6|||
44256218|NCT01439126|79103826|FG001|Overall Study|Lost to Follow-up|3|||
44256219|NCT01439126|79103825|FG000|Overall Study|Other-Use of prohibited treatment|0|||
44256220|NCT01439126|79103826|FG001|Overall Study|Other-Use of prohibited treatment|2|||
44256221|NCT01439126|79103825|FG000|Overall Study|Other-Miscellaneous|12|||
44256222|NCT01439126|79103826|FG001|Overall Study|Other-Miscellaneous|12|||
44256223|NCT01449812|79103852|FG000|Overall Study|Migrated/moved from study area|1|||
44293599|NCT03327324|79280527|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
44293600|NCT03327324|79280528|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293601|NCT03327324|79280529|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
44293602|NCT03327324|79280530|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293603|NCT03327324|79280531|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
44293604|NCT03327324|79280526|FG000|Baseline (Month 0-Month 3)|Refused|0|||
44293605|NCT03327324|79280527|FG001|Baseline (Month 0-Month 3)|Refused|0|||
44293606|NCT03327324|79280528|FG002|Baseline (Month 0-Month 3)|Refused|0|||
44293607|NCT03327324|79280529|FG003|Baseline (Month 0-Month 3)|Refused|0|||
44293608|NCT03327324|79280530|FG004|Baseline (Month 0-Month 3)|Refused|1|||
44293609|NCT03327324|79280531|FG005|Baseline (Month 0-Month 3)|Refused|0|||
44293610|NCT03327324|79280526|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
44293611|NCT03327324|79280527|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
44293612|NCT03327324|79280528|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
44293613|NCT03327324|79280529|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
44293614|NCT03327324|79280530|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
44293615|NCT03327324|79280531|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
44293616|NCT03327324|79280526|FG000|Baseline (Month 0-Month 3)|Death|0|||
44293617|NCT03327324|79280527|FG001|Baseline (Month 0-Month 3)|Death|0|||
44293618|NCT03327324|79280528|FG002|Baseline (Month 0-Month 3)|Death|0|||
44293619|NCT03327324|79280529|FG003|Baseline (Month 0-Month 3)|Death|0|||
44293620|NCT03327324|79280530|FG004|Baseline (Month 0-Month 3)|Death|1|||
44293621|NCT03327324|79280531|FG005|Baseline (Month 0-Month 3)|Death|0|||
44293622|NCT03327324|79280526|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293623|NCT03327324|79280527|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293624|NCT03327324|79280528|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44154597|NCT02690701|78945896|FG000|Treatment Period 2|Lack of Efficacy|1|||
44293625|NCT03327324|79280529|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293626|NCT03327324|79280530|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293627|NCT03327324|79280531|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
44293628|NCT03327324|79280526|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293629|NCT03327324|79280527|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44533909|NCT04429503|79544532|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
44533910|NCT04429503|79544533|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
44154598|NCT02690701|78945897|FG001|Treatment Period 2|Lack of Efficacy|0|||
44293630|NCT03327324|79280528|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
44293631|NCT03327324|79280529|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293632|NCT03327324|79280530|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293633|NCT03327324|79280531|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293634|NCT03327324|79280526|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
44416700|NCT00838097|79424466|FG000|Overall Study|Withdrawal by Subject|3|||
44416701|NCT00838097|79424466|FG000|Overall Study|Requirement for alternative therapy|2|||
44416702|NCT00838097|79424466|FG000|Overall Study|Physician Decision|4|||
44416703|NCT00838097|79424466|FG000|Overall Study|Lost to Follow-up|11|||
44416704|NCT00838097|79424466|FG000|Overall Study|Death|6|||
44416705|NCT00838097|79424466|FG000|Overall Study|Protocol-specified criteria|142|||
44416706|NCT00840827|79424470|FG000|Overall Study|Adverse Event|1|||
44416707|NCT00840827|79424470|FG000|Overall Study|Lack of Efficacy|4|||
44416708|NCT00840827|79424470|FG000|Overall Study|Physician Decision|1|||
44416709|NCT00860249|79424477|FG000|Overall Study|trial was terminated prior to completion|21|||
44416710|NCT00860249|79424478|FG001|Overall Study|trial was terminated prior to completion|18|||
44416711|NCT00860249|79424479|FG002|Overall Study|trial was terminated prior to completion|21|||
44416712|NCT00840749|79424489|FG000|Overall Study|Death|1|||
44416713|NCT00840749|79424490|FG001|Overall Study|Death|2|||
44416714|NCT00840749|79424489|FG000|Overall Study|not treated on study arm|11|||
44416715|NCT00840749|79424490|FG001|Overall Study|not treated on study arm|11|||
44416716|NCT00840749|79424489|FG000|Overall Study|study closed|19|||
44416717|NCT00840749|79424490|FG001|Overall Study|study closed|14|||
44416718|NCT00859937|79424498|FG000|Overall Study|Protocol Violation|1|||
44416719|NCT00859937|79424499|FG001|Overall Study|Protocol Violation|0|||
44416720|NCT00592007|79424505|FG000|Overall Study|Withdrawal by Subject|1|||
44416721|NCT00592007|79424505|FG000|Overall Study|patient ineligible (out of lab range)|1|||
44416722|NCT00837473|79424509|FG000|Overall Study|Lost to Follow-up|1|||
44293635|NCT03327324|79280527|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
44293636|NCT03327324|79280528|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
44293637|NCT03327324|79280529|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
44293638|NCT03327324|79280530|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
44293639|NCT03327324|79280531|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
44293640|NCT03327324|79280526|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
44293641|NCT03327324|79280527|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
44293642|NCT03327324|79280528|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
44293643|NCT03327324|79280529|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
44293644|NCT03327324|79280530|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
44293645|NCT03327324|79280531|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
44293646|NCT03327324|79280526|FG000|Intervention (Month 3-Month 6)|Death|1|||
44293647|NCT03327324|79280527|FG001|Intervention (Month 3-Month 6)|Death|0|||
44293648|NCT03327324|79280528|FG002|Intervention (Month 3-Month 6)|Death|1|||
44293649|NCT03327324|79280529|FG003|Intervention (Month 3-Month 6)|Death|1|||
44293650|NCT03327324|79280530|FG004|Intervention (Month 3-Month 6)|Death|1|||
44293651|NCT03327324|79280531|FG005|Intervention (Month 3-Month 6)|Death|0|||
44293652|NCT03327324|79280526|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293653|NCT03327324|79280527|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293654|NCT03327324|79280528|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293655|NCT03327324|79280529|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293656|NCT03327324|79280530|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293657|NCT03327324|79280531|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
44293658|NCT03327324|79280526|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
44293659|NCT03327324|79280527|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44533911|NCT04429503|79544531|FG000|Overall Study|Adverse Event|0|||
44533912|NCT04429503|79544532|FG001|Overall Study|Adverse Event|4|||
44533913|NCT04429503|79544533|FG002|Overall Study|Adverse Event|2|||
44533914|NCT04429503|79544531|FG000|Overall Study|Decision by the investigator/sponsor|0|||
44533915|NCT04429503|79544532|FG001|Overall Study|Decision by the investigator/sponsor|6|||
44533916|NCT04429503|79544533|FG002|Overall Study|Decision by the investigator/sponsor|2|||
44533917|NCT04429503|79544531|FG000|Overall Study|Withdrawal by Subject|4|||
44533918|NCT04429503|79544532|FG001|Overall Study|Withdrawal by Subject|12|||
44533919|NCT04429503|79544533|FG002|Overall Study|Withdrawal by Subject|2|||
44533920|NCT04429503|79544531|FG000|Overall Study|Lost to Follow-up|2|||
44533921|NCT04429503|79544532|FG001|Overall Study|Lost to Follow-up|8|||
44533922|NCT04429503|79544533|FG002|Overall Study|Lost to Follow-up|2|||
44533923|NCT04429503|79544531|FG000|Overall Study|Death|5|||
44533924|NCT04429503|79544532|FG001|Overall Study|Death|9|||
44293660|NCT03327324|79280528|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293661|NCT03327324|79280529|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293662|NCT03327324|79280530|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293663|NCT03327324|79280531|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
44293664|NCT03327324|79280526|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
44293665|NCT03327324|79280527|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
44293666|NCT03327324|79280528|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
44293667|NCT03327324|79280529|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
44293668|NCT03327324|79280530|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
44293669|NCT03327324|79280531|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
44293670|NCT03327324|79280526|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
44293671|NCT03327324|79280527|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
44293672|NCT03327324|79280528|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
44293673|NCT03327324|79280529|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
44293674|NCT03327324|79280530|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
44293675|NCT03327324|79280531|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
44293676|NCT03327324|79280526|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44533925|NCT04429503|79544533|FG002|Overall Study|Death|4|||
44533926|NCT04408924|79544541|FG000|Overall Study|On Study Treatment|3|||
44533927|NCT04408924|79544541|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
44293677|NCT03327324|79280527|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293678|NCT03327324|79280528|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293679|NCT03327324|79280529|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
44293680|NCT03327324|79280530|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
44293681|NCT03327324|79280531|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
44293682|NCT03327324|79280526|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
44293683|NCT03327324|79280527|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
44293684|NCT03327324|79280528|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
44293685|NCT03327324|79280529|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
44293686|NCT03327324|79280530|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
44293687|NCT03327324|79280531|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
44293688|NCT03327324|79280526|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
44293689|NCT03327324|79280527|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
44293690|NCT03327324|79280528|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
44293691|NCT03327324|79280529|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
44293692|NCT03327324|79280530|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
44293693|NCT03327324|79280531|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
44293694|NCT03252522|79280537|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
44293695|NCT03252522|79280538|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
44293696|NCT03252522|79280539|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
44293697|NCT03252522|79280537|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
44293698|NCT03252522|79280538|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
44293699|NCT03252522|79280539|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
44293700|NCT03252522|79280537|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
44293701|NCT03252522|79280538|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
44293702|NCT03252522|79280539|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
44293703|NCT03252522|79280537|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
44293704|NCT03252522|79280538|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
44293705|NCT03252522|79280539|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
44293706|NCT03252522|79280537|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
44293707|NCT03252522|79280538|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
44293708|NCT03252522|79280539|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
44293709|NCT03252522|79280537|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
44293710|NCT03252522|79280538|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
44293711|NCT03252522|79280539|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
44293712|NCT03252522|79280537|FG000|Phase 2: Open Label|Adverse Event|0|||
44293713|NCT03252522|79280538|FG001|Phase 2: Open Label|Adverse Event|0|||
44293714|NCT03252522|79280539|FG002|Phase 2: Open Label|Adverse Event|2|||
44293715|NCT03252522|79280537|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
44293716|NCT03252522|79280538|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
44293717|NCT03252522|79280539|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
44293718|NCT02756364|79280554|FG000|Overall Study|Site Terminated by Sponsor|24|||
44293719|NCT02756364|79280555|FG001|Overall Study|Site Terminated by Sponsor|30|||
44293720|NCT02756364|79280556|FG002|Overall Study|Site Terminated by Sponsor|21|||
44293721|NCT02756364|79280554|FG000|Overall Study|Death|20|||
44293722|NCT02756364|79280555|FG001|Overall Study|Death|15|||
44293723|NCT02756364|79280556|FG002|Overall Study|Death|18|||
44416723|NCT00837473|79424509|FG000|Overall Study|Withdrawal by Subject|2|||
44416724|NCT00839423|79424517|FG000|Overall Study|Adverse Event|4|||
44416725|NCT00839423|79424518|FG001|Overall Study|Adverse Event|3|||
44416726|NCT00839423|79424519|FG002|Overall Study|Adverse Event|7|||
44416727|NCT00839423|79424520|FG003|Overall Study|Adverse Event|16|||
44416728|NCT00839423|79424517|FG000|Overall Study|Lack of Efficacy|6|||
44533928|NCT04408924|79544541|FG000|Overall Study|Lost to Follow-up|1|||
44533929|NCT04408924|79544541|FG000|Overall Study|Withdrawal by Subject|7|||
44533930|NCT04400487|79544545|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
44533931|NCT04400487|79544545|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
44533932|NCT04400487|79544545|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
44533933|NCT04258254|79544553|FG000|Overall Study|Withdrawal by Subject|0|||
44533934|NCT04258254|79544554|FG001|Overall Study|Withdrawal by Subject|1|||
44533935|NCT04258254|79544555|FG002|Overall Study|Withdrawal by Subject|0|||
44533936|NCT04247594|79544563|FG000|Overall Study|Withdrawal by Subject|4|||
44416729|NCT00839423|79424518|FG001|Overall Study|Lack of Efficacy|6|||
44416730|NCT00839423|79424519|FG002|Overall Study|Lack of Efficacy|3|||
44416731|NCT00839423|79424520|FG003|Overall Study|Lack of Efficacy|2|||
44416732|NCT00839423|79424517|FG000|Overall Study|Non-compliance|0|||
44416733|NCT00839423|79424518|FG001|Overall Study|Non-compliance|0|||
44533937|NCT03954704|79544610|FG000|Overall Study|Death|1|||
44293724|NCT02756364|79280554|FG000|Overall Study|Withdrawal by Patient|2|||
44293725|NCT02756364|79280555|FG001|Overall Study|Withdrawal by Patient|1|||
44293726|NCT02756364|79280556|FG002|Overall Study|Withdrawal by Patient|8|||
44293727|NCT02756364|79280554|FG000|Overall Study|Lost to Follow-up|0|||
44293728|NCT02756364|79280555|FG001|Overall Study|Lost to Follow-up|1|||
44293729|NCT02756364|79280556|FG002|Overall Study|Lost to Follow-up|1|||
44293730|NCT01906476|79280566|FG000|Overall Study|Lost to Follow-up|17|||
44293731|NCT01906476|79280567|FG001|Overall Study|Lost to Follow-up|16|||
44293732|NCT05343624|79280573|FG000|Overall Study|Chart review not completed|1|||
44293733|NCT04208412|79280606|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
44293734|NCT04208412|79280607|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
44293735|NCT04208412|79280606|FG000|Overall Study|Withdrawal by Subject|1|||
44293736|NCT04208412|79280607|FG001|Overall Study|Withdrawal by Subject|0|||
44293737|NCT04208412|79280606|FG000|Overall Study|Lost to Follow-up|0|||
44293738|NCT04208412|79280607|FG001|Overall Study|Lost to Follow-up|1|||
44293739|NCT04095858|79280617|FG000|Overall Study|Death|1|||
44293740|NCT04095858|79280618|FG001|Overall Study|Death|0|||
44293741|NCT04095858|79280617|FG000|Overall Study|Study terminated by Sponsor|2|||
44293742|NCT04095858|79280618|FG001|Overall Study|Study terminated by Sponsor|4|||
44293743|NCT03937986|79280624|FG000|Overall Study|COVID-19 Pandemic|1|||
44293744|NCT03738150|79280639|FG000|Base Study|Withdrawal by Subject|1|||
44293745|NCT03738150|79280639|FG000|Extension Study|Withdrawal by Subject|1|||
44293746|NCT03567174|79280655|FG000|Overall Study|Death|24|||
44293747|NCT03567174|79280656|FG001|Overall Study|Death|31|||
44293748|NCT03567174|79280655|FG000|Overall Study|Lost to Follow-up|165|||
44293749|NCT03567174|79280656|FG001|Overall Study|Lost to Follow-up|174|||
44293750|NCT02545998|79280701|FG000|Overall Study|Lost to Follow-up|12|||
44293751|NCT02545998|79280702|FG001|Overall Study|Lost to Follow-up|3|||
44293752|NCT02545998|79280701|FG000|Overall Study|Withdrawal by Subject|3|||
44293753|NCT02545998|79280702|FG001|Overall Study|Withdrawal by Subject|2|||
44293754|NCT02257242|79280726|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
44293755|NCT02257242|79280727|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293756|NCT02257242|79280728|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293757|NCT02257242|79280729|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293758|NCT02257242|79280730|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293759|NCT02257242|79280731|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293760|NCT02257242|79280732|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293761|NCT02257242|79280733|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293762|NCT02257242|79280734|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
44293763|NCT01943916|79280764|FG000|Overall Study|Technically invalid images|10|||
44293764|NCT01943916|79280764|FG000|Overall Study|Enrollment Failure|23|||
44293765|NCT01943916|79280764|FG000|Overall Study|Pilot Phase exclusion|100|||
44293766|NCT01943916|79280764|FG000|Overall Study|Quality Assurance Reader Fail|130|||
44293767|NCT01943916|79280764|FG000|Overall Study|Technical Failure|39|||
44293768|NCT01943916|79280764|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
44293769|NCT01943916|79280764|FG000|Overall Study|No Truth Panel Review|38|||
44293770|NCT01943916|79280764|FG000|Overall Study|Protocol Deviation|1|||
44293771|NCT01564368|79280773|FG000|Overall Study|Ineligible|18|||
44293772|NCT01564368|79280773|FG000|Overall Study|Not Randomized in Parent study|116|||
44293773|NCT01564368|79280773|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
44293774|NCT01564368|79280773|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
44293775|NCT00281658|79280781|FG000|Randomized Phase|Adverse Event|0|||
44293776|NCT00281658|79280782|FG001|Randomized Phase|Adverse Event|2|||
44293777|NCT00281658|79280783|FG002|Randomized Phase|Adverse Event|0|||
44293778|NCT00281658|79280784|FG003|Randomized Phase|Adverse Event|0|||
44293779|NCT00281658|79280781|FG000|Randomized Phase|Lost to Follow-up|34|||
44293780|NCT00281658|79280782|FG001|Randomized Phase|Lost to Follow-up|27|||
44293781|NCT00281658|79280783|FG002|Randomized Phase|Lost to Follow-up|0|||
44293782|NCT00281658|79280784|FG003|Randomized Phase|Lost to Follow-up|0|||
44293783|NCT00281658|79280781|FG000|Randomized Phase|Withdrawal by Subject|8|||
44293784|NCT00281658|79280782|FG001|Randomized Phase|Withdrawal by Subject|7|||
44293785|NCT00281658|79280783|FG002|Randomized Phase|Withdrawal by Subject|0|||
44533938|NCT03954704|79544611|FG001|Overall Study|Death|1|||
44533939|NCT03954704|79544612|FG002|Overall Study|Death|1|||
44533940|NCT03954704|79544613|FG003|Overall Study|Death|3|||
44533941|NCT03954704|79544614|FG004|Overall Study|Death|2|||
44533942|NCT03954704|79544615|FG005|Overall Study|Death|2|||
44154599|NCT02690701|78945896|FG000|Treatment Period 2|Lost to Follow-up|0|||
44154600|NCT02690701|78945897|FG001|Treatment Period 2|Lost to Follow-up|2|||
44154601|NCT02690701|78945896|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44293786|NCT00281658|79280784|FG003|Randomized Phase|Withdrawal by Subject|0|||
44293787|NCT00281658|79280781|FG000|Randomized Phase|Study closed/terminated|1|||
44293788|NCT00281658|79280782|FG001|Randomized Phase|Study closed/terminated|1|||
44293789|NCT00281658|79280783|FG002|Randomized Phase|Study closed/terminated|0|||
44293790|NCT00281658|79280784|FG003|Randomized Phase|Study closed/terminated|0|||
44293791|NCT00281658|79280781|FG000|Randomized Phase|Disease progression|36|||
44293792|NCT00281658|79280782|FG001|Randomized Phase|Disease progression|27|||
44293793|NCT00281658|79280783|FG002|Randomized Phase|Disease progression|0|||
44293794|NCT00281658|79280784|FG003|Randomized Phase|Disease progression|0|||
44293795|NCT00281658|79280781|FG000|Randomized Phase|Physician Decision|1|||
44293796|NCT00281658|79280782|FG001|Randomized Phase|Physician Decision|1|||
44293797|NCT00281658|79280783|FG002|Randomized Phase|Physician Decision|0|||
44293798|NCT00281658|79280784|FG003|Randomized Phase|Physician Decision|0|||
44293799|NCT00281658|79280781|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
44293800|NCT00281658|79280782|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
44293801|NCT00281658|79280783|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
44293802|NCT00281658|79280784|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
44293803|NCT00281658|79280781|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
44293804|NCT00281658|79280782|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
44293805|NCT00281658|79280783|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
44293806|NCT00281658|79280784|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
44293807|NCT00281658|79280781|FG000|Randomized Phase|Treatment ongoing|1|||
44293808|NCT00281658|79280782|FG001|Randomized Phase|Treatment ongoing|0|||
44293809|NCT00281658|79280783|FG002|Randomized Phase|Treatment ongoing|0|||
44293810|NCT00281658|79280784|FG003|Randomized Phase|Treatment ongoing|0|||
44293811|NCT00281658|79280781|FG000|Open Label Phase|Adverse Event|0|||
44293812|NCT00281658|79280782|FG001|Open Label Phase|Adverse Event|0|||
44293813|NCT00281658|79280783|FG002|Open Label Phase|Adverse Event|1|||
44293814|NCT00281658|79280784|FG003|Open Label Phase|Adverse Event|0|||
44293815|NCT00281658|79280781|FG000|Open Label Phase|Lost to Follow-up|0|||
44293816|NCT00281658|79280782|FG001|Open Label Phase|Lost to Follow-up|0|||
44293817|NCT00281658|79280783|FG002|Open Label Phase|Lost to Follow-up|16|||
44293818|NCT00281658|79280784|FG003|Open Label Phase|Lost to Follow-up|2|||
44293819|NCT00281658|79280781|FG000|Open Label Phase|Withdrawal by Subject|0|||
44293820|NCT00281658|79280782|FG001|Open Label Phase|Withdrawal by Subject|0|||
44293821|NCT00281658|79280783|FG002|Open Label Phase|Withdrawal by Subject|3|||
44293822|NCT00281658|79280784|FG003|Open Label Phase|Withdrawal by Subject|2|||
44293823|NCT00281658|79280781|FG000|Open Label Phase|Disease progression|0|||
44293824|NCT00281658|79280782|FG001|Open Label Phase|Disease progression|0|||
44293825|NCT00281658|79280783|FG002|Open Label Phase|Disease progression|18|||
44293826|NCT00281658|79280784|FG003|Open Label Phase|Disease progression|0|||
44293827|NCT00281658|79280781|FG000|Open Label Phase|Physician Decision|0|||
44293828|NCT00281658|79280782|FG001|Open Label Phase|Physician Decision|0|||
44293829|NCT00281658|79280783|FG002|Open Label Phase|Physician Decision|1|||
44293830|NCT00281658|79280784|FG003|Open Label Phase|Physician Decision|0|||
44293831|NCT00281658|79280781|FG000|Open Label Phase|Relocation of patient|0|||
44293832|NCT00281658|79280782|FG001|Open Label Phase|Relocation of patient|0|||
44293833|NCT00281658|79280783|FG002|Open Label Phase|Relocation of patient|1|||
44293834|NCT00281658|79280784|FG003|Open Label Phase|Relocation of patient|0|||
44293835|NCT00281658|79280781|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
44293836|NCT00281658|79280782|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
44293837|NCT00281658|79280783|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
44293838|NCT00281658|79280784|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
44293839|NCT02758626|79282162|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
44293840|NCT02758626|79282163|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
44293841|NCT02758626|79282162|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
44293842|NCT02758626|79282163|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
44293843|NCT02758626|79282162|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
44293844|NCT02758626|79282163|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
44293845|NCT02758626|79282162|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
44293846|NCT02758626|79282163|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
44293847|NCT02357784|79282169|FG000|Overall Study|Withdrawal by Subject|1|||
44293848|NCT01448616|79282176|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
44293849|NCT01448616|79282177|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
44293850|NCT01448616|79282178|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
44293851|NCT01448616|79282179|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
44154602|NCT02690701|78945897|FG001|Treatment Period 2|Withdrawal by Subject|2|||
44293852|NCT01448616|79282176|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
44293853|NCT01448616|79282177|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
44416734|NCT00839423|79424519|FG002|Overall Study|Non-compliance|0|||
44154603|NCT02690701|78945896|FG000|Treatment Period 2|Protocol Violation|0|||
44293854|NCT01448616|79282178|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
44293855|NCT01448616|79282179|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
44293856|NCT01448616|79282176|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
44293857|NCT01448616|79282177|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
44293858|NCT01448616|79282178|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
44293859|NCT01448616|79282179|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
44293860|NCT01448616|79282176|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
44293861|NCT01448616|79282177|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
44293862|NCT01448616|79282178|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
44293863|NCT01448616|79282179|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
44293864|NCT01448616|79282176|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
44293865|NCT01448616|79282177|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
44293866|NCT01448616|79282178|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
44293867|NCT01448616|79282179|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
44293868|NCT00074412|79282216|FG000|Overall Study|Death|30|||
44293869|NCT00074412|79282217|FG001|Overall Study|Death|26|||
44293870|NCT00074412|79282216|FG000|Overall Study|Lost to Follow-up|52|||
44293871|NCT00074412|79282217|FG001|Overall Study|Lost to Follow-up|58|||
44293872|NCT04505592|79283223|FG000|Overall Study|Death|2|||
44293873|NCT04505592|79283224|FG001|Overall Study|Death|1|||
44293874|NCT04706793|79283518|FG000|Treatment|Disease worsening|10|||
44293875|NCT04706793|79283519|FG001|Treatment|Disease worsening|10|||
44293876|NCT04706793|79283518|FG000|Follow-up|Lack of Efficacy|1|||
44293877|NCT04706793|79283519|FG001|Follow-up|Lack of Efficacy|0|||
44293878|NCT04706793|79283518|FG000|Follow-up|Disease worsening|8|||
44293879|NCT04706793|79283519|FG001|Follow-up|Disease worsening|10|||
44293880|NCT04706793|79283518|FG000|Follow-up|Adverse Event|1|||
44293881|NCT04706793|79283519|FG001|Follow-up|Adverse Event|0|||
44293882|NCT04607148|79283529|FG000|Overall Study|Withdrawal by Subject|0|||
44293883|NCT04607148|79283530|FG001|Overall Study|Withdrawal by Subject|4|||
44293884|NCT04607148|79283531|FG002|Overall Study|Withdrawal by Subject|2|||
44293885|NCT04607148|79283532|FG003|Overall Study|Withdrawal by Subject|8|||
44293886|NCT04607148|79283529|FG000|Overall Study|Study Terminated by Sponsor|14|||
44293887|NCT04607148|79283530|FG001|Overall Study|Study Terminated by Sponsor|59|||
44293888|NCT04607148|79283531|FG002|Overall Study|Study Terminated by Sponsor|9|||
44293889|NCT04607148|79283532|FG003|Overall Study|Study Terminated by Sponsor|39|||
44293890|NCT04607148|79283529|FG000|Overall Study|Sponsor Decision|0|||
44293891|NCT04607148|79283530|FG001|Overall Study|Sponsor Decision|0|||
44293892|NCT04607148|79283531|FG002|Overall Study|Sponsor Decision|1|||
44293893|NCT04607148|79283532|FG003|Overall Study|Sponsor Decision|0|||
44293894|NCT04607148|79283529|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44293895|NCT04607148|79283530|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44293896|NCT04607148|79283531|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44293897|NCT04607148|79283532|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44293898|NCT04607148|79283529|FG000|Overall Study|Lost to Follow-up|0|||
44293899|NCT04607148|79283530|FG001|Overall Study|Lost to Follow-up|2|||
44293900|NCT04607148|79283531|FG002|Overall Study|Lost to Follow-up|0|||
44293901|NCT04607148|79283532|FG003|Overall Study|Lost to Follow-up|0|||
44293902|NCT04607148|79283529|FG000|Overall Study|Death|0|||
44293903|NCT04607148|79283530|FG001|Overall Study|Death|3|||
44293904|NCT04607148|79283531|FG002|Overall Study|Death|0|||
44416735|NCT00839423|79424520|FG003|Overall Study|Non-compliance|1|||
44416736|NCT00839423|79424517|FG000|Overall Study|Protocol Violation|0|||
44416737|NCT00839423|79424518|FG001|Overall Study|Protocol Violation|1|||
44416738|NCT00839423|79424519|FG002|Overall Study|Protocol Violation|2|||
44416739|NCT00839423|79424520|FG003|Overall Study|Protocol Violation|0|||
44416740|NCT00839423|79424517|FG000|Overall Study|Withdrawal of consent|4|||
44416741|NCT00839423|79424518|FG001|Overall Study|Withdrawal of consent|0|||
44416742|NCT00839423|79424519|FG002|Overall Study|Withdrawal of consent|4|||
44416743|NCT00839423|79424520|FG003|Overall Study|Withdrawal of consent|1|||
44533943|NCT03954704|79544616|FG006|Overall Study|Death|0|||
44533944|NCT03954704|79544610|FG000|Overall Study|Withdrew Consent|0|||
44533945|NCT03954704|79544611|FG001|Overall Study|Withdrew Consent|0|||
44293905|NCT04607148|79283532|FG003|Overall Study|Death|1|||
44293906|NCT04607148|79283529|FG000|Overall Study|Adverse Event|0|||
44293907|NCT04607148|79283530|FG001|Overall Study|Adverse Event|1|||
44293908|NCT04607148|79283531|FG002|Overall Study|Adverse Event|0|||
44293909|NCT04607148|79283532|FG003|Overall Study|Adverse Event|0|||
44293910|NCT04542057|79283544|FG000|Overall Study|Death|3|||
44293911|NCT04542057|79283545|FG001|Overall Study|Death|1|||
44293912|NCT04542057|79283544|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
44293913|NCT04542057|79283545|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
44293914|NCT04542057|79283544|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
44293915|NCT04542057|79283545|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
44416744|NCT00839423|79424517|FG000|Overall Study|Lost to Follow-up|1|||
44533946|NCT03954704|79544612|FG002|Overall Study|Withdrew Consent|1|||
44293916|NCT04542057|79283544|FG000|Overall Study|Adverse Event|15|||
44293917|NCT04542057|79283545|FG001|Overall Study|Adverse Event|6|||
44293918|NCT04542057|79283544|FG000|Overall Study|COVID-19 adverse event|6|||
44293919|NCT04542057|79283545|FG001|Overall Study|COVID-19 adverse event|4|||
44293920|NCT04542057|79283544|FG000|Overall Study|Lack of Efficacy|2|||
44293921|NCT04542057|79283545|FG001|Overall Study|Lack of Efficacy|5|||
44293922|NCT04542057|79283544|FG000|Overall Study|Study terminated by sponsor|1|||
44293923|NCT04542057|79283545|FG001|Overall Study|Study terminated by sponsor|0|||
44293924|NCT04542057|79283544|FG000|Overall Study|Investigator discretion|2|||
44293925|NCT04542057|79283545|FG001|Overall Study|Investigator discretion|1|||
44293926|NCT04542057|79283544|FG000|Overall Study|Withdrawal by Subject|52|||
44293927|NCT04542057|79283545|FG001|Overall Study|Withdrawal by Subject|30|||
44293928|NCT04542057|79283544|FG000|Overall Study|Lost to Follow-up|8|||
44293929|NCT04542057|79283545|FG001|Overall Study|Lost to Follow-up|11|||
44293930|NCT04542057|79283544|FG000|Overall Study|Other|2|||
44293931|NCT04542057|79283545|FG001|Overall Study|Other|2|||
44293932|NCT04193527|79283559|FG000|Overall Study|Other|1|||
44293933|NCT04193527|79283560|FG001|Overall Study|Other|1|||
44293934|NCT04193527|79283561|FG002|Overall Study|Other|0|||
44293935|NCT03915470|79283574|FG000|Overall Study|Death|3|||
44293936|NCT03915470|79283575|FG001|Overall Study|Death|1|||
44293937|NCT03915470|79283574|FG000|Overall Study|Adverse Event|1|||
44293938|NCT03915470|79283575|FG001|Overall Study|Adverse Event|0|||
44293939|NCT03915470|79283574|FG000|Overall Study|Physician Decision|1|||
44293940|NCT03915470|79283575|FG001|Overall Study|Physician Decision|0|||
44293941|NCT03915470|79283574|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
44293942|NCT03915470|79283575|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
44293943|NCT03575468|79283583|FG000|Overall Study|Withdrawal by Subject|3|||
44293944|NCT03575468|79283584|FG001|Overall Study|Withdrawal by Subject|0|||
44293945|NCT03575468|79283583|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
44293946|NCT03575468|79283584|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
44293947|NCT03575468|79283583|FG000|Overall Study|Lost to Follow-up|13|||
44293948|NCT03575468|79283584|FG001|Overall Study|Lost to Follow-up|17|||
44293949|NCT03555981|79283592|FG000|Overall Study|Lost to Follow-up|0|||
44293950|NCT03555981|79283593|FG001|Overall Study|Lost to Follow-up|2|||
44293951|NCT03382834|79283601|FG000|Overall Study|Lost to Follow-up|1|||
44293952|NCT03382834|79283602|FG001|Overall Study|Lost to Follow-up|0|||
44293953|NCT03382834|79283601|FG000|Overall Study|Withdrawal by Subject|0|||
44293954|NCT03382834|79283602|FG001|Overall Study|Withdrawal by Subject|1|||
44293955|NCT03308942|79283613|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
44293956|NCT03308942|79283614|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
44293957|NCT03308942|79283615|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
44293958|NCT03308942|79283616|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
44293959|NCT03308942|79283617|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
44293960|NCT03308942|79283613|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
44293961|NCT03308942|79283614|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
44293962|NCT03308942|79283615|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
44293963|NCT03308942|79283616|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
44293964|NCT03308942|79283617|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
44293965|NCT03308942|79283613|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
44293966|NCT03308942|79283614|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
44293967|NCT03308942|79283615|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
44293968|NCT03308942|79283616|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
44154604|NCT02690701|78945897|FG001|Treatment Period 2|Protocol Violation|1|||
44293969|NCT03308942|79283617|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
44293970|NCT03308942|79283613|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
44293971|NCT03308942|79283614|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
44293972|NCT03308942|79283615|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
44293973|NCT03308942|79283616|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
44293974|NCT03308942|79283617|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
44293975|NCT03308942|79283613|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
44293976|NCT03308942|79283614|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
44293977|NCT03308942|79283615|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
44293978|NCT03308942|79283616|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
44293979|NCT03308942|79283617|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
44293980|NCT03308942|79283613|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
44293981|NCT03308942|79283614|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
44293982|NCT03308942|79283615|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
44293983|NCT03308942|79283616|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
44293984|NCT03308942|79283617|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
44293985|NCT03308942|79283613|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
44293986|NCT03308942|79283614|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
44293987|NCT03308942|79283615|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
44293988|NCT03308942|79283616|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
44293989|NCT03308942|79283617|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
44293990|NCT03291431|79283632|FG000|Overall Study|Protocol Violation|2|||
44293991|NCT03291431|79283633|FG001|Overall Study|Protocol Violation|1|||
44293992|NCT03291431|79283632|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
44293993|NCT03291431|79283633|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
44293994|NCT03291431|79283632|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
44293995|NCT03291431|79283633|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
44293996|NCT03261401|79283652|FG000|Overall Study|Withdrawal by Subject|0|||
44293997|NCT03261401|79283653|FG001|Overall Study|Withdrawal by Subject|0|||
44293998|NCT03261401|79283654|FG002|Overall Study|Withdrawal by Subject|0|||
44293999|NCT03261401|79283655|FG003|Overall Study|Withdrawal by Subject|0|||
44294000|NCT03261401|79283656|FG004|Overall Study|Withdrawal by Subject|0|||
44294001|NCT03261401|79283657|FG005|Overall Study|Withdrawal by Subject|1|||
44294002|NCT03261401|79283658|FG006|Overall Study|Withdrawal by Subject|0|||
44294003|NCT03261401|79283659|FG007|Overall Study|Withdrawal by Subject|0|||
44294004|NCT03261401|79283660|FG008|Overall Study|Withdrawal by Subject|0|||
44294005|NCT03261401|79283661|FG009|Overall Study|Withdrawal by Subject|0|||
44294006|NCT03261401|79283662|FG010|Overall Study|Withdrawal by Subject|0|||
44294007|NCT03261401|79283663|FG011|Overall Study|Withdrawal by Subject|0|||
44294008|NCT03261401|79283664|FG012|Overall Study|Withdrawal by Subject|0|||
44294009|NCT03261401|79283652|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
44294010|NCT03261401|79283653|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
44294011|NCT03261401|79283654|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
44294012|NCT03261401|79283655|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
44294013|NCT03261401|79283656|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
44294014|NCT03261401|79283657|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
44294015|NCT03261401|79283658|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
44294016|NCT03261401|79283659|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
44294017|NCT03261401|79283660|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
44294018|NCT03261401|79283661|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
44294019|NCT03261401|79283662|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
44294020|NCT03261401|79283663|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
44294021|NCT03261401|79283664|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
44294022|NCT02998528|79283704|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
44294023|NCT02998528|79283705|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
44294024|NCT02998528|79283706|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
44294025|NCT02998528|79283704|FG000|Randomization Period|Participant withdrew consent|0|||
44294026|NCT02998528|79283705|FG001|Randomization Period|Participant withdrew consent|3|||
44294027|NCT02998528|79283706|FG002|Randomization Period|Participant withdrew consent|0|||
44294028|NCT02998528|79283704|FG000|Randomization Period|Participant no longer meets study criteria|1|||
44294029|NCT02998528|79283705|FG001|Randomization Period|Participant no longer meets study criteria|3|||
44294030|NCT02998528|79283706|FG002|Randomization Period|Participant no longer meets study criteria|2|||
44294031|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
44294032|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
44294033|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
44294034|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
44294035|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
44294036|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
44294037|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
44294038|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
44294039|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
44294040|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
44294041|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
44294042|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
44416745|NCT00839423|79424518|FG001|Overall Study|Lost to Follow-up|0|||
44294043|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
44294044|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
44294045|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
44294046|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Death|1|||
44294047|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Death|0|||
44294048|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Death|0|||
44294049|NCT02998528|79283704|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
44294050|NCT02998528|79283705|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
44294051|NCT02998528|79283706|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
44154605|NCT02694757|78945904|FG000|Overall Study|Lack of Efficacy|3|||
44294052|NCT02998528|79283704|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
44294053|NCT02998528|79283705|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
44294054|NCT02998528|79283706|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
44294055|NCT02998528|79283704|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
44294056|NCT02998528|79283705|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
44294057|NCT02998528|79283706|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
44294058|NCT02998528|79283704|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
44294059|NCT02998528|79283705|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
44294060|NCT02998528|79283706|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
44294061|NCT02998528|79283704|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
44294062|NCT02998528|79283705|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
44294063|NCT02998528|79283706|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
44294064|NCT02998528|79283704|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
44294065|NCT02998528|79283705|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
44294066|NCT02998528|79283706|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
44294067|NCT02718911|79283727|FG000|Overall Study|Adverse Event|0|||
44294068|NCT02718911|79283728|FG001|Overall Study|Adverse Event|0|||
44294069|NCT02718911|79283729|FG002|Overall Study|Adverse Event|0|||
44294070|NCT02718911|79283730|FG003|Overall Study|Adverse Event|0|||
44416746|NCT00839423|79424519|FG002|Overall Study|Lost to Follow-up|1|||
44416747|NCT00839423|79424520|FG003|Overall Study|Lost to Follow-up|0|||
44416748|NCT00839423|79424517|FG000|Overall Study|Administrative or other reasons|3|||
44416749|NCT00839423|79424518|FG001|Overall Study|Administrative or other reasons|0|||
44416750|NCT00839423|79424519|FG002|Overall Study|Administrative or other reasons|1|||
44416751|NCT00839423|79424520|FG003|Overall Study|Administrative or other reasons|0|||
44416752|NCT00837161|79424530|FG000|Overall Study|refused hysterectomy|2|||
44416753|NCT00859547|79424534|FG000|Overall Study|Lost to Follow-up|1|||
44416754|NCT00859547|79424534|FG000|Overall Study|Parent withdrew consent|1|||
44416755|NCT00859469|79424538|FG000|Overall Study|Adverse Event|2|||
44416756|NCT00859469|79424538|FG000|Overall Study|Lack of Efficacy|9|||
44416757|NCT00859469|79424538|FG000|Overall Study|Withdrawal by Subject|1|||
44416758|NCT00859469|79424538|FG000|Overall Study|Death|16|||
44416759|NCT00859313|79424542|FG000|Overall Study|Lack of Efficacy|2|||
44416760|NCT00859313|79424542|FG000|Overall Study|Adverse Event|1|||
44416761|NCT00859313|79424542|FG000|Overall Study|staff error|1|||
44416762|NCT00771810|79424549|FG000|Overall Study|Adverse Event|3|||
44416763|NCT00771810|79424550|FG001|Overall Study|Adverse Event|0|||
44416764|NCT00771810|79424551|FG002|Overall Study|Adverse Event|2|||
44154606|NCT03805841|78945911|FG000|Overall Study|Clinical Progression|2|||
44294071|NCT02718911|79283731|FG004|Overall Study|Adverse Event|0|||
44294072|NCT02718911|79283732|FG005|Overall Study|Adverse Event|0|||
44294073|NCT02718911|79283733|FG006|Overall Study|Adverse Event|0|||
44294074|NCT02718911|79283734|FG007|Overall Study|Adverse Event|0|||
44294075|NCT02718911|79283735|FG008|Overall Study|Adverse Event|0|||
44294076|NCT02718911|79283736|FG009|Overall Study|Adverse Event|2|||
44294077|NCT02718911|79283727|FG000|Overall Study|Death|2|||
44416765|NCT00771810|79424549|FG000|Overall Study|Lost to Follow-up|0|||
44416766|NCT00771810|79424550|FG001|Overall Study|Lost to Follow-up|0|||
44416767|NCT00771810|79424551|FG002|Overall Study|Lost to Follow-up|1|||
44416768|NCT00771810|79424549|FG000|Overall Study|Physician Decision|1|||
44416769|NCT00771810|79424550|FG001|Overall Study|Physician Decision|2|||
44416770|NCT00771810|79424551|FG002|Overall Study|Physician Decision|2|||
44416771|NCT00771810|79424549|FG000|Overall Study|Protocol Violation|0|||
44416772|NCT00771810|79424550|FG001|Overall Study|Protocol Violation|1|||
44416773|NCT00771810|79424551|FG002|Overall Study|Protocol Violation|1|||
44294078|NCT02718911|79283728|FG001|Overall Study|Death|3|||
44294079|NCT02718911|79283729|FG002|Overall Study|Death|1|||
44294080|NCT02718911|79283730|FG003|Overall Study|Death|0|||
44294081|NCT02718911|79283731|FG004|Overall Study|Death|1|||
44294082|NCT02718911|79283732|FG005|Overall Study|Death|3|||
44416774|NCT00771810|79424549|FG000|Overall Study|Withdrawal by Subject|1|||
44416775|NCT00771810|79424550|FG001|Overall Study|Withdrawal by Subject|2|||
44416776|NCT00771810|79424551|FG002|Overall Study|Withdrawal by Subject|0|||
44416777|NCT00771810|79424549|FG000|Overall Study|Other|0|||
44294083|NCT02718911|79283733|FG006|Overall Study|Death|1|||
44294084|NCT02718911|79283734|FG007|Overall Study|Death|1|||
44294085|NCT02718911|79283735|FG008|Overall Study|Death|4|||
44294086|NCT02718911|79283736|FG009|Overall Study|Death|3|||
44294087|NCT02718911|79283727|FG000|Overall Study|Lost to Follow-up|0|||
44294088|NCT02718911|79283728|FG001|Overall Study|Lost to Follow-up|0|||
44294089|NCT02718911|79283729|FG002|Overall Study|Lost to Follow-up|0|||
44294090|NCT02718911|79283730|FG003|Overall Study|Lost to Follow-up|0|||
44294091|NCT02718911|79283731|FG004|Overall Study|Lost to Follow-up|0|||
44294092|NCT02718911|79283732|FG005|Overall Study|Lost to Follow-up|0|||
44294093|NCT02718911|79283733|FG006|Overall Study|Lost to Follow-up|0|||
44294094|NCT02718911|79283734|FG007|Overall Study|Lost to Follow-up|0|||
44294095|NCT02718911|79283735|FG008|Overall Study|Lost to Follow-up|1|||
44294096|NCT02718911|79283736|FG009|Overall Study|Lost to Follow-up|0|||
44294097|NCT02718911|79283727|FG000|Overall Study|Physician Decision|2|||
44294098|NCT02718911|79283728|FG001|Overall Study|Physician Decision|0|||
44294099|NCT02718911|79283729|FG002|Overall Study|Physician Decision|1|||
44294100|NCT02718911|79283730|FG003|Overall Study|Physician Decision|1|||
44294101|NCT02718911|79283731|FG004|Overall Study|Physician Decision|0|||
44294102|NCT02718911|79283732|FG005|Overall Study|Physician Decision|0|||
44294103|NCT02718911|79283733|FG006|Overall Study|Physician Decision|0|||
44294104|NCT02718911|79283734|FG007|Overall Study|Physician Decision|1|||
44294105|NCT02718911|79283735|FG008|Overall Study|Physician Decision|2|||
44294106|NCT02718911|79283736|FG009|Overall Study|Physician Decision|1|||
44294107|NCT02718911|79283727|FG000|Overall Study|Withdrawal by Subject|0|||
44294108|NCT02718911|79283728|FG001|Overall Study|Withdrawal by Subject|0|||
44294109|NCT02718911|79283729|FG002|Overall Study|Withdrawal by Subject|0|||
44294110|NCT02718911|79283730|FG003|Overall Study|Withdrawal by Subject|0|||
44294111|NCT02718911|79283731|FG004|Overall Study|Withdrawal by Subject|1|||
44294112|NCT02718911|79283732|FG005|Overall Study|Withdrawal by Subject|0|||
44294113|NCT02718911|79283733|FG006|Overall Study|Withdrawal by Subject|0|||
44294114|NCT02718911|79283734|FG007|Overall Study|Withdrawal by Subject|0|||
44294115|NCT02718911|79283735|FG008|Overall Study|Withdrawal by Subject|1|||
44294116|NCT02718911|79283736|FG009|Overall Study|Withdrawal by Subject|4|||
44294117|NCT02718911|79283727|FG000|Overall Study|Reason Not Collected|0|||
44294118|NCT02718911|79283728|FG001|Overall Study|Reason Not Collected|0|||
44294119|NCT02718911|79283729|FG002|Overall Study|Reason Not Collected|1|||
44294120|NCT02718911|79283730|FG003|Overall Study|Reason Not Collected|0|||
44294121|NCT02718911|79283731|FG004|Overall Study|Reason Not Collected|0|||
44294122|NCT02718911|79283732|FG005|Overall Study|Reason Not Collected|0|||
44294123|NCT02718911|79283733|FG006|Overall Study|Reason Not Collected|2|||
44294124|NCT02718911|79283734|FG007|Overall Study|Reason Not Collected|1|||
44294125|NCT02718911|79283735|FG008|Overall Study|Reason Not Collected|4|||
44294126|NCT02718911|79283736|FG009|Overall Study|Reason Not Collected|9|||
44294127|NCT02542267|79283760|FG000|Overall Study|Withdrawal by Subject|10|||
44294128|NCT02542267|79283760|FG000|Overall Study|Physician Decision|6|||
44294129|NCT02542267|79283760|FG000|Overall Study|Lost to Follow-up|4|||
44294130|NCT02542267|79283760|FG000|Overall Study|Death|13|||
44294131|NCT02542267|79283760|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
44294132|NCT02542267|79283760|FG000|Overall Study|Other|9|||
44294133|NCT02017717|79283812|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294134|NCT02017717|79283813|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294135|NCT02017717|79283814|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294136|NCT02017717|79283815|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
44294137|NCT02017717|79283816|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294138|NCT02017717|79283817|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294139|NCT02017717|79283818|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294140|NCT02017717|79283819|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294141|NCT02017717|79283820|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
44294142|NCT02017717|79283812|FG000|Before Treatment Period|Participant request to stop therapy|0|||
44294143|NCT02017717|79283813|FG001|Before Treatment Period|Participant request to stop therapy|0|||
44294144|NCT02017717|79283814|FG002|Before Treatment Period|Participant request to stop therapy|0|||
44294145|NCT02017717|79283815|FG003|Before Treatment Period|Participant request to stop therapy|0|||
44294146|NCT02017717|79283816|FG004|Before Treatment Period|Participant request to stop therapy|5|||
44294147|NCT02017717|79283817|FG005|Before Treatment Period|Participant request to stop therapy|0|||
44294148|NCT02017717|79283818|FG006|Before Treatment Period|Participant request to stop therapy|0|||
44294149|NCT02017717|79283819|FG007|Before Treatment Period|Participant request to stop therapy|0|||
44294150|NCT02017717|79283820|FG008|Before Treatment Period|Participant request to stop therapy|0|||
44294151|NCT02017717|79283812|FG000|Before Treatment Period|Participant withdrew consent|0|||
44294152|NCT02017717|79283813|FG001|Before Treatment Period|Participant withdrew consent|0|||
44294153|NCT02017717|79283814|FG002|Before Treatment Period|Participant withdrew consent|0|||
44294154|NCT02017717|79283815|FG003|Before Treatment Period|Participant withdrew consent|0|||
44294155|NCT02017717|79283816|FG004|Before Treatment Period|Participant withdrew consent|11|||
44294156|NCT02017717|79283817|FG005|Before Treatment Period|Participant withdrew consent|0|||
44294157|NCT02017717|79283818|FG006|Before Treatment Period|Participant withdrew consent|0|||
44294158|NCT02017717|79283819|FG007|Before Treatment Period|Participant withdrew consent|0|||
44294159|NCT02017717|79283820|FG008|Before Treatment Period|Participant withdrew consent|2|||
44294160|NCT02017717|79283812|FG000|Before Treatment Period|Lost to Follow-up|0|||
44294161|NCT02017717|79283813|FG001|Before Treatment Period|Lost to Follow-up|0|||
44294162|NCT02017717|79283814|FG002|Before Treatment Period|Lost to Follow-up|0|||
44294163|NCT02017717|79283815|FG003|Before Treatment Period|Lost to Follow-up|0|||
44294164|NCT02017717|79283816|FG004|Before Treatment Period|Lost to Follow-up|1|||
44294165|NCT02017717|79283817|FG005|Before Treatment Period|Lost to Follow-up|0|||
44294166|NCT02017717|79283818|FG006|Before Treatment Period|Lost to Follow-up|0|||
44294167|NCT02017717|79283819|FG007|Before Treatment Period|Lost to Follow-up|0|||
44294168|NCT02017717|79283820|FG008|Before Treatment Period|Lost to Follow-up|0|||
44294169|NCT02017717|79283812|FG000|Before Treatment Period|Participant no longer met criteria|0|||
44294170|NCT02017717|79283813|FG001|Before Treatment Period|Participant no longer met criteria|0|||
44294171|NCT02017717|79283814|FG002|Before Treatment Period|Participant no longer met criteria|0|||
44294172|NCT02017717|79283815|FG003|Before Treatment Period|Participant no longer met criteria|1|||
44294173|NCT02017717|79283816|FG004|Before Treatment Period|Participant no longer met criteria|2|||
44294174|NCT02017717|79283817|FG005|Before Treatment Period|Participant no longer met criteria|0|||
44294175|NCT02017717|79283818|FG006|Before Treatment Period|Participant no longer met criteria|0|||
44294176|NCT02017717|79283819|FG007|Before Treatment Period|Participant no longer met criteria|1|||
44294177|NCT02017717|79283820|FG008|Before Treatment Period|Participant no longer met criteria|0|||
44294178|NCT02017717|79283812|FG000|Before Treatment Period|other reason|0|||
44294179|NCT02017717|79283813|FG001|Before Treatment Period|other reason|0|||
44294180|NCT02017717|79283814|FG002|Before Treatment Period|other reason|0|||
44294181|NCT02017717|79283815|FG003|Before Treatment Period|other reason|0|||
44294182|NCT02017717|79283816|FG004|Before Treatment Period|other reason|1|||
44294183|NCT02017717|79283817|FG005|Before Treatment Period|other reason|0|||
44294184|NCT02017717|79283818|FG006|Before Treatment Period|other reason|0|||
44294185|NCT02017717|79283819|FG007|Before Treatment Period|other reason|0|||
44294186|NCT02017717|79283820|FG008|Before Treatment Period|other reason|0|||
44294187|NCT02017717|79283812|FG000|Treatment Period|Disease progression|7|||
44294188|NCT02017717|79283813|FG001|Treatment Period|Disease progression|9|||
44294189|NCT02017717|79283814|FG002|Treatment Period|Disease progression|12|||
44294190|NCT02017717|79283815|FG003|Treatment Period|Disease progression|165|||
44294191|NCT02017717|79283816|FG004|Treatment Period|Disease progression|134|||
44294192|NCT02017717|79283817|FG005|Treatment Period|Disease progression|20|||
44294193|NCT02017717|79283818|FG006|Treatment Period|Disease progression|26|||
44294194|NCT02017717|79283819|FG007|Treatment Period|Disease progression|17|||
44294195|NCT02017717|79283820|FG008|Treatment Period|Disease progression|22|||
44294196|NCT02017717|79283812|FG000|Treatment Period|Study drug toxicity|3|||
44294197|NCT02017717|79283813|FG001|Treatment Period|Study drug toxicity|0|||
44294198|NCT02017717|79283814|FG002|Treatment Period|Study drug toxicity|1|||
44294199|NCT02017717|79283815|FG003|Treatment Period|Study drug toxicity|7|||
44294200|NCT02017717|79283816|FG004|Treatment Period|Study drug toxicity|11|||
44294201|NCT02017717|79283817|FG005|Treatment Period|Study drug toxicity|4|||
44294202|NCT02017717|79283818|FG006|Treatment Period|Study drug toxicity|4|||
44294203|NCT02017717|79283819|FG007|Treatment Period|Study drug toxicity|5|||
44294204|NCT02017717|79283820|FG008|Treatment Period|Study drug toxicity|3|||
44256224|NCT01449812|79103853|FG001|Overall Study|Migrated/moved from study area|0|||
44256225|NCT01449812|79103854|FG002|Overall Study|Migrated/moved from study area|0|||
44256226|NCT01449812|79103852|FG000|Overall Study|Withdrawal by Subject|0|||
44256227|NCT01449812|79103853|FG001|Overall Study|Withdrawal by Subject|0|||
44256228|NCT01449812|79103854|FG002|Overall Study|Withdrawal by Subject|1|||
44256229|NCT01449812|79103852|FG000|Overall Study|Lost to Follow-up|1|||
44256230|NCT01449812|79103853|FG001|Overall Study|Lost to Follow-up|0|||
44256231|NCT01449812|79103854|FG002|Overall Study|Lost to Follow-up|0|||
44256232|NCT01466660|79104025|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
44256233|NCT01466660|79104026|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
44256234|NCT01466660|79104025|FG000|Overall Study|Worsening of underlying cancer disease|5|||
44256235|NCT01466660|79104026|FG001|Overall Study|Worsening of underlying cancer disease|2|||
44256236|NCT01466660|79104025|FG000|Overall Study|Other adverse event|19|||
44256237|NCT01466660|79104026|FG001|Overall Study|Other adverse event|18|||
44256238|NCT01466660|79104025|FG000|Overall Study|Protocol Violation|2|||
44256239|NCT01466660|79104026|FG001|Overall Study|Protocol Violation|1|||
44256240|NCT01466660|79104025|FG000|Overall Study|Refused continuation of trial medication|4|||
44256241|NCT01466660|79104026|FG001|Overall Study|Refused continuation of trial medication|3|||
44256242|NCT01466660|79104025|FG000|Overall Study|Other reason not defined above|10|||
44256243|NCT01466660|79104026|FG001|Overall Study|Other reason not defined above|8|||
44256244|NCT01466348|79104036|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
44294205|NCT02017717|79283812|FG000|Treatment Period|Death|0|||
44256245|NCT01466348|79104037|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
44416778|NCT00771810|79424550|FG001|Overall Study|Other|0|||
44154607|NCT03805841|78945912|FG001|Overall Study|Clinical Progression|0|||
44154608|NCT03805841|78945913|FG002|Overall Study|Clinical Progression|0|||
44416779|NCT00771810|79424551|FG002|Overall Study|Other|1|||
44416780|NCT00836927|79424565|FG000|Overall Study|Progressive disease|2|||
44416781|NCT00836927|79424566|FG001|Overall Study|Progressive disease|0|||
44416782|NCT00836927|79424567|FG002|Overall Study|Progressive disease|0|||
44416783|NCT00836927|79424568|FG003|Overall Study|Progressive disease|1|||
44416784|NCT00836927|79424569|FG004|Overall Study|Progressive disease|1|||
44416785|NCT00836927|79424565|FG000|Overall Study|Withdrawal by Subject|1|||
44416786|NCT00836927|79424566|FG001|Overall Study|Withdrawal by Subject|0|||
44416787|NCT00836927|79424567|FG002|Overall Study|Withdrawal by Subject|0|||
44416788|NCT00836927|79424568|FG003|Overall Study|Withdrawal by Subject|0|||
44416789|NCT00836927|79424569|FG004|Overall Study|Withdrawal by Subject|0|||
44416790|NCT00771030|79424590|FG000|Overall Study|Adverse Event|0|||
44416791|NCT00771030|79424591|FG001|Overall Study|Adverse Event|1|||
44416792|NCT00771030|79424592|FG002|Overall Study|Adverse Event|0|||
44416793|NCT00771030|79424593|FG003|Overall Study|Adverse Event|0|||
44416794|NCT00771030|79424594|FG004|Overall Study|Adverse Event|0|||
44416795|NCT00771030|79424595|FG005|Overall Study|Adverse Event|0|||
44416796|NCT00771030|79424596|FG006|Overall Study|Adverse Event|0|||
44416797|NCT00768300|79424619|FG000|Overall Study|Randomized but not treated|1|||
44416798|NCT00768300|79424620|FG001|Overall Study|Randomized but not treated|1|||
44416799|NCT00768300|79424619|FG000|Overall Study|Adverse Event|10|||
44416800|NCT00768300|79424620|FG001|Overall Study|Adverse Event|2|||
44416801|NCT00768300|79424619|FG000|Overall Study|Protocol Violation|6|||
44416802|NCT00768300|79424620|FG001|Overall Study|Protocol Violation|1|||
44416803|NCT00768300|79424619|FG000|Overall Study|Withdrawal by Subject|13|||
44416804|NCT00768300|79424620|FG001|Overall Study|Withdrawal by Subject|7|||
44416805|NCT00768300|79424619|FG000|Overall Study|Physician Decision|2|||
44416806|NCT00768300|79424620|FG001|Overall Study|Physician Decision|3|||
44416807|NCT00768300|79424619|FG000|Overall Study|Study discontinued by Sponsor|271|||
44416808|NCT00768300|79424620|FG001|Overall Study|Study discontinued by Sponsor|140|||
44416809|NCT00768300|79424619|FG000|Overall Study|Death|21|||
44416810|NCT00768300|79424620|FG001|Overall Study|Death|5|||
44416811|NCT00768300|79424619|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
44416812|NCT00768300|79424620|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
44416813|NCT00768300|79424619|FG000|Overall Study|Screen failure following randomization|1|||
44416814|NCT00768300|79424620|FG001|Overall Study|Screen failure following randomization|0|||
44416815|NCT00768300|79424619|FG000|Overall Study|Received lung transplant|1|||
44416816|NCT00768300|79424620|FG001|Overall Study|Received lung transplant|1|||
44416817|NCT00768300|79424619|FG000|Overall Study|Lost to Follow-up|0|||
44416818|NCT00768300|79424620|FG001|Overall Study|Lost to Follow-up|1|||
44416819|NCT00768300|79424619|FG000|Overall Study|Began prohibited concomitant medication|0|||
44416820|NCT00768300|79424620|FG001|Overall Study|Began prohibited concomitant medication|1|||
44416821|NCT00768300|79424619|FG000|Overall Study|Treated but never dosed with Study drug|1|||
44416822|NCT00768300|79424620|FG001|Overall Study|Treated but never dosed with Study drug|0|||
44416823|NCT00768300|79424619|FG000|Overall Study|Missing data|1|||
44416824|NCT00768300|79424620|FG001|Overall Study|Missing data|0|||
44416825|NCT00768222|79424628|FG000|Overall Study|Lost to Follow-up|1|||
44416826|NCT00768222|79424629|FG001|Overall Study|Lost to Follow-up|1|||
44416827|NCT00768222|79424628|FG000|Overall Study|Withdrawal by Subject|3|||
44416828|NCT00768222|79424629|FG001|Overall Study|Withdrawal by Subject|1|||
44416829|NCT00768222|79424628|FG000|Overall Study|Protocol Violation|0|||
44416830|NCT00768222|79424629|FG001|Overall Study|Protocol Violation|2|||
44416831|NCT00768144|79424635|FG000|Overall Study|Adverse Event|13|||
44416832|NCT00768144|79424635|FG000|Overall Study|Progressive Disease|21|||
44416833|NCT00768144|79424635|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
44416834|NCT00768144|79424635|FG000|Overall Study|Pt Withdrew Consent|1|||
44416835|NCT00784836|79424639|FG000|Overall Study|Early Study Termination|3|||
44416836|NCT00784758|79424645|FG000|Overall Study|Withdrawal by Subject|3|||
44416837|NCT00784758|79424646|FG001|Overall Study|Withdrawal by Subject|0|||
44416838|NCT00784758|79424645|FG000|Overall Study|Adverse Event|1|||
44416839|NCT00784758|79424646|FG001|Overall Study|Adverse Event|0|||
44416840|NCT00768066|79424657|FG000|Overall Study|Did not receive study product injection.|3|||
44416841|NCT00768066|79424658|FG001|Overall Study|Did not receive study product injection.|3|||
44533947|NCT03954704|79544613|FG003|Overall Study|Withdrew Consent|0|||
44533948|NCT03954704|79544614|FG004|Overall Study|Withdrew Consent|0|||
44416842|NCT00768066|79424659|FG002|Overall Study|Did not receive study product injection.|0|||
44416843|NCT00767676|79424667|FG000|Overall Study|Investigator error|54|||
44416844|NCT00767520|79424673|FG000|Overall Study|Participants still on treatment|11|||
44416845|NCT00767520|79424674|FG001|Overall Study|Participants still on treatment|15|||
44154609|NCT03805841|78945911|FG000|Overall Study|Death|0|||
44416846|NCT00767520|79424673|FG000|Overall Study|Randomized in error and Never treated|0|||
44416847|NCT00767520|79424674|FG001|Overall Study|Randomized in error and Never treated|2|||
44416848|NCT00838565|79424686|FG000|Overall Study|Withdrawal by Subject|0|||
44294206|NCT02017717|79283813|FG001|Treatment Period|Death|0|||
44294207|NCT02017717|79283814|FG002|Treatment Period|Death|1|||
44294208|NCT02017717|79283815|FG003|Treatment Period|Death|0|||
44294209|NCT02017717|79283816|FG004|Treatment Period|Death|0|||
44294210|NCT02017717|79283817|FG005|Treatment Period|Death|0|||
44294211|NCT02017717|79283818|FG006|Treatment Period|Death|0|||
44294212|NCT02017717|79283819|FG007|Treatment Period|Death|1|||
44294213|NCT02017717|79283820|FG008|Treatment Period|Death|0|||
44294214|NCT02017717|79283812|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
44294215|NCT02017717|79283813|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
44294216|NCT02017717|79283814|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
44294217|NCT02017717|79283815|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
44294218|NCT02017717|79283816|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
44294219|NCT02017717|79283817|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
44294220|NCT02017717|79283818|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
44294221|NCT02017717|79283819|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
44294222|NCT02017717|79283820|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
44294223|NCT02017717|79283812|FG000|Treatment Period|Participant request to stop therapy|0|||
44294224|NCT02017717|79283813|FG001|Treatment Period|Participant request to stop therapy|0|||
44294225|NCT02017717|79283814|FG002|Treatment Period|Participant request to stop therapy|3|||
44294226|NCT02017717|79283815|FG003|Treatment Period|Participant request to stop therapy|4|||
44294227|NCT02017717|79283816|FG004|Treatment Period|Participant request to stop therapy|7|||
44294228|NCT02017717|79283817|FG005|Treatment Period|Participant request to stop therapy|5|||
44294229|NCT02017717|79283818|FG006|Treatment Period|Participant request to stop therapy|0|||
44294230|NCT02017717|79283819|FG007|Treatment Period|Participant request to stop therapy|2|||
44294231|NCT02017717|79283820|FG008|Treatment Period|Participant request to stop therapy|1|||
44294232|NCT02017717|79283812|FG000|Treatment Period|Participant withdrew consent|0|||
44294233|NCT02017717|79283813|FG001|Treatment Period|Participant withdrew consent|0|||
44294234|NCT02017717|79283814|FG002|Treatment Period|Participant withdrew consent|1|||
44294235|NCT02017717|79283815|FG003|Treatment Period|Participant withdrew consent|1|||
44294236|NCT02017717|79283816|FG004|Treatment Period|Participant withdrew consent|4|||
44294237|NCT02017717|79283817|FG005|Treatment Period|Participant withdrew consent|0|||
44294238|NCT02017717|79283818|FG006|Treatment Period|Participant withdrew consent|0|||
44294239|NCT02017717|79283819|FG007|Treatment Period|Participant withdrew consent|2|||
44294240|NCT02017717|79283820|FG008|Treatment Period|Participant withdrew consent|0|||
44294241|NCT02017717|79283812|FG000|Treatment Period|Participant no longer met criteria|0|||
44294242|NCT02017717|79283813|FG001|Treatment Period|Participant no longer met criteria|0|||
44294243|NCT02017717|79283814|FG002|Treatment Period|Participant no longer met criteria|0|||
44294244|NCT02017717|79283815|FG003|Treatment Period|Participant no longer met criteria|0|||
44294245|NCT02017717|79283816|FG004|Treatment Period|Participant no longer met criteria|1|||
44294246|NCT02017717|79283817|FG005|Treatment Period|Participant no longer met criteria|0|||
44294247|NCT02017717|79283818|FG006|Treatment Period|Participant no longer met criteria|0|||
44294248|NCT02017717|79283819|FG007|Treatment Period|Participant no longer met criteria|0|||
44294249|NCT02017717|79283820|FG008|Treatment Period|Participant no longer met criteria|0|||
44294250|NCT02017717|79283812|FG000|Treatment Period|other reasons|0|||
44294251|NCT02017717|79283813|FG001|Treatment Period|other reasons|0|||
44294252|NCT02017717|79283814|FG002|Treatment Period|other reasons|0|||
44294253|NCT02017717|79283815|FG003|Treatment Period|other reasons|0|||
44294254|NCT02017717|79283816|FG004|Treatment Period|other reasons|1|||
44294255|NCT02017717|79283817|FG005|Treatment Period|other reasons|0|||
44294256|NCT02017717|79283818|FG006|Treatment Period|other reasons|0|||
44294257|NCT02017717|79283819|FG007|Treatment Period|other reasons|1|||
44294258|NCT02017717|79283820|FG008|Treatment Period|other reasons|1|||
44294259|NCT02017717|79283812|FG000|Treatment Period|Maximum clinical benefit|0|||
44294260|NCT02017717|79283813|FG001|Treatment Period|Maximum clinical benefit|0|||
44294261|NCT02017717|79283814|FG002|Treatment Period|Maximum clinical benefit|0|||
44294262|NCT02017717|79283815|FG003|Treatment Period|Maximum clinical benefit|0|||
44533949|NCT03954704|79544615|FG005|Overall Study|Withdrew Consent|1|||
44533950|NCT03954704|79544616|FG006|Overall Study|Withdrew Consent|0|||
44294263|NCT02017717|79283816|FG004|Treatment Period|Maximum clinical benefit|1|||
44294264|NCT02017717|79283817|FG005|Treatment Period|Maximum clinical benefit|0|||
44294265|NCT02017717|79283818|FG006|Treatment Period|Maximum clinical benefit|0|||
44294266|NCT02017717|79283819|FG007|Treatment Period|Maximum clinical benefit|0|||
44294267|NCT02017717|79283820|FG008|Treatment Period|Maximum clinical benefit|0|||
44294268|NCT01539863|79283846|FG000|Overall Study|Lost to Follow-up|5|||
44294269|NCT01539863|79283847|FG001|Overall Study|Lost to Follow-up|4|||
44294270|NCT00942331|79283855|FG000|Overall Study|Did not start treatment|15|||
44294271|NCT00942331|79283856|FG001|Overall Study|Did not start treatment|22|||
44294272|NCT00827372|79283862|FG000|Overall Study|Adverse Event|5|||
44294273|NCT00827372|79283862|FG000|Overall Study|Lack of Efficacy|3|||
44294274|NCT00590902|79283871|FG000|Overall Study|Death|1|||
44294275|NCT00577122|79283877|FG000|Overall Study|Adverse Event|0|||
44294276|NCT00577122|79283878|FG001|Overall Study|Adverse Event|2|||
44294277|NCT00577122|79283877|FG000|Overall Study|Progression, relapse during active trt|6|||
44294278|NCT00577122|79283878|FG001|Overall Study|Progression, relapse during active trt|8|||
44294279|NCT00577122|79283877|FG000|Overall Study|Prog, refract disease during active trt|8|||
44294280|NCT00577122|79283878|FG001|Overall Study|Prog, refract disease during active trt|5|||
44294281|NCT00577122|79283877|FG000|Overall Study|Alternative Therapy|0|||
44294282|NCT00577122|79283878|FG001|Overall Study|Alternative Therapy|1|||
44294283|NCT00419770|79283887|FG000|Overall Study|Withdrawal by Subject|5|||
44294284|NCT00419770|79283888|FG001|Overall Study|Withdrawal by Subject|1|||
44294285|NCT00129701|79283894|FG000|Overall Study|Withdrawal by Subject|33|||
44294286|NCT04521114|79289896|FG000|Overall Study|Lost to Follow-up|1|||
44294287|NCT04521114|79289897|FG001|Overall Study|Lost to Follow-up|2|||
44294288|NCT04521114|79289898|FG002|Overall Study|Lost to Follow-up|0|||
44294289|NCT04521114|79289896|FG000|Overall Study|Withdrawal by Subject|1|||
44294290|NCT04521114|79289897|FG001|Overall Study|Withdrawal by Subject|2|||
44294291|NCT04521114|79289898|FG002|Overall Study|Withdrawal by Subject|2|||
44294292|NCT04521114|79289896|FG000|Overall Study|Adverse Event|1|||
44294293|NCT04521114|79289897|FG001|Overall Study|Adverse Event|0|||
44294294|NCT04521114|79289898|FG002|Overall Study|Adverse Event|0|||
44294295|NCT04521114|79289896|FG000|Overall Study|Sponsor Wish|1|||
44294296|NCT04521114|79289897|FG001|Overall Study|Sponsor Wish|0|||
44294297|NCT04521114|79289898|FG002|Overall Study|Sponsor Wish|0|||
44294298|NCT04521114|79289896|FG000|Overall Study|Withdrawal of Consent|2|||
44294299|NCT04521114|79289897|FG001|Overall Study|Withdrawal of Consent|2|||
44294300|NCT04521114|79289898|FG002|Overall Study|Withdrawal of Consent|0|||
44294301|NCT04360824|79289920|FG000|Overall Study|Withdrawal by Subject|2|||
44294302|NCT04360824|79289921|FG001|Overall Study|Withdrawal by Subject|1|||
44294303|NCT04360824|79289920|FG000|Overall Study|Did not receive assigned treatment|1|||
44294304|NCT04360824|79289921|FG001|Overall Study|Did not receive assigned treatment|3|||
44294305|NCT03711786|79289930|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
44294306|NCT03711786|79289931|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
44294307|NCT03711786|79289930|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
44294308|NCT03711786|79289931|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
44294309|NCT03711786|79289930|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
44294310|NCT03711786|79289931|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
44294311|NCT03711786|79289930|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
44294312|NCT03711786|79289931|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
44294313|NCT03711786|79289930|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
44294314|NCT03711786|79289931|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
44294315|NCT03711786|79289930|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
44294316|NCT03711786|79289931|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
44294317|NCT03691974|79289941|FG000|Overall Study|Physician Decision|1|||
44294318|NCT03691974|79289942|FG001|Overall Study|Physician Decision|0|||
44294319|NCT03691974|79289941|FG000|Overall Study|Adverse Event|1|||
44294320|NCT03691974|79289942|FG001|Overall Study|Adverse Event|0|||
44294321|NCT03691974|79289941|FG000|Overall Study|Withdrawal by Subject|11|||
44294322|NCT03691974|79289942|FG001|Overall Study|Withdrawal by Subject|9|||
44294323|NCT03691974|79289941|FG000|Overall Study|Protocol Violation|1|||
44294324|NCT03691974|79289942|FG001|Overall Study|Protocol Violation|0|||
44294325|NCT03691974|79289941|FG000|Overall Study|Lost to Follow-up|8|||
44294326|NCT03691974|79289942|FG001|Overall Study|Lost to Follow-up|7|||
44154610|NCT03805841|78945912|FG001|Overall Study|Death|3|||
44256246|NCT01466270|79104060|FG000|Overall Study|Withdrawal by Subject|4|||
44256247|NCT01466270|79104061|FG001|Overall Study|Withdrawal by Subject|1|||
44256248|NCT01466270|79104060|FG000|Overall Study|Physician Decision|1|||
44256249|NCT01466270|79104061|FG001|Overall Study|Physician Decision|0|||
44256250|NCT01466270|79104060|FG000|Overall Study|Lost to Follow-up|1|||
44256251|NCT01466270|79104061|FG001|Overall Study|Lost to Follow-up|3|||
44256252|NCT01466270|79104060|FG000|Overall Study|Progression|1|||
44256253|NCT01466270|79104061|FG001|Overall Study|Progression|0|||
44256254|NCT01466270|79104060|FG000|Overall Study|Toxicity|4|||
44256255|NCT01466270|79104061|FG001|Overall Study|Toxicity|1|||
44256256|NCT01466270|79104060|FG000|Overall Study|Multiple|1|||
44256257|NCT01466270|79104061|FG001|Overall Study|Multiple|1|||
44256258|NCT01466192|79104094|FG000|Overall Study|Physician Decision|1|||
44256259|NCT01466192|79104094|FG000|Overall Study|Withdrawal by Subject|3|||
44256260|NCT01438814|79104114|FG000|Overall Study|Adverse Event|3|||
44256261|NCT01438814|79104115|FG001|Overall Study|Adverse Event|3|||
44256262|NCT01438814|79104114|FG000|Overall Study|Protocol Violation|1|||
44294327|NCT02454972|79289969|FG000|Overall Study|Progressive disease|17|||
44294328|NCT02454972|79289970|FG001|Overall Study|Progressive disease|16|||
44154611|NCT03805841|78945913|FG002|Overall Study|Death|1|||
44256263|NCT01438814|79104115|FG001|Overall Study|Protocol Violation|2|||
44256264|NCT01438814|79104114|FG000|Overall Study|Lost to Follow-up|4|||
44256265|NCT01438814|79104115|FG001|Overall Study|Lost to Follow-up|3|||
44256266|NCT01438814|79104114|FG000|Overall Study|Withdrawal by Subject|4|||
44256267|NCT01438814|79104115|FG001|Overall Study|Withdrawal by Subject|2|||
44294329|NCT02454972|79289971|FG002|Overall Study|Progressive disease|59|||
44294330|NCT02454972|79289972|FG003|Overall Study|Progressive disease|23|||
44294331|NCT02454972|79289973|FG004|Overall Study|Progressive disease|16|||
44294332|NCT02454972|79289974|FG005|Overall Study|Progressive disease|12|||
44294333|NCT02454972|79289975|FG006|Overall Study|Progressive disease|19|||
44294334|NCT02454972|79289976|FG007|Overall Study|Progressive disease|27|||
44294335|NCT02454972|79289977|FG008|Overall Study|Progressive disease|0|||
44294336|NCT02454972|79289969|FG000|Overall Study|Death|0|||
44294337|NCT02454972|79289970|FG001|Overall Study|Death|0|||
44294338|NCT02454972|79289971|FG002|Overall Study|Death|5|||
44294339|NCT02454972|79289972|FG003|Overall Study|Death|1|||
44416849|NCT00838565|79424687|FG001|Overall Study|Withdrawal by Subject|0|||
44416850|NCT00838565|79424688|FG002|Overall Study|Withdrawal by Subject|1|||
44416851|NCT00838565|79424689|FG003|Overall Study|Withdrawal by Subject|0|||
44416852|NCT00838565|79424690|FG004|Overall Study|Withdrawal by Subject|0|||
44416853|NCT00838565|79424691|FG005|Overall Study|Withdrawal by Subject|2|||
44416854|NCT00838565|79424686|FG000|Overall Study|Other|0|||
44416855|NCT00838565|79424687|FG001|Overall Study|Other|2|||
44416856|NCT00838565|79424688|FG002|Overall Study|Other|0|||
44416857|NCT00838565|79424689|FG003|Overall Study|Other|0|||
44416858|NCT00838565|79424690|FG004|Overall Study|Other|0|||
44416859|NCT00838565|79424691|FG005|Overall Study|Other|0|||
44416860|NCT00838565|79424686|FG000|Overall Study|Randomized but not Treated|0|||
44416861|NCT00838565|79424687|FG001|Overall Study|Randomized but not Treated|1|||
44416862|NCT00838565|79424688|FG002|Overall Study|Randomized but not Treated|0|||
44416863|NCT00838565|79424689|FG003|Overall Study|Randomized but not Treated|0|||
44416864|NCT00838565|79424690|FG004|Overall Study|Randomized but not Treated|0|||
44416865|NCT00838565|79424691|FG005|Overall Study|Randomized but not Treated|0|||
44416866|NCT00858845|79424712|FG000|Overall Study|Patient underwent heart transplant.|0|||
44416867|NCT00858845|79424713|FG001|Overall Study|Patient underwent heart transplant.|1|||
44416868|NCT00770562|79424721|FG000|Overall Study|Did not take treatment|1|||
44416869|NCT00770562|79424722|FG001|Overall Study|Did not take treatment|1|||
44416870|NCT00836693|79424731|FG000|Overall Study|Adverse Event|4|||
44416871|NCT00836693|79424732|FG001|Overall Study|Adverse Event|1|||
44416872|NCT00836693|79424731|FG000|Overall Study|Sponsor Decision|0|||
44416873|NCT00836693|79424732|FG001|Overall Study|Sponsor Decision|1|||
44416874|NCT00836693|79424731|FG000|Overall Study|Physician Decision|2|||
44416875|NCT00836693|79424732|FG001|Overall Study|Physician Decision|0|||
44416876|NCT00836693|79424731|FG000|Overall Study|Withdrawal by Subject|9|||
44533951|NCT03954704|79544610|FG000|Overall Study|Lost to Follow-up|0|||
44533952|NCT03954704|79544611|FG001|Overall Study|Lost to Follow-up|0|||
44533953|NCT03954704|79544612|FG002|Overall Study|Lost to Follow-up|0|||
44533954|NCT03954704|79544613|FG003|Overall Study|Lost to Follow-up|0|||
44533955|NCT03954704|79544614|FG004|Overall Study|Lost to Follow-up|0|||
44533956|NCT03954704|79544615|FG005|Overall Study|Lost to Follow-up|0|||
44533957|NCT03954704|79544616|FG006|Overall Study|Lost to Follow-up|1|||
44533958|NCT03954704|79544610|FG000|Overall Study|Study Terminated by Sponsor|0|||
44533959|NCT03954704|79544611|FG001|Overall Study|Study Terminated by Sponsor|0|||
44533960|NCT03954704|79544612|FG002|Overall Study|Study Terminated by Sponsor|1|||
44533961|NCT03954704|79544613|FG003|Overall Study|Study Terminated by Sponsor|0|||
44533962|NCT03954704|79544614|FG004|Overall Study|Study Terminated by Sponsor|1|||
44533963|NCT03954704|79544615|FG005|Overall Study|Study Terminated by Sponsor|4|||
44533964|NCT03954704|79544616|FG006|Overall Study|Study Terminated by Sponsor|2|||
44533965|NCT03954704|79544610|FG000|Overall Study|Enrolled but not Treated|0|||
44416877|NCT00836693|79424732|FG001|Overall Study|Withdrawal by Subject|4|||
44416878|NCT00836693|79424731|FG000|Overall Study|Protocol Violation|1|||
44416879|NCT00836693|79424732|FG001|Overall Study|Protocol Violation|0|||
44416880|NCT00836693|79424731|FG000|Overall Study|Lost to Follow-up|1|||
44416881|NCT00836693|79424732|FG001|Overall Study|Lost to Follow-up|0|||
44416882|NCT00770484|79424740|FG000|Overall Study|Withdrawal by Subject|1|||
44416883|NCT00770484|79424741|FG001|Overall Study|Withdrawal by Subject|0|||
44416884|NCT00835679|79424751|FG000|Overall Study|Withdrawal by Subject|1|||
44416885|NCT00835679|79424752|FG001|Overall Study|Withdrawal by Subject|0|||
44416886|NCT00835679|79424753|FG002|Overall Study|Withdrawal by Subject|0|||
44416887|NCT00835679|79424754|FG003|Overall Study|Withdrawal by Subject|0|||
44533966|NCT03954704|79544611|FG001|Overall Study|Enrolled but not Treated|0|||
44533967|NCT03954704|79544612|FG002|Overall Study|Enrolled but not Treated|0|||
44533968|NCT03954704|79544613|FG003|Overall Study|Enrolled but not Treated|0|||
44533969|NCT03954704|79544614|FG004|Overall Study|Enrolled but not Treated|0|||
44294340|NCT02454972|79289973|FG004|Overall Study|Death|0|||
44294341|NCT02454972|79289974|FG005|Overall Study|Death|0|||
44416888|NCT00766506|79424770|FG000|Overall Study|Use rescue medication after 3 hours|3|||
44416889|NCT00766506|79424771|FG001|Overall Study|Use rescue medication after 3 hours|0|||
44416890|NCT00766506|79424770|FG000|Overall Study|Other|2|||
44294342|NCT02454972|79289975|FG006|Overall Study|Death|0|||
44294343|NCT02454972|79289976|FG007|Overall Study|Death|0|||
44294344|NCT02454972|79289977|FG008|Overall Study|Death|95|||
44416891|NCT00766506|79424771|FG001|Overall Study|Other|2|||
44533970|NCT03954704|79544615|FG005|Overall Study|Enrolled but not Treated|1|||
44294345|NCT02454972|79289969|FG000|Overall Study|Physician Decision|0|||
44294346|NCT02454972|79289970|FG001|Overall Study|Physician Decision|1|||
44294347|NCT02454972|79289971|FG002|Overall Study|Physician Decision|2|||
44294348|NCT02454972|79289972|FG003|Overall Study|Physician Decision|1|||
44294349|NCT02454972|79289973|FG004|Overall Study|Physician Decision|2|||
44294350|NCT02454972|79289974|FG005|Overall Study|Physician Decision|0|||
44294351|NCT02454972|79289975|FG006|Overall Study|Physician Decision|0|||
44294352|NCT02454972|79289976|FG007|Overall Study|Physician Decision|1|||
44294353|NCT02454972|79289977|FG008|Overall Study|Physician Decision|0|||
44294354|NCT02454972|79289969|FG000|Overall Study|Non treatment-related adverse event|2|||
44294355|NCT02454972|79289970|FG001|Overall Study|Non treatment-related adverse event|0|||
44294356|NCT02454972|79289971|FG002|Overall Study|Non treatment-related adverse event|1|||
44294357|NCT02454972|79289972|FG003|Overall Study|Non treatment-related adverse event|0|||
44294358|NCT02454972|79289973|FG004|Overall Study|Non treatment-related adverse event|0|||
44294359|NCT02454972|79289974|FG005|Overall Study|Non treatment-related adverse event|1|||
44294360|NCT02454972|79289975|FG006|Overall Study|Non treatment-related adverse event|0|||
44294361|NCT02454972|79289976|FG007|Overall Study|Non treatment-related adverse event|1|||
44294362|NCT02454972|79289977|FG008|Overall Study|Non treatment-related adverse event|0|||
44294363|NCT02454972|79289969|FG000|Overall Study|Treatment-related adverse events|0|||
44294364|NCT02454972|79289970|FG001|Overall Study|Treatment-related adverse events|1|||
44294365|NCT02454972|79289971|FG002|Overall Study|Treatment-related adverse events|1|||
44294366|NCT02454972|79289972|FG003|Overall Study|Treatment-related adverse events|0|||
44294367|NCT02454972|79289973|FG004|Overall Study|Treatment-related adverse events|2|||
44294368|NCT02454972|79289974|FG005|Overall Study|Treatment-related adverse events|0|||
44294369|NCT02454972|79289975|FG006|Overall Study|Treatment-related adverse events|0|||
44294370|NCT02454972|79289976|FG007|Overall Study|Treatment-related adverse events|2|||
44294371|NCT02454972|79289977|FG008|Overall Study|Treatment-related adverse events|0|||
44294372|NCT02454972|79289969|FG000|Overall Study|Patient moves to compassionate use|0|||
44294373|NCT02454972|79289970|FG001|Overall Study|Patient moves to compassionate use|0|||
44294374|NCT02454972|79289971|FG002|Overall Study|Patient moves to compassionate use|0|||
44294375|NCT02454972|79289972|FG003|Overall Study|Patient moves to compassionate use|0|||
44294376|NCT02454972|79289973|FG004|Overall Study|Patient moves to compassionate use|0|||
44294377|NCT02454972|79289974|FG005|Overall Study|Patient moves to compassionate use|0|||
44294378|NCT02454972|79289975|FG006|Overall Study|Patient moves to compassionate use|2|||
44294379|NCT02454972|79289976|FG007|Overall Study|Patient moves to compassionate use|0|||
44294380|NCT02454972|79289977|FG008|Overall Study|Patient moves to compassionate use|0|||
44294381|NCT02454972|79289969|FG000|Overall Study|Withdrawal by Subject|0|||
44294382|NCT02454972|79289970|FG001|Overall Study|Withdrawal by Subject|1|||
44294383|NCT02454972|79289971|FG002|Overall Study|Withdrawal by Subject|5|||
44294384|NCT02454972|79289972|FG003|Overall Study|Withdrawal by Subject|2|||
44294385|NCT02454972|79289973|FG004|Overall Study|Withdrawal by Subject|3|||
44294386|NCT02454972|79289974|FG005|Overall Study|Withdrawal by Subject|2|||
44294387|NCT02454972|79289975|FG006|Overall Study|Withdrawal by Subject|0|||
44294388|NCT02454972|79289976|FG007|Overall Study|Withdrawal by Subject|1|||
44294389|NCT02454972|79289977|FG008|Overall Study|Withdrawal by Subject|2|||
44294390|NCT02454972|79289969|FG000|Overall Study|Multiple delay/holds on treatment|0|||
44294391|NCT02454972|79289970|FG001|Overall Study|Multiple delay/holds on treatment|0|||
44294392|NCT02454972|79289971|FG002|Overall Study|Multiple delay/holds on treatment|0|||
44294393|NCT02454972|79289972|FG003|Overall Study|Multiple delay/holds on treatment|1|||
44294394|NCT02454972|79289973|FG004|Overall Study|Multiple delay/holds on treatment|0|||
44294395|NCT02454972|79289974|FG005|Overall Study|Multiple delay/holds on treatment|0|||
44294396|NCT02454972|79289975|FG006|Overall Study|Multiple delay/holds on treatment|0|||
44294397|NCT02454972|79289976|FG007|Overall Study|Multiple delay/holds on treatment|0|||
44294398|NCT02454972|79289977|FG008|Overall Study|Multiple delay/holds on treatment|0|||
44154612|NCT03805841|78945911|FG000|Overall Study|Lost to Follow-up|0|||
44154613|NCT03805841|78945912|FG001|Overall Study|Lost to Follow-up|0|||
44154614|NCT03805841|78945913|FG002|Overall Study|Lost to Follow-up|1|||
44154615|NCT03805841|78945911|FG000|Overall Study|Withdrawal by Subject|2|||
44533971|NCT03954704|79544616|FG006|Overall Study|Enrolled but not Treated|0|||
44533972|NCT03653390|79544657|FG000|Overall Study|Lost to Follow-up|12|||
44154616|NCT03805841|78945912|FG001|Overall Study|Withdrawal by Subject|3|||
44154617|NCT03805841|78945913|FG002|Overall Study|Withdrawal by Subject|0|||
44533973|NCT03653390|79544658|FG001|Overall Study|Lost to Follow-up|8|||
44533974|NCT03653390|79544659|FG002|Overall Study|Lost to Follow-up|7|||
44294399|NCT02454972|79289969|FG000|Overall Study|Never treated|0|||
44294400|NCT02454972|79289970|FG001|Overall Study|Never treated|0|||
44294401|NCT02454972|79289971|FG002|Overall Study|Never treated|3|||
44294402|NCT02454972|79289972|FG003|Overall Study|Never treated|1|||
44294403|NCT02454972|79289973|FG004|Overall Study|Never treated|1|||
44294404|NCT02454972|79289974|FG005|Overall Study|Never treated|0|||
44294405|NCT02454972|79289975|FG006|Overall Study|Never treated|0|||
44294406|NCT02454972|79289976|FG007|Overall Study|Never treated|0|||
44533975|NCT03653390|79544657|FG000|Overall Study|Withdrawal by Subject|6|||
44167843|NCT02528357|78961054|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44294407|NCT02454972|79289977|FG008|Overall Study|Never treated|5|||
44294408|NCT02454972|79289969|FG000|Overall Study|Lost to Follow-up|0|||
44294409|NCT02454972|79289970|FG001|Overall Study|Lost to Follow-up|0|||
44294410|NCT02454972|79289971|FG002|Overall Study|Lost to Follow-up|0|||
44294411|NCT02454972|79289972|FG003|Overall Study|Lost to Follow-up|0|||
44294412|NCT02454972|79289973|FG004|Overall Study|Lost to Follow-up|0|||
44294413|NCT02454972|79289974|FG005|Overall Study|Lost to Follow-up|0|||
44294414|NCT02454972|79289975|FG006|Overall Study|Lost to Follow-up|0|||
44294415|NCT02454972|79289976|FG007|Overall Study|Lost to Follow-up|0|||
44294416|NCT02454972|79289977|FG008|Overall Study|Lost to Follow-up|2|||
44294417|NCT02454972|79289969|FG000|Overall Study|Study termination|0|||
44294418|NCT02454972|79289970|FG001|Overall Study|Study termination|0|||
44294419|NCT02454972|79289971|FG002|Overall Study|Study termination|0|||
44294420|NCT02454972|79289972|FG003|Overall Study|Study termination|0|||
44294421|NCT02454972|79289973|FG004|Overall Study|Study termination|0|||
44294422|NCT02454972|79289974|FG005|Overall Study|Study termination|0|||
44294423|NCT02454972|79289975|FG006|Overall Study|Study termination|0|||
44294424|NCT02454972|79289976|FG007|Overall Study|Study termination|0|||
44294425|NCT02454972|79289977|FG008|Overall Study|Study termination|6|||
44294426|NCT00063882|79289995|FG000|Overall Study|Protocol Violation|3|||
44294427|NCT00063882|79289996|FG001|Overall Study|Protocol Violation|3|||
44294428|NCT00063882|79289995|FG000|Overall Study|Withdrawal by Subject|2|||
44294429|NCT00063882|79289996|FG001|Overall Study|Withdrawal by Subject|1|||
44294430|NCT01279044|79290005|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
44294431|NCT01279044|79290006|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
44294432|NCT01279044|79290007|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
44294433|NCT01279044|79290005|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
44294434|NCT01279044|79290006|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
44294435|NCT01279044|79290007|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
44294436|NCT01279044|79290005|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
44294437|NCT01279044|79290006|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
44294438|NCT01279044|79290007|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
44294439|NCT01278342|79290016|FG000|Overall Study|Physician Decision|0|||
44294440|NCT01278342|79290017|FG001|Overall Study|Physician Decision|1|||
44294441|NCT01278342|79290018|FG002|Overall Study|Physician Decision|0|||
44294442|NCT01278342|79290016|FG000|Overall Study|Lost to Follow-up|1|||
44294443|NCT01278342|79290017|FG001|Overall Study|Lost to Follow-up|0|||
44294444|NCT01278342|79290018|FG002|Overall Study|Lost to Follow-up|0|||
44294445|NCT01278342|79290016|FG000|Overall Study|Administrative problems|2|||
44294446|NCT01278342|79290017|FG001|Overall Study|Administrative problems|0|||
44294447|NCT01278342|79290018|FG002|Overall Study|Administrative problems|0|||
44294448|NCT01278342|79290016|FG000|Overall Study|Other|1|||
44294449|NCT01278342|79290017|FG001|Overall Study|Other|0|||
44294450|NCT01278342|79290018|FG002|Overall Study|Other|0|||
44294451|NCT01278030|79290028|FG000|Overall Study|Withdrawal by Subject|8|||
44294452|NCT01278030|79290029|FG001|Overall Study|Withdrawal by Subject|4|||
44294453|NCT01277718|79290035|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
44294454|NCT01277718|79290036|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
44294455|NCT01277718|79290035|FG000|Period 2 - Second Intervention|Physician Decision|0|||
44294456|NCT01277718|79290036|FG001|Period 2 - Second Intervention|Physician Decision|2|||
44294457|NCT01276236|79290044|FG000|Overall Study|Lack of Efficacy|2|||
44294458|NCT01276236|79290044|FG000|Overall Study|Withdrawal by Subject|4|||
44294459|NCT01275222|79290054|FG000|Phase l by Treatment|Adverse Event|1|||
44294460|NCT01275222|79290055|FG001|Phase l by Treatment|Adverse Event|4|||
44294461|NCT01275222|79290056|FG002|Phase l by Treatment|Adverse Event|2|||
44294462|NCT01275222|79290057|FG003|Phase l by Treatment|Adverse Event|3|||
44294463|NCT01275222|79290058|FG004|Phase l by Treatment|Adverse Event|0|||
44294464|NCT01275222|79290059|FG005|Phase l by Treatment|Adverse Event|0|||
44294465|NCT01275222|79290054|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
44294466|NCT01275222|79290055|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
44533976|NCT03653390|79544658|FG001|Overall Study|Withdrawal by Subject|1|||
44294467|NCT01275222|79290056|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
44533977|NCT03653390|79544659|FG002|Overall Study|Withdrawal by Subject|1|||
44294468|NCT01275222|79290057|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
44294469|NCT01275222|79290058|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
44294470|NCT01275222|79290059|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
44294471|NCT01275222|79290054|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
44294472|NCT01275222|79290055|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
44294473|NCT01275222|79290056|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
44294474|NCT01275222|79290057|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
44294475|NCT01275222|79290058|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
44294476|NCT01275222|79290059|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
44294477|NCT01275222|79290054|FG000|Phase l by Treatment|Disease progression|12|||
44294478|NCT01275222|79290055|FG001|Phase l by Treatment|Disease progression|8|||
44294479|NCT01275222|79290056|FG002|Phase l by Treatment|Disease progression|2|||
44294480|NCT01275222|79290057|FG003|Phase l by Treatment|Disease progression|5|||
44294481|NCT01275222|79290058|FG004|Phase l by Treatment|Disease progression|0|||
44294482|NCT01275222|79290059|FG005|Phase l by Treatment|Disease progression|0|||
44294483|NCT01275222|79290054|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
44294484|NCT01275222|79290055|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
44294485|NCT01275222|79290056|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
44294486|NCT01275222|79290057|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
44294487|NCT01275222|79290058|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
44294488|NCT01275222|79290059|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
44294489|NCT01275222|79290054|FG000|Phase l by Treatment|Death|0|||
44294490|NCT01275222|79290055|FG001|Phase l by Treatment|Death|1|||
44294491|NCT01275222|79290056|FG002|Phase l by Treatment|Death|0|||
44294492|NCT01275222|79290057|FG003|Phase l by Treatment|Death|1|||
44294493|NCT01275222|79290058|FG004|Phase l by Treatment|Death|0|||
44294494|NCT01275222|79290059|FG005|Phase l by Treatment|Death|0|||
44294495|NCT01275222|79290054|FG000|Phase ll by Stratum|Adverse Event|0|||
44294496|NCT01275222|79290055|FG001|Phase ll by Stratum|Adverse Event|0|||
44294497|NCT01275222|79290056|FG002|Phase ll by Stratum|Adverse Event|0|||
44294498|NCT01275222|79290057|FG003|Phase ll by Stratum|Adverse Event|0|||
44294499|NCT01275222|79290058|FG004|Phase ll by Stratum|Adverse Event|2|||
44294500|NCT01275222|79290059|FG005|Phase ll by Stratum|Adverse Event|10|||
44294501|NCT01275222|79290054|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
44294502|NCT01275222|79290055|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
44294503|NCT01275222|79290056|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
44294504|NCT01275222|79290057|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
44294505|NCT01275222|79290058|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
44294506|NCT01275222|79290059|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
44294507|NCT01275222|79290054|FG000|Phase ll by Stratum|Disease progression|0|||
44294508|NCT01275222|79290055|FG001|Phase ll by Stratum|Disease progression|0|||
44294509|NCT01275222|79290056|FG002|Phase ll by Stratum|Disease progression|0|||
44294510|NCT01275222|79290057|FG003|Phase ll by Stratum|Disease progression|0|||
44294511|NCT01275222|79290058|FG004|Phase ll by Stratum|Disease progression|23|||
44294512|NCT01275222|79290059|FG005|Phase ll by Stratum|Disease progression|31|||
44294513|NCT01275222|79290054|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
44294514|NCT01275222|79290055|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
44294515|NCT01275222|79290056|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
44294516|NCT01275222|79290057|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
44294517|NCT01275222|79290058|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
44294518|NCT01275222|79290059|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
44294519|NCT01275222|79290054|FG000|Phase ll by Stratum|Death|0|||
44294520|NCT01275222|79290055|FG001|Phase ll by Stratum|Death|0|||
44294521|NCT01275222|79290056|FG002|Phase ll by Stratum|Death|0|||
44294522|NCT01275222|79290057|FG003|Phase ll by Stratum|Death|0|||
44294523|NCT01275222|79290058|FG004|Phase ll by Stratum|Death|1|||
44294524|NCT01275222|79290059|FG005|Phase ll by Stratum|Death|1|||
44294525|NCT01275144|79290077|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
44294526|NCT01275144|79290078|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
44294527|NCT01275066|79290089|FG000|Overall Study|Withdrawal by Subject|0|||
44294528|NCT01275066|79290090|FG001|Overall Study|Withdrawal by Subject|0|||
44294529|NCT01275066|79290091|FG002|Overall Study|Withdrawal by Subject|1|||
44294530|NCT01275066|79290089|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
44294531|NCT01275066|79290090|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
44294532|NCT01275066|79290091|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
44294533|NCT01273038|79290101|FG000|Second Intervention (14 Days)|Adverse Event|0|||
44294534|NCT01273038|79290102|FG001|Second Intervention (14 Days)|Adverse Event|1|||
44294535|NCT01273038|79290101|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
44294536|NCT01273038|79290102|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
44294537|NCT01272180|79290112|FG000|Overall Study|Adverse Event|0|||
44294538|NCT01272180|79290113|FG001|Overall Study|Adverse Event|0|||
44294539|NCT01272180|79290114|FG002|Overall Study|Adverse Event|1|||
44294540|NCT01272180|79290115|FG003|Overall Study|Adverse Event|0|||
44533978|NCT03653390|79544657|FG000|Overall Study|Death|1|||
44154618|NCT03805841|78945911|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
44167844|NCT02528357|78961055|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
44294541|NCT01272180|79290112|FG000|Overall Study|Withdrawal by Subject|2|||
44294542|NCT01272180|79290113|FG001|Overall Study|Withdrawal by Subject|6|||
44294543|NCT01272180|79290114|FG002|Overall Study|Withdrawal by Subject|3|||
44294544|NCT01272180|79290115|FG003|Overall Study|Withdrawal by Subject|2|||
44294545|NCT01272180|79290112|FG000|Overall Study|Lost to Follow-up|15|||
44294546|NCT01272180|79290113|FG001|Overall Study|Lost to Follow-up|14|||
44294547|NCT01272180|79290114|FG002|Overall Study|Lost to Follow-up|8|||
44294548|NCT01272180|79290115|FG003|Overall Study|Lost to Follow-up|10|||
44294549|NCT01272180|79290112|FG000|Overall Study|Inappropriate enrollment|0|||
44294550|NCT01272180|79290113|FG001|Overall Study|Inappropriate enrollment|0|||
44294551|NCT01272180|79290114|FG002|Overall Study|Inappropriate enrollment|1|||
44533979|NCT03653390|79544658|FG001|Overall Study|Death|0|||
44294552|NCT01272180|79290115|FG003|Overall Study|Inappropriate enrollment|1|||
44294553|NCT01272180|79290112|FG000|Overall Study|Protocol Violation|0|||
44294554|NCT01272180|79290113|FG001|Overall Study|Protocol Violation|1|||
44294555|NCT01272180|79290114|FG002|Overall Study|Protocol Violation|0|||
44294556|NCT01272180|79290115|FG003|Overall Study|Protocol Violation|1|||
44294557|NCT01271712|79290131|FG000|Double Blind Treatment|Death|2|||
44294558|NCT01271712|79290132|FG001|Double Blind Treatment|Death|0|||
44294559|NCT01271712|79290131|FG000|Double Blind Treatment|Lack of Efficacy|1|||
44294560|NCT01271712|79290132|FG001|Double Blind Treatment|Lack of Efficacy|0|||
44294561|NCT01271712|79290131|FG000|Double Blind Treatment|Adverse Event|9|||
44294562|NCT01271712|79290132|FG001|Double Blind Treatment|Adverse Event|4|||
44294563|NCT01271712|79290131|FG000|Double Blind Treatment|Progressive disease|23|||
44294564|NCT01271712|79290132|FG001|Double Blind Treatment|Progressive disease|3|||
44294565|NCT01271712|79290131|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
44294566|NCT01271712|79290132|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
44294567|NCT01271712|79290131|FG000|Double Blind Treatment|Non compliance with study drug|2|||
44294568|NCT01271712|79290132|FG001|Double Blind Treatment|Non compliance with study drug|0|||
44294569|NCT01271712|79290131|FG000|Double Blind Treatment|receive no study drug|1|||
44294570|NCT01271712|79290132|FG001|Double Blind Treatment|receive no study drug|0|||
44294571|NCT01271712|79290131|FG000|Open Label Treatment|Death|6|||
44294572|NCT01271712|79290132|FG001|Open Label Treatment|Death|5|||
44294573|NCT01271712|79290131|FG000|Open Label Treatment|Withdrawal by Subject|6|||
44294574|NCT01271712|79290132|FG001|Open Label Treatment|Withdrawal by Subject|11|||
44294575|NCT01271712|79290131|FG000|Open Label Treatment|Physician Decision|2|||
44294576|NCT01271712|79290132|FG001|Open Label Treatment|Physician Decision|0|||
44294577|NCT01271712|79290131|FG000|Open Label Treatment|Adverse Event|14|||
44294578|NCT01271712|79290132|FG001|Open Label Treatment|Adverse Event|8|||
44294579|NCT01271712|79290131|FG000|Open Label Treatment|Progressive disease|59|||
44294580|NCT01271712|79290132|FG001|Open Label Treatment|Progressive disease|32|||
44294581|NCT01271712|79290131|FG000|Open Label Treatment|transferred to rollover study|1|||
44294582|NCT01271712|79290132|FG001|Open Label Treatment|transferred to rollover study|0|||
44294583|NCT01271712|79290131|FG000|Open Label Treatment|Non-compliance with study drug|1|||
44294584|NCT01271712|79290132|FG001|Open Label Treatment|Non-compliance with study drug|0|||
44294585|NCT01271712|79290131|FG000|Open Label Treatment|Protocol Violation|0|||
44294586|NCT01271712|79290132|FG001|Open Label Treatment|Protocol Violation|1|||
44294587|NCT01271712|79290131|FG000|Open Label Treatment|Switching to other therapy|2|||
44294588|NCT01271712|79290132|FG001|Open Label Treatment|Switching to other therapy|1|||
44294589|NCT01271712|79290131|FG000|Safety Follow-up|Death|11|||
44294590|NCT01271712|79290132|FG001|Safety Follow-up|Death|7|||
44294591|NCT01271712|79290131|FG000|Safety Follow-up|Withdrawal by Subject|4|||
44294592|NCT01271712|79290132|FG001|Safety Follow-up|Withdrawal by Subject|2|||
44294593|NCT01271712|79290131|FG000|Safety Follow-up|Protocol Violation|1|||
44294594|NCT01271712|79290132|FG001|Safety Follow-up|Protocol Violation|1|||
44294595|NCT01271712|79290131|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
44294596|NCT01271712|79290132|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
44294597|NCT01271712|79290131|FG000|Safety Follow-up|No follow-up|1|||
44294598|NCT01271712|79290132|FG001|Safety Follow-up|No follow-up|1|||
44294599|NCT01271712|79290131|FG000|Safety Follow-up|Progressive disease|1|||
44294600|NCT01271712|79290132|FG001|Safety Follow-up|Progressive disease|0|||
44294601|NCT01271712|79290131|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
44294602|NCT01271712|79290132|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
44294603|NCT01271010|79290141|FG000|Overall Study|Reason not specified|11|||
44294604|NCT01271010|79290141|FG000|Overall Study|Start of new CLL therapy|1|||
44294605|NCT01271010|79290141|FG000|Overall Study|Protocol Violation|1|||
44294606|NCT01271010|79290141|FG000|Overall Study|Death|2|||
44294607|NCT01271010|79290141|FG000|Overall Study|Progression and relapse of disease|1|||
44294608|NCT01271010|79290141|FG000|Overall Study|Withdrawal by Subject|18|||
44294609|NCT01271010|79290141|FG000|Overall Study|Disease progression|27|||
44294610|NCT01270620|79290147|FG000|Overall Study|Withdrawal by Subject|1|||
44294611|NCT01270620|79290148|FG001|Overall Study|Withdrawal by Subject|3|||
44294612|NCT01270464|79290163|FG000|Overall Study|Protocol Violation|4|||
44294613|NCT01270464|79290164|FG001|Overall Study|Protocol Violation|3|||
44294614|NCT01270464|79290165|FG002|Overall Study|Protocol Violation|2|||
44294615|NCT01270464|79290163|FG000|Overall Study|Lack of Efficacy|2|||
44294616|NCT01270464|79290164|FG001|Overall Study|Lack of Efficacy|3|||
44294617|NCT01270464|79290165|FG002|Overall Study|Lack of Efficacy|1|||
44294618|NCT01270464|79290163|FG000|Overall Study|Adverse Event|9|||
44294619|NCT01270464|79290164|FG001|Overall Study|Adverse Event|1|||
44294620|NCT01270464|79290165|FG002|Overall Study|Adverse Event|7|||
44294621|NCT01270464|79290163|FG000|Overall Study|Withdrawal by Subject|2|||
44294622|NCT01270464|79290164|FG001|Overall Study|Withdrawal by Subject|1|||
44294623|NCT01270464|79290165|FG002|Overall Study|Withdrawal by Subject|4|||
44294624|NCT01270464|79290163|FG000|Overall Study|Lost to Follow-up|2|||
44294625|NCT01270464|79290164|FG001|Overall Study|Lost to Follow-up|3|||
44294626|NCT01270464|79290165|FG002|Overall Study|Lost to Follow-up|1|||
44294627|NCT01270464|79290163|FG000|Overall Study|Other|1|||
44294628|NCT01270464|79290164|FG001|Overall Study|Other|1|||
44294629|NCT01270464|79290165|FG002|Overall Study|Other|3|||
44294630|NCT00249834|79290181|FG000|Overall Study|Ovarian stimulation failed|1|||
44294631|NCT00249834|79290182|FG001|Overall Study|Ovarian stimulation failed|0|||
44294632|NCT00249834|79290183|FG002|Overall Study|Ovarian stimulation failed|0|||
44294633|NCT00249834|79290184|FG003|Overall Study|Ovarian stimulation failed|0|||
44294634|NCT00249834|79290185|FG004|Overall Study|Ovarian stimulation failed|0|||
44294635|NCT00249834|79290186|FG005|Overall Study|Ovarian stimulation failed|0|||
44294636|NCT00249834|79290187|FG006|Overall Study|Ovarian stimulation failed|0|||
44294637|NCT00249834|79290188|FG007|Overall Study|Ovarian stimulation failed|0|||
44294638|NCT00249834|79290181|FG000|Overall Study|Failure of down-regulation|0|||
44294639|NCT00249834|79290182|FG001|Overall Study|Failure of down-regulation|0|||
44294640|NCT00249834|79290183|FG002|Overall Study|Failure of down-regulation|0|||
44294641|NCT00249834|79290184|FG003|Overall Study|Failure of down-regulation|0|||
44294642|NCT00249834|79290185|FG004|Overall Study|Failure of down-regulation|0|||
44294643|NCT00249834|79290186|FG005|Overall Study|Failure of down-regulation|0|||
44294644|NCT00249834|79290187|FG006|Overall Study|Failure of down-regulation|1|||
44294645|NCT00249834|79290188|FG007|Overall Study|Failure of down-regulation|0|||
44294646|NCT00249834|79290181|FG000|Overall Study|Protocol Violation|0|||
44294647|NCT00249834|79290182|FG001|Overall Study|Protocol Violation|19|||
44294648|NCT00249834|79290183|FG002|Overall Study|Protocol Violation|14|||
44294649|NCT00249834|79290184|FG003|Overall Study|Protocol Violation|8|||
44294650|NCT00249834|79290185|FG004|Overall Study|Protocol Violation|5|||
44294651|NCT00249834|79290186|FG005|Overall Study|Protocol Violation|2|||
44294652|NCT00249834|79290187|FG006|Overall Study|Protocol Violation|0|||
44294653|NCT00249834|79290188|FG007|Overall Study|Protocol Violation|0|||
44294654|NCT00249444|79290202|FG000|Overall Study|Lost to Follow-up|2|||
44294655|NCT00249444|79290203|FG001|Overall Study|Lost to Follow-up|2|||
44294656|NCT00249444|79290202|FG000|Overall Study|non-compliant|9|||
44294657|NCT00249444|79290203|FG001|Overall Study|non-compliant|11|||
44294658|NCT00249444|79290202|FG000|Overall Study|Adverse Event|1|||
44294659|NCT00249444|79290203|FG001|Overall Study|Adverse Event|1|||
44294660|NCT00249444|79290202|FG000|Overall Study|life event|0|||
44294661|NCT00249444|79290203|FG001|Overall Study|life event|1|||
44294662|NCT00249288|79290211|FG000|Overall Study|Lost to Follow-up|3|||
44294663|NCT00249288|79290212|FG001|Overall Study|Lost to Follow-up|3|||
44294664|NCT00249288|79290211|FG000|Overall Study|Withdrawal by Subject|2|||
44294665|NCT00249288|79290212|FG001|Overall Study|Withdrawal by Subject|2|||
44294666|NCT00247962|79290228|FG000|Overall Study|Adverse Event|15|||
44294667|NCT00247962|79290229|FG001|Overall Study|Adverse Event|12|||
44294668|NCT00247962|79290228|FG000|Overall Study|Lost to Follow-up|3|||
44294669|NCT00247962|79290229|FG001|Overall Study|Lost to Follow-up|1|||
44294670|NCT00247962|79290228|FG000|Overall Study|Physician Decision|0|||
44294671|NCT00247962|79290229|FG001|Overall Study|Physician Decision|1|||
44294672|NCT00247962|79290228|FG000|Overall Study|Protocol Violation|1|||
44294673|NCT00247962|79290229|FG001|Overall Study|Protocol Violation|1|||
44294674|NCT00247962|79290228|FG000|Overall Study|Withdrawal by Subject|3|||
44294675|NCT00247962|79290229|FG001|Overall Study|Withdrawal by Subject|2|||
44294676|NCT00247962|79290228|FG000|Overall Study|Lack of Efficacy|4|||
44294677|NCT00247962|79290229|FG001|Overall Study|Lack of Efficacy|2|||
44256268|NCT01438814|79104114|FG000|Overall Study|Other|2|||
44256269|NCT01438814|79104115|FG001|Overall Study|Other|4|||
44256270|NCT02926833|79104692|FG000|Overall Study|Full Consent Withdrawal|0|||
44256271|NCT02926833|79104693|FG001|Overall Study|Full Consent Withdrawal|0|||
44256272|NCT02926833|79104694|FG002|Overall Study|Full Consent Withdrawal|0|||
44256273|NCT02926833|79104695|FG003|Overall Study|Full Consent Withdrawal|2|||
44256274|NCT02926833|79104692|FG000|Overall Study|Death|1|||
44256275|NCT02926833|79104693|FG001|Overall Study|Death|1|||
44256276|NCT02926833|79104694|FG002|Overall Study|Death|1|||
44256277|NCT02926833|79104695|FG003|Overall Study|Death|7|||
44256278|NCT02926833|79104692|FG000|Overall Study|Still on study|2|||
44256279|NCT02926833|79104693|FG001|Overall Study|Still on study|3|||
44256280|NCT02926833|79104694|FG002|Overall Study|Still on study|5|||
44256281|NCT02926833|79104695|FG003|Overall Study|Still on study|14|||
44256282|NCT02926833|79104692|FG000|Overall Study|Adverse Event|0|||
44256283|NCT02926833|79104693|FG001|Overall Study|Adverse Event|0|||
44256284|NCT02926833|79104694|FG002|Overall Study|Adverse Event|1|||
44256285|NCT02926833|79104695|FG003|Overall Study|Adverse Event|0|||
44256286|NCT02851797|79104742|FG000|Overall Study|Withdrawal by Subject|4|||
44256287|NCT02851797|79104743|FG001|Overall Study|Withdrawal by Subject|2|||
44256288|NCT02851797|79104742|FG000|Overall Study|Adverse Event|3|||
44256289|NCT02851797|79104743|FG001|Overall Study|Adverse Event|0|||
44256290|NCT01666314|79104958|FG000|Overall Study|Adverse Event|3|||
44256291|NCT01666314|79104959|FG001|Overall Study|Adverse Event|13|||
44256292|NCT01666314|79104960|FG002|Overall Study|Adverse Event|7|||
44294678|NCT00247416|79290237|FG000|Overall Study|3 patients were found to be ineligible|1|||
44294679|NCT00247416|79290238|FG001|Overall Study|3 patients were found to be ineligible|2|||
44294680|NCT00246090|79290246|FG000|Overall Study|Adverse Event|25|||
44256293|NCT01666314|79104961|FG003|Overall Study|Adverse Event|7|||
44256294|NCT01666314|79104958|FG000|Overall Study|Progressive Disease|11|||
44256295|NCT01666314|79104959|FG001|Overall Study|Progressive Disease|9|||
44256296|NCT01666314|79104960|FG002|Overall Study|Progressive Disease|19|||
44256297|NCT01666314|79104961|FG003|Overall Study|Progressive Disease|20|||
44256298|NCT01666314|79104958|FG000|Overall Study|Symptomatic Deterioration|1|||
44256299|NCT01666314|79104959|FG001|Overall Study|Symptomatic Deterioration|0|||
44256300|NCT01666314|79104960|FG002|Overall Study|Symptomatic Deterioration|2|||
44294681|NCT00246090|79290246|FG000|Overall Study|Withdrawal by Subject|7|||
44294682|NCT00246090|79290246|FG000|Overall Study|Progressive Disease|212|||
44294683|NCT00246090|79290246|FG000|Overall Study|Clinical Progression|30|||
44294684|NCT00246090|79290246|FG000|Overall Study|Physician Decision|11|||
44294685|NCT00246090|79290246|FG000|Overall Study|Not Otherwise Specified|10|||
44294686|NCT00246012|79290259|FG000|Overall Study|Adverse Event|0|||
44294687|NCT00246012|79290260|FG001|Overall Study|Adverse Event|0|||
44294688|NCT00246012|79290261|FG002|Overall Study|Adverse Event|0|||
44294689|NCT00246012|79290262|FG003|Overall Study|Adverse Event|0|||
44294690|NCT00246012|79290263|FG004|Overall Study|Adverse Event|0|||
44294691|NCT00246012|79290264|FG005|Overall Study|Adverse Event|1|||
44294692|NCT00246012|79290265|FG006|Overall Study|Adverse Event|0|||
44294693|NCT00246012|79290266|FG007|Overall Study|Adverse Event|0|||
44294694|NCT00246012|79290267|FG008|Overall Study|Adverse Event|2|||
44294695|NCT00246012|79290259|FG000|Overall Study|Withdrawal by Subject|0|||
44294696|NCT00246012|79290260|FG001|Overall Study|Withdrawal by Subject|0|||
44294697|NCT00246012|79290261|FG002|Overall Study|Withdrawal by Subject|0|||
44294698|NCT00246012|79290262|FG003|Overall Study|Withdrawal by Subject|0|||
44294699|NCT00246012|79290263|FG004|Overall Study|Withdrawal by Subject|0|||
44294700|NCT00246012|79290264|FG005|Overall Study|Withdrawal by Subject|1|||
44294701|NCT00246012|79290265|FG006|Overall Study|Withdrawal by Subject|0|||
44294702|NCT00246012|79290266|FG007|Overall Study|Withdrawal by Subject|0|||
44294703|NCT00246012|79290267|FG008|Overall Study|Withdrawal by Subject|0|||
44294704|NCT00246012|79290259|FG000|Overall Study|Disease progression|3|||
44294705|NCT00246012|79290260|FG001|Overall Study|Disease progression|1|||
44294706|NCT00246012|79290261|FG002|Overall Study|Disease progression|2|||
44294707|NCT00246012|79290262|FG003|Overall Study|Disease progression|3|||
44294708|NCT00246012|79290263|FG004|Overall Study|Disease progression|3|||
44294709|NCT00246012|79290264|FG005|Overall Study|Disease progression|25|||
44294710|NCT00246012|79290265|FG006|Overall Study|Disease progression|30|||
44294711|NCT00246012|79290266|FG007|Overall Study|Disease progression|27|||
44294712|NCT00246012|79290267|FG008|Overall Study|Disease progression|26|||
44294713|NCT00246012|79290259|FG000|Overall Study|Other|0|||
44294714|NCT00246012|79290260|FG001|Overall Study|Other|0|||
44294715|NCT00246012|79290261|FG002|Overall Study|Other|0|||
44294716|NCT00246012|79290262|FG003|Overall Study|Other|0|||
44294717|NCT00246012|79290263|FG004|Overall Study|Other|0|||
44294718|NCT00246012|79290264|FG005|Overall Study|Other|0|||
44294719|NCT00246012|79290265|FG006|Overall Study|Other|0|||
44294720|NCT00246012|79290266|FG007|Overall Study|Other|1|||
44294721|NCT00246012|79290267|FG008|Overall Study|Other|0|||
44294722|NCT00246012|79290259|FG000|Overall Study|Randomly assigned but not treated|0|||
44294723|NCT00246012|79290260|FG001|Overall Study|Randomly assigned but not treated|0|||
44294724|NCT00246012|79290261|FG002|Overall Study|Randomly assigned but not treated|0|||
44294725|NCT00246012|79290262|FG003|Overall Study|Randomly assigned but not treated|0|||
44294726|NCT00246012|79290263|FG004|Overall Study|Randomly assigned but not treated|0|||
44294727|NCT00246012|79290264|FG005|Overall Study|Randomly assigned but not treated|1|||
44294728|NCT00246012|79290265|FG006|Overall Study|Randomly assigned but not treated|1|||
44294729|NCT00246012|79290266|FG007|Overall Study|Randomly assigned but not treated|0|||
44294730|NCT00246012|79290267|FG008|Overall Study|Randomly assigned but not treated|0|||
44294731|NCT00245856|79290289|FG000|Period Two|Withdrawal by Subject|0|||
44294732|NCT00245856|79290290|FG001|Period Two|Withdrawal by Subject|1|||
44294733|NCT00245466|79290300|FG000|Overall Study|Adverse Event|2|||
44294734|NCT00245466|79290301|FG001|Overall Study|Adverse Event|8|||
44294735|NCT00245466|79290302|FG002|Overall Study|Adverse Event|4|||
44294736|NCT00245466|79290300|FG000|Overall Study|Low prostate specific antigen suppr|16|||
44294737|NCT00245466|79290301|FG001|Overall Study|Low prostate specific antigen suppr|14|||
44294738|NCT00245466|79290302|FG002|Overall Study|Low prostate specific antigen suppr|5|||
44294739|NCT00245466|79290300|FG000|Overall Study|Insufficient testosterone suppr|12|||
44294740|NCT00245466|79290301|FG001|Overall Study|Insufficient testosterone suppr|12|||
44294741|NCT00245466|79290302|FG002|Overall Study|Insufficient testosterone suppr|21|||
44294742|NCT00245466|79290300|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
44294743|NCT00245466|79290301|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
44294744|NCT00245466|79290302|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
44256301|NCT01666314|79104961|FG003|Overall Study|Symptomatic Deterioration|0|||
44294745|NCT00245466|79290300|FG000|Overall Study|Withdrawal by Subject|2|||
44294746|NCT00245466|79290301|FG001|Overall Study|Withdrawal by Subject|2|||
44294747|NCT00245466|79290302|FG002|Overall Study|Withdrawal by Subject|1|||
44294748|NCT00245466|79290300|FG000|Overall Study|Lost to Follow-up|3|||
44294749|NCT00245466|79290301|FG001|Overall Study|Lost to Follow-up|0|||
44294750|NCT00245466|79290302|FG002|Overall Study|Lost to Follow-up|0|||
44294751|NCT00245466|79290300|FG000|Overall Study|Disease progression|0|||
44294752|NCT00245466|79290301|FG001|Overall Study|Disease progression|3|||
44294753|NCT00245466|79290302|FG002|Overall Study|Disease progression|1|||
44294754|NCT00245466|79290300|FG000|Overall Study|Protocol Violation|1|||
44294755|NCT00245466|79290301|FG001|Overall Study|Protocol Violation|2|||
44294756|NCT00245466|79290302|FG002|Overall Study|Protocol Violation|2|||
44294757|NCT00245466|79290300|FG000|Overall Study|Death|0|||
44294758|NCT00245466|79290301|FG001|Overall Study|Death|2|||
44294759|NCT00245466|79290302|FG002|Overall Study|Death|0|||
44294760|NCT00245466|79290300|FG000|Overall Study|Administrative reasons|0|||
44294761|NCT00245466|79290301|FG001|Overall Study|Administrative reasons|1|||
44294762|NCT00245466|79290302|FG002|Overall Study|Administrative reasons|0|||
44294763|NCT00244764|79290310|FG000|Overall Study|Adverse Event|37|||
44294764|NCT00244764|79290310|FG000|Overall Study|Lost to Follow-up|23|||
44294765|NCT00244764|79290310|FG000|Overall Study|Withdrawal by Subject|12|||
44294766|NCT00244764|79290310|FG000|Overall Study|Disease Progression|13|||
44294767|NCT00244764|79290310|FG000|Overall Study|Protocol Violation|2|||
44294768|NCT00244764|79290310|FG000|Overall Study|Death|1|||
44294769|NCT00244764|79290310|FG000|Overall Study|Off Study Medication for >21 Days|1|||
44294770|NCT00244764|79290310|FG000|Overall Study|Declining Performance Status|1|||
44294771|NCT00244764|79290310|FG000|Overall Study|Participant was Hospitalized until Death|1|||
44294772|NCT00244764|79290310|FG000|Overall Study|Primary Investigator Discretion|2|||
44294773|NCT00244764|79290310|FG000|Overall Study|Sponsor Terminated Study|2|||
44294774|NCT00244764|79290310|FG000|Overall Study|Developed Secondary Malignancy|1|||
44294775|NCT00244374|79290315|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
44294776|NCT00244374|79290316|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
44294777|NCT00244374|79290317|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
44294778|NCT00244374|79290318|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
44294779|NCT00244374|79290319|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
44294780|NCT00244374|79290315|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
44294781|NCT00244374|79290316|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
44294782|NCT00244374|79290317|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
44294783|NCT00244374|79290318|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
44294784|NCT00244374|79290319|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
44294785|NCT00244374|79290315|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
44294786|NCT00244374|79290316|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
44294787|NCT00244374|79290317|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
44294788|NCT00244374|79290318|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
44294789|NCT00244374|79290319|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
44294790|NCT00244374|79290315|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
44294791|NCT00244374|79290316|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
44294792|NCT00244374|79290317|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
44294793|NCT00244374|79290318|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
44294794|NCT00244374|79290319|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
44294795|NCT00244374|79290315|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
44294796|NCT00244374|79290316|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
44294797|NCT00244374|79290317|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
44294798|NCT00244374|79290318|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
44416892|NCT00770328|79424779|FG000|Overall Study|Adverse Event|11|||
44154619|NCT03805841|78945912|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
44256302|NCT01666314|79104958|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
44256303|NCT01666314|79104959|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
44256304|NCT01666314|79104960|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
44256305|NCT01666314|79104961|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
44256306|NCT01666314|79104958|FG000|Overall Study|Withdrawal by Subject|1|||
44256307|NCT01666314|79104959|FG001|Overall Study|Withdrawal by Subject|1|||
44256308|NCT01666314|79104960|FG002|Overall Study|Withdrawal by Subject|2|||
44256309|NCT01666314|79104961|FG003|Overall Study|Withdrawal by Subject|3|||
44256310|NCT01666314|79104958|FG000|Overall Study|Reason not Specified|10|||
44256311|NCT01666314|79104959|FG001|Overall Study|Reason not Specified|7|||
44256312|NCT01666314|79104960|FG002|Overall Study|Reason not Specified|5|||
44256313|NCT01666314|79104961|FG003|Overall Study|Reason not Specified|5|||
44294799|NCT00244374|79290319|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
44294800|NCT00244374|79290315|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
44294801|NCT00244374|79290316|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
44294802|NCT00244374|79290317|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
44294803|NCT00244374|79290318|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
44294804|NCT00244374|79290319|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
44256314|NCT01666002|79104992|FG000|Overall Study|Lost to Follow-up|5|||
44256315|NCT01666002|79104993|FG001|Overall Study|Lost to Follow-up|0|||
44256316|NCT01665768|79105065|FG000|Overall Study|Adverse Event|3|||
44256317|NCT01665768|79105065|FG000|Overall Study|Lack of Efficacy|19|||
44256318|NCT01665768|79105065|FG000|Overall Study|Withdrawal by Subject|1|||
44256319|NCT02584452|79105273|FG000|Overall Study|Physician Decision|1|||
44256320|NCT02584452|79105274|FG001|Overall Study|Physician Decision|1|||
44256321|NCT02584452|79105273|FG000|Overall Study|Lost to Follow-up|1|||
44256322|NCT02584452|79105274|FG001|Overall Study|Lost to Follow-up|1|||
44256323|NCT02586012|79105321|FG000|Overall Study|Withdrawal by Subject|1|||
44256324|NCT02586012|79105322|FG001|Overall Study|Withdrawal by Subject|1|||
44256325|NCT02586012|79105323|FG002|Overall Study|Withdrawal by Subject|0|||
44256326|NCT02586012|79105324|FG003|Overall Study|Withdrawal by Subject|1|||
44256327|NCT02586012|79105325|FG004|Overall Study|Withdrawal by Subject|0|||
44256328|NCT02586012|79105326|FG005|Overall Study|Withdrawal by Subject|2|||
44256329|NCT02586012|79105321|FG000|Overall Study|Protocol Violation|0|||
44256330|NCT02586012|79105322|FG001|Overall Study|Protocol Violation|0|||
44256331|NCT02586012|79105323|FG002|Overall Study|Protocol Violation|0|||
44256332|NCT02586012|79105324|FG003|Overall Study|Protocol Violation|0|||
44256333|NCT02586012|79105325|FG004|Overall Study|Protocol Violation|0|||
44256334|NCT02586012|79105326|FG005|Overall Study|Protocol Violation|1|||
44256335|NCT02586012|79105321|FG000|Overall Study|study terminated|0|||
44256336|NCT02586012|79105322|FG001|Overall Study|study terminated|2|||
44256337|NCT02586012|79105323|FG002|Overall Study|study terminated|1|||
44256338|NCT02586012|79105324|FG003|Overall Study|study terminated|1|||
44256339|NCT02586012|79105325|FG004|Overall Study|study terminated|1|||
44256340|NCT02586012|79105326|FG005|Overall Study|study terminated|0|||
44256341|NCT02582814|79105337|FG000|Overall Study|Study-specific withdrawal criteria|1|||
44256342|NCT02582814|79105338|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44256343|NCT02582814|79105337|FG000|Overall Study|Withdrawal by Subject|4|||
44256344|NCT02582814|79105338|FG001|Overall Study|Withdrawal by Subject|3|||
44256345|NCT02582814|79105337|FG000|Overall Study|Adverse Event|4|||
44256346|NCT02582814|79105338|FG001|Overall Study|Adverse Event|4|||
44256347|NCT02585934|79105486|FG000|Overall Study|Lost to Follow-up|2|||
44256348|NCT02585934|79105487|FG001|Overall Study|Lost to Follow-up|2|||
44256349|NCT02585934|79105486|FG000|Overall Study|Protocol Violation|14|||
44256350|NCT02585934|79105487|FG001|Overall Study|Protocol Violation|11|||
44256351|NCT02585934|79105486|FG000|Overall Study|Adverse Event|21|||
44256352|NCT02585934|79105487|FG001|Overall Study|Adverse Event|22|||
44256353|NCT02585934|79105486|FG000|Overall Study|Physician Decision|3|||
44256354|NCT02585934|79105487|FG001|Overall Study|Physician Decision|2|||
44294805|NCT00244374|79290315|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
44294806|NCT00244374|79290316|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
44294807|NCT00244374|79290317|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
44294808|NCT00244374|79290318|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
44294809|NCT00244374|79290319|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
44294810|NCT00244374|79290315|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
44294811|NCT00244374|79290316|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
44294812|NCT00244374|79290317|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
44294813|NCT00244374|79290318|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
44294814|NCT00244374|79290319|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
44416893|NCT00770328|79424780|FG001|Overall Study|Adverse Event|2|||
44416894|NCT00770328|79424779|FG000|Overall Study|Lost to Follow-up|2|||
44533980|NCT03653390|79544659|FG002|Overall Study|Death|0|||
44533981|NCT03653390|79544657|FG000|Overall Study|Paper Survey Lost|1|||
44533982|NCT03653390|79544658|FG001|Overall Study|Paper Survey Lost|0|||
44533983|NCT03653390|79544659|FG002|Overall Study|Paper Survey Lost|0|||
44533984|NCT03366844|79544667|FG000|Overall Study|Physician Decision|1|||
44533985|NCT03366844|79544667|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
44533986|NCT02739035|79544707|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
44154620|NCT03805841|78945913|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
44533987|NCT02739035|79544708|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
44256355|NCT02585934|79105486|FG000|Overall Study|Withdrawal by Subject|7|||
44256356|NCT02585934|79105487|FG001|Overall Study|Withdrawal by Subject|21|||
44256357|NCT02585934|79105486|FG000|Overall Study|Lack of Efficacy|2|||
44294815|NCT00244374|79290315|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
44294816|NCT00244374|79290316|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
44294817|NCT00244374|79290317|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
44294818|NCT00244374|79290318|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
44294819|NCT00244374|79290319|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
44294820|NCT00242658|79290337|FG000|Overall Study|Lost to Follow-up|22|||
44294821|NCT00242658|79290338|FG001|Overall Study|Lost to Follow-up|19|||
44294822|NCT00242580|79290347|FG000|Overall Study|Adverse Event|3|||
44294823|NCT00242580|79290348|FG001|Overall Study|Adverse Event|0|||
44294824|NCT00242580|79290349|FG002|Overall Study|Adverse Event|2|||
44294825|NCT00242580|79290347|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44294826|NCT00242580|79290348|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
44294827|NCT00242580|79290349|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
44294828|NCT00242580|79290347|FG000|Overall Study|Protocol Violation|0|||
44294829|NCT00242580|79290348|FG001|Overall Study|Protocol Violation|0|||
44294830|NCT00242580|79290349|FG002|Overall Study|Protocol Violation|1|||
44294831|NCT00242580|79290347|FG000|Overall Study|Subject withdrew consent|2|||
44294832|NCT00242580|79290348|FG001|Overall Study|Subject withdrew consent|2|||
44294833|NCT00242580|79290349|FG002|Overall Study|Subject withdrew consent|5|||
44294834|NCT00242580|79290347|FG000|Overall Study|Lost to Follow-up|0|||
44294835|NCT00242580|79290348|FG001|Overall Study|Lost to Follow-up|3|||
44294836|NCT00242580|79290349|FG002|Overall Study|Lost to Follow-up|0|||
44294837|NCT00242580|79290347|FG000|Overall Study|Death|1|||
44294838|NCT00242580|79290348|FG001|Overall Study|Death|2|||
44154621|NCT02684617|78945924|FG000|Overall Study|Adverse Event|1|||
44154622|NCT02684617|78945925|FG001|Overall Study|Adverse Event|0|||
44154623|NCT02684617|78945926|FG002|Overall Study|Adverse Event|1|||
44294839|NCT00242580|79290349|FG002|Overall Study|Death|1|||
44294840|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
44294841|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
44294842|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
44294843|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
44294844|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
44294845|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
44294846|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
44294847|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
44294848|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
44294849|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
44294850|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
44294851|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
44294852|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
44294853|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
44294854|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
44294855|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
44294856|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
44294857|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
44294858|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
44294859|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
44294860|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
44154624|NCT02684617|78945924|FG000|Overall Study|Death|8|||
44256358|NCT02585934|79105487|FG001|Overall Study|Lack of Efficacy|1|||
44256359|NCT02585934|79105486|FG000|Overall Study|Death|2|||
44256360|NCT02585934|79105487|FG001|Overall Study|Death|0|||
44256361|NCT02585934|79105486|FG000|Overall Study|Caregiver Withdrew Consent|7|||
44256362|NCT02585934|79105487|FG001|Overall Study|Caregiver Withdrew Consent|7|||
44256363|NCT02585934|79105486|FG000|Overall Study|Sponsor Termination|1|||
44256364|NCT02585934|79105487|FG001|Overall Study|Sponsor Termination|2|||
44256365|NCT02585934|79105486|FG000|Overall Study|Another Reason|10|||
44256366|NCT02585934|79105487|FG001|Overall Study|Another Reason|5|||
44256367|NCT02582658|79105516|FG000|Overall Study|Failure to Return|10|||
44256368|NCT02582658|79105516|FG000|Overall Study|Insufficient Virological Response|2|||
44256369|NCT02582658|79105516|FG000|Overall Study|Withdrawn Consent|1|||
44256370|NCT02582658|79105516|FG000|Overall Study|Death|1|||
44256371|NCT02582658|79105516|FG000|Overall Study|Not further specified|11|||
44256372|NCT02585778|79105618|FG000|Overall Study|Adverse Event|17|||
44154625|NCT02684617|78945925|FG001|Overall Study|Death|16|||
44256373|NCT02585778|79105619|FG001|Overall Study|Adverse Event|4|||
44256374|NCT02585778|79105618|FG000|Overall Study|Participant did not wish to continue|9|||
44294861|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
44294862|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
44294863|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
44294864|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
44294865|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
44294866|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
44294867|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
44294868|NCT00241644|79290361|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
44294869|NCT00241644|79290362|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
44294870|NCT00241644|79290363|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
44294871|NCT00241644|79290364|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
44294872|NCT00241644|79290361|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
44294873|NCT00241644|79290362|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
44294874|NCT00241644|79290363|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
44294875|NCT00241644|79290364|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
44294876|NCT00241644|79290361|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
44294877|NCT00241644|79290362|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
44294878|NCT00241644|79290363|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
44294879|NCT00241644|79290364|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
44294880|NCT00241644|79290361|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
44294881|NCT00241644|79290362|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
44294882|NCT00241644|79290363|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
44294883|NCT00241644|79290364|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
44294884|NCT00241644|79290361|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
44294885|NCT00241644|79290362|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
44294886|NCT00241644|79290363|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
44294887|NCT00241644|79290364|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
44294888|NCT00241644|79290361|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
44294889|NCT00241644|79290362|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
44294890|NCT00241644|79290363|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
44294891|NCT00241644|79290364|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
44294892|NCT03804684|79290385|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
44294893|NCT03804684|79290386|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
44294894|NCT04295772|79290401|FG000|Overall Study|Protocol Violation|1|||
44294895|NCT04295772|79290402|FG001|Overall Study|Protocol Violation|0|||
44294896|NCT04295772|79290401|FG000|Overall Study|Ongoing for safety monitoring|14|||
44294897|NCT04295772|79290402|FG001|Overall Study|Ongoing for safety monitoring|1|||
44294898|NCT04295772|79290401|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
44294899|NCT04295772|79290402|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
44294900|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #1|24|||
44294901|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #1|0|||
44294902|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
44294903|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
44294904|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294905|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294906|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
44294907|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
44294908|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
44294909|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
44294910|NCT03888066|79290413|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294911|NCT03888066|79290414|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294912|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294913|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294914|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
44294915|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
44294916|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294917|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294918|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
44294919|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294920|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #2|5|||
44294921|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #2|0|||
44294922|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
44294923|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
44294924|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
44294925|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
44294926|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
44294927|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
44294928|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #3|11|||
44294929|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #3|0|||
44294930|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
44294931|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
44294932|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
44294933|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
44294934|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294935|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294936|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #4|3|||
44294937|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #4|0|||
44294938|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
44294939|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
44294940|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
44294941|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
44294942|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
44294943|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
44294944|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
44294945|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
44533988|NCT02739035|79544707|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
44533989|NCT02739035|79544708|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
44294946|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
44294947|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294948|NCT03888066|79290413|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
44294949|NCT03888066|79290414|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
44294950|NCT03888066|79290413|FG000|Run-in Phase|AE (Adverse Event)|17|||
44416895|NCT00770328|79424780|FG001|Overall Study|Lost to Follow-up|2|||
44416896|NCT00766038|79424788|FG000|Overall Study|Lost to Follow-up|15|||
44533990|NCT02739035|79544707|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
44533991|NCT02739035|79544708|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
44533992|NCT02739035|79544707|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
44533993|NCT02739035|79544708|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
44256375|NCT02585778|79105619|FG001|Overall Study|Participant did not wish to continue|4|||
44256376|NCT02585778|79105618|FG000|Overall Study|Poor compliance to study protocol|0|||
44256377|NCT02585778|79105619|FG001|Overall Study|Poor compliance to study protocol|2|||
44256378|NCT02585778|79105618|FG000|Overall Study|Death|0|||
44256379|NCT02585778|79105619|FG001|Overall Study|Death|1|||
44256380|NCT02585778|79105618|FG000|Overall Study|Randomized but not treated|1|||
44256381|NCT02585778|79105619|FG001|Overall Study|Randomized but not treated|2|||
44256382|NCT02585778|79105618|FG000|Overall Study|Other than specified above|6|||
44256383|NCT02585778|79105619|FG001|Overall Study|Other than specified above|2|||
44256384|NCT01438424|79105642|FG000|Overall Study|Continuing treatment|29|||
44256385|NCT01438424|79105642|FG000|Overall Study|Minimal virologic response|95|||
44256386|NCT01438424|79105642|FG000|Overall Study|Not identified|55|||
44256387|NCT01438424|79105642|FG000|Overall Study|Withdrawal by Subject|104|||
44256388|NCT01438424|79105642|FG000|Overall Study|Progression of chronic hepatitis B|22|||
44256389|NCT01438424|79105642|FG000|Overall Study|Death|22|||
44256390|NCT01438424|79105642|FG000|Overall Study|Adverse Event|17|||
44256391|NCT01438424|79105642|FG000|Overall Study|Lost to Follow-up|17|||
44256392|NCT01438424|79105642|FG000|Overall Study|Abnormal laboratory test result|14|||
44256393|NCT01438424|79105642|FG000|Overall Study|Need for drug prohibited by protocol|14|||
44256394|NCT01438424|79105642|FG000|Overall Study|Pregnancy|7|||
44256395|NCT01438424|79105642|FG000|Overall Study|No longer met inclusion criteria|1|||
44256396|NCT01438424|79105642|FG000|Overall Study|Participant noncompliance|20|||
44256397|NCT02580240|79105658|FG000|Overall Study|Physician Decision|2|||
44256398|NCT02580240|79105659|FG001|Overall Study|Physician Decision|0|||
44256399|NCT01465958|79105665|FG000|Run-in Phase|Protocol Violation|1|||
44256400|NCT01465958|79105666|FG001|Run-in Phase|Protocol Violation|0|||
44294951|NCT03888066|79290414|FG001|Run-in Phase|AE (Adverse Event)|0|||
44294952|NCT03888066|79290413|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
44294953|NCT03888066|79290414|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
44294954|NCT03888066|79290413|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294955|NCT03888066|79290414|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294956|NCT03888066|79290413|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
44294957|NCT03888066|79290414|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294958|NCT03888066|79290413|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
44294959|NCT03888066|79290414|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
44294960|NCT03888066|79290413|FG000|Run-in Phase|Withdrawal by Subject|43|||
44294961|NCT03888066|79290414|FG001|Run-in Phase|Withdrawal by Subject|0|||
44294962|NCT03888066|79290413|FG000|Run-in Phase|AE; Physician Decision|1|||
44294963|NCT03888066|79290414|FG001|Run-in Phase|AE; Physician Decision|0|||
44294964|NCT03888066|79290413|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
44294965|NCT03888066|79290414|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
44294966|NCT03888066|79290413|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
44294967|NCT03888066|79290414|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
44294968|NCT03888066|79290413|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
44294969|NCT03888066|79290414|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
44294970|NCT03888066|79290413|FG000|Run-in Phase|Death|1|||
44294971|NCT03888066|79290414|FG001|Run-in Phase|Death|0|||
44294972|NCT03888066|79290413|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
44294973|NCT03888066|79290414|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
44294974|NCT03888066|79290413|FG000|Run-in Phase|Physician Decision|1|||
44294975|NCT03888066|79290414|FG001|Run-in Phase|Physician Decision|0|||
44294976|NCT03888066|79290413|FG000|Run-in Phase|Protocol Violation|13|||
44294977|NCT03888066|79290414|FG001|Run-in Phase|Protocol Violation|0|||
44294978|NCT03888066|79290413|FG000|Run-in Phase|Sponsor Request|34|||
44294979|NCT03888066|79290414|FG001|Run-in Phase|Sponsor Request|0|||
44294980|NCT03888066|79290413|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
44294981|NCT03888066|79290414|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
44294982|NCT03888066|79290413|FG000|Run-in Phase|Withdrawal Of Consent|1|||
44294983|NCT03888066|79290414|FG001|Run-in Phase|Withdrawal Of Consent|0|||
44294984|NCT03888066|79290413|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
44294985|NCT03888066|79290414|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
44294986|NCT03888066|79290413|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
44294987|NCT03888066|79290414|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
44294988|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
44294989|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
44294990|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
44294991|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
44294992|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
44294993|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
44294994|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
44294995|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
44294996|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
44294997|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
44294998|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
44294999|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
44295000|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
44295001|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
44295002|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
44295003|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
44295004|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
44295005|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
44295006|NCT03888066|79290413|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
44295007|NCT03888066|79290414|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
44295008|NCT01049334|79290423|FG000|Overall Study|Withdrawal by Subject|5|||
44295009|NCT01049334|79290424|FG001|Overall Study|Withdrawal by Subject|3|||
44295010|NCT01049334|79290423|FG000|Overall Study|Adverse Event|2|||
44295011|NCT01049334|79290424|FG001|Overall Study|Adverse Event|3|||
44295012|NCT01049334|79290423|FG000|Overall Study|Physician Decision|2|||
44295013|NCT01049334|79290424|FG001|Overall Study|Physician Decision|0|||
44295014|NCT01049334|79290423|FG000|Overall Study|Protocol Violation|0|||
44295015|NCT01049334|79290424|FG001|Overall Study|Protocol Violation|1|||
44416897|NCT00766038|79424789|FG001|Overall Study|Lost to Follow-up|14|||
44295016|NCT01048944|79290434|FG000|Overall Study|Protocol Violation|8|||
44295017|NCT01048944|79290435|FG001|Overall Study|Protocol Violation|10|||
44295018|NCT01048944|79290436|FG002|Overall Study|Protocol Violation|10|||
44295019|NCT01048944|79290437|FG003|Overall Study|Protocol Violation|2|||
44295020|NCT01048866|79290449|FG000|Overall Study|Adverse Event|1|||
44295021|NCT01048866|79290450|FG001|Overall Study|Adverse Event|0|||
44295022|NCT01048866|79290449|FG000|Overall Study|Protocol Violation|1|||
44295023|NCT01048866|79290450|FG001|Overall Study|Protocol Violation|0|||
44295024|NCT01048866|79290449|FG000|Overall Study|Physician Decision|1|||
44295025|NCT01048866|79290450|FG001|Overall Study|Physician Decision|0|||
44295026|NCT01048866|79290449|FG000|Overall Study|Withdrawal by Subject|0|||
44295027|NCT01048866|79290450|FG001|Overall Study|Withdrawal by Subject|2|||
44295028|NCT01048866|79290449|FG000|Overall Study|Lost to Follow-up|0|||
44295029|NCT01048866|79290450|FG001|Overall Study|Lost to Follow-up|2|||
44295030|NCT01048866|79290449|FG000|Overall Study|Other|1|||
44295031|NCT01048866|79290450|FG001|Overall Study|Other|1|||
44295032|NCT01048788|79290459|FG000|Overall Study|Adverse Event|5|||
44295033|NCT01048788|79290460|FG001|Overall Study|Adverse Event|1|||
44295034|NCT01048788|79290461|FG002|Overall Study|Adverse Event|1|||
44295035|NCT01048788|79290459|FG000|Overall Study|Lack of Efficacy|0|||
44295036|NCT01048788|79290460|FG001|Overall Study|Lack of Efficacy|0|||
44295037|NCT01048788|79290461|FG002|Overall Study|Lack of Efficacy|1|||
44295038|NCT01048788|79290459|FG000|Overall Study|Withdrawal by Subject|0|||
44295039|NCT01048788|79290460|FG001|Overall Study|Withdrawal by Subject|1|||
44295040|NCT01048788|79290461|FG002|Overall Study|Withdrawal by Subject|0|||
44295041|NCT01048242|79290471|FG000|Overall Study|See study flow chart|4|||
44295042|NCT01048242|79290472|FG001|Overall Study|See study flow chart|2|||
44295043|NCT01047306|79290480|FG000|Overall Study|Withdrawal by Subject|2|||
44295044|NCT01047306|79290481|FG001|Overall Study|Withdrawal by Subject|0|||
44295045|NCT01047306|79290480|FG000|Overall Study|Lost to Follow-up|1|||
44295046|NCT01047306|79290481|FG001|Overall Study|Lost to Follow-up|0|||
44295047|NCT01046682|79290491|FG000|Overall Study|Adverse Event|2|||
44295048|NCT01046682|79290492|FG001|Overall Study|Adverse Event|0|||
44295049|NCT01044732|79290500|FG000|Overall Study|Lost to Follow-up|2|||
44295050|NCT01044732|79290501|FG001|Overall Study|Lost to Follow-up|1|||
44295051|NCT01044732|79290500|FG000|Overall Study|Physician Decision|5|||
44295052|NCT01044732|79290501|FG001|Overall Study|Physician Decision|3|||
44295053|NCT01044732|79290500|FG000|Overall Study|Protocol Violation|11|||
44295054|NCT01044732|79290501|FG001|Overall Study|Protocol Violation|12|||
44295055|NCT01044732|79290500|FG000|Overall Study|Withdrawal by Subject|0|||
44295056|NCT01044732|79290501|FG001|Overall Study|Withdrawal by Subject|1|||
44295057|NCT01044732|79290500|FG000|Overall Study|Inadequate bowel preparation|11|||
44295058|NCT01044732|79290501|FG001|Overall Study|Inadequate bowel preparation|17|||
44295059|NCT01044732|79290500|FG000|Overall Study|Inability to reach cecum|5|||
44295060|NCT01044732|79290501|FG001|Overall Study|Inability to reach cecum|2|||
44295061|NCT01044732|79290500|FG000|Overall Study|Technical error or malfunction|15|||
44295062|NCT01044732|79290501|FG001|Overall Study|Technical error or malfunction|14|||
44295063|NCT01044498|79290511|FG000|Overall Study|Withdrew consent|1|||
44295064|NCT01044498|79290512|FG001|Overall Study|Withdrew consent|1|||
44295065|NCT01044498|79290511|FG000|Overall Study|Adverse Event|1|||
44295066|NCT01044498|79290512|FG001|Overall Study|Adverse Event|1|||
44295067|NCT01044498|79290511|FG000|Overall Study|Other|1|||
44295068|NCT01044498|79290512|FG001|Overall Study|Other|0|||
44295069|NCT01043874|79290518|FG000|Overall Study|Adverse Event|3|||
44295070|NCT01043874|79290518|FG000|Overall Study|Withdrawal by Subject|1|||
44295071|NCT01043874|79290518|FG000|Overall Study|Lack of Efficacy|1|||
44295072|NCT01043874|79290518|FG000|Overall Study|Administrative Problems|1|||
44295073|NCT01042938|79290524|FG000|Overall Study|Withdrawal by Subject|1|||
44295074|NCT01042938|79290525|FG001|Overall Study|Withdrawal by Subject|1|||
44295075|NCT01042938|79290524|FG000|Overall Study|Protocol Violation|1|||
44295076|NCT01042938|79290525|FG001|Overall Study|Protocol Violation|1|||
44295077|NCT01042938|79290524|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
44295078|NCT01042938|79290525|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
44295079|NCT01042158|79290533|FG000|Overall Study|Physician Decision|1|||
44416898|NCT00765882|79424800|FG000|Overall Study|Adverse Event|10|||
44533994|NCT02657434|79544728|FG000|Overall Study|Study Terminated By Sponsor|64|||
44533995|NCT02657434|79544729|FG001|Overall Study|Study Terminated By Sponsor|82|||
44533996|NCT02657434|79544728|FG000|Overall Study|Death|189|||
44295080|NCT03408444|79290541|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
44295081|NCT03408444|79290542|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
44295082|NCT03408444|79290543|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
44533997|NCT02657434|79544729|FG001|Overall Study|Death|190|||
44295083|NCT03408444|79290544|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
44295084|NCT03408444|79290541|FG000|Overall Study|Lens Discomfort|0|||
44295085|NCT03408444|79290542|FG001|Overall Study|Lens Discomfort|1|||
44295086|NCT03408444|79290543|FG002|Overall Study|Lens Discomfort|0|||
44295087|NCT03408444|79290544|FG003|Overall Study|Lens Discomfort|0|||
44295088|NCT03408444|79290541|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
44295089|NCT03408444|79290542|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
44295090|NCT03408444|79290543|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
44295091|NCT03408444|79290544|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
44295092|NCT03408444|79290541|FG000|Overall Study|Withdrawal by Subject|0|||
44295093|NCT03408444|79290542|FG001|Overall Study|Withdrawal by Subject|2|||
44295094|NCT03408444|79290543|FG002|Overall Study|Withdrawal by Subject|3|||
44295095|NCT03408444|79290544|FG003|Overall Study|Withdrawal by Subject|0|||
44295096|NCT03408444|79290541|FG000|Overall Study|Lost to Follow-up|0|||
44295097|NCT03408444|79290542|FG001|Overall Study|Lost to Follow-up|0|||
44295098|NCT03408444|79290543|FG002|Overall Study|Lost to Follow-up|1|||
44295099|NCT03408444|79290544|FG003|Overall Study|Lost to Follow-up|0|||
44295100|NCT03408444|79290541|FG000|Overall Study|Adverse Event|0|||
44295101|NCT03408444|79290542|FG001|Overall Study|Adverse Event|0|||
44295102|NCT03408444|79290543|FG002|Overall Study|Adverse Event|0|||
44295103|NCT03408444|79290544|FG003|Overall Study|Adverse Event|1|||
44295104|NCT03408444|79290541|FG000|Overall Study|Lens Handling Difficulties|0|||
44295105|NCT03408444|79290542|FG001|Overall Study|Lens Handling Difficulties|0|||
44295106|NCT03408444|79290543|FG002|Overall Study|Lens Handling Difficulties|1|||
44295107|NCT03408444|79290544|FG003|Overall Study|Lens Handling Difficulties|0|||
44295108|NCT03408444|79290541|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
44295109|NCT03408444|79290542|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
44295110|NCT03408444|79290543|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
44295111|NCT03408444|79290544|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
44295112|NCT03400956|79290574|FG000|Treatment Period 1|Adverse Event|0|||
44295113|NCT03400956|79290575|FG001|Treatment Period 1|Adverse Event|1|||
44295114|NCT03400956|79290576|FG002|Treatment Period 1|Adverse Event|0|||
44295115|NCT03400956|79290574|FG000|Treatment Period 1|Lost to Follow-up|0|||
44295116|NCT03400956|79290575|FG001|Treatment Period 1|Lost to Follow-up|0|||
44295117|NCT03400956|79290576|FG002|Treatment Period 1|Lost to Follow-up|1|||
44295118|NCT03400956|79290574|FG000|Treatment Period 1|Protocol Violation|0|||
44295119|NCT03400956|79290575|FG001|Treatment Period 1|Protocol Violation|2|||
44295120|NCT03400956|79290576|FG002|Treatment Period 1|Protocol Violation|0|||
44295121|NCT03400956|79290574|FG000|Treatment Period 1|Study terminated by sponsor|3|||
44295122|NCT03400956|79290575|FG001|Treatment Period 1|Study terminated by sponsor|1|||
44295123|NCT03400956|79290576|FG002|Treatment Period 1|Study terminated by sponsor|1|||
44295124|NCT03400956|79290574|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44295125|NCT03400956|79290575|FG001|Treatment Period 1|Withdrawal by Subject|2|||
44295126|NCT03400956|79290576|FG002|Treatment Period 1|Withdrawal by Subject|4|||
44295127|NCT03400956|79290574|FG000|Treatment Period 1|Other|1|||
44295128|NCT03400956|79290575|FG001|Treatment Period 1|Other|2|||
44295129|NCT03400956|79290576|FG002|Treatment Period 1|Other|3|||
44295130|NCT03400956|79290574|FG000|Post-treatment Period 1|Adverse Event|0|||
44295131|NCT03400956|79290575|FG001|Post-treatment Period 1|Adverse Event|0|||
44295132|NCT03400956|79290576|FG002|Post-treatment Period 1|Adverse Event|1|||
44295133|NCT03400956|79290574|FG000|Post-treatment Period 1|Physician Decision|2|||
44295134|NCT03400956|79290575|FG001|Post-treatment Period 1|Physician Decision|3|||
44295135|NCT03400956|79290576|FG002|Post-treatment Period 1|Physician Decision|0|||
44295136|NCT03400956|79290574|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
44295137|NCT03400956|79290575|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
44295138|NCT03400956|79290576|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
44295139|NCT03400956|79290574|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
44295140|NCT03400956|79290575|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
44295141|NCT03400956|79290576|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
44295142|NCT03400956|79290574|FG000|Post-treatment Period 1|Other|4|||
44295143|NCT03400956|79290575|FG001|Post-treatment Period 1|Other|3|||
44295144|NCT03400956|79290576|FG002|Post-treatment Period 1|Other|4|||
44295145|NCT03400956|79290574|FG000|Treatment Period 2|Adverse Event|2|||
44295146|NCT03400956|79290575|FG001|Treatment Period 2|Adverse Event|1|||
44295147|NCT03400956|79290576|FG002|Treatment Period 2|Adverse Event|1|||
44295148|NCT03400956|79290574|FG000|Treatment Period 2|Lost to Follow-up|1|||
44295149|NCT03400956|79290575|FG001|Treatment Period 2|Lost to Follow-up|1|||
44295150|NCT03400956|79290576|FG002|Treatment Period 2|Lost to Follow-up|0|||
44295151|NCT03400956|79290574|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44295152|NCT03400956|79290575|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44295153|NCT03400956|79290576|FG002|Treatment Period 2|Withdrawal by Subject|3|||
44295154|NCT03400956|79290574|FG000|Treatment Period 2|Other|1|||
44295155|NCT03400956|79290575|FG001|Treatment Period 2|Other|1|||
44295156|NCT03400956|79290576|FG002|Treatment Period 2|Other|0|||
44295157|NCT03400956|79290574|FG000|Follow-up Period|Withdrawal by Subject|0|||
44295158|NCT03400956|79290575|FG001|Follow-up Period|Withdrawal by Subject|0|||
44295159|NCT03400956|79290576|FG002|Follow-up Period|Withdrawal by Subject|1|||
44295160|NCT03400956|79290574|FG000|Follow-up Period|Other|0|||
44295161|NCT03400956|79290575|FG001|Follow-up Period|Other|0|||
44295162|NCT03400956|79290576|FG002|Follow-up Period|Other|1|||
44295163|NCT00012012|79290589|FG000|Overall Study|Protocol Violation|1|||
44295164|NCT00012012|79290590|FG001|Overall Study|Protocol Violation|1|||
44295165|NCT00012012|79290589|FG000|Overall Study|Withdrawal by Subject|0|||
44295166|NCT00012012|79290590|FG001|Overall Study|Withdrawal by Subject|2|||
44295167|NCT00010374|79290596|FG000|Overall Study|False positive phrenic nerve test|1|||
44295168|NCT00559962|79290622|FG000|Overall Study|Adverse Event|1|||
44295169|NCT00559962|79290623|FG001|Overall Study|Adverse Event|7|||
44295170|NCT00559962|79290624|FG002|Overall Study|Adverse Event|8|||
44295171|NCT00559962|79290625|FG003|Overall Study|Adverse Event|5|||
44295172|NCT00559962|79290626|FG004|Overall Study|Adverse Event|11|||
44295173|NCT00559962|79290627|FG005|Overall Study|Adverse Event|4|||
44295174|NCT00559962|79290628|FG006|Overall Study|Adverse Event|4|||
44295175|NCT00559962|79290629|FG007|Overall Study|Adverse Event|2|||
44295176|NCT00559962|79290622|FG000|Overall Study|Lost to Follow-up|0|||
44295177|NCT00559962|79290623|FG001|Overall Study|Lost to Follow-up|1|||
44295178|NCT00559962|79290624|FG002|Overall Study|Lost to Follow-up|0|||
44295179|NCT00559962|79290625|FG003|Overall Study|Lost to Follow-up|0|||
44295180|NCT00559962|79290626|FG004|Overall Study|Lost to Follow-up|0|||
44295181|NCT00559962|79290627|FG005|Overall Study|Lost to Follow-up|0|||
44295182|NCT00559962|79290628|FG006|Overall Study|Lost to Follow-up|0|||
44295183|NCT00559962|79290629|FG007|Overall Study|Lost to Follow-up|0|||
44295184|NCT00559962|79290622|FG000|Overall Study|Withdrawal by Subject|1|||
44295185|NCT00559962|79290623|FG001|Overall Study|Withdrawal by Subject|1|||
44295186|NCT00559962|79290624|FG002|Overall Study|Withdrawal by Subject|2|||
44295187|NCT00559962|79290625|FG003|Overall Study|Withdrawal by Subject|0|||
44295188|NCT00559962|79290626|FG004|Overall Study|Withdrawal by Subject|3|||
44295189|NCT00559962|79290627|FG005|Overall Study|Withdrawal by Subject|1|||
44295190|NCT00559962|79290628|FG006|Overall Study|Withdrawal by Subject|0|||
44295191|NCT00559962|79290629|FG007|Overall Study|Withdrawal by Subject|2|||
44295192|NCT00559962|79290622|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
44295193|NCT00559962|79290623|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
44295194|NCT00559962|79290624|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
44295195|NCT00559962|79290625|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
44295196|NCT00559962|79290626|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
44295197|NCT00559962|79290627|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
44295198|NCT00559962|79290628|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
44295199|NCT00559962|79290629|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
44295200|NCT00559104|79290650|FG000|Overall Study|Lack of Efficacy|9|||
44295201|NCT00559104|79290651|FG001|Overall Study|Lack of Efficacy|0|||
44295202|NCT00558636|79290659|FG000|Treatment|Adverse Event|9|||
44295203|NCT00558636|79290660|FG001|Treatment|Adverse Event|2|||
44295204|NCT00558636|79290659|FG000|Treatment|Withdrawal by Subject|2|||
44295205|NCT00558636|79290660|FG001|Treatment|Withdrawal by Subject|0|||
44295206|NCT00558636|79290659|FG000|Treatment|Premature termination of the study|35|||
44295207|NCT00558636|79290660|FG001|Treatment|Premature termination of the study|37|||
44295208|NCT00558636|79290659|FG000|Treatment|Disease progression|1|||
44295209|NCT00558636|79290660|FG001|Treatment|Disease progression|5|||
44295210|NCT00558636|79290659|FG000|Follow-up|Premature termination of the study|12|||
44295211|NCT00558636|79290660|FG001|Follow-up|Premature termination of the study|7|||
44295212|NCT00558558|79290666|FG000|Overall Study|Unable to swallow|1|||
44295213|NCT00558558|79290666|FG000|Overall Study|Withdrawal by Subject|1|||
44295214|NCT00558558|79290666|FG000|Overall Study|Lack of Efficacy|4|||
44295215|NCT00557622|79290672|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
44295216|NCT00557622|79290673|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
44295217|NCT00557622|79290672|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
44295218|NCT00557622|79290673|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
44295219|NCT00557622|79290672|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
44295220|NCT00557622|79290673|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
44295221|NCT00557466|79290685|FG000|Overall Study|Adverse Event|3|||
44295222|NCT00557466|79290686|FG001|Overall Study|Adverse Event|1|||
44295223|NCT00557466|79290687|FG002|Overall Study|Adverse Event|4|||
44295224|NCT00557466|79290688|FG003|Overall Study|Adverse Event|1|||
44295225|NCT00557466|79290689|FG004|Overall Study|Adverse Event|2|||
44416899|NCT00765882|79424801|FG001|Overall Study|Adverse Event|21|||
44416900|NCT00765882|79424802|FG002|Overall Study|Adverse Event|20|||
44295226|NCT00557466|79290690|FG005|Overall Study|Adverse Event|4|||
44295227|NCT00557466|79290685|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44295228|NCT00557466|79290686|FG001|Overall Study|Abnormal laboratory value(s)|2|||
44295229|NCT00557466|79290687|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44295230|NCT00557466|79290688|FG003|Overall Study|Abnormal laboratory value(s)|0|||
44295231|NCT00557466|79290689|FG004|Overall Study|Abnormal laboratory value(s)|0|||
44295232|NCT00557466|79290690|FG005|Overall Study|Abnormal laboratory value(s)|0|||
44295233|NCT00557466|79290685|FG000|Overall Study|Protocol deviation|0|||
44416901|NCT00765882|79424800|FG000|Overall Study|Lack of Efficacy|4|||
44295234|NCT00557466|79290686|FG001|Overall Study|Protocol deviation|1|||
44295235|NCT00557466|79290687|FG002|Overall Study|Protocol deviation|0|||
44295236|NCT00557466|79290688|FG003|Overall Study|Protocol deviation|2|||
44295237|NCT00557466|79290689|FG004|Overall Study|Protocol deviation|0|||
44295238|NCT00557466|79290690|FG005|Overall Study|Protocol deviation|0|||
44295239|NCT00557466|79290685|FG000|Overall Study|Subject withdrew consent|0|||
44295240|NCT00557466|79290686|FG001|Overall Study|Subject withdrew consent|0|||
44295241|NCT00557466|79290687|FG002|Overall Study|Subject withdrew consent|0|||
44295242|NCT00557466|79290688|FG003|Overall Study|Subject withdrew consent|0|||
44295243|NCT00557466|79290689|FG004|Overall Study|Subject withdrew consent|1|||
44295244|NCT00557466|79290690|FG005|Overall Study|Subject withdrew consent|2|||
44295245|NCT00557466|79290685|FG000|Overall Study|Administrative problems|0|||
44295246|NCT00557466|79290686|FG001|Overall Study|Administrative problems|1|||
44295247|NCT00557466|79290687|FG002|Overall Study|Administrative problems|1|||
44295248|NCT00557466|79290688|FG003|Overall Study|Administrative problems|0|||
44295249|NCT00557466|79290689|FG004|Overall Study|Administrative problems|0|||
44295250|NCT00557466|79290690|FG005|Overall Study|Administrative problems|0|||
44295251|NCT00557466|79290685|FG000|Overall Study|Abnormal test procedure results|0|||
44295252|NCT00557466|79290686|FG001|Overall Study|Abnormal test procedure results|0|||
44295253|NCT00557466|79290687|FG002|Overall Study|Abnormal test procedure results|1|||
44295254|NCT00557466|79290688|FG003|Overall Study|Abnormal test procedure results|0|||
44295255|NCT00557466|79290689|FG004|Overall Study|Abnormal test procedure results|0|||
44295256|NCT00557466|79290690|FG005|Overall Study|Abnormal test procedure results|0|||
44295257|NCT00557466|79290685|FG000|Overall Study|Lost to Follow-up|0|||
44295258|NCT00557466|79290686|FG001|Overall Study|Lost to Follow-up|0|||
44295259|NCT00557466|79290687|FG002|Overall Study|Lost to Follow-up|0|||
44295260|NCT00557466|79290688|FG003|Overall Study|Lost to Follow-up|1|||
44295261|NCT00557466|79290689|FG004|Overall Study|Lost to Follow-up|0|||
44295262|NCT00557466|79290690|FG005|Overall Study|Lost to Follow-up|0|||
44295263|NCT00557310|79290704|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
44295264|NCT00557310|79290704|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
44295265|NCT00557310|79290704|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
44295266|NCT00557310|79290704|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
44295267|NCT00557310|79290704|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
44295268|NCT00557310|79290704|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
44295269|NCT00555438|79290708|FG000|10 Days Post-operative|Death|4|||
44295270|NCT00555438|79290708|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
44295271|NCT00553644|79290712|FG000|Overall Study|Adverse Event|17|||
44295272|NCT00553644|79290712|FG000|Overall Study|Withdrawal by Subject|4|||
44295273|NCT00553644|79290712|FG000|Overall Study|Physician Decision|1|||
44295274|NCT00553644|79290712|FG000|Overall Study|Alternative therapy|6|||
44295275|NCT00553332|79290716|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
44295276|NCT00552396|79290727|FG000|Overall Study|protocol withdrawal criteria|3|||
44295277|NCT00552396|79290728|FG001|Overall Study|protocol withdrawal criteria|3|||
44295278|NCT00552396|79290729|FG002|Overall Study|protocol withdrawal criteria|3|||
44295279|NCT00552396|79290730|FG003|Overall Study|protocol withdrawal criteria|6|||
44295280|NCT00552396|79290731|FG004|Overall Study|protocol withdrawal criteria|3|||
44295281|NCT00552396|79290732|FG005|Overall Study|protocol withdrawal criteria|3|||
44295282|NCT00552396|79290733|FG006|Overall Study|protocol withdrawal criteria|9|||
44295283|NCT00552240|79290769|FG000|Overall Study|Adverse Event|9|||
44295284|NCT00552240|79290770|FG001|Overall Study|Adverse Event|9|||
44295285|NCT00552240|79290769|FG000|Overall Study|Protocol Violation|1|||
44295286|NCT00552240|79290770|FG001|Overall Study|Protocol Violation|1|||
44295287|NCT00552240|79290769|FG000|Overall Study|Lost to Follow-up|5|||
44295288|NCT00552240|79290770|FG001|Overall Study|Lost to Follow-up|6|||
44295289|NCT00552240|79290769|FG000|Overall Study|Withdrawal by Subject|2|||
44295290|NCT00552240|79290770|FG001|Overall Study|Withdrawal by Subject|2|||
44295291|NCT00552240|79290769|FG000|Overall Study|Lack of Efficacy|6|||
44295292|NCT00552240|79290770|FG001|Overall Study|Lack of Efficacy|0|||
44295293|NCT00552240|79290769|FG000|Overall Study|Other|1|||
44295294|NCT00552240|79290770|FG001|Overall Study|Other|0|||
44295295|NCT00552084|79290778|FG000|Overall Study|Adverse Event|2|||
44295296|NCT00552084|79290779|FG001|Overall Study|Adverse Event|3|||
44295297|NCT00552084|79290778|FG000|Overall Study|Withdrawal by Subject|4|||
44295298|NCT00552084|79290779|FG001|Overall Study|Withdrawal by Subject|5|||
44295299|NCT00552084|79290778|FG000|Overall Study|Protocol Violation|1|||
44533998|NCT02657434|79544728|FG000|Overall Study|Lost to Follow-up|2|||
44533999|NCT02657434|79544729|FG001|Overall Study|Lost to Follow-up|2|||
44295300|NCT00552084|79290779|FG001|Overall Study|Protocol Violation|0|||
44295301|NCT00552084|79290778|FG000|Overall Study|change in anti-arrythmic drug|1|||
44295302|NCT00552084|79290779|FG001|Overall Study|change in anti-arrythmic drug|1|||
44295303|NCT00550836|79290787|FG000|Overall Study|Withdrawal by Subject|3|||
44295304|NCT00550836|79290788|FG001|Overall Study|Withdrawal by Subject|9|||
44295305|NCT00550680|79290794|FG000|Overall Study|Administrative Reasons|1|||
44295306|NCT00550680|79290794|FG000|Overall Study|Adverse Event|5|||
44295307|NCT00550680|79290794|FG000|Overall Study|Death|3|||
44295308|NCT00550680|79290794|FG000|Overall Study|Early Improvement|1|||
44534000|NCT02657434|79544728|FG000|Overall Study|Randomization by Error|2|||
44295309|NCT00550680|79290794|FG000|Overall Study|Lost to Follow-up|3|||
44295310|NCT00550680|79290794|FG000|Overall Study|Lack of Efficacy|1|||
44295311|NCT00550680|79290794|FG000|Overall Study|Other|10|||
44295312|NCT00550680|79290794|FG000|Overall Study|Protocol Violation|7|||
44295313|NCT00550680|79290794|FG000|Overall Study|Refused Treatment|19|||
44295314|NCT00550680|79290794|FG000|Overall Study|Screen Failure|6|||
44295315|NCT00554190|79290798|FG000|Overall Study|Termination forms not completed|10|||
44295316|NCT00556374|79290804|FG000|Overall Study|Withdrawal by Subject|235|||
44295317|NCT00556374|79290805|FG001|Overall Study|Withdrawal by Subject|205|||
44295318|NCT00556374|79290804|FG000|Overall Study|Death|158|||
44295319|NCT00556374|79290805|FG001|Overall Study|Death|127|||
44295320|NCT00556374|79290804|FG000|Overall Study|Lost to Follow-up|24|||
44295321|NCT00556374|79290805|FG001|Overall Study|Lost to Follow-up|17|||
44295322|NCT00556374|79290804|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
44295323|NCT00556374|79290805|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
44295324|NCT04677959|79290836|FG000|Overall Study|Adverse Event|1|||
44295325|NCT04677959|79290837|FG001|Overall Study|Adverse Event|9|||
44295326|NCT04677959|79290836|FG000|Overall Study|Withdrawal by Subject|2|||
44295327|NCT04677959|79290837|FG001|Overall Study|Withdrawal by Subject|15|||
44295328|NCT04677959|79290836|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44295329|NCT04677959|79290837|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44295330|NCT04677959|79290836|FG000|Overall Study|Non-compliance with study drug|0|||
44295331|NCT04677959|79290837|FG001|Overall Study|Non-compliance with study drug|2|||
44295332|NCT04677959|79290836|FG000|Overall Study|Protocol deviation|0|||
44295333|NCT04677959|79290837|FG001|Overall Study|Protocol deviation|11|||
44295334|NCT04677959|79290836|FG000|Overall Study|Lost to Follow-up|9|||
44295335|NCT04677959|79290837|FG001|Overall Study|Lost to Follow-up|13|||
44295336|NCT04677959|79290836|FG000|Overall Study|Other than specified|0|||
44295337|NCT04677959|79290837|FG001|Overall Study|Other than specified|8|||
44295338|NCT04330638|79290864|FG000|Overall Study|Adverse Event|9|||
44295339|NCT04330638|79290865|FG001|Overall Study|Adverse Event|10|||
44295340|NCT04330638|79290866|FG002|Overall Study|Adverse Event|15|||
44295341|NCT04330638|79290867|FG003|Overall Study|Adverse Event|6|||
44295342|NCT04330638|79290868|FG004|Overall Study|Adverse Event|10|||
44295343|NCT04330638|79290869|FG005|Overall Study|Adverse Event|5|||
44295344|NCT04330638|79290864|FG000|Overall Study|Other|2|||
44295345|NCT04330638|79290865|FG001|Overall Study|Other|2|||
44295346|NCT04330638|79290866|FG002|Overall Study|Other|5|||
44295347|NCT04330638|79290867|FG003|Overall Study|Other|1|||
44295348|NCT04330638|79290868|FG004|Overall Study|Other|3|||
44295349|NCT04330638|79290869|FG005|Overall Study|Other|2|||
44295350|NCT04330638|79290864|FG000|Overall Study|Withdrawal by Subject|4|||
44295351|NCT04330638|79290865|FG001|Overall Study|Withdrawal by Subject|0|||
44295352|NCT04330638|79290866|FG002|Overall Study|Withdrawal by Subject|0|||
44295353|NCT04330638|79290867|FG003|Overall Study|Withdrawal by Subject|0|||
44295354|NCT04330638|79290868|FG004|Overall Study|Withdrawal by Subject|0|||
44295355|NCT04330638|79290869|FG005|Overall Study|Withdrawal by Subject|0|||
44295356|NCT04330638|79290864|FG000|Overall Study|Lost to Follow-up|3|||
44295357|NCT04330638|79290865|FG001|Overall Study|Lost to Follow-up|2|||
44295358|NCT04330638|79290866|FG002|Overall Study|Lost to Follow-up|3|||
44295359|NCT04330638|79290867|FG003|Overall Study|Lost to Follow-up|2|||
44295360|NCT04330638|79290868|FG004|Overall Study|Lost to Follow-up|3|||
44295361|NCT04330638|79290869|FG005|Overall Study|Lost to Follow-up|0|||
44295362|NCT04194541|79290890|FG000|Day 1 Through 13|Lost to Follow-up|3|||
44295363|NCT04194541|79290890|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
44295364|NCT04194541|79290890|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
44295365|NCT04006392|79290908|FG000|Overall Study|Lost to Follow-up|0|||
44295366|NCT04006392|79290909|FG001|Overall Study|Lost to Follow-up|1|||
44295367|NCT03959423|79290917|FG000|Overall Study|Withdrawal by Subject|2|||
44295368|NCT03959423|79290918|FG001|Overall Study|Withdrawal by Subject|3|||
44295369|NCT03959423|79290917|FG000|Overall Study|Physician Decision|0|||
44295370|NCT03959423|79290918|FG001|Overall Study|Physician Decision|1|||
44295371|NCT03959423|79290917|FG000|Overall Study|Lost to Follow-up|1|||
44295372|NCT03959423|79290918|FG001|Overall Study|Lost to Follow-up|0|||
44295373|NCT03959423|79290917|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
44295374|NCT03959423|79290918|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44295375|NCT03786783|79290924|FG000|Overall Study|Death|1|||
44295376|NCT03786783|79290924|FG000|Overall Study|Physician Decision|6|||
44295377|NCT03786783|79290924|FG000|Overall Study|Withdrawal by Subject|2|||
44295378|NCT03786783|79290924|FG000|Overall Study|Disease Progression|7|||
44295379|NCT03786783|79290924|FG000|Overall Study|Patient/Parent Refusal|4|||
44295380|NCT03432494|79290938|FG000|Overall Study|Death|1|||
44295381|NCT03432494|79290938|FG000|Overall Study|Noncompliance|1|||
44295382|NCT03287830|79290944|FG000|Overall Study|Withdrawal by Subject|1|||
44295383|NCT03287830|79290945|FG001|Overall Study|Withdrawal by Subject|1|||
44295384|NCT03287830|79290944|FG000|Overall Study|not meeting inclusion criteria|5|||
44295385|NCT03287830|79290945|FG001|Overall Study|not meeting inclusion criteria|12|||
44295386|NCT03181633|79290955|FG000|Overall Study|Withdrawal by Subject|1|||
44295387|NCT03181633|79290955|FG000|Overall Study|Missing follow-up visit|1|||
44295388|NCT03122223|79290972|FG000|Overall Study|Withdrawal by Subject|2|||
44295389|NCT03122223|79290973|FG001|Overall Study|Withdrawal by Subject|2|||
44295390|NCT03122223|79290974|FG002|Overall Study|Withdrawal by Subject|1|||
44295391|NCT03122223|79290975|FG003|Overall Study|Withdrawal by Subject|0|||
44295392|NCT03122223|79290972|FG000|Overall Study|Lost to Follow-up|0|||
44295393|NCT03122223|79290973|FG001|Overall Study|Lost to Follow-up|2|||
44295394|NCT03122223|79290974|FG002|Overall Study|Lost to Follow-up|2|||
44295395|NCT03122223|79290975|FG003|Overall Study|Lost to Follow-up|0|||
44295396|NCT03122223|79290972|FG000|Overall Study|Participant unable to adhere|1|||
44295397|NCT03122223|79290973|FG001|Overall Study|Participant unable to adhere|1|||
44295398|NCT03122223|79290974|FG002|Overall Study|Participant unable to adhere|1|||
44295399|NCT03122223|79290975|FG003|Overall Study|Participant unable to adhere|0|||
44295400|NCT03077087|79290985|FG000|Overall Study|Physician Decision|2|||
44295401|NCT02853604|79290991|FG000|Overall Study|Withdrawal by Subject|12|||
44295402|NCT02853604|79290992|FG001|Overall Study|Withdrawal by Subject|35|||
44295403|NCT02853604|79290991|FG000|Overall Study|Lost to Follow-up|4|||
44295404|NCT02853604|79290992|FG001|Overall Study|Lost to Follow-up|8|||
44295405|NCT02853604|79290991|FG000|Overall Study|Death|1|||
44295406|NCT02853604|79290992|FG001|Overall Study|Death|5|||
44416902|NCT00765882|79424801|FG001|Overall Study|Lack of Efficacy|0|||
44416903|NCT00765882|79424802|FG002|Overall Study|Lack of Efficacy|1|||
44416904|NCT00765882|79424800|FG000|Overall Study|Protocol Violation|4|||
44416905|NCT00765882|79424801|FG001|Overall Study|Protocol Violation|3|||
44416906|NCT00765882|79424802|FG002|Overall Study|Protocol Violation|1|||
44416907|NCT00765882|79424800|FG000|Overall Study|Withdrawal by Subject|2|||
44416908|NCT00765882|79424801|FG001|Overall Study|Withdrawal by Subject|6|||
44416909|NCT00765882|79424802|FG002|Overall Study|Withdrawal by Subject|6|||
44416910|NCT00765882|79424800|FG000|Overall Study|Lost to Follow-up|1|||
44416911|NCT00765882|79424801|FG001|Overall Study|Lost to Follow-up|9|||
44416912|NCT00765882|79424802|FG002|Overall Study|Lost to Follow-up|6|||
44154626|NCT02684617|78945926|FG002|Overall Study|Death|28|||
44154627|NCT02684617|78945924|FG000|Overall Study|Withdrawal by Subject|2|||
44534001|NCT02657434|79544729|FG001|Overall Study|Randomization by Error|0|||
44534002|NCT02657434|79544728|FG000|Overall Study|Withdrawal by Subject|28|||
44534003|NCT02657434|79544729|FG001|Overall Study|Withdrawal by Subject|17|||
44534004|NCT02657434|79544728|FG000|Overall Study|Protocol Violation|1|||
44154628|NCT02684617|78945925|FG001|Overall Study|Withdrawal by Subject|0|||
44154629|NCT02684617|78945926|FG002|Overall Study|Withdrawal by Subject|4|||
44295407|NCT02853604|79290991|FG000|Overall Study|Miscellaneous|11|||
44295408|NCT02853604|79290992|FG001|Overall Study|Miscellaneous|2|||
44295409|NCT02853604|79290991|FG000|Overall Study|Progressive Disease|0|||
44295410|NCT02853604|79290992|FG001|Overall Study|Progressive Disease|2|||
44295411|NCT02632552|79291018|FG000|Overall Study|Lost to Follow-up|14|||
44295412|NCT02632552|79291019|FG001|Overall Study|Lost to Follow-up|8|||
44295413|NCT02632552|79291018|FG000|Overall Study|Withdrawal by Subject|2|||
44295414|NCT02632552|79291019|FG001|Overall Study|Withdrawal by Subject|0|||
44295415|NCT02632552|79291018|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
44295416|NCT02632552|79291019|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
44295417|NCT01992653|79291052|FG000|Overall Study|Death|0|||
44295418|NCT01992653|79291053|FG001|Overall Study|Death|0|||
44416913|NCT00765882|79424800|FG000|Overall Study|Other Reason|3|||
44416914|NCT00765882|79424801|FG001|Overall Study|Other Reason|1|||
44416915|NCT00765882|79424802|FG002|Overall Study|Other Reason|2|||
44416916|NCT00769860|79424812|FG000|Overall Study|Withdrawal by Subject|2|||
44416917|NCT00769860|79424813|FG001|Overall Study|Withdrawal by Subject|0|||
44416918|NCT00858143|79424819|FG000|Overall Study|Adverse Event|16|||
44416919|NCT00858143|79424819|FG000|Overall Study|Lack of Efficacy|4|||
44416920|NCT00858143|79424819|FG000|Overall Study|Death|7|||
44416921|NCT00858143|79424819|FG000|Overall Study|Other|23|||
44416922|NCT00828113|79424825|FG000|Overall Study|Withdrawal by Subject|27|||
44416923|NCT00828113|79424826|FG001|Overall Study|Withdrawal by Subject|26|||
44416924|NCT00828113|79424825|FG000|Overall Study|Lost to Follow-up|3|||
44416925|NCT00828113|79424826|FG001|Overall Study|Lost to Follow-up|5|||
44416926|NCT00769704|79424834|FG000|Overall Study|Lost to Follow-up|3|||
44416927|NCT00769704|79424835|FG001|Overall Study|Lost to Follow-up|2|||
44416928|NCT00769704|79424834|FG000|Overall Study|Death|95|||
44416929|NCT00769704|79424835|FG001|Overall Study|Death|190|||
44416930|NCT00769704|79424834|FG000|Overall Study|Withdrawal by Subject|12|||
44416931|NCT00769704|79424835|FG001|Overall Study|Withdrawal by Subject|5|||
44416932|NCT00769704|79424834|FG000|Overall Study|Other|1|||
44416933|NCT00769704|79424835|FG001|Overall Study|Other|2|||
44416934|NCT00818753|79424845|FG000|Overall Study|Protocol Violation|1|||
44534005|NCT02657434|79544729|FG001|Overall Study|Protocol Violation|0|||
44534006|NCT02657434|79544728|FG000|Overall Study|Physician Decision|0|||
44534007|NCT02657434|79544729|FG001|Overall Study|Physician Decision|1|||
44534008|NCT02656290|79544736|FG000|Overall Study|Lost to Follow-up|1|||
44534009|NCT02656290|79544736|FG000|Overall Study|Reintervention|3|||
44534010|NCT02255149|79544748|FG000|Overall Study|Lost to Follow-up|2|||
44534011|NCT02255149|79544748|FG000|Overall Study|Withdrawal by Subject|1|||
44154630|NCT02684617|78945924|FG000|Overall Study|Screen Failure|1|||
44534012|NCT02255149|79544748|FG000|Overall Study|Withdrawal by PI|1|||
44295419|NCT01992653|79291054|FG002|Overall Study|Death|1|||
44295420|NCT01992653|79291055|FG003|Overall Study|Death|0|||
44295421|NCT01992653|79291056|FG004|Overall Study|Death|1|||
44295422|NCT01992653|79291057|FG005|Overall Study|Death|0|||
44295423|NCT01992653|79291058|FG006|Overall Study|Death|4|||
44295424|NCT01992653|79291059|FG007|Overall Study|Death|2|||
44295425|NCT01992653|79291052|FG000|Overall Study|Lost to Follow-up|0|||
44295426|NCT01992653|79291053|FG001|Overall Study|Lost to Follow-up|0|||
44295427|NCT01992653|79291054|FG002|Overall Study|Lost to Follow-up|0|||
44295428|NCT01992653|79291055|FG003|Overall Study|Lost to Follow-up|0|||
44295429|NCT01992653|79291056|FG004|Overall Study|Lost to Follow-up|0|||
44295430|NCT01992653|79291057|FG005|Overall Study|Lost to Follow-up|0|||
44295431|NCT01992653|79291058|FG006|Overall Study|Lost to Follow-up|0|||
44295432|NCT01992653|79291059|FG007|Overall Study|Lost to Follow-up|1|||
44295433|NCT01992653|79291052|FG000|Overall Study|Study Completed|0|||
44295434|NCT01992653|79291053|FG001|Overall Study|Study Completed|0|||
44295435|NCT01992653|79291054|FG002|Overall Study|Study Completed|0|||
44295436|NCT01992653|79291055|FG003|Overall Study|Study Completed|0|||
44295437|NCT01992653|79291056|FG004|Overall Study|Study Completed|0|||
44295438|NCT01992653|79291057|FG005|Overall Study|Study Completed|0|||
44295439|NCT01992653|79291058|FG006|Overall Study|Study Completed|0|||
44295440|NCT01992653|79291059|FG007|Overall Study|Study Completed|1|||
44295441|NCT01992653|79291052|FG000|Overall Study|Disease Progression|0|||
44295442|NCT01992653|79291053|FG001|Overall Study|Disease Progression|0|||
44295443|NCT01992653|79291054|FG002|Overall Study|Disease Progression|0|||
44295444|NCT01992653|79291055|FG003|Overall Study|Disease Progression|0|||
44295445|NCT01992653|79291056|FG004|Overall Study|Disease Progression|0|||
44295446|NCT01992653|79291057|FG005|Overall Study|Disease Progression|0|||
44295447|NCT01992653|79291058|FG006|Overall Study|Disease Progression|4|||
44295448|NCT01992653|79291059|FG007|Overall Study|Disease Progression|0|||
44295449|NCT01654276|79291094|FG000|Overall Study|Lack of Efficacy|1|||
44295450|NCT01654276|79291094|FG000|Overall Study|Lost to Follow-up|4|||
44295451|NCT01654276|79291094|FG000|Overall Study|Withdrawal by Subject|1|||
44295452|NCT01399658|79291098|FG000|Overall Study|Ineligible|1|||
44295453|NCT01399658|79291098|FG000|Overall Study|Machine Technical Issue|3|||
44295454|NCT01399658|79291098|FG000|Overall Study|Alternative therapy|1|||
44295455|NCT01399658|79291098|FG000|Overall Study|No reason given|1|||
44295456|NCT00590122|79291104|FG000|Overall Study|swallowed oral dissolving dose|1|||
44295457|NCT00590122|79291105|FG001|Overall Study|swallowed oral dissolving dose|0|||
44295458|NCT01386658|79291134|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
44295459|NCT01386658|79291135|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
44295460|NCT01386658|79291134|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
44295461|NCT01386658|79291135|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
44295462|NCT01386684|79291145|FG000|Overall Study|Lost to Follow-up|51|||
44295463|NCT01386684|79291145|FG000|Overall Study|Other|51|||
44295464|NCT01386684|79291145|FG000|Overall Study|Death|47|||
44295465|NCT01386684|79291145|FG000|Overall Study|Withdrawal of Consent|44|||
44295466|NCT01386684|79291145|FG000|Overall Study|Alternative Therapy Required|37|||
44295467|NCT01386684|79291145|FG000|Overall Study|Disease Progression|28|||
44295468|NCT01386684|79291145|FG000|Overall Study|Adverse Event|20|||
44295469|NCT01386684|79291145|FG000|Overall Study|Noncompliance|8|||
44295470|NCT01386684|79291145|FG000|Overall Study|Protocol Violation|4|||
44534013|NCT02255149|79544748|FG000|Overall Study|Implant Failure|1|||
44534014|NCT02101853|79544760|FG000|Block 1 Induction|Adverse Event|11|||
44256401|NCT01465958|79105665|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
44256402|NCT01465958|79105666|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
44256403|NCT02581488|79105879|FG000|Overall Study|Adverse Event|6|||
44256404|NCT02581488|79105880|FG001|Overall Study|Adverse Event|7|||
44256405|NCT02581488|79105879|FG000|Overall Study|Lost to Follow-up|1|||
44256406|NCT02581488|79105880|FG001|Overall Study|Lost to Follow-up|0|||
44256407|NCT02581488|79105879|FG000|Overall Study|Withdrawal by Subject|1|||
44256408|NCT02581488|79105880|FG001|Overall Study|Withdrawal by Subject|0|||
44256409|NCT02581488|79105879|FG000|Overall Study|Non-Compliance|1|||
44256410|NCT02581488|79105880|FG001|Overall Study|Non-Compliance|0|||
44256411|NCT02581488|79105879|FG000|Overall Study|Protocol Violation|0|||
44256412|NCT02581488|79105880|FG001|Overall Study|Protocol Violation|4|||
44256413|NCT02581410|79105923|FG000|Vaccination Phase|Adverse Event|2|||
44295471|NCT01386684|79291145|FG000|Overall Study|Missing|3|||
44295472|NCT04980014|79291162|FG000|Overall Study|Participants who are Duplicated|1|||
44295473|NCT04980014|79291162|FG000|Overall Study|Follow-up Failure|13|||
44534015|NCT02101853|79544761|FG001|Block 1 Induction|Adverse Event|0|||
44256414|NCT02581410|79105924|FG001|Vaccination Phase|Adverse Event|1|||
44256415|NCT02581410|79105923|FG000|Vaccination Phase|Withdrawal by Subject|0|||
44256416|NCT02581410|79105924|FG001|Vaccination Phase|Withdrawal by Subject|1|||
44256417|NCT02581410|79105923|FG000|Vaccination Phase|Migrated/moved from study area|0|||
44295474|NCT04980014|79291162|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
44295475|NCT04980014|79291162|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
44295476|NCT04980014|79291162|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
44154631|NCT02684617|78945925|FG001|Overall Study|Screen Failure|0|||
44295477|NCT05301322|79291185|FG000|Overall Study|Adverse Event|7|||
44295478|NCT05301322|79291186|FG001|Overall Study|Adverse Event|3|||
44295479|NCT05301322|79291185|FG000|Overall Study|Death|0|||
44295480|NCT05301322|79291186|FG001|Overall Study|Death|1|||
44295481|NCT05301322|79291185|FG000|Overall Study|Lost to Follow-up|2|||
44295482|NCT05301322|79291186|FG001|Overall Study|Lost to Follow-up|1|||
44295483|NCT05301322|79291185|FG000|Overall Study|Protocol Violation|3|||
44295484|NCT05301322|79291186|FG001|Overall Study|Protocol Violation|1|||
44295485|NCT05301322|79291185|FG000|Overall Study|Withdrawal by Subject|3|||
44295486|NCT05301322|79291186|FG001|Overall Study|Withdrawal by Subject|0|||
44295487|NCT05301322|79291185|FG000|Overall Study|Other|4|||
44295488|NCT05301322|79291186|FG001|Overall Study|Other|0|||
44295489|NCT04956575|79291224|FG000|Overall Study|Death|1|||
44295490|NCT04956575|79291225|FG001|Overall Study|Death|0|||
44295491|NCT04956575|79291226|FG002|Overall Study|Death|0|||
44295492|NCT04956575|79291227|FG003|Overall Study|Death|0|||
44295493|NCT04956575|79291228|FG004|Overall Study|Death|0|||
44295494|NCT04956575|79291229|FG005|Overall Study|Death|0|||
44295495|NCT04956575|79291230|FG006|Overall Study|Death|0|||
44295496|NCT04956575|79291231|FG007|Overall Study|Death|1|||
44295497|NCT04956575|79291232|FG008|Overall Study|Death|0|||
44295498|NCT04956575|79291233|FG009|Overall Study|Death|1|||
44295499|NCT04956575|79291234|FG010|Overall Study|Death|0|||
44295500|NCT04956575|79291235|FG011|Overall Study|Death|0|||
44295501|NCT04956575|79291224|FG000|Overall Study|Lost to Follow-up|3|||
44295502|NCT04956575|79291225|FG001|Overall Study|Lost to Follow-up|4|||
44295503|NCT04956575|79291226|FG002|Overall Study|Lost to Follow-up|2|||
44295504|NCT04956575|79291227|FG003|Overall Study|Lost to Follow-up|3|||
44295505|NCT04956575|79291228|FG004|Overall Study|Lost to Follow-up|1|||
44295506|NCT04956575|79291229|FG005|Overall Study|Lost to Follow-up|10|||
44295507|NCT04956575|79291230|FG006|Overall Study|Lost to Follow-up|11|||
44295508|NCT04956575|79291231|FG007|Overall Study|Lost to Follow-up|7|||
44295509|NCT04956575|79291232|FG008|Overall Study|Lost to Follow-up|4|||
44295510|NCT04956575|79291233|FG009|Overall Study|Lost to Follow-up|2|||
44295511|NCT04956575|79291234|FG010|Overall Study|Lost to Follow-up|3|||
44295512|NCT04956575|79291235|FG011|Overall Study|Lost to Follow-up|8|||
44295513|NCT04956575|79291224|FG000|Overall Study|Withdrawal by Subject|1|||
44295514|NCT04956575|79291225|FG001|Overall Study|Withdrawal by Subject|2|||
44295515|NCT04956575|79291226|FG002|Overall Study|Withdrawal by Subject|1|||
44295516|NCT04956575|79291227|FG003|Overall Study|Withdrawal by Subject|4|||
44295517|NCT04956575|79291228|FG004|Overall Study|Withdrawal by Subject|2|||
44295518|NCT04956575|79291229|FG005|Overall Study|Withdrawal by Subject|8|||
44295519|NCT04956575|79291230|FG006|Overall Study|Withdrawal by Subject|5|||
44295520|NCT04956575|79291231|FG007|Overall Study|Withdrawal by Subject|1|||
44295521|NCT04956575|79291232|FG008|Overall Study|Withdrawal by Subject|1|||
44295522|NCT04956575|79291233|FG009|Overall Study|Withdrawal by Subject|0|||
44295523|NCT04956575|79291234|FG010|Overall Study|Withdrawal by Subject|3|||
44295524|NCT04956575|79291235|FG011|Overall Study|Withdrawal by Subject|1|||
44295525|NCT04720105|79291286|FG000|Overall Study|Lack of Efficacy|1|||
44295526|NCT04720105|79291286|FG000|Overall Study|Lost to Follow-up|1|||
44295527|NCT04720105|79291286|FG000|Overall Study|Withdrawal by Subject|3|||
44295528|NCT04573309|79291296|FG000|Overall Study|Protocol Violation|1|||
44295529|NCT04573309|79291297|FG001|Overall Study|Protocol Violation|0|||
44295530|NCT04220866|79291314|FG000|Overall Study|Death|4|||
44295531|NCT04220866|79291315|FG001|Overall Study|Death|5|||
44295532|NCT04220866|79291314|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
44295533|NCT04220866|79291315|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
44295534|NCT04220866|79291314|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
44295535|NCT04220866|79291315|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
44295536|NCT04220866|79291314|FG000|Overall Study|Withdrawal by Subject|0|||
44295537|NCT04220866|79291315|FG001|Overall Study|Withdrawal by Subject|1|||
44154632|NCT02684617|78945926|FG002|Overall Study|Screen Failure|2|||
44295538|NCT04004611|79291328|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295539|NCT04004611|79291329|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295540|NCT04004611|79291330|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295541|NCT04004611|79291331|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295542|NCT04004611|79291332|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295543|NCT04004611|79291333|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295544|NCT04004611|79291334|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295545|NCT04004611|79291335|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
44295546|NCT04004611|79291336|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
44295547|NCT04004611|79291328|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
44295548|NCT04004611|79291329|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
44295549|NCT04004611|79291330|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
44295550|NCT04004611|79291331|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
44295551|NCT04004611|79291332|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
44295552|NCT04004611|79291333|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
44295553|NCT04004611|79291334|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
44295554|NCT04004611|79291335|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
44295555|NCT04004611|79291336|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
44295556|NCT04004611|79291328|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295557|NCT04004611|79291329|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295558|NCT04004611|79291330|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295559|NCT04004611|79291331|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295560|NCT04004611|79291332|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
44295561|NCT04004611|79291333|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295562|NCT04004611|79291334|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295563|NCT04004611|79291335|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295564|NCT04004611|79291336|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
44295565|NCT04004611|79291328|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
44295566|NCT04004611|79291329|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
44295567|NCT04004611|79291330|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
44295568|NCT04004611|79291331|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
44295569|NCT04004611|79291332|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
44295570|NCT04004611|79291333|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
44295571|NCT04004611|79291334|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
44295572|NCT04004611|79291335|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
44295573|NCT04004611|79291336|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
44295574|NCT04004611|79291328|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
44295575|NCT04004611|79291329|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44295576|NCT04004611|79291330|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
44295577|NCT04004611|79291331|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44295578|NCT04004611|79291332|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44295579|NCT04004611|79291333|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44295580|NCT04004611|79291334|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44416935|NCT00818753|79424846|FG001|Overall Study|Protocol Violation|0|||
44416936|NCT00818753|79424847|FG002|Overall Study|Protocol Violation|0|||
44416937|NCT00818753|79424845|FG000|Overall Study|Other reason (not specified)|0|||
44416938|NCT00818753|79424846|FG001|Overall Study|Other reason (not specified)|0|||
44416939|NCT00818753|79424847|FG002|Overall Study|Other reason (not specified)|1|||
44416940|NCT00818753|79424845|FG000|Overall Study|Randomised and not treated|2|||
44416941|NCT00818753|79424846|FG001|Overall Study|Randomised and not treated|0|||
44416942|NCT00818753|79424847|FG002|Overall Study|Randomised and not treated|0|||
44416943|NCT00765726|79424855|FG000|Overall Study|Withdrawal by Subject|1|||
44416944|NCT00765726|79424855|FG000|Overall Study|Discontinuation of study by sponsor|8|||
44416945|NCT00765336|79424861|FG000|Overall Study|Protocol Violation|4|||
44416946|NCT00765336|79424862|FG001|Overall Study|Protocol Violation|2|||
44416947|NCT00765336|79424861|FG000|Overall Study|Withdrawal by Subject|6|||
44416948|NCT00765336|79424862|FG001|Overall Study|Withdrawal by Subject|4|||
44416949|NCT00765336|79424861|FG000|Overall Study|Lost to Follow-up|7|||
44416950|NCT00765336|79424862|FG001|Overall Study|Lost to Follow-up|9|||
44416951|NCT00765336|79424861|FG000|Overall Study|Adverse Event|2|||
44416952|NCT00765336|79424862|FG001|Overall Study|Adverse Event|1|||
44416953|NCT00818519|79424870|FG000|Overall Study|Adverse Event|2|||
44416954|NCT00818519|79424871|FG001|Overall Study|Adverse Event|2|||
44416955|NCT00818519|79424870|FG000|Overall Study|Lost to Follow-up|4|||
44416956|NCT00818519|79424871|FG001|Overall Study|Lost to Follow-up|6|||
44416957|NCT00818519|79424870|FG000|Overall Study|Protocol Violation|2|||
44416958|NCT00818519|79424871|FG001|Overall Study|Protocol Violation|1|||
44416959|NCT00818519|79424870|FG000|Overall Study|Pregnancy|0|||
44416960|NCT00818519|79424871|FG001|Overall Study|Pregnancy|1|||
44416961|NCT00818519|79424870|FG000|Overall Study|Withdrawal by Subject|4|||
44416962|NCT00818519|79424871|FG001|Overall Study|Withdrawal by Subject|9|||
44416963|NCT00818519|79424870|FG000|Overall Study|participant recovered completely|1|||
44416964|NCT00818519|79424871|FG001|Overall Study|participant recovered completely|0|||
44534016|NCT02101853|79544762|FG002|Block 1 Induction|Adverse Event|0|||
44534017|NCT02101853|79544763|FG003|Block 1 Induction|Adverse Event|0|||
44256418|NCT02581410|79105924|FG001|Vaccination Phase|Migrated/moved from study area|1|||
44256419|NCT02581410|79105923|FG000|End of Study Phase|Adverse Event|4|||
44256420|NCT02581410|79105924|FG001|End of Study Phase|Adverse Event|3|||
44256421|NCT02581410|79105923|FG000|End of Study Phase|Withdrawal by Subject|1|||
44256422|NCT02581410|79105924|FG001|End of Study Phase|Withdrawal by Subject|2|||
44256423|NCT02581410|79105923|FG000|End of Study Phase|Migrated/moved from study area|0|||
44256424|NCT02581410|79105924|FG001|End of Study Phase|Migrated/moved from study area|3|||
44256425|NCT02581410|79105923|FG000|End of Study Phase|Lost to Follow-up|0|||
44256426|NCT02581410|79105924|FG001|End of Study Phase|Lost to Follow-up|2|||
44256427|NCT02581410|79105923|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
44256428|NCT02581410|79105924|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
44295581|NCT04004611|79291335|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44295582|NCT04004611|79291336|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
44295583|NCT04004611|79291328|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295584|NCT04004611|79291329|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
44295585|NCT04004611|79291330|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295586|NCT04004611|79291331|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295587|NCT04004611|79291332|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295588|NCT04004611|79291333|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295589|NCT04004611|79291334|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295590|NCT04004611|79291335|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295591|NCT04004611|79291336|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
44295592|NCT03824938|79291366|FG000|Overall Study|Withdrawal by Subject|2|||
44295593|NCT03824938|79291367|FG001|Overall Study|Withdrawal by Subject|1|||
44295594|NCT03824938|79291368|FG002|Overall Study|Withdrawal by Subject|0|||
44295595|NCT03824938|79291369|FG003|Overall Study|Withdrawal by Subject|2|||
44295596|NCT03824938|79291370|FG004|Overall Study|Withdrawal by Subject|0|||
44295597|NCT03824938|79291371|FG005|Overall Study|Withdrawal by Subject|1|||
44295598|NCT03824938|79291366|FG000|Overall Study|Lost to Follow-up|0|||
44295599|NCT03824938|79291367|FG001|Overall Study|Lost to Follow-up|1|||
44295600|NCT03824938|79291368|FG002|Overall Study|Lost to Follow-up|0|||
44295601|NCT03824938|79291369|FG003|Overall Study|Lost to Follow-up|0|||
44295602|NCT03824938|79291370|FG004|Overall Study|Lost to Follow-up|1|||
44295603|NCT03824938|79291371|FG005|Overall Study|Lost to Follow-up|0|||
44295604|NCT03636373|79291381|FG000|Overall Study|Study closure due to Covid-19|1|||
44295605|NCT03636373|79291382|FG001|Overall Study|Study closure due to Covid-19|0|||
44534018|NCT02101853|79544764|FG004|Block 1 Induction|Adverse Event|0|||
44534019|NCT02101853|79544765|FG005|Block 1 Induction|Adverse Event|0|||
44534020|NCT02101853|79544760|FG000|Block 1 Induction|Death|20|||
44534021|NCT02101853|79544761|FG001|Block 1 Induction|Death|0|||
44534022|NCT02101853|79544762|FG002|Block 1 Induction|Death|0|||
44534023|NCT02101853|79544763|FG003|Block 1 Induction|Death|0|||
44295612|NCT03004443|79291405|FG000|Overall Study|Pregnancy|0|||
44295613|NCT03004443|79291406|FG001|Overall Study|Pregnancy|1|||
44295614|NCT02277028|79291414|FG000|Overall Study|Lost to Follow-up|1|||
44295615|NCT02277028|79291415|FG001|Overall Study|Lost to Follow-up|0|||
44295616|NCT02277028|79291414|FG000|Overall Study|Withdrawal by Subject|0|||
44295617|NCT02277028|79291415|FG001|Overall Study|Withdrawal by Subject|1|||
44295618|NCT03735849|79291467|FG000|Overall Study|Lost to Follow-up|1|||
44295619|NCT03735849|79291468|FG001|Overall Study|Lost to Follow-up|0|||
44295620|NCT03735849|79291469|FG002|Overall Study|Lost to Follow-up|0|||
44295621|NCT03735849|79291467|FG000|Overall Study|Participant unable to adhere to visit|1|||
44295622|NCT03735849|79291468|FG001|Overall Study|Participant unable to adhere to visit|0|||
44295623|NCT03735849|79291469|FG002|Overall Study|Participant unable to adhere to visit|0|||
44295624|NCT03735849|79291467|FG000|Overall Study|Not Randomized|0|||
44295625|NCT03735849|79291468|FG001|Overall Study|Not Randomized|0|||
44295626|NCT03735849|79291469|FG002|Overall Study|Not Randomized|4|||
44295627|NCT03552393|79291476|FG000|Core Period|Kidney Transplant|1|||
44295628|NCT03552393|79291476|FG000|Core Period|Prohibited Medication|1|||
44295629|NCT03552393|79291476|FG000|Safety Extension Period|Kidney Transplant|4|||
44295630|NCT03333382|79291482|FG000|Overall Study|Lost to Follow-up|1|||
44295631|NCT03333382|79291483|FG001|Overall Study|Lost to Follow-up|0|||
44295632|NCT03107611|79291522|FG000|Overall Study|Adverse Event|1|||
44295633|NCT03107611|79291523|FG001|Overall Study|Adverse Event|0|||
44295634|NCT03107611|79291524|FG002|Overall Study|Adverse Event|2|||
44295635|NCT03107611|79291522|FG000|Overall Study|Lost to Follow-up|3|||
44295636|NCT03107611|79291523|FG001|Overall Study|Lost to Follow-up|3|||
44295637|NCT03107611|79291524|FG002|Overall Study|Lost to Follow-up|3|||
44295638|NCT03107611|79291522|FG000|Overall Study|Protocol Violation|0|||
44295639|NCT03107611|79291523|FG001|Overall Study|Protocol Violation|0|||
44295640|NCT03107611|79291524|FG002|Overall Study|Protocol Violation|1|||
44295641|NCT03107611|79291522|FG000|Overall Study|Withdrawal by Subject|1|||
44295642|NCT03107611|79291523|FG001|Overall Study|Withdrawal by Subject|0|||
44295643|NCT03107611|79291524|FG002|Overall Study|Withdrawal by Subject|1|||
44295644|NCT03107611|79291522|FG000|Overall Study|Worsening signs/symptoms|2|||
44295645|NCT03107611|79291523|FG001|Overall Study|Worsening signs/symptoms|1|||
44295646|NCT03107611|79291524|FG002|Overall Study|Worsening signs/symptoms|2|||
44295647|NCT02720016|79291535|FG000|Overall Study|Separation of couple|6|||
44295648|NCT02720016|79291536|FG001|Overall Study|Separation of couple|8|||
44295649|NCT02720016|79291537|FG002|Overall Study|Separation of couple|2|||
44295650|NCT02720016|79291535|FG000|Overall Study|Withdrawal by Subject|6|||
44295651|NCT02720016|79291536|FG001|Overall Study|Withdrawal by Subject|6|||
44295652|NCT02720016|79291537|FG002|Overall Study|Withdrawal by Subject|4|||
44295653|NCT02720016|79291535|FG000|Overall Study|Scheduling issues|2|||
44534024|NCT02101853|79544764|FG004|Block 1 Induction|Death|0|||
44534025|NCT02101853|79544765|FG005|Block 1 Induction|Death|0|||
44256429|NCT01664130|79105983|FG000|Overall Study|competing secondary disease|2|||
44256430|NCT02579928|79106014|FG000|Overall Study|Withdrawal by Subject|1|||
44256431|NCT02579928|79106015|FG001|Overall Study|Withdrawal by Subject|0|||
44256432|NCT00551460|79106109|FG000|Overall Study|Adverse Event|1|||
44256433|NCT00551460|79106109|FG000|Overall Study|Withdrawal by Subject|1|||
44256434|NCT00551460|79106109|FG000|Overall Study|Physician Decision|1|||
44256435|NCT00551460|79106109|FG000|Overall Study|Death|7|||
44256436|NCT00551460|79106109|FG000|Overall Study|Ineligible|4|||
44256437|NCT00551460|79106109|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
44256438|NCT02579772|79106170|FG000|Overall Study|Withdrawal by Subject|0|||
44256439|NCT02579772|79106171|FG001|Overall Study|Withdrawal by Subject|1|||
44256440|NCT02579772|79106170|FG000|Overall Study|Usage of additional antioxidants|1|||
44256441|NCT02579772|79106171|FG001|Overall Study|Usage of additional antioxidants|0|||
44256442|NCT02579772|79106170|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
44256443|NCT02579772|79106171|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
44256444|NCT02579616|79106244|FG000|Overall Study|Participants did not receive treatment|3|||
44256445|NCT04027608|79106304|FG000|Overall Study|Withdrawal by Subject|13|||
44256446|NCT04027608|79106305|FG001|Overall Study|Withdrawal by Subject|2|||
44256447|NCT04027608|79106304|FG000|Overall Study|Protocol Violation|2|||
44256448|NCT04027608|79106305|FG001|Overall Study|Protocol Violation|1|||
44256449|NCT04027608|79106304|FG000|Overall Study|Physician Decision|1|||
44256450|NCT04027608|79106305|FG001|Overall Study|Physician Decision|0|||
44256451|NCT04027608|79106304|FG000|Overall Study|Lost to Follow-up|20|||
44256452|NCT04027608|79106305|FG001|Overall Study|Lost to Follow-up|4|||
44256453|NCT01664052|79106396|FG000|Phase 1|No device placement|6|||
44256454|NCT01664052|79106397|FG001|Phase 1|No device placement|0|||
44256455|NCT01664052|79106396|FG000|Phase 1|No HSG 1 hr post placement|1|||
44256456|NCT01664052|79106397|FG001|Phase 1|No HSG 1 hr post placement|0|||
44256457|NCT01664052|79106396|FG000|Phase 2|No device placement|0|||
44256458|NCT01664052|79106397|FG001|Phase 2|No device placement|4|||
44256459|NCT01465802|79106444|FG000|Overall Study|Study terminated by sponsor|1|||
44256460|NCT01465802|79106445|FG001|Overall Study|Study terminated by sponsor|0|||
44256461|NCT01465802|79106446|FG002|Overall Study|Study terminated by sponsor|0|||
44256462|NCT01465802|79106447|FG003|Overall Study|Study terminated by sponsor|1|||
44256463|NCT01465802|79106448|FG004|Overall Study|Study terminated by sponsor|7|||
44256464|NCT01465802|79106444|FG000|Overall Study|Withdrawal by Subject|7|||
44256465|NCT01465802|79106445|FG001|Overall Study|Withdrawal by Subject|7|||
44256466|NCT01465802|79106446|FG002|Overall Study|Withdrawal by Subject|0|||
44256467|NCT01465802|79106447|FG003|Overall Study|Withdrawal by Subject|8|||
44256468|NCT01465802|79106448|FG004|Overall Study|Withdrawal by Subject|1|||
44256469|NCT01465802|79106444|FG000|Overall Study|Lost to Follow-up|1|||
44256470|NCT01465802|79106445|FG001|Overall Study|Lost to Follow-up|1|||
44256471|NCT01465802|79106446|FG002|Overall Study|Lost to Follow-up|0|||
44256472|NCT01465802|79106447|FG003|Overall Study|Lost to Follow-up|0|||
44256473|NCT01465802|79106448|FG004|Overall Study|Lost to Follow-up|0|||
44256474|NCT01465802|79106444|FG000|Overall Study|Reason not specified|9|||
44256475|NCT01465802|79106445|FG001|Overall Study|Reason not specified|4|||
44256476|NCT01465802|79106446|FG002|Overall Study|Reason not specified|0|||
44256477|NCT01465802|79106447|FG003|Overall Study|Reason not specified|10|||
44256478|NCT01465802|79106448|FG004|Overall Study|Reason not specified|2|||
44256479|NCT01465802|79106444|FG000|Overall Study|Death|15|||
44256480|NCT01465802|79106445|FG001|Overall Study|Death|12|||
44256481|NCT01465802|79106446|FG002|Overall Study|Death|0|||
44256482|NCT01465802|79106447|FG003|Overall Study|Death|10|||
44256483|NCT01465802|79106448|FG004|Overall Study|Death|2|||
44256484|NCT01437878|79106493|FG000|Overall Study|Withdrawal by Subject|1|||
44256485|NCT01437878|79106494|FG001|Overall Study|Withdrawal by Subject|0|||
44256486|NCT01465178|79106520|FG000|Overall Study|Withdrawal by Subject|1|||
44256487|NCT01465178|79106521|FG001|Overall Study|Withdrawal by Subject|0|||
44256488|NCT01445678|79106627|FG000|Overall Study|Adverse Event|12|||
44256489|NCT01445678|79106628|FG001|Overall Study|Adverse Event|8|||
44256490|NCT01445678|79106627|FG000|Overall Study|Lack of Efficacy|0|||
44256491|NCT01445678|79106628|FG001|Overall Study|Lack of Efficacy|2|||
44256492|NCT01445678|79106627|FG000|Overall Study|Lost to Follow-up|8|||
44256493|NCT01445678|79106628|FG001|Overall Study|Lost to Follow-up|5|||
44256494|NCT01445678|79106627|FG000|Overall Study|Protocol Violation|1|||
44256495|NCT01445678|79106628|FG001|Overall Study|Protocol Violation|1|||
44256496|NCT01445678|79106627|FG000|Overall Study|Withdrawal by Subject|9|||
44256497|NCT01445678|79106628|FG001|Overall Study|Withdrawal by Subject|5|||
44256498|NCT03769194|79106647|FG000|Overall Study|Withdrawal by Subject|0|||
44256499|NCT03769194|79106648|FG001|Overall Study|Withdrawal by Subject|7|||
44256500|NCT03769194|79106649|FG002|Overall Study|Withdrawal by Subject|4|||
44256501|NCT03769194|79106650|FG003|Overall Study|Withdrawal by Subject|1|||
44256502|NCT03769194|79106647|FG000|Overall Study|moved from study area|0|||
44256503|NCT03769194|79106648|FG001|Overall Study|moved from study area|2|||
44256504|NCT03769194|79106649|FG002|Overall Study|moved from study area|1|||
44256505|NCT03769194|79106650|FG003|Overall Study|moved from study area|1|||
44256506|NCT03769194|79106647|FG000|Overall Study|Lost to Follow-up|3|||
44295654|NCT02720016|79291536|FG001|Overall Study|Scheduling issues|4|||
44295655|NCT02720016|79291537|FG002|Overall Study|Scheduling issues|7|||
44295656|NCT02720016|79291535|FG000|Overall Study|Childcare|2|||
44295657|NCT02720016|79291536|FG001|Overall Study|Childcare|0|||
44295658|NCT02720016|79291537|FG002|Overall Study|Childcare|2|||
44295659|NCT02720016|79291535|FG000|Overall Study|Withdrawal by PI|2|||
44295660|NCT02720016|79291536|FG001|Overall Study|Withdrawal by PI|2|||
44295661|NCT02720016|79291537|FG002|Overall Study|Withdrawal by PI|0|||
44295662|NCT02720016|79291535|FG000|Overall Study|Moved away|2|||
44295663|NCT02720016|79291536|FG001|Overall Study|Moved away|0|||
44295664|NCT02720016|79291537|FG002|Overall Study|Moved away|0|||
44295665|NCT02720016|79291535|FG000|Overall Study|Not Primary Health Concern|0|||
44295666|NCT02720016|79291536|FG001|Overall Study|Not Primary Health Concern|0|||
44295667|NCT02720016|79291537|FG002|Overall Study|Not Primary Health Concern|2|||
44295668|NCT02720016|79291535|FG000|Overall Study|Transportation issues|0|||
44295669|NCT02720016|79291536|FG001|Overall Study|Transportation issues|0|||
44295670|NCT02720016|79291537|FG002|Overall Study|Transportation issues|1|||
44295671|NCT02720016|79291535|FG000|Overall Study|Other|0|||
44295672|NCT02720016|79291536|FG001|Overall Study|Other|0|||
44295673|NCT02720016|79291537|FG002|Overall Study|Other|2|||
44295674|NCT02607956|79291548|FG000|Double-Blinded Phase|Withdrew Consent|17|||
44295675|NCT02607956|79291549|FG001|Double-Blinded Phase|Withdrew Consent|19|||
44295676|NCT02607956|79291550|FG002|Double-Blinded Phase|Withdrew Consent|0|||
44295677|NCT02607956|79291551|FG003|Double-Blinded Phase|Withdrew Consent|0|||
44295678|NCT02607956|79291548|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
44295679|NCT02607956|79291549|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
44295680|NCT02607956|79291550|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
44295681|NCT02607956|79291551|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
44295682|NCT02607956|79291548|FG000|Double-Blinded Phase|Randomized but never treated|7|||
44295683|NCT02607956|79291549|FG001|Double-Blinded Phase|Randomized but never treated|5|||
44295684|NCT02607956|79291550|FG002|Double-Blinded Phase|Randomized but never treated|0|||
44295685|NCT02607956|79291551|FG003|Double-Blinded Phase|Randomized but never treated|0|||
44295686|NCT02607956|79291548|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
44295687|NCT02607956|79291549|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
44295688|NCT02607956|79291550|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
44295689|NCT02607956|79291551|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
44295690|NCT02607956|79291548|FG000|Double-Blinded Phase|Death|4|||
44295691|NCT02607956|79291549|FG001|Double-Blinded Phase|Death|4|||
44295692|NCT02607956|79291550|FG002|Double-Blinded Phase|Death|0|||
44295693|NCT02607956|79291551|FG003|Double-Blinded Phase|Death|0|||
44295694|NCT02607956|79291548|FG000|Double-Blinded Phase|Adverse Event|4|||
44295695|NCT02607956|79291549|FG001|Double-Blinded Phase|Adverse Event|3|||
44295696|NCT02607956|79291550|FG002|Double-Blinded Phase|Adverse Event|0|||
44295697|NCT02607956|79291551|FG003|Double-Blinded Phase|Adverse Event|0|||
44295698|NCT02607956|79291548|FG000|Double-Blinded Phase|Protocol Violation|3|||
44295699|NCT02607956|79291549|FG001|Double-Blinded Phase|Protocol Violation|1|||
44295700|NCT02607956|79291550|FG002|Double-Blinded Phase|Protocol Violation|0|||
44295701|NCT02607956|79291551|FG003|Double-Blinded Phase|Protocol Violation|0|||
44295702|NCT02607956|79291548|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
44295703|NCT02607956|79291549|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
44295704|NCT02607956|79291550|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
44295705|NCT02607956|79291551|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
44295706|NCT02607956|79291548|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
44295707|NCT02607956|79291549|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
44295708|NCT02607956|79291550|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
44295709|NCT02607956|79291551|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
44416965|NCT00818519|79424870|FG000|Overall Study|participant will leave for long tme|1|||
44416966|NCT00818519|79424871|FG001|Overall Study|participant will leave for long tme|0|||
44534026|NCT02101853|79544760|FG000|Block 1 Induction|Lack of Efficacy|6|||
44534027|NCT02101853|79544761|FG001|Block 1 Induction|Lack of Efficacy|0|||
44534028|NCT02101853|79544762|FG002|Block 1 Induction|Lack of Efficacy|0|||
44295710|NCT02607956|79291548|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
44295711|NCT02607956|79291549|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
44416967|NCT00827567|79424877|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
44416968|NCT00765102|79424881|FG000|Overall Study|Progressive disease|18|||
44534029|NCT02101853|79544763|FG003|Block 1 Induction|Lack of Efficacy|0|||
44295712|NCT02607956|79291550|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
44295713|NCT02607956|79291551|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
44295714|NCT02607956|79291548|FG000|Open-Label Extension Phase|Death|0|||
44295715|NCT02607956|79291549|FG001|Open-Label Extension Phase|Death|0|||
44295716|NCT02607956|79291550|FG002|Open-Label Extension Phase|Death|1|||
44295717|NCT02607956|79291551|FG003|Open-Label Extension Phase|Death|3|||
44295718|NCT02607956|79291548|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
44295719|NCT02607956|79291549|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
44416969|NCT00765102|79424881|FG000|Overall Study|Adverse Event|6|||
44295720|NCT02607956|79291550|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
44295721|NCT02607956|79291551|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
44295722|NCT02607956|79291548|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
44295723|NCT02607956|79291549|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
44295724|NCT02607956|79291550|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
44295725|NCT02607956|79291551|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
44295726|NCT02607956|79291548|FG000|Open-Label Extension Phase|Protocol Violation|0|||
44295727|NCT02607956|79291549|FG001|Open-Label Extension Phase|Protocol Violation|0|||
44295728|NCT02607956|79291550|FG002|Open-Label Extension Phase|Protocol Violation|0|||
44295729|NCT02607956|79291551|FG003|Open-Label Extension Phase|Protocol Violation|2|||
44295730|NCT02607956|79291548|FG000|Open-Label Extension Phase|Pregnancy|0|||
44295731|NCT02607956|79291549|FG001|Open-Label Extension Phase|Pregnancy|0|||
44295732|NCT02607956|79291550|FG002|Open-Label Extension Phase|Pregnancy|0|||
44295733|NCT02607956|79291551|FG003|Open-Label Extension Phase|Pregnancy|1|||
44295734|NCT02564523|79291581|FG000|Overall Study|Withdrawal by Subject|3|||
44295735|NCT02564523|79291582|FG001|Overall Study|Withdrawal by Subject|0|||
44295736|NCT02564523|79291583|FG002|Overall Study|Withdrawal by Subject|1|||
44295737|NCT02564523|79291584|FG003|Overall Study|Withdrawal by Subject|0|||
44295738|NCT02564523|79291585|FG004|Overall Study|Withdrawal by Subject|1|||
44295739|NCT02564523|79291586|FG005|Overall Study|Withdrawal by Subject|0|||
44295740|NCT02564523|79291587|FG006|Overall Study|Withdrawal by Subject|1|||
44295741|NCT02564523|79291588|FG007|Overall Study|Withdrawal by Subject|0|||
44295742|NCT02564523|79291589|FG008|Overall Study|Withdrawal by Subject|0|||
44295743|NCT02564523|79291590|FG009|Overall Study|Withdrawal by Subject|0|||
44295744|NCT02564523|79291591|FG010|Overall Study|Withdrawal by Subject|1|||
44295745|NCT02564523|79291592|FG011|Overall Study|Withdrawal by Subject|0|||
44295746|NCT02564523|79291593|FG012|Overall Study|Withdrawal by Subject|1|||
44295747|NCT02564523|79291594|FG013|Overall Study|Withdrawal by Subject|0|||
44295748|NCT02564523|79291595|FG014|Overall Study|Withdrawal by Subject|0|||
44295749|NCT02564523|79291596|FG015|Overall Study|Withdrawal by Subject|0|||
44295750|NCT02564523|79291597|FG016|Overall Study|Withdrawal by Subject|0|||
44295751|NCT02564523|79291598|FG017|Overall Study|Withdrawal by Subject|0|||
44295752|NCT02564523|79291581|FG000|Overall Study|Adverse Event|0|||
44295753|NCT02564523|79291582|FG001|Overall Study|Adverse Event|0|||
44295754|NCT02564523|79291583|FG002|Overall Study|Adverse Event|0|||
44295755|NCT02564523|79291584|FG003|Overall Study|Adverse Event|0|||
44295756|NCT02564523|79291585|FG004|Overall Study|Adverse Event|0|||
44295757|NCT02564523|79291586|FG005|Overall Study|Adverse Event|0|||
44295758|NCT02564523|79291587|FG006|Overall Study|Adverse Event|0|||
44295759|NCT02564523|79291588|FG007|Overall Study|Adverse Event|0|||
44295760|NCT02564523|79291589|FG008|Overall Study|Adverse Event|0|||
44295761|NCT02564523|79291590|FG009|Overall Study|Adverse Event|0|||
44295762|NCT02564523|79291591|FG010|Overall Study|Adverse Event|0|||
44295763|NCT02564523|79291592|FG011|Overall Study|Adverse Event|0|||
44295764|NCT02564523|79291593|FG012|Overall Study|Adverse Event|0|||
44295765|NCT02564523|79291594|FG013|Overall Study|Adverse Event|0|||
44295766|NCT02564523|79291595|FG014|Overall Study|Adverse Event|0|||
44295767|NCT02564523|79291596|FG015|Overall Study|Adverse Event|0|||
44295768|NCT02564523|79291597|FG016|Overall Study|Adverse Event|0|||
44295769|NCT02564523|79291598|FG017|Overall Study|Adverse Event|1|||
44295770|NCT02564523|79291581|FG000|Overall Study|Death|0|||
44295771|NCT02564523|79291582|FG001|Overall Study|Death|0|||
44295772|NCT02564523|79291583|FG002|Overall Study|Death|0|||
44295773|NCT02564523|79291584|FG003|Overall Study|Death|0|||
44295774|NCT02564523|79291585|FG004|Overall Study|Death|0|||
44416970|NCT00765102|79424881|FG000|Overall Study|Physician Decision|4|||
44416971|NCT00765102|79424881|FG000|Overall Study|Withdrawal by Subject|2|||
44416972|NCT00765102|79424881|FG000|Overall Study|Protocol Violation|1|||
44534030|NCT02101853|79544764|FG004|Block 1 Induction|Lack of Efficacy|0|||
44295775|NCT02564523|79291586|FG005|Overall Study|Death|0|||
44295776|NCT02564523|79291587|FG006|Overall Study|Death|1|||
44295777|NCT02564523|79291588|FG007|Overall Study|Death|0|||
44295778|NCT02564523|79291589|FG008|Overall Study|Death|0|||
44295779|NCT02564523|79291590|FG009|Overall Study|Death|0|||
44295780|NCT02564523|79291591|FG010|Overall Study|Death|1|||
44295781|NCT02564523|79291592|FG011|Overall Study|Death|0|||
44295782|NCT02564523|79291593|FG012|Overall Study|Death|0|||
44295783|NCT02564523|79291594|FG013|Overall Study|Death|0|||
44295784|NCT02564523|79291595|FG014|Overall Study|Death|0|||
44295785|NCT02564523|79291596|FG015|Overall Study|Death|0|||
44416973|NCT00809354|79424897|FG000|Overall Study|Adverse Event|32|||
44534031|NCT02101853|79544765|FG005|Block 1 Induction|Lack of Efficacy|0|||
44295786|NCT02564523|79291597|FG016|Overall Study|Death|0|||
44295787|NCT02564523|79291598|FG017|Overall Study|Death|0|||
44295788|NCT02564523|79291581|FG000|Overall Study|Lost to Follow-up|2|||
44295789|NCT02564523|79291582|FG001|Overall Study|Lost to Follow-up|1|||
44295790|NCT02564523|79291583|FG002|Overall Study|Lost to Follow-up|4|||
44416974|NCT00809354|79424898|FG001|Overall Study|Adverse Event|45|||
44295791|NCT02564523|79291584|FG003|Overall Study|Lost to Follow-up|0|||
44295792|NCT02564523|79291585|FG004|Overall Study|Lost to Follow-up|1|||
44295793|NCT02564523|79291586|FG005|Overall Study|Lost to Follow-up|0|||
44295794|NCT02564523|79291587|FG006|Overall Study|Lost to Follow-up|1|||
44295795|NCT02564523|79291588|FG007|Overall Study|Lost to Follow-up|0|||
44295796|NCT02564523|79291589|FG008|Overall Study|Lost to Follow-up|0|||
44295797|NCT02564523|79291590|FG009|Overall Study|Lost to Follow-up|0|||
44295798|NCT02564523|79291591|FG010|Overall Study|Lost to Follow-up|0|||
44295799|NCT02564523|79291592|FG011|Overall Study|Lost to Follow-up|1|||
44295800|NCT02564523|79291593|FG012|Overall Study|Lost to Follow-up|1|||
44295801|NCT02564523|79291594|FG013|Overall Study|Lost to Follow-up|0|||
44295802|NCT02564523|79291595|FG014|Overall Study|Lost to Follow-up|0|||
44295803|NCT02564523|79291596|FG015|Overall Study|Lost to Follow-up|0|||
44295804|NCT02564523|79291597|FG016|Overall Study|Lost to Follow-up|0|||
44295805|NCT02564523|79291598|FG017|Overall Study|Lost to Follow-up|0|||
44295806|NCT02564523|79291581|FG000|Overall Study|Physician Decision|0|||
44295807|NCT02564523|79291582|FG001|Overall Study|Physician Decision|0|||
44295808|NCT02564523|79291583|FG002|Overall Study|Physician Decision|0|||
44295809|NCT02564523|79291584|FG003|Overall Study|Physician Decision|0|||
44295810|NCT02564523|79291585|FG004|Overall Study|Physician Decision|1|||
44295811|NCT02564523|79291586|FG005|Overall Study|Physician Decision|0|||
44295812|NCT02564523|79291587|FG006|Overall Study|Physician Decision|0|||
44295813|NCT02564523|79291588|FG007|Overall Study|Physician Decision|0|||
44295814|NCT02564523|79291589|FG008|Overall Study|Physician Decision|0|||
44295815|NCT02564523|79291590|FG009|Overall Study|Physician Decision|0|||
44295816|NCT02564523|79291591|FG010|Overall Study|Physician Decision|1|||
44295817|NCT02564523|79291592|FG011|Overall Study|Physician Decision|0|||
44295818|NCT02564523|79291593|FG012|Overall Study|Physician Decision|0|||
44295819|NCT02564523|79291594|FG013|Overall Study|Physician Decision|0|||
44295820|NCT02564523|79291595|FG014|Overall Study|Physician Decision|0|||
44295821|NCT02564523|79291596|FG015|Overall Study|Physician Decision|0|||
44295822|NCT02564523|79291597|FG016|Overall Study|Physician Decision|0|||
44295823|NCT02564523|79291598|FG017|Overall Study|Physician Decision|0|||
44295824|NCT02564523|79291581|FG000|Overall Study|Protocol Violation|2|||
44295825|NCT02564523|79291582|FG001|Overall Study|Protocol Violation|2|||
44295826|NCT02564523|79291583|FG002|Overall Study|Protocol Violation|5|||
44295827|NCT02564523|79291584|FG003|Overall Study|Protocol Violation|0|||
44295828|NCT02564523|79291585|FG004|Overall Study|Protocol Violation|1|||
44295829|NCT02564523|79291586|FG005|Overall Study|Protocol Violation|0|||
44295830|NCT02564523|79291587|FG006|Overall Study|Protocol Violation|0|||
44295831|NCT02564523|79291588|FG007|Overall Study|Protocol Violation|0|||
44295832|NCT02564523|79291589|FG008|Overall Study|Protocol Violation|0|||
44295833|NCT02564523|79291590|FG009|Overall Study|Protocol Violation|0|||
44295834|NCT02564523|79291591|FG010|Overall Study|Protocol Violation|0|||
44295835|NCT02564523|79291592|FG011|Overall Study|Protocol Violation|0|||
44295836|NCT02564523|79291593|FG012|Overall Study|Protocol Violation|0|||
44295837|NCT02564523|79291594|FG013|Overall Study|Protocol Violation|0|||
44295838|NCT02564523|79291595|FG014|Overall Study|Protocol Violation|0|||
44295839|NCT02564523|79291596|FG015|Overall Study|Protocol Violation|0|||
44534032|NCT02101853|79544760|FG000|Block 1 Induction|Physician Decision|61|||
44534033|NCT02101853|79544761|FG001|Block 1 Induction|Physician Decision|0|||
44534034|NCT02101853|79544762|FG002|Block 1 Induction|Physician Decision|0|||
44534035|NCT02101853|79544763|FG003|Block 1 Induction|Physician Decision|0|||
44534036|NCT02101853|79544764|FG004|Block 1 Induction|Physician Decision|0|||
44534037|NCT02101853|79544765|FG005|Block 1 Induction|Physician Decision|0|||
44534038|NCT02101853|79544760|FG000|Block 1 Induction|Protocol Violation|2|||
44534039|NCT02101853|79544761|FG001|Block 1 Induction|Protocol Violation|0|||
44295840|NCT02564523|79291597|FG016|Overall Study|Protocol Violation|0|||
44295841|NCT02564523|79291598|FG017|Overall Study|Protocol Violation|0|||
44295842|NCT02564523|79291581|FG000|Overall Study|Other|3|||
44295843|NCT02564523|79291582|FG001|Overall Study|Other|0|||
44295844|NCT02564523|79291583|FG002|Overall Study|Other|0|||
44295845|NCT02564523|79291584|FG003|Overall Study|Other|1|||
44295846|NCT02564523|79291585|FG004|Overall Study|Other|0|||
44295847|NCT02564523|79291586|FG005|Overall Study|Other|0|||
44295848|NCT02564523|79291587|FG006|Overall Study|Other|0|||
44295849|NCT02564523|79291588|FG007|Overall Study|Other|0|||
44295850|NCT02564523|79291589|FG008|Overall Study|Other|0|||
44295851|NCT02564523|79291590|FG009|Overall Study|Other|0|||
44295852|NCT02564523|79291591|FG010|Overall Study|Other|0|||
44295853|NCT02564523|79291592|FG011|Overall Study|Other|0|||
44295854|NCT02564523|79291593|FG012|Overall Study|Other|0|||
44295855|NCT02564523|79291594|FG013|Overall Study|Other|0|||
44534040|NCT02101853|79544762|FG002|Block 1 Induction|Protocol Violation|0|||
44534041|NCT02101853|79544763|FG003|Block 1 Induction|Protocol Violation|0|||
44295856|NCT02564523|79291595|FG014|Overall Study|Other|0|||
44295857|NCT02564523|79291596|FG015|Overall Study|Other|0|||
44295858|NCT02564523|79291597|FG016|Overall Study|Other|0|||
44295859|NCT02564523|79291598|FG017|Overall Study|Other|0|||
44295860|NCT01447628|79291705|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
44295861|NCT01447628|79291706|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
44295862|NCT01447628|79291707|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
44295863|NCT01447628|79291708|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
44295864|NCT00515853|79291730|FG000|Overall Study|Lost to Follow-up|9|||
44295865|NCT00515853|79291731|FG001|Overall Study|Lost to Follow-up|13|||
44295866|NCT00515853|79291730|FG000|Overall Study|Withdrawal by Subject|6|||
44295867|NCT00515853|79291731|FG001|Overall Study|Withdrawal by Subject|4|||
44295868|NCT00003458|79291737|FG000|Overall Study|Not evaluable|4|||
44295869|NCT05032872|79291744|FG000|Overall Study|Adverse Event|1|||
44295870|NCT05032872|79291745|FG001|Overall Study|Adverse Event|0|||
44295871|NCT05032872|79291744|FG000|Overall Study|Lost to Follow-up|2|||
44295872|NCT05032872|79291745|FG001|Overall Study|Lost to Follow-up|4|||
44295873|NCT05032872|79291744|FG000|Overall Study|Withdrawal by Subject|4|||
44295874|NCT05032872|79291745|FG001|Overall Study|Withdrawal by Subject|3|||
44295875|NCT04613739|79291771|FG000|Overall Study|Lost to Follow-up|6|||
44295876|NCT04613739|79291772|FG001|Overall Study|Lost to Follow-up|9|||
44295877|NCT04613739|79291771|FG000|Overall Study|potentially duplicative/fraudulent|1|||
44295878|NCT04613739|79291772|FG001|Overall Study|potentially duplicative/fraudulent|3|||
44295879|NCT04407806|79291799|FG000|Overall Study|Withdrawal by Subject|1|||
44295880|NCT04407806|79291800|FG001|Overall Study|Withdrawal by Subject|2|||
44295881|NCT04324021|79291809|FG000|Overall Study|Adverse Event|1|||
44295882|NCT04324021|79291810|FG001|Overall Study|Adverse Event|0|||
44295883|NCT04324021|79291811|FG002|Overall Study|Adverse Event|0|||
44295884|NCT04324021|79291809|FG000|Overall Study|Lack of Efficacy|0|||
44295885|NCT04324021|79291810|FG001|Overall Study|Lack of Efficacy|0|||
44295886|NCT04324021|79291811|FG002|Overall Study|Lack of Efficacy|1|||
44295887|NCT04324021|79291809|FG000|Overall Study|Death|1|||
44295888|NCT04324021|79291810|FG001|Overall Study|Death|1|||
44295889|NCT04324021|79291811|FG002|Overall Study|Death|0|||
44295890|NCT04209621|79291822|FG000|Overall Study|Death|1|||
44295891|NCT04209621|79291822|FG000|Overall Study|Study Terminated Early|2|||
44295892|NCT04186663|79291827|FG000|Overall Study|Lost to Follow-up|1|||
44295893|NCT04186663|79291827|FG000|Overall Study|Unable to complete blood draw|3|||
44295894|NCT04158219|79291831|FG000|Overall Study|Lost to Follow-up|1|||
44295895|NCT03954743|79291864|FG000|Overall Study|Adverse Event|1|||
44295896|NCT03954743|79291865|FG001|Overall Study|Adverse Event|0|||
44295897|NCT03954743|79291864|FG000|Overall Study|Lost to Follow-up|6|||
44295898|NCT03954743|79291865|FG001|Overall Study|Lost to Follow-up|4|||
44295899|NCT03954743|79291864|FG000|Overall Study|Protocol Violation|1|||
44295900|NCT03954743|79291865|FG001|Overall Study|Protocol Violation|0|||
44295901|NCT03954743|79291864|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
44295902|NCT03954743|79291865|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
44295903|NCT03954743|79291864|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
44295904|NCT03954743|79291865|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44295905|NCT03880565|79291886|FG000|Overall Study|Withdrawal by Subject|1|||
44295906|NCT03880565|79291887|FG001|Overall Study|Withdrawal by Subject|0|||
44295907|NCT03782792|79291895|FG000|Overall Study|Patient left the country|0|||
44295908|NCT03782792|79291896|FG001|Overall Study|Patient left the country|1|||
44295909|NCT03782792|79291895|FG000|Overall Study|Withdrawal by Subject|1|||
44295910|NCT03782792|79291896|FG001|Overall Study|Withdrawal by Subject|2|||
44295911|NCT03733119|79291906|FG000|Overall Study|Physician Decision|2|||
44295912|NCT03733119|79291907|FG001|Overall Study|Physician Decision|1|||
44295913|NCT03733119|79291906|FG000|Overall Study|ineligible to treat per protocol|0|||
44295914|NCT03733119|79291907|FG001|Overall Study|ineligible to treat per protocol|1|||
44295915|NCT03661996|79291918|FG000|Overall Study|Adverse Event|0|||
44295916|NCT03661996|79291919|FG001|Overall Study|Adverse Event|0|||
44295917|NCT03661996|79291920|FG002|Overall Study|Adverse Event|1|||
44295918|NCT03661996|79291921|FG003|Overall Study|Adverse Event|1|||
44295919|NCT03661996|79291922|FG004|Overall Study|Adverse Event|0|||
44295920|NCT03661996|79291918|FG000|Overall Study|Lost to Follow-up|5|||
44534042|NCT02101853|79544764|FG004|Block 1 Induction|Protocol Violation|0|||
44534043|NCT02101853|79544765|FG005|Block 1 Induction|Protocol Violation|0|||
44534044|NCT02101853|79544760|FG000|Block 1 Induction|Withdrawal by Subject|65|||
44534045|NCT02101853|79544761|FG001|Block 1 Induction|Withdrawal by Subject|0|||
44534046|NCT02101853|79544762|FG002|Block 1 Induction|Withdrawal by Subject|0|||
44295921|NCT03661996|79291919|FG001|Overall Study|Lost to Follow-up|1|||
44295922|NCT03661996|79291920|FG002|Overall Study|Lost to Follow-up|2|||
44295923|NCT03661996|79291921|FG003|Overall Study|Lost to Follow-up|2|||
44295924|NCT03661996|79291922|FG004|Overall Study|Lost to Follow-up|6|||
44534047|NCT02101853|79544763|FG003|Block 1 Induction|Withdrawal by Subject|0|||
44534048|NCT02101853|79544764|FG004|Block 1 Induction|Withdrawal by Subject|0|||
44295925|NCT03661996|79291918|FG000|Overall Study|Physician Decision|1|||
44295926|NCT03661996|79291919|FG001|Overall Study|Physician Decision|1|||
44295927|NCT03661996|79291920|FG002|Overall Study|Physician Decision|1|||
44295928|NCT03661996|79291921|FG003|Overall Study|Physician Decision|2|||
44295929|NCT03661996|79291922|FG004|Overall Study|Physician Decision|0|||
44295930|NCT03661996|79291918|FG000|Overall Study|Protocol Violation|0|||
44295931|NCT03661996|79291919|FG001|Overall Study|Protocol Violation|0|||
44534049|NCT02101853|79544765|FG005|Block 1 Induction|Withdrawal by Subject|0|||
44295932|NCT03661996|79291920|FG002|Overall Study|Protocol Violation|0|||
44295933|NCT03661996|79291921|FG003|Overall Study|Protocol Violation|0|||
44295934|NCT03661996|79291922|FG004|Overall Study|Protocol Violation|1|||
44295935|NCT03661996|79291918|FG000|Overall Study|Withdrawal by Subject|3|||
44295936|NCT03661996|79291919|FG001|Overall Study|Withdrawal by Subject|5|||
44295937|NCT03661996|79291920|FG002|Overall Study|Withdrawal by Subject|1|||
44295938|NCT03661996|79291921|FG003|Overall Study|Withdrawal by Subject|7|||
44295939|NCT03661996|79291922|FG004|Overall Study|Withdrawal by Subject|7|||
44295940|NCT03661996|79291918|FG000|Overall Study|Sponsors Decision|2|||
44295941|NCT03661996|79291919|FG001|Overall Study|Sponsors Decision|0|||
44295942|NCT03661996|79291920|FG002|Overall Study|Sponsors Decision|0|||
44295943|NCT03661996|79291921|FG003|Overall Study|Sponsors Decision|0|||
44295944|NCT03661996|79291922|FG004|Overall Study|Sponsors Decision|0|||
44295945|NCT03661996|79291918|FG000|Overall Study|Other|1|||
44295946|NCT03661996|79291919|FG001|Overall Study|Other|1|||
44295947|NCT03661996|79291920|FG002|Overall Study|Other|1|||
44295948|NCT03661996|79291921|FG003|Overall Study|Other|1|||
44295949|NCT03661996|79291922|FG004|Overall Study|Other|0|||
44295950|NCT03633461|79291939|FG000|Overall Study|Lost to Follow-up|0|||
44295951|NCT03633461|79291940|FG001|Overall Study|Lost to Follow-up|1|||
44295952|NCT03499314|79291968|FG000|Overall Study|Time Commitment|1|||
44295953|NCT03499314|79291969|FG001|Overall Study|Time Commitment|2|||
44295954|NCT03499314|79291968|FG000|Overall Study|Medical issue unrelated to research study|1|||
44295955|NCT03499314|79291969|FG001|Overall Study|Medical issue unrelated to research study|1|||
44295956|NCT03369431|79291977|FG000|Overall Study|Lost to Follow-up|1|||
44295957|NCT03369431|79291978|FG001|Overall Study|Lost to Follow-up|3|||
44295958|NCT03369431|79291977|FG000|Overall Study|Withdrawal by Subject|2|||
44295959|NCT03369431|79291978|FG001|Overall Study|Withdrawal by Subject|3|||
44295960|NCT03369431|79291977|FG000|Overall Study|Protocol Violation|1|||
44295961|NCT03369431|79291978|FG001|Overall Study|Protocol Violation|1|||
44295962|NCT03336866|79291987|FG000|Overall Study|Lost to Follow-up|2|||
44295963|NCT03336866|79291988|FG001|Overall Study|Lost to Follow-up|0|||
44295964|NCT03336866|79291989|FG002|Overall Study|Lost to Follow-up|3|||
44295965|NCT03336866|79291987|FG000|Overall Study|Withdrawal by Subject|1|||
44295966|NCT03336866|79291988|FG001|Overall Study|Withdrawal by Subject|1|||
44295967|NCT03336866|79291989|FG002|Overall Study|Withdrawal by Subject|0|||
44295968|NCT03336866|79291987|FG000|Overall Study|Noncompliance with clinic house rules|0|||
44295969|NCT03336866|79291988|FG001|Overall Study|Noncompliance with clinic house rules|0|||
44295970|NCT03336866|79291989|FG002|Overall Study|Noncompliance with clinic house rules|1|||
44295971|NCT03332173|79292002|FG000|Overall Study|Death|7|||
44295972|NCT03332173|79292002|FG000|Overall Study|Withdrawal by Subject|6|||
44295973|NCT03332173|79292002|FG000|Overall Study|Lost to Follow-up|2|||
44295974|NCT03332173|79292002|FG000|Overall Study|Transferred to long-term extension study|29|||
44295975|NCT03322293|79292009|FG000|Overall Study|Lost to Follow-up|0|||
44295976|NCT03322293|79292010|FG001|Overall Study|Lost to Follow-up|0|||
44295977|NCT03322293|79292011|FG002|Overall Study|Lost to Follow-up|1|||
44256507|NCT03769194|79106648|FG001|Overall Study|Lost to Follow-up|6|||
44256508|NCT03769194|79106649|FG002|Overall Study|Lost to Follow-up|3|||
44256509|NCT03769194|79106650|FG003|Overall Study|Lost to Follow-up|6|||
44256510|NCT03769194|79106647|FG000|Overall Study|other|1|||
44256511|NCT03769194|79106648|FG001|Overall Study|other|3|||
44256512|NCT03769194|79106649|FG002|Overall Study|other|0|||
44256513|NCT03769194|79106650|FG003|Overall Study|other|1|||
44256514|NCT01465022|79106676|FG000|Overall Study|Lost to Follow-up|15|||
44256515|NCT01465022|79106677|FG001|Overall Study|Lost to Follow-up|14|||
44256516|NCT01465022|79106678|FG002|Overall Study|Lost to Follow-up|0|||
44256517|NCT01465022|79106676|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
44256518|NCT01465022|79106677|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
44256519|NCT01465022|79106678|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
44256520|NCT01465022|79106676|FG000|Overall Study|Not Randomized|0|||
44256521|NCT01465022|79106677|FG001|Overall Study|Not Randomized|0|||
44256522|NCT01465022|79106678|FG002|Overall Study|Not Randomized|70|||
44256523|NCT01464788|79106722|FG000|Overall Study|Lost to Follow-up|0|||
44256524|NCT01464788|79106723|FG001|Overall Study|Lost to Follow-up|1|||
44256525|NCT01464788|79106724|FG002|Overall Study|Lost to Follow-up|0|||
44256526|NCT01464788|79106722|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
44256527|NCT01464788|79106723|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
44256528|NCT01464788|79106724|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
44256529|NCT01444898|79106734|FG000|Overall Study|Withdrawal by Subject|1|||
44256530|NCT01419626|79106756|FG000|Overall Study|Protocol Violation|3|||
44295978|NCT03254394|79292033|FG000|Overall Study|Withdrawal by Subject|0|||
44295979|NCT03254394|79292034|FG001|Overall Study|Withdrawal by Subject|2|||
44295980|NCT03253809|79292040|FG000|Overall Study|Unable to obtain study related data|14|||
44295981|NCT02998476|79292119|FG000|Overall Study|Lost to Follow-up|1|||
44295982|NCT02998476|79292120|FG001|Overall Study|Lost to Follow-up|0|||
44295983|NCT02998476|79292119|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
44295984|NCT02998476|79292120|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
44295985|NCT02998476|79292119|FG000|Overall Study|Withdrawal by Subject|1|||
44295986|NCT02998476|79292120|FG001|Overall Study|Withdrawal by Subject|2|||
44295987|NCT02998476|79292119|FG000|Overall Study|Death|45|||
44295988|NCT02998476|79292120|FG001|Overall Study|Death|2|||
44295989|NCT02998476|79292119|FG000|Overall Study|Other|6|||
44295990|NCT02998476|79292120|FG001|Overall Study|Other|1|||
44295991|NCT02924064|79292138|FG000|Overall Study|Adverse Event|2|||
44295992|NCT02924064|79292139|FG001|Overall Study|Adverse Event|2|||
44295993|NCT02924064|79292138|FG000|Overall Study|Lost to Follow-up|0|||
44295994|NCT02924064|79292139|FG001|Overall Study|Lost to Follow-up|2|||
44295995|NCT02924064|79292138|FG000|Overall Study|Physician Decision|0|||
44295996|NCT02924064|79292139|FG001|Overall Study|Physician Decision|2|||
44295997|NCT02924064|79292138|FG000|Overall Study|Protocol Violation|1|||
44295998|NCT02924064|79292139|FG001|Overall Study|Protocol Violation|3|||
44295999|NCT02924064|79292138|FG000|Overall Study|Withdrawal by Subject|4|||
44296000|NCT02924064|79292139|FG001|Overall Study|Withdrawal by Subject|5|||
44296001|NCT02924064|79292138|FG000|Overall Study|Other|17|||
44296002|NCT02924064|79292139|FG001|Overall Study|Other|29|||
44296003|NCT02916706|79292147|FG000|Overall Study|Adverse Event|0|||
44296004|NCT02916706|79292148|FG001|Overall Study|Adverse Event|1|||
44296005|NCT02916706|79292147|FG000|Overall Study|Lost to Follow-up|0|||
44296006|NCT02916706|79292148|FG001|Overall Study|Lost to Follow-up|1|||
44296007|NCT02916706|79292147|FG000|Overall Study|Physician Decision|1|||
44296008|NCT02916706|79292148|FG001|Overall Study|Physician Decision|0|||
44296009|NCT02916706|79292147|FG000|Overall Study|Protocol Violation|3|||
44296010|NCT02916706|79292148|FG001|Overall Study|Protocol Violation|1|||
44296011|NCT02916706|79292147|FG000|Overall Study|Withdrawal by Subject|6|||
44296012|NCT02916706|79292148|FG001|Overall Study|Withdrawal by Subject|9|||
44296013|NCT02916706|79292147|FG000|Overall Study|Other|5|||
44296014|NCT02916706|79292148|FG001|Overall Study|Other|19|||
44296015|NCT02889900|79292154|FG000|Overall Study|Adverse Event|11|||
44296016|NCT02889900|79292154|FG000|Overall Study|Condition under investigation worsened|32|||
44296017|NCT02889900|79292154|FG000|Overall Study|Other|5|||
44296018|NCT02889900|79292154|FG000|Overall Study|Withdrawal by Subject|7|||
44296019|NCT02889900|79292154|FG000|Overall Study|Not treated|2|||
44296020|NCT02866695|79292158|FG000|Overall Study|Adverse Event|1|||
44296021|NCT02866695|79292158|FG000|Overall Study|Lost to Follow-up|1|||
44296022|NCT02834793|79292164|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
44296023|NCT02834793|79292165|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
44296024|NCT02834793|79292166|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
44296025|NCT02834793|79292167|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
44296026|NCT02834793|79292164|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
44296027|NCT02834793|79292165|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
44296028|NCT02834793|79292166|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
44296029|NCT02834793|79292167|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
44296030|NCT02834793|79292164|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
44296031|NCT02834793|79292165|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
44296032|NCT02834793|79292166|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
44296033|NCT02834793|79292167|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
44296034|NCT02834793|79292164|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
44296035|NCT02834793|79292165|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
44296036|NCT02834793|79292166|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
44296037|NCT02834793|79292167|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
44296038|NCT02834793|79292164|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
44296039|NCT02834793|79292165|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
44296040|NCT02834793|79292166|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
44296041|NCT02834793|79292167|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
44296042|NCT02834793|79292164|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
44296043|NCT02834793|79292165|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
44296044|NCT02834793|79292166|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
44416975|NCT00809354|79424899|FG002|Overall Study|Adverse Event|37|||
44416976|NCT00809354|79424900|FG003|Overall Study|Adverse Event|53|||
44416977|NCT00809354|79424901|FG004|Overall Study|Adverse Event|26|||
44296045|NCT02834793|79292167|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
44296046|NCT02834793|79292164|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
44296047|NCT02834793|79292165|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
44296048|NCT02834793|79292166|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
44296049|NCT02834793|79292167|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
44296050|NCT02834793|79292164|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
44296051|NCT02834793|79292165|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
44296052|NCT02834793|79292166|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
44296053|NCT02834793|79292167|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
44296054|NCT02834793|79292164|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
44296055|NCT02834793|79292165|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
44416978|NCT00809354|79424902|FG005|Overall Study|Adverse Event|33|||
44296056|NCT02834793|79292166|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
44296057|NCT02834793|79292167|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
44296058|NCT02834793|79292164|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
44296059|NCT02834793|79292165|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
44296060|NCT02834793|79292166|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
44296061|NCT02834793|79292167|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
44296062|NCT02834793|79292164|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
44296063|NCT02834793|79292165|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
44296064|NCT02834793|79292166|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
44296065|NCT02834793|79292167|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
44296066|NCT02834793|79292164|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
44296067|NCT02834793|79292165|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
44296068|NCT02834793|79292166|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
44296069|NCT02834793|79292167|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
44296070|NCT02834793|79292164|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
44296071|NCT02834793|79292165|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
44296072|NCT02834793|79292166|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
44296073|NCT02834793|79292167|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
44296074|NCT02834793|79292164|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
44296075|NCT02834793|79292165|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
44296076|NCT02834793|79292166|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
44296077|NCT02834793|79292167|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
44296078|NCT02834793|79292164|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
44296079|NCT02834793|79292165|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
44296080|NCT02834793|79292166|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
44296081|NCT02834793|79292167|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
44296082|NCT02810457|79292177|FG000|Overall Study|Randomised but no treatment received|2|||
44296083|NCT02810457|79292178|FG001|Overall Study|Randomised but no treatment received|1|||
44296084|NCT02810457|79292177|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
44296085|NCT02810457|79292178|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
44296086|NCT02810457|79292177|FG000|Overall Study|Adverse Event|37|||
44296087|NCT02810457|79292178|FG001|Overall Study|Adverse Event|43|||
44296088|NCT02810457|79292177|FG000|Overall Study|Patient decision|31|||
44296089|NCT02810457|79292178|FG001|Overall Study|Patient decision|35|||
44296090|NCT02810457|79292177|FG000|Overall Study|Patient lost to follow-up|2|||
44296091|NCT02810457|79292178|FG001|Overall Study|Patient lost to follow-up|2|||
44416979|NCT00809354|79424903|FG006|Overall Study|Adverse Event|44|||
44416980|NCT00809354|79424904|FG007|Overall Study|Adverse Event|40|||
44416981|NCT00809354|79424905|FG008|Overall Study|Adverse Event|46|||
44416982|NCT00809354|79424906|FG009|Overall Study|Adverse Event|26|||
44416983|NCT00809354|79424897|FG000|Overall Study|Lack of Efficacy|23|||
44416984|NCT00809354|79424898|FG001|Overall Study|Lack of Efficacy|23|||
44416985|NCT00809354|79424899|FG002|Overall Study|Lack of Efficacy|22|||
44416986|NCT00809354|79424900|FG003|Overall Study|Lack of Efficacy|15|||
44416987|NCT00809354|79424901|FG004|Overall Study|Lack of Efficacy|40|||
44416988|NCT00809354|79424902|FG005|Overall Study|Lack of Efficacy|19|||
44416989|NCT00809354|79424903|FG006|Overall Study|Lack of Efficacy|21|||
44416990|NCT00809354|79424904|FG007|Overall Study|Lack of Efficacy|15|||
44416991|NCT00809354|79424905|FG008|Overall Study|Lack of Efficacy|18|||
44416992|NCT00809354|79424906|FG009|Overall Study|Lack of Efficacy|38|||
44416993|NCT00809354|79424897|FG000|Overall Study|Lost to Follow-up|10|||
44416994|NCT00809354|79424898|FG001|Overall Study|Lost to Follow-up|11|||
44416995|NCT00809354|79424899|FG002|Overall Study|Lost to Follow-up|8|||
44416996|NCT00809354|79424900|FG003|Overall Study|Lost to Follow-up|13|||
44416997|NCT00809354|79424901|FG004|Overall Study|Lost to Follow-up|6|||
44416998|NCT00809354|79424902|FG005|Overall Study|Lost to Follow-up|2|||
44416999|NCT00809354|79424903|FG006|Overall Study|Lost to Follow-up|0|||
44417000|NCT00809354|79424904|FG007|Overall Study|Lost to Follow-up|5|||
44417001|NCT00809354|79424905|FG008|Overall Study|Lost to Follow-up|4|||
44417002|NCT00809354|79424906|FG009|Overall Study|Lost to Follow-up|0|||
44417003|NCT00809354|79424897|FG000|Overall Study|Protocol Violation|7|||
44417004|NCT00809354|79424898|FG001|Overall Study|Protocol Violation|14|||
44417005|NCT00809354|79424899|FG002|Overall Study|Protocol Violation|14|||
44296092|NCT02810457|79292177|FG000|Overall Study|Death|39|||
44296093|NCT02810457|79292178|FG001|Overall Study|Death|28|||
44296094|NCT02810457|79292177|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
44296095|NCT02810457|79292178|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
44296096|NCT02810457|79292177|FG000|Overall Study|Clinical progression|15|||
44417006|NCT00809354|79424900|FG003|Overall Study|Protocol Violation|12|||
44417007|NCT00809354|79424901|FG004|Overall Study|Protocol Violation|14|||
44417008|NCT00809354|79424902|FG005|Overall Study|Protocol Violation|6|||
44417009|NCT00809354|79424903|FG006|Overall Study|Protocol Violation|4|||
44417010|NCT00809354|79424904|FG007|Overall Study|Protocol Violation|6|||
44417011|NCT00809354|79424905|FG008|Overall Study|Protocol Violation|9|||
44417012|NCT00809354|79424906|FG009|Overall Study|Protocol Violation|3|||
44296097|NCT02810457|79292178|FG001|Overall Study|Clinical progression|16|||
44296098|NCT02810457|79292177|FG000|Overall Study|Investigator decision|3|||
44296099|NCT02810457|79292178|FG001|Overall Study|Investigator decision|2|||
44296100|NCT02810457|79292177|FG000|Overall Study|Patient ineligibility|3|||
44296101|NCT02810457|79292178|FG001|Overall Study|Patient ineligibility|0|||
44296102|NCT02810457|79292177|FG000|Overall Study|Miscalculated PD|1|||
44296103|NCT02810457|79292178|FG001|Overall Study|Miscalculated PD|0|||
44296104|NCT02810457|79292177|FG000|Overall Study|Physician Decision|0|||
44296105|NCT02810457|79292178|FG001|Overall Study|Physician Decision|1|||
44296106|NCT02745535|79292184|FG000|Overall Study|Death|1|||
44296107|NCT02745535|79292184|FG000|Overall Study|Adverse Event|3|||
44296108|NCT02745535|79292184|FG000|Overall Study|Lost to Follow-up|2|||
44296109|NCT02625090|79292218|FG000|Overall Study|Participant wants to be pregnant|2|||
44296110|NCT02625090|79292218|FG000|Overall Study|For the Promoter|1|||
44296111|NCT02625090|79292218|FG000|Overall Study|Sponsor's Decision|9|||
44296112|NCT02625090|79292218|FG000|Overall Study|Somnolence|1|||
44296113|NCT02625090|79292218|FG000|Overall Study|Study terminated by Sponsor|7|||
44296114|NCT02625090|79292218|FG000|Overall Study|Negative Benefit/Risk|1|||
44296115|NCT02625090|79292218|FG000|Overall Study|Protocol Deviation|2|||
44296116|NCT02625090|79292218|FG000|Overall Study|Lack of Efficacy|16|||
44296117|NCT02625090|79292218|FG000|Overall Study|Adverse Event|3|||
44296118|NCT02539225|79292225|FG000|Part A|Adverse Event|13|||
44296119|NCT02539225|79292226|FG001|Part A|Adverse Event|4|||
44296120|NCT02539225|79292225|FG000|Part A|Withdrawal by Subject|2|||
44296121|NCT02539225|79292226|FG001|Part A|Withdrawal by Subject|4|||
44296122|NCT02539225|79292225|FG000|Part A|Physician Decision|4|||
44296123|NCT02539225|79292226|FG001|Part A|Physician Decision|7|||
44296124|NCT02539225|79292225|FG000|Part A|Did Not Receive study Drug|1|||
44296125|NCT02539225|79292226|FG001|Part A|Did Not Receive study Drug|1|||
44296126|NCT02539225|79292225|FG000|Pre Treatment for Part B|Progressive disease|1|||
44296127|NCT02539225|79292226|FG001|Pre Treatment for Part B|Progressive disease|1|||
44296128|NCT02539225|79292225|FG000|Pre Treatment for Part B|Adverse Event|1|||
44296129|NCT02539225|79292226|FG001|Pre Treatment for Part B|Adverse Event|1|||
44296130|NCT02539225|79292225|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
44296131|NCT02539225|79292226|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
44296132|NCT02539225|79292225|FG000|Pre Treatment for Part B|Physician Decision|2|||
44296133|NCT02539225|79292226|FG001|Pre Treatment for Part B|Physician Decision|0|||
44296134|NCT02539225|79292225|FG000|Part B|Adverse Event|4|||
44296135|NCT02539225|79292226|FG001|Part B|Adverse Event|4|||
44296136|NCT02539225|79292225|FG000|Part B|Withdrawal by Subject|0|||
44296137|NCT02539225|79292226|FG001|Part B|Withdrawal by Subject|3|||
44296138|NCT02539225|79292225|FG000|Part B|Physician Decision|0|||
44296139|NCT02539225|79292226|FG001|Part B|Physician Decision|9|||
44296140|NCT02526017|79292246|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296141|NCT02526017|79292247|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296142|NCT02526017|79292248|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296143|NCT02526017|79292249|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296144|NCT02526017|79292250|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
44296145|NCT02526017|79292251|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296146|NCT02526017|79292252|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296147|NCT02526017|79292253|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296148|NCT02526017|79292254|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
44296149|NCT02369653|79292323|FG000|Overall Study|Lost to Follow-up|0|||
44296150|NCT02369653|79292324|FG001|Overall Study|Lost to Follow-up|1|||
44296151|NCT02369653|79292323|FG000|Overall Study|Administrative reason by sponsor|0|||
44296152|NCT02369653|79292324|FG001|Overall Study|Administrative reason by sponsor|1|||
44296153|NCT02369653|79292323|FG000|Overall Study|Death|1|||
44296154|NCT02369653|79292324|FG001|Overall Study|Death|2|||
44296155|NCT02369653|79292323|FG000|Overall Study|Participant withdrew consent|13|||
44296156|NCT02369653|79292324|FG001|Overall Study|Participant withdrew consent|3|||
44296157|NCT02284568|79292337|FG000|Overall Study|Adverse Event|2|||
44296158|NCT02284568|79292338|FG001|Overall Study|Adverse Event|9|||
44296159|NCT02284568|79292339|FG002|Overall Study|Adverse Event|4|||
44296160|NCT02284568|79292337|FG000|Overall Study|Withdrawal by Subject|22|||
44417013|NCT00809354|79424897|FG000|Overall Study|Withdrawal by Subject|32|||
44154633|NCT02684617|78945924|FG000|Overall Study|Study Terminated by Sponsor|6|||
44296161|NCT02284568|79292338|FG001|Overall Study|Withdrawal by Subject|21|||
44296162|NCT02284568|79292339|FG002|Overall Study|Withdrawal by Subject|1|||
44296163|NCT02284568|79292337|FG000|Overall Study|Noncompliance with study drug admin|1|||
44296164|NCT02284568|79292338|FG001|Overall Study|Noncompliance with study drug admin|2|||
44296165|NCT02284568|79292339|FG002|Overall Study|Noncompliance with study drug admin|0|||
44296166|NCT02284568|79292337|FG000|Overall Study|Noncompliance|1|||
44296167|NCT02284568|79292338|FG001|Overall Study|Noncompliance|0|||
44296168|NCT02284568|79292339|FG002|Overall Study|Noncompliance|0|||
44296169|NCT02284568|79292337|FG000|Overall Study|Protocol Violation|0|||
44296170|NCT02284568|79292338|FG001|Overall Study|Protocol Violation|1|||
44296171|NCT02284568|79292339|FG002|Overall Study|Protocol Violation|0|||
44296172|NCT02284568|79292337|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
44296173|NCT02284568|79292338|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
44296174|NCT02284568|79292339|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
44417014|NCT00809354|79424898|FG001|Overall Study|Withdrawal by Subject|27|||
44417015|NCT00809354|79424899|FG002|Overall Study|Withdrawal by Subject|31|||
44417016|NCT00809354|79424900|FG003|Overall Study|Withdrawal by Subject|33|||
44417017|NCT00809354|79424901|FG004|Overall Study|Withdrawal by Subject|34|||
44417018|NCT00809354|79424902|FG005|Overall Study|Withdrawal by Subject|29|||
44417019|NCT00809354|79424903|FG006|Overall Study|Withdrawal by Subject|27|||
44417020|NCT00809354|79424904|FG007|Overall Study|Withdrawal by Subject|19|||
44417021|NCT00809354|79424905|FG008|Overall Study|Withdrawal by Subject|18|||
44417022|NCT00809354|79424906|FG009|Overall Study|Withdrawal by Subject|20|||
44417023|NCT00809354|79424897|FG000|Overall Study|Other|10|||
44417024|NCT00809354|79424898|FG001|Overall Study|Other|2|||
44417025|NCT00809354|79424899|FG002|Overall Study|Other|7|||
44417026|NCT00809354|79424900|FG003|Overall Study|Other|10|||
44417027|NCT00809354|79424901|FG004|Overall Study|Other|5|||
44417028|NCT00809354|79424902|FG005|Overall Study|Other|3|||
44417029|NCT00809354|79424903|FG006|Overall Study|Other|2|||
44417030|NCT00809354|79424904|FG007|Overall Study|Other|3|||
44417031|NCT00809354|79424905|FG008|Overall Study|Other|4|||
44417032|NCT00809354|79424906|FG009|Overall Study|Other|3|||
44417033|NCT00809354|79424897|FG000|Overall Study|Study terminated by sponsor|138|||
44417034|NCT00809354|79424898|FG001|Overall Study|Study terminated by sponsor|134|||
44417035|NCT00809354|79424899|FG002|Overall Study|Study terminated by sponsor|129|||
44417036|NCT00809354|79424900|FG003|Overall Study|Study terminated by sponsor|120|||
44417037|NCT00809354|79424901|FG004|Overall Study|Study terminated by sponsor|126|||
44417038|NCT00809354|79424902|FG005|Overall Study|Study terminated by sponsor|133|||
44417039|NCT00809354|79424903|FG006|Overall Study|Study terminated by sponsor|124|||
44417040|NCT00809354|79424904|FG007|Overall Study|Study terminated by sponsor|148|||
44417041|NCT00809354|79424905|FG008|Overall Study|Study terminated by sponsor|127|||
44417042|NCT00809354|79424906|FG009|Overall Study|Study terminated by sponsor|135|||
44417043|NCT00809354|79424897|FG000|Overall Study|Withdrawn due to pregnancy|0|||
44417044|NCT00809354|79424898|FG001|Overall Study|Withdrawn due to pregnancy|1|||
44417045|NCT00809354|79424899|FG002|Overall Study|Withdrawn due to pregnancy|0|||
44417046|NCT00809354|79424900|FG003|Overall Study|Withdrawn due to pregnancy|0|||
44417047|NCT00809354|79424901|FG004|Overall Study|Withdrawn due to pregnancy|0|||
44417048|NCT00809354|79424902|FG005|Overall Study|Withdrawn due to pregnancy|0|||
44417049|NCT00809354|79424903|FG006|Overall Study|Withdrawn due to pregnancy|0|||
44417050|NCT00809354|79424904|FG007|Overall Study|Withdrawn due to pregnancy|0|||
44417051|NCT00809354|79424905|FG008|Overall Study|Withdrawn due to pregnancy|0|||
44417052|NCT00809354|79424906|FG009|Overall Study|Withdrawn due to pregnancy|0|||
44417053|NCT00809354|79424897|FG000|Overall Study|Randomized but not Treated|3|||
44417054|NCT00809354|79424898|FG001|Overall Study|Randomized but not Treated|1|||
44417055|NCT00809354|79424899|FG002|Overall Study|Randomized but not Treated|6|||
44417056|NCT00809354|79424900|FG003|Overall Study|Randomized but not Treated|0|||
44417057|NCT00809354|79424901|FG004|Overall Study|Randomized but not Treated|5|||
44417058|NCT00809354|79424902|FG005|Overall Study|Randomized but not Treated|0|||
44417059|NCT00809354|79424903|FG006|Overall Study|Randomized but not Treated|1|||
44417060|NCT00809354|79424904|FG007|Overall Study|Randomized but not Treated|1|||
44417061|NCT00809354|79424905|FG008|Overall Study|Randomized but not Treated|2|||
44417062|NCT00809354|79424906|FG009|Overall Study|Randomized but not Treated|1|||
44417063|NCT00809354|79424897|FG000|Overall Study|Death|0|||
44417064|NCT00809354|79424898|FG001|Overall Study|Death|0|||
44417065|NCT00809354|79424899|FG002|Overall Study|Death|0|||
44417066|NCT00809354|79424900|FG003|Overall Study|Death|0|||
44417067|NCT00809354|79424901|FG004|Overall Study|Death|0|||
44417068|NCT00809354|79424902|FG005|Overall Study|Death|0|||
44417069|NCT00809354|79424903|FG006|Overall Study|Death|0|||
44417070|NCT00809354|79424904|FG007|Overall Study|Death|1|||
44417071|NCT00809354|79424905|FG008|Overall Study|Death|0|||
44417072|NCT00809354|79424906|FG009|Overall Study|Death|0|||
44154634|NCT02684617|78945925|FG001|Overall Study|Study Terminated by Sponsor|1|||
44296175|NCT02284568|79292337|FG000|Overall Study|Lost to Follow-up|0|||
44296176|NCT02284568|79292338|FG001|Overall Study|Lost to Follow-up|3|||
44417073|NCT00834899|79424935|FG000|Overall Study|Withdrawal by Subject|1|||
44417074|NCT00834899|79424936|FG001|Overall Study|Withdrawal by Subject|1|||
44417075|NCT00764946|79424945|FG000|Overall Study|Lack of Efficacy|1|||
44417076|NCT00764946|79424946|FG001|Overall Study|Lack of Efficacy|0|||
44417077|NCT00764946|79424947|FG002|Overall Study|Lack of Efficacy|0|||
44417078|NCT00764946|79424945|FG000|Overall Study|Lost to Follow-up|3|||
44417079|NCT00764946|79424946|FG001|Overall Study|Lost to Follow-up|4|||
44417080|NCT00764946|79424947|FG002|Overall Study|Lost to Follow-up|0|||
44417081|NCT00764946|79424945|FG000|Overall Study|Physician Decision|2|||
44417082|NCT00764946|79424946|FG001|Overall Study|Physician Decision|4|||
44417083|NCT00764946|79424947|FG002|Overall Study|Physician Decision|0|||
44417084|NCT00764946|79424945|FG000|Overall Study|Adverse Event|3|||
44296177|NCT02284568|79292339|FG002|Overall Study|Lost to Follow-up|0|||
44296178|NCT02284568|79292337|FG000|Overall Study|Lack of Efficacy|4|||
44296179|NCT02284568|79292338|FG001|Overall Study|Lack of Efficacy|7|||
44296180|NCT02284568|79292339|FG002|Overall Study|Lack of Efficacy|0|||
44296181|NCT02284568|79292337|FG000|Overall Study|Other|1|||
44296182|NCT02284568|79292338|FG001|Overall Study|Other|2|||
44296183|NCT02284568|79292339|FG002|Overall Study|Other|0|||
44296184|NCT02284568|79292337|FG000|Overall Study|Withdrew before taking study drug|0|||
44296185|NCT02284568|79292338|FG001|Overall Study|Withdrew before taking study drug|1|||
44296186|NCT02284568|79292339|FG002|Overall Study|Withdrew before taking study drug|0|||
44296187|NCT02195986|79292354|FG000|Overall Study|Adverse Event|3|||
44296188|NCT02195986|79292355|FG001|Overall Study|Adverse Event|0|||
44296189|NCT02195986|79292356|FG002|Overall Study|Adverse Event|0|||
44296190|NCT02195986|79292354|FG000|Overall Study|Withdrawal by Subject|0|||
44296191|NCT02195986|79292355|FG001|Overall Study|Withdrawal by Subject|3|||
44296192|NCT02195986|79292356|FG002|Overall Study|Withdrawal by Subject|0|||
44296193|NCT02195986|79292354|FG000|Overall Study|Family Emergency|0|||
44296194|NCT02195986|79292355|FG001|Overall Study|Family Emergency|0|||
44296195|NCT02195986|79292356|FG002|Overall Study|Family Emergency|1|||
44296196|NCT02195986|79292354|FG000|Overall Study|Protocol Violation|0|||
44296197|NCT02195986|79292355|FG001|Overall Study|Protocol Violation|1|||
44296198|NCT02195986|79292356|FG002|Overall Study|Protocol Violation|1|||
44296199|NCT02195986|79292354|FG000|Overall Study|Non-compliance|0|||
44296200|NCT02195986|79292355|FG001|Overall Study|Non-compliance|1|||
44296201|NCT02195986|79292356|FG002|Overall Study|Non-compliance|0|||
44296202|NCT01982630|79292372|FG000|Overall Study|Adverse Event|2|||
44296203|NCT01982630|79292373|FG001|Overall Study|Adverse Event|0|||
44296204|NCT01982630|79292374|FG002|Overall Study|Adverse Event|1|||
44296205|NCT01982630|79292375|FG003|Overall Study|Adverse Event|0|||
44296206|NCT01982630|79292376|FG004|Overall Study|Adverse Event|1|||
44296207|NCT01982630|79292377|FG005|Overall Study|Adverse Event|2|||
44296208|NCT01982630|79292378|FG006|Overall Study|Adverse Event|1|||
44296209|NCT01982630|79292379|FG007|Overall Study|Adverse Event|0|||
44296210|NCT01982630|79292372|FG000|Overall Study|Physician Decision|1|||
44296211|NCT01982630|79292373|FG001|Overall Study|Physician Decision|0|||
44296212|NCT01982630|79292374|FG002|Overall Study|Physician Decision|2|||
44296213|NCT01982630|79292375|FG003|Overall Study|Physician Decision|1|||
44296214|NCT01982630|79292376|FG004|Overall Study|Physician Decision|2|||
44296215|NCT01982630|79292377|FG005|Overall Study|Physician Decision|0|||
44296216|NCT01982630|79292378|FG006|Overall Study|Physician Decision|0|||
44296217|NCT01982630|79292379|FG007|Overall Study|Physician Decision|0|||
44296218|NCT01982630|79292372|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296219|NCT01982630|79292373|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296220|NCT01982630|79292374|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
44296221|NCT01982630|79292375|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296222|NCT01982630|79292376|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296223|NCT01982630|79292377|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296224|NCT01982630|79292378|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296225|NCT01982630|79292379|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
44296226|NCT01982630|79292372|FG000|Overall Study|Withdrawal by Subject|0|||
44296227|NCT01982630|79292373|FG001|Overall Study|Withdrawal by Subject|0|||
44296228|NCT01982630|79292374|FG002|Overall Study|Withdrawal by Subject|0|||
44296229|NCT01982630|79292375|FG003|Overall Study|Withdrawal by Subject|0|||
44296230|NCT01982630|79292376|FG004|Overall Study|Withdrawal by Subject|0|||
44296231|NCT01982630|79292377|FG005|Overall Study|Withdrawal by Subject|1|||
44296232|NCT01982630|79292378|FG006|Overall Study|Withdrawal by Subject|0|||
44296233|NCT01982630|79292379|FG007|Overall Study|Withdrawal by Subject|0|||
44296234|NCT01729754|79292445|FG000|Part 1|Adverse Event|2|||
44296235|NCT01729754|79292446|FG001|Part 1|Adverse Event|0|||
44417085|NCT00764946|79424946|FG001|Overall Study|Adverse Event|2|||
44417086|NCT00764946|79424947|FG002|Overall Study|Adverse Event|1|||
44417087|NCT00764946|79424945|FG000|Overall Study|Withdrawal by Subject|3|||
44417088|NCT00764946|79424946|FG001|Overall Study|Withdrawal by Subject|6|||
44296236|NCT01729754|79292447|FG002|Part 1|Adverse Event|0|||
44417089|NCT00764946|79424947|FG002|Overall Study|Withdrawal by Subject|2|||
44417090|NCT00764946|79424945|FG000|Overall Study|Never Treated|1|||
44296237|NCT01729754|79292448|FG003|Part 1|Adverse Event|1|||
44296238|NCT01729754|79292449|FG004|Part 1|Adverse Event|0|||
44296239|NCT01729754|79292450|FG005|Part 1|Adverse Event|0|||
44296240|NCT01729754|79292451|FG006|Part 1|Adverse Event|2|||
44296241|NCT01729754|79292452|FG007|Part 1|Adverse Event|0|||
44296242|NCT01729754|79292453|FG008|Part 1|Adverse Event|0|||
44296243|NCT01729754|79292454|FG009|Part 1|Adverse Event|5|||
44296244|NCT01729754|79292445|FG000|Part 1|Lack of Efficacy|1|||
44296245|NCT01729754|79292446|FG001|Part 1|Lack of Efficacy|0|||
44296246|NCT01729754|79292447|FG002|Part 1|Lack of Efficacy|0|||
44296247|NCT01729754|79292448|FG003|Part 1|Lack of Efficacy|0|||
44417091|NCT00764946|79424946|FG001|Overall Study|Never Treated|1|||
44417092|NCT00764946|79424947|FG002|Overall Study|Never Treated|1|||
44296248|NCT01729754|79292449|FG004|Part 1|Lack of Efficacy|0|||
44296249|NCT01729754|79292450|FG005|Part 1|Lack of Efficacy|0|||
44296250|NCT01729754|79292451|FG006|Part 1|Lack of Efficacy|2|||
44296251|NCT01729754|79292452|FG007|Part 1|Lack of Efficacy|0|||
44296252|NCT01729754|79292453|FG008|Part 1|Lack of Efficacy|0|||
44296253|NCT01729754|79292454|FG009|Part 1|Lack of Efficacy|0|||
44296254|NCT01729754|79292445|FG000|Part 1|Lost to Follow-up|1|||
44296255|NCT01729754|79292446|FG001|Part 1|Lost to Follow-up|0|||
44296256|NCT01729754|79292447|FG002|Part 1|Lost to Follow-up|0|||
44296257|NCT01729754|79292448|FG003|Part 1|Lost to Follow-up|2|||
44296258|NCT01729754|79292449|FG004|Part 1|Lost to Follow-up|0|||
44296259|NCT01729754|79292450|FG005|Part 1|Lost to Follow-up|0|||
44296260|NCT01729754|79292451|FG006|Part 1|Lost to Follow-up|3|||
44296261|NCT01729754|79292452|FG007|Part 1|Lost to Follow-up|0|||
44296262|NCT01729754|79292453|FG008|Part 1|Lost to Follow-up|0|||
44296263|NCT01729754|79292454|FG009|Part 1|Lost to Follow-up|3|||
44296264|NCT01729754|79292445|FG000|Part 1|Non-compliance with Study Drug|1|||
44296265|NCT01729754|79292446|FG001|Part 1|Non-compliance with Study Drug|0|||
44296266|NCT01729754|79292447|FG002|Part 1|Non-compliance with Study Drug|0|||
44296267|NCT01729754|79292448|FG003|Part 1|Non-compliance with Study Drug|0|||
44296268|NCT01729754|79292449|FG004|Part 1|Non-compliance with Study Drug|0|||
44296269|NCT01729754|79292450|FG005|Part 1|Non-compliance with Study Drug|0|||
44296270|NCT01729754|79292451|FG006|Part 1|Non-compliance with Study Drug|0|||
44296271|NCT01729754|79292452|FG007|Part 1|Non-compliance with Study Drug|0|||
44296272|NCT01729754|79292453|FG008|Part 1|Non-compliance with Study Drug|0|||
44296273|NCT01729754|79292454|FG009|Part 1|Non-compliance with Study Drug|0|||
44296274|NCT01729754|79292445|FG000|Part 1|Physician Decision|0|||
44296275|NCT01729754|79292446|FG001|Part 1|Physician Decision|0|||
44296276|NCT01729754|79292447|FG002|Part 1|Physician Decision|0|||
44296277|NCT01729754|79292448|FG003|Part 1|Physician Decision|0|||
44296278|NCT01729754|79292449|FG004|Part 1|Physician Decision|0|||
44296279|NCT01729754|79292450|FG005|Part 1|Physician Decision|0|||
44296280|NCT01729754|79292451|FG006|Part 1|Physician Decision|0|||
44296281|NCT01729754|79292452|FG007|Part 1|Physician Decision|0|||
44296282|NCT01729754|79292453|FG008|Part 1|Physician Decision|0|||
44296283|NCT01729754|79292454|FG009|Part 1|Physician Decision|4|||
44296284|NCT01729754|79292445|FG000|Part 1|Pregnancy|0|||
44296285|NCT01729754|79292446|FG001|Part 1|Pregnancy|0|||
44296286|NCT01729754|79292447|FG002|Part 1|Pregnancy|0|||
44296287|NCT01729754|79292448|FG003|Part 1|Pregnancy|1|||
44296288|NCT01729754|79292449|FG004|Part 1|Pregnancy|0|||
44296289|NCT01729754|79292450|FG005|Part 1|Pregnancy|0|||
44296290|NCT01729754|79292451|FG006|Part 1|Pregnancy|0|||
44296291|NCT01729754|79292452|FG007|Part 1|Pregnancy|0|||
44417093|NCT00764868|79424961|FG000|Overall Study|Adverse Event|18|||
44417094|NCT00764868|79424961|FG000|Overall Study|Withdrawal by Subject|31|||
44417095|NCT00764868|79424961|FG000|Overall Study|Non-compliance|16|||
44417096|NCT00764868|79424961|FG000|Overall Study|Lost to Follow-up|25|||
44417097|NCT00764868|79424961|FG000|Overall Study|Lack of Efficacy|5|||
44296292|NCT01729754|79292453|FG008|Part 1|Pregnancy|0|||
44296293|NCT01729754|79292454|FG009|Part 1|Pregnancy|1|||
44296294|NCT01729754|79292445|FG000|Part 1|Progressive Disease|0|||
44296295|NCT01729754|79292446|FG001|Part 1|Progressive Disease|0|||
44296296|NCT01729754|79292447|FG002|Part 1|Progressive Disease|0|||
44296297|NCT01729754|79292448|FG003|Part 1|Progressive Disease|0|||
44296298|NCT01729754|79292449|FG004|Part 1|Progressive Disease|0|||
44296299|NCT01729754|79292450|FG005|Part 1|Progressive Disease|0|||
44296300|NCT01729754|79292451|FG006|Part 1|Progressive Disease|0|||
44296301|NCT01729754|79292452|FG007|Part 1|Progressive Disease|0|||
44296302|NCT01729754|79292453|FG008|Part 1|Progressive Disease|0|||
44296303|NCT01729754|79292454|FG009|Part 1|Progressive Disease|1|||
44296304|NCT01729754|79292445|FG000|Part 1|Protocol Violation|2|||
44417098|NCT00764868|79424961|FG000|Overall Study|Subject moved|7|||
44296305|NCT01729754|79292446|FG001|Part 1|Protocol Violation|0|||
44296306|NCT01729754|79292447|FG002|Part 1|Protocol Violation|0|||
44296307|NCT01729754|79292448|FG003|Part 1|Protocol Violation|1|||
44296308|NCT01729754|79292449|FG004|Part 1|Protocol Violation|0|||
44296309|NCT01729754|79292450|FG005|Part 1|Protocol Violation|0|||
44296310|NCT01729754|79292451|FG006|Part 1|Protocol Violation|1|||
44296311|NCT01729754|79292452|FG007|Part 1|Protocol Violation|0|||
44296312|NCT01729754|79292453|FG008|Part 1|Protocol Violation|0|||
44296313|NCT01729754|79292454|FG009|Part 1|Protocol Violation|0|||
44296314|NCT01729754|79292445|FG000|Part 1|Withdrawal by Subject|5|||
44296315|NCT01729754|79292446|FG001|Part 1|Withdrawal by Subject|0|||
44296316|NCT01729754|79292447|FG002|Part 1|Withdrawal by Subject|0|||
44296317|NCT01729754|79292448|FG003|Part 1|Withdrawal by Subject|7|||
44296318|NCT01729754|79292449|FG004|Part 1|Withdrawal by Subject|0|||
44296319|NCT01729754|79292450|FG005|Part 1|Withdrawal by Subject|0|||
44296320|NCT01729754|79292451|FG006|Part 1|Withdrawal by Subject|5|||
44296321|NCT01729754|79292452|FG007|Part 1|Withdrawal by Subject|0|||
44296322|NCT01729754|79292453|FG008|Part 1|Withdrawal by Subject|0|||
44417099|NCT00764868|79424961|FG000|Overall Study|Pregnancy|3|||
44417100|NCT00764868|79424961|FG000|Overall Study|Prohibited medication|1|||
44417101|NCT00764868|79424961|FG000|Overall Study|Out of town|1|||
44154635|NCT02684617|78945926|FG002|Overall Study|Study Terminated by Sponsor|5|||
44154636|NCT01999972|78945940|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
44154637|NCT01999972|78945941|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
44154638|NCT01999972|78945942|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
44154639|NCT01999972|78945943|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
44296323|NCT01729754|79292454|FG009|Part 1|Withdrawal by Subject|6|||
44296324|NCT01729754|79292445|FG000|Part 1|Other Protocol Specified Criteria|2|||
44296325|NCT01729754|79292446|FG001|Part 1|Other Protocol Specified Criteria|0|||
44296326|NCT01729754|79292447|FG002|Part 1|Other Protocol Specified Criteria|0|||
44296327|NCT01729754|79292448|FG003|Part 1|Other Protocol Specified Criteria|0|||
44296328|NCT01729754|79292449|FG004|Part 1|Other Protocol Specified Criteria|0|||
44296329|NCT01729754|79292450|FG005|Part 1|Other Protocol Specified Criteria|0|||
44296330|NCT01729754|79292451|FG006|Part 1|Other Protocol Specified Criteria|1|||
44296331|NCT01729754|79292452|FG007|Part 1|Other Protocol Specified Criteria|0|||
44296332|NCT01729754|79292453|FG008|Part 1|Other Protocol Specified Criteria|0|||
44296333|NCT01729754|79292454|FG009|Part 1|Other Protocol Specified Criteria|4|||
44296334|NCT01729754|79292445|FG000|Part 2|Adverse Event|2|||
44296335|NCT01729754|79292446|FG001|Part 2|Adverse Event|0|||
44296336|NCT01729754|79292447|FG002|Part 2|Adverse Event|0|||
44296337|NCT01729754|79292448|FG003|Part 2|Adverse Event|0|||
44296338|NCT01729754|79292449|FG004|Part 2|Adverse Event|0|||
44296339|NCT01729754|79292450|FG005|Part 2|Adverse Event|0|||
44296340|NCT01729754|79292451|FG006|Part 2|Adverse Event|0|||
44296341|NCT01729754|79292452|FG007|Part 2|Adverse Event|0|||
44296342|NCT01729754|79292453|FG008|Part 2|Adverse Event|1|||
44296343|NCT01729754|79292454|FG009|Part 2|Adverse Event|2|||
44296344|NCT01729754|79292445|FG000|Part 2|Lack of Efficacy|0|||
44296345|NCT01729754|79292446|FG001|Part 2|Lack of Efficacy|0|||
44296346|NCT01729754|79292447|FG002|Part 2|Lack of Efficacy|0|||
44296347|NCT01729754|79292448|FG003|Part 2|Lack of Efficacy|0|||
44296348|NCT01729754|79292449|FG004|Part 2|Lack of Efficacy|0|||
44296349|NCT01729754|79292450|FG005|Part 2|Lack of Efficacy|0|||
44296350|NCT01729754|79292451|FG006|Part 2|Lack of Efficacy|0|||
44296351|NCT01729754|79292452|FG007|Part 2|Lack of Efficacy|0|||
44296352|NCT01729754|79292453|FG008|Part 2|Lack of Efficacy|2|||
44296353|NCT01729754|79292454|FG009|Part 2|Lack of Efficacy|2|||
44296354|NCT01729754|79292445|FG000|Part 2|Lost to Follow-up|0|||
44296355|NCT01729754|79292446|FG001|Part 2|Lost to Follow-up|0|||
44296356|NCT01729754|79292447|FG002|Part 2|Lost to Follow-up|0|||
44296357|NCT01729754|79292448|FG003|Part 2|Lost to Follow-up|2|||
44296358|NCT01729754|79292449|FG004|Part 2|Lost to Follow-up|0|||
44296359|NCT01729754|79292450|FG005|Part 2|Lost to Follow-up|0|||
44296360|NCT01729754|79292451|FG006|Part 2|Lost to Follow-up|0|||
44296361|NCT01729754|79292452|FG007|Part 2|Lost to Follow-up|1|||
44296362|NCT01729754|79292453|FG008|Part 2|Lost to Follow-up|0|||
44296363|NCT01729754|79292454|FG009|Part 2|Lost to Follow-up|2|||
44296364|NCT01729754|79292445|FG000|Part 2|Non-Compliance with Study Drug|0|||
44296365|NCT01729754|79292446|FG001|Part 2|Non-Compliance with Study Drug|0|||
44296366|NCT01729754|79292447|FG002|Part 2|Non-Compliance with Study Drug|0|||
44296367|NCT01729754|79292448|FG003|Part 2|Non-Compliance with Study Drug|0|||
44296368|NCT01729754|79292449|FG004|Part 2|Non-Compliance with Study Drug|0|||
44296369|NCT01729754|79292450|FG005|Part 2|Non-Compliance with Study Drug|0|||
44296370|NCT01729754|79292451|FG006|Part 2|Non-Compliance with Study Drug|0|||
44296371|NCT01729754|79292452|FG007|Part 2|Non-Compliance with Study Drug|0|||
44296372|NCT01729754|79292453|FG008|Part 2|Non-Compliance with Study Drug|0|||
44296373|NCT01729754|79292454|FG009|Part 2|Non-Compliance with Study Drug|1|||
44296374|NCT01729754|79292445|FG000|Part 2|Pregnancy|0|||
44296375|NCT01729754|79292446|FG001|Part 2|Pregnancy|0|||
44296376|NCT01729754|79292447|FG002|Part 2|Pregnancy|0|||
44296377|NCT01729754|79292448|FG003|Part 2|Pregnancy|1|||
44296378|NCT01729754|79292449|FG004|Part 2|Pregnancy|0|||
44296379|NCT01729754|79292450|FG005|Part 2|Pregnancy|0|||
44296380|NCT01729754|79292451|FG006|Part 2|Pregnancy|0|||
44296381|NCT01729754|79292452|FG007|Part 2|Pregnancy|0|||
44296382|NCT01729754|79292453|FG008|Part 2|Pregnancy|0|||
44296383|NCT01729754|79292454|FG009|Part 2|Pregnancy|1|||
44154640|NCT01999972|78945944|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
44154641|NCT01999972|78945945|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
44154642|NCT01999972|78945940|FG000|Dose Escalation Part|Death|0|||
44296384|NCT01729754|79292445|FG000|Part 2|Withdrawal by Subject|3|||
44296385|NCT01729754|79292446|FG001|Part 2|Withdrawal by Subject|0|||
44296386|NCT01729754|79292447|FG002|Part 2|Withdrawal by Subject|0|||
44296387|NCT01729754|79292448|FG003|Part 2|Withdrawal by Subject|2|||
44296388|NCT01729754|79292449|FG004|Part 2|Withdrawal by Subject|0|||
44296389|NCT01729754|79292450|FG005|Part 2|Withdrawal by Subject|0|||
44296390|NCT01729754|79292451|FG006|Part 2|Withdrawal by Subject|0|||
44296391|NCT01729754|79292452|FG007|Part 2|Withdrawal by Subject|1|||
44296392|NCT01729754|79292453|FG008|Part 2|Withdrawal by Subject|1|||
44296393|NCT01729754|79292454|FG009|Part 2|Withdrawal by Subject|4|||
44296394|NCT01729754|79292445|FG000|Part 2|Other Protocol Specified Criteria|1|||
44296395|NCT01729754|79292446|FG001|Part 2|Other Protocol Specified Criteria|0|||
44296396|NCT01729754|79292447|FG002|Part 2|Other Protocol Specified Criteria|0|||
44296397|NCT01729754|79292448|FG003|Part 2|Other Protocol Specified Criteria|0|||
44296398|NCT01729754|79292449|FG004|Part 2|Other Protocol Specified Criteria|0|||
44296399|NCT01729754|79292450|FG005|Part 2|Other Protocol Specified Criteria|0|||
44296400|NCT01729754|79292451|FG006|Part 2|Other Protocol Specified Criteria|0|||
44296401|NCT01729754|79292452|FG007|Part 2|Other Protocol Specified Criteria|1|||
44296402|NCT01729754|79292453|FG008|Part 2|Other Protocol Specified Criteria|0|||
44296403|NCT01729754|79292454|FG009|Part 2|Other Protocol Specified Criteria|0|||
44296404|NCT01729754|79292445|FG000|Part 3|Adverse Event|0|||
44296405|NCT01729754|79292446|FG001|Part 3|Adverse Event|0|||
44296406|NCT01729754|79292447|FG002|Part 3|Adverse Event|1|||
44296407|NCT01729754|79292448|FG003|Part 3|Adverse Event|0|||
44296408|NCT01729754|79292449|FG004|Part 3|Adverse Event|0|||
44296409|NCT01729754|79292450|FG005|Part 3|Adverse Event|5|||
44296410|NCT01729754|79292451|FG006|Part 3|Adverse Event|0|||
44296411|NCT01729754|79292452|FG007|Part 3|Adverse Event|0|||
44296412|NCT01729754|79292453|FG008|Part 3|Adverse Event|0|||
44296413|NCT01729754|79292454|FG009|Part 3|Adverse Event|3|||
44296414|NCT01729754|79292445|FG000|Part 3|Death|0|||
44296415|NCT01729754|79292446|FG001|Part 3|Death|0|||
44296416|NCT01729754|79292447|FG002|Part 3|Death|0|||
44296417|NCT01729754|79292448|FG003|Part 3|Death|0|||
44296418|NCT01729754|79292449|FG004|Part 3|Death|0|||
44296419|NCT01729754|79292450|FG005|Part 3|Death|2|||
44296420|NCT01729754|79292451|FG006|Part 3|Death|0|||
44296421|NCT01729754|79292452|FG007|Part 3|Death|0|||
44296422|NCT01729754|79292453|FG008|Part 3|Death|0|||
44296423|NCT01729754|79292454|FG009|Part 3|Death|0|||
44296424|NCT01729754|79292445|FG000|Part 3|Lack of Efficacy|0|||
44296425|NCT01729754|79292446|FG001|Part 3|Lack of Efficacy|0|||
44296426|NCT01729754|79292447|FG002|Part 3|Lack of Efficacy|0|||
44296427|NCT01729754|79292448|FG003|Part 3|Lack of Efficacy|0|||
44296428|NCT01729754|79292449|FG004|Part 3|Lack of Efficacy|2|||
44296429|NCT01729754|79292450|FG005|Part 3|Lack of Efficacy|0|||
44296430|NCT01729754|79292451|FG006|Part 3|Lack of Efficacy|0|||
44296431|NCT01729754|79292452|FG007|Part 3|Lack of Efficacy|0|||
44296432|NCT01729754|79292453|FG008|Part 3|Lack of Efficacy|0|||
44296433|NCT01729754|79292454|FG009|Part 3|Lack of Efficacy|4|||
44296434|NCT01729754|79292445|FG000|Part 3|Lost to Follow-up|0|||
44296435|NCT01729754|79292446|FG001|Part 3|Lost to Follow-up|1|||
44296436|NCT01729754|79292447|FG002|Part 3|Lost to Follow-up|2|||
44296437|NCT01729754|79292448|FG003|Part 3|Lost to Follow-up|0|||
44296438|NCT01729754|79292449|FG004|Part 3|Lost to Follow-up|0|||
44296439|NCT01729754|79292450|FG005|Part 3|Lost to Follow-up|3|||
44296440|NCT01729754|79292451|FG006|Part 3|Lost to Follow-up|0|||
44296441|NCT01729754|79292452|FG007|Part 3|Lost to Follow-up|0|||
44296442|NCT01729754|79292453|FG008|Part 3|Lost to Follow-up|1|||
44296443|NCT01729754|79292454|FG009|Part 3|Lost to Follow-up|0|||
44296444|NCT01729754|79292445|FG000|Part 3|Physician Decision|0|||
44296445|NCT01729754|79292446|FG001|Part 3|Physician Decision|0|||
44296446|NCT01729754|79292447|FG002|Part 3|Physician Decision|1|||
44296447|NCT01729754|79292448|FG003|Part 3|Physician Decision|0|||
44296448|NCT01729754|79292449|FG004|Part 3|Physician Decision|0|||
44296449|NCT01729754|79292450|FG005|Part 3|Physician Decision|0|||
44296450|NCT01729754|79292451|FG006|Part 3|Physician Decision|0|||
44296451|NCT01729754|79292452|FG007|Part 3|Physician Decision|0|||
44296452|NCT01729754|79292453|FG008|Part 3|Physician Decision|0|||
44296453|NCT01729754|79292454|FG009|Part 3|Physician Decision|0|||
44296454|NCT01729754|79292445|FG000|Part 3|Withdrawal by Subject|0|||
44296455|NCT01729754|79292446|FG001|Part 3|Withdrawal by Subject|4|||
44296456|NCT01729754|79292447|FG002|Part 3|Withdrawal by Subject|1|||
44296457|NCT01729754|79292448|FG003|Part 3|Withdrawal by Subject|0|||
44296458|NCT01729754|79292449|FG004|Part 3|Withdrawal by Subject|2|||
44296459|NCT01729754|79292450|FG005|Part 3|Withdrawal by Subject|1|||
44296460|NCT01729754|79292451|FG006|Part 3|Withdrawal by Subject|0|||
44296461|NCT01729754|79292452|FG007|Part 3|Withdrawal by Subject|2|||
44296462|NCT01729754|79292453|FG008|Part 3|Withdrawal by Subject|0|||
44296463|NCT01729754|79292454|FG009|Part 3|Withdrawal by Subject|0|||
44296464|NCT01729754|79292445|FG000|Part 3|Other Protocol Specified Criteria|0|||
44296465|NCT01729754|79292446|FG001|Part 3|Other Protocol Specified Criteria|0|||
44296466|NCT01729754|79292447|FG002|Part 3|Other Protocol Specified Criteria|0|||
44296467|NCT01729754|79292448|FG003|Part 3|Other Protocol Specified Criteria|0|||
44296468|NCT01729754|79292449|FG004|Part 3|Other Protocol Specified Criteria|0|||
44296469|NCT01729754|79292450|FG005|Part 3|Other Protocol Specified Criteria|2|||
44296470|NCT01729754|79292451|FG006|Part 3|Other Protocol Specified Criteria|0|||
44296471|NCT01729754|79292452|FG007|Part 3|Other Protocol Specified Criteria|1|||
44296472|NCT01729754|79292453|FG008|Part 3|Other Protocol Specified Criteria|0|||
44296473|NCT01729754|79292454|FG009|Part 3|Other Protocol Specified Criteria|0|||
44296474|NCT01515306|79292499|FG000|Overall Study|Adverse Event|3|||
44296475|NCT01515306|79292500|FG001|Overall Study|Adverse Event|2|||
44296476|NCT01515306|79292499|FG000|Overall Study|Progressive Disease|19|||
44296477|NCT01515306|79292500|FG001|Overall Study|Progressive Disease|9|||
44296478|NCT01515306|79292499|FG000|Overall Study|Withdrawal by Subject|1|||
44296479|NCT01515306|79292500|FG001|Overall Study|Withdrawal by Subject|2|||
44296480|NCT01515306|79292499|FG000|Overall Study|Physician Decision|1|||
44296481|NCT01515306|79292500|FG001|Overall Study|Physician Decision|1|||
44296482|NCT01423851|79292521|FG000|Whole Study|Disease progression|2|||
44296483|NCT01423851|79292522|FG001|Whole Study|Disease progression|1|||
44296484|NCT01423851|79292523|FG002|Whole Study|Disease progression|1|||
44296485|NCT01423851|79292524|FG003|Whole Study|Disease progression|4|||
44296486|NCT01423851|79292525|FG004|Whole Study|Disease progression|1|||
44296487|NCT01423851|79292526|FG005|Whole Study|Disease progression|3|||
44296488|NCT01423851|79292527|FG006|Whole Study|Disease progression|1|||
44296489|NCT01423851|79292528|FG007|Whole Study|Disease progression|4|||
44296490|NCT01423851|79292529|FG008|Whole Study|Disease progression|0|||
44296491|NCT01423851|79292530|FG009|Whole Study|Disease progression|2|||
44296492|NCT01423851|79292531|FG010|Whole Study|Disease progression|10|||
44296493|NCT01423851|79292521|FG000|Whole Study|Physician Decision|0|||
44296494|NCT01423851|79292522|FG001|Whole Study|Physician Decision|1|||
44296495|NCT01423851|79292523|FG002|Whole Study|Physician Decision|2|||
44296496|NCT01423851|79292524|FG003|Whole Study|Physician Decision|0|||
44296497|NCT01423851|79292525|FG004|Whole Study|Physician Decision|2|||
44296498|NCT01423851|79292526|FG005|Whole Study|Physician Decision|0|||
44296499|NCT01423851|79292527|FG006|Whole Study|Physician Decision|2|||
44296500|NCT01423851|79292528|FG007|Whole Study|Physician Decision|1|||
44296501|NCT01423851|79292529|FG008|Whole Study|Physician Decision|3|||
44296502|NCT01423851|79292530|FG009|Whole Study|Physician Decision|4|||
44296503|NCT01423851|79292531|FG010|Whole Study|Physician Decision|12|||
44296504|NCT01423851|79292521|FG000|Whole Study|Withdrawal by Subject|1|||
44296505|NCT01423851|79292522|FG001|Whole Study|Withdrawal by Subject|1|||
44296506|NCT01423851|79292523|FG002|Whole Study|Withdrawal by Subject|0|||
44296507|NCT01423851|79292524|FG003|Whole Study|Withdrawal by Subject|0|||
44296508|NCT01423851|79292525|FG004|Whole Study|Withdrawal by Subject|0|||
44296509|NCT01423851|79292526|FG005|Whole Study|Withdrawal by Subject|0|||
44296510|NCT01423851|79292527|FG006|Whole Study|Withdrawal by Subject|0|||
44296511|NCT01423851|79292528|FG007|Whole Study|Withdrawal by Subject|0|||
44296512|NCT01423851|79292529|FG008|Whole Study|Withdrawal by Subject|2|||
44296513|NCT01423851|79292530|FG009|Whole Study|Withdrawal by Subject|0|||
44296514|NCT01423851|79292531|FG010|Whole Study|Withdrawal by Subject|4|||
44296515|NCT01423851|79292521|FG000|Whole Study|Adverse Event|0|||
44296516|NCT01423851|79292522|FG001|Whole Study|Adverse Event|0|||
44296517|NCT01423851|79292523|FG002|Whole Study|Adverse Event|0|||
44296518|NCT01423851|79292524|FG003|Whole Study|Adverse Event|2|||
44296519|NCT01423851|79292525|FG004|Whole Study|Adverse Event|0|||
44296520|NCT01423851|79292526|FG005|Whole Study|Adverse Event|0|||
44296521|NCT01423851|79292527|FG006|Whole Study|Adverse Event|0|||
44296522|NCT01423851|79292528|FG007|Whole Study|Adverse Event|3|||
44296523|NCT01423851|79292529|FG008|Whole Study|Adverse Event|3|||
44296524|NCT01423851|79292530|FG009|Whole Study|Adverse Event|2|||
44296525|NCT01423851|79292531|FG010|Whole Study|Adverse Event|3|||
44296526|NCT01334606|79292573|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
44296527|NCT01317875|79292589|FG000|Overall Study|Other|0|||
44296528|NCT01317875|79292590|FG001|Overall Study|Other|0|||
44296529|NCT01317875|79292591|FG002|Overall Study|Other|1|||
44296530|NCT01317875|79292592|FG003|Overall Study|Other|0|||
44296531|NCT01317875|79292593|FG004|Overall Study|Other|0|||
44296532|NCT01317875|79292594|FG005|Overall Study|Other|0|||
44296533|NCT01317875|79292595|FG006|Overall Study|Other|0|||
44296534|NCT01317875|79292596|FG007|Overall Study|Other|0|||
44296535|NCT01317875|79292597|FG008|Overall Study|Other|0|||
44296536|NCT01317875|79292598|FG009|Overall Study|Other|0|||
44296537|NCT01317875|79292589|FG000|Overall Study|Noncompliance with study drug|0|||
44296538|NCT01317875|79292590|FG001|Overall Study|Noncompliance with study drug|0|||
44296539|NCT01317875|79292591|FG002|Overall Study|Noncompliance with study drug|1|||
44296540|NCT01317875|79292592|FG003|Overall Study|Noncompliance with study drug|0|||
44296541|NCT01317875|79292593|FG004|Overall Study|Noncompliance with study drug|0|||
44296542|NCT01317875|79292594|FG005|Overall Study|Noncompliance with study drug|0|||
44296543|NCT01317875|79292595|FG006|Overall Study|Noncompliance with study drug|0|||
44296544|NCT01317875|79292596|FG007|Overall Study|Noncompliance with study drug|0|||
44296545|NCT01317875|79292597|FG008|Overall Study|Noncompliance with study drug|0|||
44296546|NCT01317875|79292598|FG009|Overall Study|Noncompliance with study drug|0|||
44296547|NCT01317875|79292589|FG000|Overall Study|Progressive Disease|1|||
44296548|NCT01317875|79292590|FG001|Overall Study|Progressive Disease|0|||
44296549|NCT01317875|79292591|FG002|Overall Study|Progressive Disease|2|||
44296550|NCT01317875|79292592|FG003|Overall Study|Progressive Disease|0|||
44296551|NCT01317875|79292593|FG004|Overall Study|Progressive Disease|1|||
44296552|NCT01317875|79292594|FG005|Overall Study|Progressive Disease|0|||
44296553|NCT01317875|79292595|FG006|Overall Study|Progressive Disease|0|||
44296554|NCT01317875|79292596|FG007|Overall Study|Progressive Disease|1|||
44296555|NCT01317875|79292597|FG008|Overall Study|Progressive Disease|0|||
44296556|NCT01317875|79292598|FG009|Overall Study|Progressive Disease|0|||
44296557|NCT01317875|79292589|FG000|Overall Study|Withdrawal by Subject|0|||
44296558|NCT01317875|79292590|FG001|Overall Study|Withdrawal by Subject|0|||
44296559|NCT01317875|79292591|FG002|Overall Study|Withdrawal by Subject|0|||
44296560|NCT01317875|79292592|FG003|Overall Study|Withdrawal by Subject|0|||
44534050|NCT02101853|79544760|FG000|Block 1 Induction|Ineligible|8|||
44534051|NCT02101853|79544761|FG001|Block 1 Induction|Ineligible|0|||
44296561|NCT01317875|79292593|FG004|Overall Study|Withdrawal by Subject|1|||
44296562|NCT01317875|79292594|FG005|Overall Study|Withdrawal by Subject|0|||
44296563|NCT01317875|79292595|FG006|Overall Study|Withdrawal by Subject|0|||
44296564|NCT01317875|79292596|FG007|Overall Study|Withdrawal by Subject|3|||
44296565|NCT01317875|79292597|FG008|Overall Study|Withdrawal by Subject|0|||
44296566|NCT01317875|79292598|FG009|Overall Study|Withdrawal by Subject|0|||
44296567|NCT01317875|79292589|FG000|Overall Study|Physician Decision|0|||
44296568|NCT01317875|79292590|FG001|Overall Study|Physician Decision|1|||
44296569|NCT01317875|79292591|FG002|Overall Study|Physician Decision|1|||
44296570|NCT01317875|79292592|FG003|Overall Study|Physician Decision|0|||
44296571|NCT01317875|79292593|FG004|Overall Study|Physician Decision|2|||
44296572|NCT01317875|79292594|FG005|Overall Study|Physician Decision|0|||
44296573|NCT01317875|79292595|FG006|Overall Study|Physician Decision|0|||
44296574|NCT01317875|79292596|FG007|Overall Study|Physician Decision|2|||
44296575|NCT01317875|79292597|FG008|Overall Study|Physician Decision|0|||
44296576|NCT01317875|79292598|FG009|Overall Study|Physician Decision|0|||
44296577|NCT01317875|79292589|FG000|Overall Study|Death|0|||
44296578|NCT01317875|79292590|FG001|Overall Study|Death|0|||
44296579|NCT01317875|79292591|FG002|Overall Study|Death|2|||
44296580|NCT01317875|79292592|FG003|Overall Study|Death|1|||
44296581|NCT01317875|79292593|FG004|Overall Study|Death|0|||
44296582|NCT01317875|79292594|FG005|Overall Study|Death|1|||
44296583|NCT01317875|79292595|FG006|Overall Study|Death|0|||
44296584|NCT01317875|79292596|FG007|Overall Study|Death|4|||
44296585|NCT01317875|79292597|FG008|Overall Study|Death|0|||
44296586|NCT01317875|79292598|FG009|Overall Study|Death|0|||
44296587|NCT01317875|79292589|FG000|Overall Study|Adverse Event|2|||
44296588|NCT01317875|79292590|FG001|Overall Study|Adverse Event|1|||
44296589|NCT01317875|79292591|FG002|Overall Study|Adverse Event|2|||
44296590|NCT01317875|79292592|FG003|Overall Study|Adverse Event|1|||
44296591|NCT01317875|79292593|FG004|Overall Study|Adverse Event|5|||
44296592|NCT01317875|79292594|FG005|Overall Study|Adverse Event|1|||
44296593|NCT01317875|79292595|FG006|Overall Study|Adverse Event|2|||
44296594|NCT01317875|79292596|FG007|Overall Study|Adverse Event|5|||
44296595|NCT01317875|79292597|FG008|Overall Study|Adverse Event|0|||
44296596|NCT01317875|79292598|FG009|Overall Study|Adverse Event|0|||
44296597|NCT00500071|79292674|FG000|Screening and Washout Phase|Protocol Violation|1|||
44296598|NCT00500071|79292674|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
44296599|NCT00500071|79292674|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
44296600|NCT00500071|79292674|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
44296601|NCT00500071|79292674|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
44296602|NCT00500071|79292674|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
44296603|NCT00500071|79292674|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
44296604|NCT00447122|79292682|FG000|Overall Study|worsening medical condition -came off|0|||
44296605|NCT00447122|79292683|FG001|Overall Study|worsening medical condition -came off|1|||
44296606|NCT00447122|79292684|FG002|Overall Study|worsening medical condition -came off|0|||
44296607|NCT00447122|79292685|FG003|Overall Study|worsening medical condition -came off|0|||
44296608|NCT00382252|79292695|FG000|Overall Study|Death|4|||
44296609|NCT00382252|79292695|FG000|Overall Study|Protocol Violation|8|||
44296610|NCT00382252|79292695|FG000|Overall Study|Not treated by RFA|1|||
44296611|NCT00290251|79292702|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
44296612|NCT00290251|79292703|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
44296613|NCT00290251|79292704|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
44296614|NCT00290251|79292705|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
44296615|NCT00290251|79292706|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
44296616|NCT00290251|79292707|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
44296617|NCT00290251|79292702|FG000|Treatment 1 (Months 2-4)|headache|0|||
44296618|NCT00290251|79292703|FG001|Treatment 1 (Months 2-4)|headache|0|||
44296619|NCT00290251|79292704|FG002|Treatment 1 (Months 2-4)|headache|0|||
44296620|NCT00290251|79292705|FG003|Treatment 1 (Months 2-4)|headache|0|||
44296621|NCT00290251|79292706|FG004|Treatment 1 (Months 2-4)|headache|1|||
44296622|NCT00290251|79292707|FG005|Treatment 1 (Months 2-4)|headache|0|||
44296623|NCT00290251|79292702|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
44296624|NCT00290251|79292703|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
44296625|NCT00290251|79292704|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
44534052|NCT02101853|79544762|FG002|Block 1 Induction|Ineligible|0|||
44296626|NCT00290251|79292705|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
44296627|NCT00290251|79292706|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
44296628|NCT00290251|79292707|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
44296629|NCT01403948|79292743|FG000|Overall Study|Progressive disease|0|||
44296630|NCT01403948|79292744|FG001|Overall Study|Progressive disease|2|||
44296631|NCT01403948|79292745|FG002|Overall Study|Progressive disease|2|||
44296632|NCT01403948|79292746|FG003|Overall Study|Progressive disease|4|||
44296633|NCT01403948|79292747|FG004|Overall Study|Progressive disease|2|||
44296634|NCT01403948|79292748|FG005|Overall Study|Progressive disease|6|||
44296635|NCT01403948|79292749|FG006|Overall Study|Progressive disease|2|||
44296636|NCT01403948|79292750|FG007|Overall Study|Progressive disease|4|||
44296637|NCT01403948|79292751|FG008|Overall Study|Progressive disease|5|||
44296638|NCT01403948|79292752|FG009|Overall Study|Progressive disease|5|||
44296639|NCT01403948|79292743|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296640|NCT01403948|79292744|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296641|NCT01403948|79292745|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296642|NCT01403948|79292746|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296643|NCT01403948|79292747|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
44296644|NCT01403948|79292748|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296645|NCT01403948|79292749|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
44296646|NCT01403948|79292750|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296647|NCT01403948|79292751|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
44296648|NCT01403948|79292752|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
44296649|NCT01403948|79292743|FG000|Overall Study|Lost to Follow-up|0|||
44296650|NCT01403948|79292744|FG001|Overall Study|Lost to Follow-up|0|||
44296651|NCT01403948|79292745|FG002|Overall Study|Lost to Follow-up|0|||
44296652|NCT01403948|79292746|FG003|Overall Study|Lost to Follow-up|0|||
44296653|NCT01403948|79292747|FG004|Overall Study|Lost to Follow-up|0|||
44296654|NCT01403948|79292748|FG005|Overall Study|Lost to Follow-up|0|||
44296655|NCT01403948|79292749|FG006|Overall Study|Lost to Follow-up|0|||
44296656|NCT01403948|79292750|FG007|Overall Study|Lost to Follow-up|0|||
44296657|NCT01403948|79292751|FG008|Overall Study|Lost to Follow-up|0|||
44296658|NCT01403948|79292752|FG009|Overall Study|Lost to Follow-up|1|||
44296659|NCT01403948|79292743|FG000|Overall Study|Refused cont. medication|0|||
44296660|NCT01403948|79292744|FG001|Overall Study|Refused cont. medication|0|||
44296661|NCT01403948|79292745|FG002|Overall Study|Refused cont. medication|0|||
44296662|NCT01403948|79292746|FG003|Overall Study|Refused cont. medication|0|||
44296663|NCT01403948|79292747|FG004|Overall Study|Refused cont. medication|1|||
44296664|NCT01403948|79292748|FG005|Overall Study|Refused cont. medication|0|||
44296665|NCT01403948|79292749|FG006|Overall Study|Refused cont. medication|0|||
44296666|NCT01403948|79292750|FG007|Overall Study|Refused cont. medication|0|||
44296667|NCT01403948|79292751|FG008|Overall Study|Refused cont. medication|0|||
44296668|NCT01403948|79292752|FG009|Overall Study|Refused cont. medication|1|||
44296669|NCT01403948|79292743|FG000|Overall Study|other than above|1|||
44296670|NCT01403948|79292744|FG001|Overall Study|other than above|2|||
44296671|NCT01403948|79292745|FG002|Overall Study|other than above|1|||
44296672|NCT01403948|79292746|FG003|Overall Study|other than above|0|||
44296673|NCT01403948|79292747|FG004|Overall Study|other than above|1|||
44296674|NCT01403948|79292748|FG005|Overall Study|other than above|1|||
44296675|NCT01403948|79292749|FG006|Overall Study|other than above|2|||
44296676|NCT01403948|79292750|FG007|Overall Study|other than above|0|||
44296677|NCT01403948|79292751|FG008|Overall Study|other than above|0|||
44296678|NCT01403948|79292752|FG009|Overall Study|other than above|0|||
44296679|NCT01404312|79292780|FG000|Overall Study|Death|21|||
44296680|NCT01404312|79292781|FG001|Overall Study|Death|27|||
44296681|NCT01404312|79292780|FG000|Overall Study|Withdrawal by Subject|15|||
44296682|NCT01404312|79292781|FG001|Overall Study|Withdrawal by Subject|18|||
44296683|NCT01404312|79292780|FG000|Overall Study|Participant Unable to get to clinic|93|||
44296684|NCT01404312|79292781|FG001|Overall Study|Participant Unable to get to clinic|103|||
44296685|NCT01404312|79292780|FG000|Overall Study|Lost to Follow-up|115|||
44296686|NCT01404312|79292781|FG001|Overall Study|Lost to Follow-up|111|||
44296687|NCT01404312|79292780|FG000|Overall Study|Site closed|22|||
44296688|NCT01404312|79292781|FG001|Overall Study|Site closed|21|||
44296689|NCT01404312|79292780|FG000|Overall Study|Participant not willing to adhere to req|31|||
44296690|NCT01404312|79292781|FG001|Overall Study|Participant not willing to adhere to req|29|||
44296691|NCT01404312|79292780|FG000|Overall Study|Severe debilitation, unable to continue|1|||
44296692|NCT01404312|79292781|FG001|Overall Study|Severe debilitation, unable to continue|2|||
44296693|NCT01414608|79292790|FG000|Overall Study|Ineligible|5|||
44296694|NCT01414608|79292791|FG001|Overall Study|Ineligible|2|||
44296695|NCT01420861|79292801|FG000|Overall Study|Adverse Event|2|||
44296696|NCT01420861|79292801|FG000|Overall Study|Study terminated by Sponsor|7|||
44296697|NCT01420861|79292801|FG000|Overall Study|Screen failure|7|||
44296698|NCT01420861|79292801|FG000|Overall Study|Randomized not Treated|2|||
44296699|NCT01425008|79292824|FG000|Dose Escalation Phase|Progressive Disease|2|||
44296700|NCT01425008|79292825|FG001|Dose Escalation Phase|Progressive Disease|3|||
44296701|NCT01425008|79292826|FG002|Dose Escalation Phase|Progressive Disease|2|||
44296702|NCT01425008|79292827|FG003|Dose Escalation Phase|Progressive Disease|3|||
44296703|NCT01425008|79292828|FG004|Dose Escalation Phase|Progressive Disease|5|||
44296704|NCT01425008|79292829|FG005|Dose Escalation Phase|Progressive Disease|4|||
44296705|NCT01425008|79292830|FG006|Dose Escalation Phase|Progressive Disease|0|||
44296706|NCT01425008|79292831|FG007|Dose Escalation Phase|Progressive Disease|2|||
44296707|NCT01425008|79292832|FG008|Dose Escalation Phase|Progressive Disease|6|||
44296708|NCT01425008|79292833|FG009|Dose Escalation Phase|Progressive Disease|2|||
44296709|NCT01425008|79292834|FG010|Dose Escalation Phase|Progressive Disease|0|||
44296710|NCT01425008|79292835|FG011|Dose Escalation Phase|Progressive Disease|0|||
44296711|NCT01425008|79292836|FG012|Dose Escalation Phase|Progressive Disease|0|||
44296712|NCT01425008|79292837|FG013|Dose Escalation Phase|Progressive Disease|0|||
44296713|NCT01425008|79292838|FG014|Dose Escalation Phase|Progressive Disease|0|||
44296714|NCT01425008|79292839|FG015|Dose Escalation Phase|Progressive Disease|0|||
44296715|NCT01425008|79292840|FG016|Dose Escalation Phase|Progressive Disease|0|||
44296716|NCT01425008|79292841|FG017|Dose Escalation Phase|Progressive Disease|0|||
44296717|NCT01425008|79292842|FG018|Dose Escalation Phase|Progressive Disease|0|||
44296718|NCT01425008|79292824|FG000|Dose Escalation Phase|Adverse Event|2|||
44296719|NCT01425008|79292825|FG001|Dose Escalation Phase|Adverse Event|0|||
44296720|NCT01425008|79292826|FG002|Dose Escalation Phase|Adverse Event|0|||
44296721|NCT01425008|79292827|FG003|Dose Escalation Phase|Adverse Event|0|||
44296722|NCT01425008|79292828|FG004|Dose Escalation Phase|Adverse Event|0|||
44296723|NCT01425008|79292829|FG005|Dose Escalation Phase|Adverse Event|2|||
44296724|NCT01425008|79292830|FG006|Dose Escalation Phase|Adverse Event|0|||
44296725|NCT01425008|79292831|FG007|Dose Escalation Phase|Adverse Event|0|||
44296726|NCT01425008|79292832|FG008|Dose Escalation Phase|Adverse Event|2|||
44296727|NCT01425008|79292833|FG009|Dose Escalation Phase|Adverse Event|0|||
44296728|NCT01425008|79292834|FG010|Dose Escalation Phase|Adverse Event|0|||
44296729|NCT01425008|79292835|FG011|Dose Escalation Phase|Adverse Event|0|||
44296730|NCT01425008|79292836|FG012|Dose Escalation Phase|Adverse Event|0|||
44296731|NCT01425008|79292837|FG013|Dose Escalation Phase|Adverse Event|0|||
44296732|NCT01425008|79292838|FG014|Dose Escalation Phase|Adverse Event|0|||
44296733|NCT01425008|79292839|FG015|Dose Escalation Phase|Adverse Event|0|||
44296734|NCT01425008|79292840|FG016|Dose Escalation Phase|Adverse Event|0|||
44296735|NCT01425008|79292841|FG017|Dose Escalation Phase|Adverse Event|0|||
44296736|NCT01425008|79292842|FG018|Dose Escalation Phase|Adverse Event|0|||
44296737|NCT01425008|79292824|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296738|NCT01425008|79292825|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296739|NCT01425008|79292826|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296740|NCT01425008|79292827|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296741|NCT01425008|79292828|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
44296742|NCT01425008|79292829|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296743|NCT01425008|79292830|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
44296744|NCT01425008|79292831|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
44296745|NCT01425008|79292832|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
44296746|NCT01425008|79292833|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296747|NCT01425008|79292834|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296748|NCT01425008|79292835|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296749|NCT01425008|79292836|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296750|NCT01425008|79292837|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296751|NCT01425008|79292838|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296752|NCT01425008|79292839|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296753|NCT01425008|79292840|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296754|NCT01425008|79292841|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296755|NCT01425008|79292842|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44296756|NCT01425008|79292824|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
44296757|NCT01425008|79292825|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
44296758|NCT01425008|79292826|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
44296759|NCT01425008|79292827|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44296760|NCT01425008|79292828|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
44296761|NCT01425008|79292829|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
44296762|NCT01425008|79292830|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
44296763|NCT01425008|79292831|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
44296764|NCT01425008|79292832|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
44296765|NCT01425008|79292833|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
44296766|NCT01425008|79292834|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
44296767|NCT01425008|79292835|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
44296768|NCT01425008|79292836|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
44296769|NCT01425008|79292837|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
44296770|NCT01425008|79292838|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
44296771|NCT01425008|79292839|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
44296772|NCT01425008|79292840|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
44296773|NCT01425008|79292841|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
44296774|NCT01425008|79292842|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
44296775|NCT01425008|79292824|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296776|NCT01425008|79292825|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296777|NCT01425008|79292826|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
44296778|NCT01425008|79292827|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296779|NCT01425008|79292828|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
44534053|NCT02101853|79544763|FG003|Block 1 Induction|Ineligible|0|||
44296780|NCT01425008|79292829|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296781|NCT01425008|79292830|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296782|NCT01425008|79292831|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296783|NCT01425008|79292832|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
44296784|NCT01425008|79292833|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
44296785|NCT01425008|79292834|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296786|NCT01425008|79292835|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296787|NCT01425008|79292836|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296788|NCT01425008|79292837|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296789|NCT01425008|79292838|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296790|NCT01425008|79292839|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296791|NCT01425008|79292840|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296792|NCT01425008|79292841|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296793|NCT01425008|79292842|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
44296794|NCT01425008|79292824|FG000|Dose Escalation Phase|Other|0|||
44296795|NCT01425008|79292825|FG001|Dose Escalation Phase|Other|0|||
44296796|NCT01425008|79292826|FG002|Dose Escalation Phase|Other|0|||
44296797|NCT01425008|79292827|FG003|Dose Escalation Phase|Other|0|||
44296798|NCT01425008|79292828|FG004|Dose Escalation Phase|Other|0|||
44296799|NCT01425008|79292829|FG005|Dose Escalation Phase|Other|0|||
44296800|NCT01425008|79292830|FG006|Dose Escalation Phase|Other|0|||
44296801|NCT01425008|79292831|FG007|Dose Escalation Phase|Other|0|||
44296802|NCT01425008|79292832|FG008|Dose Escalation Phase|Other|1|||
44296803|NCT01425008|79292833|FG009|Dose Escalation Phase|Other|0|||
44296804|NCT01425008|79292834|FG010|Dose Escalation Phase|Other|0|||
44296805|NCT01425008|79292835|FG011|Dose Escalation Phase|Other|0|||
44296806|NCT01425008|79292836|FG012|Dose Escalation Phase|Other|0|||
44296807|NCT01425008|79292837|FG013|Dose Escalation Phase|Other|0|||
44296808|NCT01425008|79292838|FG014|Dose Escalation Phase|Other|0|||
44296809|NCT01425008|79292839|FG015|Dose Escalation Phase|Other|0|||
44296810|NCT01425008|79292840|FG016|Dose Escalation Phase|Other|0|||
44296811|NCT01425008|79292841|FG017|Dose Escalation Phase|Other|0|||
44296812|NCT01425008|79292842|FG018|Dose Escalation Phase|Other|0|||
44296813|NCT01425008|79292824|FG000|Dose Expansion Phase|Progressive Disease|0|||
44296814|NCT01425008|79292825|FG001|Dose Expansion Phase|Progressive Disease|0|||
44296815|NCT01425008|79292826|FG002|Dose Expansion Phase|Progressive Disease|0|||
44296816|NCT01425008|79292827|FG003|Dose Expansion Phase|Progressive Disease|0|||
44296817|NCT01425008|79292828|FG004|Dose Expansion Phase|Progressive Disease|0|||
44296818|NCT01425008|79292829|FG005|Dose Expansion Phase|Progressive Disease|0|||
44296819|NCT01425008|79292830|FG006|Dose Expansion Phase|Progressive Disease|0|||
44296820|NCT01425008|79292831|FG007|Dose Expansion Phase|Progressive Disease|0|||
44296821|NCT01425008|79292832|FG008|Dose Expansion Phase|Progressive Disease|0|||
44296822|NCT01425008|79292833|FG009|Dose Expansion Phase|Progressive Disease|0|||
44296823|NCT01425008|79292834|FG010|Dose Expansion Phase|Progressive Disease|10|||
44296824|NCT01425008|79292835|FG011|Dose Expansion Phase|Progressive Disease|4|||
44296825|NCT01425008|79292836|FG012|Dose Expansion Phase|Progressive Disease|12|||
44296826|NCT01425008|79292837|FG013|Dose Expansion Phase|Progressive Disease|1|||
44296827|NCT01425008|79292838|FG014|Dose Expansion Phase|Progressive Disease|5|||
44296828|NCT01425008|79292839|FG015|Dose Expansion Phase|Progressive Disease|8|||
44296829|NCT01425008|79292840|FG016|Dose Expansion Phase|Progressive Disease|9|||
44296830|NCT01425008|79292841|FG017|Dose Expansion Phase|Progressive Disease|2|||
44296831|NCT01425008|79292842|FG018|Dose Expansion Phase|Progressive Disease|10|||
44296832|NCT01425008|79292824|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
44296833|NCT01425008|79292825|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
44296834|NCT01425008|79292826|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
44296835|NCT01425008|79292827|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
44296836|NCT01425008|79292828|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
44296837|NCT01425008|79292829|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
44296838|NCT01425008|79292830|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
44296839|NCT01425008|79292831|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
44296840|NCT01425008|79292832|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
44296841|NCT01425008|79292833|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
44296842|NCT01425008|79292834|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
44296843|NCT01425008|79292835|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
44296844|NCT01425008|79292836|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
44417102|NCT00764868|79424961|FG000|Overall Study|Misuse and compliance of study drug|1|||
44534054|NCT02101853|79544764|FG004|Block 1 Induction|Ineligible|0|||
44534055|NCT02101853|79544765|FG005|Block 1 Induction|Ineligible|0|||
44534056|NCT02101853|79544760|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
44296845|NCT01425008|79292837|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
44296846|NCT01425008|79292838|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
44296847|NCT01425008|79292839|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
44296848|NCT01425008|79292840|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
44296849|NCT01425008|79292841|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
44296850|NCT01425008|79292842|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
44296851|NCT01425008|79292824|FG000|Dose Expansion Phase|Other|0|||
44296852|NCT01425008|79292825|FG001|Dose Expansion Phase|Other|0|||
44296853|NCT01425008|79292826|FG002|Dose Expansion Phase|Other|0|||
44296854|NCT01425008|79292827|FG003|Dose Expansion Phase|Other|0|||
44296855|NCT01425008|79292828|FG004|Dose Expansion Phase|Other|0|||
44296856|NCT01425008|79292829|FG005|Dose Expansion Phase|Other|0|||
44296857|NCT01425008|79292830|FG006|Dose Expansion Phase|Other|0|||
44296858|NCT01425008|79292831|FG007|Dose Expansion Phase|Other|0|||
44296859|NCT01425008|79292832|FG008|Dose Expansion Phase|Other|0|||
44296860|NCT01425008|79292833|FG009|Dose Expansion Phase|Other|0|||
44296861|NCT01425008|79292834|FG010|Dose Expansion Phase|Other|0|||
44296862|NCT01425008|79292835|FG011|Dose Expansion Phase|Other|0|||
44296863|NCT01425008|79292836|FG012|Dose Expansion Phase|Other|1|||
44296864|NCT01425008|79292837|FG013|Dose Expansion Phase|Other|0|||
44296865|NCT01425008|79292838|FG014|Dose Expansion Phase|Other|0|||
44296866|NCT01425008|79292839|FG015|Dose Expansion Phase|Other|0|||
44296867|NCT01425008|79292840|FG016|Dose Expansion Phase|Other|2|||
44296868|NCT01425008|79292841|FG017|Dose Expansion Phase|Other|0|||
44296869|NCT01425008|79292842|FG018|Dose Expansion Phase|Other|4|||
44296870|NCT01425008|79292824|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296871|NCT01425008|79292825|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296872|NCT01425008|79292826|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296873|NCT01425008|79292827|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296874|NCT01425008|79292828|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296875|NCT01425008|79292829|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296876|NCT01425008|79292830|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296877|NCT01425008|79292831|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296878|NCT01425008|79292832|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296879|NCT01425008|79292833|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296880|NCT01425008|79292834|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
44296881|NCT01425008|79292835|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
44296882|NCT01425008|79292836|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296883|NCT01425008|79292837|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296884|NCT01425008|79292838|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296885|NCT01425008|79292839|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
44296886|NCT01425008|79292840|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
44296887|NCT01425008|79292841|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
44296888|NCT01425008|79292842|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
44296889|NCT01425008|79292824|FG000|Dose Expansion Phase|Adverse Event|0|||
44296890|NCT01425008|79292825|FG001|Dose Expansion Phase|Adverse Event|0|||
44296891|NCT01425008|79292826|FG002|Dose Expansion Phase|Adverse Event|0|||
44296892|NCT01425008|79292827|FG003|Dose Expansion Phase|Adverse Event|0|||
44296893|NCT01425008|79292828|FG004|Dose Expansion Phase|Adverse Event|0|||
44296894|NCT01425008|79292829|FG005|Dose Expansion Phase|Adverse Event|0|||
44296895|NCT01425008|79292830|FG006|Dose Expansion Phase|Adverse Event|0|||
44296896|NCT01425008|79292831|FG007|Dose Expansion Phase|Adverse Event|0|||
44296897|NCT01425008|79292832|FG008|Dose Expansion Phase|Adverse Event|0|||
44296898|NCT01425008|79292833|FG009|Dose Expansion Phase|Adverse Event|0|||
44296899|NCT01425008|79292834|FG010|Dose Expansion Phase|Adverse Event|2|||
44296900|NCT01425008|79292835|FG011|Dose Expansion Phase|Adverse Event|3|||
44296901|NCT01425008|79292836|FG012|Dose Expansion Phase|Adverse Event|3|||
44296902|NCT01425008|79292837|FG013|Dose Expansion Phase|Adverse Event|0|||
44296903|NCT01425008|79292838|FG014|Dose Expansion Phase|Adverse Event|1|||
44296904|NCT01425008|79292839|FG015|Dose Expansion Phase|Adverse Event|1|||
44296905|NCT01425008|79292840|FG016|Dose Expansion Phase|Adverse Event|5|||
44296906|NCT01425008|79292841|FG017|Dose Expansion Phase|Adverse Event|0|||
44296907|NCT01425008|79292842|FG018|Dose Expansion Phase|Adverse Event|3|||
44296908|NCT01425008|79292824|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
44296909|NCT01425008|79292825|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
44296910|NCT01425008|79292826|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
44296911|NCT01425008|79292827|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
44296912|NCT01425008|79292828|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
44296913|NCT01425008|79292829|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
44296914|NCT01425008|79292830|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
44296915|NCT01425008|79292831|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
44296916|NCT01425008|79292832|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
44296917|NCT01425008|79292833|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
44296918|NCT01425008|79292834|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
44296919|NCT01425008|79292835|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
44296920|NCT01425008|79292836|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
44296921|NCT01425008|79292837|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
44296922|NCT01425008|79292838|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
44296923|NCT01425008|79292839|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
44296924|NCT01425008|79292840|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
44296925|NCT01425008|79292841|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
44296926|NCT01425008|79292842|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
44296927|NCT01425008|79292824|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296928|NCT01425008|79292825|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296929|NCT01425008|79292826|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296930|NCT01425008|79292827|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296931|NCT01425008|79292828|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296932|NCT01425008|79292829|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296933|NCT01425008|79292830|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296934|NCT01425008|79292831|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296935|NCT01425008|79292832|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296936|NCT01425008|79292833|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296937|NCT01425008|79292834|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296938|NCT01425008|79292835|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296939|NCT01425008|79292836|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296940|NCT01425008|79292837|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296941|NCT01425008|79292838|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296942|NCT01425008|79292839|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296943|NCT01425008|79292840|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296944|NCT01425008|79292841|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44296945|NCT01425008|79292842|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
44296946|NCT04072146|79292897|FG000|Overall Study|Adverse Event|0|||
44296947|NCT04072146|79292898|FG001|Overall Study|Adverse Event|1|||
44296948|NCT03861481|79292912|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
44296949|NCT03861481|79292913|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
44296950|NCT03861481|79292912|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
44296951|NCT03861481|79292913|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
44296952|NCT03861481|79292912|FG000|Overall Study|Relapse|1|||
44296953|NCT03861481|79292913|FG001|Overall Study|Relapse|0|||
44296954|NCT03861481|79292912|FG000|Overall Study|Withdrawal by Subject|0|||
44296955|NCT03861481|79292913|FG001|Overall Study|Withdrawal by Subject|1|||
44296956|NCT03861481|79292912|FG000|Overall Study|Lack of Efficacy|4|||
44296957|NCT03861481|79292913|FG001|Overall Study|Lack of Efficacy|5|||
44296958|NCT03648476|79292925|FG000|Overall Study|Withdrawal by Subject|2|||
44296959|NCT03648476|79292926|FG001|Overall Study|Withdrawal by Subject|1|||
44296960|NCT04545060|79292957|FG000|Overall Study|Adverse Event|0|||
44296961|NCT04545060|79292958|FG001|Overall Study|Adverse Event|1|||
44296962|NCT04545060|79292957|FG000|Overall Study|Death|0|||
44296963|NCT04545060|79292958|FG001|Overall Study|Death|5|||
44296964|NCT04545060|79292957|FG000|Overall Study|Lost to Follow-up|10|||
44296965|NCT04545060|79292958|FG001|Overall Study|Lost to Follow-up|13|||
44296966|NCT04545060|79292957|FG000|Overall Study|Physician Decision|3|||
44296967|NCT04545060|79292958|FG001|Overall Study|Physician Decision|0|||
44296968|NCT04545060|79292957|FG000|Overall Study|Withdrawal by Subject|17|||
44296969|NCT04545060|79292958|FG001|Overall Study|Withdrawal by Subject|22|||
44296970|NCT03533660|79293035|FG000|Overall Study|Withdrawal by Subject|2|||
44296971|NCT03533660|79293036|FG001|Overall Study|Withdrawal by Subject|2|||
44296972|NCT03533660|79293035|FG000|Overall Study|Death|2|||
44296973|NCT03533660|79293036|FG001|Overall Study|Death|4|||
44296974|NCT03533660|79293035|FG000|Overall Study|Adverse Event|0|||
44296975|NCT03533660|79293036|FG001|Overall Study|Adverse Event|2|||
44296976|NCT03416127|79293050|FG000|Overall Study|Withdrawal by Subject|0|||
44296977|NCT03416127|79293051|FG001|Overall Study|Withdrawal by Subject|1|||
44296978|NCT03416127|79293052|FG002|Overall Study|Withdrawal by Subject|1|||
44296979|NCT02986334|79293086|FG000|Overall Study|Withdrawal by Subject|0|||
44296980|NCT02986334|79293087|FG001|Overall Study|Withdrawal by Subject|1|||
44296981|NCT02986334|79293088|FG002|Overall Study|Withdrawal by Subject|2|||
44296982|NCT02986334|79293086|FG000|Overall Study|Lost to Follow-up|1|||
44417103|NCT00764868|79424961|FG000|Overall Study|Subject sent to boarding school|1|||
44534057|NCT02101853|79544761|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
44534058|NCT02101853|79544762|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
44296983|NCT02986334|79293087|FG001|Overall Study|Lost to Follow-up|2|||
44296984|NCT02986334|79293088|FG002|Overall Study|Lost to Follow-up|1|||
44296985|NCT02986334|79293086|FG000|Overall Study|Adverse Event|0|||
44296986|NCT02986334|79293087|FG001|Overall Study|Adverse Event|2|||
44296987|NCT02986334|79293088|FG002|Overall Study|Adverse Event|1|||
44296988|NCT02986334|79293086|FG000|Overall Study|non compliance in phone ratings|2|||
44296989|NCT02986334|79293087|FG001|Overall Study|non compliance in phone ratings|1|||
44296990|NCT02986334|79293088|FG002|Overall Study|non compliance in phone ratings|2|||
44296991|NCT02986334|79293086|FG000|Overall Study|undisclosed comorbidities|0|||
44296992|NCT02986334|79293087|FG001|Overall Study|undisclosed comorbidities|1|||
44296993|NCT02986334|79293088|FG002|Overall Study|undisclosed comorbidities|1|||
44296994|NCT02210221|79293110|FG000|Overall Study|Lack of Efficacy|7|||
44296995|NCT02210221|79293110|FG000|Overall Study|Withdrawal by Subject|43|||
44296996|NCT02124902|79293123|FG000|Overall Study|Adverse Event|7|||
44296997|NCT02124902|79293124|FG001|Overall Study|Adverse Event|2|||
44296998|NCT02124902|79293123|FG000|Overall Study|Went to alternative treatment|4|||
44296999|NCT02124902|79293124|FG001|Overall Study|Went to alternative treatment|0|||
44297000|NCT02124902|79293123|FG000|Overall Study|Withdrawal by Subject|2|||
44297001|NCT02124902|79293124|FG001|Overall Study|Withdrawal by Subject|1|||
44297002|NCT02124902|79293123|FG000|Overall Study|Physician Decision|2|||
44297003|NCT02124902|79293124|FG001|Overall Study|Physician Decision|0|||
44297004|NCT02124902|79293123|FG000|Overall Study|Not eligible|1|||
44297005|NCT02124902|79293124|FG001|Overall Study|Not eligible|0|||
44297006|NCT02124902|79293123|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
44297007|NCT02124902|79293124|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
44297008|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
44297009|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
44297010|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
44297011|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
44297012|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
44297013|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
44297014|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
44297015|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
44297016|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
44297017|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
44297018|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
44297019|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
44297020|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
44297021|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
44297022|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
44297023|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
44297024|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
44297025|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
44297026|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
44297027|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
44297028|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Death|0|||
44297029|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Death|1|||
44297030|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Death|0|||
44297031|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Death|0|||
44297032|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
44297033|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
44297034|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
44297035|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
44297036|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
44297037|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
44297038|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
44297039|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
44297040|NCT01940341|79293132|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
44297041|NCT01940341|79293133|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
44297042|NCT01940341|79293134|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
44297043|NCT01940341|79293135|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
44297044|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
44154643|NCT01999972|78945941|FG001|Dose Escalation Part|Death|1|||
44297045|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
44297046|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
44297047|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
44534059|NCT02101853|79544763|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
44534060|NCT02101853|79544764|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
44154644|NCT01999972|78945942|FG002|Dose Escalation Part|Death|0|||
44154645|NCT01999972|78945943|FG003|Dose Escalation Part|Death|0|||
44154646|NCT01999972|78945944|FG004|Dose Escalation Part|Death|0|||
44154647|NCT01999972|78945945|FG005|Dose Escalation Part|Death|0|||
44154648|NCT01999972|78945940|FG000|Dose Escalation Part|Enrolled but not treated|0|||
44154649|NCT01999972|78945941|FG001|Dose Escalation Part|Enrolled but not treated|0|||
44154650|NCT01999972|78945942|FG002|Dose Escalation Part|Enrolled but not treated|1|||
44154651|NCT01999972|78945943|FG003|Dose Escalation Part|Enrolled but not treated|1|||
44154652|NCT01999972|78945944|FG004|Dose Escalation Part|Enrolled but not treated|0|||
44154653|NCT01999972|78945945|FG005|Dose Escalation Part|Enrolled but not treated|0|||
44154654|NCT01999972|78945940|FG000|Dose Escalation Part|Disease progression|3|||
44154655|NCT01999972|78945941|FG001|Dose Escalation Part|Disease progression|2|||
44154656|NCT01999972|78945942|FG002|Dose Escalation Part|Disease progression|3|||
44154657|NCT01999972|78945943|FG003|Dose Escalation Part|Disease progression|6|||
44154658|NCT01999972|78945944|FG004|Dose Escalation Part|Disease progression|0|||
44154659|NCT01999972|78945945|FG005|Dose Escalation Part|Disease progression|0|||
44154660|NCT01999972|78945940|FG000|Dose Escalation Part|Adverse Event|0|||
44154661|NCT01999972|78945941|FG001|Dose Escalation Part|Adverse Event|0|||
44154662|NCT01999972|78945942|FG002|Dose Escalation Part|Adverse Event|0|||
44154663|NCT01999972|78945943|FG003|Dose Escalation Part|Adverse Event|2|||
44154664|NCT01999972|78945944|FG004|Dose Escalation Part|Adverse Event|0|||
44154665|NCT01999972|78945945|FG005|Dose Escalation Part|Adverse Event|0|||
44154666|NCT01999972|78945940|FG000|Dose Escalation Part|Global deterioration of health status|1|||
44154667|NCT01999972|78945941|FG001|Dose Escalation Part|Global deterioration of health status|0|||
44154668|NCT01999972|78945942|FG002|Dose Escalation Part|Global deterioration of health status|0|||
44154669|NCT01999972|78945943|FG003|Dose Escalation Part|Global deterioration of health status|1|||
44154670|NCT01999972|78945944|FG004|Dose Escalation Part|Global deterioration of health status|0|||
44154671|NCT01999972|78945945|FG005|Dose Escalation Part|Global deterioration of health status|0|||
44154672|NCT01999972|78945940|FG000|Dose Expansion Part|Death|0|||
44154673|NCT01999972|78945941|FG001|Dose Expansion Part|Death|0|||
44154674|NCT01999972|78945942|FG002|Dose Expansion Part|Death|0|||
44154675|NCT01999972|78945943|FG003|Dose Expansion Part|Death|0|||
44154676|NCT01999972|78945944|FG004|Dose Expansion Part|Death|2|||
44154677|NCT01999972|78945945|FG005|Dose Expansion Part|Death|1|||
44154678|NCT01999972|78945940|FG000|Dose Expansion Part|Disease progression|0|||
44154679|NCT01999972|78945941|FG001|Dose Expansion Part|Disease progression|0|||
44154680|NCT01999972|78945942|FG002|Dose Expansion Part|Disease progression|0|||
44154681|NCT01999972|78945943|FG003|Dose Expansion Part|Disease progression|0|||
44154682|NCT01999972|78945944|FG004|Dose Expansion Part|Disease progression|9|||
44154683|NCT01999972|78945945|FG005|Dose Expansion Part|Disease progression|3|||
44154684|NCT01999972|78945940|FG000|Dose Expansion Part|Sponsor decision|0|||
44154685|NCT01999972|78945941|FG001|Dose Expansion Part|Sponsor decision|0|||
44154686|NCT01999972|78945942|FG002|Dose Expansion Part|Sponsor decision|0|||
44154687|NCT01999972|78945943|FG003|Dose Expansion Part|Sponsor decision|0|||
44154688|NCT01999972|78945944|FG004|Dose Expansion Part|Sponsor decision|1|||
44154689|NCT01999972|78945945|FG005|Dose Expansion Part|Sponsor decision|0|||
44154690|NCT01999972|78945940|FG000|Dose Expansion Part|Adverse Event|0|||
44154691|NCT01999972|78945941|FG001|Dose Expansion Part|Adverse Event|0|||
44154692|NCT01999972|78945942|FG002|Dose Expansion Part|Adverse Event|0|||
44154693|NCT01999972|78945943|FG003|Dose Expansion Part|Adverse Event|0|||
44154694|NCT01999972|78945944|FG004|Dose Expansion Part|Adverse Event|4|||
44534061|NCT02101853|79544765|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
44154695|NCT01999972|78945945|FG005|Dose Expansion Part|Adverse Event|2|||
44154696|NCT01999972|78945940|FG000|Dose Expansion Part|Participant's non-compliance|0|||
44154697|NCT01999972|78945941|FG001|Dose Expansion Part|Participant's non-compliance|0|||
44154698|NCT01999972|78945942|FG002|Dose Expansion Part|Participant's non-compliance|0|||
44154699|NCT01999972|78945943|FG003|Dose Expansion Part|Participant's non-compliance|0|||
44154700|NCT01999972|78945944|FG004|Dose Expansion Part|Participant's non-compliance|0|||
44154701|NCT01999972|78945945|FG005|Dose Expansion Part|Participant's non-compliance|1|||
44154702|NCT01999972|78945940|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
44154703|NCT01999972|78945941|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
44154704|NCT01999972|78945942|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
44154705|NCT01999972|78945943|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
44154706|NCT01999972|78945944|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
44154707|NCT01999972|78945945|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
44154708|NCT01999972|78945940|FG000|Dose Expansion Part|Changed to standard of care|0|||
44154709|NCT01999972|78945941|FG001|Dose Expansion Part|Changed to standard of care|0|||
44154710|NCT01999972|78945942|FG002|Dose Expansion Part|Changed to standard of care|0|||
44154711|NCT01999972|78945943|FG003|Dose Expansion Part|Changed to standard of care|0|||
44297048|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
44297049|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
44297050|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
44297051|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
44297052|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
44297053|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
44297054|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
44297055|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
44297056|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
44297057|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
44297058|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
44297059|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
44297060|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
44297061|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
44297062|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
44297063|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
44297064|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
44297065|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
44297066|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
44297067|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
44297068|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
44297069|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
44297070|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
44297071|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
44297072|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
44297073|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
44297074|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
44297075|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
44297076|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
44297077|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
44297078|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
44297079|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
44297080|NCT01940341|79293132|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
44297081|NCT01940341|79293133|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
44297082|NCT01940341|79293134|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
44297083|NCT01940341|79293135|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
44297084|NCT01877837|79293143|FG000|Overall Study|Lost to Follow-up|1|||
44297085|NCT01877837|79293143|FG000|Overall Study|Ineligible|4|||
44297086|NCT01624142|79293149|FG000|Overall Study|Withdrawal by Subject|14|||
44297087|NCT01624142|79293150|FG001|Overall Study|Withdrawal by Subject|4|||
44297088|NCT01624142|79293149|FG000|Overall Study|Death|3|||
44297089|NCT01624142|79293150|FG001|Overall Study|Death|6|||
44297090|NCT01624142|79293149|FG000|Overall Study|Study Closure|12|||
44297091|NCT01624142|79293150|FG001|Overall Study|Study Closure|6|||
44297092|NCT01624142|79293149|FG000|Overall Study|Lost to Follow-up|2|||
44297093|NCT01624142|79293150|FG001|Overall Study|Lost to Follow-up|0|||
44297094|NCT01624142|79293149|FG000|Overall Study|Other|1|||
44297095|NCT01624142|79293150|FG001|Overall Study|Other|0|||
44297096|NCT01535807|79293159|FG000|Overall Study|Withdrawal by Subject|1|||
44297097|NCT01535807|79293160|FG001|Overall Study|Withdrawal by Subject|1|||
44297098|NCT01535807|79293159|FG000|Overall Study|Data collection error|1|||
44297099|NCT01535807|79293160|FG001|Overall Study|Data collection error|1|||
44297100|NCT01375764|79293172|FG000|Overall Study|Lost to Follow-up|0|||
44534062|NCT02101853|79544760|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
44297101|NCT01375764|79293173|FG001|Overall Study|Lost to Follow-up|1|||
44297102|NCT01375764|79293174|FG002|Overall Study|Lost to Follow-up|0|||
44297103|NCT01375764|79293175|FG003|Overall Study|Lost to Follow-up|0|||
44297104|NCT01375764|79293176|FG004|Overall Study|Lost to Follow-up|0|||
44297105|NCT01375764|79293172|FG000|Overall Study|Withdrawal by Subject|2|||
44534063|NCT02101853|79544761|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44534064|NCT02101853|79544762|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44534065|NCT02101853|79544763|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44154712|NCT01999972|78945944|FG004|Dose Expansion Part|Changed to standard of care|1|||
44154713|NCT01999972|78945945|FG005|Dose Expansion Part|Changed to standard of care|0|||
44534066|NCT02101853|79544764|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44297106|NCT01375764|79293173|FG001|Overall Study|Withdrawal by Subject|0|||
44297107|NCT01375764|79293174|FG002|Overall Study|Withdrawal by Subject|0|||
44297108|NCT01375764|79293175|FG003|Overall Study|Withdrawal by Subject|0|||
44297109|NCT01375764|79293176|FG004|Overall Study|Withdrawal by Subject|1|||
44297110|NCT01375764|79293172|FG000|Overall Study|Other|0|||
44297111|NCT01375764|79293173|FG001|Overall Study|Other|0|||
44297112|NCT01375764|79293174|FG002|Overall Study|Other|0|||
44297113|NCT01375764|79293175|FG003|Overall Study|Other|1|||
44297114|NCT01375764|79293176|FG004|Overall Study|Other|0|||
44297115|NCT00722046|79293195|FG000|Overall Study|Adverse Event|0|||
44297116|NCT00722046|79293196|FG001|Overall Study|Adverse Event|1|||
44297117|NCT00722046|79293197|FG002|Overall Study|Adverse Event|2|||
44297118|NCT00722046|79293198|FG003|Overall Study|Adverse Event|1|||
44297119|NCT00722046|79293199|FG004|Overall Study|Adverse Event|2|||
44297120|NCT00722046|79293200|FG005|Overall Study|Adverse Event|1|||
44297121|NCT00722046|79293201|FG006|Overall Study|Adverse Event|0|||
44297122|NCT00722046|79293195|FG000|Overall Study|Death|0|||
44297123|NCT00722046|79293196|FG001|Overall Study|Death|1|||
44297124|NCT00722046|79293197|FG002|Overall Study|Death|0|||
44297125|NCT00722046|79293198|FG003|Overall Study|Death|0|||
44297126|NCT00722046|79293199|FG004|Overall Study|Death|0|||
44297127|NCT00722046|79293200|FG005|Overall Study|Death|0|||
44297128|NCT00722046|79293201|FG006|Overall Study|Death|2|||
44297129|NCT00722046|79293195|FG000|Overall Study|Protocol Violation|1|||
44297130|NCT00722046|79293196|FG001|Overall Study|Protocol Violation|0|||
44297131|NCT00722046|79293197|FG002|Overall Study|Protocol Violation|0|||
44297132|NCT00722046|79293198|FG003|Overall Study|Protocol Violation|0|||
44297133|NCT00722046|79293199|FG004|Overall Study|Protocol Violation|0|||
44297134|NCT00722046|79293200|FG005|Overall Study|Protocol Violation|1|||
44297135|NCT00722046|79293201|FG006|Overall Study|Protocol Violation|0|||
44297136|NCT00722046|79293195|FG000|Overall Study|Withdrawal by Subject|3|||
44297137|NCT00722046|79293196|FG001|Overall Study|Withdrawal by Subject|3|||
44297138|NCT00722046|79293197|FG002|Overall Study|Withdrawal by Subject|4|||
44534067|NCT02101853|79544765|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44297139|NCT00722046|79293198|FG003|Overall Study|Withdrawal by Subject|4|||
44297140|NCT00722046|79293199|FG004|Overall Study|Withdrawal by Subject|4|||
44297141|NCT00722046|79293200|FG005|Overall Study|Withdrawal by Subject|7|||
44297142|NCT00722046|79293201|FG006|Overall Study|Withdrawal by Subject|3|||
44297143|NCT00722046|79293195|FG000|Overall Study|Randomized, but not treated|1|||
44297144|NCT00722046|79293196|FG001|Overall Study|Randomized, but not treated|1|||
44297145|NCT00722046|79293197|FG002|Overall Study|Randomized, but not treated|0|||
44297146|NCT00722046|79293198|FG003|Overall Study|Randomized, but not treated|2|||
44297147|NCT00722046|79293199|FG004|Overall Study|Randomized, but not treated|0|||
44297148|NCT00722046|79293200|FG005|Overall Study|Randomized, but not treated|0|||
44297149|NCT00722046|79293201|FG006|Overall Study|Randomized, but not treated|0|||
44297150|NCT00722046|79293195|FG000|Overall Study|Other|0|||
44297151|NCT00722046|79293196|FG001|Overall Study|Other|0|||
44297152|NCT00722046|79293197|FG002|Overall Study|Other|1|||
44297153|NCT00722046|79293198|FG003|Overall Study|Other|1|||
44297154|NCT00722046|79293199|FG004|Overall Study|Other|3|||
44297155|NCT00722046|79293200|FG005|Overall Study|Other|2|||
44297156|NCT00722046|79293201|FG006|Overall Study|Other|1|||
44297157|NCT00614523|79293221|FG000|Overall Study|Adverse Event|4|||
44297158|NCT00614523|79293222|FG001|Overall Study|Adverse Event|20|||
44297159|NCT00614523|79293221|FG000|Overall Study|Death|5|||
44297160|NCT00614523|79293222|FG001|Overall Study|Death|8|||
44297161|NCT00614523|79293221|FG000|Overall Study|Lack of Efficacy|9|||
44297162|NCT00614523|79293222|FG001|Overall Study|Lack of Efficacy|11|||
44297163|NCT00614523|79293221|FG000|Overall Study|Lost to Follow-up|0|||
44297164|NCT00614523|79293222|FG001|Overall Study|Lost to Follow-up|1|||
44297165|NCT00614523|79293221|FG000|Overall Study|Protocol Violation|3|||
44534068|NCT02101853|79544760|FG000|Post Induction Randomization|Adverse Event|0|||
44534069|NCT02101853|79544761|FG001|Post Induction Randomization|Adverse Event|3|||
44534070|NCT02101853|79544762|FG002|Post Induction Randomization|Adverse Event|8|||
44534071|NCT02101853|79544763|FG003|Post Induction Randomization|Adverse Event|4|||
44534072|NCT02101853|79544764|FG004|Post Induction Randomization|Adverse Event|4|||
44297166|NCT00614523|79293222|FG001|Overall Study|Protocol Violation|2|||
44534073|NCT02101853|79544765|FG005|Post Induction Randomization|Adverse Event|0|||
44297167|NCT00614523|79293221|FG000|Overall Study|Withdrawal by Subject|12|||
44297168|NCT00614523|79293222|FG001|Overall Study|Withdrawal by Subject|22|||
44297169|NCT00614523|79293221|FG000|Overall Study|Other|6|||
44297170|NCT00614523|79293222|FG001|Overall Study|Other|11|||
44297171|NCT00614523|79293221|FG000|Overall Study|Ineligibility Determined|1|||
44297172|NCT00614523|79293222|FG001|Overall Study|Ineligibility Determined|2|||
44297173|NCT00614523|79293221|FG000|Overall Study|Disease Progression|0|||
44297174|NCT00614523|79293222|FG001|Overall Study|Disease Progression|8|||
44297175|NCT00614523|79293221|FG000|Overall Study|Administrative Decision|23|||
44297176|NCT00614523|79293222|FG001|Overall Study|Administrative Decision|46|||
44297177|NCT00523341|79293230|FG000|Overall Study|Withdrawal by Subject|399|||
44297178|NCT00523341|79293231|FG001|Overall Study|Withdrawal by Subject|427|||
44297179|NCT00523341|79293230|FG000|Overall Study|Other|181|||
44297180|NCT00523341|79293231|FG001|Overall Study|Other|198|||
44297181|NCT00523341|79293230|FG000|Overall Study|Adverse Event|122|||
44297182|NCT00523341|79293231|FG001|Overall Study|Adverse Event|155|||
44297183|NCT00523341|79293230|FG000|Overall Study|Death|101|||
44297184|NCT00523341|79293231|FG001|Overall Study|Death|110|||
44297185|NCT00523341|79293230|FG000|Overall Study|Lost to Follow-up|73|||
44297186|NCT00523341|79293231|FG001|Overall Study|Lost to Follow-up|61|||
44297187|NCT00523341|79293230|FG000|Overall Study|Non-compliance|20|||
44297188|NCT00523341|79293231|FG001|Overall Study|Non-compliance|13|||
44297189|NCT00523341|79293230|FG000|Overall Study|Physician Decision|14|||
44297190|NCT00523341|79293231|FG001|Overall Study|Physician Decision|13|||
44297191|NCT00523341|79293230|FG000|Overall Study|Requirement for Alternative Therapy|4|||
44297192|NCT00523341|79293231|FG001|Overall Study|Requirement for Alternative Therapy|14|||
44297193|NCT00523341|79293230|FG000|Overall Study|Protocol Deviation|6|||
44297194|NCT00523341|79293231|FG001|Overall Study|Protocol Deviation|5|||
44297195|NCT00523341|79293230|FG000|Overall Study|Ineligibility Determined|3|||
44297196|NCT00523341|79293231|FG001|Overall Study|Ineligibility Determined|4|||
44297197|NCT00523341|79293230|FG000|Overall Study|Disease Progression|1|||
44297198|NCT00523341|79293231|FG001|Overall Study|Disease Progression|0|||
44297199|NCT00364013|79293239|FG000|Overall Study|Ineligibility determined|4|||
44297200|NCT00364013|79293240|FG001|Overall Study|Ineligibility determined|2|||
44297201|NCT00364013|79293239|FG000|Overall Study|Adverse Event|4|||
44297202|NCT00364013|79293240|FG001|Overall Study|Adverse Event|3|||
44297203|NCT00364013|79293239|FG000|Overall Study|Withdrawal by Subject|13|||
44297204|NCT00364013|79293240|FG001|Overall Study|Withdrawal by Subject|18|||
44297205|NCT00364013|79293239|FG000|Overall Study|Physician Decision|3|||
44297206|NCT00364013|79293240|FG001|Overall Study|Physician Decision|3|||
44297207|NCT00364013|79293239|FG000|Overall Study|Lost to Follow-up|10|||
44297208|NCT00364013|79293240|FG001|Overall Study|Lost to Follow-up|3|||
44297209|NCT00364013|79293239|FG000|Overall Study|Protocol-specified criteria|6|||
44297210|NCT00364013|79293240|FG001|Overall Study|Protocol-specified criteria|6|||
44297211|NCT00364013|79293239|FG000|Overall Study|Other|41|||
44297212|NCT00364013|79293240|FG001|Overall Study|Other|47|||
44297213|NCT00364013|79293239|FG000|Overall Study|Ongoing|20|||
44297214|NCT00364013|79293240|FG001|Overall Study|Ongoing|13|||
44297215|NCT00345839|79293252|FG000|Overall Study|Withdrawal by Subject|91|||
44297216|NCT00345839|79293253|FG001|Overall Study|Withdrawal by Subject|98|||
44297217|NCT00345839|79293252|FG000|Overall Study|Lost to Follow-up|58|||
44297218|NCT00345839|79293253|FG001|Overall Study|Lost to Follow-up|61|||
44297219|NCT00330759|79293261|FG000|Overall Study|Death|316|||
44297220|NCT00330759|79293262|FG001|Overall Study|Death|310|||
44297221|NCT00330759|79293261|FG000|Overall Study|Disease progression|104|||
44297222|NCT00330759|79293262|FG001|Overall Study|Disease progression|126|||
44297223|NCT00330759|79293261|FG000|Overall Study|Withdrawal by Subject|143|||
44297224|NCT00330759|79293262|FG001|Overall Study|Withdrawal by Subject|124|||
44297225|NCT00330759|79293261|FG000|Overall Study|Adverse Event|48|||
44297226|NCT00330759|79293262|FG001|Overall Study|Adverse Event|36|||
44297227|NCT00330759|79293261|FG000|Overall Study|Participant request|31|||
44297228|NCT00330759|79293262|FG001|Overall Study|Participant request|22|||
44297229|NCT00330759|79293261|FG000|Overall Study|Lost to Follow-up|16|||
44297230|NCT00330759|79293262|FG001|Overall Study|Lost to Follow-up|22|||
44297231|NCT00330759|79293261|FG000|Overall Study|Noncompliance|15|||
44297232|NCT00330759|79293262|FG001|Overall Study|Noncompliance|17|||
44297233|NCT00330759|79293261|FG000|Overall Study|Physician Decision|1|||
44297234|NCT00330759|79293262|FG001|Overall Study|Physician Decision|2|||
44297235|NCT00330759|79293261|FG000|Overall Study|Protocol deviation|0|||
44297236|NCT00330759|79293262|FG001|Overall Study|Protocol deviation|2|||
44297237|NCT00330759|79293261|FG000|Overall Study|Ineligibility determined|2|||
44297238|NCT00330759|79293262|FG001|Overall Study|Ineligibility determined|1|||
44297239|NCT00330759|79293261|FG000|Overall Study|Other|36|||
44297240|NCT00330759|79293262|FG001|Overall Study|Other|44|||
44297241|NCT00113763|79293270|FG000|Overall Study|Adverse Event|5|||
44297242|NCT00113763|79293271|FG001|Overall Study|Adverse Event|2|||
44297243|NCT00113763|79293270|FG000|Overall Study|Disease Progression|28|||
44297244|NCT00113763|79293271|FG001|Overall Study|Disease Progression|14|||
44297245|NCT00113763|79293270|FG000|Overall Study|Lost to Follow-up|10|||
44297246|NCT00113763|79293271|FG001|Overall Study|Lost to Follow-up|0|||
44297247|NCT00113763|79293270|FG000|Overall Study|Withdrawal by Subject|1|||
44297248|NCT00113763|79293271|FG001|Overall Study|Withdrawal by Subject|4|||
44297249|NCT00113763|79293270|FG000|Overall Study|Other|27|||
44297250|NCT00113763|79293271|FG001|Overall Study|Other|6|||
44297251|NCT00113763|79293270|FG000|Overall Study|Non-compliance|1|||
44297252|NCT00113763|79293271|FG001|Overall Study|Non-compliance|0|||
44297253|NCT00113763|79293270|FG000|Overall Study|Ongoing|1|||
44297254|NCT00113763|79293271|FG001|Overall Study|Ongoing|0|||
44297255|NCT05166902|79293285|FG000|First Intervention|Lost to Follow-up|0|||
44297256|NCT05166902|79293286|FG001|First Intervention|Lost to Follow-up|1|||
44297257|NCT05142566|79293292|FG000|Overall Study|Protocol Violation|1|||
44297258|NCT05083949|79293298|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
44297259|NCT05083949|79293299|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
44297260|NCT05083949|79293298|FG000|Period 1|Adverse Event|1|||
44297261|NCT05083949|79293299|FG001|Period 1|Adverse Event|1|||
44297262|NCT05083949|79293298|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
44297263|NCT05083949|79293299|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
44297264|NCT05083949|79293298|FG000|Period 2|Adverse Event|0|||
44297265|NCT05083949|79293299|FG001|Period 2|Adverse Event|2|||
44297266|NCT04982575|79293311|FG000|Overall Study|Withdrawal by Subject|2|||
44297267|NCT04982575|79293312|FG001|Overall Study|Withdrawal by Subject|0|||
44297268|NCT04982575|79293313|FG002|Overall Study|Withdrawal by Subject|2|||
44297269|NCT05286658|79293323|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
44297270|NCT05286658|79293323|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
44297271|NCT05158140|79293331|FG000|Overall Study|Death|0|||
44297272|NCT05158140|79293332|FG001|Overall Study|Death|0|||
44297273|NCT05158140|79293333|FG002|Overall Study|Death|0|||
44297274|NCT05158140|79293334|FG003|Overall Study|Death|1|||
44417104|NCT00764868|79424961|FG000|Overall Study|Met an exclusion criteria|1|||
44417105|NCT00764868|79424961|FG000|Overall Study|Positive drug screen|2|||
44417106|NCT00764868|79424961|FG000|Overall Study|Sponsor requested withdrawal|1|||
44417107|NCT00764790|79424968|FG000|Overall Study|Protocol Violation|0|||
44417108|NCT00764790|79424969|FG001|Overall Study|Protocol Violation|0|||
44417109|NCT00764790|79424970|FG002|Overall Study|Protocol Violation|1|||
44417110|NCT00764790|79424968|FG000|Overall Study|Withdrawal by Subject|10|||
44417111|NCT00764790|79424969|FG001|Overall Study|Withdrawal by Subject|12|||
44417112|NCT00764790|79424970|FG002|Overall Study|Withdrawal by Subject|6|||
44417113|NCT00764790|79424968|FG000|Overall Study|Lost to Follow-up|28|||
44417114|NCT00764790|79424969|FG001|Overall Study|Lost to Follow-up|29|||
44417115|NCT00764790|79424970|FG002|Overall Study|Lost to Follow-up|23|||
44417116|NCT00756444|79424980|FG000|Overall Study|Adverse Event|1|||
44417117|NCT00756444|79424981|FG001|Overall Study|Adverse Event|1|||
44417118|NCT00756444|79424980|FG000|Overall Study|Withdrawal by Subject|6|||
44417119|NCT00756444|79424981|FG001|Overall Study|Withdrawal by Subject|8|||
44417120|NCT00756444|79424980|FG000|Overall Study|Lost to Follow-up|0|||
44417121|NCT00756444|79424981|FG001|Overall Study|Lost to Follow-up|1|||
44417122|NCT00756444|79424980|FG000|Overall Study|Death|5|||
44417123|NCT00756444|79424981|FG001|Overall Study|Death|4|||
44417124|NCT00756444|79424980|FG000|Overall Study|Disease Progression|2|||
44417125|NCT00756444|79424981|FG001|Overall Study|Disease Progression|7|||
44417126|NCT00756444|79424980|FG000|Overall Study|Ineligibility Determined|1|||
44417127|NCT00756444|79424981|FG001|Overall Study|Ineligibility Determined|0|||
44417128|NCT00769002|79424992|FG000|Overall Study|Study was not completed, no data|9|||
44417129|NCT00769002|79424993|FG001|Overall Study|Study was not completed, no data|9|||
44417130|NCT00753012|79425000|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
44417131|NCT00753012|79425001|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
44417132|NCT00753012|79425000|FG000|Overall Study|Adverse Event|2|||
44417133|NCT00753012|79425001|FG001|Overall Study|Adverse Event|0|||
44417134|NCT00753012|79425000|FG000|Overall Study|Withdrawal by Subject|0|||
44417135|NCT00753012|79425001|FG001|Overall Study|Withdrawal by Subject|1|||
44417136|NCT00753012|79425000|FG000|Overall Study|Lost to Follow-up|4|||
44417137|NCT00753012|79425001|FG001|Overall Study|Lost to Follow-up|0|||
44417138|NCT00753012|79425000|FG000|Overall Study|Confounded endpoint data|1|||
44417139|NCT00753012|79425001|FG001|Overall Study|Confounded endpoint data|0|||
44417140|NCT00806156|79425010|FG000|Overall Study|Death|35|||
44417141|NCT00806156|79425011|FG001|Overall Study|Death|95|||
44417142|NCT00806156|79425010|FG000|Overall Study|Did not meet eligibility criteria|1|||
44417143|NCT00806156|79425011|FG001|Overall Study|Did not meet eligibility criteria|0|||
44417144|NCT00806156|79425010|FG000|Overall Study|Study terminated by Sponsor|2|||
44417145|NCT00806156|79425011|FG001|Overall Study|Study terminated by Sponsor|40|||
44417146|NCT00806156|79425010|FG000|Overall Study|Consent withdrawn by subject|1|||
44417147|NCT00806156|79425011|FG001|Overall Study|Consent withdrawn by subject|3|||
44417148|NCT00806156|79425010|FG000|Overall Study|Lost to Follow-up|0|||
44417149|NCT00806156|79425011|FG001|Overall Study|Lost to Follow-up|1|||
44297275|NCT05158140|79293331|FG000|Overall Study|Lost to Follow-up|3|||
44297276|NCT05158140|79293332|FG001|Overall Study|Lost to Follow-up|6|||
44297277|NCT05158140|79293333|FG002|Overall Study|Lost to Follow-up|4|||
44297278|NCT05158140|79293334|FG003|Overall Study|Lost to Follow-up|3|||
44297279|NCT05158140|79293331|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44297280|NCT05158140|79293332|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
44417150|NCT00764478|79425032|FG000|Overall Study|Adverse Event|1|||
44417151|NCT00764478|79425033|FG001|Overall Study|Adverse Event|1|||
44417152|NCT00764478|79425034|FG002|Overall Study|Adverse Event|1|||
44417153|NCT00764478|79425032|FG000|Overall Study|Withdrawal by Subject|7|||
44417154|NCT00764478|79425033|FG001|Overall Study|Withdrawal by Subject|12|||
44417155|NCT00764478|79425034|FG002|Overall Study|Withdrawal by Subject|1|||
44417156|NCT00764478|79425032|FG000|Overall Study|Lost to Follow-up|7|||
44297281|NCT05158140|79293333|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
44297282|NCT05158140|79293334|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
44297283|NCT05158140|79293331|FG000|Overall Study|Withdrawal by Subject|3|||
44297284|NCT05158140|79293332|FG001|Overall Study|Withdrawal by Subject|7|||
44297285|NCT05158140|79293333|FG002|Overall Study|Withdrawal by Subject|3|||
44297286|NCT05158140|79293334|FG003|Overall Study|Withdrawal by Subject|7|||
44297287|NCT05069415|79293349|FG000|Overall Study|Withdrawal by Subject|2|||
44297288|NCT05069415|79293350|FG001|Overall Study|Withdrawal by Subject|0|||
44297289|NCT05069415|79293349|FG000|Overall Study|Adverse Event|2|||
44297290|NCT05069415|79293350|FG001|Overall Study|Adverse Event|0|||
44297291|NCT04759131|79293366|FG000|Overall Study|Investigator's discretion|1|||
44297292|NCT04759131|79293367|FG001|Overall Study|Investigator's discretion|0|||
44297293|NCT04759131|79293366|FG000|Overall Study|Subject withdrawal|1|||
44297294|NCT04759131|79293367|FG001|Overall Study|Subject withdrawal|0|||
44297295|NCT04737031|79293380|FG000|Overall Study|Patients who did not have a treatment visit|0|||
44297296|NCT04737031|79293381|FG001|Overall Study|Patients who did not have a treatment visit|31|||
44297297|NCT04737031|79293382|FG002|Overall Study|Patients who did not have a treatment visit|93|||
44297298|NCT04737031|79293383|FG003|Overall Study|Patients who did not have a treatment visit|227|||
44297299|NCT04701333|79293395|FG000|Overall Study|Lost to Follow-up|3|||
44297300|NCT04701333|79293396|FG001|Overall Study|Lost to Follow-up|7|||
44297301|NCT04701333|79293395|FG000|Overall Study|Withdrawal by Subject|0|||
44297302|NCT04701333|79293396|FG001|Overall Study|Withdrawal by Subject|1|||
44297303|NCT04493242|79293414|FG000|Overall Study|Death|10|||
44297304|NCT04493242|79293415|FG001|Overall Study|Death|14|||
44297305|NCT04493242|79293416|FG002|Overall Study|Death|16|||
44297306|NCT04493242|79293414|FG000|Overall Study|Lost to Follow-up|1|||
44297307|NCT04493242|79293415|FG001|Overall Study|Lost to Follow-up|1|||
44297308|NCT04493242|79293416|FG002|Overall Study|Lost to Follow-up|0|||
44297309|NCT04493242|79293414|FG000|Overall Study|Withdrawal by Subject|1|||
44297310|NCT04493242|79293415|FG001|Overall Study|Withdrawal by Subject|0|||
44297311|NCT04493242|79293416|FG002|Overall Study|Withdrawal by Subject|0|||
44297312|NCT04493242|79293414|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
44297313|NCT04493242|79293415|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
44297314|NCT04493242|79293416|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
44297315|NCT04493242|79293414|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
44297316|NCT04493242|79293415|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
44297317|NCT04493242|79293416|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
44297318|NCT04476277|79293428|FG000|Overall Study|Withdrawal by Subject|0|||
44297319|NCT04476277|79293429|FG001|Overall Study|Withdrawal by Subject|0|||
44297320|NCT04476277|79293430|FG002|Overall Study|Withdrawal by Subject|1|||
44297321|NCT04476277|79293431|FG003|Overall Study|Withdrawal by Subject|0|||
44297322|NCT04439357|79293441|FG000|Overall Study|Disease Progression|4|||
44297323|NCT04337931|79293448|FG000|Overall Study|Death|4|||
44297324|NCT04337931|79293449|FG001|Overall Study|Death|1|||
44297325|NCT04337931|79293450|FG002|Overall Study|Death|7|||
44297326|NCT04337931|79293448|FG000|Overall Study|Withdrawal by Subject|0|||
44297327|NCT04337931|79293449|FG001|Overall Study|Withdrawal by Subject|1|||
44297328|NCT04337931|79293450|FG002|Overall Study|Withdrawal by Subject|0|||
44297329|NCT04337931|79293448|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
44297330|NCT04337931|79293449|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
44297331|NCT04337931|79293450|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
44297332|NCT04337931|79293448|FG000|Overall Study|Study terminated by sponsor|3|||
44297333|NCT04337931|79293449|FG001|Overall Study|Study terminated by sponsor|6|||
44297334|NCT04337931|79293450|FG002|Overall Study|Study terminated by sponsor|2|||
44297335|NCT04337931|79293448|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
44297336|NCT04337931|79293449|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
44297337|NCT04337931|79293450|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
44297338|NCT04337931|79293448|FG000|Overall Study|Colorectal cancer treatment|1|||
44297339|NCT04337931|79293449|FG001|Overall Study|Colorectal cancer treatment|0|||
44417157|NCT00764478|79425033|FG001|Overall Study|Lost to Follow-up|8|||
44534074|NCT02101853|79544760|FG000|Post Induction Randomization|Death|0|||
44534075|NCT02101853|79544761|FG001|Post Induction Randomization|Death|9|||
44534076|NCT02101853|79544762|FG002|Post Induction Randomization|Death|2|||
44534077|NCT02101853|79544763|FG003|Post Induction Randomization|Death|2|||
44297340|NCT04337931|79293450|FG002|Overall Study|Colorectal cancer treatment|0|||
44297341|NCT04337931|79293448|FG000|Overall Study|Participant decision|0|||
44297342|NCT04337931|79293449|FG001|Overall Study|Participant decision|1|||
44297343|NCT04337931|79293450|FG002|Overall Study|Participant decision|0|||
44297344|NCT04143217|79293459|FG000|Overall Study|Withdrawal by Subject|42|||
44297345|NCT04143217|79293459|FG000|Overall Study|Adverse Event|29|||
44297346|NCT04143217|79293459|FG000|Overall Study|Lost to Follow-up|29|||
44297347|NCT04143217|79293459|FG000|Overall Study|Lack of Efficacy|15|||
44534078|NCT02101853|79544764|FG004|Post Induction Randomization|Death|0|||
44297348|NCT04143217|79293459|FG000|Overall Study|Physician Decision|1|||
44297349|NCT04143217|79293459|FG000|Overall Study|Non-Compliance With Study Drug|6|||
44297350|NCT04143217|79293459|FG000|Overall Study|Other, Multiple Categories|11|||
44297351|NCT03845075|79293484|FG000|Part 1 - DB|Withdrawal by Subject|1|||
44297352|NCT03845075|79293485|FG001|Part 1 - DB|Withdrawal by Subject|1|||
44297353|NCT03845075|79293486|FG002|Part 1 - DB|Withdrawal by Subject|0|||
44297354|NCT03845075|79293487|FG003|Part 1 - DB|Withdrawal by Subject|0|||
44297355|NCT03845075|79293484|FG000|Part 1 - DB|Adverse Event|0|||
44297356|NCT03845075|79293485|FG001|Part 1 - DB|Adverse Event|1|||
44297357|NCT03845075|79293486|FG002|Part 1 - DB|Adverse Event|0|||
44297358|NCT03845075|79293487|FG003|Part 1 - DB|Adverse Event|0|||
44297359|NCT03845075|79293484|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
44297360|NCT03845075|79293485|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
44297361|NCT03845075|79293486|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
44297362|NCT03845075|79293487|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
44297363|NCT03662659|79293499|FG000|Pre-treatment|Participant no longer met study criteria|1|||
44297364|NCT03662659|79293500|FG001|Pre-treatment|Participant no longer met study criteria|1|||
44297365|NCT03662659|79293499|FG000|Pre-treatment|Other reasons|1|||
44297366|NCT03662659|79293500|FG001|Pre-treatment|Other reasons|0|||
44297367|NCT03662659|79293499|FG000|Treatment|Completed Treatment|0|||
44297368|NCT03662659|79293500|FG001|Treatment|Completed Treatment|3|||
44297369|NCT03662659|79293499|FG000|Treatment|Disease Progression|69|||
44297370|NCT03662659|79293500|FG001|Treatment|Disease Progression|78|||
44297371|NCT03662659|79293499|FG000|Treatment|Study Drug Toxicity|18|||
44297372|NCT03662659|79293500|FG001|Treatment|Study Drug Toxicity|8|||
44297373|NCT03662659|79293499|FG000|Treatment|Death|12|||
44297374|NCT03662659|79293500|FG001|Treatment|Death|7|||
44297375|NCT03662659|79293499|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
44297376|NCT03662659|79293500|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
44297377|NCT03662659|79293499|FG000|Treatment|Withdrawal by Subject|1|||
44297378|NCT03662659|79293500|FG001|Treatment|Withdrawal by Subject|1|||
44297379|NCT03662659|79293499|FG000|Treatment|Poor/Non-compliance|1|||
44297380|NCT03662659|79293500|FG001|Treatment|Poor/Non-compliance|0|||
44297381|NCT03662659|79293499|FG000|Treatment|Participant no longer meets study criteria|1|||
44297382|NCT03662659|79293500|FG001|Treatment|Participant no longer meets study criteria|0|||
44297383|NCT03662659|79293499|FG000|Treatment|Other reasons|6|||
44297384|NCT03662659|79293500|FG001|Treatment|Other reasons|5|||
44297385|NCT03542682|79293521|FG000|Overall Study|COVID-19 Protocol|0|||
44297386|NCT03542682|79293522|FG001|Overall Study|COVID-19 Protocol|1|||
44297387|NCT03480386|79293532|FG000|Overall Study|Did not complete measures at 3-months|17|||
44297388|NCT03480386|79293533|FG001|Overall Study|Did not complete measures at 3-months|14|||
44297389|NCT03480386|79293532|FG000|Overall Study|No baseline measures|11|||
44297390|NCT03480386|79293533|FG001|Overall Study|No baseline measures|14|||
44297391|NCT03480386|79293532|FG000|Overall Study|Death|0|||
44297392|NCT03480386|79293533|FG001|Overall Study|Death|5|||
44297393|NCT03480386|79293532|FG000|Overall Study|Withdrawal by Subject|12|||
44297394|NCT03480386|79293533|FG001|Overall Study|Withdrawal by Subject|8|||
44297395|NCT03480386|79293532|FG000|Overall Study|Lost to Follow-up|2|||
44297396|NCT03480386|79293533|FG001|Overall Study|Lost to Follow-up|1|||
44297397|NCT03480386|79293532|FG000|Overall Study|Complicating disease|0|||
44297398|NCT03480386|79293533|FG001|Overall Study|Complicating disease|1|||
44297399|NCT03480386|79293532|FG000|Overall Study|Disease progression|3|||
44297400|NCT03480386|79293533|FG001|Overall Study|Disease progression|0|||
44297401|NCT03480386|79293532|FG000|Overall Study|Became ineligible|0|||
44297402|NCT03480386|79293533|FG001|Overall Study|Became ineligible|2|||
44297403|NCT03476343|79293539|FG000|Overall Study|Clinical exam moved to another scanner|7|||
44297404|NCT03476343|79293539|FG000|Overall Study|Clinical order cancelled|4|||
44297405|NCT03476343|79293539|FG000|Overall Study|Neonate did not settle down for the scan|1|||
44297406|NCT03412591|79293545|FG000|Overall Study|Withdrawal by Subject|1|||
44297407|NCT03412591|79293546|FG001|Overall Study|Withdrawal by Subject|8|||
44297408|NCT03412591|79293545|FG000|Overall Study|Adverse Event|0|||
44297409|NCT03412591|79293546|FG001|Overall Study|Adverse Event|1|||
44297410|NCT03389477|79293554|FG000|Step 1|Withdrawal by Subject|1|||
44297411|NCT03389477|79293555|FG001|Step 1|Withdrawal by Subject|0|||
44297412|NCT03389477|79293554|FG000|Step 2|Withdrawal by Subject|1|||
44297413|NCT03389477|79293555|FG001|Step 2|Withdrawal by Subject|2|||
44297414|NCT03389477|79293554|FG000|Step 2|Disease progression|1|||
44297415|NCT03389477|79293555|FG001|Step 2|Disease progression|0|||
44297416|NCT03389477|79293554|FG000|Step 2|Death|0|||
44297417|NCT03389477|79293555|FG001|Step 2|Death|1|||
44297418|NCT03389477|79293554|FG000|Step 2|Poor performance status and nutrition|0|||
44297419|NCT03389477|79293555|FG001|Step 2|Poor performance status and nutrition|1|||
44297420|NCT03389477|79293554|FG000|Step 3|Withdrawal after 3 cycles|0|||
44297421|NCT03389477|79293555|FG001|Step 3|Withdrawal after 3 cycles|1|||
44297422|NCT03389477|79293554|FG000|Step 3|Still receiving active treatment|4|||
44297423|NCT03389477|79293555|FG001|Step 3|Still receiving active treatment|0|||
44297424|NCT03389477|79293554|FG000|Step 3|Progressive disease after 2 cycles|1|||
44297425|NCT03389477|79293555|FG001|Step 3|Progressive disease after 2 cycles|0|||
44297426|NCT03289039|79293565|FG000|Overall Study|Withdrawal by Subject|0|||
44297427|NCT03289039|79293566|FG001|Overall Study|Withdrawal by Subject|1|||
44297428|NCT03289039|79293565|FG000|Overall Study|Became ineligible prior to treatment start|0|||
44297429|NCT03289039|79293566|FG001|Overall Study|Became ineligible prior to treatment start|1|||
44297430|NCT03289039|79293565|FG000|Overall Study|progressed before treatment start|1|||
44297431|NCT03289039|79293566|FG001|Overall Study|progressed before treatment start|0|||
44297432|NCT03275402|79293572|FG000|Overall Study|Death|17|||
44297433|NCT03275402|79293572|FG000|Overall Study|Study terminated by sponsor|21|||
44297434|NCT03275402|79293572|FG000|Overall Study|Withdrawal by Subject|1|||
44297435|NCT02864953|79293601|FG000|Overall Study|Adverse Event|22|||
44297436|NCT02864953|79293602|FG001|Overall Study|Adverse Event|19|||
44297437|NCT02864953|79293601|FG000|Overall Study|Withdrawal by Subject|1|||
44297438|NCT02864953|79293602|FG001|Overall Study|Withdrawal by Subject|0|||
44297439|NCT02864953|79293601|FG000|Overall Study|Physician Decision|4|||
44297440|NCT02864953|79293602|FG001|Overall Study|Physician Decision|2|||
44297441|NCT02864953|79293601|FG000|Overall Study|Death|3|||
44297442|NCT02864953|79293602|FG001|Overall Study|Death|13|||
44297443|NCT02864953|79293601|FG000|Overall Study|Reason not specified|14|||
44297444|NCT02864953|79293602|FG001|Overall Study|Reason not specified|12|||
44297445|NCT02864953|79293601|FG000|Overall Study|Withdrew Prior to Dosing|9|||
44297446|NCT02864953|79293602|FG001|Overall Study|Withdrew Prior to Dosing|8|||
44297447|NCT02829918|79293608|FG000|Overall Study|Death|2|||
44297448|NCT02829918|79293608|FG000|Overall Study|Withdrawal by Subject|4|||
44297449|NCT02829918|79293608|FG000|Overall Study|Adverse Event|1|||
44297450|NCT02829918|79293608|FG000|Overall Study|Progression|1|||
44297451|NCT02512965|79293640|FG000|Overall Study|Withdrawal by Subject|0|||
44297452|NCT02512965|79293641|FG001|Overall Study|Withdrawal by Subject|4|||
44297453|NCT02456857|79293656|FG000|Overall Study|Disease Progression|4|||
44297454|NCT02435849|79293662|FG000|Overall Study|Death|23|||
44297455|NCT02435849|79293663|FG001|Overall Study|Death|0|||
44297456|NCT02435849|79293662|FG000|Overall Study|Lack of Efficacy|10|||
44297457|NCT02435849|79293663|FG001|Overall Study|Lack of Efficacy|0|||
44297458|NCT02435849|79293662|FG000|Overall Study|New therapy for study indication|8|||
44297459|NCT02435849|79293663|FG001|Overall Study|New therapy for study indication|0|||
44297460|NCT02435849|79293662|FG000|Overall Study|Subject/guardian decision|5|||
44297461|NCT02435849|79293663|FG001|Overall Study|Subject/guardian decision|1|||
44297462|NCT02435849|79293662|FG000|Overall Study|Lost to Follow-up|1|||
44297463|NCT02435849|79293663|FG001|Overall Study|Lost to Follow-up|0|||
44297464|NCT02435849|79293662|FG000|Overall Study|Physician Decision|1|||
44297465|NCT02435849|79293663|FG001|Overall Study|Physician Decision|0|||
44297466|NCT02367040|79293671|FG000|Overall Study|Lost to Follow-up|1|||
44297467|NCT02367040|79293672|FG001|Overall Study|Lost to Follow-up|1|||
44297468|NCT02367040|79293671|FG000|Overall Study|Lack of Efficacy|1|||
44297469|NCT02367040|79293672|FG001|Overall Study|Lack of Efficacy|0|||
44297470|NCT02367040|79293671|FG000|Overall Study|Additional primary malignancy|0|||
44297471|NCT02367040|79293672|FG001|Overall Study|Additional primary malignancy|1|||
44297472|NCT02367040|79293671|FG000|Overall Study|AE not associated with clinical disease progression|114|||
44297473|NCT02367040|79293672|FG001|Overall Study|AE not associated with clinical disease progression|11|||
44297474|NCT02367040|79293671|FG000|Overall Study|AE associated with clinical disease progression|1|||
44297475|NCT02367040|79293672|FG001|Overall Study|AE associated with clinical disease progression|3|||
44297476|NCT02367040|79293671|FG000|Overall Study|Physician Decision|2|||
44297477|NCT02367040|79293672|FG001|Overall Study|Physician Decision|8|||
44297478|NCT02367040|79293671|FG000|Overall Study|Non-compliance with study drug|1|||
44297479|NCT02367040|79293672|FG001|Overall Study|Non-compliance with study drug|0|||
44297480|NCT02367040|79293671|FG000|Overall Study|Failure to meet continuation criteria|1|||
44297481|NCT02367040|79293672|FG001|Overall Study|Failure to meet continuation criteria|0|||
44297482|NCT02367040|79293671|FG000|Overall Study|Switching to other therapy|2|||
44297483|NCT02367040|79293672|FG001|Overall Study|Switching to other therapy|0|||
44297484|NCT02367040|79293671|FG000|Overall Study|Withdrawal by Subject|46|||
44297485|NCT02367040|79293672|FG001|Overall Study|Withdrawal by Subject|16|||
44297486|NCT02367040|79293671|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
44297487|NCT02367040|79293672|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
44297488|NCT02367040|79293671|FG000|Overall Study|Patient decision|39|||
44297489|NCT02367040|79293672|FG001|Overall Study|Patient decision|14|||
44154714|NCT01999894|78945961|FG000|Overall Study|Adverse Event|9|||
44297490|NCT02367040|79293671|FG000|Overall Study|Required procedure failed|1|||
44297491|NCT02367040|79293672|FG001|Overall Study|Required procedure failed|0|||
44297492|NCT02367040|79293671|FG000|Overall Study|Randomized by mistake with study treatment|1|||
44297493|NCT02367040|79293672|FG001|Overall Study|Randomized by mistake with study treatment|0|||
44297494|NCT02367040|79293671|FG000|Overall Study|Protocol Violation|1|||
44297495|NCT02367040|79293672|FG001|Overall Study|Protocol Violation|0|||
44297496|NCT02367040|79293671|FG000|Overall Study|Progressive disease - radiological progression|51|||
44297497|NCT02367040|79293672|FG001|Overall Study|Progressive disease - radiological progression|78|||
44297498|NCT02367040|79293671|FG000|Overall Study|Progressive disease - clinical progression|6|||
44297499|NCT02367040|79293672|FG001|Overall Study|Progressive disease - clinical progression|6|||
44297500|NCT02367040|79293671|FG000|Overall Study|Drug not administered|3|||
44297501|NCT02367040|79293672|FG001|Overall Study|Drug not administered|2|||
44297502|NCT02367040|79293671|FG000|Overall Study|Progressive disease|0|||
44297503|NCT02367040|79293672|FG001|Overall Study|Progressive disease|1|||
44297504|NCT02367040|79293671|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
44297505|NCT02367040|79293672|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
44297506|NCT02367040|79293671|FG000|Overall Study|Death|2|||
44297507|NCT02367040|79293672|FG001|Overall Study|Death|0|||
44297508|NCT02197234|79293678|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
44297509|NCT02197234|79293678|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
44297510|NCT02197234|79293678|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
44297511|NCT02197234|79293678|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
44297512|NCT02197234|79293678|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
44297513|NCT02197234|79293678|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
44297514|NCT02197234|79293678|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
44297515|NCT02152631|79293687|FG000|Overall Study|Adverse Event|32|||
44297516|NCT02152631|79293688|FG001|Overall Study|Adverse Event|4|||
44297517|NCT02152631|79293687|FG000|Overall Study|Withdrawal by Subject|13|||
44297518|NCT02152631|79293688|FG001|Overall Study|Withdrawal by Subject|16|||
44297519|NCT02152631|79293687|FG000|Overall Study|Noncompliance with study drug|1|||
44297520|NCT02152631|79293688|FG001|Overall Study|Noncompliance with study drug|0|||
44297521|NCT02152631|79293687|FG000|Overall Study|Physician Decision|1|||
44297522|NCT02152631|79293688|FG001|Overall Study|Physician Decision|2|||
44297523|NCT02152631|79293687|FG000|Overall Study|Lost to Follow-up|0|||
44297524|NCT02152631|79293688|FG001|Overall Study|Lost to Follow-up|1|||
44297525|NCT02152631|79293687|FG000|Overall Study|On Treatment|19|||
44297526|NCT02152631|79293688|FG001|Overall Study|On Treatment|3|||
44297527|NCT02075840|79293696|FG000|Overall Study|Withdrawal by Subject|13|||
44297528|NCT02075840|79293697|FG001|Overall Study|Withdrawal by Subject|22|||
44297529|NCT02075840|79293696|FG000|Overall Study|Reason not specified|1|||
44297530|NCT02075840|79293697|FG001|Overall Study|Reason not specified|0|||
44297531|NCT02075840|79293696|FG000|Overall Study|Adverse Event|0|||
44297532|NCT02075840|79293697|FG001|Overall Study|Adverse Event|2|||
44297533|NCT02075840|79293696|FG000|Overall Study|Death|35|||
44297534|NCT02075840|79293697|FG001|Overall Study|Death|40|||
44297535|NCT02075840|79293696|FG000|Overall Study|Lost to Follow-up|3|||
44297536|NCT02075840|79293697|FG001|Overall Study|Lost to Follow-up|2|||
44297537|NCT02075840|79293696|FG000|Overall Study|Physician Decision|1|||
44297538|NCT02075840|79293697|FG001|Overall Study|Physician Decision|3|||
44297539|NCT02075840|79293696|FG000|Overall Study|Ongoing at CCOD|99|||
44297540|NCT02075840|79293697|FG001|Overall Study|Ongoing at CCOD|82|||
44297541|NCT02048813|79293705|FG000|Overall Study|Still on treatment|279|||
44297542|NCT02048813|79293706|FG001|Overall Study|Still on treatment|0|||
44297543|NCT02048813|79293705|FG000|Overall Study|Adverse Event|40|||
44297544|NCT02048813|79293706|FG001|Overall Study|Adverse Event|38|||
44297545|NCT02048813|79293705|FG000|Overall Study|Disease progression|13|||
44297546|NCT02048813|79293706|FG001|Overall Study|Disease progression|3|||
44297547|NCT02048813|79293705|FG000|Overall Study|Withdrawal by Subject|7|||
44297548|NCT02048813|79293706|FG001|Overall Study|Withdrawal by Subject|8|||
44297549|NCT02048813|79293705|FG000|Overall Study|Death|2|||
44297550|NCT02048813|79293706|FG001|Overall Study|Death|1|||
44297551|NCT02048813|79293705|FG000|Overall Study|Complication|2|||
44297552|NCT02048813|79293706|FG001|Overall Study|Complication|2|||
44297553|NCT02048813|79293705|FG000|Overall Study|Non-protocol therapy|0|||
44297554|NCT02048813|79293706|FG001|Overall Study|Non-protocol therapy|1|||
44297555|NCT02048813|79293705|FG000|Overall Study|Second primary cancer|2|||
44297556|NCT02048813|79293706|FG001|Overall Study|Second primary cancer|0|||
44297557|NCT02048813|79293705|FG000|Overall Study|Insurance|2|||
44297558|NCT02048813|79293706|FG001|Overall Study|Insurance|0|||
44297559|NCT02048813|79293705|FG000|Overall Study|Wound infection/healing|2|||
44297560|NCT02048813|79293706|FG001|Overall Study|Wound infection/healing|0|||
44297561|NCT02048813|79293705|FG000|Overall Study|Missed appointment|3|||
44297562|NCT02048813|79293706|FG001|Overall Study|Missed appointment|0|||
44297563|NCT02048813|79293705|FG000|Overall Study|Never started treatment|2|||
44297564|NCT02048813|79293706|FG001|Overall Study|Never started treatment|17|||
44534079|NCT02101853|79544765|FG005|Post Induction Randomization|Death|0|||
44534080|NCT02101853|79544760|FG000|Post Induction Randomization|Lack of Efficacy|0|||
44534081|NCT02101853|79544761|FG001|Post Induction Randomization|Lack of Efficacy|14|||
44534082|NCT02101853|79544762|FG002|Post Induction Randomization|Lack of Efficacy|23|||
44534083|NCT02101853|79544763|FG003|Post Induction Randomization|Lack of Efficacy|18|||
44534084|NCT02101853|79544764|FG004|Post Induction Randomization|Lack of Efficacy|21|||
44297572|NCT05776901|79293754|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
44297573|NCT05344560|79293758|FG000|Period 1|Subject out of visit window|1|||
44297574|NCT05344560|79293759|FG001|Period 1|Subject out of visit window|1|||
44297575|NCT05344560|79293758|FG000|Period 2|Covid-19 Related|1|||
44297576|NCT05344560|79293759|FG001|Period 2|Covid-19 Related|0|||
44297577|NCT05344560|79293758|FG000|Period 2|Adverse Event|1|||
44297578|NCT05344560|79293759|FG001|Period 2|Adverse Event|0|||
44297579|NCT05344560|79293758|FG000|Period 2|Subject out of visit window|1|||
44297580|NCT05344560|79293759|FG001|Period 2|Subject out of visit window|1|||
44297581|NCT05344560|79293758|FG000|Period 3|Subject out of visit window|1|||
44297582|NCT05344560|79293759|FG001|Period 3|Subject out of visit window|0|||
44297583|NCT05024058|79293779|FG000|Treatment|Study terminated by sponsor|5|||
44297584|NCT05024058|79293780|FG001|Treatment|Study terminated by sponsor|6|||
44297585|NCT05024058|79293781|FG002|Treatment|Study terminated by sponsor|4|||
44297586|NCT05024058|79293782|FG003|Treatment|Study terminated by sponsor|2|||
44297587|NCT05024058|79293783|FG004|Treatment|Study terminated by sponsor|3|||
44297588|NCT05024058|79293784|FG005|Treatment|Study terminated by sponsor|3|||
44297589|NCT05024058|79293785|FG006|Treatment|Study terminated by sponsor|1|||
44297590|NCT05024058|79293786|FG007|Treatment|Study terminated by sponsor|3|||
44297591|NCT05024058|79293787|FG008|Treatment|Study terminated by sponsor|6|||
44297592|NCT05024058|79293788|FG009|Treatment|Study terminated by sponsor|6|||
44297593|NCT05024058|79293779|FG000|Follow-up|Withdrawal by Subject|1|||
44297594|NCT05024058|79293780|FG001|Follow-up|Withdrawal by Subject|0|||
44297595|NCT05024058|79293781|FG002|Follow-up|Withdrawal by Subject|1|||
44297596|NCT05024058|79293782|FG003|Follow-up|Withdrawal by Subject|0|||
44297597|NCT05024058|79293783|FG004|Follow-up|Withdrawal by Subject|0|||
44297598|NCT05024058|79293784|FG005|Follow-up|Withdrawal by Subject|0|||
44297599|NCT05024058|79293785|FG006|Follow-up|Withdrawal by Subject|0|||
44297600|NCT05024058|79293786|FG007|Follow-up|Withdrawal by Subject|1|||
44297601|NCT05024058|79293787|FG008|Follow-up|Withdrawal by Subject|0|||
44297602|NCT05024058|79293788|FG009|Follow-up|Withdrawal by Subject|1|||
44297603|NCT05013008|79293811|FG000|Overall Study|Exclusion from mBFAS|5|||
44297604|NCT05013008|79293812|FG001|Overall Study|Exclusion from mBFAS|25|||
44297605|NCT04826900|79293820|FG000|Overall Study|Family factor|1|||
44297606|NCT04826900|79293821|FG001|Overall Study|Family factor|1|||
44297607|NCT04721158|79293827|FG000|Overall Study|Lost to Follow-up|4|||
44297608|NCT04721158|79293827|FG000|Overall Study|Device did not connect|1|||
44297609|NCT04263766|79293834|FG000|Overall Study|Withdrawal by Subject|6|||
44297610|NCT04263766|79293835|FG001|Overall Study|Withdrawal by Subject|4|||
44297611|NCT04263766|79293834|FG000|Overall Study|Lack of Efficacy|1|||
44297612|NCT04263766|79293835|FG001|Overall Study|Lack of Efficacy|3|||
44297613|NCT04203199|79293857|FG000|First Intervention Period|Lost to Follow-up|0|||
44297614|NCT04203199|79293858|FG001|First Intervention Period|Lost to Follow-up|1|||
44297615|NCT04203199|79293857|FG000|Second Intervention Period|Medication change|1|||
44297616|NCT04203199|79293858|FG001|Second Intervention Period|Medication change|0|||
44297617|NCT04191733|79293866|FG000|Overall Study|Withdrawn due to study closure|13|||
44297618|NCT04191733|79293867|FG001|Overall Study|Withdrawn due to study closure|14|||
44297619|NCT04191733|79293866|FG000|Overall Study|Withdrawal by Subject|2|||
44297620|NCT04191733|79293867|FG001|Overall Study|Withdrawal by Subject|4|||
44297621|NCT04191733|79293866|FG000|Overall Study|Physician Decision|1|||
44297622|NCT04191733|79293867|FG001|Overall Study|Physician Decision|1|||
44297623|NCT04191733|79293866|FG000|Overall Study|Lost to Follow-up|5|||
44297624|NCT04191733|79293867|FG001|Overall Study|Lost to Follow-up|6|||
44297625|NCT04191733|79293866|FG000|Overall Study|Death|0|||
44297626|NCT04191733|79293867|FG001|Overall Study|Death|1|||
44297627|NCT04049097|79293873|FG000|Overall Study|Adverse Event|18|||
44297628|NCT04049097|79293873|FG000|Overall Study|Death|2|||
44297629|NCT04049097|79293873|FG000|Overall Study|Lost to Follow-up|1|||
44297630|NCT04049097|79293873|FG000|Overall Study|Physician Decision|2|||
44297631|NCT04049097|79293873|FG000|Overall Study|Withdrawal by Subject|9|||
44297632|NCT04049097|79293873|FG000|Overall Study|Protocol Violation|2|||
44297633|NCT04049097|79293873|FG000|Overall Study|Other|1|||
44297634|NCT04049097|79293873|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
44297635|NCT04002310|79293882|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
44297636|NCT04002310|79293883|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
44297637|NCT04002310|79293884|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
44297638|NCT04002310|79293885|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
44297639|NCT04002310|79293886|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
44297640|NCT03887650|79293909|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
44297641|NCT03887650|79293910|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
44297642|NCT03887650|79293909|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
44297643|NCT03887650|79293910|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
44297644|NCT03887650|79293909|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
44297645|NCT03887650|79293910|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
44297646|NCT03345342|79293948|FG000|Open-Label Phase|Adverse Event|30|||
44297647|NCT03345342|79293949|FG001|Open-Label Phase|Adverse Event|0|||
44297648|NCT03345342|79293950|FG002|Open-Label Phase|Adverse Event|0|||
44297649|NCT03345342|79293951|FG003|Open-Label Phase|Adverse Event|0|||
44297650|NCT03345342|79293952|FG004|Open-Label Phase|Adverse Event|0|||
44297651|NCT03345342|79293948|FG000|Open-Label Phase|Death|1|||
44297652|NCT03345342|79293949|FG001|Open-Label Phase|Death|0|||
44297653|NCT03345342|79293950|FG002|Open-Label Phase|Death|0|||
44297654|NCT03345342|79293951|FG003|Open-Label Phase|Death|0|||
44297655|NCT03345342|79293952|FG004|Open-Label Phase|Death|0|||
44297656|NCT03345342|79293948|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
44297657|NCT03345342|79293949|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
44297658|NCT03345342|79293950|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
44297659|NCT03345342|79293951|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
44297660|NCT03345342|79293952|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
44297661|NCT03345342|79293948|FG000|Open-Label Phase|Lack of Efficacy|6|||
44297662|NCT03345342|79293949|FG001|Open-Label Phase|Lack of Efficacy|0|||
44297663|NCT03345342|79293950|FG002|Open-Label Phase|Lack of Efficacy|0|||
44297664|NCT03345342|79293951|FG003|Open-Label Phase|Lack of Efficacy|0|||
44297665|NCT03345342|79293952|FG004|Open-Label Phase|Lack of Efficacy|0|||
44297666|NCT03345342|79293948|FG000|Open-Label Phase|Lost to Follow-up|9|||
44297667|NCT03345342|79293949|FG001|Open-Label Phase|Lost to Follow-up|0|||
44297668|NCT03345342|79293950|FG002|Open-Label Phase|Lost to Follow-up|0|||
44297669|NCT03345342|79293951|FG003|Open-Label Phase|Lost to Follow-up|0|||
44297670|NCT03345342|79293952|FG004|Open-Label Phase|Lost to Follow-up|0|||
44297671|NCT03345342|79293948|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
44297672|NCT03345342|79293949|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
44297673|NCT03345342|79293950|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
44297674|NCT03345342|79293951|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
44297675|NCT03345342|79293952|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
44297676|NCT03345342|79293948|FG000|Open-Label Phase|Physician Decision|4|||
44297677|NCT03345342|79293949|FG001|Open-Label Phase|Physician Decision|0|||
44297678|NCT03345342|79293950|FG002|Open-Label Phase|Physician Decision|0|||
44297679|NCT03345342|79293951|FG003|Open-Label Phase|Physician Decision|0|||
44297680|NCT03345342|79293952|FG004|Open-Label Phase|Physician Decision|0|||
44297681|NCT03345342|79293948|FG000|Open-Label Phase|Protocol Violation|8|||
44297682|NCT03345342|79293949|FG001|Open-Label Phase|Protocol Violation|0|||
44297683|NCT03345342|79293950|FG002|Open-Label Phase|Protocol Violation|0|||
44297684|NCT03345342|79293951|FG003|Open-Label Phase|Protocol Violation|0|||
44297685|NCT03345342|79293952|FG004|Open-Label Phase|Protocol Violation|0|||
44297686|NCT03345342|79293948|FG000|Open-Label Phase|Withdrawal by Subject|57|||
44297687|NCT03345342|79293949|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44297688|NCT03345342|79293950|FG002|Open-Label Phase|Withdrawal by Subject|0|||
44297689|NCT03345342|79293951|FG003|Open-Label Phase|Withdrawal by Subject|0|||
44297690|NCT03345342|79293952|FG004|Open-Label Phase|Withdrawal by Subject|0|||
44297691|NCT03345342|79293948|FG000|Open-Label Phase|Other|15|||
44297692|NCT03345342|79293949|FG001|Open-Label Phase|Other|0|||
44297693|NCT03345342|79293950|FG002|Open-Label Phase|Other|0|||
44297694|NCT03345342|79293951|FG003|Open-Label Phase|Other|0|||
44297695|NCT03345342|79293952|FG004|Open-Label Phase|Other|0|||
44297696|NCT03345342|79293948|FG000|Double-Blind Phase|Adverse Event|0|||
44297697|NCT03345342|79293949|FG001|Double-Blind Phase|Adverse Event|1|||
44297698|NCT03345342|79293950|FG002|Double-Blind Phase|Adverse Event|6|||
44297699|NCT03345342|79293951|FG003|Double-Blind Phase|Adverse Event|0|||
44534085|NCT02101853|79544765|FG005|Post Induction Randomization|Lack of Efficacy|0|||
44534086|NCT02101853|79544760|FG000|Post Induction Randomization|Physician Decision|0|||
44297700|NCT03345342|79293952|FG004|Double-Blind Phase|Adverse Event|0|||
44297701|NCT03345342|79293948|FG000|Double-Blind Phase|Death|0|||
44297702|NCT03345342|79293949|FG001|Double-Blind Phase|Death|2|||
44297703|NCT03345342|79293950|FG002|Double-Blind Phase|Death|1|||
44297704|NCT03345342|79293951|FG003|Double-Blind Phase|Death|0|||
44297705|NCT03345342|79293952|FG004|Double-Blind Phase|Death|0|||
44297706|NCT03345342|79293948|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
44297707|NCT03345342|79293949|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
44297708|NCT03345342|79293950|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
44297709|NCT03345342|79293951|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
44297710|NCT03345342|79293952|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
44297711|NCT03345342|79293948|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44297712|NCT03345342|79293949|FG001|Double-Blind Phase|Lost to Follow-up|1|||
44297713|NCT03345342|79293950|FG002|Double-Blind Phase|Lost to Follow-up|7|||
44297714|NCT03345342|79293951|FG003|Double-Blind Phase|Lost to Follow-up|0|||
44297715|NCT03345342|79293952|FG004|Double-Blind Phase|Lost to Follow-up|0|||
44297716|NCT03345342|79293948|FG000|Double-Blind Phase|Physician Decision|0|||
44297717|NCT03345342|79293949|FG001|Double-Blind Phase|Physician Decision|1|||
44297718|NCT03345342|79293950|FG002|Double-Blind Phase|Physician Decision|4|||
44297719|NCT03345342|79293951|FG003|Double-Blind Phase|Physician Decision|0|||
44297720|NCT03345342|79293952|FG004|Double-Blind Phase|Physician Decision|0|||
44297721|NCT03345342|79293948|FG000|Double-Blind Phase|Protocol Violation|0|||
44297722|NCT03345342|79293949|FG001|Double-Blind Phase|Protocol Violation|0|||
44297723|NCT03345342|79293950|FG002|Double-Blind Phase|Protocol Violation|1|||
44297724|NCT03345342|79293951|FG003|Double-Blind Phase|Protocol Violation|0|||
44297725|NCT03345342|79293952|FG004|Double-Blind Phase|Protocol Violation|0|||
44297726|NCT03345342|79293948|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
44297727|NCT03345342|79293949|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
44297728|NCT03345342|79293950|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
44297729|NCT03345342|79293951|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
44297730|NCT03345342|79293952|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
44297731|NCT03345342|79293948|FG000|Double-Blind Phase|Other|0|||
44297732|NCT03345342|79293949|FG001|Double-Blind Phase|Other|1|||
44297733|NCT03345342|79293950|FG002|Double-Blind Phase|Other|3|||
44297734|NCT03345342|79293951|FG003|Double-Blind Phase|Other|0|||
44297735|NCT03345342|79293952|FG004|Double-Blind Phase|Other|0|||
44297736|NCT03345342|79293948|FG000|Follow-Up Phase|Adverse Event|0|||
44297737|NCT03345342|79293949|FG001|Follow-Up Phase|Adverse Event|0|||
44297738|NCT03345342|79293950|FG002|Follow-Up Phase|Adverse Event|0|||
44297739|NCT03345342|79293951|FG003|Follow-Up Phase|Adverse Event|0|||
44297740|NCT03345342|79293952|FG004|Follow-Up Phase|Adverse Event|4|||
44297741|NCT03345342|79293948|FG000|Follow-Up Phase|Lost to Follow-up|0|||
44297742|NCT03345342|79293949|FG001|Follow-Up Phase|Lost to Follow-up|0|||
44297743|NCT03345342|79293950|FG002|Follow-Up Phase|Lost to Follow-up|0|||
44297744|NCT03345342|79293951|FG003|Follow-Up Phase|Lost to Follow-up|0|||
44297745|NCT03345342|79293952|FG004|Follow-Up Phase|Lost to Follow-up|6|||
44297746|NCT03345342|79293948|FG000|Follow-Up Phase|Physician Decision|0|||
44297747|NCT03345342|79293949|FG001|Follow-Up Phase|Physician Decision|0|||
44297748|NCT03345342|79293950|FG002|Follow-Up Phase|Physician Decision|0|||
44297749|NCT03345342|79293951|FG003|Follow-Up Phase|Physician Decision|0|||
44297750|NCT03345342|79293952|FG004|Follow-Up Phase|Physician Decision|5|||
44297751|NCT03345342|79293948|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
44297752|NCT03345342|79293949|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
44297753|NCT03345342|79293950|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
44297754|NCT03345342|79293951|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
44297755|NCT03345342|79293952|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
44297756|NCT03345342|79293948|FG000|Follow-Up Phase|Other|0|||
44297757|NCT03345342|79293949|FG001|Follow-Up Phase|Other|0|||
44297758|NCT03345342|79293950|FG002|Follow-Up Phase|Other|0|||
44297759|NCT03345342|79293951|FG003|Follow-Up Phase|Other|3|||
44297760|NCT03345342|79293952|FG004|Follow-Up Phase|Other|1|||
44297761|NCT03192176|79293976|FG000|Overall Study|Adverse Event|1|||
44297762|NCT03192176|79293977|FG001|Overall Study|Adverse Event|0|||
44297763|NCT03192176|79293978|FG002|Overall Study|Adverse Event|4|||
44297764|NCT03192176|79293979|FG003|Overall Study|Adverse Event|5|||
44297765|NCT03192176|79293980|FG004|Overall Study|Adverse Event|3|||
44297766|NCT03192176|79293981|FG005|Overall Study|Adverse Event|2|||
44297767|NCT03192176|79293982|FG006|Overall Study|Adverse Event|3|||
44297768|NCT03192176|79293983|FG007|Overall Study|Adverse Event|3|||
44297769|NCT03192176|79293976|FG000|Overall Study|Lost to Follow-up|0|||
44297770|NCT03192176|79293977|FG001|Overall Study|Lost to Follow-up|0|||
44297771|NCT03192176|79293978|FG002|Overall Study|Lost to Follow-up|1|||
44297772|NCT03192176|79293979|FG003|Overall Study|Lost to Follow-up|2|||
44297773|NCT03192176|79293980|FG004|Overall Study|Lost to Follow-up|3|||
44297774|NCT03192176|79293981|FG005|Overall Study|Lost to Follow-up|1|||
44297775|NCT03192176|79293982|FG006|Overall Study|Lost to Follow-up|1|||
44297776|NCT03192176|79293983|FG007|Overall Study|Lost to Follow-up|1|||
44417158|NCT00764478|79425034|FG002|Overall Study|Lost to Follow-up|5|||
44297777|NCT03192176|79293976|FG000|Overall Study|Physician Decision|1|||
44297778|NCT03192176|79293977|FG001|Overall Study|Physician Decision|0|||
44297779|NCT03192176|79293978|FG002|Overall Study|Physician Decision|0|||
44297780|NCT03192176|79293979|FG003|Overall Study|Physician Decision|0|||
44297781|NCT03192176|79293980|FG004|Overall Study|Physician Decision|0|||
44297782|NCT03192176|79293981|FG005|Overall Study|Physician Decision|2|||
44297783|NCT03192176|79293982|FG006|Overall Study|Physician Decision|1|||
44297784|NCT03192176|79293983|FG007|Overall Study|Physician Decision|0|||
44297785|NCT03192176|79293976|FG000|Overall Study|Protocol Deviation|1|||
44297786|NCT03192176|79293977|FG001|Overall Study|Protocol Deviation|1|||
44297787|NCT03192176|79293978|FG002|Overall Study|Protocol Deviation|0|||
44297788|NCT03192176|79293979|FG003|Overall Study|Protocol Deviation|0|||
44297789|NCT03192176|79293980|FG004|Overall Study|Protocol Deviation|2|||
44297790|NCT03192176|79293981|FG005|Overall Study|Protocol Deviation|0|||
44297791|NCT03192176|79293982|FG006|Overall Study|Protocol Deviation|0|||
44297792|NCT03192176|79293983|FG007|Overall Study|Protocol Deviation|0|||
44297793|NCT03192176|79293976|FG000|Overall Study|Withdrawal by Subject|3|||
44297794|NCT03192176|79293977|FG001|Overall Study|Withdrawal by Subject|4|||
44297795|NCT03192176|79293978|FG002|Overall Study|Withdrawal by Subject|0|||
44297796|NCT03192176|79293979|FG003|Overall Study|Withdrawal by Subject|4|||
44297797|NCT03192176|79293980|FG004|Overall Study|Withdrawal by Subject|3|||
44297798|NCT03192176|79293981|FG005|Overall Study|Withdrawal by Subject|4|||
44297799|NCT03192176|79293982|FG006|Overall Study|Withdrawal by Subject|4|||
44297800|NCT03192176|79293983|FG007|Overall Study|Withdrawal by Subject|2|||
44297801|NCT03192176|79293976|FG000|Overall Study|Miscellaneous|1|||
44297802|NCT03192176|79293977|FG001|Overall Study|Miscellaneous|0|||
44297803|NCT03192176|79293978|FG002|Overall Study|Miscellaneous|1|||
44297804|NCT03192176|79293979|FG003|Overall Study|Miscellaneous|1|||
44297805|NCT03192176|79293980|FG004|Overall Study|Miscellaneous|1|||
44297806|NCT03192176|79293981|FG005|Overall Study|Miscellaneous|2|||
44297807|NCT03192176|79293982|FG006|Overall Study|Miscellaneous|0|||
44297808|NCT03192176|79293983|FG007|Overall Study|Miscellaneous|1|||
44297809|NCT02531594|79294012|FG000|Overall Study|Withdrawal by Subject|7|||
44297810|NCT02531594|79294013|FG001|Overall Study|Withdrawal by Subject|8|||
44297811|NCT02365467|79294028|FG000|Overall Study|Death|3|||
44297812|NCT01256593|79294041|FG000|Overall Study|Protocol Violation|26|||
44297813|NCT01256593|79294041|FG000|Overall Study|No Drug Administration Information|2|||
44297814|NCT01256593|79294041|FG000|Overall Study|No Visit After Treatment|186|||
44297815|NCT00562640|79294059|FG000|Overall Study|Death|0|||
44297816|NCT00562640|79294060|FG001|Overall Study|Death|1|||
44297817|NCT00562640|79294061|FG002|Overall Study|Death|1|||
44297818|NCT00562640|79294062|FG003|Overall Study|Death|0|||
44297819|NCT04554394|79294087|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
44297820|NCT04554394|79294088|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
44297821|NCT04554394|79294087|FG000|Overall Study|Withdrawal by Subject|2|||
44297822|NCT04554394|79294088|FG001|Overall Study|Withdrawal by Subject|2|||
44297823|NCT04554394|79294087|FG000|Overall Study|Lost to Follow-up|2|||
44297824|NCT04554394|79294088|FG001|Overall Study|Lost to Follow-up|2|||
44297825|NCT04554394|79294087|FG000|Overall Study|Physician Decision|1|||
44297826|NCT04554394|79294088|FG001|Overall Study|Physician Decision|1|||
44297827|NCT04518410|79294118|FG000|Overall Study|Lost to Follow-up|1|||
44297828|NCT04518410|79294119|FG001|Overall Study|Lost to Follow-up|1|||
44297829|NCT04518410|79294120|FG002|Overall Study|Lost to Follow-up|8|||
44297830|NCT04518410|79294121|FG003|Overall Study|Lost to Follow-up|5|||
44297831|NCT04518410|79294122|FG004|Overall Study|Lost to Follow-up|92|||
44297832|NCT04518410|79294123|FG005|Overall Study|Lost to Follow-up|27|||
44297833|NCT04518410|79294124|FG006|Overall Study|Lost to Follow-up|26|||
44297834|NCT04518410|79294125|FG007|Overall Study|Lost to Follow-up|3|||
44297835|NCT04518410|79294126|FG008|Overall Study|Lost to Follow-up|2|||
44297836|NCT04518410|79294127|FG009|Overall Study|Lost to Follow-up|15|||
44297837|NCT04518410|79294128|FG010|Overall Study|Lost to Follow-up|9|||
44297838|NCT04518410|79294129|FG011|Overall Study|Lost to Follow-up|13|||
44534087|NCT02101853|79544761|FG001|Post Induction Randomization|Physician Decision|43|||
44534088|NCT02101853|79544762|FG002|Post Induction Randomization|Physician Decision|23|||
44534089|NCT02101853|79544763|FG003|Post Induction Randomization|Physician Decision|14|||
44534090|NCT02101853|79544764|FG004|Post Induction Randomization|Physician Decision|14|||
44534091|NCT02101853|79544765|FG005|Post Induction Randomization|Physician Decision|0|||
44534092|NCT02101853|79544760|FG000|Post Induction Randomization|Protocol Violation|0|||
44534093|NCT02101853|79544761|FG001|Post Induction Randomization|Protocol Violation|3|||
44534094|NCT02101853|79544762|FG002|Post Induction Randomization|Protocol Violation|0|||
44534095|NCT02101853|79544763|FG003|Post Induction Randomization|Protocol Violation|0|||
44534096|NCT02101853|79544764|FG004|Post Induction Randomization|Protocol Violation|0|||
44534097|NCT02101853|79544765|FG005|Post Induction Randomization|Protocol Violation|0|||
44297839|NCT04518410|79294130|FG012|Overall Study|Lost to Follow-up|9|||
44297840|NCT04518410|79294131|FG013|Overall Study|Lost to Follow-up|14|||
44297841|NCT04518410|79294132|FG014|Overall Study|Lost to Follow-up|8|||
44297842|NCT04518410|79294133|FG015|Overall Study|Lost to Follow-up|10|||
44297843|NCT04518410|79294134|FG016|Overall Study|Lost to Follow-up|6|||
44297844|NCT04518410|79294135|FG017|Overall Study|Lost to Follow-up|8|||
44297845|NCT04518410|79294136|FG018|Overall Study|Lost to Follow-up|20|||
44297846|NCT04518410|79294137|FG019|Overall Study|Lost to Follow-up|6|||
44154715|NCT01999894|78945961|FG000|Overall Study|Lack of Efficacy|5|||
44297847|NCT04518410|79294138|FG020|Overall Study|Lost to Follow-up|4|||
44297848|NCT04518410|79294139|FG021|Overall Study|Lost to Follow-up|22|||
44297849|NCT04518410|79294140|FG022|Overall Study|Lost to Follow-up|1|||
44297850|NCT04518410|79294141|FG023|Overall Study|Lost to Follow-up|7|||
44297851|NCT04518410|79294142|FG024|Overall Study|Lost to Follow-up|6|||
44297852|NCT04518410|79294118|FG000|Overall Study|Withdrawal by Subject|1|||
44297853|NCT04518410|79294119|FG001|Overall Study|Withdrawal by Subject|2|||
44297854|NCT04518410|79294120|FG002|Overall Study|Withdrawal by Subject|2|||
44297855|NCT04518410|79294121|FG003|Overall Study|Withdrawal by Subject|3|||
44297856|NCT04518410|79294122|FG004|Overall Study|Withdrawal by Subject|20|||
44297857|NCT04518410|79294123|FG005|Overall Study|Withdrawal by Subject|21|||
44297858|NCT04518410|79294124|FG006|Overall Study|Withdrawal by Subject|27|||
44297859|NCT04518410|79294125|FG007|Overall Study|Withdrawal by Subject|6|||
44297860|NCT04518410|79294126|FG008|Overall Study|Withdrawal by Subject|2|||
44297861|NCT04518410|79294127|FG009|Overall Study|Withdrawal by Subject|12|||
44297862|NCT04518410|79294128|FG010|Overall Study|Withdrawal by Subject|6|||
44297863|NCT04518410|79294129|FG011|Overall Study|Withdrawal by Subject|7|||
44297864|NCT04518410|79294130|FG012|Overall Study|Withdrawal by Subject|2|||
44297865|NCT04518410|79294131|FG013|Overall Study|Withdrawal by Subject|13|||
44297866|NCT04518410|79294132|FG014|Overall Study|Withdrawal by Subject|4|||
44297867|NCT04518410|79294133|FG015|Overall Study|Withdrawal by Subject|9|||
44297868|NCT04518410|79294134|FG016|Overall Study|Withdrawal by Subject|0|||
44297869|NCT04518410|79294135|FG017|Overall Study|Withdrawal by Subject|14|||
44297870|NCT04518410|79294136|FG018|Overall Study|Withdrawal by Subject|13|||
44297871|NCT04518410|79294137|FG019|Overall Study|Withdrawal by Subject|9|||
44297872|NCT04518410|79294138|FG020|Overall Study|Withdrawal by Subject|13|||
44297873|NCT04518410|79294139|FG021|Overall Study|Withdrawal by Subject|3|||
44297874|NCT04518410|79294140|FG022|Overall Study|Withdrawal by Subject|2|||
44297875|NCT04518410|79294141|FG023|Overall Study|Withdrawal by Subject|9|||
44297876|NCT04518410|79294142|FG024|Overall Study|Withdrawal by Subject|8|||
44297877|NCT04518410|79294118|FG000|Overall Study|Other|1|||
44297878|NCT04518410|79294119|FG001|Overall Study|Other|0|||
44297879|NCT04518410|79294120|FG002|Overall Study|Other|0|||
44297880|NCT04518410|79294121|FG003|Overall Study|Other|1|||
44297881|NCT04518410|79294122|FG004|Overall Study|Other|6|||
44297882|NCT04518410|79294123|FG005|Overall Study|Other|6|||
44297883|NCT04518410|79294124|FG006|Overall Study|Other|5|||
44297884|NCT04518410|79294125|FG007|Overall Study|Other|2|||
44297885|NCT04518410|79294126|FG008|Overall Study|Other|0|||
44297886|NCT04518410|79294127|FG009|Overall Study|Other|1|||
44297887|NCT04518410|79294128|FG010|Overall Study|Other|0|||
44297888|NCT04518410|79294129|FG011|Overall Study|Other|2|||
44297889|NCT04518410|79294130|FG012|Overall Study|Other|0|||
44297890|NCT04518410|79294131|FG013|Overall Study|Other|0|||
44297891|NCT04518410|79294132|FG014|Overall Study|Other|0|||
44297892|NCT04518410|79294133|FG015|Overall Study|Other|3|||
44297893|NCT04518410|79294134|FG016|Overall Study|Other|1|||
44297894|NCT04518410|79294135|FG017|Overall Study|Other|1|||
44297895|NCT04518410|79294136|FG018|Overall Study|Other|1|||
44297896|NCT04518410|79294137|FG019|Overall Study|Other|0|||
44297897|NCT04518410|79294138|FG020|Overall Study|Other|0|||
44297898|NCT04518410|79294139|FG021|Overall Study|Other|0|||
44297899|NCT04518410|79294140|FG022|Overall Study|Other|1|||
44297900|NCT04518410|79294141|FG023|Overall Study|Other|2|||
44297901|NCT04518410|79294142|FG024|Overall Study|Other|2|||
44297902|NCT04518410|79294118|FG000|Overall Study|Protocol Violation|0|||
44297903|NCT04518410|79294119|FG001|Overall Study|Protocol Violation|0|||
44297904|NCT04518410|79294120|FG002|Overall Study|Protocol Violation|0|||
44297905|NCT04518410|79294121|FG003|Overall Study|Protocol Violation|2|||
44297906|NCT04518410|79294122|FG004|Overall Study|Protocol Violation|17|||
44297907|NCT04518410|79294123|FG005|Overall Study|Protocol Violation|1|||
44297908|NCT04518410|79294124|FG006|Overall Study|Protocol Violation|2|||
44297909|NCT04518410|79294125|FG007|Overall Study|Protocol Violation|1|||
44297910|NCT04518410|79294126|FG008|Overall Study|Protocol Violation|0|||
44297911|NCT04518410|79294127|FG009|Overall Study|Protocol Violation|0|||
44297912|NCT04518410|79294128|FG010|Overall Study|Protocol Violation|0|||
44297913|NCT04518410|79294129|FG011|Overall Study|Protocol Violation|0|||
44297914|NCT04518410|79294130|FG012|Overall Study|Protocol Violation|0|||
44534098|NCT02101853|79544760|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
44297915|NCT04518410|79294131|FG013|Overall Study|Protocol Violation|0|||
44534099|NCT02101853|79544761|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
44534100|NCT02101853|79544762|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
44534101|NCT02101853|79544763|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
44534102|NCT02101853|79544764|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
44534103|NCT02101853|79544765|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
44297916|NCT04518410|79294132|FG014|Overall Study|Protocol Violation|0|||
44297917|NCT04518410|79294133|FG015|Overall Study|Protocol Violation|0|||
44297918|NCT04518410|79294134|FG016|Overall Study|Protocol Violation|1|||
44297919|NCT04518410|79294135|FG017|Overall Study|Protocol Violation|1|||
44297920|NCT04518410|79294136|FG018|Overall Study|Protocol Violation|0|||
44297921|NCT04518410|79294137|FG019|Overall Study|Protocol Violation|0|||
44297922|NCT04518410|79294138|FG020|Overall Study|Protocol Violation|1|||
44297923|NCT04518410|79294139|FG021|Overall Study|Protocol Violation|2|||
44297924|NCT04518410|79294140|FG022|Overall Study|Protocol Violation|0|||
44297925|NCT04518410|79294141|FG023|Overall Study|Protocol Violation|3|||
44297926|NCT04518410|79294142|FG024|Overall Study|Protocol Violation|0|||
44297927|NCT04518410|79294118|FG000|Overall Study|Death|0|||
44297928|NCT04518410|79294119|FG001|Overall Study|Death|0|||
44297929|NCT04518410|79294120|FG002|Overall Study|Death|0|||
44297930|NCT04518410|79294121|FG003|Overall Study|Death|0|||
44297931|NCT04518410|79294122|FG004|Overall Study|Death|12|||
44297932|NCT04518410|79294123|FG005|Overall Study|Death|2|||
44297933|NCT04518410|79294124|FG006|Overall Study|Death|11|||
44256531|NCT01419626|79106757|FG001|Overall Study|Protocol Violation|2|||
44256532|NCT01419626|79106758|FG002|Overall Study|Protocol Violation|2|||
44297934|NCT04518410|79294125|FG007|Overall Study|Death|0|||
44297935|NCT04518410|79294126|FG008|Overall Study|Death|1|||
44297936|NCT04518410|79294127|FG009|Overall Study|Death|0|||
44297937|NCT04518410|79294128|FG010|Overall Study|Death|0|||
44297938|NCT04518410|79294129|FG011|Overall Study|Death|0|||
44297939|NCT04518410|79294130|FG012|Overall Study|Death|0|||
44297940|NCT04518410|79294131|FG013|Overall Study|Death|1|||
44297941|NCT04518410|79294132|FG014|Overall Study|Death|1|||
44297942|NCT04518410|79294133|FG015|Overall Study|Death|0|||
44297943|NCT04518410|79294134|FG016|Overall Study|Death|0|||
44297944|NCT04518410|79294135|FG017|Overall Study|Death|1|||
44297945|NCT04518410|79294136|FG018|Overall Study|Death|3|||
44297946|NCT04518410|79294137|FG019|Overall Study|Death|4|||
44297947|NCT04518410|79294138|FG020|Overall Study|Death|1|||
44297948|NCT04518410|79294139|FG021|Overall Study|Death|0|||
44297949|NCT04518410|79294140|FG022|Overall Study|Death|0|||
44297950|NCT04518410|79294141|FG023|Overall Study|Death|0|||
44297951|NCT04518410|79294142|FG024|Overall Study|Death|0|||
44297952|NCT04518410|79294118|FG000|Overall Study|Requirement to start alternative therapy|0|||
44297953|NCT04518410|79294119|FG001|Overall Study|Requirement to start alternative therapy|0|||
44297954|NCT04518410|79294120|FG002|Overall Study|Requirement to start alternative therapy|1|||
44297955|NCT04518410|79294121|FG003|Overall Study|Requirement to start alternative therapy|0|||
44297956|NCT04518410|79294122|FG004|Overall Study|Requirement to start alternative therapy|0|||
44534104|NCT02101853|79544760|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44534105|NCT02101853|79544761|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44534106|NCT02101853|79544762|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44256533|NCT01419626|79106756|FG000|Overall Study|Withdrawal by Subject|1|||
44256534|NCT01419626|79106757|FG001|Overall Study|Withdrawal by Subject|0|||
44256535|NCT01419626|79106758|FG002|Overall Study|Withdrawal by Subject|0|||
44256536|NCT01419626|79106756|FG000|Overall Study|Lost to Follow-up|0|||
44256537|NCT01419626|79106757|FG001|Overall Study|Lost to Follow-up|1|||
44256538|NCT01419626|79106758|FG002|Overall Study|Lost to Follow-up|1|||
44256539|NCT01444742|79106797|FG000|Overall Study|Death|1|||
44256540|NCT01444430|79106997|FG000|Overall Study|Withdrawal by Subject|53|||
44256541|NCT01444430|79106998|FG001|Overall Study|Withdrawal by Subject|72|||
44256542|NCT01444430|79106997|FG000|Overall Study|Death|6|||
44256543|NCT01444430|79106998|FG001|Overall Study|Death|8|||
44256544|NCT01444430|79106997|FG000|Overall Study|Lost to Follow-up|2|||
44256545|NCT01444430|79106998|FG001|Overall Study|Lost to Follow-up|0|||
44256546|NCT01444430|79106997|FG000|Overall Study|CRF termination module not completed.|0|||
44256547|NCT01444430|79106998|FG001|Overall Study|CRF termination module not completed.|1|||
44256548|NCT01436162|79107074|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
44256549|NCT01436162|79107075|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
44256550|NCT01436162|79107076|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
44256551|NCT01436162|79107074|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
44256552|NCT01436162|79107075|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
44256553|NCT01436162|79107076|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
44256554|NCT01436162|79107074|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
44256555|NCT01436162|79107075|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
44256556|NCT01436162|79107076|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
44256557|NCT01436162|79107074|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
44256558|NCT01436162|79107075|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
44256559|NCT01436162|79107076|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
44256560|NCT01436162|79107074|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
44256561|NCT01436162|79107075|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44297957|NCT04518410|79294123|FG005|Overall Study|Requirement to start alternative therapy|0|||
44256562|NCT01436162|79107076|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
44256563|NCT01436162|79107074|FG000|Single-blind Lead-in Phase|Other|107|||
44256564|NCT01436162|79107075|FG001|Single-blind Lead-in Phase|Other|0|||
44297958|NCT04518410|79294124|FG006|Overall Study|Requirement to start alternative therapy|0|||
44297959|NCT04518410|79294125|FG007|Overall Study|Requirement to start alternative therapy|0|||
44297960|NCT04518410|79294126|FG008|Overall Study|Requirement to start alternative therapy|0|||
44297961|NCT04518410|79294127|FG009|Overall Study|Requirement to start alternative therapy|0|||
44297962|NCT04518410|79294128|FG010|Overall Study|Requirement to start alternative therapy|0|||
44297963|NCT04518410|79294129|FG011|Overall Study|Requirement to start alternative therapy|0|||
44297964|NCT04518410|79294130|FG012|Overall Study|Requirement to start alternative therapy|0|||
44297965|NCT04518410|79294131|FG013|Overall Study|Requirement to start alternative therapy|0|||
44297966|NCT04518410|79294132|FG014|Overall Study|Requirement to start alternative therapy|0|||
44297967|NCT04518410|79294133|FG015|Overall Study|Requirement to start alternative therapy|0|||
44297968|NCT04518410|79294134|FG016|Overall Study|Requirement to start alternative therapy|0|||
44297969|NCT04518410|79294135|FG017|Overall Study|Requirement to start alternative therapy|0|||
44297970|NCT04518410|79294136|FG018|Overall Study|Requirement to start alternative therapy|0|||
44297971|NCT04518410|79294137|FG019|Overall Study|Requirement to start alternative therapy|0|||
44297972|NCT04518410|79294138|FG020|Overall Study|Requirement to start alternative therapy|0|||
44297973|NCT04518410|79294139|FG021|Overall Study|Requirement to start alternative therapy|0|||
44297974|NCT04518410|79294140|FG022|Overall Study|Requirement to start alternative therapy|1|||
44297975|NCT04518410|79294141|FG023|Overall Study|Requirement to start alternative therapy|0|||
44297976|NCT04518410|79294142|FG024|Overall Study|Requirement to start alternative therapy|0|||
44297977|NCT04518410|79294118|FG000|Overall Study|Ongoing in study|0|||
44297978|NCT04518410|79294119|FG001|Overall Study|Ongoing in study|0|||
44297979|NCT04518410|79294120|FG002|Overall Study|Ongoing in study|0|||
44297980|NCT04518410|79294121|FG003|Overall Study|Ongoing in study|0|||
44297981|NCT04518410|79294122|FG004|Overall Study|Ongoing in study|0|||
44297982|NCT04518410|79294123|FG005|Overall Study|Ongoing in study|0|||
44297983|NCT04518410|79294124|FG006|Overall Study|Ongoing in study|0|||
44297984|NCT04518410|79294125|FG007|Overall Study|Ongoing in study|0|||
44297985|NCT04518410|79294126|FG008|Overall Study|Ongoing in study|0|||
44297986|NCT04518410|79294127|FG009|Overall Study|Ongoing in study|0|||
44297987|NCT04518410|79294128|FG010|Overall Study|Ongoing in study|0|||
44297988|NCT04518410|79294129|FG011|Overall Study|Ongoing in study|0|||
44297989|NCT04518410|79294130|FG012|Overall Study|Ongoing in study|0|||
44297990|NCT04518410|79294131|FG013|Overall Study|Ongoing in study|0|||
44297991|NCT04518410|79294132|FG014|Overall Study|Ongoing in study|0|||
44297992|NCT04518410|79294133|FG015|Overall Study|Ongoing in study|0|||
44297993|NCT04518410|79294134|FG016|Overall Study|Ongoing in study|0|||
44297994|NCT04518410|79294135|FG017|Overall Study|Ongoing in study|193|||
44297995|NCT04518410|79294136|FG018|Overall Study|Ongoing in study|173|||
44297996|NCT04518410|79294137|FG019|Overall Study|Ongoing in study|50|||
44297997|NCT04518410|79294138|FG020|Overall Study|Ongoing in study|65|||
44297998|NCT04518410|79294139|FG021|Overall Study|Ongoing in study|0|||
44297999|NCT04518410|79294140|FG022|Overall Study|Ongoing in study|0|||
44298000|NCT04518410|79294141|FG023|Overall Study|Ongoing in study|0|||
44298001|NCT04518410|79294142|FG024|Overall Study|Ongoing in study|0|||
44298002|NCT04518410|79294118|FG000|Overall Study|Randomized but not treated|0|||
44298003|NCT04518410|79294119|FG001|Overall Study|Randomized but not treated|0|||
44298004|NCT04518410|79294120|FG002|Overall Study|Randomized but not treated|0|||
44298005|NCT04518410|79294121|FG003|Overall Study|Randomized but not treated|2|||
44298006|NCT04518410|79294122|FG004|Overall Study|Randomized but not treated|6|||
44298007|NCT04518410|79294123|FG005|Overall Study|Randomized but not treated|6|||
44298008|NCT04518410|79294124|FG006|Overall Study|Randomized but not treated|3|||
44298009|NCT04518410|79294125|FG007|Overall Study|Randomized but not treated|3|||
44298010|NCT04518410|79294126|FG008|Overall Study|Randomized but not treated|0|||
44298011|NCT04518410|79294127|FG009|Overall Study|Randomized but not treated|4|||
44298012|NCT04518410|79294128|FG010|Overall Study|Randomized but not treated|0|||
44298013|NCT04518410|79294129|FG011|Overall Study|Randomized but not treated|0|||
44298014|NCT04518410|79294130|FG012|Overall Study|Randomized but not treated|1|||
44298015|NCT04518410|79294131|FG013|Overall Study|Randomized but not treated|4|||
44298016|NCT04518410|79294132|FG014|Overall Study|Randomized but not treated|3|||
44298017|NCT04518410|79294133|FG015|Overall Study|Randomized but not treated|3|||
44298018|NCT04518410|79294134|FG016|Overall Study|Randomized but not treated|4|||
44298019|NCT04518410|79294135|FG017|Overall Study|Randomized but not treated|6|||
44298020|NCT04518410|79294136|FG018|Overall Study|Randomized but not treated|4|||
44298021|NCT04518410|79294137|FG019|Overall Study|Randomized but not treated|0|||
44298022|NCT04518410|79294138|FG020|Overall Study|Randomized but not treated|0|||
44298023|NCT04518410|79294139|FG021|Overall Study|Randomized but not treated|5|||
44298024|NCT04518410|79294140|FG022|Overall Study|Randomized but not treated|0|||
44298025|NCT04518410|79294141|FG023|Overall Study|Randomized but not treated|3|||
44298026|NCT04518410|79294142|FG024|Overall Study|Randomized but not treated|1|||
44298027|NCT04518410|79294118|FG000|Overall Study|Screen Fail but Randomized|0|||
44298028|NCT04518410|79294119|FG001|Overall Study|Screen Fail but Randomized|0|||
44298029|NCT04518410|79294120|FG002|Overall Study|Screen Fail but Randomized|0|||
44417159|NCT00764478|79425032|FG000|Overall Study|Protocol Violation|0|||
44417160|NCT00764478|79425033|FG001|Overall Study|Protocol Violation|1|||
44298030|NCT04518410|79294121|FG003|Overall Study|Screen Fail but Randomized|0|||
44298031|NCT04518410|79294122|FG004|Overall Study|Screen Fail but Randomized|2|||
44417161|NCT00764478|79425034|FG002|Overall Study|Protocol Violation|1|||
44298032|NCT04518410|79294123|FG005|Overall Study|Screen Fail but Randomized|0|||
44298033|NCT04518410|79294124|FG006|Overall Study|Screen Fail but Randomized|0|||
44298034|NCT04518410|79294125|FG007|Overall Study|Screen Fail but Randomized|0|||
44298035|NCT04518410|79294126|FG008|Overall Study|Screen Fail but Randomized|0|||
44298036|NCT04518410|79294127|FG009|Overall Study|Screen Fail but Randomized|0|||
44298037|NCT04518410|79294128|FG010|Overall Study|Screen Fail but Randomized|0|||
44298038|NCT04518410|79294129|FG011|Overall Study|Screen Fail but Randomized|0|||
44298039|NCT04518410|79294130|FG012|Overall Study|Screen Fail but Randomized|0|||
44298040|NCT04518410|79294131|FG013|Overall Study|Screen Fail but Randomized|0|||
44298041|NCT04518410|79294132|FG014|Overall Study|Screen Fail but Randomized|0|||
44298042|NCT04518410|79294133|FG015|Overall Study|Screen Fail but Randomized|0|||
44298043|NCT04518410|79294134|FG016|Overall Study|Screen Fail but Randomized|0|||
44298044|NCT04518410|79294135|FG017|Overall Study|Screen Fail but Randomized|0|||
44298045|NCT04518410|79294136|FG018|Overall Study|Screen Fail but Randomized|0|||
44298046|NCT04518410|79294137|FG019|Overall Study|Screen Fail but Randomized|0|||
44298047|NCT04518410|79294138|FG020|Overall Study|Screen Fail but Randomized|0|||
44298048|NCT04518410|79294139|FG021|Overall Study|Screen Fail but Randomized|0|||
44298049|NCT04518410|79294140|FG022|Overall Study|Screen Fail but Randomized|0|||
44298050|NCT04518410|79294141|FG023|Overall Study|Screen Fail but Randomized|0|||
44298051|NCT04518410|79294142|FG024|Overall Study|Screen Fail but Randomized|0|||
44298052|NCT04518410|79294118|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298053|NCT04518410|79294119|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298054|NCT04518410|79294120|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298055|NCT04518410|79294121|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298056|NCT04518410|79294122|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
44298057|NCT04518410|79294123|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
44298058|NCT04518410|79294124|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
44298059|NCT04518410|79294125|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298060|NCT04518410|79294126|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
44298061|NCT04518410|79294127|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298062|NCT04518410|79294128|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298063|NCT04518410|79294129|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298064|NCT04518410|79294130|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298065|NCT04518410|79294131|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298066|NCT04518410|79294132|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298067|NCT04518410|79294133|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298068|NCT04518410|79294134|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298069|NCT04518410|79294135|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298070|NCT04518410|79294136|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298071|NCT04518410|79294137|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298072|NCT04518410|79294138|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298073|NCT04518410|79294139|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44298074|NCT04518410|79294140|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
44256565|NCT01436162|79107076|FG002|Single-blind Lead-in Phase|Other|0|||
44256566|NCT01436162|79107074|FG000|Randomized Phase|Adverse Event|1|||
44298075|NCT04518410|79294141|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
44417162|NCT00805766|79425042|FG000|Screening Period|Adverse Event|1|||
44417163|NCT00805766|79425042|FG000|Screening Period|Lack of Efficacy|2|||
44417164|NCT00805766|79425042|FG000|Screening Period|Pregnancy|1|||
44534107|NCT02101853|79544763|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
44256567|NCT01436162|79107075|FG001|Randomized Phase|Adverse Event|5|||
44256568|NCT01436162|79107076|FG002|Randomized Phase|Adverse Event|6|||
44256569|NCT01436162|79107074|FG000|Randomized Phase|Protocol Violation|4|||
44256570|NCT01436162|79107075|FG001|Randomized Phase|Protocol Violation|4|||
44256571|NCT01436162|79107076|FG002|Randomized Phase|Protocol Violation|2|||
44256572|NCT01436162|79107074|FG000|Randomized Phase|Withdrawal by Subject|16|||
44256573|NCT01436162|79107075|FG001|Randomized Phase|Withdrawal by Subject|9|||
44256574|NCT01436162|79107076|FG002|Randomized Phase|Withdrawal by Subject|8|||
44256575|NCT01436162|79107074|FG000|Randomized Phase|Lost to Follow-up|17|||
44298076|NCT04518410|79294142|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
44298077|NCT04518410|79294118|FG000|Overall Study|Dual Enrolled Subject|0|||
44298078|NCT04518410|79294119|FG001|Overall Study|Dual Enrolled Subject|0|||
44298079|NCT04518410|79294120|FG002|Overall Study|Dual Enrolled Subject|0|||
44298080|NCT04518410|79294121|FG003|Overall Study|Dual Enrolled Subject|0|||
44298081|NCT04518410|79294122|FG004|Overall Study|Dual Enrolled Subject|0|||
44298082|NCT04518410|79294123|FG005|Overall Study|Dual Enrolled Subject|0|||
44298083|NCT04518410|79294124|FG006|Overall Study|Dual Enrolled Subject|0|||
44298084|NCT04518410|79294125|FG007|Overall Study|Dual Enrolled Subject|0|||
44298085|NCT04518410|79294126|FG008|Overall Study|Dual Enrolled Subject|0|||
44298086|NCT04518410|79294127|FG009|Overall Study|Dual Enrolled Subject|0|||
44298087|NCT04518410|79294128|FG010|Overall Study|Dual Enrolled Subject|0|||
44298088|NCT04518410|79294129|FG011|Overall Study|Dual Enrolled Subject|0|||
44298089|NCT04518410|79294130|FG012|Overall Study|Dual Enrolled Subject|0|||
44298090|NCT04518410|79294131|FG013|Overall Study|Dual Enrolled Subject|0|||
44298091|NCT04518410|79294132|FG014|Overall Study|Dual Enrolled Subject|0|||
44298092|NCT04518410|79294133|FG015|Overall Study|Dual Enrolled Subject|0|||
44298093|NCT04518410|79294134|FG016|Overall Study|Dual Enrolled Subject|0|||
44298094|NCT04518410|79294135|FG017|Overall Study|Dual Enrolled Subject|1|||
44298095|NCT04518410|79294136|FG018|Overall Study|Dual Enrolled Subject|0|||
44298096|NCT04518410|79294137|FG019|Overall Study|Dual Enrolled Subject|0|||
44298097|NCT04518410|79294138|FG020|Overall Study|Dual Enrolled Subject|0|||
44298098|NCT04518410|79294139|FG021|Overall Study|Dual Enrolled Subject|0|||
44298099|NCT04518410|79294140|FG022|Overall Study|Dual Enrolled Subject|0|||
44298100|NCT04518410|79294141|FG023|Overall Study|Dual Enrolled Subject|0|||
44298101|NCT04518410|79294142|FG024|Overall Study|Dual Enrolled Subject|0|||
44298102|NCT04517864|79294202|FG000|Placebo-Controlled Phase|Adverse Event|1|||
44298103|NCT04517864|79294203|FG001|Placebo-Controlled Phase|Adverse Event|0|||
44298104|NCT04517864|79294202|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
44298105|NCT04517864|79294203|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
44298106|NCT04517864|79294202|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
44298107|NCT04517864|79294203|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
44298108|NCT04517864|79294202|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
44298109|NCT04517864|79294203|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
44298110|NCT04517864|79294202|FG000|Active Therapy Extension Phase|Adverse Event|1|||
44298111|NCT04517864|79294203|FG001|Active Therapy Extension Phase|Adverse Event|0|||
44298112|NCT04507204|79294224|FG000|Overall Study|Adverse Event|8|||
44298113|NCT04507204|79294225|FG001|Overall Study|Adverse Event|13|||
44298114|NCT04507204|79294224|FG000|Overall Study|Death|0|||
44298115|NCT04507204|79294225|FG001|Overall Study|Death|1|||
44298116|NCT04507204|79294224|FG000|Overall Study|Lost to Follow-up|15|||
44298117|NCT04507204|79294225|FG001|Overall Study|Lost to Follow-up|14|||
44298118|NCT04507204|79294224|FG000|Overall Study|Poor Compliance with Protocol|2|||
44534108|NCT02101853|79544764|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44534109|NCT02101853|79544765|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
44298119|NCT04507204|79294225|FG001|Overall Study|Poor Compliance with Protocol|4|||
44298120|NCT04507204|79294224|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
44298121|NCT04507204|79294225|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
44298122|NCT04507204|79294224|FG000|Overall Study|Withdrawal of Patient Consent|21|||
44298123|NCT04507204|79294225|FG001|Overall Study|Withdrawal of Patient Consent|13|||
44298124|NCT04135937|79294249|FG000|Overall Study|Lost to Follow-up|2|||
44298125|NCT04135937|79294249|FG000|Overall Study|Withdrawal by Subject|1|||
44534110|NCT02101853|79544760|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
44534111|NCT02101853|79544761|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
44534112|NCT02101853|79544762|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
44298126|NCT04060147|79294253|FG000|Overall Study|Withdrew consent|1|||
44298127|NCT04019041|79294287|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
44298128|NCT04019041|79294288|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
44298129|NCT04019041|79294289|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
44298130|NCT04019041|79294290|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
44298131|NCT04019041|79294291|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
44298132|NCT04019041|79294292|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
44298133|NCT04019041|79294287|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
44298134|NCT04019041|79294288|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
44298135|NCT04019041|79294289|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
44298136|NCT04019041|79294290|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
44298137|NCT04019041|79294291|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
44298138|NCT04019041|79294292|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
44298139|NCT04019041|79294287|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
44298140|NCT04019041|79294288|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
44298141|NCT04019041|79294289|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
44298142|NCT04019041|79294290|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
44298143|NCT04019041|79294291|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
44298144|NCT04019041|79294292|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
44298145|NCT04019041|79294287|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
44298146|NCT04019041|79294288|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
44298147|NCT04019041|79294289|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
44298148|NCT04019041|79294290|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
44298149|NCT04019041|79294291|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
44298150|NCT04019041|79294292|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
44298151|NCT04019041|79294287|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
44298152|NCT04019041|79294288|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
44298153|NCT04019041|79294289|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
44298154|NCT04019041|79294290|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
44298155|NCT04019041|79294291|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
44298156|NCT04019041|79294292|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
44298157|NCT04019041|79294287|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
44298158|NCT04019041|79294288|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
44298159|NCT04019041|79294289|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
44298160|NCT04019041|79294290|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
44298161|NCT04019041|79294291|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
44298162|NCT04019041|79294292|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
44298163|NCT04019041|79294287|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
44298164|NCT04019041|79294288|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
44298165|NCT04019041|79294289|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
44298166|NCT04019041|79294290|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
44298167|NCT04019041|79294291|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
44298168|NCT04019041|79294292|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
44298169|NCT04019041|79294287|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
44298170|NCT04019041|79294288|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
44298171|NCT04019041|79294289|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
44298172|NCT04019041|79294290|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
44298173|NCT04019041|79294291|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
44298174|NCT04019041|79294292|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
44298175|NCT04019041|79294287|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44298176|NCT04019041|79294288|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44298177|NCT04019041|79294289|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44298178|NCT04019041|79294290|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
44298179|NCT04019041|79294291|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
44298180|NCT04019041|79294292|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
44298181|NCT03919448|79294321|FG000|Overall Study|Withdrawal by Subject|1|||
44298182|NCT03919448|79294322|FG001|Overall Study|Withdrawal by Subject|0|||
44298183|NCT03919448|79294323|FG002|Overall Study|Withdrawal by Subject|0|||
44298184|NCT03795922|79294350|FG000|Overall Study|Adverse Event|2|||
44298185|NCT03795922|79294351|FG001|Overall Study|Adverse Event|1|||
44298186|NCT03795922|79294350|FG000|Overall Study|Withdrawal by Subject|5|||
44298187|NCT03795922|79294351|FG001|Overall Study|Withdrawal by Subject|13|||
44298188|NCT03795922|79294350|FG000|Overall Study|Lost to Follow-up|2|||
44298189|NCT03795922|79294351|FG001|Overall Study|Lost to Follow-up|3|||
44298190|NCT03795922|79294350|FG000|Overall Study|Pregnancy|0|||
44298191|NCT03795922|79294351|FG001|Overall Study|Pregnancy|1|||
44298192|NCT03795922|79294350|FG000|Overall Study|Physician Decision|1|||
44534113|NCT02101853|79544763|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
44534114|NCT02101853|79544764|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
44534115|NCT02101853|79544765|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
44256576|NCT01436162|79107075|FG001|Randomized Phase|Lost to Follow-up|5|||
44256577|NCT01436162|79107076|FG002|Randomized Phase|Lost to Follow-up|4|||
44256578|NCT01436162|79107074|FG000|Randomized Phase|Lack of Efficacy|0|||
44256579|NCT01436162|79107075|FG001|Randomized Phase|Lack of Efficacy|1|||
44256580|NCT01436162|79107076|FG002|Randomized Phase|Lack of Efficacy|1|||
44256581|NCT01436162|79107074|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
44256582|NCT01436162|79107075|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
44256583|NCT01436162|79107076|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
44298193|NCT03795922|79294351|FG001|Overall Study|Physician Decision|2|||
44298194|NCT03795922|79294350|FG000|Overall Study|Protocol Violation|0|||
44298195|NCT03795922|79294351|FG001|Overall Study|Protocol Violation|1|||
44298196|NCT03795922|79294350|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
44154716|NCT01999894|78945961|FG000|Overall Study|Protocol Violation|1|||
44154717|NCT01999894|78945961|FG000|Overall Study|Withdrawal by Subject|7|||
44154718|NCT01999894|78945961|FG000|Overall Study|Lost to Follow-up|10|||
44154719|NCT01999894|78945961|FG000|Overall Study|Other Reason|3|||
44154720|NCT01999894|78945961|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
44154721|NCT02679235|78945966|FG000|Overall Study|Withdrawal by Subject|3|||
44154722|NCT02679235|78945966|FG000|Overall Study|Adverse Event|1|||
44154723|NCT01976806|78945972|FG000|Overall Study|Lost to Follow-up|1|||
44298197|NCT03795922|79294351|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
44298198|NCT03794089|79294361|FG000|Overall Study|Lost to Follow-up|4|||
44298199|NCT03794089|79294362|FG001|Overall Study|Lost to Follow-up|1|||
44298200|NCT03794089|79294361|FG000|Overall Study|Withdrawal by Subject|2|||
44298201|NCT03794089|79294362|FG001|Overall Study|Withdrawal by Subject|0|||
44298202|NCT03769025|79294370|FG000|Overall Study|Withdrawal by Subject|1|||
44298203|NCT03769025|79294371|FG001|Overall Study|Withdrawal by Subject|1|||
44298204|NCT03769025|79294370|FG000|Overall Study|Lost to Follow-up|4|||
44298205|NCT03769025|79294371|FG001|Overall Study|Lost to Follow-up|3|||
44298206|NCT03762473|79294379|FG000|Overall Study|Death|1|||
44298207|NCT03762473|79294380|FG001|Overall Study|Death|0|||
44298208|NCT03745989|79294389|FG000|Overall Study|Death|3|||
44298209|NCT03745989|79294390|FG001|Overall Study|Death|7|||
44298210|NCT03745989|79294391|FG002|Overall Study|Death|4|||
44298211|NCT03745989|79294389|FG000|Overall Study|Lost to Follow-up|0|||
44298212|NCT03745989|79294390|FG001|Overall Study|Lost to Follow-up|2|||
44298213|NCT03745989|79294391|FG002|Overall Study|Lost to Follow-up|0|||
44298214|NCT03745989|79294389|FG000|Overall Study|Sponsor Decision|0|||
44298215|NCT03745989|79294390|FG001|Overall Study|Sponsor Decision|2|||
44298216|NCT03745989|79294391|FG002|Overall Study|Sponsor Decision|8|||
44298217|NCT03745989|79294389|FG000|Overall Study|Withdrawal by Subject|0|||
44298218|NCT03745989|79294390|FG001|Overall Study|Withdrawal by Subject|1|||
44298219|NCT03745989|79294391|FG002|Overall Study|Withdrawal by Subject|3|||
44298220|NCT03646656|79294421|FG000|Overall Study|Lost to Follow-up|1|||
44298221|NCT03646656|79294422|FG001|Overall Study|Lost to Follow-up|0|||
44298222|NCT03646656|79294421|FG000|Overall Study|Withdrawal by Subject|2|||
44298223|NCT03646656|79294422|FG001|Overall Study|Withdrawal by Subject|0|||
44298224|NCT03555435|79294435|FG000|Overall Study|Lost to Follow-up|17|||
44298225|NCT03555435|79294436|FG001|Overall Study|Lost to Follow-up|19|||
44298226|NCT03555435|79294437|FG002|Overall Study|Lost to Follow-up|8|||
44298227|NCT03521115|79294447|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
44298228|NCT03521115|79294448|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
44298229|NCT03521115|79294447|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
44298230|NCT03521115|79294448|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
44298231|NCT03520413|79294462|FG000|Overall Study|Lost to Follow-up|1|||
44298232|NCT03520413|79294463|FG001|Overall Study|Lost to Follow-up|1|||
44298233|NCT03520413|79294462|FG000|Overall Study|Withdrawal by Subject|1|||
44298234|NCT03520413|79294463|FG001|Overall Study|Withdrawal by Subject|2|||
44298235|NCT03520413|79294462|FG000|Overall Study|Death|0|||
44298236|NCT03520413|79294463|FG001|Overall Study|Death|1|||
44298237|NCT03520413|79294462|FG000|Overall Study|Physician Decision|3|||
44298238|NCT03520413|79294463|FG001|Overall Study|Physician Decision|3|||
44298239|NCT03520413|79294462|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
44298240|NCT03520413|79294463|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
44298241|NCT03419897|79294470|FG000|Overall Study|Death|180|||
44298242|NCT03419897|79294470|FG000|Overall Study|Lost to Follow-up|1|||
44298243|NCT03419897|79294470|FG000|Overall Study|Withdrawal by Subject|6|||
44417165|NCT00805766|79425042|FG000|Screening Period|Responder|2|||
44534116|NCT02101853|79544760|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
44417166|NCT00805766|79425042|FG000|Increased Dose Period|Adverse Event|4|||
44417167|NCT00805766|79425042|FG000|Increased Dose Period|Lack of Efficacy|7|||
44417168|NCT00805766|79425042|FG000|Increased Dose Period|Pregnancy|1|||
44534117|NCT02101853|79544761|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
44534118|NCT02101853|79544762|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
44534119|NCT02101853|79544763|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
44534120|NCT02101853|79544764|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
44534121|NCT02101853|79544765|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
44534122|NCT02101853|79544760|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
44298244|NCT03419897|79294470|FG000|Overall Study|Sponsor Decision|61|||
44298245|NCT03419897|79294470|FG000|Overall Study|Physician Decision|1|||
44298246|NCT03418129|79294477|FG000|Overall Study|Lost to Follow-up|11|||
44298247|NCT03418129|79294478|FG001|Overall Study|Lost to Follow-up|20|||
44417169|NCT00805766|79425042|FG000|Increased Dose Period|Withdrawal by Subject|1|||
44417170|NCT00805532|79425052|FG000|Overall Study|invalid data|0|||
44298248|NCT03418129|79294479|FG002|Overall Study|Lost to Follow-up|15|||
44298249|NCT03418129|79294477|FG000|Overall Study|Withdrawal by Subject|3|||
44298250|NCT03418129|79294478|FG001|Overall Study|Withdrawal by Subject|6|||
44298251|NCT03418129|79294479|FG002|Overall Study|Withdrawal by Subject|4|||
44298252|NCT03344796|79294497|FG000|Overall Study|Lost to Follow-up|0|||
44298253|NCT03344796|79294498|FG001|Overall Study|Lost to Follow-up|0|||
44298254|NCT03344796|79294499|FG002|Overall Study|Lost to Follow-up|0|||
44298255|NCT03344796|79294500|FG003|Overall Study|Lost to Follow-up|0|||
44298256|NCT03344796|79294501|FG004|Overall Study|Lost to Follow-up|0|||
44298257|NCT03344796|79294502|FG005|Overall Study|Lost to Follow-up|2|||
44298258|NCT03335488|79294525|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
44298259|NCT03335488|79294526|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
44298260|NCT03335488|79294525|FG000|Safety Extension Period|Adverse Event|1|||
44298261|NCT03335488|79294526|FG001|Safety Extension Period|Adverse Event|0|||
44298262|NCT03335488|79294525|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
44298263|NCT03335488|79294526|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
44298264|NCT03261700|79294545|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
44298265|NCT03261700|79294546|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
44298266|NCT03238417|79294557|FG000|Overall|non-response|955|||
44298267|NCT03238417|79294558|FG001|Overall|non-response|1920|||
44298268|NCT03238417|79294557|FG000|Overall|partial completion|48|||
44298269|NCT03238417|79294558|FG001|Overall|partial completion|68|||
44298270|NCT03238417|79294557|FG000|Baseline|Partial completion|17|||
44298271|NCT03238417|79294558|FG001|Baseline|Partial completion|48|||
44298272|NCT03238417|79294557|FG000|Baseline|non-response|372|||
44298273|NCT03238417|79294558|FG001|Baseline|non-response|669|||
44298274|NCT03238417|79294557|FG000|12-month|non-response|296|||
44298275|NCT03238417|79294558|FG001|12-month|non-response|669|||
44298276|NCT03238417|79294557|FG000|12-month|partial completion|23|||
44298277|NCT03238417|79294558|FG001|12-month|partial completion|37|||
44298278|NCT03238417|79294557|FG000|24-month|non-response|287|||
44298279|NCT03238417|79294558|FG001|24-month|non-response|594|||
44298280|NCT03238417|79294557|FG000|24-month|partial completion|8|||
44298281|NCT03238417|79294558|FG001|24-month|partial completion|31|||
44298282|NCT03215277|79294566|FG000|Overall Study|Adverse Event|2|||
44298283|NCT03215277|79294567|FG001|Overall Study|Adverse Event|3|||
44298284|NCT03215277|79294566|FG000|Overall Study|Death|1|||
44298285|NCT03215277|79294567|FG001|Overall Study|Death|0|||
44298286|NCT03215277|79294566|FG000|Overall Study|Lost to Follow-up|0|||
44298287|NCT03215277|79294567|FG001|Overall Study|Lost to Follow-up|1|||
44298288|NCT03215277|79294566|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
44298289|NCT03215277|79294567|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
44298290|NCT03185013|79294577|FG000|Overall Study|Withdrawal by Subject|5|||
44298291|NCT03185013|79294578|FG001|Overall Study|Withdrawal by Subject|3|||
44298292|NCT03185013|79294577|FG000|Overall Study|Adverse Event|1|||
44154724|NCT01976806|78945973|FG001|Overall Study|Lost to Follow-up|4|||
44256584|NCT01436162|79107074|FG000|Randomized Phase|Other|2|||
44256585|NCT01436162|79107075|FG001|Randomized Phase|Other|5|||
44256586|NCT01436162|79107076|FG002|Randomized Phase|Other|4|||
44256587|NCT02579382|79107088|FG000|Main Study Phase|Lost to Follow-up|0|||
44256588|NCT02579382|79107089|FG001|Main Study Phase|Lost to Follow-up|0|||
44256589|NCT02579382|79107090|FG002|Main Study Phase|Lost to Follow-up|2|||
44256590|NCT02579382|79107091|FG003|Main Study Phase|Lost to Follow-up|0|||
44256591|NCT02579382|79107088|FG000|Main Study Phase|Withdrew Consent|0|||
44256592|NCT02579382|79107089|FG001|Main Study Phase|Withdrew Consent|0|||
44256593|NCT02579382|79107090|FG002|Main Study Phase|Withdrew Consent|0|||
44256594|NCT02579382|79107091|FG003|Main Study Phase|Withdrew Consent|2|||
44256595|NCT02579382|79107088|FG000|Main Study Phase|Lack of Efficacy|0|||
44256596|NCT02579382|79107089|FG001|Main Study Phase|Lack of Efficacy|0|||
44256597|NCT02579382|79107090|FG002|Main Study Phase|Lack of Efficacy|0|||
44256598|NCT02579382|79107091|FG003|Main Study Phase|Lack of Efficacy|1|||
44256599|NCT02579382|79107088|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
44256600|NCT02579382|79107089|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
44256601|NCT02579382|79107090|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
44256602|NCT02579382|79107091|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
44256603|NCT02579382|79107088|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
44256604|NCT02579382|79107089|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
44256605|NCT02579382|79107090|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
44256606|NCT02579382|79107091|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
44256607|NCT02579382|79107088|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
44256608|NCT02579382|79107089|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
44256609|NCT02579382|79107090|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
44256610|NCT02579382|79107091|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
44256611|NCT02579382|79107088|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
44298293|NCT03185013|79294578|FG001|Overall Study|Adverse Event|0|||
44298294|NCT03185013|79294577|FG000|Overall Study|Progressive Disease|1|||
44298295|NCT03185013|79294578|FG001|Overall Study|Progressive Disease|0|||
44298296|NCT03185013|79294577|FG000|Overall Study|Lost to Follow-up|8|||
44298297|NCT03185013|79294578|FG001|Overall Study|Lost to Follow-up|2|||
44298298|NCT03185013|79294577|FG000|Overall Study|Physician Decision|1|||
44298299|NCT03185013|79294578|FG001|Overall Study|Physician Decision|0|||
44298300|NCT03185013|79294577|FG000|Overall Study|Protocol Deviation|2|||
44298301|NCT03185013|79294578|FG001|Overall Study|Protocol Deviation|0|||
44298302|NCT03185013|79294577|FG000|Overall Study|Reason not Specified|3|||
44298303|NCT03185013|79294578|FG001|Overall Study|Reason not Specified|2|||
44298304|NCT03185013|79294577|FG000|Overall Study|Death|1|||
44298305|NCT03185013|79294578|FG001|Overall Study|Death|0|||
44298306|NCT03182907|79294586|FG000|Overall Study|Death|3|||
44298307|NCT03182907|79294587|FG001|Overall Study|Death|0|||
44298308|NCT03182907|79294586|FG000|Overall Study|Protocol Violation|4|||
44534123|NCT02101853|79544761|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
44534124|NCT02101853|79544762|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
44534125|NCT02101853|79544763|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
44534126|NCT02101853|79544764|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
44534127|NCT02101853|79544765|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
44534128|NCT02101853|79544760|FG000|Blinatumomab Salvage Therapy|Death|0|||
44298309|NCT03182907|79294587|FG001|Overall Study|Protocol Violation|0|||
44298310|NCT03182907|79294586|FG000|Overall Study|Lost to Follow-up|1|||
44298311|NCT03182907|79294587|FG001|Overall Study|Lost to Follow-up|0|||
44298312|NCT03182907|79294586|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44298313|NCT03182907|79294587|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
44298314|NCT03036813|79294599|FG000|Overall Study|Adverse Event|6|||
44298315|NCT03036813|79294600|FG001|Overall Study|Adverse Event|11|||
44298316|NCT03036813|79294601|FG002|Overall Study|Adverse Event|6|||
44298317|NCT03036813|79294599|FG000|Overall Study|Withdrawal by Subject|12|||
44298318|NCT03036813|79294600|FG001|Overall Study|Withdrawal by Subject|6|||
44298319|NCT03036813|79294601|FG002|Overall Study|Withdrawal by Subject|10|||
44298320|NCT03036813|79294599|FG000|Overall Study|Lost to Follow-up|1|||
44298321|NCT03036813|79294600|FG001|Overall Study|Lost to Follow-up|1|||
44298322|NCT03036813|79294601|FG002|Overall Study|Lost to Follow-up|0|||
44298323|NCT03036813|79294599|FG000|Overall Study|Physician Decision|2|||
44298324|NCT03036813|79294600|FG001|Overall Study|Physician Decision|1|||
44298325|NCT03036813|79294601|FG002|Overall Study|Physician Decision|1|||
44298326|NCT03036813|79294599|FG000|Overall Study|Non-Compliance|1|||
44298327|NCT03036813|79294600|FG001|Overall Study|Non-Compliance|5|||
44298328|NCT03036813|79294601|FG002|Overall Study|Non-Compliance|3|||
44298329|NCT03036813|79294599|FG000|Overall Study|Pregnancy|0|||
44298330|NCT03036813|79294600|FG001|Overall Study|Pregnancy|0|||
44298331|NCT03036813|79294601|FG002|Overall Study|Pregnancy|1|||
44298332|NCT03036813|79294599|FG000|Overall Study|Other|0|||
44298333|NCT03036813|79294600|FG001|Overall Study|Other|3|||
44298334|NCT03036813|79294601|FG002|Overall Study|Other|5|||
44298335|NCT03007953|79294614|FG000|Overall Study|Withdrawal by Subject|5|||
44298336|NCT03007953|79294615|FG001|Overall Study|Withdrawal by Subject|2|||
44298337|NCT03007953|79294614|FG000|Overall Study|Death|5|||
44298338|NCT03007953|79294615|FG001|Overall Study|Death|7|||
44298339|NCT03007953|79294614|FG000|Overall Study|Lost to Follow-up|3|||
44298340|NCT03007953|79294615|FG001|Overall Study|Lost to Follow-up|2|||
44298341|NCT03007953|79294614|FG000|Overall Study|Enrolled in Hospice|3|||
44298342|NCT03007953|79294615|FG001|Overall Study|Enrolled in Hospice|2|||
44298343|NCT02919618|79294630|FG000|Overall Study|Death|1|||
44298344|NCT02911701|79294647|FG000|Overall Study|Withdrawal by Subject|2|||
44298345|NCT02911701|79294648|FG001|Overall Study|Withdrawal by Subject|4|||
44298346|NCT02911701|79294647|FG000|Overall Study|Adverse Event|1|||
44298347|NCT02911701|79294648|FG001|Overall Study|Adverse Event|0|||
44534129|NCT02101853|79544761|FG001|Blinatumomab Salvage Therapy|Death|0|||
44534130|NCT02101853|79544762|FG002|Blinatumomab Salvage Therapy|Death|0|||
44298348|NCT02896257|79294658|FG000|Providers|Without eligible patients|21|||
44298349|NCT02896257|79294659|FG001|Providers|Without eligible patients|28|||
44298350|NCT02896257|79294658|FG000|Patients|PFT entry criteria not met|43|||
44298351|NCT02896257|79294659|FG001|Patients|PFT entry criteria not met|50|||
44534131|NCT02101853|79544763|FG003|Blinatumomab Salvage Therapy|Death|0|||
44534132|NCT02101853|79544764|FG004|Blinatumomab Salvage Therapy|Death|0|||
44298352|NCT02896257|79294658|FG000|Patients|No capacity to review|8|||
44298353|NCT02896257|79294659|FG001|Patients|No capacity to review|11|||
44298354|NCT02896257|79294658|FG000|Patients|Appointment rescheduled/cancelled|5|||
44298355|NCT02896257|79294659|FG001|Patients|Appointment rescheduled/cancelled|7|||
44298356|NCT02896257|79294658|FG000|Patients|PCP not assigned a clinic|4|||
44298357|NCT02896257|79294659|FG001|Patients|PCP not assigned a clinic|0|||
44298358|NCT02896257|79294658|FG000|Patients|No history of COPD|0|||
44298359|NCT02896257|79294659|FG001|Patients|No history of COPD|1|||
44298360|NCT02896257|79294658|FG000|Patients|Deceased between review and index date|0|||
44298361|NCT02896257|79294659|FG001|Patients|Deceased between review and index date|1|||
44298362|NCT02896257|79294658|FG000|Patients|No ICS Rx upon review|1|||
44298363|NCT02896257|79294659|FG001|Patients|No ICS Rx upon review|1|||
44298364|NCT02896257|79294658|FG000|Patients|Protocol Violation|2|||
44298365|NCT02896257|79294659|FG001|Patients|Protocol Violation|1|||
44298366|NCT02896257|79294658|FG000|Patients|Hospice care|0|||
44298367|NCT02896257|79294659|FG001|Patients|Hospice care|1|||
44298368|NCT02874742|79294669|FG000|Overall Study|Death|0|||
44298369|NCT02874742|79294670|FG001|Overall Study|Death|1|||
44298370|NCT02874742|79294671|FG002|Overall Study|Death|0|||
44298371|NCT02874742|79294669|FG000|Overall Study|Lost to Follow-up|5|||
44298372|NCT02874742|79294670|FG001|Overall Study|Lost to Follow-up|4|||
44298373|NCT02874742|79294671|FG002|Overall Study|Lost to Follow-up|1|||
44298374|NCT02874742|79294669|FG000|Overall Study|Withdrawal by Subject|17|||
44298375|NCT02874742|79294670|FG001|Overall Study|Withdrawal by Subject|8|||
44298376|NCT02874742|79294671|FG002|Overall Study|Withdrawal by Subject|0|||
44298377|NCT02874742|79294669|FG000|Overall Study|Other|4|||
44298378|NCT02874742|79294670|FG001|Overall Study|Other|1|||
44298379|NCT02874742|79294671|FG002|Overall Study|Other|0|||
44298380|NCT02874742|79294669|FG000|Overall Study|Progressive Disease|1|||
44298381|NCT02874742|79294670|FG001|Overall Study|Progressive Disease|0|||
44298382|NCT02874742|79294671|FG002|Overall Study|Progressive Disease|0|||
44298383|NCT02874742|79294669|FG000|Overall Study|Screen Failure|0|||
44298384|NCT02874742|79294670|FG001|Overall Study|Screen Failure|2|||
44298385|NCT02874742|79294671|FG002|Overall Study|Screen Failure|0|||
44298386|NCT02749292|79294681|FG000|Overall Study|Physician Decision|1|||
44298387|NCT02749292|79294682|FG001|Overall Study|Physician Decision|0|||
44298388|NCT02749292|79294681|FG000|Overall Study|Withdrawal by Subject|5|||
44298389|NCT02749292|79294682|FG001|Overall Study|Withdrawal by Subject|7|||
44298390|NCT02749292|79294681|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
44298391|NCT02749292|79294682|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
44298392|NCT02749292|79294681|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
44298393|NCT02749292|79294682|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
44298394|NCT02749292|79294681|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
44298395|NCT02749292|79294682|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
44298396|NCT02749292|79294681|FG000|Overall Study|Adverse Event|4|||
44298397|NCT02749292|79294682|FG001|Overall Study|Adverse Event|1|||
44298398|NCT02749292|79294681|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
44298399|NCT02749292|79294682|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
44298400|NCT02749292|79294681|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
44298401|NCT02749292|79294682|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
44298402|NCT02749292|79294681|FG000|Overall Study|Requiring glucocorticoids|0|||
44298403|NCT02749292|79294682|FG001|Overall Study|Requiring glucocorticoids|3|||
44298404|NCT02749292|79294681|FG000|Overall Study|Cancer|1|||
44298405|NCT02749292|79294682|FG001|Overall Study|Cancer|0|||
44298406|NCT02689076|79294701|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
44298407|NCT02689076|79294702|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
44256612|NCT02579382|79107089|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
44256613|NCT02579382|79107090|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
44256614|NCT02579382|79107091|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
44256615|NCT02579382|79107088|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
44256616|NCT02579382|79107089|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
44256617|NCT02579382|79107090|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
44256618|NCT02579382|79107091|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
44256619|NCT02579382|79107088|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
44256620|NCT02579382|79107089|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
44256621|NCT02579382|79107090|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
44256622|NCT02579382|79107091|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
44256623|NCT01436084|79107118|FG000|Overall Study|Disease Progression|2|||
44256624|NCT01436084|79107118|FG000|Overall Study|Withdrawal by Subject|1|||
44256625|NCT01436084|79107118|FG000|Overall Study|Early Closure of Study|1|||
44256626|NCT01419314|79107133|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
44256627|NCT01419314|79107134|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
44256628|NCT01419314|79107133|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
44256629|NCT01419314|79107134|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
44256630|NCT01419314|79107133|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
44256631|NCT01419314|79107134|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
44298408|NCT02689076|79294703|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
44417171|NCT00805532|79425053|FG001|Overall Study|invalid data|1|||
44298409|NCT02689076|79294701|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
44298410|NCT02689076|79294702|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
44298411|NCT02689076|79294703|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
44298412|NCT02689076|79294701|FG000|Overall Study|Did not have an HIE match|2|||
44298413|NCT02689076|79294702|FG001|Overall Study|Did not have an HIE match|0|||
44298414|NCT02689076|79294703|FG002|Overall Study|Did not have an HIE match|0|||
44298415|NCT02689076|79294701|FG000|Overall Study|Death during non-VA encounter|2|||
44298416|NCT02689076|79294702|FG001|Overall Study|Death during non-VA encounter|5|||
44298417|NCT02689076|79294703|FG002|Overall Study|Death during non-VA encounter|0|||
44298418|NCT02689076|79294701|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
44298419|NCT02689076|79294702|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
44298420|NCT02689076|79294703|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
44298421|NCT02689076|79294701|FG000|Overall Study|Participant no longer active in VA system|1|||
44298422|NCT02689076|79294702|FG001|Overall Study|Participant no longer active in VA system|0|||
44298423|NCT02689076|79294703|FG002|Overall Study|Participant no longer active in VA system|0|||
44298424|NCT02689076|79294701|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
44298425|NCT02689076|79294702|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
44298426|NCT02689076|79294703|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
44298427|NCT02576990|79294713|FG000|Overall Study|Death|29|||
44298428|NCT02576990|79294714|FG001|Overall Study|Death|18|||
44298429|NCT02576990|79294713|FG000|Overall Study|Physician Decision|1|||
44298430|NCT02576990|79294714|FG001|Overall Study|Physician Decision|0|||
44298431|NCT02576990|79294713|FG000|Overall Study|Screen failure|2|||
44298432|NCT02576990|79294714|FG001|Overall Study|Screen failure|0|||
44298433|NCT02576990|79294713|FG000|Overall Study|Sponsor's decision|24|||
44298434|NCT02576990|79294714|FG001|Overall Study|Sponsor's decision|4|||
44298435|NCT02576990|79294713|FG000|Overall Study|Withdrawal by Subject|0|||
44298436|NCT02576990|79294714|FG001|Overall Study|Withdrawal by Subject|2|||
44298437|NCT02550561|79294720|FG000|Overall Study|Lost to Follow-up|5|||
44298438|NCT02550561|79294720|FG000|Overall Study|Withdrawal by Subject|1|||
44298439|NCT02524171|79294730|FG000|6-month Follow-up|Lost to Follow-up|53|||
44298440|NCT02524171|79294731|FG001|6-month Follow-up|Lost to Follow-up|45|||
44298441|NCT02524171|79294730|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
44298442|NCT02524171|79294731|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
44298443|NCT02511106|79294739|FG000|Overall Study|Lost to Follow-up|1|||
44298444|NCT02511106|79294740|FG001|Overall Study|Lost to Follow-up|2|||
44298445|NCT02511106|79294739|FG000|Overall Study|Withdrawal by Subject|19|||
44298446|NCT02511106|79294740|FG001|Overall Study|Withdrawal by Subject|14|||
44298447|NCT02511106|79294739|FG000|Overall Study|Ongoing study at data cut-off|309|||
44298448|NCT02511106|79294740|FG001|Overall Study|Ongoing study at data cut-off|307|||
44298449|NCT02511106|79294739|FG000|Overall Study|Without specified reason|1|||
44298450|NCT02511106|79294740|FG001|Overall Study|Without specified reason|0|||
44298451|NCT02511106|79294739|FG000|Overall Study|Missing|1|||
44298452|NCT02511106|79294740|FG001|Overall Study|Missing|0|||
44298453|NCT02500589|79294750|FG000|Overall Study|Withdrawal by Subject|11|||
44298454|NCT02500589|79294751|FG001|Overall Study|Withdrawal by Subject|14|||
44298455|NCT02500589|79294750|FG000|Overall Study|Lost to Follow-up|10|||
44298456|NCT02500589|79294751|FG001|Overall Study|Lost to Follow-up|12|||
44298457|NCT02500589|79294750|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
44298458|NCT02500589|79294751|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
44298459|NCT02500589|79294750|FG000|Overall Study|Death|7|||
44298460|NCT02500589|79294751|FG001|Overall Study|Death|5|||
44298461|NCT02481830|79294763|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
44298462|NCT02481830|79294764|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
44298463|NCT02481830|79294763|FG000|Pre-treatment|Withdrawal by Subject|0|||
44298464|NCT02481830|79294764|FG001|Pre-treatment|Withdrawal by Subject|10|||
44298465|NCT02481830|79294763|FG000|Pre-treatment|Disease Progression|1|||
44298466|NCT02481830|79294764|FG001|Pre-treatment|Disease Progression|1|||
44298467|NCT02481830|79294763|FG000|Pre-treatment|Other reasons|0|||
44298468|NCT02481830|79294764|FG001|Pre-treatment|Other reasons|1|||
44298469|NCT02481830|79294763|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
44298470|NCT02481830|79294764|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
44298471|NCT02481830|79294763|FG000|Treatment|Disease Progression|233|||
44298472|NCT02481830|79294764|FG001|Treatment|Disease Progression|171|||
44298473|NCT02481830|79294763|FG000|Treatment|Study drug toxicity|18|||
44298474|NCT02481830|79294764|FG001|Treatment|Study drug toxicity|38|||
44298475|NCT02481830|79294763|FG000|Treatment|Death|1|||
44298476|NCT02481830|79294764|FG001|Treatment|Death|1|||
44298477|NCT02481830|79294763|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
44298478|NCT02481830|79294764|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
44298479|NCT02481830|79294763|FG000|Treatment|Participants request to discontinue Study treatment|6|||
44298480|NCT02481830|79294764|FG001|Treatment|Participants request to discontinue Study treatment|34|||
44298481|NCT02481830|79294763|FG000|Treatment|Withdrawal by Subject|2|||
44298482|NCT02481830|79294764|FG001|Treatment|Withdrawal by Subject|3|||
44298483|NCT02481830|79294763|FG000|Treatment|Lost to Follow-up|1|||
44298484|NCT02481830|79294764|FG001|Treatment|Lost to Follow-up|0|||
44298485|NCT02481830|79294763|FG000|Treatment|Maximum Clinical Benefit|0|||
44298486|NCT02481830|79294764|FG001|Treatment|Maximum Clinical Benefit|5|||
44298487|NCT02481830|79294763|FG000|Treatment|Administrative reason by sponsor|1|||
44298488|NCT02481830|79294764|FG001|Treatment|Administrative reason by sponsor|1|||
44298489|NCT02481830|79294763|FG000|Treatment|Other reasons|6|||
44417172|NCT00764322|79425063|FG000|Overall Study|Withdrawal by Subject|11|||
44417173|NCT00764322|79425063|FG000|Overall Study|No CYP2D6 genotyping|9|||
44417174|NCT00752856|79425082|FG000|Overall Study|randomized but did not do viral kinetics|0|||
44417175|NCT00752856|79425083|FG001|Overall Study|randomized but did not do viral kinetics|1|||
44417176|NCT00755196|79425089|FG000|Overall Study|Lost to Follow-up|1|||
44417177|NCT00755196|79425089|FG000|Overall Study|Lack of Efficiency|1|||
44417178|NCT00805142|79425096|FG000|Titration Period|Adverse Event|3|||
44417179|NCT00805142|79425097|FG001|Titration Period|Adverse Event|3|||
44417180|NCT00805142|79425096|FG000|Titration Period|Lack of Efficacy|1|||
44417181|NCT00805142|79425097|FG001|Titration Period|Lack of Efficacy|1|||
44417182|NCT00805142|79425096|FG000|Titration Period|Lost to Follow-up|0|||
44417183|NCT00805142|79425097|FG001|Titration Period|Lost to Follow-up|1|||
44417184|NCT00805142|79425096|FG000|Titration Period|Disease Progression|2|||
44417185|NCT00805142|79425097|FG001|Titration Period|Disease Progression|1|||
44417186|NCT00805142|79425096|FG000|Titration Period|Withdrawal of consent|0|||
44417187|NCT00805142|79425097|FG001|Titration Period|Withdrawal of consent|1|||
44417188|NCT00805142|79425096|FG000|Titration Period|Other|0|||
44417189|NCT00805142|79425097|FG001|Titration Period|Other|3|||
44417190|NCT00805142|79425096|FG000|Maintenance Period|Adverse Event|0|||
44417191|NCT00805142|79425097|FG001|Maintenance Period|Adverse Event|1|||
44417192|NCT00805142|79425096|FG000|Maintenance Period|Other|0|||
44417193|NCT00805142|79425097|FG001|Maintenance Period|Other|1|||
44417194|NCT00761631|79425114|FG000|Overall Study|Parent/legal guardian request|8|||
44417195|NCT00761631|79425115|FG001|Overall Study|Parent/legal guardian request|3|||
44417196|NCT00761631|79425116|FG002|Overall Study|Parent/legal guardian request|8|||
44417197|NCT00761631|79425117|FG003|Overall Study|Parent/legal guardian request|0|||
44417198|NCT00761631|79425118|FG004|Overall Study|Parent/legal guardian request|5|||
44417199|NCT00761631|79425119|FG005|Overall Study|Parent/legal guardian request|0|||
44417200|NCT00761631|79425114|FG000|Overall Study|Lost to Follow-up|2|||
44417201|NCT00761631|79425115|FG001|Overall Study|Lost to Follow-up|4|||
44417202|NCT00761631|79425116|FG002|Overall Study|Lost to Follow-up|7|||
44417203|NCT00761631|79425117|FG003|Overall Study|Lost to Follow-up|1|||
44417204|NCT00761631|79425118|FG004|Overall Study|Lost to Follow-up|6|||
44256632|NCT01419236|79107191|FG000|Overall Study|Adverse Event|1|||
44417205|NCT00761631|79425119|FG005|Overall Study|Lost to Follow-up|1|||
44417206|NCT00761631|79425114|FG000|Overall Study|Protocol Violation|2|||
44417207|NCT00761631|79425115|FG001|Overall Study|Protocol Violation|0|||
44154725|NCT01976806|78945972|FG000|Overall Study|Adverse Event|1|||
44256633|NCT01419236|79107192|FG001|Overall Study|Adverse Event|0|||
44256634|NCT01419236|79107191|FG000|Overall Study|Lack of Efficacy|0|||
44256635|NCT01419236|79107192|FG001|Overall Study|Lack of Efficacy|1|||
44256636|NCT01419236|79107191|FG000|Overall Study|Lost to Follow-up|1|||
44256637|NCT01419236|79107192|FG001|Overall Study|Lost to Follow-up|0|||
44256638|NCT01419236|79107191|FG000|Overall Study|Physician Decision|1|||
44256639|NCT01419236|79107192|FG001|Overall Study|Physician Decision|0|||
44256640|NCT01419236|79107191|FG000|Overall Study|Withdrawal by Subject|1|||
44256641|NCT01419236|79107192|FG001|Overall Study|Withdrawal by Subject|4|||
44256642|NCT01419236|79107191|FG000|Overall Study|Entry Criteria Not Met|1|||
44256643|NCT01419236|79107192|FG001|Overall Study|Entry Criteria Not Met|0|||
44256644|NCT03323658|79107205|FG000|Overall Study|Adverse Event|0|||
44256645|NCT03323658|79107206|FG001|Overall Study|Adverse Event|1|||
44256646|NCT03323658|79107207|FG002|Overall Study|Adverse Event|0|||
44256647|NCT01443026|79107232|FG000|Overall Study|Physician Decision|1|||
44256648|NCT01443026|79107233|FG001|Overall Study|Physician Decision|0|||
44256649|NCT01443026|79107232|FG000|Overall Study|Death|0|||
44256650|NCT01443026|79107233|FG001|Overall Study|Death|1|||
44256651|NCT01443026|79107232|FG000|Overall Study|Withdrawal by Subject|0|||
44256652|NCT01443026|79107233|FG001|Overall Study|Withdrawal by Subject|3|||
44256653|NCT01443026|79107232|FG000|Overall Study|Lost to Follow-up|2|||
44298490|NCT02481830|79294764|FG001|Treatment|Other reasons|1|||
44298491|NCT02477111|79294770|FG000|Overall Study|Death|5|||
44417208|NCT00761631|79425116|FG002|Overall Study|Protocol Violation|0|||
44256654|NCT01443026|79107233|FG001|Overall Study|Lost to Follow-up|1|||
44256655|NCT01442714|79107267|FG000|Overall Study|Death|11|||
44256656|NCT01442714|79107267|FG000|Overall Study|Withdrawal by Subject|1|||
44298492|NCT02477111|79294770|FG000|Overall Study|Withdrawal by Subject|2|||
44417209|NCT00761631|79425117|FG003|Overall Study|Protocol Violation|1|||
44417210|NCT00761631|79425118|FG004|Overall Study|Protocol Violation|5|||
44417211|NCT00761631|79425119|FG005|Overall Study|Protocol Violation|1|||
44417212|NCT00761631|79425114|FG000|Overall Study|Randomized, not treated|1|||
44298493|NCT02477111|79294770|FG000|Overall Study|missed visit|4|||
44298494|NCT02425943|79294778|FG000|Overall Study|Adverse Event|3|||
44298495|NCT02425943|79294779|FG001|Overall Study|Adverse Event|1|||
44298496|NCT02425943|79294778|FG000|Overall Study|Lost to Follow-up|59|||
44298497|NCT02425943|79294779|FG001|Overall Study|Lost to Follow-up|37|||
44298498|NCT02425943|79294778|FG000|Overall Study|Protocol Violation|4|||
44298499|NCT02425943|79294779|FG001|Overall Study|Protocol Violation|1|||
44298500|NCT02425943|79294778|FG000|Overall Study|Withdrawal by Subject|64|||
44298501|NCT02425943|79294779|FG001|Overall Study|Withdrawal by Subject|31|||
44298502|NCT02425943|79294778|FG000|Overall Study|Other|6|||
44298503|NCT02425943|79294779|FG001|Overall Study|Other|0|||
44298504|NCT02383173|79294789|FG000|Overall Study|Palliative Care Team withdrew|0|||
44298505|NCT02383173|79294790|FG001|Overall Study|Palliative Care Team withdrew|2|||
44298506|NCT02380690|79294798|FG000|Overall Study|Lost to Follow-up|14|||
44298507|NCT02380690|79294799|FG001|Overall Study|Lost to Follow-up|4|||
44298508|NCT02380690|79294798|FG000|Overall Study|Withdrawal by Subject|20|||
44298509|NCT02380690|79294799|FG001|Overall Study|Withdrawal by Subject|8|||
44298510|NCT02311673|79294841|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
44298511|NCT02311673|79294842|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
44298512|NCT02311673|79294843|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
44298513|NCT02311673|79294844|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
44298514|NCT02233738|79294878|FG000|Overall Study|Lost to Follow-up|5|||
44298515|NCT02233738|79294879|FG001|Overall Study|Lost to Follow-up|12|||
44298516|NCT02233738|79294878|FG000|Overall Study|Death|0|||
44298517|NCT02233738|79294879|FG001|Overall Study|Death|1|||
44298518|NCT02233738|79294878|FG000|Overall Study|Withdrawal by Subject|0|||
44298519|NCT02233738|79294879|FG001|Overall Study|Withdrawal by Subject|1|||
44298520|NCT02233738|79294878|FG000|Overall Study|Did not return after Baseline|3|||
44298521|NCT02233738|79294879|FG001|Overall Study|Did not return after Baseline|2|||
44298522|NCT01959698|79295067|FG000|Overall Study|Adverse Event|0|||
44298523|NCT01959698|79295068|FG001|Overall Study|Adverse Event|0|||
44298524|NCT01959698|79295069|FG002|Overall Study|Adverse Event|0|||
44298525|NCT01959698|79295070|FG003|Overall Study|Adverse Event|0|||
44298526|NCT01959698|79295071|FG004|Overall Study|Adverse Event|0|||
44298527|NCT01959698|79295072|FG005|Overall Study|Adverse Event|0|||
44298528|NCT01959698|79295073|FG006|Overall Study|Adverse Event|1|||
44298529|NCT01959698|79295067|FG000|Overall Study|Physician Decision|1|||
44298530|NCT01959698|79295068|FG001|Overall Study|Physician Decision|0|||
44298531|NCT01959698|79295069|FG002|Overall Study|Physician Decision|1|||
44298532|NCT01959698|79295070|FG003|Overall Study|Physician Decision|2|||
44298533|NCT01959698|79295071|FG004|Overall Study|Physician Decision|0|||
44298534|NCT01959698|79295072|FG005|Overall Study|Physician Decision|3|||
44298535|NCT01959698|79295073|FG006|Overall Study|Physician Decision|3|||
44298536|NCT01614197|79295108|FG000|Overall Study|Withdrawal by Subject|0|||
44298537|NCT01614197|79295109|FG001|Overall Study|Withdrawal by Subject|1|||
44298538|NCT01614197|79295110|FG002|Overall Study|Withdrawal by Subject|0|||
44298539|NCT01614197|79295111|FG003|Overall Study|Withdrawal by Subject|0|||
44298540|NCT01236521|79295145|FG000|Overall Study|Withdrawal by Subject|12|||
44298541|NCT01236521|79295146|FG001|Overall Study|Withdrawal by Subject|17|||
44298542|NCT01236521|79295145|FG000|Overall Study|Death|2|||
44298543|NCT01236521|79295146|FG001|Overall Study|Death|1|||
44298544|NCT01236521|79295145|FG000|Overall Study|Lost to Follow-up|9|||
44298545|NCT01236521|79295146|FG001|Overall Study|Lost to Follow-up|7|||
44298546|NCT01226797|79295154|FG000|Overall Study|Adverse Event|1|||
44298547|NCT01226797|79295155|FG001|Overall Study|Adverse Event|0|||
44298548|NCT01226797|79295154|FG000|Overall Study|No longer willing to participate|1|||
44298549|NCT01226797|79295155|FG001|Overall Study|No longer willing to participate|0|||
44298550|NCT01226797|79295154|FG000|Overall Study|Protocol Violation|0|||
44298551|NCT01226797|79295155|FG001|Overall Study|Protocol Violation|1|||
44298552|NCT01142908|79295163|FG000|Overall Study|Lost to Follow-up|19|||
44298553|NCT01142908|79295164|FG001|Overall Study|Lost to Follow-up|13|||
44298554|NCT01142908|79295163|FG000|Overall Study|Death|1|||
44298555|NCT01142908|79295164|FG001|Overall Study|Death|4|||
44298556|NCT01142908|79295163|FG000|Overall Study|Excluded - did not meet criteria|9|||
44298557|NCT01142908|79295164|FG001|Overall Study|Excluded - did not meet criteria|5|||
44298558|NCT01142908|79295163|FG000|Overall Study|Withdrawal by Subject|3|||
44298559|NCT01142908|79295164|FG001|Overall Study|Withdrawal by Subject|0|||
44298560|NCT04962230|79295213|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
44534133|NCT02101853|79544765|FG005|Blinatumomab Salvage Therapy|Death|2|||
44154726|NCT01976806|78945973|FG001|Overall Study|Adverse Event|1|||
44298561|NCT04962230|79295213|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
44298562|NCT04919317|79295294|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
44298563|NCT04919317|79295295|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
44534134|NCT02101853|79544760|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
44298564|NCT04919317|79295294|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
44298565|NCT04919317|79295295|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
44298566|NCT04789577|79295365|FG000|Overall Study|Withdrawal by Subject|1|||
44298567|NCT04789577|79295366|FG001|Overall Study|Withdrawal by Subject|1|||
44298568|NCT04789577|79295367|FG002|Overall Study|Withdrawal by Subject|1|||
44298569|NCT04789577|79295368|FG003|Overall Study|Withdrawal by Subject|3|||
44298570|NCT04789577|79295369|FG004|Overall Study|Withdrawal by Subject|1|||
44298571|NCT04789577|79295370|FG005|Overall Study|Withdrawal by Subject|7|||
44298572|NCT04789577|79295371|FG006|Overall Study|Withdrawal by Subject|1|||
44298573|NCT04789577|79295365|FG000|Overall Study|Lost to Follow-up|7|||
44298574|NCT04789577|79295366|FG001|Overall Study|Lost to Follow-up|12|||
44298575|NCT04789577|79295367|FG002|Overall Study|Lost to Follow-up|7|||
44298576|NCT04789577|79295368|FG003|Overall Study|Lost to Follow-up|10|||
44298577|NCT04789577|79295369|FG004|Overall Study|Lost to Follow-up|8|||
44298578|NCT04789577|79295370|FG005|Overall Study|Lost to Follow-up|6|||
44298579|NCT04789577|79295371|FG006|Overall Study|Lost to Follow-up|10|||
44298580|NCT04789577|79295365|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
44298581|NCT04789577|79295366|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
44298582|NCT04789577|79295367|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
44298583|NCT04789577|79295368|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
44298584|NCT04789577|79295369|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
44298585|NCT04789577|79295370|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
44298586|NCT04789577|79295371|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
44298587|NCT04789577|79295365|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
44298588|NCT04789577|79295366|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
44298589|NCT04789577|79295367|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
44298590|NCT04789577|79295368|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
44298591|NCT04789577|79295369|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
44298592|NCT04789577|79295370|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
44298593|NCT04789577|79295371|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
44298594|NCT04480463|79295432|FG000|Overall Study|Death|0|||
44298595|NCT04480463|79295433|FG001|Overall Study|Death|1|||
44298596|NCT04480463|79295432|FG000|Overall Study|Adverse Event|6|||
44298597|NCT04480463|79295433|FG001|Overall Study|Adverse Event|8|||
44298598|NCT04480463|79295432|FG000|Overall Study|Lost to Follow-up|3|||
44298599|NCT04480463|79295433|FG001|Overall Study|Lost to Follow-up|2|||
44298600|NCT04480463|79295432|FG000|Overall Study|Physician Decision|2|||
44298601|NCT04480463|79295433|FG001|Overall Study|Physician Decision|5|||
44298602|NCT04480463|79295432|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
44298603|NCT04480463|79295433|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
44298604|NCT04480463|79295432|FG000|Overall Study|Protocol Violation|2|||
44298605|NCT04480463|79295433|FG001|Overall Study|Protocol Violation|1|||
44298606|NCT04480463|79295432|FG000|Overall Study|Withdrawal by Subject|6|||
44298607|NCT04480463|79295433|FG001|Overall Study|Withdrawal by Subject|7|||
44298608|NCT04480463|79295432|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
44298609|NCT04480463|79295433|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
44298610|NCT04480463|79295432|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
44298611|NCT04480463|79295433|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
44298612|NCT04480463|79295432|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
44298613|NCT04480463|79295433|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
44298614|NCT04480463|79295432|FG000|Overall Study|Other|6|||
44298615|NCT04480463|79295433|FG001|Overall Study|Other|4|||
44298616|NCT04285853|79295441|FG000|Overall Study|Withdrawal by Subject|1|||
44298617|NCT04285853|79295442|FG001|Overall Study|Withdrawal by Subject|0|||
44298618|NCT04285853|79295441|FG000|Overall Study|Lost to Follow-up|9|||
44298619|NCT04285853|79295442|FG001|Overall Study|Lost to Follow-up|5|||
44298620|NCT04102579|79295450|FG000|Overall Study|Withdrawal by Subject|3|||
44298621|NCT04102579|79295451|FG001|Overall Study|Withdrawal by Subject|4|||
44298622|NCT04102579|79295450|FG000|Overall Study|Lost to Follow-up|0|||
44298623|NCT04102579|79295451|FG001|Overall Study|Lost to Follow-up|1|||
44298624|NCT04102579|79295450|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
44298625|NCT04102579|79295451|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
44298626|NCT04102579|79295450|FG000|Overall Study|Other than Specified|1|||
44298627|NCT04102579|79295451|FG001|Overall Study|Other than Specified|0|||
44298628|NCT04102579|79295450|FG000|Overall Study|Not Dosed with Study Drug|0|||
44298629|NCT04102579|79295451|FG001|Overall Study|Not Dosed with Study Drug|1|||
44298630|NCT04034004|79295561|FG000|Overall Study|Withdrawal by Subject|1|||
44534135|NCT02101853|79544761|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
44534136|NCT02101853|79544762|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
44298631|NCT04034004|79295562|FG001|Overall Study|Withdrawal by Subject|2|||
44298632|NCT04034004|79295563|FG002|Overall Study|Withdrawal by Subject|2|||
44298633|NCT04034004|79295564|FG003|Overall Study|Withdrawal by Subject|3|||
44298634|NCT04034004|79295561|FG000|Overall Study|could not find vein to administer IV|2|||
44298635|NCT04034004|79295562|FG001|Overall Study|could not find vein to administer IV|1|||
44298636|NCT04034004|79295563|FG002|Overall Study|could not find vein to administer IV|0|||
44298637|NCT04034004|79295564|FG003|Overall Study|could not find vein to administer IV|0|||
44298638|NCT04034004|79295561|FG000|Overall Study|nurse accidentally unblinded subject|0|||
44298639|NCT04034004|79295562|FG001|Overall Study|nurse accidentally unblinded subject|0|||
44298640|NCT04034004|79295563|FG002|Overall Study|nurse accidentally unblinded subject|0|||
44298641|NCT04034004|79295564|FG003|Overall Study|nurse accidentally unblinded subject|1|||
44298642|NCT03629223|79295579|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
44298643|NCT03629223|79295580|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
44298644|NCT03629223|79295581|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
44298645|NCT03629223|79295582|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
44298646|NCT03629223|79295583|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
44298647|NCT03629223|79295584|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
44298648|NCT03629223|79295579|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
44298649|NCT03629223|79295580|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
44298650|NCT03629223|79295581|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
44298651|NCT03629223|79295582|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
44298652|NCT03629223|79295583|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
44298653|NCT03629223|79295584|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
44298654|NCT03629223|79295579|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
44298655|NCT03629223|79295580|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
44298656|NCT03629223|79295581|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
44298657|NCT03629223|79295582|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
44298658|NCT03629223|79295583|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
44298659|NCT03629223|79295584|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
44298660|NCT03629223|79295579|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
44298661|NCT03629223|79295580|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
44298662|NCT03629223|79295581|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
44298663|NCT03629223|79295582|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
44298664|NCT03629223|79295583|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
44298665|NCT03629223|79295584|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
44298666|NCT03629223|79295579|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
44298667|NCT03629223|79295580|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
44298668|NCT03629223|79295581|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
44298669|NCT03629223|79295582|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
44298670|NCT03629223|79295583|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
44298671|NCT03629223|79295584|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
44298672|NCT03547908|79295600|FG000|Overall Study|Still On Study|115|||
44298673|NCT03547908|79295601|FG001|Overall Study|Still On Study|118|||
44298674|NCT03547908|79295600|FG000|Overall Study|Lost to Follow-up|2|||
44298675|NCT03547908|79295601|FG001|Overall Study|Lost to Follow-up|2|||
44298676|NCT03547908|79295600|FG000|Overall Study|Withdrew Consent|2|||
44298677|NCT03547908|79295601|FG001|Overall Study|Withdrew Consent|1|||
44298678|NCT03547908|79295600|FG000|Overall Study|Adverse Event|1|||
44298679|NCT03547908|79295601|FG001|Overall Study|Adverse Event|0|||
44298680|NCT03547908|79295600|FG000|Overall Study|Death|1|||
44298681|NCT03547908|79295601|FG001|Overall Study|Death|0|||
44298682|NCT03547908|79295600|FG000|Overall Study|Investigator's Discretion|0|||
44298683|NCT03547908|79295601|FG001|Overall Study|Investigator's Discretion|1|||
44298684|NCT03547908|79295600|FG000|Overall Study|Randomized But Never Treated|1|||
44298685|NCT03547908|79295601|FG001|Overall Study|Randomized But Never Treated|0|||
44298686|NCT03395405|79295609|FG000|Overall Study|Death|0|||
44298687|NCT03395405|79295610|FG001|Overall Study|Death|2|||
44298688|NCT03395405|79295609|FG000|Overall Study|Lost to Follow-up|0|||
44298689|NCT03395405|79295610|FG001|Overall Study|Lost to Follow-up|1|||
44298690|NCT03395405|79295609|FG000|Overall Study|Protocol Violation|0|||
44298691|NCT03395405|79295610|FG001|Overall Study|Protocol Violation|1|||
44298692|NCT03395405|79295609|FG000|Overall Study|Withdrawal by Subject|3|||
44298693|NCT03395405|79295610|FG001|Overall Study|Withdrawal by Subject|1|||
44298694|NCT03395405|79295609|FG000|Overall Study|COVID-19 Pandemic|1|||
44534137|NCT02101853|79544763|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
44534138|NCT02101853|79544764|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
44534139|NCT02101853|79544765|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
44534140|NCT02101853|79544760|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
44534141|NCT02101853|79544761|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
44534142|NCT02101853|79544762|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
44534143|NCT02101853|79544763|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
44534144|NCT02101853|79544764|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
44298695|NCT03395405|79295610|FG001|Overall Study|COVID-19 Pandemic|0|||
44298696|NCT03381248|79295618|FG000|0-6 Months|Withdrawal by Subject|4|||
44298697|NCT03381248|79295619|FG001|0-6 Months|Withdrawal by Subject|1|||
44298698|NCT03381248|79295618|FG000|0-6 Months|Lost to Follow-up|3|||
44298699|NCT03381248|79295619|FG001|0-6 Months|Lost to Follow-up|2|||
44298700|NCT03381248|79295618|FG000|0-6 Months|Lack of Efficacy|1|||
44298701|NCT03381248|79295619|FG001|0-6 Months|Lack of Efficacy|0|||
44298702|NCT03381248|79295618|FG000|0-6 Months|Adverse Event|1|||
44298703|NCT03381248|79295619|FG001|0-6 Months|Adverse Event|0|||
44298704|NCT03381248|79295618|FG000|0-6 Months|Protocol Violation|2|||
44298705|NCT03381248|79295619|FG001|0-6 Months|Protocol Violation|1|||
44298706|NCT03381248|79295618|FG000|0-6 Months|Physician Decision|1|||
44298707|NCT03381248|79295619|FG001|0-6 Months|Physician Decision|0|||
44298708|NCT03381248|79295618|FG000|0-6 Months|Planning another procedure|1|||
44298709|NCT03381248|79295619|FG001|0-6 Months|Planning another procedure|2|||
44298710|NCT03381248|79295618|FG000|6-12 Months|Withdrawal by Subject|1|||
44298711|NCT03381248|79295619|FG001|6-12 Months|Withdrawal by Subject|3|||
44298712|NCT03381248|79295618|FG000|6-12 Months|Lost to Follow-up|0|||
44298713|NCT03381248|79295619|FG001|6-12 Months|Lost to Follow-up|2|||
44298714|NCT03381248|79295618|FG000|6-12 Months|Protocol Violation|3|||
44298715|NCT03381248|79295619|FG001|6-12 Months|Protocol Violation|2|||
44298716|NCT03381248|79295618|FG000|6-12 Months|Planning another procedure|6|||
44298717|NCT03381248|79295619|FG001|6-12 Months|Planning another procedure|2|||
44298718|NCT03381248|79295618|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
44298719|NCT03381248|79295619|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
44298720|NCT03381248|79295618|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
44298721|NCT03381248|79295619|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
44298722|NCT03381248|79295618|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
44298723|NCT03381248|79295619|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
44298724|NCT03354663|79295630|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
44298725|NCT03354663|79295630|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
44298726|NCT03354663|79295630|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
44417213|NCT00761631|79425115|FG001|Overall Study|Randomized, not treated|0|||
44154727|NCT01976806|78945972|FG000|Overall Study|Withdrawal by Subject|1|||
44154728|NCT01976806|78945973|FG001|Overall Study|Withdrawal by Subject|1|||
44154729|NCT02679079|78945982|FG000|Overall Study|Adverse Event|2|||
44154730|NCT02679079|78945983|FG001|Overall Study|Adverse Event|0|||
44154731|NCT02679079|78945984|FG002|Overall Study|Adverse Event|2|||
44154732|NCT02679079|78945982|FG000|Overall Study|Protocol Violation|0|||
44154733|NCT02679079|78945983|FG001|Overall Study|Protocol Violation|1|||
44154734|NCT02679079|78945984|FG002|Overall Study|Protocol Violation|0|||
44154735|NCT02679079|78945982|FG000|Overall Study|Withdrawal by Subject|2|||
44154736|NCT02679079|78945983|FG001|Overall Study|Withdrawal by Subject|1|||
44154737|NCT02679079|78945984|FG002|Overall Study|Withdrawal by Subject|0|||
44154738|NCT02678923|78945994|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
44154739|NCT02678923|78945995|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
44154740|NCT02678923|78945994|FG000|Overall Study|Withdrawal by Subject|3|||
44154741|NCT02678923|78945995|FG001|Overall Study|Withdrawal by Subject|2|||
44154742|NCT02678923|78945994|FG000|Overall Study|Lost to Follow-up|1|||
44154743|NCT02678923|78945995|FG001|Overall Study|Lost to Follow-up|0|||
44154744|NCT02678923|78945994|FG000|Overall Study|Did Not Return for Study Visits|1|||
44154745|NCT02678923|78945995|FG001|Overall Study|Did Not Return for Study Visits|0|||
44154746|NCT01976728|78946005|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
44154747|NCT01976728|78946006|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
44154748|NCT01976728|78946007|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
44154749|NCT01976728|78946008|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
44256657|NCT01418378|79107280|FG000|Overall Study|Death|1|||
44256658|NCT01418378|79107281|FG001|Overall Study|Death|2|||
44256659|NCT01418378|79107280|FG000|Overall Study|Physician Decision|0|||
44256660|NCT01418378|79107281|FG001|Overall Study|Physician Decision|1|||
44256661|NCT01418378|79107280|FG000|Overall Study|ligament imbalance|0|||
44256662|NCT01418378|79107281|FG001|Overall Study|ligament imbalance|1|||
44256663|NCT01418378|79107280|FG000|Overall Study|developed chronic myopathy|0|||
44256664|NCT01418378|79107281|FG001|Overall Study|developed chronic myopathy|1|||
44256665|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
44256666|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
44256667|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
44256668|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
44256669|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
44256670|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
44256671|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
44298727|NCT03354663|79295630|FG000|Completed 30-day Visit|Missed Visit|1|||
44298728|NCT03305419|79295646|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44298729|NCT03305419|79295647|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
44298730|NCT03305419|79295648|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44154750|NCT02689219|78946036|FG000|Overall Study|Death|1|||
44154751|NCT02689219|78946037|FG001|Overall Study|Death|1|||
44154752|NCT02689219|78946036|FG000|Overall Study|Disease Progression|10|||
44154753|NCT02689219|78946037|FG001|Overall Study|Disease Progression|6|||
44154754|NCT02683525|78946043|FG000|Overall Study|Lost to Follow-up|1|||
44154755|NCT02683525|78946043|FG000|Overall Study|Physician Decision|1|||
44154756|NCT02683525|78946043|FG000|Overall Study|Disease Progression|6|||
44154757|NCT01976338|78946049|FG000|Overall Study|Physician Decision|0|||
44154758|NCT01976338|78946050|FG001|Overall Study|Physician Decision|1|||
44298731|NCT03305419|79295649|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44298732|NCT03305419|79295650|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44298733|NCT03305419|79295651|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44298734|NCT03305419|79295652|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44298735|NCT03305419|79295653|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
44298736|NCT03305419|79295646|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
44298737|NCT03305419|79295647|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44298738|NCT03305419|79295648|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44298739|NCT03305419|79295649|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44298740|NCT03305419|79295650|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44417214|NCT00761631|79425116|FG002|Overall Study|Randomized, not treated|0|||
44417215|NCT00761631|79425117|FG003|Overall Study|Randomized, not treated|0|||
44417216|NCT00761631|79425118|FG004|Overall Study|Randomized, not treated|0|||
44417217|NCT00761631|79425119|FG005|Overall Study|Randomized, not treated|0|||
44534145|NCT02101853|79544765|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
44534146|NCT02101853|79544760|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
44534147|NCT02101853|79544761|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
44534148|NCT02101853|79544762|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
44154759|NCT01976338|78946049|FG000|Overall Study|Lost to Follow-up|3|||
44154760|NCT01976338|78946050|FG001|Overall Study|Lost to Follow-up|0|||
44154761|NCT01976338|78946049|FG000|Overall Study|Withdrawal by Subject|5|||
44154762|NCT01976338|78946050|FG001|Overall Study|Withdrawal by Subject|2|||
44298741|NCT03305419|79295651|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44298742|NCT03305419|79295652|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44298743|NCT03305419|79295653|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
44298744|NCT03305419|79295646|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
44298745|NCT03305419|79295647|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298746|NCT03305419|79295648|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298747|NCT03305419|79295649|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298748|NCT03305419|79295650|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298749|NCT03305419|79295651|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298750|NCT03305419|79295652|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298751|NCT03305419|79295653|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
44298752|NCT03305419|79295646|FG000|Part B (14 Days)|Adverse Event|0|||
44298753|NCT03305419|79295647|FG001|Part B (14 Days)|Adverse Event|0|||
44298754|NCT03305419|79295648|FG002|Part B (14 Days)|Adverse Event|0|||
44298755|NCT03305419|79295649|FG003|Part B (14 Days)|Adverse Event|0|||
44298756|NCT03305419|79295650|FG004|Part B (14 Days)|Adverse Event|1|||
44298757|NCT03305419|79295651|FG005|Part B (14 Days)|Adverse Event|2|||
44298758|NCT03305419|79295652|FG006|Part B (14 Days)|Adverse Event|4|||
44298759|NCT03305419|79295653|FG007|Part B (14 Days)|Adverse Event|0|||
44298760|NCT03305419|79295646|FG000|Part B (14 Days)|Physician Decision|0|||
44298761|NCT03305419|79295647|FG001|Part B (14 Days)|Physician Decision|0|||
44298762|NCT03305419|79295648|FG002|Part B (14 Days)|Physician Decision|0|||
44298763|NCT03305419|79295649|FG003|Part B (14 Days)|Physician Decision|0|||
44298764|NCT03305419|79295650|FG004|Part B (14 Days)|Physician Decision|2|||
44298765|NCT03305419|79295651|FG005|Part B (14 Days)|Physician Decision|8|||
44298766|NCT03305419|79295652|FG006|Part B (14 Days)|Physician Decision|1|||
44298767|NCT03305419|79295653|FG007|Part B (14 Days)|Physician Decision|0|||
44298768|NCT03096782|79295696|FG000|Overall Study|Death|1|||
44298769|NCT03096782|79295696|FG000|Overall Study|Participant Relapsed|1|||
44298770|NCT03052049|79295700|FG000|Overall Study|Withdrawal by Subject|2|||
44298771|NCT03019536|79295720|FG000|Overall Study|Withdrawal by Subject|1|||
44298772|NCT03019536|79295721|FG001|Overall Study|Withdrawal by Subject|1|||
44298773|NCT03019536|79295722|FG002|Overall Study|Withdrawal by Subject|0|||
44298774|NCT03019536|79295720|FG000|Overall Study|Adverse Event|0|||
44298775|NCT03019536|79295721|FG001|Overall Study|Adverse Event|0|||
44298776|NCT03019536|79295722|FG002|Overall Study|Adverse Event|2|||
44298777|NCT02673775|79295732|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
44298778|NCT02673775|79295733|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
44298779|NCT02673775|79295732|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
44298780|NCT02673775|79295733|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
44417218|NCT00761631|79425114|FG000|Overall Study|Failed to return|1|||
44298781|NCT02673775|79295732|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
44298782|NCT02673775|79295733|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
44298783|NCT02673775|79295732|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
44298784|NCT02673775|79295733|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
44298785|NCT02666768|79295739|FG000|Overall Study|Withdrawal by Subject|4|||
44298786|NCT02471144|79295747|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
44298787|NCT02471144|79295748|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
44298788|NCT02471144|79295749|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
44298789|NCT02471144|79295750|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
44298790|NCT02471144|79295751|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
44298791|NCT02471144|79295752|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
44298792|NCT02471144|79295753|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
44298793|NCT02471144|79295754|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
44298794|NCT02471144|79295755|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
44298795|NCT02471144|79295756|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
44298796|NCT02471144|79295757|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
44298797|NCT02471144|79295747|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298798|NCT02471144|79295748|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298799|NCT02471144|79295749|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298800|NCT02471144|79295750|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
44298801|NCT02471144|79295751|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298802|NCT02471144|79295752|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298803|NCT02471144|79295753|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298804|NCT02471144|79295754|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298805|NCT02471144|79295755|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298806|NCT02471144|79295756|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298807|NCT02471144|79295757|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
44298808|NCT02471144|79295747|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298809|NCT02471144|79295748|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298810|NCT02471144|79295749|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
44298811|NCT02471144|79295750|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298812|NCT02471144|79295751|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298813|NCT02471144|79295752|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298814|NCT02471144|79295753|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298815|NCT02471144|79295754|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298816|NCT02471144|79295755|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298817|NCT02471144|79295756|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298818|NCT02471144|79295757|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
44298819|NCT02471144|79295747|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
44298820|NCT02471144|79295748|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
44298821|NCT02471144|79295749|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298822|NCT02471144|79295750|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298823|NCT02471144|79295751|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298824|NCT02471144|79295752|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298825|NCT02471144|79295753|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298826|NCT02471144|79295754|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298827|NCT02471144|79295755|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298828|NCT02471144|79295756|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298829|NCT02471144|79295757|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
44298830|NCT02471144|79295747|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298831|NCT02471144|79295748|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298832|NCT02471144|79295749|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298833|NCT02471144|79295750|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298834|NCT02471144|79295751|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
44298835|NCT02471144|79295752|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298836|NCT02471144|79295753|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
44298837|NCT02471144|79295754|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298838|NCT02471144|79295755|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
44298839|NCT02471144|79295756|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44298840|NCT02471144|79295757|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
44534149|NCT02101853|79544763|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
44154763|NCT01976338|78946049|FG000|Overall Study|Adverse Event|5|||
44154764|NCT01976338|78946050|FG001|Overall Study|Adverse Event|1|||
44154765|NCT02674633|78946059|FG000|Overall Study|Lost to Follow-up|3|||
44154766|NCT02674633|78946060|FG001|Overall Study|Lost to Follow-up|2|||
44154767|NCT02674633|78946059|FG000|Overall Study|Physician Decision|1|||
44154768|NCT02674633|78946060|FG001|Overall Study|Physician Decision|0|||
44154769|NCT02674633|78946059|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
44298841|NCT02471144|79295747|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298842|NCT02471144|79295748|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298843|NCT02471144|79295749|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298844|NCT02471144|79295750|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298845|NCT02471144|79295751|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298846|NCT02471144|79295752|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
44298847|NCT02471144|79295753|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298848|NCT02471144|79295754|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298849|NCT02471144|79295755|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
44298850|NCT02471144|79295756|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298851|NCT02471144|79295757|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
44298852|NCT02471144|79295747|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298853|NCT02471144|79295748|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44154770|NCT02674633|78946060|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
44154771|NCT02651987|78946068|FG000|Overall Study|Adverse Event|2|||
44298854|NCT02471144|79295749|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298855|NCT02471144|79295750|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298856|NCT02471144|79295751|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298857|NCT02471144|79295752|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298858|NCT02471144|79295753|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298859|NCT02471144|79295754|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298860|NCT02471144|79295755|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
44298861|NCT02471144|79295756|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298862|NCT02471144|79295757|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
44298863|NCT02471144|79295747|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298864|NCT02471144|79295748|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298865|NCT02471144|79295749|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298866|NCT02471144|79295750|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298867|NCT02471144|79295751|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298868|NCT02471144|79295752|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298869|NCT02471144|79295753|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298870|NCT02471144|79295754|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
44298871|NCT02471144|79295755|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
44298872|NCT02471144|79295756|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298873|NCT02471144|79295757|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
44298874|NCT02471144|79295747|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298875|NCT02471144|79295748|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298876|NCT02471144|79295749|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298877|NCT02471144|79295750|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298878|NCT02471144|79295751|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298879|NCT02471144|79295752|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298880|NCT02471144|79295753|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298881|NCT02471144|79295754|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44298882|NCT02471144|79295755|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
44256672|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
44256673|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
44256674|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
44256675|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
44256676|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
44256677|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
44256678|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
44256679|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
44256680|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
44256681|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
44256682|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
44256683|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
44256684|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
44256685|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
44256686|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
44256687|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
44256688|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
44256689|NCT01435928|79107302|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
44298883|NCT02471144|79295756|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
44298884|NCT02471144|79295757|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
44298885|NCT02471144|79295747|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298886|NCT02471144|79295748|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298887|NCT02471144|79295749|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298888|NCT02471144|79295750|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298889|NCT02471144|79295751|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298890|NCT02471144|79295752|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298891|NCT02471144|79295753|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298892|NCT02471144|79295754|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298893|NCT02471144|79295755|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298894|NCT02471144|79295756|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
44298895|NCT02471144|79295757|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
44298896|NCT02471144|79295747|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298897|NCT02471144|79295748|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298898|NCT02471144|79295749|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298899|NCT02471144|79295750|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298900|NCT02471144|79295751|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298901|NCT02471144|79295752|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298902|NCT02471144|79295753|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298903|NCT02471144|79295754|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298904|NCT02471144|79295755|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298905|NCT02471144|79295756|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
44298906|NCT02471144|79295757|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
44298907|NCT02471144|79295747|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298908|NCT02471144|79295748|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298909|NCT02471144|79295749|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298910|NCT02471144|79295750|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298911|NCT02471144|79295751|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298912|NCT02471144|79295752|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298913|NCT02471144|79295753|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298914|NCT02471144|79295754|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298915|NCT02471144|79295755|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
44298916|NCT02471144|79295756|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
44298917|NCT02471144|79295757|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
44298918|NCT02471144|79295747|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298919|NCT02471144|79295748|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298920|NCT02471144|79295749|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298921|NCT02471144|79295750|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298922|NCT02471144|79295751|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298923|NCT02471144|79295752|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298924|NCT02471144|79295753|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44154772|NCT02651987|78946069|FG001|Overall Study|Adverse Event|2|||
44154773|NCT02651987|78946068|FG000|Overall Study|Consent Withdrawn|2|||
44298925|NCT02471144|79295754|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298926|NCT02471144|79295755|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298927|NCT02471144|79295756|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
44298928|NCT02471144|79295757|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
44298929|NCT02471144|79295747|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298930|NCT02471144|79295748|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298931|NCT02471144|79295749|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298932|NCT02471144|79295750|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298933|NCT02471144|79295751|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298934|NCT02471144|79295752|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298935|NCT02471144|79295753|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298936|NCT02471144|79295754|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298937|NCT02471144|79295755|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
44298938|NCT02471144|79295756|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
44298939|NCT02471144|79295757|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
44298940|NCT02403674|79295779|FG000|Overall Study|Adverse Event|10|||
44298941|NCT02403674|79295780|FG001|Overall Study|Adverse Event|23|||
44298942|NCT02403674|79295779|FG000|Overall Study|Death|1|||
44417219|NCT00761631|79425115|FG001|Overall Study|Failed to return|0|||
44417220|NCT00761631|79425116|FG002|Overall Study|Failed to return|1|||
44417221|NCT00761631|79425117|FG003|Overall Study|Failed to return|1|||
44417222|NCT00761631|79425118|FG004|Overall Study|Failed to return|5|||
44154774|NCT02651987|78946069|FG001|Overall Study|Consent Withdrawn|0|||
44154775|NCT02651987|78946068|FG000|Overall Study|Local PD|0|||
44298943|NCT02403674|79295780|FG001|Overall Study|Death|3|||
44298944|NCT02403674|79295779|FG000|Overall Study|Lack of Efficacy|18|||
44298945|NCT02403674|79295780|FG001|Overall Study|Lack of Efficacy|10|||
44298946|NCT02403674|79295779|FG000|Overall Study|Lost to Follow-up|6|||
44298947|NCT02403674|79295780|FG001|Overall Study|Lost to Follow-up|7|||
44298948|NCT02403674|79295779|FG000|Overall Study|Noncompliance with study drug|1|||
44298949|NCT02403674|79295780|FG001|Overall Study|Noncompliance with study drug|2|||
44298950|NCT02403674|79295779|FG000|Overall Study|Withdrawal by Subject|8|||
44298951|NCT02403674|79295780|FG001|Overall Study|Withdrawal by Subject|11|||
44298952|NCT02403674|79295779|FG000|Overall Study|Physician Decision|2|||
44298953|NCT02403674|79295780|FG001|Overall Study|Physician Decision|2|||
44298954|NCT02403674|79295779|FG000|Overall Study|Not treated with study drug|4|||
44298955|NCT02403674|79295780|FG001|Overall Study|Not treated with study drug|2|||
44298956|NCT02403674|79295779|FG000|Overall Study|Pregnancy|1|||
44298957|NCT02403674|79295780|FG001|Overall Study|Pregnancy|1|||
44298958|NCT02403674|79295779|FG000|Overall Study|Protocol Violation|4|||
44298959|NCT02403674|79295780|FG001|Overall Study|Protocol Violation|2|||
44298960|NCT02352948|79295797|FG000|Overall Study|Death|47|||
44298961|NCT02352948|79295798|FG001|Overall Study|Death|48|||
44298962|NCT02352948|79295799|FG002|Overall Study|Death|114|||
44298963|NCT02352948|79295800|FG003|Overall Study|Death|74|||
44298964|NCT02352948|79295801|FG004|Overall Study|Death|77|||
44298965|NCT02352948|79295802|FG005|Overall Study|Death|44|||
44298966|NCT02352948|79295797|FG000|Overall Study|Lost to Follow-up|1|||
44298967|NCT02352948|79295798|FG001|Overall Study|Lost to Follow-up|0|||
44298968|NCT02352948|79295799|FG002|Overall Study|Lost to Follow-up|2|||
44298969|NCT02352948|79295800|FG003|Overall Study|Lost to Follow-up|1|||
44298970|NCT02352948|79295801|FG004|Overall Study|Lost to Follow-up|2|||
44298971|NCT02352948|79295802|FG005|Overall Study|Lost to Follow-up|1|||
44298972|NCT02352948|79295797|FG000|Overall Study|Withdrawal by Subject|1|||
44298973|NCT02352948|79295798|FG001|Overall Study|Withdrawal by Subject|10|||
44298974|NCT02352948|79295799|FG002|Overall Study|Withdrawal by Subject|11|||
44298975|NCT02352948|79295800|FG003|Overall Study|Withdrawal by Subject|23|||
44298976|NCT02352948|79295801|FG004|Overall Study|Withdrawal by Subject|9|||
44298977|NCT02352948|79295802|FG005|Overall Study|Withdrawal by Subject|4|||
44298978|NCT02352948|79295797|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44298979|NCT02352948|79295798|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44298980|NCT02352948|79295799|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
44298981|NCT02352948|79295800|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
44298982|NCT02352948|79295801|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
44298983|NCT02352948|79295802|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
44298984|NCT02352948|79295797|FG000|Overall Study|Other|0|||
44298985|NCT02352948|79295798|FG001|Overall Study|Other|0|||
44298986|NCT02352948|79295799|FG002|Overall Study|Other|2|||
44298987|NCT02352948|79295800|FG003|Overall Study|Other|0|||
44298988|NCT02352948|79295801|FG004|Overall Study|Other|0|||
44298989|NCT02352948|79295802|FG005|Overall Study|Other|0|||
44298990|NCT02125461|79295878|FG000|Overall Study|Withdrawal by Subject|30|||
44298991|NCT02125461|79295879|FG001|Overall Study|Withdrawal by Subject|16|||
44298992|NCT02125461|79295878|FG000|Overall Study|Lost to Follow-up|8|||
44298993|NCT02125461|79295879|FG001|Overall Study|Lost to Follow-up|3|||
44298994|NCT02125461|79295878|FG000|Overall Study|Death|260|||
44298995|NCT02125461|79295879|FG001|Overall Study|Death|149|||
44298996|NCT02125461|79295878|FG000|Overall Study|Missing Termination Reason|0|||
44298997|NCT02125461|79295879|FG001|Overall Study|Missing Termination Reason|1|||
44298998|NCT02096042|79295885|FG000|Overall Study|Disease Progression|1|||
44298999|NCT02096042|79295886|FG001|Overall Study|Disease Progression|0|||
44299000|NCT02096042|79295887|FG002|Overall Study|Disease Progression|0|||
44299001|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
44299002|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
44299003|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
44299004|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
44299005|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
44299006|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
44299007|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
44154776|NCT02651987|78946069|FG001|Overall Study|Local PD|2|||
44299008|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
44299009|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
44299010|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
44299011|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
44299012|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
44299013|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
44299014|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
44299015|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
44299016|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
44299017|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
44299018|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
44299019|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
44299020|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
44299021|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
44299022|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
44299023|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
44299024|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
44299025|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Death|2|||
44299026|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Death|1|||
44299027|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Death|0|||
44299028|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Death|0|||
44299029|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
44417223|NCT00761631|79425119|FG005|Overall Study|Failed to return|2|||
44417224|NCT00761631|79425114|FG000|Overall Study|Physician Decision|1|||
44417225|NCT00761631|79425115|FG001|Overall Study|Physician Decision|0|||
44417226|NCT00761631|79425116|FG002|Overall Study|Physician Decision|0|||
44417227|NCT00761631|79425117|FG003|Overall Study|Physician Decision|0|||
44417228|NCT00761631|79425118|FG004|Overall Study|Physician Decision|0|||
44417229|NCT00761631|79425119|FG005|Overall Study|Physician Decision|0|||
44417230|NCT00761631|79425114|FG000|Overall Study|Other|0|||
44417231|NCT00761631|79425115|FG001|Overall Study|Other|0|||
44417232|NCT00761631|79425116|FG002|Overall Study|Other|0|||
44417233|NCT00761631|79425117|FG003|Overall Study|Other|0|||
44417234|NCT00761631|79425118|FG004|Overall Study|Other|1|||
44417235|NCT00761631|79425119|FG005|Overall Study|Other|1|||
44417236|NCT00763698|79425142|FG000|Overall Study|Unsuccessful Implant|5|||
44417237|NCT00763698|79425142|FG000|Overall Study|Death|4|||
44417238|NCT00763698|79425142|FG000|Overall Study|Withdrawal by Subject|1|||
44417239|NCT00763386|79425149|FG000|Overall Study|Adverse Event|43|||
44154777|NCT02651987|78946068|FG000|Overall Study|Investigator Decision|1|||
44154778|NCT02651987|78946069|FG001|Overall Study|Investigator Decision|1|||
44154779|NCT02677987|78946080|FG000|Overall Study|Withdrawal by Subject|3|||
44154780|NCT02677987|78946081|FG001|Overall Study|Withdrawal by Subject|0|||
44154781|NCT02677987|78946080|FG000|Overall Study|Lost to Follow-up|1|||
44417240|NCT00763386|79425150|FG001|Overall Study|Adverse Event|33|||
44417241|NCT00763386|79425149|FG000|Overall Study|Death|1|||
44417242|NCT00763386|79425150|FG001|Overall Study|Death|2|||
44417243|NCT00763386|79425149|FG000|Overall Study|Lost to Follow-up|3|||
44417244|NCT00763386|79425150|FG001|Overall Study|Lost to Follow-up|3|||
44417245|NCT00763386|79425149|FG000|Overall Study|Withdrawal by Subject|0|||
44417246|NCT00763386|79425150|FG001|Overall Study|Withdrawal by Subject|1|||
44417247|NCT00763386|79425149|FG000|Overall Study|CRF missing|0|||
44417248|NCT00763386|79425150|FG001|Overall Study|CRF missing|1|||
44417249|NCT00763386|79425149|FG000|Overall Study|Study Prosthesis Removed|1|||
44417250|NCT00763386|79425150|FG001|Overall Study|Study Prosthesis Removed|0|||
44417251|NCT00761319|79425158|FG000|Overall Study|Protocol Violation|21|||
44417252|NCT00761319|79425159|FG001|Overall Study|Protocol Violation|14|||
44417253|NCT00761319|79425158|FG000|Overall Study|Adverse Event|11|||
44417254|NCT00761319|79425159|FG001|Overall Study|Adverse Event|7|||
44417255|NCT00761319|79425158|FG000|Overall Study|Withdrawal by Subject|8|||
44417256|NCT00761319|79425159|FG001|Overall Study|Withdrawal by Subject|7|||
44417257|NCT00761319|79425158|FG000|Overall Study|Noncompliance|4|||
44417258|NCT00761319|79425159|FG001|Overall Study|Noncompliance|3|||
44417259|NCT00761319|79425158|FG000|Overall Study|Lost to Follow-up|1|||
44417260|NCT00761319|79425159|FG001|Overall Study|Lost to Follow-up|1|||
44417261|NCT00761319|79425158|FG000|Overall Study|Nonspecified|2|||
44417262|NCT00761319|79425159|FG001|Overall Study|Nonspecified|2|||
44417263|NCT00761319|79425158|FG000|Overall Study|Missing|1|||
44417264|NCT00761319|79425159|FG001|Overall Study|Missing|0|||
44417265|NCT00762996|79425165|FG000|Period One|Protocol Violation|0|||
44417266|NCT00762996|79425166|FG001|Period One|Protocol Violation|0|||
44417267|NCT00762996|79425167|FG002|Period One|Protocol Violation|1|||
44417268|NCT00762996|79425168|FG003|Period One|Protocol Violation|0|||
44417269|NCT00762996|79425165|FG000|Period One|ineligible|0|||
44417270|NCT00762996|79425166|FG001|Period One|ineligible|0|||
44417271|NCT00762996|79425167|FG002|Period One|ineligible|1|||
44417272|NCT00762996|79425168|FG003|Period One|ineligible|1|||
44417273|NCT00762996|79425165|FG000|Period One|Adverse Event|0|||
44417274|NCT00762996|79425166|FG001|Period One|Adverse Event|0|||
44417275|NCT00762996|79425167|FG002|Period One|Adverse Event|1|||
44417276|NCT00762996|79425168|FG003|Period One|Adverse Event|0|||
44417277|NCT00762996|79425165|FG000|Period One|Withdrawal by Subject|0|||
44154782|NCT02677987|78946081|FG001|Overall Study|Lost to Follow-up|0|||
44154783|NCT01999114|78946100|FG000|Overall Study|Adverse Event|8|||
44154784|NCT01999114|78946101|FG001|Overall Study|Adverse Event|7|||
44154785|NCT01999114|78946102|FG002|Overall Study|Adverse Event|2|||
44154786|NCT01999114|78946103|FG003|Overall Study|Adverse Event|2|||
44154787|NCT01999114|78946104|FG004|Overall Study|Adverse Event|1|||
44154788|NCT01999114|78946100|FG000|Overall Study|Withdrawal by Subject|0|||
44417278|NCT00762996|79425166|FG001|Period One|Withdrawal by Subject|0|||
44417279|NCT00762996|79425167|FG002|Period One|Withdrawal by Subject|1|||
44417280|NCT00762996|79425168|FG003|Period One|Withdrawal by Subject|0|||
44417281|NCT00762606|79425178|FG000|Overall Study|Lost to Follow-up|18|||
44417282|NCT00762606|79425179|FG001|Overall Study|Lost to Follow-up|13|||
44417283|NCT00818441|79425187|FG000|Overall Study|Death|69|||
44417284|NCT00818441|79425188|FG001|Overall Study|Death|26|||
44417285|NCT00818441|79425187|FG000|Overall Study|Other|5|||
44417286|NCT00818441|79425188|FG001|Overall Study|Other|0|||
44417287|NCT00818441|79425187|FG000|Overall Study|Lost to Follow-up|2|||
44417288|NCT00818441|79425188|FG001|Overall Study|Lost to Follow-up|1|||
44417289|NCT00818441|79425187|FG000|Overall Study|Withdrawal by Subject|2|||
44417290|NCT00818441|79425188|FG001|Overall Study|Withdrawal by Subject|0|||
44417291|NCT00818441|79425187|FG000|Overall Study|Adverse Event|0|||
44417292|NCT00818441|79425188|FG001|Overall Study|Adverse Event|1|||
44417293|NCT00818441|79425187|FG000|Overall Study|Study terminated by sponsor|11|||
44417294|NCT00818441|79425188|FG001|Overall Study|Study terminated by sponsor|2|||
44417295|NCT00826943|79425195|FG000|Overall Study|Withdrawal by Subject|0|||
44417296|NCT00826943|79425196|FG001|Overall Study|Withdrawal by Subject|0|||
44417297|NCT00826943|79425197|FG002|Overall Study|Withdrawal by Subject|0|||
44417298|NCT00826943|79425198|FG003|Overall Study|Withdrawal by Subject|0|||
44417299|NCT00826943|79425199|FG004|Overall Study|Withdrawal by Subject|1|||
44417300|NCT00826943|79425200|FG005|Overall Study|Withdrawal by Subject|0|||
44417301|NCT00834041|79425210|FG000|Overall Study|Withdrawal by Subject|1|||
44417302|NCT00834041|79425211|FG001|Overall Study|Withdrawal by Subject|0|||
44417303|NCT00834041|79425210|FG000|Overall Study|Lost to Follow-up|0|||
44417304|NCT00834041|79425211|FG001|Overall Study|Lost to Follow-up|1|||
44417305|NCT00760929|79425221|FG000|Overall Study|Adverse Event|2|||
44417306|NCT00760929|79425222|FG001|Overall Study|Adverse Event|0|||
44417307|NCT00760929|79425223|FG002|Overall Study|Adverse Event|6|||
44417308|NCT00760929|79425224|FG003|Overall Study|Adverse Event|10|||
44417309|NCT00760929|79425221|FG000|Overall Study|Lack of Efficacy|0|||
44417310|NCT00760929|79425222|FG001|Overall Study|Lack of Efficacy|2|||
44417311|NCT00760929|79425223|FG002|Overall Study|Lack of Efficacy|1|||
44417312|NCT00760929|79425224|FG003|Overall Study|Lack of Efficacy|0|||
44417313|NCT00760929|79425221|FG000|Overall Study|Withdrawal by Subject|1|||
44417314|NCT00760929|79425222|FG001|Overall Study|Withdrawal by Subject|0|||
44417315|NCT00760929|79425223|FG002|Overall Study|Withdrawal by Subject|9|||
44417316|NCT00760929|79425224|FG003|Overall Study|Withdrawal by Subject|1|||
44417317|NCT00760929|79425221|FG000|Overall Study|Lost to Follow-up|0|||
44417318|NCT00760929|79425222|FG001|Overall Study|Lost to Follow-up|0|||
44417319|NCT00760929|79425223|FG002|Overall Study|Lost to Follow-up|1|||
44417320|NCT00760929|79425224|FG003|Overall Study|Lost to Follow-up|0|||
44417321|NCT00760929|79425221|FG000|Overall Study|Progression of Disease|21|||
44417322|NCT00760929|79425222|FG001|Overall Study|Progression of Disease|26|||
44417323|NCT00760929|79425223|FG002|Overall Study|Progression of Disease|38|||
44417324|NCT00760929|79425224|FG003|Overall Study|Progression of Disease|42|||
44417325|NCT00760929|79425221|FG000|Overall Study|Other|2|||
44417326|NCT00760929|79425222|FG001|Overall Study|Other|0|||
44417327|NCT00760929|79425223|FG002|Overall Study|Other|2|||
44417328|NCT00760929|79425224|FG003|Overall Study|Other|1|||
44417329|NCT00760929|79425221|FG000|Overall Study|Death|0|||
44417330|NCT00760929|79425222|FG001|Overall Study|Death|0|||
44417331|NCT00760929|79425223|FG002|Overall Study|Death|1|||
44417332|NCT00760929|79425224|FG003|Overall Study|Death|0|||
44417333|NCT00760929|79425221|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
44417334|NCT00760929|79425222|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
44534150|NCT02101853|79544764|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
44256690|NCT01435928|79107303|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
44256691|NCT01435928|79107304|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
44256692|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
44256693|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
44256694|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
44256695|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
44256696|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
44256697|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
44256698|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
44256699|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
44256700|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
44256701|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
44256702|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
44256703|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
44417335|NCT00760929|79425223|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
44417336|NCT00760929|79425224|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
44417337|NCT00818207|79425235|FG000|Overall Study|Adverse Event|6|||
44534151|NCT02101853|79544765|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
44417338|NCT00818207|79425236|FG001|Overall Study|Adverse Event|0|||
44299030|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
44299031|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
44299032|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
44299033|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
44299034|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
44299035|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
44299036|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
44299037|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
44299038|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
44299039|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
44299040|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
44299041|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
44299042|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
44299043|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
44299044|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
44299045|NCT01940471|79295896|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
44299046|NCT01940471|79295897|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
44299047|NCT01940471|79295898|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
44299048|NCT01940471|79295899|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
44299049|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
44299050|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
44299051|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
44299052|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
44299053|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
44299054|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
44299055|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
44299056|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
44299057|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
44299058|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
44299059|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
44299060|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
44299061|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
44299062|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
44299063|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
44299064|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
44299065|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
44299066|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
44299067|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
44299068|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
44299069|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
44299070|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
44299071|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
44299072|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
44299073|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
44299074|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
44299075|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
44299076|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
44299077|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
44299078|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
44534152|NCT01193842|79544786|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
44299079|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
44299080|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
44299081|NCT01940471|79295896|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
44299082|NCT01940471|79295897|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
44299083|NCT01940471|79295898|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
44299084|NCT01940471|79295899|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
44299085|NCT01751906|79295919|FG000|Overall Study|Lost to Follow-up|151|||
44299086|NCT01751906|79295920|FG001|Overall Study|Lost to Follow-up|68|||
44299087|NCT01751906|79295919|FG000|Overall Study|Withdrawal by Subject|22|||
44299088|NCT01751906|79295920|FG001|Overall Study|Withdrawal by Subject|18|||
44299089|NCT01751906|79295919|FG000|Overall Study|Physician Decision|5|||
44534153|NCT01193842|79544787|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
44534154|NCT01193842|79544788|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
44534155|NCT01193842|79544789|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
44299090|NCT01751906|79295920|FG001|Overall Study|Physician Decision|2|||
44299091|NCT01751906|79295919|FG000|Overall Study|Death|84|||
44299092|NCT01751906|79295920|FG001|Overall Study|Death|43|||
44299093|NCT01751906|79295919|FG000|Overall Study|Denied on premises for follow-up by law|1|||
44299094|NCT01751906|79295920|FG001|Overall Study|Denied on premises for follow-up by law|0|||
44299095|NCT01730937|79295928|FG000|Overall Study|Protocol Violation|5|||
44299096|NCT01730937|79295929|FG001|Overall Study|Protocol Violation|11|||
44299097|NCT01560416|79295937|FG000|Randomized Phase|Crossover Participants|7|||
44299098|NCT01560416|79295938|FG001|Randomized Phase|Crossover Participants|0|||
44299099|NCT01279850|79295950|FG000|Overall Study|Protocol Violation|50|||
44299100|NCT01279850|79295950|FG000|Overall Study|No Drug Administration Information|7|||
44299101|NCT01279850|79295950|FG000|Overall Study|No Visit After Treatment|34|||
44299102|NCT01035463|79295956|FG000|Overall Study|Adverse Event|0|||
44299103|NCT01035463|79295957|FG001|Overall Study|Adverse Event|0|||
44299104|NCT01035463|79295958|FG002|Overall Study|Adverse Event|4|||
44299105|NCT01035463|79295959|FG003|Overall Study|Adverse Event|1|||
44299106|NCT01035463|79295960|FG004|Overall Study|Adverse Event|5|||
44299107|NCT01035463|79295961|FG005|Overall Study|Adverse Event|7|||
44299108|NCT01035463|79295956|FG000|Overall Study|Withdrawal by Subject|0|||
44299109|NCT01035463|79295957|FG001|Overall Study|Withdrawal by Subject|2|||
44299110|NCT01035463|79295958|FG002|Overall Study|Withdrawal by Subject|1|||
44299111|NCT01035463|79295959|FG003|Overall Study|Withdrawal by Subject|0|||
44299112|NCT01035463|79295960|FG004|Overall Study|Withdrawal by Subject|1|||
44299113|NCT01035463|79295961|FG005|Overall Study|Withdrawal by Subject|4|||
44299114|NCT01035463|79295956|FG000|Overall Study|Disease progression|0|||
44299115|NCT01035463|79295957|FG001|Overall Study|Disease progression|0|||
44299116|NCT01035463|79295958|FG002|Overall Study|Disease progression|0|||
44299117|NCT01035463|79295959|FG003|Overall Study|Disease progression|0|||
44299118|NCT01035463|79295960|FG004|Overall Study|Disease progression|0|||
44299119|NCT01035463|79295961|FG005|Overall Study|Disease progression|3|||
44299120|NCT01035463|79295956|FG000|Overall Study|Other Malignancy|0|||
44299121|NCT01035463|79295957|FG001|Overall Study|Other Malignancy|0|||
44299122|NCT01035463|79295958|FG002|Overall Study|Other Malignancy|0|||
44299123|NCT01035463|79295959|FG003|Overall Study|Other Malignancy|0|||
44299124|NCT01035463|79295960|FG004|Overall Study|Other Malignancy|0|||
44299125|NCT01035463|79295961|FG005|Overall Study|Other Malignancy|2|||
44299126|NCT01035463|79295956|FG000|Overall Study|Other|0|||
44299127|NCT01035463|79295957|FG001|Overall Study|Other|0|||
44299128|NCT01035463|79295958|FG002|Overall Study|Other|0|||
44299129|NCT01035463|79295959|FG003|Overall Study|Other|1|||
44299130|NCT01035463|79295960|FG004|Overall Study|Other|0|||
44417339|NCT00818207|79425235|FG000|Overall Study|Lost to Follow-up|160|||
44417340|NCT00818207|79425236|FG001|Overall Study|Lost to Follow-up|146|||
44417341|NCT00818207|79425235|FG000|Overall Study|Multiple reasons|11|||
44417342|NCT00818207|79425236|FG001|Overall Study|Multiple reasons|12|||
44417343|NCT00818207|79425235|FG000|Overall Study|Withdrawal by Subject|42|||
44417344|NCT00818207|79425236|FG001|Overall Study|Withdrawal by Subject|104|||
44417345|NCT00818207|79425235|FG000|Overall Study|Death|3|||
44417346|NCT00818207|79425236|FG001|Overall Study|Death|5|||
44417347|NCT00760617|79425245|FG000|Overall Study|Adverse Event|5|||
44417348|NCT00760617|79425246|FG001|Overall Study|Adverse Event|2|||
44417349|NCT00760617|79425247|FG002|Overall Study|Adverse Event|0|||
44417350|NCT00760617|79425245|FG000|Overall Study|Lost to Follow-up|0|||
44417351|NCT00760617|79425246|FG001|Overall Study|Lost to Follow-up|0|||
44417352|NCT00760617|79425247|FG002|Overall Study|Lost to Follow-up|5|||
44417353|NCT00760383|79425257|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
44417354|NCT00760383|79425258|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
44417355|NCT00759915|79425266|FG000|Overall Study|Withdrawal by Subject|1|||
44417356|NCT00759915|79425267|FG001|Overall Study|Withdrawal by Subject|0|||
44417357|NCT00759915|79425266|FG000|Overall Study|Adverse Event|0|||
44417358|NCT00759915|79425267|FG001|Overall Study|Adverse Event|1|||
44534156|NCT01193842|79544790|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
44154789|NCT01999114|78946101|FG001|Overall Study|Withdrawal by Subject|0|||
44299131|NCT01035463|79295961|FG005|Overall Study|Other|2|||
44299132|NCT00936390|79295970|FG000|Overall Study|Protocol Violation|21|||
44299133|NCT00936390|79295971|FG001|Overall Study|Protocol Violation|25|||
44299134|NCT01470326|79295988|FG000|Overall Study|Protocol Violation|32|||
44299135|NCT01470326|79295988|FG000|Overall Study|No Drug Administration Information|2|||
44299136|NCT01470326|79295988|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
44299137|NCT01480180|79296003|FG000|Main Phase|Withdrawal criteria|12|||
44299138|NCT01480180|79296004|FG001|Main Phase|Withdrawal criteria|1|||
44299139|NCT01480180|79296005|FG002|Main Phase|Withdrawal criteria|0|||
44299140|NCT01480180|79296006|FG003|Main Phase|Withdrawal criteria|0|||
44299141|NCT01480180|79296007|FG004|Main Phase|Withdrawal criteria|0|||
44299142|NCT01480180|79296008|FG005|Main Phase|Withdrawal criteria|0|||
44299143|NCT01480180|79296003|FG000|Main Phase|Lack of Efficacy|1|||
44417359|NCT00759759|79425275|FG000|Overall Study|didn't return for period 2|1|||
44417360|NCT00759759|79425276|FG001|Overall Study|didn't return for period 2|0|||
44417361|NCT00759759|79425275|FG000|Overall Study|Didn't receive drug in period 2|1|||
44299144|NCT01480180|79296004|FG001|Main Phase|Lack of Efficacy|0|||
44299145|NCT01480180|79296005|FG002|Main Phase|Lack of Efficacy|0|||
44299146|NCT01480180|79296006|FG003|Main Phase|Lack of Efficacy|0|||
44299147|NCT01480180|79296007|FG004|Main Phase|Lack of Efficacy|0|||
44299148|NCT01480180|79296008|FG005|Main Phase|Lack of Efficacy|0|||
44299149|NCT01480180|79296003|FG000|Main Phase|Non-compliance|3|||
44299150|NCT01480180|79296004|FG001|Main Phase|Non-compliance|0|||
44299151|NCT01480180|79296005|FG002|Main Phase|Non-compliance|0|||
44299152|NCT01480180|79296006|FG003|Main Phase|Non-compliance|0|||
44299153|NCT01480180|79296007|FG004|Main Phase|Non-compliance|0|||
44299154|NCT01480180|79296008|FG005|Main Phase|Non-compliance|0|||
44299155|NCT01480180|79296003|FG000|Main Phase|Unclassified|3|||
44299156|NCT01480180|79296004|FG001|Main Phase|Unclassified|0|||
44299157|NCT01480180|79296005|FG002|Main Phase|Unclassified|0|||
44299158|NCT01480180|79296006|FG003|Main Phase|Unclassified|0|||
44299159|NCT01480180|79296007|FG004|Main Phase|Unclassified|0|||
44299160|NCT01480180|79296008|FG005|Main Phase|Unclassified|0|||
44299161|NCT01480180|79296003|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
44299162|NCT01480180|79296004|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
44299163|NCT01480180|79296005|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
44299164|NCT01480180|79296006|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
44299165|NCT01480180|79296007|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
44299166|NCT01480180|79296008|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
44299167|NCT01480180|79296003|FG000|Extension Phase, Part 1|Unclassified|0|||
44299168|NCT01480180|79296004|FG001|Extension Phase, Part 1|Unclassified|0|||
44299169|NCT01480180|79296005|FG002|Extension Phase, Part 1|Unclassified|1|||
44299170|NCT01480180|79296006|FG003|Extension Phase, Part 1|Unclassified|0|||
44299171|NCT01480180|79296007|FG004|Extension Phase, Part 1|Unclassified|0|||
44299172|NCT01480180|79296008|FG005|Extension Phase, Part 1|Unclassified|0|||
44299173|NCT01480180|79296003|FG000|Extension Phase, Part 1|Adverse Event|0|||
44299174|NCT01480180|79296004|FG001|Extension Phase, Part 1|Adverse Event|0|||
44299175|NCT01480180|79296005|FG002|Extension Phase, Part 1|Adverse Event|4|||
44299176|NCT01480180|79296006|FG003|Extension Phase, Part 1|Adverse Event|1|||
44299177|NCT01480180|79296007|FG004|Extension Phase, Part 1|Adverse Event|0|||
44299178|NCT01480180|79296008|FG005|Extension Phase, Part 1|Adverse Event|0|||
44299179|NCT01480180|79296003|FG000|Extension Phase, Part 1|Change of treatment|0|||
44299180|NCT01480180|79296004|FG001|Extension Phase, Part 1|Change of treatment|0|||
44299181|NCT01480180|79296005|FG002|Extension Phase, Part 1|Change of treatment|0|||
44299182|NCT01480180|79296006|FG003|Extension Phase, Part 1|Change of treatment|9|||
44299183|NCT01480180|79296007|FG004|Extension Phase, Part 1|Change of treatment|0|||
44299184|NCT01480180|79296008|FG005|Extension Phase, Part 1|Change of treatment|0|||
44299185|NCT01480180|79296003|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
44299186|NCT01480180|79296004|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
44299187|NCT01480180|79296005|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
44299188|NCT01480180|79296006|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
44299189|NCT01480180|79296007|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
44299190|NCT01480180|79296008|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
44299191|NCT01480180|79296003|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
44299192|NCT01480180|79296004|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
44299193|NCT01480180|79296005|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
44299194|NCT01480180|79296006|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
44299195|NCT01480180|79296007|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
44299196|NCT01480180|79296008|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
44299197|NCT01480180|79296003|FG000|Extension Phase, Part 2|Unclassified|0|||
44299198|NCT01480180|79296004|FG001|Extension Phase, Part 2|Unclassified|0|||
44299199|NCT01480180|79296005|FG002|Extension Phase, Part 2|Unclassified|3|||
44417362|NCT00759759|79425276|FG001|Overall Study|Didn't receive drug in period 2|0|||
44417363|NCT00759759|79425275|FG000|Overall Study|Withdrawal by Subject|2|||
44417364|NCT00759759|79425276|FG001|Overall Study|Withdrawal by Subject|1|||
44417365|NCT00759681|79425284|FG000|Overall Study|Death|2|||
44417366|NCT00759681|79425285|FG001|Overall Study|Death|5|||
44417367|NCT00759681|79425284|FG000|Overall Study|Lost to Follow-up|8|||
44417368|NCT00759681|79425285|FG001|Overall Study|Lost to Follow-up|5|||
44417369|NCT00826241|79425292|FG000|Overall Study|Withdrawal from Follow-up|1|||
44417370|NCT00826241|79425292|FG000|Overall Study|Withdrew consent|2|||
44417371|NCT00826241|79425292|FG000|Overall Study|Death|4|||
44299200|NCT01480180|79296006|FG003|Extension Phase, Part 2|Unclassified|1|||
44417372|NCT00826241|79425292|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
44299201|NCT01480180|79296007|FG004|Extension Phase, Part 2|Unclassified|1|||
44299202|NCT01480180|79296008|FG005|Extension Phase, Part 2|Unclassified|0|||
44299203|NCT05300087|79296039|FG000|Overall Study|Withdrawal by Subject|0|||
44299204|NCT05300087|79296040|FG001|Overall Study|Withdrawal by Subject|1|||
44299205|NCT04803734|79296053|FG000|Overall Study|Withdrawal by Subject|0|||
44299206|NCT04803734|79296054|FG001|Overall Study|Withdrawal by Subject|1|||
44299207|NCT04803734|79296053|FG000|Overall Study|Protocol Violation|0|||
44417373|NCT00826241|79425292|FG000|Overall Study|Non-compliance|1|||
44417374|NCT00826241|79425292|FG000|Overall Study|Progression of disease|1|||
44299208|NCT04803734|79296054|FG001|Overall Study|Protocol Violation|1|||
44299209|NCT04112173|79296090|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
44299210|NCT03872453|79296098|FG000|Overall Study|Adverse Event|1|||
44299211|NCT03872453|79296099|FG001|Overall Study|Adverse Event|1|||
44299212|NCT03872453|79296100|FG002|Overall Study|Adverse Event|0|||
44299213|NCT03872453|79296101|FG003|Overall Study|Adverse Event|0|||
44299214|NCT03872453|79296098|FG000|Overall Study|Lost to Follow-up|8|||
44299215|NCT03872453|79296099|FG001|Overall Study|Lost to Follow-up|7|||
44299216|NCT03872453|79296100|FG002|Overall Study|Lost to Follow-up|4|||
44299217|NCT03872453|79296101|FG003|Overall Study|Lost to Follow-up|4|||
44299218|NCT03872453|79296098|FG000|Overall Study|Never Treated Migraine|19|||
44299219|NCT03872453|79296099|FG001|Overall Study|Never Treated Migraine|17|||
44299220|NCT03872453|79296100|FG002|Overall Study|Never Treated Migraine|13|||
44299221|NCT03872453|79296101|FG003|Overall Study|Never Treated Migraine|12|||
44299222|NCT03872453|79296098|FG000|Overall Study|Pregnancy|1|||
44299223|NCT03872453|79296099|FG001|Overall Study|Pregnancy|0|||
44299224|NCT03872453|79296100|FG002|Overall Study|Pregnancy|0|||
44299225|NCT03872453|79296101|FG003|Overall Study|Pregnancy|0|||
44299226|NCT03872453|79296098|FG000|Overall Study|Protocol Deviation|2|||
44299227|NCT03872453|79296099|FG001|Overall Study|Protocol Deviation|0|||
44299228|NCT03872453|79296100|FG002|Overall Study|Protocol Deviation|0|||
44299229|NCT03872453|79296101|FG003|Overall Study|Protocol Deviation|2|||
44299230|NCT03872453|79296098|FG000|Overall Study|Withdrawal by Subject|0|||
44299231|NCT03872453|79296099|FG001|Overall Study|Withdrawal by Subject|1|||
44299232|NCT03872453|79296100|FG002|Overall Study|Withdrawal by Subject|2|||
44299233|NCT03872453|79296101|FG003|Overall Study|Withdrawal by Subject|0|||
44299234|NCT03872453|79296098|FG000|Overall Study|Other Than Specified|1|||
44299235|NCT03872453|79296099|FG001|Overall Study|Other Than Specified|0|||
44299236|NCT03872453|79296100|FG002|Overall Study|Other Than Specified|0|||
44299237|NCT03872453|79296101|FG003|Overall Study|Other Than Specified|0|||
44299238|NCT03726879|79296113|FG000|Overall Study|Death|6|||
44299239|NCT03726879|79296114|FG001|Overall Study|Death|4|||
44299240|NCT03726879|79296113|FG000|Overall Study|Physician Decision|0|||
44299241|NCT03726879|79296114|FG001|Overall Study|Physician Decision|2|||
44299242|NCT03726879|79296113|FG000|Overall Study|Protocol Violation|0|||
44299243|NCT03726879|79296114|FG001|Overall Study|Protocol Violation|1|||
44299244|NCT03726879|79296113|FG000|Overall Study|Withdrawal by Subject|5|||
44299245|NCT03726879|79296114|FG001|Overall Study|Withdrawal by Subject|5|||
44299246|NCT03726879|79296113|FG000|Overall Study|TSH result is unstable|0|||
44299247|NCT03726879|79296114|FG001|Overall Study|TSH result is unstable|1|||
44299248|NCT03726879|79296113|FG000|Overall Study|Continuing on Study|215|||
44299249|NCT03726879|79296114|FG001|Overall Study|Continuing on Study|215|||
44299250|NCT03721835|79296120|FG000|Overall Study|Participant not able to return|1|||
44299251|NCT03721835|79296120|FG000|Overall Study|Lost to Follow-up|1|||
44299252|NCT03721835|79296120|FG000|Overall Study|Revision of the components of the study device|2|||
44299253|NCT03721835|79296120|FG000|Overall Study|Sponsor terminated study|6|||
44299254|NCT03721835|79296120|FG000|Overall Study|Death|1|||
44299255|NCT03721835|79296120|FG000|Overall Study|Sponsor decision|1|||
44299256|NCT03565991|79296126|FG000|Overall Study|Other|11|||
44299257|NCT03565991|79296127|FG001|Overall Study|Other|0|||
44299258|NCT03565991|79296126|FG000|Overall Study|Global deterioration of health status|14|||
44299259|NCT03565991|79296127|FG001|Overall Study|Global deterioration of health status|4|||
44299260|NCT03565991|79296126|FG000|Overall Study|Withdrawal by Subject|2|||
44299261|NCT03565991|79296127|FG001|Overall Study|Withdrawal by Subject|6|||
44299262|NCT03565991|79296126|FG000|Overall Study|Progressive disease|121|||
44299263|NCT03565991|79296127|FG001|Overall Study|Progressive disease|29|||
44299264|NCT03565991|79296126|FG000|Overall Study|Death|3|||
44299265|NCT03565991|79296127|FG001|Overall Study|Death|0|||
44299266|NCT03565991|79296126|FG000|Overall Study|Adverse Event|7|||
44299267|NCT03565991|79296127|FG001|Overall Study|Adverse Event|2|||
44299268|NCT03186638|79296137|FG000|Overall Study|Withdrawal by Subject|4|||
44299269|NCT03186638|79296138|FG001|Overall Study|Withdrawal by Subject|4|||
44299270|NCT03186638|79296137|FG000|Overall Study|Withdrawn due to medical problem|3|||
44299271|NCT03186638|79296138|FG001|Overall Study|Withdrawn due to medical problem|2|||
44299272|NCT03186638|79296137|FG000|Overall Study|Lost to Follow-up|1|||
44299273|NCT03186638|79296138|FG001|Overall Study|Lost to Follow-up|0|||
44299274|NCT02691663|79296155|FG000|Overall Study|Screen failure after baseline|2|||
44299275|NCT02691663|79296156|FG001|Overall Study|Screen failure after baseline|2|||
44299276|NCT02691663|79296155|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
44299277|NCT02691663|79296156|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
44299278|NCT02691663|79296155|FG000|Overall Study|Withdrawn after Follow up 2|1|||
44299279|NCT02691663|79296156|FG001|Overall Study|Withdrawn after Follow up 2|1|||
44299280|NCT02691663|79296155|FG000|Overall Study|Lost to Follow-up|3|||
44299281|NCT02691663|79296156|FG001|Overall Study|Lost to Follow-up|2|||
44299282|NCT02639065|79296163|FG000|Study Treatment|Disease Progression|13|||
44299283|NCT02639065|79296163|FG000|Study Treatment|Adverse Event|9|||
44299284|NCT02639065|79296163|FG000|Study Treatment|Withdrawal by Subject|1|||
44299285|NCT02639065|79296163|FG000|Follow up|Subject refused to follow up|1|||
44154790|NCT01999114|78946102|FG002|Overall Study|Withdrawal by Subject|1|||
44154791|NCT01999114|78946103|FG003|Overall Study|Withdrawal by Subject|0|||
44154792|NCT01999114|78946104|FG004|Overall Study|Withdrawal by Subject|1|||
44154793|NCT01999114|78946100|FG000|Overall Study|Lost to Follow-up|0|||
44154794|NCT01999114|78946101|FG001|Overall Study|Lost to Follow-up|0|||
44154795|NCT01999114|78946102|FG002|Overall Study|Lost to Follow-up|1|||
44154796|NCT01999114|78946103|FG003|Overall Study|Lost to Follow-up|0|||
44154797|NCT01999114|78946104|FG004|Overall Study|Lost to Follow-up|0|||
44154798|NCT01999114|78946100|FG000|Overall Study|Administrative|0|||
44154799|NCT01999114|78946101|FG001|Overall Study|Administrative|0|||
44154800|NCT01999114|78946102|FG002|Overall Study|Administrative|1|||
44154801|NCT01999114|78946103|FG003|Overall Study|Administrative|1|||
44154802|NCT01999114|78946104|FG004|Overall Study|Administrative|2|||
44154803|NCT02682823|78946135|FG000|Overall Study|Withdrawal by Subject|0|||
44154804|NCT02682823|78946136|FG001|Overall Study|Withdrawal by Subject|0|||
44154805|NCT02682823|78946137|FG002|Overall Study|Withdrawal by Subject|1|||
44154806|NCT02682823|78946138|FG003|Overall Study|Withdrawal by Subject|0|||
44154807|NCT02682823|78946139|FG004|Overall Study|Withdrawal by Subject|1|||
44154808|NCT02682823|78946135|FG000|Overall Study|Protocol Deviation|0|||
44299286|NCT02639065|79296163|FG000|Follow up|Symptomatic Deterioration|2|||
44299287|NCT02639065|79296163|FG000|Follow up|Death|2|||
44299288|NCT02639065|79296163|FG000|Follow up|Study Terminated|1|||
44299289|NCT02639065|79296163|FG000|Follow up|Disease Progression|3|||
44299290|NCT02566785|79296169|FG000|Overall Study|Lost to Follow-up|0|||
44299291|NCT02566785|79296170|FG001|Overall Study|Lost to Follow-up|2|||
44299292|NCT02566785|79296169|FG000|Overall Study|Worsening condition|1|||
44299293|NCT02566785|79296170|FG001|Overall Study|Worsening condition|1|||
44299294|NCT02344537|79296178|FG000|Overall Study|Protocol Violation|1|||
44299295|NCT02344537|79296179|FG001|Overall Study|Protocol Violation|1|||
44299296|NCT02344537|79296178|FG000|Overall Study|Subject started another treatment after wk 6|1|||
44299297|NCT02344537|79296179|FG001|Overall Study|Subject started another treatment after wk 6|0|||
44299298|NCT02344537|79296178|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
44299299|NCT02344537|79296179|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
44299300|NCT01092702|79296196|FG000|Overall Study|Withdrawal by Subject|7|||
44299301|NCT01092702|79296196|FG000|Overall Study|Lost to Follow-up|2|||
44299302|NCT00658879|79296225|FG000|Overall Study|Protocol Violation|1|||
44299303|NCT00591851|79296229|FG000|Overall Study|Withdrawal by Subject|3|||
44299304|NCT00591851|79296229|FG000|Overall Study|Adverse Event|2|||
44299305|NCT00591851|79296229|FG000|Overall Study|Progressive Disease|1|||
44299306|NCT00336024|79296235|FG000|Overall Study|Death|2|||
44299307|NCT00336024|79296236|FG001|Overall Study|Death|1|||
44299308|NCT00336024|79296235|FG000|Overall Study|Physician Decision|4|||
44299309|NCT00336024|79296236|FG001|Overall Study|Physician Decision|1|||
44299310|NCT00336024|79296235|FG000|Overall Study|Protocol Violation|1|||
44299311|NCT00336024|79296236|FG001|Overall Study|Protocol Violation|0|||
44299312|NCT00336024|79296235|FG000|Overall Study|Withdrawal by Subject|1|||
44299313|NCT00336024|79296236|FG001|Overall Study|Withdrawal by Subject|2|||
44299314|NCT00336024|79296235|FG000|Overall Study|Failure to fulfill consolidation|1|||
44299315|NCT00336024|79296236|FG001|Overall Study|Failure to fulfill consolidation|1|||
44299316|NCT00336024|79296235|FG000|Overall Study|Progressive Disease|4|||
44299317|NCT00336024|79296236|FG001|Overall Study|Progressive Disease|7|||
44299318|NCT00336024|79296235|FG000|Overall Study|Ineligible|7|||
44299319|NCT00336024|79296236|FG001|Overall Study|Ineligible|7|||
44299320|NCT00133705|79296244|FG000|Overall Study|Withdrawal by Subject|2|||
44299321|NCT00133705|79296245|FG001|Overall Study|Withdrawal by Subject|3|||
44299322|NCT01545050|79296256|FG000|Overall Study|Lack of Efficacy|0|||
44299323|NCT01545050|79296257|FG001|Overall Study|Lack of Efficacy|0|||
44299324|NCT01545050|79296258|FG002|Overall Study|Lack of Efficacy|0|||
44299325|NCT01545050|79296259|FG003|Overall Study|Lack of Efficacy|3|||
44299326|NCT01545050|79296260|FG004|Overall Study|Lack of Efficacy|2|||
44299327|NCT01545050|79296256|FG000|Overall Study|Adverse Event|1|||
44299328|NCT01545050|79296257|FG001|Overall Study|Adverse Event|1|||
44299329|NCT01545050|79296258|FG002|Overall Study|Adverse Event|2|||
44299330|NCT01545050|79296259|FG003|Overall Study|Adverse Event|2|||
44299331|NCT01545050|79296260|FG004|Overall Study|Adverse Event|0|||
44154809|NCT02682823|78946136|FG001|Overall Study|Protocol Deviation|1|||
44154810|NCT02682823|78946137|FG002|Overall Study|Protocol Deviation|0|||
44299332|NCT01545050|79296256|FG000|Overall Study|Discontinued study treatment|1|||
44299333|NCT01545050|79296257|FG001|Overall Study|Discontinued study treatment|0|||
44299334|NCT01545050|79296258|FG002|Overall Study|Discontinued study treatment|0|||
44299335|NCT01545050|79296259|FG003|Overall Study|Discontinued study treatment|0|||
44299336|NCT01545050|79296260|FG004|Overall Study|Discontinued study treatment|0|||
44299337|NCT01545050|79296256|FG000|Overall Study|Withdrawal by Subject|1|||
44299338|NCT01545050|79296257|FG001|Overall Study|Withdrawal by Subject|0|||
44417375|NCT00826241|79425292|FG000|Overall Study|Patient refused follow-up|3|||
44154811|NCT02682823|78946138|FG003|Overall Study|Protocol Deviation|0|||
44154812|NCT02682823|78946139|FG004|Overall Study|Protocol Deviation|0|||
44299339|NCT01545050|79296258|FG002|Overall Study|Withdrawal by Subject|0|||
44299340|NCT01545050|79296259|FG003|Overall Study|Withdrawal by Subject|2|||
44299341|NCT01545050|79296260|FG004|Overall Study|Withdrawal by Subject|1|||
44299342|NCT01545050|79296256|FG000|Overall Study|Participant no longer meets study criteria|0|||
44299343|NCT01545050|79296257|FG001|Overall Study|Participant no longer meets study criteria|2|||
44299344|NCT01545050|79296258|FG002|Overall Study|Participant no longer meets study criteria|0|||
44299345|NCT01545050|79296259|FG003|Overall Study|Participant no longer meets study criteria|0|||
44299346|NCT01545050|79296260|FG004|Overall Study|Participant no longer meets study criteria|1|||
44299347|NCT01545050|79296256|FG000|Overall Study|Administrative reason by sponsor|4|||
44299348|NCT01545050|79296257|FG001|Overall Study|Administrative reason by sponsor|2|||
44299349|NCT01545050|79296258|FG002|Overall Study|Administrative reason by sponsor|3|||
44299350|NCT01545050|79296259|FG003|Overall Study|Administrative reason by sponsor|5|||
44299351|NCT01545050|79296260|FG004|Overall Study|Administrative reason by sponsor|5|||
44299352|NCT01555021|79296287|FG000|Overall Study|Lost to Follow-up|1|||
44299353|NCT01555021|79296288|FG001|Overall Study|Lost to Follow-up|2|||
44299354|NCT04721925|79296302|FG000|2-Month Assessment|Lost to Follow-up|5|||
44299355|NCT04721925|79296303|FG001|2-Month Assessment|Lost to Follow-up|3|||
44299356|NCT04721925|79296302|FG000|4-Month Assessment|Lost to Follow-up|3|||
44299357|NCT04721925|79296303|FG001|4-Month Assessment|Lost to Follow-up|6|||
44299358|NCT04677660|79296310|FG000|Overall Study|Lost to Follow-up|0|||
44299359|NCT04677660|79296311|FG001|Overall Study|Lost to Follow-up|2|||
44299360|NCT04677660|79296310|FG000|Overall Study|Withdrawal by Subject|0|||
44299361|NCT04677660|79296311|FG001|Overall Study|Withdrawal by Subject|1|||
44299362|NCT04677660|79296310|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
44299363|NCT04677660|79296311|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
44299364|NCT04518995|79296320|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
44299365|NCT04518995|79296321|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
44299366|NCT04518995|79296322|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
44299367|NCT04518995|79296320|FG000|Overall Study|Lack of Efficacy|2|||
44299368|NCT04518995|79296321|FG001|Overall Study|Lack of Efficacy|1|||
44299369|NCT04518995|79296322|FG002|Overall Study|Lack of Efficacy|0|||
44299370|NCT04518995|79296320|FG000|Overall Study|Non-compliance With Study Drug|0|||
44299371|NCT04518995|79296321|FG001|Overall Study|Non-compliance With Study Drug|3|||
44299372|NCT04518995|79296322|FG002|Overall Study|Non-compliance With Study Drug|2|||
44299373|NCT04518995|79296320|FG000|Overall Study|Pregnancy|0|||
44299374|NCT04518995|79296321|FG001|Overall Study|Pregnancy|0|||
44299375|NCT04518995|79296322|FG002|Overall Study|Pregnancy|1|||
44299376|NCT04518995|79296320|FG000|Overall Study|Protocol Violation|2|||
44299377|NCT04518995|79296321|FG001|Overall Study|Protocol Violation|0|||
44299378|NCT04518995|79296322|FG002|Overall Study|Protocol Violation|1|||
44299379|NCT04518995|79296320|FG000|Overall Study|Reason not Specified|4|||
44299380|NCT04518995|79296321|FG001|Overall Study|Reason not Specified|11|||
44299381|NCT04518995|79296322|FG002|Overall Study|Reason not Specified|2|||
44299382|NCT04518995|79296320|FG000|Overall Study|Lost to Follow-up|1|||
44299383|NCT04518995|79296321|FG001|Overall Study|Lost to Follow-up|10|||
44299384|NCT04518995|79296322|FG002|Overall Study|Lost to Follow-up|6|||
44299385|NCT04474691|79296330|FG000|Overall Study|Withdrawal by Subject|9|||
44299386|NCT04014075|79296362|FG000|Overall Study|Progressive Disease|48|||
44299387|NCT04014075|79296362|FG000|Overall Study|Adverse Event|11|||
44299388|NCT04014075|79296362|FG000|Overall Study|Clinical Progression|4|||
44299389|NCT04014075|79296362|FG000|Overall Study|Death|2|||
44299390|NCT04014075|79296362|FG000|Overall Study|Withdrawal by Subject|2|||
44299391|NCT04014075|79296362|FG000|Overall Study|Miscellaneous|1|||
44299392|NCT04014075|79296362|FG000|Overall Study|Physician Decision|1|||
44299393|NCT03840174|79296370|FG000|Overall Study|Withdrawal by Subject|1|||
44299394|NCT03840174|79296371|FG001|Overall Study|Withdrawal by Subject|0|||
44299395|NCT03840174|79296372|FG002|Overall Study|Withdrawal by Subject|0|||
44299396|NCT03840174|79296373|FG003|Overall Study|Withdrawal by Subject|0|||
44299397|NCT03786718|79296384|FG000|Overall Study|Lost to Follow-up|3|||
44299398|NCT03786718|79296384|FG000|Overall Study|Withdrawal by Subject|1|||
44299399|NCT03786718|79296384|FG000|Overall Study|Did not use the intervention|2|||
44299400|NCT03786718|79296384|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
44299401|NCT03400943|79296417|FG000|Treatment Period 1|Adverse Event|0|||
44299402|NCT03400943|79296418|FG001|Treatment Period 1|Adverse Event|0|||
44299403|NCT03400943|79296419|FG002|Treatment Period 1|Adverse Event|0|||
44299404|NCT03400943|79296420|FG003|Treatment Period 1|Adverse Event|1|||
44299405|NCT03400943|79296417|FG000|Treatment Period 1|Lost to Follow-up|1|||
44299406|NCT03400943|79296418|FG001|Treatment Period 1|Lost to Follow-up|0|||
44299407|NCT03400943|79296419|FG002|Treatment Period 1|Lost to Follow-up|0|||
44299408|NCT03400943|79296420|FG003|Treatment Period 1|Lost to Follow-up|0|||
44299409|NCT03400943|79296417|FG000|Treatment Period 1|Protocol Violation|0|||
44299410|NCT03400943|79296418|FG001|Treatment Period 1|Protocol Violation|1|||
44299411|NCT03400943|79296419|FG002|Treatment Period 1|Protocol Violation|1|||
44299412|NCT03400943|79296420|FG003|Treatment Period 1|Protocol Violation|0|||
44299413|NCT03400943|79296417|FG000|Treatment Period 1|Study terminated by sponsor|2|||
44299414|NCT03400943|79296418|FG001|Treatment Period 1|Study terminated by sponsor|0|||
44299415|NCT03400943|79296419|FG002|Treatment Period 1|Study terminated by sponsor|0|||
44299416|NCT03400943|79296420|FG003|Treatment Period 1|Study terminated by sponsor|1|||
44417376|NCT00826241|79425292|FG000|Overall Study|Lost to Follow-up|9|||
44299417|NCT03400943|79296417|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44299418|NCT03400943|79296418|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44299419|NCT03400943|79296419|FG002|Treatment Period 1|Withdrawal by Subject|3|||
44299420|NCT03400943|79296420|FG003|Treatment Period 1|Withdrawal by Subject|1|||
44299421|NCT03400943|79296417|FG000|Treatment Period 1|Other|2|||
44299422|NCT03400943|79296418|FG001|Treatment Period 1|Other|1|||
44299423|NCT03400943|79296419|FG002|Treatment Period 1|Other|2|||
44299424|NCT03400943|79296420|FG003|Treatment Period 1|Other|2|||
44299425|NCT03400943|79296417|FG000|Post-treatment Period 1|Adverse Event|2|||
44299426|NCT03400943|79296418|FG001|Post-treatment Period 1|Adverse Event|0|||
44299427|NCT03400943|79296419|FG002|Post-treatment Period 1|Adverse Event|0|||
44299428|NCT03400943|79296420|FG003|Post-treatment Period 1|Adverse Event|0|||
44299429|NCT03400943|79296417|FG000|Post-treatment Period 1|Protocol Violation|1|||
44299430|NCT03400943|79296418|FG001|Post-treatment Period 1|Protocol Violation|0|||
44299431|NCT03400943|79296419|FG002|Post-treatment Period 1|Protocol Violation|0|||
44299432|NCT03400943|79296420|FG003|Post-treatment Period 1|Protocol Violation|0|||
44299433|NCT03400943|79296417|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
44299434|NCT03400943|79296418|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
44299435|NCT03400943|79296419|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
44299436|NCT03400943|79296420|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
44299437|NCT03400943|79296417|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
44299438|NCT03400943|79296418|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
44299439|NCT03400943|79296419|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
44299440|NCT03400943|79296420|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
44299441|NCT03400943|79296417|FG000|Post-treatment Period 1|Other|2|||
44299442|NCT03400943|79296418|FG001|Post-treatment Period 1|Other|0|||
44299443|NCT03400943|79296419|FG002|Post-treatment Period 1|Other|4|||
44299444|NCT03400943|79296420|FG003|Post-treatment Period 1|Other|5|||
44299445|NCT03400943|79296417|FG000|Treatment Period 2|Study terminated by sponsor|0|||
44299446|NCT03400943|79296418|FG001|Treatment Period 2|Study terminated by sponsor|1|||
44299447|NCT03400943|79296419|FG002|Treatment Period 2|Study terminated by sponsor|0|||
44299448|NCT03400943|79296420|FG003|Treatment Period 2|Study terminated by sponsor|0|||
44299449|NCT03400943|79296417|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44299450|NCT03400943|79296418|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44299451|NCT03400943|79296419|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44299452|NCT03400943|79296420|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44299453|NCT03400943|79296417|FG000|Treatment Period 2|Other|1|||
44299454|NCT03400943|79296418|FG001|Treatment Period 2|Other|6|||
44299455|NCT03400943|79296419|FG002|Treatment Period 2|Other|0|||
44299456|NCT03400943|79296420|FG003|Treatment Period 2|Other|0|||
44299457|NCT03400943|79296417|FG000|Follow-up Period|Withdrawal by Subject|1|||
44299458|NCT03400943|79296418|FG001|Follow-up Period|Withdrawal by Subject|0|||
44299459|NCT03400943|79296419|FG002|Follow-up Period|Withdrawal by Subject|0|||
44299460|NCT03400943|79296420|FG003|Follow-up Period|Withdrawal by Subject|0|||
44299461|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
44299462|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
44299463|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
44299464|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
44299465|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
44299466|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
44299467|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
44299468|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
44299469|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
44299470|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
44299471|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
44299472|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
44299473|NCT03321526|79296434|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
44299474|NCT03321526|79296435|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
44299475|NCT03321526|79296434|FG000|Follow-up Phase (2 Weeks)|Other|24|||
44299476|NCT03321526|79296435|FG001|Follow-up Phase (2 Weeks)|Other|24|||
44299477|NCT03153111|79296449|FG000|Overall Study|Death|2|||
44299478|NCT03153111|79296450|FG001|Overall Study|Death|5|||
44299479|NCT03153111|79296449|FG000|Overall Study|Lost to Follow-up|1|||
44299480|NCT03153111|79296450|FG001|Overall Study|Lost to Follow-up|0|||
44299481|NCT03153111|79296449|FG000|Overall Study|Physician Decision|5|||
44299482|NCT03153111|79296450|FG001|Overall Study|Physician Decision|1|||
44299483|NCT03153111|79296449|FG000|Overall Study|Withdrawal by Subject|3|||
44299484|NCT03153111|79296450|FG001|Overall Study|Withdrawal by Subject|3|||
44299485|NCT03126435|79296458|FG000|Overall Study|Death|90|||
44299486|NCT03126435|79296459|FG001|Overall Study|Death|84|||
44299487|NCT03126435|79296458|FG000|Overall Study|Lost to Follow-up|4|||
44299488|NCT03126435|79296459|FG001|Overall Study|Lost to Follow-up|3|||
44299489|NCT03126435|79296458|FG000|Overall Study|Physician Decision|0|||
44299490|NCT03126435|79296459|FG001|Overall Study|Physician Decision|1|||
44299491|NCT03126435|79296458|FG000|Overall Study|Withdrawal by Subject|6|||
44299492|NCT03126435|79296459|FG001|Overall Study|Withdrawal by Subject|12|||
44299493|NCT03126435|79296458|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
44299494|NCT03126435|79296459|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
44299495|NCT02823574|79296471|FG000|Randomization|Disease Progression|0|||
44299496|NCT02823574|79296472|FG001|Randomization|Disease Progression|0|||
44299497|NCT02823574|79296473|FG002|Randomization|Disease Progression|1|||
44299498|NCT02823574|79296474|FG003|Randomization|Disease Progression|0|||
44299499|NCT02823574|79296471|FG000|Randomization|AE unrelated to Study Drug|1|||
44299500|NCT02823574|79296472|FG001|Randomization|AE unrelated to Study Drug|0|||
44299501|NCT02823574|79296473|FG002|Randomization|AE unrelated to Study Drug|0|||
44299502|NCT02823574|79296474|FG003|Randomization|AE unrelated to Study Drug|0|||
44299503|NCT02823574|79296471|FG000|Treatment Period|Poor/Non Compliance|1|||
44299504|NCT02823574|79296472|FG001|Treatment Period|Poor/Non Compliance|0|||
44299505|NCT02823574|79296473|FG002|Treatment Period|Poor/Non Compliance|0|||
44299506|NCT02823574|79296474|FG003|Treatment Period|Poor/Non Compliance|1|||
44299507|NCT02823574|79296471|FG000|Treatment Period|Maximum Clinical Benefit|8|||
44299508|NCT02823574|79296472|FG001|Treatment Period|Maximum Clinical Benefit|4|||
44299509|NCT02823574|79296473|FG002|Treatment Period|Maximum Clinical Benefit|7|||
44299510|NCT02823574|79296474|FG003|Treatment Period|Maximum Clinical Benefit|1|||
44299511|NCT02823574|79296471|FG000|Treatment Period|Lost to Follow-up|1|||
44299512|NCT02823574|79296472|FG001|Treatment Period|Lost to Follow-up|1|||
44299513|NCT02823574|79296473|FG002|Treatment Period|Lost to Follow-up|0|||
44299514|NCT02823574|79296474|FG003|Treatment Period|Lost to Follow-up|0|||
44299515|NCT02823574|79296471|FG000|Treatment Period|Participant withdrew consent|4|||
44299516|NCT02823574|79296472|FG001|Treatment Period|Participant withdrew consent|0|||
44299517|NCT02823574|79296473|FG002|Treatment Period|Participant withdrew consent|0|||
44299518|NCT02823574|79296474|FG003|Treatment Period|Participant withdrew consent|1|||
44299519|NCT02823574|79296471|FG000|Treatment Period|Participant request to discontinue|5|||
44299520|NCT02823574|79296472|FG001|Treatment Period|Participant request to discontinue|0|||
44299521|NCT02823574|79296473|FG002|Treatment Period|Participant request to discontinue|3|||
44299522|NCT02823574|79296474|FG003|Treatment Period|Participant request to discontinue|2|||
44299523|NCT02823574|79296471|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
44299524|NCT02823574|79296472|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
44299525|NCT02823574|79296473|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
44299526|NCT02823574|79296474|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
44299527|NCT02823574|79296471|FG000|Treatment Period|Study Drug Toxicity|11|||
44299528|NCT02823574|79296472|FG001|Treatment Period|Study Drug Toxicity|2|||
44299529|NCT02823574|79296473|FG002|Treatment Period|Study Drug Toxicity|14|||
44299530|NCT02823574|79296474|FG003|Treatment Period|Study Drug Toxicity|4|||
44299531|NCT02823574|79296471|FG000|Treatment Period|Disease Progression|113|||
44299532|NCT02823574|79296472|FG001|Treatment Period|Disease Progression|64|||
44299533|NCT02823574|79296473|FG002|Treatment Period|Disease Progression|82|||
44299534|NCT02823574|79296474|FG003|Treatment Period|Disease Progression|43|||
44299535|NCT02823574|79296471|FG000|Treatment Period|Other reasons|5|||
44299536|NCT02823574|79296472|FG001|Treatment Period|Other reasons|9|||
44299537|NCT02823574|79296473|FG002|Treatment Period|Other reasons|3|||
44299538|NCT02823574|79296474|FG003|Treatment Period|Other reasons|6|||
44299539|NCT02823574|79296471|FG000|Treatment Period|Participant no longer meets study criteria|0|||
44299540|NCT02823574|79296472|FG001|Treatment Period|Participant no longer meets study criteria|0|||
44299541|NCT02823574|79296473|FG002|Treatment Period|Participant no longer meets study criteria|1|||
44299542|NCT02823574|79296474|FG003|Treatment Period|Participant no longer meets study criteria|0|||
44299543|NCT02823574|79296471|FG000|Treatment Period|Death|0|||
44299544|NCT02823574|79296472|FG001|Treatment Period|Death|0|||
44299545|NCT02823574|79296473|FG002|Treatment Period|Death|3|||
44299546|NCT02823574|79296474|FG003|Treatment Period|Death|1|||
44299547|NCT02746809|79296487|FG000|Enrollment|Inclusion Exclusion not met|9|||
44299548|NCT02746809|79296487|FG000|Enrollment|Withdrawal by Subject|1|||
44299549|NCT02746809|79296487|FG000|Enrollment|Expected Enrollment Met|2|||
44299550|NCT02746809|79296487|FG000|Procedure|Death|1|||
44299551|NCT02746809|79296487|FG000|1-Month|Death|5|||
44299552|NCT02746809|79296487|FG000|6-Month|Death|2|||
44299553|NCT02746809|79296487|FG000|6-Month|Withdrawal by Subject|1|||
44299554|NCT02746809|79296487|FG000|12-Month|Death|3|||
44299555|NCT02746809|79296487|FG000|12-Month|Withdrawal by Subject|2|||
44299556|NCT02746809|79296487|FG000|24-Month|Death|1|||
44299557|NCT02746809|79296487|FG000|24-Month|Withdrawal by Subject|1|||
44299558|NCT02746809|79296487|FG000|36-Month|Death|8|||
44534157|NCT01193842|79544786|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
44534158|NCT01193842|79544787|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
44534159|NCT01193842|79544788|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
44534160|NCT01193842|79544789|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
44299559|NCT02746809|79296487|FG000|36-Month|Withdrawal by Subject|1|||
44299560|NCT02746809|79296487|FG000|48-Month|Death|7|||
44299561|NCT02746809|79296487|FG000|48-Month|Withdrawal by Subject|1|||
44299562|NCT02746809|79296487|FG000|60-Month|Death|1|||
44299563|NCT02746809|79296487|FG000|60-Month|Lost to Follow-up|2|||
44299564|NCT02525796|79296496|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
44299565|NCT02525796|79296497|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
44299566|NCT02525796|79296498|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
44299567|NCT02525796|79296496|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
44299568|NCT02525796|79296497|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
44299569|NCT02525796|79296498|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
44299570|NCT02525796|79296496|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
44299571|NCT02525796|79296497|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
44299572|NCT02525796|79296498|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
44299573|NCT02525796|79296496|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
44299574|NCT02525796|79296497|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
44299575|NCT02525796|79296498|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
44299576|NCT02525796|79296496|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
44299577|NCT02525796|79296497|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
44299578|NCT02525796|79296498|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
44299579|NCT02360280|79296514|FG000|Overall Study|Withdrawal by Subject|2|||
44299580|NCT02360280|79296515|FG001|Overall Study|Withdrawal by Subject|0|||
44299581|NCT02360280|79296514|FG000|Overall Study|Adverse Event|0|||
44299582|NCT02360280|79296515|FG001|Overall Study|Adverse Event|1|||
44299583|NCT02360280|79296514|FG000|Overall Study|Lost to Follow-up|1|||
44299584|NCT02360280|79296515|FG001|Overall Study|Lost to Follow-up|0|||
44299585|NCT02201251|79296523|FG000|Overall Study|Adverse Event|1|||
44299586|NCT02201251|79296524|FG001|Overall Study|Adverse Event|1|||
44299587|NCT02201251|79296523|FG000|Overall Study|Protocol Violation|1|||
44299588|NCT02201251|79296524|FG001|Overall Study|Protocol Violation|0|||
44299589|NCT02201251|79296523|FG000|Overall Study|Noncompliance with Study Drug|0|||
44299590|NCT02201251|79296524|FG001|Overall Study|Noncompliance with Study Drug|1|||
44299591|NCT02201251|79296523|FG000|Overall Study|Withdrawal by Subject|2|||
44299592|NCT02201251|79296524|FG001|Overall Study|Withdrawal by Subject|1|||
44299593|NCT02027545|79296532|FG000|Overall Study|Failed to sign HIPAA|0|||
44299594|NCT02027545|79296533|FG001|Overall Study|Failed to sign HIPAA|2|||
44299595|NCT02027545|79296532|FG000|Overall Study|Failed to attend study visit|2|||
44299596|NCT02027545|79296533|FG001|Overall Study|Failed to attend study visit|0|||
44299597|NCT02027545|79296532|FG000|Overall Study|Protocol Violation|1|||
44299598|NCT02027545|79296533|FG001|Overall Study|Protocol Violation|0|||
44299599|NCT01867242|79296551|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
44299600|NCT01867242|79296552|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
44299601|NCT01867242|79296553|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
44299602|NCT01858688|79296561|FG000|Overall Study|Withdrawal by Subject|8|||
44299603|NCT01858688|79296561|FG000|Overall Study|Participant began another therapy|3|||
44299604|NCT01858688|79296561|FG000|Overall Study|Physician Decision|2|||
44299605|NCT01858688|79296561|FG000|Overall Study|Progressive Disease|2|||
44299606|NCT01858688|79296561|FG000|Overall Study|Reason not reproted|5|||
44299607|NCT01599234|79296580|FG000|Overall Study|Adverse Event|9|||
44299608|NCT01599234|79296581|FG001|Overall Study|Adverse Event|5|||
44299609|NCT01599234|79296580|FG000|Overall Study|Withdrawal by Subject|2|||
44299610|NCT01599234|79296581|FG001|Overall Study|Withdrawal by Subject|1|||
44299611|NCT01599234|79296580|FG000|Overall Study|Lost to Follow-up|1|||
44299612|NCT01599234|79296581|FG001|Overall Study|Lost to Follow-up|2|||
44299613|NCT01599234|79296580|FG000|Overall Study|Lack of Efficacy|2|||
44299614|NCT01599234|79296581|FG001|Overall Study|Lack of Efficacy|4|||
44299615|NCT01599234|79296580|FG000|Overall Study|Unable to operate spray|1|||
44299616|NCT01599234|79296581|FG001|Overall Study|Unable to operate spray|0|||
44299617|NCT01599234|79296580|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
44299618|NCT01599234|79296581|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
44299619|NCT01599234|79296580|FG000|Overall Study|Death|1|||
44299620|NCT01599234|79296581|FG001|Overall Study|Death|0|||
44299621|NCT01599234|79296580|FG000|Overall Study|Patient would not stop driving|1|||
44299622|NCT01599234|79296581|FG001|Overall Study|Patient would not stop driving|0|||
44299623|NCT01599234|79296580|FG000|Overall Study|Contra-indication discovered|0|||
44299624|NCT01599234|79296581|FG001|Overall Study|Contra-indication discovered|1|||
44299625|NCT01599234|79296580|FG000|Overall Study|Pregnancy|0|||
44299626|NCT01599234|79296581|FG001|Overall Study|Pregnancy|1|||
44299627|NCT01393301|79296589|FG000|Overall Study|Lost to Follow-up|5|||
44299628|NCT01393301|79296590|FG001|Overall Study|Lost to Follow-up|3|||
44299629|NCT01393301|79296589|FG000|Overall Study|Withdrawal by Subject|2|||
44299630|NCT01393301|79296590|FG001|Overall Study|Withdrawal by Subject|0|||
44299631|NCT01393301|79296589|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
44299632|NCT01393301|79296590|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
44299633|NCT00716625|79296596|FG000|Overall Study|Safety was not Assessable|1|||
44299634|NCT00713323|79296623|FG000|Overall Study|Adverse Event|75|||
44299635|NCT00713323|79296623|FG000|Overall Study|Withdrawal by Subject|15|||
44299636|NCT00713323|79296623|FG000|Overall Study|Lost to Follow-up|11|||
44299637|NCT00713323|79296623|FG000|Overall Study|Lack of Efficacy|36|||
44299638|NCT00713323|79296623|FG000|Overall Study|Low creatine clearance at screening|1|||
44299639|NCT00713323|79296623|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
44299640|NCT00713323|79296623|FG000|Overall Study|Surgery cured allodynic pain|1|||
44299641|NCT00713323|79296623|FG000|Overall Study|Pain free|1|||
44299642|NCT00713323|79296623|FG000|Overall Study|Non-compliance|1|||
44299643|NCT00713323|79296623|FG000|Overall Study|Pain resolved|1|||
44299644|NCT00713323|79296623|FG000|Overall Study|Subject travelling to USA|1|||
44299645|NCT00713323|79296623|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
44299646|NCT00713323|79296623|FG000|Overall Study|Treatment that may interact with Sativex|1|||
44299647|NCT00710554|79296640|FG000|Overall Study|Adverse Event|24|||
44299648|NCT00710554|79296641|FG001|Overall Study|Adverse Event|7|||
44299649|NCT00710554|79296640|FG000|Overall Study|Withdrawal by Subject|7|||
44299650|NCT00710554|79296641|FG001|Overall Study|Withdrawal by Subject|3|||
44299651|NCT00710554|79296640|FG000|Overall Study|Lost to Follow-up|7|||
44299652|NCT00710554|79296641|FG001|Overall Study|Lost to Follow-up|1|||
44299653|NCT00710554|79296640|FG000|Overall Study|Lack of Efficacy|11|||
44299654|NCT00710554|79296641|FG001|Overall Study|Lack of Efficacy|12|||
44299655|NCT00710554|79296640|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
44299656|NCT00710554|79296641|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
44299657|NCT00710424|79296649|FG000|Overall Study|Adverse Event|30|||
44299658|NCT00710424|79296650|FG001|Overall Study|Adverse Event|12|||
44299659|NCT00710424|79296649|FG000|Overall Study|Lack of Efficacy|4|||
44299660|NCT00710424|79296650|FG001|Overall Study|Lack of Efficacy|5|||
44299661|NCT00710424|79296649|FG000|Overall Study|Withdrawal by Subject|5|||
44299662|NCT00710424|79296650|FG001|Overall Study|Withdrawal by Subject|3|||
44154813|NCT02682823|78946135|FG000|Overall Study|Adverse Event|0|||
44154814|NCT02682823|78946136|FG001|Overall Study|Adverse Event|0|||
44154815|NCT02682823|78946137|FG002|Overall Study|Adverse Event|0|||
44299663|NCT00710424|79296649|FG000|Overall Study|Lost to Follow-up|0|||
44299664|NCT00710424|79296650|FG001|Overall Study|Lost to Follow-up|1|||
44299665|NCT00710424|79296649|FG000|Overall Study|Refused medication, no side effects|1|||
44299666|NCT00710424|79296650|FG001|Overall Study|Refused medication, no side effects|0|||
44299667|NCT00710424|79296649|FG000|Overall Study|Non-compliance with stable analgesia|1|||
44299668|NCT00710424|79296650|FG001|Overall Study|Non-compliance with stable analgesia|0|||
44299669|NCT00710424|79296649|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
44299670|NCT00710424|79296650|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
44299671|NCT00710424|79296649|FG000|Overall Study|Subject thought medication changed|1|||
44299672|NCT00710424|79296650|FG001|Overall Study|Subject thought medication changed|0|||
44299673|NCT00710424|79296649|FG000|Overall Study|Ceased treatment due to travel|1|||
44534161|NCT01193842|79544790|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
44534162|NCT01193842|79544786|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
44534163|NCT01193842|79544787|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
44534164|NCT01193842|79544788|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
44534165|NCT01193842|79544789|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
44534166|NCT01193842|79544790|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
44534167|NCT01193842|79544786|FG000|Phase II: Randomized Groups|Death|0|||
44534168|NCT01193842|79544787|FG001|Phase II: Randomized Groups|Death|0|||
44534169|NCT01193842|79544788|FG002|Phase II: Randomized Groups|Death|0|||
44534170|NCT01193842|79544789|FG003|Phase II: Randomized Groups|Death|1|||
44534171|NCT01193842|79544790|FG004|Phase II: Randomized Groups|Death|1|||
44534172|NCT01193842|79544786|FG000|Phase II: Randomized Groups|Adverse Event|0|||
44534173|NCT01193842|79544787|FG001|Phase II: Randomized Groups|Adverse Event|0|||
44534174|NCT01193842|79544788|FG002|Phase II: Randomized Groups|Adverse Event|0|||
44534175|NCT01193842|79544789|FG003|Phase II: Randomized Groups|Adverse Event|5|||
44534176|NCT01193842|79544790|FG004|Phase II: Randomized Groups|Adverse Event|3|||
44534177|NCT01193842|79544786|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
44534178|NCT01193842|79544787|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
44534179|NCT01193842|79544788|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
44534180|NCT01193842|79544789|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
44534181|NCT01193842|79544790|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
44534182|NCT01193842|79544786|FG000|Phase II: Randomized Groups|Ineligible|0|||
44534183|NCT01193842|79544787|FG001|Phase II: Randomized Groups|Ineligible|0|||
44534184|NCT01193842|79544788|FG002|Phase II: Randomized Groups|Ineligible|0|||
44534185|NCT01193842|79544789|FG003|Phase II: Randomized Groups|Ineligible|0|||
44534186|NCT01193842|79544790|FG004|Phase II: Randomized Groups|Ineligible|1|||
44534187|NCT01193842|79544786|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
44534188|NCT01193842|79544787|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
44534189|NCT01193842|79544788|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
44534190|NCT01193842|79544789|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
44534191|NCT01193842|79544790|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
44534192|NCT00855465|79544814|FG000|Treatment Period|Adverse Event|4|||
44154816|NCT02682823|78946138|FG003|Overall Study|Adverse Event|1|||
44299674|NCT00710424|79296650|FG001|Overall Study|Ceased treatment due to travel|0|||
44299675|NCT00710424|79296649|FG000|Overall Study|Subject preferred paracetamol|0|||
44299676|NCT00710424|79296650|FG001|Overall Study|Subject preferred paracetamol|1|||
44299677|NCT00710424|79296649|FG000|Overall Study|Felt good so stopped treatment|0|||
44299678|NCT00710424|79296650|FG001|Overall Study|Felt good so stopped treatment|1|||
44299679|NCT00118846|79296680|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
44299680|NCT00118846|79296681|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
44299681|NCT00118846|79296680|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
44299682|NCT00118846|79296681|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
44299683|NCT00118846|79296680|FG000|Overall Study|Physician Decision|1|||
44256704|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
44256705|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
44256706|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
44256707|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
44256708|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
44256709|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
44256710|NCT01435928|79107302|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
44256711|NCT01435928|79107303|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
44256712|NCT01435928|79107304|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
44256713|NCT01416272|79107316|FG000|Overall Study|Unacceptable distance visual acuity|2|||
44256714|NCT01416272|79107316|FG000|Overall Study|Lost to Follow-up|1|||
44256715|NCT01416272|79107316|FG000|Overall Study|Study related complaints|1|||
44299684|NCT00118846|79296681|FG001|Overall Study|Physician Decision|0|||
44299685|NCT00118846|79296680|FG000|Overall Study|Medical condition|2|||
44299686|NCT00118846|79296681|FG001|Overall Study|Medical condition|2|||
44299687|NCT00118846|79296680|FG000|Overall Study|Lost to Follow-up|0|||
44299688|NCT00118846|79296681|FG001|Overall Study|Lost to Follow-up|2|||
44299689|NCT00118846|79296680|FG000|Overall Study|Personal reason|4|||
44299690|NCT00118846|79296681|FG001|Overall Study|Personal reason|5|||
44299691|NCT04705051|79296687|FG000|Overall Study|Enrolled but not treated|1|||
44299692|NCT04705051|79296687|FG000|Overall Study|Study terminated by sponsor|23|||
44299693|NCT04464421|79296694|FG000|Overall Study|Lost to Follow-up|2|||
44299694|NCT04464421|79296695|FG001|Overall Study|Lost to Follow-up|2|||
44299695|NCT04112784|79296713|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
44299696|NCT04112784|79296713|FG000|Overall Study|Screen Failures|4|||
44299697|NCT04049617|79296723|FG000|Overall Study|Adverse Event|0|||
44299698|NCT04049617|79296724|FG001|Overall Study|Adverse Event|0|||
44299699|NCT04049617|79296725|FG002|Overall Study|Adverse Event|0|||
44299700|NCT04049617|79296726|FG003|Overall Study|Adverse Event|1|||
44299701|NCT04049617|79296727|FG004|Overall Study|Adverse Event|0|||
44299702|NCT04049617|79296728|FG005|Overall Study|Adverse Event|0|||
44299703|NCT04049617|79296723|FG000|Overall Study|Death|0|||
44299704|NCT04049617|79296724|FG001|Overall Study|Death|0|||
44299705|NCT04049617|79296725|FG002|Overall Study|Death|0|||
44299706|NCT04049617|79296726|FG003|Overall Study|Death|0|||
44299707|NCT04049617|79296727|FG004|Overall Study|Death|0|||
44299708|NCT04049617|79296728|FG005|Overall Study|Death|1|||
44299709|NCT04049617|79296723|FG000|Overall Study|Lost to Follow-up|0|||
44299710|NCT04049617|79296724|FG001|Overall Study|Lost to Follow-up|0|||
44299711|NCT04049617|79296725|FG002|Overall Study|Lost to Follow-up|0|||
44299712|NCT04049617|79296726|FG003|Overall Study|Lost to Follow-up|1|||
44299713|NCT04049617|79296727|FG004|Overall Study|Lost to Follow-up|0|||
44299714|NCT04049617|79296728|FG005|Overall Study|Lost to Follow-up|0|||
44299715|NCT04049617|79296723|FG000|Overall Study|Withdrew consent|0|||
44299716|NCT04049617|79296724|FG001|Overall Study|Withdrew consent|0|||
44299717|NCT04049617|79296725|FG002|Overall Study|Withdrew consent|1|||
44299718|NCT04049617|79296726|FG003|Overall Study|Withdrew consent|0|||
44299719|NCT04049617|79296727|FG004|Overall Study|Withdrew consent|0|||
44299720|NCT04049617|79296728|FG005|Overall Study|Withdrew consent|0|||
44299721|NCT03911154|79296744|FG000|Overall Study|Withdrawal by Subject|1|||
44299722|NCT03781778|79296762|FG000|Overall Study|Withdrawal by Subject|2|||
44299723|NCT03781778|79296763|FG001|Overall Study|Withdrawal by Subject|2|||
44299724|NCT03710590|79296771|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
44299725|NCT03710590|79296772|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
44299726|NCT03465722|79296824|FG000|Overall Study|Withdrawal by Subject|21|||
44299727|NCT03465722|79296825|FG001|Overall Study|Withdrawal by Subject|14|||
44299728|NCT03465722|79296824|FG000|Overall Study|Death|89|||
44299729|NCT03465722|79296825|FG001|Overall Study|Death|87|||
44299730|NCT03465722|79296824|FG000|Overall Study|Lost to Follow-up|5|||
44299731|NCT03465722|79296825|FG001|Overall Study|Lost to Follow-up|3|||
44299732|NCT03465722|79296824|FG000|Overall Study|Administrative/Other|33|||
44299733|NCT03465722|79296825|FG001|Overall Study|Administrative/Other|32|||
44299734|NCT03465722|79296824|FG000|Overall Study|Not treated|1|||
44299735|NCT03465722|79296825|FG001|Overall Study|Not treated|2|||
44299736|NCT03465722|79296824|FG000|Overall Study|Sponsor decision|91|||
44299737|NCT03465722|79296825|FG001|Overall Study|Sponsor decision|98|||
44299738|NCT03205423|79296831|FG000|Overall Study|Personal|1|||
44299739|NCT03205423|79296832|FG001|Overall Study|Personal|1|||
44299740|NCT03205423|79296831|FG000|Overall Study|Physician Decision|0|||
44299741|NCT03205423|79296832|FG001|Overall Study|Physician Decision|2|||
44299742|NCT03073603|79296841|FG000|Overall Study|Noncompliance|3|||
44299743|NCT03073603|79296842|FG001|Overall Study|Noncompliance|1|||
44299744|NCT03073603|79296841|FG000|Overall Study|Adverse Event|5|||
44299745|NCT03073603|79296842|FG001|Overall Study|Adverse Event|3|||
44299746|NCT03073603|79296841|FG000|Overall Study|Physician Decision|1|||
44299747|NCT03073603|79296842|FG001|Overall Study|Physician Decision|2|||
44299748|NCT03073603|79296841|FG000|Overall Study|Required treatment not allowed by protocol|1|||
44299749|NCT03073603|79296842|FG001|Overall Study|Required treatment not allowed by protocol|0|||
44299750|NCT03073603|79296841|FG000|Overall Study|Financial or insurance-related|8|||
44299751|NCT03073603|79296842|FG001|Overall Study|Financial or insurance-related|0|||
44299752|NCT03073603|79296841|FG000|Overall Study|Withdrawal by Subject|0|||
44299753|NCT03073603|79296842|FG001|Overall Study|Withdrawal by Subject|1|||
44299754|NCT03073603|79296841|FG000|Overall Study|Discontinued DMT|4|||
44299755|NCT03073603|79296842|FG001|Overall Study|Discontinued DMT|0|||
44299756|NCT03073603|79296841|FG000|Overall Study|Restarted DMT|0|||
44299757|NCT03073603|79296842|FG001|Overall Study|Restarted DMT|1|||
44299758|NCT03002155|79296850|FG000|Overall Study|Lost to Follow-up|1|||
44299759|NCT03002155|79296851|FG001|Overall Study|Lost to Follow-up|2|||
44299760|NCT03002155|79296850|FG000|Overall Study|Withdrawal by Subject|1|||
44299761|NCT03002155|79296851|FG001|Overall Study|Withdrawal by Subject|0|||
44299762|NCT03002155|79296850|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
44299763|NCT03002155|79296851|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
44299764|NCT02918006|79296861|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
44299765|NCT02918006|79296862|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
44299766|NCT02918006|79296863|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
44299767|NCT02918006|79296861|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
44299768|NCT02918006|79296862|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
44299769|NCT02918006|79296863|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
44299770|NCT02918006|79296861|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
44299771|NCT02918006|79296862|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
44299772|NCT02918006|79296863|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
44299773|NCT02918006|79296861|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
44299774|NCT02918006|79296862|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
44299775|NCT02918006|79296863|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
44299776|NCT02918006|79296861|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
44299777|NCT02918006|79296862|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
44299778|NCT02918006|79296863|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
44299779|NCT02918006|79296861|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
44299780|NCT02918006|79296862|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
44299781|NCT02918006|79296863|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
44299782|NCT02918006|79296861|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
44299783|NCT02918006|79296862|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
44299784|NCT02918006|79296863|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
44299785|NCT02918006|79296861|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
44299786|NCT02918006|79296862|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
44299787|NCT02918006|79296863|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
44299788|NCT02918006|79296861|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
44299789|NCT02918006|79296862|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
44299790|NCT02918006|79296863|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
44299791|NCT02179749|79296908|FG000|Overall Study|Adverse Event|0|||
44299792|NCT02179749|79296909|FG001|Overall Study|Adverse Event|0|||
44299793|NCT02179749|79296910|FG002|Overall Study|Adverse Event|1|||
44299794|NCT02179749|79296908|FG000|Overall Study|Withdrawal by Subject|0|||
44299795|NCT02179749|79296909|FG001|Overall Study|Withdrawal by Subject|0|||
44299796|NCT02179749|79296910|FG002|Overall Study|Withdrawal by Subject|1|||
44299797|NCT02075593|79296921|FG000|Overall Study|Withdrawal by Subject|1|||
44299798|NCT00641186|79296954|FG000|Overall Study|Adverse Event|3|||
44299799|NCT01595009|79296960|FG000|Core|Patients completed per protocol|85|||
44299800|NCT01595009|79296961|FG001|Core|Patients completed per protocol|44|||
44299801|NCT01595009|79296962|FG002|Core|Patients completed per protocol|0|||
44299802|NCT01595009|79296963|FG003|Core|Patients completed per protocol|0|||
44299803|NCT01595009|79296960|FG000|Core|Adverse Event|19|||
44299804|NCT01595009|79296961|FG001|Core|Adverse Event|23|||
44299805|NCT01595009|79296962|FG002|Core|Adverse Event|0|||
44299806|NCT01595009|79296963|FG003|Core|Adverse Event|0|||
44299807|NCT01595009|79296960|FG000|Core|Disease progression|14|||
44299808|NCT01595009|79296961|FG001|Core|Disease progression|26|||
44299809|NCT01595009|79296962|FG002|Core|Disease progression|0|||
44299810|NCT01595009|79296963|FG003|Core|Disease progression|0|||
44299811|NCT01595009|79296960|FG000|Core|Withdrawal by Subject|4|||
44299812|NCT01595009|79296961|FG001|Core|Withdrawal by Subject|17|||
44299813|NCT01595009|79296962|FG002|Core|Withdrawal by Subject|0|||
44299814|NCT01595009|79296963|FG003|Core|Withdrawal by Subject|0|||
44299815|NCT01595009|79296960|FG000|Core|Death|3|||
44299816|NCT01595009|79296961|FG001|Core|Death|6|||
44299817|NCT01595009|79296962|FG002|Core|Death|0|||
44299818|NCT01595009|79296963|FG003|Core|Death|0|||
44299819|NCT01595009|79296960|FG000|Core|Lost to Follow-up|1|||
44299820|NCT01595009|79296961|FG001|Core|Lost to Follow-up|2|||
44299821|NCT01595009|79296962|FG002|Core|Lost to Follow-up|0|||
44299822|NCT01595009|79296963|FG003|Core|Lost to Follow-up|0|||
44299823|NCT01595009|79296960|FG000|Core|Protocol deviation|0|||
44299824|NCT01595009|79296961|FG001|Core|Protocol deviation|1|||
44299825|NCT01595009|79296962|FG002|Core|Protocol deviation|0|||
44299826|NCT01595009|79296963|FG003|Core|Protocol deviation|0|||
44299827|NCT01595009|79296960|FG000|Core|Administrative problems|0|||
44299828|NCT01595009|79296961|FG001|Core|Administrative problems|1|||
44299829|NCT01595009|79296962|FG002|Core|Administrative problems|0|||
44299830|NCT01595009|79296963|FG003|Core|Administrative problems|0|||
44299831|NCT01595009|79296960|FG000|Extension|Administrative problems|0|||
44299832|NCT01595009|79296961|FG001|Extension|Administrative problems|0|||
44299833|NCT01595009|79296962|FG002|Extension|Administrative problems|0|||
44299834|NCT01595009|79296963|FG003|Extension|Administrative problems|1|||
44299835|NCT01595009|79296960|FG000|Extension|Patients completed per protocol|0|||
44299836|NCT01595009|79296961|FG001|Extension|Patients completed per protocol|0|||
44299837|NCT01595009|79296962|FG002|Extension|Patients completed per protocol|0|||
44299838|NCT01595009|79296963|FG003|Extension|Patients completed per protocol|2|||
44299839|NCT01595009|79296960|FG000|Extension|Disease progression|0|||
44299840|NCT01595009|79296961|FG001|Extension|Disease progression|0|||
44299841|NCT01595009|79296962|FG002|Extension|Disease progression|4|||
44299842|NCT01595009|79296963|FG003|Extension|Disease progression|7|||
44299843|NCT01595009|79296960|FG000|Extension|Adverse Event|0|||
44299844|NCT01595009|79296961|FG001|Extension|Adverse Event|0|||
44299845|NCT01595009|79296962|FG002|Extension|Adverse Event|0|||
44299846|NCT01595009|79296963|FG003|Extension|Adverse Event|1|||
44299847|NCT05553808|79296980|FG000|Overall Study|Death|25|||
44299848|NCT05553808|79296981|FG001|Overall Study|Death|62|||
44299849|NCT05553808|79296980|FG000|Overall Study|Site Closed|6|||
44299850|NCT05553808|79296981|FG001|Overall Study|Site Closed|6|||
44299851|NCT05553808|79296980|FG000|Overall Study|Lost to Follow-up|1|||
44299852|NCT05553808|79296981|FG001|Overall Study|Lost to Follow-up|0|||
44299853|NCT05553808|79296980|FG000|Overall Study|Withdrawal by Subject|3|||
44299854|NCT05553808|79296981|FG001|Overall Study|Withdrawal by Subject|2|||
44299855|NCT04997161|79296997|FG000|Overall Study|Study terminated by sponsor|3|||
44299856|NCT04753216|79297001|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
44299857|NCT04753216|79297001|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
44299858|NCT04753216|79297001|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
44299859|NCT04530747|79297034|FG000|Overall Study|Withdrawal by Subject|1|||
44299860|NCT04530747|79297035|FG001|Overall Study|Withdrawal by Subject|0|||
44299861|NCT04040751|79297056|FG000|Overall Study|Withdrawal by Subject|2|||
44299862|NCT04040751|79297057|FG001|Overall Study|Withdrawal by Subject|0|||
44299863|NCT04040751|79297058|FG002|Overall Study|Withdrawal by Subject|2|||
44299864|NCT04040751|79297059|FG003|Overall Study|Withdrawal by Subject|0|||
44299865|NCT03997916|79297069|FG000|Overall Study|Protocol Violation|35|||
44299866|NCT03596177|79297088|FG000|Single Blind Period|Withdrawal by Subject|1|||
44299867|NCT03596177|79297089|FG001|Single Blind Period|Withdrawal by Subject|1|||
44299868|NCT03596177|79297088|FG000|Single Blind Period|Other|1|||
44299869|NCT03596177|79297089|FG001|Single Blind Period|Other|0|||
44299870|NCT03596177|79297088|FG000|Double Blind Period|Withdrawal by Subject|0|||
44299871|NCT03596177|79297089|FG001|Double Blind Period|Withdrawal by Subject|1|||
44299872|NCT03596177|79297088|FG000|Double Blind Period|Other|0|||
44299873|NCT03596177|79297089|FG001|Double Blind Period|Other|4|||
44299874|NCT03596177|79297088|FG000|Double Blind Period|Death during safety follow-up|0|||
44299875|NCT03596177|79297089|FG001|Double Blind Period|Death during safety follow-up|1|||
44299876|NCT03579459|79297099|FG000|Overall Study|Adverse Event|7|||
44299877|NCT03579459|79297100|FG001|Overall Study|Adverse Event|6|||
44299878|NCT03579459|79297101|FG002|Overall Study|Adverse Event|2|||
44299879|NCT03579459|79297102|FG003|Overall Study|Adverse Event|6|||
44299880|NCT03579459|79297099|FG000|Overall Study|Death|1|||
44299881|NCT03579459|79297100|FG001|Overall Study|Death|0|||
44299882|NCT03579459|79297101|FG002|Overall Study|Death|1|||
44299883|NCT03579459|79297102|FG003|Overall Study|Death|2|||
44299884|NCT03579459|79297099|FG000|Overall Study|Lost to Follow-up|6|||
44299885|NCT03579459|79297100|FG001|Overall Study|Lost to Follow-up|2|||
44299886|NCT03579459|79297101|FG002|Overall Study|Lost to Follow-up|4|||
44299887|NCT03579459|79297102|FG003|Overall Study|Lost to Follow-up|1|||
44299888|NCT03579459|79297099|FG000|Overall Study|Physician Decision|0|||
44299889|NCT03579459|79297100|FG001|Overall Study|Physician Decision|1|||
44299890|NCT03579459|79297101|FG002|Overall Study|Physician Decision|0|||
44299891|NCT03579459|79297102|FG003|Overall Study|Physician Decision|1|||
44299892|NCT03579459|79297099|FG000|Overall Study|Protocol Violation|1|||
44299893|NCT03579459|79297100|FG001|Overall Study|Protocol Violation|2|||
44299894|NCT03579459|79297101|FG002|Overall Study|Protocol Violation|3|||
44299895|NCT03579459|79297102|FG003|Overall Study|Protocol Violation|5|||
44299896|NCT03579459|79297099|FG000|Overall Study|Withdrawal by Subject|12|||
44299897|NCT03579459|79297100|FG001|Overall Study|Withdrawal by Subject|8|||
44299898|NCT03579459|79297101|FG002|Overall Study|Withdrawal by Subject|11|||
44299899|NCT03579459|79297102|FG003|Overall Study|Withdrawal by Subject|8|||
44299900|NCT03579459|79297099|FG000|Overall Study|Medication error without associated adverse event|2|||
44299901|NCT03579459|79297100|FG001|Overall Study|Medication error without associated adverse event|1|||
44299902|NCT03579459|79297101|FG002|Overall Study|Medication error without associated adverse event|1|||
44299903|NCT03579459|79297102|FG003|Overall Study|Medication error without associated adverse event|0|||
44299904|NCT03579459|79297099|FG000|Overall Study|Other|0|||
44299905|NCT03579459|79297100|FG001|Overall Study|Other|1|||
44299906|NCT03579459|79297101|FG002|Overall Study|Other|1|||
44299907|NCT03579459|79297102|FG003|Overall Study|Other|0|||
44299908|NCT03579459|79297099|FG000|Overall Study|Randomized not vaccinated|0|||
44299909|NCT03579459|79297100|FG001|Overall Study|Randomized not vaccinated|2|||
44299910|NCT03579459|79297101|FG002|Overall Study|Randomized not vaccinated|0|||
44299911|NCT03579459|79297102|FG003|Overall Study|Randomized not vaccinated|1|||
44299912|NCT04449276|79297129|FG000|Overall Study|Adverse Event|1|||
44299913|NCT04449276|79297130|FG001|Overall Study|Adverse Event|2|||
44299914|NCT04449276|79297131|FG002|Overall Study|Adverse Event|0|||
44299915|NCT04449276|79297132|FG003|Overall Study|Adverse Event|0|||
44299916|NCT04449276|79297133|FG004|Overall Study|Adverse Event|2|||
44299917|NCT04449276|79297134|FG005|Overall Study|Adverse Event|0|||
44299918|NCT04449276|79297135|FG006|Overall Study|Adverse Event|0|||
44299919|NCT04449276|79297136|FG007|Overall Study|Adverse Event|1|||
44299920|NCT04449276|79297129|FG000|Overall Study|Withdrawal by Subject|2|||
44299921|NCT04449276|79297130|FG001|Overall Study|Withdrawal by Subject|0|||
44299922|NCT04449276|79297131|FG002|Overall Study|Withdrawal by Subject|0|||
44299923|NCT04449276|79297132|FG003|Overall Study|Withdrawal by Subject|1|||
44299924|NCT04449276|79297133|FG004|Overall Study|Withdrawal by Subject|0|||
44299925|NCT04449276|79297134|FG005|Overall Study|Withdrawal by Subject|0|||
44154817|NCT02682823|78946139|FG004|Overall Study|Adverse Event|0|||
44154818|NCT01374451|78946153|FG000|Overall Study|Administrative problems|1|||
44154819|NCT01374451|78946154|FG001|Overall Study|Administrative problems|0|||
44299926|NCT04449276|79297135|FG006|Overall Study|Withdrawal by Subject|0|||
44299927|NCT04449276|79297136|FG007|Overall Study|Withdrawal by Subject|0|||
44299928|NCT04449276|79297129|FG000|Overall Study|Other|0|||
44299929|NCT04449276|79297130|FG001|Overall Study|Other|2|||
44299930|NCT04449276|79297131|FG002|Overall Study|Other|3|||
44299931|NCT04449276|79297132|FG003|Overall Study|Other|2|||
44299932|NCT04449276|79297133|FG004|Overall Study|Other|0|||
44299933|NCT04449276|79297134|FG005|Overall Study|Other|0|||
44299934|NCT04449276|79297135|FG006|Overall Study|Other|0|||
44299935|NCT04449276|79297136|FG007|Overall Study|Other|1|||
44299936|NCT04391894|79297176|FG000|Overall Study|Adverse Event|1|||
44154820|NCT02674477|78946162|FG000|Overall Study|Protocol Violation|8|||
44154821|NCT02674477|78946163|FG001|Overall Study|Protocol Violation|2|||
44154822|NCT01352845|78946171|FG000|Overall Study|Lost to Follow-up|313|||
44299937|NCT04391894|79297177|FG001|Overall Study|Adverse Event|1|||
44299938|NCT04391894|79297178|FG002|Overall Study|Adverse Event|1|||
44299939|NCT04391894|79297179|FG003|Overall Study|Adverse Event|1|||
44299940|NCT04391894|79297180|FG004|Overall Study|Adverse Event|1|||
44299941|NCT04391894|79297176|FG000|Overall Study|Lost to Follow-up|1|||
44299942|NCT04391894|79297177|FG001|Overall Study|Lost to Follow-up|0|||
44299943|NCT04391894|79297178|FG002|Overall Study|Lost to Follow-up|0|||
44299944|NCT04391894|79297179|FG003|Overall Study|Lost to Follow-up|0|||
44299945|NCT04391894|79297180|FG004|Overall Study|Lost to Follow-up|0|||
44299946|NCT04391894|79297176|FG000|Overall Study|Protocol Violation|0|||
44299947|NCT04391894|79297177|FG001|Overall Study|Protocol Violation|0|||
44299948|NCT04391894|79297178|FG002|Overall Study|Protocol Violation|0|||
44154823|NCT01352845|78946172|FG001|Overall Study|Lost to Follow-up|92|||
44299949|NCT04391894|79297179|FG003|Overall Study|Protocol Violation|1|||
44299950|NCT04391894|79297180|FG004|Overall Study|Protocol Violation|0|||
44299951|NCT04391894|79297176|FG000|Overall Study|Withdrawal by Subject|2|||
44299952|NCT04391894|79297177|FG001|Overall Study|Withdrawal by Subject|0|||
44154824|NCT01352845|78946171|FG000|Overall Study|No Longer Willing to Participate|205|||
44154825|NCT01352845|78946172|FG001|Overall Study|No Longer Willing to Participate|58|||
44154826|NCT01352845|78946171|FG000|Overall Study|Withdrawal by Subject|48|||
44154827|NCT01352845|78946172|FG001|Overall Study|Withdrawal by Subject|16|||
44154828|NCT01352845|78946171|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
44154829|NCT01352845|78946172|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
44154830|NCT01352845|78946171|FG000|Overall Study|Pregnancy|27|||
44154831|NCT01352845|78946172|FG001|Overall Study|Pregnancy|7|||
44154832|NCT01352845|78946171|FG000|Overall Study|Adverse Event|22|||
44154833|NCT01352845|78946172|FG001|Overall Study|Adverse Event|6|||
44154834|NCT01352845|78946171|FG000|Overall Study|Other|17|||
44154835|NCT01352845|78946172|FG001|Overall Study|Other|7|||
44154836|NCT01352845|78946171|FG000|Overall Study|Protocol Violation|12|||
44154837|NCT01352845|78946172|FG001|Overall Study|Protocol Violation|6|||
44154838|NCT01352845|78946171|FG000|Overall Study|Death|3|||
44154839|NCT01352845|78946172|FG001|Overall Study|Death|0|||
44154840|NCT02674399|78946180|FG000|Overall Study|Lost to Follow-up|2|||
44154841|NCT02674399|78946181|FG001|Overall Study|Lost to Follow-up|0|||
44154842|NCT02676895|78946190|FG000|Overall Study|Administrative reason|1|||
44154843|NCT02676895|78946191|FG001|Overall Study|Administrative reason|0|||
44154844|NCT02676895|78946192|FG002|Overall Study|Administrative reason|0|||
44154845|NCT02676895|78946190|FG000|Overall Study|Protocol Violation|1|||
44154846|NCT02676895|78946191|FG001|Overall Study|Protocol Violation|0|||
44154847|NCT02676895|78946192|FG002|Overall Study|Protocol Violation|0|||
44154848|NCT02676895|78946190|FG000|Overall Study|Adverse Event|0|||
44256716|NCT01435772|79107806|FG000|Overall Study|Adverse Event|1|||
44256717|NCT01435772|79107807|FG001|Overall Study|Adverse Event|0|||
44256718|NCT01435772|79107808|FG002|Overall Study|Adverse Event|2|||
44154849|NCT02676895|78946191|FG001|Overall Study|Adverse Event|3|||
44154850|NCT02676895|78946192|FG002|Overall Study|Adverse Event|1|||
44154851|NCT02676895|78946190|FG000|Overall Study|Lost to Follow-up|0|||
44154852|NCT02676895|78946191|FG001|Overall Study|Lost to Follow-up|0|||
44154853|NCT02676895|78946192|FG002|Overall Study|Lost to Follow-up|1|||
44154854|NCT02676895|78946190|FG000|Overall Study|Withdrawal by Subject|0|||
44154855|NCT02676895|78946191|FG001|Overall Study|Withdrawal by Subject|0|||
44154856|NCT02676895|78946192|FG002|Overall Study|Withdrawal by Subject|1|||
44154857|NCT02673697|78946203|FG000|Overall Study|Adverse Event|2|||
44154858|NCT02673697|78946204|FG001|Overall Study|Adverse Event|0|||
44154859|NCT02673697|78946203|FG000|Overall Study|Death|32|||
44154860|NCT02673697|78946204|FG001|Overall Study|Death|24|||
44154861|NCT02673697|78946203|FG000|Overall Study|Lost to Follow-up|5|||
44154862|NCT02673697|78946204|FG001|Overall Study|Lost to Follow-up|2|||
44154863|NCT02673697|78946203|FG000|Overall Study|Physician Decision|2|||
44154864|NCT02673697|78946204|FG001|Overall Study|Physician Decision|1|||
44154865|NCT02673697|78946203|FG000|Overall Study|Withdrawal by Subject|10|||
44154866|NCT02673697|78946204|FG001|Overall Study|Withdrawal by Subject|7|||
44256719|NCT01435772|79107806|FG000|Overall Study|Withdrawal by Subject|0|||
44256720|NCT01435772|79107807|FG001|Overall Study|Withdrawal by Subject|1|||
44256721|NCT01435772|79107808|FG002|Overall Study|Withdrawal by Subject|3|||
44256722|NCT01435772|79107806|FG000|Overall Study|Other - study termination|2|||
44256723|NCT01435772|79107807|FG001|Overall Study|Other - study termination|2|||
44256724|NCT01435772|79107808|FG002|Overall Study|Other - study termination|10|||
44256725|NCT01435616|79108027|FG000|Overall Study|Adverse Event|39|||
44256726|NCT01435616|79108028|FG001|Overall Study|Adverse Event|21|||
44256727|NCT01435616|79108027|FG000|Overall Study|Death|7|||
44256728|NCT01435616|79108028|FG001|Overall Study|Death|2|||
44256729|NCT01435616|79108027|FG000|Overall Study|Lost to Follow-up|22|||
44256730|NCT01435616|79108028|FG001|Overall Study|Lost to Follow-up|13|||
44256731|NCT01435616|79108027|FG000|Overall Study|Protocol Violation|16|||
44256732|NCT01435616|79108028|FG001|Overall Study|Protocol Violation|13|||
44256733|NCT01435616|79108027|FG000|Overall Study|Withdrawal by Subject|66|||
44256734|NCT01435616|79108028|FG001|Overall Study|Withdrawal by Subject|24|||
44256735|NCT01435616|79108027|FG000|Overall Study|Physician Decision|20|||
44256736|NCT01435616|79108028|FG001|Overall Study|Physician Decision|7|||
44256737|NCT01435616|79108027|FG000|Overall Study|Sponsor Decision|1|||
44256738|NCT01435616|79108028|FG001|Overall Study|Sponsor Decision|0|||
44256739|NCT01435460|79108087|FG000|Overall Study|Adverse Event|2|||
44256740|NCT01435460|79108088|FG001|Overall Study|Adverse Event|1|||
44256741|NCT01435460|79108087|FG000|Overall Study|Lost to Follow-up|6|||
44256742|NCT01435460|79108088|FG001|Overall Study|Lost to Follow-up|1|||
44154867|NCT02673697|78946203|FG000|Overall Study|Change subj medical status|1|||
44154868|NCT02673697|78946204|FG001|Overall Study|Change subj medical status|2|||
44154869|NCT02673697|78946203|FG000|Overall Study|Explant|10|||
44154870|NCT02673697|78946204|FG001|Overall Study|Explant|5|||
44154871|NCT02673697|78946203|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
44154872|NCT02673697|78946204|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
44154873|NCT05168579|78946212|FG000|Overall Study|Lack of Consent|1|||
44256743|NCT01435460|79108087|FG000|Overall Study|Withdrawal by Subject|1|||
44256744|NCT01435460|79108088|FG001|Overall Study|Withdrawal by Subject|3|||
44299953|NCT04391894|79297178|FG002|Overall Study|Withdrawal by Subject|3|||
44299954|NCT04391894|79297179|FG003|Overall Study|Withdrawal by Subject|0|||
44299955|NCT04391894|79297180|FG004|Overall Study|Withdrawal by Subject|1|||
44299956|NCT04391894|79297176|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
44299957|NCT04391894|79297177|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
44299958|NCT04391894|79297178|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
44299959|NCT04391894|79297179|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
44299960|NCT04391894|79297180|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
44299961|NCT03851705|79297198|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
44256745|NCT01435460|79108087|FG000|Overall Study|Protocol Violation|0|||
44417377|NCT00826241|79425292|FG000|Overall Study|Could not obtain records|1|||
44417378|NCT00826241|79425292|FG000|Overall Study|Screen failure|2|||
44417379|NCT00826241|79425292|FG000|Overall Study|Pt unable to proceed to registration|1|||
44417380|NCT00826241|79425292|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
44417381|NCT00758589|79425300|FG000|Overall Study|Adverse Event|3|||
44417382|NCT00758589|79425301|FG001|Overall Study|Adverse Event|2|||
44417383|NCT00758589|79425302|FG002|Overall Study|Adverse Event|5|||
44417384|NCT00758589|79425303|FG003|Overall Study|Adverse Event|4|||
44417385|NCT00758589|79425300|FG000|Overall Study|Withdrawal by Subject|0|||
44417386|NCT00758589|79425301|FG001|Overall Study|Withdrawal by Subject|1|||
44417387|NCT00758589|79425302|FG002|Overall Study|Withdrawal by Subject|1|||
44417388|NCT00758589|79425303|FG003|Overall Study|Withdrawal by Subject|1|||
44417389|NCT00758589|79425300|FG000|Overall Study|Palm stopped to work|0|||
44417390|NCT00758589|79425301|FG001|Overall Study|Palm stopped to work|0|||
44417391|NCT00758589|79425302|FG002|Overall Study|Palm stopped to work|0|||
44417392|NCT00758589|79425303|FG003|Overall Study|Palm stopped to work|1|||
44417393|NCT00833417|79425315|FG000|Overall Study|Adverse Event|5|||
44417394|NCT00833417|79425316|FG001|Overall Study|Adverse Event|16|||
44417395|NCT00833417|79425315|FG000|Overall Study|Death|1|||
44417396|NCT00833417|79425316|FG001|Overall Study|Death|3|||
44417397|NCT00833417|79425315|FG000|Overall Study|Lost to Follow-up|1|||
44299962|NCT03851705|79297199|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
44417398|NCT00833417|79425316|FG001|Overall Study|Lost to Follow-up|2|||
44417399|NCT00833417|79425315|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
44417400|NCT00833417|79425316|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
44417401|NCT00833417|79425315|FG000|Overall Study|Patient Decision to Withdraw|4|||
44417402|NCT00833417|79425316|FG001|Overall Study|Patient Decision to Withdraw|23|||
44417403|NCT00833417|79425315|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
44417404|NCT00833417|79425316|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
44417405|NCT00833417|79425315|FG000|Overall Study|Disease Progression|18|||
44417406|NCT00833417|79425316|FG001|Overall Study|Disease Progression|17|||
44417407|NCT00833417|79425315|FG000|Overall Study|Reason Not Specified|0|||
44256746|NCT01435460|79108088|FG001|Overall Study|Protocol Violation|1|||
44256747|NCT01435460|79108087|FG000|Overall Study|Did not meet eligibility criteria|2|||
44256748|NCT01435460|79108088|FG001|Overall Study|Did not meet eligibility criteria|0|||
44256749|NCT01435382|79108174|FG000|Overall Study|Lost to Follow-up|1|||
44256750|NCT01435382|79108175|FG001|Overall Study|Lost to Follow-up|0|||
44256751|NCT01435382|79108176|FG002|Overall Study|Lost to Follow-up|1|||
44256752|NCT01435382|79108177|FG003|Overall Study|Lost to Follow-up|0|||
44256753|NCT01435382|79108174|FG000|Overall Study|Withdrawal by Subject|0|||
44299963|NCT03851705|79297200|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
44299964|NCT03851705|79297201|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
44417408|NCT00833417|79425316|FG001|Overall Study|Reason Not Specified|1|||
44417409|NCT00762372|79425326|FG000|Overall Study|Adverse Event|1|||
44417410|NCT00762372|79425327|FG001|Overall Study|Adverse Event|0|||
44417411|NCT00762372|79425328|FG002|Overall Study|Adverse Event|0|||
44534193|NCT00855465|79544815|FG001|Treatment Period|Adverse Event|2|||
44417412|NCT00833261|79425342|FG000|Overall Study|Withdrawal by Subject|4|||
44417413|NCT00833105|79425346|FG000|Overall Study|Withdrawal by Subject|1|||
44417414|NCT00833105|79425346|FG000|Overall Study|Adverse Event|2|||
44417415|NCT00833027|79425352|FG000|Overall Study|Adverse Event|33|||
44417416|NCT00833027|79425352|FG000|Overall Study|Death|1|||
44417417|NCT00833027|79425352|FG000|Overall Study|Lack of Efficacy|12|||
44417418|NCT00833027|79425352|FG000|Overall Study|Lost to Follow-up|24|||
44534194|NCT00855465|79544814|FG000|Treatment Period|Death|2|||
44534195|NCT00855465|79544815|FG001|Treatment Period|Death|2|||
44534196|NCT00855465|79544814|FG000|Treatment Period|Lack of Efficacy|2|||
44534197|NCT00855465|79544815|FG001|Treatment Period|Lack of Efficacy|1|||
44256754|NCT01435382|79108175|FG001|Overall Study|Withdrawal by Subject|2|||
44417419|NCT00833027|79425352|FG000|Overall Study|Protocol Violation|115|||
44417420|NCT00833027|79425352|FG000|Overall Study|Withdrawal by Subject|16|||
44417421|NCT00833027|79425352|FG000|Overall Study|Missing|10|||
44417422|NCT00752622|79425356|FG000|Induction Phase|Adverse Event|3|||
44417423|NCT00752622|79425356|FG000|Induction Phase|Other|3|||
44417424|NCT00752622|79425356|FG000|Induction Phase|Non-responder|14|||
44417425|NCT00752622|79425356|FG000|Induction Phase|Withdrawal by Subject|1|||
44534198|NCT00855465|79544814|FG000|Treatment Period|Non-compliance|1|||
44299965|NCT03851705|79297198|FG000|Part 1: Double-Blind Period|Other reason|1|||
44299966|NCT03851705|79297199|FG001|Part 1: Double-Blind Period|Other reason|0|||
44299967|NCT03851705|79297200|FG002|Part 1: Double-Blind Period|Other reason|0|||
44299968|NCT03851705|79297201|FG003|Part 1: Double-Blind Period|Other reason|0|||
44299969|NCT03851705|79297198|FG000|Part 2: Open-Label Period|Other reason|0|||
44299970|NCT03851705|79297199|FG001|Part 2: Open-Label Period|Other reason|0|||
44299971|NCT03851705|79297200|FG002|Part 2: Open-Label Period|Other reason|0|||
44299972|NCT03851705|79297201|FG003|Part 2: Open-Label Period|Other reason|1|||
44299973|NCT03851705|79297198|FG000|Part 2: Open-Label Period|Death|0|||
44299974|NCT03851705|79297199|FG001|Part 2: Open-Label Period|Death|0|||
44299975|NCT03851705|79297200|FG002|Part 2: Open-Label Period|Death|3|||
44299976|NCT03851705|79297201|FG003|Part 2: Open-Label Period|Death|0|||
44299977|NCT03851705|79297198|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
44299978|NCT03851705|79297199|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
44299979|NCT03851705|79297200|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
44299980|NCT03851705|79297201|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
44299981|NCT03824366|79297214|FG000|Overall Study|Death|1|||
44299982|NCT03824366|79297214|FG000|Overall Study|Previously unidentified metal artifact|1|||
44299983|NCT03824366|79297214|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
44299984|NCT03824366|79297214|FG000|Overall Study|Withdrawal by Subject|1|||
44299985|NCT03810313|79297220|FG000|Overall Study|Study terminated by sponsor|164|||
44299986|NCT03810313|79297221|FG001|Overall Study|Study terminated by sponsor|159|||
44299987|NCT03810313|79297220|FG000|Overall Study|Subject decision|10|||
44299988|NCT03810313|79297221|FG001|Overall Study|Subject decision|11|||
44299989|NCT03810313|79297220|FG000|Overall Study|Lost to Follow-up|3|||
44299990|NCT03810313|79297221|FG001|Overall Study|Lost to Follow-up|3|||
44299991|NCT03810313|79297220|FG000|Overall Study|Adverse Event|2|||
44299992|NCT03810313|79297221|FG001|Overall Study|Adverse Event|1|||
44299993|NCT03810313|79297220|FG000|Overall Study|Death|2|||
44299994|NCT03810313|79297221|FG001|Overall Study|Death|1|||
44299995|NCT03810313|79297220|FG000|Overall Study|Physician Decision|0|||
44299996|NCT03810313|79297221|FG001|Overall Study|Physician Decision|1|||
44299997|NCT03802630|79297230|FG000|Overall Study|Study terminated by sponsor|130|||
44299998|NCT03802630|79297231|FG001|Overall Study|Study terminated by sponsor|134|||
44299999|NCT03802630|79297230|FG000|Overall Study|Subject decision|16|||
44300000|NCT03802630|79297231|FG001|Overall Study|Subject decision|9|||
44300001|NCT03802630|79297230|FG000|Overall Study|Adverse Event|3|||
44300002|NCT03802630|79297231|FG001|Overall Study|Adverse Event|1|||
44300003|NCT03802630|79297230|FG000|Overall Study|Lost to Follow-up|2|||
44300004|NCT03802630|79297231|FG001|Overall Study|Lost to Follow-up|2|||
44300005|NCT03802630|79297230|FG000|Overall Study|Physician Decision|2|||
44300006|NCT03802630|79297231|FG001|Overall Study|Physician Decision|0|||
44300007|NCT03802630|79297230|FG000|Overall Study|Death|0|||
44300008|NCT03802630|79297231|FG001|Overall Study|Death|2|||
44300009|NCT03775213|79297240|FG000|Overall Study|Withdrawal by Subject|51|||
44300010|NCT03775213|79297241|FG001|Overall Study|Withdrawal by Subject|53|||
44300011|NCT03775213|79297240|FG000|Overall Study|Incomplete Survey|7|||
44300012|NCT03775213|79297241|FG001|Overall Study|Incomplete Survey|7|||
44300013|NCT03710564|79297249|FG000|Overall Study|Study Terminated by Sponsor|104|||
44300014|NCT03710564|79297250|FG001|Overall Study|Study Terminated by Sponsor|55|||
44300015|NCT03710564|79297249|FG000|Overall Study|Withdrawal by Subject|57|||
44300016|NCT03710564|79297250|FG001|Overall Study|Withdrawal by Subject|25|||
44300017|NCT03710564|79297249|FG000|Overall Study|Death|10|||
44300018|NCT03710564|79297250|FG001|Overall Study|Death|4|||
44300019|NCT03710564|79297249|FG000|Overall Study|Lost to Follow-up|5|||
44300020|NCT03710564|79297250|FG001|Overall Study|Lost to Follow-up|4|||
44300021|NCT03710564|79297249|FG000|Overall Study|Protocol Violation|3|||
44300022|NCT03710564|79297250|FG001|Overall Study|Protocol Violation|2|||
44300023|NCT03710564|79297249|FG000|Overall Study|Adverse Event|3|||
44300024|NCT03710564|79297250|FG001|Overall Study|Adverse Event|0|||
44300025|NCT03710564|79297249|FG000|Overall Study|Physician Decision|2|||
44300026|NCT03710564|79297250|FG001|Overall Study|Physician Decision|3|||
44300027|NCT03624127|79297260|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
44300028|NCT03624127|79297261|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
44300029|NCT03624127|79297262|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
44300030|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
44300031|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
44300032|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
44300033|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Death|0|||
44300034|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Death|1|||
44300035|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Death|0|||
44300036|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
44300037|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
44300038|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
44300039|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
44300040|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
44300041|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
44300042|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
44300043|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
44300044|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
44300045|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
44300046|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
44300047|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
44300048|NCT03624127|79297260|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
44300049|NCT03624127|79297261|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
44300050|NCT03624127|79297262|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
44300051|NCT03624127|79297260|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
44300052|NCT03624127|79297261|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
44300053|NCT03624127|79297262|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
44300054|NCT03624127|79297260|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
44300055|NCT03624127|79297261|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
44300056|NCT03624127|79297262|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
44300057|NCT03624127|79297260|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
44300058|NCT03624127|79297261|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
44300059|NCT03624127|79297262|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
44300060|NCT03624127|79297260|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
44300061|NCT03624127|79297261|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
44300062|NCT03624127|79297262|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
44300063|NCT03624127|79297260|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
44300064|NCT03624127|79297261|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
44300065|NCT03624127|79297262|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
44300066|NCT03624127|79297260|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
44300067|NCT03624127|79297261|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
44300068|NCT03624127|79297262|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
44300069|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
44300070|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
44300071|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
44300072|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
44300073|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
44300074|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
44300075|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
44300076|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
44300077|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
44300078|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
44300079|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
44300080|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
44300081|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
44300082|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
44300083|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
44300084|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
44300085|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
44300086|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
44300087|NCT03624127|79297260|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
44300088|NCT03624127|79297261|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
44300089|NCT03624127|79297262|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
44300090|NCT03616912|79297280|FG000|Overall Study|Adverse Event|17|||
44300091|NCT03616912|79297281|FG001|Overall Study|Adverse Event|21|||
44300092|NCT03616912|79297282|FG002|Overall Study|Adverse Event|9|||
44300093|NCT03616912|79297283|FG003|Overall Study|Adverse Event|0|||
44300094|NCT03616912|79297284|FG004|Overall Study|Adverse Event|0|||
44300095|NCT03616912|79297285|FG005|Overall Study|Adverse Event|0|||
44300096|NCT03616912|79297280|FG000|Overall Study|Death|1|||
44300097|NCT03616912|79297281|FG001|Overall Study|Death|1|||
44300098|NCT03616912|79297282|FG002|Overall Study|Death|0|||
44300099|NCT03616912|79297283|FG003|Overall Study|Death|0|||
44300100|NCT03616912|79297284|FG004|Overall Study|Death|0|||
44417426|NCT00752622|79425356|FG000|Induction Phase|Premature study termination|14|||
44417427|NCT00752622|79425356|FG000|Observational Phase|Premature Study Termination|36|||
44300101|NCT03616912|79297285|FG005|Overall Study|Death|0|||
44300102|NCT03616912|79297280|FG000|Overall Study|Lack of Efficacy|13|||
44300103|NCT03616912|79297281|FG001|Overall Study|Lack of Efficacy|6|||
44300104|NCT03616912|79297282|FG002|Overall Study|Lack of Efficacy|8|||
44417428|NCT00752622|79425356|FG000|Observational Phase|Non-responder|2|||
44417429|NCT00752622|79425356|FG000|Observational Phase|Withdrawal by Subject|2|||
44300105|NCT03616912|79297283|FG003|Overall Study|Lack of Efficacy|4|||
44300106|NCT03616912|79297284|FG004|Overall Study|Lack of Efficacy|5|||
44300107|NCT03616912|79297285|FG005|Overall Study|Lack of Efficacy|1|||
44300108|NCT03616912|79297280|FG000|Overall Study|Lost to Follow-up|1|||
44300109|NCT03616912|79297281|FG001|Overall Study|Lost to Follow-up|2|||
44300110|NCT03616912|79297282|FG002|Overall Study|Lost to Follow-up|3|||
44300111|NCT03616912|79297283|FG003|Overall Study|Lost to Follow-up|0|||
44300112|NCT03616912|79297284|FG004|Overall Study|Lost to Follow-up|0|||
44300113|NCT03616912|79297285|FG005|Overall Study|Lost to Follow-up|0|||
44300114|NCT03616912|79297280|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
44300115|NCT03616912|79297281|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
44300116|NCT03616912|79297282|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
44300117|NCT03616912|79297283|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
44300118|NCT03616912|79297284|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
44300119|NCT03616912|79297285|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
44154874|NCT05168579|78946213|FG001|Overall Study|Lack of Consent|0|||
44300120|NCT03616912|79297280|FG000|Overall Study|Withdrawal by Subject|12|||
44300121|NCT03616912|79297281|FG001|Overall Study|Withdrawal by Subject|12|||
44300122|NCT03616912|79297282|FG002|Overall Study|Withdrawal by Subject|15|||
44300123|NCT03616912|79297283|FG003|Overall Study|Withdrawal by Subject|2|||
44534199|NCT00855465|79544815|FG001|Treatment Period|Non-compliance|0|||
44154875|NCT05168579|78946212|FG000|Overall Study|Conflicts with time|2|||
44534200|NCT00855465|79544814|FG000|Treatment Period|Protocol Violation|2|||
44534201|NCT00855465|79544815|FG001|Treatment Period|Protocol Violation|0|||
44534202|NCT00855465|79544814|FG000|Treatment Period|Withdrawal by Subject|2|||
44534203|NCT00855465|79544815|FG001|Treatment Period|Withdrawal by Subject|0|||
44534204|NCT00855465|79544814|FG000|Treatment Period|Not treated|1|||
44534205|NCT00855465|79544815|FG001|Treatment Period|Not treated|0|||
44534206|NCT00855465|79544814|FG000|Follow-up Period (FUP)|Adverse Event|0|||
44534207|NCT00855465|79544815|FG001|Follow-up Period (FUP)|Adverse Event|1|||
44534208|NCT00855465|79544814|FG000|Follow-up Period (FUP)|Death|0|||
44534209|NCT00855465|79544815|FG001|Follow-up Period (FUP)|Death|1|||
44534210|NCT00855465|79544814|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
44534211|NCT00855465|79544815|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
44300124|NCT03616912|79297284|FG004|Overall Study|Withdrawal by Subject|0|||
44300125|NCT03616912|79297285|FG005|Overall Study|Withdrawal by Subject|2|||
44300126|NCT03616912|79297280|FG000|Overall Study|Study Terminated by Sponsor|0|||
44300127|NCT03616912|79297281|FG001|Overall Study|Study Terminated by Sponsor|0|||
44300128|NCT03616912|79297282|FG002|Overall Study|Study Terminated by Sponsor|0|||
44300129|NCT03616912|79297283|FG003|Overall Study|Study Terminated by Sponsor|10|||
44300130|NCT03616912|79297284|FG004|Overall Study|Study Terminated by Sponsor|9|||
44300131|NCT03616912|79297285|FG005|Overall Study|Study Terminated by Sponsor|11|||
44300132|NCT03616912|79297280|FG000|Overall Study|Protocol Deviation|1|||
44300133|NCT03616912|79297281|FG001|Overall Study|Protocol Deviation|1|||
44300134|NCT03616912|79297282|FG002|Overall Study|Protocol Deviation|0|||
44300135|NCT03616912|79297283|FG003|Overall Study|Protocol Deviation|0|||
44300136|NCT03616912|79297284|FG004|Overall Study|Protocol Deviation|0|||
44300137|NCT03616912|79297285|FG005|Overall Study|Protocol Deviation|0|||
44300138|NCT03616912|79297280|FG000|Overall Study|Pregnancy|1|||
44300139|NCT03616912|79297281|FG001|Overall Study|Pregnancy|0|||
44300140|NCT03616912|79297282|FG002|Overall Study|Pregnancy|4|||
44534212|NCT00855465|79544814|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
44534213|NCT00855465|79544815|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
44534214|NCT00855465|79544814|FG000|Follow-up Period (FUP)|Missing|1|||
44534215|NCT00855465|79544815|FG001|Follow-up Period (FUP)|Missing|0|||
44534216|NCT00602641|79544823|FG000|Overall Study|Never started protocol therapy|6|||
44534217|NCT00602641|79544824|FG001|Overall Study|Never started protocol therapy|2|||
44534218|NCT00602641|79544823|FG000|Overall Study|Still on treatment at time of analysis|8|||
44534219|NCT00602641|79544824|FG001|Overall Study|Still on treatment at time of analysis|15|||
44534220|NCT00602641|79544823|FG000|Overall Study|Adverse Event|62|||
44534221|NCT00602641|79544824|FG001|Overall Study|Adverse Event|53|||
44534222|NCT00602641|79544823|FG000|Overall Study|Disease progression|38|||
44534223|NCT00602641|79544824|FG001|Overall Study|Disease progression|55|||
44534224|NCT00602641|79544823|FG000|Overall Study|Death|6|||
44534225|NCT00602641|79544824|FG001|Overall Study|Death|5|||
44300141|NCT03616912|79297283|FG003|Overall Study|Pregnancy|0|||
44300142|NCT03616912|79297284|FG004|Overall Study|Pregnancy|0|||
44300143|NCT03616912|79297285|FG005|Overall Study|Pregnancy|0|||
44534226|NCT00602641|79544823|FG000|Overall Study|Withdrawal by Subject|15|||
44534227|NCT00602641|79544824|FG001|Overall Study|Withdrawal by Subject|12|||
44300144|NCT03616912|79297280|FG000|Overall Study|Protocol Violation|1|||
44300145|NCT03616912|79297281|FG001|Overall Study|Protocol Violation|0|||
44300146|NCT03616912|79297282|FG002|Overall Study|Protocol Violation|2|||
44300147|NCT03616912|79297283|FG003|Overall Study|Protocol Violation|0|||
44300148|NCT03616912|79297284|FG004|Overall Study|Protocol Violation|0|||
44300149|NCT03616912|79297285|FG005|Overall Study|Protocol Violation|0|||
44300150|NCT03616912|79297280|FG000|Overall Study|Physician Decision|2|||
44300151|NCT03616912|79297281|FG001|Overall Study|Physician Decision|0|||
44300152|NCT03616912|79297282|FG002|Overall Study|Physician Decision|0|||
44300153|NCT03616912|79297283|FG003|Overall Study|Physician Decision|0|||
44300154|NCT03616912|79297284|FG004|Overall Study|Physician Decision|1|||
44300155|NCT03616912|79297285|FG005|Overall Study|Physician Decision|0|||
44300156|NCT03616912|79297280|FG000|Overall Study|Randomized But Never Treated|0|||
44300157|NCT03616912|79297281|FG001|Overall Study|Randomized But Never Treated|2|||
44300158|NCT03616912|79297282|FG002|Overall Study|Randomized But Never Treated|0|||
44300159|NCT03616912|79297283|FG003|Overall Study|Randomized But Never Treated|0|||
44300160|NCT03616912|79297284|FG004|Overall Study|Randomized But Never Treated|0|||
44300161|NCT03616912|79297285|FG005|Overall Study|Randomized But Never Treated|0|||
44300162|NCT03499899|79297302|FG000|Overall Study|Adverse Event|2|||
44300163|NCT03499899|79297303|FG001|Overall Study|Adverse Event|3|||
44300164|NCT03499899|79297304|FG002|Overall Study|Adverse Event|3|||
44300165|NCT03499899|79297302|FG000|Overall Study|Death|0|||
44300166|NCT03499899|79297303|FG001|Overall Study|Death|0|||
44300167|NCT03499899|79297304|FG002|Overall Study|Death|1|||
44300168|NCT03499899|79297302|FG000|Overall Study|Physician Decision|3|||
44300169|NCT03499899|79297303|FG001|Overall Study|Physician Decision|6|||
44300170|NCT03499899|79297304|FG002|Overall Study|Physician Decision|6|||
44300171|NCT03499899|79297302|FG000|Overall Study|Progressive disease|15|||
44300172|NCT03499899|79297303|FG001|Overall Study|Progressive disease|23|||
44300173|NCT03499899|79297304|FG002|Overall Study|Progressive disease|23|||
44300174|NCT03499899|79297302|FG000|Overall Study|Patient decision|0|||
44300175|NCT03499899|79297303|FG001|Overall Study|Patient decision|1|||
44300176|NCT03499899|79297304|FG002|Overall Study|Patient decision|1|||
44300177|NCT03499899|79297302|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
44300178|NCT03499899|79297303|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
44300179|NCT03499899|79297304|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
44300180|NCT03481634|79297320|FG000|Overall Study|Withdrawal by Subject|16|||
44300181|NCT03481634|79297321|FG001|Overall Study|Withdrawal by Subject|19|||
44300182|NCT03481634|79297322|FG002|Overall Study|Withdrawal by Subject|14|||
44300183|NCT03481634|79297320|FG000|Overall Study|Protocol Violation|1|||
44300184|NCT03481634|79297321|FG001|Overall Study|Protocol Violation|0|||
44300185|NCT03481634|79297322|FG002|Overall Study|Protocol Violation|1|||
44300186|NCT03481634|79297320|FG000|Overall Study|Progressive disease|0|||
44300187|NCT03481634|79297321|FG001|Overall Study|Progressive disease|1|||
44300188|NCT03481634|79297322|FG002|Overall Study|Progressive disease|0|||
44300189|NCT03481634|79297320|FG000|Overall Study|Physician Decision|3|||
44300190|NCT03481634|79297321|FG001|Overall Study|Physician Decision|0|||
44300191|NCT03481634|79297322|FG002|Overall Study|Physician Decision|1|||
44300192|NCT03481634|79297320|FG000|Overall Study|Lost to Follow-up|3|||
44300193|NCT03481634|79297321|FG001|Overall Study|Lost to Follow-up|4|||
44300194|NCT03481634|79297322|FG002|Overall Study|Lost to Follow-up|4|||
44300195|NCT03481634|79297320|FG000|Overall Study|Death|4|||
44300196|NCT03481634|79297321|FG001|Overall Study|Death|8|||
44300197|NCT03481634|79297322|FG002|Overall Study|Death|7|||
44300198|NCT03481634|79297320|FG000|Overall Study|Adverse Event|6|||
44300199|NCT03481634|79297321|FG001|Overall Study|Adverse Event|3|||
44300200|NCT03481634|79297322|FG002|Overall Study|Adverse Event|7|||
44300201|NCT03373461|79297336|FG000|Part 2|Adverse Event|0|||
44300202|NCT03373461|79297337|FG001|Part 2|Adverse Event|1|||
44300203|NCT03373461|79297338|FG002|Part 2|Adverse Event|0|||
44300204|NCT03373461|79297339|FG003|Part 2|Adverse Event|0|||
44300205|NCT03373461|79297340|FG004|Part 2|Adverse Event|1|||
44300206|NCT03364751|79297391|FG000|Overall Study|Withdrawal by Subject|1|||
44300207|NCT03364751|79297392|FG001|Overall Study|Withdrawal by Subject|0|||
44154876|NCT05168579|78946213|FG001|Overall Study|Conflicts with time|0|||
44154877|NCT05168579|78946212|FG000|Overall Study|Time slots were full|3|||
44300208|NCT03364751|79297393|FG002|Overall Study|Withdrawal by Subject|0|||
44300209|NCT03364751|79297394|FG003|Overall Study|Withdrawal by Subject|0|||
44300210|NCT03364751|79297391|FG000|Overall Study|Lost to Follow-up|0|||
44300211|NCT03364751|79297392|FG001|Overall Study|Lost to Follow-up|1|||
44300212|NCT03364751|79297393|FG002|Overall Study|Lost to Follow-up|0|||
44300213|NCT03364751|79297394|FG003|Overall Study|Lost to Follow-up|0|||
44300214|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
44300215|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
44300216|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
44154878|NCT05168579|78946213|FG001|Overall Study|Time slots were full|0|||
44154879|NCT05168579|78946212|FG000|Overall Study|Lost to Follow-up|0|||
44300217|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
44300218|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
44300219|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
44300220|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
44300221|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
44300222|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
44300223|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
44300224|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
44300225|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
44300226|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
44300227|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
44300228|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
44300229|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
44300230|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
44300231|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
44300232|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
44300233|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
44300234|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
44300235|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
44300236|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
44300237|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
44300238|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
44300239|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
44300240|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
44300241|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
44300242|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Death|0|||
44300243|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Death|1|||
44300244|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Death|0|||
44300245|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Death|0|||
44300246|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
44300247|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
44300248|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
44300249|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
44300250|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
44300251|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
44300252|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
44300253|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
44300254|NCT02990806|79297414|FG000|Stage 1 (22 Weeks)|Other|1|||
44300255|NCT02990806|79297415|FG001|Stage 1 (22 Weeks)|Other|3|||
44300256|NCT02990806|79297416|FG002|Stage 1 (22 Weeks)|Other|0|||
44300257|NCT02990806|79297417|FG003|Stage 1 (22 Weeks)|Other|0|||
44300258|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
44300259|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
44300260|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
44300261|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
44300262|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Death|1|||
44300263|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Death|0|||
44300264|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Death|0|||
44300265|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Death|0|||
44300266|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
44300267|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
44300268|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
44300269|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
44300270|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
44300271|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
44300272|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
44300273|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
44300274|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
44300275|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
44300276|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
44300277|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
44300278|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
44300279|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
44300280|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
44300281|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
44300282|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
44300283|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
44300284|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
44300285|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
44300286|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
44300287|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
44534228|NCT00602641|79544823|FG000|Overall Study|Alternative therapy|5|||
44534229|NCT00602641|79544824|FG001|Overall Study|Alternative therapy|2|||
44300288|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
44300289|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
44300290|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
44300291|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
44300292|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
44300293|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
44300294|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
44300295|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
44300296|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
44300297|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
44300298|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
44300299|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
44300300|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
44300301|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
44300302|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Other|3|||
44300303|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Other|0|||
44300304|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Other|4|||
44300305|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Other|1|||
44300306|NCT02990806|79297414|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
44300307|NCT02990806|79297415|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
44300308|NCT02990806|79297416|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
44300309|NCT02990806|79297417|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
44300310|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
44300311|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
44300312|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
44300313|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
44300314|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
44300315|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
44300316|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
44300317|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
44300318|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
44300319|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
44300320|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
44300321|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
44300322|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
44300323|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
44300324|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
44300325|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
44300326|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
44300327|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
44300328|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
44300329|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
44300330|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
44300331|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
44300332|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
44300333|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
44300334|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
44300335|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
44300336|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
44300337|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
44300338|NCT02990806|79297414|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
44300339|NCT02990806|79297415|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
44300340|NCT02990806|79297416|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
44300341|NCT02990806|79297417|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
44300342|NCT02420821|79297480|FG000|Overall Study|Lost to Follow-up|6|||
44534230|NCT00602641|79544823|FG000|Overall Study|Other Complicating Disease|5|||
44534231|NCT00602641|79544824|FG001|Overall Study|Other Complicating Disease|2|||
44154880|NCT05168579|78946213|FG001|Overall Study|Lost to Follow-up|15|||
44256755|NCT01435382|79108176|FG002|Overall Study|Withdrawal by Subject|0|||
44256756|NCT01435382|79108177|FG003|Overall Study|Withdrawal by Subject|1|||
44256757|NCT01414166|79108242|FG000|Overall Study|Adverse Event|10|||
44256758|NCT01414166|79108243|FG001|Overall Study|Adverse Event|2|||
44256759|NCT01414166|79108242|FG000|Overall Study|Lost to Follow-up|4|||
44256760|NCT01414166|79108243|FG001|Overall Study|Lost to Follow-up|1|||
44256761|NCT01414166|79108242|FG000|Overall Study|Non-compliance with study drug|2|||
44256762|NCT01414166|79108243|FG001|Overall Study|Non-compliance with study drug|0|||
44256763|NCT01414166|79108242|FG000|Overall Study|Physician Decision|2|||
44256764|NCT01414166|79108243|FG001|Overall Study|Physician Decision|0|||
44300343|NCT02420821|79297481|FG001|Overall Study|Lost to Follow-up|6|||
44300344|NCT02420821|79297480|FG000|Overall Study|Non-compliance|0|||
44300345|NCT02420821|79297481|FG001|Overall Study|Non-compliance|2|||
44300346|NCT02420821|79297480|FG000|Overall Study|Physician Decision|6|||
44300347|NCT02420821|79297481|FG001|Overall Study|Physician Decision|2|||
44300348|NCT02420821|79297480|FG000|Overall Study|Withdrawal by Subject|32|||
44300349|NCT02420821|79297481|FG001|Overall Study|Withdrawal by Subject|25|||
44300350|NCT02420821|79297480|FG000|Overall Study|Death|270|||
44300351|NCT02420821|79297481|FG001|Overall Study|Death|263|||
44300352|NCT02420821|79297480|FG000|Overall Study|Study Terminated By Sponsor|145|||
44300353|NCT02420821|79297481|FG001|Overall Study|Study Terminated By Sponsor|149|||
44300354|NCT02420821|79297480|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
44300355|NCT02420821|79297481|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
44300356|NCT02420821|79297480|FG000|Overall Study|Adverse Event|0|||
44300357|NCT02420821|79297481|FG001|Overall Study|Adverse Event|1|||
44300358|NCT02420821|79297480|FG000|Overall Study|Protinuria|0|||
44300359|NCT02420821|79297481|FG001|Overall Study|Protinuria|1|||
44300360|NCT02420821|79297480|FG000|Overall Study|Progressive Disease|1|||
44300361|NCT02420821|79297481|FG001|Overall Study|Progressive Disease|1|||
44300362|NCT02420821|79297480|FG000|Overall Study|Disease Progression|0|||
44300363|NCT02420821|79297481|FG001|Overall Study|Disease Progression|1|||
44300364|NCT02420821|79297480|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
44300365|NCT02420821|79297481|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
44300366|NCT02039063|79297512|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
44300367|NCT02039063|79297513|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
44300368|NCT02039063|79297514|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
44300369|NCT02039063|79297515|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
44300370|NCT02039063|79297512|FG000|Treatment Phase|Progression of disease|0|||
44300371|NCT02039063|79297513|FG001|Treatment Phase|Progression of disease|0|||
44300372|NCT02039063|79297514|FG002|Treatment Phase|Progression of disease|1|||
44300373|NCT02039063|79297515|FG003|Treatment Phase|Progression of disease|1|||
44300374|NCT02039063|79297512|FG000|Extension Phase|Inadequate therapeutic effect|0|||
44300375|NCT02039063|79297513|FG001|Extension Phase|Inadequate therapeutic effect|1|||
44300376|NCT02039063|79297514|FG002|Extension Phase|Inadequate therapeutic effect|2|||
44300377|NCT02039063|79297515|FG003|Extension Phase|Inadequate therapeutic effect|0|||
44300378|NCT02039063|79297512|FG000|Extension Phase|Progression of disease|0|||
44300379|NCT02039063|79297513|FG001|Extension Phase|Progression of disease|0|||
44300380|NCT02039063|79297514|FG002|Extension Phase|Progression of disease|0|||
44300381|NCT02039063|79297515|FG003|Extension Phase|Progression of disease|1|||
44300382|NCT02039063|79297512|FG000|Extension Phase|Adverse Event|0|||
44300383|NCT02039063|79297513|FG001|Extension Phase|Adverse Event|0|||
44300384|NCT02039063|79297514|FG002|Extension Phase|Adverse Event|1|||
44300385|NCT02039063|79297515|FG003|Extension Phase|Adverse Event|0|||
44300386|NCT01746173|79297532|FG000|Overall Study|Disease Progression|2|||
44300387|NCT02995733|79297572|FG000|Overall Study|Study site closed|9|||
44300388|NCT02995733|79297573|FG001|Overall Study|Study site closed|10|||
44300389|NCT02995733|79297572|FG000|Overall Study|Death|3|||
44300390|NCT02995733|79297573|FG001|Overall Study|Death|4|||
44300391|NCT02995733|79297572|FG000|Overall Study|Withdrawal by Subject|6|||
44300392|NCT02995733|79297573|FG001|Overall Study|Withdrawal by Subject|2|||
44300393|NCT02995733|79297572|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
44300394|NCT02995733|79297573|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
44300395|NCT02995733|79297572|FG000|Overall Study|Lost to Follow-up|48|||
44300396|NCT02995733|79297573|FG001|Overall Study|Lost to Follow-up|37|||
44300397|NCT02995733|79297572|FG000|Overall Study|Other|0|||
44300398|NCT02995733|79297573|FG001|Overall Study|Other|1|||
44300399|NCT02815566|79297590|FG000|Overall Study|Adverse Event|1|||
44300400|NCT02815566|79297591|FG001|Overall Study|Adverse Event|1|||
44300401|NCT02815566|79297590|FG000|Overall Study|Withdrawal by Subject|1|||
44300402|NCT02815566|79297591|FG001|Overall Study|Withdrawal by Subject|0|||
44300403|NCT02815566|79297590|FG000|Overall Study|Lost to Follow-up|0|||
44300404|NCT02815566|79297591|FG001|Overall Study|Lost to Follow-up|1|||
44300405|NCT02525783|79297598|FG000|Overall Study|Lost to Follow-up|10|||
44300406|NCT02466243|79297614|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
44300407|NCT02466243|79297615|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
44300408|NCT02466243|79297614|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
44300409|NCT02466243|79297615|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
44300410|NCT02466243|79297614|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
44300411|NCT02466243|79297615|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
44300412|NCT02466243|79297614|FG000|Part B Open-label Treatment Period|Missing|2|||
44300413|NCT02466243|79297615|FG001|Part B Open-label Treatment Period|Missing|2|||
44300414|NCT02321098|79297628|FG000|12 Weeks Treament|Lost to Follow-up|1|||
44300415|NCT02321098|79297629|FG001|12 Weeks Treament|Lost to Follow-up|1|||
44300416|NCT02321098|79297630|FG002|12 Weeks Treament|Lost to Follow-up|0|||
44300417|NCT02321098|79297628|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
44300418|NCT02321098|79297629|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
44300419|NCT02321098|79297630|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
44300420|NCT02321098|79297628|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
44300421|NCT02321098|79297629|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
44300422|NCT02321098|79297630|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
44300423|NCT02321098|79297628|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
44300424|NCT02321098|79297629|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
44300425|NCT02321098|79297630|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
44300426|NCT01627561|79297652|FG000|Overall Study|Lost to Follow-up|1|||
44300427|NCT01627561|79297653|FG001|Overall Study|Lost to Follow-up|0|||
44300428|NCT01627561|79297652|FG000|Overall Study|Withdrawal by Subject|0|||
44300429|NCT01627561|79297653|FG001|Overall Study|Withdrawal by Subject|1|||
44300430|NCT01627561|79297652|FG000|Overall Study|Migrated/moved from study area|0|||
44300431|NCT01627561|79297653|FG001|Overall Study|Migrated/moved from study area|2|||
44300432|NCT01652534|79297687|FG000|Overall Study|Lack of Efficacy|1|||
44300433|NCT01652534|79297688|FG001|Overall Study|Lack of Efficacy|0|||
44300434|NCT04709575|79297696|FG000|Overall Study|Withdrawal by Subject|6|||
44300435|NCT04709575|79297697|FG001|Overall Study|Withdrawal by Subject|2|||
44300436|NCT04709575|79297696|FG000|Overall Study|Lost to Follow-up|2|||
44300437|NCT04709575|79297697|FG001|Overall Study|Lost to Follow-up|2|||
44300438|NCT04709575|79297696|FG000|Overall Study|Adverse Event|1|||
44300439|NCT04709575|79297697|FG001|Overall Study|Adverse Event|0|||
44300440|NCT04709575|79297696|FG000|Overall Study|Protocol Violation|1|||
44300441|NCT04709575|79297697|FG001|Overall Study|Protocol Violation|1|||
44300442|NCT04450407|79297706|FG000|Overall Study|Withdrawal by Subject|10|||
44300443|NCT04450407|79297707|FG001|Overall Study|Withdrawal by Subject|1|||
44300444|NCT04450407|79297708|FG002|Overall Study|Withdrawal by Subject|4|||
44300445|NCT04450407|79297706|FG000|Overall Study|Adverse Event|0|||
44300446|NCT04450407|79297707|FG001|Overall Study|Adverse Event|0|||
44300447|NCT04450407|79297708|FG002|Overall Study|Adverse Event|1|||
44300448|NCT04450407|79297706|FG000|Overall Study|Lost to Follow-up|1|||
44300449|NCT04450407|79297707|FG001|Overall Study|Lost to Follow-up|0|||
44300450|NCT04450407|79297708|FG002|Overall Study|Lost to Follow-up|0|||
44300451|NCT04450407|79297706|FG000|Overall Study|Physician Decision|0|||
44300452|NCT04450407|79297707|FG001|Overall Study|Physician Decision|0|||
44300453|NCT04450407|79297708|FG002|Overall Study|Physician Decision|1|||
44300454|NCT04450407|79297706|FG000|Overall Study|Pregnancy|1|||
44300455|NCT04450407|79297707|FG001|Overall Study|Pregnancy|0|||
44300456|NCT04450407|79297708|FG002|Overall Study|Pregnancy|0|||
44417430|NCT00752622|79425356|FG000|Observational Phase|Adverse Event|1|||
44300457|NCT04450407|79297706|FG000|Overall Study|Protocol Violation|2|||
44300458|NCT04450407|79297707|FG001|Overall Study|Protocol Violation|0|||
44300459|NCT04450407|79297708|FG002|Overall Study|Protocol Violation|0|||
44300460|NCT04450407|79297706|FG000|Overall Study|Investigational site terminated by sponsor|3|||
44300461|NCT04450407|79297707|FG001|Overall Study|Investigational site terminated by sponsor|0|||
44300462|NCT04450407|79297708|FG002|Overall Study|Investigational site terminated by sponsor|2|||
44300463|NCT04388826|79297717|FG000|Overall Study|Lost to Follow-up|3|||
44300464|NCT04388826|79297718|FG001|Overall Study|Lost to Follow-up|2|||
44300465|NCT04388826|79297717|FG000|Overall Study|Adverse Event|1|||
44417431|NCT00752622|79425356|FG000|Observational Phase|Other|2|||
44417432|NCT00752622|79425356|FG000|Interventional Phase|Non-responder|2|||
44417433|NCT00752622|79425356|FG000|Interventional Phase|Physician Decision|1|||
44300466|NCT04388826|79297718|FG001|Overall Study|Adverse Event|0|||
44300467|NCT04218266|79297740|FG000|Overall Study|Death|1|||
44300468|NCT04218266|79297741|FG001|Overall Study|Death|2|||
44300469|NCT04218266|79297742|FG002|Overall Study|Death|3|||
44300470|NCT04218266|79297740|FG000|Overall Study|Adverse Event|13|||
44300471|NCT04218266|79297741|FG001|Overall Study|Adverse Event|14|||
44300472|NCT04218266|79297742|FG002|Overall Study|Adverse Event|11|||
44417434|NCT00752622|79425356|FG000|Interventional Phase|Premature Study Termination|5|||
44300473|NCT04218266|79297740|FG000|Overall Study|Other|7|||
44300474|NCT04218266|79297741|FG001|Overall Study|Other|5|||
44300475|NCT04218266|79297742|FG002|Overall Study|Other|14|||
44300476|NCT04218266|79297740|FG000|Overall Study|Physician Decision|1|||
44300477|NCT04218266|79297741|FG001|Overall Study|Physician Decision|3|||
44300478|NCT04218266|79297742|FG002|Overall Study|Physician Decision|2|||
44300479|NCT04218266|79297740|FG000|Overall Study|Non-compliance with study drug|0|||
44300480|NCT04218266|79297741|FG001|Overall Study|Non-compliance with study drug|0|||
44300481|NCT04218266|79297742|FG002|Overall Study|Non-compliance with study drug|1|||
44300482|NCT04218266|79297740|FG000|Overall Study|Withdrawal by Subject|1|||
44300483|NCT04218266|79297741|FG001|Overall Study|Withdrawal by Subject|3|||
44300484|NCT04218266|79297742|FG002|Overall Study|Withdrawal by Subject|1|||
44300485|NCT04218266|79297740|FG000|Overall Study|Study drug never administered|2|||
44300486|NCT04218266|79297741|FG001|Overall Study|Study drug never administered|0|||
44300487|NCT04218266|79297742|FG002|Overall Study|Study drug never administered|0|||
44300488|NCT03894904|79297764|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
44300489|NCT03894904|79297765|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
44300490|NCT03894904|79297764|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
44300491|NCT03894904|79297765|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
44300492|NCT03099265|79297785|FG000|Overall Study|Adverse Event|1|||
44300493|NCT02658656|79297803|FG000|Screening|Failed eligibility criteria|0|||
44300494|NCT02658656|79297804|FG001|Screening|Failed eligibility criteria|0|||
44300495|NCT02658656|79297805|FG002|Screening|Failed eligibility criteria|263|||
44300496|NCT02658656|79297803|FG000|Randomization|Withdrawal by Subject|8|||
44300497|NCT02658656|79297804|FG001|Randomization|Withdrawal by Subject|7|||
44300498|NCT02658656|79297805|FG002|Randomization|Withdrawal by Subject|0|||
44300499|NCT02658656|79297803|FG000|Randomization|Lost to Follow-up|1|||
44300500|NCT02658656|79297804|FG001|Randomization|Lost to Follow-up|3|||
44300501|NCT02658656|79297805|FG002|Randomization|Lost to Follow-up|0|||
44300502|NCT02658656|79297803|FG000|Randomization|Adverse Event|4|||
44300503|NCT02658656|79297804|FG001|Randomization|Adverse Event|0|||
44300504|NCT02658656|79297805|FG002|Randomization|Adverse Event|0|||
44300505|NCT02658656|79297803|FG000|Randomization|Administrative Termination|3|||
44300506|NCT02658656|79297804|FG001|Randomization|Administrative Termination|1|||
44300507|NCT02658656|79297805|FG002|Randomization|Administrative Termination|0|||
44300508|NCT02658656|79297803|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
44300509|NCT02658656|79297804|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
44300510|NCT02658656|79297805|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
44300511|NCT02658656|79297803|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
44300512|NCT02658656|79297804|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
44300513|NCT02658656|79297805|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
44300514|NCT02658656|79297803|FG000|Randomization|Not eligible for Randomization|1|||
44300515|NCT02658656|79297804|FG001|Randomization|Not eligible for Randomization|0|||
44300516|NCT02658656|79297805|FG002|Randomization|Not eligible for Randomization|0|||
44300517|NCT02658656|79297803|FG000|Randomization|Protocol Violation|1|||
44300518|NCT02658656|79297804|FG001|Randomization|Protocol Violation|0|||
44300519|NCT02658656|79297805|FG002|Randomization|Protocol Violation|0|||
44300520|NCT05141175|79297863|FG000|Overall Study|Withdrawal by Subject|1|||
44300521|NCT04869345|79297869|FG000|Overall Study|Lost to Follow-up|8|||
44300522|NCT04869345|79297870|FG001|Overall Study|Lost to Follow-up|3|||
44300531|NCT03321929|79297949|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
44300532|NCT03250624|79297956|FG000|Overall Study|Lack of Efficacy|1|||
44300533|NCT03250624|79297957|FG001|Overall Study|Lack of Efficacy|4|||
44300534|NCT03250624|79297956|FG000|Overall Study|Adverse Event|0|||
44300535|NCT03250624|79297957|FG001|Overall Study|Adverse Event|1|||
44300536|NCT03250624|79297956|FG000|Overall Study|Other|1|||
44300537|NCT03250624|79297957|FG001|Overall Study|Other|2|||
44300538|NCT02507297|79297965|FG000|Overall Study|Withdrawal by Subject|1|||
44300539|NCT02507297|79297966|FG001|Overall Study|Withdrawal by Subject|0|||
44300540|NCT02507297|79297965|FG000|Overall Study|Lost to Follow-up|0|||
44300541|NCT02507297|79297966|FG001|Overall Study|Lost to Follow-up|1|||
44300542|NCT01333514|79297974|FG000|Overall Study|Withdrawal by Subject|1|||
44300543|NCT01333514|79297975|FG001|Overall Study|Withdrawal by Subject|0|||
44300544|NCT02066636|79297984|FG000|Overall Study|Disease progression|51|||
44300545|NCT02066636|79297985|FG001|Overall Study|Disease progression|60|||
44300546|NCT02066636|79297986|FG002|Overall Study|Disease progression|700|||
44300547|NCT02066636|79297984|FG000|Overall Study|Study drug toxicity|13|||
44300548|NCT02066636|79297985|FG001|Overall Study|Study drug toxicity|2|||
44300549|NCT02066636|79297986|FG002|Overall Study|Study drug toxicity|58|||
44300550|NCT02066636|79297984|FG000|Overall Study|Death|4|||
44300551|NCT02066636|79297985|FG001|Overall Study|Death|2|||
44300552|NCT02066636|79297986|FG002|Overall Study|Death|158|||
44300553|NCT02066636|79297984|FG000|Overall Study|Adverse event unrelated to study drug|6|||
44300554|NCT02066636|79297985|FG001|Overall Study|Adverse event unrelated to study drug|4|||
44300555|NCT02066636|79297986|FG002|Overall Study|Adverse event unrelated to study drug|45|||
44300556|NCT02066636|79297984|FG000|Overall Study|Participant request to discontinue treatment|12|||
44300557|NCT02066636|79297985|FG001|Overall Study|Participant request to discontinue treatment|12|||
44300558|NCT02066636|79297986|FG002|Overall Study|Participant request to discontinue treatment|70|||
44300559|NCT02066636|79297984|FG000|Overall Study|Participant withdrew consent|10|||
44300560|NCT02066636|79297985|FG001|Overall Study|Participant withdrew consent|18|||
44300561|NCT02066636|79297986|FG002|Overall Study|Participant withdrew consent|61|||
44300562|NCT02066636|79297984|FG000|Overall Study|Lost to Follow-up|0|||
44300563|NCT02066636|79297985|FG001|Overall Study|Lost to Follow-up|2|||
44300564|NCT02066636|79297986|FG002|Overall Study|Lost to Follow-up|2|||
44300565|NCT02066636|79297984|FG000|Overall Study|Maximum clinical benefit|2|||
44300566|NCT02066636|79297985|FG001|Overall Study|Maximum clinical benefit|2|||
44300567|NCT02066636|79297986|FG002|Overall Study|Maximum clinical benefit|3|||
44300568|NCT02066636|79297984|FG000|Overall Study|Poor/non-compliance|2|||
44300569|NCT02066636|79297985|FG001|Overall Study|Poor/non-compliance|1|||
44300570|NCT02066636|79297986|FG002|Overall Study|Poor/non-compliance|1|||
44300571|NCT02066636|79297984|FG000|Overall Study|Participant no loner meets study criteria|3|||
44300572|NCT02066636|79297985|FG001|Overall Study|Participant no loner meets study criteria|2|||
44300573|NCT02066636|79297986|FG002|Overall Study|Participant no loner meets study criteria|28|||
44300574|NCT02066636|79297984|FG000|Overall Study|Administrative reasons by sponsor|8|||
44300575|NCT02066636|79297985|FG001|Overall Study|Administrative reasons by sponsor|5|||
44300576|NCT02066636|79297986|FG002|Overall Study|Administrative reasons by sponsor|0|||
44300577|NCT02066636|79297984|FG000|Overall Study|Other reasons|16|||
44300578|NCT02066636|79297985|FG001|Overall Study|Other reasons|15|||
44300579|NCT02066636|79297986|FG002|Overall Study|Other reasons|50|||
44300580|NCT01486264|79297998|FG000|Overall Study|Death|1|||
44300581|NCT01486264|79297999|FG001|Overall Study|Death|1|||
44300582|NCT01486264|79297998|FG000|Overall Study|Adverse Event|3|||
44300583|NCT01486264|79297999|FG001|Overall Study|Adverse Event|3|||
44300584|NCT01486264|79297998|FG000|Overall Study|Lack of Efficacy|6|||
44300585|NCT01486264|79297999|FG001|Overall Study|Lack of Efficacy|10|||
44300586|NCT01486264|79297998|FG000|Overall Study|Withdrawal by Subject|7|||
44300587|NCT01486264|79297999|FG001|Overall Study|Withdrawal by Subject|18|||
44300588|NCT01486264|79297998|FG000|Overall Study|Physician Decision|1|||
44300589|NCT01486264|79297999|FG001|Overall Study|Physician Decision|1|||
44300590|NCT01486264|79297998|FG000|Overall Study|Protocol Violation|3|||
44300591|NCT01486264|79297999|FG001|Overall Study|Protocol Violation|0|||
44300592|NCT01486264|79297998|FG000|Overall Study|Lost to Follow-up|3|||
44300593|NCT01486264|79297999|FG001|Overall Study|Lost to Follow-up|2|||
44300594|NCT01486264|79297998|FG000|Overall Study|Other|5|||
44300595|NCT01486264|79297999|FG001|Overall Study|Other|11|||
44154881|NCT02673619|78946226|FG000|Overall Study|Lost to Follow-up|1|||
44300596|NCT01486264|79297998|FG000|Overall Study|Not treated|0|||
44300597|NCT01486264|79297999|FG001|Overall Study|Not treated|1|||
44300598|NCT01323270|79298007|FG000|Overall Study|Withdrawal by Subject|19|||
44300599|NCT01323270|79298008|FG001|Overall Study|Withdrawal by Subject|10|||
44300600|NCT01323270|79298007|FG000|Overall Study|Protocol Violation|9|||
44300601|NCT01323270|79298008|FG001|Overall Study|Protocol Violation|7|||
44300602|NCT01323270|79298007|FG000|Overall Study|Lost to Follow-up|4|||
44300603|NCT01323270|79298008|FG001|Overall Study|Lost to Follow-up|6|||
44300604|NCT01323270|79298007|FG000|Overall Study|Adverse Event|8|||
44534232|NCT00602641|79544823|FG000|Overall Study|Physician Decision|5|||
44300605|NCT01323270|79298008|FG001|Overall Study|Adverse Event|0|||
44300606|NCT01323270|79298007|FG000|Overall Study|Other|0|||
44300607|NCT01323270|79298008|FG001|Overall Study|Other|3|||
44300608|NCT01323270|79298007|FG000|Overall Study|Physician Decision|0|||
44300609|NCT01323270|79298008|FG001|Overall Study|Physician Decision|2|||
44300610|NCT01323270|79298007|FG000|Overall Study|Not eligible|1|||
44300611|NCT01323270|79298008|FG001|Overall Study|Not eligible|1|||
44300612|NCT01323270|79298007|FG000|Overall Study|Death|1|||
44300613|NCT01323270|79298008|FG001|Overall Study|Death|0|||
44300614|NCT01323270|79298007|FG000|Overall Study|Randomized, but not vaccinated|1|||
44300615|NCT01323270|79298008|FG001|Overall Study|Randomized, but not vaccinated|0|||
44300616|NCT01300728|79298017|FG000|Overall Study|Withdrawal by Subject|1|||
44300617|NCT01300728|79298018|FG001|Overall Study|Withdrawal by Subject|1|||
44300618|NCT01300728|79298017|FG000|Overall Study|Physician Decision|1|||
44300619|NCT01300728|79298018|FG001|Overall Study|Physician Decision|0|||
44300620|NCT01299480|79298029|FG000|Overall Study|No longer willing to participate|19|||
44300621|NCT01299480|79298030|FG001|Overall Study|No longer willing to participate|17|||
44300622|NCT01299480|79298031|FG002|Overall Study|No longer willing to participate|14|||
44300623|NCT01299480|79298032|FG003|Overall Study|No longer willing to participate|13|||
44300624|NCT01299480|79298033|FG004|Overall Study|No longer willing to participate|10|||
44300625|NCT01299480|79298029|FG000|Overall Study|Protocol Violation|7|||
44300626|NCT01299480|79298030|FG001|Overall Study|Protocol Violation|5|||
44300627|NCT01299480|79298031|FG002|Overall Study|Protocol Violation|8|||
44300628|NCT01299480|79298032|FG003|Overall Study|Protocol Violation|1|||
44300629|NCT01299480|79298033|FG004|Overall Study|Protocol Violation|1|||
44300630|NCT01299480|79298029|FG000|Overall Study|Withdrawal by Subject|3|||
44300631|NCT01299480|79298030|FG001|Overall Study|Withdrawal by Subject|4|||
44300632|NCT01299480|79298031|FG002|Overall Study|Withdrawal by Subject|7|||
44300633|NCT01299480|79298032|FG003|Overall Study|Withdrawal by Subject|3|||
44300634|NCT01299480|79298033|FG004|Overall Study|Withdrawal by Subject|4|||
44300635|NCT01299480|79298029|FG000|Overall Study|Adverse Event|6|||
44300636|NCT01299480|79298030|FG001|Overall Study|Adverse Event|4|||
44300637|NCT01299480|79298031|FG002|Overall Study|Adverse Event|5|||
44300638|NCT01299480|79298032|FG003|Overall Study|Adverse Event|4|||
44300639|NCT01299480|79298033|FG004|Overall Study|Adverse Event|0|||
44300640|NCT01299480|79298029|FG000|Overall Study|Withdrawal due to pregnancy|0|||
44300641|NCT01299480|79298030|FG001|Overall Study|Withdrawal due to pregnancy|1|||
44300642|NCT01299480|79298031|FG002|Overall Study|Withdrawal due to pregnancy|1|||
44300643|NCT01299480|79298032|FG003|Overall Study|Withdrawal due to pregnancy|0|||
44300644|NCT01299480|79298033|FG004|Overall Study|Withdrawal due to pregnancy|0|||
44300645|NCT01299480|79298029|FG000|Overall Study|Physician Decision|1|||
44300646|NCT01299480|79298030|FG001|Overall Study|Physician Decision|1|||
44300647|NCT01299480|79298031|FG002|Overall Study|Physician Decision|0|||
44300648|NCT01299480|79298032|FG003|Overall Study|Physician Decision|2|||
44300649|NCT01299480|79298033|FG004|Overall Study|Physician Decision|0|||
44300650|NCT01299480|79298029|FG000|Overall Study|Lost to Follow-up|3|||
44300651|NCT01299480|79298030|FG001|Overall Study|Lost to Follow-up|1|||
44300652|NCT01299480|79298031|FG002|Overall Study|Lost to Follow-up|2|||
44300653|NCT01299480|79298032|FG003|Overall Study|Lost to Follow-up|1|||
44534233|NCT00602641|79544824|FG001|Overall Study|Physician Decision|4|||
44534234|NCT00602641|79544823|FG000|Overall Study|Administrative Closure|1|||
44534235|NCT00602641|79544824|FG001|Overall Study|Administrative Closure|1|||
44534236|NCT00602641|79544823|FG000|Overall Study|Other|3|||
44534237|NCT00602641|79544824|FG001|Overall Study|Other|1|||
44534238|NCT00098475|79544843|FG000|Step 1|Progressive disease|33|||
44534239|NCT00098475|79544844|FG001|Step 1|Progressive disease|35|||
44534240|NCT00098475|79544845|FG002|Step 1|Progressive disease|2|||
44300654|NCT01299480|79298033|FG004|Overall Study|Lost to Follow-up|2|||
44300655|NCT01299480|79298029|FG000|Overall Study|Other|3|||
44300656|NCT01299480|79298030|FG001|Overall Study|Other|2|||
44300657|NCT01299480|79298031|FG002|Overall Study|Other|3|||
44300658|NCT01299480|79298032|FG003|Overall Study|Other|0|||
44417435|NCT00754650|79425361|FG000|Overall Study|Disease Progression|2|||
44300659|NCT01299480|79298033|FG004|Overall Study|Other|3|||
44300660|NCT01299480|79298029|FG000|Overall Study|Started, but not vaccinated|0|||
44300661|NCT01299480|79298030|FG001|Overall Study|Started, but not vaccinated|0|||
44300662|NCT01299480|79298031|FG002|Overall Study|Started, but not vaccinated|1|||
44534241|NCT00098475|79544846|FG003|Step 1|Progressive disease|1|||
44300663|NCT01299480|79298032|FG003|Overall Study|Started, but not vaccinated|1|||
44300664|NCT01299480|79298033|FG004|Overall Study|Started, but not vaccinated|0|||
44300665|NCT05631548|79298048|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
44300666|NCT05631548|79298049|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
44300667|NCT05278858|79298079|FG000|Overall Study|Withdrawal by Subject|1|||
44300668|NCT05239221|79298099|FG000|Overall Study|Adverse Event|0|||
44300669|NCT05239221|79298100|FG001|Overall Study|Adverse Event|0|||
44534242|NCT00098475|79544843|FG000|Step 1|Adverse Event|56|||
44417436|NCT00761748|79425365|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
44417437|NCT00761748|79425366|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
44417438|NCT00761748|79425365|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
44417439|NCT00761748|79425366|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
44417440|NCT00825305|79425374|FG000|Overall Study|Adverse Event|1|||
44417441|NCT00825305|79425375|FG001|Overall Study|Adverse Event|1|||
44417442|NCT00825305|79425374|FG000|Overall Study|Withdrawal by Subject|6|||
44417443|NCT00825305|79425375|FG001|Overall Study|Withdrawal by Subject|12|||
44417444|NCT00825305|79425374|FG000|Overall Study|Inappropriate inclusion|1|||
44417445|NCT00825305|79425375|FG001|Overall Study|Inappropriate inclusion|0|||
44417446|NCT00825305|79425374|FG000|Overall Study|Protocol Violation|9|||
44417447|NCT00825305|79425375|FG001|Overall Study|Protocol Violation|9|||
44417448|NCT00825305|79425374|FG000|Overall Study|Can not be classified|0|||
44417449|NCT00825305|79425375|FG001|Overall Study|Can not be classified|1|||
44417450|NCT00754572|79425381|FG000|Overall Study|Adverse Event|19|||
44417451|NCT00754572|79425381|FG000|Overall Study|Other|39|||
44417452|NCT00754572|79425381|FG000|Overall Study|Protocol Violation|3|||
44417453|NCT00754572|79425381|FG000|Overall Study|Withdrawal by Subject|3|||
44417454|NCT00754572|79425381|FG000|Overall Study|Lack of Efficacy|2|||
44417455|NCT00754572|79425381|FG000|Overall Study|Death|1|||
44417456|NCT00754572|79425381|FG000|Overall Study|Administrative Reason|3|||
44417457|NCT00754572|79425381|FG000|Overall Study|Lost to Follow-up|1|||
44417458|NCT00824993|79425387|FG000|Overall Study|Withdrawal by Subject|1|||
44417459|NCT00824993|79425388|FG001|Overall Study|Withdrawal by Subject|1|||
44417460|NCT00824993|79425387|FG000|Overall Study|Malignancy Relapse|9|||
44417461|NCT00824993|79425388|FG001|Overall Study|Malignancy Relapse|10|||
44417462|NCT00824993|79425387|FG000|Overall Study|Rapid Bone Loss|0|||
44417463|NCT00824993|79425388|FG001|Overall Study|Rapid Bone Loss|1|||
44417464|NCT00824993|79425387|FG000|Overall Study|Non-Compliant|2|||
44417465|NCT00824993|79425388|FG001|Overall Study|Non-Compliant|1|||
44417466|NCT00824993|79425387|FG000|Overall Study|Insurance Issue|2|||
44417467|NCT00824993|79425388|FG001|Overall Study|Insurance Issue|1|||
44417468|NCT00824993|79425387|FG000|Overall Study|Death|0|||
44417469|NCT00824993|79425388|FG001|Overall Study|Death|3|||
44417470|NCT00832091|79425396|FG000|Overall Study|Adverse Event|1|||
44417471|NCT00832091|79425397|FG001|Overall Study|Adverse Event|1|||
44417472|NCT00832091|79425396|FG000|Overall Study|Protocol Violation|1|||
44417473|NCT00832091|79425397|FG001|Overall Study|Protocol Violation|0|||
44417474|NCT00832091|79425396|FG000|Overall Study|Withdrawal by Subject|2|||
44417475|NCT00832091|79425397|FG001|Overall Study|Withdrawal by Subject|1|||
44417476|NCT00832091|79425396|FG000|Overall Study|Prohibited Medication|1|||
44417477|NCT00832091|79425397|FG001|Overall Study|Prohibited Medication|0|||
44417478|NCT00761514|79425403|FG000|Overall Study|Adverse Event|1|||
44417479|NCT00761514|79425403|FG000|Overall Study|Withdrawal by Subject|2|||
44417480|NCT00761514|79425403|FG000|Overall Study|Lost to Follow-up|1|||
44417481|NCT00761514|79425403|FG000|Overall Study|Health insurance didn't cover study drug|1|||
44417482|NCT00761514|79425403|FG000|Overall Study|Problem complying with study visit|1|||
44417483|NCT00761514|79425403|FG000|Overall Study|Unable to pay for medications|1|||
44417484|NCT00831779|79425409|FG000|Overall Study|Lost to Follow-up|1|||
44417485|NCT00831779|79425410|FG001|Overall Study|Lost to Follow-up|0|||
44417486|NCT00831779|79425409|FG000|Overall Study|No longer met criteria|0|||
44417487|NCT00831779|79425410|FG001|Overall Study|No longer met criteria|1|||
44417488|NCT00758043|79425420|FG000|Overall Study|Adverse Event|1|||
44417489|NCT00758043|79425421|FG001|Overall Study|Adverse Event|20|||
44417490|NCT00758043|79425422|FG002|Overall Study|Adverse Event|12|||
44417491|NCT00758043|79425423|FG003|Overall Study|Adverse Event|62|||
44417492|NCT00758043|79425420|FG000|Overall Study|Lack of Efficacy|0|||
44417493|NCT00758043|79425421|FG001|Overall Study|Lack of Efficacy|6|||
44417494|NCT00758043|79425422|FG002|Overall Study|Lack of Efficacy|18|||
44256765|NCT01414166|79108242|FG000|Overall Study|Protocol Violation|2|||
44256766|NCT01414166|79108243|FG001|Overall Study|Protocol Violation|0|||
44256767|NCT01414166|79108242|FG000|Overall Study|Study terminated by Sponsor|68|||
44256768|NCT01414166|79108243|FG001|Overall Study|Study terminated by Sponsor|75|||
44256769|NCT01414166|79108242|FG000|Overall Study|Withdrawal by Subject|3|||
44256770|NCT01414166|79108243|FG001|Overall Study|Withdrawal by Subject|5|||
44256771|NCT01434680|79108253|FG000|Overall Study|Withdrawal by Subject|1|||
44256772|NCT01434680|79108254|FG001|Overall Study|Withdrawal by Subject|0|||
44417495|NCT00758043|79425423|FG003|Overall Study|Lack of Efficacy|12|||
44417496|NCT00758043|79425420|FG000|Overall Study|Refused Further Treatment|0|||
44417497|NCT00758043|79425421|FG001|Overall Study|Refused Further Treatment|11|||
44417498|NCT00758043|79425422|FG002|Overall Study|Refused Further Treatment|5|||
44417499|NCT00758043|79425423|FG003|Overall Study|Refused Further Treatment|8|||
44417500|NCT00758043|79425420|FG000|Overall Study|Lost to Follow-up|0|||
44256773|NCT01434680|79108255|FG002|Overall Study|Withdrawal by Subject|2|||
44417501|NCT00758043|79425421|FG001|Overall Study|Lost to Follow-up|2|||
44417502|NCT00758043|79425422|FG002|Overall Study|Lost to Follow-up|2|||
44417503|NCT00758043|79425423|FG003|Overall Study|Lost to Follow-up|5|||
44417504|NCT00758043|79425420|FG000|Overall Study|Withdrawal by Subject|0|||
44300670|NCT05239221|79298101|FG002|Overall Study|Adverse Event|0|||
44300671|NCT05239221|79298102|FG003|Overall Study|Adverse Event|0|||
44300672|NCT05239221|79298103|FG004|Overall Study|Adverse Event|0|||
44300673|NCT05239221|79298104|FG005|Overall Study|Adverse Event|0|||
44300674|NCT05239221|79298105|FG006|Overall Study|Adverse Event|1|||
44300675|NCT05239221|79298106|FG007|Overall Study|Adverse Event|0|||
44300676|NCT05239221|79298107|FG008|Overall Study|Adverse Event|0|||
44300677|NCT05239221|79298108|FG009|Overall Study|Adverse Event|0|||
44300678|NCT05239221|79298109|FG010|Overall Study|Adverse Event|1|||
44300679|NCT05239221|79298110|FG011|Overall Study|Adverse Event|1|||
44300680|NCT05239221|79298111|FG012|Overall Study|Adverse Event|0|||
44300681|NCT05239221|79298112|FG013|Overall Study|Adverse Event|0|||
44300682|NCT05239221|79298113|FG014|Overall Study|Adverse Event|0|||
44300683|NCT05239221|79298114|FG015|Overall Study|Adverse Event|0|||
44300684|NCT05239221|79298099|FG000|Overall Study|Withdrawal by Subject|0|||
44300685|NCT05239221|79298100|FG001|Overall Study|Withdrawal by Subject|0|||
44300686|NCT05239221|79298101|FG002|Overall Study|Withdrawal by Subject|0|||
44300687|NCT05239221|79298102|FG003|Overall Study|Withdrawal by Subject|0|||
44300688|NCT05239221|79298103|FG004|Overall Study|Withdrawal by Subject|0|||
44300689|NCT05239221|79298104|FG005|Overall Study|Withdrawal by Subject|0|||
44300690|NCT05239221|79298105|FG006|Overall Study|Withdrawal by Subject|0|||
44300691|NCT05239221|79298106|FG007|Overall Study|Withdrawal by Subject|0|||
44300692|NCT05239221|79298107|FG008|Overall Study|Withdrawal by Subject|0|||
44300693|NCT05239221|79298108|FG009|Overall Study|Withdrawal by Subject|0|||
44300694|NCT05239221|79298109|FG010|Overall Study|Withdrawal by Subject|1|||
44300695|NCT05239221|79298110|FG011|Overall Study|Withdrawal by Subject|0|||
44300696|NCT05239221|79298111|FG012|Overall Study|Withdrawal by Subject|0|||
44300697|NCT05239221|79298112|FG013|Overall Study|Withdrawal by Subject|0|||
44300698|NCT05239221|79298113|FG014|Overall Study|Withdrawal by Subject|0|||
44300699|NCT05239221|79298114|FG015|Overall Study|Withdrawal by Subject|1|||
44300700|NCT04751656|79298188|FG000|Overall Study|Lost to Follow-up|1|||
44300701|NCT04682366|79298204|FG000|Overall Study|Lost to Follow-up|1|||
44300702|NCT04682366|79298205|FG001|Overall Study|Lost to Follow-up|1|||
44300703|NCT04390243|79298240|FG000|Overall Study|Death|1|||
44300704|NCT04390243|79298240|FG000|Overall Study|Disease Progression|4|||
44300705|NCT04390243|79298240|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
44300706|NCT04378270|79298244|FG000|Overall Study|Lack of Efficacy|1|||
44300707|NCT04378270|79298244|FG000|Overall Study|Withdrawal by Subject|1|||
44300708|NCT04378270|79298244|FG000|Overall Study|Screen Failure|1|||
44300709|NCT04378270|79298244|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
44300710|NCT04200651|79298250|FG000|Overall Study|Moved to another country during follow-up|2|||
44300711|NCT04200651|79298251|FG001|Overall Study|Moved to another country during follow-up|2|||
44300712|NCT04200651|79298250|FG000|Overall Study|Lost to Follow-up|1|||
44300713|NCT04200651|79298251|FG001|Overall Study|Lost to Follow-up|3|||
44300714|NCT03813147|79298278|FG000|Overall Study|Lack of Efficacy|4|||
44300715|NCT03813147|79298279|FG001|Overall Study|Lack of Efficacy|4|||
44300716|NCT03813147|79298278|FG000|Overall Study|Physician Decision|2|||
44300717|NCT03813147|79298279|FG001|Overall Study|Physician Decision|1|||
44300718|NCT03691207|79298287|FG000|Overall Study|Death|41|||
44300719|NCT03691207|79298288|FG001|Overall Study|Death|26|||
44300720|NCT03691207|79298287|FG000|Overall Study|Lost to Follow-up|1|||
44300721|NCT03691207|79298288|FG001|Overall Study|Lost to Follow-up|1|||
44300722|NCT03691207|79298287|FG000|Overall Study|Withdrawal by Subject|2|||
44300723|NCT03691207|79298288|FG001|Overall Study|Withdrawal by Subject|8|||
44300724|NCT03691207|79298287|FG000|Overall Study|Sponsor decision|1|||
44300725|NCT03691207|79298288|FG001|Overall Study|Sponsor decision|7|||
44300726|NCT03511664|79298305|FG000|Overall Study|Treatment ongoing|49|||
44300727|NCT03511664|79298306|FG001|Overall Study|Treatment ongoing|5|||
44300728|NCT03511664|79298305|FG000|Overall Study|Entered long-term follow-up|140|||
44300729|NCT03511664|79298306|FG001|Overall Study|Entered long-term follow-up|50|||
44300730|NCT03511664|79298305|FG000|Overall Study|Withdrawal by Subject|29|||
44300731|NCT03511664|79298306|FG001|Overall Study|Withdrawal by Subject|53|||
44300732|NCT03511664|79298305|FG000|Overall Study|Lost to Follow-up|4|||
44300733|NCT03511664|79298306|FG001|Overall Study|Lost to Follow-up|4|||
44300734|NCT03511664|79298305|FG000|Overall Study|Physician Decision|0|||
44300735|NCT03511664|79298306|FG001|Overall Study|Physician Decision|1|||
44300736|NCT03382561|79298314|FG000|Overall Study|Disease progression|47|||
44300737|NCT03382561|79298315|FG001|Overall Study|Disease progression|6|||
44300738|NCT03382561|79298314|FG000|Overall Study|Adverse Event|10|||
44300739|NCT03382561|79298315|FG001|Overall Study|Adverse Event|2|||
44300740|NCT03382561|79298314|FG000|Overall Study|Death|8|||
44300741|NCT03382561|79298315|FG001|Overall Study|Death|3|||
44300742|NCT03382561|79298314|FG000|Overall Study|Withdrawal by Subject|6|||
44300743|NCT03382561|79298315|FG001|Overall Study|Withdrawal by Subject|5|||
44300744|NCT03382561|79298314|FG000|Overall Study|Alternative therapy|2|||
44300745|NCT03382561|79298315|FG001|Overall Study|Alternative therapy|8|||
44300746|NCT03382561|79298314|FG000|Overall Study|Never started treatment|3|||
44300747|NCT03382561|79298315|FG001|Overall Study|Never started treatment|6|||
44300748|NCT03382561|79298314|FG000|Overall Study|Lack of Efficacy|0|||
44300749|NCT03382561|79298315|FG001|Overall Study|Lack of Efficacy|1|||
44300750|NCT03382561|79298314|FG000|Overall Study|Physician Decision|0|||
44300751|NCT03382561|79298315|FG001|Overall Study|Physician Decision|1|||
44300752|NCT03382561|79298314|FG000|Overall Study|Other complicating disease|0|||
44300753|NCT03382561|79298315|FG001|Overall Study|Other complicating disease|1|||
44300754|NCT03110770|79298352|FG000|Overall Study|Death|1|||
44300755|NCT03110770|79298353|FG001|Overall Study|Death|0|||
44300756|NCT03110770|79298354|FG002|Overall Study|Death|0|||
44300757|NCT03110770|79298355|FG003|Overall Study|Death|1|||
44300758|NCT03110770|79298356|FG004|Overall Study|Death|0|||
44300759|NCT03110770|79298352|FG000|Overall Study|Enrolled but did not receive product|0|||
44300760|NCT03110770|79298353|FG001|Overall Study|Enrolled but did not receive product|0|||
44300761|NCT03110770|79298354|FG002|Overall Study|Enrolled but did not receive product|0|||
44300762|NCT03110770|79298355|FG003|Overall Study|Enrolled but did not receive product|8|||
44300763|NCT03110770|79298356|FG004|Overall Study|Enrolled but did not receive product|7|||
44300764|NCT03110770|79298352|FG000|Overall Study|Lost to Follow-up|0|||
44300765|NCT03110770|79298353|FG001|Overall Study|Lost to Follow-up|0|||
44300766|NCT03110770|79298354|FG002|Overall Study|Lost to Follow-up|0|||
44300767|NCT03110770|79298355|FG003|Overall Study|Lost to Follow-up|53|||
44300768|NCT03110770|79298356|FG004|Overall Study|Lost to Follow-up|45|||
44300769|NCT03110770|79298352|FG000|Overall Study|Investigator Decision|0|||
44300770|NCT03110770|79298353|FG001|Overall Study|Investigator Decision|0|||
44300771|NCT03110770|79298354|FG002|Overall Study|Investigator Decision|0|||
44300772|NCT03110770|79298355|FG003|Overall Study|Investigator Decision|5|||
44300773|NCT03110770|79298356|FG004|Overall Study|Investigator Decision|3|||
44300774|NCT03110770|79298352|FG000|Overall Study|Withdrawal by Subject|0|||
44300775|NCT03110770|79298353|FG001|Overall Study|Withdrawal by Subject|0|||
44300776|NCT03110770|79298354|FG002|Overall Study|Withdrawal by Subject|0|||
44300777|NCT03110770|79298355|FG003|Overall Study|Withdrawal by Subject|24|||
44300778|NCT03110770|79298356|FG004|Overall Study|Withdrawal by Subject|24|||
44300779|NCT03110770|79298352|FG000|Overall Study|Moved from area|5|||
44300780|NCT03110770|79298353|FG001|Overall Study|Moved from area|0|||
44300781|NCT03110770|79298354|FG002|Overall Study|Moved from area|2|||
44300782|NCT03110770|79298355|FG003|Overall Study|Moved from area|42|||
44300783|NCT03110770|79298356|FG004|Overall Study|Moved from area|43|||
44300784|NCT03110770|79298352|FG000|Overall Study|Illness/Injury unrelated to product|0|||
44300785|NCT03110770|79298353|FG001|Overall Study|Illness/Injury unrelated to product|0|||
44300786|NCT03110770|79298354|FG002|Overall Study|Illness/Injury unrelated to product|0|||
44300787|NCT03110770|79298355|FG003|Overall Study|Illness/Injury unrelated to product|0|||
44300788|NCT03110770|79298356|FG004|Overall Study|Illness/Injury unrelated to product|1|||
44300789|NCT03110354|79298375|FG000|Overall Study|Death|1|||
44300790|NCT03110354|79298376|FG001|Overall Study|Death|0|||
44300791|NCT03110354|79298377|FG002|Overall Study|Death|0|||
44300792|NCT03110354|79298378|FG003|Overall Study|Death|1|||
44300793|NCT03110354|79298379|FG004|Overall Study|Death|0|||
44300794|NCT03110354|79298375|FG000|Overall Study|Start of new therapy|0|||
44300795|NCT03110354|79298376|FG001|Overall Study|Start of new therapy|0|||
44300796|NCT03110354|79298377|FG002|Overall Study|Start of new therapy|0|||
44300797|NCT03110354|79298378|FG003|Overall Study|Start of new therapy|0|||
44300798|NCT03110354|79298379|FG004|Overall Study|Start of new therapy|1|||
44300799|NCT03110354|79298375|FG000|Overall Study|Failure to achieve response|2|||
44300800|NCT03110354|79298376|FG001|Overall Study|Failure to achieve response|3|||
44300801|NCT03110354|79298377|FG002|Overall Study|Failure to achieve response|0|||
44300802|NCT03110354|79298378|FG003|Overall Study|Failure to achieve response|2|||
44300803|NCT03110354|79298379|FG004|Overall Study|Failure to achieve response|1|||
44300804|NCT03110354|79298375|FG000|Overall Study|Progressive disease|1|||
44300805|NCT03110354|79298376|FG001|Overall Study|Progressive disease|1|||
44300806|NCT03110354|79298377|FG002|Overall Study|Progressive disease|3|||
44300807|NCT03110354|79298378|FG003|Overall Study|Progressive disease|4|||
44300808|NCT03110354|79298379|FG004|Overall Study|Progressive disease|2|||
44300809|NCT03110354|79298375|FG000|Overall Study|Adverse Event|0|||
44300810|NCT03110354|79298376|FG001|Overall Study|Adverse Event|0|||
44300811|NCT03110354|79298377|FG002|Overall Study|Adverse Event|0|||
44300812|NCT03110354|79298378|FG003|Overall Study|Adverse Event|2|||
44300813|NCT03110354|79298379|FG004|Overall Study|Adverse Event|2|||
44300814|NCT03110354|79298375|FG000|Overall Study|Other|0|||
44300815|NCT03110354|79298376|FG001|Overall Study|Other|0|||
44300816|NCT03110354|79298377|FG002|Overall Study|Other|0|||
44300817|NCT03110354|79298378|FG003|Overall Study|Other|1|||
44300818|NCT03110354|79298379|FG004|Overall Study|Other|1|||
44300819|NCT02948400|79298422|FG000|Overall Study|Withdrawal by Subject|17|||
44300820|NCT02948400|79298423|FG001|Overall Study|Withdrawal by Subject|10|||
44300821|NCT02948400|79298422|FG000|Overall Study|failed to attend appointments|47|||
44300822|NCT02948400|79298423|FG001|Overall Study|failed to attend appointments|34|||
44300823|NCT02948400|79298422|FG000|Overall Study|COVID-related closure|6|||
44300824|NCT02948400|79298423|FG001|Overall Study|COVID-related closure|2|||
44300825|NCT02948400|79298422|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
44300826|NCT02948400|79298423|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
44300827|NCT02948400|79298422|FG000|Overall Study|motion sickness in virtual reality|2|||
44300828|NCT02948400|79298423|FG001|Overall Study|motion sickness in virtual reality|0|||
44354565|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
44354566|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
44354567|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
44354568|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
44354569|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Other|0|||
44354570|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Other|1|||
44354571|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Other|0|||
44354572|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Other|0|||
44354573|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
44354574|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
44354575|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
44354576|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
44354577|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
44354578|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
44354579|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
44354580|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
44354581|NCT01194414|79359012|FG000|24 Weeks Double Blind Period|Death|0|||
44354582|NCT01194414|79359013|FG001|24 Weeks Double Blind Period|Death|1|||
44354583|NCT01194414|79359014|FG002|24 Weeks Double Blind Period|Death|0|||
44354584|NCT01194414|79359015|FG003|24 Weeks Double Blind Period|Death|0|||
44354585|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
44354586|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
44354587|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
44354588|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
44354589|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
44354590|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
44354591|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
44354592|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
44354593|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
44354594|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
44354595|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
44354596|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
44354597|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
44354598|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
44354599|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
44354600|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
44354601|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
44354602|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
44354603|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
44354604|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
44354605|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
44354606|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
44354607|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
44354608|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
44354609|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Other|2|||
44354610|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Other|1|||
44354611|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Other|0|||
44354612|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Other|0|||
44354613|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
44354614|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
44354615|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
44354616|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
44354617|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
44354618|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
44354619|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
44354620|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
44354621|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
44354622|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
44354623|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
44354624|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
44354625|NCT01194414|79359012|FG000|72 Weeks Open Label Extension|Death|1|||
44354626|NCT01194414|79359013|FG001|72 Weeks Open Label Extension|Death|2|||
44354627|NCT01194414|79359014|FG002|72 Weeks Open Label Extension|Death|0|||
44154882|NCT02673619|78946227|FG001|Overall Study|Lost to Follow-up|0|||
44300829|NCT02695628|79298429|FG000|Overall Study|Withdrawal by Subject|1|||
44300830|NCT02671435|79298448|FG000|Overall Study|Death|1|||
44300831|NCT02671435|79298449|FG001|Overall Study|Death|3|||
44300832|NCT02671435|79298450|FG002|Overall Study|Death|0|||
44300833|NCT02671435|79298451|FG003|Overall Study|Death|16|||
44300834|NCT02671435|79298452|FG004|Overall Study|Death|14|||
44300835|NCT02671435|79298453|FG005|Overall Study|Death|29|||
44300836|NCT02671435|79298454|FG006|Overall Study|Death|34|||
44300837|NCT02671435|79298455|FG007|Overall Study|Death|28|||
44300838|NCT02671435|79298456|FG008|Overall Study|Death|19|||
44300839|NCT02671435|79298457|FG009|Overall Study|Death|10|||
44300840|NCT02671435|79298458|FG010|Overall Study|Death|8|||
44300841|NCT02671435|79298459|FG011|Overall Study|Death|29|||
44300842|NCT02671435|79298460|FG012|Overall Study|Death|29|||
44300843|NCT02671435|79298461|FG013|Overall Study|Death|29|||
44300844|NCT02671435|79298462|FG014|Overall Study|Death|27|||
44300845|NCT02671435|79298448|FG000|Overall Study|Lost to Follow-up|0|||
44300846|NCT02671435|79298449|FG001|Overall Study|Lost to Follow-up|0|||
44300847|NCT02671435|79298450|FG002|Overall Study|Lost to Follow-up|1|||
44300848|NCT02671435|79298451|FG003|Overall Study|Lost to Follow-up|0|||
44300849|NCT02671435|79298452|FG004|Overall Study|Lost to Follow-up|1|||
44300850|NCT02671435|79298453|FG005|Overall Study|Lost to Follow-up|1|||
44300851|NCT02671435|79298454|FG006|Overall Study|Lost to Follow-up|2|||
44300852|NCT02671435|79298455|FG007|Overall Study|Lost to Follow-up|2|||
44300853|NCT02671435|79298456|FG008|Overall Study|Lost to Follow-up|0|||
44300854|NCT02671435|79298457|FG009|Overall Study|Lost to Follow-up|2|||
44300855|NCT02671435|79298458|FG010|Overall Study|Lost to Follow-up|0|||
44300856|NCT02671435|79298459|FG011|Overall Study|Lost to Follow-up|3|||
44300857|NCT02671435|79298460|FG012|Overall Study|Lost to Follow-up|3|||
44300858|NCT02671435|79298461|FG013|Overall Study|Lost to Follow-up|2|||
44300859|NCT02671435|79298462|FG014|Overall Study|Lost to Follow-up|0|||
44300860|NCT02671435|79298448|FG000|Overall Study|Withdrawal by Subject|2|||
44300861|NCT02671435|79298449|FG001|Overall Study|Withdrawal by Subject|0|||
44300862|NCT02671435|79298450|FG002|Overall Study|Withdrawal by Subject|2|||
44300863|NCT02671435|79298451|FG003|Overall Study|Withdrawal by Subject|2|||
44300864|NCT02671435|79298452|FG004|Overall Study|Withdrawal by Subject|2|||
44300865|NCT02671435|79298453|FG005|Overall Study|Withdrawal by Subject|7|||
44300866|NCT02671435|79298454|FG006|Overall Study|Withdrawal by Subject|2|||
44300867|NCT02671435|79298455|FG007|Overall Study|Withdrawal by Subject|7|||
44300868|NCT02671435|79298456|FG008|Overall Study|Withdrawal by Subject|1|||
44300869|NCT02671435|79298457|FG009|Overall Study|Withdrawal by Subject|1|||
44300870|NCT02671435|79298458|FG010|Overall Study|Withdrawal by Subject|2|||
44300871|NCT02671435|79298459|FG011|Overall Study|Withdrawal by Subject|4|||
44300872|NCT02671435|79298460|FG012|Overall Study|Withdrawal by Subject|4|||
44300873|NCT02671435|79298461|FG013|Overall Study|Withdrawal by Subject|4|||
44300874|NCT02671435|79298462|FG014|Overall Study|Withdrawal by Subject|2|||
44300875|NCT02671435|79298448|FG000|Overall Study|Un-specified|0|||
44300876|NCT02671435|79298449|FG001|Overall Study|Un-specified|0|||
44300877|NCT02671435|79298450|FG002|Overall Study|Un-specified|0|||
44300878|NCT02671435|79298451|FG003|Overall Study|Un-specified|0|||
44300879|NCT02671435|79298452|FG004|Overall Study|Un-specified|1|||
44300880|NCT02671435|79298453|FG005|Overall Study|Un-specified|3|||
44300881|NCT02671435|79298454|FG006|Overall Study|Un-specified|2|||
44300882|NCT02671435|79298455|FG007|Overall Study|Un-specified|3|||
44417505|NCT00758043|79425421|FG001|Overall Study|Withdrawal by Subject|1|||
44417506|NCT00758043|79425422|FG002|Overall Study|Withdrawal by Subject|1|||
44417507|NCT00758043|79425423|FG003|Overall Study|Withdrawal by Subject|4|||
44417508|NCT00758043|79425420|FG000|Overall Study|Required Prohibited Medication|0|||
44417509|NCT00758043|79425421|FG001|Overall Study|Required Prohibited Medication|0|||
44534243|NCT00098475|79544844|FG001|Step 1|Adverse Event|37|||
44534244|NCT00098475|79544845|FG002|Step 1|Adverse Event|0|||
44534245|NCT00098475|79544846|FG003|Step 1|Adverse Event|1|||
44154883|NCT02673619|78946228|FG002|Overall Study|Lost to Follow-up|0|||
44300883|NCT02671435|79298456|FG008|Overall Study|Un-specified|0|||
44300884|NCT02671435|79298457|FG009|Overall Study|Un-specified|5|||
44300885|NCT02671435|79298458|FG010|Overall Study|Un-specified|8|||
44300886|NCT02671435|79298459|FG011|Overall Study|Un-specified|4|||
44300887|NCT02671435|79298460|FG012|Overall Study|Un-specified|5|||
44300888|NCT02671435|79298461|FG013|Overall Study|Un-specified|9|||
44300889|NCT02671435|79298462|FG014|Overall Study|Un-specified|8|||
44300890|NCT01922076|79298536|FG000|Overall Study|Adverse Event|0|||
44300891|NCT01922076|79298537|FG001|Overall Study|Adverse Event|0|||
44300892|NCT01922076|79298538|FG002|Overall Study|Adverse Event|0|||
44300893|NCT01922076|79298539|FG003|Overall Study|Adverse Event|0|||
44300894|NCT01922076|79298540|FG004|Overall Study|Adverse Event|1|||
44300895|NCT01922076|79298541|FG005|Overall Study|Adverse Event|0|||
44300896|NCT01922076|79298542|FG006|Overall Study|Adverse Event|0|||
44300897|NCT01922076|79298536|FG000|Overall Study|Physician Decision|0|||
44300898|NCT01922076|79298537|FG001|Overall Study|Physician Decision|0|||
44300899|NCT01922076|79298538|FG002|Overall Study|Physician Decision|1|||
44300900|NCT01922076|79298539|FG003|Overall Study|Physician Decision|0|||
44300901|NCT01922076|79298540|FG004|Overall Study|Physician Decision|0|||
44300902|NCT01922076|79298541|FG005|Overall Study|Physician Decision|0|||
44300903|NCT01922076|79298542|FG006|Overall Study|Physician Decision|0|||
44300904|NCT01922076|79298536|FG000|Overall Study|Withdrawal by Subject|0|||
44300905|NCT01922076|79298537|FG001|Overall Study|Withdrawal by Subject|0|||
44300906|NCT01922076|79298538|FG002|Overall Study|Withdrawal by Subject|0|||
44300907|NCT01922076|79298539|FG003|Overall Study|Withdrawal by Subject|1|||
44300908|NCT01922076|79298540|FG004|Overall Study|Withdrawal by Subject|0|||
44300909|NCT01922076|79298541|FG005|Overall Study|Withdrawal by Subject|1|||
44300910|NCT01922076|79298542|FG006|Overall Study|Withdrawal by Subject|1|||
44300911|NCT01366092|79298574|FG000|Overall Study|Progressive cGVHD|2|||
44300912|NCT01366092|79298574|FG000|Overall Study|Physician Decision|1|||
44300913|NCT01366092|79298574|FG000|Overall Study|Withdrawal by Subject|1|||
44300914|NCT01065454|79298582|FG000|Treatment|Adverse Event|7|||
44300915|NCT01065454|79298583|FG001|Treatment|Adverse Event|4|||
44300916|NCT01065454|79298584|FG002|Treatment|Adverse Event|3|||
44300917|NCT01065454|79298585|FG003|Treatment|Adverse Event|6|||
44300918|NCT01065454|79298582|FG000|Treatment|Death|1|||
44300919|NCT01065454|79298583|FG001|Treatment|Death|0|||
44417510|NCT00758043|79425422|FG002|Overall Study|Required Prohibited Medication|1|||
44417511|NCT00758043|79425423|FG003|Overall Study|Required Prohibited Medication|3|||
44417512|NCT00758043|79425420|FG000|Overall Study|Non-Compliant With study Drug|0|||
44417513|NCT00758043|79425421|FG001|Overall Study|Non-Compliant With study Drug|0|||
44417514|NCT00758043|79425422|FG002|Overall Study|Non-Compliant With study Drug|0|||
44300920|NCT01065454|79298584|FG002|Treatment|Death|0|||
44300921|NCT01065454|79298585|FG003|Treatment|Death|0|||
44300922|NCT01065454|79298582|FG000|Treatment|Non-compliance|1|||
44300923|NCT01065454|79298583|FG001|Treatment|Non-compliance|0|||
44300924|NCT01065454|79298584|FG002|Treatment|Non-compliance|0|||
44300925|NCT01065454|79298585|FG003|Treatment|Non-compliance|1|||
44300926|NCT01065454|79298582|FG000|Treatment|Protocol Decision|0|||
44300927|NCT01065454|79298583|FG001|Treatment|Protocol Decision|0|||
44300928|NCT01065454|79298584|FG002|Treatment|Protocol Decision|3|||
44300929|NCT01065454|79298585|FG003|Treatment|Protocol Decision|2|||
44300930|NCT01065454|79298582|FG000|Treatment|Protocol Violation|1|||
44300931|NCT01065454|79298583|FG001|Treatment|Protocol Violation|0|||
44300932|NCT01065454|79298584|FG002|Treatment|Protocol Violation|1|||
44300933|NCT01065454|79298585|FG003|Treatment|Protocol Violation|0|||
44300934|NCT01065454|79298582|FG000|Treatment|Withdrawal by Subject|3|||
44300935|NCT01065454|79298583|FG001|Treatment|Withdrawal by Subject|1|||
44300936|NCT01065454|79298584|FG002|Treatment|Withdrawal by Subject|2|||
44300937|NCT01065454|79298585|FG003|Treatment|Withdrawal by Subject|3|||
44300938|NCT01065454|79298582|FG000|Follow up|Adverse Event|1|||
44300939|NCT01065454|79298583|FG001|Follow up|Adverse Event|0|||
44300940|NCT01065454|79298584|FG002|Follow up|Adverse Event|0|||
44300941|NCT01065454|79298585|FG003|Follow up|Adverse Event|1|||
44300942|NCT01065454|79298582|FG000|Follow up|Death|0|||
44300943|NCT01065454|79298583|FG001|Follow up|Death|1|||
44300944|NCT01065454|79298584|FG002|Follow up|Death|1|||
44300945|NCT01065454|79298585|FG003|Follow up|Death|0|||
44300946|NCT01065454|79298582|FG000|Follow up|Lost to Follow-up|0|||
44300947|NCT01065454|79298583|FG001|Follow up|Lost to Follow-up|0|||
44300948|NCT01065454|79298584|FG002|Follow up|Lost to Follow-up|0|||
44300949|NCT01065454|79298585|FG003|Follow up|Lost to Follow-up|1|||
44300950|NCT01065454|79298582|FG000|Follow up|Progressive disease|0|||
44300951|NCT01065454|79298583|FG001|Follow up|Progressive disease|0|||
44300952|NCT01065454|79298584|FG002|Follow up|Progressive disease|0|||
44300953|NCT01065454|79298585|FG003|Follow up|Progressive disease|1|||
44300954|NCT01065454|79298582|FG000|Follow up|Withdrawal by Subject|1|||
44300955|NCT01065454|79298583|FG001|Follow up|Withdrawal by Subject|1|||
44300956|NCT01065454|79298584|FG002|Follow up|Withdrawal by Subject|1|||
44300957|NCT01065454|79298585|FG003|Follow up|Withdrawal by Subject|0|||
44300958|NCT01065454|79298582|FG000|Follow up|study ongoing|37|||
44300959|NCT01065454|79298583|FG001|Follow up|study ongoing|22|||
44300960|NCT01065454|79298584|FG002|Follow up|study ongoing|15|||
44300961|NCT01065454|79298585|FG003|Follow up|study ongoing|41|||
44300962|NCT00569127|79298597|FG000|Overall Study|Adverse Event|57|||
44300963|NCT00569127|79298598|FG001|Overall Study|Adverse Event|47|||
44300964|NCT00569127|79298597|FG000|Overall Study|Withdrawal by Subject|13|||
44300965|NCT00569127|79298598|FG001|Overall Study|Withdrawal by Subject|27|||
44300966|NCT00569127|79298597|FG000|Overall Study|Progression|99|||
44300967|NCT00569127|79298598|FG001|Overall Study|Progression|100|||
44300968|NCT00569127|79298597|FG000|Overall Study|Death|4|||
44300969|NCT00569127|79298598|FG001|Overall Study|Death|3|||
44300970|NCT00569127|79298597|FG000|Overall Study|Other|20|||
44417515|NCT00758043|79425423|FG003|Overall Study|Non-Compliant With study Drug|1|||
44300971|NCT00569127|79298598|FG001|Overall Study|Other|19|||
44300972|NCT00569127|79298597|FG000|Overall Study|Lost to Follow-up|0|||
44300973|NCT00569127|79298598|FG001|Overall Study|Lost to Follow-up|3|||
44300974|NCT00569127|79298597|FG000|Overall Study|Not Eligible|14|||
44300975|NCT00569127|79298598|FG001|Overall Study|Not Eligible|11|||
44300976|NCT00569127|79298597|FG000|Overall Study|Still on Treatment|7|||
44300977|NCT00569127|79298598|FG001|Overall Study|Still on Treatment|3|||
44300978|NCT04700137|79298658|FG000|Overall Study|Lost to Follow-up|1|||
44300979|NCT04700137|79298659|FG001|Overall Study|Lost to Follow-up|6|||
44300980|NCT04700137|79298660|FG002|Overall Study|Lost to Follow-up|1|||
44300981|NCT04700137|79298661|FG003|Overall Study|Lost to Follow-up|1|||
44300982|NCT04700137|79298658|FG000|Overall Study|Withdrawal by Subject|0|||
44300983|NCT04700137|79298659|FG001|Overall Study|Withdrawal by Subject|0|||
44300984|NCT04700137|79298660|FG002|Overall Study|Withdrawal by Subject|1|||
44300985|NCT04700137|79298661|FG003|Overall Study|Withdrawal by Subject|0|||
44300986|NCT04700137|79298658|FG000|Overall Study|Death|0|||
44300987|NCT04700137|79298659|FG001|Overall Study|Death|0|||
44300988|NCT04700137|79298660|FG002|Overall Study|Death|1|||
44300989|NCT04700137|79298661|FG003|Overall Study|Death|0|||
44300990|NCT04260191|79298691|FG000|Overall Study|Decision by Sponsor|0|||
44300991|NCT04260191|79298692|FG001|Overall Study|Decision by Sponsor|1|||
44300992|NCT04260191|79298693|FG002|Overall Study|Decision by Sponsor|0|||
44300993|NCT04260191|79298691|FG000|Overall Study|Withdrawal by Subject|1|||
44300994|NCT04260191|79298692|FG001|Overall Study|Withdrawal by Subject|0|||
44300995|NCT04260191|79298693|FG002|Overall Study|Withdrawal by Subject|3|||
44300996|NCT04260191|79298691|FG000|Overall Study|Death|4|||
44300997|NCT04260191|79298692|FG001|Overall Study|Death|3|||
44300998|NCT04260191|79298693|FG002|Overall Study|Death|2|||
44300999|NCT03188510|79298754|FG000|Overall Study|Inappropriate behavior with site staff|0|||
44301000|NCT03188510|79298755|FG001|Overall Study|Inappropriate behavior with site staff|1|||
44301001|NCT03188510|79298756|FG002|Overall Study|Inappropriate behavior with site staff|0|||
44301002|NCT03100149|79298767|FG000|Overall Study|Adverse Event|0|||
44301003|NCT03100149|79298768|FG001|Overall Study|Adverse Event|1|||
44301004|NCT03100149|79298769|FG002|Overall Study|Adverse Event|0|||
44301005|NCT03100149|79298767|FG000|Overall Study|Participant Moved out of Country|0|||
44301006|NCT03100149|79298768|FG001|Overall Study|Participant Moved out of Country|0|||
44301007|NCT03100149|79298769|FG002|Overall Study|Participant Moved out of Country|1|||
44301008|NCT03100149|79298767|FG000|Overall Study|Withdrawal by Subject|0|||
44301009|NCT03100149|79298768|FG001|Overall Study|Withdrawal by Subject|3|||
44301010|NCT03100149|79298769|FG002|Overall Study|Withdrawal by Subject|1|||
44301011|NCT03075527|79298777|FG000|Overall Study|Ongoing treatment|2|||
44301012|NCT02734004|79298797|FG000|Overall Study|Death|36|||
44301013|NCT02734004|79298798|FG001|Overall Study|Death|24|||
44301014|NCT02734004|79298799|FG002|Overall Study|Death|26|||
44301015|NCT02734004|79298800|FG003|Overall Study|Death|35|||
44301016|NCT02734004|79298801|FG004|Overall Study|Death|13|||
44301017|NCT02734004|79298802|FG005|Overall Study|Death|17|||
44301018|NCT02734004|79298803|FG006|Overall Study|Death|20|||
44301019|NCT02734004|79298797|FG000|Overall Study|Lost to Follow-up|1|||
44301020|NCT02734004|79298798|FG001|Overall Study|Lost to Follow-up|1|||
44301021|NCT02734004|79298799|FG002|Overall Study|Lost to Follow-up|0|||
44301022|NCT02734004|79298800|FG003|Overall Study|Lost to Follow-up|0|||
44301023|NCT02734004|79298801|FG004|Overall Study|Lost to Follow-up|1|||
44301024|NCT02734004|79298802|FG005|Overall Study|Lost to Follow-up|0|||
44301025|NCT02734004|79298803|FG006|Overall Study|Lost to Follow-up|0|||
44301026|NCT02734004|79298797|FG000|Overall Study|Withdrawal by Subject|3|||
44301027|NCT02734004|79298798|FG001|Overall Study|Withdrawal by Subject|1|||
44417516|NCT00758043|79425420|FG000|Overall Study|Other Reasons|0|||
44417517|NCT00758043|79425421|FG001|Overall Study|Other Reasons|1|||
44417518|NCT00758043|79425422|FG002|Overall Study|Other Reasons|0|||
44417519|NCT00758043|79425423|FG003|Overall Study|Other Reasons|5|||
44417520|NCT00831701|79425441|FG000|Overall Study|Withdrawal by Subject|2|||
44417521|NCT00831701|79425442|FG001|Overall Study|Withdrawal by Subject|0|||
44417522|NCT00831701|79425441|FG000|Overall Study|Stone expulsion before first medication|2|||
44417523|NCT00831701|79425442|FG001|Overall Study|Stone expulsion before first medication|2|||
44417524|NCT00831701|79425441|FG000|Overall Study|Lost to Follow-up|1|||
44417525|NCT00831701|79425442|FG001|Overall Study|Lost to Follow-up|3|||
44417526|NCT00752895|79425450|FG000|Overall Study|Withdrawal by Subject|8|||
44417527|NCT00752895|79425451|FG001|Overall Study|Withdrawal by Subject|3|||
44417528|NCT00831389|79425459|FG000|Overall Study|Withdrawal by Subject|0|||
44417529|NCT00831389|79425460|FG001|Overall Study|Withdrawal by Subject|1|||
44301028|NCT02734004|79298799|FG002|Overall Study|Withdrawal by Subject|1|||
44301029|NCT02734004|79298800|FG003|Overall Study|Withdrawal by Subject|1|||
44301030|NCT02734004|79298801|FG004|Overall Study|Withdrawal by Subject|3|||
44301031|NCT02734004|79298802|FG005|Overall Study|Withdrawal by Subject|0|||
44301032|NCT02734004|79298803|FG006|Overall Study|Withdrawal by Subject|2|||
44301033|NCT02734004|79298797|FG000|Overall Study|Other|0|||
44301034|NCT02734004|79298798|FG001|Overall Study|Other|8|||
44301035|NCT02734004|79298799|FG002|Overall Study|Other|7|||
44301036|NCT02734004|79298800|FG003|Overall Study|Other|4|||
44301037|NCT02734004|79298801|FG004|Overall Study|Other|34|||
44301038|NCT02734004|79298802|FG005|Overall Study|Other|14|||
44301039|NCT02734004|79298803|FG006|Overall Study|Other|10|||
44301040|NCT02677922|79298832|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
44417530|NCT00831311|79425468|FG000|Overall Study|Definitive Contraindication|3|||
44301041|NCT02677922|79298833|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
44301042|NCT02677922|79298834|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
44301043|NCT02677922|79298835|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
44301044|NCT02677922|79298836|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
44301045|NCT02677922|79298837|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
44301046|NCT02677922|79298832|FG000|Treatment Period|Adverse Event|0|||
44301047|NCT02677922|79298833|FG001|Treatment Period|Adverse Event|0|||
44301048|NCT02677922|79298834|FG002|Treatment Period|Adverse Event|1|||
44301049|NCT02677922|79298835|FG003|Treatment Period|Adverse Event|3|||
44301050|NCT02677922|79298836|FG004|Treatment Period|Adverse Event|5|||
44301051|NCT02677922|79298837|FG005|Treatment Period|Adverse Event|2|||
44301052|NCT02677922|79298832|FG000|Treatment Period|Progressive Disease|1|||
44301053|NCT02677922|79298833|FG001|Treatment Period|Progressive Disease|1|||
44301054|NCT02677922|79298834|FG002|Treatment Period|Progressive Disease|0|||
44301055|NCT02677922|79298835|FG003|Treatment Period|Progressive Disease|0|||
44301056|NCT02677922|79298836|FG004|Treatment Period|Progressive Disease|8|||
44301057|NCT02677922|79298837|FG005|Treatment Period|Progressive Disease|7|||
44301058|NCT02677922|79298832|FG000|Treatment Period|Lack of Efficacy|0|||
44301059|NCT02677922|79298833|FG001|Treatment Period|Lack of Efficacy|0|||
44301060|NCT02677922|79298834|FG002|Treatment Period|Lack of Efficacy|0|||
44301061|NCT02677922|79298835|FG003|Treatment Period|Lack of Efficacy|1|||
44301062|NCT02677922|79298836|FG004|Treatment Period|Lack of Efficacy|1|||
44301063|NCT02677922|79298837|FG005|Treatment Period|Lack of Efficacy|6|||
44301064|NCT02677922|79298832|FG000|Treatment Period|Withdrawal by Subject|0|||
44301065|NCT02677922|79298833|FG001|Treatment Period|Withdrawal by Subject|0|||
44301066|NCT02677922|79298834|FG002|Treatment Period|Withdrawal by Subject|1|||
44301067|NCT02677922|79298835|FG003|Treatment Period|Withdrawal by Subject|3|||
44301068|NCT02677922|79298836|FG004|Treatment Period|Withdrawal by Subject|5|||
44301069|NCT02677922|79298837|FG005|Treatment Period|Withdrawal by Subject|5|||
44301070|NCT02677922|79298832|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
44301071|NCT02677922|79298833|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
44301072|NCT02677922|79298834|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
44301073|NCT02677922|79298835|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
44301074|NCT02677922|79298836|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
44301075|NCT02677922|79298837|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
44301076|NCT02677922|79298832|FG000|Treatment Period|Disease Relapse|0|||
44301077|NCT02677922|79298833|FG001|Treatment Period|Disease Relapse|0|||
44301078|NCT02677922|79298834|FG002|Treatment Period|Disease Relapse|0|||
44301079|NCT02677922|79298835|FG003|Treatment Period|Disease Relapse|3|||
44301080|NCT02677922|79298836|FG004|Treatment Period|Disease Relapse|6|||
44301081|NCT02677922|79298837|FG005|Treatment Period|Disease Relapse|1|||
44301082|NCT02677922|79298832|FG000|Treatment Period|Allogeneic HSCT|1|||
44301083|NCT02677922|79298833|FG001|Treatment Period|Allogeneic HSCT|0|||
44301084|NCT02677922|79298834|FG002|Treatment Period|Allogeneic HSCT|0|||
44301085|NCT02677922|79298835|FG003|Treatment Period|Allogeneic HSCT|1|||
44301086|NCT02677922|79298836|FG004|Treatment Period|Allogeneic HSCT|4|||
44417531|NCT00831311|79425469|FG001|Overall Study|Definitive Contraindication|3|||
44417532|NCT00831311|79425468|FG000|Overall Study|Lost to Follow-up|3|||
44417533|NCT00831311|79425469|FG001|Overall Study|Lost to Follow-up|0|||
44154884|NCT02673619|78946229|FG003|Overall Study|Lost to Follow-up|0|||
44301087|NCT02677922|79298837|FG005|Treatment Period|Allogeneic HSCT|1|||
44301088|NCT02677922|79298832|FG000|Treatment Period|Other Reasons|0|||
44301089|NCT02677922|79298833|FG001|Treatment Period|Other Reasons|0|||
44301090|NCT02677922|79298834|FG002|Treatment Period|Other Reasons|0|||
44301091|NCT02677922|79298835|FG003|Treatment Period|Other Reasons|1|||
44301092|NCT02677922|79298836|FG004|Treatment Period|Other Reasons|3|||
44301093|NCT02677922|79298837|FG005|Treatment Period|Other Reasons|5|||
44301094|NCT02677922|79298832|FG000|Treatment Period|Death|0|||
44301095|NCT02677922|79298833|FG001|Treatment Period|Death|0|||
44301096|NCT02677922|79298834|FG002|Treatment Period|Death|0|||
44301097|NCT02677922|79298835|FG003|Treatment Period|Death|0|||
44301098|NCT02677922|79298836|FG004|Treatment Period|Death|12|||
44301099|NCT02677922|79298837|FG005|Treatment Period|Death|1|||
44301100|NCT02677922|79298832|FG000|Treatment Period|Non-compliance with Study Drug|0|||
44301101|NCT02677922|79298833|FG001|Treatment Period|Non-compliance with Study Drug|0|||
44301102|NCT02677922|79298834|FG002|Treatment Period|Non-compliance with Study Drug|0|||
44301103|NCT02677922|79298835|FG003|Treatment Period|Non-compliance with Study Drug|0|||
44301104|NCT02677922|79298836|FG004|Treatment Period|Non-compliance with Study Drug|1|||
44301105|NCT02677922|79298837|FG005|Treatment Period|Non-compliance with Study Drug|0|||
44301106|NCT02677922|79298832|FG000|Treatment Period|Physician Decision|0|||
44301107|NCT02677922|79298833|FG001|Treatment Period|Physician Decision|0|||
44301108|NCT02677922|79298834|FG002|Treatment Period|Physician Decision|0|||
44301109|NCT02677922|79298835|FG003|Treatment Period|Physician Decision|0|||
44301110|NCT02677922|79298836|FG004|Treatment Period|Physician Decision|0|||
44301111|NCT02677922|79298837|FG005|Treatment Period|Physician Decision|1|||
44301112|NCT02677922|79298832|FG000|Treatment Period|Symptomatic Deterioration|0|||
44301113|NCT02677922|79298833|FG001|Treatment Period|Symptomatic Deterioration|0|||
44301114|NCT02677922|79298834|FG002|Treatment Period|Symptomatic Deterioration|0|||
44301115|NCT02677922|79298835|FG003|Treatment Period|Symptomatic Deterioration|0|||
44301116|NCT02677922|79298836|FG004|Treatment Period|Symptomatic Deterioration|1|||
44301117|NCT02677922|79298837|FG005|Treatment Period|Symptomatic Deterioration|0|||
44301118|NCT02567799|79298855|FG000|Concurrent Chemoradiotherapy|Death|1|||
44301119|NCT02567799|79298856|FG001|Concurrent Chemoradiotherapy|Death|0|||
44301120|NCT02567799|79298857|FG002|Concurrent Chemoradiotherapy|Death|0|||
44301121|NCT02567799|79298855|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
44301122|NCT02567799|79298856|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
44417534|NCT00831311|79425468|FG000|Overall Study|Physician Decision|0|||
44154885|NCT02673619|78946226|FG000|Overall Study|Withdrawal by Subject|1|||
44301123|NCT02567799|79298857|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
44301124|NCT02567799|79298855|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
44301125|NCT02567799|79298856|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
44301126|NCT02567799|79298857|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
44301127|NCT02567799|79298855|FG000|Follow-up|Death|1|||
44301128|NCT02567799|79298856|FG001|Follow-up|Death|0|||
44301129|NCT02567799|79298857|FG002|Follow-up|Death|1|||
44301130|NCT02567799|79298855|FG000|Follow-up|Progressive Disease|1|||
44301131|NCT02567799|79298856|FG001|Follow-up|Progressive Disease|1|||
44301132|NCT02567799|79298857|FG002|Follow-up|Progressive Disease|3|||
44301133|NCT01696994|79298886|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
44301134|NCT01696994|79298887|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
44301135|NCT01696994|79298886|FG000|Overall Study|Died Before Randomization|1|||
44301136|NCT01696994|79298887|FG001|Overall Study|Died Before Randomization|2|||
44301137|NCT01696994|79298886|FG000|Overall Study|Died Before ASU (Control)|73|||
44301138|NCT01696994|79298887|FG001|Overall Study|Died Before ASU (Control)|0|||
44301139|NCT01696994|79298886|FG000|Overall Study|No Ovaries at Baseline|4807|||
44301140|NCT01696994|79298887|FG001|Overall Study|No Ovaries at Baseline|4851|||
44301141|NCT01696994|79298886|FG000|Overall Study|Refused ASU (Control)|311|||
44301142|NCT01696994|79298887|FG001|Overall Study|Refused ASU (Control)|0|||
44301143|NCT01696994|79298886|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
44301144|NCT01696994|79298887|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
44301145|NCT01696981|79298897|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
44301146|NCT01696981|79298898|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
44301147|NCT01696981|79298897|FG000|Overall Study|Died Before Randomization|3|||
44301148|NCT01696981|79298898|FG001|Overall Study|Died Before Randomization|8|||
44301149|NCT01696981|79298897|FG000|Overall Study|Died Before ASU (Control)|278|||
44301150|NCT01696981|79298898|FG001|Overall Study|Died Before ASU (Control)|0|||
44301151|NCT01696981|79298897|FG000|Overall Study|Refused ASU (Control)|920|||
44301152|NCT01696981|79298898|FG001|Overall Study|Refused ASU (Control)|0|||
44301153|NCT01696981|79298897|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
44301154|NCT01696981|79298898|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
44301155|NCT01696968|79298906|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
44301156|NCT01696968|79298907|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
44301157|NCT01696968|79298906|FG000|Overall Study|Died Before Randomization|3|||
44301158|NCT01696968|79298907|FG001|Overall Study|Died Before Randomization|8|||
44301159|NCT01696968|79298906|FG000|Overall Study|Died Before ASU (Control)|278|||
44301160|NCT01696968|79298907|FG001|Overall Study|Died Before ASU (Control)|0|||
44301161|NCT01696968|79298906|FG000|Overall Study|Refused ASU (Control)|920|||
44301162|NCT01696968|79298907|FG001|Overall Study|Refused ASU (Control)|0|||
44301163|NCT01696968|79298906|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
44301164|NCT01696968|79298907|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
44301165|NCT01155050|79298918|FG000|Overall Study|Lost to Follow-up|15|||
44301166|NCT01155050|79298919|FG001|Overall Study|Lost to Follow-up|20|||
44301167|NCT01155050|79298920|FG002|Overall Study|Lost to Follow-up|19|||
44301168|NCT01155050|79298921|FG003|Overall Study|Lost to Follow-up|22|||
44301169|NCT00002540|79298943|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
44301170|NCT00002540|79298944|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
44301171|NCT00002540|79298943|FG000|Overall Study|Died Before Randomization|2|||
44301172|NCT00002540|79298944|FG001|Overall Study|Died Before Randomization|6|||
44301173|NCT00002540|79298943|FG000|Overall Study|Died Before ASU (Control)|202|||
44301174|NCT00002540|79298944|FG001|Overall Study|Died Before ASU (Control)|0|||
44301175|NCT00002540|79298943|FG000|Overall Study|Refused ASU (Control)|597|||
44301176|NCT00002540|79298944|FG001|Overall Study|Refused ASU (Control)|0|||
44301177|NCT00002540|79298943|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
44301178|NCT00002540|79298944|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
44301179|NCT04799405|79298959|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
44301180|NCT04529499|79298969|FG000|Overall Study|Withdrawal by Subject|9|||
44301181|NCT04529499|79298970|FG001|Overall Study|Withdrawal by Subject|11|||
44301182|NCT04529499|79298969|FG000|Overall Study|Physician Decision|1|||
44301183|NCT04529499|79298970|FG001|Overall Study|Physician Decision|2|||
44301184|NCT04529499|79298969|FG000|Overall Study|Adverse Event|4|||
44301185|NCT04529499|79298970|FG001|Overall Study|Adverse Event|4|||
44301186|NCT04529499|79298969|FG000|Overall Study|Death|14|||
44301187|NCT04529499|79298970|FG001|Overall Study|Death|11|||
44301188|NCT04529499|79298969|FG000|Overall Study|Lost to Follow-up|1|||
44301189|NCT04529499|79298970|FG001|Overall Study|Lost to Follow-up|1|||
44301190|NCT04529499|79298969|FG000|Overall Study|Others|7|||
44301191|NCT04529499|79298970|FG001|Overall Study|Others|11|||
44301192|NCT04501094|79298978|FG000|Overall Study|Death (unrelated to research)|1|||
44301193|NCT04501094|79298979|FG001|Overall Study|Death (unrelated to research)|0|||
44301194|NCT04414618|79298987|FG000|Overall Study|Death|3|||
44301195|NCT04414618|79298988|FG001|Overall Study|Death|3|||
44301196|NCT04414618|79298987|FG000|Overall Study|Withdrawal by Subject|2|||
44301197|NCT04414618|79298988|FG001|Overall Study|Withdrawal by Subject|1|||
44301198|NCT04414618|79298987|FG000|Overall Study|Lost to Follow-up|2|||
44301199|NCT04414618|79298988|FG001|Overall Study|Lost to Follow-up|3|||
44301200|NCT04414618|79298987|FG000|Overall Study|Physician Decision|1|||
44301201|NCT04414618|79298988|FG001|Overall Study|Physician Decision|0|||
44301202|NCT04412057|79298997|FG000|Overall Study|Death|3|||
44301203|NCT04412057|79298998|FG001|Overall Study|Death|7|||
44301204|NCT04412057|79298997|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
44301205|NCT04412057|79298998|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
44301206|NCT04402060|79299007|FG000|Overall Study|Death|1|||
44301207|NCT04402060|79299008|FG001|Overall Study|Death|12|||
44301208|NCT04402060|79299009|FG002|Overall Study|Death|7|||
44301209|NCT04402060|79299007|FG000|Overall Study|Adverse Event|0|||
44301210|NCT04402060|79299008|FG001|Overall Study|Adverse Event|0|||
44301211|NCT04402060|79299009|FG002|Overall Study|Adverse Event|1|||
44301212|NCT04402060|79299007|FG000|Overall Study|Withdrawal by Subject|0|||
44301213|NCT04402060|79299008|FG001|Overall Study|Withdrawal by Subject|1|||
44301214|NCT04402060|79299009|FG002|Overall Study|Withdrawal by Subject|2|||
44301215|NCT04402060|79299007|FG000|Overall Study|Sponsor Request|0|||
44301216|NCT04402060|79299008|FG001|Overall Study|Sponsor Request|2|||
44301217|NCT04402060|79299009|FG002|Overall Study|Sponsor Request|0|||
44301218|NCT04402060|79299007|FG000|Overall Study|Physician Decision|0|||
44301219|NCT04402060|79299008|FG001|Overall Study|Physician Decision|0|||
44301220|NCT04402060|79299009|FG002|Overall Study|Physician Decision|1|||
44301221|NCT04402060|79299007|FG000|Overall Study|Other|0|||
44301222|NCT04402060|79299008|FG001|Overall Study|Other|1|||
44301223|NCT04402060|79299009|FG002|Overall Study|Other|0|||
44301224|NCT04376684|79299044|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
44301225|NCT04376684|79299045|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
44301226|NCT04376684|79299046|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
44301227|NCT04376684|79299047|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
44301228|NCT04376684|79299044|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
44301229|NCT04376684|79299045|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
44301230|NCT04376684|79299046|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
44301231|NCT04376684|79299047|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
44301232|NCT04376684|79299044|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
44301233|NCT04376684|79299045|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
44301234|NCT04376684|79299046|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
44301235|NCT04376684|79299047|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
44301236|NCT04376684|79299044|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
44301237|NCT04376684|79299045|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
44301238|NCT04376684|79299046|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
44301239|NCT04376684|79299047|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
44301240|NCT04376684|79299044|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
44301241|NCT04376684|79299045|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
44301242|NCT04376684|79299046|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
44301243|NCT04376684|79299047|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
44301244|NCT04376684|79299044|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
44301245|NCT04376684|79299045|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
44301246|NCT04376684|79299046|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
44301247|NCT04376684|79299047|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
44301248|NCT04376684|79299044|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
44301249|NCT04376684|79299045|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
44301250|NCT04376684|79299046|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
44301251|NCT04376684|79299047|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
44301252|NCT04353284|79299059|FG000|Overall Study|Adverse Event|1|||
44301253|NCT04353284|79299060|FG001|Overall Study|Adverse Event|1|||
44301254|NCT04353284|79299059|FG000|Overall Study|Lost to Follow-up|1|||
44301255|NCT04353284|79299060|FG001|Overall Study|Lost to Follow-up|0|||
44301256|NCT04294147|79299068|FG000|Overall Study|Protocol Violation|2|||
44301257|NCT04294147|79299069|FG001|Overall Study|Protocol Violation|0|||
44301258|NCT04231825|79299081|FG000|Overall Study|Protocol Violation|3|||
44301259|NCT04231825|79299082|FG001|Overall Study|Protocol Violation|3|||
44301260|NCT04231825|79299081|FG000|Overall Study|Lost to Follow-up|0|||
44301261|NCT04231825|79299082|FG001|Overall Study|Lost to Follow-up|1|||
44301262|NCT04178772|79299088|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
44301263|NCT04178772|79299088|FG000|Overall Study|study terminated early due to COVID-19|7|||
44301264|NCT04148651|79299092|FG000|Overall Study|Lost to Follow-up|2|||
44301265|NCT03924427|79299105|FG000|Overall Study|Adverse Event|4|||
44301266|NCT03924427|79299105|FG000|Overall Study|Lack of Efficacy|1|||
44301267|NCT03924427|79299105|FG000|Overall Study|Withdrawal by Subject|1|||
44301268|NCT03642132|79299149|FG000|Chemotherapy Period|Adverse Event|1|||
44301269|NCT03642132|79299150|FG001|Chemotherapy Period|Adverse Event|1|||
44301270|NCT03642132|79299151|FG002|Chemotherapy Period|Adverse Event|0|||
44301271|NCT03642132|79299149|FG000|Chemotherapy Period|Physician's decision|4|||
44301272|NCT03642132|79299150|FG001|Chemotherapy Period|Physician's decision|1|||
44301273|NCT03642132|79299151|FG002|Chemotherapy Period|Physician's decision|0|||
44301274|NCT03642132|79299149|FG000|Chemotherapy Period|Progressive disease|0|||
44301275|NCT03642132|79299150|FG001|Chemotherapy Period|Progressive disease|0|||
44301276|NCT03642132|79299151|FG002|Chemotherapy Period|Progressive disease|1|||
44301277|NCT03642132|79299149|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
44301278|NCT03642132|79299150|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
44301279|NCT03642132|79299151|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
44301280|NCT03642132|79299149|FG000|Chemotherapy Period|Other|1|||
44301281|NCT03642132|79299150|FG001|Chemotherapy Period|Other|0|||
44301282|NCT03642132|79299151|FG002|Chemotherapy Period|Other|2|||
44301283|NCT03642132|79299149|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
44301284|NCT03642132|79299150|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
44301285|NCT03642132|79299151|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
44301286|NCT03642132|79299149|FG000|Maintenance Period|Adverse Event|1|||
44301287|NCT03642132|79299150|FG001|Maintenance Period|Adverse Event|2|||
44301288|NCT03642132|79299151|FG002|Maintenance Period|Adverse Event|0|||
44301289|NCT03642132|79299149|FG000|Maintenance Period|Non-compliance with study drug|0|||
44301290|NCT03642132|79299150|FG001|Maintenance Period|Non-compliance with study drug|0|||
44301291|NCT03642132|79299151|FG002|Maintenance Period|Non-compliance with study drug|1|||
44301292|NCT03642132|79299149|FG000|Maintenance Period|Physician's decision|2|||
44301293|NCT03642132|79299150|FG001|Maintenance Period|Physician's decision|2|||
44301294|NCT03642132|79299151|FG002|Maintenance Period|Physician's decision|2|||
44301295|NCT03642132|79299149|FG000|Maintenance Period|Progressive disease|9|||
44301296|NCT03642132|79299150|FG001|Maintenance Period|Progressive disease|3|||
44301297|NCT03642132|79299151|FG002|Maintenance Period|Progressive disease|6|||
44301298|NCT03642132|79299149|FG000|Maintenance Period|Other|0|||
44301299|NCT03642132|79299150|FG001|Maintenance Period|Other|0|||
44301300|NCT03642132|79299151|FG002|Maintenance Period|Other|3|||
44301301|NCT03642132|79299149|FG000|Maintenance Period|Withdrawal by Subject|1|||
44301302|NCT03642132|79299150|FG001|Maintenance Period|Withdrawal by Subject|1|||
44301303|NCT03642132|79299151|FG002|Maintenance Period|Withdrawal by Subject|2|||
44301304|NCT03642132|79299149|FG000|Follow-up Period|Other|0|||
44301305|NCT03642132|79299150|FG001|Follow-up Period|Other|0|||
44301306|NCT03642132|79299151|FG002|Follow-up Period|Other|1|||
44301307|NCT03642132|79299149|FG000|Follow-up Period|Withdrawal by Subject|1|||
44301308|NCT03642132|79299150|FG001|Follow-up Period|Withdrawal by Subject|2|||
44301309|NCT03642132|79299151|FG002|Follow-up Period|Withdrawal by Subject|0|||
44301310|NCT03642132|79299149|FG000|Follow-up Period|Study terminated by sponsor|1|||
44301311|NCT03642132|79299150|FG001|Follow-up Period|Study terminated by sponsor|0|||
44301312|NCT03642132|79299151|FG002|Follow-up Period|Study terminated by sponsor|1|||
44301313|NCT03642132|79299149|FG000|Follow-up Period|Lack of Efficacy|1|||
44301314|NCT03642132|79299150|FG001|Follow-up Period|Lack of Efficacy|0|||
44301315|NCT03642132|79299151|FG002|Follow-up Period|Lack of Efficacy|0|||
44301316|NCT03642132|79299149|FG000|Follow-up Period|Death|1|||
44301317|NCT03642132|79299150|FG001|Follow-up Period|Death|0|||
44301318|NCT03642132|79299151|FG002|Follow-up Period|Death|2|||
44301319|NCT03642132|79299149|FG000|Follow-up Period|Adverse Event|1|||
44301320|NCT03642132|79299150|FG001|Follow-up Period|Adverse Event|0|||
44301321|NCT03642132|79299151|FG002|Follow-up Period|Adverse Event|0|||
44301322|NCT03008122|79299162|FG000|Overall Study|Physician Decision|3|||
44301323|NCT03008122|79299163|FG001|Overall Study|Physician Decision|2|||
44301324|NCT03008122|79299164|FG002|Overall Study|Physician Decision|0|||
44301325|NCT03008122|79299162|FG000|Overall Study|Withdrawal by Subject|1|||
44301326|NCT03008122|79299163|FG001|Overall Study|Withdrawal by Subject|3|||
44301327|NCT03008122|79299164|FG002|Overall Study|Withdrawal by Subject|0|||
44301328|NCT03008122|79299162|FG000|Overall Study|Lost to Follow-up|4|||
44301329|NCT03008122|79299163|FG001|Overall Study|Lost to Follow-up|8|||
44301330|NCT03008122|79299164|FG002|Overall Study|Lost to Follow-up|3|||
44301331|NCT03008122|79299162|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
44301332|NCT03008122|79299163|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
44301333|NCT03008122|79299164|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
44301334|NCT03008122|79299162|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
44301335|NCT03008122|79299163|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
44301336|NCT03008122|79299164|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
44301337|NCT03008122|79299162|FG000|Overall Study|Death|0|||
44301338|NCT03008122|79299163|FG001|Overall Study|Death|0|||
44417535|NCT00831311|79425469|FG001|Overall Study|Physician Decision|1|||
44154886|NCT02673619|78946227|FG001|Overall Study|Withdrawal by Subject|1|||
44534246|NCT00098475|79544843|FG000|Step 1|Death|8|||
44301339|NCT03008122|79299164|FG002|Overall Study|Death|1|||
44301340|NCT01817751|79299206|FG000|Overall Study|Physician Decision|1|||
44301341|NCT01349322|79299222|FG000|Overall Study|Protocol Violation|45|||
44301342|NCT01349322|79299223|FG001|Overall Study|Protocol Violation|47|||
44301343|NCT01182415|79299235|FG000|Overall Study|Lost to Follow-up|1|||
44301344|NCT01030523|79299241|FG000|Initial Study (5 Years)|Death|1|||
44301345|NCT01030523|79299242|FG001|Initial Study (5 Years)|Death|0|||
44301346|NCT01030523|79299241|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
44301347|NCT01030523|79299242|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
44301348|NCT01030523|79299241|FG000|Initial Study (5 Years)|Implant failure|1|||
44301349|NCT01030523|79299242|FG001|Initial Study (5 Years)|Implant failure|0|||
44301350|NCT01030523|79299241|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
44301351|NCT01030523|79299242|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
44301352|NCT01030523|79299241|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
44301353|NCT01030523|79299242|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
44301354|NCT01030523|79299241|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
44301355|NCT01030523|79299242|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
44301356|NCT03811574|79299281|FG000|Overall Study|Withdrawal by Subject|2|||
44301357|NCT03811574|79299282|FG001|Overall Study|Withdrawal by Subject|4|||
44301358|NCT03811574|79299283|FG002|Overall Study|Withdrawal by Subject|0|||
44301359|NCT03727750|79299306|FG000|Overall Study|Death|45|||
44301360|NCT03727750|79299306|FG000|Overall Study|Withdrawal by Subject|2|||
44301361|NCT03727750|79299306|FG000|Overall Study|Lost to Follow-up|1|||
44301362|NCT03727750|79299306|FG000|Overall Study|Other|1|||
44301363|NCT03715829|79299316|FG000|Dose Ranging Period|Adverse Event|2|||
44301364|NCT03715829|79299317|FG001|Dose Ranging Period|Adverse Event|4|||
44301365|NCT03715829|79299318|FG002|Dose Ranging Period|Adverse Event|5|||
44301366|NCT03715829|79299319|FG003|Dose Ranging Period|Adverse Event|2|||
44301367|NCT03715829|79299320|FG004|Dose Ranging Period|Adverse Event|3|||
44301368|NCT03715829|79299321|FG005|Dose Ranging Period|Adverse Event|3|||
44301369|NCT03715829|79299322|FG006|Dose Ranging Period|Adverse Event|0|||
44301370|NCT03715829|79299323|FG007|Dose Ranging Period|Adverse Event|0|||
44301371|NCT03715829|79299324|FG008|Dose Ranging Period|Adverse Event|0|||
44154887|NCT02673619|78946228|FG002|Overall Study|Withdrawal by Subject|1|||
44154888|NCT02673619|78946229|FG003|Overall Study|Withdrawal by Subject|0|||
44154889|NCT02673619|78946226|FG000|Overall Study|Adverse Event|0|||
44534247|NCT00098475|79544844|FG001|Step 1|Death|5|||
44534248|NCT00098475|79544845|FG002|Step 1|Death|0|||
44534249|NCT00098475|79544846|FG003|Step 1|Death|1|||
44154890|NCT02673619|78946227|FG001|Overall Study|Adverse Event|0|||
44154891|NCT02673619|78946228|FG002|Overall Study|Adverse Event|1|||
44301372|NCT03715829|79299325|FG009|Dose Ranging Period|Adverse Event|0|||
44301373|NCT03715829|79299326|FG010|Dose Ranging Period|Adverse Event|0|||
44301374|NCT03715829|79299316|FG000|Dose Ranging Period|Lack of Efficacy|0|||
44417536|NCT00831311|79425468|FG000|Overall Study|Withdrawal by Subject|6|||
44154892|NCT02673619|78946229|FG003|Overall Study|Adverse Event|0|||
44154893|NCT02673619|78946226|FG000|Overall Study|Lack of Efficacy|0|||
44417537|NCT00831311|79425469|FG001|Overall Study|Withdrawal by Subject|4|||
44154894|NCT02673619|78946227|FG001|Overall Study|Lack of Efficacy|0|||
44301375|NCT03715829|79299317|FG001|Dose Ranging Period|Lack of Efficacy|1|||
44301376|NCT03715829|79299318|FG002|Dose Ranging Period|Lack of Efficacy|0|||
44301377|NCT03715829|79299319|FG003|Dose Ranging Period|Lack of Efficacy|1|||
44301378|NCT03715829|79299320|FG004|Dose Ranging Period|Lack of Efficacy|0|||
44301379|NCT03715829|79299321|FG005|Dose Ranging Period|Lack of Efficacy|0|||
44534250|NCT00098475|79544843|FG000|Step 1|Withdrawal by Subject|14|||
44301380|NCT03715829|79299322|FG006|Dose Ranging Period|Lack of Efficacy|0|||
44301381|NCT03715829|79299323|FG007|Dose Ranging Period|Lack of Efficacy|0|||
44301382|NCT03715829|79299324|FG008|Dose Ranging Period|Lack of Efficacy|0|||
44301383|NCT03715829|79299325|FG009|Dose Ranging Period|Lack of Efficacy|0|||
44301384|NCT03715829|79299326|FG010|Dose Ranging Period|Lack of Efficacy|0|||
44301385|NCT03715829|79299316|FG000|Dose Ranging Period|Lost to Follow-up|2|||
44301386|NCT03715829|79299317|FG001|Dose Ranging Period|Lost to Follow-up|0|||
44301387|NCT03715829|79299318|FG002|Dose Ranging Period|Lost to Follow-up|1|||
44301388|NCT03715829|79299319|FG003|Dose Ranging Period|Lost to Follow-up|1|||
44301389|NCT03715829|79299320|FG004|Dose Ranging Period|Lost to Follow-up|1|||
44301390|NCT03715829|79299321|FG005|Dose Ranging Period|Lost to Follow-up|2|||
44301391|NCT03715829|79299322|FG006|Dose Ranging Period|Lost to Follow-up|0|||
44301392|NCT03715829|79299323|FG007|Dose Ranging Period|Lost to Follow-up|0|||
44301393|NCT03715829|79299324|FG008|Dose Ranging Period|Lost to Follow-up|0|||
44301394|NCT03715829|79299325|FG009|Dose Ranging Period|Lost to Follow-up|0|||
44301395|NCT03715829|79299326|FG010|Dose Ranging Period|Lost to Follow-up|0|||
44301396|NCT03715829|79299316|FG000|Dose Ranging Period|Protocol Violation|0|||
44301397|NCT03715829|79299317|FG001|Dose Ranging Period|Protocol Violation|0|||
44301398|NCT03715829|79299318|FG002|Dose Ranging Period|Protocol Violation|0|||
44301399|NCT03715829|79299319|FG003|Dose Ranging Period|Protocol Violation|1|||
44301400|NCT03715829|79299320|FG004|Dose Ranging Period|Protocol Violation|0|||
44301401|NCT03715829|79299321|FG005|Dose Ranging Period|Protocol Violation|0|||
44301402|NCT03715829|79299322|FG006|Dose Ranging Period|Protocol Violation|0|||
44301403|NCT03715829|79299323|FG007|Dose Ranging Period|Protocol Violation|0|||
44301404|NCT03715829|79299324|FG008|Dose Ranging Period|Protocol Violation|0|||
44301405|NCT03715829|79299325|FG009|Dose Ranging Period|Protocol Violation|0|||
44301406|NCT03715829|79299326|FG010|Dose Ranging Period|Protocol Violation|0|||
44301407|NCT03715829|79299316|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
44301408|NCT03715829|79299317|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
44301409|NCT03715829|79299318|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
44301410|NCT03715829|79299319|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
44301411|NCT03715829|79299320|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
44301412|NCT03715829|79299321|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
44301413|NCT03715829|79299322|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
44301414|NCT03715829|79299323|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
44301415|NCT03715829|79299324|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
44301416|NCT03715829|79299325|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
44301417|NCT03715829|79299326|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
44301418|NCT03715829|79299316|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301419|NCT03715829|79299317|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301420|NCT03715829|79299318|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
44301421|NCT03715829|79299319|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301422|NCT03715829|79299320|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301423|NCT03715829|79299321|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301424|NCT03715829|79299322|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301425|NCT03715829|79299323|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301426|NCT03715829|79299324|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301427|NCT03715829|79299325|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301428|NCT03715829|79299326|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
44301429|NCT03715829|79299316|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301430|NCT03715829|79299317|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301431|NCT03715829|79299318|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
44301432|NCT03715829|79299319|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301433|NCT03715829|79299320|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
44301434|NCT03715829|79299321|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301435|NCT03715829|79299322|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301436|NCT03715829|79299323|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301437|NCT03715829|79299324|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301438|NCT03715829|79299325|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301439|NCT03715829|79299326|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
44301440|NCT03715829|79299316|FG000|Dose Ranging Period|Other|0|||
44301441|NCT03715829|79299317|FG001|Dose Ranging Period|Other|0|||
44534251|NCT00098475|79544844|FG001|Step 1|Withdrawal by Subject|11|||
44534252|NCT00098475|79544845|FG002|Step 1|Withdrawal by Subject|0|||
44534253|NCT00098475|79544846|FG003|Step 1|Withdrawal by Subject|0|||
44301442|NCT03715829|79299318|FG002|Dose Ranging Period|Other|2|||
44301443|NCT03715829|79299319|FG003|Dose Ranging Period|Other|0|||
44301444|NCT03715829|79299320|FG004|Dose Ranging Period|Other|0|||
44301445|NCT03715829|79299321|FG005|Dose Ranging Period|Other|3|||
44301446|NCT03715829|79299322|FG006|Dose Ranging Period|Other|0|||
44301447|NCT03715829|79299323|FG007|Dose Ranging Period|Other|0|||
44534254|NCT00098475|79544843|FG000|Step 1|Physician Decision|5|||
44301448|NCT03715829|79299324|FG008|Dose Ranging Period|Other|0|||
44301449|NCT03715829|79299325|FG009|Dose Ranging Period|Other|0|||
44301450|NCT03715829|79299326|FG010|Dose Ranging Period|Other|0|||
44301451|NCT03715829|79299316|FG000|Extension Period|Adverse Event|0|||
44301452|NCT03715829|79299317|FG001|Extension Period|Adverse Event|0|||
44301453|NCT03715829|79299318|FG002|Extension Period|Adverse Event|0|||
44301454|NCT03715829|79299319|FG003|Extension Period|Adverse Event|0|||
44301455|NCT03715829|79299320|FG004|Extension Period|Adverse Event|0|||
44417538|NCT00831233|79425478|FG000|Overall Study|Adverse Event|0|||
44417539|NCT00831233|79425479|FG001|Overall Study|Adverse Event|1|||
44417540|NCT00831233|79425478|FG000|Overall Study|Protocol Violation|1|||
44417541|NCT00831233|79425479|FG001|Overall Study|Protocol Violation|0|||
44417542|NCT00831233|79425478|FG000|Overall Study|Selection Criteria Not Met|2|||
44417543|NCT00831233|79425479|FG001|Overall Study|Selection Criteria Not Met|0|||
44417544|NCT00761280|79425496|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
44417545|NCT00761280|79425497|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
44417546|NCT00761280|79425496|FG000|Randomization to First Dose|Sponsor decision|1|||
44417547|NCT00761280|79425497|FG001|Randomization to First Dose|Sponsor decision|0|||
44417548|NCT00761280|79425496|FG000|Randomization to First Dose|Other|1|||
44417549|NCT00761280|79425497|FG001|Randomization to First Dose|Other|0|||
44417550|NCT00761280|79425496|FG000|First Dose to End of Study|End of trial|5|||
44417551|NCT00761280|79425497|FG001|First Dose to End of Study|End of trial|5|||
44417552|NCT00761280|79425496|FG000|First Dose to End of Study|Progressive disease|5|||
44417553|NCT00761280|79425497|FG001|First Dose to End of Study|Progressive disease|3|||
44417554|NCT00761280|79425496|FG000|First Dose to End of Study|Sponsor decision|1|||
44417555|NCT00761280|79425497|FG001|First Dose to End of Study|Sponsor decision|2|||
44417556|NCT00761280|79425496|FG000|First Dose to End of Study|Death|1|||
44417557|NCT00761280|79425497|FG001|First Dose to End of Study|Death|0|||
44417558|NCT00761280|79425496|FG000|First Dose to End of Study|Lost to Follow-up|0|||
44417559|NCT00761280|79425497|FG001|First Dose to End of Study|Lost to Follow-up|1|||
44417560|NCT00824369|79425509|FG000|Overall Study|Nolonger willing to participate in study|1|||
44417561|NCT00824369|79425510|FG001|Overall Study|Nolonger willing to participate in study|0|||
44417562|NCT00824369|79425511|FG002|Overall Study|Nolonger willing to participate in study|1|||
44417563|NCT00824369|79425512|FG003|Overall Study|Nolonger willing to participate in study|2|||
44417564|NCT00824369|79425513|FG004|Overall Study|Nolonger willing to participate in study|0|||
44417565|NCT00824369|79425514|FG005|Overall Study|Nolonger willing to participate in study|1|||
44417566|NCT00824369|79425509|FG000|Overall Study|Lost to Follow-up|0|||
44417567|NCT00824369|79425510|FG001|Overall Study|Lost to Follow-up|0|||
44417568|NCT00824369|79425511|FG002|Overall Study|Lost to Follow-up|0|||
44417569|NCT00824369|79425512|FG003|Overall Study|Lost to Follow-up|0|||
44417570|NCT00824369|79425513|FG004|Overall Study|Lost to Follow-up|1|||
44417571|NCT00824369|79425514|FG005|Overall Study|Lost to Follow-up|0|||
44417572|NCT00824291|79425530|FG000|Overall Study|Adverse Event|15|||
44417573|NCT00824291|79425531|FG001|Overall Study|Adverse Event|6|||
44417574|NCT00824291|79425530|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
44417575|NCT00824291|79425531|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
44417576|NCT00824291|79425530|FG000|Overall Study|Lost to Follow-up|11|||
44417577|NCT00824291|79425531|FG001|Overall Study|Lost to Follow-up|9|||
44417578|NCT00824291|79425530|FG000|Overall Study|Non-compliance|1|||
44417579|NCT00824291|79425531|FG001|Overall Study|Non-compliance|1|||
44417580|NCT00824291|79425530|FG000|Overall Study|Protocol Violation|4|||
44417581|NCT00824291|79425531|FG001|Overall Study|Protocol Violation|1|||
44417582|NCT00824291|79425530|FG000|Overall Study|Withdrawal by Subject|14|||
44417583|NCT00824291|79425531|FG001|Overall Study|Withdrawal by Subject|8|||
44417584|NCT00824291|79425530|FG000|Overall Study|Lack of Efficacy|7|||
44417585|NCT00824291|79425531|FG001|Overall Study|Lack of Efficacy|8|||
44417586|NCT00824291|79425530|FG000|Overall Study|Participant on prohibited medication|1|||
44417587|NCT00824291|79425531|FG001|Overall Study|Participant on prohibited medication|0|||
44417588|NCT00804986|79425543|FG000|Overall Study|Adverse Event|0|||
44417589|NCT00804986|79425544|FG001|Overall Study|Adverse Event|1|||
44417590|NCT00804986|79425545|FG002|Overall Study|Adverse Event|2|||
44417591|NCT00804986|79425546|FG003|Overall Study|Adverse Event|1|||
44417592|NCT00804986|79425547|FG004|Overall Study|Adverse Event|3|||
44417593|NCT00804986|79425548|FG005|Overall Study|Adverse Event|0|||
44417594|NCT00804986|79425543|FG000|Overall Study|Lack of Efficacy|0|||
44417595|NCT00804986|79425544|FG001|Overall Study|Lack of Efficacy|0|||
44417596|NCT00804986|79425545|FG002|Overall Study|Lack of Efficacy|0|||
44417597|NCT00804986|79425546|FG003|Overall Study|Lack of Efficacy|1|||
44417598|NCT00804986|79425547|FG004|Overall Study|Lack of Efficacy|0|||
44417599|NCT00804986|79425548|FG005|Overall Study|Lack of Efficacy|3|||
44417600|NCT00804986|79425543|FG000|Overall Study|Lost to Follow-up|0|||
44417601|NCT00804986|79425544|FG001|Overall Study|Lost to Follow-up|0|||
44417602|NCT00804986|79425545|FG002|Overall Study|Lost to Follow-up|0|||
44417603|NCT00804986|79425546|FG003|Overall Study|Lost to Follow-up|1|||
44301456|NCT03715829|79299321|FG005|Extension Period|Adverse Event|0|||
44301457|NCT03715829|79299322|FG006|Extension Period|Adverse Event|3|||
44301458|NCT03715829|79299323|FG007|Extension Period|Adverse Event|1|||
44301459|NCT03715829|79299324|FG008|Extension Period|Adverse Event|6|||
44301460|NCT03715829|79299325|FG009|Extension Period|Adverse Event|0|||
44301461|NCT03715829|79299326|FG010|Extension Period|Adverse Event|0|||
44301462|NCT03715829|79299316|FG000|Extension Period|Lack of Efficacy|0|||
44301463|NCT03715829|79299317|FG001|Extension Period|Lack of Efficacy|0|||
44301464|NCT03715829|79299318|FG002|Extension Period|Lack of Efficacy|0|||
44301465|NCT03715829|79299319|FG003|Extension Period|Lack of Efficacy|0|||
44301466|NCT03715829|79299320|FG004|Extension Period|Lack of Efficacy|0|||
44301467|NCT03715829|79299321|FG005|Extension Period|Lack of Efficacy|0|||
44301468|NCT03715829|79299322|FG006|Extension Period|Lack of Efficacy|1|||
44301469|NCT03715829|79299323|FG007|Extension Period|Lack of Efficacy|9|||
44301470|NCT03715829|79299324|FG008|Extension Period|Lack of Efficacy|2|||
44301471|NCT03715829|79299325|FG009|Extension Period|Lack of Efficacy|0|||
44301472|NCT03715829|79299326|FG010|Extension Period|Lack of Efficacy|0|||
44301473|NCT03715829|79299316|FG000|Extension Period|Lost to Follow-up|0|||
44301474|NCT03715829|79299317|FG001|Extension Period|Lost to Follow-up|0|||
44301475|NCT03715829|79299318|FG002|Extension Period|Lost to Follow-up|0|||
44301476|NCT03715829|79299319|FG003|Extension Period|Lost to Follow-up|0|||
44301477|NCT03715829|79299320|FG004|Extension Period|Lost to Follow-up|0|||
44301478|NCT03715829|79299321|FG005|Extension Period|Lost to Follow-up|0|||
44301479|NCT03715829|79299322|FG006|Extension Period|Lost to Follow-up|0|||
44301480|NCT03715829|79299323|FG007|Extension Period|Lost to Follow-up|0|||
44301481|NCT03715829|79299324|FG008|Extension Period|Lost to Follow-up|2|||
44301482|NCT03715829|79299325|FG009|Extension Period|Lost to Follow-up|0|||
44301483|NCT03715829|79299326|FG010|Extension Period|Lost to Follow-up|0|||
44301484|NCT03715829|79299316|FG000|Extension Period|Protocol Violation|0|||
44301485|NCT03715829|79299317|FG001|Extension Period|Protocol Violation|0|||
44301486|NCT03715829|79299318|FG002|Extension Period|Protocol Violation|0|||
44301487|NCT03715829|79299319|FG003|Extension Period|Protocol Violation|0|||
44301488|NCT03715829|79299320|FG004|Extension Period|Protocol Violation|0|||
44301489|NCT03715829|79299321|FG005|Extension Period|Protocol Violation|0|||
44301490|NCT03715829|79299322|FG006|Extension Period|Protocol Violation|0|||
44301491|NCT03715829|79299323|FG007|Extension Period|Protocol Violation|0|||
44301492|NCT03715829|79299324|FG008|Extension Period|Protocol Violation|1|||
44301493|NCT03715829|79299325|FG009|Extension Period|Protocol Violation|0|||
44301494|NCT03715829|79299326|FG010|Extension Period|Protocol Violation|0|||
44301495|NCT03715829|79299316|FG000|Extension Period|Withdrawal by Subject|0|||
44301496|NCT03715829|79299317|FG001|Extension Period|Withdrawal by Subject|0|||
44301497|NCT03715829|79299318|FG002|Extension Period|Withdrawal by Subject|0|||
44301498|NCT03715829|79299319|FG003|Extension Period|Withdrawal by Subject|0|||
44301499|NCT03715829|79299320|FG004|Extension Period|Withdrawal by Subject|0|||
44301500|NCT03715829|79299321|FG005|Extension Period|Withdrawal by Subject|0|||
44301501|NCT03715829|79299322|FG006|Extension Period|Withdrawal by Subject|3|||
44301502|NCT03715829|79299323|FG007|Extension Period|Withdrawal by Subject|3|||
44301503|NCT03715829|79299324|FG008|Extension Period|Withdrawal by Subject|12|||
44301504|NCT03715829|79299325|FG009|Extension Period|Withdrawal by Subject|3|||
44301505|NCT03715829|79299326|FG010|Extension Period|Withdrawal by Subject|0|||
44301506|NCT03715829|79299316|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301507|NCT03715829|79299317|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301508|NCT03715829|79299318|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301509|NCT03715829|79299319|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301510|NCT03715829|79299320|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301511|NCT03715829|79299321|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301512|NCT03715829|79299322|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301513|NCT03715829|79299323|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
44301514|NCT03715829|79299324|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
44301515|NCT03715829|79299325|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301516|NCT03715829|79299326|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
44301517|NCT03715829|79299316|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301518|NCT03715829|79299317|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
44534255|NCT00098475|79544844|FG001|Step 1|Physician Decision|2|||
44534256|NCT00098475|79544845|FG002|Step 1|Physician Decision|0|||
44154895|NCT02673619|78946228|FG002|Overall Study|Lack of Efficacy|1|||
44301519|NCT03715829|79299318|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301520|NCT03715829|79299319|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301521|NCT03715829|79299320|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301522|NCT03715829|79299321|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301523|NCT03715829|79299322|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301524|NCT03715829|79299323|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301525|NCT03715829|79299324|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
44301526|NCT03715829|79299325|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
44534257|NCT00098475|79544846|FG003|Step 1|Physician Decision|0|||
44301527|NCT03715829|79299326|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
44301528|NCT03715829|79299316|FG000|Extension Period|Other|0|||
44301529|NCT03715829|79299317|FG001|Extension Period|Other|0|||
44301530|NCT03715829|79299318|FG002|Extension Period|Other|0|||
44301531|NCT03715829|79299319|FG003|Extension Period|Other|0|||
44301532|NCT03715829|79299320|FG004|Extension Period|Other|0|||
44301533|NCT03715829|79299321|FG005|Extension Period|Other|0|||
44301534|NCT03715829|79299322|FG006|Extension Period|Other|1|||
44301535|NCT03715829|79299323|FG007|Extension Period|Other|2|||
44301536|NCT03715829|79299324|FG008|Extension Period|Other|4|||
44301537|NCT03715829|79299325|FG009|Extension Period|Other|0|||
44301538|NCT03715829|79299326|FG010|Extension Period|Other|0|||
44301539|NCT03575104|79299388|FG000|Overall Study|Adverse Event|4|||
44301540|NCT03575104|79299389|FG001|Overall Study|Adverse Event|3|||
44301541|NCT03575104|79299390|FG002|Overall Study|Adverse Event|4|||
44301542|NCT03575104|79299388|FG000|Overall Study|Withdrawal by Subject|13|||
44301543|NCT03575104|79299389|FG001|Overall Study|Withdrawal by Subject|16|||
44301544|NCT03575104|79299390|FG002|Overall Study|Withdrawal by Subject|11|||
44301545|NCT03575104|79299388|FG000|Overall Study|Other reasons|6|||
44301546|NCT03575104|79299389|FG001|Overall Study|Other reasons|8|||
44301547|NCT03575104|79299390|FG002|Overall Study|Other reasons|6|||
44301548|NCT03575104|79299388|FG000|Overall Study|Lost to Follow-up|1|||
44301549|NCT03575104|79299389|FG001|Overall Study|Lost to Follow-up|2|||
44301550|NCT03575104|79299390|FG002|Overall Study|Lost to Follow-up|1|||
44301551|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
44301552|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
44301553|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
44301554|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
44301555|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
44301556|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
44301557|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
44301558|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
44301559|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
44301560|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
44301561|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
44301562|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
44301563|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
44301564|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
44301565|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
44301566|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
44301567|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
44301568|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
44301569|NCT03569475|79299401|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
44301570|NCT03569475|79299402|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
44301571|NCT03569475|79299403|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
44301572|NCT03569475|79299401|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
44301573|NCT03569475|79299402|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
44301574|NCT03569475|79299403|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
44301575|NCT03569475|79299401|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
44301576|NCT03569475|79299402|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
44301577|NCT03569475|79299403|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
44301578|NCT03545191|79299417|FG000|Overall Study|Death|1|||
44301579|NCT03545191|79299418|FG001|Overall Study|Death|0|||
44301580|NCT03545191|79299419|FG002|Overall Study|Death|0|||
44301581|NCT03545191|79299417|FG000|Overall Study|Adverse Event|4|||
44301582|NCT03545191|79299418|FG001|Overall Study|Adverse Event|2|||
44301583|NCT03545191|79299419|FG002|Overall Study|Adverse Event|7|||
44301584|NCT03545191|79299417|FG000|Overall Study|Other reasons|3|||
44301585|NCT03545191|79299418|FG001|Overall Study|Other reasons|11|||
44301586|NCT03545191|79299419|FG002|Overall Study|Other reasons|8|||
44301587|NCT03545191|79299417|FG000|Overall Study|Withdrawal by Subject|13|||
44154896|NCT02673619|78946229|FG003|Overall Study|Lack of Efficacy|0|||
44154897|NCT02680639|78946251|FG000|Screening Period|Screen Failure|7|||
44301588|NCT03545191|79299418|FG001|Overall Study|Withdrawal by Subject|10|||
44301589|NCT03545191|79299419|FG002|Overall Study|Withdrawal by Subject|12|||
44301590|NCT03545191|79299417|FG000|Overall Study|Lost to Follow-up|1|||
44301591|NCT03545191|79299418|FG001|Overall Study|Lost to Follow-up|2|||
44301592|NCT03545191|79299419|FG002|Overall Study|Lost to Follow-up|3|||
44301593|NCT03500549|79299429|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
44301594|NCT03500549|79299430|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
44301595|NCT03500549|79299429|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
44301596|NCT03500549|79299430|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
44154898|NCT02680639|78946252|FG001|Screening Period|Screen Failure|0|||
44154899|NCT02680639|78946253|FG002|Screening Period|Screen Failure|0|||
44154900|NCT01674725|78946265|FG000|Overall Study|Adverse Event|1|||
44154901|NCT01674725|78946266|FG001|Overall Study|Adverse Event|0|||
44154902|NCT01674725|78946265|FG000|Overall Study|Did not receive study drug|1|||
44154903|NCT01674725|78946266|FG001|Overall Study|Did not receive study drug|0|||
44154904|NCT01674725|78946265|FG000|Overall Study|Withdrawal by Subject|1|||
44154905|NCT01674725|78946266|FG001|Overall Study|Withdrawal by Subject|0|||
44154906|NCT01674725|78946265|FG000|Overall Study|Lost to Follow-up|0|||
44154907|NCT01674725|78946266|FG001|Overall Study|Lost to Follow-up|1|||
44154908|NCT01674569|78946272|FG000|Overall Study|Adverse Event|0|||
44154909|NCT01674569|78946273|FG001|Overall Study|Adverse Event|2|||
44154910|NCT01674569|78946274|FG002|Overall Study|Adverse Event|0|||
44154911|NCT01674569|78946275|FG003|Overall Study|Adverse Event|1|||
44154912|NCT01674569|78946276|FG004|Overall Study|Adverse Event|2|||
44154913|NCT01674569|78946277|FG005|Overall Study|Adverse Event|2|||
44154914|NCT01674569|78946272|FG000|Overall Study|Protocol Violation|0|||
44154915|NCT01674569|78946273|FG001|Overall Study|Protocol Violation|1|||
44154916|NCT01674569|78946274|FG002|Overall Study|Protocol Violation|1|||
44154917|NCT01674569|78946275|FG003|Overall Study|Protocol Violation|0|||
44154918|NCT01674569|78946276|FG004|Overall Study|Protocol Violation|0|||
44154919|NCT01674569|78946277|FG005|Overall Study|Protocol Violation|0|||
44154920|NCT01674569|78946272|FG000|Overall Study|Withdrawal by Subject|0|||
44154921|NCT01674569|78946273|FG001|Overall Study|Withdrawal by Subject|0|||
44154922|NCT01674569|78946274|FG002|Overall Study|Withdrawal by Subject|1|||
44154923|NCT01674569|78946275|FG003|Overall Study|Withdrawal by Subject|0|||
44154924|NCT01674569|78946276|FG004|Overall Study|Withdrawal by Subject|0|||
44154925|NCT01674569|78946277|FG005|Overall Study|Withdrawal by Subject|0|||
44154926|NCT01374217|78946281|FG000|Overall Study|Lack of Efficacy|13|||
44154927|NCT01674647|78946287|FG000|Treatment Period|Death|4|||
44154928|NCT01674647|78946288|FG001|Treatment Period|Death|1|||
44154929|NCT01674647|78946287|FG000|Treatment Period|Efficacy outcome reached|0|||
44154930|NCT01674647|78946288|FG001|Treatment Period|Efficacy outcome reached|1|||
44154931|NCT01674647|78946287|FG000|Treatment Period|Physician Decision|3|||
44154932|NCT01674647|78946288|FG001|Treatment Period|Physician Decision|1|||
44154933|NCT01674647|78946287|FG000|Treatment Period|Adverse Event|60|||
44154934|NCT01674647|78946288|FG001|Treatment Period|Adverse Event|22|||
44154935|NCT01674647|78946287|FG000|Treatment Period|Non-compliance with study drug|3|||
44154936|NCT01674647|78946288|FG001|Treatment Period|Non-compliance with study drug|0|||
44154937|NCT01674647|78946287|FG000|Treatment Period|Lost to Follow-up|1|||
44154938|NCT01674647|78946288|FG001|Treatment Period|Lost to Follow-up|1|||
44154939|NCT01674647|78946287|FG000|Treatment Period|Withdrawal by Subject|19|||
44154940|NCT01674647|78946288|FG001|Treatment Period|Withdrawal by Subject|16|||
44154941|NCT01674647|78946287|FG000|Treatment Period|Switching to other therapy|5|||
44154942|NCT01674647|78946288|FG001|Treatment Period|Switching to other therapy|2|||
44154943|NCT01674647|78946287|FG000|Treatment Period|Logistical difficulties|5|||
44154944|NCT01674647|78946288|FG001|Treatment Period|Logistical difficulties|8|||
44154945|NCT01674647|78946287|FG000|Treatment Period|Treatment failure|0|||
44154946|NCT01674647|78946288|FG001|Treatment Period|Treatment failure|14|||
44154947|NCT01674647|78946287|FG000|Treatment Period|Protocol Violation|56|||
44154948|NCT01674647|78946288|FG001|Treatment Period|Protocol Violation|36|||
44154949|NCT01674647|78946287|FG000|30-day Safety Follow-up Period|Death|3|||
44154950|NCT01674647|78946288|FG001|30-day Safety Follow-up Period|Death|2|||
44256774|NCT01434680|79108256|FG003|Overall Study|Withdrawal by Subject|0|||
44256775|NCT01434680|79108253|FG000|Overall Study|Lost to Follow-up|1|||
44256776|NCT01434680|79108254|FG001|Overall Study|Lost to Follow-up|1|||
44256777|NCT01434680|79108255|FG002|Overall Study|Lost to Follow-up|0|||
44256778|NCT01434680|79108256|FG003|Overall Study|Lost to Follow-up|0|||
44256779|NCT01434680|79108253|FG000|Overall Study|Protocol Violation|1|||
44256780|NCT01434680|79108254|FG001|Overall Study|Protocol Violation|1|||
44256781|NCT01434680|79108255|FG002|Overall Study|Protocol Violation|0|||
44256782|NCT01434680|79108256|FG003|Overall Study|Protocol Violation|0|||
44256783|NCT01433978|79108389|FG000|Core Study|Adverse Event, Non-Fatal|0|||
44256784|NCT01433978|79108390|FG001|Core Study|Adverse Event, Non-Fatal|1|||
44256785|NCT01433978|79108391|FG002|Core Study|Adverse Event, Non-Fatal|0|||
44256786|NCT01433978|79108389|FG000|Core Study|Lack of Efficacy|5|||
44256787|NCT01433978|79108390|FG001|Core Study|Lack of Efficacy|1|||
44256788|NCT01433978|79108391|FG002|Core Study|Lack of Efficacy|0|||
44154951|NCT01674647|78946287|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
44154952|NCT01674647|78946288|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
44154953|NCT01674647|78946287|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
44154954|NCT01674647|78946288|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
44154955|NCT01674647|78946287|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
44154956|NCT01674647|78946288|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
44154957|NCT01674647|78946287|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
44154958|NCT01674647|78946288|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
44154959|NCT01674647|78946287|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
44154960|NCT01674647|78946288|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
44154961|NCT02669407|78946294|FG000|Overall Study|Physician Decision|3|||
44154962|NCT02667457|78946300|FG000|Overall Study|Withdrawal by Subject|1|||
44154963|NCT02667457|78946301|FG001|Overall Study|Withdrawal by Subject|0|||
44154964|NCT02667457|78946300|FG000|Overall Study|Other Reason|0|||
44154965|NCT02667457|78946301|FG001|Overall Study|Other Reason|2|||
44154966|NCT02669095|78946310|FG000|Overall Study|Adverse Event|1|||
44154967|NCT02669095|78946311|FG001|Overall Study|Adverse Event|0|||
44154968|NCT02669095|78946310|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
44154969|NCT02669095|78946311|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
44154970|NCT02669095|78946310|FG000|Overall Study|Torn Lens|0|||
44154971|NCT02669095|78946311|FG001|Overall Study|Torn Lens|1|||
44154972|NCT02669095|78946310|FG000|Overall Study|Visit 5 assessments not completed|0|||
44154973|NCT02669095|78946311|FG001|Overall Study|Visit 5 assessments not completed|1|||
44154974|NCT02667301|78946317|FG000|Overall Study|Adverse Event|1|||
44154975|NCT02667301|78946317|FG000|Overall Study|Lack of Efficacy|1|||
44154976|NCT05274165|78946325|FG000|Overall Study|Withdrawal by Subject|3|||
44154977|NCT05274165|78946326|FG001|Overall Study|Withdrawal by Subject|3|||
44154978|NCT04510090|78946368|FG000|FE-HS|Withdrawal by Subject|0|||
44154979|NCT04510090|78946369|FG001|FE-HS|Withdrawal by Subject|0|||
44154980|NCT04510090|78946370|FG002|FE-HS|Withdrawal by Subject|0|||
44154981|NCT04510090|78946371|FG003|FE-HS|Withdrawal by Subject|0|||
44154982|NCT04510090|78946372|FG004|FE-HS|Withdrawal by Subject|1|||
44154983|NCT04510090|78946373|FG005|FE-HS|Withdrawal by Subject|0|||
44154984|NCT04510090|78946374|FG006|FE-HS|Withdrawal by Subject|0|||
44154985|NCT04510090|78946375|FG007|FE-HS|Withdrawal by Subject|0|||
44154986|NCT04491006|78946405|FG000|Overall Study|Adverse Event|0|||
44154987|NCT04491006|78946406|FG001|Overall Study|Adverse Event|3|||
44154988|NCT04491006|78946407|FG002|Overall Study|Adverse Event|5|||
44154989|NCT04491006|78946405|FG000|Overall Study|Withdrawal by Subject|1|||
44154990|NCT04491006|78946406|FG001|Overall Study|Withdrawal by Subject|0|||
44154991|NCT04491006|78946407|FG002|Overall Study|Withdrawal by Subject|2|||
44154992|NCT04162470|78946450|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
44154993|NCT04122625|78946460|FG000|Part A (up to 2.92 Years)|Death|2|||
44154994|NCT04122625|78946461|FG001|Part A (up to 2.92 Years)|Death|4|||
44154995|NCT04122625|78946462|FG002|Part A (up to 2.92 Years)|Death|0|||
44154996|NCT04122625|78946463|FG003|Part A (up to 2.92 Years)|Death|0|||
44154997|NCT04122625|78946464|FG004|Part A (up to 2.92 Years)|Death|0|||
44154998|NCT04122625|78946465|FG005|Part A (up to 2.92 Years)|Death|0|||
44154999|NCT04122625|78946460|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
44155000|NCT04122625|78946461|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
44534258|NCT00098475|79544843|FG000|Step 1|Alternative therapy|31|||
44534259|NCT00098475|79544844|FG001|Step 1|Alternative therapy|43|||
44534260|NCT00098475|79544845|FG002|Step 1|Alternative therapy|1|||
44155001|NCT04122625|78946462|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
44155002|NCT04122625|78946463|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
44155003|NCT04122625|78946464|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
44155004|NCT04122625|78946465|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
44155005|NCT04122625|78946460|FG000|Part B (up to 2.33 Years)|Death|0|||
44417604|NCT00804986|79425547|FG004|Overall Study|Lost to Follow-up|1|||
44417605|NCT00804986|79425548|FG005|Overall Study|Lost to Follow-up|3|||
44417606|NCT00804986|79425543|FG000|Overall Study|Protocol Violation|0|||
44534261|NCT00098475|79544846|FG003|Step 1|Alternative therapy|0|||
44534262|NCT00098475|79544843|FG000|Step 1|Other disease|2|||
44534263|NCT00098475|79544844|FG001|Step 1|Other disease|1|||
44155006|NCT04122625|78946461|FG001|Part B (up to 2.33 Years)|Death|0|||
44155007|NCT04122625|78946462|FG002|Part B (up to 2.33 Years)|Death|5|||
44155008|NCT04122625|78946463|FG003|Part B (up to 2.33 Years)|Death|7|||
44155009|NCT04122625|78946464|FG004|Part B (up to 2.33 Years)|Death|6|||
44155010|NCT04122625|78946465|FG005|Part B (up to 2.33 Years)|Death|7|||
44155011|NCT03824704|78946483|FG000|Overall Study|Study Terminated by Sponsor|1|||
44155012|NCT03766581|78946499|FG000|Randomization|Other reasons|2|||
44155013|NCT03766581|78946500|FG001|Randomization|Other reasons|1|||
44417607|NCT00804986|79425544|FG001|Overall Study|Protocol Violation|1|||
44155014|NCT03766581|78946501|FG002|Randomization|Other reasons|0|||
44155015|NCT03766581|78946502|FG003|Randomization|Other reasons|1|||
44155016|NCT03766581|78946503|FG004|Randomization|Other reasons|0|||
44155017|NCT03766581|78946504|FG005|Randomization|Other reasons|0|||
44534264|NCT00098475|79544845|FG002|Step 1|Other disease|1|||
44155018|NCT03766581|78946505|FG006|Randomization|Other reasons|0|||
44155019|NCT03766581|78946506|FG007|Randomization|Other reasons|0|||
44155020|NCT03766581|78946499|FG000|Randomization|Participant no longer meets study criteria|5|||
44155021|NCT03766581|78946500|FG001|Randomization|Participant no longer meets study criteria|3|||
44155022|NCT03766581|78946501|FG002|Randomization|Participant no longer meets study criteria|4|||
44155023|NCT03766581|78946502|FG003|Randomization|Participant no longer meets study criteria|0|||
44155024|NCT03766581|78946503|FG004|Randomization|Participant no longer meets study criteria|2|||
44155025|NCT03766581|78946504|FG005|Randomization|Participant no longer meets study criteria|3|||
44155026|NCT03766581|78946505|FG006|Randomization|Participant no longer meets study criteria|0|||
44155027|NCT03766581|78946506|FG007|Randomization|Participant no longer meets study criteria|1|||
44155028|NCT03766581|78946499|FG000|Randomization|Participant request to discontinue study treatment|1|||
44301597|NCT03366792|79299450|FG000|Overall Study|Withdrawal by Subject|7|||
44301598|NCT03366792|79299450|FG000|Overall Study|Lost to Follow-up|2|||
44301599|NCT03366792|79299450|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
44301600|NCT03366792|79299450|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
44301601|NCT03342053|79299456|FG000|Overall Study|Adverse Event|2|||
44155029|NCT03766581|78946500|FG001|Randomization|Participant request to discontinue study treatment|0|||
44155030|NCT03766581|78946501|FG002|Randomization|Participant request to discontinue study treatment|0|||
44155031|NCT03766581|78946502|FG003|Randomization|Participant request to discontinue study treatment|0|||
44301602|NCT03342053|79299457|FG001|Overall Study|Adverse Event|0|||
44301603|NCT03342053|79299456|FG000|Overall Study|Withdrawal by Subject|0|||
44301604|NCT03342053|79299457|FG001|Overall Study|Withdrawal by Subject|1|||
44301605|NCT03325777|79299465|FG000|Overall Study|Lost to Follow-up|9|||
44301606|NCT03325777|79299466|FG001|Overall Study|Lost to Follow-up|12|||
44301607|NCT03283241|79299474|FG000|Overall Study|Adverse Event|4|||
44301608|NCT03283241|79299475|FG001|Overall Study|Adverse Event|1|||
44301609|NCT03283241|79299474|FG000|Overall Study|Withdrawal by Subject|0|||
44301610|NCT03283241|79299475|FG001|Overall Study|Withdrawal by Subject|1|||
44301611|NCT03283241|79299474|FG000|Overall Study|Subject relocated to Finland|0|||
44301612|NCT03283241|79299475|FG001|Overall Study|Subject relocated to Finland|1|||
44301613|NCT03242772|79299483|FG000|Overall Study|Lost to Follow-up|2|||
44301614|NCT03242772|79299484|FG001|Overall Study|Lost to Follow-up|0|||
44301615|NCT03242772|79299483|FG000|Overall Study|Physician Decision|0|||
44301616|NCT03242772|79299484|FG001|Overall Study|Physician Decision|1|||
44301617|NCT03242772|79299483|FG000|Overall Study|Withdrawal by Subject|1|||
44301618|NCT03242772|79299484|FG001|Overall Study|Withdrawal by Subject|0|||
44301619|NCT03236311|79299492|FG000|Overall Study|Study terminated by sponsor|0|||
44301620|NCT03236311|79299493|FG001|Overall Study|Study terminated by sponsor|2|||
44301621|NCT03236311|79299492|FG000|Overall Study|Adverse Event|0|||
44301622|NCT03236311|79299493|FG001|Overall Study|Adverse Event|1|||
44301623|NCT03192046|79299501|FG000|Overall Study|Withdrawal by Subject|1|||
44301624|NCT03192046|79299502|FG001|Overall Study|Withdrawal by Subject|1|||
44301625|NCT03190369|79299510|FG000|Overall Study|Poor compliance to protocol|0|||
44301626|NCT03190369|79299511|FG001|Overall Study|Poor compliance to protocol|1|||
44301627|NCT03190369|79299510|FG000|Overall Study|Withdraw before treatment|1|||
44301628|NCT03190369|79299511|FG001|Overall Study|Withdraw before treatment|5|||
44301629|NCT03190369|79299510|FG000|Overall Study|Randomized but not treated|0|||
44301630|NCT03190369|79299511|FG001|Overall Study|Randomized but not treated|2|||
44301631|NCT04657198|79299520|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
44301632|NCT04657198|79299521|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
44301633|NCT04657198|79299522|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
44301634|NCT04590586|79299536|FG000|Overall Study|Death|7|||
44155032|NCT03766581|78946503|FG004|Randomization|Participant request to discontinue study treatment|1|||
44301635|NCT04590586|79299537|FG001|Overall Study|Death|1|||
44301636|NCT04590586|79299538|FG002|Overall Study|Death|37|||
44301637|NCT04590586|79299539|FG003|Overall Study|Death|34|||
44301638|NCT04590586|79299540|FG004|Overall Study|Death|19|||
44301639|NCT04590586|79299541|FG005|Overall Study|Death|3|||
44301640|NCT04590586|79299536|FG000|Overall Study|Lost to Follow-up|3|||
44301641|NCT04590586|79299537|FG001|Overall Study|Lost to Follow-up|0|||
44301642|NCT04590586|79299538|FG002|Overall Study|Lost to Follow-up|11|||
44301643|NCT04590586|79299539|FG003|Overall Study|Lost to Follow-up|11|||
44301644|NCT04590586|79299540|FG004|Overall Study|Lost to Follow-up|6|||
44301645|NCT04590586|79299541|FG005|Overall Study|Lost to Follow-up|0|||
44301646|NCT04590586|79299536|FG000|Overall Study|Withdrawal by Subject|0|||
44301647|NCT04590586|79299537|FG001|Overall Study|Withdrawal by Subject|0|||
44301648|NCT04590586|79299538|FG002|Overall Study|Withdrawal by Subject|6|||
44155033|NCT03766581|78946504|FG005|Randomization|Participant request to discontinue study treatment|2|||
44301649|NCT04590586|79299539|FG003|Overall Study|Withdrawal by Subject|0|||
44301650|NCT04590586|79299540|FG004|Overall Study|Withdrawal by Subject|3|||
44301651|NCT04590586|79299541|FG005|Overall Study|Withdrawal by Subject|0|||
44155034|NCT03766581|78946505|FG006|Randomization|Participant request to discontinue study treatment|0|||
44301652|NCT04590586|79299536|FG000|Overall Study|Other|3|||
44301653|NCT04590586|79299537|FG001|Overall Study|Other|0|||
44301654|NCT04590586|79299538|FG002|Overall Study|Other|1|||
44301655|NCT04590586|79299539|FG003|Overall Study|Other|1|||
44301656|NCT04590586|79299540|FG004|Overall Study|Other|2|||
44301657|NCT04590586|79299541|FG005|Overall Study|Other|1|||
44301658|NCT04312009|79299567|FG000|Overall Study|Withdrawal by Subject|2|||
44301659|NCT04312009|79299568|FG001|Overall Study|Withdrawal by Subject|1|||
44301660|NCT03937466|79299583|FG000|Overall Study|not eligbile after the 2-week diary|9|||
44301661|NCT03937466|79299583|FG000|Overall Study|never returned their diary|6|||
44301662|NCT03937466|79299583|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
44301663|NCT03937466|79299583|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
44301664|NCT03850483|79299596|FG000|Treatment for Stage 1|Adverse Event|1|||
44301665|NCT03850483|79299597|FG001|Treatment for Stage 1|Adverse Event|1|||
44301666|NCT03850483|79299598|FG002|Treatment for Stage 1|Adverse Event|3|||
44301667|NCT03850483|79299599|FG003|Treatment for Stage 1|Adverse Event|0|||
44301668|NCT03850483|79299600|FG004|Treatment for Stage 1|Adverse Event|2|||
44301669|NCT03850483|79299601|FG005|Treatment for Stage 1|Adverse Event|0|||
44301670|NCT03850483|79299602|FG006|Treatment for Stage 1|Adverse Event|2|||
44301671|NCT03850483|79299603|FG007|Treatment for Stage 1|Adverse Event|2|||
44301672|NCT03850483|79299604|FG008|Treatment for Stage 1|Adverse Event|0|||
44301673|NCT03850483|79299605|FG009|Treatment for Stage 1|Adverse Event|0|||
44301674|NCT03850483|79299596|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
44301675|NCT03850483|79299597|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
44301676|NCT03850483|79299598|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
44301677|NCT03850483|79299599|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
44301678|NCT03850483|79299600|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
44301679|NCT03850483|79299601|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
44301680|NCT03850483|79299602|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
44301681|NCT03850483|79299603|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
44301682|NCT03850483|79299604|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
44301683|NCT03850483|79299605|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
44301684|NCT03850483|79299596|FG000|Treatment for Stage 1|Protocol Violation|1|||
44301685|NCT03850483|79299597|FG001|Treatment for Stage 1|Protocol Violation|0|||
44301686|NCT03850483|79299598|FG002|Treatment for Stage 1|Protocol Violation|0|||
44301687|NCT03850483|79299599|FG003|Treatment for Stage 1|Protocol Violation|0|||
44301688|NCT03850483|79299600|FG004|Treatment for Stage 1|Protocol Violation|0|||
44301689|NCT03850483|79299601|FG005|Treatment for Stage 1|Protocol Violation|0|||
44301690|NCT03850483|79299602|FG006|Treatment for Stage 1|Protocol Violation|1|||
44301691|NCT03850483|79299603|FG007|Treatment for Stage 1|Protocol Violation|0|||
44301692|NCT03850483|79299604|FG008|Treatment for Stage 1|Protocol Violation|0|||
44301693|NCT03850483|79299605|FG009|Treatment for Stage 1|Protocol Violation|0|||
44301694|NCT03850483|79299596|FG000|Treatment for Stage 1|Physician Decision|0|||
44301695|NCT03850483|79299597|FG001|Treatment for Stage 1|Physician Decision|0|||
44301696|NCT03850483|79299598|FG002|Treatment for Stage 1|Physician Decision|0|||
44301697|NCT03850483|79299599|FG003|Treatment for Stage 1|Physician Decision|0|||
44301698|NCT03850483|79299600|FG004|Treatment for Stage 1|Physician Decision|0|||
44301699|NCT03850483|79299601|FG005|Treatment for Stage 1|Physician Decision|1|||
44301700|NCT03850483|79299602|FG006|Treatment for Stage 1|Physician Decision|0|||
44301701|NCT03850483|79299603|FG007|Treatment for Stage 1|Physician Decision|0|||
44301702|NCT03850483|79299604|FG008|Treatment for Stage 1|Physician Decision|0|||
44301703|NCT03850483|79299605|FG009|Treatment for Stage 1|Physician Decision|0|||
44301704|NCT03850483|79299596|FG000|Treatment for Stage 1|Other|0|||
44301705|NCT03850483|79299597|FG001|Treatment for Stage 1|Other|0|||
44301706|NCT03850483|79299598|FG002|Treatment for Stage 1|Other|0|||
44301707|NCT03850483|79299599|FG003|Treatment for Stage 1|Other|0|||
44301708|NCT03850483|79299600|FG004|Treatment for Stage 1|Other|2|||
44301709|NCT03850483|79299601|FG005|Treatment for Stage 1|Other|1|||
44301710|NCT03850483|79299602|FG006|Treatment for Stage 1|Other|0|||
44301711|NCT03850483|79299603|FG007|Treatment for Stage 1|Other|0|||
44301712|NCT03850483|79299604|FG008|Treatment for Stage 1|Other|0|||
44301713|NCT03850483|79299605|FG009|Treatment for Stage 1|Other|0|||
44301714|NCT03850483|79299596|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301715|NCT03850483|79299597|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44256789|NCT01433978|79108389|FG000|Core Study|Study Terminated by Sponsor|6|||
44256790|NCT01433978|79108390|FG001|Core Study|Study Terminated by Sponsor|9|||
44155035|NCT03766581|78946506|FG007|Randomization|Participant request to discontinue study treatment|0|||
44256791|NCT01433978|79108391|FG002|Core Study|Study Terminated by Sponsor|0|||
44256792|NCT01433978|79108389|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
44256793|NCT01433978|79108390|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
44256794|NCT01433978|79108391|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
44256795|NCT01433978|79108389|FG000|Extension Phase|Lack of Efficacy|0|||
44256796|NCT01433978|79108390|FG001|Extension Phase|Lack of Efficacy|0|||
44256797|NCT01433978|79108391|FG002|Extension Phase|Lack of Efficacy|1|||
44256798|NCT01433978|79108389|FG000|Extension Phase|Study Terminated by Sponsor|0|||
44256799|NCT01433978|79108390|FG001|Extension Phase|Study Terminated by Sponsor|0|||
44256800|NCT01433978|79108391|FG002|Extension Phase|Study Terminated by Sponsor|4|||
44256801|NCT01433354|79108440|FG000|Overall Study|Adverse Event|6|||
44256802|NCT01433354|79108440|FG000|Overall Study|Lost to Follow-up|1|||
44256803|NCT01433354|79108440|FG000|Overall Study|Administrative problems|90|||
44256804|NCT01433354|79108440|FG000|Overall Study|Protocol Violation|2|||
44256805|NCT01433354|79108440|FG000|Overall Study|Lack of Efficacy|17|||
44256806|NCT01433354|79108440|FG000|Overall Study|Subject Withdrew Consent|3|||
44256807|NCT05209360|79109000|FG000|Overall Study|Withdrawal by Subject|0|||
44256808|NCT05209360|79109001|FG001|Overall Study|Withdrawal by Subject|0|||
44256809|NCT05209360|79109002|FG002|Overall Study|Withdrawal by Subject|1|||
44301716|NCT03850483|79299598|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
44301717|NCT03850483|79299599|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301718|NCT03850483|79299600|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301719|NCT03850483|79299601|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301720|NCT03850483|79299602|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301721|NCT03850483|79299603|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301722|NCT03850483|79299604|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301723|NCT03850483|79299605|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
44301724|NCT03850483|79299596|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301725|NCT03850483|79299597|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301726|NCT03850483|79299598|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301727|NCT03850483|79299599|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301728|NCT03850483|79299600|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301729|NCT03850483|79299601|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
44301730|NCT03850483|79299602|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301731|NCT03850483|79299603|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301732|NCT03850483|79299604|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301733|NCT03850483|79299605|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
44301734|NCT03850483|79299596|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
44301735|NCT03850483|79299597|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
44301736|NCT03850483|79299598|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
44301737|NCT03850483|79299599|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
44417608|NCT00804986|79425545|FG002|Overall Study|Protocol Violation|0|||
44417609|NCT00804986|79425546|FG003|Overall Study|Protocol Violation|1|||
44155036|NCT03766581|78946499|FG000|Randomization|Participant withdrew consent|1|||
44155037|NCT03766581|78946500|FG001|Randomization|Participant withdrew consent|0|||
44301738|NCT03850483|79299600|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
44301739|NCT03850483|79299601|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
44301740|NCT03850483|79299602|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
44301741|NCT03850483|79299603|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
44301742|NCT03850483|79299604|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
44301743|NCT03850483|79299605|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
44301744|NCT03850483|79299596|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
44301745|NCT03850483|79299597|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
44301746|NCT03850483|79299598|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
44301747|NCT03850483|79299599|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
44301748|NCT03850483|79299600|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
44301749|NCT03850483|79299601|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
44301750|NCT03850483|79299602|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
44301751|NCT03850483|79299603|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
44301752|NCT03850483|79299604|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
44301753|NCT03850483|79299605|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
44301754|NCT03850483|79299596|FG000|Treatment for Stage 1|Death|0|||
44301755|NCT03850483|79299597|FG001|Treatment for Stage 1|Death|0|||
44301756|NCT03850483|79299598|FG002|Treatment for Stage 1|Death|0|||
44301757|NCT03850483|79299599|FG003|Treatment for Stage 1|Death|0|||
44301758|NCT03850483|79299600|FG004|Treatment for Stage 1|Death|0|||
44301759|NCT03850483|79299601|FG005|Treatment for Stage 1|Death|1|||
44301760|NCT03850483|79299602|FG006|Treatment for Stage 1|Death|0|||
44301761|NCT03850483|79299603|FG007|Treatment for Stage 1|Death|0|||
44301762|NCT03850483|79299604|FG008|Treatment for Stage 1|Death|0|||
44301763|NCT03850483|79299605|FG009|Treatment for Stage 1|Death|0|||
44301764|NCT03850483|79299596|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
44301765|NCT03850483|79299597|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
44301766|NCT03850483|79299598|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
44301767|NCT03850483|79299599|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
44301768|NCT03850483|79299600|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
44301769|NCT03850483|79299601|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
44301770|NCT03850483|79299602|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
44301771|NCT03850483|79299603|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
44301772|NCT03850483|79299604|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
44301773|NCT03850483|79299605|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
44301774|NCT03850483|79299596|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
44301775|NCT03850483|79299597|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
44301776|NCT03850483|79299598|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
44301777|NCT03850483|79299599|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
44301778|NCT03850483|79299600|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
44301779|NCT03850483|79299601|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
44301780|NCT03850483|79299602|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
44301781|NCT03850483|79299603|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
44301782|NCT03850483|79299604|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
44301783|NCT03850483|79299605|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
44301784|NCT03850483|79299596|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301785|NCT03850483|79299597|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301786|NCT03850483|79299598|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301787|NCT03850483|79299599|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301788|NCT03850483|79299600|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301789|NCT03850483|79299601|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301790|NCT03850483|79299602|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
44301791|NCT03850483|79299603|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
44301792|NCT03850483|79299604|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301793|NCT03850483|79299605|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
44301794|NCT03850483|79299596|FG000|Follow-up for Stage 1|Physician Decision|0|||
44301795|NCT03850483|79299597|FG001|Follow-up for Stage 1|Physician Decision|0|||
44301796|NCT03850483|79299598|FG002|Follow-up for Stage 1|Physician Decision|0|||
44301797|NCT03850483|79299599|FG003|Follow-up for Stage 1|Physician Decision|0|||
44301798|NCT03850483|79299600|FG004|Follow-up for Stage 1|Physician Decision|1|||
44301799|NCT03850483|79299601|FG005|Follow-up for Stage 1|Physician Decision|0|||
44301800|NCT03850483|79299602|FG006|Follow-up for Stage 1|Physician Decision|1|||
44301801|NCT03850483|79299603|FG007|Follow-up for Stage 1|Physician Decision|0|||
44301802|NCT03850483|79299604|FG008|Follow-up for Stage 1|Physician Decision|0|||
44301803|NCT03850483|79299605|FG009|Follow-up for Stage 1|Physician Decision|0|||
44534265|NCT00098475|79544846|FG003|Step 1|Other disease|0|||
44534266|NCT00098475|79544843|FG000|Step 1|Never started treatment|0|||
44534267|NCT00098475|79544844|FG001|Step 1|Never started treatment|2|||
44534268|NCT00098475|79544845|FG002|Step 1|Never started treatment|0|||
44301804|NCT03850483|79299596|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
44301805|NCT03850483|79299597|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
44301806|NCT03850483|79299598|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
44301807|NCT03850483|79299599|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
44301808|NCT03850483|79299600|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
44301809|NCT03850483|79299601|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
44301810|NCT03850483|79299602|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
44301811|NCT03850483|79299603|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
44534269|NCT00098475|79544846|FG003|Step 1|Never started treatment|0|||
44301812|NCT03850483|79299604|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
44301813|NCT03850483|79299605|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
44301814|NCT03850483|79299596|FG000|Follow-up for Stage 1|Adverse Event|0|||
44301815|NCT03850483|79299597|FG001|Follow-up for Stage 1|Adverse Event|0|||
44301816|NCT03850483|79299598|FG002|Follow-up for Stage 1|Adverse Event|1|||
44301817|NCT03850483|79299599|FG003|Follow-up for Stage 1|Adverse Event|0|||
44301818|NCT03850483|79299600|FG004|Follow-up for Stage 1|Adverse Event|0|||
44301819|NCT03850483|79299601|FG005|Follow-up for Stage 1|Adverse Event|1|||
44301820|NCT03850483|79299602|FG006|Follow-up for Stage 1|Adverse Event|0|||
44301821|NCT03850483|79299603|FG007|Follow-up for Stage 1|Adverse Event|0|||
44301822|NCT03850483|79299604|FG008|Follow-up for Stage 1|Adverse Event|0|||
44301823|NCT03850483|79299605|FG009|Follow-up for Stage 1|Adverse Event|0|||
44301824|NCT03850483|79299596|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301825|NCT03850483|79299597|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
44301826|NCT03850483|79299598|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301827|NCT03850483|79299599|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301828|NCT03850483|79299600|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
44301829|NCT03850483|79299601|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
44301830|NCT03850483|79299602|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301831|NCT03850483|79299603|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301832|NCT03850483|79299604|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301833|NCT03850483|79299605|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
44301834|NCT03850483|79299596|FG000|Follow-up for Stage 1|Other|0|||
44301835|NCT03850483|79299597|FG001|Follow-up for Stage 1|Other|2|||
44301836|NCT03850483|79299598|FG002|Follow-up for Stage 1|Other|0|||
44301837|NCT03850483|79299599|FG003|Follow-up for Stage 1|Other|2|||
44301838|NCT03850483|79299600|FG004|Follow-up for Stage 1|Other|0|||
44301839|NCT03850483|79299601|FG005|Follow-up for Stage 1|Other|1|||
44301840|NCT03850483|79299602|FG006|Follow-up for Stage 1|Other|0|||
44301841|NCT03850483|79299603|FG007|Follow-up for Stage 1|Other|0|||
44301842|NCT03850483|79299604|FG008|Follow-up for Stage 1|Other|0|||
44301843|NCT03850483|79299605|FG009|Follow-up for Stage 1|Other|0|||
44301844|NCT03850483|79299596|FG000|Treatment for Stage 2|Adverse Event|0|||
44301845|NCT03850483|79299597|FG001|Treatment for Stage 2|Adverse Event|0|||
44301846|NCT03850483|79299598|FG002|Treatment for Stage 2|Adverse Event|0|||
44301847|NCT03850483|79299599|FG003|Treatment for Stage 2|Adverse Event|0|||
44301848|NCT03850483|79299600|FG004|Treatment for Stage 2|Adverse Event|0|||
44301849|NCT03850483|79299601|FG005|Treatment for Stage 2|Adverse Event|0|||
44301850|NCT03850483|79299602|FG006|Treatment for Stage 2|Adverse Event|0|||
44301851|NCT03850483|79299603|FG007|Treatment for Stage 2|Adverse Event|0|||
44301852|NCT03850483|79299604|FG008|Treatment for Stage 2|Adverse Event|0|||
44301853|NCT03850483|79299605|FG009|Treatment for Stage 2|Adverse Event|1|||
44301854|NCT03850483|79299596|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
44301855|NCT03850483|79299597|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
44301856|NCT03850483|79299598|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
44301857|NCT03850483|79299599|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
44301858|NCT03850483|79299600|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
44301859|NCT03850483|79299601|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
44301860|NCT03850483|79299602|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
44301861|NCT03850483|79299603|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
44301862|NCT03850483|79299604|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
44301863|NCT03850483|79299605|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
44301864|NCT03850483|79299596|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
44301865|NCT03850483|79299597|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
44301866|NCT03850483|79299598|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
44301867|NCT03850483|79299599|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
44301868|NCT03850483|79299600|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
44301869|NCT03850483|79299601|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
44301870|NCT03850483|79299602|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
44301871|NCT03850483|79299603|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
44301872|NCT03850483|79299604|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
44301873|NCT03850483|79299605|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
44301874|NCT03850483|79299596|FG000|Treatment for Stage 2|Physician Decision|0|||
44301875|NCT03850483|79299597|FG001|Treatment for Stage 2|Physician Decision|0|||
44301876|NCT03850483|79299598|FG002|Treatment for Stage 2|Physician Decision|0|||
44301877|NCT03850483|79299599|FG003|Treatment for Stage 2|Physician Decision|0|||
44301878|NCT03850483|79299600|FG004|Treatment for Stage 2|Physician Decision|0|||
44301879|NCT03850483|79299601|FG005|Treatment for Stage 2|Physician Decision|0|||
44301880|NCT03850483|79299602|FG006|Treatment for Stage 2|Physician Decision|0|||
44301881|NCT03850483|79299603|FG007|Treatment for Stage 2|Physician Decision|0|||
44301882|NCT03850483|79299604|FG008|Treatment for Stage 2|Physician Decision|0|||
44301883|NCT03850483|79299605|FG009|Treatment for Stage 2|Physician Decision|1|||
44301884|NCT03850483|79299596|FG000|Treatment for Stage 2|Protocol Violation|0|||
44301885|NCT03850483|79299597|FG001|Treatment for Stage 2|Protocol Violation|0|||
44301886|NCT03850483|79299598|FG002|Treatment for Stage 2|Protocol Violation|0|||
44301887|NCT03850483|79299599|FG003|Treatment for Stage 2|Protocol Violation|0|||
44301888|NCT03850483|79299600|FG004|Treatment for Stage 2|Protocol Violation|0|||
44301889|NCT03850483|79299601|FG005|Treatment for Stage 2|Protocol Violation|0|||
44301890|NCT03850483|79299602|FG006|Treatment for Stage 2|Protocol Violation|0|||
44301891|NCT03850483|79299603|FG007|Treatment for Stage 2|Protocol Violation|0|||
44301892|NCT03850483|79299604|FG008|Treatment for Stage 2|Protocol Violation|1|||
44301893|NCT03850483|79299605|FG009|Treatment for Stage 2|Protocol Violation|0|||
44301894|NCT03850483|79299596|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
44301895|NCT03850483|79299597|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
44301896|NCT03850483|79299598|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
44301897|NCT03850483|79299599|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
44301898|NCT03850483|79299600|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
44301899|NCT03850483|79299601|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
44301900|NCT03850483|79299602|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
44301901|NCT03850483|79299603|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
44301902|NCT03850483|79299604|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
44301903|NCT03850483|79299605|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
44301904|NCT03850483|79299596|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301905|NCT03850483|79299597|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301906|NCT03850483|79299598|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301907|NCT03850483|79299599|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301908|NCT03850483|79299600|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301909|NCT03850483|79299601|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301910|NCT03850483|79299602|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301911|NCT03850483|79299603|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301912|NCT03850483|79299604|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
44301913|NCT03850483|79299605|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
44301914|NCT03850483|79299596|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
44301915|NCT03850483|79299597|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
44301916|NCT03850483|79299598|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
44301917|NCT03850483|79299599|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
44301918|NCT03850483|79299600|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
44301919|NCT03850483|79299601|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
44301920|NCT03850483|79299602|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
44301921|NCT03850483|79299603|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
44301922|NCT03850483|79299604|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
44301923|NCT03850483|79299605|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
44301924|NCT03850483|79299596|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
44301925|NCT03850483|79299597|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
44301926|NCT03850483|79299598|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
44301927|NCT03850483|79299599|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
44301928|NCT03850483|79299600|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
44301929|NCT03850483|79299601|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
44301930|NCT03850483|79299602|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
44301931|NCT03850483|79299603|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
44301932|NCT03850483|79299604|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
44301933|NCT03850483|79299605|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
44301934|NCT03850483|79299596|FG000|Follow-up For Stage 2|Other|0|||
44301935|NCT03850483|79299597|FG001|Follow-up For Stage 2|Other|0|||
44301936|NCT03850483|79299598|FG002|Follow-up For Stage 2|Other|0|||
44301937|NCT03850483|79299599|FG003|Follow-up For Stage 2|Other|0|||
44301938|NCT03850483|79299600|FG004|Follow-up For Stage 2|Other|0|||
44301939|NCT03850483|79299601|FG005|Follow-up For Stage 2|Other|0|||
44301940|NCT03850483|79299602|FG006|Follow-up For Stage 2|Other|0|||
44301941|NCT03850483|79299603|FG007|Follow-up For Stage 2|Other|0|||
44301942|NCT03850483|79299604|FG008|Follow-up For Stage 2|Other|0|||
44301943|NCT03850483|79299605|FG009|Follow-up For Stage 2|Other|1|||
44301944|NCT03473925|79299636|FG000|Overall Study|Death|48|||
44301945|NCT03473925|79299637|FG001|Overall Study|Death|44|||
44301946|NCT03473925|79299636|FG000|Overall Study|Sponsor Decision|2|||
44301947|NCT03473925|79299637|FG001|Overall Study|Sponsor Decision|7|||
44301948|NCT03473925|79299636|FG000|Overall Study|Withdrawal by Subject|1|||
44301949|NCT03473925|79299637|FG001|Overall Study|Withdrawal by Subject|3|||
44301950|NCT03473925|79299636|FG000|Overall Study|Not Treated|1|||
44301951|NCT03473925|79299637|FG001|Overall Study|Not Treated|1|||
44301952|NCT03230097|79299645|FG000|Overall Study|Adverse Event|2|||
44301953|NCT03230097|79299646|FG001|Overall Study|Adverse Event|1|||
44301954|NCT03230097|79299645|FG000|Overall Study|non-compliance|0|||
44301955|NCT03230097|79299646|FG001|Overall Study|non-compliance|1|||
44301956|NCT03230097|79299645|FG000|Overall Study|Lost to Follow-up|2|||
44301957|NCT03230097|79299646|FG001|Overall Study|Lost to Follow-up|4|||
44301958|NCT03230097|79299645|FG000|Overall Study|Withdrawal by Subject|7|||
44301959|NCT03230097|79299646|FG001|Overall Study|Withdrawal by Subject|3|||
44301960|NCT03230097|79299645|FG000|Overall Study|Trial termination|4|||
44301961|NCT03230097|79299646|FG001|Overall Study|Trial termination|5|||
44301962|NCT03230097|79299645|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
44301963|NCT03230097|79299646|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
44301964|NCT03230097|79299645|FG000|Overall Study|outcome event|0|||
44301965|NCT03230097|79299646|FG001|Overall Study|outcome event|1|||
44301966|NCT02803593|79299671|FG000|Overall Study|Lost to Follow-up|17|||
44301967|NCT02803593|79299672|FG001|Overall Study|Lost to Follow-up|35|||
44301968|NCT02663908|79299680|FG000|Overall Study|Withdrawal by Subject|8|||
44301969|NCT02663908|79299681|FG001|Overall Study|Withdrawal by Subject|5|||
44301970|NCT02663908|79299680|FG000|Overall Study|Lost to Follow-up|1|||
44301971|NCT02663908|79299681|FG001|Overall Study|Lost to Follow-up|5|||
44301972|NCT02663908|79299680|FG000|Overall Study|Adverse Event|13|||
44301973|NCT02663908|79299681|FG001|Overall Study|Adverse Event|11|||
44301974|NCT02663908|79299680|FG000|Overall Study|Protocol Violation|1|||
44301975|NCT02663908|79299681|FG001|Overall Study|Protocol Violation|2|||
44301976|NCT02663908|79299680|FG000|Overall Study|Lack of therapeutic response|2|||
44301977|NCT02663908|79299681|FG001|Overall Study|Lack of therapeutic response|0|||
44301978|NCT02663908|79299680|FG000|Overall Study|COVID-19|1|||
44301979|NCT02663908|79299681|FG001|Overall Study|COVID-19|0|||
44301980|NCT02663908|79299680|FG000|Overall Study|Site closed|1|||
44301981|NCT02663908|79299681|FG001|Overall Study|Site closed|0|||
44301982|NCT02663908|79299680|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
44301983|NCT02663908|79299681|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
44301984|NCT02663908|79299680|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
44301985|NCT02663908|79299681|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
44301986|NCT02663908|79299680|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
44301987|NCT02663908|79299681|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
44301988|NCT02663908|79299680|FG000|Overall Study|Death|1|||
44301989|NCT02663908|79299681|FG001|Overall Study|Death|0|||
44301990|NCT02663908|79299680|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
44301991|NCT02663908|79299681|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
44301992|NCT02663908|79299680|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
44301993|NCT02663908|79299681|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
44301994|NCT02650284|79299689|FG000|Overall Study|Lost to Follow-up|3|||
44301995|NCT02650284|79299690|FG001|Overall Study|Lost to Follow-up|3|||
44301996|NCT02650284|79299689|FG000|Overall Study|Consent incorrectly taken|0|||
44301997|NCT02650284|79299690|FG001|Overall Study|Consent incorrectly taken|1|||
44301998|NCT02175030|79299698|FG000|Overall Study|Failed screen after consent|7|||
44301999|NCT02175030|79299699|FG001|Overall Study|Failed screen after consent|6|||
44302000|NCT02175030|79299698|FG000|Overall Study|Failed IUD Insertion|20|||
44302001|NCT02175030|79299699|FG001|Overall Study|Failed IUD Insertion|21|||
44302002|NCT02175030|79299698|FG000|Overall Study|Physician Decision|1|||
44302003|NCT02175030|79299699|FG001|Overall Study|Physician Decision|1|||
44302004|NCT02175030|79299698|FG000|Overall Study|Lost to Follow-up|6|||
44302005|NCT02175030|79299699|FG001|Overall Study|Lost to Follow-up|6|||
44302006|NCT02175030|79299698|FG000|Overall Study|Withdrawal by Subject|1|||
44302007|NCT02175030|79299699|FG001|Overall Study|Withdrawal by Subject|4|||
44302008|NCT03096834|79299724|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
44302009|NCT03096834|79299725|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
44302010|NCT03096834|79299726|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
44302011|NCT03096834|79299727|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
44534270|NCT00098475|79544843|FG000|Step 1|Still on treatment as of this analysis|14|||
44534271|NCT00098475|79544844|FG001|Step 1|Still on treatment as of this analysis|27|||
44302012|NCT03096834|79299724|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
44302013|NCT03096834|79299725|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
44302014|NCT03096834|79299726|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
44302015|NCT03096834|79299727|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
44302016|NCT03096834|79299724|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
44302017|NCT03096834|79299725|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
44302018|NCT03096834|79299726|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
44302019|NCT03096834|79299727|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
44302020|NCT03096834|79299724|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
44302021|NCT03096834|79299725|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
44302022|NCT03096834|79299726|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
44302023|NCT03096834|79299727|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
44302024|NCT03096834|79299724|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
44417610|NCT00804986|79425547|FG004|Overall Study|Protocol Violation|0|||
44302025|NCT03096834|79299725|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
44302026|NCT03096834|79299726|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
44302027|NCT03096834|79299727|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
44302028|NCT03096834|79299724|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
44302029|NCT03096834|79299725|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
44302030|NCT03096834|79299726|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
44302031|NCT03096834|79299727|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
44302032|NCT03096834|79299724|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
44302033|NCT03096834|79299725|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
44302034|NCT03096834|79299726|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
44302035|NCT03096834|79299727|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
44302036|NCT03096834|79299724|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
44302037|NCT03096834|79299725|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
44302038|NCT03096834|79299726|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
44302039|NCT03096834|79299727|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
44302040|NCT03096834|79299724|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
44302041|NCT03096834|79299725|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
44302042|NCT03096834|79299726|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
44302043|NCT03096834|79299727|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
44302044|NCT03096834|79299724|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
44302045|NCT03096834|79299725|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
44302046|NCT03096834|79299726|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
44302047|NCT03096834|79299727|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
44302048|NCT03096834|79299724|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
44302049|NCT03096834|79299725|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
44302050|NCT03096834|79299726|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
44302051|NCT03096834|79299727|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
44302052|NCT03096834|79299724|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
44302053|NCT03096834|79299725|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
44302054|NCT03096834|79299726|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
44302055|NCT03096834|79299727|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
44302056|NCT03012815|79299738|FG000|Overall Study|Lost to Follow-up|1|||
44302057|NCT03012815|79299739|FG001|Overall Study|Lost to Follow-up|0|||
44302058|NCT03012815|79299738|FG000|Overall Study|Physician Decision|3|||
44302059|NCT03012815|79299739|FG001|Overall Study|Physician Decision|2|||
44302060|NCT03012815|79299738|FG000|Overall Study|Adverse Event|1|||
44302061|NCT03012815|79299739|FG001|Overall Study|Adverse Event|0|||
44302062|NCT03001011|79299748|FG000|Overall Study|Adverse Event|9|||
44302063|NCT03001011|79299749|FG001|Overall Study|Adverse Event|3|||
44302064|NCT03001011|79299748|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
44302065|NCT03001011|79299749|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
44302066|NCT03001011|79299748|FG000|Overall Study|Other than specified above|3|||
44302067|NCT03001011|79299749|FG001|Overall Study|Other than specified above|8|||
44302068|NCT02993757|79299758|FG000|Overall Study|Non compliance with the protocol|155|||
44302069|NCT02993757|79299759|FG001|Overall Study|Non compliance with the protocol|170|||
44302070|NCT02993757|79299758|FG000|Overall Study|Lost to Follow-up|1|||
44302071|NCT02993757|79299759|FG001|Overall Study|Lost to Follow-up|0|||
44302072|NCT02993757|79299758|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
44302073|NCT02993757|79299759|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
44302074|NCT02979535|79299767|FG000|Overall Study|Non compliance with the protocol|78|||
44302075|NCT02979535|79299768|FG001|Overall Study|Non compliance with the protocol|82|||
44302076|NCT02979535|79299767|FG000|Overall Study|Consent withdrawn by participant|11|||
44302077|NCT02979535|79299768|FG001|Overall Study|Consent withdrawn by participant|18|||
44302078|NCT02979535|79299767|FG000|Overall Study|Lost to Follow-up|6|||
44534272|NCT00098475|79544845|FG002|Step 1|Still on treatment as of this analysis|0|||
44534273|NCT00098475|79544846|FG003|Step 1|Still on treatment as of this analysis|0|||
44534274|NCT00098475|79544843|FG000|Step 1|Knee surgery|1|||
44534275|NCT00098475|79544844|FG001|Step 1|Knee surgery|0|||
44534276|NCT00098475|79544845|FG002|Step 1|Knee surgery|0|||
44534277|NCT00098475|79544846|FG003|Step 1|Knee surgery|0|||
44534278|NCT00098475|79544843|FG000|Step 1|Complications|1|||
44534279|NCT00098475|79544844|FG001|Step 1|Complications|0|||
44534280|NCT00098475|79544845|FG002|Step 1|Complications|0|||
44302079|NCT02979535|79299768|FG001|Overall Study|Lost to Follow-up|1|||
44302080|NCT02978716|79299777|FG000|Overall Study|Death|25|||
44302081|NCT02978716|79299778|FG001|Overall Study|Death|13|||
44302082|NCT02978716|79299779|FG002|Overall Study|Death|20|||
44302083|NCT02978716|79299777|FG000|Overall Study|Lost to Follow-up|0|||
44302084|NCT02978716|79299778|FG001|Overall Study|Lost to Follow-up|0|||
44302085|NCT02978716|79299779|FG002|Overall Study|Lost to Follow-up|1|||
44302086|NCT02978716|79299777|FG000|Overall Study|Withdrawal by Subject|6|||
44302087|NCT02978716|79299778|FG001|Overall Study|Withdrawal by Subject|4|||
44302088|NCT02978716|79299779|FG002|Overall Study|Withdrawal by Subject|5|||
44302089|NCT02978716|79299777|FG000|Overall Study|Sponsor terminated|2|||
44534281|NCT00098475|79544846|FG003|Step 1|Complications|0|||
44302090|NCT02978716|79299778|FG001|Overall Study|Sponsor terminated|13|||
44302091|NCT02978716|79299779|FG002|Overall Study|Sponsor terminated|9|||
44302092|NCT02978716|79299777|FG000|Overall Study|Other|1|||
44302093|NCT02978716|79299778|FG001|Overall Study|Other|3|||
44302094|NCT02978716|79299779|FG002|Overall Study|Other|0|||
44302095|NCT02973321|79299794|FG000|Overall Study|Other than specified|0|||
44302096|NCT02973321|79299795|FG001|Overall Study|Other than specified|5|||
44302097|NCT02973321|79299796|FG002|Overall Study|Other than specified|3|||
44302098|NCT02973321|79299797|FG003|Overall Study|Other than specified|3|||
44302099|NCT02973321|79299798|FG004|Overall Study|Other than specified|1|||
44302100|NCT02973321|79299794|FG000|Overall Study|Lack of Efficacy|0|||
44302101|NCT02973321|79299795|FG001|Overall Study|Lack of Efficacy|0|||
44302102|NCT02973321|79299796|FG002|Overall Study|Lack of Efficacy|0|||
44302103|NCT02973321|79299797|FG003|Overall Study|Lack of Efficacy|0|||
44302104|NCT02973321|79299798|FG004|Overall Study|Lack of Efficacy|1|||
44302105|NCT02973321|79299794|FG000|Overall Study|Adverse Event|1|||
44302106|NCT02973321|79299795|FG001|Overall Study|Adverse Event|10|||
44302107|NCT02973321|79299796|FG002|Overall Study|Adverse Event|11|||
44302108|NCT02973321|79299797|FG003|Overall Study|Adverse Event|13|||
44302109|NCT02973321|79299798|FG004|Overall Study|Adverse Event|3|||
44302110|NCT02943785|79299813|FG000|Overall Study|Adverse Event|112|||
44302111|NCT02943785|79299814|FG001|Overall Study|Adverse Event|97|||
44302112|NCT02943785|79299813|FG000|Overall Study|Withdrawal by Subject|63|||
44302113|NCT02943785|79299814|FG001|Overall Study|Withdrawal by Subject|126|||
44302114|NCT02943785|79299813|FG000|Overall Study|Physician Decision|23|||
44302115|NCT02943785|79299814|FG001|Overall Study|Physician Decision|47|||
44302116|NCT02943785|79299813|FG000|Overall Study|Death|46|||
44302117|NCT02943785|79299814|FG001|Overall Study|Death|46|||
44302118|NCT02943785|79299813|FG000|Overall Study|Lost to Follow-up|1|||
44302119|NCT02943785|79299814|FG001|Overall Study|Lost to Follow-up|0|||
44302120|NCT02943785|79299813|FG000|Overall Study|Other|16|||
44302121|NCT02943785|79299814|FG001|Overall Study|Other|19|||
44302122|NCT02943785|79299813|FG000|Overall Study|Did not receive any study medication|21|||
44302123|NCT02943785|79299814|FG001|Overall Study|Did not receive any study medication|28|||
44302124|NCT02923674|79299823|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
44302125|NCT02923674|79299824|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
44302126|NCT02923674|79299825|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
44302127|NCT02923674|79299823|FG000|Overall Study|Lost to Follow-up|7|||
44302128|NCT02923674|79299824|FG001|Overall Study|Lost to Follow-up|12|||
44302129|NCT02923674|79299825|FG002|Overall Study|Lost to Follow-up|7|||
44302130|NCT02923674|79299823|FG000|Overall Study|Problem with intervention|2|||
44302131|NCT02923674|79299824|FG001|Overall Study|Problem with intervention|2|||
44302132|NCT02923674|79299825|FG002|Overall Study|Problem with intervention|1|||
44302133|NCT02923674|79299823|FG000|Overall Study|Adverse Event|3|||
44302134|NCT02923674|79299824|FG001|Overall Study|Adverse Event|1|||
44302135|NCT02923674|79299825|FG002|Overall Study|Adverse Event|1|||
44302136|NCT02923674|79299823|FG000|Overall Study|Withdrawal by Subject|2|||
44302137|NCT02923674|79299824|FG001|Overall Study|Withdrawal by Subject|2|||
44302138|NCT02923674|79299825|FG002|Overall Study|Withdrawal by Subject|2|||
44302139|NCT02921971|79299835|FG000|Overall Study|Adverse Event|1|||
44302140|NCT02921971|79299836|FG001|Overall Study|Adverse Event|2|||
44302141|NCT02921971|79299835|FG000|Overall Study|Lack of Efficacy|3|||
44302142|NCT02921971|79299836|FG001|Overall Study|Lack of Efficacy|1|||
44302143|NCT02921971|79299835|FG000|Overall Study|Other than specified above|2|||
44302144|NCT02921971|79299836|FG001|Overall Study|Other than specified above|1|||
44302145|NCT02886286|79299844|FG000|Overall Study|pump motor stall|0|||
44302146|NCT02886286|79299845|FG001|Overall Study|pump motor stall|1|||
44302147|NCT02865187|79299853|FG000|Overall Study|Lost to Follow-up|12|||
44302148|NCT02865187|79299854|FG001|Overall Study|Lost to Follow-up|7|||
44302149|NCT02865187|79299853|FG000|Overall Study|Adverse Event|1|||
44302150|NCT02865187|79299854|FG001|Overall Study|Adverse Event|0|||
44302151|NCT02824198|79299862|FG000|Overall Study|Non-compliance with the protocol|5|||
44302152|NCT02824198|79299863|FG001|Overall Study|Non-compliance with the protocol|1|||
44302153|NCT02824198|79299862|FG000|Overall Study|Lost to Follow-up|5|||
44302154|NCT02824198|79299863|FG001|Overall Study|Lost to Follow-up|2|||
44417611|NCT00804986|79425548|FG005|Overall Study|Protocol Violation|0|||
44302155|NCT02824198|79299862|FG000|Overall Study|Withdrawal by Subject|5|||
44302156|NCT02824198|79299863|FG001|Overall Study|Withdrawal by Subject|0|||
44302157|NCT02787551|79299873|FG000|Core Period: 26 Weeks|Adverse Event|10|||
44417612|NCT00804986|79425543|FG000|Overall Study|Withdrawal by Subject|0|||
44302158|NCT02787551|79299874|FG001|Core Period: 26 Weeks|Adverse Event|0|||
44302159|NCT02787551|79299873|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
44302160|NCT02787551|79299874|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
44302161|NCT02787551|79299873|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
44302162|NCT02787551|79299874|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
44302163|NCT02787551|79299873|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
44302164|NCT02787551|79299874|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
44302165|NCT02787551|79299873|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
44302166|NCT02787551|79299874|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
44302167|NCT02787551|79299873|FG000|Core Period: 26 Weeks|Other than specified|3|||
44302168|NCT02787551|79299874|FG001|Core Period: 26 Weeks|Other than specified|1|||
44302169|NCT02787551|79299873|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
44302170|NCT02787551|79299874|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
44302171|NCT02787551|79299873|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
44302172|NCT02787551|79299874|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
44302173|NCT02787551|79299873|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
44302174|NCT02787551|79299874|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
44302175|NCT02735044|79299894|FG000|Overall Study|Adverse Event|3|||
44302176|NCT02735044|79299895|FG001|Overall Study|Adverse Event|3|||
44302177|NCT02735044|79299894|FG000|Overall Study|Lack of Efficacy|1|||
44302178|NCT02735044|79299895|FG001|Overall Study|Lack of Efficacy|0|||
44302179|NCT02735044|79299894|FG000|Overall Study|Poor compliance to protocol|7|||
44302180|NCT02735044|79299895|FG001|Overall Study|Poor compliance to protocol|7|||
44302181|NCT02735044|79299894|FG000|Overall Study|Randomized and not treated|0|||
44302182|NCT02735044|79299895|FG001|Overall Study|Randomized and not treated|2|||
44302183|NCT02735044|79299894|FG000|Overall Study|Other, not specified above|5|||
44302184|NCT02735044|79299895|FG001|Overall Study|Other, not specified above|11|||
44302185|NCT02720744|79299903|FG000|Overall Study|Protocol Violation|0|||
44302186|NCT02720744|79299904|FG001|Overall Study|Protocol Violation|2|||
44302187|NCT02720744|79299903|FG000|Overall Study|Pregnancy|2|||
44302188|NCT02720744|79299904|FG001|Overall Study|Pregnancy|0|||
44302189|NCT02720744|79299903|FG000|Overall Study|Lack of Efficacy|2|||
44302190|NCT02720744|79299904|FG001|Overall Study|Lack of Efficacy|8|||
44302191|NCT02720744|79299903|FG000|Overall Study|Adverse Event|21|||
44302192|NCT02720744|79299904|FG001|Overall Study|Adverse Event|3|||
44302193|NCT02720744|79299903|FG000|Overall Study|Withdrawal by Subject|11|||
44302194|NCT02720744|79299904|FG001|Overall Study|Withdrawal by Subject|11|||
44302195|NCT02720744|79299903|FG000|Overall Study|Lost to follow up|2|||
44302196|NCT02720744|79299904|FG001|Overall Study|Lost to follow up|0|||
44302197|NCT02720744|79299903|FG000|Overall Study|Non Compliance with Investigational Product|0|||
44302198|NCT02720744|79299904|FG001|Overall Study|Non Compliance with Investigational Product|1|||
44302199|NCT02720744|79299903|FG000|Overall Study|Excluded Concomitant Medication|0|||
44302200|NCT02720744|79299904|FG001|Overall Study|Excluded Concomitant Medication|1|||
44302201|NCT02692651|79299912|FG000|Study Treatment|Death|7|||
44302202|NCT02692651|79299913|FG001|Study Treatment|Death|3|||
44302203|NCT02692651|79299912|FG000|Study Treatment|comfort care|1|||
44302204|NCT02692651|79299913|FG001|Study Treatment|comfort care|1|||
44302205|NCT02692651|79299912|FG000|Study Treatment|Protocol violation per treating team preference|8|||
44302206|NCT02692651|79299913|FG001|Study Treatment|Protocol violation per treating team preference|6|||
44302207|NCT02692651|79299912|FG000|Post Study Treatment Follow-up|Death|4|||
44302208|NCT02692651|79299913|FG001|Post Study Treatment Follow-up|Death|4|||
44302209|NCT02674061|79299921|FG000|Overall Study|Death|229|||
44302210|NCT02674061|79299922|FG001|Overall Study|Death|77|||
44302211|NCT02674061|79299921|FG000|Overall Study|Lost to Follow-up|3|||
44302212|NCT02674061|79299922|FG001|Overall Study|Lost to Follow-up|3|||
44302213|NCT02674061|79299921|FG000|Overall Study|Withdrawal by Subject|9|||
44302214|NCT02674061|79299922|FG001|Overall Study|Withdrawal by Subject|1|||
44302215|NCT02674061|79299921|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
44302216|NCT02674061|79299922|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
44302217|NCT02628444|79299942|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
44302218|NCT02628444|79299943|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44302219|NCT02628444|79299944|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44302220|NCT02628444|79299945|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44302221|NCT02628444|79299946|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44302222|NCT02628444|79299947|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44417613|NCT00804986|79425544|FG001|Overall Study|Withdrawal by Subject|3|||
44417614|NCT00804986|79425545|FG002|Overall Study|Withdrawal by Subject|0|||
44302223|NCT02628444|79299948|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44417615|NCT00804986|79425546|FG003|Overall Study|Withdrawal by Subject|3|||
44417616|NCT00804986|79425547|FG004|Overall Study|Withdrawal by Subject|5|||
44302224|NCT02628444|79299949|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44302225|NCT02628444|79299950|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
44302226|NCT02628444|79299942|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302227|NCT02628444|79299943|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
44302228|NCT02628444|79299944|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
44302229|NCT02628444|79299945|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302230|NCT02628444|79299946|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302231|NCT02628444|79299947|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302232|NCT02628444|79299948|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302233|NCT02628444|79299949|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302234|NCT02628444|79299950|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
44302235|NCT02628444|79299942|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
44302236|NCT02628444|79299943|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
44302237|NCT02628444|79299944|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
44302238|NCT02628444|79299945|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302239|NCT02628444|79299946|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302240|NCT02628444|79299947|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302241|NCT02628444|79299948|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302242|NCT02628444|79299949|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302243|NCT02628444|79299950|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302244|NCT02628444|79299942|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
44302245|NCT02628444|79299943|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
44302246|NCT02628444|79299944|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
44302247|NCT02628444|79299945|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
44302248|NCT02628444|79299946|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
44302249|NCT02628444|79299947|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
44302250|NCT02628444|79299948|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
44302251|NCT02628444|79299949|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
44302252|NCT02628444|79299950|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
44302253|NCT02628444|79299942|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
44302254|NCT02628444|79299943|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
44302255|NCT02628444|79299944|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
44302256|NCT02628444|79299945|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
44302257|NCT02628444|79299946|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
44302258|NCT02628444|79299947|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
44302259|NCT02628444|79299948|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
44302260|NCT02628444|79299949|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
44302261|NCT02628444|79299950|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
44302262|NCT02628444|79299942|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302263|NCT02628444|79299943|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302264|NCT02628444|79299944|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302265|NCT02628444|79299945|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
44302266|NCT02628444|79299946|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302267|NCT02628444|79299947|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302268|NCT02628444|79299948|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302269|NCT02628444|79299949|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302270|NCT02628444|79299950|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
44302271|NCT02628444|79299942|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
44302272|NCT02628444|79299943|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
44302273|NCT02628444|79299944|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
44302274|NCT02628444|79299945|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
44302275|NCT02628444|79299946|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
44302276|NCT02628444|79299947|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
44302277|NCT02628444|79299948|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
44302278|NCT02628444|79299949|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
44302279|NCT02628444|79299950|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
44302280|NCT02628444|79299942|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302281|NCT02628444|79299943|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302282|NCT02628444|79299944|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
44302283|NCT02628444|79299945|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
44302284|NCT02628444|79299946|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
44302285|NCT02628444|79299947|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
44302286|NCT02628444|79299948|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
44302287|NCT02628444|79299949|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
44302288|NCT02628444|79299950|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
44302289|NCT02628444|79299942|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
44302290|NCT02628444|79299943|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
44302291|NCT02628444|79299944|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
44302292|NCT02628444|79299945|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
44302293|NCT02628444|79299946|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
44302294|NCT02628444|79299947|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
44302295|NCT02628444|79299948|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
44302296|NCT02628444|79299949|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
44302297|NCT02628444|79299950|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
44302298|NCT02628444|79299942|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
44302299|NCT02628444|79299943|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
44302300|NCT02628444|79299944|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
44302301|NCT02628444|79299945|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
44302302|NCT02628444|79299946|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
44302303|NCT02628444|79299947|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
44302304|NCT02628444|79299948|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
44302305|NCT02628444|79299949|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
44302306|NCT02628444|79299950|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
44302307|NCT02623725|79299986|FG000|Overall Study|Non compliance with protocol|9|||
44302308|NCT02623725|79299987|FG001|Overall Study|Non compliance with protocol|3|||
44302309|NCT02623725|79299986|FG000|Overall Study|Serious adverse event|0|||
44302310|NCT02623725|79299987|FG001|Overall Study|Serious adverse event|2|||
44302311|NCT02623725|79299986|FG000|Overall Study|Withdrawal by Subject|7|||
44302312|NCT02623725|79299987|FG001|Overall Study|Withdrawal by Subject|1|||
44302313|NCT02608684|79299995|FG000|Overall Study|Physician Decision|2|||
44302314|NCT02608684|79299995|FG000|Overall Study|Withdrawal by Subject|1|||
44302315|NCT02587520|79300017|FG000|Overall Study|Protocol Violation|2|||
44302316|NCT02587520|79300018|FG001|Overall Study|Protocol Violation|0|||
44302317|NCT02587520|79300019|FG002|Overall Study|Protocol Violation|0|||
44302318|NCT02587520|79300020|FG003|Overall Study|Protocol Violation|2|||
44302319|NCT02587520|79300021|FG004|Overall Study|Protocol Violation|0|||
44302320|NCT02587520|79300022|FG005|Overall Study|Protocol Violation|1|||
44302321|NCT02587520|79300023|FG006|Overall Study|Protocol Violation|1|||
44302322|NCT02587520|79300024|FG007|Overall Study|Protocol Violation|1|||
44302323|NCT02587520|79300025|FG008|Overall Study|Protocol Violation|3|||
44302324|NCT02587520|79300026|FG009|Overall Study|Protocol Violation|3|||
44302325|NCT02587520|79300027|FG010|Overall Study|Protocol Violation|1|||
44302326|NCT02587520|79300028|FG011|Overall Study|Protocol Violation|2|||
44302327|NCT02587520|79300029|FG012|Overall Study|Protocol Violation|0|||
44302328|NCT02587520|79300030|FG013|Overall Study|Protocol Violation|0|||
44302329|NCT02587520|79300031|FG014|Overall Study|Protocol Violation|0|||
44302330|NCT02587520|79300032|FG015|Overall Study|Protocol Violation|0|||
44302331|NCT02587520|79300033|FG016|Overall Study|Protocol Violation|0|||
44302332|NCT02587520|79300034|FG017|Overall Study|Protocol Violation|0|||
44302333|NCT02587520|79300017|FG000|Overall Study|Adverse Event|0|||
44302334|NCT02587520|79300018|FG001|Overall Study|Adverse Event|0|||
44302335|NCT02587520|79300019|FG002|Overall Study|Adverse Event|0|||
44302336|NCT02587520|79300020|FG003|Overall Study|Adverse Event|0|||
44302337|NCT02587520|79300021|FG004|Overall Study|Adverse Event|0|||
44302338|NCT02587520|79300022|FG005|Overall Study|Adverse Event|0|||
44302339|NCT02587520|79300023|FG006|Overall Study|Adverse Event|0|||
44302340|NCT02587520|79300024|FG007|Overall Study|Adverse Event|0|||
44302341|NCT02587520|79300025|FG008|Overall Study|Adverse Event|0|||
44302342|NCT02587520|79300026|FG009|Overall Study|Adverse Event|0|||
44302343|NCT02587520|79300027|FG010|Overall Study|Adverse Event|0|||
44302344|NCT02587520|79300028|FG011|Overall Study|Adverse Event|1|||
44302345|NCT02587520|79300029|FG012|Overall Study|Adverse Event|0|||
44302346|NCT02587520|79300030|FG013|Overall Study|Adverse Event|0|||
44302347|NCT02587520|79300031|FG014|Overall Study|Adverse Event|0|||
44302348|NCT02587520|79300032|FG015|Overall Study|Adverse Event|0|||
44302349|NCT02587520|79300033|FG016|Overall Study|Adverse Event|0|||
44302350|NCT02587520|79300034|FG017|Overall Study|Adverse Event|0|||
44302351|NCT02587520|79300017|FG000|Overall Study|Withdrawal by Subject|0|||
44302352|NCT02587520|79300018|FG001|Overall Study|Withdrawal by Subject|0|||
44302353|NCT02587520|79300019|FG002|Overall Study|Withdrawal by Subject|1|||
44302354|NCT02587520|79300020|FG003|Overall Study|Withdrawal by Subject|1|||
44302355|NCT02587520|79300021|FG004|Overall Study|Withdrawal by Subject|0|||
44302356|NCT02587520|79300022|FG005|Overall Study|Withdrawal by Subject|1|||
44302357|NCT02587520|79300023|FG006|Overall Study|Withdrawal by Subject|1|||
44302358|NCT02587520|79300024|FG007|Overall Study|Withdrawal by Subject|0|||
44302359|NCT02587520|79300025|FG008|Overall Study|Withdrawal by Subject|0|||
44302360|NCT02587520|79300026|FG009|Overall Study|Withdrawal by Subject|0|||
44302361|NCT02587520|79300027|FG010|Overall Study|Withdrawal by Subject|0|||
44302362|NCT02587520|79300028|FG011|Overall Study|Withdrawal by Subject|0|||
44302363|NCT02587520|79300029|FG012|Overall Study|Withdrawal by Subject|0|||
44302364|NCT02587520|79300030|FG013|Overall Study|Withdrawal by Subject|1|||
44302365|NCT02587520|79300031|FG014|Overall Study|Withdrawal by Subject|0|||
44302366|NCT02587520|79300032|FG015|Overall Study|Withdrawal by Subject|0|||
44302367|NCT02587520|79300033|FG016|Overall Study|Withdrawal by Subject|0|||
44302368|NCT02587520|79300034|FG017|Overall Study|Withdrawal by Subject|0|||
44302369|NCT02587520|79300017|FG000|Overall Study|Lost to Follow-up|0|||
44302370|NCT02587520|79300018|FG001|Overall Study|Lost to Follow-up|2|||
44302371|NCT02587520|79300019|FG002|Overall Study|Lost to Follow-up|0|||
44302372|NCT02587520|79300020|FG003|Overall Study|Lost to Follow-up|2|||
44302373|NCT02587520|79300021|FG004|Overall Study|Lost to Follow-up|0|||
44302374|NCT02587520|79300022|FG005|Overall Study|Lost to Follow-up|1|||
44302375|NCT02587520|79300023|FG006|Overall Study|Lost to Follow-up|1|||
44302376|NCT02587520|79300024|FG007|Overall Study|Lost to Follow-up|1|||
44302377|NCT02587520|79300025|FG008|Overall Study|Lost to Follow-up|0|||
44302378|NCT02587520|79300026|FG009|Overall Study|Lost to Follow-up|2|||
44302379|NCT02587520|79300027|FG010|Overall Study|Lost to Follow-up|2|||
44302380|NCT02587520|79300028|FG011|Overall Study|Lost to Follow-up|1|||
44302381|NCT02587520|79300029|FG012|Overall Study|Lost to Follow-up|0|||
44302382|NCT02587520|79300030|FG013|Overall Study|Lost to Follow-up|0|||
44302383|NCT02587520|79300031|FG014|Overall Study|Lost to Follow-up|0|||
44302384|NCT02587520|79300032|FG015|Overall Study|Lost to Follow-up|0|||
44302385|NCT02587520|79300033|FG016|Overall Study|Lost to Follow-up|0|||
44302386|NCT02587520|79300034|FG017|Overall Study|Lost to Follow-up|0|||
44302387|NCT02584829|79300074|FG000|Overall Study|Physician Decision|1|||
44302388|NCT02584829|79300075|FG001|Overall Study|Physician Decision|0|||
44302389|NCT02584829|79300074|FG000|Overall Study|Withdrawal by Subject|0|||
44302390|NCT02584829|79300075|FG001|Overall Study|Withdrawal by Subject|1|||
44302391|NCT02584829|79300074|FG000|Overall Study|Progressive Disease|0|||
44302392|NCT02584829|79300075|FG001|Overall Study|Progressive Disease|3|||
44302393|NCT02570308|79300088|FG000|Overall Study|Death|1|||
44302394|NCT02570308|79300089|FG001|Overall Study|Death|5|||
44302395|NCT02570308|79300090|FG002|Overall Study|Death|4|||
44302396|NCT02570308|79300091|FG003|Overall Study|Death|4|||
44302397|NCT02570308|79300092|FG004|Overall Study|Death|69|||
44302398|NCT02570308|79300088|FG000|Overall Study|Lost to Follow-up|0|||
44302399|NCT02570308|79300089|FG001|Overall Study|Lost to Follow-up|0|||
44302400|NCT02570308|79300090|FG002|Overall Study|Lost to Follow-up|0|||
44302401|NCT02570308|79300091|FG003|Overall Study|Lost to Follow-up|0|||
44302402|NCT02570308|79300092|FG004|Overall Study|Lost to Follow-up|2|||
44302403|NCT02570308|79300088|FG000|Overall Study|Withdrawal by Subject|0|||
44302404|NCT02570308|79300089|FG001|Overall Study|Withdrawal by Subject|0|||
44302405|NCT02570308|79300090|FG002|Overall Study|Withdrawal by Subject|0|||
44302406|NCT02570308|79300091|FG003|Overall Study|Withdrawal by Subject|0|||
44302407|NCT02570308|79300092|FG004|Overall Study|Withdrawal by Subject|1|||
44302408|NCT02570308|79300088|FG000|Overall Study|Other|0|||
44302409|NCT02570308|79300089|FG001|Overall Study|Other|0|||
44302410|NCT02570308|79300090|FG002|Overall Study|Other|0|||
44302411|NCT02570308|79300091|FG003|Overall Study|Other|0|||
44302412|NCT02570308|79300092|FG004|Overall Study|Other|2|||
44302413|NCT02497612|79300114|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
44302414|NCT02497612|79300115|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
44302415|NCT02497612|79300116|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
44302416|NCT02497612|79300117|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
44302417|NCT02497612|79300114|FG000|Overall Study|Participant's request|2|||
44302418|NCT02497612|79300115|FG001|Overall Study|Participant's request|3|||
44302419|NCT02497612|79300116|FG002|Overall Study|Participant's request|4|||
44302420|NCT02497612|79300117|FG003|Overall Study|Participant's request|1|||
44302421|NCT02497612|79300114|FG000|Overall Study|Investigator's judgement|1|||
44302422|NCT02497612|79300115|FG001|Overall Study|Investigator's judgement|0|||
44302423|NCT02497612|79300116|FG002|Overall Study|Investigator's judgement|0|||
44302424|NCT02497612|79300117|FG003|Overall Study|Investigator's judgement|2|||
44302425|NCT02497612|79300114|FG000|Overall Study|Adverse Event|3|||
44302426|NCT02497612|79300115|FG001|Overall Study|Adverse Event|1|||
44302427|NCT02497612|79300116|FG002|Overall Study|Adverse Event|4|||
44302428|NCT02497612|79300117|FG003|Overall Study|Adverse Event|1|||
44302429|NCT02497612|79300114|FG000|Overall Study|Lost to Follow-up|1|||
44302430|NCT02497612|79300115|FG001|Overall Study|Lost to Follow-up|1|||
44302431|NCT02497612|79300116|FG002|Overall Study|Lost to Follow-up|0|||
44302432|NCT02497612|79300117|FG003|Overall Study|Lost to Follow-up|1|||
44302433|NCT02497612|79300114|FG000|Overall Study|Other unspecified|1|||
44302434|NCT02497612|79300115|FG001|Overall Study|Other unspecified|1|||
44302435|NCT02497612|79300116|FG002|Overall Study|Other unspecified|2|||
44302436|NCT02497612|79300117|FG003|Overall Study|Other unspecified|0|||
44302437|NCT02497612|79300114|FG000|Overall Study|Not eligible|1|||
44302438|NCT02497612|79300115|FG001|Overall Study|Not eligible|0|||
44302439|NCT02497612|79300116|FG002|Overall Study|Not eligible|0|||
44302440|NCT02497612|79300117|FG003|Overall Study|Not eligible|1|||
44302441|NCT02460458|79300127|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
44302442|NCT02460458|79300127|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
44302443|NCT02460458|79300127|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
44302444|NCT02460458|79300127|FG000|First Prospective Phase|Lost to Follow-up|16|||
44417617|NCT00804986|79425548|FG005|Overall Study|Withdrawal by Subject|3|||
44417618|NCT00804986|79425543|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
44417619|NCT00804986|79425544|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
44302445|NCT02460458|79300127|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
44302446|NCT02457559|79300142|FG000|Overall Study|Progressive Disease|1|||
44302447|NCT02457559|79300143|FG001|Overall Study|Progressive Disease|2|||
44302448|NCT02457559|79300144|FG002|Overall Study|Progressive Disease|3|||
44302449|NCT02457559|79300145|FG003|Overall Study|Progressive Disease|0|||
44302450|NCT02457559|79300146|FG004|Overall Study|Progressive Disease|0|||
44302451|NCT02457559|79300147|FG005|Overall Study|Progressive Disease|2|||
44302452|NCT02457559|79300148|FG006|Overall Study|Progressive Disease|1|||
44302453|NCT02457559|79300149|FG007|Overall Study|Progressive Disease|0|||
44302454|NCT02457559|79300150|FG008|Overall Study|Progressive Disease|1|||
44302455|NCT02457559|79300151|FG009|Overall Study|Progressive Disease|1|||
44302456|NCT02457559|79300152|FG010|Overall Study|Progressive Disease|1|||
44302457|NCT02457559|79300142|FG000|Overall Study|Investigator's Discretion|0|||
44302458|NCT02457559|79300143|FG001|Overall Study|Investigator's Discretion|0|||
44302459|NCT02457559|79300144|FG002|Overall Study|Investigator's Discretion|2|||
44302460|NCT02457559|79300145|FG003|Overall Study|Investigator's Discretion|0|||
44302461|NCT02457559|79300146|FG004|Overall Study|Investigator's Discretion|1|||
44302462|NCT02457559|79300147|FG005|Overall Study|Investigator's Discretion|0|||
44302463|NCT02457559|79300148|FG006|Overall Study|Investigator's Discretion|1|||
44302464|NCT02457559|79300149|FG007|Overall Study|Investigator's Discretion|0|||
44302465|NCT02457559|79300150|FG008|Overall Study|Investigator's Discretion|1|||
44302466|NCT02457559|79300151|FG009|Overall Study|Investigator's Discretion|0|||
44302467|NCT02457559|79300152|FG010|Overall Study|Investigator's Discretion|1|||
44302468|NCT02457559|79300142|FG000|Overall Study|Adverse Event|0|||
44302469|NCT02457559|79300143|FG001|Overall Study|Adverse Event|1|||
44302470|NCT02457559|79300144|FG002|Overall Study|Adverse Event|2|||
44302471|NCT02457559|79300145|FG003|Overall Study|Adverse Event|0|||
44302472|NCT02457559|79300146|FG004|Overall Study|Adverse Event|0|||
44302473|NCT02457559|79300147|FG005|Overall Study|Adverse Event|0|||
44302474|NCT02457559|79300148|FG006|Overall Study|Adverse Event|0|||
44302475|NCT02457559|79300149|FG007|Overall Study|Adverse Event|0|||
44302476|NCT02457559|79300150|FG008|Overall Study|Adverse Event|0|||
44302477|NCT02457559|79300151|FG009|Overall Study|Adverse Event|0|||
44302478|NCT02457559|79300152|FG010|Overall Study|Adverse Event|0|||
44302479|NCT02457559|79300142|FG000|Overall Study|Reason not Specified|1|||
44302480|NCT02457559|79300143|FG001|Overall Study|Reason not Specified|0|||
44302481|NCT02457559|79300144|FG002|Overall Study|Reason not Specified|0|||
44302482|NCT02457559|79300145|FG003|Overall Study|Reason not Specified|0|||
44256810|NCT05209360|79109003|FG003|Overall Study|Withdrawal by Subject|0|||
44256811|NCT05209360|79109004|FG004|Overall Study|Withdrawal by Subject|0|||
44256812|NCT05209360|79109005|FG005|Overall Study|Withdrawal by Subject|0|||
44256813|NCT04644237|79109066|FG000|Overall Study|Death|3|||
44256814|NCT04644237|79109067|FG001|Overall Study|Death|2|||
44256815|NCT04644237|79109066|FG000|Overall Study|Adverse Event|15|||
44256816|NCT04644237|79109067|FG001|Overall Study|Adverse Event|12|||
44256817|NCT04644237|79109066|FG000|Overall Study|Progressive Disease|47|||
44256818|NCT04644237|79109067|FG001|Overall Study|Progressive Disease|19|||
44302483|NCT02457559|79300146|FG004|Overall Study|Reason not Specified|0|||
44302484|NCT02457559|79300147|FG005|Overall Study|Reason not Specified|0|||
44302485|NCT02457559|79300148|FG006|Overall Study|Reason not Specified|0|||
44302486|NCT02457559|79300149|FG007|Overall Study|Reason not Specified|0|||
44302487|NCT02457559|79300150|FG008|Overall Study|Reason not Specified|0|||
44302488|NCT02457559|79300151|FG009|Overall Study|Reason not Specified|2|||
44302489|NCT02457559|79300152|FG010|Overall Study|Reason not Specified|0|||
44417620|NCT00804986|79425545|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
44302490|NCT02457559|79300142|FG000|Overall Study|Death|0|||
44302491|NCT02457559|79300143|FG001|Overall Study|Death|0|||
44302492|NCT02457559|79300144|FG002|Overall Study|Death|0|||
44302493|NCT02457559|79300145|FG003|Overall Study|Death|0|||
44302494|NCT02457559|79300146|FG004|Overall Study|Death|0|||
44417621|NCT00804986|79425546|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
44417622|NCT00804986|79425547|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
44256819|NCT04644237|79109066|FG000|Overall Study|Clinical Progression|4|||
44302495|NCT02457559|79300147|FG005|Overall Study|Death|0|||
44302496|NCT02457559|79300148|FG006|Overall Study|Death|0|||
44302497|NCT02457559|79300149|FG007|Overall Study|Death|0|||
44302498|NCT02457559|79300150|FG008|Overall Study|Death|1|||
44302499|NCT02457559|79300151|FG009|Overall Study|Death|1|||
44302500|NCT02457559|79300152|FG010|Overall Study|Death|0|||
44302501|NCT02381652|79300202|FG000|Overall Study|Withdrawal by Subject|0|||
44302502|NCT02381652|79300203|FG001|Overall Study|Withdrawal by Subject|0|||
44302503|NCT02381652|79300204|FG002|Overall Study|Withdrawal by Subject|1|||
44302504|NCT02367794|79300213|FG000|Overall Study|Death|252|||
44302505|NCT02367794|79300214|FG001|Overall Study|Death|245|||
44302506|NCT02367794|79300215|FG002|Overall Study|Death|243|||
44302507|NCT02367794|79300213|FG000|Overall Study|Lost to Follow-up|1|||
44302508|NCT02367794|79300214|FG001|Overall Study|Lost to Follow-up|2|||
44302509|NCT02367794|79300215|FG002|Overall Study|Lost to Follow-up|2|||
44302510|NCT02367794|79300213|FG000|Overall Study|Physician Decision|0|||
44302511|NCT02367794|79300214|FG001|Overall Study|Physician Decision|5|||
44302512|NCT02367794|79300215|FG002|Overall Study|Physician Decision|3|||
44302513|NCT02367794|79300213|FG000|Overall Study|Protocol Violation|1|||
44302514|NCT02367794|79300214|FG001|Overall Study|Protocol Violation|0|||
44302515|NCT02367794|79300215|FG002|Overall Study|Protocol Violation|1|||
44302516|NCT02367794|79300213|FG000|Overall Study|Withdrawal by Subject|25|||
44302517|NCT02367794|79300214|FG001|Overall Study|Withdrawal by Subject|12|||
44302518|NCT02367794|79300215|FG002|Overall Study|Withdrawal by Subject|20|||
44302519|NCT02367794|79300213|FG000|Overall Study|Brain metastasis|1|||
44302520|NCT02367794|79300214|FG001|Overall Study|Brain metastasis|0|||
44302521|NCT02367794|79300215|FG002|Overall Study|Brain metastasis|0|||
44302522|NCT02367794|79300213|FG000|Overall Study|Randomized in error|0|||
44302523|NCT02367794|79300214|FG001|Overall Study|Randomized in error|0|||
44302524|NCT02367794|79300215|FG002|Overall Study|Randomized in error|1|||
44302525|NCT02367794|79300213|FG000|Overall Study|Patient unable to receive carboplatin|0|||
44302526|NCT02367794|79300214|FG001|Overall Study|Patient unable to receive carboplatin|0|||
44302527|NCT02367794|79300215|FG002|Overall Study|Patient unable to receive carboplatin|1|||
44302528|NCT02367794|79300213|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
44302529|NCT02367794|79300214|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
44302530|NCT02367794|79300215|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
44302531|NCT02367794|79300213|FG000|Overall Study|Adverse Event|0|||
44302532|NCT02367794|79300214|FG001|Overall Study|Adverse Event|0|||
44302533|NCT02367794|79300215|FG002|Overall Study|Adverse Event|2|||
44302534|NCT02367794|79300213|FG000|Overall Study|Study Terminated By Sponsor|0|||
44155038|NCT03766581|78946501|FG002|Randomization|Participant withdrew consent|1|||
44302535|NCT02367794|79300214|FG001|Overall Study|Study Terminated By Sponsor|1|||
44302536|NCT02367794|79300215|FG002|Overall Study|Study Terminated By Sponsor|1|||
44302537|NCT02367794|79300213|FG000|Overall Study|Moved to Roll-Over Study|0|||
44302538|NCT02367794|79300214|FG001|Overall Study|Moved to Roll-Over Study|15|||
44302539|NCT02367794|79300215|FG002|Overall Study|Moved to Roll-Over Study|13|||
44302540|NCT02367794|79300213|FG000|Overall Study|Sponsor Request|60|||
44302541|NCT02367794|79300214|FG001|Overall Study|Sponsor Request|57|||
44302542|NCT02367794|79300215|FG002|Overall Study|Sponsor Request|45|||
44302543|NCT02367794|79300213|FG000|Overall Study|Moved into PTAP Study|0|||
44302544|NCT02367794|79300214|FG001|Overall Study|Moved into PTAP Study|2|||
44302545|NCT02367794|79300215|FG002|Overall Study|Moved into PTAP Study|3|||
44302546|NCT02367794|79300213|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
44302547|NCT02367794|79300214|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
44302548|NCT02367794|79300215|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
44302549|NCT02367794|79300213|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
44302550|NCT02367794|79300214|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
44302551|NCT02367794|79300215|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
44302552|NCT02367794|79300213|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
44302553|NCT02367794|79300214|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
44302554|NCT02367794|79300215|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
44302555|NCT02367794|79300213|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
44302556|NCT02367794|79300214|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
44302557|NCT02367794|79300215|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
44302558|NCT02353832|79300248|FG000|Overall Study|Ineligible after enrollment|1|||
44302559|NCT02353832|79300248|FG000|Overall Study|Lost to Follow-up|1|||
44302560|NCT02353728|79300252|FG000|Overall Study|Subject non-compliance|1|||
44302561|NCT02345070|79300259|FG000|Overall Study|Adverse Event|12|||
44302562|NCT02345070|79300260|FG001|Overall Study|Adverse Event|8|||
44302563|NCT02345070|79300261|FG002|Overall Study|Adverse Event|16|||
44302564|NCT02345070|79300259|FG000|Overall Study|Poor compliance to protocol|2|||
44302565|NCT02345070|79300260|FG001|Overall Study|Poor compliance to protocol|0|||
44302566|NCT02345070|79300261|FG002|Overall Study|Poor compliance to protocol|0|||
44302567|NCT02345070|79300259|FG000|Overall Study|Other than specified above|6|||
44302568|NCT02345070|79300260|FG001|Overall Study|Other than specified above|3|||
44302569|NCT02345070|79300261|FG002|Overall Study|Other than specified above|7|||
44302570|NCT02325466|79300269|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
44302571|NCT02325466|79300270|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
44302572|NCT02325466|79300271|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
44302573|NCT02325466|79300269|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
44302574|NCT02325466|79300270|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
44302575|NCT02325466|79300271|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
44302576|NCT02325466|79300269|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
44302577|NCT02325466|79300270|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
44302578|NCT02325466|79300271|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
44302579|NCT02325466|79300269|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
44302580|NCT02325466|79300270|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
44302581|NCT02325466|79300271|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
44302582|NCT02325466|79300269|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
44302583|NCT02325466|79300270|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
44302584|NCT02325466|79300271|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
44302585|NCT02325466|79300269|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
44302586|NCT02325466|79300270|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
44302587|NCT02325466|79300271|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
44302588|NCT02325466|79300269|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
44302589|NCT02325466|79300270|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
44302590|NCT02325466|79300271|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
44302591|NCT02325466|79300269|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
44302592|NCT02325466|79300270|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
44302593|NCT02325466|79300271|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
44302594|NCT02325466|79300269|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
44302595|NCT02325466|79300270|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
44302596|NCT02325466|79300271|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
44302597|NCT02322710|79300282|FG000|Overall Study|No efficacy assessment post-baseline|0|||
44302598|NCT02322710|79300283|FG001|Overall Study|No efficacy assessment post-baseline|1|||
44302599|NCT02322710|79300282|FG000|Overall Study|Protocol Violation|20|||
44302600|NCT02322710|79300283|FG001|Overall Study|Protocol Violation|25|||
44302601|NCT02234310|79300326|FG000|Overall Study|Physician Decision|1|||
44302602|NCT02234310|79300326|FG000|Overall Study|Adverse Event|1|||
44302603|NCT02234310|79300326|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
44302604|NCT02234310|79300326|FG000|Overall Study|Withdrawal by Subject|2|||
44302605|NCT02106195|79300359|FG000|Overall Study|Adverse Event|2|||
44302606|NCT02106195|79300359|FG000|Overall Study|Protocol Violation|1|||
44302607|NCT02104180|79300371|FG000|Overall Study|Protocol Violation|1|||
44302608|NCT02104180|79300372|FG001|Overall Study|Protocol Violation|0|||
44302609|NCT01943825|79300395|FG000|Overall Study|Lost to Follow-up|9|||
44302610|NCT01943825|79300396|FG001|Overall Study|Lost to Follow-up|3|||
44302611|NCT01943825|79300397|FG002|Overall Study|Lost to Follow-up|12|||
44302612|NCT01943825|79300398|FG003|Overall Study|Lost to Follow-up|8|||
44302613|NCT01943825|79300395|FG000|Overall Study|Withdrawal by Subject|1|||
44302614|NCT01943825|79300396|FG001|Overall Study|Withdrawal by Subject|0|||
44302615|NCT01943825|79300397|FG002|Overall Study|Withdrawal by Subject|3|||
44302616|NCT01943825|79300398|FG003|Overall Study|Withdrawal by Subject|2|||
44302617|NCT01943825|79300395|FG000|Overall Study|Other than specified above|0|||
44302618|NCT01943825|79300396|FG001|Overall Study|Other than specified above|1|||
44302619|NCT01943825|79300397|FG002|Overall Study|Other than specified above|0|||
44302620|NCT01943825|79300398|FG003|Overall Study|Other than specified above|1|||
44302621|NCT01722331|79300430|FG000|Part 1|Adverse Event|5|||
44302622|NCT01722331|79300431|FG001|Part 1|Adverse Event|0|||
44302623|NCT01722331|79300432|FG002|Part 1|Adverse Event|0|||
44302624|NCT01722331|79300433|FG003|Part 1|Adverse Event|0|||
44302625|NCT01722331|79300434|FG004|Part 1|Adverse Event|0|||
44302626|NCT01722331|79300435|FG005|Part 1|Adverse Event|0|||
44302627|NCT01722331|79300436|FG006|Part 1|Adverse Event|0|||
44302628|NCT01722331|79300430|FG000|Part 1|Lack of Efficacy|0|||
44302629|NCT01722331|79300431|FG001|Part 1|Lack of Efficacy|0|||
44302630|NCT01722331|79300432|FG002|Part 1|Lack of Efficacy|1|||
44302631|NCT01722331|79300433|FG003|Part 1|Lack of Efficacy|0|||
44302632|NCT01722331|79300434|FG004|Part 1|Lack of Efficacy|2|||
44302633|NCT01722331|79300435|FG005|Part 1|Lack of Efficacy|0|||
44302634|NCT01722331|79300436|FG006|Part 1|Lack of Efficacy|0|||
44302635|NCT01722331|79300430|FG000|Part 1|Lost to Follow-up|1|||
44302636|NCT01722331|79300431|FG001|Part 1|Lost to Follow-up|0|||
44302637|NCT01722331|79300432|FG002|Part 1|Lost to Follow-up|2|||
44302638|NCT01722331|79300433|FG003|Part 1|Lost to Follow-up|0|||
44302639|NCT01722331|79300434|FG004|Part 1|Lost to Follow-up|1|||
44302640|NCT01722331|79300435|FG005|Part 1|Lost to Follow-up|0|||
44302641|NCT01722331|79300436|FG006|Part 1|Lost to Follow-up|0|||
44302642|NCT01722331|79300430|FG000|Part 1|Physician Decision|0|||
44302643|NCT01722331|79300431|FG001|Part 1|Physician Decision|0|||
44302644|NCT01722331|79300432|FG002|Part 1|Physician Decision|3|||
44302645|NCT01722331|79300433|FG003|Part 1|Physician Decision|0|||
44302646|NCT01722331|79300434|FG004|Part 1|Physician Decision|1|||
44302647|NCT01722331|79300435|FG005|Part 1|Physician Decision|0|||
44302648|NCT01722331|79300436|FG006|Part 1|Physician Decision|0|||
44302649|NCT01722331|79300430|FG000|Part 1|Pregnancy|1|||
44302650|NCT01722331|79300431|FG001|Part 1|Pregnancy|0|||
44302651|NCT01722331|79300432|FG002|Part 1|Pregnancy|0|||
44302652|NCT01722331|79300433|FG003|Part 1|Pregnancy|0|||
44302653|NCT01722331|79300434|FG004|Part 1|Pregnancy|0|||
44302654|NCT01722331|79300435|FG005|Part 1|Pregnancy|0|||
44302655|NCT01722331|79300436|FG006|Part 1|Pregnancy|0|||
44302656|NCT01722331|79300430|FG000|Part 1|Progressive Disease|0|||
44302657|NCT01722331|79300431|FG001|Part 1|Progressive Disease|0|||
44302658|NCT01722331|79300432|FG002|Part 1|Progressive Disease|0|||
44302659|NCT01722331|79300433|FG003|Part 1|Progressive Disease|0|||
44302660|NCT01722331|79300434|FG004|Part 1|Progressive Disease|1|||
44302661|NCT01722331|79300435|FG005|Part 1|Progressive Disease|0|||
44302662|NCT01722331|79300436|FG006|Part 1|Progressive Disease|0|||
44302663|NCT01722331|79300430|FG000|Part 1|Protocol Violation|1|||
44302664|NCT01722331|79300431|FG001|Part 1|Protocol Violation|0|||
44302665|NCT01722331|79300432|FG002|Part 1|Protocol Violation|0|||
44302666|NCT01722331|79300433|FG003|Part 1|Protocol Violation|0|||
44302667|NCT01722331|79300434|FG004|Part 1|Protocol Violation|1|||
44302668|NCT01722331|79300435|FG005|Part 1|Protocol Violation|0|||
44302669|NCT01722331|79300436|FG006|Part 1|Protocol Violation|0|||
44302670|NCT01722331|79300430|FG000|Part 1|Withdrawal by Subject|2|||
44302671|NCT01722331|79300431|FG001|Part 1|Withdrawal by Subject|0|||
44302672|NCT01722331|79300432|FG002|Part 1|Withdrawal by Subject|3|||
44302673|NCT01722331|79300433|FG003|Part 1|Withdrawal by Subject|0|||
44302674|NCT01722331|79300434|FG004|Part 1|Withdrawal by Subject|3|||
44302675|NCT01722331|79300435|FG005|Part 1|Withdrawal by Subject|0|||
44302676|NCT01722331|79300436|FG006|Part 1|Withdrawal by Subject|0|||
44302677|NCT01722331|79300430|FG000|Part 2|Adverse Event|3|||
44302678|NCT01722331|79300431|FG001|Part 2|Adverse Event|0|||
44302679|NCT01722331|79300432|FG002|Part 2|Adverse Event|0|||
44302680|NCT01722331|79300433|FG003|Part 2|Adverse Event|0|||
44302681|NCT01722331|79300434|FG004|Part 2|Adverse Event|0|||
44302682|NCT01722331|79300435|FG005|Part 2|Adverse Event|1|||
44302683|NCT01722331|79300436|FG006|Part 2|Adverse Event|0|||
44302684|NCT01722331|79300430|FG000|Part 2|Lack of Efficacy|3|||
44302685|NCT01722331|79300431|FG001|Part 2|Lack of Efficacy|0|||
44302686|NCT01722331|79300432|FG002|Part 2|Lack of Efficacy|11|||
44302687|NCT01722331|79300433|FG003|Part 2|Lack of Efficacy|0|||
44302688|NCT01722331|79300434|FG004|Part 2|Lack of Efficacy|0|||
44302689|NCT01722331|79300435|FG005|Part 2|Lack of Efficacy|3|||
44302690|NCT01722331|79300436|FG006|Part 2|Lack of Efficacy|3|||
44302691|NCT01722331|79300430|FG000|Part 2|Lost to Follow-up|0|||
44302692|NCT01722331|79300431|FG001|Part 2|Lost to Follow-up|0|||
44302693|NCT01722331|79300432|FG002|Part 2|Lost to Follow-up|3|||
44302694|NCT01722331|79300433|FG003|Part 2|Lost to Follow-up|0|||
44302695|NCT01722331|79300434|FG004|Part 2|Lost to Follow-up|0|||
44302696|NCT01722331|79300435|FG005|Part 2|Lost to Follow-up|1|||
44302697|NCT01722331|79300436|FG006|Part 2|Lost to Follow-up|1|||
44302698|NCT01722331|79300430|FG000|Part 2|Non-Compliance with Study Drug|1|||
44302699|NCT01722331|79300431|FG001|Part 2|Non-Compliance with Study Drug|0|||
44302700|NCT01722331|79300432|FG002|Part 2|Non-Compliance with Study Drug|1|||
44302701|NCT01722331|79300433|FG003|Part 2|Non-Compliance with Study Drug|0|||
44302702|NCT01722331|79300434|FG004|Part 2|Non-Compliance with Study Drug|0|||
44302703|NCT01722331|79300435|FG005|Part 2|Non-Compliance with Study Drug|0|||
44302704|NCT01722331|79300436|FG006|Part 2|Non-Compliance with Study Drug|0|||
44302705|NCT01722331|79300430|FG000|Part 2|Physician Decision|0|||
44417623|NCT00804986|79425548|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
44302706|NCT01722331|79300431|FG001|Part 2|Physician Decision|0|||
44302707|NCT01722331|79300432|FG002|Part 2|Physician Decision|2|||
44302708|NCT01722331|79300433|FG003|Part 2|Physician Decision|0|||
44417624|NCT00804986|79425543|FG000|Overall Study|Sponsor Decision|0|||
44302709|NCT01722331|79300434|FG004|Part 2|Physician Decision|0|||
44302710|NCT01722331|79300435|FG005|Part 2|Physician Decision|0|||
44302711|NCT01722331|79300436|FG006|Part 2|Physician Decision|0|||
44302712|NCT01722331|79300430|FG000|Part 2|Pregnancy|0|||
44302713|NCT01722331|79300431|FG001|Part 2|Pregnancy|0|||
44302714|NCT01722331|79300432|FG002|Part 2|Pregnancy|0|||
44302715|NCT01722331|79300433|FG003|Part 2|Pregnancy|0|||
44302716|NCT01722331|79300434|FG004|Part 2|Pregnancy|0|||
44302717|NCT01722331|79300435|FG005|Part 2|Pregnancy|1|||
44302718|NCT01722331|79300436|FG006|Part 2|Pregnancy|0|||
44302719|NCT01722331|79300430|FG000|Part 2|Progressive Disease|0|||
44417625|NCT00804986|79425544|FG001|Overall Study|Sponsor Decision|1|||
44417626|NCT00804986|79425545|FG002|Overall Study|Sponsor Decision|0|||
44302720|NCT01722331|79300431|FG001|Part 2|Progressive Disease|0|||
44302721|NCT01722331|79300432|FG002|Part 2|Progressive Disease|1|||
44302722|NCT01722331|79300433|FG003|Part 2|Progressive Disease|0|||
44302723|NCT01722331|79300434|FG004|Part 2|Progressive Disease|0|||
44302724|NCT01722331|79300435|FG005|Part 2|Progressive Disease|0|||
44302725|NCT01722331|79300436|FG006|Part 2|Progressive Disease|0|||
44302726|NCT01722331|79300430|FG000|Part 2|Protocol Violation|1|||
44302727|NCT01722331|79300431|FG001|Part 2|Protocol Violation|0|||
44302728|NCT01722331|79300432|FG002|Part 2|Protocol Violation|0|||
44302729|NCT01722331|79300433|FG003|Part 2|Protocol Violation|0|||
44302730|NCT01722331|79300434|FG004|Part 2|Protocol Violation|0|||
44302731|NCT01722331|79300435|FG005|Part 2|Protocol Violation|0|||
44302732|NCT01722331|79300436|FG006|Part 2|Protocol Violation|0|||
44302733|NCT01722331|79300430|FG000|Part 2|Withdrawal by Subject|5|||
44302734|NCT01722331|79300431|FG001|Part 2|Withdrawal by Subject|0|||
44302735|NCT01722331|79300432|FG002|Part 2|Withdrawal by Subject|3|||
44302736|NCT01722331|79300433|FG003|Part 2|Withdrawal by Subject|0|||
44302737|NCT01722331|79300434|FG004|Part 2|Withdrawal by Subject|0|||
44302738|NCT01722331|79300435|FG005|Part 2|Withdrawal by Subject|2|||
44302739|NCT01722331|79300436|FG006|Part 2|Withdrawal by Subject|2|||
44302740|NCT01722331|79300430|FG000|Part 2|Other Protocol Specified Criteria|6|||
44302741|NCT01722331|79300431|FG001|Part 2|Other Protocol Specified Criteria|0|||
44302742|NCT01722331|79300432|FG002|Part 2|Other Protocol Specified Criteria|10|||
44302743|NCT01722331|79300433|FG003|Part 2|Other Protocol Specified Criteria|0|||
44302744|NCT01722331|79300434|FG004|Part 2|Other Protocol Specified Criteria|0|||
44302745|NCT01722331|79300435|FG005|Part 2|Other Protocol Specified Criteria|2|||
44302746|NCT01722331|79300436|FG006|Part 2|Other Protocol Specified Criteria|1|||
44302747|NCT01722331|79300430|FG000|Part 3|Adverse Event|2|||
44302748|NCT01722331|79300431|FG001|Part 3|Adverse Event|2|||
44302749|NCT01722331|79300432|FG002|Part 3|Adverse Event|0|||
44302750|NCT01722331|79300433|FG003|Part 3|Adverse Event|1|||
44302751|NCT01722331|79300434|FG004|Part 3|Adverse Event|0|||
44302752|NCT01722331|79300435|FG005|Part 3|Adverse Event|0|||
44302753|NCT01722331|79300436|FG006|Part 3|Adverse Event|0|||
44302754|NCT01722331|79300430|FG000|Part 3|Death|1|||
44302755|NCT01722331|79300431|FG001|Part 3|Death|0|||
44302756|NCT01722331|79300432|FG002|Part 3|Death|0|||
44302757|NCT01722331|79300433|FG003|Part 3|Death|0|||
44302758|NCT01722331|79300434|FG004|Part 3|Death|0|||
44302759|NCT01722331|79300435|FG005|Part 3|Death|0|||
44302760|NCT01722331|79300436|FG006|Part 3|Death|0|||
44302761|NCT01722331|79300430|FG000|Part 3|Lack of Efficacy|1|||
44302762|NCT01722331|79300431|FG001|Part 3|Lack of Efficacy|0|||
44302763|NCT01722331|79300432|FG002|Part 3|Lack of Efficacy|0|||
44302764|NCT01722331|79300433|FG003|Part 3|Lack of Efficacy|0|||
44302765|NCT01722331|79300434|FG004|Part 3|Lack of Efficacy|0|||
44302766|NCT01722331|79300435|FG005|Part 3|Lack of Efficacy|0|||
44302767|NCT01722331|79300436|FG006|Part 3|Lack of Efficacy|0|||
44302768|NCT01722331|79300430|FG000|Part 3|Lost to Follow-up|3|||
44302769|NCT01722331|79300431|FG001|Part 3|Lost to Follow-up|4|||
44302770|NCT01722331|79300432|FG002|Part 3|Lost to Follow-up|0|||
44302771|NCT01722331|79300433|FG003|Part 3|Lost to Follow-up|0|||
44302772|NCT01722331|79300434|FG004|Part 3|Lost to Follow-up|0|||
44302773|NCT01722331|79300435|FG005|Part 3|Lost to Follow-up|1|||
44302774|NCT01722331|79300436|FG006|Part 3|Lost to Follow-up|0|||
44302775|NCT01722331|79300430|FG000|Part 3|Non-Compliance with Study Drug|0|||
44302776|NCT01722331|79300431|FG001|Part 3|Non-Compliance with Study Drug|1|||
44302777|NCT01722331|79300432|FG002|Part 3|Non-Compliance with Study Drug|0|||
44302778|NCT01722331|79300433|FG003|Part 3|Non-Compliance with Study Drug|0|||
44302779|NCT01722331|79300434|FG004|Part 3|Non-Compliance with Study Drug|0|||
44302780|NCT01722331|79300435|FG005|Part 3|Non-Compliance with Study Drug|0|||
44302781|NCT01722331|79300436|FG006|Part 3|Non-Compliance with Study Drug|0|||
44302782|NCT01722331|79300430|FG000|Part 3|Physician Decision|1|||
44302783|NCT01722331|79300431|FG001|Part 3|Physician Decision|1|||
44302784|NCT01722331|79300432|FG002|Part 3|Physician Decision|0|||
44302785|NCT01722331|79300433|FG003|Part 3|Physician Decision|0|||
44302786|NCT01722331|79300434|FG004|Part 3|Physician Decision|0|||
44302787|NCT01722331|79300435|FG005|Part 3|Physician Decision|0|||
44302788|NCT01722331|79300436|FG006|Part 3|Physician Decision|1|||
44302789|NCT01722331|79300430|FG000|Part 3|Protocol Violation|2|||
44302790|NCT01722331|79300431|FG001|Part 3|Protocol Violation|1|||
44302791|NCT01722331|79300432|FG002|Part 3|Protocol Violation|0|||
44302792|NCT01722331|79300433|FG003|Part 3|Protocol Violation|0|||
44302793|NCT01722331|79300434|FG004|Part 3|Protocol Violation|0|||
44302794|NCT01722331|79300435|FG005|Part 3|Protocol Violation|0|||
44302795|NCT01722331|79300436|FG006|Part 3|Protocol Violation|0|||
44302796|NCT01722331|79300430|FG000|Part 3|Withdrawal by Subject|4|||
44302797|NCT01722331|79300431|FG001|Part 3|Withdrawal by Subject|7|||
44302798|NCT01722331|79300432|FG002|Part 3|Withdrawal by Subject|0|||
44302799|NCT01722331|79300433|FG003|Part 3|Withdrawal by Subject|0|||
44302800|NCT01722331|79300434|FG004|Part 3|Withdrawal by Subject|0|||
44302801|NCT01722331|79300435|FG005|Part 3|Withdrawal by Subject|2|||
44302802|NCT01722331|79300436|FG006|Part 3|Withdrawal by Subject|1|||
44302803|NCT01722331|79300430|FG000|Part 3|Other Protocol Specified Criteria|1|||
44302804|NCT01722331|79300431|FG001|Part 3|Other Protocol Specified Criteria|1|||
44302805|NCT01722331|79300432|FG002|Part 3|Other Protocol Specified Criteria|0|||
44302806|NCT01722331|79300433|FG003|Part 3|Other Protocol Specified Criteria|0|||
44302807|NCT01722331|79300434|FG004|Part 3|Other Protocol Specified Criteria|0|||
44302808|NCT01722331|79300435|FG005|Part 3|Other Protocol Specified Criteria|0|||
44302809|NCT01722331|79300436|FG006|Part 3|Other Protocol Specified Criteria|0|||
44302810|NCT01630590|79300448|FG000|Overall Study|Adverse Event|9|||
44302811|NCT01630590|79300448|FG000|Overall Study|Lack of Efficacy|37|||
44302812|NCT01630590|79300448|FG000|Overall Study|Withdrawal by Subject|4|||
44302813|NCT01630590|79300448|FG000|Overall Study|2nd primary tumor|2|||
44302814|NCT01630590|79300448|FG000|Overall Study|Automobile accident|1|||
44302815|NCT01630590|79300448|FG000|Overall Study|Maximum benefit|4|||
44302816|NCT01619085|79300452|FG000|Overall Study|Adverse Event|231|||
44302817|NCT01619085|79300452|FG000|Overall Study|Protocol Violation|4|||
44302818|NCT01619085|79300452|FG000|Overall Study|Lost to Follow-up|3|||
44302819|NCT01619085|79300452|FG000|Overall Study|Withdrawal by Subject|45|||
44302820|NCT01619085|79300452|FG000|Overall Study|Other than specified|96|||
44302821|NCT01619085|79300452|FG000|Overall Study|Not treated|1|||
44302822|NCT01619085|79300452|FG000|Overall Study|Death|145|||
44302823|NCT01499095|79300465|FG000|Overall Study|Randomized But Not Treated|1|||
44302824|NCT01499095|79300466|FG001|Overall Study|Randomized But Not Treated|1|||
44302825|NCT01499095|79300465|FG000|Overall Study|Adverse Event|12|||
44302826|NCT01499095|79300466|FG001|Overall Study|Adverse Event|7|||
44302827|NCT01499095|79300465|FG000|Overall Study|Lack of Efficacy|2|||
44302828|NCT01499095|79300466|FG001|Overall Study|Lack of Efficacy|1|||
44302829|NCT01499095|79300465|FG000|Overall Study|Protocol Violation|6|||
44302830|NCT01499095|79300466|FG001|Overall Study|Protocol Violation|7|||
44302831|NCT01499095|79300465|FG000|Overall Study|Received Rescue Therapy|32|||
44302832|NCT01499095|79300466|FG001|Overall Study|Received Rescue Therapy|40|||
44302833|NCT01499095|79300465|FG000|Overall Study|Diverse Reasons|22|||
44302834|NCT01499095|79300466|FG001|Overall Study|Diverse Reasons|25|||
44302835|NCT01499095|79300465|FG000|Overall Study|Lost to Follow-up|6|||
44302836|NCT01499095|79300466|FG001|Overall Study|Lost to Follow-up|4|||
44302837|NCT01499095|79300465|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
44302838|NCT01499095|79300466|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
44302839|NCT01499095|79300465|FG000|Overall Study|Hypoglycemia|3|||
44302840|NCT01499095|79300466|FG001|Overall Study|Hypoglycemia|1|||
44302841|NCT01499095|79300465|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
44302842|NCT01499095|79300466|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
44302843|NCT01499095|79300465|FG000|Overall Study|Change in Injection Schedule|2|||
44302844|NCT01499095|79300466|FG001|Overall Study|Change in Injection Schedule|0|||
44302845|NCT01499095|79300465|FG000|Overall Study|Perceived Lack of Efficacy|1|||
44417627|NCT00804986|79425546|FG003|Overall Study|Sponsor Decision|0|||
44417628|NCT00804986|79425547|FG004|Overall Study|Sponsor Decision|0|||
44417629|NCT00804986|79425548|FG005|Overall Study|Sponsor Decision|0|||
44417630|NCT00804986|79425543|FG000|Overall Study|Physician Decision|1|||
44417631|NCT00804986|79425544|FG001|Overall Study|Physician Decision|0|||
44417632|NCT00804986|79425545|FG002|Overall Study|Physician Decision|0|||
44417633|NCT00804986|79425546|FG003|Overall Study|Physician Decision|0|||
44417634|NCT00804986|79425547|FG004|Overall Study|Physician Decision|0|||
44417635|NCT00804986|79425548|FG005|Overall Study|Physician Decision|0|||
44417636|NCT00752232|79425569|FG000|Overall Study|Protocol Violation|0|||
44417637|NCT00752232|79425570|FG001|Overall Study|Protocol Violation|0|||
44417638|NCT00752232|79425571|FG002|Overall Study|Protocol Violation|0|||
44417639|NCT00752232|79425572|FG003|Overall Study|Protocol Violation|0|||
44417640|NCT00752232|79425573|FG004|Overall Study|Protocol Violation|0|||
44417641|NCT00752232|79425574|FG005|Overall Study|Protocol Violation|1|||
44417642|NCT00752232|79425575|FG006|Overall Study|Protocol Violation|0|||
44417643|NCT00752232|79425569|FG000|Overall Study|Caregiver request|2|||
44417644|NCT00752232|79425570|FG001|Overall Study|Caregiver request|0|||
44417645|NCT00752232|79425571|FG002|Overall Study|Caregiver request|0|||
44417646|NCT00752232|79425572|FG003|Overall Study|Caregiver request|0|||
44417647|NCT00752232|79425573|FG004|Overall Study|Caregiver request|1|||
44417648|NCT00752232|79425574|FG005|Overall Study|Caregiver request|0|||
44417649|NCT00752232|79425575|FG006|Overall Study|Caregiver request|0|||
44417650|NCT00752232|79425569|FG000|Overall Study|Investigator request|0|||
44302846|NCT01499095|79300466|FG001|Overall Study|Perceived Lack of Efficacy|1|||
44302847|NCT01499082|79300477|FG000|Overall Study|Randomized but not Treated|0|||
44302848|NCT01499082|79300478|FG001|Overall Study|Randomized but not Treated|1|||
44302849|NCT01499082|79300477|FG000|Overall Study|Adverse Event|12|||
44302850|NCT01499082|79300478|FG001|Overall Study|Adverse Event|16|||
44302851|NCT01499082|79300477|FG000|Overall Study|Lack of Efficacy|1|||
44302852|NCT01499082|79300478|FG001|Overall Study|Lack of Efficacy|1|||
44302853|NCT01499082|79300477|FG000|Overall Study|Protocol Violation|6|||
44302854|NCT01499082|79300478|FG001|Overall Study|Protocol Violation|8|||
44302855|NCT01499082|79300477|FG000|Overall Study|Diverse Reasons|18|||
44302856|NCT01499082|79300478|FG001|Overall Study|Diverse Reasons|14|||
44417651|NCT00752232|79425570|FG001|Overall Study|Investigator request|0|||
44417652|NCT00752232|79425571|FG002|Overall Study|Investigator request|0|||
44417653|NCT00752232|79425572|FG003|Overall Study|Investigator request|0|||
44302857|NCT01499082|79300477|FG000|Overall Study|Site Closure for Noncompliance|5|||
44302858|NCT01499082|79300478|FG001|Overall Study|Site Closure for Noncompliance|2|||
44302859|NCT01499082|79300477|FG000|Overall Study|Hypoglycemia|2|||
44417654|NCT00752232|79425573|FG004|Overall Study|Investigator request|1|||
44417655|NCT00752232|79425574|FG005|Overall Study|Investigator request|0|||
44302860|NCT01499082|79300478|FG001|Overall Study|Hypoglycemia|3|||
44302861|NCT01499082|79300477|FG000|Overall Study|Lost to Follow-up|1|||
44302862|NCT01499082|79300478|FG001|Overall Study|Lost to Follow-up|3|||
44302863|NCT01488890|79300490|FG000|Overall Study|Serious adverse event|2|||
44302864|NCT01488890|79300491|FG001|Overall Study|Serious adverse event|0|||
44302865|NCT01488890|79300492|FG002|Overall Study|Serious adverse event|0|||
44302866|NCT01488890|79300493|FG003|Overall Study|Serious adverse event|0|||
44302867|NCT01488890|79300490|FG000|Overall Study|Protocol Violation|3|||
44302868|NCT01488890|79300491|FG001|Overall Study|Protocol Violation|0|||
44302869|NCT01488890|79300492|FG002|Overall Study|Protocol Violation|4|||
44302870|NCT01488890|79300493|FG003|Overall Study|Protocol Violation|0|||
44302871|NCT01488890|79300490|FG000|Overall Study|Lost to Follow-up|13|||
44302872|NCT01488890|79300491|FG001|Overall Study|Lost to Follow-up|10|||
44302873|NCT01488890|79300492|FG002|Overall Study|Lost to Follow-up|20|||
44302874|NCT01488890|79300493|FG003|Overall Study|Lost to Follow-up|3|||
44302875|NCT01488890|79300490|FG000|Overall Study|Withdrawal by Subject|14|||
44302876|NCT01488890|79300491|FG001|Overall Study|Withdrawal by Subject|10|||
44302877|NCT01488890|79300492|FG002|Overall Study|Withdrawal by Subject|11|||
44302878|NCT01488890|79300493|FG003|Overall Study|Withdrawal by Subject|2|||
44302879|NCT01436396|79300509|FG000|Overall Study|Protocol Violation|7|||
44302880|NCT01436396|79300510|FG001|Overall Study|Protocol Violation|5|||
44302881|NCT01436396|79300509|FG000|Overall Study|Adverse Event|1|||
44302882|NCT01436396|79300510|FG001|Overall Study|Adverse Event|2|||
44302883|NCT01436396|79300509|FG000|Overall Study|Withdrawal by Subject|19|||
44302884|NCT01436396|79300510|FG001|Overall Study|Withdrawal by Subject|29|||
44302885|NCT01436396|79300509|FG000|Overall Study|Serious adverse event|2|||
44302886|NCT01436396|79300510|FG001|Overall Study|Serious adverse event|3|||
44302887|NCT01436396|79300509|FG000|Overall Study|Lost to Follow-up|3|||
44302888|NCT01436396|79300510|FG001|Overall Study|Lost to Follow-up|3|||
44302889|NCT01411241|79300518|FG000|Overall Study|Protocol Violation|0|||
44302890|NCT01411241|79300519|FG001|Overall Study|Protocol Violation|5|||
44302891|NCT01411241|79300518|FG000|Overall Study|Withdrawal by Subject|9|||
44302892|NCT01411241|79300519|FG001|Overall Study|Withdrawal by Subject|10|||
44302893|NCT01411241|79300518|FG000|Overall Study|Serious Adverse Event|0|||
44302894|NCT01411241|79300519|FG001|Overall Study|Serious Adverse Event|3|||
44302895|NCT01411241|79300518|FG000|Overall Study|Lost to Follow-up|2|||
44302896|NCT01411241|79300519|FG001|Overall Study|Lost to Follow-up|4|||
44302897|NCT01374516|79300527|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
44302898|NCT01374516|79300528|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
44302899|NCT01374516|79300527|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
44302900|NCT01374516|79300528|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
44302901|NCT01374516|79300527|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
44302902|NCT01374516|79300528|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
44302903|NCT01374516|79300527|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
44302904|NCT01374516|79300528|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
44302905|NCT01374516|79300527|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
44302906|NCT01374516|79300528|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
44302907|NCT01374516|79300527|FG000|Surveillance Expansion Period|Protocol Violation|386|||
44302908|NCT01374516|79300528|FG001|Surveillance Expansion Period|Protocol Violation|217|||
44302909|NCT01374516|79300527|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
44302910|NCT01374516|79300528|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
44302911|NCT01374516|79300527|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
44302912|NCT01374516|79300528|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
44302913|NCT01374516|79300527|FG000|Surveillance Expansion Period|Serious adverse event|20|||
44302914|NCT01374516|79300528|FG001|Surveillance Expansion Period|Serious adverse event|5|||
44302915|NCT01373281|79300543|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
44302916|NCT01373281|79300544|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
44302917|NCT01373281|79300543|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
44302918|NCT01373281|79300544|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
44302919|NCT01373281|79300543|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
44302920|NCT01373281|79300544|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
44302921|NCT01373281|79300543|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
44302922|NCT01373281|79300544|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
44302923|NCT01373281|79300543|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
44534282|NCT00098475|79544843|FG000|Step 1|Cannot comply due to other tx|0|||
44534283|NCT00098475|79544844|FG001|Step 1|Cannot comply due to other tx|1|||
44302924|NCT01373281|79300544|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
44302925|NCT01373281|79300543|FG000|Surveillance Expansion Period|Protocol Violation|9|||
44302926|NCT01373281|79300544|FG001|Surveillance Expansion Period|Protocol Violation|1|||
44302927|NCT01373281|79300543|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
44302928|NCT01373281|79300544|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
44534284|NCT00098475|79544845|FG002|Step 1|Cannot comply due to other tx|0|||
44534285|NCT00098475|79544846|FG003|Step 1|Cannot comply due to other tx|0|||
44302929|NCT01373281|79300543|FG000|Surveillance Expansion Period|Serious adverse event|3|||
44302930|NCT01373281|79300544|FG001|Surveillance Expansion Period|Serious adverse event|4|||
44302931|NCT01254422|79300559|FG000|Overall Study|Protocol Violation|1|||
44302932|NCT01254422|79300560|FG001|Overall Study|Protocol Violation|0|||
44302933|NCT01254422|79300559|FG000|Overall Study|Adverse Event|1|||
44302934|NCT01254422|79300560|FG001|Overall Study|Adverse Event|0|||
44302935|NCT01254422|79300559|FG000|Overall Study|Serious adverse event|0|||
44302936|NCT01254422|79300560|FG001|Overall Study|Serious adverse event|1|||
44302937|NCT01254422|79300559|FG000|Overall Study|Lost to Follow-up|1|||
44302938|NCT01254422|79300560|FG001|Overall Study|Lost to Follow-up|0|||
44302939|NCT01187433|79300568|FG000|Overall Study|Protocol Violation|6|||
44302940|NCT01187433|79300569|FG001|Overall Study|Protocol Violation|2|||
44302941|NCT01187433|79300568|FG000|Overall Study|Withdrawal by Subject|5|||
44302942|NCT01187433|79300569|FG001|Overall Study|Withdrawal by Subject|2|||
44302943|NCT01150045|79300579|FG000|Overall Study|Protocol Violation|0|||
44302944|NCT01150045|79300580|FG001|Overall Study|Protocol Violation|1|||
44302945|NCT01150045|79300581|FG002|Overall Study|Protocol Violation|0|||
44302946|NCT01150045|79300582|FG003|Overall Study|Protocol Violation|1|||
44302947|NCT01098032|79300592|FG000|Overall Study|Withdrawal by Subject|1|||
44302948|NCT01098032|79300593|FG001|Overall Study|Withdrawal by Subject|1|||
44302949|NCT01034306|79300601|FG000|Overall Study|Adverse Event|1|||
44302950|NCT01034306|79300602|FG001|Overall Study|Adverse Event|0|||
44302951|NCT01034306|79300601|FG000|Overall Study|Lost to Follow-up|0|||
44302952|NCT01034306|79300602|FG001|Overall Study|Lost to Follow-up|1|||
44302953|NCT01034306|79300601|FG000|Overall Study|Withdrawal by Subject|2|||
44302954|NCT01034306|79300602|FG001|Overall Study|Withdrawal by Subject|2|||
44302955|NCT01034306|79300601|FG000|Overall Study|hospitalized and decided to stop|1|||
44302956|NCT01034306|79300602|FG001|Overall Study|hospitalized and decided to stop|0|||
44302957|NCT01034306|79300601|FG000|Overall Study|Noncomplience|1|||
44302958|NCT01034306|79300602|FG001|Overall Study|Noncomplience|0|||
44302959|NCT00993447|79300610|FG000|Overall Study|Withdrawal by Subject|23|||
44302960|NCT00993447|79300611|FG001|Overall Study|Withdrawal by Subject|8|||
44302961|NCT00993447|79300610|FG000|Overall Study|Protocol Violation|12|||
44302962|NCT00993447|79300611|FG001|Overall Study|Protocol Violation|8|||
44302963|NCT00993447|79300610|FG000|Overall Study|Lost to Follow-up|1|||
44302964|NCT00993447|79300611|FG001|Overall Study|Lost to Follow-up|3|||
44302965|NCT00993447|79300610|FG000|Overall Study|Adverse Event|1|||
44302966|NCT00993447|79300611|FG001|Overall Study|Adverse Event|0|||
44302967|NCT00945009|79300620|FG000|Overall Study|Lack of Efficacy|10|||
44302968|NCT00945009|79300621|FG001|Overall Study|Lack of Efficacy|0|||
44302969|NCT00945009|79300622|FG002|Overall Study|Lack of Efficacy|0|||
44302970|NCT00945009|79300620|FG000|Overall Study|Physician Decision|21|||
44302971|NCT00945009|79300621|FG001|Overall Study|Physician Decision|4|||
44302972|NCT00945009|79300622|FG002|Overall Study|Physician Decision|3|||
44302973|NCT00945009|79300620|FG000|Overall Study|Protocol Violation|6|||
44302974|NCT00945009|79300621|FG001|Overall Study|Protocol Violation|1|||
44302975|NCT00945009|79300622|FG002|Overall Study|Protocol Violation|0|||
44302976|NCT00945009|79300620|FG000|Overall Study|Withdrawal by Subject|1|||
44302977|NCT00945009|79300621|FG001|Overall Study|Withdrawal by Subject|0|||
44302978|NCT00945009|79300622|FG002|Overall Study|Withdrawal by Subject|0|||
44302979|NCT00945009|79300620|FG000|Overall Study|Ineligible|6|||
44302980|NCT00945009|79300621|FG001|Overall Study|Ineligible|1|||
44302981|NCT00945009|79300622|FG002|Overall Study|Ineligible|0|||
44302982|NCT00945009|79300620|FG000|Overall Study|Inevaluable|0|||
44302983|NCT00945009|79300621|FG001|Overall Study|Inevaluable|1|||
44302984|NCT00945009|79300622|FG002|Overall Study|Inevaluable|0|||
44302985|NCT00945009|79300620|FG000|Overall Study|Refusal of further protocol|1|||
44302986|NCT00945009|79300621|FG001|Overall Study|Refusal of further protocol|0|||
44302987|NCT00945009|79300622|FG002|Overall Study|Refusal of further protocol|0|||
44302988|NCT00942877|79300632|FG000|Overall Study|Refused further treatment|1|||
44302989|NCT00942877|79300633|FG001|Overall Study|Refused further treatment|1|||
44302990|NCT00942877|79300632|FG000|Overall Study|Patient was not treated|1|||
44302991|NCT00942877|79300633|FG001|Overall Study|Patient was not treated|0|||
44302992|NCT00942877|79300632|FG000|Overall Study|Adverse Event|1|||
44302993|NCT00942877|79300633|FG001|Overall Study|Adverse Event|0|||
44302994|NCT00942877|79300632|FG000|Overall Study|Progressive disease|42|||
44302995|NCT00942877|79300633|FG001|Overall Study|Progressive disease|3|||
44302996|NCT00880893|79300648|FG000|Overall Study|Protocol Violation|13|||
44302997|NCT00880893|79300649|FG001|Overall Study|Protocol Violation|1|||
44302998|NCT00880893|79300648|FG000|Overall Study|Withdrawal by Subject|15|||
44302999|NCT00880893|79300649|FG001|Overall Study|Withdrawal by Subject|11|||
44303000|NCT00880893|79300648|FG000|Overall Study|Lost to Follow-up|76|||
44303001|NCT00880893|79300649|FG001|Overall Study|Lost to Follow-up|33|||
44303002|NCT00880893|79300648|FG000|Overall Study|Serious adverse event|3|||
44303003|NCT00880893|79300649|FG001|Overall Study|Serious adverse event|0|||
44303004|NCT00587301|79300655|FG000|Overall Study|Screen Failure|9|||
44303005|NCT00587301|79300655|FG000|Overall Study|Lost to Follow-up|22|||
44303006|NCT00587301|79300655|FG000|Overall Study|Withdrawal by Subject|7|||
44303007|NCT00587301|79300655|FG000|Overall Study|Protocol Violation|7|||
44303008|NCT00579527|79300659|FG000|Overall Study|Death|4|||
44303009|NCT00576836|79300664|FG000|Overall Study|Death|0|||
44303010|NCT00576836|79300665|FG001|Overall Study|Death|1|||
44303011|NCT00576836|79300664|FG000|Overall Study|Physician Decision|0|||
44303012|NCT00576836|79300665|FG001|Overall Study|Physician Decision|1|||
44303013|NCT00576407|79300669|FG000|Overall Study|Death|7|||
44303014|NCT00576407|79300669|FG000|Overall Study|Physician Decision|1|||
44303015|NCT00531232|79300677|FG000|Overall Study|Investigator decision|0|||
44303016|NCT00531232|79300678|FG001|Overall Study|Investigator decision|0|||
44303017|NCT00531232|79300679|FG002|Overall Study|Investigator decision|4|||
44303018|NCT00531232|79300677|FG000|Overall Study|Participants refused further treatment|0|||
44303019|NCT00531232|79300678|FG001|Overall Study|Participants refused further treatment|1|||
44303020|NCT00531232|79300679|FG002|Overall Study|Participants refused further treatment|2|||
44303021|NCT00531232|79300677|FG000|Overall Study|Adverse events (AEs)|1|||
44303022|NCT00531232|79300678|FG001|Overall Study|Adverse events (AEs)|2|||
44303023|NCT00531232|79300679|FG002|Overall Study|Adverse events (AEs)|2|||
44303024|NCT00531232|79300677|FG000|Overall Study|Treatment failure|1|||
44303025|NCT00531232|79300678|FG001|Overall Study|Treatment failure|3|||
44303026|NCT00531232|79300679|FG002|Overall Study|Treatment failure|7|||
44303027|NCT00531232|79300677|FG000|Overall Study|Disease recurrence|0|||
44303028|NCT00531232|79300678|FG001|Overall Study|Disease recurrence|0|||
44303029|NCT00531232|79300679|FG002|Overall Study|Disease recurrence|1|||
44303030|NCT00531232|79300677|FG000|Overall Study|Deceased|2|||
44303031|NCT00531232|79300678|FG001|Overall Study|Deceased|2|||
44303032|NCT00531232|79300679|FG002|Overall Study|Deceased|2|||
44303033|NCT00531232|79300677|FG000|Overall Study|Withdrawal by Subject|0|||
44303034|NCT00531232|79300678|FG001|Overall Study|Withdrawal by Subject|1|||
44303035|NCT00531232|79300679|FG002|Overall Study|Withdrawal by Subject|2|||
44303036|NCT00531232|79300677|FG000|Overall Study|Other|0|||
44303037|NCT00531232|79300678|FG001|Overall Study|Other|0|||
44303038|NCT00531232|79300679|FG002|Overall Study|Other|5|||
44303039|NCT01701583|79300692|FG000|Overall Study|Withdrawal by Subject|2|||
44303040|NCT01701583|79300693|FG001|Overall Study|Withdrawal by Subject|0|||
44303041|NCT01714817|79300702|FG000|Year 1 Period|Lack of Efficacy|11|||
44303042|NCT01714817|79300703|FG001|Year 1 Period|Lack of Efficacy|9|||
44303043|NCT01714817|79300702|FG000|Year 1 Period|Adverse Event|20|||
44303044|NCT01714817|79300703|FG001|Year 1 Period|Adverse Event|17|||
44303045|NCT01714817|79300702|FG000|Year 1 Period|Withdrawal by Subject|6|||
44303046|NCT01714817|79300703|FG001|Year 1 Period|Withdrawal by Subject|7|||
44303047|NCT01714817|79300702|FG000|Year 1 Period|Death|1|||
44303048|NCT01714817|79300703|FG001|Year 1 Period|Death|1|||
44303049|NCT01714817|79300702|FG000|Year 1 Period|Lost to Follow-up|0|||
44303050|NCT01714817|79300703|FG001|Year 1 Period|Lost to Follow-up|2|||
44303051|NCT01714817|79300702|FG000|Year 1 Period|Poor / non-compliance|0|||
44303052|NCT01714817|79300703|FG001|Year 1 Period|Poor / non-compliance|1|||
44303053|NCT01714817|79300702|FG000|Year 1 Period|Pregnancy|2|||
44303054|NCT01714817|79300703|FG001|Year 1 Period|Pregnancy|0|||
44303055|NCT01714817|79300702|FG000|Year 1 Period|Participant no longer meets criteria|6|||
44303056|NCT01714817|79300703|FG001|Year 1 Period|Participant no longer meets criteria|2|||
44303057|NCT01714817|79300702|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
44303058|NCT01714817|79300703|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
44303059|NCT01714817|79300702|FG000|Year 1 Period|Change in Concomitant Medication|0|||
44303060|NCT01714817|79300703|FG001|Year 1 Period|Change in Concomitant Medication|1|||
44303061|NCT01714817|79300702|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
44303062|NCT01714817|79300703|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
44303063|NCT01714817|79300702|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
44303064|NCT01714817|79300703|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
44303065|NCT01714817|79300702|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
44303066|NCT01714817|79300703|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
44303067|NCT01714817|79300702|FG000|Year 2 Period|Lack of Efficacy|4|||
44303068|NCT01714817|79300703|FG001|Year 2 Period|Lack of Efficacy|12|||
44303069|NCT01714817|79300702|FG000|Year 2 Period|Adverse Event|7|||
44303070|NCT01714817|79300703|FG001|Year 2 Period|Adverse Event|6|||
44534286|NCT00098475|79544843|FG000|Step 1|Both patient and physician's decision|2|||
44303071|NCT01714817|79300702|FG000|Year 2 Period|Participant request to stop treatment|4|||
44534287|NCT00098475|79544844|FG001|Step 1|Both patient and physician's decision|1|||
44534288|NCT00098475|79544845|FG002|Step 1|Both patient and physician's decision|0|||
44303072|NCT01714817|79300703|FG001|Year 2 Period|Participant request to stop treatment|4|||
44303073|NCT01714817|79300702|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
44303074|NCT01714817|79300703|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
44303075|NCT01714817|79300702|FG000|Year 2 Period|Participant withdrew consent|1|||
44303076|NCT01714817|79300703|FG001|Year 2 Period|Participant withdrew consent|5|||
44534289|NCT00098475|79544846|FG003|Step 1|Both patient and physician's decision|0|||
44303077|NCT01714817|79300702|FG000|Year 2 Period|Participant no longer meets criteria|1|||
44303078|NCT01714817|79300703|FG001|Year 2 Period|Participant no longer meets criteria|4|||
44534290|NCT00098475|79544843|FG000|Step 1|Incorrect disease assessment|2|||
44303079|NCT01714817|79300702|FG000|Year 2 Period|Lost to Follow-up|2|||
44303080|NCT01714817|79300703|FG001|Year 2 Period|Lost to Follow-up|0|||
44303081|NCT01714817|79300702|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
44303082|NCT01714817|79300703|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
44303083|NCT01714817|79300702|FG000|Year 2 Period|Pregnancy|1|||
44303084|NCT01714817|79300703|FG001|Year 2 Period|Pregnancy|1|||
44303085|NCT01714817|79300702|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
44303086|NCT01714817|79300703|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
44303087|NCT01714817|79300702|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
44303088|NCT01714817|79300703|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
44303089|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
44303090|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
44303091|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
44303092|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
44303093|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
44303094|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
44303095|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
44303096|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
44303097|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
44303098|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
44303099|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
44303100|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
44303101|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
44303102|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
44303103|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
44303104|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
44303105|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
44303106|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
44303107|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
44303108|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
44303109|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
44303110|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
44303111|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
44303112|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
44303113|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
44303114|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
44303115|NCT01714817|79300702|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
44303116|NCT01714817|79300703|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
44303117|NCT04477187|79300740|FG000|Overall Study|Lost to Follow-up|2|||
44303118|NCT04142242|79300760|FG000|Stage I|Non-compliance with the protocol|1|||
44303119|NCT04142242|79300761|FG001|Stage I|Non-compliance with the protocol|0|||
44303120|NCT04142242|79300762|FG002|Stage I|Non-compliance with the protocol|0|||
44303121|NCT04142242|79300763|FG003|Stage I|Non-compliance with the protocol|0|||
44303122|NCT04142242|79300764|FG004|Stage I|Non-compliance with the protocol|0|||
44303123|NCT04142242|79300765|FG005|Stage I|Non-compliance with the protocol|1|||
44303124|NCT04142242|79300760|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
44303125|NCT04142242|79300761|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
44303126|NCT04142242|79300762|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
44303127|NCT04142242|79300763|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
44303128|NCT04142242|79300764|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
44303129|NCT04142242|79300765|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
44303130|NCT04142242|79300760|FG000|Stage II|Non-compliance with the protocol|0|||
44303131|NCT04142242|79300761|FG001|Stage II|Non-compliance with the protocol|0|||
44303132|NCT04142242|79300762|FG002|Stage II|Non-compliance with the protocol|0|||
44303133|NCT04142242|79300763|FG003|Stage II|Non-compliance with the protocol|2|||
44303134|NCT04142242|79300764|FG004|Stage II|Non-compliance with the protocol|0|||
44303135|NCT04142242|79300765|FG005|Stage II|Non-compliance with the protocol|0|||
44303136|NCT04142242|79300760|FG000|Stage II|Lost to Follow-up|0|||
44303137|NCT04142242|79300761|FG001|Stage II|Lost to Follow-up|0|||
44303138|NCT04142242|79300762|FG002|Stage II|Lost to Follow-up|1|||
44303139|NCT04142242|79300763|FG003|Stage II|Lost to Follow-up|2|||
44303140|NCT04142242|79300764|FG004|Stage II|Lost to Follow-up|0|||
44303141|NCT04142242|79300765|FG005|Stage II|Lost to Follow-up|0|||
44303142|NCT04142242|79300760|FG000|Stage II|Withdrawal by Subject|0|||
44303143|NCT04142242|79300761|FG001|Stage II|Withdrawal by Subject|0|||
44303144|NCT04142242|79300762|FG002|Stage II|Withdrawal by Subject|5|||
44303145|NCT04142242|79300763|FG003|Stage II|Withdrawal by Subject|9|||
44303146|NCT04142242|79300764|FG004|Stage II|Withdrawal by Subject|0|||
44303147|NCT04142242|79300765|FG005|Stage II|Withdrawal by Subject|0|||
44303148|NCT03912259|79300784|FG000|Overall Study|Adverse Event (AE)|2|||
44303149|NCT03912259|79300785|FG001|Overall Study|Adverse Event (AE)|4|||
44417656|NCT00752232|79425575|FG006|Overall Study|Investigator request|0|||
44417657|NCT00752232|79425569|FG000|Overall Study|Subject request|0|||
44417658|NCT00752232|79425570|FG001|Overall Study|Subject request|0|||
44417659|NCT00752232|79425571|FG002|Overall Study|Subject request|1|||
44417660|NCT00752232|79425572|FG003|Overall Study|Subject request|0|||
44417661|NCT00752232|79425573|FG004|Overall Study|Subject request|0|||
44417662|NCT00752232|79425574|FG005|Overall Study|Subject request|0|||
44417663|NCT00752232|79425575|FG006|Overall Study|Subject request|0|||
44417664|NCT00752232|79425569|FG000|Overall Study|Group home admission|0|||
44417665|NCT00752232|79425570|FG001|Overall Study|Group home admission|0|||
44417666|NCT00752232|79425571|FG002|Overall Study|Group home admission|0|||
44417667|NCT00752232|79425572|FG003|Overall Study|Group home admission|1|||
44417668|NCT00752232|79425573|FG004|Overall Study|Group home admission|0|||
44417669|NCT00752232|79425574|FG005|Overall Study|Group home admission|0|||
44417670|NCT00752232|79425575|FG006|Overall Study|Group home admission|0|||
44417671|NCT00752232|79425569|FG000|Overall Study|Caregiver could not attend the subject|0|||
44417672|NCT00752232|79425570|FG001|Overall Study|Caregiver could not attend the subject|0|||
44417673|NCT00752232|79425571|FG002|Overall Study|Caregiver could not attend the subject|0|||
44417674|NCT00752232|79425572|FG003|Overall Study|Caregiver could not attend the subject|0|||
44417675|NCT00752232|79425573|FG004|Overall Study|Caregiver could not attend the subject|1|||
44417676|NCT00752232|79425574|FG005|Overall Study|Caregiver could not attend the subject|0|||
44417677|NCT00752232|79425575|FG006|Overall Study|Caregiver could not attend the subject|0|||
44417678|NCT00760266|79425594|FG000|Overall Study|Adverse Event|13|||
44417679|NCT00760266|79425595|FG001|Overall Study|Adverse Event|7|||
44417680|NCT00760266|79425594|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44417681|NCT00760266|79425595|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44417682|NCT00760266|79425594|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44417683|NCT00760266|79425595|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44417684|NCT00760266|79425594|FG000|Overall Study|Lack of Efficacy|2|||
44417685|NCT00760266|79425595|FG001|Overall Study|Lack of Efficacy|2|||
44417686|NCT00760266|79425594|FG000|Overall Study|Protocol deviation|2|||
44417687|NCT00760266|79425595|FG001|Overall Study|Protocol deviation|4|||
44417688|NCT00760266|79425594|FG000|Overall Study|Patient withdrew consent|3|||
44417689|NCT00760266|79425595|FG001|Overall Study|Patient withdrew consent|3|||
44417690|NCT00760266|79425594|FG000|Overall Study|Lost to Follow-up|2|||
44417691|NCT00760266|79425595|FG001|Overall Study|Lost to Follow-up|1|||
44417692|NCT00760266|79425594|FG000|Overall Study|Administrative Problems|0|||
44417693|NCT00760266|79425595|FG001|Overall Study|Administrative Problems|1|||
44417694|NCT00753714|79425603|FG000|Overall Study|Lack of Efficacy|21|||
44417695|NCT00753714|79425604|FG001|Overall Study|Lack of Efficacy|34|||
44417696|NCT00753714|79425603|FG000|Overall Study|Adverse Event|26|||
44417697|NCT00753714|79425604|FG001|Overall Study|Adverse Event|18|||
44417698|NCT00753714|79425603|FG000|Overall Study|Protocol Violation|1|||
44417699|NCT00753714|79425604|FG001|Overall Study|Protocol Violation|0|||
44417700|NCT00753714|79425603|FG000|Overall Study|Lost to Follow-up|0|||
44417701|NCT00753714|79425604|FG001|Overall Study|Lost to Follow-up|1|||
44417702|NCT00753714|79425603|FG000|Overall Study|Withdrawal by Subject|2|||
44417703|NCT00753714|79425604|FG001|Overall Study|Withdrawal by Subject|1|||
44417704|NCT00753714|79425603|FG000|Overall Study|Death|3|||
44417705|NCT00753714|79425604|FG001|Overall Study|Death|3|||
44417706|NCT00753714|79425603|FG000|Overall Study|Other|7|||
44417707|NCT00753714|79425604|FG001|Overall Study|Other|5|||
44417708|NCT00759954|79425615|FG000|Overall Study|Personal reason|1|||
44417709|NCT00759954|79425616|FG001|Overall Study|Personal reason|0|||
44417710|NCT00759954|79425615|FG000|Overall Study|Adverse Event|1|||
44417711|NCT00759954|79425616|FG001|Overall Study|Adverse Event|2|||
44417712|NCT00804908|79425625|FG000|Overall Study|Other|115|||
44534291|NCT00098475|79544844|FG001|Step 1|Incorrect disease assessment|0|||
44534292|NCT00098475|79544845|FG002|Step 1|Incorrect disease assessment|0|||
44534293|NCT00098475|79544846|FG003|Step 1|Incorrect disease assessment|0|||
44417713|NCT00804908|79425626|FG001|Overall Study|Other|116|||
44417714|NCT00804908|79425627|FG002|Overall Study|Other|114|||
44417715|NCT00808808|79425638|FG000|Overall Study|Vaccinated; survey not completed|131|||
44417716|NCT00808808|79425639|FG001|Overall Study|Vaccinated; survey not completed|169|||
44417717|NCT00808808|79425640|FG002|Overall Study|Vaccinated; survey not completed|302|||
44417718|NCT00808808|79425638|FG000|Overall Study|Employee was not vaccinated.|2686|||
44417719|NCT00808808|79425639|FG001|Overall Study|Employee was not vaccinated.|2268|||
44417720|NCT00808808|79425640|FG002|Overall Study|Employee was not vaccinated.|2255|||
44534294|NCT00098475|79544843|FG000|Step 1|Off treatment for > specified timeframe|1|||
44303150|NCT03912259|79300784|FG000|Overall Study|Lack of Efficacy|4|||
44303151|NCT03912259|79300785|FG001|Overall Study|Lack of Efficacy|1|||
44303152|NCT03912259|79300784|FG000|Overall Study|Withdrawal by Subject|11|||
44303153|NCT03912259|79300785|FG001|Overall Study|Withdrawal by Subject|1|||
44303154|NCT03871829|79300794|FG000|Overall Study|Lost to Follow-up|0|||
44303155|NCT03871829|79300795|FG001|Overall Study|Lost to Follow-up|1|||
44303156|NCT03871829|79300794|FG000|Overall Study|Withdrawal by Subject|1|||
44303157|NCT03871829|79300795|FG001|Overall Study|Withdrawal by Subject|1|||
44303158|NCT03871829|79300794|FG000|Overall Study|Death|12|||
44303159|NCT03871829|79300795|FG001|Overall Study|Death|8|||
44303160|NCT03871829|79300794|FG000|Overall Study|Study terminated by sponsor|31|||
44303161|NCT03871829|79300795|FG001|Overall Study|Study terminated by sponsor|34|||
44303162|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
44303163|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
44303164|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
44303165|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
44303166|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
44303167|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
44303168|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
44303169|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
44303170|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
44303171|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
44303172|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
44303173|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
44303174|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
44303175|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
44303176|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
44303177|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
44303178|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
44303179|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
44303180|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
44303181|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
44303182|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
44303183|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
44303184|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
44303185|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
44303186|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
44303187|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
44303188|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
44303189|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
44303190|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
44303191|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
44303192|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
44303193|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
44303194|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
44303195|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
44303196|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
44303197|NCT03373383|79300842|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
44303198|NCT03373383|79300843|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
44303199|NCT03373383|79300844|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
44417721|NCT00589784|79425656|FG000|Overall Study|Withdrawal by Subject|0|||
44417722|NCT00589784|79425657|FG001|Overall Study|Withdrawal by Subject|6|||
44417723|NCT00589784|79425656|FG000|Overall Study|Patient inevaluable|1|||
44417724|NCT00589784|79425657|FG001|Overall Study|Patient inevaluable|0|||
44417725|NCT00589784|79425656|FG000|Overall Study|Adverse Event|0|||
44417726|NCT00589784|79425657|FG001|Overall Study|Adverse Event|4|||
44417727|NCT00759876|79425662|FG000|Overall Study|Sponsor terminated study early|36|||
44417728|NCT00823979|79425669|FG000|Overall Study|Lack of Efficacy|13|||
44417729|NCT00823979|79425670|FG001|Overall Study|Lack of Efficacy|16|||
44303200|NCT03373383|79300845|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
44303201|NCT03373383|79300846|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
44303202|NCT03373383|79300842|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
44303203|NCT03373383|79300843|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
44303204|NCT03373383|79300844|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
44303205|NCT03373383|79300845|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
44155039|NCT03766581|78946502|FG003|Randomization|Participant withdrew consent|2|||
44155040|NCT03766581|78946503|FG004|Randomization|Participant withdrew consent|1|||
44303206|NCT03373383|79300846|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
44303207|NCT03320018|79300875|FG000|Treatment Period|Withdrawal by Subject|1|||
44417730|NCT00823979|79425671|FG002|Overall Study|Lack of Efficacy|9|||
44417731|NCT00823979|79425669|FG000|Overall Study|Lost to Follow-up|2|||
44303208|NCT03320018|79300876|FG001|Treatment Period|Withdrawal by Subject|0|||
44303209|NCT03320018|79300875|FG000|Day 90 Follow up|Death|0|||
44303210|NCT03320018|79300876|FG001|Day 90 Follow up|Death|1|||
44303211|NCT03230318|79300884|FG000|Overall Study|Radiographic disease progression|72|||
44303212|NCT03230318|79300885|FG001|Overall Study|Radiographic disease progression|19|||
44303213|NCT03230318|79300884|FG000|Overall Study|Clinical progression|17|||
44303214|NCT03230318|79300885|FG001|Overall Study|Clinical progression|7|||
44303215|NCT03230318|79300884|FG000|Overall Study|Adverse Event|5|||
44303216|NCT03230318|79300885|FG001|Overall Study|Adverse Event|3|||
44303217|NCT03230318|79300884|FG000|Overall Study|Physician Decision|2|||
44303218|NCT03230318|79300885|FG001|Overall Study|Physician Decision|3|||
44303219|NCT03230318|79300884|FG000|Overall Study|Death|3|||
44303220|NCT03230318|79300885|FG001|Overall Study|Death|2|||
44303221|NCT03230318|79300884|FG000|Overall Study|Lost to Follow-up|1|||
44303222|NCT03230318|79300885|FG001|Overall Study|Lost to Follow-up|0|||
44303223|NCT03230318|79300884|FG000|Overall Study|Withdrawal by Subject|1|||
44303224|NCT03230318|79300885|FG001|Overall Study|Withdrawal by Subject|3|||
44303225|NCT03230318|79300884|FG000|Overall Study|Other|3|||
44303226|NCT03230318|79300885|FG001|Overall Study|Other|7|||
44303227|NCT03080883|79300896|FG000|Overall Study|Withdrawal by Subject|11|||
44303228|NCT03080883|79300897|FG001|Overall Study|Withdrawal by Subject|15|||
44303229|NCT03080883|79300896|FG000|Overall Study|Adverse Event|22|||
44303230|NCT03080883|79300897|FG001|Overall Study|Adverse Event|22|||
44303231|NCT03080883|79300896|FG000|Overall Study|Alternative Therapy|0|||
44303232|NCT03080883|79300897|FG001|Overall Study|Alternative Therapy|3|||
44303233|NCT03080883|79300896|FG000|Overall Study|Other Complicating Disease|9|||
44303234|NCT03080883|79300897|FG001|Overall Study|Other Complicating Disease|5|||
44303235|NCT03080883|79300896|FG000|Overall Study|Death|21|||
44303236|NCT03080883|79300897|FG001|Overall Study|Death|16|||
44303237|NCT03080883|79300896|FG000|Overall Study|Physician Decision|2|||
44303238|NCT03080883|79300897|FG001|Overall Study|Physician Decision|2|||
44303239|NCT03080883|79300896|FG000|Overall Study|Disease Progression|2|||
44303240|NCT03080883|79300897|FG001|Overall Study|Disease Progression|8|||
44303241|NCT03080883|79300896|FG000|Overall Study|Lost to Follow-up|1|||
44303242|NCT03080883|79300897|FG001|Overall Study|Lost to Follow-up|1|||
44303243|NCT03060291|79300906|FG000|3-month Follow-up|Declined to respond|8|||
44303244|NCT03060291|79300907|FG001|3-month Follow-up|Declined to respond|10|||
44303245|NCT03060291|79300908|FG002|3-month Follow-up|Declined to respond|2|||
44303246|NCT03060291|79300906|FG000|6-month Follow-up|Declined to respond|7|||
44303247|NCT03060291|79300907|FG001|6-month Follow-up|Declined to respond|13|||
44303248|NCT03060291|79300908|FG002|6-month Follow-up|Declined to respond|4|||
44303249|NCT03060291|79300906|FG000|12-month Follow-up|Declined to respond|7|||
44303250|NCT03060291|79300907|FG001|12-month Follow-up|Declined to respond|16|||
44303251|NCT03060291|79300908|FG002|12-month Follow-up|Declined to respond|6|||
44417732|NCT00823979|79425670|FG001|Overall Study|Lost to Follow-up|1|||
44417733|NCT00823979|79425671|FG002|Overall Study|Lost to Follow-up|0|||
44417734|NCT00823979|79425669|FG000|Overall Study|Withdrawal by Subject|2|||
44417735|NCT00823979|79425670|FG001|Overall Study|Withdrawal by Subject|3|||
44417736|NCT00823979|79425671|FG002|Overall Study|Withdrawal by Subject|2|||
44417737|NCT00823979|79425669|FG000|Overall Study|Protocol Violation|1|||
44417738|NCT00823979|79425670|FG001|Overall Study|Protocol Violation|1|||
44417739|NCT00823979|79425671|FG002|Overall Study|Protocol Violation|0|||
44417740|NCT00823979|79425669|FG000|Overall Study|Pregnancy|0|||
44417741|NCT00823979|79425670|FG001|Overall Study|Pregnancy|1|||
44303252|NCT01514864|79300954|FG000|Overall Study|Disease progression|7|||
44303253|NCT01514864|79300955|FG001|Overall Study|Disease progression|5|||
44303254|NCT01514864|79300954|FG000|Overall Study|Study drug toxicity|2|||
44303255|NCT01514864|79300955|FG001|Overall Study|Study drug toxicity|0|||
44303256|NCT01458366|79300967|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
44303257|NCT01458366|79300968|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
44303258|NCT01458366|79300969|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
44303259|NCT01458366|79300970|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
44417742|NCT00823979|79425671|FG002|Overall Study|Pregnancy|0|||
44417743|NCT00823979|79425669|FG000|Overall Study|Adverse Event|0|||
44417744|NCT00823979|79425670|FG001|Overall Study|Adverse Event|2|||
44417745|NCT00823979|79425671|FG002|Overall Study|Adverse Event|4|||
44303260|NCT01458366|79300971|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
44303261|NCT01458366|79300967|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
44303262|NCT01458366|79300968|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
44303263|NCT01458366|79300969|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
44417746|NCT00823979|79425669|FG000|Overall Study|Other|2|||
44417747|NCT00823979|79425670|FG001|Overall Study|Other|0|||
44417748|NCT00823979|79425671|FG002|Overall Study|Other|1|||
44417749|NCT00823979|79425669|FG000|Overall Study|Randomized but not Treated|4|||
44303264|NCT01458366|79300970|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
44303265|NCT01458366|79300971|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
44303266|NCT00364286|79300988|FG000|Overall Study|Withdrawal by Subject|1|||
44303267|NCT00364286|79300988|FG000|Overall Study|Adverse Event|2|||
44303268|NCT01755689|79301017|FG000|Overall Study|Withdrawal by Subject|1|||
44303269|NCT01755689|79301018|FG001|Overall Study|Withdrawal by Subject|3|||
44303270|NCT01755689|79301019|FG002|Overall Study|Withdrawal by Subject|2|||
44303271|NCT01755689|79301020|FG003|Overall Study|Withdrawal by Subject|1|||
44303272|NCT01755689|79301021|FG004|Overall Study|Withdrawal by Subject|1|||
44303273|NCT01755689|79301017|FG000|Overall Study|Migrated/moved from study area|0|||
44303274|NCT01755689|79301018|FG001|Overall Study|Migrated/moved from study area|1|||
44303275|NCT01755689|79301019|FG002|Overall Study|Migrated/moved from study area|1|||
44303276|NCT01755689|79301020|FG003|Overall Study|Migrated/moved from study area|1|||
44303277|NCT01755689|79301021|FG004|Overall Study|Migrated/moved from study area|1|||
44303278|NCT01755689|79301017|FG000|Overall Study|Lost to Follow-up|1|||
44303279|NCT01755689|79301018|FG001|Overall Study|Lost to Follow-up|0|||
44303280|NCT01755689|79301019|FG002|Overall Study|Lost to Follow-up|1|||
44303281|NCT01755689|79301020|FG003|Overall Study|Lost to Follow-up|0|||
44303282|NCT01755689|79301021|FG004|Overall Study|Lost to Follow-up|2|||
44303283|NCT01755689|79301017|FG000|Overall Study|Pregnancy|1|||
44303284|NCT01755689|79301018|FG001|Overall Study|Pregnancy|1|||
44303285|NCT01755689|79301019|FG002|Overall Study|Pregnancy|2|||
44303286|NCT01755689|79301020|FG003|Overall Study|Pregnancy|4|||
44303287|NCT01755689|79301021|FG004|Overall Study|Pregnancy|2|||
44303288|NCT01762761|79301043|FG000|Overall Study|Adverse Event|15|||
44303289|NCT01762761|79301044|FG001|Overall Study|Adverse Event|17|||
44303290|NCT01762761|79301043|FG000|Overall Study|Lack of Efficacy|9|||
44303291|NCT01762761|79301044|FG001|Overall Study|Lack of Efficacy|25|||
44303292|NCT01762761|79301043|FG000|Overall Study|Protocol Violation|1|||
44303293|NCT01762761|79301044|FG001|Overall Study|Protocol Violation|1|||
44303294|NCT01762761|79301043|FG000|Overall Study|Study closed/terminated|0|||
44303295|NCT01762761|79301044|FG001|Overall Study|Study closed/terminated|2|||
44303296|NCT01762761|79301043|FG000|Overall Study|Lost to Follow-up|3|||
44303297|NCT01762761|79301044|FG001|Overall Study|Lost to Follow-up|6|||
44155041|NCT03766581|78946504|FG005|Randomization|Participant withdrew consent|1|||
44155042|NCT03766581|78946505|FG006|Randomization|Participant withdrew consent|0|||
44155043|NCT03766581|78946506|FG007|Randomization|Participant withdrew consent|0|||
44155044|NCT03766581|78946499|FG000|Treatment|Adverse Event|82|||
44155045|NCT03766581|78946500|FG001|Treatment|Adverse Event|44|||
44155046|NCT03766581|78946501|FG002|Treatment|Adverse Event|47|||
44155047|NCT03766581|78946502|FG003|Treatment|Adverse Event|46|||
44155048|NCT03766581|78946503|FG004|Treatment|Adverse Event|50|||
44155049|NCT03766581|78946504|FG005|Treatment|Adverse Event|77|||
44155050|NCT03766581|78946505|FG006|Treatment|Adverse Event|5|||
44155051|NCT03766581|78946506|FG007|Treatment|Adverse Event|2|||
44155052|NCT03766581|78946499|FG000|Treatment|Participant request to discontinue treatment|34|||
44155053|NCT03766581|78946500|FG001|Treatment|Participant request to discontinue treatment|6|||
44155054|NCT03766581|78946501|FG002|Treatment|Participant request to discontinue treatment|10|||
44155055|NCT03766581|78946502|FG003|Treatment|Participant request to discontinue treatment|10|||
44155056|NCT03766581|78946503|FG004|Treatment|Participant request to discontinue treatment|14|||
44155057|NCT03766581|78946504|FG005|Treatment|Participant request to discontinue treatment|15|||
44155058|NCT03766581|78946505|FG006|Treatment|Participant request to discontinue treatment|0|||
44155059|NCT03766581|78946506|FG007|Treatment|Participant request to discontinue treatment|1|||
44155060|NCT03766581|78946499|FG000|Treatment|Participant withdrew consent|11|||
44155061|NCT03766581|78946500|FG001|Treatment|Participant withdrew consent|4|||
44155062|NCT03766581|78946501|FG002|Treatment|Participant withdrew consent|5|||
44303298|NCT01762761|79301043|FG000|Overall Study|Physician Decision|4|||
44303299|NCT01762761|79301044|FG001|Overall Study|Physician Decision|6|||
44534295|NCT00098475|79544844|FG001|Step 1|Off treatment for > specified timeframe|1|||
44534296|NCT00098475|79544845|FG002|Step 1|Off treatment for > specified timeframe|0|||
44155063|NCT03766581|78946502|FG003|Treatment|Participant withdrew consent|5|||
44155064|NCT03766581|78946503|FG004|Treatment|Participant withdrew consent|4|||
44155065|NCT03766581|78946504|FG005|Treatment|Participant withdrew consent|4|||
44155066|NCT03766581|78946505|FG006|Treatment|Participant withdrew consent|0|||
44155067|NCT03766581|78946506|FG007|Treatment|Participant withdrew consent|0|||
44256820|NCT04644237|79109067|FG001|Overall Study|Clinical Progression|1|||
44256821|NCT04644237|79109066|FG000|Overall Study|Withdrawal by Subject|1|||
44256822|NCT04644237|79109067|FG001|Overall Study|Withdrawal by Subject|2|||
44256823|NCT04644237|79109066|FG000|Overall Study|Physician Decision|3|||
44256824|NCT04644237|79109067|FG001|Overall Study|Physician Decision|0|||
44256825|NCT04644237|79109066|FG000|Overall Study|Other|1|||
44256826|NCT04644237|79109067|FG001|Overall Study|Other|0|||
44256827|NCT04644237|79109066|FG000|Overall Study|Randomized but not Treated|1|||
44256828|NCT04644237|79109067|FG001|Overall Study|Randomized but not Treated|0|||
44256829|NCT04594733|79109075|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
44256830|NCT04594733|79109076|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
44256831|NCT04594733|79109075|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
44303300|NCT01762761|79301043|FG000|Overall Study|Withdrawal by Subject|7|||
44303301|NCT01762761|79301044|FG001|Overall Study|Withdrawal by Subject|8|||
44303302|NCT01763788|79301055|FG000|Overall Study|Lost to Follow-up|0|||
44303303|NCT01763788|79301056|FG001|Overall Study|Lost to Follow-up|0|||
44303304|NCT01763788|79301057|FG002|Overall Study|Lost to Follow-up|1|||
44303305|NCT01763788|79301058|FG003|Overall Study|Lost to Follow-up|0|||
44303306|NCT01774370|79301068|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
44303307|NCT01774370|79301068|FG000|Overall Study|Administered prior to the contract date|4|||
44303308|NCT01774370|79301068|FG000|Overall Study|Subjects of contraindications|34|||
44303309|NCT01774370|79301068|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
44303310|NCT01774370|79301068|FG000|Overall Study|Follow-up failure|34|||
44303311|NCT01777295|79301074|FG000|Overall Study|Withdrawal by Subject|2|||
44303312|NCT01777295|79301075|FG001|Overall Study|Withdrawal by Subject|2|||
44303313|NCT01777295|79301074|FG000|Overall Study|Pregnancy|0|||
44303314|NCT01777295|79301075|FG001|Overall Study|Pregnancy|1|||
44303315|NCT01777295|79301074|FG000|Overall Study|Personal problem|1|||
44303316|NCT01777295|79301075|FG001|Overall Study|Personal problem|0|||
44303317|NCT01777295|79301074|FG000|Overall Study|Investigator call for AEs check|1|||
44303318|NCT01777295|79301075|FG001|Overall Study|Investigator call for AEs check|0|||
44303319|NCT01787552|79301112|FG000|Overall Study|Withdrawal by Subject|2|||
44303320|NCT01787552|79301113|FG001|Overall Study|Withdrawal by Subject|0|||
44303321|NCT01787552|79301114|FG002|Overall Study|Withdrawal by Subject|0|||
44303322|NCT01787552|79301115|FG003|Overall Study|Withdrawal by Subject|4|||
44303323|NCT01787552|79301112|FG000|Overall Study|Physician Decision|2|||
44303324|NCT01787552|79301113|FG001|Overall Study|Physician Decision|2|||
44303325|NCT01787552|79301114|FG002|Overall Study|Physician Decision|1|||
44303326|NCT01787552|79301115|FG003|Overall Study|Physician Decision|2|||
44303327|NCT01787552|79301112|FG000|Overall Study|Death|0|||
44303328|NCT01787552|79301113|FG001|Overall Study|Death|0|||
44303329|NCT01787552|79301114|FG002|Overall Study|Death|0|||
44303330|NCT01787552|79301115|FG003|Overall Study|Death|1|||
44303331|NCT01787552|79301112|FG000|Overall Study|Adverse Event|2|||
44303332|NCT01787552|79301113|FG001|Overall Study|Adverse Event|5|||
44303333|NCT01787552|79301114|FG002|Overall Study|Adverse Event|2|||
44303334|NCT01787552|79301115|FG003|Overall Study|Adverse Event|16|||
44303335|NCT01787552|79301112|FG000|Overall Study|Study terminated by Sponsor|0|||
44303336|NCT01787552|79301113|FG001|Overall Study|Study terminated by Sponsor|0|||
44303337|NCT01787552|79301114|FG002|Overall Study|Study terminated by Sponsor|1|||
44303338|NCT01787552|79301115|FG003|Overall Study|Study terminated by Sponsor|3|||
44303339|NCT01787552|79301112|FG000|Overall Study|Progressive Disease|2|||
44303340|NCT01787552|79301113|FG001|Overall Study|Progressive Disease|2|||
44303341|NCT01787552|79301114|FG002|Overall Study|Progressive Disease|1|||
44303342|NCT01787552|79301115|FG003|Overall Study|Progressive Disease|1|||
44303343|NCT01808261|79301132|FG000|Overall Study|Physician Decision|0|||
44303344|NCT01808261|79301133|FG001|Overall Study|Physician Decision|2|||
44303345|NCT01808261|79301132|FG000|Overall Study|Study Closed/Terminated|25|||
44303346|NCT01808261|79301133|FG001|Overall Study|Study Closed/Terminated|23|||
44303347|NCT01808261|79301132|FG000|Overall Study|Adverse event, non-fatal|2|||
44303348|NCT01808261|79301133|FG001|Overall Study|Adverse event, non-fatal|0|||
44303349|NCT01808261|79301132|FG000|Overall Study|Consent withdrawn by subject|6|||
44303350|NCT01808261|79301133|FG001|Overall Study|Consent withdrawn by subject|7|||
44303351|NCT01808261|79301132|FG000|Overall Study|Lost to Follow-up|3|||
44303352|NCT01808261|79301133|FG001|Overall Study|Lost to Follow-up|1|||
44303353|NCT01814826|79301152|FG000|Overall Study|Other|3|||
44303354|NCT01814826|79301153|FG001|Overall Study|Other|5|||
44303355|NCT01814826|79301154|FG002|Overall Study|Other|0|||
44303356|NCT01814826|79301152|FG000|Overall Study|Death|29|||
44303357|NCT01814826|79301153|FG001|Overall Study|Death|24|||
44303358|NCT01814826|79301154|FG002|Overall Study|Death|3|||
44303359|NCT01819467|79301165|FG000|Overall Study|Physician Decision|20|||
44155068|NCT03766581|78946499|FG000|Treatment|Death|1|||
44155069|NCT03766581|78946500|FG001|Treatment|Death|0|||
44155070|NCT03766581|78946501|FG002|Treatment|Death|0|||
44303360|NCT01819467|79301166|FG001|Overall Study|Physician Decision|9|||
44303361|NCT01829711|79301172|FG000|Overall Study|Lost to Follow-up|2|||
44303362|NCT01829711|79301172|FG000|Overall Study|Withdrawal by Subject|3|||
44303363|NCT01829711|79301172|FG000|Overall Study|Death|4|||
44303364|NCT01829711|79301172|FG000|Overall Study|Started new therapies|17|||
44303365|NCT01829711|79301172|FG000|Overall Study|Adverse Event|3|||
44417750|NCT00823979|79425670|FG001|Overall Study|Randomized but not Treated|3|||
44155071|NCT03766581|78946502|FG003|Treatment|Death|0|||
44155072|NCT03766581|78946503|FG004|Treatment|Death|0|||
44303366|NCT01829711|79301172|FG000|Overall Study|Due to progression of disease|13|||
44303367|NCT01829711|79301172|FG000|Overall Study|Due to lack of response|1|||
44303368|NCT01846273|79301179|FG000|Overall Study|Adverse Event|9|||
44303369|NCT01846273|79301180|FG001|Overall Study|Adverse Event|7|||
44303370|NCT01846273|79301181|FG002|Overall Study|Adverse Event|0|||
44303371|NCT01846273|79301179|FG000|Overall Study|Subject withdrew consent|5|||
44303372|NCT01846273|79301180|FG001|Overall Study|Subject withdrew consent|8|||
44303373|NCT01846273|79301181|FG002|Overall Study|Subject withdrew consent|0|||
44303374|NCT01846273|79301179|FG000|Overall Study|Lost to Follow-up|2|||
44303375|NCT01846273|79301180|FG001|Overall Study|Lost to Follow-up|1|||
44303376|NCT01846273|79301181|FG002|Overall Study|Lost to Follow-up|0|||
44303377|NCT01846273|79301179|FG000|Overall Study|Administrative problems|1|||
44303378|NCT01846273|79301180|FG001|Overall Study|Administrative problems|0|||
44303379|NCT01846273|79301181|FG002|Overall Study|Administrative problems|0|||
44303380|NCT01846273|79301179|FG000|Overall Study|Death|2|||
44303381|NCT01846273|79301180|FG001|Overall Study|Death|1|||
44303382|NCT01846273|79301181|FG002|Overall Study|Death|0|||
44303383|NCT01846273|79301179|FG000|Overall Study|Disease Progression|0|||
44303384|NCT01846273|79301180|FG001|Overall Study|Disease Progression|4|||
44303385|NCT01846273|79301181|FG002|Overall Study|Disease Progression|0|||
44303386|NCT01846273|79301179|FG000|Overall Study|Protocol Deviation|2|||
44303387|NCT01846273|79301180|FG001|Overall Study|Protocol Deviation|3|||
44303388|NCT01846273|79301181|FG002|Overall Study|Protocol Deviation|0|||
44303389|NCT01846273|79301179|FG000|Overall Study|Physician Decision|1|||
44303390|NCT01846273|79301180|FG001|Overall Study|Physician Decision|2|||
44303391|NCT01846273|79301181|FG002|Overall Study|Physician Decision|0|||
44303392|NCT01871896|79301189|FG000|Overall Study|Lost to Follow-up|1|||
44303393|NCT05855616|79301196|FG000|Overall Study|Lost to Follow-up|1|||
44303394|NCT05855616|79301197|FG001|Overall Study|Lost to Follow-up|2|||
44303395|NCT04752475|79301207|FG000|Overall Study|Withdrawal by Subject|1|||
44303396|NCT04752475|79301208|FG001|Overall Study|Withdrawal by Subject|1|||
44303397|NCT03846947|79301254|FG000|Overall Study|technical issues with imaging sequence|2|||
44303398|NCT03675308|79301267|FG000|Overall Study|Adverse Event|3|||
44417751|NCT00823979|79425671|FG002|Overall Study|Randomized but not Treated|1|||
44417752|NCT00823979|79425669|FG000|Overall Study|Study Terminated by Sponsor|5|||
44417753|NCT00823979|79425670|FG001|Overall Study|Study Terminated by Sponsor|5|||
44303399|NCT03675308|79301268|FG001|Overall Study|Adverse Event|2|||
44303400|NCT03675308|79301267|FG000|Overall Study|Withdrawal by Subject|6|||
44303401|NCT03675308|79301268|FG001|Overall Study|Withdrawal by Subject|4|||
44417754|NCT00823979|79425671|FG002|Overall Study|Study Terminated by Sponsor|7|||
44417755|NCT00823901|79425681|FG000|Overall Study|Adverse Event|1|||
44417756|NCT00823901|79425682|FG001|Overall Study|Adverse Event|1|||
44417757|NCT00823901|79425681|FG000|Overall Study|Lack of Efficacy|1|||
44417758|NCT00823901|79425682|FG001|Overall Study|Lack of Efficacy|0|||
44417759|NCT00823901|79425681|FG000|Overall Study|Lost to Follow-up|2|||
44417760|NCT00823901|79425682|FG001|Overall Study|Lost to Follow-up|1|||
44417761|NCT00823823|79425690|FG000|Overall Study|Lost to Follow-up|3|||
44417762|NCT00823823|79425691|FG001|Overall Study|Lost to Follow-up|1|||
44417763|NCT00823823|79425690|FG000|Overall Study|Protocol Violation|5|||
44417764|NCT00823823|79425691|FG001|Overall Study|Protocol Violation|5|||
44417765|NCT00759564|79425711|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
44417766|NCT00759564|79425712|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
44417767|NCT00759564|79425713|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
44417768|NCT00759564|79425714|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
44417769|NCT00759564|79425715|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
44417770|NCT00816023|79425751|FG000|Overall Study|Lost to Follow-up|1|||
44417771|NCT00816023|79425752|FG001|Overall Study|Lost to Follow-up|1|||
44417772|NCT00816023|79425753|FG002|Overall Study|Lost to Follow-up|0|||
44417773|NCT00816023|79425754|FG003|Overall Study|Lost to Follow-up|0|||
44417774|NCT00816023|79425751|FG000|Overall Study|Withdrawal by Subject|1|||
44417775|NCT00816023|79425752|FG001|Overall Study|Withdrawal by Subject|0|||
44417776|NCT00816023|79425753|FG002|Overall Study|Withdrawal by Subject|0|||
44417777|NCT00816023|79425754|FG003|Overall Study|Withdrawal by Subject|0|||
44417778|NCT00816023|79425751|FG000|Overall Study|Physician Decision|0|||
44417779|NCT00816023|79425752|FG001|Overall Study|Physician Decision|0|||
44417780|NCT00816023|79425753|FG002|Overall Study|Physician Decision|1|||
44417781|NCT00816023|79425754|FG003|Overall Study|Physician Decision|0|||
44417782|NCT00816023|79425751|FG000|Overall Study|assessments complete prior to window|1|||
44417783|NCT00816023|79425752|FG001|Overall Study|assessments complete prior to window|1|||
44417784|NCT00816023|79425753|FG002|Overall Study|assessments complete prior to window|2|||
44534297|NCT00098475|79544846|FG003|Step 1|Off treatment for > specified timeframe|0|||
44417785|NCT00816023|79425754|FG003|Overall Study|assessments complete prior to window|1|||
44534298|NCT00098475|79544843|FG000|Step 1|Declining performance status|0|||
44303402|NCT03675308|79301267|FG000|Overall Study|Lost to Follow-up|3|||
44303403|NCT03675308|79301268|FG001|Overall Study|Lost to Follow-up|0|||
44303404|NCT03675308|79301267|FG000|Overall Study|Lack of Efficacy|1|||
44303405|NCT03675308|79301268|FG001|Overall Study|Lack of Efficacy|1|||
44303406|NCT03675308|79301267|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
44303407|NCT03675308|79301268|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
44417786|NCT00816023|79425751|FG000|Overall Study|Randomized Not Treated|6|||
44417787|NCT00816023|79425752|FG001|Overall Study|Randomized Not Treated|4|||
44417788|NCT00816023|79425753|FG002|Overall Study|Randomized Not Treated|6|||
44303408|NCT03675308|79301267|FG000|Overall Study|Other|0|||
44303409|NCT03675308|79301268|FG001|Overall Study|Other|1|||
44417789|NCT00816023|79425754|FG003|Overall Study|Randomized Not Treated|11|||
44417790|NCT00759174|79425766|FG000|Overall Study|Other|0|||
44417791|NCT00759174|79425767|FG001|Overall Study|Other|2|||
44417792|NCT00815633|79425774|FG000|Overall Study|study terminated|1|||
44417793|NCT00830765|79425780|FG000|Overall Study|Protocol Violation|3|||
44417794|NCT00830765|79425781|FG001|Overall Study|Protocol Violation|2|||
44417795|NCT00830375|79425787|FG000|Overall Study|Lost to Follow-up|1|||
44417796|NCT00803270|79425793|FG000|Overall Study|Lost to Follow-up|1|||
44417797|NCT00803270|79425794|FG001|Overall Study|Lost to Follow-up|2|||
44417798|NCT00751998|79425800|FG000|Overall Study|Lost to Follow-up|7|||
44417799|NCT00751998|79425800|FG000|Overall Study|Death|11|||
44417800|NCT00751998|79425800|FG000|Overall Study|Withdrawal by Subject|2|||
44417801|NCT00803738|79425806|FG000|Overall Study|Adverse Event|3|||
44417802|NCT00803738|79425807|FG001|Overall Study|Adverse Event|5|||
44417803|NCT00803738|79425806|FG000|Overall Study|Lost to Follow-up|4|||
44417804|NCT00803738|79425807|FG001|Overall Study|Lost to Follow-up|4|||
44417805|NCT00803738|79425806|FG000|Overall Study|Protocol Violation|18|||
44417806|NCT00803738|79425807|FG001|Overall Study|Protocol Violation|10|||
44417807|NCT00803738|79425806|FG000|Overall Study|Withdrawal by Subject|1|||
44417808|NCT00803738|79425807|FG001|Overall Study|Withdrawal by Subject|4|||
44417809|NCT00803738|79425806|FG000|Overall Study|Lack of Efficacy|10|||
44417810|NCT00803738|79425807|FG001|Overall Study|Lack of Efficacy|16|||
44303410|NCT03131219|79301276|FG000|Initial Evaluation Period|Adverse Event|1|||
44303411|NCT03131219|79301277|FG001|Initial Evaluation Period|Adverse Event|0|||
44303412|NCT03131219|79301276|FG000|Initial Evaluation Period|Protocol Violation|1|||
44303413|NCT03131219|79301277|FG001|Initial Evaluation Period|Protocol Violation|0|||
44303414|NCT03131219|79301276|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
44303415|NCT03131219|79301277|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
44303416|NCT02914613|79301285|FG000|Overall Study|Withdrawal by Subject|1|||
44303417|NCT02914613|79301286|FG001|Overall Study|Withdrawal by Subject|2|||
44303418|NCT02914613|79301285|FG000|Overall Study|Adverse Event|1|||
44303419|NCT02914613|79301286|FG001|Overall Study|Adverse Event|0|||
44303420|NCT02586207|79301296|FG000|Overall Study|Physician Decision|1|||
44303421|NCT02586207|79301296|FG000|Overall Study|Withdrawal by Subject|1|||
44303422|NCT02573324|79301303|FG000|Overall Study|Withdrawal by Subject|26|||
44303423|NCT02573324|79301304|FG001|Overall Study|Withdrawal by Subject|23|||
44417811|NCT00803738|79425806|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
44417812|NCT00803738|79425807|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
44417813|NCT00803738|79425806|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
44417814|NCT00803738|79425807|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
44417815|NCT00758706|79425815|FG000|Overall Study|Adverse Event|4|||
44417816|NCT00758706|79425816|FG001|Overall Study|Adverse Event|4|||
44417817|NCT00591266|79425825|FG000|Overall Study|Adverse Event|2|||
44417818|NCT00591266|79425826|FG001|Overall Study|Adverse Event|2|||
44417819|NCT00591266|79425827|FG002|Overall Study|Adverse Event|3|||
44417820|NCT00591266|79425825|FG000|Overall Study|Lost to Follow-up|0|||
44417821|NCT00591266|79425826|FG001|Overall Study|Lost to Follow-up|1|||
44417822|NCT00591266|79425827|FG002|Overall Study|Lost to Follow-up|0|||
44417823|NCT00591266|79425825|FG000|Overall Study|Protocol Violation|0|||
44417824|NCT00591266|79425826|FG001|Overall Study|Protocol Violation|0|||
44417825|NCT00591266|79425827|FG002|Overall Study|Protocol Violation|1|||
44417826|NCT00591266|79425825|FG000|Overall Study|Withdrawal by Subject|6|||
44417827|NCT00591266|79425826|FG001|Overall Study|Withdrawal by Subject|2|||
44417828|NCT00591266|79425827|FG002|Overall Study|Withdrawal by Subject|5|||
44417829|NCT00591266|79425825|FG000|Overall Study|Lack of Efficacy|0|||
44534299|NCT00098475|79544844|FG001|Step 1|Declining performance status|1|||
44534300|NCT00098475|79544845|FG002|Step 1|Declining performance status|0|||
44303424|NCT02573324|79301305|FG002|Overall Study|Withdrawal by Subject|3|||
44303425|NCT02573324|79301303|FG000|Overall Study|Lost to Follow-up|4|||
44303426|NCT02573324|79301304|FG001|Overall Study|Lost to Follow-up|5|||
44303427|NCT02573324|79301305|FG002|Overall Study|Lost to Follow-up|0|||
44303428|NCT02573324|79301303|FG000|Overall Study|Study Terminated by Sponsor|107|||
44303429|NCT02573324|79301304|FG001|Overall Study|Study Terminated by Sponsor|89|||
44303430|NCT02573324|79301305|FG002|Overall Study|Study Terminated by Sponsor|2|||
44303431|NCT02573324|79301303|FG000|Overall Study|Death|182|||
44303432|NCT02573324|79301304|FG001|Overall Study|Death|200|||
44303433|NCT02573324|79301305|FG002|Overall Study|Death|1|||
44303434|NCT02573324|79301303|FG000|Overall Study|Other, Not Specified|20|||
44303435|NCT02573324|79301304|FG001|Overall Study|Other, Not Specified|27|||
44417830|NCT00591266|79425826|FG001|Overall Study|Lack of Efficacy|2|||
44417831|NCT00591266|79425827|FG002|Overall Study|Lack of Efficacy|0|||
44417832|NCT00591266|79425825|FG000|Overall Study|Other|1|||
44417833|NCT00591266|79425826|FG001|Overall Study|Other|4|||
44417834|NCT00591266|79425827|FG002|Overall Study|Other|5|||
44417835|NCT00758394|79425839|FG000|2nd Intervention Order|Lost to Follow-up|0|||
44417836|NCT00758394|79425840|FG001|2nd Intervention Order|Lost to Follow-up|1|||
44417837|NCT00758394|79425841|FG002|2nd Intervention Order|Lost to Follow-up|0|||
44417838|NCT00758394|79425842|FG003|2nd Intervention Order|Lost to Follow-up|0|||
44417839|NCT00758394|79425839|FG000|3rd Intervention|Lost to Follow-up|1|||
44417840|NCT00758394|79425840|FG001|3rd Intervention|Lost to Follow-up|0|||
44303436|NCT02573324|79301305|FG002|Overall Study|Other, Not Specified|0|||
44303437|NCT02573324|79301303|FG000|Overall Study|Unknown Reason|2|||
44303438|NCT02573324|79301304|FG001|Overall Study|Unknown Reason|0|||
44303439|NCT02573324|79301305|FG002|Overall Study|Unknown Reason|0|||
44303440|NCT02296684|79301321|FG000|Overall Study|Withdrawal by Subject|0|||
44303441|NCT02296684|79301322|FG001|Overall Study|Withdrawal by Subject|1|||
44303442|NCT02296684|79301323|FG002|Overall Study|Withdrawal by Subject|1|||
44303443|NCT02296684|79301321|FG000|Overall Study|Death|2|||
44303444|NCT02296684|79301322|FG001|Overall Study|Death|0|||
44303445|NCT02296684|79301323|FG002|Overall Study|Death|0|||
44303446|NCT02107261|79301332|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
44303447|NCT02107261|79301333|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
44303448|NCT02107261|79301332|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
44303449|NCT02107261|79301333|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
44303450|NCT02014597|79301343|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
44303451|NCT02014597|79301344|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
44303452|NCT01342367|79301352|FG000|Overall Study|Death|1|||
44303453|NCT01342367|79301353|FG001|Overall Study|Death|0|||
44303454|NCT01342367|79301352|FG000|Overall Study|Withdrawal by Subject|1|||
44303455|NCT01342367|79301353|FG001|Overall Study|Withdrawal by Subject|2|||
44303456|NCT01185171|79301359|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
44303457|NCT01185171|79301359|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
44303458|NCT01185171|79301359|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
44303459|NCT01185171|79301359|FG000|Maintenance|Elevated liver transaminases|3|||
44303460|NCT01185171|79301359|FG000|Maintenance|Rush|2|||
44303461|NCT01185171|79301359|FG000|Maintenance|Diarrhea|1|||
44303462|NCT01185171|79301359|FG000|Maintenance|Xerostomia|1|||
44303463|NCT01185171|79301359|FG000|Maintenance|Nausea|1|||
44303464|NCT01185171|79301359|FG000|Maintenance|Comorbid Illness|2|||
44303465|NCT01185171|79301359|FG000|Maintenance|Withdrawal by Subject|1|||
44303466|NCT01185171|79301359|FG000|Maintenance|Disease Recurrence|1|||
44303467|NCT00896493|79301363|FG000|Overall Study|Early disease relapse|3|||
44303468|NCT01875185|79301378|FG000|Overall Study|study was terminated|52|||
44303469|NCT01875185|79301379|FG001|Overall Study|study was terminated|48|||
44303470|NCT01901432|79301408|FG000|Overall Study|Adverse Event|0|||
44303471|NCT01901432|79301409|FG001|Overall Study|Adverse Event|1|||
44303472|NCT01901432|79301410|FG002|Overall Study|Adverse Event|1|||
44303473|NCT01901432|79301411|FG003|Overall Study|Adverse Event|0|||
44303474|NCT01901432|79301412|FG004|Overall Study|Adverse Event|1|||
44303475|NCT01901432|79301408|FG000|Overall Study|Withdrawal by Subject|0|||
44303476|NCT01901432|79301409|FG001|Overall Study|Withdrawal by Subject|0|||
44303477|NCT01901432|79301410|FG002|Overall Study|Withdrawal by Subject|1|||
44303478|NCT01901432|79301411|FG003|Overall Study|Withdrawal by Subject|0|||
44303479|NCT01901432|79301412|FG004|Overall Study|Withdrawal by Subject|5|||
44303480|NCT01901432|79301408|FG000|Overall Study|Physician Decision|0|||
44303481|NCT01901432|79301409|FG001|Overall Study|Physician Decision|0|||
44303482|NCT01901432|79301410|FG002|Overall Study|Physician Decision|0|||
44303483|NCT01901432|79301411|FG003|Overall Study|Physician Decision|0|||
44303484|NCT01901432|79301412|FG004|Overall Study|Physician Decision|2|||
44303485|NCT01901432|79301408|FG000|Overall Study|Patient decision to stop study drug|0|||
44303486|NCT01901432|79301409|FG001|Overall Study|Patient decision to stop study drug|0|||
44303487|NCT01901432|79301410|FG002|Overall Study|Patient decision to stop study drug|0|||
44303488|NCT01901432|79301411|FG003|Overall Study|Patient decision to stop study drug|0|||
44303489|NCT01901432|79301412|FG004|Overall Study|Patient decision to stop study drug|1|||
44303490|NCT01904279|79301433|FG000|Overall Study|Lack of Efficacy|2|||
44303491|NCT01904279|79301434|FG001|Overall Study|Lack of Efficacy|3|||
44303492|NCT01904279|79301433|FG000|Overall Study|Withdrawal by Subject|1|||
44303493|NCT01904279|79301434|FG001|Overall Study|Withdrawal by Subject|0|||
44303494|NCT01917318|79301443|FG000|First Treatment|Withdrawal by Subject|0|||
44303495|NCT01917318|79301444|FG001|First Treatment|Withdrawal by Subject|1|||
44303496|NCT01923168|79301453|FG000|Overall Study|Protocol Violation|1|||
44303497|NCT01923168|79301454|FG001|Overall Study|Protocol Violation|1|||
44303498|NCT01923168|79301455|FG002|Overall Study|Protocol Violation|0|||
44303499|NCT01923168|79301453|FG000|Overall Study|Subject/guardian decision|14|||
44303500|NCT01923168|79301454|FG001|Overall Study|Subject/guardian decision|14|||
44303501|NCT01923168|79301455|FG002|Overall Study|Subject/guardian decision|4|||
44303502|NCT01923168|79301453|FG000|Overall Study|Adverse Event|12|||
44303503|NCT01923168|79301454|FG001|Overall Study|Adverse Event|12|||
44303504|NCT01923168|79301455|FG002|Overall Study|Adverse Event|0|||
44303505|NCT01923168|79301453|FG000|Overall Study|Physician Decision|6|||
44303506|NCT01923168|79301454|FG001|Overall Study|Physician Decision|9|||
44303507|NCT01923168|79301455|FG002|Overall Study|Physician Decision|5|||
44303508|NCT01923168|79301453|FG000|Overall Study|Progressive disease|4|||
44303509|NCT01923168|79301454|FG001|Overall Study|Progressive disease|3|||
44303510|NCT01923168|79301455|FG002|Overall Study|Progressive disease|7|||
44303511|NCT01923168|79301453|FG000|Overall Study|Death|0|||
44303512|NCT01923168|79301454|FG001|Overall Study|Death|0|||
44303513|NCT01923168|79301455|FG002|Overall Study|Death|1|||
44303514|NCT01931098|79301465|FG000|Overall Study|Withdrawal by Subject|0|||
44303515|NCT01931098|79301466|FG001|Overall Study|Withdrawal by Subject|1|||
44303516|NCT01931098|79301465|FG000|Overall Study|Enrolled in different protocol|0|||
44303517|NCT01931098|79301466|FG001|Overall Study|Enrolled in different protocol|1|||
44303518|NCT01931098|79301465|FG000|Overall Study|Unable to begin trmt:active infection|0|||
44303519|NCT01931098|79301466|FG001|Overall Study|Unable to begin trmt:active infection|1|||
44303520|NCT01931098|79301465|FG000|Overall Study|Refused further treatment|0|||
44303521|NCT01931098|79301466|FG001|Overall Study|Refused further treatment|1|||
44303522|NCT05097716|79301476|FG000|Period 1|Adverse Event|1|||
44303523|NCT05097716|79301476|FG000|Period 1|Close contact with highly-transmissible infection|1|||
44303524|NCT04781647|79301497|FG000|Overall Study|Study terminated by Sponsor|11|||
44303525|NCT04781647|79301498|FG001|Overall Study|Study terminated by Sponsor|9|||
44303526|NCT04781647|79301499|FG002|Overall Study|Study terminated by Sponsor|9|||
44303527|NCT04781647|79301497|FG000|Overall Study|Withdrawal by Subject|1|||
44534301|NCT00098475|79544846|FG003|Step 1|Declining performance status|0|||
44534302|NCT00098475|79544843|FG000|Step 1|Insurance issue|0|||
44534303|NCT00098475|79544844|FG001|Step 1|Insurance issue|1|||
44534304|NCT00098475|79544845|FG002|Step 1|Insurance issue|0|||
44534305|NCT00098475|79544846|FG003|Step 1|Insurance issue|0|||
44534306|NCT00098475|79544843|FG000|Step 1|Rising paraprotein|0|||
44155073|NCT03766581|78946504|FG005|Treatment|Death|0|||
44155074|NCT03766581|78946505|FG006|Treatment|Death|0|||
44155075|NCT03766581|78946506|FG007|Treatment|Death|0|||
44155076|NCT03766581|78946499|FG000|Treatment|Lost to Follow-up|1|||
44155077|NCT03766581|78946500|FG001|Treatment|Lost to Follow-up|0|||
44155078|NCT03766581|78946501|FG002|Treatment|Lost to Follow-up|0|||
44303528|NCT04781647|79301498|FG001|Overall Study|Withdrawal by Subject|2|||
44534307|NCT00098475|79544844|FG001|Step 1|Rising paraprotein|1|||
44303529|NCT04781647|79301499|FG002|Overall Study|Withdrawal by Subject|0|||
44303530|NCT04781647|79301497|FG000|Overall Study|Adverse Event|0|||
44303531|NCT04781647|79301498|FG001|Overall Study|Adverse Event|1|||
44303532|NCT04781647|79301499|FG002|Overall Study|Adverse Event|1|||
44303533|NCT04781647|79301497|FG000|Overall Study|Protocol Violation|1|||
44303534|NCT04781647|79301498|FG001|Overall Study|Protocol Violation|0|||
44303535|NCT04781647|79301499|FG002|Overall Study|Protocol Violation|0|||
44303536|NCT04781647|79301497|FG000|Overall Study|Pregnancy|0|||
44303537|NCT04781647|79301498|FG001|Overall Study|Pregnancy|0|||
44256832|NCT04594733|79109076|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
44256833|NCT04594733|79109075|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
44256834|NCT04594733|79109076|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
44256835|NCT04570657|79109086|FG000|Overall Study|Adverse Event|0|||
44256836|NCT04570657|79109087|FG001|Overall Study|Adverse Event|0|||
44256837|NCT04570657|79109088|FG002|Overall Study|Adverse Event|1|||
44256838|NCT04570657|79109086|FG000|Overall Study|Lost to Follow-up|0|||
44256839|NCT04570657|79109087|FG001|Overall Study|Lost to Follow-up|0|||
44256840|NCT04570657|79109088|FG002|Overall Study|Lost to Follow-up|1|||
44256841|NCT04570657|79109086|FG000|Overall Study|Physician Decision|0|||
44256842|NCT04570657|79109087|FG001|Overall Study|Physician Decision|1|||
44256843|NCT04570657|79109088|FG002|Overall Study|Physician Decision|0|||
44256844|NCT04570657|79109086|FG000|Overall Study|Withdrawal by Subject|1|||
44303538|NCT04781647|79301499|FG002|Overall Study|Pregnancy|1|||
44303539|NCT04781647|79301497|FG000|Overall Study|Virology rebounded|1|||
44303540|NCT04781647|79301498|FG001|Overall Study|Virology rebounded|0|||
44303541|NCT04781647|79301499|FG002|Overall Study|Virology rebounded|0|||
44303542|NCT04727528|79301511|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
44303543|NCT04727528|79301512|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
44155079|NCT03766581|78946502|FG003|Treatment|Lost to Follow-up|1|||
44155080|NCT03766581|78946503|FG004|Treatment|Lost to Follow-up|0|||
44155081|NCT03766581|78946504|FG005|Treatment|Lost to Follow-up|0|||
44256845|NCT04570657|79109087|FG001|Overall Study|Withdrawal by Subject|2|||
44256846|NCT04570657|79109088|FG002|Overall Study|Withdrawal by Subject|2|||
44256847|NCT04566601|79109101|FG000|Overall Study|Other than listed|13|||
44256848|NCT04566601|79109102|FG001|Overall Study|Other than listed|4|||
44256849|NCT04566601|79109103|FG002|Overall Study|Other than listed|2|||
44303544|NCT04727528|79301511|FG000|Open-label Period|Randomized who did not receive treatment|1|||
44303545|NCT04727528|79301512|FG001|Open-label Period|Randomized who did not receive treatment|0|||
44303546|NCT04727528|79301511|FG000|Double-blind Treatment Phase|Adverse Event|0|||
44303547|NCT04727528|79301512|FG001|Double-blind Treatment Phase|Adverse Event|1|||
44303548|NCT04727528|79301511|FG000|Double-blind Treatment Phase|Death|0|||
44303549|NCT04727528|79301512|FG001|Double-blind Treatment Phase|Death|1|||
44303550|NCT04727528|79301511|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
44303551|NCT04727528|79301512|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
44303552|NCT04727528|79301511|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
44303553|NCT04727528|79301512|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
44303554|NCT04727528|79301511|FG000|Double-blind Treatment Phase|Physician Decision|0|||
44303555|NCT04727528|79301512|FG001|Double-blind Treatment Phase|Physician Decision|1|||
44303556|NCT04727528|79301511|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
44303557|NCT04727528|79301512|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
44303558|NCT04674189|79301540|FG000|Overall Study|Adverse Event|0|||
44303559|NCT04674189|79301541|FG001|Overall Study|Adverse Event|0|||
44303560|NCT04674189|79301542|FG002|Overall Study|Adverse Event|1|||
44303561|NCT04674189|79301540|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
44303562|NCT04674189|79301541|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
44303563|NCT04674189|79301542|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
44303564|NCT04674189|79301540|FG000|Overall Study|Physician Decision|1|||
44303565|NCT04674189|79301541|FG001|Overall Study|Physician Decision|0|||
44303566|NCT04674189|79301542|FG002|Overall Study|Physician Decision|0|||
44303567|NCT04674189|79301540|FG000|Overall Study|Withdrawal by Participant|83|||
44303568|NCT04674189|79301541|FG001|Overall Study|Withdrawal by Participant|71|||
44303569|NCT04674189|79301542|FG002|Overall Study|Withdrawal by Participant|142|||
44303570|NCT04674189|79301540|FG000|Overall Study|Lost to Follow-up|55|||
44303571|NCT04674189|79301541|FG001|Overall Study|Lost to Follow-up|53|||
44303572|NCT04674189|79301542|FG002|Overall Study|Lost to Follow-up|44|||
44303573|NCT04674189|79301540|FG000|Overall Study|Miscellaneous|27|||
44417841|NCT00758394|79425841|FG002|3rd Intervention|Lost to Follow-up|0|||
44417842|NCT00758394|79425842|FG003|3rd Intervention|Lost to Follow-up|1|||
44417843|NCT04450394|79425855|FG000|Overall Study|Adverse Event|2|||
44417844|NCT04450394|79425856|FG001|Overall Study|Adverse Event|0|||
44417845|NCT04450394|79425857|FG002|Overall Study|Adverse Event|0|||
44417846|NCT04450394|79425855|FG000|Overall Study|Death|0|||
44417847|NCT04450394|79425856|FG001|Overall Study|Death|1|||
44417848|NCT04450394|79425857|FG002|Overall Study|Death|0|||
44417849|NCT04450394|79425855|FG000|Overall Study|Lost to Follow-up|0|||
44417850|NCT04450394|79425856|FG001|Overall Study|Lost to Follow-up|3|||
44417851|NCT04450394|79425857|FG002|Overall Study|Lost to Follow-up|0|||
44417852|NCT04450394|79425855|FG000|Overall Study|Physician Decision|0|||
44417853|NCT04450394|79425856|FG001|Overall Study|Physician Decision|1|||
44417854|NCT04450394|79425857|FG002|Overall Study|Physician Decision|0|||
44417855|NCT04450394|79425855|FG000|Overall Study|Protocol Violation|2|||
44417856|NCT04450394|79425856|FG001|Overall Study|Protocol Violation|0|||
44417857|NCT04450394|79425857|FG002|Overall Study|Protocol Violation|0|||
44417858|NCT04450394|79425855|FG000|Overall Study|Withdrawal by Subject|6|||
44417859|NCT04450394|79425856|FG001|Overall Study|Withdrawal by Subject|9|||
44417860|NCT04450394|79425857|FG002|Overall Study|Withdrawal by Subject|0|||
44417861|NCT00758160|79425864|FG000|Overall Study|No Longer Requires Study Medication|4|||
44417862|NCT00758160|79425864|FG000|Overall Study|Administration Problems|3|||
44417863|NCT00758160|79425864|FG000|Overall Study|Adverse Event|15|||
44417864|NCT00758160|79425864|FG000|Overall Study|Lack of Efficacy|10|||
44417865|NCT00758160|79425864|FG000|Overall Study|Lost to Follow-up|14|||
44417866|NCT00758160|79425864|FG000|Overall Study|Protocol Violation|12|||
44417867|NCT00758160|79425864|FG000|Overall Study|Withdrawal by Subject|8|||
44417868|NCT00757848|79425874|FG000|Overall Study|Voluntary discontinuation|1|||
44417869|NCT00757848|79425875|FG001|Overall Study|Voluntary discontinuation|0|||
44417870|NCT00757848|79425874|FG000|Overall Study|Adverse Event|1|||
44417871|NCT00757848|79425875|FG001|Overall Study|Adverse Event|2|||
44417872|NCT00757848|79425874|FG000|Overall Study|Incorrect enrolment|1|||
44417873|NCT00757848|79425875|FG001|Overall Study|Incorrect enrolment|0|||
44417874|NCT00751296|79425881|FG000|Overall Study|Adverse Event|2|||
44417875|NCT00751140|79425885|FG000|Overall Study|benign angioma excluded from analysis|1|||
44417876|NCT00751881|79425896|FG000|Core Treatment Period|Not treated|1|||
44417877|NCT00751881|79425897|FG001|Core Treatment Period|Not treated|1|||
44417878|NCT00751881|79425898|FG002|Core Treatment Period|Not treated|2|||
44417879|NCT00751881|79425896|FG000|Core Treatment Period|Adverse Event|26|||
44417880|NCT00751881|79425897|FG001|Core Treatment Period|Adverse Event|54|||
44417881|NCT00751881|79425898|FG002|Core Treatment Period|Adverse Event|58|||
44417882|NCT00751881|79425896|FG000|Core Treatment Period|Lack of Efficacy|37|||
44417883|NCT00751881|79425897|FG001|Core Treatment Period|Lack of Efficacy|30|||
44155082|NCT03766581|78946505|FG006|Treatment|Lost to Follow-up|0|||
44155083|NCT03766581|78946506|FG007|Treatment|Lost to Follow-up|0|||
44417884|NCT00751881|79425898|FG002|Core Treatment Period|Lack of Efficacy|20|||
44417885|NCT00751881|79425896|FG000|Core Treatment Period|Poor compliance to protocol|15|||
44417886|NCT00751881|79425897|FG001|Core Treatment Period|Poor compliance to protocol|3|||
44534308|NCT00098475|79544845|FG002|Step 1|Rising paraprotein|0|||
44303574|NCT04674189|79301541|FG001|Overall Study|Miscellaneous|23|||
44303575|NCT04674189|79301542|FG002|Overall Study|Miscellaneous|207|||
44303576|NCT04674189|79301540|FG000|Overall Study|Did Not Receive Treatment|3|||
44303577|NCT04674189|79301541|FG001|Overall Study|Did Not Receive Treatment|1|||
44303578|NCT04674189|79301542|FG002|Overall Study|Did Not Receive Treatment|2|||
44303579|NCT04380857|79301574|FG000|Overall Study|Lost to Follow-up|3|||
44303580|NCT04380857|79301575|FG001|Overall Study|Lost to Follow-up|3|||
44303581|NCT04189588|79301584|FG000|Overall Study|Death|0|||
44303582|NCT04189588|79301585|FG001|Overall Study|Death|1|||
44303583|NCT04189588|79301584|FG000|Overall Study|Lost to Follow-up|0|||
44303584|NCT04189588|79301585|FG001|Overall Study|Lost to Follow-up|1|||
44303585|NCT04162210|79301593|FG000|Overall Study|Lost to Follow-up|4|||
44303586|NCT04162210|79301594|FG001|Overall Study|Lost to Follow-up|1|||
44303587|NCT04162210|79301593|FG000|Overall Study|Withdrawal by Subject|17|||
44303588|NCT04162210|79301594|FG001|Overall Study|Withdrawal by Subject|9|||
44303589|NCT04162210|79301593|FG000|Overall Study|Ongoing|113|||
44303590|NCT04162210|79301594|FG001|Overall Study|Ongoing|59|||
44303591|NCT04010461|79301600|FG000|Overall Study|COVID based withdrawal|5|||
44303592|NCT04010461|79301600|FG000|Overall Study|Withdrawal by Subject|5|||
44303593|NCT04010461|79301600|FG000|Overall Study|Adverse Event|1|||
44303594|NCT04010461|79301600|FG000|Overall Study|No Motor Threshold obtainable|1|||
44303595|NCT04010461|79301600|FG000|Overall Study|Physician Decision|1|||
44303596|NCT03985423|79301609|FG000|Overall Study|Adverse Event|1|||
44303597|NCT03985423|79301609|FG000|Overall Study|Death|2|||
44303598|NCT03985423|79301609|FG000|Overall Study|Physician Decision|1|||
44303599|NCT03985423|79301609|FG000|Overall Study|Withdrawal by Subject|2|||
44303600|NCT03985423|79301609|FG000|Overall Study|Lack of insurance and citizenship|1|||
44303601|NCT03875092|79301615|FG000|Overall Study|Adverse Event|2|||
44303602|NCT03875092|79301616|FG001|Overall Study|Adverse Event|5|||
44303603|NCT03875092|79301615|FG000|Overall Study|Death|28|||
44303604|NCT03875092|79301616|FG001|Overall Study|Death|41|||
44303605|NCT03875092|79301615|FG000|Overall Study|Ongoing in Study|35|||
44303606|NCT03875092|79301616|FG001|Overall Study|Ongoing in Study|14|||
44303607|NCT03634072|79301624|FG000|Overall Study|Early termination of overall study|1|||
44303608|NCT03634072|79301625|FG001|Overall Study|Early termination of overall study|0|||
44303609|NCT03471182|79301636|FG000|Overall Study|Withdrawal by Subject|1|||
44303610|NCT03471182|79301637|FG001|Overall Study|Withdrawal by Subject|1|||
44303611|NCT03471182|79301638|FG002|Overall Study|Withdrawal by Subject|0|||
44303612|NCT03471182|79301636|FG000|Overall Study|Technical failure|2|||
44303613|NCT03471182|79301637|FG001|Overall Study|Technical failure|0|||
44303614|NCT03471182|79301638|FG002|Overall Study|Technical failure|0|||
44303615|NCT03051659|79301675|FG000|Treatment Period|Withdrawal by Subject|0|||
44303616|NCT03051659|79301676|FG001|Treatment Period|Withdrawal by Subject|2|||
44303617|NCT03051659|79301675|FG000|Survival Follow-up|Lost to Follow-up|23|||
44303618|NCT03051659|79301676|FG001|Survival Follow-up|Lost to Follow-up|22|||
44303619|NCT02975882|79301686|FG000|Overall Study|Adverse Event|1|||
44303620|NCT02975882|79301687|FG001|Overall Study|Adverse Event|2|||
44303621|NCT02975882|79301688|FG002|Overall Study|Adverse Event|1|||
44303622|NCT02975882|79301689|FG003|Overall Study|Adverse Event|1|||
44303623|NCT02975882|79301686|FG000|Overall Study|Death|0|||
44303624|NCT02975882|79301687|FG001|Overall Study|Death|1|||
44303625|NCT02975882|79301688|FG002|Overall Study|Death|0|||
44303626|NCT02975882|79301689|FG003|Overall Study|Death|0|||
44303627|NCT02975882|79301686|FG000|Overall Study|Lack of Efficacy|3|||
44303628|NCT02975882|79301687|FG001|Overall Study|Lack of Efficacy|7|||
44303629|NCT02975882|79301688|FG002|Overall Study|Lack of Efficacy|4|||
44303630|NCT02975882|79301689|FG003|Overall Study|Lack of Efficacy|3|||
44417887|NCT00751881|79425898|FG002|Core Treatment Period|Poor compliance to protocol|4|||
44417888|NCT00751881|79425896|FG000|Core Treatment Period|Lost to Follow-up|6|||
44417889|NCT00751881|79425897|FG001|Core Treatment Period|Lost to Follow-up|4|||
44417890|NCT00751881|79425898|FG002|Core Treatment Period|Lost to Follow-up|3|||
44534309|NCT00098475|79544846|FG003|Step 1|Rising paraprotein|0|||
44534310|NCT00098475|79544843|FG000|Step 1|Referred to other physicians|0|||
44303631|NCT02975882|79301686|FG000|Overall Study|Physician Decision|0|||
44303632|NCT02975882|79301687|FG001|Overall Study|Physician Decision|2|||
44303633|NCT02975882|79301688|FG002|Overall Study|Physician Decision|4|||
44303634|NCT02975882|79301689|FG003|Overall Study|Physician Decision|2|||
44303635|NCT02975882|79301686|FG000|Overall Study|Ineligible|0|||
44303636|NCT02975882|79301687|FG001|Overall Study|Ineligible|1|||
44303637|NCT02975882|79301688|FG002|Overall Study|Ineligible|0|||
44303638|NCT02975882|79301689|FG003|Overall Study|Ineligible|0|||
44303639|NCT02908672|79301701|FG000|Overall Study|Death|112|||
44303640|NCT02908672|79301702|FG001|Overall Study|Death|93|||
44303641|NCT02908672|79301701|FG000|Overall Study|Lost to Follow-up|3|||
44303642|NCT02908672|79301702|FG001|Overall Study|Lost to Follow-up|3|||
44303643|NCT02908672|79301701|FG000|Overall Study|Other|2|||
44303644|NCT02908672|79301702|FG001|Overall Study|Other|0|||
44303645|NCT02908672|79301701|FG000|Overall Study|Protocol Violation|1|||
44303646|NCT02908672|79301702|FG001|Overall Study|Protocol Violation|1|||
44303647|NCT02908672|79301701|FG000|Overall Study|Withdrawal by Subject|13|||
44303648|NCT02908672|79301702|FG001|Overall Study|Withdrawal by Subject|18|||
44303649|NCT02908672|79301701|FG000|Overall Study|Study is ongoing|124|||
44303650|NCT02908672|79301702|FG001|Overall Study|Study is ongoing|141|||
44303651|NCT02908672|79301701|FG000|Overall Study|Discontinued the study during run-in|3|||
44303652|NCT02908672|79301702|FG001|Overall Study|Discontinued the study during run-in|0|||
44303653|NCT02775435|79301710|FG000|Overall Study|Adverse Event|48|||
44303654|NCT02775435|79301711|FG001|Overall Study|Adverse Event|25|||
44303655|NCT02775435|79301710|FG000|Overall Study|Lost to Follow-up|0|||
44303656|NCT02775435|79301711|FG001|Overall Study|Lost to Follow-up|2|||
44303657|NCT02775435|79301710|FG000|Overall Study|Physician Decision|5|||
44303658|NCT02775435|79301711|FG001|Overall Study|Physician Decision|6|||
44303659|NCT02775435|79301710|FG000|Overall Study|Withdrawal by Subject|5|||
44303660|NCT02775435|79301711|FG001|Overall Study|Withdrawal by Subject|9|||
44303661|NCT02775435|79301710|FG000|Overall Study|Progressive Disease|86|||
44303662|NCT02775435|79301711|FG001|Overall Study|Progressive Disease|140|||
44303663|NCT02775435|79301710|FG000|Overall Study|Clinical Progression|13|||
44303664|NCT02775435|79301711|FG001|Overall Study|Clinical Progression|26|||
44303665|NCT02775435|79301710|FG000|Overall Study|Ongoing in Study|121|||
44303666|NCT02775435|79301711|FG001|Overall Study|Ongoing in Study|72|||
44303667|NCT02775435|79301710|FG000|Overall Study|Not Treated|0|||
44303668|NCT02775435|79301711|FG001|Overall Study|Not Treated|1|||
44303669|NCT02685826|79301720|FG000|Overall Study|Adverse Event|2|||
44303670|NCT02685826|79301721|FG001|Overall Study|Adverse Event|0|||
44303671|NCT02685826|79301722|FG002|Overall Study|Adverse Event|1|||
44303672|NCT02685826|79301720|FG000|Overall Study|Progressive Disease|2|||
44303673|NCT02685826|79301721|FG001|Overall Study|Progressive Disease|1|||
44303674|NCT02685826|79301722|FG002|Overall Study|Progressive Disease|0|||
44303675|NCT02685826|79301720|FG000|Overall Study|Withdrawal by Subject|2|||
44303676|NCT02685826|79301721|FG001|Overall Study|Withdrawal by Subject|0|||
44303677|NCT02685826|79301722|FG002|Overall Study|Withdrawal by Subject|0|||
44303678|NCT02685826|79301720|FG000|Overall Study|Full Clinical Hold by FDA|19|||
44303679|NCT02685826|79301721|FG001|Overall Study|Full Clinical Hold by FDA|9|||
44303680|NCT02685826|79301722|FG002|Overall Study|Full Clinical Hold by FDA|20|||
44303681|NCT01177683|79301733|FG000|Study Treatment|Disease Progressions during treatment|2|||
44303682|NCT01177683|79301734|FG001|Study Treatment|Disease Progressions during treatment|0|||
44303683|NCT01177683|79301735|FG002|Study Treatment|Disease Progressions during treatment|3|||
44303684|NCT01177683|79301733|FG000|Study Treatment|Adverse Event|0|||
44303685|NCT01177683|79301734|FG001|Study Treatment|Adverse Event|1|||
44303686|NCT01177683|79301735|FG002|Study Treatment|Adverse Event|12|||
44303687|NCT01177683|79301733|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
44303688|NCT01177683|79301734|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
44303689|NCT01177683|79301735|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
44303690|NCT01177683|79301733|FG000|Study Treatment|Alternative therapy|0|||
44303691|NCT01177683|79301734|FG001|Study Treatment|Alternative therapy|0|||
44303692|NCT01177683|79301735|FG002|Study Treatment|Alternative therapy|4|||
44303693|NCT01177683|79301733|FG000|Study Treatment|Physician Decision|1|||
44303694|NCT01177683|79301734|FG001|Study Treatment|Physician Decision|0|||
44303695|NCT01177683|79301735|FG002|Study Treatment|Physician Decision|1|||
44303696|NCT01177683|79301733|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
44303697|NCT01177683|79301734|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
44303698|NCT01177683|79301735|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
44303699|NCT01177683|79301733|FG000|Study Treatment|Symptomatic Deterioration|0|||
44534311|NCT00098475|79544844|FG001|Step 1|Referred to other physicians|1|||
44534312|NCT00098475|79544845|FG002|Step 1|Referred to other physicians|0|||
44155084|NCT03766581|78946499|FG000|Treatment|Poor/Non compliance|2|||
44155085|NCT03766581|78946500|FG001|Treatment|Poor/Non compliance|2|||
44155086|NCT03766581|78946501|FG002|Treatment|Poor/Non compliance|1|||
44155087|NCT03766581|78946502|FG003|Treatment|Poor/Non compliance|1|||
44155088|NCT03766581|78946503|FG004|Treatment|Poor/Non compliance|1|||
44155089|NCT03766581|78946504|FG005|Treatment|Poor/Non compliance|1|||
44155090|NCT03766581|78946505|FG006|Treatment|Poor/Non compliance|0|||
44534313|NCT00098475|79544846|FG003|Step 1|Referred to other physicians|0|||
44303700|NCT01177683|79301734|FG001|Study Treatment|Symptomatic Deterioration|0|||
44303701|NCT01177683|79301735|FG002|Study Treatment|Symptomatic Deterioration|1|||
44303702|NCT01177683|79301733|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
44303703|NCT01177683|79301734|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
44303704|NCT01177683|79301735|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
44303705|NCT01177683|79301733|FG000|Follow up|Patient lost to follow up|0|||
44303706|NCT01177683|79301734|FG001|Follow up|Patient lost to follow up|0|||
44303707|NCT01177683|79301735|FG002|Follow up|Patient lost to follow up|2|||
44303708|NCT01177683|79301733|FG000|Follow up|Death|2|||
44303709|NCT01177683|79301734|FG001|Follow up|Death|1|||
44303710|NCT01177683|79301735|FG002|Follow up|Death|7|||
44155091|NCT03766581|78946506|FG007|Treatment|Poor/Non compliance|0|||
44303711|NCT01177683|79301733|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
44303712|NCT01177683|79301734|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
44303713|NCT01177683|79301735|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
44303714|NCT01084252|79301760|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
44303715|NCT01084252|79301761|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
44303716|NCT01084252|79301762|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
44155092|NCT03766581|78946499|FG000|Treatment|Participant no longer meets study criteria|9|||
44155093|NCT03766581|78946500|FG001|Treatment|Participant no longer meets study criteria|1|||
44155094|NCT03766581|78946501|FG002|Treatment|Participant no longer meets study criteria|5|||
44155095|NCT03766581|78946502|FG003|Treatment|Participant no longer meets study criteria|4|||
44155096|NCT03766581|78946503|FG004|Treatment|Participant no longer meets study criteria|4|||
44155097|NCT03766581|78946504|FG005|Treatment|Participant no longer meets study criteria|4|||
44155098|NCT03766581|78946505|FG006|Treatment|Participant no longer meets study criteria|2|||
44155099|NCT03766581|78946506|FG007|Treatment|Participant no longer meets study criteria|0|||
44155100|NCT03766581|78946499|FG000|Treatment|Other reasons|13|||
44155101|NCT03766581|78946500|FG001|Treatment|Other reasons|8|||
44155102|NCT03766581|78946501|FG002|Treatment|Other reasons|3|||
44303717|NCT01084252|79301763|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
44303718|NCT01084252|79301764|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
44303719|NCT01084252|79301765|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
44303720|NCT01084252|79301766|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
44303721|NCT01084252|79301767|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
44303722|NCT01084252|79301768|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
44303723|NCT01084252|79301769|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
44303724|NCT01084252|79301770|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
44303725|NCT01084252|79301771|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
44303726|NCT01084252|79301772|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
44303727|NCT01084252|79301773|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
44303728|NCT01084252|79301760|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
44303729|NCT01084252|79301761|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
44303730|NCT01084252|79301762|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
44303731|NCT01084252|79301763|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
44303732|NCT01084252|79301764|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
44303733|NCT01084252|79301765|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
44303734|NCT01084252|79301766|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
44303735|NCT01084252|79301767|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
44303736|NCT01084252|79301768|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
44303737|NCT01084252|79301769|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
44303738|NCT01084252|79301770|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
44303739|NCT01084252|79301771|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
44303740|NCT01084252|79301772|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
44303741|NCT01084252|79301773|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
44303742|NCT01084252|79301760|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
44303743|NCT01084252|79301761|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
44303744|NCT01084252|79301762|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
44303745|NCT01084252|79301763|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
44303746|NCT01084252|79301764|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
44303747|NCT01084252|79301765|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
44303748|NCT01084252|79301766|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
44303749|NCT01084252|79301767|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
44303750|NCT01084252|79301768|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
44303751|NCT01084252|79301769|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
44303752|NCT01084252|79301770|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
44303753|NCT01084252|79301771|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
44303754|NCT01084252|79301772|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
44303755|NCT01084252|79301773|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
44303756|NCT01084252|79301760|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303757|NCT01084252|79301761|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303758|NCT01084252|79301762|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303759|NCT01084252|79301763|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303760|NCT01084252|79301764|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303761|NCT01084252|79301765|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303762|NCT01084252|79301766|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303763|NCT01084252|79301767|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303764|NCT01084252|79301768|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44534314|NCT00098475|79544843|FG000|Step 1|Criteria to continue treatment not met|0|||
44417891|NCT00751881|79425896|FG000|Core Treatment Period|Other: protocol deviation|3|||
44303765|NCT01084252|79301769|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
44303766|NCT01084252|79301770|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
44303767|NCT01084252|79301771|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
44534315|NCT00098475|79544844|FG001|Step 1|Criteria to continue treatment not met|1|||
44534316|NCT00098475|79544845|FG002|Step 1|Criteria to continue treatment not met|0|||
44155103|NCT03766581|78946502|FG003|Treatment|Other reasons|7|||
44303768|NCT01084252|79301772|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303769|NCT01084252|79301773|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
44303770|NCT01084252|79301760|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303771|NCT01084252|79301761|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303772|NCT01084252|79301762|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303773|NCT01084252|79301763|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303774|NCT01084252|79301764|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303775|NCT01084252|79301765|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303776|NCT01084252|79301766|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303777|NCT01084252|79301767|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303778|NCT01084252|79301768|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
44303779|NCT01084252|79301769|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
44303780|NCT01084252|79301770|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
44303781|NCT01084252|79301771|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
44303782|NCT01084252|79301772|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303783|NCT01084252|79301773|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
44303784|NCT01084252|79301760|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303785|NCT01084252|79301761|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303786|NCT01084252|79301762|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303787|NCT01084252|79301763|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303788|NCT01084252|79301764|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303789|NCT01084252|79301765|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303790|NCT01084252|79301766|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303791|NCT01084252|79301767|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303792|NCT01084252|79301768|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
44303793|NCT01084252|79301769|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303794|NCT01084252|79301770|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
44303795|NCT01084252|79301771|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
44303796|NCT01084252|79301772|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303797|NCT01084252|79301773|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
44303798|NCT01084252|79301760|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303799|NCT01084252|79301761|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303800|NCT01084252|79301762|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303801|NCT01084252|79301763|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303802|NCT01084252|79301764|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303803|NCT01084252|79301765|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303804|NCT01084252|79301766|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303805|NCT01084252|79301767|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303806|NCT01084252|79301768|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
44303807|NCT01084252|79301769|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
44303808|NCT01084252|79301770|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
44303809|NCT01084252|79301771|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
44303810|NCT01084252|79301772|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303811|NCT01084252|79301773|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
44303812|NCT01084252|79301760|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303813|NCT01084252|79301761|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303814|NCT01084252|79301762|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303815|NCT01084252|79301763|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303816|NCT01084252|79301764|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303817|NCT01084252|79301765|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303818|NCT01084252|79301766|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303819|NCT01084252|79301767|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303820|NCT01084252|79301768|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303821|NCT01084252|79301769|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44417892|NCT00751881|79425897|FG001|Core Treatment Period|Other: protocol deviation|3|||
44417893|NCT00751881|79425898|FG002|Core Treatment Period|Other: protocol deviation|7|||
44417894|NCT00751881|79425896|FG000|Core Treatment Period|Other: wish to parent|5|||
44417895|NCT00751881|79425897|FG001|Core Treatment Period|Other: wish to parent|7|||
44417896|NCT00751881|79425898|FG002|Core Treatment Period|Other: wish to parent|4|||
44417897|NCT00751881|79425896|FG000|Core Treatment Period|Other: personal/family constraints|6|||
44417898|NCT00751881|79425897|FG001|Core Treatment Period|Other: personal/family constraints|7|||
44417899|NCT00751881|79425898|FG002|Core Treatment Period|Other: personal/family constraints|10|||
44417900|NCT00751881|79425896|FG000|Core Treatment Period|Other: MS treatment change|6|||
44303822|NCT01084252|79301770|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303823|NCT01084252|79301771|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
44303824|NCT01084252|79301772|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
44303825|NCT01084252|79301773|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
44303826|NCT01084252|79301760|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303827|NCT01084252|79301761|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303828|NCT01084252|79301762|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303829|NCT01084252|79301763|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303830|NCT01084252|79301764|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303831|NCT01084252|79301765|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303832|NCT01084252|79301766|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303833|NCT01084252|79301767|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303834|NCT01084252|79301768|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303835|NCT01084252|79301769|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303836|NCT01084252|79301770|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303837|NCT01084252|79301771|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
44303838|NCT01084252|79301772|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
44303839|NCT01084252|79301773|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
44303840|NCT01084252|79301760|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303841|NCT01084252|79301761|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303842|NCT01084252|79301762|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303843|NCT01084252|79301763|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303844|NCT01084252|79301764|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303845|NCT01084252|79301765|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303846|NCT01084252|79301766|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303847|NCT01084252|79301767|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303848|NCT01084252|79301768|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303849|NCT01084252|79301769|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303850|NCT01084252|79301770|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303851|NCT01084252|79301771|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303852|NCT01084252|79301772|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
44303853|NCT01084252|79301773|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
44303854|NCT01084252|79301760|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303855|NCT01084252|79301761|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303856|NCT01084252|79301762|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303857|NCT01084252|79301763|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303858|NCT01084252|79301764|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303859|NCT01084252|79301765|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303860|NCT01084252|79301766|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303861|NCT01084252|79301767|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303862|NCT01084252|79301768|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303863|NCT01084252|79301769|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303864|NCT01084252|79301770|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303865|NCT01084252|79301771|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
44303866|NCT01084252|79301772|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
44303867|NCT01084252|79301773|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
44303868|NCT01084252|79301760|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303869|NCT01084252|79301761|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303870|NCT01084252|79301762|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303871|NCT01084252|79301763|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303872|NCT01084252|79301764|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303873|NCT01084252|79301765|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303874|NCT01084252|79301766|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303875|NCT01084252|79301767|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303876|NCT01084252|79301768|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303877|NCT01084252|79301769|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303878|NCT01084252|79301770|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44417901|NCT00751881|79425897|FG001|Core Treatment Period|Other: MS treatment change|4|||
44534317|NCT00098475|79544846|FG003|Step 1|Criteria to continue treatment not met|0|||
44534318|NCT00098475|79544843|FG000|Step 1|Misinterpretation of lab data|0|||
44534319|NCT00098475|79544844|FG001|Step 1|Misinterpretation of lab data|1|||
44534320|NCT00098475|79544845|FG002|Step 1|Misinterpretation of lab data|0|||
44534321|NCT00098475|79544846|FG003|Step 1|Misinterpretation of lab data|0|||
44417902|NCT00751881|79425898|FG002|Core Treatment Period|Other: MS treatment change|4|||
44417903|NCT00751881|79425896|FG000|Core Treatment Period|Other: tolerability complaints|2|||
44534322|NCT00098475|79544843|FG000|Step 1|Patient fell with fracture|1|||
44303879|NCT01084252|79301771|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
44303880|NCT01084252|79301772|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
44417904|NCT00751881|79425897|FG001|Core Treatment Period|Other: tolerability complaints|0|||
44534323|NCT00098475|79544844|FG001|Step 1|Patient fell with fracture|0|||
44303881|NCT01084252|79301773|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
44303882|NCT01084252|79301760|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303883|NCT01084252|79301761|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303884|NCT01084252|79301762|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303885|NCT01084252|79301763|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303886|NCT01084252|79301764|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303887|NCT01084252|79301765|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303888|NCT01084252|79301766|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303889|NCT01084252|79301767|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303890|NCT01084252|79301768|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303891|NCT01084252|79301769|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303892|NCT01084252|79301770|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303893|NCT01084252|79301771|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303894|NCT01084252|79301772|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
44303895|NCT01084252|79301773|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
44303896|NCT00993044|79301837|FG000|Irinotecan 50 mg|Physician Decision|1|||
44303897|NCT00116272|79301844|FG000|Overall Study|Lost to Follow-up|11|||
44303898|NCT00116272|79301845|FG001|Overall Study|Lost to Follow-up|6|||
44303899|NCT01945021|79301853|FG000|Overall Study|Adverse Event|1|||
44303900|NCT01945021|79301853|FG000|Overall Study|Withdrawal of consent|12|||
44303901|NCT01945021|79301853|FG000|Overall Study|Lost to Follow-up|5|||
44303902|NCT01945021|79301853|FG000|Overall Study|Death|65|||
44303903|NCT01945060|79301859|FG000|Overall Study|Lost to follow up|1|||
44303904|NCT01945060|79301860|FG001|Overall Study|Lost to follow up|0|||
44303905|NCT01945060|79301859|FG000|Overall Study|Distress related to IV access|0|||
44303906|NCT01945060|79301860|FG001|Overall Study|Distress related to IV access|1|||
44303907|NCT03951077|79301903|FG000|Overall Study|Adverse Event|1|||
44303908|NCT03951077|79301904|FG001|Overall Study|Adverse Event|0|||
44303909|NCT03951077|79301905|FG002|Overall Study|Adverse Event|0|||
44303910|NCT03951077|79301906|FG003|Overall Study|Adverse Event|0|||
44303911|NCT03951077|79301907|FG004|Overall Study|Adverse Event|0|||
44303912|NCT03951077|79301908|FG005|Overall Study|Adverse Event|0|||
44303913|NCT03951077|79301903|FG000|Overall Study|Withdrawal by Subject|3|||
44303914|NCT03951077|79301904|FG001|Overall Study|Withdrawal by Subject|3|||
44303915|NCT03951077|79301905|FG002|Overall Study|Withdrawal by Subject|0|||
44303916|NCT03951077|79301906|FG003|Overall Study|Withdrawal by Subject|3|||
44303917|NCT03951077|79301907|FG004|Overall Study|Withdrawal by Subject|3|||
44303918|NCT03951077|79301908|FG005|Overall Study|Withdrawal by Subject|2|||
44303919|NCT03951077|79301903|FG000|Overall Study|Lost to Follow-up|1|||
44303920|NCT03951077|79301904|FG001|Overall Study|Lost to Follow-up|1|||
44303921|NCT03951077|79301905|FG002|Overall Study|Lost to Follow-up|2|||
44303922|NCT03951077|79301906|FG003|Overall Study|Lost to Follow-up|3|||
44303923|NCT03951077|79301907|FG004|Overall Study|Lost to Follow-up|2|||
44303924|NCT03951077|79301908|FG005|Overall Study|Lost to Follow-up|3|||
44303925|NCT03951077|79301903|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
44303926|NCT03951077|79301904|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
44303927|NCT03951077|79301905|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
44303928|NCT03951077|79301906|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
44303929|NCT03951077|79301907|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
44303930|NCT03951077|79301908|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
44303931|NCT03951077|79301903|FG000|Overall Study|Other, Not Specified|12|||
44303932|NCT03951077|79301904|FG001|Overall Study|Other, Not Specified|10|||
44303933|NCT03951077|79301905|FG002|Overall Study|Other, Not Specified|10|||
44303934|NCT03951077|79301906|FG003|Overall Study|Other, Not Specified|5|||
44303935|NCT03951077|79301907|FG004|Overall Study|Other, Not Specified|9|||
44303936|NCT03951077|79301908|FG005|Overall Study|Other, Not Specified|6|||
44303937|NCT03951077|79301903|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
44303938|NCT03951077|79301904|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
44303939|NCT03951077|79301905|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
44303940|NCT03951077|79301906|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
44303941|NCT03951077|79301907|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
44303942|NCT03951077|79301908|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
44534324|NCT00098475|79544845|FG002|Step 1|Patient fell with fracture|0|||
44303943|NCT03873246|79301925|FG000|Overall Study|Adverse Event|1|||
44303944|NCT03873246|79301926|FG001|Overall Study|Adverse Event|3|||
44303945|NCT03873246|79301927|FG002|Overall Study|Adverse Event|3|||
44303946|NCT03873246|79301925|FG000|Overall Study|Lost to Follow-up|4|||
44303947|NCT03873246|79301926|FG001|Overall Study|Lost to Follow-up|4|||
44303948|NCT03873246|79301927|FG002|Overall Study|Lost to Follow-up|5|||
44303949|NCT03873246|79301925|FG000|Overall Study|Protocol Violation|0|||
44303950|NCT03873246|79301926|FG001|Overall Study|Protocol Violation|1|||
44303951|NCT03873246|79301927|FG002|Overall Study|Protocol Violation|0|||
44303952|NCT03873246|79301925|FG000|Overall Study|Withdrawal by Subject|0|||
44303953|NCT03873246|79301926|FG001|Overall Study|Withdrawal by Subject|4|||
44303954|NCT03873246|79301927|FG002|Overall Study|Withdrawal by Subject|1|||
44303955|NCT03769649|79301936|FG000|Overall Study|Lost to Follow-up|4|||
44303956|NCT02862548|79301962|FG000|Randomized Phase (Up to Week 48)|Death|0|||
44303957|NCT02862548|79301963|FG001|Randomized Phase (Up to Week 48)|Death|1|||
44303958|NCT02862548|79301962|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
44303959|NCT02862548|79301963|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
44303960|NCT02862548|79301962|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
44303961|NCT02862548|79301963|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
44303962|NCT02862548|79301962|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
44303963|NCT02862548|79301963|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
44303964|NCT02335099|79301982|FG000|Treatment|Withdrawal by Subject|1|||
44303965|NCT02335099|79301983|FG001|Treatment|Withdrawal by Subject|3|||
44303966|NCT02335099|79301982|FG000|Treatment|Lost to Follow-up|2|||
44303967|NCT02335099|79301983|FG001|Treatment|Lost to Follow-up|0|||
44303968|NCT02335099|79301982|FG000|Treatment|Death|1|||
44303969|NCT02335099|79301983|FG001|Treatment|Death|0|||
44303970|NCT02335099|79301982|FG000|Treatment|Adverse Event|1|||
44303971|NCT02335099|79301983|FG001|Treatment|Adverse Event|2|||
44303972|NCT02335099|79301982|FG000|Follow-up|Death|0|||
44303973|NCT02335099|79301983|FG001|Follow-up|Death|1|||
44303974|NCT02330562|79302000|FG000|Overall Study|Adverse Event|0|||
44303975|NCT02330562|79302001|FG001|Overall Study|Adverse Event|0|||
44534325|NCT00098475|79544846|FG003|Step 1|Patient fell with fracture|0|||
44534326|NCT00098475|79544843|FG000|Step 1|Not documented|0|||
44534327|NCT00098475|79544844|FG001|Step 1|Not documented|1|||
44534328|NCT00098475|79544845|FG002|Step 1|Not documented|0|||
44534329|NCT00098475|79544846|FG003|Step 1|Not documented|0|||
44534330|NCT00098475|79544843|FG000|Step 2|Disease progression|1|||
44534331|NCT00098475|79544844|FG001|Step 2|Disease progression|4|||
44534332|NCT00098475|79544845|FG002|Step 2|Disease progression|0|||
44534333|NCT00098475|79544846|FG003|Step 2|Disease progression|0|||
44534334|NCT00098475|79544843|FG000|Step 2|Adverse Event|2|||
44534335|NCT00098475|79544844|FG001|Step 2|Adverse Event|0|||
44534336|NCT00098475|79544845|FG002|Step 2|Adverse Event|0|||
44534337|NCT00098475|79544846|FG003|Step 2|Adverse Event|0|||
44534338|NCT00098475|79544843|FG000|Step 2|Withdrawal by Subject|0|||
44534339|NCT00098475|79544844|FG001|Step 2|Withdrawal by Subject|2|||
44534340|NCT00098475|79544845|FG002|Step 2|Withdrawal by Subject|0|||
44534341|NCT00098475|79544846|FG003|Step 2|Withdrawal by Subject|0|||
44534342|NCT00098475|79544843|FG000|Step 2|Physician Decision|0|||
44534343|NCT00098475|79544844|FG001|Step 2|Physician Decision|1|||
44534344|NCT00098475|79544845|FG002|Step 2|Physician Decision|0|||
44534345|NCT00098475|79544846|FG003|Step 2|Physician Decision|0|||
44534346|NCT00098475|79544843|FG000|Step 2|Alternative therapy|1|||
44303976|NCT02330562|79302002|FG002|Overall Study|Adverse Event|3|||
44303977|NCT02330562|79302003|FG003|Overall Study|Adverse Event|0|||
44303978|NCT02330562|79302004|FG004|Overall Study|Adverse Event|3|||
44303979|NCT02330562|79302005|FG005|Overall Study|Adverse Event|1|||
44303980|NCT02330562|79302006|FG006|Overall Study|Adverse Event|0|||
44303981|NCT02330562|79302007|FG007|Overall Study|Adverse Event|0|||
44303982|NCT02330562|79302008|FG008|Overall Study|Adverse Event|0|||
44303983|NCT02330562|79302009|FG009|Overall Study|Adverse Event|1|||
44303984|NCT02330562|79302010|FG010|Overall Study|Adverse Event|1|||
44303985|NCT02330562|79302000|FG000|Overall Study|Participant decision|1|||
44303986|NCT02330562|79302001|FG001|Overall Study|Participant decision|0|||
44303987|NCT02330562|79302002|FG002|Overall Study|Participant decision|4|||
44303988|NCT02330562|79302003|FG003|Overall Study|Participant decision|1|||
44303989|NCT02330562|79302004|FG004|Overall Study|Participant decision|5|||
44303990|NCT02330562|79302005|FG005|Overall Study|Participant decision|2|||
44303991|NCT02330562|79302006|FG006|Overall Study|Participant decision|0|||
44303992|NCT02330562|79302007|FG007|Overall Study|Participant decision|0|||
44534347|NCT00098475|79544844|FG001|Step 2|Alternative therapy|2|||
44534348|NCT00098475|79544845|FG002|Step 2|Alternative therapy|0|||
44303993|NCT02330562|79302008|FG008|Overall Study|Participant decision|0|||
44303994|NCT02330562|79302009|FG009|Overall Study|Participant decision|3|||
44303995|NCT02330562|79302010|FG010|Overall Study|Participant decision|0|||
44303996|NCT02330562|79302000|FG000|Overall Study|Disease progression|5|||
44303997|NCT02330562|79302001|FG001|Overall Study|Disease progression|3|||
44303998|NCT02330562|79302002|FG002|Overall Study|Disease progression|20|||
44534349|NCT00098475|79544846|FG003|Step 2|Alternative therapy|0|||
44303999|NCT02330562|79302003|FG003|Overall Study|Disease progression|28|||
44304000|NCT02330562|79302004|FG004|Overall Study|Disease progression|23|||
44304001|NCT02330562|79302005|FG005|Overall Study|Disease progression|7|||
44304002|NCT02330562|79302006|FG006|Overall Study|Disease progression|1|||
44304003|NCT02330562|79302007|FG007|Overall Study|Disease progression|1|||
44304004|NCT02330562|79302008|FG008|Overall Study|Disease progression|1|||
44304005|NCT02330562|79302009|FG009|Overall Study|Disease progression|0|||
44534350|NCT00098475|79544843|FG000|Step 2|Never started treatment|1|||
44534351|NCT00098475|79544844|FG001|Step 2|Never started treatment|1|||
44304006|NCT02330562|79302010|FG010|Overall Study|Disease progression|5|||
44304007|NCT02330562|79302000|FG000|Overall Study|Other reasons|0|||
44304008|NCT02330562|79302001|FG001|Overall Study|Other reasons|0|||
44304009|NCT02330562|79302002|FG002|Overall Study|Other reasons|0|||
44304010|NCT02330562|79302003|FG003|Overall Study|Other reasons|1|||
44304011|NCT02330562|79302004|FG004|Overall Study|Other reasons|0|||
44304012|NCT02330562|79302005|FG005|Overall Study|Other reasons|0|||
44304013|NCT02330562|79302006|FG006|Overall Study|Other reasons|0|||
44304014|NCT02330562|79302007|FG007|Overall Study|Other reasons|0|||
44304015|NCT02330562|79302008|FG008|Overall Study|Other reasons|0|||
44304016|NCT02330562|79302009|FG009|Overall Study|Other reasons|0|||
44304017|NCT02330562|79302010|FG010|Overall Study|Other reasons|0|||
44304018|NCT02330562|79302000|FG000|Overall Study|Withdrawal by Subject|0|||
44304019|NCT02330562|79302001|FG001|Overall Study|Withdrawal by Subject|0|||
44304020|NCT02330562|79302002|FG002|Overall Study|Withdrawal by Subject|0|||
44304021|NCT02330562|79302003|FG003|Overall Study|Withdrawal by Subject|0|||
44304022|NCT02330562|79302004|FG004|Overall Study|Withdrawal by Subject|0|||
44304023|NCT02330562|79302005|FG005|Overall Study|Withdrawal by Subject|0|||
44304024|NCT02330562|79302006|FG006|Overall Study|Withdrawal by Subject|0|||
44304025|NCT02330562|79302007|FG007|Overall Study|Withdrawal by Subject|0|||
44304026|NCT02330562|79302008|FG008|Overall Study|Withdrawal by Subject|0|||
44304027|NCT02330562|79302009|FG009|Overall Study|Withdrawal by Subject|1|||
44304028|NCT02330562|79302010|FG010|Overall Study|Withdrawal by Subject|0|||
44304029|NCT03703102|79302124|FG000|Overall Study|Adverse Event|4|||
44304030|NCT03703102|79302125|FG001|Overall Study|Adverse Event|3|||
44304031|NCT03703102|79302126|FG002|Overall Study|Adverse Event|7|||
44304032|NCT03703102|79302127|FG003|Overall Study|Adverse Event|3|||
44304033|NCT03703102|79302128|FG004|Overall Study|Adverse Event|13|||
44304034|NCT03703102|79302124|FG000|Overall Study|Lack of Efficacy|4|||
44417905|NCT00751881|79425898|FG002|Core Treatment Period|Other: tolerability complaints|0|||
44417906|NCT00751881|79425896|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
44417907|NCT00751881|79425897|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
44534352|NCT00098475|79544845|FG002|Step 2|Never started treatment|0|||
44534353|NCT00098475|79544846|FG003|Step 2|Never started treatment|0|||
44534354|NCT03136484|79544862|FG000|Overall Study|Withdrawal by Subject|19|||
44534355|NCT03136484|79544863|FG001|Overall Study|Withdrawal by Subject|14|||
44155104|NCT03766581|78946503|FG004|Treatment|Other reasons|3|||
44534356|NCT03136484|79544862|FG000|Overall Study|Lost to Follow-up|7|||
44534357|NCT03136484|79544863|FG001|Overall Study|Lost to Follow-up|8|||
44534358|NCT03136484|79544862|FG000|Overall Study|Death|1|||
44534359|NCT03136484|79544863|FG001|Overall Study|Death|0|||
44534360|NCT03922711|79544872|FG000|Overall Study|Adverse Event|3|||
44534361|NCT03922711|79544873|FG001|Overall Study|Adverse Event|2|||
44534362|NCT03922711|79544874|FG002|Overall Study|Adverse Event|2|||
44534363|NCT03922711|79544872|FG000|Overall Study|Protocol Violation|1|||
44534364|NCT03922711|79544873|FG001|Overall Study|Protocol Violation|0|||
44534365|NCT03922711|79544874|FG002|Overall Study|Protocol Violation|0|||
44155105|NCT03766581|78946504|FG005|Treatment|Other reasons|3|||
44256850|NCT04566601|79109104|FG003|Overall Study|Other than listed|1|||
44256851|NCT04566601|79109105|FG004|Overall Study|Other than listed|4|||
44256852|NCT04566601|79109101|FG000|Overall Study|Protocol deviation|3|||
44256853|NCT04566601|79109102|FG001|Overall Study|Protocol deviation|0|||
44256854|NCT04566601|79109103|FG002|Overall Study|Protocol deviation|1|||
44256855|NCT04566601|79109104|FG003|Overall Study|Protocol deviation|1|||
44256856|NCT04566601|79109105|FG004|Overall Study|Protocol deviation|1|||
44256857|NCT04566601|79109101|FG000|Overall Study|Technical problems|0|||
44304035|NCT03703102|79302125|FG001|Overall Study|Lack of Efficacy|0|||
44304036|NCT03703102|79302126|FG002|Overall Study|Lack of Efficacy|1|||
44304037|NCT03703102|79302127|FG003|Overall Study|Lack of Efficacy|4|||
44304038|NCT03703102|79302128|FG004|Overall Study|Lack of Efficacy|1|||
44417908|NCT00751881|79425898|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
44534366|NCT03922711|79544872|FG000|Overall Study|Withdrawal by Subject|0|||
44155106|NCT03766581|78946505|FG006|Treatment|Other reasons|0|||
44256858|NCT04566601|79109102|FG001|Overall Study|Technical problems|0|||
44256859|NCT04566601|79109103|FG002|Overall Study|Technical problems|1|||
44304039|NCT03703102|79302124|FG000|Overall Study|Lost to Follow-up|0|||
44304040|NCT03703102|79302125|FG001|Overall Study|Lost to Follow-up|0|||
44304041|NCT03703102|79302126|FG002|Overall Study|Lost to Follow-up|1|||
44304042|NCT03703102|79302127|FG003|Overall Study|Lost to Follow-up|2|||
44304043|NCT03703102|79302128|FG004|Overall Study|Lost to Follow-up|2|||
44417909|NCT00751881|79425896|FG000|Extension Study Period|Adverse Event|18|||
44417910|NCT00751881|79425897|FG001|Extension Study Period|Adverse Event|20|||
44417911|NCT00751881|79425898|FG002|Extension Study Period|Adverse Event|21|||
44534367|NCT03922711|79544873|FG001|Overall Study|Withdrawal by Subject|3|||
44534368|NCT03922711|79544874|FG002|Overall Study|Withdrawal by Subject|1|||
44534369|NCT03922711|79544872|FG000|Overall Study|Not further specified|0|||
44534370|NCT03922711|79544873|FG001|Overall Study|Not further specified|0|||
44534371|NCT03922711|79544874|FG002|Overall Study|Not further specified|1|||
44534372|NCT02877680|79544883|FG000|Overall Study|Lost to Follow-up|1|||
44534373|NCT02877680|79544884|FG001|Overall Study|Lost to Follow-up|1|||
44534374|NCT03141086|79544896|FG000|Overall Study|Study Terminated By Sponsor|1|||
44534375|NCT03141086|79544897|FG001|Overall Study|Study Terminated By Sponsor|1|||
44534376|NCT03141086|79544896|FG000|Overall Study|Withdrawal by Subject|0|||
44534377|NCT03141086|79544897|FG001|Overall Study|Withdrawal by Subject|1|||
44534378|NCT03141086|79544896|FG000|Overall Study|Protocol Violation|0|||
44534379|NCT03141086|79544897|FG001|Overall Study|Protocol Violation|1|||
44534380|NCT03141086|79544896|FG000|Overall Study|Adverse Event|0|||
44534381|NCT03141086|79544897|FG001|Overall Study|Adverse Event|2|||
44534382|NCT03135548|79544906|FG000|Overall Study|Lost to Follow-up|3|||
44534383|NCT03135548|79544907|FG001|Overall Study|Lost to Follow-up|0|||
44534384|NCT03135548|79544908|FG002|Overall Study|Lost to Follow-up|0|||
44534385|NCT03135548|79544906|FG000|Overall Study|Withdrawal by Subject|2|||
44534386|NCT03135548|79544907|FG001|Overall Study|Withdrawal by Subject|2|||
44534387|NCT03135548|79544908|FG002|Overall Study|Withdrawal by Subject|1|||
44534388|NCT03135548|79544906|FG000|Overall Study|Other than listed|0|||
44534389|NCT03135548|79544907|FG001|Overall Study|Other than listed|2|||
44534390|NCT03135548|79544908|FG002|Overall Study|Other than listed|2|||
44534391|NCT03134222|79544919|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
44534392|NCT03134222|79544920|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
44534393|NCT03134222|79544921|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
44534394|NCT03134222|79544922|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
44534395|NCT03134222|79544923|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
44534396|NCT03134222|79544919|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
44534397|NCT03134222|79544920|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
44534398|NCT03134222|79544921|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
44534399|NCT03134222|79544922|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
44534400|NCT03134222|79544923|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
44534401|NCT03134222|79544919|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
44304044|NCT03703102|79302124|FG000|Overall Study|Physician Decision|2|||
44304045|NCT03703102|79302125|FG001|Overall Study|Physician Decision|2|||
44304046|NCT03703102|79302126|FG002|Overall Study|Physician Decision|2|||
44304047|NCT03703102|79302127|FG003|Overall Study|Physician Decision|2|||
44304048|NCT03703102|79302128|FG004|Overall Study|Physician Decision|4|||
44534402|NCT03134222|79544920|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
44304049|NCT03703102|79302124|FG000|Overall Study|Withdrawal by Subject|7|||
44304050|NCT03703102|79302125|FG001|Overall Study|Withdrawal by Subject|5|||
44304051|NCT03703102|79302126|FG002|Overall Study|Withdrawal by Subject|5|||
44417912|NCT00751881|79425896|FG000|Extension Study Period|Lack of Efficacy|14|||
44417913|NCT00751881|79425897|FG001|Extension Study Period|Lack of Efficacy|10|||
44534403|NCT03134222|79544921|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
44534404|NCT03134222|79544922|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
44534405|NCT03134222|79544923|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
44534406|NCT03134222|79544919|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
44304052|NCT03703102|79302127|FG003|Overall Study|Withdrawal by Subject|5|||
44304053|NCT03703102|79302128|FG004|Overall Study|Withdrawal by Subject|9|||
44304054|NCT03703102|79302124|FG000|Overall Study|Ineligibility|0|||
44304055|NCT03703102|79302125|FG001|Overall Study|Ineligibility|0|||
44304056|NCT03703102|79302126|FG002|Overall Study|Ineligibility|1|||
44304057|NCT03703102|79302127|FG003|Overall Study|Ineligibility|0|||
44304058|NCT03703102|79302128|FG004|Overall Study|Ineligibility|0|||
44304059|NCT03703102|79302124|FG000|Overall Study|Protocol Deviation|4|||
44304060|NCT03703102|79302125|FG001|Overall Study|Protocol Deviation|4|||
44304061|NCT03703102|79302126|FG002|Overall Study|Protocol Deviation|3|||
44304062|NCT03703102|79302127|FG003|Overall Study|Protocol Deviation|0|||
44304063|NCT03703102|79302128|FG004|Overall Study|Protocol Deviation|0|||
44304064|NCT03703102|79302124|FG000|Overall Study|Non-Compliance with Study Drug|1|||
44304065|NCT03703102|79302125|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44304066|NCT03703102|79302126|FG002|Overall Study|Non-Compliance with Study Drug|2|||
44304067|NCT03703102|79302127|FG003|Overall Study|Non-Compliance with Study Drug|1|||
44304068|NCT03703102|79302128|FG004|Overall Study|Non-Compliance with Study Drug|4|||
44304069|NCT03395704|79302147|FG000|Overall Study|Adverse Event|2|||
44304070|NCT03395704|79302148|FG001|Overall Study|Adverse Event|1|||
44304071|NCT03395704|79302147|FG000|Overall Study|Withdrawal by Subject|2|||
44304072|NCT03395704|79302148|FG001|Overall Study|Withdrawal by Subject|1|||
44304073|NCT03395704|79302147|FG000|Overall Study|Physician Decision|0|||
44304074|NCT03395704|79302148|FG001|Overall Study|Physician Decision|1|||
44304075|NCT03335813|79302154|FG000|Overall Study|Withdrawal by Subject|1|||
44304076|NCT03246503|79302158|FG000|Overall Study|Lost to Follow-up|23|||
44304077|NCT03246503|79302158|FG000|Overall Study|Withdrawal by Subject|20|||
44304078|NCT03246503|79302158|FG000|Overall Study|Physician Decision|5|||
44304079|NCT03246503|79302158|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
44304080|NCT02514447|79302219|FG000|Overall Study|Withdrawal by Subject|3|||
44304081|NCT02514447|79302220|FG001|Overall Study|Withdrawal by Subject|1|||
44304082|NCT02514447|79302221|FG002|Overall Study|Withdrawal by Subject|1|||
44304083|NCT02514447|79302222|FG003|Overall Study|Withdrawal by Subject|0|||
44304084|NCT02514447|79302223|FG004|Overall Study|Withdrawal by Subject|0|||
44304085|NCT02514447|79302224|FG005|Overall Study|Withdrawal by Subject|0|||
44304086|NCT02514447|79302225|FG006|Overall Study|Withdrawal by Subject|0|||
44304087|NCT02514447|79302226|FG007|Overall Study|Withdrawal by Subject|1|||
44304088|NCT02514447|79302227|FG008|Overall Study|Withdrawal by Subject|1|||
44304089|NCT02514447|79302219|FG000|Overall Study|Death|24|||
44304090|NCT02514447|79302220|FG001|Overall Study|Death|28|||
44304091|NCT02514447|79302221|FG002|Overall Study|Death|29|||
44304092|NCT02514447|79302222|FG003|Overall Study|Death|0|||
44304093|NCT02514447|79302223|FG004|Overall Study|Death|3|||
44304094|NCT02514447|79302224|FG005|Overall Study|Death|4|||
44304095|NCT02514447|79302225|FG006|Overall Study|Death|8|||
44304096|NCT02514447|79302226|FG007|Overall Study|Death|6|||
44304097|NCT02514447|79302227|FG008|Overall Study|Death|5|||
44304098|NCT02514447|79302219|FG000|Overall Study|Lost to Follow-up|1|||
44304099|NCT02514447|79302220|FG001|Overall Study|Lost to Follow-up|0|||
44304100|NCT02514447|79302221|FG002|Overall Study|Lost to Follow-up|0|||
44304101|NCT02514447|79302222|FG003|Overall Study|Lost to Follow-up|0|||
44304102|NCT02514447|79302223|FG004|Overall Study|Lost to Follow-up|0|||
44304103|NCT02514447|79302224|FG005|Overall Study|Lost to Follow-up|0|||
44304104|NCT02514447|79302225|FG006|Overall Study|Lost to Follow-up|0|||
44304105|NCT02514447|79302226|FG007|Overall Study|Lost to Follow-up|0|||
44304106|NCT02514447|79302227|FG008|Overall Study|Lost to Follow-up|1|||
44304107|NCT02514447|79302219|FG000|Overall Study|Sponsor Termination of Study|0|||
44304108|NCT02514447|79302220|FG001|Overall Study|Sponsor Termination of Study|1|||
44304109|NCT02514447|79302221|FG002|Overall Study|Sponsor Termination of Study|1|||
44304110|NCT02514447|79302222|FG003|Overall Study|Sponsor Termination of Study|0|||
44304111|NCT02514447|79302223|FG004|Overall Study|Sponsor Termination of Study|0|||
44304112|NCT02514447|79302224|FG005|Overall Study|Sponsor Termination of Study|0|||
44155107|NCT03766581|78946506|FG007|Treatment|Other reasons|0|||
44155108|NCT03675321|78946531|FG000|Overall Study|Lack of Efficacy|2|||
44155109|NCT03675321|78946532|FG001|Overall Study|Lack of Efficacy|2|||
44304113|NCT02514447|79302225|FG006|Overall Study|Sponsor Termination of Study|0|||
44417914|NCT00751881|79425898|FG002|Extension Study Period|Lack of Efficacy|20|||
44155110|NCT03675321|78946531|FG000|Overall Study|Withdrawal by Subject|1|||
44155111|NCT03675321|78946532|FG001|Overall Study|Withdrawal by Subject|3|||
44304114|NCT02514447|79302226|FG007|Overall Study|Sponsor Termination of Study|0|||
44304115|NCT02514447|79302227|FG008|Overall Study|Sponsor Termination of Study|0|||
44304116|NCT02514447|79302219|FG000|Overall Study|Study completion per Investigator|1|||
44417915|NCT00751881|79425896|FG000|Extension Study Period|Lost to Follow-up|4|||
44304117|NCT02514447|79302220|FG001|Overall Study|Study completion per Investigator|0|||
44304118|NCT02514447|79302221|FG002|Overall Study|Study completion per Investigator|1|||
44304119|NCT02514447|79302222|FG003|Overall Study|Study completion per Investigator|2|||
44304120|NCT02514447|79302223|FG004|Overall Study|Study completion per Investigator|0|||
44304121|NCT02514447|79302224|FG005|Overall Study|Study completion per Investigator|0|||
44304122|NCT02514447|79302225|FG006|Overall Study|Study completion per Investigator|0|||
44417916|NCT00751881|79425897|FG001|Extension Study Period|Lost to Follow-up|9|||
44417917|NCT00751881|79425898|FG002|Extension Study Period|Lost to Follow-up|6|||
44417918|NCT00751881|79425896|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
44417919|NCT00751881|79425897|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
44417920|NCT00751881|79425898|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
44417921|NCT00751881|79425896|FG000|Extension Study Period|Other than specified above|26|||
44417922|NCT00751881|79425897|FG001|Extension Study Period|Other than specified above|30|||
44417923|NCT00751881|79425898|FG002|Extension Study Period|Other than specified above|18|||
44417924|NCT00747474|79425912|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44304123|NCT02514447|79302226|FG007|Overall Study|Study completion per Investigator|0|||
44304124|NCT02514447|79302227|FG008|Overall Study|Study completion per Investigator|1|||
44304125|NCT01785563|79302271|FG000|Overall Study|Physician Decision|10|||
44304126|NCT01785563|79302271|FG000|Overall Study|Withdrawal by Subject|1|||
44417925|NCT00747474|79425913|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417926|NCT00747474|79425914|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417927|NCT00747474|79425915|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417928|NCT00747474|79425916|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417929|NCT00747474|79425917|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417930|NCT00747474|79425918|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417931|NCT00747474|79425919|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
44417932|NCT00747474|79425920|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417933|NCT00747474|79425921|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417934|NCT00747474|79425922|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417935|NCT00747474|79425923|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
44417936|NCT00830063|79425932|FG000|Overall Study|Adverse Event|7|||
44417937|NCT00830063|79425933|FG001|Overall Study|Adverse Event|13|||
44417938|NCT00830063|79425934|FG002|Overall Study|Adverse Event|16|||
44417939|NCT00830063|79425935|FG003|Overall Study|Adverse Event|13|||
44417940|NCT00830063|79425932|FG000|Overall Study|Death|1|||
44417941|NCT00830063|79425933|FG001|Overall Study|Death|0|||
44417942|NCT00830063|79425934|FG002|Overall Study|Death|0|||
44417943|NCT00830063|79425935|FG003|Overall Study|Death|0|||
44417944|NCT00830063|79425932|FG000|Overall Study|Lost to Follow-up|0|||
44417945|NCT00830063|79425933|FG001|Overall Study|Lost to Follow-up|0|||
44417946|NCT00830063|79425934|FG002|Overall Study|Lost to Follow-up|3|||
44417947|NCT00830063|79425935|FG003|Overall Study|Lost to Follow-up|1|||
44417948|NCT00830063|79425932|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
44417949|NCT00830063|79425933|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
44417950|NCT00830063|79425934|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
44417951|NCT00830063|79425935|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
44417952|NCT00830063|79425932|FG000|Overall Study|Lack of Efficacy|51|||
44417953|NCT00830063|79425933|FG001|Overall Study|Lack of Efficacy|23|||
44417954|NCT00830063|79425934|FG002|Overall Study|Lack of Efficacy|25|||
44417955|NCT00830063|79425935|FG003|Overall Study|Lack of Efficacy|32|||
44417956|NCT00830063|79425932|FG000|Overall Study|Other|5|||
44417957|NCT00830063|79425933|FG001|Overall Study|Other|5|||
44417958|NCT00830063|79425934|FG002|Overall Study|Other|8|||
44417959|NCT00830063|79425935|FG003|Overall Study|Other|6|||
44417960|NCT00830063|79425932|FG000|Overall Study|Withdrawal by Subject|16|||
44417961|NCT00830063|79425933|FG001|Overall Study|Withdrawal by Subject|10|||
44417962|NCT00830063|79425934|FG002|Overall Study|Withdrawal by Subject|16|||
44417963|NCT00830063|79425935|FG003|Overall Study|Withdrawal by Subject|13|||
44417964|NCT00830063|79425932|FG000|Overall Study|Protocol Violation|1|||
44417965|NCT00830063|79425933|FG001|Overall Study|Protocol Violation|0|||
44417966|NCT00830063|79425934|FG002|Overall Study|Protocol Violation|3|||
44417967|NCT00830063|79425935|FG003|Overall Study|Protocol Violation|2|||
44417968|NCT00830063|79425932|FG000|Overall Study|Randomized But Not Treated|0|||
44417969|NCT00830063|79425933|FG001|Overall Study|Randomized But Not Treated|2|||
44417970|NCT00830063|79425934|FG002|Overall Study|Randomized But Not Treated|0|||
44417971|NCT00830063|79425935|FG003|Overall Study|Randomized But Not Treated|2|||
44417972|NCT00750438|79425949|FG000|Overall Study|Protocol Violation|4|||
44417973|NCT00750438|79425950|FG001|Overall Study|Protocol Violation|1|||
44304127|NCT01785563|79302271|FG000|Overall Study|Protocol Violation|2|||
44304128|NCT01434290|79302277|FG000|Overall Study|Protocol Violation|6|||
44304129|NCT01434290|79302278|FG001|Overall Study|Protocol Violation|3|||
44304130|NCT01434290|79302277|FG000|Overall Study|No protocol treatment|2|||
44304131|NCT01434290|79302278|FG001|Overall Study|No protocol treatment|4|||
44417974|NCT00750438|79425949|FG000|Overall Study|Physician Decision|2|||
44417975|NCT00750438|79425950|FG001|Overall Study|Physician Decision|2|||
44417976|NCT00750438|79425949|FG000|Overall Study|Withdrawal by Subject|1|||
44304132|NCT00750269|79302290|FG000|Overall Study|Protocol Violation|0|||
44417977|NCT00750438|79425950|FG001|Overall Study|Withdrawal by Subject|1|||
44417978|NCT00586326|79425956|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
44304133|NCT00750269|79302291|FG001|Overall Study|Protocol Violation|1|||
44417979|NCT00586326|79425956|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
44417980|NCT00586326|79425956|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
44417981|NCT00586326|79425956|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
44417982|NCT00586326|79425956|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
44417983|NCT00586326|79425956|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
44417984|NCT00586326|79425956|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
44417985|NCT00586326|79425956|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
44417986|NCT00586326|79425956|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
44417987|NCT00586326|79425956|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
44417988|NCT00586326|79425956|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
44417989|NCT00586326|79425956|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
44417990|NCT00586326|79425956|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
44417991|NCT00586326|79425956|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
44417992|NCT00586326|79425956|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
44417993|NCT00586326|79425956|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
44417994|NCT00586326|79425956|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
44417995|NCT00751101|79425966|FG000|Overall Study|Withdrawal by Subject|1|||
44417996|NCT00751101|79425967|FG001|Overall Study|Withdrawal by Subject|0|||
44417997|NCT00751101|79425966|FG000|Overall Study|No HFS / Never Started Patch/|0|||
44417998|NCT00751101|79425967|FG001|Overall Study|No HFS / Never Started Patch/|4|||
44417999|NCT00751101|79425966|FG000|Overall Study|Never began capecitabine|1|||
44418000|NCT00751101|79425967|FG001|Overall Study|Never began capecitabine|0|||
44418001|NCT00751101|79425966|FG000|Overall Study|Physician Decision|0|||
44418002|NCT00751101|79425967|FG001|Overall Study|Physician Decision|1|||
44418003|NCT00750204|79425979|FG000|Overall Study|study halted prematurely|1|||
44418004|NCT00750204|79425980|FG001|Overall Study|study halted prematurely|1|||
44418005|NCT00751023|79425988|FG000|Overall Study|Lost to Follow-up|11|||
44418006|NCT00751023|79425989|FG001|Overall Study|Lost to Follow-up|7|||
44418007|NCT00591773|79425998|FG000|Overall Study|Adverse Event|9|||
44418008|NCT00591773|79425999|FG001|Overall Study|Adverse Event|9|||
44418009|NCT00591773|79426000|FG002|Overall Study|Adverse Event|6|||
44418010|NCT00591773|79425998|FG000|Overall Study|Protocol Violation|2|||
44418011|NCT00591773|79425999|FG001|Overall Study|Protocol Violation|3|||
44418012|NCT00591773|79426000|FG002|Overall Study|Protocol Violation|0|||
44418013|NCT00591773|79425998|FG000|Overall Study|Lost to Follow-up|1|||
44418014|NCT00591773|79425999|FG001|Overall Study|Lost to Follow-up|4|||
44418015|NCT00591773|79426000|FG002|Overall Study|Lost to Follow-up|1|||
44418016|NCT00591773|79425998|FG000|Overall Study|Withdrawal by Subject|2|||
44418017|NCT00591773|79425999|FG001|Overall Study|Withdrawal by Subject|5|||
44418018|NCT00591773|79426000|FG002|Overall Study|Withdrawal by Subject|3|||
44418019|NCT00591773|79425998|FG000|Overall Study|Lack of Efficacy|1|||
44418020|NCT00591773|79425999|FG001|Overall Study|Lack of Efficacy|2|||
44418021|NCT00591773|79426000|FG002|Overall Study|Lack of Efficacy|2|||
44418022|NCT00591773|79425998|FG000|Overall Study|Other|1|||
44418023|NCT00591773|79425999|FG001|Overall Study|Other|1|||
44418024|NCT00591773|79426000|FG002|Overall Study|Other|4|||
44418025|NCT00750867|79426008|FG000|Overall Study|Adverse Event|2|||
44155112|NCT03527745|78946578|FG000|Overall Study|Lost to Follow-up|3|||
44155113|NCT03527745|78946579|FG001|Overall Study|Lost to Follow-up|6|||
44418026|NCT00744042|79426012|FG000|Overall Study|Withdrawal by Subject|1|||
44418027|NCT00829829|79426025|FG000|Overall Study|Protocol Violation|0|||
44418028|NCT00829829|79426026|FG001|Overall Study|Protocol Violation|3|||
44418029|NCT00829829|79426027|FG002|Overall Study|Protocol Violation|0|||
44418030|NCT00829829|79426025|FG000|Overall Study|Adverse Event|4|||
44418031|NCT00829829|79426026|FG001|Overall Study|Adverse Event|4|||
44418032|NCT00829829|79426027|FG002|Overall Study|Adverse Event|3|||
44418033|NCT00829829|79426025|FG000|Overall Study|Withdrawal by Subject|8|||
44418034|NCT00829829|79426026|FG001|Overall Study|Withdrawal by Subject|4|||
44418035|NCT00829829|79426027|FG002|Overall Study|Withdrawal by Subject|2|||
44418036|NCT00829829|79426025|FG000|Overall Study|Decision by the Sponsor|1|||
44256860|NCT04566601|79109104|FG003|Overall Study|Technical problems|0|||
44256861|NCT04566601|79109105|FG004|Overall Study|Technical problems|0|||
44256862|NCT04566601|79109101|FG000|Overall Study|No reason available|3|||
44256863|NCT04566601|79109102|FG001|Overall Study|No reason available|2|||
44256864|NCT04566601|79109103|FG002|Overall Study|No reason available|7|||
44256865|NCT04566601|79109104|FG003|Overall Study|No reason available|1|||
44256866|NCT04566601|79109105|FG004|Overall Study|No reason available|5|||
44256867|NCT04566601|79109101|FG000|Overall Study|Burden of study procedures|3|||
44256868|NCT04566601|79109102|FG001|Overall Study|Burden of study procedures|0|||
44256869|NCT04566601|79109103|FG002|Overall Study|Burden of study procedures|0|||
44418037|NCT00829829|79426026|FG001|Overall Study|Decision by the Sponsor|0|||
44418038|NCT00829829|79426027|FG002|Overall Study|Decision by the Sponsor|2|||
44155114|NCT03527745|78946580|FG002|Overall Study|Lost to Follow-up|7|||
44256870|NCT04566601|79109104|FG003|Overall Study|Burden of study procedures|3|||
44304134|NCT00750269|79302292|FG002|Overall Study|Protocol Violation|1|||
44304135|NCT00750269|79302293|FG003|Overall Study|Protocol Violation|2|||
44304136|NCT00750269|79302294|FG004|Overall Study|Protocol Violation|4|||
44304137|NCT00750269|79302290|FG000|Overall Study|Withdrawal by Subject|0|||
44304138|NCT00750269|79302291|FG001|Overall Study|Withdrawal by Subject|0|||
44304139|NCT00750269|79302292|FG002|Overall Study|Withdrawal by Subject|2|||
44304140|NCT00750269|79302293|FG003|Overall Study|Withdrawal by Subject|2|||
44304141|NCT00750269|79302294|FG004|Overall Study|Withdrawal by Subject|2|||
44304142|NCT00750269|79302290|FG000|Overall Study|Physician Decision|0|||
44304143|NCT00750269|79302291|FG001|Overall Study|Physician Decision|0|||
44304144|NCT00750269|79302292|FG002|Overall Study|Physician Decision|0|||
44304145|NCT00750269|79302293|FG003|Overall Study|Physician Decision|0|||
44304146|NCT00750269|79302294|FG004|Overall Study|Physician Decision|2|||
44304147|NCT00750269|79302290|FG000|Overall Study|Patient too large for positioning|0|||
44304148|NCT00750269|79302291|FG001|Overall Study|Patient too large for positioning|0|||
44304149|NCT00750269|79302292|FG002|Overall Study|Patient too large for positioning|1|||
44304150|NCT00750269|79302293|FG003|Overall Study|Patient too large for positioning|0|||
44304151|NCT00750269|79302294|FG004|Overall Study|Patient too large for positioning|0|||
44304152|NCT00750269|79302290|FG000|Overall Study|Site error|0|||
44304153|NCT00750269|79302291|FG001|Overall Study|Site error|0|||
44304154|NCT00750269|79302292|FG002|Overall Study|Site error|0|||
44304155|NCT00750269|79302293|FG003|Overall Study|Site error|1|||
44304156|NCT00750269|79302294|FG004|Overall Study|Site error|0|||
44304157|NCT00750269|79302290|FG000|Overall Study|SBRT plan could not be drawn|0|||
44304158|NCT00750269|79302291|FG001|Overall Study|SBRT plan could not be drawn|0|||
44304159|NCT00750269|79302292|FG002|Overall Study|SBRT plan could not be drawn|0|||
44304160|NCT00750269|79302293|FG003|Overall Study|SBRT plan could not be drawn|0|||
44304161|NCT00750269|79302294|FG004|Overall Study|SBRT plan could not be drawn|1|||
44304162|NCT00750269|79302290|FG000|Overall Study|Fiducials could not be placed|0|||
44304163|NCT00750269|79302291|FG001|Overall Study|Fiducials could not be placed|0|||
44304164|NCT00750269|79302292|FG002|Overall Study|Fiducials could not be placed|0|||
44304165|NCT00750269|79302293|FG003|Overall Study|Fiducials could not be placed|0|||
44304166|NCT00750269|79302294|FG004|Overall Study|Fiducials could not be placed|1|||
44304167|NCT00712322|79302316|FG000|Overall Study|Protocol deviation|0|||
44304168|NCT00712322|79302317|FG001|Overall Study|Protocol deviation|1|||
44304169|NCT00712322|79302318|FG002|Overall Study|Protocol deviation|0|||
44304170|NCT00323856|79302326|FG000|Overall Study|Withdrawal by Subject|1|||
44304171|NCT00323856|79302326|FG000|Overall Study|Was uncooperative and noncompliant|1|||
44304172|NCT00323856|79302326|FG000|Overall Study|Reason not specified|1|||
44304173|NCT00323856|79302326|FG000|Overall Study|Missing|2|||
44304174|NCT04594941|79302341|FG000|Overall Study|Other|0|||
44304175|NCT04594941|79302342|FG001|Overall Study|Other|3|||
44304176|NCT04594941|79302343|FG002|Overall Study|Other|1|||
44304177|NCT04594941|79302344|FG003|Overall Study|Other|0|||
44304178|NCT04524663|79302362|FG000|Overall Study|Withdrawal by Subject|0|||
44304179|NCT04524663|79302363|FG001|Overall Study|Withdrawal by Subject|2|||
44304180|NCT03738423|79302392|FG000|Overall Study|Withdrawal by Subject|9|||
44304181|NCT03738423|79302393|FG001|Overall Study|Withdrawal by Subject|12|||
44304182|NCT03738423|79302394|FG002|Overall Study|Withdrawal by Subject|9|||
44304183|NCT03738423|79302395|FG003|Overall Study|Withdrawal by Subject|12|||
44304184|NCT03738423|79302396|FG004|Overall Study|Withdrawal by Subject|10|||
44304185|NCT03738423|79302392|FG000|Overall Study|Lack of Efficacy|3|||
44304186|NCT03738423|79302393|FG001|Overall Study|Lack of Efficacy|1|||
44304187|NCT03738423|79302394|FG002|Overall Study|Lack of Efficacy|1|||
44304188|NCT03738423|79302395|FG003|Overall Study|Lack of Efficacy|1|||
44304189|NCT03738423|79302396|FG004|Overall Study|Lack of Efficacy|2|||
44304190|NCT03738423|79302392|FG000|Overall Study|Lost to Follow-up|1|||
44304191|NCT03738423|79302393|FG001|Overall Study|Lost to Follow-up|0|||
44304192|NCT03738423|79302394|FG002|Overall Study|Lost to Follow-up|1|||
44304193|NCT03738423|79302395|FG003|Overall Study|Lost to Follow-up|1|||
44304194|NCT03738423|79302396|FG004|Overall Study|Lost to Follow-up|0|||
44304195|NCT03738423|79302392|FG000|Overall Study|Protocol Violation|1|||
44304196|NCT03738423|79302393|FG001|Overall Study|Protocol Violation|0|||
44304197|NCT03738423|79302394|FG002|Overall Study|Protocol Violation|0|||
44304198|NCT03738423|79302395|FG003|Overall Study|Protocol Violation|0|||
44304199|NCT03738423|79302396|FG004|Overall Study|Protocol Violation|1|||
44304200|NCT03738423|79302392|FG000|Overall Study|Physician Decision|0|||
44304201|NCT03738423|79302393|FG001|Overall Study|Physician Decision|0|||
44304202|NCT03738423|79302394|FG002|Overall Study|Physician Decision|1|||
44304203|NCT03738423|79302395|FG003|Overall Study|Physician Decision|0|||
44304204|NCT03738423|79302396|FG004|Overall Study|Physician Decision|1|||
44304205|NCT03738423|79302392|FG000|Overall Study|Death|0|||
44304206|NCT03738423|79302393|FG001|Overall Study|Death|0|||
44304207|NCT03738423|79302394|FG002|Overall Study|Death|0|||
44304208|NCT03738423|79302395|FG003|Overall Study|Death|0|||
44304209|NCT03738423|79302396|FG004|Overall Study|Death|1|||
44304210|NCT03738423|79302392|FG000|Overall Study|Randomized but never treated|0|||
44304211|NCT03738423|79302393|FG001|Overall Study|Randomized but never treated|0|||
44304212|NCT03738423|79302394|FG002|Overall Study|Randomized but never treated|1|||
44304213|NCT03738423|79302395|FG003|Overall Study|Randomized but never treated|1|||
44304214|NCT03738423|79302396|FG004|Overall Study|Randomized but never treated|0|||
44304215|NCT03712228|79302414|FG000|Treatment Period 1|Lack of Efficacy|0|||
44304216|NCT03712228|79302415|FG001|Treatment Period 1|Lack of Efficacy|0|||
44304217|NCT03712228|79302416|FG002|Treatment Period 1|Lack of Efficacy|0|||
44304218|NCT03712228|79302417|FG003|Treatment Period 1|Lack of Efficacy|0|||
44304219|NCT03712228|79302418|FG004|Treatment Period 1|Lack of Efficacy|0|||
44304220|NCT03712228|79302419|FG005|Treatment Period 1|Lack of Efficacy|1|||
44304221|NCT03712228|79302414|FG000|Treatment Period 2|Pregnancy|0|||
44304222|NCT03712228|79302415|FG001|Treatment Period 2|Pregnancy|0|||
44304223|NCT03712228|79302416|FG002|Treatment Period 2|Pregnancy|0|||
44304224|NCT03712228|79302417|FG003|Treatment Period 2|Pregnancy|1|||
44304225|NCT03712228|79302418|FG004|Treatment Period 2|Pregnancy|0|||
44304226|NCT03712228|79302419|FG005|Treatment Period 2|Pregnancy|0|||
44304227|NCT03712228|79302414|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44304228|NCT03712228|79302415|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44304229|NCT03712228|79302416|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44304230|NCT03712228|79302417|FG003|Treatment Period 2|Withdrawal by Subject|1|||
44304231|NCT03712228|79302418|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44304232|NCT03712228|79302419|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44304233|NCT03600818|79302438|FG000|Overall Study|Adverse Event|4|||
44304234|NCT03600818|79302439|FG001|Overall Study|Adverse Event|7|||
44304235|NCT03600818|79302438|FG000|Overall Study|Lack of Efficacy|9|||
44304236|NCT03600818|79302439|FG001|Overall Study|Lack of Efficacy|4|||
44304237|NCT03600818|79302438|FG000|Overall Study|Withdrawal by Subject|4|||
44304238|NCT03600818|79302439|FG001|Overall Study|Withdrawal by Subject|3|||
44304239|NCT03600818|79302438|FG000|Overall Study|Other-unspecified|5|||
44304240|NCT03600818|79302439|FG001|Overall Study|Other-unspecified|3|||
44304241|NCT03600818|79302438|FG000|Overall Study|Randomized and not treated|0|||
44304242|NCT03600818|79302439|FG001|Overall Study|Randomized and not treated|1|||
44304243|NCT03578276|79302448|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
44304244|NCT03578276|79302449|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
44304245|NCT02034110|79302514|FG000|Overall Study|Physician Decision|0|||
44304246|NCT02034110|79302515|FG001|Overall Study|Physician Decision|0|||
44304247|NCT02034110|79302516|FG002|Overall Study|Physician Decision|0|||
44304248|NCT02034110|79302517|FG003|Overall Study|Physician Decision|0|||
44304249|NCT02034110|79302518|FG004|Overall Study|Physician Decision|2|||
44304250|NCT02034110|79302519|FG005|Overall Study|Physician Decision|0|||
44304251|NCT02034110|79302520|FG006|Overall Study|Physician Decision|1|||
44304252|NCT02034110|79302521|FG007|Overall Study|Physician Decision|0|||
44304253|NCT02034110|79302514|FG000|Overall Study|Lost to Follow-up|1|||
44304254|NCT02034110|79302515|FG001|Overall Study|Lost to Follow-up|0|||
44304255|NCT02034110|79302516|FG002|Overall Study|Lost to Follow-up|0|||
44304256|NCT02034110|79302517|FG003|Overall Study|Lost to Follow-up|0|||
44304257|NCT02034110|79302518|FG004|Overall Study|Lost to Follow-up|1|||
44304258|NCT02034110|79302519|FG005|Overall Study|Lost to Follow-up|0|||
44304259|NCT02034110|79302520|FG006|Overall Study|Lost to Follow-up|1|||
44304260|NCT02034110|79302521|FG007|Overall Study|Lost to Follow-up|0|||
44304261|NCT02034110|79302514|FG000|Overall Study|Withdrawal by Subject|5|||
44304262|NCT02034110|79302515|FG001|Overall Study|Withdrawal by Subject|7|||
44304263|NCT02034110|79302516|FG002|Overall Study|Withdrawal by Subject|0|||
44304264|NCT02034110|79302517|FG003|Overall Study|Withdrawal by Subject|3|||
44304265|NCT02034110|79302518|FG004|Overall Study|Withdrawal by Subject|7|||
44304266|NCT02034110|79302519|FG005|Overall Study|Withdrawal by Subject|0|||
44304267|NCT02034110|79302520|FG006|Overall Study|Withdrawal by Subject|3|||
44304268|NCT02034110|79302521|FG007|Overall Study|Withdrawal by Subject|1|||
44304269|NCT02034110|79302514|FG000|Overall Study|Study closed by sponsor|6|||
44304270|NCT02034110|79302515|FG001|Overall Study|Study closed by sponsor|2|||
44304271|NCT02034110|79302516|FG002|Overall Study|Study closed by sponsor|0|||
44304272|NCT02034110|79302517|FG003|Overall Study|Study closed by sponsor|6|||
44304273|NCT02034110|79302518|FG004|Overall Study|Study closed by sponsor|7|||
44534407|NCT03134222|79544920|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
44534408|NCT03134222|79544921|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
44534409|NCT03134222|79544922|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
44304274|NCT02034110|79302519|FG005|Overall Study|Study closed by sponsor|0|||
44534410|NCT03134222|79544923|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
44304275|NCT02034110|79302520|FG006|Overall Study|Study closed by sponsor|42|||
44304276|NCT02034110|79302521|FG007|Overall Study|Study closed by sponsor|0|||
44304277|NCT01627574|79302569|FG000|Overall Study|Withdrawal by Subject|8|||
44534411|NCT03134222|79544919|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
44534412|NCT03134222|79544920|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
44304278|NCT01627574|79302570|FG001|Overall Study|Withdrawal by Subject|5|||
44304279|NCT01627574|79302569|FG000|Overall Study|Lost to Follow-up|13|||
44304280|NCT01627574|79302570|FG001|Overall Study|Lost to Follow-up|13|||
44304281|NCT01498458|79302576|FG000|Overall Study|Adverse Event|4|||
44304282|NCT01498458|79302576|FG000|Overall Study|Physician Decision|3|||
44304283|NCT01427712|79302585|FG000|Overall Study|Transfer to a different hospital|2|||
44304284|NCT01427712|79302585|FG000|Overall Study|Lost to Follow-up|1|||
44304285|NCT01427712|79302585|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
44304286|NCT01427712|79302585|FG000|Overall Study|Failure to visit|1|||
44304287|NCT01369147|79302592|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
44304288|NCT01369147|79302593|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
44304289|NCT01369147|79302594|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
44304290|NCT04846231|79302610|FG000|Overall Study|Lost to Follow-up|1|||
44304291|NCT04846231|79302611|FG001|Overall Study|Lost to Follow-up|0|||
44304292|NCT04846231|79302612|FG002|Overall Study|Lost to Follow-up|0|||
44304293|NCT04846231|79302613|FG003|Overall Study|Lost to Follow-up|0|||
44304294|NCT04846231|79302614|FG004|Overall Study|Lost to Follow-up|0|||
44304295|NCT04846231|79302615|FG005|Overall Study|Lost to Follow-up|0|||
44304296|NCT04846231|79302616|FG006|Overall Study|Lost to Follow-up|0|||
44304297|NCT04846231|79302617|FG007|Overall Study|Lost to Follow-up|1|||
44304298|NCT04846231|79302610|FG000|Overall Study|Withdrawal by Subject|0|||
44304299|NCT04846231|79302611|FG001|Overall Study|Withdrawal by Subject|1|||
44304300|NCT04846231|79302612|FG002|Overall Study|Withdrawal by Subject|2|||
44304301|NCT04846231|79302613|FG003|Overall Study|Withdrawal by Subject|1|||
44304302|NCT04846231|79302614|FG004|Overall Study|Withdrawal by Subject|0|||
44304303|NCT04846231|79302615|FG005|Overall Study|Withdrawal by Subject|0|||
44304304|NCT04846231|79302616|FG006|Overall Study|Withdrawal by Subject|0|||
44304305|NCT04846231|79302617|FG007|Overall Study|Withdrawal by Subject|0|||
44304306|NCT04846231|79302610|FG000|Overall Study|Protocol Violation|0|||
44304307|NCT04846231|79302611|FG001|Overall Study|Protocol Violation|1|||
44304308|NCT04846231|79302612|FG002|Overall Study|Protocol Violation|0|||
44304309|NCT04846231|79302613|FG003|Overall Study|Protocol Violation|0|||
44304310|NCT04846231|79302614|FG004|Overall Study|Protocol Violation|0|||
44304311|NCT04846231|79302615|FG005|Overall Study|Protocol Violation|0|||
44304312|NCT04846231|79302616|FG006|Overall Study|Protocol Violation|0|||
44304313|NCT04846231|79302617|FG007|Overall Study|Protocol Violation|0|||
44304314|NCT04846231|79302610|FG000|Overall Study|Adverse Event|0|||
44304315|NCT04846231|79302611|FG001|Overall Study|Adverse Event|0|||
44304316|NCT04846231|79302612|FG002|Overall Study|Adverse Event|0|||
44304317|NCT04846231|79302613|FG003|Overall Study|Adverse Event|0|||
44304318|NCT04846231|79302614|FG004|Overall Study|Adverse Event|0|||
44304319|NCT04846231|79302615|FG005|Overall Study|Adverse Event|0|||
44304320|NCT04846231|79302616|FG006|Overall Study|Adverse Event|1|||
44304321|NCT04846231|79302617|FG007|Overall Study|Adverse Event|1|||
44304322|NCT04533594|79302643|FG000|Overall Study|Death|26|||
44304323|NCT04447846|79302647|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
44304324|NCT04405245|79302654|FG000|Overall Study|Adverse Event|0|||
44304325|NCT04405245|79302655|FG001|Overall Study|Adverse Event|1|||
44304326|NCT04405245|79302656|FG002|Overall Study|Adverse Event|0|||
44304327|NCT04277507|79302664|FG000|Overall Study|Lost to Follow-up|17|||
44304328|NCT04277507|79302664|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
44304329|NCT04277507|79302664|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
44304330|NCT04277507|79302664|FG000|Overall Study|Withdrawal by Subject|3|||
44304331|NCT04277507|79302664|FG000|Overall Study|Death due to COVID-19|1|||
44304332|NCT04277507|79302664|FG000|Overall Study|Data missing for full evaluation|5|||
44304333|NCT04198805|79302676|FG000|Overall Study|Death|0|||
44304334|NCT04198805|79302677|FG001|Overall Study|Death|0|||
44304335|NCT04198805|79302678|FG002|Overall Study|Death|0|||
44304336|NCT04198805|79302679|FG003|Overall Study|Death|1|||
44304337|NCT04198805|79302676|FG000|Overall Study|Early Termination|8|||
44304338|NCT04198805|79302677|FG001|Overall Study|Early Termination|4|||
44304339|NCT04198805|79302678|FG002|Overall Study|Early Termination|6|||
44304340|NCT04198805|79302679|FG003|Overall Study|Early Termination|9|||
44304341|NCT04179890|79302695|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
44304342|NCT04179890|79302696|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
44304343|NCT04179890|79302695|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
44418039|NCT00829829|79426025|FG000|Overall Study|Lost to Follow-up|7|||
44418040|NCT00829829|79426026|FG001|Overall Study|Lost to Follow-up|3|||
44418041|NCT00829829|79426027|FG002|Overall Study|Lost to Follow-up|3|||
44418042|NCT00829829|79426025|FG000|Overall Study|Other than specified above|2|||
44418043|NCT00829829|79426026|FG001|Overall Study|Other than specified above|2|||
44304344|NCT04179890|79302696|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
44304345|NCT04179890|79302695|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
44304346|NCT04179890|79302696|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
44304347|NCT04179890|79302695|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
44304348|NCT04179890|79302696|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
44304349|NCT04179890|79302695|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
44354628|NCT01194414|79359015|FG003|72 Weeks Open Label Extension|Death|2|||
44304350|NCT04179890|79302696|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
44304351|NCT04179890|79302695|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
44304352|NCT04179890|79302696|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
44304353|NCT04179890|79302695|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
44304354|NCT04179890|79302696|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
44304355|NCT04179890|79302695|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
44304356|NCT04179890|79302696|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
44304357|NCT04179890|79302695|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
44304358|NCT04179890|79302696|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
44304359|NCT03721016|79302737|FG000|Overall Study|Adverse Event|0|||
44304360|NCT03721016|79302738|FG001|Overall Study|Adverse Event|1|||
44304361|NCT03721016|79302739|FG002|Overall Study|Adverse Event|1|||
44304362|NCT03721016|79302737|FG000|Overall Study|Withdrawal by Subject|8|||
44304363|NCT03721016|79302738|FG001|Overall Study|Withdrawal by Subject|16|||
44304364|NCT03721016|79302739|FG002|Overall Study|Withdrawal by Subject|13|||
44304365|NCT03721016|79302737|FG000|Overall Study|Lost to Follow-up|4|||
44304366|NCT03721016|79302738|FG001|Overall Study|Lost to Follow-up|6|||
44304367|NCT03721016|79302739|FG002|Overall Study|Lost to Follow-up|5|||
44304368|NCT03721016|79302737|FG000|Overall Study|Physician Decision|0|||
44304369|NCT03721016|79302738|FG001|Overall Study|Physician Decision|1|||
44304370|NCT03721016|79302739|FG002|Overall Study|Physician Decision|2|||
44304371|NCT03721016|79302737|FG000|Overall Study|Protocol Violation|0|||
44304372|NCT03721016|79302738|FG001|Overall Study|Protocol Violation|1|||
44304373|NCT03721016|79302739|FG002|Overall Study|Protocol Violation|0|||
44304374|NCT03721016|79302737|FG000|Overall Study|Site terminated by sponsor|3|||
44304375|NCT03721016|79302738|FG001|Overall Study|Site terminated by sponsor|7|||
44304376|NCT03721016|79302739|FG002|Overall Study|Site terminated by sponsor|6|||
44304377|NCT03721016|79302737|FG000|Overall Study|Subject exited early due to COVID-19|1|||
44304378|NCT03721016|79302738|FG001|Overall Study|Subject exited early due to COVID-19|0|||
44304379|NCT03721016|79302739|FG002|Overall Study|Subject exited early due to COVID-19|0|||
44304380|NCT03117998|79302775|FG000|Overall Study|Adverse Event|1|||
44304381|NCT03117998|79302776|FG001|Overall Study|Adverse Event|0|||
44304382|NCT03117998|79302777|FG002|Overall Study|Adverse Event|0|||
44304383|NCT03117998|79302778|FG003|Overall Study|Adverse Event|0|||
44304384|NCT03117998|79302779|FG004|Overall Study|Adverse Event|0|||
44304385|NCT03117998|79302780|FG005|Overall Study|Adverse Event|0|||
44304386|NCT03117998|79302775|FG000|Overall Study|Withdrawal by Subject|0|||
44304387|NCT03117998|79302776|FG001|Overall Study|Withdrawal by Subject|0|||
44304388|NCT03117998|79302777|FG002|Overall Study|Withdrawal by Subject|2|||
44304389|NCT03117998|79302778|FG003|Overall Study|Withdrawal by Subject|3|||
44304390|NCT03117998|79302779|FG004|Overall Study|Withdrawal by Subject|3|||
44304391|NCT03117998|79302780|FG005|Overall Study|Withdrawal by Subject|0|||
44304392|NCT03117998|79302775|FG000|Overall Study|Physician Decision|0|||
44304393|NCT03117998|79302776|FG001|Overall Study|Physician Decision|1|||
44304394|NCT03117998|79302777|FG002|Overall Study|Physician Decision|1|||
44304395|NCT03117998|79302778|FG003|Overall Study|Physician Decision|0|||
44304396|NCT03117998|79302779|FG004|Overall Study|Physician Decision|0|||
44304397|NCT03117998|79302780|FG005|Overall Study|Physician Decision|0|||
44304398|NCT03117998|79302775|FG000|Overall Study|Lost to Follow-up|0|||
44304399|NCT03117998|79302776|FG001|Overall Study|Lost to Follow-up|0|||
44304400|NCT03117998|79302777|FG002|Overall Study|Lost to Follow-up|0|||
44304401|NCT03117998|79302778|FG003|Overall Study|Lost to Follow-up|1|||
44304402|NCT03117998|79302779|FG004|Overall Study|Lost to Follow-up|4|||
44304403|NCT03117998|79302780|FG005|Overall Study|Lost to Follow-up|0|||
44304404|NCT03117998|79302775|FG000|Overall Study|Subject noncompliance|0|||
44304405|NCT03117998|79302776|FG001|Overall Study|Subject noncompliance|0|||
44304406|NCT03117998|79302777|FG002|Overall Study|Subject noncompliance|1|||
44304407|NCT03117998|79302778|FG003|Overall Study|Subject noncompliance|0|||
44304408|NCT03117998|79302779|FG004|Overall Study|Subject noncompliance|0|||
44304409|NCT03117998|79302780|FG005|Overall Study|Subject noncompliance|2|||
44304410|NCT03117998|79302775|FG000|Overall Study|Protocol Violation|0|||
44304411|NCT03117998|79302776|FG001|Overall Study|Protocol Violation|0|||
44304412|NCT03117998|79302777|FG002|Overall Study|Protocol Violation|0|||
44304413|NCT03117998|79302778|FG003|Overall Study|Protocol Violation|0|||
44534413|NCT03134222|79544921|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
44304414|NCT03117998|79302779|FG004|Overall Study|Protocol Violation|0|||
44304415|NCT03117998|79302780|FG005|Overall Study|Protocol Violation|1|||
44304416|NCT03100370|79302805|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44304417|NCT03100370|79302806|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44304418|NCT03100370|79302807|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44304419|NCT03100370|79302808|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
44304420|NCT03100370|79302809|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44304421|NCT03100370|79302810|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
44304422|NCT02920008|79302820|FG000|Overall Study|Death|117|||
44304423|NCT02920008|79302821|FG001|Overall Study|Death|127|||
44304424|NCT02920008|79302820|FG000|Overall Study|Withdrawal by Subject|3|||
44304425|NCT02920008|79302821|FG001|Overall Study|Withdrawal by Subject|6|||
44304426|NCT02920008|79302820|FG000|Overall Study|Lost to Follow-up|0|||
44304427|NCT02920008|79302821|FG001|Overall Study|Lost to Follow-up|1|||
44304428|NCT02766335|79302829|FG000|Initial Registration|Adverse Event|6|||
44304429|NCT02766335|79302830|FG001|Initial Registration|Adverse Event|3|||
44304430|NCT02766335|79302831|FG002|Initial Registration|Adverse Event|0|||
44304431|NCT02766335|79302829|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
44304432|NCT02766335|79302830|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
44304433|NCT02766335|79302831|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
44304434|NCT02766335|79302829|FG000|Initial Registration|Progression/relapse|49|||
44304435|NCT02766335|79302830|FG001|Initial Registration|Progression/relapse|15|||
44304436|NCT02766335|79302831|FG002|Initial Registration|Progression/relapse|0|||
44304437|NCT02766335|79302829|FG000|Initial Registration|Death|1|||
44304438|NCT02766335|79302830|FG001|Initial Registration|Death|3|||
44304439|NCT02766335|79302831|FG002|Initial Registration|Death|0|||
44304440|NCT02766335|79302829|FG000|Initial Registration|not protocol specified|1|||
44304441|NCT02766335|79302830|FG001|Initial Registration|not protocol specified|9|||
44304442|NCT02766335|79302831|FG002|Initial Registration|not protocol specified|0|||
44304443|NCT02766335|79302829|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
44304444|NCT02766335|79302830|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
44304445|NCT02766335|79302831|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
44304446|NCT02766335|79302829|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
44304447|NCT02766335|79302830|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
44304448|NCT02766335|79302831|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
44304449|NCT02577523|79302839|FG000|Overall Study|Adverse Event|1|||
44304450|NCT02577523|79302840|FG001|Overall Study|Adverse Event|1|||
44304451|NCT02577523|79302839|FG000|Overall Study|Lack of Efficacy|1|||
44304452|NCT02577523|79302840|FG001|Overall Study|Lack of Efficacy|1|||
44304453|NCT02577523|79302839|FG000|Overall Study|Withdrawal by Subject|1|||
44304454|NCT02577523|79302840|FG001|Overall Study|Withdrawal by Subject|0|||
44304455|NCT02499328|79302865|FG000|Overall Study|Withdrawal by Subject|1|||
44304456|NCT02499328|79302866|FG001|Overall Study|Withdrawal by Subject|1|||
44304457|NCT02499328|79302867|FG002|Overall Study|Withdrawal by Subject|5|||
44304458|NCT02499328|79302868|FG003|Overall Study|Withdrawal by Subject|3|||
44304459|NCT02499328|79302869|FG004|Overall Study|Withdrawal by Subject|5|||
44304460|NCT02499328|79302870|FG005|Overall Study|Withdrawal by Subject|0|||
44304461|NCT02499328|79302871|FG006|Overall Study|Withdrawal by Subject|0|||
44304462|NCT02499328|79302872|FG007|Overall Study|Withdrawal by Subject|0|||
44304463|NCT02499328|79302873|FG008|Overall Study|Withdrawal by Subject|2|||
44304464|NCT02499328|79302874|FG009|Overall Study|Withdrawal by Subject|2|||
44304465|NCT02499328|79302875|FG010|Overall Study|Withdrawal by Subject|0|||
44304466|NCT02499328|79302876|FG011|Overall Study|Withdrawal by Subject|3|||
44304467|NCT02499328|79302877|FG012|Overall Study|Withdrawal by Subject|7|||
44304468|NCT02499328|79302878|FG013|Overall Study|Withdrawal by Subject|3|||
44304469|NCT02499328|79302879|FG014|Overall Study|Withdrawal by Subject|1|||
44304470|NCT02499328|79302880|FG015|Overall Study|Withdrawal by Subject|0|||
44304471|NCT02499328|79302881|FG016|Overall Study|Withdrawal by Subject|0|||
44304472|NCT02499328|79302882|FG017|Overall Study|Withdrawal by Subject|3|||
44304473|NCT02499328|79302883|FG018|Overall Study|Withdrawal by Subject|0|||
44304474|NCT02499328|79302865|FG000|Overall Study|Lost to Follow-up|0|||
44304475|NCT02499328|79302866|FG001|Overall Study|Lost to Follow-up|1|||
44304476|NCT02499328|79302867|FG002|Overall Study|Lost to Follow-up|1|||
44304477|NCT02499328|79302868|FG003|Overall Study|Lost to Follow-up|2|||
44304478|NCT02499328|79302869|FG004|Overall Study|Lost to Follow-up|0|||
44304479|NCT02499328|79302870|FG005|Overall Study|Lost to Follow-up|0|||
44304480|NCT02499328|79302871|FG006|Overall Study|Lost to Follow-up|0|||
44304481|NCT02499328|79302872|FG007|Overall Study|Lost to Follow-up|2|||
44534414|NCT03134222|79544922|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
44534415|NCT03134222|79544923|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
44534416|NCT03134222|79544919|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
44534417|NCT03134222|79544920|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
44534418|NCT03134222|79544921|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
44534419|NCT03134222|79544922|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
44534420|NCT03134222|79544923|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
44304482|NCT02499328|79302873|FG008|Overall Study|Lost to Follow-up|3|||
44304483|NCT02499328|79302874|FG009|Overall Study|Lost to Follow-up|0|||
44304484|NCT02499328|79302875|FG010|Overall Study|Lost to Follow-up|0|||
44304485|NCT02499328|79302876|FG011|Overall Study|Lost to Follow-up|0|||
44304486|NCT02499328|79302877|FG012|Overall Study|Lost to Follow-up|0|||
44304487|NCT02499328|79302878|FG013|Overall Study|Lost to Follow-up|0|||
44304488|NCT02499328|79302879|FG014|Overall Study|Lost to Follow-up|0|||
44304489|NCT02499328|79302880|FG015|Overall Study|Lost to Follow-up|0|||
44304490|NCT02499328|79302881|FG016|Overall Study|Lost to Follow-up|0|||
44304491|NCT02499328|79302882|FG017|Overall Study|Lost to Follow-up|0|||
44304492|NCT02499328|79302883|FG018|Overall Study|Lost to Follow-up|1|||
44304493|NCT02499328|79302865|FG000|Overall Study|Death|0|||
44304494|NCT02499328|79302866|FG001|Overall Study|Death|3|||
44304495|NCT02499328|79302867|FG002|Overall Study|Death|3|||
44304496|NCT02499328|79302868|FG003|Overall Study|Death|2|||
44304497|NCT02499328|79302869|FG004|Overall Study|Death|4|||
44304498|NCT02499328|79302870|FG005|Overall Study|Death|7|||
44304499|NCT02499328|79302871|FG006|Overall Study|Death|3|||
44304500|NCT02499328|79302872|FG007|Overall Study|Death|0|||
44304501|NCT02499328|79302873|FG008|Overall Study|Death|2|||
44304502|NCT02499328|79302874|FG009|Overall Study|Death|6|||
44304503|NCT02499328|79302875|FG010|Overall Study|Death|6|||
44304504|NCT02499328|79302876|FG011|Overall Study|Death|20|||
44304505|NCT02499328|79302877|FG012|Overall Study|Death|9|||
44304506|NCT02499328|79302878|FG013|Overall Study|Death|7|||
44304507|NCT02499328|79302879|FG014|Overall Study|Death|3|||
44304508|NCT02499328|79302880|FG015|Overall Study|Death|1|||
44304509|NCT02499328|79302881|FG016|Overall Study|Death|1|||
44304510|NCT02499328|79302882|FG017|Overall Study|Death|16|||
44304511|NCT02499328|79302883|FG018|Overall Study|Death|5|||
44304512|NCT02499328|79302865|FG000|Overall Study|"Other"|2|||
44304513|NCT02499328|79302866|FG001|Overall Study|"Other"|2|||
44304514|NCT02499328|79302867|FG002|Overall Study|"Other"|1|||
44304515|NCT02499328|79302868|FG003|Overall Study|"Other"|3|||
44304516|NCT02499328|79302869|FG004|Overall Study|"Other"|6|||
44304517|NCT02499328|79302870|FG005|Overall Study|"Other"|2|||
44304518|NCT02499328|79302871|FG006|Overall Study|"Other"|3|||
44304519|NCT02499328|79302872|FG007|Overall Study|"Other"|4|||
44304520|NCT02499328|79302873|FG008|Overall Study|"Other"|6|||
44304521|NCT02499328|79302874|FG009|Overall Study|"Other"|16|||
44304522|NCT02499328|79302875|FG010|Overall Study|"Other"|13|||
44304523|NCT02499328|79302876|FG011|Overall Study|"Other"|31|||
44304524|NCT02499328|79302877|FG012|Overall Study|"Other"|8|||
44304525|NCT02499328|79302878|FG013|Overall Study|"Other"|7|||
44304526|NCT02499328|79302879|FG014|Overall Study|"Other"|6|||
44304527|NCT02499328|79302880|FG015|Overall Study|"Other"|0|||
44304528|NCT02499328|79302881|FG016|Overall Study|"Other"|0|||
44304529|NCT02499328|79302882|FG017|Overall Study|"Other"|34|||
44304530|NCT02499328|79302883|FG018|Overall Study|"Other"|43|||
44304531|NCT02499328|79302865|FG000|Overall Study|Disease Progression|0|||
44304532|NCT02499328|79302866|FG001|Overall Study|Disease Progression|0|||
44304533|NCT02499328|79302867|FG002|Overall Study|Disease Progression|0|||
44304534|NCT02499328|79302868|FG003|Overall Study|Disease Progression|0|||
44304535|NCT02499328|79302869|FG004|Overall Study|Disease Progression|0|||
44304536|NCT02499328|79302870|FG005|Overall Study|Disease Progression|0|||
44304537|NCT02499328|79302871|FG006|Overall Study|Disease Progression|1|||
44304538|NCT02499328|79302872|FG007|Overall Study|Disease Progression|0|||
44304539|NCT02499328|79302873|FG008|Overall Study|Disease Progression|1|||
44304540|NCT02499328|79302874|FG009|Overall Study|Disease Progression|0|||
44304541|NCT02499328|79302875|FG010|Overall Study|Disease Progression|1|||
44304542|NCT02499328|79302876|FG011|Overall Study|Disease Progression|0|||
44304543|NCT02499328|79302877|FG012|Overall Study|Disease Progression|0|||
44304544|NCT02499328|79302878|FG013|Overall Study|Disease Progression|0|||
44304545|NCT02499328|79302879|FG014|Overall Study|Disease Progression|0|||
44304546|NCT02499328|79302880|FG015|Overall Study|Disease Progression|0|||
44304547|NCT02499328|79302881|FG016|Overall Study|Disease Progression|0|||
44304548|NCT02499328|79302882|FG017|Overall Study|Disease Progression|2|||
44304549|NCT02499328|79302883|FG018|Overall Study|Disease Progression|0|||
44304550|NCT02499328|79302865|FG000|Overall Study|Adverse Event|1|||
44304551|NCT02499328|79302866|FG001|Overall Study|Adverse Event|0|||
44304552|NCT02499328|79302867|FG002|Overall Study|Adverse Event|0|||
44304553|NCT02499328|79302868|FG003|Overall Study|Adverse Event|1|||
44304554|NCT02499328|79302869|FG004|Overall Study|Adverse Event|0|||
44304555|NCT02499328|79302870|FG005|Overall Study|Adverse Event|0|||
44304556|NCT02499328|79302871|FG006|Overall Study|Adverse Event|0|||
44304557|NCT02499328|79302872|FG007|Overall Study|Adverse Event|0|||
44304558|NCT02499328|79302873|FG008|Overall Study|Adverse Event|0|||
44304559|NCT02499328|79302874|FG009|Overall Study|Adverse Event|0|||
44304560|NCT02499328|79302875|FG010|Overall Study|Adverse Event|0|||
44304561|NCT02499328|79302876|FG011|Overall Study|Adverse Event|0|||
44304562|NCT02499328|79302877|FG012|Overall Study|Adverse Event|1|||
44304563|NCT02499328|79302878|FG013|Overall Study|Adverse Event|0|||
44304564|NCT02499328|79302879|FG014|Overall Study|Adverse Event|0|||
44304565|NCT02499328|79302880|FG015|Overall Study|Adverse Event|0|||
44304566|NCT02499328|79302881|FG016|Overall Study|Adverse Event|0|||
44304567|NCT02499328|79302882|FG017|Overall Study|Adverse Event|0|||
44304568|NCT02499328|79302883|FG018|Overall Study|Adverse Event|0|||
44304569|NCT02177695|79302979|FG000|ITT Analysis|Ineligible|5|||
44304570|NCT02177695|79302980|FG001|ITT Analysis|Ineligible|5|||
44304571|NCT02177695|79302979|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
44304572|NCT02177695|79302980|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
44304573|NCT02177695|79302979|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
44304574|NCT02177695|79302980|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
44304575|NCT02177695|79302979|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
44304576|NCT02177695|79302980|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
44304577|NCT01719237|79302995|FG000|Overall Study|Physician Decision|0|||
44304578|NCT01719237|79302996|FG001|Overall Study|Physician Decision|1|||
44304579|NCT01956669|79303019|FG000|Overall Study|Disease Progression|12|||
44304580|NCT01956669|79303020|FG001|Overall Study|Disease Progression|7|||
44304581|NCT01956669|79303021|FG002|Overall Study|Disease Progression|7|||
44304582|NCT01956669|79303022|FG003|Overall Study|Disease Progression|8|||
44304583|NCT01956669|79303023|FG004|Overall Study|Disease Progression|4|||
44304584|NCT01956669|79303024|FG005|Overall Study|Disease Progression|3|||
44304585|NCT01956669|79303025|FG006|Overall Study|Disease Progression|5|||
44304586|NCT01956669|79303019|FG000|Overall Study|Adverse Event|0|||
44304587|NCT01956669|79303020|FG001|Overall Study|Adverse Event|2|||
44304588|NCT01956669|79303021|FG002|Overall Study|Adverse Event|2|||
44304589|NCT01956669|79303022|FG003|Overall Study|Adverse Event|1|||
44304590|NCT01956669|79303023|FG004|Overall Study|Adverse Event|0|||
44304591|NCT01956669|79303024|FG005|Overall Study|Adverse Event|0|||
44304592|NCT01956669|79303025|FG006|Overall Study|Adverse Event|0|||
44304593|NCT01956669|79303019|FG000|Overall Study|Physician Decision|0|||
44304594|NCT01956669|79303020|FG001|Overall Study|Physician Decision|2|||
44304595|NCT01956669|79303021|FG002|Overall Study|Physician Decision|0|||
44304596|NCT01956669|79303022|FG003|Overall Study|Physician Decision|0|||
44304597|NCT01956669|79303023|FG004|Overall Study|Physician Decision|0|||
44304598|NCT01956669|79303024|FG005|Overall Study|Physician Decision|1|||
44304599|NCT01956669|79303025|FG006|Overall Study|Physician Decision|0|||
44304600|NCT01956669|79303019|FG000|Overall Study|Withdrawal by Subject|0|||
44304601|NCT01956669|79303020|FG001|Overall Study|Withdrawal by Subject|0|||
44304602|NCT01956669|79303021|FG002|Overall Study|Withdrawal by Subject|1|||
44304603|NCT01956669|79303022|FG003|Overall Study|Withdrawal by Subject|1|||
44304604|NCT01956669|79303023|FG004|Overall Study|Withdrawal by Subject|0|||
44304605|NCT01956669|79303024|FG005|Overall Study|Withdrawal by Subject|0|||
44304606|NCT01956669|79303025|FG006|Overall Study|Withdrawal by Subject|1|||
44304607|NCT01967823|79303054|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
44304608|NCT01982760|79303064|FG000|Overall Study|Physician Decision|1|||
44304609|NCT01982760|79303065|FG001|Overall Study|Physician Decision|0|||
44304610|NCT01985022|79303073|FG000|Overall Study|Lost to Follow-up|0|||
44304611|NCT01985022|79303074|FG001|Overall Study|Lost to Follow-up|1|||
44304612|NCT01985022|79303073|FG000|Overall Study|Protocol Violation|0|||
44304613|NCT01985022|79303074|FG001|Overall Study|Protocol Violation|1|||
44304614|NCT01985022|79303073|FG000|Overall Study|Withdrawal by Subject|4|||
44304615|NCT01985022|79303074|FG001|Overall Study|Withdrawal by Subject|1|||
44304616|NCT01989676|79303082|FG000|Overall Study|Death|52|||
44304617|NCT01989676|79303083|FG001|Overall Study|Death|60|||
44304618|NCT01989676|79303082|FG000|Overall Study|Protocol Violation|2|||
44304619|NCT01989676|79303083|FG001|Overall Study|Protocol Violation|1|||
44304620|NCT01989676|79303082|FG000|Overall Study|Lost to Follow-up|8|||
44304621|NCT01989676|79303083|FG001|Overall Study|Lost to Follow-up|18|||
44304622|NCT01989676|79303082|FG000|Overall Study|No longer willing to participate in study|26|||
44304623|NCT01989676|79303083|FG001|Overall Study|No longer willing to participate in study|26|||
44304624|NCT01989676|79303082|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
44304625|NCT01989676|79303083|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
44304626|NCT01989676|79303082|FG000|Overall Study|Other|4|||
44304627|NCT01989676|79303083|FG001|Overall Study|Other|3|||
44304628|NCT02001974|79303093|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
44304629|NCT02001974|79303094|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
44304630|NCT02001974|79303095|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
44304631|NCT02001974|79303093|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
44304632|NCT02001974|79303094|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
44304633|NCT02001974|79303095|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
44304634|NCT02001974|79303093|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
44304635|NCT02001974|79303094|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
44304636|NCT02001974|79303095|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
44155115|NCT03527745|78946581|FG003|Overall Study|Lost to Follow-up|9|||
44155116|NCT03527745|78946582|FG004|Overall Study|Lost to Follow-up|0|||
44155117|NCT03527745|78946583|FG005|Overall Study|Lost to Follow-up|2|||
44155118|NCT03527745|78946584|FG006|Overall Study|Lost to Follow-up|3|||
44155119|NCT03527745|78946585|FG007|Overall Study|Lost to Follow-up|2|||
44304637|NCT02001974|79303093|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
44304638|NCT02001974|79303094|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
44304639|NCT02001974|79303095|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
44304640|NCT05229406|79303133|FG000|Overall Study|Withdrawal by Subject|1|||
44304641|NCT05229406|79303134|FG001|Overall Study|Withdrawal by Subject|2|||
44304642|NCT04971187|79303149|FG000|Overall Study|Screen failures|2|||
44304643|NCT04756154|79303174|FG000|Overall Study|Did not meet treatment day baseline|30|||
44304644|NCT04756154|79303175|FG001|Overall Study|Did not meet treatment day baseline|28|||
44304645|NCT04756154|79303176|FG002|Overall Study|Did not meet treatment day baseline|7|||
44304646|NCT04756154|79303174|FG000|Overall Study|Did not return for final sample collection|1|||
44304647|NCT04756154|79303175|FG001|Overall Study|Did not return for final sample collection|1|||
44304648|NCT04756154|79303176|FG002|Overall Study|Did not return for final sample collection|0|||
44304649|NCT04614246|79303194|FG000|Overall Study|Adverse Event|0|||
44304650|NCT04614246|79303195|FG001|Overall Study|Adverse Event|1|||
44304651|NCT04614246|79303196|FG002|Overall Study|Adverse Event|1|||
44304652|NCT04614246|79303197|FG003|Overall Study|Adverse Event|2|||
44304653|NCT04614246|79303198|FG004|Overall Study|Adverse Event|1|||
44304654|NCT04614246|79303194|FG000|Overall Study|Lost to Follow-up|0|||
44304655|NCT04614246|79303195|FG001|Overall Study|Lost to Follow-up|1|||
44304656|NCT04614246|79303196|FG002|Overall Study|Lost to Follow-up|0|||
44304657|NCT04614246|79303197|FG003|Overall Study|Lost to Follow-up|1|||
44304658|NCT04614246|79303198|FG004|Overall Study|Lost to Follow-up|3|||
44304659|NCT04614246|79303194|FG000|Overall Study|Other reason|0|||
44304660|NCT04614246|79303195|FG001|Overall Study|Other reason|1|||
44304661|NCT04614246|79303196|FG002|Overall Study|Other reason|2|||
44304662|NCT04614246|79303197|FG003|Overall Study|Other reason|0|||
44304663|NCT04614246|79303198|FG004|Overall Study|Other reason|0|||
44304664|NCT04614246|79303194|FG000|Overall Study|Withdrawal by Subject|4|||
44304665|NCT04614246|79303195|FG001|Overall Study|Withdrawal by Subject|2|||
44304666|NCT04614246|79303196|FG002|Overall Study|Withdrawal by Subject|4|||
44304667|NCT04614246|79303197|FG003|Overall Study|Withdrawal by Subject|3|||
44304668|NCT04614246|79303198|FG004|Overall Study|Withdrawal by Subject|4|||
44304669|NCT04614246|79303194|FG000|Overall Study|Physician Decision|0|||
44304670|NCT04614246|79303195|FG001|Overall Study|Physician Decision|2|||
44304671|NCT04614246|79303196|FG002|Overall Study|Physician Decision|1|||
44304672|NCT04614246|79303197|FG003|Overall Study|Physician Decision|0|||
44304673|NCT04614246|79303198|FG004|Overall Study|Physician Decision|0|||
44304674|NCT04614246|79303194|FG000|Overall Study|Study terminated by sponsor|10|||
44304675|NCT04614246|79303195|FG001|Overall Study|Study terminated by sponsor|15|||
44534421|NCT03134222|79544919|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
44534422|NCT03134222|79544920|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
44304676|NCT04614246|79303196|FG002|Overall Study|Study terminated by sponsor|12|||
44304677|NCT04614246|79303197|FG003|Overall Study|Study terminated by sponsor|13|||
44304678|NCT04614246|79303198|FG004|Overall Study|Study terminated by sponsor|9|||
44304679|NCT04614246|79303194|FG000|Overall Study|Pregnancy|2|||
44304680|NCT04614246|79303195|FG001|Overall Study|Pregnancy|0|||
44304681|NCT04614246|79303196|FG002|Overall Study|Pregnancy|1|||
44534423|NCT03134222|79544921|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
44534424|NCT03134222|79544922|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
44534425|NCT03134222|79544923|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
44534426|NCT03134222|79544919|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
44534427|NCT03134222|79544920|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
44534428|NCT03134222|79544921|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
44534429|NCT03134222|79544922|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
44534430|NCT03134222|79544923|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
44534431|NCT03769753|79544933|FG000|Overall Study|Not Treated|6|||
44534432|NCT03769753|79544933|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
44155120|NCT03527745|78946586|FG008|Overall Study|Lost to Follow-up|3|||
44155121|NCT03527745|78946587|FG009|Overall Study|Lost to Follow-up|2|||
44155122|NCT03527745|78946588|FG010|Overall Study|Lost to Follow-up|1|||
44304682|NCT04614246|79303197|FG003|Overall Study|Pregnancy|0|||
44304683|NCT04614246|79303198|FG004|Overall Study|Pregnancy|0|||
44304684|NCT04593823|79303216|FG000|Overall Study|Withdrawal by Subject|1|||
44304685|NCT04593823|79303217|FG001|Overall Study|Withdrawal by Subject|1|||
44304686|NCT04593823|79303216|FG000|Overall Study|Lost to Follow-up|0|||
44304687|NCT04593823|79303217|FG001|Overall Study|Lost to Follow-up|1|||
44304688|NCT04556383|79303237|FG000|PCP|Lack of Efficacy|28|||
44304689|NCT04556383|79303238|FG001|PCP|Lack of Efficacy|23|||
44304690|NCT04556383|79303239|FG002|PCP|Lack of Efficacy|23|||
44155123|NCT03527745|78946589|FG011|Overall Study|Lost to Follow-up|1|||
44155124|NCT03527745|78946590|FG012|Overall Study|Lost to Follow-up|0|||
44304691|NCT04556383|79303240|FG003|PCP|Lack of Efficacy|0|||
44304692|NCT04556383|79303237|FG000|PCP|Study terminated by sponsor|15|||
44304693|NCT04556383|79303238|FG001|PCP|Study terminated by sponsor|13|||
44304694|NCT04556383|79303239|FG002|PCP|Study terminated by sponsor|16|||
44304695|NCT04556383|79303240|FG003|PCP|Study terminated by sponsor|0|||
44304696|NCT04556383|79303237|FG000|PCP|Withdrawal by Subject|8|||
44304697|NCT04556383|79303238|FG001|PCP|Withdrawal by Subject|6|||
44304698|NCT04556383|79303239|FG002|PCP|Withdrawal by Subject|6|||
44304699|NCT04556383|79303240|FG003|PCP|Withdrawal by Subject|0|||
44304700|NCT04556383|79303237|FG000|PCP|Adverse Event|1|||
44304701|NCT04556383|79303238|FG001|PCP|Adverse Event|7|||
44304702|NCT04556383|79303239|FG002|PCP|Adverse Event|7|||
44304703|NCT04556383|79303240|FG003|PCP|Adverse Event|0|||
44304704|NCT04556383|79303237|FG000|PCP|Other, Not Specified|1|||
44304705|NCT04556383|79303238|FG001|PCP|Other, Not Specified|2|||
44304706|NCT04556383|79303239|FG002|PCP|Other, Not Specified|1|||
44304707|NCT04556383|79303240|FG003|PCP|Other, Not Specified|0|||
44304708|NCT04556383|79303237|FG000|PCP|Protocol Violation|1|||
44304709|NCT04556383|79303238|FG001|PCP|Protocol Violation|0|||
44304710|NCT04556383|79303239|FG002|PCP|Protocol Violation|1|||
44304711|NCT04556383|79303240|FG003|PCP|Protocol Violation|0|||
44304712|NCT04556383|79303237|FG000|PCP|Lost to Follow-up|1|||
44304713|NCT04556383|79303238|FG001|PCP|Lost to Follow-up|0|||
44304714|NCT04556383|79303239|FG002|PCP|Lost to Follow-up|0|||
44304715|NCT04556383|79303240|FG003|PCP|Lost to Follow-up|0|||
44304716|NCT04556383|79303237|FG000|PCP|Physician Decision|0|||
44304717|NCT04556383|79303238|FG001|PCP|Physician Decision|1|||
44304718|NCT04556383|79303239|FG002|PCP|Physician Decision|0|||
44304719|NCT04556383|79303240|FG003|PCP|Physician Decision|0|||
44304720|NCT04556383|79303237|FG000|PCP|Site terminated by sponsor|0|||
44304721|NCT04556383|79303238|FG001|PCP|Site terminated by sponsor|1|||
44304722|NCT04556383|79303239|FG002|PCP|Site terminated by sponsor|0|||
44418044|NCT00829829|79426027|FG002|Overall Study|Other than specified above|1|||
44418045|NCT00823199|79426036|FG000|Overall Study|Withdrawal by Subject|2|||
44418046|NCT00829439|79426041|FG000|Overall Study|Adverse Event|0|||
44418047|NCT00829439|79426042|FG001|Overall Study|Adverse Event|0|||
44418048|NCT00829439|79426043|FG002|Overall Study|Adverse Event|1|||
44418049|NCT00829439|79426044|FG003|Overall Study|Adverse Event|0|||
44418050|NCT00749775|79426048|FG000|Overall Study|Protocol Violation|24|||
44418051|NCT00749775|79426048|FG000|Overall Study|Lost to Follow-up|36|||
44418052|NCT00749775|79426048|FG000|Overall Study|No visit after first day of treatment|44|||
44418053|NCT00749775|79426048|FG000|Overall Study|No drug administration|3|||
44418054|NCT00829283|79426064|FG000|Overall Study|Lost to Follow-up|7|||
44418055|NCT00829283|79426065|FG001|Overall Study|Lost to Follow-up|25|||
44418056|NCT00821873|79426071|FG000|Overall Study|Lost to Follow-up|4|||
44418057|NCT00749463|79426078|FG000|Overall Study|Adverse Event|0|||
44418058|NCT00749463|79426079|FG001|Overall Study|Adverse Event|4|||
44418059|NCT00749463|79426080|FG002|Overall Study|Adverse Event|1|||
44418060|NCT00749463|79426078|FG000|Overall Study|Withdrawal by Subject|1|||
44418061|NCT00749463|79426079|FG001|Overall Study|Withdrawal by Subject|0|||
44418062|NCT00749463|79426080|FG002|Overall Study|Withdrawal by Subject|0|||
44418063|NCT00821327|79426088|FG000|Overall Study|Adverse Event|13|||
44418064|NCT00821327|79426088|FG000|Overall Study|Patient Request|1|||
44418065|NCT00821327|79426088|FG000|Overall Study|Investigator Request|2|||
44418066|NCT00821327|79426088|FG000|Overall Study|Sponsor Request|1|||
44418067|NCT00821327|79426088|FG000|Overall Study|Disease Progression|13|||
44418068|NCT00821327|79426088|FG000|Overall Study|Other/Unknown|5|||
44418069|NCT00821093|79426094|FG000|Overall Study|Adverse Event|20|||
44418070|NCT00821093|79426095|FG001|Overall Study|Adverse Event|12|||
44418071|NCT00821093|79426094|FG000|Overall Study|Withdrawal by Subject|9|||
44418072|NCT00821093|79426095|FG001|Overall Study|Withdrawal by Subject|13|||
44418073|NCT00821093|79426094|FG000|Overall Study|Lost to Follow-up|9|||
44418074|NCT00821093|79426095|FG001|Overall Study|Lost to Follow-up|3|||
44304723|NCT04556383|79303240|FG003|PCP|Site terminated by sponsor|0|||
44304724|NCT04556383|79303237|FG000|OLE|Study terminated by sponsor|0|||
44418075|NCT00821093|79426094|FG000|Overall Study|Protocol deviation|3|||
44418076|NCT00821093|79426095|FG001|Overall Study|Protocol deviation|6|||
44418077|NCT00821093|79426094|FG000|Overall Study|Abnormal laboratory value(s)|2|||
44304725|NCT04556383|79303238|FG001|OLE|Study terminated by sponsor|0|||
44304726|NCT04556383|79303239|FG002|OLE|Study terminated by sponsor|0|||
44304727|NCT04556383|79303240|FG003|OLE|Study terminated by sponsor|68|||
44304728|NCT04556383|79303237|FG000|OLE|Withdrawal by Subject|0|||
44418078|NCT00821093|79426095|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44418079|NCT00821093|79426094|FG000|Overall Study|Lack of Efficacy|2|||
44418080|NCT00821093|79426095|FG001|Overall Study|Lack of Efficacy|2|||
44418081|NCT00821093|79426094|FG000|Overall Study|Death|2|||
44304729|NCT04556383|79303238|FG001|OLE|Withdrawal by Subject|0|||
44304730|NCT04556383|79303239|FG002|OLE|Withdrawal by Subject|0|||
44304731|NCT04556383|79303240|FG003|OLE|Withdrawal by Subject|10|||
44304732|NCT04556383|79303237|FG000|OLE|Lack of Efficacy|0|||
44304733|NCT04556383|79303238|FG001|OLE|Lack of Efficacy|0|||
44304734|NCT04556383|79303239|FG002|OLE|Lack of Efficacy|0|||
44304735|NCT04556383|79303240|FG003|OLE|Lack of Efficacy|7|||
44304736|NCT04556383|79303237|FG000|OLE|Adverse Event|0|||
44304737|NCT04556383|79303238|FG001|OLE|Adverse Event|0|||
44304738|NCT04556383|79303239|FG002|OLE|Adverse Event|0|||
44304739|NCT04556383|79303240|FG003|OLE|Adverse Event|2|||
44304740|NCT04556383|79303237|FG000|OLE|Other, Not Specified|0|||
44304741|NCT04556383|79303238|FG001|OLE|Other, Not Specified|0|||
44534433|NCT03263923|79544948|FG000|Overall Study|Withdrawal by Subject|10|||
44534434|NCT03263923|79544949|FG001|Overall Study|Withdrawal by Subject|8|||
44534435|NCT03263923|79544948|FG000|Overall Study|Lost to Follow-up|15|||
44534436|NCT03263923|79544949|FG001|Overall Study|Lost to Follow-up|13|||
44534437|NCT03139604|79544959|FG000|Overall Study|Other|7|||
44534438|NCT03139604|79544960|FG001|Overall Study|Other|3|||
44534439|NCT03139604|79544959|FG000|Overall Study|Withdrawal by Subject|16|||
44534440|NCT03139604|79544960|FG001|Overall Study|Withdrawal by Subject|17|||
44534441|NCT03139604|79544959|FG000|Overall Study|Physician Decision|1|||
44534442|NCT03139604|79544960|FG001|Overall Study|Physician Decision|2|||
44534443|NCT03139604|79544959|FG000|Overall Study|Lost to Follow-up|3|||
44534444|NCT03139604|79544960|FG001|Overall Study|Lost to Follow-up|1|||
44534445|NCT03139604|79544959|FG000|Overall Study|Death|65|||
44534446|NCT03139604|79544960|FG001|Overall Study|Death|67|||
44534447|NCT03139604|79544959|FG000|Overall Study|Study Terminated by Sponsor|122|||
44534448|NCT03139604|79544960|FG001|Overall Study|Study Terminated by Sponsor|127|||
44534449|NCT03139604|79544959|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
44534450|NCT03139604|79544960|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
44534451|NCT03139448|79544969|FG000|Overall Study|Lack of Efficacy|6|||
44534452|NCT03139448|79544970|FG001|Overall Study|Lack of Efficacy|7|||
44534453|NCT03139448|79544969|FG000|Overall Study|Location of procedure changed|2|||
44534454|NCT03139448|79544970|FG001|Overall Study|Location of procedure changed|8|||
44534455|NCT03139448|79544969|FG000|Overall Study|Withdrawal by Subject|3|||
44534456|NCT03139448|79544970|FG001|Overall Study|Withdrawal by Subject|6|||
44534457|NCT03139448|79544969|FG000|Overall Study|Screen fail|1|||
44534458|NCT03139448|79544970|FG001|Overall Study|Screen fail|3|||
44534459|NCT03139448|79544969|FG000|Overall Study|Physician Decision|0|||
44534460|NCT03139448|79544970|FG001|Overall Study|Physician Decision|2|||
44534461|NCT02875340|79544976|FG000|Overall Study|Death|2|||
44534462|NCT02875340|79544976|FG000|Overall Study|Withdrawal by Subject|2|||
44534463|NCT02875340|79544976|FG000|Overall Study|Physician Decision|3|||
44534464|NCT02875340|79544976|FG000|Overall Study|Adverse Event|1|||
44534465|NCT03237325|79544988|FG000|Overall Study|Lost to Follow-up|3|||
44534466|NCT03237325|79544989|FG001|Overall Study|Lost to Follow-up|5|||
44534467|NCT03237325|79544988|FG000|Overall Study|Physician Decision|2|||
44534468|NCT03237325|79544989|FG001|Overall Study|Physician Decision|4|||
44534469|NCT03237325|79544988|FG000|Overall Study|Withdrawal by Subject|9|||
44534470|NCT03237325|79544989|FG001|Overall Study|Withdrawal by Subject|12|||
44534471|NCT03237325|79544988|FG000|Overall Study|Noncompliance with Study Procedures|1|||
44534472|NCT03237325|79544989|FG001|Overall Study|Noncompliance with Study Procedures|1|||
44534473|NCT03237325|79544988|FG000|Overall Study|Termination by Sponsor|0|||
44534474|NCT03237325|79544989|FG001|Overall Study|Termination by Sponsor|1|||
44534475|NCT03237325|79544988|FG000|Overall Study|Reason other than described|0|||
44534476|NCT03237325|79544989|FG001|Overall Study|Reason other than described|2|||
44534477|NCT03113383|79544995|FG000|Overall Study|Death|4|||
44534478|NCT03113383|79544996|FG001|Overall Study|Death|0|||
44534479|NCT03131960|79545017|FG000|Overall Study|Adverse Event|0|||
44304742|NCT04556383|79303239|FG002|OLE|Other, Not Specified|0|||
44304743|NCT04556383|79303240|FG003|OLE|Other, Not Specified|2|||
44304744|NCT04556383|79303237|FG000|OLE|Death|0|||
44304745|NCT04556383|79303238|FG001|OLE|Death|0|||
44304746|NCT04556383|79303239|FG002|OLE|Death|0|||
44304747|NCT04556383|79303240|FG003|OLE|Death|1|||
44304748|NCT04556383|79303237|FG000|OLE|Lost to Follow-up|0|||
44304749|NCT04556383|79303238|FG001|OLE|Lost to Follow-up|0|||
44304750|NCT04556383|79303239|FG002|OLE|Lost to Follow-up|0|||
44304751|NCT04556383|79303240|FG003|OLE|Lost to Follow-up|1|||
44304752|NCT04444752|79303274|FG000|Overall Study|Adverse Event|1|||
44304753|NCT04444752|79303275|FG001|Overall Study|Adverse Event|0|||
44304754|NCT04444752|79303276|FG002|Overall Study|Adverse Event|0|||
44304755|NCT04444752|79303277|FG003|Overall Study|Adverse Event|2|||
44534480|NCT03131960|79545018|FG001|Overall Study|Adverse Event|1|||
44304756|NCT04444752|79303274|FG000|Overall Study|Lost to Follow-up|2|||
44304757|NCT04444752|79303275|FG001|Overall Study|Lost to Follow-up|6|||
44304758|NCT04444752|79303276|FG002|Overall Study|Lost to Follow-up|2|||
44304759|NCT04444752|79303277|FG003|Overall Study|Lost to Follow-up|5|||
44304760|NCT04444752|79303274|FG000|Overall Study|Physician Decision|0|||
44534481|NCT03225170|79545027|FG000|Overall Study|Lost to Follow-up|4|||
44534482|NCT03225170|79545028|FG001|Overall Study|Lost to Follow-up|4|||
44534483|NCT03225170|79545029|FG002|Overall Study|Lost to Follow-up|0|||
44534484|NCT03225170|79545027|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
44304761|NCT04444752|79303275|FG001|Overall Study|Physician Decision|0|||
44304762|NCT04444752|79303276|FG002|Overall Study|Physician Decision|0|||
44304763|NCT04444752|79303277|FG003|Overall Study|Physician Decision|2|||
44304764|NCT04444752|79303274|FG000|Overall Study|Pregnancy|0|||
44304765|NCT04444752|79303275|FG001|Overall Study|Pregnancy|0|||
44304766|NCT04444752|79303276|FG002|Overall Study|Pregnancy|0|||
44304767|NCT04444752|79303277|FG003|Overall Study|Pregnancy|1|||
44304768|NCT04444752|79303274|FG000|Overall Study|Withdrawal by Subject|6|||
44304769|NCT04444752|79303275|FG001|Overall Study|Withdrawal by Subject|5|||
44304770|NCT04444752|79303276|FG002|Overall Study|Withdrawal by Subject|3|||
44304771|NCT04444752|79303277|FG003|Overall Study|Withdrawal by Subject|4|||
44304772|NCT04444752|79303274|FG000|Overall Study|Protocol Violation|1|||
44304773|NCT04444752|79303275|FG001|Overall Study|Protocol Violation|1|||
44304774|NCT04444752|79303276|FG002|Overall Study|Protocol Violation|0|||
44304775|NCT04444752|79303277|FG003|Overall Study|Protocol Violation|0|||
44304776|NCT04444752|79303274|FG000|Overall Study|Patient moving out of town|1|||
44304777|NCT04444752|79303275|FG001|Overall Study|Patient moving out of town|0|||
44304778|NCT04444752|79303276|FG002|Overall Study|Patient moving out of town|0|||
44304779|NCT04444752|79303277|FG003|Overall Study|Patient moving out of town|1|||
44304780|NCT04444752|79303274|FG000|Overall Study|Lack of Efficacy|0|||
44304781|NCT04444752|79303275|FG001|Overall Study|Lack of Efficacy|0|||
44304782|NCT04444752|79303276|FG002|Overall Study|Lack of Efficacy|0|||
44304783|NCT04444752|79303277|FG003|Overall Study|Lack of Efficacy|1|||
44304784|NCT04444752|79303274|FG000|Overall Study|Death|0|||
44304785|NCT04444752|79303275|FG001|Overall Study|Death|0|||
44304786|NCT04444752|79303276|FG002|Overall Study|Death|1|||
44304787|NCT04444752|79303277|FG003|Overall Study|Death|0|||
44304788|NCT04429022|79303289|FG000|Overall Study|Protocol Violation|18|||
44304789|NCT04429022|79303290|FG001|Overall Study|Protocol Violation|1|||
44304790|NCT04351373|79303320|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
44304791|NCT04239924|79303333|FG000|Overall Study|Lost to Follow-up|2|||
44304792|NCT04154904|79303345|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
44304793|NCT04154904|79303346|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
44304794|NCT04154904|79303347|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
44304795|NCT04114656|79303359|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
44304796|NCT04114656|79303360|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
44304797|NCT04114656|79303359|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
44304798|NCT04114656|79303360|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
44304799|NCT04114656|79303359|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
44304800|NCT04114656|79303360|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
44304801|NCT04114656|79303359|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
44304802|NCT04114656|79303360|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
44304803|NCT04114656|79303359|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
44304804|NCT04114656|79303360|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
44304805|NCT04034238|79303378|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
44304806|NCT04034238|79303379|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
44304807|NCT04034238|79303380|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
44304808|NCT04034238|79303381|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44304809|NCT04034238|79303378|FG000|Dose Escalation Phase|Screen failures|0|||
44304810|NCT04034238|79303379|FG001|Dose Escalation Phase|Screen failures|0|||
44304811|NCT04034238|79303380|FG002|Dose Escalation Phase|Screen failures|0|||
44304812|NCT04034238|79303381|FG003|Dose Escalation Phase|Screen failures|2|||
44304813|NCT04034238|79303378|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
44418082|NCT00821093|79426095|FG001|Overall Study|Death|1|||
44418083|NCT00821093|79426094|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44418084|NCT00821093|79426095|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44304814|NCT04034238|79303379|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
44304815|NCT04034238|79303380|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
44304816|NCT04034238|79303381|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
44304817|NCT04034238|79303378|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
44304818|NCT04034238|79303379|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
44304819|NCT04034238|79303380|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
44304820|NCT04034238|79303381|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
44304821|NCT03956056|79303392|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
44304822|NCT03956056|79303392|FG000|Overall Study|Lack of Efficacy|1|||
44304823|NCT03954041|79303399|FG000|Overall Study|Lost to Follow-up|3|||
44304824|NCT03954041|79303400|FG001|Overall Study|Lost to Follow-up|3|||
44304825|NCT03954041|79303401|FG002|Overall Study|Lost to Follow-up|6|||
44304826|NCT03954041|79303399|FG000|Overall Study|Death|4|||
44304827|NCT03954041|79303400|FG001|Overall Study|Death|0|||
44304828|NCT03954041|79303401|FG002|Overall Study|Death|1|||
44304829|NCT03954041|79303399|FG000|Overall Study|Death by neurologic criteria|0|||
44304830|NCT03954041|79303400|FG001|Overall Study|Death by neurologic criteria|0|||
44304831|NCT03954041|79303401|FG002|Overall Study|Death by neurologic criteria|1|||
44304832|NCT03954041|79303399|FG000|Overall Study|Reason not specified|7|||
44304833|NCT03954041|79303400|FG001|Overall Study|Reason not specified|4|||
44304834|NCT03954041|79303401|FG002|Overall Study|Reason not specified|2|||
44304835|NCT03954041|79303399|FG000|Overall Study|Withdrew prior to dosing|4|||
44304836|NCT03954041|79303400|FG001|Overall Study|Withdrew prior to dosing|2|||
44304837|NCT03954041|79303401|FG002|Overall Study|Withdrew prior to dosing|0|||
44304838|NCT03926195|79303411|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
44304839|NCT03926195|79303412|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
44304840|NCT03926195|79303411|FG000|EXT Phase (Through Week 26)|Ongoing in the study|29|||
44304841|NCT03926195|79303412|FG001|EXT Phase (Through Week 26)|Ongoing in the study|36|||
44304842|NCT03926195|79303411|FG000|EXT Phase (Through Week 26)|Adverse Event|5|||
44304843|NCT03926195|79303412|FG001|EXT Phase (Through Week 26)|Adverse Event|0|||
44304844|NCT03926195|79303411|FG000|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|12|||
44304845|NCT03926195|79303412|FG001|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|11|||
44304846|NCT03926195|79303411|FG000|EXT Phase (Through Week 26)|Withdrawal by Subject|0|||
44304847|NCT03926195|79303412|FG001|EXT Phase (Through Week 26)|Withdrawal by Subject|2|||
44304848|NCT03908476|79303427|FG000|Overall Study|Death|3|||
44304849|NCT03908476|79303428|FG001|Overall Study|Death|0|||
44304850|NCT03908476|79303427|FG000|Overall Study|Lost to Follow-up|3|||
44304851|NCT03908476|79303428|FG001|Overall Study|Lost to Follow-up|1|||
44304852|NCT03908476|79303427|FG000|Overall Study|Withdrawal by Subject|7|||
44304853|NCT03908476|79303428|FG001|Overall Study|Withdrawal by Subject|1|||
44304854|NCT03908476|79303427|FG000|Overall Study|Physician Decision|2|||
44304855|NCT03908476|79303428|FG001|Overall Study|Physician Decision|0|||
44304856|NCT03908476|79303427|FG000|Overall Study|System Explanted and not Replaced|4|||
44304857|NCT03908476|79303428|FG001|Overall Study|System Explanted and not Replaced|0|||
44304858|NCT03908476|79303427|FG000|Overall Study|Intrathecal Pump|1|||
44304859|NCT03908476|79303428|FG001|Overall Study|Intrathecal Pump|0|||
44304860|NCT03908476|79303427|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
44304861|NCT03908476|79303428|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
44304862|NCT03830866|79303436|FG000|Overall Study|Ongoing study at DCO|312|||
44304863|NCT03830866|79303437|FG001|Overall Study|Ongoing study at DCO|295|||
44304864|NCT03830866|79303436|FG000|Overall Study|Death|58|||
44304865|NCT03830866|79303437|FG001|Overall Study|Death|74|||
44304866|NCT03830866|79303436|FG000|Overall Study|Lost to Follow-up|0|||
44304867|NCT03830866|79303437|FG001|Overall Study|Lost to Follow-up|1|||
44418085|NCT00821093|79426094|FG000|Overall Study|Administrative problems|1|||
44418086|NCT00821093|79426095|FG001|Overall Study|Administrative problems|2|||
44418087|NCT00821015|79426101|FG000|Overall Study|Lost to Follow-up|12|||
44418088|NCT00814463|79426105|FG000|Overall Study|Lost to Follow-up|1|||
44418089|NCT00743652|79426115|FG000|Overall Study|Parent/Legal Guardian Request|3|||
44418090|NCT00743652|79426116|FG001|Overall Study|Parent/Legal Guardian Request|2|||
44418091|NCT00743652|79426117|FG002|Overall Study|Parent/Legal Guardian Request|2|||
44418092|NCT00743652|79426118|FG003|Overall Study|Parent/Legal Guardian Request|2|||
44418093|NCT00743652|79426119|FG004|Overall Study|Parent/Legal Guardian Request|0|||
44418094|NCT00743652|79426115|FG000|Overall Study|Adverse Event|3|||
44418095|NCT00743652|79426116|FG001|Overall Study|Adverse Event|0|||
44418096|NCT00743652|79426117|FG002|Overall Study|Adverse Event|0|||
44418097|NCT00743652|79426118|FG003|Overall Study|Adverse Event|0|||
44418098|NCT00743652|79426119|FG004|Overall Study|Adverse Event|0|||
44534485|NCT03225170|79545028|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
44534486|NCT03225170|79545029|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
44534487|NCT02115139|79545035|FG000|Overall Study|Protocol Violation|1|||
44534488|NCT02115139|79545035|FG000|Overall Study|treatment discontinuation|6|||
44304868|NCT03830866|79303436|FG000|Overall Study|Withdrawal by Subject|15|||
44304869|NCT03830866|79303437|FG001|Overall Study|Withdrawal by Subject|13|||
44304870|NCT03830866|79303436|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
44418099|NCT00743652|79426115|FG000|Overall Study|Death|2|||
44418100|NCT00743652|79426116|FG001|Overall Study|Death|0|||
44418101|NCT00743652|79426117|FG002|Overall Study|Death|0|||
44534489|NCT01763827|79545083|FG000|Overall Study|Withdrawal by Subject|1|||
44304871|NCT03830866|79303437|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
44304872|NCT03830866|79303436|FG000|Overall Study|Other|0|||
44304873|NCT03830866|79303437|FG001|Overall Study|Other|1|||
44304874|NCT03699007|79303454|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
44418102|NCT00743652|79426118|FG003|Overall Study|Death|0|||
44418103|NCT00743652|79426119|FG004|Overall Study|Death|0|||
44418104|NCT00743652|79426115|FG000|Overall Study|Investigator Request|0|||
44418105|NCT00743652|79426116|FG001|Overall Study|Investigator Request|0|||
44418106|NCT00743652|79426117|FG002|Overall Study|Investigator Request|0|||
44418107|NCT00743652|79426118|FG003|Overall Study|Investigator Request|2|||
44418108|NCT00743652|79426119|FG004|Overall Study|Investigator Request|0|||
44418109|NCT00743652|79426115|FG000|Overall Study|Other|1|||
44418110|NCT00743652|79426116|FG001|Overall Study|Other|1|||
44534490|NCT01763827|79545084|FG001|Overall Study|Withdrawal by Subject|0|||
44534491|NCT01763827|79545085|FG002|Overall Study|Withdrawal by Subject|0|||
44534492|NCT01763827|79545086|FG003|Overall Study|Withdrawal by Subject|0|||
44534493|NCT01763827|79545087|FG004|Overall Study|Withdrawal by Subject|2|||
44534494|NCT01763827|79545088|FG005|Overall Study|Withdrawal by Subject|0|||
44534495|NCT01763827|79545083|FG000|Overall Study|Decision by sponsor|2|||
44534496|NCT01763827|79545084|FG001|Overall Study|Decision by sponsor|0|||
44534497|NCT01763827|79545085|FG002|Overall Study|Decision by sponsor|3|||
44418111|NCT00743652|79426117|FG002|Overall Study|Other|0|||
44534498|NCT01763827|79545086|FG003|Overall Study|Decision by sponsor|0|||
44418112|NCT00743652|79426118|FG003|Overall Study|Other|0|||
44418113|NCT00743652|79426119|FG004|Overall Study|Other|0|||
44418114|NCT00743652|79426115|FG000|Overall Study|Lost to Follow-up|1|||
44418115|NCT00743652|79426116|FG001|Overall Study|Lost to Follow-up|0|||
44418116|NCT00743652|79426117|FG002|Overall Study|Lost to Follow-up|0|||
44418117|NCT00743652|79426118|FG003|Overall Study|Lost to Follow-up|0|||
44418118|NCT00743652|79426119|FG004|Overall Study|Lost to Follow-up|0|||
44418119|NCT00748215|79426137|FG000|Overall Study|Withdrawal by Subject|7|||
44534499|NCT01763827|79545087|FG004|Overall Study|Decision by sponsor|2|||
44534500|NCT01763827|79545088|FG005|Overall Study|Decision by sponsor|1|||
44534501|NCT01763827|79545083|FG000|Overall Study|Lost to Follow-up|0|||
44534502|NCT01763827|79545084|FG001|Overall Study|Lost to Follow-up|1|||
44534503|NCT01763827|79545085|FG002|Overall Study|Lost to Follow-up|1|||
44534504|NCT01763827|79545086|FG003|Overall Study|Lost to Follow-up|1|||
44534505|NCT01763827|79545087|FG004|Overall Study|Lost to Follow-up|2|||
44534506|NCT01763827|79545088|FG005|Overall Study|Lost to Follow-up|1|||
44534507|NCT01732783|79545141|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
44534508|NCT01732783|79545142|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
44534509|NCT01732783|79545143|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
44534510|NCT01732783|79545141|FG000|Overall Study|Death|13|||
44534511|NCT01732783|79545142|FG001|Overall Study|Death|4|||
44534512|NCT01732783|79545143|FG002|Overall Study|Death|1|||
44534513|NCT01732783|79545141|FG000|Overall Study|Lost to Follow-up|7|||
44534514|NCT01732783|79545142|FG001|Overall Study|Lost to Follow-up|1|||
44534515|NCT01732783|79545143|FG002|Overall Study|Lost to Follow-up|1|||
44534516|NCT01732783|79545141|FG000|Overall Study|Administrative Decision|8|||
44534517|NCT01732783|79545142|FG001|Overall Study|Administrative Decision|2|||
44534518|NCT01732783|79545143|FG002|Overall Study|Administrative Decision|1|||
44534519|NCT01732783|79545141|FG000|Overall Study|Withdrawal by Subject|1|||
44534520|NCT01732783|79545142|FG001|Overall Study|Withdrawal by Subject|0|||
44534521|NCT01732783|79545143|FG002|Overall Study|Withdrawal by Subject|0|||
44534522|NCT02787850|79545170|FG000|Overall Study|Withdrawal by Subject|0|||
44534523|NCT02787850|79545171|FG001|Overall Study|Withdrawal by Subject|1|||
44534524|NCT01375777|79545195|FG000|Overall Study|Withdrawal by Subject|0|||
44534525|NCT01375777|79545196|FG001|Overall Study|Withdrawal by Subject|2|||
44534526|NCT01375777|79545197|FG002|Overall Study|Withdrawal by Subject|1|||
44534527|NCT01375777|79545198|FG003|Overall Study|Withdrawal by Subject|0|||
44534528|NCT01375777|79545199|FG004|Overall Study|Withdrawal by Subject|1|||
44534529|NCT01375777|79545200|FG005|Overall Study|Withdrawal by Subject|1|||
44534530|NCT01375777|79545201|FG006|Overall Study|Withdrawal by Subject|1|||
44418120|NCT00748215|79426138|FG001|Overall Study|Withdrawal by Subject|7|||
44418121|NCT00748215|79426137|FG000|Overall Study|Treatment change|2|||
44418122|NCT00748215|79426138|FG001|Overall Study|Treatment change|1|||
44534531|NCT01375777|79545202|FG007|Overall Study|Withdrawal by Subject|2|||
44534532|NCT01375777|79545203|FG008|Overall Study|Withdrawal by Subject|1|||
44534533|NCT01375777|79545195|FG000|Overall Study|Lost to Follow-up|1|||
44534534|NCT01375777|79545196|FG001|Overall Study|Lost to Follow-up|0|||
44534535|NCT01375777|79545197|FG002|Overall Study|Lost to Follow-up|0|||
44304875|NCT03699007|79303455|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
44304876|NCT03699007|79303454|FG000|6-month Follow Up|Lost to Follow-up|2|||
44304877|NCT03699007|79303455|FG001|6-month Follow Up|Lost to Follow-up|3|||
44304878|NCT03581188|79303465|FG000|Overall Study|Inclusion criteria not met|3|||
44304879|NCT03581188|79303466|FG001|Overall Study|Inclusion criteria not met|2|||
44304880|NCT03581188|79303465|FG000|Overall Study|Lost to Follow-up|5|||
44304881|NCT03581188|79303466|FG001|Overall Study|Lost to Follow-up|5|||
44304882|NCT03581188|79303465|FG000|Overall Study|Discontinued intervention|11|||
44304883|NCT03581188|79303466|FG001|Overall Study|Discontinued intervention|8|||
44304884|NCT03576131|79303483|FG000|Overall Study|Investigator decision|0|||
44304885|NCT03576131|79303484|FG001|Overall Study|Investigator decision|0|||
44304886|NCT03576131|79303485|FG002|Overall Study|Investigator decision|0|||
44304887|NCT03576131|79303486|FG003|Overall Study|Investigator decision|1|||
44304888|NCT03576131|79303487|FG004|Overall Study|Investigator decision|0|||
44304889|NCT03576131|79303488|FG005|Overall Study|Investigator decision|1|||
44304890|NCT03576131|79303489|FG006|Overall Study|Investigator decision|0|||
44304891|NCT03576131|79303490|FG007|Overall Study|Investigator decision|0|||
44304892|NCT03576131|79303483|FG000|Overall Study|Withdrawal by Subject|1|||
44304893|NCT03576131|79303484|FG001|Overall Study|Withdrawal by Subject|1|||
44304894|NCT03576131|79303485|FG002|Overall Study|Withdrawal by Subject|0|||
44304895|NCT03576131|79303486|FG003|Overall Study|Withdrawal by Subject|1|||
44304896|NCT03576131|79303487|FG004|Overall Study|Withdrawal by Subject|2|||
44304897|NCT03576131|79303488|FG005|Overall Study|Withdrawal by Subject|3|||
44304898|NCT03576131|79303489|FG006|Overall Study|Withdrawal by Subject|1|||
44304899|NCT03576131|79303490|FG007|Overall Study|Withdrawal by Subject|0|||
44304900|NCT03576131|79303483|FG000|Overall Study|Death|3|||
44304901|NCT03576131|79303484|FG001|Overall Study|Death|3|||
44304902|NCT03576131|79303485|FG002|Overall Study|Death|1|||
44304903|NCT03576131|79303486|FG003|Overall Study|Death|5|||
44304904|NCT03576131|79303487|FG004|Overall Study|Death|4|||
44304905|NCT03576131|79303488|FG005|Overall Study|Death|1|||
44304906|NCT03576131|79303489|FG006|Overall Study|Death|0|||
44304907|NCT03576131|79303490|FG007|Overall Study|Death|1|||
44304908|NCT03576131|79303483|FG000|Overall Study|New anti-cancer treatment|5|||
44304909|NCT03576131|79303484|FG001|Overall Study|New anti-cancer treatment|1|||
44304910|NCT03576131|79303485|FG002|Overall Study|New anti-cancer treatment|2|||
44304911|NCT03576131|79303486|FG003|Overall Study|New anti-cancer treatment|3|||
44304912|NCT03576131|79303487|FG004|Overall Study|New anti-cancer treatment|0|||
44304913|NCT03576131|79303488|FG005|Overall Study|New anti-cancer treatment|0|||
44304914|NCT03576131|79303489|FG006|Overall Study|New anti-cancer treatment|0|||
44304915|NCT03576131|79303490|FG007|Overall Study|New anti-cancer treatment|0|||
44304916|NCT03576131|79303483|FG000|Overall Study|Unspecified reason|0|||
44304917|NCT03576131|79303484|FG001|Overall Study|Unspecified reason|0|||
44304918|NCT03576131|79303485|FG002|Overall Study|Unspecified reason|1|||
44304919|NCT03576131|79303486|FG003|Overall Study|Unspecified reason|1|||
44304920|NCT03576131|79303487|FG004|Overall Study|Unspecified reason|1|||
44304921|NCT03576131|79303488|FG005|Overall Study|Unspecified reason|1|||
44304922|NCT03576131|79303489|FG006|Overall Study|Unspecified reason|0|||
44304923|NCT03576131|79303490|FG007|Overall Study|Unspecified reason|0|||
44304924|NCT03576131|79303483|FG000|Overall Study|Subject non-compliance|0|||
44304925|NCT03576131|79303484|FG001|Overall Study|Subject non-compliance|0|||
44304926|NCT03576131|79303485|FG002|Overall Study|Subject non-compliance|0|||
44304927|NCT03576131|79303486|FG003|Overall Study|Subject non-compliance|0|||
44304928|NCT03576131|79303487|FG004|Overall Study|Subject non-compliance|0|||
44304929|NCT03576131|79303488|FG005|Overall Study|Subject non-compliance|1|||
44304930|NCT03576131|79303489|FG006|Overall Study|Subject non-compliance|0|||
44304931|NCT03576131|79303490|FG007|Overall Study|Subject non-compliance|0|||
44304932|NCT03454529|79303527|FG000|Overall Study|Did not receive treatment|6|||
44304933|NCT03454529|79303527|FG000|Overall Study|Received < 80% doses|1|||
44304934|NCT03409731|79303531|FG000|Overall Study|Withdrawal by Subject|1|||
44304935|NCT03409731|79303531|FG000|Overall Study|Death|4|||
44304936|NCT02988817|79303573|FG000|Overall Study|Withdrawal by Subject|1|||
44418123|NCT00748215|79426137|FG000|Overall Study|Change in patient condition|0|||
44304937|NCT02988817|79303574|FG001|Overall Study|Withdrawal by Subject|0|||
44304938|NCT02988817|79303575|FG002|Overall Study|Withdrawal by Subject|0|||
44304939|NCT02988817|79303576|FG003|Overall Study|Withdrawal by Subject|1|||
44304940|NCT02988817|79303577|FG004|Overall Study|Withdrawal by Subject|3|||
44304941|NCT02988817|79303578|FG005|Overall Study|Withdrawal by Subject|1|||
44304942|NCT02988817|79303579|FG006|Overall Study|Withdrawal by Subject|2|||
44304943|NCT02988817|79303580|FG007|Overall Study|Withdrawal by Subject|1|||
44304944|NCT02988817|79303581|FG008|Overall Study|Withdrawal by Subject|1|||
44304945|NCT02988817|79303582|FG009|Overall Study|Withdrawal by Subject|1|||
44304946|NCT02988817|79303583|FG010|Overall Study|Withdrawal by Subject|1|||
44304947|NCT02988817|79303584|FG011|Overall Study|Withdrawal by Subject|12|||
44534536|NCT01375777|79545198|FG003|Overall Study|Lost to Follow-up|0|||
44304948|NCT02988817|79303585|FG012|Overall Study|Withdrawal by Subject|6|||
44304949|NCT02988817|79303586|FG013|Overall Study|Withdrawal by Subject|6|||
44304950|NCT02988817|79303587|FG014|Overall Study|Withdrawal by Subject|4|||
44304951|NCT02988817|79303588|FG015|Overall Study|Withdrawal by Subject|5|||
44304952|NCT02988817|79303589|FG016|Overall Study|Withdrawal by Subject|4|||
44304953|NCT02988817|79303590|FG017|Overall Study|Withdrawal by Subject|11|||
44304954|NCT02988817|79303591|FG018|Overall Study|Withdrawal by Subject|4|||
44304955|NCT02988817|79303592|FG019|Overall Study|Withdrawal by Subject|2|||
44304956|NCT02988817|79303573|FG000|Overall Study|Death|0|||
44304957|NCT02988817|79303574|FG001|Overall Study|Death|1|||
44304958|NCT02988817|79303575|FG002|Overall Study|Death|3|||
44304959|NCT02988817|79303576|FG003|Overall Study|Death|1|||
44304960|NCT02988817|79303577|FG004|Overall Study|Death|6|||
44304961|NCT02988817|79303578|FG005|Overall Study|Death|10|||
44304962|NCT02988817|79303579|FG006|Overall Study|Death|1|||
44304963|NCT02988817|79303580|FG007|Overall Study|Death|2|||
44304964|NCT02988817|79303581|FG008|Overall Study|Death|1|||
44304965|NCT02988817|79303582|FG009|Overall Study|Death|5|||
44304966|NCT02988817|79303583|FG010|Overall Study|Death|1|||
44304967|NCT02988817|79303584|FG011|Overall Study|Death|8|||
44304968|NCT02988817|79303585|FG012|Overall Study|Death|9|||
44304969|NCT02988817|79303586|FG013|Overall Study|Death|17|||
44304970|NCT02988817|79303587|FG014|Overall Study|Death|18|||
44304971|NCT02988817|79303588|FG015|Overall Study|Death|30|||
44304972|NCT02988817|79303589|FG016|Overall Study|Death|17|||
44304973|NCT02988817|79303590|FG017|Overall Study|Death|38|||
44304974|NCT02988817|79303591|FG018|Overall Study|Death|14|||
44304975|NCT02988817|79303592|FG019|Overall Study|Death|16|||
44304976|NCT02988817|79303573|FG000|Overall Study|Other|0|||
44304977|NCT02988817|79303574|FG001|Overall Study|Other|0|||
44304978|NCT02988817|79303575|FG002|Overall Study|Other|0|||
44304979|NCT02988817|79303576|FG003|Overall Study|Other|1|||
44304980|NCT02988817|79303577|FG004|Overall Study|Other|1|||
44304981|NCT02988817|79303578|FG005|Overall Study|Other|0|||
44304982|NCT02988817|79303579|FG006|Overall Study|Other|0|||
44304983|NCT02988817|79303580|FG007|Overall Study|Other|0|||
44304984|NCT02988817|79303581|FG008|Overall Study|Other|0|||
44304985|NCT02988817|79303582|FG009|Overall Study|Other|0|||
44304986|NCT02988817|79303583|FG010|Overall Study|Other|0|||
44304987|NCT02988817|79303584|FG011|Overall Study|Other|0|||
44304988|NCT02988817|79303585|FG012|Overall Study|Other|0|||
44304989|NCT02988817|79303586|FG013|Overall Study|Other|0|||
44304990|NCT02988817|79303587|FG014|Overall Study|Other|0|||
44304991|NCT02988817|79303588|FG015|Overall Study|Other|1|||
44304992|NCT02988817|79303589|FG016|Overall Study|Other|0|||
44304993|NCT02988817|79303590|FG017|Overall Study|Other|0|||
44304994|NCT02988817|79303591|FG018|Overall Study|Other|0|||
44304995|NCT02988817|79303592|FG019|Overall Study|Other|0|||
44304996|NCT02988817|79303573|FG000|Overall Study|Lost to Follow-up|0|||
44304997|NCT02988817|79303574|FG001|Overall Study|Lost to Follow-up|0|||
44304998|NCT02988817|79303575|FG002|Overall Study|Lost to Follow-up|0|||
44304999|NCT02988817|79303576|FG003|Overall Study|Lost to Follow-up|0|||
44305000|NCT02988817|79303577|FG004|Overall Study|Lost to Follow-up|0|||
44305001|NCT02988817|79303578|FG005|Overall Study|Lost to Follow-up|0|||
44305002|NCT02988817|79303579|FG006|Overall Study|Lost to Follow-up|0|||
44305003|NCT02988817|79303580|FG007|Overall Study|Lost to Follow-up|0|||
44305004|NCT02988817|79303581|FG008|Overall Study|Lost to Follow-up|1|||
44305005|NCT02988817|79303582|FG009|Overall Study|Lost to Follow-up|0|||
44305006|NCT02988817|79303583|FG010|Overall Study|Lost to Follow-up|1|||
44305007|NCT02988817|79303584|FG011|Overall Study|Lost to Follow-up|1|||
44305008|NCT02988817|79303585|FG012|Overall Study|Lost to Follow-up|0|||
44305009|NCT02988817|79303586|FG013|Overall Study|Lost to Follow-up|0|||
44305010|NCT02988817|79303587|FG014|Overall Study|Lost to Follow-up|1|||
44305011|NCT02988817|79303588|FG015|Overall Study|Lost to Follow-up|1|||
44305012|NCT02988817|79303589|FG016|Overall Study|Lost to Follow-up|2|||
44305013|NCT02988817|79303590|FG017|Overall Study|Lost to Follow-up|3|||
44305014|NCT02988817|79303591|FG018|Overall Study|Lost to Follow-up|0|||
44305015|NCT02988817|79303592|FG019|Overall Study|Lost to Follow-up|0|||
44305016|NCT02988817|79303573|FG000|Overall Study|Sponsor decision|0|||
44305017|NCT02988817|79303574|FG001|Overall Study|Sponsor decision|0|||
44305018|NCT02988817|79303575|FG002|Overall Study|Sponsor decision|0|||
44305019|NCT02988817|79303576|FG003|Overall Study|Sponsor decision|0|||
44305020|NCT02988817|79303577|FG004|Overall Study|Sponsor decision|0|||
44305021|NCT02988817|79303578|FG005|Overall Study|Sponsor decision|0|||
44305022|NCT02988817|79303579|FG006|Overall Study|Sponsor decision|0|||
44305023|NCT02988817|79303580|FG007|Overall Study|Sponsor decision|0|||
44305024|NCT02988817|79303581|FG008|Overall Study|Sponsor decision|0|||
44305025|NCT02988817|79303582|FG009|Overall Study|Sponsor decision|0|||
44305026|NCT02988817|79303583|FG010|Overall Study|Sponsor decision|0|||
44305027|NCT02988817|79303584|FG011|Overall Study|Sponsor decision|1|||
44305028|NCT02988817|79303585|FG012|Overall Study|Sponsor decision|1|||
44305029|NCT02988817|79303586|FG013|Overall Study|Sponsor decision|2|||
44534537|NCT01375777|79545199|FG004|Overall Study|Lost to Follow-up|0|||
44534538|NCT01375777|79545200|FG005|Overall Study|Lost to Follow-up|0|||
44534539|NCT01375777|79545201|FG006|Overall Study|Lost to Follow-up|1|||
44534540|NCT01375777|79545202|FG007|Overall Study|Lost to Follow-up|0|||
44534541|NCT01375777|79545203|FG008|Overall Study|Lost to Follow-up|0|||
44534542|NCT01375777|79545195|FG000|Overall Study|Other|1|||
44155125|NCT03527745|78946591|FG013|Overall Study|Lost to Follow-up|0|||
44305030|NCT02988817|79303587|FG014|Overall Study|Sponsor decision|2|||
44305031|NCT02988817|79303588|FG015|Overall Study|Sponsor decision|6|||
44305032|NCT02988817|79303589|FG016|Overall Study|Sponsor decision|2|||
44305033|NCT02988817|79303590|FG017|Overall Study|Sponsor decision|3|||
44305034|NCT02988817|79303591|FG018|Overall Study|Sponsor decision|2|||
44305035|NCT02988817|79303592|FG019|Overall Study|Sponsor decision|7|||
44305036|NCT02988817|79303573|FG000|Overall Study|Physician Decision|0|||
44305037|NCT02988817|79303574|FG001|Overall Study|Physician Decision|0|||
44305038|NCT02988817|79303575|FG002|Overall Study|Physician Decision|0|||
44305039|NCT02988817|79303576|FG003|Overall Study|Physician Decision|0|||
44305040|NCT02988817|79303577|FG004|Overall Study|Physician Decision|0|||
44305041|NCT02988817|79303578|FG005|Overall Study|Physician Decision|0|||
44305042|NCT02988817|79303579|FG006|Overall Study|Physician Decision|0|||
44305043|NCT02988817|79303580|FG007|Overall Study|Physician Decision|0|||
44305044|NCT02988817|79303581|FG008|Overall Study|Physician Decision|0|||
44305045|NCT02988817|79303582|FG009|Overall Study|Physician Decision|0|||
44305046|NCT02988817|79303583|FG010|Overall Study|Physician Decision|0|||
44305047|NCT02988817|79303584|FG011|Overall Study|Physician Decision|0|||
44305048|NCT02988817|79303585|FG012|Overall Study|Physician Decision|0|||
44305049|NCT02988817|79303586|FG013|Overall Study|Physician Decision|0|||
44305050|NCT02988817|79303587|FG014|Overall Study|Physician Decision|0|||
44305051|NCT02988817|79303588|FG015|Overall Study|Physician Decision|1|||
44305052|NCT02988817|79303589|FG016|Overall Study|Physician Decision|0|||
44305053|NCT02988817|79303590|FG017|Overall Study|Physician Decision|0|||
44305054|NCT02988817|79303591|FG018|Overall Study|Physician Decision|1|||
44305055|NCT02988817|79303592|FG019|Overall Study|Physician Decision|1|||
44305056|NCT02960659|79303647|FG000|Overall Study|Withdrawal by Subject|1|||
44305057|NCT02960659|79303648|FG001|Overall Study|Withdrawal by Subject|0|||
44305058|NCT02960659|79303647|FG000|Overall Study|Poor compliance|0|||
44305059|NCT02960659|79303648|FG001|Overall Study|Poor compliance|1|||
44305060|NCT02844933|79303656|FG000|Overall Study|Discontinued due to premature termination of study|3|||
44305061|NCT02844933|79303657|FG001|Overall Study|Discontinued due to premature termination of study|2|||
44305062|NCT02499835|79303686|FG000|Overall Study|Withdrawal by Subject|1|||
44305063|NCT02499835|79303687|FG001|Overall Study|Withdrawal by Subject|0|||
44305064|NCT02499835|79303688|FG002|Overall Study|Withdrawal by Subject|0|||
44305065|NCT02499835|79303689|FG003|Overall Study|Withdrawal by Subject|1|||
44305066|NCT02499835|79303686|FG000|Overall Study|Physician Decision|0|||
44305067|NCT02499835|79303687|FG001|Overall Study|Physician Decision|3|||
44305068|NCT02499835|79303688|FG002|Overall Study|Physician Decision|18|||
44305069|NCT02499835|79303689|FG003|Overall Study|Physician Decision|7|||
44305070|NCT02499835|79303686|FG000|Overall Study|Adverse Event|0|||
44305071|NCT02499835|79303687|FG001|Overall Study|Adverse Event|0|||
44305072|NCT02499835|79303688|FG002|Overall Study|Adverse Event|0|||
44305073|NCT02499835|79303689|FG003|Overall Study|Adverse Event|1|||
44305074|NCT02499835|79303686|FG000|Overall Study|Disease progression|2|||
44305075|NCT02499835|79303687|FG001|Overall Study|Disease progression|1|||
44305076|NCT02499835|79303688|FG002|Overall Study|Disease progression|0|||
44305077|NCT02499835|79303689|FG003|Overall Study|Disease progression|7|||
44305078|NCT02460497|79303701|FG000|Overall Study|Participant Requested Withdrawal|4|||
44305079|NCT02460497|79303701|FG000|Overall Study|Non-Compliance|1|||
44305080|NCT02460497|79303701|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
44305081|NCT02460497|79303701|FG000|Overall Study|Lost to Follow-up|2|||
44305082|NCT02460497|79303701|FG000|Overall Study|Investigator Decision|1|||
44305083|NCT02460289|79303705|FG000|Overall Study|Adverse Event|1|||
44305084|NCT02460289|79303705|FG000|Overall Study|Withdrawal by Subject|8|||
44305085|NCT02460289|79303705|FG000|Overall Study|Lost to Follow-up|1|||
44305086|NCT02354651|79303716|FG000|Overall Study|Withdrawal by Subject|2|||
44534543|NCT01375777|79545196|FG001|Overall Study|Other|1|||
44155126|NCT03527745|78946592|FG014|Overall Study|Lost to Follow-up|0|||
44155127|NCT03527745|78946593|FG015|Overall Study|Lost to Follow-up|0|||
44155128|NCT03527745|78946594|FG016|Overall Study|Lost to Follow-up|1|||
44305087|NCT02354651|79303716|FG000|Overall Study|Physician Decision|1|||
44534544|NCT01375777|79545197|FG002|Overall Study|Other|0|||
44305088|NCT02253316|79303723|FG000|Consolidation|Progression|4|||
44305089|NCT02253316|79303724|FG001|Consolidation|Progression|0|||
44305090|NCT02253316|79303725|FG002|Consolidation|Progression|0|||
44305091|NCT02253316|79303723|FG000|Consolidation|Non-Compliance|1|||
44305092|NCT02253316|79303724|FG001|Consolidation|Non-Compliance|0|||
44305093|NCT02253316|79303725|FG002|Consolidation|Non-Compliance|0|||
44305094|NCT02253316|79303723|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
44305095|NCT02253316|79303724|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
44534545|NCT01375777|79545198|FG003|Overall Study|Other|0|||
44534546|NCT01375777|79545199|FG004|Overall Study|Other|0|||
44305096|NCT02253316|79303725|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
44305097|NCT02253316|79303723|FG000|Consolidation|Secondary Malignancy|2|||
44305098|NCT02253316|79303724|FG001|Consolidation|Secondary Malignancy|0|||
44305099|NCT02253316|79303725|FG002|Consolidation|Secondary Malignancy|0|||
44305100|NCT02253316|79303723|FG000|Consolidation|Adverse Event|7|||
44305101|NCT02253316|79303724|FG001|Consolidation|Adverse Event|0|||
44305102|NCT02253316|79303725|FG002|Consolidation|Adverse Event|0|||
44305103|NCT02253316|79303723|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
44305104|NCT02253316|79303724|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
44305105|NCT02253316|79303725|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
44305106|NCT02253316|79303723|FG000|Maintenance|Physician Decision|0|||
44305107|NCT02253316|79303724|FG001|Maintenance|Physician Decision|5|||
44305108|NCT02253316|79303725|FG002|Maintenance|Physician Decision|16|||
44305109|NCT02253316|79303723|FG000|Maintenance|Non-Compliance|0|||
44305110|NCT02253316|79303724|FG001|Maintenance|Non-Compliance|1|||
44305111|NCT02253316|79303725|FG002|Maintenance|Non-Compliance|1|||
44305112|NCT02253316|79303723|FG000|Maintenance|Secondary Malignancy|0|||
44305113|NCT02253316|79303724|FG001|Maintenance|Secondary Malignancy|2|||
44305114|NCT02253316|79303725|FG002|Maintenance|Secondary Malignancy|5|||
44305115|NCT02253316|79303723|FG000|Maintenance|Adverse Event|0|||
44305116|NCT02253316|79303724|FG001|Maintenance|Adverse Event|8|||
44305117|NCT02253316|79303725|FG002|Maintenance|Adverse Event|12|||
44305118|NCT02253316|79303723|FG000|Maintenance|Still receiving active treatment|0|||
44418124|NCT00748215|79426138|FG001|Overall Study|Change in patient condition|3|||
44418125|NCT00748215|79426137|FG000|Overall Study|Non-compliant|0|||
44418126|NCT00748215|79426138|FG001|Overall Study|Non-compliant|2|||
44418127|NCT00748215|79426137|FG000|Overall Study|Adverse Event|0|||
44418128|NCT00748215|79426138|FG001|Overall Study|Adverse Event|5|||
44418129|NCT00749892|79426144|FG000|Overall Study|Withdrawal by Subject|3|||
44418130|NCT00749580|79426150|FG000|Overall Study|Lost to Follow-up|4|||
44418131|NCT00749580|79426151|FG001|Overall Study|Lost to Follow-up|8|||
44418132|NCT00749580|79426150|FG000|Overall Study|Adverse Event|0|||
44418133|NCT00749580|79426151|FG001|Overall Study|Adverse Event|1|||
44418134|NCT00747006|79426160|FG000|Overall Study|Adverse Event|1|||
44418135|NCT00747006|79426161|FG001|Overall Study|Adverse Event|0|||
44418136|NCT00747006|79426162|FG002|Overall Study|Adverse Event|0|||
44418137|NCT00747006|79426160|FG000|Overall Study|Lost to Follow-up|0|||
44418138|NCT00747006|79426161|FG001|Overall Study|Lost to Follow-up|1|||
44418139|NCT00747006|79426162|FG002|Overall Study|Lost to Follow-up|0|||
44418140|NCT00747006|79426160|FG000|Overall Study|Physician Decision|2|||
44418141|NCT00747006|79426161|FG001|Overall Study|Physician Decision|0|||
44418142|NCT00747006|79426162|FG002|Overall Study|Physician Decision|1|||
44418143|NCT00743340|79426173|FG000|Overall Study|Study medication non-compliance|1|||
44418144|NCT00743340|79426173|FG000|Overall Study|Lost to Follow-up|1|||
44418145|NCT00743340|79426173|FG000|Overall Study|Withdrawal from the Study|5|||
44418146|NCT00743340|79426173|FG000|Overall Study|Protocol Violation|1|||
44418147|NCT00743340|79426173|FG000|Overall Study|Virologic failure|8|||
44418148|NCT00743340|79426173|FG000|Overall Study|Pregnancy|1|||
44418149|NCT00743340|79426173|FG000|Overall Study|Rolled over to other Gilead Study|23|||
44418150|NCT00743340|79426173|FG000|Overall Study|Participant Relocated|1|||
44418151|NCT00749190|79426184|FG000|Overall Study|Adverse Event|0|||
44418152|NCT00749190|79426185|FG001|Overall Study|Adverse Event|2|||
44418153|NCT00749190|79426186|FG002|Overall Study|Adverse Event|0|||
44418154|NCT00749190|79426187|FG003|Overall Study|Adverse Event|4|||
44418155|NCT00749190|79426188|FG004|Overall Study|Adverse Event|0|||
44418156|NCT00749190|79426189|FG005|Overall Study|Adverse Event|3|||
44305119|NCT02253316|79303724|FG001|Maintenance|Still receiving active treatment|8|||
44305120|NCT02253316|79303725|FG002|Maintenance|Still receiving active treatment|1|||
44305121|NCT02214160|79303736|FG000|Overall Study|Withdrawal by Subject|1|||
44305122|NCT02214160|79303737|FG001|Overall Study|Withdrawal by Subject|0|||
44305123|NCT02214160|79303738|FG002|Overall Study|Withdrawal by Subject|6|||
44305124|NCT02214160|79303736|FG000|Overall Study|Death|2|||
44305125|NCT02214160|79303737|FG001|Overall Study|Death|2|||
44305126|NCT02214160|79303738|FG002|Overall Study|Death|1|||
44305127|NCT02214160|79303736|FG000|Overall Study|Subject Non-Compliance|0|||
44305128|NCT02214160|79303737|FG001|Overall Study|Subject Non-Compliance|3|||
44305129|NCT02214160|79303738|FG002|Overall Study|Subject Non-Compliance|1|||
44305130|NCT02214160|79303736|FG000|Overall Study|Adverse Event|0|||
44305131|NCT02214160|79303737|FG001|Overall Study|Adverse Event|1|||
44305132|NCT02214160|79303738|FG002|Overall Study|Adverse Event|1|||
44305133|NCT02214160|79303736|FG000|Overall Study|Sponsor Decision|0|||
44418157|NCT00749190|79426190|FG006|Overall Study|Adverse Event|0|||
44418158|NCT00749190|79426184|FG000|Overall Study|Lack of Efficacy|3|||
44418159|NCT00749190|79426185|FG001|Overall Study|Lack of Efficacy|1|||
44418160|NCT00749190|79426186|FG002|Overall Study|Lack of Efficacy|1|||
44418161|NCT00749190|79426187|FG003|Overall Study|Lack of Efficacy|0|||
44418162|NCT00749190|79426188|FG004|Overall Study|Lack of Efficacy|0|||
44418163|NCT00749190|79426189|FG005|Overall Study|Lack of Efficacy|1|||
44418164|NCT00749190|79426190|FG006|Overall Study|Lack of Efficacy|0|||
44305134|NCT02214160|79303737|FG001|Overall Study|Sponsor Decision|2|||
44305135|NCT02214160|79303738|FG002|Overall Study|Sponsor Decision|0|||
44305136|NCT02214160|79303736|FG000|Overall Study|Protocol Violation|1|||
44305137|NCT02214160|79303737|FG001|Overall Study|Protocol Violation|0|||
44305138|NCT02214160|79303738|FG002|Overall Study|Protocol Violation|0|||
44305139|NCT02214160|79303736|FG000|Overall Study|Physician Decision|0|||
44305140|NCT02214160|79303737|FG001|Overall Study|Physician Decision|0|||
44305141|NCT02214160|79303738|FG002|Overall Study|Physician Decision|1|||
44305142|NCT02059265|79303767|FG000|Overall Study|Ineligible|4|||
44305143|NCT04983589|79303781|FG000|Overall Study|Withdrawal by Subject|0|||
44305144|NCT04983589|79303782|FG001|Overall Study|Withdrawal by Subject|3|||
44305145|NCT04983589|79303781|FG000|Overall Study|COVID-19 Infection|1|||
44305146|NCT04983589|79303782|FG001|Overall Study|COVID-19 Infection|0|||
44305147|NCT04983589|79303781|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
44305148|NCT04983589|79303782|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
44305149|NCT04783389|79303803|FG000|Overall Study|Withdrawal by Subject|2|||
44305150|NCT04783389|79303804|FG001|Overall Study|Withdrawal by Subject|0|||
44305151|NCT04783389|79303805|FG002|Overall Study|Withdrawal by Subject|0|||
44305152|NCT04783389|79303803|FG000|Overall Study|Termination of Study by Sponsor|10|||
44305153|NCT04783389|79303804|FG001|Overall Study|Termination of Study by Sponsor|12|||
44305154|NCT04783389|79303805|FG002|Overall Study|Termination of Study by Sponsor|14|||
44305155|NCT04556591|79303826|FG000|Overall Study|Lost to Follow-up|1|||
44305156|NCT04556591|79303827|FG001|Overall Study|Lost to Follow-up|0|||
44305157|NCT04556591|79303826|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
44305158|NCT04556591|79303827|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
44305159|NCT04428034|79303836|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
44305160|NCT04364984|79303847|FG000|Overall Study|Death|2|||
44305161|NCT04364984|79303848|FG001|Overall Study|Death|2|||
44305162|NCT04364984|79303849|FG002|Overall Study|Death|0|||
44305163|NCT04294095|79303859|FG000|Overall Study|Adverse Event|1|||
44305164|NCT04294095|79303860|FG001|Overall Study|Adverse Event|0|||
44305165|NCT04266028|79303876|FG000|Overall Study|Adverse Event|0|||
44305166|NCT04266028|79303877|FG001|Overall Study|Adverse Event|0|||
44305167|NCT04266028|79303878|FG002|Overall Study|Adverse Event|1|||
44305168|NCT04266028|79303879|FG003|Overall Study|Adverse Event|0|||
44305169|NCT04266028|79303880|FG004|Overall Study|Adverse Event|1|||
44305170|NCT04266028|79303881|FG005|Overall Study|Adverse Event|0|||
44305171|NCT04266028|79303882|FG006|Overall Study|Adverse Event|2|||
44305172|NCT04266028|79303883|FG007|Overall Study|Adverse Event|0|||
44305173|NCT04266028|79303876|FG000|Overall Study|temporary halt of the study|0|||
44305174|NCT04266028|79303877|FG001|Overall Study|temporary halt of the study|0|||
44305175|NCT04266028|79303878|FG002|Overall Study|temporary halt of the study|0|||
44305176|NCT04266028|79303879|FG003|Overall Study|temporary halt of the study|0|||
44305177|NCT04266028|79303880|FG004|Overall Study|temporary halt of the study|0|||
44305178|NCT04266028|79303881|FG005|Overall Study|temporary halt of the study|0|||
44305179|NCT04266028|79303882|FG006|Overall Study|temporary halt of the study|2|||
44305180|NCT04266028|79303883|FG007|Overall Study|temporary halt of the study|1|||
44305181|NCT04266028|79303876|FG000|Overall Study|Onset of birch pollen season|0|||
44305182|NCT04266028|79303877|FG001|Overall Study|Onset of birch pollen season|0|||
44305183|NCT04266028|79303878|FG002|Overall Study|Onset of birch pollen season|0|||
44305184|NCT04266028|79303879|FG003|Overall Study|Onset of birch pollen season|0|||
44305185|NCT04266028|79303880|FG004|Overall Study|Onset of birch pollen season|1|||
44305186|NCT04266028|79303881|FG005|Overall Study|Onset of birch pollen season|0|||
44305187|NCT04266028|79303882|FG006|Overall Study|Onset of birch pollen season|0|||
44305188|NCT04266028|79303883|FG007|Overall Study|Onset of birch pollen season|0|||
44305189|NCT03994731|79303925|FG000|Pegloticase + IMM Period|Death|2|||
44305190|NCT03994731|79303926|FG001|Pegloticase + IMM Period|Death|0|||
44305191|NCT03994731|79303925|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
44305192|NCT03994731|79303926|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
44305193|NCT03994731|79303925|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
44305194|NCT03994731|79303926|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
44305195|NCT03801915|79303938|FG000|Overall Study|Screen failure|0|||
44305196|NCT03801915|79303939|FG001|Overall Study|Screen failure|0|||
44305197|NCT03801915|79303940|FG002|Overall Study|Screen failure|1|||
44534547|NCT01375777|79545200|FG005|Overall Study|Other|0|||
44534548|NCT01375777|79545201|FG006|Overall Study|Other|0|||
44305198|NCT03801915|79303938|FG000|Overall Study|Ineligible|1|||
44305199|NCT03801915|79303939|FG001|Overall Study|Ineligible|0|||
44305200|NCT03801915|79303940|FG002|Overall Study|Ineligible|0|||
44305201|NCT03801915|79303938|FG000|Overall Study|Physician Decision|2|||
44305202|NCT03801915|79303939|FG001|Overall Study|Physician Decision|1|||
44305203|NCT03801915|79303940|FG002|Overall Study|Physician Decision|0|||
44305204|NCT03581305|79303954|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
44305205|NCT03581305|79303955|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
44305206|NCT03581305|79303954|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
44534549|NCT01375777|79545202|FG007|Overall Study|Other|0|||
44305207|NCT03581305|79303955|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
44305208|NCT03581305|79303954|FG000|Serotonergic Study|Withdrawal by Subject|5|||
44305209|NCT03581305|79303955|FG001|Serotonergic Study|Withdrawal by Subject|1|||
44305210|NCT03556202|79303966|FG000|Extension Treatment Period|Adverse Event|18|||
44305211|NCT03556202|79303967|FG001|Extension Treatment Period|Adverse Event|14|||
44305212|NCT03556202|79303968|FG002|Extension Treatment Period|Adverse Event|9|||
44305213|NCT03556202|79303966|FG000|Extension Treatment Period|Death|2|||
44305214|NCT03556202|79303967|FG001|Extension Treatment Period|Death|6|||
44305215|NCT03556202|79303968|FG002|Extension Treatment Period|Death|0|||
44305216|NCT03556202|79303966|FG000|Extension Treatment Period|Lack of Efficacy|5|||
44305217|NCT03556202|79303967|FG001|Extension Treatment Period|Lack of Efficacy|12|||
44305218|NCT03556202|79303968|FG002|Extension Treatment Period|Lack of Efficacy|18|||
44305219|NCT03556202|79303966|FG000|Extension Treatment Period|Lost to Follow-up|9|||
44305220|NCT03556202|79303967|FG001|Extension Treatment Period|Lost to Follow-up|20|||
44305221|NCT03556202|79303968|FG002|Extension Treatment Period|Lost to Follow-up|2|||
44305222|NCT03556202|79303966|FG000|Extension Treatment Period|Pregnancy|2|||
44305223|NCT03556202|79303967|FG001|Extension Treatment Period|Pregnancy|4|||
44305224|NCT03556202|79303968|FG002|Extension Treatment Period|Pregnancy|3|||
44305225|NCT03556202|79303966|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
44305226|NCT03556202|79303967|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
44305227|NCT03556202|79303968|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
44305228|NCT03556202|79303966|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
44305229|NCT03556202|79303967|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
44534550|NCT01375777|79545203|FG008|Overall Study|Other|1|||
44305230|NCT03556202|79303968|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
44305231|NCT03556202|79303966|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
44305232|NCT03556202|79303967|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
44305233|NCT03556202|79303968|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
44305234|NCT03556202|79303966|FG000|Extension Treatment Period|Physician Decision|0|||
44305235|NCT03556202|79303967|FG001|Extension Treatment Period|Physician Decision|8|||
44305236|NCT03556202|79303968|FG002|Extension Treatment Period|Physician Decision|2|||
44305237|NCT03556202|79303966|FG000|Extension Treatment Period|Protocol Violation|0|||
44305238|NCT03556202|79303967|FG001|Extension Treatment Period|Protocol Violation|1|||
44305239|NCT03556202|79303968|FG002|Extension Treatment Period|Protocol Violation|1|||
44305240|NCT03556202|79303966|FG000|Extension Treatment Period|Sponsor Decision|0|||
44305241|NCT03556202|79303967|FG001|Extension Treatment Period|Sponsor Decision|1|||
44305242|NCT03556202|79303968|FG002|Extension Treatment Period|Sponsor Decision|0|||
44305243|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
44305244|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
44305245|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
44305246|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Death|1|||
44305247|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Death|0|||
44305248|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Death|0|||
44305249|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
44305250|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
44305251|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
44305252|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
44305253|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
44305254|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
44305255|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
44305256|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
44305257|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
44305258|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
44305259|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
44305260|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
44305261|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
44305262|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
44305263|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
44305264|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
44305265|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
44305266|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
44305267|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
44305268|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
44305269|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
44305270|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
44305271|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
44305272|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
44534551|NCT02431702|79545223|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
44534552|NCT02431702|79545224|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
44534553|NCT02431702|79545225|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
44305273|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
44305274|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
44305275|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
44305276|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
44305277|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
44305278|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
44305279|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
44305280|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
44305281|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
44305282|NCT03556202|79303966|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
44305283|NCT03556202|79303967|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
44305284|NCT03556202|79303968|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
44305285|NCT03541174|79303982|FG000|Part 1 Double-Blind|Adverse Event|6|||
44305286|NCT03541174|79303983|FG001|Part 1 Double-Blind|Adverse Event|5|||
44305287|NCT03541174|79303984|FG002|Part 1 Double-Blind|Adverse Event|2|||
44305288|NCT03541174|79303985|FG003|Part 1 Double-Blind|Adverse Event|0|||
44305289|NCT03541174|79303986|FG004|Part 1 Double-Blind|Adverse Event|0|||
44305290|NCT03541174|79303987|FG005|Part 1 Double-Blind|Adverse Event|0|||
44305291|NCT03541174|79303982|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
44305292|NCT03541174|79303983|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
44305293|NCT03541174|79303984|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
44305294|NCT03541174|79303985|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
44305295|NCT03541174|79303986|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
44305296|NCT03541174|79303987|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
44305297|NCT03541174|79303982|FG000|Part 1 Double-Blind|Other reasons|3|||
44305298|NCT03541174|79303983|FG001|Part 1 Double-Blind|Other reasons|2|||
44305299|NCT03541174|79303984|FG002|Part 1 Double-Blind|Other reasons|3|||
44305300|NCT03541174|79303985|FG003|Part 1 Double-Blind|Other reasons|0|||
44305301|NCT03541174|79303986|FG004|Part 1 Double-Blind|Other reasons|0|||
44305302|NCT03541174|79303987|FG005|Part 1 Double-Blind|Other reasons|0|||
44305303|NCT03541174|79303982|FG000|Part 2 Single-Blind|Adverse Event|0|||
44305304|NCT03541174|79303983|FG001|Part 2 Single-Blind|Adverse Event|0|||
44305305|NCT03541174|79303984|FG002|Part 2 Single-Blind|Adverse Event|0|||
44305306|NCT03541174|79303985|FG003|Part 2 Single-Blind|Adverse Event|25|||
44305307|NCT03541174|79303986|FG004|Part 2 Single-Blind|Adverse Event|0|||
44305308|NCT03541174|79303987|FG005|Part 2 Single-Blind|Adverse Event|0|||
44305309|NCT03541174|79303982|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
44305310|NCT03541174|79303983|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
44305311|NCT03541174|79303984|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
44305312|NCT03541174|79303985|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
44305313|NCT03541174|79303986|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
44305314|NCT03541174|79303987|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
44305315|NCT03541174|79303982|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
44305316|NCT03541174|79303983|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
44305317|NCT03541174|79303984|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
44305318|NCT03541174|79303985|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
44305319|NCT03541174|79303986|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
44305320|NCT03541174|79303987|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
44305321|NCT03541174|79303982|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
44305322|NCT03541174|79303983|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
44305323|NCT03541174|79303984|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
44305324|NCT03541174|79303985|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
44305325|NCT03541174|79303986|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
44305326|NCT03541174|79303987|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
44305327|NCT03541174|79303982|FG000|Part 2 Single-Blind|Death|0|||
44305328|NCT03541174|79303983|FG001|Part 2 Single-Blind|Death|0|||
44305329|NCT03541174|79303984|FG002|Part 2 Single-Blind|Death|0|||
44305330|NCT03541174|79303985|FG003|Part 2 Single-Blind|Death|5|||
44305331|NCT03541174|79303986|FG004|Part 2 Single-Blind|Death|0|||
44305332|NCT03541174|79303987|FG005|Part 2 Single-Blind|Death|0|||
44305333|NCT03541174|79303982|FG000|Part 2 Single-Blind|Pregnancy|0|||
44305334|NCT03541174|79303983|FG001|Part 2 Single-Blind|Pregnancy|0|||
44305335|NCT03541174|79303984|FG002|Part 2 Single-Blind|Pregnancy|0|||
44305336|NCT03541174|79303985|FG003|Part 2 Single-Blind|Pregnancy|1|||
44305337|NCT03541174|79303986|FG004|Part 2 Single-Blind|Pregnancy|0|||
44305338|NCT03541174|79303987|FG005|Part 2 Single-Blind|Pregnancy|0|||
44305339|NCT03541174|79303982|FG000|Part 2 Single-Blind|Other reasons|0|||
44305340|NCT03541174|79303983|FG001|Part 2 Single-Blind|Other reasons|0|||
44418165|NCT00749190|79426184|FG000|Overall Study|Withdrawal by Subject|2|||
44418166|NCT00749190|79426185|FG001|Overall Study|Withdrawal by Subject|1|||
44305341|NCT03541174|79303984|FG002|Part 2 Single-Blind|Other reasons|0|||
44305342|NCT03541174|79303985|FG003|Part 2 Single-Blind|Other reasons|32|||
44305343|NCT03541174|79303986|FG004|Part 2 Single-Blind|Other reasons|0|||
44305344|NCT03541174|79303987|FG005|Part 2 Single-Blind|Other reasons|0|||
44418167|NCT00749190|79426186|FG002|Overall Study|Withdrawal by Subject|0|||
44418168|NCT00749190|79426187|FG003|Overall Study|Withdrawal by Subject|0|||
44418169|NCT00749190|79426188|FG004|Overall Study|Withdrawal by Subject|0|||
44418170|NCT00749190|79426189|FG005|Overall Study|Withdrawal by Subject|1|||
44534554|NCT02431702|79545226|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
44155129|NCT03527745|78946595|FG017|Overall Study|Lost to Follow-up|0|||
44155130|NCT03527745|78946596|FG018|Overall Study|Lost to Follow-up|0|||
44155131|NCT03527745|78946597|FG019|Overall Study|Lost to Follow-up|1|||
44155132|NCT03527745|78946598|FG020|Overall Study|Lost to Follow-up|1|||
44155133|NCT03527745|78946599|FG021|Overall Study|Lost to Follow-up|5|||
44155134|NCT03527745|78946600|FG022|Overall Study|Lost to Follow-up|6|||
44155135|NCT03527745|78946601|FG023|Overall Study|Lost to Follow-up|8|||
44155136|NCT03527745|78946602|FG024|Overall Study|Lost to Follow-up|1|||
44155137|NCT03527745|78946603|FG025|Overall Study|Lost to Follow-up|3|||
44256871|NCT04566601|79109105|FG004|Overall Study|Burden of study procedures|1|||
44256872|NCT04566601|79109101|FG000|Overall Study|Change of residence|2|||
44256873|NCT04566601|79109102|FG001|Overall Study|Change of residence|2|||
44256874|NCT04566601|79109103|FG002|Overall Study|Change of residence|0|||
44256875|NCT04566601|79109104|FG003|Overall Study|Change of residence|1|||
44256876|NCT04566601|79109105|FG004|Overall Study|Change of residence|2|||
44256877|NCT04566601|79109101|FG000|Overall Study|Perceived lack of efficacy|2|||
44256878|NCT04566601|79109102|FG001|Overall Study|Perceived lack of efficacy|0|||
44256879|NCT04566601|79109103|FG002|Overall Study|Perceived lack of efficacy|1|||
44256880|NCT04566601|79109104|FG003|Overall Study|Perceived lack of efficacy|1|||
44256881|NCT04566601|79109105|FG004|Overall Study|Perceived lack of efficacy|2|||
44256882|NCT04566601|79109101|FG000|Overall Study|Adverse Event|7|||
44256883|NCT04566601|79109102|FG001|Overall Study|Adverse Event|4|||
44256884|NCT04566601|79109103|FG002|Overall Study|Adverse Event|6|||
44256885|NCT04566601|79109104|FG003|Overall Study|Adverse Event|5|||
44256886|NCT04566601|79109105|FG004|Overall Study|Adverse Event|12|||
44256887|NCT04168112|79109159|FG000|Overall Study|Lost to Follow-up|1|||
44256888|NCT04168112|79109160|FG001|Overall Study|Lost to Follow-up|0|||
44256889|NCT04168112|79109159|FG000|Overall Study|Withdrawal by Subject|1|||
44256890|NCT04168112|79109160|FG001|Overall Study|Withdrawal by Subject|0|||
44256891|NCT04005352|79109168|FG000|Overall Study|Adverse Event|4|||
44256892|NCT04005352|79109169|FG001|Overall Study|Adverse Event|5|||
44256893|NCT04005352|79109168|FG000|Overall Study|Death|4|||
44256894|NCT04005352|79109169|FG001|Overall Study|Death|2|||
44256895|NCT04005352|79109168|FG000|Overall Study|Lost to Follow-up|6|||
44256896|NCT04005352|79109169|FG001|Overall Study|Lost to Follow-up|2|||
44256897|NCT04005352|79109168|FG000|Overall Study|Physician Decision|7|||
44256898|NCT04005352|79109169|FG001|Overall Study|Physician Decision|13|||
44256899|NCT04005352|79109168|FG000|Overall Study|Protocol Violation|0|||
44256900|NCT04005352|79109169|FG001|Overall Study|Protocol Violation|1|||
44256901|NCT04005352|79109168|FG000|Overall Study|Withdrawal by Subject|28|||
44256902|NCT04005352|79109169|FG001|Overall Study|Withdrawal by Subject|38|||
44256903|NCT03952039|79109182|FG000|Overall Study|Adverse Event|22|||
44256904|NCT03952039|79109183|FG001|Overall Study|Adverse Event|8|||
44256905|NCT03952039|79109182|FG000|Overall Study|Withdrawal by Participant|17|||
44256906|NCT03952039|79109183|FG001|Overall Study|Withdrawal by Participant|12|||
44256907|NCT03952039|79109182|FG000|Overall Study|Death|13|||
44256908|NCT03952039|79109183|FG001|Overall Study|Death|6|||
44256909|NCT03952039|79109182|FG000|Overall Study|Lack of Efficacy|12|||
44256910|NCT03952039|79109183|FG001|Overall Study|Lack of Efficacy|2|||
44256911|NCT03952039|79109182|FG000|Overall Study|Physician Decision|9|||
44256912|NCT03952039|79109183|FG001|Overall Study|Physician Decision|3|||
44256913|NCT03952039|79109182|FG000|Overall Study|Progressive Disease|6|||
44256914|NCT03952039|79109183|FG001|Overall Study|Progressive Disease|4|||
44256915|NCT03952039|79109182|FG000|Overall Study|Other Reasons|12|||
44256916|NCT03952039|79109183|FG001|Overall Study|Other Reasons|4|||
44256917|NCT03940586|79109202|FG000|Overall Study|Death|3|||
44256918|NCT03940586|79109203|FG001|Overall Study|Death|2|||
44256919|NCT03940586|79109204|FG002|Overall Study|Death|0|||
44256920|NCT03940586|79109202|FG000|Overall Study|Physician Decision|1|||
44256921|NCT03940586|79109203|FG001|Overall Study|Physician Decision|0|||
44256922|NCT03940586|79109204|FG002|Overall Study|Physician Decision|1|||
44256923|NCT03940586|79109202|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
44256924|NCT03940586|79109203|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
44256925|NCT03940586|79109204|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
44256926|NCT03940586|79109202|FG000|Overall Study|Not Treated|0|||
44256927|NCT03940586|79109203|FG001|Overall Study|Not Treated|2|||
44418171|NCT00749190|79426190|FG006|Overall Study|Withdrawal by Subject|0|||
44155138|NCT03174782|78946685|FG000|Overall Study|Protocol Violation|1|||
44256928|NCT03940586|79109204|FG002|Overall Study|Not Treated|0|||
44256929|NCT03782974|79109256|FG000|Overall Study|Withdrawal by Subject|7|||
44256930|NCT03782974|79109257|FG001|Overall Study|Withdrawal by Subject|7|||
44256931|NCT03782974|79109256|FG000|Overall Study|Pregnancy|1|||
44256932|NCT03782974|79109257|FG001|Overall Study|Pregnancy|0|||
44256933|NCT03674411|79109279|FG000|Overall Study|Non-treatment|4|||
44418172|NCT00749190|79426184|FG000|Overall Study|Protocol Violation|0|||
44155139|NCT03174782|78946686|FG001|Overall Study|Protocol Violation|0|||
44155140|NCT03174782|78946685|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
44418173|NCT00749190|79426185|FG001|Overall Study|Protocol Violation|1|||
44418174|NCT00749190|79426186|FG002|Overall Study|Protocol Violation|0|||
44418175|NCT00749190|79426187|FG003|Overall Study|Protocol Violation|0|||
44418176|NCT00749190|79426188|FG004|Overall Study|Protocol Violation|0|||
44418177|NCT00749190|79426189|FG005|Overall Study|Protocol Violation|0|||
44418178|NCT00749190|79426190|FG006|Overall Study|Protocol Violation|1|||
44418179|NCT00749190|79426184|FG000|Overall Study|Other reason not defined above|0|||
44418180|NCT00749190|79426185|FG001|Overall Study|Other reason not defined above|0|||
44418181|NCT00749190|79426186|FG002|Overall Study|Other reason not defined above|0|||
44418182|NCT00749190|79426187|FG003|Overall Study|Other reason not defined above|1|||
44418183|NCT00749190|79426188|FG004|Overall Study|Other reason not defined above|0|||
44418184|NCT00749190|79426189|FG005|Overall Study|Other reason not defined above|0|||
44418185|NCT00749190|79426190|FG006|Overall Study|Other reason not defined above|0|||
44418186|NCT00748566|79426211|FG000|Overall Study|Adverse Event|49|||
44418187|NCT00748566|79426211|FG000|Overall Study|Death|1|||
44418188|NCT00748566|79426211|FG000|Overall Study|Lack of Efficacy|12|||
44418189|NCT00748566|79426211|FG000|Overall Study|Lost to Follow-up|1|||
44418190|NCT00748566|79426211|FG000|Overall Study|Protocol Violation|13|||
44418191|NCT00748566|79426211|FG000|Overall Study|Withdrawal by Subject|22|||
44418192|NCT00748566|79426211|FG000|Overall Study|Study terminated by sponsor|5|||
44418193|NCT00748566|79426211|FG000|Overall Study|Other|9|||
44418194|NCT00743106|79426217|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
44418195|NCT00743106|79426218|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
44418196|NCT00738699|79426226|FG000|Overall Study|Withdrawal by Subject|5|||
44418197|NCT00738699|79426227|FG001|Overall Study|Withdrawal by Subject|0|||
44418198|NCT00738699|79426226|FG000|Overall Study|Lost to Follow-up|1|||
44418199|NCT00738699|79426227|FG001|Overall Study|Lost to Follow-up|0|||
44418200|NCT00738699|79426226|FG000|Overall Study|Death|144|||
44418201|NCT00738699|79426227|FG001|Overall Study|Death|68|||
44418202|NCT00738699|79426226|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
44418203|NCT00738699|79426227|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
44418204|NCT00738699|79426226|FG000|Overall Study|Other|2|||
44418205|NCT00738699|79426227|FG001|Overall Study|Other|0|||
44418206|NCT00814307|79426237|FG000|Overall Study|Randomized but not treated|1|||
44418207|NCT00814307|79426238|FG001|Overall Study|Randomized but not treated|0|||
44418208|NCT00814307|79426239|FG002|Overall Study|Randomized but not treated|0|||
44418209|NCT00814307|79426240|FG003|Overall Study|Randomized but not treated|0|||
44418210|NCT00814307|79426237|FG000|Overall Study|Adverse Event|3|||
44418211|NCT00814307|79426238|FG001|Overall Study|Adverse Event|9|||
44418212|NCT00814307|79426239|FG002|Overall Study|Adverse Event|3|||
44418213|NCT00814307|79426240|FG003|Overall Study|Adverse Event|2|||
44418214|NCT00814307|79426237|FG000|Overall Study|Lack of Efficacy|1|||
44418215|NCT00814307|79426238|FG001|Overall Study|Lack of Efficacy|1|||
44418216|NCT00814307|79426239|FG002|Overall Study|Lack of Efficacy|3|||
44418217|NCT00814307|79426240|FG003|Overall Study|Lack of Efficacy|4|||
44418218|NCT00814307|79426237|FG000|Overall Study|Other|1|||
44418219|NCT00814307|79426238|FG001|Overall Study|Other|2|||
44418220|NCT00814307|79426239|FG002|Overall Study|Other|0|||
44418221|NCT00814307|79426240|FG003|Overall Study|Other|1|||
44418222|NCT00814307|79426237|FG000|Overall Study|Protocol Violation|2|||
44418223|NCT00814307|79426238|FG001|Overall Study|Protocol Violation|8|||
44418224|NCT00814307|79426239|FG002|Overall Study|Protocol Violation|1|||
44418225|NCT00814307|79426240|FG003|Overall Study|Protocol Violation|1|||
44418226|NCT00814307|79426237|FG000|Overall Study|Withdrawal by Subject|4|||
44534555|NCT02431702|79545227|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
44534556|NCT02431702|79545228|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
44534557|NCT02431702|79545229|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
44534558|NCT02431702|79545223|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
44534559|NCT02431702|79545224|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
44155141|NCT03174782|78946686|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
44155142|NCT02919969|78946692|FG000|Overall Study|Lack of Efficacy|22|||
44155143|NCT02919969|78946692|FG000|Overall Study|Death|4|||
44155144|NCT02919969|78946692|FG000|Overall Study|Physician Decision|3|||
44155145|NCT02919969|78946692|FG000|Overall Study|Withdrawal by Subject|2|||
44418227|NCT00814307|79426238|FG001|Overall Study|Withdrawal by Subject|6|||
44418228|NCT00814307|79426239|FG002|Overall Study|Withdrawal by Subject|0|||
44418229|NCT00814307|79426240|FG003|Overall Study|Withdrawal by Subject|2|||
44418230|NCT00814307|79426237|FG000|Overall Study|Death|0|||
44418231|NCT00814307|79426238|FG001|Overall Study|Death|1|||
44418232|NCT00814307|79426239|FG002|Overall Study|Death|0|||
44418233|NCT00814307|79426240|FG003|Overall Study|Death|0|||
44534560|NCT02431702|79545225|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
44534561|NCT02431702|79545226|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
44534562|NCT02431702|79545227|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
44534563|NCT02431702|79545228|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
44155146|NCT01891344|78946714|FG000|Overall Study|Ongoing|6|||
44155147|NCT01891344|78946715|FG001|Overall Study|Ongoing|2|||
44155148|NCT01891344|78946716|FG002|Overall Study|Ongoing|0|||
44155149|NCT01891344|78946717|FG003|Overall Study|Ongoing|1|||
44155150|NCT01891344|78946718|FG004|Overall Study|Ongoing|4|||
44155151|NCT01891344|78946719|FG005|Overall Study|Ongoing|1|||
44305345|NCT03541174|79303982|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
44305346|NCT03541174|79303983|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
44305347|NCT03541174|79303984|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
44305348|NCT03541174|79303985|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
44305349|NCT03541174|79303986|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
44305350|NCT03541174|79303987|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
44305351|NCT03541174|79303982|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
44305352|NCT03541174|79303983|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
44305353|NCT03541174|79303984|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
44305354|NCT03541174|79303985|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
44305355|NCT03541174|79303986|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
44305356|NCT03541174|79303987|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
44305357|NCT03541174|79303982|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
44305358|NCT03541174|79303983|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
44305359|NCT03541174|79303984|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
44305360|NCT03541174|79303985|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
44305361|NCT03541174|79303986|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
44305362|NCT03541174|79303987|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
44305363|NCT03541174|79303982|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
44305364|NCT03541174|79303983|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
44305365|NCT03541174|79303984|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
44305366|NCT03541174|79303985|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
44305367|NCT03541174|79303986|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
44305368|NCT03541174|79303987|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
44305369|NCT03541174|79303982|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
44155152|NCT01891344|78946720|FG006|Overall Study|Ongoing|0|||
44155153|NCT01891344|78946721|FG007|Overall Study|Ongoing|0|||
44155154|NCT01188096|78946739|FG000|Overall Study|progression of disease|4|||
44155155|NCT01188096|78946739|FG000|Overall Study|Withdrawal by Subject|2|||
44305370|NCT03541174|79303983|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
44305371|NCT03541174|79303984|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
44305372|NCT03541174|79303985|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
44305373|NCT03541174|79303986|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
44305374|NCT03541174|79303987|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
44305375|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
44305376|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
44305377|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
44305378|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
44305379|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
44305380|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
44305381|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
44305382|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
44305383|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Death|0|||
44305384|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Death|1|||
44305385|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
44305386|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
44305387|NCT03281304|79304019|FG000|Treatment Phase (up to 42 Months)|Other|0|||
44305388|NCT03281304|79304020|FG001|Treatment Phase (up to 42 Months)|Other|2|||
44305389|NCT03281304|79304019|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
44305390|NCT03281304|79304020|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
44305391|NCT03204305|79304029|FG000|Overall Study|Lost to Follow-up|6|||
44305392|NCT03204305|79304030|FG001|Overall Study|Lost to Follow-up|4|||
44305393|NCT03204305|79304031|FG002|Overall Study|Lost to Follow-up|0|||
44305394|NCT03204305|79304032|FG003|Overall Study|Lost to Follow-up|0|||
44305395|NCT03204305|79304029|FG000|Overall Study|Physician Decision|1|||
44305396|NCT03204305|79304030|FG001|Overall Study|Physician Decision|0|||
44305397|NCT03204305|79304031|FG002|Overall Study|Physician Decision|0|||
44155156|NCT00579826|78946759|FG000|Overall Study|Withdrawal by Subject|5|||
44155157|NCT00579826|78946760|FG001|Overall Study|Withdrawal by Subject|3|||
44155158|NCT00106691|78946768|FG000|Overall Study|Adverse Event|60|||
44155159|NCT00106691|78946769|FG001|Overall Study|Adverse Event|64|||
44155160|NCT00106691|78946768|FG000|Overall Study|Lost to Follow-up|23|||
44155161|NCT00106691|78946769|FG001|Overall Study|Lost to Follow-up|18|||
44155162|NCT00106691|78946768|FG000|Overall Study|Physician Decision|18|||
44155163|NCT00106691|78946769|FG001|Overall Study|Physician Decision|21|||
44305398|NCT03204305|79304032|FG003|Overall Study|Physician Decision|0|||
44305399|NCT03204305|79304029|FG000|Overall Study|failure to place arterial line|2|||
44305400|NCT03204305|79304030|FG001|Overall Study|failure to place arterial line|1|||
44305401|NCT03204305|79304031|FG002|Overall Study|failure to place arterial line|0|||
44305402|NCT03204305|79304032|FG003|Overall Study|failure to place arterial line|0|||
44305403|NCT03204305|79304029|FG000|Overall Study|Withdrawal by Subject|2|||
44305404|NCT03204305|79304030|FG001|Overall Study|Withdrawal by Subject|0|||
44305405|NCT03204305|79304031|FG002|Overall Study|Withdrawal by Subject|0|||
44305406|NCT03204305|79304032|FG003|Overall Study|Withdrawal by Subject|0|||
44305407|NCT03200717|79304044|FG000|Overall Study|Progressive disease|24|||
44305408|NCT03200717|79304045|FG001|Overall Study|Progressive disease|5|||
44305409|NCT03200717|79304044|FG000|Overall Study|Adverse Event|11|||
44305410|NCT03200717|79304045|FG001|Overall Study|Adverse Event|8|||
44305411|NCT03200717|79304044|FG000|Overall Study|Physician Decision|3|||
44305412|NCT03200717|79304045|FG001|Overall Study|Physician Decision|2|||
44305413|NCT03200717|79304044|FG000|Overall Study|Death|2|||
44305414|NCT03200717|79304045|FG001|Overall Study|Death|0|||
44305415|NCT03200717|79304044|FG000|Overall Study|Subject/Guardian Decision|1|||
44305416|NCT03200717|79304045|FG001|Overall Study|Subject/Guardian Decision|0|||
44305417|NCT03105700|79304054|FG000|Overall Study|screen fail|3|||
44305418|NCT03105700|79304054|FG000|Overall Study|Lost to Follow-up|4|||
44305419|NCT02738853|79304077|FG000|Enrollment|Inclusion/Exclusion not met|21|||
44305420|NCT02738853|79304077|FG000|Enrollment|Withdrawal by Subject|3|||
44305421|NCT02738853|79304077|FG000|Enrollment|Subject treated with commercially available device|6|||
44305422|NCT02738853|79304077|FG000|Enrollment|Study Enrollment Closed|3|||
44305423|NCT02738853|79304077|FG000|Procedure|Death|1|||
44305424|NCT02738853|79304077|FG000|1 Month|Death|2|||
44305425|NCT02738853|79304077|FG000|6 Month|Death|4|||
44305426|NCT02738853|79304077|FG000|6 Month|Withdrawal by Subject|2|||
44305427|NCT02738853|79304077|FG000|1 Year|Death|6|||
44305428|NCT02738853|79304077|FG000|1 Year|Withdrawal by Subject|1|||
44305429|NCT02738853|79304077|FG000|2 Year|Death|2|||
44305430|NCT02738853|79304077|FG000|2 Year|Lost to Follow-up|1|||
44305431|NCT02738853|79304077|FG000|3 Year|Death|2|||
44305432|NCT02738853|79304077|FG000|3 Year|Withdrawal by Subject|1|||
44305433|NCT02738853|79304077|FG000|4 Year|Death|9|||
44305434|NCT02738853|79304077|FG000|5 Year|Lost to Follow-up|4|||
44305435|NCT02358538|79304085|FG000|Through Week 26|Adverse Event|0|||
44305436|NCT02358538|79304086|FG001|Through Week 26|Adverse Event|1|||
44305437|NCT02358538|79304087|FG002|Through Week 26|Adverse Event|1|||
44305438|NCT02358538|79304088|FG003|Through Week 26|Adverse Event|2|||
44305439|NCT02358538|79304085|FG000|Through Week 26|Lack of Efficacy|1|||
44305440|NCT02358538|79304086|FG001|Through Week 26|Lack of Efficacy|1|||
44305441|NCT02358538|79304087|FG002|Through Week 26|Lack of Efficacy|3|||
44305442|NCT02358538|79304088|FG003|Through Week 26|Lack of Efficacy|3|||
44305443|NCT02358538|79304085|FG000|Through Week 26|Withdrawal by Subject|1|||
44305444|NCT02358538|79304086|FG001|Through Week 26|Withdrawal by Subject|0|||
44305445|NCT02358538|79304087|FG002|Through Week 26|Withdrawal by Subject|0|||
44305446|NCT02358538|79304088|FG003|Through Week 26|Withdrawal by Subject|0|||
44305447|NCT02358538|79304085|FG000|Through Week 26|Non-Compliance|0|||
44305448|NCT02358538|79304086|FG001|Through Week 26|Non-Compliance|0|||
44305449|NCT02358538|79304087|FG002|Through Week 26|Non-Compliance|1|||
44305450|NCT02358538|79304088|FG003|Through Week 26|Non-Compliance|0|||
44305451|NCT02358538|79304085|FG000|Through Week 26|Family did not see benefit from IP|1|||
44305452|NCT02358538|79304086|FG001|Through Week 26|Family did not see benefit from IP|0|||
44305453|NCT02358538|79304087|FG002|Through Week 26|Family did not see benefit from IP|0|||
44305454|NCT02358538|79304088|FG003|Through Week 26|Family did not see benefit from IP|0|||
44305455|NCT02358538|79304085|FG000|52 Week Extension Period|Lack of Efficacy|0|||
44305456|NCT02358538|79304086|FG001|52 Week Extension Period|Lack of Efficacy|0|||
44305457|NCT02358538|79304087|FG002|52 Week Extension Period|Lack of Efficacy|2|||
44305458|NCT02358538|79304088|FG003|52 Week Extension Period|Lack of Efficacy|4|||
44305459|NCT02056119|79304123|FG000|Overall Study|Death|1|||
44305460|NCT02056119|79304124|FG001|Overall Study|Death|2|||
44305461|NCT02056119|79304123|FG000|Overall Study|Intubated for less than 24 hrs|2|||
44305462|NCT02056119|79304124|FG001|Overall Study|Intubated for less than 24 hrs|7|||
44305463|NCT02056119|79304123|FG000|Overall Study|No aerosol treatments were given.|3|||
44305464|NCT02056119|79304124|FG001|Overall Study|No aerosol treatments were given.|2|||
44305465|NCT02056119|79304123|FG000|Overall Study|Received Metaneb treatment|0|||
44305466|NCT02056119|79304124|FG001|Overall Study|Received Metaneb treatment|2|||
44305467|NCT02056119|79304123|FG000|Overall Study|Protocol Violation|4|||
44534564|NCT02431702|79545229|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
44534565|NCT02431702|79545223|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
44534566|NCT02431702|79545224|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
44534567|NCT02431702|79545225|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
44305468|NCT02056119|79304124|FG001|Overall Study|Protocol Violation|7|||
44305469|NCT02038452|79304132|FG000|Overall Study|Withdrawal by Subject|7|||
44305470|NCT02038452|79304133|FG001|Overall Study|Withdrawal by Subject|9|||
44305471|NCT02038452|79304132|FG000|Overall Study|Lost to Follow-up|31|||
44305472|NCT02038452|79304133|FG001|Overall Study|Lost to Follow-up|28|||
44305473|NCT01238172|79304172|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
44305474|NCT01238172|79304173|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
44305475|NCT01238172|79304172|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
44305476|NCT01238172|79304173|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
44305477|NCT00967005|79304181|FG000|Overall Study|Lost to Follow-up|7|||
44305478|NCT00967005|79304182|FG001|Overall Study|Lost to Follow-up|10|||
44305479|NCT00203996|79304240|FG000|Overall Study|Lost to Follow-up|0|||
44305480|NCT00203996|79304241|FG001|Overall Study|Lost to Follow-up|0|||
44305481|NCT00203996|79304242|FG002|Overall Study|Lost to Follow-up|0|||
44305482|NCT00203996|79304243|FG003|Overall Study|Lost to Follow-up|1|||
44305483|NCT00203996|79304244|FG004|Overall Study|Lost to Follow-up|0|||
44418234|NCT00748098|79426252|FG000|First Treatment Intervention Period|Adverse Event|1|||
44418235|NCT00748098|79426253|FG001|First Treatment Intervention Period|Adverse Event|1|||
44418236|NCT00748098|79426252|FG000|First Treatment Intervention Period|Protocol Violation|1|||
44418237|NCT00748098|79426253|FG001|First Treatment Intervention Period|Protocol Violation|0|||
44418238|NCT00748098|79426252|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
44418239|NCT00748098|79426253|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
44418240|NCT00748098|79426252|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
44418241|NCT00748098|79426253|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
44418242|NCT00748098|79426252|FG000|First Taper Period|Protocol Violation|1|||
44418243|NCT00748098|79426253|FG001|First Taper Period|Protocol Violation|0|||
44418244|NCT00748098|79426252|FG000|First Taper Period|Withdrawal by Subject|2|||
44418245|NCT00748098|79426253|FG001|First Taper Period|Withdrawal by Subject|0|||
44418246|NCT00748098|79426252|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
44418247|NCT00748098|79426253|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
44418248|NCT00748098|79426252|FG000|1-Week Washout Period|Adverse Event|0|||
44418249|NCT00748098|79426253|FG001|1-Week Washout Period|Adverse Event|1|||
44418250|NCT00748098|79426252|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
44418251|NCT00748098|79426253|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
44418252|NCT00748098|79426252|FG000|Second Treatment Intervention Period|Adverse Event|4|||
44418253|NCT00748098|79426253|FG001|Second Treatment Intervention Period|Adverse Event|1|||
44418254|NCT00748098|79426252|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
44418255|NCT00748098|79426253|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
44418256|NCT00748098|79426252|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
44418257|NCT00748098|79426253|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
44418258|NCT00813995|79426262|FG000|Overall Study|Clinical adverse event|9|||
44418259|NCT00813995|79426263|FG001|Overall Study|Clinical adverse event|3|||
44418260|NCT00813995|79426262|FG000|Overall Study|Laboratory adverse event|0|||
44418261|NCT00813995|79426263|FG001|Overall Study|Laboratory adverse event|2|||
44418262|NCT00813995|79426262|FG000|Overall Study|Lack of Efficacy|1|||
44534568|NCT02431702|79545226|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
44155164|NCT00106691|78946768|FG000|Overall Study|Protocol Violation|13|||
44305484|NCT00203996|79304245|FG005|Overall Study|Lost to Follow-up|0|||
44305485|NCT00203996|79304246|FG006|Overall Study|Lost to Follow-up|0|||
44305486|NCT00203996|79304247|FG007|Overall Study|Lost to Follow-up|0|||
44305487|NCT00203996|79304248|FG008|Overall Study|Lost to Follow-up|0|||
44305488|NCT00203996|79304249|FG009|Overall Study|Lost to Follow-up|0|||
44305489|NCT00203996|79304240|FG000|Overall Study|Protocol Violation|0|||
44305490|NCT00203996|79304241|FG001|Overall Study|Protocol Violation|0|||
44305491|NCT00203996|79304242|FG002|Overall Study|Protocol Violation|0|||
44305492|NCT00203996|79304243|FG003|Overall Study|Protocol Violation|6|||
44305493|NCT00203996|79304244|FG004|Overall Study|Protocol Violation|1|||
44305494|NCT00203996|79304245|FG005|Overall Study|Protocol Violation|0|||
44305495|NCT00203996|79304246|FG006|Overall Study|Protocol Violation|0|||
44305496|NCT00203996|79304247|FG007|Overall Study|Protocol Violation|0|||
44305497|NCT00203996|79304248|FG008|Overall Study|Protocol Violation|0|||
44305498|NCT00203996|79304249|FG009|Overall Study|Protocol Violation|0|||
44305499|NCT00203996|79304240|FG000|Overall Study|Physician Decision|0|||
44305500|NCT00203996|79304241|FG001|Overall Study|Physician Decision|0|||
44305501|NCT00203996|79304242|FG002|Overall Study|Physician Decision|0|||
44305502|NCT00203996|79304243|FG003|Overall Study|Physician Decision|2|||
44305503|NCT00203996|79304244|FG004|Overall Study|Physician Decision|0|||
44418263|NCT00813995|79426263|FG001|Overall Study|Lack of Efficacy|0|||
44418264|NCT00813995|79426262|FG000|Overall Study|Lost to Follow-up|4|||
44418265|NCT00813995|79426263|FG001|Overall Study|Lost to Follow-up|2|||
44155165|NCT00106691|78946769|FG001|Overall Study|Protocol Violation|18|||
44305504|NCT00203996|79304245|FG005|Overall Study|Physician Decision|0|||
44305505|NCT00203996|79304246|FG006|Overall Study|Physician Decision|0|||
44305506|NCT00203996|79304247|FG007|Overall Study|Physician Decision|0|||
44305507|NCT00203996|79304248|FG008|Overall Study|Physician Decision|0|||
44305508|NCT00203996|79304249|FG009|Overall Study|Physician Decision|1|||
44305509|NCT00203996|79304240|FG000|Overall Study|CPAP machine malfunction|0|||
44305510|NCT00203996|79304241|FG001|Overall Study|CPAP machine malfunction|0|||
44418266|NCT00813995|79426262|FG000|Overall Study|Other reason|2|||
44305511|NCT00203996|79304242|FG002|Overall Study|CPAP machine malfunction|0|||
44305512|NCT00203996|79304243|FG003|Overall Study|CPAP machine malfunction|1|||
44305513|NCT00203996|79304244|FG004|Overall Study|CPAP machine malfunction|0|||
44305514|NCT00203996|79304245|FG005|Overall Study|CPAP machine malfunction|0|||
44305515|NCT00203996|79304246|FG006|Overall Study|CPAP machine malfunction|0|||
44305516|NCT00203996|79304247|FG007|Overall Study|CPAP machine malfunction|0|||
44305517|NCT00203996|79304248|FG008|Overall Study|CPAP machine malfunction|0|||
44305518|NCT00203996|79304249|FG009|Overall Study|CPAP machine malfunction|0|||
44305519|NCT00203996|79304240|FG000|Overall Study|Scheduling issue|0|||
44305520|NCT00203996|79304241|FG001|Overall Study|Scheduling issue|0|||
44305521|NCT00203996|79304242|FG002|Overall Study|Scheduling issue|0|||
44305522|NCT00203996|79304243|FG003|Overall Study|Scheduling issue|0|||
44305523|NCT00203996|79304244|FG004|Overall Study|Scheduling issue|0|||
44305524|NCT00203996|79304245|FG005|Overall Study|Scheduling issue|0|||
44305525|NCT00203996|79304246|FG006|Overall Study|Scheduling issue|0|||
44305526|NCT00203996|79304247|FG007|Overall Study|Scheduling issue|2|||
44305527|NCT00203996|79304248|FG008|Overall Study|Scheduling issue|0|||
44305528|NCT00203996|79304249|FG009|Overall Study|Scheduling issue|0|||
44305529|NCT02014558|79304278|FG000|Overall Study|Never Received Study Drug|0|||
44305530|NCT02014558|79304279|FG001|Overall Study|Never Received Study Drug|0|||
44305531|NCT02014558|79304280|FG002|Overall Study|Never Received Study Drug|0|||
44305532|NCT02014558|79304281|FG003|Overall Study|Never Received Study Drug|0|||
44305533|NCT02014558|79304282|FG004|Overall Study|Never Received Study Drug|1|||
44305534|NCT02014558|79304283|FG005|Overall Study|Never Received Study Drug|0|||
44305535|NCT02014558|79304284|FG006|Overall Study|Never Received Study Drug|1|||
44305536|NCT02014558|79304285|FG007|Overall Study|Never Received Study Drug|0|||
44305537|NCT02014558|79304286|FG008|Overall Study|Never Received Study Drug|2|||
44305538|NCT02014558|79304287|FG009|Overall Study|Never Received Study Drug|0|||
44305539|NCT02014558|79304288|FG010|Overall Study|Never Received Study Drug|2|||
44305540|NCT02014558|79304289|FG011|Overall Study|Never Received Study Drug|2|||
44305541|NCT02014558|79304290|FG012|Overall Study|Never Received Study Drug|0|||
44305542|NCT02014558|79304278|FG000|Overall Study|Adverse Event|0|||
44305543|NCT02014558|79304279|FG001|Overall Study|Adverse Event|0|||
44305544|NCT02014558|79304280|FG002|Overall Study|Adverse Event|0|||
44305545|NCT02014558|79304281|FG003|Overall Study|Adverse Event|0|||
44305546|NCT02014558|79304282|FG004|Overall Study|Adverse Event|1|||
44305547|NCT02014558|79304283|FG005|Overall Study|Adverse Event|0|||
44155166|NCT00106691|78946768|FG000|Overall Study|Withdrawal by Subject|75|||
44155167|NCT00106691|78946769|FG001|Overall Study|Withdrawal by Subject|70|||
44155168|NCT00106691|78946768|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
44155169|NCT00106691|78946769|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
44155170|NCT00106691|78946768|FG000|Overall Study|QTc>480|3|||
44155171|NCT00106691|78946769|FG001|Overall Study|QTc>480|1|||
44155172|NCT00106691|78946768|FG000|Overall Study|mililtary deployment|2|||
44155173|NCT00106691|78946769|FG001|Overall Study|mililtary deployment|0|||
44155174|NCT00106691|78946768|FG000|Overall Study|Study Site Closing/PI Moved|1|||
44155175|NCT00106691|78946769|FG001|Overall Study|Study Site Closing/PI Moved|2|||
44155176|NCT00106691|78946768|FG000|Overall Study|Cardiologist recommendation|1|||
44155177|NCT00106691|78946769|FG001|Overall Study|Cardiologist recommendation|0|||
44155178|NCT00106691|78946768|FG000|Overall Study|Pt. moved to another state|1|||
44155179|NCT00106691|78946769|FG001|Overall Study|Pt. moved to another state|0|||
44155180|NCT00106691|78946768|FG000|Overall Study|Taking exclusionary avodart|1|||
44155181|NCT00106691|78946769|FG001|Overall Study|Taking exclusionary avodart|0|||
44256934|NCT03655470|79109285|FG000|Overall Study|Lost to Follow-up|6|||
44256935|NCT03655470|79109286|FG001|Overall Study|Lost to Follow-up|7|||
44256936|NCT03570619|79109295|FG000|Overall Study|Adverse Event|2|||
44256937|NCT03570619|79109296|FG001|Overall Study|Adverse Event|0|||
44256938|NCT03570619|79109297|FG002|Overall Study|Adverse Event|1|||
44256939|NCT03570619|79109295|FG000|Overall Study|new diagnosis of new malignancy|1|||
44256940|NCT03570619|79109296|FG001|Overall Study|new diagnosis of new malignancy|0|||
44256941|NCT03570619|79109297|FG002|Overall Study|new diagnosis of new malignancy|0|||
44256942|NCT03570619|79109295|FG000|Overall Study|Physician Decision|1|||
44256943|NCT03570619|79109296|FG001|Overall Study|Physician Decision|1|||
44256944|NCT03570619|79109297|FG002|Overall Study|Physician Decision|0|||
44256945|NCT03570619|79109295|FG000|Overall Study|Withdrawal by Subject|0|||
44256946|NCT03570619|79109296|FG001|Overall Study|Withdrawal by Subject|2|||
44256947|NCT03570619|79109297|FG002|Overall Study|Withdrawal by Subject|0|||
44256948|NCT03568461|79109305|FG000|Overall Study|Death|7|||
44305548|NCT02014558|79304284|FG006|Overall Study|Adverse Event|0|||
44305549|NCT02014558|79304285|FG007|Overall Study|Adverse Event|0|||
44305550|NCT02014558|79304286|FG008|Overall Study|Adverse Event|2|||
44305551|NCT02014558|79304287|FG009|Overall Study|Adverse Event|2|||
44305552|NCT02014558|79304288|FG010|Overall Study|Adverse Event|5|||
44305553|NCT02014558|79304289|FG011|Overall Study|Adverse Event|21|||
44305554|NCT02014558|79304290|FG012|Overall Study|Adverse Event|3|||
44305555|NCT02014558|79304278|FG000|Overall Study|Death|1|||
44305556|NCT02014558|79304279|FG001|Overall Study|Death|0|||
44305557|NCT02014558|79304280|FG002|Overall Study|Death|0|||
44305558|NCT02014558|79304281|FG003|Overall Study|Death|0|||
44305559|NCT02014558|79304282|FG004|Overall Study|Death|0|||
44305560|NCT02014558|79304283|FG005|Overall Study|Death|0|||
44305561|NCT02014558|79304284|FG006|Overall Study|Death|1|||
44305562|NCT02014558|79304285|FG007|Overall Study|Death|1|||
44305563|NCT02014558|79304286|FG008|Overall Study|Death|2|||
44305564|NCT02014558|79304287|FG009|Overall Study|Death|5|||
44305565|NCT02014558|79304288|FG010|Overall Study|Death|5|||
44305566|NCT02014558|79304289|FG011|Overall Study|Death|19|||
44305567|NCT02014558|79304290|FG012|Overall Study|Death|2|||
44305568|NCT02014558|79304278|FG000|Overall Study|Lack of Efficacy|1|||
44305569|NCT02014558|79304279|FG001|Overall Study|Lack of Efficacy|2|||
44305570|NCT02014558|79304280|FG002|Overall Study|Lack of Efficacy|1|||
44305571|NCT02014558|79304281|FG003|Overall Study|Lack of Efficacy|1|||
44305572|NCT02014558|79304282|FG004|Overall Study|Lack of Efficacy|0|||
44305573|NCT02014558|79304283|FG005|Overall Study|Lack of Efficacy|0|||
44305574|NCT02014558|79304284|FG006|Overall Study|Lack of Efficacy|1|||
44305575|NCT02014558|79304285|FG007|Overall Study|Lack of Efficacy|3|||
44305576|NCT02014558|79304286|FG008|Overall Study|Lack of Efficacy|3|||
44305577|NCT02014558|79304287|FG009|Overall Study|Lack of Efficacy|3|||
44305578|NCT02014558|79304288|FG010|Overall Study|Lack of Efficacy|16|||
44305579|NCT02014558|79304289|FG011|Overall Study|Lack of Efficacy|8|||
44305580|NCT02014558|79304290|FG012|Overall Study|Lack of Efficacy|5|||
44305581|NCT02014558|79304278|FG000|Overall Study|Lost to Follow-up|0|||
44305582|NCT02014558|79304279|FG001|Overall Study|Lost to Follow-up|0|||
44305583|NCT02014558|79304280|FG002|Overall Study|Lost to Follow-up|0|||
44305584|NCT02014558|79304281|FG003|Overall Study|Lost to Follow-up|0|||
44305585|NCT02014558|79304282|FG004|Overall Study|Lost to Follow-up|0|||
44305586|NCT02014558|79304283|FG005|Overall Study|Lost to Follow-up|0|||
44305587|NCT02014558|79304284|FG006|Overall Study|Lost to Follow-up|0|||
44305588|NCT02014558|79304285|FG007|Overall Study|Lost to Follow-up|0|||
44305589|NCT02014558|79304286|FG008|Overall Study|Lost to Follow-up|0|||
44305590|NCT02014558|79304287|FG009|Overall Study|Lost to Follow-up|0|||
44305591|NCT02014558|79304288|FG010|Overall Study|Lost to Follow-up|1|||
44305592|NCT02014558|79304289|FG011|Overall Study|Lost to Follow-up|0|||
44305593|NCT02014558|79304290|FG012|Overall Study|Lost to Follow-up|0|||
44305594|NCT02014558|79304278|FG000|Overall Study|Progressive Disease|1|||
44305595|NCT02014558|79304279|FG001|Overall Study|Progressive Disease|0|||
44305596|NCT02014558|79304280|FG002|Overall Study|Progressive Disease|1|||
44305597|NCT02014558|79304281|FG003|Overall Study|Progressive Disease|1|||
44305598|NCT02014558|79304282|FG004|Overall Study|Progressive Disease|1|||
44305599|NCT02014558|79304283|FG005|Overall Study|Progressive Disease|2|||
44305600|NCT02014558|79304284|FG006|Overall Study|Progressive Disease|1|||
44305601|NCT02014558|79304285|FG007|Overall Study|Progressive Disease|6|||
44305602|NCT02014558|79304286|FG008|Overall Study|Progressive Disease|5|||
44305603|NCT02014558|79304287|FG009|Overall Study|Progressive Disease|6|||
44305604|NCT02014558|79304288|FG010|Overall Study|Progressive Disease|22|||
44305605|NCT02014558|79304289|FG011|Overall Study|Progressive Disease|31|||
44305606|NCT02014558|79304290|FG012|Overall Study|Progressive Disease|6|||
44305607|NCT02014558|79304278|FG000|Overall Study|Withdrawal by Subject|0|||
44305608|NCT02014558|79304279|FG001|Overall Study|Withdrawal by Subject|0|||
44305609|NCT02014558|79304280|FG002|Overall Study|Withdrawal by Subject|0|||
44305610|NCT02014558|79304281|FG003|Overall Study|Withdrawal by Subject|0|||
44305611|NCT02014558|79304282|FG004|Overall Study|Withdrawal by Subject|1|||
44305612|NCT02014558|79304283|FG005|Overall Study|Withdrawal by Subject|0|||
44305613|NCT02014558|79304284|FG006|Overall Study|Withdrawal by Subject|0|||
44305614|NCT02014558|79304285|FG007|Overall Study|Withdrawal by Subject|0|||
44305615|NCT02014558|79304286|FG008|Overall Study|Withdrawal by Subject|0|||
44305616|NCT02014558|79304287|FG009|Overall Study|Withdrawal by Subject|2|||
44305617|NCT02014558|79304288|FG010|Overall Study|Withdrawal by Subject|6|||
44305618|NCT02014558|79304289|FG011|Overall Study|Withdrawal by Subject|10|||
44534569|NCT02431702|79545227|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
44305619|NCT02014558|79304290|FG012|Overall Study|Withdrawal by Subject|0|||
44305620|NCT02014558|79304278|FG000|Overall Study|Miscellaneous|2|||
44305621|NCT02014558|79304279|FG001|Overall Study|Miscellaneous|1|||
44305622|NCT02014558|79304280|FG002|Overall Study|Miscellaneous|1|||
44305623|NCT02014558|79304281|FG003|Overall Study|Miscellaneous|1|||
44305624|NCT02014558|79304282|FG004|Overall Study|Miscellaneous|0|||
44534570|NCT02431702|79545228|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
44534571|NCT02431702|79545229|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
44305625|NCT02014558|79304283|FG005|Overall Study|Miscellaneous|1|||
44418267|NCT00813995|79426263|FG001|Overall Study|Other reason|2|||
44305626|NCT02014558|79304284|FG006|Overall Study|Miscellaneous|0|||
44305627|NCT02014558|79304285|FG007|Overall Study|Miscellaneous|1|||
44305628|NCT02014558|79304286|FG008|Overall Study|Miscellaneous|1|||
44305629|NCT02014558|79304287|FG009|Overall Study|Miscellaneous|3|||
44305630|NCT02014558|79304288|FG010|Overall Study|Miscellaneous|12|||
44305631|NCT02014558|79304289|FG011|Overall Study|Miscellaneous|11|||
44305632|NCT02014558|79304290|FG012|Overall Study|Miscellaneous|1|||
44305633|NCT02024555|79304345|FG000|Overall Study|Lost to Follow-up|1|||
44305634|NCT02024555|79304346|FG001|Overall Study|Lost to Follow-up|1|||
44305635|NCT02024555|79304345|FG000|Overall Study|Withdrawal by Subject|5|||
44305636|NCT02024555|79304346|FG001|Overall Study|Withdrawal by Subject|1|||
44305637|NCT02040584|79304354|FG000|Overall Study|Adverse Event|13|||
44305638|NCT02040584|79304355|FG001|Overall Study|Adverse Event|6|||
44305639|NCT02040584|79304354|FG000|Overall Study|Protocol Violation|9|||
44305640|NCT02040584|79304355|FG001|Overall Study|Protocol Violation|11|||
44305641|NCT02040584|79304354|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44305642|NCT02040584|79304355|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44305643|NCT02040584|79304354|FG000|Overall Study|Death|6|||
44305644|NCT02040584|79304355|FG001|Overall Study|Death|3|||
44305645|NCT02040584|79304354|FG000|Overall Study|Transplant rejection/retransplant|0|||
44305646|NCT02040584|79304355|FG001|Overall Study|Transplant rejection/retransplant|1|||
44305647|NCT02040584|79304354|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
44305648|NCT02040584|79304355|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
44305649|NCT02045797|79304374|FG000|Overall Study|Adverse Event|3|||
44305650|NCT02045797|79304375|FG001|Overall Study|Adverse Event|1|||
44305651|NCT02045797|79304376|FG002|Overall Study|Adverse Event|0|||
44305652|NCT02045797|79304374|FG000|Overall Study|Lack of Efficacy|1|||
44305653|NCT02045797|79304375|FG001|Overall Study|Lack of Efficacy|0|||
44305654|NCT02045797|79304376|FG002|Overall Study|Lack of Efficacy|0|||
44305655|NCT02045797|79304374|FG000|Overall Study|Lost to Follow-up|2|||
44305656|NCT02045797|79304375|FG001|Overall Study|Lost to Follow-up|3|||
44305657|NCT02045797|79304376|FG002|Overall Study|Lost to Follow-up|1|||
44305658|NCT02045797|79304374|FG000|Overall Study|Physician Decision|0|||
44305659|NCT02045797|79304375|FG001|Overall Study|Physician Decision|1|||
44305660|NCT02045797|79304376|FG002|Overall Study|Physician Decision|0|||
44305661|NCT02045797|79304374|FG000|Overall Study|Withdrawal by Subject|1|||
44305662|NCT02045797|79304375|FG001|Overall Study|Withdrawal by Subject|2|||
44305663|NCT02045797|79304376|FG002|Overall Study|Withdrawal by Subject|0|||
44305664|NCT03385239|79304406|FG000|Overall Study|Voluntary Withdrawal|2|||
44305665|NCT03385239|79304407|FG001|Overall Study|Voluntary Withdrawal|3|||
44305666|NCT03385239|79304408|FG002|Overall Study|Voluntary Withdrawal|2|||
44305667|NCT03385239|79304409|FG003|Overall Study|Voluntary Withdrawal|3|||
44305668|NCT03385239|79304410|FG004|Overall Study|Voluntary Withdrawal|0|||
44305669|NCT03385239|79304406|FG000|Overall Study|Adverse Event|0|||
44305670|NCT03385239|79304407|FG001|Overall Study|Adverse Event|0|||
44305671|NCT03385239|79304408|FG002|Overall Study|Adverse Event|1|||
44305672|NCT03385239|79304409|FG003|Overall Study|Adverse Event|0|||
44305673|NCT03385239|79304410|FG004|Overall Study|Adverse Event|0|||
44305674|NCT03385239|79304406|FG000|Overall Study|Other|0|||
44305675|NCT03385239|79304407|FG001|Overall Study|Other|0|||
44305676|NCT03385239|79304408|FG002|Overall Study|Other|0|||
44305677|NCT03385239|79304409|FG003|Overall Study|Other|1|||
44305678|NCT03385239|79304410|FG004|Overall Study|Other|0|||
44305679|NCT03020160|79304428|FG000|Overall Study|Withdrawal by Subject|1|||
44305680|NCT03020160|79304429|FG001|Overall Study|Withdrawal by Subject|0|||
44305681|NCT02593110|79304440|FG000|Overall Study|Withdrawal by Subject|0|||
44305682|NCT02593110|79304441|FG001|Overall Study|Withdrawal by Subject|3|||
44305683|NCT02593110|79304442|FG002|Overall Study|Withdrawal by Subject|3|||
44305684|NCT02593110|79304443|FG003|Overall Study|Withdrawal by Subject|2|||
44305685|NCT02593110|79304440|FG000|Overall Study|Death|0|||
44305686|NCT02593110|79304441|FG001|Overall Study|Death|0|||
44305687|NCT02593110|79304442|FG002|Overall Study|Death|1|||
44305688|NCT02593110|79304443|FG003|Overall Study|Death|0|||
44305689|NCT02373813|79304456|FG000|Run-In Period|Other, Not Specified|5|||
44305690|NCT02373813|79304457|FG001|Run-In Period|Other, Not Specified|0|||
44305691|NCT02373813|79304458|FG002|Run-In Period|Other, Not Specified|0|||
44155182|NCT00106691|78946768|FG000|Overall Study|Not able to discontinue plavix|0|||
44155183|NCT00106691|78946769|FG001|Overall Study|Not able to discontinue plavix|1|||
44155184|NCT02644967|78946858|FG000|Overall Study|Death|26|||
44305692|NCT02373813|79304459|FG003|Run-In Period|Other, Not Specified|0|||
44305693|NCT02373813|79304456|FG000|Run-In Period|Withdrawal by Subject|16|||
44305694|NCT02373813|79304457|FG001|Run-In Period|Withdrawal by Subject|0|||
44305695|NCT02373813|79304458|FG002|Run-In Period|Withdrawal by Subject|0|||
44305696|NCT02373813|79304459|FG003|Run-In Period|Withdrawal by Subject|0|||
44305697|NCT02373813|79304456|FG000|Run-In Period|Decision by Sponsor|11|||
44305698|NCT02373813|79304457|FG001|Run-In Period|Decision by Sponsor|0|||
44305699|NCT02373813|79304458|FG002|Run-In Period|Decision by Sponsor|0|||
44305700|NCT02373813|79304459|FG003|Run-In Period|Decision by Sponsor|0|||
44305701|NCT02373813|79304456|FG000|Run-In Period|Protocol Violation|75|||
44305702|NCT02373813|79304457|FG001|Run-In Period|Protocol Violation|0|||
44305703|NCT02373813|79304458|FG002|Run-In Period|Protocol Violation|0|||
44305704|NCT02373813|79304459|FG003|Run-In Period|Protocol Violation|0|||
44305705|NCT02373813|79304456|FG000|Run-In Period|Lost to Follow-up|2|||
44305706|NCT02373813|79304457|FG001|Run-In Period|Lost to Follow-up|0|||
44305707|NCT02373813|79304458|FG002|Run-In Period|Lost to Follow-up|0|||
44305708|NCT02373813|79304459|FG003|Run-In Period|Lost to Follow-up|0|||
44305709|NCT02373813|79304456|FG000|Run-In Period|Adverse Event|3|||
44305710|NCT02373813|79304457|FG001|Run-In Period|Adverse Event|0|||
44305711|NCT02373813|79304458|FG002|Run-In Period|Adverse Event|0|||
44305712|NCT02373813|79304459|FG003|Run-In Period|Adverse Event|0|||
44305713|NCT02373813|79304456|FG000|Run-In Period|Noncompliance|1|||
44305714|NCT02373813|79304457|FG001|Run-In Period|Noncompliance|0|||
44305715|NCT02373813|79304458|FG002|Run-In Period|Noncompliance|0|||
44305716|NCT02373813|79304459|FG003|Run-In Period|Noncompliance|0|||
44305717|NCT02373813|79304456|FG000|Run-In Period|Ineligibility Determined|3|||
44305718|NCT02373813|79304457|FG001|Run-In Period|Ineligibility Determined|0|||
44305719|NCT02373813|79304458|FG002|Run-In Period|Ineligibility Determined|0|||
44305720|NCT02373813|79304459|FG003|Run-In Period|Ineligibility Determined|0|||
44305721|NCT02373813|79304456|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
44305722|NCT02373813|79304457|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
44305723|NCT02373813|79304458|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
44305724|NCT02373813|79304459|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
44305725|NCT02373813|79304456|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
44305726|NCT02373813|79304457|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
44305727|NCT02373813|79304458|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
44305728|NCT02373813|79304459|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
44305729|NCT02373813|79304456|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44305730|NCT02373813|79304457|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
44305731|NCT02373813|79304458|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
44305732|NCT02373813|79304459|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
44305733|NCT02373813|79304456|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44305734|NCT02373813|79304457|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
44305735|NCT02373813|79304458|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
44305736|NCT02373813|79304459|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
44305737|NCT03863509|79304494|FG000|Overall Study|COVID-19 shutdown period|0|||
44305738|NCT03863509|79304495|FG001|Overall Study|COVID-19 shutdown period|4|||
44305739|NCT03863509|79304496|FG002|Overall Study|COVID-19 shutdown period|0|||
44305740|NCT03863509|79304494|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
44305741|NCT03863509|79304495|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
44305742|NCT03863509|79304496|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
44305743|NCT03863509|79304494|FG000|Overall Study|Lost to Follow-up|8|||
44305744|NCT03863509|79304495|FG001|Overall Study|Lost to Follow-up|0|||
44305745|NCT03863509|79304496|FG002|Overall Study|Lost to Follow-up|2|||
44305746|NCT03863509|79304494|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
44305747|NCT03863509|79304495|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
44305748|NCT03863509|79304496|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
44305749|NCT03863509|79304494|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
44305750|NCT03863509|79304495|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
44305751|NCT03863509|79304496|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
44305752|NCT03116347|79304525|FG000|Overall Study|Withdrawal by Subject|1|||
44305753|NCT03116347|79304526|FG001|Overall Study|Withdrawal by Subject|2|||
44305754|NCT00001213|79304572|FG000|Overall Study|Death|18|||
44305755|NCT00000135|79304578|FG000|Overall Study|Death|27|||
44155185|NCT02644967|78946858|FG000|Overall Study|Physician Decision|1|||
44256949|NCT03568461|79109305|FG000|Overall Study|Physician Decision|5|||
44256950|NCT03568461|79109305|FG000|Overall Study|Subject decision|5|||
44256951|NCT03568461|79109305|FG000|Overall Study|Lost to Follow-up|1|||
44256952|NCT03543254|79109309|FG000|Overall Study|Lost to Follow-up|1|||
44256953|NCT03447769|79109320|FG000|Overall Study|Progressive disease|138|||
44256954|NCT03447769|79109321|FG001|Overall Study|Progressive disease|148|||
44256955|NCT03447769|79109320|FG000|Overall Study|Study terminated by Sponsor|60|||
44256956|NCT03447769|79109321|FG001|Overall Study|Study terminated by Sponsor|44|||
44256957|NCT03447769|79109320|FG000|Overall Study|Adverse Event|34|||
44256958|NCT03447769|79109321|FG001|Overall Study|Adverse Event|31|||
44256959|NCT03447769|79109320|FG000|Overall Study|Patient decision|27|||
44256960|NCT03447769|79109321|FG001|Overall Study|Patient decision|27|||
44256961|NCT03447769|79109320|FG000|Overall Study|Protocol deviation|4|||
44256962|NCT03447769|79109321|FG001|Overall Study|Protocol deviation|6|||
44256963|NCT03447769|79109320|FG000|Overall Study|Death|2|||
44256964|NCT03447769|79109321|FG001|Overall Study|Death|7|||
44256965|NCT03447769|79109320|FG000|Overall Study|Technical problems|1|||
44256966|NCT03447769|79109321|FG001|Overall Study|Technical problems|0|||
44256967|NCT03447769|79109320|FG000|Overall Study|Lost to Follow-up|0|||
44256968|NCT03447769|79109321|FG001|Overall Study|Lost to Follow-up|1|||
44256969|NCT03447769|79109320|FG000|Overall Study|Physician Decision|13|||
44256970|NCT03447769|79109321|FG001|Overall Study|Physician Decision|5|||
44256971|NCT03446651|79109332|FG000|Overall Study|Lost to Follow-up|4|||
44256972|NCT03446651|79109333|FG001|Overall Study|Lost to Follow-up|0|||
44256973|NCT03446651|79109332|FG000|Overall Study|Open Label Participants|5|||
44305756|NCT00000135|79304579|FG001|Overall Study|Death|14|||
44305757|NCT00001723|79304587|FG000|Overall Study|Lack of Efficacy|6|||
44305758|NCT00001723|79304588|FG001|Overall Study|Lack of Efficacy|7|||
44305759|NCT00001723|79304587|FG000|Overall Study|Lack of family interest|4|||
44305760|NCT00001723|79304588|FG001|Overall Study|Lack of family interest|5|||
44305761|NCT00001723|79304587|FG000|Overall Study|Lost to Follow-up|2|||
44305762|NCT00001723|79304588|FG001|Overall Study|Lost to Follow-up|2|||
44305763|NCT00001723|79304587|FG000|Overall Study|medication intolerance|1|||
44305764|NCT00001723|79304588|FG001|Overall Study|medication intolerance|2|||
44305765|NCT00000378|79304600|FG000|Overall Study|Lack of Efficacy|16|||
44305766|NCT00000378|79304601|FG001|Overall Study|Lack of Efficacy|14|||
44305767|NCT01350115|79304609|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
44305768|NCT01350115|79304610|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
44305769|NCT01350115|79304609|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
44305770|NCT01350115|79304610|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
44305771|NCT01350115|79304609|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
44305772|NCT01350115|79304610|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
44305773|NCT04142983|79304618|FG000|Overall Study|Lost to Follow-up|73|||
44305774|NCT04142983|79304618|FG000|Overall Study|Withdrawal by Subject|10|||
44305775|NCT04142983|79304618|FG000|Overall Study|Physician Decision|1|||
44305776|NCT04142983|79304618|FG000|Overall Study|Adverse Event|1|||
44305777|NCT04142983|79304618|FG000|Overall Study|No longer eligible|4|||
44305778|NCT04142983|79304618|FG000|Overall Study|Screen Failure|10|||
44305779|NCT03801031|79304634|FG000|Overall Study|Lost to Follow-up|1|||
44305780|NCT03801031|79304635|FG001|Overall Study|Lost to Follow-up|0|||
44305781|NCT03801031|79304634|FG000|Overall Study|Unable to comply|1|||
44305782|NCT03801031|79304635|FG001|Overall Study|Unable to comply|0|||
44305783|NCT03801031|79304634|FG000|Overall Study|Withdrawal by Subject|0|||
44305784|NCT03801031|79304635|FG001|Overall Study|Withdrawal by Subject|1|||
44305785|NCT03357952|79304643|FG000|Overall Study|Withdrawal by Subject|0|||
44305786|NCT03357952|79304644|FG001|Overall Study|Withdrawal by Subject|1|||
44305787|NCT03357952|79304643|FG000|Overall Study|Sponsor Decision|9|||
44305788|NCT03357952|79304644|FG001|Overall Study|Sponsor Decision|0|||
44305789|NCT03055858|79304650|FG000|Overall Study|Death|9|||
44305790|NCT03055858|79304650|FG000|Overall Study|Withdrawal by Subject|11|||
44305791|NCT03055858|79304650|FG000|Overall Study|Lost to Follow-up|6|||
44305792|NCT03055858|79304650|FG000|Overall Study|Missed Follow-Up Visits|18|||
44305793|NCT02393716|79304675|FG000|Overall Study|Death|29|||
44305794|NCT02393716|79304675|FG000|Overall Study|Withdrawal by Subject|8|||
44305795|NCT02393716|79304675|FG000|Overall Study|Device Explanted|8|||
44305796|NCT02393716|79304675|FG000|Overall Study|Missed visit|16|||
44305797|NCT00584233|79304680|FG000|Overall Study|Withdrawal by Subject|5|||
44305798|NCT00584233|79304680|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
44305799|NCT00001566|79304692|FG000|Overall Study|patients' choice to discontinue protocol|3|||
44305800|NCT00001566|79304692|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
44305801|NCT00001566|79304692|FG000|Overall Study|Death|13|||
44305802|NCT00001566|79304692|FG000|Overall Study|Lost to Follow-up|1|||
44305803|NCT00001566|79304692|FG000|Overall Study|unable to complete initial apheresis|1|||
44305804|NCT00001575|79304696|FG000|Overall Study|Screening failures-Ph I portion|22|||
44305805|NCT00001575|79304696|FG000|Overall Study|Withdrawn/deaths|23|||
44305806|NCT00001596|79304702|FG000|Overall Study|Death|1|||
44305807|NCT00001596|79304703|FG001|Overall Study|Death|0|||
44305808|NCT00001596|79304702|FG000|Overall Study|Withdrawal by Subject|3|||
44305809|NCT00001596|79304703|FG001|Overall Study|Withdrawal by Subject|1|||
44305810|NCT00001596|79304702|FG000|Overall Study|Study Termination|12|||
44418268|NCT00813995|79426262|FG000|Overall Study|Protocol Violation|3|||
44418269|NCT00813995|79426263|FG001|Overall Study|Protocol Violation|2|||
44418270|NCT00813995|79426262|FG000|Overall Study|Subject moved|4|||
44418271|NCT00813995|79426263|FG001|Overall Study|Subject moved|0|||
44418272|NCT00813995|79426262|FG000|Overall Study|Withdrawal by Subject|0|||
44418273|NCT00813995|79426263|FG001|Overall Study|Withdrawal by Subject|5|||
44418274|NCT00737529|79426273|FG000|Overall Study|Disease Progression|95|||
44534572|NCT02431702|79545223|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
44305811|NCT00001596|79304703|FG001|Overall Study|Study Termination|9|||
44305812|NCT00001596|79304702|FG000|Overall Study|Adverse Event|1|||
44305813|NCT00001596|79304703|FG001|Overall Study|Adverse Event|0|||
44305814|NCT01349803|79304740|FG000|Overall Study|Adverse Event|0|||
44305815|NCT01349803|79304741|FG001|Overall Study|Adverse Event|0|||
44305816|NCT01349803|79304742|FG002|Overall Study|Adverse Event|0|||
44305817|NCT01349803|79304743|FG003|Overall Study|Adverse Event|2|||
44305818|NCT01349803|79304740|FG000|Overall Study|Withdrawal by Subject|1|||
44305819|NCT01349803|79304741|FG001|Overall Study|Withdrawal by Subject|0|||
44305820|NCT01349803|79304742|FG002|Overall Study|Withdrawal by Subject|0|||
44305821|NCT01349803|79304743|FG003|Overall Study|Withdrawal by Subject|0|||
44305822|NCT01349803|79304740|FG000|Overall Study|Protocol-specified criteria|0|||
44305823|NCT01349803|79304741|FG001|Overall Study|Protocol-specified criteria|1|||
44418275|NCT00737529|79426273|FG000|Overall Study|Adverse Event|24|||
44305824|NCT01349803|79304742|FG002|Overall Study|Protocol-specified criteria|3|||
44305825|NCT01349803|79304743|FG003|Overall Study|Protocol-specified criteria|0|||
44305826|NCT04059146|79304856|FG000|Overall Study|Withdrawal by Subject|0|||
44305827|NCT04059146|79304857|FG001|Overall Study|Withdrawal by Subject|1|||
44418276|NCT00737529|79426273|FG000|Overall Study|Withdrawal by Subject|5|||
44418277|NCT00737529|79426273|FG000|Overall Study|Death|4|||
44418278|NCT00737529|79426273|FG000|Overall Study|Protocol Violation|1|||
44418279|NCT00737529|79426273|FG000|Overall Study|Other|4|||
44418280|NCT00813917|79426279|FG000|Overall Study|Adverse Event|0|||
44418281|NCT00813917|79426280|FG001|Overall Study|Adverse Event|1|||
44418282|NCT00813917|79426279|FG000|Overall Study|Withdrawal by Subject|3|||
44418283|NCT00813917|79426280|FG001|Overall Study|Withdrawal by Subject|4|||
44418284|NCT00813917|79426279|FG000|Overall Study|Lost to Follow-up|3|||
44418285|NCT00813917|79426280|FG001|Overall Study|Lost to Follow-up|1|||
44418286|NCT00737061|79426286|FG000|Waiting Period|Lost to Follow-up|6|||
44418287|NCT00737061|79426286|FG000|Waiting Period|Withdrawal by Subject|1|||
44418288|NCT00737061|79426286|FG000|Waiting Period|Bilateral placement failure|34|||
44418289|NCT00737061|79426286|FG000|Waiting Period|Deemed patent following HSG|26|||
44418290|NCT00737061|79426286|FG000|Waiting Period|Alternative contraception failure|3|||
44418291|NCT00737061|79426286|FG000|Waiting Period|Elected surgical tubal ligation|5|||
44418292|NCT00737061|79426286|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
44418293|NCT00737061|79426286|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
44418294|NCT00737061|79426286|FG000|1 Year Wearing Period|Discontinued reilance|3|||
44418295|NCT00737061|79426286|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
44418296|NCT00585975|79426292|FG000|Overall Study|Withdrawal by Subject|3|||
44418297|NCT00585975|79426293|FG001|Overall Study|Withdrawal by Subject|3|||
44418298|NCT00585975|79426292|FG000|Overall Study|Lost to Follow-up|2|||
44418299|NCT00585975|79426293|FG001|Overall Study|Lost to Follow-up|1|||
44418300|NCT00585975|79426292|FG000|Overall Study|Enrollment met/over-enrolled|10|||
44418301|NCT00585975|79426293|FG001|Overall Study|Enrollment met/over-enrolled|9|||
44418302|NCT00585585|79426299|FG000|Overall Study|Adverse Event|1|||
44418303|NCT00734097|79426303|FG000|Screening|Protocol Violation|12|||
44418304|NCT00734097|79426303|FG000|Screening|Withdrawal by Subject|5|||
44418305|NCT00734097|79426303|FG000|Screening|Lost to Follow-up|2|||
44418306|NCT00734097|79426303|FG000|Screening|Unconfirmed pregnancy|1|||
44418307|NCT00734097|79426303|FG000|Open Label|Lost to Follow-up|7|||
44418308|NCT00734097|79426303|FG000|Open Label|Withdrawal by Subject|5|||
44418309|NCT00734097|79426303|FG000|Open Label|Protocol Violation|4|||
44418310|NCT00819767|79426309|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44418311|NCT00819767|79426310|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44418312|NCT00733005|79426318|FG000|Overall Study|Adverse Event|0|||
44418313|NCT00733005|79426319|FG001|Overall Study|Adverse Event|1|||
44418314|NCT00733005|79426318|FG000|Overall Study|Treatment Failure|0|||
44418315|NCT00733005|79426319|FG001|Overall Study|Treatment Failure|1|||
44418316|NCT00733005|79426318|FG000|Overall Study|Withdrawal by Subject|0|||
44418317|NCT00733005|79426319|FG001|Overall Study|Withdrawal by Subject|1|||
44418318|NCT00733005|79426318|FG000|Overall Study|Protocol Violation|2|||
44418319|NCT00733005|79426319|FG001|Overall Study|Protocol Violation|0|||
44418320|NCT00812981|79426327|FG000|Overall Study|Other|0|||
44418321|NCT00812981|79426328|FG001|Overall Study|Other|1|||
44418322|NCT00732615|79426336|FG000|Overall Study|Withdrawal by Subject|3|||
44418323|NCT00732615|79426337|FG001|Overall Study|Withdrawal by Subject|1|||
44418324|NCT00732615|79426336|FG000|Overall Study|Lost to Follow-up|0|||
44418325|NCT00732615|79426337|FG001|Overall Study|Lost to Follow-up|1|||
44418326|NCT00732615|79426336|FG000|Overall Study|Adverse Event|0|||
44418327|NCT00732615|79426337|FG001|Overall Study|Adverse Event|2|||
44418328|NCT00732615|79426336|FG000|Overall Study|Physician Decision|3|||
44418329|NCT00732615|79426337|FG001|Overall Study|Physician Decision|0|||
44418330|NCT00732615|79426336|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
44418331|NCT00732615|79426337|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
44418332|NCT00732381|79426346|FG000|Overall Study|Adverse Event|1|||
44418333|NCT00732381|79426347|FG001|Overall Study|Adverse Event|0|||
44418334|NCT00732381|79426346|FG000|Overall Study|Treatment Failure|1|||
44534573|NCT02431702|79545224|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
44305828|NCT03969641|79304878|FG000|Overall Study|Lost to Follow-up|5|||
44418335|NCT00732381|79426347|FG001|Overall Study|Treatment Failure|1|||
44305829|NCT03969641|79304879|FG001|Overall Study|Lost to Follow-up|3|||
44305830|NCT03969641|79304878|FG000|Overall Study|Withdrawal by Subject|1|||
44418336|NCT00732303|79426353|FG000|Overall Study|Study Terminated|2|||
44418337|NCT00813761|79426359|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
44418338|NCT00813761|79426360|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
44418339|NCT00813761|79426361|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
44418340|NCT00813761|79426362|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
44418341|NCT00813761|79426359|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
44418342|NCT00813761|79426360|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
44418343|NCT00813761|79426361|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
44418344|NCT00813761|79426362|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
44305831|NCT03969641|79304879|FG001|Overall Study|Withdrawal by Subject|2|||
44305832|NCT03969641|79304878|FG000|Overall Study|Found to be ineligible|1|||
44305833|NCT03969641|79304879|FG001|Overall Study|Found to be ineligible|1|||
44305834|NCT03969641|79304878|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
44305835|NCT03969641|79304879|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
44305836|NCT03969641|79304878|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
44305837|NCT03969641|79304879|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
44305838|NCT03969641|79304878|FG000|Overall Study|Elective termination|0|||
44305839|NCT03969641|79304879|FG001|Overall Study|Elective termination|1|||
44305840|NCT03721172|79304929|FG000|Placebo-controlled Phase|Adverse Event|7|||
44305841|NCT03721172|79304930|FG001|Placebo-controlled Phase|Adverse Event|7|||
44305842|NCT03721172|79304931|FG002|Placebo-controlled Phase|Adverse Event|0|||
44305843|NCT03721172|79304929|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
44305844|NCT03721172|79304930|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
44305845|NCT03721172|79304931|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
44305846|NCT03721172|79304929|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
44305847|NCT03721172|79304930|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
44305848|NCT03721172|79304931|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
44305849|NCT03721172|79304929|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
44305850|NCT03721172|79304930|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
44305851|NCT03721172|79304931|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
44305852|NCT03721172|79304929|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
44305853|NCT03721172|79304930|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
44305854|NCT03721172|79304931|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
44305855|NCT03721172|79304929|FG000|Placebo-controlled Phase|Other|3|||
44418345|NCT00813761|79426359|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
44418346|NCT00813761|79426360|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
44418347|NCT00813761|79426361|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
44305856|NCT03721172|79304930|FG001|Placebo-controlled Phase|Other|0|||
44305857|NCT03721172|79304931|FG002|Placebo-controlled Phase|Other|0|||
44305858|NCT03721172|79304929|FG000|Apremilast Extension Phase|Adverse Event|0|||
44305859|NCT03721172|79304930|FG001|Apremilast Extension Phase|Adverse Event|0|||
44305860|NCT03721172|79304931|FG002|Apremilast Extension Phase|Adverse Event|10|||
44305861|NCT03721172|79304929|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
44305862|NCT03721172|79304930|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
44418348|NCT00813761|79426362|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
44305863|NCT03721172|79304931|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
44305864|NCT03721172|79304929|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
44305865|NCT03721172|79304930|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
44305866|NCT03721172|79304931|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
44305867|NCT03721172|79304929|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
44305868|NCT03721172|79304930|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
44305869|NCT03721172|79304931|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
44305870|NCT03721172|79304929|FG000|Apremilast Extension Phase|Protocol Violation|0|||
44305871|NCT03721172|79304930|FG001|Apremilast Extension Phase|Protocol Violation|0|||
44305872|NCT03721172|79304931|FG002|Apremilast Extension Phase|Protocol Violation|1|||
44305873|NCT03721172|79304929|FG000|Apremilast Extension Phase|Physician Decision|0|||
44305874|NCT03721172|79304930|FG001|Apremilast Extension Phase|Physician Decision|0|||
44305875|NCT03721172|79304931|FG002|Apremilast Extension Phase|Physician Decision|1|||
44305876|NCT03721172|79304929|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
44305877|NCT03721172|79304930|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
44305878|NCT03721172|79304931|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
44305879|NCT03721172|79304929|FG000|Apremilast Extension Phase|Other|0|||
44305880|NCT03721172|79304930|FG001|Apremilast Extension Phase|Other|0|||
44305881|NCT03721172|79304931|FG002|Apremilast Extension Phase|Other|3|||
44305882|NCT03721172|79304929|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
44305883|NCT03721172|79304930|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
44305884|NCT03721172|79304931|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
44305885|NCT04540887|79304987|FG000|Overall Study|Withdrawal by Subject|2|||
44305886|NCT04294680|79304998|FG000|Overall Study|Withdrawal by Subject|2|||
44305887|NCT04294680|79304999|FG001|Overall Study|Withdrawal by Subject|1|||
44305888|NCT04294680|79304998|FG000|Overall Study|Follow-up visits completed outside of window|1|||
44305889|NCT04294680|79304999|FG001|Overall Study|Follow-up visits completed outside of window|0|||
44305890|NCT01350102|79305009|FG000|Overall Study|Adverse Event|0|||
44305891|NCT01350102|79305010|FG001|Overall Study|Adverse Event|0|||
44305892|NCT01350102|79305011|FG002|Overall Study|Adverse Event|1|||
44305893|NCT01350102|79305012|FG003|Overall Study|Adverse Event|0|||
44305894|NCT04059549|79305026|FG000|Overall Study|Withdrawal by Subject|2|||
44305895|NCT04059549|79305027|FG001|Overall Study|Withdrawal by Subject|0|||
44305896|NCT04041570|79305039|FG000|Overall Study|Moved from Area|0|||
44305897|NCT04041570|79305040|FG001|Overall Study|Moved from Area|2|||
44305898|NCT03879408|79305052|FG000|Overall Study|Lost to Follow-up|0|||
44305899|NCT03879408|79305053|FG001|Overall Study|Lost to Follow-up|3|||
44305900|NCT03879408|79305054|FG002|Overall Study|Lost to Follow-up|2|||
44305901|NCT03879408|79305055|FG003|Overall Study|Lost to Follow-up|1|||
44305902|NCT03879408|79305056|FG004|Overall Study|Lost to Follow-up|0|||
44305903|NCT03879408|79305052|FG000|Overall Study|Withdrawal by Subject|2|||
44305904|NCT03879408|79305053|FG001|Overall Study|Withdrawal by Subject|1|||
44305905|NCT03879408|79305054|FG002|Overall Study|Withdrawal by Subject|1|||
44305906|NCT03879408|79305055|FG003|Overall Study|Withdrawal by Subject|0|||
44305907|NCT03879408|79305056|FG004|Overall Study|Withdrawal by Subject|1|||
44305908|NCT02993406|79305074|FG000|Overall Study|Withdrawal by Subject|170|||
44305909|NCT02993406|79305075|FG001|Overall Study|Withdrawal by Subject|196|||
44305910|NCT02993406|79305074|FG000|Overall Study|Physician Decision|3|||
44305911|NCT02993406|79305075|FG001|Overall Study|Physician Decision|5|||
44305912|NCT02993406|79305074|FG000|Overall Study|Lost to Follow-up|12|||
44305913|NCT02993406|79305075|FG001|Overall Study|Lost to Follow-up|13|||
44305914|NCT02993406|79305074|FG000|Overall Study|Unclassifiable Response|105|||
44305915|NCT02993406|79305075|FG001|Overall Study|Unclassifiable Response|139|||
44305916|NCT02993406|79305074|FG000|Overall Study|Administrative decision|1|||
44305917|NCT02993406|79305075|FG001|Overall Study|Administrative decision|0|||
44305918|NCT02993406|79305074|FG000|Overall Study|Sponsor decision|4|||
44305919|NCT02993406|79305075|FG001|Overall Study|Sponsor decision|5|||
44305920|NCT00819780|79305083|FG000|Overall Study|Did not receive study drug|3|||
44305921|NCT00819780|79305084|FG001|Overall Study|Did not receive study drug|4|||
44305922|NCT00819780|79305083|FG000|Overall Study|Still in treatment|25|||
44305923|NCT00819780|79305084|FG001|Overall Study|Still in treatment|17|||
44155186|NCT02644967|78946858|FG000|Overall Study|Withdrawal by Subject|2|||
44305924|NCT00000620|79305176|FG000|Overall Study|Death|86|||
44305925|NCT00000620|79305177|FG001|Overall Study|Death|67|||
44305926|NCT00000620|79305178|FG002|Overall Study|Death|112|||
44305927|NCT00000620|79305179|FG003|Overall Study|Death|126|||
44305928|NCT00000620|79305180|FG004|Overall Study|Death|64|||
44305929|NCT00000620|79305181|FG005|Overall Study|Death|77|||
44305930|NCT00000620|79305182|FG006|Overall Study|Death|91|||
44305931|NCT00000620|79305183|FG007|Overall Study|Death|95|||
44305932|NCT00000620|79305176|FG000|Overall Study|Lost to Follow-up|14|||
44305933|NCT00000620|79305177|FG001|Overall Study|Lost to Follow-up|14|||
44305934|NCT00000620|79305178|FG002|Overall Study|Lost to Follow-up|14|||
44305935|NCT00000620|79305179|FG003|Overall Study|Lost to Follow-up|14|||
44305936|NCT00000620|79305180|FG004|Overall Study|Lost to Follow-up|15|||
44305937|NCT00000620|79305181|FG005|Overall Study|Lost to Follow-up|15|||
44305938|NCT00000620|79305182|FG006|Overall Study|Lost to Follow-up|13|||
44305939|NCT00000620|79305183|FG007|Overall Study|Lost to Follow-up|14|||
44305940|NCT00000620|79305176|FG000|Overall Study|Withdrawal by Subject|40|||
44305941|NCT00000620|79305177|FG001|Overall Study|Withdrawal by Subject|27|||
44305942|NCT00000620|79305178|FG002|Overall Study|Withdrawal by Subject|28|||
44305943|NCT00000620|79305179|FG003|Overall Study|Withdrawal by Subject|27|||
44155187|NCT02644967|78946858|FG000|Overall Study|Protocol Violation|1|||
44155188|NCT02644967|78946858|FG000|Overall Study|Progressive Disease|1|||
44305944|NCT00000620|79305180|FG004|Overall Study|Withdrawal by Subject|30|||
44305945|NCT00000620|79305181|FG005|Overall Study|Withdrawal by Subject|32|||
44305946|NCT00000620|79305182|FG006|Overall Study|Withdrawal by Subject|32|||
44305947|NCT00000620|79305183|FG007|Overall Study|Withdrawal by Subject|21|||
44305948|NCT00000620|79305176|FG000|Overall Study|missed closeout visit|22|||
44305949|NCT00000620|79305177|FG001|Overall Study|missed closeout visit|28|||
44305950|NCT00000620|79305178|FG002|Overall Study|missed closeout visit|16|||
44305951|NCT00000620|79305179|FG003|Overall Study|missed closeout visit|11|||
44305952|NCT00000620|79305180|FG004|Overall Study|missed closeout visit|26|||
44305953|NCT00000620|79305181|FG005|Overall Study|missed closeout visit|28|||
44305954|NCT00000620|79305182|FG006|Overall Study|missed closeout visit|13|||
44305955|NCT00000620|79305183|FG007|Overall Study|missed closeout visit|16|||
44305956|NCT00001262|79305246|FG000|Overall Study|Death|10|||
44305957|NCT00001262|79305247|FG001|Overall Study|Death|11|||
44305958|NCT00001262|79305248|FG002|Overall Study|Death|0|||
44305959|NCT00001262|79305246|FG000|Overall Study|Withdrawal by Subject|0|||
44305960|NCT00001262|79305247|FG001|Overall Study|Withdrawal by Subject|3|||
44305961|NCT00001262|79305248|FG002|Overall Study|Withdrawal by Subject|0|||
44305962|NCT00001277|79305265|FG000|Overall Study|Adverse Event|0|||
44305963|NCT00001277|79305266|FG001|Overall Study|Adverse Event|0|||
44305964|NCT00001277|79305267|FG002|Overall Study|Adverse Event|1|||
44305965|NCT00001277|79305265|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
44305966|NCT00001277|79305266|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
44305967|NCT00001277|79305267|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
44305968|NCT00001703|79305309|FG000|Overall Study|progressed disease|2|||
44305969|NCT00001703|79305309|FG000|Overall Study|No evidence of disease|1|||
44305970|NCT00001703|79305309|FG000|Overall Study|recurrent disease|2|||
44305971|NCT01349907|79305333|FG000|Overall Study|Adverse Event|37|||
44305972|NCT01349907|79305334|FG001|Overall Study|Adverse Event|11|||
44305973|NCT01349907|79305333|FG000|Overall Study|Treatment failure|13|||
44305974|NCT01349907|79305334|FG001|Overall Study|Treatment failure|4|||
44305975|NCT01349907|79305333|FG000|Overall Study|Lost to Follow-up|25|||
44305976|NCT01349907|79305334|FG001|Overall Study|Lost to Follow-up|6|||
44305977|NCT01349907|79305333|FG000|Overall Study|Withdrawal by Subject|30|||
44305978|NCT01349907|79305334|FG001|Overall Study|Withdrawal by Subject|8|||
44305979|NCT01349907|79305333|FG000|Overall Study|Protocol Violation|33|||
44305980|NCT01349907|79305334|FG001|Overall Study|Protocol Violation|13|||
44305981|NCT01349907|79305333|FG000|Overall Study|Administrative|1|||
44305982|NCT01349907|79305334|FG001|Overall Study|Administrative|1|||
44305983|NCT05512949|79305343|FG000|Overall Study|Lost to Follow-up|4|||
44534574|NCT02431702|79545225|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
44534575|NCT02431702|79545226|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
44534576|NCT02431702|79545227|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
44534577|NCT02431702|79545228|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
44534578|NCT02431702|79545229|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
44155189|NCT02644967|78946858|FG000|Overall Study|Study Terminated by Sponsor|4|||
44155190|NCT02644343|78946862|FG000|Overall Study|Withdrawal by Subject|1|||
44256974|NCT03446651|79109333|FG001|Overall Study|Open Label Participants|0|||
44256975|NCT03442751|79109341|FG000|Overall Study|Withdrawal by Subject|3|||
44256976|NCT03442751|79109342|FG001|Overall Study|Withdrawal by Subject|1|||
44305984|NCT05512949|79305344|FG001|Overall Study|Lost to Follow-up|6|||
44305985|NCT05512949|79305345|FG002|Overall Study|Lost to Follow-up|2|||
44534579|NCT02431702|79545223|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
44534580|NCT02431702|79545224|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
44256977|NCT03442751|79109341|FG000|Overall Study|Lost to Follow-up|3|||
44256978|NCT03442751|79109342|FG001|Overall Study|Lost to Follow-up|0|||
44256979|NCT03255967|79109355|FG000|Overall Study|Adverse Event|26|||
44256980|NCT03255967|79109356|FG001|Overall Study|Adverse Event|30|||
44256981|NCT03255967|79109355|FG000|Overall Study|Withdrawal by Subject|6|||
44256982|NCT03255967|79109356|FG001|Overall Study|Withdrawal by Subject|6|||
44256983|NCT03255967|79109355|FG000|Overall Study|Schedule conflict|6|||
44256984|NCT03255967|79109356|FG001|Overall Study|Schedule conflict|4|||
44256985|NCT03255967|79109355|FG000|Overall Study|POA did not sign consent form|2|||
44305986|NCT05512949|79305343|FG000|Overall Study|Protocol Violation|0|||
44305987|NCT05512949|79305344|FG001|Overall Study|Protocol Violation|0|||
44305988|NCT05512949|79305345|FG002|Overall Study|Protocol Violation|1|||
44305989|NCT05512949|79305343|FG000|Overall Study|Withdrawal by Subject|1|||
44305990|NCT05512949|79305344|FG001|Overall Study|Withdrawal by Subject|1|||
44305991|NCT05512949|79305345|FG002|Overall Study|Withdrawal by Subject|2|||
44305992|NCT05512949|79305343|FG000|Overall Study|Completion status unknown|1|||
44305993|NCT05512949|79305344|FG001|Overall Study|Completion status unknown|3|||
44305994|NCT05512949|79305345|FG002|Overall Study|Completion status unknown|0|||
44305995|NCT04794491|79305372|FG000|Overall Study|Adverse Event|1|||
44305996|NCT04794491|79305372|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
44305997|NCT04794491|79305372|FG000|Overall Study|Noncompliance With Study Intervention|1|||
44305998|NCT04794491|79305372|FG000|Overall Study|Withdrawal by Subject|2|||
44305999|NCT04453202|79305387|FG000|Overall Study|Adverse Event|0|||
44306000|NCT04453202|79305388|FG001|Overall Study|Adverse Event|0|||
44534581|NCT02431702|79545225|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
44534582|NCT02431702|79545226|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
44256986|NCT03255967|79109356|FG001|Overall Study|POA did not sign consent form|0|||
44256987|NCT03151811|79109366|FG000|Overall Study|Randomized But Not Treated|18|||
44256988|NCT03151811|79109367|FG001|Overall Study|Randomized But Not Treated|3|||
44256989|NCT03151811|79109366|FG000|Overall Study|Progressive Disease|130|||
44256990|NCT03151811|79109367|FG001|Overall Study|Progressive Disease|170|||
44256991|NCT03151811|79109366|FG000|Overall Study|Adverse Event|49|||
44256992|NCT03151811|79109367|FG001|Overall Study|Adverse Event|40|||
44256993|NCT03151811|79109366|FG000|Overall Study|Lack of Efficacy|6|||
44256994|NCT03151811|79109367|FG001|Overall Study|Lack of Efficacy|8|||
44256995|NCT03151811|79109366|FG000|Overall Study|Physician Decision|21|||
44256996|NCT03151811|79109367|FG001|Overall Study|Physician Decision|9|||
44256997|NCT03151811|79109366|FG000|Overall Study|Withdrawal by Subject|17|||
44256998|NCT03151811|79109367|FG001|Overall Study|Withdrawal by Subject|7|||
44256999|NCT03151811|79109366|FG000|Overall Study|Lost to Follow-up|0|||
44257000|NCT03151811|79109367|FG001|Overall Study|Lost to Follow-up|1|||
44257001|NCT03151811|79109366|FG000|Overall Study|Study Terminated by Sponsor|5|||
44257002|NCT03151811|79109367|FG001|Overall Study|Study Terminated by Sponsor|11|||
44534583|NCT02431702|79545227|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
44534584|NCT02431702|79545228|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
44534585|NCT02431702|79545229|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
44534586|NCT02431702|79545223|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
44534587|NCT02431702|79545224|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
44534588|NCT02431702|79545225|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
44534589|NCT02431702|79545226|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
44534590|NCT02431702|79545227|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
44534591|NCT02431702|79545228|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
44534592|NCT02431702|79545229|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
44534593|NCT02431702|79545223|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
44534594|NCT02431702|79545224|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
44534595|NCT02431702|79545225|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
44534596|NCT02431702|79545226|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
44534597|NCT02431702|79545227|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
44257023|NCT02706951|79109422|FG000|Period 1|Adverse Event|1|||
44257024|NCT02706951|79109423|FG001|Period 1|Adverse Event|5|||
44257025|NCT02706951|79109424|FG002|Period 1|Adverse Event|3|||
44257026|NCT02706951|79109425|FG003|Period 1|Adverse Event|0|||
44257027|NCT02706951|79109426|FG004|Period 1|Adverse Event|0|||
44257028|NCT02706951|79109422|FG000|Period 1|Withdrawal by Subject|10|||
44257029|NCT02706951|79109423|FG001|Period 1|Withdrawal by Subject|6|||
44257030|NCT02706951|79109424|FG002|Period 1|Withdrawal by Subject|6|||
44257031|NCT02706951|79109425|FG003|Period 1|Withdrawal by Subject|0|||
44257032|NCT02706951|79109426|FG004|Period 1|Withdrawal by Subject|0|||
44257033|NCT02706951|79109422|FG000|Period 1|Lost to Follow-up|0|||
44257034|NCT02706951|79109423|FG001|Period 1|Lost to Follow-up|4|||
44257035|NCT02706951|79109424|FG002|Period 1|Lost to Follow-up|1|||
44257036|NCT02706951|79109425|FG003|Period 1|Lost to Follow-up|0|||
44257037|NCT02706951|79109426|FG004|Period 1|Lost to Follow-up|0|||
44257038|NCT02706951|79109422|FG000|Period 1|Other|2|||
44257039|NCT02706951|79109423|FG001|Period 1|Other|1|||
44257040|NCT02706951|79109424|FG002|Period 1|Other|0|||
44257041|NCT02706951|79109425|FG003|Period 1|Other|0|||
44257042|NCT02706951|79109426|FG004|Period 1|Other|0|||
44257043|NCT02706951|79109422|FG000|Period 2|Adverse Event|0|||
44257044|NCT02706951|79109423|FG001|Period 2|Adverse Event|0|||
44306001|NCT04453202|79305389|FG002|Overall Study|Adverse Event|0|||
44257045|NCT02706951|79109424|FG002|Period 2|Adverse Event|0|||
44257046|NCT02706951|79109425|FG003|Period 2|Adverse Event|25|||
44257047|NCT02706951|79109426|FG004|Period 2|Adverse Event|34|||
44257048|NCT02706951|79109422|FG000|Period 2|Withdrawal by Subject|0|||
44257049|NCT02706951|79109423|FG001|Period 2|Withdrawal by Subject|0|||
44257050|NCT02706951|79109424|FG002|Period 2|Withdrawal by Subject|0|||
44257051|NCT02706951|79109425|FG003|Period 2|Withdrawal by Subject|38|||
44257052|NCT02706951|79109426|FG004|Period 2|Withdrawal by Subject|44|||
44306002|NCT04453202|79305390|FG003|Overall Study|Adverse Event|0|||
44306003|NCT04453202|79305391|FG004|Overall Study|Adverse Event|0|||
44306004|NCT04453202|79305392|FG005|Overall Study|Adverse Event|0|||
44306005|NCT04453202|79305393|FG006|Overall Study|Adverse Event|1|||
44306006|NCT04453202|79305394|FG007|Overall Study|Adverse Event|0|||
44306007|NCT04453202|79305395|FG008|Overall Study|Adverse Event|0|||
44306008|NCT04453202|79305396|FG009|Overall Study|Adverse Event|0|||
44306009|NCT04453202|79305397|FG010|Overall Study|Adverse Event|0|||
44306010|NCT04453202|79305387|FG000|Overall Study|Death|0|||
44306011|NCT04453202|79305388|FG001|Overall Study|Death|0|||
44306012|NCT04453202|79305389|FG002|Overall Study|Death|0|||
44306013|NCT04453202|79305390|FG003|Overall Study|Death|0|||
44306014|NCT04453202|79305391|FG004|Overall Study|Death|0|||
44306015|NCT04453202|79305392|FG005|Overall Study|Death|0|||
44306016|NCT04453202|79305393|FG006|Overall Study|Death|0|||
44306017|NCT04453202|79305394|FG007|Overall Study|Death|0|||
44306018|NCT04453202|79305395|FG008|Overall Study|Death|0|||
44306019|NCT04453202|79305396|FG009|Overall Study|Death|1|||
44306020|NCT04453202|79305397|FG010|Overall Study|Death|0|||
44306021|NCT04453202|79305387|FG000|Overall Study|Lost to Follow-up|0|||
44306022|NCT04453202|79305388|FG001|Overall Study|Lost to Follow-up|1|||
44306023|NCT04453202|79305389|FG002|Overall Study|Lost to Follow-up|0|||
44306024|NCT04453202|79305390|FG003|Overall Study|Lost to Follow-up|1|||
44306025|NCT04453202|79305391|FG004|Overall Study|Lost to Follow-up|0|||
44306026|NCT04453202|79305392|FG005|Overall Study|Lost to Follow-up|0|||
44306027|NCT04453202|79305393|FG006|Overall Study|Lost to Follow-up|0|||
44306028|NCT04453202|79305394|FG007|Overall Study|Lost to Follow-up|0|||
44306029|NCT04453202|79305395|FG008|Overall Study|Lost to Follow-up|0|||
44306030|NCT04453202|79305396|FG009|Overall Study|Lost to Follow-up|1|||
44306031|NCT04453202|79305397|FG010|Overall Study|Lost to Follow-up|1|||
44306032|NCT04453202|79305387|FG000|Overall Study|Withdrawal by Subject|1|||
44306033|NCT04453202|79305388|FG001|Overall Study|Withdrawal by Subject|2|||
44306034|NCT04453202|79305389|FG002|Overall Study|Withdrawal by Subject|1|||
44306035|NCT04453202|79305390|FG003|Overall Study|Withdrawal by Subject|2|||
44306036|NCT04453202|79305391|FG004|Overall Study|Withdrawal by Subject|1|||
44306037|NCT04453202|79305392|FG005|Overall Study|Withdrawal by Subject|1|||
44306038|NCT04453202|79305393|FG006|Overall Study|Withdrawal by Subject|0|||
44306039|NCT04453202|79305394|FG007|Overall Study|Withdrawal by Subject|0|||
44306040|NCT04453202|79305395|FG008|Overall Study|Withdrawal by Subject|0|||
44306041|NCT04453202|79305396|FG009|Overall Study|Withdrawal by Subject|1|||
44306042|NCT04453202|79305397|FG010|Overall Study|Withdrawal by Subject|0|||
44306043|NCT04453202|79305387|FG000|Overall Study|Adverse Event|0|||
44306044|NCT04453202|79305388|FG001|Overall Study|Adverse Event|0|||
44306045|NCT04453202|79305389|FG002|Overall Study|Adverse Event|0|||
44306046|NCT04453202|79305390|FG003|Overall Study|Adverse Event|0|||
44306047|NCT04453202|79305391|FG004|Overall Study|Adverse Event|0|||
44306048|NCT04453202|79305392|FG005|Overall Study|Adverse Event|1|||
44306049|NCT04453202|79305393|FG006|Overall Study|Adverse Event|0|||
44306050|NCT04453202|79305394|FG007|Overall Study|Adverse Event|0|||
44306051|NCT04453202|79305395|FG008|Overall Study|Adverse Event|0|||
44306052|NCT04453202|79305396|FG009|Overall Study|Adverse Event|0|||
44306053|NCT04453202|79305397|FG010|Overall Study|Adverse Event|0|||
44306054|NCT04436289|79305425|FG000|Overall Study|Death prior to hospital discharge|8|||
44306055|NCT04436289|79305426|FG001|Overall Study|Death prior to hospital discharge|5|||
44306056|NCT04436289|79305427|FG002|Overall Study|Death prior to hospital discharge|0|||
44306057|NCT04436289|79305428|FG003|Overall Study|Death prior to hospital discharge|1|||
44306058|NCT04436289|79305425|FG000|Overall Study|Withdrawal by Subject|0|||
44306059|NCT04436289|79305426|FG001|Overall Study|Withdrawal by Subject|1|||
44306060|NCT04436289|79305427|FG002|Overall Study|Withdrawal by Subject|4|||
44306061|NCT04436289|79305428|FG003|Overall Study|Withdrawal by Subject|0|||
44306062|NCT04436289|79305425|FG000|Overall Study|Extended hospital stay|0|||
44306063|NCT04436289|79305426|FG001|Overall Study|Extended hospital stay|1|||
44306064|NCT04436289|79305427|FG002|Overall Study|Extended hospital stay|0|||
44306065|NCT04436289|79305428|FG003|Overall Study|Extended hospital stay|0|||
44306066|NCT04436289|79305425|FG000|Overall Study|Lost to Follow-up|0|||
44306067|NCT04436289|79305426|FG001|Overall Study|Lost to Follow-up|4|||
44306068|NCT04436289|79305427|FG002|Overall Study|Lost to Follow-up|1|||
44306069|NCT04436289|79305428|FG003|Overall Study|Lost to Follow-up|3|||
44306070|NCT04396795|79305443|FG000|Month 1|Lost to Follow-up|2|||
44306071|NCT04396795|79305444|FG001|Month 1|Lost to Follow-up|3|||
44306072|NCT04396795|79305443|FG000|Month 3|Lost to Follow-up|1|||
44306073|NCT04396795|79305444|FG001|Month 3|Lost to Follow-up|3|||
44306074|NCT04396795|79305443|FG000|Month 6|Lost to Follow-up|3|||
44306075|NCT04396795|79305444|FG001|Month 6|Lost to Follow-up|3|||
44306076|NCT04211766|79305452|FG000|Overall Study|Withdrawal by Subject|5|||
44306077|NCT04211766|79305453|FG001|Overall Study|Withdrawal by Subject|1|||
44306078|NCT03773562|79305501|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
44306079|NCT03773562|79305501|FG000|Overall Study|Lost to Follow-up|10|||
44306080|NCT03773562|79305501|FG000|Overall Study|Withdrawal by Subject|1|||
44306081|NCT03706456|79305514|FG000|Overall Study|Lack of Efficacy|1|||
44306082|NCT03706456|79305514|FG000|Overall Study|Ongoing|21|||
44306083|NCT03599141|79305528|FG000|Overall Study|Lost to Follow-up|3|||
44306084|NCT03599141|79305529|FG001|Overall Study|Lost to Follow-up|1|||
44306085|NCT03525678|79305538|FG000|Overall Study|Withdrawal by Subject|8|||
44306086|NCT03525678|79305539|FG001|Overall Study|Withdrawal by Subject|2|||
44306087|NCT03525678|79305540|FG002|Overall Study|Withdrawal by Subject|2|||
44306088|NCT03525678|79305538|FG000|Overall Study|Physician Decision|2|||
44306089|NCT03525678|79305539|FG001|Overall Study|Physician Decision|4|||
44306090|NCT03525678|79305540|FG002|Overall Study|Physician Decision|0|||
44306091|NCT03525678|79305538|FG000|Overall Study|Lost to Follow-up|2|||
44306092|NCT03525678|79305539|FG001|Overall Study|Lost to Follow-up|1|||
44306093|NCT03525678|79305540|FG002|Overall Study|Lost to Follow-up|2|||
44306094|NCT03525678|79305538|FG000|Overall Study|Death|70|||
44306095|NCT03525678|79305539|FG001|Overall Study|Death|80|||
44306096|NCT03525678|79305540|FG002|Overall Study|Death|16|||
44306097|NCT03525678|79305538|FG000|Overall Study|other reasons|14|||
44306098|NCT03525678|79305539|FG001|Overall Study|other reasons|10|||
44306099|NCT03525678|79305540|FG002|Overall Study|other reasons|5|||
44306100|NCT03525678|79305538|FG000|Overall Study|ongoing at the time of analysis|1|||
44306101|NCT03525678|79305539|FG001|Overall Study|ongoing at the time of analysis|2|||
44306102|NCT03525678|79305540|FG002|Overall Study|ongoing at the time of analysis|0|||
44306103|NCT03439514|79305563|FG000|Double-Blind Treatment Period|Other|4|||
44306104|NCT03439514|79305564|FG001|Double-Blind Treatment Period|Other|1|||
44306105|NCT03439514|79305563|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
44306106|NCT03439514|79305564|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44306107|NCT03439514|79305563|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
44306108|NCT03439514|79305564|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
44306109|NCT03439514|79305563|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
44306110|NCT03439514|79305564|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
44306111|NCT03439514|79305563|FG000|Double-Blind Treatment Period|Death|1|||
44306112|NCT03439514|79305564|FG001|Double-Blind Treatment Period|Death|2|||
44306113|NCT03272828|79305576|FG000|Overall Study|Lost to Follow-up|7|||
44306114|NCT03272828|79305577|FG001|Overall Study|Lost to Follow-up|7|||
44306115|NCT03272828|79305576|FG000|Overall Study|Withdrawal by Subject|2|||
44306116|NCT03272828|79305577|FG001|Overall Study|Withdrawal by Subject|0|||
44306117|NCT03272828|79305576|FG000|Overall Study|Deceased|1|||
44306118|NCT03272828|79305577|FG001|Overall Study|Deceased|1|||
44306119|NCT03272828|79305576|FG000|Overall Study|Failed implant|1|||
44306120|NCT03272828|79305577|FG001|Overall Study|Failed implant|2|||
44306121|NCT03250273|79305589|FG000|Overall Study|Disease Progression|2|||
44306122|NCT03250273|79305590|FG001|Overall Study|Disease Progression|11|||
44306123|NCT03250273|79305589|FG000|Overall Study|Death|0|||
44306124|NCT03250273|79305590|FG001|Overall Study|Death|1|||
44306125|NCT03122886|79305609|FG000|Overall Study|Withdrawal by Subject|1|||
44306126|NCT03122886|79305610|FG001|Overall Study|Withdrawal by Subject|2|||
44306127|NCT02910401|79305624|FG000|Overall Study|Study closure Study closure|0|||
44306128|NCT02910401|79305625|FG001|Overall Study|Study closure Study closure|0|||
44306129|NCT02910401|79305626|FG002|Overall Study|Study closure Study closure|2|||
44306130|NCT02910401|79305624|FG000|Overall Study|Physician Decision|1|||
44306131|NCT02910401|79305625|FG001|Overall Study|Physician Decision|0|||
44306132|NCT02910401|79305626|FG002|Overall Study|Physician Decision|0|||
44306133|NCT02609503|79305656|FG000|Overall Study|Adverse Event|1|||
44306134|NCT02609503|79305656|FG000|Overall Study|Death|1|||
44306135|NCT02609503|79305656|FG000|Overall Study|Withdrawal by Subject|1|||
44306136|NCT02609503|79305656|FG000|Overall Study|Disease progression|1|||
44306137|NCT02437110|79305688|FG000|Screening|Lost to Follow-up|3|||
44306138|NCT02437110|79305688|FG000|Screening|Physician Decision|1|||
44306139|NCT02437110|79305688|FG000|ART|Adverse Event|3|||
44306140|NCT02437110|79305688|FG000|ART|Protocol Violation|3|||
44418349|NCT00813761|79426359|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
44418350|NCT00813761|79426360|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
44306141|NCT02437110|79305688|FG000|ART|Withdrawal by Subject|4|||
44306142|NCT02437110|79305688|FG000|ART|Lost to follow-up prior to start of intervention|1|||
44306143|NCT02437110|79305688|FG000|ART|Physician decision prior to start of intervention|2|||
44306144|NCT02437110|79305688|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
44306145|NCT02437110|79305688|FG000|Post-ART|Lost to Follow-up|3|||
44306146|NCT02437110|79305688|FG000|Post-ART|Protocol Violation|4|||
44306147|NCT02437110|79305688|FG000|Post-ART|Withdrawal by Subject|3|||
44418351|NCT00813761|79426361|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
44418352|NCT00813761|79426362|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
44306148|NCT02268851|79305700|FG000|Overall Study|Death|0|||
44306149|NCT02268851|79305701|FG001|Overall Study|Death|0|||
44306150|NCT02268851|79305702|FG002|Overall Study|Death|0|||
44306151|NCT02268851|79305703|FG003|Overall Study|Death|1|||
44306152|NCT02268851|79305704|FG004|Overall Study|Death|2|||
44306153|NCT02268851|79305705|FG005|Overall Study|Death|1|||
44306154|NCT02268851|79305700|FG000|Overall Study|Adverse Event|0|||
44306155|NCT02268851|79305701|FG001|Overall Study|Adverse Event|0|||
44306156|NCT02268851|79305702|FG002|Overall Study|Adverse Event|0|||
44306157|NCT02268851|79305703|FG003|Overall Study|Adverse Event|0|||
44306158|NCT02268851|79305704|FG004|Overall Study|Adverse Event|2|||
44306159|NCT02268851|79305705|FG005|Overall Study|Adverse Event|2|||
44306160|NCT02268851|79305700|FG000|Overall Study|Withdrawal by Subject|0|||
44306161|NCT02268851|79305701|FG001|Overall Study|Withdrawal by Subject|0|||
44306162|NCT02268851|79305702|FG002|Overall Study|Withdrawal by Subject|0|||
44306163|NCT02268851|79305703|FG003|Overall Study|Withdrawal by Subject|2|||
44306164|NCT02268851|79305704|FG004|Overall Study|Withdrawal by Subject|0|||
44306165|NCT02268851|79305705|FG005|Overall Study|Withdrawal by Subject|1|||
44306166|NCT02268851|79305700|FG000|Overall Study|Progressive Disease|1|||
44306167|NCT02268851|79305701|FG001|Overall Study|Progressive Disease|3|||
44306168|NCT02268851|79305702|FG002|Overall Study|Progressive Disease|0|||
44306169|NCT02268851|79305703|FG003|Overall Study|Progressive Disease|0|||
44306170|NCT02268851|79305704|FG004|Overall Study|Progressive Disease|1|||
44306171|NCT02268851|79305705|FG005|Overall Study|Progressive Disease|4|||
44306172|NCT02268851|79305700|FG000|Overall Study|Physician Decision|0|||
44306173|NCT02268851|79305701|FG001|Overall Study|Physician Decision|0|||
44306174|NCT02268851|79305702|FG002|Overall Study|Physician Decision|1|||
44306175|NCT02268851|79305703|FG003|Overall Study|Physician Decision|0|||
44306176|NCT02268851|79305704|FG004|Overall Study|Physician Decision|0|||
44306177|NCT02268851|79305705|FG005|Overall Study|Physician Decision|1|||
44306178|NCT02268851|79305700|FG000|Overall Study|Patient Compliance|0|||
44306179|NCT02268851|79305701|FG001|Overall Study|Patient Compliance|0|||
44306180|NCT02268851|79305702|FG002|Overall Study|Patient Compliance|0|||
44306181|NCT02268851|79305703|FG003|Overall Study|Patient Compliance|0|||
44306182|NCT02268851|79305704|FG004|Overall Study|Patient Compliance|1|||
44306183|NCT02268851|79305705|FG005|Overall Study|Patient Compliance|1|||
44306184|NCT02268851|79305700|FG000|Overall Study|Co-Morbid Condition|0|||
44306185|NCT02268851|79305701|FG001|Overall Study|Co-Morbid Condition|0|||
44306186|NCT02268851|79305702|FG002|Overall Study|Co-Morbid Condition|0|||
44306187|NCT02268851|79305703|FG003|Overall Study|Co-Morbid Condition|0|||
44306188|NCT02268851|79305704|FG004|Overall Study|Co-Morbid Condition|1|||
44306189|NCT02268851|79305705|FG005|Overall Study|Co-Morbid Condition|1|||
44418353|NCT00813761|79426359|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
44418354|NCT00813761|79426360|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
44418355|NCT00813761|79426361|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
44418356|NCT00813761|79426362|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
44418357|NCT00813761|79426359|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
44418358|NCT00813761|79426360|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
44418359|NCT00813761|79426361|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
44418360|NCT00813761|79426362|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
44418361|NCT00813761|79426359|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
44418362|NCT00813761|79426360|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
44418363|NCT00813761|79426361|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
44418364|NCT00813761|79426362|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
44418365|NCT00813761|79426359|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
44418366|NCT00813761|79426360|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
44418367|NCT00813761|79426361|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
44418368|NCT00813761|79426362|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
44418369|NCT00813761|79426359|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
44418370|NCT00813761|79426360|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
44418371|NCT00813761|79426361|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
44418372|NCT00813761|79426362|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
44418373|NCT00813761|79426359|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
44418374|NCT00813761|79426360|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
44418375|NCT00813761|79426361|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
44418376|NCT00813761|79426362|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
44257053|NCT02706951|79109422|FG000|Period 2|Lost to Follow-up|0|||
44257054|NCT02706951|79109423|FG001|Period 2|Lost to Follow-up|0|||
44257055|NCT02706951|79109424|FG002|Period 2|Lost to Follow-up|0|||
44257056|NCT02706951|79109425|FG003|Period 2|Lost to Follow-up|17|||
44257057|NCT02706951|79109426|FG004|Period 2|Lost to Follow-up|9|||
44257058|NCT02706951|79109422|FG000|Period 2|COVID-19 Related|0|||
44257059|NCT02706951|79109423|FG001|Period 2|COVID-19 Related|0|||
44257060|NCT02706951|79109424|FG002|Period 2|COVID-19 Related|0|||
44257061|NCT02706951|79109425|FG003|Period 2|COVID-19 Related|1|||
44306190|NCT02136134|79305721|FG000|Overall Study|Death|170|||
44306191|NCT02136134|79305722|FG001|Overall Study|Death|148|||
44306192|NCT02136134|79305721|FG000|Overall Study|Withdrawal by Subject|19|||
44257062|NCT02706951|79109426|FG004|Period 2|COVID-19 Related|2|||
44257063|NCT02706951|79109422|FG000|Period 2|Other|0|||
44257064|NCT02706951|79109423|FG001|Period 2|Other|0|||
44257065|NCT02706951|79109424|FG002|Period 2|Other|0|||
44306193|NCT02136134|79305722|FG001|Overall Study|Withdrawal by Subject|10|||
44306194|NCT02136134|79305721|FG000|Overall Study|Lost to Follow-up|3|||
44306195|NCT02136134|79305722|FG001|Overall Study|Lost to Follow-up|3|||
44306196|NCT02136134|79305721|FG000|Overall Study|Uspecified|55|||
44306197|NCT02136134|79305722|FG001|Overall Study|Uspecified|90|||
44306198|NCT01846663|79305731|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
44306199|NCT01846663|79305732|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
44306200|NCT01846663|79305731|FG000|Overall Study|Withdrawal by Subject|1|||
44306201|NCT01846663|79305732|FG001|Overall Study|Withdrawal by Subject|0|||
44306202|NCT01846663|79305731|FG000|Overall Study|Adverse Event|1|||
44306203|NCT01846663|79305732|FG001|Overall Study|Adverse Event|2|||
44306204|NCT01659151|79305738|FG000|Overall Study|Inadequate TIL growth|1|||
44306205|NCT04847141|79305859|FG000|Overall Study|Adverse Event|1|||
44306206|NCT04847141|79305860|FG001|Overall Study|Adverse Event|0|||
44306207|NCT04847141|79305861|FG002|Overall Study|Adverse Event|1|||
44306208|NCT04847141|79305859|FG000|Overall Study|Withdrawal by Subject|2|||
44306209|NCT04847141|79305860|FG001|Overall Study|Withdrawal by Subject|4|||
44306210|NCT04847141|79305861|FG002|Overall Study|Withdrawal by Subject|3|||
44306211|NCT04847141|79305859|FG000|Overall Study|Lost to Follow-up|7|||
44306212|NCT04847141|79305860|FG001|Overall Study|Lost to Follow-up|5|||
44306213|NCT04847141|79305861|FG002|Overall Study|Lost to Follow-up|7|||
44306214|NCT04847141|79305859|FG000|Overall Study|Reason not Specified|0|||
44306215|NCT04847141|79305860|FG001|Overall Study|Reason not Specified|1|||
44306216|NCT04847141|79305861|FG002|Overall Study|Reason not Specified|0|||
44306217|NCT01349829|79305871|FG000|Overall Study|Lost to Follow-up|4|||
44306218|NCT01349829|79305872|FG001|Overall Study|Lost to Follow-up|8|||
44306219|NCT01349829|79305871|FG000|Overall Study|Consent withdrawal|3|||
44306220|NCT01349829|79305872|FG001|Overall Study|Consent withdrawal|8|||
44306221|NCT01349829|79305871|FG000|Overall Study|Migrated/moved|2|||
44306222|NCT01349829|79305872|FG001|Overall Study|Migrated/moved|7|||
44306223|NCT01350128|79305880|FG000|Overall Study|Withdrawal by Subject|3|||
44306224|NCT01350128|79305880|FG000|Overall Study|Protocol discontinuation criteria|8|||
44306225|NCT01350128|79305880|FG000|Overall Study|Physician Decision|1|||
44306226|NCT01350128|79305880|FG000|Overall Study|Lost to Follow-up|2|||
44306227|NCT03893825|79305939|FG000|Overall Study|Death|2|||
44306228|NCT03893825|79305940|FG001|Overall Study|Death|1|||
44306229|NCT03893825|79305939|FG000|Overall Study|Adverse Event|0|||
44306230|NCT03893825|79305940|FG001|Overall Study|Adverse Event|2|||
44306231|NCT03893825|79305939|FG000|Overall Study|Withdrawal by Subject|19|||
44306232|NCT03893825|79305940|FG001|Overall Study|Withdrawal by Subject|21|||
44306233|NCT03893825|79305939|FG000|Overall Study|Protocol deviation|1|||
44306234|NCT03893825|79305940|FG001|Overall Study|Protocol deviation|0|||
44306235|NCT03893825|79305939|FG000|Overall Study|Lost to Follow-up|10|||
44306236|NCT03893825|79305940|FG001|Overall Study|Lost to Follow-up|10|||
44306237|NCT03893825|79305939|FG000|Overall Study|Other than specified|7|||
44306238|NCT03893825|79305940|FG001|Overall Study|Other than specified|6|||
44306239|NCT03890666|79305948|FG000|Overall Study|Withdrawal by Subject|0|||
44306240|NCT03890666|79305949|FG001|Overall Study|Withdrawal by Subject|1|||
44306241|NCT03890666|79305948|FG000|Overall Study|Protocol deviation|1|||
44306242|NCT03890666|79305949|FG001|Overall Study|Protocol deviation|4|||
44306243|NCT03890666|79305948|FG000|Overall Study|Lost to Follow-up|2|||
44306244|NCT03890666|79305949|FG001|Overall Study|Lost to Follow-up|5|||
44306245|NCT03890666|79305948|FG000|Overall Study|Other than specified|1|||
44306246|NCT03890666|79305949|FG001|Overall Study|Other than specified|8|||
44306247|NCT03090737|79305987|FG000|Overall Study|Other reasons|1|||
44306248|NCT03090737|79305987|FG000|Overall Study|Completed treatment as per protocol|17|||
44306249|NCT03090737|79305987|FG000|Overall Study|Maximum clinical benefit|2|||
44306250|NCT03090737|79305987|FG000|Overall Study|Adverse event unrelated to study drug|7|||
44306251|NCT03090737|79305987|FG000|Overall Study|Study drug toxicity|4|||
44306252|NCT03090737|79305987|FG000|Overall Study|Disease progression|98|||
44306253|NCT03004976|79306032|FG000|Overall Study|Lost to Follow-up|7|||
44306254|NCT03004976|79306033|FG001|Overall Study|Lost to Follow-up|5|||
44306255|NCT03004976|79306032|FG000|Overall Study|Physician Decision|1|||
44306256|NCT03004976|79306033|FG001|Overall Study|Physician Decision|0|||
44306257|NCT03004976|79306032|FG000|Overall Study|Withdrawal by Subject|1|||
44306258|NCT03004976|79306033|FG001|Overall Study|Withdrawal by Subject|0|||
44306259|NCT03004976|79306032|FG000|Overall Study|Death|4|||
44306260|NCT03004976|79306033|FG001|Overall Study|Death|1|||
44418377|NCT00813761|79426359|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
44418378|NCT00813761|79426360|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
44306261|NCT02985866|79306041|FG000|Overall Study|Poor CGM data|1|||
44306262|NCT02985866|79306042|FG001|Overall Study|Poor CGM data|1|||
44306263|NCT02762981|79306067|FG000|Overall Study|Adverse Event|2|||
44306264|NCT02762981|79306068|FG001|Overall Study|Adverse Event|3|||
44306265|NCT02762981|79306069|FG002|Overall Study|Adverse Event|1|||
44306266|NCT02762981|79306070|FG003|Overall Study|Adverse Event|1|||
44306267|NCT02762981|79306071|FG004|Overall Study|Adverse Event|3|||
44306268|NCT02762981|79306067|FG000|Overall Study|Physician Decision|0|||
44306269|NCT02762981|79306068|FG001|Overall Study|Physician Decision|1|||
44306270|NCT02762981|79306069|FG002|Overall Study|Physician Decision|0|||
44306271|NCT02762981|79306070|FG003|Overall Study|Physician Decision|0|||
44306272|NCT02762981|79306071|FG004|Overall Study|Physician Decision|1|||
44306273|NCT02762981|79306067|FG000|Overall Study|Disease progression|11|||
44306274|NCT02762981|79306068|FG001|Overall Study|Disease progression|23|||
44306275|NCT02762981|79306069|FG002|Overall Study|Disease progression|4|||
44306276|NCT02762981|79306070|FG003|Overall Study|Disease progression|10|||
44306277|NCT02762981|79306071|FG004|Overall Study|Disease progression|1|||
44306278|NCT02762981|79306067|FG000|Overall Study|Enrolled not treated|1|||
44306279|NCT02762981|79306068|FG001|Overall Study|Enrolled not treated|5|||
44306280|NCT02762981|79306069|FG002|Overall Study|Enrolled not treated|0|||
44306281|NCT02762981|79306070|FG003|Overall Study|Enrolled not treated|2|||
44306282|NCT02762981|79306071|FG004|Overall Study|Enrolled not treated|0|||
44306283|NCT02762981|79306067|FG000|Overall Study|Other|2|||
44306284|NCT02762981|79306068|FG001|Overall Study|Other|3|||
44306285|NCT02762981|79306069|FG002|Overall Study|Other|1|||
44306286|NCT02762981|79306070|FG003|Overall Study|Other|0|||
44306287|NCT02762981|79306071|FG004|Overall Study|Other|0|||
44306288|NCT02762981|79306067|FG000|Overall Study|Missing|1|||
44306289|NCT02762981|79306068|FG001|Overall Study|Missing|0|||
44306290|NCT02762981|79306069|FG002|Overall Study|Missing|0|||
44306291|NCT02762981|79306070|FG003|Overall Study|Missing|0|||
44306292|NCT02762981|79306071|FG004|Overall Study|Missing|0|||
44306293|NCT02762981|79306067|FG000|Overall Study|Withdrawal by Subject|0|||
44306294|NCT02762981|79306068|FG001|Overall Study|Withdrawal by Subject|5|||
44306295|NCT02762981|79306069|FG002|Overall Study|Withdrawal by Subject|1|||
44306296|NCT02762981|79306070|FG003|Overall Study|Withdrawal by Subject|3|||
44306297|NCT02762981|79306071|FG004|Overall Study|Withdrawal by Subject|0|||
44306298|NCT00001832|79306147|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
44306299|NCT00001832|79306148|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
44306300|NCT00001832|79306149|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
44306301|NCT00001832|79306150|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
44306302|NCT00001832|79306151|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
44306303|NCT00001832|79306152|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
44306304|NCT00001832|79306153|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
44306305|NCT00001832|79306154|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
44306306|NCT00001832|79306155|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
44306307|NCT00001832|79306156|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
44306308|NCT00001832|79306157|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
44306309|NCT00001832|79306158|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
44306310|NCT00001832|79306159|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
44306311|NCT00001832|79306160|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
44306312|NCT00001832|79306161|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
44306313|NCT00001832|79306147|FG000|Treatment Period|Death during treatment|0|||
44306314|NCT00001832|79306148|FG001|Treatment Period|Death during treatment|0|||
44306315|NCT00001832|79306149|FG002|Treatment Period|Death during treatment|0|||
44306316|NCT00001832|79306150|FG003|Treatment Period|Death during treatment|0|||
44306317|NCT00001832|79306151|FG004|Treatment Period|Death during treatment|0|||
44306318|NCT00001832|79306152|FG005|Treatment Period|Death during treatment|1|||
44306319|NCT00001832|79306153|FG006|Treatment Period|Death during treatment|0|||
44306320|NCT00001832|79306154|FG007|Treatment Period|Death during treatment|0|||
44306321|NCT00001832|79306155|FG008|Treatment Period|Death during treatment|0|||
44306322|NCT00001832|79306156|FG009|Treatment Period|Death during treatment|0|||
44306323|NCT00001832|79306157|FG010|Treatment Period|Death during treatment|0|||
44306324|NCT00001832|79306158|FG011|Treatment Period|Death during treatment|0|||
44306325|NCT00001832|79306159|FG012|Treatment Period|Death during treatment|0|||
44306326|NCT00001832|79306160|FG013|Treatment Period|Death during treatment|0|||
44306327|NCT00001832|79306161|FG014|Treatment Period|Death during treatment|0|||
44306328|NCT00001832|79306147|FG000|Treatment Period|Not treated|0|||
44306329|NCT00001832|79306148|FG001|Treatment Period|Not treated|0|||
44306330|NCT00001832|79306149|FG002|Treatment Period|Not treated|0|||
44306331|NCT00001832|79306150|FG003|Treatment Period|Not treated|0|||
44306332|NCT00001832|79306151|FG004|Treatment Period|Not treated|0|||
44306333|NCT00001832|79306152|FG005|Treatment Period|Not treated|0|||
44306334|NCT00001832|79306153|FG006|Treatment Period|Not treated|0|||
44306335|NCT00001832|79306154|FG007|Treatment Period|Not treated|1|||
44418379|NCT00813761|79426361|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
44306336|NCT00001832|79306155|FG008|Treatment Period|Not treated|0|||
44306337|NCT00001832|79306156|FG009|Treatment Period|Not treated|0|||
44306338|NCT00001832|79306157|FG010|Treatment Period|Not treated|0|||
44306339|NCT00001832|79306158|FG011|Treatment Period|Not treated|0|||
44306340|NCT00001832|79306159|FG012|Treatment Period|Not treated|0|||
44306341|NCT00001832|79306160|FG013|Treatment Period|Not treated|0|||
44306342|NCT00001832|79306161|FG014|Treatment Period|Not treated|0|||
44306343|NCT01349816|79306386|FG000|Overall Study|Withdrawal by Subject|4|||
44306344|NCT01349816|79306386|FG000|Overall Study|Physician Decision|1|||
44306345|NCT01349816|79306386|FG000|Overall Study|Adverse Event|14|||
44306346|NCT01349816|79306386|FG000|Overall Study|Lost to Follow-up|2|||
44306347|NCT01349816|79306386|FG000|Overall Study|Protocol Violation|1|||
44306348|NCT01349816|79306386|FG000|Overall Study|Protocol-specified criteria|8|||
44354629|NCT01194258|79359027|FG000|Titration Period|Withdrawal by Subject|6|||
44354630|NCT01194258|79359028|FG001|Titration Period|Withdrawal by Subject|0|||
44354631|NCT01194258|79359029|FG002|Titration Period|Withdrawal by Subject|0|||
44354632|NCT01194258|79359030|FG003|Titration Period|Withdrawal by Subject|0|||
44354633|NCT01194258|79359031|FG004|Titration Period|Withdrawal by Subject|0|||
44354634|NCT01194258|79359027|FG000|Titration Period|Lost to Follow-up|2|||
44354635|NCT01194258|79359028|FG001|Titration Period|Lost to Follow-up|0|||
44354636|NCT01194258|79359029|FG002|Titration Period|Lost to Follow-up|0|||
44354637|NCT01194258|79359030|FG003|Titration Period|Lost to Follow-up|0|||
44354638|NCT01194258|79359031|FG004|Titration Period|Lost to Follow-up|0|||
44354639|NCT01194258|79359027|FG000|Titration Period|Titration failure|3|||
44354640|NCT01194258|79359028|FG001|Titration Period|Titration failure|0|||
44354641|NCT01194258|79359029|FG002|Titration Period|Titration failure|0|||
44354642|NCT01194258|79359030|FG003|Titration Period|Titration failure|0|||
44354643|NCT01194258|79359031|FG004|Titration Period|Titration failure|0|||
44354644|NCT01194258|79359027|FG000|Period 1 (12 Weeks)|Death|0|||
44354645|NCT01194258|79359028|FG001|Period 1 (12 Weeks)|Death|0|||
44354646|NCT01194258|79359029|FG002|Period 1 (12 Weeks)|Death|0|||
44354647|NCT01194258|79359030|FG003|Period 1 (12 Weeks)|Death|0|||
44354648|NCT01194258|79359031|FG004|Period 1 (12 Weeks)|Death|1|||
44354649|NCT01194258|79359027|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44354650|NCT01194258|79359028|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44354651|NCT01194258|79359029|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44354652|NCT01194258|79359030|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44354653|NCT01194258|79359031|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
44354654|NCT01194258|79359027|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
44354655|NCT01194258|79359028|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
44354656|NCT01194258|79359029|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
44354657|NCT01194258|79359030|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
44354658|NCT01194258|79359031|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
44354659|NCT01194258|79359027|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44354660|NCT01194258|79359028|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44354661|NCT01194258|79359029|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44354662|NCT01194258|79359030|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44354663|NCT01194258|79359031|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44354664|NCT01193556|79359044|FG000|Overall Study|Study termination|26|||
44354665|NCT01193556|79359045|FG001|Overall Study|Study termination|25|||
44354666|NCT00951496|79359058|FG000|Overall Study|Did not initiate study treatment|10|||
44354667|NCT00951496|79359059|FG001|Overall Study|Did not initiate study treatment|8|||
44354668|NCT00951496|79359060|FG002|Overall Study|Did not initiate study treatment|13|||
44354669|NCT01193244|79359073|FG000|Overall Study|Withdrawal by Subject|79|||
44354670|NCT01193244|79359074|FG001|Overall Study|Withdrawal by Subject|97|||
44354671|NCT01193244|79359073|FG000|Overall Study|Other|303|||
44354672|NCT01193244|79359074|FG001|Overall Study|Other|278|||
44354673|NCT01193244|79359073|FG000|Overall Study|Lost to Follow-up|6|||
44354674|NCT01193244|79359074|FG001|Overall Study|Lost to Follow-up|15|||
44354675|NCT01192152|79359080|FG000|Period 1|left prematurely (while on treatment B)|0|||
44354676|NCT01192152|79359081|FG001|Period 1|left prematurely (while on treatment B)|1|||
44354677|NCT01192152|79359080|FG000|Period 3|family emergency|1|||
44354678|NCT01192152|79359081|FG001|Period 3|family emergency|0|||
44354679|NCT01191840|79359091|FG000|Overall Study|withdrew consent|2|||
44354680|NCT01191840|79359092|FG001|Overall Study|withdrew consent|1|||
44354681|NCT01191840|79359091|FG000|Overall Study|Subject discontinued treatment|1|||
44354682|NCT01191840|79359092|FG001|Overall Study|Subject discontinued treatment|2|||
44354683|NCT01191840|79359091|FG000|Overall Study|Lost to Follow-up|4|||
44354684|NCT01191840|79359092|FG001|Overall Study|Lost to Follow-up|6|||
44354685|NCT01191840|79359091|FG000|Overall Study|Non Staph Infection|4|||
44354686|NCT01191840|79359092|FG001|Overall Study|Non Staph Infection|3|||
44354687|NCT01191840|79359091|FG000|Overall Study|ineligible at enrollment|1|||
44354688|NCT01191840|79359092|FG001|Overall Study|ineligible at enrollment|0|||
44354689|NCT01191840|79359091|FG000|Overall Study|IRB approval lapse|0|||
44354690|NCT01191840|79359092|FG001|Overall Study|IRB approval lapse|2|||
44354691|NCT01191840|79359091|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
44155191|NCT02644109|78946868|FG000|Overall Study|Adverse Event|0|||
44354692|NCT01191840|79359092|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
44354693|NCT01191840|79359091|FG000|Overall Study|Withdrawal by Subject|2|||
44354694|NCT01191840|79359092|FG001|Overall Study|Withdrawal by Subject|0|||
44354695|NCT00943072|79359104|FG000|Overall Study|Adverse Event|0|||
44354696|NCT00943072|79359105|FG001|Overall Study|Adverse Event|3|||
44354697|NCT00943072|79359104|FG000|Overall Study|Death|0|||
44354698|NCT00943072|79359105|FG001|Overall Study|Death|2|||
44354699|NCT00943072|79359104|FG000|Overall Study|Withdrawal by Subject|3|||
44354700|NCT00943072|79359105|FG001|Overall Study|Withdrawal by Subject|1|||
44354701|NCT00943072|79359104|FG000|Overall Study|Protocol Violation|0|||
44354702|NCT00943072|79359105|FG001|Overall Study|Protocol Violation|1|||
44354703|NCT00943072|79359104|FG000|Overall Study|Lost to Follow-up|1|||
44354704|NCT00943072|79359105|FG001|Overall Study|Lost to Follow-up|2|||
44306349|NCT05201807|79306565|FG000|Overall Study|Adverse Event|1|||
44306350|NCT05201807|79306565|FG000|Overall Study|COVID-19 Related|1|||
44306351|NCT04978337|79306571|FG000|Overall Study|Withdrawal by Subject|0|||
44306352|NCT04978337|79306572|FG001|Overall Study|Withdrawal by Subject|1|||
44306353|NCT04828707|79306581|FG000|Overall Study|Lost to Follow-up|3|||
44306354|NCT04828707|79306582|FG001|Overall Study|Lost to Follow-up|2|||
44306355|NCT04828707|79306581|FG000|Overall Study|Withdrawal by Subject|2|||
44306356|NCT04828707|79306582|FG001|Overall Study|Withdrawal by Subject|1|||
44306357|NCT04629534|79306590|FG000|Overall Study|Physician Decision|1|||
44306358|NCT04629534|79306591|FG001|Overall Study|Physician Decision|0|||
44306359|NCT04629534|79306590|FG000|Overall Study|Protocol Violation|0|||
44306360|NCT04629534|79306591|FG001|Overall Study|Protocol Violation|2|||
44306361|NCT04481191|79306603|FG000|Overall Study|Withdrawn by parent/guardian|15|||
44306362|NCT04481191|79306604|FG001|Overall Study|Withdrawn by parent/guardian|10|||
44306363|NCT03695185|79306627|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
44306364|NCT03695185|79306627|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
44306365|NCT03695185|79306627|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
44306366|NCT03695185|79306627|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
44306367|NCT03695185|79306627|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
44306368|NCT03695185|79306627|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
44306369|NCT03596164|79306634|FG000|Overall Study|Adverse Event|0|||
44306370|NCT03596164|79306635|FG001|Overall Study|Adverse Event|1|||
44306371|NCT03596164|79306634|FG000|Overall Study|Death|1|||
44306372|NCT03596164|79306635|FG001|Overall Study|Death|0|||
44306373|NCT02990468|79306646|FG000|Phase 2: MTD|Change in treatment|0|||
44306374|NCT02990468|79306647|FG001|Phase 2: MTD|Change in treatment|0|||
44306375|NCT02990468|79306648|FG002|Phase 2: MTD|Change in treatment|1|||
44306376|NCT02855944|79306658|FG000|Period 1: Treatment|Ongoing|14|||
44306377|NCT02855944|79306659|FG001|Period 1: Treatment|Ongoing|0|||
44306378|NCT02855944|79306658|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
44306379|NCT02855944|79306659|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
44306380|NCT02855944|79306658|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
44306381|NCT02855944|79306659|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
44306382|NCT02681055|79306666|FG000|Weeks 5-12|Adverse Event|1|||
44306383|NCT02409342|79306673|FG000|Overall Study|Death|211|||
44306384|NCT02409342|79306674|FG001|Overall Study|Death|201|||
44306385|NCT02409342|79306673|FG000|Overall Study|Withdrawal by Subject|24|||
44306386|NCT02409342|79306674|FG001|Overall Study|Withdrawal by Subject|17|||
44306387|NCT02409342|79306673|FG000|Overall Study|Study Terminated By Sponsor|48|||
44306388|NCT02409342|79306674|FG001|Overall Study|Study Terminated By Sponsor|59|||
44306389|NCT02409342|79306673|FG000|Overall Study|Lost to Follow-up|3|||
44306390|NCT02409342|79306674|FG001|Overall Study|Lost to Follow-up|5|||
44306391|NCT02409342|79306673|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
44306392|NCT02409342|79306674|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
44306393|NCT02409342|79306673|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
44306394|NCT02409342|79306674|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
44306395|NCT02409342|79306673|FG000|Overall Study|Sponsor Decision|1|||
44306396|NCT02409342|79306674|FG001|Overall Study|Sponsor Decision|0|||
44306397|NCT02336503|79306686|FG000|Overall Study|Lost to Follow-up|0|||
44306398|NCT02336503|79306687|FG001|Overall Study|Lost to Follow-up|3|||
44306399|NCT02336503|79306688|FG002|Overall Study|Lost to Follow-up|0|||
44306400|NCT02336503|79306689|FG003|Overall Study|Lost to Follow-up|2|||
44306401|NCT02336503|79306686|FG000|Overall Study|Withdrawal by Subject|2|||
44306402|NCT02336503|79306687|FG001|Overall Study|Withdrawal by Subject|0|||
44306403|NCT02336503|79306688|FG002|Overall Study|Withdrawal by Subject|0|||
44306404|NCT02336503|79306689|FG003|Overall Study|Withdrawal by Subject|4|||
44306405|NCT02336503|79306686|FG000|Overall Study|Adverse Event|0|||
44306406|NCT02336503|79306687|FG001|Overall Study|Adverse Event|0|||
44306407|NCT02336503|79306688|FG002|Overall Study|Adverse Event|1|||
44306408|NCT02336503|79306689|FG003|Overall Study|Adverse Event|0|||
44306409|NCT02255409|79306705|FG000|Overall Study|Administrative Reason|3|||
44306410|NCT02255409|79306706|FG001|Overall Study|Administrative Reason|7|||
44306411|NCT02255409|79306705|FG000|Overall Study|Withdrawal by Subject|1|||
44306412|NCT02255409|79306706|FG001|Overall Study|Withdrawal by Subject|5|||
44306413|NCT02255409|79306705|FG000|Overall Study|Lost to Follow-up|10|||
44306414|NCT02255409|79306706|FG001|Overall Study|Lost to Follow-up|19|||
44306415|NCT00465517|79306737|FG000|Overall Study|Adverse Event|7|||
44306416|NCT00465517|79306738|FG001|Overall Study|Adverse Event|3|||
44306417|NCT00465517|79306737|FG000|Overall Study|Lost to Follow-up|1|||
44306418|NCT00465517|79306738|FG001|Overall Study|Lost to Follow-up|0|||
44306419|NCT00465517|79306737|FG000|Overall Study|Withdrawal by Subject|4|||
44306420|NCT00465517|79306738|FG001|Overall Study|Withdrawal by Subject|1|||
44306421|NCT05050578|79306746|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
44306422|NCT05050578|79306747|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
44306423|NCT05050578|79306746|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
44306424|NCT05050578|79306747|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
44306425|NCT05050578|79306746|FG000|Period 2, 30 Days|Protocol Violation|0|||
44306426|NCT05050578|79306747|FG001|Period 2, 30 Days|Protocol Violation|1|||
44306427|NCT04490278|79306756|FG000|Overall Study|Lost to Follow-up|6|||
44306428|NCT04004221|79306760|FG000|Overall Study|Death|89|||
44306429|NCT04004221|79306760|FG000|Overall Study|Withdrawal by Subject|5|||
44306430|NCT04004221|79306760|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
44306431|NCT04004221|79306760|FG000|Overall Study|Sponsor Decision|9|||
44306432|NCT04004221|79306760|FG000|Overall Study|Participant refused to enter LTE|1|||
44306433|NCT03775512|79306766|FG000|Overall Study|Death|1|||
44306434|NCT03775512|79306767|FG001|Overall Study|Death|1|||
44306435|NCT03775512|79306766|FG000|Overall Study|Withdrawal by Subject|7|||
44306436|NCT03775512|79306767|FG001|Overall Study|Withdrawal by Subject|4|||
44306437|NCT03775512|79306766|FG000|Overall Study|Lost to Follow-up|5|||
44306438|NCT03775512|79306767|FG001|Overall Study|Lost to Follow-up|5|||
44306439|NCT03775512|79306766|FG000|Overall Study|Excluded before Catheter insertion|14|||
44306440|NCT03775512|79306767|FG001|Overall Study|Excluded before Catheter insertion|5|||
44306441|NCT03775512|79306766|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
44306442|NCT03775512|79306767|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
44306443|NCT03775512|79306766|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
44306444|NCT03775512|79306767|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
44306445|NCT03620747|79306773|FG000|Overall Study|Participant decision|7|||
44306446|NCT03620747|79306773|FG000|Overall Study|Adverse Event|6|||
44306447|NCT03620747|79306773|FG000|Overall Study|Lack of Efficacy|1|||
44306448|NCT03620747|79306773|FG000|Overall Study|Poor compliance to protocol|2|||
44306449|NCT03620747|79306773|FG000|Overall Study|Other-unspecified|3|||
44306450|NCT03338790|79306798|FG000|Overall Study|Disease Progression|65|||
44306451|NCT03338790|79306799|FG001|Overall Study|Disease Progression|43|||
44306452|NCT03338790|79306800|FG002|Overall Study|Disease Progression|50|||
44306453|NCT03338790|79306801|FG003|Overall Study|Disease Progression|37|||
44306454|NCT03338790|79306798|FG000|Overall Study|Study Drug Toxicity|9|||
44306455|NCT03338790|79306799|FG001|Overall Study|Study Drug Toxicity|8|||
44306456|NCT03338790|79306800|FG002|Overall Study|Study Drug Toxicity|15|||
44306457|NCT03338790|79306801|FG003|Overall Study|Study Drug Toxicity|0|||
44306458|NCT03338790|79306798|FG000|Overall Study|Death|1|||
44306459|NCT03338790|79306799|FG001|Overall Study|Death|1|||
44306460|NCT03338790|79306800|FG002|Overall Study|Death|1|||
44306461|NCT03338790|79306801|FG003|Overall Study|Death|0|||
44306462|NCT03338790|79306798|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
44306463|NCT03338790|79306799|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
44306464|NCT03338790|79306800|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
44306465|NCT03338790|79306801|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
44306466|NCT03338790|79306798|FG000|Overall Study|Participant request to discontinue study treatment|3|||
44306467|NCT03338790|79306799|FG001|Overall Study|Participant request to discontinue study treatment|3|||
44306468|NCT03338790|79306800|FG002|Overall Study|Participant request to discontinue study treatment|2|||
44306469|NCT03338790|79306801|FG003|Overall Study|Participant request to discontinue study treatment|1|||
44306470|NCT03338790|79306798|FG000|Overall Study|Poor/non-compliance|0|||
44306471|NCT03338790|79306799|FG001|Overall Study|Poor/non-compliance|1|||
44306472|NCT03338790|79306800|FG002|Overall Study|Poor/non-compliance|0|||
44306473|NCT03338790|79306801|FG003|Overall Study|Poor/non-compliance|0|||
44306474|NCT03338790|79306798|FG000|Overall Study|Participant withdrew consent|1|||
44306475|NCT03338790|79306799|FG001|Overall Study|Participant withdrew consent|0|||
44306476|NCT03338790|79306800|FG002|Overall Study|Participant withdrew consent|1|||
44306477|NCT03338790|79306801|FG003|Overall Study|Participant withdrew consent|1|||
44306478|NCT03338790|79306798|FG000|Overall Study|Other reasons|0|||
44306479|NCT03338790|79306799|FG001|Overall Study|Other reasons|5|||
44306480|NCT03338790|79306800|FG002|Overall Study|Other reasons|0|||
44306481|NCT03338790|79306801|FG003|Overall Study|Other reasons|2|||
44257066|NCT02706951|79109425|FG003|Period 2|Other|37|||
44257067|NCT02706951|79109426|FG004|Period 2|Other|31|||
44257068|NCT02609386|79109439|FG000|Overall Study|Withdrawal by Subject|6|||
44257069|NCT02609386|79109440|FG001|Overall Study|Withdrawal by Subject|1|||
44257070|NCT02609386|79109439|FG000|Overall Study|Lost to Follow-up|3|||
44257071|NCT02609386|79109440|FG001|Overall Study|Lost to Follow-up|5|||
44257072|NCT02609386|79109439|FG000|Overall Study|Death|19|||
44257073|NCT02609386|79109440|FG001|Overall Study|Death|9|||
44257074|NCT02609386|79109439|FG000|Overall Study|Physician Decision|0|||
44306482|NCT03338790|79306798|FG000|Overall Study|Not reported|0|||
44306483|NCT03338790|79306799|FG001|Overall Study|Not reported|0|||
44306484|NCT03338790|79306800|FG002|Overall Study|Not reported|1|||
44306485|NCT03338790|79306801|FG003|Overall Study|Not reported|0|||
44306486|NCT03338790|79306798|FG000|Overall Study|Completed treatment period|1|||
44257075|NCT02609386|79109440|FG001|Overall Study|Physician Decision|2|||
44306487|NCT03338790|79306799|FG001|Overall Study|Completed treatment period|2|||
44257076|NCT02576717|79109450|FG000|Overall Study|Other Reasons|16|||
44257077|NCT02576717|79109451|FG001|Overall Study|Other Reasons|18|||
44306488|NCT03338790|79306800|FG002|Overall Study|Completed treatment period|0|||
44306489|NCT03338790|79306801|FG003|Overall Study|Completed treatment period|0|||
44306490|NCT02954536|79306828|FG000|Overall Study|Adverse Event|2|||
44306491|NCT02954536|79306828|FG000|Overall Study|Death|12|||
44306492|NCT02919670|79306834|FG000|Overall Study|Only 17 participants met compliance|43|||
44306493|NCT02919670|79306835|FG001|Overall Study|Only 17 participants met compliance|39|||
44306494|NCT02250326|79306934|FG000|Treatment Period|Death|1|||
44306495|NCT02250326|79306935|FG001|Treatment Period|Death|12|||
44306496|NCT02250326|79306936|FG002|Treatment Period|Death|2|||
44306497|NCT02250326|79306934|FG000|Treatment Period|Adverse Event|8|||
44306498|NCT02250326|79306935|FG001|Treatment Period|Adverse Event|4|||
44306499|NCT02250326|79306936|FG002|Treatment Period|Adverse Event|8|||
44306500|NCT02250326|79306934|FG000|Treatment Period|Progressive Disease|42|||
44306501|NCT02250326|79306935|FG001|Treatment Period|Progressive Disease|36|||
44306502|NCT02250326|79306936|FG002|Treatment Period|Progressive Disease|45|||
44306503|NCT02250326|79306934|FG000|Treatment Period|Symptomatic Deterioration|9|||
44306504|NCT02250326|79306935|FG001|Treatment Period|Symptomatic Deterioration|4|||
44306505|NCT02250326|79306936|FG002|Treatment Period|Symptomatic Deterioration|10|||
44306506|NCT02250326|79306934|FG000|Treatment Period|Withdrawal by Subject|11|||
44306507|NCT02250326|79306935|FG001|Treatment Period|Withdrawal by Subject|5|||
44306508|NCT02250326|79306936|FG002|Treatment Period|Withdrawal by Subject|4|||
44306509|NCT02250326|79306934|FG000|Treatment Period|Miscellaneous|8|||
44306510|NCT02250326|79306935|FG001|Treatment Period|Miscellaneous|2|||
44306511|NCT02250326|79306936|FG002|Treatment Period|Miscellaneous|7|||
44306512|NCT02250326|79306934|FG000|Treatment Period|Randomized or assigned; not treated|2|||
44306513|NCT02250326|79306935|FG001|Treatment Period|Randomized or assigned; not treated|1|||
44306514|NCT02250326|79306936|FG002|Treatment Period|Randomized or assigned; not treated|1|||
44306515|NCT02250326|79306934|FG000|Follow-Up Period|Death|46|||
44306516|NCT02250326|79306935|FG001|Follow-Up Period|Death|26|||
44306517|NCT02250326|79306936|FG002|Follow-Up Period|Death|32|||
44306518|NCT02250326|79306934|FG000|Follow-Up Period|Unknown or Missing|2|||
44306519|NCT02250326|79306935|FG001|Follow-Up Period|Unknown or Missing|3|||
44306520|NCT02250326|79306936|FG002|Follow-Up Period|Unknown or Missing|3|||
44306521|NCT02250326|79306934|FG000|Follow-Up Period|Lost to Follow-up|1|||
44306522|NCT02250326|79306935|FG001|Follow-Up Period|Lost to Follow-up|1|||
44306523|NCT02250326|79306936|FG002|Follow-Up Period|Lost to Follow-up|3|||
44306524|NCT01567722|79306948|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
44306525|NCT01567722|79306949|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
44306526|NCT01567722|79306950|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
44306527|NCT01567722|79306948|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
44306528|NCT01567722|79306949|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
44306529|NCT01567722|79306950|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
44306530|NCT01567722|79306948|FG000|Overall Study|Protocol closure by the OCG|2|||
44306531|NCT01567722|79306949|FG001|Overall Study|Protocol closure by the OCG|0|||
44306532|NCT01567722|79306950|FG002|Overall Study|Protocol closure by the OCG|0|||
44306533|NCT01567722|79306948|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
44306534|NCT01567722|79306949|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
44306535|NCT01567722|79306950|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
44306536|NCT01349790|79306975|FG000|Overall Study|Investigator Judgement|3|||
44306537|NCT01349790|79306975|FG000|Overall Study|Death|2|||
44306538|NCT01349790|79306975|FG000|Overall Study|Withdrawal by Patient|2|||
44306539|NCT01349790|79306975|FG000|Overall Study|Adverse Event|1|||
44306540|NCT01349790|79306975|FG000|Overall Study|Lost to Follow-up|1|||
44306541|NCT01349595|79306981|FG000|Overall Study|Lack of funding|2|||
44306542|NCT01349595|79306982|FG001|Overall Study|Lack of funding|2|||
44306543|NCT01349673|79306992|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
44306544|NCT01349673|79306992|FG000|Overall Study|No Longer Qualified For Study|1|||
44306545|NCT01349673|79306992|FG000|Overall Study|Site Closure|10|||
44306546|NCT01349673|79306992|FG000|Overall Study|Withdrawal by Subject|21|||
44306547|NCT01349673|79306992|FG000|Overall Study|Lost to Follow-up|6|||
44306548|NCT01349673|79306992|FG000|Overall Study|Adverse Event|17|||
44306549|NCT01349673|79306992|FG000|Overall Study|Study Terminated By Sponsor|50|||
44306550|NCT01349673|79306992|FG000|Overall Study|Lack of Efficacy|8|||
44306551|NCT04725682|79307022|FG000|Overall Study|Withdrawal by Subject|7|||
44155192|NCT02644109|78946869|FG001|Overall Study|Adverse Event|4|||
44306552|NCT04725682|79307023|FG001|Overall Study|Withdrawal by Subject|5|||
44306553|NCT04725682|79307022|FG000|Overall Study|Failed to comply with the requirements|2|||
44306554|NCT04725682|79307023|FG001|Overall Study|Failed to comply with the requirements|1|||
44155193|NCT02642159|78946877|FG000|Overall Study|Randomized but not treated|1|||
44306555|NCT04725682|79307022|FG000|Overall Study|Adverse Event|1|||
44306556|NCT04725682|79307023|FG001|Overall Study|Adverse Event|1|||
44306557|NCT04725682|79307022|FG000|Overall Study|Death|0|||
44306558|NCT04725682|79307023|FG001|Overall Study|Death|1|||
44418380|NCT00813761|79426362|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
44534598|NCT02431702|79545228|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
44534599|NCT02431702|79545229|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
44534600|NCT02431702|79545223|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
44306559|NCT01349660|79307055|FG000|Overall Study|Still Receiving Study Treatment|0|||
44306560|NCT01349660|79307056|FG001|Overall Study|Still Receiving Study Treatment|0|||
44306561|NCT01349660|79307057|FG002|Overall Study|Still Receiving Study Treatment|1|||
44418381|NCT00813761|79426359|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
44418382|NCT00813761|79426360|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
44418383|NCT00813761|79426361|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
44418384|NCT00813761|79426362|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
44418385|NCT00732069|79426378|FG000|Washout After First Study Drug|Adverse Event|1|||
44418386|NCT00732069|79426379|FG001|Washout After First Study Drug|Adverse Event|0|||
44418387|NCT00732069|79426380|FG002|Washout After First Study Drug|Adverse Event|0|||
44418388|NCT00732069|79426381|FG003|Washout After First Study Drug|Adverse Event|0|||
44418389|NCT00732069|79426382|FG004|Washout After First Study Drug|Adverse Event|0|||
44418390|NCT00732069|79426383|FG005|Washout After First Study Drug|Adverse Event|0|||
44418391|NCT00731679|79426393|FG000|Overall Study|Adverse Event|7|||
44418392|NCT00731679|79426394|FG001|Overall Study|Adverse Event|8|||
44418393|NCT00731679|79426393|FG000|Overall Study|Withdrawal by Subject|8|||
44418394|NCT00731679|79426394|FG001|Overall Study|Withdrawal by Subject|8|||
44418395|NCT00731679|79426393|FG000|Overall Study|Lost to Follow-up|7|||
44418396|NCT00731679|79426394|FG001|Overall Study|Lost to Follow-up|8|||
44418397|NCT00731679|79426393|FG000|Overall Study|Noncompliance|0|||
44418398|NCT00731679|79426394|FG001|Overall Study|Noncompliance|1|||
44418399|NCT00731679|79426393|FG000|Overall Study|Pregnancy|0|||
44418400|NCT00731679|79426394|FG001|Overall Study|Pregnancy|1|||
44418401|NCT00731133|79426400|FG000|Overall Study|Withdrawal by Subject|10|||
44418402|NCT00730275|79426408|FG000|Overall Study|Withdrawal by Subject|0|||
44418403|NCT00730275|79426409|FG001|Overall Study|Withdrawal by Subject|0|||
44534601|NCT02431702|79545224|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
44534602|NCT02431702|79545225|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
44534603|NCT02431702|79545226|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
44306562|NCT01349660|79307055|FG000|Overall Study|Disease Progression|2|||
44306563|NCT01349660|79307056|FG001|Overall Study|Disease Progression|4|||
44306564|NCT01349660|79307057|FG002|Overall Study|Disease Progression|50|||
44306565|NCT01349660|79307055|FG000|Overall Study|Adverse Event|1|||
44306566|NCT01349660|79307056|FG001|Overall Study|Adverse Event|1|||
44306567|NCT01349660|79307057|FG002|Overall Study|Adverse Event|12|||
44306568|NCT01349660|79307055|FG000|Overall Study|Withdrawal by Subject|2|||
44306569|NCT01349660|79307056|FG001|Overall Study|Withdrawal by Subject|0|||
44306570|NCT01349660|79307057|FG002|Overall Study|Withdrawal by Subject|9|||
44306571|NCT01349660|79307055|FG000|Overall Study|Death|1|||
44306572|NCT01349660|79307056|FG001|Overall Study|Death|1|||
44418404|NCT00730275|79426410|FG002|Overall Study|Withdrawal by Subject|0|||
44418405|NCT00730275|79426411|FG003|Overall Study|Withdrawal by Subject|1|||
44418406|NCT00730041|79426429|FG000|Overall Study|Lost to Follow-up|0|||
44418407|NCT00730041|79426430|FG001|Overall Study|Lost to Follow-up|2|||
44418408|NCT00729651|79426438|FG000|Overall Study|Withdrawal by Subject|5|||
44418409|NCT00729651|79426439|FG001|Overall Study|Withdrawal by Subject|6|||
44534604|NCT02431702|79545227|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
44418410|NCT00729651|79426438|FG000|Overall Study|Lost to Follow-up|5|||
44418411|NCT00729651|79426439|FG001|Overall Study|Lost to Follow-up|4|||
44418412|NCT00729651|79426438|FG000|Overall Study|Protocol Violation|0|||
44306573|NCT01349660|79307057|FG002|Overall Study|Death|0|||
44257078|NCT02576717|79109452|FG002|Overall Study|Other Reasons|15|||
44306574|NCT01349660|79307055|FG000|Overall Study|Non-Permitted Interventions|0|||
44306575|NCT01349660|79307056|FG001|Overall Study|Non-Permitted Interventions|0|||
44306576|NCT01349660|79307057|FG002|Overall Study|Non-Permitted Interventions|2|||
44306577|NCT01349660|79307055|FG000|Overall Study|Study Compliance|0|||
44306578|NCT01349660|79307056|FG001|Overall Study|Study Compliance|0|||
44306579|NCT01349660|79307057|FG002|Overall Study|Study Compliance|1|||
44306580|NCT01349660|79307055|FG000|Overall Study|Declining Performance Status|0|||
44306581|NCT01349660|79307056|FG001|Overall Study|Declining Performance Status|0|||
44306582|NCT01349660|79307057|FG002|Overall Study|Declining Performance Status|1|||
44418413|NCT00729651|79426439|FG001|Overall Study|Protocol Violation|1|||
44418414|NCT00729651|79426438|FG000|Overall Study|Adverse Event|7|||
44418415|NCT00729651|79426439|FG001|Overall Study|Adverse Event|3|||
44418416|NCT00729651|79426438|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
44418417|NCT00729651|79426439|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
44418418|NCT00729651|79426438|FG000|Overall Study|Subject's private reason|2|||
44418419|NCT00729651|79426439|FG001|Overall Study|Subject's private reason|0|||
44418420|NCT00729183|79426447|FG000|Overall Study|Adverse Event|11|||
44418421|NCT00729183|79426448|FG001|Overall Study|Adverse Event|5|||
44418422|NCT00729183|79426447|FG000|Overall Study|Lack of Efficacy|0|||
44418423|NCT00729183|79426448|FG001|Overall Study|Lack of Efficacy|1|||
44418424|NCT00729183|79426447|FG000|Overall Study|Lost to Follow-up|3|||
44418425|NCT00729183|79426448|FG001|Overall Study|Lost to Follow-up|1|||
44418426|NCT00729183|79426447|FG000|Overall Study|Physician Decision|1|||
44418427|NCT00729183|79426448|FG001|Overall Study|Physician Decision|1|||
44418428|NCT00729183|79426447|FG000|Overall Study|Protocol Violation|1|||
44418429|NCT00729183|79426448|FG001|Overall Study|Protocol Violation|0|||
44418430|NCT00729183|79426447|FG000|Overall Study|Withdrawal by Subject|9|||
44418431|NCT00729183|79426448|FG001|Overall Study|Withdrawal by Subject|7|||
44418432|NCT00811733|79426456|FG000|Overall Study|Investigator Discretion|10|||
44418433|NCT00811733|79426457|FG001|Overall Study|Investigator Discretion|8|||
44418434|NCT00811733|79426456|FG000|Overall Study|Withdrawal by Subject|1|||
44418435|NCT00811733|79426457|FG001|Overall Study|Withdrawal by Subject|2|||
44418436|NCT00728949|79426465|FG000|Overall Study|Adverse Event|8|||
44418437|NCT00728949|79426466|FG001|Overall Study|Adverse Event|0|||
44418438|NCT00728949|79426465|FG000|Overall Study|Withdrawal by Subject|2|||
44418439|NCT00728949|79426466|FG001|Overall Study|Withdrawal by Subject|2|||
44418440|NCT00728949|79426465|FG000|Overall Study|Abnormal Lab Results|0|||
44418441|NCT00728949|79426466|FG001|Overall Study|Abnormal Lab Results|2|||
44418442|NCT00728949|79426465|FG000|Overall Study|On treatment at cutoff date|1|||
44418443|NCT00728949|79426466|FG001|Overall Study|On treatment at cutoff date|0|||
44418444|NCT00728481|79426474|FG000|Overall Study|Withdrawal by Subject|0|||
44418445|NCT00728481|79426475|FG001|Overall Study|Withdrawal by Subject|1|||
44418446|NCT00728481|79426474|FG000|Overall Study|Adverse Event|0|||
44418447|NCT00728481|79426475|FG001|Overall Study|Adverse Event|1|||
44418448|NCT00728481|79426474|FG000|Overall Study|Study medication non-compliance|0|||
44418449|NCT00728481|79426475|FG001|Overall Study|Study medication non-compliance|2|||
44418450|NCT00728481|79426474|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
44418451|NCT00728481|79426475|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
44418452|NCT00811655|79426481|FG000|Overall Study|Physician Decision|1|||
44418453|NCT00727311|79426485|FG000|Overall Study|Did not receive drug|316|||
44418454|NCT00727311|79426485|FG000|Overall Study|Missing end of therapy data|205|||
44418455|NCT00727311|79426485|FG000|Overall Study|Adverse Event|58|||
44418456|NCT00727311|79426485|FG000|Overall Study|Lack of Efficacy|242|||
44418457|NCT00727311|79426485|FG000|Overall Study|Lost to Follow-up|73|||
44418458|NCT00727311|79426485|FG000|Overall Study|Withdrawal by Subject|77|||
44418459|NCT00727311|79426485|FG000|Overall Study|Other|97|||
44418460|NCT00727311|79426485|FG000|Overall Study|Multiple reasons|39|||
44418461|NCT00726999|79426491|FG000|Overall Study|Physician Decision|0|||
44418462|NCT00726999|79426492|FG001|Overall Study|Physician Decision|1|||
44418463|NCT00726999|79426491|FG000|Overall Study|Withdrawal by Subject|2|||
44257079|NCT02576717|79109450|FG000|Overall Study|Covid-19 Pandemic|0|||
44257080|NCT02576717|79109451|FG001|Overall Study|Covid-19 Pandemic|1|||
44257081|NCT02576717|79109452|FG002|Overall Study|Covid-19 Pandemic|1|||
44257082|NCT02576717|79109450|FG000|Overall Study|Sponsor Decision|0|||
44257083|NCT02576717|79109451|FG001|Overall Study|Sponsor Decision|0|||
44257084|NCT02576717|79109452|FG002|Overall Study|Sponsor Decision|1|||
44257085|NCT02576717|79109450|FG000|Overall Study|Physician Decision|3|||
44257086|NCT02576717|79109451|FG001|Overall Study|Physician Decision|8|||
44257087|NCT02576717|79109452|FG002|Overall Study|Physician Decision|9|||
44257088|NCT02576717|79109450|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
44257089|NCT02576717|79109451|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
44257090|NCT02576717|79109452|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
44257091|NCT02576717|79109450|FG000|Overall Study|Death|3|||
44257092|NCT02576717|79109451|FG001|Overall Study|Death|5|||
44306583|NCT01349569|79307076|FG000|Overall Study|Lack of Efficacy|4|||
44306584|NCT05221749|79307127|FG000|Overall Study|Lost to Follow-up|2|||
44306585|NCT05221749|79307128|FG001|Overall Study|Lost to Follow-up|3|||
44418464|NCT00726999|79426492|FG001|Overall Study|Withdrawal by Subject|0|||
44418465|NCT00726999|79426491|FG000|Overall Study|Protocol Violation|1|||
44418466|NCT00726999|79426492|FG001|Overall Study|Protocol Violation|0|||
44418467|NCT00585351|79426506|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
44418468|NCT00585351|79426507|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
44418469|NCT00585351|79426508|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
44418470|NCT00585351|79426509|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
44418471|NCT00585351|79426510|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
44418472|NCT00585351|79426511|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
44418473|NCT00585351|79426512|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
44418474|NCT00585351|79426513|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
44418475|NCT00585351|79426506|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
44418476|NCT00585351|79426507|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
44418477|NCT00585351|79426508|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
44418478|NCT00585351|79426509|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
44418479|NCT00585351|79426510|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
44418480|NCT00585351|79426511|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
44418481|NCT00585351|79426512|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
44418482|NCT00585351|79426513|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
44418483|NCT00585351|79426506|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
44418484|NCT00585351|79426507|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
44418485|NCT00585351|79426508|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
44418486|NCT00585351|79426509|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
44418487|NCT00585351|79426510|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
44418488|NCT00585351|79426511|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
44418489|NCT00585351|79426512|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
44418490|NCT00585351|79426513|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
44418491|NCT00585351|79426506|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
44418492|NCT00585351|79426507|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
44418493|NCT00585351|79426508|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
44418494|NCT00585351|79426509|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
44418495|NCT00585351|79426510|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
44418496|NCT00585351|79426511|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
44418497|NCT00585351|79426512|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
44418498|NCT00585351|79426513|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
44418499|NCT00585351|79426506|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
44418500|NCT00585351|79426507|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
44418501|NCT00585351|79426508|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
44418502|NCT00585351|79426509|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
44418503|NCT00585351|79426510|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
44418504|NCT00585351|79426511|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
44418505|NCT00585351|79426512|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
44418506|NCT00585351|79426513|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
44418507|NCT00585351|79426506|FG000|Enrollment Period (Intervention)|Death|0|||
44418508|NCT00585351|79426507|FG001|Enrollment Period (Intervention)|Death|0|||
44418509|NCT00585351|79426508|FG002|Enrollment Period (Intervention)|Death|0|||
44418510|NCT00585351|79426509|FG003|Enrollment Period (Intervention)|Death|0|||
44418511|NCT00585351|79426510|FG004|Enrollment Period (Intervention)|Death|1|||
44418512|NCT00585351|79426511|FG005|Enrollment Period (Intervention)|Death|0|||
44418513|NCT00585351|79426512|FG006|Enrollment Period (Intervention)|Death|1|||
44418514|NCT00585351|79426513|FG007|Enrollment Period (Intervention)|Death|0|||
44418515|NCT00585351|79426506|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
44418516|NCT00585351|79426507|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
44418517|NCT00585351|79426508|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
44418518|NCT00585351|79426509|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
44306586|NCT04965389|79307182|FG000|Overall Study|Other reasons|1|||
44306587|NCT04965389|79307183|FG001|Overall Study|Other reasons|0|||
44306588|NCT04965389|79307184|FG002|Overall Study|Other reasons|0|||
44306589|NCT04965389|79307185|FG003|Overall Study|Other reasons|0|||
44306590|NCT04965389|79307182|FG000|Overall Study|Participant withdrew consent|0|||
44306591|NCT04965389|79307183|FG001|Overall Study|Participant withdrew consent|1|||
44306592|NCT04965389|79307184|FG002|Overall Study|Participant withdrew consent|0|||
44306593|NCT04965389|79307185|FG003|Overall Study|Participant withdrew consent|0|||
44306594|NCT04965389|79307182|FG000|Overall Study|Poor/Non-compliance|0|||
44306595|NCT04965389|79307183|FG001|Overall Study|Poor/Non-compliance|1|||
44306596|NCT04965389|79307184|FG002|Overall Study|Poor/Non-compliance|0|||
44306597|NCT04965389|79307185|FG003|Overall Study|Poor/Non-compliance|0|||
44306598|NCT04935931|79307202|FG000|Overall Study|Withdrawal by Subject|1|||
44306599|NCT04839393|79307214|FG000|Overall Study|Adverse Event|0|||
44306600|NCT04839393|79307215|FG001|Overall Study|Adverse Event|0|||
44306601|NCT04839393|79307216|FG002|Overall Study|Adverse Event|2|||
44306602|NCT04839393|79307214|FG000|Overall Study|Withdrawal by participant|0|||
44306603|NCT04839393|79307215|FG001|Overall Study|Withdrawal by participant|0|||
44306604|NCT04839393|79307216|FG002|Overall Study|Withdrawal by participant|1|||
44306605|NCT04677712|79307283|FG000|Overall Study|Lost to Follow-up|0|||
44306606|NCT04677712|79307284|FG001|Overall Study|Lost to Follow-up|1|||
44306607|NCT04677712|79307285|FG002|Overall Study|Lost to Follow-up|0|||
44534605|NCT02431702|79545228|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
44534606|NCT02431702|79545229|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
44534607|NCT02431702|79545223|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
44306608|NCT04677712|79307286|FG003|Overall Study|Lost to Follow-up|0|||
44306609|NCT04677712|79307287|FG004|Overall Study|Lost to Follow-up|0|||
44306610|NCT04677712|79307288|FG005|Overall Study|Lost to Follow-up|0|||
44306611|NCT04630002|79307311|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
44306612|NCT04630002|79307312|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
44306613|NCT04630002|79307313|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
44306614|NCT04630002|79307311|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
44306615|NCT04630002|79307312|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
44306616|NCT04630002|79307313|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
44306617|NCT04630002|79307311|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
44306618|NCT04630002|79307312|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
44418519|NCT00585351|79426510|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
44418520|NCT00585351|79426511|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
44418521|NCT00585351|79426512|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
44306619|NCT04630002|79307313|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
44354705|NCT00943072|79359104|FG000|Overall Study|Lack of Efficacy|0|||
44418522|NCT00585351|79426513|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
44418523|NCT00726609|79426527|FG000|Overall Study|Adverse Event|10|||
44418524|NCT00726609|79426527|FG000|Overall Study|Withdrawal by Subject|2|||
44418525|NCT00726609|79426527|FG000|Overall Study|Lack of Efficacy|25|||
44418526|NCT00726609|79426527|FG000|Overall Study|Other|16|||
44418527|NCT00726609|79426527|FG000|Overall Study|Missing|42|||
44418528|NCT00726609|79426527|FG000|Overall Study|Other|3|||
44418529|NCT00726453|79426533|FG000|Primary Enrollment Group|Death|18|||
44418530|NCT00726453|79426534|FG001|Primary Enrollment Group|Death|0|||
44418531|NCT00726453|79426533|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
44418532|NCT00726453|79426534|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
44418533|NCT00726453|79426533|FG000|38 mm Length Group|Death|0|||
44418534|NCT00726453|79426534|FG001|38 mm Length Group|Death|3|||
44418535|NCT00726063|79426541|FG000|Overall Study|Adverse Event|9|||
44418536|NCT00726063|79426542|FG001|Overall Study|Adverse Event|7|||
44418537|NCT00808028|79426552|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
44418538|NCT00808028|79426553|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
44418539|NCT00808028|79426554|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
44534608|NCT02431702|79545224|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
44534609|NCT02431702|79545225|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
44534610|NCT02431702|79545226|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
44534611|NCT02431702|79545227|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
44534612|NCT02431702|79545228|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
44534613|NCT02431702|79545229|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
44534614|NCT02431702|79545223|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
44534615|NCT02431702|79545224|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
44534616|NCT02431702|79545225|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
44534617|NCT02431702|79545226|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
44534618|NCT02431702|79545227|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
44354706|NCT00943072|79359105|FG001|Overall Study|Lack of Efficacy|4|||
44354707|NCT00943072|79359104|FG000|Overall Study|Other|1|||
44354708|NCT00943072|79359105|FG001|Overall Study|Other|1|||
44354709|NCT00942994|79359115|FG000|Overall Study|Adverse Event|7|||
44354710|NCT00942994|79359116|FG001|Overall Study|Adverse Event|4|||
44354711|NCT00942994|79359115|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44354712|NCT00942994|79359116|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44354713|NCT00942994|79359115|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44354714|NCT00942994|79359116|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44306620|NCT04630002|79307311|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
44306621|NCT04630002|79307312|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
44306622|NCT04630002|79307313|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
44306623|NCT04630002|79307311|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
44306624|NCT04630002|79307312|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
44306625|NCT04630002|79307313|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
44306626|NCT04630002|79307311|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
44306627|NCT04630002|79307312|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
44306628|NCT04630002|79307313|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
44306629|NCT04630002|79307311|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
44306630|NCT04630002|79307312|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
44306631|NCT04630002|79307313|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
44306632|NCT04630002|79307311|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
44306633|NCT04630002|79307312|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
44306634|NCT04630002|79307313|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
44306635|NCT04576923|79307346|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
44306636|NCT04526197|79307360|FG000|Period 1|Adverse Event|0|||
44306637|NCT04526197|79307361|FG001|Period 1|Adverse Event|1|||
44306638|NCT04526197|79307360|FG000|Period 1|Withdrawal by Subject|1|||
44306639|NCT04526197|79307361|FG001|Period 1|Withdrawal by Subject|0|||
44306640|NCT04526197|79307360|FG000|Period 2|Adverse Event|0|||
44306641|NCT04526197|79307361|FG001|Period 2|Adverse Event|1|||
44306642|NCT04526197|79307360|FG000|Period 2|Withdrawal by Subject|0|||
44306643|NCT04526197|79307361|FG001|Period 2|Withdrawal by Subject|1|||
44306644|NCT04412668|79307371|FG000|Overall Study|Death - multiple comorbidities|2|||
44306645|NCT04412668|79307372|FG001|Overall Study|Death - multiple comorbidities|0|||
44306646|NCT04412668|79307373|FG002|Overall Study|Death - multiple comorbidities|0|||
44306647|NCT04412668|79307371|FG000|Overall Study|Withdrawal by Subject|3|||
44306648|NCT04412668|79307372|FG001|Overall Study|Withdrawal by Subject|0|||
44306649|NCT04412668|79307373|FG002|Overall Study|Withdrawal by Subject|0|||
44306650|NCT04412668|79307371|FG000|Overall Study|Other than Specified|2|||
44306651|NCT04412668|79307372|FG001|Overall Study|Other than Specified|0|||
44306652|NCT04412668|79307373|FG002|Overall Study|Other than Specified|0|||
44306653|NCT04360551|79307383|FG000|Overall Study|Withdrawal by Subject|1|||
44306654|NCT04360551|79307384|FG001|Overall Study|Withdrawal by Subject|0|||
44306655|NCT04299087|79307392|FG000|Overall Study|Lost to Follow-up|2|||
44306656|NCT04299087|79307393|FG001|Overall Study|Lost to Follow-up|1|||
44306657|NCT04288778|79307399|FG000|Overall Study|Withdrawal by Subject|2|||
44306658|NCT04288778|79307399|FG000|Overall Study|Adverse Event|5|||
44306659|NCT04288778|79307399|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44306660|NCT04288778|79307399|FG000|Overall Study|Other|1|||
44306661|NCT04288778|79307399|FG000|Overall Study|Started but not treated|2|||
44306662|NCT04233164|79307418|FG000|Overall Study|Unable to obtain specimen|0|||
44306663|NCT04233164|79307419|FG001|Overall Study|Unable to obtain specimen|1|||
44306664|NCT04147195|79307435|FG000|Overall Study|Adverse Event|0|||
44306665|NCT04147195|79307436|FG001|Overall Study|Adverse Event|3|||
44306666|NCT04147195|79307435|FG000|Overall Study|Study Terminated by Sponsor|4|||
44306667|NCT04147195|79307436|FG001|Overall Study|Study Terminated by Sponsor|2|||
44306668|NCT04147195|79307435|FG000|Overall Study|Withdrawal by Subject|0|||
44306669|NCT04147195|79307436|FG001|Overall Study|Withdrawal by Subject|1|||
44306670|NCT04092816|79307449|FG000|Overall Study|Lost to Follow-up|1|||
44306671|NCT04092816|79307450|FG001|Overall Study|Lost to Follow-up|2|||
44306672|NCT03985878|79307467|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
44306673|NCT03985878|79307467|FG000|Overall Study|Study Terminated by Sponsor|12|||
44306674|NCT03985878|79307467|FG000|Overall Study|Withdrawal by Subject|1|||
44306675|NCT03774394|79307549|FG000|Overall Study|Withdrawal by Subject|2|||
44534619|NCT02431702|79545228|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
44534620|NCT02431702|79545229|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
44534621|NCT02431702|79545223|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
44534622|NCT02431702|79545224|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
44534623|NCT02431702|79545225|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
44306676|NCT03774394|79307550|FG001|Overall Study|Withdrawal by Subject|0|||
44306677|NCT03765788|79307558|FG000|Overall Study|Subject decision|2|||
44306678|NCT03765788|79307559|FG001|Overall Study|Subject decision|3|||
44306679|NCT03765788|79307558|FG000|Overall Study|Physician Decision|2|||
44306680|NCT03765788|79307559|FG001|Overall Study|Physician Decision|4|||
44306681|NCT03765788|79307558|FG000|Overall Study|Death|0|||
44534624|NCT02431702|79545226|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
44306682|NCT03765788|79307559|FG001|Overall Study|Death|1|||
44306683|NCT03765788|79307558|FG000|Overall Study|Lost to Follow-up|1|||
44306684|NCT03765788|79307559|FG001|Overall Study|Lost to Follow-up|0|||
44306685|NCT03692403|79307570|FG000|Overall Study|Withdrawal by Subject|1|||
44306686|NCT03692403|79307571|FG001|Overall Study|Withdrawal by Subject|0|||
44306687|NCT03692403|79307572|FG002|Overall Study|Withdrawal by Subject|1|||
44306688|NCT03692403|79307573|FG003|Overall Study|Withdrawal by Subject|0|||
44306689|NCT03692403|79307570|FG000|Overall Study|Adverse Event|0|||
44306690|NCT03692403|79307571|FG001|Overall Study|Adverse Event|0|||
44306691|NCT03692403|79307572|FG002|Overall Study|Adverse Event|0|||
44306692|NCT03692403|79307573|FG003|Overall Study|Adverse Event|1|||
44306693|NCT03692403|79307570|FG000|Overall Study|Pregnancy|0|||
44306694|NCT03692403|79307571|FG001|Overall Study|Pregnancy|1|||
44306695|NCT03692403|79307572|FG002|Overall Study|Pregnancy|0|||
44306696|NCT03692403|79307573|FG003|Overall Study|Pregnancy|0|||
44306697|NCT03692403|79307570|FG000|Overall Study|Other|0|||
44306698|NCT03692403|79307571|FG001|Overall Study|Other|0|||
44306699|NCT03692403|79307572|FG002|Overall Study|Other|1|||
44306700|NCT03692403|79307573|FG003|Overall Study|Other|0|||
44306701|NCT03654651|79307588|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
44306702|NCT03654651|79307589|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
44306703|NCT03649230|79307596|FG000|Overall Study|Adverse Event|12|||
44306704|NCT03649230|79307596|FG000|Overall Study|Death|8|||
44306705|NCT03649230|79307596|FG000|Overall Study|Withdrawal by Subject|6|||
44306706|NCT03649230|79307596|FG000|Overall Study|Physician Decision|5|||
44306707|NCT03649230|79307596|FG000|Overall Study|Disease progression|5|||
44306708|NCT03649230|79307596|FG000|Overall Study|Switched to non-HEC|5|||
44306709|NCT03649230|79307596|FG000|Overall Study|Chemotherapy discontinued|4|||
44306710|NCT03649230|79307596|FG000|Overall Study|Received only 3 HEC cycles|4|||
44306711|NCT03649230|79307596|FG000|Overall Study|Screen Failure|3|||
44306712|NCT03649230|79307596|FG000|Overall Study|Patient stopped treatment|2|||
44306713|NCT03649230|79307596|FG000|Overall Study|Protocol Violation|1|||
44306714|NCT03649230|79307596|FG000|Overall Study|Non-compliance|1|||
44306715|NCT03649230|79307596|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
44306716|NCT03626545|79307607|FG000|Overall Study|Progressive disease|3|||
44306717|NCT03626545|79307608|FG001|Overall Study|Progressive disease|82|||
44306718|NCT03626545|79307609|FG002|Overall Study|Progressive disease|85|||
44306719|NCT03626545|79307607|FG000|Overall Study|Adverse Event|3|||
44306720|NCT03626545|79307608|FG001|Overall Study|Adverse Event|13|||
44306721|NCT03626545|79307609|FG002|Overall Study|Adverse Event|10|||
44306722|NCT03626545|79307607|FG000|Overall Study|Physician Decision|1|||
44306723|NCT03626545|79307608|FG001|Overall Study|Physician Decision|18|||
44306724|NCT03626545|79307609|FG002|Overall Study|Physician Decision|14|||
44306725|NCT03626545|79307607|FG000|Overall Study|Subject Decision|0|||
44306726|NCT03626545|79307608|FG001|Overall Study|Subject Decision|5|||
44306727|NCT03626545|79307609|FG002|Overall Study|Subject Decision|5|||
44306728|NCT03626545|79307607|FG000|Overall Study|Death|1|||
44306729|NCT03626545|79307608|FG001|Overall Study|Death|1|||
44306730|NCT03626545|79307609|FG002|Overall Study|Death|1|||
44306731|NCT03626545|79307607|FG000|Overall Study|Protocol Deviation|0|||
44306732|NCT03626545|79307608|FG001|Overall Study|Protocol Deviation|1|||
44306733|NCT03626545|79307609|FG002|Overall Study|Protocol Deviation|1|||
44306734|NCT03626545|79307607|FG000|Overall Study|Guardian Decision|0|||
44306735|NCT03626545|79307608|FG001|Overall Study|Guardian Decision|0|||
44306736|NCT03626545|79307609|FG002|Overall Study|Guardian Decision|1|||
44306737|NCT03575143|79307626|FG000|Overall Study|Lost to Follow-up|0|||
44306738|NCT03575143|79307627|FG001|Overall Study|Lost to Follow-up|0|||
44306739|NCT03575143|79307628|FG002|Overall Study|Lost to Follow-up|4|||
44306740|NCT03575143|79307626|FG000|Overall Study|Withdrawal by Subject|0|||
44306741|NCT03575143|79307627|FG001|Overall Study|Withdrawal by Subject|0|||
44306742|NCT03575143|79307628|FG002|Overall Study|Withdrawal by Subject|5|||
44306743|NCT03575143|79307626|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
44306744|NCT03575143|79307627|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
44306745|NCT03575143|79307628|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
44306746|NCT03548064|79307646|FG000|Overall Study|Withdrawal by Subject|0|||
44306747|NCT03548064|79307647|FG001|Overall Study|Withdrawal by Subject|0|||
44306748|NCT03548064|79307648|FG002|Overall Study|Withdrawal by Subject|0|||
44306749|NCT03548064|79307649|FG003|Overall Study|Withdrawal by Subject|1|||
44306750|NCT03548064|79307650|FG004|Overall Study|Withdrawal by Subject|0|||
44306751|NCT03548064|79307651|FG005|Overall Study|Withdrawal by Subject|0|||
44306752|NCT03548064|79307652|FG006|Overall Study|Withdrawal by Subject|0|||
44306753|NCT03548064|79307653|FG007|Overall Study|Withdrawal by Subject|0|||
44306754|NCT03548064|79307646|FG000|Overall Study|Lost to Follow-up|0|||
44306755|NCT03548064|79307647|FG001|Overall Study|Lost to Follow-up|0|||
44306756|NCT03548064|79307648|FG002|Overall Study|Lost to Follow-up|0|||
44306757|NCT03548064|79307649|FG003|Overall Study|Lost to Follow-up|0|||
44306758|NCT03548064|79307650|FG004|Overall Study|Lost to Follow-up|2|||
44306759|NCT03548064|79307651|FG005|Overall Study|Lost to Follow-up|0|||
44306760|NCT03548064|79307652|FG006|Overall Study|Lost to Follow-up|0|||
44418540|NCT00808028|79426555|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
44418541|NCT00808028|79426552|FG000|Stage 1 (6 Months)|Other|1|||
44418542|NCT00808028|79426553|FG001|Stage 1 (6 Months)|Other|0|||
44418543|NCT00808028|79426554|FG002|Stage 1 (6 Months)|Other|2|||
44418544|NCT00808028|79426555|FG003|Stage 1 (6 Months)|Other|4|||
44418545|NCT00808028|79426552|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
44418546|NCT00808028|79426553|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
44418547|NCT00808028|79426554|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
44418548|NCT00808028|79426555|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
44418549|NCT00808028|79426552|FG000|Stage 1 (6 Months)|Adverse Event|0|||
44418550|NCT00808028|79426553|FG001|Stage 1 (6 Months)|Adverse Event|0|||
44418551|NCT00808028|79426554|FG002|Stage 1 (6 Months)|Adverse Event|1|||
44418552|NCT00808028|79426555|FG003|Stage 1 (6 Months)|Adverse Event|2|||
44418553|NCT00808028|79426552|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
44155194|NCT02642159|78946878|FG001|Overall Study|Randomized but not treated|0|||
44155195|NCT02642159|78946877|FG000|Overall Study|Adverse Event|10|||
44155196|NCT02642159|78946878|FG001|Overall Study|Adverse Event|4|||
44306761|NCT03548064|79307653|FG007|Overall Study|Lost to Follow-up|0|||
44306762|NCT03548064|79307646|FG000|Overall Study|Covid-19 Pandemic|0|||
44306763|NCT03548064|79307647|FG001|Overall Study|Covid-19 Pandemic|0|||
44306764|NCT03548064|79307648|FG002|Overall Study|Covid-19 Pandemic|0|||
44306765|NCT03548064|79307649|FG003|Overall Study|Covid-19 Pandemic|0|||
44306766|NCT03548064|79307650|FG004|Overall Study|Covid-19 Pandemic|10|||
44306767|NCT03548064|79307651|FG005|Overall Study|Covid-19 Pandemic|3|||
44306768|NCT03548064|79307652|FG006|Overall Study|Covid-19 Pandemic|0|||
44306769|NCT03548064|79307653|FG007|Overall Study|Covid-19 Pandemic|0|||
44306770|NCT03512197|79307679|FG000|Overall Study|Guardian decision|1|||
44306771|NCT03512197|79307680|FG001|Overall Study|Guardian decision|1|||
44306772|NCT03512197|79307679|FG000|Overall Study|Lack of Efficacy|19|||
44306773|NCT03512197|79307680|FG001|Overall Study|Lack of Efficacy|11|||
44306774|NCT03512197|79307679|FG000|Overall Study|New Therapy for Study Indication|16|||
44306775|NCT03512197|79307680|FG001|Overall Study|New Therapy for Study Indication|16|||
44306776|NCT03512197|79307679|FG000|Overall Study|Physician Decision|60|||
44306777|NCT03512197|79307680|FG001|Overall Study|Physician Decision|60|||
44306778|NCT03512197|79307679|FG000|Overall Study|Protocol Violation|0|||
44306779|NCT03512197|79307680|FG001|Overall Study|Protocol Violation|2|||
44306780|NCT03512197|79307679|FG000|Overall Study|Terminated by Sponsored|46|||
44418554|NCT00808028|79426553|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
44155197|NCT02642159|78946877|FG000|Overall Study|Withdrawal by Subject|9|||
44155198|NCT02642159|78946878|FG001|Overall Study|Withdrawal by Subject|1|||
44155199|NCT02642159|78946877|FG000|Overall Study|Poor compliance to study protocol|1|||
44306781|NCT03512197|79307680|FG001|Overall Study|Terminated by Sponsored|50|||
44306782|NCT03512197|79307679|FG000|Overall Study|Subject Decision|15|||
44306783|NCT03512197|79307680|FG001|Overall Study|Subject Decision|12|||
44306784|NCT03512197|79307679|FG000|Overall Study|Withdrawal of informed consent|20|||
44306785|NCT03512197|79307680|FG001|Overall Study|Withdrawal of informed consent|14|||
44418555|NCT00808028|79426554|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
44418556|NCT00808028|79426555|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
44418557|NCT00808028|79426552|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
44418558|NCT00808028|79426553|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
44418559|NCT00808028|79426554|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
44418560|NCT00808028|79426555|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
44418561|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
44418562|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
44418563|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
44155200|NCT02642159|78946878|FG001|Overall Study|Poor compliance to study protocol|0|||
44306786|NCT03512197|79307679|FG000|Overall Study|Adverse Event|30|||
44306787|NCT03512197|79307680|FG001|Overall Study|Adverse Event|34|||
44306788|NCT03512197|79307679|FG000|Overall Study|Death|14|||
44306789|NCT03512197|79307680|FG001|Overall Study|Death|9|||
44306790|NCT03512197|79307679|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
44418564|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
44306791|NCT03512197|79307680|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
44306792|NCT03512197|79307679|FG000|Overall Study|Missing|3|||
44306793|NCT03512197|79307680|FG001|Overall Study|Missing|13|||
44306794|NCT03502330|79307700|FG000|Overall Study|Adverse Event|2|||
44306795|NCT03502330|79307701|FG001|Overall Study|Adverse Event|1|||
44306796|NCT03502330|79307702|FG002|Overall Study|Adverse Event|0|||
44306797|NCT03502330|79307703|FG003|Overall Study|Adverse Event|0|||
44306798|NCT03502330|79307704|FG004|Overall Study|Adverse Event|1|||
44306799|NCT03502330|79307705|FG005|Overall Study|Adverse Event|0|||
44306800|NCT03502330|79307706|FG006|Overall Study|Adverse Event|1|||
44306801|NCT03502330|79307707|FG007|Overall Study|Adverse Event|1|||
44306802|NCT03502330|79307708|FG008|Overall Study|Adverse Event|0|||
44306803|NCT03502330|79307700|FG000|Overall Study|Lack of Efficacy|1|||
44306804|NCT03502330|79307701|FG001|Overall Study|Lack of Efficacy|5|||
44306805|NCT03502330|79307702|FG002|Overall Study|Lack of Efficacy|3|||
44306806|NCT03502330|79307703|FG003|Overall Study|Lack of Efficacy|5|||
44306807|NCT03502330|79307704|FG004|Overall Study|Lack of Efficacy|1|||
44306808|NCT03502330|79307705|FG005|Overall Study|Lack of Efficacy|5|||
44306809|NCT03502330|79307706|FG006|Overall Study|Lack of Efficacy|5|||
44306810|NCT03502330|79307707|FG007|Overall Study|Lack of Efficacy|6|||
44306811|NCT03502330|79307708|FG008|Overall Study|Lack of Efficacy|0|||
44306812|NCT03502330|79307700|FG000|Overall Study|Physician Decision|0|||
44306813|NCT03502330|79307701|FG001|Overall Study|Physician Decision|0|||
44306814|NCT03502330|79307702|FG002|Overall Study|Physician Decision|0|||
44306815|NCT03502330|79307703|FG003|Overall Study|Physician Decision|0|||
44306816|NCT03502330|79307704|FG004|Overall Study|Physician Decision|1|||
44306817|NCT03502330|79307705|FG005|Overall Study|Physician Decision|0|||
44306818|NCT03502330|79307706|FG006|Overall Study|Physician Decision|0|||
44306819|NCT03502330|79307707|FG007|Overall Study|Physician Decision|0|||
44306820|NCT03502330|79307708|FG008|Overall Study|Physician Decision|0|||
44306821|NCT03502330|79307700|FG000|Overall Study|Withdrawal by Subject|0|||
44306822|NCT03502330|79307701|FG001|Overall Study|Withdrawal by Subject|0|||
44306823|NCT03502330|79307702|FG002|Overall Study|Withdrawal by Subject|0|||
44306824|NCT03502330|79307703|FG003|Overall Study|Withdrawal by Subject|0|||
44306825|NCT03502330|79307704|FG004|Overall Study|Withdrawal by Subject|0|||
44306826|NCT03502330|79307705|FG005|Overall Study|Withdrawal by Subject|1|||
44306827|NCT03502330|79307706|FG006|Overall Study|Withdrawal by Subject|0|||
44306828|NCT03502330|79307707|FG007|Overall Study|Withdrawal by Subject|1|||
44306829|NCT03502330|79307708|FG008|Overall Study|Withdrawal by Subject|0|||
44306830|NCT03502330|79307700|FG000|Overall Study|Death|0|||
44306831|NCT03502330|79307701|FG001|Overall Study|Death|0|||
44306832|NCT03502330|79307702|FG002|Overall Study|Death|0|||
44306833|NCT03502330|79307703|FG003|Overall Study|Death|0|||
44306834|NCT03502330|79307704|FG004|Overall Study|Death|0|||
44306835|NCT03502330|79307705|FG005|Overall Study|Death|0|||
44306836|NCT03502330|79307706|FG006|Overall Study|Death|2|||
44306837|NCT03502330|79307707|FG007|Overall Study|Death|0|||
44306838|NCT03502330|79307708|FG008|Overall Study|Death|0|||
44306839|NCT03460756|79307730|FG000|Overall Study|Adverse Event|0|||
44306840|NCT03460756|79307731|FG001|Overall Study|Adverse Event|0|||
44306841|NCT03460756|79307732|FG002|Overall Study|Adverse Event|0|||
44306842|NCT03460756|79307733|FG003|Overall Study|Adverse Event|1|||
44534625|NCT02431702|79545227|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
44534626|NCT02431702|79545228|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
44534627|NCT02431702|79545229|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
44534628|NCT02431702|79545223|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
44534629|NCT02431702|79545224|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
44534630|NCT02431702|79545225|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
44534631|NCT02431702|79545226|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
44534632|NCT02431702|79545227|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
44534633|NCT02431702|79545228|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
44534634|NCT02431702|79545229|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
44534635|NCT02431702|79545223|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
44534636|NCT02431702|79545224|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
44306843|NCT03460756|79307730|FG000|Overall Study|Lack of Efficacy|0|||
44306844|NCT03460756|79307731|FG001|Overall Study|Lack of Efficacy|0|||
44306845|NCT03460756|79307732|FG002|Overall Study|Lack of Efficacy|0|||
44306846|NCT03460756|79307733|FG003|Overall Study|Lack of Efficacy|2|||
44306847|NCT03460756|79307730|FG000|Overall Study|Lost to Follow-up|0|||
44306848|NCT03460756|79307731|FG001|Overall Study|Lost to Follow-up|1|||
44306849|NCT03460756|79307732|FG002|Overall Study|Lost to Follow-up|2|||
44306850|NCT03460756|79307733|FG003|Overall Study|Lost to Follow-up|1|||
44306851|NCT03460756|79307730|FG000|Overall Study|Pregnancy|0|||
44418565|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
44306852|NCT03460756|79307731|FG001|Overall Study|Pregnancy|0|||
44306853|NCT03460756|79307732|FG002|Overall Study|Pregnancy|0|||
44306854|NCT03460756|79307733|FG003|Overall Study|Pregnancy|1|||
44306855|NCT03460756|79307730|FG000|Overall Study|Protocol Violation|0|||
44306856|NCT03460756|79307731|FG001|Overall Study|Protocol Violation|0|||
44306857|NCT03460756|79307732|FG002|Overall Study|Protocol Violation|0|||
44306858|NCT03460756|79307733|FG003|Overall Study|Protocol Violation|1|||
44306859|NCT03460756|79307730|FG000|Overall Study|Withdrawal by Subject|0|||
44306860|NCT03460756|79307731|FG001|Overall Study|Withdrawal by Subject|4|||
44306861|NCT03460756|79307732|FG002|Overall Study|Withdrawal by Subject|7|||
44306862|NCT03460756|79307733|FG003|Overall Study|Withdrawal by Subject|3|||
44306863|NCT03459443|79307745|FG000|Overall Study|Lack of Efficacy|3|||
44306864|NCT03459443|79307745|FG000|Overall Study|Adverse Event|1|||
44306865|NCT03459443|79307745|FG000|Overall Study|Sponsor's decision to close the study|18|||
44306866|NCT03316885|79307758|FG000|Overall Study|Adverse Event|1|||
44306867|NCT03316885|79307758|FG000|Overall Study|Death|10|||
44306868|NCT03316885|79307758|FG000|Overall Study|Lost to Follow-up|4|||
44306869|NCT03316885|79307758|FG000|Overall Study|Withdrawal by Subject|9|||
44306870|NCT03316885|79307758|FG000|Overall Study|COVID related|8|||
44306871|NCT03259074|79307794|FG000|Overall Study|Adverse Event|9|||
44306872|NCT03259074|79307795|FG001|Overall Study|Adverse Event|12|||
44306873|NCT03259074|79307796|FG002|Overall Study|Adverse Event|8|||
44418566|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
44418567|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
44418568|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
44418569|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
44418570|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
44418571|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
44418572|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
44418573|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
44418574|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
44418575|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
44418576|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
44418577|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
44418578|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
44418579|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
44418580|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
44418581|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
44418582|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
44418583|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
44418584|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
44418585|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
44418586|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
44418587|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
44418588|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
44418589|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
44418590|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
44418591|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
44418592|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
44418593|NCT00808028|79426552|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
44534637|NCT02431702|79545225|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
44534638|NCT02431702|79545226|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
44534639|NCT02431702|79545227|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
44534640|NCT02431702|79545228|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
44534641|NCT02431702|79545229|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
44534642|NCT02431702|79545223|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
44306874|NCT03259074|79307794|FG000|Overall Study|Death|1|||
44306875|NCT03259074|79307795|FG001|Overall Study|Death|1|||
44306876|NCT03259074|79307796|FG002|Overall Study|Death|3|||
44418594|NCT00808028|79426553|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
44418595|NCT00808028|79426554|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
44418596|NCT00808028|79426555|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
44418597|NCT00809783|79426578|FG000|Overall Study|Death|1|||
44418598|NCT00809783|79426579|FG001|Overall Study|Death|0|||
44418599|NCT00809783|79426580|FG002|Overall Study|Death|0|||
44534643|NCT02431702|79545224|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
44534644|NCT02431702|79545225|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
44306877|NCT03259074|79307794|FG000|Overall Study|Lost to Follow-up|2|||
44418600|NCT00809783|79426578|FG000|Overall Study|Adverse Event|34|||
44418601|NCT00809783|79426579|FG001|Overall Study|Adverse Event|52|||
44534645|NCT02431702|79545226|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
44306878|NCT03259074|79307795|FG001|Overall Study|Lost to Follow-up|4|||
44306879|NCT03259074|79307796|FG002|Overall Study|Lost to Follow-up|3|||
44306880|NCT03259074|79307794|FG000|Overall Study|New Therapy For Study Indication|1|||
44306881|NCT03259074|79307795|FG001|Overall Study|New Therapy For Study Indication|2|||
44306882|NCT03259074|79307796|FG002|Overall Study|New Therapy For Study Indication|2|||
44306883|NCT03259074|79307794|FG000|Overall Study|Physician Decision|4|||
44306884|NCT03259074|79307795|FG001|Overall Study|Physician Decision|12|||
44306885|NCT03259074|79307796|FG002|Overall Study|Physician Decision|10|||
44306886|NCT03259074|79307794|FG000|Overall Study|Pregnancy|1|||
44306887|NCT03259074|79307795|FG001|Overall Study|Pregnancy|1|||
44306888|NCT03259074|79307796|FG002|Overall Study|Pregnancy|0|||
44306889|NCT03259074|79307794|FG000|Overall Study|Progressive Disease|1|||
44306890|NCT03259074|79307795|FG001|Overall Study|Progressive Disease|0|||
44306891|NCT03259074|79307796|FG002|Overall Study|Progressive Disease|0|||
44306892|NCT03259074|79307794|FG000|Overall Study|Protocol Deviation|1|||
44306893|NCT03259074|79307795|FG001|Overall Study|Protocol Deviation|1|||
44306894|NCT03259074|79307796|FG002|Overall Study|Protocol Deviation|3|||
44306895|NCT03259074|79307794|FG000|Overall Study|Subject/Guardian Decision|13|||
44306896|NCT03259074|79307795|FG001|Overall Study|Subject/Guardian Decision|16|||
44306897|NCT03259074|79307796|FG002|Overall Study|Subject/Guardian Decision|14|||
44306898|NCT03159104|79307806|FG000|Overall Study|Violation of inclusion criteria|1|||
44306899|NCT03159104|79307807|FG001|Overall Study|Violation of inclusion criteria|2|||
44306900|NCT03149237|79307815|FG000|Overall Study|Withdrawal by Subject|4|||
44306901|NCT03149237|79307816|FG001|Overall Study|Withdrawal by Subject|5|||
44306902|NCT03132467|79307822|FG000|Overall Study|Adverse Event|2|||
44306903|NCT03132467|79307822|FG000|Overall Study|Withdrawal by Subject|2|||
44306904|NCT03127852|79307829|FG000|Overall Study|Withdrawal by Subject|4|||
44306905|NCT03127852|79307830|FG001|Overall Study|Withdrawal by Subject|1|||
44306906|NCT03127852|79307829|FG000|Overall Study|Death|1|||
44306907|NCT03127852|79307830|FG001|Overall Study|Death|1|||
44306908|NCT03107793|79307836|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
44306909|NCT03107793|79307837|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
44306910|NCT03107793|79307838|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
44306911|NCT03107793|79307839|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
44306912|NCT03107793|79307840|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
44306913|NCT03107793|79307836|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
44306914|NCT03107793|79307837|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
44306915|NCT03107793|79307838|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
44306916|NCT03107793|79307839|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
44306917|NCT03107793|79307840|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
44306918|NCT03107793|79307836|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
44306919|NCT03107793|79307837|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
44306920|NCT03107793|79307838|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
44306921|NCT03107793|79307839|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
44306922|NCT03107793|79307840|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
44306923|NCT03107793|79307836|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
44306924|NCT03107793|79307837|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44306925|NCT03107793|79307838|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44306926|NCT03107793|79307839|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44306927|NCT03107793|79307840|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
44306928|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
44306929|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
44306930|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
44306931|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
44306932|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
44306933|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
44306934|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
44306935|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
44306936|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
44306937|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
44306938|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
44306939|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
44306940|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
44306941|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
44306942|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
44257093|NCT02576717|79109452|FG002|Overall Study|Death|3|||
44257094|NCT02576717|79109450|FG000|Overall Study|Lost to Follow-up|9|||
44257095|NCT02576717|79109451|FG001|Overall Study|Lost to Follow-up|10|||
44257096|NCT02576717|79109452|FG002|Overall Study|Lost to Follow-up|19|||
44257097|NCT02576717|79109450|FG000|Overall Study|Protocol Violation|4|||
44257098|NCT02576717|79109451|FG001|Overall Study|Protocol Violation|0|||
44257099|NCT02576717|79109452|FG002|Overall Study|Protocol Violation|5|||
44257100|NCT02576717|79109450|FG000|Overall Study|Lack of Efficacy|24|||
44257101|NCT02576717|79109451|FG001|Overall Study|Lack of Efficacy|28|||
44257102|NCT02576717|79109452|FG002|Overall Study|Lack of Efficacy|20|||
44257103|NCT02576717|79109450|FG000|Overall Study|Adverse Event|26|||
44257104|NCT02576717|79109451|FG001|Overall Study|Adverse Event|32|||
44257105|NCT02576717|79109452|FG002|Overall Study|Adverse Event|26|||
44306943|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
44306944|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
44306945|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
44306946|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
44306947|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
44306948|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
44306949|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
44306950|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
44306951|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
44306952|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
44306953|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
44306954|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
44306955|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
44306956|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
44306957|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
44306958|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
44306959|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
44306960|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
44306961|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
44306962|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
44306963|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
44306964|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
44306965|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
44306966|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
44306967|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
44306968|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
44306969|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
44306970|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
44306971|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
44306972|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
44534646|NCT02431702|79545227|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
44534647|NCT02431702|79545228|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
44534648|NCT02431702|79545229|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
44534649|NCT02431702|79545223|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
44534650|NCT02431702|79545224|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
44534651|NCT02431702|79545225|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
44534652|NCT02431702|79545226|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
44534653|NCT02431702|79545227|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
44534654|NCT02431702|79545228|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
44306973|NCT03107793|79307836|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
44306974|NCT03107793|79307837|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
44306975|NCT03107793|79307838|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
44306976|NCT03107793|79307839|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
44306977|NCT03107793|79307840|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
44306978|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
44306979|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
44306980|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
44306981|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
44306982|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
44306983|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
44306984|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
44306985|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
44418602|NCT00809783|79426580|FG002|Overall Study|Adverse Event|71|||
44534655|NCT02431702|79545229|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
44155201|NCT02642159|78946877|FG000|Overall Study|Other than specified above|10|||
44257106|NCT02554474|79109465|FG000|Overall Study|Protocol Violation|1|||
44257107|NCT02554474|79109466|FG001|Overall Study|Protocol Violation|1|||
44257108|NCT02554474|79109465|FG000|Overall Study|Health issue not related to the study|1|||
44257109|NCT02554474|79109466|FG001|Overall Study|Health issue not related to the study|0|||
44257110|NCT02554474|79109465|FG000|Overall Study|Withdrawal by Subject|1|||
44257111|NCT02554474|79109466|FG001|Overall Study|Withdrawal by Subject|1|||
44257112|NCT02517307|79109495|FG000|Overall Study|Withdrawal by Subject|1|||
44257113|NCT02517307|79109496|FG001|Overall Study|Withdrawal by Subject|0|||
44257114|NCT02517307|79109497|FG002|Overall Study|Withdrawal by Subject|1|||
44257115|NCT02517307|79109498|FG003|Overall Study|Withdrawal by Subject|0|||
44257116|NCT02517307|79109495|FG000|Overall Study|Protocol Violation|0|||
44257117|NCT02517307|79109496|FG001|Overall Study|Protocol Violation|0|||
44306986|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
44306987|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
44306988|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
44306989|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
44306990|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
44306991|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
44306992|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
44306993|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Death|0|||
44306994|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Death|0|||
44306995|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Death|0|||
44306996|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Death|0|||
44306997|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Death|1|||
44306998|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
44306999|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
44307000|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
44307001|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
44307002|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
44307003|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
44307004|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
44307005|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
44307006|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
44307007|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
44307008|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
44307009|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
44307010|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
44307011|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
44307012|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
44307013|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
44307014|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
44307015|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
44307016|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
44307017|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
44307018|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
44307019|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
44307020|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
44307021|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
44307022|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
44307023|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Other|0|||
44307024|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Other|0|||
44307025|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Other|0|||
44307026|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Other|1|||
44307027|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Other|3|||
44307028|NCT03107793|79307836|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
44307029|NCT03107793|79307837|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
44307030|NCT03107793|79307838|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
44307031|NCT03107793|79307839|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
44307032|NCT03107793|79307840|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
44307033|NCT03013543|79307859|FG000|Overall Study|Withdrawal by Subject|0|||
44307034|NCT03013543|79307860|FG001|Overall Study|Withdrawal by Subject|2|||
44307035|NCT03013543|79307861|FG002|Overall Study|Withdrawal by Subject|0|||
44418603|NCT00809783|79426578|FG000|Overall Study|Lack of Efficacy|39|||
44418604|NCT00809783|79426579|FG001|Overall Study|Lack of Efficacy|52|||
44418605|NCT00809783|79426580|FG002|Overall Study|Lack of Efficacy|63|||
44257118|NCT02517307|79109497|FG002|Overall Study|Protocol Violation|1|||
44257119|NCT02517307|79109498|FG003|Overall Study|Protocol Violation|1|||
44257120|NCT02499354|79109510|FG000|Overall Study|Withdrawal by Subject|1|||
44257121|NCT02499354|79109511|FG001|Overall Study|Withdrawal by Subject|0|||
44257122|NCT02362503|79109533|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
44257123|NCT02362503|79109534|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
44257124|NCT02362503|79109535|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
44257125|NCT02362503|79109533|FG000|Double-blind Period-Up to 8 Days|Death|1|||
44257126|NCT02362503|79109534|FG001|Double-blind Period-Up to 8 Days|Death|0|||
44257127|NCT02362503|79109535|FG002|Double-blind Period-Up to 8 Days|Death|0|||
44257128|NCT02362503|79109533|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
44257129|NCT02362503|79109534|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
44257130|NCT02362503|79109535|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
44307036|NCT03013543|79307862|FG003|Overall Study|Withdrawal by Subject|5|||
44307037|NCT03013543|79307863|FG004|Overall Study|Withdrawal by Subject|6|||
44307038|NCT03013543|79307864|FG005|Overall Study|Withdrawal by Subject|2|||
44307039|NCT03013543|79307865|FG006|Overall Study|Withdrawal by Subject|3|||
44307040|NCT03013543|79307866|FG007|Overall Study|Withdrawal by Subject|1|||
44307041|NCT03013543|79307867|FG008|Overall Study|Withdrawal by Subject|0|||
44307042|NCT03013543|79307868|FG009|Overall Study|Withdrawal by Subject|4|||
44307043|NCT03013543|79307859|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
44307044|NCT03013543|79307860|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
44307045|NCT03013543|79307861|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
44307046|NCT03013543|79307862|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
44307047|NCT03013543|79307863|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
44307048|NCT03013543|79307864|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
44307049|NCT03013543|79307865|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
44307050|NCT03013543|79307866|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
44307051|NCT03013543|79307867|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
44307052|NCT03013543|79307868|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
44307053|NCT03013543|79307859|FG000|Overall Study|Other|0|||
44307054|NCT03013543|79307860|FG001|Overall Study|Other|0|||
44307055|NCT03013543|79307861|FG002|Overall Study|Other|2|||
44307056|NCT03013543|79307862|FG003|Overall Study|Other|0|||
44307057|NCT03013543|79307863|FG004|Overall Study|Other|2|||
44307058|NCT03013543|79307864|FG005|Overall Study|Other|0|||
44307059|NCT03013543|79307865|FG006|Overall Study|Other|0|||
44307060|NCT03013543|79307866|FG007|Overall Study|Other|0|||
44307061|NCT03013543|79307867|FG008|Overall Study|Other|1|||
44307062|NCT03013543|79307868|FG009|Overall Study|Other|0|||
44307063|NCT03013543|79307859|FG000|Overall Study|Adverse Event|0|||
44307064|NCT03013543|79307860|FG001|Overall Study|Adverse Event|0|||
44307065|NCT03013543|79307861|FG002|Overall Study|Adverse Event|0|||
44307066|NCT03013543|79307862|FG003|Overall Study|Adverse Event|3|||
44307067|NCT03013543|79307863|FG004|Overall Study|Adverse Event|2|||
44307068|NCT03013543|79307864|FG005|Overall Study|Adverse Event|1|||
44307069|NCT03013543|79307865|FG006|Overall Study|Adverse Event|3|||
44307070|NCT03013543|79307866|FG007|Overall Study|Adverse Event|8|||
44307071|NCT03013543|79307867|FG008|Overall Study|Adverse Event|0|||
44307072|NCT03013543|79307868|FG009|Overall Study|Adverse Event|2|||
44307073|NCT03013543|79307859|FG000|Overall Study|Death|0|||
44307074|NCT03013543|79307860|FG001|Overall Study|Death|0|||
44307075|NCT03013543|79307861|FG002|Overall Study|Death|0|||
44307076|NCT03013543|79307862|FG003|Overall Study|Death|1|||
44307077|NCT03013543|79307863|FG004|Overall Study|Death|0|||
44307078|NCT03013543|79307864|FG005|Overall Study|Death|0|||
44307079|NCT03013543|79307865|FG006|Overall Study|Death|0|||
44307080|NCT03013543|79307866|FG007|Overall Study|Death|0|||
44307081|NCT03013543|79307867|FG008|Overall Study|Death|0|||
44307082|NCT03013543|79307868|FG009|Overall Study|Death|0|||
44307083|NCT03013543|79307859|FG000|Overall Study|Lack of Efficacy|0|||
44307084|NCT03013543|79307860|FG001|Overall Study|Lack of Efficacy|0|||
44307085|NCT03013543|79307861|FG002|Overall Study|Lack of Efficacy|0|||
44307086|NCT03013543|79307862|FG003|Overall Study|Lack of Efficacy|1|||
44307087|NCT03013543|79307863|FG004|Overall Study|Lack of Efficacy|0|||
44307088|NCT03013543|79307864|FG005|Overall Study|Lack of Efficacy|0|||
44307089|NCT03013543|79307865|FG006|Overall Study|Lack of Efficacy|0|||
44307090|NCT03013543|79307866|FG007|Overall Study|Lack of Efficacy|0|||
44307091|NCT03013543|79307867|FG008|Overall Study|Lack of Efficacy|0|||
44307092|NCT03013543|79307868|FG009|Overall Study|Lack of Efficacy|0|||
44307093|NCT03013543|79307859|FG000|Overall Study|Lost to Follow-up|0|||
44307094|NCT03013543|79307860|FG001|Overall Study|Lost to Follow-up|0|||
44307095|NCT03013543|79307861|FG002|Overall Study|Lost to Follow-up|0|||
44534656|NCT02086552|79545245|FG000|Overall Study|Withdrawal by Subject|1|||
44534657|NCT03131570|79545290|FG000|Overall Study|Adverse Event|1|||
44534658|NCT03131570|79545291|FG001|Overall Study|Adverse Event|0|||
44534659|NCT02930018|79545301|FG000|Overall Study|Lost to Follow-up|1|||
44534660|NCT02930018|79545302|FG001|Overall Study|Lost to Follow-up|1|||
44534661|NCT02930018|79545301|FG000|Overall Study|Withdrawal by Subject|5|||
44257131|NCT02362503|79109533|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
44257132|NCT02362503|79109534|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
44257133|NCT02362503|79109535|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
44257134|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
44257135|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
44257136|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
44257137|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
44257138|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
44257139|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
44257140|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
44257141|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
44307096|NCT03013543|79307862|FG003|Overall Study|Lost to Follow-up|1|||
44307097|NCT03013543|79307863|FG004|Overall Study|Lost to Follow-up|0|||
44307098|NCT03013543|79307864|FG005|Overall Study|Lost to Follow-up|0|||
44307099|NCT03013543|79307865|FG006|Overall Study|Lost to Follow-up|1|||
44307100|NCT03013543|79307866|FG007|Overall Study|Lost to Follow-up|0|||
44307101|NCT03013543|79307867|FG008|Overall Study|Lost to Follow-up|0|||
44307102|NCT03013543|79307868|FG009|Overall Study|Lost to Follow-up|2|||
44307103|NCT03013543|79307859|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44307104|NCT03013543|79307860|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44307105|NCT03013543|79307861|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44257142|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
44257143|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
44257144|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
44257145|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
44307106|NCT03013543|79307862|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44307107|NCT03013543|79307863|FG004|Overall Study|Non-Compliance With Study Drug|0|||
44307108|NCT03013543|79307864|FG005|Overall Study|Non-Compliance With Study Drug|0|||
44307109|NCT03013543|79307865|FG006|Overall Study|Non-Compliance With Study Drug|0|||
44307110|NCT03013543|79307866|FG007|Overall Study|Non-Compliance With Study Drug|0|||
44307111|NCT03013543|79307867|FG008|Overall Study|Non-Compliance With Study Drug|1|||
44307112|NCT03013543|79307868|FG009|Overall Study|Non-Compliance With Study Drug|0|||
44307113|NCT03013543|79307859|FG000|Overall Study|Physician Decision|0|||
44307114|NCT03013543|79307860|FG001|Overall Study|Physician Decision|0|||
44307115|NCT03013543|79307861|FG002|Overall Study|Physician Decision|0|||
44307116|NCT03013543|79307862|FG003|Overall Study|Physician Decision|0|||
44307117|NCT03013543|79307863|FG004|Overall Study|Physician Decision|1|||
44307118|NCT03013543|79307864|FG005|Overall Study|Physician Decision|0|||
44307119|NCT03013543|79307865|FG006|Overall Study|Physician Decision|0|||
44307120|NCT03013543|79307866|FG007|Overall Study|Physician Decision|0|||
44307121|NCT03013543|79307867|FG008|Overall Study|Physician Decision|0|||
44307122|NCT03013543|79307868|FG009|Overall Study|Physician Decision|0|||
44307123|NCT03013543|79307859|FG000|Overall Study|Protocol Violation|0|||
44307124|NCT03013543|79307860|FG001|Overall Study|Protocol Violation|0|||
44307125|NCT03013543|79307861|FG002|Overall Study|Protocol Violation|0|||
44307126|NCT03013543|79307862|FG003|Overall Study|Protocol Violation|0|||
44307127|NCT03013543|79307863|FG004|Overall Study|Protocol Violation|0|||
44307128|NCT03013543|79307864|FG005|Overall Study|Protocol Violation|0|||
44307129|NCT03013543|79307865|FG006|Overall Study|Protocol Violation|0|||
44307130|NCT03013543|79307866|FG007|Overall Study|Protocol Violation|0|||
44307131|NCT03013543|79307867|FG008|Overall Study|Protocol Violation|0|||
44307132|NCT03013543|79307868|FG009|Overall Study|Protocol Violation|1|||
44307133|NCT02811549|79307894|FG000|Overall Study|Lost to Follow-up|1|||
44307134|NCT02811549|79307894|FG000|Overall Study|Withdrawal by Subject|3|||
44307135|NCT02811549|79307894|FG000|Overall Study|Subject screen failed|4|||
44307136|NCT02811549|79307894|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
44307137|NCT02426125|79307922|FG000|Overall Study|Lost to Follow-up|14|||
44307138|NCT02426125|79307923|FG001|Overall Study|Lost to Follow-up|12|||
44307139|NCT02426125|79307922|FG000|Overall Study|Withdrawal by Subject|13|||
44307140|NCT02426125|79307923|FG001|Overall Study|Withdrawal by Subject|14|||
44307141|NCT02426125|79307922|FG000|Overall Study|Death|185|||
44307142|NCT02426125|79307923|FG001|Overall Study|Death|200|||
44307143|NCT02426125|79307922|FG000|Overall Study|Randomized, But Never Treated|5|||
44307144|NCT02426125|79307923|FG001|Overall Study|Randomized, But Never Treated|2|||
44307145|NCT02331277|79307942|FG000|Overall Study|Withdrawal by Subject|1|||
44155202|NCT02642159|78946878|FG001|Overall Study|Other than specified above|3|||
44155203|NCT02669017|78946894|FG000|Overall Study|Death|1|||
44155204|NCT02669017|78946895|FG001|Overall Study|Death|2|||
44155205|NCT02669017|78946896|FG002|Overall Study|Death|2|||
44257146|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
44257147|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
44257148|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
44257149|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
44257150|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
44257151|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
44257152|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
44257153|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
44257154|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
44307146|NCT02331277|79307943|FG001|Overall Study|Withdrawal by Subject|0|||
44307147|NCT02120365|79307961|FG000|Overall Study|Withdrawal by Subject|0|||
44307148|NCT02120365|79307962|FG001|Overall Study|Withdrawal by Subject|0|||
44155206|NCT02669017|78946897|FG003|Overall Study|Death|3|||
44307149|NCT02120365|79307963|FG002|Overall Study|Withdrawal by Subject|2|||
44307150|NCT02120365|79307964|FG003|Overall Study|Withdrawal by Subject|4|||
44307151|NCT02120365|79307965|FG004|Overall Study|Withdrawal by Subject|0|||
44155207|NCT02669017|78946898|FG004|Overall Study|Death|8|||
44307152|NCT02120365|79307966|FG005|Overall Study|Withdrawal by Subject|2|||
44307177|NCT00938340|79308062|FG000|Overall Study|Withdrawal by Subject|3|||
44307178|NCT00938340|79308062|FG000|Overall Study|Protocol Violation|1|||
44307179|NCT00938340|79308062|FG000|Overall Study|Adverse Event|1|||
44307180|NCT00539643|79308119|FG000|Overall Study|Adverse Event|1|||
44307181|NCT00539643|79308120|FG001|Overall Study|Adverse Event|0|||
44307182|NCT00539643|79308119|FG000|Overall Study|Death|2|||
44307183|NCT00539643|79308120|FG001|Overall Study|Death|1|||
44307184|NCT00539643|79308119|FG000|Overall Study|Physician Decision|3|||
44307185|NCT00539643|79308120|FG001|Overall Study|Physician Decision|1|||
44307186|NCT00539643|79308119|FG000|Overall Study|Withdrawal by Subject|0|||
44307187|NCT00539643|79308120|FG001|Overall Study|Withdrawal by Subject|1|||
44307188|NCT00039130|79308135|FG000|Overall Study|Adverse Event|11|||
44307189|NCT00039130|79308135|FG000|Overall Study|Death|9|||
44307190|NCT00039130|79308135|FG000|Overall Study|Withdrawal by Subject|3|||
44307191|NCT00039130|79308135|FG000|Overall Study|Progression|2|||
44307192|NCT00039130|79308135|FG000|Overall Study|Subsequent treatment|2|||
44307193|NCT00039130|79308135|FG000|Overall Study|Physician Decision|3|||
44307194|NCT00005957|79308141|FG000|Overall Study|No treated|3|||
44307195|NCT00005957|79308142|FG001|Overall Study|No treated|9|||
44307196|NCT00005957|79308141|FG000|Overall Study|Crossover to the other arm|5|||
44307197|NCT00005957|79308142|FG001|Overall Study|Crossover to the other arm|19|||
44307198|NCT04920916|79308228|FG000|Phase IIa 60 Day Study|Death|2|||
44307199|NCT04920916|79308229|FG001|Phase IIa 60 Day Study|Death|5|||
44307200|NCT04920916|79308228|FG000|1 Year Follow up (Phone Call)|Death|1|||
44307201|NCT04920916|79308229|FG001|1 Year Follow up (Phone Call)|Death|3|||
44307202|NCT04920916|79308228|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
44307203|NCT04920916|79308229|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
44307204|NCT04419493|79308242|FG000|Wash-out After Period 1|Adverse Event|1|||
44307205|NCT04419493|79308243|FG001|Wash-out After Period 1|Adverse Event|2|||
44307206|NCT04419493|79308244|FG002|Wash-out After Period 1|Adverse Event|1|||
44307207|NCT04419493|79308245|FG003|Wash-out After Period 1|Adverse Event|0|||
44307208|NCT04147611|79308273|FG000|Overall Study|Physician Decision|0|||
44307209|NCT04147611|79308274|FG001|Overall Study|Physician Decision|1|||
44307210|NCT03603964|79308305|FG000|Overall Study|Death|9|||
44307211|NCT03603964|79308305|FG000|Overall Study|Withdrawal by participant|7|||
44307212|NCT03603964|79308305|FG000|Overall Study|Study terminated by Sponsor|19|||
44307213|NCT03363919|79308322|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
44534662|NCT02930018|79545302|FG001|Overall Study|Withdrawal by Subject|2|||
44307214|NCT03363919|79308323|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
44307215|NCT03363919|79308322|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
44307216|NCT03363919|79308323|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
44307217|NCT03191864|79308334|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
44534663|NCT02875028|79545310|FG000|Washout Period|Withdrawal by Subject|0|||
44307218|NCT03191864|79308335|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
44307219|NCT03191864|79308336|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
44307220|NCT03191864|79308337|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
44307221|NCT03191864|79308338|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
44307222|NCT03191864|79308339|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
44307223|NCT03191864|79308334|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
44307224|NCT03191864|79308335|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
44307225|NCT03191864|79308336|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
44307226|NCT03191864|79308337|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
44307227|NCT03191864|79308338|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
44307228|NCT03191864|79308339|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
44307229|NCT03191864|79308334|FG000|Baseline Symptom Assessment|Adverse Event|0|||
44307230|NCT03191864|79308335|FG001|Baseline Symptom Assessment|Adverse Event|0|||
44307231|NCT03191864|79308336|FG002|Baseline Symptom Assessment|Adverse Event|0|||
44307232|NCT03191864|79308337|FG003|Baseline Symptom Assessment|Adverse Event|0|||
44307233|NCT03191864|79308338|FG004|Baseline Symptom Assessment|Adverse Event|0|||
44307234|NCT03191864|79308339|FG005|Baseline Symptom Assessment|Adverse Event|2|||
44307235|NCT03191864|79308334|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
44307236|NCT03191864|79308335|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
44307237|NCT03191864|79308336|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
44307238|NCT03191864|79308337|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
44307239|NCT03191864|79308338|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
44307240|NCT03191864|79308339|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
44307241|NCT03191864|79308334|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
44307242|NCT03191864|79308335|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
44307243|NCT03191864|79308336|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
44307244|NCT03191864|79308337|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
44307245|NCT03191864|79308338|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
44307246|NCT03191864|79308339|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
44307247|NCT03191864|79308334|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
44307248|NCT03191864|79308335|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
44307249|NCT03191864|79308336|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
44307250|NCT03191864|79308337|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
44307251|NCT03191864|79308338|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
44307252|NCT03191864|79308339|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
44307253|NCT03191864|79308334|FG000|Part 1 - Induction|Adverse Event|0|||
44307254|NCT03191864|79308335|FG001|Part 1 - Induction|Adverse Event|2|||
44307255|NCT03191864|79308336|FG002|Part 1 - Induction|Adverse Event|0|||
44307256|NCT03191864|79308337|FG003|Part 1 - Induction|Adverse Event|1|||
44307257|NCT03191864|79308338|FG004|Part 1 - Induction|Adverse Event|0|||
44307258|NCT03191864|79308339|FG005|Part 1 - Induction|Adverse Event|2|||
44307259|NCT03191864|79308334|FG000|Part 1 - Induction|Randomized but never dosed|0|||
44307260|NCT03191864|79308335|FG001|Part 1 - Induction|Randomized but never dosed|0|||
44307261|NCT03191864|79308336|FG002|Part 1 - Induction|Randomized but never dosed|1|||
44307262|NCT03191864|79308337|FG003|Part 1 - Induction|Randomized but never dosed|0|||
44307263|NCT03191864|79308338|FG004|Part 1 - Induction|Randomized but never dosed|0|||
44307264|NCT03191864|79308339|FG005|Part 1 - Induction|Randomized but never dosed|0|||
44307265|NCT03191864|79308334|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
44307266|NCT03191864|79308335|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
44307267|NCT03191864|79308336|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
44307268|NCT03191864|79308337|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
44307269|NCT03191864|79308338|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
44307270|NCT03191864|79308339|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
44307271|NCT03191864|79308334|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
44307272|NCT03191864|79308335|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
44307273|NCT03191864|79308336|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
44307274|NCT03191864|79308337|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
44307275|NCT03191864|79308338|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
44307276|NCT03191864|79308339|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
44307277|NCT03191864|79308334|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
44307278|NCT03191864|79308335|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
44418606|NCT00809783|79426578|FG000|Overall Study|Lost to Follow-up|0|||
44534664|NCT02875028|79545311|FG001|Washout Period|Withdrawal by Subject|1|||
44534665|NCT00943618|79545322|FG000|Overall Study|Lost to Follow-up|38|||
44534666|NCT00943618|79545323|FG001|Overall Study|Lost to Follow-up|48|||
44534667|NCT00943618|79545324|FG002|Overall Study|Lost to Follow-up|20|||
44257155|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
44257156|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
44257157|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
44257158|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
44257159|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
44257160|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
44257161|NCT02362503|79109533|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
44257162|NCT02362503|79109534|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
44307279|NCT03191864|79308336|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
44307280|NCT03191864|79308337|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
44307281|NCT03191864|79308338|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
44307282|NCT03191864|79308339|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
44307283|NCT03191864|79308334|FG000|Part 2 - Maintenance|Physician Decision|1|||
44307284|NCT03191864|79308335|FG001|Part 2 - Maintenance|Physician Decision|0|||
44307285|NCT03191864|79308336|FG002|Part 2 - Maintenance|Physician Decision|0|||
44307286|NCT03191864|79308337|FG003|Part 2 - Maintenance|Physician Decision|0|||
44307287|NCT03191864|79308338|FG004|Part 2 - Maintenance|Physician Decision|0|||
44307288|NCT03191864|79308339|FG005|Part 2 - Maintenance|Physician Decision|0|||
44307289|NCT03191864|79308334|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
44307290|NCT03191864|79308335|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
44307291|NCT03191864|79308336|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
44307292|NCT03191864|79308337|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
44307293|NCT03191864|79308338|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
44307294|NCT03191864|79308339|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
44307295|NCT03191864|79308334|FG000|Part 2 - Maintenance|Adverse Event|0|||
44307296|NCT03191864|79308335|FG001|Part 2 - Maintenance|Adverse Event|0|||
44307297|NCT03191864|79308336|FG002|Part 2 - Maintenance|Adverse Event|0|||
44307298|NCT03191864|79308337|FG003|Part 2 - Maintenance|Adverse Event|0|||
44307299|NCT03191864|79308338|FG004|Part 2 - Maintenance|Adverse Event|1|||
44307300|NCT03191864|79308339|FG005|Part 2 - Maintenance|Adverse Event|0|||
44307301|NCT03191864|79308334|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
44307302|NCT03191864|79308335|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
44307303|NCT03191864|79308336|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
44307304|NCT03191864|79308337|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
44307305|NCT03191864|79308338|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
44307306|NCT03191864|79308339|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
44307307|NCT03191864|79308334|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
44307308|NCT03191864|79308335|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
44307309|NCT03191864|79308336|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
44307310|NCT03191864|79308337|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
44307311|NCT03191864|79308338|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
44307312|NCT03191864|79308339|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
44307313|NCT02636725|79308403|FG000|Baseline|Adverse Event|1|||
44307314|NCT02636725|79308403|FG000|Baseline|Lack of Efficacy|2|||
44307315|NCT02573493|79308411|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
44307316|NCT02573493|79308412|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
44307317|NCT02573493|79308413|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
44307318|NCT02573493|79308414|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
44307319|NCT02327078|79308447|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
44307320|NCT02327078|79308448|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
44307321|NCT02327078|79308449|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
44307322|NCT02327078|79308450|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
44307323|NCT02327078|79308451|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
44307324|NCT02327078|79308452|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
44307325|NCT02327078|79308453|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
44307326|NCT02327078|79308454|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
44307327|NCT02327078|79308455|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
44307328|NCT02327078|79308447|FG000|Overall Study|Death|2|||
44307329|NCT02327078|79308448|FG001|Overall Study|Death|4|||
44307330|NCT02327078|79308449|FG002|Overall Study|Death|10|||
44307331|NCT02327078|79308450|FG003|Overall Study|Death|6|||
44155208|NCT02669017|78946899|FG005|Overall Study|Death|18|||
44155209|NCT02669017|78946900|FG006|Overall Study|Death|10|||
44307332|NCT02327078|79308451|FG004|Overall Study|Death|4|||
44307333|NCT02327078|79308452|FG005|Overall Study|Death|3|||
44307334|NCT02327078|79308453|FG006|Overall Study|Death|2|||
44534668|NCT00943618|79545322|FG000|Overall Study|Discontinued Medication|17|||
44534669|NCT00943618|79545323|FG001|Overall Study|Discontinued Medication|29|||
44534670|NCT00943618|79545324|FG002|Overall Study|Discontinued Medication|11|||
44534671|NCT02710084|79545334|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
44534672|NCT02710084|79545335|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
44307335|NCT02327078|79308454|FG007|Overall Study|Death|51|||
44307336|NCT02327078|79308455|FG008|Overall Study|Death|97|||
44534673|NCT02849990|79545342|FG000|Overall Study|Adverse Event|1|||
44534674|NCT02849990|79545342|FG000|Overall Study|Withdrawal by Subject|1|||
44534675|NCT02017964|79545346|FG000|Overall Study|Patient deemed ineligible|1|||
44155210|NCT02669017|78946901|FG007|Overall Study|Death|47|||
44534676|NCT01956110|79545352|FG000|Overall Study|Protocol Violation|25|||
44534677|NCT01956110|79545353|FG001|Overall Study|Protocol Violation|11|||
44534678|NCT01956110|79545352|FG000|Overall Study|Adverse Event|9|||
44534679|NCT01956110|79545353|FG001|Overall Study|Adverse Event|10|||
44534680|NCT01956110|79545352|FG000|Overall Study|Personal reasons|1|||
44534681|NCT01956110|79545353|FG001|Overall Study|Personal reasons|1|||
44534682|NCT03116828|79545384|FG000|Overall Study|Adverse Event|1|||
44534683|NCT03116828|79545385|FG001|Overall Study|Adverse Event|10|||
44155211|NCT02669017|78946902|FG008|Overall Study|Death|20|||
44307337|NCT02327078|79308447|FG000|Overall Study|Lost to Follow-up|0|||
44307338|NCT02327078|79308448|FG001|Overall Study|Lost to Follow-up|1|||
44307339|NCT02327078|79308449|FG002|Overall Study|Lost to Follow-up|1|||
44155212|NCT02669017|78946894|FG000|Overall Study|Withdrawal by Subject|0|||
44155213|NCT02669017|78946895|FG001|Overall Study|Withdrawal by Subject|0|||
44155214|NCT02669017|78946896|FG002|Overall Study|Withdrawal by Subject|0|||
44155215|NCT02669017|78946897|FG003|Overall Study|Withdrawal by Subject|1|||
44307340|NCT02327078|79308450|FG003|Overall Study|Lost to Follow-up|0|||
44307341|NCT02327078|79308451|FG004|Overall Study|Lost to Follow-up|0|||
44307342|NCT02327078|79308452|FG005|Overall Study|Lost to Follow-up|0|||
44307343|NCT02327078|79308453|FG006|Overall Study|Lost to Follow-up|0|||
44307344|NCT02327078|79308454|FG007|Overall Study|Lost to Follow-up|2|||
44307345|NCT02327078|79308455|FG008|Overall Study|Lost to Follow-up|5|||
44307346|NCT02327078|79308447|FG000|Overall Study|Site Terminated by Sponsor|1|||
44307347|NCT02327078|79308448|FG001|Overall Study|Site Terminated by Sponsor|0|||
44307348|NCT02327078|79308449|FG002|Overall Study|Site Terminated by Sponsor|1|||
44307349|NCT02327078|79308450|FG003|Overall Study|Site Terminated by Sponsor|4|||
44307350|NCT02327078|79308451|FG004|Overall Study|Site Terminated by Sponsor|0|||
44307351|NCT02327078|79308452|FG005|Overall Study|Site Terminated by Sponsor|0|||
44307352|NCT02327078|79308453|FG006|Overall Study|Site Terminated by Sponsor|0|||
44307353|NCT02327078|79308454|FG007|Overall Study|Site Terminated by Sponsor|11|||
44307354|NCT02327078|79308455|FG008|Overall Study|Site Terminated by Sponsor|25|||
44307355|NCT02327078|79308447|FG000|Overall Study|Physician Decision|0|||
44307356|NCT02327078|79308448|FG001|Overall Study|Physician Decision|0|||
44307357|NCT02327078|79308449|FG002|Overall Study|Physician Decision|0|||
44534684|NCT03116828|79545384|FG000|Overall Study|Withdrawal by Subject|4|||
44155216|NCT02669017|78946898|FG004|Overall Study|Withdrawal by Subject|2|||
44155217|NCT02669017|78946899|FG005|Overall Study|Withdrawal by Subject|0|||
44155218|NCT02669017|78946900|FG006|Overall Study|Withdrawal by Subject|0|||
44155219|NCT02669017|78946901|FG007|Overall Study|Withdrawal by Subject|2|||
44155220|NCT02669017|78946902|FG008|Overall Study|Withdrawal by Subject|2|||
44155221|NCT02669017|78946894|FG000|Overall Study|Lost to Follow-up|0|||
44257163|NCT02362503|79109535|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
44257164|NCT02224924|79109548|FG000|Overall Study|Withdrawal by Subject|7|||
44257165|NCT02224924|79109549|FG001|Overall Study|Withdrawal by Subject|6|||
44257166|NCT02224924|79109548|FG000|Overall Study|Biopsy cancelled|20|||
44257167|NCT02224924|79109549|FG001|Overall Study|Biopsy cancelled|14|||
44257168|NCT02224924|79109548|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
44257169|NCT02224924|79109549|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
44257170|NCT02224924|79109548|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
44257171|NCT02224924|79109549|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
44257172|NCT02152956|79109568|FG000|Overall Study|Adverse Event|0|||
44257173|NCT02152956|79109569|FG001|Overall Study|Adverse Event|0|||
44257174|NCT02152956|79109570|FG002|Overall Study|Adverse Event|0|||
44257175|NCT02152956|79109571|FG003|Overall Study|Adverse Event|0|||
44257176|NCT02152956|79109572|FG004|Overall Study|Adverse Event|0|||
44257177|NCT02152956|79109573|FG005|Overall Study|Adverse Event|0|||
44257178|NCT02152956|79109574|FG006|Overall Study|Adverse Event|0|||
44257179|NCT02152956|79109575|FG007|Overall Study|Adverse Event|0|||
44257180|NCT02152956|79109576|FG008|Overall Study|Adverse Event|0|||
44257181|NCT02152956|79109577|FG009|Overall Study|Adverse Event|0|||
44257182|NCT02152956|79109578|FG010|Overall Study|Adverse Event|0|||
44257183|NCT02152956|79109579|FG011|Overall Study|Adverse Event|4|||
44257184|NCT02152956|79109580|FG012|Overall Study|Adverse Event|0|||
44307358|NCT02327078|79308450|FG003|Overall Study|Physician Decision|1|||
44307359|NCT02327078|79308451|FG004|Overall Study|Physician Decision|0|||
44307360|NCT02327078|79308452|FG005|Overall Study|Physician Decision|0|||
44307361|NCT02327078|79308453|FG006|Overall Study|Physician Decision|0|||
44307362|NCT02327078|79308454|FG007|Overall Study|Physician Decision|0|||
44534685|NCT03116828|79545385|FG001|Overall Study|Withdrawal by Subject|8|||
44257185|NCT02152956|79109568|FG000|Overall Study|Death|0|||
44257186|NCT02152956|79109569|FG001|Overall Study|Death|3|||
44307363|NCT02327078|79308455|FG008|Overall Study|Physician Decision|1|||
44307364|NCT02327078|79308447|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
44257187|NCT02152956|79109570|FG002|Overall Study|Death|3|||
44534686|NCT03116828|79545384|FG000|Overall Study|OTHER|3|||
44257188|NCT02152956|79109571|FG003|Overall Study|Death|4|||
44257189|NCT02152956|79109572|FG004|Overall Study|Death|1|||
44257190|NCT02152956|79109573|FG005|Overall Study|Death|2|||
44307365|NCT02327078|79308448|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
44307366|NCT02327078|79308449|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
44307367|NCT02327078|79308450|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
44307368|NCT02327078|79308451|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
44307369|NCT02327078|79308452|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
44307370|NCT02327078|79308453|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
44307371|NCT02327078|79308454|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
44307372|NCT02327078|79308455|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
44307373|NCT02327078|79308447|FG000|Overall Study|Reason not Specified|0|||
44307374|NCT02327078|79308448|FG001|Overall Study|Reason not Specified|0|||
44307375|NCT02327078|79308449|FG002|Overall Study|Reason not Specified|0|||
44307376|NCT02327078|79308450|FG003|Overall Study|Reason not Specified|0|||
44307377|NCT02327078|79308451|FG004|Overall Study|Reason not Specified|0|||
44307378|NCT02327078|79308452|FG005|Overall Study|Reason not Specified|0|||
44307379|NCT02327078|79308453|FG006|Overall Study|Reason not Specified|0|||
44307380|NCT02327078|79308454|FG007|Overall Study|Reason not Specified|5|||
44307381|NCT02327078|79308455|FG008|Overall Study|Reason not Specified|12|||
44307382|NCT02304458|79308498|FG000|Overall Study|Adverse Event|0|||
44307383|NCT02304458|79308499|FG001|Overall Study|Adverse Event|0|||
44307384|NCT02304458|79308500|FG002|Overall Study|Adverse Event|7|||
44307385|NCT02304458|79308501|FG003|Overall Study|Adverse Event|0|||
44307386|NCT02304458|79308502|FG004|Overall Study|Adverse Event|0|||
44307387|NCT02304458|79308503|FG005|Overall Study|Adverse Event|0|||
44307388|NCT02304458|79308504|FG006|Overall Study|Adverse Event|3|||
44307389|NCT02304458|79308505|FG007|Overall Study|Adverse Event|4|||
44307390|NCT02304458|79308498|FG000|Overall Study|Death|0|||
44307391|NCT02304458|79308499|FG001|Overall Study|Death|0|||
44307392|NCT02304458|79308500|FG002|Overall Study|Death|2|||
44307393|NCT02304458|79308501|FG003|Overall Study|Death|0|||
44307394|NCT02304458|79308502|FG004|Overall Study|Death|0|||
44307395|NCT02304458|79308503|FG005|Overall Study|Death|0|||
44307396|NCT02304458|79308504|FG006|Overall Study|Death|1|||
44307397|NCT02304458|79308505|FG007|Overall Study|Death|0|||
44307398|NCT02304458|79308498|FG000|Overall Study|Lack of Efficacy|4|||
44307399|NCT02304458|79308499|FG001|Overall Study|Lack of Efficacy|6|||
44307400|NCT02304458|79308500|FG002|Overall Study|Lack of Efficacy|38|||
44307401|NCT02304458|79308501|FG003|Overall Study|Lack of Efficacy|5|||
44307402|NCT02304458|79308502|FG004|Overall Study|Lack of Efficacy|6|||
44307403|NCT02304458|79308503|FG005|Overall Study|Lack of Efficacy|6|||
44307404|NCT02304458|79308504|FG006|Overall Study|Lack of Efficacy|21|||
44307405|NCT02304458|79308505|FG007|Overall Study|Lack of Efficacy|4|||
44307406|NCT02304458|79308498|FG000|Overall Study|Physician Decision|2|||
44307407|NCT02304458|79308499|FG001|Overall Study|Physician Decision|0|||
44307408|NCT02304458|79308500|FG002|Overall Study|Physician Decision|16|||
44307409|NCT02304458|79308501|FG003|Overall Study|Physician Decision|1|||
44307410|NCT02304458|79308502|FG004|Overall Study|Physician Decision|0|||
44307411|NCT02304458|79308503|FG005|Overall Study|Physician Decision|0|||
44307412|NCT02304458|79308504|FG006|Overall Study|Physician Decision|3|||
44307413|NCT02304458|79308505|FG007|Overall Study|Physician Decision|0|||
44307414|NCT02304458|79308498|FG000|Overall Study|Protocol Violation|0|||
44307415|NCT02304458|79308499|FG001|Overall Study|Protocol Violation|0|||
44307416|NCT02304458|79308500|FG002|Overall Study|Protocol Violation|1|||
44307417|NCT02304458|79308501|FG003|Overall Study|Protocol Violation|0|||
44534687|NCT03116828|79545385|FG001|Overall Study|OTHER|3|||
44534688|NCT03938272|79545393|FG000|Overall Study|Withdrawal by Subject|1|||
44534689|NCT03938272|79545394|FG001|Overall Study|Withdrawal by Subject|0|||
44534690|NCT03938272|79545393|FG000|Overall Study|Physician Decision|0|||
44534691|NCT03938272|79545394|FG001|Overall Study|Physician Decision|2|||
44534692|NCT03938272|79545393|FG000|Overall Study|Study termination by sponsor|10|||
44534693|NCT03938272|79545394|FG001|Overall Study|Study termination by sponsor|8|||
44534694|NCT03126344|79545412|FG000|Overall Study|Lost to Follow-up|0|||
44534695|NCT03126344|79545413|FG001|Overall Study|Lost to Follow-up|0|||
44534696|NCT03126344|79545414|FG002|Overall Study|Lost to Follow-up|5|||
44534697|NCT03115112|79545435|FG000|Overall Study|Adverse Event|5|||
44534698|NCT03115112|79545436|FG001|Overall Study|Adverse Event|1|||
44534699|NCT03115112|79545435|FG000|Overall Study|Withdrawal by Subject|4|||
44534700|NCT03115112|79545436|FG001|Overall Study|Withdrawal by Subject|2|||
44534701|NCT03115112|79545435|FG000|Overall Study|Lost to Follow-up|0|||
44307418|NCT02304458|79308502|FG004|Overall Study|Protocol Violation|0|||
44307419|NCT02304458|79308503|FG005|Overall Study|Protocol Violation|0|||
44307420|NCT02304458|79308504|FG006|Overall Study|Protocol Violation|0|||
44307421|NCT02304458|79308505|FG007|Overall Study|Protocol Violation|0|||
44307422|NCT02304458|79308498|FG000|Overall Study|Withdrawal by Subject|1|||
44307423|NCT02304458|79308499|FG001|Overall Study|Withdrawal by Subject|0|||
44534702|NCT03115112|79545436|FG001|Overall Study|Lost to Follow-up|1|||
44534703|NCT03115112|79545435|FG000|Overall Study|Death|1|||
44534704|NCT03115112|79545436|FG001|Overall Study|Death|0|||
44534705|NCT03115112|79545435|FG000|Overall Study|Pregnancy|1|||
44534706|NCT03115112|79545436|FG001|Overall Study|Pregnancy|0|||
44534707|NCT03115112|79545435|FG000|Overall Study|Site closure|1|||
44534708|NCT03115112|79545436|FG001|Overall Study|Site closure|1|||
44534709|NCT03556358|79545455|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
44534710|NCT03556358|79545456|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
44534711|NCT03556358|79545455|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
44534712|NCT03556358|79545456|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
44534713|NCT03556358|79545455|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
44534714|NCT03556358|79545456|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
44534715|NCT03556358|79545455|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
44534716|NCT03556358|79545456|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
44534717|NCT03556358|79545455|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
44534718|NCT03556358|79545456|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
44534719|NCT03556358|79545455|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
44534720|NCT03556358|79545456|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
44307424|NCT02304458|79308500|FG002|Overall Study|Withdrawal by Subject|7|||
44307425|NCT02304458|79308501|FG003|Overall Study|Withdrawal by Subject|0|||
44307426|NCT02304458|79308502|FG004|Overall Study|Withdrawal by Subject|0|||
44418607|NCT00809783|79426579|FG001|Overall Study|Lost to Follow-up|3|||
44418608|NCT00809783|79426580|FG002|Overall Study|Lost to Follow-up|4|||
44418609|NCT00809783|79426578|FG000|Overall Study|Withdrawal by Subject|47|||
44418610|NCT00809783|79426579|FG001|Overall Study|Withdrawal by Subject|72|||
44418611|NCT00809783|79426580|FG002|Overall Study|Withdrawal by Subject|64|||
44418612|NCT00809783|79426578|FG000|Overall Study|Protocol Violation|2|||
44418613|NCT00809783|79426579|FG001|Overall Study|Protocol Violation|6|||
44418614|NCT00809783|79426580|FG002|Overall Study|Protocol Violation|5|||
44418615|NCT00809783|79426578|FG000|Overall Study|Randomized, but not treated|3|||
44418616|NCT00809783|79426579|FG001|Overall Study|Randomized, but not treated|0|||
44418617|NCT00809783|79426580|FG002|Overall Study|Randomized, but not treated|2|||
44418618|NCT00809783|79426578|FG000|Overall Study|Study Terminated by Sponsor|378|||
44418619|NCT00809783|79426579|FG001|Overall Study|Study Terminated by Sponsor|626|||
44418620|NCT00809783|79426580|FG002|Overall Study|Study Terminated by Sponsor|565|||
44418621|NCT00809783|79426578|FG000|Overall Study|Other|21|||
44418622|NCT00809783|79426579|FG001|Overall Study|Other|21|||
44418623|NCT00809783|79426580|FG002|Overall Study|Other|16|||
44418624|NCT00809471|79426591|FG000|Overall Study|Protocol non-compliance|15|||
44418625|NCT00809471|79426592|FG001|Overall Study|Protocol non-compliance|15|||
44418626|NCT00809471|79426593|FG002|Overall Study|Protocol non-compliance|6|||
44418627|NCT00809471|79426591|FG000|Overall Study|Lost to Follow-up|4|||
44418628|NCT00809471|79426592|FG001|Overall Study|Lost to Follow-up|2|||
44418629|NCT00809471|79426593|FG002|Overall Study|Lost to Follow-up|9|||
44418630|NCT00809471|79426591|FG000|Overall Study|Adverse Event|0|||
44418631|NCT00809471|79426592|FG001|Overall Study|Adverse Event|2|||
44418632|NCT00809471|79426593|FG002|Overall Study|Adverse Event|2|||
44418633|NCT00809471|79426591|FG000|Overall Study|Requirement for restricted medication|1|||
44418634|NCT00809471|79426592|FG001|Overall Study|Requirement for restricted medication|1|||
44418635|NCT00809471|79426593|FG002|Overall Study|Requirement for restricted medication|0|||
44418636|NCT00807248|79426605|FG000|Overall Study|Adverse Event|1|||
44418637|NCT00807248|79426606|FG001|Overall Study|Adverse Event|2|||
44418638|NCT00807248|79426607|FG002|Overall Study|Adverse Event|2|||
44418639|NCT00807248|79426608|FG003|Overall Study|Adverse Event|6|||
44418640|NCT00807248|79426605|FG000|Overall Study|Lack of Efficacy|14|||
44418641|NCT00807248|79426606|FG001|Overall Study|Lack of Efficacy|4|||
44418642|NCT00807248|79426607|FG002|Overall Study|Lack of Efficacy|8|||
44418643|NCT00807248|79426608|FG003|Overall Study|Lack of Efficacy|3|||
44418644|NCT00807248|79426605|FG000|Overall Study|Protocol Violation|0|||
44418645|NCT00807248|79426606|FG001|Overall Study|Protocol Violation|1|||
44418646|NCT00807248|79426607|FG002|Overall Study|Protocol Violation|1|||
44418647|NCT00807248|79426608|FG003|Overall Study|Protocol Violation|0|||
44418648|NCT00807248|79426605|FG000|Overall Study|Withdrawal of Consent|5|||
44418649|NCT00807248|79426606|FG001|Overall Study|Withdrawal of Consent|5|||
44418650|NCT00807248|79426607|FG002|Overall Study|Withdrawal of Consent|5|||
44418651|NCT00807248|79426608|FG003|Overall Study|Withdrawal of Consent|5|||
44418652|NCT00807248|79426605|FG000|Overall Study|Lost to Follow-up|1|||
44418653|NCT00807248|79426606|FG001|Overall Study|Lost to Follow-up|0|||
44418654|NCT00807248|79426607|FG002|Overall Study|Lost to Follow-up|0|||
44418655|NCT00807248|79426608|FG003|Overall Study|Lost to Follow-up|0|||
44418656|NCT00807248|79426605|FG000|Overall Study|Other Reason|0|||
44307427|NCT02304458|79308503|FG005|Overall Study|Withdrawal by Subject|0|||
44307428|NCT02304458|79308504|FG006|Overall Study|Withdrawal by Subject|1|||
44307429|NCT02304458|79308505|FG007|Overall Study|Withdrawal by Subject|0|||
44307430|NCT02187224|79308541|FG000|Overall Study|Did not show up for test day|1|||
44534721|NCT03556358|79545455|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
44534722|NCT03556358|79545456|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
44534723|NCT03118934|79545483|FG000|Overall Study|Adverse Event|0|||
44534724|NCT03118934|79545484|FG001|Overall Study|Adverse Event|0|||
44534725|NCT03118934|79545485|FG002|Overall Study|Adverse Event|0|||
44534726|NCT03118934|79545486|FG003|Overall Study|Adverse Event|0|||
44534727|NCT03118934|79545487|FG004|Overall Study|Adverse Event|0|||
44534728|NCT03118934|79545488|FG005|Overall Study|Adverse Event|1|||
44534729|NCT03118934|79545483|FG000|Overall Study|Physician Decision|0|||
44534730|NCT03118934|79545484|FG001|Overall Study|Physician Decision|0|||
44534731|NCT03118934|79545485|FG002|Overall Study|Physician Decision|0|||
44155222|NCT02669017|78946895|FG001|Overall Study|Lost to Follow-up|0|||
44307431|NCT02187224|79308542|FG001|Overall Study|Did not show up for test day|0|||
44307432|NCT02176226|79308552|FG000|Overall Study|Lost to Follow-up|3|||
44307433|NCT02176226|79308552|FG000|Overall Study|Withdrew prior to treatment|6|||
44307434|NCT01958021|79308558|FG000|Overall Study|Progressive disease|87|||
44307435|NCT01958021|79308559|FG001|Overall Study|Progressive disease|146|||
44307436|NCT01958021|79308558|FG000|Overall Study|Adverse Event|25|||
44307437|NCT01958021|79308559|FG001|Overall Study|Adverse Event|7|||
44307438|NCT01958021|79308558|FG000|Overall Study|Subject/guardian decision|12|||
44307439|NCT01958021|79308559|FG001|Overall Study|Subject/guardian decision|13|||
44307440|NCT01958021|79308558|FG000|Overall Study|Physician Decision|10|||
44307441|NCT01958021|79308559|FG001|Overall Study|Physician Decision|13|||
44307442|NCT01958021|79308558|FG000|Overall Study|Protocol Violation|3|||
44307443|NCT01958021|79308559|FG001|Overall Study|Protocol Violation|1|||
44307444|NCT01958021|79308558|FG000|Overall Study|Death|2|||
44307445|NCT01958021|79308559|FG001|Overall Study|Death|0|||
44307446|NCT05059600|79308565|FG000|Overall Study|Enrolled but not Treated|10|||
44307447|NCT04608448|79308578|FG000|Overall Study|Withdrawal by Subject|1|||
44307448|NCT04608448|79308578|FG000|Overall Study|Adverse Event|1|||
44307449|NCT04530344|79308588|FG000|Overall Study|Lost to Follow-up|3|||
44307450|NCT04530344|79308589|FG001|Overall Study|Lost to Follow-up|3|||
44307451|NCT04530344|79308590|FG002|Overall Study|Lost to Follow-up|3|||
44307452|NCT04530344|79308591|FG003|Overall Study|Lost to Follow-up|10|||
44307453|NCT04530344|79308588|FG000|Overall Study|Withdrawal by Subject|14|||
44307454|NCT04530344|79308589|FG001|Overall Study|Withdrawal by Subject|5|||
44307455|NCT04530344|79308590|FG002|Overall Study|Withdrawal by Subject|18|||
44307456|NCT04530344|79308591|FG003|Overall Study|Withdrawal by Subject|33|||
44307457|NCT04530344|79308588|FG000|Overall Study|Adverse Event|0|||
44307458|NCT04530344|79308589|FG001|Overall Study|Adverse Event|0|||
44307459|NCT04530344|79308590|FG002|Overall Study|Adverse Event|0|||
44307460|NCT04530344|79308591|FG003|Overall Study|Adverse Event|1|||
44307461|NCT04530344|79308588|FG000|Overall Study|Lack of Efficacy|0|||
44307462|NCT04530344|79308589|FG001|Overall Study|Lack of Efficacy|0|||
44307463|NCT04530344|79308590|FG002|Overall Study|Lack of Efficacy|0|||
44307464|NCT04530344|79308591|FG003|Overall Study|Lack of Efficacy|1|||
44307465|NCT04530344|79308588|FG000|Overall Study|Physician Decision|0|||
44307466|NCT04530344|79308589|FG001|Overall Study|Physician Decision|0|||
44307467|NCT04530344|79308590|FG002|Overall Study|Physician Decision|1|||
44534732|NCT03118934|79545486|FG003|Overall Study|Physician Decision|0|||
44534733|NCT03118934|79545487|FG004|Overall Study|Physician Decision|0|||
44155223|NCT02669017|78946896|FG002|Overall Study|Lost to Follow-up|0|||
44257191|NCT02152956|79109574|FG006|Overall Study|Death|6|||
44257192|NCT02152956|79109575|FG007|Overall Study|Death|6|||
44257193|NCT02152956|79109576|FG008|Overall Study|Death|4|||
44257194|NCT02152956|79109577|FG009|Overall Study|Death|5|||
44257195|NCT02152956|79109578|FG010|Overall Study|Death|3|||
44257196|NCT02152956|79109579|FG011|Overall Study|Death|143|||
44257197|NCT02152956|79109580|FG012|Overall Study|Death|12|||
44257198|NCT02152956|79109568|FG000|Overall Study|Lost to Follow-up|0|||
44257199|NCT02152956|79109569|FG001|Overall Study|Lost to Follow-up|1|||
44257200|NCT02152956|79109570|FG002|Overall Study|Lost to Follow-up|0|||
44257201|NCT02152956|79109571|FG003|Overall Study|Lost to Follow-up|0|||
44534734|NCT03118934|79545488|FG005|Overall Study|Physician Decision|1|||
44534735|NCT03118934|79545483|FG000|Overall Study|Discontinued prior to exposure|0|||
44155224|NCT02669017|78946897|FG003|Overall Study|Lost to Follow-up|0|||
44155225|NCT02669017|78946898|FG004|Overall Study|Lost to Follow-up|0|||
44257202|NCT02152956|79109572|FG004|Overall Study|Lost to Follow-up|0|||
44257203|NCT02152956|79109573|FG005|Overall Study|Lost to Follow-up|0|||
44257204|NCT02152956|79109574|FG006|Overall Study|Lost to Follow-up|0|||
44257205|NCT02152956|79109575|FG007|Overall Study|Lost to Follow-up|0|||
44307468|NCT04530344|79308591|FG003|Overall Study|Physician Decision|1|||
44307469|NCT04530344|79308588|FG000|Overall Study|Pregnancy|0|||
44307470|NCT04530344|79308589|FG001|Overall Study|Pregnancy|0|||
44307471|NCT04530344|79308590|FG002|Overall Study|Pregnancy|2|||
44307472|NCT04530344|79308591|FG003|Overall Study|Pregnancy|1|||
44307473|NCT04530344|79308588|FG000|Overall Study|Protocol Violation|0|||
44307474|NCT04530344|79308589|FG001|Overall Study|Protocol Violation|0|||
44307475|NCT04530344|79308590|FG002|Overall Study|Protocol Violation|0|||
44307476|NCT04530344|79308591|FG003|Overall Study|Protocol Violation|1|||
44307477|NCT04530344|79308588|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
44307478|NCT04530344|79308589|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
44307479|NCT04530344|79308590|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
44307480|NCT04530344|79308591|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
44307481|NCT04530344|79308588|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
44307482|NCT04530344|79308589|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
44307483|NCT04530344|79308590|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
44307484|NCT04530344|79308591|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
44307485|NCT04530344|79308588|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
44307486|NCT04530344|79308589|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
44307487|NCT04530344|79308590|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
44307488|NCT04530344|79308591|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
44307489|NCT04530344|79308588|FG000|Overall Study|Personal Reasons|0|||
44307490|NCT04530344|79308589|FG001|Overall Study|Personal Reasons|0|||
44307491|NCT04530344|79308590|FG002|Overall Study|Personal Reasons|0|||
44307492|NCT04530344|79308591|FG003|Overall Study|Personal Reasons|1|||
44307493|NCT04530344|79308588|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
44307494|NCT04530344|79308589|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
44307495|NCT04530344|79308590|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
44307496|NCT04530344|79308591|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
44307497|NCT04058886|79308616|FG000|Overall Study|Withdrawal by Subject|4|||
44307498|NCT04058886|79308616|FG000|Overall Study|Inadequate deafness interpreter service|1|||
44307499|NCT03704194|79308639|FG000|Overall Study|Withdrawal by Subject|0|||
44307500|NCT03704194|79308640|FG001|Overall Study|Withdrawal by Subject|1|||
44307501|NCT03451422|79308654|FG000|Overall Study|Lost to Follow-up|0|||
44307502|NCT03451422|79308655|FG001|Overall Study|Lost to Follow-up|0|||
44307503|NCT03451422|79308656|FG002|Overall Study|Lost to Follow-up|0|||
44307504|NCT03451422|79308657|FG003|Overall Study|Lost to Follow-up|0|||
44307505|NCT03451422|79308658|FG004|Overall Study|Lost to Follow-up|0|||
44307506|NCT03451422|79308659|FG005|Overall Study|Lost to Follow-up|1|||
44307507|NCT03451422|79308654|FG000|Overall Study|Decision by sponsor|1|||
44307508|NCT03451422|79308655|FG001|Overall Study|Decision by sponsor|0|||
44307509|NCT03451422|79308656|FG002|Overall Study|Decision by sponsor|1|||
44307510|NCT03451422|79308657|FG003|Overall Study|Decision by sponsor|0|||
44307511|NCT03451422|79308658|FG004|Overall Study|Decision by sponsor|0|||
44307512|NCT03451422|79308659|FG005|Overall Study|Decision by sponsor|0|||
44307513|NCT03451422|79308654|FG000|Overall Study|Withdrawal by Subject|0|||
44307514|NCT03451422|79308655|FG001|Overall Study|Withdrawal by Subject|0|||
44307515|NCT03451422|79308656|FG002|Overall Study|Withdrawal by Subject|2|||
44307516|NCT03451422|79308657|FG003|Overall Study|Withdrawal by Subject|3|||
44307517|NCT03451422|79308658|FG004|Overall Study|Withdrawal by Subject|2|||
44307518|NCT03451422|79308659|FG005|Overall Study|Withdrawal by Subject|1|||
44307519|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
44307520|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
44307521|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
44307522|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
44307523|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
44307524|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
44307525|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
44307526|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
44307527|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
44307528|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
44307529|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
44307530|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
44307531|NCT03446573|79308680|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
44307532|NCT03446573|79308681|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
44307533|NCT03446573|79308680|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
44307534|NCT03446573|79308681|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
44307535|NCT03446573|79308680|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
44307536|NCT03446573|79308681|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
44307537|NCT03446573|79308680|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
44307538|NCT03446573|79308681|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
44307539|NCT03446573|79308680|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
44307540|NCT03446573|79308681|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
44307541|NCT03446573|79308680|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
44155226|NCT02669017|78946899|FG005|Overall Study|Lost to Follow-up|0|||
44307542|NCT03446573|79308681|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
44307543|NCT03446573|79308680|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
44307544|NCT03446573|79308681|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
44307545|NCT03422536|79308699|FG000|Randomized|Physician Decision|1|||
44307546|NCT03422536|79308700|FG001|Randomized|Physician Decision|1|||
44307547|NCT03422536|79308699|FG000|Allocation - Received Intervention|Disease progression|19|||
44307548|NCT03422536|79308700|FG001|Allocation - Received Intervention|Disease progression|25|||
44307549|NCT03422536|79308699|FG000|Allocation - Received Intervention|Death|1|||
44307550|NCT03422536|79308700|FG001|Allocation - Received Intervention|Death|3|||
44307551|NCT03422536|79308699|FG000|Allocation - Received Intervention|Adverse Event|1|||
44307552|NCT03422536|79308700|FG001|Allocation - Received Intervention|Adverse Event|0|||
44307553|NCT03422536|79308699|FG000|Allocation - Received Intervention|Physician Decision|1|||
44307554|NCT03422536|79308700|FG001|Allocation - Received Intervention|Physician Decision|1|||
44307555|NCT03422536|79308699|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
44307556|NCT03422536|79308700|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
44307557|NCT03422536|79308699|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
44307558|NCT03422536|79308700|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
44307559|NCT03228394|79308714|FG000|Overall Study|Lost to Follow-up|0|||
44307560|NCT03228394|79308715|FG001|Overall Study|Lost to Follow-up|0|||
44307561|NCT03228394|79308716|FG002|Overall Study|Lost to Follow-up|1|||
44307562|NCT03228394|79308717|FG003|Overall Study|Lost to Follow-up|1|||
44307563|NCT03228394|79308718|FG004|Overall Study|Lost to Follow-up|0|||
44307564|NCT03228394|79308719|FG005|Overall Study|Lost to Follow-up|0|||
44307565|NCT03228394|79308720|FG006|Overall Study|Lost to Follow-up|2|||
44307566|NCT03228394|79308721|FG007|Overall Study|Lost to Follow-up|0|||
44307567|NCT03228394|79308714|FG000|Overall Study|Withdrawal by Subject|0|||
44307568|NCT03228394|79308715|FG001|Overall Study|Withdrawal by Subject|0|||
44307569|NCT03228394|79308716|FG002|Overall Study|Withdrawal by Subject|1|||
44307570|NCT03228394|79308717|FG003|Overall Study|Withdrawal by Subject|0|||
44307571|NCT03228394|79308718|FG004|Overall Study|Withdrawal by Subject|0|||
44307572|NCT03228394|79308719|FG005|Overall Study|Withdrawal by Subject|0|||
44307573|NCT03228394|79308720|FG006|Overall Study|Withdrawal by Subject|1|||
44307574|NCT03228394|79308721|FG007|Overall Study|Withdrawal by Subject|3|||
44307575|NCT03228394|79308714|FG000|Overall Study|Protocol Violation|0|||
44307576|NCT03228394|79308715|FG001|Overall Study|Protocol Violation|0|||
44307577|NCT03228394|79308716|FG002|Overall Study|Protocol Violation|0|||
44307578|NCT03228394|79308717|FG003|Overall Study|Protocol Violation|1|||
44307579|NCT03228394|79308718|FG004|Overall Study|Protocol Violation|0|||
44307580|NCT03228394|79308719|FG005|Overall Study|Protocol Violation|0|||
44307581|NCT03228394|79308720|FG006|Overall Study|Protocol Violation|0|||
44307582|NCT03228394|79308721|FG007|Overall Study|Protocol Violation|0|||
44307583|NCT03228394|79308714|FG000|Overall Study|Physician Decision|0|||
44307584|NCT03228394|79308715|FG001|Overall Study|Physician Decision|0|||
44307585|NCT03228394|79308716|FG002|Overall Study|Physician Decision|0|||
44307586|NCT03228394|79308717|FG003|Overall Study|Physician Decision|0|||
44307587|NCT03228394|79308718|FG004|Overall Study|Physician Decision|0|||
44307588|NCT03228394|79308719|FG005|Overall Study|Physician Decision|0|||
44307589|NCT03228394|79308720|FG006|Overall Study|Physician Decision|1|||
44307590|NCT03228394|79308721|FG007|Overall Study|Physician Decision|0|||
44307591|NCT03228394|79308714|FG000|Overall Study|Noncompliance|0|||
44307592|NCT03228394|79308715|FG001|Overall Study|Noncompliance|0|||
44307593|NCT03228394|79308716|FG002|Overall Study|Noncompliance|0|||
44307594|NCT03228394|79308717|FG003|Overall Study|Noncompliance|0|||
44307595|NCT03228394|79308718|FG004|Overall Study|Noncompliance|0|||
44307596|NCT03228394|79308719|FG005|Overall Study|Noncompliance|0|||
44307597|NCT03228394|79308720|FG006|Overall Study|Noncompliance|1|||
44307598|NCT03228394|79308721|FG007|Overall Study|Noncompliance|0|||
44307599|NCT03008070|79308743|FG000|Overall Study|Adverse Event|3|||
44307600|NCT03008070|79308744|FG001|Overall Study|Adverse Event|3|||
44307601|NCT03008070|79308745|FG002|Overall Study|Adverse Event|3|||
44307602|NCT03008070|79308743|FG000|Overall Study|Lost to Follow-up|1|||
44307603|NCT03008070|79308744|FG001|Overall Study|Lost to Follow-up|1|||
44307604|NCT03008070|79308745|FG002|Overall Study|Lost to Follow-up|0|||
44307605|NCT03008070|79308743|FG000|Overall Study|Non compliance|0|||
44307606|NCT03008070|79308744|FG001|Overall Study|Non compliance|1|||
44307607|NCT03008070|79308745|FG002|Overall Study|Non compliance|1|||
44307608|NCT03008070|79308743|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
44307609|NCT03008070|79308744|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
44307610|NCT03008070|79308745|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
44307611|NCT03008070|79308743|FG000|Overall Study|Withdrawal by Subject|2|||
44307612|NCT03008070|79308744|FG001|Overall Study|Withdrawal by Subject|0|||
44307613|NCT03008070|79308745|FG002|Overall Study|Withdrawal by Subject|1|||
44307614|NCT03008070|79308743|FG000|Overall Study|Use of prohibited drug|0|||
44307615|NCT03008070|79308744|FG001|Overall Study|Use of prohibited drug|0|||
44307616|NCT03008070|79308745|FG002|Overall Study|Use of prohibited drug|2|||
44307617|NCT02979353|79308757|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
44307618|NCT02979353|79308758|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
44307619|NCT02979353|79308757|FG000|Overall Study|Withdrawal by Subject|16|||
44307620|NCT02979353|79308758|FG001|Overall Study|Withdrawal by Subject|12|||
44307621|NCT02979353|79308757|FG000|Overall Study|Death|10|||
44307622|NCT02979353|79308758|FG001|Overall Study|Death|11|||
44307623|NCT02979353|79308757|FG000|Overall Study|Transfer to Hospice Care|19|||
44307624|NCT02979353|79308758|FG001|Overall Study|Transfer to Hospice Care|14|||
44307625|NCT02979353|79308757|FG000|Overall Study|Lost to Follow-up|1|||
44307626|NCT02979353|79308758|FG001|Overall Study|Lost to Follow-up|5|||
44307627|NCT02633397|79308777|FG000|Overall Study|Adverse Event|8|||
44307628|NCT02633397|79308778|FG001|Overall Study|Adverse Event|8|||
44307629|NCT02633397|79308777|FG000|Overall Study|Study Burden|4|||
44307630|NCT02633397|79308778|FG001|Overall Study|Study Burden|1|||
44307631|NCT02633397|79308777|FG000|Overall Study|Treatment interruption|2|||
44307632|NCT02633397|79308778|FG001|Overall Study|Treatment interruption|5|||
44307633|NCT02633397|79308777|FG000|Overall Study|Death|2|||
44307634|NCT02633397|79308778|FG001|Overall Study|Death|2|||
44307635|NCT02633397|79308777|FG000|Overall Study|Physician Decision|0|||
44307636|NCT02633397|79308778|FG001|Overall Study|Physician Decision|1|||
44307637|NCT02592707|79308788|FG000|Overall Study|Consent Withdrawn|0|||
44307638|NCT02592707|79308789|FG001|Overall Study|Consent Withdrawn|1|||
44307639|NCT02592707|79308790|FG002|Overall Study|Consent Withdrawn|2|||
44307640|NCT02592707|79308791|FG003|Overall Study|Consent Withdrawn|0|||
44307641|NCT02592707|79308788|FG000|Overall Study|Death|1|||
44307642|NCT02592707|79308789|FG001|Overall Study|Death|0|||
44307643|NCT02592707|79308790|FG002|Overall Study|Death|0|||
44307644|NCT02592707|79308791|FG003|Overall Study|Death|0|||
44307645|NCT02592707|79308788|FG000|Overall Study|Progressive Disease|4|||
44307646|NCT02592707|79308789|FG001|Overall Study|Progressive Disease|4|||
44307647|NCT02592707|79308790|FG002|Overall Study|Progressive Disease|3|||
44307648|NCT02592707|79308791|FG003|Overall Study|Progressive Disease|3|||
44307649|NCT02592707|79308788|FG000|Overall Study|Other|0|||
44307650|NCT02592707|79308789|FG001|Overall Study|Other|0|||
44307651|NCT02592707|79308790|FG002|Overall Study|Other|1|||
44307652|NCT02592707|79308791|FG003|Overall Study|Other|2|||
44307653|NCT02592707|79308788|FG000|Overall Study|Never entered LTFU period|1|||
44307654|NCT02592707|79308789|FG001|Overall Study|Never entered LTFU period|0|||
44307655|NCT02592707|79308790|FG002|Overall Study|Never entered LTFU period|0|||
44307656|NCT02592707|79308791|FG003|Overall Study|Never entered LTFU period|2|||
44307657|NCT01423812|79308819|FG000|Overall Study|Lost to Follow-up|2|||
44307658|NCT01423812|79308820|FG001|Overall Study|Lost to Follow-up|2|||
44307659|NCT01423812|79308819|FG000|Overall Study|Withdrawal by Subject|1|||
44307660|NCT01423812|79308820|FG001|Overall Study|Withdrawal by Subject|2|||
44307661|NCT00965718|79308828|FG000|Overall Study|Withdrawal by Subject|4|||
44307662|NCT00792740|79308843|FG000|Overall Study|Disease Worsening|3|||
44307663|NCT00792740|79308844|FG001|Overall Study|Disease Worsening|2|||
44307664|NCT00792740|79308843|FG000|Overall Study|Personal Reason|1|||
44307665|NCT00792740|79308844|FG001|Overall Study|Personal Reason|0|||
44307666|NCT00792740|79308843|FG000|Overall Study|Adverse Event|1|||
44307667|NCT00792740|79308844|FG001|Overall Study|Adverse Event|3|||
44307668|NCT00792740|79308843|FG000|Overall Study|Patient's withdrawal of consent|0|||
44307669|NCT00792740|79308844|FG001|Overall Study|Patient's withdrawal of consent|1|||
44307670|NCT00792740|79308843|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
44307671|NCT00792740|79308844|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
44307672|NCT00792740|79308843|FG000|Overall Study|Other reasons|0|||
44307673|NCT00792740|79308844|FG001|Overall Study|Other reasons|1|||
44307674|NCT00567580|79308863|FG000|Overall Study|Protocol Violation|28|||
44307675|NCT00567580|79308864|FG001|Overall Study|Protocol Violation|24|||
44307676|NCT00567580|79308865|FG002|Overall Study|Protocol Violation|24|||
44307677|NCT01058863|79308876|FG000|Overall Study|Lost to Follow-up|1|||
44418657|NCT00807248|79426606|FG001|Overall Study|Other Reason|0|||
44418658|NCT00807248|79426607|FG002|Overall Study|Other Reason|2|||
44418659|NCT00807248|79426608|FG003|Overall Study|Other Reason|0|||
44418660|NCT00589628|79426620|FG000|Overall Study|Lost to Follow-up|0|||
44418661|NCT00589628|79426621|FG001|Overall Study|Lost to Follow-up|1|||
44418662|NCT00588848|79426629|FG000|Overall Study|Physician Decision|0|||
44418663|NCT00588848|79426630|FG001|Overall Study|Physician Decision|3|||
44418664|NCT00797108|79426641|FG000|Overall Study|Adverse Event|1|||
44418665|NCT00797108|79426642|FG001|Overall Study|Adverse Event|0|||
44534736|NCT03118934|79545484|FG001|Overall Study|Discontinued prior to exposure|1|||
44534737|NCT03118934|79545485|FG002|Overall Study|Discontinued prior to exposure|1|||
44534738|NCT03118934|79545486|FG003|Overall Study|Discontinued prior to exposure|1|||
44534739|NCT03118934|79545487|FG004|Overall Study|Discontinued prior to exposure|2|||
44534740|NCT03118934|79545488|FG005|Overall Study|Discontinued prior to exposure|0|||
44534741|NCT03114488|79545498|FG000|Time Period 2|Withdrawal by Subject|1|||
44534742|NCT03114488|79545499|FG001|Time Period 2|Withdrawal by Subject|3|||
44534743|NCT03135262|79545518|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
44534744|NCT03135262|79545519|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
44534745|NCT03135262|79545520|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
44534746|NCT03135262|79545521|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
44534747|NCT03135262|79545522|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
44534748|NCT03135262|79545518|FG000|Overall Study|Progression of disease|0|||
44534749|NCT03135262|79545519|FG001|Overall Study|Progression of disease|0|||
44534750|NCT03135262|79545520|FG002|Overall Study|Progression of disease|0|||
44534751|NCT03135262|79545521|FG003|Overall Study|Progression of disease|1|||
44534752|NCT03135262|79545522|FG004|Overall Study|Progression of disease|0|||
44534753|NCT03135262|79545518|FG000|Overall Study|Death|6|||
44534754|NCT03135262|79545519|FG001|Overall Study|Death|2|||
44534755|NCT03135262|79545520|FG002|Overall Study|Death|2|||
44534756|NCT03135262|79545521|FG003|Overall Study|Death|2|||
44534757|NCT03135262|79545522|FG004|Overall Study|Death|0|||
44534758|NCT03135262|79545518|FG000|Overall Study|Withdrawal by Subject|0|||
44534759|NCT03135262|79545519|FG001|Overall Study|Withdrawal by Subject|0|||
44534760|NCT03135262|79545520|FG002|Overall Study|Withdrawal by Subject|1|||
44534761|NCT03135262|79545521|FG003|Overall Study|Withdrawal by Subject|0|||
44534762|NCT03135262|79545522|FG004|Overall Study|Withdrawal by Subject|1|||
44534763|NCT03135262|79545518|FG000|Overall Study|Study terminated by sponsor|2|||
44534764|NCT03135262|79545519|FG001|Overall Study|Study terminated by sponsor|4|||
44534765|NCT03135262|79545520|FG002|Overall Study|Study terminated by sponsor|4|||
44534766|NCT03135262|79545521|FG003|Overall Study|Study terminated by sponsor|3|||
44534767|NCT03135262|79545522|FG004|Overall Study|Study terminated by sponsor|0|||
44534768|NCT03535194|79545557|FG000|Induction Period|Adverse Event|2|||
44534769|NCT03535194|79545558|FG001|Induction Period|Adverse Event|2|||
44534770|NCT03535194|79545559|FG002|Induction Period|Adverse Event|1|||
44534771|NCT03535194|79545560|FG003|Induction Period|Adverse Event|3|||
44534772|NCT03535194|79545561|FG004|Induction Period|Adverse Event|0|||
44534773|NCT03535194|79545557|FG000|Induction Period|Death|0|||
44534774|NCT03535194|79545558|FG001|Induction Period|Death|1|||
44534775|NCT03535194|79545559|FG002|Induction Period|Death|0|||
44534776|NCT03535194|79545560|FG003|Induction Period|Death|0|||
44534777|NCT03535194|79545561|FG004|Induction Period|Death|0|||
44534778|NCT03535194|79545557|FG000|Induction Period|Lack of Efficacy|1|||
44257206|NCT02152956|79109576|FG008|Overall Study|Lost to Follow-up|0|||
44257207|NCT02152956|79109577|FG009|Overall Study|Lost to Follow-up|0|||
44257208|NCT02152956|79109578|FG010|Overall Study|Lost to Follow-up|0|||
44257209|NCT02152956|79109579|FG011|Overall Study|Lost to Follow-up|3|||
44257210|NCT02152956|79109580|FG012|Overall Study|Lost to Follow-up|0|||
44257211|NCT02152956|79109568|FG000|Overall Study|Withdrawal by Subject|1|||
44257212|NCT02152956|79109569|FG001|Overall Study|Withdrawal by Subject|0|||
44257213|NCT02152956|79109570|FG002|Overall Study|Withdrawal by Subject|1|||
44257214|NCT02152956|79109571|FG003|Overall Study|Withdrawal by Subject|0|||
44257215|NCT02152956|79109572|FG004|Overall Study|Withdrawal by Subject|2|||
44257216|NCT02152956|79109573|FG005|Overall Study|Withdrawal by Subject|2|||
44257217|NCT02152956|79109574|FG006|Overall Study|Withdrawal by Subject|0|||
44257218|NCT02152956|79109575|FG007|Overall Study|Withdrawal by Subject|0|||
44257219|NCT02152956|79109576|FG008|Overall Study|Withdrawal by Subject|1|||
44257220|NCT02152956|79109577|FG009|Overall Study|Withdrawal by Subject|0|||
44257221|NCT02152956|79109578|FG010|Overall Study|Withdrawal by Subject|0|||
44257222|NCT02152956|79109579|FG011|Overall Study|Withdrawal by Subject|4|||
44257223|NCT02152956|79109580|FG012|Overall Study|Withdrawal by Subject|0|||
44257224|NCT02152956|79109568|FG000|Overall Study|Physician Decision|0|||
44257225|NCT02152956|79109569|FG001|Overall Study|Physician Decision|0|||
44418666|NCT00797108|79426643|FG002|Overall Study|Adverse Event|3|||
44418667|NCT00797108|79426641|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
44418668|NCT00797108|79426642|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
44418669|NCT00797108|79426643|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
44307678|NCT01058863|79308876|FG000|Overall Study|Withdrawal by Subject|1|||
44307679|NCT01058863|79308876|FG000|Overall Study|Sponsor requested withdrawal|1|||
44307680|NCT01058863|79308876|FG000|Overall Study|Randomized in error|1|||
44307681|NCT01058395|79308891|FG000|Overall Study|Death|2|||
44307682|NCT01058395|79308892|FG001|Overall Study|Death|1|||
44307683|NCT01058395|79308891|FG000|Overall Study|Lost to Follow-up|1|||
44307684|NCT01058395|79308892|FG001|Overall Study|Lost to Follow-up|0|||
44307685|NCT01058356|79308898|FG000|Overall Study|Adverse Event|5|||
44307686|NCT01058356|79308898|FG000|Overall Study|Administration of contraindicated drugs|12|||
44307687|NCT01058356|79308898|FG000|Overall Study|Withdrawal by Subject|21|||
44307688|NCT01058356|79308898|FG000|Overall Study|Lost to Follow-up|4|||
44307689|NCT01058005|79308905|FG000|Overall Study|Adverse Event|0|||
44307690|NCT01058005|79308906|FG001|Overall Study|Adverse Event|2|||
44307691|NCT01058005|79308907|FG002|Overall Study|Adverse Event|1|||
44307692|NCT01058005|79308905|FG000|Overall Study|Physician Decision|2|||
44307693|NCT01058005|79308906|FG001|Overall Study|Physician Decision|2|||
44307694|NCT01058005|79308907|FG002|Overall Study|Physician Decision|0|||
44307695|NCT01058005|79308905|FG000|Overall Study|Withdrawal by Subject|4|||
44307696|NCT01058005|79308906|FG001|Overall Study|Withdrawal by Subject|5|||
44307697|NCT01058005|79308907|FG002|Overall Study|Withdrawal by Subject|11|||
44307698|NCT01058005|79308905|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
44307699|NCT01058005|79308906|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
44307700|NCT01058005|79308907|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
44307701|NCT01058005|79308905|FG000|Overall Study|Reason Missing|5|||
44307702|NCT01058005|79308906|FG001|Overall Study|Reason Missing|3|||
44307703|NCT01058005|79308907|FG002|Overall Study|Reason Missing|1|||
44307704|NCT01056640|79308917|FG000|Overall Study|Withdrawal by Subject|11|||
44307705|NCT01056640|79308918|FG001|Overall Study|Withdrawal by Subject|8|||
44307706|NCT01056640|79308917|FG000|Overall Study|Death|15|||
44307707|NCT01056640|79308918|FG001|Overall Study|Death|4|||
44307708|NCT01056484|79308926|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
44307709|NCT01056484|79308927|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
44307710|NCT01056484|79308926|FG000|Randomized Controlled Trial|Physician Decision|1|||
44307711|NCT01056484|79308927|FG001|Randomized Controlled Trial|Physician Decision|0|||
44307712|NCT01056484|79308926|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
44307713|NCT01056484|79308927|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
44307714|NCT01055314|79308936|FG000|Overall Study|Adverse Event|7|||
44307715|NCT01055314|79308937|FG001|Overall Study|Adverse Event|4|||
44307716|NCT01055314|79308936|FG000|Overall Study|Death|2|||
44307717|NCT01055314|79308937|FG001|Overall Study|Death|1|||
44307718|NCT01055314|79308936|FG000|Overall Study|Lack of Efficacy|11|||
44307719|NCT01055314|79308937|FG001|Overall Study|Lack of Efficacy|19|||
44307720|NCT01055314|79308936|FG000|Overall Study|Physician Decision|10|||
44307721|NCT01055314|79308937|FG001|Overall Study|Physician Decision|5|||
44307722|NCT01055314|79308936|FG000|Overall Study|Withdrawal by Subject|1|||
44307723|NCT01055314|79308937|FG001|Overall Study|Withdrawal by Subject|0|||
44307724|NCT01055314|79308936|FG000|Overall Study|Ineligible|3|||
44307725|NCT01055314|79308937|FG001|Overall Study|Ineligible|5|||
44307726|NCT01055314|79308936|FG000|Overall Study|Refusal of further protocol therapy|10|||
44307727|NCT01055314|79308937|FG001|Overall Study|Refusal of further protocol therapy|4|||
44307728|NCT01055314|79308936|FG000|Overall Study|No treatment|1|||
44307729|NCT01055314|79308937|FG001|Overall Study|No treatment|0|||
44307730|NCT01055197|79308946|FG000|Overall Study|Protocol Violation|7|||
44307731|NCT01055197|79308947|FG001|Overall Study|Protocol Violation|2|||
44307732|NCT01055197|79308946|FG000|Overall Study|Withdrawal by Subject|2|||
44307733|NCT01055197|79308947|FG001|Overall Study|Withdrawal by Subject|0|||
44307734|NCT01054885|79308959|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
44307735|NCT01054885|79308960|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307736|NCT01054885|79308961|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307737|NCT01054885|79308962|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307738|NCT01054885|79308963|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307739|NCT01054885|79308964|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307740|NCT01054885|79308965|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307741|NCT01054885|79308959|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
44307742|NCT01054885|79308960|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307743|NCT01054885|79308961|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307744|NCT01054885|79308962|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307745|NCT01054885|79308963|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307746|NCT01054885|79308964|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307747|NCT01054885|79308965|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307748|NCT01054885|79308959|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
44307749|NCT01054885|79308960|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307750|NCT01054885|79308961|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307751|NCT01054885|79308962|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307752|NCT01054885|79308963|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307753|NCT01054885|79308964|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307754|NCT01054885|79308965|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44418670|NCT00797108|79426641|FG000|Overall Study|Global Deterioration of Health Status|0|||
44418671|NCT00797108|79426642|FG001|Overall Study|Global Deterioration of Health Status|1|||
44418672|NCT00797108|79426643|FG002|Overall Study|Global Deterioration of Health Status|0|||
44418673|NCT00797108|79426641|FG000|Overall Study|Lack of Efficacy|1|||
44418674|NCT00797108|79426642|FG001|Overall Study|Lack of Efficacy|0|||
44418675|NCT00797108|79426643|FG002|Overall Study|Lack of Efficacy|1|||
44418676|NCT00797108|79426641|FG000|Overall Study|Other|0|||
44418677|NCT00797108|79426642|FG001|Overall Study|Other|0|||
44418678|NCT00797108|79426643|FG002|Overall Study|Other|2|||
44418679|NCT00797108|79426641|FG000|Overall Study|Randomized but not Treated|2|||
44418680|NCT00797108|79426642|FG001|Overall Study|Randomized but not Treated|0|||
44418681|NCT00797108|79426643|FG002|Overall Study|Randomized but not Treated|0|||
44418682|NCT00742560|79426656|FG000|Overall Study|Adverse Event|0|||
44418683|NCT00742560|79426657|FG001|Overall Study|Adverse Event|0|||
44418684|NCT00742560|79426658|FG002|Overall Study|Adverse Event|1|||
44418685|NCT00742560|79426659|FG003|Overall Study|Adverse Event|1|||
44418686|NCT00742560|79426660|FG004|Overall Study|Adverse Event|1|||
44418687|NCT00742560|79426656|FG000|Overall Study|Death|0|||
44418688|NCT00742560|79426657|FG001|Overall Study|Death|2|||
44418689|NCT00742560|79426658|FG002|Overall Study|Death|0|||
44418690|NCT00742560|79426659|FG003|Overall Study|Death|2|||
44418691|NCT00742560|79426660|FG004|Overall Study|Death|3|||
44418692|NCT00742560|79426656|FG000|Overall Study|Subject's Decision|1|||
44418693|NCT00742560|79426657|FG001|Overall Study|Subject's Decision|0|||
44418694|NCT00742560|79426658|FG002|Overall Study|Subject's Decision|2|||
44418695|NCT00742560|79426659|FG003|Overall Study|Subject's Decision|3|||
44418696|NCT00742560|79426660|FG004|Overall Study|Subject's Decision|3|||
44418697|NCT00742560|79426656|FG000|Overall Study|Investigator's Decision|0|||
44418698|NCT00742560|79426657|FG001|Overall Study|Investigator's Decision|0|||
44418699|NCT00742560|79426658|FG002|Overall Study|Investigator's Decision|4|||
44418700|NCT00742560|79426659|FG003|Overall Study|Investigator's Decision|1|||
44418701|NCT00742560|79426660|FG004|Overall Study|Investigator's Decision|0|||
44418702|NCT00742560|79426656|FG000|Overall Study|Disease Progression|1|||
44418703|NCT00742560|79426657|FG001|Overall Study|Disease Progression|0|||
44418704|NCT00742560|79426658|FG002|Overall Study|Disease Progression|5|||
44155227|NCT02669017|78946900|FG006|Overall Study|Lost to Follow-up|0|||
44155228|NCT02669017|78946901|FG007|Overall Study|Lost to Follow-up|0|||
44155229|NCT02669017|78946902|FG008|Overall Study|Lost to Follow-up|1|||
44155230|NCT02669017|78946894|FG000|Overall Study|Miscellaneous|0|||
44155231|NCT02669017|78946895|FG001|Overall Study|Miscellaneous|0|||
44155232|NCT02669017|78946896|FG002|Overall Study|Miscellaneous|0|||
44155233|NCT02669017|78946897|FG003|Overall Study|Miscellaneous|0|||
44155234|NCT02669017|78946898|FG004|Overall Study|Miscellaneous|2|||
44155235|NCT02669017|78946899|FG005|Overall Study|Miscellaneous|1|||
44155236|NCT02669017|78946900|FG006|Overall Study|Miscellaneous|1|||
44155237|NCT02669017|78946901|FG007|Overall Study|Miscellaneous|13|||
44155238|NCT02669017|78946902|FG008|Overall Study|Miscellaneous|2|||
44418705|NCT00742560|79426659|FG003|Overall Study|Disease Progression|17|||
44418706|NCT00742560|79426660|FG004|Overall Study|Disease Progression|16|||
44418707|NCT00742560|79426656|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
44534779|NCT03535194|79545558|FG001|Induction Period|Lack of Efficacy|3|||
44534780|NCT03535194|79545559|FG002|Induction Period|Lack of Efficacy|2|||
44534781|NCT03535194|79545560|FG003|Induction Period|Lack of Efficacy|2|||
44534782|NCT03535194|79545561|FG004|Induction Period|Lack of Efficacy|0|||
44534783|NCT03535194|79545557|FG000|Induction Period|Lost to Follow-up|3|||
44534784|NCT03535194|79545558|FG001|Induction Period|Lost to Follow-up|5|||
44307755|NCT01054885|79308959|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
44307756|NCT01054885|79308960|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307757|NCT01054885|79308961|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307758|NCT01054885|79308962|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44418708|NCT00742560|79426657|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
44418709|NCT00742560|79426658|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
44418710|NCT00742560|79426659|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
44418711|NCT00742560|79426660|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
44418712|NCT00742560|79426656|FG000|Overall Study|Other|0|||
44418713|NCT00742560|79426657|FG001|Overall Study|Other|1|||
44418714|NCT00742560|79426658|FG002|Overall Study|Other|8|||
44418715|NCT00742560|79426659|FG003|Overall Study|Other|9|||
44534785|NCT03535194|79545559|FG002|Induction Period|Lost to Follow-up|2|||
44418716|NCT00742560|79426660|FG004|Overall Study|Other|9|||
44418717|NCT00742560|79426656|FG000|Overall Study|MIssing|0|||
44418718|NCT00742560|79426657|FG001|Overall Study|MIssing|0|||
44418719|NCT00742560|79426658|FG002|Overall Study|MIssing|0|||
44418720|NCT00742560|79426659|FG003|Overall Study|MIssing|0|||
44307759|NCT01054885|79308963|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307760|NCT01054885|79308964|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307761|NCT01054885|79308965|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307762|NCT01054885|79308959|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
44307763|NCT01054885|79308960|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307764|NCT01054885|79308961|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307765|NCT01054885|79308962|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307766|NCT01054885|79308963|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307767|NCT01054885|79308964|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307768|NCT01054885|79308965|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307769|NCT01054885|79308959|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
44307770|NCT01054885|79308960|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307771|NCT01054885|79308961|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307772|NCT01054885|79308962|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307773|NCT01054885|79308963|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307774|NCT01054885|79308964|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307775|NCT01054885|79308965|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307776|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
44307777|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
44307778|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
44307779|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
44307780|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
44307781|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
44307782|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
44307783|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44307784|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44307785|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
44307786|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
44307787|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44307788|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
44307789|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44307790|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
44307791|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
44307792|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
44307793|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
44307794|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
44307795|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
44307796|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
44307797|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
44307798|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
44307799|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
44307800|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
44307801|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
44307802|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
44307803|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
44307804|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
44307805|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
44307806|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
44307807|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
44307808|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
44307809|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
44307810|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
44307811|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
44307812|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
44307813|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
44307814|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
44307815|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
44307816|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
44307817|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
44307818|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44307819|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
44155239|NCT02668393|78946932|FG000|Overall Study|Progressive disease|6|||
44307820|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
44307821|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44307822|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44307823|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
44307824|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
44307825|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
44307826|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
44307827|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
44307828|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
44307829|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
44307830|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
44307831|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
44307832|NCT01054885|79308959|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44307833|NCT01054885|79308960|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
44307834|NCT01054885|79308961|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
44307835|NCT01054885|79308962|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
44307836|NCT01054885|79308963|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
44307837|NCT01054885|79308964|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
44307838|NCT01054885|79308965|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
44307839|NCT01054846|79308982|FG000|Overall Study|Lost to Follow-up|76|||
44307840|NCT01054846|79308983|FG001|Overall Study|Lost to Follow-up|17|||
44307841|NCT01054729|79308992|FG000|Overall Study|Randomized but Not Treated|0|||
44307842|NCT01054729|79308993|FG001|Overall Study|Randomized but Not Treated|1|||
44307843|NCT01054729|79308994|FG002|Overall Study|Randomized but Not Treated|0|||
44307844|NCT01054729|79308995|FG003|Overall Study|Randomized but Not Treated|0|||
44307845|NCT01054729|79308992|FG000|Overall Study|Adverse Event|1|||
44307846|NCT01054729|79308993|FG001|Overall Study|Adverse Event|1|||
44307847|NCT01054729|79308994|FG002|Overall Study|Adverse Event|2|||
44307848|NCT01054729|79308995|FG003|Overall Study|Adverse Event|1|||
44307849|NCT01054729|79308992|FG000|Overall Study|Withdrawal by Subject|1|||
44307850|NCT01054729|79308993|FG001|Overall Study|Withdrawal by Subject|0|||
44307851|NCT01054729|79308994|FG002|Overall Study|Withdrawal by Subject|1|||
44307852|NCT01054729|79308995|FG003|Overall Study|Withdrawal by Subject|0|||
44418721|NCT00742560|79426660|FG004|Overall Study|MIssing|1|||
44418722|NCT00740220|79426691|FG000|Overall Study|screen failures (non-COPD patients)|9|||
44418723|NCT00796718|79426695|FG000|Overall Study|Adverse Event|2|||
44418724|NCT00796718|79426695|FG000|Overall Study|Exclusion Criteria|1|||
44418725|NCT00796718|79426695|FG000|Overall Study|Lost to Follow-up|5|||
44418726|NCT00796718|79426695|FG000|Overall Study|Withdrawal by Informed Consent|1|||
44418727|NCT00809159|79426703|FG000|Part 1|Adverse Event|1|||
44418728|NCT00809159|79426704|FG001|Part 1|Adverse Event|1|||
44418729|NCT00809159|79426705|FG002|Part 1|Adverse Event|0|||
44418730|NCT00809159|79426706|FG003|Part 1|Adverse Event|0|||
44418731|NCT00809159|79426707|FG004|Part 1|Adverse Event|0|||
44418732|NCT00809159|79426708|FG005|Part 1|Adverse Event|0|||
44418733|NCT00809159|79426703|FG000|Part 1|Lost to Follow-up|1|||
44418734|NCT00809159|79426704|FG001|Part 1|Lost to Follow-up|0|||
44418735|NCT00809159|79426705|FG002|Part 1|Lost to Follow-up|0|||
44418736|NCT00809159|79426706|FG003|Part 1|Lost to Follow-up|0|||
44418737|NCT00809159|79426707|FG004|Part 1|Lost to Follow-up|0|||
44418738|NCT00809159|79426708|FG005|Part 1|Lost to Follow-up|0|||
44418739|NCT00809159|79426703|FG000|Part 1|Withdrawal by Subject|3|||
44418740|NCT00809159|79426704|FG001|Part 1|Withdrawal by Subject|1|||
44418741|NCT00809159|79426705|FG002|Part 1|Withdrawal by Subject|0|||
44418742|NCT00809159|79426706|FG003|Part 1|Withdrawal by Subject|0|||
44418743|NCT00809159|79426707|FG004|Part 1|Withdrawal by Subject|0|||
44418744|NCT00809159|79426708|FG005|Part 1|Withdrawal by Subject|0|||
44418745|NCT00809159|79426703|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
44418746|NCT00809159|79426704|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
44418747|NCT00809159|79426705|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
44307853|NCT01054729|79308992|FG000|Overall Study|Lost to Follow-up|0|||
44307854|NCT01054729|79308993|FG001|Overall Study|Lost to Follow-up|1|||
44307855|NCT01054729|79308994|FG002|Overall Study|Lost to Follow-up|0|||
44307856|NCT01054729|79308995|FG003|Overall Study|Lost to Follow-up|0|||
44307857|NCT01054729|79308992|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
44307858|NCT01054729|79308993|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
44418748|NCT00809159|79426706|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
44418749|NCT00809159|79426707|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
44418750|NCT00809159|79426708|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
44418751|NCT00809159|79426703|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
44534786|NCT03535194|79545560|FG003|Induction Period|Lost to Follow-up|3|||
44155240|NCT02668393|78946933|FG001|Overall Study|Progressive disease|3|||
44418752|NCT00809159|79426704|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
44534787|NCT03535194|79545561|FG004|Induction Period|Lost to Follow-up|0|||
44534788|NCT03535194|79545557|FG000|Induction Period|Physician Decision|1|||
44307859|NCT01054729|79308994|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
44155241|NCT02668393|78946932|FG000|Overall Study|Adverse Event|0|||
44155242|NCT02668393|78946933|FG001|Overall Study|Adverse Event|2|||
44155243|NCT02668393|78946932|FG000|Overall Study|Withdrawal from the trial|0|||
44155244|NCT02668393|78946933|FG001|Overall Study|Withdrawal from the trial|1|||
44155245|NCT02668393|78946932|FG000|Overall Study|Lack of benefit and side effects|1|||
44307860|NCT01054729|79308995|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
44307861|NCT01054729|79308992|FG000|Overall Study|Non-responder|1|||
44307862|NCT01054729|79308993|FG001|Overall Study|Non-responder|0|||
44307863|NCT01054729|79308994|FG002|Overall Study|Non-responder|1|||
44307864|NCT01054729|79308995|FG003|Overall Study|Non-responder|1|||
44307865|NCT01054729|79308992|FG000|Overall Study|PEG/RBV Non-responder|1|||
44307866|NCT01054729|79308993|FG001|Overall Study|PEG/RBV Non-responder|0|||
44307867|NCT01054729|79308994|FG002|Overall Study|PEG/RBV Non-responder|1|||
44307868|NCT01054729|79308995|FG003|Overall Study|PEG/RBV Non-responder|0|||
44307869|NCT01054729|79308992|FG000|Overall Study|Personal/Obligations|0|||
44307870|NCT01054729|79308993|FG001|Overall Study|Personal/Obligations|1|||
44307871|NCT01054729|79308994|FG002|Overall Study|Personal/Obligations|0|||
44307872|NCT01054729|79308995|FG003|Overall Study|Personal/Obligations|0|||
44307873|NCT01054729|79308992|FG000|Overall Study|Subject moved|0|||
44307874|NCT01054729|79308993|FG001|Overall Study|Subject moved|0|||
44307875|NCT01054729|79308994|FG002|Overall Study|Subject moved|1|||
44307876|NCT01054729|79308995|FG003|Overall Study|Subject moved|0|||
44307877|NCT01054729|79308992|FG000|Overall Study|Lack of Efficacy|0|||
44307878|NCT01054729|79308993|FG001|Overall Study|Lack of Efficacy|0|||
44307879|NCT01054729|79308994|FG002|Overall Study|Lack of Efficacy|0|||
44307880|NCT01054729|79308995|FG003|Overall Study|Lack of Efficacy|1|||
44307881|NCT01054573|79309009|FG000|Overall Study|Adverse Event|1|||
44307882|NCT01054573|79309010|FG001|Overall Study|Adverse Event|0|||
44307883|NCT01054573|79309011|FG002|Overall Study|Adverse Event|1|||
44307884|NCT01054573|79309012|FG003|Overall Study|Adverse Event|1|||
44307885|NCT01054573|79309009|FG000|Overall Study|Lost to Follow-up|0|||
44307886|NCT01054573|79309010|FG001|Overall Study|Lost to Follow-up|2|||
44307887|NCT01054573|79309011|FG002|Overall Study|Lost to Follow-up|0|||
44307888|NCT01054573|79309012|FG003|Overall Study|Lost to Follow-up|0|||
44307889|NCT01054573|79309009|FG000|Overall Study|Withdrawal by Subject|0|||
44307890|NCT01054573|79309010|FG001|Overall Study|Withdrawal by Subject|2|||
44307891|NCT01054573|79309011|FG002|Overall Study|Withdrawal by Subject|2|||
44307892|NCT01054573|79309012|FG003|Overall Study|Withdrawal by Subject|1|||
44307893|NCT01054456|79309031|FG000|Overall Study|Other|1|||
44307894|NCT01054300|79309037|FG000|Period 1|Adverse Event|1|||
44307895|NCT01054300|79309038|FG001|Period 1|Adverse Event|0|||
44307896|NCT01054300|79309039|FG002|Period 1|Adverse Event|0|||
44307897|NCT01054300|79309040|FG003|Period 1|Adverse Event|0|||
44307898|NCT01054300|79309037|FG000|Period 2|Withdrawal by Subject|0|||
44307899|NCT01054300|79309038|FG001|Period 2|Withdrawal by Subject|0|||
44307900|NCT01054300|79309039|FG002|Period 2|Withdrawal by Subject|1|||
44307901|NCT01054300|79309040|FG003|Period 2|Withdrawal by Subject|0|||
44307902|NCT01053988|79309055|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
44307903|NCT01053988|79309056|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307904|NCT01053988|79309057|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307905|NCT01053988|79309058|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307906|NCT01053988|79309059|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307907|NCT01053988|79309060|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
44307908|NCT01053988|79309055|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
44307909|NCT01053988|79309056|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44418753|NCT00809159|79426705|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
44418754|NCT00809159|79426706|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
44534789|NCT03535194|79545558|FG001|Induction Period|Physician Decision|1|||
44534790|NCT03535194|79545559|FG002|Induction Period|Physician Decision|0|||
44534791|NCT03535194|79545560|FG003|Induction Period|Physician Decision|0|||
44307910|NCT01053988|79309057|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44534792|NCT03535194|79545561|FG004|Induction Period|Physician Decision|0|||
44534793|NCT03535194|79545557|FG000|Induction Period|Protocol Violation|1|||
44534794|NCT03535194|79545558|FG001|Induction Period|Protocol Violation|0|||
44534795|NCT03535194|79545559|FG002|Induction Period|Protocol Violation|0|||
44534796|NCT03535194|79545560|FG003|Induction Period|Protocol Violation|1|||
44155246|NCT02668393|78946933|FG001|Overall Study|Lack of benefit and side effects|0|||
44307911|NCT01053988|79309058|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307912|NCT01053988|79309059|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307913|NCT01053988|79309060|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
44307914|NCT01053988|79309055|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
44534797|NCT03535194|79545561|FG004|Induction Period|Protocol Violation|0|||
44534798|NCT03535194|79545557|FG000|Induction Period|Screen Failure|0|||
44307915|NCT01053988|79309056|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307916|NCT01053988|79309057|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307917|NCT01053988|79309058|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307918|NCT01053988|79309059|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307919|NCT01053988|79309060|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
44307920|NCT01053988|79309055|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
44307921|NCT01053988|79309056|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307922|NCT01053988|79309057|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307923|NCT01053988|79309058|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307924|NCT01053988|79309059|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307925|NCT01053988|79309060|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
44307926|NCT01053988|79309055|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
44307927|NCT01053988|79309056|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307928|NCT01053988|79309057|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307929|NCT01053988|79309058|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307930|NCT01053988|79309059|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307931|NCT01053988|79309060|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
44307932|NCT01053988|79309055|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
44307933|NCT01053988|79309056|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307934|NCT01053988|79309057|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307935|NCT01053988|79309058|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307936|NCT01053988|79309059|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307937|NCT01053988|79309060|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
44307938|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
44307939|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
44307940|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
44307941|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
44307942|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
44307943|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
44307944|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44307945|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
44307946|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
44307947|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
44307948|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
44307949|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
44307950|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
44307951|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
44307952|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
44307953|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
44307954|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
44307955|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
44307956|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
44307957|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
44307958|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
44307959|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
44307960|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
44307961|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
44307962|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
44307963|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
44307964|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
44307965|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
44307966|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
44307967|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
44307968|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44307969|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
44307970|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44307971|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
44307972|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
44307973|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
44307974|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
44307975|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
44307976|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
44307977|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
44307978|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
44307979|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
44307980|NCT01053988|79309055|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44418755|NCT00809159|79426707|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
44418756|NCT00809159|79426708|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
44418757|NCT00809159|79426703|FG000|Part 1 and 2|Administrative problems|0|||
44418758|NCT00809159|79426704|FG001|Part 1 and 2|Administrative problems|0|||
44418759|NCT00809159|79426705|FG002|Part 1 and 2|Administrative problems|0|||
44418760|NCT00809159|79426706|FG003|Part 1 and 2|Administrative problems|1|||
44418761|NCT00809159|79426707|FG004|Part 1 and 2|Administrative problems|0|||
44418762|NCT00809159|79426708|FG005|Part 1 and 2|Administrative problems|0|||
44418763|NCT00809159|79426703|FG000|Part 1 and 2|Adverse Event|0|||
44418764|NCT00809159|79426704|FG001|Part 1 and 2|Adverse Event|0|||
44418765|NCT00809159|79426705|FG002|Part 1 and 2|Adverse Event|1|||
44418766|NCT00809159|79426706|FG003|Part 1 and 2|Adverse Event|0|||
44418767|NCT00809159|79426707|FG004|Part 1 and 2|Adverse Event|1|||
44418768|NCT00809159|79426708|FG005|Part 1 and 2|Adverse Event|1|||
44418769|NCT00809159|79426703|FG000|Part 1 and 2|Lost to Follow-up|0|||
44418770|NCT00809159|79426704|FG001|Part 1 and 2|Lost to Follow-up|0|||
44418771|NCT00809159|79426705|FG002|Part 1 and 2|Lost to Follow-up|1|||
44418772|NCT00809159|79426706|FG003|Part 1 and 2|Lost to Follow-up|1|||
44418773|NCT00809159|79426707|FG004|Part 1 and 2|Lost to Follow-up|0|||
44418774|NCT00809159|79426708|FG005|Part 1 and 2|Lost to Follow-up|0|||
44418775|NCT00809159|79426703|FG000|Part 1 and 2|Withdrawal by Subject|0|||
44418776|NCT00809159|79426704|FG001|Part 1 and 2|Withdrawal by Subject|0|||
44418777|NCT00809159|79426705|FG002|Part 1 and 2|Withdrawal by Subject|4|||
44418778|NCT00809159|79426706|FG003|Part 1 and 2|Withdrawal by Subject|0|||
44418779|NCT00809159|79426707|FG004|Part 1 and 2|Withdrawal by Subject|0|||
44418780|NCT00809159|79426708|FG005|Part 1 and 2|Withdrawal by Subject|1|||
44418781|NCT00745368|79426722|FG000|Overall Study|Unable to provide sample|3|||
44534799|NCT03535194|79545558|FG001|Induction Period|Screen Failure|1|||
44534800|NCT03535194|79545559|FG002|Induction Period|Screen Failure|0|||
44534801|NCT03535194|79545560|FG003|Induction Period|Screen Failure|0|||
44534802|NCT03535194|79545561|FG004|Induction Period|Screen Failure|0|||
44534803|NCT03535194|79545557|FG000|Induction Period|Withdrawal by Subject|3|||
44534804|NCT03535194|79545558|FG001|Induction Period|Withdrawal by Subject|4|||
44534805|NCT03535194|79545559|FG002|Induction Period|Withdrawal by Subject|3|||
44534806|NCT03535194|79545560|FG003|Induction Period|Withdrawal by Subject|2|||
44534807|NCT03535194|79545561|FG004|Induction Period|Withdrawal by Subject|0|||
44534808|NCT03535194|79545557|FG000|Maintenance Period|Adverse Event|6|||
44534809|NCT03535194|79545558|FG001|Maintenance Period|Adverse Event|5|||
44534810|NCT03535194|79545559|FG002|Maintenance Period|Adverse Event|1|||
44534811|NCT03535194|79545560|FG003|Maintenance Period|Adverse Event|11|||
44534812|NCT03535194|79545561|FG004|Maintenance Period|Adverse Event|4|||
44534813|NCT03535194|79545557|FG000|Maintenance Period|Lack of Efficacy|3|||
44534814|NCT03535194|79545558|FG001|Maintenance Period|Lack of Efficacy|2|||
44534815|NCT03535194|79545559|FG002|Maintenance Period|Lack of Efficacy|5|||
44534816|NCT03535194|79545560|FG003|Maintenance Period|Lack of Efficacy|9|||
44534817|NCT03535194|79545561|FG004|Maintenance Period|Lack of Efficacy|0|||
44534818|NCT03535194|79545557|FG000|Maintenance Period|Lost to Follow-up|4|||
44534819|NCT03535194|79545558|FG001|Maintenance Period|Lost to Follow-up|2|||
44534820|NCT03535194|79545559|FG002|Maintenance Period|Lost to Follow-up|1|||
44534821|NCT03535194|79545560|FG003|Maintenance Period|Lost to Follow-up|5|||
44534822|NCT03535194|79545561|FG004|Maintenance Period|Lost to Follow-up|2|||
44534823|NCT03535194|79545557|FG000|Maintenance Period|Other|1|||
44534824|NCT03535194|79545558|FG001|Maintenance Period|Other|2|||
44534825|NCT03535194|79545559|FG002|Maintenance Period|Other|0|||
44534826|NCT03535194|79545560|FG003|Maintenance Period|Other|0|||
44534827|NCT03535194|79545561|FG004|Maintenance Period|Other|0|||
44534828|NCT03535194|79545557|FG000|Maintenance Period|Physician Decision|1|||
44534829|NCT03535194|79545558|FG001|Maintenance Period|Physician Decision|2|||
44534830|NCT03535194|79545559|FG002|Maintenance Period|Physician Decision|0|||
44534831|NCT03535194|79545560|FG003|Maintenance Period|Physician Decision|2|||
44418782|NCT00589472|79426726|FG000|Overall Study|Adverse Event|1|||
44418783|NCT00811577|79426732|FG000|Overall Study|Lost to Follow-up|7|||
44418784|NCT00811577|79426733|FG001|Overall Study|Lost to Follow-up|1|||
44418785|NCT00811577|79426732|FG000|Overall Study|Withdrawal by Subject|3|||
44418786|NCT00811577|79426733|FG001|Overall Study|Withdrawal by Subject|0|||
44418787|NCT00802178|79426782|FG000|Overall Study|Lack of Efficacy|36|||
44418788|NCT00802178|79426782|FG000|Overall Study|Insufficient tolerability (IT)|17|||
44418789|NCT00802178|79426782|FG000|Overall Study|Withdrawal by Subject|18|||
44418790|NCT00802178|79426782|FG000|Overall Study|Other|32|||
44534832|NCT03535194|79545561|FG004|Maintenance Period|Physician Decision|0|||
44534833|NCT03535194|79545557|FG000|Maintenance Period|Pregnancy|0|||
44534834|NCT03535194|79545558|FG001|Maintenance Period|Pregnancy|0|||
44534835|NCT03535194|79545559|FG002|Maintenance Period|Pregnancy|0|||
44534836|NCT03535194|79545560|FG003|Maintenance Period|Pregnancy|2|||
44534837|NCT03535194|79545561|FG004|Maintenance Period|Pregnancy|0|||
44307981|NCT01053988|79309056|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
44307982|NCT01053988|79309057|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
44307983|NCT01053988|79309058|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
44307984|NCT01053988|79309059|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
44307985|NCT01053988|79309060|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
44307986|NCT01053247|79309075|FG000|Overall Study|Withdrawal by Subject|9|||
44307987|NCT01053247|79309076|FG001|Overall Study|Withdrawal by Subject|4|||
44307988|NCT01053247|79309077|FG002|Overall Study|Withdrawal by Subject|15|||
44307989|NCT01053247|79309075|FG000|Overall Study|Lack of Efficacy|1|||
44307990|NCT01053247|79309076|FG001|Overall Study|Lack of Efficacy|0|||
44307991|NCT01053247|79309077|FG002|Overall Study|Lack of Efficacy|1|||
44307992|NCT01053247|79309075|FG000|Overall Study|Protocol Violation|2|||
44307993|NCT01053247|79309076|FG001|Overall Study|Protocol Violation|1|||
44307994|NCT01053247|79309077|FG002|Overall Study|Protocol Violation|2|||
44307995|NCT01053247|79309075|FG000|Overall Study|Lost to Follow-up|8|||
44307996|NCT01053247|79309076|FG001|Overall Study|Lost to Follow-up|5|||
44307997|NCT01053247|79309077|FG002|Overall Study|Lost to Follow-up|7|||
44307998|NCT01053247|79309075|FG000|Overall Study|Adverse Event|0|||
44307999|NCT01053247|79309076|FG001|Overall Study|Adverse Event|9|||
44308000|NCT01053247|79309077|FG002|Overall Study|Adverse Event|3|||
44308001|NCT01052662|79309088|FG000|Overall Study|Lost to Follow-up|15|||
44308002|NCT01052662|79309089|FG001|Overall Study|Lost to Follow-up|13|||
44308003|NCT01052662|79309090|FG002|Overall Study|Lost to Follow-up|18|||
44308004|NCT01052662|79309088|FG000|Overall Study|Withdrawal by Subject|3|||
44308005|NCT01052662|79309089|FG001|Overall Study|Withdrawal by Subject|2|||
44308006|NCT01052662|79309090|FG002|Overall Study|Withdrawal by Subject|1|||
44308007|NCT01052662|79309088|FG000|Overall Study|Pharmacy issue|1|||
44308008|NCT01052662|79309089|FG001|Overall Study|Pharmacy issue|3|||
44308009|NCT01052662|79309090|FG002|Overall Study|Pharmacy issue|3|||
44308010|NCT01052662|79309088|FG000|Overall Study|Adverse Event|1|||
44308011|NCT01052662|79309089|FG001|Overall Study|Adverse Event|1|||
44308012|NCT01052662|79309090|FG002|Overall Study|Adverse Event|0|||
44308013|NCT01052662|79309088|FG000|Overall Study|Legal Problem|2|||
44308014|NCT01052662|79309089|FG001|Overall Study|Legal Problem|0|||
44308015|NCT01052662|79309090|FG002|Overall Study|Legal Problem|0|||
44308016|NCT01052662|79309088|FG000|Overall Study|Administrative|0|||
44308017|NCT01052662|79309089|FG001|Overall Study|Administrative|3|||
44308018|NCT01052662|79309090|FG002|Overall Study|Administrative|0|||
44308019|NCT01052116|79309100|FG000|Overall Study|Lost to Follow-up|11|||
44308020|NCT01052116|79309101|FG001|Overall Study|Lost to Follow-up|17|||
44308021|NCT01052116|79309100|FG000|Overall Study|Withdrawal by Subject|3|||
44308022|NCT01052116|79309101|FG001|Overall Study|Withdrawal by Subject|6|||
44308023|NCT01052116|79309100|FG000|Overall Study|Spirometry not performed|0|||
44308024|NCT01052116|79309101|FG001|Overall Study|Spirometry not performed|4|||
44308025|NCT01052077|79309109|FG000|Phase A|Lost to Follow-up|22|||
44308026|NCT01052077|79309110|FG001|Phase A|Lost to Follow-up|0|||
44308027|NCT01052077|79309111|FG002|Phase A|Lost to Follow-up|0|||
44308028|NCT01052077|79309112|FG003|Phase A|Lost to Follow-up|0|||
44308029|NCT01052077|79309109|FG000|Phase A|Adverse Event|32|||
44418791|NCT00802178|79426782|FG000|Overall Study|Lack of efficacy and patient wish|1|||
44418792|NCT00802178|79426782|FG000|Overall Study|IT and patient wish|8|||
44418793|NCT00802178|79426782|FG000|Overall Study|Patients wish and other reason|1|||
44534838|NCT03535194|79545557|FG000|Maintenance Period|Protocol Violation|0|||
44534839|NCT03535194|79545558|FG001|Maintenance Period|Protocol Violation|1|||
44155247|NCT01998958|78946947|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44308030|NCT01052077|79309110|FG001|Phase A|Adverse Event|0|||
44308031|NCT01052077|79309111|FG002|Phase A|Adverse Event|0|||
44308032|NCT01052077|79309112|FG003|Phase A|Adverse Event|0|||
44308033|NCT01052077|79309109|FG000|Phase A|Met Withdrawal Criteria|26|||
44308034|NCT01052077|79309110|FG001|Phase A|Met Withdrawal Criteria|0|||
44308035|NCT01052077|79309111|FG002|Phase A|Met Withdrawal Criteria|0|||
44308036|NCT01052077|79309112|FG003|Phase A|Met Withdrawal Criteria|0|||
44308037|NCT01052077|79309109|FG000|Phase A|Physician Decision|10|||
44308038|NCT01052077|79309110|FG001|Phase A|Physician Decision|0|||
44308039|NCT01052077|79309111|FG002|Phase A|Physician Decision|0|||
44418794|NCT00744978|79426788|FG000|Period 1|Lost to Follow-up|1|||
44418795|NCT00744978|79426789|FG001|Period 1|Lost to Follow-up|0|||
44418796|NCT00744978|79426788|FG000|Period 1|Withdrawal by Subject|0|||
44308040|NCT01052077|79309112|FG003|Phase A|Physician Decision|0|||
44308041|NCT01052077|79309109|FG000|Phase A|Withdrawal by Subject|29|||
44308042|NCT01052077|79309110|FG001|Phase A|Withdrawal by Subject|0|||
44308043|NCT01052077|79309111|FG002|Phase A|Withdrawal by Subject|0|||
44308044|NCT01052077|79309112|FG003|Phase A|Withdrawal by Subject|0|||
44308045|NCT01052077|79309109|FG000|Phase A|Protocol Deviation|27|||
44308046|NCT01052077|79309110|FG001|Phase A|Protocol Deviation|0|||
44308047|NCT01052077|79309111|FG002|Phase A|Protocol Deviation|0|||
44308048|NCT01052077|79309112|FG003|Phase A|Protocol Deviation|0|||
44308049|NCT01052077|79309109|FG000|Phase B|Lost to Follow-up|0|||
44308050|NCT01052077|79309110|FG001|Phase B|Lost to Follow-up|2|||
44308051|NCT01052077|79309111|FG002|Phase B|Lost to Follow-up|3|||
44308052|NCT01052077|79309112|FG003|Phase B|Lost to Follow-up|0|||
44308053|NCT01052077|79309109|FG000|Phase B|Adverse Event|0|||
44308054|NCT01052077|79309110|FG001|Phase B|Adverse Event|9|||
44308055|NCT01052077|79309111|FG002|Phase B|Adverse Event|2|||
44308056|NCT01052077|79309112|FG003|Phase B|Adverse Event|0|||
44308057|NCT01052077|79309109|FG000|Phase B|Met Withdrawal Criteria|0|||
44308058|NCT01052077|79309110|FG001|Phase B|Met Withdrawal Criteria|2|||
44308059|NCT01052077|79309111|FG002|Phase B|Met Withdrawal Criteria|1|||
44308060|NCT01052077|79309112|FG003|Phase B|Met Withdrawal Criteria|0|||
44308061|NCT01052077|79309109|FG000|Phase B|Physician Decision|0|||
44308062|NCT01052077|79309110|FG001|Phase B|Physician Decision|1|||
44308063|NCT01052077|79309111|FG002|Phase B|Physician Decision|1|||
44308064|NCT01052077|79309112|FG003|Phase B|Physician Decision|0|||
44308065|NCT01052077|79309109|FG000|Phase B|Withdrawal by Subject|0|||
44308066|NCT01052077|79309110|FG001|Phase B|Withdrawal by Subject|0|||
44308067|NCT01052077|79309111|FG002|Phase B|Withdrawal by Subject|5|||
44308068|NCT01052077|79309112|FG003|Phase B|Withdrawal by Subject|0|||
44534840|NCT03535194|79545559|FG002|Maintenance Period|Protocol Violation|0|||
44534841|NCT03535194|79545560|FG003|Maintenance Period|Protocol Violation|0|||
44155248|NCT01998958|78946948|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
44155249|NCT01998958|78946949|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44257226|NCT02152956|79109570|FG002|Overall Study|Physician Decision|0|||
44257227|NCT02152956|79109571|FG003|Overall Study|Physician Decision|0|||
44257228|NCT02152956|79109572|FG004|Overall Study|Physician Decision|0|||
44257229|NCT02152956|79109573|FG005|Overall Study|Physician Decision|0|||
44257230|NCT02152956|79109574|FG006|Overall Study|Physician Decision|0|||
44257231|NCT02152956|79109575|FG007|Overall Study|Physician Decision|0|||
44257232|NCT02152956|79109576|FG008|Overall Study|Physician Decision|0|||
44257233|NCT02152956|79109577|FG009|Overall Study|Physician Decision|0|||
44257234|NCT02152956|79109578|FG010|Overall Study|Physician Decision|0|||
44257235|NCT02152956|79109579|FG011|Overall Study|Physician Decision|1|||
44257236|NCT02152956|79109580|FG012|Overall Study|Physician Decision|0|||
44257237|NCT02152956|79109568|FG000|Overall Study|Study terminated by sponsor|0|||
44257238|NCT02152956|79109569|FG001|Overall Study|Study terminated by sponsor|0|||
44257239|NCT02152956|79109570|FG002|Overall Study|Study terminated by sponsor|0|||
44257240|NCT02152956|79109571|FG003|Overall Study|Study terminated by sponsor|0|||
44257241|NCT02152956|79109572|FG004|Overall Study|Study terminated by sponsor|0|||
44257242|NCT02152956|79109573|FG005|Overall Study|Study terminated by sponsor|0|||
44257243|NCT02152956|79109574|FG006|Overall Study|Study terminated by sponsor|0|||
44257244|NCT02152956|79109575|FG007|Overall Study|Study terminated by sponsor|0|||
44257245|NCT02152956|79109576|FG008|Overall Study|Study terminated by sponsor|0|||
44257246|NCT02152956|79109577|FG009|Overall Study|Study terminated by sponsor|0|||
44257247|NCT02152956|79109578|FG010|Overall Study|Study terminated by sponsor|0|||
44257248|NCT02152956|79109579|FG011|Overall Study|Study terminated by sponsor|29|||
44257249|NCT02152956|79109580|FG012|Overall Study|Study terminated by sponsor|0|||
44257250|NCT02152956|79109568|FG000|Overall Study|progressive disease|0|||
44257251|NCT02152956|79109569|FG001|Overall Study|progressive disease|0|||
44257252|NCT02152956|79109570|FG002|Overall Study|progressive disease|0|||
44257253|NCT02152956|79109571|FG003|Overall Study|progressive disease|0|||
44257254|NCT02152956|79109572|FG004|Overall Study|progressive disease|0|||
44257255|NCT02152956|79109573|FG005|Overall Study|progressive disease|0|||
44257256|NCT02152956|79109574|FG006|Overall Study|progressive disease|0|||
44257257|NCT02152956|79109575|FG007|Overall Study|progressive disease|0|||
44257258|NCT02152956|79109576|FG008|Overall Study|progressive disease|1|||
44257259|NCT02152956|79109577|FG009|Overall Study|progressive disease|0|||
44257260|NCT02152956|79109578|FG010|Overall Study|progressive disease|0|||
44257261|NCT02152956|79109579|FG011|Overall Study|progressive disease|1|||
44257262|NCT02152956|79109580|FG012|Overall Study|progressive disease|0|||
44257263|NCT01553149|79109660|FG000|Overall Study|Adverse Event|0|||
44257264|NCT01553149|79109661|FG001|Overall Study|Adverse Event|9|||
44257265|NCT01553149|79109660|FG000|Overall Study|Physician Decision|5|||
44257266|NCT01553149|79109661|FG001|Overall Study|Physician Decision|10|||
44257267|NCT01553149|79109660|FG000|Overall Study|Ineligible|0|||
44257268|NCT01553149|79109661|FG001|Overall Study|Ineligible|1|||
44257269|NCT01437189|79109684|FG000|Overall Study|Adverse Event|3|||
44257270|NCT01437189|79109684|FG000|Overall Study|Lack of Efficacy|4|||
44257271|NCT01437189|79109684|FG000|Overall Study|Withdrawal by Subject|8|||
44257272|NCT01311713|79109708|FG000|Overall Study|Death|0|||
44257273|NCT01311713|79109709|FG001|Overall Study|Death|0|||
44257274|NCT01311713|79109710|FG002|Overall Study|Death|1|||
44257275|NCT01311713|79109711|FG003|Overall Study|Death|1|||
44257276|NCT01311713|79109712|FG004|Overall Study|Death|0|||
44257277|NCT01311713|79109713|FG005|Overall Study|Death|1|||
44257278|NCT01311713|79109714|FG006|Overall Study|Death|0|||
44257279|NCT01311713|79109708|FG000|Overall Study|Adverse Event|0|||
44257280|NCT01311713|79109709|FG001|Overall Study|Adverse Event|1|||
44257281|NCT01311713|79109710|FG002|Overall Study|Adverse Event|0|||
44257282|NCT01311713|79109711|FG003|Overall Study|Adverse Event|2|||
44257283|NCT01311713|79109712|FG004|Overall Study|Adverse Event|0|||
44257284|NCT01311713|79109713|FG005|Overall Study|Adverse Event|0|||
44308069|NCT01052077|79309109|FG000|Phase B|Protocol Deviation|0|||
44308070|NCT01052077|79309110|FG001|Phase B|Protocol Deviation|3|||
44308071|NCT01052077|79309111|FG002|Phase B|Protocol Deviation|4|||
44308072|NCT01052077|79309112|FG003|Phase B|Protocol Deviation|0|||
44308073|NCT01052077|79309109|FG000|Phase B|Lack of Efficacy|0|||
44308074|NCT01052077|79309110|FG001|Phase B|Lack of Efficacy|1|||
44308075|NCT01052077|79309111|FG002|Phase B|Lack of Efficacy|0|||
44308076|NCT01052077|79309112|FG003|Phase B|Lack of Efficacy|0|||
44308077|NCT01052077|79309109|FG000|Phase A+|Lost to Follow-up|0|||
44308078|NCT01052077|79309110|FG001|Phase A+|Lost to Follow-up|0|||
44308079|NCT01052077|79309111|FG002|Phase A+|Lost to Follow-up|0|||
44308080|NCT01052077|79309112|FG003|Phase A+|Lost to Follow-up|8|||
44308081|NCT01052077|79309109|FG000|Phase A+|Adverse Event|0|||
44308082|NCT01052077|79309110|FG001|Phase A+|Adverse Event|0|||
44308083|NCT01052077|79309111|FG002|Phase A+|Adverse Event|0|||
44308084|NCT01052077|79309112|FG003|Phase A+|Adverse Event|4|||
44308085|NCT01052077|79309109|FG000|Phase A+|Met Withdrawal Criteria|0|||
44308086|NCT01052077|79309110|FG001|Phase A+|Met Withdrawal Criteria|0|||
44308087|NCT01052077|79309111|FG002|Phase A+|Met Withdrawal Criteria|0|||
44308088|NCT01052077|79309112|FG003|Phase A+|Met Withdrawal Criteria|2|||
44308089|NCT01052077|79309109|FG000|Phase A+|Withdrawal by Subject|0|||
44308090|NCT01052077|79309110|FG001|Phase A+|Withdrawal by Subject|0|||
44308091|NCT01052077|79309111|FG002|Phase A+|Withdrawal by Subject|0|||
44308092|NCT01052077|79309112|FG003|Phase A+|Withdrawal by Subject|7|||
44308093|NCT01052038|79309121|FG000|Overall Study|Lost to Follow-up|2|||
44308094|NCT01052038|79309122|FG001|Overall Study|Lost to Follow-up|3|||
44308095|NCT01052038|79309123|FG002|Overall Study|Lost to Follow-up|1|||
44308096|NCT01052038|79309121|FG000|Overall Study|Protocol Violation|2|||
44308097|NCT01052038|79309122|FG001|Overall Study|Protocol Violation|3|||
44308098|NCT01052038|79309123|FG002|Overall Study|Protocol Violation|3|||
44308099|NCT01051960|79309131|FG000|Overall Study|Adverse Event|1|||
44308100|NCT01051921|79309135|FG000|Overall Study|Physician Decision|9|||
44308101|NCT01051921|79309135|FG000|Overall Study|Adverse Event|8|||
44308102|NCT01051921|79309135|FG000|Overall Study|Withdrawal by Subject|7|||
44308103|NCT01051921|79309135|FG000|Overall Study|Lost to Follow-up|4|||
44308104|NCT01051921|79309135|FG000|Overall Study|virological failure|1|||
44308105|NCT01051921|79309135|FG000|Overall Study|patient moved|1|||
44308106|NCT01051063|79309141|FG000|Overall Study|Death|2|||
44308107|NCT01051063|79309142|FG001|Overall Study|Death|2|||
44308108|NCT01051063|79309141|FG000|Overall Study|Withdrawal by Subject|1|||
44308109|NCT01051063|79309142|FG001|Overall Study|Withdrawal by Subject|1|||
44308110|NCT01051063|79309141|FG000|Overall Study|Termination of the study|5|||
44308111|NCT01051063|79309142|FG001|Overall Study|Termination of the study|0|||
44308112|NCT01051063|79309141|FG000|Overall Study|Moved from the study site area|1|||
44308113|NCT01051063|79309142|FG001|Overall Study|Moved from the study site area|0|||
44308114|NCT01051063|79309141|FG000|Overall Study|Other|1|||
44308115|NCT01051063|79309142|FG001|Overall Study|Other|0|||
44308116|NCT01051063|79309141|FG000|Overall Study|Lost to Follow-up|0|||
44308117|NCT01051063|79309142|FG001|Overall Study|Lost to Follow-up|1|||
44308118|NCT01050790|79309149|FG000|Overall Study|Adverse Event|1|||
44308119|NCT01050673|79309156|FG000|Overall Study|Physician Decision|4|||
44308120|NCT01050673|79309157|FG001|Overall Study|Physician Decision|5|||
44308121|NCT01050205|79309165|FG000|Overall Study|Lost to Follow-up|7|||
44308122|NCT01050205|79309166|FG001|Overall Study|Lost to Follow-up|1|||
44308123|NCT01050205|79309165|FG000|Overall Study|Withdrawal by Subject|1|||
44308124|NCT01050205|79309166|FG001|Overall Study|Withdrawal by Subject|1|||
44308125|NCT01050205|79309165|FG000|Overall Study|Relocated from area|1|||
44308126|NCT01050205|79309166|FG001|Overall Study|Relocated from area|2|||
44308127|NCT01050205|79309165|FG000|Overall Study|Discontinued Intervention|2|||
44418797|NCT00744978|79426789|FG001|Period 1|Withdrawal by Subject|2|||
44418798|NCT00744978|79426788|FG000|Period 1|Other|0|||
44418799|NCT00744978|79426789|FG001|Period 1|Other|2|||
44308128|NCT01050205|79309166|FG001|Overall Study|Discontinued Intervention|0|||
44418800|NCT00744978|79426788|FG000|Period 1|Adverse Event|4|||
44257285|NCT01311713|79109714|FG006|Overall Study|Adverse Event|2|||
44257286|NCT01311713|79109708|FG000|Overall Study|Withdrawal by Subject|0|||
44257287|NCT01311713|79109709|FG001|Overall Study|Withdrawal by Subject|1|||
44257288|NCT01311713|79109710|FG002|Overall Study|Withdrawal by Subject|1|||
44257289|NCT01311713|79109711|FG003|Overall Study|Withdrawal by Subject|0|||
44257290|NCT01311713|79109712|FG004|Overall Study|Withdrawal by Subject|0|||
44257291|NCT01311713|79109713|FG005|Overall Study|Withdrawal by Subject|1|||
44257292|NCT01311713|79109714|FG006|Overall Study|Withdrawal by Subject|2|||
44257293|NCT01311713|79109708|FG000|Overall Study|Disease progression|3|||
44257294|NCT01311713|79109709|FG001|Overall Study|Disease progression|4|||
44257295|NCT01311713|79109710|FG002|Overall Study|Disease progression|3|||
44308129|NCT01059448|79309176|FG000|Overall Study|Adverse Event|1|||
44308130|NCT01059448|79309177|FG001|Overall Study|Adverse Event|3|||
44308131|NCT01059448|79309178|FG002|Overall Study|Adverse Event|0|||
44308132|NCT01059448|79309179|FG003|Overall Study|Adverse Event|1|||
44308133|NCT01059448|79309176|FG000|Overall Study|Withdrawal by Subject|2|||
44308134|NCT01059448|79309177|FG001|Overall Study|Withdrawal by Subject|0|||
44308135|NCT01059448|79309178|FG002|Overall Study|Withdrawal by Subject|2|||
44308136|NCT01059448|79309179|FG003|Overall Study|Withdrawal by Subject|4|||
44308137|NCT01059448|79309176|FG000|Overall Study|Disease Progression|2|||
44308138|NCT01059448|79309177|FG001|Overall Study|Disease Progression|1|||
44308139|NCT01059448|79309178|FG002|Overall Study|Disease Progression|4|||
44308140|NCT01059448|79309179|FG003|Overall Study|Disease Progression|2|||
44308141|NCT01059448|79309176|FG000|Overall Study|Administrative Decision|43|||
44308142|NCT01059448|79309177|FG001|Overall Study|Administrative Decision|49|||
44308143|NCT01059448|79309178|FG002|Overall Study|Administrative Decision|45|||
44418801|NCT00744978|79426789|FG001|Period 1|Adverse Event|0|||
44418802|NCT00744978|79426788|FG000|Period 1|Randomized but not Treated|1|||
44418803|NCT00744978|79426789|FG001|Period 1|Randomized but not Treated|1|||
44418804|NCT00744978|79426788|FG000|Period 2|Adverse Event|0|||
44418805|NCT00744978|79426789|FG001|Period 2|Adverse Event|1|||
44418806|NCT00739908|79426797|FG000|Overall Study|Adverse Event|5|||
44418807|NCT00739908|79426798|FG001|Overall Study|Adverse Event|6|||
44418808|NCT00739908|79426797|FG000|Overall Study|Withdrawal by Subject|4|||
44308144|NCT01059448|79309179|FG003|Overall Study|Administrative Decision|46|||
44418809|NCT00739908|79426798|FG001|Overall Study|Withdrawal by Subject|2|||
44418810|NCT00739908|79426797|FG000|Overall Study|Lost to Follow-up|14|||
44418811|NCT00739908|79426798|FG001|Overall Study|Lost to Follow-up|9|||
44418812|NCT00739908|79426797|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
44418813|NCT00739908|79426798|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
44418814|NCT00739908|79426797|FG000|Overall Study|Non-Compliance With Study Medication|0|||
44418815|NCT00739908|79426798|FG001|Overall Study|Non-Compliance With Study Medication|3|||
44418816|NCT00739908|79426797|FG000|Overall Study|Lack of Efficacy|0|||
44418817|NCT00739908|79426798|FG001|Overall Study|Lack of Efficacy|1|||
44418818|NCT00739908|79426797|FG000|Overall Study|Relocation|0|||
44418819|NCT00739908|79426798|FG001|Overall Study|Relocation|1|||
44418820|NCT00739596|79426808|FG000|Overall Study|Adverse Event|12|||
44418821|NCT00739596|79426809|FG001|Overall Study|Adverse Event|6|||
44418822|NCT00739596|79426808|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
44418823|NCT00739596|79426809|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44418824|NCT00739596|79426808|FG000|Overall Study|Patient Withdrew Consent|8|||
44418825|NCT00739596|79426809|FG001|Overall Study|Patient Withdrew Consent|8|||
44418826|NCT00739596|79426808|FG000|Overall Study|Lost to Follow-up|0|||
44418827|NCT00739596|79426809|FG001|Overall Study|Lost to Follow-up|2|||
44418828|NCT00739596|79426808|FG000|Overall Study|Protocol Deviation|1|||
44418829|NCT00739596|79426809|FG001|Overall Study|Protocol Deviation|1|||
44418830|NCT00742326|79426817|FG000|Overall Study|Physician Decision|0|||
44418831|NCT00742326|79426818|FG001|Overall Study|Physician Decision|1|||
44418832|NCT00741936|79426826|FG000|Overall Study|Lost to Follow-up|1|||
44418833|NCT00741936|79426827|FG001|Overall Study|Lost to Follow-up|1|||
44418834|NCT00741936|79426826|FG000|Overall Study|Adverse Event|3|||
44418835|NCT00741936|79426827|FG001|Overall Study|Adverse Event|4|||
44418836|NCT00741936|79426826|FG000|Overall Study|Pregnancy|0|||
44418837|NCT00741936|79426827|FG001|Overall Study|Pregnancy|1|||
44418838|NCT00741936|79426826|FG000|Overall Study|Protocol Violation|2|||
44418839|NCT00741936|79426827|FG001|Overall Study|Protocol Violation|0|||
44418840|NCT00741936|79426826|FG000|Overall Study|Lack of Efficacy|0|||
44418841|NCT00741936|79426827|FG001|Overall Study|Lack of Efficacy|2|||
44418842|NCT00741936|79426826|FG000|Overall Study|Low compliance|3|||
44418843|NCT00741936|79426827|FG001|Overall Study|Low compliance|0|||
44418844|NCT00811187|79426835|FG000|Overall Study|Unable to place device / procedure abort|3|||
44418845|NCT00811187|79426836|FG001|Overall Study|Unable to place device / procedure abort|3|||
44418846|NCT00591149|79426842|FG000|Overall Study|Adverse Event|4|||
44418847|NCT00591149|79426842|FG000|Overall Study|Withdrawal by Subject|1|||
44418848|NCT00735072|79426848|FG000|Overall Study|interrupted study med during ARV change|1|||
44418849|NCT00735072|79426849|FG001|Overall Study|interrupted study med during ARV change|0|||
44418850|NCT00735072|79426848|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
44418851|NCT00735072|79426849|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
44534842|NCT03535194|79545561|FG004|Maintenance Period|Protocol Violation|0|||
44308145|NCT01059448|79309176|FG000|Overall Study|Lost to Follow-up|0|||
44308146|NCT01059448|79309177|FG001|Overall Study|Lost to Follow-up|0|||
44418852|NCT00810641|79426860|FG000|Overall Study|Withdrawal by Subject|0|||
44418853|NCT00810641|79426861|FG001|Overall Study|Withdrawal by Subject|1|||
44418854|NCT00810641|79426862|FG002|Overall Study|Withdrawal by Subject|2|||
44418855|NCT00793598|79426875|FG000|Overall Study|Patient Request|0|||
44418856|NCT00793598|79426876|FG001|Overall Study|Patient Request|1|||
44418857|NCT00793598|79426877|FG002|Overall Study|Patient Request|0|||
44418858|NCT00793598|79426878|FG003|Overall Study|Patient Request|0|||
44418859|NCT00793598|79426879|FG004|Overall Study|Patient Request|0|||
44308147|NCT01059448|79309178|FG002|Overall Study|Lost to Follow-up|2|||
44308148|NCT01059448|79309179|FG003|Overall Study|Lost to Follow-up|0|||
44308149|NCT01059448|79309176|FG000|Overall Study|Death|0|||
44308150|NCT01059448|79309177|FG001|Overall Study|Death|1|||
44308151|NCT01059448|79309178|FG002|Overall Study|Death|0|||
44308152|NCT01059448|79309179|FG003|Overall Study|Death|0|||
44308153|NCT01059448|79309176|FG000|Overall Study|Other|1|||
44308154|NCT01059448|79309177|FG001|Overall Study|Other|1|||
44308155|NCT01059448|79309178|FG002|Overall Study|Other|0|||
44308156|NCT01059448|79309179|FG003|Overall Study|Other|1|||
44308157|NCT01058707|79309200|FG000|Overall Study|Disease Progression|15|||
44308158|NCT01058707|79309201|FG001|Overall Study|Disease Progression|20|||
44308159|NCT01058707|79309202|FG002|Overall Study|Disease Progression|20|||
44308160|NCT01058707|79309203|FG003|Overall Study|Disease Progression|15|||
44308161|NCT01058707|79309204|FG004|Overall Study|Disease Progression|23|||
44308162|NCT01058707|79309205|FG005|Overall Study|Disease Progression|10|||
44308163|NCT01058707|79309206|FG006|Overall Study|Disease Progression|12|||
44308164|NCT01058707|79309200|FG000|Overall Study|Adverse Event|11|||
44308165|NCT01058707|79309201|FG001|Overall Study|Adverse Event|4|||
44308166|NCT01058707|79309202|FG002|Overall Study|Adverse Event|7|||
44308167|NCT01058707|79309203|FG003|Overall Study|Adverse Event|6|||
44308168|NCT01058707|79309204|FG004|Overall Study|Adverse Event|7|||
44308169|NCT01058707|79309205|FG005|Overall Study|Adverse Event|3|||
44308170|NCT01058707|79309206|FG006|Overall Study|Adverse Event|1|||
44308171|NCT01058707|79309200|FG000|Overall Study|Subject Decision|5|||
44308172|NCT01058707|79309201|FG001|Overall Study|Subject Decision|3|||
44308173|NCT01058707|79309202|FG002|Overall Study|Subject Decision|3|||
44308174|NCT01058707|79309203|FG003|Overall Study|Subject Decision|1|||
44308175|NCT01058707|79309204|FG004|Overall Study|Subject Decision|2|||
44308176|NCT01058707|79309205|FG005|Overall Study|Subject Decision|3|||
44308177|NCT01058707|79309206|FG006|Overall Study|Subject Decision|6|||
44308178|NCT01058707|79309200|FG000|Overall Study|Lost to Follow-up|0|||
44308179|NCT01058707|79309201|FG001|Overall Study|Lost to Follow-up|0|||
44308180|NCT01058707|79309202|FG002|Overall Study|Lost to Follow-up|1|||
44308181|NCT01058707|79309203|FG003|Overall Study|Lost to Follow-up|0|||
44308182|NCT01058707|79309204|FG004|Overall Study|Lost to Follow-up|0|||
44308183|NCT01058707|79309205|FG005|Overall Study|Lost to Follow-up|0|||
44534843|NCT03535194|79545557|FG000|Maintenance Period|Withdrawal by Subject|7|||
44534844|NCT03535194|79545558|FG001|Maintenance Period|Withdrawal by Subject|2|||
44534845|NCT03535194|79545559|FG002|Maintenance Period|Withdrawal by Subject|1|||
44534846|NCT03535194|79545560|FG003|Maintenance Period|Withdrawal by Subject|8|||
44534847|NCT03535194|79545561|FG004|Maintenance Period|Withdrawal by Subject|0|||
44534848|NCT03535194|79545557|FG000|Post-Treatment Followup Period|Adverse Event|4|||
44534849|NCT03535194|79545558|FG001|Post-Treatment Followup Period|Adverse Event|5|||
44534850|NCT03535194|79545559|FG002|Post-Treatment Followup Period|Adverse Event|1|||
44534851|NCT03535194|79545560|FG003|Post-Treatment Followup Period|Adverse Event|8|||
44534852|NCT03535194|79545561|FG004|Post-Treatment Followup Period|Adverse Event|0|||
44534853|NCT03535194|79545557|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
44534854|NCT03535194|79545558|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
44534855|NCT03535194|79545559|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
44534856|NCT03535194|79545560|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
44534857|NCT03535194|79545561|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
44534858|NCT03535194|79545557|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
44534859|NCT03535194|79545558|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
44534860|NCT03535194|79545559|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
44534861|NCT03535194|79545560|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
44534862|NCT03535194|79545561|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
44534863|NCT03535194|79545557|FG000|Post-Treatment Followup Period|Other|1|||
44534864|NCT03535194|79545558|FG001|Post-Treatment Followup Period|Other|0|||
44534865|NCT03535194|79545559|FG002|Post-Treatment Followup Period|Other|0|||
44534866|NCT03535194|79545560|FG003|Post-Treatment Followup Period|Other|5|||
44534867|NCT03535194|79545561|FG004|Post-Treatment Followup Period|Other|0|||
44534868|NCT03535194|79545557|FG000|Post-Treatment Followup Period|Physician Decision|0|||
44534869|NCT03535194|79545558|FG001|Post-Treatment Followup Period|Physician Decision|2|||
44534870|NCT03535194|79545559|FG002|Post-Treatment Followup Period|Physician Decision|1|||
44534871|NCT03535194|79545560|FG003|Post-Treatment Followup Period|Physician Decision|1|||
44534872|NCT03535194|79545561|FG004|Post-Treatment Followup Period|Physician Decision|0|||
44534873|NCT03535194|79545557|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
44534874|NCT03535194|79545558|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
44534875|NCT03535194|79545559|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
44534876|NCT03535194|79545560|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
44534877|NCT03535194|79545561|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
44534878|NCT03559530|79545585|FG000|Overall Study|non-location of medical records|44|||
44534879|NCT03559530|79545586|FG001|Overall Study|non-location of medical records|0|||
44534880|NCT03559530|79545585|FG000|Overall Study|culture results not considered for treat|29|||
44534881|NCT03559530|79545586|FG001|Overall Study|culture results not considered for treat|0|||
44308184|NCT01058707|79309206|FG006|Overall Study|Lost to Follow-up|0|||
44308185|NCT01058707|79309200|FG000|Overall Study|Reason Not Specified|0|||
44534882|NCT03559530|79545585|FG000|Overall Study|duplicate cases|8|||
44534883|NCT03559530|79545586|FG001|Overall Study|duplicate cases|0|||
44534884|NCT03559530|79545585|FG000|Overall Study|other species of Acinetobacte|7|||
44534885|NCT03559530|79545586|FG001|Overall Study|other species of Acinetobacte|0|||
44534886|NCT03559530|79545585|FG000|Overall Study|contamination / colonization|3|||
44534887|NCT03559530|79545586|FG001|Overall Study|contamination / colonization|0|||
44534888|NCT03124784|79545614|FG000|Overall Study|Adverse Event|1|||
44534889|NCT03124784|79545614|FG000|Overall Study|Computer/Equip Malfunction|1|||
44534890|NCT03531840|79545622|FG000|Overall Study|Death on study|3|||
44534891|NCT03531840|79545623|FG001|Overall Study|Death on study|2|||
44534892|NCT03531840|79545624|FG002|Overall Study|Death on study|1|||
44534893|NCT03531840|79545625|FG003|Overall Study|Death on study|2|||
44534894|NCT03531840|79545622|FG000|Overall Study|Death during follow up|2|||
44418860|NCT00793598|79426880|FG005|Overall Study|Patient Request|0|||
44418861|NCT00793598|79426881|FG006|Overall Study|Patient Request|0|||
44418862|NCT00793598|79426882|FG007|Overall Study|Patient Request|0|||
44418863|NCT00793598|79426875|FG000|Overall Study|Protocol Violation|0|||
44155250|NCT01998958|78946950|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44534895|NCT03531840|79545623|FG001|Overall Study|Death during follow up|3|||
44534896|NCT03531840|79545624|FG002|Overall Study|Death during follow up|4|||
44534897|NCT03531840|79545625|FG003|Overall Study|Death during follow up|1|||
44534898|NCT03110900|79545642|FG000|Overall Study|Sponsor withdrew|1|||
44155251|NCT01998958|78946951|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44534899|NCT03110900|79545643|FG001|Overall Study|Sponsor withdrew|1|||
44534900|NCT03867734|79545649|FG000|Overall Study|Lost to Follow-up|2|||
44534901|NCT03446456|79545659|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
44534902|NCT03446456|79545660|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
44534903|NCT03446456|79545659|FG000|Overall Study|Lost to Follow-up|1|||
44534904|NCT03446456|79545660|FG001|Overall Study|Lost to Follow-up|3|||
44534905|NCT03446456|79545659|FG000|Overall Study|Participant failed the toxicology test|1|||
44534906|NCT03446456|79545660|FG001|Overall Study|Participant failed the toxicology test|0|||
44534907|NCT03446456|79545659|FG000|Overall Study|Break down of the experimental equipment|1|||
44534908|NCT03446456|79545660|FG001|Overall Study|Break down of the experimental equipment|0|||
44534909|NCT03495102|79545669|FG000|Overall Study|Adverse Event|5|||
44534910|NCT03495102|79545670|FG001|Overall Study|Adverse Event|7|||
44534911|NCT03495102|79545671|FG002|Overall Study|Adverse Event|10|||
44534912|NCT03495102|79545669|FG000|Overall Study|Death|3|||
44534913|NCT03495102|79545670|FG001|Overall Study|Death|4|||
44534914|NCT03495102|79545671|FG002|Overall Study|Death|4|||
44534915|NCT03495102|79545669|FG000|Overall Study|Lost to Follow-up|15|||
44534916|NCT03495102|79545670|FG001|Overall Study|Lost to Follow-up|16|||
44534917|NCT03495102|79545671|FG002|Overall Study|Lost to Follow-up|17|||
44534918|NCT03495102|79545669|FG000|Overall Study|Physician Decision|2|||
44534919|NCT03495102|79545670|FG001|Overall Study|Physician Decision|0|||
44534920|NCT03495102|79545671|FG002|Overall Study|Physician Decision|2|||
44534921|NCT03495102|79545669|FG000|Overall Study|Withdrawal by Subject|25|||
44534922|NCT03495102|79545670|FG001|Overall Study|Withdrawal by Subject|36|||
44534923|NCT03495102|79545671|FG002|Overall Study|Withdrawal by Subject|18|||
44534924|NCT03495102|79545669|FG000|Overall Study|Protocol Violation|1|||
44534925|NCT03495102|79545670|FG001|Overall Study|Protocol Violation|1|||
44534926|NCT03495102|79545671|FG002|Overall Study|Protocol Violation|0|||
44534927|NCT03495102|79545669|FG000|Overall Study|Site Closure|3|||
44534928|NCT03495102|79545670|FG001|Overall Study|Site Closure|1|||
44534929|NCT03495102|79545671|FG002|Overall Study|Site Closure|2|||
44534930|NCT03495102|79545669|FG000|Overall Study|Non-compliance|1|||
44534931|NCT03495102|79545670|FG001|Overall Study|Non-compliance|0|||
44534932|NCT03495102|79545671|FG002|Overall Study|Non-compliance|0|||
44534933|NCT03495102|79545669|FG000|Overall Study|Participant Duplicated at Another Site|0|||
44534934|NCT03495102|79545670|FG001|Overall Study|Participant Duplicated at Another Site|0|||
44534935|NCT03495102|79545671|FG002|Overall Study|Participant Duplicated at Another Site|1|||
44418864|NCT00793598|79426876|FG001|Overall Study|Protocol Violation|0|||
44534936|NCT03495102|79545669|FG000|Overall Study|Primary Care Physician Recommendation|0|||
44534937|NCT03495102|79545670|FG001|Overall Study|Primary Care Physician Recommendation|1|||
44534938|NCT03495102|79545671|FG002|Overall Study|Primary Care Physician Recommendation|0|||
44534939|NCT03495102|79545669|FG000|Overall Study|Relocated to Another Country|0|||
44534940|NCT03495102|79545670|FG001|Overall Study|Relocated to Another Country|1|||
44534941|NCT03495102|79545671|FG002|Overall Study|Relocated to Another Country|0|||
44534942|NCT03495102|79545669|FG000|Overall Study|Participant was in Rehabilitation|1|||
44534943|NCT03495102|79545670|FG001|Overall Study|Participant was in Rehabilitation|0|||
44534944|NCT03495102|79545671|FG002|Overall Study|Participant was in Rehabilitation|0|||
44534945|NCT03105362|79545679|FG000|Overall Study|Withdrawal by Subject|1|||
44534946|NCT03105362|79545679|FG000|Overall Study|Lost to Follow-up|1|||
44534947|NCT03559218|79545688|FG000|Overall Study|Withdrawal by Subject|1|||
44418865|NCT00793598|79426877|FG002|Overall Study|Protocol Violation|0|||
44534948|NCT03559218|79545689|FG001|Overall Study|Withdrawal by Subject|0|||
44534949|NCT03104816|79545698|FG000|Overall Study|Lack of Efficacy|0|||
44534950|NCT03104816|79545699|FG001|Overall Study|Lack of Efficacy|2|||
44534951|NCT03104816|79545700|FG002|Overall Study|Lack of Efficacy|0|||
44534952|NCT03104816|79545698|FG000|Overall Study|Protocol Violation|2|||
44534953|NCT03104816|79545699|FG001|Overall Study|Protocol Violation|0|||
44534954|NCT03104816|79545700|FG002|Overall Study|Protocol Violation|2|||
44534955|NCT03559062|79545711|FG000|Overall Study|Other|0|||
44534956|NCT03559062|79545712|FG001|Overall Study|Other|1|||
44534957|NCT03559062|79545713|FG002|Overall Study|Other|0|||
44534958|NCT00089791|79545724|FG000|Overall Study|Physician Decision|6|||
44534959|NCT00089791|79545725|FG001|Overall Study|Physician Decision|3|||
44534960|NCT00089791|79545724|FG000|Overall Study|Adverse Event|81|||
44534961|NCT00089791|79545725|FG001|Overall Study|Adverse Event|93|||
44534962|NCT00089791|79545724|FG000|Overall Study|Withdrawal by Subject|403|||
44534963|NCT00089791|79545725|FG001|Overall Study|Withdrawal by Subject|344|||
44534964|NCT00089791|79545724|FG000|Overall Study|Death|78|||
44534965|NCT00089791|79545725|FG001|Overall Study|Death|62|||
44534966|NCT00089791|79545724|FG000|Overall Study|Disease progression|7|||
44534967|NCT00089791|79545725|FG001|Overall Study|Disease progression|3|||
44534968|NCT00089791|79545724|FG000|Overall Study|Ineligibility determined|12|||
44534969|NCT00089791|79545725|FG001|Overall Study|Ineligibility determined|9|||
44534970|NCT00089791|79545724|FG000|Overall Study|Lost to Follow-up|57|||
44534971|NCT00089791|79545725|FG001|Overall Study|Lost to Follow-up|57|||
44534972|NCT00089791|79545724|FG000|Overall Study|Noncompliance|17|||
44534973|NCT00089791|79545725|FG001|Overall Study|Noncompliance|13|||
44534974|NCT00089791|79545724|FG000|Overall Study|Other|20|||
44534975|NCT00089791|79545725|FG001|Overall Study|Other|32|||
44534976|NCT00089791|79545724|FG000|Overall Study|Protocol deviation|12|||
44534977|NCT00089791|79545725|FG001|Overall Study|Protocol deviation|10|||
44534978|NCT00089791|79545724|FG000|Overall Study|Requirement for alternative therapy|7|||
44534979|NCT00089791|79545725|FG001|Overall Study|Requirement for alternative therapy|4|||
44534980|NCT03558672|79545731|FG000|Overall Study|Study Early Termination|10|||
44534981|NCT03558516|79545737|FG000|Overall Study|Protocol Violation|2|||
44534982|NCT03558516|79545738|FG001|Overall Study|Protocol Violation|2|||
44534983|NCT03557970|79545746|FG000|Overall Study|Study closure|1|||
44534984|NCT03557970|79545747|FG001|Overall Study|Study closure|0|||
44534985|NCT03557970|79545746|FG000|Overall Study|Physician Decision|0|||
44534986|NCT03557970|79545747|FG001|Overall Study|Physician Decision|1|||
44534987|NCT03557970|79545746|FG000|Overall Study|Death|0|||
44534988|NCT03557970|79545747|FG001|Overall Study|Death|1|||
44534989|NCT02815280|79545755|FG000|Double-Blind Phase|Adverse Event|1|||
44534990|NCT02815280|79545756|FG001|Double-Blind Phase|Adverse Event|1|||
44534991|NCT02815280|79545755|FG000|Double-Blind Phase|Lost to Follow-up|10|||
44534992|NCT02815280|79545756|FG001|Double-Blind Phase|Lost to Follow-up|9|||
44534993|NCT02815280|79545755|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
44534994|NCT02815280|79545756|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
44534995|NCT02815280|79545755|FG000|Double-Blind Phase|Protocol Violation|2|||
44534996|NCT02815280|79545756|FG001|Double-Blind Phase|Protocol Violation|2|||
44534997|NCT02815280|79545755|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
44534998|NCT02815280|79545756|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
44534999|NCT02815280|79545755|FG000|Open-Label Phase|Adverse Event|2|||
44535000|NCT02815280|79545756|FG001|Open-Label Phase|Adverse Event|3|||
44535001|NCT02815280|79545755|FG000|Open-Label Phase|Lost to Follow-up|18|||
44535002|NCT02815280|79545756|FG001|Open-Label Phase|Lost to Follow-up|9|||
44535003|NCT02815280|79545755|FG000|Open-Label Phase|Withdrawal by Subject|33|||
44535004|NCT02815280|79545756|FG001|Open-Label Phase|Withdrawal by Subject|18|||
44535005|NCT02815280|79545755|FG000|Open-Label Phase|Protocol Violation|3|||
44535006|NCT02815280|79545756|FG001|Open-Label Phase|Protocol Violation|0|||
44535007|NCT02815280|79545755|FG000|Open-Label Phase|Administrative|26|||
44535008|NCT02815280|79545756|FG001|Open-Label Phase|Administrative|12|||
44535009|NCT02815280|79545755|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
44535010|NCT02815280|79545756|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
44535011|NCT02737930|79545768|FG000|Overall Study|Withdrawal by Subject|0|||
44535012|NCT02737930|79545769|FG001|Overall Study|Withdrawal by Subject|1|||
44535013|NCT03493698|79545775|FG000|Treatment Period C|Adverse Event|1|||
44535014|NCT03493698|79545775|FG000|Treatment Period C|Withdrawal by Subject|1|||
44535015|NCT02737852|79545789|FG000|Overall Study|Withdrawal by Subject|2|||
44535016|NCT03528174|79545793|FG000|Overall Study|Adverse Event|1|||
44535017|NCT03528174|79545793|FG000|Overall Study|sensors dislodged|1|||
44535018|NCT03109184|79545803|FG000|Overall Study|Lost to Follow-up|6|||
44535019|NCT03109184|79545804|FG001|Overall Study|Lost to Follow-up|6|||
44535020|NCT03109184|79545803|FG000|Overall Study|Withdrawal by Subject|1|||
44535021|NCT03109184|79545804|FG001|Overall Study|Withdrawal by Subject|1|||
44535022|NCT03493386|79545822|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44535023|NCT03493386|79545823|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
44535024|NCT03493386|79545824|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44535025|NCT03493386|79545825|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
44535026|NCT03478644|79545844|FG000|Phase 2|Withdrawal by Subject|2|||
44535027|NCT03478644|79545845|FG001|Phase 2|Withdrawal by Subject|1|||
44535028|NCT03478644|79545844|FG000|Phase 2|Lost to Follow-up|1|||
44535029|NCT03478644|79545845|FG001|Phase 2|Lost to Follow-up|0|||
44535030|NCT03527550|79545853|FG000|Overall Study|Lost to Follow-up|4|||
44535031|NCT03527550|79545854|FG001|Overall Study|Lost to Follow-up|2|||
44535032|NCT03527550|79545853|FG000|Overall Study|Withdrawal by Subject|4|||
44535033|NCT03527550|79545854|FG001|Overall Study|Withdrawal by Subject|1|||
44535034|NCT03527550|79545853|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
44535035|NCT03527550|79545854|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
44535036|NCT03475056|79545864|FG000|Overall Study|Lost to Follow-up|0|||
44535037|NCT03475056|79545865|FG001|Overall Study|Lost to Follow-up|1|||
44535038|NCT03475056|79545864|FG000|Overall Study|Moved from Area|0|||
44535039|NCT03475056|79545865|FG001|Overall Study|Moved from Area|2|||
44535040|NCT00938912|79545872|FG000|Overall Study|Withdrawal by Subject|28|||
44535041|NCT00938912|79545872|FG000|Overall Study|Lost to Follow-up|4|||
44418866|NCT00793598|79426878|FG003|Overall Study|Protocol Violation|0|||
44418867|NCT00793598|79426879|FG004|Overall Study|Protocol Violation|0|||
44418868|NCT00793598|79426880|FG005|Overall Study|Protocol Violation|0|||
44418869|NCT00793598|79426881|FG006|Overall Study|Protocol Violation|0|||
44418870|NCT00793598|79426882|FG007|Overall Study|Protocol Violation|1|||
44418871|NCT00793598|79426875|FG000|Overall Study|Subject not dosed|0|||
44418872|NCT00793598|79426876|FG001|Overall Study|Subject not dosed|0|||
44418873|NCT00793598|79426877|FG002|Overall Study|Subject not dosed|0|||
44418874|NCT00793598|79426878|FG003|Overall Study|Subject not dosed|0|||
44418875|NCT00793598|79426879|FG004|Overall Study|Subject not dosed|0|||
44418876|NCT00793598|79426880|FG005|Overall Study|Subject not dosed|1|||
44418877|NCT00793598|79426881|FG006|Overall Study|Subject not dosed|0|||
44418878|NCT00793598|79426882|FG007|Overall Study|Subject not dosed|0|||
44418879|NCT00796562|79426904|FG000|Overall Study|Death|49|||
44418880|NCT00801632|79426908|FG000|Overall Study|Re-transplant|1|||
44418881|NCT00806819|79426914|FG000|Overall Study|progressive disease (modified RECIST )|217|||
44418882|NCT00806819|79426915|FG001|Overall Study|progressive disease (modified RECIST )|216|||
44418883|NCT00806819|79426914|FG000|Overall Study|Worsening or AE of underlying disease|18|||
44418884|NCT00806819|79426915|FG001|Overall Study|Worsening or AE of underlying disease|25|||
44418885|NCT00806819|79426914|FG000|Overall Study|Other AE|38|||
44418886|NCT00806819|79426915|FG001|Overall Study|Other AE|40|||
44418887|NCT00806819|79426914|FG000|Overall Study|Protocol Violation|9|||
44418888|NCT00806819|79426915|FG001|Overall Study|Protocol Violation|4|||
44418889|NCT00806819|79426914|FG000|Overall Study|Lost to Follow-up|1|||
44418890|NCT00806819|79426915|FG001|Overall Study|Lost to Follow-up|0|||
44418891|NCT00806819|79426914|FG000|Overall Study|Withdrawal by Subject|32|||
44418892|NCT00806819|79426915|FG001|Overall Study|Withdrawal by Subject|29|||
44418893|NCT00806819|79426914|FG000|Overall Study|Not treated|6|||
44418894|NCT00806819|79426915|FG001|Overall Study|Not treated|3|||
44418895|NCT00806819|79426914|FG000|Overall Study|Reasons other than stated above|25|||
44418896|NCT00806819|79426915|FG001|Overall Study|Reasons other than stated above|41|||
44418897|NCT00801242|79426922|FG000|Overall Study|Adverse Event|10|||
44418898|NCT00801242|79426922|FG000|Overall Study|Withdrawal by Subject|13|||
44418899|NCT00801242|79426922|FG000|Overall Study|Protocol Violation|5|||
44418900|NCT00801242|79426922|FG000|Overall Study|Physician Decision|3|||
44418901|NCT00801242|79426922|FG000|Overall Study|Lost to Follow-up|1|||
44418902|NCT00801242|79426922|FG000|Overall Study|Miscellaneous reasons|20|||
44418903|NCT00800540|79426935|FG000|Period One: 6 Weeks|Noncompliance|1|||
44418904|NCT00800540|79426936|FG001|Period One: 6 Weeks|Noncompliance|0|||
44418905|NCT00800540|79426935|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
44418906|NCT00800540|79426936|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
44418907|NCT00800540|79426935|FG000|Period 2: 6 Weeks|Adverse Event|0|||
44418908|NCT00800540|79426936|FG001|Period 2: 6 Weeks|Adverse Event|1|||
44418909|NCT00800384|79426944|FG000|Overall Study|Withdrawal by Subject|24|||
44418910|NCT00800384|79426945|FG001|Overall Study|Withdrawal by Subject|17|||
44418911|NCT00800384|79426944|FG000|Overall Study|Lost to Follow-up|17|||
44418912|NCT00800384|79426945|FG001|Overall Study|Lost to Follow-up|26|||
44418913|NCT00796328|79426952|FG000|Overall Study|experienced hypotension requiring tx|6|||
44418914|NCT00588692|79426958|FG000|Overall Study|Withdrawal by Subject|4|||
44418915|NCT00588692|79426959|FG001|Overall Study|Withdrawal by Subject|2|||
44418916|NCT00588692|79426958|FG000|Overall Study|Hip Surgery|0|||
44418917|NCT00588692|79426959|FG001|Overall Study|Hip Surgery|1|||
44535042|NCT00938912|79545872|FG000|Overall Study|Lack of Efficacy|43|||
44535043|NCT00938912|79545872|FG000|Overall Study|Adverse event, non-fatal|24|||
44535044|NCT00938912|79545872|FG000|Overall Study|Adverse event, fatal|1|||
44535045|NCT00938912|79545872|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
44535046|NCT00938912|79545872|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
44418918|NCT00588692|79426958|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
44535047|NCT00938912|79545872|FG000|Overall Study|Participant needed prohibit medication|1|||
44535048|NCT00938912|79545872|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
44535049|NCT00938912|79545872|FG000|Overall Study|Did not meet Eligibility criteria|1|||
44535050|NCT00938912|79545872|FG000|Overall Study|Participant relocated not related to AE|1|||
44535051|NCT00938912|79545872|FG000|Overall Study|Participant moved to another city|1|||
44535052|NCT00938912|79545872|FG000|Overall Study|Participant experienced break through seizures|1|||
44535053|NCT00938912|79545872|FG000|Overall Study|No longer wished to participate in the study|1|||
44535054|NCT00938912|79545872|FG000|Overall Study|Protocol Deviation|2|||
44535055|NCT03473808|79545879|FG000|Overall Study|Withdrawal by Subject|1|||
44535056|NCT03473340|79545885|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
44535057|NCT03473340|79545886|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
44535058|NCT03473340|79545885|FG000|Overall Study|Withdrawal by Subject|1|||
44535059|NCT03473340|79545886|FG001|Overall Study|Withdrawal by Subject|0|||
44535060|NCT03473340|79545885|FG000|Overall Study|Lost to Follow-up|1|||
44535061|NCT03473340|79545886|FG001|Overall Study|Lost to Follow-up|2|||
44535062|NCT03490032|79545895|FG000|Overall Study|family issue (child custody)|1|||
44535063|NCT03490032|79545896|FG001|Overall Study|family issue (child custody)|0|||
44535064|NCT03490032|79545897|FG002|Overall Study|family issue (child custody)|0|||
44535065|NCT03489720|79545917|FG000|Overall Study|Withdrawal by Subject|2|||
44535066|NCT03489720|79545918|FG001|Overall Study|Withdrawal by Subject|0|||
44535067|NCT03527160|79545930|FG000|Overall Study|No urine collected|13|||
44535068|NCT03527160|79545930|FG000|Overall Study|No clinical serum creatinine collected|6|||
44535069|NCT03527160|79545930|FG000|Overall Study|Did not meet inclusion|2|||
44535070|NCT03739138|79545940|FG000|Overall Study|Death|0|||
44535071|NCT03739138|79545941|FG001|Overall Study|Death|7|||
44535072|NCT03739138|79545942|FG002|Overall Study|Death|4|||
44535073|NCT03739138|79545943|FG003|Overall Study|Death|13|||
44535074|NCT03739138|79545944|FG004|Overall Study|Death|0|||
44535075|NCT03739138|79545940|FG000|Overall Study|Lost to Follow-up|0|||
44535076|NCT03739138|79545941|FG001|Overall Study|Lost to Follow-up|0|||
44535077|NCT03739138|79545942|FG002|Overall Study|Lost to Follow-up|1|||
44535078|NCT03739138|79545943|FG003|Overall Study|Lost to Follow-up|0|||
44535079|NCT03739138|79545944|FG004|Overall Study|Lost to Follow-up|0|||
44535080|NCT03739138|79545940|FG000|Overall Study|Study Terminated By Sponsor|0|||
44535081|NCT03739138|79545941|FG001|Overall Study|Study Terminated By Sponsor|0|||
44535082|NCT03739138|79545942|FG002|Overall Study|Study Terminated By Sponsor|0|||
44535083|NCT03739138|79545943|FG003|Overall Study|Study Terminated By Sponsor|4|||
44535084|NCT03739138|79545944|FG004|Overall Study|Study Terminated By Sponsor|0|||
44535085|NCT03739138|79545940|FG000|Overall Study|Withdrawal by Subject|0|||
44535086|NCT03739138|79545941|FG001|Overall Study|Withdrawal by Subject|0|||
44535087|NCT03739138|79545942|FG002|Overall Study|Withdrawal by Subject|0|||
44535088|NCT03739138|79545943|FG003|Overall Study|Withdrawal by Subject|1|||
44418919|NCT00588692|79426959|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
44418920|NCT00588692|79426958|FG000|Overall Study|Cancer|1|||
44418921|NCT00588692|79426959|FG001|Overall Study|Cancer|0|||
44418922|NCT00588692|79426958|FG000|Overall Study|Death|1|||
44418923|NCT00588692|79426959|FG001|Overall Study|Death|0|||
44418924|NCT00588146|79426967|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
44418925|NCT00588146|79426968|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
44418926|NCT00795704|79426976|FG000|Overall Study|Withdrawal by Subject|3|||
44418927|NCT00795704|79426977|FG001|Overall Study|Withdrawal by Subject|2|||
44418928|NCT00795704|79426976|FG000|Overall Study|Adverse Event|1|||
44418929|NCT00795704|79426977|FG001|Overall Study|Adverse Event|1|||
44418930|NCT00444457|79426987|FG000|Infant Series|Other|0|||
44535089|NCT03739138|79545944|FG004|Overall Study|Withdrawal by Subject|0|||
44535090|NCT03472326|79545954|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
44535091|NCT03472326|79545955|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
44535092|NCT03472326|79545956|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
44535093|NCT03472326|79545957|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
44535094|NCT03472326|79545954|FG000|Part 2: Combination Therapy|Pregnancy|0|||
44535095|NCT03472326|79545955|FG001|Part 2: Combination Therapy|Pregnancy|0|||
44535096|NCT03472326|79545956|FG002|Part 2: Combination Therapy|Pregnancy|0|||
44418931|NCT00444457|79426988|FG001|Infant Series|Other|1|||
44418932|NCT00444457|79426989|FG002|Infant Series|Other|0|||
44535097|NCT03472326|79545957|FG003|Part 2: Combination Therapy|Pregnancy|1|||
44535098|NCT02737618|79545966|FG000|Overall Study|Withdrawal by Subject|9|||
44535099|NCT03472014|79545970|FG000|Overall Study|Lost to Follow-up|4|||
44535100|NCT03526458|79545976|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
44535101|NCT03526458|79545977|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
44535102|NCT03526458|79545976|FG000|Overall Study|Stone passed, surgery cancelled|2|||
44535103|NCT03526458|79545977|FG001|Overall Study|Stone passed, surgery cancelled|1|||
44535104|NCT03526458|79545976|FG000|Overall Study|Withdrawal by Subject|1|||
44535105|NCT03526458|79545977|FG001|Overall Study|Withdrawal by Subject|0|||
44535106|NCT03526458|79545976|FG000|Overall Study|Physician Decision|2|||
44535107|NCT03526458|79545977|FG001|Overall Study|Physician Decision|1|||
44535108|NCT03526458|79545976|FG000|Overall Study|Lack of equipment|1|||
44535109|NCT03526458|79545977|FG001|Overall Study|Lack of equipment|1|||
44535110|NCT03488238|79545983|FG000|Overall Study|Equipment malfunction|1|||
44535111|NCT03488238|79545983|FG000|Overall Study|Adverse Event|1|||
44535112|NCT03525834|79545987|FG000|Overall Study|Progressive disease|1|||
44535113|NCT03525444|79546029|FG000|Overall Study|Adverse Event|0|||
44535114|NCT03525444|79546030|FG001|Overall Study|Adverse Event|1|||
44535115|NCT03525444|79546029|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
44535116|NCT03525444|79546030|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
44535117|NCT03525444|79546029|FG000|Overall Study|Other|0|||
44535118|NCT03525444|79546030|FG001|Overall Study|Other|1|||
44535119|NCT03487848|79546037|FG000|Overall Study|Lost to Follow-up|1|||
44308186|NCT01058707|79309201|FG001|Overall Study|Reason Not Specified|3|||
44308187|NCT01058707|79309202|FG002|Overall Study|Reason Not Specified|2|||
44308188|NCT01058707|79309203|FG003|Overall Study|Reason Not Specified|0|||
44308189|NCT01058707|79309204|FG004|Overall Study|Reason Not Specified|7|||
44308190|NCT01058707|79309205|FG005|Overall Study|Reason Not Specified|1|||
44308191|NCT01058707|79309206|FG006|Overall Study|Reason Not Specified|7|||
44308192|NCT01054144|79309244|FG000|Overall Study|Death|2|||
44308193|NCT03276052|79309251|FG000|Overall Study|Withdrawal by Subject|5|||
44308194|NCT03276052|79309251|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
44308195|NCT00105586|79309261|FG000|Overall Study|Adverse Event|4|||
44308196|NCT00105586|79309262|FG001|Overall Study|Adverse Event|3|||
44308197|NCT00105586|79309261|FG000|Overall Study|Physician Decision|13|||
44308198|NCT00105586|79309262|FG001|Overall Study|Physician Decision|13|||
44308199|NCT01059643|79309270|FG000|Overall Study|Adverse Event|3|||
44308200|NCT01059643|79309270|FG000|Overall Study|Withdrawal by Subject|2|||
44308201|NCT01059643|79309270|FG000|Overall Study|Physician Decision|1|||
44308202|NCT01059565|79309279|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
44308203|NCT01059565|79309280|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
44308204|NCT01059565|79309279|FG000|24-Week Randomized Phase|Adverse Event|5|||
44308205|NCT01059565|79309280|FG001|24-Week Randomized Phase|Adverse Event|0|||
44308206|NCT01059565|79309279|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
44308207|NCT01059565|79309280|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
44308208|NCT01059565|79309279|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
44308209|NCT01059565|79309280|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
44308210|NCT01059565|79309279|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
44308211|NCT01059565|79309280|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
44308212|NCT01059565|79309279|FG000|24-Week Open-Label Phase|Adverse Event|2|||
44308213|NCT01059565|79309280|FG001|24-Week Open-Label Phase|Adverse Event|0|||
44308214|NCT01059565|79309279|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
44308215|NCT01059565|79309280|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
44308216|NCT01059565|79309279|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
44308217|NCT01059565|79309280|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
44308218|NCT01059565|79309279|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
44308219|NCT01059565|79309280|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
44308220|NCT01059565|79309279|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
44308221|NCT01059565|79309280|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
44308222|NCT01059565|79309279|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
44308223|NCT01059565|79309280|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
44308224|NCT01059526|79309290|FG000|Overall Study|Patient enrolled but not treated|20|||
44308225|NCT01059526|79309291|FG001|Overall Study|Patient enrolled but not treated|17|||
44308226|NCT01059526|79309290|FG000|Overall Study|Adverse Event|2|||
44308227|NCT01059526|79309291|FG001|Overall Study|Adverse Event|2|||
44308228|NCT01059526|79309290|FG000|Overall Study|Protocol Violation|0|||
44308229|NCT01059526|79309291|FG001|Overall Study|Protocol Violation|1|||
44308230|NCT01059526|79309290|FG000|Overall Study|Withdrawal by Subject|3|||
44308231|NCT01059526|79309291|FG001|Overall Study|Withdrawal by Subject|1|||
44535120|NCT03524664|79546043|FG000|Overall Study|Withdrawal by Subject|1|||
44257296|NCT01311713|79109711|FG003|Overall Study|Disease progression|2|||
44257297|NCT01311713|79109712|FG004|Overall Study|Disease progression|4|||
44257298|NCT01311713|79109713|FG005|Overall Study|Disease progression|4|||
44257299|NCT01311713|79109714|FG006|Overall Study|Disease progression|5|||
44257300|NCT01311713|79109708|FG000|Overall Study|Lost to Follow-up|0|||
44257301|NCT01311713|79109709|FG001|Overall Study|Lost to Follow-up|0|||
44257302|NCT01311713|79109710|FG002|Overall Study|Lost to Follow-up|1|||
44257303|NCT01311713|79109711|FG003|Overall Study|Lost to Follow-up|0|||
44308232|NCT01059526|79309290|FG000|Overall Study|Lost to Follow-up|4|||
44535121|NCT03524664|79546044|FG001|Overall Study|Withdrawal by Subject|2|||
44535122|NCT03524664|79546043|FG000|Overall Study|Lost to Follow-up|4|||
44535123|NCT03524664|79546044|FG001|Overall Study|Lost to Follow-up|13|||
44257304|NCT01311713|79109712|FG004|Overall Study|Lost to Follow-up|0|||
44257305|NCT01311713|79109713|FG005|Overall Study|Lost to Follow-up|0|||
44308233|NCT01059526|79309291|FG001|Overall Study|Lost to Follow-up|1|||
44308234|NCT01059526|79309290|FG000|Overall Study|Patient found to be dermatographic|1|||
44308235|NCT01059526|79309291|FG001|Overall Study|Patient found to be dermatographic|0|||
44308236|NCT03277261|79309299|FG000|Overall Study|Adverse Event|17|||
44308237|NCT03277261|79309300|FG001|Overall Study|Adverse Event|1|||
44308238|NCT03277261|79309299|FG000|Overall Study|Participant Withdrawal of Consent|6|||
44308239|NCT03277261|79309300|FG001|Overall Study|Participant Withdrawal of Consent|15|||
44308240|NCT03277261|79309299|FG000|Overall Study|Investigator / Sponsor Decision|4|||
44308241|NCT03277261|79309300|FG001|Overall Study|Investigator / Sponsor Decision|2|||
44308242|NCT03277261|79309299|FG000|Overall Study|Pregnancy|2|||
44308243|NCT03277261|79309300|FG001|Overall Study|Pregnancy|0|||
44308244|NCT03277261|79309299|FG000|Overall Study|Lost to Follow-up|2|||
44308245|NCT03277261|79309300|FG001|Overall Study|Lost to Follow-up|2|||
44308246|NCT03277261|79309299|FG000|Overall Study|Lack of Efficacy|2|||
44308247|NCT03277261|79309300|FG001|Overall Study|Lack of Efficacy|2|||
44308248|NCT03277261|79309299|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
44308249|NCT03277261|79309300|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
44308250|NCT03277690|79309322|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
44308251|NCT03277690|79309323|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
44308252|NCT03277690|79309322|FG000|Dose Titration and Maintenance|Physician Decision|1|||
44308253|NCT03277690|79309323|FG001|Dose Titration and Maintenance|Physician Decision|0|||
44308254|NCT03277690|79309322|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
44308255|NCT03277690|79309323|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
44308256|NCT03277690|79309322|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
44308257|NCT03277690|79309323|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
44308258|NCT03277690|79309322|FG000|Dose Titration and Maintenance|Adverse Event|15|||
44308259|NCT03277690|79309323|FG001|Dose Titration and Maintenance|Adverse Event|0|||
44308260|NCT03277690|79309322|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
44308261|NCT03277690|79309323|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
44308262|NCT03277690|79309322|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
44308263|NCT03277690|79309323|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
44308264|NCT03271021|79309332|FG000|Overall Study|Adverse Event|3|||
44308265|NCT03271021|79309333|FG001|Overall Study|Adverse Event|2|||
44308266|NCT03271021|79309332|FG000|Overall Study|Withdrawal by Subject|36|||
44308267|NCT03271021|79309333|FG001|Overall Study|Withdrawal by Subject|53|||
44308268|NCT03271021|79309332|FG000|Overall Study|Lost to Follow-up|34|||
44308269|NCT03271021|79309333|FG001|Overall Study|Lost to Follow-up|39|||
44308270|NCT03271021|79309332|FG000|Overall Study|Protocol Violation|6|||
44308271|NCT03271021|79309333|FG001|Overall Study|Protocol Violation|4|||
44308272|NCT03271021|79309332|FG000|Overall Study|Abnormal Lab Results|1|||
44308273|NCT03271021|79309333|FG001|Overall Study|Abnormal Lab Results|0|||
44308274|NCT03271021|79309332|FG000|Overall Study|Miscellaneous|9|||
44308275|NCT03271021|79309333|FG001|Overall Study|Miscellaneous|8|||
44308276|NCT01249651|79309354|FG000|Overall Study|Withdrawal by Subject|4|||
44308277|NCT01249651|79309354|FG000|Overall Study|Adverse Event|1|||
44308278|NCT01249651|79309354|FG000|Overall Study|Protocol Violation|1|||
44308279|NCT01249651|79309354|FG000|Overall Study|Sponsor Decision|1|||
44308280|NCT01249417|79309361|FG000|Randomised Population|Study treatment not received|0|||
44308281|NCT01249417|79309362|FG001|Randomised Population|Study treatment not received|0|||
44308282|NCT01249417|79309363|FG002|Randomised Population|Study treatment not received|2|||
44308283|NCT01249417|79309361|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
44308284|NCT01249417|79309362|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
44308285|NCT01249417|79309363|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
44308286|NCT01249417|79309361|FG000|Treatment Phase - ITT Population|Other|0|||
44308287|NCT01249417|79309362|FG001|Treatment Phase - ITT Population|Other|0|||
44308288|NCT01249417|79309363|FG002|Treatment Phase - ITT Population|Other|1|||
44308289|NCT01249417|79309361|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
44308290|NCT01249417|79309362|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
44308291|NCT01249417|79309363|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
44308292|NCT01249417|79309361|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
44308293|NCT01249417|79309362|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
44308294|NCT01249417|79309363|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
44308295|NCT01249417|79309361|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
44308296|NCT01249417|79309362|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
44308297|NCT01249417|79309363|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
44308298|NCT01249261|79309373|FG000|Overall Study|Withdrawal by Subject|1|||
44308299|NCT01249261|79309374|FG001|Overall Study|Withdrawal by Subject|0|||
44308300|NCT01248949|79309390|FG000|Overall Study|Lost to Follow-up|2|||
44308301|NCT01248949|79309391|FG001|Overall Study|Lost to Follow-up|2|||
44308302|NCT01248949|79309392|FG002|Overall Study|Lost to Follow-up|2|||
44308303|NCT01248949|79309393|FG003|Overall Study|Lost to Follow-up|1|||
44308304|NCT01248949|79309394|FG004|Overall Study|Lost to Follow-up|0|||
44308305|NCT01248949|79309390|FG000|Overall Study|Withdrawal by Subject|5|||
44308306|NCT01248949|79309391|FG001|Overall Study|Withdrawal by Subject|3|||
44308307|NCT01248949|79309392|FG002|Overall Study|Withdrawal by Subject|11|||
44308308|NCT01248949|79309393|FG003|Overall Study|Withdrawal by Subject|3|||
44308309|NCT01248949|79309394|FG004|Overall Study|Withdrawal by Subject|1|||
44308310|NCT01248949|79309390|FG000|Overall Study|Death|22|||
44308311|NCT01248949|79309391|FG001|Overall Study|Death|7|||
44308312|NCT01248949|79309392|FG002|Overall Study|Death|21|||
44308313|NCT01248949|79309393|FG003|Overall Study|Death|6|||
44308314|NCT01248949|79309394|FG004|Overall Study|Death|2|||
44308315|NCT01248949|79309390|FG000|Overall Study|Alternative Therapy|1|||
44308316|NCT01248949|79309391|FG001|Overall Study|Alternative Therapy|0|||
44308317|NCT01248949|79309392|FG002|Overall Study|Alternative Therapy|0|||
44308318|NCT01248949|79309393|FG003|Overall Study|Alternative Therapy|0|||
44308319|NCT01248949|79309394|FG004|Overall Study|Alternative Therapy|0|||
44308320|NCT01248949|79309390|FG000|Overall Study|Alternative Therapy.|1|||
44308321|NCT01248949|79309391|FG001|Overall Study|Alternative Therapy.|0|||
44308322|NCT01248949|79309392|FG002|Overall Study|Alternative Therapy.|0|||
44308323|NCT01248949|79309393|FG003|Overall Study|Alternative Therapy.|0|||
44308324|NCT01248949|79309394|FG004|Overall Study|Alternative Therapy.|0|||
44308325|NCT01248949|79309390|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
44308326|NCT01248949|79309391|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
44308327|NCT01248949|79309392|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
44308328|NCT01248949|79309393|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
44308329|NCT01248949|79309394|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
44308330|NCT01248949|79309390|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
44308331|NCT01248949|79309391|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
44308332|NCT01248949|79309392|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
44308333|NCT01248949|79309393|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
44308334|NCT01248949|79309394|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
44308335|NCT01248949|79309390|FG000|Overall Study|Participant Went To Hospice|0|||
44308336|NCT01248949|79309391|FG001|Overall Study|Participant Went To Hospice|0|||
44308337|NCT01248949|79309392|FG002|Overall Study|Participant Went To Hospice|1|||
44308338|NCT01248949|79309393|FG003|Overall Study|Participant Went To Hospice|0|||
44308339|NCT01248949|79309394|FG004|Overall Study|Participant Went To Hospice|0|||
44308340|NCT01248949|79309390|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
44308341|NCT01248949|79309391|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
44308342|NCT01248949|79309392|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
44308343|NCT01248949|79309393|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
44308344|NCT01248949|79309394|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
44308345|NCT01248949|79309390|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
44308346|NCT01248949|79309391|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
44308347|NCT01248949|79309392|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
44308348|NCT01248949|79309393|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
44308349|NCT01248949|79309394|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
44308350|NCT01248949|79309390|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
44308351|NCT01248949|79309391|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
44308352|NCT01248949|79309392|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
44308353|NCT01248949|79309393|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
44308354|NCT01248949|79309394|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
44308355|NCT01248949|79309390|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
44308356|NCT01248949|79309391|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
44308357|NCT01248949|79309392|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
44308358|NCT01248949|79309393|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
44308359|NCT01248949|79309394|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
44308360|NCT01248793|79309408|FG000|Overall Study|Lost to Follow-up|0|||
44308361|NCT01248793|79309409|FG001|Overall Study|Lost to Follow-up|1|||
44308362|NCT01248793|79309408|FG000|Overall Study|Adverse Event|1|||
44308363|NCT01248793|79309409|FG001|Overall Study|Adverse Event|1|||
44308364|NCT01248793|79309408|FG000|Overall Study|Protocol Violation|0|||
44308365|NCT01248793|79309409|FG001|Overall Study|Protocol Violation|1|||
44257306|NCT01311713|79109714|FG006|Overall Study|Lost to Follow-up|0|||
44257307|NCT01311713|79109708|FG000|Overall Study|Stopped taking study medication|0|||
44257308|NCT01311713|79109709|FG001|Overall Study|Stopped taking study medication|0|||
44257309|NCT01311713|79109710|FG002|Overall Study|Stopped taking study medication|0|||
44257310|NCT01311713|79109711|FG003|Overall Study|Stopped taking study medication|1|||
44257311|NCT01311713|79109712|FG004|Overall Study|Stopped taking study medication|1|||
44257312|NCT01311713|79109713|FG005|Overall Study|Stopped taking study medication|0|||
44257313|NCT01311713|79109714|FG006|Overall Study|Stopped taking study medication|0|||
44257314|NCT01311713|79109708|FG000|Overall Study|Enrolled but not treated|0|||
44257315|NCT01311713|79109709|FG001|Overall Study|Enrolled but not treated|0|||
44257316|NCT01311713|79109710|FG002|Overall Study|Enrolled but not treated|1|||
44308366|NCT01248793|79309408|FG000|Overall Study|Withdrawal by Subject|3|||
44308367|NCT01248793|79309409|FG001|Overall Study|Withdrawal by Subject|3|||
44308368|NCT01248364|79309419|FG000|Overall Study|Adverse Event|0|||
44308369|NCT01248364|79309420|FG001|Overall Study|Adverse Event|1|||
44308370|NCT01248364|79309421|FG002|Overall Study|Adverse Event|0|||
44308371|NCT01248364|79309422|FG003|Overall Study|Adverse Event|0|||
44308372|NCT01248130|79309434|FG000|Overall Study|Protocol Violation|1|||
44308373|NCT01248130|79309435|FG001|Overall Study|Protocol Violation|0|||
44308374|NCT01248130|79309434|FG000|Overall Study|Ineligible|1|||
44308375|NCT01248130|79309435|FG001|Overall Study|Ineligible|0|||
44308376|NCT01248013|79309441|FG000|Overall Study|Withdrawal by Subject|14|||
44308377|NCT01247350|79309450|FG000|Overall Study|Adverse Event|0|||
44308378|NCT01247350|79309451|FG001|Overall Study|Adverse Event|0|||
44308379|NCT01247350|79309452|FG002|Overall Study|Adverse Event|1|||
44308380|NCT01247350|79309453|FG003|Overall Study|Adverse Event|0|||
44308381|NCT01247350|79309454|FG004|Overall Study|Adverse Event|0|||
44308382|NCT01247350|79309450|FG000|Overall Study|Withdrawal by Subject|0|||
44308383|NCT01247350|79309451|FG001|Overall Study|Withdrawal by Subject|0|||
44308384|NCT01247350|79309452|FG002|Overall Study|Withdrawal by Subject|0|||
44308385|NCT01247350|79309453|FG003|Overall Study|Withdrawal by Subject|1|||
44308386|NCT01247350|79309454|FG004|Overall Study|Withdrawal by Subject|0|||
44308387|NCT01247350|79309450|FG000|Overall Study|Entry criteria not met|0|||
44308388|NCT01247350|79309451|FG001|Overall Study|Entry criteria not met|0|||
44308389|NCT01247350|79309452|FG002|Overall Study|Entry criteria not met|0|||
44308390|NCT01247350|79309453|FG003|Overall Study|Entry criteria not met|0|||
44308391|NCT01247350|79309454|FG004|Overall Study|Entry criteria not met|1|||
44308392|NCT01246999|79309484|FG000|Overall Study|Lost to Follow-up|0|||
44308393|NCT01246999|79309485|FG001|Overall Study|Lost to Follow-up|1|||
44308394|NCT01246999|79309486|FG002|Overall Study|Lost to Follow-up|0|||
44308395|NCT01246999|79309487|FG003|Overall Study|Lost to Follow-up|0|||
44308396|NCT01246999|79309484|FG000|Overall Study|Withdrawal by Subject|0|||
44308397|NCT01246999|79309485|FG001|Overall Study|Withdrawal by Subject|0|||
44308398|NCT01246999|79309486|FG002|Overall Study|Withdrawal by Subject|0|||
44308399|NCT01246999|79309487|FG003|Overall Study|Withdrawal by Subject|2|||
44308400|NCT01245751|79309509|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
44308401|NCT01245751|79309510|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
44308402|NCT01245751|79309511|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
44308403|NCT01245751|79309512|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
44308404|NCT01245751|79309509|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
44308405|NCT01245751|79309510|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
44308406|NCT01245751|79309511|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
44308407|NCT01245751|79309512|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
44308408|NCT01245751|79309509|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
44308409|NCT01245751|79309510|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
44308410|NCT01245751|79309511|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
44308411|NCT01245751|79309512|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
44308412|NCT01245673|79309523|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
44308413|NCT01245283|79309530|FG000|Overall Study|Lost to Follow-up|14|||
44308414|NCT01245283|79309531|FG001|Overall Study|Lost to Follow-up|11|||
44308415|NCT01245283|79309532|FG002|Overall Study|Lost to Follow-up|11|||
44308416|NCT01245049|79309545|FG000|Overall Study|Migrated/moved from study area|0|||
44308417|NCT01245049|79309546|FG001|Overall Study|Migrated/moved from study area|1|||
44308418|NCT01245049|79309545|FG000|Overall Study|Withdrawal by Subject|0|||
44308419|NCT01245049|79309546|FG001|Overall Study|Withdrawal by Subject|1|||
44308420|NCT01245049|79309545|FG000|Overall Study|Lost to Follow-up|1|||
44308421|NCT01245049|79309546|FG001|Overall Study|Lost to Follow-up|2|||
44308422|NCT01244893|79309552|FG000|Baseline|Protocol Violation|0|||
44308423|NCT01244893|79309553|FG001|Baseline|Protocol Violation|1|||
44308424|NCT01244893|79309552|FG000|1-Week Follow Up|Lost to Follow-up|1|||
44308425|NCT01244893|79309553|FG001|1-Week Follow Up|Lost to Follow-up|0|||
44308426|NCT01244815|79309568|FG000|Overall Study|Not Treated|0|||
44308427|NCT01244815|79309569|FG001|Overall Study|Not Treated|1|||
44308428|NCT01244815|79309570|FG002|Overall Study|Not Treated|0|||
44308429|NCT01244815|79309571|FG003|Overall Study|Not Treated|0|||
44308430|NCT01244815|79309568|FG000|Overall Study|Adverse Event|4|||
44535124|NCT04377620|79546053|FG000|Overall Study|Death|42|||
44308431|NCT01244815|79309569|FG001|Overall Study|Adverse Event|7|||
44308432|NCT01244815|79309570|FG002|Overall Study|Adverse Event|5|||
44308433|NCT01244815|79309571|FG003|Overall Study|Adverse Event|5|||
44308434|NCT01244815|79309568|FG000|Overall Study|Treatment Failure|0|||
44308435|NCT01244815|79309569|FG001|Overall Study|Treatment Failure|0|||
44308436|NCT01244815|79309570|FG002|Overall Study|Treatment Failure|0|||
44308437|NCT01244815|79309571|FG003|Overall Study|Treatment Failure|1|||
44308438|NCT01244815|79309568|FG000|Overall Study|Lost to Follow-up|3|||
44308439|NCT01244815|79309569|FG001|Overall Study|Lost to Follow-up|2|||
44308440|NCT01244815|79309570|FG002|Overall Study|Lost to Follow-up|3|||
44308441|NCT01244815|79309571|FG003|Overall Study|Lost to Follow-up|2|||
44308442|NCT01244815|79309568|FG000|Overall Study|Withdrawal by Subject|0|||
44308443|NCT01244815|79309569|FG001|Overall Study|Withdrawal by Subject|2|||
44308444|NCT01244815|79309570|FG002|Overall Study|Withdrawal by Subject|0|||
44308445|NCT01244815|79309571|FG003|Overall Study|Withdrawal by Subject|3|||
44308446|NCT01244815|79309568|FG000|Overall Study|Protocol Violation|7|||
44308447|NCT01244815|79309569|FG001|Overall Study|Protocol Violation|4|||
44308448|NCT01244815|79309570|FG002|Overall Study|Protocol Violation|3|||
44308449|NCT01244815|79309571|FG003|Overall Study|Protocol Violation|1|||
44308450|NCT01244815|79309568|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
44308451|NCT01244815|79309569|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
44308452|NCT01244815|79309570|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
44308453|NCT01244815|79309571|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
44308454|NCT01244425|79309583|FG000|Overall Study|Withdrawal by Subject|2|||
44308455|NCT01244425|79309584|FG001|Overall Study|Withdrawal by Subject|2|||
44308456|NCT01244425|79309583|FG000|Overall Study|Adverse Event|1|||
44308457|NCT01244425|79309584|FG001|Overall Study|Adverse Event|1|||
44308458|NCT01244191|79309600|FG000|Overall Study|Progressive disease|295|||
44308459|NCT01244191|79309601|FG001|Overall Study|Progressive disease|350|||
44308460|NCT01244191|79309600|FG000|Overall Study|Clinical disease progression|54|||
44308461|NCT01244191|79309601|FG001|Overall Study|Clinical disease progression|36|||
44308462|NCT01244191|79309600|FG000|Overall Study|Adverse Event|65|||
44308463|NCT01244191|79309601|FG001|Overall Study|Adverse Event|48|||
44308464|NCT01244191|79309600|FG000|Overall Study|Death|22|||
44308465|NCT01244191|79309601|FG001|Overall Study|Death|29|||
44308466|NCT01244191|79309600|FG000|Overall Study|Lost to Follow-up|0|||
44308467|NCT01244191|79309601|FG001|Overall Study|Lost to Follow-up|2|||
44308468|NCT01244191|79309600|FG000|Overall Study|Protocol Violation|1|||
44308469|NCT01244191|79309601|FG001|Overall Study|Protocol Violation|2|||
44308470|NCT01244191|79309600|FG000|Overall Study|Withdrawal by Subject|31|||
44308471|NCT01244191|79309601|FG001|Overall Study|Withdrawal by Subject|23|||
44308472|NCT01244191|79309600|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
44308473|NCT01244191|79309601|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
44308474|NCT01244035|79309607|FG000|Part 1: Period 1|Adverse Event|0|||
44308475|NCT01244035|79309608|FG001|Part 1: Period 1|Adverse Event|0|||
44308476|NCT01244035|79309609|FG002|Part 1: Period 1|Adverse Event|0|||
44308477|NCT01244035|79309610|FG003|Part 1: Period 1|Adverse Event|0|||
44308478|NCT01244035|79309611|FG004|Part 1: Period 1|Adverse Event|0|||
44308479|NCT01244035|79309612|FG005|Part 1: Period 1|Adverse Event|1|||
44308480|NCT01244035|79309607|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
44308481|NCT01244035|79309608|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
44308482|NCT01244035|79309609|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
44308483|NCT01244035|79309610|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
44308484|NCT01244035|79309611|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
44308485|NCT01244035|79309612|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
44308486|NCT01244035|79309607|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
44308487|NCT01244035|79309608|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
44308488|NCT01244035|79309609|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
44308489|NCT01244035|79309610|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
44308490|NCT01244035|79309611|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
44308491|NCT01244035|79309612|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
44535125|NCT04377620|79546054|FG001|Overall Study|Death|48|||
44535126|NCT04377620|79546055|FG002|Overall Study|Death|36|||
44535127|NCT04377620|79546053|FG000|Overall Study|Withdrawal by Subject|0|||
44535128|NCT04377620|79546054|FG001|Overall Study|Withdrawal by Subject|2|||
44535129|NCT04377620|79546055|FG002|Overall Study|Withdrawal by Subject|0|||
44535130|NCT03522948|79546064|FG000|Overall Study|Lost to Follow-up|1|||
44535131|NCT03406078|79546070|FG000|Overall Study|Death|1|||
44535132|NCT03406078|79546071|FG001|Overall Study|Death|0|||
44535133|NCT03406078|79546070|FG000|Overall Study|Lost to Follow-up|0|||
44535134|NCT03406078|79546071|FG001|Overall Study|Lost to Follow-up|1|||
44535135|NCT03406078|79546070|FG000|Overall Study|Withdrawal by Subject|5|||
44535136|NCT03406078|79546071|FG001|Overall Study|Withdrawal by Subject|2|||
44535137|NCT03634033|79546084|FG000|Overall Study|Did not have a post-assessment|384|||
44535138|NCT03634033|79546085|FG001|Overall Study|Did not have a post-assessment|291|||
44308492|NCT01244035|79309607|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
44308493|NCT01244035|79309608|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
44308494|NCT01244035|79309609|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
44308495|NCT01244035|79309610|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
44308496|NCT01244035|79309611|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
44535139|NCT03634033|79546086|FG002|Overall Study|Did not have a post-assessment|114|||
44535140|NCT03634033|79546087|FG003|Overall Study|Did not have a post-assessment|161|||
44535141|NCT03634033|79546088|FG004|Overall Study|Did not have a post-assessment|5|||
44308497|NCT01244035|79309612|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
44308498|NCT01244035|79309607|FG000|Part 1: Period 3|Adverse Event|0|||
44308499|NCT01244035|79309608|FG001|Part 1: Period 3|Adverse Event|0|||
44308500|NCT01244035|79309609|FG002|Part 1: Period 3|Adverse Event|0|||
44535142|NCT03634033|79546089|FG005|Overall Study|Did not have a post-assessment|0|||
44535143|NCT03634033|79546090|FG006|Overall Study|Did not have a post-assessment|0|||
44535144|NCT03634033|79546084|FG000|Overall Study|Death|0|||
44535145|NCT03634033|79546085|FG001|Overall Study|Death|0|||
44535146|NCT03634033|79546086|FG002|Overall Study|Death|0|||
44535147|NCT03634033|79546087|FG003|Overall Study|Death|0|||
44535148|NCT03634033|79546088|FG004|Overall Study|Death|0|||
44535149|NCT03634033|79546089|FG005|Overall Study|Death|7|||
44535150|NCT03634033|79546090|FG006|Overall Study|Death|7|||
44535151|NCT03634033|79546084|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
44535152|NCT03634033|79546085|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
44535153|NCT03634033|79546086|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
44535154|NCT03634033|79546087|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
44535155|NCT03634033|79546088|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
44535156|NCT03634033|79546089|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
44535157|NCT03634033|79546090|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
44535158|NCT03634033|79546084|FG000|Overall Study|Lost to Follow-up|0|||
44308501|NCT01244035|79309610|FG003|Part 1: Period 3|Adverse Event|0|||
44308502|NCT01244035|79309611|FG004|Part 1: Period 3|Adverse Event|0|||
44308503|NCT01244035|79309612|FG005|Part 1: Period 3|Adverse Event|1|||
44308504|NCT01244035|79309607|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
44308505|NCT01244035|79309608|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
44308506|NCT01244035|79309609|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
44308507|NCT01244035|79309610|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
44308508|NCT01244035|79309611|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
44308509|NCT01244035|79309612|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
44308510|NCT01244035|79309607|FG000|Part 1: Period 3|Protocol Deviation|0|||
44308511|NCT01244035|79309608|FG001|Part 1: Period 3|Protocol Deviation|1|||
44308512|NCT01244035|79309609|FG002|Part 1: Period 3|Protocol Deviation|0|||
44308513|NCT01244035|79309610|FG003|Part 1: Period 3|Protocol Deviation|0|||
44308514|NCT01244035|79309611|FG004|Part 1: Period 3|Protocol Deviation|0|||
44308515|NCT01244035|79309612|FG005|Part 1: Period 3|Protocol Deviation|0|||
44308516|NCT01243762|79309648|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
44308517|NCT01243762|79309649|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
44308518|NCT01243762|79309650|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
44308519|NCT01243762|79309651|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
44308520|NCT01243762|79309652|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
44308521|NCT01243762|79309653|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
44308522|NCT01243762|79309654|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
44308523|NCT01243762|79309648|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
44308524|NCT01243762|79309649|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
44308525|NCT01243762|79309650|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
44308526|NCT01243762|79309651|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
44308527|NCT01243762|79309652|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
44308528|NCT01243762|79309653|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
44308529|NCT01243762|79309654|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
44308530|NCT01243762|79309648|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
44308531|NCT01243762|79309649|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
44308532|NCT01243762|79309650|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
44308533|NCT01243762|79309651|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
44308534|NCT01243762|79309652|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
44308535|NCT01243762|79309653|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
44308536|NCT01243762|79309654|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
44308537|NCT01243762|79309648|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
44308538|NCT01243762|79309649|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
44308539|NCT01243762|79309650|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
44308540|NCT01243762|79309651|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
44308541|NCT01243762|79309652|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
44308542|NCT01243762|79309653|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
44308543|NCT01243762|79309654|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
44308544|NCT01243762|79309648|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
44308545|NCT01243762|79309649|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
44308546|NCT01243762|79309650|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
44308547|NCT01243762|79309651|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
44308548|NCT01243762|79309652|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
44308549|NCT01243762|79309653|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
44535159|NCT03634033|79546085|FG001|Overall Study|Lost to Follow-up|0|||
44535160|NCT03634033|79546086|FG002|Overall Study|Lost to Follow-up|0|||
44308550|NCT01243762|79309654|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
44308551|NCT01243762|79309648|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
44308552|NCT01243762|79309649|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
44535161|NCT03634033|79546087|FG003|Overall Study|Lost to Follow-up|0|||
44308553|NCT01243762|79309650|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
44308554|NCT01243762|79309651|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
44418933|NCT00444457|79426990|FG003|Infant Series|Other|0|||
44418934|NCT00444457|79426987|FG000|Infant Series|Parent or legal guardian request|18|||
44418935|NCT00444457|79426988|FG001|Infant Series|Parent or legal guardian request|29|||
44418936|NCT00444457|79426989|FG002|Infant Series|Parent or legal guardian request|34|||
44418937|NCT00444457|79426990|FG003|Infant Series|Parent or legal guardian request|14|||
44418938|NCT00444457|79426987|FG000|Infant Series|Lost to Follow-up|10|||
44418939|NCT00444457|79426988|FG001|Infant Series|Lost to Follow-up|11|||
44418940|NCT00444457|79426989|FG002|Infant Series|Lost to Follow-up|7|||
44418941|NCT00444457|79426990|FG003|Infant Series|Lost to Follow-up|6|||
44418942|NCT00444457|79426987|FG000|Infant Series|Protocol Violation|16|||
44418943|NCT00444457|79426988|FG001|Infant Series|Protocol Violation|8|||
44418944|NCT00444457|79426989|FG002|Infant Series|Protocol Violation|6|||
44418945|NCT00444457|79426990|FG003|Infant Series|Protocol Violation|3|||
44418946|NCT00444457|79426987|FG000|Infant Series|Failed to return|5|||
44418947|NCT00444457|79426988|FG001|Infant Series|Failed to return|4|||
44418948|NCT00444457|79426989|FG002|Infant Series|Failed to return|4|||
44418949|NCT00444457|79426990|FG003|Infant Series|Failed to return|2|||
44418950|NCT00444457|79426987|FG000|Infant Series|Investigator request|4|||
44418951|NCT00444457|79426988|FG001|Infant Series|Investigator request|3|||
44418952|NCT00444457|79426989|FG002|Infant Series|Investigator request|3|||
44418953|NCT00444457|79426990|FG003|Infant Series|Investigator request|2|||
44418954|NCT00444457|79426987|FG000|Infant Series|Other|0|||
44418955|NCT00444457|79426988|FG001|Infant Series|Other|2|||
44418956|NCT00444457|79426989|FG002|Infant Series|Other|4|||
44418957|NCT00444457|79426990|FG003|Infant Series|Other|0|||
44418958|NCT00444457|79426987|FG000|Infant Series|Adverse Event|1|||
44418959|NCT00444457|79426988|FG001|Infant Series|Adverse Event|2|||
44418960|NCT00444457|79426989|FG002|Infant Series|Adverse Event|2|||
44418961|NCT00444457|79426990|FG003|Infant Series|Adverse Event|0|||
44418962|NCT00444457|79426987|FG000|Infant Series|Death|0|||
44418963|NCT00444457|79426988|FG001|Infant Series|Death|1|||
44418964|NCT00444457|79426989|FG002|Infant Series|Death|1|||
44418965|NCT00444457|79426990|FG003|Infant Series|Death|1|||
44418966|NCT00444457|79426987|FG000|After Infant Series|Other|0|||
44418967|NCT00444457|79426988|FG001|After Infant Series|Other|1|||
44418968|NCT00444457|79426989|FG002|After Infant Series|Other|1|||
44418969|NCT00444457|79426990|FG003|After Infant Series|Other|1|||
44418970|NCT00444457|79426987|FG000|After Infant Series|Parent or legal guardian request|4|||
44418971|NCT00444457|79426988|FG001|After Infant Series|Parent or legal guardian request|11|||
44418972|NCT00444457|79426989|FG002|After Infant Series|Parent or legal guardian request|6|||
44418973|NCT00444457|79426990|FG003|After Infant Series|Parent or legal guardian request|3|||
44418974|NCT00444457|79426987|FG000|After Infant Series|Failed to return|7|||
44418975|NCT00444457|79426988|FG001|After Infant Series|Failed to return|6|||
44418976|NCT00444457|79426989|FG002|After Infant Series|Failed to return|5|||
44418977|NCT00444457|79426990|FG003|After Infant Series|Failed to return|1|||
44418978|NCT00444457|79426987|FG000|After Infant Series|Lost to Follow-up|5|||
44418979|NCT00444457|79426988|FG001|After Infant Series|Lost to Follow-up|5|||
44418980|NCT00444457|79426989|FG002|After Infant Series|Lost to Follow-up|5|||
44418981|NCT00444457|79426990|FG003|After Infant Series|Lost to Follow-up|2|||
44418982|NCT00444457|79426987|FG000|After Infant Series|Protocol Violation|2|||
44418983|NCT00444457|79426988|FG001|After Infant Series|Protocol Violation|4|||
44418984|NCT00444457|79426989|FG002|After Infant Series|Protocol Violation|2|||
44418985|NCT00444457|79426990|FG003|After Infant Series|Protocol Violation|2|||
44418986|NCT00444457|79426987|FG000|After Infant Series|Adverse Event|2|||
44418987|NCT00444457|79426988|FG001|After Infant Series|Adverse Event|2|||
44418988|NCT00444457|79426989|FG002|After Infant Series|Adverse Event|0|||
44418989|NCT00444457|79426990|FG003|After Infant Series|Adverse Event|0|||
44418990|NCT00444457|79426987|FG000|After Infant Series|Investigator request|0|||
44308555|NCT01243762|79309652|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
44418991|NCT00444457|79426988|FG001|After Infant Series|Investigator request|0|||
44418992|NCT00444457|79426989|FG002|After Infant Series|Investigator request|0|||
44418993|NCT00444457|79426990|FG003|After Infant Series|Investigator request|1|||
44418994|NCT00444457|79426987|FG000|After Infant Series|Other|0|||
44418995|NCT00444457|79426988|FG001|After Infant Series|Other|1|||
44418996|NCT00444457|79426989|FG002|After Infant Series|Other|0|||
44418997|NCT00444457|79426990|FG003|After Infant Series|Other|0|||
44418998|NCT00444457|79426987|FG000|Toddler Dose|Lost to Follow-up|4|||
44418999|NCT00444457|79426988|FG001|Toddler Dose|Lost to Follow-up|1|||
44419000|NCT00444457|79426989|FG002|Toddler Dose|Lost to Follow-up|1|||
44419001|NCT00444457|79426990|FG003|Toddler Dose|Lost to Follow-up|3|||
44419002|NCT00444457|79426987|FG000|Toddler Dose|Failed to return|2|||
44419003|NCT00444457|79426988|FG001|Toddler Dose|Failed to return|2|||
44419004|NCT00444457|79426989|FG002|Toddler Dose|Failed to return|1|||
44419005|NCT00444457|79426990|FG003|Toddler Dose|Failed to return|3|||
44419006|NCT00444457|79426987|FG000|Toddler Dose|Parent or legal guardian request|0|||
44419007|NCT00444457|79426988|FG001|Toddler Dose|Parent or legal guardian request|3|||
44308556|NCT01243762|79309653|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
44308557|NCT01243762|79309654|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
44308558|NCT01243762|79309648|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
44308559|NCT01243762|79309649|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
44308560|NCT01243762|79309650|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
44308561|NCT01243762|79309651|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
44308562|NCT01243762|79309652|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
44308563|NCT01243762|79309653|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
44308564|NCT01243762|79309654|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
44308565|NCT01243762|79309648|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
44308566|NCT01243762|79309649|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
44308567|NCT01243762|79309650|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
44308568|NCT01243762|79309651|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
44308569|NCT01243762|79309652|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
44308570|NCT01243762|79309653|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
44308571|NCT01243762|79309654|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
44308572|NCT01243411|79309673|FG000|Overall Study|Withdrawal by Subject|18|||
44308573|NCT01243411|79309673|FG000|Overall Study|Lost to Follow-up|10|||
44308574|NCT01243411|79309673|FG000|Overall Study|Adverse Event|5|||
44308575|NCT01243411|79309673|FG000|Overall Study|Other|8|||
44308576|NCT01243177|79309679|FG000|Overall Study|Lack of Efficacy|47|||
44308577|NCT01243177|79309680|FG001|Overall Study|Lack of Efficacy|31|||
44308578|NCT01243177|79309679|FG000|Overall Study|Protocol Violation|11|||
44308579|NCT01243177|79309680|FG001|Overall Study|Protocol Violation|10|||
44308580|NCT01243177|79309679|FG000|Overall Study|Lost to Follow-up|15|||
44308581|NCT01243177|79309680|FG001|Overall Study|Lost to Follow-up|18|||
44308582|NCT01243177|79309679|FG000|Overall Study|Withdrawal by Subject|46|||
44308583|NCT01243177|79309680|FG001|Overall Study|Withdrawal by Subject|38|||
44308584|NCT01243177|79309679|FG000|Overall Study|AE, serious fatal|0|||
44308585|NCT01243177|79309680|FG001|Overall Study|AE, serious fatal|1|||
44308586|NCT01243177|79309679|FG000|Overall Study|SAE, non-fatal|7|||
44308587|NCT01243177|79309680|FG001|Overall Study|SAE, non-fatal|9|||
44308588|NCT01243177|79309679|FG000|Overall Study|AE, non-serious non-fatal|40|||
44308589|NCT01243177|79309680|FG001|Overall Study|AE, non-serious non-fatal|58|||
44308590|NCT01243177|79309679|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
44308591|NCT01243177|79309680|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
44308592|NCT01243177|79309679|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
44308593|NCT01243177|79309680|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
44308594|NCT01243177|79309679|FG000|Overall Study|Other Reason|11|||
44308595|NCT01243177|79309680|FG001|Overall Study|Other Reason|12|||
44308596|NCT01242748|79309688|FG000|Overall Study|Adverse Event|10|||
44308597|NCT01242748|79309689|FG001|Overall Study|Adverse Event|5|||
44308598|NCT01242748|79309688|FG000|Overall Study|Lost to Follow-up|6|||
44308599|NCT01242748|79309689|FG001|Overall Study|Lost to Follow-up|2|||
44419008|NCT00444457|79426989|FG002|Toddler Dose|Parent or legal guardian request|2|||
44419009|NCT00444457|79426990|FG003|Toddler Dose|Parent or legal guardian request|1|||
44419010|NCT00444457|79426987|FG000|Toddler Dose|Protocol Violation|1|||
44419011|NCT00444457|79426988|FG001|Toddler Dose|Protocol Violation|0|||
44419012|NCT00444457|79426989|FG002|Toddler Dose|Protocol Violation|0|||
44419013|NCT00444457|79426990|FG003|Toddler Dose|Protocol Violation|1|||
44419014|NCT00799058|79427014|FG000|Overall Study|Withdrawal by Subject|2|||
44419015|NCT00799058|79427015|FG001|Overall Study|Withdrawal by Subject|2|||
44419016|NCT00799058|79427016|FG002|Overall Study|Withdrawal by Subject|2|||
44419017|NCT00799058|79427014|FG000|Overall Study|Lost to Follow-up|1|||
44419018|NCT00799058|79427015|FG001|Overall Study|Lost to Follow-up|2|||
44419019|NCT00799058|79427016|FG002|Overall Study|Lost to Follow-up|1|||
44419020|NCT00799058|79427014|FG000|Overall Study|Adverse Event|0|||
44535162|NCT03634033|79546088|FG004|Overall Study|Lost to Follow-up|0|||
44535163|NCT03634033|79546089|FG005|Overall Study|Lost to Follow-up|1|||
44308600|NCT01242748|79309688|FG000|Overall Study|Physician Decision|3|||
44308601|NCT01242748|79309689|FG001|Overall Study|Physician Decision|2|||
44308602|NCT01242748|79309688|FG000|Overall Study|Protocol Violation|1|||
44308603|NCT01242748|79309689|FG001|Overall Study|Protocol Violation|0|||
44308604|NCT01242748|79309688|FG000|Overall Study|Withdrawal by Subject|10|||
44308605|NCT01242748|79309689|FG001|Overall Study|Withdrawal by Subject|2|||
44308606|NCT01242748|79309688|FG000|Overall Study|Miscellaneous reasons|8|||
44535164|NCT03634033|79546090|FG006|Overall Study|Lost to Follow-up|2|||
44308607|NCT01242748|79309689|FG001|Overall Study|Miscellaneous reasons|3|||
44308608|NCT01242514|79309698|FG000|Overall Study|e.g., project closure|1042|||
44308609|NCT01242514|79309699|FG001|Overall Study|e.g., project closure|305|||
44419021|NCT00799058|79427015|FG001|Overall Study|Adverse Event|2|||
44419022|NCT00799058|79427016|FG002|Overall Study|Adverse Event|0|||
44419023|NCT00799058|79427014|FG000|Overall Study|Pregnancy|1|||
44419024|NCT00799058|79427015|FG001|Overall Study|Pregnancy|0|||
44535165|NCT03634033|79546084|FG000|Overall Study|Withdrawal by Subject|0|||
44308610|NCT01242514|79309700|FG002|Overall Study|e.g., project closure|171|||
44308611|NCT01242514|79309698|FG000|Overall Study|Subject decision|33|||
44308612|NCT01242514|79309699|FG001|Overall Study|Subject decision|8|||
44308613|NCT01242514|79309700|FG002|Overall Study|Subject decision|2|||
44308614|NCT01242514|79309698|FG000|Overall Study|Severe non-compliance to protocol|5|||
44308615|NCT01242514|79309699|FG001|Overall Study|Severe non-compliance to protocol|2|||
44308616|NCT01242514|79309700|FG002|Overall Study|Severe non-compliance to protocol|1|||
44308617|NCT01242514|79309698|FG000|Overall Study|Lack of therapeutic response|99|||
44308618|NCT01242514|79309699|FG001|Overall Study|Lack of therapeutic response|16|||
44308619|NCT01242514|79309700|FG002|Overall Study|Lack of therapeutic response|10|||
44308620|NCT01242514|79309698|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
44308621|NCT01242514|79309699|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
44308622|NCT01242514|79309700|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
44308623|NCT01242514|79309698|FG000|Overall Study|Lost to Follow-up|14|||
44308624|NCT01242514|79309699|FG001|Overall Study|Lost to Follow-up|5|||
44308625|NCT01242514|79309700|FG002|Overall Study|Lost to Follow-up|4|||
44308626|NCT01242514|79309698|FG000|Overall Study|Adverse Event|129|||
44308627|NCT01242514|79309699|FG001|Overall Study|Adverse Event|18|||
44308628|NCT01242514|79309700|FG002|Overall Study|Adverse Event|19|||
44308629|NCT01242085|79309711|FG000|Overall Study|Withdrawal by Subject|4|||
44308630|NCT01242085|79309712|FG001|Overall Study|Withdrawal by Subject|2|||
44308631|NCT01242085|79309713|FG002|Overall Study|Withdrawal by Subject|0|||
44308632|NCT01242085|79309711|FG000|Overall Study|medically unable to have surgery|4|||
44308633|NCT01242085|79309712|FG001|Overall Study|medically unable to have surgery|5|||
44308634|NCT01242085|79309713|FG002|Overall Study|medically unable to have surgery|0|||
44308635|NCT01241461|79309721|FG000|Overall Study|Progressive Disease|3|||
44308636|NCT01241461|79309722|FG001|Overall Study|Progressive Disease|6|||
44419025|NCT00799058|79427016|FG002|Overall Study|Pregnancy|0|||
44419026|NCT00799058|79427014|FG000|Overall Study|Not adherent|3|||
44419027|NCT00799058|79427015|FG001|Overall Study|Not adherent|2|||
44419028|NCT00799058|79427016|FG002|Overall Study|Not adherent|1|||
44419029|NCT00799058|79427014|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
44419030|NCT00799058|79427015|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
44419031|NCT00799058|79427016|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
44419032|NCT00799058|79427014|FG000|Overall Study|IP dispensing error|1|||
44419033|NCT00799058|79427015|FG001|Overall Study|IP dispensing error|0|||
44419034|NCT00799058|79427016|FG002|Overall Study|IP dispensing error|0|||
44419035|NCT00799058|79427014|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
44419036|NCT00799058|79427015|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
44419037|NCT00799058|79427016|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
44419038|NCT00799058|79427014|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
44419039|NCT00799058|79427015|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
44419040|NCT00799058|79427016|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
44419041|NCT00799058|79427014|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
44419042|NCT00799058|79427015|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
44419043|NCT00799058|79427016|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
44419044|NCT00799058|79427014|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
44419045|NCT00799058|79427015|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
44419046|NCT00799058|79427016|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
44419047|NCT00725985|79427029|FG000|ITP- Treatment Disposition|Adverse Event|20|||
44419048|NCT00725985|79427030|FG001|ITP- Treatment Disposition|Adverse Event|10|||
44419049|NCT00725985|79427031|FG002|ITP- Treatment Disposition|Adverse Event|5|||
44419050|NCT00725985|79427032|FG003|ITP- Treatment Disposition|Adverse Event|0|||
44419051|NCT00725985|79427033|FG004|ITP- Treatment Disposition|Adverse Event|0|||
44419052|NCT00725985|79427034|FG005|ITP- Treatment Disposition|Adverse Event|0|||
44419053|NCT00725985|79427035|FG006|ITP- Treatment Disposition|Adverse Event|0|||
44419054|NCT00725985|79427036|FG007|ITP- Treatment Disposition|Adverse Event|0|||
44419055|NCT00725985|79427037|FG008|ITP- Treatment Disposition|Adverse Event|0|||
44419056|NCT00725985|79427038|FG009|ITP- Treatment Disposition|Adverse Event|0|||
44419057|NCT00725985|79427039|FG010|ITP- Treatment Disposition|Adverse Event|0|||
44419058|NCT00725985|79427040|FG011|ITP- Treatment Disposition|Adverse Event|0|||
44419059|NCT00725985|79427029|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
44308637|NCT01240135|79309734|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
44419060|NCT00725985|79427030|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
44308638|NCT01240135|79309735|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
44308639|NCT01240135|79309734|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
44308640|NCT01240135|79309735|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
44308641|NCT01247701|79309741|FG000|Overall Study|Death|2|||
44419061|NCT00725985|79427031|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
44419062|NCT00725985|79427032|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419063|NCT00725985|79427033|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419064|NCT00725985|79427034|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419065|NCT00725985|79427035|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419066|NCT00725985|79427036|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419067|NCT00725985|79427037|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419068|NCT00725985|79427038|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419069|NCT00725985|79427039|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419070|NCT00725985|79427040|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
44419071|NCT00725985|79427029|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
44419072|NCT00725985|79427030|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
44419073|NCT00725985|79427031|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
44419074|NCT00725985|79427032|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
44419075|NCT00725985|79427033|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
44419076|NCT00725985|79427034|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
44419077|NCT00725985|79427035|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
44419078|NCT00725985|79427036|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
44419079|NCT00725985|79427037|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
44419080|NCT00725985|79427038|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
44419081|NCT00725985|79427039|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
44535166|NCT03634033|79546085|FG001|Overall Study|Withdrawal by Subject|0|||
44535167|NCT03634033|79546086|FG002|Overall Study|Withdrawal by Subject|0|||
44535168|NCT03634033|79546087|FG003|Overall Study|Withdrawal by Subject|0|||
44535169|NCT03634033|79546088|FG004|Overall Study|Withdrawal by Subject|0|||
44535170|NCT03634033|79546089|FG005|Overall Study|Withdrawal by Subject|0|||
44419082|NCT00725985|79427040|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
44419083|NCT00725985|79427029|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
44419084|NCT00725985|79427030|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
44419085|NCT00725985|79427031|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
44419086|NCT00725985|79427032|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
44419087|NCT00725985|79427033|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
44419088|NCT00725985|79427034|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
44419089|NCT00725985|79427035|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
44419090|NCT00725985|79427036|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
44419091|NCT00725985|79427037|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
44419092|NCT00725985|79427038|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
44419093|NCT00725985|79427039|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
44419094|NCT00725985|79427040|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
44419095|NCT00725985|79427029|FG000|ITP- Treatment Disposition|Other|50|||
44419096|NCT00725985|79427030|FG001|ITP- Treatment Disposition|Other|38|||
44419097|NCT00725985|79427031|FG002|ITP- Treatment Disposition|Other|24|||
44419098|NCT00725985|79427032|FG003|ITP- Treatment Disposition|Other|0|||
44419099|NCT00725985|79427033|FG004|ITP- Treatment Disposition|Other|0|||
44419100|NCT00725985|79427034|FG005|ITP- Treatment Disposition|Other|0|||
44419101|NCT00725985|79427035|FG006|ITP- Treatment Disposition|Other|0|||
44419102|NCT00725985|79427036|FG007|ITP- Treatment Disposition|Other|0|||
44419103|NCT00725985|79427037|FG008|ITP- Treatment Disposition|Other|0|||
44419104|NCT00725985|79427038|FG009|ITP- Treatment Disposition|Other|0|||
44419105|NCT00725985|79427039|FG010|ITP- Treatment Disposition|Other|0|||
44419106|NCT00725985|79427040|FG011|ITP- Treatment Disposition|Other|0|||
44419107|NCT00725985|79427029|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44419108|NCT00725985|79427030|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44419109|NCT00725985|79427031|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44419110|NCT00725985|79427032|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
44419111|NCT00725985|79427033|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
44419112|NCT00725985|79427034|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
44419113|NCT00725985|79427035|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44419114|NCT00725985|79427036|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44535171|NCT03634033|79546090|FG006|Overall Study|Withdrawal by Subject|1|||
44535172|NCT03103100|79546124|FG000|Overall Study|Adverse Event|1|||
44535173|NCT03103100|79546125|FG001|Overall Study|Adverse Event|0|||
44535174|NCT03103100|79546126|FG002|Overall Study|Adverse Event|0|||
44535175|NCT03103100|79546124|FG000|Overall Study|Physician Decision|1|||
44535176|NCT03103100|79546125|FG001|Overall Study|Physician Decision|0|||
44535177|NCT03103100|79546126|FG002|Overall Study|Physician Decision|2|||
44257317|NCT01311713|79109711|FG003|Overall Study|Enrolled but not treated|0|||
44419115|NCT00725985|79427037|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44257318|NCT01311713|79109712|FG004|Overall Study|Enrolled but not treated|0|||
44419116|NCT00725985|79427038|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44419117|NCT00725985|79427039|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44535178|NCT03438006|79546134|FG000|Overall Study|Adverse Event|1|||
44535179|NCT03438006|79546134|FG000|Overall Study|Lost to Follow-up|67|||
44308642|NCT01247701|79309741|FG000|Overall Study|Relapsed|8|||
44535180|NCT03438006|79546134|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
44535181|NCT03438006|79546134|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
44535182|NCT04206020|79546140|FG000|Overall Study|Adverse Event|1|||
44419118|NCT00725985|79427040|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
44419119|NCT00725985|79427029|FG000|OLMP (Up to 96 Weeks)|Death|0|||
44419120|NCT00725985|79427030|FG001|OLMP (Up to 96 Weeks)|Death|0|||
44419121|NCT00725985|79427031|FG002|OLMP (Up to 96 Weeks)|Death|0|||
44419122|NCT00725985|79427032|FG003|OLMP (Up to 96 Weeks)|Death|0|||
44419123|NCT00725985|79427033|FG004|OLMP (Up to 96 Weeks)|Death|1|||
44419124|NCT00725985|79427034|FG005|OLMP (Up to 96 Weeks)|Death|0|||
44419125|NCT00725985|79427035|FG006|OLMP (Up to 96 Weeks)|Death|0|||
44419126|NCT00725985|79427036|FG007|OLMP (Up to 96 Weeks)|Death|0|||
44419127|NCT00725985|79427037|FG008|OLMP (Up to 96 Weeks)|Death|0|||
44419128|NCT00725985|79427038|FG009|OLMP (Up to 96 Weeks)|Death|0|||
44419129|NCT00725985|79427039|FG010|OLMP (Up to 96 Weeks)|Death|0|||
44419130|NCT00725985|79427040|FG011|OLMP (Up to 96 Weeks)|Death|0|||
44419131|NCT00725985|79427029|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419132|NCT00725985|79427030|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419133|NCT00725985|79427031|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44535183|NCT04206020|79546141|FG001|Overall Study|Adverse Event|4|||
44535184|NCT04206020|79546140|FG000|Overall Study|Protocol Violation|2|||
44535185|NCT04206020|79546141|FG001|Overall Study|Protocol Violation|0|||
44535186|NCT04206020|79546140|FG000|Overall Study|Withdrawal by Subject|2|||
44535187|NCT04206020|79546141|FG001|Overall Study|Withdrawal by Subject|0|||
44535188|NCT04206020|79546140|FG000|Overall Study|Lost to Follow-up|2|||
44535189|NCT04206020|79546141|FG001|Overall Study|Lost to Follow-up|0|||
44535190|NCT04206020|79546140|FG000|Overall Study|Pregnancy|0|||
44535191|NCT04206020|79546141|FG001|Overall Study|Pregnancy|1|||
44535192|NCT04206020|79546140|FG000|Overall Study|Unable to attend visits|1|||
44535193|NCT04206020|79546141|FG001|Overall Study|Unable to attend visits|2|||
44535194|NCT03466086|79546147|FG000|Period 1|Sponsor decision due to study timeline|1|||
44535195|NCT03466086|79546148|FG001|Period 1|Sponsor decision due to study timeline|0|||
44308643|NCT01248247|79309749|FG000|Overall Study|Adverse Event|2|||
44308644|NCT01248247|79309750|FG001|Overall Study|Adverse Event|4|||
44308645|NCT01248247|79309751|FG002|Overall Study|Adverse Event|4|||
44308646|NCT01248247|79309752|FG003|Overall Study|Adverse Event|2|||
44308647|NCT01248247|79309749|FG000|Overall Study|Death|0|||
44308648|NCT01248247|79309750|FG001|Overall Study|Death|1|||
44308649|NCT01248247|79309751|FG002|Overall Study|Death|4|||
44308650|NCT01248247|79309752|FG003|Overall Study|Death|7|||
44308651|NCT01248247|79309749|FG000|Overall Study|Lost to Follow-up|0|||
44308652|NCT01248247|79309750|FG001|Overall Study|Lost to Follow-up|1|||
44308653|NCT01248247|79309751|FG002|Overall Study|Lost to Follow-up|1|||
44308654|NCT01248247|79309752|FG003|Overall Study|Lost to Follow-up|0|||
44308655|NCT01248247|79309749|FG000|Overall Study|Alternative treatment|0|||
44308656|NCT01248247|79309750|FG001|Overall Study|Alternative treatment|1|||
44308657|NCT01248247|79309751|FG002|Overall Study|Alternative treatment|0|||
44308658|NCT01248247|79309752|FG003|Overall Study|Alternative treatment|0|||
44308659|NCT01248247|79309749|FG000|Overall Study|Other|2|||
44308660|NCT01248247|79309750|FG001|Overall Study|Other|8|||
44308661|NCT01248247|79309751|FG002|Overall Study|Other|8|||
44308662|NCT01248247|79309752|FG003|Overall Study|Other|5|||
44308663|NCT01248247|79309749|FG000|Overall Study|Progression|18|||
44419134|NCT00725985|79427032|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
44308664|NCT01248247|79309750|FG001|Overall Study|Progression|27|||
44308665|NCT01248247|79309751|FG002|Overall Study|Progression|56|||
44308666|NCT01248247|79309752|FG003|Overall Study|Progression|44|||
44308667|NCT01248247|79309749|FG000|Overall Study|Refuse further treatment|0|||
44308668|NCT01248247|79309750|FG001|Overall Study|Refuse further treatment|0|||
44308669|NCT01248247|79309751|FG002|Overall Study|Refuse further treatment|1|||
44308670|NCT01248247|79309752|FG003|Overall Study|Refuse further treatment|2|||
44419135|NCT00725985|79427033|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419136|NCT00725985|79427034|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44535196|NCT03466086|79546147|FG000|Period 1|Withdrawal by Subject|1|||
44535197|NCT03466086|79546148|FG001|Period 1|Withdrawal by Subject|0|||
44419137|NCT00725985|79427035|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419138|NCT00725985|79427036|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419139|NCT00725985|79427037|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419140|NCT00725985|79427038|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419141|NCT00725985|79427039|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419142|NCT00725985|79427040|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
44419143|NCT00725985|79427029|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419144|NCT00725985|79427030|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419145|NCT00725985|79427031|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419146|NCT00725985|79427032|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419147|NCT00725985|79427033|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419148|NCT00725985|79427034|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
44419149|NCT00725985|79427035|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419150|NCT00725985|79427036|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419151|NCT00725985|79427037|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419152|NCT00725985|79427038|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419153|NCT00725985|79427039|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419154|NCT00725985|79427040|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
44419155|NCT00725985|79427029|FG000|OLMP (Up to 96 Weeks)|Other|0|||
44419156|NCT00725985|79427030|FG001|OLMP (Up to 96 Weeks)|Other|0|||
44535198|NCT03101462|79546156|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
44535199|NCT03101462|79546157|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
44535200|NCT02873936|79546166|FG000|Overall Study|Withdrew Consent|4|||
44155252|NCT01998958|78946952|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155253|NCT01998958|78946953|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155254|NCT01998958|78946954|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155255|NCT01998958|78946955|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44535201|NCT02873936|79546167|FG001|Overall Study|Withdrew Consent|11|||
44155256|NCT01998958|78946956|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155257|NCT01998958|78946957|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155258|NCT01998958|78946958|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155259|NCT01998958|78946959|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155260|NCT01998958|78946960|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155261|NCT01998958|78946961|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155262|NCT01998958|78946962|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155263|NCT01998958|78946963|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155264|NCT01998958|78946964|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155265|NCT01998958|78946965|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155266|NCT01998958|78946966|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155267|NCT01998958|78946967|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155268|NCT01998958|78946968|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155269|NCT01998958|78946969|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155270|NCT01998958|78946970|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155271|NCT01998958|78946971|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155272|NCT01998958|78946972|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155273|NCT01998958|78946973|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155274|NCT01998958|78946974|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155275|NCT01998958|78946975|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155276|NCT01998958|78946976|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155277|NCT01998958|78946977|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155278|NCT01998958|78946978|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
44155279|NCT01998958|78946947|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155280|NCT01998958|78946948|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
44155281|NCT01998958|78946949|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155282|NCT01998958|78946950|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155283|NCT01998958|78946951|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155284|NCT01998958|78946952|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155285|NCT01998958|78946953|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155286|NCT01998958|78946954|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155287|NCT01998958|78946955|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155288|NCT01998958|78946956|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155289|NCT01998958|78946957|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44419157|NCT00725985|79427031|FG002|OLMP (Up to 96 Weeks)|Other|0|||
44535202|NCT02873936|79546168|FG002|Overall Study|Withdrew Consent|20|||
44535203|NCT02873936|79546166|FG000|Overall Study|Investigator's Discretion|3|||
44419158|NCT00725985|79427032|FG003|OLMP (Up to 96 Weeks)|Other|15|||
44535204|NCT02873936|79546167|FG001|Overall Study|Investigator's Discretion|5|||
44535205|NCT02873936|79546168|FG002|Overall Study|Investigator's Discretion|4|||
44535206|NCT02873936|79546166|FG000|Overall Study|Adverse Event|3|||
44535207|NCT02873936|79546167|FG001|Overall Study|Adverse Event|5|||
44535208|NCT02873936|79546168|FG002|Overall Study|Adverse Event|3|||
44419159|NCT00725985|79427033|FG004|OLMP (Up to 96 Weeks)|Other|20|||
44419160|NCT00725985|79427034|FG005|OLMP (Up to 96 Weeks)|Other|44|||
44535209|NCT02873936|79546166|FG000|Overall Study|Protocol Violation|0|||
44535210|NCT02873936|79546167|FG001|Overall Study|Protocol Violation|1|||
44535211|NCT02873936|79546168|FG002|Overall Study|Protocol Violation|3|||
44535212|NCT02873936|79546166|FG000|Overall Study|Lost to Follow-up|1|||
44535213|NCT02873936|79546167|FG001|Overall Study|Lost to Follow-up|1|||
44535214|NCT02873936|79546168|FG002|Overall Study|Lost to Follow-up|1|||
44155290|NCT01998958|78946958|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155291|NCT01998958|78946959|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155292|NCT01998958|78946960|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155293|NCT01998958|78946961|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155294|NCT01998958|78946962|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155295|NCT01998958|78946963|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155296|NCT01998958|78946964|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155297|NCT01998958|78946965|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155298|NCT01998958|78946966|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155299|NCT01998958|78946967|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155300|NCT01998958|78946968|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155301|NCT01998958|78946969|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155302|NCT01998958|78946970|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155303|NCT01998958|78946971|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155304|NCT01998958|78946972|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155305|NCT01998958|78946973|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155306|NCT01998958|78946974|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155307|NCT01998958|78946975|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155308|NCT01998958|78946976|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155309|NCT01998958|78946977|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155310|NCT01998958|78946978|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
44155311|NCT01998958|78946947|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
44155312|NCT01998958|78946948|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
44155313|NCT01998958|78946949|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
44155314|NCT01998958|78946950|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
44155315|NCT01998958|78946951|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
44155316|NCT01998958|78946952|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
44155317|NCT01998958|78946953|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
44155318|NCT01998958|78946954|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
44155319|NCT01998958|78946955|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
44155320|NCT01998958|78946956|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
44155321|NCT01998958|78946957|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
44308671|NCT01248247|79309749|FG000|Overall Study|Complicating disease|0|||
44308672|NCT01248247|79309750|FG001|Overall Study|Complicating disease|0|||
44308673|NCT01248247|79309751|FG002|Overall Study|Complicating disease|1|||
44308674|NCT01248247|79309752|FG003|Overall Study|Complicating disease|1|||
44308675|NCT02598583|79309764|FG000|Extension Period|Withdrawal by Subject|1|||
44308676|NCT02598583|79309765|FG001|Extension Period|Withdrawal by Subject|0|||
44308677|NCT04940130|79309787|FG000|Overall Study|Travel|1|||
44308678|NCT04940130|79309788|FG001|Overall Study|Travel|0|||
44308679|NCT04940130|79309789|FG002|Overall Study|Travel|2|||
44308680|NCT04940130|79309787|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
44308681|NCT04940130|79309788|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
44308682|NCT04940130|79309789|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
44308683|NCT04940130|79309787|FG000|Overall Study|Adverse Event|0|||
44535215|NCT02873936|79546166|FG000|Overall Study|Non-compliance With Study Drug|1|||
44155322|NCT01998958|78946958|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
44155323|NCT01998958|78946959|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
44535216|NCT02873936|79546167|FG001|Overall Study|Non-compliance With Study Drug|0|||
44535217|NCT02873936|79546168|FG002|Overall Study|Non-compliance With Study Drug|1|||
44535218|NCT02873936|79546166|FG000|Overall Study|Randomized but not Dosed|1|||
44155324|NCT01998958|78946960|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
44308684|NCT04940130|79309788|FG001|Overall Study|Adverse Event|0|||
44535219|NCT02873936|79546167|FG001|Overall Study|Randomized but not Dosed|0|||
44308685|NCT04940130|79309789|FG002|Overall Study|Adverse Event|2|||
44535220|NCT02873936|79546168|FG002|Overall Study|Randomized but not Dosed|0|||
44535221|NCT02874794|79546178|FG000|Overall Study|Physician Decision|3|||
44535222|NCT02874794|79546179|FG001|Overall Study|Physician Decision|2|||
44535223|NCT02874794|79546178|FG000|Overall Study|Withdrawal by Subject|2|||
44535224|NCT02874794|79546179|FG001|Overall Study|Withdrawal by Subject|8|||
44419161|NCT00725985|79427035|FG006|OLMP (Up to 96 Weeks)|Other|0|||
44419162|NCT00725985|79427036|FG007|OLMP (Up to 96 Weeks)|Other|0|||
44419163|NCT00725985|79427037|FG008|OLMP (Up to 96 Weeks)|Other|0|||
44419164|NCT00725985|79427038|FG009|OLMP (Up to 96 Weeks)|Other|0|||
44419165|NCT00725985|79427039|FG010|OLMP (Up to 96 Weeks)|Other|0|||
44419166|NCT00725985|79427040|FG011|OLMP (Up to 96 Weeks)|Other|0|||
44419167|NCT00725985|79427029|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419168|NCT00725985|79427030|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419169|NCT00725985|79427031|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419170|NCT00725985|79427032|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419171|NCT00725985|79427033|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419172|NCT00725985|79427034|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419173|NCT00725985|79427035|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419174|NCT00725985|79427036|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
44419175|NCT00725985|79427037|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419176|NCT00725985|79427038|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419177|NCT00725985|79427039|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419178|NCT00725985|79427040|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
44419179|NCT00725985|79427029|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419180|NCT00725985|79427030|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419181|NCT00725985|79427031|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419182|NCT00725985|79427032|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419183|NCT00725985|79427033|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419184|NCT00725985|79427034|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419185|NCT00725985|79427035|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44535225|NCT02874794|79546178|FG000|Overall Study|Death|2|||
44419186|NCT00725985|79427036|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419187|NCT00725985|79427037|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
44419188|NCT00725985|79427038|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419189|NCT00725985|79427039|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419190|NCT00725985|79427040|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
44419191|NCT00725985|79427029|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419192|NCT00725985|79427030|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419193|NCT00725985|79427031|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419194|NCT00725985|79427032|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419195|NCT00725985|79427033|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419196|NCT00725985|79427034|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419197|NCT00725985|79427035|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
44419198|NCT00725985|79427036|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
44419199|NCT00725985|79427037|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
44419200|NCT00725985|79427038|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419201|NCT00725985|79427039|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419202|NCT00725985|79427040|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
44419203|NCT00725985|79427029|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419204|NCT00725985|79427030|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44535226|NCT02874794|79546179|FG001|Overall Study|Death|1|||
44535227|NCT03102710|79546191|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
44535228|NCT03102710|79546192|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
44535229|NCT03102710|79546193|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
44535230|NCT03102710|79546191|FG000|Overall Study|Technical issues during final MRI scan|0|||
44535231|NCT03102710|79546192|FG001|Overall Study|Technical issues during final MRI scan|1|||
44535232|NCT03102710|79546193|FG002|Overall Study|Technical issues during final MRI scan|0|||
44535233|NCT03102710|79546191|FG000|Overall Study|Nausea during MRI scan|0|||
44535234|NCT03102710|79546192|FG001|Overall Study|Nausea during MRI scan|1|||
44155325|NCT01998958|78946961|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
44419205|NCT00725985|79427031|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419206|NCT00725985|79427032|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419207|NCT00725985|79427033|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419208|NCT00725985|79427034|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419209|NCT00725985|79427035|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419210|NCT00725985|79427036|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44419211|NCT00725985|79427037|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
44308686|NCT04940130|79309787|FG000|Overall Study|Disease progression/treatment failure|0|||
44308687|NCT04940130|79309788|FG001|Overall Study|Disease progression/treatment failure|0|||
44419212|NCT00725985|79427038|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
44419213|NCT00725985|79427039|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
44419214|NCT00725985|79427040|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
44419215|NCT00793910|79427068|FG000|Overall Study|discarded study pills|0|||
44419216|NCT00793910|79427069|FG001|Overall Study|discarded study pills|1|||
44419217|NCT00793910|79427068|FG000|Overall Study|did not pick up medications|1|||
44419218|NCT00793910|79427069|FG001|Overall Study|did not pick up medications|1|||
44419219|NCT00793910|79427068|FG000|Overall Study|ineligible based on entry criteria|2|||
44419220|NCT00793910|79427069|FG001|Overall Study|ineligible based on entry criteria|3|||
44419221|NCT00793910|79427068|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
44419222|NCT00793910|79427069|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
44419223|NCT00793910|79427068|FG000|Overall Study|Withdrawal by Subject|0|||
44419224|NCT00793910|79427069|FG001|Overall Study|Withdrawal by Subject|1|||
44419225|NCT00444145|79427075|FG000|Overall Study|Withdrawal by Subject|2|||
44419226|NCT00444145|79427075|FG000|Overall Study|Lost to Follow-up|1|||
44419227|NCT00444145|79427075|FG000|Overall Study|non-compliant|11|||
44419228|NCT00444145|79427075|FG000|Overall Study|Screen Failures|5|||
44419229|NCT00725283|79427079|FG000|Overall Study|Missing Code|3|||
44419230|NCT00725283|79427079|FG000|Overall Study|Death|5|||
44419231|NCT00725283|79427079|FG000|Overall Study|Other|6|||
44419232|NCT00725283|79427079|FG000|Overall Study|Withdrawal by Subject|10|||
44419233|NCT00444067|79427085|FG000|Overall Study|Lost to Follow-up|0|||
44419234|NCT00444067|79427086|FG001|Overall Study|Lost to Follow-up|1|||
44419235|NCT00789854|79427095|FG000|Overall Study|Adverse Event|28|||
44419236|NCT00789854|79427096|FG001|Overall Study|Adverse Event|23|||
44419237|NCT00789854|79427097|FG002|Overall Study|Adverse Event|18|||
44419238|NCT00789854|79427095|FG000|Overall Study|Lost to Follow-up|1|||
44419239|NCT00789854|79427096|FG001|Overall Study|Lost to Follow-up|1|||
44419240|NCT00789854|79427097|FG002|Overall Study|Lost to Follow-up|4|||
44419241|NCT00789854|79427095|FG000|Overall Study|Withdrawal by Subject|9|||
44419242|NCT00789854|79427096|FG001|Overall Study|Withdrawal by Subject|6|||
44419243|NCT00789854|79427097|FG002|Overall Study|Withdrawal by Subject|17|||
44419244|NCT00789854|79427095|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44419245|NCT00789854|79427096|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
44419246|NCT00789854|79427097|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
44419247|NCT00789854|79427095|FG000|Overall Study|Severe non-compliance to the protocol|3|||
44419248|NCT00789854|79427096|FG001|Overall Study|Severe non-compliance to the protocol|0|||
44419249|NCT00789854|79427097|FG002|Overall Study|Severe non-compliance to the protocol|0|||
44419250|NCT00789854|79427095|FG000|Overall Study|Safety reasons|0|||
44419251|NCT00789854|79427096|FG001|Overall Study|Safety reasons|0|||
44419252|NCT00789854|79427097|FG002|Overall Study|Safety reasons|2|||
44419253|NCT00789854|79427095|FG000|Overall Study|Other|6|||
44419254|NCT00789854|79427096|FG001|Overall Study|Other|0|||
44419255|NCT00789854|79427097|FG002|Overall Study|Other|5|||
44419256|NCT00725205|79427105|FG000|Overall Study|Adverse Event|22|||
44419257|NCT00725205|79427105|FG000|Overall Study|Investigator Discontinued|1|||
44419258|NCT00725205|79427105|FG000|Overall Study|Non-compliance With Protocol|14|||
44419259|NCT00725205|79427105|FG000|Overall Study|Other|8|||
44419260|NCT00725205|79427105|FG000|Overall Study|Protocol Defined Clinical Event|1|||
44419261|NCT00725205|79427105|FG000|Overall Study|Treatment Failure|41|||
44419262|NCT00443755|79427111|FG000|Overall Study|Withdrawal by Subject|2|||
44419263|NCT00443755|79427112|FG001|Overall Study|Withdrawal by Subject|1|||
44419264|NCT00724971|79427118|FG000|Overall Study|Adverse Event|5|||
44419265|NCT00724971|79427118|FG000|Overall Study|Withdrawal by Subject|1|||
44419266|NCT00443599|79427124|FG000|Overall Study|Physician Decision|2|||
44419267|NCT00443599|79427125|FG001|Overall Study|Physician Decision|1|||
44419268|NCT00443599|79427124|FG000|Overall Study|Death|1|||
44419269|NCT00443599|79427125|FG001|Overall Study|Death|1|||
44419270|NCT00443599|79427124|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
44419271|NCT00443599|79427125|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
44419272|NCT00455143|79427131|FG000|Overall Study|Physician Decision|1|||
44419273|NCT00455143|79427131|FG000|Overall Study|Withdrawal by Subject|1|||
44419274|NCT00455143|79427131|FG000|Overall Study|Staff was not avail to follow patient|2|||
44419275|NCT00455143|79427131|FG000|Overall Study|No longer met Inclusion Criteria|1|||
44419276|NCT00455143|79427131|FG000|Overall Study|Surgical time, staff not available|1|||
44419277|NCT00454987|79427139|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
44419278|NCT00454987|79427140|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
44419279|NCT00454987|79427141|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
44419280|NCT00454987|79427139|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
44419281|NCT00454987|79427140|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
44419282|NCT00454987|79427141|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
44419283|NCT00454987|79427139|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
44419284|NCT00454987|79427140|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
44419285|NCT00454987|79427141|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
44419286|NCT00724893|79427152|FG000|Overall Study|Adverse Event|76|||
44419287|NCT00724893|79427153|FG001|Overall Study|Adverse Event|142|||
44419288|NCT00724893|79427152|FG000|Overall Study|Withdrawal by Subject|0|||
44419289|NCT00724893|79427153|FG001|Overall Study|Withdrawal by Subject|1|||
44419290|NCT00724893|79427152|FG000|Overall Study|Lack of virologic response|94|||
44419291|NCT00724893|79427153|FG001|Overall Study|Lack of virologic response|202|||
44419292|NCT00724893|79427152|FG000|Overall Study|Reason not specified|193|||
44419293|NCT00724893|79427153|FG001|Overall Study|Reason not specified|7|||
44419294|NCT00724893|79427152|FG000|Overall Study|Patient choice|0|||
44419295|NCT00724893|79427153|FG001|Overall Study|Patient choice|26|||
44419296|NCT00724893|79427152|FG000|Overall Study|Geographic reasons|0|||
44419297|NCT00724893|79427153|FG001|Overall Study|Geographic reasons|11|||
44419298|NCT00724893|79427152|FG000|Overall Study|Incarceration|0|||
44419299|NCT00724893|79427153|FG001|Overall Study|Incarceration|9|||
44419300|NCT00724893|79427152|FG000|Overall Study|Substance abuse|0|||
44419301|NCT00724893|79427153|FG001|Overall Study|Substance abuse|3|||
44419302|NCT00724893|79427152|FG000|Overall Study|Financial reasons|0|||
44419303|NCT00724893|79427153|FG001|Overall Study|Financial reasons|2|||
44419304|NCT00724893|79427152|FG000|Overall Study|Assigned shorter treatment|0|||
44419305|NCT00724893|79427153|FG001|Overall Study|Assigned shorter treatment|2|||
44419306|NCT00724893|79427152|FG000|Overall Study|Lost to Follow-up|0|||
44419307|NCT00724893|79427153|FG001|Overall Study|Lost to Follow-up|52|||
44419308|NCT00724893|79427152|FG000|Overall Study|Unknown, missing data|1|||
44419309|NCT00724893|79427153|FG001|Overall Study|Unknown, missing data|1|||
44419310|NCT00789698|79427178|FG000|Overall Study|Lack of Efficacy|10|||
44419311|NCT00789698|79427179|FG001|Overall Study|Lack of Efficacy|4|||
44419312|NCT00789698|79427180|FG002|Overall Study|Lack of Efficacy|5|||
44419313|NCT00789698|79427181|FG003|Overall Study|Lack of Efficacy|18|||
44419314|NCT00789698|79427178|FG000|Overall Study|Adverse Event|5|||
44419315|NCT00789698|79427179|FG001|Overall Study|Adverse Event|5|||
44419316|NCT00789698|79427180|FG002|Overall Study|Adverse Event|3|||
44419317|NCT00789698|79427181|FG003|Overall Study|Adverse Event|4|||
44419318|NCT00789698|79427178|FG000|Overall Study|Lost to Follow-up|5|||
44419319|NCT00789698|79427179|FG001|Overall Study|Lost to Follow-up|5|||
44419320|NCT00789698|79427180|FG002|Overall Study|Lost to Follow-up|2|||
44419321|NCT00789698|79427181|FG003|Overall Study|Lost to Follow-up|9|||
44419322|NCT00789698|79427178|FG000|Overall Study|Protocol Violation|6|||
44419323|NCT00789698|79427179|FG001|Overall Study|Protocol Violation|1|||
44419324|NCT00789698|79427180|FG002|Overall Study|Protocol Violation|2|||
44419325|NCT00789698|79427181|FG003|Overall Study|Protocol Violation|1|||
44419326|NCT00789698|79427178|FG000|Overall Study|Withdrawal by Subject|14|||
44419327|NCT00789698|79427179|FG001|Overall Study|Withdrawal by Subject|15|||
44419328|NCT00789698|79427180|FG002|Overall Study|Withdrawal by Subject|12|||
44419329|NCT00789698|79427181|FG003|Overall Study|Withdrawal by Subject|19|||
44419330|NCT00789698|79427178|FG000|Overall Study|Administrative|0|||
44419331|NCT00789698|79427179|FG001|Overall Study|Administrative|3|||
44419332|NCT00789698|79427180|FG002|Overall Study|Administrative|3|||
44419333|NCT00789698|79427181|FG003|Overall Study|Administrative|1|||
44419334|NCT00724815|79427192|FG000|Overall Study|Randomized, not treated|31|||
44419335|NCT00724815|79427193|FG001|Overall Study|Randomized, not treated|30|||
44419336|NCT00724815|79427192|FG000|Overall Study|Adverse Event|5|||
44419337|NCT00724815|79427193|FG001|Overall Study|Adverse Event|3|||
44419338|NCT00724815|79427192|FG000|Overall Study|Lost to Follow-up|4|||
44419339|NCT00724815|79427193|FG001|Overall Study|Lost to Follow-up|1|||
44419340|NCT00724815|79427192|FG000|Overall Study|Other Various|3|||
44419341|NCT00724815|79427193|FG001|Overall Study|Other Various|5|||
44419342|NCT00454909|79427202|FG000|Overall Study|Withdrawal by Subject|1|||
44419343|NCT00454909|79427203|FG001|Overall Study|Withdrawal by Subject|0|||
44419344|NCT00454909|79427204|FG002|Overall Study|Withdrawal by Subject|0|||
44419345|NCT00454909|79427202|FG000|Overall Study|Migrated/moved from study area|0|||
44419346|NCT00454909|79427203|FG001|Overall Study|Migrated/moved from study area|0|||
44419347|NCT00454909|79427204|FG002|Overall Study|Migrated/moved from study area|1|||
44419348|NCT00454909|79427202|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
44419349|NCT00454909|79427203|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
44419350|NCT00454909|79427204|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
44419351|NCT00454909|79427202|FG000|Overall Study|Others|1|||
44419352|NCT00454909|79427203|FG001|Overall Study|Others|0|||
44419353|NCT00454909|79427204|FG002|Overall Study|Others|0|||
44419354|NCT00798590|79427215|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
44419355|NCT00798590|79427216|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
44419356|NCT00481195|79427224|FG000|Overall Study|Adverse Event|16|||
44419357|NCT00481195|79427225|FG001|Overall Study|Adverse Event|11|||
44419358|NCT00481195|79427224|FG000|Overall Study|Lack of Efficacy|1|||
44419359|NCT00481195|79427225|FG001|Overall Study|Lack of Efficacy|3|||
44419360|NCT00481195|79427224|FG000|Overall Study|Lost to Follow-up|4|||
44419361|NCT00481195|79427225|FG001|Overall Study|Lost to Follow-up|6|||
44419362|NCT00481195|79427224|FG000|Overall Study|Physician Decision|3|||
44419363|NCT00481195|79427225|FG001|Overall Study|Physician Decision|1|||
44419364|NCT00481195|79427224|FG000|Overall Study|Protocol Violation|10|||
44419365|NCT00481195|79427225|FG001|Overall Study|Protocol Violation|7|||
44419366|NCT00481195|79427224|FG000|Overall Study|Withdrawal by Subject|3|||
44419367|NCT00481195|79427225|FG001|Overall Study|Withdrawal by Subject|9|||
44419368|NCT00481195|79427224|FG000|Overall Study|Miscellaneous|2|||
44419369|NCT00481195|79427225|FG001|Overall Study|Miscellaneous|2|||
44419370|NCT00454363|79427242|FG000|Overall Study|Adverse Event|1|||
44419371|NCT00454363|79427243|FG001|Overall Study|Adverse Event|2|||
44419372|NCT00454363|79427242|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
44419373|NCT00454363|79427243|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
44419374|NCT00454207|79427250|FG000|Overall Study|Adverse Event|3|||
44419375|NCT00454207|79427251|FG001|Overall Study|Adverse Event|1|||
44419376|NCT00454207|79427250|FG000|Overall Study|Lack of Efficacy|1|||
44419377|NCT00454207|79427251|FG001|Overall Study|Lack of Efficacy|0|||
44419378|NCT00454207|79427250|FG000|Overall Study|Protocol Violation|0|||
44419379|NCT00454207|79427251|FG001|Overall Study|Protocol Violation|1|||
44419380|NCT00738894|79427271|FG000|Overall Study|Lost to Follow-up|23|||
44419381|NCT00738894|79427272|FG001|Overall Study|Lost to Follow-up|13|||
44419382|NCT00738894|79427271|FG000|Overall Study|Withdrawal by Subject|10|||
44419383|NCT00738894|79427272|FG001|Overall Study|Withdrawal by Subject|15|||
44419384|NCT00738894|79427271|FG000|Overall Study|Physician Decision|4|||
44419385|NCT00738894|79427272|FG001|Overall Study|Physician Decision|5|||
44419386|NCT00738894|79427271|FG000|Overall Study|Death|2|||
44419387|NCT00738894|79427272|FG001|Overall Study|Death|0|||
44419388|NCT00480493|79427280|FG000|Overall Study|moved|2|||
44419389|NCT00480493|79427281|FG001|Overall Study|moved|7|||
44419390|NCT00734994|79427289|FG000|Overall Study|Withdrawal by Subject|1|||
44419391|NCT00798434|79427296|FG000|Double-Blind|Adverse Event|22|||
44419392|NCT00798434|79427297|FG001|Double-Blind|Adverse Event|46|||
44419393|NCT00798434|79427296|FG000|Double-Blind|Death|0|||
44419394|NCT00798434|79427297|FG001|Double-Blind|Death|1|||
44419395|NCT00798434|79427296|FG000|Double-Blind|Lost to Follow-up|1|||
44419396|NCT00798434|79427297|FG001|Double-Blind|Lost to Follow-up|0|||
44419397|NCT00798434|79427296|FG000|Double-Blind|Lack of Efficacy|8|||
44419398|NCT00798434|79427297|FG001|Double-Blind|Lack of Efficacy|12|||
44419399|NCT00798434|79427296|FG000|Double-Blind|Withdrawal by Subject|17|||
44419400|NCT00798434|79427297|FG001|Double-Blind|Withdrawal by Subject|14|||
44419401|NCT00798434|79427296|FG000|Double-Blind|Protocol Violation|1|||
44419402|NCT00798434|79427297|FG001|Double-Blind|Protocol Violation|4|||
44419403|NCT00798434|79427296|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
44535235|NCT03102710|79546193|FG002|Overall Study|Nausea during MRI scan|0|||
44535236|NCT03102710|79546191|FG000|Overall Study|Subject unable to attend final session|0|||
44535237|NCT03102710|79546192|FG001|Overall Study|Subject unable to attend final session|1|||
44257319|NCT01311713|79109713|FG005|Overall Study|Enrolled but not treated|0|||
44257320|NCT01311713|79109714|FG006|Overall Study|Enrolled but not treated|0|||
44257321|NCT01311713|79109708|FG000|Overall Study|Other than specified|0|||
44257322|NCT01311713|79109709|FG001|Overall Study|Other than specified|1|||
44257323|NCT01311713|79109710|FG002|Overall Study|Other than specified|2|||
44257324|NCT01311713|79109711|FG003|Overall Study|Other than specified|0|||
44257325|NCT01311713|79109712|FG004|Overall Study|Other than specified|0|||
44257326|NCT01311713|79109713|FG005|Overall Study|Other than specified|0|||
44257327|NCT01311713|79109714|FG006|Overall Study|Other than specified|0|||
44257328|NCT00728884|79109767|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
44257329|NCT00728884|79109767|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
44257330|NCT00659776|79109774|FG000|Overall Study|Withdrawal by Subject|12|||
44257331|NCT00659776|79109775|FG001|Overall Study|Withdrawal by Subject|2|||
44257332|NCT00659776|79109776|FG002|Overall Study|Withdrawal by Subject|0|||
44257333|NCT00617656|79109786|FG000|Overall Study|Inclusion error|4|||
44419404|NCT00798434|79427297|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
44419405|NCT00798434|79427296|FG000|Double-Blind|Other|1|||
44419406|NCT00798434|79427297|FG001|Double-Blind|Other|0|||
44419407|NCT00798434|79427296|FG000|Double-Blind|Not Treated|3|||
44419408|NCT00798434|79427297|FG001|Double-Blind|Not Treated|6|||
44419409|NCT00798434|79427296|FG000|Open-Label|Adverse Event|33|||
44419410|NCT00798434|79427297|FG001|Open-Label|Adverse Event|11|||
44419411|NCT00798434|79427296|FG000|Open-Label|Lack of Efficacy|5|||
44257334|NCT00617656|79109787|FG001|Overall Study|Inclusion error|4|||
44419412|NCT00798434|79427297|FG001|Open-Label|Lack of Efficacy|11|||
44419413|NCT00798434|79427296|FG000|Open-Label|Withdrawal by Subject|2|||
44419414|NCT00798434|79427297|FG001|Open-Label|Withdrawal by Subject|7|||
44419415|NCT00798434|79427296|FG000|Open-Label|Protocol Violation|1|||
44308688|NCT04940130|79309789|FG002|Overall Study|Disease progression/treatment failure|1|||
44308689|NCT04940130|79309787|FG000|Overall Study|Participant refusal|0|||
44308690|NCT04940130|79309788|FG001|Overall Study|Participant refusal|0|||
44308691|NCT04940130|79309789|FG002|Overall Study|Participant refusal|1|||
44308692|NCT04618471|79309801|FG000|Overall Study|Screen Failure|62|||
44308693|NCT04618471|79309801|FG000|Overall Study|Withdrawal by Subject|6|||
44308694|NCT04618471|79309801|FG000|Overall Study|Physician Decision|2|||
44308695|NCT04618471|79309801|FG000|Overall Study|Lost to Follow-up|1|||
44308696|NCT04618471|79309801|FG000|Overall Study|Various other reasons|2|||
44308697|NCT04618471|79309801|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
44308698|NCT04581824|79309807|FG000|Overall Study|Ongoing|75|||
44308699|NCT04581824|79309808|FG001|Overall Study|Ongoing|69|||
44308700|NCT04581824|79309807|FG000|Overall Study|Withdrawal by Subject|3|||
44308701|NCT04581824|79309808|FG001|Overall Study|Withdrawal by Subject|5|||
44308702|NCT04581824|79309807|FG000|Overall Study|Lost to Follow-up|1|||
44308703|NCT04581824|79309808|FG001|Overall Study|Lost to Follow-up|0|||
44308704|NCT04458922|79309826|FG000|Overall Study|Withdrawal by Subject|1|||
44308705|NCT04458922|79309827|FG001|Overall Study|Withdrawal by Subject|0|||
44308706|NCT04458922|79309828|FG002|Overall Study|Withdrawal by Subject|2|||
44308707|NCT04458922|79309826|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
44308708|NCT04458922|79309827|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
44308709|NCT04458922|79309828|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
44308710|NCT04458922|79309826|FG000|Overall Study|Adverse Event|1|||
44308711|NCT04458922|79309827|FG001|Overall Study|Adverse Event|0|||
44308712|NCT04458922|79309828|FG002|Overall Study|Adverse Event|0|||
44308713|NCT04458922|79309826|FG000|Overall Study|Started new study|0|||
44308714|NCT04458922|79309827|FG001|Overall Study|Started new study|0|||
44308715|NCT04458922|79309828|FG002|Overall Study|Started new study|1|||
44308716|NCT04458922|79309826|FG000|Overall Study|Progressive disease|6|||
44308717|NCT04458922|79309827|FG001|Overall Study|Progressive disease|8|||
44308718|NCT04458922|79309828|FG002|Overall Study|Progressive disease|2|||
44308719|NCT04458922|79309826|FG000|Overall Study|Death|1|||
44308720|NCT04458922|79309827|FG001|Overall Study|Death|0|||
44308721|NCT04458922|79309828|FG002|Overall Study|Death|2|||
44308722|NCT04458922|79309826|FG000|Overall Study|Participant started chemotherapy|0|||
44308723|NCT04458922|79309827|FG001|Overall Study|Participant started chemotherapy|1|||
44308724|NCT04458922|79309828|FG002|Overall Study|Participant started chemotherapy|0|||
44308725|NCT04333147|79309838|FG000|Overall Study|Adverse Event|43|||
44308726|NCT04333147|79309839|FG001|Overall Study|Adverse Event|40|||
44308727|NCT04333147|79309838|FG000|Overall Study|Lack of Efficacy|49|||
44308728|NCT04333147|79309839|FG001|Overall Study|Lack of Efficacy|48|||
44308729|NCT04333147|79309838|FG000|Overall Study|Lost to Follow-up|19|||
44308730|NCT04333147|79309839|FG001|Overall Study|Lost to Follow-up|16|||
44308731|NCT04333147|79309838|FG000|Overall Study|Physician Decision|17|||
44308732|NCT04333147|79309839|FG001|Overall Study|Physician Decision|20|||
44308733|NCT04333147|79309838|FG000|Overall Study|Withdrawal by Subject|65|||
44308734|NCT04333147|79309839|FG001|Overall Study|Withdrawal by Subject|68|||
44308735|NCT04333147|79309838|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
44535238|NCT03102710|79546193|FG002|Overall Study|Subject unable to attend final session|0|||
44535239|NCT03101150|79546203|FG000|Overall Study|Lost to Follow-up|2|||
44535240|NCT03101150|79546204|FG001|Overall Study|Lost to Follow-up|4|||
44535241|NCT03101150|79546203|FG000|Overall Study|Miscarriage|3|||
44535242|NCT03101150|79546204|FG001|Overall Study|Miscarriage|6|||
44535243|NCT03101930|79546213|FG000|Overall Study|Withdrawal by Subject|2|||
44535244|NCT03101930|79546214|FG001|Overall Study|Withdrawal by Subject|1|||
44535245|NCT03101930|79546215|FG002|Overall Study|Withdrawal by Subject|2|||
44257335|NCT00617656|79109788|FG002|Overall Study|Inclusion error|0|||
44257336|NCT00617656|79109789|FG003|Overall Study|Inclusion error|0|||
44257337|NCT00617656|79109786|FG000|Overall Study|Missing data|44|||
44257338|NCT00617656|79109787|FG001|Overall Study|Missing data|30|||
44257339|NCT00617656|79109788|FG002|Overall Study|Missing data|13|||
44257340|NCT00617656|79109789|FG003|Overall Study|Missing data|6|||
44257341|NCT00617656|79109786|FG000|Overall Study|Withdrawal by Subject|0|||
44257342|NCT00617656|79109787|FG001|Overall Study|Withdrawal by Subject|2|||
44257343|NCT00617656|79109788|FG002|Overall Study|Withdrawal by Subject|0|||
44257344|NCT00617656|79109789|FG003|Overall Study|Withdrawal by Subject|0|||
44257345|NCT04508023|79109803|FG000|Overall Study|Withdrawal by Subject|1|||
44257346|NCT04508023|79109804|FG001|Overall Study|Withdrawal by Subject|2|||
44257347|NCT04187144|79109812|FG000|Overall Study|Lost to Follow-up|12|||
44257348|NCT04187144|79109813|FG001|Overall Study|Lost to Follow-up|11|||
44257349|NCT04187144|79109812|FG000|Overall Study|Withdrawal by Subject|20|||
44308736|NCT04333147|79309839|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
44308737|NCT04333147|79309838|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
44308738|NCT04333147|79309839|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
44308739|NCT04333147|79309838|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
44308740|NCT04333147|79309839|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
44308741|NCT04313244|79309847|FG000|Overall Study|Withdrawal of Consent|3|||
44308742|NCT04313244|79309848|FG001|Overall Study|Withdrawal of Consent|3|||
44308743|NCT04313244|79309847|FG000|Overall Study|Met Exclusion Criteria|1|||
44308744|NCT04313244|79309848|FG001|Overall Study|Met Exclusion Criteria|0|||
44308745|NCT04313244|79309847|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
44308746|NCT04313244|79309848|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
44308751|NCT04128696|79309907|FG000|Overall Study|Lost to Follow-up|0|||
44308752|NCT04128696|79309908|FG001|Overall Study|Lost to Follow-up|1|||
44308753|NCT04128696|79309907|FG000|Overall Study|Withdrawal by Subject|8|||
44308754|NCT04128696|79309908|FG001|Overall Study|Withdrawal by Subject|5|||
44308755|NCT04128696|79309907|FG000|Overall Study|In Follow-up|47|||
44308756|NCT04128696|79309908|FG001|Overall Study|In Follow-up|51|||
44308757|NCT04128696|79309907|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
44308758|NCT04128696|79309908|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
44308759|NCT03946670|79309970|FG000|Overall Study|Progressive Disease|26|||
44308760|NCT03946670|79309971|FG001|Overall Study|Progressive Disease|23|||
44308761|NCT03946670|79309970|FG000|Overall Study|Adverse Event|7|||
44308762|NCT03946670|79309971|FG001|Overall Study|Adverse Event|9|||
44308763|NCT03946670|79309970|FG000|Overall Study|Death|5|||
44308764|NCT03946670|79309971|FG001|Overall Study|Death|6|||
44308765|NCT03946670|79309970|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
44308766|NCT03946670|79309971|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
44308767|NCT03946670|79309970|FG000|Overall Study|Subject Decision|4|||
44308768|NCT03946670|79309971|FG001|Overall Study|Subject Decision|4|||
44308769|NCT03946670|79309970|FG000|Overall Study|Physician Decision|3|||
44308770|NCT03946670|79309971|FG001|Overall Study|Physician Decision|3|||
44308771|NCT03946670|79309970|FG000|Overall Study|New Therapy for Study Indication|1|||
44308772|NCT03946670|79309971|FG001|Overall Study|New Therapy for Study Indication|0|||
44308773|NCT03946670|79309970|FG000|Overall Study|Not treated|1|||
44308774|NCT03946670|79309971|FG001|Overall Study|Not treated|1|||
44308775|NCT03848065|79309980|FG000|Overall Study|Death|0|||
44308776|NCT03848065|79309981|FG001|Overall Study|Death|1|||
44308777|NCT03848065|79309982|FG002|Overall Study|Death|0|||
44308778|NCT03848065|79309980|FG000|Overall Study|Lost to Follow-up|0|||
44308779|NCT03848065|79309981|FG001|Overall Study|Lost to Follow-up|0|||
44308780|NCT03848065|79309982|FG002|Overall Study|Lost to Follow-up|1|||
44308781|NCT03848065|79309980|FG000|Overall Study|Physician Decision|0|||
44308782|NCT03848065|79309981|FG001|Overall Study|Physician Decision|0|||
44308783|NCT03848065|79309982|FG002|Overall Study|Physician Decision|1|||
44308784|NCT03834220|79309993|FG000|Overall Study|Adverse Event|1|||
44308785|NCT03834220|79309994|FG001|Overall Study|Adverse Event|0|||
44308786|NCT03834220|79309995|FG002|Overall Study|Adverse Event|0|||
44308787|NCT03834220|79309993|FG000|Overall Study|Death|8|||
44308788|NCT03834220|79309994|FG001|Overall Study|Death|1|||
44308789|NCT03834220|79309995|FG002|Overall Study|Death|17|||
44308790|NCT03834220|79309993|FG000|Overall Study|Reason not Specified|9|||
44308791|NCT03834220|79309994|FG001|Overall Study|Reason not Specified|0|||
44308792|NCT03834220|79309995|FG002|Overall Study|Reason not Specified|6|||
44308793|NCT03834220|79309993|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
44308794|NCT03834220|79309994|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
44308795|NCT03834220|79309995|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
44308796|NCT03834220|79309993|FG000|Overall Study|Withdrawal of Consent|2|||
44308797|NCT03834220|79309994|FG001|Overall Study|Withdrawal of Consent|2|||
44308798|NCT03834220|79309995|FG002|Overall Study|Withdrawal of Consent|2|||
44308799|NCT03682770|79310007|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
44308800|NCT03682770|79310008|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
44308801|NCT03682770|79310009|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
44308802|NCT03682770|79310010|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
44308803|NCT03682770|79310011|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
44308804|NCT03682770|79310012|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
44308805|NCT03682770|79310013|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
44308806|NCT03682770|79310007|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
44308807|NCT03682770|79310008|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
44308808|NCT03682770|79310009|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
44308809|NCT03682770|79310010|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
44308810|NCT03682770|79310011|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
44308811|NCT03682770|79310012|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
44419416|NCT00798434|79427297|FG001|Open-Label|Protocol Violation|0|||
44419417|NCT00798434|79427296|FG000|Open-Label|Other|1|||
44308812|NCT03682770|79310013|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
44308813|NCT03682770|79310007|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
44308814|NCT03682770|79310008|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
44308815|NCT03682770|79310009|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
44308816|NCT03682770|79310010|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
44308817|NCT03682770|79310011|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
44308818|NCT03682770|79310012|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
44308819|NCT03682770|79310013|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
44308820|NCT03682770|79310007|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
44308821|NCT03682770|79310008|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
44308822|NCT03682770|79310009|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
44308823|NCT03682770|79310010|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
44308824|NCT03682770|79310011|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
44308825|NCT03682770|79310012|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
44308826|NCT03682770|79310013|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
44308827|NCT03682770|79310007|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
44308828|NCT03682770|79310008|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
44308829|NCT03682770|79310009|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
44308830|NCT03682770|79310010|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
44308831|NCT03682770|79310011|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
44308832|NCT03682770|79310012|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
44308833|NCT03682770|79310013|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
44308834|NCT03682770|79310007|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
44308835|NCT03682770|79310008|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
44308836|NCT03682770|79310009|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
44308837|NCT03682770|79310010|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
44308838|NCT03682770|79310011|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
44308839|NCT03682770|79310012|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
44308840|NCT03682770|79310013|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
44308841|NCT03682770|79310007|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
44308842|NCT03682770|79310008|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
44308843|NCT03682770|79310009|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
44308844|NCT03682770|79310010|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
44308845|NCT03682770|79310011|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
44308846|NCT03682770|79310012|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
44419418|NCT00798434|79427297|FG001|Open-Label|Other|2|||
44419419|NCT00798434|79427296|FG000|Open-Label|Not Treated|0|||
44419420|NCT00798434|79427297|FG001|Open-Label|Not Treated|1|||
44257350|NCT04187144|79109813|FG001|Overall Study|Withdrawal by Subject|18|||
44257351|NCT04187144|79109812|FG000|Overall Study|Adverse Event|19|||
44257352|NCT04187144|79109813|FG001|Overall Study|Adverse Event|4|||
44257353|NCT04187144|79109812|FG000|Overall Study|Physician Decision|5|||
44257354|NCT04187144|79109813|FG001|Overall Study|Physician Decision|3|||
44257355|NCT04187144|79109812|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
44257356|NCT04187144|79109813|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
44257357|NCT04187144|79109812|FG000|Overall Study|Protocol Deviation|1|||
44257358|NCT04187144|79109813|FG001|Overall Study|Protocol Deviation|4|||
44257359|NCT04027946|79109819|FG000|Overall Study|Screen failures|3|||
44257360|NCT03856047|79109840|FG000|Overall Study|Withdrawal by Subject|0|||
44257361|NCT03856047|79109841|FG001|Overall Study|Withdrawal by Subject|1|||
44257362|NCT03856047|79109842|FG002|Overall Study|Withdrawal by Subject|1|||
44257363|NCT03856047|79109843|FG003|Overall Study|Withdrawal by Subject|0|||
44257364|NCT03856047|79109844|FG004|Overall Study|Withdrawal by Subject|3|||
44257365|NCT03856047|79109845|FG005|Overall Study|Withdrawal by Subject|0|||
44257366|NCT03856047|79109846|FG006|Overall Study|Withdrawal by Subject|2|||
44257367|NCT03856047|79109840|FG000|Overall Study|Lost to Follow-up|4|||
44257368|NCT03856047|79109841|FG001|Overall Study|Lost to Follow-up|2|||
44257369|NCT03856047|79109842|FG002|Overall Study|Lost to Follow-up|3|||
44257370|NCT03856047|79109843|FG003|Overall Study|Lost to Follow-up|1|||
44257371|NCT03856047|79109844|FG004|Overall Study|Lost to Follow-up|4|||
44257372|NCT03856047|79109845|FG005|Overall Study|Lost to Follow-up|4|||
44257373|NCT03856047|79109846|FG006|Overall Study|Lost to Follow-up|4|||
44257374|NCT03112603|79109897|FG000|End of Randomization Period|Lost to Follow-up|3|||
44257375|NCT03112603|79109898|FG001|End of Randomization Period|Lost to Follow-up|0|||
44257376|NCT03112603|79109899|FG002|End of Randomization Period|Lost to Follow-up|0|||
44257377|NCT03112603|79109897|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
44535246|NCT02928848|79546225|FG000|Arm 2|Withdrawal by Subject|1|||
44535247|NCT02928848|79546226|FG001|Arm 2|Withdrawal by Subject|0|||
44535248|NCT02928770|79546234|FG000|Overall Study|Withdrawal by Subject|2|||
44535249|NCT03100838|79546238|FG000|Overall Study|Adverse Event|1|||
44535250|NCT03100838|79546239|FG001|Overall Study|Adverse Event|0|||
44535251|NCT03100838|79546240|FG002|Overall Study|Adverse Event|0|||
44535252|NCT03100838|79546241|FG003|Overall Study|Adverse Event|0|||
44535253|NCT03100838|79546238|FG000|Overall Study|Physician Decision|1|||
44535254|NCT03100838|79546239|FG001|Overall Study|Physician Decision|1|||
44535255|NCT03100838|79546240|FG002|Overall Study|Physician Decision|1|||
44535256|NCT03100838|79546241|FG003|Overall Study|Physician Decision|1|||
44535257|NCT03100838|79546238|FG000|Overall Study|Pregnancy|0|||
44535258|NCT03100838|79546239|FG001|Overall Study|Pregnancy|1|||
44535259|NCT03100838|79546240|FG002|Overall Study|Pregnancy|0|||
44535260|NCT03100838|79546241|FG003|Overall Study|Pregnancy|0|||
44535261|NCT03100838|79546238|FG000|Overall Study|Lost to Follow-up|0|||
44535262|NCT03100838|79546239|FG001|Overall Study|Lost to Follow-up|0|||
44535263|NCT03100838|79546240|FG002|Overall Study|Lost to Follow-up|1|||
44535264|NCT03100838|79546241|FG003|Overall Study|Lost to Follow-up|0|||
44535265|NCT03480750|79546257|FG000|Overall Study|Withdrawal by Subject|0|||
44535266|NCT03480750|79546258|FG001|Overall Study|Withdrawal by Subject|1|||
44535267|NCT03480750|79546259|FG002|Overall Study|Withdrawal by Subject|0|||
44155326|NCT01998958|78946962|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
44535268|NCT03480750|79546260|FG003|Overall Study|Withdrawal by Subject|0|||
44155327|NCT01998958|78946963|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
44535269|NCT03480750|79546261|FG004|Overall Study|Withdrawal by Subject|0|||
44535270|NCT03480750|79546262|FG005|Overall Study|Withdrawal by Subject|0|||
44155328|NCT01998958|78946964|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
44155329|NCT01998958|78946965|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
44155330|NCT01998958|78946966|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
44155331|NCT01998958|78946967|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
44155332|NCT01998958|78946968|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
44155333|NCT01998958|78946969|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
44155334|NCT01998958|78946970|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
44155335|NCT01998958|78946971|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
44155336|NCT01998958|78946972|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
44155337|NCT01998958|78946973|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
44155338|NCT01998958|78946974|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
44155339|NCT01998958|78946975|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
44155340|NCT01998958|78946976|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
44155341|NCT01998958|78946977|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
44155342|NCT01998958|78946978|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
44155343|NCT01998958|78946947|FG000|Period 1 (Panel A and B)|Other|1|||
44155344|NCT01998958|78946948|FG001|Period 1 (Panel A and B)|Other|0|||
44155345|NCT01998958|78946949|FG002|Period 1 (Panel A and B)|Other|0|||
44155346|NCT01998958|78946950|FG003|Period 1 (Panel A and B)|Other|0|||
44155347|NCT01998958|78946951|FG004|Period 1 (Panel A and B)|Other|0|||
44155348|NCT01998958|78946952|FG005|Period 1 (Panel A and B)|Other|0|||
44155349|NCT01998958|78946953|FG006|Period 1 (Panel A and B)|Other|0|||
44155350|NCT01998958|78946954|FG007|Period 1 (Panel A and B)|Other|0|||
44155351|NCT01998958|78946955|FG008|Period 1 (Panel A and B)|Other|0|||
44155352|NCT01998958|78946956|FG009|Period 1 (Panel A and B)|Other|0|||
44155353|NCT01998958|78946957|FG010|Period 1 (Panel A and B)|Other|0|||
44155354|NCT01998958|78946958|FG011|Period 1 (Panel A and B)|Other|0|||
44155355|NCT01998958|78946959|FG012|Period 1 (Panel A and B)|Other|0|||
44155356|NCT01998958|78946960|FG013|Period 1 (Panel A and B)|Other|0|||
44155357|NCT01998958|78946961|FG014|Period 1 (Panel A and B)|Other|0|||
44155358|NCT01998958|78946962|FG015|Period 1 (Panel A and B)|Other|0|||
44155359|NCT01998958|78946963|FG016|Period 1 (Panel A and B)|Other|0|||
44155360|NCT01998958|78946964|FG017|Period 1 (Panel A and B)|Other|0|||
44155361|NCT01998958|78946965|FG018|Period 1 (Panel A and B)|Other|0|||
44155362|NCT01998958|78946966|FG019|Period 1 (Panel A and B)|Other|0|||
44155363|NCT01998958|78946967|FG020|Period 1 (Panel A and B)|Other|0|||
44155364|NCT01998958|78946968|FG021|Period 1 (Panel A and B)|Other|0|||
44155365|NCT01998958|78946969|FG022|Period 1 (Panel A and B)|Other|0|||
44155366|NCT01998958|78946970|FG023|Period 1 (Panel A and B)|Other|0|||
44155367|NCT01998958|78946971|FG024|Period 1 (Panel A and B)|Other|0|||
44155368|NCT01998958|78946972|FG025|Period 1 (Panel A and B)|Other|0|||
44155369|NCT01998958|78946973|FG026|Period 1 (Panel A and B)|Other|0|||
44155370|NCT01998958|78946974|FG027|Period 1 (Panel A and B)|Other|0|||
44155371|NCT01998958|78946975|FG028|Period 1 (Panel A and B)|Other|0|||
44155372|NCT01998958|78946976|FG029|Period 1 (Panel A and B)|Other|0|||
44155373|NCT01998958|78946977|FG030|Period 1 (Panel A and B)|Other|0|||
44155374|NCT01998958|78946978|FG031|Period 1 (Panel A and B)|Other|0|||
44155375|NCT01998958|78946947|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
44155376|NCT01998958|78946948|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
44257378|NCT03112603|79109898|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
44257379|NCT03112603|79109899|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
44257380|NCT03112603|79109897|FG000|End of Randomization Period|Physician Decision|43|||
44155377|NCT01998958|78946949|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
44257381|NCT03112603|79109898|FG001|End of Randomization Period|Physician Decision|18|||
44257382|NCT03112603|79109899|FG002|End of Randomization Period|Physician Decision|0|||
44257383|NCT03112603|79109897|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
44419421|NCT00724503|79427310|FG000|Overall Study|Lost to Follow-up|4|||
44419422|NCT00724503|79427311|FG001|Overall Study|Lost to Follow-up|8|||
44155378|NCT01998958|78946950|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
44155379|NCT01998958|78946951|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
44155380|NCT01998958|78946952|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
44155381|NCT01998958|78946953|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
44155382|NCT01998958|78946954|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
44308847|NCT03682770|79310013|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
44308848|NCT03682770|79310007|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
44308849|NCT03682770|79310008|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
44308850|NCT03682770|79310009|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
44308851|NCT03682770|79310010|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
44308852|NCT03682770|79310011|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
44308853|NCT03682770|79310012|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
44308854|NCT03682770|79310013|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
44308855|NCT03682770|79310007|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
44308856|NCT03682770|79310008|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
44308857|NCT03682770|79310009|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
44308858|NCT03682770|79310010|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
44308859|NCT03682770|79310011|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
44308860|NCT03682770|79310012|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
44308861|NCT03682770|79310013|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
44308862|NCT03682770|79310007|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
44308863|NCT03682770|79310008|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
44257384|NCT03112603|79109898|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
44257385|NCT03112603|79109899|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
44257386|NCT03112603|79109897|FG000|End of Randomization Period|Death|10|||
44257387|NCT03112603|79109898|FG001|End of Randomization Period|Death|7|||
44257388|NCT03112603|79109899|FG002|End of Randomization Period|Death|0|||
44257389|NCT03112603|79109897|FG000|End of Randomization Period|Disease Relapse|12|||
44257390|NCT03112603|79109898|FG001|End of Randomization Period|Disease Relapse|7|||
44257391|NCT03112603|79109899|FG002|End of Randomization Period|Disease Relapse|0|||
44257392|NCT03112603|79109897|FG000|End of Randomization Period|Lack of Efficacy|25|||
44257393|NCT03112603|79109898|FG001|End of Randomization Period|Lack of Efficacy|77|||
44257394|NCT03112603|79109899|FG002|End of Randomization Period|Lack of Efficacy|0|||
44257395|NCT03112603|79109897|FG000|End of Randomization Period|Adverse Event|32|||
44257396|NCT03112603|79109898|FG001|End of Randomization Period|Adverse Event|12|||
44257397|NCT03112603|79109899|FG002|End of Randomization Period|Adverse Event|0|||
44257398|NCT03112603|79109897|FG000|End of Cross Over Period|Death|0|||
44257399|NCT03112603|79109898|FG001|End of Cross Over Period|Death|0|||
44257400|NCT03112603|79109899|FG002|End of Cross Over Period|Death|2|||
44257401|NCT03112603|79109897|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
44257402|NCT03112603|79109898|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
44257403|NCT03112603|79109899|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
44257404|NCT03112603|79109897|FG000|End of Cross Over Period|Physician Decision|0|||
44257405|NCT03112603|79109898|FG001|End of Cross Over Period|Physician Decision|0|||
44308864|NCT03682770|79310009|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
44354715|NCT00942994|79359115|FG000|Overall Study|Patient withdrew consent|5|||
44419423|NCT00724503|79427310|FG000|Overall Study|Withdrawal by Subject|11|||
44419424|NCT00724503|79427311|FG001|Overall Study|Withdrawal by Subject|23|||
44419425|NCT00724503|79427310|FG000|Overall Study|Death|190|||
44419426|NCT00724503|79427311|FG001|Overall Study|Death|182|||
44419427|NCT00724503|79427310|FG000|Overall Study|Adverse Event|1|||
44419428|NCT00724503|79427311|FG001|Overall Study|Adverse Event|0|||
44419429|NCT00724503|79427310|FG000|Overall Study|Not otherwise specified|4|||
44419430|NCT00724503|79427311|FG001|Overall Study|Not otherwise specified|7|||
44419431|NCT00791648|79427321|FG000|Overall Study|Physician Decision|0|||
44419432|NCT00791648|79427322|FG001|Overall Study|Physician Decision|1|||
44419433|NCT00791648|79427321|FG000|Overall Study|Withdrawal by Subject|0|||
44419434|NCT00791648|79427322|FG001|Overall Study|Withdrawal by Subject|1|||
44419435|NCT00791492|79427330|FG000|Overall Study|Withdrawal by Subject|1|||
44419436|NCT00791492|79427331|FG001|Overall Study|Withdrawal by Subject|2|||
44419437|NCT00791492|79427330|FG000|Overall Study|Liver transplantation|5|||
44419438|NCT00791492|79427331|FG001|Overall Study|Liver transplantation|1|||
44419439|NCT00723957|79427339|FG000|Overall Study|Adverse event unrelated to study drug|1|||
44419440|NCT00723957|79427340|FG001|Overall Study|Adverse event unrelated to study drug|4|||
44419441|NCT00723957|79427339|FG000|Overall Study|Death|3|||
44419442|NCT00723957|79427340|FG001|Overall Study|Death|4|||
44419443|NCT00723957|79427339|FG000|Overall Study|Disease progression|27|||
44419444|NCT00723957|79427340|FG001|Overall Study|Disease progression|25|||
44257406|NCT03112603|79109899|FG002|End of Cross Over Period|Physician Decision|29|||
44257407|NCT03112603|79109897|FG000|End of Cross Over Period|Lack of Efficacy|0|||
44257408|NCT03112603|79109898|FG001|End of Cross Over Period|Lack of Efficacy|0|||
44257409|NCT03112603|79109899|FG002|End of Cross Over Period|Lack of Efficacy|8|||
44354716|NCT00942994|79359116|FG001|Overall Study|Patient withdrew consent|8|||
44354717|NCT00942994|79359115|FG000|Overall Study|Lost to Follow-up|1|||
44354718|NCT00942994|79359116|FG001|Overall Study|Lost to Follow-up|4|||
44354719|NCT00942994|79359115|FG000|Overall Study|Protocol deviation|1|||
44354720|NCT00942994|79359116|FG001|Overall Study|Protocol deviation|2|||
44308865|NCT03682770|79310010|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
44308866|NCT03682770|79310011|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
44308867|NCT03682770|79310012|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
44308868|NCT03682770|79310013|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
44308869|NCT03682770|79310007|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
44308870|NCT03682770|79310008|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
44308871|NCT03682770|79310009|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
44308872|NCT03682770|79310010|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
44308873|NCT03682770|79310011|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
44308874|NCT03682770|79310012|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
44308875|NCT03682770|79310013|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
44308876|NCT03682770|79310007|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
44308877|NCT03682770|79310008|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
44308878|NCT03682770|79310009|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
44308879|NCT03682770|79310010|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
44308880|NCT03682770|79310011|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
44308881|NCT03682770|79310012|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
44308882|NCT03682770|79310013|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
44308883|NCT03651271|79310032|FG000|Overall Study|Death|4|||
44308884|NCT03651271|79310033|FG001|Overall Study|Death|37|||
44308885|NCT03651271|79310034|FG002|Overall Study|Death|0|||
44308886|NCT03651271|79310035|FG003|Overall Study|Death|2|||
44308887|NCT03651271|79310036|FG004|Overall Study|Death|6|||
44308888|NCT03651271|79310032|FG000|Overall Study|Lost to Follow-up|1|||
44308889|NCT03651271|79310033|FG001|Overall Study|Lost to Follow-up|5|||
44308890|NCT03651271|79310034|FG002|Overall Study|Lost to Follow-up|0|||
44308891|NCT03651271|79310035|FG003|Overall Study|Lost to Follow-up|1|||
44308892|NCT03651271|79310036|FG004|Overall Study|Lost to Follow-up|0|||
44308893|NCT03651271|79310032|FG000|Overall Study|Physician Decision|0|||
44308894|NCT03651271|79310033|FG001|Overall Study|Physician Decision|2|||
44308895|NCT03651271|79310034|FG002|Overall Study|Physician Decision|0|||
44308896|NCT03651271|79310035|FG003|Overall Study|Physician Decision|0|||
44308897|NCT03651271|79310036|FG004|Overall Study|Physician Decision|0|||
44308898|NCT03651271|79310032|FG000|Overall Study|Withdrawal by Subject|1|||
44308899|NCT03651271|79310033|FG001|Overall Study|Withdrawal by Subject|15|||
44308900|NCT03651271|79310034|FG002|Overall Study|Withdrawal by Subject|0|||
44308901|NCT03651271|79310035|FG003|Overall Study|Withdrawal by Subject|0|||
44308902|NCT03651271|79310036|FG004|Overall Study|Withdrawal by Subject|1|||
44308903|NCT03651271|79310032|FG000|Overall Study|Patient medically unable to continue|0|||
44419445|NCT00723957|79427339|FG000|Overall Study|Maximum clinical benefit|4|||
44419446|NCT00723957|79427340|FG001|Overall Study|Maximum clinical benefit|5|||
44419447|NCT00723957|79427339|FG000|Overall Study|Investigator decision|1|||
44419448|NCT00723957|79427340|FG001|Overall Study|Investigator decision|1|||
44419449|NCT00723957|79427339|FG000|Overall Study|Study drug toxicity|4|||
44419450|NCT00723957|79427340|FG001|Overall Study|Study drug toxicity|6|||
44419451|NCT00723957|79427339|FG000|Overall Study|Withdrawal by Subject|7|||
44419452|NCT00723957|79427340|FG001|Overall Study|Withdrawal by Subject|5|||
44419453|NCT00723957|79427339|FG000|Overall Study|Reason not analyzed|1|||
44419454|NCT00723957|79427340|FG001|Overall Study|Reason not analyzed|0|||
44419455|NCT00723957|79427339|FG000|Overall Study|Never received treatment|3|||
44419456|NCT00723957|79427340|FG001|Overall Study|Never received treatment|3|||
44419457|NCT00723801|79427348|FG000|Overall Study|Lost to Follow-up|1|||
44419458|NCT00723801|79427349|FG001|Overall Study|Lost to Follow-up|2|||
44419459|NCT00723801|79427348|FG000|Overall Study|Protocol Violation|2|||
44419460|NCT00723801|79427349|FG001|Overall Study|Protocol Violation|1|||
44419461|NCT00797966|79427359|FG000|Phase A|Lost to Follow-up|0|||
44419462|NCT00797966|79427360|FG001|Phase A|Lost to Follow-up|0|||
44419463|NCT00797966|79427361|FG002|Phase A|Lost to Follow-up|0|||
44419464|NCT00797966|79427362|FG003|Phase A|Lost to Follow-up|0|||
44308904|NCT03651271|79310033|FG001|Overall Study|Patient medically unable to continue|0|||
44308905|NCT03651271|79310034|FG002|Overall Study|Patient medically unable to continue|0|||
44308906|NCT03651271|79310035|FG003|Overall Study|Patient medically unable to continue|1|||
44308907|NCT03651271|79310036|FG004|Overall Study|Patient medically unable to continue|0|||
44308908|NCT03569891|79310051|FG000|Lead-in|Ineligible during lead-in|8|||
44308909|NCT03569891|79310051|FG000|Lead-in|Withdrawal by Subject|3|||
44419465|NCT00797966|79427363|FG004|Phase A|Lost to Follow-up|33|||
44419466|NCT00797966|79427364|FG005|Phase A|Lost to Follow-up|0|||
44419467|NCT00797966|79427359|FG000|Phase A|Adverse Event|0|||
44419468|NCT00797966|79427360|FG001|Phase A|Adverse Event|0|||
44419469|NCT00797966|79427361|FG002|Phase A|Adverse Event|0|||
44419470|NCT00797966|79427362|FG003|Phase A|Adverse Event|0|||
44419471|NCT00797966|79427363|FG004|Phase A|Adverse Event|46|||
44419472|NCT00797966|79427364|FG005|Phase A|Adverse Event|0|||
44419473|NCT00797966|79427359|FG000|Phase A|Met withdrawal criteria|0|||
44419474|NCT00797966|79427360|FG001|Phase A|Met withdrawal criteria|0|||
44308910|NCT03569891|79310051|FG000|Lead-in|Risks related to COVID-19|2|||
44308911|NCT03569891|79310051|FG000|AMT-061|Adverse Event|1|||
44308912|NCT03473548|79310060|FG000|Overall Study|Did not attempt HST testing|3|||
44308913|NCT03473548|79310061|FG001|Overall Study|Did not attempt HST testing|0|||
44308914|NCT03375203|79310070|FG000|Overall Study|Protocol Violation|0|||
44308915|NCT03375203|79310071|FG001|Overall Study|Protocol Violation|0|||
44308916|NCT03375203|79310072|FG002|Overall Study|Protocol Violation|1|||
44308917|NCT03375203|79310073|FG003|Overall Study|Protocol Violation|0|||
44308918|NCT03375203|79310074|FG004|Overall Study|Protocol Violation|0|||
44308919|NCT03375203|79310070|FG000|Overall Study|Adverse Event|2|||
44308920|NCT03375203|79310071|FG001|Overall Study|Adverse Event|3|||
44308921|NCT03375203|79310072|FG002|Overall Study|Adverse Event|0|||
44308922|NCT03375203|79310073|FG003|Overall Study|Adverse Event|2|||
44308923|NCT03375203|79310074|FG004|Overall Study|Adverse Event|2|||
44308924|NCT03375203|79310070|FG000|Overall Study|Withdrawal by Subject|3|||
44308925|NCT03375203|79310071|FG001|Overall Study|Withdrawal by Subject|0|||
44308926|NCT03375203|79310072|FG002|Overall Study|Withdrawal by Subject|1|||
44308927|NCT03375203|79310073|FG003|Overall Study|Withdrawal by Subject|0|||
44308928|NCT03375203|79310074|FG004|Overall Study|Withdrawal by Subject|2|||
44308929|NCT03375203|79310070|FG000|Overall Study|Non-compliance with study drug|1|||
44308930|NCT03375203|79310071|FG001|Overall Study|Non-compliance with study drug|0|||
44308931|NCT03375203|79310072|FG002|Overall Study|Non-compliance with study drug|0|||
44308932|NCT03375203|79310073|FG003|Overall Study|Non-compliance with study drug|0|||
44308933|NCT03375203|79310074|FG004|Overall Study|Non-compliance with study drug|0|||
44308934|NCT03375203|79310070|FG000|Overall Study|Randomized, not treated.|0|||
44308935|NCT03375203|79310071|FG001|Overall Study|Randomized, not treated.|1|||
44308936|NCT03375203|79310072|FG002|Overall Study|Randomized, not treated.|0|||
44308937|NCT03375203|79310073|FG003|Overall Study|Randomized, not treated.|0|||
44308938|NCT03375203|79310074|FG004|Overall Study|Randomized, not treated.|0|||
44308939|NCT03365882|79310089|FG000|Randomization|Still Receiving Protocol Treatment|2|||
44308940|NCT03365882|79310090|FG001|Randomization|Still Receiving Protocol Treatment|0|||
44308941|NCT03365882|79310089|FG000|Randomization|Adverse Event|1|||
44308942|NCT03365882|79310090|FG001|Randomization|Adverse Event|2|||
44308943|NCT03365882|79310089|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
44308944|NCT03365882|79310090|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
44308945|NCT03365882|79310089|FG000|Randomization|Progression/Relapse|21|||
44308946|NCT03365882|79310090|FG001|Randomization|Progression/Relapse|3|||
44308947|NCT03365882|79310089|FG000|Randomization|Death|1|||
44308948|NCT03365882|79310090|FG001|Randomization|Death|0|||
44308949|NCT03365882|79310089|FG000|Randomization|Other - Not Protocol Specified|1|||
44308950|NCT03365882|79310090|FG001|Randomization|Other - Not Protocol Specified|1|||
44308951|NCT03365882|79310089|FG000|Randomization|Major Protocol Deviation|0|||
44308952|NCT03365882|79310090|FG001|Randomization|Major Protocol Deviation|1|||
44308953|NCT03365882|79310089|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
44308954|NCT03365882|79310090|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
44308955|NCT03365882|79310089|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
44308956|NCT03365882|79310090|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
44308957|NCT03365882|79310089|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
44308958|NCT03365882|79310090|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
44308959|NCT03365882|79310089|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
44308960|NCT03365882|79310090|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
44308961|NCT03181789|79310101|FG000|Overall Study|Withdrawal by Subject|0|||
44308962|NCT03181789|79310102|FG001|Overall Study|Withdrawal by Subject|1|||
44308963|NCT03181789|79310103|FG002|Overall Study|Withdrawal by Subject|1|||
44308964|NCT03181789|79310104|FG003|Overall Study|Withdrawal by Subject|0|||
44308965|NCT03181789|79310101|FG000|Overall Study|Lost to Follow-up|7|||
44308966|NCT03181789|79310102|FG001|Overall Study|Lost to Follow-up|1|||
44308967|NCT03181789|79310103|FG002|Overall Study|Lost to Follow-up|0|||
44308968|NCT03181789|79310104|FG003|Overall Study|Lost to Follow-up|0|||
44308969|NCT03181789|79310101|FG000|Overall Study|Participant unable to adhere to visit|0|||
44308970|NCT03181789|79310102|FG001|Overall Study|Participant unable to adhere to visit|1|||
44257410|NCT03112603|79109897|FG000|End of Cross Over Period|Adverse Event|0|||
44257411|NCT03112603|79109898|FG001|End of Cross Over Period|Adverse Event|0|||
44257412|NCT03112603|79109899|FG002|End of Cross Over Period|Adverse Event|6|||
44257413|NCT03112603|79109897|FG000|End of Cross Over Period|Disease Relapse|0|||
44257414|NCT03112603|79109898|FG001|End of Cross Over Period|Disease Relapse|0|||
44257415|NCT03112603|79109899|FG002|End of Cross Over Period|Disease Relapse|2|||
44257416|NCT02725528|79109914|FG000|Overall Study|Lost to Follow-up|1|||
44257417|NCT02725528|79109915|FG001|Overall Study|Lost to Follow-up|4|||
44308971|NCT03181789|79310103|FG002|Overall Study|Participant unable to adhere to visit|0|||
44308972|NCT03181789|79310104|FG003|Overall Study|Participant unable to adhere to visit|0|||
44308973|NCT03106779|79310126|FG000|Overall Study|Lack of Efficacy|33|||
44257418|NCT02725528|79109914|FG000|Overall Study|Withdrawal by Subject|0|||
44257419|NCT02725528|79109915|FG001|Overall Study|Withdrawal by Subject|1|||
44308974|NCT03106779|79310127|FG001|Overall Study|Lack of Efficacy|24|||
44308975|NCT03106779|79310126|FG000|Overall Study|Adverse Event|8|||
44308976|NCT03106779|79310127|FG001|Overall Study|Adverse Event|16|||
44308977|NCT03106779|79310126|FG000|Overall Study|Physician Decision|10|||
44308978|NCT03106779|79310127|FG001|Overall Study|Physician Decision|6|||
44308979|NCT03106779|79310126|FG000|Overall Study|Patient/guardian decision|4|||
44308980|NCT03106779|79310127|FG001|Overall Study|Patient/guardian decision|3|||
44308981|NCT03106779|79310126|FG000|Overall Study|Progressive disease|1|||
44308982|NCT03106779|79310127|FG001|Overall Study|Progressive disease|3|||
44308983|NCT03106779|79310126|FG000|Overall Study|Lost to Follow-up|1|||
44308984|NCT03106779|79310127|FG001|Overall Study|Lost to Follow-up|2|||
44308985|NCT03106779|79310126|FG000|Overall Study|Death|1|||
44308986|NCT03106779|79310127|FG001|Overall Study|Death|0|||
44308987|NCT03106779|79310126|FG000|Overall Study|Protocol Violation|1|||
44308988|NCT03106779|79310127|FG001|Overall Study|Protocol Violation|0|||
44308989|NCT03106779|79310126|FG000|Overall Study|Not treated|1|||
44308990|NCT03106779|79310127|FG001|Overall Study|Not treated|0|||
44308991|NCT02903160|79310142|FG000|Overall Study|Adverse Event|2|||
44308992|NCT02903160|79310142|FG000|Overall Study|Death|1|||
44308993|NCT02903160|79310142|FG000|Overall Study|Lost to Follow-up|2|||
44308994|NCT02903160|79310142|FG000|Overall Study|Withdrawal by Subject|1|||
44308995|NCT02903160|79310142|FG000|Overall Study|Medical Insurance Barriers|1|||
44308996|NCT02768792|79310146|FG000|Overall Study|Adverse Event|1|||
44308997|NCT02545127|79310156|FG000|Overall Study|Lost to Follow-up|1|||
44308998|NCT02545127|79310157|FG001|Overall Study|Lost to Follow-up|0|||
44308999|NCT01824875|79310165|FG000|Overall Study|Disease progression|22|||
44309000|NCT01824875|79310166|FG001|Overall Study|Disease progression|15|||
44309001|NCT01824875|79310165|FG000|Overall Study|Withdrawal by Subject|5|||
44309002|NCT01824875|79310166|FG001|Overall Study|Withdrawal by Subject|4|||
44309003|NCT01824875|79310165|FG000|Overall Study|Adverse Event|4|||
44309004|NCT01824875|79310166|FG001|Overall Study|Adverse Event|10|||
44309005|NCT01824875|79310165|FG000|Overall Study|Alternative therapy|3|||
44309006|NCT01824875|79310166|FG001|Overall Study|Alternative therapy|0|||
44309007|NCT01824875|79310165|FG000|Overall Study|Complicating disease|1|||
44309008|NCT01824875|79310166|FG001|Overall Study|Complicating disease|0|||
44309009|NCT01824875|79310165|FG000|Overall Study|Physician Decision|0|||
44309010|NCT01824875|79310166|FG001|Overall Study|Physician Decision|1|||
44309011|NCT01824875|79310165|FG000|Overall Study|Non-compliance|1|||
44309012|NCT01824875|79310166|FG001|Overall Study|Non-compliance|1|||
44309013|NCT01824875|79310165|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
44309014|NCT01824875|79310166|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
44309015|NCT01824875|79310165|FG000|Overall Study|Administrative issues|0|||
44309016|NCT01824875|79310166|FG001|Overall Study|Administrative issues|2|||
44309017|NCT01824875|79310165|FG000|Overall Study|Ineligible or never started treatment|9|||
44309018|NCT01824875|79310166|FG001|Overall Study|Ineligible or never started treatment|5|||
44309019|NCT01824875|79310165|FG000|Overall Study|Other|0|||
44309020|NCT01824875|79310166|FG001|Overall Study|Other|2|||
44309021|NCT01814397|79310176|FG000|Overall Study|Adverse Event|7|||
44309022|NCT01814397|79310176|FG000|Overall Study|Withdrawal by Subject|7|||
44309023|NCT01665144|79310182|FG000|Overall Study|New therapy for study indication|2|||
44309024|NCT01665144|79310183|FG001|Overall Study|New therapy for study indication|1|||
44309025|NCT01665144|79310182|FG000|Overall Study|Technical problems|2|||
44309026|NCT01665144|79310183|FG001|Overall Study|Technical problems|0|||
44309027|NCT01665144|79310182|FG000|Overall Study|Death|3|||
44309028|NCT01665144|79310183|FG001|Overall Study|Death|1|||
44309029|NCT01665144|79310182|FG000|Overall Study|Protocol deviation|3|||
44309030|NCT01665144|79310183|FG001|Overall Study|Protocol deviation|1|||
44309031|NCT01665144|79310182|FG000|Overall Study|Non-compliance w/study treatment|5|||
44309032|NCT01665144|79310183|FG001|Overall Study|Non-compliance w/study treatment|0|||
44309033|NCT01665144|79310182|FG000|Overall Study|Progressive disease|8|||
44309034|NCT01665144|79310183|FG001|Overall Study|Progressive disease|4|||
44309035|NCT01665144|79310182|FG000|Overall Study|Lost to Follow-up|9|||
44309036|NCT01665144|79310183|FG001|Overall Study|Lost to Follow-up|8|||
44309037|NCT01665144|79310182|FG000|Overall Study|Physician Decision|13|||
44309038|NCT01665144|79310183|FG001|Overall Study|Physician Decision|1|||
44309039|NCT01665144|79310182|FG000|Overall Study|Lack of Efficacy|16|||
44309040|NCT01665144|79310183|FG001|Overall Study|Lack of Efficacy|11|||
44309041|NCT01665144|79310182|FG000|Overall Study|Adverse Event|45|||
44309042|NCT01665144|79310183|FG001|Overall Study|Adverse Event|18|||
44309043|NCT01665144|79310182|FG000|Overall Study|Withdrawal by Subject|96|||
44309044|NCT01665144|79310183|FG001|Overall Study|Withdrawal by Subject|77|||
44309045|NCT01602666|79310191|FG000|Induction Chemotherapy|Death|2|||
44309046|NCT01602666|79310192|FG001|Induction Chemotherapy|Death|1|||
44309047|NCT01602666|79310191|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
44309048|NCT01602666|79310192|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
44309049|NCT01602666|79310191|FG000|Induction Chemotherapy|Physician Decision|12|||
44535271|NCT03480750|79546257|FG000|Overall Study|The interruption in Trientine shippment|0|||
44309050|NCT01602666|79310192|FG001|Induction Chemotherapy|Physician Decision|5|||
44309051|NCT01602666|79310191|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
44309052|NCT01602666|79310192|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
44309053|NCT01602666|79310191|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
44309054|NCT01602666|79310192|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
44309055|NCT01602666|79310191|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
44309056|NCT01602666|79310192|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
44309057|NCT01602666|79310191|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
44309058|NCT01602666|79310192|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
44309059|NCT01602666|79310191|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
44309060|NCT01602666|79310192|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
44309061|NCT01602666|79310191|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
44309062|NCT01602666|79310192|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
44309063|NCT01602666|79310191|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
44309064|NCT01602666|79310192|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
44309065|NCT01602666|79310191|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
44309066|NCT01602666|79310192|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
44309067|NCT01527149|79310200|FG000|Overall Study|Death|2|||
44309068|NCT00946881|79310222|FG000|First Treatment|Withdrawal by Subject|1|||
44309069|NCT00946881|79310222|FG000|First Treatment|Patient relocated to another state|1|||
44309070|NCT00946881|79310222|FG000|Retreatment|Withdrawal by Subject|1|||
44309071|NCT00616967|79310249|FG000|Overall Study|Withdrawal by Subject|0|||
44309072|NCT00616967|79310250|FG001|Overall Study|Withdrawal by Subject|0|||
44309073|NCT00616967|79310251|FG002|Overall Study|Withdrawal by Subject|1|||
44309074|NCT05172050|79310326|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
44309075|NCT05172050|79310327|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
44309076|NCT05172050|79310328|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
44309077|NCT05172050|79310326|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
44309078|NCT05172050|79310327|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
44309079|NCT05172050|79310328|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
44309080|NCT05172050|79310326|FG000|Overall Study|Other|2|||
44309081|NCT05172050|79310327|FG001|Overall Study|Other|2|||
44309082|NCT05172050|79310328|FG002|Overall Study|Other|1|||
44309083|NCT04924062|79310341|FG000|Overall Study|Death|49|||
44309084|NCT04924062|79310342|FG001|Overall Study|Death|63|||
44309085|NCT04924062|79310341|FG000|Overall Study|Participant On-going|26|||
44309086|NCT04924062|79310342|FG001|Overall Study|Participant On-going|20|||
44309087|NCT04826484|79310350|FG000|Overall Study|Lost to Follow-up|2|||
44309088|NCT04826484|79310351|FG001|Overall Study|Lost to Follow-up|0|||
44309089|NCT04820842|79310360|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
44419475|NCT00797966|79427361|FG002|Phase A|Met withdrawal criteria|0|||
44419476|NCT00797966|79427362|FG003|Phase A|Met withdrawal criteria|0|||
44419477|NCT00797966|79427363|FG004|Phase A|Met withdrawal criteria|4|||
44419478|NCT00797966|79427364|FG005|Phase A|Met withdrawal criteria|0|||
44535272|NCT03480750|79546258|FG001|Overall Study|The interruption in Trientine shippment|0|||
44257420|NCT02627963|79109932|FG000|Overall Study|Randomized but not treated|2|||
44257421|NCT02627963|79109933|FG001|Overall Study|Randomized but not treated|6|||
44257422|NCT02585258|79109941|FG000|Overall Study|Adverse Event|28|||
44257423|NCT02585258|79109942|FG001|Overall Study|Adverse Event|29|||
44257424|NCT02585258|79109941|FG000|Overall Study|Death|3|||
44257425|NCT02585258|79109942|FG001|Overall Study|Death|2|||
44257426|NCT02585258|79109941|FG000|Overall Study|Lack of Efficacy|7|||
44257427|NCT02585258|79109942|FG001|Overall Study|Lack of Efficacy|9|||
44257428|NCT02585258|79109941|FG000|Overall Study|includes covid-related access problems|42|||
44257429|NCT02585258|79109942|FG001|Overall Study|includes covid-related access problems|46|||
44257430|NCT02585258|79109941|FG000|Overall Study|Lost to Follow-up|5|||
44257431|NCT02585258|79109942|FG001|Overall Study|Lost to Follow-up|2|||
44257432|NCT02132611|79109959|FG000|Overall Study|Death|2|||
44257433|NCT01941030|79109965|FG000|Overall Study|Death|3|||
44257434|NCT01941030|79109966|FG001|Overall Study|Death|2|||
44257435|NCT01941030|79109965|FG000|Overall Study|Lost to Follow-up|6|||
44257436|NCT01941030|79109966|FG001|Overall Study|Lost to Follow-up|5|||
44257437|NCT01941030|79109965|FG000|Overall Study|Withdrawal by Subject|4|||
44257438|NCT01941030|79109966|FG001|Overall Study|Withdrawal by Subject|6|||
44257439|NCT01092416|79109977|FG000|Enrollment|Atherectomy device not inserted|3|||
44257440|NCT01092416|79109977|FG000|30-Day Follow-up|Death|2|||
44257441|NCT01092416|79109977|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
44257442|NCT01092416|79109977|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
44257443|NCT01092416|79109977|FG000|12-Month Follow-up|Death|16|||
44257444|NCT01092416|79109977|FG000|12-Month Follow-up|Lost to Follow-up|4|||
44257445|NCT01092416|79109977|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
44257446|NCT01092416|79109977|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
44257447|NCT01092416|79109977|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
44257448|NCT00701220|79109986|FG000|Overall Study|Withdrawal by Subject|0|||
44309090|NCT04820842|79310361|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
44309091|NCT04820842|79310362|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
44309092|NCT04820842|79310363|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
44309093|NCT04820842|79310364|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
44309094|NCT04820842|79310365|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
44309095|NCT04820842|79310366|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
44309096|NCT04820842|79310360|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
44309097|NCT04820842|79310361|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
44309098|NCT04820842|79310362|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
44309099|NCT04820842|79310363|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309100|NCT04820842|79310364|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309101|NCT04820842|79310365|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309102|NCT04820842|79310366|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309103|NCT04820842|79310360|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44309104|NCT04820842|79310361|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
44309105|NCT04820842|79310362|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44309106|NCT04820842|79310363|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44309107|NCT04820842|79310364|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44309108|NCT04820842|79310365|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44309109|NCT04820842|79310366|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
44309110|NCT04820842|79310360|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309111|NCT04820842|79310361|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309112|NCT04820842|79310362|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309113|NCT04820842|79310363|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
44309114|NCT04820842|79310364|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44309115|NCT04820842|79310365|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
44354721|NCT00942604|79359124|FG000|Overall Study|Protocol Violation|1|||
44155383|NCT01998958|78946955|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
44155384|NCT01998958|78946956|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
44155385|NCT01998958|78946957|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
44155386|NCT01998958|78946958|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
44155387|NCT01998958|78946959|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
44155388|NCT01998958|78946960|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
44155389|NCT01998958|78946961|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
44155390|NCT01998958|78946962|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
44155391|NCT01998958|78946963|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
44155392|NCT01998958|78946964|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
44155393|NCT01998958|78946965|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
44155394|NCT01998958|78946966|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
44155395|NCT01998958|78946967|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
44155396|NCT01998958|78946968|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
44155397|NCT01998958|78946969|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
44155398|NCT01998958|78946970|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
44155399|NCT01998958|78946971|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
44155400|NCT01998958|78946972|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
44155401|NCT01998958|78946973|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
44155402|NCT01998958|78946974|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
44155403|NCT01998958|78946975|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
44155404|NCT01998958|78946976|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
44155405|NCT01998958|78946977|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
44155406|NCT01998958|78946978|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
44155407|NCT01998958|78946947|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155408|NCT01998958|78946948|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155409|NCT01998958|78946949|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155410|NCT01998958|78946950|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155411|NCT01998958|78946951|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155412|NCT01998958|78946952|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155413|NCT01998958|78946953|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155414|NCT01998958|78946954|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155415|NCT01998958|78946955|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155416|NCT01998958|78946956|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44309116|NCT04820842|79310366|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
44309117|NCT04744285|79310396|FG000|Overall Study|Withdrawal by Subject|1|||
44309118|NCT04744285|79310397|FG001|Overall Study|Withdrawal by Subject|1|||
44309119|NCT04744285|79310398|FG002|Overall Study|Withdrawal by Subject|2|||
44309120|NCT04744285|79310399|FG003|Overall Study|Withdrawal by Subject|1|||
44309121|NCT04737187|79310411|FG000|Overall Study|Continuing the study on treatment|32|||
44309122|NCT04737187|79310412|FG001|Overall Study|Continuing the study on treatment|4|||
44309123|NCT04737187|79310411|FG000|Overall Study|Radiological Progressive Disease|145|||
44309124|NCT04737187|79310412|FG001|Overall Study|Radiological Progressive Disease|146|||
44309125|NCT04737187|79310411|FG000|Overall Study|Clinical Progressive Disease|20|||
44309126|NCT04737187|79310412|FG001|Overall Study|Clinical Progressive Disease|20|||
44309127|NCT04737187|79310411|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
44309128|NCT04737187|79310412|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
44309129|NCT04737187|79310411|FG000|Overall Study|Adverse Event|16|||
44309130|NCT04737187|79310412|FG001|Overall Study|Adverse Event|16|||
44309131|NCT04737187|79310411|FG000|Overall Study|Physician Decision|2|||
44309132|NCT04737187|79310412|FG001|Overall Study|Physician Decision|0|||
44309133|NCT04737187|79310411|FG000|Overall Study|Withdrawal by Subject|5|||
44309134|NCT04737187|79310412|FG001|Overall Study|Withdrawal by Subject|8|||
44309135|NCT04555044|79310420|FG000|Overall Study|Adverse Event|0|||
44309136|NCT04555044|79310421|FG001|Overall Study|Adverse Event|1|||
44309137|NCT04492722|79310452|FG000|Overall Study|Adverse Event|7|||
44309138|NCT04492722|79310453|FG001|Overall Study|Adverse Event|2|||
44309139|NCT04492722|79310454|FG002|Overall Study|Adverse Event|3|||
44309140|NCT04492722|79310455|FG003|Overall Study|Adverse Event|0|||
44309141|NCT04492722|79310452|FG000|Overall Study|Death|0|||
44309142|NCT04492722|79310453|FG001|Overall Study|Death|0|||
44309143|NCT04492722|79310454|FG002|Overall Study|Death|0|||
44309144|NCT04492722|79310455|FG003|Overall Study|Death|1|||
44309145|NCT04492722|79310452|FG000|Overall Study|Lost to Follow-up|0|||
44309146|NCT04492722|79310453|FG001|Overall Study|Lost to Follow-up|1|||
44309147|NCT04492722|79310454|FG002|Overall Study|Lost to Follow-up|0|||
44309148|NCT04492722|79310455|FG003|Overall Study|Lost to Follow-up|1|||
44309149|NCT04492722|79310452|FG000|Overall Study|Physician Decision|0|||
44309150|NCT04492722|79310453|FG001|Overall Study|Physician Decision|3|||
44309151|NCT04492722|79310454|FG002|Overall Study|Physician Decision|1|||
44309152|NCT04492722|79310455|FG003|Overall Study|Physician Decision|1|||
44309153|NCT04492722|79310452|FG000|Overall Study|Withdrawal by Subject|6|||
44309154|NCT04492722|79310453|FG001|Overall Study|Withdrawal by Subject|6|||
44309155|NCT04492722|79310454|FG002|Overall Study|Withdrawal by Subject|0|||
44309156|NCT04492722|79310455|FG003|Overall Study|Withdrawal by Subject|3|||
44309157|NCT04492722|79310452|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
44309158|NCT04492722|79310453|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
44309159|NCT04492722|79310454|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
44309160|NCT04492722|79310455|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
44309161|NCT04492722|79310452|FG000|Overall Study|Due to Covid-19 pandemic|7|||
44309162|NCT04492722|79310453|FG001|Overall Study|Due to Covid-19 pandemic|3|||
44309163|NCT04492722|79310454|FG002|Overall Study|Due to Covid-19 pandemic|7|||
44309164|NCT04492722|79310455|FG003|Overall Study|Due to Covid-19 pandemic|6|||
44309165|NCT04492722|79310452|FG000|Overall Study|Failure to meet randomisation criteria|2|||
44309166|NCT04492722|79310453|FG001|Overall Study|Failure to meet randomisation criteria|3|||
44309167|NCT04492722|79310454|FG002|Overall Study|Failure to meet randomisation criteria|4|||
44309168|NCT04492722|79310455|FG003|Overall Study|Failure to meet randomisation criteria|2|||
44309169|NCT04492722|79310452|FG000|Overall Study|Early termination from the study|54|||
44309170|NCT04492722|79310453|FG001|Overall Study|Early termination from the study|51|||
44309171|NCT04492722|79310454|FG002|Overall Study|Early termination from the study|50|||
44309172|NCT04492722|79310455|FG003|Overall Study|Early termination from the study|50|||
44309173|NCT04492722|79310452|FG000|Overall Study|Missing|3|||
44309174|NCT04492722|79310453|FG001|Overall Study|Missing|0|||
44309175|NCT04492722|79310454|FG002|Overall Study|Missing|0|||
44309176|NCT04492722|79310455|FG003|Overall Study|Missing|5|||
44309177|NCT04492722|79310452|FG000|Overall Study|Participants who did not receive treatment|0|||
44309178|NCT04492722|79310453|FG001|Overall Study|Participants who did not receive treatment|1|||
44309179|NCT04492722|79310454|FG002|Overall Study|Participants who did not receive treatment|4|||
44309180|NCT04492722|79310455|FG003|Overall Study|Participants who did not receive treatment|0|||
44309181|NCT04466618|79310467|FG000|Overall Study|Withdrawal by Subject|0|||
44419479|NCT00797966|79427359|FG000|Phase A|Physician Decision|0|||
44535273|NCT03480750|79546259|FG002|Overall Study|The interruption in Trientine shippment|0|||
44309182|NCT04466618|79310468|FG001|Overall Study|Withdrawal by Subject|1|||
44309183|NCT04271735|79310480|FG000|Overall Study|Physician Decision|2|||
44309184|NCT04271735|79310481|FG001|Overall Study|Physician Decision|0|||
44309185|NCT04221373|79310489|FG000|Overall Study|Physician Decision|4|||
44419480|NCT00797966|79427360|FG001|Phase A|Physician Decision|0|||
44419481|NCT00797966|79427361|FG002|Phase A|Physician Decision|0|||
44309186|NCT04221373|79310490|FG001|Overall Study|Physician Decision|0|||
44309187|NCT04206605|79310498|FG000|Overall Study|Adverse Event|0|||
44309188|NCT04206605|79310499|FG001|Overall Study|Adverse Event|1|||
44309189|NCT04206605|79310498|FG000|Overall Study|Withdrawal by Subject|1|||
44309190|NCT04206605|79310499|FG001|Overall Study|Withdrawal by Subject|0|||
44309191|NCT04177212|79310509|FG000|Overall Study|Withdrawal by Subject|9|||
44309192|NCT04177212|79310510|FG001|Overall Study|Withdrawal by Subject|7|||
44309193|NCT04177212|79310509|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
44309194|NCT04177212|79310510|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
44309195|NCT04177212|79310509|FG000|Overall Study|Physician Decision|1|||
44309196|NCT04177212|79310510|FG001|Overall Study|Physician Decision|0|||
44309197|NCT04177212|79310509|FG000|Overall Study|Lost to Follow-up|0|||
44309198|NCT04177212|79310510|FG001|Overall Study|Lost to Follow-up|3|||
44309199|NCT04177212|79310509|FG000|Overall Study|Adverse Event|0|||
44309200|NCT04177212|79310510|FG001|Overall Study|Adverse Event|1|||
44309201|NCT04177212|79310509|FG000|Overall Study|Other|1|||
44309202|NCT04177212|79310510|FG001|Overall Study|Other|2|||
44309203|NCT04065841|79310526|FG000|Overall Study|Adverse Event|4|||
44309204|NCT04065841|79310527|FG001|Overall Study|Adverse Event|2|||
44309205|NCT04065841|79310528|FG002|Overall Study|Adverse Event|10|||
44309206|NCT04065841|79310529|FG003|Overall Study|Adverse Event|1|||
44309207|NCT04065841|79310526|FG000|Overall Study|Lost to Follow-up|1|||
44309208|NCT04065841|79310527|FG001|Overall Study|Lost to Follow-up|2|||
44309209|NCT04065841|79310528|FG002|Overall Study|Lost to Follow-up|2|||
44309210|NCT04065841|79310529|FG003|Overall Study|Lost to Follow-up|2|||
44309211|NCT04065841|79310526|FG000|Overall Study|Physician Decision|1|||
44309212|NCT04065841|79310527|FG001|Overall Study|Physician Decision|0|||
44309213|NCT04065841|79310528|FG002|Overall Study|Physician Decision|0|||
44309214|NCT04065841|79310529|FG003|Overall Study|Physician Decision|0|||
44309215|NCT04065841|79310526|FG000|Overall Study|Protocol Violation|0|||
44309216|NCT04065841|79310527|FG001|Overall Study|Protocol Violation|1|||
44309217|NCT04065841|79310528|FG002|Overall Study|Protocol Violation|0|||
44309218|NCT04065841|79310529|FG003|Overall Study|Protocol Violation|0|||
44309219|NCT04065841|79310526|FG000|Overall Study|Study terminated by Sponsor|22|||
44309220|NCT04065841|79310527|FG001|Overall Study|Study terminated by Sponsor|16|||
44309221|NCT04065841|79310528|FG002|Overall Study|Study terminated by Sponsor|28|||
44309222|NCT04065841|79310529|FG003|Overall Study|Study terminated by Sponsor|17|||
44309223|NCT04065841|79310526|FG000|Overall Study|Withdrawal by Subject|1|||
44309224|NCT04065841|79310527|FG001|Overall Study|Withdrawal by Subject|1|||
44309225|NCT04065841|79310528|FG002|Overall Study|Withdrawal by Subject|2|||
44419482|NCT00797966|79427362|FG003|Phase A|Physician Decision|0|||
44419483|NCT00797966|79427363|FG004|Phase A|Physician Decision|13|||
44419484|NCT00797966|79427364|FG005|Phase A|Physician Decision|0|||
44419485|NCT00797966|79427359|FG000|Phase A|Withdrawal by Subject|0|||
44419486|NCT00797966|79427360|FG001|Phase A|Withdrawal by Subject|0|||
44419487|NCT00797966|79427361|FG002|Phase A|Withdrawal by Subject|0|||
44419488|NCT00797966|79427362|FG003|Phase A|Withdrawal by Subject|0|||
44419489|NCT00797966|79427363|FG004|Phase A|Withdrawal by Subject|33|||
44419490|NCT00797966|79427364|FG005|Phase A|Withdrawal by Subject|0|||
44419491|NCT00797966|79427359|FG000|Phase A|Protocol deviation|0|||
44419492|NCT00797966|79427360|FG001|Phase A|Protocol deviation|0|||
44535274|NCT03480750|79546260|FG003|Overall Study|The interruption in Trientine shippment|0|||
44535275|NCT03480750|79546261|FG004|Overall Study|The interruption in Trientine shippment|0|||
44309226|NCT04065841|79310529|FG003|Overall Study|Withdrawal by Subject|0|||
44309227|NCT04045132|79310542|FG000|Overall Study|Lost to Follow-up|3|||
44309228|NCT04045132|79310543|FG001|Overall Study|Lost to Follow-up|6|||
44309229|NCT03912831|79310566|FG000|Overall Study|Death|1|||
44309230|NCT03912831|79310567|FG001|Overall Study|Death|1|||
44309231|NCT03912831|79310568|FG002|Overall Study|Death|1|||
44309232|NCT03912831|79310569|FG003|Overall Study|Death|1|||
44309233|NCT03912831|79310570|FG004|Overall Study|Death|1|||
44309234|NCT03912831|79310571|FG005|Overall Study|Death|1|||
44309235|NCT03912831|79310566|FG000|Overall Study|Reason not Specified|0|||
44309236|NCT03912831|79310567|FG001|Overall Study|Reason not Specified|0|||
44309237|NCT03912831|79310568|FG002|Overall Study|Reason not Specified|0|||
44309238|NCT03912831|79310569|FG003|Overall Study|Reason not Specified|0|||
44309239|NCT03912831|79310570|FG004|Overall Study|Reason not Specified|1|||
44309240|NCT03912831|79310571|FG005|Overall Study|Reason not Specified|0|||
44309241|NCT03912831|79310566|FG000|Overall Study|Withdrawal by Participant|0|||
44309242|NCT03912831|79310567|FG001|Overall Study|Withdrawal by Participant|0|||
44419493|NCT00797966|79427361|FG002|Phase A|Protocol deviation|0|||
44419494|NCT00797966|79427362|FG003|Phase A|Protocol deviation|0|||
44309243|NCT03912831|79310568|FG002|Overall Study|Withdrawal by Participant|0|||
44309244|NCT03912831|79310569|FG003|Overall Study|Withdrawal by Participant|0|||
44309245|NCT03912831|79310570|FG004|Overall Study|Withdrawal by Participant|1|||
44309246|NCT03912831|79310571|FG005|Overall Study|Withdrawal by Participant|0|||
44309247|NCT03524612|79310608|FG000|Overall Study|Lack of Efficacy|10|||
44419495|NCT00797966|79427363|FG004|Phase A|Protocol deviation|56|||
44419496|NCT00797966|79427364|FG005|Phase A|Protocol deviation|0|||
44309248|NCT03524612|79310608|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
44309249|NCT03524612|79310608|FG000|Overall Study|Adverse Event|10|||
44309250|NCT03524612|79310608|FG000|Overall Study|Withdrawal by Subject|7|||
44309251|NCT03524612|79310608|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
44309252|NCT03524612|79310608|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
44309253|NCT03524612|79310608|FG000|Overall Study|New therapy for study indication|6|||
44309254|NCT03524612|79310608|FG000|Overall Study|Death|3|||
44309255|NCT03524612|79310608|FG000|Overall Study|Lost to Follow-up|2|||
44309256|NCT03524612|79310608|FG000|Overall Study|Protocol Violation|1|||
44309257|NCT03495453|79310615|FG000|Overall Study|Withdrawal by Subject|0|||
44309258|NCT03495453|79310616|FG001|Overall Study|Withdrawal by Subject|1|||
44309259|NCT03473743|79310630|FG000|Overall Study|Withdrawal by Subject|0|||
44309260|NCT03473743|79310631|FG001|Overall Study|Withdrawal by Subject|0|||
44309261|NCT03473743|79310632|FG002|Overall Study|Withdrawal by Subject|0|||
44309262|NCT03473743|79310633|FG003|Overall Study|Withdrawal by Subject|0|||
44309263|NCT03473743|79310634|FG004|Overall Study|Withdrawal by Subject|0|||
44309264|NCT03473743|79310635|FG005|Overall Study|Withdrawal by Subject|0|||
44309265|NCT03473743|79310636|FG006|Overall Study|Withdrawal by Subject|0|||
44309266|NCT03473743|79310637|FG007|Overall Study|Withdrawal by Subject|3|||
44309267|NCT03473743|79310630|FG000|Overall Study|Other|0|||
44309268|NCT03473743|79310631|FG001|Overall Study|Other|0|||
44309269|NCT03473743|79310632|FG002|Overall Study|Other|0|||
44309270|NCT03473743|79310633|FG003|Overall Study|Other|1|||
44309271|NCT03473743|79310634|FG004|Overall Study|Other|0|||
44309272|NCT03473743|79310635|FG005|Overall Study|Other|0|||
44309273|NCT03473743|79310636|FG006|Overall Study|Other|0|||
44309274|NCT03473743|79310637|FG007|Overall Study|Other|0|||
44309275|NCT03473743|79310630|FG000|Overall Study|Ongoing|0|||
44309276|NCT03473743|79310631|FG001|Overall Study|Ongoing|0|||
44309277|NCT03473743|79310632|FG002|Overall Study|Ongoing|6|||
44309278|NCT03473743|79310633|FG003|Overall Study|Ongoing|8|||
44309279|NCT03473743|79310634|FG004|Overall Study|Ongoing|1|||
44309280|NCT03473743|79310635|FG005|Overall Study|Ongoing|1|||
44309281|NCT03473743|79310636|FG006|Overall Study|Ongoing|22|||
44309282|NCT03473743|79310637|FG007|Overall Study|Ongoing|24|||
44309283|NCT03473743|79310630|FG000|Overall Study|Randomized but not treated|0|||
44309284|NCT03473743|79310631|FG001|Overall Study|Randomized but not treated|0|||
44309285|NCT03473743|79310632|FG002|Overall Study|Randomized but not treated|0|||
44309286|NCT03473743|79310633|FG003|Overall Study|Randomized but not treated|0|||
44309287|NCT03473743|79310634|FG004|Overall Study|Randomized but not treated|0|||
44309288|NCT03473743|79310635|FG005|Overall Study|Randomized but not treated|0|||
44309289|NCT03473743|79310636|FG006|Overall Study|Randomized but not treated|1|||
44309290|NCT03473743|79310637|FG007|Overall Study|Randomized but not treated|1|||
44309291|NCT03212794|79310657|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
44309292|NCT03212794|79310658|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
44309293|NCT03212794|79310657|FG000|Overall Study|Lost to Follow-up|5|||
44309294|NCT03212794|79310658|FG001|Overall Study|Lost to Follow-up|6|||
44309295|NCT03212794|79310657|FG000|Overall Study|Incarcerated; unable to participate|2|||
44309296|NCT03212794|79310658|FG001|Overall Study|Incarcerated; unable to participate|0|||
44309297|NCT03212794|79310657|FG000|Overall Study|Withdrawal by Subject|1|||
44309298|NCT03212794|79310658|FG001|Overall Study|Withdrawal by Subject|0|||
44309299|NCT03212794|79310657|FG000|Overall Study|Death|0|||
44309300|NCT03212794|79310658|FG001|Overall Study|Death|1|||
44309301|NCT03212794|79310657|FG000|Overall Study|Found to be ineligible after allocation|0|||
44309302|NCT03212794|79310658|FG001|Overall Study|Found to be ineligible after allocation|1|||
44309303|NCT03212794|79310657|FG000|Overall Study|Relocated out of area|2|||
44309304|NCT03212794|79310658|FG001|Overall Study|Relocated out of area|0|||
44309305|NCT03200574|79310664|FG000|Overall Study|Death|4|||
44309306|NCT03200574|79310664|FG000|Overall Study|Withdrawal by Subject|8|||
44309307|NCT03200574|79310664|FG000|Overall Study|Long-Term need for anticoagulation|1|||
44309308|NCT03200574|79310664|FG000|Overall Study|Relocation|2|||
44309309|NCT03200574|79310664|FG000|Overall Study|Lost to Follow-up|2|||
44419497|NCT00797966|79427359|FG000|Phase B|Lost to Follow-up|0|||
44419498|NCT00797966|79427360|FG001|Phase B|Lost to Follow-up|1|||
44419499|NCT00797966|79427361|FG002|Phase B|Lost to Follow-up|3|||
44419500|NCT00797966|79427362|FG003|Phase B|Lost to Follow-up|0|||
44309310|NCT03194958|79310681|FG000|Overall Study|Death|0|||
44309311|NCT03194958|79310682|FG001|Overall Study|Death|1|||
44309312|NCT03194958|79310683|FG002|Overall Study|Death|1|||
44309313|NCT03194958|79310684|FG003|Overall Study|Death|1|||
44309314|NCT03194958|79310681|FG000|Overall Study|Withdrawal by Subject|24|||
44419501|NCT00797966|79427363|FG004|Phase B|Lost to Follow-up|0|||
44309315|NCT03194958|79310682|FG001|Overall Study|Withdrawal by Subject|27|||
44309316|NCT03194958|79310683|FG002|Overall Study|Withdrawal by Subject|7|||
44309317|NCT03194958|79310684|FG003|Overall Study|Withdrawal by Subject|22|||
44309318|NCT03194958|79310681|FG000|Overall Study|Lost to Follow-up|168|||
44309319|NCT03194958|79310682|FG001|Overall Study|Lost to Follow-up|196|||
44419502|NCT00797966|79427364|FG005|Phase B|Lost to Follow-up|0|||
44309320|NCT03194958|79310683|FG002|Overall Study|Lost to Follow-up|174|||
44309321|NCT03194958|79310684|FG003|Overall Study|Lost to Follow-up|186|||
44309322|NCT03123783|79310701|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
44309323|NCT03123783|79310702|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
44309324|NCT03123783|79310703|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
44309325|NCT03123783|79310704|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
44309326|NCT03123783|79310705|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
44309327|NCT03123783|79310706|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
44309328|NCT03123783|79310707|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
44309329|NCT03123783|79310701|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
44309330|NCT03123783|79310702|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
44309331|NCT03123783|79310703|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
44309332|NCT03123783|79310704|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
44309333|NCT03123783|79310705|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
44309334|NCT03123783|79310706|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
44309335|NCT03123783|79310707|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
44309336|NCT03123783|79310701|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
44309337|NCT03123783|79310702|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
44309338|NCT03123783|79310703|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
44309339|NCT03123783|79310704|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
44309340|NCT03123783|79310705|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
44309341|NCT03123783|79310706|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
44309342|NCT03123783|79310707|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
44309343|NCT03123783|79310701|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
44309344|NCT03123783|79310702|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
44309345|NCT03123783|79310703|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
44309346|NCT03123783|79310704|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
44309347|NCT03123783|79310705|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
44309348|NCT03123783|79310706|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
44309349|NCT03123783|79310707|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
44309350|NCT03003962|79310748|FG000|Overall Study|Withdrawal by Subject|5|||
44309351|NCT03003962|79310749|FG001|Overall Study|Withdrawal by Subject|17|||
44309352|NCT03003962|79310748|FG000|Overall Study|Death|274|||
44309353|NCT03003962|79310749|FG001|Overall Study|Death|277|||
44309354|NCT03003962|79310748|FG000|Overall Study|Participants ongoing at DCO|55|||
44309355|NCT03003962|79310749|FG001|Overall Study|Participants ongoing at DCO|40|||
44309356|NCT02943408|79310759|FG000|Overall Study|Lost to Follow-up|7|||
44309357|NCT02943408|79310760|FG001|Overall Study|Lost to Follow-up|1|||
44309358|NCT02943408|79310759|FG000|Overall Study|Withdrawal by Subject|0|||
44309359|NCT02943408|79310760|FG001|Overall Study|Withdrawal by Subject|1|||
44309360|NCT02728102|79310769|FG000|Overall Study|Death|3|||
44309361|NCT02728102|79310770|FG001|Overall Study|Death|0|||
44309362|NCT02728102|79310771|FG002|Overall Study|Death|1|||
44309363|NCT02728102|79310769|FG000|Overall Study|Withdrawal by Subject|0|||
44309364|NCT02728102|79310770|FG001|Overall Study|Withdrawal by Subject|2|||
44309365|NCT02728102|79310771|FG002|Overall Study|Withdrawal by Subject|3|||
44309366|NCT02728102|79310769|FG000|Overall Study|Physician Decision|1|||
44309367|NCT02728102|79310770|FG001|Overall Study|Physician Decision|1|||
44309368|NCT02728102|79310771|FG002|Overall Study|Physician Decision|0|||
44309369|NCT02728102|79310769|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
44309370|NCT02728102|79310770|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
44309371|NCT02728102|79310771|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
44309372|NCT02728102|79310769|FG000|Overall Study|Covid|0|||
44309373|NCT02728102|79310770|FG001|Overall Study|Covid|0|||
44309374|NCT02728102|79310771|FG002|Overall Study|Covid|1|||
44309375|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
44309376|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
44309377|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
44419503|NCT00797966|79427359|FG000|Phase B|Adverse Event|2|||
44419504|NCT00797966|79427360|FG001|Phase B|Adverse Event|1|||
44419505|NCT00797966|79427361|FG002|Phase B|Adverse Event|3|||
44419506|NCT00797966|79427362|FG003|Phase B|Adverse Event|1|||
44419507|NCT00797966|79427363|FG004|Phase B|Adverse Event|0|||
44419508|NCT00797966|79427364|FG005|Phase B|Adverse Event|0|||
44419509|NCT00797966|79427359|FG000|Phase B|Met Withdrawal Criteria|3|||
44419510|NCT00797966|79427360|FG001|Phase B|Met Withdrawal Criteria|3|||
44419511|NCT00797966|79427361|FG002|Phase B|Met Withdrawal Criteria|6|||
44419512|NCT00797966|79427362|FG003|Phase B|Met Withdrawal Criteria|1|||
44419513|NCT00797966|79427363|FG004|Phase B|Met Withdrawal Criteria|0|||
44309378|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
44309379|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
44309380|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
44309381|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
44309382|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
44309383|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
44309384|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
44309385|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
44309386|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
44309387|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
44309388|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
44309389|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
44309390|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
44309391|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
44309392|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
44309393|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
44257449|NCT00701220|79109987|FG001|Overall Study|Withdrawal by Subject|2|||
44309394|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
44309395|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
44309396|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
44309397|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
44309398|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
44309399|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
44309400|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
44309401|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
44309402|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
44309403|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
44309404|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
44309405|NCT02660580|79310782|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
44309406|NCT02660580|79310783|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
44309407|NCT02660580|79310784|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
44309408|NCT02660580|79310785|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
44309409|NCT02660580|79310786|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
44309410|NCT02660580|79310782|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
44309411|NCT02660580|79310783|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
44309412|NCT02660580|79310784|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
44309413|NCT02660580|79310785|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
44309414|NCT02660580|79310786|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
44309415|NCT02660580|79310782|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
44309416|NCT02660580|79310783|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
44309417|NCT02660580|79310784|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
44309418|NCT02660580|79310785|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
44309419|NCT02660580|79310786|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
44309420|NCT02660580|79310782|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
44309421|NCT02660580|79310783|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
44309422|NCT02660580|79310784|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
44309423|NCT02660580|79310785|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
44309424|NCT02660580|79310786|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
44309425|NCT02660580|79310782|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
44309426|NCT02660580|79310783|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
44309427|NCT02660580|79310784|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
44257450|NCT00701220|79109986|FG000|Overall Study|Protocol Violation|2|||
44257451|NCT00701220|79109987|FG001|Overall Study|Protocol Violation|0|||
44257452|NCT00559845|79110061|FG000|Overall Study|Withdrew Consent|1|||
44257453|NCT00559845|79110061|FG000|Overall Study|Disease Progression|1|||
44257454|NCT00559845|79110061|FG000|Overall Study|Adverse Event|3|||
44257455|NCT00559845|79110061|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
44257456|NCT00559845|79110061|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
44257457|NCT01393964|79110164|FG000|Overall Study|Disease Progression|4|||
44257458|NCT01393964|79110165|FG001|Overall Study|Disease Progression|3|||
44257459|NCT01393964|79110166|FG002|Overall Study|Disease Progression|5|||
44257460|NCT01393964|79110164|FG000|Overall Study|Study drug toxicity|1|||
44257461|NCT01393964|79110165|FG001|Overall Study|Study drug toxicity|0|||
44257462|NCT01393964|79110166|FG002|Overall Study|Study drug toxicity|0|||
44309428|NCT02660580|79310785|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
44309429|NCT02660580|79310786|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
44309430|NCT02660580|79310782|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
44309431|NCT02660580|79310783|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
44309432|NCT02660580|79310784|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
44309433|NCT02660580|79310785|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
44309434|NCT02660580|79310786|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
44309435|NCT02660580|79310782|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
44309436|NCT02660580|79310783|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
44309437|NCT02660580|79310784|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
44419514|NCT00797966|79427364|FG005|Phase B|Met Withdrawal Criteria|0|||
44419515|NCT00797966|79427359|FG000|Phase B|Physician Decision|1|||
44419516|NCT00797966|79427360|FG001|Phase B|Physician Decision|0|||
44419517|NCT00797966|79427361|FG002|Phase B|Physician Decision|3|||
44419518|NCT00797966|79427362|FG003|Phase B|Physician Decision|1|||
44257463|NCT01393964|79110164|FG000|Overall Study|Withdrawal by Subject|0|||
44257464|NCT01393964|79110165|FG001|Overall Study|Withdrawal by Subject|0|||
44257465|NCT01393964|79110166|FG002|Overall Study|Withdrawal by Subject|1|||
44257466|NCT01393964|79110164|FG000|Overall Study|Adverse event unrelated to study drug|0|||
44257467|NCT01393964|79110165|FG001|Overall Study|Adverse event unrelated to study drug|3|||
44257468|NCT01393964|79110166|FG002|Overall Study|Adverse event unrelated to study drug|0|||
44257469|NCT01393964|79110164|FG000|Overall Study|Subject request stop study treatment|0|||
44257470|NCT01393964|79110165|FG001|Overall Study|Subject request stop study treatment|1|||
44257471|NCT01393964|79110166|FG002|Overall Study|Subject request stop study treatment|0|||
44257472|NCT01393964|79110164|FG000|Overall Study|Subject decided to move to transplant|1|||
44257473|NCT01393964|79110165|FG001|Overall Study|Subject decided to move to transplant|0|||
44257474|NCT01393964|79110166|FG002|Overall Study|Subject decided to move to transplant|0|||
44257475|NCT01393964|79110164|FG000|Overall Study|Subject switched to commercial supply|1|||
44257476|NCT01393964|79110165|FG001|Overall Study|Subject switched to commercial supply|0|||
44419519|NCT00797966|79427363|FG004|Phase B|Physician Decision|0|||
44419520|NCT00797966|79427364|FG005|Phase B|Physician Decision|0|||
44419521|NCT00797966|79427359|FG000|Phase B|Withdrawal by Subject|1|||
44419522|NCT00797966|79427360|FG001|Phase B|Withdrawal by Subject|4|||
44419523|NCT00797966|79427361|FG002|Phase B|Withdrawal by Subject|3|||
44419524|NCT00797966|79427362|FG003|Phase B|Withdrawal by Subject|3|||
44419525|NCT00797966|79427363|FG004|Phase B|Withdrawal by Subject|0|||
44419526|NCT00797966|79427364|FG005|Phase B|Withdrawal by Subject|0|||
44257477|NCT01393964|79110166|FG002|Overall Study|Subject switched to commercial supply|2|||
44257478|NCT01393964|79110164|FG000|Overall Study|Subject plateaued in terms of effect|1|||
44257479|NCT01393964|79110165|FG001|Overall Study|Subject plateaued in terms of effect|0|||
44257480|NCT01393964|79110166|FG002|Overall Study|Subject plateaued in terms of effect|0|||
44419527|NCT00797966|79427359|FG000|Phase B|Protocol Deviation|4|||
44419528|NCT00797966|79427360|FG001|Phase B|Protocol Deviation|8|||
44419529|NCT00797966|79427361|FG002|Phase B|Protocol Deviation|2|||
44419530|NCT00797966|79427362|FG003|Phase B|Protocol Deviation|6|||
44419531|NCT00797966|79427363|FG004|Phase B|Protocol Deviation|0|||
44419532|NCT00797966|79427364|FG005|Phase B|Protocol Deviation|0|||
44419533|NCT00797966|79427359|FG000|Phase B|Lack of Efficacy|0|||
44419534|NCT00797966|79427360|FG001|Phase B|Lack of Efficacy|1|||
44419535|NCT00797966|79427361|FG002|Phase B|Lack of Efficacy|1|||
44419536|NCT00797966|79427362|FG003|Phase B|Lack of Efficacy|4|||
44419537|NCT00797966|79427363|FG004|Phase B|Lack of Efficacy|0|||
44419538|NCT00797966|79427364|FG005|Phase B|Lack of Efficacy|0|||
44419539|NCT00797966|79427359|FG000|Phase A+|Lost to Follow-up|0|||
44419540|NCT00797966|79427360|FG001|Phase A+|Lost to Follow-up|0|||
44419541|NCT00797966|79427361|FG002|Phase A+|Lost to Follow-up|0|||
44419542|NCT00797966|79427362|FG003|Phase A+|Lost to Follow-up|0|||
44419543|NCT00797966|79427363|FG004|Phase A+|Lost to Follow-up|0|||
44419544|NCT00797966|79427364|FG005|Phase A+|Lost to Follow-up|9|||
44419545|NCT00797966|79427359|FG000|Phase A+|Met withdrawal criteria|0|||
44419546|NCT00797966|79427360|FG001|Phase A+|Met withdrawal criteria|0|||
44419547|NCT00797966|79427361|FG002|Phase A+|Met withdrawal criteria|0|||
44419548|NCT00797966|79427362|FG003|Phase A+|Met withdrawal criteria|0|||
44419549|NCT00797966|79427363|FG004|Phase A+|Met withdrawal criteria|0|||
44419550|NCT00797966|79427364|FG005|Phase A+|Met withdrawal criteria|5|||
44419551|NCT00797966|79427359|FG000|Phase A+|Withdrawal by Subject|0|||
44419552|NCT00797966|79427360|FG001|Phase A+|Withdrawal by Subject|0|||
44419553|NCT00797966|79427361|FG002|Phase A+|Withdrawal by Subject|0|||
44419554|NCT00797966|79427362|FG003|Phase A+|Withdrawal by Subject|0|||
44155417|NCT01998958|78946957|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44257481|NCT01393964|79110164|FG000|Overall Study|Investigator removed subject from study|0|||
44257482|NCT01393964|79110165|FG001|Overall Study|Investigator removed subject from study|1|||
44257483|NCT01393964|79110166|FG002|Overall Study|Investigator removed subject from study|0|||
44257484|NCT01393964|79110164|FG000|Overall Study|Subject converted to roll-over study|0|||
44309438|NCT02660580|79310785|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
44309439|NCT02660580|79310786|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
44309440|NCT02600897|79310814|FG000|Overall Study|Death|1|||
44309441|NCT02600897|79310815|FG001|Overall Study|Death|2|||
44309442|NCT02600897|79310816|FG002|Overall Study|Death|1|||
44309443|NCT02600897|79310817|FG003|Overall Study|Death|2|||
44309444|NCT02600897|79310818|FG004|Overall Study|Death|3|||
44309445|NCT02600897|79310819|FG005|Overall Study|Death|2|||
44309446|NCT02600897|79310820|FG006|Overall Study|Death|10|||
44309447|NCT02600897|79310821|FG007|Overall Study|Death|7|||
44309448|NCT02600897|79310822|FG008|Overall Study|Death|20|||
44309449|NCT02600897|79310814|FG000|Overall Study|Lost to Follow-up|1|||
44309450|NCT02600897|79310815|FG001|Overall Study|Lost to Follow-up|0|||
44309451|NCT02600897|79310816|FG002|Overall Study|Lost to Follow-up|0|||
44309452|NCT02600897|79310817|FG003|Overall Study|Lost to Follow-up|0|||
44309453|NCT02600897|79310818|FG004|Overall Study|Lost to Follow-up|0|||
44309454|NCT02600897|79310819|FG005|Overall Study|Lost to Follow-up|0|||
44309455|NCT02600897|79310820|FG006|Overall Study|Lost to Follow-up|0|||
44309456|NCT02600897|79310821|FG007|Overall Study|Lost to Follow-up|1|||
44309457|NCT02600897|79310822|FG008|Overall Study|Lost to Follow-up|0|||
44309458|NCT02600897|79310814|FG000|Overall Study|Withdrawal by Subject|0|||
44309459|NCT02600897|79310815|FG001|Overall Study|Withdrawal by Subject|0|||
44309460|NCT02600897|79310816|FG002|Overall Study|Withdrawal by Subject|0|||
44309461|NCT02600897|79310817|FG003|Overall Study|Withdrawal by Subject|0|||
44309462|NCT02600897|79310818|FG004|Overall Study|Withdrawal by Subject|0|||
44309463|NCT02600897|79310819|FG005|Overall Study|Withdrawal by Subject|0|||
44309464|NCT02600897|79310820|FG006|Overall Study|Withdrawal by Subject|0|||
44309465|NCT02600897|79310821|FG007|Overall Study|Withdrawal by Subject|4|||
44309466|NCT02600897|79310822|FG008|Overall Study|Withdrawal by Subject|2|||
44309467|NCT02600897|79310814|FG000|Overall Study|Reason Not Specified|0|||
44309468|NCT02600897|79310815|FG001|Overall Study|Reason Not Specified|0|||
44309469|NCT02600897|79310816|FG002|Overall Study|Reason Not Specified|0|||
44309470|NCT02600897|79310817|FG003|Overall Study|Reason Not Specified|0|||
44309471|NCT02600897|79310818|FG004|Overall Study|Reason Not Specified|0|||
44309472|NCT02600897|79310819|FG005|Overall Study|Reason Not Specified|0|||
44309473|NCT02600897|79310820|FG006|Overall Study|Reason Not Specified|0|||
44309474|NCT02600897|79310821|FG007|Overall Study|Reason Not Specified|0|||
44309475|NCT02600897|79310822|FG008|Overall Study|Reason Not Specified|1|||
44309476|NCT02399215|79310851|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
44309477|NCT02399215|79310851|FG000|Overall Study|Withdrawal by Subject|1|||
44309478|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309479|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309480|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309481|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
44309482|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309483|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309484|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309485|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309486|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309487|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
44309488|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
44309489|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
44309490|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
44309491|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
44309492|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
44309493|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
44309494|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
44309495|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
44309496|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
44309497|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
44309498|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
44309499|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
44309500|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
44309501|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
44309502|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
44309503|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
44309504|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
44309505|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
44309506|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
44155418|NCT01998958|78946958|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44309507|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
44309508|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
44309509|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
44309510|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
44309511|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
44309512|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
44309513|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
44309514|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
44309515|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
44309516|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
44309517|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
44309518|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
44309519|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309520|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
44309521|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309522|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
44309523|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309524|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309525|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309526|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309527|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
44309528|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
44309529|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309530|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309531|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309532|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
44309533|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
44309534|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309535|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309536|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309537|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
44309538|NCT02365649|79310861|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309539|NCT02365649|79310862|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309540|NCT02365649|79310863|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
44309541|NCT02365649|79310864|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309542|NCT02365649|79310865|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309543|NCT02365649|79310866|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44354722|NCT00942604|79359125|FG001|Overall Study|Protocol Violation|1|||
44257485|NCT01393964|79110165|FG001|Overall Study|Subject converted to roll-over study|1|||
44257486|NCT01393964|79110166|FG002|Overall Study|Subject converted to roll-over study|0|||
44257487|NCT01393964|79110164|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
44257488|NCT01393964|79110165|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
44257489|NCT01393964|79110166|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
44257490|NCT01393730|79110254|FG000|Overall Study|Withdrawal by Subject|3|||
44257491|NCT01393730|79110254|FG000|Overall Study|Other|2|||
44257492|NCT01393730|79110254|FG000|Overall Study|Adverse Event|1|||
44257493|NCT01393106|79110273|FG000|Overall Study|Adverse Event|3|||
44257494|NCT01393106|79110273|FG000|Overall Study|Withdrawal by Subject|1|||
44257495|NCT01393106|79110273|FG000|Overall Study|Lack of Efficacy|1|||
44257496|NCT00553059|79110279|FG000|Overall Study|Deemed ineligible|1|||
44257497|NCT00553059|79110280|FG001|Overall Study|Deemed ineligible|1|||
44257498|NCT00553059|79110279|FG000|Overall Study|Drug supply not available|0|||
44257499|NCT00553059|79110280|FG001|Overall Study|Drug supply not available|1|||
44257500|NCT01413542|79110302|FG000|Overall Study|Physician Decision|1|||
44257501|NCT01413542|79110303|FG001|Overall Study|Physician Decision|0|||
44257502|NCT01413542|79110304|FG002|Overall Study|Physician Decision|3|||
44257503|NCT01413542|79110305|FG003|Overall Study|Physician Decision|0|||
44257504|NCT01413542|79110302|FG000|Overall Study|Adverse Event|0|||
44257505|NCT01413542|79110303|FG001|Overall Study|Adverse Event|0|||
44257506|NCT01413542|79110304|FG002|Overall Study|Adverse Event|0|||
44257507|NCT01413542|79110305|FG003|Overall Study|Adverse Event|1|||
44257508|NCT01432730|79110337|FG000|Period 1|Adverse Event|2|||
44257509|NCT01432730|79110338|FG001|Period 1|Adverse Event|0|||
44257510|NCT01432730|79110337|FG000|Period 2|Adverse Event|0|||
44257511|NCT01432730|79110338|FG001|Period 2|Adverse Event|4|||
44257512|NCT01432574|79110353|FG000|Overall Study|Moved|2|||
44257513|NCT01432574|79110353|FG000|Overall Study|Not interested|1|||
44257514|NCT01392560|79110386|FG000|Overall Study|Adverse Event|2|||
44257515|NCT01392560|79110386|FG000|Overall Study|not entered|8|||
44257516|NCT01392560|79110386|FG000|Overall Study|discontinued during placebo run-in|2|||
44257517|NCT00552279|79110447|FG000|Overall Study|Adverse Event|0|||
44257518|NCT00552279|79110448|FG001|Overall Study|Adverse Event|1|||
44309544|NCT02365649|79310867|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309545|NCT02365649|79310868|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309546|NCT02365649|79310869|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309547|NCT02365649|79310870|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
44309548|NCT02365649|79310861|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309549|NCT02365649|79310862|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309550|NCT02365649|79310863|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309551|NCT02365649|79310864|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44535276|NCT03480750|79546262|FG005|Overall Study|The interruption in Trientine shippment|1|||
44535277|NCT03412734|79546287|FG000|Overall Study|Incorrect labeling of samples|2|||
44309552|NCT02365649|79310865|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309553|NCT02365649|79310866|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309554|NCT02365649|79310867|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
44309555|NCT02365649|79310868|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309556|NCT02365649|79310869|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309557|NCT02365649|79310870|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
44309558|NCT02365649|79310861|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309559|NCT02365649|79310862|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309560|NCT02365649|79310863|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309561|NCT02365649|79310864|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309562|NCT02365649|79310865|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309563|NCT02365649|79310866|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309564|NCT02365649|79310867|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
44309565|NCT02365649|79310868|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
44309566|NCT02365649|79310869|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
44309567|NCT02365649|79310870|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
44309568|NCT02365649|79310861|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
44309569|NCT02365649|79310862|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
44309570|NCT02365649|79310863|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
44309571|NCT02365649|79310864|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
44309572|NCT02365649|79310865|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
44309573|NCT02365649|79310866|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
44309574|NCT02365649|79310867|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
44309575|NCT02365649|79310868|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
44309576|NCT02365649|79310869|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
44309577|NCT02365649|79310870|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
44309578|NCT02365649|79310861|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309579|NCT02365649|79310862|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309580|NCT02365649|79310863|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309581|NCT02365649|79310864|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309582|NCT02365649|79310865|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309583|NCT02365649|79310866|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309584|NCT02365649|79310867|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
44309585|NCT02365649|79310868|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
44309586|NCT02365649|79310869|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
44309587|NCT02365649|79310870|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
44309588|NCT02365649|79310861|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309589|NCT02365649|79310862|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309590|NCT02365649|79310863|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309591|NCT02365649|79310864|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309592|NCT02365649|79310865|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309593|NCT02365649|79310866|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309594|NCT02365649|79310867|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
44309595|NCT02365649|79310868|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309596|NCT02365649|79310869|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
44309597|NCT02365649|79310870|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
44309598|NCT02110225|79310912|FG000|Overall Study|Lost to Follow-up|0|||
44309599|NCT02110225|79310913|FG001|Overall Study|Lost to Follow-up|1|||
44309600|NCT02110225|79310914|FG002|Overall Study|Lost to Follow-up|0|||
44309601|NCT02016820|79310925|FG000|Overall Study|Lost to Follow-up|2|||
44309602|NCT02016820|79310926|FG001|Overall Study|Lost to Follow-up|4|||
44309603|NCT01902173|79310938|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
44535278|NCT03412734|79546288|FG001|Overall Study|Incorrect labeling of samples|0|||
44309604|NCT01902173|79310939|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
44309605|NCT01902173|79310940|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
44535279|NCT03412734|79546287|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
44535280|NCT03412734|79546288|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
44309606|NCT01902173|79310941|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
44309607|NCT01902173|79310942|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
44309608|NCT01902173|79310943|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
44309609|NCT01902173|79310938|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
44309610|NCT01902173|79310939|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
44309611|NCT01902173|79310940|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
44309612|NCT01902173|79310941|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
44309613|NCT01902173|79310942|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
44309614|NCT01902173|79310943|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
44309615|NCT01902173|79310938|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
44309616|NCT01902173|79310939|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
44309617|NCT01902173|79310940|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
44309618|NCT01902173|79310941|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
44309619|NCT01902173|79310942|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
44309620|NCT01902173|79310943|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
44309621|NCT01902173|79310938|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
44309622|NCT01902173|79310939|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
44309623|NCT01902173|79310940|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
44309624|NCT01902173|79310941|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
44309625|NCT01902173|79310942|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
44309626|NCT01902173|79310943|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
44309627|NCT01902173|79310938|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
44309628|NCT01902173|79310939|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
44309629|NCT01902173|79310940|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
44309630|NCT01902173|79310941|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
44309631|NCT01902173|79310942|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
44309632|NCT01902173|79310943|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
44309633|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
44309634|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
44309635|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
44309636|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
44309637|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
44309638|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
44309639|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
44419555|NCT00797966|79427363|FG004|Phase A+|Withdrawal by Subject|0|||
44419556|NCT00797966|79427364|FG005|Phase A+|Withdrawal by Subject|6|||
44419557|NCT00797966|79427359|FG000|Phase A+|Adverse Event|0|||
44419558|NCT00797966|79427360|FG001|Phase A+|Adverse Event|0|||
44419559|NCT00797966|79427361|FG002|Phase A+|Adverse Event|0|||
44419560|NCT00797966|79427362|FG003|Phase A+|Adverse Event|0|||
44419561|NCT00797966|79427363|FG004|Phase A+|Adverse Event|0|||
44419562|NCT00797966|79427364|FG005|Phase A+|Adverse Event|4|||
44419563|NCT00797966|79427359|FG000|Phase A+|Protocol deviation|0|||
44419564|NCT00797966|79427360|FG001|Phase A+|Protocol deviation|0|||
44535281|NCT02374814|79546300|FG000|Overall Study|Lost to Follow-up|1|||
44535282|NCT02374814|79546301|FG001|Overall Study|Lost to Follow-up|1|||
44535283|NCT02374814|79546302|FG002|Overall Study|Lost to Follow-up|0|||
44535284|NCT02374814|79546303|FG003|Overall Study|Lost to Follow-up|1|||
44535285|NCT02374814|79546304|FG004|Overall Study|Lost to Follow-up|0|||
44535286|NCT02374814|79546305|FG005|Overall Study|Lost to Follow-up|0|||
44535287|NCT02374814|79546300|FG000|Overall Study|Withdrawal by Subject|0|||
44155419|NCT01998958|78946959|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44257519|NCT00552279|79110447|FG000|Overall Study|Withdrawal by Subject|12|||
44257520|NCT00552279|79110448|FG001|Overall Study|Withdrawal by Subject|1|||
44257521|NCT00552279|79110447|FG000|Overall Study|Lost to Follow-up|1|||
44257522|NCT00552279|79110448|FG001|Overall Study|Lost to Follow-up|0|||
44257523|NCT00552279|79110447|FG000|Overall Study|Other|1|||
44257524|NCT00552279|79110448|FG001|Overall Study|Other|1|||
44257525|NCT00559377|79110489|FG000|Overall Study|Withdrawal by Subject|9|||
44257526|NCT01412060|79110496|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
44257527|NCT01412060|79110497|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
44257528|NCT01412060|79110498|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
44309640|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
44309641|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
44309642|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
44419565|NCT00797966|79427361|FG002|Phase A+|Protocol deviation|0|||
44419566|NCT00797966|79427362|FG003|Phase A+|Protocol deviation|0|||
44419567|NCT00797966|79427363|FG004|Phase A+|Protocol deviation|0|||
44535288|NCT02374814|79546301|FG001|Overall Study|Withdrawal by Subject|0|||
44257529|NCT01412060|79110496|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
44309643|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
44309644|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
44309645|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
44309646|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
44309647|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
44309648|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
44309649|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
44309650|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
44309651|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
44309652|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
44309653|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
44309654|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
44309655|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
44309656|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
44309657|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
44309658|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
44309659|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
44309660|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
44309661|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
44309662|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
44309663|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
44309664|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
44309665|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
44309666|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
44309667|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
44309668|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
44309669|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
44309670|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
44309671|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
44309672|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
44309673|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
44309674|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
44309675|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
44309676|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
44309677|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
44309678|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
44309679|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
44309680|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
44309681|NCT01902173|79310938|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
44309682|NCT01902173|79310939|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
44309683|NCT01902173|79310940|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
44309684|NCT01902173|79310941|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
44309685|NCT01902173|79310942|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
44309686|NCT01902173|79310943|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
44309687|NCT01756456|79310981|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
44309688|NCT01756456|79310982|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
44309689|NCT01756456|79310983|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
44309690|NCT01756456|79310984|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
44309691|NCT01756456|79310985|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
44309692|NCT01756456|79310986|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
44309693|NCT01756456|79310981|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
44309694|NCT01756456|79310982|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
44309695|NCT01756456|79310983|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
44309696|NCT01756456|79310984|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
44309697|NCT01756456|79310985|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
44309698|NCT01756456|79310986|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
44309699|NCT01756456|79310981|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
44309700|NCT01756456|79310982|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
44309701|NCT01756456|79310983|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
44309702|NCT01756456|79310984|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
44309703|NCT01756456|79310985|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
44309704|NCT01756456|79310986|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
44309705|NCT01756456|79310981|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
44309706|NCT01756456|79310982|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
44309707|NCT01756456|79310983|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
44309708|NCT01756456|79310984|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
44309709|NCT01756456|79310985|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
44309710|NCT01756456|79310986|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
44354723|NCT00942604|79359124|FG000|Overall Study|Adverse Event|0|||
44419568|NCT00797966|79427364|FG005|Phase A+|Protocol deviation|4|||
44419569|NCT00723489|79427380|FG000|Overall Study|Physician Decision|0|||
44419570|NCT00723489|79427381|FG001|Overall Study|Physician Decision|1|||
44419571|NCT00723489|79427382|FG002|Overall Study|Physician Decision|0|||
44419572|NCT00723489|79427383|FG003|Overall Study|Physician Decision|0|||
44419573|NCT00723489|79427380|FG000|Overall Study|Pregnancy|0|||
44419574|NCT00723489|79427381|FG001|Overall Study|Pregnancy|0|||
44419575|NCT00723489|79427382|FG002|Overall Study|Pregnancy|0|||
44419576|NCT00723489|79427383|FG003|Overall Study|Pregnancy|1|||
44419577|NCT00723489|79427380|FG000|Overall Study|Withdrawal by Subject|0|||
44419578|NCT00723489|79427381|FG001|Overall Study|Withdrawal by Subject|0|||
44419579|NCT00723489|79427382|FG002|Overall Study|Withdrawal by Subject|0|||
44419580|NCT00723489|79427383|FG003|Overall Study|Withdrawal by Subject|1|||
44419581|NCT00723489|79427380|FG000|Overall Study|Seropositive at baseline|1|||
44419582|NCT00723489|79427381|FG001|Overall Study|Seropositive at baseline|0|||
44419583|NCT00723489|79427382|FG002|Overall Study|Seropositive at baseline|0|||
44419584|NCT00723489|79427383|FG003|Overall Study|Seropositive at baseline|0|||
44419585|NCT00723489|79427380|FG000|Overall Study|Prohibited Medication|0|||
44419586|NCT00723489|79427381|FG001|Overall Study|Prohibited Medication|0|||
44419587|NCT00723489|79427382|FG002|Overall Study|Prohibited Medication|0|||
44419588|NCT00723489|79427383|FG003|Overall Study|Prohibited Medication|1|||
44419589|NCT00723489|79427380|FG000|Overall Study|Samples Collected Out of Window|0|||
44419590|NCT00723489|79427381|FG001|Overall Study|Samples Collected Out of Window|3|||
44419591|NCT00723489|79427382|FG002|Overall Study|Samples Collected Out of Window|0|||
44257530|NCT01412060|79110497|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
44257531|NCT01412060|79110498|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
44257532|NCT01412060|79110496|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
44257533|NCT01412060|79110497|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
44257534|NCT01412060|79110498|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
44257535|NCT01412060|79110496|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
44257536|NCT01412060|79110497|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
44257537|NCT01412060|79110498|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
44419592|NCT00723489|79427383|FG003|Overall Study|Samples Collected Out of Window|0|||
44419593|NCT00587990|79427409|FG000|Overall Study|Death|0|||
44419594|NCT00587990|79427410|FG001|Overall Study|Death|0|||
44419595|NCT00587990|79427411|FG002|Overall Study|Death|1|||
44419596|NCT00723255|79427419|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
44419597|NCT00723255|79427419|FG000|Overall Study|Ineligible: Second primary|1|||
44419598|NCT00723255|79427419|FG000|Overall Study|Ineligible: Wrong Primary|2|||
44419599|NCT00791258|79427435|FG000|Overall Study|Adverse Event|87|||
44419600|NCT00791258|79427435|FG000|Overall Study|Lost to Follow-up|18|||
44419601|NCT00791258|79427435|FG000|Overall Study|Protocol Violation|109|||
44419602|NCT00791258|79427435|FG000|Overall Study|Withdrawal by Subject|40|||
44419603|NCT00791258|79427435|FG000|Overall Study|Did not take medication for >3 days|1|||
44419604|NCT00791258|79427435|FG000|Overall Study|subject left area|2|||
44155420|NCT01998958|78946960|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155421|NCT01998958|78946961|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
44155422|NCT01998958|78946962|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155423|NCT01998958|78946963|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155424|NCT01998958|78946964|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155425|NCT01998958|78946965|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
44155426|NCT01998958|78946966|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155427|NCT01998958|78946967|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155428|NCT01998958|78946968|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155429|NCT01998958|78946969|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155430|NCT01998958|78946970|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155431|NCT01998958|78946971|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155432|NCT01998958|78946972|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155433|NCT01998958|78946973|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155434|NCT01998958|78946974|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155435|NCT01998958|78946975|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155436|NCT01998958|78946976|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44155437|NCT01998958|78946977|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44257538|NCT01412060|79110496|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
44257539|NCT01412060|79110497|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
44354724|NCT00942604|79359125|FG001|Overall Study|Adverse Event|1|||
44354725|NCT00942604|79359124|FG000|Overall Study|Withdrawal by Subject|0|||
44354726|NCT00942604|79359125|FG001|Overall Study|Withdrawal by Subject|1|||
44354727|NCT00942604|79359124|FG000|Overall Study|Patient relocation|1|||
44354728|NCT00942604|79359125|FG001|Overall Study|Patient relocation|1|||
44354729|NCT01188564|79359133|FG000|Double-blind Phase|randomized not treated|1|||
44354730|NCT01188564|79359134|FG001|Double-blind Phase|randomized not treated|0|||
44354731|NCT01187550|79359142|FG000|Overall Study|Protocol Violation|3|||
44309711|NCT01756456|79310981|FG000|Treatment Period: Phase I/II|Other causes|0|||
44309712|NCT01756456|79310982|FG001|Treatment Period: Phase I/II|Other causes|0|||
44309713|NCT01756456|79310983|FG002|Treatment Period: Phase I/II|Other causes|0|||
44309714|NCT01756456|79310984|FG003|Treatment Period: Phase I/II|Other causes|1|||
44309715|NCT01756456|79310985|FG004|Treatment Period: Phase I/II|Other causes|2|||
44309716|NCT01756456|79310986|FG005|Treatment Period: Phase I/II|Other causes|2|||
44309717|NCT01756456|79310981|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
44309718|NCT01756456|79310982|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
44309719|NCT01756456|79310983|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
44309720|NCT01756456|79310984|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
44309721|NCT01756456|79310985|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
44309722|NCT01756456|79310986|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
44309723|NCT01756456|79310981|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
44309724|NCT01756456|79310982|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
44309725|NCT01756456|79310983|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
44309726|NCT01756456|79310984|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
44309727|NCT01756456|79310985|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
44309728|NCT01756456|79310986|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
44309729|NCT01756456|79310981|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
44309730|NCT01756456|79310982|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
44309731|NCT01756456|79310983|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
44309732|NCT01756456|79310984|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
44309733|NCT01756456|79310985|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
44309734|NCT01756456|79310986|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
44309735|NCT01756456|79310981|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
44309736|NCT01756456|79310982|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
44309737|NCT01756456|79310983|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
44309738|NCT01756456|79310984|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
44309739|NCT01756456|79310985|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
44309740|NCT01756456|79310986|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
44309741|NCT01756456|79310981|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
44309742|NCT01756456|79310982|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
44309743|NCT01756456|79310983|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
44309744|NCT01756456|79310984|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
44309745|NCT01756456|79310985|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
44309746|NCT01756456|79310986|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
44309747|NCT01756456|79310981|FG000|Follow Up Period Phase I/II|Other causes|0|||
44309748|NCT01756456|79310982|FG001|Follow Up Period Phase I/II|Other causes|0|||
44309749|NCT01756456|79310983|FG002|Follow Up Period Phase I/II|Other causes|0|||
44309750|NCT01756456|79310984|FG003|Follow Up Period Phase I/II|Other causes|1|||
44309751|NCT01756456|79310985|FG004|Follow Up Period Phase I/II|Other causes|3|||
44309752|NCT01756456|79310986|FG005|Follow Up Period Phase I/II|Other causes|5|||
44309753|NCT01477333|79311062|FG000|Overall Study|Adverse Event|1|||
44309754|NCT01477333|79311062|FG000|Overall Study|Withdrawal by Subject|1|||
44309755|NCT01477333|79311062|FG000|Overall Study|Clinical Deterioration|1|||
44309756|NCT01262625|79311084|FG000|Overall Study|Administrative Error|1|||
44309757|NCT01262625|79311085|FG001|Overall Study|Administrative Error|1|||
44309758|NCT01262625|79311084|FG000|Overall Study|Site Closed|1|||
44309759|NCT01262625|79311085|FG001|Overall Study|Site Closed|0|||
44309775|NCT04831736|79311189|FG000|Overall Study|Withdrawal by Subject|0|||
44309776|NCT04831736|79311190|FG001|Overall Study|Withdrawal by Subject|1|||
44309777|NCT04583956|79311205|FG000|Overall Study|Death|9|||
44309778|NCT04583956|79311206|FG001|Overall Study|Death|11|||
44309779|NCT04583956|79311205|FG000|Overall Study|Lost to Follow-up|7|||
44309780|NCT04583956|79311206|FG001|Overall Study|Lost to Follow-up|9|||
44309781|NCT04583956|79311205|FG000|Overall Study|Protocol Violation|2|||
44309782|NCT04583956|79311206|FG001|Overall Study|Protocol Violation|0|||
44309783|NCT04583956|79311205|FG000|Overall Study|Withdrawal by Subject|0|||
44309784|NCT04583956|79311206|FG001|Overall Study|Withdrawal by Subject|2|||
44309785|NCT04583956|79311205|FG000|Overall Study|Randomized but not dosed|2|||
44309786|NCT04583956|79311206|FG001|Overall Study|Randomized but not dosed|3|||
44309787|NCT04583956|79311205|FG000|Overall Study|Withdrawal of consent before product administration|1|||
44309788|NCT04583956|79311206|FG001|Overall Study|Withdrawal of consent before product administration|0|||
44309789|NCT04463680|79311222|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
44309790|NCT04463680|79311222|FG000|Overall Study|Not eligible due to implant duration of use|1|||
44309791|NCT04463680|79311222|FG000|Overall Study|Withdrawal by Subject|3|||
44309792|NCT04449029|79311234|FG000|Overall Study|Adverse Event|0|||
44309793|NCT04449029|79311235|FG001|Overall Study|Adverse Event|1|||
44309794|NCT04449029|79311236|FG002|Overall Study|Adverse Event|1|||
44309795|NCT04449029|79311237|FG003|Overall Study|Adverse Event|0|||
44309796|NCT04449029|79311238|FG004|Overall Study|Adverse Event|1|||
44309797|NCT04449029|79311239|FG005|Overall Study|Adverse Event|0|||
44309798|NCT04449029|79311240|FG006|Overall Study|Adverse Event|1|||
44309799|NCT04449029|79311241|FG007|Overall Study|Adverse Event|0|||
44309800|NCT04449029|79311234|FG000|Overall Study|Lost to Follow-up|0|||
44309801|NCT04449029|79311235|FG001|Overall Study|Lost to Follow-up|1|||
44309802|NCT04449029|79311236|FG002|Overall Study|Lost to Follow-up|0|||
44309803|NCT04449029|79311237|FG003|Overall Study|Lost to Follow-up|0|||
44309804|NCT04449029|79311238|FG004|Overall Study|Lost to Follow-up|0|||
44309805|NCT04449029|79311239|FG005|Overall Study|Lost to Follow-up|0|||
44309806|NCT04449029|79311240|FG006|Overall Study|Lost to Follow-up|0|||
44309807|NCT04449029|79311241|FG007|Overall Study|Lost to Follow-up|0|||
44309808|NCT04449029|79311234|FG000|Overall Study|Protocol Violation|0|||
44309809|NCT04449029|79311235|FG001|Overall Study|Protocol Violation|1|||
44309810|NCT04449029|79311236|FG002|Overall Study|Protocol Violation|0|||
44309811|NCT04449029|79311237|FG003|Overall Study|Protocol Violation|0|||
44309812|NCT04449029|79311238|FG004|Overall Study|Protocol Violation|0|||
44309813|NCT04449029|79311239|FG005|Overall Study|Protocol Violation|0|||
44309814|NCT04449029|79311240|FG006|Overall Study|Protocol Violation|0|||
44309815|NCT04449029|79311241|FG007|Overall Study|Protocol Violation|0|||
44309816|NCT04449029|79311234|FG000|Overall Study|Physician Decision|0|||
44309817|NCT04449029|79311235|FG001|Overall Study|Physician Decision|0|||
44309818|NCT04449029|79311236|FG002|Overall Study|Physician Decision|0|||
44309819|NCT04449029|79311237|FG003|Overall Study|Physician Decision|0|||
44309820|NCT04449029|79311238|FG004|Overall Study|Physician Decision|0|||
44309821|NCT04449029|79311239|FG005|Overall Study|Physician Decision|1|||
44309822|NCT04449029|79311240|FG006|Overall Study|Physician Decision|0|||
44309823|NCT04449029|79311241|FG007|Overall Study|Physician Decision|0|||
44309824|NCT04449029|79311234|FG000|Overall Study|Withdrawal by Subject|3|||
44309825|NCT04449029|79311235|FG001|Overall Study|Withdrawal by Subject|0|||
44309826|NCT04449029|79311236|FG002|Overall Study|Withdrawal by Subject|1|||
44309827|NCT04449029|79311237|FG003|Overall Study|Withdrawal by Subject|1|||
44309828|NCT04449029|79311238|FG004|Overall Study|Withdrawal by Subject|5|||
44309829|NCT04449029|79311239|FG005|Overall Study|Withdrawal by Subject|1|||
44309830|NCT04449029|79311240|FG006|Overall Study|Withdrawal by Subject|4|||
44309831|NCT04449029|79311241|FG007|Overall Study|Withdrawal by Subject|0|||
44309832|NCT04193202|79311271|FG000|Overall Study|Adverse Event|2|||
44309833|NCT04193202|79311272|FG001|Overall Study|Adverse Event|1|||
44309834|NCT04193202|79311271|FG000|Overall Study|Death|0|||
44309835|NCT04193202|79311272|FG001|Overall Study|Death|1|||
44309836|NCT04193202|79311271|FG000|Overall Study|Physician Decision|1|||
44309837|NCT04193202|79311272|FG001|Overall Study|Physician Decision|1|||
44419605|NCT00791258|79427435|FG000|Overall Study|non-compliance|3|||
44419606|NCT00791258|79427435|FG000|Overall Study|Subject incarcerated|1|||
44419607|NCT00791258|79427435|FG000|Overall Study|Subject required restricted medication|1|||
44419608|NCT00791258|79427435|FG000|Overall Study|Lack of Efficacy|1|||
44419609|NCT00808067|79427441|FG000|Overall Study|Major/minor bleed|30|||
44535289|NCT02374814|79546302|FG002|Overall Study|Withdrawal by Subject|1|||
44535290|NCT02374814|79546303|FG003|Overall Study|Withdrawal by Subject|1|||
44309838|NCT04193202|79311271|FG000|Overall Study|Protocol Violation|2|||
44309839|NCT04193202|79311272|FG001|Overall Study|Protocol Violation|2|||
44309840|NCT04193202|79311271|FG000|Overall Study|Withdrawal by Subject|11|||
44535291|NCT02374814|79546304|FG004|Overall Study|Withdrawal by Subject|0|||
44535292|NCT02374814|79546305|FG005|Overall Study|Withdrawal by Subject|0|||
44309841|NCT04193202|79311272|FG001|Overall Study|Withdrawal by Subject|5|||
44309842|NCT04159935|79311280|FG000|Overall Study|Study terminated due to COVID-19|1|||
44309843|NCT04159935|79311281|FG001|Overall Study|Study terminated due to COVID-19|3|||
44309844|NCT03871543|79311305|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
44309845|NCT03871543|79311305|FG000|Period 1|Investigator Error|1|||
44309846|NCT03871543|79311305|FG000|Period 1|Protocol Violation|2|||
44155438|NCT01998958|78946978|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
44309847|NCT03871543|79311305|FG000|Period 1|COVID-19 Related|1|||
44309848|NCT03871543|79311305|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
44309849|NCT03871543|79311305|FG000|Period 1|Withdrawal by Subject|10|||
44309850|NCT03871543|79311305|FG000|Period 2|Adverse Event|1|||
44419610|NCT00808067|79427442|FG001|Overall Study|Major/minor bleed|44|||
44309851|NCT03871543|79311305|FG000|Period 2|Withdrawal by Subject|1|||
44309852|NCT03843125|79311317|FG000|Overall Study|Adverse Event|17|||
44309853|NCT03843125|79311318|FG001|Overall Study|Adverse Event|13|||
44309854|NCT03843125|79311319|FG002|Overall Study|Adverse Event|5|||
44309855|NCT03843125|79311320|FG003|Overall Study|Adverse Event|9|||
44309856|NCT03843125|79311317|FG000|Overall Study|Death|0|||
44309857|NCT03843125|79311318|FG001|Overall Study|Death|6|||
44309858|NCT03843125|79311319|FG002|Overall Study|Death|2|||
44309859|NCT03843125|79311320|FG003|Overall Study|Death|0|||
44309860|NCT03843125|79311317|FG000|Overall Study|Lack of Efficacy|14|||
44309861|NCT03843125|79311318|FG001|Overall Study|Lack of Efficacy|11|||
44309862|NCT03843125|79311319|FG002|Overall Study|Lack of Efficacy|9|||
44309863|NCT03843125|79311320|FG003|Overall Study|Lack of Efficacy|4|||
44419611|NCT00808067|79427441|FG000|Overall Study|Outcome event - other|33|||
44419612|NCT00808067|79427442|FG001|Overall Study|Outcome event - other|25|||
44419613|NCT00808067|79427441|FG000|Overall Study|Adverse Event|111|||
44419614|NCT00808067|79427442|FG001|Overall Study|Adverse Event|121|||
44419615|NCT00808067|79427441|FG000|Overall Study|Hospitalization (not including surgery)|18|||
44309864|NCT03843125|79311317|FG000|Overall Study|Lost to Follow-up|3|||
44309865|NCT03843125|79311318|FG001|Overall Study|Lost to Follow-up|4|||
44309866|NCT03843125|79311319|FG002|Overall Study|Lost to Follow-up|0|||
44309867|NCT03843125|79311320|FG003|Overall Study|Lost to Follow-up|2|||
44309868|NCT03843125|79311317|FG000|Overall Study|Other|12|||
44309869|NCT03843125|79311318|FG001|Overall Study|Other|14|||
44309870|NCT03843125|79311319|FG002|Overall Study|Other|3|||
44309871|NCT03843125|79311320|FG003|Overall Study|Other|4|||
44309872|NCT03843125|79311317|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
44309873|NCT03843125|79311318|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
44309874|NCT03843125|79311319|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
44309875|NCT03843125|79311320|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
44309876|NCT03843125|79311317|FG000|Overall Study|Study Terminated by Sponsor|318|||
44309877|NCT03843125|79311318|FG001|Overall Study|Study Terminated by Sponsor|318|||
44309878|NCT03843125|79311319|FG002|Overall Study|Study Terminated by Sponsor|163|||
44309879|NCT03843125|79311320|FG003|Overall Study|Study Terminated by Sponsor|163|||
44309880|NCT03843125|79311317|FG000|Overall Study|Withdrawal by Subject|23|||
44309881|NCT03843125|79311318|FG001|Overall Study|Withdrawal by Subject|12|||
44309882|NCT03843125|79311319|FG002|Overall Study|Withdrawal by Subject|6|||
44309883|NCT03843125|79311320|FG003|Overall Study|Withdrawal by Subject|9|||
44309884|NCT03843125|79311317|FG000|Overall Study|Missing data|0|||
44309885|NCT03843125|79311318|FG001|Overall Study|Missing data|1|||
44309886|NCT03843125|79311319|FG002|Overall Study|Missing data|1|||
44309887|NCT03843125|79311320|FG003|Overall Study|Missing data|0|||
44309888|NCT03603509|79311333|FG000|Overall Study|Lost to Follow-up|3|||
44309889|NCT03603509|79311334|FG001|Overall Study|Lost to Follow-up|4|||
44309890|NCT03567993|79311342|FG000|Overall Study|Lost to Follow-up|4|||
44419616|NCT00808067|79427442|FG001|Overall Study|Hospitalization (not including surgery)|17|||
44419617|NCT00808067|79427441|FG000|Overall Study|Hospitalization due to surgery|37|||
44419618|NCT00808067|79427442|FG001|Overall Study|Hospitalization due to surgery|40|||
44419619|NCT00808067|79427441|FG000|Overall Study|Reduced creatinine clearance|53|||
44419620|NCT00808067|79427442|FG001|Overall Study|Reduced creatinine clearance|55|||
44535293|NCT04608344|79546329|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
44535294|NCT04608344|79546330|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
44535295|NCT04608344|79546329|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
44309891|NCT03567993|79311343|FG001|Overall Study|Lost to Follow-up|2|||
44309892|NCT03567993|79311342|FG000|Overall Study|Death|1|||
44309893|NCT03567993|79311343|FG001|Overall Study|Death|1|||
44309894|NCT03567993|79311342|FG000|Overall Study|Withdrawal by Subject|1|||
44309895|NCT03567993|79311343|FG001|Overall Study|Withdrawal by Subject|0|||
44309896|NCT03386487|79311360|FG000|Overall Study|Lost to Follow-up|5|||
44535296|NCT04608344|79546330|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
44535297|NCT03433482|79546348|FG000|Overall Study|Lost to Follow-up|1|||
44535298|NCT03433482|79546349|FG001|Overall Study|Lost to Follow-up|0|||
44309897|NCT03386487|79311361|FG001|Overall Study|Lost to Follow-up|6|||
44309898|NCT03386487|79311360|FG000|Overall Study|Withdrawal by Subject|11|||
44309899|NCT03386487|79311361|FG001|Overall Study|Withdrawal by Subject|7|||
44309900|NCT03386487|79311360|FG000|Overall Study|Physician Decision|11|||
44309901|NCT03386487|79311361|FG001|Overall Study|Physician Decision|8|||
44309902|NCT03066258|79311376|FG000|Overall Study|Death|1|||
44309903|NCT03066258|79311377|FG001|Overall Study|Death|0|||
44309904|NCT03066258|79311378|FG002|Overall Study|Death|0|||
44309905|NCT03066258|79311379|FG003|Overall Study|Death|0|||
44309906|NCT03066258|79311380|FG004|Overall Study|Death|1|||
44155439|NCT01998958|78946947|FG000|Open Label Phase (Optional)|Adverse Event|0|||
44309907|NCT03024255|79311396|FG000|Overall Study|Adverse Event|1|||
44309908|NCT03024255|79311397|FG001|Overall Study|Adverse Event|4|||
44309909|NCT03024255|79311398|FG002|Overall Study|Adverse Event|8|||
44309910|NCT03024255|79311399|FG003|Overall Study|Adverse Event|0|||
44309911|NCT03024255|79311396|FG000|Overall Study|Withdrawal by Subject|3|||
44419621|NCT00808067|79427441|FG000|Overall Study|Elevated LFT results|7|||
44155440|NCT01998958|78946948|FG001|Open Label Phase (Optional)|Adverse Event|0|||
44155441|NCT01998958|78946949|FG002|Open Label Phase (Optional)|Adverse Event|0|||
44155442|NCT01998958|78946950|FG003|Open Label Phase (Optional)|Adverse Event|0|||
44155443|NCT01998958|78946951|FG004|Open Label Phase (Optional)|Adverse Event|0|||
44155444|NCT01998958|78946952|FG005|Open Label Phase (Optional)|Adverse Event|0|||
44155445|NCT01998958|78946953|FG006|Open Label Phase (Optional)|Adverse Event|0|||
44155446|NCT01998958|78946954|FG007|Open Label Phase (Optional)|Adverse Event|0|||
44155447|NCT01998958|78946955|FG008|Open Label Phase (Optional)|Adverse Event|0|||
44155448|NCT01998958|78946956|FG009|Open Label Phase (Optional)|Adverse Event|0|||
44155449|NCT01998958|78946957|FG010|Open Label Phase (Optional)|Adverse Event|0|||
44155450|NCT01998958|78946958|FG011|Open Label Phase (Optional)|Adverse Event|0|||
44155451|NCT01998958|78946959|FG012|Open Label Phase (Optional)|Adverse Event|0|||
44155452|NCT01998958|78946960|FG013|Open Label Phase (Optional)|Adverse Event|0|||
44155453|NCT01998958|78946961|FG014|Open Label Phase (Optional)|Adverse Event|0|||
44155454|NCT01998958|78946962|FG015|Open Label Phase (Optional)|Adverse Event|0|||
44155455|NCT01998958|78946963|FG016|Open Label Phase (Optional)|Adverse Event|0|||
44257540|NCT01412060|79110498|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
44257541|NCT01412060|79110496|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
44257542|NCT01412060|79110497|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
44257543|NCT01412060|79110498|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
44257544|NCT01412060|79110496|FG000|Period Between RIP and SP|Adverse Event|4|||
44257545|NCT01412060|79110497|FG001|Period Between RIP and SP|Adverse Event|0|||
44257546|NCT01412060|79110498|FG002|Period Between RIP and SP|Adverse Event|0|||
44257547|NCT01412060|79110496|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
44257548|NCT01412060|79110497|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
44257549|NCT01412060|79110498|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
44257550|NCT01412060|79110496|FG000|Period Between RIP and SP|Protocol Violation|2|||
44257551|NCT01412060|79110497|FG001|Period Between RIP and SP|Protocol Violation|0|||
44257552|NCT01412060|79110498|FG002|Period Between RIP and SP|Protocol Violation|0|||
44257553|NCT01412060|79110496|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
44257554|NCT01412060|79110497|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
44257555|NCT01412060|79110498|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
44257556|NCT01412060|79110496|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
44257557|NCT01412060|79110497|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
44257558|NCT01412060|79110498|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
44257559|NCT01412060|79110496|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
44257560|NCT01412060|79110497|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
44257561|NCT01412060|79110498|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
44257562|NCT01412060|79110496|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
44257563|NCT01412060|79110497|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
44257564|NCT01412060|79110498|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
44257565|NCT01412060|79110496|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
44257566|NCT01412060|79110497|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
44257567|NCT01412060|79110498|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
44257568|NCT01412060|79110496|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
44257569|NCT01412060|79110497|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
44257570|NCT01412060|79110498|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
44257571|NCT01412060|79110496|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
44257572|NCT01412060|79110497|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
44257573|NCT01412060|79110498|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
44257574|NCT01412060|79110496|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
44257575|NCT01412060|79110497|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
44257576|NCT01412060|79110498|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
44257577|NCT01412060|79110496|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
44257578|NCT01412060|79110497|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
44257579|NCT01412060|79110498|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
44257580|NCT01412060|79110496|FG000|Period Between SP and DBP|Protocol Violation|2|||
44257581|NCT01412060|79110497|FG001|Period Between SP and DBP|Protocol Violation|0|||
44257582|NCT01412060|79110498|FG002|Period Between SP and DBP|Protocol Violation|0|||
44354732|NCT01187550|79359143|FG001|Overall Study|Protocol Violation|1|||
44257583|NCT01412060|79110496|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
44257584|NCT01412060|79110497|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
44309912|NCT03024255|79311397|FG001|Overall Study|Withdrawal by Subject|1|||
44309913|NCT03024255|79311398|FG002|Overall Study|Withdrawal by Subject|0|||
44309914|NCT03024255|79311399|FG003|Overall Study|Withdrawal by Subject|3|||
44309915|NCT03024255|79311396|FG000|Overall Study|Protocol Violation|0|||
44309916|NCT03024255|79311397|FG001|Overall Study|Protocol Violation|0|||
44309917|NCT03024255|79311398|FG002|Overall Study|Protocol Violation|2|||
44309918|NCT03024255|79311399|FG003|Overall Study|Protocol Violation|0|||
44309919|NCT03024255|79311396|FG000|Overall Study|Lost to Follow-up|1|||
44309920|NCT03024255|79311397|FG001|Overall Study|Lost to Follow-up|2|||
44309921|NCT03024255|79311398|FG002|Overall Study|Lost to Follow-up|1|||
44309922|NCT03024255|79311399|FG003|Overall Study|Lost to Follow-up|1|||
44309923|NCT03024255|79311396|FG000|Overall Study|Lack of Efficacy|1|||
44309924|NCT03024255|79311397|FG001|Overall Study|Lack of Efficacy|0|||
44309925|NCT03024255|79311398|FG002|Overall Study|Lack of Efficacy|0|||
44309926|NCT03024255|79311399|FG003|Overall Study|Lack of Efficacy|0|||
44309927|NCT03024255|79311396|FG000|Overall Study|Protocol Noncompliance|1|||
44309928|NCT03024255|79311397|FG001|Overall Study|Protocol Noncompliance|1|||
44309929|NCT03024255|79311398|FG002|Overall Study|Protocol Noncompliance|0|||
44309930|NCT03024255|79311399|FG003|Overall Study|Protocol Noncompliance|1|||
44309931|NCT01252953|79311422|FG000|Overall Study|Withdrawal by Subject|16|||
44309932|NCT01252953|79311423|FG001|Overall Study|Withdrawal by Subject|17|||
44309933|NCT01252953|79311422|FG000|Overall Study|Lost to Follow-up|22|||
44155456|NCT01998958|78946964|FG017|Open Label Phase (Optional)|Adverse Event|0|||
44155457|NCT01998958|78946965|FG018|Open Label Phase (Optional)|Adverse Event|0|||
44155458|NCT01998958|78946966|FG019|Open Label Phase (Optional)|Adverse Event|0|||
44155459|NCT01998958|78946967|FG020|Open Label Phase (Optional)|Adverse Event|0|||
44155460|NCT01998958|78946968|FG021|Open Label Phase (Optional)|Adverse Event|0|||
44155461|NCT01998958|78946969|FG022|Open Label Phase (Optional)|Adverse Event|0|||
44155462|NCT01998958|78946970|FG023|Open Label Phase (Optional)|Adverse Event|1|||
44155463|NCT01998958|78946971|FG024|Open Label Phase (Optional)|Adverse Event|0|||
44155464|NCT01998958|78946972|FG025|Open Label Phase (Optional)|Adverse Event|0|||
44155465|NCT01998958|78946973|FG026|Open Label Phase (Optional)|Adverse Event|0|||
44155466|NCT01998958|78946974|FG027|Open Label Phase (Optional)|Adverse Event|0|||
44155467|NCT01998958|78946975|FG028|Open Label Phase (Optional)|Adverse Event|0|||
44155468|NCT01998958|78946976|FG029|Open Label Phase (Optional)|Adverse Event|0|||
44309934|NCT01252953|79311423|FG001|Overall Study|Lost to Follow-up|21|||
44309935|NCT01234480|79311430|FG000|Overall Study|Pregnancy|88|||
44309936|NCT01234480|79311430|FG000|Overall Study|>36/Normal History|50|||
44309937|NCT01234480|79311430|FG000|Overall Study|Age|3|||
44309938|NCT01234480|79311430|FG000|Overall Study|HPV Vaccine History|28|||
44309939|NCT01234480|79311430|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
44309940|NCT01234480|79311430|FG000|Overall Study|Hysterectomy|2|||
44309941|NCT01234480|79311430|FG000|Overall Study|Hysterectomy post enrollment|1|||
44309942|NCT01234480|79311430|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
44309943|NCT01234480|79311430|FG000|Overall Study|Informed Consent Form Violation|30|||
44309944|NCT01234480|79311430|FG000|Overall Study|Incorrect Visit|3|||
44309945|NCT01234480|79311430|FG000|Overall Study|No Florida Lab License|20|||
44309946|NCT01234480|79311430|FG000|Overall Study|Out of Window|42|||
44309947|NCT01234480|79311430|FG000|Overall Study|Sample Processing/Storage|92|||
44309948|NCT01234480|79311430|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
44309949|NCT01234480|79311430|FG000|Overall Study|Site/Subject non-compliance|44|||
44309950|NCT01234480|79311430|FG000|Overall Study|Missing Sample|9|||
44309951|NCT00877851|79311439|FG000|Overall Study|Lost to Follow-up|5|||
44309952|NCT00877851|79311440|FG001|Overall Study|Lost to Follow-up|5|||
44309953|NCT00877851|79311439|FG000|Overall Study|computer problem|3|||
44309954|NCT00877851|79311440|FG001|Overall Study|computer problem|0|||
44535299|NCT03433482|79546350|FG002|Overall Study|Lost to Follow-up|1|||
44535300|NCT03433482|79546351|FG003|Overall Study|Lost to Follow-up|1|||
44535301|NCT03433482|79546348|FG000|Overall Study|Withdrawal by Subject|0|||
44535302|NCT03433482|79546349|FG001|Overall Study|Withdrawal by Subject|0|||
44535303|NCT03433482|79546350|FG002|Overall Study|Withdrawal by Subject|1|||
44535304|NCT03433482|79546351|FG003|Overall Study|Withdrawal by Subject|0|||
44535305|NCT03433482|79546348|FG000|Overall Study|Unknown reason|0|||
44309955|NCT00877851|79311439|FG000|Overall Study|no longer interested in participating|1|||
44309956|NCT00877851|79311440|FG001|Overall Study|no longer interested in participating|0|||
44309957|NCT00837616|79311448|FG000|Overall Study|Withdrawal by Subject|0|||
44309958|NCT00837616|79311449|FG001|Overall Study|Withdrawal by Subject|1|||
44309959|NCT00176254|79311455|FG000|Overall Study|Lost to Follow-up|1|||
44309960|NCT03083873|79311468|FG000|Overall Study|Death|6|||
44309961|NCT03083873|79311469|FG001|Overall Study|Death|15|||
44309962|NCT03083873|79311470|FG002|Overall Study|Death|13|||
44309963|NCT03083873|79311471|FG003|Overall Study|Death|9|||
44535306|NCT03433482|79546349|FG001|Overall Study|Unknown reason|0|||
44309964|NCT03083873|79311472|FG004|Overall Study|Death|0|||
44309965|NCT03083873|79311468|FG000|Overall Study|Sponsor Terminated Study|0|||
44354733|NCT01187550|79359142|FG000|Overall Study|Other|3|||
44309966|NCT03083873|79311469|FG001|Overall Study|Sponsor Terminated Study|1|||
44309967|NCT03083873|79311470|FG002|Overall Study|Sponsor Terminated Study|2|||
44309968|NCT03083873|79311471|FG003|Overall Study|Sponsor Terminated Study|3|||
44309969|NCT03083873|79311472|FG004|Overall Study|Sponsor Terminated Study|0|||
44309970|NCT03083873|79311468|FG000|Overall Study|Lost to Follow-up|0|||
44309971|NCT03083873|79311469|FG001|Overall Study|Lost to Follow-up|1|||
44309972|NCT03083873|79311470|FG002|Overall Study|Lost to Follow-up|1|||
44309973|NCT03083873|79311471|FG003|Overall Study|Lost to Follow-up|0|||
44309974|NCT03083873|79311472|FG004|Overall Study|Lost to Follow-up|0|||
44309975|NCT03083873|79311468|FG000|Overall Study|Withdrawal by Subject|2|||
44309976|NCT03083873|79311469|FG001|Overall Study|Withdrawal by Subject|0|||
44309977|NCT03083873|79311470|FG002|Overall Study|Withdrawal by Subject|0|||
44309978|NCT03083873|79311471|FG003|Overall Study|Withdrawal by Subject|0|||
44309979|NCT03083873|79311472|FG004|Overall Study|Withdrawal by Subject|0|||
44309980|NCT03083873|79311468|FG000|Overall Study|Did Not Receive TIL|2|||
44309981|NCT03083873|79311469|FG001|Overall Study|Did Not Receive TIL|5|||
44309982|NCT03083873|79311470|FG002|Overall Study|Did Not Receive TIL|3|||
44309983|NCT03083873|79311471|FG003|Overall Study|Did Not Receive TIL|1|||
44309984|NCT03083873|79311472|FG004|Overall Study|Did Not Receive TIL|0|||
44309985|NCT04834726|79311506|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
44309986|NCT04834726|79311507|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
44309987|NCT04834726|79311508|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
44309988|NCT04834726|79311509|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
44309989|NCT04834726|79311510|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
44309990|NCT04834726|79311511|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
44309991|NCT04834726|79311512|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
44309992|NCT04834726|79311513|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
44309993|NCT04834726|79311514|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
44309994|NCT04732949|79311530|FG000|Overall Study|Withdrawal by Subject|23|||
44309995|NCT04732949|79311531|FG001|Overall Study|Withdrawal by Subject|27|||
44309996|NCT04732949|79311530|FG000|Overall Study|Protocol Violation|0|||
44309997|NCT04732949|79311531|FG001|Overall Study|Protocol Violation|1|||
44309998|NCT04732949|79311530|FG000|Overall Study|Non-compliance|0|||
44309999|NCT04732949|79311531|FG001|Overall Study|Non-compliance|2|||
44310000|NCT04732949|79311530|FG000|Overall Study|Physician Decision|2|||
44310001|NCT04732949|79311531|FG001|Overall Study|Physician Decision|1|||
44310002|NCT04732949|79311530|FG000|Overall Study|Serious adverse event (Fatal)|16|||
44310003|NCT04732949|79311531|FG001|Overall Study|Serious adverse event (Fatal)|18|||
44310004|NCT04732949|79311530|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
44310005|NCT04732949|79311531|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
44310006|NCT04732949|79311530|FG000|Overall Study|Non-serious adverse event|1|||
44310007|NCT04732949|79311531|FG001|Overall Study|Non-serious adverse event|3|||
44310008|NCT04732949|79311530|FG000|Overall Study|Lost to Follow-up|26|||
44310009|NCT04732949|79311531|FG001|Overall Study|Lost to Follow-up|27|||
44310010|NCT04732949|79311530|FG000|Overall Study|Other|6|||
44310011|NCT04732949|79311531|FG001|Overall Study|Other|3|||
44310012|NCT04235504|79311586|FG000|Study Phase|Withdrawal by Subject|5|||
44310013|NCT04235504|79311587|FG001|Study Phase|Withdrawal by Subject|2|||
44310014|NCT04235504|79311588|FG002|Study Phase|Withdrawal by Subject|0|||
44310015|NCT04235504|79311589|FG003|Study Phase|Withdrawal by Subject|0|||
44310016|NCT04235504|79311586|FG000|Continuation Phase|Withdrawal by Subject|0|||
44310017|NCT04235504|79311587|FG001|Continuation Phase|Withdrawal by Subject|4|||
44310018|NCT04235504|79311588|FG002|Continuation Phase|Withdrawal by Subject|0|||
44310019|NCT04235504|79311589|FG003|Continuation Phase|Withdrawal by Subject|0|||
44310020|NCT04235504|79311586|FG000|Continuation Phase|Adverse Event|0|||
44310021|NCT04235504|79311587|FG001|Continuation Phase|Adverse Event|1|||
44310022|NCT04235504|79311588|FG002|Continuation Phase|Adverse Event|0|||
44310023|NCT04235504|79311589|FG003|Continuation Phase|Adverse Event|0|||
44310024|NCT04235504|79311586|FG000|Continuation Phase|Physician Decision|1|||
44310025|NCT04235504|79311587|FG001|Continuation Phase|Physician Decision|2|||
44310026|NCT04235504|79311588|FG002|Continuation Phase|Physician Decision|1|||
44310027|NCT04235504|79311589|FG003|Continuation Phase|Physician Decision|0|||
44310028|NCT04172987|79311604|FG000|Lead In Period|Adverse Event|1|||
44310029|NCT04172987|79311604|FG000|Lead In Period|Protocol Violation|1|||
44310030|NCT04172987|79311604|FG000|Period 1|Physician Decision|1|||
44310031|NCT04172987|79311604|FG000|Period 2|Adverse Event|5|||
44310032|NCT04172987|79311604|FG000|Period 2|Dosing Termination by Sponsor|4|||
44310033|NCT03705832|79311613|FG000|Overall Study|Physician Decision|0|||
44310034|NCT03705832|79311614|FG001|Overall Study|Physician Decision|1|||
44310035|NCT03705832|79311613|FG000|Overall Study|Withdrawal by Subject|1|||
44310036|NCT03705832|79311614|FG001|Overall Study|Withdrawal by Subject|0|||
44310037|NCT03447743|79311620|FG000|Overall Study|Withdrawal by Subject|2|||
44310038|NCT03447743|79311620|FG000|Overall Study|Lost to Follow-up|3|||
44310039|NCT03447743|79311620|FG000|Overall Study|Adverse Event|1|||
44310040|NCT03447743|79311620|FG000|Overall Study|Did not meet criteria to continue|1|||
44310041|NCT03433755|79311628|FG000|Overall Study|Lost to Follow-up|1|||
44310042|NCT03433755|79311629|FG001|Overall Study|Lost to Follow-up|0|||
44310043|NCT03433755|79311630|FG002|Overall Study|Lost to Follow-up|0|||
44310044|NCT03433755|79311631|FG003|Overall Study|Lost to Follow-up|0|||
44310045|NCT03433755|79311628|FG000|Overall Study|Decision by Sponsor|1|||
44310046|NCT03433755|79311629|FG001|Overall Study|Decision by Sponsor|0|||
44310047|NCT03433755|79311630|FG002|Overall Study|Decision by Sponsor|0|||
44310048|NCT03433755|79311631|FG003|Overall Study|Decision by Sponsor|0|||
44310049|NCT03406507|79311654|FG000|Extension Period|Lack of Efficacy|0|||
44310050|NCT03406507|79311655|FG001|Extension Period|Lack of Efficacy|1|||
44310051|NCT03283150|79311664|FG000|Overall Study|Withdrawal by Subject|6|||
44310052|NCT03283150|79311665|FG001|Overall Study|Withdrawal by Subject|0|||
44310053|NCT03283150|79311666|FG002|Overall Study|Withdrawal by Subject|0|||
44310054|NCT03218917|79311677|FG000|Overall Study|Adverse Event|3|||
44310055|NCT03218917|79311678|FG001|Overall Study|Adverse Event|3|||
44310056|NCT03218917|79311679|FG002|Overall Study|Adverse Event|2|||
44310057|NCT03218917|79311677|FG000|Overall Study|Subject withdrew consent|2|||
44310058|NCT03218917|79311678|FG001|Overall Study|Subject withdrew consent|4|||
44310059|NCT03218917|79311679|FG002|Overall Study|Subject withdrew consent|10|||
44310060|NCT03218917|79311677|FG000|Overall Study|Physician Decision|0|||
44310061|NCT03218917|79311678|FG001|Overall Study|Physician Decision|1|||
44310062|NCT03218917|79311679|FG002|Overall Study|Physician Decision|1|||
44310063|NCT03218917|79311677|FG000|Overall Study|Lost to Follow-up|1|||
44310064|NCT03218917|79311678|FG001|Overall Study|Lost to Follow-up|0|||
44310065|NCT03218917|79311679|FG002|Overall Study|Lost to Follow-up|0|||
44310066|NCT03218917|79311677|FG000|Overall Study|Reason Missing|0|||
44310067|NCT03218917|79311678|FG001|Overall Study|Reason Missing|2|||
44310068|NCT03218917|79311679|FG002|Overall Study|Reason Missing|0|||
44310069|NCT03218917|79311677|FG000|Overall Study|Death|0|||
44310070|NCT03218917|79311678|FG001|Overall Study|Death|1|||
44310071|NCT03218917|79311679|FG002|Overall Study|Death|0|||
44310072|NCT03218917|79311677|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44310073|NCT03218917|79311678|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44310074|NCT03218917|79311679|FG002|Overall Study|Non-Compliance with Study Drug|0|||
44310075|NCT03056040|79311690|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
44310076|NCT03056040|79311691|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
44310077|NCT03056040|79311690|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
44310078|NCT03056040|79311691|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
44310079|NCT03056040|79311690|FG000|Primary Evaluation Period|Pregnancy|0|||
44310080|NCT03056040|79311691|FG001|Primary Evaluation Period|Pregnancy|1|||
44310081|NCT03056040|79311690|FG000|Extension Period|Physician Decision|3|||
44310082|NCT03056040|79311691|FG001|Extension Period|Physician Decision|3|||
44310083|NCT03056040|79311690|FG000|Extension Period|Lost to Follow-up|0|||
44310084|NCT03056040|79311691|FG001|Extension Period|Lost to Follow-up|1|||
44310085|NCT03056040|79311690|FG000|Extension Period|Death|0|||
44310086|NCT03056040|79311691|FG001|Extension Period|Death|3|||
44310087|NCT03056040|79311690|FG000|Extension Period|Withdrawal by Subject|1|||
44310088|NCT03056040|79311691|FG001|Extension Period|Withdrawal by Subject|0|||
44310089|NCT03021499|79311702|FG000|Overall Study|Adverse Event|1|||
44310090|NCT03021499|79311703|FG001|Overall Study|Adverse Event|0|||
44310091|NCT03021499|79311702|FG000|Overall Study|Death|1|||
44310092|NCT03021499|79311703|FG001|Overall Study|Death|5|||
44310093|NCT03021499|79311702|FG000|Overall Study|Lack of Efficacy|0|||
44310094|NCT03021499|79311703|FG001|Overall Study|Lack of Efficacy|1|||
44310095|NCT03021499|79311702|FG000|Overall Study|Lost to Follow-up|1|||
44310096|NCT03021499|79311703|FG001|Overall Study|Lost to Follow-up|3|||
44310097|NCT03021499|79311702|FG000|Overall Study|Physician Decision|2|||
44310098|NCT03021499|79311703|FG001|Overall Study|Physician Decision|3|||
44310099|NCT03021499|79311702|FG000|Overall Study|Pregnancy|1|||
44419622|NCT00808067|79427442|FG001|Overall Study|Elevated LFT results|3|||
44419623|NCT00808067|79427441|FG000|Overall Study|Patient refused to take study medication|65|||
44419624|NCT00808067|79427442|FG001|Overall Study|Patient refused to take study medication|76|||
44419625|NCT00808067|79427441|FG000|Overall Study|Missing|1|||
44310100|NCT03021499|79311703|FG001|Overall Study|Pregnancy|0|||
44310101|NCT03021499|79311702|FG000|Overall Study|Withdrawal by Subject|7|||
44310102|NCT03021499|79311703|FG001|Overall Study|Withdrawal by Subject|14|||
44310103|NCT03021499|79311702|FG000|Overall Study|Prohibited medication required|1|||
44310104|NCT03021499|79311703|FG001|Overall Study|Prohibited medication required|0|||
44310105|NCT03021499|79311702|FG000|Overall Study|Protocol non-compliance|1|||
44310106|NCT03021499|79311703|FG001|Overall Study|Protocol non-compliance|1|||
44310107|NCT03021499|79311702|FG000|Overall Study|None of the above|0|||
44310108|NCT03021499|79311703|FG001|Overall Study|None of the above|4|||
44419626|NCT00808067|79427442|FG001|Overall Study|Missing|0|||
44155469|NCT01998958|78946977|FG030|Open Label Phase (Optional)|Adverse Event|0|||
44310109|NCT03021499|79311702|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
44310110|NCT03021499|79311703|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
44310111|NCT02726581|79311732|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
44310112|NCT02726581|79311733|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
44310113|NCT02726581|79311734|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
44310114|NCT02726581|79311732|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
44310115|NCT02726581|79311733|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
44310116|NCT02726581|79311734|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
44310117|NCT02726581|79311732|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44310118|NCT02726581|79311733|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44310119|NCT02726581|79311734|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44310120|NCT02726581|79311732|FG000|Treatment Period|Disease progression|47|||
44310121|NCT02726581|79311733|FG001|Treatment Period|Disease progression|50|||
44310122|NCT02726581|79311734|FG002|Treatment Period|Disease progression|16|||
44310123|NCT02726581|79311732|FG000|Treatment Period|Other reasons|9|||
44310124|NCT02726581|79311733|FG001|Treatment Period|Other reasons|8|||
44310125|NCT02726581|79311734|FG002|Treatment Period|Other reasons|2|||
44310126|NCT02726581|79311732|FG000|Treatment Period|Study drug toxicity|6|||
44310127|NCT02726581|79311733|FG001|Treatment Period|Study drug toxicity|3|||
44310128|NCT02726581|79311734|FG002|Treatment Period|Study drug toxicity|2|||
44310129|NCT02726581|79311732|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
44310130|NCT02726581|79311733|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
44310131|NCT02726581|79311734|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
44310132|NCT02726581|79311732|FG000|Treatment Period|Participant withdrew consent|3|||
44310133|NCT02726581|79311733|FG001|Treatment Period|Participant withdrew consent|1|||
44310134|NCT02726581|79311734|FG002|Treatment Period|Participant withdrew consent|1|||
44310135|NCT02726581|79311732|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
44310136|NCT02726581|79311733|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
44310137|NCT02726581|79311734|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
44310138|NCT02726581|79311732|FG000|Treatment Period|Maximum clinical benefit|0|||
44310139|NCT02726581|79311733|FG001|Treatment Period|Maximum clinical benefit|2|||
44310140|NCT02726581|79311734|FG002|Treatment Period|Maximum clinical benefit|0|||
44310141|NCT02726581|79311732|FG000|Treatment Period|Death|1|||
44310142|NCT02726581|79311733|FG001|Treatment Period|Death|0|||
44310143|NCT02726581|79311734|FG002|Treatment Period|Death|0|||
44310144|NCT02726581|79311732|FG000|Treatment Period|Poor/non-compliance|1|||
44310145|NCT02726581|79311733|FG001|Treatment Period|Poor/non-compliance|0|||
44310146|NCT02726581|79311734|FG002|Treatment Period|Poor/non-compliance|0|||
44310147|NCT02726581|79311732|FG000|Treatment Period|Participant no longer meets study criteria|0|||
44310148|NCT02726581|79311733|FG001|Treatment Period|Participant no longer meets study criteria|1|||
44310149|NCT02726581|79311734|FG002|Treatment Period|Participant no longer meets study criteria|0|||
44310150|NCT02700048|79311744|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
44310151|NCT02700048|79311745|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
44310152|NCT02425904|79311762|FG000|Overall Study|Lost to Follow-up|1|||
44310153|NCT02425904|79311763|FG001|Overall Study|Lost to Follow-up|0|||
44310154|NCT02425904|79311762|FG000|Overall Study|Withdrawal by Subject|2|||
44310155|NCT02425904|79311763|FG001|Overall Study|Withdrawal by Subject|0|||
44310156|NCT02425904|79311762|FG000|Overall Study|Death|0|||
44310157|NCT02425904|79311763|FG001|Overall Study|Death|3|||
44310158|NCT01964989|79311785|FG000|Overall Study|Protocol Violation|3|||
44310159|NCT01964989|79311786|FG001|Overall Study|Protocol Violation|4|||
44310160|NCT01964989|79311785|FG000|Overall Study|Administrative Reason|103|||
44310161|NCT01964989|79311786|FG001|Overall Study|Administrative Reason|95|||
44310162|NCT01964989|79311785|FG000|Overall Study|Adverse Event|0|||
44310163|NCT01964989|79311786|FG001|Overall Study|Adverse Event|1|||
44310164|NCT01964989|79311785|FG000|Overall Study|Death|1|||
44310165|NCT01964989|79311786|FG001|Overall Study|Death|3|||
44310166|NCT01964989|79311785|FG000|Overall Study|Withdrawal by Subject|156|||
44310167|NCT01964989|79311786|FG001|Overall Study|Withdrawal by Subject|160|||
44310168|NCT01964989|79311785|FG000|Overall Study|Lost to Follow-up|254|||
44310169|NCT01964989|79311786|FG001|Overall Study|Lost to Follow-up|232|||
44310170|NCT01964989|79311785|FG000|Overall Study|Other|267|||
44310171|NCT01964989|79311786|FG001|Overall Study|Other|252|||
44310172|NCT01575860|79311814|FG000|Overall Study|Withdrawal by Subject|1|||
44310173|NCT01575860|79311814|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
44310174|NCT01416831|79311821|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
44310175|NCT01416831|79311822|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
44310176|NCT00382070|79311843|FG000|Overall Study|No follow up data mapped to Other|17|||
44310177|NCT00382070|79311844|FG001|Overall Study|No follow up data mapped to Other|19|||
44310178|NCT00382070|79311843|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
44310179|NCT00382070|79311844|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
44310180|NCT00382070|79311843|FG000|Overall Study|No clinical assessment|9|||
44310181|NCT00382070|79311844|FG001|Overall Study|No clinical assessment|11|||
44310182|NCT02921269|79311875|FG000|Overall Study|Did not complete DLT period|1|||
44310183|NCT04303559|79311914|FG000|Overall Study|Study closed due to poor enrollment.|1|||
44310184|NCT03784820|79311920|FG000|Overall Study|Lost to Follow-up|5|||
44310185|NCT03784820|79311921|FG001|Overall Study|Lost to Follow-up|5|||
44310186|NCT03784820|79311922|FG002|Overall Study|Lost to Follow-up|3|||
44310187|NCT03784820|79311923|FG003|Overall Study|Lost to Follow-up|3|||
44310188|NCT03769675|79311931|FG000|Overall Study|Lost to Follow-up|1|||
44310189|NCT03729245|79311937|FG000|Overall Study|Lost to Follow-up|5|||
44310190|NCT03729245|79311938|FG001|Overall Study|Lost to Follow-up|6|||
44310191|NCT03729245|79311937|FG000|Overall Study|Withdrawal by Subject|16|||
44310192|NCT03729245|79311938|FG001|Overall Study|Withdrawal by Subject|19|||
44310193|NCT03729245|79311937|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
44310194|NCT03729245|79311938|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
44310195|NCT03311711|79311958|FG000|Overall Study|Death|1|||
44310196|NCT03311711|79311959|FG001|Overall Study|Death|0|||
44310197|NCT03311711|79311960|FG002|Overall Study|Death|0|||
44310198|NCT03311711|79311961|FG003|Overall Study|Death|0|||
44310199|NCT03311711|79311962|FG004|Overall Study|Death|0|||
44310200|NCT03311711|79311963|FG005|Overall Study|Death|0|||
44310201|NCT03311711|79311964|FG006|Overall Study|Death|1|||
44310202|NCT03311711|79311965|FG007|Overall Study|Death|0|||
44310203|NCT03311711|79311966|FG008|Overall Study|Death|1|||
44310204|NCT03311711|79311967|FG009|Overall Study|Death|0|||
44310205|NCT03311711|79311958|FG000|Overall Study|Death of dyad partner|0|||
44310206|NCT03311711|79311959|FG001|Overall Study|Death of dyad partner|1|||
44310207|NCT03311711|79311960|FG002|Overall Study|Death of dyad partner|0|||
44310208|NCT03311711|79311961|FG003|Overall Study|Death of dyad partner|0|||
44310209|NCT03311711|79311962|FG004|Overall Study|Death of dyad partner|0|||
44310210|NCT03311711|79311963|FG005|Overall Study|Death of dyad partner|0|||
44310211|NCT03311711|79311964|FG006|Overall Study|Death of dyad partner|0|||
44310212|NCT03311711|79311965|FG007|Overall Study|Death of dyad partner|1|||
44310213|NCT03311711|79311966|FG008|Overall Study|Death of dyad partner|0|||
44310214|NCT03311711|79311967|FG009|Overall Study|Death of dyad partner|1|||
44310215|NCT03311711|79311958|FG000|Overall Study|Lost to Follow-up|2|||
44310216|NCT03311711|79311959|FG001|Overall Study|Lost to Follow-up|2|||
44310217|NCT03311711|79311960|FG002|Overall Study|Lost to Follow-up|0|||
44310218|NCT03311711|79311961|FG003|Overall Study|Lost to Follow-up|0|||
44310219|NCT03311711|79311962|FG004|Overall Study|Lost to Follow-up|0|||
44310220|NCT03311711|79311963|FG005|Overall Study|Lost to Follow-up|0|||
44310221|NCT03311711|79311964|FG006|Overall Study|Lost to Follow-up|1|||
44310222|NCT03311711|79311965|FG007|Overall Study|Lost to Follow-up|1|||
44310223|NCT03311711|79311966|FG008|Overall Study|Lost to Follow-up|0|||
44310224|NCT03311711|79311967|FG009|Overall Study|Lost to Follow-up|0|||
44310225|NCT03311711|79311958|FG000|Overall Study|Withdrawal by Subject|1|||
44310226|NCT03311711|79311959|FG001|Overall Study|Withdrawal by Subject|1|||
44310227|NCT03311711|79311960|FG002|Overall Study|Withdrawal by Subject|0|||
44310228|NCT03311711|79311961|FG003|Overall Study|Withdrawal by Subject|0|||
44310229|NCT03311711|79311962|FG004|Overall Study|Withdrawal by Subject|0|||
44310230|NCT03311711|79311963|FG005|Overall Study|Withdrawal by Subject|0|||
44310231|NCT03311711|79311964|FG006|Overall Study|Withdrawal by Subject|3|||
44310232|NCT03311711|79311965|FG007|Overall Study|Withdrawal by Subject|3|||
44310233|NCT03311711|79311966|FG008|Overall Study|Withdrawal by Subject|0|||
44310234|NCT03311711|79311967|FG009|Overall Study|Withdrawal by Subject|0|||
44310235|NCT03270891|79311997|FG000|Overall Study|Lost to Follow-up|3|||
44310236|NCT03270891|79311998|FG001|Overall Study|Lost to Follow-up|6|||
44310237|NCT03270891|79311999|FG002|Overall Study|Lost to Follow-up|0|||
44310238|NCT03270891|79311997|FG000|Overall Study|Withdrawal by Subject|1|||
44310239|NCT03270891|79311998|FG001|Overall Study|Withdrawal by Subject|0|||
44310240|NCT03270891|79311999|FG002|Overall Study|Withdrawal by Subject|0|||
44310241|NCT03270891|79311997|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
44310242|NCT03270891|79311998|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
44310243|NCT03270891|79311999|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
44310244|NCT02992743|79312007|FG000|Overall Study|Withdrawal by Subject|1|||
44310245|NCT02992743|79312008|FG001|Overall Study|Withdrawal by Subject|1|||
44310246|NCT02992743|79312007|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
44310247|NCT02992743|79312008|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
44310248|NCT02992743|79312007|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
44310249|NCT02992743|79312008|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
44310250|NCT02992743|79312007|FG000|Overall Study|No measurable disease|1|||
44310251|NCT02992743|79312008|FG001|Overall Study|No measurable disease|0|||
44310252|NCT02992743|79312007|FG000|Overall Study|Lost to Follow-up|0|||
44310253|NCT02992743|79312008|FG001|Overall Study|Lost to Follow-up|1|||
44310254|NCT02853344|79312016|FG000|Overall Study|Lost to Follow-up|1|||
44155470|NCT01998958|78946978|FG031|Open Label Phase (Optional)|Adverse Event|0|||
44155471|NCT01998958|78946947|FG000|Open Label Phase (Optional)|Other|0|||
44155472|NCT01998958|78946948|FG001|Open Label Phase (Optional)|Other|0|||
44310255|NCT02853344|79312017|FG001|Overall Study|Lost to Follow-up|1|||
44310256|NCT02853344|79312016|FG000|Overall Study|Withdrawal by Subject|2|||
44310257|NCT02853344|79312017|FG001|Overall Study|Withdrawal by Subject|4|||
44310258|NCT02853344|79312016|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
44310259|NCT02853344|79312017|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
44310260|NCT02853344|79312016|FG000|Overall Study|Death|70|||
44310261|NCT02853344|79312017|FG001|Overall Study|Death|112|||
44310262|NCT02739620|79312028|FG000|Overall Study|Lost to Follow-up|3|||
44310263|NCT02739620|79312029|FG001|Overall Study|Lost to Follow-up|1|||
44310264|NCT02739620|79312028|FG000|Overall Study|Adverse Event|0|||
44310265|NCT02739620|79312029|FG001|Overall Study|Adverse Event|1|||
44310266|NCT02675426|79312038|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
44310267|NCT02675426|79312039|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
44310268|NCT02675426|79312040|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
44310269|NCT02675426|79312041|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
44310270|NCT02675426|79312038|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
44310271|NCT02675426|79312039|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
44310272|NCT02675426|79312040|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
44310273|NCT02675426|79312041|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
44310274|NCT02675426|79312038|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
44310275|NCT02675426|79312039|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
44310276|NCT02675426|79312040|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
44310277|NCT02675426|79312041|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
44310278|NCT02675426|79312038|FG000|Period 1: Week 1 to Week 12|Other|2|||
44310279|NCT02675426|79312039|FG001|Period 1: Week 1 to Week 12|Other|1|||
44310280|NCT02675426|79312040|FG002|Period 1: Week 1 to Week 12|Other|0|||
44310281|NCT02675426|79312041|FG003|Period 1: Week 1 to Week 12|Other|2|||
44310282|NCT02675426|79312038|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
44310283|NCT02675426|79312039|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
44310284|NCT02675426|79312040|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
44310285|NCT02675426|79312041|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
44310286|NCT02675426|79312038|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
44310287|NCT02675426|79312039|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
44310288|NCT02675426|79312040|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
44310289|NCT02675426|79312041|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
44310290|NCT02675426|79312038|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
44310291|NCT02675426|79312039|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
44155473|NCT01998958|78946949|FG002|Open Label Phase (Optional)|Other|0|||
44310292|NCT02675426|79312040|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
44155474|NCT01998958|78946950|FG003|Open Label Phase (Optional)|Other|0|||
44310293|NCT02675426|79312041|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
44310294|NCT02675426|79312038|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
44155475|NCT01998958|78946951|FG004|Open Label Phase (Optional)|Other|0|||
44310295|NCT02675426|79312039|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
44310296|NCT02675426|79312040|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
44310297|NCT02675426|79312041|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
44310298|NCT02675426|79312038|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
44310299|NCT02675426|79312039|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
44310300|NCT02675426|79312040|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
44310301|NCT02675426|79312041|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
44310302|NCT02675426|79312038|FG000|Period 2: Week 12 to Week 260|Other|8|||
44310303|NCT02675426|79312039|FG001|Period 2: Week 12 to Week 260|Other|12|||
44310304|NCT02675426|79312040|FG002|Period 2: Week 12 to Week 260|Other|23|||
44310305|NCT02675426|79312041|FG003|Period 2: Week 12 to Week 260|Other|15|||
44310306|NCT02060721|79312082|FG000|Overall Study|Lost to Follow-up|1|||
44535307|NCT03433482|79546350|FG002|Overall Study|Unknown reason|2|||
44535308|NCT03433482|79546351|FG003|Overall Study|Unknown reason|0|||
44535309|NCT03432858|79546364|FG000|Overall Study|Protocol Violation|2|||
44535310|NCT03432858|79546365|FG001|Overall Study|Protocol Violation|1|||
44535311|NCT03432858|79546366|FG002|Overall Study|Protocol Violation|9|||
44535312|NCT03432858|79546364|FG000|Overall Study|Withdrawal by Subject|0|||
44535313|NCT03432858|79546365|FG001|Overall Study|Withdrawal by Subject|1|||
44535314|NCT03432858|79546366|FG002|Overall Study|Withdrawal by Subject|1|||
44155476|NCT01998958|78946952|FG005|Open Label Phase (Optional)|Other|0|||
44155477|NCT01998958|78946953|FG006|Open Label Phase (Optional)|Other|0|||
44155478|NCT01998958|78946954|FG007|Open Label Phase (Optional)|Other|0|||
44310307|NCT02060721|79312082|FG000|Overall Study|Physician Decision|2|||
44310308|NCT02060721|79312082|FG000|Overall Study|Death|14|||
44310309|NCT02060721|79312082|FG000|Overall Study|Withdrawal by Subject|2|||
44310310|NCT02060721|79312082|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
44310311|NCT01359956|79312090|FG000|Overall Study|Death|58|||
44310312|NCT01359956|79312091|FG001|Overall Study|Death|60|||
44310313|NCT01359956|79312092|FG002|Overall Study|Death|66|||
44310314|NCT01359956|79312093|FG003|Overall Study|Death|57|||
44310315|NCT01359956|79312090|FG000|Overall Study|Lost to Follow-up|3|||
44310316|NCT01359956|79312091|FG001|Overall Study|Lost to Follow-up|4|||
44310317|NCT01359956|79312092|FG002|Overall Study|Lost to Follow-up|1|||
44310318|NCT01359956|79312093|FG003|Overall Study|Lost to Follow-up|1|||
44310319|NCT01306045|79312106|FG000|Met General Eligibility Criteria|Screen failures|193|||
44310320|NCT01306045|79312107|FG001|Met General Eligibility Criteria|Screen failures|11|||
44310321|NCT01306045|79312108|FG002|Met General Eligibility Criteria|Screen failures|8|||
44310322|NCT05121480|79312157|FG000|Overall Study|Lack of Efficacy|2|||
44310323|NCT05121480|79312158|FG001|Overall Study|Lack of Efficacy|2|||
44310324|NCT05121480|79312159|FG002|Overall Study|Lack of Efficacy|1|||
44310325|NCT05121480|79312160|FG003|Overall Study|Lack of Efficacy|4|||
44310326|NCT05121480|79312161|FG004|Overall Study|Lack of Efficacy|0|||
44310327|NCT05121480|79312162|FG005|Overall Study|Lack of Efficacy|1|||
44310328|NCT05121480|79312163|FG006|Overall Study|Lack of Efficacy|0|||
44310329|NCT05121480|79312164|FG007|Overall Study|Lack of Efficacy|2|||
44310330|NCT05121480|79312157|FG000|Overall Study|Treatment Failure|0|||
44310331|NCT05121480|79312158|FG001|Overall Study|Treatment Failure|2|||
44310332|NCT05121480|79312159|FG002|Overall Study|Treatment Failure|0|||
44310333|NCT05121480|79312160|FG003|Overall Study|Treatment Failure|1|||
44310334|NCT05121480|79312161|FG004|Overall Study|Treatment Failure|0|||
44310335|NCT05121480|79312162|FG005|Overall Study|Treatment Failure|0|||
44310336|NCT05121480|79312163|FG006|Overall Study|Treatment Failure|0|||
44310337|NCT05121480|79312164|FG007|Overall Study|Treatment Failure|0|||
44310338|NCT05121480|79312157|FG000|Overall Study|Adverse Event|0|||
44310339|NCT05121480|79312158|FG001|Overall Study|Adverse Event|1|||
44310340|NCT05121480|79312159|FG002|Overall Study|Adverse Event|0|||
44310341|NCT05121480|79312160|FG003|Overall Study|Adverse Event|5|||
44419627|NCT00808067|79427441|FG000|Overall Study|Death|1|||
44419628|NCT00808067|79427442|FG001|Overall Study|Death|1|||
44419629|NCT00808067|79427441|FG000|Overall Study|Procedure|6|||
44419630|NCT00808067|79427442|FG001|Overall Study|Procedure|7|||
44419631|NCT00808067|79427441|FG000|Overall Study|Withdrawal by Subject|21|||
44155479|NCT01998958|78946955|FG008|Open Label Phase (Optional)|Other|0|||
44310342|NCT05121480|79312161|FG004|Overall Study|Adverse Event|3|||
44310343|NCT05121480|79312162|FG005|Overall Study|Adverse Event|2|||
44310344|NCT05121480|79312163|FG006|Overall Study|Adverse Event|0|||
44310345|NCT05121480|79312164|FG007|Overall Study|Adverse Event|4|||
44310346|NCT05121480|79312157|FG000|Overall Study|Withdrawal by Subject|4|||
44310347|NCT05121480|79312158|FG001|Overall Study|Withdrawal by Subject|9|||
44310348|NCT05121480|79312159|FG002|Overall Study|Withdrawal by Subject|1|||
44419632|NCT00808067|79427442|FG001|Overall Study|Withdrawal by Subject|25|||
44535315|NCT03432858|79546364|FG000|Overall Study|Procedure canceled/rescheduled|0|||
44535316|NCT03432858|79546365|FG001|Overall Study|Procedure canceled/rescheduled|9|||
44310349|NCT05121480|79312160|FG003|Overall Study|Withdrawal by Subject|8|||
44310350|NCT05121480|79312161|FG004|Overall Study|Withdrawal by Subject|0|||
44310351|NCT05121480|79312162|FG005|Overall Study|Withdrawal by Subject|9|||
44310352|NCT05121480|79312163|FG006|Overall Study|Withdrawal by Subject|0|||
44310353|NCT05121480|79312164|FG007|Overall Study|Withdrawal by Subject|4|||
44310354|NCT05121480|79312157|FG000|Overall Study|Non-compliance with the protocol|0|||
44310355|NCT05121480|79312158|FG001|Overall Study|Non-compliance with the protocol|0|||
44419633|NCT00808067|79427441|FG000|Overall Study|Site closed|4|||
44310356|NCT05121480|79312159|FG002|Overall Study|Non-compliance with the protocol|0|||
44310357|NCT05121480|79312160|FG003|Overall Study|Non-compliance with the protocol|0|||
44310358|NCT05121480|79312161|FG004|Overall Study|Non-compliance with the protocol|1|||
44310359|NCT05121480|79312162|FG005|Overall Study|Non-compliance with the protocol|6|||
44310360|NCT05121480|79312163|FG006|Overall Study|Non-compliance with the protocol|0|||
44310361|NCT05121480|79312164|FG007|Overall Study|Non-compliance with the protocol|1|||
44310362|NCT05121480|79312157|FG000|Overall Study|Lost to Follow-up|0|||
44310363|NCT05121480|79312158|FG001|Overall Study|Lost to Follow-up|4|||
44419634|NCT00808067|79427442|FG001|Overall Study|Site closed|3|||
44419635|NCT00808067|79427441|FG000|Overall Study|Physician Decision|47|||
44419636|NCT00808067|79427442|FG001|Overall Study|Physician Decision|38|||
44419637|NCT00808067|79427441|FG000|Overall Study|Protocol Violation|3|||
44419638|NCT00808067|79427442|FG001|Overall Study|Protocol Violation|11|||
44419639|NCT00808067|79427441|FG000|Overall Study|Patient elected|7|||
44419640|NCT00808067|79427442|FG001|Overall Study|Patient elected|9|||
44419641|NCT00808067|79427441|FG000|Overall Study|Site closed for cause|19|||
44419642|NCT00808067|79427442|FG001|Overall Study|Site closed for cause|19|||
44419643|NCT00808067|79427441|FG000|Overall Study|Other reason not defined above|5|||
44419644|NCT00808067|79427442|FG001|Overall Study|Other reason not defined above|5|||
44419645|NCT00808067|79427441|FG000|Overall Study|Excluded from analysis|13|||
44419646|NCT00808067|79427442|FG001|Overall Study|Excluded from analysis|19|||
44419647|NCT00723021|79427448|FG000|Intervention Period 4|Adverse Event|0|||
44419648|NCT00723021|79427449|FG001|Intervention Period 4|Adverse Event|0|||
44419649|NCT00723021|79427450|FG002|Intervention Period 4|Adverse Event|0|||
44419650|NCT00723021|79427451|FG003|Intervention Period 4|Adverse Event|0|||
44419651|NCT00723021|79427452|FG004|Intervention Period 4|Adverse Event|1|||
44419652|NCT00721227|79427473|FG000|Overall Study|Lost to Follow-up|3|||
44419653|NCT00721227|79427474|FG001|Overall Study|Lost to Follow-up|0|||
44419654|NCT00721227|79427473|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
44419655|NCT00721227|79427474|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
44419656|NCT00807599|79427482|FG000|Overall Study|Not treated on protocol study|0|||
44419657|NCT00807599|79427483|FG001|Overall Study|Not treated on protocol study|0|||
44419658|NCT00807599|79427484|FG002|Overall Study|Not treated on protocol study|2|||
44419659|NCT00807599|79427482|FG000|Overall Study|Adverse Event|0|||
44419660|NCT00807599|79427483|FG001|Overall Study|Adverse Event|0|||
44419661|NCT00807599|79427484|FG002|Overall Study|Adverse Event|5|||
44419662|NCT00807599|79427482|FG000|Overall Study|Inadequate response to induction|0|||
44419663|NCT00807599|79427483|FG001|Overall Study|Inadequate response to induction|0|||
44419664|NCT00807599|79427484|FG002|Overall Study|Inadequate response to induction|9|||
44419665|NCT00807599|79427482|FG000|Overall Study|Withdrawal by Subject|0|||
44419666|NCT00807599|79427483|FG001|Overall Study|Withdrawal by Subject|0|||
44419667|NCT00807599|79427484|FG002|Overall Study|Withdrawal by Subject|1|||
44419668|NCT00721149|79427490|FG000|Overall Study|Physician Decision|1|||
44419669|NCT00788372|79427494|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
44419670|NCT00788372|79427494|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
44419671|NCT00788372|79427494|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
44419672|NCT00788372|79427494|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
44419673|NCT00788372|79427494|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
44419674|NCT00788372|79427494|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
44419675|NCT00788372|79427494|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
44419676|NCT00738582|79427498|FG000|Combination Therapy|Completed Combination Therapy|1|||
44419677|NCT00738582|79427499|FG001|Combination Therapy|Completed Combination Therapy|0|||
44419678|NCT00738582|79427498|FG000|Combination Therapy|Physician Decision|1|||
44419679|NCT00738582|79427499|FG001|Combination Therapy|Physician Decision|0|||
44419680|NCT00738582|79427498|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
44419681|NCT00738582|79427499|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
44419682|NCT00738582|79427498|FG000|Combination Therapy|Other|5|||
44419683|NCT00738582|79427499|FG001|Combination Therapy|Other|0|||
44419684|NCT00738582|79427498|FG000|Combination Therapy|Adverse Event|16|||
44419685|NCT00738582|79427499|FG001|Combination Therapy|Adverse Event|0|||
44310364|NCT05121480|79312159|FG002|Overall Study|Lost to Follow-up|1|||
44310365|NCT05121480|79312160|FG003|Overall Study|Lost to Follow-up|3|||
44310366|NCT05121480|79312161|FG004|Overall Study|Lost to Follow-up|1|||
44310367|NCT05121480|79312162|FG005|Overall Study|Lost to Follow-up|1|||
44310368|NCT05121480|79312163|FG006|Overall Study|Lost to Follow-up|1|||
44310369|NCT05121480|79312164|FG007|Overall Study|Lost to Follow-up|4|||
44310370|NCT05121480|79312157|FG000|Overall Study|Physician Decision|0|||
44310371|NCT05121480|79312158|FG001|Overall Study|Physician Decision|0|||
44310372|NCT05121480|79312159|FG002|Overall Study|Physician Decision|0|||
44310373|NCT05121480|79312160|FG003|Overall Study|Physician Decision|0|||
44419686|NCT00738582|79427498|FG000|Combination Therapy|Progressive Disease|9|||
44419687|NCT00738582|79427499|FG001|Combination Therapy|Progressive Disease|0|||
44419688|NCT00738582|79427498|FG000|Maintenance Therapy|Other|0|||
44310374|NCT05121480|79312161|FG004|Overall Study|Physician Decision|0|||
44310375|NCT05121480|79312162|FG005|Overall Study|Physician Decision|1|||
44310376|NCT05121480|79312163|FG006|Overall Study|Physician Decision|0|||
44310377|NCT05121480|79312164|FG007|Overall Study|Physician Decision|1|||
44310378|NCT05121480|79312157|FG000|Overall Study|Other Reason|0|||
44310379|NCT05121480|79312158|FG001|Overall Study|Other Reason|0|||
44310380|NCT05121480|79312159|FG002|Overall Study|Other Reason|0|||
44310381|NCT05121480|79312160|FG003|Overall Study|Other Reason|0|||
44535317|NCT03432858|79546366|FG002|Overall Study|Procedure canceled/rescheduled|6|||
44257585|NCT01412060|79110498|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
44310382|NCT05121480|79312161|FG004|Overall Study|Other Reason|0|||
44310383|NCT05121480|79312162|FG005|Overall Study|Other Reason|1|||
44419689|NCT00738582|79427499|FG001|Maintenance Therapy|Other|2|||
44419690|NCT00738582|79427498|FG000|Maintenance Therapy|Adverse Event|0|||
44419691|NCT00738582|79427499|FG001|Maintenance Therapy|Adverse Event|6|||
44419692|NCT00738582|79427498|FG000|Maintenance Therapy|Progressive Disease|0|||
44419693|NCT00738582|79427499|FG001|Maintenance Therapy|Progressive Disease|47|||
44419694|NCT00738582|79427498|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
44419695|NCT00738582|79427499|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
44419696|NCT00720759|79427510|FG000|Overall Study|Lost to Follow-up|0|||
44419697|NCT00720759|79427511|FG001|Overall Study|Lost to Follow-up|1|||
44419698|NCT00720759|79427512|FG002|Overall Study|Lost to Follow-up|1|||
44419699|NCT00720759|79427513|FG003|Overall Study|Lost to Follow-up|0|||
44419700|NCT00720213|79427523|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
44419701|NCT00720213|79427524|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
44419702|NCT00720213|79427525|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
44419703|NCT00810407|79427533|FG000|Overall Study|Protocol Violation|3|||
44419704|NCT00810407|79427533|FG000|Overall Study|No Visit After First Day of Treatment|3|||
44419705|NCT00720057|79427539|FG000|Overall Study|Lost to Follow-up|0|||
44419706|NCT00720057|79427540|FG001|Overall Study|Lost to Follow-up|2|||
44419707|NCT00720057|79427539|FG000|Overall Study|Protocol Violation|1|||
44419708|NCT00720057|79427540|FG001|Overall Study|Protocol Violation|0|||
44419709|NCT00720057|79427539|FG000|Overall Study|Withdrawal by Subject|0|||
44419710|NCT00720057|79427540|FG001|Overall Study|Withdrawal by Subject|1|||
44419711|NCT00790868|79427548|FG000|Overall Study|Withdrawal by Subject|4|||
44419712|NCT00790868|79427549|FG001|Overall Study|Withdrawal by Subject|5|||
44419713|NCT00790868|79427548|FG000|Overall Study|Lost to Follow-up|2|||
44419714|NCT00790868|79427549|FG001|Overall Study|Lost to Follow-up|12|||
44419715|NCT00719901|79427557|FG000|Overall Study|Adverse Event|5|||
44419716|NCT00719901|79427557|FG000|Overall Study|Withdrawal by Subject|1|||
44419717|NCT00719901|79427557|FG000|Overall Study|Alternate Treatment|1|||
44419718|NCT00719901|79427557|FG000|Overall Study|Disease Progression|3|||
44419719|NCT00719901|79427557|FG000|Overall Study|Availability of Study Drug|1|||
44419720|NCT00807365|79427561|FG000|Overall Study|Study Terminated|5|||
44419721|NCT00719355|79427567|FG000|Overall Study|Death|0|||
44419722|NCT00719355|79427568|FG001|Overall Study|Death|1|||
44419723|NCT00719355|79427567|FG000|Overall Study|Medical|14|||
44419724|NCT00719355|79427568|FG001|Overall Study|Medical|5|||
44419725|NCT00719355|79427567|FG000|Overall Study|Compliance|4|||
44419726|NCT00719355|79427568|FG001|Overall Study|Compliance|6|||
44419727|NCT00719355|79427567|FG000|Overall Study|Moved|0|||
44419728|NCT00719355|79427568|FG001|Overall Study|Moved|1|||
44419729|NCT00590759|79427574|FG000|Overall Study|Death|52|||
44419730|NCT00590759|79427574|FG000|Overall Study|Lost to Follow-up|28|||
44419731|NCT00734604|79427584|FG000|Overall Study|Adverse Event|0|||
44419732|NCT00734604|79427585|FG001|Overall Study|Adverse Event|2|||
44419733|NCT00734604|79427586|FG002|Overall Study|Adverse Event|0|||
44419734|NCT00734604|79427587|FG003|Overall Study|Adverse Event|2|||
44419735|NCT00734604|79427588|FG004|Overall Study|Adverse Event|1|||
44419736|NCT00734604|79427589|FG005|Overall Study|Adverse Event|1|||
44419737|NCT00734604|79427584|FG000|Overall Study|Serious Adverse Event|1|||
44535318|NCT03432858|79546364|FG000|Overall Study|Required postop mobilization with splinting|0|||
44257586|NCT01412060|79110496|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
44257587|NCT01412060|79110497|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
44257588|NCT01412060|79110498|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
44257589|NCT01412060|79110496|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
44257590|NCT01412060|79110497|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
44257591|NCT01412060|79110498|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
44257592|NCT01412060|79110496|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
44257593|NCT01412060|79110497|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
44310384|NCT05121480|79312163|FG006|Overall Study|Other Reason|1|||
44310385|NCT05121480|79312164|FG007|Overall Study|Other Reason|1|||
44310386|NCT04772755|79312190|FG000|Overall Study|Withdrawal by Subject|1|||
44310387|NCT04772755|79312191|FG001|Overall Study|Withdrawal by Subject|0|||
44419738|NCT00734604|79427585|FG001|Overall Study|Serious Adverse Event|0|||
44419739|NCT00734604|79427586|FG002|Overall Study|Serious Adverse Event|1|||
44155480|NCT01998958|78946956|FG009|Open Label Phase (Optional)|Other|0|||
44419740|NCT00734604|79427587|FG003|Overall Study|Serious Adverse Event|2|||
44535319|NCT03432858|79546365|FG001|Overall Study|Required postop mobilization with splinting|0|||
44310388|NCT04772755|79312190|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
44310389|NCT04772755|79312191|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
44310390|NCT04590040|79312201|FG000|Treatment Period|Lost to Follow-up|2|||
44310391|NCT04590040|79312202|FG001|Treatment Period|Lost to Follow-up|5|||
44310392|NCT04590040|79312203|FG002|Treatment Period|Lost to Follow-up|0|||
44310393|NCT04590040|79312201|FG000|Treatment Period|Physician Decision|0|||
44310394|NCT04590040|79312202|FG001|Treatment Period|Physician Decision|0|||
44310395|NCT04590040|79312203|FG002|Treatment Period|Physician Decision|2|||
44310396|NCT04430335|79312221|FG000|Overall Study|Withdrawal by Subject|1|||
44310397|NCT03690427|79312234|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
44310398|NCT03690427|79312235|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
44310399|NCT03658668|79312244|FG000|Overall Study|Time Commitment|1|||
44310400|NCT03658668|79312245|FG001|Overall Study|Time Commitment|1|||
44310401|NCT03469934|79312253|FG000|Overall Study|Withdrawal by Subject|0|||
44310402|NCT03469934|79312254|FG001|Overall Study|Withdrawal by Subject|1|||
44310403|NCT03004404|79312271|FG000|Period 2|Adverse Event|0|||
44310404|NCT03004404|79312272|FG001|Period 2|Adverse Event|0|||
44310405|NCT03004404|79312273|FG002|Period 2|Adverse Event|0|||
44310406|NCT03004404|79312274|FG003|Period 2|Adverse Event|0|||
44310407|NCT03004404|79312275|FG004|Period 2|Adverse Event|0|||
44310408|NCT03004404|79312276|FG005|Period 2|Adverse Event|0|||
44310409|NCT03004404|79312277|FG006|Period 2|Adverse Event|0|||
44310410|NCT03004404|79312278|FG007|Period 2|Adverse Event|0|||
44310411|NCT03004404|79312279|FG008|Period 2|Adverse Event|1|||
44310412|NCT03004404|79312280|FG009|Period 2|Adverse Event|0|||
44310413|NCT03004404|79312281|FG010|Period 2|Adverse Event|0|||
44310414|NCT03004404|79312282|FG011|Period 2|Adverse Event|0|||
44310415|NCT03004404|79312283|FG012|Period 2|Adverse Event|0|||
44310416|NCT03004404|79312284|FG013|Period 2|Adverse Event|0|||
44310417|NCT03004404|79312285|FG014|Period 2|Adverse Event|0|||
44310418|NCT03004404|79312286|FG015|Period 2|Adverse Event|1|||
44310419|NCT02335268|79312353|FG000|Overall Study|Physician Decision|5|||
44310420|NCT02335268|79312354|FG001|Overall Study|Physician Decision|1|||
44310421|NCT02335268|79312353|FG000|Overall Study|Lack of Efficacy|2|||
44310422|NCT02335268|79312354|FG001|Overall Study|Lack of Efficacy|1|||
44310423|NCT02335268|79312353|FG000|Overall Study|Adverse Event|5|||
44310424|NCT02335268|79312354|FG001|Overall Study|Adverse Event|2|||
44310425|NCT02335268|79312353|FG000|Overall Study|increase blasts|2|||
44535320|NCT03432858|79546366|FG002|Overall Study|Required postop mobilization with splinting|1|||
44535321|NCT03432390|79546376|FG000|Apnea Period|Protocol Violation|2|||
44535322|NCT03432390|79546377|FG001|Apnea Period|Protocol Violation|2|||
44310426|NCT02335268|79312354|FG001|Overall Study|increase blasts|0|||
44310427|NCT02335268|79312353|FG000|Overall Study|Withdrawal by Subject|3|||
44310428|NCT02335268|79312354|FG001|Overall Study|Withdrawal by Subject|2|||
44310429|NCT01029002|79312376|FG000|Overall Study|Lost to Follow-up|2|||
44310430|NCT01029002|79312377|FG001|Overall Study|Lost to Follow-up|4|||
44310431|NCT01011478|79312385|FG000|Overall Study|No follow up data|12|||
44310432|NCT01011478|79312386|FG001|Overall Study|No follow up data|7|||
44310433|NCT00546260|79312394|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
44310434|NCT00546260|79312395|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
44310435|NCT02896192|79312418|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
44310436|NCT02896192|79312418|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
44310437|NCT02896192|79312418|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
44310438|NCT01356940|79312434|FG000|First Intervention (28 Days)|Adverse Event|1|||
44310439|NCT01356940|79312435|FG001|First Intervention (28 Days)|Adverse Event|0|||
44310440|NCT01356940|79312434|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
44310441|NCT01356940|79312435|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
44310442|NCT01330030|79312454|FG000|Overall Study|Lost to Follow-up|16|||
44535323|NCT03456960|79546389|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44535324|NCT03456960|79546390|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44535325|NCT03456960|79546391|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
44535326|NCT03456960|79546392|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
44535327|NCT03456960|79546393|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44535328|NCT03456960|79546394|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44535329|NCT03456960|79546389|FG000|Period 2 (1 Day)|Adverse Event|1|||
44535330|NCT03456960|79546390|FG001|Period 2 (1 Day)|Adverse Event|0|||
44535331|NCT03456960|79546391|FG002|Period 2 (1 Day)|Adverse Event|0|||
44535332|NCT03456960|79546392|FG003|Period 2 (1 Day)|Adverse Event|1|||
44535333|NCT03456960|79546393|FG004|Period 2 (1 Day)|Adverse Event|0|||
44535334|NCT03456960|79546394|FG005|Period 2 (1 Day)|Adverse Event|0|||
44535335|NCT03430986|79546412|FG000|24-week Control Period|Adverse Event|1|||
44535336|NCT03430986|79546413|FG001|24-week Control Period|Adverse Event|0|||
44535337|NCT03430986|79546412|FG000|24-week Control Period|Lost to Follow-up|2|||
44535338|NCT03430986|79546413|FG001|24-week Control Period|Lost to Follow-up|2|||
44535339|NCT03430986|79546412|FG000|24-week Control Period|Withdrawal by Participant|5|||
44535340|NCT03430986|79546413|FG001|24-week Control Period|Withdrawal by Participant|0|||
44310443|NCT01330030|79312455|FG001|Overall Study|Lost to Follow-up|17|||
44310444|NCT00477295|79312570|FG000|Overall Study|Adverse Event|31|||
44310445|NCT00477295|79312571|FG001|Overall Study|Adverse Event|35|||
44310446|NCT00477295|79312570|FG000|Overall Study|Withdrawal by Subject|35|||
44310447|NCT00477295|79312571|FG001|Overall Study|Withdrawal by Subject|24|||
44310448|NCT00477295|79312570|FG000|Overall Study|Lack of Efficacy|23|||
44310449|NCT00477295|79312571|FG001|Overall Study|Lack of Efficacy|23|||
44310450|NCT00477295|79312570|FG000|Overall Study|Protocol Violation|3|||
44310451|NCT00477295|79312571|FG001|Overall Study|Protocol Violation|8|||
44310452|NCT00477295|79312570|FG000|Overall Study|Physician Decision|4|||
44310453|NCT00477295|79312571|FG001|Overall Study|Physician Decision|5|||
44310454|NCT00477295|79312570|FG000|Overall Study|Lost to Follow-up|21|||
44310455|NCT00477295|79312571|FG001|Overall Study|Lost to Follow-up|11|||
44310456|NCT00477295|79312570|FG000|Overall Study|Other|4|||
44310457|NCT00477295|79312571|FG001|Overall Study|Other|3|||
44310458|NCT00476593|79312583|FG000|Overall Study|Lost to Follow-up|10|||
44310459|NCT00476593|79312584|FG001|Overall Study|Lost to Follow-up|2|||
44310460|NCT00476593|79312585|FG002|Overall Study|Lost to Follow-up|8|||
44310461|NCT00476593|79312586|FG003|Overall Study|Lost to Follow-up|22|||
44310462|NCT00476476|79312598|FG000|Overall Study|Adverse Event|2|||
44310463|NCT00476476|79312599|FG001|Overall Study|Adverse Event|7|||
44310464|NCT00476476|79312598|FG000|Overall Study|Progressive Disease|0|||
44310465|NCT00476476|79312599|FG001|Overall Study|Progressive Disease|17|||
44310466|NCT00476086|79312604|FG000|Overall Study|Alternative therapy|1|||
44310467|NCT00476086|79312604|FG000|Overall Study|Progressive Disease|4|||
44310468|NCT00476047|79312610|FG000|Overall Study|Lost to Follow-up|1|||
44310469|NCT00476008|79312618|FG000|Overall Study|Adverse Event|4|||
44310470|NCT00476008|79312619|FG001|Overall Study|Adverse Event|4|||
44310471|NCT00476008|79312618|FG000|Overall Study|Placebo concerns|2|||
44310472|NCT00476008|79312619|FG001|Overall Study|Placebo concerns|2|||
44310473|NCT00476008|79312618|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
44310474|NCT00476008|79312619|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
44310475|NCT00476008|79312618|FG000|Overall Study|Withdrawal by Subject|0|||
44310476|NCT00476008|79312619|FG001|Overall Study|Withdrawal by Subject|1|||
44419741|NCT00734604|79427588|FG004|Overall Study|Serious Adverse Event|0|||
44419742|NCT00734604|79427589|FG005|Overall Study|Serious Adverse Event|1|||
44419743|NCT00734604|79427584|FG000|Overall Study|Lost to Follow-up|1|||
44419744|NCT00734604|79427585|FG001|Overall Study|Lost to Follow-up|2|||
44535341|NCT03430986|79546412|FG000|24-week Control Period|Protocol Deviation|0|||
44535342|NCT03430986|79546413|FG001|24-week Control Period|Protocol Deviation|2|||
44155481|NCT01998958|78946957|FG010|Open Label Phase (Optional)|Other|0|||
44155482|NCT01998958|78946958|FG011|Open Label Phase (Optional)|Other|0|||
44155483|NCT01998958|78946959|FG012|Open Label Phase (Optional)|Other|0|||
44310477|NCT00476008|79312618|FG000|Overall Study|Death|1|||
44310478|NCT00476008|79312619|FG001|Overall Study|Death|0|||
44310479|NCT00475735|79312635|FG000|Treatment Period 1|Adverse Event|2|||
44310480|NCT00475735|79312636|FG001|Treatment Period 1|Adverse Event|0|||
44535343|NCT03430986|79546412|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
44535344|NCT03430986|79546413|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
44535345|NCT03430986|79546412|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
44155484|NCT01998958|78946960|FG013|Open Label Phase (Optional)|Other|0|||
44310481|NCT00475735|79312637|FG002|Treatment Period 1|Adverse Event|0|||
44310482|NCT00475735|79312638|FG003|Treatment Period 1|Adverse Event|0|||
44310483|NCT00475735|79312639|FG004|Treatment Period 1|Adverse Event|0|||
44310484|NCT00475735|79312640|FG005|Treatment Period 1|Adverse Event|0|||
44310485|NCT00475735|79312635|FG000|Treatment Period 1|Lack of Efficacy|1|||
44310486|NCT00475735|79312636|FG001|Treatment Period 1|Lack of Efficacy|0|||
44310487|NCT00475735|79312637|FG002|Treatment Period 1|Lack of Efficacy|0|||
44310488|NCT00475735|79312638|FG003|Treatment Period 1|Lack of Efficacy|0|||
44310489|NCT00475735|79312639|FG004|Treatment Period 1|Lack of Efficacy|0|||
44310490|NCT00475735|79312640|FG005|Treatment Period 1|Lack of Efficacy|0|||
44310491|NCT00475735|79312635|FG000|Treatment Period 1|Lost to Follow-up|0|||
44310492|NCT00475735|79312636|FG001|Treatment Period 1|Lost to Follow-up|0|||
44310493|NCT00475735|79312637|FG002|Treatment Period 1|Lost to Follow-up|0|||
44310494|NCT00475735|79312638|FG003|Treatment Period 1|Lost to Follow-up|0|||
44310495|NCT00475735|79312639|FG004|Treatment Period 1|Lost to Follow-up|0|||
44310496|NCT00475735|79312640|FG005|Treatment Period 1|Lost to Follow-up|1|||
44310497|NCT00475735|79312635|FG000|Treatment Period 1|Protocol Violation|0|||
44310498|NCT00475735|79312636|FG001|Treatment Period 1|Protocol Violation|0|||
44310499|NCT00475735|79312637|FG002|Treatment Period 1|Protocol Violation|0|||
44310500|NCT00475735|79312638|FG003|Treatment Period 1|Protocol Violation|1|||
44310501|NCT00475735|79312639|FG004|Treatment Period 1|Protocol Violation|0|||
44310502|NCT00475735|79312640|FG005|Treatment Period 1|Protocol Violation|0|||
44310503|NCT00475735|79312635|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44310504|NCT00475735|79312636|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44310505|NCT00475735|79312637|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44310506|NCT00475735|79312638|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44310507|NCT00475735|79312639|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44310508|NCT00475735|79312640|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44310509|NCT00475735|79312635|FG000|Treatment Period 1|DC due to AE but continuing|0|||
44310510|NCT00475735|79312636|FG001|Treatment Period 1|DC due to AE but continuing|0|||
44310511|NCT00475735|79312637|FG002|Treatment Period 1|DC due to AE but continuing|0|||
44310512|NCT00475735|79312638|FG003|Treatment Period 1|DC due to AE but continuing|1|||
44310513|NCT00475735|79312639|FG004|Treatment Period 1|DC due to AE but continuing|2|||
44310514|NCT00475735|79312640|FG005|Treatment Period 1|DC due to AE but continuing|2|||
44310515|NCT00475735|79312635|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
44310516|NCT00475735|79312636|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
44310517|NCT00475735|79312637|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
44310518|NCT00475735|79312638|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
44310519|NCT00475735|79312639|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
44310520|NCT00475735|79312640|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
44310521|NCT00475735|79312635|FG000|Treatment Washout|Lost to Follow-up|0|||
44535346|NCT03430986|79546413|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
44535347|NCT03448536|79546424|FG000|Overall Study|Protocol Violation|2|||
44535348|NCT03448536|79546425|FG001|Overall Study|Protocol Violation|0|||
44535349|NCT03448536|79546424|FG000|Overall Study|Pregnancy|1|||
44155485|NCT01998958|78946961|FG014|Open Label Phase (Optional)|Other|0|||
44310522|NCT00475735|79312636|FG001|Treatment Washout|Lost to Follow-up|1|||
44310523|NCT00475735|79312637|FG002|Treatment Washout|Lost to Follow-up|0|||
44310524|NCT00475735|79312638|FG003|Treatment Washout|Lost to Follow-up|0|||
44310525|NCT00475735|79312639|FG004|Treatment Washout|Lost to Follow-up|0|||
44310526|NCT00475735|79312640|FG005|Treatment Washout|Lost to Follow-up|0|||
44310527|NCT00475735|79312635|FG000|Treatment Washout|Protocol Violation|0|||
44310528|NCT00475735|79312636|FG001|Treatment Washout|Protocol Violation|1|||
44310529|NCT00475735|79312637|FG002|Treatment Washout|Protocol Violation|0|||
44310530|NCT00475735|79312638|FG003|Treatment Washout|Protocol Violation|0|||
44310531|NCT00475735|79312639|FG004|Treatment Washout|Protocol Violation|0|||
44310532|NCT00475735|79312640|FG005|Treatment Washout|Protocol Violation|0|||
44310533|NCT00475735|79312635|FG000|Treatment Period 2|Adverse Event|0|||
44310534|NCT00475735|79312636|FG001|Treatment Period 2|Adverse Event|1|||
44310535|NCT00475735|79312637|FG002|Treatment Period 2|Adverse Event|0|||
44310536|NCT00475735|79312638|FG003|Treatment Period 2|Adverse Event|2|||
44310537|NCT00475735|79312639|FG004|Treatment Period 2|Adverse Event|0|||
44310538|NCT00475735|79312640|FG005|Treatment Period 2|Adverse Event|0|||
44310539|NCT00475735|79312635|FG000|Treatment Period 2|Lack of Efficacy|0|||
44310540|NCT00475735|79312636|FG001|Treatment Period 2|Lack of Efficacy|0|||
44419745|NCT00734604|79427586|FG002|Overall Study|Lost to Follow-up|2|||
44419746|NCT00734604|79427587|FG003|Overall Study|Lost to Follow-up|4|||
44535350|NCT03448536|79546425|FG001|Overall Study|Pregnancy|0|||
44535351|NCT03448536|79546424|FG000|Overall Study|Withdrawal by Subject|1|||
44155486|NCT01998958|78946962|FG015|Open Label Phase (Optional)|Other|0|||
44155487|NCT01998958|78946963|FG016|Open Label Phase (Optional)|Other|0|||
44310541|NCT00475735|79312637|FG002|Treatment Period 2|Lack of Efficacy|0|||
44310542|NCT00475735|79312638|FG003|Treatment Period 2|Lack of Efficacy|0|||
44310543|NCT00475735|79312639|FG004|Treatment Period 2|Lack of Efficacy|0|||
44310544|NCT00475735|79312640|FG005|Treatment Period 2|Lack of Efficacy|1|||
44310545|NCT00475735|79312635|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44310546|NCT00475735|79312636|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44310547|NCT00475735|79312637|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44310548|NCT00475735|79312638|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44310549|NCT00475735|79312639|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44535352|NCT03448536|79546425|FG001|Overall Study|Withdrawal by Subject|2|||
44310550|NCT00475735|79312640|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44310551|NCT00475657|79312648|FG000|Overall Study|Death|1|||
44310552|NCT00475657|79312648|FG000|Overall Study|Sponsor's Decision|3|||
44310553|NCT00475423|79312652|FG000|Overall Study|Protocol Violation|5|||
44310554|NCT00475423|79312652|FG000|Overall Study|Adverse Event|4|||
44310555|NCT00475423|79312652|FG000|Overall Study|Withdrawal by Subject|6|||
44310556|NCT00475423|79312652|FG000|Overall Study|Lack of Efficacy|8|||
44310557|NCT00475423|79312652|FG000|Overall Study|Death|1|||
44310558|NCT00475423|79312652|FG000|Overall Study|Reason not specified|1|||
44310559|NCT00475423|79312652|FG000|Overall Study|Lost to Follow-up|7|||
44310560|NCT00475306|79312660|FG000|Overall Study|Protocol Violation|1|||
44310561|NCT00475306|79312661|FG001|Overall Study|Protocol Violation|1|||
44310562|NCT00475306|79312662|FG002|Overall Study|Protocol Violation|0|||
44310563|NCT00475306|79312663|FG003|Overall Study|Protocol Violation|1|||
44310564|NCT00475228|79312675|FG000|Overall Study|Lost to Follow-up|17|||
44310565|NCT00475228|79312676|FG001|Overall Study|Lost to Follow-up|17|||
44310566|NCT05186311|79312704|FG000|Part A: Serum|Withdrawal by Subject|1|||
44535353|NCT03448536|79546424|FG000|Overall Study|Lost to Follow-up|3|||
44535354|NCT03448536|79546425|FG001|Overall Study|Lost to Follow-up|2|||
44535355|NCT03448536|79546424|FG000|Overall Study|Inadequate pain reporter|1|||
44535356|NCT03448536|79546425|FG001|Overall Study|Inadequate pain reporter|0|||
44535357|NCT03448536|79546424|FG000|Overall Study|Other|3|||
44535358|NCT03448536|79546425|FG001|Overall Study|Other|0|||
44535359|NCT03448536|79546424|FG000|Overall Study|Physician Decision|1|||
44535360|NCT03448536|79546425|FG001|Overall Study|Physician Decision|0|||
44310567|NCT04854434|79312712|FG000|Overall Study|Death|1|||
44310568|NCT04854434|79312713|FG001|Overall Study|Death|3|||
44310569|NCT04854434|79312714|FG002|Overall Study|Death|4|||
44310570|NCT04854434|79312712|FG000|Overall Study|Study Terminated by Sponsor|2|||
44310571|NCT04854434|79312713|FG001|Overall Study|Study Terminated by Sponsor|0|||
44310572|NCT04854434|79312714|FG002|Overall Study|Study Terminated by Sponsor|0|||
44310573|NCT04854434|79312712|FG000|Overall Study|Other|1|||
44310574|NCT04854434|79312713|FG001|Overall Study|Other|1|||
44310575|NCT04854434|79312714|FG002|Overall Study|Other|0|||
44310576|NCT03797014|79312749|FG000|Overall Study|Withdrawal by Subject|1|||
44310577|NCT03797014|79312749|FG000|Overall Study|Lost to Follow-up|1|||
44310578|NCT03797014|79312749|FG000|Overall Study|Protocol Violation|1|||
44310579|NCT03596450|79312755|FG000|Overall Study|Death|4|||
44310580|NCT03596450|79312756|FG001|Overall Study|Death|4|||
44310581|NCT03596450|79312755|FG000|Overall Study|Protocol Violation|7|||
44310582|NCT03596450|79312756|FG001|Overall Study|Protocol Violation|12|||
44310583|NCT03596450|79312755|FG000|Overall Study|Lost to Follow-up|7|||
44310584|NCT03596450|79312756|FG001|Overall Study|Lost to Follow-up|6|||
44310585|NCT03596450|79312755|FG000|Overall Study|Adverse Event|9|||
44419747|NCT00734604|79427588|FG004|Overall Study|Lost to Follow-up|2|||
44419748|NCT00734604|79427589|FG005|Overall Study|Lost to Follow-up|3|||
44419749|NCT00734604|79427584|FG000|Overall Study|Physician Decision|0|||
44419750|NCT00734604|79427585|FG001|Overall Study|Physician Decision|1|||
44419751|NCT00734604|79427586|FG002|Overall Study|Physician Decision|1|||
44419752|NCT00734604|79427587|FG003|Overall Study|Physician Decision|0|||
44419753|NCT00734604|79427588|FG004|Overall Study|Physician Decision|0|||
44419754|NCT00734604|79427589|FG005|Overall Study|Physician Decision|0|||
44419755|NCT00734604|79427584|FG000|Overall Study|Protocol Violation|0|||
44419756|NCT00734604|79427585|FG001|Overall Study|Protocol Violation|2|||
44419757|NCT00734604|79427586|FG002|Overall Study|Protocol Violation|0|||
44419758|NCT00734604|79427587|FG003|Overall Study|Protocol Violation|0|||
44419759|NCT00734604|79427588|FG004|Overall Study|Protocol Violation|1|||
44419760|NCT00734604|79427589|FG005|Overall Study|Protocol Violation|0|||
44419761|NCT00734604|79427584|FG000|Overall Study|Sponsor Decision|1|||
44419762|NCT00734604|79427585|FG001|Overall Study|Sponsor Decision|2|||
44419763|NCT00734604|79427586|FG002|Overall Study|Sponsor Decision|1|||
44535361|NCT03448224|79546433|FG000|Overall Study|Provided same answer to every question|1|||
44310586|NCT03596450|79312756|FG001|Overall Study|Adverse Event|6|||
44310587|NCT03596450|79312755|FG000|Overall Study|Withdrawal by Subject|16|||
44310588|NCT03596450|79312756|FG001|Overall Study|Withdrawal by Subject|9|||
44310589|NCT03596450|79312755|FG000|Overall Study|Accidentally Randomized|2|||
44310590|NCT03596450|79312756|FG001|Overall Study|Accidentally Randomized|0|||
44310591|NCT03596450|79312755|FG000|Overall Study|Other reasons|21|||
44310592|NCT03596450|79312756|FG001|Overall Study|Other reasons|22|||
44310593|NCT03596450|79312755|FG000|Overall Study|Missed the Year 1 study visit|56|||
44419764|NCT00734604|79427587|FG003|Overall Study|Sponsor Decision|0|||
44419765|NCT00734604|79427588|FG004|Overall Study|Sponsor Decision|2|||
44310594|NCT03596450|79312756|FG001|Overall Study|Missed the Year 1 study visit|50|||
44310595|NCT03300817|79312771|FG000|Overall Study|Withdrawal by Subject|1|||
44310596|NCT03300817|79312771|FG000|Overall Study|Adverse Event|1|||
44310597|NCT03300817|79312771|FG000|Overall Study|Subject Found to be Ineligible|2|||
44310598|NCT02948842|79312801|FG000|Overall Study|Withdrawal by Subject|4|||
44310599|NCT02782468|79312809|FG000|Overall Study|Progressive Disease|2|||
44419766|NCT00734604|79427589|FG005|Overall Study|Sponsor Decision|0|||
44419767|NCT00734604|79427584|FG000|Overall Study|Withdrawal by Subject|0|||
44310600|NCT02782468|79312810|FG001|Overall Study|Progressive Disease|5|||
44310601|NCT02782468|79312811|FG002|Overall Study|Progressive Disease|0|||
44310602|NCT02782468|79312812|FG003|Overall Study|Progressive Disease|4|||
44310603|NCT02782468|79312809|FG000|Overall Study|Adverse Event|0|||
44310604|NCT02782468|79312810|FG001|Overall Study|Adverse Event|2|||
44310605|NCT02782468|79312811|FG002|Overall Study|Adverse Event|2|||
44310606|NCT02782468|79312812|FG003|Overall Study|Adverse Event|3|||
44310607|NCT02782468|79312809|FG000|Overall Study|Other|0|||
44310608|NCT02782468|79312810|FG001|Overall Study|Other|0|||
44310609|NCT02782468|79312811|FG002|Overall Study|Other|1|||
44310610|NCT02782468|79312812|FG003|Overall Study|Other|1|||
44310611|NCT02782468|79312809|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
44310612|NCT02782468|79312810|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
44310613|NCT02782468|79312811|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
44310614|NCT02782468|79312812|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
44310615|NCT02782468|79312809|FG000|Overall Study|Symptomatic Deterioration|0|||
44310616|NCT02782468|79312810|FG001|Overall Study|Symptomatic Deterioration|0|||
44310617|NCT02782468|79312811|FG002|Overall Study|Symptomatic Deterioration|0|||
44310618|NCT02782468|79312812|FG003|Overall Study|Symptomatic Deterioration|1|||
44310619|NCT02782468|79312809|FG000|Overall Study|Withdrawal by Subject|1|||
44310620|NCT02782468|79312810|FG001|Overall Study|Withdrawal by Subject|0|||
44310621|NCT02782468|79312811|FG002|Overall Study|Withdrawal by Subject|0|||
44310622|NCT02782468|79312812|FG003|Overall Study|Withdrawal by Subject|0|||
44310623|NCT02563769|79312834|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
44310624|NCT02563769|79312835|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
44310625|NCT02563769|79312836|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
44310626|NCT02420717|79312872|FG000|Overall Study|Did not receive all study medication|2|||
44310627|NCT02420717|79312873|FG001|Overall Study|Did not receive all study medication|0|||
44310628|NCT02420717|79312874|FG002|Overall Study|Did not receive all study medication|0|||
44310636|NCT01970306|79312931|FG000|Overall Study|Not eligible|3|||
44310637|NCT01970306|79312931|FG000|Overall Study|Not able to be treated|9|||
44310638|NCT01574274|79312937|FG000|Overall Study|Ineligible|0|||
44310639|NCT01574274|79312938|FG001|Overall Study|Ineligible|1|||
44310640|NCT01574274|79312937|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
44310641|NCT01574274|79312938|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
44310642|NCT01574274|79312937|FG000|Overall Study|Ph+ B-ALL|3|||
44310643|NCT01574274|79312938|FG001|Overall Study|Ph+ B-ALL|4|||
44310644|NCT01574274|79312937|FG000|Overall Study|Induction Death|2|||
44310645|NCT01574274|79312938|FG001|Overall Study|Induction Death|0|||
44310646|NCT01574274|79312937|FG000|Overall Study|Induction Failure|4|||
44310647|NCT01574274|79312938|FG001|Overall Study|Induction Failure|1|||
44310648|NCT01574274|79312937|FG000|Overall Study|Adverse Event|16|||
44310649|NCT01574274|79312938|FG001|Overall Study|Adverse Event|13|||
44310650|NCT01574274|79312937|FG000|Overall Study|Remission Death|1|||
44310651|NCT01574274|79312938|FG001|Overall Study|Remission Death|0|||
44310652|NCT01574274|79312937|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
44310653|NCT01574274|79312938|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
44310654|NCT01574274|79312937|FG000|Overall Study|Other, unknown|3|||
44310655|NCT01574274|79312938|FG001|Overall Study|Other, unknown|2|||
44310656|NCT01268514|79312948|FG000|Overall Study|Adverse Event|20|||
44310657|NCT01268514|79312948|FG000|Overall Study|Death|8|||
44310658|NCT01268514|79312948|FG000|Overall Study|Lost to Follow-up|5|||
44310659|NCT01268514|79312948|FG000|Overall Study|Withdrawal by Subject|3|||
44310660|NCT01268514|79312948|FG000|Overall Study|Withdrawal by Surgeon|5|||
44310661|NCT00625586|79312954|FG000|Overall Study|Adverse Event|1|||
44419768|NCT00734604|79427585|FG001|Overall Study|Withdrawal by Subject|2|||
44419769|NCT00734604|79427586|FG002|Overall Study|Withdrawal by Subject|0|||
44310662|NCT00625586|79312954|FG000|Overall Study|Progressive disease|1|||
44310663|NCT00400946|79312963|FG000|Overall Study|Ineligible|0|||
44310664|NCT00400946|79312964|FG001|Overall Study|Ineligible|0|||
44310665|NCT00400946|79312965|FG002|Overall Study|Ineligible|0|||
44310666|NCT00400946|79312966|FG003|Overall Study|Ineligible|5|||
44310667|NCT00400946|79312967|FG004|Overall Study|Ineligible|1|||
44310668|NCT00400946|79312963|FG000|Overall Study|Induction Failure|0|||
44310669|NCT00400946|79312964|FG001|Overall Study|Induction Failure|0|||
44310670|NCT00400946|79312965|FG002|Overall Study|Induction Failure|0|||
44310671|NCT00400946|79312966|FG003|Overall Study|Induction Failure|11|||
44310672|NCT00400946|79312967|FG004|Overall Study|Induction Failure|8|||
44310673|NCT00400946|79312963|FG000|Overall Study|Induction Death|0|||
44310674|NCT00400946|79312964|FG001|Overall Study|Induction Death|0|||
44419770|NCT00734604|79427587|FG003|Overall Study|Withdrawal by Subject|1|||
44419771|NCT00734604|79427588|FG004|Overall Study|Withdrawal by Subject|2|||
44419772|NCT00734604|79427589|FG005|Overall Study|Withdrawal by Subject|1|||
44419773|NCT00734604|79427584|FG000|Overall Study|Lack of Efficacy|0|||
44419774|NCT00734604|79427585|FG001|Overall Study|Lack of Efficacy|1|||
44419775|NCT00734604|79427586|FG002|Overall Study|Lack of Efficacy|1|||
44419776|NCT00734604|79427587|FG003|Overall Study|Lack of Efficacy|0|||
44419777|NCT00734604|79427588|FG004|Overall Study|Lack of Efficacy|0|||
44419778|NCT00734604|79427589|FG005|Overall Study|Lack of Efficacy|0|||
44419779|NCT00590681|79427600|FG000|Overall Study|Withdrawal by Subject|7|||
44419780|NCT00590681|79427600|FG000|Overall Study|Adverse Event|8|||
44419781|NCT00590681|79427600|FG000|Overall Study|Death|3|||
44419782|NCT00590681|79427600|FG000|Overall Study|Lost to Follow-up|1|||
44419783|NCT00590681|79427600|FG000|Overall Study|disease progression|1|||
44419784|NCT00727272|79427604|FG000|Washout Period A|Adverse Event|0|||
44419785|NCT00727272|79427605|FG001|Washout Period A|Adverse Event|0|||
44419786|NCT00727272|79427606|FG002|Washout Period A|Adverse Event|1|||
44419787|NCT00727272|79427604|FG000|Washout Period B|Withdrawal by Subject|0|||
44419788|NCT00727272|79427605|FG001|Washout Period B|Withdrawal by Subject|0|||
44419789|NCT00727272|79427606|FG002|Washout Period B|Withdrawal by Subject|1|||
44419790|NCT00805025|79427616|FG000|Overall Study|Screened but not enrolled/treated|42|||
44419791|NCT00805025|79427616|FG000|Overall Study|Adverse Event|4|||
44419792|NCT00805025|79427616|FG000|Overall Study|Withdrawal by Subject|2|||
44419793|NCT00805025|79427616|FG000|Overall Study|Physician Decision|1|||
44419794|NCT00734214|79427622|FG000|Overall Study|Withdrawal by Subject|3|||
44419795|NCT00734214|79427623|FG001|Overall Study|Withdrawal by Subject|4|||
44419796|NCT00734214|79427622|FG000|Overall Study|MD withdrawal|1|||
44419797|NCT00734214|79427623|FG001|Overall Study|MD withdrawal|0|||
44419798|NCT00787202|79427634|FG000|Overall Study|Adverse Event|3|||
44419799|NCT00787202|79427635|FG001|Overall Study|Adverse Event|2|||
44419800|NCT00787202|79427636|FG002|Overall Study|Adverse Event|0|||
44419801|NCT00787202|79427637|FG003|Overall Study|Adverse Event|0|||
44419802|NCT00787202|79427638|FG004|Overall Study|Adverse Event|2|||
44419803|NCT00787202|79427634|FG000|Overall Study|Lack of Efficacy|5|||
44419804|NCT00787202|79427635|FG001|Overall Study|Lack of Efficacy|6|||
44419805|NCT00787202|79427636|FG002|Overall Study|Lack of Efficacy|5|||
44419806|NCT00787202|79427637|FG003|Overall Study|Lack of Efficacy|2|||
44535362|NCT03448224|79546434|FG001|Overall Study|Provided same answer to every question|0|||
44257594|NCT01412060|79110498|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
44257595|NCT01412060|79110496|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
44257596|NCT01412060|79110497|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
44257597|NCT01412060|79110498|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
44257598|NCT01412060|79110496|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
44257599|NCT01412060|79110497|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
44257600|NCT01412060|79110498|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
44257601|NCT01412060|79110496|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
44257602|NCT01412060|79110497|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
44257603|NCT01412060|79110498|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
44257604|NCT01412060|79110496|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
44257605|NCT01412060|79110497|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
44257606|NCT01412060|79110498|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
44257607|NCT01412060|79110496|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
44257608|NCT01412060|79110497|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
44257609|NCT01412060|79110498|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
44257610|NCT01412060|79110496|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
44257611|NCT01412060|79110497|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
44257612|NCT01412060|79110498|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
44257613|NCT00551421|79110529|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
44257614|NCT01891643|79110549|FG000|Overall Study|Adverse event unrelated to study drug|2|||
44257615|NCT01891643|79110550|FG001|Overall Study|Adverse event unrelated to study drug|5|||
44257616|NCT01891643|79110549|FG000|Overall Study|Disease Progression|4|||
44257617|NCT01891643|79110550|FG001|Overall Study|Disease Progression|3|||
44257618|NCT01891643|79110549|FG000|Overall Study|Study Drug Toxicity|3|||
44257619|NCT01891643|79110550|FG001|Overall Study|Study Drug Toxicity|0|||
44257620|NCT01891643|79110549|FG000|Overall Study|Maximum Clinical Benefit|0|||
44257621|NCT01891643|79110550|FG001|Overall Study|Maximum Clinical Benefit|1|||
44257622|NCT01891643|79110549|FG000|Overall Study|Poor/Non-compliance|0|||
44257623|NCT01891643|79110550|FG001|Overall Study|Poor/Non-compliance|1|||
44257624|NCT01891643|79110549|FG000|Overall Study|Participant request to discontinue|1|||
44257625|NCT01891643|79110550|FG001|Overall Study|Participant request to discontinue|0|||
44257626|NCT01392326|79110684|FG000|Overall Study|Death|2|||
44419807|NCT00787202|79427638|FG004|Overall Study|Lack of Efficacy|1|||
44419808|NCT00787202|79427634|FG000|Overall Study|Lost to Follow-up|1|||
44419809|NCT00787202|79427635|FG001|Overall Study|Lost to Follow-up|0|||
44310675|NCT00400946|79312965|FG002|Overall Study|Induction Death|0|||
44310676|NCT00400946|79312966|FG003|Overall Study|Induction Death|13|||
44310677|NCT00400946|79312967|FG004|Overall Study|Induction Death|3|||
44310678|NCT00400946|79312963|FG000|Overall Study|Lost to Follow-up|1|||
44310679|NCT00400946|79312964|FG001|Overall Study|Lost to Follow-up|1|||
44310680|NCT00400946|79312965|FG002|Overall Study|Lost to Follow-up|0|||
44310681|NCT00400946|79312966|FG003|Overall Study|Lost to Follow-up|0|||
44310682|NCT00400946|79312967|FG004|Overall Study|Lost to Follow-up|1|||
44310683|NCT00400946|79312963|FG000|Overall Study|Remission Death|1|||
44310684|NCT00400946|79312964|FG001|Overall Study|Remission Death|1|||
44310685|NCT00400946|79312965|FG002|Overall Study|Remission Death|0|||
44310686|NCT00400946|79312966|FG003|Overall Study|Remission Death|0|||
44310687|NCT00400946|79312967|FG004|Overall Study|Remission Death|1|||
44310688|NCT00400946|79312963|FG000|Overall Study|Relapse|9|||
44310689|NCT00400946|79312964|FG001|Overall Study|Relapse|2|||
44310690|NCT00400946|79312965|FG002|Overall Study|Relapse|1|||
44310691|NCT00400946|79312966|FG003|Overall Study|Relapse|1|||
44310692|NCT00400946|79312967|FG004|Overall Study|Relapse|5|||
44310693|NCT00400946|79312963|FG000|Overall Study|Transplant in CR1|0|||
44310694|NCT00400946|79312964|FG001|Overall Study|Transplant in CR1|0|||
44419810|NCT00787202|79427636|FG002|Overall Study|Lost to Follow-up|0|||
44419811|NCT00787202|79427637|FG003|Overall Study|Lost to Follow-up|0|||
44419812|NCT00787202|79427638|FG004|Overall Study|Lost to Follow-up|0|||
44419813|NCT00787202|79427634|FG000|Overall Study|Withdrawal by Subject|2|||
44419814|NCT00787202|79427635|FG001|Overall Study|Withdrawal by Subject|2|||
44419815|NCT00787202|79427636|FG002|Overall Study|Withdrawal by Subject|2|||
44419816|NCT00787202|79427637|FG003|Overall Study|Withdrawal by Subject|0|||
44419817|NCT00787202|79427638|FG004|Overall Study|Withdrawal by Subject|0|||
44419818|NCT00787202|79427634|FG000|Overall Study|Protocol Violation|2|||
44419819|NCT00787202|79427635|FG001|Overall Study|Protocol Violation|1|||
44419820|NCT00787202|79427636|FG002|Overall Study|Protocol Violation|0|||
44419821|NCT00787202|79427637|FG003|Overall Study|Protocol Violation|0|||
44419822|NCT00787202|79427638|FG004|Overall Study|Protocol Violation|1|||
44419823|NCT00787202|79427634|FG000|Overall Study|Randomized, not treated|1|||
44419824|NCT00787202|79427635|FG001|Overall Study|Randomized, not treated|0|||
44419825|NCT00787202|79427636|FG002|Overall Study|Randomized, not treated|0|||
44419826|NCT00787202|79427637|FG003|Overall Study|Randomized, not treated|0|||
44419827|NCT00787202|79427638|FG004|Overall Study|Randomized, not treated|0|||
44419828|NCT04033367|79427656|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
44419829|NCT04033367|79427657|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
44535363|NCT03424044|79546440|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535364|NCT03424044|79546441|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535365|NCT03424044|79546442|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
44535366|NCT03424044|79546443|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535367|NCT03424044|79546444|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535368|NCT03424044|79546445|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535369|NCT03424044|79546446|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535370|NCT03424044|79546447|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44535371|NCT03424044|79546448|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
44257627|NCT01392326|79110685|FG001|Overall Study|Death|0|||
44257628|NCT01392326|79110686|FG002|Overall Study|Death|0|||
44257629|NCT01392326|79110684|FG000|Overall Study|Withdrawal by Subject|12|||
44257630|NCT01392326|79110685|FG001|Overall Study|Withdrawal by Subject|11|||
44257631|NCT01392326|79110686|FG002|Overall Study|Withdrawal by Subject|15|||
44257632|NCT01392326|79110684|FG000|Overall Study|Protocol Violation|2|||
44257633|NCT01392326|79110685|FG001|Overall Study|Protocol Violation|0|||
44257634|NCT01392326|79110686|FG002|Overall Study|Protocol Violation|0|||
44257635|NCT01392326|79110684|FG000|Overall Study|Pregnancy|0|||
44257636|NCT01392326|79110685|FG001|Overall Study|Pregnancy|0|||
44310695|NCT00400946|79312965|FG002|Overall Study|Transplant in CR1|0|||
44310696|NCT00400946|79312966|FG003|Overall Study|Transplant in CR1|10|||
44310697|NCT00400946|79312967|FG004|Overall Study|Transplant in CR1|1|||
44310698|NCT00400946|79312963|FG000|Overall Study|Withdrawal by Subject|2|||
44310699|NCT00400946|79312964|FG001|Overall Study|Withdrawal by Subject|5|||
44310700|NCT00400946|79312965|FG002|Overall Study|Withdrawal by Subject|1|||
44310701|NCT00400946|79312966|FG003|Overall Study|Withdrawal by Subject|5|||
44310702|NCT00400946|79312967|FG004|Overall Study|Withdrawal by Subject|8|||
44310703|NCT00400946|79312963|FG000|Overall Study|Clinical|1|||
44310704|NCT00400946|79312964|FG001|Overall Study|Clinical|2|||
44310705|NCT00400946|79312965|FG002|Overall Study|Clinical|0|||
44310706|NCT00400946|79312966|FG003|Overall Study|Clinical|2|||
44310707|NCT00400946|79312967|FG004|Overall Study|Clinical|9|||
44310708|NCT00400946|79312963|FG000|Overall Study|Other|0|||
44419830|NCT04033367|79427656|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
44419831|NCT04033367|79427657|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
44419832|NCT04033367|79427656|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
44419833|NCT04033367|79427657|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
44419834|NCT04033367|79427656|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
44535372|NCT03424044|79546440|FG000|First Intervention (76 Hours)|Adverse Event|0|||
44535373|NCT03424044|79546441|FG001|First Intervention (76 Hours)|Adverse Event|0|||
44535374|NCT03424044|79546442|FG002|First Intervention (76 Hours)|Adverse Event|0|||
44535375|NCT03424044|79546443|FG003|First Intervention (76 Hours)|Adverse Event|0|||
44535376|NCT03424044|79546444|FG004|First Intervention (76 Hours)|Adverse Event|1|||
44535377|NCT03424044|79546445|FG005|First Intervention (76 Hours)|Adverse Event|0|||
44535378|NCT03424044|79546446|FG006|First Intervention (76 Hours)|Adverse Event|0|||
44535379|NCT03424044|79546447|FG007|First Intervention (76 Hours)|Adverse Event|0|||
44535380|NCT03424044|79546448|FG008|First Intervention (76 Hours)|Adverse Event|0|||
44535381|NCT03424044|79546440|FG000|First Intervention (76 Hours)|device issues|0|||
44535382|NCT03424044|79546441|FG001|First Intervention (76 Hours)|device issues|0|||
44535383|NCT03424044|79546442|FG002|First Intervention (76 Hours)|device issues|0|||
44535384|NCT03424044|79546443|FG003|First Intervention (76 Hours)|device issues|0|||
44535385|NCT03424044|79546444|FG004|First Intervention (76 Hours)|device issues|0|||
44535386|NCT03424044|79546445|FG005|First Intervention (76 Hours)|device issues|0|||
44535387|NCT03424044|79546446|FG006|First Intervention (76 Hours)|device issues|1|||
44535388|NCT03424044|79546447|FG007|First Intervention (76 Hours)|device issues|1|||
44535389|NCT03424044|79546448|FG008|First Intervention (76 Hours)|device issues|1|||
44535390|NCT03424044|79546440|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
44535391|NCT03424044|79546441|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
44535392|NCT03424044|79546442|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
44535393|NCT03424044|79546443|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
44535394|NCT03424044|79546444|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
44535395|NCT03424044|79546445|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
44535396|NCT03424044|79546446|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
44535397|NCT03424044|79546447|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
44535398|NCT03424044|79546448|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
44535399|NCT03424044|79546440|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535400|NCT03424044|79546441|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535401|NCT03424044|79546442|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44257637|NCT01392326|79110686|FG002|Overall Study|Pregnancy|1|||
44257638|NCT01392326|79110684|FG000|Overall Study|Physician Decision|7|||
44257639|NCT01392326|79110685|FG001|Overall Study|Physician Decision|5|||
44257640|NCT01392326|79110686|FG002|Overall Study|Physician Decision|2|||
44257641|NCT01392326|79110684|FG000|Overall Study|Lost to Follow-up|1|||
44257642|NCT01392326|79110685|FG001|Overall Study|Lost to Follow-up|3|||
44257643|NCT01392326|79110686|FG002|Overall Study|Lost to Follow-up|4|||
44257644|NCT01392326|79110684|FG000|Overall Study|Lack of Efficacy|14|||
44257645|NCT01392326|79110685|FG001|Overall Study|Lack of Efficacy|10|||
44257646|NCT01392326|79110686|FG002|Overall Study|Lack of Efficacy|15|||
44257647|NCT01392326|79110684|FG000|Overall Study|Adverse Event|9|||
44257648|NCT01392326|79110685|FG001|Overall Study|Adverse Event|6|||
44257649|NCT01392326|79110686|FG002|Overall Study|Adverse Event|11|||
44257650|NCT01432262|79110729|FG000|Overall Study|Withdrawal by Subject|2|||
44257651|NCT01432262|79110730|FG001|Overall Study|Withdrawal by Subject|1|||
44257652|NCT01410890|79110750|FG000|Overall Study|Withdrawal by Subject|0|||
44257653|NCT01410890|79110751|FG001|Overall Study|Withdrawal by Subject|1|||
44257654|NCT01431950|79110761|FG000|Overall Study|Study Site Closed/Terminated|7|||
44257655|NCT01431950|79110762|FG001|Overall Study|Study Site Closed/Terminated|3|||
44257656|NCT01431950|79110761|FG000|Overall Study|Withdrawal by Subject|4|||
44257657|NCT01431950|79110762|FG001|Overall Study|Withdrawal by Subject|3|||
44257658|NCT01431950|79110761|FG000|Overall Study|Protocol Violation|2|||
44535402|NCT03424044|79546443|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
44310709|NCT00400946|79312964|FG001|Overall Study|Other|0|||
44310710|NCT00400946|79312965|FG002|Overall Study|Other|0|||
44257659|NCT01431950|79110762|FG001|Overall Study|Protocol Violation|3|||
44310711|NCT00400946|79312966|FG003|Overall Study|Other|0|||
44535403|NCT03424044|79546444|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535404|NCT03424044|79546445|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535405|NCT03424044|79546446|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535406|NCT03424044|79546447|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535407|NCT03424044|79546448|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
44535408|NCT03422250|79546462|FG000|Intervention|Adverse Event|0|||
44535409|NCT03422250|79546463|FG001|Intervention|Adverse Event|1|||
44535410|NCT03422250|79546464|FG002|Intervention|Adverse Event|0|||
44535411|NCT03422250|79546465|FG003|Intervention|Adverse Event|1|||
44535412|NCT03422250|79546462|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
44535413|NCT03422250|79546463|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
44535414|NCT03422250|79546464|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
44535415|NCT03422250|79546465|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
44535416|NCT03422250|79546462|FG000|Follow-up|Withdrawal by Subject|0|||
44535417|NCT03422250|79546463|FG001|Follow-up|Withdrawal by Subject|0|||
44535418|NCT03422250|79546464|FG002|Follow-up|Withdrawal by Subject|0|||
44535419|NCT03422250|79546465|FG003|Follow-up|Withdrawal by Subject|1|||
44535420|NCT03422250|79546462|FG000|Follow-up|Adverse Event|0|||
44535421|NCT03422250|79546463|FG001|Follow-up|Adverse Event|0|||
44535422|NCT03422250|79546464|FG002|Follow-up|Adverse Event|0|||
44310712|NCT00400946|79312967|FG004|Overall Study|Other|1|||
44310713|NCT00475033|79312987|FG000|Infant Series|Failed to return|3|||
44310714|NCT00475033|79312988|FG001|Infant Series|Failed to return|4|||
44310715|NCT00475033|79312987|FG000|Infant Series|Parent or legal guardian request|1|||
44310716|NCT00475033|79312988|FG001|Infant Series|Parent or legal guardian request|5|||
44310717|NCT00475033|79312987|FG000|Infant Series|Protocol Violation|1|||
44310718|NCT00475033|79312988|FG001|Infant Series|Protocol Violation|2|||
44310719|NCT00475033|79312987|FG000|Infant Series|Lost to Follow-up|2|||
44310720|NCT00475033|79312988|FG001|Infant Series|Lost to Follow-up|0|||
44310721|NCT00475033|79312987|FG000|Infant Series|Adverse Event|0|||
44419835|NCT04033367|79427657|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
44419836|NCT00733980|79427669|FG000|Overall Study|Adverse Event|5|||
44419837|NCT00733980|79427670|FG001|Overall Study|Adverse Event|2|||
44419838|NCT00733980|79427669|FG000|Overall Study|Lack of Efficacy|0|||
44419839|NCT00733980|79427670|FG001|Overall Study|Lack of Efficacy|1|||
44419840|NCT00733980|79427669|FG000|Overall Study|Protocol Violation|2|||
44419841|NCT00733980|79427670|FG001|Overall Study|Protocol Violation|1|||
44419842|NCT00733980|79427669|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
44419843|NCT00733980|79427670|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
44419844|NCT00733980|79427669|FG000|Overall Study|Lost to Follow-up|6|||
44419845|NCT00733980|79427670|FG001|Overall Study|Lost to Follow-up|11|||
44419846|NCT00733980|79427669|FG000|Overall Study|Physician Decision|2|||
44419847|NCT00733980|79427670|FG001|Overall Study|Physician Decision|3|||
44419848|NCT00733980|79427669|FG000|Overall Study|Withdrawal by Subject|6|||
44419849|NCT00733980|79427670|FG001|Overall Study|Withdrawal by Subject|2|||
44419850|NCT00806585|79427682|FG000|Overall Study|Study terminated by Sponsor|0|||
44419851|NCT00806585|79427683|FG001|Overall Study|Study terminated by Sponsor|0|||
44419852|NCT00806585|79427684|FG002|Overall Study|Study terminated by Sponsor|1|||
44419853|NCT00806585|79427685|FG003|Overall Study|Study terminated by Sponsor|2|||
44419854|NCT00806585|79427686|FG004|Overall Study|Study terminated by Sponsor|0|||
44419855|NCT00806585|79427682|FG000|Overall Study|Protocol Violation|3|||
44419856|NCT00806585|79427683|FG001|Overall Study|Protocol Violation|1|||
44419857|NCT00806585|79427684|FG002|Overall Study|Protocol Violation|2|||
44419858|NCT00806585|79427685|FG003|Overall Study|Protocol Violation|0|||
44419859|NCT00806585|79427686|FG004|Overall Study|Protocol Violation|0|||
44419860|NCT00806585|79427682|FG000|Overall Study|Physician Decision|0|||
44419861|NCT00806585|79427683|FG001|Overall Study|Physician Decision|2|||
44419862|NCT00806585|79427684|FG002|Overall Study|Physician Decision|3|||
44419863|NCT00806585|79427685|FG003|Overall Study|Physician Decision|0|||
44419864|NCT00806585|79427686|FG004|Overall Study|Physician Decision|1|||
44419865|NCT00806585|79427682|FG000|Overall Study|Lost to Follow-up|2|||
44419866|NCT00806585|79427683|FG001|Overall Study|Lost to Follow-up|1|||
44419867|NCT00806585|79427684|FG002|Overall Study|Lost to Follow-up|2|||
44419868|NCT00806585|79427685|FG003|Overall Study|Lost to Follow-up|2|||
44419869|NCT00806585|79427686|FG004|Overall Study|Lost to Follow-up|5|||
44419870|NCT00806585|79427682|FG000|Overall Study|Lack of Efficacy|1|||
44535423|NCT03422250|79546465|FG003|Follow-up|Adverse Event|1|||
44535424|NCT01266031|79546480|FG000|Overall Study|Not treated|0|||
44310722|NCT00475033|79312988|FG001|Infant Series|Adverse Event|2|||
44310723|NCT00475033|79312987|FG000|After the Infant Series|Adverse Event|0|||
44419871|NCT00806585|79427683|FG001|Overall Study|Lack of Efficacy|0|||
44419872|NCT00806585|79427684|FG002|Overall Study|Lack of Efficacy|0|||
44535425|NCT01266031|79546481|FG001|Overall Study|Not treated|3|||
44310724|NCT00475033|79312988|FG001|After the Infant Series|Adverse Event|4|||
44419873|NCT00806585|79427685|FG003|Overall Study|Lack of Efficacy|0|||
44419874|NCT00806585|79427686|FG004|Overall Study|Lack of Efficacy|0|||
44419875|NCT00806585|79427682|FG000|Overall Study|Adverse Event|1|||
44419876|NCT00806585|79427683|FG001|Overall Study|Adverse Event|5|||
44535426|NCT01266031|79546482|FG002|Overall Study|Not treated|2|||
44535427|NCT00075725|79546513|FG000|Overall Study|Adverse Event|6|||
44535428|NCT00075725|79546514|FG001|Overall Study|Adverse Event|6|||
44535429|NCT00075725|79546515|FG002|Overall Study|Adverse Event|20|||
44535430|NCT00075725|79546516|FG003|Overall Study|Adverse Event|8|||
44535431|NCT00075725|79546517|FG004|Overall Study|Adverse Event|4|||
44535432|NCT00075725|79546518|FG005|Overall Study|Adverse Event|38|||
44535433|NCT00075725|79546519|FG006|Overall Study|Adverse Event|3|||
44535434|NCT00075725|79546520|FG007|Overall Study|Adverse Event|51|||
44535435|NCT00075725|79546521|FG008|Overall Study|Adverse Event|15|||
44535436|NCT00075725|79546522|FG009|Overall Study|Adverse Event|4|||
44535437|NCT00075725|79546523|FG010|Overall Study|Adverse Event|2|||
44535438|NCT00075725|79546524|FG011|Overall Study|Adverse Event|2|||
44535439|NCT00075725|79546513|FG000|Overall Study|Death|3|||
44535440|NCT00075725|79546514|FG001|Overall Study|Death|5|||
44535441|NCT00075725|79546515|FG002|Overall Study|Death|10|||
44535442|NCT00075725|79546516|FG003|Overall Study|Death|2|||
44535443|NCT00075725|79546517|FG004|Overall Study|Death|3|||
44535444|NCT00075725|79546518|FG005|Overall Study|Death|25|||
44535445|NCT00075725|79546519|FG006|Overall Study|Death|4|||
44535446|NCT00075725|79546520|FG007|Overall Study|Death|22|||
44535447|NCT00075725|79546521|FG008|Overall Study|Death|14|||
44535448|NCT00075725|79546522|FG009|Overall Study|Death|4|||
44535449|NCT00075725|79546523|FG010|Overall Study|Death|3|||
44535450|NCT00075725|79546524|FG011|Overall Study|Death|0|||
44535451|NCT00075725|79546513|FG000|Overall Study|Lost to Follow-up|1|||
44535452|NCT00075725|79546514|FG001|Overall Study|Lost to Follow-up|1|||
44535453|NCT00075725|79546515|FG002|Overall Study|Lost to Follow-up|4|||
44535454|NCT00075725|79546516|FG003|Overall Study|Lost to Follow-up|1|||
44310725|NCT00475033|79312987|FG000|After the Infant Series|Parent or legal guardian request|2|||
44310726|NCT00475033|79312988|FG001|After the Infant Series|Parent or legal guardian request|2|||
44310727|NCT00475033|79312987|FG000|After the Infant Series|Failed to return|2|||
44310728|NCT00475033|79312988|FG001|After the Infant Series|Failed to return|1|||
44310729|NCT00475033|79312987|FG000|After the Infant Series|Protocol Violation|1|||
44310730|NCT00475033|79312988|FG001|After the Infant Series|Protocol Violation|0|||
44310731|NCT00475033|79312987|FG000|After the Infant Series|Lost to Follow-up|1|||
44310732|NCT00475033|79312988|FG001|After the Infant Series|Lost to Follow-up|0|||
44310733|NCT00475033|79312987|FG000|After the Infant Series|Other|0|||
44310734|NCT00475033|79312988|FG001|After the Infant Series|Other|1|||
44310735|NCT00475033|79312987|FG000|Toddler Dose|Parent or legal guardian request|2|||
44310736|NCT00475033|79312988|FG001|Toddler Dose|Parent or legal guardian request|0|||
44310737|NCT00475033|79312987|FG000|Toddler Dose|Failed to return|1|||
44310738|NCT00475033|79312988|FG001|Toddler Dose|Failed to return|0|||
44310739|NCT00475033|79312987|FG000|Toddler Dose|Lost to Follow-up|1|||
44310740|NCT00475033|79312988|FG001|Toddler Dose|Lost to Follow-up|0|||
44310741|NCT00474994|79313001|FG000|Overall Study|Patient Not treated|1|||
44310742|NCT00474994|79313001|FG000|Overall Study|Patient evaluable for toxicity only|3|||
44310743|NCT00474994|79313001|FG000|Overall Study|Patient found to be ineligible|1|||
44310744|NCT00474955|79313005|FG000|Overall Study|Adverse Event|2|||
44310745|NCT00474955|79313005|FG000|Overall Study|Drug unavailability|1|||
44310746|NCT00474955|79313005|FG000|Overall Study|Personal reasons|5|||
44310747|NCT00474487|79313013|FG000|Overall Study|Withdrawal by Subject|6|||
44310748|NCT00474487|79313014|FG001|Overall Study|Withdrawal by Subject|0|||
44310749|NCT00474487|79313015|FG002|Overall Study|Withdrawal by Subject|0|||
44310750|NCT00474487|79313016|FG003|Overall Study|Withdrawal by Subject|0|||
44310751|NCT00474487|79313013|FG000|Overall Study|Lost to Follow-up|20|||
44535455|NCT00075725|79546517|FG004|Overall Study|Lost to Follow-up|0|||
44535456|NCT00075725|79546518|FG005|Overall Study|Lost to Follow-up|13|||
44535457|NCT00075725|79546519|FG006|Overall Study|Lost to Follow-up|2|||
44535458|NCT00075725|79546520|FG007|Overall Study|Lost to Follow-up|4|||
44535459|NCT00075725|79546521|FG008|Overall Study|Lost to Follow-up|1|||
44535460|NCT00075725|79546522|FG009|Overall Study|Lost to Follow-up|0|||
44155488|NCT01998958|78946964|FG017|Open Label Phase (Optional)|Other|0|||
44310752|NCT00474487|79313014|FG001|Overall Study|Lost to Follow-up|1|||
44310753|NCT00474487|79313015|FG002|Overall Study|Lost to Follow-up|7|||
44535461|NCT00075725|79546523|FG010|Overall Study|Lost to Follow-up|0|||
44535462|NCT00075725|79546524|FG011|Overall Study|Lost to Follow-up|0|||
44535463|NCT00075725|79546513|FG000|Overall Study|Physician Decision|2|||
44535464|NCT00075725|79546514|FG001|Overall Study|Physician Decision|6|||
44535465|NCT00075725|79546515|FG002|Overall Study|Physician Decision|5|||
44535466|NCT00075725|79546516|FG003|Overall Study|Physician Decision|8|||
44535467|NCT00075725|79546517|FG004|Overall Study|Physician Decision|4|||
44535468|NCT00075725|79546518|FG005|Overall Study|Physician Decision|19|||
44535469|NCT00075725|79546519|FG006|Overall Study|Physician Decision|3|||
44535470|NCT00075725|79546520|FG007|Overall Study|Physician Decision|17|||
44535471|NCT00075725|79546521|FG008|Overall Study|Physician Decision|5|||
44535472|NCT00075725|79546522|FG009|Overall Study|Physician Decision|0|||
44535473|NCT00075725|79546523|FG010|Overall Study|Physician Decision|1|||
44535474|NCT00075725|79546524|FG011|Overall Study|Physician Decision|0|||
44535475|NCT00075725|79546513|FG000|Overall Study|Pregnancy|0|||
44535476|NCT00075725|79546514|FG001|Overall Study|Pregnancy|0|||
44535477|NCT00075725|79546515|FG002|Overall Study|Pregnancy|0|||
44535478|NCT00075725|79546516|FG003|Overall Study|Pregnancy|0|||
44535479|NCT00075725|79546517|FG004|Overall Study|Pregnancy|0|||
44535480|NCT00075725|79546518|FG005|Overall Study|Pregnancy|1|||
44535481|NCT00075725|79546519|FG006|Overall Study|Pregnancy|0|||
44535482|NCT00075725|79546520|FG007|Overall Study|Pregnancy|1|||
44535483|NCT00075725|79546521|FG008|Overall Study|Pregnancy|0|||
44535484|NCT00075725|79546522|FG009|Overall Study|Pregnancy|0|||
44535485|NCT00075725|79546523|FG010|Overall Study|Pregnancy|0|||
44310754|NCT00474487|79313016|FG003|Overall Study|Lost to Follow-up|0|||
44310755|NCT00474487|79313013|FG000|Overall Study|Inappropriate enrollment|4|||
44310756|NCT00474487|79313014|FG001|Overall Study|Inappropriate enrollment|0|||
44310757|NCT00474487|79313015|FG002|Overall Study|Inappropriate enrollment|7|||
44310758|NCT00474487|79313016|FG003|Overall Study|Inappropriate enrollment|0|||
44310759|NCT00474487|79313013|FG000|Overall Study|Death|0|||
44310760|NCT00474487|79313014|FG001|Overall Study|Death|1|||
44310761|NCT00474487|79313015|FG002|Overall Study|Death|0|||
44310762|NCT00474487|79313016|FG003|Overall Study|Death|0|||
44535486|NCT00075725|79546524|FG011|Overall Study|Pregnancy|0|||
44535487|NCT00075725|79546513|FG000|Overall Study|Protocol Violation|1|||
44535488|NCT00075725|79546514|FG001|Overall Study|Protocol Violation|1|||
44535489|NCT00075725|79546515|FG002|Overall Study|Protocol Violation|0|||
44535490|NCT00075725|79546516|FG003|Overall Study|Protocol Violation|3|||
44535491|NCT00075725|79546517|FG004|Overall Study|Protocol Violation|3|||
44535492|NCT00075725|79546518|FG005|Overall Study|Protocol Violation|2|||
44535493|NCT00075725|79546519|FG006|Overall Study|Protocol Violation|1|||
44535494|NCT00075725|79546520|FG007|Overall Study|Protocol Violation|2|||
44535495|NCT00075725|79546521|FG008|Overall Study|Protocol Violation|3|||
44535496|NCT00075725|79546522|FG009|Overall Study|Protocol Violation|0|||
44535497|NCT00075725|79546523|FG010|Overall Study|Protocol Violation|0|||
44535498|NCT00075725|79546524|FG011|Overall Study|Protocol Violation|1|||
44535499|NCT00075725|79546513|FG000|Overall Study|Withdrawal by Subject|12|||
44535500|NCT00075725|79546514|FG001|Overall Study|Withdrawal by Subject|3|||
44535501|NCT00075725|79546515|FG002|Overall Study|Withdrawal by Subject|6|||
44535502|NCT00075725|79546516|FG003|Overall Study|Withdrawal by Subject|10|||
44535503|NCT00075725|79546517|FG004|Overall Study|Withdrawal by Subject|6|||
44535504|NCT00075725|79546518|FG005|Overall Study|Withdrawal by Subject|27|||
44535505|NCT00075725|79546519|FG006|Overall Study|Withdrawal by Subject|7|||
44535506|NCT00075725|79546520|FG007|Overall Study|Withdrawal by Subject|31|||
44535507|NCT00075725|79546521|FG008|Overall Study|Withdrawal by Subject|10|||
44535508|NCT00075725|79546522|FG009|Overall Study|Withdrawal by Subject|2|||
44535509|NCT00075725|79546523|FG010|Overall Study|Withdrawal by Subject|0|||
44535510|NCT00075725|79546524|FG011|Overall Study|Withdrawal by Subject|0|||
44535511|NCT00075725|79546513|FG000|Overall Study|Disease Progression, all other reasons|17|||
44535512|NCT00075725|79546514|FG001|Overall Study|Disease Progression, all other reasons|5|||
44535513|NCT00075725|79546515|FG002|Overall Study|Disease Progression, all other reasons|33|||
44535514|NCT00075725|79546516|FG003|Overall Study|Disease Progression, all other reasons|6|||
44535515|NCT00075725|79546517|FG004|Overall Study|Disease Progression, all other reasons|21|||
44535516|NCT00075725|79546518|FG005|Overall Study|Disease Progression, all other reasons|59|||
44535517|NCT00075725|79546519|FG006|Overall Study|Disease Progression, all other reasons|20|||
44535518|NCT00075725|79546520|FG007|Overall Study|Disease Progression, all other reasons|46|||
44535519|NCT00075725|79546521|FG008|Overall Study|Disease Progression, all other reasons|21|||
44535520|NCT00075725|79546522|FG009|Overall Study|Disease Progression, all other reasons|4|||
44535521|NCT00075725|79546523|FG010|Overall Study|Disease Progression, all other reasons|0|||
44535522|NCT00075725|79546524|FG011|Overall Study|Disease Progression, all other reasons|5|||
44535523|NCT00075725|79546513|FG000|Overall Study|Patient off treatment|0|||
44535524|NCT00075725|79546514|FG001|Overall Study|Patient off treatment|0|||
44535525|NCT00075725|79546515|FG002|Overall Study|Patient off treatment|1|||
44310763|NCT00474253|79313028|FG000|Overall Study|Withdrew consent|2|||
44535526|NCT00075725|79546516|FG003|Overall Study|Patient off treatment|2|||
44535527|NCT00075725|79546517|FG004|Overall Study|Patient off treatment|1|||
44535528|NCT00075725|79546518|FG005|Overall Study|Patient off treatment|0|||
44535529|NCT00075725|79546519|FG006|Overall Study|Patient off treatment|0|||
44535530|NCT00075725|79546520|FG007|Overall Study|Patient off treatment|2|||
44535531|NCT00075725|79546521|FG008|Overall Study|Patient off treatment|1|||
44310764|NCT00474253|79313029|FG001|Overall Study|Withdrew consent|0|||
44310765|NCT00474253|79313028|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
44535532|NCT00075725|79546522|FG009|Overall Study|Patient off treatment|0|||
44535533|NCT00075725|79546523|FG010|Overall Study|Patient off treatment|0|||
44310766|NCT00474253|79313029|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
44535534|NCT00075725|79546524|FG011|Overall Study|Patient off treatment|0|||
44535535|NCT00075725|79546513|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
44535536|NCT00075725|79546514|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
44535537|NCT00075725|79546515|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
44535538|NCT00075725|79546516|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
44535539|NCT00075725|79546517|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
44535540|NCT00075725|79546518|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
44535541|NCT00075725|79546519|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
44535542|NCT00075725|79546520|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
44535543|NCT00075725|79546521|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
44535544|NCT00075725|79546522|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
44535545|NCT00075725|79546523|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
44535546|NCT00075725|79546524|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
44535547|NCT00075725|79546513|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
44535548|NCT00075725|79546514|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
44535549|NCT00075725|79546515|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
44535550|NCT00075725|79546516|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
44535551|NCT00075725|79546517|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
44535552|NCT00075725|79546518|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
44535553|NCT00075725|79546519|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
44535554|NCT00075725|79546520|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
44535555|NCT00075725|79546521|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
44535556|NCT00075725|79546522|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
44535557|NCT00075725|79546523|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
44535558|NCT00075725|79546524|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
44535559|NCT00075725|79546513|FG000|Overall Study|Pt non compliant with therapy|2|||
44535560|NCT00075725|79546514|FG001|Overall Study|Pt non compliant with therapy|1|||
44535561|NCT00075725|79546515|FG002|Overall Study|Pt non compliant with therapy|1|||
44535562|NCT00075725|79546516|FG003|Overall Study|Pt non compliant with therapy|0|||
44535563|NCT00075725|79546517|FG004|Overall Study|Pt non compliant with therapy|2|||
44535564|NCT00075725|79546518|FG005|Overall Study|Pt non compliant with therapy|14|||
44535565|NCT00075725|79546519|FG006|Overall Study|Pt non compliant with therapy|2|||
44535566|NCT00075725|79546520|FG007|Overall Study|Pt non compliant with therapy|5|||
44535567|NCT00075725|79546521|FG008|Overall Study|Pt non compliant with therapy|3|||
44535568|NCT00075725|79546522|FG009|Overall Study|Pt non compliant with therapy|0|||
44535569|NCT00075725|79546523|FG010|Overall Study|Pt non compliant with therapy|0|||
44535570|NCT00075725|79546524|FG011|Overall Study|Pt non compliant with therapy|0|||
44535571|NCT00075725|79546513|FG000|Overall Study|Pt age out of range for treatment|0|||
44535572|NCT00075725|79546514|FG001|Overall Study|Pt age out of range for treatment|1|||
44535573|NCT00075725|79546515|FG002|Overall Study|Pt age out of range for treatment|0|||
44535574|NCT00075725|79546516|FG003|Overall Study|Pt age out of range for treatment|0|||
44535575|NCT00075725|79546517|FG004|Overall Study|Pt age out of range for treatment|0|||
44535576|NCT00075725|79546518|FG005|Overall Study|Pt age out of range for treatment|1|||
44535577|NCT00075725|79546519|FG006|Overall Study|Pt age out of range for treatment|0|||
44535578|NCT00075725|79546520|FG007|Overall Study|Pt age out of range for treatment|1|||
44535579|NCT00075725|79546521|FG008|Overall Study|Pt age out of range for treatment|0|||
44535580|NCT00075725|79546522|FG009|Overall Study|Pt age out of range for treatment|0|||
44535581|NCT00075725|79546523|FG010|Overall Study|Pt age out of range for treatment|0|||
44535582|NCT00075725|79546524|FG011|Overall Study|Pt age out of range for treatment|0|||
44535583|NCT00075725|79546513|FG000|Overall Study|Insurance issues|0|||
44535584|NCT00075725|79546514|FG001|Overall Study|Insurance issues|1|||
44535585|NCT00075725|79546515|FG002|Overall Study|Insurance issues|0|||
44535586|NCT00075725|79546516|FG003|Overall Study|Insurance issues|1|||
44535587|NCT00075725|79546517|FG004|Overall Study|Insurance issues|1|||
44535588|NCT00075725|79546518|FG005|Overall Study|Insurance issues|1|||
44535589|NCT00075725|79546519|FG006|Overall Study|Insurance issues|0|||
44535590|NCT00075725|79546520|FG007|Overall Study|Insurance issues|1|||
44535591|NCT00075725|79546521|FG008|Overall Study|Insurance issues|0|||
44535592|NCT00075725|79546522|FG009|Overall Study|Insurance issues|0|||
44535593|NCT00075725|79546523|FG010|Overall Study|Insurance issues|0|||
44535594|NCT00075725|79546524|FG011|Overall Study|Insurance issues|0|||
44535595|NCT00075725|79546513|FG000|Overall Study|MRD positive after extended ind|0|||
44535596|NCT00075725|79546514|FG001|Overall Study|MRD positive after extended ind|1|||
44535597|NCT00075725|79546515|FG002|Overall Study|MRD positive after extended ind|1|||
44535598|NCT00075725|79546516|FG003|Overall Study|MRD positive after extended ind|0|||
44535599|NCT00075725|79546517|FG004|Overall Study|MRD positive after extended ind|1|||
44535600|NCT00075725|79546518|FG005|Overall Study|MRD positive after extended ind|2|||
44535601|NCT00075725|79546519|FG006|Overall Study|MRD positive after extended ind|0|||
44535602|NCT00075725|79546520|FG007|Overall Study|MRD positive after extended ind|1|||
44535603|NCT00075725|79546521|FG008|Overall Study|MRD positive after extended ind|0|||
44257660|NCT01431950|79110761|FG000|Overall Study|Adverse Event|2|||
44535604|NCT00075725|79546522|FG009|Overall Study|MRD positive after extended ind|0|||
44535605|NCT00075725|79546523|FG010|Overall Study|MRD positive after extended ind|0|||
44535606|NCT00075725|79546524|FG011|Overall Study|MRD positive after extended ind|0|||
44535607|NCT00075725|79546513|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
44535608|NCT00075725|79546514|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
44535609|NCT00075725|79546515|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
44535610|NCT00075725|79546516|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
44535611|NCT00075725|79546517|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
44535612|NCT00075725|79546518|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
44535613|NCT00075725|79546519|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
44535614|NCT00075725|79546520|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
44535615|NCT00075725|79546521|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
44535616|NCT00075725|79546522|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
44535617|NCT00075725|79546523|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
44535618|NCT00075725|79546524|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
44535619|NCT00075725|79546513|FG000|Overall Study|Inevaluable|1|||
44535620|NCT00075725|79546514|FG001|Overall Study|Inevaluable|1|||
44535621|NCT00075725|79546515|FG002|Overall Study|Inevaluable|4|||
44535622|NCT00075725|79546516|FG003|Overall Study|Inevaluable|2|||
44535623|NCT00075725|79546517|FG004|Overall Study|Inevaluable|2|||
44535624|NCT00075725|79546518|FG005|Overall Study|Inevaluable|9|||
44535625|NCT00075725|79546519|FG006|Overall Study|Inevaluable|1|||
44535626|NCT00075725|79546520|FG007|Overall Study|Inevaluable|11|||
44535627|NCT00075725|79546521|FG008|Overall Study|Inevaluable|2|||
44535628|NCT00075725|79546522|FG009|Overall Study|Inevaluable|0|||
44535629|NCT00075725|79546523|FG010|Overall Study|Inevaluable|1|||
44535630|NCT00075725|79546524|FG011|Overall Study|Inevaluable|0|||
44535631|NCT00075725|79546513|FG000|Overall Study|Other|4|||
44419877|NCT00806585|79427684|FG002|Overall Study|Adverse Event|3|||
44419878|NCT00806585|79427685|FG003|Overall Study|Adverse Event|4|||
44419879|NCT00806585|79427686|FG004|Overall Study|Adverse Event|2|||
44419880|NCT00806585|79427682|FG000|Overall Study|Withdrawal by Subject|10|||
44419881|NCT00806585|79427683|FG001|Overall Study|Withdrawal by Subject|8|||
44419882|NCT00806585|79427684|FG002|Overall Study|Withdrawal by Subject|9|||
44419883|NCT00806585|79427685|FG003|Overall Study|Withdrawal by Subject|3|||
44419884|NCT00806585|79427686|FG004|Overall Study|Withdrawal by Subject|11|||
44419885|NCT00806585|79427682|FG000|Overall Study|Completion status unknown|15|||
44419886|NCT00806585|79427683|FG001|Overall Study|Completion status unknown|14|||
44419887|NCT00806585|79427684|FG002|Overall Study|Completion status unknown|12|||
44419888|NCT00806585|79427685|FG003|Overall Study|Completion status unknown|4|||
44419889|NCT00806585|79427686|FG004|Overall Study|Completion status unknown|12|||
44419890|NCT00480025|79427700|FG000|Overall Study|Protocol Violation|12|||
44419891|NCT00480025|79427701|FG001|Overall Study|Protocol Violation|7|||
44419892|NCT00480025|79427700|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
44419893|NCT00480025|79427701|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
44419894|NCT00480025|79427700|FG000|Overall Study|Disease Progression / Recurrence|449|||
44419895|NCT00480025|79427701|FG001|Overall Study|Disease Progression / Recurrence|224|||
44419896|NCT00480025|79427700|FG000|Overall Study|Adverse Event|44|||
44419897|NCT00480025|79427701|FG001|Overall Study|Adverse Event|12|||
44419898|NCT00480025|79427700|FG000|Overall Study|Other|70|||
44419899|NCT00480025|79427701|FG001|Overall Study|Other|29|||
44419900|NCT00480025|79427700|FG000|Overall Study|SAE including intercurrent illness|76|||
44419901|NCT00480025|79427701|FG001|Overall Study|SAE including intercurrent illness|42|||
44419902|NCT00806351|79427715|FG000|Overall Study|Death|5|||
44419903|NCT00806351|79427716|FG001|Overall Study|Death|4|||
44535632|NCT00075725|79546514|FG001|Overall Study|Other|2|||
44535633|NCT00075725|79546515|FG002|Overall Study|Other|1|||
44535634|NCT00075725|79546516|FG003|Overall Study|Other|1|||
44535635|NCT00075725|79546517|FG004|Overall Study|Other|1|||
44535636|NCT00075725|79546518|FG005|Overall Study|Other|4|||
44535637|NCT00075725|79546519|FG006|Overall Study|Other|2|||
44419904|NCT00733902|79427726|FG000|Overall Study|Death|0|||
44419905|NCT00733902|79427727|FG001|Overall Study|Death|0|||
44419906|NCT00733902|79427728|FG002|Overall Study|Death|0|||
44419907|NCT00733902|79427729|FG003|Overall Study|Death|1|||
44419908|NCT00733902|79427726|FG000|Overall Study|Adverse Event|3|||
44535638|NCT00075725|79546520|FG007|Overall Study|Other|9|||
44535639|NCT00075725|79546521|FG008|Overall Study|Other|2|||
44535640|NCT00075725|79546522|FG009|Overall Study|Other|1|||
44419909|NCT00733902|79427727|FG001|Overall Study|Adverse Event|4|||
44535641|NCT00075725|79546523|FG010|Overall Study|Other|0|||
44535642|NCT00075725|79546524|FG011|Overall Study|Other|3|||
44535643|NCT00075725|79546513|FG000|Overall Study|Pt trying to find a BM donor|0|||
44535644|NCT00075725|79546514|FG001|Overall Study|Pt trying to find a BM donor|1|||
44419910|NCT00733902|79427728|FG002|Overall Study|Adverse Event|7|||
44419911|NCT00733902|79427729|FG003|Overall Study|Adverse Event|11|||
44535645|NCT00075725|79546515|FG002|Overall Study|Pt trying to find a BM donor|0|||
44535646|NCT00075725|79546516|FG003|Overall Study|Pt trying to find a BM donor|0|||
44419912|NCT00733902|79427726|FG000|Overall Study|Lack of Efficacy|56|||
44419913|NCT00733902|79427727|FG001|Overall Study|Lack of Efficacy|21|||
44419914|NCT00733902|79427728|FG002|Overall Study|Lack of Efficacy|34|||
44419915|NCT00733902|79427729|FG003|Overall Study|Lack of Efficacy|23|||
44419916|NCT00733902|79427726|FG000|Overall Study|Protocol Violation|4|||
44419917|NCT00733902|79427727|FG001|Overall Study|Protocol Violation|6|||
44535647|NCT00075725|79546517|FG004|Overall Study|Pt trying to find a BM donor|0|||
44535648|NCT00075725|79546518|FG005|Overall Study|Pt trying to find a BM donor|0|||
44535649|NCT00075725|79546519|FG006|Overall Study|Pt trying to find a BM donor|0|||
44419918|NCT00733902|79427728|FG002|Overall Study|Protocol Violation|3|||
44419919|NCT00733902|79427729|FG003|Overall Study|Protocol Violation|3|||
44419920|NCT00733902|79427726|FG000|Overall Study|Withdrawal by Subject|10|||
44419921|NCT00733902|79427727|FG001|Overall Study|Withdrawal by Subject|5|||
44419922|NCT00733902|79427728|FG002|Overall Study|Withdrawal by Subject|4|||
44535650|NCT00075725|79546520|FG007|Overall Study|Pt trying to find a BM donor|0|||
44535651|NCT00075725|79546521|FG008|Overall Study|Pt trying to find a BM donor|0|||
44535652|NCT00075725|79546522|FG009|Overall Study|Pt trying to find a BM donor|0|||
44535653|NCT00075725|79546523|FG010|Overall Study|Pt trying to find a BM donor|0|||
44535654|NCT00075725|79546524|FG011|Overall Study|Pt trying to find a BM donor|0|||
44535655|NCT00075725|79546513|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
44155489|NCT01998958|78946965|FG018|Open Label Phase (Optional)|Other|0|||
44155490|NCT01998958|78946966|FG019|Open Label Phase (Optional)|Other|0|||
44155491|NCT01998958|78946967|FG020|Open Label Phase (Optional)|Other|0|||
44257661|NCT01431950|79110762|FG001|Overall Study|Adverse Event|2|||
44257662|NCT01431950|79110761|FG000|Overall Study|Physician Decision|2|||
44257663|NCT01431950|79110762|FG001|Overall Study|Physician Decision|1|||
44257664|NCT01431950|79110761|FG000|Overall Study|Lack of Efficacy|2|||
44257665|NCT01431950|79110762|FG001|Overall Study|Lack of Efficacy|1|||
44257666|NCT01431950|79110761|FG000|Overall Study|Lost to Follow-up|0|||
44257667|NCT01431950|79110762|FG001|Overall Study|Lost to Follow-up|1|||
44257668|NCT01431950|79110761|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44257669|NCT01431950|79110762|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44257670|NCT00551031|79110773|FG000|Overall Study|Adverse Event|0|||
44257671|NCT00551031|79110774|FG001|Overall Study|Adverse Event|1|||
44257672|NCT00551031|79110775|FG002|Overall Study|Adverse Event|0|||
44257673|NCT00551031|79110776|FG003|Overall Study|Adverse Event|0|||
44257674|NCT00551031|79110777|FG004|Overall Study|Adverse Event|0|||
44257675|NCT00551031|79110773|FG000|Overall Study|Protocol Violation|1|||
44257676|NCT00551031|79110774|FG001|Overall Study|Protocol Violation|1|||
44257677|NCT00551031|79110775|FG002|Overall Study|Protocol Violation|0|||
44257678|NCT00551031|79110776|FG003|Overall Study|Protocol Violation|0|||
44257679|NCT00551031|79110777|FG004|Overall Study|Protocol Violation|0|||
44257680|NCT00551031|79110773|FG000|Overall Study|Lost to Follow-up|0|||
44257681|NCT00551031|79110774|FG001|Overall Study|Lost to Follow-up|1|||
44257682|NCT00551031|79110775|FG002|Overall Study|Lost to Follow-up|0|||
44257683|NCT00551031|79110776|FG003|Overall Study|Lost to Follow-up|1|||
44257684|NCT00551031|79110777|FG004|Overall Study|Lost to Follow-up|1|||
44257685|NCT00551031|79110773|FG000|Overall Study|Withdrawal by Subject|0|||
44257686|NCT00551031|79110774|FG001|Overall Study|Withdrawal by Subject|4|||
44257687|NCT00551031|79110775|FG002|Overall Study|Withdrawal by Subject|1|||
44257688|NCT00551031|79110776|FG003|Overall Study|Withdrawal by Subject|2|||
44257689|NCT00551031|79110777|FG004|Overall Study|Withdrawal by Subject|0|||
44257690|NCT00551031|79110773|FG000|Overall Study|Serious Adverse Event|0|||
44257691|NCT00551031|79110774|FG001|Overall Study|Serious Adverse Event|2|||
44257692|NCT00551031|79110775|FG002|Overall Study|Serious Adverse Event|1|||
44257693|NCT00551031|79110776|FG003|Overall Study|Serious Adverse Event|0|||
44257694|NCT00551031|79110777|FG004|Overall Study|Serious Adverse Event|0|||
44257695|NCT00551031|79110773|FG000|Overall Study|Did not receive vaccine|1|||
44257696|NCT00551031|79110774|FG001|Overall Study|Did not receive vaccine|2|||
44257697|NCT00551031|79110775|FG002|Overall Study|Did not receive vaccine|0|||
44257698|NCT00551031|79110776|FG003|Overall Study|Did not receive vaccine|0|||
44257699|NCT00551031|79110777|FG004|Overall Study|Did not receive vaccine|0|||
44257700|NCT01431716|79110789|FG000|Overall Study|Withdrawal of consent|1|||
44257701|NCT00550953|79110795|FG000|Overall Study|Adverse Event|4|||
44257702|NCT00550953|79110796|FG001|Overall Study|Adverse Event|3|||
44257703|NCT00550953|79110795|FG000|Overall Study|Not able to visit the site|2|||
44257704|NCT00550953|79110796|FG001|Overall Study|Not able to visit the site|3|||
44257705|NCT00558831|79110831|FG000|Overall Study|Lost to Follow-up|1|||
44155492|NCT01998958|78946968|FG021|Open Label Phase (Optional)|Other|0|||
44419923|NCT00733902|79427729|FG003|Overall Study|Withdrawal by Subject|16|||
44419924|NCT00733902|79427726|FG000|Overall Study|Entered extension study|89|||
44535656|NCT00075725|79546514|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
44535657|NCT00075725|79546515|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
44535658|NCT00075725|79546516|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
44535659|NCT00075725|79546517|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
44535660|NCT00075725|79546518|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
44535661|NCT00075725|79546519|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
44535662|NCT00075725|79546520|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
44535663|NCT00075725|79546521|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
44535664|NCT00075725|79546522|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
44535665|NCT00075725|79546523|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
44535666|NCT00075725|79546524|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
44535667|NCT00075725|79546513|FG000|Overall Study|Unsuccessful institutional transfer|0|||
44535668|NCT00075725|79546514|FG001|Overall Study|Unsuccessful institutional transfer|0|||
44535669|NCT00075725|79546515|FG002|Overall Study|Unsuccessful institutional transfer|2|||
44535670|NCT00075725|79546516|FG003|Overall Study|Unsuccessful institutional transfer|0|||
44535671|NCT00075725|79546517|FG004|Overall Study|Unsuccessful institutional transfer|0|||
44535672|NCT00075725|79546518|FG005|Overall Study|Unsuccessful institutional transfer|0|||
44535673|NCT00075725|79546519|FG006|Overall Study|Unsuccessful institutional transfer|0|||
44535674|NCT00075725|79546520|FG007|Overall Study|Unsuccessful institutional transfer|0|||
44535675|NCT00075725|79546521|FG008|Overall Study|Unsuccessful institutional transfer|0|||
44535676|NCT00075725|79546522|FG009|Overall Study|Unsuccessful institutional transfer|1|||
44535677|NCT00075725|79546523|FG010|Overall Study|Unsuccessful institutional transfer|0|||
44535678|NCT00075725|79546524|FG011|Overall Study|Unsuccessful institutional transfer|0|||
44535679|NCT00075725|79546513|FG000|Overall Study|specimen(s) not submitted|0|||
44535680|NCT00075725|79546514|FG001|Overall Study|specimen(s) not submitted|0|||
44535681|NCT00075725|79546515|FG002|Overall Study|specimen(s) not submitted|2|||
44535682|NCT00075725|79546516|FG003|Overall Study|specimen(s) not submitted|0|||
44535683|NCT00075725|79546517|FG004|Overall Study|specimen(s) not submitted|0|||
44535684|NCT00075725|79546518|FG005|Overall Study|specimen(s) not submitted|0|||
44535685|NCT00075725|79546519|FG006|Overall Study|specimen(s) not submitted|0|||
44535686|NCT00075725|79546520|FG007|Overall Study|specimen(s) not submitted|0|||
44535687|NCT00075725|79546521|FG008|Overall Study|specimen(s) not submitted|0|||
44535688|NCT00075725|79546522|FG009|Overall Study|specimen(s) not submitted|0|||
44535689|NCT00075725|79546523|FG010|Overall Study|specimen(s) not submitted|0|||
44535690|NCT00075725|79546524|FG011|Overall Study|specimen(s) not submitted|0|||
44535691|NCT00075725|79546513|FG000|Overall Study|Pt went to transplant|0|||
44535692|NCT00075725|79546514|FG001|Overall Study|Pt went to transplant|0|||
44535693|NCT00075725|79546515|FG002|Overall Study|Pt went to transplant|0|||
44535694|NCT00075725|79546516|FG003|Overall Study|Pt went to transplant|1|||
44535695|NCT00075725|79546517|FG004|Overall Study|Pt went to transplant|0|||
44535696|NCT00075725|79546518|FG005|Overall Study|Pt went to transplant|1|||
44535697|NCT00075725|79546519|FG006|Overall Study|Pt went to transplant|0|||
44535698|NCT00075725|79546520|FG007|Overall Study|Pt went to transplant|0|||
44535699|NCT00075725|79546521|FG008|Overall Study|Pt went to transplant|0|||
44535700|NCT00075725|79546522|FG009|Overall Study|Pt went to transplant|0|||
44535701|NCT00075725|79546523|FG010|Overall Study|Pt went to transplant|0|||
44535702|NCT00075725|79546524|FG011|Overall Study|Pt went to transplant|0|||
44535703|NCT00075725|79546513|FG000|Overall Study|Pt received additional steroids|0|||
44535704|NCT00075725|79546514|FG001|Overall Study|Pt received additional steroids|0|||
44535705|NCT00075725|79546515|FG002|Overall Study|Pt received additional steroids|0|||
44535706|NCT00075725|79546516|FG003|Overall Study|Pt received additional steroids|1|||
44535707|NCT00075725|79546517|FG004|Overall Study|Pt received additional steroids|0|||
44535708|NCT00075725|79546518|FG005|Overall Study|Pt received additional steroids|0|||
44535709|NCT00075725|79546519|FG006|Overall Study|Pt received additional steroids|0|||
44535710|NCT00075725|79546520|FG007|Overall Study|Pt received additional steroids|0|||
44535711|NCT00075725|79546521|FG008|Overall Study|Pt received additional steroids|0|||
44535712|NCT00075725|79546522|FG009|Overall Study|Pt received additional steroids|0|||
44535713|NCT00075725|79546523|FG010|Overall Study|Pt received additional steroids|0|||
44535714|NCT00075725|79546524|FG011|Overall Study|Pt received additional steroids|0|||
44535715|NCT00075725|79546513|FG000|Overall Study|Pt relocated|0|||
44535716|NCT00075725|79546514|FG001|Overall Study|Pt relocated|0|||
44535717|NCT00075725|79546515|FG002|Overall Study|Pt relocated|0|||
44535718|NCT00075725|79546516|FG003|Overall Study|Pt relocated|2|||
44535719|NCT00075725|79546517|FG004|Overall Study|Pt relocated|0|||
44535720|NCT00075725|79546518|FG005|Overall Study|Pt relocated|1|||
44535721|NCT00075725|79546519|FG006|Overall Study|Pt relocated|1|||
44535722|NCT00075725|79546520|FG007|Overall Study|Pt relocated|2|||
44257706|NCT01431638|79110840|FG000|Overall Study|Adverse Event|1|||
44535723|NCT00075725|79546521|FG008|Overall Study|Pt relocated|1|||
44535724|NCT00075725|79546522|FG009|Overall Study|Pt relocated|0|||
44535725|NCT00075725|79546523|FG010|Overall Study|Pt relocated|0|||
44535726|NCT00075725|79546524|FG011|Overall Study|Pt relocated|0|||
44535727|NCT00075725|79546513|FG000|Overall Study|Institution Terminated|0|||
44535728|NCT00075725|79546514|FG001|Overall Study|Institution Terminated|0|||
44535729|NCT00075725|79546515|FG002|Overall Study|Institution Terminated|0|||
44535730|NCT00075725|79546516|FG003|Overall Study|Institution Terminated|0|||
44535731|NCT00075725|79546517|FG004|Overall Study|Institution Terminated|1|||
44535732|NCT00075725|79546518|FG005|Overall Study|Institution Terminated|0|||
44535733|NCT00075725|79546519|FG006|Overall Study|Institution Terminated|0|||
44535734|NCT00075725|79546520|FG007|Overall Study|Institution Terminated|3|||
44535735|NCT00075725|79546521|FG008|Overall Study|Institution Terminated|0|||
44535736|NCT00075725|79546522|FG009|Overall Study|Institution Terminated|0|||
44535737|NCT00075725|79546523|FG010|Overall Study|Institution Terminated|0|||
44535738|NCT00075725|79546524|FG011|Overall Study|Institution Terminated|0|||
44535739|NCT00075725|79546513|FG000|Overall Study|Study Closure|1|||
44535740|NCT00075725|79546514|FG001|Overall Study|Study Closure|0|||
44535741|NCT00075725|79546515|FG002|Overall Study|Study Closure|0|||
44535742|NCT00075725|79546516|FG003|Overall Study|Study Closure|0|||
44535743|NCT00075725|79546517|FG004|Overall Study|Study Closure|1|||
44535744|NCT00075725|79546518|FG005|Overall Study|Study Closure|3|||
44535745|NCT00075725|79546519|FG006|Overall Study|Study Closure|0|||
44535746|NCT00075725|79546520|FG007|Overall Study|Study Closure|1|||
44535747|NCT00075725|79546521|FG008|Overall Study|Study Closure|0|||
44535748|NCT00075725|79546522|FG009|Overall Study|Study Closure|0|||
44535749|NCT00075725|79546523|FG010|Overall Study|Study Closure|0|||
44535750|NCT00075725|79546524|FG011|Overall Study|Study Closure|0|||
44535751|NCT00075725|79546513|FG000|Overall Study|Other complications|0|||
44535752|NCT00075725|79546514|FG001|Overall Study|Other complications|0|||
44535753|NCT00075725|79546515|FG002|Overall Study|Other complications|0|||
44535754|NCT00075725|79546516|FG003|Overall Study|Other complications|0|||
44535755|NCT00075725|79546517|FG004|Overall Study|Other complications|0|||
44535756|NCT00075725|79546518|FG005|Overall Study|Other complications|1|||
44535757|NCT00075725|79546519|FG006|Overall Study|Other complications|0|||
44535758|NCT00075725|79546520|FG007|Overall Study|Other complications|0|||
44535759|NCT00075725|79546521|FG008|Overall Study|Other complications|0|||
44535760|NCT00075725|79546522|FG009|Overall Study|Other complications|0|||
44535761|NCT00075725|79546523|FG010|Overall Study|Other complications|0|||
44535762|NCT00075725|79546524|FG011|Overall Study|Other complications|0|||
44535763|NCT00075725|79546513|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
44535764|NCT00075725|79546514|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
44535765|NCT00075725|79546515|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
44535766|NCT00075725|79546516|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
44535767|NCT00075725|79546517|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
44535768|NCT00075725|79546518|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
44535769|NCT00075725|79546519|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
44535770|NCT00075725|79546520|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
44535771|NCT00075725|79546521|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
44535772|NCT00075725|79546522|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
44535773|NCT00075725|79546523|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
44535774|NCT00075725|79546524|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
44535775|NCT00075725|79546513|FG000|Overall Study|Pt incarcerated|0|||
44535776|NCT00075725|79546514|FG001|Overall Study|Pt incarcerated|0|||
44535777|NCT00075725|79546515|FG002|Overall Study|Pt incarcerated|0|||
44535778|NCT00075725|79546516|FG003|Overall Study|Pt incarcerated|0|||
44535779|NCT00075725|79546517|FG004|Overall Study|Pt incarcerated|0|||
44535780|NCT00075725|79546518|FG005|Overall Study|Pt incarcerated|0|||
44535781|NCT00075725|79546519|FG006|Overall Study|Pt incarcerated|0|||
44535782|NCT00075725|79546520|FG007|Overall Study|Pt incarcerated|1|||
44535783|NCT00075725|79546521|FG008|Overall Study|Pt incarcerated|0|||
44535784|NCT00075725|79546522|FG009|Overall Study|Pt incarcerated|0|||
44535785|NCT00075725|79546523|FG010|Overall Study|Pt incarcerated|0|||
44535786|NCT00075725|79546524|FG011|Overall Study|Pt incarcerated|0|||
44535787|NCT02953782|79546563|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
44257707|NCT01431638|79110841|FG001|Overall Study|Adverse Event|3|||
44535788|NCT02953782|79546564|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
44535789|NCT02953782|79546565|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
44535790|NCT02953782|79546566|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
44535791|NCT02953782|79546567|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
44535792|NCT02953782|79546568|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
44535793|NCT02953782|79546569|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
44535794|NCT02953782|79546570|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
44535795|NCT02953782|79546563|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
44535796|NCT02953782|79546564|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
44535797|NCT02953782|79546565|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
44535798|NCT02953782|79546566|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
44535799|NCT02953782|79546567|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
44535800|NCT02953782|79546568|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
44535801|NCT02953782|79546569|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
44535802|NCT02953782|79546570|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
44535803|NCT02953782|79546563|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
44535804|NCT02953782|79546564|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
44535805|NCT02953782|79546565|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
44535806|NCT02953782|79546566|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
44535807|NCT02953782|79546567|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
44535808|NCT02953782|79546568|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
44535809|NCT02953782|79546569|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
44535810|NCT02953782|79546570|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
44535811|NCT02953782|79546563|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
44535812|NCT02953782|79546564|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
44535813|NCT02953782|79546565|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
44535814|NCT02953782|79546566|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
44535815|NCT02953782|79546567|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
44535816|NCT02953782|79546568|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
44535817|NCT02953782|79546569|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
44535818|NCT02953782|79546570|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
44535819|NCT02953782|79546563|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
44535820|NCT02953782|79546564|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
44535821|NCT02953782|79546565|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
44535822|NCT02953782|79546566|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
44535823|NCT02953782|79546567|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
44535824|NCT02953782|79546568|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
44535825|NCT02953782|79546569|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
44535826|NCT02953782|79546570|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
44535827|NCT02953782|79546563|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
44535828|NCT02953782|79546564|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
44535829|NCT02953782|79546565|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
44535830|NCT02953782|79546566|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
44535831|NCT02953782|79546567|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
44535832|NCT02953782|79546568|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
44535833|NCT02953782|79546569|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
44535834|NCT02953782|79546570|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
44535835|NCT02953782|79546563|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
44535836|NCT02953782|79546564|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
44535837|NCT02953782|79546565|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
44535838|NCT02953782|79546566|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
44535839|NCT02953782|79546567|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
44535840|NCT02953782|79546568|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
44535841|NCT02953782|79546569|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
44535842|NCT02953782|79546570|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
44535843|NCT02953782|79546563|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535844|NCT02953782|79546564|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535845|NCT02953782|79546565|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535846|NCT02953782|79546566|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535847|NCT02953782|79546567|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535848|NCT02953782|79546568|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535849|NCT02953782|79546569|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
44535850|NCT02953782|79546570|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
44535851|NCT03760081|79546593|FG000|Overall Study|Miscellaneous|0|||
44535852|NCT03760081|79546594|FG001|Overall Study|Miscellaneous|1|||
44535853|NCT03760081|79546593|FG000|Overall Study|Progressive Disease|5|||
44155493|NCT01998958|78946969|FG022|Open Label Phase (Optional)|Other|5|||
44310767|NCT00474253|79313028|FG000|Overall Study|Lost to Follow-up|1|||
44310768|NCT00474253|79313029|FG001|Overall Study|Lost to Follow-up|0|||
44310769|NCT00474253|79313028|FG000|Overall Study|Discharged prior to study completion|0|||
44310770|NCT00474253|79313029|FG001|Overall Study|Discharged prior to study completion|1|||
44310771|NCT00474058|79313037|FG000|Overall Study|Adverse Event|11|||
44310772|NCT00474058|79313038|FG001|Overall Study|Adverse Event|6|||
44310773|NCT00474058|79313037|FG000|Overall Study|Lack of Efficacy|0|||
44310774|NCT00474058|79313038|FG001|Overall Study|Lack of Efficacy|4|||
44310775|NCT00474058|79313037|FG000|Overall Study|Withdrawal by Subject|11|||
44310776|NCT00474058|79313038|FG001|Overall Study|Withdrawal by Subject|7|||
44310777|NCT00474058|79313037|FG000|Overall Study|Other|2|||
44310778|NCT00474058|79313038|FG001|Overall Study|Other|0|||
44310779|NCT00473824|79313046|FG000|Overall Study|Virologic Breakthrough|1|||
44310780|NCT00473824|79313047|FG001|Overall Study|Virologic Breakthrough|0|||
44310781|NCT00473824|79313046|FG000|Overall Study|Adverse Event|1|||
44310782|NCT00473824|79313047|FG001|Overall Study|Adverse Event|0|||
44310783|NCT00473824|79313046|FG000|Overall Study|Death|1|||
44310784|NCT00473824|79313047|FG001|Overall Study|Death|0|||
44310785|NCT00473824|79313046|FG000|Overall Study|Lost to Follow-up|1|||
44310786|NCT00473824|79313047|FG001|Overall Study|Lost to Follow-up|0|||
44310787|NCT00473824|79313046|FG000|Overall Study|Withdrawal by physician|1|||
44310788|NCT00473824|79313047|FG001|Overall Study|Withdrawal by physician|0|||
44310789|NCT00473746|79313058|FG000|Period 1 (Phase 1)|Adverse Event|1|||
44310790|NCT00473746|79313059|FG001|Period 1 (Phase 1)|Adverse Event|0|||
44310791|NCT00473746|79313060|FG002|Period 1 (Phase 1)|Adverse Event|0|||
44310792|NCT00473746|79313061|FG003|Period 1 (Phase 1)|Adverse Event|0|||
44310793|NCT00473746|79313062|FG004|Period 1 (Phase 1)|Adverse Event|0|||
44310794|NCT00473746|79313058|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
44310795|NCT00473746|79313059|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
44310796|NCT00473746|79313060|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
44310797|NCT00473746|79313061|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
44535854|NCT03760081|79546594|FG001|Overall Study|Progressive Disease|10|||
44535855|NCT03760081|79546593|FG000|Overall Study|Death|1|||
44535856|NCT03760081|79546594|FG001|Overall Study|Death|1|||
44535857|NCT03422172|79546602|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
44535858|NCT03422172|79546602|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
44535859|NCT03422172|79546602|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
44535860|NCT00057863|79546611|FG000|Overall Study|Death|1|||
44535861|NCT00057863|79546611|FG000|Overall Study|Withdrawal by Subject|2|||
44535862|NCT00075023|79546617|FG000|Pilot Study|Physician Decision|1|||
44535863|NCT00075023|79546618|FG001|Pilot Study|Physician Decision|2|||
44535864|NCT00075023|79546617|FG000|Pilot Study|Withdrawal by Subject|1|||
44535865|NCT00075023|79546618|FG001|Pilot Study|Withdrawal by Subject|0|||
44535866|NCT00074711|79546627|FG000|Overall Study|Withdrawal by Subject|1|||
44535867|NCT00074711|79546628|FG001|Overall Study|Withdrawal by Subject|1|||
44535868|NCT00074711|79546627|FG000|Overall Study|Lost to Follow-up|10|||
44535869|NCT00074711|79546628|FG001|Overall Study|Lost to Follow-up|8|||
44535870|NCT00074711|79546627|FG000|Overall Study|Participant stopped study drug|4|||
44535871|NCT00074711|79546628|FG001|Overall Study|Participant stopped study drug|6|||
44535872|NCT03420300|79546634|FG000|Overall Study|Death|2|||
44535873|NCT03419598|79546638|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
44535874|NCT03407430|79546646|FG000|Washout|Protocol Violation|1|||
44535875|NCT03407430|79546647|FG001|Washout|Protocol Violation|0|||
44535876|NCT03407118|79546660|FG000|Period 2|Withdrawal by Subject|1|||
44535877|NCT03407118|79546661|FG001|Period 2|Withdrawal by Subject|0|||
44535878|NCT03406962|79546667|FG000|Overall Study|Death|2|||
44535879|NCT03406962|79546667|FG000|Overall Study|Adverse Event|1|||
44535880|NCT03406260|79546678|FG000|Period 1|Adverse Event|0|||
44535881|NCT03406260|79546679|FG001|Period 1|Adverse Event|0|||
44535882|NCT03406260|79546680|FG002|Period 1|Adverse Event|0|||
44535883|NCT03406260|79546681|FG003|Period 1|Adverse Event|0|||
44535884|NCT03406260|79546682|FG004|Period 1|Adverse Event|1|||
44535885|NCT03406260|79546683|FG005|Period 1|Adverse Event|0|||
44535886|NCT03419364|79546696|FG000|Overall Study|Delivery due to maternal condition|2|||
44535887|NCT03419364|79546697|FG001|Overall Study|Delivery due to maternal condition|0|||
44535888|NCT03419364|79546698|FG002|Overall Study|Delivery due to maternal condition|0|||
44310798|NCT00473746|79313062|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
44310799|NCT00473746|79313058|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
44310800|NCT00473746|79313059|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
44310801|NCT00473746|79313060|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
44310802|NCT00473746|79313061|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
44310803|NCT00473746|79313062|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
44310804|NCT00473746|79313058|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
44535889|NCT02954172|79546708|FG000|Overall Study|Protocol Violation|3|||
44535890|NCT02954172|79546709|FG001|Overall Study|Protocol Violation|0|||
44535891|NCT02954172|79546708|FG000|Overall Study|allergic reaction|2|||
44535892|NCT02954172|79546709|FG001|Overall Study|allergic reaction|1|||
44535893|NCT02954172|79546708|FG000|Overall Study|non-measurable lesions at baseline|1|||
44535894|NCT02954172|79546709|FG001|Overall Study|non-measurable lesions at baseline|2|||
44535895|NCT02953938|79546718|FG000|Overall Study|Adverse Event|0|||
44535896|NCT02953938|79546719|FG001|Overall Study|Adverse Event|1|||
44535897|NCT02953938|79546718|FG000|Overall Study|Withdrawal by Subject|1|||
44535898|NCT02953938|79546719|FG001|Overall Study|Withdrawal by Subject|1|||
44535899|NCT03758443|79546730|FG000|Induction Period|Adverse Event|2|||
44535900|NCT03758443|79546731|FG001|Induction Period|Adverse Event|4|||
44535901|NCT03758443|79546732|FG002|Induction Period|Adverse Event|2|||
44535902|NCT03758443|79546733|FG003|Induction Period|Adverse Event|3|||
44535903|NCT03758443|79546730|FG000|Induction Period|Physician Decision|1|||
44535904|NCT03758443|79546731|FG001|Induction Period|Physician Decision|1|||
44535905|NCT03758443|79546732|FG002|Induction Period|Physician Decision|3|||
44535906|NCT03758443|79546733|FG003|Induction Period|Physician Decision|0|||
44535907|NCT03758443|79546730|FG000|Induction Period|Protocol Violation|0|||
44535908|NCT03758443|79546731|FG001|Induction Period|Protocol Violation|0|||
44535909|NCT03758443|79546732|FG002|Induction Period|Protocol Violation|0|||
44310805|NCT00473746|79313059|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
44310806|NCT00473746|79313060|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
44310807|NCT00473746|79313061|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
44310808|NCT00473746|79313062|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
44310809|NCT00473746|79313058|FG000|Period 1 (Phase 1)|Reason not specified|0|||
44310810|NCT00473746|79313059|FG001|Period 1 (Phase 1)|Reason not specified|1|||
44310811|NCT00473746|79313060|FG002|Period 1 (Phase 1)|Reason not specified|0|||
44310812|NCT00473746|79313061|FG003|Period 1 (Phase 1)|Reason not specified|0|||
44310813|NCT00473746|79313062|FG004|Period 1 (Phase 1)|Reason not specified|0|||
44310814|NCT00473746|79313058|FG000|Period 2 (Phase 2)|Adverse Event|0|||
44310815|NCT00473746|79313059|FG001|Period 2 (Phase 2)|Adverse Event|0|||
44310816|NCT00473746|79313060|FG002|Period 2 (Phase 2)|Adverse Event|0|||
44310817|NCT00473746|79313061|FG003|Period 2 (Phase 2)|Adverse Event|0|||
44310818|NCT00473746|79313062|FG004|Period 2 (Phase 2)|Adverse Event|3|||
44310819|NCT00473746|79313058|FG000|Period 2 (Phase 2)|Death|0|||
44310820|NCT00473746|79313059|FG001|Period 2 (Phase 2)|Death|0|||
44310821|NCT00473746|79313060|FG002|Period 2 (Phase 2)|Death|0|||
44310822|NCT00473746|79313061|FG003|Period 2 (Phase 2)|Death|0|||
44310823|NCT00473746|79313062|FG004|Period 2 (Phase 2)|Death|1|||
44310824|NCT00473746|79313058|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
44310825|NCT00473746|79313059|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
44310826|NCT00473746|79313060|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
44310827|NCT00473746|79313061|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
44310828|NCT00473746|79313062|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
44310829|NCT00473746|79313058|FG000|Period 2 (Phase 2)|Reason not specified|0|||
44310830|NCT00473746|79313059|FG001|Period 2 (Phase 2)|Reason not specified|0|||
44310831|NCT00473746|79313060|FG002|Period 2 (Phase 2)|Reason not specified|0|||
44310832|NCT00473746|79313061|FG003|Period 2 (Phase 2)|Reason not specified|0|||
44310833|NCT00473746|79313062|FG004|Period 2 (Phase 2)|Reason not specified|3|||
44310834|NCT00473668|79313079|FG000|Overall Study|Withdrawal by Subject|0|||
44310835|NCT00473668|79313080|FG001|Overall Study|Withdrawal by Subject|2|||
44310836|NCT00473668|79313081|FG002|Overall Study|Withdrawal by Subject|0|||
44310837|NCT00473668|79313079|FG000|Overall Study|Migrated/moved from study area|3|||
44310838|NCT00473668|79313080|FG001|Overall Study|Migrated/moved from study area|2|||
44310839|NCT00473668|79313081|FG002|Overall Study|Migrated/moved from study area|0|||
44310840|NCT00473668|79313079|FG000|Overall Study|Lost to Follow-up|0|||
44310841|NCT00473668|79313080|FG001|Overall Study|Lost to Follow-up|4|||
44310842|NCT00473668|79313081|FG002|Overall Study|Lost to Follow-up|6|||
44310843|NCT00473668|79313079|FG000|Overall Study|Other|2|||
44310844|NCT00473668|79313080|FG001|Overall Study|Other|3|||
44310845|NCT00473668|79313081|FG002|Overall Study|Other|4|||
44310846|NCT00473590|79313091|FG000|Overall Study|Adverse Event|3|||
44310847|NCT00473590|79313092|FG001|Overall Study|Adverse Event|3|||
44310848|NCT00473590|79313091|FG000|Overall Study|Death|4|||
44310849|NCT00473590|79313092|FG001|Overall Study|Death|2|||
44310850|NCT00473590|79313091|FG000|Overall Study|Progression not resulting in death|24|||
44310851|NCT00473590|79313092|FG001|Overall Study|Progression not resulting in death|20|||
44310852|NCT00473590|79313091|FG000|Overall Study|Non-protocol-specified therapy|7|||
44310853|NCT00473590|79313092|FG001|Overall Study|Non-protocol-specified therapy|5|||
44310854|NCT00473590|79313091|FG000|Overall Study|Physician Decision|2|||
44535910|NCT03758443|79546733|FG003|Induction Period|Protocol Violation|1|||
44535911|NCT03758443|79546730|FG000|Induction Period|Withdrawal by Subject|3|||
44310855|NCT00473590|79313092|FG001|Overall Study|Physician Decision|4|||
44310856|NCT00473590|79313091|FG000|Overall Study|Withdrawal by Subject|5|||
44535912|NCT03758443|79546731|FG001|Induction Period|Withdrawal by Subject|2|||
44310857|NCT00473590|79313092|FG001|Overall Study|Withdrawal by Subject|3|||
44310858|NCT00473590|79313091|FG000|Overall Study|Other|0|||
44310859|NCT00473590|79313092|FG001|Overall Study|Other|1|||
44310860|NCT00473512|79313103|FG000|Period 1 (Phase 1)|Adverse Event|0|||
44535913|NCT03758443|79546732|FG002|Induction Period|Withdrawal by Subject|2|||
44155494|NCT01998958|78946970|FG023|Open Label Phase (Optional)|Other|1|||
44310861|NCT00473512|79313104|FG001|Period 1 (Phase 1)|Adverse Event|0|||
44310862|NCT00473512|79313105|FG002|Period 1 (Phase 1)|Adverse Event|0|||
44310863|NCT00473512|79313106|FG003|Period 1 (Phase 1)|Adverse Event|5|||
44310864|NCT00473512|79313107|FG004|Period 1 (Phase 1)|Adverse Event|0|||
44310865|NCT00473512|79313103|FG000|Period 1 (Phase 1)|Death|0|||
44310866|NCT00473512|79313104|FG001|Period 1 (Phase 1)|Death|0|||
44310867|NCT00473512|79313105|FG002|Period 1 (Phase 1)|Death|0|||
44310868|NCT00473512|79313106|FG003|Period 1 (Phase 1)|Death|1|||
44310869|NCT00473512|79313107|FG004|Period 1 (Phase 1)|Death|0|||
44310870|NCT00473512|79313103|FG000|Period 1 (Phase 1)|Disease Progression|1|||
44310871|NCT00473512|79313104|FG001|Period 1 (Phase 1)|Disease Progression|1|||
44310872|NCT00473512|79313105|FG002|Period 1 (Phase 1)|Disease Progression|0|||
44310873|NCT00473512|79313106|FG003|Period 1 (Phase 1)|Disease Progression|10|||
44310874|NCT00473512|79313107|FG004|Period 1 (Phase 1)|Disease Progression|1|||
44310875|NCT00473512|79313103|FG000|Period 1 (Phase 1)|Other|0|||
44310876|NCT00473512|79313104|FG001|Period 1 (Phase 1)|Other|0|||
44310877|NCT00473512|79313105|FG002|Period 1 (Phase 1)|Other|0|||
44310878|NCT00473512|79313106|FG003|Period 1 (Phase 1)|Other|1|||
44310879|NCT00473512|79313107|FG004|Period 1 (Phase 1)|Other|0|||
44310880|NCT00473512|79313103|FG000|Period 2 (Phase 2)|Adverse Event|0|||
44310881|NCT00473512|79313104|FG001|Period 2 (Phase 2)|Adverse Event|0|||
44310882|NCT00473512|79313105|FG002|Period 2 (Phase 2)|Adverse Event|0|||
44310883|NCT00473512|79313106|FG003|Period 2 (Phase 2)|Adverse Event|1|||
44310884|NCT00473512|79313107|FG004|Period 2 (Phase 2)|Adverse Event|0|||
44310885|NCT00473512|79313103|FG000|Period 2 (Phase 2)|Death|0|||
44310886|NCT00473512|79313104|FG001|Period 2 (Phase 2)|Death|0|||
44310887|NCT00473512|79313105|FG002|Period 2 (Phase 2)|Death|0|||
44310888|NCT00473512|79313106|FG003|Period 2 (Phase 2)|Death|1|||
44310889|NCT00473512|79313107|FG004|Period 2 (Phase 2)|Death|1|||
44310890|NCT00473512|79313103|FG000|Period 2 (Phase 2)|Disease Progression|0|||
44310891|NCT00473512|79313104|FG001|Period 2 (Phase 2)|Disease Progression|2|||
44310892|NCT00473512|79313105|FG002|Period 2 (Phase 2)|Disease Progression|2|||
44310893|NCT00473512|79313106|FG003|Period 2 (Phase 2)|Disease Progression|17|||
44310894|NCT00473512|79313107|FG004|Period 2 (Phase 2)|Disease Progression|1|||
44310895|NCT00473512|79313103|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
44310896|NCT00473512|79313104|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
44310897|NCT00473512|79313105|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
44310898|NCT00473512|79313106|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
44310899|NCT00473512|79313107|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
44310900|NCT00473512|79313103|FG000|Period 2 (Phase 2)|Other|1|||
44310901|NCT00473512|79313104|FG001|Period 2 (Phase 2)|Other|0|||
44310902|NCT00473512|79313105|FG002|Period 2 (Phase 2)|Other|0|||
44310903|NCT00473512|79313106|FG003|Period 2 (Phase 2)|Other|3|||
44310904|NCT00473512|79313107|FG004|Period 2 (Phase 2)|Other|0|||
44310905|NCT00473434|79313127|FG000|Overall Study|Physician Decision|3|||
44310906|NCT00473434|79313127|FG000|Overall Study|Withdrawal by Subject|9|||
44310907|NCT00473434|79313127|FG000|Overall Study|Compliance|3|||
44310908|NCT00473434|79313127|FG000|Overall Study|Lack of Efficacy|3|||
44310909|NCT00473434|79313127|FG000|Overall Study|Adverse Event|3|||
44310910|NCT00473434|79313127|FG000|Overall Study|Patient was selling medication to others|1|||
44310911|NCT00473434|79313127|FG000|Overall Study|Safety evaluation|1|||
44310912|NCT00473434|79313127|FG000|Overall Study|Reason not specified|6|||
44310913|NCT00473434|79313127|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
44310914|NCT00473434|79313127|FG000|Overall Study|Switching to trial medication|1|||
44310915|NCT00473434|79313127|FG000|Overall Study|No longer required|1|||
44310916|NCT00473083|79313147|FG000|Overall Study|Adverse Event|1|||
44310917|NCT00473083|79313148|FG001|Overall Study|Adverse Event|0|||
44310918|NCT00473083|79313149|FG002|Overall Study|Adverse Event|0|||
44310919|NCT00472420|79313160|FG000|Induction Treatment Period|Physician Decision|9|||
44310920|NCT00472420|79313160|FG000|Induction Treatment Period|Adverse Event|3|||
44310921|NCT00472420|79313160|FG000|Induction Treatment Period|Non-compliance|1|||
44310922|NCT00472420|79313160|FG000|Induction Treatment Period|Death|3|||
44310923|NCT00472420|79313160|FG000|Follow-up Period|Death|5|||
44310924|NCT00472420|79313160|FG000|Follow-up Period|Physician Decision|9|||
44310925|NCT00472420|79313160|FG000|Follow-up Period|Lost to Follow-up|2|||
44310926|NCT00472420|79313160|FG000|Follow-up Period|Protocol Violation|1|||
44310927|NCT00472303|79313166|FG000|Titration Phase|Adverse Event|22|||
44310928|NCT00472303|79313167|FG001|Titration Phase|Adverse Event|12|||
44310929|NCT00472303|79313168|FG002|Titration Phase|Adverse Event|0|||
44310930|NCT00472303|79313166|FG000|Titration Phase|Death|4|||
44310931|NCT00472303|79313167|FG001|Titration Phase|Death|2|||
44310932|NCT00472303|79313168|FG002|Titration Phase|Death|0|||
44310933|NCT00472303|79313166|FG000|Titration Phase|Lack of Efficacy|10|||
44310934|NCT00472303|79313167|FG001|Titration Phase|Lack of Efficacy|0|||
44310935|NCT00472303|79313168|FG002|Titration Phase|Lack of Efficacy|0|||
44310936|NCT00472303|79313166|FG000|Titration Phase|Withdrawal by Subject|16|||
44310937|NCT00472303|79313167|FG001|Titration Phase|Withdrawal by Subject|13|||
44310938|NCT00472303|79313168|FG002|Titration Phase|Withdrawal by Subject|0|||
44310939|NCT00472303|79313166|FG000|Titration Phase|Trial Medication non-compliant|4|||
44310940|NCT00472303|79313167|FG001|Titration Phase|Trial Medication non-compliant|1|||
44310941|NCT00472303|79313168|FG002|Titration Phase|Trial Medication non-compliant|0|||
44310942|NCT00472303|79313166|FG000|Titration Phase|Other|3|||
44310943|NCT00472303|79313167|FG001|Titration Phase|Other|1|||
44310944|NCT00472303|79313168|FG002|Titration Phase|Other|0|||
44310945|NCT00472303|79313166|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
44310946|NCT00472303|79313167|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
44310947|NCT00472303|79313168|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
44310948|NCT00472303|79313166|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
44310949|NCT00472303|79313167|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
44310950|NCT00472303|79313168|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
44310951|NCT00472303|79313166|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
44310952|NCT00472303|79313167|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
44310953|NCT00472303|79313168|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
44310954|NCT00472303|79313166|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
44310955|NCT00472303|79313167|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
44310956|NCT00472303|79313168|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
44310957|NCT00472303|79313166|FG000|Discontinuations After Titration Phase|Other|5|||
44310958|NCT00472303|79313167|FG001|Discontinuations After Titration Phase|Other|0|||
44310959|NCT00472303|79313168|FG002|Discontinuations After Titration Phase|Other|0|||
44310960|NCT00472303|79313166|FG000|Maintenance Phase|Adverse Event|5|||
44310961|NCT00472303|79313167|FG001|Maintenance Phase|Adverse Event|6|||
44310962|NCT00472303|79313168|FG002|Maintenance Phase|Adverse Event|6|||
44310963|NCT00472303|79313166|FG000|Maintenance Phase|Death|3|||
44310964|NCT00472303|79313167|FG001|Maintenance Phase|Death|0|||
44310965|NCT00472303|79313168|FG002|Maintenance Phase|Death|2|||
44310966|NCT00472303|79313166|FG000|Maintenance Phase|Lack of Efficacy|2|||
44310967|NCT00472303|79313167|FG001|Maintenance Phase|Lack of Efficacy|2|||
44310968|NCT00472303|79313168|FG002|Maintenance Phase|Lack of Efficacy|4|||
44310969|NCT00472303|79313166|FG000|Maintenance Phase|Withdrawal by Subject|6|||
44310970|NCT00472303|79313167|FG001|Maintenance Phase|Withdrawal by Subject|7|||
44310971|NCT00472303|79313168|FG002|Maintenance Phase|Withdrawal by Subject|3|||
44310972|NCT00472303|79313166|FG000|Maintenance Phase|Trial medication non-compliant|0|||
44310973|NCT00472303|79313167|FG001|Maintenance Phase|Trial medication non-compliant|0|||
44310974|NCT00472303|79313168|FG002|Maintenance Phase|Trial medication non-compliant|1|||
44310975|NCT00472303|79313166|FG000|Maintenance Phase|Resolution of pain|0|||
44310976|NCT00472303|79313167|FG001|Maintenance Phase|Resolution of pain|0|||
44310977|NCT00472303|79313168|FG002|Maintenance Phase|Resolution of pain|1|||
44310978|NCT00472303|79313166|FG000|Maintenance Phase|Other|1|||
44310979|NCT00472303|79313167|FG001|Maintenance Phase|Other|1|||
44310980|NCT00472303|79313168|FG002|Maintenance Phase|Other|0|||
44310981|NCT00471718|79313196|FG000|Overall Study|Adverse Event|3|||
44310982|NCT00471718|79313196|FG000|Overall Study|other complicating disease|1|||
44310983|NCT00471718|79313196|FG000|Overall Study|disease progression|22|||
44310984|NCT00471718|79313196|FG000|Overall Study|Withdrawal by Subject|1|||
44310985|NCT00471445|79313206|FG000|Overall Study|Withdrawal by Subject|1|||
44310986|NCT00471445|79313207|FG001|Overall Study|Withdrawal by Subject|1|||
44310987|NCT00471445|79313206|FG000|Overall Study|Ineligible|1|||
44310988|NCT00471445|79313207|FG001|Overall Study|Ineligible|0|||
44310989|NCT00471445|79313206|FG000|Overall Study|Protocol Violation|0|||
44310990|NCT00471445|79313207|FG001|Overall Study|Protocol Violation|1|||
44310991|NCT00471328|79313215|FG000|Core Phase|Adverse Event|18|||
44310992|NCT00471328|79313216|FG001|Core Phase|Adverse Event|6|||
44310993|NCT00471328|79313215|FG000|Core Phase|Death|8|||
44310994|NCT00471328|79313216|FG001|Core Phase|Death|4|||
44310995|NCT00471328|79313215|FG000|Core Phase|Withdrawal by Subject|2|||
44310996|NCT00471328|79313216|FG001|Core Phase|Withdrawal by Subject|2|||
44310997|NCT00471328|79313215|FG000|Core Phase|Abnormal laboratory value|1|||
44310998|NCT00471328|79313216|FG001|Core Phase|Abnormal laboratory value|0|||
44310999|NCT00471328|79313215|FG000|Core Phase|Disease Progression|78|||
44311000|NCT00471328|79313216|FG001|Core Phase|Disease Progression|53|||
44311001|NCT00471328|79313215|FG000|Core Phase|Administrative Problem|0|||
44311002|NCT00471328|79313216|FG001|Core Phase|Administrative Problem|1|||
44311003|NCT00471328|79313215|FG000|Core Phase|Protocol Deviation|0|||
44535914|NCT03758443|79546733|FG003|Induction Period|Withdrawal by Subject|4|||
44535915|NCT03758443|79546730|FG000|Extended Induction Period|Adverse Event|1|||
44311004|NCT00471328|79313216|FG001|Core Phase|Protocol Deviation|1|||
44311005|NCT00471328|79313215|FG000|Extension Phase|Adverse Event|3|||
44311006|NCT00471328|79313216|FG001|Extension Phase|Adverse Event|12|||
44311007|NCT00471328|79313215|FG000|Extension Phase|Withdrawal by Subject|0|||
44311008|NCT00471328|79313216|FG001|Extension Phase|Withdrawal by Subject|2|||
44311009|NCT00471328|79313215|FG000|Extension Phase|Death|1|||
44311010|NCT00471328|79313216|FG001|Extension Phase|Death|7|||
44311011|NCT00471328|79313215|FG000|Extension Phase|Protocol Deviation|3|||
44311012|NCT00471328|79313216|FG001|Extension Phase|Protocol Deviation|1|||
44311013|NCT00471328|79313215|FG000|Extension Phase|Treatment duration as per protocol|0|||
44311014|NCT00471328|79313216|FG001|Extension Phase|Treatment duration as per protocol|1|||
44311015|NCT00471328|79313215|FG000|Extension Phase|Disease Progression|32|||
44311016|NCT00471328|79313216|FG001|Extension Phase|Disease Progression|44|||
44311017|NCT00471328|79313215|FG000|Extension Phase|New cancer Therapy|1|||
44419925|NCT00733902|79427727|FG001|Overall Study|Entered extension study|124|||
44535916|NCT03758443|79546731|FG001|Extended Induction Period|Adverse Event|1|||
44311018|NCT00471328|79313216|FG001|Extension Phase|New cancer Therapy|0|||
44311019|NCT00471328|79313215|FG000|Extension Phase|Administrative Problem|1|||
44311020|NCT00471328|79313216|FG001|Extension Phase|Administrative Problem|0|||
44311021|NCT00470470|79313224|FG000|Overall Study|Adverse Event|2|||
44311022|NCT00470470|79313224|FG000|Overall Study|Death|2|||
44311023|NCT00470470|79313224|FG000|Overall Study|Not treated|1|||
44311024|NCT00470275|79313228|FG000|Overall Study|Death|1|||
44311025|NCT00470275|79313228|FG000|Overall Study|Lack of Efficacy|7|||
44311026|NCT00470275|79313228|FG000|Overall Study|Withdrawal by Subject|2|||
44311027|NCT00470158|79313237|FG000|Overall Study|Death|0|||
44311028|NCT00470158|79313238|FG001|Overall Study|Death|0|||
44419926|NCT00733902|79427728|FG002|Overall Study|Entered extension study|111|||
44419927|NCT00733902|79427729|FG003|Overall Study|Entered extension study|109|||
44419928|NCT00733902|79427726|FG000|Overall Study|Randomized but not treated|2|||
44419929|NCT00733902|79427727|FG001|Overall Study|Randomized but not treated|2|||
44419930|NCT00733902|79427728|FG002|Overall Study|Randomized but not treated|2|||
44419931|NCT00733902|79427729|FG003|Overall Study|Randomized but not treated|1|||
44419932|NCT00790790|79427742|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
44419933|NCT00790790|79427743|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
44419934|NCT00790790|79427744|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
44419935|NCT00790790|79427742|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
44419936|NCT00790790|79427743|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
44419937|NCT00790790|79427744|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
44419938|NCT00790790|79427742|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
44419939|NCT00790790|79427743|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
44419940|NCT00790790|79427744|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
44419941|NCT00790790|79427742|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
44419942|NCT00790790|79427743|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
44419943|NCT00790790|79427744|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
44419944|NCT00790790|79427742|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
44419945|NCT00790790|79427743|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
44419946|NCT00790790|79427744|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
44419947|NCT00719043|79427764|FG000|Overall Study|Adverse Event|5|||
44419948|NCT00719043|79427765|FG001|Overall Study|Adverse Event|1|||
44419949|NCT00719043|79427766|FG002|Overall Study|Adverse Event|2|||
44419950|NCT00719043|79427767|FG003|Overall Study|Adverse Event|2|||
44419951|NCT00719043|79427768|FG004|Overall Study|Adverse Event|1|||
44419952|NCT00719043|79427769|FG005|Overall Study|Adverse Event|4|||
44419953|NCT00719043|79427770|FG006|Overall Study|Adverse Event|4|||
44419954|NCT00719043|79427764|FG000|Overall Study|Lost to Follow-up|14|||
44419955|NCT00719043|79427765|FG001|Overall Study|Lost to Follow-up|10|||
44419956|NCT00719043|79427766|FG002|Overall Study|Lost to Follow-up|8|||
44419957|NCT00719043|79427767|FG003|Overall Study|Lost to Follow-up|9|||
44419958|NCT00719043|79427768|FG004|Overall Study|Lost to Follow-up|10|||
44419959|NCT00719043|79427769|FG005|Overall Study|Lost to Follow-up|9|||
44419960|NCT00719043|79427770|FG006|Overall Study|Lost to Follow-up|9|||
44419961|NCT00719043|79427764|FG000|Overall Study|Protocol Violation|0|||
44419962|NCT00719043|79427765|FG001|Overall Study|Protocol Violation|0|||
44419963|NCT00719043|79427766|FG002|Overall Study|Protocol Violation|0|||
44419964|NCT00719043|79427767|FG003|Overall Study|Protocol Violation|0|||
44419965|NCT00719043|79427768|FG004|Overall Study|Protocol Violation|0|||
44419966|NCT00719043|79427769|FG005|Overall Study|Protocol Violation|1|||
44419967|NCT00719043|79427770|FG006|Overall Study|Protocol Violation|0|||
44419968|NCT00719043|79427764|FG000|Overall Study|Other|1|||
44419969|NCT00719043|79427765|FG001|Overall Study|Other|0|||
44419970|NCT00719043|79427766|FG002|Overall Study|Other|1|||
44419971|NCT00719043|79427767|FG003|Overall Study|Other|2|||
44419972|NCT00719043|79427768|FG004|Overall Study|Other|0|||
44419973|NCT00719043|79427769|FG005|Overall Study|Other|2|||
44419974|NCT00719043|79427770|FG006|Overall Study|Other|1|||
44419975|NCT00719043|79427764|FG000|Overall Study|Withdrawal by Subject|12|||
44419976|NCT00719043|79427765|FG001|Overall Study|Withdrawal by Subject|14|||
44419977|NCT00719043|79427766|FG002|Overall Study|Withdrawal by Subject|9|||
44419978|NCT00719043|79427767|FG003|Overall Study|Withdrawal by Subject|10|||
44419979|NCT00719043|79427768|FG004|Overall Study|Withdrawal by Subject|16|||
44419980|NCT00719043|79427769|FG005|Overall Study|Withdrawal by Subject|18|||
44419981|NCT00719043|79427770|FG006|Overall Study|Withdrawal by Subject|14|||
44419982|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Death|2|||
44419983|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
44419984|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
44419985|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Physician Decision|1|||
44419986|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
44311029|NCT00470158|79313239|FG002|Overall Study|Death|0|||
44311030|NCT00470158|79313240|FG003|Overall Study|Death|0|||
44311031|NCT00470158|79313241|FG004|Overall Study|Death|2|||
44419987|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
44419988|NCT00786422|79427798|FG000|Rivaroxaban Treatment|Adverse Event|2|||
44419989|NCT00786422|79427798|FG000|Follow-up Period|Death|1|||
44311032|NCT00470158|79313237|FG000|Overall Study|Lost to Follow-up|7|||
44311033|NCT00470158|79313238|FG001|Overall Study|Lost to Follow-up|8|||
44311034|NCT00470158|79313239|FG002|Overall Study|Lost to Follow-up|8|||
44311035|NCT00470158|79313240|FG003|Overall Study|Lost to Follow-up|5|||
44311036|NCT00470158|79313241|FG004|Overall Study|Lost to Follow-up|4|||
44311037|NCT00470158|79313237|FG000|Overall Study|Protocol Violation|1|||
44311038|NCT00470158|79313238|FG001|Overall Study|Protocol Violation|0|||
44311039|NCT00470158|79313239|FG002|Overall Study|Protocol Violation|0|||
44311040|NCT00470158|79313240|FG003|Overall Study|Protocol Violation|0|||
44311041|NCT00470158|79313241|FG004|Overall Study|Protocol Violation|0|||
44311042|NCT00475540|79313255|FG000|36 Months|Lost to Follow-up|4|||
44311043|NCT00475540|79313256|FG001|36 Months|Lost to Follow-up|4|||
44311044|NCT00475540|79313255|FG000|36 Months|Death|1|||
44311045|NCT00475540|79313256|FG001|36 Months|Death|2|||
44311046|NCT00475540|79313255|FG000|36 Months|Censored due to reoperation|3|||
44311047|NCT00475540|79313256|FG001|36 Months|Censored due to reoperation|0|||
44311048|NCT00472186|79313264|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
44311049|NCT00472186|79313265|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
44311050|NCT00479713|79313275|FG000|Overall Study|Adverse Event|8|||
44311051|NCT00479713|79313276|FG001|Overall Study|Adverse Event|6|||
44311052|NCT00479713|79313275|FG000|Overall Study|Death|1|||
44311053|NCT00479713|79313276|FG001|Overall Study|Death|0|||
44311054|NCT00479713|79313275|FG000|Overall Study|Lost to Follow-up|0|||
44311055|NCT00479713|79313276|FG001|Overall Study|Lost to Follow-up|1|||
44311056|NCT00479713|79313275|FG000|Overall Study|Protocol Violation|0|||
44311057|NCT00479713|79313276|FG001|Overall Study|Protocol Violation|1|||
44311058|NCT00479713|79313275|FG000|Overall Study|Withdrawal by Subject|4|||
44311059|NCT00479713|79313276|FG001|Overall Study|Withdrawal by Subject|1|||
44311060|NCT00474526|79313308|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
44311061|NCT00474526|79313309|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
44311062|NCT00474526|79313310|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
44311063|NCT00474526|79313311|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
44311064|NCT00474526|79313312|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
44311065|NCT00474526|79313313|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
44311066|NCT00474526|79313314|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
44311067|NCT00474526|79313315|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
44311068|NCT00474526|79313316|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
44311069|NCT00474526|79313317|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
44311070|NCT00474526|79313318|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
44311071|NCT00474526|79313319|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
44311072|NCT00474526|79313320|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
44311073|NCT00474526|79313321|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
44311074|NCT00474526|79313322|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
44311075|NCT00474526|79313323|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
44311076|NCT00474526|79313324|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
44311077|NCT00474526|79313308|FG000|Overall Study|Adverse Event|2|||
44311078|NCT00474526|79313309|FG001|Overall Study|Adverse Event|0|||
44311079|NCT00474526|79313310|FG002|Overall Study|Adverse Event|2|||
44311080|NCT00474526|79313311|FG003|Overall Study|Adverse Event|4|||
44311081|NCT00474526|79313312|FG004|Overall Study|Adverse Event|2|||
44311082|NCT00474526|79313313|FG005|Overall Study|Adverse Event|1|||
44311083|NCT00474526|79313314|FG006|Overall Study|Adverse Event|1|||
44311084|NCT00474526|79313315|FG007|Overall Study|Adverse Event|0|||
44311085|NCT00474526|79313316|FG008|Overall Study|Adverse Event|0|||
44311086|NCT00474526|79313317|FG009|Overall Study|Adverse Event|0|||
44311087|NCT00474526|79313318|FG010|Overall Study|Adverse Event|0|||
44311088|NCT00474526|79313319|FG011|Overall Study|Adverse Event|0|||
44311089|NCT00474526|79313320|FG012|Overall Study|Adverse Event|0|||
44311090|NCT00474526|79313321|FG013|Overall Study|Adverse Event|0|||
44311091|NCT00474526|79313322|FG014|Overall Study|Adverse Event|1|||
44419990|NCT00786422|79427798|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
44311092|NCT00474526|79313323|FG015|Overall Study|Adverse Event|1|||
44311093|NCT00474526|79313324|FG016|Overall Study|Adverse Event|0|||
44311094|NCT00474526|79313308|FG000|Overall Study|Death|0|||
44311095|NCT00474526|79313309|FG001|Overall Study|Death|0|||
44311096|NCT00474526|79313310|FG002|Overall Study|Death|0|||
44311097|NCT00474526|79313311|FG003|Overall Study|Death|0|||
44311098|NCT00474526|79313312|FG004|Overall Study|Death|0|||
44311099|NCT00474526|79313313|FG005|Overall Study|Death|0|||
44311100|NCT00474526|79313314|FG006|Overall Study|Death|0|||
44311101|NCT00474526|79313315|FG007|Overall Study|Death|0|||
44311102|NCT00474526|79313316|FG008|Overall Study|Death|0|||
44311103|NCT00474526|79313317|FG009|Overall Study|Death|0|||
44311104|NCT00474526|79313318|FG010|Overall Study|Death|0|||
44311105|NCT00474526|79313319|FG011|Overall Study|Death|0|||
44311106|NCT00474526|79313320|FG012|Overall Study|Death|0|||
44311107|NCT00474526|79313321|FG013|Overall Study|Death|3|||
44311108|NCT00474526|79313322|FG014|Overall Study|Death|0|||
44311109|NCT00474526|79313323|FG015|Overall Study|Death|0|||
44311110|NCT00474526|79313324|FG016|Overall Study|Death|0|||
44311111|NCT00474526|79313308|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311112|NCT00474526|79313309|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
44311113|NCT00474526|79313310|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311114|NCT00474526|79313311|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
44419991|NCT00718887|79427806|FG000|Overall Study|Withdrawal by Subject|3|||
44419992|NCT00718887|79427807|FG001|Overall Study|Withdrawal by Subject|2|||
44419993|NCT00718887|79427806|FG000|Overall Study|Not identified|2|||
44419994|NCT00718887|79427807|FG001|Overall Study|Not identified|7|||
44419995|NCT00786188|79427821|FG000|Overall Study|Adverse Event|3|||
44419996|NCT00786188|79427822|FG001|Overall Study|Adverse Event|1|||
44419997|NCT00786188|79427821|FG000|Overall Study|Withdrawal by Subject|2|||
44419998|NCT00786188|79427822|FG001|Overall Study|Withdrawal by Subject|0|||
44419999|NCT00790556|79427830|FG000|Treatment Period 1|Physician Decision|1|||
44420000|NCT00790556|79427831|FG001|Treatment Period 1|Physician Decision|0|||
44420001|NCT00790556|79427830|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44420002|NCT00790556|79427831|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44420003|NCT00733824|79427842|FG000|Phase I|Withdrawal by Subject|1|||
44420004|NCT00733824|79427843|FG001|Phase I|Withdrawal by Subject|0|||
44420005|NCT00733824|79427844|FG002|Phase I|Withdrawal by Subject|0|||
44420006|NCT00733824|79427845|FG003|Phase I|Withdrawal by Subject|0|||
44420007|NCT00733824|79427846|FG004|Phase I|Withdrawal by Subject|0|||
44420008|NCT00718809|79427862|FG000|Overall Study|Disease progression|9|||
44420009|NCT00718809|79427863|FG001|Overall Study|Disease progression|7|||
44420010|NCT00718809|79427862|FG000|Overall Study|Adverse Event|1|||
44420011|NCT00718809|79427863|FG001|Overall Study|Adverse Event|1|||
44420012|NCT00718809|79427862|FG000|Overall Study|Withdrawal by Subject|0|||
44420013|NCT00718809|79427863|FG001|Overall Study|Withdrawal by Subject|1|||
44420014|NCT00718809|79427862|FG000|Overall Study|Lost to Follow-up|1|||
44420015|NCT00718809|79427863|FG001|Overall Study|Lost to Follow-up|0|||
44420016|NCT00718809|79427862|FG000|Overall Study|Noncompliance|1|||
44420017|NCT00718809|79427863|FG001|Overall Study|Noncompliance|0|||
44420018|NCT00585039|79427871|FG000|Overall Study|medication spilled|2|||
44420019|NCT00585039|79427872|FG001|Overall Study|medication spilled|0|||
44420020|NCT00806195|79427884|FG000|Overall Study|Death|6|||
44420021|NCT00806195|79427885|FG001|Overall Study|Death|0|||
44420022|NCT00806195|79427886|FG002|Overall Study|Death|1|||
44420023|NCT00806195|79427887|FG003|Overall Study|Death|0|||
44420024|NCT00806195|79427884|FG000|Overall Study|Adverse Event|25|||
44420025|NCT00806195|79427885|FG001|Overall Study|Adverse Event|5|||
44420026|NCT00806195|79427886|FG002|Overall Study|Adverse Event|11|||
44420027|NCT00806195|79427887|FG003|Overall Study|Adverse Event|2|||
44420028|NCT00806195|79427884|FG000|Overall Study|Withdrawal by Subject|119|||
44420029|NCT00806195|79427885|FG001|Overall Study|Withdrawal by Subject|31|||
44420030|NCT00806195|79427886|FG002|Overall Study|Withdrawal by Subject|76|||
44420031|NCT00806195|79427887|FG003|Overall Study|Withdrawal by Subject|35|||
44420032|NCT00806195|79427884|FG000|Overall Study|Lost to Follow-up|217|||
44420033|NCT00806195|79427885|FG001|Overall Study|Lost to Follow-up|66|||
44420034|NCT00806195|79427886|FG002|Overall Study|Lost to Follow-up|90|||
44420035|NCT00806195|79427887|FG003|Overall Study|Lost to Follow-up|34|||
44420036|NCT00806195|79427884|FG000|Overall Study|Inappropriate Enrollment|0|||
44420037|NCT00806195|79427885|FG001|Overall Study|Inappropriate Enrollment|1|||
44420038|NCT00806195|79427886|FG002|Overall Study|Inappropriate Enrollment|0|||
44420039|NCT00806195|79427887|FG003|Overall Study|Inappropriate Enrollment|0|||
44257708|NCT01431638|79110842|FG002|Overall Study|Adverse Event|1|||
44257709|NCT01431638|79110840|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44257710|NCT01431638|79110841|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44257711|NCT01431638|79110842|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
44257712|NCT01431638|79110840|FG000|Overall Study|Participants condition no longer requires study drug|0|||
44257713|NCT01431638|79110841|FG001|Overall Study|Participants condition no longer requires study drug|1|||
44257714|NCT01431638|79110842|FG002|Overall Study|Participants condition no longer requires study drug|0|||
44257715|NCT01431638|79110840|FG000|Overall Study|Participant withdrew consent|14|||
44257716|NCT01431638|79110841|FG001|Overall Study|Participant withdrew consent|5|||
44257717|NCT01431638|79110842|FG002|Overall Study|Participant withdrew consent|8|||
44257718|NCT01431638|79110840|FG000|Overall Study|Lost to Follow-up|7|||
44257719|NCT01431638|79110841|FG001|Overall Study|Lost to Follow-up|9|||
44257720|NCT01431638|79110842|FG002|Overall Study|Lost to Follow-up|7|||
44257721|NCT01431638|79110840|FG000|Overall Study|Administrative problems|1|||
44311115|NCT00474526|79313312|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
44420040|NCT00806195|79427884|FG000|Overall Study|Administrative Reason|113|||
44420041|NCT00806195|79427885|FG001|Overall Study|Administrative Reason|35|||
44420042|NCT00806195|79427886|FG002|Overall Study|Administrative Reason|66|||
44420043|NCT00806195|79427887|FG003|Overall Study|Administrative Reason|26|||
44420044|NCT00806195|79427884|FG000|Overall Study|Protocol Violation|34|||
44311116|NCT00474526|79313313|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44420045|NCT00806195|79427885|FG001|Overall Study|Protocol Violation|24|||
44420046|NCT00806195|79427886|FG002|Overall Study|Protocol Violation|26|||
44420047|NCT00806195|79427887|FG003|Overall Study|Protocol Violation|9|||
44420048|NCT00733746|79427899|FG000|Overall Study|Ineligible|5|||
44420049|NCT00718419|79427905|FG000|Overall Study|Adverse Event|2|||
44311117|NCT00474526|79313314|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311118|NCT00474526|79313315|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311119|NCT00474526|79313316|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311120|NCT00474526|79313317|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311121|NCT00474526|79313318|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311122|NCT00474526|79313319|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311123|NCT00474526|79313320|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311124|NCT00474526|79313321|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
44311125|NCT00474526|79313322|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
44311126|NCT00474526|79313323|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311127|NCT00474526|79313324|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
44311128|NCT00474526|79313308|FG000|Overall Study|Lost to Follow-up|8|||
44311129|NCT00474526|79313309|FG001|Overall Study|Lost to Follow-up|6|||
44420050|NCT00718419|79427906|FG001|Overall Study|Adverse Event|1|||
44420051|NCT00718419|79427905|FG000|Overall Study|Physician Decision|1|||
44420052|NCT00718419|79427906|FG001|Overall Study|Physician Decision|6|||
44420053|NCT00718419|79427905|FG000|Overall Study|Sponsor decision|0|||
44420054|NCT00718419|79427906|FG001|Overall Study|Sponsor decision|1|||
44420055|NCT00718419|79427905|FG000|Overall Study|Withdrawal by Subject|0|||
44420056|NCT00718419|79427906|FG001|Overall Study|Withdrawal by Subject|5|||
44420057|NCT00718419|79427905|FG000|Overall Study|Progressive Disease|7|||
44420058|NCT00718419|79427906|FG001|Overall Study|Progressive Disease|25|||
44420059|NCT00718419|79427905|FG000|Overall Study|Death Due to Progressive Disease|2|||
44420060|NCT00718419|79427906|FG001|Overall Study|Death Due to Progressive Disease|0|||
44420061|NCT00718419|79427905|FG000|Overall Study|Death Due to Study Drug Related|0|||
44420062|NCT00718419|79427906|FG001|Overall Study|Death Due to Study Drug Related|1|||
44420063|NCT00718419|79427905|FG000|Overall Study|Death Due to Adverse Events|1|||
44311130|NCT00474526|79313310|FG002|Overall Study|Lost to Follow-up|13|||
44311131|NCT00474526|79313311|FG003|Overall Study|Lost to Follow-up|29|||
44311132|NCT00474526|79313312|FG004|Overall Study|Lost to Follow-up|11|||
44311133|NCT00474526|79313313|FG005|Overall Study|Lost to Follow-up|5|||
44311134|NCT00474526|79313314|FG006|Overall Study|Lost to Follow-up|8|||
44311135|NCT00474526|79313315|FG007|Overall Study|Lost to Follow-up|1|||
44420064|NCT00718419|79427906|FG001|Overall Study|Death Due to Adverse Events|0|||
44420065|NCT00717249|79427914|FG000|Overall Study|Lens Discomfort|4|||
44420066|NCT00717249|79427915|FG001|Overall Study|Lens Discomfort|1|||
44420067|NCT00717249|79427914|FG000|Overall Study|Unsatisfactory visual Response|0|||
44420068|NCT00717249|79427915|FG001|Overall Study|Unsatisfactory visual Response|2|||
44420069|NCT00717249|79427914|FG000|Overall Study|Adverse Event|4|||
44420070|NCT00717249|79427915|FG001|Overall Study|Adverse Event|2|||
44420071|NCT00717249|79427914|FG000|Overall Study|Lost to Follow-up|2|||
44420072|NCT00717249|79427915|FG001|Overall Study|Lost to Follow-up|0|||
44420073|NCT00717249|79427914|FG000|Overall Study|Withdrawal by Subject|1|||
44420074|NCT00717249|79427915|FG001|Overall Study|Withdrawal by Subject|2|||
44311136|NCT00474526|79313316|FG008|Overall Study|Lost to Follow-up|0|||
44311137|NCT00474526|79313317|FG009|Overall Study|Lost to Follow-up|6|||
44311138|NCT00474526|79313318|FG010|Overall Study|Lost to Follow-up|2|||
44311139|NCT00474526|79313319|FG011|Overall Study|Lost to Follow-up|4|||
44311140|NCT00474526|79313320|FG012|Overall Study|Lost to Follow-up|6|||
44311141|NCT00474526|79313321|FG013|Overall Study|Lost to Follow-up|74|||
44311142|NCT00474526|79313322|FG014|Overall Study|Lost to Follow-up|29|||
44311143|NCT00474526|79313323|FG015|Overall Study|Lost to Follow-up|4|||
44311144|NCT00474526|79313324|FG016|Overall Study|Lost to Follow-up|5|||
44311145|NCT00474526|79313308|FG000|Overall Study|Protocol Violation|2|||
44311146|NCT00474526|79313309|FG001|Overall Study|Protocol Violation|6|||
44311147|NCT00474526|79313310|FG002|Overall Study|Protocol Violation|4|||
44311148|NCT00474526|79313311|FG003|Overall Study|Protocol Violation|12|||
44311149|NCT00474526|79313312|FG004|Overall Study|Protocol Violation|3|||
44311150|NCT00474526|79313313|FG005|Overall Study|Protocol Violation|1|||
44311151|NCT00474526|79313314|FG006|Overall Study|Protocol Violation|3|||
44420075|NCT00717249|79427914|FG000|Overall Study|Pregnancy|6|||
44420076|NCT00717249|79427915|FG001|Overall Study|Pregnancy|3|||
44420077|NCT00717249|79427914|FG000|Overall Study|Protocol Violation|0|||
44420078|NCT00717249|79427915|FG001|Overall Study|Protocol Violation|2|||
44420079|NCT00717249|79427914|FG000|Overall Study|Subject became Ineligible|1|||
44420080|NCT00717249|79427915|FG001|Overall Study|Subject became Ineligible|1|||
44311152|NCT00474526|79313315|FG007|Overall Study|Protocol Violation|0|||
44311153|NCT00474526|79313316|FG008|Overall Study|Protocol Violation|0|||
44420081|NCT00717249|79427914|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
44311154|NCT00474526|79313317|FG009|Overall Study|Protocol Violation|4|||
44311155|NCT00474526|79313318|FG010|Overall Study|Protocol Violation|2|||
44311156|NCT00474526|79313319|FG011|Overall Study|Protocol Violation|2|||
44311157|NCT00474526|79313320|FG012|Overall Study|Protocol Violation|4|||
44311158|NCT00474526|79313321|FG013|Overall Study|Protocol Violation|19|||
44311159|NCT00474526|79313322|FG014|Overall Study|Protocol Violation|9|||
44311160|NCT00474526|79313323|FG015|Overall Study|Protocol Violation|6|||
44311161|NCT00474526|79313324|FG016|Overall Study|Protocol Violation|2|||
44311162|NCT00474526|79313308|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
44311163|NCT00474526|79313309|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
44311164|NCT00474526|79313310|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
44311165|NCT00474526|79313311|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
44311166|NCT00474526|79313312|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
44311167|NCT00474526|79313313|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
44311168|NCT00474526|79313314|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
44311169|NCT00474526|79313315|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
44311170|NCT00474526|79313316|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
44311171|NCT00474526|79313317|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
44311172|NCT00474526|79313318|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
44311173|NCT00474526|79313319|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
44311174|NCT00474526|79313320|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
44311175|NCT00474526|79313321|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
44311176|NCT00474526|79313322|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
44311177|NCT00474526|79313323|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
44311178|NCT00474526|79313324|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
44311179|NCT00474526|79313308|FG000|Overall Study|Withdrawal by Subject|9|||
44311180|NCT00474526|79313309|FG001|Overall Study|Withdrawal by Subject|24|||
44311181|NCT00474526|79313310|FG002|Overall Study|Withdrawal by Subject|21|||
44311182|NCT00474526|79313311|FG003|Overall Study|Withdrawal by Subject|52|||
44311183|NCT00474526|79313312|FG004|Overall Study|Withdrawal by Subject|38|||
44311184|NCT00474526|79313313|FG005|Overall Study|Withdrawal by Subject|6|||
44311185|NCT00474526|79313314|FG006|Overall Study|Withdrawal by Subject|12|||
44311186|NCT00474526|79313315|FG007|Overall Study|Withdrawal by Subject|4|||
44311187|NCT00474526|79313316|FG008|Overall Study|Withdrawal by Subject|4|||
44311188|NCT00474526|79313317|FG009|Overall Study|Withdrawal by Subject|13|||
44311189|NCT00474526|79313318|FG010|Overall Study|Withdrawal by Subject|5|||
44311190|NCT00474526|79313319|FG011|Overall Study|Withdrawal by Subject|4|||
44311191|NCT00474526|79313320|FG012|Overall Study|Withdrawal by Subject|4|||
44311192|NCT00474526|79313321|FG013|Overall Study|Withdrawal by Subject|37|||
44311193|NCT00474526|79313322|FG014|Overall Study|Withdrawal by Subject|22|||
44311194|NCT00474526|79313323|FG015|Overall Study|Withdrawal by Subject|1|||
44311195|NCT00474526|79313324|FG016|Overall Study|Withdrawal by Subject|1|||
44311196|NCT00478426|79313410|FG000|Overall Study|Withdrawal by Subject|1|||
44311197|NCT00477412|79313418|FG000|Overall Study|Death|0|||
44311198|NCT00477412|79313419|FG001|Overall Study|Death|0|||
44311199|NCT00477412|79313420|FG002|Overall Study|Death|0|||
44311200|NCT00477412|79313421|FG003|Overall Study|Death|4|||
44311201|NCT00477412|79313418|FG000|Overall Study|Lost to Follow-up|0|||
44311202|NCT00477412|79313419|FG001|Overall Study|Lost to Follow-up|0|||
44311203|NCT00477412|79313420|FG002|Overall Study|Lost to Follow-up|0|||
44311204|NCT00477412|79313421|FG003|Overall Study|Lost to Follow-up|1|||
44311205|NCT00477412|79313418|FG000|Overall Study|Withdrawal by Subject|0|||
44311206|NCT00477412|79313419|FG001|Overall Study|Withdrawal by Subject|0|||
44311207|NCT00477412|79313420|FG002|Overall Study|Withdrawal by Subject|0|||
44311208|NCT00477412|79313421|FG003|Overall Study|Withdrawal by Subject|2|||
44311209|NCT00477412|79313418|FG000|Overall Study|Second Malignancy|0|||
44311210|NCT00477412|79313419|FG001|Overall Study|Second Malignancy|0|||
44311211|NCT00477412|79313420|FG002|Overall Study|Second Malignancy|0|||
44311212|NCT00477412|79313421|FG003|Overall Study|Second Malignancy|1|||
44311213|NCT00477412|79313418|FG000|Overall Study|Adverse Event|1|||
44311214|NCT00477412|79313419|FG001|Overall Study|Adverse Event|0|||
44311215|NCT00477412|79313420|FG002|Overall Study|Adverse Event|1|||
44311216|NCT00477412|79313421|FG003|Overall Study|Adverse Event|0|||
44311217|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
44311218|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
44311219|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
44311220|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
44311221|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
44311222|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
44311223|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
44311224|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
44311225|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
44311226|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
44311227|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
44311228|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
44311229|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
44311230|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
44311231|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
44311232|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
44311233|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
44311234|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
44311235|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
44311236|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
44311237|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
44311238|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
44311239|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
44311240|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
44311241|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
44311242|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
44311243|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
44311244|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
44311245|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
44311246|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
44311247|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
44311248|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
44311249|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
44311250|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
44311251|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
44311252|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
44311253|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
44311254|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
44311255|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
44311256|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
44311257|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
44311258|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
44311259|NCT01089556|79313431|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
44311260|NCT01089556|79313432|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
44311261|NCT01089556|79313433|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
44311262|NCT01089556|79313434|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
44311263|NCT01089556|79313435|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
44311264|NCT01089556|79313436|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
44311265|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
44311266|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
44311267|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
44311268|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
44311269|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
44311270|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
44311271|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
44311272|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
44311273|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
44311274|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
44311275|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
44311276|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
44311277|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
44311278|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
44155495|NCT01998958|78946971|FG024|Open Label Phase (Optional)|Other|0|||
44311279|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
44311280|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
44311281|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
44311282|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
44311283|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
44311284|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
44311285|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
44311286|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
44311287|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
44311288|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
44311289|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
44311290|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
44311291|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
44311292|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
44311293|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
44311294|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
44311295|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
44311296|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
44311297|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
44311298|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
44311299|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
44311300|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
44311301|NCT01089556|79313431|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
44311302|NCT01089556|79313432|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
44311303|NCT01089556|79313433|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
44311304|NCT01089556|79313434|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
44311305|NCT01089556|79313435|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
44311306|NCT01089556|79313436|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
44311307|NCT01089127|79313454|FG000|Overall Study|Adverse Event|5|||
44311308|NCT01089127|79313455|FG001|Overall Study|Adverse Event|1|||
44311309|NCT01089127|79313456|FG002|Overall Study|Adverse Event|1|||
44311310|NCT01089127|79313457|FG003|Overall Study|Adverse Event|0|||
44311311|NCT01089127|79313458|FG004|Overall Study|Adverse Event|0|||
44311312|NCT01089127|79313459|FG005|Overall Study|Adverse Event|1|||
44311313|NCT01089127|79313454|FG000|Overall Study|Subject withdrew consent|0|||
44311314|NCT01089127|79313455|FG001|Overall Study|Subject withdrew consent|1|||
44311315|NCT01089127|79313456|FG002|Overall Study|Subject withdrew consent|1|||
44311316|NCT01089127|79313457|FG003|Overall Study|Subject withdrew consent|1|||
44311317|NCT01089127|79313458|FG004|Overall Study|Subject withdrew consent|0|||
44311318|NCT01089127|79313459|FG005|Overall Study|Subject withdrew consent|2|||
44311319|NCT01089127|79313454|FG000|Overall Study|Abnormal test procedure result(s)|2|||
44311320|NCT01089127|79313455|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44311321|NCT01089127|79313456|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44311322|NCT01089127|79313457|FG003|Overall Study|Abnormal test procedure result(s)|0|||
44311323|NCT01089127|79313458|FG004|Overall Study|Abnormal test procedure result(s)|0|||
44311324|NCT01089127|79313459|FG005|Overall Study|Abnormal test procedure result(s)|0|||
44311325|NCT01089127|79313454|FG000|Overall Study|Lost to Follow-up|1|||
44311326|NCT01089127|79313455|FG001|Overall Study|Lost to Follow-up|1|||
44311327|NCT01089127|79313456|FG002|Overall Study|Lost to Follow-up|0|||
44311328|NCT01089127|79313457|FG003|Overall Study|Lost to Follow-up|0|||
44311329|NCT01089127|79313458|FG004|Overall Study|Lost to Follow-up|1|||
44311330|NCT01089127|79313459|FG005|Overall Study|Lost to Follow-up|0|||
44311331|NCT01089127|79313454|FG000|Overall Study|Protocol deviation|0|||
44311332|NCT01089127|79313455|FG001|Overall Study|Protocol deviation|1|||
44311333|NCT01089127|79313456|FG002|Overall Study|Protocol deviation|0|||
44420082|NCT00717249|79427915|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
44420083|NCT00717249|79427914|FG000|Overall Study|Gastric Surgery|0|||
44420084|NCT00717249|79427915|FG001|Overall Study|Gastric Surgery|1|||
44420085|NCT00717249|79427914|FG000|Overall Study|Diagnosed with Diabetes|1|||
44420086|NCT00717249|79427915|FG001|Overall Study|Diagnosed with Diabetes|0|||
44420087|NCT00717249|79427914|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
44420088|NCT00717249|79427915|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
44420089|NCT00717249|79427914|FG000|Overall Study|Subject relocated|1|||
44420090|NCT00717249|79427915|FG001|Overall Study|Subject relocated|0|||
44420091|NCT00717249|79427914|FG000|Overall Study|Headaches|1|||
44420092|NCT00717249|79427915|FG001|Overall Study|Headaches|0|||
44535917|NCT03758443|79546732|FG002|Extended Induction Period|Adverse Event|0|||
44311334|NCT01089127|79313457|FG003|Overall Study|Protocol deviation|0|||
44311335|NCT01089127|79313458|FG004|Overall Study|Protocol deviation|1|||
44311336|NCT01089127|79313459|FG005|Overall Study|Protocol deviation|0|||
44420093|NCT00727194|79427921|FG000|Screening Period|Low QMG scores|0|||
44420094|NCT00727194|79427922|FG001|Screening Period|Low QMG scores|0|||
44535918|NCT03758443|79546733|FG003|Extended Induction Period|Adverse Event|1|||
44535919|NCT03758443|79546730|FG000|Extended Induction Period|Lost to Follow-up|1|||
44535920|NCT03758443|79546731|FG001|Extended Induction Period|Lost to Follow-up|0|||
44535921|NCT03758443|79546732|FG002|Extended Induction Period|Lost to Follow-up|0|||
44535922|NCT03758443|79546733|FG003|Extended Induction Period|Lost to Follow-up|0|||
44535923|NCT03758443|79546730|FG000|Extended Induction Period|Physician Decision|2|||
44535924|NCT03758443|79546731|FG001|Extended Induction Period|Physician Decision|1|||
44311337|NCT01087957|79313475|FG000|Overall Study|Death|2|||
44311338|NCT01087957|79313476|FG001|Overall Study|Death|2|||
44311339|NCT01087957|79313475|FG000|Overall Study|Lost to Follow-up|3|||
44311340|NCT01087957|79313476|FG001|Overall Study|Lost to Follow-up|4|||
44311341|NCT01087957|79313475|FG000|Overall Study|Protocol Violation|13|||
44311342|NCT01087957|79313476|FG001|Overall Study|Protocol Violation|25|||
44311343|NCT01087957|79313475|FG000|Overall Study|Withdrawal by Subject|18|||
44311344|NCT01087957|79313476|FG001|Overall Study|Withdrawal by Subject|15|||
44311345|NCT01087957|79313475|FG000|Overall Study|Physician Decision|5|||
44311346|NCT01087957|79313476|FG001|Overall Study|Physician Decision|9|||
44420095|NCT00727194|79427923|FG002|Screening Period|Low QMG scores|6|||
44420096|NCT00727194|79427921|FG000|Screening Period|Lacked AChR antibodies|0|||
44420097|NCT00727194|79427922|FG001|Screening Period|Lacked AChR antibodies|0|||
44420098|NCT00727194|79427923|FG002|Screening Period|Lacked AChR antibodies|5|||
44420099|NCT00727194|79427921|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
44420100|NCT00727194|79427922|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
44420101|NCT00727194|79427923|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
44420102|NCT00727194|79427921|FG000|Screening Period|Severe infections|0|||
44420103|NCT00727194|79427922|FG001|Screening Period|Severe infections|0|||
44420104|NCT00727194|79427923|FG002|Screening Period|Severe infections|2|||
44420105|NCT00727194|79427921|FG000|Screening Period|History of thymoma|0|||
44420106|NCT00727194|79427922|FG001|Screening Period|History of thymoma|0|||
44420107|NCT00727194|79427923|FG002|Screening Period|History of thymoma|1|||
44420108|NCT00727194|79427921|FG000|Treatment Period 2|Lack of Efficacy|0|||
44420109|NCT00727194|79427922|FG001|Treatment Period 2|Lack of Efficacy|1|||
44420110|NCT00727194|79427923|FG002|Treatment Period 2|Lack of Efficacy|0|||
44420111|NCT00717093|79427939|FG000|Overall Study|Adverse Event|19|||
44420112|NCT00717093|79427940|FG001|Overall Study|Adverse Event|9|||
44420113|NCT00717093|79427939|FG000|Overall Study|Lack of Efficacy|3|||
44420114|NCT00717093|79427940|FG001|Overall Study|Lack of Efficacy|13|||
44420115|NCT00717093|79427939|FG000|Overall Study|Lost to Follow-up|9|||
44420116|NCT00717093|79427940|FG001|Overall Study|Lost to Follow-up|6|||
44420117|NCT00717093|79427939|FG000|Overall Study|Withdrawal by Subject|12|||
44420118|NCT00717093|79427940|FG001|Overall Study|Withdrawal by Subject|19|||
44420119|NCT00717093|79427939|FG000|Overall Study|Other|0|||
44420120|NCT00717093|79427940|FG001|Overall Study|Other|1|||
44420121|NCT00717093|79427939|FG000|Overall Study|Randomized but not treated|1|||
44420122|NCT00717093|79427940|FG001|Overall Study|Randomized but not treated|0|||
44420123|NCT00716859|79427948|FG000|Overall Study|Adverse Event|4|||
44420124|NCT00716859|79427949|FG001|Overall Study|Adverse Event|1|||
44420125|NCT00716859|79427948|FG000|Overall Study|Lack of Efficacy|3|||
44420126|NCT00716859|79427949|FG001|Overall Study|Lack of Efficacy|0|||
44420127|NCT00716859|79427948|FG000|Overall Study|Withdrawal by Subject|1|||
44420128|NCT00716859|79427949|FG001|Overall Study|Withdrawal by Subject|3|||
44420129|NCT00716859|79427948|FG000|Overall Study|Not treated|1|||
44420130|NCT00716859|79427949|FG001|Overall Study|Not treated|1|||
44420131|NCT00589121|79427957|FG000|Overall Study|Protocol Violation|2|||
44420132|NCT00589121|79427958|FG001|Overall Study|Protocol Violation|6|||
44420133|NCT00589121|79427957|FG000|Overall Study|No protocol treatment received|0|||
44420134|NCT00589121|79427958|FG001|Overall Study|No protocol treatment received|1|||
44420135|NCT00590135|79427967|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
44420136|NCT00589667|79427972|FG000|Overall Study|Adverse Event|2|||
44420137|NCT00589667|79427972|FG000|Overall Study|Withdrawal by Subject|1|||
44420138|NCT00737568|79427978|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
44420139|NCT00737568|79427979|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
44420140|NCT00737568|79427978|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
44420141|NCT00737568|79427979|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
44420142|NCT00737568|79427978|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
44420143|NCT00737568|79427979|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
44420144|NCT00737568|79427978|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
44420145|NCT00737568|79427979|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
44420146|NCT00737568|79427978|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
44535925|NCT03758443|79546732|FG002|Extended Induction Period|Physician Decision|2|||
44535926|NCT03758443|79546733|FG003|Extended Induction Period|Physician Decision|2|||
44535927|NCT03758443|79546730|FG000|Extended Induction Period|Protocol Violation|0|||
44535928|NCT03758443|79546731|FG001|Extended Induction Period|Protocol Violation|0|||
44535929|NCT03758443|79546732|FG002|Extended Induction Period|Protocol Violation|0|||
44535930|NCT03758443|79546733|FG003|Extended Induction Period|Protocol Violation|1|||
44535931|NCT03758443|79546730|FG000|Extended Induction Period|Withdrawal by Subject|8|||
44420147|NCT00737568|79427979|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
44420148|NCT00737568|79427978|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
44535932|NCT03758443|79546731|FG001|Extended Induction Period|Withdrawal by Subject|1|||
44420149|NCT00737568|79427979|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
44420150|NCT00737568|79427978|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
44420151|NCT00737568|79427979|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
44420152|NCT00737568|79427978|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
44420153|NCT00737568|79427979|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
44420154|NCT00737568|79427978|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
44420155|NCT00737568|79427979|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
44420156|NCT00737100|79427988|FG000|Overall Study|Adverse Event|6|||
44420157|NCT00737100|79427989|FG001|Overall Study|Adverse Event|5|||
44420158|NCT00737100|79427990|FG002|Overall Study|Adverse Event|3|||
44420159|NCT00737100|79427988|FG000|Overall Study|Lost to Follow-up|0|||
44420160|NCT00737100|79427989|FG001|Overall Study|Lost to Follow-up|1|||
44420161|NCT00737100|79427990|FG002|Overall Study|Lost to Follow-up|0|||
44420162|NCT00737100|79427988|FG000|Overall Study|Withdrawal by Subject|0|||
44420163|NCT00737100|79427989|FG001|Overall Study|Withdrawal by Subject|0|||
44420164|NCT00737100|79427990|FG002|Overall Study|Withdrawal by Subject|3|||
44420165|NCT00737100|79427988|FG000|Overall Study|Reason discontinued not explained above|1|||
44420166|NCT00737100|79427989|FG001|Overall Study|Reason discontinued not explained above|1|||
44420167|NCT00737100|79427990|FG002|Overall Study|Reason discontinued not explained above|1|||
44420168|NCT00732498|79428000|FG000|Overall Study|Ineligible|1|||
44420169|NCT00732498|79428000|FG000|Overall Study|Adverse Event|2|||
44420170|NCT00732498|79428000|FG000|Overall Study|Physician Decision|3|||
44420171|NCT00726882|79428004|FG000|Overall Study|Withdrawal by Subject|5|||
44420172|NCT00726882|79428004|FG000|Overall Study|Lost to Follow-up|7|||
44420173|NCT00726882|79428004|FG000|Overall Study|Other|10|||
44535933|NCT03758443|79546732|FG002|Extended Induction Period|Withdrawal by Subject|7|||
44535934|NCT03758443|79546733|FG003|Extended Induction Period|Withdrawal by Subject|3|||
44535935|NCT03758443|79546730|FG000|Extended Induction Period|Miscellaneous|1|||
44535936|NCT03758443|79546731|FG001|Extended Induction Period|Miscellaneous|0|||
44535937|NCT03758443|79546732|FG002|Extended Induction Period|Miscellaneous|0|||
44535938|NCT03758443|79546733|FG003|Extended Induction Period|Miscellaneous|0|||
44535939|NCT03758443|79546730|FG000|Maintenance Period|Adverse Event|1|||
44535940|NCT03758443|79546731|FG001|Maintenance Period|Adverse Event|2|||
44311347|NCT01087723|79313484|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
44311348|NCT01087723|79313485|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
44311349|NCT01087723|79313484|FG000|Overall Study|Withdrawal by Subject|10|||
44311350|NCT01087723|79313485|FG001|Overall Study|Withdrawal by Subject|13|||
44311351|NCT01087723|79313484|FG000|Overall Study|Physician Decision|2|||
44311352|NCT01087723|79313485|FG001|Overall Study|Physician Decision|0|||
44311353|NCT01087723|79313484|FG000|Overall Study|Lost to Follow-up|1|||
44311354|NCT01087723|79313485|FG001|Overall Study|Lost to Follow-up|4|||
44311355|NCT01087723|79313484|FG000|Overall Study|Reason Not Specified|1|||
44311356|NCT01087723|79313485|FG001|Overall Study|Reason Not Specified|2|||
44311357|NCT01087528|79313491|FG000|Overall Study|Withdrawal by Subject|1|||
44311358|NCT01087528|79313491|FG000|Overall Study|Incomplete CE procedure|6|||
44311359|NCT01085812|79313497|FG000|Open-Label Period|Adverse Event|0|||
44311360|NCT01085812|79313498|FG001|Open-Label Period|Adverse Event|80|||
44311361|NCT01085812|79313497|FG000|Open-Label Period|Lack of Efficacy|0|||
44311362|NCT01085812|79313498|FG001|Open-Label Period|Lack of Efficacy|26|||
44311363|NCT01085812|79313497|FG000|Open-Label Period|Protocol Violation|0|||
44311364|NCT01085812|79313498|FG001|Open-Label Period|Protocol Violation|39|||
44311365|NCT01085812|79313497|FG000|Open-Label Period|Withdrawal by Subject|0|||
44311366|NCT01085812|79313498|FG001|Open-Label Period|Withdrawal by Subject|53|||
44311367|NCT01085812|79313497|FG000|Open-Label Period|Lost to Follow-up|0|||
44311368|NCT01085812|79313498|FG001|Open-Label Period|Lost to Follow-up|42|||
44311369|NCT01085812|79313497|FG000|Double-Blind Period|Adverse Event|3|||
44311370|NCT01085812|79313498|FG001|Double-Blind Period|Adverse Event|8|||
44311371|NCT01085812|79313497|FG000|Double-Blind Period|Protocol Violation|2|||
44311372|NCT01085812|79313498|FG001|Double-Blind Period|Protocol Violation|7|||
44311373|NCT01085812|79313497|FG000|Double-Blind Period|Withdrawal by Subject|11|||
44311374|NCT01085812|79313498|FG001|Double-Blind Period|Withdrawal by Subject|24|||
44311375|NCT01085812|79313497|FG000|Double-Blind Period|Lost to Follow-up|5|||
44311376|NCT01085812|79313498|FG001|Double-Blind Period|Lost to Follow-up|17|||
44311377|NCT01085812|79313497|FG000|Double-Blind Period|Other Reasons|0|||
44311378|NCT01085812|79313498|FG001|Double-Blind Period|Other Reasons|2|||
44311379|NCT01085812|79313497|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
44311380|NCT01085812|79313498|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
44311381|NCT01085812|79313497|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
44311382|NCT01085812|79313498|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
44311383|NCT01085812|79313497|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
44311384|NCT01085812|79313498|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
44311385|NCT01085812|79313497|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
44311386|NCT01085812|79313498|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
44311387|NCT01085812|79313497|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
44311388|NCT01085812|79313498|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
44311389|NCT01085734|79313507|FG000|Overall Study|Adverse Event|0|||
44311390|NCT01085734|79313508|FG001|Overall Study|Adverse Event|2|||
44311391|NCT01085734|79313507|FG000|Overall Study|Death|1|||
44311392|NCT01085734|79313508|FG001|Overall Study|Death|0|||
44311393|NCT01085734|79313507|FG000|Overall Study|Lost to Follow-up|0|||
44311394|NCT01085734|79313508|FG001|Overall Study|Lost to Follow-up|1|||
44311395|NCT01085734|79313507|FG000|Overall Study|Withdrawal by Subject|0|||
44420174|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
44420175|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
44420176|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
44420177|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
44420178|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
44420179|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
44420180|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
44420181|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
44420182|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
44420183|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
44420184|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
44420185|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
44420186|NCT00790400|79428012|FG000|Double-blind Period (Core Phase)|Death|1|||
44420187|NCT00790400|79428013|FG001|Double-blind Period (Core Phase)|Death|0|||
44420188|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
44420189|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
44420190|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
44420191|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
44420192|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
44420193|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
44420194|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
44420195|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
44420196|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
44420197|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
44420198|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Death|1|||
44420199|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Death|0|||
44420200|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
44420201|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
44420202|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
44420203|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
44420204|NCT00790400|79428012|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
44420205|NCT00790400|79428013|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
44420206|NCT00786032|79428022|FG000|Overall Study|Death|4|||
44420207|NCT00786032|79428022|FG000|Overall Study|Withdrawal by Subject|14|||
44420208|NCT00786032|79428022|FG000|Overall Study|Did not complete in the timeframe|6|||
44420209|NCT00785486|79428028|FG000|Midazolam Alone|Withdrawal by Subject|1|||
44420210|NCT00589979|79428051|FG000|Run-In Period|Adverse Event|5|||
44311396|NCT01085734|79313508|FG001|Overall Study|Withdrawal by Subject|1|||
44311397|NCT01084603|79313515|FG000|Baseline|Withdrawal by Subject|2|||
44311398|NCT01084603|79313515|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
44311399|NCT01084603|79313515|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
44311400|NCT01084603|79313515|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
44311401|NCT01084603|79313515|FG000|Washout Period 4|Adverse Event|1|||
44311402|NCT01084174|79313530|FG000|Overall Study|gastrointestinal symptoms|1|||
44311403|NCT01084174|79313531|FG001|Overall Study|gastrointestinal symptoms|1|||
44311404|NCT01084174|79313530|FG000|Overall Study|Eosinophilic esophagitis|0|||
44311405|NCT01084174|79313531|FG001|Overall Study|Eosinophilic esophagitis|1|||
44311406|NCT01084174|79313530|FG000|Overall Study|Anaphylaxis|0|||
44311407|NCT01084174|79313531|FG001|Overall Study|Anaphylaxis|1|||
44311408|NCT01084174|79313530|FG000|Overall Study|Participant noncompliance|0|||
44311409|NCT01084174|79313531|FG001|Overall Study|Participant noncompliance|1|||
44311410|NCT01084135|79313541|FG000|20 Week|Physician Decision|0|||
44311411|NCT01084135|79313542|FG001|20 Week|Physician Decision|1|||
44311412|NCT01083316|79313550|FG000|Overall Study|Adverse Event|2|||
44311413|NCT01083316|79313550|FG000|Overall Study|Withdrawal by Subject|1|||
44311414|NCT01083160|79313555|FG000|Overall Study|Adverse Event|1|||
44311415|NCT01083121|79313559|FG000|Overall Study|Use of Humira outside the approved label|81|||
44311416|NCT01082614|79313569|FG000|Overall Study|Adverse Event|1|||
44311417|NCT01082614|79313570|FG001|Overall Study|Adverse Event|4|||
44535941|NCT03758443|79546732|FG002|Maintenance Period|Adverse Event|0|||
44535942|NCT03758443|79546733|FG003|Maintenance Period|Adverse Event|0|||
44535943|NCT03758443|79546730|FG000|Maintenance Period|Lost to Follow-up|0|||
44535944|NCT03758443|79546731|FG001|Maintenance Period|Lost to Follow-up|0|||
44535945|NCT03758443|79546732|FG002|Maintenance Period|Lost to Follow-up|0|||
44535946|NCT03758443|79546733|FG003|Maintenance Period|Lost to Follow-up|1|||
44311418|NCT01082614|79313569|FG000|Overall Study|Equipment Malfunction|0|||
44420211|NCT00589979|79428052|FG001|Run-In Period|Adverse Event|0|||
44535947|NCT03758443|79546730|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
44155496|NCT01998958|78946972|FG025|Open Label Phase (Optional)|Other|0|||
44311419|NCT01082614|79313570|FG001|Overall Study|Equipment Malfunction|1|||
44311420|NCT01082614|79313569|FG000|Overall Study|Physician Decision|2|||
44311421|NCT01082614|79313570|FG001|Overall Study|Physician Decision|0|||
44311422|NCT01081873|79313576|FG000|Overall Study|Death|86|||
44311423|NCT01081873|79313576|FG000|Overall Study|Withdrawal by Subject|10|||
44311424|NCT01081873|79313576|FG000|Overall Study|Lost to Follow-up|142|||
44311425|NCT01081873|79313576|FG000|Overall Study|Progression of prostate cancer|13|||
44311426|NCT01081873|79313576|FG000|Overall Study|Other|47|||
44311427|NCT01081795|79313608|FG000|Overall Study|Adverse Event|18|||
44311428|NCT01081795|79313609|FG001|Overall Study|Adverse Event|23|||
44311429|NCT01081795|79313610|FG002|Overall Study|Adverse Event|6|||
44311430|NCT01081795|79313608|FG000|Overall Study|Lack of Efficacy|7|||
44311431|NCT01081795|79313609|FG001|Overall Study|Lack of Efficacy|5|||
44311432|NCT01081795|79313610|FG002|Overall Study|Lack of Efficacy|19|||
44311433|NCT01081795|79313608|FG000|Overall Study|Subject's schedule|1|||
44311434|NCT01081795|79313609|FG001|Overall Study|Subject's schedule|1|||
44311435|NCT01081795|79313610|FG002|Overall Study|Subject's schedule|2|||
44311436|NCT01081795|79313608|FG000|Overall Study|Revocation of informed consent|2|||
44311437|NCT01081795|79313609|FG001|Overall Study|Revocation of informed consent|0|||
44311438|NCT01081795|79313610|FG002|Overall Study|Revocation of informed consent|0|||
44311439|NCT01081795|79313608|FG000|Overall Study|Ineligible for participation|1|||
44311440|NCT01081795|79313609|FG001|Overall Study|Ineligible for participation|0|||
44311441|NCT01081795|79313610|FG002|Overall Study|Ineligible for participation|0|||
44311442|NCT01081795|79313608|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
44311443|NCT01081795|79313609|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
44311444|NCT01081795|79313610|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
44311445|NCT01081795|79313608|FG000|Overall Study|Using drug with restricted days of use|2|||
44311446|NCT01081795|79313609|FG001|Overall Study|Using drug with restricted days of use|3|||
44311447|NCT01081795|79313610|FG002|Overall Study|Using drug with restricted days of use|2|||
44311448|NCT01081795|79313608|FG000|Overall Study|Other|1|||
44311449|NCT01081795|79313609|FG001|Overall Study|Other|2|||
44311450|NCT01081795|79313610|FG002|Overall Study|Other|0|||
44311451|NCT01081678|79313622|FG000|Overall Study|Ineligibility Determined|0|||
44311452|NCT01081678|79313623|FG001|Overall Study|Ineligibility Determined|0|||
44311453|NCT01081678|79313624|FG002|Overall Study|Ineligibility Determined|1|||
44311454|NCT01081678|79313625|FG003|Overall Study|Ineligibility Determined|1|||
44311455|NCT01081678|79313622|FG000|Overall Study|Noncompliance|3|||
44311456|NCT01081678|79313623|FG001|Overall Study|Noncompliance|4|||
44311457|NCT01081678|79313624|FG002|Overall Study|Noncompliance|5|||
44311458|NCT01081678|79313625|FG003|Overall Study|Noncompliance|2|||
44311459|NCT01081678|79313622|FG000|Overall Study|Adverse Event|2|||
44311460|NCT01081678|79313623|FG001|Overall Study|Adverse Event|1|||
44311461|NCT01081678|79313624|FG002|Overall Study|Adverse Event|2|||
44311462|NCT01081678|79313625|FG003|Overall Study|Adverse Event|2|||
44311463|NCT01081678|79313622|FG000|Overall Study|Withdrawal by Subject|15|||
44311464|NCT01081678|79313623|FG001|Overall Study|Withdrawal by Subject|7|||
44311465|NCT01081678|79313624|FG002|Overall Study|Withdrawal by Subject|17|||
44311466|NCT01081678|79313625|FG003|Overall Study|Withdrawal by Subject|14|||
44311467|NCT01081678|79313622|FG000|Overall Study|Administrative Decision|1|||
44311468|NCT01081678|79313623|FG001|Overall Study|Administrative Decision|0|||
44311469|NCT01081678|79313624|FG002|Overall Study|Administrative Decision|0|||
44311470|NCT01081678|79313625|FG003|Overall Study|Administrative Decision|1|||
44311471|NCT01081678|79313622|FG000|Overall Study|Lost to Follow-up|4|||
44311472|NCT01081678|79313623|FG001|Overall Study|Lost to Follow-up|1|||
44311473|NCT01081678|79313624|FG002|Overall Study|Lost to Follow-up|4|||
44311474|NCT01081678|79313625|FG003|Overall Study|Lost to Follow-up|3|||
44311475|NCT01081678|79313622|FG000|Overall Study|Death|2|||
44311476|NCT01081678|79313623|FG001|Overall Study|Death|2|||
44311477|NCT01081678|79313624|FG002|Overall Study|Death|2|||
44311478|NCT01081678|79313625|FG003|Overall Study|Death|6|||
44311479|NCT01081678|79313622|FG000|Overall Study|Other|0|||
44311480|NCT01081678|79313623|FG001|Overall Study|Other|1|||
44311481|NCT01081678|79313624|FG002|Overall Study|Other|0|||
44311482|NCT01081678|79313625|FG003|Overall Study|Other|0|||
44311483|NCT01081249|79313635|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
44311484|NCT01081249|79313636|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
44311485|NCT01081132|79313644|FG000|Overall Study|Lack of Efficacy|25|||
44311486|NCT01081132|79313645|FG001|Overall Study|Lack of Efficacy|9|||
44311487|NCT01081132|79313644|FG000|Overall Study|Withdrawal by Subject|13|||
44311488|NCT01081132|79313645|FG001|Overall Study|Withdrawal by Subject|16|||
44311489|NCT01081132|79313644|FG000|Overall Study|Lost to Follow-up|4|||
44311490|NCT01081132|79313645|FG001|Overall Study|Lost to Follow-up|11|||
44311491|NCT01081132|79313644|FG000|Overall Study|Adverse Event|3|||
44311492|NCT01081132|79313645|FG001|Overall Study|Adverse Event|9|||
44311493|NCT01081132|79313644|FG000|Overall Study|Non Compliance|4|||
44311494|NCT01081132|79313645|FG001|Overall Study|Non Compliance|2|||
44311495|NCT01081132|79313644|FG000|Overall Study|Lack Of Compliance|0|||
44311496|NCT01081132|79313645|FG001|Overall Study|Lack Of Compliance|1|||
44311497|NCT01081132|79313644|FG000|Overall Study|Missed Visits|1|||
44311498|NCT01081132|79313645|FG001|Overall Study|Missed Visits|1|||
44311499|NCT01081132|79313644|FG000|Overall Study|Stopped Taking Meds|2|||
44311500|NCT01081132|79313645|FG001|Overall Study|Stopped Taking Meds|0|||
44420212|NCT00589979|79428053|FG002|Run-In Period|Adverse Event|0|||
44420213|NCT00589979|79428051|FG000|Run-In Period|Protocol Violation|3|||
44420214|NCT00589979|79428052|FG001|Run-In Period|Protocol Violation|0|||
44420215|NCT00589979|79428053|FG002|Run-In Period|Protocol Violation|0|||
44420216|NCT00589979|79428051|FG000|Run-In Period|Did not qualify for randomization|54|||
44420217|NCT00589979|79428052|FG001|Run-In Period|Did not qualify for randomization|0|||
44535948|NCT03758443|79546731|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
44535949|NCT03758443|79546732|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
44535950|NCT03758443|79546733|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
44535951|NCT03758443|79546730|FG000|Maintenance Period|Protocol Violation|0|||
44535952|NCT03758443|79546731|FG001|Maintenance Period|Protocol Violation|1|||
44535953|NCT03758443|79546732|FG002|Maintenance Period|Protocol Violation|0|||
44535954|NCT03758443|79546733|FG003|Maintenance Period|Protocol Violation|0|||
44535955|NCT03758443|79546730|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
44535956|NCT03758443|79546731|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
44311501|NCT01081132|79313644|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
44311502|NCT01081132|79313645|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
44311503|NCT01081132|79313644|FG000|Overall Study|Declined Taper Phase|0|||
44420218|NCT00589979|79428053|FG002|Run-In Period|Did not qualify for randomization|0|||
44420219|NCT00589979|79428051|FG000|Run-In Period|Withdrawal by Subject|10|||
44420220|NCT00589979|79428052|FG001|Run-In Period|Withdrawal by Subject|0|||
44420221|NCT00589979|79428053|FG002|Run-In Period|Withdrawal by Subject|0|||
44420222|NCT00589979|79428051|FG000|Run-In Period|Informed Consent Withdrawn|4|||
44420223|NCT00589979|79428052|FG001|Run-In Period|Informed Consent Withdrawn|0|||
44311504|NCT01081132|79313645|FG001|Overall Study|Declined Taper Phase|1|||
44311505|NCT01081132|79313644|FG000|Overall Study|Protocol Violation|3|||
44311506|NCT01081132|79313645|FG001|Overall Study|Protocol Violation|1|||
44311507|NCT01080625|79313654|FG000|Overall Study|Physician Decision|0|||
44311508|NCT01080625|79313655|FG001|Overall Study|Physician Decision|2|||
44311509|NCT01080625|79313656|FG002|Overall Study|Physician Decision|1|||
44311510|NCT01059903|79313666|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
44311511|NCT01059903|79313667|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
44311512|NCT05562011|79313702|FG000|Overall Study|Withdrawal by Subject|3|||
44311513|NCT05562011|79313702|FG000|Overall Study|Lost to Follow-up|1|||
44311514|NCT05562011|79313702|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
44311515|NCT05562011|79313702|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
44311516|NCT05562011|79313702|FG000|Overall Study|Device malfunction|13|||
44311517|NCT05089708|79313761|FG000|Overall Study|Lost to Follow-up|9|||
44311518|NCT05089708|79313762|FG001|Overall Study|Lost to Follow-up|7|||
44311519|NCT05089708|79313761|FG000|Overall Study|Withdrawal by Subject|3|||
44311520|NCT05089708|79313762|FG001|Overall Study|Withdrawal by Subject|1|||
44311521|NCT05089708|79313761|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
44311522|NCT05089708|79313762|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
44311523|NCT05089708|79313761|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
44311524|NCT05089708|79313762|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
44311525|NCT04642638|79313814|FG000|Overall Study|Withdrawal by Subject|23|||
44311526|NCT04642638|79313815|FG001|Overall Study|Withdrawal by Subject|29|||
44311527|NCT04642638|79313816|FG002|Overall Study|Withdrawal by Subject|9|||
44311528|NCT04642638|79313817|FG003|Overall Study|Withdrawal by Subject|7|||
44311529|NCT04642638|79313818|FG004|Overall Study|Withdrawal by Subject|61|||
44311530|NCT04642638|79313819|FG005|Overall Study|Withdrawal by Subject|27|||
44311531|NCT04642638|79313814|FG000|Overall Study|Lost to Follow-up|17|||
44311532|NCT04642638|79313815|FG001|Overall Study|Lost to Follow-up|18|||
44311533|NCT04642638|79313816|FG002|Overall Study|Lost to Follow-up|5|||
44311534|NCT04642638|79313817|FG003|Overall Study|Lost to Follow-up|5|||
44311535|NCT04642638|79313818|FG004|Overall Study|Lost to Follow-up|6|||
44311536|NCT04642638|79313819|FG005|Overall Study|Lost to Follow-up|3|||
44420224|NCT00589979|79428053|FG002|Run-In Period|Informed Consent Withdrawn|0|||
44420225|NCT00589979|79428051|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
44420226|NCT00589979|79428052|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
44535957|NCT03758443|79546732|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
44535958|NCT03758443|79546733|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
44311537|NCT04642638|79313814|FG000|Overall Study|Adverse Event|0|||
44420227|NCT00589979|79428053|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
44420228|NCT00589979|79428051|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
44535959|NCT03758443|79546730|FG000|Maintenance Period|Withdrawal by Subject|1|||
44420229|NCT00589979|79428052|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
44311538|NCT04642638|79313815|FG001|Overall Study|Adverse Event|0|||
44311539|NCT04642638|79313816|FG002|Overall Study|Adverse Event|1|||
44420230|NCT00589979|79428053|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
44311540|NCT04642638|79313817|FG003|Overall Study|Adverse Event|0|||
44311541|NCT04642638|79313818|FG004|Overall Study|Adverse Event|10|||
44311542|NCT04642638|79313819|FG005|Overall Study|Adverse Event|3|||
44311543|NCT04642638|79313814|FG000|Overall Study|Reason Not Specified|1|||
44311544|NCT04642638|79313815|FG001|Overall Study|Reason Not Specified|4|||
44311545|NCT04642638|79313816|FG002|Overall Study|Reason Not Specified|0|||
44311546|NCT04642638|79313817|FG003|Overall Study|Reason Not Specified|0|||
44311547|NCT04642638|79313818|FG004|Overall Study|Reason Not Specified|38|||
44311548|NCT04642638|79313819|FG005|Overall Study|Reason Not Specified|16|||
44311549|NCT04642638|79313814|FG000|Overall Study|Physician Decision|0|||
44311550|NCT04642638|79313815|FG001|Overall Study|Physician Decision|0|||
44311551|NCT04642638|79313816|FG002|Overall Study|Physician Decision|0|||
44311552|NCT04642638|79313817|FG003|Overall Study|Physician Decision|0|||
44311553|NCT04642638|79313818|FG004|Overall Study|Physician Decision|2|||
44311554|NCT04642638|79313819|FG005|Overall Study|Physician Decision|1|||
44311555|NCT04642638|79313814|FG000|Overall Study|Protocol Deviation|0|||
44311556|NCT04642638|79313815|FG001|Overall Study|Protocol Deviation|0|||
44311557|NCT04642638|79313816|FG002|Overall Study|Protocol Deviation|0|||
44311558|NCT04642638|79313817|FG003|Overall Study|Protocol Deviation|0|||
44420231|NCT00589979|79428051|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
44420232|NCT00589979|79428052|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
44420233|NCT00589979|79428053|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
44420234|NCT00589979|79428051|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
44420235|NCT00589979|79428052|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
44420236|NCT00589979|79428053|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
44420237|NCT00589979|79428051|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
44420238|NCT00589979|79428052|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
44420239|NCT00589979|79428053|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
44420240|NCT00589979|79428051|FG000|Double-Blind Treatment Period 2|Other|0|||
44420241|NCT00589979|79428052|FG001|Double-Blind Treatment Period 2|Other|0|||
44420242|NCT00589979|79428053|FG002|Double-Blind Treatment Period 2|Other|1|||
44420243|NCT00589979|79428051|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
44420244|NCT00589979|79428052|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
44420245|NCT00589979|79428053|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
44420246|NCT00589979|79428051|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
44420247|NCT00589979|79428052|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
44420248|NCT00589979|79428053|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
44420249|NCT00797732|79428067|FG000|Overall Study|Withdrawal by Subject|3|||
44420250|NCT00797732|79428068|FG001|Overall Study|Withdrawal by Subject|3|||
44420251|NCT00797732|79428069|FG002|Overall Study|Withdrawal by Subject|0|||
44420252|NCT00797732|79428067|FG000|Overall Study|Lost to Follow-up|1|||
44420253|NCT00797732|79428068|FG001|Overall Study|Lost to Follow-up|0|||
44420254|NCT00797732|79428069|FG002|Overall Study|Lost to Follow-up|0|||
44420255|NCT00797732|79428067|FG000|Overall Study|Death|1|||
44420256|NCT00797732|79428068|FG001|Overall Study|Death|0|||
44420257|NCT00797732|79428069|FG002|Overall Study|Death|0|||
44420258|NCT00797732|79428067|FG000|Overall Study|Not meet inclusion criteria|0|||
44420259|NCT00797732|79428068|FG001|Overall Study|Not meet inclusion criteria|0|||
44420260|NCT00797732|79428069|FG002|Overall Study|Not meet inclusion criteria|7|||
44420261|NCT00797732|79428067|FG000|Overall Study|Excluded due to time constraints|0|||
44420262|NCT00797732|79428068|FG001|Overall Study|Excluded due to time constraints|0|||
44420263|NCT00797732|79428069|FG002|Overall Study|Excluded due to time constraints|24|||
44420264|NCT00797732|79428067|FG000|Overall Study|Refused to Participate|0|||
44420265|NCT00797732|79428068|FG001|Overall Study|Refused to Participate|0|||
44420266|NCT00797732|79428069|FG002|Overall Study|Refused to Participate|123|||
44420267|NCT00790088|79428075|FG000|Overall Study|Protocol Violation|11|||
44420268|NCT00790088|79428075|FG000|Overall Study|Withdrawal by Subject|17|||
44420269|NCT00790088|79428075|FG000|Overall Study|Lost to Follow-up|7|||
44420270|NCT00790088|79428075|FG000|Overall Study|Physician Decision|4|||
44420271|NCT00736944|79428081|FG000|Induction|Death|1|||
44420272|NCT00736944|79428081|FG000|Definitive Treatment|Physician Decision|1|||
44420273|NCT00736476|79428090|FG000|Overall Study|Adverse Event|1|||
44420274|NCT00736476|79428091|FG001|Overall Study|Adverse Event|0|||
44420275|NCT00715299|79428103|FG000|Overall Study|Withdrawal by Subject|1|||
44420276|NCT00715299|79428103|FG000|Overall Study|Adverse Event|3|||
44420277|NCT00715299|79428103|FG000|Overall Study|failed the pre-screen exercise test|2|||
44155497|NCT01998958|78946973|FG026|Open Label Phase (Optional)|Other|0|||
44420278|NCT00730236|79428107|FG000|Overall Study|Adverse Event|4|||
44420279|NCT00730236|79428107|FG000|Overall Study|Withdrawal by Subject|1|||
44420280|NCT00730236|79428107|FG000|Overall Study|Non-compliance|1|||
44311559|NCT04642638|79313818|FG004|Overall Study|Protocol Deviation|1|||
44420281|NCT00714285|79428115|FG000|Overall Study|Lost to Follow-up|0|||
44420282|NCT00714285|79428116|FG001|Overall Study|Lost to Follow-up|2|||
44420283|NCT00714285|79428117|FG002|Overall Study|Lost to Follow-up|0|||
44311560|NCT04642638|79313819|FG005|Overall Study|Protocol Deviation|3|||
44311561|NCT04642638|79313814|FG000|Overall Study|Study Terminated|0|||
44420284|NCT00714285|79428118|FG003|Overall Study|Lost to Follow-up|1|||
44420285|NCT00714285|79428115|FG000|Overall Study|Migrated/moved from study area|0|||
44420286|NCT00714285|79428116|FG001|Overall Study|Migrated/moved from study area|1|||
44420287|NCT00714285|79428117|FG002|Overall Study|Migrated/moved from study area|0|||
44420288|NCT00714285|79428118|FG003|Overall Study|Migrated/moved from study area|0|||
44420289|NCT00776984|79428132|FG000|Overall Study|Adverse Event|8|||
44420290|NCT00776984|79428133|FG001|Overall Study|Adverse Event|2|||
44420291|NCT00776984|79428132|FG000|Overall Study|Protocol Violation|4|||
44420292|NCT00776984|79428133|FG001|Overall Study|Protocol Violation|2|||
44420293|NCT00776984|79428132|FG000|Overall Study|Lost to Follow-up|2|||
44420294|NCT00776984|79428133|FG001|Overall Study|Lost to Follow-up|0|||
44420295|NCT00776984|79428132|FG000|Overall Study|Withdrawal by Subject|12|||
44420296|NCT00776984|79428133|FG001|Overall Study|Withdrawal by Subject|7|||
44420297|NCT00776984|79428132|FG000|Overall Study|Lack of Efficacy|0|||
44420298|NCT00776984|79428133|FG001|Overall Study|Lack of Efficacy|1|||
44420299|NCT00776984|79428132|FG000|Overall Study|Other|5|||
44420300|NCT00776984|79428133|FG001|Overall Study|Other|9|||
44420301|NCT00714051|79428141|FG000|Overall Study|Withdrawal by Subject|1|||
44420302|NCT00714051|79428142|FG001|Overall Study|Withdrawal by Subject|0|||
44420303|NCT00714051|79428141|FG000|Overall Study|Death|0|||
44420304|NCT00714051|79428142|FG001|Overall Study|Death|1|||
44311562|NCT04642638|79313815|FG001|Overall Study|Study Terminated|0|||
44311563|NCT04642638|79313816|FG002|Overall Study|Study Terminated|0|||
44311564|NCT04642638|79313817|FG003|Overall Study|Study Terminated|0|||
44311565|NCT04642638|79313818|FG004|Overall Study|Study Terminated|484|||
44311566|NCT04642638|79313819|FG005|Overall Study|Study Terminated|250|||
44311567|NCT04642638|79313814|FG000|Overall Study|Pregnancy|0|||
44311568|NCT04642638|79313815|FG001|Overall Study|Pregnancy|0|||
44311569|NCT04642638|79313816|FG002|Overall Study|Pregnancy|0|||
44311570|NCT04642638|79313817|FG003|Overall Study|Pregnancy|0|||
44311571|NCT04642638|79313818|FG004|Overall Study|Pregnancy|1|||
44311572|NCT04642638|79313819|FG005|Overall Study|Pregnancy|0|||
44311573|NCT04634825|79313837|FG000|Overall Study|Death|10|||
44311574|NCT04634825|79313838|FG001|Overall Study|Death|3|||
44311575|NCT04634825|79313837|FG000|Overall Study|Lost to Follow-up|1|||
44311576|NCT04634825|79313838|FG001|Overall Study|Lost to Follow-up|0|||
44311577|NCT04634825|79313837|FG000|Overall Study|Study terminated by sponsor|35|||
44311578|NCT04634825|79313838|FG001|Overall Study|Study terminated by sponsor|11|||
44311579|NCT04634825|79313837|FG000|Overall Study|Withdrawal by Subject|2|||
44311580|NCT04634825|79313838|FG001|Overall Study|Withdrawal by Subject|0|||
44311581|NCT04398537|79313852|FG000|Overall Study|Physician Decision|10|||
44311582|NCT04398537|79313853|FG001|Overall Study|Physician Decision|15|||
44311583|NCT04176939|79313873|FG000|Overall Study|Adverse Event|7|||
44311584|NCT04176939|79313873|FG000|Overall Study|Unspecified reason|2|||
44311585|NCT04176939|79313873|FG000|Overall Study|Migrated/Moved from the study area|1|||
44311586|NCT04176939|79313873|FG000|Overall Study|Withdrawal by Subject|4|||
44311587|NCT04176939|79313873|FG000|Overall Study|In follow-up|54|||
44311588|NCT03894891|79313893|FG000|Overall Study|Withdrawal by Subject|1|||
44311589|NCT03894891|79313893|FG000|Overall Study|Completed protocol treatment per protocol|5|||
44311590|NCT03863080|79313900|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
44311591|NCT03863080|79313901|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
44311592|NCT03863080|79313902|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
44311593|NCT03863080|79313903|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
44311594|NCT03863080|79313900|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
44311595|NCT03863080|79313901|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
44311596|NCT03863080|79313902|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
44311597|NCT03863080|79313903|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
44311598|NCT03863080|79313900|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
44311599|NCT03863080|79313901|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
44311600|NCT03863080|79313902|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
44311601|NCT03863080|79313903|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
44311602|NCT03834493|79313918|FG000|Overall Study|Participants Ongoing|311|||
44420305|NCT00784784|79428150|FG000|Overall Study|Withdrawal by Subject|2|||
44420306|NCT00784784|79428151|FG001|Overall Study|Withdrawal by Subject|2|||
44420307|NCT00801983|79428159|FG000|Period 1|Lost to Follow-up|2|||
44311603|NCT03834493|79313919|FG001|Overall Study|Participants Ongoing|324|||
44311604|NCT03834493|79313918|FG000|Overall Study|Withdrawal by Subject|20|||
44311605|NCT03834493|79313919|FG001|Overall Study|Withdrawal by Subject|17|||
44311606|NCT03834493|79313918|FG000|Overall Study|Physician Decision|1|||
44311607|NCT03834493|79313919|FG001|Overall Study|Physician Decision|0|||
44311608|NCT03834493|79313918|FG000|Overall Study|Death|289|||
44420308|NCT00801983|79428160|FG001|Period 1|Lost to Follow-up|0|||
44420309|NCT00801983|79428159|FG000|Period 1|Withdrawal by Subject|2|||
44420310|NCT00801983|79428160|FG001|Period 1|Withdrawal by Subject|8|||
44420311|NCT00801983|79428159|FG000|Period 2|Withdrawal by Subject|2|||
44420312|NCT00801983|79428160|FG001|Period 2|Withdrawal by Subject|1|||
44420313|NCT00587288|79428168|FG000|Overall Study|Adverse Event|0|||
44311609|NCT03834493|79313919|FG001|Overall Study|Death|282|||
44311610|NCT03483103|79313926|FG000|Pre-Treatment Phase|Other reasons|1|||
44311611|NCT03483103|79313926|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
44311612|NCT03483103|79313926|FG000|Pre-Treatment Phase|Disease-related complications|1|||
44311613|NCT03483103|79313926|FG000|Pre-Treatment Phase|Death|5|||
44311614|NCT03483103|79313926|FG000|Treatment Phase|Withdrawal by Subject|7|||
44311615|NCT03483103|79313926|FG000|Treatment Phase|Other reasons|1|||
44311616|NCT03483103|79313926|FG000|Treatment Phase|Death|23|||
44311617|NCT03483103|79313926|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
44311618|NCT03483103|79313926|FG000|Treatment Phase|Received nonconforming product|1|||
44311619|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
44311620|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
44311621|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
44311622|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
44311623|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
44311624|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
44311625|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
44420314|NCT00587288|79428169|FG001|Overall Study|Adverse Event|1|||
44420315|NCT00587288|79428168|FG000|Overall Study|Lack of Efficacy|2|||
44420316|NCT00587288|79428169|FG001|Overall Study|Lack of Efficacy|8|||
44420317|NCT00587288|79428168|FG000|Overall Study|Protocol Violation|1|||
44420318|NCT00587288|79428169|FG001|Overall Study|Protocol Violation|0|||
44420319|NCT00800735|79428177|FG000|Overall Study|Administrative/Other|2|||
44420320|NCT00800735|79428177|FG000|Overall Study|Insufficient Therapeutic Response|2|||
44420321|NCT00800735|79428177|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
44420322|NCT00800735|79428177|FG000|Overall Study|Withdrew Consent|3|||
44420323|NCT00730158|79428183|FG000|Overall Study|Withdrawal by Subject|1|||
44420324|NCT00730158|79428184|FG001|Overall Study|Withdrawal by Subject|1|||
44420325|NCT00784550|79428196|FG000|Overall Study|Adverse Event|12|||
44420326|NCT00784550|79428197|FG001|Overall Study|Adverse Event|10|||
44420327|NCT00784550|79428196|FG000|Overall Study|Lack of Efficacy|0|||
44420328|NCT00784550|79428197|FG001|Overall Study|Lack of Efficacy|1|||
44420329|NCT00784550|79428196|FG000|Overall Study|Protocol Violation|10|||
44420330|NCT00784550|79428197|FG001|Overall Study|Protocol Violation|10|||
44420331|NCT00784550|79428196|FG000|Overall Study|Lost to Follow-up|8|||
44420332|NCT00784550|79428197|FG001|Overall Study|Lost to Follow-up|5|||
44420333|NCT00784550|79428196|FG000|Overall Study|Physician Decision|2|||
44420334|NCT00784550|79428197|FG001|Overall Study|Physician Decision|3|||
44420335|NCT00784550|79428196|FG000|Overall Study|Withdrawal by Subject|4|||
44420336|NCT00784550|79428197|FG001|Overall Study|Withdrawal by Subject|13|||
44420337|NCT00729690|79428206|FG000|Overall Study|IT Catheter Malfunction|0|||
44420338|NCT00729690|79428207|FG001|Overall Study|IT Catheter Malfunction|2|||
44420339|NCT00729690|79428208|FG002|Overall Study|IT Catheter Malfunction|2|||
44420340|NCT00784238|79428216|FG000|Overall Study|Adverse Event|14|||
44420341|NCT00784238|79428216|FG000|Overall Study|Death|2|||
44420342|NCT00784238|79428216|FG000|Overall Study|Lack of Efficacy|33|||
44420343|NCT00784238|79428216|FG000|Overall Study|Lost to Follow-up|29|||
44311626|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
44311627|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
44311628|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
44311629|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
44311630|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
44311631|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
44311632|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
44420344|NCT00784238|79428216|FG000|Overall Study|Pregnancy|1|||
44420345|NCT00784238|79428216|FG000|Overall Study|Withdrawal by Subject|26|||
44420346|NCT00784238|79428216|FG000|Overall Study|Other|14|||
44420347|NCT00729612|79428223|FG000|Overall Study|Non evaluable for response|10|||
44420348|NCT00585546|79428227|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
44420349|NCT00585546|79428227|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
44420350|NCT00768248|79428233|FG000|Overall Study|Research coordinator didn't collect data|1|||
44420351|NCT00768248|79428234|FG001|Overall Study|Research coordinator didn't collect data|1|||
44420352|NCT00775268|79428242|FG000|Baseline|Drug not synthesize dose|1|||
44420353|NCT00775268|79428243|FG001|Baseline|Drug not synthesize dose|0|||
44535960|NCT03758443|79546731|FG001|Maintenance Period|Withdrawal by Subject|0|||
44535961|NCT03758443|79546732|FG002|Maintenance Period|Withdrawal by Subject|1|||
44354734|NCT01187550|79359143|FG001|Overall Study|Other|0|||
44354735|NCT01187550|79359142|FG000|Overall Study|Randomized but not treated|8|||
44354736|NCT01187550|79359143|FG001|Overall Study|Randomized but not treated|0|||
44354737|NCT01186770|79359153|FG000|Overall Study|Ineligibility|0|||
44354738|NCT01186770|79359154|FG001|Overall Study|Ineligibility|0|||
44354739|NCT01186770|79359155|FG002|Overall Study|Ineligibility|2|||
44354740|NCT01186770|79359156|FG003|Overall Study|Ineligibility|0|||
44354741|NCT01186770|79359153|FG000|Overall Study|Protocol Violation|7|||
44354742|NCT01186770|79359154|FG001|Overall Study|Protocol Violation|9|||
44420354|NCT00775268|79428242|FG000|Baseline|Not treated-ineligible per CT|0|||
44420355|NCT00775268|79428243|FG001|Baseline|Not treated-ineligible per CT|1|||
44420356|NCT00775268|79428242|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
44420357|NCT00775268|79428243|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
44420358|NCT00775268|79428242|FG000|After Completion|Participant missed scan appointment|1|||
44420359|NCT00775268|79428243|FG001|After Completion|Participant missed scan appointment|0|||
44311633|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
44311634|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
44311635|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
44311636|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
44311637|NCT03412747|79313942|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
44311638|NCT03412747|79313943|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
44311639|NCT03412747|79313944|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
44311640|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
44311641|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
44311642|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
44311643|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
44311644|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
44311645|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
44311646|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
44311647|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
44311648|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
44311649|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
44311650|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
44311651|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
44311652|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
44311653|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
44311654|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
44311655|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
44311656|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
44311657|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
44311658|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
44311659|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
44311660|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
44311661|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
44311662|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
44311663|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
44311664|NCT03412747|79313942|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
44311665|NCT03412747|79313943|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
44311666|NCT03412747|79313944|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
44311667|NCT03410992|79313964|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311668|NCT03410992|79313965|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
44311669|NCT03410992|79313966|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311670|NCT03410992|79313967|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311671|NCT03410992|79313968|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311672|NCT03410992|79313969|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311673|NCT03410992|79313970|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311674|NCT03410992|79313971|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311675|NCT03410992|79313972|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311676|NCT03410992|79313973|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311677|NCT03410992|79313974|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
44311678|NCT03410992|79313964|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
44311679|NCT03410992|79313965|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
44311680|NCT03410992|79313966|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311681|NCT03410992|79313967|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311682|NCT03410992|79313968|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311683|NCT03410992|79313969|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311684|NCT03410992|79313970|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311685|NCT03410992|79313971|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311686|NCT03410992|79313972|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311687|NCT03410992|79313973|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44420360|NCT00775190|79428262|FG000|Overall Study|Lost to Follow-up|2|||
44420361|NCT00775190|79428263|FG001|Overall Study|Lost to Follow-up|3|||
44420362|NCT00775190|79428262|FG000|Overall Study|Withdrawal by Subject|1|||
44535962|NCT03758443|79546733|FG003|Maintenance Period|Withdrawal by Subject|1|||
44535963|NCT03758443|79546730|FG000|Maintenance Period|Miscellaneous|0|||
44311688|NCT03410992|79313974|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
44311689|NCT03410992|79313964|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
44311690|NCT03410992|79313965|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
44311691|NCT03410992|79313966|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311692|NCT03410992|79313967|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311693|NCT03410992|79313968|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311694|NCT03410992|79313969|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311695|NCT03410992|79313970|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311696|NCT03410992|79313971|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311697|NCT03410992|79313972|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311698|NCT03410992|79313973|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311699|NCT03410992|79313974|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
44311700|NCT03410992|79313964|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
44311701|NCT03410992|79313965|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311702|NCT03410992|79313966|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311703|NCT03410992|79313967|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311704|NCT03410992|79313968|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311705|NCT03410992|79313969|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311706|NCT03410992|79313970|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311707|NCT03410992|79313971|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311708|NCT03410992|79313972|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311709|NCT03410992|79313973|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311710|NCT03410992|79313974|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
44311711|NCT03410992|79313964|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
44311712|NCT03410992|79313965|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
44311713|NCT03410992|79313966|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311714|NCT03410992|79313967|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311715|NCT03410992|79313968|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311716|NCT03410992|79313969|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311717|NCT03410992|79313970|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311718|NCT03410992|79313971|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311719|NCT03410992|79313972|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311720|NCT03410992|79313973|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311721|NCT03410992|79313974|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
44311722|NCT03410992|79313964|FG000|Week 16 Assessment|Incorrect escapers|0|||
44311723|NCT03410992|79313965|FG001|Week 16 Assessment|Incorrect escapers|6|||
44311724|NCT03410992|79313966|FG002|Week 16 Assessment|Incorrect escapers|0|||
44311725|NCT03410992|79313967|FG003|Week 16 Assessment|Incorrect escapers|0|||
44311726|NCT03410992|79313968|FG004|Week 16 Assessment|Incorrect escapers|0|||
44311727|NCT03410992|79313969|FG005|Week 16 Assessment|Incorrect escapers|0|||
44311728|NCT03410992|79313970|FG006|Week 16 Assessment|Incorrect escapers|0|||
44311729|NCT03410992|79313971|FG007|Week 16 Assessment|Incorrect escapers|0|||
44311730|NCT03410992|79313972|FG008|Week 16 Assessment|Incorrect escapers|0|||
44311731|NCT03410992|79313973|FG009|Week 16 Assessment|Incorrect escapers|0|||
44311732|NCT03410992|79313974|FG010|Week 16 Assessment|Incorrect escapers|0|||
44311733|NCT03410992|79313964|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311734|NCT03410992|79313965|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311735|NCT03410992|79313966|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311736|NCT03410992|79313967|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
44311737|NCT03410992|79313968|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
44311738|NCT03410992|79313969|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311739|NCT03410992|79313970|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311740|NCT03410992|79313971|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311741|NCT03410992|79313972|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44420363|NCT00775190|79428263|FG001|Overall Study|Withdrawal by Subject|2|||
44420364|NCT00775190|79428262|FG000|Overall Study|Protocol Violation|1|||
44420365|NCT00775190|79428263|FG001|Overall Study|Protocol Violation|0|||
44311742|NCT03410992|79313973|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44311743|NCT03410992|79313974|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
44535964|NCT03758443|79546731|FG001|Maintenance Period|Miscellaneous|0|||
44535965|NCT03758443|79546732|FG002|Maintenance Period|Miscellaneous|1|||
44535966|NCT03758443|79546733|FG003|Maintenance Period|Miscellaneous|0|||
44535967|NCT03442764|79546755|FG000|Overall Study|Adverse Event|1|||
44535968|NCT03442764|79546756|FG001|Overall Study|Adverse Event|0|||
44535969|NCT03442764|79546757|FG002|Overall Study|Adverse Event|0|||
44535970|NCT03442296|79546768|FG000|3 Month Follow-up|Death|3|||
44155498|NCT01998958|78946974|FG027|Open Label Phase (Optional)|Other|0|||
44311744|NCT03410992|79313964|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311745|NCT03410992|79313965|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311746|NCT03410992|79313966|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311747|NCT03410992|79313967|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
44311748|NCT03410992|79313968|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
44311749|NCT03410992|79313969|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
44311750|NCT03410992|79313970|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311751|NCT03410992|79313971|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311752|NCT03410992|79313972|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311753|NCT03410992|79313973|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311754|NCT03410992|79313974|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
44311755|NCT03410992|79313964|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311756|NCT03410992|79313965|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311757|NCT03410992|79313966|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311758|NCT03410992|79313967|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311759|NCT03410992|79313968|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311760|NCT03410992|79313969|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
44311761|NCT03410992|79313970|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311762|NCT03410992|79313971|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311763|NCT03410992|79313972|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311764|NCT03410992|79313973|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44311765|NCT03410992|79313974|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
44155499|NCT01998958|78946975|FG028|Open Label Phase (Optional)|Other|0|||
44155500|NCT01998958|78946976|FG029|Open Label Phase (Optional)|Other|0|||
44311766|NCT03410992|79313964|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311767|NCT03410992|79313965|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311768|NCT03410992|79313966|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311769|NCT03410992|79313967|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
44311770|NCT03410992|79313968|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
44311771|NCT03410992|79313969|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
44311772|NCT03410992|79313970|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311773|NCT03410992|79313971|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311774|NCT03410992|79313972|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311775|NCT03410992|79313973|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311776|NCT03410992|79313974|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
44311777|NCT03410992|79313964|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311778|NCT03410992|79313965|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311779|NCT03410992|79313966|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311780|NCT03410992|79313967|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311781|NCT03410992|79313968|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311782|NCT03410992|79313969|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311783|NCT03410992|79313970|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311784|NCT03410992|79313971|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
44420366|NCT00479557|79428276|FG000|Overall Study|Death|0|||
44420367|NCT00479557|79428277|FG001|Overall Study|Death|0|||
44420368|NCT00479557|79428278|FG002|Overall Study|Death|0|||
44420369|NCT00479557|79428279|FG003|Overall Study|Death|0|||
44420370|NCT00479557|79428280|FG004|Overall Study|Death|0|||
44420371|NCT00479557|79428281|FG005|Overall Study|Death|1|||
44420372|NCT00479557|79428282|FG006|Overall Study|Death|0|||
44420373|NCT00479557|79428276|FG000|Overall Study|Lack of Efficacy|1|||
44420374|NCT00479557|79428277|FG001|Overall Study|Lack of Efficacy|0|||
44155501|NCT01998958|78946977|FG030|Open Label Phase (Optional)|Other|0|||
44420375|NCT00479557|79428278|FG002|Overall Study|Lack of Efficacy|0|||
44420376|NCT00479557|79428279|FG003|Overall Study|Lack of Efficacy|0|||
44420377|NCT00479557|79428280|FG004|Overall Study|Lack of Efficacy|0|||
44420378|NCT00479557|79428281|FG005|Overall Study|Lack of Efficacy|0|||
44420379|NCT00479557|79428282|FG006|Overall Study|Lack of Efficacy|0|||
44420380|NCT00479557|79428276|FG000|Overall Study|Lost to Follow-up|0|||
44420381|NCT00479557|79428277|FG001|Overall Study|Lost to Follow-up|2|||
44311785|NCT03410992|79313972|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311786|NCT03410992|79313973|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
44420382|NCT00479557|79428278|FG002|Overall Study|Lost to Follow-up|0|||
44420383|NCT00479557|79428279|FG003|Overall Study|Lost to Follow-up|2|||
44420384|NCT00479557|79428280|FG004|Overall Study|Lost to Follow-up|0|||
44420385|NCT00479557|79428281|FG005|Overall Study|Lost to Follow-up|0|||
44311787|NCT03410992|79313974|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
44311788|NCT03410992|79313964|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311789|NCT03410992|79313965|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311790|NCT03410992|79313966|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311791|NCT03410992|79313967|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311792|NCT03410992|79313968|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311793|NCT03410992|79313969|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311794|NCT03410992|79313970|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311795|NCT03410992|79313971|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311796|NCT03410992|79313972|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
44420386|NCT00479557|79428282|FG006|Overall Study|Lost to Follow-up|0|||
44420387|NCT00479557|79428276|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
44420388|NCT00479557|79428277|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
44420389|NCT00479557|79428278|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
44420390|NCT00479557|79428279|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
44420391|NCT00479557|79428280|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
44420392|NCT00479557|79428281|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
44420393|NCT00479557|79428282|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
44420394|NCT00479557|79428276|FG000|Overall Study|AE not related to Study Drug|1|||
44420395|NCT00479557|79428277|FG001|Overall Study|AE not related to Study Drug|3|||
44420396|NCT00479557|79428278|FG002|Overall Study|AE not related to Study Drug|0|||
44420397|NCT00479557|79428279|FG003|Overall Study|AE not related to Study Drug|0|||
44420398|NCT00479557|79428280|FG004|Overall Study|AE not related to Study Drug|2|||
44420399|NCT00479557|79428281|FG005|Overall Study|AE not related to Study Drug|2|||
44420400|NCT00479557|79428282|FG006|Overall Study|AE not related to Study Drug|1|||
44420401|NCT00479557|79428276|FG000|Overall Study|Caregiver Request|2|||
44420402|NCT00479557|79428277|FG001|Overall Study|Caregiver Request|2|||
44420403|NCT00479557|79428278|FG002|Overall Study|Caregiver Request|2|||
44420404|NCT00479557|79428279|FG003|Overall Study|Caregiver Request|0|||
44420405|NCT00479557|79428280|FG004|Overall Study|Caregiver Request|1|||
44420406|NCT00479557|79428281|FG005|Overall Study|Caregiver Request|2|||
44420407|NCT00479557|79428282|FG006|Overall Study|Caregiver Request|0|||
44420408|NCT00479557|79428276|FG000|Overall Study|Investigator Request|0|||
44420409|NCT00479557|79428277|FG001|Overall Study|Investigator Request|0|||
44420410|NCT00479557|79428278|FG002|Overall Study|Investigator Request|1|||
44420411|NCT00479557|79428279|FG003|Overall Study|Investigator Request|0|||
44420412|NCT00479557|79428280|FG004|Overall Study|Investigator Request|0|||
44420413|NCT00479557|79428281|FG005|Overall Study|Investigator Request|0|||
44535971|NCT03442296|79546769|FG001|3 Month Follow-up|Death|1|||
44535972|NCT03442296|79546768|FG000|3 Month Follow-up|Lost to Follow-up|1|||
44535973|NCT03442296|79546769|FG001|3 Month Follow-up|Lost to Follow-up|1|||
44535974|NCT03442296|79546768|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
44535975|NCT03442296|79546769|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
44535976|NCT03442296|79546768|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
44535977|NCT03442296|79546769|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
44311797|NCT03410992|79313973|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311798|NCT03410992|79313974|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
44311799|NCT03370913|79314004|FG000|Overall Study|Death|1|||
44311800|NCT03370913|79314004|FG000|Overall Study|Lost to Follow-up|1|||
44420414|NCT00479557|79428282|FG006|Overall Study|Investigator Request|0|||
44420415|NCT00479557|79428276|FG000|Overall Study|Subject Request|3|||
44420416|NCT00479557|79428277|FG001|Overall Study|Subject Request|0|||
44420417|NCT00479557|79428278|FG002|Overall Study|Subject Request|1|||
44535978|NCT03442296|79546768|FG000|12 Month Follow-up|Incomplete measurement|1|||
44535979|NCT03442296|79546769|FG001|12 Month Follow-up|Incomplete measurement|1|||
44420418|NCT00479557|79428279|FG003|Overall Study|Subject Request|1|||
44420419|NCT00479557|79428280|FG004|Overall Study|Subject Request|1|||
44420420|NCT00479557|79428281|FG005|Overall Study|Subject Request|4|||
44420421|NCT00479557|79428282|FG006|Overall Study|Subject Request|1|||
44420422|NCT00479557|79428276|FG000|Overall Study|Other|2|||
44420423|NCT00479557|79428277|FG001|Overall Study|Other|3|||
44535980|NCT03441984|79546777|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44420424|NCT00479557|79428278|FG002|Overall Study|Other|1|||
44420425|NCT00479557|79428279|FG003|Overall Study|Other|0|||
44420426|NCT00479557|79428280|FG004|Overall Study|Other|0|||
44420427|NCT00479557|79428281|FG005|Overall Study|Other|3|||
44420428|NCT00479557|79428282|FG006|Overall Study|Other|0|||
44420429|NCT00774800|79428304|FG000|Intervention 4|Withdrawal by Subject|1|||
44420430|NCT00439309|79428316|FG000|Follow-Up|Death|1|||
44420431|NCT00439309|79428317|FG001|Follow-Up|Death|0|||
44420432|NCT00439309|79428316|FG000|Follow-Up|Lost to Follow-up|2|||
44420433|NCT00439309|79428317|FG001|Follow-Up|Lost to Follow-up|0|||
44420434|NCT00439309|79428316|FG000|Follow-Up|Withdrawal by Subject|0|||
44420435|NCT00439309|79428317|FG001|Follow-Up|Withdrawal by Subject|1|||
44420436|NCT00439309|79428316|FG000|Follow-Up|Late response by subject|0|||
44420437|NCT00439309|79428317|FG001|Follow-Up|Late response by subject|1|||
44420438|NCT00479167|79428323|FG000|Overall Study|Withdrawal by Subject|1|||
44420439|NCT00725712|79428330|FG000|Overall Study|Withdrawal by Subject|2|||
44420440|NCT00725712|79428331|FG001|Overall Study|Withdrawal by Subject|1|||
44420441|NCT00725712|79428330|FG000|Overall Study|Protocol Violation|1|||
44420442|NCT00725712|79428331|FG001|Overall Study|Protocol Violation|0|||
44420443|NCT00725712|79428330|FG000|Overall Study|Progressive disease|37|||
44420444|NCT00725712|79428331|FG001|Overall Study|Progressive disease|16|||
44420445|NCT00725712|79428330|FG000|Overall Study|Clinical progression not based on RECIST|0|||
44420446|NCT00725712|79428331|FG001|Overall Study|Clinical progression not based on RECIST|3|||
44420447|NCT00725712|79428330|FG000|Overall Study|Adverse Event|5|||
44420448|NCT00725712|79428331|FG001|Overall Study|Adverse Event|5|||
44420449|NCT00725712|79428330|FG000|Overall Study|Death|2|||
44420450|NCT00725712|79428331|FG001|Overall Study|Death|0|||
44420451|NCT00725712|79428330|FG000|Overall Study|Other: Death|1|||
44420452|NCT00725712|79428331|FG001|Overall Study|Other: Death|0|||
44420453|NCT00725712|79428330|FG000|Overall Study|Hospitalized, unable to continue|0|||
44420454|NCT00725712|79428331|FG001|Overall Study|Hospitalized, unable to continue|1|||
44420455|NCT00729378|79428343|FG000|Baseline|Did not complete study measurements|72|||
44420456|NCT00729378|79428344|FG001|Baseline|Did not complete study measurements|33|||
44311801|NCT03342404|79314010|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
44311802|NCT03342404|79314011|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
44311803|NCT03342404|79314010|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
44311804|NCT03342404|79314011|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
44311805|NCT03342404|79314010|FG000|Blinded Treatment Phase|Adverse Event|5|||
44311806|NCT03342404|79314011|FG001|Blinded Treatment Phase|Adverse Event|4|||
44420457|NCT00729378|79428343|FG000|Baseline|Withdrawal by Subject|66|||
44420458|NCT00729378|79428344|FG001|Baseline|Withdrawal by Subject|59|||
44420459|NCT00729378|79428343|FG000|12-months|Lost to Follow-up|100|||
44420460|NCT00729378|79428344|FG001|12-months|Lost to Follow-up|65|||
44311807|NCT03342404|79314010|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
44311808|NCT03342404|79314011|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
44311809|NCT03342404|79314010|FG000|Blinded Treatment Phase|Other reasons|1|||
44311810|NCT03342404|79314011|FG001|Blinded Treatment Phase|Other reasons|0|||
44311811|NCT03342404|79314010|FG000|Blinded Treatment Phase|Physician Decision|1|||
44311812|NCT03342404|79314011|FG001|Blinded Treatment Phase|Physician Decision|0|||
44311813|NCT03342404|79314010|FG000|Blinded Treatment Phase|Death|1|||
44311814|NCT03342404|79314011|FG001|Blinded Treatment Phase|Death|0|||
44311815|NCT03342404|79314010|FG000|Open-Label Phase|Lost to Follow-up|0|||
44311816|NCT03342404|79314011|FG001|Open-Label Phase|Lost to Follow-up|1|||
44311817|NCT03342404|79314010|FG000|Open-Label Phase|Other reasons|0|||
44311818|NCT03342404|79314011|FG001|Open-Label Phase|Other reasons|1|||
44311819|NCT03342404|79314010|FG000|Open-Label Phase|Adverse Event|0|||
44311820|NCT03342404|79314011|FG001|Open-Label Phase|Adverse Event|3|||
44311821|NCT03342404|79314010|FG000|Open-Label Phase|Withdrawal by Subject|0|||
44311822|NCT03342404|79314011|FG001|Open-Label Phase|Withdrawal by Subject|6|||
44311823|NCT03213457|79314030|FG000|Overall Study|Not Treated|1|||
44420461|NCT00729378|79428343|FG000|24-months|Lost to Follow-up|72|||
44420462|NCT00729378|79428344|FG001|24-months|Lost to Follow-up|51|||
44420463|NCT00729378|79428343|FG000|36-months|Lost to Follow-up|15|||
44420464|NCT00729378|79428344|FG001|36-months|Lost to Follow-up|6|||
44311824|NCT03213457|79314031|FG001|Overall Study|Not Treated|1|||
44311825|NCT03213457|79314032|FG002|Overall Study|Not Treated|0|||
44311826|NCT03213457|79314030|FG000|Overall Study|Adverse Event|16|||
44311827|NCT03213457|79314031|FG001|Overall Study|Adverse Event|9|||
44311828|NCT03213457|79314032|FG002|Overall Study|Adverse Event|41|||
44311829|NCT03213457|79314030|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44311830|NCT03213457|79314031|FG001|Overall Study|Non-Compliance With Study Drug|2|||
44420465|NCT00478933|79428353|FG000|Overall Study|Protocol Violation|22|||
44420466|NCT00478933|79428353|FG000|Overall Study|Informed consent not verified|3|||
44420467|NCT00478933|79428353|FG000|Overall Study|Inadequate data available|53|||
44420468|NCT00725322|79428379|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
44420469|NCT00725322|79428380|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
44420470|NCT00725322|79428379|FG000|Washout (28 Days)|Protocol Violation|0|||
44420471|NCT00725322|79428380|FG001|Washout (28 Days)|Protocol Violation|1|||
44420472|NCT00725010|79428386|FG000|Overall Study|Toxicity|9|||
44420473|NCT00725010|79428386|FG000|Overall Study|Tumor Progression|7|||
44420474|NCT00725010|79428386|FG000|Overall Study|Withdrawal by Subject|2|||
44420475|NCT00725010|79428386|FG000|Overall Study|Death|1|||
44420476|NCT00725010|79428386|FG000|Overall Study|Lost to Follow-up|1|||
44420477|NCT00725010|79428386|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
44420478|NCT00725010|79428386|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
44420479|NCT00725010|79428386|FG000|Overall Study|No further documentation|1|||
44420480|NCT00725010|79428386|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
44420481|NCT00767000|79428397|FG000|54-week Study|Adverse Event|4|||
44420482|NCT00767000|79428398|FG001|54-week Study|Adverse Event|6|||
44420483|NCT00767000|79428399|FG002|54-week Study|Adverse Event|6|||
44420484|NCT00767000|79428400|FG003|54-week Study|Adverse Event|8|||
44420485|NCT00767000|79428401|FG004|54-week Study|Adverse Event|4|||
44420486|NCT00767000|79428397|FG000|54-week Study|Creaninine/creatinine clearance|2|||
44420487|NCT00767000|79428398|FG001|54-week Study|Creaninine/creatinine clearance|1|||
44420488|NCT00767000|79428399|FG002|54-week Study|Creaninine/creatinine clearance|2|||
44420489|NCT00767000|79428400|FG003|54-week Study|Creaninine/creatinine clearance|2|||
44420490|NCT00767000|79428401|FG004|54-week Study|Creaninine/creatinine clearance|4|||
44420491|NCT00767000|79428397|FG000|54-week Study|Hyperglycemia|0|||
44420492|NCT00767000|79428398|FG001|54-week Study|Hyperglycemia|0|||
44420493|NCT00767000|79428399|FG002|54-week Study|Hyperglycemia|1|||
44420494|NCT00767000|79428400|FG003|54-week Study|Hyperglycemia|0|||
44420495|NCT00767000|79428401|FG004|54-week Study|Hyperglycemia|1|||
44420496|NCT00767000|79428397|FG000|54-week Study|Hypoglycemia|0|||
44420497|NCT00767000|79428398|FG001|54-week Study|Hypoglycemia|1|||
44420498|NCT00767000|79428399|FG002|54-week Study|Hypoglycemia|0|||
44420499|NCT00767000|79428400|FG003|54-week Study|Hypoglycemia|0|||
44420500|NCT00767000|79428401|FG004|54-week Study|Hypoglycemia|0|||
44420501|NCT00767000|79428397|FG000|54-week Study|Interruption of study medication|0|||
44420502|NCT00767000|79428398|FG001|54-week Study|Interruption of study medication|0|||
44420503|NCT00767000|79428399|FG002|54-week Study|Interruption of study medication|1|||
44420504|NCT00767000|79428400|FG003|54-week Study|Interruption of study medication|0|||
44420505|NCT00767000|79428401|FG004|54-week Study|Interruption of study medication|0|||
44420506|NCT00767000|79428397|FG000|54-week Study|Lack of Efficacy|2|||
44420507|NCT00767000|79428398|FG001|54-week Study|Lack of Efficacy|0|||
44420508|NCT00767000|79428399|FG002|54-week Study|Lack of Efficacy|1|||
44420509|NCT00767000|79428400|FG003|54-week Study|Lack of Efficacy|0|||
44420510|NCT00767000|79428401|FG004|54-week Study|Lack of Efficacy|5|||
44420511|NCT00767000|79428397|FG000|54-week Study|Lost to Follow-up|4|||
44420512|NCT00767000|79428398|FG001|54-week Study|Lost to Follow-up|0|||
44420513|NCT00767000|79428399|FG002|54-week Study|Lost to Follow-up|1|||
44420514|NCT00767000|79428400|FG003|54-week Study|Lost to Follow-up|4|||
44420515|NCT00767000|79428401|FG004|54-week Study|Lost to Follow-up|2|||
44420516|NCT00767000|79428397|FG000|54-week Study|Physician Decision|4|||
44420517|NCT00767000|79428398|FG001|54-week Study|Physician Decision|0|||
44420518|NCT00767000|79428399|FG002|54-week Study|Physician Decision|1|||
44420519|NCT00767000|79428400|FG003|54-week Study|Physician Decision|1|||
44420520|NCT00767000|79428401|FG004|54-week Study|Physician Decision|1|||
44420521|NCT00767000|79428397|FG000|54-week Study|Progressive disease|0|||
44420522|NCT00767000|79428398|FG001|54-week Study|Progressive disease|0|||
44420523|NCT00767000|79428399|FG002|54-week Study|Progressive disease|1|||
44420524|NCT00767000|79428400|FG003|54-week Study|Progressive disease|0|||
44420525|NCT00767000|79428401|FG004|54-week Study|Progressive disease|0|||
44420526|NCT00767000|79428397|FG000|54-week Study|Protocol Violation|0|||
44420527|NCT00767000|79428398|FG001|54-week Study|Protocol Violation|0|||
44420528|NCT00767000|79428399|FG002|54-week Study|Protocol Violation|1|||
44420529|NCT00767000|79428400|FG003|54-week Study|Protocol Violation|2|||
44420530|NCT00767000|79428401|FG004|54-week Study|Protocol Violation|0|||
44420531|NCT00767000|79428397|FG000|54-week Study|Withdrawal by Subject|2|||
44311831|NCT03213457|79314032|FG002|Overall Study|Non-Compliance With Study Drug|7|||
44420532|NCT00767000|79428398|FG001|54-week Study|Withdrawal by Subject|3|||
44420533|NCT00767000|79428399|FG002|54-week Study|Withdrawal by Subject|5|||
44420534|NCT00767000|79428400|FG003|54-week Study|Withdrawal by Subject|11|||
44420535|NCT00767000|79428401|FG004|54-week Study|Withdrawal by Subject|13|||
44311832|NCT03213457|79314030|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
44311833|NCT03213457|79314031|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
44420536|NCT00767000|79428397|FG000|54-week Study|Study terminated by sponsor|90|||
44420537|NCT00767000|79428398|FG001|54-week Study|Study terminated by sponsor|102|||
44420538|NCT00767000|79428399|FG002|54-week Study|Study terminated by sponsor|89|||
44420539|NCT00767000|79428400|FG003|54-week Study|Study terminated by sponsor|196|||
44420540|NCT00767000|79428401|FG004|54-week Study|Study terminated by sponsor|194|||
44311834|NCT03213457|79314032|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
44420541|NCT00767000|79428397|FG000|54-week Study|Reason not reported|0|||
44420542|NCT00767000|79428398|FG001|54-week Study|Reason not reported|0|||
44420543|NCT00767000|79428399|FG002|54-week Study|Reason not reported|0|||
44420544|NCT00767000|79428400|FG003|54-week Study|Reason not reported|1|||
44420545|NCT00767000|79428401|FG004|54-week Study|Reason not reported|0|||
44420546|NCT00767000|79428397|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
44420547|NCT00767000|79428398|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
44420548|NCT00767000|79428399|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
44420549|NCT00767000|79428400|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
44420550|NCT00767000|79428401|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
44420551|NCT00724932|79428415|FG000|Overall Study|Lost to Follow-up|1|||
44420552|NCT00724932|79428416|FG001|Overall Study|Lost to Follow-up|0|||
44420553|NCT00724932|79428415|FG000|Overall Study|Not treated|4|||
44420554|NCT00724932|79428416|FG001|Overall Study|Not treated|3|||
44420555|NCT00766532|79428424|FG000|Overall Study|Protocol Violation|2|||
44420556|NCT00774566|79428430|FG000|Overall Study|Protocol Violation|18|||
44311835|NCT03213457|79314030|FG000|Overall Study|Withdrawal by Subject|18|||
44311836|NCT03213457|79314031|FG001|Overall Study|Withdrawal by Subject|7|||
44311837|NCT03213457|79314032|FG002|Overall Study|Withdrawal by Subject|35|||
44420557|NCT00774566|79428431|FG001|Overall Study|Protocol Violation|15|||
44420558|NCT00766376|79428437|FG000|Overall Study|Withdrawal by Subject|27|||
44420559|NCT00587054|79428441|FG000|Overall Study|Patient not treated|9|||
44420560|NCT00766142|79428445|FG000|Overall Study|Protocol Violation|4|||
44420561|NCT00724854|79428451|FG000|Overall Study|Lack of Efficacy|187|||
44420562|NCT00724854|79428452|FG001|Overall Study|Lack of Efficacy|13|||
44420563|NCT00724854|79428451|FG000|Overall Study|Lost to Follow-up|87|||
44420564|NCT00724854|79428452|FG001|Overall Study|Lost to Follow-up|10|||
44420565|NCT00724854|79428451|FG000|Overall Study|Adverse Event|62|||
44420566|NCT00724854|79428452|FG001|Overall Study|Adverse Event|4|||
44420567|NCT00724854|79428451|FG000|Overall Study|Other|42|||
44420568|NCT00724854|79428452|FG001|Overall Study|Other|3|||
44420569|NCT00724854|79428451|FG000|Overall Study|Death|11|||
44420570|NCT00724854|79428452|FG001|Overall Study|Death|0|||
44420571|NCT00724854|79428451|FG000|Overall Study|Change of treatment|7|||
44420572|NCT00724854|79428452|FG001|Overall Study|Change of treatment|0|||
44420573|NCT00724854|79428451|FG000|Overall Study|Withdrawal by Subject|5|||
44420574|NCT00724854|79428452|FG001|Overall Study|Withdrawal by Subject|0|||
44420575|NCT00724854|79428451|FG000|Overall Study|Adverse event + lack of efficacy|2|||
44535981|NCT03441984|79546778|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535982|NCT03441984|79546779|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
44535983|NCT03441984|79546780|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535984|NCT03441984|79546781|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535985|NCT03441984|79546782|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535986|NCT03441984|79546783|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535987|NCT03441984|79546784|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535988|NCT03441984|79546785|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44311838|NCT03213457|79314030|FG000|Overall Study|Lost to Follow-up|12|||
44420576|NCT00724854|79428452|FG001|Overall Study|Adverse event + lack of efficacy|1|||
44420577|NCT00728988|79428461|FG000|Overall Study|Not Treated|2|||
44420578|NCT00728988|79428462|FG001|Overall Study|Not Treated|2|||
44420579|NCT00728988|79428461|FG000|Overall Study|Death|1|||
44420580|NCT00728988|79428462|FG001|Overall Study|Death|1|||
44420581|NCT00728988|79428461|FG000|Overall Study|Adverse Event|3|||
44420582|NCT00728988|79428462|FG001|Overall Study|Adverse Event|2|||
44420583|NCT00728988|79428461|FG000|Overall Study|Other|85|||
44420584|NCT00728988|79428462|FG001|Overall Study|Other|77|||
44420585|NCT00728988|79428461|FG000|Overall Study|Withdrawal by Subject|2|||
44420586|NCT00728988|79428462|FG001|Overall Study|Withdrawal by Subject|6|||
44420587|NCT00728754|79428471|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
44420588|NCT00728754|79428472|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
44311839|NCT03213457|79314031|FG001|Overall Study|Lost to Follow-up|12|||
44420589|NCT00728754|79428471|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
44420590|NCT00728754|79428472|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
44420591|NCT00728754|79428471|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
44535989|NCT03441984|79546786|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535990|NCT03441984|79546787|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535991|NCT03441984|79546788|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
44535992|NCT03441360|79546806|FG000|Overall Study|Radiological disease progression|5|||
44535993|NCT03441360|79546807|FG001|Overall Study|Radiological disease progression|6|||
44535994|NCT03441360|79546808|FG002|Overall Study|Radiological disease progression|4|||
44311840|NCT03213457|79314032|FG002|Overall Study|Lost to Follow-up|33|||
44420592|NCT00728754|79428472|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
44420593|NCT00728130|79428478|FG000|Overall Study|Withdrawal by Subject|1|||
44311841|NCT03213457|79314030|FG000|Overall Study|Pregnancy|11|||
44311842|NCT03213457|79314031|FG001|Overall Study|Pregnancy|0|||
44420594|NCT00728130|79428478|FG000|Overall Study|Paperwork not completed in time|1|||
44420595|NCT00728130|79428478|FG000|Overall Study|Physician Decision|1|||
44311843|NCT03213457|79314032|FG002|Overall Study|Pregnancy|7|||
44311844|NCT03213457|79314030|FG000|Overall Study|Protocol Violation|1|||
44311845|NCT03213457|79314031|FG001|Overall Study|Protocol Violation|1|||
44311846|NCT03213457|79314032|FG002|Overall Study|Protocol Violation|6|||
44311847|NCT03213457|79314030|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
44311848|NCT03213457|79314031|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
44311849|NCT03213457|79314032|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
44311850|NCT03213457|79314030|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
44311851|NCT03213457|79314031|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
44311852|NCT03213457|79314032|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
44311853|NCT03213457|79314030|FG000|Overall Study|Lack of Efficacy|12|||
44311854|NCT03213457|79314031|FG001|Overall Study|Lack of Efficacy|2|||
44311855|NCT03213457|79314032|FG002|Overall Study|Lack of Efficacy|9|||
44311856|NCT03213457|79314030|FG000|Overall Study|Other, Not Specified|11|||
44311857|NCT03213457|79314031|FG001|Overall Study|Other, Not Specified|3|||
44311858|NCT03213457|79314032|FG002|Overall Study|Other, Not Specified|26|||
44311859|NCT03198078|79314043|FG000|Overall Study|Adverse Event|0|||
44311860|NCT03198078|79314044|FG001|Overall Study|Adverse Event|1|||
44311861|NCT03198078|79314045|FG002|Overall Study|Adverse Event|2|||
44311862|NCT03198078|79314043|FG000|Overall Study|Lack of Efficacy|0|||
44311863|NCT03198078|79314044|FG001|Overall Study|Lack of Efficacy|0|||
44311864|NCT03198078|79314045|FG002|Overall Study|Lack of Efficacy|3|||
44311865|NCT03198078|79314043|FG000|Overall Study|Lost to Follow-up|1|||
44311866|NCT03198078|79314044|FG001|Overall Study|Lost to Follow-up|0|||
44311867|NCT03198078|79314045|FG002|Overall Study|Lost to Follow-up|0|||
44311868|NCT03198078|79314043|FG000|Overall Study|Pregnancy|0|||
44311869|NCT03198078|79314044|FG001|Overall Study|Pregnancy|1|||
44311870|NCT03198078|79314045|FG002|Overall Study|Pregnancy|0|||
44311871|NCT03198078|79314043|FG000|Overall Study|Withdrawal by Subject|1|||
44311872|NCT03198078|79314044|FG001|Overall Study|Withdrawal by Subject|0|||
44311873|NCT03198078|79314045|FG002|Overall Study|Withdrawal by Subject|2|||
44311874|NCT03198078|79314043|FG000|Overall Study|Withdrawal by Caregiver|1|||
44311875|NCT03198078|79314044|FG001|Overall Study|Withdrawal by Caregiver|3|||
44311876|NCT03198078|79314045|FG002|Overall Study|Withdrawal by Caregiver|5|||
44311877|NCT02808650|79314069|FG000|Overall Study|Death|0|||
44311878|NCT02808650|79314070|FG001|Overall Study|Death|0|||
44311879|NCT02808650|79314071|FG002|Overall Study|Death|0|||
44311880|NCT02808650|79314072|FG003|Overall Study|Death|0|||
44311881|NCT02808650|79314073|FG004|Overall Study|Death|1|||
44535995|NCT03441360|79546806|FG000|Overall Study|Clinical disease progression|2|||
44535996|NCT03441360|79546807|FG001|Overall Study|Clinical disease progression|2|||
44535997|NCT03441360|79546808|FG002|Overall Study|Clinical disease progression|0|||
44257722|NCT01431638|79110841|FG001|Overall Study|Administrative problems|4|||
44257723|NCT01431638|79110842|FG002|Overall Study|Administrative problems|6|||
44257724|NCT01431638|79110840|FG000|Overall Study|Death|1|||
44257725|NCT01431638|79110841|FG001|Overall Study|Death|0|||
44257726|NCT01431638|79110842|FG002|Overall Study|Death|0|||
44257727|NCT01431638|79110840|FG000|Overall Study|Protocol deviation|1|||
44257728|NCT01431638|79110841|FG001|Overall Study|Protocol deviation|1|||
44257729|NCT01431638|79110842|FG002|Overall Study|Protocol deviation|4|||
44257730|NCT01431638|79110840|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
44257731|NCT01431638|79110841|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
44257732|NCT01431638|79110842|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
44257733|NCT01392170|79110850|FG000|Overall Study|Withdrawal by Subject|1|||
44257734|NCT01392170|79110850|FG000|Overall Study|Ineligible|1|||
44257735|NCT00558753|79110856|FG000|Overall Study|Lost to Follow-up|5|||
44257736|NCT00558753|79110857|FG001|Overall Study|Lost to Follow-up|7|||
44257737|NCT01391546|79110865|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
44257738|NCT01391546|79110866|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
44257739|NCT01410110|79110875|FG000|Overall Study|Withdrawal by Subject|4|||
44257740|NCT01410110|79110876|FG001|Overall Study|Withdrawal by Subject|2|||
44311882|NCT02808650|79314069|FG000|Overall Study|Lack of Efficacy|5|||
44311883|NCT02808650|79314070|FG001|Overall Study|Lack of Efficacy|5|||
44311884|NCT02808650|79314071|FG002|Overall Study|Lack of Efficacy|6|||
44311885|NCT02808650|79314072|FG003|Overall Study|Lack of Efficacy|5|||
44311886|NCT02808650|79314073|FG004|Overall Study|Lack of Efficacy|4|||
44311887|NCT02808650|79314069|FG000|Overall Study|Physician Decision|1|||
44311888|NCT02808650|79314070|FG001|Overall Study|Physician Decision|1|||
44311889|NCT02808650|79314071|FG002|Overall Study|Physician Decision|0|||
44311890|NCT02808650|79314072|FG003|Overall Study|Physician Decision|0|||
44311891|NCT02808650|79314073|FG004|Overall Study|Physician Decision|0|||
44311892|NCT02808650|79314069|FG000|Overall Study|Withdrawal by Subject|0|||
44311893|NCT02808650|79314070|FG001|Overall Study|Withdrawal by Subject|0|||
44420596|NCT00735696|79428482|FG000|Overall Study|Withdrawal by Subject|1|||
44535998|NCT03441360|79546806|FG000|Overall Study|Adverse Event|1|||
44257741|NCT01391000|79110884|FG000|Overall Study|Lost to Follow-up|2|||
44257742|NCT01391000|79110885|FG001|Overall Study|Lost to Follow-up|0|||
44257743|NCT01390844|79110960|FG000|Treatment Phase|Adverse Event|12|||
44257744|NCT01390844|79110961|FG001|Treatment Phase|Adverse Event|2|||
44257745|NCT01390844|79110962|FG002|Treatment Phase|Adverse Event|3|||
44257746|NCT01390844|79110963|FG003|Treatment Phase|Adverse Event|2|||
44257747|NCT01390844|79110960|FG000|Treatment Phase|Treatment Failure|23|||
44257748|NCT01390844|79110961|FG001|Treatment Phase|Treatment Failure|25|||
44257749|NCT01390844|79110962|FG002|Treatment Phase|Treatment Failure|10|||
44257750|NCT01390844|79110963|FG003|Treatment Phase|Treatment Failure|13|||
44257751|NCT01390844|79110960|FG000|Treatment Phase|Non-Medical Reasons|5|||
44257752|NCT01390844|79110961|FG001|Treatment Phase|Non-Medical Reasons|1|||
44257753|NCT01390844|79110962|FG002|Treatment Phase|Non-Medical Reasons|8|||
44257754|NCT01390844|79110963|FG003|Treatment Phase|Non-Medical Reasons|1|||
44257755|NCT01390844|79110960|FG000|Treatment Phase|Non-GCP Compliant|0|||
44257756|NCT01390844|79110961|FG001|Treatment Phase|Non-GCP Compliant|0|||
44257757|NCT01390844|79110962|FG002|Treatment Phase|Non-GCP Compliant|10|||
44257758|NCT01390844|79110963|FG003|Treatment Phase|Non-GCP Compliant|3|||
44257759|NCT01390844|79110960|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
44257760|NCT01390844|79110961|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
44257761|NCT01390844|79110962|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
44257762|NCT01390844|79110963|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
44257763|NCT01430624|79110976|FG000|Overall Study|Lost to Follow-up|23|||
44257764|NCT01430624|79110977|FG001|Overall Study|Lost to Follow-up|29|||
44257765|NCT01430624|79110978|FG002|Overall Study|Lost to Follow-up|27|||
44257766|NCT01430624|79110976|FG000|Overall Study|technical or eligibility|5|||
44257767|NCT01430624|79110977|FG001|Overall Study|technical or eligibility|5|||
44311894|NCT02808650|79314071|FG002|Overall Study|Withdrawal by Subject|0|||
44311895|NCT02808650|79314072|FG003|Overall Study|Withdrawal by Subject|1|||
44311896|NCT02808650|79314073|FG004|Overall Study|Withdrawal by Subject|1|||
44311897|NCT02630693|79314088|FG000|Overall Study|No receive treatment|0|||
44311898|NCT02630693|79314089|FG001|Overall Study|No receive treatment|1|||
44311899|NCT02626338|79314098|FG000|Overall Study|Lack of Efficacy|3|||
44311900|NCT02626338|79314099|FG001|Overall Study|Lack of Efficacy|2|||
44311901|NCT02626338|79314100|FG002|Overall Study|Lack of Efficacy|0|||
44311902|NCT02603146|79314112|FG000|Overall Study|Lost to Follow-up|5|||
44311903|NCT02603146|79314113|FG001|Overall Study|Lost to Follow-up|6|||
44311904|NCT02603146|79314112|FG000|Overall Study|Withdrawal by Subject|8|||
44311905|NCT02603146|79314113|FG001|Overall Study|Withdrawal by Subject|10|||
44311906|NCT02603146|79314112|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
44311907|NCT02603146|79314113|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
44311908|NCT02603146|79314112|FG000|Overall Study|Participant moved|2|||
44311909|NCT02603146|79314113|FG001|Overall Study|Participant moved|0|||
44311910|NCT02603146|79314112|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
44311911|NCT02603146|79314113|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
44311912|NCT01723774|79314183|FG000|Neoadjuvant|Ki67 > 10%|4|||
44311913|NCT01723774|79314184|FG001|Neoadjuvant|Ki67 > 10%|0|||
44311914|NCT01723774|79314185|FG002|Neoadjuvant|Ki67 > 10%|10|||
44311915|NCT01723774|79314186|FG003|Neoadjuvant|Ki67 > 10%|0|||
44311916|NCT01723774|79314183|FG000|Neoadjuvant|Withdrawal by Subject|3|||
44311917|NCT01723774|79314184|FG001|Neoadjuvant|Withdrawal by Subject|1|||
44311918|NCT01723774|79314185|FG002|Neoadjuvant|Withdrawal by Subject|0|||
44311919|NCT01723774|79314186|FG003|Neoadjuvant|Withdrawal by Subject|0|||
44311920|NCT01723774|79314183|FG000|Neoadjuvant|Disease progression|0|||
44311921|NCT01723774|79314184|FG001|Neoadjuvant|Disease progression|1|||
44311922|NCT01723774|79314185|FG002|Neoadjuvant|Disease progression|1|||
44311923|NCT01723774|79314186|FG003|Neoadjuvant|Disease progression|0|||
44311924|NCT01723774|79314183|FG000|Neoadjuvant|Adverse Event|0|||
44311925|NCT01723774|79314184|FG001|Neoadjuvant|Adverse Event|1|||
44311926|NCT01723774|79314185|FG002|Neoadjuvant|Adverse Event|2|||
44311927|NCT01723774|79314186|FG003|Neoadjuvant|Adverse Event|0|||
44311928|NCT01723774|79314183|FG000|Neoadjuvant|High estradiol|0|||
44311929|NCT01723774|79314184|FG001|Neoadjuvant|High estradiol|1|||
44311930|NCT01723774|79314185|FG002|Neoadjuvant|High estradiol|0|||
44311931|NCT01723774|79314186|FG003|Neoadjuvant|High estradiol|0|||
44311932|NCT01012817|79314223|FG000|Overall Study|Withdrawal by Subject|0|||
44311933|NCT01012817|79314224|FG001|Overall Study|Withdrawal by Subject|0|||
44311934|NCT01012817|79314225|FG002|Overall Study|Withdrawal by Subject|0|||
44311935|NCT01012817|79314226|FG003|Overall Study|Withdrawal by Subject|1|||
44257768|NCT01430624|79110978|FG002|Overall Study|technical or eligibility|2|||
44257769|NCT01430468|79111003|FG000|Overall Study|Physician Decision|2|||
44257770|NCT01430468|79111004|FG001|Overall Study|Physician Decision|1|||
44257771|NCT01430468|79111003|FG000|Overall Study|Withdrawal by Subject|5|||
44257772|NCT01430468|79111004|FG001|Overall Study|Withdrawal by Subject|5|||
44257773|NCT01409564|79111025|FG000|Overall Study|low medication compliance|4|||
44257774|NCT01409564|79111026|FG001|Overall Study|low medication compliance|3|||
44311936|NCT01012817|79314227|FG004|Overall Study|Withdrawal by Subject|0|||
44311937|NCT01012817|79314228|FG005|Overall Study|Withdrawal by Subject|0|||
44311938|NCT01012817|79314229|FG006|Overall Study|Withdrawal by Subject|0|||
44311939|NCT01012817|79314230|FG007|Overall Study|Withdrawal by Subject|1|||
44311940|NCT01012817|79314231|FG008|Overall Study|Withdrawal by Subject|0|||
44311941|NCT01012817|79314232|FG009|Overall Study|Withdrawal by Subject|0|||
44311942|NCT01012817|79314233|FG010|Overall Study|Withdrawal by Subject|1|||
44311943|NCT01012817|79314234|FG011|Overall Study|Withdrawal by Subject|1|||
44311944|NCT01012817|79314235|FG012|Overall Study|Withdrawal by Subject|0|||
44311945|NCT01012817|79314236|FG013|Overall Study|Withdrawal by Subject|1|||
44311946|NCT01012817|79314223|FG000|Overall Study|Adverse Event|0|||
44311947|NCT01012817|79314224|FG001|Overall Study|Adverse Event|0|||
44311948|NCT01012817|79314225|FG002|Overall Study|Adverse Event|0|||
44311949|NCT01012817|79314226|FG003|Overall Study|Adverse Event|0|||
44311950|NCT01012817|79314227|FG004|Overall Study|Adverse Event|0|||
44311951|NCT01012817|79314228|FG005|Overall Study|Adverse Event|1|||
44311952|NCT01012817|79314229|FG006|Overall Study|Adverse Event|0|||
44311953|NCT01012817|79314230|FG007|Overall Study|Adverse Event|0|||
44311954|NCT01012817|79314231|FG008|Overall Study|Adverse Event|0|||
44311955|NCT01012817|79314232|FG009|Overall Study|Adverse Event|0|||
44311956|NCT01012817|79314233|FG010|Overall Study|Adverse Event|1|||
44311957|NCT01012817|79314234|FG011|Overall Study|Adverse Event|0|||
44311958|NCT01012817|79314235|FG012|Overall Study|Adverse Event|0|||
44311959|NCT01012817|79314236|FG013|Overall Study|Adverse Event|1|||
44311960|NCT00920582|79314270|FG000|Overall Study|Lost to Follow-up|5|||
44311961|NCT00920582|79314271|FG001|Overall Study|Lost to Follow-up|1|||
44257775|NCT01409564|79111025|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
44257776|NCT01409564|79111026|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
44257777|NCT01390298|79111036|FG000|Overall Study|Death|1|||
44257778|NCT01390298|79111036|FG000|Overall Study|long term ICU admission|1|||
44257779|NCT01390298|79111036|FG000|Overall Study|Withdrawal by Subject|14|||
44257780|NCT01390298|79111036|FG000|Overall Study|Lost to Follow-up|7|||
44257781|NCT01390298|79111036|FG000|Overall Study|Surgery cancelled|1|||
44257782|NCT01390220|79111054|FG000|Test Dose Phase|Adverse Event|17|||
44257783|NCT01390220|79111055|FG001|Test Dose Phase|Adverse Event|0|||
44257784|NCT01390220|79111056|FG002|Test Dose Phase|Adverse Event|0|||
44257785|NCT01390220|79111054|FG000|Test Dose Phase|Withdrawal by Subject|8|||
44257786|NCT01390220|79111055|FG001|Test Dose Phase|Withdrawal by Subject|0|||
44257787|NCT01390220|79111056|FG002|Test Dose Phase|Withdrawal by Subject|0|||
44257788|NCT01390220|79111054|FG000|Test Dose Phase|Lost to Follow-up|2|||
44257789|NCT01390220|79111055|FG001|Test Dose Phase|Lost to Follow-up|0|||
44257790|NCT01390220|79111056|FG002|Test Dose Phase|Lost to Follow-up|0|||
44257791|NCT01390220|79111054|FG000|Test Dose Phase|Protocol Violation|8|||
44311962|NCT00920582|79314272|FG002|Overall Study|Lost to Follow-up|2|||
44311963|NCT00920582|79314273|FG003|Overall Study|Lost to Follow-up|0|||
44311964|NCT00920582|79314270|FG000|Overall Study|Withdrawal by Subject|5|||
44311965|NCT00920582|79314271|FG001|Overall Study|Withdrawal by Subject|4|||
44311966|NCT00920582|79314272|FG002|Overall Study|Withdrawal by Subject|6|||
44311967|NCT00920582|79314273|FG003|Overall Study|Withdrawal by Subject|3|||
44311968|NCT00920582|79314270|FG000|Overall Study|Protocol Violation|1|||
44311969|NCT00920582|79314271|FG001|Overall Study|Protocol Violation|0|||
44311970|NCT00920582|79314272|FG002|Overall Study|Protocol Violation|0|||
44311971|NCT00920582|79314273|FG003|Overall Study|Protocol Violation|0|||
44311972|NCT00920582|79314270|FG000|Overall Study|Other|2|||
44311973|NCT00920582|79314271|FG001|Overall Study|Other|1|||
44311974|NCT00920582|79314272|FG002|Overall Study|Other|3|||
44311975|NCT00920582|79314273|FG003|Overall Study|Other|2|||
44311976|NCT00199888|79314322|FG000|Overall Study|Lost to Follow-up|1|||
44311977|NCT00199849|79314329|FG000|Overall Study|Unrelated illness or complication|0|||
44311978|NCT00199849|79314330|FG001|Overall Study|Unrelated illness or complication|1|||
44311979|NCT00199849|79314331|FG002|Overall Study|Unrelated illness or complication|0|||
44311980|NCT00199849|79314329|FG000|Overall Study|Progressive disease requiring intervention|0|||
44311981|NCT00199849|79314330|FG001|Overall Study|Progressive disease requiring intervention|0|||
44311982|NCT00199849|79314331|FG002|Overall Study|Progressive disease requiring intervention|1|||
44311983|NCT00199849|79314329|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
44311984|NCT00199849|79314330|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
44311985|NCT00199849|79314331|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
44311986|NCT00199381|79314339|FG000|Overall Study|Withdrawal by Subject|38|||
44311987|NCT00199381|79314339|FG000|Overall Study|Adverse Event|73|||
44311988|NCT00199381|79314339|FG000|Overall Study|Protocol Violation|6|||
44311989|NCT00199381|79314339|FG000|Overall Study|Lack of Efficacy|27|||
44311990|NCT00199381|79314339|FG000|Overall Study|Not including due to early termination|37|||
44311991|NCT00199381|79314339|FG000|Overall Study|Study termination by Sponsor|323|||
44311992|NCT00198133|79314345|FG000|Overall Study|Disease progression|2|||
44311993|NCT00198133|79314346|FG001|Overall Study|Disease progression|5|||
44420597|NCT00735696|79428482|FG000|Overall Study|Enrolled but never Treated|1|||
44311994|NCT00198133|79314345|FG000|Overall Study|Adverse Event|1|||
44311995|NCT00198133|79314346|FG001|Overall Study|Adverse Event|3|||
44311996|NCT00198133|79314345|FG000|Overall Study|Withdrawal by Subject|1|||
44311997|NCT00198133|79314346|FG001|Overall Study|Withdrawal by Subject|0|||
44311998|NCT00198133|79314345|FG000|Overall Study|Physician Decision|1|||
44311999|NCT00198133|79314346|FG001|Overall Study|Physician Decision|0|||
44312000|NCT00197236|79314355|FG000|Overall Study|Adverse Event|1|||
44312001|NCT00197236|79314356|FG001|Overall Study|Adverse Event|0|||
44312002|NCT00197236|79314357|FG002|Overall Study|Adverse Event|1|||
44312003|NCT00197236|79314355|FG000|Overall Study|Lost to Follow-up|5|||
44312004|NCT00197236|79314356|FG001|Overall Study|Lost to Follow-up|14|||
44312005|NCT00197236|79314357|FG002|Overall Study|Lost to Follow-up|6|||
44312006|NCT00197236|79314355|FG000|Overall Study|Protocol Violation|0|||
44312007|NCT00197236|79314356|FG001|Overall Study|Protocol Violation|0|||
44312008|NCT00197236|79314357|FG002|Overall Study|Protocol Violation|1|||
44312009|NCT00197236|79314355|FG000|Overall Study|Withdrawal by Subject|7|||
44312010|NCT00197236|79314356|FG001|Overall Study|Withdrawal by Subject|3|||
44312011|NCT00197236|79314357|FG002|Overall Study|Withdrawal by Subject|11|||
44312012|NCT00197236|79314355|FG000|Overall Study|Study drug/medication expiration|1|||
44312013|NCT00197236|79314356|FG001|Overall Study|Study drug/medication expiration|0|||
44312014|NCT00197236|79314357|FG002|Overall Study|Study drug/medication expiration|3|||
44312015|NCT00197236|79314355|FG000|Overall Study|Returned out of specified time window|0|||
44312016|NCT00197236|79314356|FG001|Overall Study|Returned out of specified time window|0|||
44312017|NCT00197236|79314357|FG002|Overall Study|Returned out of specified time window|1|||
44312018|NCT00197002|79314371|FG000|Overall Study|Adverse Event|0|||
44312019|NCT00197002|79314372|FG001|Overall Study|Adverse Event|1|||
44312020|NCT00197002|79314373|FG002|Overall Study|Adverse Event|0|||
44312021|NCT00197002|79314371|FG000|Overall Study|Protocol Violation|1|||
44312022|NCT00197002|79314372|FG001|Overall Study|Protocol Violation|0|||
44312023|NCT00197002|79314373|FG002|Overall Study|Protocol Violation|2|||
44312024|NCT00197002|79314371|FG000|Overall Study|Withdrawal by Subject|9|||
44312025|NCT00197002|79314372|FG001|Overall Study|Withdrawal by Subject|5|||
44312026|NCT00197002|79314373|FG002|Overall Study|Withdrawal by Subject|7|||
44312027|NCT00197002|79314371|FG000|Overall Study|Migrated/moved from study area|3|||
44312028|NCT00197002|79314372|FG001|Overall Study|Migrated/moved from study area|5|||
44312029|NCT00197002|79314373|FG002|Overall Study|Migrated/moved from study area|1|||
44312030|NCT00197002|79314371|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
44312031|NCT00197002|79314372|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
44312032|NCT00197002|79314373|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
44312033|NCT00197002|79314371|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
44312034|NCT00197002|79314372|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
44312035|NCT00197002|79314373|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
44312036|NCT00197002|79314371|FG000|Overall Study|Others|3|||
44312037|NCT00197002|79314372|FG001|Overall Study|Others|1|||
44312038|NCT00197002|79314373|FG002|Overall Study|Others|1|||
44312039|NCT00196105|79314387|FG000|Overall Study|Lost to Follow-up|4|||
44312040|NCT00196105|79314388|FG001|Overall Study|Lost to Follow-up|5|||
44312041|NCT00196105|79314389|FG002|Overall Study|Lost to Follow-up|7|||
44312042|NCT00195715|79314397|FG000|Overall Study|Adverse Event|122|||
44312043|NCT00195715|79314397|FG000|Overall Study|Withdrawal by Subject|58|||
44312044|NCT00195715|79314397|FG000|Overall Study|Lost to Follow-up|27|||
44312045|NCT00195715|79314397|FG000|Overall Study|Protocol Violation|13|||
44312046|NCT00195715|79314397|FG000|Overall Study|Lack of Efficacy|93|||
44312047|NCT00195715|79314397|FG000|Overall Study|Pregnancy|14|||
44312048|NCT00195715|79314397|FG000|Overall Study|Investigative site closure|8|||
44312049|NCT00195715|79314397|FG000|Overall Study|Subject moved/relocated|7|||
44312050|NCT00195715|79314397|FG000|Overall Study|Subject non-compliance|6|||
44312051|NCT00195715|79314397|FG000|Overall Study|Subject started commercial Humira|5|||
44312052|NCT00195715|79314397|FG000|Overall Study|Subject choice|3|||
44312053|NCT00195715|79314397|FG000|Overall Study|Loss of response/no improvement|3|||
44312054|NCT00195715|79314397|FG000|Overall Study|Sponsor stopped study|1|||
44312055|NCT00195715|79314397|FG000|Overall Study|Administrative reasons|2|||
44312056|NCT00195715|79314397|FG000|Overall Study|Investigator's decision|2|||
44312057|NCT00195715|79314397|FG000|Overall Study|Subject wants to get pregnant|4|||
44312058|NCT00195715|79314397|FG000|Overall Study|Use of prohibited medication|2|||
44312059|NCT00195715|79314397|FG000|Overall Study|Planned surgery|2|||
44420598|NCT00478231|79428491|FG000|Overall Study|Death|7|||
44420599|NCT00478231|79428491|FG000|Overall Study|Lack of Efficacy|47|||
44420600|NCT00478231|79428491|FG000|Overall Study|Lost to Follow-up|7|||
44312060|NCT00195715|79314397|FG000|Overall Study|Increased infection rate|1|||
44312061|NCT00195715|79314397|FG000|Overall Study|Ineligible|1|||
44312062|NCT00195715|79314397|FG000|Overall Study|Colonic stricture|1|||
44312063|NCT00195715|79314397|FG000|Overall Study|Sponsor discontinued trial|1|||
44312064|NCT00195715|79314397|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
44312065|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Adverse Event|82|||
44312066|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Death|6|||
44312067|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
44312068|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
44420601|NCT00478231|79428491|FG000|Overall Study|Withdrawal by Subject|6|||
44312069|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
44354743|NCT01186770|79359155|FG002|Overall Study|Protocol Violation|12|||
44312070|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
44312071|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
44312072|NCT00195676|79314401|FG000|Period O - Open-label Treatment|Other reasons|68|||
44312073|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
44312074|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
44312075|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
44312076|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
44312077|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
44312078|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
44312079|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
44312080|NCT00195676|79314401|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
44312081|NCT00195676|79314401|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
44312082|NCT00195676|79314401|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
44312083|NCT00195676|79314401|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
44312084|NCT00195676|79314401|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
44312085|NCT00195676|79314401|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
44312086|NCT00194077|79314411|FG000|Overall Study|Lack of Efficacy|22|||
44312087|NCT00194077|79314412|FG001|Overall Study|Lack of Efficacy|29|||
44312088|NCT00194077|79314411|FG000|Overall Study|Study nonadherence|1|||
44312089|NCT00194077|79314412|FG001|Overall Study|Study nonadherence|0|||
44312090|NCT00194077|79314411|FG000|Overall Study|Withdrawal by Subject|1|||
44312091|NCT00194077|79314412|FG001|Overall Study|Withdrawal by Subject|1|||
44312092|NCT00193609|79314418|FG000|Overall Study|Lack of Efficacy|2|||
44312093|NCT00193609|79314418|FG000|Overall Study|Adverse Event|2|||
44312094|NCT00193180|79314422|FG000|Overall Study|Lack of Efficacy|1|||
44312095|NCT00193180|79314422|FG000|Overall Study|Adverse Event|8|||
44312096|NCT00193180|79314422|FG000|Overall Study|Protocol Violation|1|||
44312097|NCT00193063|79314427|FG000|Overall Study|Lack of Efficacy|3|||
44312098|NCT00193063|79314427|FG000|Overall Study|Adverse Event|1|||
44312099|NCT00191854|79314434|FG000|Overall Study|Death|26|||
44312100|NCT00191854|79314435|FG001|Overall Study|Death|23|||
44312101|NCT00191854|79314436|FG002|Overall Study|Death|29|||
44312102|NCT00191854|79314434|FG000|Overall Study|Lost to Follow-up|7|||
44312103|NCT00191854|79314435|FG001|Overall Study|Lost to Follow-up|5|||
44312104|NCT00191854|79314436|FG002|Overall Study|Lost to Follow-up|5|||
44312105|NCT00191854|79314434|FG000|Overall Study|Withdrawal by Subject|4|||
44312106|NCT00191854|79314435|FG001|Overall Study|Withdrawal by Subject|2|||
44312107|NCT00191854|79314436|FG002|Overall Study|Withdrawal by Subject|3|||
44312108|NCT00191854|79314434|FG000|Overall Study|Sponsor Decision|0|||
44312109|NCT00191854|79314435|FG001|Overall Study|Sponsor Decision|0|||
44312110|NCT00191854|79314436|FG002|Overall Study|Sponsor Decision|1|||
44312111|NCT00191854|79314434|FG000|Overall Study|Screen Failure|0|||
44312112|NCT00191854|79314435|FG001|Overall Study|Screen Failure|0|||
44312113|NCT00191854|79314436|FG002|Overall Study|Screen Failure|1|||
44312114|NCT00191815|79314444|FG000|Overall Study|Adverse Event|2|||
44312115|NCT00191815|79314444|FG000|Overall Study|Disease progression or relapse|24|||
44312116|NCT00191815|79314444|FG000|Overall Study|Death|2|||
44312117|NCT00191815|79314444|FG000|Overall Study|Protocol Violation|3|||
44312118|NCT00191815|79314444|FG000|Overall Study|Physician Decision|2|||
44312119|NCT00191815|79314444|FG000|Overall Study|Withdrawal by Subject|7|||
44312120|NCT00191386|79314448|FG000|Overall Study|Adverse Event|16|||
44312121|NCT00191386|79314448|FG000|Overall Study|Lost to Follow-up|1|||
44312122|NCT00191386|79314448|FG000|Overall Study|Entry Criteria Exclusion|3|||
44312123|NCT00191386|79314448|FG000|Overall Study|Protocol Violation|18|||
44312124|NCT00191386|79314448|FG000|Overall Study|Withdrawal by Subject|96|||
44312125|NCT00191386|79314448|FG000|Overall Study|Physician Decision|11|||
44312126|NCT00191386|79314448|FG000|Overall Study|Lack of Efficacy|15|||
44312127|NCT00191308|79314452|FG000|Overall Study|Adverse Event|1|||
44312128|NCT00191269|79314458|FG000|Overall Study|Protocol Violation|0|||
44312129|NCT00191269|79314459|FG001|Overall Study|Protocol Violation|2|||
44312130|NCT00191269|79314458|FG000|Overall Study|Adverse Event|1|||
44312131|NCT00191269|79314459|FG001|Overall Study|Adverse Event|4|||
44535999|NCT03441360|79546807|FG001|Overall Study|Adverse Event|0|||
44312132|NCT00191269|79314458|FG000|Overall Study|Progression of Disease|4|||
44312133|NCT00191269|79314459|FG001|Overall Study|Progression of Disease|42|||
44312134|NCT00191269|79314458|FG000|Overall Study|Lack of Efficacy|1|||
44312135|NCT00191269|79314459|FG001|Overall Study|Lack of Efficacy|5|||
44536000|NCT03441360|79546808|FG002|Overall Study|Adverse Event|1|||
44536001|NCT01347840|79546816|FG000|Overall Study|Withdrawal by Subject|1|||
44536002|NCT01347762|79546824|FG000|Overall Study|Lost to Follow-up|0|||
44312136|NCT00191269|79314458|FG000|Overall Study|Withdrawal by Subject|0|||
44312137|NCT00191269|79314459|FG001|Overall Study|Withdrawal by Subject|1|||
44312138|NCT00191269|79314458|FG000|Overall Study|Pathologic Aggrevation|0|||
44312139|NCT00191269|79314459|FG001|Overall Study|Pathologic Aggrevation|1|||
44312140|NCT00191269|79314458|FG000|Overall Study|Physician Decision|0|||
44536003|NCT01347762|79546825|FG001|Overall Study|Lost to Follow-up|1|||
44312141|NCT00191269|79314459|FG001|Overall Study|Physician Decision|3|||
44312142|NCT00191191|79314468|FG000|Overall Study|Entry Criteria Exclusion|2|||
44312143|NCT00191191|79314469|FG001|Overall Study|Entry Criteria Exclusion|0|||
44312144|NCT00191191|79314468|FG000|Overall Study|Treated with Another Systemic Agent|1|||
44312145|NCT00191191|79314469|FG001|Overall Study|Treated with Another Systemic Agent|1|||
44312146|NCT00191191|79314468|FG000|Overall Study|Adverse Event|11|||
44312147|NCT00191191|79314469|FG001|Overall Study|Adverse Event|21|||
44312148|NCT00191191|79314468|FG000|Overall Study|Progressive Disease|84|||
44312149|NCT00191191|79314469|FG001|Overall Study|Progressive Disease|72|||
44312150|NCT00191191|79314468|FG000|Overall Study|Toxicity After Dose Reduction|7|||
44312151|NCT00191191|79314469|FG001|Overall Study|Toxicity After Dose Reduction|8|||
44312152|NCT00191191|79314468|FG000|Overall Study|Family/Caregiver Decision|5|||
44312153|NCT00191191|79314469|FG001|Overall Study|Family/Caregiver Decision|7|||
44312154|NCT00191191|79314468|FG000|Overall Study|Lost to Follow-up|1|||
44312155|NCT00191191|79314469|FG001|Overall Study|Lost to Follow-up|0|||
44312156|NCT00191191|79314468|FG000|Overall Study|Physician Decision|3|||
44312157|NCT00191191|79314469|FG001|Overall Study|Physician Decision|2|||
44312158|NCT00191191|79314468|FG000|Overall Study|Good Clinical Practice Violation|0|||
44312159|NCT00191191|79314469|FG001|Overall Study|Good Clinical Practice Violation|1|||
44312160|NCT00191152|79314477|FG000|Initial Treatment|Adverse Event|43|||
44420602|NCT00478231|79428491|FG000|Overall Study|Other|9|||
44420603|NCT00478231|79428491|FG000|Overall Study|Adverse Event|5|||
44420604|NCT00478231|79428491|FG000|Overall Study|Randomized, not treated|3|||
44420605|NCT00474175|79428498|FG000|Overall Study|Lack of Efficacy|0|||
44420606|NCT00474175|79428499|FG001|Overall Study|Lack of Efficacy|0|||
44420607|NCT00474175|79428500|FG002|Overall Study|Lack of Efficacy|1|||
44420608|NCT00474175|79428498|FG000|Overall Study|Withdrawal by Subject|0|||
44420609|NCT00474175|79428499|FG001|Overall Study|Withdrawal by Subject|1|||
44420610|NCT00474175|79428500|FG002|Overall Study|Withdrawal by Subject|1|||
44420611|NCT00474175|79428498|FG000|Overall Study|Ineligible|1|||
44420612|NCT00474175|79428499|FG001|Overall Study|Ineligible|3|||
44420613|NCT00474175|79428500|FG002|Overall Study|Ineligible|1|||
44420614|NCT00474175|79428498|FG000|Overall Study|Protocol Violation|0|||
44420615|NCT00474175|79428499|FG001|Overall Study|Protocol Violation|2|||
44420616|NCT00474175|79428500|FG002|Overall Study|Protocol Violation|1|||
44420617|NCT00474175|79428498|FG000|Overall Study|Administrative|0|||
44420618|NCT00474175|79428499|FG001|Overall Study|Administrative|1|||
44420619|NCT00474175|79428500|FG002|Overall Study|Administrative|0|||
44420620|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
44420621|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
44420622|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
44420623|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
44420624|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
44420625|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
44420626|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
44420627|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
44420628|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
44420629|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
44420630|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
44420631|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
44420632|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
44420633|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
44420634|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
44420635|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
44420636|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
44420637|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
44420638|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Missing|2|||
44420639|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Missing|1|||
44420640|NCT00443209|79428531|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
44536004|NCT01347762|79546826|FG002|Overall Study|Lost to Follow-up|6|||
44155502|NCT01998958|78946978|FG031|Open Label Phase (Optional)|Other|0|||
44257792|NCT01390220|79111055|FG001|Test Dose Phase|Protocol Violation|0|||
44257793|NCT01390220|79111056|FG002|Test Dose Phase|Protocol Violation|0|||
44257794|NCT01390220|79111054|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
44257795|NCT01390220|79111055|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
44257796|NCT01390220|79111056|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
44257797|NCT01390220|79111054|FG000|Test Dose Phase|Study/Site closure|6|||
44257798|NCT01390220|79111055|FG001|Test Dose Phase|Study/Site closure|0|||
44257799|NCT01390220|79111056|FG002|Test Dose Phase|Study/Site closure|0|||
44257800|NCT01390220|79111054|FG000|Test Dose Phase|Caregiver no longer available|5|||
44257801|NCT01390220|79111055|FG001|Test Dose Phase|Caregiver no longer available|0|||
44257802|NCT01390220|79111056|FG002|Test Dose Phase|Caregiver no longer available|0|||
44312161|NCT00191152|79314478|FG001|Initial Treatment|Adverse Event|67|||
44257803|NCT01390220|79111054|FG000|Test Dose Phase|Noncompliance|2|||
44257804|NCT01390220|79111055|FG001|Test Dose Phase|Noncompliance|0|||
44312162|NCT00191152|79314477|FG000|Initial Treatment|Physician Decision|40|||
44312163|NCT00191152|79314478|FG001|Initial Treatment|Physician Decision|31|||
44312164|NCT00191152|79314477|FG000|Initial Treatment|Withdrawal by Subject|40|||
44312165|NCT00191152|79314478|FG001|Initial Treatment|Withdrawal by Subject|28|||
44312166|NCT00191152|79314477|FG000|Initial Treatment|Lost to Follow-up|0|||
44312167|NCT00191152|79314478|FG001|Initial Treatment|Lost to Follow-up|6|||
44312168|NCT00191152|79314477|FG000|Initial Treatment|Other|18|||
44312169|NCT00191152|79314478|FG001|Initial Treatment|Other|21|||
44312170|NCT00191152|79314477|FG000|Crossover Treatment|Adverse Event|8|||
44312171|NCT00191152|79314478|FG001|Crossover Treatment|Adverse Event|8|||
44312172|NCT00191152|79314477|FG000|Crossover Treatment|Physician Decision|7|||
44312173|NCT00191152|79314478|FG001|Crossover Treatment|Physician Decision|7|||
44312174|NCT00191152|79314477|FG000|Crossover Treatment|Withdrawal by Subject|6|||
44312175|NCT00191152|79314478|FG001|Crossover Treatment|Withdrawal by Subject|9|||
44312176|NCT00191152|79314477|FG000|Crossover Treatment|Lost to Follow-up|2|||
44312177|NCT00191152|79314478|FG001|Crossover Treatment|Lost to Follow-up|1|||
44312178|NCT00191152|79314477|FG000|Crossover Treatment|Other|4|||
44312179|NCT00191152|79314478|FG001|Crossover Treatment|Other|3|||
44312180|NCT00190684|79314496|FG000|Overall Study|Adverse Event|86|||
44312181|NCT00190684|79314496|FG000|Overall Study|Satisfactory response|80|||
44312182|NCT00190684|79314496|FG000|Overall Study|Lack of efficacy|204|||
44312183|NCT00190684|79314496|FG000|Overall Study|Lost to Follow-up|232|||
44312184|NCT00190684|79314496|FG000|Overall Study|Patient moved|60|||
44312185|NCT00190684|79314496|FG000|Overall Study|Patient Decision|432|||
44312186|NCT00190684|79314496|FG000|Overall Study|Clinical relapse|67|||
44312187|NCT00190684|79314496|FG000|Overall Study|Sponsor's decision|17|||
44312188|NCT00190684|79314496|FG000|Overall Study|Physician Decision|84|||
44312189|NCT00190684|79314496|FG000|Overall Study|Protocol Violation|123|||
44312190|NCT00190684|79314496|FG000|Overall Study|Study Period III Completed|103|||
44312191|NCT00190684|79314496|FG000|Overall Study|Study Period V Completed|1|||
44312192|NCT00179959|79314507|FG000|Overall Study|Lost to Follow-up|3|||
44312193|NCT00179959|79314508|FG001|Overall Study|Lost to Follow-up|1|||
44312194|NCT00179959|79314507|FG000|Overall Study|Withdrawal by Subject|3|||
44312195|NCT00179959|79314508|FG001|Overall Study|Withdrawal by Subject|2|||
44312196|NCT00179647|79314514|FG000|Overall Study|Adverse Event|294|||
44312197|NCT00179647|79314514|FG000|Overall Study|Lack of Efficacy|478|||
44312198|NCT00179647|79314514|FG000|Overall Study|Withdrawal by Subject|83|||
44312199|NCT00179647|79314514|FG000|Overall Study|Lost to Follow-up|4|||
44312200|NCT00179647|79314514|FG000|Overall Study|Death|94|||
44312201|NCT00179647|79314514|FG000|Overall Study|Other|960|||
44312202|NCT00179413|79314520|FG000|Overall Study|Adverse Event|38|||
44312203|NCT00179413|79314521|FG001|Overall Study|Adverse Event|20|||
44312204|NCT00179413|79314520|FG000|Overall Study|Withdrawal by Subject|87|||
44312205|NCT00179413|79314521|FG001|Overall Study|Withdrawal by Subject|95|||
44312206|NCT00178633|79314527|FG000|Overall Study|Lost to Follow-up|6|||
44312207|NCT00178399|79314532|FG000|Overall Study|Physician Decision|4|||
44312208|NCT00178399|79314532|FG000|Overall Study|Withdrawal by Subject|8|||
44312209|NCT00178399|79314532|FG000|Overall Study|Lost to Follow-up|1|||
44312210|NCT00178126|79314539|FG000|Overall Study|Lost to Follow-up|21|||
44312211|NCT00178126|79314540|FG001|Overall Study|Lost to Follow-up|21|||
44420641|NCT00443209|79428532|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
44420642|NCT00443209|79428531|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
44155503|NCT01998958|78946947|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155504|NCT01998958|78946948|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155505|NCT01998958|78946949|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155506|NCT01998958|78946950|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
44257805|NCT01390220|79111056|FG002|Test Dose Phase|Noncompliance|0|||
44257806|NCT01390220|79111054|FG000|Test Dose Phase|Logistical|6|||
44257807|NCT01390220|79111055|FG001|Test Dose Phase|Logistical|0|||
44257808|NCT01390220|79111056|FG002|Test Dose Phase|Logistical|0|||
44257809|NCT01390220|79111054|FG000|Comparative Phase|Withdrawal by Subject|0|||
44257810|NCT01390220|79111055|FG001|Comparative Phase|Withdrawal by Subject|1|||
44257811|NCT01390220|79111056|FG002|Comparative Phase|Withdrawal by Subject|0|||
44257812|NCT00550173|79111086|FG000|Overall Study|Death|45|||
44257813|NCT00550173|79111087|FG001|Overall Study|Death|38|||
44257814|NCT00550173|79111088|FG002|Overall Study|Death|50|||
44312212|NCT00178126|79314539|FG000|Overall Study|did not receive intervention|4|||
44312213|NCT00178126|79314540|FG001|Overall Study|did not receive intervention|6|||
44312214|NCT00177307|79314546|FG000|Overall Study|Withdrawal by Subject|1|||
44312215|NCT00176605|79314554|FG000|Overall Study|Withdrawal by Subject|2|||
44312216|NCT00176488|79314558|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
44257815|NCT00550173|79111086|FG000|Overall Study|Physician Decision|1|||
44257816|NCT00550173|79111087|FG001|Overall Study|Physician Decision|2|||
44312217|NCT00175825|79314566|FG000|Overall Study|Adverse Event|3|||
44312218|NCT00175825|79314567|FG001|Overall Study|Adverse Event|2|||
44312219|NCT00175825|79314568|FG002|Overall Study|Adverse Event|1|||
44312220|NCT00175825|79314569|FG003|Overall Study|Adverse Event|1|||
44312221|NCT00175825|79314566|FG000|Overall Study|Lost to Follow-up|1|||
44312222|NCT00175825|79314567|FG001|Overall Study|Lost to Follow-up|2|||
44312223|NCT00175825|79314568|FG002|Overall Study|Lost to Follow-up|0|||
44312224|NCT00175825|79314569|FG003|Overall Study|Lost to Follow-up|0|||
44312225|NCT00175825|79314566|FG000|Overall Study|Withdrawal by Subject|1|||
44312226|NCT00175825|79314567|FG001|Overall Study|Withdrawal by Subject|0|||
44312227|NCT00175825|79314568|FG002|Overall Study|Withdrawal by Subject|0|||
44312228|NCT00175825|79314569|FG003|Overall Study|Withdrawal by Subject|0|||
44312229|NCT00174967|79314583|FG000|Overall Study|Adverse Event|1|||
44312230|NCT00174967|79314584|FG001|Overall Study|Adverse Event|2|||
44312231|NCT00174967|79314585|FG002|Overall Study|Adverse Event|2|||
44312232|NCT00174967|79314586|FG003|Overall Study|Adverse Event|1|||
44312233|NCT00174967|79314583|FG000|Overall Study|Gout Flare|0|||
44312234|NCT00174967|79314584|FG001|Overall Study|Gout Flare|0|||
44312235|NCT00174967|79314585|FG002|Overall Study|Gout Flare|0|||
44312236|NCT00174967|79314586|FG003|Overall Study|Gout Flare|1|||
44312237|NCT00174967|79314583|FG000|Overall Study|Other|0|||
44312238|NCT00174967|79314584|FG001|Overall Study|Other|1|||
44312239|NCT00174967|79314585|FG002|Overall Study|Other|0|||
44312240|NCT00174967|79314586|FG003|Overall Study|Other|0|||
44312241|NCT00174265|79314598|FG000|Overall Study|Adverse Event|7|||
44312242|NCT00174265|79314599|FG001|Overall Study|Adverse Event|4|||
44312243|NCT00174265|79314598|FG000|Overall Study|Lack of Efficacy|2|||
44312244|NCT00174265|79314599|FG001|Overall Study|Lack of Efficacy|2|||
44312245|NCT00174265|79314598|FG000|Overall Study|Withdrawal by Subject|3|||
44312246|NCT00174265|79314599|FG001|Overall Study|Withdrawal by Subject|5|||
44312247|NCT00174265|79314598|FG000|Overall Study|Lost to Follow-up|1|||
44312248|NCT00174265|79314599|FG001|Overall Study|Lost to Follow-up|0|||
44312249|NCT00174265|79314598|FG000|Overall Study|Other (Not specified)|16|||
44312250|NCT00174265|79314599|FG001|Overall Study|Other (Not specified)|10|||
44312251|NCT00172042|79314607|FG000|Overall Study|Adverse Event|27|||
44312252|NCT00172042|79314608|FG001|Overall Study|Adverse Event|13|||
44312253|NCT00172042|79314607|FG000|Overall Study|Abnormal laboratory value(s)|5|||
44312254|NCT00172042|79314608|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44312255|NCT00172042|79314607|FG000|Overall Study|Abnormal test procedure(s)|0|||
44312256|NCT00172042|79314608|FG001|Overall Study|Abnormal test procedure(s)|3|||
44312257|NCT00172042|79314607|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
44312258|NCT00172042|79314608|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
44312259|NCT00172042|79314607|FG000|Overall Study|Patient no longer requires study drug|10|||
44312260|NCT00172042|79314608|FG001|Overall Study|Patient no longer requires study drug|8|||
44312261|NCT00172042|79314607|FG000|Overall Study|Protocol Violation|8|||
44312262|NCT00172042|79314608|FG001|Overall Study|Protocol Violation|7|||
44312263|NCT00172042|79314607|FG000|Overall Study|Withdrawal by Subject|37|||
44312264|NCT00172042|79314608|FG001|Overall Study|Withdrawal by Subject|25|||
44312265|NCT00172042|79314607|FG000|Overall Study|Lost to Follow-up|3|||
44312266|NCT00172042|79314608|FG001|Overall Study|Lost to Follow-up|5|||
44312267|NCT00172042|79314607|FG000|Overall Study|Administrative problems|13|||
44312268|NCT00172042|79314608|FG001|Overall Study|Administrative problems|10|||
44312269|NCT00172042|79314607|FG000|Overall Study|Death|42|||
44312270|NCT00172042|79314608|FG001|Overall Study|Death|42|||
44312271|NCT00171925|79314616|FG000|Overall Study|Adverse Event|10|||
44312272|NCT00171925|79314617|FG001|Overall Study|Adverse Event|6|||
44312273|NCT00171925|79314616|FG000|Overall Study|Protocol Violation|1|||
44312274|NCT00171925|79314617|FG001|Overall Study|Protocol Violation|1|||
44312275|NCT00171925|79314616|FG000|Overall Study|Withdrawal by Subject|6|||
44312276|NCT00171925|79314617|FG001|Overall Study|Withdrawal by Subject|9|||
44420643|NCT00443209|79428532|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
44420644|NCT00443209|79428531|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
44420645|NCT00443209|79428532|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
44312277|NCT00171925|79314616|FG000|Overall Study|Lost to Follow-up|2|||
44312278|NCT00171925|79314617|FG001|Overall Study|Lost to Follow-up|2|||
44312279|NCT00171925|79314616|FG000|Overall Study|Administrative problems|10|||
44312280|NCT00171925|79314617|FG001|Overall Study|Administrative problems|11|||
44312281|NCT00171925|79314616|FG000|Overall Study|Death|1|||
44312282|NCT00171925|79314617|FG001|Overall Study|Death|2|||
44312283|NCT00171340|79314625|FG000|Overall Study|Adverse Event|46|||
44312284|NCT00171340|79314626|FG001|Overall Study|Adverse Event|42|||
44312285|NCT00171340|79314625|FG000|Overall Study|Lack of Efficacy|29|||
44312286|NCT00171340|79314626|FG001|Overall Study|Lack of Efficacy|41|||
44312287|NCT00171340|79314625|FG000|Overall Study|Protocol Violation|7|||
44312288|NCT00171340|79314626|FG001|Overall Study|Protocol Violation|8|||
44312289|NCT00171340|79314625|FG000|Overall Study|Withdrawal by Subject|22|||
44312290|NCT00171340|79314626|FG001|Overall Study|Withdrawal by Subject|19|||
44312291|NCT00171340|79314625|FG000|Overall Study|Lost to Follow-up|0|||
44312292|NCT00171340|79314626|FG001|Overall Study|Lost to Follow-up|5|||
44312293|NCT00171340|79314625|FG000|Overall Study|Abnormal Laboratory Results|2|||
44312294|NCT00171340|79314626|FG001|Overall Study|Abnormal Laboratory Results|0|||
44312295|NCT00171340|79314625|FG000|Overall Study|Abnormal Test Procedure Results|6|||
44312296|NCT00171340|79314626|FG001|Overall Study|Abnormal Test Procedure Results|11|||
44312297|NCT00171340|79314625|FG000|Overall Study|No Longer Required Study Drug|1|||
44312298|NCT00171340|79314626|FG001|Overall Study|No Longer Required Study Drug|1|||
44312299|NCT00171340|79314625|FG000|Overall Study|Administrative Problems|5|||
44312300|NCT00171340|79314626|FG001|Overall Study|Administrative Problems|2|||
44312301|NCT00171340|79314625|FG000|Overall Study|Death|6|||
44312302|NCT00171340|79314626|FG001|Overall Study|Death|6|||
44312303|NCT00171301|79314636|FG000|Overall Study|Death|1|||
44312304|NCT00171301|79314637|FG001|Overall Study|Death|2|||
44312305|NCT00171301|79314636|FG000|Overall Study|Adverse Event|1|||
44312306|NCT00171301|79314637|FG001|Overall Study|Adverse Event|2|||
44312307|NCT00171301|79314636|FG000|Overall Study|Lost to Follow-up|6|||
44312308|NCT00171301|79314637|FG001|Overall Study|Lost to Follow-up|2|||
44312309|NCT00171301|79314636|FG000|Overall Study|Protocol Violation|0|||
44312310|NCT00171301|79314637|FG001|Overall Study|Protocol Violation|2|||
44312311|NCT00171301|79314636|FG000|Overall Study|Withdrawal by Subject|0|||
44312312|NCT00171301|79314637|FG001|Overall Study|Withdrawal by Subject|1|||
44312313|NCT00171223|79314647|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
44312314|NCT00171223|79314648|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
44312315|NCT00171223|79314649|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
44312316|NCT00171223|79314647|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
44312317|NCT00171223|79314648|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
44312318|NCT00171223|79314649|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
44312319|NCT00171223|79314647|FG000|Overall Study|Abnormal Procedure|1|||
44312320|NCT00171223|79314648|FG001|Overall Study|Abnormal Procedure|0|||
44312321|NCT00171223|79314649|FG002|Overall Study|Abnormal Procedure|0|||
44312322|NCT00171223|79314647|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
44312323|NCT00171223|79314648|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
44312324|NCT00171223|79314649|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
44312325|NCT00171223|79314647|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
44312326|NCT00171223|79314648|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
44312327|NCT00171223|79314649|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
44312328|NCT00171223|79314647|FG000|Overall Study|Protocol Violation|2|||
44312329|NCT00171223|79314648|FG001|Overall Study|Protocol Violation|2|||
44312330|NCT00171223|79314649|FG002|Overall Study|Protocol Violation|3|||
44312331|NCT00171223|79314647|FG000|Overall Study|Participant Withdrew Consent|12|||
44312332|NCT00171223|79314648|FG001|Overall Study|Participant Withdrew Consent|21|||
44312333|NCT00171223|79314649|FG002|Overall Study|Participant Withdrew Consent|15|||
44312334|NCT00171223|79314647|FG000|Overall Study|Lost to Follow-up|5|||
44312335|NCT00171223|79314648|FG001|Overall Study|Lost to Follow-up|2|||
44312336|NCT00171223|79314649|FG002|Overall Study|Lost to Follow-up|3|||
44312337|NCT00171223|79314647|FG000|Overall Study|Administrative Problems|4|||
44312338|NCT00171223|79314648|FG001|Overall Study|Administrative Problems|7|||
44312339|NCT00171223|79314649|FG002|Overall Study|Administrative Problems|6|||
44312340|NCT00171223|79314647|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
44312341|NCT00171223|79314648|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
44312342|NCT00171223|79314649|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
44312343|NCT00171223|79314647|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
44312344|NCT00171223|79314648|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
44312345|NCT00171223|79314649|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
44312346|NCT00479674|79314655|FG000|Overall Study|Adverse Event|18|||
44312347|NCT00479674|79314655|FG000|Overall Study|Withdrawal by Subject|6|||
44312348|NCT00479674|79314655|FG000|Overall Study|Physician Decision|14|||
44312349|NCT00479674|79314655|FG000|Overall Study|none provided|3|||
44312350|NCT00479401|79314662|FG000|Overall Study|Adverse Event|24|||
44312351|NCT00479401|79314663|FG001|Overall Study|Adverse Event|20|||
44312352|NCT00479401|79314664|FG002|Overall Study|Adverse Event|4|||
44312353|NCT00479401|79314662|FG000|Overall Study|Lack of Efficacy|2|||
44312354|NCT00479401|79314663|FG001|Overall Study|Lack of Efficacy|2|||
44312355|NCT00479401|79314664|FG002|Overall Study|Lack of Efficacy|4|||
44312356|NCT00479401|79314662|FG000|Overall Study|Protocol Violation|2|||
44312357|NCT00479401|79314663|FG001|Overall Study|Protocol Violation|1|||
44312358|NCT00479401|79314664|FG002|Overall Study|Protocol Violation|1|||
44312359|NCT00479401|79314662|FG000|Overall Study|Lost to Follow-up|1|||
44312360|NCT00479401|79314663|FG001|Overall Study|Lost to Follow-up|1|||
44312361|NCT00479401|79314664|FG002|Overall Study|Lost to Follow-up|1|||
44536005|NCT01347762|79546827|FG003|Overall Study|Lost to Follow-up|5|||
44312362|NCT00479401|79314662|FG000|Overall Study|Withdrawal by Subject|16|||
44312363|NCT00479401|79314663|FG001|Overall Study|Withdrawal by Subject|10|||
44312364|NCT00479401|79314664|FG002|Overall Study|Withdrawal by Subject|2|||
44312365|NCT00479401|79314662|FG000|Overall Study|Exclusion criteria, relocation|4|||
44312366|NCT00479401|79314663|FG001|Overall Study|Exclusion criteria, relocation|3|||
44312367|NCT00479401|79314664|FG002|Overall Study|Exclusion criteria, relocation|0|||
44312368|NCT00478777|79314672|FG000|Overall Study|Adverse Event|29|||
44312369|NCT00478777|79314672|FG000|Overall Study|Lack of Efficacy|23|||
44354744|NCT01186770|79359156|FG003|Overall Study|Protocol Violation|14|||
44312370|NCT00478777|79314672|FG000|Overall Study|Withdrawal by Subject|4|||
44312371|NCT00478777|79314672|FG000|Overall Study|Death|3|||
44312372|NCT00478777|79314672|FG000|Overall Study|Protocol Violation|3|||
44312373|NCT00478777|79314672|FG000|Overall Study|Lost to Follow-up|3|||
44312374|NCT00478777|79314672|FG000|Overall Study|Physician Decision|1|||
44312375|NCT00478777|79314672|FG000|Overall Study|Intolerance of therapy|1|||
44312376|NCT00478777|79314672|FG000|Overall Study|Lack of compliance|1|||
44312377|NCT00478777|79314672|FG000|Overall Study|Lymphocytes infusion|1|||
44312378|NCT00478777|79314672|FG000|Overall Study|End of therapy|2|||
44312379|NCT00478777|79314672|FG000|Overall Study|Not treated with lenalidomide|6|||
44312380|NCT00477607|79314678|FG000|Overall Study|Lost to Follow-up|7|||
44312381|NCT00477607|79314679|FG001|Overall Study|Lost to Follow-up|7|||
44312382|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
44312383|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
44312384|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
44312385|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
44312386|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
44312387|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
44312388|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
44312389|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
44312390|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
44312391|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
44312392|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
44312393|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
44312394|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
44312395|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
44312396|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
44312397|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
44312398|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
44312399|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
44312400|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
44312401|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312402|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312403|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312404|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
44312405|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312406|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312407|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312408|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
44312409|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
44312410|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
44312411|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
44312412|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
44312413|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
44312414|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
44312415|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
44312416|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
44312417|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
44312418|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
44312419|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
44312420|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
44312421|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
44312422|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
44312423|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
44312424|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
44312425|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
44312426|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
44312427|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
44312428|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
44312429|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
44312430|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
44312431|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
44312432|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
44312433|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
44312434|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
44312435|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
44312436|NCT00477490|79314690|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
44312437|NCT00477490|79314691|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
44312438|NCT00477490|79314692|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
44312439|NCT00477490|79314693|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
44312440|NCT00477490|79314694|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
44312441|NCT00477490|79314695|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
44312442|NCT00477490|79314696|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
44312443|NCT00477490|79314697|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
44312444|NCT00477490|79314698|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
44312445|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
44312446|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
44312447|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
44312448|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
44312449|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
44312450|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
44312451|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
44312452|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
44312453|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
44312454|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
44312455|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
44312456|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
44312457|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
44312458|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
44312459|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
44312460|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
44312461|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
44312462|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
44312463|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
44312464|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
44312465|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
44312466|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
44312467|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
44312468|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
44312469|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
44312470|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
44312471|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
44312472|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
44312473|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
44312474|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
44312475|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
44312476|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
44312477|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
44312478|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
44312479|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
44312480|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
44312481|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312482|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
44312483|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312484|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312485|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312486|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312487|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312488|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312489|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
44312490|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
44312491|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
44312492|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
44312493|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
44312494|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
44312495|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
44312496|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
44312497|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
44312498|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
44312499|NCT00477490|79314690|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
44312500|NCT00477490|79314691|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
44312501|NCT00477490|79314692|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
44312502|NCT00477490|79314693|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
44312503|NCT00477490|79314694|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
44312504|NCT00477490|79314695|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
44536006|NCT01347762|79546824|FG000|Overall Study|Withdrawal by Subject|4|||
44536007|NCT01347762|79546825|FG001|Overall Study|Withdrawal by Subject|1|||
44312505|NCT00477490|79314696|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
44312506|NCT00477490|79314697|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
44312507|NCT00477490|79314698|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
44312508|NCT00477334|79314728|FG000|Overall Study|Discontinued prior to taking study drug|106|||
44312509|NCT00477334|79314729|FG001|Overall Study|Discontinued prior to taking study drug|53|||
44312510|NCT00477334|79314728|FG000|Overall Study|Adverse Event|1|||
44312511|NCT00477334|79314729|FG001|Overall Study|Adverse Event|2|||
44312512|NCT00477334|79314728|FG000|Overall Study|Withdrawal by Subject|2|||
44312513|NCT00477334|79314729|FG001|Overall Study|Withdrawal by Subject|1|||
44312514|NCT00477334|79314728|FG000|Overall Study|Lost to Follow-up|15|||
44312515|NCT00477334|79314729|FG001|Overall Study|Lost to Follow-up|4|||
44312516|NCT00477334|79314728|FG000|Overall Study|Administrative Problems|39|||
44312517|NCT00477334|79314729|FG001|Overall Study|Administrative Problems|15|||
44312518|NCT00477334|79314728|FG000|Overall Study|Protocol Violation|7|||
44312519|NCT00477334|79314729|FG001|Overall Study|Protocol Violation|1|||
44312520|NCT04536727|79314808|FG000|Overall Study|Lost to Follow-up|1|||
44312521|NCT04536727|79314809|FG001|Overall Study|Lost to Follow-up|1|||
44312522|NCT04536727|79314808|FG000|Overall Study|Death|0|||
44312523|NCT04536727|79314809|FG001|Overall Study|Death|1|||
44312524|NCT04971967|79314870|FG000|Overall Study|Lost to Follow-up|6|||
44312525|NCT04971967|79314871|FG001|Overall Study|Lost to Follow-up|7|||
44312526|NCT04582266|79314898|FG000|Overall Study|Lost to Follow-up|7|||
44312527|NCT04582266|79314899|FG001|Overall Study|Lost to Follow-up|5|||
44312528|NCT04582266|79314898|FG000|Overall Study|Withdrawal by Subject|1|||
44312529|NCT04582266|79314899|FG001|Overall Study|Withdrawal by Subject|0|||
44312530|NCT04582266|79314898|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
44312531|NCT04582266|79314899|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
44312532|NCT04459338|79314909|FG000|Overall Study|Loss of IV during study|1|||
44312533|NCT04459338|79314910|FG001|Overall Study|Loss of IV during study|0|||
44312534|NCT03740048|79314956|FG000|Overall Study|Withdrawal by Subject|1|||
44312535|NCT03740048|79314957|FG001|Overall Study|Withdrawal by Subject|1|||
44312536|NCT03740048|79314956|FG000|Overall Study|Death|1|||
44312537|NCT03740048|79314957|FG001|Overall Study|Death|6|||
44312538|NCT03740048|79314956|FG000|Overall Study|Switched to thrice-weekly HD|2|||
44312539|NCT03740048|79314957|FG001|Overall Study|Switched to thrice-weekly HD|0|||
44312540|NCT03740048|79314956|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
44312541|NCT03740048|79314957|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
44312542|NCT03740048|79314956|FG000|Overall Study|Lost to Follow-up|0|||
44312543|NCT03740048|79314957|FG001|Overall Study|Lost to Follow-up|1|||
44312544|NCT03740048|79314956|FG000|Overall Study|Non-compliance with HD|0|||
44312545|NCT03740048|79314957|FG001|Overall Study|Non-compliance with HD|1|||
44312546|NCT03373760|79315034|FG000|Overall Study|Adverse Event|8|||
44312547|NCT03373760|79315034|FG000|Overall Study|Disease Progression|46|||
44312548|NCT03373760|79315034|FG000|Overall Study|Death|4|||
44312549|NCT03324880|79315043|FG000|Overall Study|Adverse Event|0|||
44312550|NCT03324880|79315044|FG001|Overall Study|Adverse Event|2|||
44312551|NCT03324880|79315043|FG000|Overall Study|Withdrawal by Subject|2|||
44312552|NCT03324880|79315044|FG001|Overall Study|Withdrawal by Subject|2|||
44312553|NCT03324880|79315043|FG000|Overall Study|Lost to Follow-up|0|||
44312554|NCT03324880|79315044|FG001|Overall Study|Lost to Follow-up|1|||
44312555|NCT03324880|79315043|FG000|Overall Study|Product Recall|0|||
44312556|NCT03324880|79315044|FG001|Overall Study|Product Recall|1|||
44312557|NCT03053440|79315054|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
44312558|NCT03053440|79315055|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
44312559|NCT03053440|79315054|FG000|Overall Study|Death|18|||
44312560|NCT03053440|79315055|FG001|Overall Study|Death|14|||
44312561|NCT03053440|79315054|FG000|Overall Study|Withdrawal by Subject|9|||
44312562|NCT03053440|79315055|FG001|Overall Study|Withdrawal by Subject|8|||
44312563|NCT03053440|79315054|FG000|Overall Study|Lost to Follow-up|1|||
44312564|NCT03053440|79315055|FG001|Overall Study|Lost to Follow-up|0|||
44312565|NCT03053440|79315054|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
44312566|NCT03053440|79315055|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
44312567|NCT03053440|79315054|FG000|Overall Study|Physician Decision|2|||
44312568|NCT03053440|79315055|FG001|Overall Study|Physician Decision|1|||
44420646|NCT00443209|79428531|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
44420647|NCT00443209|79428532|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
44536008|NCT01347762|79546826|FG002|Overall Study|Withdrawal by Subject|3|||
44312569|NCT03053440|79315054|FG000|Overall Study|Participant Randomized but died before dosing|1|||
44312570|NCT03053440|79315055|FG001|Overall Study|Participant Randomized but died before dosing|0|||
44312571|NCT02985684|79315062|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
44312572|NCT02985684|79315062|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
44312573|NCT02985684|79315062|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
44312574|NCT02949934|79315101|FG000|Natural Drinking Period|Adverse Event|1|||
44312575|NCT02949934|79315102|FG001|Natural Drinking Period|Adverse Event|0|||
44312576|NCT02949934|79315103|FG002|Natural Drinking Period|Adverse Event|0|||
44312577|NCT02949934|79315104|FG003|Natural Drinking Period|Adverse Event|1|||
44312578|NCT02949934|79315105|FG004|Natural Drinking Period|Adverse Event|0|||
44312579|NCT02949934|79315106|FG005|Natural Drinking Period|Adverse Event|0|||
44312580|NCT02949934|79315101|FG000|Natural Drinking Period|Lost to Follow-up|0|||
44312581|NCT02949934|79315102|FG001|Natural Drinking Period|Lost to Follow-up|0|||
44312582|NCT02949934|79315103|FG002|Natural Drinking Period|Lost to Follow-up|0|||
44312583|NCT02949934|79315104|FG003|Natural Drinking Period|Lost to Follow-up|0|||
44312584|NCT02949934|79315105|FG004|Natural Drinking Period|Lost to Follow-up|1|||
44312585|NCT02949934|79315106|FG005|Natural Drinking Period|Lost to Follow-up|0|||
44312586|NCT02949934|79315101|FG000|Neuroimaging|Protocol Violation|2|||
44312587|NCT02949934|79315102|FG001|Neuroimaging|Protocol Violation|0|||
44312588|NCT02949934|79315103|FG002|Neuroimaging|Protocol Violation|0|||
44312589|NCT02949934|79315104|FG003|Neuroimaging|Protocol Violation|0|||
44312590|NCT02949934|79315105|FG004|Neuroimaging|Protocol Violation|1|||
44312591|NCT02949934|79315106|FG005|Neuroimaging|Protocol Violation|0|||
44312592|NCT02949934|79315101|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
44312593|NCT02949934|79315102|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
44312594|NCT02949934|79315103|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
44312595|NCT02949934|79315104|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
44312596|NCT02949934|79315105|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
44312597|NCT02949934|79315106|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
44312598|NCT02949934|79315101|FG000|Neuroimaging|Not scanned|0|||
44312599|NCT02949934|79315102|FG001|Neuroimaging|Not scanned|0|||
44312600|NCT02949934|79315103|FG002|Neuroimaging|Not scanned|1|||
44312601|NCT02949934|79315104|FG003|Neuroimaging|Not scanned|0|||
44312602|NCT02949934|79315105|FG004|Neuroimaging|Not scanned|0|||
44312603|NCT02949934|79315106|FG005|Neuroimaging|Not scanned|2|||
44312604|NCT02949934|79315101|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
44312605|NCT02949934|79315102|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
44312606|NCT02949934|79315103|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
44312607|NCT02949934|79315104|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
44312608|NCT02949934|79315105|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
44312609|NCT02949934|79315106|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
44312610|NCT02949934|79315101|FG000|Bar Laboratory|Adverse Event|1|||
44312611|NCT02949934|79315102|FG001|Bar Laboratory|Adverse Event|0|||
44312612|NCT02949934|79315103|FG002|Bar Laboratory|Adverse Event|2|||
44312613|NCT02949934|79315104|FG003|Bar Laboratory|Adverse Event|0|||
44312614|NCT02949934|79315105|FG004|Bar Laboratory|Adverse Event|1|||
44312615|NCT02949934|79315106|FG005|Bar Laboratory|Adverse Event|0|||
44536009|NCT01347762|79546827|FG003|Overall Study|Withdrawal by Subject|3|||
44155507|NCT01998958|78946951|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155508|NCT01998958|78946952|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155509|NCT01998958|78946953|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155510|NCT01998958|78946954|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155511|NCT01998958|78946955|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155512|NCT01998958|78946956|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155513|NCT01998958|78946957|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155514|NCT01998958|78946958|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155515|NCT01998958|78946959|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155516|NCT01998958|78946960|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
44257817|NCT00550173|79111088|FG002|Overall Study|Physician Decision|2|||
44536010|NCT03438396|79546837|FG000|Overall Study|Reason Not Specified|9|||
44536011|NCT03438396|79546837|FG000|Overall Study|Withdrawal by Subject|5|||
44536012|NCT03438396|79546837|FG000|Overall Study|Lost to Follow-up|2|||
44536013|NCT03438396|79546837|FG000|Overall Study|Death|85|||
44257818|NCT00550173|79111086|FG000|Overall Study|Withdrawal by Subject|9|||
44257819|NCT00550173|79111087|FG001|Overall Study|Withdrawal by Subject|12|||
44257820|NCT00550173|79111088|FG002|Overall Study|Withdrawal by Subject|17|||
44257821|NCT00550173|79111086|FG000|Overall Study|Sponsor Decision|13|||
44257822|NCT00550173|79111087|FG001|Overall Study|Sponsor Decision|7|||
44257823|NCT00550173|79111088|FG002|Overall Study|Sponsor Decision|1|||
44257824|NCT00550173|79111086|FG000|Overall Study|Lost to Follow-up|4|||
44257825|NCT00550173|79111087|FG001|Overall Study|Lost to Follow-up|4|||
44257826|NCT00550173|79111088|FG002|Overall Study|Lost to Follow-up|3|||
44257827|NCT01429298|79111099|FG000|Overall Study|Protocol Violation|4|||
44257828|NCT01429298|79111100|FG001|Overall Study|Protocol Violation|6|||
44257829|NCT01408706|79111112|FG000|Overall Study|Physician Decision|1|||
44257830|NCT01408706|79111113|FG001|Overall Study|Physician Decision|0|||
44257831|NCT01408628|79111121|FG000|Consented|Withdrawal by Subject|12|||
44257832|NCT01408628|79111121|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
44257833|NCT01408628|79111121|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
44257834|NCT01408628|79111121|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
44257835|NCT01389752|79111126|FG000|Study Period 1|Sponsor decision|0|||
44257836|NCT01389752|79111127|FG001|Study Period 1|Sponsor decision|2|||
44257837|NCT01389752|79111126|FG000|Study Period 2|Sponsor decision|1|||
44312616|NCT02949934|79315101|FG000|Bar Laboratory|Protocol Violation|0|||
44312617|NCT02949934|79315102|FG001|Bar Laboratory|Protocol Violation|0|||
44312618|NCT02949934|79315103|FG002|Bar Laboratory|Protocol Violation|0|||
44312619|NCT02949934|79315104|FG003|Bar Laboratory|Protocol Violation|1|||
44312620|NCT02949934|79315105|FG004|Bar Laboratory|Protocol Violation|0|||
44312621|NCT02949934|79315106|FG005|Bar Laboratory|Protocol Violation|0|||
44312622|NCT02935634|79315138|FG000|Randomization|Participant withdrew consent|0|||
44312623|NCT02935634|79315139|FG001|Randomization|Participant withdrew consent|1|||
44312624|NCT02935634|79315140|FG002|Randomization|Participant withdrew consent|0|||
44312625|NCT02935634|79315141|FG003|Randomization|Participant withdrew consent|0|||
44312626|NCT02935634|79315142|FG004|Randomization|Participant withdrew consent|0|||
44312627|NCT02935634|79315143|FG005|Randomization|Participant withdrew consent|0|||
44312628|NCT02935634|79315138|FG000|Randomization|Death|2|||
44312629|NCT02935634|79315139|FG001|Randomization|Death|1|||
44312630|NCT02935634|79315140|FG002|Randomization|Death|1|||
44312631|NCT02935634|79315141|FG003|Randomization|Death|0|||
44312632|NCT02935634|79315142|FG004|Randomization|Death|0|||
44312633|NCT02935634|79315143|FG005|Randomization|Death|0|||
44312634|NCT02935634|79315138|FG000|Randomization|Other reasons|0|||
44312635|NCT02935634|79315139|FG001|Randomization|Other reasons|2|||
44312636|NCT02935634|79315140|FG002|Randomization|Other reasons|2|||
44312637|NCT02935634|79315141|FG003|Randomization|Other reasons|0|||
44312638|NCT02935634|79315142|FG004|Randomization|Other reasons|0|||
44312639|NCT02935634|79315143|FG005|Randomization|Other reasons|0|||
44312640|NCT02935634|79315138|FG000|Treatment: Track 1|Disease progression|15|||
44312641|NCT02935634|79315139|FG001|Treatment: Track 1|Disease progression|17|||
44312642|NCT02935634|79315140|FG002|Treatment: Track 1|Disease progression|28|||
44312643|NCT02935634|79315141|FG003|Treatment: Track 1|Disease progression|4|||
44312644|NCT02935634|79315142|FG004|Treatment: Track 1|Disease progression|6|||
44312645|NCT02935634|79315143|FG005|Treatment: Track 1|Disease progression|2|||
44312646|NCT02935634|79315138|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
44312647|NCT02935634|79315139|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
44312648|NCT02935634|79315140|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
44312649|NCT02935634|79315141|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
44312650|NCT02935634|79315142|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
44312651|NCT02935634|79315143|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
44312652|NCT02935634|79315138|FG000|Treatment: Track 1|Lost to Follow-up|1|||
44312653|NCT02935634|79315139|FG001|Treatment: Track 1|Lost to Follow-up|0|||
44312654|NCT02935634|79315140|FG002|Treatment: Track 1|Lost to Follow-up|0|||
44312655|NCT02935634|79315141|FG003|Treatment: Track 1|Lost to Follow-up|0|||
44312656|NCT02935634|79315142|FG004|Treatment: Track 1|Lost to Follow-up|0|||
44312657|NCT02935634|79315143|FG005|Treatment: Track 1|Lost to Follow-up|0|||
44312658|NCT02935634|79315138|FG000|Treatment: Track 1|Study drug toxicity|2|||
44312659|NCT02935634|79315139|FG001|Treatment: Track 1|Study drug toxicity|1|||
44312660|NCT02935634|79315140|FG002|Treatment: Track 1|Study drug toxicity|3|||
44312661|NCT02935634|79315141|FG003|Treatment: Track 1|Study drug toxicity|0|||
44312662|NCT02935634|79315142|FG004|Treatment: Track 1|Study drug toxicity|0|||
44312663|NCT02935634|79315143|FG005|Treatment: Track 1|Study drug toxicity|1|||
44312664|NCT02935634|79315138|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
44312665|NCT02935634|79315139|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
44312666|NCT02935634|79315140|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
44312667|NCT02935634|79315141|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
44312668|NCT02935634|79315142|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
44312669|NCT02935634|79315143|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
44312670|NCT02935634|79315138|FG000|Treatment: Track 1|Participant withdrew consent|2|||
44155517|NCT01998958|78946961|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155518|NCT01998958|78946962|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155519|NCT01998958|78946963|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155520|NCT01998958|78946964|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
44312671|NCT02935634|79315139|FG001|Treatment: Track 1|Participant withdrew consent|0|||
44312672|NCT02935634|79315140|FG002|Treatment: Track 1|Participant withdrew consent|1|||
44312673|NCT02935634|79315141|FG003|Treatment: Track 1|Participant withdrew consent|0|||
44312674|NCT02935634|79315142|FG004|Treatment: Track 1|Participant withdrew consent|1|||
44536014|NCT03438396|79546837|FG000|Overall Study|Not treated|1|||
44536015|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
44155521|NCT01998958|78946965|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155522|NCT01998958|78946966|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
44536016|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
44312675|NCT02935634|79315143|FG005|Treatment: Track 1|Participant withdrew consent|0|||
44312676|NCT02935634|79315138|FG000|Treatment: Track 1|Other reasons|0|||
44312677|NCT02935634|79315139|FG001|Treatment: Track 1|Other reasons|0|||
44312678|NCT02935634|79315140|FG002|Treatment: Track 1|Other reasons|2|||
44312679|NCT02935634|79315141|FG003|Treatment: Track 1|Other reasons|0|||
44312680|NCT02935634|79315142|FG004|Treatment: Track 1|Other reasons|0|||
44312681|NCT02935634|79315143|FG005|Treatment: Track 1|Other reasons|0|||
44312682|NCT02935634|79315138|FG000|Treatment: Track 2|Disease progression|13|||
44312683|NCT02935634|79315139|FG001|Treatment: Track 2|Disease progression|26|||
44312684|NCT02935634|79315140|FG002|Treatment: Track 2|Disease progression|20|||
44312685|NCT02935634|79315141|FG003|Treatment: Track 2|Disease progression|5|||
44312686|NCT02935634|79315142|FG004|Treatment: Track 2|Disease progression|1|||
44312687|NCT02935634|79315143|FG005|Treatment: Track 2|Disease progression|4|||
44312688|NCT02935634|79315138|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
44312689|NCT02935634|79315139|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
44312690|NCT02935634|79315140|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
44312691|NCT02935634|79315141|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
44312692|NCT02935634|79315142|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
44312693|NCT02935634|79315143|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
44312694|NCT02935634|79315138|FG000|Treatment: Track 2|Study drug toxicity|7|||
44312695|NCT02935634|79315139|FG001|Treatment: Track 2|Study drug toxicity|3|||
44312696|NCT02935634|79315140|FG002|Treatment: Track 2|Study drug toxicity|0|||
44312697|NCT02935634|79315141|FG003|Treatment: Track 2|Study drug toxicity|0|||
44312698|NCT02935634|79315142|FG004|Treatment: Track 2|Study drug toxicity|0|||
44312699|NCT02935634|79315143|FG005|Treatment: Track 2|Study drug toxicity|0|||
44312700|NCT02935634|79315138|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
44312701|NCT02935634|79315139|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
44312702|NCT02935634|79315140|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
44312703|NCT02935634|79315141|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
44312704|NCT02935634|79315142|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
44312705|NCT02935634|79315143|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
44312706|NCT02935634|79315138|FG000|Treatment: Track 2|Participant withdrew consent|0|||
44312707|NCT02935634|79315139|FG001|Treatment: Track 2|Participant withdrew consent|1|||
44312708|NCT02935634|79315140|FG002|Treatment: Track 2|Participant withdrew consent|1|||
44312709|NCT02935634|79315141|FG003|Treatment: Track 2|Participant withdrew consent|0|||
44312710|NCT02935634|79315142|FG004|Treatment: Track 2|Participant withdrew consent|1|||
44312711|NCT02935634|79315143|FG005|Treatment: Track 2|Participant withdrew consent|0|||
44312712|NCT02864992|79315172|FG000|Overall Study|still on treatment|15|||
44312713|NCT02864992|79315173|FG001|Overall Study|still on treatment|1|||
44312714|NCT02864992|79315174|FG002|Overall Study|still on treatment|33|||
44312715|NCT02684578|79315182|FG000|Overall Study|Withdrawal by Subject|10|||
44312716|NCT02684578|79315183|FG001|Overall Study|Withdrawal by Subject|7|||
44312717|NCT02684578|79315182|FG000|Overall Study|Lost to Follow-up|0|||
44312718|NCT02684578|79315183|FG001|Overall Study|Lost to Follow-up|3|||
44312719|NCT02684578|79315182|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
44312720|NCT02684578|79315183|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
44312721|NCT02684578|79315182|FG000|Overall Study|Missing follow-up data|0|||
44312722|NCT02684578|79315183|FG001|Overall Study|Missing follow-up data|1|||
44312723|NCT02612129|79315191|FG000|Single Dose Treatment Period|Screening Failure|1|||
44312724|NCT02612129|79315192|FG001|Single Dose Treatment Period|Screening Failure|0|||
44312725|NCT02612129|79315193|FG002|Single Dose Treatment Period|Screening Failure|0|||
44312726|NCT02612129|79315191|FG000|Continuous Treatment Period|Early Escape|0|||
44312727|NCT02612129|79315192|FG001|Continuous Treatment Period|Early Escape|2|||
44312728|NCT02612129|79315193|FG002|Continuous Treatment Period|Early Escape|0|||
44312729|NCT02612129|79315191|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
44312730|NCT02612129|79315192|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
44312731|NCT02612129|79315193|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
44312732|NCT02612129|79315191|FG000|Continuous Treatment Period|Safety Reasons|0|||
44312733|NCT02612129|79315192|FG001|Continuous Treatment Period|Safety Reasons|3|||
44536017|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
44536018|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
44536019|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
44536020|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
44536021|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
44536022|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
44536023|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
44312734|NCT02612129|79315193|FG002|Continuous Treatment Period|Safety Reasons|0|||
44312735|NCT02612129|79315191|FG000|Continuous Treatment Period|Death|0|||
44312736|NCT02612129|79315192|FG001|Continuous Treatment Period|Death|1|||
44312737|NCT02612129|79315193|FG002|Continuous Treatment Period|Death|0|||
44312738|NCT02612129|79315191|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
44312739|NCT02612129|79315192|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
44312740|NCT02612129|79315193|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
44312741|NCT02580305|79315203|FG000|Overall Study|Adverse Event|15|||
44312742|NCT02580305|79315204|FG001|Overall Study|Adverse Event|19|||
44312743|NCT02580305|79315205|FG002|Overall Study|Adverse Event|10|||
44312744|NCT02580305|79315203|FG000|Overall Study|Lack of Efficacy|5|||
44312745|NCT02580305|79315204|FG001|Overall Study|Lack of Efficacy|0|||
44312746|NCT02580305|79315205|FG002|Overall Study|Lack of Efficacy|2|||
44312747|NCT02580305|79315203|FG000|Overall Study|Protocol Violation|4|||
44312748|NCT02580305|79315204|FG001|Overall Study|Protocol Violation|9|||
44312749|NCT02580305|79315205|FG002|Overall Study|Protocol Violation|6|||
44312750|NCT02580305|79315203|FG000|Overall Study|Lost to Follow-up|4|||
44312751|NCT02580305|79315204|FG001|Overall Study|Lost to Follow-up|4|||
44312752|NCT02580305|79315205|FG002|Overall Study|Lost to Follow-up|2|||
44312753|NCT02580305|79315203|FG000|Overall Study|Withdrawal by Subject|11|||
44312754|NCT02580305|79315204|FG001|Overall Study|Withdrawal by Subject|9|||
44312755|NCT02580305|79315205|FG002|Overall Study|Withdrawal by Subject|7|||
44312756|NCT02580305|79315203|FG000|Overall Study|Randomized in error and never treated|4|||
44312757|NCT02580305|79315204|FG001|Overall Study|Randomized in error and never treated|8|||
44312758|NCT02580305|79315205|FG002|Overall Study|Randomized in error and never treated|5|||
44312759|NCT02054741|79315224|FG000|Overall Study|Protocol Violation|13|||
44312760|NCT02054741|79315225|FG001|Overall Study|Protocol Violation|2|||
44312761|NCT02054741|79315224|FG000|Overall Study|Withdrawal by Subject|10|||
44312762|NCT02054741|79315225|FG001|Overall Study|Withdrawal by Subject|5|||
44312763|NCT02054741|79315224|FG000|Overall Study|Death|94|||
44312764|NCT02054741|79315225|FG001|Overall Study|Death|90|||
44312765|NCT02054741|79315224|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
44312766|NCT02054741|79315225|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
44312767|NCT01555463|79315233|FG000|Treatment|Adverse Event|6|||
44312768|NCT01555463|79315234|FG001|Treatment|Adverse Event|12|||
44312769|NCT01555463|79315233|FG000|Treatment|Withdrawal by Subject|24|||
44312770|NCT01555463|79315234|FG001|Treatment|Withdrawal by Subject|36|||
44312771|NCT01555463|79315233|FG000|Treatment|Lost to Follow-up|28|||
44312772|NCT01555463|79315234|FG001|Treatment|Lost to Follow-up|23|||
44312773|NCT01555463|79315233|FG000|Treatment|Protocol Violation|4|||
44312774|NCT01555463|79315234|FG001|Treatment|Protocol Violation|5|||
44312775|NCT01555463|79315233|FG000|Treatment|Other reason|2|||
44312776|NCT01555463|79315234|FG001|Treatment|Other reason|3|||
44312777|NCT01555463|79315233|FG000|Follow up|Adverse Event|2|||
44312778|NCT01555463|79315234|FG001|Follow up|Adverse Event|5|||
44312779|NCT01555463|79315233|FG000|Follow up|Death|0|||
44312780|NCT01555463|79315234|FG001|Follow up|Death|1|||
44312781|NCT01555463|79315233|FG000|Follow up|Withdrawal by Subject|22|||
44312782|NCT01555463|79315234|FG001|Follow up|Withdrawal by Subject|22|||
44312783|NCT01555463|79315233|FG000|Follow up|Lost to Follow-up|9|||
44312784|NCT01555463|79315234|FG001|Follow up|Lost to Follow-up|10|||
44312785|NCT01555463|79315233|FG000|Follow up|Protocol Violation|2|||
44312786|NCT01555463|79315234|FG001|Follow up|Protocol Violation|4|||
44312787|NCT01555463|79315233|FG000|Follow up|Other reason|3|||
44312788|NCT01555463|79315234|FG001|Follow up|Other reason|3|||
44312789|NCT02277106|79315310|FG000|Stage 2|Adverse Event|0|||
44312790|NCT02277106|79315311|FG001|Stage 2|Adverse Event|0|||
44312791|NCT02277106|79315312|FG002|Stage 2|Adverse Event|1|||
44312792|NCT02215096|79315335|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
44312793|NCT02215096|79315336|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
44155523|NCT01998958|78946967|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155524|NCT01998958|78946968|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155525|NCT01998958|78946969|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
44155526|NCT01998958|78946970|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155527|NCT01998958|78946971|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155528|NCT01998958|78946972|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155529|NCT01998958|78946973|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155530|NCT01998958|78946974|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
44312794|NCT02215096|79315337|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
44312795|NCT02215096|79315338|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
44312796|NCT02215096|79315339|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
44312797|NCT02215096|79315335|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
44312798|NCT02215096|79315336|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
44420648|NCT00443209|79428531|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
44420649|NCT00443209|79428532|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
44312799|NCT02215096|79315337|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
44312800|NCT02215096|79315338|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
44312801|NCT02215096|79315339|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
44312802|NCT02215096|79315335|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
44312803|NCT02215096|79315336|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
44312804|NCT02215096|79315337|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
44312805|NCT02215096|79315338|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
44312806|NCT02215096|79315339|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
44312807|NCT02215096|79315335|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
44312808|NCT02215096|79315336|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
44312809|NCT02215096|79315337|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
44312810|NCT02215096|79315338|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
44312811|NCT02215096|79315339|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
44312812|NCT03189862|79315374|FG000|Overall Study|Withdrawal by Subject|1|||
44312813|NCT03189862|79315375|FG001|Overall Study|Withdrawal by Subject|0|||
44312814|NCT03189862|79315374|FG000|Overall Study|Lost to Follow-up|54|||
44312815|NCT03189862|79315375|FG001|Overall Study|Lost to Follow-up|62|||
44312816|NCT00107614|79315403|FG000|Overall Study|Physician Decision|10|||
44312817|NCT00107614|79315403|FG000|Overall Study|Death|2|||
44312818|NCT00107380|79315407|FG000|Overall Study|Adverse Event|7|||
44312819|NCT00107380|79315407|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
44312820|NCT00107380|79315407|FG000|Overall Study|Progression/relapse|4|||
44312821|NCT00107380|79315407|FG000|Overall Study|Death|3|||
44312822|NCT00107380|79315407|FG000|Overall Study|Other - not protocol specified|7|||
44312823|NCT00107380|79315407|FG000|Overall Study|Ineligible|2|||
44312824|NCT01340014|79315414|FG000|Period 1, First 7 Days|Adverse Event|1|||
44312825|NCT01340014|79315415|FG001|Period 1, First 7 Days|Adverse Event|0|||
44312826|NCT01340014|79315414|FG000|Period 1, First 7 Days|Personal Reasons|1|||
44312827|NCT01340014|79315415|FG001|Period 1, First 7 Days|Personal Reasons|0|||
44312828|NCT01340014|79315414|FG000|Period 2, Second 7 Days|Adverse Event|0|||
44312829|NCT01340014|79315415|FG001|Period 2, Second 7 Days|Adverse Event|1|||
44312830|NCT01339897|79315425|FG000|Overall Study|Adverse Event|1|||
44312831|NCT01339897|79315426|FG001|Overall Study|Adverse Event|0|||
44312832|NCT01339897|79315427|FG002|Overall Study|Adverse Event|0|||
44312833|NCT01339897|79315428|FG003|Overall Study|Adverse Event|1|||
44312834|NCT01339429|79315440|FG000|Overall Study|Withdrawal by Subject|1|||
44312835|NCT01339429|79315440|FG000|Overall Study|Physician Decision|3|||
44312836|NCT01339390|79315446|FG000|Overall Study|Death|32|||
44312837|NCT01339390|79315447|FG001|Overall Study|Death|29|||
44312838|NCT01339390|79315446|FG000|Overall Study|Lost to Follow-up|125|||
44312839|NCT01339390|79315447|FG001|Overall Study|Lost to Follow-up|127|||
44312840|NCT01339273|79315455|FG000|Overall Study|Lost to Follow-up|8|||
44312841|NCT01339273|79315456|FG001|Overall Study|Lost to Follow-up|8|||
44312842|NCT01334866|79315462|FG000|Overall Study|Withdrawal by Subject|10|||
44312843|NCT01334866|79315462|FG000|Overall Study|Lost to Follow-up|3|||
44312844|NCT01334866|79315462|FG000|Overall Study|Physician Decision|3|||
44312845|NCT01334866|79315462|FG000|Overall Study|medically necessary prior to procedure|2|||
44312846|NCT01334866|79315462|FG000|Overall Study|medically necessary post-procedure|1|||
44312847|NCT01334710|79315468|FG000|Overall Study|Trial was terminated|3|||
44312848|NCT01334554|79315475|FG000|Overall Study|Adverse Event|4|||
44312849|NCT01334554|79315476|FG001|Overall Study|Adverse Event|2|||
44312850|NCT01332799|79315486|FG000|Overall Study|Insufficient funding|10|||
44312851|NCT01332799|79315487|FG001|Overall Study|Insufficient funding|10|||
44312852|NCT01332331|79315495|FG000|Overall Study|Lost to Follow-up|0|||
44312853|NCT01332331|79315496|FG001|Overall Study|Lost to Follow-up|1|||
44312854|NCT01332331|79315495|FG000|Overall Study|Adverse Event|1|||
44312855|NCT01332331|79315496|FG001|Overall Study|Adverse Event|1|||
44312856|NCT01332331|79315495|FG000|Overall Study|Physician Decision|1|||
44312857|NCT01332331|79315496|FG001|Overall Study|Physician Decision|0|||
44312858|NCT01332292|79315503|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
44312859|NCT01332292|79315504|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
44312860|NCT01332292|79315503|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
44312861|NCT01332292|79315504|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
44312862|NCT01332292|79315503|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
44312863|NCT01332292|79315504|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
44420650|NCT00443209|79428531|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
44312864|NCT01332019|79315514|FG000|Overall Study|Was Not Dosed|1|||
44312865|NCT01332019|79315515|FG001|Overall Study|Was Not Dosed|0|||
44312866|NCT01332019|79315514|FG000|Overall Study|Other|16|||
44312867|NCT01332019|79315515|FG001|Overall Study|Other|18|||
44312868|NCT01332019|79315514|FG000|Overall Study|Death|2|||
44312869|NCT01332019|79315515|FG001|Overall Study|Death|1|||
44312870|NCT01332019|79315514|FG000|Overall Study|Physician Decision|4|||
44312871|NCT01332019|79315515|FG001|Overall Study|Physician Decision|3|||
44312872|NCT01332019|79315514|FG000|Overall Study|Withdrawal by Subject|73|||
44312873|NCT01332019|79315515|FG001|Overall Study|Withdrawal by Subject|71|||
44312874|NCT01332019|79315514|FG000|Overall Study|Lost to Follow-up|4|||
44312875|NCT01332019|79315515|FG001|Overall Study|Lost to Follow-up|7|||
44312876|NCT01332019|79315514|FG000|Overall Study|Adverse Event|13|||
44312877|NCT01332019|79315515|FG001|Overall Study|Adverse Event|22|||
44312878|NCT01331239|79315523|FG000|Part II: Core Study|Adverse Event|0|||
44312879|NCT01331239|79315524|FG001|Part II: Core Study|Adverse Event|3|||
44312880|NCT01331239|79315525|FG002|Part II: Core Study|Adverse Event|0|||
44312881|NCT01331239|79315523|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
44312882|NCT01331239|79315524|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
44312883|NCT01331239|79315525|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
44312884|NCT01331239|79315523|FG000|Part II: Core Study|Withdrawal by Subject|0|||
44312885|NCT01331239|79315524|FG001|Part II: Core Study|Withdrawal by Subject|2|||
44312886|NCT01331239|79315525|FG002|Part II: Core Study|Withdrawal by Subject|0|||
44312887|NCT01331239|79315523|FG000|Part II: Core Study|Administrative problems|0|||
44312888|NCT01331239|79315524|FG001|Part II: Core Study|Administrative problems|1|||
44312889|NCT01331239|79315525|FG002|Part II: Core Study|Administrative problems|0|||
44312890|NCT01331161|79315543|FG000|Overall Study|Physician Decision|1|||
44312891|NCT01331161|79315544|FG001|Overall Study|Physician Decision|0|||
44312892|NCT01331161|79315543|FG000|Overall Study|Lost to Follow-up|0|||
44312893|NCT01331161|79315544|FG001|Overall Study|Lost to Follow-up|1|||
44312894|NCT01331161|79315543|FG000|Overall Study|Pregnancy|0|||
44312895|NCT01331161|79315544|FG001|Overall Study|Pregnancy|1|||
44312896|NCT01331005|79315554|FG000|Overall Study|Lost to Follow-up|2|||
44312897|NCT01331005|79315555|FG001|Overall Study|Lost to Follow-up|1|||
44312898|NCT01331005|79315554|FG000|Overall Study|Withdrawal by Subject|2|||
44312899|NCT01331005|79315555|FG001|Overall Study|Withdrawal by Subject|3|||
44312900|NCT01330459|79315563|FG000|Overall Study|Physician Decision|0|||
44312901|NCT01330459|79315564|FG001|Overall Study|Physician Decision|2|||
44312902|NCT01330381|79315574|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
44312903|NCT01330381|79315575|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
44312904|NCT01330381|79315576|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
44312905|NCT01330381|79315574|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
44312906|NCT01330381|79315575|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
44312907|NCT01330381|79315576|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
44312908|NCT01330381|79315574|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
44312909|NCT01330381|79315575|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
44312910|NCT01330381|79315576|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
44312911|NCT01330381|79315574|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
44312912|NCT01330381|79315575|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
44312913|NCT01330381|79315576|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
44312914|NCT01330381|79315574|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
44312915|NCT01330381|79315575|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
44312916|NCT01330381|79315576|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
44312917|NCT01330381|79315574|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
44312918|NCT01330381|79315575|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
44312919|NCT01330381|79315576|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
44312920|NCT01330381|79315574|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
44312921|NCT01330381|79315575|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
44312922|NCT01330381|79315576|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
44312923|NCT01330381|79315574|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
44312924|NCT01330381|79315575|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
44312925|NCT01330381|79315576|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
44312926|NCT01330381|79315574|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
44312927|NCT01330381|79315575|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
44312928|NCT01330381|79315576|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
44312929|NCT01330381|79315574|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
44312930|NCT01330381|79315575|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
44312931|NCT01330381|79315576|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
44312932|NCT01330303|79315585|FG000|Period 1|Adverse Event|1|||
44312933|NCT01330303|79315586|FG001|Period 1|Adverse Event|0|||
44312934|NCT01330303|79315585|FG000|Period 1|Protocol Violation|0|||
44312935|NCT01330303|79315586|FG001|Period 1|Protocol Violation|1|||
44312936|NCT01330303|79315585|FG000|Period 1|Withdrawal by Subject|0|||
44312937|NCT01330303|79315586|FG001|Period 1|Withdrawal by Subject|1|||
44312938|NCT01330108|79315593|FG000|Overall Study|Withdrawal by Subject|4|||
44312939|NCT04849988|79315637|FG000|Overall Study|Lack of Efficacy|3|||
44312940|NCT04849988|79315638|FG001|Overall Study|Lack of Efficacy|4|||
44312941|NCT04849988|79315639|FG002|Overall Study|Lack of Efficacy|1|||
44312942|NCT04849988|79315640|FG003|Overall Study|Lack of Efficacy|4|||
44312943|NCT04849988|79315637|FG000|Overall Study|Other reasons|1|||
44312944|NCT04849988|79315638|FG001|Overall Study|Other reasons|2|||
44312945|NCT04849988|79315639|FG002|Overall Study|Other reasons|2|||
44312946|NCT04849988|79315640|FG003|Overall Study|Other reasons|1|||
44312947|NCT04678661|79315653|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
44312948|NCT04678661|79315654|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
44312949|NCT04678661|79315653|FG000|Overall Study|Protocol Violation|2|||
44312950|NCT04678661|79315654|FG001|Overall Study|Protocol Violation|0|||
44312951|NCT04678661|79315653|FG000|Overall Study|Withdrawal by Subject|1|||
44312952|NCT04678661|79315654|FG001|Overall Study|Withdrawal by Subject|0|||
44312953|NCT04678661|79315653|FG000|Overall Study|Lost to Follow-up|2|||
44312954|NCT04678661|79315654|FG001|Overall Study|Lost to Follow-up|0|||
44312955|NCT04678661|79315653|FG000|Overall Study|Death|2|||
44312956|NCT04678661|79315654|FG001|Overall Study|Death|0|||
44312957|NCT04478123|79315675|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
44312958|NCT04478123|79315675|FG000|Overall Study|NE|1|||
44312959|NCT04191135|79315686|FG000|Induction Treatment|Not Treated|2|||
44312960|NCT04191135|79315687|FG001|Induction Treatment|Not Treated|0|||
44312961|NCT04191135|79315688|FG002|Induction Treatment|Not Treated|0|||
44312962|NCT04191135|79315686|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
44312963|NCT04191135|79315687|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
44312964|NCT04191135|79315688|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
44312965|NCT04191135|79315686|FG000|Induction Treatment|Adverse Event|25|||
44312966|NCT04191135|79315687|FG001|Induction Treatment|Adverse Event|0|||
44312967|NCT04191135|79315688|FG002|Induction Treatment|Adverse Event|0|||
44312968|NCT04191135|79315686|FG000|Induction Treatment|Clinical Progression|8|||
44312969|NCT04191135|79315687|FG001|Induction Treatment|Clinical Progression|0|||
44312970|NCT04191135|79315688|FG002|Induction Treatment|Clinical Progression|0|||
44312971|NCT04191135|79315686|FG000|Induction Treatment|Excluded Medication|1|||
44312972|NCT04191135|79315687|FG001|Induction Treatment|Excluded Medication|0|||
44312973|NCT04191135|79315688|FG002|Induction Treatment|Excluded Medication|0|||
44312974|NCT04191135|79315686|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
44312975|NCT04191135|79315687|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
44312976|NCT04191135|79315688|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
44312977|NCT04191135|79315686|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
44257838|NCT01389752|79111127|FG001|Study Period 2|Sponsor decision|0|||
44257839|NCT01428128|79111134|FG000|Overall Study|Withdrawal by Subject|4|||
44257840|NCT01428128|79111134|FG000|Overall Study|Screen failure by p53|10|||
44257841|NCT01428128|79111134|FG000|Overall Study|Received Neulasta in one cycle|2|||
44257842|NCT01428128|79111134|FG000|Overall Study|Adverse Event|1|||
44257843|NCT01407926|79111139|FG000|Overall Study|Lost to Follow-up|55|||
44257844|NCT01427972|79111166|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257845|NCT01427972|79111167|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257846|NCT01427972|79111168|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257847|NCT01427972|79111169|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257848|NCT01427972|79111170|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257849|NCT01427972|79111171|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257850|NCT01427972|79111172|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257851|NCT01427972|79111173|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
44257852|NCT01427972|79111174|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257853|NCT01427972|79111175|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257854|NCT01427972|79111176|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257855|NCT01427972|79111177|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
44257856|NCT01427972|79111166|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257857|NCT01427972|79111167|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257858|NCT01427972|79111168|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257859|NCT01427972|79111169|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257860|NCT01427972|79111170|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257861|NCT01427972|79111171|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
44257862|NCT01427972|79111172|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257863|NCT01427972|79111173|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257864|NCT01427972|79111174|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257865|NCT01427972|79111175|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257866|NCT01427972|79111176|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257867|NCT01427972|79111177|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
44257868|NCT01427972|79111166|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257869|NCT01427972|79111167|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
44257870|NCT01427972|79111168|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257871|NCT01427972|79111169|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257872|NCT01427972|79111170|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257873|NCT01427972|79111171|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257874|NCT01427972|79111172|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44312978|NCT04191135|79315687|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
44312979|NCT04191135|79315688|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
44312980|NCT04191135|79315686|FG000|Induction Treatment|Physician Decision|2|||
44312981|NCT04191135|79315687|FG001|Induction Treatment|Physician Decision|0|||
44312982|NCT04191135|79315688|FG002|Induction Treatment|Physician Decision|0|||
44312983|NCT04191135|79315686|FG000|Induction Treatment|Progressive Disease|135|||
44312984|NCT04191135|79315687|FG001|Induction Treatment|Progressive Disease|0|||
44312985|NCT04191135|79315688|FG002|Induction Treatment|Progressive Disease|0|||
44312986|NCT04191135|79315686|FG000|Induction Treatment|Protocol Violation|10|||
44312987|NCT04191135|79315687|FG001|Induction Treatment|Protocol Violation|0|||
44312988|NCT04191135|79315688|FG002|Induction Treatment|Protocol Violation|0|||
44312989|NCT04191135|79315686|FG000|Induction Treatment|Withdrawal by Subject|4|||
44312990|NCT04191135|79315687|FG001|Induction Treatment|Withdrawal by Subject|0|||
44312991|NCT04191135|79315688|FG002|Induction Treatment|Withdrawal by Subject|0|||
44312992|NCT04191135|79315686|FG000|Randomized Treatment|Death|0|||
44312993|NCT04191135|79315687|FG001|Randomized Treatment|Death|50|||
44312994|NCT04191135|79315688|FG002|Randomized Treatment|Death|54|||
44312995|NCT04191135|79315686|FG000|Randomized Treatment|Lost to Follow-up|0|||
44312996|NCT04191135|79315687|FG001|Randomized Treatment|Lost to Follow-up|0|||
44312997|NCT04191135|79315688|FG002|Randomized Treatment|Lost to Follow-up|1|||
44312998|NCT04191135|79315686|FG000|Randomized Treatment|Withdrawal by Subject|0|||
44312999|NCT04191135|79315687|FG001|Randomized Treatment|Withdrawal by Subject|2|||
44313000|NCT04191135|79315688|FG002|Randomized Treatment|Withdrawal by Subject|0|||
44313001|NCT04191135|79315686|FG000|Randomized Treatment|Ongoing in Trial|0|||
44313002|NCT04191135|79315687|FG001|Randomized Treatment|Ongoing in Trial|83|||
44313003|NCT04191135|79315688|FG002|Randomized Treatment|Ongoing in Trial|81|||
44313004|NCT04152200|79315697|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
44313005|NCT04152200|79315698|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
44313006|NCT03905694|79315715|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
44313007|NCT03692052|79315736|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
44313008|NCT03692052|79315736|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
44313009|NCT03692052|79315736|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
44313010|NCT03692052|79315736|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
44313011|NCT03682848|79315740|FG000|Overall Study|Withdrawal by Subject|2|||
44313012|NCT03682848|79315740|FG000|Overall Study|Site closed|5|||
44313013|NCT03682848|79315740|FG000|Overall Study|Protocol Deviation|1|||
44313014|NCT03682848|79315740|FG000|Overall Study|Adverse Event|1|||
44313015|NCT03551496|79315781|FG000|Overall Study|Death|11|||
44313016|NCT03551496|79315782|FG001|Overall Study|Death|7|||
44313017|NCT03551496|79315781|FG000|Overall Study|Withdrawal by Subject|4|||
44313018|NCT03551496|79315782|FG001|Overall Study|Withdrawal by Subject|3|||
44313019|NCT03551496|79315781|FG000|Overall Study|Other Reasons|1|||
44313020|NCT03551496|79315782|FG001|Overall Study|Other Reasons|0|||
44313021|NCT03530124|79315790|FG000|Overall Study|Withdrawal by Subject|0|||
44313022|NCT03530124|79315791|FG001|Overall Study|Withdrawal by Subject|1|||
44313023|NCT03530124|79315790|FG000|Overall Study|Protocol Violation|1|||
44313024|NCT03530124|79315791|FG001|Overall Study|Protocol Violation|0|||
44313025|NCT03530124|79315790|FG000|Overall Study|Discharged prior to study completion|1|||
44313026|NCT03530124|79315791|FG001|Overall Study|Discharged prior to study completion|0|||
44313027|NCT03514017|79315797|FG000|Overall Study|Death|1|||
44313028|NCT03514017|79315797|FG000|Overall Study|Adverse Event|1|||
44313029|NCT03370276|79315813|FG000|Overall Study|Death|0|||
44313030|NCT03370276|79315814|FG001|Overall Study|Death|2|||
44313031|NCT03370276|79315815|FG002|Overall Study|Death|5|||
44313032|NCT03329404|79315825|FG000|Overall Study|The study was suspended.|1|||
44313033|NCT03329404|79315826|FG001|Overall Study|The study was suspended.|4|||
44313034|NCT03275064|79315839|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
44313035|NCT03275064|79315840|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
44313036|NCT03275064|79315841|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
44313037|NCT03275064|79315842|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
44313038|NCT03275064|79315843|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
44313039|NCT03275064|79315839|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
44313040|NCT03275064|79315840|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
44313041|NCT03275064|79315841|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
44313042|NCT03275064|79315842|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
44313043|NCT03275064|79315843|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
44313044|NCT03275064|79315839|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
44313045|NCT03275064|79315840|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
44313046|NCT03275064|79315841|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
44313047|NCT03275064|79315842|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
44313048|NCT03275064|79315843|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
44313049|NCT03275064|79315839|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
44313050|NCT03275064|79315840|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
44313051|NCT03275064|79315841|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
44313052|NCT03275064|79315842|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
44313053|NCT03275064|79315843|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
44313054|NCT03275064|79315839|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
44313055|NCT03275064|79315840|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
44313056|NCT03275064|79315841|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
44313057|NCT03275064|79315842|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
44313058|NCT03275064|79315843|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
44313059|NCT03238248|79315863|FG000|Overall Study|Death|5|||
44313060|NCT03238248|79315863|FG000|Overall Study|Withdrawal by Subject|7|||
44313061|NCT03238248|79315863|FG000|Overall Study|Participant proceeding to transplant|10|||
44313062|NCT03238248|79315863|FG000|Overall Study|Lack of Efficacy|4|||
44313063|NCT03238248|79315863|FG000|Overall Study|Physician Decision|3|||
44313064|NCT03238248|79315863|FG000|Overall Study|Transitioning to another study|1|||
44313065|NCT03238248|79315863|FG000|Overall Study|No longer benefiting|1|||
44313066|NCT03238248|79315863|FG000|Overall Study|Other complicating disease|1|||
44313067|NCT03238248|79315863|FG000|Overall Study|Adverse Event|5|||
44313068|NCT03238248|79315863|FG000|Overall Study|Disease progression|26|||
44313069|NCT03238248|79315863|FG000|Overall Study|N/A participant is still on treatment|1|||
44313070|NCT03238248|79315863|FG000|Overall Study|Decline in condition|1|||
44313071|NCT03238248|79315863|FG000|Overall Study|Alternative therapy|2|||
44313072|NCT03088605|79315878|FG000|Overall Study|Withdrawal by Subject|1|||
44313073|NCT03088605|79315879|FG001|Overall Study|Withdrawal by Subject|0|||
44313074|NCT02951052|79315887|FG000|Overall Study|Adverse Event|13|||
44313075|NCT02951052|79315888|FG001|Overall Study|Adverse Event|5|||
44313076|NCT02951052|79315887|FG000|Overall Study|Withdrawal by Subject|1|||
44313077|NCT02951052|79315888|FG001|Overall Study|Withdrawal by Subject|5|||
44313078|NCT02951052|79315887|FG000|Overall Study|Physician Decision|2|||
44313079|NCT02951052|79315888|FG001|Overall Study|Physician Decision|0|||
44313080|NCT02951052|79315887|FG000|Overall Study|Lost to Follow-up|1|||
44313081|NCT02951052|79315888|FG001|Overall Study|Lost to Follow-up|1|||
44313082|NCT02951052|79315887|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
44313083|NCT02951052|79315888|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
44313084|NCT02951052|79315887|FG000|Overall Study|Protocol Violation|5|||
44313085|NCT02951052|79315888|FG001|Overall Study|Protocol Violation|3|||
44313086|NCT02951052|79315887|FG000|Overall Study|Lack of Efficacy|3|||
44313087|NCT02951052|79315888|FG001|Overall Study|Lack of Efficacy|4|||
44313088|NCT02951052|79315887|FG000|Overall Study|Ongoing|1|||
44313089|NCT02951052|79315888|FG001|Overall Study|Ongoing|0|||
44313090|NCT02879383|79315902|FG000|First 24 Weeks|Physician Decision|0|||
44313091|NCT02879383|79315903|FG001|First 24 Weeks|Physician Decision|1|||
44313092|NCT02879383|79315904|FG002|First 24 Weeks|Physician Decision|0|||
44313093|NCT02879383|79315905|FG003|First 24 Weeks|Physician Decision|0|||
44313094|NCT02724878|79315917|FG000|Overall Study|Still on Active Therapy|15|||
44313095|NCT02724878|79315917|FG000|Overall Study|Disease Progression|31|||
44313096|NCT02724878|79315917|FG000|Overall Study|Toxicity|5|||
44313097|NCT02724878|79315917|FG000|Overall Study|Death|1|||
44313098|NCT02724878|79315917|FG000|Overall Study|Withdrawal by Subject|4|||
44313099|NCT02724878|79315917|FG000|Overall Study|Lost to Follow-up|2|||
44420651|NCT00443209|79428532|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
44420652|NCT00443209|79428531|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
44536024|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
44536025|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
44536026|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
44536027|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
44536028|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
44536029|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
44536030|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
44313100|NCT02724878|79315917|FG000|Overall Study|Protocol Violation|1|||
44313101|NCT02724878|79315917|FG000|Overall Study|Ineligible for Study Drug|5|||
44313102|NCT02724878|79315917|FG000|Overall Study|not started|1|||
44313103|NCT02542293|79316037|FG000|Overall Study|Death|367|||
44313104|NCT02542293|79316038|FG001|Overall Study|Death|377|||
44313105|NCT02542293|79316037|FG000|Overall Study|Withdrawal by Subject|8|||
44313106|NCT02542293|79316038|FG001|Overall Study|Withdrawal by Subject|19|||
44313107|NCT02476916|79316067|FG000|Core Period|Adverse Event|2|||
44313108|NCT02476916|79316068|FG001|Core Period|Adverse Event|2|||
44313109|NCT02476916|79316067|FG000|Core Period|Investigator decision|1|||
44313110|NCT02476916|79316068|FG001|Core Period|Investigator decision|1|||
44313111|NCT02476916|79316067|FG000|Core Period|Withdrawal by Subject|3|||
44313112|NCT02476916|79316068|FG001|Core Period|Withdrawal by Subject|0|||
44313113|NCT02476916|79316067|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
44313114|NCT02476916|79316068|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
44313115|NCT02476916|79316067|FG000|Extension Period|On Treatment|12|||
44313116|NCT02476916|79316068|FG001|Extension Period|On Treatment|17|||
44313117|NCT02447029|79316077|FG000|Overall Study|Withdrawal by Subject|3|||
44313118|NCT02447029|79316078|FG001|Overall Study|Withdrawal by Subject|2|||
44313119|NCT01927562|79316084|FG000|Overall Study|Lost to Follow-up|30|||
44313120|NCT01927562|79316084|FG000|Overall Study|Withdrawal by Subject|3|||
44313121|NCT01927562|79316084|FG000|Overall Study|Physician Decision|5|||
44313122|NCT01862991|79316091|FG000|Overall Study|Lost to Follow-up|2|||
44313123|NCT01862991|79316092|FG001|Overall Study|Lost to Follow-up|1|||
44313124|NCT01862991|79316093|FG002|Overall Study|Lost to Follow-up|1|||
44313125|NCT01862991|79316091|FG000|Overall Study|Protocol Violation|1|||
44313126|NCT01862991|79316092|FG001|Overall Study|Protocol Violation|0|||
44313127|NCT01862991|79316093|FG002|Overall Study|Protocol Violation|0|||
44313128|NCT01701674|79316105|FG000|Overall Study|Unable to safely complete treatment|1|||
44313129|NCT04543409|79316144|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44313130|NCT04543409|79316145|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44313131|NCT04543409|79316144|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
44313132|NCT04543409|79316145|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
44313133|NCT04543409|79316144|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
44313134|NCT04543409|79316145|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
44313135|NCT04543409|79316144|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
44313136|NCT04543409|79316145|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
44313137|NCT04543409|79316144|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
44313138|NCT04543409|79316145|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
44313139|NCT04543409|79316144|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
44313140|NCT04543409|79316145|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
44313141|NCT04543409|79316144|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
44313142|NCT04543409|79316145|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
44313143|NCT04543409|79316144|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
44313144|NCT04543409|79316145|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
44313145|NCT04543409|79316144|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
44313146|NCT04543409|79316145|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
44313147|NCT04543409|79316144|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
44313148|NCT04543409|79316145|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
44313149|NCT04543409|79316144|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
44313150|NCT04543409|79316145|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
44536031|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
44536032|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
44536033|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
44536034|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
44536035|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
44536036|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
44257875|NCT01427972|79111173|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257876|NCT01427972|79111174|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257877|NCT01427972|79111175|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257878|NCT01427972|79111176|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257879|NCT01427972|79111177|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
44257880|NCT01427738|79111214|FG000|Overall Study|Death|12|||
44257881|NCT01427738|79111215|FG001|Overall Study|Death|9|||
44257882|NCT01427738|79111214|FG000|Overall Study|Severe debilitation, unable to continue|0|||
44257883|NCT01427738|79111215|FG001|Overall Study|Severe debilitation, unable to continue|1|||
44257884|NCT01427738|79111214|FG000|Overall Study|Subject unable to get to clinic|5|||
44257885|NCT01427738|79111215|FG001|Overall Study|Subject unable to get to clinic|2|||
44257886|NCT01427738|79111214|FG000|Overall Study|Withdrawal by Subject|0|||
44257887|NCT01427738|79111215|FG001|Overall Study|Withdrawal by Subject|2|||
44257888|NCT01427738|79111214|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
44257889|NCT01427738|79111215|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
44257890|NCT01427738|79111214|FG000|Overall Study|Lost to Follow-up|1|||
44257891|NCT01427738|79111215|FG001|Overall Study|Lost to Follow-up|5|||
44257892|NCT01426958|79111221|FG000|Overall Study|Adverse Event|2|||
44257893|NCT02578992|79111399|FG000|Overall Study|equipment not available or malfunction|3|||
44257894|NCT02578992|79111400|FG001|Overall Study|equipment not available or malfunction|3|||
44257895|NCT00558519|79111464|FG000|Overall Study|Ph+|20|||
44257896|NCT00558519|79111464|FG000|Overall Study|Ineligible|1|||
44257897|NCT00558519|79111464|FG000|Overall Study|Insufficient data|1|||
44536037|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
44536038|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
44536039|NCT00073307|79546843|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
44313151|NCT04434937|79316152|FG000|Overall Study|Death|4|||
44313152|NCT04434937|79316152|FG000|Overall Study|Withdrawal by Subject|1|||
44313153|NCT04434937|79316152|FG000|Overall Study|"Captured as Other in Database"|1|||
44313154|NCT04434937|79316152|FG000|Overall Study|Ongoing|36|||
44313155|NCT04030143|79316188|FG000|Overall Study|Adverse Event|5|||
44313156|NCT04030143|79316189|FG001|Overall Study|Adverse Event|10|||
44313157|NCT04030143|79316188|FG000|Overall Study|Lost to Follow-up|3|||
44313158|NCT04030143|79316189|FG001|Overall Study|Lost to Follow-up|7|||
44313159|NCT04030143|79316188|FG000|Overall Study|Protocol Deviation|2|||
44313160|NCT04030143|79316189|FG001|Overall Study|Protocol Deviation|2|||
44313161|NCT04030143|79316188|FG000|Overall Study|Withdrawal by Subject|16|||
44313162|NCT04030143|79316189|FG001|Overall Study|Withdrawal by Subject|18|||
44313163|NCT04030143|79316188|FG000|Overall Study|Physician Decision|1|||
44313164|NCT04030143|79316189|FG001|Overall Study|Physician Decision|1|||
44313165|NCT04030143|79316188|FG000|Overall Study|Due to Covid-19|2|||
44313166|NCT04030143|79316189|FG001|Overall Study|Due to Covid-19|3|||
44313167|NCT04030143|79316188|FG000|Overall Study|Not Due to Covid-19|1|||
44313168|NCT04030143|79316189|FG001|Overall Study|Not Due to Covid-19|1|||
44313169|NCT03934931|79316204|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
44313170|NCT03934931|79316205|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
44313171|NCT03934931|79316206|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
44313172|NCT03927144|79316216|FG000|Core Phase|Adverse Event|9|||
44313173|NCT03927144|79316217|FG001|Core Phase|Adverse Event|5|||
44313174|NCT03927144|79316216|FG000|Core Phase|Lost to Follow-up|3|||
44313175|NCT03927144|79316217|FG001|Core Phase|Lost to Follow-up|2|||
44313176|NCT03927144|79316216|FG000|Core Phase|New Therapy for Study Indication|0|||
44313177|NCT03927144|79316217|FG001|Core Phase|New Therapy for Study Indication|1|||
44313178|NCT03927144|79316216|FG000|Core Phase|No Longer Clinically Benefiting|4|||
44313179|NCT03927144|79316217|FG001|Core Phase|No Longer Clinically Benefiting|4|||
44313180|NCT03927144|79316216|FG000|Core Phase|Physician Decision|2|||
44313181|NCT03927144|79316217|FG001|Core Phase|Physician Decision|8|||
44313182|NCT03927144|79316216|FG000|Core Phase|Protocol Violation|2|||
44313183|NCT03927144|79316217|FG001|Core Phase|Protocol Violation|2|||
44313184|NCT03927144|79316216|FG000|Core Phase|Withdrawal by Subject|16|||
44313185|NCT03927144|79316217|FG001|Core Phase|Withdrawal by Subject|40|||
44313186|NCT03927144|79316216|FG000|Extension Phase|Adverse Event|2|||
44313187|NCT03927144|79316217|FG001|Extension Phase|Adverse Event|1|||
44313188|NCT03927144|79316216|FG000|Extension Phase|No longer clinically benefiting|4|||
44313189|NCT03927144|79316217|FG001|Extension Phase|No longer clinically benefiting|5|||
44313190|NCT03927144|79316216|FG000|Extension Phase|Pregnancy|1|||
44313191|NCT03927144|79316217|FG001|Extension Phase|Pregnancy|0|||
44313192|NCT03927144|79316216|FG000|Extension Phase|Protocol Violation|0|||
44313193|NCT03927144|79316217|FG001|Extension Phase|Protocol Violation|1|||
44313194|NCT03927144|79316216|FG000|Extension Phase|Withdrawal by Subject|8|||
44313195|NCT03927144|79316217|FG001|Extension Phase|Withdrawal by Subject|3|||
44313196|NCT03859973|79316227|FG000|Overall Study|Other reason than listed|3|||
44313197|NCT03859973|79316228|FG001|Overall Study|Other reason than listed|2|||
44313198|NCT03859973|79316227|FG000|Overall Study|COVID-19 related, not due to AE|3|||
44313199|NCT03859973|79316228|FG001|Overall Study|COVID-19 related, not due to AE|4|||
44313200|NCT03859973|79316227|FG000|Overall Study|Withdrawal by Subject|8|||
44313201|NCT03859973|79316228|FG001|Overall Study|Withdrawal by Subject|9|||
44313202|NCT03859973|79316227|FG000|Overall Study|Lost to Follow-up|2|||
44313203|NCT03859973|79316228|FG001|Overall Study|Lost to Follow-up|3|||
44313204|NCT03859973|79316227|FG000|Overall Study|Protocol Violation|1|||
44313205|NCT03859973|79316228|FG001|Overall Study|Protocol Violation|3|||
44313206|NCT03859973|79316227|FG000|Overall Study|Adverse Event|3|||
44313207|NCT03859973|79316228|FG001|Overall Study|Adverse Event|5|||
44313208|NCT03761394|79316238|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
44313209|NCT03761394|79316239|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
44313210|NCT03761394|79316240|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
44313211|NCT03761394|79316241|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
44313212|NCT03761394|79316238|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
44313213|NCT03761394|79316239|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
44313214|NCT03761394|79316240|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
44313215|NCT03761394|79316241|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
44313216|NCT03761394|79316238|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
44313217|NCT03761394|79316239|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
44313218|NCT03761394|79316240|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
44313219|NCT03761394|79316241|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
44313220|NCT03761394|79316238|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
44313221|NCT03761394|79316239|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
44313222|NCT03761394|79316240|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
44313223|NCT03761394|79316241|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
44313224|NCT03699020|79316253|FG000|Overall Study|Withdrawal by Subject|3|||
44313225|NCT03699020|79316254|FG001|Overall Study|Withdrawal by Subject|2|||
44313226|NCT03661723|79316292|FG000|Overall Study|Disease Progression|4|||
44313227|NCT03661723|79316293|FG001|Overall Study|Disease Progression|24|||
44313228|NCT03661723|79316294|FG002|Overall Study|Disease Progression|4|||
44313229|NCT03661723|79316295|FG003|Overall Study|Disease Progression|19|||
44313230|NCT03661723|79316292|FG000|Overall Study|Withdrawal by Subject|1|||
44313231|NCT03661723|79316293|FG001|Overall Study|Withdrawal by Subject|0|||
44313232|NCT03661723|79316294|FG002|Overall Study|Withdrawal by Subject|2|||
44420653|NCT00443209|79428532|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
44420654|NCT00439231|79428538|FG000|Overall Study|Lack of Efficacy|28|||
44420655|NCT00437983|79428544|FG000|Overall Study|Adverse Event|6|||
44420656|NCT00437983|79428545|FG001|Overall Study|Adverse Event|6|||
44420657|NCT00437983|79428544|FG000|Overall Study|Protocol Violation|2|||
44420658|NCT00437983|79428545|FG001|Overall Study|Protocol Violation|1|||
44420659|NCT00437983|79428544|FG000|Overall Study|Withdrawal by Subject|5|||
44420660|NCT00437983|79428545|FG001|Overall Study|Withdrawal by Subject|6|||
44536040|NCT00073307|79546844|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
44536041|NCT00073307|79546845|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
44536042|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
44536043|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
44536044|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
44536045|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
44536046|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
44536047|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
44536048|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
44313233|NCT03661723|79316295|FG003|Overall Study|Withdrawal by Subject|4|||
44313234|NCT03661723|79316292|FG000|Overall Study|Physician Decision|1|||
44313235|NCT03661723|79316293|FG001|Overall Study|Physician Decision|0|||
44313236|NCT03661723|79316294|FG002|Overall Study|Physician Decision|0|||
44313237|NCT03661723|79316295|FG003|Overall Study|Physician Decision|0|||
44313238|NCT03661723|79316292|FG000|Overall Study|Clinical Deterioration|0|||
44313239|NCT03661723|79316293|FG001|Overall Study|Clinical Deterioration|0|||
44313240|NCT03661723|79316294|FG002|Overall Study|Clinical Deterioration|0|||
44313241|NCT03661723|79316295|FG003|Overall Study|Clinical Deterioration|1|||
44313242|NCT03414983|79316316|FG000|Pre-Treatment|Other reasons|1|||
44313243|NCT03414983|79316317|FG001|Pre-Treatment|Other reasons|0|||
44313244|NCT03414983|79316316|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
44313245|NCT03414983|79316317|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
44313246|NCT03414983|79316316|FG000|Pre-Treatment|Participant withdrew consent|1|||
44313247|NCT03414983|79316317|FG001|Pre-Treatment|Participant withdrew consent|3|||
44313248|NCT03414983|79316316|FG000|Treatment|Participant withdrew consent|4|||
44313249|NCT03414983|79316317|FG001|Treatment|Participant withdrew consent|3|||
44313250|NCT03414983|79316316|FG000|Treatment|Participant request to discontinue study treatment|8|||
44313251|NCT03414983|79316317|FG001|Treatment|Participant request to discontinue study treatment|10|||
44313252|NCT03414983|79316316|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
44313253|NCT03414983|79316317|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
44313254|NCT03414983|79316316|FG000|Treatment|Death|0|||
44313255|NCT03414983|79316317|FG001|Treatment|Death|1|||
44313256|NCT03414983|79316316|FG000|Treatment|Study Drug Toxicity|10|||
44313257|NCT03414983|79316317|FG001|Treatment|Study Drug Toxicity|5|||
44313258|NCT03414983|79316316|FG000|Treatment|Disease Progression|75|||
44313259|NCT03414983|79316317|FG001|Treatment|Disease Progression|29|||
44313260|NCT03414983|79316316|FG000|Treatment|Not reported|1|||
44420661|NCT00783692|79428554|FG000|Induction Phase|Adverse Event|7|||
44420662|NCT00783692|79428555|FG001|Induction Phase|Adverse Event|9|||
44536049|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
44536050|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
44313261|NCT03414983|79316317|FG001|Treatment|Not reported|0|||
44313262|NCT03414983|79316316|FG000|Treatment|Other reasons|3|||
44420663|NCT00783692|79428556|FG002|Induction Phase|Adverse Event|24|||
44420664|NCT00783692|79428557|FG003|Induction Phase|Adverse Event|0|||
44313263|NCT03414983|79316317|FG001|Treatment|Other reasons|2|||
44313264|NCT03414983|79316316|FG000|Treatment|Poor/non-compliance|2|||
44313265|NCT03414983|79316317|FG001|Treatment|Poor/non-compliance|0|||
44313266|NCT03414983|79316316|FG000|Treatment|Maximum clinical benefit|5|||
44313267|NCT03414983|79316317|FG001|Treatment|Maximum clinical benefit|9|||
44313268|NCT03414983|79316316|FG000|Treatment|Lost to Follow-up|0|||
44313269|NCT03414983|79316317|FG001|Treatment|Lost to Follow-up|1|||
44313270|NCT03414983|79316316|FG000|Treatment|Administrative reasons by sponsor|1|||
44420665|NCT00783692|79428558|FG004|Induction Phase|Adverse Event|0|||
44420666|NCT00783692|79428559|FG005|Induction Phase|Adverse Event|0|||
44420667|NCT00783692|79428560|FG006|Induction Phase|Adverse Event|0|||
44313271|NCT03414983|79316317|FG001|Treatment|Administrative reasons by sponsor|0|||
44313272|NCT02986659|79316351|FG000|First Intervention Period|Adverse Event|3|||
44313273|NCT02986659|79316352|FG001|First Intervention Period|Adverse Event|1|||
44313274|NCT02986659|79316351|FG000|First Intervention Period|Lost to Follow-up|1|||
44313275|NCT02986659|79316352|FG001|First Intervention Period|Lost to Follow-up|0|||
44313276|NCT02986659|79316351|FG000|First Intervention Period|Withdrawal by Subject|0|||
44313277|NCT02986659|79316352|FG001|First Intervention Period|Withdrawal by Subject|1|||
44313278|NCT02986659|79316351|FG000|Second Intervention Period|Adverse Event|0|||
44313279|NCT02986659|79316352|FG001|Second Intervention Period|Adverse Event|6|||
44313280|NCT02933489|79316360|FG000|Overall Study|Ineligible|3|||
44313281|NCT02933489|79316361|FG001|Overall Study|Ineligible|3|||
44313282|NCT02933489|79316360|FG000|Overall Study|Withdrawal by Subject|27|||
44313283|NCT02933489|79316361|FG001|Overall Study|Withdrawal by Subject|18|||
44313284|NCT02933489|79316360|FG000|Overall Study|Unable to complete exams (other)|14|||
44313285|NCT02933489|79316361|FG001|Overall Study|Unable to complete exams (other)|7|||
44313286|NCT02743806|79316379|FG000|Overall Study|Adverse Event|9|||
44313287|NCT02743806|79316379|FG000|Overall Study|Lost to Follow-up|8|||
44313288|NCT02743806|79316379|FG000|Overall Study|Voluntary Withdrawal|54|||
44313289|NCT02743806|79316379|FG000|Overall Study|Study Termination|65|||
44313290|NCT02743806|79316379|FG000|Overall Study|Pregnancy|6|||
44313291|NCT02743806|79316379|FG000|Overall Study|No Longer Clinically Benefiting|27|||
44313292|NCT02743806|79316379|FG000|Overall Study|Reason Not Specified|12|||
44313293|NCT02668653|79316385|FG000|Overall Study|Refractory disease|41|||
44313294|NCT02668653|79316386|FG001|Overall Study|Refractory disease|70|||
44313295|NCT02668653|79316385|FG000|Overall Study|Relapse|44|||
44313296|NCT02668653|79316386|FG001|Overall Study|Relapse|65|||
44313297|NCT02668653|79316385|FG000|Overall Study|Adverse Event|58|||
44313298|NCT02668653|79316386|FG001|Overall Study|Adverse Event|23|||
44313299|NCT02668653|79316385|FG000|Overall Study|Subject decision to stop study drug|25|||
44313300|NCT02668653|79316386|FG001|Overall Study|Subject decision to stop study drug|23|||
44313301|NCT02668653|79316385|FG000|Overall Study|Other reasons not specified|16|||
44313302|NCT02668653|79316386|FG001|Overall Study|Other reasons not specified|11|||
44313303|NCT02668653|79316385|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
44313304|NCT02668653|79316386|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
44313305|NCT02668653|79316385|FG000|Overall Study|Investigator decision|10|||
44313306|NCT02668653|79316386|FG001|Overall Study|Investigator decision|7|||
44313307|NCT02668653|79316385|FG000|Overall Study|Failure to meet continuation criteria|5|||
44313308|NCT02668653|79316386|FG001|Overall Study|Failure to meet continuation criteria|12|||
44313309|NCT02668653|79316385|FG000|Overall Study|Lost to Follow-up|1|||
44313310|NCT02668653|79316386|FG001|Overall Study|Lost to Follow-up|0|||
44313311|NCT02668653|79316385|FG000|Overall Study|Pregnancy|0|||
44313312|NCT02668653|79316386|FG001|Overall Study|Pregnancy|1|||
44313313|NCT02668653|79316385|FG000|Overall Study|Death|0|||
44313314|NCT02668653|79316386|FG001|Overall Study|Death|1|||
44313315|NCT02649972|79316392|FG000|Overall Study|Not treated|1|||
44313316|NCT02437318|79316407|FG000|Overall Study|Progressive disease|173|||
44313317|NCT02437318|79316408|FG001|Overall Study|Progressive disease|208|||
44313318|NCT02437318|79316407|FG000|Overall Study|Subject/guardian decision|22|||
44313319|NCT02437318|79316408|FG001|Overall Study|Subject/guardian decision|10|||
44313320|NCT02437318|79316407|FG000|Overall Study|Physician Decision|11|||
44313321|NCT02437318|79316408|FG001|Overall Study|Physician Decision|10|||
44313322|NCT02437318|79316407|FG000|Overall Study|Adverse Event|14|||
44313323|NCT02437318|79316408|FG001|Overall Study|Adverse Event|3|||
44313324|NCT02437318|79316407|FG000|Overall Study|Death|4|||
44313325|NCT02437318|79316408|FG001|Overall Study|Death|4|||
44313326|NCT02437318|79316407|FG000|Overall Study|Protocol Violation|5|||
44313327|NCT02437318|79316408|FG001|Overall Study|Protocol Violation|6|||
44420668|NCT00783692|79428554|FG000|Induction Phase|Protocol Violation|0|||
44420669|NCT00783692|79428555|FG001|Induction Phase|Protocol Violation|0|||
44313328|NCT02437318|79316407|FG000|Overall Study|Untreated|0|||
44313329|NCT02437318|79316408|FG001|Overall Study|Untreated|1|||
44313330|NCT02305238|79316417|FG000|Overall Study|Death|2|||
44420670|NCT00783692|79428556|FG002|Induction Phase|Protocol Violation|1|||
44536051|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
44313331|NCT02305238|79316418|FG001|Overall Study|Death|1|||
44313332|NCT02305238|79316419|FG002|Overall Study|Death|0|||
44313333|NCT02305238|79316417|FG000|Overall Study|Progressive disease|4|||
44313334|NCT02305238|79316418|FG001|Overall Study|Progressive disease|4|||
44313335|NCT02305238|79316419|FG002|Overall Study|Progressive disease|0|||
44313336|NCT02305238|79316417|FG000|Overall Study|Logistical difficulties|1|||
44313337|NCT02305238|79316418|FG001|Overall Study|Logistical difficulties|3|||
44313338|NCT02305238|79316419|FG002|Overall Study|Logistical difficulties|0|||
44313339|NCT02305238|79316417|FG000|Overall Study|Protocol Violation|0|||
44313340|NCT02305238|79316418|FG001|Overall Study|Protocol Violation|3|||
44536052|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
44313341|NCT02305238|79316419|FG002|Overall Study|Protocol Violation|0|||
44313342|NCT02305238|79316417|FG000|Overall Study|Physician Decision|2|||
44313343|NCT02305238|79316418|FG001|Overall Study|Physician Decision|1|||
44313344|NCT02305238|79316419|FG002|Overall Study|Physician Decision|0|||
44313345|NCT02305238|79316417|FG000|Overall Study|Adverse Event|4|||
44313346|NCT02305238|79316418|FG001|Overall Study|Adverse Event|2|||
44313347|NCT02305238|79316419|FG002|Overall Study|Adverse Event|0|||
44313348|NCT02305238|79316417|FG000|Overall Study|Withdrawal by Subject|3|||
44313349|NCT02305238|79316418|FG001|Overall Study|Withdrawal by Subject|4|||
44313350|NCT02305238|79316419|FG002|Overall Study|Withdrawal by Subject|0|||
44313351|NCT02305238|79316417|FG000|Overall Study|Randomized failure|0|||
44313352|NCT02305238|79316418|FG001|Overall Study|Randomized failure|0|||
44313353|NCT02305238|79316419|FG002|Overall Study|Randomized failure|8|||
44313354|NCT02305238|79316417|FG000|Overall Study|Required procedure failed|0|||
44313355|NCT02305238|79316418|FG001|Overall Study|Required procedure failed|1|||
44313356|NCT02305238|79316419|FG002|Overall Study|Required procedure failed|0|||
44313357|NCT02175004|79316428|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
44313358|NCT02175004|79316429|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
44313359|NCT02175004|79316428|FG000|Overall Study|Investigator Judgment|1|||
44313360|NCT02175004|79316429|FG001|Overall Study|Investigator Judgment|4|||
44313361|NCT02175004|79316428|FG000|Overall Study|Voluntary Withdrawal|6|||
44313362|NCT02175004|79316429|FG001|Overall Study|Voluntary Withdrawal|19|||
44313363|NCT02175004|79316428|FG000|Overall Study|Liver Transplant|1|||
44313364|NCT02175004|79316429|FG001|Overall Study|Liver Transplant|0|||
44313365|NCT02175004|79316428|FG000|Overall Study|Disease Progression|1|||
44313366|NCT02175004|79316429|FG001|Overall Study|Disease Progression|0|||
44313367|NCT02175004|79316428|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
44313368|NCT02175004|79316429|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
44313369|NCT01059825|79316441|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
44313370|NCT01059825|79316442|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
44313371|NCT01059825|79316443|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
44313372|NCT01059825|79316444|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
44313373|NCT01059825|79316445|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
44313374|NCT01059825|79316446|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
44313375|NCT01059825|79316447|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
44313376|NCT01059825|79316441|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
44313377|NCT01059825|79316442|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
44313378|NCT01059825|79316443|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
44313379|NCT01059825|79316444|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
44313380|NCT01059825|79316445|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
44313381|NCT01059825|79316446|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
44313382|NCT01059825|79316447|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
44313383|NCT01059825|79316441|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
44313384|NCT01059825|79316442|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
44313385|NCT01059825|79316443|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
44313386|NCT01059825|79316444|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
44313387|NCT01059825|79316445|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
44313388|NCT01059825|79316446|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
44313389|NCT01059825|79316447|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
44313390|NCT01059825|79316441|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
44313391|NCT01059825|79316442|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
44313392|NCT01059825|79316443|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
44313393|NCT01059825|79316444|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
44313394|NCT01059825|79316445|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
44313395|NCT01059825|79316446|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
44313396|NCT01059825|79316447|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
44313397|NCT01059825|79316441|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
44313398|NCT01059825|79316442|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
44313399|NCT01059825|79316443|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
44313400|NCT01059825|79316444|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
44313401|NCT01059825|79316445|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
44313402|NCT01059825|79316446|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
44313403|NCT01059825|79316447|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
44155531|NCT01998958|78946975|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155532|NCT01998958|78946976|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
44155533|NCT01998958|78946977|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
44313404|NCT01059825|79316441|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
44313405|NCT01059825|79316442|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
44155534|NCT01998958|78946978|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
44313406|NCT01059825|79316443|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
44155535|NCT01998958|78946947|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313407|NCT01059825|79316444|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
44313408|NCT01059825|79316445|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
44313409|NCT01059825|79316446|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
44313410|NCT01059825|79316447|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
44313411|NCT01059825|79316441|FG000|Treatment Period|Lost to Follow-up|2|||
44313412|NCT01059825|79316442|FG001|Treatment Period|Lost to Follow-up|1|||
44313413|NCT01059825|79316443|FG002|Treatment Period|Lost to Follow-up|0|||
44313414|NCT01059825|79316444|FG003|Treatment Period|Lost to Follow-up|1|||
44313415|NCT01059825|79316445|FG004|Treatment Period|Lost to Follow-up|2|||
44313416|NCT01059825|79316446|FG005|Treatment Period|Lost to Follow-up|0|||
44313417|NCT01059825|79316447|FG006|Treatment Period|Lost to Follow-up|0|||
44313418|NCT01059825|79316441|FG000|Treatment Period|Withdrawal by Subject|3|||
44313419|NCT01059825|79316442|FG001|Treatment Period|Withdrawal by Subject|0|||
44313420|NCT01059825|79316443|FG002|Treatment Period|Withdrawal by Subject|1|||
44313421|NCT01059825|79316444|FG003|Treatment Period|Withdrawal by Subject|5|||
44313422|NCT01059825|79316445|FG004|Treatment Period|Withdrawal by Subject|4|||
44313423|NCT01059825|79316446|FG005|Treatment Period|Withdrawal by Subject|1|||
44313424|NCT01059825|79316447|FG006|Treatment Period|Withdrawal by Subject|0|||
44313425|NCT01059825|79316441|FG000|Treatment Period|Other reason not specified|1|||
44313426|NCT01059825|79316442|FG001|Treatment Period|Other reason not specified|2|||
44313427|NCT01059825|79316443|FG002|Treatment Period|Other reason not specified|1|||
44313428|NCT01059825|79316444|FG003|Treatment Period|Other reason not specified|2|||
44313429|NCT01059825|79316445|FG004|Treatment Period|Other reason not specified|0|||
44313430|NCT01059825|79316446|FG005|Treatment Period|Other reason not specified|0|||
44313431|NCT01059825|79316447|FG006|Treatment Period|Other reason not specified|0|||
44313432|NCT01059825|79316441|FG000|Treatment Period|Protocol Violation|0|||
44313433|NCT01059825|79316442|FG001|Treatment Period|Protocol Violation|0|||
44313434|NCT01059825|79316443|FG002|Treatment Period|Protocol Violation|1|||
44313435|NCT01059825|79316444|FG003|Treatment Period|Protocol Violation|1|||
44313436|NCT01059825|79316445|FG004|Treatment Period|Protocol Violation|1|||
44313437|NCT01059825|79316446|FG005|Treatment Period|Protocol Violation|1|||
44313438|NCT01059825|79316447|FG006|Treatment Period|Protocol Violation|0|||
44313439|NCT01059825|79316441|FG000|Treatment Period|Adverse event related to study drug|1|||
44313440|NCT01059825|79316442|FG001|Treatment Period|Adverse event related to study drug|0|||
44313441|NCT01059825|79316443|FG002|Treatment Period|Adverse event related to study drug|1|||
44313442|NCT01059825|79316444|FG003|Treatment Period|Adverse event related to study drug|1|||
44313443|NCT01059825|79316445|FG004|Treatment Period|Adverse event related to study drug|0|||
44313444|NCT01059825|79316446|FG005|Treatment Period|Adverse event related to study drug|0|||
44313445|NCT01059825|79316447|FG006|Treatment Period|Adverse event related to study drug|0|||
44313446|NCT01059825|79316441|FG000|Treatment Period|Insufficient clinical response|3|||
44313447|NCT01059825|79316442|FG001|Treatment Period|Insufficient clinical response|0|||
44313448|NCT01059825|79316443|FG002|Treatment Period|Insufficient clinical response|0|||
44420671|NCT00783692|79428557|FG003|Induction Phase|Protocol Violation|0|||
44420672|NCT00783692|79428558|FG004|Induction Phase|Protocol Violation|0|||
44420673|NCT00783692|79428559|FG005|Induction Phase|Protocol Violation|0|||
44420674|NCT00783692|79428560|FG006|Induction Phase|Protocol Violation|0|||
44420675|NCT00783692|79428554|FG000|Induction Phase|Lack of Efficacy|1|||
44420676|NCT00783692|79428555|FG001|Induction Phase|Lack of Efficacy|3|||
44420677|NCT00783692|79428556|FG002|Induction Phase|Lack of Efficacy|28|||
44420678|NCT00783692|79428557|FG003|Induction Phase|Lack of Efficacy|0|||
44313449|NCT01059825|79316444|FG003|Treatment Period|Insufficient clinical response|0|||
44313450|NCT01059825|79316445|FG004|Treatment Period|Insufficient clinical response|0|||
44420679|NCT00783692|79428558|FG004|Induction Phase|Lack of Efficacy|0|||
44420680|NCT00783692|79428559|FG005|Induction Phase|Lack of Efficacy|0|||
44313451|NCT01059825|79316446|FG005|Treatment Period|Insufficient clinical response|0|||
44420681|NCT00783692|79428560|FG006|Induction Phase|Lack of Efficacy|0|||
44420682|NCT00783692|79428554|FG000|Induction Phase|Withdrawal by Subject|3|||
44420683|NCT00783692|79428555|FG001|Induction Phase|Withdrawal by Subject|9|||
44420684|NCT00783692|79428556|FG002|Induction Phase|Withdrawal by Subject|16|||
44420685|NCT00783692|79428557|FG003|Induction Phase|Withdrawal by Subject|0|||
44313452|NCT01059825|79316447|FG006|Treatment Period|Insufficient clinical response|0|||
44313453|NCT01059825|79316441|FG000|Treatment Period|Adverse event not related to study drug|0|||
44313454|NCT01059825|79316442|FG001|Treatment Period|Adverse event not related to study drug|1|||
44313455|NCT01059825|79316443|FG002|Treatment Period|Adverse event not related to study drug|2|||
44313456|NCT01059825|79316444|FG003|Treatment Period|Adverse event not related to study drug|1|||
44313457|NCT01059825|79316445|FG004|Treatment Period|Adverse event not related to study drug|1|||
44313458|NCT01059825|79316446|FG005|Treatment Period|Adverse event not related to study drug|1|||
44313459|NCT01059825|79316447|FG006|Treatment Period|Adverse event not related to study drug|0|||
44313460|NCT03439839|79316474|FG000|Overall Study|Death|3|||
44313461|NCT03439839|79316475|FG001|Overall Study|Death|0|||
44313462|NCT04618770|79316539|FG000|Overall Study|Censored from Analysis|12|||
44313463|NCT04618770|79316539|FG000|Overall Study|Early Termination|25|||
44313464|NCT04568603|79316543|FG000|Overall Study|Physician Decision|1|||
44313465|NCT04544709|79316548|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
44313466|NCT04528732|79316557|FG000|Overall Study|Death|1|||
44313467|NCT04528732|79316558|FG001|Overall Study|Death|0|||
44313468|NCT04528732|79316559|FG002|Overall Study|Death|1|||
44313469|NCT04528732|79316557|FG000|Overall Study|Lost to Follow-up|0|||
44313470|NCT04528732|79316558|FG001|Overall Study|Lost to Follow-up|1|||
44313471|NCT04528732|79316559|FG002|Overall Study|Lost to Follow-up|2|||
44313472|NCT04505540|79316572|FG000|Baseline|Protocol Violation|10|||
44313473|NCT04505540|79316572|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
44313474|NCT04505540|79316572|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
44313475|NCT04505540|79316572|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
44313476|NCT04505540|79316572|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
44313477|NCT04505540|79316572|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
44313478|NCT04505540|79316572|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
44313479|NCT04505540|79316572|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
44313480|NCT04505540|79316572|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
44313481|NCT04505540|79316572|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
44313482|NCT04505540|79316572|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
44313483|NCT04505540|79316572|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
44313484|NCT04505540|79316572|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
44313485|NCT04455815|79316578|FG000|Randomisation Phase|Adverse Event|1|||
44313486|NCT04455815|79316579|FG001|Randomisation Phase|Adverse Event|0|||
44313487|NCT04455815|79316578|FG000|Treatment Phase|Adverse Event|0|||
44313488|NCT04455815|79316579|FG001|Treatment Phase|Adverse Event|1|||
44313489|NCT04455815|79316578|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
44313490|NCT04455815|79316579|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
44313491|NCT04455815|79316578|FG000|Treatment Phase|Withdrawal by Subject|1|||
44313492|NCT04455815|79316579|FG001|Treatment Phase|Withdrawal by Subject|1|||
44313493|NCT04220411|79316589|FG000|Overall Study|Adverse Event|0|||
44313494|NCT04220411|79316590|FG001|Overall Study|Adverse Event|0|||
44313495|NCT04220411|79316591|FG002|Overall Study|Adverse Event|0|||
44313496|NCT04220411|79316592|FG003|Overall Study|Adverse Event|1|||
44313497|NCT04194489|79316604|FG000|Overall Study|Withdrawal by Subject|5|||
44313498|NCT04194489|79316604|FG000|Overall Study|Lost to Follow-up|48|||
44313499|NCT04194450|79316608|FG000|Overall Study|not eligible|1|||
44313500|NCT04194450|79316609|FG001|Overall Study|not eligible|0|||
44313501|NCT04158739|79316616|FG000|Overall Study|Adverse Event|1|||
44313502|NCT04158739|79316617|FG001|Overall Study|Adverse Event|0|||
44313503|NCT04158739|79316616|FG000|Overall Study|Death|0|||
44313504|NCT04158739|79316617|FG001|Overall Study|Death|1|||
44313505|NCT04158739|79316616|FG000|Overall Study|Lack of Efficacy|3|||
44313506|NCT04158739|79316617|FG001|Overall Study|Lack of Efficacy|7|||
44313507|NCT04158739|79316616|FG000|Overall Study|Physician Decision|0|||
44313508|NCT04158739|79316617|FG001|Overall Study|Physician Decision|1|||
44313509|NCT04158739|79316616|FG000|Overall Study|Withdrawal by Subject|3|||
44313510|NCT04158739|79316617|FG001|Overall Study|Withdrawal by Subject|0|||
44313511|NCT04123093|79316627|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
44313512|NCT04123093|79316628|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
44313513|NCT04123093|79316627|FG000|Phase 2|Physician Decision|0|||
44313514|NCT04123093|79316628|FG001|Phase 2|Physician Decision|1|||
44313515|NCT04123093|79316627|FG000|Phase 2|Withdrawal by Subject|0|||
44313516|NCT04123093|79316628|FG001|Phase 2|Withdrawal by Subject|1|||
44313517|NCT03538301|79316690|FG000|Overall Study|Adverse Event|1|||
44313518|NCT03538301|79316691|FG001|Overall Study|Adverse Event|4|||
44313519|NCT03538301|79316692|FG002|Overall Study|Adverse Event|4|||
44313520|NCT03538301|79316690|FG000|Overall Study|Death|1|||
44313521|NCT03538301|79316691|FG001|Overall Study|Death|1|||
44313522|NCT03538301|79316692|FG002|Overall Study|Death|0|||
44313523|NCT03538301|79316690|FG000|Overall Study|Physician Decision|0|||
44313524|NCT03538301|79316691|FG001|Overall Study|Physician Decision|1|||
44313525|NCT03538301|79316692|FG002|Overall Study|Physician Decision|0|||
44313526|NCT03538301|79316690|FG000|Overall Study|Protocol Violation|0|||
44313527|NCT03538301|79316691|FG001|Overall Study|Protocol Violation|0|||
44313528|NCT03538301|79316692|FG002|Overall Study|Protocol Violation|1|||
44313529|NCT03538301|79316690|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
44313530|NCT03538301|79316691|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
44313531|NCT03538301|79316692|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
44313532|NCT03485157|79316702|FG000|Double Blind Phase|Lost to Follow-up|4|||
44313533|NCT03485157|79316703|FG001|Double Blind Phase|Lost to Follow-up|4|||
44313534|NCT03485157|79316702|FG000|Double Blind Phase|Adverse Event|2|||
44313535|NCT03485157|79316703|FG001|Double Blind Phase|Adverse Event|1|||
44313536|NCT03485157|79316702|FG000|Double Blind Phase|Withdrawal by Subject|6|||
44313537|NCT03485157|79316703|FG001|Double Blind Phase|Withdrawal by Subject|9|||
44313538|NCT03485157|79316702|FG000|Double Blind Phase|Removal by PI|3|||
44313539|NCT03485157|79316703|FG001|Double Blind Phase|Removal by PI|7|||
44313540|NCT03485157|79316702|FG000|Open Label Phase|Lost to Follow-up|1|||
44313541|NCT03485157|79316703|FG001|Open Label Phase|Lost to Follow-up|2|||
44313542|NCT03485157|79316702|FG000|Open Label Phase|Adverse Event|0|||
44313543|NCT03485157|79316703|FG001|Open Label Phase|Adverse Event|1|||
44313544|NCT03485157|79316702|FG000|Open Label Phase|Withdrawal by Subject|1|||
44313545|NCT03485157|79316703|FG001|Open Label Phase|Withdrawal by Subject|2|||
44313546|NCT03485157|79316702|FG000|Open Label Phase|Removal by PI|2|||
44313547|NCT03485157|79316703|FG001|Open Label Phase|Removal by PI|0|||
44313548|NCT03383692|79316712|FG000|Overall Study|Progressive disease as per RECIST|3|||
44313549|NCT03383692|79316713|FG001|Overall Study|Progressive disease as per RECIST|3|||
44313550|NCT03383692|79316712|FG000|Overall Study|Clinical progression|0|||
44313551|NCT03383692|79316713|FG001|Overall Study|Clinical progression|1|||
44313552|NCT03383692|79316712|FG000|Overall Study|Adverse Event|3|||
44313553|NCT03383692|79316713|FG001|Overall Study|Adverse Event|0|||
44313554|NCT03048019|79316732|FG000|Overall Study|Adverse Event|1|||
44313555|NCT03048019|79316733|FG001|Overall Study|Adverse Event|0|||
44313556|NCT02998645|79316739|FG000|Treatment Period 1|Adverse Event|6|||
44313557|NCT02998645|79316739|FG000|Treatment Period 1|Death|5|||
44313558|NCT02998645|79316739|FG000|Treatment Period 1|Technical Problems|4|||
44313559|NCT02998645|79316739|FG000|Treatment Period 1|Lack of Efficacy|2|||
44313560|NCT02998645|79316739|FG000|Treatment Period 1|Progressive disease|1|||
44313561|NCT02998645|79316739|FG000|Treatment Period 1|Subject/guardian decision|1|||
44313562|NCT02998645|79316739|FG000|Treatment Period 2|Lack of Efficacy|5|||
44313563|NCT02998645|79316739|FG000|Treatment Period 2|Adverse Event|2|||
44313564|NCT02998645|79316739|FG000|Treatment Period 2|Progressive disease|2|||
44313565|NCT02998645|79316739|FG000|Treatment Period 2|Physician Decision|1|||
44313566|NCT02094261|79316752|FG000|Overall Study|Death|24|||
44313567|NCT02094261|79316752|FG000|Overall Study|Lost to Follow-up|1|||
44313568|NCT02094261|79316752|FG000|Overall Study|Withdrawal by Subject|4|||
44313569|NCT02094261|79316752|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
44313570|NCT02074553|79316763|FG000|Intervention Period 1|Family Emergency|0|||
44313571|NCT02074553|79316764|FG001|Intervention Period 1|Family Emergency|0|||
44313572|NCT02074553|79316765|FG002|Intervention Period 1|Family Emergency|0|||
44313573|NCT02074553|79316766|FG003|Intervention Period 1|Family Emergency|1|||
44313574|NCT02074553|79316767|FG004|Intervention Period 1|Family Emergency|0|||
44313575|NCT02074553|79316768|FG005|Intervention Period 1|Family Emergency|0|||
44313576|NCT02074553|79316769|FG006|Intervention Period 1|Family Emergency|0|||
44313577|NCT02074553|79316770|FG007|Intervention Period 1|Family Emergency|0|||
44313578|NCT02074553|79316763|FG000|Washout Period 1|Adverse Event|1|||
44313579|NCT02074553|79316764|FG001|Washout Period 1|Adverse Event|0|||
44313580|NCT02074553|79316765|FG002|Washout Period 1|Adverse Event|0|||
44313581|NCT02074553|79316766|FG003|Washout Period 1|Adverse Event|0|||
44313582|NCT02074553|79316767|FG004|Washout Period 1|Adverse Event|0|||
44313583|NCT02074553|79316768|FG005|Washout Period 1|Adverse Event|0|||
44313584|NCT02074553|79316769|FG006|Washout Period 1|Adverse Event|0|||
44313585|NCT02074553|79316770|FG007|Washout Period 1|Adverse Event|0|||
44313586|NCT02074553|79316763|FG000|Washout Period 1|Physician Decision|0|||
44155536|NCT01998958|78946948|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313587|NCT02074553|79316764|FG001|Washout Period 1|Physician Decision|0|||
44313588|NCT02074553|79316765|FG002|Washout Period 1|Physician Decision|0|||
44313589|NCT02074553|79316766|FG003|Washout Period 1|Physician Decision|1|||
44313590|NCT02074553|79316767|FG004|Washout Period 1|Physician Decision|0|||
44313591|NCT02074553|79316768|FG005|Washout Period 1|Physician Decision|0|||
44155537|NCT01998958|78946949|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313592|NCT02074553|79316769|FG006|Washout Period 1|Physician Decision|0|||
44313593|NCT02074553|79316770|FG007|Washout Period 1|Physician Decision|0|||
44313594|NCT02074553|79316763|FG000|Washout Period 1|Other|0|||
44313595|NCT02074553|79316764|FG001|Washout Period 1|Other|0|||
44313596|NCT02074553|79316765|FG002|Washout Period 1|Other|0|||
44313597|NCT02074553|79316766|FG003|Washout Period 1|Other|0|||
44313598|NCT02074553|79316767|FG004|Washout Period 1|Other|0|||
44313599|NCT02074553|79316768|FG005|Washout Period 1|Other|1|||
44313600|NCT02074553|79316769|FG006|Washout Period 1|Other|0|||
44313601|NCT02074553|79316770|FG007|Washout Period 1|Other|0|||
44313602|NCT02074553|79316763|FG000|Washout Period 2|Adverse Event|0|||
44313603|NCT02074553|79316764|FG001|Washout Period 2|Adverse Event|0|||
44313604|NCT02074553|79316765|FG002|Washout Period 2|Adverse Event|0|||
44313605|NCT02074553|79316766|FG003|Washout Period 2|Adverse Event|0|||
44313606|NCT02074553|79316767|FG004|Washout Period 2|Adverse Event|0|||
44313607|NCT02074553|79316768|FG005|Washout Period 2|Adverse Event|0|||
44313608|NCT02074553|79316769|FG006|Washout Period 2|Adverse Event|1|||
44313609|NCT02074553|79316770|FG007|Washout Period 2|Adverse Event|0|||
44313610|NCT02074553|79316763|FG000|Washout Period 2|Physician Decision|0|||
44313611|NCT02074553|79316764|FG001|Washout Period 2|Physician Decision|0|||
44313612|NCT02074553|79316765|FG002|Washout Period 2|Physician Decision|0|||
44313613|NCT02074553|79316766|FG003|Washout Period 2|Physician Decision|0|||
44313614|NCT02074553|79316767|FG004|Washout Period 2|Physician Decision|0|||
44313615|NCT02074553|79316768|FG005|Washout Period 2|Physician Decision|1|||
44313616|NCT02074553|79316769|FG006|Washout Period 2|Physician Decision|0|||
44313617|NCT02074553|79316770|FG007|Washout Period 2|Physician Decision|0|||
44313618|NCT02074553|79316763|FG000|Washout Period 2|Lost to Follow-up|0|||
44313619|NCT02074553|79316764|FG001|Washout Period 2|Lost to Follow-up|0|||
44313620|NCT02074553|79316765|FG002|Washout Period 2|Lost to Follow-up|1|||
44313621|NCT02074553|79316766|FG003|Washout Period 2|Lost to Follow-up|0|||
44313622|NCT02074553|79316767|FG004|Washout Period 2|Lost to Follow-up|0|||
44313623|NCT02074553|79316768|FG005|Washout Period 2|Lost to Follow-up|0|||
44313624|NCT02074553|79316769|FG006|Washout Period 2|Lost to Follow-up|0|||
44313625|NCT02074553|79316770|FG007|Washout Period 2|Lost to Follow-up|0|||
44313626|NCT02074553|79316763|FG000|Washout Period 3|Physician Decision|0|||
44313627|NCT02074553|79316764|FG001|Washout Period 3|Physician Decision|0|||
44313628|NCT02074553|79316765|FG002|Washout Period 3|Physician Decision|0|||
44313629|NCT02074553|79316766|FG003|Washout Period 3|Physician Decision|0|||
44313630|NCT02074553|79316767|FG004|Washout Period 3|Physician Decision|0|||
44313631|NCT02074553|79316768|FG005|Washout Period 3|Physician Decision|0|||
44313632|NCT02074553|79316769|FG006|Washout Period 3|Physician Decision|0|||
44313633|NCT02074553|79316770|FG007|Washout Period 3|Physician Decision|1|||
44313634|NCT01664598|79316788|FG000|Overall Study|Sponsor Decision|1|||
44313635|NCT01664598|79316788|FG000|Overall Study|Withdrawal of Informed Consent|4|||
44313636|NCT01664598|79316788|FG000|Overall Study|Adverse Event|1|||
44313637|NCT01280682|79316798|FG000|Overall Study|Lost to Follow-up|0|||
44313638|NCT01280682|79316799|FG001|Overall Study|Lost to Follow-up|6|||
44313639|NCT01280682|79316798|FG000|Overall Study|Withdrawal by Subject|0|||
44313640|NCT01280682|79316799|FG001|Overall Study|Withdrawal by Subject|7|||
44313641|NCT01050218|79316816|FG000|Overall Study|Adverse Event|37|||
44313642|NCT01050218|79316816|FG000|Overall Study|Lack of Efficacy|8|||
44313643|NCT01050218|79316816|FG000|Overall Study|Protocol Violation|3|||
44313644|NCT01050218|79316816|FG000|Overall Study|Withdrawal by Subject|18|||
44313645|NCT01050218|79316816|FG000|Overall Study|Discontinued by sponsor|18|||
44313646|NCT01050218|79316816|FG000|Overall Study|Compliance|2|||
44313647|NCT01050218|79316816|FG000|Overall Study|Failed to return|7|||
44313648|NCT01050218|79316816|FG000|Overall Study|Serious Adverse Event|1|||
44313649|NCT01050218|79316816|FG000|Overall Study|Family emergency|1|||
44313650|NCT00679029|79316820|FG000|Overall Study|Adverse Event|3|||
44313651|NCT00679029|79316820|FG000|Overall Study|Withdrawal by Subject|1|||
44313652|NCT00679029|79316820|FG000|Overall Study|Lost to Follow-up|1|||
44313653|NCT00195429|79316826|FG000|Overall Study|Adverse Event|2|||
44313654|NCT00195429|79316827|FG001|Overall Study|Adverse Event|4|||
44313655|NCT00195429|79316826|FG000|Overall Study|Lack of Efficacy|2|||
44313656|NCT00195429|79316827|FG001|Overall Study|Lack of Efficacy|1|||
44313657|NCT00195429|79316826|FG000|Overall Study|Lost to Follow-up|1|||
44313658|NCT00195429|79316827|FG001|Overall Study|Lost to Follow-up|0|||
44313659|NCT01059773|79316835|FG000|Overall Study|Adverse Event|2|||
44313660|NCT01059773|79316836|FG001|Overall Study|Adverse Event|2|||
44313661|NCT01059773|79316835|FG000|Overall Study|Withdrawal by Subject|1|||
44313662|NCT01059773|79316836|FG001|Overall Study|Withdrawal by Subject|5|||
44313663|NCT01059773|79316835|FG000|Overall Study|Lost to Follow-up|1|||
44313664|NCT01059773|79316836|FG001|Overall Study|Lost to Follow-up|1|||
44313665|NCT01059773|79316835|FG000|Overall Study|Pregnancy|1|||
44313666|NCT01059773|79316836|FG001|Overall Study|Pregnancy|1|||
44313667|NCT01059773|79316835|FG000|Overall Study|Protocol Violation|6|||
44313668|NCT01059773|79316836|FG001|Overall Study|Protocol Violation|2|||
44313669|NCT01059773|79316835|FG000|Overall Study|Physician Decision|5|||
44313670|NCT01059773|79316836|FG001|Overall Study|Physician Decision|4|||
44313671|NCT01059773|79316835|FG000|Overall Study|Lack of Efficacy|3|||
44313672|NCT01059773|79316836|FG001|Overall Study|Lack of Efficacy|3|||
44313673|NCT01059773|79316835|FG000|Overall Study|Death|0|||
44313674|NCT01059773|79316836|FG001|Overall Study|Death|1|||
44313675|NCT01059773|79316835|FG000|Overall Study|Malignancy including squamous cell skin|0|||
44313676|NCT01059773|79316836|FG001|Overall Study|Malignancy including squamous cell skin|1|||
44313677|NCT01059773|79316835|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
44313678|NCT01059773|79316836|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
44313679|NCT01059773|79316835|FG000|Overall Study|Other|1|||
44313680|NCT01059773|79316836|FG001|Overall Study|Other|3|||
44313681|NCT01059318|79316847|FG000|Core Study (26 Week)|Adverse Event|3|||
44313682|NCT01059318|79316847|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
44313683|NCT01059318|79316847|FG000|Extension (36 Week)|Adverse Event|3|||
44313684|NCT01058655|79316858|FG000|Overall Study|Withdrawal by Subject|1|||
44313685|NCT01058655|79316859|FG001|Overall Study|Withdrawal by Subject|0|||
44313686|NCT01058655|79316860|FG002|Overall Study|Withdrawal by Subject|3|||
44313687|NCT01058655|79316861|FG003|Overall Study|Withdrawal by Subject|4|||
44313688|NCT01058655|79316858|FG000|Overall Study|Prolonged Treatment Delay|0|||
44313689|NCT01058655|79316859|FG001|Overall Study|Prolonged Treatment Delay|0|||
44313690|NCT01058655|79316860|FG002|Overall Study|Prolonged Treatment Delay|0|||
44313691|NCT01058655|79316861|FG003|Overall Study|Prolonged Treatment Delay|2|||
44313692|NCT01058655|79316858|FG000|Overall Study|Symptomatic Deterioration|0|||
44313693|NCT01058655|79316859|FG001|Overall Study|Symptomatic Deterioration|0|||
44313694|NCT01058655|79316860|FG002|Overall Study|Symptomatic Deterioration|0|||
44313695|NCT01058655|79316861|FG003|Overall Study|Symptomatic Deterioration|1|||
44313696|NCT01058655|79316858|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
44313697|NCT01058655|79316859|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
44313698|NCT01058655|79316860|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
44313699|NCT01058655|79316861|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
44313700|NCT01058655|79316858|FG000|Overall Study|Death|0|||
44313701|NCT01058655|79316859|FG001|Overall Study|Death|1|||
44313702|NCT01058655|79316860|FG002|Overall Study|Death|1|||
44313703|NCT01058655|79316861|FG003|Overall Study|Death|0|||
44313704|NCT01058655|79316858|FG000|Overall Study|Disease Progression|1|||
44313705|NCT01058655|79316859|FG001|Overall Study|Disease Progression|2|||
44313706|NCT01058655|79316860|FG002|Overall Study|Disease Progression|4|||
44313707|NCT01058655|79316861|FG003|Overall Study|Disease Progression|24|||
44313708|NCT01058655|79316858|FG000|Overall Study|Other|0|||
44313709|NCT01058655|79316859|FG001|Overall Study|Other|0|||
44313710|NCT01058655|79316860|FG002|Overall Study|Other|0|||
44313711|NCT01058655|79316861|FG003|Overall Study|Other|4|||
44313712|NCT01058421|79316874|FG000|1 Month Outcomes|Death|10|||
44313713|NCT01058421|79316875|FG001|1 Month Outcomes|Death|6|||
44313714|NCT01058421|79316874|FG000|1 Month Outcomes|Lost to Follow-up|8|||
44313715|NCT01058421|79316875|FG001|1 Month Outcomes|Lost to Follow-up|7|||
44313716|NCT01058421|79316874|FG000|1 Month Outcomes|Remained in Hospital|5|||
44313717|NCT01058421|79316875|FG001|1 Month Outcomes|Remained in Hospital|12|||
44313718|NCT01058421|79316874|FG000|1 Month Outcomes|Remained in Other Facility|16|||
44313719|NCT01058421|79316875|FG001|1 Month Outcomes|Remained in Other Facility|17|||
44313720|NCT01058421|79316874|FG000|3 Month Outcomes|Death|3|||
44313721|NCT01058421|79316875|FG001|3 Month Outcomes|Death|5|||
44313722|NCT01058421|79316874|FG000|3 Month Outcomes|Lost to Follow-up|12|||
44313723|NCT01058421|79316875|FG001|3 Month Outcomes|Lost to Follow-up|11|||
44313724|NCT01058421|79316874|FG000|3 Month Outcomes|Remained in Hospital|0|||
44313725|NCT01058421|79316875|FG001|3 Month Outcomes|Remained in Hospital|2|||
44313726|NCT01058421|79316874|FG000|3 Month Outcomes|Remained in Other Facility|5|||
44313727|NCT01058421|79316875|FG001|3 Month Outcomes|Remained in Other Facility|8|||
44313728|NCT01058421|79316874|FG000|6 Month Outcomes|Death|2|||
44313729|NCT01058421|79316875|FG001|6 Month Outcomes|Death|2|||
44313730|NCT01058421|79316874|FG000|6 Month Outcomes|Lost to Follow-up|16|||
44313731|NCT01058421|79316875|FG001|6 Month Outcomes|Lost to Follow-up|21|||
44313732|NCT01058421|79316874|FG000|6 Month Outcomes|Remained in Other Facility|1|||
44313733|NCT01058421|79316875|FG001|6 Month Outcomes|Remained in Other Facility|3|||
44313734|NCT01058304|79316883|FG000|Overall Study|Withdrawal by Subject|8|||
44313735|NCT01058304|79316884|FG001|Overall Study|Withdrawal by Subject|5|||
44313736|NCT01058304|79316883|FG000|Overall Study|Lost to Follow-up|13|||
44313737|NCT01058304|79316884|FG001|Overall Study|Lost to Follow-up|16|||
44313738|NCT01058304|79316883|FG000|Overall Study|Developed exclusion criterion|6|||
44313739|NCT01058304|79316884|FG001|Overall Study|Developed exclusion criterion|12|||
44313740|NCT01058265|79316892|FG000|Overall Study|Lost to Follow-up|11|||
44313741|NCT01058265|79316893|FG001|Overall Study|Lost to Follow-up|12|||
44313742|NCT01057251|79316901|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
44313743|NCT01057251|79316902|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
44313744|NCT01057251|79316901|FG000|Overall Study|Adverse Event|4|||
44313745|NCT01057251|79316902|FG001|Overall Study|Adverse Event|2|||
44313746|NCT01057251|79316901|FG000|Overall Study|Lack of Efficacy|2|||
44313747|NCT01057251|79316902|FG001|Overall Study|Lack of Efficacy|11|||
44313748|NCT01057251|79316901|FG000|Overall Study|Protocol Violation|6|||
44313749|NCT01057251|79316902|FG001|Overall Study|Protocol Violation|2|||
44313750|NCT01057251|79316901|FG000|Overall Study|Withdrawal by Subject|4|||
44313751|NCT01057251|79316902|FG001|Overall Study|Withdrawal by Subject|5|||
44313752|NCT01057251|79316901|FG000|Overall Study|Lost to Follow-up|7|||
44313753|NCT01057251|79316902|FG001|Overall Study|Lost to Follow-up|6|||
44313754|NCT01057251|79316901|FG000|Overall Study|Other Reason|1|||
44313755|NCT01057251|79316902|FG001|Overall Study|Other Reason|1|||
44313756|NCT01056822|79316910|FG000|Overall Study|Adverse Event|0|||
44313757|NCT01056822|79316911|FG001|Overall Study|Adverse Event|1|||
44313758|NCT01056822|79316910|FG000|Overall Study|Protocol Violation|6|||
44313759|NCT01056822|79316911|FG001|Overall Study|Protocol Violation|5|||
44313760|NCT01056822|79316910|FG000|Overall Study|Withdrawal by Subject|1|||
44313761|NCT01056822|79316911|FG001|Overall Study|Withdrawal by Subject|1|||
44313762|NCT01056822|79316910|FG000|Overall Study|Lost to Follow-up|1|||
44313763|NCT01056822|79316911|FG001|Overall Study|Lost to Follow-up|0|||
44313764|NCT01051791|79316918|FG000|Overall Study|Failed screening|3|||
44313765|NCT01051791|79316918|FG000|Overall Study|Withdrawal by Subject|1|||
44313766|NCT01056510|79316930|FG000|Overall Study|Dropout Before Start of Treatment|1|||
44313767|NCT01056510|79316931|FG001|Overall Study|Dropout Before Start of Treatment|1|||
44313768|NCT01056510|79316930|FG000|Overall Study|Withdrawal by Subject|4|||
44313769|NCT01056510|79316931|FG001|Overall Study|Withdrawal by Subject|2|||
44313770|NCT01056510|79316930|FG000|Overall Study|Death|29|||
44313771|NCT01056510|79316931|FG001|Overall Study|Death|34|||
44313772|NCT01056510|79316930|FG000|Overall Study|Noncompliance|1|||
44313773|NCT01056510|79316931|FG001|Overall Study|Noncompliance|3|||
44313774|NCT01056510|79316930|FG000|Overall Study|Physician Decision|4|||
44313775|NCT01056510|79316931|FG001|Overall Study|Physician Decision|5|||
44313776|NCT01056510|79316930|FG000|Overall Study|Lost to Follow-up|5|||
44313777|NCT01056510|79316931|FG001|Overall Study|Lost to Follow-up|6|||
44313778|NCT01056510|79316930|FG000|Overall Study|Other|10|||
44313779|NCT01056510|79316931|FG001|Overall Study|Other|12|||
44313780|NCT01056510|79316930|FG000|Overall Study|Missing|0|||
44313781|NCT01056510|79316931|FG001|Overall Study|Missing|1|||
44313782|NCT01051323|79316939|FG000|Overall Study|Discontinuation of treatment|103|||
44313783|NCT01051323|79316939|FG000|Overall Study|Transplantation|28|||
44313784|NCT01051323|79316939|FG000|Overall Study|Dialysis dependency|22|||
44313785|NCT01051323|79316939|FG000|Overall Study|Withdrawal by Subject|13|||
44313786|NCT01051323|79316939|FG000|Overall Study|Lost to Follow-up|31|||
44313787|NCT01051323|79316939|FG000|Overall Study|Death|129|||
44313788|NCT01051323|79316939|FG000|Overall Study|Hospitalization|28|||
44313789|NCT01051323|79316939|FG000|Overall Study|Other|148|||
44313790|NCT01051323|79316939|FG000|Overall Study|Missing|37|||
44313791|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
44313792|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
44313793|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
44313794|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
44313795|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
44313796|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
44313797|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
44313798|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
44313799|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
44313800|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
44313801|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Death|3|||
44313802|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Death|1|||
44313803|NCT01056276|79316949|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
44313804|NCT01056276|79316950|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
44313805|NCT01056276|79316949|FG000|Maintenance Therapy|Toxicity|0|||
44313806|NCT01056276|79316950|FG001|Maintenance Therapy|Toxicity|2|||
44313807|NCT01056276|79316949|FG000|Maintenance Therapy|Progressive Disease|0|||
44313808|NCT01056276|79316950|FG001|Maintenance Therapy|Progressive Disease|9|||
44313809|NCT01056276|79316949|FG000|Maintenance Therapy|Physician Decision|0|||
44313810|NCT01056276|79316950|FG001|Maintenance Therapy|Physician Decision|1|||
44313811|NCT01056276|79316949|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
44313812|NCT01056276|79316950|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
44313813|NCT01056276|79316949|FG000|Maintenance Therapy|Intercurrent Illness|0|||
44313814|NCT01056276|79316950|FG001|Maintenance Therapy|Intercurrent Illness|1|||
44313815|NCT01056276|79316949|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
44313816|NCT01056276|79316950|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
44313817|NCT01055886|79316963|FG000|Overall Study|Withdrawal by Subject|4|||
44313818|NCT01055886|79316964|FG001|Overall Study|Withdrawal by Subject|9|||
44313819|NCT01055886|79316963|FG000|Overall Study|Lost to Follow-up|1|||
44313820|NCT01055886|79316964|FG001|Overall Study|Lost to Follow-up|1|||
44313821|NCT01055886|79316963|FG000|Overall Study|Withdrawal by PI|0|||
44313822|NCT01055886|79316964|FG001|Overall Study|Withdrawal by PI|1|||
44313823|NCT01055613|79316972|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
44313824|NCT01055613|79316973|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44313825|NCT01055613|79316972|FG000|Overall Study|Unacceptable lens fit|1|||
44313826|NCT01055613|79316973|FG001|Overall Study|Unacceptable lens fit|0|||
44313827|NCT01055613|79316972|FG000|Overall Study|Discomfort|2|||
44313828|NCT01055613|79316973|FG001|Overall Study|Discomfort|1|||
44313829|NCT01055613|79316972|FG000|Overall Study|Lost to Follow-up|1|||
44313830|NCT01055613|79316973|FG001|Overall Study|Lost to Follow-up|1|||
44313831|NCT01055613|79316972|FG000|Overall Study|Protocol Violation|1|||
44313832|NCT01055613|79316973|FG001|Overall Study|Protocol Violation|1|||
44313833|NCT01055613|79316972|FG000|Overall Study|Subject Disinterest|1|||
44313834|NCT01055613|79316973|FG001|Overall Study|Subject Disinterest|1|||
44313835|NCT01055457|79316989|FG000|Overall Study|Lost to Follow-up|0|||
44313836|NCT01055457|79316990|FG001|Overall Study|Lost to Follow-up|1|||
44313837|NCT01055457|79316991|FG002|Overall Study|Lost to Follow-up|0|||
44313838|NCT01055457|79316992|FG003|Overall Study|Lost to Follow-up|0|||
44313839|NCT01055457|79316993|FG004|Overall Study|Lost to Follow-up|0|||
44313840|NCT01055457|79316994|FG005|Overall Study|Lost to Follow-up|1|||
44313841|NCT01055457|79316995|FG006|Overall Study|Lost to Follow-up|0|||
44313842|NCT01055457|79316996|FG007|Overall Study|Lost to Follow-up|0|||
44155538|NCT01998958|78946950|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155539|NCT01998958|78946951|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155540|NCT01998958|78946952|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155541|NCT01998958|78946953|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155542|NCT01998958|78946954|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155543|NCT01998958|78946955|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155544|NCT01998958|78946956|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313843|NCT01055457|79316997|FG008|Overall Study|Lost to Follow-up|0|||
44313844|NCT01055457|79316998|FG009|Overall Study|Lost to Follow-up|0|||
44313845|NCT01055457|79316989|FG000|Overall Study|Protocol Violation|0|||
44313846|NCT01055457|79316990|FG001|Overall Study|Protocol Violation|0|||
44313847|NCT01055457|79316991|FG002|Overall Study|Protocol Violation|1|||
44313848|NCT01055457|79316992|FG003|Overall Study|Protocol Violation|1|||
44313849|NCT01055457|79316993|FG004|Overall Study|Protocol Violation|1|||
44313850|NCT01055457|79316994|FG005|Overall Study|Protocol Violation|2|||
44313851|NCT01055457|79316995|FG006|Overall Study|Protocol Violation|1|||
44313852|NCT01055457|79316996|FG007|Overall Study|Protocol Violation|0|||
44313853|NCT01055457|79316997|FG008|Overall Study|Protocol Violation|0|||
44313854|NCT01055457|79316998|FG009|Overall Study|Protocol Violation|1|||
44313855|NCT01055457|79316989|FG000|Overall Study|Subject Disinterest|0|||
44313856|NCT01055457|79316990|FG001|Overall Study|Subject Disinterest|0|||
44313857|NCT01055457|79316991|FG002|Overall Study|Subject Disinterest|0|||
44313858|NCT01055457|79316992|FG003|Overall Study|Subject Disinterest|0|||
44313859|NCT01055457|79316993|FG004|Overall Study|Subject Disinterest|0|||
44313860|NCT01055457|79316994|FG005|Overall Study|Subject Disinterest|0|||
44313861|NCT01055457|79316995|FG006|Overall Study|Subject Disinterest|0|||
44313862|NCT01055457|79316996|FG007|Overall Study|Subject Disinterest|1|||
44313863|NCT01055457|79316997|FG008|Overall Study|Subject Disinterest|0|||
44313864|NCT01055457|79316998|FG009|Overall Study|Subject Disinterest|0|||
44313865|NCT01055457|79316989|FG000|Overall Study|Subject Ineligible|1|||
44313866|NCT01055457|79316990|FG001|Overall Study|Subject Ineligible|0|||
44313867|NCT01055457|79316991|FG002|Overall Study|Subject Ineligible|1|||
44313868|NCT01055457|79316992|FG003|Overall Study|Subject Ineligible|0|||
44313869|NCT01055457|79316993|FG004|Overall Study|Subject Ineligible|1|||
44313870|NCT01055457|79316994|FG005|Overall Study|Subject Ineligible|0|||
44313871|NCT01055457|79316995|FG006|Overall Study|Subject Ineligible|0|||
44313872|NCT01055457|79316996|FG007|Overall Study|Subject Ineligible|0|||
44313873|NCT01055457|79316997|FG008|Overall Study|Subject Ineligible|0|||
44313874|NCT01055457|79316998|FG009|Overall Study|Subject Ineligible|0|||
44313875|NCT01055457|79316989|FG000|Overall Study|Discomfort|0|||
44313876|NCT01055457|79316990|FG001|Overall Study|Discomfort|0|||
44313877|NCT01055457|79316991|FG002|Overall Study|Discomfort|0|||
44313878|NCT01055457|79316992|FG003|Overall Study|Discomfort|0|||
44313879|NCT01055457|79316993|FG004|Overall Study|Discomfort|1|||
44313880|NCT01055457|79316994|FG005|Overall Study|Discomfort|0|||
44313881|NCT01055457|79316995|FG006|Overall Study|Discomfort|0|||
44313882|NCT01055457|79316996|FG007|Overall Study|Discomfort|0|||
44313883|NCT01055457|79316997|FG008|Overall Study|Discomfort|0|||
44313884|NCT01055457|79316998|FG009|Overall Study|Discomfort|0|||
44313885|NCT01055457|79316989|FG000|Overall Study|Pregnancy|0|||
44313886|NCT01055457|79316990|FG001|Overall Study|Pregnancy|0|||
44313887|NCT01055457|79316991|FG002|Overall Study|Pregnancy|0|||
44155545|NCT01998958|78946957|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155546|NCT01998958|78946958|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313888|NCT01055457|79316992|FG003|Overall Study|Pregnancy|1|||
44313889|NCT01055457|79316993|FG004|Overall Study|Pregnancy|0|||
44313890|NCT01055457|79316994|FG005|Overall Study|Pregnancy|0|||
44313891|NCT01055457|79316995|FG006|Overall Study|Pregnancy|0|||
44313892|NCT01055457|79316996|FG007|Overall Study|Pregnancy|0|||
44155547|NCT01998958|78946959|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155548|NCT01998958|78946960|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313893|NCT01055457|79316997|FG008|Overall Study|Pregnancy|0|||
44313894|NCT01055457|79316998|FG009|Overall Study|Pregnancy|0|||
44313895|NCT01055457|79316989|FG000|Overall Study|Adverse Event|0|||
44313896|NCT01055457|79316990|FG001|Overall Study|Adverse Event|0|||
44313897|NCT01055457|79316991|FG002|Overall Study|Adverse Event|0|||
44313898|NCT01055457|79316992|FG003|Overall Study|Adverse Event|1|||
44313899|NCT01055457|79316993|FG004|Overall Study|Adverse Event|0|||
44313900|NCT01055457|79316994|FG005|Overall Study|Adverse Event|0|||
44313901|NCT01055457|79316995|FG006|Overall Study|Adverse Event|0|||
44313902|NCT01055457|79316996|FG007|Overall Study|Adverse Event|0|||
44313903|NCT01055457|79316997|FG008|Overall Study|Adverse Event|0|||
44313904|NCT01055457|79316998|FG009|Overall Study|Adverse Event|0|||
44313905|NCT01055028|79317022|FG000|Screening|Screen Failure|1|||
44313906|NCT01055028|79317023|FG001|Screening|Screen Failure|1|||
44313907|NCT01055028|79317022|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
44313908|NCT01055028|79317023|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
44313909|NCT01055028|79317022|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
44313910|NCT01055028|79317023|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
44313911|NCT01055028|79317022|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
44313912|NCT01055028|79317023|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
44313913|NCT01050816|79317055|FG000|Overall Study|Lost to Follow-up|2|||
44313914|NCT01050816|79317055|FG000|Overall Study|patient's refusal|2|||
44313915|NCT01054560|79317061|FG000|Overall Study|Death|10|||
44313916|NCT01054560|79317062|FG001|Overall Study|Death|21|||
44313917|NCT01054560|79317061|FG000|Overall Study|Lost to Follow-up|2|||
44313918|NCT01054560|79317062|FG001|Overall Study|Lost to Follow-up|5|||
44313919|NCT01054560|79317061|FG000|Overall Study|Withdrawal by Subject|0|||
44313920|NCT01054560|79317062|FG001|Overall Study|Withdrawal by Subject|2|||
44313921|NCT01054560|79317061|FG000|Overall Study|Physician Decision|1|||
44313922|NCT01054560|79317062|FG001|Overall Study|Physician Decision|0|||
44313923|NCT01054443|79317074|FG000|Overall Study|Withdrawal by Subject|0|||
44313924|NCT01054443|79317075|FG001|Overall Study|Withdrawal by Subject|0|||
44313925|NCT01054443|79317076|FG002|Overall Study|Withdrawal by Subject|0|||
44313926|NCT01054443|79317077|FG003|Overall Study|Withdrawal by Subject|1|||
44313927|NCT01050543|79317092|FG000|Overall Study|Withdrawal by Subject|0|||
44313928|NCT01050543|79317093|FG001|Overall Study|Withdrawal by Subject|2|||
44313929|NCT01050543|79317092|FG000|Overall Study|Protocol Violation|0|||
44313930|NCT01050543|79317093|FG001|Overall Study|Protocol Violation|1|||
44313931|NCT01050543|79317092|FG000|Overall Study|Administrative|4|||
44313932|NCT01050543|79317093|FG001|Overall Study|Administrative|1|||
44313933|NCT01051557|79317106|FG000|Overall Study|Physician Decision|1|||
44313934|NCT01051557|79317107|FG001|Overall Study|Physician Decision|0|||
44313935|NCT01051557|79317108|FG002|Overall Study|Physician Decision|0|||
44313936|NCT01051557|79317109|FG003|Overall Study|Physician Decision|0|||
44313937|NCT01051557|79317110|FG004|Overall Study|Physician Decision|0|||
44313938|NCT01051557|79317111|FG005|Overall Study|Physician Decision|0|||
44313939|NCT01051557|79317112|FG006|Overall Study|Physician Decision|0|||
44313940|NCT01051557|79317106|FG000|Overall Study|disease progression|3|||
44313941|NCT01051557|79317107|FG001|Overall Study|disease progression|3|||
44313942|NCT01051557|79317108|FG002|Overall Study|disease progression|5|||
44313943|NCT01051557|79317109|FG003|Overall Study|disease progression|2|||
44313944|NCT01051557|79317110|FG004|Overall Study|disease progression|4|||
44313945|NCT01051557|79317111|FG005|Overall Study|disease progression|3|||
44313946|NCT01051557|79317112|FG006|Overall Study|disease progression|1|||
44313947|NCT01051557|79317106|FG000|Overall Study|Withdrawal by Subject|0|||
44313948|NCT01051557|79317107|FG001|Overall Study|Withdrawal by Subject|0|||
44313949|NCT01051557|79317108|FG002|Overall Study|Withdrawal by Subject|1|||
44313950|NCT01051557|79317109|FG003|Overall Study|Withdrawal by Subject|0|||
44313951|NCT01051557|79317110|FG004|Overall Study|Withdrawal by Subject|2|||
44313952|NCT01051557|79317111|FG005|Overall Study|Withdrawal by Subject|0|||
44313953|NCT01051557|79317112|FG006|Overall Study|Withdrawal by Subject|1|||
44313954|NCT01051557|79317106|FG000|Overall Study|Adverse Event|0|||
44313955|NCT01051557|79317107|FG001|Overall Study|Adverse Event|0|||
44313956|NCT01051557|79317108|FG002|Overall Study|Adverse Event|0|||
44313957|NCT01051557|79317109|FG003|Overall Study|Adverse Event|1|||
44313958|NCT01051557|79317110|FG004|Overall Study|Adverse Event|1|||
44313959|NCT01051557|79317111|FG005|Overall Study|Adverse Event|3|||
44313960|NCT01051557|79317112|FG006|Overall Study|Adverse Event|4|||
44155549|NCT01998958|78946961|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155550|NCT01998958|78946962|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155551|NCT01998958|78946963|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313961|NCT01054170|79317131|FG000|Overall Study|Protocol Violation|1|||
44313962|NCT01054170|79317132|FG001|Overall Study|Protocol Violation|0|||
44313963|NCT01054170|79317131|FG000|Overall Study|Withdrawal by Subject|3|||
44313964|NCT01054170|79317132|FG001|Overall Study|Withdrawal by Subject|2|||
44313965|NCT01054170|79317131|FG000|Overall Study|Adverse Event|0|||
44313966|NCT01054170|79317132|FG001|Overall Study|Adverse Event|4|||
44313967|NCT01053741|79317140|FG000|2nd Study Intervention|Physician Decision|0|||
44313968|NCT01053741|79317141|FG001|2nd Study Intervention|Physician Decision|1|||
44313969|NCT01052493|79317147|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
44313970|NCT01052493|79317148|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
44155552|NCT01998958|78946964|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
44313971|NCT01052493|79317149|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
44313972|NCT01052103|79317164|FG000|Overall Study|Adverse Event|10|||
44313973|NCT01052103|79317165|FG001|Overall Study|Adverse Event|6|||
44313974|NCT01052103|79317164|FG000|Overall Study|Entry Criteria Not Met|3|||
44313975|NCT01052103|79317165|FG001|Overall Study|Entry Criteria Not Met|1|||
44313976|NCT01052103|79317164|FG000|Overall Study|Lost to Follow-up|3|||
44313977|NCT01052103|79317165|FG001|Overall Study|Lost to Follow-up|5|||
44313978|NCT01052103|79317164|FG000|Overall Study|Protocol Violation|10|||
44313979|NCT01052103|79317165|FG001|Overall Study|Protocol Violation|4|||
44313980|NCT01052103|79317164|FG000|Overall Study|Scheduling conflict|2|||
44313981|NCT01052103|79317165|FG001|Overall Study|Scheduling conflict|1|||
44313982|NCT01052103|79317164|FG000|Overall Study|Sponsor Decision|2|||
44313983|NCT01052103|79317165|FG001|Overall Study|Sponsor Decision|0|||
44313984|NCT01052103|79317164|FG000|Overall Study|Withdrawal by Subject|3|||
44313985|NCT01052103|79317165|FG001|Overall Study|Withdrawal by Subject|6|||
44313986|NCT01052103|79317164|FG000|Overall Study|Perceived Lack of Efficacy|1|||
44313987|NCT01052103|79317165|FG001|Overall Study|Perceived Lack of Efficacy|0|||
44313988|NCT01051986|79317174|FG000|Overall Study|Death|1|||
44313989|NCT01051986|79317175|FG001|Overall Study|Death|0|||
44313990|NCT01051986|79317174|FG000|Overall Study|Withdrawal by Subject|2|||
44313991|NCT01051986|79317175|FG001|Overall Study|Withdrawal by Subject|1|||
44313992|NCT01051986|79317174|FG000|Overall Study|Protocol Violation|2|||
44313993|NCT01051986|79317175|FG001|Overall Study|Protocol Violation|3|||
44313994|NCT03279978|79317191|FG000|Overall Study|Withdrawal by Subject|0|||
44313995|NCT03279978|79317192|FG001|Overall Study|Withdrawal by Subject|1|||
44313996|NCT03279978|79317193|FG002|Overall Study|Withdrawal by Subject|0|||
44313997|NCT03279978|79317194|FG003|Overall Study|Withdrawal by Subject|0|||
44313998|NCT03279978|79317195|FG004|Overall Study|Withdrawal by Subject|0|||
44313999|NCT03279978|79317196|FG005|Overall Study|Withdrawal by Subject|0|||
44314000|NCT03279978|79317197|FG006|Overall Study|Withdrawal by Subject|0|||
44314001|NCT03279978|79317198|FG007|Overall Study|Withdrawal by Subject|0|||
44314002|NCT03279978|79317199|FG008|Overall Study|Withdrawal by Subject|0|||
44314003|NCT03279978|79317200|FG009|Overall Study|Withdrawal by Subject|1|||
44314004|NCT03279978|79317191|FG000|Overall Study|Lost to Follow-up|1|||
44314005|NCT03279978|79317192|FG001|Overall Study|Lost to Follow-up|0|||
44314006|NCT03279978|79317193|FG002|Overall Study|Lost to Follow-up|1|||
44314007|NCT03279978|79317194|FG003|Overall Study|Lost to Follow-up|0|||
44314008|NCT03279978|79317195|FG004|Overall Study|Lost to Follow-up|0|||
44314009|NCT03279978|79317196|FG005|Overall Study|Lost to Follow-up|0|||
44314010|NCT03279978|79317197|FG006|Overall Study|Lost to Follow-up|0|||
44314011|NCT03279978|79317198|FG007|Overall Study|Lost to Follow-up|0|||
44314012|NCT03279978|79317199|FG008|Overall Study|Lost to Follow-up|0|||
44314013|NCT03279978|79317200|FG009|Overall Study|Lost to Follow-up|0|||
44314014|NCT03279978|79317191|FG000|Overall Study|Other than stated above|0|||
44314015|NCT03279978|79317192|FG001|Overall Study|Other than stated above|0|||
44314016|NCT03279978|79317193|FG002|Overall Study|Other than stated above|0|||
44314017|NCT03279978|79317194|FG003|Overall Study|Other than stated above|0|||
44314018|NCT03279978|79317195|FG004|Overall Study|Other than stated above|0|||
44314019|NCT03279978|79317196|FG005|Overall Study|Other than stated above|0|||
44314020|NCT03279978|79317197|FG006|Overall Study|Other than stated above|1|||
44314021|NCT03279978|79317198|FG007|Overall Study|Other than stated above|0|||
44314022|NCT03279978|79317199|FG008|Overall Study|Other than stated above|0|||
44314023|NCT03279978|79317200|FG009|Overall Study|Other than stated above|0|||
44314024|NCT00105534|79317233|FG000|Overall Study|Adverse Event|2|||
44314025|NCT00105534|79317234|FG001|Overall Study|Adverse Event|5|||
44314026|NCT00105534|79317233|FG000|Overall Study|Protocol Violation|1|||
44314027|NCT00105534|79317234|FG001|Overall Study|Protocol Violation|4|||
44314028|NCT00105534|79317233|FG000|Overall Study|Withdrawal by Subject|6|||
44314029|NCT00105534|79317234|FG001|Overall Study|Withdrawal by Subject|6|||
44314030|NCT00105534|79317233|FG000|Overall Study|Lost to Follow-up|5|||
44314031|NCT00105534|79317234|FG001|Overall Study|Lost to Follow-up|1|||
44314032|NCT00105534|79317233|FG000|Overall Study|Lack of Efficacy|7|||
44314033|NCT00105534|79317234|FG001|Overall Study|Lack of Efficacy|15|||
44314034|NCT00105534|79317233|FG000|Overall Study|Treatment unmasked|1|||
44314035|NCT00105534|79317234|FG001|Overall Study|Treatment unmasked|0|||
44314036|NCT00105534|79317233|FG000|Overall Study|Other Reason|0|||
44314037|NCT00105534|79317234|FG001|Overall Study|Other Reason|2|||
44155553|NCT01998958|78946965|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155554|NCT01998958|78946966|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
44314038|NCT00105183|79317243|FG000|Overall Study|Death|19|||
44314039|NCT00105183|79317244|FG001|Overall Study|Death|13|||
44314040|NCT00105183|79317245|FG002|Overall Study|Death|15|||
44314041|NCT00105183|79317243|FG000|Overall Study|Withdrawal by Subject|1|||
44314042|NCT00105183|79317244|FG001|Overall Study|Withdrawal by Subject|1|||
44314043|NCT00105183|79317245|FG002|Overall Study|Withdrawal by Subject|4|||
44314044|NCT00105183|79317243|FG000|Overall Study|Physician Decision|1|||
44314045|NCT00105183|79317244|FG001|Overall Study|Physician Decision|2|||
44314046|NCT00105183|79317245|FG002|Overall Study|Physician Decision|3|||
44314047|NCT00105183|79317243|FG000|Overall Study|Lost to Follow-up|0|||
44314048|NCT00105183|79317244|FG001|Overall Study|Lost to Follow-up|1|||
44314049|NCT00105183|79317245|FG002|Overall Study|Lost to Follow-up|1|||
44314050|NCT00105183|79317243|FG000|Overall Study|Other reason|1|||
44314051|NCT00105183|79317244|FG001|Overall Study|Other reason|2|||
44314052|NCT00105183|79317245|FG002|Overall Study|Other reason|0|||
44314053|NCT01059617|79317257|FG000|Overall Study|Other|7|||
44314054|NCT01059617|79317258|FG001|Overall Study|Other|1|||
44314055|NCT01059617|79317259|FG002|Overall Study|Other|8|||
44314056|NCT01059617|79317260|FG003|Overall Study|Other|6|||
44314057|NCT01059344|79317280|FG000|Overall Study|Adverse Event|12|||
44314058|NCT01059344|79317281|FG001|Overall Study|Adverse Event|30|||
44314059|NCT01059344|79317280|FG000|Overall Study|Withdrawal by Subject|6|||
44314060|NCT01059344|79317281|FG001|Overall Study|Withdrawal by Subject|9|||
44314061|NCT01059344|79317280|FG000|Overall Study|Lost to Follow-up|1|||
44314062|NCT01059344|79317281|FG001|Overall Study|Lost to Follow-up|1|||
44314063|NCT01059344|79317280|FG000|Overall Study|Other|3|||
44314064|NCT01059344|79317281|FG001|Overall Study|Other|6|||
44314065|NCT01058369|79317289|FG000|Overall Study|Adverse Event|1|||
44314066|NCT01058369|79317289|FG000|Overall Study|Early termination study|1|||
44314067|NCT01057433|79317293|FG000|Overall Study|Adverse Event|1|||
44314068|NCT01057394|79317297|FG000|Overall Study|Not eligible|0|||
44314069|NCT01057394|79317298|FG001|Overall Study|Not eligible|2|||
44314070|NCT01058642|79317306|FG000|Treatment Period 1|Adverse Event|0|||
44420686|NCT00783692|79428558|FG004|Induction Phase|Withdrawal by Subject|0|||
44420687|NCT00783692|79428559|FG005|Induction Phase|Withdrawal by Subject|0|||
44420688|NCT00783692|79428560|FG006|Induction Phase|Withdrawal by Subject|0|||
44420689|NCT00783692|79428554|FG000|Induction Phase|Lost to Follow-up|0|||
44420690|NCT00783692|79428555|FG001|Induction Phase|Lost to Follow-up|0|||
44420691|NCT00783692|79428556|FG002|Induction Phase|Lost to Follow-up|3|||
44420692|NCT00783692|79428557|FG003|Induction Phase|Lost to Follow-up|0|||
44420693|NCT00783692|79428558|FG004|Induction Phase|Lost to Follow-up|0|||
44420694|NCT00783692|79428559|FG005|Induction Phase|Lost to Follow-up|0|||
44420695|NCT00783692|79428560|FG006|Induction Phase|Lost to Follow-up|0|||
44420696|NCT00783692|79428554|FG000|Induction Phase|Other|0|||
44420697|NCT00783692|79428555|FG001|Induction Phase|Other|0|||
44420698|NCT00783692|79428556|FG002|Induction Phase|Other|2|||
44420699|NCT00783692|79428557|FG003|Induction Phase|Other|0|||
44420700|NCT00783692|79428558|FG004|Induction Phase|Other|0|||
44420701|NCT00783692|79428559|FG005|Induction Phase|Other|0|||
44420702|NCT00783692|79428560|FG006|Induction Phase|Other|0|||
44420703|NCT00783692|79428554|FG000|Maintenance Phase|Adverse Event|7|||
44420704|NCT00783692|79428555|FG001|Maintenance Phase|Adverse Event|0|||
44420705|NCT00783692|79428556|FG002|Maintenance Phase|Adverse Event|0|||
44420706|NCT00783692|79428557|FG003|Maintenance Phase|Adverse Event|15|||
44420707|NCT00783692|79428558|FG004|Maintenance Phase|Adverse Event|12|||
44420708|NCT00783692|79428559|FG005|Maintenance Phase|Adverse Event|9|||
44420709|NCT00783692|79428560|FG006|Maintenance Phase|Adverse Event|38|||
44420710|NCT00783692|79428554|FG000|Maintenance Phase|Protocol Violation|0|||
44420711|NCT00783692|79428555|FG001|Maintenance Phase|Protocol Violation|0|||
44420712|NCT00783692|79428556|FG002|Maintenance Phase|Protocol Violation|0|||
44420713|NCT00783692|79428557|FG003|Maintenance Phase|Protocol Violation|1|||
44420714|NCT00783692|79428558|FG004|Maintenance Phase|Protocol Violation|2|||
44420715|NCT00783692|79428559|FG005|Maintenance Phase|Protocol Violation|3|||
44420716|NCT00783692|79428560|FG006|Maintenance Phase|Protocol Violation|4|||
44420717|NCT00783692|79428554|FG000|Maintenance Phase|Lack of Efficacy|79|||
44420718|NCT00783692|79428555|FG001|Maintenance Phase|Lack of Efficacy|0|||
44420719|NCT00783692|79428556|FG002|Maintenance Phase|Lack of Efficacy|0|||
44420720|NCT00783692|79428557|FG003|Maintenance Phase|Lack of Efficacy|64|||
44420721|NCT00783692|79428558|FG004|Maintenance Phase|Lack of Efficacy|58|||
44420722|NCT00783692|79428559|FG005|Maintenance Phase|Lack of Efficacy|48|||
44420723|NCT00783692|79428560|FG006|Maintenance Phase|Lack of Efficacy|177|||
44420724|NCT00783692|79428554|FG000|Maintenance Phase|Withdrawal by Subject|7|||
44420725|NCT00783692|79428555|FG001|Maintenance Phase|Withdrawal by Subject|0|||
44420726|NCT00783692|79428556|FG002|Maintenance Phase|Withdrawal by Subject|0|||
44420727|NCT00783692|79428557|FG003|Maintenance Phase|Withdrawal by Subject|7|||
44420728|NCT00783692|79428558|FG004|Maintenance Phase|Withdrawal by Subject|6|||
44420729|NCT00783692|79428559|FG005|Maintenance Phase|Withdrawal by Subject|9|||
44420730|NCT00783692|79428560|FG006|Maintenance Phase|Withdrawal by Subject|24|||
44420731|NCT00783692|79428554|FG000|Maintenance Phase|Lost to Follow-up|2|||
44420732|NCT00783692|79428555|FG001|Maintenance Phase|Lost to Follow-up|0|||
44420733|NCT00783692|79428556|FG002|Maintenance Phase|Lost to Follow-up|0|||
44420734|NCT00783692|79428557|FG003|Maintenance Phase|Lost to Follow-up|1|||
44420735|NCT00783692|79428558|FG004|Maintenance Phase|Lost to Follow-up|3|||
44420736|NCT00783692|79428559|FG005|Maintenance Phase|Lost to Follow-up|2|||
44420737|NCT00783692|79428560|FG006|Maintenance Phase|Lost to Follow-up|5|||
44420738|NCT00783692|79428554|FG000|Maintenance Phase|Other|0|||
44314071|NCT01058642|79317307|FG001|Treatment Period 1|Adverse Event|1|||
44314072|NCT01058642|79317308|FG002|Treatment Period 1|Adverse Event|1|||
44420739|NCT00783692|79428555|FG001|Maintenance Phase|Other|0|||
44420740|NCT00783692|79428556|FG002|Maintenance Phase|Other|0|||
44420741|NCT00783692|79428557|FG003|Maintenance Phase|Other|1|||
44420742|NCT00783692|79428558|FG004|Maintenance Phase|Other|0|||
44420743|NCT00783692|79428559|FG005|Maintenance Phase|Other|1|||
44420744|NCT00783692|79428560|FG006|Maintenance Phase|Other|1|||
44420745|NCT04992273|79428575|FG000|Overall Study|Lost to Follow-up|0|||
44420746|NCT04992273|79428576|FG001|Overall Study|Lost to Follow-up|1|||
44314073|NCT01058642|79317309|FG003|Treatment Period 1|Adverse Event|0|||
44314074|NCT01058642|79317306|FG000|Treatment Period 1|Physician Decision|0|||
44314075|NCT01058642|79317307|FG001|Treatment Period 1|Physician Decision|0|||
44314076|NCT01058642|79317308|FG002|Treatment Period 1|Physician Decision|1|||
44314077|NCT01058642|79317309|FG003|Treatment Period 1|Physician Decision|0|||
44314078|NCT01058642|79317306|FG000|Treatment Period 1|Withdrawal by Subject|1|||
44314079|NCT01058642|79317307|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44314080|NCT01058642|79317308|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44314081|NCT01058642|79317309|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44314082|NCT01058642|79317306|FG000|Treatment Period 1|Lack of Efficacy|0|||
44314083|NCT01058642|79317307|FG001|Treatment Period 1|Lack of Efficacy|0|||
44314084|NCT01058642|79317308|FG002|Treatment Period 1|Lack of Efficacy|0|||
44314085|NCT01058642|79317309|FG003|Treatment Period 1|Lack of Efficacy|1|||
44314086|NCT01058642|79317306|FG000|Treatment Period 1|Protocol Violation|0|||
44314087|NCT01058642|79317307|FG001|Treatment Period 1|Protocol Violation|0|||
44314088|NCT01058642|79317308|FG002|Treatment Period 1|Protocol Violation|0|||
44314089|NCT01058642|79317309|FG003|Treatment Period 1|Protocol Violation|1|||
44314090|NCT01058642|79317306|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
44314091|NCT01058642|79317307|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
44314092|NCT01058642|79317308|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
44314093|NCT01058642|79317309|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
44314094|NCT01056653|79317320|FG000|Overall Study|Lost to Follow-up|0|||
44314095|NCT01056653|79317321|FG001|Overall Study|Lost to Follow-up|0|||
44314096|NCT01056653|79317322|FG002|Overall Study|Lost to Follow-up|2|||
44314097|NCT01056536|79317334|FG000|Overall Study|Lost to Follow-up|202|||
44314098|NCT01056536|79317335|FG001|Overall Study|Lost to Follow-up|116|||
44314099|NCT01056536|79317336|FG002|Overall Study|Lost to Follow-up|248|||
44314100|NCT01056380|79317346|FG000|Overall Study|Lost to Follow-up|2|||
44314101|NCT01056380|79317347|FG001|Overall Study|Lost to Follow-up|3|||
44314102|NCT01055834|79317357|FG000|Treatment Period I|Adverse Event|1|||
44314103|NCT01055834|79317358|FG001|Treatment Period I|Adverse Event|0|||
44314104|NCT01055639|79317369|FG000|Overall Study|Adverse Event|0|||
44314105|NCT01055639|79317370|FG001|Overall Study|Adverse Event|1|||
44314106|NCT01055639|79317369|FG000|Overall Study|Lack of Efficacy|0|||
44314107|NCT01055639|79317370|FG001|Overall Study|Lack of Efficacy|1|||
44314108|NCT01055639|79317369|FG000|Overall Study|Lost to Follow-up|8|||
44314109|NCT01055639|79317370|FG001|Overall Study|Lost to Follow-up|11|||
44314110|NCT01055639|79317369|FG000|Overall Study|Protocol Violation|5|||
44314111|NCT01055639|79317370|FG001|Overall Study|Protocol Violation|5|||
44314112|NCT01055639|79317369|FG000|Overall Study|Withdrawal by Subject|8|||
44314113|NCT01055639|79317370|FG001|Overall Study|Withdrawal by Subject|11|||
44314114|NCT01055132|79317385|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
44314115|NCT01055132|79317386|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
44314116|NCT01055132|79317385|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
44314117|NCT01055132|79317386|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
44314118|NCT01054976|79317396|FG000|Overall Study|Adverse Event|16|||
44314119|NCT01054976|79317396|FG000|Overall Study|Uncooperative participations to study|7|||
44314120|NCT01054976|79317396|FG000|Overall Study|Withdrawal by Subject|4|||
44314121|NCT01054976|79317396|FG000|Overall Study|Other|8|||
44314122|NCT05490771|79317430|FG000|Overall Study|Disease progression|18|||
44314123|NCT05490771|79317430|FG000|Overall Study|Adverse Event|3|||
44314124|NCT05490771|79317430|FG000|Overall Study|Other complicating disease|1|||
44314125|NCT05490771|79317430|FG000|Overall Study|Withdrawal by Subject|3|||
44314126|NCT05490771|79317430|FG000|Overall Study|Physician Decision|1|||
44314127|NCT05490771|79317430|FG000|Overall Study|Still on treatment|2|||
44314128|NCT05490771|79317430|FG000|Overall Study|Never start protocol therapy|5|||
44314129|NCT05490771|79317430|FG000|Overall Study|Ineligible|2|||
44314130|NCT05480514|79317434|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
44314131|NCT05480514|79317435|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
44314132|NCT05480514|79317434|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
44314133|NCT05480514|79317435|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
44314134|NCT05480514|79317434|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
44314135|NCT05480514|79317435|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
44314136|NCT05480514|79317434|FG000|Period 1|Covid-19 Related|1|||
44314137|NCT05480514|79317435|FG001|Period 1|Covid-19 Related|0|||
44420747|NCT00783302|79428583|FG000|Overall Study|Lost to Follow-up|17|||
44314138|NCT05480514|79317434|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
44314139|NCT05480514|79317435|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
44314140|NCT05379920|79317445|FG000|Overall Study|Lost to Follow-up|0|||
44314141|NCT05379920|79317446|FG001|Overall Study|Lost to Follow-up|5|||
44314142|NCT05379920|79317447|FG002|Overall Study|Lost to Follow-up|0|||
44314143|NCT05379920|79317448|FG003|Overall Study|Lost to Follow-up|0|||
44314144|NCT05227027|79317458|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
44354745|NCT01186770|79359153|FG000|Overall Study|Adverse Event|2|||
44155555|NCT01998958|78946967|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
44314145|NCT05227027|79317459|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
44314146|NCT05124210|79317480|FG000|Overall Study|Lost to Follow-up|1|||
44314147|NCT05124210|79317481|FG001|Overall Study|Lost to Follow-up|0|||
44314148|NCT05124210|79317480|FG000|Overall Study|Withdrawal by Subject|1|||
44314149|NCT05124210|79317481|FG001|Overall Study|Withdrawal by Subject|0|||
44314150|NCT05041062|79317496|FG000|Overall Study|Adverse Event|2|||
44314151|NCT04800315|79317544|FG000|Randomization|Did not receive study treatment|1|||
44314152|NCT04800315|79317545|FG001|Randomization|Did not receive study treatment|0|||
44314153|NCT04800315|79317546|FG002|Randomization|Did not receive study treatment|0|||
44314154|NCT04800315|79317547|FG003|Randomization|Did not receive study treatment|0|||
44314155|NCT04800315|79317544|FG000|Treatment Period|Adverse Event|4|||
44314156|NCT04800315|79317545|FG001|Treatment Period|Adverse Event|2|||
44314157|NCT04800315|79317546|FG002|Treatment Period|Adverse Event|1|||
44314158|NCT04800315|79317547|FG003|Treatment Period|Adverse Event|2|||
44314159|NCT04800315|79317544|FG000|Treatment Period|Lack of Efficacy|1|||
44314160|NCT04800315|79317545|FG001|Treatment Period|Lack of Efficacy|0|||
44314161|NCT04800315|79317546|FG002|Treatment Period|Lack of Efficacy|0|||
44314162|NCT04800315|79317547|FG003|Treatment Period|Lack of Efficacy|3|||
44314163|NCT04800315|79317544|FG000|Treatment Period|Lost to Follow-up|0|||
44314164|NCT04800315|79317545|FG001|Treatment Period|Lost to Follow-up|1|||
44314165|NCT04800315|79317546|FG002|Treatment Period|Lost to Follow-up|2|||
44314166|NCT04800315|79317547|FG003|Treatment Period|Lost to Follow-up|2|||
44314167|NCT04800315|79317544|FG000|Treatment Period|Withdrawal by participant|0|||
44314168|NCT04800315|79317545|FG001|Treatment Period|Withdrawal by participant|0|||
44314169|NCT04800315|79317546|FG002|Treatment Period|Withdrawal by participant|0|||
44314170|NCT04800315|79317547|FG003|Treatment Period|Withdrawal by participant|4|||
44314171|NCT04800315|79317544|FG000|Treatment Period|Other Reasons|0|||
44314172|NCT04800315|79317545|FG001|Treatment Period|Other Reasons|2|||
44314173|NCT04800315|79317546|FG002|Treatment Period|Other Reasons|0|||
44314174|NCT04800315|79317547|FG003|Treatment Period|Other Reasons|1|||
44314175|NCT04768114|79317559|FG000|Overall Study|Lost to Follow-up|5|||
44314176|NCT04768114|79317560|FG001|Overall Study|Lost to Follow-up|10|||
44314177|NCT04768114|79317559|FG000|Overall Study|Withdrawal by Subject|0|||
44314178|NCT04768114|79317560|FG001|Overall Study|Withdrawal by Subject|1|||
44314179|NCT04547192|79317593|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
44314180|NCT04547192|79317594|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
44314181|NCT04547192|79317595|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
44314182|NCT04547192|79317596|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
44314183|NCT04547192|79317593|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
44314184|NCT04547192|79317594|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
44314185|NCT04547192|79317595|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
44314186|NCT04547192|79317596|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
44314187|NCT04547192|79317593|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
44314188|NCT04547192|79317594|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
44314189|NCT04547192|79317595|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
44314190|NCT04547192|79317596|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
44314191|NCT04547192|79317593|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
44314192|NCT04547192|79317594|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
44314193|NCT04547192|79317595|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
44314194|NCT04547192|79317596|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
44314195|NCT04547192|79317593|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
44314196|NCT04547192|79317594|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
44314197|NCT04547192|79317595|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
44314198|NCT04547192|79317596|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
44314199|NCT04514510|79317606|FG000|Overall Study|Lost to Follow-up|0|||
44314200|NCT04514510|79317607|FG001|Overall Study|Lost to Follow-up|1|||
44314201|NCT04514510|79317606|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
44314202|NCT04514510|79317607|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
44314203|NCT04439123|79317623|FG000|Overall Study|Adverse Event|11|||
44314204|NCT04439123|79317623|FG000|Overall Study|Death|1|||
44314205|NCT04439123|79317623|FG000|Overall Study|Disease progression|19|||
44420748|NCT00783302|79428583|FG000|Overall Study|Technical Problems|11|||
44420749|NCT00783302|79428583|FG000|Overall Study|Protocol Violation|3|||
44420750|NCT00783302|79428583|FG000|Overall Study|Physician Decision|1|||
44420751|NCT00783302|79428583|FG000|Overall Study|Withdrawal by Subject|3|||
44314206|NCT04439123|79317623|FG000|Overall Study|Withdrawal by Subject|2|||
44420752|NCT00783224|79428605|FG000|Overall Study|Adverse Event|0|||
44314207|NCT04439123|79317623|FG000|Overall Study|Still on treatment|2|||
44314209|NCT04283461|79317667|FG000|Overall Study|Enrolled in separate trial|0|||
44314210|NCT04283461|79317668|FG001|Overall Study|Enrolled in separate trial|0|||
44314211|NCT04283461|79317669|FG002|Overall Study|Enrolled in separate trial|8|||
44314212|NCT04283461|79317670|FG003|Overall Study|Enrolled in separate trial|13|||
44314213|NCT04283461|79317671|FG004|Overall Study|Enrolled in separate trial|12|||
44420753|NCT00783224|79428606|FG001|Overall Study|Adverse Event|0|||
44420754|NCT00783224|79428607|FG002|Overall Study|Adverse Event|1|||
44314214|NCT04283461|79317672|FG005|Overall Study|Enrolled in separate trial|0|||
44314215|NCT04283461|79317673|FG006|Overall Study|Enrolled in separate trial|0|||
44314216|NCT04283461|79317674|FG007|Overall Study|Enrolled in separate trial|8|||
44314217|NCT04283461|79317675|FG008|Overall Study|Enrolled in separate trial|0|||
44314218|NCT04283461|79317676|FG009|Overall Study|Enrolled in separate trial|0|||
44314219|NCT04283461|79317677|FG010|Overall Study|Enrolled in separate trial|0|||
44314220|NCT04283461|79317678|FG011|Overall Study|Enrolled in separate trial|7|||
44314221|NCT04283461|79317679|FG012|Overall Study|Enrolled in separate trial|0|||
44314222|NCT04213079|79317712|FG000|Overall Study|Lost to Follow-up|0|||
44314223|NCT04213079|79317713|FG001|Overall Study|Lost to Follow-up|2|||
44314224|NCT04102189|79317743|FG000|Overall Study|Withdrawal by Subject|1|||
44314225|NCT04102189|79317744|FG001|Overall Study|Withdrawal by Subject|2|||
44314226|NCT04102189|79317743|FG000|Overall Study|Withdrawal by parent/guardian|0|||
44314227|NCT04102189|79317744|FG001|Overall Study|Withdrawal by parent/guardian|1|||
44314228|NCT04102189|79317743|FG000|Overall Study|Lost to Follow-up|1|||
44314229|NCT04102189|79317744|FG001|Overall Study|Lost to Follow-up|0|||
44314230|NCT04034927|79317752|FG000|Overall Study|Adverse Event|4|||
44314231|NCT04034927|79317753|FG001|Overall Study|Adverse Event|9|||
44314232|NCT04034927|79317752|FG000|Overall Study|Death|0|||
44314233|NCT04034927|79317753|FG001|Overall Study|Death|1|||
44314234|NCT04034927|79317752|FG000|Overall Study|Withdrawal by Subject|0|||
44314235|NCT04034927|79317753|FG001|Overall Study|Withdrawal by Subject|3|||
44314236|NCT04034927|79317752|FG000|Overall Study|Still on Treatment|2|||
44314237|NCT04034927|79317753|FG001|Overall Study|Still on Treatment|1|||
44314238|NCT04034927|79317752|FG000|Overall Study|Other|1|||
44314239|NCT04034927|79317753|FG001|Overall Study|Other|1|||
44314240|NCT04025580|79317775|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
44314241|NCT04025580|79317776|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
44314242|NCT04025580|79317777|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
44314243|NCT03982368|79317787|FG000|Overall Study|Adverse Event|6|||
44314244|NCT03982368|79317788|FG001|Overall Study|Adverse Event|4|||
44314245|NCT03982368|79317789|FG002|Overall Study|Adverse Event|3|||
44314246|NCT03982368|79317787|FG000|Overall Study|Lost to Follow-up|2|||
44314247|NCT03982368|79317788|FG001|Overall Study|Lost to Follow-up|1|||
44314248|NCT03982368|79317789|FG002|Overall Study|Lost to Follow-up|0|||
44314249|NCT03982368|79317787|FG000|Overall Study|Withdrawal by Subject|1|||
44314250|NCT03982368|79317788|FG001|Overall Study|Withdrawal by Subject|2|||
44314251|NCT03982368|79317789|FG002|Overall Study|Withdrawal by Subject|0|||
44314252|NCT03982368|79317787|FG000|Overall Study|unknow|4|||
44314253|NCT03982368|79317788|FG001|Overall Study|unknow|0|||
44314254|NCT03982368|79317789|FG002|Overall Study|unknow|2|||
44314255|NCT03934684|79317802|FG000|Overall Study|Participants continuing in study|11|||
44314256|NCT03934684|79317803|FG001|Overall Study|Participants continuing in study|4|||
44314257|NCT03934684|79317802|FG000|Overall Study|Discontinuation of carfilzomib|20|||
44314258|NCT03934684|79317803|FG001|Overall Study|Discontinuation of carfilzomib|30|||
44314259|NCT03934684|79317802|FG000|Overall Study|Death|2|||
44314260|NCT03934684|79317803|FG001|Overall Study|Death|2|||
44314261|NCT03934684|79317802|FG000|Overall Study|Lost to Follow-up|2|||
44314262|NCT03934684|79317803|FG001|Overall Study|Lost to Follow-up|5|||
44314263|NCT03934684|79317802|FG000|Overall Study|Withdrawal by Subject|7|||
44314264|NCT03934684|79317803|FG001|Overall Study|Withdrawal by Subject|8|||
44314265|NCT03880019|79317809|FG000|Overall Study|Competing disease|1|||
44314266|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
44314267|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
44314268|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
44314269|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
44314270|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
44314271|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
44314272|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
44314273|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
44314274|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
44155556|NCT01998958|78946968|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
44257898|NCT00558519|79111464|FG000|Overall Study|Never received treatment|1|||
44314275|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
44314276|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
44314277|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
44314278|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
44314279|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
44257899|NCT00558285|79111508|FG000|Overall Study|Adverse Event|1|||
44257900|NCT00558285|79111509|FG001|Overall Study|Adverse Event|1|||
44257901|NCT00558285|79111510|FG002|Overall Study|Adverse Event|4|||
44257902|NCT00558285|79111511|FG003|Overall Study|Adverse Event|1|||
44257903|NCT00558285|79111512|FG004|Overall Study|Adverse Event|2|||
44257904|NCT00558285|79111508|FG000|Overall Study|Abnormal test procedure result(s)|1|||
44257905|NCT00558285|79111509|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44257906|NCT00558285|79111510|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44257907|NCT00558285|79111511|FG003|Overall Study|Abnormal test procedure result(s)|0|||
44314280|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
44314281|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
44314282|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
44314283|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
44314284|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
44314285|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
44314286|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
44314287|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
44314288|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
44314289|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
44314290|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
44314291|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
44314292|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
44314293|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
44314294|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
44314295|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
44314296|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
44314297|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
44314298|NCT03818035|79317813|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
44314299|NCT03818035|79317814|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
44314300|NCT03818035|79317815|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
44314301|NCT03818035|79317816|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
44314302|NCT03818035|79317813|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
44314303|NCT03818035|79317814|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
44314304|NCT03818035|79317815|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
44314305|NCT03818035|79317816|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
44314306|NCT03818035|79317813|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
44314307|NCT03818035|79317814|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
44314308|NCT03818035|79317815|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
44314309|NCT03818035|79317816|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
44314310|NCT03818035|79317813|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
44314311|NCT03818035|79317814|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
44314312|NCT03818035|79317815|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
44314313|NCT03818035|79317816|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
44314314|NCT03818035|79317813|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
44314315|NCT03818035|79317814|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
44314316|NCT03818035|79317815|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
44314317|NCT03818035|79317816|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
44314318|NCT03818035|79317813|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
44314319|NCT03818035|79317814|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
44314320|NCT03818035|79317815|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
44314321|NCT03818035|79317816|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
44314322|NCT03818035|79317813|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
44314323|NCT03818035|79317814|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
44314324|NCT03818035|79317815|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
44314325|NCT03818035|79317816|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
44314326|NCT03748641|79317830|FG000|Overall Study|Ongoing|155|||
44314327|NCT03748641|79317831|FG001|Overall Study|Ongoing|148|||
44536053|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
44536054|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
44536055|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
44536056|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
44536057|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
44536058|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
44536059|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
44536060|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
44536061|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
44314328|NCT03748641|79317832|FG002|Overall Study|Ongoing|66|||
44314329|NCT03748641|79317833|FG003|Overall Study|Ongoing|79|||
44314330|NCT03748641|79317834|FG004|Overall Study|Ongoing|84|||
44314331|NCT03748641|79317830|FG000|Overall Study|Death|54|||
44314332|NCT03748641|79317831|FG001|Overall Study|Death|59|||
44314333|NCT03748641|79317832|FG002|Overall Study|Death|51|||
44420755|NCT00783224|79428608|FG003|Overall Study|Adverse Event|0|||
44420756|NCT00783224|79428605|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
44420757|NCT00783224|79428606|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
44420758|NCT00783224|79428607|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
44420759|NCT00783224|79428608|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
44420760|NCT00783224|79428605|FG000|Overall Study|Inappropriate as a study subject|0|||
44420761|NCT00783224|79428606|FG001|Overall Study|Inappropriate as a study subject|0|||
44420762|NCT00783224|79428607|FG002|Overall Study|Inappropriate as a study subject|0|||
44420763|NCT00783224|79428608|FG003|Overall Study|Inappropriate as a study subject|1|||
44420764|NCT00782834|79428617|FG000|Treatment Phase|fibrous tumor not GIST|1|||
44420765|NCT00584805|79428621|FG000|Overall Study|No longer at risk of exposure|39|||
44420766|NCT00584805|79428621|FG000|Overall Study|Relocation|36|||
44420767|NCT00584805|79428621|FG000|Overall Study|Withdrawal by Subject|18|||
44420768|NCT00584805|79428621|FG000|Overall Study|Non-compliance|1|||
44420769|NCT00584805|79428621|FG000|Overall Study|Lost to follow up|3|||
44420770|NCT00584805|79428621|FG000|Overall Study|Screen failures|2|||
44420771|NCT00765674|79428631|FG000|Overall Study|Adverse Event|7|||
44420772|NCT00765674|79428632|FG001|Overall Study|Adverse Event|2|||
44420773|NCT00765674|79428633|FG002|Overall Study|Adverse Event|8|||
44420774|NCT00765674|79428634|FG003|Overall Study|Adverse Event|11|||
44420775|NCT00765674|79428631|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
44420776|NCT00765674|79428632|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
44420777|NCT00765674|79428633|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
44420778|NCT00765674|79428634|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
44420779|NCT00765674|79428631|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
44420780|NCT00765674|79428632|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
44420781|NCT00765674|79428633|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
44420782|NCT00765674|79428634|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
44420783|NCT00765674|79428631|FG000|Overall Study|Lack of Efficacy|2|||
44420784|NCT00765674|79428632|FG001|Overall Study|Lack of Efficacy|3|||
44420785|NCT00765674|79428633|FG002|Overall Study|Lack of Efficacy|1|||
44420786|NCT00765674|79428634|FG003|Overall Study|Lack of Efficacy|2|||
44420787|NCT00765674|79428631|FG000|Overall Study|Protocol Violation|2|||
44420788|NCT00765674|79428632|FG001|Overall Study|Protocol Violation|0|||
44420789|NCT00765674|79428633|FG002|Overall Study|Protocol Violation|1|||
44420790|NCT00765674|79428634|FG003|Overall Study|Protocol Violation|0|||
44420791|NCT00765674|79428631|FG000|Overall Study|Withdrawal by Subject|5|||
44420792|NCT00765674|79428632|FG001|Overall Study|Withdrawal by Subject|7|||
44420793|NCT00765674|79428633|FG002|Overall Study|Withdrawal by Subject|3|||
44420794|NCT00765674|79428634|FG003|Overall Study|Withdrawal by Subject|8|||
44420795|NCT00765674|79428631|FG000|Overall Study|Lost to Follow-up|4|||
44420796|NCT00765674|79428632|FG001|Overall Study|Lost to Follow-up|6|||
44420797|NCT00765674|79428633|FG002|Overall Study|Lost to Follow-up|2|||
44420798|NCT00765674|79428634|FG003|Overall Study|Lost to Follow-up|1|||
44420799|NCT00765674|79428631|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
44420800|NCT00765674|79428632|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
44420801|NCT00765674|79428633|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
44420802|NCT00765674|79428634|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
44420803|NCT00765362|79428644|FG000|Overall Study|Death|9|||
44420804|NCT00765362|79428644|FG000|Overall Study|Adverse Event|2|||
44420805|NCT00765362|79428644|FG000|Overall Study|Protocol Violation|18|||
44420806|NCT00765362|79428644|FG000|Overall Study|Withdrawal by Subject|13|||
44420807|NCT00765362|79428644|FG000|Overall Study|Lost to Follow-up|95|||
44420808|NCT00586898|79428648|FG000|Overall Study|Adverse Event|1|||
44420809|NCT00586898|79428648|FG000|Overall Study|Patiemt Non-compliance|1|||
44420810|NCT00586898|79428648|FG000|Overall Study|Evaluable for Toxicity Only|5|||
44420811|NCT04912245|79428652|FG000|Overall Study|Withdrawal by Subject|21|||
44420812|NCT04912245|79428653|FG001|Overall Study|Withdrawal by Subject|4|||
44420813|NCT04912245|79428652|FG000|Overall Study|Lost to Follow-up|5|||
44420814|NCT04912245|79428653|FG001|Overall Study|Lost to Follow-up|11|||
44155557|NCT01998958|78946969|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
44155558|NCT01998958|78946970|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
44420815|NCT00796991|79428660|FG000|Overall Study|Adverse Event|0|||
44420816|NCT00796991|79428661|FG001|Overall Study|Adverse Event|0|||
44420817|NCT00796991|79428662|FG002|Overall Study|Adverse Event|1|||
44420818|NCT00796991|79428660|FG000|Overall Study|Death|2|||
44420819|NCT00796991|79428661|FG001|Overall Study|Death|0|||
44420820|NCT00796991|79428662|FG002|Overall Study|Death|0|||
44420821|NCT00796991|79428660|FG000|Overall Study|Disease Progression|10|||
44420822|NCT00796991|79428661|FG001|Overall Study|Disease Progression|9|||
44420823|NCT00796991|79428662|FG002|Overall Study|Disease Progression|7|||
44420824|NCT00796991|79428660|FG000|Overall Study|Study Drug Toxicity|3|||
44314334|NCT03748641|79317833|FG003|Overall Study|Death|42|||
44314335|NCT03748641|79317834|FG004|Overall Study|Death|9|||
44314336|NCT03748641|79317830|FG000|Overall Study|Lost to Follow-up|0|||
44314337|NCT03748641|79317831|FG001|Overall Study|Lost to Follow-up|2|||
44314338|NCT03748641|79317832|FG002|Overall Study|Lost to Follow-up|1|||
44314339|NCT03748641|79317833|FG003|Overall Study|Lost to Follow-up|0|||
44314340|NCT03748641|79317834|FG004|Overall Study|Lost to Follow-up|0|||
44314341|NCT03748641|79317830|FG000|Overall Study|Withdrawal by Subject|3|||
44314342|NCT03748641|79317831|FG001|Overall Study|Withdrawal by Subject|2|||
44314343|NCT03748641|79317832|FG002|Overall Study|Withdrawal by Subject|5|||
44314344|NCT03748641|79317833|FG003|Overall Study|Withdrawal by Subject|3|||
44314345|NCT03748641|79317834|FG004|Overall Study|Withdrawal by Subject|2|||
44314346|NCT03737994|79317848|FG000|Overall Study|Withdrawal by Subject|0|||
44314347|NCT03737994|79317849|FG001|Overall Study|Withdrawal by Subject|0|||
44314348|NCT03737994|79317850|FG002|Overall Study|Withdrawal by Subject|0|||
44314349|NCT03737994|79317851|FG003|Overall Study|Withdrawal by Subject|0|||
44314350|NCT03737994|79317852|FG004|Overall Study|Withdrawal by Subject|0|||
44314351|NCT03737994|79317853|FG005|Overall Study|Withdrawal by Subject|0|||
44314352|NCT03737994|79317854|FG006|Overall Study|Withdrawal by Subject|1|||
44314353|NCT03674112|79317876|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
44314354|NCT03674112|79317877|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
44314355|NCT03674112|79317876|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
44314356|NCT03674112|79317877|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
44314357|NCT03674112|79317876|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
44314358|NCT03674112|79317877|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
44314359|NCT03674112|79317876|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
44314360|NCT03674112|79317877|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
44314361|NCT03674112|79317876|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
44314362|NCT03674112|79317877|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
44314363|NCT03674112|79317876|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
44314364|NCT03674112|79317877|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
44314365|NCT03674112|79317876|FG000|Follow-Up Period (≥3 Years)|Death|2|||
44314366|NCT03674112|79317877|FG001|Follow-Up Period (≥3 Years)|Death|0|||
44314367|NCT03674112|79317876|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
44314368|NCT03674112|79317877|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
44314369|NCT03673501|79317909|FG000|Overall Study|Participants ongoing.|36|||
44314370|NCT03673501|79317910|FG001|Overall Study|Participants ongoing.|24|||
44314371|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
44314372|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
44314373|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Death|0|||
44314374|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Death|4|||
44314375|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
44314376|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
44314377|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
44314378|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
44314379|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
44314380|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
44314381|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
44314382|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
44314383|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
44314384|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
44314385|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Other|4|||
44314386|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Other|3|||
44314387|NCT03517722|79317927|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
44314388|NCT03517722|79317928|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
44314389|NCT03517722|79317927|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
44314390|NCT03517722|79317928|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
44314391|NCT03517722|79317927|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
44314392|NCT03517722|79317928|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
44314393|NCT03517722|79317927|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
44314394|NCT03517722|79317928|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
44155559|NCT01998958|78946971|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
44420825|NCT00796991|79428661|FG001|Overall Study|Study Drug Toxicity|3|||
44314395|NCT03517722|79317927|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
44314396|NCT03517722|79317928|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
44314397|NCT03258593|79317967|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
44314398|NCT03258593|79317968|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
44314399|NCT03258593|79317969|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
44314400|NCT03258593|79317970|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
44314401|NCT03258593|79317967|FG000|Run-In Maintenance Phase|Disease progression|3|||
44314402|NCT03258593|79317968|FG001|Run-In Maintenance Phase|Disease progression|0|||
44314403|NCT03258593|79317969|FG002|Run-In Maintenance Phase|Disease progression|0|||
44314404|NCT03258593|79317970|FG003|Run-In Maintenance Phase|Disease progression|0|||
44314405|NCT03258593|79317967|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
44314406|NCT03258593|79317968|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
44314407|NCT03258593|79317969|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
44314408|NCT03258593|79317970|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
44314409|NCT03258593|79317967|FG000|Expansion Maintenance Phase|Physician Decision|0|||
44314410|NCT03258593|79317968|FG001|Expansion Maintenance Phase|Physician Decision|1|||
44314411|NCT03258593|79317969|FG002|Expansion Maintenance Phase|Physician Decision|0|||
44314412|NCT03258593|79317970|FG003|Expansion Maintenance Phase|Physician Decision|0|||
44314413|NCT03201458|79317983|FG000|Overall Study|No longer eligible|2|||
44314414|NCT03201458|79317984|FG001|Overall Study|No longer eligible|5|||
44314415|NCT03201458|79317983|FG000|Overall Study|Health event before starting|1|||
44314416|NCT03201458|79317984|FG001|Overall Study|Health event before starting|0|||
44314417|NCT03201458|79317983|FG000|Overall Study|Physician Decision|1|||
44314418|NCT03201458|79317984|FG001|Overall Study|Physician Decision|0|||
44314419|NCT02924129|79318017|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
44314420|NCT02924129|79318018|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
44314421|NCT02924129|79318017|FG000|Overall Study|Withdrawal by Subject|2|||
44314422|NCT02924129|79318018|FG001|Overall Study|Withdrawal by Subject|2|||
44314423|NCT02924129|79318017|FG000|Overall Study|Physician Decision|1|||
44314424|NCT02924129|79318018|FG001|Overall Study|Physician Decision|0|||
44314425|NCT02924129|79318017|FG000|Overall Study|Missed Visit|0|||
44314426|NCT02924129|79318018|FG001|Overall Study|Missed Visit|1|||
44314427|NCT02824263|79318026|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
44314428|NCT02824263|79318027|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
44314429|NCT02824263|79318026|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
44314430|NCT02824263|79318027|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
44314431|NCT02814838|79318035|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
44314432|NCT02814838|79318036|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
44314433|NCT02814838|79318035|FG000|Overall Study|Consent withdrawal|1|||
44314434|NCT02814838|79318036|FG001|Overall Study|Consent withdrawal|1|||
44314435|NCT02661464|79318046|FG000|Overall Study|Lost to Follow-up|28|||
44314436|NCT02661464|79318047|FG001|Overall Study|Lost to Follow-up|0|||
44314437|NCT02661464|79318048|FG002|Overall Study|Lost to Follow-up|0|||
44314438|NCT02661464|79318049|FG003|Overall Study|Lost to Follow-up|0|||
44314439|NCT02661464|79318046|FG000|Overall Study|Withdrawal by Subject|3|||
44314440|NCT02661464|79318047|FG001|Overall Study|Withdrawal by Subject|1|||
44314441|NCT02661464|79318048|FG002|Overall Study|Withdrawal by Subject|0|||
44314442|NCT02661464|79318049|FG003|Overall Study|Withdrawal by Subject|0|||
44314443|NCT02661464|79318046|FG000|Overall Study|Participants terminated prematurely|288|||
44314444|NCT02661464|79318047|FG001|Overall Study|Participants terminated prematurely|52|||
44314445|NCT02661464|79318048|FG002|Overall Study|Participants terminated prematurely|1|||
44314446|NCT02661464|79318049|FG003|Overall Study|Participants terminated prematurely|1|||
44314447|NCT02661464|79318046|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
44314448|NCT02661464|79318047|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
44314449|NCT02661464|79318048|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
44314450|NCT02661464|79318049|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
44314451|NCT02618408|79318071|FG000|Overall Study|Withdrawal by Subject|1|||
44314452|NCT02618408|79318072|FG001|Overall Study|Withdrawal by Subject|0|||
44314453|NCT02618408|79318073|FG002|Overall Study|Withdrawal by Subject|4|||
44314454|NCT02618408|79318071|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
44314455|NCT02618408|79318072|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
44314456|NCT02618408|79318073|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
44314457|NCT02618408|79318071|FG000|Overall Study|Lost to Follow-up|4|||
44314458|NCT02618408|79318072|FG001|Overall Study|Lost to Follow-up|2|||
44314459|NCT02618408|79318073|FG002|Overall Study|Lost to Follow-up|6|||
44314460|NCT02618408|79318071|FG000|Overall Study|Adverse Event|4|||
44314461|NCT02618408|79318072|FG001|Overall Study|Adverse Event|0|||
44314462|NCT02618408|79318073|FG002|Overall Study|Adverse Event|10|||
44314463|NCT02618408|79318071|FG000|Overall Study|Physician Decision|1|||
44314464|NCT02618408|79318072|FG001|Overall Study|Physician Decision|1|||
44314465|NCT02618408|79318073|FG002|Overall Study|Physician Decision|2|||
44314466|NCT02618408|79318071|FG000|Overall Study|Protocol Violation|1|||
44314467|NCT02618408|79318072|FG001|Overall Study|Protocol Violation|1|||
44314468|NCT02618408|79318073|FG002|Overall Study|Protocol Violation|2|||
44314469|NCT02618408|79318071|FG000|Overall Study|Other, Multiple Categories|0|||
44314470|NCT02618408|79318072|FG001|Overall Study|Other, Multiple Categories|0|||
44314471|NCT02618408|79318073|FG002|Overall Study|Other, Multiple Categories|4|||
44314472|NCT02499172|79318088|FG000|Overall Study|Financial reason|0|||
44314473|NCT02499172|79318089|FG001|Overall Study|Financial reason|0|||
44314474|NCT02499172|79318090|FG002|Overall Study|Financial reason|523|||
44314475|NCT02499172|79318091|FG003|Overall Study|Financial reason|436|||
44314476|NCT02499172|79318088|FG000|Overall Study|Lost to Follow-up|65|||
44314477|NCT02499172|79318089|FG001|Overall Study|Lost to Follow-up|64|||
44314478|NCT02499172|79318090|FG002|Overall Study|Lost to Follow-up|0|||
44314479|NCT02499172|79318091|FG003|Overall Study|Lost to Follow-up|0|||
44314480|NCT02446600|79318105|FG000|Overall Study|Never treated|20|||
44314481|NCT02446600|79318106|FG001|Overall Study|Never treated|2|||
44314482|NCT02446600|79318107|FG002|Overall Study|Never treated|6|||
44314483|NCT02446600|79318108|FG003|Overall Study|Never treated|0|||
44314484|NCT02446600|79318105|FG000|Overall Study|Withdrawal by Subject|19|||
44314485|NCT02446600|79318106|FG001|Overall Study|Withdrawal by Subject|5|||
44314486|NCT02446600|79318107|FG002|Overall Study|Withdrawal by Subject|17|||
44314487|NCT02446600|79318108|FG003|Overall Study|Withdrawal by Subject|0|||
44314488|NCT02446600|79318105|FG000|Overall Study|Ineligible|1|||
44314489|NCT02446600|79318106|FG001|Overall Study|Ineligible|4|||
44314490|NCT02446600|79318107|FG002|Overall Study|Ineligible|4|||
44314491|NCT02446600|79318108|FG003|Overall Study|Ineligible|1|||
44314492|NCT02446600|79318105|FG000|Overall Study|Duplicate Enrollment|0|||
44314493|NCT02446600|79318106|FG001|Overall Study|Duplicate Enrollment|1|||
44314494|NCT02446600|79318107|FG002|Overall Study|Duplicate Enrollment|0|||
44314495|NCT02446600|79318108|FG003|Overall Study|Duplicate Enrollment|0|||
44314496|NCT02323880|79318130|FG000|Overall Study|Adverse Event|2|||
44314497|NCT02323880|79318131|FG001|Overall Study|Adverse Event|0|||
44314498|NCT02323880|79318132|FG002|Overall Study|Adverse Event|1|||
44314499|NCT02323880|79318133|FG003|Overall Study|Adverse Event|1|||
44314500|NCT02323880|79318134|FG004|Overall Study|Adverse Event|1|||
44314501|NCT02323880|79318135|FG005|Overall Study|Adverse Event|0|||
44314502|NCT02323880|79318136|FG006|Overall Study|Adverse Event|1|||
44314503|NCT02323880|79318137|FG007|Overall Study|Adverse Event|0|||
44314504|NCT02323880|79318130|FG000|Overall Study|Death|0|||
44314505|NCT02323880|79318131|FG001|Overall Study|Death|0|||
44314506|NCT02323880|79318132|FG002|Overall Study|Death|0|||
44314507|NCT02323880|79318133|FG003|Overall Study|Death|0|||
44314508|NCT02323880|79318134|FG004|Overall Study|Death|0|||
44314509|NCT02323880|79318135|FG005|Overall Study|Death|1|||
44314510|NCT02323880|79318136|FG006|Overall Study|Death|0|||
44314511|NCT02323880|79318137|FG007|Overall Study|Death|0|||
44314512|NCT02323880|79318130|FG000|Overall Study|Lack of Efficacy|4|||
44314513|NCT02323880|79318131|FG001|Overall Study|Lack of Efficacy|11|||
44314514|NCT02323880|79318132|FG002|Overall Study|Lack of Efficacy|5|||
44314515|NCT02323880|79318133|FG003|Overall Study|Lack of Efficacy|5|||
44314516|NCT02323880|79318134|FG004|Overall Study|Lack of Efficacy|4|||
44314517|NCT02323880|79318135|FG005|Overall Study|Lack of Efficacy|8|||
44314518|NCT02323880|79318136|FG006|Overall Study|Lack of Efficacy|4|||
44314519|NCT02323880|79318137|FG007|Overall Study|Lack of Efficacy|6|||
44314520|NCT02323880|79318130|FG000|Overall Study|Physician Decision|0|||
44420826|NCT00796991|79428662|FG002|Overall Study|Study Drug Toxicity|5|||
44420827|NCT00796991|79428660|FG000|Overall Study|Withdrawal by Subject|0|||
44420828|NCT00796991|79428661|FG001|Overall Study|Withdrawal by Subject|0|||
44420829|NCT00796991|79428662|FG002|Overall Study|Withdrawal by Subject|1|||
44420830|NCT00799487|79428673|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
44420831|NCT00799487|79428674|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
44420832|NCT00799487|79428675|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
44420833|NCT00799487|79428673|FG000|Dose Adjustment Period|Adverse Event|2|||
44420834|NCT00799487|79428674|FG001|Dose Adjustment Period|Adverse Event|0|||
44536062|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
44536063|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
44420835|NCT00799487|79428675|FG002|Dose Adjustment Period|Adverse Event|0|||
44420836|NCT00799487|79428673|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
44536064|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
44536065|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
44536066|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
44536067|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
44536068|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
44536069|NCT00073307|79546843|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
44314521|NCT02323880|79318131|FG001|Overall Study|Physician Decision|0|||
44314522|NCT02323880|79318132|FG002|Overall Study|Physician Decision|0|||
44314523|NCT02323880|79318133|FG003|Overall Study|Physician Decision|0|||
44314524|NCT02323880|79318134|FG004|Overall Study|Physician Decision|1|||
44314525|NCT02323880|79318135|FG005|Overall Study|Physician Decision|1|||
44314526|NCT02323880|79318136|FG006|Overall Study|Physician Decision|1|||
44314527|NCT02323880|79318137|FG007|Overall Study|Physician Decision|0|||
44314528|NCT02323880|79318130|FG000|Overall Study|Withdrawal by Subject|0|||
44314529|NCT02323880|79318131|FG001|Overall Study|Withdrawal by Subject|2|||
44420837|NCT00799487|79428674|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
44314530|NCT02323880|79318132|FG002|Overall Study|Withdrawal by Subject|0|||
44314531|NCT02323880|79318133|FG003|Overall Study|Withdrawal by Subject|0|||
44314532|NCT02323880|79318134|FG004|Overall Study|Withdrawal by Subject|0|||
44314533|NCT02323880|79318135|FG005|Overall Study|Withdrawal by Subject|0|||
44314534|NCT02323880|79318136|FG006|Overall Study|Withdrawal by Subject|0|||
44314535|NCT02323880|79318137|FG007|Overall Study|Withdrawal by Subject|0|||
44314536|NCT02115282|79318177|FG000|Overall Study|Disease progression during treatment|216|||
44314537|NCT02115282|79318178|FG001|Overall Study|Disease progression during treatment|229|||
44314538|NCT02115282|79318177|FG000|Overall Study|Adverse Event|49|||
44314539|NCT02115282|79318178|FG001|Overall Study|Adverse Event|23|||
44314540|NCT02115282|79318177|FG000|Overall Study|Death|1|||
44314541|NCT02115282|79318178|FG001|Overall Study|Death|3|||
44314542|NCT02115282|79318177|FG000|Overall Study|Alternative therapy|1|||
44314543|NCT02115282|79318178|FG001|Overall Study|Alternative therapy|1|||
44314544|NCT02115282|79318177|FG000|Overall Study|Complicating disease|0|||
44314545|NCT02115282|79318178|FG001|Overall Study|Complicating disease|3|||
44314546|NCT02115282|79318177|FG000|Overall Study|Withdrawal by Subject|12|||
44314547|NCT02115282|79318178|FG001|Overall Study|Withdrawal by Subject|10|||
44314548|NCT02115282|79318177|FG000|Overall Study|Symptomatic progression/deterioration|7|||
44314549|NCT02115282|79318178|FG001|Overall Study|Symptomatic progression/deterioration|18|||
44314550|NCT02115282|79318177|FG000|Overall Study|Non-compliance|5|||
44314551|NCT02115282|79318178|FG001|Overall Study|Non-compliance|1|||
44314552|NCT02115282|79318177|FG000|Overall Study|Protocol Violation|2|||
44314553|NCT02115282|79318178|FG001|Overall Study|Protocol Violation|2|||
44314554|NCT02115282|79318177|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
44314555|NCT02115282|79318178|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
44314556|NCT02115282|79318177|FG000|Overall Study|Not start protocol therapy|9|||
44314557|NCT02115282|79318178|FG001|Overall Study|Not start protocol therapy|10|||
44314558|NCT01991977|79318186|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
44314559|NCT01991977|79318186|FG000|Overall Study|Withdrew after start of treatment|5|||
44314560|NCT01854554|79318198|FG000|Overall Study|Denial of Insurance Coverage|12|||
44314561|NCT01854554|79318199|FG001|Overall Study|Denial of Insurance Coverage|0|||
44314562|NCT01854554|79318198|FG000|Overall Study|Decided to get treatment locally|1|||
44314563|NCT01854554|79318199|FG001|Overall Study|Decided to get treatment locally|5|||
44314564|NCT01854554|79318198|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
44314565|NCT01854554|79318199|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
44314566|NCT01854554|79318198|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
44314567|NCT01854554|79318199|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
44314568|NCT01854554|79318198|FG000|Overall Study|Progression|0|||
44314569|NCT01854554|79318199|FG001|Overall Study|Progression|1|||
44314570|NCT01854554|79318198|FG000|Overall Study|Lost to Follow-up|0|||
44314571|NCT01854554|79318199|FG001|Overall Study|Lost to Follow-up|1|||
44314572|NCT01817959|79318207|FG000|Overall Study|Graft loss|1|||
44314573|NCT01817959|79318208|FG001|Overall Study|Graft loss|1|||
44314574|NCT01817959|79318207|FG000|Overall Study|forbidden medication|1|||
44314575|NCT01817959|79318208|FG001|Overall Study|forbidden medication|1|||
44314576|NCT01817959|79318207|FG000|Overall Study|Adverse Event|1|||
44314577|NCT01817959|79318208|FG001|Overall Study|Adverse Event|0|||
44314578|NCT01817959|79318207|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
44314579|NCT01817959|79318208|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
44314580|NCT01755195|79318214|FG000|Overall Study|Participant noncompliance|2|||
44314581|NCT01755195|79318214|FG000|Overall Study|Switched to alternative treatment|4|||
44314582|NCT01755195|79318214|FG000|Overall Study|Withdrawal by Subject|1|||
44314583|NCT01755195|79318214|FG000|Overall Study|Participant refused to start treatment|1|||
44314584|NCT01755195|79318214|FG000|Overall Study|Participant has been consented for another trial|1|||
44314585|NCT01755195|79318214|FG000|Overall Study|Refused further treatment|3|||
44314586|NCT01755195|79318214|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
44314587|NCT01263769|79318225|FG000|Overall Study|Non-Compliant with treatment|1|||
44314588|NCT01004978|79318238|FG000|Overall Study|Disease progression|31|||
44314589|NCT01004978|79318239|FG001|Overall Study|Disease progression|48|||
44314590|NCT01004978|79318238|FG000|Overall Study|Adverse Event|42|||
44314591|NCT01004978|79318239|FG001|Overall Study|Adverse Event|22|||
44314592|NCT01004978|79318238|FG000|Overall Study|Death|3|||
44314593|NCT01004978|79318239|FG001|Overall Study|Death|2|||
44314594|NCT01004978|79318238|FG000|Overall Study|Withdrawal by Subject|16|||
44314595|NCT01004978|79318239|FG001|Overall Study|Withdrawal by Subject|16|||
44314596|NCT01004978|79318238|FG000|Overall Study|Alternative therapy|4|||
44314597|NCT01004978|79318239|FG001|Overall Study|Alternative therapy|8|||
44314598|NCT01004978|79318238|FG000|Overall Study|Physician Decision|6|||
44314599|NCT01004978|79318239|FG001|Overall Study|Physician Decision|3|||
44314600|NCT01004978|79318238|FG000|Overall Study|Other complicating disease|2|||
44314601|NCT01004978|79318239|FG001|Overall Study|Other complicating disease|2|||
44314602|NCT01004978|79318238|FG000|Overall Study|Protocol Violation|2|||
44314603|NCT01004978|79318239|FG001|Overall Study|Protocol Violation|3|||
44314604|NCT01004978|79318238|FG000|Overall Study|Non-compliance|3|||
44314605|NCT01004978|79318239|FG001|Overall Study|Non-compliance|2|||
44314606|NCT01004978|79318238|FG000|Overall Study|Ineligible|1|||
44314607|NCT01004978|79318239|FG001|Overall Study|Ineligible|0|||
44314608|NCT01004978|79318238|FG000|Overall Study|Unblinded|0|||
44314609|NCT01004978|79318239|FG001|Overall Study|Unblinded|1|||
44314610|NCT01004978|79318238|FG000|Overall Study|Performance status worsening|0|||
44314611|NCT01004978|79318239|FG001|Overall Study|Performance status worsening|1|||
44314612|NCT01004978|79318238|FG000|Overall Study|Never started treatment|8|||
44314613|NCT01004978|79318239|FG001|Overall Study|Never started treatment|9|||
44314614|NCT00643604|79318245|FG000|Overall Study|Death|1|||
44314615|NCT00447382|79318251|FG000|Overall Study|Adverse Event|1|||
44314616|NCT00447382|79318252|FG001|Overall Study|Adverse Event|1|||
44314617|NCT00447382|79318251|FG000|Overall Study|Lack of Efficacy|1|||
44314618|NCT00447382|79318252|FG001|Overall Study|Lack of Efficacy|0|||
44314619|NCT00447382|79318251|FG000|Overall Study|Protocol Violation|2|||
44314620|NCT00447382|79318252|FG001|Overall Study|Protocol Violation|0|||
44314621|NCT00447382|79318251|FG000|Overall Study|Unclassified|2|||
44314622|NCT00447382|79318252|FG001|Overall Study|Unclassified|5|||
44314623|NCT00135668|79318286|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
44314624|NCT00135668|79318287|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
44314625|NCT00135668|79318288|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
44314626|NCT00135668|79318289|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
44314627|NCT00066703|79318320|FG000|Overall Study|Adverse Event|80|||
44314628|NCT00066703|79318321|FG001|Overall Study|Adverse Event|111|||
44314629|NCT00066703|79318320|FG000|Overall Study|Death|3|||
44314630|NCT00066703|79318321|FG001|Overall Study|Death|0|||
44314631|NCT00066703|79318320|FG000|Overall Study|Lack of Efficacy|114|||
44314632|NCT00066703|79318321|FG001|Overall Study|Lack of Efficacy|69|||
44314633|NCT00066703|79318320|FG000|Overall Study|Lost to Follow-up|31|||
44314634|NCT00066703|79318321|FG001|Overall Study|Lost to Follow-up|28|||
44314635|NCT00066703|79318320|FG000|Overall Study|Withdrawal by Subject|38|||
44314636|NCT00066703|79318321|FG001|Overall Study|Withdrawal by Subject|63|||
44314637|NCT00066703|79318320|FG000|Overall Study|Treatment ongoing|346|||
44314638|NCT00066703|79318321|FG001|Overall Study|Treatment ongoing|311|||
44314639|NCT00066690|79318330|FG000|Overall Study|Adverse Event|145|||
44314640|NCT00066690|79318331|FG001|Overall Study|Adverse Event|58|||
44314641|NCT00066690|79318332|FG002|Overall Study|Adverse Event|126|||
44314642|NCT00066690|79318330|FG000|Overall Study|Death|3|||
44314643|NCT00066690|79318331|FG001|Overall Study|Death|0|||
44314644|NCT00066690|79318332|FG002|Overall Study|Death|2|||
44314645|NCT00066690|79318330|FG000|Overall Study|Lack of Efficacy|114|||
44314646|NCT00066690|79318331|FG001|Overall Study|Lack of Efficacy|110|||
44314647|NCT00066690|79318332|FG002|Overall Study|Lack of Efficacy|76|||
44314648|NCT00066690|79318330|FG000|Overall Study|Lost to Follow-up|40|||
44314649|NCT00066690|79318331|FG001|Overall Study|Lost to Follow-up|21|||
44314650|NCT00066690|79318332|FG002|Overall Study|Lost to Follow-up|29|||
44314651|NCT00066690|79318330|FG000|Overall Study|Withdrawal by Subject|50|||
44314652|NCT00066690|79318331|FG001|Overall Study|Withdrawal by Subject|55|||
44314653|NCT00066690|79318332|FG002|Overall Study|Withdrawal by Subject|49|||
44314654|NCT00066690|79318330|FG000|Overall Study|Treatment Ongoing|246|||
44314655|NCT00066690|79318331|FG001|Overall Study|Treatment Ongoing|278|||
44314656|NCT00066690|79318332|FG002|Overall Study|Treatment Ongoing|282|||
44314657|NCT01053962|79318348|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
44314658|NCT01053962|79318349|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
44314659|NCT01053962|79318350|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
44314660|NCT01053962|79318351|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
44314661|NCT01053962|79318352|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
44314662|NCT01053962|79318348|FG000|Pretreatment Period|Venipuncture Failure|0|||
44314663|NCT01053962|79318349|FG001|Pretreatment Period|Venipuncture Failure|0|||
44314664|NCT01053962|79318350|FG002|Pretreatment Period|Venipuncture Failure|1|||
44314665|NCT01053962|79318351|FG003|Pretreatment Period|Venipuncture Failure|0|||
44314666|NCT01053962|79318352|FG004|Pretreatment Period|Venipuncture Failure|0|||
44314667|NCT01053962|79318348|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
44536070|NCT00073307|79546844|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
44536071|NCT00073307|79546845|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
44314668|NCT01053962|79318349|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
44314669|NCT01053962|79318350|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
44314670|NCT01053962|79318351|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
44536072|NCT03388164|79546856|FG000|Overall Study|Withdrawal by Subject|3|||
44314671|NCT01053962|79318352|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
44314672|NCT01053962|79318348|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
44314673|NCT01053962|79318349|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
44314674|NCT01053962|79318350|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
44420838|NCT00799487|79428675|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
44314675|NCT01053962|79318351|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
44314676|NCT01053962|79318352|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
44420839|NCT00799487|79428673|FG000|Dose Adjustment Period|Investigator Discretion|2|||
44314677|NCT01053962|79318348|FG000|Treatment Period|Lack of Efficacy|0|||
44314678|NCT01053962|79318349|FG001|Treatment Period|Lack of Efficacy|0|||
44314679|NCT01053962|79318350|FG002|Treatment Period|Lack of Efficacy|0|||
44314680|NCT01053962|79318351|FG003|Treatment Period|Lack of Efficacy|0|||
44314681|NCT01053962|79318352|FG004|Treatment Period|Lack of Efficacy|1|||
44314682|NCT01053962|79318348|FG000|Treatment Period|Adverse Event|0|||
44314683|NCT01053962|79318349|FG001|Treatment Period|Adverse Event|0|||
44314684|NCT01053962|79318350|FG002|Treatment Period|Adverse Event|0|||
44314685|NCT01053962|79318351|FG003|Treatment Period|Adverse Event|0|||
44314686|NCT01053962|79318352|FG004|Treatment Period|Adverse Event|1|||
44314687|NCT01053962|79318348|FG000|Treatment Period|Withdrawal by Subject|0|||
44314688|NCT01053962|79318349|FG001|Treatment Period|Withdrawal by Subject|0|||
44314689|NCT01053962|79318350|FG002|Treatment Period|Withdrawal by Subject|0|||
44314690|NCT01053962|79318351|FG003|Treatment Period|Withdrawal by Subject|0|||
44314691|NCT01053962|79318352|FG004|Treatment Period|Withdrawal by Subject|1|||
44314692|NCT01053962|79318348|FG000|Treatment Period|Noncompliance with protocol|1|||
44314693|NCT01053962|79318349|FG001|Treatment Period|Noncompliance with protocol|0|||
44314694|NCT01053962|79318350|FG002|Treatment Period|Noncompliance with protocol|0|||
44314695|NCT01053962|79318351|FG003|Treatment Period|Noncompliance with protocol|0|||
44314696|NCT01053962|79318352|FG004|Treatment Period|Noncompliance with protocol|0|||
44314697|NCT01053221|79318371|FG000|Overall Study|The study was closed prematurely|5|||
44314698|NCT01053221|79318372|FG001|Overall Study|The study was closed prematurely|9|||
44314699|NCT01052012|79318384|FG000|Overall Study|Not treated|2|||
44314700|NCT01052012|79318385|FG001|Overall Study|Not treated|5|||
44314701|NCT01052012|79318386|FG002|Overall Study|Not treated|0|||
44314702|NCT01052012|79318387|FG003|Overall Study|Not treated|0|||
44314703|NCT01052012|79318388|FG004|Overall Study|Not treated|11|||
44314704|NCT01052012|79318389|FG005|Overall Study|Not treated|8|||
44314705|NCT01052012|79318384|FG000|Overall Study|Adverse Event|1|||
44314706|NCT01052012|79318385|FG001|Overall Study|Adverse Event|0|||
44314707|NCT01052012|79318386|FG002|Overall Study|Adverse Event|0|||
44314708|NCT01052012|79318387|FG003|Overall Study|Adverse Event|1|||
44314709|NCT01052012|79318388|FG004|Overall Study|Adverse Event|0|||
44314710|NCT01052012|79318389|FG005|Overall Study|Adverse Event|0|||
44314711|NCT01052012|79318384|FG000|Overall Study|Lost to Follow-up|0|||
44314712|NCT01052012|79318385|FG001|Overall Study|Lost to Follow-up|0|||
44314713|NCT01052012|79318386|FG002|Overall Study|Lost to Follow-up|0|||
44314714|NCT01052012|79318387|FG003|Overall Study|Lost to Follow-up|0|||
44314715|NCT01052012|79318388|FG004|Overall Study|Lost to Follow-up|1|||
44314716|NCT01052012|79318389|FG005|Overall Study|Lost to Follow-up|0|||
44314717|NCT01052012|79318384|FG000|Overall Study|Withdrawal by Subject|1|||
44314718|NCT01052012|79318385|FG001|Overall Study|Withdrawal by Subject|1|||
44314719|NCT01052012|79318386|FG002|Overall Study|Withdrawal by Subject|0|||
44314720|NCT01052012|79318387|FG003|Overall Study|Withdrawal by Subject|0|||
44314721|NCT01052012|79318388|FG004|Overall Study|Withdrawal by Subject|3|||
44314722|NCT01052012|79318389|FG005|Overall Study|Withdrawal by Subject|1|||
44314723|NCT01052012|79318384|FG000|Overall Study|Physician Decision|0|||
44314724|NCT01052012|79318385|FG001|Overall Study|Physician Decision|0|||
44314725|NCT01052012|79318386|FG002|Overall Study|Physician Decision|0|||
44314726|NCT01052012|79318387|FG003|Overall Study|Physician Decision|0|||
44314727|NCT01052012|79318388|FG004|Overall Study|Physician Decision|0|||
44314728|NCT01052012|79318389|FG005|Overall Study|Physician Decision|1|||
44314729|NCT01052012|79318384|FG000|Overall Study|Other|0|||
44314730|NCT01052012|79318385|FG001|Overall Study|Other|0|||
44314731|NCT01052012|79318386|FG002|Overall Study|Other|0|||
44314732|NCT01052012|79318387|FG003|Overall Study|Other|0|||
44314733|NCT01052012|79318388|FG004|Overall Study|Other|1|||
44314734|NCT01052012|79318389|FG005|Overall Study|Other|0|||
44314735|NCT01051817|79318405|FG000|Overall Study|Adverse Event|0|||
44314736|NCT01051817|79318406|FG001|Overall Study|Adverse Event|2|||
44314737|NCT01051817|79318405|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
44314738|NCT01051817|79318406|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
44314739|NCT01051817|79318405|FG000|Overall Study|Withdrawal by Subject|3|||
44314740|NCT01051817|79318406|FG001|Overall Study|Withdrawal by Subject|5|||
44314741|NCT01051817|79318405|FG000|Overall Study|Protocol Violation|0|||
44314742|NCT01051817|79318406|FG001|Overall Study|Protocol Violation|1|||
44536073|NCT03388164|79546857|FG001|Overall Study|Withdrawal by Subject|1|||
44536074|NCT03403374|79546863|FG000|Overall Study|Lost to Follow-up|1|||
44314743|NCT01327846|79318416|FG000|Core Phase|Subject decision (vital status: missing)|1|||
44314744|NCT01327846|79318417|FG001|Core Phase|Subject decision (vital status: missing)|2|||
44314745|NCT01327846|79318418|FG002|Core Phase|Subject decision (vital status: missing)|2|||
44314746|NCT01327846|79318419|FG003|Core Phase|Subject decision (vital status: missing)|1|||
44536075|NCT03387462|79546867|FG000|Overall Study|Lost to Follow-up|1|||
44314747|NCT01327846|79318416|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
44314748|NCT01327846|79318417|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
44314749|NCT01327846|79318418|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
44314750|NCT01327846|79318419|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
44314751|NCT01327846|79318416|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
44314752|NCT01327846|79318417|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
44314753|NCT01327846|79318418|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
44314754|NCT01327846|79318419|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
44314755|NCT01327846|79318416|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
44314756|NCT01327846|79318417|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
44314757|NCT01327846|79318418|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
44314758|NCT01327846|79318419|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
44314759|NCT01327846|79318416|FG000|Core Phase|Lost to Follow-up|3|||
44314760|NCT01327846|79318417|FG001|Core Phase|Lost to Follow-up|3|||
44314761|NCT01327846|79318418|FG002|Core Phase|Lost to Follow-up|4|||
44314762|NCT01327846|79318419|FG003|Core Phase|Lost to Follow-up|5|||
44314763|NCT01327846|79318416|FG000|Extension Phase|Study terminated by sponsor|1073|||
44314764|NCT01327846|79318417|FG001|Extension Phase|Study terminated by sponsor|1124|||
44314765|NCT01327846|79318418|FG002|Extension Phase|Study terminated by sponsor|1067|||
44314766|NCT01327846|79318419|FG003|Extension Phase|Study terminated by sponsor|1660|||
44314767|NCT01327846|79318416|FG000|Extension Phase|Withdrawal by Subject|20|||
44314768|NCT01327846|79318417|FG001|Extension Phase|Withdrawal by Subject|13|||
44314769|NCT01327846|79318418|FG002|Extension Phase|Withdrawal by Subject|19|||
44314770|NCT01327846|79318419|FG003|Extension Phase|Withdrawal by Subject|37|||
44314771|NCT01327846|79318416|FG000|Extension Phase|Lost to Follow-up|4|||
44314772|NCT01327846|79318417|FG001|Extension Phase|Lost to Follow-up|3|||
44314773|NCT01327846|79318418|FG002|Extension Phase|Lost to Follow-up|4|||
44314774|NCT01327846|79318419|FG003|Extension Phase|Lost to Follow-up|7|||
44314775|NCT01327846|79318416|FG000|Extension Phase|Technical Problems|2|||
44314776|NCT01327846|79318417|FG001|Extension Phase|Technical Problems|4|||
44314777|NCT01327846|79318418|FG002|Extension Phase|Technical Problems|2|||
44314778|NCT01327846|79318419|FG003|Extension Phase|Technical Problems|2|||
44314779|NCT01051739|79318432|FG000|Overall Study|Death|3|||
44314780|NCT01051739|79318433|FG001|Overall Study|Death|3|||
44314781|NCT01051739|79318432|FG000|Overall Study|Withdrawal by Subject|25|||
44314782|NCT01051739|79318433|FG001|Overall Study|Withdrawal by Subject|10|||
44314783|NCT01051661|79318445|FG000|Overall Study|Adverse Event|1|||
44314784|NCT01051661|79318446|FG001|Overall Study|Adverse Event|1|||
44314785|NCT01051661|79318447|FG002|Overall Study|Adverse Event|1|||
44314786|NCT01051661|79318448|FG003|Overall Study|Adverse Event|1|||
44314787|NCT01051661|79318449|FG004|Overall Study|Adverse Event|0|||
44314788|NCT01051661|79318450|FG005|Overall Study|Adverse Event|0|||
44314789|NCT01051661|79318445|FG000|Overall Study|Lost to Follow-up|13|||
44314790|NCT01051661|79318446|FG001|Overall Study|Lost to Follow-up|22|||
44314791|NCT01051661|79318447|FG002|Overall Study|Lost to Follow-up|15|||
44314792|NCT01051661|79318448|FG003|Overall Study|Lost to Follow-up|17|||
44314793|NCT01051661|79318449|FG004|Overall Study|Lost to Follow-up|10|||
44314794|NCT01051661|79318450|FG005|Overall Study|Lost to Follow-up|24|||
44314795|NCT01051661|79318445|FG000|Overall Study|Migrated/moved from study area|1|||
44314796|NCT01051661|79318446|FG001|Overall Study|Migrated/moved from study area|6|||
44314797|NCT01051661|79318447|FG002|Overall Study|Migrated/moved from study area|6|||
44314798|NCT01051661|79318448|FG003|Overall Study|Migrated/moved from study area|8|||
44314799|NCT01051661|79318449|FG004|Overall Study|Migrated/moved from study area|7|||
44314800|NCT01051661|79318450|FG005|Overall Study|Migrated/moved from study area|3|||
44314801|NCT01051661|79318445|FG000|Overall Study|Refused blood sampling|0|||
44314802|NCT01051661|79318446|FG001|Overall Study|Refused blood sampling|0|||
44314803|NCT01051661|79318447|FG002|Overall Study|Refused blood sampling|0|||
44314804|NCT01051661|79318448|FG003|Overall Study|Refused blood sampling|0|||
44314805|NCT01051661|79318449|FG004|Overall Study|Refused blood sampling|0|||
44314806|NCT01051661|79318450|FG005|Overall Study|Refused blood sampling|1|||
44314807|NCT01051661|79318445|FG000|Overall Study|Data not reliable|1|||
44314808|NCT01051661|79318446|FG001|Overall Study|Data not reliable|0|||
44314809|NCT01051661|79318447|FG002|Overall Study|Data not reliable|0|||
44314810|NCT01051661|79318448|FG003|Overall Study|Data not reliable|0|||
44314811|NCT01051661|79318449|FG004|Overall Study|Data not reliable|0|||
44314812|NCT01051661|79318450|FG005|Overall Study|Data not reliable|1|||
44314813|NCT01051661|79318445|FG000|Overall Study|Unable to attend visit(s)|2|||
44314814|NCT01051661|79318446|FG001|Overall Study|Unable to attend visit(s)|4|||
44314815|NCT01051661|79318447|FG002|Overall Study|Unable to attend visit(s)|2|||
44314816|NCT01051661|79318448|FG003|Overall Study|Unable to attend visit(s)|1|||
44314817|NCT01051661|79318449|FG004|Overall Study|Unable to attend visit(s)|3|||
44314818|NCT01051661|79318450|FG005|Overall Study|Unable to attend visit(s)|2|||
44314819|NCT01051661|79318445|FG000|Overall Study|Consent not received from both parents|0|||
44314820|NCT01051661|79318446|FG001|Overall Study|Consent not received from both parents|0|||
44314821|NCT01051661|79318447|FG002|Overall Study|Consent not received from both parents|0|||
44314822|NCT01051661|79318448|FG003|Overall Study|Consent not received from both parents|0|||
44314823|NCT01051661|79318449|FG004|Overall Study|Consent not received from both parents|0|||
44314824|NCT01051661|79318450|FG005|Overall Study|Consent not received from both parents|1|||
44314825|NCT01051661|79318445|FG000|Overall Study|Failure to comply with protocol|0|||
44314826|NCT01051661|79318446|FG001|Overall Study|Failure to comply with protocol|0|||
44420840|NCT00799487|79428674|FG001|Dose Adjustment Period|Investigator Discretion|0|||
44314827|NCT01051661|79318447|FG002|Overall Study|Failure to comply with protocol|2|||
44314828|NCT01051661|79318448|FG003|Overall Study|Failure to comply with protocol|0|||
44314829|NCT01051661|79318449|FG004|Overall Study|Failure to comply with protocol|0|||
44314830|NCT01051661|79318450|FG005|Overall Study|Failure to comply with protocol|0|||
44314831|NCT01051661|79318445|FG000|Overall Study|Subject lost legal representation|0|||
44314832|NCT01051661|79318446|FG001|Overall Study|Subject lost legal representation|0|||
44314833|NCT01051661|79318447|FG002|Overall Study|Subject lost legal representation|0|||
44314834|NCT01051661|79318448|FG003|Overall Study|Subject lost legal representation|0|||
44314835|NCT01051661|79318449|FG004|Overall Study|Subject lost legal representation|1|||
44314836|NCT01051661|79318450|FG005|Overall Study|Subject lost legal representation|0|||
44314837|NCT01051661|79318445|FG000|Overall Study|Protocol Violation|0|||
44314838|NCT01051661|79318446|FG001|Overall Study|Protocol Violation|0|||
44314839|NCT01051661|79318447|FG002|Overall Study|Protocol Violation|0|||
44314840|NCT01051661|79318448|FG003|Overall Study|Protocol Violation|1|||
44314841|NCT01051661|79318449|FG004|Overall Study|Protocol Violation|2|||
44314842|NCT01051661|79318450|FG005|Overall Study|Protocol Violation|1|||
44314843|NCT01051661|79318445|FG000|Overall Study|Withdrawal by Subject|16|||
44314844|NCT01051661|79318446|FG001|Overall Study|Withdrawal by Subject|30|||
44314845|NCT01051661|79318447|FG002|Overall Study|Withdrawal by Subject|13|||
44314846|NCT01051661|79318448|FG003|Overall Study|Withdrawal by Subject|28|||
44314847|NCT01051661|79318449|FG004|Overall Study|Withdrawal by Subject|12|||
44314848|NCT01051661|79318450|FG005|Overall Study|Withdrawal by Subject|34|||
44314849|NCT01051466|79318487|FG000|Overall Study|Adverse Event|1|||
44314850|NCT01051466|79318488|FG001|Overall Study|Adverse Event|0|||
44314851|NCT01051466|79318487|FG000|Overall Study|Lost to Follow-up|1|||
44314852|NCT01051466|79318488|FG001|Overall Study|Lost to Follow-up|1|||
44314853|NCT01051466|79318487|FG000|Overall Study|Withdrawal by Subject|5|||
44314854|NCT01051466|79318488|FG001|Overall Study|Withdrawal by Subject|1|||
44314855|NCT01051466|79318487|FG000|Overall Study|Entry Criteria Not Met|0|||
44314856|NCT01051466|79318488|FG001|Overall Study|Entry Criteria Not Met|3|||
44314857|NCT01051466|79318487|FG000|Overall Study|Physician Decision|1|||
44314858|NCT01051466|79318488|FG001|Overall Study|Physician Decision|0|||
44314859|NCT01051349|79318502|FG000|Overall Study|Adverse Event|88|||
44314860|NCT01051349|79318502|FG000|Overall Study|Consent Withdrawn|54|||
44314861|NCT01051349|79318502|FG000|Overall Study|Investigator Decision|6|||
44314862|NCT01051349|79318502|FG000|Overall Study|Lost to Follow-up|6|||
44314863|NCT01051349|79318502|FG000|Overall Study|Subject non-compliance|7|||
44314864|NCT01051349|79318502|FG000|Overall Study|Reason not Specified|12|||
44314865|NCT01050998|79318514|FG000|Overall Study|Adverse Event|1|||
44314866|NCT01050998|79318515|FG001|Overall Study|Adverse Event|0|||
44314867|NCT01050998|79318516|FG002|Overall Study|Adverse Event|1|||
44314868|NCT01050998|79318517|FG003|Overall Study|Adverse Event|0|||
44314869|NCT01050998|79318518|FG004|Overall Study|Adverse Event|2|||
44314870|NCT01050998|79318514|FG000|Overall Study|Withdrawal by Subject|0|||
44314871|NCT01050998|79318515|FG001|Overall Study|Withdrawal by Subject|0|||
44314872|NCT01050998|79318516|FG002|Overall Study|Withdrawal by Subject|0|||
44314873|NCT01050998|79318517|FG003|Overall Study|Withdrawal by Subject|1|||
44314874|NCT01050998|79318518|FG004|Overall Study|Withdrawal by Subject|3|||
44314875|NCT01050998|79318514|FG000|Overall Study|Other|3|||
44314876|NCT01050998|79318515|FG001|Overall Study|Other|2|||
44314877|NCT01050998|79318516|FG002|Overall Study|Other|1|||
44314878|NCT01050998|79318517|FG003|Overall Study|Other|1|||
44314879|NCT01050998|79318518|FG004|Overall Study|Other|5|||
44314880|NCT01050998|79318514|FG000|Overall Study|Data integrity issues|0|||
44314881|NCT01050998|79318515|FG001|Overall Study|Data integrity issues|0|||
44314882|NCT01050998|79318516|FG002|Overall Study|Data integrity issues|1|||
44314883|NCT01050998|79318517|FG003|Overall Study|Data integrity issues|1|||
44314884|NCT01050998|79318518|FG004|Overall Study|Data integrity issues|4|||
44314885|NCT00106028|79318536|FG000|Overall Study|Adverse Event|3|||
44314886|NCT00106028|79318537|FG001|Overall Study|Adverse Event|2|||
44536076|NCT03756883|79546874|FG000|Overall Study|Adverse Event|2|||
44536077|NCT03756883|79546875|FG001|Overall Study|Adverse Event|2|||
44536078|NCT03756883|79546876|FG002|Overall Study|Adverse Event|2|||
44536079|NCT03756883|79546874|FG000|Overall Study|Lack of Efficacy|0|||
44536080|NCT03756883|79546875|FG001|Overall Study|Lack of Efficacy|1|||
44314887|NCT00106028|79318536|FG000|Overall Study|Protocol Violation|1|||
44314888|NCT00106028|79318537|FG001|Overall Study|Protocol Violation|1|||
44314889|NCT00106028|79318536|FG000|Overall Study|Withdrawal by Subject|2|||
44314890|NCT00106028|79318537|FG001|Overall Study|Withdrawal by Subject|8|||
44314891|NCT00106028|79318536|FG000|Overall Study|Lost to Follow-up|0|||
44314892|NCT00106028|79318537|FG001|Overall Study|Lost to Follow-up|1|||
44314893|NCT01050764|79318545|FG000|Overall Study|Death, before HSCT|1|||
44314894|NCT01050764|79318545|FG000|Overall Study|Donor mobilization failure, death|1|||
44536081|NCT03756883|79546876|FG002|Overall Study|Lack of Efficacy|2|||
44536082|NCT03756883|79546874|FG000|Overall Study|Lost to Follow-up|3|||
44314895|NCT01050764|79318545|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
44314896|NCT01050569|79318552|FG000|Overall Study|Lost to Follow-up|20|||
44536083|NCT03756883|79546875|FG001|Overall Study|Lost to Follow-up|3|||
44314897|NCT01050569|79318553|FG001|Overall Study|Lost to Follow-up|14|||
44314898|NCT01050569|79318554|FG002|Overall Study|Lost to Follow-up|16|||
44314899|NCT01050569|79318552|FG000|Overall Study|Withdrawal by Subject|9|||
44314900|NCT01050569|79318553|FG001|Overall Study|Withdrawal by Subject|3|||
44314901|NCT01050569|79318554|FG002|Overall Study|Withdrawal by Subject|11|||
44314902|NCT01050569|79318552|FG000|Overall Study|Lack of Efficacy|5|||
44314903|NCT01050569|79318553|FG001|Overall Study|Lack of Efficacy|4|||
44314904|NCT01050569|79318554|FG002|Overall Study|Lack of Efficacy|3|||
44314905|NCT01050569|79318552|FG000|Overall Study|Adverse Event|1|||
44314906|NCT01050569|79318553|FG001|Overall Study|Adverse Event|0|||
44314907|NCT01050569|79318554|FG002|Overall Study|Adverse Event|0|||
44314908|NCT01050569|79318552|FG000|Overall Study|Physician Decision|3|||
44314909|NCT01050569|79318553|FG001|Overall Study|Physician Decision|3|||
44314910|NCT01050569|79318554|FG002|Overall Study|Physician Decision|3|||
44314911|NCT01050530|79318568|FG000|Overall Study|Adverse Event|6|||
44314912|NCT01050530|79318569|FG001|Overall Study|Adverse Event|3|||
44314913|NCT01050530|79318568|FG000|Overall Study|Lack of Efficacy|1|||
44314914|NCT01050530|79318569|FG001|Overall Study|Lack of Efficacy|4|||
44314915|NCT01050530|79318568|FG000|Overall Study|Withdrawal by Subject|0|||
44314916|NCT01050530|79318569|FG001|Overall Study|Withdrawal by Subject|3|||
44314917|NCT01050530|79318568|FG000|Overall Study|Protocol Violation|1|||
44314918|NCT01050530|79318569|FG001|Overall Study|Protocol Violation|0|||
44314919|NCT01050257|79318578|FG000|Overall Study|Adverse Event|4|||
44314920|NCT01050257|79318579|FG001|Overall Study|Adverse Event|4|||
44314921|NCT01050257|79318580|FG002|Overall Study|Adverse Event|2|||
44314922|NCT01050257|79318578|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
44314923|NCT01050257|79318579|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
44314924|NCT01050257|79318580|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
44314925|NCT01050257|79318578|FG000|Overall Study|Withdrawal by Subject|0|||
44314926|NCT01050257|79318579|FG001|Overall Study|Withdrawal by Subject|3|||
44314927|NCT01050257|79318580|FG002|Overall Study|Withdrawal by Subject|0|||
44314928|NCT01050257|79318578|FG000|Overall Study|No reason specified|0|||
44314929|NCT01050257|79318579|FG001|Overall Study|No reason specified|0|||
44314930|NCT01050257|79318580|FG002|Overall Study|No reason specified|2|||
44314931|NCT01050257|79318578|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
44314932|NCT01050257|79318579|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
44314933|NCT01050257|79318580|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
44314934|NCT01050257|79318578|FG000|Overall Study|Violation criteria|0|||
44314935|NCT01050257|79318579|FG001|Overall Study|Violation criteria|1|||
44314936|NCT01050257|79318580|FG002|Overall Study|Violation criteria|0|||
44314937|NCT01050257|79318578|FG000|Overall Study|Failure to return|0|||
44314938|NCT01050257|79318579|FG001|Overall Study|Failure to return|2|||
44314939|NCT01050257|79318580|FG002|Overall Study|Failure to return|0|||
44314940|NCT01050257|79318578|FG000|Overall Study|Death|0|||
44314941|NCT01050257|79318579|FG001|Overall Study|Death|0|||
44314942|NCT01050257|79318580|FG002|Overall Study|Death|1|||
44420841|NCT00799487|79428675|FG002|Dose Adjustment Period|Investigator Discretion|0|||
44536084|NCT03756883|79546876|FG002|Overall Study|Lost to Follow-up|0|||
44536085|NCT03756883|79546874|FG000|Overall Study|Protocol Violation|2|||
44536086|NCT03756883|79546875|FG001|Overall Study|Protocol Violation|0|||
44536087|NCT03756883|79546876|FG002|Overall Study|Protocol Violation|1|||
44314943|NCT01050062|79318590|FG000|Overall Study|Adverse Event|75|||
44314944|NCT01050062|79318591|FG001|Overall Study|Adverse Event|22|||
44314945|NCT01050062|79318590|FG000|Overall Study|Lost to Follow-up|83|||
44314946|NCT01050062|79318591|FG001|Overall Study|Lost to Follow-up|35|||
44536088|NCT03756883|79546874|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
44536089|NCT03756883|79546875|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
44536090|NCT03756883|79546876|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
44536091|NCT03756883|79546874|FG000|Overall Study|Withdrawal by Subject|4|||
44536092|NCT03756883|79546875|FG001|Overall Study|Withdrawal by Subject|1|||
44314947|NCT01050062|79318590|FG000|Overall Study|Lack of Efficacy|22|||
44314948|NCT01050062|79318591|FG001|Overall Study|Lack of Efficacy|35|||
44314949|NCT01050062|79318590|FG000|Overall Study|Physician Decision|74|||
44314950|NCT01050062|79318591|FG001|Overall Study|Physician Decision|9|||
44314951|NCT01050062|79318590|FG000|Overall Study|Others|17|||
44536093|NCT03756883|79546876|FG002|Overall Study|Withdrawal by Subject|0|||
44536094|NCT03756883|79546874|FG000|Overall Study|Other Reasons|2|||
44314952|NCT01050062|79318591|FG001|Overall Study|Others|11|||
44314953|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
44314954|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
44314955|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
44314956|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
44354746|NCT01186770|79359154|FG001|Overall Study|Adverse Event|9|||
44354747|NCT01186770|79359155|FG002|Overall Study|Adverse Event|7|||
44354748|NCT01186770|79359156|FG003|Overall Study|Adverse Event|9|||
44354749|NCT01186770|79359153|FG000|Overall Study|Withdrawal by Subject|15|||
44314957|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
44314958|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
44314959|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
44314960|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
44314961|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
44314962|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
44314963|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
44314964|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
44314965|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
44314966|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
44314967|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Death|1|||
44314968|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Death|0|||
44314969|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
44314970|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
44314971|NCT00105989|79318609|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
44314972|NCT00105989|79318610|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
44314973|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
44314974|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
44314975|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
44314976|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
44314977|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
44314978|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
44314979|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
44314980|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
44314981|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
44314982|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
44314983|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
44314984|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
44314985|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
44314986|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
44314987|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Death|0|||
44314988|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Death|0|||
44314989|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
44314990|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
44314991|NCT00105989|79318609|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
44314992|NCT00105989|79318610|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
44314993|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
44314994|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
44314995|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
44314996|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
44314997|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
44314998|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
44314999|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
44315000|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
44315001|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
44315002|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
44315003|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
44315004|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
44315005|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
44315006|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
44315007|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
44315008|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
44315009|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
44315010|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
44315011|NCT00105989|79318609|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
44315012|NCT00105989|79318610|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
44315013|NCT03277248|79318628|FG000|Overall Study|Adverse Event|3|||
44315014|NCT03277248|79318629|FG001|Overall Study|Adverse Event|1|||
44315015|NCT03277248|79318628|FG000|Overall Study|Subject Withdrawal of Consent|6|||
44315016|NCT03277248|79318629|FG001|Overall Study|Subject Withdrawal of Consent|23|||
44315017|NCT03277248|79318628|FG000|Overall Study|Investigator/Sponsor Decision|2|||
44315018|NCT03277248|79318629|FG001|Overall Study|Investigator/Sponsor Decision|2|||
44315019|NCT03277248|79318628|FG000|Overall Study|Pregnancy|4|||
44315020|NCT03277248|79318629|FG001|Overall Study|Pregnancy|1|||
44536095|NCT03756883|79546875|FG001|Overall Study|Other Reasons|4|||
44536096|NCT03756883|79546876|FG002|Overall Study|Other Reasons|0|||
44315021|NCT03277248|79318628|FG000|Overall Study|Lost to Follow-up|0|||
44315022|NCT03277248|79318629|FG001|Overall Study|Lost to Follow-up|2|||
44315023|NCT03277248|79318628|FG000|Overall Study|Lack of Efficacy|0|||
44315024|NCT03277248|79318629|FG001|Overall Study|Lack of Efficacy|2|||
44315025|NCT03277248|79318628|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
44315026|NCT03277248|79318629|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
44315027|NCT03276780|79318637|FG000|Overall Study|Withdrawal by Subject|5|||
44315028|NCT03276780|79318638|FG001|Overall Study|Withdrawal by Subject|3|||
44315029|NCT03276780|79318637|FG000|Overall Study|Lost to Follow-up|3|||
44315030|NCT03276780|79318638|FG001|Overall Study|Lost to Follow-up|5|||
44315031|NCT03276780|79318637|FG000|Overall Study|Moved out of state|1|||
44315032|NCT03276780|79318638|FG001|Overall Study|Moved out of state|1|||
44315033|NCT03276780|79318637|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
44315034|NCT03276780|79318638|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
44315035|NCT03276780|79318637|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
44315036|NCT03276780|79318638|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
44315037|NCT03271047|79318654|FG000|Phase 1b: Dose Finding Period|Death|8|||
44315038|NCT03271047|79318655|FG001|Phase 1b: Dose Finding Period|Death|8|||
44315039|NCT03271047|79318656|FG002|Phase 1b: Dose Finding Period|Death|0|||
44315040|NCT03271047|79318657|FG003|Phase 1b: Dose Finding Period|Death|0|||
44315041|NCT03271047|79318654|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
44315042|NCT03271047|79318655|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
44315043|NCT03271047|79318656|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
44315044|NCT03271047|79318657|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
44315045|NCT03271047|79318654|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
44315046|NCT03271047|79318655|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
44315047|NCT03271047|79318656|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
44315048|NCT03271047|79318657|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
44315049|NCT03271047|79318654|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
44315050|NCT03271047|79318655|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
44315051|NCT03271047|79318656|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
44155560|NCT01998958|78946972|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155561|NCT01998958|78946973|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155562|NCT01998958|78946974|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155563|NCT01998958|78946975|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155564|NCT01998958|78946976|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155565|NCT01998958|78946977|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155566|NCT01998958|78946978|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
44155567|NCT01998958|78946947|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155568|NCT01998958|78946948|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155569|NCT01998958|78946949|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44315052|NCT03271047|79318657|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
44315053|NCT03271047|79318654|FG000|Randomized Phase 2 Period|Other|0|||
44315054|NCT03271047|79318655|FG001|Randomized Phase 2 Period|Other|0|||
44315055|NCT03271047|79318656|FG002|Randomized Phase 2 Period|Other|0|||
44315056|NCT03271047|79318657|FG003|Randomized Phase 2 Period|Other|1|||
44315057|NCT03271047|79318654|FG000|Randomized Phase 2 Period|Death|0|||
44315058|NCT03271047|79318655|FG001|Randomized Phase 2 Period|Death|0|||
44315059|NCT03271047|79318656|FG002|Randomized Phase 2 Period|Death|20|||
44315060|NCT03271047|79318657|FG003|Randomized Phase 2 Period|Death|21|||
44315061|NCT03271047|79318654|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
44315062|NCT03271047|79318655|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
44315063|NCT03271047|79318656|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
44315064|NCT03271047|79318657|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
44315065|NCT03271047|79318654|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
44315066|NCT03271047|79318655|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
44315067|NCT03271047|79318656|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
44155570|NCT01998958|78946950|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155571|NCT01998958|78946951|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44315068|NCT03271047|79318657|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
44315069|NCT03271047|79318654|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
44315070|NCT03271047|79318655|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
44155572|NCT01998958|78946952|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44315071|NCT03271047|79318656|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
44315072|NCT03271047|79318657|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
44315073|NCT03276936|79318671|FG000|Overall Study|Adverse Event|4|||
44315074|NCT03276936|79318672|FG001|Overall Study|Adverse Event|2|||
44315075|NCT03276936|79318671|FG000|Overall Study|Lost to Follow-up|16|||
44155573|NCT01998958|78946953|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44315076|NCT03276936|79318672|FG001|Overall Study|Lost to Follow-up|13|||
44315077|NCT03276936|79318671|FG000|Overall Study|Withdrawal by Subject|30|||
44315078|NCT03276936|79318672|FG001|Overall Study|Withdrawal by Subject|20|||
44315079|NCT03276936|79318671|FG000|Overall Study|Not mentioned|6|||
44315080|NCT03276936|79318672|FG001|Overall Study|Not mentioned|3|||
44315081|NCT00106002|79318678|FG000|Overall Study|Did not take any study drug|1|||
44315082|NCT00106002|79318678|FG000|Overall Study|Ineligible after Registration|1|||
44315083|NCT00105482|79318696|FG000|Overall Study|Adverse Event|1|||
44315084|NCT00105482|79318697|FG001|Overall Study|Adverse Event|1|||
44315085|NCT00105482|79318696|FG000|Overall Study|Lost to Follow-up|26|||
44315086|NCT00105482|79318697|FG001|Overall Study|Lost to Follow-up|17|||
44315087|NCT00105482|79318696|FG000|Overall Study|Withdrawal by Subject|0|||
44315088|NCT00105482|79318697|FG001|Overall Study|Withdrawal by Subject|1|||
44315089|NCT00105482|79318696|FG000|Overall Study|Lost Interest|29|||
44315090|NCT00105482|79318697|FG001|Overall Study|Lost Interest|32|||
44315091|NCT00105482|79318696|FG000|Overall Study|Scheduling Conflict|2|||
44315092|NCT00105482|79318697|FG001|Overall Study|Scheduling Conflict|3|||
44315093|NCT00105482|79318696|FG000|Overall Study|Withdrawn by PI|1|||
44315094|NCT00105482|79318697|FG001|Overall Study|Withdrawn by PI|1|||
44315095|NCT01327651|79318712|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
44315096|NCT01327651|79318713|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
44536097|NCT03386994|79546887|FG000|Overall Study|Lung transplant|1|||
44536098|NCT03386994|79546887|FG000|Overall Study|Adverse Event|14|||
44536099|NCT03386994|79546887|FG000|Overall Study|Lost to Follow-up|4|||
44536100|NCT03386994|79546887|FG000|Overall Study|Withdrawal by Subject|3|||
44536101|NCT03386994|79546887|FG000|Overall Study|Death|16|||
44536102|NCT03756571|79546904|FG000|Overall Study|Lost to Follow-up|1|||
44536103|NCT03756571|79546905|FG001|Overall Study|Lost to Follow-up|1|||
44536104|NCT03386448|79546913|FG000|Overall Study|Adverse Event|0|||
44536105|NCT03386448|79546914|FG001|Overall Study|Adverse Event|2|||
44536106|NCT02951988|79546923|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
44155574|NCT01998958|78946954|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44257908|NCT00558285|79111512|FG004|Overall Study|Abnormal test procedure result(s)|0|||
44257909|NCT00558285|79111508|FG000|Overall Study|Subject withdrew consent|2|||
44257910|NCT00558285|79111509|FG001|Overall Study|Subject withdrew consent|0|||
44257911|NCT00558285|79111510|FG002|Overall Study|Subject withdrew consent|1|||
44257912|NCT00558285|79111511|FG003|Overall Study|Subject withdrew consent|1|||
44257913|NCT00558285|79111512|FG004|Overall Study|Subject withdrew consent|1|||
44257914|NCT00558285|79111508|FG000|Overall Study|Lost to Follow-up|1|||
44257915|NCT00558285|79111509|FG001|Overall Study|Lost to Follow-up|1|||
44257916|NCT00558285|79111510|FG002|Overall Study|Lost to Follow-up|0|||
44257917|NCT00558285|79111511|FG003|Overall Study|Lost to Follow-up|0|||
44257918|NCT00558285|79111512|FG004|Overall Study|Lost to Follow-up|0|||
44257919|NCT00558285|79111508|FG000|Overall Study|Administrative problems|0|||
44257920|NCT00558285|79111509|FG001|Overall Study|Administrative problems|0|||
44257921|NCT00558285|79111510|FG002|Overall Study|Administrative problems|0|||
44257922|NCT00558285|79111511|FG003|Overall Study|Administrative problems|1|||
44257923|NCT00558285|79111512|FG004|Overall Study|Administrative problems|1|||
44257924|NCT00558285|79111508|FG000|Overall Study|Protocol deviation|1|||
44257925|NCT00558285|79111509|FG001|Overall Study|Protocol deviation|1|||
44257926|NCT00558285|79111510|FG002|Overall Study|Protocol deviation|0|||
44257927|NCT00558285|79111511|FG003|Overall Study|Protocol deviation|1|||
44315097|NCT01327651|79318714|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
44315098|NCT01327651|79318715|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
44315099|NCT01327651|79318716|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
44315100|NCT01327651|79318717|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
44315101|NCT01327651|79318718|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
44315102|NCT01327651|79318719|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
44315103|NCT01327651|79318720|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
44315104|NCT01327651|79318712|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
44315105|NCT01327651|79318713|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315106|NCT01327651|79318714|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315107|NCT01327651|79318715|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315108|NCT01327651|79318716|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315109|NCT01327651|79318717|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315110|NCT01327651|79318718|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315111|NCT01327651|79318719|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315112|NCT01327651|79318720|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
44315113|NCT01327651|79318712|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
44315114|NCT01327651|79318713|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
44315115|NCT01327651|79318714|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
44315116|NCT01327651|79318715|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
44315117|NCT01327651|79318716|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
44315118|NCT01327651|79318717|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
44315119|NCT01327651|79318718|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
44315120|NCT01327651|79318719|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
44315121|NCT01327651|79318720|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
44315122|NCT01327651|79318712|FG000|Post Study Follow-up|Lost to Follow-up|0|||
44315123|NCT01327651|79318713|FG001|Post Study Follow-up|Lost to Follow-up|1|||
44315124|NCT01327651|79318714|FG002|Post Study Follow-up|Lost to Follow-up|1|||
44315125|NCT01327651|79318715|FG003|Post Study Follow-up|Lost to Follow-up|0|||
44315126|NCT01327651|79318716|FG004|Post Study Follow-up|Lost to Follow-up|0|||
44315127|NCT01327651|79318717|FG005|Post Study Follow-up|Lost to Follow-up|0|||
44315128|NCT01327651|79318718|FG006|Post Study Follow-up|Lost to Follow-up|4|||
44315129|NCT01327651|79318719|FG007|Post Study Follow-up|Lost to Follow-up|1|||
44315130|NCT01327651|79318720|FG008|Post Study Follow-up|Lost to Follow-up|2|||
44315131|NCT00105443|79318761|FG000|Double-Blind Treatment|Adverse Event|1|||
44315132|NCT00105443|79318762|FG001|Double-Blind Treatment|Adverse Event|0|||
44315133|NCT00105443|79318763|FG002|Double-Blind Treatment|Adverse Event|0|||
44315134|NCT00105443|79318764|FG003|Double-Blind Treatment|Adverse Event|0|||
44315135|NCT00105443|79318761|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
44315136|NCT00105443|79318762|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
44315137|NCT00105443|79318763|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
44315138|NCT00105443|79318764|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
44315139|NCT00105443|79318761|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
44315140|NCT00105443|79318762|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
44315141|NCT00105443|79318763|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
44315142|NCT00105443|79318764|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
44315143|NCT00105443|79318761|FG000|Double-Blind Treatment|Physician Decision|1|||
44315144|NCT00105443|79318762|FG001|Double-Blind Treatment|Physician Decision|0|||
44315145|NCT00105443|79318763|FG002|Double-Blind Treatment|Physician Decision|2|||
44315146|NCT00105443|79318764|FG003|Double-Blind Treatment|Physician Decision|0|||
44315147|NCT00105443|79318761|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
44315148|NCT00105443|79318762|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
44315149|NCT00105443|79318763|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
44315150|NCT00105443|79318764|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
44315151|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
44315152|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
44315153|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
44315154|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
44315155|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
44420842|NCT00799487|79428673|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
44420843|NCT00799487|79428674|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
44420844|NCT00799487|79428675|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
44315156|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
44420845|NCT00799487|79428673|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
44420846|NCT00799487|79428674|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
44420847|NCT00799487|79428675|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
44420848|NCT00799487|79428673|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
44420849|NCT00799487|79428674|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
44315157|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
44315158|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
44315159|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
44315160|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
44315161|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
44315162|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
44315163|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
44315164|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
44315165|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
44315166|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
44315167|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
44315168|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
44315169|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
44315170|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
44315171|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
44315172|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
44315173|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
44315174|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
44315175|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
44315176|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
44315177|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
44315178|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
44315179|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
44315180|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
44315181|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
44315182|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
44315183|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
44315184|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
44315185|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
44315186|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
44315187|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
44315188|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
44315189|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
44315190|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
44315191|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
44315192|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
44315193|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
44315194|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
44315195|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
44315196|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
44315197|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
44315198|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
44315199|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
44315200|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
44315201|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
44315202|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
44315203|NCT00105443|79318761|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
44315204|NCT00105443|79318762|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
44315205|NCT00105443|79318763|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
44315206|NCT00105443|79318764|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
44315207|NCT01327612|79318780|FG000|Overall Study|Withdrawal by Subject|0|||
44315208|NCT01327612|79318781|FG001|Overall Study|Withdrawal by Subject|0|||
44315209|NCT01327612|79318782|FG002|Overall Study|Withdrawal by Subject|0|||
44315210|NCT01327612|79318783|FG003|Overall Study|Withdrawal by Subject|0|||
44315211|NCT01327612|79318784|FG004|Overall Study|Withdrawal by Subject|0|||
44536107|NCT02951988|79546924|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
44536108|NCT02951988|79546925|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
44315212|NCT01327612|79318785|FG005|Overall Study|Withdrawal by Subject|1|||
44315213|NCT01327612|79318786|FG006|Overall Study|Withdrawal by Subject|0|||
44420850|NCT00799487|79428675|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
44420851|NCT00799487|79428673|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
44536109|NCT02951988|79546926|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
44536110|NCT02951988|79546923|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
44315214|NCT01327612|79318780|FG000|Overall Study|Disease Progression|1|||
44315215|NCT01327612|79318781|FG001|Overall Study|Disease Progression|1|||
44315216|NCT01327612|79318782|FG002|Overall Study|Disease Progression|1|||
44315217|NCT01327612|79318783|FG003|Overall Study|Disease Progression|0|||
44315218|NCT01327612|79318784|FG004|Overall Study|Disease Progression|1|||
44315219|NCT01327612|79318785|FG005|Overall Study|Disease Progression|2|||
44315220|NCT01327612|79318786|FG006|Overall Study|Disease Progression|2|||
44315221|NCT01327612|79318780|FG000|Overall Study|Administrative Decision|0|||
44315222|NCT01327612|79318781|FG001|Overall Study|Administrative Decision|0|||
44315223|NCT01327612|79318782|FG002|Overall Study|Administrative Decision|0|||
44315224|NCT01327612|79318783|FG003|Overall Study|Administrative Decision|1|||
44315225|NCT01327612|79318784|FG004|Overall Study|Administrative Decision|0|||
44315226|NCT01327612|79318785|FG005|Overall Study|Administrative Decision|0|||
44315227|NCT01327612|79318786|FG006|Overall Study|Administrative Decision|0|||
44315228|NCT01327612|79318780|FG000|Overall Study|Death|0|||
44315229|NCT01327612|79318781|FG001|Overall Study|Death|0|||
44536111|NCT02951988|79546924|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
44536112|NCT02951988|79546925|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
44536113|NCT02951988|79546926|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
44257928|NCT00558285|79111512|FG004|Overall Study|Protocol deviation|0|||
44257929|NCT01389596|79111527|FG000|Overall Study|Protocol Violation|3|||
44257930|NCT01389596|79111528|FG001|Overall Study|Protocol Violation|4|||
44257931|NCT01389596|79111529|FG002|Overall Study|Protocol Violation|3|||
44257932|NCT01389596|79111527|FG000|Overall Study|Withdrawal by Subject|1|||
44257933|NCT01389596|79111528|FG001|Overall Study|Withdrawal by Subject|2|||
44257934|NCT01389596|79111529|FG002|Overall Study|Withdrawal by Subject|2|||
44257935|NCT01389596|79111527|FG000|Overall Study|Insufficient Clinical Response|3|||
44315230|NCT01327612|79318782|FG002|Overall Study|Death|0|||
44315231|NCT01327612|79318783|FG003|Overall Study|Death|0|||
44315232|NCT01327612|79318784|FG004|Overall Study|Death|1|||
44315233|NCT01327612|79318785|FG005|Overall Study|Death|0|||
44315234|NCT01327612|79318786|FG006|Overall Study|Death|0|||
44315235|NCT01327573|79318805|FG000|Overall Study|Physician Decision|3|||
44315236|NCT01327573|79318806|FG001|Overall Study|Physician Decision|1|||
44315237|NCT01327495|79318819|FG000|Overall Study|Adverse Event|2|||
44315238|NCT01327495|79318820|FG001|Overall Study|Adverse Event|1|||
44315239|NCT01327495|79318821|FG002|Overall Study|Adverse Event|1|||
44315240|NCT01327495|79318822|FG003|Overall Study|Adverse Event|0|||
44315241|NCT01327495|79318823|FG004|Overall Study|Adverse Event|0|||
44315242|NCT01327495|79318824|FG005|Overall Study|Adverse Event|2|||
44315243|NCT01327495|79318819|FG000|Overall Study|Withdrawal by Subject|0|||
44315244|NCT01327495|79318820|FG001|Overall Study|Withdrawal by Subject|1|||
44315245|NCT01327495|79318821|FG002|Overall Study|Withdrawal by Subject|1|||
44315246|NCT01327495|79318822|FG003|Overall Study|Withdrawal by Subject|0|||
44315247|NCT01327495|79318823|FG004|Overall Study|Withdrawal by Subject|1|||
44315248|NCT01327495|79318824|FG005|Overall Study|Withdrawal by Subject|0|||
44315249|NCT01327495|79318819|FG000|Overall Study|Physician Decision|0|||
44315250|NCT01327495|79318820|FG001|Overall Study|Physician Decision|0|||
44315251|NCT01327495|79318821|FG002|Overall Study|Physician Decision|0|||
44315252|NCT01327495|79318822|FG003|Overall Study|Physician Decision|0|||
44315253|NCT01327495|79318823|FG004|Overall Study|Physician Decision|2|||
44315254|NCT01327495|79318824|FG005|Overall Study|Physician Decision|0|||
44315255|NCT01327339|79318844|FG000|Overall Study|Protocol Violation|8|||
44315256|NCT01327300|79318848|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
44315257|NCT01327300|79318849|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
44315258|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Adverse Event|3|||
44315259|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Adverse Event|0|||
44315260|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
44315261|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
44315262|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Disease Progression|23|||
44315263|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Disease Progression|22|||
44315264|NCT01379521|79318867|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
44315265|NCT01379521|79318868|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
44315266|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
44315267|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
44315268|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
44315269|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
44315270|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
44315271|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
44420852|NCT00799487|79428674|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
44315272|NCT01379521|79318867|FG000|Overall Study -Treatment Period|Death|2|||
44315273|NCT01379521|79318868|FG001|Overall Study -Treatment Period|Death|1|||
44315274|NCT01379521|79318867|FG000|Post-Treatment Evaluations|Disease Progression|22|||
44315275|NCT01379521|79318868|FG001|Post-Treatment Evaluations|Disease Progression|20|||
44315276|NCT01379521|79318867|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
44315277|NCT01379521|79318868|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
44315278|NCT01379521|79318867|FG000|Post-Treatment Evaluations|Death|1|||
44315279|NCT01379521|79318868|FG001|Post-Treatment Evaluations|Death|0|||
44315280|NCT01371994|79318876|FG000|Overall Study|Adverse Event|3|||
44315281|NCT01371994|79318877|FG001|Overall Study|Adverse Event|6|||
44315282|NCT01371994|79318876|FG000|Overall Study|Lack of Efficacy|3|||
44315283|NCT01371994|79318877|FG001|Overall Study|Lack of Efficacy|0|||
44315284|NCT01371994|79318876|FG000|Overall Study|Withdrawal by Subject|13|||
44315285|NCT01371994|79318877|FG001|Overall Study|Withdrawal by Subject|7|||
44315286|NCT01371994|79318876|FG000|Overall Study|Lost to Follow-up|1|||
44315287|NCT01371994|79318877|FG001|Overall Study|Lost to Follow-up|1|||
44315288|NCT01371994|79318876|FG000|Overall Study|Protocol Violation|24|||
44315289|NCT01371994|79318877|FG001|Overall Study|Protocol Violation|17|||
44315290|NCT01371994|79318876|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
44315291|NCT01371994|79318877|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
44315292|NCT01371994|79318876|FG000|Overall Study|Physician Decision|1|||
44315293|NCT01371994|79318877|FG001|Overall Study|Physician Decision|1|||
44315294|NCT01371994|79318876|FG000|Overall Study|Miscellaneous Reasons|6|||
44315295|NCT01371994|79318877|FG001|Overall Study|Miscellaneous Reasons|4|||
44315296|NCT01371877|79318885|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
44315297|NCT01371877|79318886|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
44315298|NCT01371838|79318894|FG000|Overall Study|Withdrawal by Subject|27|||
44315299|NCT01371838|79318895|FG001|Overall Study|Withdrawal by Subject|33|||
44315300|NCT01371838|79318894|FG000|Overall Study|Lost to Follow-up|10|||
44315301|NCT01371838|79318895|FG001|Overall Study|Lost to Follow-up|20|||
44315302|NCT01371838|79318894|FG000|Overall Study|Death|3|||
44315303|NCT01371838|79318895|FG001|Overall Study|Death|4|||
44315304|NCT01371838|79318894|FG000|Overall Study|Protocol Violation|3|||
44315305|NCT01371838|79318895|FG001|Overall Study|Protocol Violation|0|||
44315306|NCT01371838|79318894|FG000|Overall Study|Investigator Decision|3|||
44315307|NCT01371838|79318895|FG001|Overall Study|Investigator Decision|8|||
44315308|NCT01371838|79318894|FG000|Overall Study|Last follow-up visit not conducted|2|||
44315309|NCT01371838|79318895|FG001|Overall Study|Last follow-up visit not conducted|0|||
44315310|NCT01371838|79318894|FG000|Overall Study|Lack of therapeutic response|0|||
44315311|NCT01371838|79318895|FG001|Overall Study|Lack of therapeutic response|1|||
44315312|NCT01371838|79318894|FG000|Overall Study|Surgery|1|||
44315313|NCT01371838|79318895|FG001|Overall Study|Surgery|0|||
44315314|NCT01371721|79318904|FG000|Overall Study|Adverse Event|5|||
44315315|NCT01371721|79318905|FG001|Overall Study|Adverse Event|4|||
44315316|NCT01371721|79318906|FG002|Overall Study|Adverse Event|5|||
44315317|NCT01371721|79318904|FG000|Overall Study|Protocol Violation|6|||
44315318|NCT01371721|79318905|FG001|Overall Study|Protocol Violation|4|||
44315319|NCT01371721|79318906|FG002|Overall Study|Protocol Violation|5|||
44315320|NCT01371721|79318904|FG000|Overall Study|Lost to Follow-up|8|||
44315321|NCT01371721|79318905|FG001|Overall Study|Lost to Follow-up|2|||
44315322|NCT01371721|79318906|FG002|Overall Study|Lost to Follow-up|6|||
44315323|NCT01371721|79318904|FG000|Overall Study|Withdrawal by Subject|5|||
44315324|NCT01371721|79318905|FG001|Overall Study|Withdrawal by Subject|7|||
44315325|NCT01371721|79318906|FG002|Overall Study|Withdrawal by Subject|11|||
44315326|NCT01371721|79318904|FG000|Overall Study|Other|2|||
44315327|NCT01371721|79318905|FG001|Overall Study|Other|3|||
44315328|NCT01371721|79318906|FG002|Overall Study|Other|0|||
44420853|NCT00799487|79428675|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
44420854|NCT00799487|79428673|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
44155575|NCT01998958|78946955|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155576|NCT01998958|78946956|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44257936|NCT01389596|79111528|FG001|Overall Study|Insufficient Clinical Response|4|||
44257937|NCT01389596|79111529|FG002|Overall Study|Insufficient Clinical Response|5|||
44257938|NCT01389596|79111527|FG000|Overall Study|Adverse Event|1|||
44257939|NCT01389596|79111528|FG001|Overall Study|Adverse Event|4|||
44257940|NCT01389596|79111529|FG002|Overall Study|Adverse Event|0|||
44257941|NCT01389596|79111527|FG000|Overall Study|Death|0|||
44257942|NCT01389596|79111528|FG001|Overall Study|Death|1|||
44257943|NCT01389596|79111529|FG002|Overall Study|Death|0|||
44257944|NCT01389596|79111527|FG000|Overall Study|Other Unspecified|2|||
44257945|NCT01389596|79111528|FG001|Overall Study|Other Unspecified|1|||
44257946|NCT01389596|79111529|FG002|Overall Study|Other Unspecified|0|||
44257947|NCT01405898|79111565|FG000|Overall Study|Withdrawal by Subject|2|||
44257948|NCT01405898|79111566|FG001|Overall Study|Withdrawal by Subject|2|||
44257949|NCT01389128|79111592|FG000|Overall Study|Fetal distress|1|||
44257950|NCT01389128|79111593|FG001|Overall Study|Fetal distress|0|||
44257951|NCT01389128|79111592|FG000|Overall Study|Cervix dilation stop|1|||
44257952|NCT01389128|79111593|FG001|Overall Study|Cervix dilation stop|2|||
44257953|NCT01389128|79111592|FG000|Overall Study|Rapid labor evolution|3|||
44257954|NCT01389128|79111593|FG001|Overall Study|Rapid labor evolution|2|||
44257955|NCT01389128|79111592|FG000|Overall Study|Intolerance to procedure|0|||
44257956|NCT01389128|79111593|FG001|Overall Study|Intolerance to procedure|2|||
44315329|NCT01371721|79318904|FG000|Overall Study|Lack of Efficacy|2|||
44315330|NCT01371721|79318905|FG001|Overall Study|Lack of Efficacy|4|||
44315331|NCT01371721|79318906|FG002|Overall Study|Lack of Efficacy|3|||
44315332|NCT01371721|79318904|FG000|Overall Study|Randomized but not treated|1|||
44315333|NCT01371721|79318905|FG001|Overall Study|Randomized but not treated|0|||
44315334|NCT01371721|79318906|FG002|Overall Study|Randomized but not treated|0|||
44315335|NCT01366534|79318919|FG000|Overall Study|Lost to Follow-up|1|||
44315336|NCT01366534|79318920|FG001|Overall Study|Lost to Follow-up|0|||
44315337|NCT01366534|79318921|FG002|Overall Study|Lost to Follow-up|0|||
44315338|NCT01366534|79318919|FG000|Overall Study|Migrated|1|||
44315339|NCT01366534|79318920|FG001|Overall Study|Migrated|1|||
44315340|NCT01366534|79318921|FG002|Overall Study|Migrated|0|||
44315341|NCT01366534|79318919|FG000|Overall Study|Declined challenged|0|||
44315342|NCT01366534|79318920|FG001|Overall Study|Declined challenged|1|||
44315343|NCT01366534|79318921|FG002|Overall Study|Declined challenged|0|||
44315344|NCT01365910|79318929|FG000|Overall Study|Withdrawal by Subject|7|||
44315345|NCT01365910|79318929|FG000|Overall Study|disease progression|18|||
44315346|NCT01365910|79318929|FG000|Overall Study|Adverse Event|3|||
44315347|NCT01365910|79318929|FG000|Overall Study|other complicating disease|1|||
44315348|NCT01365910|79318929|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
44315349|NCT01365481|79318937|FG000|Overall Study|Adverse Event|6|||
44315350|NCT01365481|79318938|FG001|Overall Study|Adverse Event|9|||
44315351|NCT01365481|79318939|FG002|Overall Study|Adverse Event|0|||
44315352|NCT01365481|79318940|FG003|Overall Study|Adverse Event|2|||
44315353|NCT01365481|79318937|FG000|Overall Study|Withdrawal by Subject|0|||
44315354|NCT01365481|79318938|FG001|Overall Study|Withdrawal by Subject|2|||
44315355|NCT01365481|79318939|FG002|Overall Study|Withdrawal by Subject|1|||
44315356|NCT01365481|79318940|FG003|Overall Study|Withdrawal by Subject|1|||
44315357|NCT01365481|79318937|FG000|Overall Study|Lost to Follow-up|1|||
44315358|NCT01365481|79318938|FG001|Overall Study|Lost to Follow-up|1|||
44315359|NCT01365481|79318939|FG002|Overall Study|Lost to Follow-up|2|||
44315360|NCT01365481|79318940|FG003|Overall Study|Lost to Follow-up|3|||
44315361|NCT01365481|79318937|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44315362|NCT01365481|79318938|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44315363|NCT01365481|79318939|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44315364|NCT01365481|79318940|FG003|Overall Study|Abnormal laboratory value(s)|0|||
44315365|NCT01365481|79318937|FG000|Overall Study|Administrative problems|0|||
44315366|NCT01365481|79318938|FG001|Overall Study|Administrative problems|1|||
44315367|NCT01365481|79318939|FG002|Overall Study|Administrative problems|0|||
44315368|NCT01365481|79318940|FG003|Overall Study|Administrative problems|0|||
44315369|NCT01365481|79318937|FG000|Overall Study|Protocol deviation|0|||
44315370|NCT01365481|79318938|FG001|Overall Study|Protocol deviation|1|||
44315371|NCT01365481|79318939|FG002|Overall Study|Protocol deviation|0|||
44315372|NCT01365481|79318940|FG003|Overall Study|Protocol deviation|1|||
44315373|NCT01365481|79318937|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44315374|NCT01365481|79318938|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44315375|NCT01365481|79318939|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
44315376|NCT01365481|79318940|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
44315377|NCT01357915|79318952|FG000|Overall Study|Lost to Follow-up|3|||
44315378|NCT01357915|79318953|FG001|Overall Study|Lost to Follow-up|0|||
44315379|NCT01350973|79318962|FG000|Overall Study|Adverse Event|4|||
44315380|NCT01350973|79318963|FG001|Overall Study|Adverse Event|7|||
44315381|NCT01350973|79318964|FG002|Overall Study|Adverse Event|7|||
44315382|NCT01350973|79318962|FG000|Overall Study|Voluntary Withdrawal|2|||
44315383|NCT01350973|79318963|FG001|Overall Study|Voluntary Withdrawal|1|||
44315384|NCT01350973|79318964|FG002|Overall Study|Voluntary Withdrawal|1|||
44315385|NCT01350544|79318974|FG000|Overall Study|Administrative Withdrawal|0|||
44420855|NCT00799487|79428674|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
44420856|NCT00799487|79428675|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
44536114|NCT02951988|79546923|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
44315386|NCT01350544|79318975|FG001|Overall Study|Administrative Withdrawal|1|||
44315387|NCT01350544|79318974|FG000|Overall Study|Death|1|||
44315388|NCT01350544|79318975|FG001|Overall Study|Death|2|||
44315389|NCT01350544|79318974|FG000|Overall Study|Moved out of LA County|2|||
44315390|NCT01350544|79318975|FG001|Overall Study|Moved out of LA County|2|||
44315391|NCT01350544|79318974|FG000|Overall Study|Medical Issues|1|||
44315392|NCT01350544|79318975|FG001|Overall Study|Medical Issues|1|||
44315393|NCT01350544|79318974|FG000|Overall Study|Withdrawal by Subject|0|||
44315394|NCT01350544|79318975|FG001|Overall Study|Withdrawal by Subject|1|||
44315395|NCT01350544|79318974|FG000|Overall Study|Incarceration|1|||
44315396|NCT01350544|79318975|FG001|Overall Study|Incarceration|0|||
44315397|NCT01350544|79318974|FG000|Overall Study|Lost to Follow-up|18|||
44315398|NCT01350544|79318975|FG001|Overall Study|Lost to Follow-up|15|||
44315399|NCT01350505|79318981|FG000|Overall Study|Lost to Follow-up|4|||
44315400|NCT01350271|79318988|FG000|Overall Study|Lost to Follow-up|21|||
44315401|NCT01350271|79318989|FG001|Overall Study|Lost to Follow-up|17|||
44315402|NCT01350271|79318990|FG002|Overall Study|Lost to Follow-up|26|||
44315403|NCT01348828|79319001|FG000|Overall Study|Death|20|||
44315404|NCT01348828|79319001|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
44315405|NCT01348828|79319001|FG000|Overall Study|Conversion|2|||
44315406|NCT01348828|79319001|FG000|Overall Study|missed visit|1|||
44315407|NCT01348789|79319005|FG000|Overall Study|Protocol Violation|2|||
44315408|NCT01348789|79319005|FG000|Overall Study|Withdrawal by Subject|2|||
44315409|NCT01342510|79319020|FG000|Overall Study|Protocol Violation|12|||
44315410|NCT01342510|79319021|FG001|Overall Study|Protocol Violation|6|||
44315411|NCT01342510|79319022|FG002|Overall Study|Protocol Violation|13|||
44315412|NCT01342510|79319023|FG003|Overall Study|Protocol Violation|11|||
44315413|NCT01340872|79319043|FG000|Double-blind Phase|Adverse Event|6|||
44315414|NCT01340872|79319044|FG001|Double-blind Phase|Adverse Event|4|||
44315415|NCT01340872|79319045|FG002|Double-blind Phase|Adverse Event|0|||
44315416|NCT01340872|79319046|FG003|Double-blind Phase|Adverse Event|0|||
44315417|NCT01340872|79319043|FG000|Double-blind Phase|Withdrawal by Subject|3|||
44315418|NCT01340872|79319044|FG001|Double-blind Phase|Withdrawal by Subject|5|||
44315419|NCT01340872|79319045|FG002|Double-blind Phase|Withdrawal by Subject|0|||
44315420|NCT01340872|79319046|FG003|Double-blind Phase|Withdrawal by Subject|0|||
44315421|NCT01340872|79319043|FG000|Double-blind Phase|Lost to Follow-up|0|||
44315422|NCT01340872|79319044|FG001|Double-blind Phase|Lost to Follow-up|1|||
44315423|NCT01340872|79319045|FG002|Double-blind Phase|Lost to Follow-up|0|||
44315424|NCT01340872|79319046|FG003|Double-blind Phase|Lost to Follow-up|0|||
44315425|NCT01340872|79319043|FG000|Double-blind Phase|Protocol Violation|0|||
44315426|NCT01340872|79319044|FG001|Double-blind Phase|Protocol Violation|1|||
44315427|NCT01340872|79319045|FG002|Double-blind Phase|Protocol Violation|0|||
44315428|NCT01340872|79319046|FG003|Double-blind Phase|Protocol Violation|0|||
44315429|NCT01340872|79319043|FG000|Open-label Phase|Physician Decision|0|||
44315430|NCT01340872|79319044|FG001|Open-label Phase|Physician Decision|0|||
44315431|NCT01340872|79319045|FG002|Open-label Phase|Physician Decision|2|||
44315432|NCT01340872|79319046|FG003|Open-label Phase|Physician Decision|1|||
44315433|NCT01340872|79319043|FG000|Open-label Phase|Pregnancy|0|||
44315434|NCT01340872|79319044|FG001|Open-label Phase|Pregnancy|0|||
44315435|NCT01340872|79319045|FG002|Open-label Phase|Pregnancy|1|||
44315436|NCT01340872|79319046|FG003|Open-label Phase|Pregnancy|0|||
44315437|NCT01340872|79319043|FG000|Open-label Phase|Adverse Event|0|||
44315438|NCT01340872|79319044|FG001|Open-label Phase|Adverse Event|0|||
44315439|NCT01340872|79319045|FG002|Open-label Phase|Adverse Event|8|||
44315440|NCT01340872|79319046|FG003|Open-label Phase|Adverse Event|4|||
44315441|NCT01340872|79319043|FG000|Open-label Phase|Withdrawal by Subject|0|||
44315442|NCT01340872|79319044|FG001|Open-label Phase|Withdrawal by Subject|0|||
44315443|NCT01340872|79319045|FG002|Open-label Phase|Withdrawal by Subject|1|||
44315444|NCT01340872|79319046|FG003|Open-label Phase|Withdrawal by Subject|6|||
44315445|NCT01340872|79319043|FG000|Open-label Phase|Worsening of IBD|0|||
44315446|NCT01340872|79319044|FG001|Open-label Phase|Worsening of IBD|0|||
44315447|NCT01340872|79319045|FG002|Open-label Phase|Worsening of IBD|1|||
44315448|NCT01340872|79319046|FG003|Open-label Phase|Worsening of IBD|0|||
44315449|NCT01340794|79319060|FG000|Overall Study|Withdrawal by Subject|0|||
44315450|NCT01340794|79319061|FG001|Overall Study|Withdrawal by Subject|1|||
44315451|NCT01340482|79319072|FG000|Overall Study|Adverse Event|2|||
44315452|NCT01340482|79319073|FG001|Overall Study|Adverse Event|0|||
44315453|NCT01340482|79319074|FG002|Overall Study|Adverse Event|0|||
44315454|NCT01340209|79319087|FG000|Overall Study|Adverse Event|1|||
44315455|NCT01340209|79319088|FG001|Overall Study|Adverse Event|1|||
44315456|NCT01340209|79319089|FG002|Overall Study|Adverse Event|2|||
44315457|NCT01340209|79319087|FG000|Overall Study|Protocol Violation|1|||
44315458|NCT01340209|79319088|FG001|Overall Study|Protocol Violation|2|||
44315459|NCT01340209|79319089|FG002|Overall Study|Protocol Violation|1|||
44315460|NCT01340209|79319087|FG000|Overall Study|Withdrawal by Subject|0|||
44315461|NCT01340209|79319088|FG001|Overall Study|Withdrawal by Subject|0|||
44420857|NCT00799487|79428673|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
44257957|NCT01388816|79111624|FG000|Overall Study|Adverse Event|0|||
44257958|NCT01388816|79111625|FG001|Overall Study|Adverse Event|2|||
44257959|NCT01388816|79111626|FG002|Overall Study|Adverse Event|0|||
44257960|NCT01388816|79111627|FG003|Overall Study|Adverse Event|0|||
44257961|NCT01388816|79111624|FG000|Overall Study|Lost to Follow-up|0|||
44257962|NCT01388816|79111625|FG001|Overall Study|Lost to Follow-up|1|||
44257963|NCT01388816|79111626|FG002|Overall Study|Lost to Follow-up|0|||
44257964|NCT01388816|79111627|FG003|Overall Study|Lost to Follow-up|0|||
44257965|NCT01388816|79111624|FG000|Overall Study|Withdrawal by Subject|2|||
44257966|NCT01388816|79111625|FG001|Overall Study|Withdrawal by Subject|1|||
44257967|NCT01388816|79111626|FG002|Overall Study|Withdrawal by Subject|1|||
44257968|NCT01388816|79111627|FG003|Overall Study|Withdrawal by Subject|0|||
44257969|NCT01388816|79111624|FG000|Overall Study|Protocol Violation|0|||
44257970|NCT01388816|79111625|FG001|Overall Study|Protocol Violation|0|||
44315462|NCT01340209|79319089|FG002|Overall Study|Withdrawal by Subject|1|||
44315463|NCT01340209|79319087|FG000|Overall Study|Other reason not defined above|3|||
44315464|NCT01340209|79319088|FG001|Overall Study|Other reason not defined above|5|||
44257971|NCT01388816|79111626|FG002|Overall Study|Protocol Violation|2|||
44315465|NCT01340209|79319089|FG002|Overall Study|Other reason not defined above|4|||
44315466|NCT01326910|79319099|FG000|Overall Study|Withdrawal by Subject|3|||
44315467|NCT01326910|79319100|FG001|Overall Study|Withdrawal by Subject|2|||
44315468|NCT01326910|79319099|FG000|Overall Study|Protocol Violation|1|||
44315469|NCT01326910|79319100|FG001|Overall Study|Protocol Violation|1|||
44315470|NCT01326481|79319106|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
44315471|NCT01325701|79319114|FG000|Overall Study|Adverse Event|12|||
44315472|NCT01325701|79319115|FG001|Overall Study|Adverse Event|0|||
44315473|NCT01325701|79319114|FG000|Overall Study|Protocol Violation|1|||
44315474|NCT01325701|79319115|FG001|Overall Study|Protocol Violation|0|||
44315475|NCT01325701|79319114|FG000|Overall Study|Physician Decision|2|||
44315476|NCT01325701|79319115|FG001|Overall Study|Physician Decision|2|||
44315477|NCT01325701|79319114|FG000|Overall Study|Withdrawal by Subject|2|||
44315478|NCT01325701|79319115|FG001|Overall Study|Withdrawal by Subject|1|||
44315479|NCT01325701|79319114|FG000|Overall Study|Rollerover Extension Study|4|||
44315480|NCT01325701|79319115|FG001|Overall Study|Rollerover Extension Study|0|||
44315481|NCT01325623|79319122|FG000|Overall Study|Withdrawal by Subject|3|||
44315482|NCT01325584|79319159|FG000|Overall Study|Death|1|||
44315483|NCT01325428|79319163|FG000|Part A|Progressive disease according to RECIST|9|||
44315484|NCT01325428|79319163|FG000|Part A|Clinical signs, symptoms of progression|2|||
44315485|NCT01325428|79319163|FG000|Part A|Other adverse event|1|||
44315486|NCT01325428|79319163|FG000|Part A|Refused continue taking trial medication|2|||
44315487|NCT01325428|79319163|FG000|Part A|Other reason not defined above|2|||
44315488|NCT01325428|79319163|FG000|Part B|Refused continue taking trial medication|2|||
44315489|NCT01325428|79319163|FG000|Part B|Other reason not defined above|1|||
44315490|NCT01325350|79319177|FG000|Overall Study|Adverse Event|3|||
44315491|NCT01325350|79319178|FG001|Overall Study|Adverse Event|3|||
44315492|NCT01325350|79319179|FG002|Overall Study|Adverse Event|3|||
44315493|NCT01325350|79319180|FG003|Overall Study|Adverse Event|1|||
44315494|NCT01325350|79319181|FG004|Overall Study|Adverse Event|2|||
44315495|NCT01325350|79319177|FG000|Overall Study|Pregnancy|0|||
44315496|NCT01325350|79319178|FG001|Overall Study|Pregnancy|0|||
44315497|NCT01325350|79319179|FG002|Overall Study|Pregnancy|1|||
44315498|NCT01325350|79319180|FG003|Overall Study|Pregnancy|0|||
44315499|NCT01325350|79319181|FG004|Overall Study|Pregnancy|1|||
44315500|NCT01325350|79319177|FG000|Overall Study|Lost to Follow-up|1|||
44315501|NCT01325350|79319178|FG001|Overall Study|Lost to Follow-up|0|||
44315502|NCT01325350|79319179|FG002|Overall Study|Lost to Follow-up|5|||
44315503|NCT01325350|79319180|FG003|Overall Study|Lost to Follow-up|1|||
44315504|NCT01325350|79319181|FG004|Overall Study|Lost to Follow-up|5|||
44315505|NCT01325350|79319177|FG000|Overall Study|Personal Reasons|2|||
44420858|NCT00799487|79428674|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
44420859|NCT00799487|79428675|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
44420860|NCT00799487|79428673|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
44420861|NCT00799487|79428674|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
44420862|NCT00799487|79428675|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
44420863|NCT00799487|79428673|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
44420864|NCT00799487|79428674|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
44420865|NCT00799487|79428675|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
44420866|NCT00584727|79428686|FG000|First Intervention|Discontinuation|0|||
44420867|NCT00584727|79428687|FG001|First Intervention|Discontinuation|0|||
44420868|NCT00584727|79428688|FG002|First Intervention|Discontinuation|1|||
44420869|NCT00584727|79428689|FG003|First Intervention|Discontinuation|0|||
44420870|NCT00584727|79428690|FG004|First Intervention|Discontinuation|0|||
44420871|NCT00584727|79428691|FG005|First Intervention|Discontinuation|0|||
44420872|NCT00584727|79428686|FG000|Third Intervention|Protocol Violation|0|||
44420873|NCT00584727|79428687|FG001|Third Intervention|Protocol Violation|0|||
44536115|NCT02951988|79546924|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
44536116|NCT02951988|79546925|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
44536117|NCT02951988|79546926|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
44536118|NCT02951988|79546923|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
44536119|NCT02951988|79546924|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
44315506|NCT01325350|79319178|FG001|Overall Study|Personal Reasons|1|||
44315507|NCT01325350|79319179|FG002|Overall Study|Personal Reasons|6|||
44420874|NCT00584727|79428688|FG002|Third Intervention|Protocol Violation|1|||
44420875|NCT00584727|79428689|FG003|Third Intervention|Protocol Violation|0|||
44420876|NCT00584727|79428690|FG004|Third Intervention|Protocol Violation|4|||
44536120|NCT02951988|79546925|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
44315508|NCT01325350|79319180|FG003|Overall Study|Personal Reasons|5|||
44315509|NCT01325350|79319181|FG004|Overall Study|Personal Reasons|3|||
44315510|NCT01325350|79319177|FG000|Overall Study|Protocol Violation|0|||
44315511|NCT01325350|79319178|FG001|Overall Study|Protocol Violation|0|||
44315512|NCT01325350|79319179|FG002|Overall Study|Protocol Violation|0|||
44315513|NCT01325350|79319180|FG003|Overall Study|Protocol Violation|1|||
44315514|NCT01325350|79319181|FG004|Overall Study|Protocol Violation|0|||
44315515|NCT01325350|79319177|FG000|Overall Study|Withdrawal by Subject|0|||
44315516|NCT01325350|79319178|FG001|Overall Study|Withdrawal by Subject|0|||
44315517|NCT01325350|79319179|FG002|Overall Study|Withdrawal by Subject|1|||
44315518|NCT01325350|79319180|FG003|Overall Study|Withdrawal by Subject|1|||
44315519|NCT01325350|79319181|FG004|Overall Study|Withdrawal by Subject|0|||
44315520|NCT01325350|79319177|FG000|Overall Study|Did Not Receive Treatment|0|||
44315521|NCT01325350|79319178|FG001|Overall Study|Did Not Receive Treatment|1|||
44315522|NCT01325350|79319179|FG002|Overall Study|Did Not Receive Treatment|1|||
44315523|NCT01325350|79319180|FG003|Overall Study|Did Not Receive Treatment|0|||
44315524|NCT01325350|79319181|FG004|Overall Study|Did Not Receive Treatment|1|||
44315525|NCT01324999|79319193|FG000|Overall Study|Adverse Event|3|||
44315526|NCT01324999|79319193|FG000|Overall Study|Withdrawal by Subject|2|||
44315527|NCT01324570|79319199|FG000|Overall Study|Adverse Event|4|||
44315528|NCT01324570|79319200|FG001|Overall Study|Adverse Event|7|||
44315529|NCT01324570|79319199|FG000|Overall Study|Withdrawal by Subject|0|||
44315530|NCT01324570|79319200|FG001|Overall Study|Withdrawal by Subject|3|||
44315531|NCT01324570|79319199|FG000|Overall Study|Lack of Efficacy|0|||
44315532|NCT01324570|79319200|FG001|Overall Study|Lack of Efficacy|1|||
44315533|NCT01324570|79319199|FG000|Overall Study|Confirmed or suspected diversion|0|||
44315534|NCT01324570|79319200|FG001|Overall Study|Confirmed or suspected diversion|1|||
44315535|NCT01324570|79319199|FG000|Overall Study|Administrative|0|||
44315536|NCT01324570|79319200|FG001|Overall Study|Administrative|2|||
44315537|NCT01324141|79319208|FG000|Overall Study|Declined to participate before treatment started|1|||
44315538|NCT01324141|79319208|FG000|Overall Study|Disease progression on study|1|||
44315539|NCT01324102|79319224|FG000|Overall Study|illness|1|||
44315540|NCT01324102|79319225|FG001|Overall Study|illness|6|||
44315541|NCT01324024|79319232|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
44315542|NCT01324024|79319233|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44315543|NCT01323946|79319246|FG000|Overall Study|Lost to Follow-up|0|||
44315544|NCT01323946|79319247|FG001|Overall Study|Lost to Follow-up|1|||
44315545|NCT01323946|79319248|FG002|Overall Study|Lost to Follow-up|0|||
44315546|NCT01323946|79319246|FG000|Overall Study|Parents refused the last blood draw|1|||
44315547|NCT01323946|79319247|FG001|Overall Study|Parents refused the last blood draw|0|||
44315548|NCT01323946|79319248|FG002|Overall Study|Parents refused the last blood draw|0|||
44315549|NCT01323946|79319246|FG000|Overall Study|Withdrawal by Subject|2|||
44315550|NCT01323946|79319247|FG001|Overall Study|Withdrawal by Subject|2|||
44315551|NCT01323946|79319248|FG002|Overall Study|Withdrawal by Subject|0|||
44315552|NCT01323790|79319261|FG000|Overall Study|Other|3|||
44315553|NCT01323790|79319262|FG001|Overall Study|Other|2|||
44315554|NCT01323790|79319263|FG002|Overall Study|Other|1|||
44315555|NCT01323790|79319261|FG000|Overall Study|Lost to Follow-up|11|||
44315556|NCT01323790|79319262|FG001|Overall Study|Lost to Follow-up|9|||
44315557|NCT01323790|79319263|FG002|Overall Study|Lost to Follow-up|9|||
44315558|NCT01323790|79319261|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
44315559|NCT01323790|79319262|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
44315560|NCT01323790|79319263|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
44315561|NCT01323790|79319261|FG000|Overall Study|Lack of Efficacy|3|||
44315562|NCT01323790|79319262|FG001|Overall Study|Lack of Efficacy|0|||
44315563|NCT01323790|79319263|FG002|Overall Study|Lack of Efficacy|3|||
44315564|NCT01323790|79319261|FG000|Overall Study|Adverse Event|11|||
44315565|NCT01323790|79319262|FG001|Overall Study|Adverse Event|24|||
44315566|NCT01323790|79319263|FG002|Overall Study|Adverse Event|12|||
44315567|NCT01323790|79319261|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44315568|NCT01323790|79319262|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44315569|NCT01323790|79319263|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
44315570|NCT01323790|79319261|FG000|Overall Study|Withdrawal by Subject|23|||
44315571|NCT01323790|79319262|FG001|Overall Study|Withdrawal by Subject|20|||
44315572|NCT01323790|79319263|FG002|Overall Study|Withdrawal by Subject|13|||
44315573|NCT01323790|79319261|FG000|Overall Study|Did Not Receive Treatment|2|||
44315574|NCT01323790|79319262|FG001|Overall Study|Did Not Receive Treatment|0|||
44315575|NCT01323790|79319263|FG002|Overall Study|Did Not Receive Treatment|1|||
44315576|NCT01323790|79319261|FG000|Overall Study|Severe non-compliance with protocol|2|||
44315577|NCT01323790|79319262|FG001|Overall Study|Severe non-compliance with protocol|2|||
44315578|NCT01323790|79319263|FG002|Overall Study|Severe non-compliance with protocol|2|||
44315579|NCT01323673|79319273|FG000|Overall Study|Adverse Event|0|||
44315580|NCT01323673|79319274|FG001|Overall Study|Adverse Event|1|||
44315581|NCT01323673|79319273|FG000|Overall Study|Lost to Follow-up|0|||
44315582|NCT01323673|79319274|FG001|Overall Study|Lost to Follow-up|1|||
44315583|NCT01323673|79319273|FG000|Overall Study|Protocol Violation|1|||
44315584|NCT01323673|79319274|FG001|Overall Study|Protocol Violation|0|||
44315585|NCT01323673|79319273|FG000|Overall Study|Withdrawal by Subject|2|||
44315586|NCT01323673|79319274|FG001|Overall Study|Withdrawal by Subject|3|||
44315587|NCT01323634|79319282|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
44315588|NCT01323634|79319283|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
44315589|NCT01323634|79319284|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
44315590|NCT01323634|79319282|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
44315591|NCT01323634|79319283|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
44315592|NCT01323634|79319284|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
44315593|NCT01323634|79319282|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
44315594|NCT01323634|79319283|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44315595|NCT01323634|79319284|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44315596|NCT01323634|79319282|FG000|2-week Run-in Period|Physician Decision|5|||
44315597|NCT01323634|79319283|FG001|2-week Run-in Period|Physician Decision|0|||
44315598|NCT01323634|79319284|FG002|2-week Run-in Period|Physician Decision|0|||
44315599|NCT01323634|79319282|FG000|2-week Run-in Period|Protocol Violation|1|||
44315600|NCT01323634|79319283|FG001|2-week Run-in Period|Protocol Violation|0|||
44315601|NCT01323634|79319284|FG002|2-week Run-in Period|Protocol Violation|0|||
44315602|NCT01323634|79319282|FG000|2-week Run-in Period|Adverse Event|1|||
44315603|NCT01323634|79319283|FG001|2-week Run-in Period|Adverse Event|0|||
44315604|NCT01323634|79319284|FG002|2-week Run-in Period|Adverse Event|0|||
44315605|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
44315606|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
44315607|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
44315608|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44315609|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
44315610|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
44315611|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
44315612|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
44315613|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
44315614|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
44315615|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
44315616|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
44315617|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
44315618|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
44536121|NCT02951988|79546926|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
44536122|NCT02951988|79546923|FG000|Open-Label Treatment Period|Protocol Violation|22|||
44536123|NCT02951988|79546924|FG001|Open-Label Treatment Period|Protocol Violation|0|||
44536124|NCT02951988|79546925|FG002|Open-Label Treatment Period|Protocol Violation|0|||
44536125|NCT02951988|79546926|FG003|Open-Label Treatment Period|Protocol Violation|0|||
44536126|NCT02951988|79546923|FG000|Open-Label Treatment Period|Pregnancy|2|||
44315619|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
44315620|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
44315621|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
44315622|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
44315623|NCT01323634|79319282|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
44315624|NCT01323634|79319283|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
44315625|NCT01323634|79319284|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
44315626|NCT01323478|79319290|FG000|Overall Study|Adverse Event|7|||
44315627|NCT01323478|79319290|FG000|Overall Study|Lack of Efficacy|4|||
44315628|NCT01323478|79319290|FG000|Overall Study|Non-compliance With Study Product|3|||
44315629|NCT01323478|79319290|FG000|Overall Study|Protocol Violation|1|||
44315630|NCT01323478|79319290|FG000|Overall Study|Withdrawal of Consent|1|||
44315631|NCT01323478|79319290|FG000|Overall Study|Administrative or Other Reasons|8|||
44315632|NCT01322386|79319296|FG000|Overall Study|Protocol Violation|0|||
44315633|NCT01322386|79319297|FG001|Overall Study|Protocol Violation|1|||
44315634|NCT01322386|79319296|FG000|Overall Study|Physician Decision|0|||
44315635|NCT01322386|79319297|FG001|Overall Study|Physician Decision|1|||
44315636|NCT01322347|79319307|FG000|Overall Study|Adverse Event|7|||
44315637|NCT01322347|79319308|FG001|Overall Study|Adverse Event|2|||
44315638|NCT01322347|79319307|FG000|Overall Study|Death|5|||
44315639|NCT01322347|79319308|FG001|Overall Study|Death|3|||
44315640|NCT01322347|79319307|FG000|Overall Study|Physician Decision|2|||
44315641|NCT01322347|79319308|FG001|Overall Study|Physician Decision|1|||
44315642|NCT01322347|79319307|FG000|Overall Study|Protocol Violation|5|||
44315643|NCT01322347|79319308|FG001|Overall Study|Protocol Violation|2|||
44315644|NCT01322347|79319307|FG000|Overall Study|Withdrawal by Subject|1|||
44315645|NCT01322347|79319308|FG001|Overall Study|Withdrawal by Subject|4|||
44315646|NCT01322347|79319307|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
44315647|NCT01322347|79319308|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
44315648|NCT01322347|79319307|FG000|Overall Study|blood transfusion|5|||
44315649|NCT01322347|79319308|FG001|Overall Study|blood transfusion|5|||
44315650|NCT01322347|79319307|FG000|Overall Study|sponsor decision|1|||
44315651|NCT01322347|79319308|FG001|Overall Study|sponsor decision|3|||
44315652|NCT01322347|79319307|FG000|Overall Study|ineligible|6|||
44315653|NCT01322347|79319308|FG001|Overall Study|ineligible|3|||
44315654|NCT01322347|79319307|FG000|Overall Study|kidney transplant|3|||
44315655|NCT01322347|79319308|FG001|Overall Study|kidney transplant|1|||
44315656|NCT01322347|79319307|FG000|Overall Study|study drug withheld > 12 wks|0|||
44315657|NCT01322347|79319308|FG001|Overall Study|study drug withheld > 12 wks|1|||
44315658|NCT01322347|79319307|FG000|Overall Study|moved/changed dialysis|2|||
44315659|NCT01322347|79319308|FG001|Overall Study|moved/changed dialysis|4|||
44315660|NCT01321879|79319315|FG000|Overall Study|Lack of Efficacy|5|||
44315661|NCT01321879|79319315|FG000|Overall Study|Adverse Event|5|||
44315662|NCT01321879|79319315|FG000|Overall Study|Death|3|||
44315663|NCT01321879|79319315|FG000|Overall Study|Withdrawal by Subject|1|||
44315664|NCT01321723|79319322|FG000|Overall Study|Adverse Event|3|||
44315665|NCT01321723|79319323|FG001|Overall Study|Adverse Event|5|||
44315666|NCT01321723|79319324|FG002|Overall Study|Adverse Event|2|||
44315667|NCT01321723|79319322|FG000|Overall Study|Withdrawal by Subject|2|||
44315668|NCT01321723|79319323|FG001|Overall Study|Withdrawal by Subject|0|||
44315669|NCT01321723|79319324|FG002|Overall Study|Withdrawal by Subject|2|||
44315670|NCT01321606|79319334|FG000|Overall Study|Lost to Follow-up|0|||
44315671|NCT01321606|79319335|FG001|Overall Study|Lost to Follow-up|0|||
44315672|NCT01321606|79319336|FG002|Overall Study|Lost to Follow-up|0|||
44315673|NCT01321606|79319337|FG003|Overall Study|Lost to Follow-up|1|||
44315674|NCT01320943|79319349|FG000|Overall Study|Lost to Follow-up|1|||
44315675|NCT01320943|79319350|FG001|Overall Study|Lost to Follow-up|0|||
44315676|NCT01320943|79319349|FG000|Overall Study|Physician Decision|0|||
44315677|NCT01320943|79319350|FG001|Overall Study|Physician Decision|1|||
44315678|NCT01320943|79319349|FG000|Overall Study|Randomized but not Treated|0|||
44315679|NCT01320943|79319350|FG001|Overall Study|Randomized but not Treated|1|||
44315680|NCT02482233|79319365|FG000|Overall Study|Lost to Follow-up|1|||
44315681|NCT02482233|79319366|FG001|Overall Study|Lost to Follow-up|1|||
44315682|NCT01320202|79319376|FG000|Overall Study|Adverse Event|5|||
44315683|NCT01320202|79319377|FG001|Overall Study|Adverse Event|5|||
44315684|NCT01320202|79319376|FG000|Overall Study|Death|5|||
44315685|NCT01320202|79319377|FG001|Overall Study|Death|3|||
44315686|NCT01320202|79319376|FG000|Overall Study|Lost to Follow-up|1|||
44315687|NCT01320202|79319377|FG001|Overall Study|Lost to Follow-up|0|||
44315688|NCT01320202|79319376|FG000|Overall Study|Physician Decision|3|||
44315689|NCT01320202|79319377|FG001|Overall Study|Physician Decision|1|||
44315690|NCT01320202|79319376|FG000|Overall Study|Protocol Violation|2|||
44315691|NCT01320202|79319377|FG001|Overall Study|Protocol Violation|1|||
44315692|NCT01320202|79319376|FG000|Overall Study|Withdrawal by Subject|10|||
44315693|NCT01320202|79319377|FG001|Overall Study|Withdrawal by Subject|3|||
44315694|NCT01320202|79319376|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
44315695|NCT01320202|79319377|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
44315696|NCT01320202|79319376|FG000|Overall Study|kidney transplant|1|||
44315697|NCT01320202|79319377|FG001|Overall Study|kidney transplant|2|||
44315698|NCT01320202|79319376|FG000|Overall Study|blood transfusion|1|||
44315699|NCT01320202|79319377|FG001|Overall Study|blood transfusion|7|||
44315700|NCT01320202|79319376|FG000|Overall Study|moved/changed dialysis|5|||
44315701|NCT01320202|79319377|FG001|Overall Study|moved/changed dialysis|2|||
44315702|NCT01320202|79319376|FG000|Overall Study|sponsor request|2|||
44315703|NCT01320202|79319377|FG001|Overall Study|sponsor request|0|||
44315704|NCT01320202|79319376|FG000|Overall Study|ineligible|3|||
44315705|NCT01320202|79319377|FG001|Overall Study|ineligible|0|||
44420877|NCT00584727|79428691|FG005|Third Intervention|Protocol Violation|2|||
44420878|NCT00799409|79428705|FG000|Overall Study|Withdrawal by Subject|1|||
44536127|NCT02951988|79546924|FG001|Open-Label Treatment Period|Pregnancy|0|||
44536128|NCT02951988|79546925|FG002|Open-Label Treatment Period|Pregnancy|0|||
44536129|NCT02951988|79546926|FG003|Open-Label Treatment Period|Pregnancy|0|||
44315706|NCT01320202|79319376|FG000|Overall Study|regained renal function|1|||
44315707|NCT01320202|79319377|FG001|Overall Study|regained renal function|0|||
44315708|NCT01319383|79319386|FG000|Overall Study|No ex vivo or in vivo response|4|||
44315709|NCT01319383|79319387|FG001|Overall Study|No ex vivo or in vivo response|0|||
44315710|NCT01319383|79319386|FG000|Overall Study|Physician Decision|3|||
44315711|NCT01319383|79319387|FG001|Overall Study|Physician Decision|0|||
44315712|NCT01319383|79319386|FG000|Overall Study|Lack of Efficacy|5|||
44315713|NCT01319383|79319387|FG001|Overall Study|Lack of Efficacy|9|||
44315714|NCT01319383|79319386|FG000|Overall Study|No in vivo response to interval doses|0|||
44315715|NCT01319383|79319387|FG001|Overall Study|No in vivo response to interval doses|1|||
44315716|NCT01316614|79319404|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
44315717|NCT01316614|79319404|FG000|Overall Study|Cytology slides not available for review|4|||
44315718|NCT01316614|79319404|FG000|Overall Study|Cystic lesion|5|||
44315719|NCT01316614|79319404|FG000|Overall Study|Inadequate number of passes|2|||
44315720|NCT01316614|79319404|FG000|Overall Study|Medically unstable|1|||
44420879|NCT00799409|79428706|FG001|Overall Study|Withdrawal by Subject|0|||
44315721|NCT01316575|79319411|FG000|Overall Study|Withdrawal by Subject|2|||
44315722|NCT01316575|79319412|FG001|Overall Study|Withdrawal by Subject|0|||
44315723|NCT01316575|79319411|FG000|Overall Study|Required alternate treatment|0|||
44315724|NCT01316575|79319412|FG001|Overall Study|Required alternate treatment|1|||
44315725|NCT01315678|79319420|FG000|Overall Study|Withdrawal by Subject|7|||
44315726|NCT01315678|79319421|FG001|Overall Study|Withdrawal by Subject|3|||
44315727|NCT01315678|79319420|FG000|Overall Study|Adverse Event|3|||
44315728|NCT01315678|79319421|FG001|Overall Study|Adverse Event|1|||
44315729|NCT01315678|79319420|FG000|Overall Study|Lost to Follow-up|1|||
44315730|NCT01315678|79319421|FG001|Overall Study|Lost to Follow-up|0|||
44315731|NCT01315678|79319420|FG000|Overall Study|similar reason to those listed above|3|||
44315732|NCT01315678|79319421|FG001|Overall Study|similar reason to those listed above|2|||
44315733|NCT01315249|79319431|FG000|Overall Study|Adverse Event|22|||
44315734|NCT01315249|79319432|FG001|Overall Study|Adverse Event|26|||
44315735|NCT01315249|79319431|FG000|Overall Study|Withdrawal by Subject|11|||
44315736|NCT01315249|79319432|FG001|Overall Study|Withdrawal by Subject|10|||
44315737|NCT01315249|79319431|FG000|Overall Study|Protocol Violation|8|||
44315738|NCT01315249|79319432|FG001|Overall Study|Protocol Violation|5|||
44315739|NCT01315249|79319431|FG000|Overall Study|Abnormal test results|1|||
44315740|NCT01315249|79319432|FG001|Overall Study|Abnormal test results|2|||
44315741|NCT01315249|79319431|FG000|Overall Study|Administrative problems|1|||
44315742|NCT01315249|79319432|FG001|Overall Study|Administrative problems|0|||
44315743|NCT01315249|79319431|FG000|Overall Study|inability to use device|1|||
44315744|NCT01315249|79319432|FG001|Overall Study|inability to use device|0|||
44315745|NCT01315249|79319431|FG000|Overall Study|Lack of Efficacy|0|||
44315746|NCT01315249|79319432|FG001|Overall Study|Lack of Efficacy|1|||
44315747|NCT01315249|79319431|FG000|Overall Study|Lost to Follow-up|0|||
44315748|NCT01315249|79319432|FG001|Overall Study|Lost to Follow-up|2|||
44315749|NCT01315249|79319431|FG000|Overall Study|Death|0|||
44315750|NCT01315249|79319432|FG001|Overall Study|Death|1|||
44315751|NCT01315132|79319438|FG000|Overall Study|not treated due to disease progression|1|||
44315752|NCT01313767|79319444|FG000|Overall Study|Adverse Event|1|||
44315753|NCT01313767|79319445|FG001|Overall Study|Adverse Event|0|||
44315754|NCT01313767|79319444|FG000|Overall Study|Lost to Follow-up|1|||
44315755|NCT01313767|79319445|FG001|Overall Study|Lost to Follow-up|0|||
44315756|NCT01313767|79319444|FG000|Overall Study|Withdrawal by Subject|2|||
44315757|NCT01313767|79319445|FG001|Overall Study|Withdrawal by Subject|1|||
44315758|NCT01313767|79319444|FG000|Overall Study|Protocol Violation|3|||
44315759|NCT01313767|79319445|FG001|Overall Study|Protocol Violation|1|||
44420880|NCT00799409|79428707|FG002|Overall Study|Withdrawal by Subject|0|||
44420881|NCT00799409|79428705|FG000|Overall Study|Lost to Follow-up|1|||
44420882|NCT00799409|79428706|FG001|Overall Study|Lost to Follow-up|0|||
44420883|NCT00799409|79428707|FG002|Overall Study|Lost to Follow-up|0|||
44420884|NCT00799409|79428705|FG000|Overall Study|Optimal Dose Not Achieved|2|||
44420885|NCT00799409|79428706|FG001|Overall Study|Optimal Dose Not Achieved|0|||
44420886|NCT00799409|79428707|FG002|Overall Study|Optimal Dose Not Achieved|0|||
44420887|NCT00799409|79428705|FG000|Overall Study|Failure to follow study protocol)|1|||
44420888|NCT00799409|79428706|FG001|Overall Study|Failure to follow study protocol)|0|||
44420889|NCT00799409|79428707|FG002|Overall Study|Failure to follow study protocol)|0|||
44420890|NCT00799409|79428705|FG000|Overall Study|Did not attend lab school day 1|1|||
44420891|NCT00799409|79428706|FG001|Overall Study|Did not attend lab school day 1|0|||
44420892|NCT00799409|79428707|FG002|Overall Study|Did not attend lab school day 1|0|||
44420893|NCT00799409|79428705|FG000|Overall Study|medication compliance|1|||
44420894|NCT00799409|79428706|FG001|Overall Study|medication compliance|0|||
44420895|NCT00799409|79428707|FG002|Overall Study|medication compliance|0|||
44420896|NCT00782210|79428718|FG000|Overall Study|Adverse Event|21|||
44420897|NCT00782210|79428719|FG001|Overall Study|Adverse Event|17|||
44420898|NCT00782210|79428720|FG002|Overall Study|Adverse Event|16|||
44420899|NCT00782210|79428718|FG000|Overall Study|Lost to Follow-up|2|||
44420900|NCT00782210|79428719|FG001|Overall Study|Lost to Follow-up|1|||
44420901|NCT00782210|79428720|FG002|Overall Study|Lost to Follow-up|2|||
44420902|NCT00782210|79428718|FG000|Overall Study|Withdrawal by Subject|11|||
44315760|NCT01313728|79319451|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
44315761|NCT01313650|79319460|FG000|Overall Study|Adverse Event|9|||
44315762|NCT01313650|79319461|FG001|Overall Study|Adverse Event|34|||
44315763|NCT01313650|79319462|FG002|Overall Study|Adverse Event|24|||
44315764|NCT01313650|79319463|FG003|Overall Study|Adverse Event|23|||
44315765|NCT01313650|79319460|FG000|Overall Study|Lack of Efficacy|37|||
44420903|NCT00782210|79428719|FG001|Overall Study|Withdrawal by Subject|8|||
44420904|NCT00782210|79428720|FG002|Overall Study|Withdrawal by Subject|11|||
44315766|NCT01313650|79319461|FG001|Overall Study|Lack of Efficacy|20|||
44315767|NCT01313650|79319462|FG002|Overall Study|Lack of Efficacy|32|||
44315768|NCT01313650|79319463|FG003|Overall Study|Lack of Efficacy|20|||
44315769|NCT01313650|79319460|FG000|Overall Study|Lost to Follow-up|1|||
44315770|NCT01313650|79319461|FG001|Overall Study|Lost to Follow-up|0|||
44315771|NCT01313650|79319462|FG002|Overall Study|Lost to Follow-up|3|||
44420905|NCT00782210|79428718|FG000|Overall Study|Non compliance with protocol|0|||
44315772|NCT01313650|79319463|FG003|Overall Study|Lost to Follow-up|2|||
44315773|NCT01313650|79319460|FG000|Overall Study|Withdrawal by Subject|16|||
44315774|NCT01313650|79319461|FG001|Overall Study|Withdrawal by Subject|20|||
44315775|NCT01313650|79319462|FG002|Overall Study|Withdrawal by Subject|15|||
44315776|NCT01313650|79319463|FG003|Overall Study|Withdrawal by Subject|15|||
44315777|NCT01313650|79319460|FG000|Overall Study|Protocol Violation|4|||
44315778|NCT01313650|79319461|FG001|Overall Study|Protocol Violation|7|||
44315779|NCT01313650|79319462|FG002|Overall Study|Protocol Violation|5|||
44315780|NCT01313650|79319463|FG003|Overall Study|Protocol Violation|6|||
44315781|NCT01313650|79319460|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
44315782|NCT01313650|79319461|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
44315783|NCT01313650|79319462|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
44315784|NCT01313650|79319463|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
44315785|NCT01313299|79319476|FG000|Overall Study|Adverse Event|3|||
44315786|NCT01313299|79319477|FG001|Overall Study|Adverse Event|1|||
44315787|NCT01313299|79319478|FG002|Overall Study|Adverse Event|1|||
44315788|NCT01313299|79319476|FG000|Overall Study|Lost to Follow-up|1|||
44315789|NCT01313299|79319477|FG001|Overall Study|Lost to Follow-up|0|||
44315790|NCT01313299|79319478|FG002|Overall Study|Lost to Follow-up|0|||
44315791|NCT01313299|79319476|FG000|Overall Study|Protocol Violation|2|||
44315792|NCT01313299|79319477|FG001|Overall Study|Protocol Violation|0|||
44315793|NCT01313299|79319478|FG002|Overall Study|Protocol Violation|0|||
44315794|NCT01313299|79319476|FG000|Overall Study|Withdrawal by Subject|1|||
44315795|NCT01313299|79319477|FG001|Overall Study|Withdrawal by Subject|0|||
44315796|NCT01313299|79319478|FG002|Overall Study|Withdrawal by Subject|2|||
44315797|NCT01313299|79319476|FG000|Overall Study|Family reason and moved out of state|0|||
44315798|NCT01313299|79319477|FG001|Overall Study|Family reason and moved out of state|2|||
44315799|NCT01313299|79319478|FG002|Overall Study|Family reason and moved out of state|0|||
44315800|NCT01313299|79319476|FG000|Overall Study|Lack of subject compliance|0|||
44315801|NCT01313299|79319477|FG001|Overall Study|Lack of subject compliance|0|||
44315802|NCT01313299|79319478|FG002|Overall Study|Lack of subject compliance|1|||
44315803|NCT01313221|79319489|FG000|Overall Study|Protocol Violation|0|||
44315804|NCT01313221|79319490|FG001|Overall Study|Protocol Violation|1|||
44315805|NCT01313221|79319491|FG002|Overall Study|Protocol Violation|1|||
44315806|NCT01313221|79319489|FG000|Overall Study|Non-compliance|3|||
44315807|NCT01313221|79319490|FG001|Overall Study|Non-compliance|0|||
44315808|NCT01313221|79319491|FG002|Overall Study|Non-compliance|2|||
44315809|NCT01313221|79319489|FG000|Overall Study|Withdrawal by Subject|2|||
44315810|NCT01313221|79319490|FG001|Overall Study|Withdrawal by Subject|3|||
44315811|NCT01313221|79319491|FG002|Overall Study|Withdrawal by Subject|5|||
44315812|NCT01313221|79319489|FG000|Overall Study|Requirement for alternative therapy|0|||
44315813|NCT01313221|79319490|FG001|Overall Study|Requirement for alternative therapy|1|||
44315814|NCT01313221|79319491|FG002|Overall Study|Requirement for alternative therapy|1|||
44315815|NCT01313221|79319489|FG000|Overall Study|Lost to Follow-up|6|||
44315816|NCT01313221|79319490|FG001|Overall Study|Lost to Follow-up|3|||
44315817|NCT01313221|79319491|FG002|Overall Study|Lost to Follow-up|1|||
44315818|NCT01313221|79319489|FG000|Overall Study|Other|1|||
44315819|NCT01313221|79319490|FG001|Overall Study|Other|0|||
44315820|NCT01313221|79319491|FG002|Overall Study|Other|0|||
44315821|NCT01313221|79319489|FG000|Overall Study|Adverse Event|0|||
44315822|NCT01313221|79319490|FG001|Overall Study|Adverse Event|0|||
44315823|NCT01313221|79319491|FG002|Overall Study|Adverse Event|7|||
44315824|NCT01313221|79319489|FG000|Overall Study|Disease progression|0|||
44315825|NCT01313221|79319490|FG001|Overall Study|Disease progression|0|||
44315826|NCT01313221|79319491|FG002|Overall Study|Disease progression|2|||
44315827|NCT01313221|79319489|FG000|Overall Study|Physician Decision|0|||
44315828|NCT01313221|79319490|FG001|Overall Study|Physician Decision|0|||
44315829|NCT01313221|79319491|FG002|Overall Study|Physician Decision|2|||
44315830|NCT01313221|79319489|FG000|Overall Study|Pregnancy|0|||
44315831|NCT01313221|79319490|FG001|Overall Study|Pregnancy|0|||
44315832|NCT01313221|79319491|FG002|Overall Study|Pregnancy|2|||
44315833|NCT01313182|79319501|FG000|Overall Study|Protocol Violation|66|||
44315834|NCT01313182|79319502|FG001|Overall Study|Protocol Violation|92|||
44315835|NCT01312909|79319511|FG000|Overall Study|Randomized but not treated|1|||
44315836|NCT01312909|79319512|FG001|Overall Study|Randomized but not treated|3|||
44315837|NCT01312909|79319513|FG002|Overall Study|Randomized but not treated|1|||
44536130|NCT02951988|79546923|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
44315838|NCT01312909|79319511|FG000|Overall Study|Adverse Event|1|||
44315839|NCT01312909|79319512|FG001|Overall Study|Adverse Event|0|||
44315840|NCT01312909|79319513|FG002|Overall Study|Adverse Event|3|||
44315841|NCT01312909|79319511|FG000|Overall Study|Protocol Violation|2|||
44315842|NCT01312909|79319512|FG001|Overall Study|Protocol Violation|0|||
44315843|NCT01312909|79319513|FG002|Overall Study|Protocol Violation|2|||
44315844|NCT01312909|79319511|FG000|Overall Study|Other|9|||
44315845|NCT01312909|79319512|FG001|Overall Study|Other|6|||
44315846|NCT01312909|79319513|FG002|Overall Study|Other|11|||
44315847|NCT01312909|79319511|FG000|Overall Study|Withdrawal by Subject|8|||
44315848|NCT01312909|79319512|FG001|Overall Study|Withdrawal by Subject|10|||
44315849|NCT01312909|79319513|FG002|Overall Study|Withdrawal by Subject|7|||
44315850|NCT01312909|79319511|FG000|Overall Study|Lost to Follow-up|21|||
44315851|NCT01312909|79319512|FG001|Overall Study|Lost to Follow-up|17|||
44315852|NCT01312909|79319513|FG002|Overall Study|Lost to Follow-up|20|||
44315853|NCT01312909|79319511|FG000|Overall Study|Insufficient clinical response|0|||
44315854|NCT01312909|79319512|FG001|Overall Study|Insufficient clinical response|0|||
44315855|NCT01312909|79319513|FG002|Overall Study|Insufficient clinical response|1|||
44315856|NCT01312909|79319511|FG000|Overall Study|Entrance criteria not met|0|||
44315857|NCT01312909|79319512|FG001|Overall Study|Entrance criteria not met|0|||
44315858|NCT01312909|79319513|FG002|Overall Study|Entrance criteria not met|2|||
44315859|NCT01312129|79319523|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
44315860|NCT01312129|79319524|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
44315861|NCT01311661|79319530|FG000|Overall Study|Adverse Event|2|||
44315862|NCT01311661|79319530|FG000|Overall Study|Protocol Violation|3|||
44315863|NCT01311661|79319530|FG000|Overall Study|Withdrawal by Subject|2|||
44315864|NCT01311505|79319542|FG000|First Intervention Period|Protocol Violation|0|||
44315865|NCT01311505|79319543|FG001|First Intervention Period|Protocol Violation|1|||
44315866|NCT01310803|79319554|FG000|Overall Study|Subject terminated by Sponsor|1|||
44315867|NCT01310803|79319555|FG001|Overall Study|Subject terminated by Sponsor|0|||
44315868|NCT01310413|79319567|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
44315869|NCT01310413|79319568|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
44315870|NCT01310413|79319569|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
44315871|NCT01310413|79319570|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
44315872|NCT01310413|79319571|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
44315873|NCT01310413|79319572|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
44315874|NCT01310413|79319573|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
44315875|NCT01310413|79319567|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
44315876|NCT01310413|79319568|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
44315877|NCT01310413|79319569|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
44315878|NCT01310413|79319570|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
44315879|NCT01310413|79319571|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
44315880|NCT01310413|79319572|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
44315881|NCT01310413|79319573|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
44315882|NCT01310413|79319567|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
44315883|NCT01310413|79319568|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
44315884|NCT01310413|79319569|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
44315885|NCT01310413|79319570|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
44315886|NCT01310413|79319571|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
44315887|NCT01310413|79319572|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
44315888|NCT01310413|79319573|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
44315889|NCT01310413|79319567|FG000|Day 0 to Day 385|Other|1|||
44315890|NCT01310413|79319568|FG001|Day 0 to Day 385|Other|0|||
44315891|NCT01310413|79319569|FG002|Day 0 to Day 385|Other|3|||
44315892|NCT01310413|79319570|FG003|Day 0 to Day 385|Other|0|||
44315893|NCT01310413|79319571|FG004|Day 0 to Day 385|Other|0|||
44315894|NCT01310413|79319572|FG005|Day 0 to Day 385|Other|0|||
44315895|NCT01310413|79319573|FG006|Day 0 to Day 385|Other|0|||
44315896|NCT01310413|79319567|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
44315897|NCT01310413|79319568|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
44155577|NCT01998958|78946957|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44257972|NCT01388816|79111627|FG003|Overall Study|Protocol Violation|0|||
44257973|NCT00555477|79111781|FG000|Overall Study|Adverse Event|0|||
44257974|NCT00555477|79111782|FG001|Overall Study|Adverse Event|9|||
44257975|NCT00555477|79111781|FG000|Overall Study|Withdrawal by Subject|1|||
44257976|NCT00555477|79111782|FG001|Overall Study|Withdrawal by Subject|2|||
44257977|NCT00555477|79111781|FG000|Overall Study|Physician Decision|1|||
44257978|NCT00555477|79111782|FG001|Overall Study|Physician Decision|2|||
44257979|NCT00554619|79111799|FG000|Overall Study|Adverse Event|1|||
44257980|NCT00554619|79111799|FG000|Overall Study|Physician Decision|1|||
44315898|NCT01310413|79319569|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
44257981|NCT00554619|79111799|FG000|Overall Study|Liver Function Test Abnormality|1|||
44315899|NCT01310413|79319570|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
44315900|NCT01310413|79319571|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
44315901|NCT01310413|79319572|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
44315902|NCT01310413|79319573|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
44315903|NCT01310413|79319567|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
44315904|NCT01310413|79319568|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
44315905|NCT01310413|79319569|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
44315906|NCT01310413|79319570|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
44315907|NCT01310413|79319571|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
44315908|NCT01310413|79319572|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
44315909|NCT01310413|79319573|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
44315910|NCT01309828|79319604|FG000|Overall Study|Adverse Event|10|||
44315911|NCT01309828|79319605|FG001|Overall Study|Adverse Event|11|||
44315912|NCT01309828|79319604|FG000|Overall Study|Voluntary Withdrawal|5|||
44315913|NCT01309828|79319605|FG001|Overall Study|Voluntary Withdrawal|4|||
44315914|NCT01309828|79319604|FG000|Overall Study|Major Protocol Deviation|0|||
44315915|NCT01309828|79319605|FG001|Overall Study|Major Protocol Deviation|1|||
44315916|NCT01309828|79319604|FG000|Overall Study|Other|1|||
44315917|NCT01309828|79319605|FG001|Overall Study|Other|0|||
44315918|NCT01309282|79319611|FG000|Overall Study|Lost to Follow-up|1|||
44315919|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
44315920|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
44315921|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
44315922|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
44315923|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Death|0|||
44315924|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Death|1|||
44315925|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
44315926|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
44315927|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
44315928|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
44315929|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
44315930|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
44315931|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
44315932|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
44315933|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
44315934|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
44315935|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
44315936|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
44315937|NCT01309243|79319617|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
44315938|NCT01309243|79319618|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
44315939|NCT01309243|79319617|FG000|Extension Phase|Lost to Follow-up|6|||
44315940|NCT01309243|79319618|FG001|Extension Phase|Lost to Follow-up|0|||
44315941|NCT01309204|79319626|FG000|Overall Study|Adverse Event|48|||
44315942|NCT01309204|79319627|FG001|Overall Study|Adverse Event|58|||
44315943|NCT01309204|79319626|FG000|Overall Study|Lost to Follow-up|2|||
44315944|NCT01309204|79319627|FG001|Overall Study|Lost to Follow-up|2|||
44315945|NCT01309204|79319626|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
44315946|NCT01309204|79319627|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
44315947|NCT01309204|79319626|FG000|Overall Study|Inadequate control of IOP|4|||
44315948|NCT01309204|79319627|FG001|Overall Study|Inadequate control of IOP|4|||
44315949|NCT01309204|79319626|FG000|Overall Study|Other|4|||
44315950|NCT01309204|79319627|FG001|Overall Study|Other|1|||
44315951|NCT01309165|79319635|FG000|Overall Study|Lost to Follow-up|4|||
44315952|NCT01309165|79319636|FG001|Overall Study|Lost to Follow-up|3|||
44315953|NCT01309165|79319635|FG000|Overall Study|Return to work|1|||
44315954|NCT01309165|79319636|FG001|Overall Study|Return to work|2|||
44315955|NCT01309165|79319635|FG000|Overall Study|Left country|0|||
44315956|NCT01309165|79319636|FG001|Overall Study|Left country|1|||
44315957|NCT01309165|79319635|FG000|Overall Study|No transportation|0|||
44315958|NCT01309165|79319636|FG001|Overall Study|No transportation|1|||
44315959|NCT01309165|79319635|FG000|Overall Study|Admitted to hospital for second stroke|1|||
44315960|NCT01309165|79319636|FG001|Overall Study|Admitted to hospital for second stroke|0|||
44315961|NCT01308853|79319643|FG000|Overall Study|Adverse Event|1|||
44315962|NCT01308853|79319643|FG000|Overall Study|Lost to Follow-up|2|||
44315963|NCT01308853|79319643|FG000|Overall Study|Insertion of permanent implants|1|||
44315964|NCT01308736|79319649|FG000|Overall Study|Did not attend a single session|6|||
44155578|NCT01998958|78946958|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44315965|NCT01308736|79319650|FG001|Overall Study|Did not attend a single session|5|||
44536131|NCT02951988|79546924|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
44315966|NCT01308580|79319658|FG000|Overall Study|Lost to Follow-up|12|||
44315967|NCT01308580|79319659|FG001|Overall Study|Lost to Follow-up|7|||
44315968|NCT01308463|79319666|FG000|Overall Study|Study Discontinued|23|||
44315969|NCT01308463|79319666|FG000|Overall Study|Death|4|||
44315970|NCT01308463|79319666|FG000|Overall Study|Revision|2|||
44315971|NCT01308424|79319672|FG000|Baseline Eligibility|Screen Failures|71|||
44315972|NCT01308424|79319673|FG001|Baseline Eligibility|Screen Failures|0|||
44315973|NCT01308424|79319674|FG002|Baseline Eligibility|Screen Failures|0|||
44315974|NCT01308424|79319672|FG000|Randomization|Adverse Event|0|||
44315975|NCT01308424|79319673|FG001|Randomization|Adverse Event|1|||
44315976|NCT01308424|79319674|FG002|Randomization|Adverse Event|1|||
44315977|NCT01308424|79319672|FG000|Randomization|Lost to Follow-up|0|||
44315978|NCT01308424|79319673|FG001|Randomization|Lost to Follow-up|1|||
44315979|NCT01308424|79319674|FG002|Randomization|Lost to Follow-up|0|||
44315980|NCT01308424|79319672|FG000|Randomization|Physician Decision|0|||
44315981|NCT01308424|79319673|FG001|Randomization|Physician Decision|1|||
44315982|NCT01308424|79319674|FG002|Randomization|Physician Decision|1|||
44315983|NCT01307800|79319685|FG000|Overall Study|Adverse Event|9|||
44315984|NCT01307800|79319686|FG001|Overall Study|Adverse Event|8|||
44315985|NCT01307800|79319687|FG002|Overall Study|Adverse Event|10|||
44315986|NCT01307800|79319688|FG003|Overall Study|Adverse Event|14|||
44315987|NCT01307800|79319685|FG000|Overall Study|Entry Criteria Not Met|0|||
44315988|NCT01307800|79319686|FG001|Overall Study|Entry Criteria Not Met|0|||
44315989|NCT01307800|79319687|FG002|Overall Study|Entry Criteria Not Met|0|||
44315990|NCT01307800|79319688|FG003|Overall Study|Entry Criteria Not Met|2|||
44315991|NCT01307800|79319685|FG000|Overall Study|Lost to Follow-up|5|||
44315992|NCT01307800|79319686|FG001|Overall Study|Lost to Follow-up|6|||
44315993|NCT01307800|79319687|FG002|Overall Study|Lost to Follow-up|2|||
44315994|NCT01307800|79319688|FG003|Overall Study|Lost to Follow-up|8|||
44315995|NCT01307800|79319685|FG000|Overall Study|Perceived Lack of Efficacy|24|||
44315996|NCT01307800|79319686|FG001|Overall Study|Perceived Lack of Efficacy|23|||
44315997|NCT01307800|79319687|FG002|Overall Study|Perceived Lack of Efficacy|20|||
44315998|NCT01307800|79319688|FG003|Overall Study|Perceived Lack of Efficacy|33|||
44315999|NCT01307800|79319685|FG000|Overall Study|Protocol Violation|0|||
44316000|NCT01307800|79319686|FG001|Overall Study|Protocol Violation|3|||
44316001|NCT01307800|79319687|FG002|Overall Study|Protocol Violation|4|||
44316002|NCT01307800|79319688|FG003|Overall Study|Protocol Violation|5|||
44316003|NCT01307800|79319685|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
44316004|NCT01307800|79319686|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
44316005|NCT01307800|79319687|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
44316006|NCT01307800|79319688|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
44316007|NCT01307800|79319685|FG000|Overall Study|Sponsor Decision|6|||
44316008|NCT01307800|79319686|FG001|Overall Study|Sponsor Decision|9|||
44316009|NCT01307800|79319687|FG002|Overall Study|Sponsor Decision|12|||
44316010|NCT01307800|79319688|FG003|Overall Study|Sponsor Decision|28|||
44316011|NCT01307800|79319685|FG000|Overall Study|Withdrawal by Subject|10|||
44316012|NCT01307800|79319686|FG001|Overall Study|Withdrawal by Subject|11|||
44316013|NCT01307800|79319687|FG002|Overall Study|Withdrawal by Subject|8|||
44316014|NCT01307800|79319688|FG003|Overall Study|Withdrawal by Subject|15|||
44316015|NCT01307800|79319685|FG000|Overall Study|Participant Moved|0|||
44316016|NCT01307800|79319686|FG001|Overall Study|Participant Moved|2|||
44316017|NCT01307800|79319687|FG002|Overall Study|Participant Moved|1|||
44316018|NCT01307800|79319688|FG003|Overall Study|Participant Moved|3|||
44316019|NCT01307449|79319702|FG000|Overall Study|Adverse Event|1|||
44316020|NCT01307449|79319703|FG001|Overall Study|Adverse Event|0|||
44316021|NCT01307449|79319704|FG002|Overall Study|Adverse Event|0|||
44316022|NCT01307449|79319705|FG003|Overall Study|Adverse Event|0|||
44316023|NCT01307020|79319725|FG000|Overall Study|Lost to Follow-up|0|||
44316024|NCT01307020|79319726|FG001|Overall Study|Lost to Follow-up|0|||
44316025|NCT01307020|79319727|FG002|Overall Study|Lost to Follow-up|1|||
44316026|NCT01307020|79319728|FG003|Overall Study|Lost to Follow-up|1|||
44316027|NCT01307020|79319729|FG004|Overall Study|Lost to Follow-up|0|||
44316028|NCT01307020|79319730|FG005|Overall Study|Lost to Follow-up|0|||
44316029|NCT01307020|79319731|FG006|Overall Study|Lost to Follow-up|1|||
44316030|NCT01307020|79319732|FG007|Overall Study|Lost to Follow-up|0|||
44316031|NCT01307020|79319733|FG008|Overall Study|Lost to Follow-up|0|||
44420906|NCT00782210|79428719|FG001|Overall Study|Non compliance with protocol|3|||
44420907|NCT00782210|79428720|FG002|Overall Study|Non compliance with protocol|2|||
44420908|NCT00782210|79428718|FG000|Overall Study|Lack of Efficacy|13|||
44420909|NCT00782210|79428719|FG001|Overall Study|Lack of Efficacy|4|||
44316032|NCT01307020|79319734|FG009|Overall Study|Lost to Follow-up|0|||
44316033|NCT01307020|79319725|FG000|Overall Study|Electronic data capture failure|0|||
44316034|NCT01307020|79319726|FG001|Overall Study|Electronic data capture failure|1|||
44316035|NCT01307020|79319727|FG002|Overall Study|Electronic data capture failure|0|||
44316036|NCT01307020|79319728|FG003|Overall Study|Electronic data capture failure|0|||
44316037|NCT01307020|79319729|FG004|Overall Study|Electronic data capture failure|0|||
44316038|NCT01307020|79319730|FG005|Overall Study|Electronic data capture failure|0|||
44316039|NCT01307020|79319731|FG006|Overall Study|Electronic data capture failure|0|||
44316040|NCT01307020|79319732|FG007|Overall Study|Electronic data capture failure|0|||
44316041|NCT01307020|79319733|FG008|Overall Study|Electronic data capture failure|0|||
44316042|NCT01307020|79319734|FG009|Overall Study|Electronic data capture failure|0|||
44316043|NCT01306201|79319756|FG000|Overall Study|Arrhythmia|4|||
44316044|NCT01306201|79319756|FG000|Overall Study|Files could not be processed|3|||
44316045|NCT01306201|79319756|FG000|Overall Study|Files unreadable|3|||
44316046|NCT01306162|79319768|FG000|Period 1|Adverse Event|0|||
44316047|NCT01306162|79319769|FG001|Period 1|Adverse Event|0|||
44316048|NCT01306162|79319770|FG002|Period 1|Adverse Event|0|||
44316049|NCT01306162|79319771|FG003|Period 1|Adverse Event|1|||
44316050|NCT01306162|79319768|FG000|Washout 1|Non-compliance to protocol|0|||
44316051|NCT01306162|79319769|FG001|Washout 1|Non-compliance to protocol|1|||
44316052|NCT01306162|79319770|FG002|Washout 1|Non-compliance to protocol|0|||
44316053|NCT01306162|79319771|FG003|Washout 1|Non-compliance to protocol|0|||
44316054|NCT01305577|79319787|FG000|Overall Study|Adverse Event|2|||
44316055|NCT01305577|79319788|FG001|Overall Study|Adverse Event|2|||
44316056|NCT01305577|79319789|FG002|Overall Study|Adverse Event|1|||
44316057|NCT01305577|79319787|FG000|Overall Study|Withdrawal by Subject|7|||
44316058|NCT01305577|79319788|FG001|Overall Study|Withdrawal by Subject|5|||
44316059|NCT01305577|79319789|FG002|Overall Study|Withdrawal by Subject|6|||
44316060|NCT01305577|79319787|FG000|Overall Study|Lost to Follow-up|4|||
44316061|NCT01305577|79319788|FG001|Overall Study|Lost to Follow-up|3|||
44316062|NCT01305577|79319789|FG002|Overall Study|Lost to Follow-up|2|||
44316063|NCT01305577|79319787|FG000|Overall Study|Protocol Deviation|0|||
44316064|NCT01305577|79319788|FG001|Overall Study|Protocol Deviation|1|||
44316065|NCT01305577|79319789|FG002|Overall Study|Protocol Deviation|1|||
44316066|NCT01304329|79319797|FG000|Third Intervention (3 Days)|Adverse Event|0|||
44316067|NCT01304329|79319798|FG001|Third Intervention (3 Days)|Adverse Event|1|||
44316068|NCT01304329|79319799|FG002|Third Intervention (3 Days)|Adverse Event|0|||
44316069|NCT01304329|79319800|FG003|Third Intervention (3 Days)|Adverse Event|0|||
44316070|NCT01304329|79319801|FG004|Third Intervention (3 Days)|Adverse Event|0|||
44316071|NCT01304329|79319802|FG005|Third Intervention (3 Days)|Adverse Event|0|||
44316072|NCT01303861|79319815|FG000|Overall Study|Lost to Follow-up|34|||
44316073|NCT01303861|79319816|FG001|Overall Study|Lost to Follow-up|14|||
44316074|NCT01303861|79319817|FG002|Overall Study|Lost to Follow-up|27|||
44316075|NCT01303861|79319818|FG003|Overall Study|Lost to Follow-up|31|||
44316076|NCT01303861|79319815|FG000|Overall Study|Lack of Efficacy|3|||
44316077|NCT01303861|79319816|FG001|Overall Study|Lack of Efficacy|2|||
44316078|NCT01303861|79319817|FG002|Overall Study|Lack of Efficacy|1|||
44316079|NCT01303861|79319818|FG003|Overall Study|Lack of Efficacy|0|||
44316080|NCT01303861|79319815|FG000|Overall Study|Withdrawal by Subject|16|||
44316081|NCT01303861|79319816|FG001|Overall Study|Withdrawal by Subject|8|||
44316082|NCT01303861|79319817|FG002|Overall Study|Withdrawal by Subject|8|||
44316083|NCT01303861|79319818|FG003|Overall Study|Withdrawal by Subject|23|||
44536132|NCT02951988|79546925|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
44316084|NCT01303861|79319815|FG000|Overall Study|Adverse Event|4|||
44316085|NCT01303861|79319816|FG001|Overall Study|Adverse Event|1|||
44316086|NCT01303861|79319817|FG002|Overall Study|Adverse Event|0|||
44316087|NCT01303861|79319818|FG003|Overall Study|Adverse Event|5|||
44316088|NCT01303861|79319815|FG000|Overall Study|Pregnancy|1|||
44316089|NCT01303861|79319816|FG001|Overall Study|Pregnancy|0|||
44316090|NCT01303861|79319817|FG002|Overall Study|Pregnancy|0|||
44316091|NCT01303861|79319818|FG003|Overall Study|Pregnancy|0|||
44316092|NCT01303627|79319831|FG000|Overall Study|the failure while performing URS|0|||
44316093|NCT01303627|79319832|FG001|Overall Study|the failure while performing URS|1|||
44316094|NCT01303510|79319840|FG000|Overall Study|Lost to Follow-up|1|||
44316095|NCT01303510|79319841|FG001|Overall Study|Lost to Follow-up|0|||
44316096|NCT01303159|79319847|FG000|Overall Study|Death|16|||
44316097|NCT01303159|79319847|FG000|Overall Study|Study Termination|7|||
44316098|NCT01302964|79319853|FG000|Overall Study|Adverse Event|1|||
44316099|NCT01302964|79319854|FG001|Overall Study|Adverse Event|0|||
44316100|NCT01302691|79319862|FG000|Overall Study|Adverse Event|2|||
44536133|NCT02951988|79546926|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
44536134|NCT02951988|79546923|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
44316101|NCT01302691|79319863|FG001|Overall Study|Adverse Event|0|||
44316102|NCT01302691|79319862|FG000|Overall Study|Death|0|||
44316103|NCT01302691|79319863|FG001|Overall Study|Death|1|||
44420910|NCT00782210|79428720|FG002|Overall Study|Lack of Efficacy|1|||
44420911|NCT00782210|79428718|FG000|Overall Study|Other reason not described above|3|||
44316104|NCT01302691|79319862|FG000|Overall Study|Lost to Follow-up|1|||
44316105|NCT01302691|79319863|FG001|Overall Study|Lost to Follow-up|0|||
44316106|NCT01302691|79319862|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
44316107|NCT01302691|79319863|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
44316108|NCT01302691|79319862|FG000|Overall Study|Physician Decision|0|||
44316109|NCT01302691|79319863|FG001|Overall Study|Physician Decision|1|||
44316110|NCT01302691|79319862|FG000|Overall Study|Protocol Violation|1|||
44316111|NCT01302691|79319863|FG001|Overall Study|Protocol Violation|0|||
44316112|NCT01302418|79319869|FG000|Overall Study|Protocol Violation|9|||
44536135|NCT02951988|79546924|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
44316113|NCT01302418|79319869|FG000|Overall Study|Non-evaluable|9|||
44316114|NCT01302067|79319876|FG000|Overall Study|Death|0|||
44316115|NCT01302067|79319877|FG001|Overall Study|Death|0|||
44316116|NCT01302067|79319878|FG002|Overall Study|Death|1|||
44316117|NCT01302067|79319876|FG000|Overall Study|Physician Decision|9|||
44316118|NCT01302067|79319877|FG001|Overall Study|Physician Decision|5|||
44316119|NCT01302067|79319878|FG002|Overall Study|Physician Decision|14|||
44316120|NCT01302067|79319876|FG000|Overall Study|Lack of Efficacy|8|||
44316121|NCT01302067|79319877|FG001|Overall Study|Lack of Efficacy|4|||
44316122|NCT01302067|79319878|FG002|Overall Study|Lack of Efficacy|2|||
44316123|NCT01302067|79319876|FG000|Overall Study|Lost to Follow-up|9|||
44316124|NCT01302067|79319877|FG001|Overall Study|Lost to Follow-up|4|||
44316125|NCT01302067|79319878|FG002|Overall Study|Lost to Follow-up|15|||
44316126|NCT01302067|79319876|FG000|Overall Study|Withdrawal by Subject|13|||
44316127|NCT01302067|79319877|FG001|Overall Study|Withdrawal by Subject|6|||
44316128|NCT01302067|79319878|FG002|Overall Study|Withdrawal by Subject|10|||
44316129|NCT01302067|79319876|FG000|Overall Study|Other|1|||
44316130|NCT01302067|79319877|FG001|Overall Study|Other|1|||
44316131|NCT01302067|79319878|FG002|Overall Study|Other|3|||
44316132|NCT01302067|79319876|FG000|Overall Study|Protocol Violation|11|||
44316133|NCT01302067|79319877|FG001|Overall Study|Protocol Violation|0|||
44316134|NCT01302067|79319878|FG002|Overall Study|Protocol Violation|8|||
44316135|NCT01302067|79319876|FG000|Overall Study|Adverse Event|27|||
44316136|NCT01302067|79319877|FG001|Overall Study|Adverse Event|14|||
44316137|NCT01302067|79319878|FG002|Overall Study|Adverse Event|45|||
44316138|NCT01301950|79319888|FG000|Overall Study|Surgery was cancelled by patient|0|||
44316139|NCT01301950|79319889|FG001|Overall Study|Surgery was cancelled by patient|1|||
44316140|NCT01301833|79319899|FG000|Overall Study|Adverse Event|7|||
44316141|NCT01301833|79319900|FG001|Overall Study|Adverse Event|5|||
44316142|NCT01301833|79319901|FG002|Overall Study|Adverse Event|5|||
44316143|NCT01301833|79319902|FG003|Overall Study|Adverse Event|5|||
44316144|NCT01301833|79319899|FG000|Overall Study|Lack of Efficacy|1|||
44316145|NCT01301833|79319900|FG001|Overall Study|Lack of Efficacy|1|||
44316146|NCT01301833|79319901|FG002|Overall Study|Lack of Efficacy|0|||
44316147|NCT01301833|79319902|FG003|Overall Study|Lack of Efficacy|0|||
44316148|NCT01301833|79319899|FG000|Overall Study|Physician Decision|3|||
44316149|NCT01301833|79319900|FG001|Overall Study|Physician Decision|1|||
44316150|NCT01301833|79319901|FG002|Overall Study|Physician Decision|1|||
44316151|NCT01301833|79319902|FG003|Overall Study|Physician Decision|0|||
44316152|NCT01301833|79319899|FG000|Overall Study|Withdrawal by Subject|3|||
44316153|NCT01301833|79319900|FG001|Overall Study|Withdrawal by Subject|1|||
44316154|NCT01301833|79319901|FG002|Overall Study|Withdrawal by Subject|1|||
44316155|NCT01301833|79319902|FG003|Overall Study|Withdrawal by Subject|2|||
44316156|NCT01301833|79319899|FG000|Overall Study|Personal matter|1|||
44316157|NCT01301833|79319900|FG001|Overall Study|Personal matter|0|||
44316158|NCT01301833|79319901|FG002|Overall Study|Personal matter|0|||
44316159|NCT01301833|79319902|FG003|Overall Study|Personal matter|0|||
44316160|NCT01301092|79319915|FG000|Overall Study|Lost to Follow-up|0|||
44316161|NCT01301092|79319916|FG001|Overall Study|Lost to Follow-up|0|||
44316162|NCT01301092|79319917|FG002|Overall Study|Lost to Follow-up|1|||
44316163|NCT01300819|79319932|FG000|Overall Study|Adverse Event|9|||
44316164|NCT01300819|79319933|FG001|Overall Study|Adverse Event|27|||
44316165|NCT01300819|79319932|FG000|Overall Study|Lack of Efficacy|2|||
44316166|NCT01300819|79319933|FG001|Overall Study|Lack of Efficacy|1|||
44316167|NCT01300819|79319932|FG000|Overall Study|Withdrawal by Subject|10|||
44316168|NCT01300819|79319933|FG001|Overall Study|Withdrawal by Subject|12|||
44316169|NCT01300819|79319932|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
44316170|NCT01300819|79319933|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
44316171|NCT01300819|79319932|FG000|Overall Study|Refusal to down titrate study drug|0|||
44316172|NCT01300819|79319933|FG001|Overall Study|Refusal to down titrate study drug|1|||
44316173|NCT01300819|79319932|FG000|Overall Study|Administrative reason|0|||
44316174|NCT01300819|79319933|FG001|Overall Study|Administrative reason|1|||
44316175|NCT01300819|79319932|FG000|Overall Study|Safety follow up not done by mistake|0|||
44316176|NCT01300819|79319933|FG001|Overall Study|Safety follow up not done by mistake|1|||
44316177|NCT01300819|79319932|FG000|Overall Study|Follow up call was not done|1|||
44316178|NCT01300819|79319933|FG001|Overall Study|Follow up call was not done|0|||
44316179|NCT01300741|79319939|FG000|Overall Study|Lens deposits|1|||
44316180|NCT01300741|79319939|FG000|Overall Study|Lost to Follow-up|1|||
44316181|NCT01300741|79319939|FG000|Overall Study|Discomfort|1|||
44316182|NCT01300546|79319947|FG000|Overall Study|Withdrawal by Subject|1|||
44316183|NCT01300546|79319948|FG001|Overall Study|Withdrawal by Subject|0|||
44316184|NCT01300546|79319947|FG000|Overall Study|Lost to Follow-up|0|||
44316185|NCT01300546|79319948|FG001|Overall Study|Lost to Follow-up|2|||
44316186|NCT01300546|79319947|FG000|Overall Study|Lack of Efficacy|0|||
44316187|NCT01300546|79319948|FG001|Overall Study|Lack of Efficacy|3|||
44316188|NCT01300546|79319947|FG000|Overall Study|Adverse Event|0|||
44316189|NCT01300546|79319948|FG001|Overall Study|Adverse Event|1|||
44316190|NCT01300351|79319956|FG000|Overall Study|Did not receive treatment|2|||
44316191|NCT01300351|79319957|FG001|Overall Study|Did not receive treatment|0|||
44316192|NCT01300351|79319956|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
44316193|NCT01300351|79319957|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
44316194|NCT01300351|79319956|FG000|Overall Study|Lost to Follow-up|0|||
44316195|NCT01300351|79319957|FG001|Overall Study|Lost to Follow-up|1|||
44316196|NCT01300351|79319956|FG000|Overall Study|Adverse Event|0|||
44316197|NCT01300351|79319957|FG001|Overall Study|Adverse Event|4|||
44316198|NCT01300351|79319956|FG000|Overall Study|Withdrawal by Subject|7|||
44316199|NCT01300351|79319957|FG001|Overall Study|Withdrawal by Subject|10|||
44316200|NCT01300234|79319965|FG000|Overall Study|Adverse Event|1|||
44316201|NCT01300234|79319966|FG001|Overall Study|Adverse Event|1|||
44316202|NCT01300234|79319965|FG000|Overall Study|Protocol Violation|2|||
44316203|NCT01300234|79319966|FG001|Overall Study|Protocol Violation|3|||
44316204|NCT01300234|79319965|FG000|Overall Study|Withdrawal by Subject|5|||
44316205|NCT01300234|79319966|FG001|Overall Study|Withdrawal by Subject|9|||
44316206|NCT01300234|79319965|FG000|Overall Study|Lost to Follow-up|14|||
44316207|NCT01300234|79319966|FG001|Overall Study|Lost to Follow-up|12|||
44316208|NCT01300234|79319965|FG000|Overall Study|Pregnancy|2|||
44316209|NCT01300234|79319966|FG001|Overall Study|Pregnancy|1|||
44316210|NCT01300234|79319965|FG000|Overall Study|Participant reached stopping critera|2|||
44316211|NCT01300234|79319966|FG001|Overall Study|Participant reached stopping critera|0|||
44316212|NCT01300234|79319965|FG000|Overall Study|Participant stopped medication|1|||
44316213|NCT01300234|79319966|FG001|Overall Study|Participant stopped medication|1|||
44316214|NCT01300234|79319965|FG000|Overall Study|Participant refused return to hospital|1|||
44316215|NCT01300234|79319966|FG001|Overall Study|Participant refused return to hospital|0|||
44316216|NCT01299961|79319983|FG000|Overall Study|Adverse Event|3|||
44316217|NCT01299961|79319983|FG000|Overall Study|Lack of Efficacy|2|||
44316218|NCT01299961|79319983|FG000|Overall Study|Lost to Follow-up|1|||
44316219|NCT01299805|79319989|FG000|Overall Study|Adverse Event|2|||
44316220|NCT01299805|79319990|FG001|Overall Study|Adverse Event|0|||
44316221|NCT01299766|79319998|FG000|Overall Study|Death|5|||
44316222|NCT01299766|79319999|FG001|Overall Study|Death|4|||
44316223|NCT01299766|79319998|FG000|Overall Study|Withdrawal by Subject|29|||
44316224|NCT01299766|79319999|FG001|Overall Study|Withdrawal by Subject|19|||
44316225|NCT01299727|79320008|FG000|Overall Study|Withdrawal by Subject|1|||
44316226|NCT01299727|79320009|FG001|Overall Study|Withdrawal by Subject|0|||
44316227|NCT01299727|79320010|FG002|Overall Study|Withdrawal by Subject|0|||
44316228|NCT01299727|79320008|FG000|Overall Study|Adverse Event|0|||
44316229|NCT01299727|79320009|FG001|Overall Study|Adverse Event|0|||
44316230|NCT01299727|79320010|FG002|Overall Study|Adverse Event|1|||
44316231|NCT01299727|79320008|FG000|Overall Study|Completed the Treatment Period|3|||
44316232|NCT01299727|79320009|FG001|Overall Study|Completed the Treatment Period|4|||
44316233|NCT01299727|79320010|FG002|Overall Study|Completed the Treatment Period|3|||
44316234|NCT01299571|79320018|FG000|Overall Study|Protocol Violation|107|||
44316235|NCT01299376|79320025|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
44316236|NCT01299376|79320026|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
44316237|NCT01299376|79320025|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
44316238|NCT01299376|79320026|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
44316239|NCT01299376|79320025|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
44316240|NCT01299376|79320026|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
44316241|NCT01299376|79320025|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
44316242|NCT01299376|79320026|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
44316243|NCT01299376|79320025|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
44316244|NCT01299376|79320026|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
44316245|NCT01299376|79320025|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
44316246|NCT01299376|79320026|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
44316247|NCT01299376|79320025|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
44316248|NCT01299376|79320026|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
44316249|NCT01299376|79320025|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
44316250|NCT01299376|79320026|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
44316251|NCT01299376|79320025|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
44536136|NCT02951988|79546925|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
44536137|NCT02951988|79546926|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
44536138|NCT02951988|79546923|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
44536139|NCT02951988|79546924|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
44536140|NCT02951988|79546925|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
44536141|NCT02951988|79546926|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
44316252|NCT01299376|79320026|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
44316253|NCT01299376|79320025|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
44316254|NCT01299376|79320026|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
44316255|NCT01299376|79320025|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
44316256|NCT01299376|79320026|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
44316257|NCT01299025|79320038|FG000|Overall Study|Withdrawal by Subject|2|||
44316258|NCT01299025|79320039|FG001|Overall Study|Withdrawal by Subject|1|||
44316259|NCT01299025|79320038|FG000|Overall Study|Lost to Follow-up|1|||
44316260|NCT01299025|79320039|FG001|Overall Study|Lost to Follow-up|0|||
44316261|NCT01298596|79320047|FG000|Overall Study|Withdrawal by Subject|1|||
44316262|NCT01298596|79320048|FG001|Overall Study|Withdrawal by Subject|1|||
44316263|NCT01298596|79320047|FG000|Overall Study|Death|5|||
44316264|NCT01298596|79320048|FG001|Overall Study|Death|3|||
44316265|NCT01298596|79320047|FG000|Overall Study|Lost to Follow-up|6|||
44316266|NCT01298596|79320048|FG001|Overall Study|Lost to Follow-up|14|||
44316267|NCT01298596|79320047|FG000|Overall Study|Referred for further management|16|||
44316268|NCT01298596|79320048|FG001|Overall Study|Referred for further management|15|||
44316269|NCT01298518|79320057|FG000|Overall Study|Withdrawal by Subject|0|||
44316270|NCT01298518|79320058|FG001|Overall Study|Withdrawal by Subject|0|||
44316271|NCT01298518|79320059|FG002|Overall Study|Withdrawal by Subject|1|||
44316272|NCT01298362|79320069|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
44316273|NCT01298362|79320070|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
44316274|NCT01297504|79320078|FG000|Overall Study|Invalid Consent|1|||
44316275|NCT01297504|79320078|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
44316276|NCT01297504|79320078|FG000|Overall Study|No Study Visits|4|||
44316277|NCT01297504|79320078|FG000|Overall Study|Death|3|||
44316278|NCT01297504|79320078|FG000|Overall Study|Lost to Follow-up|43|||
44316279|NCT01297504|79320078|FG000|Overall Study|Withdrawal by Subject|9|||
44316280|NCT01297504|79320078|FG000|Overall Study|Site Closure|3|||
44316281|NCT01297504|79320078|FG000|Overall Study|Protocol Violation|3|||
44316282|NCT01297465|79320088|FG000|Overall Study|Lack of Ovarian Response|1|||
44316283|NCT01297465|79320089|FG001|Overall Study|Lack of Ovarian Response|1|||
44316284|NCT01297465|79320088|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
44316285|NCT01297465|79320089|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
44316286|NCT01297465|79320088|FG000|Overall Study|No Oocytes Retrieved|1|||
44316287|NCT01297465|79320089|FG001|Overall Study|No Oocytes Retrieved|1|||
44316288|NCT01297465|79320088|FG000|Overall Study|Poor oocyte quality|0|||
44316289|NCT01297465|79320089|FG001|Overall Study|Poor oocyte quality|1|||
44316290|NCT01297465|79320088|FG000|Overall Study|No Fertilization|6|||
44316291|NCT01297465|79320089|FG001|Overall Study|No Fertilization|4|||
44316292|NCT01297465|79320088|FG000|Overall Study|All Embryos Discarded|0|||
44316293|NCT01297465|79320089|FG001|Overall Study|All Embryos Discarded|1|||
44316294|NCT01297465|79320088|FG000|Overall Study|Intention to Freeze all Embryos|0|||
44316295|NCT01297465|79320089|FG001|Overall Study|Intention to Freeze all Embryos|1|||
44316296|NCT01297309|79320095|FG000|Overall Study|Eligibility failure|2|||
44316297|NCT01297309|79320095|FG000|Overall Study|Screen failure|2|||
44316298|NCT01297309|79320095|FG000|Overall Study|Withdrawal by Subject|5|||
44316299|NCT01297309|79320095|FG000|Overall Study|Adverse Event|1|||
44316300|NCT01297309|79320095|FG000|Overall Study|Investigator Decision|2|||
44316301|NCT01297309|79320095|FG000|Overall Study|Death|1|||
44316302|NCT01297309|79320095|FG000|Overall Study|Participant not entering extensionperiod|1|||
44316303|NCT04518462|79320102|FG000|Overall Study|Withdrawal by Subject|0|||
44316304|NCT04518462|79320103|FG001|Overall Study|Withdrawal by Subject|0|||
44316305|NCT04518462|79320104|FG002|Overall Study|Withdrawal by Subject|1|||
44316306|NCT04518462|79320102|FG000|Overall Study|Physician Decision|1|||
44316307|NCT04518462|79320103|FG001|Overall Study|Physician Decision|1|||
44316308|NCT04518462|79320104|FG002|Overall Study|Physician Decision|0|||
44316309|NCT01297270|79320115|FG000|Overall Study|Adverse Event|19|||
44316310|NCT01297270|79320116|FG001|Overall Study|Adverse Event|32|||
44316311|NCT01297270|79320117|FG002|Overall Study|Adverse Event|5|||
44316312|NCT01297270|79320115|FG000|Overall Study|Lack of Efficacy|15|||
44316313|NCT01297270|79320116|FG001|Overall Study|Lack of Efficacy|17|||
44316314|NCT01297270|79320117|FG002|Overall Study|Lack of Efficacy|15|||
44316315|NCT01297270|79320115|FG000|Overall Study|Lost to Follow-up|1|||
44316316|NCT01297270|79320116|FG001|Overall Study|Lost to Follow-up|2|||
44316317|NCT01297270|79320117|FG002|Overall Study|Lost to Follow-up|1|||
44316318|NCT01297270|79320115|FG000|Overall Study|Protocol Violation|0|||
44316319|NCT01297270|79320116|FG001|Overall Study|Protocol Violation|2|||
44316320|NCT01297270|79320117|FG002|Overall Study|Protocol Violation|0|||
44316321|NCT01297270|79320115|FG000|Overall Study|Withdrawal by Subject|7|||
44316322|NCT01297270|79320116|FG001|Overall Study|Withdrawal by Subject|15|||
44316323|NCT01297270|79320117|FG002|Overall Study|Withdrawal by Subject|7|||
44316324|NCT01297270|79320115|FG000|Overall Study|Other reason not defined above|3|||
44316325|NCT01297270|79320116|FG001|Overall Study|Other reason not defined above|3|||
44316326|NCT01297270|79320117|FG002|Overall Study|Other reason not defined above|1|||
44316327|NCT01297270|79320115|FG000|Overall Study|Not treated|0|||
44316328|NCT01297270|79320116|FG001|Overall Study|Not treated|1|||
44316329|NCT01297270|79320117|FG002|Overall Study|Not treated|0|||
44316330|NCT01296568|79320125|FG000|Continued Access Phase|Lost to Follow-up|1|||
44316331|NCT01296568|79320125|FG000|Continued Access Phase|Withdrawal by Subject|1|||
44316332|NCT01296568|79320125|FG000|Continued Access Phase|Disease Progression|1|||
44316333|NCT01296412|79320133|FG000|Overall Study|Adverse Event|8|||
44316334|NCT01296412|79320134|FG001|Overall Study|Adverse Event|29|||
44316335|NCT01296412|79320133|FG000|Overall Study|Lack of Efficacy|1|||
44316336|NCT01296412|79320134|FG001|Overall Study|Lack of Efficacy|0|||
44316337|NCT01296412|79320133|FG000|Overall Study|Lost to Follow-up|10|||
44316338|NCT01296412|79320134|FG001|Overall Study|Lost to Follow-up|7|||
44316339|NCT01296412|79320133|FG000|Overall Study|Non-compliance with study drug|1|||
44316340|NCT01296412|79320134|FG001|Overall Study|Non-compliance with study drug|2|||
44316341|NCT01296412|79320133|FG000|Overall Study|Other reason not specified|20|||
44316342|NCT01296412|79320134|FG001|Overall Study|Other reason not specified|15|||
44316343|NCT01296412|79320133|FG000|Overall Study|Physician Decision|1|||
44316344|NCT01296412|79320134|FG001|Overall Study|Physician Decision|3|||
44316345|NCT01296412|79320133|FG000|Overall Study|Pregnancy|0|||
44316346|NCT01296412|79320134|FG001|Overall Study|Pregnancy|1|||
44316347|NCT01296412|79320133|FG000|Overall Study|Withdrawal by Subject|10|||
44316348|NCT01296412|79320134|FG001|Overall Study|Withdrawal by Subject|13|||
44316349|NCT01295905|79320142|FG000|Overall Study|Did not meet inclusion criteria|1|||
44316350|NCT01295905|79320143|FG001|Overall Study|Did not meet inclusion criteria|0|||
44316351|NCT01295905|79320142|FG000|Overall Study|Met exclusion criteria|1|||
44316352|NCT01295905|79320143|FG001|Overall Study|Met exclusion criteria|0|||
44316353|NCT02596035|79320152|FG000|Overall Study|Disease Progression|64|||
44316354|NCT02596035|79320153|FG001|Overall Study|Disease Progression|32|||
44316355|NCT02596035|79320154|FG002|Overall Study|Disease Progression|1|||
44316356|NCT02596035|79320152|FG000|Overall Study|study drug toxicity|12|||
44316357|NCT02596035|79320153|FG001|Overall Study|study drug toxicity|3|||
44316358|NCT02596035|79320154|FG002|Overall Study|study drug toxicity|0|||
44316359|NCT02596035|79320152|FG000|Overall Study|AE unrelated to study drug|5|||
44316360|NCT02596035|79320153|FG001|Overall Study|AE unrelated to study drug|2|||
44316361|NCT02596035|79320154|FG002|Overall Study|AE unrelated to study drug|0|||
44316362|NCT02596035|79320152|FG000|Overall Study|participant request to discontinue study treatment|2|||
44316363|NCT02596035|79320153|FG001|Overall Study|participant request to discontinue study treatment|0|||
44316364|NCT02596035|79320154|FG002|Overall Study|participant request to discontinue study treatment|0|||
44316365|NCT02596035|79320152|FG000|Overall Study|participant withdrew consent|2|||
44316366|NCT02596035|79320153|FG001|Overall Study|participant withdrew consent|2|||
44316367|NCT02596035|79320154|FG002|Overall Study|participant withdrew consent|0|||
44316368|NCT02596035|79320152|FG000|Overall Study|Poor/Non Comlpiance|0|||
44316369|NCT02596035|79320153|FG001|Overall Study|Poor/Non Comlpiance|1|||
44316370|NCT02596035|79320154|FG002|Overall Study|Poor/Non Comlpiance|0|||
44316371|NCT02596035|79320152|FG000|Overall Study|participant no longer meets study criteria|1|||
44316372|NCT02596035|79320153|FG001|Overall Study|participant no longer meets study criteria|0|||
44316373|NCT02596035|79320154|FG002|Overall Study|participant no longer meets study criteria|0|||
44316374|NCT02596035|79320152|FG000|Overall Study|other reasons|11|||
44316375|NCT02596035|79320153|FG001|Overall Study|other reasons|4|||
44316376|NCT02596035|79320154|FG002|Overall Study|other reasons|0|||
44316377|NCT02595372|79320163|FG000|Overall Study|Adverse Event|6|||
44316378|NCT02595372|79320163|FG000|Overall Study|Physician Decision|2|||
44316379|NCT02595372|79320163|FG000|Overall Study|Disease Progression|1|||
44316380|NCT04829916|79320200|FG000|Overall Study|Withdrawal by Subject|1|||
44316381|NCT04829916|79320201|FG001|Overall Study|Withdrawal by Subject|0|||
44316382|NCT04761822|79320213|FG000|Overall Study|Adverse Event|3|||
44316383|NCT04761822|79320214|FG001|Overall Study|Adverse Event|1|||
44316384|NCT04761822|79320215|FG002|Overall Study|Adverse Event|1|||
44316385|NCT04761822|79320216|FG003|Overall Study|Adverse Event|3|||
44316386|NCT04761822|79320213|FG000|Overall Study|Lost to Follow-up|1|||
44316387|NCT04761822|79320214|FG001|Overall Study|Lost to Follow-up|0|||
44316388|NCT04761822|79320215|FG002|Overall Study|Lost to Follow-up|2|||
44316389|NCT04761822|79320216|FG003|Overall Study|Lost to Follow-up|3|||
44316390|NCT04761822|79320213|FG000|Overall Study|Physician Decision|0|||
44316391|NCT04761822|79320214|FG001|Overall Study|Physician Decision|1|||
44316392|NCT04761822|79320215|FG002|Overall Study|Physician Decision|0|||
44316393|NCT04761822|79320216|FG003|Overall Study|Physician Decision|0|||
44316394|NCT04761822|79320213|FG000|Overall Study|Withdrawal by Subject|3|||
44316395|NCT04761822|79320214|FG001|Overall Study|Withdrawal by Subject|8|||
44316396|NCT04761822|79320215|FG002|Overall Study|Withdrawal by Subject|1|||
44420912|NCT00782210|79428719|FG001|Overall Study|Other reason not described above|2|||
44536142|NCT02951988|79546923|FG000|Open-Label Treatment Period|Adverse Event|45|||
44536143|NCT02951988|79546924|FG001|Open-Label Treatment Period|Adverse Event|0|||
44316397|NCT04761822|79320216|FG003|Overall Study|Withdrawal by Subject|11|||
44316398|NCT04761822|79320213|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
44316399|NCT04761822|79320214|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
44316400|NCT04761822|79320215|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
44316401|NCT04761822|79320216|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
44316402|NCT04761822|79320213|FG000|Overall Study|Participant requested unblinding|0|||
44316403|NCT04761822|79320214|FG001|Overall Study|Participant requested unblinding|0|||
44316404|NCT04761822|79320215|FG002|Overall Study|Participant requested unblinding|0|||
44316405|NCT04761822|79320216|FG003|Overall Study|Participant requested unblinding|1|||
44316406|NCT04596267|79320254|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
44316407|NCT04596267|79320255|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
44316408|NCT04596267|79320254|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
44316409|NCT04596267|79320255|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
44316410|NCT04439903|79320278|FG000|Overall Study|Withdrawal by Subject|2|||
44316411|NCT04439903|79320278|FG000|Overall Study|Screen Failure|1|||
44316412|NCT04280783|79320284|FG000|Overall Study|Family issues unrelated to the study.|1|||
44316413|NCT04280783|79320285|FG001|Overall Study|Family issues unrelated to the study.|0|||
44316414|NCT04280783|79320284|FG000|Overall Study|Withdrawal by Subject|0|||
44316415|NCT04280783|79320285|FG001|Overall Study|Withdrawal by Subject|1|||
44316416|NCT04177095|79320292|FG000|Overall Study|Withdrawal by Subject|3|||
44316417|NCT04177095|79320292|FG000|Overall Study|Screen Failure|3|||
44316418|NCT04177095|79320292|FG000|Overall Study|Problems with the Trugraf assay|1|||
44316419|NCT03799718|79320314|FG000|Overall Study|Adverse Event|2|||
44316420|NCT03458728|79320349|FG000|Overall Study|Adverse Event|1|||
44316421|NCT03458728|79320350|FG001|Overall Study|Adverse Event|0|||
44316422|NCT03458728|79320349|FG000|Overall Study|Physician Decision|1|||
44316423|NCT03458728|79320350|FG001|Overall Study|Physician Decision|0|||
44316424|NCT03458728|79320349|FG000|Overall Study|Progressive disease - clinical assessment|1|||
44316425|NCT03458728|79320350|FG001|Overall Study|Progressive disease - clinical assessment|0|||
44316426|NCT03458728|79320349|FG000|Overall Study|Progressive disease - radiological progression|21|||
44316427|NCT03458728|79320350|FG001|Overall Study|Progressive disease - radiological progression|6|||
44316428|NCT03458728|79320349|FG000|Overall Study|Withdrawal by Subject|0|||
44316429|NCT03458728|79320350|FG001|Overall Study|Withdrawal by Subject|1|||
44316430|NCT03220035|79320358|FG000|Overall Study|Adverse Event|1|||
44316431|NCT03220035|79320358|FG000|Overall Study|Protocol Violation|1|||
44316432|NCT03220035|79320358|FG000|Overall Study|Progressive Disease|2|||
44316433|NCT03215706|79320364|FG000|Randomization|Adverse Event unrelated to study drug|1|||
44316434|NCT03215706|79320365|FG001|Randomization|Adverse Event unrelated to study drug|0|||
44316435|NCT03215706|79320364|FG000|Randomization|participant withdrew consent|1|||
44316436|NCT03215706|79320365|FG001|Randomization|participant withdrew consent|3|||
44316437|NCT03215706|79320364|FG000|Randomization|no longer meets study criteria|1|||
44316438|NCT03215706|79320365|FG001|Randomization|no longer meets study criteria|4|||
44316439|NCT03215706|79320364|FG000|Randomization|other reasons|0|||
44316440|NCT03215706|79320365|FG001|Randomization|other reasons|2|||
44316441|NCT03215706|79320364|FG000|Treatment Period|Disease Progression|150|||
44316442|NCT03215706|79320365|FG001|Treatment Period|Disease Progression|142|||
44316443|NCT03215706|79320364|FG000|Treatment Period|Study Drug Toxicity|53|||
44316444|NCT03215706|79320365|FG001|Treatment Period|Study Drug Toxicity|21|||
44316445|NCT03215706|79320364|FG000|Treatment Period|Death|2|||
44316446|NCT03215706|79320365|FG001|Treatment Period|Death|1|||
44316447|NCT03215706|79320364|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
44316448|NCT03215706|79320365|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
44316449|NCT03215706|79320364|FG000|Treatment Period|Request to D/C treatment|1|||
44316450|NCT03215706|79320365|FG001|Treatment Period|Request to D/C treatment|6|||
44316451|NCT03215706|79320364|FG000|Treatment Period|Participant withdrew consent|3|||
44316452|NCT03215706|79320365|FG001|Treatment Period|Participant withdrew consent|4|||
44316453|NCT03215706|79320364|FG000|Treatment Period|Lost to Follow-up|0|||
44316454|NCT03215706|79320365|FG001|Treatment Period|Lost to Follow-up|1|||
44316455|NCT03215706|79320364|FG000|Treatment Period|Other Reasons|4|||
44316456|NCT03215706|79320365|FG001|Treatment Period|Other Reasons|5|||
44316457|NCT03215706|79320364|FG000|Treatment Period|Ongoing in the treatment period|105|||
44316458|NCT03215706|79320365|FG001|Treatment Period|Ongoing in the treatment period|43|||
44316459|NCT03213691|79320371|FG000|Overall Study|Adverse Event|2|||
44316460|NCT03213691|79320371|FG000|Overall Study|Death|3|||
44316461|NCT03213691|79320371|FG000|Overall Study|Physician Decision|1|||
44316462|NCT03213691|79320371|FG000|Overall Study|Progressive Disease|14|||
44316463|NCT03213691|79320371|FG000|Overall Study|Ineligible|1|||
44316464|NCT03213665|79320375|FG000|Overall Study|Adverse Event|1|||
44316465|NCT03213665|79320375|FG000|Overall Study|Physician Decision|2|||
44316466|NCT03213665|79320375|FG000|Overall Study|Withdrawal by Subject|3|||
44316467|NCT03213665|79320375|FG000|Overall Study|Progressive Disease|13|||
44316468|NCT03151005|79320381|FG000|Overall Study|Lost to Follow-up|5|||
44316469|NCT03151005|79320382|FG001|Overall Study|Lost to Follow-up|5|||
44316470|NCT03143153|79320391|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
44316471|NCT03143153|79320392|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
44316472|NCT03143153|79320393|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
44316473|NCT03143153|79320391|FG000|Pre-Treatment|Participant withdrew consent|0|||
44316474|NCT03143153|79320392|FG001|Pre-Treatment|Participant withdrew consent|1|||
44316475|NCT03143153|79320393|FG002|Pre-Treatment|Participant withdrew consent|12|||
44316476|NCT03143153|79320391|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
44316477|NCT03143153|79320392|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
44316478|NCT03143153|79320393|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
44316479|NCT03143153|79320391|FG000|Pre-Treatment|Other Reasons|1|||
44316480|NCT03143153|79320392|FG001|Pre-Treatment|Other Reasons|2|||
44316481|NCT03143153|79320393|FG002|Pre-Treatment|Other Reasons|1|||
44316482|NCT03143153|79320391|FG000|Pre-Treatment|Disease Progression|1|||
44316483|NCT03143153|79320392|FG001|Pre-Treatment|Disease Progression|1|||
44316484|NCT03143153|79320393|FG002|Pre-Treatment|Disease Progression|2|||
44420913|NCT00782210|79428720|FG002|Overall Study|Other reason not described above|3|||
44420914|NCT01558115|79428737|FG000|Overall Study|Withdrawal by Subject|3|||
44420915|NCT01558115|79428737|FG000|Overall Study|Study closed due to poor enrollment|4|||
44420916|NCT00764660|79428751|FG000|Overall Study|Adverse Event|6|||
44420917|NCT00764660|79428752|FG001|Overall Study|Adverse Event|3|||
44420918|NCT00764660|79428751|FG000|Overall Study|Lost to Follow-up|3|||
44420919|NCT00764660|79428752|FG001|Overall Study|Lost to Follow-up|4|||
44420920|NCT00764660|79428751|FG000|Overall Study|Withdrawal by Subject|7|||
44420921|NCT00764660|79428752|FG001|Overall Study|Withdrawal by Subject|3|||
44420922|NCT00764660|79428751|FG000|Overall Study|Noncompliance With Protocol|5|||
44420923|NCT00764660|79428752|FG001|Overall Study|Noncompliance With Protocol|1|||
44420924|NCT00764660|79428751|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
44536144|NCT02951988|79546925|FG002|Open-Label Treatment Period|Adverse Event|0|||
44536145|NCT02951988|79546926|FG003|Open-Label Treatment Period|Adverse Event|0|||
44536146|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
44536147|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
44536148|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
44316485|NCT03143153|79320391|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
44316486|NCT03143153|79320392|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
44316487|NCT03143153|79320393|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
44316488|NCT03143153|79320391|FG000|Treatment|Disease progression|174|||
44316489|NCT03143153|79320392|FG001|Treatment|Disease progression|184|||
44316490|NCT03143153|79320393|FG002|Treatment|Disease progression|193|||
44316491|NCT03143153|79320391|FG000|Treatment|Study drug toxicity|59|||
44316492|NCT03143153|79320392|FG001|Treatment|Study drug toxicity|33|||
44316493|NCT03143153|79320393|FG002|Treatment|Study drug toxicity|40|||
44316494|NCT03143153|79320391|FG000|Treatment|Death|5|||
44316495|NCT03143153|79320392|FG001|Treatment|Death|3|||
44316496|NCT03143153|79320393|FG002|Treatment|Death|4|||
44316497|NCT03143153|79320391|FG000|Treatment|Adverse event unrelated to study drug|19|||
44316498|NCT03143153|79320392|FG001|Treatment|Adverse event unrelated to study drug|28|||
44316499|NCT03143153|79320393|FG002|Treatment|Adverse event unrelated to study drug|12|||
44316500|NCT03143153|79320391|FG000|Treatment|Participant request to discontinue study treatment|13|||
44316501|NCT03143153|79320392|FG001|Treatment|Participant request to discontinue study treatment|15|||
44316502|NCT03143153|79320393|FG002|Treatment|Participant request to discontinue study treatment|20|||
44316503|NCT03143153|79320391|FG000|Treatment|Participant withdrew consent|3|||
44316504|NCT03143153|79320392|FG001|Treatment|Participant withdrew consent|4|||
44316505|NCT03143153|79320393|FG002|Treatment|Participant withdrew consent|12|||
44316506|NCT03143153|79320391|FG000|Treatment|Pregnancy|1|||
44316507|NCT03143153|79320392|FG001|Treatment|Pregnancy|0|||
44316508|NCT03143153|79320393|FG002|Treatment|Pregnancy|0|||
44316509|NCT03143153|79320391|FG000|Treatment|Maximum clinical benefit|1|||
44316510|NCT03143153|79320392|FG001|Treatment|Maximum clinical benefit|3|||
44316511|NCT03143153|79320393|FG002|Treatment|Maximum clinical benefit|4|||
44316512|NCT03143153|79320391|FG000|Treatment|Completed treatment as per Protocol|13|||
44316513|NCT03143153|79320392|FG001|Treatment|Completed treatment as per Protocol|8|||
44316514|NCT03143153|79320393|FG002|Treatment|Completed treatment as per Protocol|0|||
44316515|NCT03143153|79320391|FG000|Treatment|Other reasons|12|||
44316516|NCT03143153|79320392|FG001|Treatment|Other reasons|7|||
44316517|NCT03143153|79320393|FG002|Treatment|Other reasons|15|||
44316518|NCT03143153|79320391|FG000|Treatment|Not reported|1|||
44316519|NCT03143153|79320392|FG001|Treatment|Not reported|0|||
44316520|NCT03143153|79320393|FG002|Treatment|Not reported|0|||
44420925|NCT00764660|79428752|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
44420926|NCT00584415|79428758|FG000|Overall Study|Adverse Event|7|||
44536149|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
44316521|NCT02872116|79320404|FG000|Pre-Treatment|Disease Progression|0|||
44316522|NCT02872116|79320405|FG001|Pre-Treatment|Disease Progression|1|||
44316523|NCT02872116|79320406|FG002|Pre-Treatment|Disease Progression|0|||
44316524|NCT02872116|79320404|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
44316525|NCT02872116|79320405|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
44316526|NCT02872116|79320406|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
44420927|NCT00764504|79428766|FG000|Overall Study|Death|12|||
44420928|NCT00764504|79428767|FG001|Overall Study|Death|6|||
44420929|NCT00764504|79428768|FG002|Overall Study|Death|13|||
44316527|NCT02872116|79320404|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
44316528|NCT02872116|79320405|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
44316529|NCT02872116|79320406|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
44316530|NCT02872116|79320404|FG000|Pre-Treatment|Participant withdrew consent|2|||
44420930|NCT00764504|79428766|FG000|Overall Study|Revision of Device|12|||
44316531|NCT02872116|79320405|FG001|Pre-Treatment|Participant withdrew consent|20|||
44316532|NCT02872116|79320406|FG002|Pre-Treatment|Participant withdrew consent|3|||
44316533|NCT02872116|79320404|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
44316534|NCT02872116|79320405|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
44316535|NCT02872116|79320406|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
44316536|NCT02872116|79320404|FG000|Pre-Treatment|Other reasons|1|||
44316537|NCT02872116|79320405|FG001|Pre-Treatment|Other reasons|2|||
44316538|NCT02872116|79320406|FG002|Pre-Treatment|Other reasons|2|||
44316539|NCT02872116|79320404|FG000|Treatment|Death|122|||
44316540|NCT02872116|79320405|FG001|Treatment|Death|94|||
44316541|NCT02872116|79320406|FG002|Treatment|Death|68|||
44316542|NCT02872116|79320404|FG000|Treatment|Lost to Follow-up|5|||
44316543|NCT02872116|79320405|FG001|Treatment|Lost to Follow-up|7|||
44316544|NCT02872116|79320406|FG002|Treatment|Lost to Follow-up|3|||
44316545|NCT02872116|79320404|FG000|Treatment|Participant withdrew consent|20|||
44316546|NCT02872116|79320405|FG001|Treatment|Participant withdrew consent|40|||
44316547|NCT02872116|79320406|FG002|Treatment|Participant withdrew consent|8|||
44316548|NCT02872116|79320404|FG000|Treatment|Other reasons|12|||
44316549|NCT02872116|79320405|FG001|Treatment|Other reasons|12|||
44316550|NCT02872116|79320406|FG002|Treatment|Other reasons|5|||
44316551|NCT02828358|79320420|FG000|Overall Study|Physician Decision|7|||
44316552|NCT02828358|79320421|FG001|Overall Study|Physician Decision|1|||
44316553|NCT02828358|79320420|FG000|Overall Study|Treatment Failure|6|||
44316554|NCT02828358|79320421|FG001|Overall Study|Treatment Failure|0|||
44316555|NCT02828358|79320420|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
44316556|NCT02828358|79320421|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
44316557|NCT02828358|79320420|FG000|Overall Study|Refusal of further protocol therapy|2|||
44316558|NCT02828358|79320421|FG001|Overall Study|Refusal of further protocol therapy|0|||
44316559|NCT02828358|79320420|FG000|Overall Study|Relapse|25|||
44316560|NCT02828358|79320421|FG001|Overall Study|Relapse|0|||
44316561|NCT02828358|79320420|FG000|Overall Study|Still on therapy|5|||
44316562|NCT02828358|79320421|FG001|Overall Study|Still on therapy|0|||
44316563|NCT02592824|79320428|FG000|Overall Study|Protocol Violation|5|||
44316564|NCT02592824|79320429|FG001|Overall Study|Protocol Violation|3|||
44316565|NCT02592824|79320428|FG000|Overall Study|Lost to Follow-up|2|||
44316566|NCT02592824|79320429|FG001|Overall Study|Lost to Follow-up|1|||
44316567|NCT02348112|79320448|FG000|Overall Study|Withdrawal by Subject|32|||
44316568|NCT02348112|79320449|FG001|Overall Study|Withdrawal by Subject|29|||
44316569|NCT02348112|79320448|FG000|Overall Study|Lost to Follow-up|24|||
44316570|NCT02348112|79320449|FG001|Overall Study|Lost to Follow-up|20|||
44316571|NCT02348112|79320448|FG000|Overall Study|Physician Decision|17|||
44316572|NCT02348112|79320449|FG001|Overall Study|Physician Decision|15|||
44316573|NCT02348112|79320448|FG000|Overall Study|Site closed due to PI leaving|0|||
44316574|NCT02348112|79320449|FG001|Overall Study|Site closed due to PI leaving|30|||
44316575|NCT02348112|79320448|FG000|Overall Study|Sponsor withdrawal|0|||
44316576|NCT02348112|79320449|FG001|Overall Study|Sponsor withdrawal|7|||
44316577|NCT02348112|79320448|FG000|Overall Study|Death|0|||
44316578|NCT02348112|79320449|FG001|Overall Study|Death|1|||
44316579|NCT02004691|79320479|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
44316580|NCT02004691|79320480|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
44316581|NCT02004691|79320479|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
44316582|NCT02004691|79320480|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
44316583|NCT02004691|79320479|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
44420931|NCT00764504|79428767|FG001|Overall Study|Revision of Device|23|||
44420932|NCT00764504|79428768|FG002|Overall Study|Revision of Device|14|||
44316584|NCT02004691|79320480|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
44316585|NCT02004691|79320479|FG000|ETP: Ongoing From Week 52|Other|0|||
44316586|NCT02004691|79320480|FG001|ETP: Ongoing From Week 52|Other|1|||
44316587|NCT02004691|79320479|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
44316588|NCT02004691|79320480|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
44316589|NCT01248962|79320541|FG000|Overall Study|Withdrawal by Subject|1|||
44316590|NCT01248962|79320542|FG001|Overall Study|Withdrawal by Subject|1|||
44316591|NCT01248962|79320541|FG000|Overall Study|Adverse Event|2|||
44316592|NCT01248962|79320542|FG001|Overall Study|Adverse Event|1|||
44316593|NCT01248962|79320541|FG000|Overall Study|Complete Response after 4 Cycles|1|||
44316594|NCT01248962|79320542|FG001|Overall Study|Complete Response after 4 Cycles|0|||
44316595|NCT01248962|79320541|FG000|Overall Study|Complete Response after 3 Cycles|0|||
44316596|NCT01248962|79320542|FG001|Overall Study|Complete Response after 3 Cycles|1|||
44316597|NCT01248962|79320541|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
44316598|NCT01248962|79320542|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
44420933|NCT00764504|79428766|FG000|Overall Study|Physician Decision|1|||
44420934|NCT00764504|79428767|FG001|Overall Study|Physician Decision|0|||
44420935|NCT00764504|79428768|FG002|Overall Study|Physician Decision|0|||
44420936|NCT00764504|79428766|FG000|Overall Study|Withdrawal by Subject|1|||
44420937|NCT00764504|79428767|FG001|Overall Study|Withdrawal by Subject|7|||
44420938|NCT00764504|79428768|FG002|Overall Study|Withdrawal by Subject|4|||
44420939|NCT00764504|79428766|FG000|Overall Study|Lost to Follow-up|40|||
44420940|NCT00764504|79428767|FG001|Overall Study|Lost to Follow-up|34|||
44420941|NCT00764504|79428768|FG002|Overall Study|Lost to Follow-up|72|||
44420942|NCT00763958|79428778|FG000|Overall Study|did not meet final criteria|4|||
44420943|NCT00763958|79428779|FG001|Overall Study|did not meet final criteria|4|||
44420944|NCT00763958|79428778|FG000|Overall Study|Lost to Follow-up|10|||
44420945|NCT00763958|79428779|FG001|Overall Study|Lost to Follow-up|2|||
44420946|NCT00763958|79428778|FG000|Overall Study|Believed they were receiving placebo|0|||
44420947|NCT00763958|79428779|FG001|Overall Study|Believed they were receiving placebo|5|||
44420948|NCT00763256|79428788|FG000|Overall Study|Didn't return for appointments|7|||
44420949|NCT00763256|79428789|FG001|Overall Study|Didn't return for appointments|10|||
44420950|NCT00762788|79428801|FG000|Overall Study|Lost to Follow-up|26|||
44420951|NCT00762788|79428802|FG001|Overall Study|Lost to Follow-up|37|||
44420952|NCT00762788|79428803|FG002|Overall Study|Lost to Follow-up|21|||
44420953|NCT00762788|79428804|FG003|Overall Study|Lost to Follow-up|26|||
44420954|NCT00762788|79428805|FG004|Overall Study|Lost to Follow-up|13|||
44420955|NCT00762788|79428806|FG005|Overall Study|Lost to Follow-up|21|||
44420956|NCT00583947|79428822|FG000|Cross-over Period|Adverse Event|2|||
44420957|NCT00583947|79428823|FG001|Cross-over Period|Adverse Event|0|||
44420958|NCT00583947|79428822|FG000|Cross-over Period|Withdrawal by Subject|2|||
44420959|NCT00583947|79428823|FG001|Cross-over Period|Withdrawal by Subject|0|||
44420960|NCT00583947|79428822|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
44420961|NCT00583947|79428823|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
44420962|NCT00583947|79428822|FG000|Cross-over Period|Other|1|||
44420963|NCT00583947|79428823|FG001|Cross-over Period|Other|1|||
44420964|NCT00772928|79428833|FG000|Overall Study|Lost to Follow-up|9|||
44420965|NCT00772928|79428834|FG001|Overall Study|Lost to Follow-up|6|||
44420966|NCT00772928|79428833|FG000|Overall Study|Protocol Violation|10|||
44420967|NCT00772928|79428834|FG001|Overall Study|Protocol Violation|12|||
44420968|NCT00772928|79428833|FG000|Overall Study|Withdrawal by Subject|25|||
44420969|NCT00772928|79428834|FG001|Overall Study|Withdrawal by Subject|22|||
44420970|NCT00772928|79428833|FG000|Overall Study|Did not receive vaccine|0|||
44420971|NCT00772928|79428834|FG001|Overall Study|Did not receive vaccine|1|||
44420972|NCT00762476|79428842|FG000|Overall Study|Adverse Event|7|||
44420973|NCT00762476|79428843|FG001|Overall Study|Adverse Event|1|||
44420974|NCT00762476|79428842|FG000|Overall Study|Lost to Follow-up|2|||
44420975|NCT00762476|79428843|FG001|Overall Study|Lost to Follow-up|0|||
44420976|NCT00762476|79428842|FG000|Overall Study|Protocol Violation|5|||
44420977|NCT00762476|79428843|FG001|Overall Study|Protocol Violation|6|||
44420978|NCT00762476|79428842|FG000|Overall Study|Physician Decision|2|||
44420979|NCT00762476|79428843|FG001|Overall Study|Physician Decision|14|||
44536150|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
44536151|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
44536152|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
44536153|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
44420980|NCT00762476|79428842|FG000|Overall Study|Withdrawal by Subject|6|||
44420981|NCT00762476|79428843|FG001|Overall Study|Withdrawal by Subject|12|||
44420982|NCT00762476|79428842|FG000|Overall Study|antibiotic use|0|||
44420983|NCT00762476|79428843|FG001|Overall Study|antibiotic use|1|||
44420984|NCT00762476|79428842|FG000|Overall Study|non-compliance with study visits|0|||
44420985|NCT00762476|79428843|FG001|Overall Study|non-compliance with study visits|2|||
44420986|NCT00762476|79428842|FG000|Overall Study|Seasonal allergies|1|||
44536154|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
44316599|NCT01248455|79320549|FG000|Overall Study|switched to alternate treatment|1|||
44420987|NCT00762476|79428843|FG001|Overall Study|Seasonal allergies|0|||
44420988|NCT00762164|79428852|FG000|Overall Study|Lost to Follow-up|1|||
44420989|NCT00762164|79428853|FG001|Overall Study|Lost to Follow-up|1|||
44420990|NCT00762164|79428852|FG000|Overall Study|Discontinued medication|2|||
44420991|NCT00762164|79428853|FG001|Overall Study|Discontinued medication|0|||
44420992|NCT00762164|79428852|FG000|Overall Study|Withdrawal by Subject|0|||
44420993|NCT00762164|79428853|FG001|Overall Study|Withdrawal by Subject|1|||
44316600|NCT01247090|79320556|FG000|Overall Study|Physician Decision|1|||
44316601|NCT01247090|79320557|FG001|Overall Study|Physician Decision|0|||
44316602|NCT01247090|79320558|FG002|Overall Study|Physician Decision|0|||
44316603|NCT01247090|79320556|FG000|Overall Study|Withdrawal by Subject|0|||
44316604|NCT01247090|79320557|FG001|Overall Study|Withdrawal by Subject|1|||
44316605|NCT01247090|79320558|FG002|Overall Study|Withdrawal by Subject|0|||
44316606|NCT01249664|79320568|FG000|Overall Study|Withdrawal by Subject|5|||
44316607|NCT01249664|79320569|FG001|Overall Study|Withdrawal by Subject|0|||
44316608|NCT01249664|79320568|FG000|Overall Study|Adverse Event|1|||
44316609|NCT01249664|79320569|FG001|Overall Study|Adverse Event|0|||
44316610|NCT01249274|79320579|FG000|Overall Study|Lost to Follow-up|3|||
44316611|NCT01249274|79320580|FG001|Overall Study|Lost to Follow-up|4|||
44316612|NCT01249274|79320579|FG000|Overall Study|Received inpatient substance treatment|1|||
44316613|NCT01249274|79320580|FG001|Overall Study|Received inpatient substance treatment|2|||
44316614|NCT01249157|79320588|FG000|Overall Study|Withdrawal by Subject|1|||
44316615|NCT01249118|79320592|FG000|First Washout Period|Physician Decision|0|||
44316616|NCT01249118|79320593|FG001|First Washout Period|Physician Decision|1|||
44316617|NCT01249118|79320594|FG002|First Washout Period|Physician Decision|0|||
44316618|NCT01248884|79320604|FG000|Overall Study|Withdrawal by Subject|1|||
44316619|NCT01248884|79320605|FG001|Overall Study|Withdrawal by Subject|3|||
44316620|NCT01248884|79320606|FG002|Overall Study|Withdrawal by Subject|1|||
44316621|NCT01248884|79320604|FG000|Overall Study|Adverse Event|1|||
44316622|NCT01248884|79320605|FG001|Overall Study|Adverse Event|0|||
44316623|NCT01248884|79320606|FG002|Overall Study|Adverse Event|0|||
44316624|NCT01248728|79320618|FG000|Overall Study|Adverse Event|1|||
44316625|NCT01248728|79320619|FG001|Overall Study|Adverse Event|1|||
44316626|NCT01248728|79320618|FG000|Overall Study|Withdrawal by Subject|2|||
44316627|NCT01248728|79320619|FG001|Overall Study|Withdrawal by Subject|1|||
44316628|NCT01248728|79320618|FG000|Overall Study|Lack of Efficacy|1|||
44316629|NCT01248728|79320619|FG001|Overall Study|Lack of Efficacy|0|||
44316630|NCT01246973|79320629|FG000|Overall Study|Other|38|||
44316631|NCT01246973|79320630|FG001|Overall Study|Other|25|||
44316632|NCT01246973|79320629|FG000|Overall Study|Adverse Event|16|||
44316633|NCT01246973|79320630|FG001|Overall Study|Adverse Event|9|||
44316634|NCT01246973|79320629|FG000|Overall Study|Withdrawal by Subject|7|||
44316635|NCT01246973|79320630|FG001|Overall Study|Withdrawal by Subject|13|||
44316636|NCT01246466|79320636|FG000|Overall Study|Death|1|||
44316637|NCT01246466|79320636|FG000|Overall Study|Withdrawal by Subject|1|||
44316638|NCT01245764|79320645|FG000|Study Phase A|Other|3|||
44316639|NCT01245764|79320646|FG001|Study Phase A|Other|2|||
44316640|NCT01245764|79320647|FG002|Study Phase A|Other|3|||
44316641|NCT01245764|79320648|FG003|Study Phase A|Other|1|||
44316642|NCT01245764|79320645|FG000|Study Phase A|Protocol Violation|6|||
44316643|NCT01245764|79320646|FG001|Study Phase A|Protocol Violation|3|||
44316644|NCT01245764|79320647|FG002|Study Phase A|Protocol Violation|2|||
44316645|NCT01245764|79320648|FG003|Study Phase A|Protocol Violation|2|||
44316646|NCT01245764|79320645|FG000|Study Phase A|Lost to Follow-up|0|||
44316647|NCT01245764|79320646|FG001|Study Phase A|Lost to Follow-up|0|||
44316648|NCT01245764|79320647|FG002|Study Phase A|Lost to Follow-up|5|||
44316649|NCT01245764|79320648|FG003|Study Phase A|Lost to Follow-up|0|||
44420994|NCT00762086|79428861|FG000|Overall Study|Adverse Event|2|||
44420995|NCT00762086|79428862|FG001|Overall Study|Adverse Event|0|||
44420996|NCT00762086|79428861|FG000|Overall Study|Lost to Follow-up|0|||
44420997|NCT00762086|79428862|FG001|Overall Study|Lost to Follow-up|2|||
44420998|NCT00762086|79428861|FG000|Overall Study|Non compliance|1|||
44420999|NCT00762086|79428862|FG001|Overall Study|Non compliance|0|||
44421000|NCT00762086|79428861|FG000|Overall Study|Withdrawal by Subject|2|||
44421001|NCT00762086|79428862|FG001|Overall Study|Withdrawal by Subject|2|||
44421002|NCT00762086|79428861|FG000|Overall Study|Ineligible to participate in the study|1|||
44421003|NCT00762086|79428862|FG001|Overall Study|Ineligible to participate in the study|0|||
44421004|NCT00761774|79428868|FG000|Overall Study|Adverse Event|17|||
44421005|NCT00761774|79428868|FG000|Overall Study|Lack of Efficacy|37|||
44421006|NCT00761774|79428868|FG000|Overall Study|Lost to Follow-up|2|||
44421007|NCT00761774|79428868|FG000|Overall Study|Withdrawal by Subject|9|||
44421008|NCT00761774|79428868|FG000|Overall Study|Non-compliance|4|||
44421009|NCT00761774|79428868|FG000|Overall Study|End of study|2|||
44421010|NCT00761774|79428868|FG000|Overall Study|Reclassification of seizures|1|||
44316650|NCT01245140|79320668|FG000|Overall Study|Adverse Event|1|||
44316651|NCT01245140|79320669|FG001|Overall Study|Adverse Event|3|||
44316652|NCT01245140|79320668|FG000|Overall Study|Lack of Efficacy|2|||
44316653|NCT01245140|79320669|FG001|Overall Study|Lack of Efficacy|4|||
44316654|NCT01245140|79320668|FG000|Overall Study|Protocol Violation|0|||
44316655|NCT01245140|79320669|FG001|Overall Study|Protocol Violation|1|||
44316656|NCT01245140|79320668|FG000|Overall Study|Withdrawal by Subject|0|||
44316657|NCT01245140|79320669|FG001|Overall Study|Withdrawal by Subject|1|||
44316658|NCT01245140|79320668|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
44316659|NCT01245140|79320669|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
44316660|NCT01245101|79320677|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
44316661|NCT01245101|79320678|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
44316662|NCT01245101|79320677|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
44316663|NCT01245101|79320678|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
44316664|NCT01245101|79320677|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
44316665|NCT01245101|79320678|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
44316666|NCT01245062|79320686|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
44316667|NCT01245062|79320687|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
44316668|NCT01245062|79320688|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
44316669|NCT01245062|79320686|FG000|Randomization and Crossover Phase|Physician Decision|2|||
44316670|NCT01245062|79320687|FG001|Randomization and Crossover Phase|Physician Decision|4|||
44316671|NCT01245062|79320688|FG002|Randomization and Crossover Phase|Physician Decision|0|||
44316672|NCT01245062|79320686|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
44316673|NCT01245062|79320687|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
44316674|NCT01245062|79320688|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
44316675|NCT01245062|79320686|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
44316676|NCT01245062|79320687|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
44316677|NCT01245062|79320688|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
44316678|NCT01245062|79320686|FG000|Cross-over Phase|Lost to Follow-up|0|||
44316679|NCT01245062|79320687|FG001|Cross-over Phase|Lost to Follow-up|0|||
44316680|NCT01245062|79320688|FG002|Cross-over Phase|Lost to Follow-up|1|||
44316681|NCT01245062|79320686|FG000|Cross-over Phase|Physician Decision|0|||
44316682|NCT01245062|79320687|FG001|Cross-over Phase|Physician Decision|0|||
44316683|NCT01245062|79320688|FG002|Cross-over Phase|Physician Decision|1|||
44316684|NCT01245062|79320686|FG000|Cross-over Phase|Withdrew Consent|0|||
44316685|NCT01245062|79320687|FG001|Cross-over Phase|Withdrew Consent|0|||
44316686|NCT01245062|79320688|FG002|Cross-over Phase|Withdrew Consent|4|||
44316687|NCT01245062|79320686|FG000|Cross-over Phase|Study closed/ terminated|0|||
44316688|NCT01245062|79320687|FG001|Cross-over Phase|Study closed/ terminated|0|||
44316689|NCT01245062|79320688|FG002|Cross-over Phase|Study closed/ terminated|11|||
44316690|NCT01244984|79320699|FG000|Overall Study|Adverse Event|2|||
44316691|NCT01244984|79320700|FG001|Overall Study|Adverse Event|11|||
44316692|NCT01244984|79320701|FG002|Overall Study|Adverse Event|2|||
44316693|NCT01244984|79320699|FG000|Overall Study|Protocol Violation|1|||
44316694|NCT01244984|79320700|FG001|Overall Study|Protocol Violation|0|||
44316695|NCT01244984|79320701|FG002|Overall Study|Protocol Violation|0|||
44316696|NCT01244984|79320699|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
44316697|NCT01244984|79320700|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
44316698|NCT01244984|79320701|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
44316699|NCT01244984|79320699|FG000|Overall Study|Withdrawal by Subject|1|||
44316700|NCT01244984|79320700|FG001|Overall Study|Withdrawal by Subject|2|||
44316701|NCT01244984|79320701|FG002|Overall Study|Withdrawal by Subject|2|||
44316702|NCT01244516|79320713|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
44316703|NCT01244516|79320714|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
44316704|NCT01244516|79320715|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
44316705|NCT01244516|79320713|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
44316706|NCT01244516|79320714|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
44316707|NCT01244516|79320715|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
44316708|NCT01244516|79320713|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
44316709|NCT01244516|79320714|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
44316710|NCT01244516|79320715|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
44316711|NCT01244516|79320713|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
44316712|NCT01244516|79320714|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
44316713|NCT01244516|79320715|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
44316714|NCT01244516|79320713|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
44316715|NCT01244516|79320714|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
44316716|NCT01244516|79320715|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
44316717|NCT01244516|79320713|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
44316718|NCT01244516|79320714|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
44316719|NCT01244516|79320715|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
44316720|NCT01244516|79320713|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
44316721|NCT01244516|79320714|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
44316722|NCT01244516|79320715|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
44316723|NCT01244126|79320727|FG000|Overall Study|Protocol Violation|3|||
44316724|NCT01244126|79320728|FG001|Overall Study|Protocol Violation|3|||
44316725|NCT01244126|79320729|FG002|Overall Study|Protocol Violation|9|||
44316726|NCT01243892|79320739|FG000|Overall Study|Did not meet eligibility criteria|2|||
44316727|NCT01243892|79320740|FG001|Overall Study|Did not meet eligibility criteria|0|||
44316728|NCT01243775|79320746|FG000|Overall Study|Withdrawal by Subject|2|||
44316729|NCT01243268|79320750|FG000|Overall Study|Lost to Follow-up|4|||
44316730|NCT01243268|79320750|FG000|Overall Study|Protocol Violation|51|||
44316731|NCT01243268|79320750|FG000|Overall Study|Deviation with contract date|7|||
44316732|NCT01243268|79320750|FG000|Overall Study|Duplicate subject|2|||
44316733|NCT01242371|79320756|FG000|Overall Study|Withdrawal by Subject|2|||
44316734|NCT01242371|79320757|FG001|Overall Study|Withdrawal by Subject|2|||
44316735|NCT01242371|79320756|FG000|Overall Study|Protocol Violation|0|||
44316736|NCT01242371|79320757|FG001|Overall Study|Protocol Violation|3|||
44316737|NCT01242176|79320763|FG000|Washout Period of 7 Days|Adverse Event|0|||
44316738|NCT01242176|79320764|FG001|Washout Period of 7 Days|Adverse Event|2|||
44316739|NCT01242176|79320763|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
44316740|NCT01242176|79320764|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
44316741|NCT01242020|79320772|FG000|Overall Study|Withdrawal by Subject|2|||
44316742|NCT01242020|79320773|FG001|Overall Study|Withdrawal by Subject|0|||
44316743|NCT01242020|79320772|FG000|Overall Study|Failed screening|1|||
44316744|NCT01242020|79320773|FG001|Overall Study|Failed screening|0|||
44316745|NCT01241786|79320779|FG000|Overall Study|Lack of Efficacy|5|||
44316746|NCT01241318|79320786|FG000|Overall Study|Woman: false pregnancies|27|||
44316747|NCT01241318|79320787|FG001|Overall Study|Woman: false pregnancies|15|||
44316748|NCT01241318|79320786|FG000|Overall Study|Woman: miscarriage/abortion|46|||
44316749|NCT01241318|79320787|FG001|Overall Study|Woman: miscarriage/abortion|38|||
44316750|NCT01241318|79320786|FG000|Overall Study|Withdrawal by Subject|175|||
44316751|NCT01241318|79320787|FG001|Overall Study|Withdrawal by Subject|46|||
44316752|NCT01241318|79320786|FG000|Overall Study|Lost to Follow-up|740|||
44316753|NCT01241318|79320787|FG001|Overall Study|Lost to Follow-up|455|||
44316754|NCT01241318|79320786|FG000|Overall Study|Death|2|||
44316755|NCT01241318|79320787|FG001|Overall Study|Death|4|||
44316756|NCT01241318|79320786|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
44316757|NCT01241318|79320787|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
44316758|NCT01241318|79320786|FG000|Overall Study|Woman: Stillborn infant|129|||
44316759|NCT01241318|79320787|FG001|Overall Study|Woman: Stillborn infant|146|||
44316760|NCT01241279|79320798|FG000|Overall Study|Lost to Follow-up|0|||
44316761|NCT01241279|79320799|FG001|Overall Study|Lost to Follow-up|1|||
44316762|NCT01241240|79320807|FG000|Overall Study|Adverse Event|5|||
44316763|NCT01241240|79320808|FG001|Overall Study|Adverse Event|4|||
44316764|NCT01241240|79320807|FG000|Overall Study|Lost to Follow-up|2|||
44316765|NCT01241240|79320808|FG001|Overall Study|Lost to Follow-up|4|||
44316766|NCT01241240|79320807|FG000|Overall Study|Personal Reasons|1|||
44316767|NCT01241240|79320808|FG001|Overall Study|Personal Reasons|1|||
44316768|NCT01240811|79320817|FG000|Overall Study|Physician Decision|0|||
44316769|NCT01240811|79320818|FG001|Overall Study|Physician Decision|1|||
44316770|NCT01240811|79320819|FG002|Overall Study|Physician Decision|0|||
44316771|NCT01240811|79320817|FG000|Overall Study|Withdrawal by Subject|0|||
44316772|NCT01240811|79320818|FG001|Overall Study|Withdrawal by Subject|0|||
44316773|NCT01240811|79320819|FG002|Overall Study|Withdrawal by Subject|1|||
44316774|NCT01240382|79320831|FG000|Overall Study|Adverse Event|2|||
44316775|NCT01240382|79320832|FG001|Overall Study|Adverse Event|1|||
44316776|NCT01240382|79320831|FG000|Overall Study|Lack of Efficacy|0|||
44316777|NCT01240382|79320832|FG001|Overall Study|Lack of Efficacy|2|||
44316778|NCT01240382|79320831|FG000|Overall Study|Fear of adverse events|0|||
44316779|NCT01240382|79320832|FG001|Overall Study|Fear of adverse events|1|||
44316780|NCT01244828|79320838|FG000|Overall Study|Adverse Event|37|||
44316781|NCT01244828|79320838|FG000|Overall Study|Withdrawal by Subject|31|||
44316782|NCT01244828|79320838|FG000|Overall Study|Lack of Efficacy|7|||
44316783|NCT01244828|79320838|FG000|Overall Study|Lost to Follow-up|2|||
44316784|NCT01244828|79320838|FG000|Overall Study|Other reason (not specified)|1|||
44316785|NCT01249833|79320844|FG000|Overall Study|Lost to Follow-up|0|||
44316786|NCT01249833|79320845|FG001|Overall Study|Lost to Follow-up|1|||
44421011|NCT00761774|79428868|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
44421012|NCT00761774|79428868|FG000|Overall Study|Sponsor decision|1|||
44421013|NCT00761774|79428868|FG000|Overall Study|Investigator clinical judgement|1|||
44421014|NCT00761774|79428868|FG000|Overall Study|Patient moved out of study area|1|||
44421015|NCT00761774|79428868|FG000|Overall Study|Coordinator leaving site|1|||
44421016|NCT00761774|79428868|FG000|Overall Study|Subject IP non-compliance|1|||
44421017|NCT00761774|79428868|FG000|Overall Study|IP stopped by hospital physician|1|||
44421018|NCT00583791|79428874|FG000|Overall Study|Other|67|||
44421019|NCT00583791|79428874|FG000|Overall Study|Death|6|||
44421020|NCT00781274|79428878|FG000|Overall Study|Withdrawal by Subject|2|||
44316787|NCT01249404|79320854|FG000|Overall Study|Study treatment not received|0|||
44316788|NCT01249404|79320855|FG001|Overall Study|Study treatment not received|1|||
44316789|NCT01249404|79320856|FG002|Overall Study|Study treatment not received|2|||
44316790|NCT01249404|79320854|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
44421021|NCT00780416|79428884|FG000|Overall Study|Physician Decision|3|||
44316791|NCT01249404|79320855|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
44316792|NCT01249404|79320856|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
44316793|NCT01249404|79320854|FG000|Overall Study|Adverse Event|2|||
44316794|NCT01249404|79320855|FG001|Overall Study|Adverse Event|2|||
44316795|NCT01249404|79320856|FG002|Overall Study|Adverse Event|2|||
44316796|NCT01249404|79320854|FG000|Overall Study|Withdrawal by Subject|2|||
44316797|NCT01249404|79320855|FG001|Overall Study|Withdrawal by Subject|2|||
44316798|NCT01249404|79320856|FG002|Overall Study|Withdrawal by Subject|0|||
44316799|NCT01249404|79320854|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
44316800|NCT01249404|79320855|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
44316801|NCT01249404|79320856|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
44316802|NCT01249404|79320854|FG000|Overall Study|Non compliance to visit schedule|0|||
44316803|NCT01249404|79320855|FG001|Overall Study|Non compliance to visit schedule|1|||
44316804|NCT01249404|79320856|FG002|Overall Study|Non compliance to visit schedule|0|||
44316805|NCT01249365|79320864|FG000|Overall Study|Lost to Follow-up|1|||
44316806|NCT01249131|79320868|FG000|Washout Period of 10 Days|Adverse Event|0|||
44316807|NCT01249131|79320869|FG001|Washout Period of 10 Days|Adverse Event|0|||
44316808|NCT01249131|79320870|FG002|Washout Period of 10 Days|Adverse Event|0|||
44316809|NCT01249131|79320871|FG003|Washout Period of 10 Days|Adverse Event|0|||
44316810|NCT01249131|79320872|FG004|Washout Period of 10 Days|Adverse Event|1|||
44316811|NCT01249131|79320873|FG005|Washout Period of 10 Days|Adverse Event|0|||
44316812|NCT01249092|79320881|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
44316813|NCT01249092|79320881|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
44316814|NCT01248936|79320887|FG000|Overall Study|Sponsor Decision|259|||
44316815|NCT01248936|79320887|FG000|Overall Study|Progression of Disease|50|||
44316816|NCT01248936|79320887|FG000|Overall Study|Death|26|||
44316817|NCT01248936|79320887|FG000|Overall Study|Withdrawal of Consent|20|||
44316818|NCT01248936|79320887|FG000|Overall Study|Adverse Event|8|||
44316819|NCT01248936|79320887|FG000|Overall Study|Lost to Follow-up|7|||
44316820|NCT01248936|79320887|FG000|Overall Study|Refused Treatment|1|||
44316821|NCT01248936|79320887|FG000|Overall Study|Other reason|3|||
44316822|NCT01248780|79320894|FG000|Overall Study|Lack of Efficacy|2|||
44316823|NCT01248780|79320895|FG001|Overall Study|Lack of Efficacy|0|||
44316824|NCT01248780|79320894|FG000|Overall Study|Lost to Follow-up|0|||
44316825|NCT01248780|79320895|FG001|Overall Study|Lost to Follow-up|1|||
44316826|NCT01248780|79320894|FG000|Overall Study|Death|0|||
44257982|NCT01426412|79111859|FG000|Overall Study|Withdrawal by Subject|1|||
44316827|NCT01248780|79320895|FG001|Overall Study|Death|1|||
44316828|NCT01248780|79320894|FG000|Overall Study|Adverse Event|2|||
44316829|NCT01248780|79320895|FG001|Overall Study|Adverse Event|7|||
44316830|NCT01248780|79320894|FG000|Overall Study|Protocol Violation|1|||
44316831|NCT01248780|79320895|FG001|Overall Study|Protocol Violation|1|||
44316832|NCT01248780|79320894|FG000|Overall Study|Withdrawal by Subject|4|||
44316833|NCT01248780|79320895|FG001|Overall Study|Withdrawal by Subject|4|||
44316834|NCT01248780|79320894|FG000|Overall Study|Not treated|0|||
44257983|NCT01426412|79111860|FG001|Overall Study|Withdrawal by Subject|0|||
44257984|NCT01426412|79111861|FG002|Overall Study|Withdrawal by Subject|0|||
44257985|NCT01426412|79111862|FG003|Overall Study|Withdrawal by Subject|0|||
44257986|NCT01426412|79111863|FG004|Overall Study|Withdrawal by Subject|1|||
44257987|NCT01426412|79111864|FG005|Overall Study|Withdrawal by Subject|0|||
44257988|NCT01426412|79111865|FG006|Overall Study|Withdrawal by Subject|0|||
44257989|NCT01426412|79111866|FG007|Overall Study|Withdrawal by Subject|3|||
44257990|NCT01426412|79111867|FG008|Overall Study|Withdrawal by Subject|1|||
44257991|NCT00554229|79112071|FG000|Overall Study|Lost to Follow-up|3|||
44257992|NCT00554229|79112072|FG001|Overall Study|Lost to Follow-up|6|||
44257993|NCT00554229|79112071|FG000|Overall Study|Withdrawal by Subject|29|||
44257994|NCT00554229|79112072|FG001|Overall Study|Withdrawal by Subject|37|||
44257995|NCT00554229|79112071|FG000|Overall Study|Adverse Event|71|||
44257996|NCT00554229|79112072|FG001|Overall Study|Adverse Event|39|||
44257997|NCT00554229|79112071|FG000|Overall Study|Protocol Violation|3|||
44257998|NCT00554229|79112072|FG001|Overall Study|Protocol Violation|3|||
44257999|NCT00554229|79112071|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
44258000|NCT00554229|79112072|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
44258001|NCT00554229|79112071|FG000|Overall Study|Randomised but no treatment received|1|||
44258002|NCT00554229|79112072|FG001|Overall Study|Randomised but no treatment received|0|||
44258003|NCT01405820|79112182|FG000|Randomized Treatment Period|Adverse Event|3|||
44258004|NCT01405820|79112183|FG001|Randomized Treatment Period|Adverse Event|3|||
44258005|NCT01405820|79112184|FG002|Randomized Treatment Period|Adverse Event|3|||
44258006|NCT01405820|79112185|FG003|Randomized Treatment Period|Adverse Event|0|||
44258007|NCT01405820|79112186|FG004|Randomized Treatment Period|Adverse Event|2|||
44258008|NCT01405820|79112187|FG005|Randomized Treatment Period|Adverse Event|1|||
44258009|NCT01405820|79112182|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
44258010|NCT01405820|79112183|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
44258011|NCT01405820|79112184|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
44258012|NCT01405820|79112185|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
44258013|NCT01405820|79112186|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
44258014|NCT01405820|79112187|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
44316835|NCT01248780|79320895|FG001|Overall Study|Not treated|1|||
44316836|NCT01248468|79320904|FG000|Overall Study|Administrative problem|1|||
44316837|NCT01248468|79320905|FG001|Overall Study|Administrative problem|0|||
44316838|NCT01248468|79320906|FG002|Overall Study|Administrative problem|0|||
44316839|NCT01248468|79320904|FG000|Overall Study|Lost to Follow-up|9|||
44316840|NCT01248468|79320905|FG001|Overall Study|Lost to Follow-up|12|||
44316841|NCT01248468|79320906|FG002|Overall Study|Lost to Follow-up|4|||
44316842|NCT01248468|79320904|FG000|Overall Study|Pregnancy|1|||
44316843|NCT01248468|79320905|FG001|Overall Study|Pregnancy|0|||
44316844|NCT01248468|79320906|FG002|Overall Study|Pregnancy|0|||
44316845|NCT01248468|79320904|FG000|Overall Study|Withdrawal by Subject|4|||
44316846|NCT01248468|79320905|FG001|Overall Study|Withdrawal by Subject|2|||
44316847|NCT01248468|79320906|FG002|Overall Study|Withdrawal by Subject|0|||
44316848|NCT01247922|79320914|FG000|Overall Study|Disease progression|4|||
44316849|NCT01246206|79320918|FG000|Overall Study|Patient did not receive study regiments.|1|||
44316850|NCT01246011|79320925|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
44316851|NCT01246011|79320926|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
44316852|NCT01246011|79320927|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
44316853|NCT01246011|79320925|FG000|Overall Study|Withdrawal by Subject|0|||
44316854|NCT01246011|79320926|FG001|Overall Study|Withdrawal by Subject|0|||
44316855|NCT01246011|79320927|FG002|Overall Study|Withdrawal by Subject|1|||
44316856|NCT01244490|79320939|FG000|Overall Study|Lack of Efficacy|14|||
44316857|NCT01244490|79320940|FG001|Overall Study|Lack of Efficacy|5|||
44316858|NCT01244490|79320941|FG002|Overall Study|Lack of Efficacy|5|||
44316859|NCT01244490|79320939|FG000|Overall Study|Withdrawal by Subject|4|||
44316860|NCT01244490|79320940|FG001|Overall Study|Withdrawal by Subject|4|||
44316861|NCT01244490|79320941|FG002|Overall Study|Withdrawal by Subject|9|||
44316862|NCT01244490|79320939|FG000|Overall Study|Adverse Event|1|||
44316863|NCT01244490|79320940|FG001|Overall Study|Adverse Event|9|||
44316864|NCT01244490|79320941|FG002|Overall Study|Adverse Event|5|||
44316865|NCT01244490|79320939|FG000|Overall Study|Lost to Follow-up|0|||
44316866|NCT01244490|79320940|FG001|Overall Study|Lost to Follow-up|6|||
44316867|NCT01244490|79320941|FG002|Overall Study|Lost to Follow-up|3|||
44316868|NCT01244490|79320939|FG000|Overall Study|Other|0|||
44316869|NCT01244490|79320940|FG001|Overall Study|Other|0|||
44316870|NCT01244490|79320941|FG002|Overall Study|Other|1|||
44316871|NCT01243944|79320951|FG000|Overall Study|Adverse Event|15|||
44316872|NCT01243944|79320952|FG001|Overall Study|Adverse Event|13|||
44316873|NCT01243944|79320951|FG000|Overall Study|Lost to Follow-up|2|||
44316874|NCT01243944|79320952|FG001|Overall Study|Lost to Follow-up|1|||
44316875|NCT01243944|79320951|FG000|Overall Study|Physician Decision|2|||
44316876|NCT01243944|79320952|FG001|Overall Study|Physician Decision|7|||
44316877|NCT01243944|79320951|FG000|Overall Study|Disease progression|12|||
44316878|NCT01243944|79320952|FG001|Overall Study|Disease progression|11|||
44316879|NCT01243944|79320951|FG000|Overall Study|Protocol deviation|1|||
44316880|NCT01243944|79320952|FG001|Overall Study|Protocol deviation|1|||
44316881|NCT01243944|79320951|FG000|Overall Study|Participant decision|10|||
44316882|NCT01243944|79320952|FG001|Overall Study|Participant decision|15|||
44316883|NCT01243944|79320951|FG000|Overall Study|Death|2|||
44316884|NCT01243944|79320952|FG001|Overall Study|Death|3|||
44316885|NCT01243944|79320951|FG000|Overall Study|Non-compliance with study treatment|1|||
44316886|NCT01243944|79320952|FG001|Overall Study|Non-compliance with study treatment|0|||
44316887|NCT01243242|79320961|FG000|Overall Study|Adverse Event|1|||
44316888|NCT01243242|79320962|FG001|Overall Study|Adverse Event|1|||
44316889|NCT01243242|79320961|FG000|Overall Study|Withdrawal by Subject|1|||
44316890|NCT01243242|79320962|FG001|Overall Study|Withdrawal by Subject|1|||
44316891|NCT01243242|79320961|FG000|Overall Study|Physician Decision|0|||
44316892|NCT01243242|79320962|FG001|Overall Study|Physician Decision|1|||
44316893|NCT01243242|79320961|FG000|Overall Study|sponsor decision|0|||
44316894|NCT01243242|79320962|FG001|Overall Study|sponsor decision|1|||
44316895|NCT01243242|79320961|FG000|Overall Study|non compliance|1|||
44316896|NCT01243242|79320962|FG001|Overall Study|non compliance|0|||
44316897|NCT01242813|79320968|FG000|Overall Study|Lost to Follow-up|2|||
44316898|NCT01242111|79320972|FG000|Overall Study|Adverse Event|1|||
44316899|NCT01242111|79320972|FG000|Overall Study|Withdrawal by Subject|1|||
44316900|NCT01242111|79320972|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
44316901|NCT01241604|79320976|FG000|Screening Period|Screen Failure|3|||
44316902|NCT01241604|79320977|FG001|Screening Period|Screen Failure|0|||
44316903|NCT01241604|79320978|FG002|Screening Period|Screen Failure|0|||
44316904|NCT01241292|79320987|FG000|Overall Study|Administrative Reason by Sponsor|1|||
44316905|NCT01241292|79320988|FG001|Overall Study|Administrative Reason by Sponsor|0|||
44536155|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
44316906|NCT01241292|79320987|FG000|Overall Study|Disease Progression|2|||
44316907|NCT01241292|79320988|FG001|Overall Study|Disease Progression|0|||
44316908|NCT01241292|79320987|FG000|Overall Study|Study Drug Toxicity|0|||
44316909|NCT01241292|79320988|FG001|Overall Study|Study Drug Toxicity|1|||
44316910|NCT01241292|79320987|FG000|Overall Study|Participant Discontinued Treatment|0|||
44316911|NCT01241292|79320988|FG001|Overall Study|Participant Discontinued Treatment|2|||
44316912|NCT01240863|79321000|FG000|Open-label Titration Period|Adverse Event|47|||
44316913|NCT01240863|79321001|FG001|Open-label Titration Period|Adverse Event|0|||
44316914|NCT01240863|79321002|FG002|Open-label Titration Period|Adverse Event|0|||
44316915|NCT01240863|79321000|FG000|Open-label Titration Period|Lack of Efficacy|19|||
44316916|NCT01240863|79321001|FG001|Open-label Titration Period|Lack of Efficacy|0|||
44316917|NCT01240863|79321002|FG002|Open-label Titration Period|Lack of Efficacy|0|||
44316918|NCT01240863|79321000|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
44316919|NCT01240863|79321001|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
44316920|NCT01240863|79321002|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
44316921|NCT01240863|79321000|FG000|Open-label Titration Period|Protocol Violation|7|||
44316922|NCT01240863|79321001|FG001|Open-label Titration Period|Protocol Violation|0|||
44316923|NCT01240863|79321002|FG002|Open-label Titration Period|Protocol Violation|0|||
44316924|NCT01240863|79321000|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
44316925|NCT01240863|79321001|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
44316926|NCT01240863|79321002|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
44316927|NCT01240863|79321000|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
44316928|NCT01240863|79321001|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
44316929|NCT01240863|79321002|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
44316930|NCT01240863|79321000|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
44316931|NCT01240863|79321001|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
44316932|NCT01240863|79321002|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
44316933|NCT01240863|79321000|FG000|Open-label Titration Period|Other|7|||
44316934|NCT01240863|79321001|FG001|Open-label Titration Period|Other|0|||
44316935|NCT01240863|79321002|FG002|Open-label Titration Period|Other|0|||
44316936|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
44316937|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
44316938|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
44316939|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
44316940|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
44316941|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
44316942|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
44316943|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
44316944|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
44316945|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
44316946|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
44316947|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
44316948|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
44316949|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
44316950|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
44316951|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
44316952|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
44316953|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
44316954|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
44316955|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
44316956|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
44316957|NCT01240863|79321000|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
44316958|NCT01240863|79321001|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
44316959|NCT01240863|79321002|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
44316960|NCT01240746|79321017|FG000|Overall Study|Adverse Event|2|||
44316961|NCT01240746|79321018|FG001|Overall Study|Adverse Event|0|||
44316962|NCT01240746|79321019|FG002|Overall Study|Adverse Event|10|||
44316963|NCT01240746|79321017|FG000|Overall Study|Lost to Follow-up|23|||
44316964|NCT01240746|79321018|FG001|Overall Study|Lost to Follow-up|20|||
44316965|NCT01240746|79321019|FG002|Overall Study|Lost to Follow-up|102|||
44316966|NCT01240746|79321017|FG000|Overall Study|Protocol Violation|24|||
44316967|NCT01240746|79321018|FG001|Overall Study|Protocol Violation|15|||
44316968|NCT01240746|79321019|FG002|Overall Study|Protocol Violation|72|||
44316969|NCT01240746|79321017|FG000|Overall Study|Withdrawal by Subject|10|||
44316970|NCT01240746|79321018|FG001|Overall Study|Withdrawal by Subject|13|||
44316971|NCT01240746|79321019|FG002|Overall Study|Withdrawal by Subject|59|||
44316972|NCT01240590|79321032|FG000|Phase I|Refused further treatment|0|||
44316973|NCT01240590|79321033|FG001|Phase I|Refused further treatment|0|||
44316974|NCT01240590|79321034|FG002|Phase I|Refused further treatment|3|||
44316975|NCT01240590|79321035|FG003|Phase I|Refused further treatment|0|||
44316976|NCT01240590|79321036|FG004|Phase I|Refused further treatment|0|||
44316977|NCT01240590|79321032|FG000|Phase II|Refused further treatment|0|||
44316978|NCT01240590|79321033|FG001|Phase II|Refused further treatment|0|||
44316979|NCT01240590|79321034|FG002|Phase II|Refused further treatment|0|||
44316980|NCT01240590|79321035|FG003|Phase II|Refused further treatment|2|||
44316981|NCT01240590|79321036|FG004|Phase II|Refused further treatment|1|||
44316982|NCT01240200|79321064|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
44316983|NCT01240200|79321065|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
44316984|NCT01356966|79321076|FG000|Overall Study|Withdrawal by Subject|1|||
44421022|NCT00780416|79428885|FG001|Overall Study|Physician Decision|3|||
44316985|NCT01356966|79321077|FG001|Overall Study|Withdrawal by Subject|2|||
44316986|NCT01356966|79321076|FG000|Overall Study|Physician Decision|1|||
44316987|NCT01356966|79321077|FG001|Overall Study|Physician Decision|0|||
44316988|NCT05289271|79321115|FG000|Overall Study|Mistakenly allocated, untreated|1|||
44316989|NCT05289271|79321116|FG001|Overall Study|Mistakenly allocated, untreated|0|||
44316990|NCT05080660|79321157|FG000|Overall Study|Adverse Event|4|||
44316991|NCT05080660|79321158|FG001|Overall Study|Adverse Event|0|||
44316992|NCT05080660|79321157|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
44316993|NCT05080660|79321158|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
44316994|NCT05080660|79321157|FG000|Overall Study|Physician Decision|1|||
44316995|NCT05080660|79321158|FG001|Overall Study|Physician Decision|0|||
44316996|NCT05080660|79321157|FG000|Overall Study|Protocol Deviation|2|||
44316997|NCT05080660|79321158|FG001|Overall Study|Protocol Deviation|0|||
44316998|NCT05080660|79321157|FG000|Overall Study|Withdrawal by Subject|5|||
44316999|NCT05080660|79321158|FG001|Overall Study|Withdrawal by Subject|2|||
44317000|NCT05005312|79321166|FG000|Overall Study|Enrolled, but not treated|0|||
44317001|NCT05005312|79321167|FG001|Overall Study|Enrolled, but not treated|1|||
44317002|NCT04867902|79321182|FG000|Overall Study|Lost to Follow-up|1|||
44317003|NCT04867902|79321182|FG000|Overall Study|Withdrawal by Subject|2|||
44317004|NCT04867902|79321182|FG000|Overall Study|Protocol Violation|1|||
44317005|NCT04677179|79321189|FG000|Induction Treatment Period|Adverse Event|1|||
44317006|NCT04677179|79321190|FG001|Induction Treatment Period|Adverse Event|0|||
44317007|NCT04677179|79321191|FG002|Induction Treatment Period|Adverse Event|0|||
44317008|NCT04677179|79321192|FG003|Induction Treatment Period|Adverse Event|0|||
44317009|NCT04677179|79321193|FG004|Induction Treatment Period|Adverse Event|0|||
44317010|NCT04677179|79321194|FG005|Induction Treatment Period|Adverse Event|0|||
44317011|NCT04677179|79321195|FG006|Induction Treatment Period|Adverse Event|0|||
44317012|NCT04677179|79321196|FG007|Induction Treatment Period|Adverse Event|0|||
44317013|NCT04677179|79321197|FG008|Induction Treatment Period|Adverse Event|0|||
44317014|NCT04677179|79321198|FG009|Induction Treatment Period|Adverse Event|0|||
44317015|NCT04677179|79321189|FG000|Induction Treatment Period|Physician Decision|1|||
44317016|NCT04677179|79321190|FG001|Induction Treatment Period|Physician Decision|0|||
44317017|NCT04677179|79321191|FG002|Induction Treatment Period|Physician Decision|1|||
44317018|NCT04677179|79321192|FG003|Induction Treatment Period|Physician Decision|0|||
44317019|NCT04677179|79321193|FG004|Induction Treatment Period|Physician Decision|0|||
44317020|NCT04677179|79321194|FG005|Induction Treatment Period|Physician Decision|0|||
44317021|NCT04677179|79321195|FG006|Induction Treatment Period|Physician Decision|0|||
44317022|NCT04677179|79321196|FG007|Induction Treatment Period|Physician Decision|0|||
44317023|NCT04677179|79321197|FG008|Induction Treatment Period|Physician Decision|0|||
44317024|NCT04677179|79321198|FG009|Induction Treatment Period|Physician Decision|0|||
44317025|NCT04677179|79321189|FG000|Induction Treatment Period|Protocol Violation|0|||
44317026|NCT04677179|79321190|FG001|Induction Treatment Period|Protocol Violation|1|||
44317027|NCT04677179|79321191|FG002|Induction Treatment Period|Protocol Violation|0|||
44317028|NCT04677179|79321192|FG003|Induction Treatment Period|Protocol Violation|0|||
44317029|NCT04677179|79321193|FG004|Induction Treatment Period|Protocol Violation|0|||
44317030|NCT04677179|79321194|FG005|Induction Treatment Period|Protocol Violation|0|||
44317031|NCT04677179|79321195|FG006|Induction Treatment Period|Protocol Violation|0|||
44317032|NCT04677179|79321196|FG007|Induction Treatment Period|Protocol Violation|0|||
44317033|NCT04677179|79321197|FG008|Induction Treatment Period|Protocol Violation|0|||
44317034|NCT04677179|79321198|FG009|Induction Treatment Period|Protocol Violation|0|||
44317035|NCT04677179|79321189|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
44317036|NCT04677179|79321190|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
44317037|NCT04677179|79321191|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
44317038|NCT04677179|79321192|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
44317039|NCT04677179|79321193|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
44317040|NCT04677179|79321194|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
44317041|NCT04677179|79321195|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
44317042|NCT04677179|79321196|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
44317043|NCT04677179|79321197|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
44317044|NCT04677179|79321198|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
44317045|NCT04677179|79321189|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
44317046|NCT04677179|79321190|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
44317047|NCT04677179|79321191|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
44317048|NCT04677179|79321192|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
44317049|NCT04677179|79321193|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
44317050|NCT04677179|79321194|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
44317051|NCT04677179|79321195|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
44317052|NCT04677179|79321196|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
44317053|NCT04677179|79321197|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
44317054|NCT04677179|79321198|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
44317055|NCT04677179|79321189|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
44421023|NCT00780416|79428884|FG000|Overall Study|Protocol Violation|1|||
44317056|NCT04677179|79321190|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
44317057|NCT04677179|79321191|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
44317058|NCT04677179|79321192|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
44317059|NCT04677179|79321193|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
44317060|NCT04677179|79321194|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
44317061|NCT04677179|79321195|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
44317062|NCT04677179|79321196|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
44317063|NCT04677179|79321197|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
44317064|NCT04677179|79321198|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
44317065|NCT04677179|79321189|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317066|NCT04677179|79321190|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317067|NCT04677179|79321191|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317068|NCT04677179|79321192|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
44317069|NCT04677179|79321193|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317070|NCT04677179|79321194|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317071|NCT04677179|79321195|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317072|NCT04677179|79321196|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317073|NCT04677179|79321197|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317074|NCT04677179|79321198|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
44317075|NCT04677179|79321189|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317076|NCT04677179|79321190|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317077|NCT04677179|79321191|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317078|NCT04677179|79321192|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
44317079|NCT04677179|79321193|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
44317080|NCT04677179|79321194|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
44317081|NCT04677179|79321195|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317082|NCT04677179|79321196|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317083|NCT04677179|79321197|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317084|NCT04677179|79321198|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
44317085|NCT04677179|79321189|FG000|Extension Treatment Period|Lack of Efficacy|0|||
44317086|NCT04677179|79321190|FG001|Extension Treatment Period|Lack of Efficacy|0|||
44317087|NCT04677179|79321191|FG002|Extension Treatment Period|Lack of Efficacy|0|||
44317088|NCT04677179|79321192|FG003|Extension Treatment Period|Lack of Efficacy|0|||
44317089|NCT04677179|79321193|FG004|Extension Treatment Period|Lack of Efficacy|0|||
44317090|NCT04677179|79321194|FG005|Extension Treatment Period|Lack of Efficacy|0|||
44317091|NCT04677179|79321195|FG006|Extension Treatment Period|Lack of Efficacy|6|||
44317092|NCT04677179|79321196|FG007|Extension Treatment Period|Lack of Efficacy|0|||
44317093|NCT04677179|79321197|FG008|Extension Treatment Period|Lack of Efficacy|0|||
44317094|NCT04677179|79321198|FG009|Extension Treatment Period|Lack of Efficacy|0|||
44317095|NCT04677179|79321189|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
44317096|NCT04677179|79321190|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
44317097|NCT04677179|79321191|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
44317098|NCT04677179|79321192|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
44317099|NCT04677179|79321193|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
44317100|NCT04677179|79321194|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
44317101|NCT04677179|79321195|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
44317102|NCT04677179|79321196|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
44317103|NCT04677179|79321197|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
44317104|NCT04677179|79321198|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
44317105|NCT04677179|79321189|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
44317106|NCT04677179|79321190|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
44317107|NCT04677179|79321191|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
44317108|NCT04677179|79321192|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
44317109|NCT04677179|79321193|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
44317110|NCT04677179|79321194|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
44317111|NCT04677179|79321195|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
44317112|NCT04677179|79321196|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
44317113|NCT04677179|79321197|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
44317114|NCT04677179|79321198|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
44317115|NCT04677179|79321189|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
44317116|NCT04677179|79321190|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
44317117|NCT04677179|79321191|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
44317118|NCT04677179|79321192|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
44317119|NCT04677179|79321193|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
44317120|NCT04677179|79321194|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
44317121|NCT04677179|79321195|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
44317122|NCT04677179|79321196|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
44317123|NCT04677179|79321197|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
44317124|NCT04677179|79321198|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
44317125|NCT04677179|79321189|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317126|NCT04677179|79321190|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317127|NCT04677179|79321191|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317128|NCT04677179|79321192|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317129|NCT04677179|79321193|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317130|NCT04677179|79321194|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317131|NCT04677179|79321195|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317132|NCT04677179|79321196|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
44317133|NCT04677179|79321197|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
44317134|NCT04677179|79321198|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
44317135|NCT04677179|79321189|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317136|NCT04677179|79321190|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317137|NCT04677179|79321191|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44258015|NCT01405820|79112182|FG000|Randomized Treatment Period|Other|2|||
44258016|NCT01405820|79112183|FG001|Randomized Treatment Period|Other|2|||
44258017|NCT01405820|79112184|FG002|Randomized Treatment Period|Other|1|||
44258018|NCT01405820|79112185|FG003|Randomized Treatment Period|Other|1|||
44317138|NCT04677179|79321192|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317139|NCT04677179|79321193|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317140|NCT04677179|79321194|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317141|NCT04677179|79321195|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317142|NCT04677179|79321196|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
44317143|NCT04677179|79321197|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317144|NCT04677179|79321198|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
44317145|NCT04677179|79321189|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317146|NCT04677179|79321190|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317147|NCT04677179|79321191|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317148|NCT04677179|79321192|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317149|NCT04677179|79321193|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317150|NCT04677179|79321194|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317151|NCT04677179|79321195|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317152|NCT04677179|79321196|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
44317153|NCT04677179|79321197|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
44317154|NCT04677179|79321198|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
44317155|NCT04677179|79321189|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317156|NCT04677179|79321190|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317157|NCT04677179|79321191|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317158|NCT04677179|79321192|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317159|NCT04677179|79321193|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317160|NCT04677179|79321194|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317161|NCT04677179|79321195|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
44317162|NCT04677179|79321196|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
44317163|NCT04677179|79321197|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
44317164|NCT04677179|79321198|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
44317165|NCT04590937|79321215|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
44317166|NCT04576897|79321229|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
44317167|NCT04166435|79321261|FG000|Overall Study|2 patients ineligible for response|2|||
44317168|NCT04124965|79321267|FG000|Overall Study|Adverse event, non-fatal|3|||
44317169|NCT04124965|79321268|FG001|Overall Study|Adverse event, non-fatal|1|||
44317170|NCT04124965|79321267|FG000|Overall Study|Withdrawal by Subject|1|||
44317171|NCT04124965|79321268|FG001|Overall Study|Withdrawal by Subject|1|||
44317172|NCT04124965|79321267|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
44317173|NCT04124965|79321268|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
44317174|NCT04124965|79321267|FG000|Overall Study|Pregnancy|1|||
44317175|NCT04124965|79321268|FG001|Overall Study|Pregnancy|0|||
44421024|NCT00780416|79428885|FG001|Overall Study|Protocol Violation|0|||
44258019|NCT01405820|79112186|FG004|Randomized Treatment Period|Other|0|||
44258020|NCT01405820|79112187|FG005|Randomized Treatment Period|Other|0|||
44258021|NCT01405820|79112182|FG000|Randomized Treatment Period|Physician Decision|0|||
44258022|NCT01405820|79112183|FG001|Randomized Treatment Period|Physician Decision|2|||
44258023|NCT01405820|79112184|FG002|Randomized Treatment Period|Physician Decision|1|||
44258024|NCT01405820|79112185|FG003|Randomized Treatment Period|Physician Decision|0|||
44317176|NCT04124965|79321267|FG000|Overall Study|Sponsor and participant decision|0|||
44317177|NCT04124965|79321268|FG001|Overall Study|Sponsor and participant decision|1|||
44317178|NCT04124965|79321267|FG000|Overall Study|Personal surgery|0|||
44317179|NCT04124965|79321268|FG001|Overall Study|Personal surgery|1|||
44317180|NCT04124965|79321267|FG000|Overall Study|Physician Decision|0|||
44317181|NCT04124965|79321268|FG001|Overall Study|Physician Decision|1|||
44317182|NCT04021862|79321277|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
44317183|NCT04021862|79321278|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
44317184|NCT04021862|79321279|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
44317185|NCT04021862|79321280|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
44317186|NCT04021862|79321281|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
44317187|NCT04021862|79321282|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
44317188|NCT04021862|79321277|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
44317189|NCT04021862|79321278|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
44317190|NCT04021862|79321279|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
44317191|NCT04021862|79321280|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
44317192|NCT04021862|79321281|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
44317193|NCT04021862|79321282|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
44317194|NCT04021862|79321277|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
44317195|NCT04021862|79321278|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
44317196|NCT04021862|79321279|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
44317197|NCT04021862|79321280|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
44317198|NCT04021862|79321281|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
44317199|NCT04021862|79321282|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
44317200|NCT04021862|79321277|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
44317201|NCT04021862|79321278|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
44317202|NCT04021862|79321279|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
44317203|NCT04021862|79321280|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
44317204|NCT04021862|79321281|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
44317205|NCT04021862|79321282|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
44317206|NCT04021862|79321277|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
44317207|NCT04021862|79321278|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
44317208|NCT04021862|79321279|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
44317209|NCT04021862|79321280|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
44421025|NCT00780416|79428884|FG000|Overall Study|Withdrawal by Subject|8|||
44421026|NCT00780416|79428885|FG001|Overall Study|Withdrawal by Subject|6|||
44421027|NCT00761462|79428893|FG000|Treatment|Subjects never received study medication|23|||
44421028|NCT00761462|79428894|FG001|Treatment|Subjects never received study medication|12|||
44421029|NCT00761462|79428893|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
44421030|NCT00761462|79428894|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
44421031|NCT00761462|79428893|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
44421032|NCT00761462|79428894|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
44421033|NCT00761462|79428893|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
44421034|NCT00761462|79428894|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
44421035|NCT00761306|79428900|FG000|Overall Study|Adverse Event|5|||
44421036|NCT00761306|79428900|FG000|Overall Study|Lack of Efficacy|4|||
44421037|NCT00761306|79428900|FG000|Overall Study|Protocol Violation|2|||
44421038|NCT00761306|79428900|FG000|Overall Study|Withdrawal of Consent|3|||
44421039|NCT00761306|79428900|FG000|Overall Study|Lost to Follow-up|1|||
44421040|NCT00761306|79428900|FG000|Overall Study|Administrative or Other Reasons|5|||
44421041|NCT00772538|79428906|FG000|Overall Study|Adverse Event|6|||
44421042|NCT00772538|79428907|FG001|Overall Study|Adverse Event|6|||
44421043|NCT00772538|79428906|FG000|Overall Study|Protocol Violation|3|||
44421044|NCT00772538|79428907|FG001|Overall Study|Protocol Violation|3|||
44421045|NCT00772538|79428906|FG000|Overall Study|Lost to Follow-up|1|||
44421046|NCT00772538|79428907|FG001|Overall Study|Lost to Follow-up|1|||
44421047|NCT00772538|79428906|FG000|Overall Study|Withdrawal by Subject|3|||
44421048|NCT00772538|79428907|FG001|Overall Study|Withdrawal by Subject|8|||
44421049|NCT00772538|79428906|FG000|Overall Study|Lack of Efficacy|0|||
44421050|NCT00772538|79428907|FG001|Overall Study|Lack of Efficacy|1|||
44421051|NCT00772538|79428906|FG000|Overall Study|Other|7|||
44421052|NCT00772538|79428907|FG001|Overall Study|Other|7|||
44421053|NCT00761150|79428916|FG000|Open-label Period|Adverse Event|36|||
44421054|NCT00761150|79428917|FG001|Open-label Period|Adverse Event|0|||
44421055|NCT00761150|79428918|FG002|Open-label Period|Adverse Event|0|||
44421056|NCT00761150|79428916|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
44421057|NCT00761150|79428917|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
44421058|NCT00761150|79428918|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
44421059|NCT00761150|79428916|FG000|Open-label Period|Lost to Follow-up|7|||
44421060|NCT00761150|79428917|FG001|Open-label Period|Lost to Follow-up|0|||
44421061|NCT00761150|79428918|FG002|Open-label Period|Lost to Follow-up|0|||
44421062|NCT00761150|79428916|FG000|Open-label Period|Lack of Efficacy|4|||
44317210|NCT04021862|79321281|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
44317211|NCT04021862|79321282|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
44317212|NCT04003155|79321299|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
44317213|NCT04003155|79321300|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
44317214|NCT04003155|79321301|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
44317215|NCT04003155|79321302|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
44317216|NCT04003155|79321303|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
44317217|NCT04003155|79321299|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
44317218|NCT04003155|79321300|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
44317219|NCT04003155|79321301|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
44317220|NCT04003155|79321302|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
44317221|NCT04003155|79321303|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
44317222|NCT04003155|79321299|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
44317223|NCT04003155|79321300|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
44317224|NCT04003155|79321301|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
44317225|NCT04003155|79321302|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
44317226|NCT04003155|79321303|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
44317227|NCT04003155|79321299|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
44317228|NCT04003155|79321300|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
44317229|NCT04003155|79321301|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
44317230|NCT04003155|79321302|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
44317231|NCT04003155|79321303|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
44317232|NCT04003155|79321299|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
44317233|NCT04003155|79321300|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
44317234|NCT04003155|79321301|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
44317235|NCT04003155|79321302|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
44317236|NCT04003155|79321303|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
44317237|NCT04003155|79321299|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
44317238|NCT04003155|79321300|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
44317239|NCT04003155|79321301|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
44317240|NCT04003155|79321302|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
44317241|NCT04003155|79321303|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
44317242|NCT04003155|79321299|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
44317243|NCT04003155|79321300|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
44317244|NCT04003155|79321301|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
44317245|NCT04003155|79321302|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
44317246|NCT04003155|79321303|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
44317247|NCT04003155|79321299|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
44317248|NCT04003155|79321300|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
44317249|NCT04003155|79321301|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
44317250|NCT04003155|79321302|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
44317251|NCT04003155|79321303|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
44317252|NCT04003155|79321299|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
44317253|NCT04003155|79321300|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
44317254|NCT04003155|79321301|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
44317255|NCT04003155|79321302|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
44317256|NCT04003155|79321303|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
44317257|NCT04003142|79321324|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
44317258|NCT04003142|79321325|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
44317259|NCT04003142|79321326|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
44317260|NCT04003142|79321327|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
44317261|NCT04003142|79321328|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
44317262|NCT04003142|79321324|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
44317263|NCT04003142|79321325|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
44317264|NCT04003142|79321326|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
44317265|NCT04003142|79321327|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
44317266|NCT04003142|79321328|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
44317267|NCT04003142|79321324|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
44536156|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
44536157|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
44536158|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
44536159|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
44536160|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
44317268|NCT04003142|79321325|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
44317269|NCT04003142|79321326|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
44317270|NCT04003142|79321327|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
44317271|NCT04003142|79321328|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
44317272|NCT04003142|79321324|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
44317273|NCT04003142|79321325|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
44317274|NCT04003142|79321326|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
44317275|NCT04003142|79321327|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
44317276|NCT04003142|79321328|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
44317277|NCT04003142|79321324|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
44317278|NCT04003142|79321325|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
44317279|NCT04003142|79321326|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
44317280|NCT04003142|79321327|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
44317281|NCT04003142|79321328|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
44317282|NCT04003142|79321324|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
44317283|NCT04003142|79321325|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
44317284|NCT04003142|79321326|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
44317285|NCT04003142|79321327|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
44317286|NCT04003142|79321328|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
44317287|NCT04003142|79321324|FG000|Extension Period (40 Weeks)|Death|0|||
44317288|NCT04003142|79321325|FG001|Extension Period (40 Weeks)|Death|0|||
44317289|NCT04003142|79321326|FG002|Extension Period (40 Weeks)|Death|0|||
44317290|NCT04003142|79321327|FG003|Extension Period (40 Weeks)|Death|0|||
44317291|NCT04003142|79321328|FG004|Extension Period (40 Weeks)|Death|1|||
44317292|NCT04003142|79321324|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
44317293|NCT04003142|79321325|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
44317294|NCT04003142|79321326|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
44317295|NCT04003142|79321327|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
44317296|NCT04003142|79321328|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
44317297|NCT04003142|79321324|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
44317298|NCT04003142|79321325|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
44317299|NCT04003142|79321326|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
44317300|NCT04003142|79321327|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
44317301|NCT04003142|79321328|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
44317302|NCT04003142|79321324|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
44317303|NCT04003142|79321325|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
44317304|NCT04003142|79321326|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
44317305|NCT04003142|79321327|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
44317306|NCT04003142|79321328|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
44317307|NCT04003142|79321324|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
44317308|NCT04003142|79321325|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
44317309|NCT04003142|79321326|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
44317310|NCT04003142|79321327|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
44317311|NCT04003142|79321328|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
44317312|NCT03971422|79321349|FG000|Overall Study|Lost to Follow-up|0|||
44317313|NCT03971422|79321350|FG001|Overall Study|Lost to Follow-up|1|||
44317314|NCT03971422|79321351|FG002|Overall Study|Lost to Follow-up|0|||
44317315|NCT03971422|79321349|FG000|Overall Study|Lack of Efficacy|5|||
44317316|NCT03971422|79321350|FG001|Overall Study|Lack of Efficacy|1|||
44317317|NCT03971422|79321351|FG002|Overall Study|Lack of Efficacy|1|||
44317318|NCT03971422|79321349|FG000|Overall Study|Adverse event, not fatal|2|||
44317319|NCT03971422|79321350|FG001|Overall Study|Adverse event, not fatal|2|||
44317320|NCT03971422|79321351|FG002|Overall Study|Adverse event, not fatal|5|||
44317321|NCT03971422|79321349|FG000|Overall Study|Worsening of MG Symptoms|1|||
44317322|NCT03971422|79321350|FG001|Overall Study|Worsening of MG Symptoms|4|||
44317323|NCT03971422|79321351|FG002|Overall Study|Worsening of MG Symptoms|2|||
44317324|NCT03971422|79321349|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
44317325|NCT03971422|79321350|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
44317326|NCT03971422|79321351|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
44317327|NCT03971422|79321349|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
44317328|NCT03971422|79321350|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
44317329|NCT03971422|79321351|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
44317330|NCT03971422|79321349|FG000|Overall Study|Due to COVID-19 pandemic|0|||
44317331|NCT03971422|79321350|FG001|Overall Study|Due to COVID-19 pandemic|1|||
44317332|NCT03971422|79321351|FG002|Overall Study|Due to COVID-19 pandemic|1|||
44317333|NCT03770260|79321366|FG000|Overall Study|Disease progression|0|||
44317334|NCT03770260|79321367|FG001|Overall Study|Disease progression|1|||
44317335|NCT03770260|79321368|FG002|Overall Study|Disease progression|0|||
44317336|NCT03770260|79321369|FG003|Overall Study|Disease progression|0|||
44317337|NCT03737110|79321380|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
44317338|NCT03737110|79321381|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
44317339|NCT03737110|79321382|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
44317340|NCT03737110|79321383|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
44317341|NCT03737110|79321384|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
44421063|NCT00761150|79428917|FG001|Open-label Period|Lack of Efficacy|0|||
44317342|NCT03737110|79321385|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
44317343|NCT03737110|79321380|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
44317344|NCT03737110|79321381|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
44317345|NCT03737110|79321382|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
44317346|NCT03737110|79321383|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
44317347|NCT03737110|79321384|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
44317348|NCT03737110|79321385|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
44317349|NCT03737110|79321380|FG000|Run-in (RI) Period|Adverse Event|4|||
44317350|NCT03737110|79321381|FG001|Run-in (RI) Period|Adverse Event|0|||
44317351|NCT03737110|79321382|FG002|Run-in (RI) Period|Adverse Event|0|||
44317352|NCT03737110|79321383|FG003|Run-in (RI) Period|Adverse Event|0|||
44317353|NCT03737110|79321384|FG004|Run-in (RI) Period|Adverse Event|0|||
44317354|NCT03737110|79321385|FG005|Run-in (RI) Period|Adverse Event|0|||
44317355|NCT03737110|79321380|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
44317356|NCT03737110|79321381|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
44317357|NCT03737110|79321382|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
44317358|NCT03737110|79321383|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
44317359|NCT03737110|79321384|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
44317360|NCT03737110|79321385|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
44317361|NCT03737110|79321380|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
44317362|NCT03737110|79321381|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
44317363|NCT03737110|79321382|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
44317364|NCT03737110|79321383|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
44317365|NCT03737110|79321384|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
44317366|NCT03737110|79321385|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
44317367|NCT03737110|79321380|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
44317368|NCT03737110|79321381|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
44317369|NCT03737110|79321382|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
44317370|NCT03737110|79321383|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
44317371|NCT03737110|79321384|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
44317372|NCT03737110|79321385|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
44317373|NCT03737110|79321380|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
44317374|NCT03737110|79321381|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
44317375|NCT03737110|79321382|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
44317376|NCT03737110|79321383|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
44317377|NCT03737110|79321384|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
44317378|NCT03737110|79321385|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
44317379|NCT03737110|79321380|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
44317380|NCT03737110|79321381|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
44317381|NCT03737110|79321382|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
44317382|NCT03737110|79321383|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
44317383|NCT03737110|79321384|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
44317384|NCT03737110|79321385|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
44317385|NCT03592771|79321420|FG000|Overall Study|Adverse Event|2|||
44317386|NCT03592771|79321421|FG001|Overall Study|Adverse Event|0|||
44317387|NCT03592771|79321422|FG002|Overall Study|Adverse Event|1|||
44317388|NCT03592771|79321420|FG000|Overall Study|Death|0|||
44317389|NCT03592771|79321421|FG001|Overall Study|Death|1|||
44317390|NCT03592771|79321422|FG002|Overall Study|Death|1|||
44317391|NCT03592771|79321420|FG000|Overall Study|Lost to Follow-up|5|||
44317392|NCT03592771|79321421|FG001|Overall Study|Lost to Follow-up|11|||
44317393|NCT03592771|79321422|FG002|Overall Study|Lost to Follow-up|15|||
44317394|NCT03592771|79321420|FG000|Overall Study|Withdrawal by Subject|0|||
44317395|NCT03592771|79321421|FG001|Overall Study|Withdrawal by Subject|2|||
44317396|NCT03592771|79321422|FG002|Overall Study|Withdrawal by Subject|0|||
44317397|NCT03495154|79321430|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
44317398|NCT03495154|79321430|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
44317399|NCT03495154|79321430|FG000|Overall Study|Screen Failures During Surgery|6|||
44317400|NCT03495154|79321430|FG000|Overall Study|Death|2|||
44317401|NCT03495154|79321430|FG000|Overall Study|Lost to Follow-up|16|||
44317402|NCT03495154|79321430|FG000|Overall Study|Withdrawal by Subject|2|||
44317403|NCT03495154|79321430|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
44317404|NCT03334253|79321470|FG000|Overall Study|Withdrawal by Subject|1|||
44317405|NCT03334253|79321471|FG001|Overall Study|Withdrawal by Subject|0|||
44317406|NCT03334253|79321470|FG000|Overall Study|Lost to Follow-up|4|||
44317407|NCT03334253|79321471|FG001|Overall Study|Lost to Follow-up|3|||
44317408|NCT03334253|79321470|FG000|Overall Study|Moved residence|2|||
44317409|NCT03334253|79321471|FG001|Overall Study|Moved residence|2|||
44317410|NCT03314857|79321477|FG000|Overall Study|Death|4|||
44317411|NCT03314857|79321477|FG000|Overall Study|Physician Decision|1|||
44421064|NCT00761150|79428918|FG002|Open-label Period|Lack of Efficacy|0|||
44421065|NCT00761150|79428916|FG000|Open-label Period|Withdrawal by Subject|5|||
44317412|NCT03302156|79321483|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
44317413|NCT03302156|79321484|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
44317414|NCT03302156|79321485|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
44317415|NCT03235739|79321494|FG000|Overall Study|Withdrawal by Subject|2|||
44317416|NCT03235739|79321495|FG001|Overall Study|Withdrawal by Subject|2|||
44317417|NCT03235739|79321494|FG000|Overall Study|Physician Decision|0|||
44317418|NCT03235739|79321495|FG001|Overall Study|Physician Decision|1|||
44317419|NCT03176771|79321504|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
44317420|NCT03176771|79321505|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
44317421|NCT03176771|79321506|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
44317422|NCT03176771|79321507|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
44317423|NCT03176771|79321508|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
44317424|NCT03176771|79321504|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
44317425|NCT03176771|79321505|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
44317426|NCT03176771|79321506|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
44317427|NCT03176771|79321507|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
44317428|NCT03176771|79321508|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
44317429|NCT03176771|79321504|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
44317430|NCT03176771|79321505|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
44317431|NCT03176771|79321506|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
44317432|NCT03176771|79321507|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
44317433|NCT03176771|79321508|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
44317434|NCT03176771|79321504|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
44317435|NCT03176771|79321505|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
44317436|NCT03176771|79321506|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
44317437|NCT03176771|79321507|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
44317438|NCT03176771|79321508|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
44317439|NCT03176771|79321504|FG000|Double-Blind Extension Period|Adverse Event|0|||
44317440|NCT03176771|79321505|FG001|Double-Blind Extension Period|Adverse Event|0|||
44317441|NCT03176771|79321506|FG002|Double-Blind Extension Period|Adverse Event|0|||
44317442|NCT03176771|79321507|FG003|Double-Blind Extension Period|Adverse Event|15|||
44317443|NCT03176771|79321508|FG004|Double-Blind Extension Period|Adverse Event|18|||
44317444|NCT03176771|79321504|FG000|Double-Blind Extension Period|Death|0|||
44317445|NCT03176771|79321505|FG001|Double-Blind Extension Period|Death|0|||
44317446|NCT03176771|79321506|FG002|Double-Blind Extension Period|Death|0|||
44317447|NCT03176771|79321507|FG003|Double-Blind Extension Period|Death|3|||
44317448|NCT03176771|79321508|FG004|Double-Blind Extension Period|Death|4|||
44317449|NCT03176771|79321504|FG000|Double-Blind Extension Period|Physician Decision|0|||
44317450|NCT03176771|79321505|FG001|Double-Blind Extension Period|Physician Decision|0|||
44317451|NCT03176771|79321506|FG002|Double-Blind Extension Period|Physician Decision|0|||
44317452|NCT03176771|79321507|FG003|Double-Blind Extension Period|Physician Decision|3|||
44317453|NCT03176771|79321508|FG004|Double-Blind Extension Period|Physician Decision|1|||
44317454|NCT03176771|79321504|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
44317455|NCT03176771|79321505|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
44317456|NCT03176771|79321506|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
44317457|NCT03176771|79321507|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
44317458|NCT03176771|79321508|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
44317459|NCT02789020|79321524|FG000|Overall Study|Withdrawal by Subject|6|||
44317460|NCT02789020|79321525|FG001|Overall Study|Withdrawal by Subject|5|||
44317461|NCT02427841|79321562|FG000|Overall Study|Lack of Efficacy|5|||
44317462|NCT02427841|79321562|FG000|Overall Study|Physician Decision|2|||
44317463|NCT02427841|79321562|FG000|Overall Study|Withdrawal by Subject|1|||
44317464|NCT02348216|79321574|FG000|Overall Study|Death|4|||
44317465|NCT02348216|79321575|FG001|Overall Study|Death|27|||
44421066|NCT00761150|79428917|FG001|Open-label Period|Withdrawal by Subject|0|||
44421067|NCT00761150|79428918|FG002|Open-label Period|Withdrawal by Subject|0|||
44317466|NCT02348216|79321576|FG002|Overall Study|Death|3|||
44317467|NCT02348216|79321577|FG003|Overall Study|Death|18|||
44317468|NCT02348216|79321578|FG004|Overall Study|Death|9|||
44317469|NCT02348216|79321579|FG005|Overall Study|Death|23|||
44317470|NCT02348216|79321580|FG006|Overall Study|Death|6|||
44317471|NCT02348216|79321574|FG000|Overall Study|Full consent withdrawal|0|||
44317472|NCT02348216|79321575|FG001|Overall Study|Full consent withdrawal|0|||
44421068|NCT00761150|79428916|FG000|Open-label Period|Noncompliance|2|||
44421069|NCT00761150|79428917|FG001|Open-label Period|Noncompliance|0|||
44421070|NCT00761150|79428918|FG002|Open-label Period|Noncompliance|0|||
44317473|NCT02348216|79321576|FG002|Overall Study|Full consent withdrawal|0|||
44421071|NCT00761150|79428916|FG000|Open-label Period|Other|5|||
44317474|NCT02348216|79321577|FG003|Overall Study|Full consent withdrawal|1|||
44421072|NCT00761150|79428917|FG001|Open-label Period|Other|0|||
44421073|NCT00761150|79428918|FG002|Open-label Period|Other|0|||
44421074|NCT00761150|79428916|FG000|Double-blind Period|Lack of Efficacy|0|||
44317475|NCT02348216|79321578|FG004|Overall Study|Full consent withdrawal|0|||
44317476|NCT02348216|79321579|FG005|Overall Study|Full consent withdrawal|0|||
44317477|NCT02348216|79321580|FG006|Overall Study|Full consent withdrawal|1|||
44317478|NCT02348216|79321574|FG000|Overall Study|Lost to Follow-up|0|||
44317479|NCT02348216|79321575|FG001|Overall Study|Lost to Follow-up|0|||
44317480|NCT02348216|79321576|FG002|Overall Study|Lost to Follow-up|0|||
44317481|NCT02348216|79321577|FG003|Overall Study|Lost to Follow-up|0|||
44421075|NCT00761150|79428917|FG001|Double-blind Period|Lack of Efficacy|2|||
44421076|NCT00761150|79428918|FG002|Double-blind Period|Lack of Efficacy|19|||
44421077|NCT00761150|79428916|FG000|Double-blind Period|Adverse Event|0|||
44421078|NCT00761150|79428917|FG001|Double-blind Period|Adverse Event|3|||
44421079|NCT00761150|79428918|FG002|Double-blind Period|Adverse Event|3|||
44421080|NCT00761150|79428916|FG000|Double-blind Period|Withdrawal by Subject|0|||
44421081|NCT00761150|79428917|FG001|Double-blind Period|Withdrawal by Subject|3|||
44421082|NCT00761150|79428918|FG002|Double-blind Period|Withdrawal by Subject|2|||
44421083|NCT00761150|79428916|FG000|Double-blind Period|Lost to Follow-up|0|||
44421084|NCT00761150|79428917|FG001|Double-blind Period|Lost to Follow-up|2|||
44421085|NCT00761150|79428918|FG002|Double-blind Period|Lost to Follow-up|1|||
44421086|NCT00761150|79428916|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
44421087|NCT00761150|79428917|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
44421088|NCT00761150|79428918|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
44421089|NCT00761150|79428916|FG000|Double-blind Period|Noncompliance|0|||
44421090|NCT00761150|79428917|FG001|Double-blind Period|Noncompliance|1|||
44421091|NCT00761150|79428918|FG002|Double-blind Period|Noncompliance|0|||
44421092|NCT00761150|79428916|FG000|Double-blind Period|Other|0|||
44421093|NCT00761150|79428917|FG001|Double-blind Period|Other|3|||
44421094|NCT00761150|79428918|FG002|Double-blind Period|Other|3|||
44421095|NCT00760994|79428928|FG000|Overall Study|Lost to Follow-up|4|||
44421096|NCT00760994|79428929|FG001|Overall Study|Lost to Follow-up|4|||
44421097|NCT00760994|79428930|FG002|Overall Study|Lost to Follow-up|3|||
44421098|NCT00583557|79428940|FG000|Overall Study|Withdrawal by Subject|18|||
44421099|NCT00583557|79428940|FG000|Overall Study|Adverse Event|9|||
44421100|NCT00583557|79428940|FG000|Overall Study|Lack of Efficacy|31|||
44421101|NCT00583557|79428940|FG000|Overall Study|Lack of Compliance|5|||
44421102|NCT00583557|79428940|FG000|Overall Study|Other|5|||
44421103|NCT00583557|79428940|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
44421104|NCT00586820|79428946|FG000|Overall Study|Unsuccessful PCI|1|||
44421105|NCT00586820|79428947|FG001|Overall Study|Unsuccessful PCI|0|||
44421106|NCT00760838|79428955|FG000|Overall Study|Adverse Event|1|||
44421107|NCT00760838|79428956|FG001|Overall Study|Adverse Event|1|||
44421108|NCT00760838|79428955|FG000|Overall Study|Lack of Efficacy|1|||
44421109|NCT00760838|79428956|FG001|Overall Study|Lack of Efficacy|0|||
44421110|NCT00760838|79428955|FG000|Overall Study|Lost to Follow-up|2|||
44421111|NCT00760838|79428956|FG001|Overall Study|Lost to Follow-up|0|||
44421112|NCT00760838|79428955|FG000|Overall Study|Withdrawal by Subject|1|||
44421113|NCT00760838|79428956|FG001|Overall Study|Withdrawal by Subject|1|||
44421114|NCT00586664|79428965|FG000|Overall Study|Withdrawal by Subject|3|||
44421115|NCT00586664|79428966|FG001|Overall Study|Withdrawal by Subject|7|||
44421116|NCT00586664|79428967|FG002|Overall Study|Withdrawal by Subject|1|||
44421117|NCT00586664|79428965|FG000|Overall Study|Exclusion criteria met|2|||
44536161|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
44536162|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Pregnancy|0|||
44536163|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Pregnancy|1|||
44536164|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Pregnancy|1|||
44536165|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Pregnancy|0|||
44536166|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44536167|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
44317482|NCT02348216|79321578|FG004|Overall Study|Lost to Follow-up|0|||
44317483|NCT02348216|79321579|FG005|Overall Study|Lost to Follow-up|0|||
44317484|NCT02348216|79321580|FG006|Overall Study|Lost to Follow-up|1|||
44317485|NCT02348216|79321574|FG000|Overall Study|Still on study|3|||
44317486|NCT02348216|79321575|FG001|Overall Study|Still on study|50|||
44317487|NCT02348216|79321576|FG002|Overall Study|Still on study|21|||
44317488|NCT02348216|79321577|FG003|Overall Study|Still on study|19|||
44317489|NCT02348216|79321578|FG004|Overall Study|Still on study|32|||
44421118|NCT00586664|79428966|FG001|Overall Study|Exclusion criteria met|0|||
44421119|NCT00586664|79428967|FG002|Overall Study|Exclusion criteria met|0|||
44421120|NCT00437281|79428995|FG000|Overall Study|Adverse Event|0|||
44421121|NCT00437281|79428996|FG001|Overall Study|Adverse Event|0|||
44421122|NCT00437281|79428997|FG002|Overall Study|Adverse Event|0|||
44421123|NCT00437281|79428998|FG003|Overall Study|Adverse Event|1|||
44317490|NCT02348216|79321579|FG005|Overall Study|Still on study|27|||
44317491|NCT02348216|79321580|FG006|Overall Study|Still on study|32|||
44317492|NCT02348216|79321574|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
44317493|NCT02348216|79321575|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
44317494|NCT02348216|79321576|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
44317495|NCT02348216|79321577|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
44317496|NCT02348216|79321578|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
44317497|NCT02348216|79321579|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
44317498|NCT02348216|79321580|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
44317499|NCT02037529|79321620|FG000|Overall Study|Withdrawal by Subject|1|||
44317500|NCT02037529|79321621|FG001|Overall Study|Withdrawal by Subject|3|||
44317501|NCT02037529|79321620|FG000|Overall Study|Adverse Event|0|||
44317502|NCT02037529|79321621|FG001|Overall Study|Adverse Event|1|||
44317503|NCT02030028|79321628|FG000|Overall Study|Withdrawal by Subject|4|||
44317504|NCT02030028|79321628|FG000|Overall Study|lack of transportation|1|||
44317505|NCT01956123|79321634|FG000|COS Cycle 2|Protocol Violation|8|||
44317506|NCT01956123|79321635|FG001|COS Cycle 2|Protocol Violation|3|||
44317507|NCT01956123|79321636|FG002|COS Cycle 2|Protocol Violation|0|||
44317508|NCT01956123|79321637|FG003|COS Cycle 2|Protocol Violation|0|||
44317509|NCT01956123|79321634|FG000|COS Cycle 2|Adverse Event|3|||
44317510|NCT01956123|79321635|FG001|COS Cycle 2|Adverse Event|4|||
44317511|NCT01956123|79321636|FG002|COS Cycle 2|Adverse Event|0|||
44317512|NCT01956123|79321637|FG003|COS Cycle 2|Adverse Event|0|||
44317513|NCT01956123|79321634|FG000|COS Cycle 2|Personal Reasons|2|||
44317514|NCT01956123|79321635|FG001|COS Cycle 2|Personal Reasons|0|||
44317515|NCT01956123|79321636|FG002|COS Cycle 2|Personal Reasons|0|||
44317516|NCT01956123|79321637|FG003|COS Cycle 2|Personal Reasons|0|||
44317517|NCT01956123|79321634|FG000|COS Cycle 2|Withdrawal by Subject|1|||
44317518|NCT01956123|79321635|FG001|COS Cycle 2|Withdrawal by Subject|0|||
44317519|NCT01956123|79321636|FG002|COS Cycle 2|Withdrawal by Subject|0|||
44317520|NCT01956123|79321637|FG003|COS Cycle 2|Withdrawal by Subject|0|||
44317521|NCT01956123|79321634|FG000|COS Cycle 3|Protocol Violation|0|||
44317522|NCT01956123|79321635|FG001|COS Cycle 3|Protocol Violation|0|||
44317523|NCT01956123|79321636|FG002|COS Cycle 3|Protocol Violation|2|||
44317524|NCT01956123|79321637|FG003|COS Cycle 3|Protocol Violation|1|||
44317525|NCT01956123|79321634|FG000|COS Cycle 3|Adverse Event|0|||
44317526|NCT01956123|79321635|FG001|COS Cycle 3|Adverse Event|0|||
44317527|NCT01956123|79321636|FG002|COS Cycle 3|Adverse Event|3|||
44317528|NCT01956123|79321637|FG003|COS Cycle 3|Adverse Event|0|||
44317529|NCT01956123|79321634|FG000|COS Cycle 3|Personal Reasons|0|||
44317530|NCT01956123|79321635|FG001|COS Cycle 3|Personal Reasons|0|||
44317531|NCT01956123|79321636|FG002|COS Cycle 3|Personal Reasons|1|||
44317532|NCT01956123|79321637|FG003|COS Cycle 3|Personal Reasons|0|||
44317533|NCT01956123|79321634|FG000|COS Cycle 3|Withdrawal by Subject|0|||
44317534|NCT01956123|79321635|FG001|COS Cycle 3|Withdrawal by Subject|0|||
44317535|NCT01956123|79321636|FG002|COS Cycle 3|Withdrawal by Subject|0|||
44317536|NCT01956123|79321637|FG003|COS Cycle 3|Withdrawal by Subject|1|||
44317537|NCT01191697|79321657|FG000|Overall Study|Death|1|||
44317538|NCT01191697|79321657|FG000|Overall Study|Physician Decision|2|||
44317539|NCT01191697|79321657|FG000|Overall Study|Pursue chemoradiation|2|||
44317540|NCT01191697|79321657|FG000|Overall Study|Break from chemotherapy|2|||
44317541|NCT01191697|79321657|FG000|Overall Study|Withdrawal by Subject|1|||
44317542|NCT01191697|79321657|FG000|Overall Study|Surveillance|1|||
44317543|NCT01191697|79321657|FG000|Overall Study|Adverse Event|2|||
44317544|NCT01191697|79321657|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
44317545|NCT01191697|79321657|FG000|Overall Study|Not completed but analyzed|25|||
44317546|NCT01044745|79321661|FG000|Overall Study|Ineiligible|2|||
44317547|NCT01295827|79321678|FG000|Overall Study|Adverse Event|1|||
44317548|NCT01295827|79321679|FG001|Overall Study|Adverse Event|2|||
44317549|NCT01295827|79321680|FG002|Overall Study|Adverse Event|2|||
44317550|NCT01295827|79321681|FG003|Overall Study|Adverse Event|1|||
44317551|NCT01295827|79321682|FG004|Overall Study|Adverse Event|1|||
44317552|NCT01295827|79321683|FG005|Overall Study|Adverse Event|4|||
44317553|NCT01295827|79321684|FG006|Overall Study|Adverse Event|15|||
44317554|NCT01295827|79321685|FG007|Overall Study|Adverse Event|49|||
44317555|NCT01295827|79321686|FG008|Overall Study|Adverse Event|22|||
44317556|NCT01295827|79321687|FG009|Overall Study|Adverse Event|7|||
44421124|NCT00437281|79428999|FG004|Overall Study|Adverse Event|0|||
44421125|NCT00437281|79429000|FG005|Overall Study|Adverse Event|1|||
44317557|NCT01295827|79321688|FG010|Overall Study|Adverse Event|50|||
44317558|NCT01295827|79321689|FG011|Overall Study|Adverse Event|21|||
44317559|NCT01295827|79321690|FG012|Overall Study|Adverse Event|0|||
44317560|NCT01295827|79321691|FG013|Overall Study|Adverse Event|0|||
44317561|NCT01295827|79321692|FG014|Overall Study|Adverse Event|0|||
44317562|NCT01295827|79321678|FG000|Overall Study|Lost to Follow-up|0|||
44317563|NCT01295827|79321679|FG001|Overall Study|Lost to Follow-up|0|||
44317564|NCT01295827|79321680|FG002|Overall Study|Lost to Follow-up|3|||
44317565|NCT01295827|79321681|FG003|Overall Study|Lost to Follow-up|0|||
44317566|NCT01295827|79321682|FG004|Overall Study|Lost to Follow-up|1|||
44317567|NCT01295827|79321683|FG005|Overall Study|Lost to Follow-up|0|||
44317568|NCT01295827|79321684|FG006|Overall Study|Lost to Follow-up|4|||
44421126|NCT00437281|79429001|FG006|Overall Study|Adverse Event|0|||
44317569|NCT01295827|79321685|FG007|Overall Study|Lost to Follow-up|8|||
44317570|NCT01295827|79321686|FG008|Overall Study|Lost to Follow-up|7|||
44317571|NCT01295827|79321687|FG009|Overall Study|Lost to Follow-up|4|||
44317572|NCT01295827|79321688|FG010|Overall Study|Lost to Follow-up|7|||
44317573|NCT01295827|79321689|FG011|Overall Study|Lost to Follow-up|3|||
44317574|NCT01295827|79321690|FG012|Overall Study|Lost to Follow-up|0|||
44317575|NCT01295827|79321691|FG013|Overall Study|Lost to Follow-up|0|||
44317576|NCT01295827|79321692|FG014|Overall Study|Lost to Follow-up|0|||
44317577|NCT01295827|79321678|FG000|Overall Study|Not Reported|0|||
44317578|NCT01295827|79321679|FG001|Overall Study|Not Reported|0|||
44317579|NCT01295827|79321680|FG002|Overall Study|Not Reported|0|||
44317580|NCT01295827|79321681|FG003|Overall Study|Not Reported|1|||
44317581|NCT01295827|79321682|FG004|Overall Study|Not Reported|0|||
44317582|NCT01295827|79321683|FG005|Overall Study|Not Reported|0|||
44317583|NCT01295827|79321684|FG006|Overall Study|Not Reported|24|||
44317584|NCT01295827|79321685|FG007|Overall Study|Not Reported|58|||
44155579|NCT01998958|78946959|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155580|NCT01998958|78946960|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155581|NCT01998958|78946961|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155582|NCT01998958|78946962|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44317585|NCT01295827|79321686|FG008|Overall Study|Not Reported|41|||
44317586|NCT01295827|79321687|FG009|Overall Study|Not Reported|2|||
44317587|NCT01295827|79321688|FG010|Overall Study|Not Reported|23|||
44317588|NCT01295827|79321689|FG011|Overall Study|Not Reported|13|||
44317589|NCT01295827|79321690|FG012|Overall Study|Not Reported|0|||
44317590|NCT01295827|79321691|FG013|Overall Study|Not Reported|0|||
44317591|NCT01295827|79321692|FG014|Overall Study|Not Reported|0|||
44317592|NCT01295827|79321678|FG000|Overall Study|Progressive Disease|2|||
44317593|NCT01295827|79321679|FG001|Overall Study|Progressive Disease|1|||
44317594|NCT01295827|79321680|FG002|Overall Study|Progressive Disease|5|||
44317595|NCT01295827|79321681|FG003|Overall Study|Progressive Disease|2|||
44317596|NCT01295827|79321682|FG004|Overall Study|Progressive Disease|0|||
44317597|NCT01295827|79321683|FG005|Overall Study|Progressive Disease|1|||
44317598|NCT01295827|79321684|FG006|Overall Study|Progressive Disease|87|||
44317599|NCT01295827|79321685|FG007|Overall Study|Progressive Disease|144|||
44317600|NCT01295827|79321686|FG008|Overall Study|Progressive Disease|85|||
44317601|NCT01295827|79321687|FG009|Overall Study|Progressive Disease|40|||
44317602|NCT01295827|79321688|FG010|Overall Study|Progressive Disease|175|||
44317603|NCT01295827|79321689|FG011|Overall Study|Progressive Disease|136|||
44317604|NCT01295827|79321690|FG012|Overall Study|Progressive Disease|0|||
44317605|NCT01295827|79321691|FG013|Overall Study|Progressive Disease|0|||
44317606|NCT01295827|79321692|FG014|Overall Study|Progressive Disease|0|||
44317607|NCT01295827|79321678|FG000|Overall Study|Screen Failure|0|||
44317608|NCT01295827|79321679|FG001|Overall Study|Screen Failure|0|||
44317609|NCT01295827|79321680|FG002|Overall Study|Screen Failure|0|||
44317610|NCT01295827|79321681|FG003|Overall Study|Screen Failure|0|||
44317611|NCT01295827|79321682|FG004|Overall Study|Screen Failure|0|||
44317612|NCT01295827|79321683|FG005|Overall Study|Screen Failure|0|||
44317613|NCT01295827|79321684|FG006|Overall Study|Screen Failure|2|||
44317614|NCT01295827|79321685|FG007|Overall Study|Screen Failure|2|||
44317615|NCT01295827|79321686|FG008|Overall Study|Screen Failure|2|||
44317616|NCT01295827|79321687|FG009|Overall Study|Screen Failure|0|||
44317617|NCT01295827|79321688|FG010|Overall Study|Screen Failure|1|||
44317618|NCT01295827|79321689|FG011|Overall Study|Screen Failure|0|||
44317619|NCT01295827|79321690|FG012|Overall Study|Screen Failure|0|||
44317620|NCT01295827|79321691|FG013|Overall Study|Screen Failure|0|||
44317621|NCT01295827|79321692|FG014|Overall Study|Screen Failure|0|||
44317622|NCT01295827|79321678|FG000|Overall Study|Withdrawal by Subject|1|||
44317623|NCT01295827|79321679|FG001|Overall Study|Withdrawal by Subject|0|||
44317624|NCT01295827|79321680|FG002|Overall Study|Withdrawal by Subject|2|||
44317625|NCT01295827|79321681|FG003|Overall Study|Withdrawal by Subject|0|||
44317626|NCT01295827|79321682|FG004|Overall Study|Withdrawal by Subject|0|||
44317627|NCT01295827|79321683|FG005|Overall Study|Withdrawal by Subject|1|||
44317628|NCT01295827|79321684|FG006|Overall Study|Withdrawal by Subject|13|||
44317629|NCT01295827|79321685|FG007|Overall Study|Withdrawal by Subject|35|||
44317630|NCT01295827|79321686|FG008|Overall Study|Withdrawal by Subject|11|||
44317631|NCT01295827|79321687|FG009|Overall Study|Withdrawal by Subject|2|||
44317632|NCT01295827|79321688|FG010|Overall Study|Withdrawal by Subject|18|||
44317633|NCT01295827|79321689|FG011|Overall Study|Withdrawal by Subject|13|||
44317634|NCT01295827|79321690|FG012|Overall Study|Withdrawal by Subject|0|||
44317635|NCT01295827|79321691|FG013|Overall Study|Withdrawal by Subject|0|||
44317636|NCT01295827|79321692|FG014|Overall Study|Withdrawal by Subject|0|||
44317637|NCT01295827|79321678|FG000|Overall Study|Other|0|||
44317638|NCT01295827|79321679|FG001|Overall Study|Other|0|||
44317639|NCT01295827|79321680|FG002|Overall Study|Other|0|||
44317640|NCT01295827|79321681|FG003|Overall Study|Other|0|||
44317641|NCT01295827|79321682|FG004|Overall Study|Other|0|||
44317642|NCT01295827|79321683|FG005|Overall Study|Other|0|||
44317643|NCT01295827|79321684|FG006|Overall Study|Other|1|||
44317644|NCT01295827|79321685|FG007|Overall Study|Other|1|||
44317645|NCT01295827|79321686|FG008|Overall Study|Other|1|||
44317646|NCT01295827|79321687|FG009|Overall Study|Other|0|||
44317647|NCT01295827|79321688|FG010|Overall Study|Other|2|||
44317648|NCT01295827|79321689|FG011|Overall Study|Other|0|||
44317649|NCT01295827|79321690|FG012|Overall Study|Other|0|||
44317650|NCT01295827|79321691|FG013|Overall Study|Other|0|||
44317651|NCT01295827|79321692|FG014|Overall Study|Other|0|||
44317652|NCT01295671|79321748|FG000|Overall Study|Lost to Follow-up|4|||
44317653|NCT01295671|79321749|FG001|Overall Study|Lost to Follow-up|6|||
44317654|NCT01295671|79321750|FG002|Overall Study|Lost to Follow-up|3|||
44317655|NCT01295671|79321748|FG000|Overall Study|Withdrawal by Subject|3|||
44317656|NCT01295671|79321749|FG001|Overall Study|Withdrawal by Subject|1|||
44317657|NCT01295671|79321750|FG002|Overall Study|Withdrawal by Subject|0|||
44317658|NCT01295320|79321758|FG000|Overall Study|Adverse Event|2|||
44317659|NCT01295320|79321758|FG000|Overall Study|Lost to Follow-up|4|||
44317660|NCT01295320|79321758|FG000|Overall Study|Withdrawal by Subject|2|||
44317661|NCT01295320|79321758|FG000|Overall Study|Subject was bedridden|1|||
44317662|NCT01295320|79321758|FG000|Overall Study|Unable to travel|1|||
44317663|NCT01295281|79321764|FG000|First Intervention (7 Days)|Death|0|||
44317664|NCT01295281|79321765|FG001|First Intervention (7 Days)|Death|1|||
44317665|NCT01294696|79321773|FG000|Overall Study|Screening failures|7|||
44317666|NCT01294696|79321773|FG000|Overall Study|Protocol Violation|8|||
44317667|NCT01294696|79321773|FG000|Overall Study|Missing BPI Response|7|||
44317668|NCT01294696|79321773|FG000|Overall Study|Site closure|52|||
44317669|NCT01294579|79321778|FG000|Overall Study|Disease progression|12|||
44317670|NCT01294579|79321778|FG000|Overall Study|Adverse Event|11|||
44317671|NCT01294579|79321778|FG000|Overall Study|Study closed/terminated|3|||
44317672|NCT01294579|79321778|FG000|Overall Study|Lost to Follow-up|1|||
44317673|NCT01294579|79321778|FG000|Overall Study|Physician Decision|3|||
44317674|NCT01294579|79321778|FG000|Overall Study|Withdrawal by Subject|5|||
44317675|NCT01294462|79321784|FG000|Overall Study|Lost to Follow-up|1|||
44317676|NCT01294462|79321785|FG001|Overall Study|Lost to Follow-up|0|||
44317677|NCT01294462|79321784|FG000|Overall Study|Withdrawal by Subject|65|||
44317678|NCT01294462|79321785|FG001|Overall Study|Withdrawal by Subject|63|||
44317679|NCT01294423|79321794|FG000|Overall Study|Adverse Event|1|||
44317680|NCT01294423|79321795|FG001|Overall Study|Adverse Event|2|||
44317681|NCT01294423|79321796|FG002|Overall Study|Adverse Event|3|||
44317682|NCT01294423|79321794|FG000|Overall Study|Withdrawal by Subject|1|||
44317683|NCT01294423|79321795|FG001|Overall Study|Withdrawal by Subject|2|||
44317684|NCT01294423|79321796|FG002|Overall Study|Withdrawal by Subject|2|||
44317685|NCT01294423|79321794|FG000|Overall Study|subject no longer meets study criteria|2|||
44317686|NCT01294423|79321795|FG001|Overall Study|subject no longer meets study criteria|5|||
44317687|NCT01294423|79321796|FG002|Overall Study|subject no longer meets study criteria|2|||
44317688|NCT01294423|79321794|FG000|Overall Study|poor/non-compliance|1|||
44317689|NCT01294423|79321795|FG001|Overall Study|poor/non-compliance|0|||
44317690|NCT01294423|79321796|FG002|Overall Study|poor/non-compliance|1|||
44317691|NCT01294150|79321806|FG000|Overall Study|Physician Decision|2|||
44317692|NCT01294150|79321807|FG001|Overall Study|Physician Decision|2|||
44317693|NCT01292473|79321819|FG000|Overall Study|Adverse Event|1|||
44317694|NCT01292473|79321820|FG001|Overall Study|Adverse Event|0|||
44317695|NCT01292473|79321821|FG002|Overall Study|Adverse Event|1|||
44317696|NCT01292473|79321822|FG003|Overall Study|Adverse Event|1|||
44317697|NCT01292473|79321819|FG000|Overall Study|Lost to Follow-up|1|||
44317698|NCT01292473|79321820|FG001|Overall Study|Lost to Follow-up|1|||
44317699|NCT01292473|79321821|FG002|Overall Study|Lost to Follow-up|2|||
44317700|NCT01292473|79321822|FG003|Overall Study|Lost to Follow-up|2|||
44317701|NCT01292473|79321819|FG000|Overall Study|Withdrawal by Subject|3|||
44317702|NCT01292473|79321820|FG001|Overall Study|Withdrawal by Subject|4|||
44317703|NCT01292473|79321821|FG002|Overall Study|Withdrawal by Subject|3|||
44317704|NCT01292473|79321822|FG003|Overall Study|Withdrawal by Subject|3|||
44317705|NCT01292473|79321819|FG000|Overall Study|Physician Decision|0|||
44317706|NCT01292473|79321820|FG001|Overall Study|Physician Decision|1|||
44317707|NCT01292473|79321821|FG002|Overall Study|Physician Decision|0|||
44317708|NCT01292473|79321822|FG003|Overall Study|Physician Decision|0|||
44317709|NCT01292473|79321819|FG000|Overall Study|Disease Progression|0|||
44317710|NCT01292473|79321820|FG001|Overall Study|Disease Progression|1|||
44317711|NCT01292473|79321821|FG002|Overall Study|Disease Progression|3|||
44317712|NCT01292473|79321822|FG003|Overall Study|Disease Progression|6|||
44317713|NCT01292239|79321838|FG000|Overall Study|Other|1|||
44317714|NCT01292239|79321839|FG001|Overall Study|Other|1|||
44317715|NCT01292239|79321838|FG000|Overall Study|Withdrawal by Subject|3|||
44317716|NCT01292239|79321839|FG001|Overall Study|Withdrawal by Subject|6|||
44317717|NCT01291225|79321847|FG000|Overall Study|Lost to Follow-up|85|||
44317718|NCT01291225|79321848|FG001|Overall Study|Lost to Follow-up|39|||
44317719|NCT01290796|79321858|FG000|Overall Study|Lost to Follow-up|21|||
44317720|NCT01290796|79321858|FG000|Overall Study|Withdrawal by Subject|4|||
44317721|NCT01290796|79321858|FG000|Overall Study|Physician Decision|2|||
44317722|NCT01290796|79321858|FG000|Overall Study|Secondary Surgical Intervention|2|||
44317723|NCT01290796|79321858|FG000|Overall Study|Withdrawal by Sponsor|1|||
44317724|NCT01290757|79321864|FG000|Overall Study|Adverse Event|1|||
44317725|NCT01290757|79321865|FG001|Overall Study|Adverse Event|0|||
44317726|NCT01290757|79321864|FG000|Overall Study|Protocol Violation|1|||
44317727|NCT01290757|79321865|FG001|Overall Study|Protocol Violation|1|||
44317728|NCT01290757|79321864|FG000|Overall Study|Other|0|||
44317729|NCT01290757|79321865|FG001|Overall Study|Other|1|||
44317730|NCT01290718|79321871|FG000|Overall Study|Early termination of the study|4|||
44317731|NCT01290679|79321877|FG000|Overall Study|Adverse Event|2|||
44317732|NCT01290679|79321878|FG001|Overall Study|Adverse Event|0|||
44317733|NCT01290679|79321877|FG000|Overall Study|Lost to Follow-up|8|||
44317734|NCT01290679|79321878|FG001|Overall Study|Lost to Follow-up|10|||
44317735|NCT01290679|79321877|FG000|Overall Study|Protocol Violation|0|||
44317736|NCT01290679|79321878|FG001|Overall Study|Protocol Violation|1|||
44317737|NCT01290679|79321877|FG000|Overall Study|Withdrawal by Subject|6|||
44317738|NCT01290679|79321878|FG001|Overall Study|Withdrawal by Subject|5|||
44317739|NCT01290679|79321877|FG000|Overall Study|Subject Entered Another Trial|0|||
44317740|NCT01290679|79321878|FG001|Overall Study|Subject Entered Another Trial|5|||
44317741|NCT01290601|79321886|FG000|Overall Study|Adverse Event|0|||
44317742|NCT01290601|79321887|FG001|Overall Study|Adverse Event|2|||
44317743|NCT01290601|79321888|FG002|Overall Study|Adverse Event|0|||
44317744|NCT01290601|79321889|FG003|Overall Study|Adverse Event|0|||
44317745|NCT01290601|79321886|FG000|Overall Study|Lack of Efficacy|2|||
44317746|NCT01290601|79321887|FG001|Overall Study|Lack of Efficacy|1|||
44317747|NCT01290601|79321888|FG002|Overall Study|Lack of Efficacy|0|||
44317748|NCT01290601|79321889|FG003|Overall Study|Lack of Efficacy|0|||
44317749|NCT01290601|79321886|FG000|Overall Study|Lost to Follow-up|7|||
44317750|NCT01290601|79321887|FG001|Overall Study|Lost to Follow-up|2|||
44317751|NCT01290601|79321888|FG002|Overall Study|Lost to Follow-up|0|||
44317752|NCT01290601|79321889|FG003|Overall Study|Lost to Follow-up|0|||
44317753|NCT01290601|79321886|FG000|Overall Study|Other|1|||
44317754|NCT01290601|79321887|FG001|Overall Study|Other|0|||
44317755|NCT01290601|79321888|FG002|Overall Study|Other|0|||
44317756|NCT01290601|79321889|FG003|Overall Study|Other|0|||
44317757|NCT01290601|79321886|FG000|Overall Study|Protocol Violation|1|||
44317758|NCT01290601|79321887|FG001|Overall Study|Protocol Violation|0|||
44317759|NCT01290601|79321888|FG002|Overall Study|Protocol Violation|0|||
44317760|NCT01290601|79321889|FG003|Overall Study|Protocol Violation|0|||
44317761|NCT01290523|79321895|FG000|Overall Study|Death|3|||
44317762|NCT01290094|79321899|FG000|Overall Study|Withdrawal by Subject|1|||
44317763|NCT01290094|79321899|FG000|Overall Study|Lost to Follow-up|5|||
44317764|NCT01289821|79321912|FG000|Treatment Period|Withdrawal by Subject|1|||
44317765|NCT01289821|79321912|FG000|Treatment Period|Physician Decision|3|||
44317766|NCT01289821|79321912|FG000|Treatment Period|Adverse Event|4|||
44317767|NCT01289821|79321912|FG000|Treatment Period|Radiological Progression|43|||
44317768|NCT01289821|79321912|FG000|Treatment Period|Clinical Progression|2|||
44317769|NCT01289821|79321912|FG000|Treatment Period|Therapeutic procedure required|1|||
44317770|NCT01289821|79321912|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
44317771|NCT01289821|79321912|FG000|Safety Follow-up Period|Protocol Violation|3|||
44317772|NCT01289821|79321912|FG000|Safety Follow-up Period|Unspecified reason|1|||
44317773|NCT01289821|79321912|FG000|Survival Follow-up Period|Protocol Violation|1|||
44317774|NCT01289821|79321912|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
44317775|NCT01289821|79321912|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
44317776|NCT01289782|79321918|FG000|Overall Study|Lost to Follow-up|14|||
44317777|NCT01289782|79321919|FG001|Overall Study|Lost to Follow-up|7|||
44317778|NCT01289782|79321918|FG000|Overall Study|Protocol Violation|1|||
44317779|NCT01289782|79321919|FG001|Overall Study|Protocol Violation|1|||
44155583|NCT01998958|78946963|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44317780|NCT01289782|79321918|FG000|Overall Study|Withdrawal by Subject|8|||
44317781|NCT01289782|79321919|FG001|Overall Study|Withdrawal by Subject|2|||
44317782|NCT01289782|79321918|FG000|Overall Study|Sponsor's Decision|1|||
44317783|NCT01289782|79321919|FG001|Overall Study|Sponsor's Decision|0|||
44317784|NCT01289782|79321918|FG000|Overall Study|Reason not specified|1|||
44317785|NCT01289782|79321919|FG001|Overall Study|Reason not specified|2|||
44317786|NCT01289353|79321925|FG000|Overall Study|Lost to Follow-up|2|||
44317787|NCT01289119|79321935|FG000|Overall Study|Adverse Event|2|||
44317788|NCT01289119|79321936|FG001|Overall Study|Adverse Event|1|||
44155584|NCT01998958|78946964|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44317789|NCT01289119|79321937|FG002|Overall Study|Adverse Event|0|||
44317790|NCT01289119|79321938|FG003|Overall Study|Adverse Event|2|||
44317791|NCT01289119|79321939|FG004|Overall Study|Adverse Event|1|||
44317792|NCT01289119|79321940|FG005|Overall Study|Adverse Event|0|||
44317793|NCT01289119|79321935|FG000|Overall Study|Major Protocol Deviation|2|||
44317794|NCT01289119|79321936|FG001|Overall Study|Major Protocol Deviation|1|||
44317795|NCT01289119|79321937|FG002|Overall Study|Major Protocol Deviation|3|||
44317796|NCT01289119|79321938|FG003|Overall Study|Major Protocol Deviation|0|||
44317797|NCT01289119|79321939|FG004|Overall Study|Major Protocol Deviation|2|||
44317798|NCT01289119|79321940|FG005|Overall Study|Major Protocol Deviation|1|||
44317799|NCT01289119|79321935|FG000|Overall Study|Lost to Follow-up|0|||
44317800|NCT01289119|79321936|FG001|Overall Study|Lost to Follow-up|3|||
44317801|NCT01289119|79321937|FG002|Overall Study|Lost to Follow-up|0|||
44317802|NCT01289119|79321938|FG003|Overall Study|Lost to Follow-up|0|||
44317803|NCT01289119|79321939|FG004|Overall Study|Lost to Follow-up|0|||
44317804|NCT01289119|79321940|FG005|Overall Study|Lost to Follow-up|1|||
44317805|NCT01289119|79321935|FG000|Overall Study|Withdrawal by Subject|4|||
44317806|NCT01289119|79321936|FG001|Overall Study|Withdrawal by Subject|2|||
44317807|NCT01289119|79321937|FG002|Overall Study|Withdrawal by Subject|4|||
44317808|NCT01289119|79321938|FG003|Overall Study|Withdrawal by Subject|3|||
44317809|NCT01289119|79321939|FG004|Overall Study|Withdrawal by Subject|1|||
44317810|NCT01289119|79321940|FG005|Overall Study|Withdrawal by Subject|1|||
44317811|NCT01289119|79321935|FG000|Overall Study|Pregnancy|0|||
44317812|NCT01289119|79321936|FG001|Overall Study|Pregnancy|1|||
44317813|NCT01289119|79321937|FG002|Overall Study|Pregnancy|0|||
44317814|NCT01289119|79321938|FG003|Overall Study|Pregnancy|0|||
44317815|NCT01289119|79321939|FG004|Overall Study|Pregnancy|0|||
44317816|NCT01289119|79321940|FG005|Overall Study|Pregnancy|0|||
44317817|NCT01289119|79321935|FG000|Overall Study|Lack of Efficacy|0|||
44317818|NCT01289119|79321936|FG001|Overall Study|Lack of Efficacy|1|||
44317819|NCT01289119|79321937|FG002|Overall Study|Lack of Efficacy|1|||
44317820|NCT01289119|79321938|FG003|Overall Study|Lack of Efficacy|1|||
44317821|NCT01289119|79321939|FG004|Overall Study|Lack of Efficacy|1|||
44317822|NCT01289119|79321940|FG005|Overall Study|Lack of Efficacy|1|||
44317823|NCT01289119|79321935|FG000|Overall Study|Other|1|||
44317824|NCT01289119|79321936|FG001|Overall Study|Other|0|||
44317825|NCT01289119|79321937|FG002|Overall Study|Other|1|||
44317826|NCT01289119|79321938|FG003|Overall Study|Other|0|||
44317827|NCT01289119|79321939|FG004|Overall Study|Other|0|||
44317828|NCT01289119|79321940|FG005|Overall Study|Other|0|||
44317829|NCT01289041|79321954|FG000|Overall Study|Adverse Event|24|||
44317830|NCT01289041|79321954|FG000|Overall Study|Physician Decision|1|||
44317831|NCT01289041|79321954|FG000|Overall Study|Progressive Disease|41|||
44317832|NCT01289041|79321954|FG000|Overall Study|Withdrawal by Subject|3|||
44317833|NCT01289041|79321954|FG000|Overall Study|Death|1|||
44317834|NCT01288729|79321962|FG000|Overall Study|Withdrawal by Subject|1|||
44317835|NCT01288729|79321963|FG001|Overall Study|Withdrawal by Subject|0|||
44317836|NCT01288612|79321972|FG000|Overall Study|Unable to contact|11|||
44317837|NCT01288612|79321973|FG001|Overall Study|Unable to contact|16|||
44317838|NCT01288612|79321974|FG002|Overall Study|Unable to contact|20|||
44317839|NCT01288612|79321972|FG000|Overall Study|Declined|78|||
44317840|NCT01288612|79321973|FG001|Overall Study|Declined|63|||
44317841|NCT01288612|79321974|FG002|Overall Study|Declined|62|||
44317842|NCT01288612|79321972|FG000|Overall Study|Unable to intubate|0|||
44317843|NCT01288612|79321973|FG001|Overall Study|Unable to intubate|3|||
44317844|NCT01288612|79321974|FG002|Overall Study|Unable to intubate|0|||
44317845|NCT01287832|79321984|FG000|Overall Study|Adverse Event|1|||
44317846|NCT01287832|79321985|FG001|Overall Study|Adverse Event|0|||
44317847|NCT01287832|79321984|FG000|Overall Study|Death|0|||
44317848|NCT01287832|79321985|FG001|Overall Study|Death|1|||
44317849|NCT01287754|79321993|FG000|Overall Study|Death|2|||
44317850|NCT01287754|79321994|FG001|Overall Study|Death|12|||
44317851|NCT01287754|79321993|FG000|Overall Study|Lost to Follow-up|1|||
44317852|NCT01287754|79321994|FG001|Overall Study|Lost to Follow-up|6|||
44317853|NCT01287754|79321993|FG000|Overall Study|Protocol Violation|0|||
44317854|NCT01287754|79321994|FG001|Overall Study|Protocol Violation|3|||
44317855|NCT01287520|79322009|FG000|Overall Study|Adverse Event|2|||
44317856|NCT01287520|79322010|FG001|Overall Study|Adverse Event|2|||
44317857|NCT01287520|79322011|FG002|Overall Study|Adverse Event|2|||
44317858|NCT01287520|79322012|FG003|Overall Study|Adverse Event|1|||
44317859|NCT01287520|79322013|FG004|Overall Study|Adverse Event|1|||
44317860|NCT01287520|79322014|FG005|Overall Study|Adverse Event|2|||
44317861|NCT01287520|79322015|FG006|Overall Study|Adverse Event|0|||
44317862|NCT01287520|79322016|FG007|Overall Study|Adverse Event|2|||
44317863|NCT01287520|79322017|FG008|Overall Study|Adverse Event|0|||
44317864|NCT01287520|79322009|FG000|Overall Study|Physician Decision|1|||
44317865|NCT01287520|79322010|FG001|Overall Study|Physician Decision|1|||
44317866|NCT01287520|79322011|FG002|Overall Study|Physician Decision|2|||
44317867|NCT01287520|79322012|FG003|Overall Study|Physician Decision|0|||
44317868|NCT01287520|79322013|FG004|Overall Study|Physician Decision|1|||
44317869|NCT01287520|79322014|FG005|Overall Study|Physician Decision|1|||
44317870|NCT01287520|79322015|FG006|Overall Study|Physician Decision|0|||
44317871|NCT01287520|79322016|FG007|Overall Study|Physician Decision|1|||
44317872|NCT01287520|79322017|FG008|Overall Study|Physician Decision|0|||
44317873|NCT01287520|79322009|FG000|Overall Study|Progressive disease|0|||
44317874|NCT01287520|79322010|FG001|Overall Study|Progressive disease|4|||
44317875|NCT01287520|79322011|FG002|Overall Study|Progressive disease|1|||
44317876|NCT01287520|79322012|FG003|Overall Study|Progressive disease|6|||
44317877|NCT01287520|79322013|FG004|Overall Study|Progressive disease|1|||
44317878|NCT01287520|79322014|FG005|Overall Study|Progressive disease|0|||
44421127|NCT00437281|79429002|FG007|Overall Study|Adverse Event|0|||
44317879|NCT01287520|79322015|FG006|Overall Study|Progressive disease|2|||
44317880|NCT01287520|79322016|FG007|Overall Study|Progressive disease|2|||
44317881|NCT01287520|79322017|FG008|Overall Study|Progressive disease|4|||
44317882|NCT01287520|79322009|FG000|Overall Study|Withdrawal by Subject|0|||
44317883|NCT01287520|79322010|FG001|Overall Study|Withdrawal by Subject|0|||
44317884|NCT01287520|79322011|FG002|Overall Study|Withdrawal by Subject|0|||
44317885|NCT01287520|79322012|FG003|Overall Study|Withdrawal by Subject|0|||
44317886|NCT01287520|79322013|FG004|Overall Study|Withdrawal by Subject|0|||
44317887|NCT01287520|79322014|FG005|Overall Study|Withdrawal by Subject|1|||
44317888|NCT01287520|79322015|FG006|Overall Study|Withdrawal by Subject|0|||
44317889|NCT01287520|79322016|FG007|Overall Study|Withdrawal by Subject|0|||
44317890|NCT01287520|79322017|FG008|Overall Study|Withdrawal by Subject|1|||
44317891|NCT01287403|79322066|FG000|1st Intervention (1 Day)|Adverse Event|1|||
44317892|NCT01287364|79322082|FG000|Overall Study|Adverse Event|0|||
44317893|NCT01287364|79322083|FG001|Overall Study|Adverse Event|3|||
44317894|NCT01287364|79322082|FG000|Overall Study|Protocol Violation|5|||
44317895|NCT01287364|79322083|FG001|Overall Study|Protocol Violation|5|||
44317896|NCT01287364|79322082|FG000|Overall Study|Other Reason|4|||
44317897|NCT01287364|79322083|FG001|Overall Study|Other Reason|2|||
44317898|NCT02889835|79322102|FG000|Overall Study|Lost to Follow-up|13|||
44317899|NCT02889835|79322103|FG001|Overall Study|Lost to Follow-up|13|||
44317900|NCT02889835|79322104|FG002|Overall Study|Lost to Follow-up|13|||
44317901|NCT02889835|79322102|FG000|Overall Study|Withdrawal by Subject|2|||
44317902|NCT02889835|79322103|FG001|Overall Study|Withdrawal by Subject|2|||
44317903|NCT02889835|79322104|FG002|Overall Study|Withdrawal by Subject|2|||
44317904|NCT02889835|79322102|FG000|Overall Study|Protocol Violation|1|||
44317905|NCT02889835|79322103|FG001|Overall Study|Protocol Violation|1|||
44317906|NCT02889835|79322104|FG002|Overall Study|Protocol Violation|1|||
44317907|NCT02889835|79322102|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
44317908|NCT02889835|79322103|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
44317909|NCT02889835|79322104|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
44317910|NCT02889835|79322102|FG000|Overall Study|Death|1|||
44317911|NCT02889835|79322103|FG001|Overall Study|Death|1|||
44317912|NCT02889835|79322104|FG002|Overall Study|Death|1|||
44421128|NCT00437281|79429003|FG008|Overall Study|Adverse Event|0|||
44421129|NCT00437281|79429004|FG009|Overall Study|Adverse Event|1|||
44421130|NCT00437281|79429005|FG010|Overall Study|Adverse Event|0|||
44421131|NCT00437281|79429006|FG011|Overall Study|Adverse Event|0|||
44421132|NCT00437281|79429007|FG012|Overall Study|Adverse Event|0|||
44421133|NCT00437281|79429008|FG013|Overall Study|Adverse Event|1|||
44421134|NCT00437281|79429009|FG014|Overall Study|Adverse Event|1|||
44421135|NCT00437281|79429010|FG015|Overall Study|Adverse Event|0|||
44421136|NCT00437281|79429011|FG016|Overall Study|Adverse Event|0|||
44421137|NCT00437281|79429012|FG017|Overall Study|Adverse Event|0|||
44421138|NCT00437281|79429013|FG018|Overall Study|Adverse Event|1|||
44421139|NCT00437281|79429014|FG019|Overall Study|Adverse Event|0|||
44421140|NCT00437281|79428995|FG000|Overall Study|Lost to Follow-up|0|||
44421141|NCT00437281|79428996|FG001|Overall Study|Lost to Follow-up|0|||
44421142|NCT00437281|79428997|FG002|Overall Study|Lost to Follow-up|0|||
44421143|NCT00437281|79428998|FG003|Overall Study|Lost to Follow-up|0|||
44421144|NCT00437281|79428999|FG004|Overall Study|Lost to Follow-up|0|||
44421145|NCT00437281|79429000|FG005|Overall Study|Lost to Follow-up|0|||
44421146|NCT00437281|79429001|FG006|Overall Study|Lost to Follow-up|0|||
44421147|NCT00437281|79429002|FG007|Overall Study|Lost to Follow-up|0|||
44421148|NCT00437281|79429003|FG008|Overall Study|Lost to Follow-up|0|||
44421149|NCT00437281|79429004|FG009|Overall Study|Lost to Follow-up|0|||
44421150|NCT00437281|79429005|FG010|Overall Study|Lost to Follow-up|0|||
44421151|NCT00437281|79429006|FG011|Overall Study|Lost to Follow-up|0|||
44421152|NCT00437281|79429007|FG012|Overall Study|Lost to Follow-up|0|||
44421153|NCT00437281|79429008|FG013|Overall Study|Lost to Follow-up|0|||
44421154|NCT00437281|79429009|FG014|Overall Study|Lost to Follow-up|0|||
44421155|NCT00437281|79429010|FG015|Overall Study|Lost to Follow-up|0|||
44421156|NCT00437281|79429011|FG016|Overall Study|Lost to Follow-up|0|||
44421157|NCT00437281|79429012|FG017|Overall Study|Lost to Follow-up|0|||
44421158|NCT00437281|79429013|FG018|Overall Study|Lost to Follow-up|0|||
44421159|NCT00437281|79429014|FG019|Overall Study|Lost to Follow-up|1|||
44421160|NCT00741039|79429088|FG000|Overall Study|Patient non-compliance|2|||
44421161|NCT00741039|79429089|FG001|Overall Study|Patient non-compliance|0|||
44421162|NCT00772382|79429095|FG000|Overall Study|Adverse Event|19|||
44317913|NCT01287013|79322115|FG000|Overall Study|Non-evaluable|3|||
44421163|NCT00772382|79429095|FG000|Overall Study|Death|6|||
44317914|NCT01287013|79322116|FG001|Overall Study|Non-evaluable|5|||
44317915|NCT01287013|79322117|FG002|Overall Study|Non-evaluable|21|||
44421164|NCT00772382|79429095|FG000|Overall Study|Lack of Efficacy|4|||
44421165|NCT00772382|79429095|FG000|Overall Study|Physician Decision|5|||
44317916|NCT01286779|79322125|FG000|Overall Study|Withdrawal by Subject|9|||
44317917|NCT01286779|79322125|FG000|Overall Study|Protocol Violation|5|||
44317918|NCT01286779|79322125|FG000|Overall Study|Physician Decision|2|||
44317919|NCT01286779|79322125|FG000|Overall Study|Participant had scheduled surgery|1|||
44421166|NCT00772382|79429095|FG000|Overall Study|Protocol Violation|1|||
44421167|NCT00772382|79429095|FG000|Overall Study|Withdrawal by Subject|10|||
44317920|NCT01286779|79322125|FG000|Overall Study|Participant moved to another country|1|||
44317921|NCT01286779|79322125|FG000|Overall Study|Discontinued by sponsor|1|||
44317922|NCT01286740|79322139|FG000|Overall Study|Enrolled but not treated|1|||
44317923|NCT01286740|79322139|FG000|Overall Study|Protocol Violation|1|||
44317924|NCT01286311|79322145|FG000|Overall Study|Physician did not want outreach sent|14|||
44317925|NCT01286311|79322146|FG001|Overall Study|Physician did not want outreach sent|0|||
44317926|NCT01286077|79322154|FG000|Overall Study|Adverse Event|2|||
44317927|NCT01286077|79322155|FG001|Overall Study|Adverse Event|0|||
44317928|NCT01286077|79322154|FG000|Overall Study|Death|1|||
44317929|NCT01286077|79322155|FG001|Overall Study|Death|0|||
44317930|NCT01286077|79322154|FG000|Overall Study|Protocol Violation|1|||
44317931|NCT01286077|79322155|FG001|Overall Study|Protocol Violation|1|||
44317932|NCT01286077|79322154|FG000|Overall Study|Withdrawal by Subject|0|||
44317933|NCT01286077|79322155|FG001|Overall Study|Withdrawal by Subject|2|||
44317934|NCT01286077|79322154|FG000|Overall Study|Intercurrent illness|1|||
44317935|NCT01286077|79322155|FG001|Overall Study|Intercurrent illness|0|||
44317936|NCT01286077|79322154|FG000|Overall Study|Non-compliance|1|||
44317937|NCT01286077|79322155|FG001|Overall Study|Non-compliance|0|||
44317938|NCT01286077|79322154|FG000|Overall Study|The subject starts with alternative MMY|0|||
44317939|NCT01286077|79322155|FG001|Overall Study|The subject starts with alternative MMY|3|||
44317940|NCT01286077|79322154|FG000|Overall Study|Patient's decision to stop treatment|3|||
44317941|NCT01286077|79322155|FG001|Overall Study|Patient's decision to stop treatment|0|||
44317942|NCT01286077|79322154|FG000|Overall Study|Progression of disease|0|||
44317943|NCT01286077|79322155|FG001|Overall Study|Progression of disease|1|||
44317944|NCT01286077|79322154|FG000|Overall Study|refill medication not received in time|1|||
44317945|NCT01286077|79322155|FG001|Overall Study|refill medication not received in time|0|||
44317946|NCT01285960|79322161|FG000|Overall Study|Withdrawal by Subject|2|||
44317947|NCT01285960|79322161|FG000|Overall Study|Lost to Follow-up|2|||
44317948|NCT01285960|79322161|FG000|Overall Study|2 subjects received less 10 sonications|2|||
44317949|NCT01285609|79322172|FG000|Randomized|Progressive Disease|41|||
44317950|NCT01285609|79322173|FG001|Randomized|Progressive Disease|61|||
44317951|NCT01285609|79322172|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
44317952|NCT01285609|79322173|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
44317953|NCT01285609|79322172|FG000|Randomized|Study Drug Toxicity|13|||
44317954|NCT01285609|79322173|FG001|Randomized|Study Drug Toxicity|14|||
44317955|NCT01285609|79322172|FG000|Randomized|Death|5|||
44317956|NCT01285609|79322173|FG001|Randomized|Death|7|||
44317957|NCT01285609|79322172|FG000|Randomized|Withdrawal by Subject|8|||
44317958|NCT01285609|79322173|FG001|Randomized|Withdrawal by Subject|11|||
44317959|NCT01285609|79322172|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
44317960|NCT01285609|79322173|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
44317961|NCT01285609|79322172|FG000|Randomized|Undisclosed Reasons|1|||
44317962|NCT01285609|79322173|FG001|Randomized|Undisclosed Reasons|0|||
44317963|NCT01285609|79322172|FG000|Randomized|Randomized but not Treated|4|||
44317964|NCT01285609|79322173|FG001|Randomized|Randomized but not Treated|4|||
44317965|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
44317966|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
44317967|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
44317968|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
44317969|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
44317970|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
44317971|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
44317972|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
44317973|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Death|11|||
44317974|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Death|3|||
44317975|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
44317976|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
44317977|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Not Reported|0|||
44317978|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Not Reported|2|||
44317979|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
44317980|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
44317981|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
44317982|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
44317983|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
44317984|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
44317985|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
44317986|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
44421168|NCT00772382|79429095|FG000|Overall Study|Other Reasons|10|||
44421169|NCT00798707|79429102|FG000|Overall Study|Adverse Event|6|||
44317987|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
44317988|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
44317989|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
44317990|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
44317991|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
44317992|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
44317993|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
44317994|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
44317995|NCT01285609|79322172|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
44317996|NCT01285609|79322173|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
44317997|NCT01285609|79322172|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
44317998|NCT01285609|79322173|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
44317999|NCT01285492|79322183|FG000|Overall Study|Adverse Event|11|||
44318000|NCT01285492|79322184|FG001|Overall Study|Adverse Event|0|||
44318001|NCT01285492|79322183|FG000|Overall Study|Protocol Violation|3|||
44318002|NCT01285492|79322184|FG001|Overall Study|Protocol Violation|0|||
44318003|NCT01285492|79322183|FG000|Overall Study|Withdrawal by Subject|2|||
44318004|NCT01285492|79322184|FG001|Overall Study|Withdrawal by Subject|1|||
44318005|NCT01285492|79322183|FG000|Overall Study|Death|1|||
44318006|NCT01285492|79322184|FG001|Overall Study|Death|0|||
44318007|NCT01284634|79322194|FG000|Overall Study|Adverse Event|1|||
44318008|NCT01284634|79322195|FG001|Overall Study|Adverse Event|0|||
44318009|NCT01284634|79322196|FG002|Overall Study|Adverse Event|2|||
44318010|NCT01284634|79322197|FG003|Overall Study|Adverse Event|1|||
44318011|NCT01284361|79322207|FG000|Overall Study|Withdrawal by Subject|1|||
44318012|NCT01284361|79322207|FG000|Overall Study|Protocol Violation|5|||
44318013|NCT01284361|79322207|FG000|Overall Study|Adverse Event|1|||
44318014|NCT01284361|79322207|FG000|Overall Study|Lost to Follow-up|2|||
44318015|NCT01284127|79322214|FG000|Overall Study|Adverse Event|2|||
44318016|NCT01284127|79322214|FG000|Overall Study|Withdrawal by Subject|4|||
44318017|NCT01284127|79322214|FG000|Overall Study|Physician Decision|1|||
44318018|NCT01283971|79322220|FG000|Overall Study|Adverse Event|3|||
44318019|NCT01283971|79322221|FG001|Overall Study|Adverse Event|5|||
44318020|NCT01283971|79322220|FG000|Overall Study|Insufficient therapeutic responses|3|||
44318021|NCT01283971|79322221|FG001|Overall Study|Insufficient therapeutic responses|3|||
44318022|NCT01283971|79322220|FG000|Overall Study|Protocol Violation|5|||
44318023|NCT01283971|79322221|FG001|Overall Study|Protocol Violation|1|||
44318024|NCT01283971|79322220|FG000|Overall Study|Refused treatment|3|||
44318025|NCT01283971|79322221|FG001|Overall Study|Refused treatment|1|||
44318026|NCT01283971|79322220|FG000|Overall Study|Failure to return|0|||
44318027|NCT01283971|79322221|FG001|Overall Study|Failure to return|1|||
44318028|NCT01283971|79322220|FG000|Overall Study|Administrative reasons|1|||
44318029|NCT01283971|79322221|FG001|Overall Study|Administrative reasons|1|||
44318030|NCT01283581|79322230|FG000|Overall Study|Lost to Follow-up|8|||
44318031|NCT01283581|79322231|FG001|Overall Study|Lost to Follow-up|6|||
44318032|NCT01283581|79322232|FG002|Overall Study|Lost to Follow-up|8|||
44318033|NCT01283581|79322230|FG000|Overall Study|Withdrawal by Subject|2|||
44318034|NCT01283581|79322231|FG001|Overall Study|Withdrawal by Subject|5|||
44318035|NCT01283581|79322232|FG002|Overall Study|Withdrawal by Subject|2|||
44318036|NCT01283581|79322230|FG000|Overall Study|Adverse Event|1|||
44318037|NCT01283581|79322231|FG001|Overall Study|Adverse Event|1|||
44318038|NCT01283581|79322232|FG002|Overall Study|Adverse Event|4|||
44318039|NCT01283581|79322230|FG000|Overall Study|Physician Decision|0|||
44318040|NCT01283581|79322231|FG001|Overall Study|Physician Decision|1|||
44318041|NCT01283581|79322232|FG002|Overall Study|Physician Decision|2|||
44318042|NCT01283581|79322230|FG000|Overall Study|Protocol Violation|0|||
44318043|NCT01283581|79322231|FG001|Overall Study|Protocol Violation|1|||
44318044|NCT01283581|79322232|FG002|Overall Study|Protocol Violation|2|||
44318045|NCT01283581|79322230|FG000|Overall Study|Noncompliance|1|||
44318046|NCT01283581|79322231|FG001|Overall Study|Noncompliance|0|||
44318047|NCT01283581|79322232|FG002|Overall Study|Noncompliance|0|||
44318048|NCT01283581|79322230|FG000|Overall Study|Investigator unblinded|0|||
44155585|NCT01998958|78946965|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155586|NCT01998958|78946966|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155587|NCT01998958|78946967|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44318049|NCT01283581|79322231|FG001|Overall Study|Investigator unblinded|0|||
44318050|NCT01283581|79322232|FG002|Overall Study|Investigator unblinded|1|||
44318051|NCT01283581|79322230|FG000|Overall Study|"Early termination"|0|||
44318052|NCT01283581|79322231|FG001|Overall Study|"Early termination"|0|||
44318053|NCT01283581|79322232|FG002|Overall Study|"Early termination"|1|||
44318054|NCT01283542|79322243|FG000|Main Phase|Acute or progressive vision loss|1|||
44318055|NCT01283542|79322243|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
44318056|NCT01283542|79322243|FG000|Main Phase|abnormal laboratory values|5|||
44318057|NCT01283542|79322243|FG000|Extension Phase|Physician Decision|1|||
44318058|NCT01283542|79322243|FG000|Extension Phase|Adverse Event|1|||
44318059|NCT01283542|79322243|FG000|Extension Phase|Administrative problems|1|||
44318060|NCT01283386|79322267|FG000|Overall Study|Death|2|||
44318061|NCT01283386|79322268|FG001|Overall Study|Death|0|||
44318062|NCT01283386|79322267|FG000|Overall Study|Withdrawal by Subject|2|||
44318063|NCT01283386|79322268|FG001|Overall Study|Withdrawal by Subject|1|||
44318064|NCT01283386|79322267|FG000|Overall Study|Relapse of underlying disease|1|||
44318065|NCT01283386|79322268|FG001|Overall Study|Relapse of underlying disease|3|||
44318066|NCT01283386|79322267|FG000|Overall Study|Progression of underlying disease|2|||
44318067|NCT01283386|79322268|FG001|Overall Study|Progression of underlying disease|7|||
44318068|NCT01283386|79322267|FG000|Overall Study|Reason not specified|1|||
44318069|NCT01283386|79322268|FG001|Overall Study|Reason not specified|0|||
44318070|NCT01283386|79322267|FG000|Overall Study|Protocol Violation|0|||
44318071|NCT01283386|79322268|FG001|Overall Study|Protocol Violation|1|||
44318072|NCT01283152|79322276|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
44318073|NCT01283152|79322277|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
44318074|NCT01283152|79322276|FG000|Overall Study|Refused HESA|1|||
44318075|NCT01283152|79322277|FG001|Overall Study|Refused HESA|0|||
44318076|NCT01283035|79322283|FG000|Overall Study|Subject later found ineligible|1|||
44318077|NCT01283464|79322289|FG000|Overall Study|Lost to Follow-up|0|||
44318078|NCT01283464|79322290|FG001|Overall Study|Lost to Follow-up|1|||
44318079|NCT01283464|79322289|FG000|Overall Study|Withdrawal by Subject|1|||
44318080|NCT01283464|79322290|FG001|Overall Study|Withdrawal by Subject|0|||
44318081|NCT01283464|79322289|FG000|Overall Study|Physician Decision|1|||
44318082|NCT01283464|79322290|FG001|Overall Study|Physician Decision|0|||
44318083|NCT01282801|79322298|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
44318084|NCT01282801|79322299|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
44318085|NCT01282372|79322305|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
44318086|NCT01282372|79322305|FG000|Overall Study|Lost to Follow-up|23|||
44318087|NCT01282372|79322305|FG000|Overall Study|Withdrawal by Subject|11|||
44318088|NCT01282372|79322305|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
44318089|NCT01282372|79322305|FG000|Overall Study|Death|1|||
44318090|NCT01282372|79322305|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
44318091|NCT01282372|79322305|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
44318092|NCT01282372|79322305|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
44318093|NCT01282372|79322305|FG000|Overall Study|Adverse Event|12|||
44318094|NCT01282294|79322316|FG000|Overall Study|Lost to Follow-up|14|||
44318095|NCT01282294|79322316|FG000|Overall Study|Screening failure|1|||
44318096|NCT01282294|79322316|FG000|Overall Study|Adverse Event|1|||
44318097|NCT01282294|79322316|FG000|Overall Study|Patient non-compliance|2|||
44318098|NCT01282294|79322316|FG000|Overall Study|Physician Decision|1|||
44318099|NCT01282216|79322322|FG000|Overall Study|Graft failure|0|||
44318100|NCT01282216|79322323|FG001|Overall Study|Graft failure|0|||
44318101|NCT01282216|79322324|FG002|Overall Study|Graft failure|3|||
44318102|NCT01282216|79322325|FG003|Overall Study|Graft failure|2|||
44318103|NCT01282216|79322322|FG000|Overall Study|Physician Decision|0|||
44318104|NCT01282216|79322323|FG001|Overall Study|Physician Decision|0|||
44318105|NCT01282216|79322324|FG002|Overall Study|Physician Decision|11|||
44318106|NCT01282216|79322325|FG003|Overall Study|Physician Decision|0|||
44318107|NCT01282216|79322322|FG000|Overall Study|Relapse|0|||
44318108|NCT01282216|79322323|FG001|Overall Study|Relapse|0|||
44318109|NCT01282216|79322324|FG002|Overall Study|Relapse|17|||
44318110|NCT01282216|79322325|FG003|Overall Study|Relapse|6|||
44318111|NCT01282216|79322322|FG000|Overall Study|Death|0|||
44318112|NCT01282216|79322323|FG001|Overall Study|Death|0|||
44318113|NCT01282216|79322324|FG002|Overall Study|Death|2|||
44318114|NCT01282216|79322325|FG003|Overall Study|Death|0|||
44318115|NCT01281865|79322333|FG000|Overall Study|Adverse Event|1|||
44318116|NCT01281865|79322334|FG001|Overall Study|Adverse Event|1|||
44318117|NCT01281865|79322333|FG000|Overall Study|Withdrawal by Subject|1|||
44318118|NCT01281865|79322334|FG001|Overall Study|Withdrawal by Subject|0|||
44318119|NCT01281865|79322333|FG000|Overall Study|Lack of Efficacy|1|||
44318120|NCT01281865|79322334|FG001|Overall Study|Lack of Efficacy|0|||
44318121|NCT01281202|79322342|FG000|Overall Study|Adverse Event|2|||
44318122|NCT01281202|79322343|FG001|Overall Study|Adverse Event|0|||
44318123|NCT01281202|79322342|FG000|Overall Study|Withdrawal by Subject|2|||
44318124|NCT01281202|79322343|FG001|Overall Study|Withdrawal by Subject|2|||
44318125|NCT01281202|79322342|FG000|Overall Study|Protocol Violation|11|||
44318126|NCT01281202|79322343|FG001|Overall Study|Protocol Violation|10|||
44318127|NCT01281202|79322342|FG000|Overall Study|Administrative|2|||
44318128|NCT01281202|79322343|FG001|Overall Study|Administrative|8|||
44318129|NCT01281202|79322342|FG000|Overall Study|Lost to Follow-up|11|||
44318130|NCT01281202|79322343|FG001|Overall Study|Lost to Follow-up|13|||
44318131|NCT01281202|79322342|FG000|Overall Study|Incarceration|0|||
44318132|NCT01281202|79322343|FG001|Overall Study|Incarceration|3|||
44318133|NCT01281124|79322351|FG000|Overall Study|Death|1|||
44318134|NCT01280968|79322359|FG000|Overall Study|Lost to Follow-up|8|||
44318135|NCT01280968|79322360|FG001|Overall Study|Lost to Follow-up|2|||
44318136|NCT01280968|79322359|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
44318137|NCT01280968|79322360|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
44318138|NCT01280968|79322359|FG000|Overall Study|Commuting Problems|2|||
44318139|NCT01280968|79322360|FG001|Overall Study|Commuting Problems|0|||
44318140|NCT01280968|79322359|FG000|Overall Study|Anxiety|2|||
44318141|NCT01280968|79322360|FG001|Overall Study|Anxiety|0|||
44318142|NCT01280968|79322359|FG000|Overall Study|Adverse Event|1|||
44318143|NCT01280968|79322360|FG001|Overall Study|Adverse Event|0|||
44318144|NCT01280968|79322359|FG000|Overall Study|Scheduling Conflicts|1|||
44318145|NCT01280968|79322360|FG001|Overall Study|Scheduling Conflicts|1|||
44318146|NCT01280968|79322359|FG000|Overall Study|Pre-existing Neurological Condition|1|||
44318147|NCT01280968|79322360|FG001|Overall Study|Pre-existing Neurological Condition|0|||
44318148|NCT01280968|79322359|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
44318149|NCT01280968|79322360|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
44318150|NCT01280812|79322370|FG000|Overall Study|Withdrawal by Subject|2|||
44318151|NCT01280812|79322371|FG001|Overall Study|Withdrawal by Subject|1|||
44318152|NCT01280812|79322372|FG002|Overall Study|Withdrawal by Subject|0|||
44318153|NCT01280812|79322370|FG000|Overall Study|Lost to Follow-up|1|||
44318154|NCT01280812|79322371|FG001|Overall Study|Lost to Follow-up|1|||
44318155|NCT01280812|79322372|FG002|Overall Study|Lost to Follow-up|1|||
44318156|NCT01280656|79322384|FG000|Overall Study|Adverse Event|1|||
44318157|NCT01280656|79322385|FG001|Overall Study|Adverse Event|14|||
44318158|NCT01280656|79322386|FG002|Overall Study|Adverse Event|13|||
44318159|NCT01280656|79322384|FG000|Overall Study|Lack of Efficacy|1|||
44318160|NCT01280656|79322385|FG001|Overall Study|Lack of Efficacy|22|||
44318161|NCT01280656|79322386|FG002|Overall Study|Lack of Efficacy|38|||
44318162|NCT01280656|79322384|FG000|Overall Study|Treatment shortening (RGT)|0|||
44318163|NCT01280656|79322385|FG001|Overall Study|Treatment shortening (RGT)|4|||
44318164|NCT01280656|79322386|FG002|Overall Study|Treatment shortening (RGT)|5|||
44318165|NCT01280656|79322384|FG000|Overall Study|Other|1|||
44318166|NCT01280656|79322385|FG001|Overall Study|Other|7|||
44318167|NCT01280656|79322386|FG002|Overall Study|Other|7|||
44318168|NCT01280617|79322396|FG000|Overall Study|Adverse Event|0|||
44318169|NCT01280617|79322397|FG001|Overall Study|Adverse Event|1|||
44318170|NCT01280266|79322405|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
44318171|NCT01280266|79322406|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
44318172|NCT01280266|79322405|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
44318173|NCT01280266|79322406|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
44318174|NCT01279447|79322418|FG000|Overall Study|Lost to Follow-up|3|||
44318175|NCT01279447|79322419|FG001|Overall Study|Lost to Follow-up|1|||
44318176|NCT01276639|79322441|FG000|Week 0 to 16|Death|1|||
44318177|NCT01276639|79322442|FG001|Week 0 to 16|Death|0|||
44318178|NCT01276639|79322443|FG002|Week 0 to 16|Death|0|||
44318179|NCT01276639|79322444|FG003|Week 0 to 16|Death|0|||
44318180|NCT01276639|79322445|FG004|Week 0 to 16|Death|0|||
44318181|NCT01276639|79322441|FG000|Week 0 to 16|Adverse Event|11|||
44318182|NCT01276639|79322442|FG001|Week 0 to 16|Adverse Event|8|||
44318183|NCT01276639|79322443|FG002|Week 0 to 16|Adverse Event|11|||
44318184|NCT01276639|79322444|FG003|Week 0 to 16|Adverse Event|0|||
44318185|NCT01276639|79322445|FG004|Week 0 to 16|Adverse Event|0|||
44318186|NCT01276639|79322441|FG000|Week 0 to 16|Lack of Efficacy|20|||
44318187|NCT01276639|79322442|FG001|Week 0 to 16|Lack of Efficacy|15|||
44318188|NCT01276639|79322443|FG002|Week 0 to 16|Lack of Efficacy|25|||
44318189|NCT01276639|79322444|FG003|Week 0 to 16|Lack of Efficacy|0|||
44318190|NCT01276639|79322445|FG004|Week 0 to 16|Lack of Efficacy|0|||
44318191|NCT01276639|79322441|FG000|Week 0 to 16|Lost to Follow-up|3|||
44318192|NCT01276639|79322442|FG001|Week 0 to 16|Lost to Follow-up|5|||
44318193|NCT01276639|79322443|FG002|Week 0 to 16|Lost to Follow-up|3|||
44318194|NCT01276639|79322444|FG003|Week 0 to 16|Lost to Follow-up|0|||
44318195|NCT01276639|79322445|FG004|Week 0 to 16|Lost to Follow-up|0|||
44318196|NCT01276639|79322441|FG000|Week 0 to 16|Withdrawal by Subject|8|||
44318197|NCT01276639|79322442|FG001|Week 0 to 16|Withdrawal by Subject|5|||
44318198|NCT01276639|79322443|FG002|Week 0 to 16|Withdrawal by Subject|4|||
44318199|NCT01276639|79322444|FG003|Week 0 to 16|Withdrawal by Subject|0|||
44318200|NCT01276639|79322445|FG004|Week 0 to 16|Withdrawal by Subject|0|||
44318201|NCT01276639|79322441|FG000|Week 0 to 16|Other|7|||
44318202|NCT01276639|79322442|FG001|Week 0 to 16|Other|7|||
44318203|NCT01276639|79322443|FG002|Week 0 to 16|Other|2|||
44318204|NCT01276639|79322444|FG003|Week 0 to 16|Other|0|||
44318205|NCT01276639|79322445|FG004|Week 0 to 16|Other|0|||
44318206|NCT01276639|79322441|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
44318207|NCT01276639|79322442|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
44318208|NCT01276639|79322443|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
44318209|NCT01276639|79322444|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
44318210|NCT01276639|79322445|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
44318211|NCT01276639|79322441|FG000|Week 16 to 52|Death|1|||
44318212|NCT01276639|79322442|FG001|Week 16 to 52|Death|0|||
44318213|NCT01276639|79322443|FG002|Week 16 to 52|Death|0|||
44318214|NCT01276639|79322444|FG003|Week 16 to 52|Death|0|||
44318215|NCT01276639|79322445|FG004|Week 16 to 52|Death|0|||
44318216|NCT01276639|79322441|FG000|Week 16 to 52|Adverse Event|10|||
44318217|NCT01276639|79322442|FG001|Week 16 to 52|Adverse Event|13|||
44318218|NCT01276639|79322443|FG002|Week 16 to 52|Adverse Event|0|||
44318219|NCT01276639|79322444|FG003|Week 16 to 52|Adverse Event|1|||
44318220|NCT01276639|79322445|FG004|Week 16 to 52|Adverse Event|3|||
44318221|NCT01276639|79322441|FG000|Week 16 to 52|Lack of Efficacy|99|||
44318222|NCT01276639|79322442|FG001|Week 16 to 52|Lack of Efficacy|71|||
44318223|NCT01276639|79322443|FG002|Week 16 to 52|Lack of Efficacy|0|||
44318224|NCT01276639|79322444|FG003|Week 16 to 52|Lack of Efficacy|14|||
44318225|NCT01276639|79322445|FG004|Week 16 to 52|Lack of Efficacy|13|||
44318226|NCT01276639|79322441|FG000|Week 16 to 52|Lost to Follow-up|3|||
44318227|NCT01276639|79322442|FG001|Week 16 to 52|Lost to Follow-up|1|||
44318228|NCT01276639|79322443|FG002|Week 16 to 52|Lost to Follow-up|0|||
44318229|NCT01276639|79322444|FG003|Week 16 to 52|Lost to Follow-up|0|||
44318230|NCT01276639|79322445|FG004|Week 16 to 52|Lost to Follow-up|1|||
44318231|NCT01276639|79322441|FG000|Week 16 to 52|Withdrawal by Subject|4|||
44318232|NCT01276639|79322442|FG001|Week 16 to 52|Withdrawal by Subject|4|||
44318233|NCT01276639|79322443|FG002|Week 16 to 52|Withdrawal by Subject|0|||
44318234|NCT01276639|79322444|FG003|Week 16 to 52|Withdrawal by Subject|0|||
44318235|NCT01276639|79322445|FG004|Week 16 to 52|Withdrawal by Subject|1|||
44318236|NCT01276639|79322441|FG000|Week 16 to 52|Other|10|||
44318237|NCT01276639|79322442|FG001|Week 16 to 52|Other|12|||
44318238|NCT01276639|79322443|FG002|Week 16 to 52|Other|0|||
44318239|NCT01276639|79322444|FG003|Week 16 to 52|Other|1|||
44318240|NCT01276639|79322445|FG004|Week 16 to 52|Other|3|||
44318241|NCT01275625|79322460|FG000|Overall Study|Death|1|||
44318242|NCT01275625|79322460|FG000|Overall Study|Lack of Efficacy|2|||
44318243|NCT01275625|79322460|FG000|Overall Study|Lost to Follow-up|1|||
44318244|NCT01275625|79322460|FG000|Overall Study|Withdrawal by Subject|3|||
44318245|NCT01275625|79322460|FG000|Overall Study|Protocol Violation|1|||
44318246|NCT01275625|79322460|FG000|Overall Study|Adverse Event|4|||
44318247|NCT01275625|79322460|FG000|Overall Study|Other|1|||
44318248|NCT01272193|79322466|FG000|Overall Study|Adverse Event|1|||
44318249|NCT01272193|79322467|FG001|Overall Study|Adverse Event|1|||
44318250|NCT01272193|79322466|FG000|Overall Study|Lack of Efficacy|0|||
44318251|NCT01272193|79322467|FG001|Overall Study|Lack of Efficacy|3|||
44318252|NCT01272193|79322466|FG000|Overall Study|Withdrawal Criteria|1|||
44318253|NCT01272193|79322467|FG001|Overall Study|Withdrawal Criteria|1|||
44318254|NCT01272193|79322466|FG000|Overall Study|Unclassified|8|||
44318255|NCT01272193|79322467|FG001|Overall Study|Unclassified|7|||
44318256|NCT01270828|79322479|FG000|Pregabalin CR SB|Reason Unspecified|0|||
44421170|NCT00798707|79429103|FG001|Overall Study|Adverse Event|8|||
44421171|NCT00798707|79429104|FG002|Overall Study|Adverse Event|8|||
44421172|NCT00798707|79429102|FG000|Overall Study|Failed to return|2|||
44421173|NCT00798707|79429103|FG001|Overall Study|Failed to return|2|||
44421174|NCT00798707|79429104|FG002|Overall Study|Failed to return|0|||
44421175|NCT00798707|79429102|FG000|Overall Study|Investigator|0|||
44421176|NCT00798707|79429103|FG001|Overall Study|Investigator|1|||
44421177|NCT00798707|79429104|FG002|Overall Study|Investigator|2|||
44421178|NCT00798707|79429102|FG000|Overall Study|Lack of Efficacy|2|||
44421179|NCT00798707|79429103|FG001|Overall Study|Lack of Efficacy|2|||
44421180|NCT00798707|79429104|FG002|Overall Study|Lack of Efficacy|1|||
44421181|NCT00798707|79429102|FG000|Overall Study|Lost to Follow-up|5|||
44421182|NCT00798707|79429103|FG001|Overall Study|Lost to Follow-up|6|||
44421183|NCT00798707|79429104|FG002|Overall Study|Lost to Follow-up|6|||
44421184|NCT00798707|79429102|FG000|Overall Study|Other|0|||
44421185|NCT00798707|79429103|FG001|Overall Study|Other|1|||
44421186|NCT00798707|79429104|FG002|Overall Study|Other|0|||
44421187|NCT00798707|79429102|FG000|Overall Study|Protocol Violation|4|||
44421188|NCT00798707|79429103|FG001|Overall Study|Protocol Violation|0|||
44421189|NCT00798707|79429104|FG002|Overall Study|Protocol Violation|2|||
44421190|NCT00798707|79429102|FG000|Overall Study|Withdrawal by Subject|3|||
44421191|NCT00798707|79429103|FG001|Overall Study|Withdrawal by Subject|8|||
44421192|NCT00798707|79429104|FG002|Overall Study|Withdrawal by Subject|2|||
44421193|NCT00798707|79429102|FG000|Overall Study|Randomized not treated|4|||
44421194|NCT00798707|79429103|FG001|Overall Study|Randomized not treated|5|||
44421195|NCT00798707|79429104|FG002|Overall Study|Randomized not treated|1|||
44421196|NCT00760214|79429115|FG000|Overall Study|Adverse Event|8|||
44421197|NCT00760214|79429116|FG001|Overall Study|Adverse Event|9|||
44421198|NCT00760214|79429117|FG002|Overall Study|Adverse Event|12|||
44421199|NCT00760214|79429115|FG000|Overall Study|Protocol Violation|3|||
44421200|NCT00760214|79429116|FG001|Overall Study|Protocol Violation|0|||
44421201|NCT00760214|79429117|FG002|Overall Study|Protocol Violation|3|||
44421202|NCT00760214|79429115|FG000|Overall Study|Lost to Follow-up|0|||
44421203|NCT00760214|79429116|FG001|Overall Study|Lost to Follow-up|0|||
44421204|NCT00760214|79429117|FG002|Overall Study|Lost to Follow-up|1|||
44318257|NCT01270828|79322480|FG001|Pregabalin CR SB|Reason Unspecified|0|||
44318258|NCT01270828|79322481|FG002|Pregabalin CR SB|Reason Unspecified|8|||
44421205|NCT00760214|79429115|FG000|Overall Study|Withdrawal by Subject|12|||
44421206|NCT00760214|79429116|FG001|Overall Study|Withdrawal by Subject|14|||
44421207|NCT00760214|79429117|FG002|Overall Study|Withdrawal by Subject|13|||
44318259|NCT01270828|79322479|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
44318260|NCT01270828|79322480|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
44318261|NCT01270828|79322481|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
44318262|NCT01270828|79322479|FG000|Pregabalin CR SB|Related adverse event|0|||
44318263|NCT01270828|79322480|FG001|Pregabalin CR SB|Related adverse event|0|||
44318264|NCT01270828|79322481|FG002|Pregabalin CR SB|Related adverse event|46|||
44318265|NCT01270828|79322479|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
44318266|NCT01270828|79322480|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
44318267|NCT01270828|79322481|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
44318268|NCT01270828|79322479|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
44318269|NCT01270828|79322480|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
44318270|NCT01270828|79322481|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
44318271|NCT01270828|79322479|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
44318272|NCT01270828|79322480|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
44318273|NCT01270828|79322481|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
44318274|NCT01270828|79322479|FG000|Pregabalin CR SB|Unrelated AE|0|||
44318275|NCT01270828|79322480|FG001|Pregabalin CR SB|Unrelated AE|0|||
44318276|NCT01270828|79322481|FG002|Pregabalin CR SB|Unrelated AE|8|||
44318277|NCT01270828|79322479|FG000|Pregabalin CR SB|Protocol Violation|0|||
44318278|NCT01270828|79322480|FG001|Pregabalin CR SB|Protocol Violation|0|||
44318279|NCT01270828|79322481|FG002|Pregabalin CR SB|Protocol Violation|8|||
44318280|NCT01270828|79322479|FG000|Double Blind Phase|Death|0|||
44318281|NCT01270828|79322480|FG001|Double Blind Phase|Death|1|||
44318282|NCT01270828|79322481|FG002|Double Blind Phase|Death|0|||
44318283|NCT01270828|79322479|FG000|Double Blind Phase|Protocol Violation|0|||
44318284|NCT01270828|79322480|FG001|Double Blind Phase|Protocol Violation|1|||
44318285|NCT01270828|79322481|FG002|Double Blind Phase|Protocol Violation|0|||
44318286|NCT01270828|79322479|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
44318287|NCT01270828|79322480|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
44318288|NCT01270828|79322481|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
44318289|NCT01270828|79322479|FG000|Double Blind Phase|Reason Unspecified|7|||
44318290|NCT01270828|79322480|FG001|Double Blind Phase|Reason Unspecified|4|||
44318291|NCT01270828|79322481|FG002|Double Blind Phase|Reason Unspecified|0|||
44318292|NCT01270828|79322479|FG000|Double Blind Phase|Withdrawal by Subject|6|||
44318293|NCT01270828|79322480|FG001|Double Blind Phase|Withdrawal by Subject|15|||
44318294|NCT01270828|79322481|FG002|Double Blind Phase|Withdrawal by Subject|0|||
44318295|NCT01270828|79322479|FG000|Double Blind Phase|Lost to Follow-up|1|||
44318296|NCT01270828|79322480|FG001|Double Blind Phase|Lost to Follow-up|2|||
44318297|NCT01270828|79322481|FG002|Double Blind Phase|Lost to Follow-up|0|||
44318298|NCT01270828|79322479|FG000|Double Blind Phase|Lack of Efficacy|2|||
44318299|NCT01270828|79322480|FG001|Double Blind Phase|Lack of Efficacy|11|||
44318300|NCT01270828|79322481|FG002|Double Blind Phase|Lack of Efficacy|0|||
44318301|NCT01270828|79322479|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
44318302|NCT01270828|79322480|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
44318303|NCT01270828|79322481|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
44318304|NCT01270828|79322479|FG000|Double Blind Phase|Adverse event related to study drug|5|||
44318305|NCT01270828|79322480|FG001|Double Blind Phase|Adverse event related to study drug|7|||
44318306|NCT01270828|79322481|FG002|Double Blind Phase|Adverse event related to study drug|0|||
44536168|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
44536169|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
44536170|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44536171|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
44536172|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
44536173|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
44536174|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44536175|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Adverse Event|8|||
44536176|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Adverse Event|3|||
44536177|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Adverse Event|6|||
44536178|NCT02951988|79546923|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
44536179|NCT02951988|79546924|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
44318307|NCT01269385|79322489|FG000|Overall Study|Adverse Event|1|||
44318308|NCT01269385|79322490|FG001|Overall Study|Adverse Event|1|||
44318309|NCT01269385|79322491|FG002|Overall Study|Adverse Event|0|||
44318310|NCT01269385|79322492|FG003|Overall Study|Adverse Event|0|||
44318311|NCT01268683|79322502|FG000|Overall Study|Lost to Follow-up|1|||
44318312|NCT01268683|79322502|FG000|Overall Study|Death|1|||
44318313|NCT01268566|79322506|FG000|Overall Study|Lost to Follow-up|1|||
44536180|NCT02951988|79546925|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
44318314|NCT01268566|79322506|FG000|Overall Study|Withdrawal by Subject|12|||
44318315|NCT01268566|79322506|FG000|Overall Study|Death|30|||
44318316|NCT01268488|79322510|FG000|Overall Study|Adverse Event|3|||
44318317|NCT01268488|79322510|FG000|Overall Study|Physician Decision|2|||
44318318|NCT01268098|79322517|FG000|Overall Study|Adverse Event|1|||
44318319|NCT01268098|79322518|FG001|Overall Study|Adverse Event|0|||
44318320|NCT01268059|79322528|FG000|Overall Study|Lost to Follow-up|0|||
44318321|NCT01268059|79322529|FG001|Overall Study|Lost to Follow-up|1|||
44318322|NCT01268059|79322530|FG002|Overall Study|Lost to Follow-up|0|||
44318323|NCT01268059|79322531|FG003|Overall Study|Lost to Follow-up|0|||
44318324|NCT01268059|79322528|FG000|Overall Study|Withdrawal by Subject|7|||
44318325|NCT01268059|79322529|FG001|Overall Study|Withdrawal by Subject|4|||
44318326|NCT01268059|79322530|FG002|Overall Study|Withdrawal by Subject|0|||
44318327|NCT01268059|79322531|FG003|Overall Study|Withdrawal by Subject|0|||
44318328|NCT01268059|79322528|FG000|Overall Study|Death|20|||
44318329|NCT01268059|79322529|FG001|Overall Study|Death|30|||
44318330|NCT01268059|79322530|FG002|Overall Study|Death|3|||
44318331|NCT01268059|79322531|FG003|Overall Study|Death|5|||
44318332|NCT01268059|79322528|FG000|Overall Study|Progression of disease|1|||
44318333|NCT01268059|79322529|FG001|Overall Study|Progression of disease|0|||
44318334|NCT01268059|79322530|FG002|Overall Study|Progression of disease|0|||
44318335|NCT01268059|79322531|FG003|Overall Study|Progression of disease|0|||
44318336|NCT01267825|79322546|FG000|Overall Study|study terminated. no data collected.|1|||
44318337|NCT01267825|79322547|FG001|Overall Study|study terminated. no data collected.|0|||
44318338|NCT01260181|79322553|FG000|Overall Study|Decision of Investigator|1|||
44318339|NCT01260142|79322563|FG000|Treatment Period 1|Study on hold|1|||
44318340|NCT01260142|79322564|FG001|Treatment Period 1|Study on hold|1|||
44318341|NCT01260142|79322565|FG002|Treatment Period 1|Study on hold|0|||
44318342|NCT01260142|79322566|FG003|Treatment Period 1|Study on hold|0|||
44318343|NCT01260142|79322567|FG004|Treatment Period 1|Study on hold|1|||
44318344|NCT01260142|79322568|FG005|Treatment Period 1|Study on hold|2|||
44318345|NCT01260142|79322563|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
44318346|NCT01260142|79322564|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
44318347|NCT01260142|79322565|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
44318348|NCT01260142|79322566|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
44318349|NCT01260142|79322567|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
44318350|NCT01260142|79322568|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
44318351|NCT01260142|79322563|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44318352|NCT01260142|79322564|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44318353|NCT01260142|79322565|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44318354|NCT01260142|79322566|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44318355|NCT01260142|79322567|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44318356|NCT01260142|79322568|FG005|Treatment Period 1|Withdrawal by Subject|1|||
44318357|NCT01259869|79322588|FG000|Overall Study|Duplicated registration|1|||
44318358|NCT01259713|79322594|FG000|Overall Study|Adverse Event|54|||
44318359|NCT01259713|79322595|FG001|Overall Study|Adverse Event|23|||
44318360|NCT01259713|79322594|FG000|Overall Study|Death Not Related to IFI|8|||
44318361|NCT01259713|79322595|FG001|Overall Study|Death Not Related to IFI|1|||
44318362|NCT01259713|79322594|FG000|Overall Study|Investigators Discretion|14|||
44318363|NCT01259713|79322595|FG001|Overall Study|Investigators Discretion|6|||
44318364|NCT01259713|79322594|FG000|Overall Study|Lack of Efficacy|2|||
44318365|NCT01259713|79322595|FG001|Overall Study|Lack of Efficacy|0|||
44318366|NCT01259713|79322594|FG000|Overall Study|Protocol Violation|5|||
44318367|NCT01259713|79322595|FG001|Overall Study|Protocol Violation|4|||
44318368|NCT01259713|79322594|FG000|Overall Study|Subject Withdrew Consent|12|||
44318369|NCT01259713|79322595|FG001|Overall Study|Subject Withdrew Consent|7|||
44318370|NCT01259401|79322603|FG000|4-month Follow-up|Death|0|||
44318371|NCT01259401|79322604|FG001|4-month Follow-up|Death|1|||
44318372|NCT01259401|79322603|FG000|4-month Follow-up|Lost to Follow-up|0|||
44318373|NCT01259401|79322604|FG001|4-month Follow-up|Lost to Follow-up|1|||
44318374|NCT01313923|79322619|FG000|Overall Study|Physician Decision|3|||
44318375|NCT01313884|79322623|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
44318376|NCT01135459|79322629|FG000|Overall Study|Adverse Event|8|||
44318377|NCT01135459|79322630|FG001|Overall Study|Adverse Event|10|||
44318378|NCT01135459|79322629|FG000|Overall Study|Lack of Efficacy|3|||
44318379|NCT01135459|79322630|FG001|Overall Study|Lack of Efficacy|1|||
44318380|NCT01135459|79322629|FG000|Overall Study|Withdrawal by Subject|2|||
44318381|NCT01135459|79322630|FG001|Overall Study|Withdrawal by Subject|3|||
44318382|NCT01135459|79322629|FG000|Overall Study|Protocol Violation|5|||
44318383|NCT01135459|79322630|FG001|Overall Study|Protocol Violation|3|||
44318384|NCT01135459|79322629|FG000|Overall Study|Lost to Follow-up|2|||
44318385|NCT01135459|79322630|FG001|Overall Study|Lost to Follow-up|1|||
44318386|NCT01135459|79322629|FG000|Overall Study|Non-compliance to study procedures|0|||
44318387|NCT01135459|79322630|FG001|Overall Study|Non-compliance to study procedures|1|||
44318388|NCT01135459|79322629|FG000|Overall Study|Other than specified|1|||
44318389|NCT01135459|79322630|FG001|Overall Study|Other than specified|1|||
44318390|NCT01259284|79322639|FG000|Overall Study|Study Termination|2|||
44318391|NCT01259284|79322640|FG001|Overall Study|Study Termination|0|||
44318392|NCT01259284|79322641|FG002|Overall Study|Study Termination|0|||
44318393|NCT01259245|79322651|FG000|Overall Study|Withdrawal by Subject|27|||
44318394|NCT01259245|79322652|FG001|Overall Study|Withdrawal by Subject|24|||
44318395|NCT01259245|79322651|FG000|Overall Study|Death|1|||
44318396|NCT01259245|79322652|FG001|Overall Study|Death|2|||
44318397|NCT01259089|79322660|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
44318398|NCT01259089|79322661|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
44318399|NCT01259089|79322662|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
44318400|NCT01259089|79322663|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
44318401|NCT01259089|79322664|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
44318402|NCT01259089|79322665|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
44318403|NCT01259089|79322660|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
44318404|NCT01259089|79322661|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
44318405|NCT01259089|79322662|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
44318406|NCT01259089|79322663|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
44318407|NCT01259089|79322664|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
44318408|NCT01259089|79322665|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
44318409|NCT01259089|79322660|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
44318410|NCT01259089|79322661|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
44318411|NCT01259089|79322662|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
44318412|NCT01259089|79322663|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
44318413|NCT01259089|79322664|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
44318414|NCT01259089|79322665|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
44318415|NCT01259089|79322660|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
44318416|NCT01259089|79322661|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
44318417|NCT01259089|79322662|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
44318418|NCT01259089|79322663|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
44318419|NCT01259089|79322664|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
44318420|NCT01259089|79322665|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
44318421|NCT01259089|79322660|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
44318422|NCT01259089|79322661|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
44318423|NCT01259089|79322662|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
44318424|NCT01259089|79322663|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
44318425|NCT01259089|79322664|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
44318426|NCT01259089|79322665|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
44318427|NCT01259089|79322660|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
44318428|NCT01259089|79322661|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
44318429|NCT01259089|79322662|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
44318430|NCT01259089|79322663|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
44318431|NCT01259089|79322664|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
44318432|NCT01259089|79322665|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
44318433|NCT01259089|79322660|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
44318434|NCT01259089|79322661|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
44318435|NCT01259089|79322662|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
44318436|NCT01259089|79322663|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
44318437|NCT01259089|79322664|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
44318438|NCT01259089|79322665|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
44318439|NCT01259089|79322660|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
44318440|NCT01259089|79322661|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
44318441|NCT01259089|79322662|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
44318442|NCT01259089|79322663|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
44318443|NCT01259089|79322664|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
44318444|NCT01259089|79322665|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
44318445|NCT01259089|79322660|FG000|Survival Follow up for Two Years|Death|3|||
44318446|NCT01259089|79322661|FG001|Survival Follow up for Two Years|Death|2|||
44318447|NCT01259089|79322662|FG002|Survival Follow up for Two Years|Death|2|||
44318448|NCT01259089|79322663|FG003|Survival Follow up for Two Years|Death|3|||
44318449|NCT01259089|79322664|FG004|Survival Follow up for Two Years|Death|6|||
44318450|NCT01259089|79322665|FG005|Survival Follow up for Two Years|Death|13|||
44318451|NCT01259089|79322660|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
44318452|NCT01259089|79322661|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
44318453|NCT01259089|79322662|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
44318454|NCT01259089|79322663|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
44318455|NCT01259089|79322664|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
44318456|NCT01259089|79322665|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
44318457|NCT01259089|79322660|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
44318458|NCT01259089|79322661|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
44318459|NCT01259089|79322662|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
44318460|NCT01259089|79322663|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
44318461|NCT01259089|79322664|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
44318462|NCT01259089|79322665|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
44318463|NCT01258738|79322681|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
44318464|NCT01258738|79322682|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
44318465|NCT01258738|79322681|FG000|Double-blind Period|Withdrawal by Subject|2|||
44318466|NCT01258738|79322682|FG001|Double-blind Period|Withdrawal by Subject|2|||
44318467|NCT01258738|79322681|FG000|Double-blind Period|Protocol Violation|1|||
44318468|NCT01258738|79322682|FG001|Double-blind Period|Protocol Violation|1|||
44318469|NCT01258738|79322681|FG000|Double-blind Period|Adverse Event|3|||
44318470|NCT01258738|79322682|FG001|Double-blind Period|Adverse Event|1|||
44318471|NCT01258738|79322681|FG000|Open-label Period|Did not meet inclusion criteria|0|||
44318472|NCT01258738|79322682|FG001|Open-label Period|Did not meet inclusion criteria|1|||
44318473|NCT01258738|79322681|FG000|Open-label Period|Insufficient clinical response|5|||
44318474|NCT01258738|79322682|FG001|Open-label Period|Insufficient clinical response|3|||
44318475|NCT01258738|79322681|FG000|Open-label Period|Lost to Follow-up|0|||
44318476|NCT01258738|79322682|FG001|Open-label Period|Lost to Follow-up|2|||
44318477|NCT01258738|79322681|FG000|Open-label Period|Withdrawal by Subject|5|||
44318478|NCT01258738|79322682|FG001|Open-label Period|Withdrawal by Subject|6|||
44318479|NCT01258738|79322681|FG000|Open-label Period|Protocol Violation|2|||
44318480|NCT01258738|79322682|FG001|Open-label Period|Protocol Violation|2|||
44318481|NCT01258738|79322681|FG000|Open-label Period|Adverse Event|4|||
44318482|NCT01258738|79322682|FG001|Open-label Period|Adverse Event|5|||
44318483|NCT01258738|79322681|FG000|Open-label Period|Other Reasons|0|||
44318484|NCT01258738|79322682|FG001|Open-label Period|Other Reasons|1|||
44318485|NCT01258738|79322681|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
44318486|NCT01258738|79322682|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
44318487|NCT01258660|79322690|FG000|Overall Study|Adverse Event|2|||
44318488|NCT01258660|79322691|FG001|Overall Study|Adverse Event|4|||
44318489|NCT01258660|79322690|FG000|Overall Study|Withdrawal by Subject|3|||
44318490|NCT01258660|79322691|FG001|Overall Study|Withdrawal by Subject|0|||
44318491|NCT01258660|79322690|FG000|Overall Study|due to relocation|2|||
44318492|NCT01258660|79322691|FG001|Overall Study|due to relocation|0|||
44421208|NCT00760214|79429115|FG000|Overall Study|Lack of Efficacy|3|||
44421209|NCT00760214|79429116|FG001|Overall Study|Lack of Efficacy|2|||
44421210|NCT00760214|79429117|FG002|Overall Study|Lack of Efficacy|4|||
44421211|NCT00760214|79429115|FG000|Overall Study|Pregnancy|0|||
44421212|NCT00760214|79429116|FG001|Overall Study|Pregnancy|0|||
44421213|NCT00760214|79429117|FG002|Overall Study|Pregnancy|1|||
44421214|NCT00760214|79429115|FG000|Overall Study|Physician Decision|1|||
44421215|NCT00760214|79429116|FG001|Overall Study|Physician Decision|1|||
44421216|NCT00760214|79429117|FG002|Overall Study|Physician Decision|1|||
44421217|NCT00760214|79429115|FG000|Overall Study|Other|3|||
44421218|NCT00760214|79429116|FG001|Overall Study|Other|4|||
44421219|NCT00760214|79429117|FG002|Overall Study|Other|6|||
44421220|NCT00802841|79429127|FG000|Overall Study|Administrative problems|1|||
44421221|NCT00802841|79429128|FG001|Overall Study|Administrative problems|0|||
44421222|NCT00802841|79429127|FG000|Overall Study|Lost to Follow-up|2|||
44318493|NCT01258660|79322690|FG000|Overall Study|Protocol Violation|0|||
44318494|NCT01258660|79322691|FG001|Overall Study|Protocol Violation|1|||
44318495|NCT01258660|79322690|FG000|Overall Study|Invalid for primary analysis data set|4|||
44318496|NCT01258660|79322691|FG001|Overall Study|Invalid for primary analysis data set|6|||
44318497|NCT01258348|79322698|FG000|Overall Study|Adverse Event|1|||
44318498|NCT01258348|79322699|FG001|Overall Study|Adverse Event|1|||
44318499|NCT01258348|79322700|FG002|Overall Study|Adverse Event|3|||
44318500|NCT01258348|79322701|FG003|Overall Study|Adverse Event|2|||
44421223|NCT00802841|79429128|FG001|Overall Study|Lost to Follow-up|1|||
44421224|NCT00802841|79429127|FG000|Overall Study|Death|1|||
44536181|NCT02951988|79546926|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
44536182|NCT00009737|79546938|FG000|Overall Study|Adverse Event|112|||
44318501|NCT01258348|79322702|FG004|Overall Study|Adverse Event|4|||
44318502|NCT01258348|79322698|FG000|Overall Study|Progressive Disease|0|||
44318503|NCT01258348|79322699|FG001|Overall Study|Progressive Disease|3|||
44318504|NCT01258348|79322700|FG002|Overall Study|Progressive Disease|0|||
44318505|NCT01258348|79322701|FG003|Overall Study|Progressive Disease|2|||
44318506|NCT01258348|79322702|FG004|Overall Study|Progressive Disease|2|||
44318507|NCT01258348|79322698|FG000|Overall Study|Physician Decision|0|||
44318508|NCT01258348|79322699|FG001|Overall Study|Physician Decision|0|||
44421225|NCT00802841|79429128|FG001|Overall Study|Death|2|||
44421226|NCT00802841|79429127|FG000|Overall Study|Adverse Event|8|||
44318509|NCT01258348|79322700|FG002|Overall Study|Physician Decision|0|||
44318510|NCT01258348|79322701|FG003|Overall Study|Physician Decision|2|||
44318511|NCT01258348|79322702|FG004|Overall Study|Physician Decision|0|||
44318512|NCT01258348|79322698|FG000|Overall Study|Withdrawal by Subject|0|||
44421227|NCT00802841|79429128|FG001|Overall Study|Adverse Event|2|||
44421228|NCT00802841|79429127|FG000|Overall Study|Disease progression|7|||
44318513|NCT01258348|79322699|FG001|Overall Study|Withdrawal by Subject|1|||
44318514|NCT01258348|79322700|FG002|Overall Study|Withdrawal by Subject|0|||
44318515|NCT01258348|79322701|FG003|Overall Study|Withdrawal by Subject|0|||
44318516|NCT01258348|79322702|FG004|Overall Study|Withdrawal by Subject|0|||
44318517|NCT01258075|79322718|FG000|Overall Study|Adverse Event|8|||
44318518|NCT01258075|79322719|FG001|Overall Study|Adverse Event|3|||
44318519|NCT01258075|79322718|FG000|Overall Study|Lost to Follow-up|11|||
44318520|NCT01258075|79322719|FG001|Overall Study|Lost to Follow-up|6|||
44318521|NCT01258075|79322718|FG000|Overall Study|Withdrawal by Subject|10|||
44318522|NCT01258075|79322719|FG001|Overall Study|Withdrawal by Subject|7|||
44318523|NCT01258075|79322718|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
44318524|NCT01258075|79322719|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
44318525|NCT01258075|79322718|FG000|Overall Study|Other|12|||
44318526|NCT01258075|79322719|FG001|Overall Study|Other|5|||
44318527|NCT01257568|79322725|FG000|Overall Study|Lost to Follow-up|2|||
44318528|NCT01257568|79322725|FG000|Overall Study|Withdrawal by Subject|6|||
44318529|NCT01257568|79322725|FG000|Overall Study|Terminated|1|||
44318530|NCT01257568|79322725|FG000|Overall Study|Component Revision|24|||
44318531|NCT01256788|79322734|FG000|Overall Study|Lost to Follow-up|5|||
44318532|NCT01256788|79322735|FG001|Overall Study|Lost to Follow-up|8|||
44318533|NCT01256788|79322736|FG002|Overall Study|Lost to Follow-up|3|||
44318534|NCT01256671|79322744|FG000|Overall Study|Adverse Event|29|||
44318535|NCT01256671|79322744|FG000|Overall Study|Lost to Follow-up|16|||
44318536|NCT01256671|79322744|FG000|Overall Study|Withdrawal by Subject|31|||
44318537|NCT01256671|79322744|FG000|Overall Study|Physician Decision|3|||
44318538|NCT01256671|79322744|FG000|Overall Study|Lack of Efficacy|4|||
44318539|NCT01256671|79322744|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
44318540|NCT01256476|79322750|FG000|Overall Study|Adverse Event|2|||
44318541|NCT01256476|79322751|FG001|Overall Study|Adverse Event|1|||
44318542|NCT01256476|79322750|FG000|Overall Study|Withdrawal by Subject|2|||
44318543|NCT01256476|79322751|FG001|Overall Study|Withdrawal by Subject|1|||
44318544|NCT01256476|79322750|FG000|Overall Study|Lost to Follow-up|1|||
44318545|NCT01256476|79322751|FG001|Overall Study|Lost to Follow-up|2|||
44318546|NCT01256476|79322750|FG000|Overall Study|Persistent ALT or AST elevation|1|||
44318547|NCT01256476|79322751|FG001|Overall Study|Persistent ALT or AST elevation|0|||
44318548|NCT01256476|79322750|FG000|Overall Study|Physician Decision|0|||
44318549|NCT01256476|79322751|FG001|Overall Study|Physician Decision|1|||
44318550|NCT01256476|79322750|FG000|Overall Study|Subject non-compliance|0|||
44318551|NCT01256476|79322751|FG001|Overall Study|Subject non-compliance|1|||
44318552|NCT01256476|79322750|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
44318553|NCT01256476|79322751|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
44318554|NCT01256008|79322760|FG000|Overall Study|Lost to Follow-up|6|||
44318555|NCT01256008|79322761|FG001|Overall Study|Lost to Follow-up|4|||
44318556|NCT01256008|79322762|FG002|Overall Study|Lost to Follow-up|11|||
44318557|NCT01256008|79322760|FG000|Overall Study|Withdrawal by Subject|2|||
44318558|NCT01256008|79322761|FG001|Overall Study|Withdrawal by Subject|3|||
44318559|NCT01256008|79322762|FG002|Overall Study|Withdrawal by Subject|10|||
44318560|NCT01255423|79322774|FG000|Overall Study|Abnormal Laboratory value|3|||
44318561|NCT01255423|79322775|FG001|Overall Study|Abnormal Laboratory value|2|||
44318562|NCT01255423|79322774|FG000|Overall Study|Use of prohibited medications|0|||
44318563|NCT01255423|79322775|FG001|Overall Study|Use of prohibited medications|1|||
44318564|NCT01255306|79322783|FG000|Overall Study|Physician Decision|1|||
44318565|NCT01255306|79322784|FG001|Overall Study|Physician Decision|1|||
44318566|NCT01254721|79322795|FG000|Overall Study|Lost to Follow-up|0|||
44318567|NCT01254721|79322796|FG001|Overall Study|Lost to Follow-up|4|||
44318568|NCT01254721|79322795|FG000|Overall Study|Lack of Efficacy|4|||
44536183|NCT00009737|79546939|FG001|Overall Study|Adverse Event|75|||
44318569|NCT01254721|79322796|FG001|Overall Study|Lack of Efficacy|2|||
44318570|NCT01254721|79322795|FG000|Overall Study|Death|0|||
44318571|NCT01254721|79322796|FG001|Overall Study|Death|1|||
44318572|NCT01254721|79322795|FG000|Overall Study|technical problum|1|||
44318573|NCT01254721|79322796|FG001|Overall Study|technical problum|0|||
44318574|NCT01254721|79322795|FG000|Overall Study|Adverse Event|2|||
44318575|NCT01254721|79322796|FG001|Overall Study|Adverse Event|3|||
44318576|NCT01254721|79322795|FG000|Overall Study|Withdrawal by Subject|8|||
44318577|NCT01254721|79322796|FG001|Overall Study|Withdrawal by Subject|11|||
44318578|NCT01254721|79322795|FG000|Overall Study|Wrongly randomization|0|||
44536184|NCT00009737|79546938|FG000|Overall Study|Death|4|||
44318579|NCT01254721|79322796|FG001|Overall Study|Wrongly randomization|1|||
44318580|NCT01254643|79322802|FG000|Overall Study|Withdrawal by Subject|1|||
44318581|NCT01254604|79322808|FG000|Overall Study|Lost to Follow-up|1|||
44318582|NCT01254604|79322809|FG001|Overall Study|Lost to Follow-up|1|||
44318583|NCT01254604|79322808|FG000|Overall Study|Protocol Violation|2|||
44318584|NCT01254604|79322809|FG001|Overall Study|Protocol Violation|2|||
44318585|NCT01254604|79322808|FG000|Overall Study|Withdrawal by Subject|2|||
44318586|NCT01254604|79322809|FG001|Overall Study|Withdrawal by Subject|4|||
44318587|NCT01254604|79322808|FG000|Overall Study|Adverse Event|3|||
44536185|NCT00009737|79546939|FG001|Overall Study|Death|6|||
44318588|NCT01254604|79322809|FG001|Overall Study|Adverse Event|2|||
44318589|NCT01254565|79322821|FG000|Overall Study|Non-compliance to Study Procedures|0|||
44318590|NCT01254565|79322822|FG001|Overall Study|Non-compliance to Study Procedures|0|||
44318591|NCT01254565|79322823|FG002|Overall Study|Non-compliance to Study Procedures|0|||
44318592|NCT01254565|79322824|FG003|Overall Study|Non-compliance to Study Procedures|0|||
44318593|NCT01254565|79322825|FG004|Overall Study|Non-compliance to Study Procedures|1|||
44318594|NCT01254565|79322826|FG005|Overall Study|Non-compliance to Study Procedures|0|||
44318595|NCT01254565|79322821|FG000|Overall Study|Did not Receive Treatment|1|||
44318596|NCT01254565|79322822|FG001|Overall Study|Did not Receive Treatment|1|||
44318597|NCT01254565|79322823|FG002|Overall Study|Did not Receive Treatment|0|||
44318598|NCT01254565|79322824|FG003|Overall Study|Did not Receive Treatment|0|||
44318599|NCT01254565|79322825|FG004|Overall Study|Did not Receive Treatment|3|||
44318600|NCT01254565|79322826|FG005|Overall Study|Did not Receive Treatment|4|||
44318601|NCT01254565|79322821|FG000|Overall Study|Other|0|||
44318602|NCT01254565|79322822|FG001|Overall Study|Other|0|||
44318603|NCT01254565|79322823|FG002|Overall Study|Other|0|||
44318604|NCT01254565|79322824|FG003|Overall Study|Other|1|||
44318605|NCT01254565|79322825|FG004|Overall Study|Other|0|||
44318606|NCT01254565|79322826|FG005|Overall Study|Other|0|||
44318607|NCT01254409|79322844|FG000|Overall Study|Adverse Event|0|||
44318608|NCT01254409|79322845|FG001|Overall Study|Adverse Event|1|||
44318609|NCT01254409|79322846|FG002|Overall Study|Adverse Event|0|||
44318610|NCT01254409|79322847|FG003|Overall Study|Adverse Event|0|||
44318611|NCT01254331|79322860|FG000|Initial Phase|Adverse Event|3|||
44318612|NCT01254331|79322860|FG000|Initial Phase|Withdrawal by Subject|1|||
44318613|NCT01254331|79322860|FG000|Initial Phase|Pregnancy|1|||
44318614|NCT01254331|79322860|FG000|Extension Phase|Lack of Efficacy|1|||
44318615|NCT01254331|79322860|FG000|Extension Phase|Lost to Follow-up|3|||
44318616|NCT01254292|79322875|FG000|Comparative Phase|Adverse Event|25|||
44318617|NCT01254292|79322876|FG001|Comparative Phase|Adverse Event|25|||
44318618|NCT01254292|79322875|FG000|Comparative Phase|Lost to Follow-up|3|||
44318619|NCT01254292|79322876|FG001|Comparative Phase|Lost to Follow-up|21|||
44318620|NCT01254292|79322875|FG000|Comparative Phase|Pregnancy|2|||
44318621|NCT01254292|79322876|FG001|Comparative Phase|Pregnancy|6|||
44318622|NCT01254292|79322875|FG000|Comparative Phase|Withdrawal by Subject|20|||
44318623|NCT01254292|79322876|FG001|Comparative Phase|Withdrawal by Subject|21|||
44318624|NCT01254292|79322875|FG000|Comparative Phase|Protocol Violation|1|||
44318625|NCT01254292|79322876|FG001|Comparative Phase|Protocol Violation|2|||
44318626|NCT01254292|79322875|FG000|Comparative Phase|Wish for pregnancy|4|||
44318627|NCT01254292|79322876|FG001|Comparative Phase|Wish for pregnancy|6|||
44318628|NCT01254292|79322875|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
44318629|NCT01254292|79322876|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
44318630|NCT01254292|79322875|FG000|LCS12 Extension Phase|Adverse Event|9|||
44318631|NCT01254292|79322876|FG001|LCS12 Extension Phase|Adverse Event|0|||
44318632|NCT01254292|79322875|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
44318633|NCT01254292|79322876|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
44318634|NCT01254292|79322875|FG000|LCS12 Extension Phase|Other unknown|4|||
44318635|NCT01254292|79322876|FG001|LCS12 Extension Phase|Other unknown|0|||
44318636|NCT01254292|79322875|FG000|LCS12 Extension Phase|Pregnancy|2|||
44318637|NCT01254292|79322876|FG001|LCS12 Extension Phase|Pregnancy|0|||
44318638|NCT01254292|79322875|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
44318639|NCT01254292|79322876|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
44318640|NCT01254019|79322885|FG000|Overall Study|Adverse Event|0|||
44318641|NCT01254019|79322886|FG001|Overall Study|Adverse Event|2|||
44318642|NCT01254019|79322885|FG000|Overall Study|Protocol Violation|1|||
44318643|NCT01254019|79322886|FG001|Overall Study|Protocol Violation|0|||
44318644|NCT01254019|79322885|FG000|Overall Study|Withdrawal by Subject|0|||
44536186|NCT00009737|79546938|FG000|Overall Study|Lack of Efficacy|17|||
44155588|NCT01998958|78946968|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
44155589|NCT01998958|78946969|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
44155590|NCT01998958|78946970|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
44318645|NCT01254019|79322886|FG001|Overall Study|Withdrawal by Subject|2|||
44318646|NCT01253317|79322895|FG000|Overall Study|Adverse Event|2|||
44318647|NCT01253200|79322908|FG000|Overall Study|Death|1|||
44318648|NCT01253200|79322909|FG001|Overall Study|Death|0|||
44318649|NCT01253200|79322910|FG002|Overall Study|Death|0|||
44318650|NCT01253200|79322911|FG003|Overall Study|Death|0|||
44318651|NCT01253200|79322912|FG004|Overall Study|Death|0|||
44318652|NCT01253200|79322908|FG000|Overall Study|Lost to Follow-up|1|||
44318653|NCT01253200|79322909|FG001|Overall Study|Lost to Follow-up|1|||
44318654|NCT01253200|79322910|FG002|Overall Study|Lost to Follow-up|0|||
44318655|NCT01253200|79322911|FG003|Overall Study|Lost to Follow-up|0|||
44536187|NCT00009737|79546939|FG001|Overall Study|Lack of Efficacy|15|||
44318656|NCT01253200|79322912|FG004|Overall Study|Lost to Follow-up|0|||
44318657|NCT01253200|79322908|FG000|Overall Study|Withdrawal by Subject|2|||
44318658|NCT01253200|79322909|FG001|Overall Study|Withdrawal by Subject|0|||
44318659|NCT01253200|79322910|FG002|Overall Study|Withdrawal by Subject|0|||
44318660|NCT01253200|79322911|FG003|Overall Study|Withdrawal by Subject|0|||
44318661|NCT01253200|79322912|FG004|Overall Study|Withdrawal by Subject|0|||
44318662|NCT01253200|79322908|FG000|Overall Study|Protocol Violation|1|||
44318663|NCT01253200|79322909|FG001|Overall Study|Protocol Violation|4|||
44318664|NCT01253200|79322910|FG002|Overall Study|Protocol Violation|0|||
44318665|NCT01253200|79322911|FG003|Overall Study|Protocol Violation|0|||
44318666|NCT01253200|79322912|FG004|Overall Study|Protocol Violation|5|||
44318667|NCT01253200|79322908|FG000|Overall Study|intents|10|||
44318668|NCT01253200|79322909|FG001|Overall Study|intents|10|||
44318669|NCT01253200|79322910|FG002|Overall Study|intents|1|||
44318670|NCT01253200|79322911|FG003|Overall Study|intents|3|||
44318671|NCT01253200|79322912|FG004|Overall Study|intents|0|||
44318672|NCT01253200|79322908|FG000|Overall Study|Attempts|6|||
44318673|NCT01253200|79322909|FG001|Overall Study|Attempts|4|||
44318674|NCT01253200|79322910|FG002|Overall Study|Attempts|1|||
44318675|NCT01253200|79322911|FG003|Overall Study|Attempts|2|||
44318676|NCT01253200|79322912|FG004|Overall Study|Attempts|0|||
44318677|NCT01253044|79322923|FG000|Overall Study|Lost to Follow-up|38|||
44318678|NCT01253044|79322924|FG001|Overall Study|Lost to Follow-up|29|||
44318679|NCT01252966|79322932|FG000|Overall Study|Lost to Follow-up|16|||
44318680|NCT01252966|79322933|FG001|Overall Study|Lost to Follow-up|10|||
44318681|NCT01252966|79322932|FG000|Overall Study|Withdrawal by Subject|7|||
44318682|NCT01252966|79322933|FG001|Overall Study|Withdrawal by Subject|3|||
44318683|NCT01252810|79322943|FG000|Overall Study|Withdrawal by Subject|4|||
44318684|NCT01252810|79322944|FG001|Overall Study|Withdrawal by Subject|1|||
44318685|NCT01252810|79322943|FG000|Overall Study|Lost to Follow-up|0|||
44318686|NCT01252810|79322944|FG001|Overall Study|Lost to Follow-up|1|||
44318687|NCT01252810|79322943|FG000|Overall Study|Physician Decision|2|||
44318688|NCT01252810|79322944|FG001|Overall Study|Physician Decision|1|||
44318689|NCT01252810|79322943|FG000|Overall Study|Various reasons|8|||
44318690|NCT01252810|79322944|FG001|Overall Study|Various reasons|0|||
44318691|NCT01252186|79322953|FG000|Overall Study|Adverse Event|9|||
44318692|NCT01252186|79322954|FG001|Overall Study|Adverse Event|6|||
44318693|NCT01252186|79322955|FG002|Overall Study|Adverse Event|8|||
44318694|NCT01252186|79322953|FG000|Overall Study|Withdrawal by Subject|2|||
44318695|NCT01252186|79322954|FG001|Overall Study|Withdrawal by Subject|5|||
44318696|NCT01252186|79322955|FG002|Overall Study|Withdrawal by Subject|2|||
44318697|NCT01252186|79322953|FG000|Overall Study|Physician Decision|0|||
44318698|NCT01252186|79322954|FG001|Overall Study|Physician Decision|0|||
44536188|NCT00009737|79546938|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
44536189|NCT00009737|79546939|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
44536190|NCT00009737|79546938|FG000|Overall Study|Other Protocol Violation|1|||
44536191|NCT00009737|79546939|FG001|Overall Study|Other Protocol Violation|0|||
44536192|NCT00009737|79546938|FG000|Overall Study|Refused Treatment|15|||
44536193|NCT00009737|79546939|FG001|Overall Study|Refused Treatment|16|||
44536194|NCT00009737|79546938|FG000|Overall Study|Lost to Follow-up|1|||
44536195|NCT00009737|79546939|FG001|Overall Study|Lost to Follow-up|1|||
44536196|NCT00009737|79546938|FG000|Overall Study|Administrative/Other Reasons|7|||
44536197|NCT00009737|79546939|FG001|Overall Study|Administrative/Other Reasons|1|||
44536198|NCT03417102|79546947|FG000|Overall Study|Adverse Event|0|||
44536199|NCT03417102|79546948|FG001|Overall Study|Adverse Event|1|||
44536200|NCT03417102|79546947|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
44536201|NCT03417102|79546948|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
44536202|NCT03417102|79546947|FG000|Overall Study|Other|0|||
44536203|NCT03417102|79546948|FG001|Overall Study|Other|1|||
44536204|NCT03417024|79546954|FG000|Overall Study|Study Termination prior to follow-up|11|||
44536205|NCT03417024|79546954|FG000|Overall Study|Physician Decision|2|||
44536206|NCT00028769|79546958|FG000|Overall Study|Adverse Event|2|||
44536207|NCT00028769|79546958|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
44318699|NCT01252186|79322955|FG002|Overall Study|Physician Decision|1|||
44318700|NCT01252186|79322953|FG000|Overall Study|Non-compliance|0|||
44318701|NCT01252186|79322954|FG001|Overall Study|Non-compliance|3|||
44318702|NCT01252186|79322955|FG002|Overall Study|Non-compliance|4|||
44318703|NCT01252186|79322953|FG000|Overall Study|Protocol Violation|0|||
44318704|NCT01252186|79322954|FG001|Overall Study|Protocol Violation|0|||
44421229|NCT00802841|79429128|FG001|Overall Study|Disease progression|3|||
44318705|NCT01252186|79322955|FG002|Overall Study|Protocol Violation|1|||
44318706|NCT01252186|79322953|FG000|Overall Study|Pregnancy|2|||
44318707|NCT01252186|79322954|FG001|Overall Study|Pregnancy|2|||
44421230|NCT00802841|79429127|FG000|Overall Study|Withdrawal by Subject|9|||
44318708|NCT01252186|79322955|FG002|Overall Study|Pregnancy|0|||
44318709|NCT01252186|79322953|FG000|Overall Study|Sponsor Request|2|||
44536208|NCT00028769|79546958|FG000|Overall Study|Progression or Death|31|||
44536209|NCT00028769|79546958|FG000|Overall Study|Other - Not Protocol Specified|1|||
44536210|NCT00028769|79546958|FG000|Overall Study|Ineligible|5|||
44536211|NCT00028769|79546958|FG000|Overall Study|Not Analyzable|1|||
44318710|NCT01252186|79322954|FG001|Overall Study|Sponsor Request|1|||
44318711|NCT01252186|79322955|FG002|Overall Study|Sponsor Request|0|||
44421231|NCT00802841|79429128|FG001|Overall Study|Withdrawal by Subject|5|||
44536212|NCT02953314|79546964|FG000|Overall Study|Adverse Event|0|||
44536213|NCT02953314|79546965|FG001|Overall Study|Adverse Event|1|||
44318712|NCT01252186|79322953|FG000|Overall Study|Lost to Follow-up|10|||
44318713|NCT01252186|79322954|FG001|Overall Study|Lost to Follow-up|10|||
44318714|NCT01252186|79322955|FG002|Overall Study|Lost to Follow-up|11|||
44318715|NCT01252186|79322953|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
44318716|NCT01252186|79322954|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
44318717|NCT01252186|79322955|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
44318718|NCT01251952|79322990|FG000|Overall Study|Adverse Event|1|||
44318719|NCT01251367|79322994|FG000|Overall Study|Protocol Violation|1|||
44318720|NCT01251367|79322994|FG000|Overall Study|Lack of Efficacy|2|||
44318721|NCT01251367|79322994|FG000|Overall Study|Adverse Event|19|||
44318722|NCT01251367|79322994|FG000|Overall Study|Withdrawal by Subject|36|||
44318723|NCT01251367|79322994|FG000|Overall Study|Lost to Follow-up|5|||
44318724|NCT01251367|79322994|FG000|Overall Study|Subject Required Alternative Treatment|7|||
44318725|NCT01251367|79322994|FG000|Overall Study|No Study Drug Available|1|||
44318726|NCT01251367|79322994|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
44318727|NCT01251367|79322994|FG000|Overall Study|End of Study Visit Performed in Error|1|||
44318728|NCT01250509|79323000|FG000|Overall Study|Lost to Follow-up|5|||
44318729|NCT01250509|79323001|FG001|Overall Study|Lost to Follow-up|2|||
44318730|NCT01250119|79323009|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
44318731|NCT01250119|79323010|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
44318732|NCT01250119|79323009|FG000|Diagnostic Phase|Participants Not Tested|44|||
44318733|NCT01250119|79323010|FG001|Diagnostic Phase|Participants Not Tested|0|||
44318734|NCT01250119|79323009|FG000|Treatment Phase|Progressive Disease|0|||
44318735|NCT01250119|79323010|FG001|Treatment Phase|Progressive Disease|32|||
44318736|NCT01250119|79323009|FG000|Treatment Phase|Death|0|||
44318737|NCT01250119|79323010|FG001|Treatment Phase|Death|2|||
44318738|NCT01250119|79323009|FG000|Treatment Phase|Withdrawal by Subject|0|||
44318739|NCT01250119|79323010|FG001|Treatment Phase|Withdrawal by Subject|1|||
44318740|NCT01250119|79323009|FG000|Treatment Phase|Adverse Event|0|||
44318741|NCT01250119|79323010|FG001|Treatment Phase|Adverse Event|2|||
44318742|NCT01250119|79323009|FG000|Treatment Phase|Unknown reason|0|||
44318743|NCT01250119|79323010|FG001|Treatment Phase|Unknown reason|4|||
44318744|NCT01250002|79323019|FG000|Overall Study|Change to open surgical procedure|4|||
44318745|NCT01250002|79323020|FG001|Overall Study|Change to open surgical procedure|3|||
44318746|NCT01246960|79323028|FG000|Overall Study|Lost to Follow-up|3|||
44318747|NCT01246960|79323029|FG001|Overall Study|Lost to Follow-up|1|||
44318748|NCT01246960|79323028|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
44318749|NCT01246960|79323029|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
44318750|NCT01244620|79323035|FG000|Overall Study|Study terminated|4|||
44318751|NCT01244620|79323036|FG001|Overall Study|Study terminated|4|||
44318752|NCT01244620|79323037|FG002|Overall Study|Study terminated|4|||
44318753|NCT01244620|79323038|FG003|Overall Study|Study terminated|4|||
44318754|NCT01267201|79323048|FG000|First Intervention Period|Withdrawal by Subject|1|||
44318755|NCT01267201|79323049|FG001|First Intervention Period|Withdrawal by Subject|0|||
44318756|NCT01267201|79323050|FG002|First Intervention Period|Withdrawal by Subject|0|||
44318757|NCT01267201|79323051|FG003|First Intervention Period|Withdrawal by Subject|0|||
44318758|NCT01267201|79323052|FG004|First Intervention Period|Withdrawal by Subject|0|||
44318759|NCT01267201|79323053|FG005|First Intervention Period|Withdrawal by Subject|0|||
44318760|NCT01267201|79323048|FG000|Second Intervention Period|Withdrawal by Subject|0|||
44318761|NCT01267201|79323049|FG001|Second Intervention Period|Withdrawal by Subject|1|||
44318762|NCT01267201|79323050|FG002|Second Intervention Period|Withdrawal by Subject|0|||
44155591|NCT01998958|78946971|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155592|NCT01998958|78946972|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155593|NCT01998958|78946973|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44318763|NCT01267201|79323051|FG003|Second Intervention Period|Withdrawal by Subject|0|||
44318764|NCT01267201|79323052|FG004|Second Intervention Period|Withdrawal by Subject|0|||
44318765|NCT01267201|79323053|FG005|Second Intervention Period|Withdrawal by Subject|0|||
44318766|NCT01266967|79323063|FG000|Overall Study|Death|69|||
44318767|NCT01266967|79323064|FG001|Overall Study|Death|61|||
44318768|NCT01266967|79323063|FG000|Overall Study|Study Closed/Terminated|15|||
44318769|NCT01266967|79323064|FG001|Overall Study|Study Closed/Terminated|17|||
44318770|NCT01266967|79323063|FG000|Overall Study|Lost to Follow-up|2|||
44318771|NCT01266967|79323064|FG001|Overall Study|Lost to Follow-up|1|||
44318772|NCT01266967|79323063|FG000|Overall Study|Physician Decision|0|||
44318773|NCT01266967|79323064|FG001|Overall Study|Physician Decision|1|||
44318774|NCT01266967|79323063|FG000|Overall Study|Withdrawal by Subject|3|||
44318775|NCT01266967|79323064|FG001|Overall Study|Withdrawal by Subject|3|||
44318776|NCT01266850|79323078|FG000|Overall Study|Lost to Follow-up|19|||
44318777|NCT01266850|79323079|FG001|Overall Study|Lost to Follow-up|19|||
44318778|NCT01266850|79323080|FG002|Overall Study|Lost to Follow-up|13|||
44318779|NCT01266850|79323081|FG003|Overall Study|Lost to Follow-up|13|||
44318780|NCT01266850|79323082|FG004|Overall Study|Lost to Follow-up|12|||
44318781|NCT01266850|79323078|FG000|Overall Study|Withdrawal by Subject|8|||
44318782|NCT01266850|79323079|FG001|Overall Study|Withdrawal by Subject|9|||
44318783|NCT01266850|79323080|FG002|Overall Study|Withdrawal by Subject|6|||
44318784|NCT01266850|79323081|FG003|Overall Study|Withdrawal by Subject|9|||
44318785|NCT01266850|79323082|FG004|Overall Study|Withdrawal by Subject|12|||
44318786|NCT01266850|79323078|FG000|Overall Study|Physician Decision|3|||
44318787|NCT01266850|79323079|FG001|Overall Study|Physician Decision|6|||
44318788|NCT01266850|79323080|FG002|Overall Study|Physician Decision|4|||
44318789|NCT01266850|79323081|FG003|Overall Study|Physician Decision|4|||
44318790|NCT01266850|79323082|FG004|Overall Study|Physician Decision|3|||
44318791|NCT01266850|79323078|FG000|Overall Study|Protocol Violation|0|||
44318792|NCT01266850|79323079|FG001|Overall Study|Protocol Violation|1|||
44318793|NCT01266850|79323080|FG002|Overall Study|Protocol Violation|0|||
44318794|NCT01266850|79323081|FG003|Overall Study|Protocol Violation|1|||
44318795|NCT01266850|79323082|FG004|Overall Study|Protocol Violation|2|||
44318796|NCT01266850|79323078|FG000|Overall Study|Adverse Event|0|||
44318797|NCT01266850|79323079|FG001|Overall Study|Adverse Event|0|||
44318798|NCT01266850|79323080|FG002|Overall Study|Adverse Event|0|||
44318799|NCT01266850|79323081|FG003|Overall Study|Adverse Event|0|||
44318800|NCT01266850|79323082|FG004|Overall Study|Adverse Event|1|||
44318801|NCT01266850|79323078|FG000|Overall Study|Site Closure|0|||
44318802|NCT01266850|79323079|FG001|Overall Study|Site Closure|1|||
44318803|NCT01266850|79323080|FG002|Overall Study|Site Closure|1|||
44318804|NCT01266850|79323081|FG003|Overall Study|Site Closure|1|||
44318805|NCT01266850|79323082|FG004|Overall Study|Site Closure|0|||
44318806|NCT01266460|79323094|FG000|Overall Study|Adverse Event|3|||
44318807|NCT01266460|79323094|FG000|Overall Study|Withdrawal by Subject|5|||
44318808|NCT01266460|79323094|FG000|Overall Study|Disease Progression|18|||
44318809|NCT01266460|79323094|FG000|Overall Study|Not otherwise specified|8|||
44318810|NCT01266265|79323100|FG000|Overall Study|Death|95|||
44318811|NCT01266265|79323101|FG001|Overall Study|Death|73|||
44318812|NCT01266265|79323100|FG000|Overall Study|Lost to Follow-up|23|||
44318813|NCT01266265|79323101|FG001|Overall Study|Lost to Follow-up|28|||
44318814|NCT01266265|79323100|FG000|Overall Study|Withdrawal by Subject|13|||
44318815|NCT01266265|79323101|FG001|Overall Study|Withdrawal by Subject|11|||
44318816|NCT01266265|79323100|FG000|Overall Study|Respiratory-related adverse event|2|||
44318817|NCT01266265|79323101|FG001|Overall Study|Respiratory-related adverse event|1|||
44318818|NCT01266265|79323100|FG000|Overall Study|Transferred care to another provider|22|||
44318819|NCT01266265|79323101|FG001|Overall Study|Transferred care to another provider|28|||
44318820|NCT01266265|79323100|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
44318821|NCT01266265|79323101|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
44318822|NCT01266265|79323100|FG000|Overall Study|Enrolled in another clinical study|15|||
44318823|NCT01266265|79323101|FG001|Overall Study|Enrolled in another clinical study|26|||
44318824|NCT01266265|79323100|FG000|Overall Study|Non-compliance|8|||
44318825|NCT01266265|79323101|FG001|Overall Study|Non-compliance|5|||
44318826|NCT01266265|79323100|FG000|Overall Study|Lung transplant|6|||
44318827|NCT01266265|79323101|FG001|Overall Study|Lung transplant|5|||
44318828|NCT01266265|79323100|FG000|Overall Study|Site closed early|4|||
44318829|NCT01266265|79323101|FG001|Overall Study|Site closed early|3|||
44318830|NCT01266265|79323100|FG000|Overall Study|Clinical worsening|1|||
44318831|NCT01266265|79323101|FG001|Overall Study|Clinical worsening|1|||
44318832|NCT01266148|79323126|FG000|Overall Study|Adverse Event|2|||
44318833|NCT01266148|79323127|FG001|Overall Study|Adverse Event|0|||
44318834|NCT01266148|79323126|FG000|Overall Study|Ongoing rejection|1|||
44318835|NCT01266148|79323127|FG001|Overall Study|Ongoing rejection|0|||
44318836|NCT01266148|79323126|FG000|Overall Study|2 2R rejections|1|||
44318837|NCT01266148|79323127|FG001|Overall Study|2 2R rejections|0|||
44318838|NCT01266148|79323126|FG000|Overall Study|Death|2|||
44318839|NCT01266148|79323127|FG001|Overall Study|Death|3|||
44318840|NCT01266148|79323126|FG000|Overall Study|missing mGFR value + AE|1|||
44421232|NCT00802841|79429127|FG000|Overall Study|Protocol deviation|2|||
44421233|NCT00802841|79429128|FG001|Overall Study|Protocol deviation|6|||
44421234|NCT00802841|79429127|FG000|Overall Study|Treatment duration completed|66|||
44421235|NCT00802841|79429128|FG001|Overall Study|Treatment duration completed|76|||
44421236|NCT00772148|79429138|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
44318841|NCT01266148|79323127|FG001|Overall Study|missing mGFR value + AE|0|||
44318842|NCT01266070|79323133|FG000|Overall Study|Adverse Event|3|||
44318843|NCT01266070|79323133|FG000|Overall Study|Protocol Violation|1|||
44318844|NCT01265992|79323137|FG000|Overall Study|Lost to Follow-up|1|||
44421237|NCT00772148|79429139|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
44421238|NCT00772148|79429138|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
44421239|NCT00772148|79429139|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
44318845|NCT01265992|79323137|FG000|Overall Study|Withdrawal by Subject|1|||
44318846|NCT01265992|79323137|FG000|Overall Study|Adverse Event|1|||
44318847|NCT01265992|79323137|FG000|Overall Study|Administrative reasons|2|||
44318848|NCT01265992|79323137|FG000|Overall Study|Stopped treatment|3|||
44318849|NCT01265992|79323137|FG000|Overall Study|Did not receive treatment|1|||
44318850|NCT01265953|79323143|FG000|Overall Study|Non compliance|5|||
44318851|NCT01265953|79323144|FG001|Overall Study|Non compliance|3|||
44318852|NCT01265875|79323150|FG000|Overall Study|Uncooperative/unreliable|1|||
44318853|NCT01265797|79323157|FG000|Run-in Month|Withdrawal by Subject|0|||
44318854|NCT01265797|79323158|FG001|Run-in Month|Withdrawal by Subject|4|||
44318855|NCT01265797|79323157|FG000|Run-in Month|1st seizure during run-in month|0|||
44318856|NCT01265797|79323158|FG001|Run-in Month|1st seizure during run-in month|1|||
44318857|NCT01265797|79323157|FG000|Blinded Month|Lack of Efficacy|5|||
44318858|NCT01265797|79323158|FG001|Blinded Month|Lack of Efficacy|0|||
44318859|NCT01265797|79323157|FG000|Blinded Month|Lost to Follow-up|1|||
44318860|NCT01265797|79323158|FG001|Blinded Month|Lost to Follow-up|0|||
44318861|NCT01265797|79323157|FG000|Blinded Month|Protocol Violation|2|||
44318862|NCT01265797|79323158|FG001|Blinded Month|Protocol Violation|1|||
44318863|NCT01265797|79323157|FG000|Blinded Month|Adverse Event|2|||
44318864|NCT01265797|79323158|FG001|Blinded Month|Adverse Event|0|||
44318865|NCT01265797|79323157|FG000|Blinded Month|Diary data incomplete|0|||
44318866|NCT01265797|79323158|FG001|Blinded Month|Diary data incomplete|1|||
44318867|NCT01265797|79323157|FG000|Open Label Month|Lost to Follow-up|0|||
44318868|NCT01265797|79323158|FG001|Open Label Month|Lost to Follow-up|1|||
44318869|NCT01265719|79323168|FG000|Overall Study|Does not meet entrance criteria|0|||
44318870|NCT01265719|79323169|FG001|Overall Study|Does not meet entrance criteria|3|||
44318871|NCT01265719|79323168|FG000|Overall Study|Other reasons|2|||
44318872|NCT01265719|79323169|FG001|Overall Study|Other reasons|0|||
44318873|NCT01265719|79323168|FG000|Overall Study|Withdrawal by Subject|8|||
44318874|NCT01265719|79323169|FG001|Overall Study|Withdrawal by Subject|3|||
44318875|NCT01265719|79323168|FG000|Overall Study|Lost to Follow-up|2|||
44318876|NCT01265719|79323169|FG001|Overall Study|Lost to Follow-up|7|||
44318877|NCT01265719|79323168|FG000|Overall Study|Adverse Event|2|||
44318878|NCT01265719|79323169|FG001|Overall Study|Adverse Event|0|||
44318879|NCT01265563|79323201|FG000|Overall Study|Withdrawal by Subject|0|||
44318880|NCT01265563|79323202|FG001|Overall Study|Withdrawal by Subject|1|||
44318881|NCT01265563|79323203|FG002|Overall Study|Withdrawal by Subject|1|||
44318882|NCT01265563|79323204|FG003|Overall Study|Withdrawal by Subject|0|||
44318883|NCT01265563|79323205|FG004|Overall Study|Withdrawal by Subject|2|||
44318884|NCT01265056|79323224|FG000|Initial Study Period|Withdrawal by Subject|1|||
44318885|NCT01265056|79323225|FG001|Initial Study Period|Withdrawal by Subject|1|||
44318886|NCT01265056|79323224|FG000|Initial Study Period|Withdrawal by Subject|1|||
44318887|NCT01265056|79323225|FG001|Initial Study Period|Withdrawal by Subject|1|||
44318888|NCT01265056|79323224|FG000|Follow up|Lost to Follow-up|7|||
44318889|NCT01265056|79323225|FG001|Follow up|Lost to Follow-up|3|||
44318890|NCT01264939|79323233|FG000|Overall Study|Adverse Event|1|||
44318891|NCT01264939|79323234|FG001|Overall Study|Adverse Event|3|||
44318892|NCT01264939|79323233|FG000|Overall Study|Lost to Follow-up|0|||
44318893|NCT01264939|79323234|FG001|Overall Study|Lost to Follow-up|3|||
44318894|NCT01264939|79323233|FG000|Overall Study|Physician Decision|1|||
44318895|NCT01264939|79323234|FG001|Overall Study|Physician Decision|1|||
44318896|NCT01264939|79323233|FG000|Overall Study|Patient/Guardian Decision|8|||
44318897|NCT01264939|79323234|FG001|Overall Study|Patient/Guardian Decision|10|||
44318898|NCT01264939|79323233|FG000|Overall Study|Disease Progression|8|||
44318899|NCT01264939|79323234|FG001|Overall Study|Disease Progression|11|||
44318900|NCT01264081|79323240|FG000|Participants Screened|Screening failures|30|||
44318901|NCT01264081|79323240|FG000|Started Treatment|Withdrawal by Subject|1|||
44318902|NCT01264081|79323240|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
44318903|NCT01263925|79323246|FG000|Overall Study|Protocol Violation|1|||
44318904|NCT01263925|79323247|FG001|Overall Study|Protocol Violation|0|||
44318905|NCT01263925|79323246|FG000|Overall Study|Lack of Efficacy|0|||
44318906|NCT01263925|79323247|FG001|Overall Study|Lack of Efficacy|1|||
44318907|NCT01263925|79323246|FG000|Overall Study|Adverse Event|23|||
44318908|NCT01263925|79323247|FG001|Overall Study|Adverse Event|22|||
44318909|NCT01263925|79323246|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
44318910|NCT01263925|79323247|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
44318911|NCT01263925|79323246|FG000|Overall Study|Withdrawal by Subject|6|||
44318912|NCT01263925|79323247|FG001|Overall Study|Withdrawal by Subject|8|||
44318913|NCT01263925|79323246|FG000|Overall Study|Other|4|||
44318914|NCT01263925|79323247|FG001|Overall Study|Other|4|||
44318915|NCT01263925|79323246|FG000|Overall Study|Lost to Follow-up|3|||
44318916|NCT01263925|79323247|FG001|Overall Study|Lost to Follow-up|1|||
44318917|NCT01263925|79323246|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
44318918|NCT01263925|79323247|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
44318919|NCT01263925|79323246|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
44318920|NCT01263925|79323247|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
44318921|NCT01263925|79323246|FG000|Overall Study|AE/ Withdrawal|1|||
44318922|NCT01263925|79323247|FG001|Overall Study|AE/ Withdrawal|4|||
44318923|NCT01263925|79323246|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
44318924|NCT01263925|79323247|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
44318925|NCT01263925|79323246|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
44318926|NCT01263925|79323247|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
44318927|NCT01263925|79323246|FG000|Overall Study|Withdrawal/ Not specified|0|||
44318928|NCT01263925|79323247|FG001|Overall Study|Withdrawal/ Not specified|1|||
44318929|NCT01263691|79323259|FG000|Overall Study|Lost to Follow-up|1|||
44318930|NCT01263691|79323260|FG001|Overall Study|Lost to Follow-up|0|||
44318931|NCT01263691|79323261|FG002|Overall Study|Lost to Follow-up|1|||
44318932|NCT01263691|79323262|FG003|Overall Study|Lost to Follow-up|1|||
44318933|NCT01263691|79323263|FG004|Overall Study|Lost to Follow-up|0|||
44318934|NCT01263691|79323264|FG005|Overall Study|Lost to Follow-up|0|||
44318935|NCT01263691|79323259|FG000|Overall Study|Withdrawal by Subject|1|||
44318936|NCT01263691|79323260|FG001|Overall Study|Withdrawal by Subject|0|||
44318937|NCT01263691|79323261|FG002|Overall Study|Withdrawal by Subject|0|||
44318938|NCT01263691|79323262|FG003|Overall Study|Withdrawal by Subject|0|||
44318939|NCT01263691|79323263|FG004|Overall Study|Withdrawal by Subject|0|||
44318940|NCT01263691|79323264|FG005|Overall Study|Withdrawal by Subject|0|||
44318941|NCT01263691|79323259|FG000|Overall Study|Adverse Event|1|||
44318942|NCT01263691|79323260|FG001|Overall Study|Adverse Event|0|||
44318943|NCT01263691|79323261|FG002|Overall Study|Adverse Event|0|||
44318944|NCT01263691|79323262|FG003|Overall Study|Adverse Event|0|||
44318945|NCT01263691|79323263|FG004|Overall Study|Adverse Event|0|||
44318946|NCT01263691|79323264|FG005|Overall Study|Adverse Event|0|||
44318947|NCT01263496|79323341|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
44318948|NCT01263496|79323342|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318949|NCT01263496|79323343|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318950|NCT01263496|79323344|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318951|NCT01263496|79323345|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318952|NCT01263496|79323346|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318953|NCT01263496|79323347|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318954|NCT01263496|79323348|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318955|NCT01263496|79323349|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
44318956|NCT01263496|79323341|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318957|NCT01263496|79323342|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318958|NCT01263496|79323343|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318959|NCT01263496|79323344|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
44318960|NCT01263496|79323345|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
44318961|NCT01263496|79323346|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318962|NCT01263496|79323347|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318963|NCT01263496|79323348|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318964|NCT01263496|79323349|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
44318965|NCT01263496|79323341|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
44318966|NCT01263496|79323342|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
44318967|NCT01263496|79323343|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
44318968|NCT01263496|79323344|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
44318969|NCT01263496|79323345|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
44318970|NCT01263496|79323346|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
44318971|NCT01263496|79323347|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
44318972|NCT01263496|79323348|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
44318973|NCT01263496|79323349|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
44318974|NCT01263496|79323341|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318975|NCT01263496|79323342|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
44318976|NCT01263496|79323343|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318977|NCT01263496|79323344|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318978|NCT01263496|79323345|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318979|NCT01263496|79323346|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318980|NCT01263496|79323347|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318981|NCT01263496|79323348|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318982|NCT01263496|79323349|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
44318983|NCT01263496|79323341|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44318984|NCT01263496|79323342|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44318985|NCT01263496|79323343|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44318986|NCT01263496|79323344|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44318987|NCT01263496|79323345|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
44318988|NCT01263496|79323346|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44318989|NCT01263496|79323347|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44318990|NCT01263496|79323348|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44318991|NCT01263496|79323349|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44318992|NCT01263496|79323341|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
44318993|NCT01263496|79323342|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
44318994|NCT01263496|79323343|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
44318995|NCT01263496|79323344|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
44318996|NCT01263496|79323345|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
44318997|NCT01263496|79323346|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
44318998|NCT01263496|79323347|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
44318999|NCT01263496|79323348|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
44319000|NCT01263496|79323349|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
44319001|NCT01263496|79323341|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319002|NCT01263496|79323342|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319003|NCT01263496|79323343|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319004|NCT01263496|79323344|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319005|NCT01263496|79323345|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319006|NCT01263496|79323346|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319007|NCT01263496|79323347|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319008|NCT01263496|79323348|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
44319009|NCT01263496|79323349|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44319010|NCT01263223|79323361|FG000|Period 2|Withdrawal by Subject|0|||
44319011|NCT01263223|79323362|FG001|Period 2|Withdrawal by Subject|1|||
44319012|NCT01263223|79323361|FG000|7-day Follow-up|Withdrawal by Subject|0|||
44319013|NCT01263223|79323362|FG001|7-day Follow-up|Withdrawal by Subject|1|||
44319014|NCT01263223|79323361|FG000|7-day Follow-up|Lost to Follow-up|1|||
44319015|NCT01263223|79323362|FG001|7-day Follow-up|Lost to Follow-up|0|||
44319016|NCT01263106|79323371|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
44319017|NCT01263106|79323372|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
44319018|NCT01263028|79323381|FG000|Overall Study|Withdrawal by Subject|1|||
44319019|NCT01263028|79323381|FG000|Overall Study|Adverse Event|1|||
44319020|NCT01263028|79323381|FG000|Overall Study|Study terminated due to low enrollment.|4|||
44319021|NCT01262989|79323385|FG000|Period 1|Lost to Follow-up|1|||
44319022|NCT01262989|79323386|FG001|Period 1|Lost to Follow-up|1|||
44319023|NCT01262989|79323385|FG000|Period 1|Intercurrent disease|0|||
44319024|NCT01262989|79323386|FG001|Period 1|Intercurrent disease|1|||
44319025|NCT01262989|79323385|FG000|Period 1|Positive answer for exclusion criteria|0|||
44319026|NCT01262989|79323386|FG001|Period 1|Positive answer for exclusion criteria|1|||
44319027|NCT01262989|79323385|FG000|Period 2|Intercurrent disease|0|||
44319028|NCT01262989|79323386|FG001|Period 2|Intercurrent disease|1|||
44319029|NCT01262872|79323400|FG000|Step 2|Death|0|||
44319030|NCT01262872|79323401|FG001|Step 2|Death|0|||
44319031|NCT01262872|79323402|FG002|Step 2|Death|0|||
44319032|NCT01262872|79323403|FG003|Step 2|Death|1|||
44319033|NCT01262872|79323404|FG004|Step 2|Death|0|||
44319034|NCT01262872|79323405|FG005|Step 2|Death|2|||
44319035|NCT01262872|79323406|FG006|Step 2|Death|2|||
44319036|NCT01262872|79323407|FG007|Step 2|Death|1|||
44319037|NCT01262872|79323400|FG000|Step 2|Protocol Violation|0|||
44319038|NCT01262872|79323401|FG001|Step 2|Protocol Violation|0|||
44319039|NCT01262872|79323402|FG002|Step 2|Protocol Violation|1|||
44319040|NCT01262872|79323403|FG003|Step 2|Protocol Violation|0|||
44319041|NCT01262872|79323404|FG004|Step 2|Protocol Violation|0|||
44319042|NCT01262872|79323405|FG005|Step 2|Protocol Violation|0|||
44319043|NCT01262872|79323406|FG006|Step 2|Protocol Violation|3|||
44319044|NCT01262872|79323407|FG007|Step 2|Protocol Violation|1|||
44319045|NCT01262872|79323400|FG000|Step 2|Withdrawal by Subject|0|||
44319046|NCT01262872|79323401|FG001|Step 2|Withdrawal by Subject|0|||
44319047|NCT01262872|79323402|FG002|Step 2|Withdrawal by Subject|4|||
44319048|NCT01262872|79323403|FG003|Step 2|Withdrawal by Subject|6|||
44319049|NCT01262872|79323404|FG004|Step 2|Withdrawal by Subject|3|||
44319050|NCT01262872|79323405|FG005|Step 2|Withdrawal by Subject|1|||
44319051|NCT01262872|79323406|FG006|Step 2|Withdrawal by Subject|2|||
44319052|NCT01262872|79323407|FG007|Step 2|Withdrawal by Subject|1|||
44319053|NCT01262872|79323400|FG000|Step 2|Migrated/moved from study area|0|||
44319054|NCT01262872|79323401|FG001|Step 2|Migrated/moved from study area|0|||
44319055|NCT01262872|79323402|FG002|Step 2|Migrated/moved from study area|4|||
44319056|NCT01262872|79323403|FG003|Step 2|Migrated/moved from study area|3|||
44319057|NCT01262872|79323404|FG004|Step 2|Migrated/moved from study area|2|||
44319058|NCT01262872|79323405|FG005|Step 2|Migrated/moved from study area|6|||
44319059|NCT01262872|79323406|FG006|Step 2|Migrated/moved from study area|2|||
44319060|NCT01262872|79323407|FG007|Step 2|Migrated/moved from study area|3|||
44319061|NCT01262677|79323444|FG000|Overall Study|Does not meet entrance criteria|0|||
44319062|NCT01262677|79323445|FG001|Overall Study|Does not meet entrance criteria|2|||
44319063|NCT01262677|79323446|FG002|Overall Study|Does not meet entrance criteria|0|||
44319064|NCT01262677|79323444|FG000|Overall Study|Insufficient clinical response|0|||
44319065|NCT01262677|79323445|FG001|Overall Study|Insufficient clinical response|0|||
44319066|NCT01262677|79323446|FG002|Overall Study|Insufficient clinical response|1|||
44319067|NCT01262677|79323444|FG000|Overall Study|Lost to Follow-up|1|||
44319068|NCT01262677|79323445|FG001|Overall Study|Lost to Follow-up|0|||
44319069|NCT01262677|79323446|FG002|Overall Study|Lost to Follow-up|2|||
44319070|NCT01262677|79323444|FG000|Overall Study|No longer willing to participate|3|||
44319071|NCT01262677|79323445|FG001|Overall Study|No longer willing to participate|3|||
44319072|NCT01262677|79323446|FG002|Overall Study|No longer willing to participate|2|||
44319073|NCT01262677|79323444|FG000|Overall Study|Reason not provided|2|||
44319074|NCT01262677|79323445|FG001|Overall Study|Reason not provided|1|||
44319075|NCT01262677|79323446|FG002|Overall Study|Reason not provided|3|||
44319076|NCT01262677|79323444|FG000|Overall Study|Protocol Violation|0|||
44319077|NCT01262677|79323445|FG001|Overall Study|Protocol Violation|1|||
44319078|NCT01262677|79323446|FG002|Overall Study|Protocol Violation|1|||
44319079|NCT01262677|79323444|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
44319080|NCT01262677|79323445|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
44319081|NCT01262677|79323446|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
44319082|NCT01262638|79323458|FG000|Overall Study|Adverse Event|3|||
44319083|NCT01262638|79323459|FG001|Overall Study|Adverse Event|4|||
44319084|NCT01262638|79323460|FG002|Overall Study|Adverse Event|3|||
44319085|NCT01262638|79323461|FG003|Overall Study|Adverse Event|4|||
44319086|NCT01262638|79323458|FG000|Overall Study|Protocol Violation|1|||
44319087|NCT01262638|79323459|FG001|Overall Study|Protocol Violation|0|||
44319088|NCT01262638|79323460|FG002|Overall Study|Protocol Violation|0|||
44319089|NCT01262638|79323461|FG003|Overall Study|Protocol Violation|1|||
44319090|NCT01262638|79323458|FG000|Overall Study|Withdrawal by Subject|2|||
44319091|NCT01262638|79323459|FG001|Overall Study|Withdrawal by Subject|1|||
44319092|NCT01262638|79323460|FG002|Overall Study|Withdrawal by Subject|0|||
44319093|NCT01262638|79323461|FG003|Overall Study|Withdrawal by Subject|1|||
44319094|NCT01262638|79323458|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
44319095|NCT01262638|79323459|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
44319096|NCT01262638|79323460|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
44319097|NCT01262638|79323461|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
44319098|NCT01262638|79323458|FG000|Overall Study|Lost to Follow-up|1|||
44319099|NCT01262638|79323459|FG001|Overall Study|Lost to Follow-up|1|||
44319100|NCT01262638|79323460|FG002|Overall Study|Lost to Follow-up|1|||
44319101|NCT01262638|79323461|FG003|Overall Study|Lost to Follow-up|1|||
44319102|NCT01262638|79323458|FG000|Overall Study|Participant Went Out of Town|0|||
44319103|NCT01262638|79323459|FG001|Overall Study|Participant Went Out of Town|0|||
44319104|NCT01262638|79323460|FG002|Overall Study|Participant Went Out of Town|1|||
44319105|NCT01262638|79323461|FG003|Overall Study|Participant Went Out of Town|0|||
44319106|NCT01262560|79323477|FG000|Overall Study|Protocol Violation|0|||
44319107|NCT01262560|79323478|FG001|Overall Study|Protocol Violation|1|||
44319108|NCT01262560|79323479|FG002|Overall Study|Protocol Violation|2|||
44319109|NCT01262365|79323490|FG000|Overall Study|Lack of Efficacy|35|||
44319110|NCT01262365|79323491|FG001|Overall Study|Lack of Efficacy|30|||
44319111|NCT01262365|79323492|FG002|Overall Study|Lack of Efficacy|47|||
44319112|NCT01262365|79323490|FG000|Overall Study|Protocol Violation|3|||
44319113|NCT01262365|79323491|FG001|Overall Study|Protocol Violation|1|||
44319114|NCT01262365|79323492|FG002|Overall Study|Protocol Violation|1|||
44319115|NCT01262365|79323490|FG000|Overall Study|Lost to Follow-up|3|||
44319116|NCT01262365|79323491|FG001|Overall Study|Lost to Follow-up|7|||
44319117|NCT01262365|79323492|FG002|Overall Study|Lost to Follow-up|6|||
44319118|NCT01262365|79323490|FG000|Overall Study|Withdrawal by Subject|17|||
44319119|NCT01262365|79323491|FG001|Overall Study|Withdrawal by Subject|22|||
44319120|NCT01262365|79323492|FG002|Overall Study|Withdrawal by Subject|22|||
44319121|NCT01262365|79323490|FG000|Overall Study|Death|1|||
44319122|NCT01262365|79323491|FG001|Overall Study|Death|2|||
44319123|NCT01262365|79323492|FG002|Overall Study|Death|1|||
44319124|NCT01262365|79323490|FG000|Overall Study|Adverse Event|26|||
44319125|NCT01262365|79323491|FG001|Overall Study|Adverse Event|16|||
44319126|NCT01262365|79323492|FG002|Overall Study|Adverse Event|11|||
44319127|NCT01262365|79323490|FG000|Overall Study|sponsor decision|1|||
44319128|NCT01262365|79323491|FG001|Overall Study|sponsor decision|1|||
44319129|NCT01262365|79323492|FG002|Overall Study|sponsor decision|0|||
44319130|NCT01262365|79323490|FG000|Overall Study|Randomization error|1|||
44319131|NCT01262365|79323491|FG001|Overall Study|Randomization error|0|||
44319132|NCT01262365|79323492|FG002|Overall Study|Randomization error|2|||
44319133|NCT01262365|79323490|FG000|Overall Study|Non-compliance|1|||
44319134|NCT01262365|79323491|FG001|Overall Study|Non-compliance|0|||
44319135|NCT01262365|79323492|FG002|Overall Study|Non-compliance|2|||
44319136|NCT01262365|79323490|FG000|Overall Study|Suspected pregnancy|1|||
44319137|NCT01262365|79323491|FG001|Overall Study|Suspected pregnancy|0|||
44319138|NCT01262365|79323492|FG002|Overall Study|Suspected pregnancy|0|||
44319139|NCT01262365|79323490|FG000|Overall Study|Patient pregnant|1|||
44319140|NCT01262365|79323491|FG001|Overall Study|Patient pregnant|0|||
44319141|NCT01262365|79323492|FG002|Overall Study|Patient pregnant|1|||
44319142|NCT01262365|79323490|FG000|Overall Study|Toxicity related to study drug|0|||
44319143|NCT01262365|79323491|FG001|Overall Study|Toxicity related to study drug|1|||
44319144|NCT01262365|79323492|FG002|Overall Study|Toxicity related to study drug|0|||
44319145|NCT01262365|79323490|FG000|Overall Study|Cannot tolerate the protocol|0|||
44319146|NCT01262365|79323491|FG001|Overall Study|Cannot tolerate the protocol|1|||
44319147|NCT01262365|79323492|FG002|Overall Study|Cannot tolerate the protocol|0|||
44319148|NCT01262365|79323490|FG000|Overall Study|Patient unavailable|0|||
44319149|NCT01262365|79323491|FG001|Overall Study|Patient unavailable|0|||
44319150|NCT01262365|79323492|FG002|Overall Study|Patient unavailable|1|||
44319151|NCT03932812|79323502|FG000|Overall Study|Lost to Follow-up|12|||
44319152|NCT03932812|79323503|FG001|Overall Study|Lost to Follow-up|14|||
44319153|NCT03932812|79323502|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
44319154|NCT03932812|79323503|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
44319155|NCT01262287|79323512|FG000|Overall Study|Lost to Follow-up|2|||
44319156|NCT01262287|79323513|FG001|Overall Study|Lost to Follow-up|1|||
44319157|NCT01262092|79323525|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
44319158|NCT01262092|79323526|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
44319159|NCT01262092|79323525|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
44319160|NCT01262092|79323526|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
44319161|NCT01262092|79323525|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
44319162|NCT01262092|79323526|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
44319163|NCT01262092|79323525|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
44319164|NCT01262092|79323526|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
44319165|NCT01261975|79323532|FG000|Overall Study|Surgical complication|1|||
44319166|NCT01261780|79323541|FG000|Overall Study|Withdrawal by Subject|1|||
44319167|NCT01261780|79323542|FG001|Overall Study|Withdrawal by Subject|0|||
44319168|NCT01261780|79323541|FG000|Overall Study|Event not related to subject|1|||
44319169|NCT01261780|79323542|FG001|Overall Study|Event not related to subject|2|||
44319170|NCT01261624|79323550|FG000|Week 0 to Week 12|Disease Progression|1|||
44319171|NCT01261624|79323551|FG001|Week 0 to Week 12|Disease Progression|1|||
44319172|NCT01261624|79323550|FG000|Week 0 to Week 12|Insufficient Response|0|||
44319173|NCT01261624|79323551|FG001|Week 0 to Week 12|Insufficient Response|2|||
44319174|NCT01261624|79323550|FG000|Week 13 to Week 24|Insufficient Response|0|||
44319175|NCT01261624|79323551|FG001|Week 13 to Week 24|Insufficient Response|1|||
44319184|NCT01261390|79323576|FG000|Overall Study|Significant Concurrent Illness|1|||
44319185|NCT01261390|79323577|FG001|Overall Study|Significant Concurrent Illness|0|||
44319186|NCT01261390|79323578|FG002|Overall Study|Significant Concurrent Illness|1|||
44319187|NCT01261390|79323579|FG003|Overall Study|Significant Concurrent Illness|0|||
44319188|NCT01261390|79323576|FG000|Overall Study|Dissatisfaction with Treatment|2|||
44319189|NCT01261390|79323577|FG001|Overall Study|Dissatisfaction with Treatment|1|||
44319190|NCT01261390|79323578|FG002|Overall Study|Dissatisfaction with Treatment|1|||
44319191|NCT01261390|79323579|FG003|Overall Study|Dissatisfaction with Treatment|2|||
44319192|NCT01261390|79323576|FG000|Overall Study|Relocation|0|||
44536214|NCT02953314|79546964|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
44536215|NCT02953314|79546965|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
44536216|NCT03402750|79546973|FG000|Overall Study|Lost to Follow-up|2|||
44319193|NCT01261390|79323577|FG001|Overall Study|Relocation|1|||
44319194|NCT01261390|79323578|FG002|Overall Study|Relocation|0|||
44319195|NCT01261390|79323579|FG003|Overall Study|Relocation|0|||
44536217|NCT03402750|79546974|FG001|Overall Study|Lost to Follow-up|1|||
44319196|NCT01261390|79323576|FG000|Overall Study|Loss of Interest in the Study|3|||
44319197|NCT01261390|79323577|FG001|Overall Study|Loss of Interest in the Study|1|||
44319198|NCT01261390|79323578|FG002|Overall Study|Loss of Interest in the Study|0|||
44319199|NCT01261390|79323579|FG003|Overall Study|Loss of Interest in the Study|0|||
44319200|NCT01261390|79323576|FG000|Overall Study|Lost to Follow-up|1|||
44319201|NCT01261390|79323577|FG001|Overall Study|Lost to Follow-up|6|||
44319202|NCT01261390|79323578|FG002|Overall Study|Lost to Follow-up|5|||
44319203|NCT01261390|79323579|FG003|Overall Study|Lost to Follow-up|6|||
44319204|NCT03391882|79323600|FG000|Study Overall|Adverse Event|3|||
44319205|NCT03391882|79323601|FG001|Study Overall|Adverse Event|6|||
44319206|NCT03391882|79323602|FG002|Study Overall|Adverse Event|1|||
44319207|NCT03391882|79323603|FG003|Study Overall|Adverse Event|1|||
44319208|NCT03391882|79323604|FG004|Study Overall|Adverse Event|3|||
44319209|NCT03391882|79323605|FG005|Study Overall|Adverse Event|1|||
44319210|NCT03391882|79323600|FG000|Study Overall|Lack of Efficacy|13|||
44319211|NCT03391882|79323601|FG001|Study Overall|Lack of Efficacy|9|||
44319212|NCT03391882|79323602|FG002|Study Overall|Lack of Efficacy|0|||
44319213|NCT03391882|79323603|FG003|Study Overall|Lack of Efficacy|0|||
44319214|NCT03391882|79323604|FG004|Study Overall|Lack of Efficacy|0|||
44319215|NCT03391882|79323605|FG005|Study Overall|Lack of Efficacy|0|||
44319216|NCT03391882|79323600|FG000|Study Overall|Withdrawal by Subject|3|||
44319217|NCT03391882|79323601|FG001|Study Overall|Withdrawal by Subject|3|||
44319218|NCT03391882|79323602|FG002|Study Overall|Withdrawal by Subject|2|||
44319219|NCT03391882|79323603|FG003|Study Overall|Withdrawal by Subject|2|||
44319220|NCT03391882|79323604|FG004|Study Overall|Withdrawal by Subject|1|||
44319221|NCT03391882|79323605|FG005|Study Overall|Withdrawal by Subject|3|||
44319222|NCT03391882|79323600|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
44319223|NCT03391882|79323601|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
44319224|NCT03391882|79323602|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
44319225|NCT03391882|79323603|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
44319226|NCT03391882|79323604|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
44319227|NCT03391882|79323605|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
44319228|NCT03391882|79323600|FG000|Study Overall|Protocol Violation|1|||
44319229|NCT03391882|79323601|FG001|Study Overall|Protocol Violation|0|||
44319230|NCT03391882|79323602|FG002|Study Overall|Protocol Violation|0|||
44319231|NCT03391882|79323603|FG003|Study Overall|Protocol Violation|0|||
44319232|NCT03391882|79323604|FG004|Study Overall|Protocol Violation|0|||
44319233|NCT03391882|79323605|FG005|Study Overall|Protocol Violation|0|||
44319234|NCT03391882|79323600|FG000|Part A - Titration Phase|Adverse Event|3|||
44319235|NCT03391882|79323601|FG001|Part A - Titration Phase|Adverse Event|6|||
44319236|NCT03391882|79323602|FG002|Part A - Titration Phase|Adverse Event|0|||
44319237|NCT03391882|79323603|FG003|Part A - Titration Phase|Adverse Event|0|||
44319238|NCT03391882|79323604|FG004|Part A - Titration Phase|Adverse Event|0|||
44319239|NCT03391882|79323605|FG005|Part A - Titration Phase|Adverse Event|0|||
44319240|NCT03391882|79323600|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
44319241|NCT03391882|79323601|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
44319242|NCT03391882|79323602|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
44319243|NCT03391882|79323603|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
44319244|NCT03391882|79323604|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
44319245|NCT03391882|79323605|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
44319246|NCT03391882|79323600|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
44319247|NCT03391882|79323601|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
44319248|NCT03391882|79323602|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
44319249|NCT03391882|79323603|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
44319250|NCT03391882|79323604|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
44319251|NCT03391882|79323605|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
44319252|NCT03391882|79323600|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
44319253|NCT03391882|79323601|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
44319254|NCT03391882|79323602|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
44319255|NCT03391882|79323603|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
44319256|NCT03391882|79323604|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
44319257|NCT03391882|79323605|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
44319258|NCT03391882|79323600|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
44319259|NCT03391882|79323601|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
44319260|NCT03391882|79323602|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
44421240|NCT00772148|79429138|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
44421241|NCT00772148|79429139|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
44319261|NCT03391882|79323603|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
44319262|NCT03391882|79323604|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
44319263|NCT03391882|79323605|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
44319264|NCT03391882|79323600|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
44319265|NCT03391882|79323601|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
44319266|NCT03391882|79323602|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
44319267|NCT03391882|79323603|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
44319268|NCT03391882|79323604|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
44319269|NCT03391882|79323605|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
44319270|NCT03391882|79323600|FG000|Part B - Treatment Phase|Adverse Event|0|||
44319271|NCT03391882|79323601|FG001|Part B - Treatment Phase|Adverse Event|0|||
44319272|NCT03391882|79323602|FG002|Part B - Treatment Phase|Adverse Event|1|||
44319273|NCT03391882|79323603|FG003|Part B - Treatment Phase|Adverse Event|1|||
44319274|NCT03391882|79323604|FG004|Part B - Treatment Phase|Adverse Event|3|||
44319275|NCT03391882|79323605|FG005|Part B - Treatment Phase|Adverse Event|1|||
44319276|NCT03391882|79323600|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
44319277|NCT03391882|79323601|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
44319278|NCT03391882|79323602|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
44319279|NCT03391882|79323603|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
44155594|NCT01998958|78946974|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155595|NCT01998958|78946975|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155596|NCT01998958|78946976|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155597|NCT01998958|78946977|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155598|NCT01998958|78946978|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
44155599|NCT01958164|78947030|FG000|Overall Study|Adverse Event|0|||
44155600|NCT01958164|78947031|FG001|Overall Study|Adverse Event|2|||
44155601|NCT01958164|78947030|FG000|Overall Study|Lost to Follow-up|2|||
44155602|NCT01958164|78947031|FG001|Overall Study|Lost to Follow-up|3|||
44155603|NCT01976104|78947041|FG000|Overall Study|Adverse Event|0|||
44155604|NCT01976104|78947042|FG001|Overall Study|Adverse Event|0|||
44155605|NCT01976104|78947043|FG002|Overall Study|Adverse Event|1|||
44155606|NCT01976104|78947044|FG003|Overall Study|Adverse Event|0|||
44155607|NCT01976104|78947041|FG000|Overall Study|Lost to Follow-up|3|||
44319280|NCT03391882|79323604|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
44319281|NCT03391882|79323605|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
44319282|NCT01261000|79323615|FG000|Overall Study|Screen failure|1|||
44319283|NCT01234402|79323648|FG000|Overall Study|Lost to Follow-up|0|||
44319284|NCT01234402|79323649|FG001|Overall Study|Lost to Follow-up|1|||
44319285|NCT01234402|79323650|FG002|Overall Study|Lost to Follow-up|3|||
44319286|NCT01234402|79323648|FG000|Overall Study|Withdrawal by Subject|1|||
44319287|NCT01234402|79323649|FG001|Overall Study|Withdrawal by Subject|3|||
44319288|NCT01234402|79323650|FG002|Overall Study|Withdrawal by Subject|4|||
44319289|NCT01234402|79323648|FG000|Overall Study|Never treated: Death|0|||
44319290|NCT01234402|79323649|FG001|Overall Study|Never treated: Death|0|||
44319291|NCT01234402|79323650|FG002|Overall Study|Never treated: Death|1|||
44319292|NCT01234402|79323648|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
44319293|NCT01234402|79323649|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
44319294|NCT01234402|79323650|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
44319295|NCT01234402|79323648|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
44319296|NCT01234402|79323649|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
44319297|NCT01234402|79323650|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
44319298|NCT01260922|79323662|FG000|First Intervention|Withdrawal by Subject|0|||
44319299|NCT01260922|79323663|FG001|First Intervention|Withdrawal by Subject|1|||
44319300|NCT01260922|79323662|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
44319301|NCT01260922|79323663|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
44319302|NCT01260922|79323662|FG000|Second Intervention|Emesis|0|||
44319303|NCT01260922|79323663|FG001|Second Intervention|Emesis|2|||
44319304|NCT01233817|79323669|FG000|Overall Study|Lost to Follow-up|1|||
44319305|NCT01233817|79323669|FG000|Overall Study|Withdrawal by Subject|2|||
44319306|NCT01233232|79323676|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
44319307|NCT01233232|79323677|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
44319308|NCT01233232|79323678|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
44319309|NCT01233076|79323688|FG000|Period 2, One Week|Lost to Follow-up|1|||
44319310|NCT01233076|79323689|FG001|Period 2, One Week|Lost to Follow-up|0|||
44319311|NCT01212094|79323698|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
44319312|NCT01212094|79323699|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
44319313|NCT01212094|79323700|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
44319314|NCT01212094|79323698|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
44319315|NCT01212094|79323699|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
44319316|NCT01212094|79323700|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
44319317|NCT01212094|79323698|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
44319318|NCT01212094|79323699|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
44319319|NCT01212094|79323700|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
44319320|NCT01212094|79323698|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
44319321|NCT01212094|79323699|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
44536218|NCT00007475|79546983|FG000|Overall Study|Withdrawal by Subject|1|||
44536219|NCT00007475|79546984|FG001|Overall Study|Withdrawal by Subject|0|||
44319322|NCT01212094|79323700|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
44319323|NCT01212094|79323698|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
44319324|NCT01212094|79323699|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
44421242|NCT00772148|79429138|FG000|Maintenance Phase (Week 52)|Death|2|||
44155608|NCT01976104|78947042|FG001|Overall Study|Lost to Follow-up|0|||
44155609|NCT01976104|78947043|FG002|Overall Study|Lost to Follow-up|1|||
44319325|NCT01212094|79323700|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
44319326|NCT01212094|79323698|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
44319327|NCT01212094|79323699|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
44319328|NCT01212094|79323700|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
44319329|NCT01232569|79323709|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
44319330|NCT01232569|79323710|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
44319331|NCT01232569|79323711|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44319332|NCT01232569|79323712|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
44319333|NCT01232569|79323709|FG000|Double-blind Treatment Period|Escape|2|||
44319334|NCT01232569|79323710|FG001|Double-blind Treatment Period|Escape|2|||
44319335|NCT01232569|79323711|FG002|Double-blind Treatment Period|Escape|0|||
44319336|NCT01232569|79323712|FG003|Double-blind Treatment Period|Escape|0|||
44319337|NCT01232569|79323709|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
44319338|NCT01232569|79323710|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
44319339|NCT01232569|79323711|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
44319340|NCT01232569|79323712|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
44319341|NCT01232569|79323709|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
44319342|NCT01232569|79323710|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
44319343|NCT01232569|79323711|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
44319344|NCT01232569|79323712|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
44319345|NCT01232569|79323709|FG000|Double-blind Treatment Period|Physician Decision|1|||
44319346|NCT01232569|79323710|FG001|Double-blind Treatment Period|Physician Decision|0|||
44319347|NCT01232569|79323711|FG002|Double-blind Treatment Period|Physician Decision|0|||
44319348|NCT01232569|79323712|FG003|Double-blind Treatment Period|Physician Decision|0|||
44319349|NCT01232569|79323709|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
44319350|NCT01232569|79323710|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
44319351|NCT01232569|79323711|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
44319352|NCT01232569|79323712|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
44319353|NCT01232569|79323709|FG000|Double-blind Treatment Period|Death|2|||
44319354|NCT01232569|79323710|FG001|Double-blind Treatment Period|Death|0|||
44319355|NCT01232569|79323711|FG002|Double-blind Treatment Period|Death|0|||
44319356|NCT01232569|79323712|FG003|Double-blind Treatment Period|Death|0|||
44319357|NCT01211665|79323723|FG000|Overall Study|Withdrawal by Subject|1|||
44319358|NCT01211665|79323724|FG001|Overall Study|Withdrawal by Subject|0|||
44319359|NCT01211665|79323723|FG000|Overall Study|Death|1|||
44319360|NCT01211665|79323724|FG001|Overall Study|Death|0|||
44319361|NCT01232491|79323732|FG000|Overall Study|Adverse Event|13|||
44319362|NCT01232491|79323733|FG001|Overall Study|Adverse Event|8|||
44319363|NCT01232491|79323732|FG000|Overall Study|Lack of Efficacy|1|||
44319364|NCT01232491|79323733|FG001|Overall Study|Lack of Efficacy|5|||
44319365|NCT01232491|79323732|FG000|Overall Study|Protocol Violation|13|||
44319366|NCT01232491|79323733|FG001|Overall Study|Protocol Violation|11|||
44319367|NCT01232491|79323732|FG000|Overall Study|Withdrawal Criteria|12|||
44319368|NCT01232491|79323733|FG001|Overall Study|Withdrawal Criteria|21|||
44319369|NCT01232491|79323732|FG000|Overall Study|Other|21|||
44319370|NCT01232491|79323733|FG001|Overall Study|Other|18|||
44319371|NCT01232452|79323741|FG000|Overall Study|Adverse Event|17|||
44319372|NCT01232452|79323742|FG001|Overall Study|Adverse Event|15|||
44319373|NCT01232452|79323741|FG000|Overall Study|Withdrawal by Subject|11|||
44319374|NCT01232452|79323742|FG001|Overall Study|Withdrawal by Subject|8|||
44319375|NCT01232452|79323741|FG000|Overall Study|Physician Decision|8|||
44319376|NCT01232452|79323742|FG001|Overall Study|Physician Decision|12|||
44319377|NCT01232452|79323741|FG000|Overall Study|Protocol entry criterion not met|0|||
44319378|NCT01232452|79323742|FG001|Overall Study|Protocol entry criterion not met|2|||
44319379|NCT01232452|79323741|FG000|Overall Study|Sponsor Decision|3|||
44319380|NCT01232452|79323742|FG001|Overall Study|Sponsor Decision|1|||
44319381|NCT01232452|79323741|FG000|Overall Study|Protocol Violation|0|||
44319382|NCT01232452|79323742|FG001|Overall Study|Protocol Violation|1|||
44319383|NCT01211197|79323748|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44319384|NCT01211197|79323749|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44319385|NCT01211197|79323750|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
44319386|NCT01211197|79323751|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44319387|NCT01211197|79323752|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44319388|NCT01211197|79323753|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
44319389|NCT01211197|79323748|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
44319390|NCT01211197|79323749|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
44319391|NCT01211197|79323750|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
44319392|NCT01211197|79323751|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
44319393|NCT01211197|79323752|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
44319394|NCT01211197|79323753|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
44319395|NCT01232296|79323763|FG000|Overall Study|Adverse Event|24|||
44319396|NCT01232296|79323764|FG001|Overall Study|Adverse Event|12|||
44319397|NCT01232296|79323763|FG000|Overall Study|Physician Decision|1|||
44319398|NCT01232296|79323764|FG001|Overall Study|Physician Decision|1|||
44319399|NCT01232296|79323763|FG000|Overall Study|Progressive disease|43|||
44319400|NCT01232296|79323764|FG001|Overall Study|Progressive disease|61|||
44319401|NCT01232296|79323763|FG000|Overall Study|Study terminated by sponsor|0|||
44319402|NCT01232296|79323764|FG001|Overall Study|Study terminated by sponsor|1|||
44319403|NCT01232296|79323763|FG000|Overall Study|Technical problems|3|||
44319404|NCT01232296|79323764|FG001|Overall Study|Technical problems|0|||
44319405|NCT01232296|79323763|FG000|Overall Study|Subject/guardian decision|10|||
44319406|NCT01232296|79323764|FG001|Overall Study|Subject/guardian decision|2|||
44319407|NCT01232296|79323763|FG000|Overall Study|Death|1|||
44319408|NCT01232296|79323764|FG001|Overall Study|Death|6|||
44319409|NCT01231984|79323772|FG000|Study Period 1|Withdrawal by Subject|0|||
44319410|NCT01231984|79323773|FG001|Study Period 1|Withdrawal by Subject|0|||
44319411|NCT01231984|79323774|FG002|Study Period 1|Withdrawal by Subject|0|||
44319412|NCT01231984|79323775|FG003|Study Period 1|Withdrawal by Subject|1|||
44319413|NCT01231984|79323772|FG000|Study Period 1|Lost to Follow-up|1|||
44319414|NCT01231984|79323773|FG001|Study Period 1|Lost to Follow-up|1|||
44319415|NCT01231984|79323774|FG002|Study Period 1|Lost to Follow-up|1|||
44319416|NCT01231984|79323775|FG003|Study Period 1|Lost to Follow-up|0|||
44319417|NCT01231984|79323772|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
44319418|NCT01231984|79323773|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
44319419|NCT01231984|79323774|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
44319420|NCT01231984|79323775|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
44319421|NCT01231984|79323772|FG000|Study Period 1|Screen Failure|0|||
44319422|NCT01231984|79323773|FG001|Study Period 1|Screen Failure|0|||
44319423|NCT01231984|79323774|FG002|Study Period 1|Screen Failure|0|||
44319424|NCT01231984|79323775|FG003|Study Period 1|Screen Failure|1|||
44319425|NCT01231984|79323772|FG000|Study Period 1|Non-compliance with study requirements|5|||
44319426|NCT01231984|79323773|FG001|Study Period 1|Non-compliance with study requirements|0|||
44319427|NCT01231984|79323774|FG002|Study Period 1|Non-compliance with study requirements|2|||
44319428|NCT01231984|79323775|FG003|Study Period 1|Non-compliance with study requirements|1|||
44319429|NCT01231984|79323772|FG000|Study Period 1|Protocol Violation|3|||
44319430|NCT01231984|79323773|FG001|Study Period 1|Protocol Violation|4|||
44319431|NCT01231984|79323774|FG002|Study Period 1|Protocol Violation|2|||
44319432|NCT01231984|79323775|FG003|Study Period 1|Protocol Violation|3|||
44319433|NCT01231984|79323772|FG000|Study Period 1|Adverse Event|1|||
44319434|NCT01231984|79323773|FG001|Study Period 1|Adverse Event|0|||
44319435|NCT01231984|79323774|FG002|Study Period 1|Adverse Event|0|||
44319436|NCT01231984|79323775|FG003|Study Period 1|Adverse Event|0|||
44319437|NCT01231984|79323772|FG000|Study Period 1|Other|0|||
44319438|NCT01231984|79323773|FG001|Study Period 1|Other|0|||
44319439|NCT01231984|79323774|FG002|Study Period 1|Other|0|||
44319440|NCT01231984|79323775|FG003|Study Period 1|Other|1|||
44319441|NCT01231984|79323772|FG000|Study Period 2|Withdrawal by Subject|1|||
44319442|NCT01231984|79323773|FG001|Study Period 2|Withdrawal by Subject|1|||
44319443|NCT01231984|79323774|FG002|Study Period 2|Withdrawal by Subject|0|||
44319444|NCT01231984|79323775|FG003|Study Period 2|Withdrawal by Subject|0|||
44319445|NCT01231984|79323772|FG000|Study Period 2|Lost to Follow-up|1|||
44319446|NCT01231984|79323773|FG001|Study Period 2|Lost to Follow-up|0|||
44319447|NCT01231984|79323774|FG002|Study Period 2|Lost to Follow-up|0|||
44319448|NCT01231984|79323775|FG003|Study Period 2|Lost to Follow-up|3|||
44319449|NCT01231984|79323772|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
44319450|NCT01231984|79323773|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
44319451|NCT01231984|79323774|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
44319452|NCT01231984|79323775|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
44319453|NCT01210807|79323795|FG000|Overall Study|Lost to Follow-up|1|||
44319454|NCT01210807|79323796|FG001|Overall Study|Lost to Follow-up|2|||
44319455|NCT01210807|79323795|FG000|Overall Study|Not implanted bilaterally|2|||
44319456|NCT01210807|79323796|FG001|Overall Study|Not implanted bilaterally|1|||
44319457|NCT01231555|79323805|FG000|Overall Study|Study terminated|8|||
44319458|NCT01231555|79323806|FG001|Overall Study|Study terminated|5|||
44319459|NCT01231555|79323807|FG002|Overall Study|Study terminated|8|||
44319460|NCT01231555|79323805|FG000|Overall Study|Withdrawal by Subject|0|||
44319461|NCT01231555|79323806|FG001|Overall Study|Withdrawal by Subject|2|||
44319462|NCT01231555|79323807|FG002|Overall Study|Withdrawal by Subject|0|||
44319463|NCT01210690|79323815|FG000|Overall Study|Adverse Event|7|||
44319464|NCT01210690|79323815|FG000|Overall Study|Lack of Efficacy|12|||
44319465|NCT01210690|79323815|FG000|Overall Study|Lost to Follow-up|3|||
44155610|NCT01976104|78947044|FG003|Overall Study|Lost to Follow-up|1|||
44319466|NCT01210690|79323815|FG000|Overall Study|Disease Remission|1|||
44319467|NCT01210690|79323815|FG000|Overall Study|Withdrawal by Subject|1|||
44319468|NCT01210690|79323815|FG000|Overall Study|Patient refused to swallow|1|||
44319469|NCT01210690|79323815|FG000|Overall Study|Patient could not take glucose|1|||
44319470|NCT01210651|79323822|FG000|Overall Study|Lost to Follow-up|1|||
44319471|NCT01210651|79323823|FG001|Overall Study|Lost to Follow-up|1|||
44319472|NCT01210651|79323822|FG000|Overall Study|schedule conflicts|1|||
44319473|NCT01210651|79323823|FG001|Overall Study|schedule conflicts|5|||
44319474|NCT01210651|79323822|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
44319475|NCT01210651|79323823|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
44319476|NCT01210651|79323822|FG000|Overall Study|Withdrawal by Subject|1|||
44319477|NCT01210651|79323823|FG001|Overall Study|Withdrawal by Subject|1|||
44319478|NCT01210651|79323822|FG000|Overall Study|Injury outside study|2|||
44319479|NCT01210651|79323823|FG001|Overall Study|Injury outside study|0|||
44319480|NCT01210495|79323902|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
44319481|NCT01210495|79323903|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
44319482|NCT01210495|79323904|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
44319483|NCT01210495|79323905|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
44319484|NCT01210495|79323902|FG000|Overall Study|Death|14|||
44319485|NCT01210495|79323903|FG001|Overall Study|Death|7|||
44319486|NCT01210495|79323904|FG002|Overall Study|Death|112|||
44319487|NCT01210495|79323905|FG003|Overall Study|Death|54|||
44319488|NCT01210495|79323902|FG000|Overall Study|Study Terminated by Sponsor|0|||
44319489|NCT01210495|79323903|FG001|Overall Study|Study Terminated by Sponsor|0|||
44319490|NCT01210495|79323904|FG002|Overall Study|Study Terminated by Sponsor|4|||
44319491|NCT01210495|79323905|FG003|Overall Study|Study Terminated by Sponsor|11|||
44319492|NCT01210495|79323902|FG000|Overall Study|Lost to Follow-up|0|||
44319493|NCT01210495|79323903|FG001|Overall Study|Lost to Follow-up|0|||
44319494|NCT01210495|79323904|FG002|Overall Study|Lost to Follow-up|1|||
44319495|NCT01210495|79323905|FG003|Overall Study|Lost to Follow-up|1|||
44319496|NCT01210495|79323902|FG000|Overall Study|Other unspecified|0|||
44319497|NCT01210495|79323903|FG001|Overall Study|Other unspecified|0|||
44319498|NCT01210495|79323904|FG002|Overall Study|Other unspecified|6|||
44319499|NCT01210495|79323905|FG003|Overall Study|Other unspecified|0|||
44319500|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
44319501|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
44319502|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
44319503|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
44319504|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
44319505|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
44319506|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
44319507|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
44319508|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
44319509|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
44319510|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
44319511|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
44319512|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
44319513|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
44319514|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
44319515|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
44319516|NCT01231516|79323917|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
44319517|NCT01231516|79323918|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
44319518|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
44319519|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
44319520|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
44319521|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
44319522|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
44319523|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
44319524|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
44319525|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
44319526|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
44319527|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
44319528|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
44319529|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
44319530|NCT01231516|79323917|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
44319531|NCT01231516|79323918|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
44319532|NCT01231321|79323924|FG000|Overall Study|Adverse Event|3|||
44536220|NCT00007475|79546985|FG002|Overall Study|Withdrawal by Subject|0|||
44319533|NCT01231321|79323924|FG000|Overall Study|Lack of Efficacy|2|||
44319534|NCT01210222|79323934|FG000|Overall Study|Ineligible|2|||
44319535|NCT01210222|79323934|FG000|Overall Study|Never treated|1|||
44421243|NCT00772148|79429139|FG001|Maintenance Phase (Week 52)|Death|2|||
44421244|NCT00772148|79429138|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
44536221|NCT00007475|79546986|FG003|Overall Study|Withdrawal by Subject|0|||
44319536|NCT01210144|79323946|FG000|Overall Study|Lack of ovarian response|1|||
44319537|NCT01210144|79323947|FG001|Overall Study|Lack of ovarian response|0|||
44421245|NCT00772148|79429139|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
44421246|NCT00772148|79429138|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
44319538|NCT01210144|79323946|FG000|Overall Study|No fertilization|1|||
44319539|NCT01210144|79323947|FG001|Overall Study|No fertilization|0|||
44319540|NCT01210144|79323946|FG000|Overall Study|No transfer|1|||
44319541|NCT01210144|79323947|FG001|Overall Study|No transfer|0|||
44319542|NCT01209949|79323954|FG000|Overall Study|Lost to Follow-up|3|||
44319543|NCT01209832|79323958|FG000|Period 1|Sponsor Decision and was not dosed|1|||
44319544|NCT01209832|79323958|FG000|Period 2|Sponsor Decision|1|||
44319545|NCT01230892|79323971|FG000|Overall Study|Withdrawal by Subject|1|||
44319546|NCT01230892|79323972|FG001|Overall Study|Withdrawal by Subject|1|||
44319547|NCT01230892|79323971|FG000|Overall Study|Lost to Follow-up|2|||
44319548|NCT01230892|79323972|FG001|Overall Study|Lost to Follow-up|0|||
44319549|NCT01230814|79323980|FG000|Overall Study|Lost to Follow-up|11|||
44319550|NCT01230814|79323981|FG001|Overall Study|Lost to Follow-up|3|||
44319551|NCT01230814|79323980|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
44319552|NCT01230814|79323981|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
44319553|NCT01230307|79323989|FG000|Overall Study|LVAD Placement|0|||
44319554|NCT01230307|79323990|FG001|Overall Study|LVAD Placement|2|||
44319555|NCT01209598|79323998|FG000|Overall Study|Withdrawal by Subject|1|||
44319556|NCT01209598|79323999|FG001|Overall Study|Withdrawal by Subject|0|||
44319557|NCT01209520|79324006|FG000|Overall Study|Withdrawal by Subject|3|||
44319558|NCT01209325|79324010|FG000|Overall Study|Lost to Follow-up|24|||
44319559|NCT01209325|79324010|FG000|Overall Study|Adverse Event|1|||
44319560|NCT01209325|79324010|FG000|Overall Study|Relocated|3|||
44319561|NCT01209325|79324010|FG000|Overall Study|Refusal after starting therapy|8|||
44319562|NCT01209325|79324010|FG000|Overall Study|Protocol Violation|4|||
44319563|NCT01209325|79324010|FG000|Overall Study|Refusal prior to therapy|1|||
44319564|NCT01209325|79324010|FG000|Overall Study|Incarceration|2|||
44319565|NCT01209286|79324048|FG000|Overall Study|Adverse Event|4|||
44319566|NCT01209286|79324049|FG001|Overall Study|Adverse Event|3|||
44319567|NCT01209286|79324050|FG002|Overall Study|Adverse Event|1|||
44319568|NCT01209286|79324048|FG000|Overall Study|Hematological Relapse After Remission|0|||
44319569|NCT01209286|79324049|FG001|Overall Study|Hematological Relapse After Remission|1|||
44319570|NCT01209286|79324050|FG002|Overall Study|Hematological Relapse After Remission|1|||
44319571|NCT01209286|79324048|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
44319572|NCT01209286|79324049|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
44319573|NCT01209286|79324050|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
44319574|NCT01209286|79324048|FG000|Overall Study|Physician Decision|0|||
44319575|NCT01209286|79324049|FG001|Overall Study|Physician Decision|2|||
44319576|NCT01209286|79324050|FG002|Overall Study|Physician Decision|0|||
44319577|NCT01209286|79324048|FG000|Overall Study|Other|0|||
44319578|NCT01209286|79324049|FG001|Overall Study|Other|1|||
44319579|NCT01209286|79324050|FG002|Overall Study|Other|0|||
44319580|NCT05048719|79324083|FG000|Overall Study|Withdrawal by Subject|2|||
44319581|NCT05048719|79324084|FG001|Overall Study|Withdrawal by Subject|1|||
44319582|NCT05048719|79324085|FG002|Overall Study|Withdrawal by Subject|3|||
44319583|NCT05048719|79324086|FG003|Overall Study|Withdrawal by Subject|1|||
44319584|NCT05048719|79324087|FG004|Overall Study|Withdrawal by Subject|0|||
44319585|NCT05048719|79324088|FG005|Overall Study|Withdrawal by Subject|2|||
44319586|NCT05048719|79324089|FG006|Overall Study|Withdrawal by Subject|1|||
44319587|NCT05048719|79324090|FG007|Overall Study|Withdrawal by Subject|1|||
44319588|NCT05048719|79324091|FG008|Overall Study|Withdrawal by Subject|0|||
44319589|NCT05048719|79324083|FG000|Overall Study|Death|1|||
44155611|NCT01976104|78947041|FG000|Overall Study|Subject Choice|0|||
44155612|NCT01976104|78947042|FG001|Overall Study|Subject Choice|1|||
44155613|NCT01976104|78947043|FG002|Overall Study|Subject Choice|0|||
44155614|NCT01976104|78947044|FG003|Overall Study|Subject Choice|1|||
44155615|NCT01976104|78947041|FG000|Overall Study|Withdrawal by Subject|3|||
44155616|NCT01976104|78947042|FG001|Overall Study|Withdrawal by Subject|0|||
44155617|NCT01976104|78947043|FG002|Overall Study|Withdrawal by Subject|0|||
44155618|NCT01976104|78947044|FG003|Overall Study|Withdrawal by Subject|1|||
44155619|NCT01976104|78947041|FG000|Overall Study|Other|0|||
44319590|NCT05048719|79324084|FG001|Overall Study|Death|0|||
44319591|NCT05048719|79324085|FG002|Overall Study|Death|0|||
44319592|NCT05048719|79324086|FG003|Overall Study|Death|0|||
44319593|NCT05048719|79324087|FG004|Overall Study|Death|0|||
44319594|NCT05048719|79324088|FG005|Overall Study|Death|0|||
44319595|NCT05048719|79324089|FG006|Overall Study|Death|0|||
44319596|NCT05048719|79324090|FG007|Overall Study|Death|0|||
44319597|NCT05048719|79324091|FG008|Overall Study|Death|0|||
44319598|NCT05048719|79324083|FG000|Overall Study|Adverse Event|0|||
44319599|NCT05048719|79324084|FG001|Overall Study|Adverse Event|1|||
44319600|NCT05048719|79324085|FG002|Overall Study|Adverse Event|2|||
44319601|NCT05048719|79324086|FG003|Overall Study|Adverse Event|0|||
44319602|NCT05048719|79324087|FG004|Overall Study|Adverse Event|1|||
44319603|NCT05048719|79324088|FG005|Overall Study|Adverse Event|0|||
44319604|NCT05048719|79324089|FG006|Overall Study|Adverse Event|0|||
44319605|NCT05048719|79324090|FG007|Overall Study|Adverse Event|0|||
44319606|NCT05048719|79324091|FG008|Overall Study|Adverse Event|0|||
44319607|NCT05048719|79324083|FG000|Overall Study|Lost to Follow-up|0|||
44319608|NCT05048719|79324084|FG001|Overall Study|Lost to Follow-up|0|||
44319609|NCT05048719|79324085|FG002|Overall Study|Lost to Follow-up|1|||
44319610|NCT05048719|79324086|FG003|Overall Study|Lost to Follow-up|3|||
44319611|NCT05048719|79324087|FG004|Overall Study|Lost to Follow-up|1|||
44319612|NCT05048719|79324088|FG005|Overall Study|Lost to Follow-up|1|||
44319613|NCT05048719|79324089|FG006|Overall Study|Lost to Follow-up|1|||
44319614|NCT05048719|79324090|FG007|Overall Study|Lost to Follow-up|1|||
44319615|NCT05048719|79324091|FG008|Overall Study|Lost to Follow-up|0|||
44319616|NCT05048719|79324083|FG000|Overall Study|Physician Decision|0|||
44319617|NCT05048719|79324084|FG001|Overall Study|Physician Decision|0|||
44319618|NCT05048719|79324085|FG002|Overall Study|Physician Decision|0|||
44319619|NCT05048719|79324086|FG003|Overall Study|Physician Decision|0|||
44319620|NCT05048719|79324087|FG004|Overall Study|Physician Decision|0|||
44319621|NCT05048719|79324088|FG005|Overall Study|Physician Decision|0|||
44319622|NCT05048719|79324089|FG006|Overall Study|Physician Decision|0|||
44319623|NCT05048719|79324090|FG007|Overall Study|Physician Decision|1|||
44319624|NCT05048719|79324091|FG008|Overall Study|Physician Decision|1|||
44319625|NCT05048719|79324083|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
44319626|NCT05048719|79324084|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319627|NCT05048719|79324085|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319628|NCT05048719|79324086|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319629|NCT05048719|79324087|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319630|NCT05048719|79324088|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319631|NCT05048719|79324089|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319632|NCT05048719|79324090|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319633|NCT05048719|79324091|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
44319634|NCT05048719|79324083|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319635|NCT05048719|79324084|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
44319636|NCT05048719|79324085|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319637|NCT05048719|79324086|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319638|NCT05048719|79324087|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319639|NCT05048719|79324088|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319640|NCT05048719|79324089|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319641|NCT05048719|79324090|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319642|NCT05048719|79324091|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
44319643|NCT05048719|79324083|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44319644|NCT05048719|79324084|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
44319645|NCT05048719|79324085|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44319646|NCT05048719|79324086|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44319647|NCT05048719|79324087|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44421247|NCT00772148|79429139|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
44421248|NCT00772148|79429138|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
44421249|NCT00772148|79429139|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
44421250|NCT00759902|79429147|FG000|Overall Study|Adverse Event|0|||
44421251|NCT00759902|79429148|FG001|Overall Study|Adverse Event|1|||
44421252|NCT00772070|79429156|FG000|Overall Study|Lost to Follow-up|0|||
44421253|NCT00772070|79429157|FG001|Overall Study|Lost to Follow-up|8|||
44421254|NCT00772070|79429156|FG000|Overall Study|Withdrawal by Subject|0|||
44421255|NCT00772070|79429157|FG001|Overall Study|Withdrawal by Subject|2|||
44421256|NCT00772070|79429156|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
44421257|NCT00772070|79429157|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
44421258|NCT00796757|79429163|FG000|Overall Study|Withdrawal by Subject|14|||
44421259|NCT00796757|79429163|FG000|Overall Study|Death|61|||
44421260|NCT00796757|79429163|FG000|Overall Study|Protocol Violation|1|||
44421261|NCT00796757|79429163|FG000|Overall Study|Participant noncompliance|1|||
44421262|NCT00796757|79429163|FG000|Overall Study|Investigator's decision|2|||
44421263|NCT00796757|79429163|FG000|Overall Study|Other|7|||
44421264|NCT00759356|79429169|FG000|Overall Study|Adverse Event|0|||
44421265|NCT00759356|79429170|FG001|Overall Study|Adverse Event|1|||
44421266|NCT00759356|79429169|FG000|Overall Study|Withdrawal by Subject|0|||
44421267|NCT00759356|79429170|FG001|Overall Study|Withdrawal by Subject|2|||
44421268|NCT00759356|79429169|FG000|Overall Study|Subject was unable to return|1|||
44421269|NCT00759356|79429170|FG001|Overall Study|Subject was unable to return|0|||
44536222|NCT00007475|79546983|FG000|Overall Study|Adverse Event|3|||
44536223|NCT00007475|79546984|FG001|Overall Study|Adverse Event|0|||
44536224|NCT00007475|79546985|FG002|Overall Study|Adverse Event|0|||
44319648|NCT05048719|79324088|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44536225|NCT00007475|79546986|FG003|Overall Study|Adverse Event|0|||
44536226|NCT00025883|79546998|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
44319649|NCT05048719|79324089|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44319650|NCT05048719|79324090|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44319651|NCT05048719|79324091|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
44319652|NCT05048719|79324083|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319653|NCT05048719|79324084|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319654|NCT05048719|79324085|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319655|NCT05048719|79324086|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
44319656|NCT05048719|79324087|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319657|NCT05048719|79324088|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319658|NCT05048719|79324089|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319659|NCT05048719|79324090|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319660|NCT05048719|79324091|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
44319661|NCT05048719|79324083|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319662|NCT05048719|79324084|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319663|NCT05048719|79324085|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319664|NCT05048719|79324086|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319665|NCT05048719|79324087|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319666|NCT05048719|79324088|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
44319667|NCT05048719|79324089|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319668|NCT05048719|79324090|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319669|NCT05048719|79324091|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
44319670|NCT04949802|79324116|FG000|Overall Study|Lost to Follow-up|3|||
44319671|NCT04626297|79324132|FG000|Overall Study|Adverse Event|5|||
44319672|NCT04626297|79324133|FG001|Overall Study|Adverse Event|3|||
44319673|NCT04626297|79324132|FG000|Overall Study|Lost to Follow-up|7|||
44319674|NCT04626297|79324133|FG001|Overall Study|Lost to Follow-up|3|||
44319675|NCT04626297|79324132|FG000|Overall Study|Protocol Violation|5|||
44319676|NCT04626297|79324133|FG001|Overall Study|Protocol Violation|1|||
44319677|NCT04626297|79324132|FG000|Overall Study|Withdrawal by Subject|20|||
44319678|NCT04626297|79324133|FG001|Overall Study|Withdrawal by Subject|6|||
44319679|NCT04626297|79324132|FG000|Overall Study|Sponsor decision|2|||
44319680|NCT04626297|79324133|FG001|Overall Study|Sponsor decision|1|||
44319681|NCT04154189|79324145|FG000|Overall Study|Death|16|||
44319682|NCT04154189|79324146|FG001|Overall Study|Death|15|||
44319683|NCT04154189|79324145|FG000|Overall Study|Withdrawal by Subject|4|||
44319684|NCT04154189|79324146|FG001|Overall Study|Withdrawal by Subject|6|||
44319685|NCT04154189|79324145|FG000|Overall Study|Ongoing|20|||
44319686|NCT04154189|79324146|FG001|Overall Study|Ongoing|20|||
44319687|NCT03905512|79324169|FG000|Overall Study|Withdrawal by Subject|9|||
44319688|NCT03905512|79324170|FG001|Overall Study|Withdrawal by Subject|8|||
44319689|NCT03905512|79324169|FG000|Overall Study|Adverse Event|1|||
44319690|NCT03905512|79324170|FG001|Overall Study|Adverse Event|2|||
44319691|NCT03905512|79324169|FG000|Overall Study|Lost to Follow-up|4|||
44319692|NCT03905512|79324170|FG001|Overall Study|Lost to Follow-up|3|||
44319693|NCT03905512|79324169|FG000|Overall Study|Other than Specified|7|||
44319694|NCT03905512|79324170|FG001|Overall Study|Other than Specified|4|||
44319695|NCT03891875|79324179|FG000|Overall Study|Withdrawal by Subject|20|||
44319696|NCT03891875|79324180|FG001|Overall Study|Withdrawal by Subject|3|||
44319697|NCT03891875|79324179|FG000|Overall Study|Adverse Event|10|||
44319698|NCT03891875|79324180|FG001|Overall Study|Adverse Event|4|||
44421270|NCT00721734|79429181|FG000|Overall Study|Progressive Disease|3|||
44421271|NCT00721734|79429182|FG001|Overall Study|Progressive Disease|10|||
44536227|NCT00025883|79546998|FG000|Overall Study|no baseline data|1|||
44536228|NCT00025883|79546998|FG000|Overall Study|Death|1|||
44536229|NCT00025883|79546998|FG000|Overall Study|Adverse Event|1|||
44536230|NCT00025883|79546998|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
44536231|NCT00072293|79547005|FG000|Overall Study|Lost to Follow-up|1|||
44319699|NCT03891875|79324179|FG000|Overall Study|Physician Decision|1|||
44319700|NCT03891875|79324180|FG001|Overall Study|Physician Decision|1|||
44319701|NCT03891875|79324179|FG000|Overall Study|Protocol Violation|1|||
44319702|NCT03891875|79324180|FG001|Overall Study|Protocol Violation|0|||
44319703|NCT03891875|79324179|FG000|Overall Study|Lost to Follow-up|1|||
44319704|NCT03891875|79324180|FG001|Overall Study|Lost to Follow-up|0|||
44319705|NCT03891875|79324179|FG000|Overall Study|COVID-19 infection|1|||
44319706|NCT03891875|79324180|FG001|Overall Study|COVID-19 infection|0|||
44319707|NCT03830164|79324189|FG000|Overall Study|Adverse Event|0|||
44319708|NCT03830164|79324190|FG001|Overall Study|Adverse Event|2|||
44421272|NCT00721734|79429183|FG002|Overall Study|Progressive Disease|4|||
44536232|NCT00072293|79547006|FG001|Overall Study|Lost to Follow-up|1|||
44536233|NCT00072293|79547005|FG000|Overall Study|Withdrawal by Subject|0|||
44319709|NCT03830164|79324191|FG002|Overall Study|Adverse Event|0|||
44319710|NCT03830164|79324189|FG000|Overall Study|Lack of Efficacy|1|||
44319711|NCT03830164|79324190|FG001|Overall Study|Lack of Efficacy|5|||
44319712|NCT03830164|79324191|FG002|Overall Study|Lack of Efficacy|0|||
44319713|NCT03830164|79324189|FG000|Overall Study|Lost to Follow-up|0|||
44258025|NCT01405820|79112186|FG004|Randomized Treatment Period|Physician Decision|0|||
44258026|NCT01405820|79112187|FG005|Randomized Treatment Period|Physician Decision|0|||
44258027|NCT01405820|79112182|FG000|Randomized Treatment Period|Rescue|0|||
44258028|NCT01405820|79112183|FG001|Randomized Treatment Period|Rescue|1|||
44319714|NCT03830164|79324190|FG001|Overall Study|Lost to Follow-up|1|||
44319715|NCT03830164|79324191|FG002|Overall Study|Lost to Follow-up|0|||
44319716|NCT03830164|79324189|FG000|Overall Study|Withdrawal by Subject|1|||
44319717|NCT03830164|79324190|FG001|Overall Study|Withdrawal by Subject|0|||
44319718|NCT03830164|79324191|FG002|Overall Study|Withdrawal by Subject|0|||
44319719|NCT03769181|79324203|FG000|Overall Study|Adverse Event|1|||
44319720|NCT03769181|79324204|FG001|Overall Study|Adverse Event|0|||
44319721|NCT03769181|79324205|FG002|Overall Study|Adverse Event|2|||
44319722|NCT03769181|79324206|FG003|Overall Study|Adverse Event|4|||
44319723|NCT03769181|79324203|FG000|Overall Study|Withdrawal by Subject|1|||
44319724|NCT03769181|79324204|FG001|Overall Study|Withdrawal by Subject|0|||
44319725|NCT03769181|79324205|FG002|Overall Study|Withdrawal by Subject|2|||
44319726|NCT03769181|79324206|FG003|Overall Study|Withdrawal by Subject|1|||
44319727|NCT03769181|79324203|FG000|Overall Study|Progressive disease|9|||
44319728|NCT03769181|79324204|FG001|Overall Study|Progressive disease|7|||
44319729|NCT03769181|79324205|FG002|Overall Study|Progressive disease|13|||
44319730|NCT03769181|79324206|FG003|Overall Study|Progressive disease|6|||
44319731|NCT03769181|79324203|FG000|Overall Study|Other - Unspecified|2|||
44319732|NCT03769181|79324204|FG001|Overall Study|Other - Unspecified|1|||
44319733|NCT03769181|79324205|FG002|Overall Study|Other - Unspecified|0|||
44319734|NCT03769181|79324206|FG003|Overall Study|Other - Unspecified|0|||
44319735|NCT03621696|79324249|FG000|Overall Study|Not eligible|0|||
44319736|NCT03621696|79324250|FG001|Overall Study|Not eligible|0|||
44319737|NCT03621696|79324251|FG002|Overall Study|Not eligible|0|||
44319738|NCT03621696|79324252|FG003|Overall Study|Not eligible|5|||
44319739|NCT03621696|79324249|FG000|Overall Study|Withdrawal by Subject|1|||
44319740|NCT03621696|79324250|FG001|Overall Study|Withdrawal by Subject|1|||
44319741|NCT03621696|79324251|FG002|Overall Study|Withdrawal by Subject|1|||
44319742|NCT03621696|79324252|FG003|Overall Study|Withdrawal by Subject|0|||
44319743|NCT03621696|79324249|FG000|Overall Study|Physician Decision|0|||
44319744|NCT03621696|79324250|FG001|Overall Study|Physician Decision|0|||
44319745|NCT03621696|79324251|FG002|Overall Study|Physician Decision|1|||
44319746|NCT03621696|79324252|FG003|Overall Study|Physician Decision|0|||
44319747|NCT03594747|79324263|FG000|Overall Study|Remain on study at the time of data cut off|69|||
44319748|NCT03594747|79324264|FG001|Overall Study|Remain on study at the time of data cut off|67|||
44319749|NCT03594747|79324265|FG002|Overall Study|Remain on study at the time of data cut off|53|||
44319750|NCT03594747|79324263|FG000|Overall Study|Death|48|||
44319751|NCT03594747|79324264|FG001|Overall Study|Death|47|||
44319752|NCT03594747|79324265|FG002|Overall Study|Death|52|||
44319753|NCT03594747|79324263|FG000|Overall Study|Withdrawal by Subject|3|||
44319754|NCT03594747|79324264|FG001|Overall Study|Withdrawal by Subject|4|||
44319755|NCT03594747|79324265|FG002|Overall Study|Withdrawal by Subject|14|||
44319756|NCT03594747|79324263|FG000|Overall Study|Lost to Follow-up|0|||
44319757|NCT03594747|79324264|FG001|Overall Study|Lost to Follow-up|0|||
44319758|NCT03594747|79324265|FG002|Overall Study|Lost to Follow-up|1|||
44319759|NCT03594747|79324263|FG000|Overall Study|Physician Decision|0|||
44319760|NCT03594747|79324264|FG001|Overall Study|Physician Decision|1|||
44319761|NCT03594747|79324265|FG002|Overall Study|Physician Decision|0|||
44421273|NCT00721734|79429184|FG003|Overall Study|Progressive Disease|5|||
44421274|NCT00721734|79429185|FG004|Overall Study|Progressive Disease|2|||
44421275|NCT00721734|79429181|FG000|Overall Study|Adverse Event|3|||
44421276|NCT00721734|79429182|FG001|Overall Study|Adverse Event|1|||
44421277|NCT00721734|79429183|FG002|Overall Study|Adverse Event|4|||
44258029|NCT01405820|79112184|FG002|Randomized Treatment Period|Rescue|13|||
44258030|NCT01405820|79112185|FG003|Randomized Treatment Period|Rescue|10|||
44258031|NCT01405820|79112186|FG004|Randomized Treatment Period|Rescue|8|||
44258032|NCT01405820|79112187|FG005|Randomized Treatment Period|Rescue|8|||
44319762|NCT03594747|79324263|FG000|Overall Study|Did not meet inclusion criteria|0|||
44319763|NCT03594747|79324264|FG001|Overall Study|Did not meet inclusion criteria|0|||
44319764|NCT03594747|79324265|FG002|Overall Study|Did not meet inclusion criteria|1|||
44319765|NCT03592641|79324273|FG000|Overall Study|Withdrawal by Subject|1|||
44319766|NCT03468985|79324281|FG000|Overall Study|Adverse Event|0|||
44319767|NCT03468985|79324282|FG001|Overall Study|Adverse Event|2|||
44319768|NCT03468985|79324283|FG002|Overall Study|Adverse Event|0|||
44319769|NCT03468985|79324284|FG003|Overall Study|Adverse Event|0|||
44319770|NCT03468985|79324281|FG000|Overall Study|Withdrawal by Subject|0|||
44319771|NCT03468985|79324282|FG001|Overall Study|Withdrawal by Subject|0|||
44319772|NCT03468985|79324283|FG002|Overall Study|Withdrawal by Subject|0|||
44319773|NCT03468985|79324284|FG003|Overall Study|Withdrawal by Subject|1|||
44319774|NCT03434418|79324303|FG000|Overall Study|Disease Progression|11|||
44319775|NCT03434418|79324303|FG000|Overall Study|Adverse Event|2|||
44319776|NCT03434418|79324303|FG000|Overall Study|Physician Decision|1|||
44319777|NCT03434418|79324303|FG000|Overall Study|Decline in Performance Status (PS)|1|||
44319778|NCT03366103|79324310|FG000|Overall Study|Disease Progression|3|||
44319779|NCT03366103|79324311|FG001|Overall Study|Disease Progression|1|||
44319780|NCT03366103|79324312|FG002|Overall Study|Disease Progression|0|||
44319781|NCT03366103|79324310|FG000|Overall Study|Adverse Event|0|||
44319782|NCT03366103|79324311|FG001|Overall Study|Adverse Event|1|||
44319783|NCT03366103|79324312|FG002|Overall Study|Adverse Event|0|||
44319784|NCT03253679|79324323|FG000|Overall Study|Screen Failure|1|||
44319785|NCT03099148|79324327|FG000|Wash-out|scheduling conflict|0|||
44319786|NCT03099148|79324328|FG001|Wash-out|scheduling conflict|1|||
44319787|NCT03099148|79324329|FG002|Wash-out|scheduling conflict|0|||
44319788|NCT03099148|79324330|FG003|Wash-out|scheduling conflict|0|||
44319789|NCT03099148|79324327|FG000|Wash-out|Adverse Event|0|||
44319790|NCT03099148|79324328|FG001|Wash-out|Adverse Event|1|||
44319791|NCT03099148|79324329|FG002|Wash-out|Adverse Event|0|||
44319792|NCT03099148|79324330|FG003|Wash-out|Adverse Event|0|||
44319793|NCT03088813|79324345|FG000|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
44319794|NCT03088813|79324346|FG001|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|1|||
44319795|NCT03088813|79324347|FG002|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
44319796|NCT03088813|79324348|FG003|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
44319797|NCT03088813|79324345|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
44319798|NCT03088813|79324346|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
44319799|NCT03088813|79324347|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
44319800|NCT03088813|79324348|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
44319801|NCT03088813|79324345|FG000|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
44319802|NCT03088813|79324346|FG001|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
44319803|NCT03088813|79324347|FG002|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
44319804|NCT03088813|79324348|FG003|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
44319805|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
44319806|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
44319807|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
44319808|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
44319809|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
44319810|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
44319811|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
44319812|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
44319813|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
44319814|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
44319815|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|2|||
44319816|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
44319817|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
44319818|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
44319819|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
44319820|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|12|||
44319821|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
44319822|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
44319823|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|20|||
44319824|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|37|||
44319825|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
44319826|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
44319827|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|7|||
44319828|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|3|||
44319829|NCT03088813|79324345|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
44319830|NCT03088813|79324346|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
44319831|NCT03088813|79324347|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
44319832|NCT03088813|79324348|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
44536234|NCT00072293|79547006|FG001|Overall Study|Withdrawal by Subject|1|||
44536235|NCT03753763|79547014|FG000|Overall Study|Adverse Event|2|||
44536236|NCT03753763|79547015|FG001|Overall Study|Adverse Event|0|||
44319833|NCT03061474|79324361|FG000|Overall Study|Adverse Event|2|||
44319834|NCT03061474|79324362|FG001|Overall Study|Adverse Event|0|||
44319835|NCT03061474|79324361|FG000|Overall Study|Safety Risk|0|||
44319836|NCT03061474|79324362|FG001|Overall Study|Safety Risk|1|||
44155620|NCT01976104|78947042|FG001|Overall Study|Other|1|||
44421278|NCT00721734|79429184|FG003|Overall Study|Adverse Event|0|||
44319837|NCT03061474|79324361|FG000|Overall Study|Participant unwilling or unable to participate|0|||
44319838|NCT03061474|79324362|FG001|Overall Study|Participant unwilling or unable to participate|2|||
44319839|NCT03061474|79324361|FG000|Overall Study|Lost to Follow-up|0|||
44319840|NCT03061474|79324362|FG001|Overall Study|Lost to Follow-up|1|||
44319841|NCT03040726|79324370|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
44319842|NCT03040726|79324371|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
44319843|NCT03040726|79324370|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
44319844|NCT03040726|79324371|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
44319845|NCT03040726|79324370|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
44319846|NCT03040726|79324371|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
44319847|NCT03040726|79324370|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
44319848|NCT03040726|79324371|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
44319849|NCT03040726|79324370|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
44319850|NCT03040726|79324371|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
44319851|NCT02899728|79324380|FG000|Overall Study|Withdrawal by Subject|1|||
44319852|NCT02899728|79324381|FG001|Overall Study|Withdrawal by Subject|1|||
44319853|NCT02899065|79324389|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
44319854|NCT02899065|79324390|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
44319855|NCT02899065|79324389|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
44319856|NCT02899065|79324390|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
44319857|NCT02899065|79324389|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
44319858|NCT02899065|79324390|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
44319859|NCT02893930|79324396|FG000|Overall Study|Adverse Event|3|||
44319860|NCT02893930|79324396|FG000|Overall Study|Death|1|||
44319861|NCT02893930|79324396|FG000|Overall Study|Disease progression|5|||
44319862|NCT02893930|79324396|FG000|Overall Study|Withdrawal by Subject|2|||
44319863|NCT02893930|79324396|FG000|Overall Study|Physician Decision|1|||
44319864|NCT02893930|79324396|FG000|Overall Study|Ineligible|1|||
44319865|NCT02780804|79324403|FG000|Overall Study|Death|1|||
44319866|NCT02780804|79324404|FG001|Overall Study|Death|0|||
44319867|NCT02780804|79324405|FG002|Overall Study|Death|0|||
44319868|NCT02780804|79324403|FG000|Overall Study|Lack of Efficacy|5|||
44319869|NCT02780804|79324404|FG001|Overall Study|Lack of Efficacy|8|||
44319870|NCT02780804|79324405|FG002|Overall Study|Lack of Efficacy|4|||
44319871|NCT02780804|79324403|FG000|Overall Study|Physician Decision|0|||
44319872|NCT02780804|79324404|FG001|Overall Study|Physician Decision|0|||
44319873|NCT02780804|79324405|FG002|Overall Study|Physician Decision|2|||
44319874|NCT02780804|79324403|FG000|Overall Study|Withdrawal by Subject|0|||
44319875|NCT02780804|79324404|FG001|Overall Study|Withdrawal by Subject|1|||
44319876|NCT02780804|79324405|FG002|Overall Study|Withdrawal by Subject|0|||
44319877|NCT02629393|79324414|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
44155621|NCT01976104|78947043|FG002|Overall Study|Other|0|||
44155622|NCT01976104|78947044|FG003|Overall Study|Other|0|||
44155623|NCT01372501|78947055|FG000|Overall Study|Adverse Event|4|||
44155624|NCT01372501|78947055|FG000|Overall Study|Device migration|1|||
44155625|NCT01958008|78947064|FG000|Overall Study|Worsening of disease under study|0|||
44155626|NCT01958008|78947065|FG001|Overall Study|Worsening of disease under study|0|||
44155627|NCT01958008|78947066|FG002|Overall Study|Worsening of disease under study|1|||
44155628|NCT01958008|78947067|FG003|Overall Study|Worsening of disease under study|0|||
44155629|NCT01958008|78947064|FG000|Overall Study|Other adverse event|1|||
44155630|NCT01958008|78947065|FG001|Overall Study|Other adverse event|0|||
44155631|NCT01958008|78947066|FG002|Overall Study|Other adverse event|0|||
44155632|NCT01958008|78947067|FG003|Overall Study|Other adverse event|0|||
44319878|NCT02629393|79324414|FG000|Overall Study|Physician Decision|1|||
44319879|NCT02500797|79324461|FG000|Overall Study|Cancel (rapid disease progression)|0|||
44319880|NCT02500797|79324462|FG001|Overall Study|Cancel (rapid disease progression)|0|||
44319881|NCT02500797|79324463|FG002|Overall Study|Cancel (rapid disease progression)|0|||
44319882|NCT02500797|79324464|FG003|Overall Study|Cancel (rapid disease progression)|0|||
44319883|NCT02500797|79324465|FG004|Overall Study|Cancel (rapid disease progression)|1|||
44319884|NCT02500797|79324466|FG005|Overall Study|Cancel (rapid disease progression)|1|||
44319885|NCT02500797|79324467|FG006|Overall Study|Cancel (rapid disease progression)|0|||
44319886|NCT02500797|79324468|FG007|Overall Study|Cancel (rapid disease progression)|0|||
44319887|NCT02500797|79324461|FG000|Overall Study|Withdrawal by Subject|1|||
44319888|NCT02500797|79324462|FG001|Overall Study|Withdrawal by Subject|0|||
44319889|NCT02500797|79324463|FG002|Overall Study|Withdrawal by Subject|0|||
44319890|NCT02500797|79324464|FG003|Overall Study|Withdrawal by Subject|0|||
44319891|NCT02500797|79324465|FG004|Overall Study|Withdrawal by Subject|0|||
44319892|NCT02500797|79324466|FG005|Overall Study|Withdrawal by Subject|0|||
44319893|NCT02500797|79324467|FG006|Overall Study|Withdrawal by Subject|0|||
44319894|NCT02500797|79324468|FG007|Overall Study|Withdrawal by Subject|0|||
44319895|NCT02017704|79324501|FG000|Overall Study|Withdrawal by Subject|2|||
44421279|NCT00721734|79429185|FG004|Overall Study|Adverse Event|3|||
44319896|NCT02017704|79324502|FG001|Overall Study|Withdrawal by Subject|0|||
44319897|NCT02005471|79324512|FG000|Main Study|Adverse Event|0|||
44319898|NCT02005471|79324513|FG001|Main Study|Adverse Event|1|||
44319899|NCT02005471|79324514|FG002|Main Study|Adverse Event|0|||
44319900|NCT02005471|79324515|FG003|Main Study|Adverse Event|0|||
44319901|NCT02005471|79324512|FG000|Main Study|Death|83|||
44319902|NCT02005471|79324513|FG001|Main Study|Death|52|||
44319903|NCT02005471|79324514|FG002|Main Study|Death|0|||
44319904|NCT02005471|79324515|FG003|Main Study|Death|0|||
44319905|NCT02005471|79324512|FG000|Main Study|Lost to Follow-up|4|||
44319906|NCT02005471|79324513|FG001|Main Study|Lost to Follow-up|5|||
44319907|NCT02005471|79324514|FG002|Main Study|Lost to Follow-up|0|||
44319908|NCT02005471|79324515|FG003|Main Study|Lost to Follow-up|0|||
44319909|NCT02005471|79324512|FG000|Main Study|Physician Decision|3|||
44319910|NCT02005471|79324513|FG001|Main Study|Physician Decision|1|||
44319911|NCT02005471|79324514|FG002|Main Study|Physician Decision|0|||
44319912|NCT02005471|79324515|FG003|Main Study|Physician Decision|0|||
44319913|NCT02005471|79324512|FG000|Main Study|Withdrawal by Subject|26|||
44319914|NCT02005471|79324513|FG001|Main Study|Withdrawal by Subject|11|||
44319915|NCT02005471|79324514|FG002|Main Study|Withdrawal by Subject|0|||
44319916|NCT02005471|79324515|FG003|Main Study|Withdrawal by Subject|0|||
44319917|NCT02005471|79324512|FG000|Main Study|Reason not Specified|0|||
44319918|NCT02005471|79324513|FG001|Main Study|Reason not Specified|6|||
44319919|NCT02005471|79324514|FG002|Main Study|Reason not Specified|0|||
44319920|NCT02005471|79324515|FG003|Main Study|Reason not Specified|0|||
44319921|NCT02005471|79324512|FG000|Main Study|Randomized but not Dosed|8|||
44319922|NCT02005471|79324513|FG001|Main Study|Randomized but not Dosed|0|||
44319923|NCT02005471|79324514|FG002|Main Study|Randomized but not Dosed|0|||
44319924|NCT02005471|79324515|FG003|Main Study|Randomized but not Dosed|0|||
44319925|NCT02005471|79324512|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
44319926|NCT02005471|79324513|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
44319927|NCT02005471|79324514|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
44319928|NCT02005471|79324515|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
44319929|NCT02005471|79324512|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
44319930|NCT02005471|79324513|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
44319931|NCT02005471|79324514|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
44319932|NCT02005471|79324515|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
44319933|NCT02005471|79324512|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
44319934|NCT02005471|79324513|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
44319935|NCT02005471|79324514|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
44319936|NCT02005471|79324515|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
44319937|NCT01977651|79324526|FG000|4 Month Treatment Period|Adverse Event|34|||
44319938|NCT01977651|79324526|FG000|4 Month Treatment Period|Death|3|||
44319939|NCT01977651|79324526|FG000|4 Month Treatment Period|Progressive Disease|43|||
44319940|NCT01977651|79324526|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
44319941|NCT01977651|79324526|FG000|4 Month Treatment Period|Physician Decision|4|||
44155633|NCT01998880|78947095|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
44319942|NCT01977651|79324526|FG000|1 Year Extension Period|Adverse Event|14|||
44319943|NCT01977651|79324526|FG000|1 Year Extension Period|Death|10|||
44319944|NCT01977651|79324526|FG000|1 Year Extension Period|Lost to Follow-up|2|||
44319945|NCT01977651|79324526|FG000|1 Year Extension Period|Progressive Disease|86|||
44319946|NCT01977651|79324526|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
44319947|NCT01977651|79324526|FG000|1 Year Extension Period|Physician Decision|6|||
44319948|NCT01977651|79324526|FG000|1 Year Extension Period|Miscellaneous|1|||
44319949|NCT01977651|79324526|FG000|Post 1 Year Extension Period|Adverse Event|5|||
44319950|NCT01977651|79324526|FG000|Post 1 Year Extension Period|Death|13|||
44319951|NCT01977651|79324526|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
44319952|NCT01977651|79324526|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
44319953|NCT01977651|79324526|FG000|Post 1 Year Extension Period|Physician Decision|4|||
44319954|NCT01977651|79324526|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
44319955|NCT01949311|79324530|FG000|Overall Study|Lost to Follow-up|73|||
44319956|NCT01949311|79324530|FG000|Overall Study|Terminated by Sponsor|708|||
44319957|NCT01949311|79324530|FG000|Overall Study|Withdrawal by Subject|375|||
44319958|NCT01949311|79324530|FG000|Overall Study|Lack of Efficacy|50|||
44319959|NCT01949311|79324530|FG000|Overall Study|Protocol Deviation|34|||
44319960|NCT01949311|79324530|FG000|Overall Study|Pregnancy|20|||
44319961|NCT01949311|79324530|FG000|Overall Study|Physician Decision|9|||
44319962|NCT01949311|79324530|FG000|Overall Study|Other|4|||
44319963|NCT01949311|79324530|FG000|Overall Study|Adverse Event|107|||
44319964|NCT01933932|79324537|FG000|Overall Study|Death|173|||
44319965|NCT01933932|79324538|FG001|Overall Study|Death|163|||
44319966|NCT01933932|79324537|FG000|Overall Study|Withdrawal by Subject|11|||
44319967|NCT01933932|79324538|FG001|Overall Study|Withdrawal by Subject|14|||
44319968|NCT01933932|79324537|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44319969|NCT01933932|79324538|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44319970|NCT01892722|79324546|FG000|Overall Study|Protocol deviation|0|||
44155634|NCT01998880|78947096|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
44155635|NCT01998880|78947095|FG000|Overall Study|Disease Progression|1|||
44155636|NCT01998880|78947096|FG001|Overall Study|Disease Progression|8|||
44155637|NCT01998880|78947095|FG000|Overall Study|Withdrew Consent|2|||
44155638|NCT01998880|78947096|FG001|Overall Study|Withdrew Consent|1|||
44155639|NCT01998880|78947095|FG000|Overall Study|Death|3|||
44155640|NCT01998880|78947096|FG001|Overall Study|Death|6|||
44155641|NCT01998880|78947095|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44155642|NCT01998880|78947096|FG001|Overall Study|Insufficient Therapeutic Response|5|||
44319971|NCT01892722|79324547|FG001|Overall Study|Protocol deviation|1|||
44319972|NCT01892722|79324546|FG000|Overall Study|Administrative problems|0|||
44319973|NCT01892722|79324547|FG001|Overall Study|Administrative problems|1|||
44319974|NCT01892722|79324546|FG000|Overall Study|Patient/guardian decision|0|||
44319975|NCT01892722|79324547|FG001|Overall Study|Patient/guardian decision|2|||
44319976|NCT01892722|79324546|FG000|Overall Study|Physician Decision|1|||
44319977|NCT01892722|79324547|FG001|Overall Study|Physician Decision|2|||
44319978|NCT01892722|79324546|FG000|Overall Study|Adverse Event|3|||
44319979|NCT01892722|79324547|FG001|Overall Study|Adverse Event|2|||
44319980|NCT01892722|79324546|FG000|Overall Study|Lack of Efficacy|0|||
44319981|NCT01892722|79324547|FG001|Overall Study|Lack of Efficacy|7|||
44319982|NCT01892722|79324546|FG000|Overall Study|Withdrawal by Subject|3|||
44319983|NCT01892722|79324547|FG001|Overall Study|Withdrawal by Subject|5|||
44319984|NCT01698008|79324565|FG000|Overall Study|Withdrawal by Subject|1|||
44319985|NCT01698008|79324566|FG001|Overall Study|Withdrawal by Subject|2|||
44319986|NCT01622868|79324574|FG000|Overall Study|Protocol Violation|7|||
44319987|NCT01622868|79324575|FG001|Overall Study|Protocol Violation|0|||
44319988|NCT01208233|79324604|FG000|Overall Study|Adverse Event|0|||
44319989|NCT01208233|79324605|FG001|Overall Study|Adverse Event|1|||
44421280|NCT00721734|79429181|FG000|Overall Study|Withdrawal by Subject|2|||
44421281|NCT00721734|79429182|FG001|Overall Study|Withdrawal by Subject|1|||
44421282|NCT00721734|79429183|FG002|Overall Study|Withdrawal by Subject|0|||
44421283|NCT00721734|79429184|FG003|Overall Study|Withdrawal by Subject|0|||
44421284|NCT00721734|79429185|FG004|Overall Study|Withdrawal by Subject|1|||
44421285|NCT00721734|79429181|FG000|Overall Study|Other|0|||
44421286|NCT00721734|79429182|FG001|Overall Study|Other|0|||
44421287|NCT00721734|79429183|FG002|Overall Study|Other|0|||
44421288|NCT00721734|79429184|FG003|Overall Study|Other|1|||
44421289|NCT00721734|79429185|FG004|Overall Study|Other|0|||
44421290|NCT00798317|79429199|FG000|Overall Study|Physician Decision|0|||
44421291|NCT00798317|79429200|FG001|Overall Study|Physician Decision|1|||
44421292|NCT00798317|79429199|FG000|Overall Study|Withdrawal by Subject|5|||
44421293|NCT00798317|79429200|FG001|Overall Study|Withdrawal by Subject|4|||
44421294|NCT00798317|79429199|FG000|Overall Study|Lost to Follow-up|2|||
44421295|NCT00798317|79429200|FG001|Overall Study|Lost to Follow-up|2|||
44421296|NCT00798317|79429199|FG000|Overall Study|Adverse Event|2|||
44421297|NCT00798317|79429200|FG001|Overall Study|Adverse Event|0|||
44421298|NCT00798317|79429199|FG000|Overall Study|Death|1|||
44421299|NCT00798317|79429200|FG001|Overall Study|Death|0|||
44421300|NCT00779402|79429208|FG000|Treatment Phase 1|Disease Progression|1|||
44421301|NCT00779402|79429209|FG001|Treatment Phase 1|Disease Progression|0|||
44421302|NCT00779402|79429208|FG000|Treatment Phase 1|Adverse Event|2|||
44421303|NCT00779402|79429209|FG001|Treatment Phase 1|Adverse Event|0|||
44421304|NCT00779402|79429208|FG000|Treatment Phase 1|Protocol Violation|1|||
44421305|NCT00779402|79429209|FG001|Treatment Phase 1|Protocol Violation|0|||
44421306|NCT00779402|79429208|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
44421307|NCT00779402|79429209|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
44421308|NCT00779402|79429208|FG000|Treatment Phase 1|Lost to Follow-up|0|||
44421309|NCT00779402|79429209|FG001|Treatment Phase 1|Lost to Follow-up|1|||
44421310|NCT00779402|79429208|FG000|Treatment Phase 1|Death|0|||
44421311|NCT00779402|79429209|FG001|Treatment Phase 1|Death|1|||
44421312|NCT00779402|79429208|FG000|Treatment Phase 1|Intercurrent Illness|1|||
44155643|NCT01998880|78947095|FG000|Overall Study|Administrative/Other|1|||
44319990|NCT01208233|79324606|FG002|Overall Study|Adverse Event|2|||
44319991|NCT01208233|79324607|FG003|Overall Study|Adverse Event|0|||
44421313|NCT00779402|79429209|FG001|Treatment Phase 1|Intercurrent Illness|1|||
44155644|NCT01998880|78947096|FG001|Overall Study|Administrative/Other|1|||
44319992|NCT01208233|79324608|FG004|Overall Study|Adverse Event|3|||
44319993|NCT01208233|79324609|FG005|Overall Study|Adverse Event|5|||
44319994|NCT01208233|79324604|FG000|Overall Study|Death|0|||
44319995|NCT01208233|79324605|FG001|Overall Study|Death|0|||
44319996|NCT01208233|79324606|FG002|Overall Study|Death|0|||
44319997|NCT01208233|79324607|FG003|Overall Study|Death|0|||
44319998|NCT01208233|79324608|FG004|Overall Study|Death|3|||
44319999|NCT01208233|79324609|FG005|Overall Study|Death|5|||
44320000|NCT01208233|79324604|FG000|Overall Study|Did not meet entrance criteria|2|||
44421314|NCT00779402|79429208|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
44421315|NCT00779402|79429209|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
44421316|NCT00779402|79429208|FG000|Treatment Phase 1|Other|4|||
44421317|NCT00779402|79429209|FG001|Treatment Phase 1|Other|2|||
44320001|NCT01208233|79324605|FG001|Overall Study|Did not meet entrance criteria|1|||
44320002|NCT01208233|79324606|FG002|Overall Study|Did not meet entrance criteria|1|||
44320003|NCT01208233|79324607|FG003|Overall Study|Did not meet entrance criteria|0|||
44320004|NCT01208233|79324608|FG004|Overall Study|Did not meet entrance criteria|1|||
44320005|NCT01208233|79324609|FG005|Overall Study|Did not meet entrance criteria|0|||
44320006|NCT01208233|79324604|FG000|Overall Study|Medication error without adverse event|0|||
44320007|NCT01208233|79324605|FG001|Overall Study|Medication error without adverse event|0|||
44320008|NCT01208233|79324606|FG002|Overall Study|Medication error without adverse event|0|||
44320009|NCT01208233|79324607|FG003|Overall Study|Medication error without adverse event|0|||
44320010|NCT01208233|79324608|FG004|Overall Study|Medication error without adverse event|0|||
44320011|NCT01208233|79324609|FG005|Overall Study|Medication error without adverse event|1|||
44320012|NCT01208233|79324604|FG000|Overall Study|Study terminated by sponsor|0|||
44320013|NCT01208233|79324605|FG001|Overall Study|Study terminated by sponsor|0|||
44320014|NCT01208233|79324606|FG002|Overall Study|Study terminated by sponsor|0|||
44320015|NCT01208233|79324607|FG003|Overall Study|Study terminated by sponsor|0|||
44320016|NCT01208233|79324608|FG004|Overall Study|Study terminated by sponsor|10|||
44320017|NCT01208233|79324609|FG005|Overall Study|Study terminated by sponsor|7|||
44320018|NCT01208233|79324604|FG000|Overall Study|Protocol Violation|0|||
44320019|NCT01208233|79324605|FG001|Overall Study|Protocol Violation|0|||
44320020|NCT01208233|79324606|FG002|Overall Study|Protocol Violation|0|||
44320021|NCT01208233|79324607|FG003|Overall Study|Protocol Violation|0|||
44320022|NCT01208233|79324608|FG004|Overall Study|Protocol Violation|3|||
44320023|NCT01208233|79324609|FG005|Overall Study|Protocol Violation|0|||
44320024|NCT01208233|79324604|FG000|Overall Study|Other|2|||
44320025|NCT01208233|79324605|FG001|Overall Study|Other|1|||
44320026|NCT01208233|79324606|FG002|Overall Study|Other|0|||
44320027|NCT01208233|79324607|FG003|Overall Study|Other|0|||
44320028|NCT01208233|79324608|FG004|Overall Study|Other|0|||
44320029|NCT01208233|79324609|FG005|Overall Study|Other|1|||
44320030|NCT01208233|79324604|FG000|Overall Study|Withdrawal by Subject|1|||
44536237|NCT03753763|79547014|FG000|Overall Study|Withdrawal by Subject|3|||
44536238|NCT03753763|79547015|FG001|Overall Study|Withdrawal by Subject|1|||
44536239|NCT03753763|79547014|FG000|Overall Study|clinical deterioration|1|||
44536240|NCT03753763|79547015|FG001|Overall Study|clinical deterioration|0|||
44536241|NCT03384966|79547024|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
44155645|NCT01998880|78947095|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
44155646|NCT01998880|78947096|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
44155647|NCT01998880|78947095|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
44155648|NCT01998880|78947096|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
44155649|NCT01998880|78947095|FG000|Overall Study|Did Not Receive Treatment|3|||
44155650|NCT01998880|78947096|FG001|Overall Study|Did Not Receive Treatment|2|||
44258033|NCT01405820|79112182|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
44258034|NCT01405820|79112183|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
44258035|NCT01405820|79112184|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
44258036|NCT01405820|79112185|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
44258037|NCT01405820|79112186|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
44258038|NCT01405820|79112187|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
44258039|NCT01405820|79112182|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
44258040|NCT01405820|79112183|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
44258041|NCT01405820|79112184|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
44258042|NCT01405820|79112185|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
44258043|NCT01405820|79112186|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
44258044|NCT01405820|79112187|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
44258045|NCT01405820|79112182|FG000|Randomized Treatment Period|Death|0|||
44258046|NCT01405820|79112183|FG001|Randomized Treatment Period|Death|0|||
44258047|NCT01405820|79112184|FG002|Randomized Treatment Period|Death|0|||
44258048|NCT01405820|79112185|FG003|Randomized Treatment Period|Death|1|||
44258049|NCT01405820|79112186|FG004|Randomized Treatment Period|Death|0|||
44258050|NCT01405820|79112187|FG005|Randomized Treatment Period|Death|0|||
44258051|NCT01405820|79112182|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
44258052|NCT01405820|79112183|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
44258053|NCT01405820|79112184|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
44258054|NCT01405820|79112185|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
44258055|NCT01405820|79112186|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
44258056|NCT01405820|79112187|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
44258057|NCT01405820|79112182|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
44258058|NCT01405820|79112183|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
44258059|NCT01405820|79112184|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
44320031|NCT01208233|79324605|FG001|Overall Study|Withdrawal by Subject|0|||
44320032|NCT01208233|79324606|FG002|Overall Study|Withdrawal by Subject|1|||
44536242|NCT03384966|79547025|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
44536243|NCT03384966|79547026|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
44320033|NCT01208233|79324607|FG003|Overall Study|Withdrawal by Subject|1|||
44320034|NCT01208233|79324608|FG004|Overall Study|Withdrawal by Subject|4|||
44320035|NCT01208233|79324609|FG005|Overall Study|Withdrawal by Subject|2|||
44320036|NCT01208038|79324629|FG000|Overall Study|Withdrawal by Subject|1|||
44320037|NCT01207687|79324633|FG000|Overall Study|Adverse Event|1|||
44320038|NCT01207687|79324633|FG000|Overall Study|Withdrawal by Subject|1|||
44320039|NCT01207453|79324645|FG000|First Intervention|Adverse Event|2|||
44320040|NCT01207453|79324646|FG001|First Intervention|Adverse Event|1|||
44320041|NCT01207453|79324645|FG000|Washout|Adverse Event|1|||
44320042|NCT01207453|79324646|FG001|Washout|Adverse Event|0|||
44320043|NCT01207453|79324645|FG000|Washout|Lost to Follow-up|1|||
44320044|NCT01207453|79324646|FG001|Washout|Lost to Follow-up|0|||
44320045|NCT01207453|79324645|FG000|2nd Intervention|Adverse Event|1|||
44320046|NCT01207453|79324646|FG001|2nd Intervention|Adverse Event|2|||
44320047|NCT01207453|79324645|FG000|2nd Intervention|Lost to Follow-up|1|||
44320048|NCT01207453|79324646|FG001|2nd Intervention|Lost to Follow-up|0|||
44320049|NCT01207414|79324657|FG000|Overall Study|Adverse Event|25|||
44320050|NCT01207414|79324658|FG001|Overall Study|Adverse Event|39|||
44320051|NCT01207414|79324657|FG000|Overall Study|Abnormal test procedure results|0|||
44320052|NCT01207414|79324658|FG001|Overall Study|Abnormal test procedure results|1|||
44320053|NCT01207414|79324657|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
44320054|NCT01207414|79324658|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
44320055|NCT01207414|79324657|FG000|Overall Study|Patient withdrew consent|14|||
44320056|NCT01207414|79324658|FG001|Overall Study|Patient withdrew consent|11|||
44320057|NCT01207414|79324657|FG000|Overall Study|Lost to Follow-up|15|||
44320058|NCT01207414|79324658|FG001|Overall Study|Lost to Follow-up|17|||
44320059|NCT01207414|79324657|FG000|Overall Study|Administrative problems|1|||
44320060|NCT01207414|79324658|FG001|Overall Study|Administrative problems|1|||
44320061|NCT01207414|79324657|FG000|Overall Study|Protocol deviation|12|||
44320062|NCT01207414|79324658|FG001|Overall Study|Protocol deviation|9|||
44320063|NCT01207414|79324657|FG000|Overall Study|Randomized in error|1|||
44320064|NCT01207414|79324658|FG001|Overall Study|Randomized in error|0|||
44320065|NCT01207219|79324667|FG000|Overall Study|changed diagnosis during study period|5|||
44320066|NCT01207219|79324668|FG001|Overall Study|changed diagnosis during study period|3|||
44320067|NCT01207219|79324669|FG002|Overall Study|changed diagnosis during study period|1|||
44320068|NCT01207219|79324667|FG000|Overall Study|Lost to Follow-up|6|||
44320069|NCT01207219|79324668|FG001|Overall Study|Lost to Follow-up|8|||
44320070|NCT01207219|79324669|FG002|Overall Study|Lost to Follow-up|6|||
44320071|NCT01206517|79324683|FG000|Overall Study|Withdrawal by Subject|0|||
44320072|NCT01206517|79324684|FG001|Overall Study|Withdrawal by Subject|0|||
44320073|NCT01206517|79324685|FG002|Overall Study|Withdrawal by Subject|2|||
44320074|NCT01206517|79324686|FG003|Overall Study|Withdrawal by Subject|0|||
44320075|NCT01206517|79324687|FG004|Overall Study|Withdrawal by Subject|1|||
44320076|NCT01206517|79324688|FG005|Overall Study|Withdrawal by Subject|0|||
44320077|NCT01206439|79324699|FG000|Overall Study|subject did not meet inclusion criteria|1|||
44320078|NCT01206322|79324705|FG000|Overall Study|Adverse Event|0|||
44320079|NCT01206322|79324706|FG001|Overall Study|Adverse Event|0|||
44320080|NCT01206322|79324707|FG002|Overall Study|Adverse Event|0|||
44320081|NCT01206322|79324708|FG003|Overall Study|Adverse Event|1|||
44320082|NCT01206166|79324720|FG000|Overall Study|No evaluable data|2|||
44320083|NCT01206166|79324721|FG001|Overall Study|No evaluable data|3|||
44320084|NCT01207102|79324730|FG000|Overall Study|Withdrawal by Subject|5|||
44320085|NCT01207102|79324730|FG000|Overall Study|Adverse Event|2|||
44320086|NCT01207102|79324730|FG000|Overall Study|progression|2|||
44320087|NCT01207102|79324730|FG000|Overall Study|Withdrawal by Treating Physician|1|||
44320088|NCT01205776|79324746|FG000|Overall Study|Lost to Follow-up|53|||
44320089|NCT01205776|79324747|FG001|Overall Study|Lost to Follow-up|61|||
44320090|NCT01205776|79324746|FG000|Overall Study|Withdrawal by Subject|11|||
44320091|NCT01205776|79324747|FG001|Overall Study|Withdrawal by Subject|34|||
44320092|NCT01205581|79324759|FG000|Overall Study|Withdrawal by Subject|1|||
44320093|NCT01205581|79324760|FG001|Overall Study|Withdrawal by Subject|0|||
44320094|NCT01205581|79324761|FG002|Overall Study|Withdrawal by Subject|0|||
44320095|NCT01205581|79324762|FG003|Overall Study|Withdrawal by Subject|0|||
44320096|NCT01205581|79324763|FG004|Overall Study|Withdrawal by Subject|0|||
44320097|NCT01205581|79324764|FG005|Overall Study|Withdrawal by Subject|0|||
44320098|NCT01205269|79324795|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
44320099|NCT01205269|79324796|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
44320100|NCT01205269|79324797|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
44320101|NCT01205269|79324798|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
44320102|NCT01205269|79324799|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
44320103|NCT01205269|79324800|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
44320104|NCT01240915|79324825|FG000|Overall Study|Adverse Event|0|||
44320105|NCT01240915|79324826|FG001|Overall Study|Adverse Event|0|||
44320106|NCT01240915|79324827|FG002|Overall Study|Adverse Event|0|||
44421318|NCT00779402|79429208|FG000|Treatment Phase 1|Closure of Study|3|||
44421319|NCT00779402|79429209|FG001|Treatment Phase 1|Closure of Study|2|||
44320107|NCT01240915|79324828|FG003|Overall Study|Adverse Event|1|||
44320108|NCT01240915|79324829|FG004|Overall Study|Adverse Event|0|||
44320109|NCT01240915|79324830|FG005|Overall Study|Adverse Event|2|||
44320110|NCT01240915|79324831|FG006|Overall Study|Adverse Event|0|||
44320111|NCT01240915|79324832|FG007|Overall Study|Adverse Event|0|||
44320112|NCT01240915|79324833|FG008|Overall Study|Adverse Event|1|||
44320113|NCT01240915|79324825|FG000|Overall Study|Lost to Follow-up|0|||
44320114|NCT01240915|79324826|FG001|Overall Study|Lost to Follow-up|0|||
44320115|NCT01240915|79324827|FG002|Overall Study|Lost to Follow-up|0|||
44320116|NCT01240915|79324828|FG003|Overall Study|Lost to Follow-up|0|||
44320117|NCT01240915|79324829|FG004|Overall Study|Lost to Follow-up|1|||
44320118|NCT01240915|79324830|FG005|Overall Study|Lost to Follow-up|1|||
44320119|NCT01240915|79324831|FG006|Overall Study|Lost to Follow-up|0|||
44155651|NCT01975948|78947106|FG000|Overall Study|Withdrawal by Subject|17|||
44155652|NCT01975948|78947107|FG001|Overall Study|Withdrawal by Subject|21|||
44155653|NCT01975948|78947108|FG002|Overall Study|Withdrawal by Subject|7|||
44155654|NCT01975948|78947109|FG003|Overall Study|Withdrawal by Subject|6|||
44155655|NCT01975246|78947121|FG000|Overall Study|Adverse Event|2|||
44155656|NCT01975246|78947122|FG001|Overall Study|Adverse Event|1|||
44155657|NCT01975246|78947121|FG000|Overall Study|Lack of Efficacy|1|||
44155658|NCT01975246|78947122|FG001|Overall Study|Lack of Efficacy|0|||
44155659|NCT01975246|78947121|FG000|Overall Study|Protocol Violation|1|||
44155660|NCT01975246|78947122|FG001|Overall Study|Protocol Violation|0|||
44320120|NCT01240915|79324832|FG007|Overall Study|Lost to Follow-up|1|||
44320121|NCT01240915|79324833|FG008|Overall Study|Lost to Follow-up|1|||
44320122|NCT01240915|79324825|FG000|Overall Study|Withdrawal by Subject|2|||
44320123|NCT01240915|79324826|FG001|Overall Study|Withdrawal by Subject|1|||
44320124|NCT01240915|79324827|FG002|Overall Study|Withdrawal by Subject|0|||
44320125|NCT01240915|79324828|FG003|Overall Study|Withdrawal by Subject|2|||
44320126|NCT01240915|79324829|FG004|Overall Study|Withdrawal by Subject|0|||
44320127|NCT01240915|79324830|FG005|Overall Study|Withdrawal by Subject|4|||
44320128|NCT01240915|79324831|FG006|Overall Study|Withdrawal by Subject|2|||
44536244|NCT03384966|79547024|FG000|Follow-up Period|Adverse Event|1|||
44536245|NCT03384966|79547025|FG001|Follow-up Period|Adverse Event|0|||
44536246|NCT03384966|79547026|FG002|Follow-up Period|Adverse Event|0|||
44536247|NCT03402126|79547043|FG000|Overall Study|Lost to Follow-up|6|||
44536248|NCT03402126|79547043|FG000|Overall Study|Protocol Violation|10|||
44536249|NCT03402126|79547043|FG000|Overall Study|Sponsor request/Study termination|29|||
44536250|NCT03402126|79547043|FG000|Overall Study|Study product no longer in use|1|||
44536251|NCT03402126|79547043|FG000|Overall Study|Technical problems|1|||
44320129|NCT01240915|79324832|FG007|Overall Study|Withdrawal by Subject|3|||
44320130|NCT01240915|79324833|FG008|Overall Study|Withdrawal by Subject|3|||
44536252|NCT03402126|79547043|FG000|Overall Study|Withdrawal by Subject|6|||
44536253|NCT03402126|79547043|FG000|Overall Study|Physician Decision|2|||
44320131|NCT01240915|79324825|FG000|Overall Study|Other|0|||
44320132|NCT01240915|79324826|FG001|Overall Study|Other|0|||
44320133|NCT01240915|79324827|FG002|Overall Study|Other|0|||
44320134|NCT01240915|79324828|FG003|Overall Study|Other|0|||
44536254|NCT03402126|79547043|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
44536255|NCT03402126|79547043|FG000|Overall Study|Death|4|||
44536256|NCT03355326|79547049|FG000|Overall Study|Protocol Violation|3|||
44536257|NCT03355326|79547050|FG001|Overall Study|Protocol Violation|3|||
44536258|NCT03353220|79547056|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
44536259|NCT03353220|79547057|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
44536260|NCT03751657|79547065|FG000|Overall Study|Physician Decision|0|||
44536261|NCT03751657|79547066|FG001|Overall Study|Physician Decision|1|||
44536262|NCT03751657|79547065|FG000|Overall Study|Withdrawal by Subject|1|||
44536263|NCT03751657|79547066|FG001|Overall Study|Withdrawal by Subject|1|||
44536264|NCT03751657|79547065|FG000|Overall Study|Lost to Follow-up|2|||
44536265|NCT03751657|79547066|FG001|Overall Study|Lost to Follow-up|1|||
44536266|NCT00025259|79547079|FG000|Overall Study|Death|1|||
44155661|NCT01975246|78947121|FG000|Overall Study|Other than stated|0|||
44320135|NCT01240915|79324829|FG004|Overall Study|Other|2|||
44320136|NCT01240915|79324830|FG005|Overall Study|Other|0|||
44320137|NCT01240915|79324831|FG006|Overall Study|Other|0|||
44320138|NCT01240915|79324832|FG007|Overall Study|Other|0|||
44320139|NCT01240915|79324833|FG008|Overall Study|Other|0|||
44421320|NCT00779402|79429208|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
44536267|NCT00025259|79547080|FG001|Overall Study|Death|3|||
44536268|NCT00025259|79547081|FG002|Overall Study|Death|0|||
44155662|NCT01975246|78947122|FG001|Overall Study|Other than stated|1|||
44155663|NCT01621126|78947128|FG000|Overall Study|Physician Decision|6|||
44536269|NCT00025259|79547082|FG003|Overall Study|Death|3|||
44536270|NCT00025259|79547083|FG004|Overall Study|Death|0|||
44421321|NCT00779402|79429209|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
44320140|NCT01240915|79324825|FG000|Overall Study|Insufficient Clinical Response|0|||
44320141|NCT01240915|79324826|FG001|Overall Study|Insufficient Clinical Response|0|||
44320142|NCT01240915|79324827|FG002|Overall Study|Insufficient Clinical Response|0|||
44536271|NCT00025259|79547084|FG005|Overall Study|Death|1|||
44320143|NCT01240915|79324828|FG003|Overall Study|Insufficient Clinical Response|0|||
44320144|NCT01240915|79324829|FG004|Overall Study|Insufficient Clinical Response|1|||
44320145|NCT01240915|79324830|FG005|Overall Study|Insufficient Clinical Response|3|||
44320146|NCT01240915|79324831|FG006|Overall Study|Insufficient Clinical Response|6|||
44320147|NCT01240915|79324832|FG007|Overall Study|Insufficient Clinical Response|0|||
44320148|NCT01240915|79324833|FG008|Overall Study|Insufficient Clinical Response|3|||
44320149|NCT01239745|79324855|FG000|Overall Study|Study terminated by sponsor|45|||
44320150|NCT01239745|79324855|FG000|Overall Study|Adverse Event|1|||
44320151|NCT01239472|79324861|FG000|Overall Study|Withdrawal by Subject|5|||
44320152|NCT01239472|79324862|FG001|Overall Study|Withdrawal by Subject|1|||
44320153|NCT01239472|79324861|FG000|Overall Study|Adverse Event|0|||
44320154|NCT01239472|79324862|FG001|Overall Study|Adverse Event|1|||
44320155|NCT01239472|79324861|FG000|Overall Study|Lack of Efficacy|0|||
44320156|NCT01239472|79324862|FG001|Overall Study|Lack of Efficacy|1|||
44320157|NCT01229449|79324875|FG000|Overall Study|Withdrawal by Subject|0|||
44320158|NCT01229449|79324876|FG001|Overall Study|Withdrawal by Subject|3|||
44320159|NCT01229449|79324877|FG002|Overall Study|Withdrawal by Subject|0|||
44320160|NCT01229449|79324878|FG003|Overall Study|Withdrawal by Subject|1|||
44536272|NCT00025259|79547085|FG006|Overall Study|Death|2|||
44536273|NCT00025259|79547079|FG000|Overall Study|Lack of Efficacy|2|||
44536274|NCT00025259|79547080|FG001|Overall Study|Lack of Efficacy|46|||
44320161|NCT01229449|79324879|FG004|Overall Study|Withdrawal by Subject|1|||
44320162|NCT01229449|79324875|FG000|Overall Study|Lost to Follow-up|1|||
44320163|NCT01229449|79324876|FG001|Overall Study|Lost to Follow-up|1|||
44320164|NCT01229449|79324877|FG002|Overall Study|Lost to Follow-up|1|||
44320165|NCT01229449|79324878|FG003|Overall Study|Lost to Follow-up|0|||
44320166|NCT01229449|79324879|FG004|Overall Study|Lost to Follow-up|0|||
44320167|NCT01229449|79324875|FG000|Overall Study|Physician Decision|0|||
44320168|NCT01229449|79324876|FG001|Overall Study|Physician Decision|0|||
44320169|NCT01229449|79324877|FG002|Overall Study|Physician Decision|1|||
44320170|NCT01229449|79324878|FG003|Overall Study|Physician Decision|0|||
44320171|NCT01229449|79324879|FG004|Overall Study|Physician Decision|0|||
44320172|NCT01239316|79324891|FG000|Overall Study|Progression/Relapse|11|||
44536275|NCT00025259|79547081|FG002|Overall Study|Lack of Efficacy|60|||
44536276|NCT00025259|79547082|FG003|Overall Study|Lack of Efficacy|78|||
44536277|NCT00025259|79547083|FG004|Overall Study|Lack of Efficacy|11|||
44536278|NCT00025259|79547084|FG005|Overall Study|Lack of Efficacy|30|||
44536279|NCT00025259|79547085|FG006|Overall Study|Lack of Efficacy|38|||
44536280|NCT00025259|79547079|FG000|Overall Study|Lost to Follow-up|2|||
44536281|NCT00025259|79547080|FG001|Overall Study|Lost to Follow-up|9|||
44536282|NCT00025259|79547081|FG002|Overall Study|Lost to Follow-up|13|||
44536283|NCT00025259|79547082|FG003|Overall Study|Lost to Follow-up|13|||
44536284|NCT00025259|79547083|FG004|Overall Study|Lost to Follow-up|1|||
44536285|NCT00025259|79547084|FG005|Overall Study|Lost to Follow-up|3|||
44536286|NCT00025259|79547085|FG006|Overall Study|Lost to Follow-up|1|||
44536287|NCT00025259|79547079|FG000|Overall Study|Physician Decision|12|||
44536288|NCT00025259|79547080|FG001|Overall Study|Physician Decision|1|||
44536289|NCT00025259|79547081|FG002|Overall Study|Physician Decision|0|||
44536290|NCT00025259|79547082|FG003|Overall Study|Physician Decision|5|||
44536291|NCT00025259|79547083|FG004|Overall Study|Physician Decision|4|||
44536292|NCT00025259|79547084|FG005|Overall Study|Physician Decision|2|||
44536293|NCT00025259|79547085|FG006|Overall Study|Physician Decision|1|||
44536294|NCT00025259|79547079|FG000|Overall Study|Protocol Violation|3|||
44536295|NCT00025259|79547080|FG001|Overall Study|Protocol Violation|2|||
44536296|NCT00025259|79547081|FG002|Overall Study|Protocol Violation|2|||
44536297|NCT00025259|79547082|FG003|Overall Study|Protocol Violation|1|||
44536298|NCT00025259|79547083|FG004|Overall Study|Protocol Violation|2|||
44155664|NCT01973998|78947134|FG000|Overall Study|Death|2|||
44320173|NCT01239316|79324891|FG000|Overall Study|Adverse Event|1|||
44320174|NCT01239160|79324897|FG000|Overall Study|Lost to Follow-up|3|||
44320175|NCT01239160|79324898|FG001|Overall Study|Lost to Follow-up|5|||
44320176|NCT01239160|79324899|FG002|Overall Study|Lost to Follow-up|0|||
44320177|NCT01239160|79324897|FG000|Overall Study|Withdrawal by Subject|17|||
44320178|NCT01239160|79324898|FG001|Overall Study|Withdrawal by Subject|6|||
44320179|NCT01239160|79324899|FG002|Overall Study|Withdrawal by Subject|2|||
44320180|NCT01239160|79324897|FG000|Overall Study|Physician Decision|5|||
44536299|NCT00025259|79547084|FG005|Overall Study|Protocol Violation|1|||
44536300|NCT00025259|79547085|FG006|Overall Study|Protocol Violation|3|||
44536301|NCT00025259|79547079|FG000|Overall Study|Withdrawal by Subject|9|||
44536302|NCT00025259|79547080|FG001|Overall Study|Withdrawal by Subject|27|||
44536303|NCT00025259|79547081|FG002|Overall Study|Withdrawal by Subject|6|||
44536304|NCT00025259|79547082|FG003|Overall Study|Withdrawal by Subject|14|||
44536305|NCT00025259|79547083|FG004|Overall Study|Withdrawal by Subject|11|||
44536306|NCT00025259|79547084|FG005|Overall Study|Withdrawal by Subject|8|||
44320181|NCT01239160|79324898|FG001|Overall Study|Physician Decision|7|||
44320182|NCT01239160|79324899|FG002|Overall Study|Physician Decision|2|||
44536307|NCT00025259|79547085|FG006|Overall Study|Withdrawal by Subject|3|||
44536308|NCT00025259|79547079|FG000|Overall Study|Ineligible|14|||
44320183|NCT01239160|79324897|FG000|Overall Study|Early Termination Due to Study Closure|0|||
44320184|NCT01239160|79324898|FG001|Overall Study|Early Termination Due to Study Closure|1|||
44320185|NCT01239160|79324899|FG002|Overall Study|Early Termination Due to Study Closure|6|||
44320186|NCT01239121|79324908|FG000|Overall Study|Withdrawal by Subject|2|||
44320187|NCT01239121|79324909|FG001|Overall Study|Withdrawal by Subject|4|||
44320188|NCT01239121|79324910|FG002|Overall Study|Withdrawal by Subject|0|||
44320189|NCT01239043|79324920|FG000|Overall Study|Protocol Violation|2|||
44320190|NCT01239043|79324921|FG001|Overall Study|Protocol Violation|1|||
44320191|NCT01238848|79324929|FG000|Overall Study|Physician Decision|13|||
44320192|NCT01238848|79324930|FG001|Overall Study|Physician Decision|5|||
44320193|NCT01238575|79324938|FG000|Overall Study|Lack of Efficacy|2|||
44320194|NCT01238575|79324939|FG001|Overall Study|Lack of Efficacy|4|||
44320195|NCT01238575|79324938|FG000|Overall Study|Adverse Event|2|||
44320196|NCT01238575|79324939|FG001|Overall Study|Adverse Event|0|||
44320197|NCT05376215|79324951|FG000|Overall Study|Withdrawal by Subject|2|||
44320198|NCT05376215|79324952|FG001|Overall Study|Withdrawal by Subject|1|||
44320199|NCT05376215|79324951|FG000|Overall Study|Lost to Follow-up|0|||
44320200|NCT05376215|79324952|FG001|Overall Study|Lost to Follow-up|1|||
44421322|NCT00779402|79429208|FG000|Surveillance Phase|Protocol Violation|0|||
44536309|NCT00025259|79547080|FG001|Overall Study|Ineligible|1|||
44536310|NCT00025259|79547081|FG002|Overall Study|Ineligible|0|||
44536311|NCT00025259|79547082|FG003|Overall Study|Ineligible|0|||
44536312|NCT00025259|79547083|FG004|Overall Study|Ineligible|6|||
44536313|NCT00025259|79547084|FG005|Overall Study|Ineligible|0|||
44536314|NCT00025259|79547085|FG006|Overall Study|Ineligible|1|||
44536315|NCT00025259|79547079|FG000|Overall Study|Randomization error|1|||
44536316|NCT00025259|79547080|FG001|Overall Study|Randomization error|0|||
44536317|NCT00025259|79547081|FG002|Overall Study|Randomization error|0|||
44536318|NCT00025259|79547082|FG003|Overall Study|Randomization error|0|||
44536319|NCT00025259|79547083|FG004|Overall Study|Randomization error|1|||
44536320|NCT00025259|79547084|FG005|Overall Study|Randomization error|7|||
44536321|NCT00025259|79547085|FG006|Overall Study|Randomization error|2|||
44536322|NCT00025259|79547079|FG000|Overall Study|Adverse Event|1|||
44536323|NCT00025259|79547080|FG001|Overall Study|Adverse Event|0|||
44536324|NCT00025259|79547081|FG002|Overall Study|Adverse Event|0|||
44536325|NCT00025259|79547082|FG003|Overall Study|Adverse Event|0|||
44536326|NCT00025259|79547083|FG004|Overall Study|Adverse Event|0|||
44536327|NCT00025259|79547084|FG005|Overall Study|Adverse Event|0|||
44536328|NCT00025259|79547085|FG006|Overall Study|Adverse Event|0|||
44536329|NCT03351738|79547110|FG000|Overall Study|Withdrawal by Subject|0|||
44536330|NCT03351738|79547111|FG001|Overall Study|Withdrawal by Subject|1|||
44536331|NCT03351738|79547112|FG002|Overall Study|Withdrawal by Subject|0|||
44155665|NCT01973998|78947135|FG001|Overall Study|Death|2|||
44155666|NCT02664415|78947143|FG000|Overall Study|Adverse Event|1|||
44155667|NCT02664415|78947144|FG001|Overall Study|Adverse Event|0|||
44155668|NCT02661061|78947152|FG000|Overall Study|Lack of Efficacy|1|||
44155669|NCT02661061|78947153|FG001|Overall Study|Lack of Efficacy|1|||
44155670|NCT02661061|78947152|FG000|Overall Study|Withdrawal by Subject|1|||
44155671|NCT02661061|78947153|FG001|Overall Study|Withdrawal by Subject|1|||
44155672|NCT01995838|78947166|FG000|Overall Study|Lost to Follow-up|0|||
44155673|NCT01995838|78947167|FG001|Overall Study|Lost to Follow-up|1|||
44155674|NCT01995838|78947168|FG002|Overall Study|Lost to Follow-up|0|||
44155675|NCT01995838|78947169|FG003|Overall Study|Lost to Follow-up|0|||
44155676|NCT01995838|78947170|FG004|Overall Study|Lost to Follow-up|0|||
44155677|NCT01995838|78947171|FG005|Overall Study|Lost to Follow-up|0|||
44155678|NCT01995838|78947172|FG006|Overall Study|Lost to Follow-up|1|||
44155679|NCT01995838|78947166|FG000|Overall Study|Participant choice|2|||
44155680|NCT01995838|78947167|FG001|Overall Study|Participant choice|0|||
44155681|NCT01995838|78947168|FG002|Overall Study|Participant choice|0|||
44155682|NCT01995838|78947169|FG003|Overall Study|Participant choice|0|||
44155683|NCT01995838|78947170|FG004|Overall Study|Participant choice|0|||
44155684|NCT01995838|78947171|FG005|Overall Study|Participant choice|1|||
44155685|NCT01995838|78947172|FG006|Overall Study|Participant choice|1|||
44155686|NCT01995838|78947166|FG000|Overall Study|Adverse Event|0|||
44155687|NCT01995838|78947167|FG001|Overall Study|Adverse Event|0|||
44155688|NCT01995838|78947168|FG002|Overall Study|Adverse Event|0|||
44155689|NCT01995838|78947169|FG003|Overall Study|Adverse Event|0|||
44155690|NCT01995838|78947170|FG004|Overall Study|Adverse Event|0|||
44536332|NCT03351738|79547113|FG003|Overall Study|Withdrawal by Subject|1|||
44536333|NCT03351738|79547114|FG004|Overall Study|Withdrawal by Subject|0|||
44536334|NCT03351738|79547115|FG005|Overall Study|Withdrawal by Subject|0|||
44536335|NCT03351114|79547134|FG000|Overall Study|Withdrawal by Subject|1|||
44536336|NCT03350256|79547138|FG000|Overall Study|Inclusion/exclusion violation|4|||
44536337|NCT03350256|79547138|FG000|Overall Study|Recommended for other therapies|2|||
44536338|NCT03350256|79547138|FG000|Overall Study|Protocol Violation|3|||
44536339|NCT03350256|79547138|FG000|Overall Study|Non compliance|2|||
44155691|NCT01995838|78947171|FG005|Overall Study|Adverse Event|0|||
44155692|NCT01995838|78947172|FG006|Overall Study|Adverse Event|1|||
44155693|NCT01995838|78947166|FG000|Overall Study|Withdrawal by Subject|0|||
44536340|NCT03350256|79547138|FG000|Overall Study|Denial by insurance|1|||
44536341|NCT03350256|79547138|FG000|Overall Study|Adverse Event|2|||
44536342|NCT03350256|79547138|FG000|Overall Study|Trial failure|12|||
44536343|NCT03350256|79547138|FG000|Overall Study|Did not proceed to permanent implant|3|||
44536344|NCT03350256|79547138|FG000|Overall Study|Withdrawal by Subject|3|||
44536345|NCT03350256|79547138|FG000|Overall Study|Subject moving out of state|1|||
44536346|NCT03350256|79547138|FG000|Overall Study|Lost to Follow-up|1|||
44536347|NCT03350256|79547138|FG000|Overall Study|Lack of Efficacy|2|||
44536348|NCT00024167|79547145|FG000|Overall Study|Death|53|||
44536349|NCT00024167|79547146|FG001|Overall Study|Death|47|||
44536350|NCT00022763|79547155|FG000|Overall Study|Adverse Event|1|||
44536351|NCT00022763|79547156|FG001|Overall Study|Adverse Event|2|||
44536352|NCT00022763|79547155|FG000|Overall Study|Injection Site Reactions|0|||
44536353|NCT00022763|79547156|FG001|Overall Study|Injection Site Reactions|2|||
44536354|NCT00022763|79547155|FG000|Overall Study|Death|0|||
44536355|NCT00022763|79547156|FG001|Overall Study|Death|1|||
44536356|NCT00022763|79547155|FG000|Overall Study|Lost to Follow-up|0|||
44536357|NCT00022763|79547156|FG001|Overall Study|Lost to Follow-up|3|||
44536358|NCT00022763|79547155|FG000|Overall Study|Withdrawal by Subject|4|||
44536359|NCT00022763|79547156|FG001|Overall Study|Withdrawal by Subject|7|||
44536360|NCT00022763|79547155|FG000|Overall Study|Insufficient Therapy|1|||
44536361|NCT00022763|79547156|FG001|Overall Study|Insufficient Therapy|0|||
44536362|NCT00022763|79547155|FG000|Overall Study|Admin|3|||
44536363|NCT00022763|79547156|FG001|Overall Study|Admin|2|||
44536364|NCT00071513|79547163|FG000|Intervention Component|Withdrawal by Subject|2|||
44536365|NCT00071513|79547164|FG001|Intervention Component|Withdrawal by Subject|3|||
44536366|NCT00071513|79547163|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
44536367|NCT00071513|79547164|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
44536368|NCT00006389|79547172|FG000|Overall Study|Adverse Event|1|||
44536369|NCT00006305|79547181|FG000|Overall Study|Withdrawal by Subject|17|||
44536370|NCT00006305|79547182|FG001|Overall Study|Withdrawal by Subject|10|||
44536371|NCT00006305|79547183|FG002|Overall Study|Withdrawal by Subject|15|||
44536372|NCT00006305|79547184|FG003|Overall Study|Withdrawal by Subject|14|||
44320201|NCT04447794|79324981|FG000|Overall Study|Lost to Follow-up|2|||
44536373|NCT03529773|79547234|FG000|Overall Study|Adverse Event|0|||
44536374|NCT03529773|79547235|FG001|Overall Study|Adverse Event|0|||
44536375|NCT03529773|79547236|FG002|Overall Study|Adverse Event|0|||
44536376|NCT03529773|79547237|FG003|Overall Study|Adverse Event|0|||
44536377|NCT03529773|79547238|FG004|Overall Study|Adverse Event|0|||
44536378|NCT03529773|79547239|FG005|Overall Study|Adverse Event|0|||
44536379|NCT03529773|79547240|FG006|Overall Study|Adverse Event|0|||
44536380|NCT03529773|79547241|FG007|Overall Study|Adverse Event|0|||
44536381|NCT03529773|79547242|FG008|Overall Study|Adverse Event|0|||
44536382|NCT03529773|79547243|FG009|Overall Study|Adverse Event|0|||
44536383|NCT03529773|79547244|FG010|Overall Study|Adverse Event|0|||
44536384|NCT03529773|79547245|FG011|Overall Study|Adverse Event|0|||
44536385|NCT03529773|79547246|FG012|Overall Study|Adverse Event|0|||
44320202|NCT04447794|79324982|FG001|Overall Study|Lost to Follow-up|3|||
44320203|NCT04447794|79324983|FG002|Overall Study|Lost to Follow-up|8|||
44320204|NCT04447794|79324981|FG000|Overall Study|Withdrawal by Subject|1|||
44320205|NCT04447794|79324982|FG001|Overall Study|Withdrawal by Subject|1|||
44320206|NCT04447794|79324983|FG002|Overall Study|Withdrawal by Subject|0|||
44320207|NCT04138576|79324996|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
44320208|NCT04009291|79325010|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
44320209|NCT04009291|79325011|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
44320210|NCT04009291|79325012|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
44320211|NCT04009291|79325013|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
44320212|NCT04009291|79325014|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
44320213|NCT04009291|79325010|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
44320214|NCT04009291|79325011|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
44320215|NCT04009291|79325012|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
44320216|NCT04009291|79325013|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
44320217|NCT04009291|79325014|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
44320218|NCT03811340|79325025|FG000|Overall Study|subjects did not complete the survey.|90|||
44320219|NCT03668119|79325040|FG000|Pre-treatment|Disease Progression|1|||
44320220|NCT03668119|79325041|FG001|Pre-treatment|Disease Progression|0|||
44320221|NCT03668119|79325040|FG000|Treatment|Disease Progression|75|||
44536386|NCT03529773|79547247|FG013|Overall Study|Adverse Event|0|||
44536387|NCT03529773|79547248|FG014|Overall Study|Adverse Event|0|||
44536388|NCT03529773|79547249|FG015|Overall Study|Adverse Event|0|||
44536389|NCT03529773|79547250|FG016|Overall Study|Adverse Event|0|||
44536390|NCT03529773|79547251|FG017|Overall Study|Adverse Event|0|||
44536391|NCT03529773|79547252|FG018|Overall Study|Adverse Event|0|||
44536392|NCT03529773|79547253|FG019|Overall Study|Adverse Event|0|||
44536393|NCT03529773|79547254|FG020|Overall Study|Adverse Event|0|||
44536394|NCT03529773|79547255|FG021|Overall Study|Adverse Event|0|||
44536395|NCT03529773|79547256|FG022|Overall Study|Adverse Event|0|||
44320222|NCT03668119|79325041|FG001|Treatment|Disease Progression|55|||
44320223|NCT03668119|79325040|FG000|Treatment|Study drug toxicity|19|||
44320224|NCT03668119|79325041|FG001|Treatment|Study drug toxicity|1|||
44320225|NCT03668119|79325040|FG000|Treatment|Death|3|||
44320226|NCT03668119|79325041|FG001|Treatment|Death|0|||
44320227|NCT03668119|79325040|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
44320228|NCT03668119|79325041|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
44320229|NCT03668119|79325040|FG000|Treatment|Withdrawal by Subject|2|||
44258060|NCT01405820|79112185|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
44258061|NCT01405820|79112186|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
44258062|NCT01405820|79112187|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
44536396|NCT03529773|79547257|FG023|Overall Study|Adverse Event|0|||
44536397|NCT03529773|79547258|FG024|Overall Study|Adverse Event|0|||
44536398|NCT03529773|79547259|FG025|Overall Study|Adverse Event|0|||
44536399|NCT03529773|79547260|FG026|Overall Study|Adverse Event|0|||
44536400|NCT03529773|79547261|FG027|Overall Study|Adverse Event|0|||
44536401|NCT03529773|79547262|FG028|Overall Study|Adverse Event|0|||
44258063|NCT01405820|79112182|FG000|Open-Label Treatment Period|Other|1|||
44258064|NCT01405820|79112183|FG001|Open-Label Treatment Period|Other|1|||
44258065|NCT01405820|79112184|FG002|Open-Label Treatment Period|Other|1|||
44258066|NCT01405820|79112185|FG003|Open-Label Treatment Period|Other|1|||
44258067|NCT01405820|79112186|FG004|Open-Label Treatment Period|Other|1|||
44258068|NCT01405820|79112187|FG005|Open-Label Treatment Period|Other|1|||
44258069|NCT01405820|79112182|FG000|Open-Label Treatment Period|Physician Decision|0|||
44258070|NCT01405820|79112183|FG001|Open-Label Treatment Period|Physician Decision|0|||
44320230|NCT03668119|79325041|FG001|Treatment|Withdrawal by Subject|1|||
44320231|NCT03668119|79325040|FG000|Treatment|Participant request to discontinue study treatment|3|||
44320232|NCT03668119|79325041|FG001|Treatment|Participant request to discontinue study treatment|1|||
44536402|NCT03529773|79547263|FG029|Overall Study|Adverse Event|0|||
44536403|NCT03529773|79547264|FG030|Overall Study|Adverse Event|1|||
44155694|NCT01995838|78947167|FG001|Overall Study|Withdrawal by Subject|0|||
44155695|NCT01995838|78947168|FG002|Overall Study|Withdrawal by Subject|0|||
44536404|NCT03529773|79547265|FG031|Overall Study|Adverse Event|0|||
44536405|NCT03529773|79547266|FG032|Overall Study|Adverse Event|0|||
44536406|NCT03529773|79547267|FG033|Overall Study|Adverse Event|0|||
44536407|NCT03529773|79547268|FG034|Overall Study|Adverse Event|0|||
44320233|NCT03668119|79325040|FG000|Treatment|Maximum Clinical Benefit|0|||
44320234|NCT03668119|79325041|FG001|Treatment|Maximum Clinical Benefit|1|||
44320235|NCT03668119|79325040|FG000|Treatment|Participants completed treatment|20|||
44536408|NCT03529773|79547269|FG035|Overall Study|Adverse Event|1|||
44320236|NCT03668119|79325041|FG001|Treatment|Participants completed treatment|8|||
44536409|NCT03529773|79547270|FG036|Overall Study|Adverse Event|0|||
44320237|NCT03668119|79325040|FG000|Treatment|Other reasons|1|||
44320238|NCT03668119|79325041|FG001|Treatment|Other reasons|2|||
44320239|NCT03224819|79325067|FG000|Overall Study|Withdrawal by Subject|0|||
44536410|NCT03529773|79547271|FG037|Overall Study|Adverse Event|0|||
44536411|NCT03529773|79547272|FG038|Overall Study|Adverse Event|1|||
44536412|NCT03529773|79547273|FG039|Overall Study|Adverse Event|1|||
44536413|NCT03529773|79547234|FG000|Overall Study|Death|0|||
44536414|NCT03529773|79547235|FG001|Overall Study|Death|0|||
44536415|NCT03529773|79547236|FG002|Overall Study|Death|0|||
44155696|NCT01995838|78947169|FG003|Overall Study|Withdrawal by Subject|0|||
44155697|NCT01995838|78947170|FG004|Overall Study|Withdrawal by Subject|1|||
44155698|NCT01995838|78947171|FG005|Overall Study|Withdrawal by Subject|0|||
44155699|NCT01995838|78947172|FG006|Overall Study|Withdrawal by Subject|0|||
44155700|NCT01995838|78947166|FG000|Overall Study|Other|3|||
44155701|NCT01995838|78947167|FG001|Overall Study|Other|1|||
44155702|NCT01995838|78947168|FG002|Overall Study|Other|0|||
44536416|NCT03529773|79547237|FG003|Overall Study|Death|0|||
44536417|NCT03529773|79547238|FG004|Overall Study|Death|0|||
44155703|NCT01995838|78947169|FG003|Overall Study|Other|2|||
44155704|NCT01995838|78947170|FG004|Overall Study|Other|1|||
44155705|NCT01995838|78947171|FG005|Overall Study|Other|1|||
44155706|NCT01995838|78947172|FG006|Overall Study|Other|2|||
44320240|NCT03224819|79325068|FG001|Overall Study|Withdrawal by Subject|0|||
44320241|NCT03224819|79325069|FG002|Overall Study|Withdrawal by Subject|0|||
44320242|NCT03224819|79325070|FG003|Overall Study|Withdrawal by Subject|0|||
44320243|NCT03224819|79325071|FG004|Overall Study|Withdrawal by Subject|0|||
44320244|NCT03224819|79325072|FG005|Overall Study|Withdrawal by Subject|0|||
44320245|NCT03224819|79325073|FG006|Overall Study|Withdrawal by Subject|0|||
44320246|NCT03224819|79325074|FG007|Overall Study|Withdrawal by Subject|0|||
44320247|NCT03224819|79325075|FG008|Overall Study|Withdrawal by Subject|0|||
44320248|NCT03224819|79325076|FG009|Overall Study|Withdrawal by Subject|0|||
44320249|NCT03224819|79325077|FG010|Overall Study|Withdrawal by Subject|0|||
44320250|NCT03224819|79325078|FG011|Overall Study|Withdrawal by Subject|0|||
44320251|NCT03224819|79325079|FG012|Overall Study|Withdrawal by Subject|1|||
44320252|NCT03224819|79325080|FG013|Overall Study|Withdrawal by Subject|0|||
44320253|NCT03224819|79325067|FG000|Overall Study|Sponsor Decision|0|||
44320254|NCT03224819|79325068|FG001|Overall Study|Sponsor Decision|0|||
44320255|NCT03224819|79325069|FG002|Overall Study|Sponsor Decision|0|||
44320256|NCT03224819|79325070|FG003|Overall Study|Sponsor Decision|1|||
44320257|NCT03224819|79325071|FG004|Overall Study|Sponsor Decision|1|||
44320258|NCT03224819|79325072|FG005|Overall Study|Sponsor Decision|2|||
44320259|NCT03224819|79325073|FG006|Overall Study|Sponsor Decision|1|||
44421323|NCT00779402|79429209|FG001|Surveillance Phase|Protocol Violation|1|||
44421324|NCT00779402|79429208|FG000|Surveillance Phase|Patient refused to continue|22|||
44421325|NCT00779402|79429209|FG001|Surveillance Phase|Patient refused to continue|14|||
44421326|NCT00779402|79429208|FG000|Surveillance Phase|Lost to Follow-up|2|||
44421327|NCT00779402|79429209|FG001|Surveillance Phase|Lost to Follow-up|1|||
44421328|NCT00779402|79429208|FG000|Surveillance Phase|Death|0|||
44421329|NCT00779402|79429209|FG001|Surveillance Phase|Death|1|||
44421330|NCT00779402|79429208|FG000|Surveillance Phase|Intercurrent Illness|2|||
44536418|NCT03529773|79547239|FG005|Overall Study|Death|0|||
44536419|NCT03529773|79547240|FG006|Overall Study|Death|0|||
44536420|NCT03529773|79547241|FG007|Overall Study|Death|0|||
44155707|NCT01957462|78947189|FG000|Test Period 1|Withdrawal by Subject|1|||
44421331|NCT00779402|79429209|FG001|Surveillance Phase|Intercurrent Illness|0|||
44421332|NCT00779402|79429208|FG000|Surveillance Phase|Other|5|||
44155708|NCT01957462|78947190|FG001|Test Period 1|Withdrawal by Subject|0|||
44421333|NCT00779402|79429209|FG001|Surveillance Phase|Other|5|||
44421334|NCT00779402|79429208|FG000|Surveillance Phase|Withdrawal by Subject|4|||
44536421|NCT03529773|79547242|FG008|Overall Study|Death|0|||
44155709|NCT01957462|78947189|FG000|Test Period 1|Adverse Event|1|||
44421335|NCT00779402|79429209|FG001|Surveillance Phase|Withdrawal by Subject|1|||
44536422|NCT03529773|79547243|FG009|Overall Study|Death|0|||
44155710|NCT01957462|78947190|FG001|Test Period 1|Adverse Event|0|||
44320260|NCT03224819|79325074|FG007|Overall Study|Sponsor Decision|1|||
44536423|NCT03529773|79547244|FG010|Overall Study|Death|0|||
44320261|NCT03224819|79325075|FG008|Overall Study|Sponsor Decision|1|||
44320262|NCT03224819|79325076|FG009|Overall Study|Sponsor Decision|2|||
44320263|NCT03224819|79325077|FG010|Overall Study|Sponsor Decision|1|||
44320264|NCT03224819|79325078|FG011|Overall Study|Sponsor Decision|1|||
44320265|NCT03224819|79325079|FG012|Overall Study|Sponsor Decision|1|||
44320266|NCT03224819|79325080|FG013|Overall Study|Sponsor Decision|0|||
44320267|NCT03224819|79325067|FG000|Overall Study|Lost to Follow-up|0|||
44320268|NCT03224819|79325068|FG001|Overall Study|Lost to Follow-up|0|||
44320269|NCT03224819|79325069|FG002|Overall Study|Lost to Follow-up|0|||
44320270|NCT03224819|79325070|FG003|Overall Study|Lost to Follow-up|0|||
44320271|NCT03224819|79325071|FG004|Overall Study|Lost to Follow-up|0|||
44320272|NCT03224819|79325072|FG005|Overall Study|Lost to Follow-up|0|||
44320273|NCT03224819|79325073|FG006|Overall Study|Lost to Follow-up|0|||
44320274|NCT03224819|79325074|FG007|Overall Study|Lost to Follow-up|0|||
44320275|NCT03224819|79325075|FG008|Overall Study|Lost to Follow-up|1|||
44320276|NCT03224819|79325076|FG009|Overall Study|Lost to Follow-up|0|||
44320277|NCT03224819|79325077|FG010|Overall Study|Lost to Follow-up|0|||
44320278|NCT03224819|79325078|FG011|Overall Study|Lost to Follow-up|0|||
44320279|NCT03224819|79325079|FG012|Overall Study|Lost to Follow-up|0|||
44320280|NCT03224819|79325080|FG013|Overall Study|Lost to Follow-up|0|||
44320281|NCT03224819|79325067|FG000|Overall Study|Death|0|||
44320282|NCT03224819|79325068|FG001|Overall Study|Death|1|||
44320283|NCT03224819|79325069|FG002|Overall Study|Death|0|||
44320284|NCT03224819|79325070|FG003|Overall Study|Death|0|||
44320285|NCT03224819|79325071|FG004|Overall Study|Death|0|||
44320286|NCT03224819|79325072|FG005|Overall Study|Death|0|||
44320287|NCT03224819|79325073|FG006|Overall Study|Death|0|||
44320288|NCT03224819|79325074|FG007|Overall Study|Death|1|||
44320289|NCT03224819|79325075|FG008|Overall Study|Death|0|||
44320290|NCT03224819|79325076|FG009|Overall Study|Death|0|||
44320291|NCT03224819|79325077|FG010|Overall Study|Death|0|||
44320292|NCT03224819|79325078|FG011|Overall Study|Death|1|||
44320293|NCT03224819|79325079|FG012|Overall Study|Death|0|||
44320294|NCT03224819|79325080|FG013|Overall Study|Death|0|||
44320295|NCT02549573|79325123|FG000|Overall Study|Withdrawal by Subject|0|||
44320296|NCT02549573|79325124|FG001|Overall Study|Withdrawal by Subject|2|||
44320297|NCT02549573|79325123|FG000|Overall Study|Protocol Violation|0|||
44320298|NCT02549573|79325124|FG001|Overall Study|Protocol Violation|1|||
44320299|NCT02378181|79325132|FG000|Overall Study|Lost to Follow-up|2|||
44421336|NCT00779402|79429208|FG000|Surveillance Phase|Closure of study|5|||
44421337|NCT00779402|79429209|FG001|Surveillance Phase|Closure of study|6|||
44421338|NCT00779402|79429208|FG000|Surveillance Phase|Completed Protocol Visits|3|||
44320300|NCT02378181|79325133|FG001|Overall Study|Lost to Follow-up|5|||
44320301|NCT02378181|79325132|FG000|Overall Study|Withdrawal by Subject|1|||
44320302|NCT02378181|79325133|FG001|Overall Study|Withdrawal by Subject|1|||
44320303|NCT02378181|79325132|FG000|Overall Study|Incarcerated|0|||
44320304|NCT02378181|79325133|FG001|Overall Study|Incarcerated|1|||
44320305|NCT02201108|79325141|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
44320306|NCT02201108|79325142|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
44320307|NCT02201108|79325141|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
44320308|NCT02201108|79325142|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
44320309|NCT02201108|79325141|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
44320310|NCT02201108|79325142|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
44320311|NCT02201108|79325141|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
44320312|NCT02201108|79325142|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
44320313|NCT02201108|79325141|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
44320314|NCT02201108|79325142|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
44320315|NCT02201108|79325141|FG000|Open Label Period (up to Week 192)|Other reason|4|||
44320316|NCT02201108|79325142|FG001|Open Label Period (up to Week 192)|Other reason|7|||
44320317|NCT02201108|79325141|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
44320318|NCT02201108|79325142|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
44320319|NCT02180243|79325163|FG000|Overall Study|Withdrawal by Subject|12|||
44536424|NCT03529773|79547245|FG011|Overall Study|Death|0|||
44536425|NCT03529773|79547246|FG012|Overall Study|Death|1|||
44536426|NCT03529773|79547247|FG013|Overall Study|Death|0|||
44536427|NCT03529773|79547248|FG014|Overall Study|Death|0|||
44536428|NCT03529773|79547249|FG015|Overall Study|Death|0|||
44536429|NCT03529773|79547250|FG016|Overall Study|Death|0|||
44536430|NCT03529773|79547251|FG017|Overall Study|Death|0|||
44536431|NCT03529773|79547252|FG018|Overall Study|Death|0|||
44536432|NCT03529773|79547253|FG019|Overall Study|Death|1|||
44320320|NCT02180243|79325164|FG001|Overall Study|Withdrawal by Subject|12|||
44320321|NCT02180243|79325163|FG000|Overall Study|Lost to Follow-up|12|||
44320322|NCT02180243|79325164|FG001|Overall Study|Lost to Follow-up|2|||
44320323|NCT01772563|79325171|FG000|Cycle 1|Dose limiting toxicity|2|||
44320324|NCT01772563|79325171|FG000|Cycle 1|Progressive disease|2|||
44320325|NCT01772563|79325171|FG000|Cycle 2 and Beyond|Progressive disease|17|||
44320326|NCT01772563|79325171|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
44320327|NCT01772563|79325171|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
44320328|NCT01445171|79325177|FG000|Overall Study|Lost to Follow-up|11|||
44320329|NCT01445171|79325177|FG000|Overall Study|Withdrawal by Subject|16|||
44320330|NCT01445171|79325177|FG000|Overall Study|Death|51|||
44320331|NCT01445171|79325177|FG000|Overall Study|Subjects declined to return for followup|9|||
44320332|NCT01445171|79325177|FG000|Overall Study|Consented but did not receive device|8|||
44320333|NCT01237951|79325183|FG000|Overall Study|Death|1|||
44320334|NCT01239394|79325187|FG000|Overall Study|Adverse Event|1|||
44320335|NCT01237678|79325194|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
44320336|NCT01237678|79325195|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
44320337|NCT01237678|79325196|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
44320338|NCT01237678|79325194|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
44320339|NCT01237678|79325195|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
44320340|NCT01237678|79325196|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
44320341|NCT01237678|79325194|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
44320342|NCT01237678|79325195|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
44536433|NCT03529773|79547254|FG020|Overall Study|Death|0|||
44536434|NCT03529773|79547255|FG021|Overall Study|Death|0|||
44536435|NCT03529773|79547256|FG022|Overall Study|Death|1|||
44536436|NCT03529773|79547257|FG023|Overall Study|Death|0|||
44536437|NCT03529773|79547258|FG024|Overall Study|Death|0|||
44536438|NCT03529773|79547259|FG025|Overall Study|Death|0|||
44536439|NCT03529773|79547260|FG026|Overall Study|Death|0|||
44536440|NCT03529773|79547261|FG027|Overall Study|Death|0|||
44536441|NCT03529773|79547262|FG028|Overall Study|Death|0|||
44536442|NCT03529773|79547263|FG029|Overall Study|Death|0|||
44536443|NCT03529773|79547264|FG030|Overall Study|Death|0|||
44536444|NCT03529773|79547265|FG031|Overall Study|Death|0|||
44536445|NCT03529773|79547266|FG032|Overall Study|Death|0|||
44536446|NCT03529773|79547267|FG033|Overall Study|Death|1|||
44536447|NCT03529773|79547268|FG034|Overall Study|Death|1|||
44536448|NCT03529773|79547269|FG035|Overall Study|Death|0|||
44536449|NCT03529773|79547270|FG036|Overall Study|Death|1|||
44536450|NCT03529773|79547271|FG037|Overall Study|Death|0|||
44536451|NCT03529773|79547272|FG038|Overall Study|Death|0|||
44155711|NCT01957150|78947198|FG000|Overall Study|Adverse Event|23|||
44320343|NCT01237678|79325196|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
44320344|NCT01237678|79325194|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
44320345|NCT01237678|79325195|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
44320346|NCT01237678|79325196|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
44536452|NCT03529773|79547273|FG039|Overall Study|Death|0|||
44536453|NCT03529773|79547234|FG000|Overall Study|Lost to Follow-up|0|||
44536454|NCT03529773|79547235|FG001|Overall Study|Lost to Follow-up|0|||
44536455|NCT03529773|79547236|FG002|Overall Study|Lost to Follow-up|1|||
44536456|NCT03529773|79547237|FG003|Overall Study|Lost to Follow-up|0|||
44155712|NCT01957150|78947199|FG001|Overall Study|Adverse Event|20|||
44536457|NCT03529773|79547238|FG004|Overall Study|Lost to Follow-up|1|||
44536458|NCT03529773|79547239|FG005|Overall Study|Lost to Follow-up|1|||
44536459|NCT03529773|79547240|FG006|Overall Study|Lost to Follow-up|0|||
44320347|NCT01237678|79325194|FG000|Phase II|Adverse Event|0|||
44320348|NCT01237678|79325195|FG001|Phase II|Adverse Event|39|||
44320349|NCT01237678|79325196|FG002|Phase II|Adverse Event|9|||
44320350|NCT01237678|79325194|FG000|Phase II|Death|0|||
44320351|NCT01237678|79325195|FG001|Phase II|Death|0|||
44320352|NCT01237678|79325196|FG002|Phase II|Death|2|||
44320353|NCT01237678|79325194|FG000|Phase II|Lack of Efficacy|0|||
44320354|NCT01237678|79325195|FG001|Phase II|Lack of Efficacy|25|||
44320355|NCT01237678|79325196|FG002|Phase II|Lack of Efficacy|3|||
44320356|NCT01237678|79325194|FG000|Phase II|Withdrawal by Subject|0|||
44320357|NCT01237678|79325195|FG001|Phase II|Withdrawal by Subject|1|||
44320358|NCT01237678|79325196|FG002|Phase II|Withdrawal by Subject|5|||
44320359|NCT01237678|79325194|FG000|Phase II|Completed Cycles 4-6|0|||
44320360|NCT01237678|79325195|FG001|Phase II|Completed Cycles 4-6|11|||
44320361|NCT01237678|79325196|FG002|Phase II|Completed Cycles 4-6|21|||
44320362|NCT01237678|79325194|FG000|Phase II|Sponsor Decision/Study Closed|0|||
44320363|NCT01237678|79325195|FG001|Phase II|Sponsor Decision/Study Closed|18|||
44320364|NCT01237678|79325196|FG002|Phase II|Sponsor Decision/Study Closed|7|||
44320365|NCT01237678|79325194|FG000|Phase II|Randomized but were not treated|0|||
44320366|NCT01237678|79325195|FG001|Phase II|Randomized but were not treated|4|||
44320367|NCT01237678|79325196|FG002|Phase II|Randomized but were not treated|3|||
44320368|NCT01229371|79325219|FG000|Overall Study|Withdrawal by Subject|0|||
44320369|NCT01229371|79325220|FG001|Overall Study|Withdrawal by Subject|1|||
44320370|NCT01229371|79325221|FG002|Overall Study|Withdrawal by Subject|0|||
44320371|NCT01229371|79325222|FG003|Overall Study|Withdrawal by Subject|0|||
44320372|NCT01237327|79325234|FG000|Overall Study|Protocol Violation: Core Study|1|||
44320373|NCT01237327|79325235|FG001|Overall Study|Protocol Violation: Core Study|0|||
44320374|NCT01237327|79325234|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
44320375|NCT01237327|79325235|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
44320376|NCT01237327|79325234|FG000|Overall Study|Progression of Disease: Core Study|18|||
44320377|NCT01237327|79325235|FG001|Overall Study|Progression of Disease: Core Study|22|||
44536460|NCT03529773|79547241|FG007|Overall Study|Lost to Follow-up|0|||
44536461|NCT03529773|79547242|FG008|Overall Study|Lost to Follow-up|0|||
44536462|NCT03529773|79547243|FG009|Overall Study|Lost to Follow-up|0|||
44536463|NCT03529773|79547244|FG010|Overall Study|Lost to Follow-up|0|||
44536464|NCT03529773|79547245|FG011|Overall Study|Lost to Follow-up|0|||
44536465|NCT03529773|79547246|FG012|Overall Study|Lost to Follow-up|0|||
44536466|NCT03529773|79547247|FG013|Overall Study|Lost to Follow-up|1|||
44536467|NCT03529773|79547248|FG014|Overall Study|Lost to Follow-up|4|||
44536468|NCT03529773|79547249|FG015|Overall Study|Lost to Follow-up|1|||
44536469|NCT03529773|79547250|FG016|Overall Study|Lost to Follow-up|1|||
44421339|NCT00779402|79429209|FG001|Surveillance Phase|Completed Protocol Visits|2|||
44536470|NCT03529773|79547251|FG017|Overall Study|Lost to Follow-up|0|||
44536471|NCT03529773|79547252|FG018|Overall Study|Lost to Follow-up|1|||
44536472|NCT03529773|79547253|FG019|Overall Study|Lost to Follow-up|1|||
44536473|NCT03529773|79547254|FG020|Overall Study|Lost to Follow-up|2|||
44536474|NCT03529773|79547255|FG021|Overall Study|Lost to Follow-up|4|||
44320378|NCT01237327|79325234|FG000|Overall Study|Progression of Disease: Extension Study|15|||
44320379|NCT01237327|79325235|FG001|Overall Study|Progression of Disease: Extension Study|13|||
44320380|NCT01237327|79325234|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
44320381|NCT01237327|79325235|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
44536475|NCT03529773|79547256|FG022|Overall Study|Lost to Follow-up|3|||
44536476|NCT03529773|79547257|FG023|Overall Study|Lost to Follow-up|4|||
44536477|NCT03529773|79547258|FG024|Overall Study|Lost to Follow-up|3|||
44536478|NCT03529773|79547259|FG025|Overall Study|Lost to Follow-up|5|||
44536479|NCT03529773|79547260|FG026|Overall Study|Lost to Follow-up|5|||
44536480|NCT03529773|79547261|FG027|Overall Study|Lost to Follow-up|0|||
44536481|NCT03529773|79547262|FG028|Overall Study|Lost to Follow-up|0|||
44536482|NCT03529773|79547263|FG029|Overall Study|Lost to Follow-up|0|||
44320382|NCT01237327|79325234|FG000|Overall Study|Withdrawal by Subject|1|||
44320383|NCT01237327|79325235|FG001|Overall Study|Withdrawal by Subject|3|||
44320384|NCT01237327|79325234|FG000|Overall Study|Lost to Follow-up|3|||
44320385|NCT01237327|79325235|FG001|Overall Study|Lost to Follow-up|0|||
44320386|NCT01237054|79325241|FG000|Overall Study|imaging 10C0096|1|||
44320387|NCT05333289|79325266|FG000|Overall Study|Other|1|||
44320388|NCT05333289|79325267|FG001|Overall Study|Other|0|||
44320389|NCT05333289|79325268|FG002|Overall Study|Other|0|||
44320390|NCT05333289|79325269|FG003|Overall Study|Other|1|||
44421340|NCT00779402|79429208|FG000|Long-term Follow-up|Patient refused to continue|2|||
44421341|NCT00779402|79429209|FG001|Long-term Follow-up|Patient refused to continue|0|||
44536483|NCT03529773|79547264|FG030|Overall Study|Lost to Follow-up|1|||
44320391|NCT05333289|79325270|FG004|Overall Study|Other|1|||
44320392|NCT05333289|79325271|FG005|Overall Study|Other|2|||
44320393|NCT05333289|79325272|FG006|Overall Study|Other|2|||
44320394|NCT05333289|79325273|FG007|Overall Study|Other|0|||
44320395|NCT05333289|79325266|FG000|Overall Study|Withdrawal by Subject|1|||
44320396|NCT05333289|79325267|FG001|Overall Study|Withdrawal by Subject|2|||
44320397|NCT05333289|79325268|FG002|Overall Study|Withdrawal by Subject|2|||
44536484|NCT03529773|79547265|FG031|Overall Study|Lost to Follow-up|0|||
44536485|NCT03529773|79547266|FG032|Overall Study|Lost to Follow-up|0|||
44536486|NCT03529773|79547267|FG033|Overall Study|Lost to Follow-up|1|||
44536487|NCT03529773|79547268|FG034|Overall Study|Lost to Follow-up|1|||
44536488|NCT03529773|79547269|FG035|Overall Study|Lost to Follow-up|0|||
44536489|NCT03529773|79547270|FG036|Overall Study|Lost to Follow-up|0|||
44536490|NCT03529773|79547271|FG037|Overall Study|Lost to Follow-up|3|||
44536491|NCT03529773|79547272|FG038|Overall Study|Lost to Follow-up|1|||
44536492|NCT03529773|79547273|FG039|Overall Study|Lost to Follow-up|1|||
44536493|NCT03529773|79547234|FG000|Overall Study|No longer meets eligibility criteria|0|||
44536494|NCT03529773|79547235|FG001|Overall Study|No longer meets eligibility criteria|0|||
44536495|NCT03529773|79547236|FG002|Overall Study|No longer meets eligibility criteria|0|||
44536496|NCT03529773|79547237|FG003|Overall Study|No longer meets eligibility criteria|0|||
44536497|NCT03529773|79547238|FG004|Overall Study|No longer meets eligibility criteria|0|||
44536498|NCT03529773|79547239|FG005|Overall Study|No longer meets eligibility criteria|0|||
44536499|NCT03529773|79547240|FG006|Overall Study|No longer meets eligibility criteria|0|||
44536500|NCT03529773|79547241|FG007|Overall Study|No longer meets eligibility criteria|0|||
44536501|NCT03529773|79547242|FG008|Overall Study|No longer meets eligibility criteria|0|||
44536502|NCT03529773|79547243|FG009|Overall Study|No longer meets eligibility criteria|0|||
44536503|NCT03529773|79547244|FG010|Overall Study|No longer meets eligibility criteria|0|||
44536504|NCT03529773|79547245|FG011|Overall Study|No longer meets eligibility criteria|0|||
44536505|NCT03529773|79547246|FG012|Overall Study|No longer meets eligibility criteria|0|||
44536506|NCT03529773|79547247|FG013|Overall Study|No longer meets eligibility criteria|0|||
44536507|NCT03529773|79547248|FG014|Overall Study|No longer meets eligibility criteria|0|||
44536508|NCT03529773|79547249|FG015|Overall Study|No longer meets eligibility criteria|0|||
44536509|NCT03529773|79547250|FG016|Overall Study|No longer meets eligibility criteria|0|||
44536510|NCT03529773|79547251|FG017|Overall Study|No longer meets eligibility criteria|0|||
44536511|NCT03529773|79547252|FG018|Overall Study|No longer meets eligibility criteria|0|||
44536512|NCT03529773|79547253|FG019|Overall Study|No longer meets eligibility criteria|0|||
44536513|NCT03529773|79547254|FG020|Overall Study|No longer meets eligibility criteria|0|||
44536514|NCT03529773|79547255|FG021|Overall Study|No longer meets eligibility criteria|0|||
44536515|NCT03529773|79547256|FG022|Overall Study|No longer meets eligibility criteria|1|||
44536516|NCT03529773|79547257|FG023|Overall Study|No longer meets eligibility criteria|0|||
44536517|NCT03529773|79547258|FG024|Overall Study|No longer meets eligibility criteria|0|||
44536518|NCT03529773|79547259|FG025|Overall Study|No longer meets eligibility criteria|0|||
44536519|NCT03529773|79547260|FG026|Overall Study|No longer meets eligibility criteria|0|||
44536520|NCT03529773|79547261|FG027|Overall Study|No longer meets eligibility criteria|0|||
44536521|NCT03529773|79547262|FG028|Overall Study|No longer meets eligibility criteria|0|||
44536522|NCT03529773|79547263|FG029|Overall Study|No longer meets eligibility criteria|0|||
44536523|NCT03529773|79547264|FG030|Overall Study|No longer meets eligibility criteria|0|||
44536524|NCT03529773|79547265|FG031|Overall Study|No longer meets eligibility criteria|0|||
44536525|NCT03529773|79547266|FG032|Overall Study|No longer meets eligibility criteria|0|||
44536526|NCT03529773|79547267|FG033|Overall Study|No longer meets eligibility criteria|0|||
44536527|NCT03529773|79547268|FG034|Overall Study|No longer meets eligibility criteria|0|||
44536528|NCT03529773|79547269|FG035|Overall Study|No longer meets eligibility criteria|0|||
44536529|NCT03529773|79547270|FG036|Overall Study|No longer meets eligibility criteria|0|||
44536530|NCT03529773|79547271|FG037|Overall Study|No longer meets eligibility criteria|0|||
44536531|NCT03529773|79547272|FG038|Overall Study|No longer meets eligibility criteria|1|||
44536532|NCT03529773|79547273|FG039|Overall Study|No longer meets eligibility criteria|0|||
44536533|NCT03529773|79547234|FG000|Overall Study|Other|0|||
44536534|NCT03529773|79547235|FG001|Overall Study|Other|0|||
44536535|NCT03529773|79547236|FG002|Overall Study|Other|0|||
44536536|NCT03529773|79547237|FG003|Overall Study|Other|0|||
44536537|NCT03529773|79547238|FG004|Overall Study|Other|0|||
44536538|NCT03529773|79547239|FG005|Overall Study|Other|0|||
44536539|NCT03529773|79547240|FG006|Overall Study|Other|0|||
44536540|NCT03529773|79547241|FG007|Overall Study|Other|0|||
44536541|NCT03529773|79547242|FG008|Overall Study|Other|0|||
44536542|NCT03529773|79547243|FG009|Overall Study|Other|0|||
44536543|NCT03529773|79547244|FG010|Overall Study|Other|0|||
44536544|NCT03529773|79547245|FG011|Overall Study|Other|0|||
44536545|NCT03529773|79547246|FG012|Overall Study|Other|1|||
44536546|NCT03529773|79547247|FG013|Overall Study|Other|0|||
44536547|NCT03529773|79547248|FG014|Overall Study|Other|2|||
44536548|NCT03529773|79547249|FG015|Overall Study|Other|0|||
44421342|NCT00779402|79429208|FG000|Long-term Follow-up|Other|5|||
44421343|NCT00779402|79429209|FG001|Long-term Follow-up|Other|0|||
44421344|NCT00779402|79429208|FG000|Long-term Follow-up|Closure of Study|8|||
44421345|NCT00779402|79429209|FG001|Long-term Follow-up|Closure of Study|4|||
44421346|NCT00779402|79429208|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
44421347|NCT00779402|79429209|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
44536549|NCT03529773|79547250|FG016|Overall Study|Other|0|||
44536550|NCT03529773|79547251|FG017|Overall Study|Other|3|||
44536551|NCT03529773|79547252|FG018|Overall Study|Other|0|||
44536552|NCT03529773|79547253|FG019|Overall Study|Other|0|||
44536553|NCT03529773|79547254|FG020|Overall Study|Other|1|||
44536554|NCT03529773|79547255|FG021|Overall Study|Other|0|||
44536555|NCT03529773|79547256|FG022|Overall Study|Other|1|||
44536556|NCT03529773|79547257|FG023|Overall Study|Other|0|||
44536557|NCT03529773|79547258|FG024|Overall Study|Other|3|||
44536558|NCT03529773|79547259|FG025|Overall Study|Other|2|||
44536559|NCT03529773|79547260|FG026|Overall Study|Other|2|||
44536560|NCT03529773|79547261|FG027|Overall Study|Other|0|||
44536561|NCT03529773|79547262|FG028|Overall Study|Other|0|||
44536562|NCT03529773|79547263|FG029|Overall Study|Other|0|||
44536563|NCT03529773|79547264|FG030|Overall Study|Other|0|||
44536564|NCT03529773|79547265|FG031|Overall Study|Other|0|||
44536565|NCT03529773|79547266|FG032|Overall Study|Other|0|||
44536566|NCT03529773|79547267|FG033|Overall Study|Other|0|||
44536567|NCT03529773|79547268|FG034|Overall Study|Other|1|||
44536568|NCT03529773|79547269|FG035|Overall Study|Other|1|||
44536569|NCT03529773|79547270|FG036|Overall Study|Other|0|||
44536570|NCT03529773|79547271|FG037|Overall Study|Other|0|||
44536571|NCT03529773|79547272|FG038|Overall Study|Other|0|||
44536572|NCT03529773|79547273|FG039|Overall Study|Other|0|||
44536573|NCT03529773|79547234|FG000|Overall Study|Physician Decision|0|||
44536574|NCT03529773|79547235|FG001|Overall Study|Physician Decision|0|||
44536575|NCT03529773|79547236|FG002|Overall Study|Physician Decision|0|||
44536576|NCT03529773|79547237|FG003|Overall Study|Physician Decision|0|||
44536577|NCT03529773|79547238|FG004|Overall Study|Physician Decision|0|||
44536578|NCT03529773|79547239|FG005|Overall Study|Physician Decision|0|||
44536579|NCT03529773|79547240|FG006|Overall Study|Physician Decision|0|||
44536580|NCT03529773|79547241|FG007|Overall Study|Physician Decision|0|||
44536581|NCT03529773|79547242|FG008|Overall Study|Physician Decision|0|||
44536582|NCT03529773|79547243|FG009|Overall Study|Physician Decision|0|||
44536583|NCT03529773|79547244|FG010|Overall Study|Physician Decision|0|||
44536584|NCT03529773|79547245|FG011|Overall Study|Physician Decision|0|||
44536585|NCT03529773|79547246|FG012|Overall Study|Physician Decision|0|||
44536586|NCT03529773|79547247|FG013|Overall Study|Physician Decision|0|||
44536587|NCT03529773|79547248|FG014|Overall Study|Physician Decision|0|||
44536588|NCT03529773|79547249|FG015|Overall Study|Physician Decision|0|||
44536589|NCT03529773|79547250|FG016|Overall Study|Physician Decision|0|||
44536590|NCT03529773|79547251|FG017|Overall Study|Physician Decision|0|||
44536591|NCT03529773|79547252|FG018|Overall Study|Physician Decision|0|||
44536592|NCT03529773|79547253|FG019|Overall Study|Physician Decision|1|||
44536593|NCT03529773|79547254|FG020|Overall Study|Physician Decision|1|||
44536594|NCT03529773|79547255|FG021|Overall Study|Physician Decision|0|||
44536595|NCT03529773|79547256|FG022|Overall Study|Physician Decision|0|||
44536596|NCT03529773|79547257|FG023|Overall Study|Physician Decision|0|||
44536597|NCT03529773|79547258|FG024|Overall Study|Physician Decision|0|||
44536598|NCT03529773|79547259|FG025|Overall Study|Physician Decision|0|||
44536599|NCT03529773|79547260|FG026|Overall Study|Physician Decision|0|||
44536600|NCT03529773|79547261|FG027|Overall Study|Physician Decision|0|||
44536601|NCT03529773|79547262|FG028|Overall Study|Physician Decision|0|||
44536602|NCT03529773|79547263|FG029|Overall Study|Physician Decision|0|||
44536603|NCT03529773|79547264|FG030|Overall Study|Physician Decision|0|||
44536604|NCT03529773|79547265|FG031|Overall Study|Physician Decision|0|||
44536605|NCT03529773|79547266|FG032|Overall Study|Physician Decision|0|||
44536606|NCT03529773|79547267|FG033|Overall Study|Physician Decision|0|||
44536607|NCT03529773|79547268|FG034|Overall Study|Physician Decision|0|||
44536608|NCT03529773|79547269|FG035|Overall Study|Physician Decision|0|||
44536609|NCT03529773|79547270|FG036|Overall Study|Physician Decision|0|||
44536610|NCT03529773|79547271|FG037|Overall Study|Physician Decision|0|||
44536611|NCT03529773|79547272|FG038|Overall Study|Physician Decision|0|||
44536612|NCT03529773|79547273|FG039|Overall Study|Physician Decision|0|||
44536613|NCT03529773|79547234|FG000|Overall Study|Protocol Violation|0|||
44536614|NCT03529773|79547235|FG001|Overall Study|Protocol Violation|0|||
44536615|NCT03529773|79547236|FG002|Overall Study|Protocol Violation|0|||
44155713|NCT01957150|78947198|FG000|Overall Study|Withdrawal by Subject|13|||
44155714|NCT01957150|78947199|FG001|Overall Study|Withdrawal by Subject|17|||
44155715|NCT01957150|78947198|FG000|Overall Study|Physician Decision|3|||
44536616|NCT03529773|79547237|FG003|Overall Study|Protocol Violation|0|||
44536617|NCT03529773|79547238|FG004|Overall Study|Protocol Violation|0|||
44536618|NCT03529773|79547239|FG005|Overall Study|Protocol Violation|0|||
44536619|NCT03529773|79547240|FG006|Overall Study|Protocol Violation|0|||
44421348|NCT00771914|79429219|FG000|Overall Study|Physician Decision|0|||
44155716|NCT01957150|78947199|FG001|Overall Study|Physician Decision|6|||
44155717|NCT01957150|78947198|FG000|Overall Study|Lost to Follow-up|4|||
44536620|NCT03529773|79547241|FG007|Overall Study|Protocol Violation|0|||
44536621|NCT03529773|79547242|FG008|Overall Study|Protocol Violation|0|||
44536622|NCT03529773|79547243|FG009|Overall Study|Protocol Violation|0|||
44536623|NCT03529773|79547244|FG010|Overall Study|Protocol Violation|0|||
44536624|NCT03529773|79547245|FG011|Overall Study|Protocol Violation|0|||
44536625|NCT03529773|79547246|FG012|Overall Study|Protocol Violation|0|||
44536626|NCT03529773|79547247|FG013|Overall Study|Protocol Violation|0|||
44536627|NCT03529773|79547248|FG014|Overall Study|Protocol Violation|0|||
44155718|NCT01957150|78947199|FG001|Overall Study|Lost to Follow-up|4|||
44155719|NCT01957150|78947198|FG000|Overall Study|Protocol Violation|1|||
44155720|NCT01957150|78947199|FG001|Overall Study|Protocol Violation|0|||
44155721|NCT01957150|78947198|FG000|Overall Study|Lack of Efficacy|11|||
44155722|NCT01957150|78947199|FG001|Overall Study|Lack of Efficacy|11|||
44155723|NCT01955122|78947207|FG000|Overall Study|Physician Decision|5|||
44155724|NCT01955122|78947208|FG001|Overall Study|Physician Decision|5|||
44155725|NCT01995526|78947220|FG000|Overall Study|Physician Decision|1|||
44320398|NCT05333289|79325269|FG003|Overall Study|Withdrawal by Subject|1|||
44320399|NCT05333289|79325270|FG004|Overall Study|Withdrawal by Subject|1|||
44320400|NCT05333289|79325271|FG005|Overall Study|Withdrawal by Subject|2|||
44320401|NCT05333289|79325272|FG006|Overall Study|Withdrawal by Subject|1|||
44320402|NCT05333289|79325273|FG007|Overall Study|Withdrawal by Subject|3|||
44320403|NCT05333289|79325266|FG000|Overall Study|Protocol Violation|1|||
44320404|NCT05333289|79325267|FG001|Overall Study|Protocol Violation|0|||
44320405|NCT05333289|79325268|FG002|Overall Study|Protocol Violation|0|||
44320406|NCT05333289|79325269|FG003|Overall Study|Protocol Violation|0|||
44320407|NCT05333289|79325270|FG004|Overall Study|Protocol Violation|0|||
44320408|NCT05333289|79325271|FG005|Overall Study|Protocol Violation|0|||
44320409|NCT05333289|79325272|FG006|Overall Study|Protocol Violation|0|||
44320410|NCT05333289|79325273|FG007|Overall Study|Protocol Violation|0|||
44320411|NCT05333289|79325266|FG000|Overall Study|Physician Decision|0|||
44320412|NCT05333289|79325267|FG001|Overall Study|Physician Decision|0|||
44320413|NCT05333289|79325268|FG002|Overall Study|Physician Decision|1|||
44320414|NCT05333289|79325269|FG003|Overall Study|Physician Decision|0|||
44320415|NCT05333289|79325270|FG004|Overall Study|Physician Decision|0|||
44320416|NCT05333289|79325271|FG005|Overall Study|Physician Decision|2|||
44320417|NCT05333289|79325272|FG006|Overall Study|Physician Decision|0|||
44320418|NCT05333289|79325273|FG007|Overall Study|Physician Decision|0|||
44320419|NCT05333289|79325266|FG000|Overall Study|Lost to Follow-up|6|||
44320420|NCT05333289|79325267|FG001|Overall Study|Lost to Follow-up|0|||
44320421|NCT05333289|79325268|FG002|Overall Study|Lost to Follow-up|1|||
44320422|NCT05333289|79325269|FG003|Overall Study|Lost to Follow-up|6|||
44320423|NCT05333289|79325270|FG004|Overall Study|Lost to Follow-up|3|||
44320424|NCT05333289|79325271|FG005|Overall Study|Lost to Follow-up|3|||
44320425|NCT05333289|79325272|FG006|Overall Study|Lost to Follow-up|2|||
44320426|NCT05333289|79325273|FG007|Overall Study|Lost to Follow-up|1|||
44320427|NCT05333289|79325266|FG000|Overall Study|Death|1|||
44320428|NCT05333289|79325267|FG001|Overall Study|Death|0|||
44320429|NCT05333289|79325268|FG002|Overall Study|Death|0|||
44320430|NCT05333289|79325269|FG003|Overall Study|Death|0|||
44320431|NCT05333289|79325270|FG004|Overall Study|Death|0|||
44320432|NCT05333289|79325271|FG005|Overall Study|Death|0|||
44320433|NCT05333289|79325272|FG006|Overall Study|Death|0|||
44320434|NCT05333289|79325273|FG007|Overall Study|Death|0|||
44320435|NCT04749914|79325297|FG000|Period 1|Adverse Event|1|||
44320436|NCT04749914|79325298|FG001|Period 1|Adverse Event|0|||
44320437|NCT04749914|79325299|FG002|Period 1|Adverse Event|0|||
44320438|NCT04749914|79325300|FG003|Period 1|Adverse Event|0|||
44320439|NCT04749914|79325297|FG000|Period 1|Withdrawal by Subject|1|||
44320440|NCT04749914|79325298|FG001|Period 1|Withdrawal by Subject|0|||
44320441|NCT04749914|79325299|FG002|Period 1|Withdrawal by Subject|1|||
44320442|NCT04749914|79325300|FG003|Period 1|Withdrawal by Subject|0|||
44320443|NCT04608773|79325315|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
44320444|NCT04608773|79325316|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
44320445|NCT04608773|79325315|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
44155726|NCT01955044|78947227|FG000|Overall Study|Death|1|||
44155727|NCT01955044|78947228|FG001|Overall Study|Death|1|||
44155728|NCT01955044|78947229|FG002|Overall Study|Death|0|||
44155729|NCT01973218|78947239|FG000|Overall Study|Adverse Event|1|||
44320446|NCT04608773|79325316|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
44320447|NCT04608773|79325315|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
44320448|NCT04608773|79325316|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
44320449|NCT04608773|79325315|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
44320450|NCT04608773|79325316|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
44155730|NCT01973218|78947240|FG001|Overall Study|Adverse Event|0|||
44155731|NCT01973218|78947239|FG000|Overall Study|Withdrawal by Subject|1|||
44155732|NCT01973218|78947240|FG001|Overall Study|Withdrawal by Subject|0|||
44320451|NCT04608773|79325315|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
44320452|NCT04608773|79325316|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
44320453|NCT04601532|79325332|FG000|Overall Study|Lost to Follow-up|1|||
44320454|NCT04601532|79325333|FG001|Overall Study|Lost to Follow-up|2|||
44155733|NCT01954342|78947252|FG000|Overall Study|Missing data from 13-16week study visit|0|||
44320455|NCT04601532|79325332|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
44320456|NCT04601532|79325333|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
44320457|NCT04114539|79325366|FG000|Overall Study|Adverse Event|14|||
44320458|NCT04114539|79325366|FG000|Overall Study|Lost to Follow-up|2|||
44320459|NCT04114539|79325366|FG000|Overall Study|Non-compliance with Protocol|2|||
44320460|NCT04114539|79325366|FG000|Overall Study|Non-compliance with Study Drug|1|||
44155734|NCT01954342|78947253|FG001|Overall Study|Missing data from 13-16week study visit|0|||
44155735|NCT01954342|78947254|FG002|Overall Study|Missing data from 13-16week study visit|0|||
44155736|NCT01954342|78947255|FG003|Overall Study|Missing data from 13-16week study visit|1|||
44320461|NCT04114539|79325366|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
44320462|NCT04114539|79325366|FG000|Overall Study|Withdrew consent|10|||
44536628|NCT03529773|79547249|FG015|Overall Study|Protocol Violation|0|||
44536629|NCT03529773|79547250|FG016|Overall Study|Protocol Violation|0|||
44536630|NCT03529773|79547251|FG017|Overall Study|Protocol Violation|0|||
44536631|NCT03529773|79547252|FG018|Overall Study|Protocol Violation|0|||
44320463|NCT04114539|79325366|FG000|Overall Study|Others not specified|5|||
44320464|NCT04114539|79325366|FG000|Overall Study|Investigator Decision|2|||
44320465|NCT03904693|79325391|FG000|Overall Study|Death|0|||
44320466|NCT03904693|79325392|FG001|Overall Study|Death|0|||
44320467|NCT03904693|79325393|FG002|Overall Study|Death|3|||
44320468|NCT03904693|79325391|FG000|Overall Study|Physician Decision|0|||
44320469|NCT03904693|79325392|FG001|Overall Study|Physician Decision|0|||
44320470|NCT03904693|79325393|FG002|Overall Study|Physician Decision|2|||
44320471|NCT03904693|79325391|FG000|Overall Study|Withdrawal by Subject|0|||
44320472|NCT03904693|79325392|FG001|Overall Study|Withdrawal by Subject|1|||
44320473|NCT03904693|79325393|FG002|Overall Study|Withdrawal by Subject|4|||
44320474|NCT03768505|79325403|FG000|Overall Study|sponsor decision|76|||
44320475|NCT03768505|79325403|FG000|Overall Study|Death|35|||
44320476|NCT03768505|79325403|FG000|Overall Study|Other -Various|30|||
44320477|NCT03768505|79325403|FG000|Overall Study|Withdrawal by Subject|22|||
44320478|NCT03768505|79325403|FG000|Overall Study|Lost to Follow-up|6|||
44320479|NCT03563716|79325421|FG000|Overall Study|Death|20|||
44320480|NCT03563716|79325422|FG001|Overall Study|Death|14|||
44320481|NCT03563716|79325421|FG000|Overall Study|Withdrawal by Subject|3|||
44320482|NCT03563716|79325422|FG001|Overall Study|Withdrawal by Subject|3|||
44320483|NCT03563716|79325421|FG000|Overall Study|Still on Study|45|||
44320484|NCT03563716|79325422|FG001|Overall Study|Still on Study|50|||
44421349|NCT00771914|79429220|FG001|Overall Study|Physician Decision|0|||
44421350|NCT00771914|79429221|FG002|Overall Study|Physician Decision|0|||
44536632|NCT03529773|79547253|FG019|Overall Study|Protocol Violation|0|||
44536633|NCT03529773|79547254|FG020|Overall Study|Protocol Violation|0|||
44421351|NCT00771914|79429222|FG003|Overall Study|Physician Decision|1|||
44421352|NCT00771914|79429219|FG000|Overall Study|Lost to Follow-up|0|||
44421353|NCT00771914|79429220|FG001|Overall Study|Lost to Follow-up|0|||
44421354|NCT00771914|79429221|FG002|Overall Study|Lost to Follow-up|0|||
44421355|NCT00771914|79429222|FG003|Overall Study|Lost to Follow-up|1|||
44421356|NCT00779324|79429234|FG000|Overall Study|Lost to Follow-up|2|||
44421357|NCT00779324|79429235|FG001|Overall Study|Lost to Follow-up|1|||
44536634|NCT03529773|79547255|FG021|Overall Study|Protocol Violation|0|||
44536635|NCT03529773|79547256|FG022|Overall Study|Protocol Violation|0|||
44536636|NCT03529773|79547257|FG023|Overall Study|Protocol Violation|0|||
44536637|NCT03529773|79547258|FG024|Overall Study|Protocol Violation|0|||
44536638|NCT03529773|79547259|FG025|Overall Study|Protocol Violation|0|||
44536639|NCT03529773|79547260|FG026|Overall Study|Protocol Violation|0|||
44536640|NCT03529773|79547261|FG027|Overall Study|Protocol Violation|0|||
44536641|NCT03529773|79547262|FG028|Overall Study|Protocol Violation|0|||
44536642|NCT03529773|79547263|FG029|Overall Study|Protocol Violation|0|||
44155737|NCT01954342|78947252|FG000|Overall Study|Miscarriage|0|||
44320485|NCT03538626|79325436|FG000|Overall Study|Withdrawal by Subject|0|||
44320486|NCT03538626|79325437|FG001|Overall Study|Withdrawal by Subject|1|||
44320487|NCT03538626|79325438|FG002|Overall Study|Withdrawal by Subject|0|||
44320488|NCT03538626|79325439|FG003|Overall Study|Withdrawal by Subject|0|||
44320489|NCT03538626|79325440|FG004|Overall Study|Withdrawal by Subject|0|||
44421358|NCT00779324|79429234|FG000|Overall Study|Withdrawal by Subject|4|||
44536643|NCT03529773|79547264|FG030|Overall Study|Protocol Violation|1|||
44536644|NCT03529773|79547265|FG031|Overall Study|Protocol Violation|0|||
44320490|NCT03538626|79325441|FG005|Overall Study|Withdrawal by Subject|0|||
44320491|NCT03538626|79325442|FG006|Overall Study|Withdrawal by Subject|0|||
44320492|NCT03538626|79325443|FG007|Overall Study|Withdrawal by Subject|0|||
44320493|NCT03538626|79325436|FG000|Overall Study|Lost to Follow-up|0|||
44320494|NCT03538626|79325437|FG001|Overall Study|Lost to Follow-up|0|||
44320495|NCT03538626|79325438|FG002|Overall Study|Lost to Follow-up|0|||
44320496|NCT03538626|79325439|FG003|Overall Study|Lost to Follow-up|0|||
44320497|NCT03538626|79325440|FG004|Overall Study|Lost to Follow-up|0|||
44320498|NCT03538626|79325441|FG005|Overall Study|Lost to Follow-up|0|||
44320499|NCT03538626|79325442|FG006|Overall Study|Lost to Follow-up|1|||
44320500|NCT03538626|79325443|FG007|Overall Study|Lost to Follow-up|0|||
44320501|NCT03462719|79325463|FG000|Overall Study|Withdrawal by Subject|4|||
44320502|NCT03462719|79325464|FG001|Overall Study|Withdrawal by Subject|3|||
44320503|NCT03462719|79325463|FG000|Overall Study|Ongoing|87|||
44320504|NCT03462719|79325464|FG001|Overall Study|Ongoing|72|||
44320505|NCT03276221|79325473|FG000|Overall Study|Lost to Follow-up|6|||
44320506|NCT03276221|79325474|FG001|Overall Study|Lost to Follow-up|2|||
44320507|NCT03276221|79325475|FG002|Overall Study|Lost to Follow-up|0|||
44320508|NCT03276221|79325473|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
44320509|NCT03276221|79325474|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
44320510|NCT03276221|79325475|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
44320511|NCT03266770|79325483|FG000|Overall Study|Physician Decision|3|||
44320512|NCT03266770|79325483|FG000|Overall Study|Insufficient study supplies|1|||
44320513|NCT03266770|79325483|FG000|Overall Study|Adverse Event|1|||
44320514|NCT03243422|79325489|FG000|Overall Study|Death|20|||
44320515|NCT03243422|79325490|FG001|Overall Study|Death|21|||
44320516|NCT03243422|79325489|FG000|Overall Study|Lost to Follow-up|9|||
44320517|NCT03243422|79325490|FG001|Overall Study|Lost to Follow-up|21|||
44320518|NCT03243422|79325489|FG000|Overall Study|Withdrawal by Subject|22|||
44320519|NCT03243422|79325490|FG001|Overall Study|Withdrawal by Subject|8|||
44536645|NCT03529773|79547266|FG032|Overall Study|Protocol Violation|0|||
44536646|NCT03529773|79547267|FG033|Overall Study|Protocol Violation|0|||
44536647|NCT03529773|79547268|FG034|Overall Study|Protocol Violation|0|||
44536648|NCT03529773|79547269|FG035|Overall Study|Protocol Violation|0|||
44536649|NCT03529773|79547270|FG036|Overall Study|Protocol Violation|0|||
44536650|NCT03529773|79547271|FG037|Overall Study|Protocol Violation|0|||
44536651|NCT03529773|79547272|FG038|Overall Study|Protocol Violation|0|||
44536652|NCT03529773|79547273|FG039|Overall Study|Protocol Violation|0|||
44536653|NCT03529773|79547234|FG000|Overall Study|Withdrawal by Subject|0|||
44536654|NCT03529773|79547235|FG001|Overall Study|Withdrawal by Subject|0|||
44536655|NCT03529773|79547236|FG002|Overall Study|Withdrawal by Subject|0|||
44536656|NCT03529773|79547237|FG003|Overall Study|Withdrawal by Subject|0|||
44536657|NCT03529773|79547238|FG004|Overall Study|Withdrawal by Subject|0|||
44536658|NCT03529773|79547239|FG005|Overall Study|Withdrawal by Subject|0|||
44320520|NCT03238196|79325504|FG000|Overall Study|Adverse Event|3|||
44320521|NCT03238196|79325505|FG001|Overall Study|Adverse Event|0|||
44320522|NCT03238196|79325506|FG002|Overall Study|Adverse Event|2|||
44320523|NCT03238196|79325507|FG003|Overall Study|Adverse Event|2|||
44320524|NCT03238196|79325504|FG000|Overall Study|Withdrawal by Subject|4|||
44320525|NCT03238196|79325505|FG001|Overall Study|Withdrawal by Subject|1|||
44320526|NCT03238196|79325506|FG002|Overall Study|Withdrawal by Subject|1|||
44320527|NCT03238196|79325507|FG003|Overall Study|Withdrawal by Subject|0|||
44320528|NCT03238196|79325504|FG000|Overall Study|Disease progression|14|||
44320529|NCT03238196|79325505|FG001|Overall Study|Disease progression|2|||
44320530|NCT03238196|79325506|FG002|Overall Study|Disease progression|3|||
44320531|NCT03238196|79325507|FG003|Overall Study|Disease progression|2|||
44320532|NCT03238196|79325504|FG000|Overall Study|Still on treatment|1|||
44320533|NCT03238196|79325505|FG001|Overall Study|Still on treatment|0|||
44320534|NCT03238196|79325506|FG002|Overall Study|Still on treatment|0|||
44320535|NCT03238196|79325507|FG003|Overall Study|Still on treatment|0|||
44320536|NCT03201965|79325519|FG000|Overall Study|Death|5|||
44320537|NCT03201965|79325520|FG001|Overall Study|Death|27|||
44320538|NCT03201965|79325521|FG002|Overall Study|Death|27|||
44320539|NCT03201965|79325519|FG000|Overall Study|Lost to Follow-up|0|||
44536659|NCT03529773|79547240|FG006|Overall Study|Withdrawal by Subject|0|||
44536660|NCT03529773|79547241|FG007|Overall Study|Withdrawal by Subject|1|||
44536661|NCT03529773|79547242|FG008|Overall Study|Withdrawal by Subject|0|||
44320540|NCT03201965|79325520|FG001|Overall Study|Lost to Follow-up|1|||
44320541|NCT03201965|79325521|FG002|Overall Study|Lost to Follow-up|0|||
44320542|NCT03201965|79325519|FG000|Overall Study|Withdrawal by Subject|3|||
44320543|NCT03201965|79325520|FG001|Overall Study|Withdrawal by Subject|13|||
44320544|NCT03201965|79325521|FG002|Overall Study|Withdrawal by Subject|4|||
44320545|NCT03201965|79325519|FG000|Overall Study|Ongoing|20|||
44536662|NCT03529773|79547243|FG009|Overall Study|Withdrawal by Subject|1|||
44320546|NCT03201965|79325520|FG001|Overall Study|Ongoing|152|||
44320547|NCT03201965|79325521|FG002|Overall Study|Ongoing|164|||
44320548|NCT03173560|79325530|FG000|Overall Study|Ongoing on Treatment|38|||
44320549|NCT03173560|79325531|FG001|Overall Study|Ongoing on Treatment|50|||
44320550|NCT03173560|79325530|FG000|Overall Study|Ongoing Survival Follow-up|56|||
44320551|NCT03173560|79325531|FG001|Overall Study|Ongoing Survival Follow-up|57|||
44320552|NCT03173560|79325530|FG000|Overall Study|Lost to Follow-up|1|||
44421359|NCT00779324|79429235|FG001|Overall Study|Withdrawal by Subject|2|||
44421360|NCT00779324|79429234|FG000|Overall Study|Missed visit|1|||
44421361|NCT00779324|79429235|FG001|Overall Study|Missed visit|1|||
44536663|NCT03529773|79547244|FG010|Overall Study|Withdrawal by Subject|1|||
44536664|NCT03529773|79547245|FG011|Overall Study|Withdrawal by Subject|0|||
44536665|NCT03529773|79547246|FG012|Overall Study|Withdrawal by Subject|0|||
44536666|NCT03529773|79547247|FG013|Overall Study|Withdrawal by Subject|0|||
44536667|NCT03529773|79547248|FG014|Overall Study|Withdrawal by Subject|0|||
44536668|NCT03529773|79547249|FG015|Overall Study|Withdrawal by Subject|3|||
44536669|NCT03529773|79547250|FG016|Overall Study|Withdrawal by Subject|0|||
44536670|NCT03529773|79547251|FG017|Overall Study|Withdrawal by Subject|2|||
44155738|NCT01954342|78947253|FG001|Overall Study|Miscarriage|0|||
44155739|NCT01954342|78947254|FG002|Overall Study|Miscarriage|0|||
44155740|NCT01954342|78947255|FG003|Overall Study|Miscarriage|3|||
44155741|NCT01954342|78947252|FG000|Overall Study|Lost to Follow-up|0|||
44155742|NCT01954342|78947253|FG001|Overall Study|Lost to Follow-up|0|||
44155743|NCT01954342|78947254|FG002|Overall Study|Lost to Follow-up|0|||
44421362|NCT00779246|79429243|FG000|Overall Study|Missing sufficient data for analysis|33|||
44421363|NCT00779246|79429244|FG001|Overall Study|Missing sufficient data for analysis|53|||
44421364|NCT00771758|79429253|FG000|Overall Study|Adverse Event|2|||
44421365|NCT00771758|79429254|FG001|Overall Study|Adverse Event|8|||
44421366|NCT00771758|79429255|FG002|Overall Study|Adverse Event|1|||
44421367|NCT00771758|79429253|FG000|Overall Study|Lack of Efficacy|0|||
44421368|NCT00771758|79429254|FG001|Overall Study|Lack of Efficacy|2|||
44421369|NCT00771758|79429255|FG002|Overall Study|Lack of Efficacy|1|||
44421370|NCT00771758|79429253|FG000|Overall Study|Lost to Follow-up|1|||
44421371|NCT00771758|79429254|FG001|Overall Study|Lost to Follow-up|0|||
44421372|NCT00771758|79429255|FG002|Overall Study|Lost to Follow-up|0|||
44421373|NCT00771758|79429253|FG000|Overall Study|Protocol Violation|1|||
44421374|NCT00771758|79429254|FG001|Overall Study|Protocol Violation|0|||
44421375|NCT00771758|79429255|FG002|Overall Study|Protocol Violation|0|||
44421376|NCT00771758|79429253|FG000|Overall Study|Withdrawal by Subject|1|||
44421377|NCT00771758|79429254|FG001|Overall Study|Withdrawal by Subject|0|||
44421378|NCT00771758|79429255|FG002|Overall Study|Withdrawal by Subject|0|||
44421379|NCT00771758|79429253|FG000|Overall Study|Other|3|||
44421380|NCT00771758|79429254|FG001|Overall Study|Other|2|||
44421381|NCT00771758|79429255|FG002|Overall Study|Other|0|||
44421382|NCT00758498|79429283|FG000|Overall Study|Adverse Event|2|||
44421383|NCT00758498|79429284|FG001|Overall Study|Adverse Event|2|||
44421384|NCT00758498|79429285|FG002|Overall Study|Adverse Event|3|||
44421385|NCT00758498|79429283|FG000|Overall Study|Subject legally detained out of state|1|||
44421386|NCT00758498|79429284|FG001|Overall Study|Subject legally detained out of state|0|||
44421387|NCT00758498|79429285|FG002|Overall Study|Subject legally detained out of state|0|||
44421388|NCT00758498|79429283|FG000|Overall Study|Withdrawal by Subject|0|||
44421389|NCT00758498|79429284|FG001|Overall Study|Withdrawal by Subject|0|||
44421390|NCT00758498|79429285|FG002|Overall Study|Withdrawal by Subject|1|||
44421391|NCT00758498|79429283|FG000|Overall Study|Noncompliance to study procedures|0|||
44421392|NCT00758498|79429284|FG001|Overall Study|Noncompliance to study procedures|0|||
44421393|NCT00758498|79429285|FG002|Overall Study|Noncompliance to study procedures|1|||
44421394|NCT00798161|79429300|FG000|Overall Study|Adverse Event|3|||
44421395|NCT00798161|79429301|FG001|Overall Study|Adverse Event|4|||
44421396|NCT00798161|79429302|FG002|Overall Study|Adverse Event|6|||
44421397|NCT00798161|79429303|FG003|Overall Study|Adverse Event|6|||
44421398|NCT00798161|79429304|FG004|Overall Study|Adverse Event|5|||
44155744|NCT01954342|78947255|FG003|Overall Study|Lost to Follow-up|5|||
44320553|NCT03173560|79325531|FG001|Overall Study|Lost to Follow-up|4|||
44320554|NCT03173560|79325530|FG000|Overall Study|Withdrawal by Subject|10|||
44320555|NCT03173560|79325531|FG001|Overall Study|Withdrawal by Subject|5|||
44320556|NCT03173560|79325530|FG000|Overall Study|Other|0|||
44421399|NCT00798161|79429305|FG005|Overall Study|Adverse Event|2|||
44536671|NCT03529773|79547252|FG018|Overall Study|Withdrawal by Subject|3|||
44320557|NCT03173560|79325531|FG001|Overall Study|Other|1|||
44320558|NCT03052127|79325589|FG000|Overall Study|Withdrawal by Subject|0|||
44421400|NCT00798161|79429306|FG006|Overall Study|Adverse Event|4|||
44421401|NCT00798161|79429300|FG000|Overall Study|Protocol Violation|2|||
44421402|NCT00798161|79429301|FG001|Overall Study|Protocol Violation|1|||
44421403|NCT00798161|79429302|FG002|Overall Study|Protocol Violation|3|||
44421404|NCT00798161|79429303|FG003|Overall Study|Protocol Violation|3|||
44536672|NCT03529773|79547253|FG019|Overall Study|Withdrawal by Subject|1|||
44155745|NCT01954342|78947252|FG000|Overall Study|Preterm delivery|0|||
44155746|NCT01954342|78947253|FG001|Overall Study|Preterm delivery|0|||
44320559|NCT03052127|79325590|FG001|Overall Study|Withdrawal by Subject|0|||
44320560|NCT03052127|79325591|FG002|Overall Study|Withdrawal by Subject|0|||
44320561|NCT03052127|79325592|FG003|Overall Study|Withdrawal by Subject|0|||
44320562|NCT03052127|79325593|FG004|Overall Study|Withdrawal by Subject|0|||
44320563|NCT03052127|79325594|FG005|Overall Study|Withdrawal by Subject|0|||
44320564|NCT03052127|79325595|FG006|Overall Study|Withdrawal by Subject|0|||
44320565|NCT03052127|79325596|FG007|Overall Study|Withdrawal by Subject|1|||
44320566|NCT03052127|79325597|FG008|Overall Study|Withdrawal by Subject|1|||
44320567|NCT03052127|79325598|FG009|Overall Study|Withdrawal by Subject|1|||
44320568|NCT03052127|79325599|FG010|Overall Study|Withdrawal by Subject|0|||
44320569|NCT03052127|79325600|FG011|Overall Study|Withdrawal by Subject|0|||
44320570|NCT03052127|79325589|FG000|Overall Study|Discontinuation by Sponsor|0|||
44320571|NCT03052127|79325590|FG001|Overall Study|Discontinuation by Sponsor|0|||
44320572|NCT03052127|79325591|FG002|Overall Study|Discontinuation by Sponsor|0|||
44320573|NCT03052127|79325592|FG003|Overall Study|Discontinuation by Sponsor|0|||
44421405|NCT00798161|79429304|FG004|Overall Study|Protocol Violation|3|||
44421406|NCT00798161|79429305|FG005|Overall Study|Protocol Violation|2|||
44421407|NCT00798161|79429306|FG006|Overall Study|Protocol Violation|0|||
44421408|NCT00798161|79429300|FG000|Overall Study|Lost to Follow-up|1|||
44421409|NCT00798161|79429301|FG001|Overall Study|Lost to Follow-up|3|||
44421410|NCT00798161|79429302|FG002|Overall Study|Lost to Follow-up|4|||
44421411|NCT00798161|79429303|FG003|Overall Study|Lost to Follow-up|3|||
44421412|NCT00798161|79429304|FG004|Overall Study|Lost to Follow-up|4|||
44421413|NCT00798161|79429305|FG005|Overall Study|Lost to Follow-up|0|||
44421414|NCT00798161|79429306|FG006|Overall Study|Lost to Follow-up|0|||
44421415|NCT00798161|79429300|FG000|Overall Study|Withdrawal by Subject|5|||
44421416|NCT00798161|79429301|FG001|Overall Study|Withdrawal by Subject|4|||
44421417|NCT00798161|79429302|FG002|Overall Study|Withdrawal by Subject|5|||
44421418|NCT00798161|79429303|FG003|Overall Study|Withdrawal by Subject|4|||
44421419|NCT00798161|79429304|FG004|Overall Study|Withdrawal by Subject|2|||
44421420|NCT00798161|79429305|FG005|Overall Study|Withdrawal by Subject|3|||
44421421|NCT00798161|79429306|FG006|Overall Study|Withdrawal by Subject|1|||
44421422|NCT00798161|79429300|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
44421423|NCT00798161|79429301|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
44421424|NCT00798161|79429302|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
44421425|NCT00798161|79429303|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
44421426|NCT00798161|79429304|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
44421427|NCT00798161|79429305|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
44421428|NCT00798161|79429306|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
44421429|NCT00588341|79429322|FG000|Overall Study|Withdrawal by Subject|3|||
44421430|NCT00588341|79429322|FG000|Overall Study|Not treated due to metastatic disease|1|||
44421431|NCT00588341|79429322|FG000|Overall Study|Patient ineligible|1|||
44421432|NCT00802529|79429328|FG000|Overall Study|Lost to Follow-up|0|||
44421433|NCT00802529|79429329|FG001|Overall Study|Lost to Follow-up|1|||
44421434|NCT00758264|79429338|FG000|Active Phase|Withdrawal by Subject|0|||
44421435|NCT00758264|79429339|FG001|Active Phase|Withdrawal by Subject|0|||
44421436|NCT00758264|79429340|FG002|Active Phase|Withdrawal by Subject|1|||
44421437|NCT00758264|79429338|FG000|Active Phase|Lost to Follow-up|1|||
44421438|NCT00758264|79429339|FG001|Active Phase|Lost to Follow-up|0|||
44421439|NCT00758264|79429340|FG002|Active Phase|Lost to Follow-up|0|||
44421440|NCT00758264|79429338|FG000|Active Phase|Other|0|||
44421441|NCT00758264|79429339|FG001|Active Phase|Other|0|||
44421442|NCT00758264|79429340|FG002|Active Phase|Other|4|||
44421443|NCT00588731|79429350|FG000|Overall Study|Withdrawal by Subject|3|||
44421444|NCT00588731|79429351|FG001|Overall Study|Withdrawal by Subject|2|||
44421445|NCT00757172|79429357|FG000|Overall Study|Withdrawal by Subject|4|||
44421446|NCT00757172|79429357|FG000|Overall Study|Physician Decision|3|||
44421447|NCT00757172|79429357|FG000|Overall Study|Progression|4|||
44421448|NCT00797225|79429365|FG000|Weeks 1 to 12|Adverse Event|0|||
44421449|NCT00797225|79429366|FG001|Weeks 1 to 12|Adverse Event|0|||
44421450|NCT00797225|79429367|FG002|Weeks 1 to 12|Adverse Event|1|||
44421451|NCT00797225|79429368|FG003|Weeks 1 to 12|Adverse Event|0|||
44421452|NCT00797225|79429369|FG004|Weeks 1 to 12|Adverse Event|0|||
44421453|NCT00797225|79429370|FG005|Weeks 1 to 12|Adverse Event|0|||
44421454|NCT00797225|79429371|FG006|Weeks 1 to 12|Adverse Event|0|||
44421455|NCT00797225|79429372|FG007|Weeks 1 to 12|Adverse Event|0|||
44421456|NCT00797225|79429365|FG000|Weeks 1 to 12|Non-compliance|0|||
44421457|NCT00797225|79429366|FG001|Weeks 1 to 12|Non-compliance|1|||
44320574|NCT03052127|79325593|FG004|Overall Study|Discontinuation by Sponsor|0|||
44421458|NCT00797225|79429367|FG002|Weeks 1 to 12|Non-compliance|0|||
44421459|NCT00797225|79429368|FG003|Weeks 1 to 12|Non-compliance|0|||
44320575|NCT03052127|79325594|FG005|Overall Study|Discontinuation by Sponsor|0|||
44320576|NCT03052127|79325595|FG006|Overall Study|Discontinuation by Sponsor|0|||
44320577|NCT03052127|79325596|FG007|Overall Study|Discontinuation by Sponsor|0|||
44320578|NCT03052127|79325597|FG008|Overall Study|Discontinuation by Sponsor|4|||
44320579|NCT03052127|79325598|FG009|Overall Study|Discontinuation by Sponsor|2|||
44320580|NCT03052127|79325599|FG010|Overall Study|Discontinuation by Sponsor|5|||
44320581|NCT03052127|79325600|FG011|Overall Study|Discontinuation by Sponsor|13|||
44320582|NCT03052127|79325589|FG000|Overall Study|Inability to comply with trial requirements|0|||
44320583|NCT03052127|79325590|FG001|Overall Study|Inability to comply with trial requirements|0|||
44421460|NCT00797225|79429369|FG004|Weeks 1 to 12|Non-compliance|0|||
44421461|NCT00797225|79429370|FG005|Weeks 1 to 12|Non-compliance|0|||
44421462|NCT00797225|79429371|FG006|Weeks 1 to 12|Non-compliance|0|||
44421463|NCT00797225|79429372|FG007|Weeks 1 to 12|Non-compliance|0|||
44421464|NCT00797225|79429365|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
44421465|NCT00797225|79429366|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
44421466|NCT00797225|79429367|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
44421467|NCT00797225|79429368|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
44421468|NCT00797225|79429369|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
44421469|NCT00797225|79429370|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
44421470|NCT00797225|79429371|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
44421471|NCT00797225|79429372|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
44421472|NCT00797225|79429365|FG000|Weeks 1 to 12|Sponsor Decision|1|||
44421473|NCT00797225|79429366|FG001|Weeks 1 to 12|Sponsor Decision|0|||
44421474|NCT00797225|79429367|FG002|Weeks 1 to 12|Sponsor Decision|0|||
44421475|NCT00797225|79429368|FG003|Weeks 1 to 12|Sponsor Decision|0|||
44320584|NCT03052127|79325591|FG002|Overall Study|Inability to comply with trial requirements|1|||
44536673|NCT03529773|79547254|FG020|Overall Study|Withdrawal by Subject|3|||
44536674|NCT03529773|79547255|FG021|Overall Study|Withdrawal by Subject|1|||
44536675|NCT03529773|79547256|FG022|Overall Study|Withdrawal by Subject|1|||
44536676|NCT03529773|79547257|FG023|Overall Study|Withdrawal by Subject|2|||
44536677|NCT03529773|79547258|FG024|Overall Study|Withdrawal by Subject|2|||
44536678|NCT03529773|79547259|FG025|Overall Study|Withdrawal by Subject|4|||
44536679|NCT03529773|79547260|FG026|Overall Study|Withdrawal by Subject|2|||
44536680|NCT03529773|79547261|FG027|Overall Study|Withdrawal by Subject|1|||
44536681|NCT03529773|79547262|FG028|Overall Study|Withdrawal by Subject|1|||
44536682|NCT03529773|79547263|FG029|Overall Study|Withdrawal by Subject|0|||
44320585|NCT03052127|79325592|FG003|Overall Study|Inability to comply with trial requirements|0|||
44320586|NCT03052127|79325593|FG004|Overall Study|Inability to comply with trial requirements|0|||
44320587|NCT03052127|79325594|FG005|Overall Study|Inability to comply with trial requirements|0|||
44320588|NCT03052127|79325595|FG006|Overall Study|Inability to comply with trial requirements|0|||
44320589|NCT03052127|79325596|FG007|Overall Study|Inability to comply with trial requirements|0|||
44320590|NCT03052127|79325597|FG008|Overall Study|Inability to comply with trial requirements|0|||
44320591|NCT03052127|79325598|FG009|Overall Study|Inability to comply with trial requirements|0|||
44320592|NCT03052127|79325599|FG010|Overall Study|Inability to comply with trial requirements|0|||
44320593|NCT03052127|79325600|FG011|Overall Study|Inability to comply with trial requirements|0|||
44320594|NCT03052127|79325589|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
44320595|NCT03052127|79325590|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44320596|NCT03052127|79325591|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44320597|NCT03052127|79325592|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44320598|NCT03052127|79325593|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
44320599|NCT03052127|79325594|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
44320600|NCT03052127|79325595|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
44421476|NCT00797225|79429369|FG004|Weeks 1 to 12|Sponsor Decision|0|||
44421477|NCT00797225|79429370|FG005|Weeks 1 to 12|Sponsor Decision|0|||
44421478|NCT00797225|79429371|FG006|Weeks 1 to 12|Sponsor Decision|0|||
44421479|NCT00797225|79429372|FG007|Weeks 1 to 12|Sponsor Decision|0|||
44421480|NCT00797225|79429365|FG000|Weeks 13 to 24|Non-compliance|0|||
44421481|NCT00797225|79429366|FG001|Weeks 13 to 24|Non-compliance|2|||
44421482|NCT00797225|79429367|FG002|Weeks 13 to 24|Non-compliance|0|||
44421483|NCT00797225|79429368|FG003|Weeks 13 to 24|Non-compliance|0|||
44421484|NCT00797225|79429369|FG004|Weeks 13 to 24|Non-compliance|0|||
44421485|NCT00797225|79429370|FG005|Weeks 13 to 24|Non-compliance|0|||
44421486|NCT00797225|79429371|FG006|Weeks 13 to 24|Non-compliance|0|||
44536683|NCT03529773|79547264|FG030|Overall Study|Withdrawal by Subject|0|||
44320601|NCT03052127|79325596|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44421487|NCT00797225|79429372|FG007|Weeks 13 to 24|Non-compliance|0|||
44421488|NCT00797225|79429365|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
44421489|NCT00797225|79429366|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
44421490|NCT00797225|79429367|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
44320602|NCT03052127|79325597|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44320603|NCT03052127|79325598|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44421491|NCT00797225|79429368|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
44536684|NCT03529773|79547265|FG031|Overall Study|Withdrawal by Subject|0|||
44421492|NCT00797225|79429369|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
44421493|NCT00797225|79429370|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
44320604|NCT03052127|79325599|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44320605|NCT03052127|79325600|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
44320606|NCT02967692|79325632|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
44320607|NCT02967692|79325633|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
44320608|NCT02967692|79325634|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
44320609|NCT02967692|79325635|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
44320610|NCT02967692|79325632|FG000|Overall Study|Progressive disease|3|||
44320611|NCT02967692|79325633|FG001|Overall Study|Progressive disease|15|||
44320612|NCT02967692|79325634|FG002|Overall Study|Progressive disease|99|||
44320613|NCT02967692|79325635|FG003|Overall Study|Progressive disease|128|||
44320614|NCT02967692|79325632|FG000|Overall Study|Subject/guardian decision|1|||
44320615|NCT02967692|79325633|FG001|Overall Study|Subject/guardian decision|1|||
44320616|NCT02967692|79325634|FG002|Overall Study|Subject/guardian decision|6|||
44320617|NCT02967692|79325635|FG003|Overall Study|Subject/guardian decision|13|||
44320618|NCT02967692|79325632|FG000|Overall Study|Death|0|||
44320619|NCT02967692|79325633|FG001|Overall Study|Death|1|||
44320620|NCT02967692|79325634|FG002|Overall Study|Death|10|||
44320621|NCT02967692|79325635|FG003|Overall Study|Death|9|||
44320622|NCT02967692|79325632|FG000|Overall Study|Protocol deviation|1|||
44320623|NCT02967692|79325633|FG001|Overall Study|Protocol deviation|0|||
44320624|NCT02967692|79325634|FG002|Overall Study|Protocol deviation|1|||
44320625|NCT02967692|79325635|FG003|Overall Study|Protocol deviation|1|||
44320626|NCT02967692|79325632|FG000|Overall Study|Lost to Follow-up|0|||
44320627|NCT02967692|79325633|FG001|Overall Study|Lost to Follow-up|0|||
44320628|NCT02967692|79325634|FG002|Overall Study|Lost to Follow-up|1|||
44320629|NCT02967692|79325635|FG003|Overall Study|Lost to Follow-up|0|||
44320630|NCT02967692|79325632|FG000|Overall Study|Physician Decision|0|||
44320631|NCT02967692|79325633|FG001|Overall Study|Physician Decision|0|||
44320632|NCT02967692|79325634|FG002|Overall Study|Physician Decision|13|||
44320633|NCT02967692|79325635|FG003|Overall Study|Physician Decision|9|||
44320634|NCT02967692|79325632|FG000|Overall Study|Adverse Event|1|||
44320635|NCT02967692|79325633|FG001|Overall Study|Adverse Event|9|||
44320636|NCT02967692|79325634|FG002|Overall Study|Adverse Event|51|||
44320637|NCT02967692|79325635|FG003|Overall Study|Adverse Event|23|||
44320638|NCT02925416|79325671|FG000|Overall Study|Adverse Event|2|||
44320639|NCT02925416|79325672|FG001|Overall Study|Adverse Event|0|||
44320640|NCT02564978|79325687|FG000|Overall Study|Adverse Event|8|||
44320641|NCT02564978|79325687|FG000|Overall Study|Death|1|||
44320642|NCT02564978|79325687|FG000|Overall Study|Lost to Follow-up|1|||
44320643|NCT02564978|79325687|FG000|Overall Study|Withdrawal by Subject|15|||
44320644|NCT02564978|79325687|FG000|Overall Study|Early Study Closure|2|||
44320645|NCT02564978|79325687|FG000|Overall Study|Other Reason|5|||
44320646|NCT02561962|79325700|FG000|Overall Study|Withdrawal by Subject|1|||
44320647|NCT02561962|79325701|FG001|Overall Study|Withdrawal by Subject|0|||
44320648|NCT02561962|79325702|FG002|Overall Study|Withdrawal by Subject|0|||
44320649|NCT02561962|79325703|FG003|Overall Study|Withdrawal by Subject|0|||
44320650|NCT02561962|79325704|FG004|Overall Study|Withdrawal by Subject|1|||
44320651|NCT02561962|79325705|FG005|Overall Study|Withdrawal by Subject|1|||
44320652|NCT02561962|79325706|FG006|Overall Study|Withdrawal by Subject|2|||
44320653|NCT02561962|79325707|FG007|Overall Study|Withdrawal by Subject|1|||
44320654|NCT02561962|79325708|FG008|Overall Study|Withdrawal by Subject|0|||
44320655|NCT02561962|79325700|FG000|Overall Study|Decision by sponsor|0|||
44320656|NCT02561962|79325701|FG001|Overall Study|Decision by sponsor|0|||
44320657|NCT02561962|79325702|FG002|Overall Study|Decision by sponsor|0|||
44320658|NCT02561962|79325703|FG003|Overall Study|Decision by sponsor|0|||
44320659|NCT02561962|79325704|FG004|Overall Study|Decision by sponsor|1|||
44320660|NCT02561962|79325705|FG005|Overall Study|Decision by sponsor|1|||
44320661|NCT02561962|79325706|FG006|Overall Study|Decision by sponsor|0|||
44320662|NCT02561962|79325707|FG007|Overall Study|Decision by sponsor|3|||
44320663|NCT02561962|79325708|FG008|Overall Study|Decision by sponsor|0|||
44421494|NCT00797225|79429371|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
44421495|NCT00797225|79429372|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
44421496|NCT00797225|79429365|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
44421497|NCT00797225|79429366|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
44320664|NCT02561962|79325700|FG000|Overall Study|Lost to Follow-up|0|||
44320665|NCT02561962|79325701|FG001|Overall Study|Lost to Follow-up|0|||
44320666|NCT02561962|79325702|FG002|Overall Study|Lost to Follow-up|0|||
44421498|NCT00797225|79429367|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
44421499|NCT00797225|79429368|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
44320667|NCT02561962|79325703|FG003|Overall Study|Lost to Follow-up|0|||
44320668|NCT02561962|79325704|FG004|Overall Study|Lost to Follow-up|0|||
44320669|NCT02561962|79325705|FG005|Overall Study|Lost to Follow-up|1|||
44320670|NCT02561962|79325706|FG006|Overall Study|Lost to Follow-up|0|||
44320671|NCT02561962|79325707|FG007|Overall Study|Lost to Follow-up|0|||
44320672|NCT02561962|79325708|FG008|Overall Study|Lost to Follow-up|0|||
44320673|NCT02519348|79325738|FG000|Overall Study|Death|31|||
44320674|NCT02519348|79325739|FG001|Overall Study|Death|74|||
44421500|NCT00797225|79429369|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
44320675|NCT02519348|79325740|FG002|Overall Study|Death|47|||
44320676|NCT02519348|79325741|FG003|Overall Study|Death|54|||
44320677|NCT02519348|79325742|FG004|Overall Study|Death|63|||
44320678|NCT02519348|79325743|FG005|Overall Study|Death|18|||
44320679|NCT02519348|79325744|FG006|Overall Study|Death|2|||
44320680|NCT02519348|79325745|FG007|Overall Study|Death|5|||
44320681|NCT02519348|79325746|FG008|Overall Study|Death|5|||
44320682|NCT02519348|79325738|FG000|Overall Study|Withdrawal by Subject|4|||
44320683|NCT02519348|79325739|FG001|Overall Study|Withdrawal by Subject|7|||
44320684|NCT02519348|79325740|FG002|Overall Study|Withdrawal by Subject|4|||
44320685|NCT02519348|79325741|FG003|Overall Study|Withdrawal by Subject|3|||
44320686|NCT02519348|79325742|FG004|Overall Study|Withdrawal by Subject|3|||
44320687|NCT02519348|79325743|FG005|Overall Study|Withdrawal by Subject|2|||
44320688|NCT02519348|79325744|FG006|Overall Study|Withdrawal by Subject|0|||
44320689|NCT02519348|79325745|FG007|Overall Study|Withdrawal by Subject|0|||
44320690|NCT02519348|79325746|FG008|Overall Study|Withdrawal by Subject|1|||
44320691|NCT02519348|79325738|FG000|Overall Study|Lost to Follow-up|0|||
44320692|NCT02519348|79325739|FG001|Overall Study|Lost to Follow-up|0|||
44320693|NCT02519348|79325740|FG002|Overall Study|Lost to Follow-up|1|||
44320694|NCT02519348|79325741|FG003|Overall Study|Lost to Follow-up|0|||
44320695|NCT02519348|79325742|FG004|Overall Study|Lost to Follow-up|2|||
44320696|NCT02519348|79325743|FG005|Overall Study|Lost to Follow-up|1|||
44320697|NCT02519348|79325744|FG006|Overall Study|Lost to Follow-up|1|||
44320698|NCT02519348|79325745|FG007|Overall Study|Lost to Follow-up|0|||
44320699|NCT02519348|79325746|FG008|Overall Study|Lost to Follow-up|0|||
44320700|NCT02519348|79325738|FG000|Overall Study|Other|0|||
44320701|NCT02519348|79325739|FG001|Overall Study|Other|3|||
44320702|NCT02519348|79325740|FG002|Overall Study|Other|0|||
44320703|NCT02519348|79325741|FG003|Overall Study|Other|0|||
44320704|NCT02519348|79325742|FG004|Overall Study|Other|1|||
44320705|NCT02519348|79325743|FG005|Overall Study|Other|0|||
44320706|NCT02519348|79325744|FG006|Overall Study|Other|0|||
44320707|NCT02519348|79325745|FG007|Overall Study|Other|0|||
44320708|NCT02519348|79325746|FG008|Overall Study|Other|0|||
44320709|NCT02519348|79325738|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
44320710|NCT02519348|79325739|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
44320711|NCT02519348|79325740|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
44320712|NCT02519348|79325741|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
44320713|NCT02519348|79325742|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
44320714|NCT02519348|79325743|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
44320715|NCT02519348|79325744|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
44320716|NCT02519348|79325745|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
44320717|NCT02519348|79325746|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
44320718|NCT02496156|79325769|FG000|Overall Study|Lost to Follow-up|5|||
44320719|NCT02496156|79325770|FG001|Overall Study|Lost to Follow-up|0|||
44320720|NCT02496156|79325769|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
44320721|NCT02496156|79325770|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
44320722|NCT02477696|79325778|FG000|Overall Study|Death|89|||
44320723|NCT02477696|79325779|FG001|Overall Study|Death|106|||
44320724|NCT02477696|79325778|FG000|Overall Study|Lost to Follow-up|7|||
44320725|NCT02477696|79325779|FG001|Overall Study|Lost to Follow-up|5|||
44320726|NCT02477696|79325778|FG000|Overall Study|Withdrawal by Subject|37|||
44320727|NCT02477696|79325779|FG001|Overall Study|Withdrawal by Subject|34|||
44320728|NCT02477696|79325778|FG000|Overall Study|Physician Decision|7|||
44320729|NCT02477696|79325779|FG001|Overall Study|Physician Decision|9|||
44320730|NCT02477696|79325778|FG000|Overall Study|Study terminated by sponsor|103|||
44421501|NCT00797225|79429370|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
44320731|NCT02477696|79325779|FG001|Overall Study|Study terminated by sponsor|99|||
44320732|NCT02477696|79325778|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
44320733|NCT02477696|79325779|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
44320734|NCT02477696|79325778|FG000|Overall Study|Missing/Unknown|2|||
44320735|NCT02477696|79325779|FG001|Overall Study|Missing/Unknown|0|||
44320736|NCT02361944|79325787|FG000|Overall Study|surgery cancellation|0|||
44320737|NCT02361944|79325788|FG001|Overall Study|surgery cancellation|1|||
44320738|NCT02246621|79325796|FG000|Overall Study|Withdrawal by Subject|28|||
44320739|NCT02246621|79325797|FG001|Overall Study|Withdrawal by Subject|16|||
44320740|NCT02246621|79325796|FG000|Overall Study|Lost to Follow-up|1|||
44320741|NCT02246621|79325797|FG001|Overall Study|Lost to Follow-up|0|||
44320742|NCT02246621|79325796|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
44320743|NCT02246621|79325797|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
44320744|NCT02076009|79325805|FG000|Overall Study|Death|172|||
44320745|NCT02076009|79325806|FG001|Overall Study|Death|153|||
44320746|NCT02076009|79325805|FG000|Overall Study|Withdrawal by Subject|16|||
44320747|NCT02076009|79325806|FG001|Overall Study|Withdrawal by Subject|12|||
44320748|NCT02076009|79325805|FG000|Overall Study|Lost to Follow-up|4|||
44320749|NCT02076009|79325806|FG001|Overall Study|Lost to Follow-up|2|||
44320750|NCT02076009|79325805|FG000|Overall Study|Progressive Disease|1|||
44320751|NCT02076009|79325806|FG001|Overall Study|Progressive Disease|0|||
44320752|NCT02076009|79325805|FG000|Overall Study|Physician Decision|0|||
44320753|NCT02076009|79325806|FG001|Overall Study|Physician Decision|1|||
44320754|NCT02076009|79325805|FG000|Overall Study|End of data collection|90|||
44320755|NCT02076009|79325806|FG001|Overall Study|End of data collection|118|||
44320756|NCT01946204|79325814|FG000|Overall Study|Death|38|||
44320757|NCT01946204|79325815|FG001|Overall Study|Death|59|||
44320758|NCT01946204|79325814|FG000|Overall Study|Withdrawal by Subject|37|||
44320759|NCT01946204|79325815|FG001|Overall Study|Withdrawal by Subject|50|||
44320760|NCT01946204|79325814|FG000|Overall Study|Lost to Follow-up|3|||
44320761|NCT01946204|79325815|FG001|Overall Study|Lost to Follow-up|7|||
44320762|NCT01946204|79325814|FG000|Overall Study|Ongoing|316|||
44155747|NCT01954342|78947254|FG002|Overall Study|Preterm delivery|0|||
44320763|NCT01946204|79325815|FG001|Overall Study|Ongoing|687|||
44320764|NCT01946204|79325814|FG000|Overall Study|Other|7|||
44320765|NCT01946204|79325815|FG001|Overall Study|Other|3|||
44320766|NCT01776840|79325823|FG000|Overall Study|Lost to Follow-up|4|||
44320767|NCT01776840|79325824|FG001|Overall Study|Lost to Follow-up|4|||
44320768|NCT01776840|79325823|FG000|Overall Study|Withdrawal by Subject|42|||
44320769|NCT01776840|79325824|FG001|Overall Study|Withdrawal by Subject|22|||
44320770|NCT01776840|79325823|FG000|Overall Study|Ongoing|112|||
44320771|NCT01776840|79325824|FG001|Overall Study|Ongoing|129|||
44320772|NCT01615029|79325835|FG000|Overall Study|Adverse Event|0|||
44320773|NCT01615029|79325836|FG001|Overall Study|Adverse Event|0|||
44320774|NCT01615029|79325837|FG002|Overall Study|Adverse Event|0|||
44320775|NCT01615029|79325838|FG003|Overall Study|Adverse Event|0|||
44320776|NCT01615029|79325839|FG004|Overall Study|Adverse Event|1|||
44320777|NCT01615029|79325835|FG000|Overall Study|Death|0|||
44320778|NCT01615029|79325836|FG001|Overall Study|Death|0|||
44320779|NCT01615029|79325837|FG002|Overall Study|Death|0|||
44320780|NCT01615029|79325838|FG003|Overall Study|Death|0|||
44320781|NCT01615029|79325839|FG004|Overall Study|Death|1|||
44320782|NCT01615029|79325835|FG000|Overall Study|Lost to Follow-up|0|||
44320783|NCT01615029|79325836|FG001|Overall Study|Lost to Follow-up|0|||
44320784|NCT01615029|79325837|FG002|Overall Study|Lost to Follow-up|0|||
44320785|NCT01615029|79325838|FG003|Overall Study|Lost to Follow-up|0|||
44320786|NCT01615029|79325839|FG004|Overall Study|Lost to Follow-up|1|||
44320787|NCT01615029|79325835|FG000|Overall Study|Progressive disease|2|||
44320788|NCT01615029|79325836|FG001|Overall Study|Progressive disease|1|||
44320789|NCT01615029|79325837|FG002|Overall Study|Progressive disease|1|||
44320790|NCT01615029|79325838|FG003|Overall Study|Progressive disease|1|||
44320791|NCT01615029|79325839|FG004|Overall Study|Progressive disease|5|||
44155748|NCT01954342|78947255|FG003|Overall Study|Preterm delivery|3|||
44155749|NCT01954342|78947252|FG000|Overall Study|Pre-eclampsia|0|||
44155750|NCT01954342|78947253|FG001|Overall Study|Pre-eclampsia|0|||
44320792|NCT01615029|79325835|FG000|Overall Study|Physician Decision|0|||
44320793|NCT01615029|79325836|FG001|Overall Study|Physician Decision|0|||
44320794|NCT01615029|79325837|FG002|Overall Study|Physician Decision|0|||
44320795|NCT01615029|79325838|FG003|Overall Study|Physician Decision|0|||
44320796|NCT01615029|79325839|FG004|Overall Study|Physician Decision|1|||
44320797|NCT01615029|79325835|FG000|Overall Study|Ongoing|1|||
44320798|NCT01615029|79325836|FG001|Overall Study|Ongoing|2|||
44320799|NCT01615029|79325837|FG002|Overall Study|Ongoing|3|||
44320800|NCT01615029|79325838|FG003|Overall Study|Ongoing|2|||
44320801|NCT01615029|79325839|FG004|Overall Study|Ongoing|23|||
44320802|NCT01575834|79325853|FG000|Overall Study|Withdrawal by Subject|352|||
44155751|NCT01954342|78947254|FG002|Overall Study|Pre-eclampsia|0|||
44320803|NCT01575834|79325854|FG001|Overall Study|Withdrawal by Subject|390|||
44320804|NCT01575834|79325853|FG000|Overall Study|Death|81|||
44320805|NCT01575834|79325854|FG001|Overall Study|Death|74|||
44320806|NCT01575834|79325853|FG000|Overall Study|Other|70|||
44320807|NCT01575834|79325854|FG001|Overall Study|Other|70|||
44320808|NCT01575834|79325853|FG000|Overall Study|Adverse Event|63|||
44320809|NCT01575834|79325854|FG001|Overall Study|Adverse Event|61|||
44320810|NCT01575834|79325853|FG000|Overall Study|Lost to Follow-up|55|||
44320811|NCT01575834|79325854|FG001|Overall Study|Lost to Follow-up|68|||
44320812|NCT01575834|79325853|FG000|Overall Study|Noncompliance|52|||
44320813|NCT01575834|79325854|FG001|Overall Study|Noncompliance|27|||
44320814|NCT01575834|79325853|FG000|Overall Study|Administrative decision|15|||
44320815|NCT01575834|79325854|FG001|Overall Study|Administrative decision|33|||
44320816|NCT01575834|79325853|FG000|Overall Study|Ineligibility Determined|5|||
44320817|NCT01575834|79325854|FG001|Overall Study|Ineligibility Determined|8|||
44320818|NCT01575834|79325853|FG000|Overall Study|Protocol Deviation|4|||
44320819|NCT01575834|79325854|FG001|Overall Study|Protocol Deviation|3|||
44320820|NCT01575834|79325853|FG000|Overall Study|Requirement for Alternative Therapy|2|||
44320821|NCT01575834|79325854|FG001|Overall Study|Requirement for Alternative Therapy|4|||
44320822|NCT01385176|79325866|FG000|Randomization Phase|Death|1|||
44421502|NCT00797225|79429371|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
44421503|NCT00797225|79429372|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
44421504|NCT00797225|79429365|FG000|Weeks 13 to 24|Adverse Event|0|||
44421505|NCT00797225|79429366|FG001|Weeks 13 to 24|Adverse Event|1|||
44421506|NCT00797225|79429367|FG002|Weeks 13 to 24|Adverse Event|0|||
44421507|NCT00797225|79429368|FG003|Weeks 13 to 24|Adverse Event|0|||
44421508|NCT00797225|79429369|FG004|Weeks 13 to 24|Adverse Event|0|||
44421509|NCT00797225|79429370|FG005|Weeks 13 to 24|Adverse Event|0|||
44421510|NCT00797225|79429371|FG006|Weeks 13 to 24|Adverse Event|1|||
44421511|NCT00797225|79429372|FG007|Weeks 13 to 24|Adverse Event|0|||
44421512|NCT00797225|79429365|FG000|Weeks 13 to 24|Sponsor Decision|0|||
44421513|NCT00797225|79429366|FG001|Weeks 13 to 24|Sponsor Decision|0|||
44421514|NCT00797225|79429367|FG002|Weeks 13 to 24|Sponsor Decision|0|||
44421515|NCT00797225|79429368|FG003|Weeks 13 to 24|Sponsor Decision|0|||
44421516|NCT00797225|79429369|FG004|Weeks 13 to 24|Sponsor Decision|0|||
44421517|NCT00797225|79429370|FG005|Weeks 13 to 24|Sponsor Decision|0|||
44421518|NCT00797225|79429371|FG006|Weeks 13 to 24|Sponsor Decision|1|||
44421519|NCT00797225|79429372|FG007|Weeks 13 to 24|Sponsor Decision|0|||
44421520|NCT00778700|79429392|FG000|Overall Study|Adverse Event|6|||
44421521|NCT00778700|79429393|FG001|Overall Study|Adverse Event|1|||
44421522|NCT00778700|79429394|FG002|Overall Study|Adverse Event|3|||
44421523|NCT00778700|79429395|FG003|Overall Study|Adverse Event|5|||
44421524|NCT00778700|79429392|FG000|Overall Study|Protocol Violation|1|||
44421525|NCT00778700|79429393|FG001|Overall Study|Protocol Violation|1|||
44421526|NCT00778700|79429394|FG002|Overall Study|Protocol Violation|0|||
44421527|NCT00778700|79429395|FG003|Overall Study|Protocol Violation|0|||
44421528|NCT00778700|79429392|FG000|Overall Study|Subject Withdrew Consent|6|||
44421529|NCT00778700|79429393|FG001|Overall Study|Subject Withdrew Consent|4|||
44421530|NCT00778700|79429394|FG002|Overall Study|Subject Withdrew Consent|1|||
44421531|NCT00778700|79429395|FG003|Overall Study|Subject Withdrew Consent|4|||
44421532|NCT00778700|79429392|FG000|Overall Study|Lost to Follow-up|3|||
44421533|NCT00778700|79429393|FG001|Overall Study|Lost to Follow-up|1|||
44421534|NCT00778700|79429394|FG002|Overall Study|Lost to Follow-up|0|||
44421535|NCT00778700|79429395|FG003|Overall Study|Lost to Follow-up|1|||
44421536|NCT00778700|79429392|FG000|Overall Study|Reason not Specified|2|||
44421537|NCT00778700|79429393|FG001|Overall Study|Reason not Specified|0|||
44421538|NCT00778700|79429394|FG002|Overall Study|Reason not Specified|1|||
44421539|NCT00778700|79429395|FG003|Overall Study|Reason not Specified|3|||
44421540|NCT00778700|79429392|FG000|Overall Study|Other|0|||
44421541|NCT00778700|79429393|FG001|Overall Study|Other|0|||
44421542|NCT00778700|79429394|FG002|Overall Study|Other|1|||
44421543|NCT00778700|79429395|FG003|Overall Study|Other|0|||
44421544|NCT00793403|79429409|FG000|Overall Study|Other|73|||
44421545|NCT00793325|79429413|FG000|Overall Study|Protocol Violation|18|||
44421546|NCT00793325|79429413|FG000|Overall Study|Lost to Follow-up|1|||
44421547|NCT00778622|79429439|FG000|Overall Study|Adverse Event|5|||
44421548|NCT00778622|79429440|FG001|Overall Study|Adverse Event|4|||
44421549|NCT00778622|79429441|FG002|Overall Study|Adverse Event|7|||
44421550|NCT00778622|79429439|FG000|Overall Study|Withdrawal by Subject|4|||
44421551|NCT00778622|79429440|FG001|Overall Study|Withdrawal by Subject|5|||
44421552|NCT00778622|79429441|FG002|Overall Study|Withdrawal by Subject|5|||
44421553|NCT00778622|79429439|FG000|Overall Study|Lost to Follow-up|3|||
44421554|NCT00778622|79429440|FG001|Overall Study|Lost to Follow-up|3|||
44421555|NCT00778622|79429441|FG002|Overall Study|Lost to Follow-up|2|||
44320823|NCT01385176|79325867|FG001|Randomization Phase|Death|2|||
44320824|NCT01385176|79325866|FG000|6-18 Month All VNS Active|Death|1|||
44320825|NCT01385176|79325867|FG001|6-18 Month All VNS Active|Death|2|||
44421556|NCT00778622|79429439|FG000|Overall Study|Protocol Violation|0|||
44421557|NCT00778622|79429440|FG001|Overall Study|Protocol Violation|3|||
44320826|NCT01385176|79325866|FG000|6-18 Month All VNS Active|Physician Decision|0|||
44421558|NCT00778622|79429441|FG002|Overall Study|Protocol Violation|0|||
44421559|NCT00778622|79429439|FG000|Overall Study|Lack of Efficacy|2|||
44421560|NCT00778622|79429440|FG001|Overall Study|Lack of Efficacy|0|||
44421561|NCT00778622|79429441|FG002|Overall Study|Lack of Efficacy|0|||
44320827|NCT01385176|79325867|FG001|6-18 Month All VNS Active|Physician Decision|1|||
44320828|NCT01385176|79325866|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
44320829|NCT01385176|79325867|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
44320830|NCT01385176|79325866|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
44320831|NCT01385176|79325867|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
44320832|NCT01186328|79325878|FG000|Overall Study|Death|1|||
44320833|NCT01186328|79325879|FG001|Overall Study|Death|0|||
44320834|NCT01186328|79325880|FG002|Overall Study|Death|0|||
44320835|NCT00455858|79325921|FG000|Overall Study|Lost to Follow-up|2|||
44320836|NCT00455858|79325921|FG000|Overall Study|Protocol Violation|1|||
44320837|NCT00455858|79325921|FG000|Overall Study|Lack of Efficacy|1|||
44320838|NCT00455858|79325921|FG000|Overall Study|Well controlled FPG without insulin|1|||
44320839|NCT00455858|79325921|FG000|Overall Study|Withdrawal|1|||
44320840|NCT00408005|79325927|FG000|Induction|Adverse Event|19|||
44320841|NCT00408005|79325928|FG001|Induction|Adverse Event|3|||
44320842|NCT00408005|79325929|FG002|Induction|Adverse Event|0|||
44320843|NCT00408005|79325930|FG003|Induction|Adverse Event|0|||
44320844|NCT00408005|79325931|FG004|Induction|Adverse Event|0|||
44320845|NCT00408005|79325932|FG005|Induction|Adverse Event|0|||
44320846|NCT00408005|79325933|FG006|Induction|Adverse Event|0|||
44320847|NCT00408005|79325934|FG007|Induction|Adverse Event|0|||
44320848|NCT00408005|79325927|FG000|Induction|Death|6|||
44320849|NCT00408005|79325928|FG001|Induction|Death|0|||
44320850|NCT00408005|79325929|FG002|Induction|Death|0|||
44320851|NCT00408005|79325930|FG003|Induction|Death|0|||
44320852|NCT00408005|79325931|FG004|Induction|Death|0|||
44320853|NCT00408005|79325932|FG005|Induction|Death|0|||
44320854|NCT00408005|79325933|FG006|Induction|Death|0|||
44320855|NCT00408005|79325934|FG007|Induction|Death|0|||
44320856|NCT00408005|79325927|FG000|Induction|Physician Decision|83|||
44421562|NCT00778622|79429439|FG000|Overall Study|immigration|1|||
44421563|NCT00778622|79429440|FG001|Overall Study|immigration|0|||
44421564|NCT00778622|79429441|FG002|Overall Study|immigration|0|||
44421565|NCT00778622|79429439|FG000|Overall Study|Other|1|||
44421566|NCT00778622|79429440|FG001|Overall Study|Other|0|||
44421567|NCT00778622|79429441|FG002|Overall Study|Other|1|||
44421568|NCT00777920|79429453|FG000|Overall Study|Adverse Event|39|||
44421569|NCT00777920|79429453|FG000|Overall Study|Withdrawal of Consent|4|||
44421570|NCT00777920|79429453|FG000|Overall Study|Lost to Follow-up|1|||
44421571|NCT00777920|79429453|FG000|Overall Study|Investigator's discretion|1|||
44421572|NCT00777920|79429453|FG000|Overall Study|Clinical status did not improve|1|||
44421573|NCT00777920|79429453|FG000|Overall Study|Other, not specified|4|||
44421574|NCT04236141|79429459|FG000|Overall Study|Death|18|||
44421575|NCT04236141|79429460|FG001|Overall Study|Death|10|||
44421576|NCT04236141|79429459|FG000|Overall Study|Withdrawal by Participant|1|||
44421577|NCT04236141|79429460|FG001|Overall Study|Withdrawal by Participant|0|||
44421578|NCT04236141|79429459|FG000|Overall Study|Reason not Specified|1|||
44421579|NCT04236141|79429460|FG001|Overall Study|Reason not Specified|0|||
44421580|NCT04236141|79429459|FG000|Overall Study|Study terminated by Sponsor|8|||
44421581|NCT04236141|79429460|FG001|Overall Study|Study terminated by Sponsor|4|||
44421582|NCT00796445|79429468|FG000|Overall Study|Protocol Violation|5|||
44421583|NCT00796445|79429469|FG001|Overall Study|Protocol Violation|3|||
44421584|NCT00796445|79429468|FG000|Overall Study|Adverse event, serious fatal|10|||
44421585|NCT00796445|79429469|FG001|Overall Study|Adverse event, serious fatal|5|||
44320857|NCT00408005|79325928|FG001|Induction|Physician Decision|9|||
44320858|NCT00408005|79325929|FG002|Induction|Physician Decision|0|||
44320859|NCT00408005|79325930|FG003|Induction|Physician Decision|0|||
44320860|NCT00408005|79325931|FG004|Induction|Physician Decision|0|||
44155752|NCT01954342|78947255|FG003|Overall Study|Pre-eclampsia|4|||
44421586|NCT00796445|79429468|FG000|Overall Study|Adverse event, non-fatal|4|||
44421587|NCT00796445|79429469|FG001|Overall Study|Adverse event, non-fatal|0|||
44421588|NCT00796445|79429468|FG000|Overall Study|Disease progression/recurrence|537|||
44421589|NCT00796445|79429469|FG001|Overall Study|Disease progression/recurrence|268|||
44421590|NCT00796445|79429468|FG000|Overall Study|Other|10|||
44421591|NCT00796445|79429469|FG001|Overall Study|Other|7|||
44320861|NCT00408005|79325932|FG005|Induction|Physician Decision|0|||
44320862|NCT00408005|79325933|FG006|Induction|Physician Decision|0|||
44320863|NCT00408005|79325934|FG007|Induction|Physician Decision|0|||
44320864|NCT00408005|79325927|FG000|Induction|Withdrawal by Subject|2|||
44320865|NCT00408005|79325928|FG001|Induction|Withdrawal by Subject|4|||
44320866|NCT00408005|79325929|FG002|Induction|Withdrawal by Subject|0|||
44320867|NCT00408005|79325930|FG003|Induction|Withdrawal by Subject|0|||
44320868|NCT00408005|79325931|FG004|Induction|Withdrawal by Subject|0|||
44320869|NCT00408005|79325932|FG005|Induction|Withdrawal by Subject|0|||
44320870|NCT00408005|79325933|FG006|Induction|Withdrawal by Subject|0|||
44320871|NCT00408005|79325934|FG007|Induction|Withdrawal by Subject|0|||
44320872|NCT00408005|79325927|FG000|Induction|Ineligible|33|||
44320873|NCT00408005|79325928|FG001|Induction|Ineligible|14|||
44320874|NCT00408005|79325929|FG002|Induction|Ineligible|0|||
44320875|NCT00408005|79325930|FG003|Induction|Ineligible|0|||
44320876|NCT00408005|79325931|FG004|Induction|Ineligible|0|||
44320877|NCT00408005|79325932|FG005|Induction|Ineligible|0|||
44320878|NCT00408005|79325933|FG006|Induction|Ineligible|0|||
44320879|NCT00408005|79325934|FG007|Induction|Ineligible|0|||
44320880|NCT00408005|79325927|FG000|Induction|Refusal of Further Protocol Therapy|225|||
44320881|NCT00408005|79325928|FG001|Induction|Refusal of Further Protocol Therapy|44|||
44320882|NCT00408005|79325929|FG002|Induction|Refusal of Further Protocol Therapy|0|||
44320883|NCT00408005|79325930|FG003|Induction|Refusal of Further Protocol Therapy|0|||
44320884|NCT00408005|79325931|FG004|Induction|Refusal of Further Protocol Therapy|0|||
44320885|NCT00408005|79325932|FG005|Induction|Refusal of Further Protocol Therapy|0|||
44320886|NCT00408005|79325933|FG006|Induction|Refusal of Further Protocol Therapy|0|||
44320887|NCT00408005|79325934|FG007|Induction|Refusal of Further Protocol Therapy|0|||
44320888|NCT00408005|79325927|FG000|Induction|Entered another COG therapeutic protocol|4|||
44320889|NCT00408005|79325928|FG001|Induction|Entered another COG therapeutic protocol|0|||
44320890|NCT00408005|79325929|FG002|Induction|Entered another COG therapeutic protocol|0|||
44320891|NCT00408005|79325930|FG003|Induction|Entered another COG therapeutic protocol|0|||
44320892|NCT00408005|79325931|FG004|Induction|Entered another COG therapeutic protocol|0|||
44320893|NCT00408005|79325932|FG005|Induction|Entered another COG therapeutic protocol|0|||
44320894|NCT00408005|79325933|FG006|Induction|Entered another COG therapeutic protocol|0|||
44320895|NCT00408005|79325934|FG007|Induction|Entered another COG therapeutic protocol|0|||
44320896|NCT00408005|79325927|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
44320897|NCT00408005|79325928|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
44320898|NCT00408005|79325929|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
44320899|NCT00408005|79325930|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
44320900|NCT00408005|79325931|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
44320901|NCT00408005|79325932|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
44320902|NCT00408005|79325933|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
44320903|NCT00408005|79325934|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
44320904|NCT00408005|79325927|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
44320905|NCT00408005|79325928|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
44320906|NCT00408005|79325929|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
44320907|NCT00408005|79325930|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
44320908|NCT00408005|79325931|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
44320909|NCT00408005|79325932|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
44320910|NCT00408005|79325933|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
44320911|NCT00408005|79325934|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
44320912|NCT00408005|79325927|FG000|Induction|Progressive Disease|0|||
44320913|NCT00408005|79325928|FG001|Induction|Progressive Disease|1|||
44320914|NCT00408005|79325929|FG002|Induction|Progressive Disease|0|||
44320915|NCT00408005|79325930|FG003|Induction|Progressive Disease|0|||
44320916|NCT00408005|79325931|FG004|Induction|Progressive Disease|0|||
44320917|NCT00408005|79325932|FG005|Induction|Progressive Disease|0|||
44320918|NCT00408005|79325933|FG006|Induction|Progressive Disease|0|||
44320919|NCT00408005|79325934|FG007|Induction|Progressive Disease|0|||
44320920|NCT00408005|79325927|FG000|Induction|Inevaluable|18|||
44320921|NCT00408005|79325928|FG001|Induction|Inevaluable|14|||
44320922|NCT00408005|79325929|FG002|Induction|Inevaluable|0|||
44320923|NCT00408005|79325930|FG003|Induction|Inevaluable|0|||
44155753|NCT01954342|78947252|FG000|Overall Study|Unreliable Data|0|||
44155754|NCT01954342|78947253|FG001|Overall Study|Unreliable Data|0|||
44320924|NCT00408005|79325931|FG004|Induction|Inevaluable|0|||
44155755|NCT01954342|78947254|FG002|Overall Study|Unreliable Data|0|||
44155756|NCT01954342|78947255|FG003|Overall Study|Unreliable Data|2|||
44155757|NCT01972438|78947267|FG000|Baseline-Month 3 Crossover Period|Death|1|||
44155758|NCT01972438|78947268|FG001|Baseline-Month 3 Crossover Period|Death|0|||
44155759|NCT01972438|78947267|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
44320925|NCT00408005|79325932|FG005|Induction|Inevaluable|0|||
44320926|NCT00408005|79325933|FG006|Induction|Inevaluable|0|||
44320927|NCT00408005|79325934|FG007|Induction|Inevaluable|0|||
44320928|NCT00408005|79325927|FG000|Induction|Failed to Complete Randomization|3|||
44320929|NCT00408005|79325928|FG001|Induction|Failed to Complete Randomization|2|||
44320930|NCT00408005|79325929|FG002|Induction|Failed to Complete Randomization|0|||
44320931|NCT00408005|79325930|FG003|Induction|Failed to Complete Randomization|0|||
44320932|NCT00408005|79325931|FG004|Induction|Failed to Complete Randomization|0|||
44320933|NCT00408005|79325932|FG005|Induction|Failed to Complete Randomization|0|||
44320934|NCT00408005|79325933|FG006|Induction|Failed to Complete Randomization|0|||
44320935|NCT00408005|79325934|FG007|Induction|Failed to Complete Randomization|0|||
44320936|NCT00408005|79325927|FG000|Induction|Protocol Deviation|3|||
44320937|NCT00408005|79325928|FG001|Induction|Protocol Deviation|1|||
44320938|NCT00408005|79325929|FG002|Induction|Protocol Deviation|0|||
44320939|NCT00408005|79325930|FG003|Induction|Protocol Deviation|0|||
44320940|NCT00408005|79325931|FG004|Induction|Protocol Deviation|0|||
44320941|NCT00408005|79325932|FG005|Induction|Protocol Deviation|0|||
44320942|NCT00408005|79325933|FG006|Induction|Protocol Deviation|0|||
44320943|NCT00408005|79325934|FG007|Induction|Protocol Deviation|0|||
44320944|NCT00408005|79325927|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
44320945|NCT00408005|79325928|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320946|NCT00408005|79325929|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320947|NCT00408005|79325930|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320948|NCT00408005|79325931|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320949|NCT00408005|79325932|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320950|NCT00408005|79325933|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320951|NCT00408005|79325934|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
44320952|NCT00408005|79325927|FG000|Induction|Recurrent leukemia|1|||
44320953|NCT00408005|79325928|FG001|Induction|Recurrent leukemia|0|||
44320954|NCT00408005|79325929|FG002|Induction|Recurrent leukemia|0|||
44320955|NCT00408005|79325930|FG003|Induction|Recurrent leukemia|0|||
44320956|NCT00408005|79325931|FG004|Induction|Recurrent leukemia|0|||
44320957|NCT00408005|79325932|FG005|Induction|Recurrent leukemia|0|||
44320958|NCT00408005|79325933|FG006|Induction|Recurrent leukemia|0|||
44320959|NCT00408005|79325934|FG007|Induction|Recurrent leukemia|0|||
44320960|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
44320961|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
44320962|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
44320963|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
44320964|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
44320965|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
44320966|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
44320967|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
44320968|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
44320969|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
44320970|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
44320971|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
44320972|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
44320973|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
44320974|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
44320975|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
44320976|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
44320977|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
44320978|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
44320979|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
44320980|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
44320981|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
44320982|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
44320983|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
44320984|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
44320985|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
44320986|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
44320987|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
44320988|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
44320989|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
44320990|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
44320991|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
44155760|NCT01972438|78947268|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
44320992|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
44320993|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
44320994|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
44320995|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
44320996|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
44320997|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
44320998|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
44320999|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
44321000|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
44321001|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
44321002|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
44321003|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
44321004|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
44321005|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
44321006|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
44321007|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
44321008|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321009|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321010|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321011|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321012|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
44321013|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321014|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321015|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
44321016|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
44321017|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
44321018|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
44321019|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
44321020|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
44321021|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
44321022|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
44321023|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
44321024|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
44321025|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
44321026|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
44321027|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
44321028|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
44321029|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
44321030|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
44321031|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
44321032|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321033|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321034|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321035|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321036|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321037|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
44321038|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321039|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
44321040|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
44321041|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
44321042|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
44321043|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
44321044|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
44321045|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
44321046|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
44321047|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
44321048|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
44321049|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
44321050|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
44321051|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
44321052|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
44321053|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
44321054|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
44321055|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
44321056|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
44321057|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
44321058|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
44321059|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
44321060|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
44321061|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
44321062|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
44321063|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
44321064|NCT00408005|79325927|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
44321065|NCT00408005|79325928|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
44321066|NCT00408005|79325929|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
44321067|NCT00408005|79325930|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
44321068|NCT00408005|79325931|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
44321069|NCT00408005|79325932|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
44321070|NCT00408005|79325933|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
44321071|NCT00408005|79325934|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
44321072|NCT00075946|79325958|FG000|Overall Study|Path ineligible: undetermined histology|0|||
44321073|NCT00075946|79325959|FG001|Overall Study|Path ineligible: undetermined histology|0|||
44321074|NCT00075946|79325960|FG002|Overall Study|Path ineligible: undetermined histology|0|||
44321075|NCT00075946|79325961|FG003|Overall Study|Path ineligible: undetermined histology|0|||
44321076|NCT00075946|79325962|FG004|Overall Study|Path ineligible: undetermined histology|6|||
44321077|NCT00075946|79325958|FG000|Overall Study|Did not achieve response after induction|0|||
44321078|NCT00075946|79325959|FG001|Overall Study|Did not achieve response after induction|0|||
44321079|NCT00075946|79325960|FG002|Overall Study|Did not achieve response after induction|0|||
44321080|NCT00075946|79325961|FG003|Overall Study|Did not achieve response after induction|0|||
44321081|NCT00075946|79325962|FG004|Overall Study|Did not achieve response after induction|182|||
44321082|NCT00075946|79325958|FG000|Overall Study|Incorrectly randomized (no response)|5|||
44321083|NCT00075946|79325959|FG001|Overall Study|Incorrectly randomized (no response)|5|||
44321084|NCT00075946|79325960|FG002|Overall Study|Incorrectly randomized (no response)|5|||
44321085|NCT00075946|79325961|FG003|Overall Study|Incorrectly randomized (no response)|1|||
44321086|NCT00075946|79325962|FG004|Overall Study|Incorrectly randomized (no response)|0|||
44321087|NCT00075946|79325958|FG000|Overall Study|Adverse Event|2|||
44321088|NCT00075946|79325959|FG001|Overall Study|Adverse Event|10|||
44321089|NCT00075946|79325960|FG002|Overall Study|Adverse Event|0|||
44321090|NCT00075946|79325961|FG003|Overall Study|Adverse Event|2|||
44321091|NCT00075946|79325962|FG004|Overall Study|Adverse Event|0|||
44321092|NCT00075946|79325958|FG000|Overall Study|Death|0|||
44321093|NCT00075946|79325959|FG001|Overall Study|Death|1|||
44321094|NCT00075946|79325960|FG002|Overall Study|Death|0|||
44321095|NCT00075946|79325961|FG003|Overall Study|Death|0|||
44321096|NCT00075946|79325962|FG004|Overall Study|Death|0|||
44321097|NCT00075946|79325958|FG000|Overall Study|Withdrawal by Subject|23|||
44321098|NCT00075946|79325959|FG001|Overall Study|Withdrawal by Subject|58|||
44321099|NCT00075946|79325960|FG002|Overall Study|Withdrawal by Subject|4|||
44321100|NCT00075946|79325961|FG003|Overall Study|Withdrawal by Subject|9|||
44321101|NCT00075946|79325962|FG004|Overall Study|Withdrawal by Subject|0|||
44321102|NCT00075946|79325958|FG000|Overall Study|Alternative therapy|16|||
44321103|NCT00075946|79325959|FG001|Overall Study|Alternative therapy|2|||
44321104|NCT00075946|79325960|FG002|Overall Study|Alternative therapy|5|||
44321105|NCT00075946|79325961|FG003|Overall Study|Alternative therapy|0|||
44321106|NCT00075946|79325962|FG004|Overall Study|Alternative therapy|0|||
44321107|NCT00075946|79325958|FG000|Overall Study|Other complicating disease|7|||
44321108|NCT00075946|79325959|FG001|Overall Study|Other complicating disease|13|||
44321109|NCT00075946|79325960|FG002|Overall Study|Other complicating disease|1|||
44321110|NCT00075946|79325961|FG003|Overall Study|Other complicating disease|4|||
44321111|NCT00075946|79325962|FG004|Overall Study|Other complicating disease|0|||
44321112|NCT00075946|79325958|FG000|Overall Study|No response to retreatment|23|||
44321113|NCT00075946|79325959|FG001|Overall Study|No response to retreatment|0|||
44155761|NCT01972438|78947267|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
44321114|NCT00075946|79325960|FG002|Overall Study|No response to retreatment|2|||
44321115|NCT00075946|79325961|FG003|Overall Study|No response to retreatment|0|||
44155762|NCT01972438|78947268|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
44321116|NCT00075946|79325962|FG004|Overall Study|No response to retreatment|0|||
44321117|NCT00075946|79325958|FG000|Overall Study|Time to progression less than 6 months|15|||
44321118|NCT00075946|79325959|FG001|Overall Study|Time to progression less than 6 months|30|||
44321119|NCT00075946|79325960|FG002|Overall Study|Time to progression less than 6 months|8|||
44321120|NCT00075946|79325961|FG003|Overall Study|Time to progression less than 6 months|3|||
44321121|NCT00075946|79325962|FG004|Overall Study|Time to progression less than 6 months|0|||
44321122|NCT00075946|79325958|FG000|Overall Study|Other|57|||
44321123|NCT00075946|79325959|FG001|Overall Study|Other|32|||
44321124|NCT00075946|79325960|FG002|Overall Study|Other|3|||
44321125|NCT00075946|79325961|FG003|Overall Study|Other|11|||
44321126|NCT00075946|79325962|FG004|Overall Study|Other|0|||
44321127|NCT01236352|79326003|FG000|Overall Study|Death|0|||
44321128|NCT01236352|79326004|FG001|Overall Study|Death|0|||
44321129|NCT01236352|79326005|FG002|Overall Study|Death|0|||
44321130|NCT01236352|79326006|FG003|Overall Study|Death|0|||
44321131|NCT01236352|79326007|FG004|Overall Study|Death|0|||
44321132|NCT01236352|79326008|FG005|Overall Study|Death|0|||
44321133|NCT01236352|79326009|FG006|Overall Study|Death|0|||
44321134|NCT01236352|79326010|FG007|Overall Study|Death|1|||
44321135|NCT01236352|79326011|FG008|Overall Study|Death|0|||
44321136|NCT01236352|79326012|FG009|Overall Study|Death|0|||
44321137|NCT01236352|79326013|FG010|Overall Study|Death|0|||
44321138|NCT01236352|79326003|FG000|Overall Study|Withdrawal by Subject|0|||
44321139|NCT01236352|79326004|FG001|Overall Study|Withdrawal by Subject|0|||
44321140|NCT01236352|79326005|FG002|Overall Study|Withdrawal by Subject|0|||
44321141|NCT01236352|79326006|FG003|Overall Study|Withdrawal by Subject|0|||
44321142|NCT01236352|79326007|FG004|Overall Study|Withdrawal by Subject|0|||
44321143|NCT01236352|79326008|FG005|Overall Study|Withdrawal by Subject|0|||
44321144|NCT01236352|79326009|FG006|Overall Study|Withdrawal by Subject|0|||
44321145|NCT01236352|79326010|FG007|Overall Study|Withdrawal by Subject|0|||
44321146|NCT01236352|79326011|FG008|Overall Study|Withdrawal by Subject|0|||
44321147|NCT01236352|79326012|FG009|Overall Study|Withdrawal by Subject|2|||
44321148|NCT01236352|79326013|FG010|Overall Study|Withdrawal by Subject|1|||
44321149|NCT01236352|79326003|FG000|Overall Study|Adverse Event|0|||
44321150|NCT01236352|79326004|FG001|Overall Study|Adverse Event|0|||
44321151|NCT01236352|79326005|FG002|Overall Study|Adverse Event|0|||
44321152|NCT01236352|79326006|FG003|Overall Study|Adverse Event|0|||
44321153|NCT01236352|79326007|FG004|Overall Study|Adverse Event|0|||
44321154|NCT01236352|79326008|FG005|Overall Study|Adverse Event|0|||
44321155|NCT01236352|79326009|FG006|Overall Study|Adverse Event|2|||
44321156|NCT01236352|79326010|FG007|Overall Study|Adverse Event|0|||
44321157|NCT01236352|79326011|FG008|Overall Study|Adverse Event|0|||
44321158|NCT01236352|79326012|FG009|Overall Study|Adverse Event|4|||
44321159|NCT01236352|79326013|FG010|Overall Study|Adverse Event|1|||
44321160|NCT01236352|79326003|FG000|Overall Study|Study drug toxicity|0|||
44321161|NCT01236352|79326004|FG001|Overall Study|Study drug toxicity|0|||
44321162|NCT01236352|79326005|FG002|Overall Study|Study drug toxicity|0|||
44321163|NCT01236352|79326006|FG003|Overall Study|Study drug toxicity|0|||
44321164|NCT01236352|79326007|FG004|Overall Study|Study drug toxicity|0|||
44321165|NCT01236352|79326008|FG005|Overall Study|Study drug toxicity|1|||
44321166|NCT01236352|79326009|FG006|Overall Study|Study drug toxicity|1|||
44321167|NCT01236352|79326010|FG007|Overall Study|Study drug toxicity|0|||
44321168|NCT01236352|79326011|FG008|Overall Study|Study drug toxicity|0|||
44321169|NCT01236352|79326012|FG009|Overall Study|Study drug toxicity|2|||
44321170|NCT01236352|79326013|FG010|Overall Study|Study drug toxicity|2|||
44321171|NCT01236352|79326003|FG000|Overall Study|Disease progression|1|||
44321172|NCT01236352|79326004|FG001|Overall Study|Disease progression|2|||
44321173|NCT01236352|79326005|FG002|Overall Study|Disease progression|1|||
44321174|NCT01236352|79326006|FG003|Overall Study|Disease progression|2|||
44321175|NCT01236352|79326007|FG004|Overall Study|Disease progression|2|||
44321176|NCT01236352|79326008|FG005|Overall Study|Disease progression|2|||
44321177|NCT01236352|79326009|FG006|Overall Study|Disease progression|1|||
44321178|NCT01236352|79326010|FG007|Overall Study|Disease progression|3|||
44321179|NCT01236352|79326011|FG008|Overall Study|Disease progression|2|||
44321180|NCT01236352|79326012|FG009|Overall Study|Disease progression|2|||
44321181|NCT01236352|79326013|FG010|Overall Study|Disease progression|2|||
44321182|NCT01236352|79326003|FG000|Overall Study|Poor/Non-compliance|1|||
44321183|NCT01236352|79326004|FG001|Overall Study|Poor/Non-compliance|0|||
44321184|NCT01236352|79326005|FG002|Overall Study|Poor/Non-compliance|0|||
44321185|NCT01236352|79326006|FG003|Overall Study|Poor/Non-compliance|0|||
44321186|NCT01236352|79326007|FG004|Overall Study|Poor/Non-compliance|0|||
44321187|NCT01236352|79326008|FG005|Overall Study|Poor/Non-compliance|0|||
44321188|NCT01236352|79326009|FG006|Overall Study|Poor/Non-compliance|0|||
44321189|NCT01236352|79326010|FG007|Overall Study|Poor/Non-compliance|0|||
44321190|NCT01236352|79326011|FG008|Overall Study|Poor/Non-compliance|0|||
44321191|NCT01236352|79326012|FG009|Overall Study|Poor/Non-compliance|0|||
44321192|NCT01236352|79326013|FG010|Overall Study|Poor/Non-compliance|0|||
44321193|NCT01236352|79326003|FG000|Overall Study|Maximum clinical benefit|1|||
44321194|NCT01236352|79326004|FG001|Overall Study|Maximum clinical benefit|1|||
44321195|NCT01236352|79326005|FG002|Overall Study|Maximum clinical benefit|1|||
44321196|NCT01236352|79326006|FG003|Overall Study|Maximum clinical benefit|0|||
44321197|NCT01236352|79326007|FG004|Overall Study|Maximum clinical benefit|2|||
44321198|NCT01236352|79326008|FG005|Overall Study|Maximum clinical benefit|0|||
44321199|NCT01236352|79326009|FG006|Overall Study|Maximum clinical benefit|3|||
44321200|NCT01236352|79326010|FG007|Overall Study|Maximum clinical benefit|1|||
44321201|NCT01236352|79326011|FG008|Overall Study|Maximum clinical benefit|1|||
44321202|NCT01236352|79326012|FG009|Overall Study|Maximum clinical benefit|4|||
44321203|NCT01236352|79326013|FG010|Overall Study|Maximum clinical benefit|2|||
44321204|NCT01236352|79326003|FG000|Overall Study|Subject request to discontinue treatment|0|||
44321205|NCT01236352|79326004|FG001|Overall Study|Subject request to discontinue treatment|0|||
44321206|NCT01236352|79326005|FG002|Overall Study|Subject request to discontinue treatment|1|||
44321207|NCT01236352|79326006|FG003|Overall Study|Subject request to discontinue treatment|1|||
44321208|NCT01236352|79326007|FG004|Overall Study|Subject request to discontinue treatment|0|||
44321209|NCT01236352|79326008|FG005|Overall Study|Subject request to discontinue treatment|1|||
44321210|NCT01236352|79326009|FG006|Overall Study|Subject request to discontinue treatment|0|||
44321211|NCT01236352|79326010|FG007|Overall Study|Subject request to discontinue treatment|0|||
44321212|NCT01236352|79326011|FG008|Overall Study|Subject request to discontinue treatment|0|||
44321213|NCT01236352|79326012|FG009|Overall Study|Subject request to discontinue treatment|1|||
44321214|NCT01236352|79326013|FG010|Overall Study|Subject request to discontinue treatment|4|||
44321215|NCT01236352|79326003|FG000|Overall Study|Subject to receive drug via EAP|1|||
44321216|NCT01236352|79326004|FG001|Overall Study|Subject to receive drug via EAP|1|||
44321217|NCT01236352|79326005|FG002|Overall Study|Subject to receive drug via EAP|1|||
44321218|NCT01236352|79326006|FG003|Overall Study|Subject to receive drug via EAP|0|||
44321219|NCT01236352|79326007|FG004|Overall Study|Subject to receive drug via EAP|0|||
44321220|NCT01236352|79326008|FG005|Overall Study|Subject to receive drug via EAP|0|||
44321221|NCT01236352|79326009|FG006|Overall Study|Subject to receive drug via EAP|0|||
44321222|NCT01236352|79326010|FG007|Overall Study|Subject to receive drug via EAP|2|||
44321223|NCT01236352|79326011|FG008|Overall Study|Subject to receive drug via EAP|0|||
44321224|NCT01236352|79326012|FG009|Overall Study|Subject to receive drug via EAP|4|||
44321225|NCT01236352|79326013|FG010|Overall Study|Subject to receive drug via EAP|0|||
44421592|NCT00796445|79429468|FG000|Overall Study|Withdrawal by Subject|18|||
44421593|NCT00796445|79429469|FG001|Overall Study|Withdrawal by Subject|9|||
44421594|NCT00796445|79429468|FG000|Overall Study|Invalid Informed Consent Form|1|||
44421595|NCT00796445|79429469|FG001|Overall Study|Invalid Informed Consent Form|0|||
44421596|NCT03939819|79429485|FG000|Overall Study|Death|2|||
44421597|NCT03939819|79429486|FG001|Overall Study|Death|0|||
44421598|NCT00756938|79429495|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
44421599|NCT00756938|79429496|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
44421600|NCT00756938|79429497|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
44421601|NCT00756938|79429498|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
44421602|NCT00756938|79429495|FG000|12-week Base Study|Protocol Violation|0|||
44421603|NCT00756938|79429496|FG001|12-week Base Study|Protocol Violation|0|||
44421604|NCT00756938|79429497|FG002|12-week Base Study|Protocol Violation|1|||
44421605|NCT00756938|79429498|FG003|12-week Base Study|Protocol Violation|0|||
44421606|NCT00756938|79429495|FG000|12-week Base Study|Lost to Follow-up|1|||
44421607|NCT00756938|79429496|FG001|12-week Base Study|Lost to Follow-up|0|||
44421608|NCT00756938|79429497|FG002|12-week Base Study|Lost to Follow-up|0|||
44421609|NCT00756938|79429498|FG003|12-week Base Study|Lost to Follow-up|0|||
44421610|NCT00756938|79429495|FG000|Optional Extension|Lack of Efficacy|0|||
44421611|NCT00756938|79429496|FG001|Optional Extension|Lack of Efficacy|0|||
44421612|NCT00756938|79429497|FG002|Optional Extension|Lack of Efficacy|0|||
44421613|NCT00756938|79429498|FG003|Optional Extension|Lack of Efficacy|1|||
44421614|NCT00756938|79429495|FG000|Optional Extension|End of Study|0|||
44421615|NCT00756938|79429496|FG001|Optional Extension|End of Study|0|||
44421616|NCT00756938|79429497|FG002|Optional Extension|End of Study|0|||
44421617|NCT00756938|79429498|FG003|Optional Extension|End of Study|11|||
44421618|NCT00756938|79429495|FG000|Optional Extension|Protocol-specific criteria met|0|||
44421619|NCT00756938|79429496|FG001|Optional Extension|Protocol-specific criteria met|0|||
44421620|NCT00756938|79429497|FG002|Optional Extension|Protocol-specific criteria met|0|||
44421621|NCT00756938|79429498|FG003|Optional Extension|Protocol-specific criteria met|9|||
44421622|NCT00756938|79429495|FG000|Optional Extension|Physician Decision|0|||
44421623|NCT00756938|79429496|FG001|Optional Extension|Physician Decision|0|||
44421624|NCT00756938|79429497|FG002|Optional Extension|Physician Decision|0|||
44421625|NCT00756938|79429498|FG003|Optional Extension|Physician Decision|3|||
44421626|NCT00756938|79429495|FG000|Optional Extension|Lost to Follow-up|0|||
44421627|NCT00756938|79429496|FG001|Optional Extension|Lost to Follow-up|0|||
44421628|NCT00756938|79429497|FG002|Optional Extension|Lost to Follow-up|0|||
44421629|NCT00756938|79429498|FG003|Optional Extension|Lost to Follow-up|1|||
44421630|NCT00756938|79429495|FG000|Optional Extension|Protocol Violation|0|||
44421631|NCT00756938|79429496|FG001|Optional Extension|Protocol Violation|0|||
44421632|NCT00756938|79429497|FG002|Optional Extension|Protocol Violation|0|||
44421633|NCT00756938|79429498|FG003|Optional Extension|Protocol Violation|1|||
44421634|NCT00756938|79429495|FG000|Optional Extension|Withdrawal by Subject|0|||
44421635|NCT00756938|79429496|FG001|Optional Extension|Withdrawal by Subject|0|||
44421636|NCT00756938|79429497|FG002|Optional Extension|Withdrawal by Subject|0|||
44421637|NCT00756938|79429498|FG003|Optional Extension|Withdrawal by Subject|10|||
44421638|NCT00756938|79429495|FG000|Optional Extension|Adverse Event|0|||
44421639|NCT00756938|79429496|FG001|Optional Extension|Adverse Event|0|||
44421640|NCT00756938|79429497|FG002|Optional Extension|Adverse Event|0|||
44321226|NCT01236352|79326003|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
44321227|NCT01236352|79326004|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
44321228|NCT01236352|79326005|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
44321229|NCT01236352|79326006|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
44321230|NCT01236352|79326007|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
44321231|NCT01236352|79326008|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
44321232|NCT01236352|79326009|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
44321233|NCT01236352|79326010|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
44321234|NCT01236352|79326011|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
44321235|NCT01236352|79326012|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
44321236|NCT01236352|79326013|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
44321237|NCT01236352|79326003|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321238|NCT01236352|79326004|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321239|NCT01236352|79326005|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321240|NCT01236352|79326006|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321241|NCT01236352|79326007|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321242|NCT01236352|79326008|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321243|NCT01236352|79326009|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321244|NCT01236352|79326010|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321245|NCT01236352|79326011|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321246|NCT01236352|79326012|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
44321247|NCT01236352|79326013|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
44321248|NCT01236352|79326003|FG000|Overall Study|Lack of response to drug|0|||
44321249|NCT01236352|79326004|FG001|Overall Study|Lack of response to drug|0|||
44321250|NCT01236352|79326005|FG002|Overall Study|Lack of response to drug|0|||
44321251|NCT01236352|79326006|FG003|Overall Study|Lack of response to drug|0|||
44321252|NCT01236352|79326007|FG004|Overall Study|Lack of response to drug|0|||
44321253|NCT01236352|79326008|FG005|Overall Study|Lack of response to drug|0|||
44321254|NCT01236352|79326009|FG006|Overall Study|Lack of response to drug|0|||
44321255|NCT01236352|79326010|FG007|Overall Study|Lack of response to drug|0|||
44321256|NCT01236352|79326011|FG008|Overall Study|Lack of response to drug|0|||
44321257|NCT01236352|79326012|FG009|Overall Study|Lack of response to drug|1|||
44321258|NCT01236352|79326013|FG010|Overall Study|Lack of response to drug|1|||
44321259|NCT01236352|79326003|FG000|Overall Study|Patient transferred to IST|0|||
44321260|NCT01236352|79326004|FG001|Overall Study|Patient transferred to IST|0|||
44321261|NCT01236352|79326005|FG002|Overall Study|Patient transferred to IST|0|||
44321262|NCT01236352|79326006|FG003|Overall Study|Patient transferred to IST|0|||
44321263|NCT01236352|79326007|FG004|Overall Study|Patient transferred to IST|0|||
44321264|NCT01236352|79326008|FG005|Overall Study|Patient transferred to IST|0|||
44321265|NCT01236352|79326009|FG006|Overall Study|Patient transferred to IST|0|||
44321266|NCT01236352|79326010|FG007|Overall Study|Patient transferred to IST|0|||
44321267|NCT01236352|79326011|FG008|Overall Study|Patient transferred to IST|0|||
44321268|NCT01236352|79326012|FG009|Overall Study|Patient transferred to IST|2|||
44321269|NCT01236352|79326013|FG010|Overall Study|Patient transferred to IST|6|||
44321270|NCT01236118|79326040|FG000|Overall Study|Adverse Event|2|||
44321271|NCT01236118|79326041|FG001|Overall Study|Adverse Event|0|||
44321272|NCT01236118|79326042|FG002|Overall Study|Adverse Event|2|||
44321273|NCT01236118|79326040|FG000|Overall Study|Physician Decision|0|||
44321274|NCT01236118|79326041|FG001|Overall Study|Physician Decision|1|||
44321275|NCT01236118|79326042|FG002|Overall Study|Physician Decision|0|||
44321276|NCT01236118|79326040|FG000|Overall Study|Withdrawal by Subject|0|||
44321277|NCT01236118|79326041|FG001|Overall Study|Withdrawal by Subject|0|||
44321278|NCT01236118|79326042|FG002|Overall Study|Withdrawal by Subject|1|||
44321279|NCT01236001|79326052|FG000|Overall Study|Adverse Event|5|||
44321280|NCT01236001|79326053|FG001|Overall Study|Adverse Event|14|||
44321281|NCT01236001|79326052|FG000|Overall Study|Lack of Efficacy|6|||
44321282|NCT01236001|79326053|FG001|Overall Study|Lack of Efficacy|6|||
44321283|NCT01236001|79326052|FG000|Overall Study|Lost to Follow-up|6|||
44321284|NCT01236001|79326053|FG001|Overall Study|Lost to Follow-up|1|||
44321285|NCT01236001|79326052|FG000|Overall Study|Incompliance|1|||
44321286|NCT01236001|79326053|FG001|Overall Study|Incompliance|0|||
44321287|NCT01236001|79326052|FG000|Overall Study|Planned Visit After End of Study|0|||
44321288|NCT01236001|79326053|FG001|Overall Study|Planned Visit After End of Study|1|||
44321289|NCT01229254|79326063|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
44321290|NCT01229254|79326064|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
44321291|NCT01229254|79326065|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
44321292|NCT01229254|79326063|FG000|Overall Study|Adverse Event|4|||
44321293|NCT01229254|79326064|FG001|Overall Study|Adverse Event|5|||
44321294|NCT01229254|79326065|FG002|Overall Study|Adverse Event|3|||
44321295|NCT01229254|79326063|FG000|Overall Study|Lost to Follow-up|3|||
44321296|NCT01229254|79326064|FG001|Overall Study|Lost to Follow-up|0|||
44321297|NCT01229254|79326065|FG002|Overall Study|Lost to Follow-up|1|||
44321298|NCT01229254|79326063|FG000|Overall Study|Physician Decision|0|||
44321299|NCT01229254|79326064|FG001|Overall Study|Physician Decision|3|||
44321300|NCT01229254|79326065|FG002|Overall Study|Physician Decision|0|||
44321301|NCT01229254|79326063|FG000|Overall Study|Protocol Violation|4|||
44321302|NCT01229254|79326064|FG001|Overall Study|Protocol Violation|6|||
44321303|NCT01229254|79326065|FG002|Overall Study|Protocol Violation|5|||
44321304|NCT01229254|79326063|FG000|Overall Study|Withdrawal by Subject|1|||
44321305|NCT01229254|79326064|FG001|Overall Study|Withdrawal by Subject|0|||
44321306|NCT01229254|79326065|FG002|Overall Study|Withdrawal by Subject|1|||
44321307|NCT01229254|79326063|FG000|Overall Study|Non-compliance with Study Drug|0|||
44321308|NCT01229254|79326064|FG001|Overall Study|Non-compliance with Study Drug|1|||
44321309|NCT01229254|79326065|FG002|Overall Study|Non-compliance with Study Drug|1|||
44321310|NCT01235728|79326074|FG000|Overall Study|Protocol Violation|0|||
44321311|NCT01235728|79326075|FG001|Overall Study|Protocol Violation|0|||
44321312|NCT01235728|79326076|FG002|Overall Study|Protocol Violation|0|||
44321313|NCT01235728|79326077|FG003|Overall Study|Protocol Violation|1|||
44321314|NCT01235728|79326078|FG004|Overall Study|Protocol Violation|0|||
44321315|NCT01235728|79326079|FG005|Overall Study|Protocol Violation|0|||
44321316|NCT01235728|79326080|FG006|Overall Study|Protocol Violation|0|||
44321317|NCT01235728|79326081|FG007|Overall Study|Protocol Violation|0|||
44321318|NCT01235689|79326091|FG000|Overall Study|Adverse Event|12|||
44321319|NCT01235689|79326092|FG001|Overall Study|Adverse Event|16|||
44321320|NCT01235689|79326091|FG000|Overall Study|Lack of Efficacy|12|||
44321321|NCT01235689|79326092|FG001|Overall Study|Lack of Efficacy|5|||
44321322|NCT01235689|79326091|FG000|Overall Study|Withdrawal by Subject|3|||
44321323|NCT01235689|79326092|FG001|Overall Study|Withdrawal by Subject|4|||
44321324|NCT01235689|79326091|FG000|Overall Study|Lost to Follow-up|1|||
44321325|NCT01235689|79326092|FG001|Overall Study|Lost to Follow-up|2|||
44321326|NCT01235689|79326091|FG000|Overall Study|Miscellaneous|1|||
44321327|NCT01235689|79326092|FG001|Overall Study|Miscellaneous|5|||
44321328|NCT01229176|79326106|FG000|Overall Study|Withdrawal by Subject|0|||
44321329|NCT01229176|79326107|FG001|Overall Study|Withdrawal by Subject|0|||
44321330|NCT01229176|79326108|FG002|Overall Study|Withdrawal by Subject|0|||
44321331|NCT01229176|79326109|FG003|Overall Study|Withdrawal by Subject|1|||
44321332|NCT01229176|79326110|FG004|Overall Study|Withdrawal by Subject|1|||
44321333|NCT01229176|79326111|FG005|Overall Study|Withdrawal by Subject|1|||
44321334|NCT01229176|79326112|FG006|Overall Study|Withdrawal by Subject|0|||
44321335|NCT01229176|79326113|FG007|Overall Study|Withdrawal by Subject|1|||
44321336|NCT01229176|79326106|FG000|Overall Study|Lost to Follow-up|0|||
44321337|NCT01229176|79326107|FG001|Overall Study|Lost to Follow-up|3|||
44321338|NCT01229176|79326108|FG002|Overall Study|Lost to Follow-up|0|||
44321339|NCT01229176|79326109|FG003|Overall Study|Lost to Follow-up|0|||
44321340|NCT01229176|79326110|FG004|Overall Study|Lost to Follow-up|1|||
44321341|NCT01229176|79326111|FG005|Overall Study|Lost to Follow-up|1|||
44321342|NCT01229176|79326112|FG006|Overall Study|Lost to Follow-up|0|||
44321343|NCT01229176|79326113|FG007|Overall Study|Lost to Follow-up|2|||
44321344|NCT01228747|79326133|FG000|Overall Study|Adverse Event|8|||
44321345|NCT01228747|79326134|FG001|Overall Study|Adverse Event|4|||
44321346|NCT01228747|79326133|FG000|Overall Study|Lack of Efficacy|40|||
44321347|NCT01228747|79326134|FG001|Overall Study|Lack of Efficacy|27|||
44321348|NCT01228747|79326133|FG000|Overall Study|Protocol Violation|6|||
44321349|NCT01228747|79326134|FG001|Overall Study|Protocol Violation|5|||
44321350|NCT01228747|79326133|FG000|Overall Study|Lost to Follow-up|4|||
44321351|NCT01228747|79326134|FG001|Overall Study|Lost to Follow-up|3|||
44321352|NCT01228747|79326133|FG000|Overall Study|Withdrawal by Subject|5|||
44321353|NCT01228747|79326134|FG001|Overall Study|Withdrawal by Subject|1|||
44321354|NCT01228747|79326133|FG000|Overall Study|Other Reason|2|||
44321355|NCT01228747|79326134|FG001|Overall Study|Other Reason|5|||
44321356|NCT01228591|79326140|FG000|Baseline|Lack of Efficacy|1|||
44321357|NCT01228591|79326141|FG001|Baseline|Lack of Efficacy|2|||
44321358|NCT01235338|79326153|FG000|Overall Study|Adverse Event|3|||
44321359|NCT01235338|79326154|FG001|Overall Study|Adverse Event|2|||
44321360|NCT01235338|79326153|FG000|Overall Study|Protocol Violation|1|||
44321361|NCT01235338|79326154|FG001|Overall Study|Protocol Violation|1|||
44155763|NCT01972438|78947267|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
44321362|NCT01235338|79326153|FG000|Overall Study|Withdrawal by Subject|5|||
44321363|NCT01235338|79326154|FG001|Overall Study|Withdrawal by Subject|0|||
44155764|NCT01972438|78947268|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
44155765|NCT01972438|78947267|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
44155766|NCT01972438|78947268|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
44155767|NCT01972438|78947267|FG000|Months 6-12 Study Period|Death|1|||
44155768|NCT01972438|78947268|FG001|Months 6-12 Study Period|Death|0|||
44155769|NCT01972438|78947267|FG000|Months 6-12 Study Period|Early Study Closure|2|||
44155770|NCT01972438|78947268|FG001|Months 6-12 Study Period|Early Study Closure|2|||
44155771|NCT01972438|78947267|FG000|Post Month 12 Study Period|Early Study Closure|3|||
44155772|NCT01972438|78947268|FG001|Post Month 12 Study Period|Early Study Closure|4|||
44155773|NCT01946152|78947280|FG000|Overall Study|Adverse Event|1|||
44155774|NCT01946152|78947281|FG001|Overall Study|Adverse Event|0|||
44421641|NCT00756938|79429498|FG003|Optional Extension|Adverse Event|1|||
44321364|NCT01235338|79326153|FG000|Overall Study|Exclusion criteria violations|1|||
44321365|NCT01235338|79326154|FG001|Overall Study|Exclusion criteria violations|1|||
44321366|NCT01235338|79326153|FG000|Overall Study|Positive drug screen|0|||
44321367|NCT01235338|79326154|FG001|Overall Study|Positive drug screen|1|||
44321368|NCT01235338|79326153|FG000|Overall Study|Prohibited meds|1|||
44321369|NCT01235338|79326154|FG001|Overall Study|Prohibited meds|0|||
44321370|NCT01234675|79326162|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
44321371|NCT01234675|79326163|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
44321372|NCT01234675|79326162|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
44321373|NCT01234675|79326163|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
44321374|NCT01228318|79326171|FG000|Overall Study|Clinic no show to receive intervention|1|||
44321375|NCT01228318|79326172|FG001|Overall Study|Clinic no show to receive intervention|0|||
44321376|NCT01228318|79326171|FG000|Overall Study|Unable to contact|2|||
44321377|NCT01228318|79326172|FG001|Overall Study|Unable to contact|5|||
44321378|NCT01228318|79326171|FG000|Overall Study|Moved|0|||
44321379|NCT01228318|79326172|FG001|Overall Study|Moved|2|||
44321380|NCT01228318|79326171|FG000|Overall Study|Incarcerated|1|||
44321381|NCT01228318|79326172|FG001|Overall Study|Incarcerated|0|||
44321382|NCT01227967|79326180|FG000|Overall Study|Protocol Violation|3|||
44321383|NCT01227967|79326181|FG001|Overall Study|Protocol Violation|1|||
44321384|NCT01227967|79326180|FG000|Overall Study|Death|0|||
44321385|NCT01227967|79326181|FG001|Overall Study|Death|1|||
44421642|NCT00796367|79429519|FG000|Overall Study|Adverse Event|6|||
44421643|NCT00796367|79429520|FG001|Overall Study|Adverse Event|4|||
44421644|NCT00796367|79429521|FG002|Overall Study|Adverse Event|7|||
44421645|NCT00796367|79429519|FG000|Overall Study|Lost to Follow-up|5|||
44421646|NCT00796367|79429520|FG001|Overall Study|Lost to Follow-up|4|||
44421647|NCT00796367|79429521|FG002|Overall Study|Lost to Follow-up|21|||
44421648|NCT00796367|79429519|FG000|Overall Study|Withdrawal by Subject|9|||
44421649|NCT00796367|79429520|FG001|Overall Study|Withdrawal by Subject|11|||
44421650|NCT00796367|79429521|FG002|Overall Study|Withdrawal by Subject|12|||
44421651|NCT00796367|79429519|FG000|Overall Study|Lack of Efficacy|2|||
44421652|NCT00796367|79429520|FG001|Overall Study|Lack of Efficacy|1|||
44421653|NCT00796367|79429521|FG002|Overall Study|Lack of Efficacy|0|||
44421654|NCT00796367|79429519|FG000|Overall Study|non compliance|3|||
44421655|NCT00796367|79429520|FG001|Overall Study|non compliance|1|||
44421656|NCT00796367|79429521|FG002|Overall Study|non compliance|1|||
44421657|NCT00796367|79429519|FG000|Overall Study|Pregnancy|1|||
44421658|NCT00796367|79429520|FG001|Overall Study|Pregnancy|0|||
44421659|NCT00796367|79429521|FG002|Overall Study|Pregnancy|1|||
44421660|NCT00796367|79429519|FG000|Overall Study|Requirement for restricted medication|2|||
44421661|NCT00796367|79429520|FG001|Overall Study|Requirement for restricted medication|0|||
44421662|NCT00796367|79429521|FG002|Overall Study|Requirement for restricted medication|2|||
44421663|NCT00796367|79429519|FG000|Overall Study|other|2|||
44421664|NCT00796367|79429520|FG001|Overall Study|other|4|||
44421665|NCT00796367|79429521|FG002|Overall Study|other|3|||
44421666|NCT00770588|79429531|FG000|Overall Study|Adverse Event|9|||
44421667|NCT00770588|79429532|FG001|Overall Study|Adverse Event|2|||
44421668|NCT00770588|79429531|FG000|Overall Study|Death caused by progression of disease|70|||
44421669|NCT00770588|79429532|FG001|Overall Study|Death caused by progression of disease|91|||
44421670|NCT00770588|79429531|FG000|Overall Study|Lost to Follow-up|1|||
44421671|NCT00770588|79429532|FG001|Overall Study|Lost to Follow-up|1|||
44421672|NCT00770588|79429531|FG000|Overall Study|Withdrawal by Subject|1|||
44421673|NCT00770588|79429532|FG001|Overall Study|Withdrawal by Subject|1|||
44421674|NCT00777608|79429541|FG000|Overall Study|Lost to Follow-up|1|||
44421675|NCT00777608|79429542|FG001|Overall Study|Lost to Follow-up|1|||
44421676|NCT00777608|79429541|FG000|Overall Study|Withdrawal by Subject|1|||
44421677|NCT00777608|79429542|FG001|Overall Study|Withdrawal by Subject|3|||
44421678|NCT00777608|79429541|FG000|Overall Study|Protocol Violation|1|||
44421679|NCT00777608|79429542|FG001|Overall Study|Protocol Violation|0|||
44421680|NCT00777608|79429541|FG000|Overall Study|Investigator Decision|1|||
44321386|NCT01227967|79326180|FG000|Overall Study|Lost to Follow-up|8|||
44321387|NCT01227967|79326181|FG001|Overall Study|Lost to Follow-up|3|||
44321388|NCT01227967|79326180|FG000|Overall Study|Withdrawal by Subject|4|||
44321389|NCT01227967|79326181|FG001|Overall Study|Withdrawal by Subject|3|||
44421681|NCT00777608|79429542|FG001|Overall Study|Investigator Decision|2|||
44421682|NCT00792935|79429550|FG000|Overall Study|Adverse Event|2|||
44321390|NCT01227967|79326180|FG000|Overall Study|Physician Decision|0|||
44321391|NCT01227967|79326181|FG001|Overall Study|Physician Decision|1|||
44421683|NCT00792935|79429551|FG001|Overall Study|Adverse Event|1|||
44421684|NCT00792935|79429550|FG000|Overall Study|Lost to Follow-up|0|||
44421685|NCT00792935|79429551|FG001|Overall Study|Lost to Follow-up|1|||
44421686|NCT00792935|79429550|FG000|Overall Study|Protocol Violation|2|||
44421687|NCT00792935|79429551|FG001|Overall Study|Protocol Violation|0|||
44421688|NCT00792935|79429550|FG000|Overall Study|Withdrawal by Subject|0|||
44421689|NCT00792935|79429551|FG001|Overall Study|Withdrawal by Subject|1|||
44421690|NCT00770510|79429557|FG000|Overall Study|Lost to Follow-up|2|||
44321392|NCT01227967|79326180|FG000|Overall Study|Never Started Treatment|0|||
44321393|NCT01227967|79326181|FG001|Overall Study|Never Started Treatment|4|||
44321394|NCT01227967|79326180|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
44321395|NCT01227967|79326181|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
44321396|NCT01227928|79326189|FG000|Overall Study|Lost to Follow-up|4|||
44321397|NCT01227928|79326190|FG001|Overall Study|Lost to Follow-up|2|||
44321398|NCT01227928|79326189|FG000|Overall Study|Withdrawal by Subject|4|||
44321399|NCT01227928|79326190|FG001|Overall Study|Withdrawal by Subject|3|||
44321400|NCT01227928|79326189|FG000|Overall Study|Death|14|||
44321401|NCT01227928|79326190|FG001|Overall Study|Death|12|||
44321402|NCT01227889|79326198|FG000|Randomized Phase (RP)|Adverse Event|13|||
44321403|NCT01227889|79326199|FG001|Randomized Phase (RP)|Adverse Event|0|||
44321404|NCT01227889|79326198|FG000|Randomized Phase (RP)|Physician Decision|13|||
44321405|NCT01227889|79326199|FG001|Randomized Phase (RP)|Physician Decision|5|||
44321406|NCT01227889|79326198|FG000|Randomized Phase (RP)|Progressive Disease|135|||
44321407|NCT01227889|79326199|FG001|Randomized Phase (RP)|Progressive Disease|52|||
44321408|NCT01227889|79326198|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
44321409|NCT01227889|79326199|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
44321410|NCT01227889|79326198|FG000|Randomized Phase (RP)|Missing|1|||
44321411|NCT01227889|79326199|FG001|Randomized Phase (RP)|Missing|3|||
44321412|NCT01227889|79326198|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
44321413|NCT01227889|79326199|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
44321414|NCT01227889|79326198|FG000|Crossover Phase|Adverse Event|0|||
44321415|NCT01227889|79326199|FG001|Crossover Phase|Adverse Event|1|||
44321416|NCT01227889|79326198|FG000|Crossover Phase|Physician Decision|0|||
44321417|NCT01227889|79326199|FG001|Crossover Phase|Physician Decision|3|||
44321418|NCT01227889|79326198|FG000|Crossover Phase|Progressive Disease|0|||
44321419|NCT01227889|79326199|FG001|Crossover Phase|Progressive Disease|31|||
44321420|NCT01227889|79326198|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
44321421|NCT01227889|79326199|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
44321422|NCT01227889|79326198|FG000|Crossover Phase|Withdrawal by Subject|0|||
44321423|NCT01227889|79326199|FG001|Crossover Phase|Withdrawal by Subject|1|||
44321424|NCT01227577|79326213|FG000|Overall Study|Protocol deviation|3|||
44321425|NCT01227577|79326213|FG000|Overall Study|Death|3|||
44321426|NCT01227577|79326213|FG000|Overall Study|Administrative problems|2|||
44321427|NCT01227577|79326213|FG000|Overall Study|Lost to Follow-up|1|||
44321428|NCT01227577|79326213|FG000|Overall Study|Withdrawal by Subject|4|||
44321429|NCT01227577|79326213|FG000|Overall Study|Lack of Efficacy|5|||
44321430|NCT01227577|79326213|FG000|Overall Study|Adverse Event|17|||
44321431|NCT01227421|79326233|FG000|Overall Study|Lost to Follow-up|6|||
44321432|NCT01227421|79326234|FG001|Overall Study|Lost to Follow-up|7|||
44321433|NCT01227421|79326235|FG002|Overall Study|Lost to Follow-up|5|||
44321434|NCT01227421|79326233|FG000|Overall Study|Adverse Event|2|||
44321435|NCT01227421|79326234|FG001|Overall Study|Adverse Event|7|||
44321436|NCT01227421|79326235|FG002|Overall Study|Adverse Event|2|||
44321437|NCT01227421|79326233|FG000|Overall Study|Withdrawal by Subject|1|||
44321438|NCT01227421|79326234|FG001|Overall Study|Withdrawal by Subject|2|||
44321439|NCT01227421|79326235|FG002|Overall Study|Withdrawal by Subject|1|||
44321440|NCT01227421|79326233|FG000|Overall Study|Protocol Violation|1|||
44321441|NCT01227421|79326234|FG001|Overall Study|Protocol Violation|1|||
44321442|NCT01227421|79326235|FG002|Overall Study|Protocol Violation|2|||
44421691|NCT00770510|79429557|FG000|Overall Study|Pregnancy|1|||
44421692|NCT00770510|79429557|FG000|Overall Study|Withdrawal by Subject|2|||
44421693|NCT00770432|79429571|FG000|Overall Study|Other|4|||
44421694|NCT00770432|79429572|FG001|Overall Study|Other|6|||
44536685|NCT03529773|79547266|FG032|Overall Study|Withdrawal by Subject|0|||
44421695|NCT00770432|79429571|FG000|Overall Study|Non-compliance|0|||
44536686|NCT03529773|79547267|FG033|Overall Study|Withdrawal by Subject|0|||
44536687|NCT03529773|79547268|FG034|Overall Study|Withdrawal by Subject|1|||
44536688|NCT03529773|79547269|FG035|Overall Study|Withdrawal by Subject|2|||
44536689|NCT03529773|79547270|FG036|Overall Study|Withdrawal by Subject|0|||
44536690|NCT03529773|79547271|FG037|Overall Study|Withdrawal by Subject|2|||
44536691|NCT03529773|79547272|FG038|Overall Study|Withdrawal by Subject|1|||
44536692|NCT03529773|79547273|FG039|Overall Study|Withdrawal by Subject|1|||
44536693|NCT03529773|79547234|FG000|Overall Study|Screen Failure|0|||
44536694|NCT03529773|79547235|FG001|Overall Study|Screen Failure|0|||
44321443|NCT01227421|79326233|FG000|Overall Study|Randomized in error|1|||
44321444|NCT01227421|79326234|FG001|Overall Study|Randomized in error|1|||
44321445|NCT01227421|79326235|FG002|Overall Study|Randomized in error|0|||
44536695|NCT03529773|79547236|FG002|Overall Study|Screen Failure|0|||
44321446|NCT01227265|79326246|FG000|Overall Study|Did Not Receive Treatment|1|||
44321447|NCT01227265|79326247|FG001|Overall Study|Did Not Receive Treatment|2|||
44321448|NCT01227265|79326248|FG002|Overall Study|Did Not Receive Treatment|0|||
44321449|NCT01227265|79326246|FG000|Overall Study|Administrative|1|||
44321450|NCT01227265|79326247|FG001|Overall Study|Administrative|0|||
44321451|NCT01227265|79326248|FG002|Overall Study|Administrative|2|||
44321452|NCT01227265|79326246|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
44421696|NCT00770432|79429572|FG001|Overall Study|Non-compliance|1|||
44321453|NCT01227265|79326247|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
44321454|NCT01227265|79326248|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
44321455|NCT01227265|79326246|FG000|Overall Study|Protocol Violation|2|||
44321456|NCT01227265|79326247|FG001|Overall Study|Protocol Violation|1|||
44321457|NCT01227265|79326248|FG002|Overall Study|Protocol Violation|0|||
44321458|NCT01227265|79326246|FG000|Overall Study|Withdrawal by Subject|7|||
44321459|NCT01227265|79326247|FG001|Overall Study|Withdrawal by Subject|7|||
44321460|NCT01227265|79326248|FG002|Overall Study|Withdrawal by Subject|3|||
44321461|NCT01227265|79326246|FG000|Overall Study|Lost to Follow-up|2|||
44321462|NCT01227265|79326247|FG001|Overall Study|Lost to Follow-up|0|||
44321463|NCT01227265|79326248|FG002|Overall Study|Lost to Follow-up|3|||
44321464|NCT01227265|79326246|FG000|Overall Study|Adverse Event|6|||
44321465|NCT01227265|79326247|FG001|Overall Study|Adverse Event|10|||
44321466|NCT01227265|79326248|FG002|Overall Study|Adverse Event|5|||
44321467|NCT01226095|79326256|FG000|Overall Study|Poor compliance|1|||
44321468|NCT01225822|79326272|FG000|Overall Study|Adverse Event|13|||
44321469|NCT01225822|79326273|FG001|Overall Study|Adverse Event|31|||
44321470|NCT01225822|79326274|FG002|Overall Study|Adverse Event|18|||
44321471|NCT01225822|79326275|FG003|Overall Study|Adverse Event|23|||
44321472|NCT01225822|79326276|FG004|Overall Study|Adverse Event|14|||
44321473|NCT01225822|79326272|FG000|Overall Study|Protocol Violation|6|||
44321474|NCT01225822|79326273|FG001|Overall Study|Protocol Violation|8|||
44321475|NCT01225822|79326274|FG002|Overall Study|Protocol Violation|6|||
44321476|NCT01225822|79326275|FG003|Overall Study|Protocol Violation|7|||
44321477|NCT01225822|79326276|FG004|Overall Study|Protocol Violation|4|||
44321478|NCT01225822|79326272|FG000|Overall Study|Lost to Follow-up|0|||
44321479|NCT01225822|79326273|FG001|Overall Study|Lost to Follow-up|0|||
44321480|NCT01225822|79326274|FG002|Overall Study|Lost to Follow-up|0|||
44321481|NCT01225822|79326275|FG003|Overall Study|Lost to Follow-up|1|||
44321482|NCT01225822|79326276|FG004|Overall Study|Lost to Follow-up|0|||
44321483|NCT01225822|79326272|FG000|Overall Study|Withdrawal by Subject|6|||
44321484|NCT01225822|79326273|FG001|Overall Study|Withdrawal by Subject|7|||
44321485|NCT01225822|79326274|FG002|Overall Study|Withdrawal by Subject|7|||
44321486|NCT01225822|79326275|FG003|Overall Study|Withdrawal by Subject|11|||
44321487|NCT01225822|79326276|FG004|Overall Study|Withdrawal by Subject|6|||
44321488|NCT01225822|79326272|FG000|Overall Study|Other|13|||
44321489|NCT01225822|79326273|FG001|Overall Study|Other|10|||
44321490|NCT01225822|79326274|FG002|Overall Study|Other|7|||
44321491|NCT01225822|79326275|FG003|Overall Study|Other|10|||
44321492|NCT01225822|79326276|FG004|Overall Study|Other|7|||
44321493|NCT01225549|79326291|FG000|Period 4 - Washout|Disallowed medication|0|||
44321494|NCT01225549|79326292|FG001|Period 4 - Washout|Disallowed medication|1|||
44321495|NCT01225549|79326293|FG002|Period 4 - Washout|Disallowed medication|0|||
44321496|NCT01225549|79326294|FG003|Period 4 - Washout|Disallowed medication|0|||
44421697|NCT00792701|79429580|FG000|Overall Study|Adverse Event|0|||
44421698|NCT00792701|79429581|FG001|Overall Study|Adverse Event|22|||
44421699|NCT00792701|79429580|FG000|Overall Study|Ineligible|1|||
44421700|NCT00792701|79429581|FG001|Overall Study|Ineligible|3|||
44155775|NCT01946152|78947282|FG002|Overall Study|Adverse Event|0|||
44155776|NCT01946152|78947283|FG003|Overall Study|Adverse Event|0|||
44155777|NCT01946152|78947280|FG000|Overall Study|Withdrawal by Subject|0|||
44155778|NCT01946152|78947281|FG001|Overall Study|Withdrawal by Subject|2|||
44155779|NCT01946152|78947282|FG002|Overall Study|Withdrawal by Subject|0|||
44155780|NCT01946152|78947283|FG003|Overall Study|Withdrawal by Subject|0|||
44155781|NCT01946152|78947280|FG000|Overall Study|Progression|0|||
44155782|NCT01946152|78947281|FG001|Overall Study|Progression|1|||
44155783|NCT01946152|78947282|FG002|Overall Study|Progression|4|||
44321497|NCT01225549|79326295|FG004|Period 4 - Washout|Disallowed medication|0|||
44321498|NCT01225549|79326296|FG005|Period 4 - Washout|Disallowed medication|0|||
44536696|NCT03529773|79547237|FG003|Overall Study|Screen Failure|0|||
44536697|NCT03529773|79547238|FG004|Overall Study|Screen Failure|0|||
44321499|NCT01225549|79326297|FG006|Period 4 - Washout|Disallowed medication|0|||
44536698|NCT03529773|79547239|FG005|Overall Study|Screen Failure|0|||
44536699|NCT03529773|79547240|FG006|Overall Study|Screen Failure|0|||
44536700|NCT03529773|79547241|FG007|Overall Study|Screen Failure|0|||
44536701|NCT03529773|79547242|FG008|Overall Study|Screen Failure|0|||
44155784|NCT01946152|78947283|FG003|Overall Study|Progression|7|||
44155785|NCT01946152|78947280|FG000|Overall Study|Physician Decision|0|||
44321500|NCT01225549|79326298|FG007|Period 4 - Washout|Disallowed medication|0|||
44321501|NCT01225549|79326299|FG008|Period 4 - Washout|Disallowed medication|0|||
44321502|NCT01225549|79326300|FG009|Period 4 - Washout|Disallowed medication|0|||
44321503|NCT01225549|79326291|FG000|Period 6 - Washout|Disallowed medication|0|||
44321504|NCT01225549|79326292|FG001|Period 6 - Washout|Disallowed medication|0|||
44321505|NCT01225549|79326293|FG002|Period 6 - Washout|Disallowed medication|0|||
44321506|NCT01225549|79326294|FG003|Period 6 - Washout|Disallowed medication|1|||
44321507|NCT01225549|79326295|FG004|Period 6 - Washout|Disallowed medication|0|||
44321508|NCT01225549|79326296|FG005|Period 6 - Washout|Disallowed medication|0|||
44321509|NCT01225549|79326297|FG006|Period 6 - Washout|Disallowed medication|0|||
44421701|NCT00792701|79429580|FG000|Overall Study|Withdrawal by Subject|1|||
44321510|NCT01225549|79326298|FG007|Period 6 - Washout|Disallowed medication|0|||
44321511|NCT01225549|79326299|FG008|Period 6 - Washout|Disallowed medication|0|||
44321512|NCT01225549|79326300|FG009|Period 6 - Washout|Disallowed medication|0|||
44321513|NCT01225159|79326312|FG000|Overall Study|Change operation|1|||
44321514|NCT01225159|79326313|FG001|Overall Study|Change operation|0|||
44321515|NCT01224925|79326321|FG000|Overall Study|Lost to Follow-up|3|||
44321516|NCT01224925|79326322|FG001|Overall Study|Lost to Follow-up|2|||
44321517|NCT01223404|79326330|FG000|First Intervention (1 Day)|Adverse Event|0|||
44321518|NCT01223404|79326331|FG001|First Intervention (1 Day)|Adverse Event|0|||
44321519|NCT01223404|79326332|FG002|First Intervention (1 Day)|Adverse Event|0|||
44321520|NCT01223404|79326333|FG003|First Intervention (1 Day)|Adverse Event|1|||
44321521|NCT01223404|79326334|FG004|First Intervention (1 Day)|Adverse Event|0|||
44321522|NCT01223404|79326335|FG005|First Intervention (1 Day)|Adverse Event|0|||
44321523|NCT01223404|79326330|FG000|Second Intervention (1 Day)|Adverse Event|1|||
44321524|NCT01223404|79326331|FG001|Second Intervention (1 Day)|Adverse Event|0|||
44321525|NCT01223404|79326332|FG002|Second Intervention (1 Day)|Adverse Event|0|||
44321526|NCT01223404|79326333|FG003|Second Intervention (1 Day)|Adverse Event|0|||
44321527|NCT01223404|79326334|FG004|Second Intervention (1 Day)|Adverse Event|0|||
44321528|NCT01223404|79326335|FG005|Second Intervention (1 Day)|Adverse Event|0|||
44321529|NCT01223404|79326330|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
44321530|NCT01223404|79326331|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
44321531|NCT01223404|79326332|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
44321532|NCT01223404|79326333|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
44321533|NCT01223404|79326334|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
44321534|NCT01223404|79326335|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
44321535|NCT01223365|79326383|FG000|Open-label Titration Period|Enrolled but not treated|1|||
44321536|NCT01223365|79326383|FG000|Open-label Titration Period|Adverse Event|23|||
44321537|NCT01223365|79326383|FG000|Open-label Titration Period|Lack of Efficacy|3|||
44321538|NCT01223365|79326383|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
44321539|NCT01223365|79326383|FG000|Open-label Titration Period|Protocol Violation|1|||
44321540|NCT01223365|79326383|FG000|Open-label Titration Period|Lost to Follow-up|2|||
44321541|NCT01223365|79326383|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
44321542|NCT01223365|79326383|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
44321543|NCT01223365|79326383|FG000|Open-label Titration Period|Starting physical therapy|1|||
44321544|NCT01223365|79326383|FG000|Open-label Treatment Period|Adverse Event|39|||
44321545|NCT01223365|79326383|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
44321546|NCT01223365|79326383|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
44321547|NCT01223365|79326383|FG000|Open-label Treatment Period|Protocol Violation|15|||
44321548|NCT01223365|79326383|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
44321549|NCT01223365|79326383|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
44321550|NCT01223365|79326383|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
44321551|NCT01223365|79326383|FG000|Open-label Treatment Period|Moved out of area|2|||
44321552|NCT01223365|79326383|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
44321553|NCT01223365|79326383|FG000|Open-label Treatment Period|"Out of window"|1|||
44321554|NCT01223365|79326383|FG000|Open-label Treatment Period|Starting physical therapy|1|||
44321555|NCT01223365|79326383|FG000|Open-label Treatment Period|Physician Decision|2|||
44321556|NCT01222507|79326392|FG000|Overall Study|Physician Decision|1|||
44321557|NCT01222507|79326392|FG000|Overall Study|Withdrawal by Subject|1|||
44321558|NCT01222078|79326396|FG000|Overall Study|Early termination of the study|1|||
44321559|NCT01221727|79326403|FG000|Overall Study|Physician Decision|2|||
44321560|NCT01221727|79326404|FG001|Overall Study|Physician Decision|0|||
44321561|NCT01221727|79326403|FG000|Overall Study|Withdrawal by Subject|1|||
44321562|NCT01221727|79326404|FG001|Overall Study|Withdrawal by Subject|1|||
44321563|NCT01221181|79326416|FG000|Overall Study|Lost to Follow-up|1|||
44321564|NCT01220557|79326422|FG000|Overall Study|Lost to Follow-up|5|||
44321565|NCT01220557|79326423|FG001|Overall Study|Lost to Follow-up|3|||
44321566|NCT01220557|79326422|FG000|Overall Study|attended less than 6 lessons|1|||
44321567|NCT01220557|79326423|FG001|Overall Study|attended less than 6 lessons|2|||
44321568|NCT01220401|79326429|FG000|Overall Study|Withdrawal by Subject|2|||
44321569|NCT01220401|79326429|FG000|Overall Study|Protocol Violation|1|||
44321570|NCT01220167|79326436|FG000|Period 3|Urine positive for substance abuse|0|||
44321571|NCT01220167|79326437|FG001|Period 3|Urine positive for substance abuse|1|||
44321572|NCT01220167|79326438|FG002|Period 3|Urine positive for substance abuse|0|||
44321573|NCT01220128|79326451|FG000|Overall Study|Progressive disease|0|||
44321574|NCT01220128|79326452|FG001|Overall Study|Progressive disease|0|||
44321575|NCT01220128|79326453|FG002|Overall Study|Progressive disease|2|||
44321576|NCT01220128|79326454|FG003|Overall Study|Progressive disease|0|||
44321577|NCT01220128|79326455|FG004|Overall Study|Progressive disease|0|||
44321578|NCT01220128|79326456|FG005|Overall Study|Progressive disease|0|||
44321579|NCT01220128|79326457|FG006|Overall Study|Progressive disease|0|||
44321580|NCT01220128|79326451|FG000|Overall Study|Sponsor study termination|0|||
44321581|NCT01220128|79326452|FG001|Overall Study|Sponsor study termination|1|||
44321582|NCT01220128|79326453|FG002|Overall Study|Sponsor study termination|0|||
44321583|NCT01220128|79326454|FG003|Overall Study|Sponsor study termination|0|||
44321584|NCT01220128|79326455|FG004|Overall Study|Sponsor study termination|0|||
44321585|NCT01220128|79326456|FG005|Overall Study|Sponsor study termination|0|||
44321586|NCT01220128|79326457|FG006|Overall Study|Sponsor study termination|1|||
44321587|NCT01220128|79326451|FG000|Overall Study|Adverse event, serious fatal|2|||
44321588|NCT01220128|79326452|FG001|Overall Study|Adverse event, serious fatal|0|||
44321589|NCT01220128|79326453|FG002|Overall Study|Adverse event, serious fatal|0|||
44321590|NCT01220128|79326454|FG003|Overall Study|Adverse event, serious fatal|0|||
44321591|NCT01220128|79326455|FG004|Overall Study|Adverse event, serious fatal|0|||
44321592|NCT01220128|79326456|FG005|Overall Study|Adverse event, serious fatal|0|||
44321593|NCT01220128|79326457|FG006|Overall Study|Adverse event, serious fatal|1|||
44321594|NCT01220128|79326451|FG000|Overall Study|Adverse event, non-fatal|1|||
44321595|NCT01220128|79326452|FG001|Overall Study|Adverse event, non-fatal|0|||
44321596|NCT01220128|79326453|FG002|Overall Study|Adverse event, non-fatal|0|||
44321597|NCT01220128|79326454|FG003|Overall Study|Adverse event, non-fatal|0|||
44321598|NCT01220128|79326455|FG004|Overall Study|Adverse event, non-fatal|0|||
44321599|NCT01220128|79326456|FG005|Overall Study|Adverse event, non-fatal|0|||
44321600|NCT01220128|79326457|FG006|Overall Study|Adverse event, non-fatal|3|||
44321601|NCT01220128|79326451|FG000|Overall Study|Other|0|||
44321602|NCT01220128|79326452|FG001|Overall Study|Other|0|||
44321603|NCT01220128|79326453|FG002|Overall Study|Other|1|||
44321604|NCT01220128|79326454|FG003|Overall Study|Other|0|||
44321605|NCT01220128|79326455|FG004|Overall Study|Other|0|||
44321606|NCT01220128|79326456|FG005|Overall Study|Other|0|||
44321607|NCT01220128|79326457|FG006|Overall Study|Other|0|||
44321608|NCT01220128|79326451|FG000|Overall Study|Consent withdrawn by subject|1|||
44321609|NCT01220128|79326452|FG001|Overall Study|Consent withdrawn by subject|0|||
44321610|NCT01220128|79326453|FG002|Overall Study|Consent withdrawn by subject|0|||
44321611|NCT01220128|79326454|FG003|Overall Study|Consent withdrawn by subject|0|||
44321612|NCT01220128|79326455|FG004|Overall Study|Consent withdrawn by subject|0|||
44321613|NCT01220128|79326456|FG005|Overall Study|Consent withdrawn by subject|0|||
44321614|NCT01220128|79326457|FG006|Overall Study|Consent withdrawn by subject|0|||
44321615|NCT01219933|79326474|FG000|Overall Study|Adverse Event|8|||
44321616|NCT01219933|79326474|FG000|Overall Study|No LDA reached|5|||
44321617|NCT01219933|79326474|FG000|Overall Study|No LDA maintained|7|||
44321618|NCT01219933|79326474|FG000|Overall Study|Lost to Follow-up|3|||
44321619|NCT01219933|79326474|FG000|Overall Study|GC free|1|||
44321620|NCT01219933|79326474|FG000|Overall Study|Withdrawal by Subject|5|||
44321621|NCT01219933|79326474|FG000|Overall Study|Protocol Violation|8|||
44321622|NCT01219933|79326474|FG000|Overall Study|Lack of Efficacy|1|||
44321623|NCT01218802|79326481|FG000|Overall Study|Lost to Follow-up|5|||
44321624|NCT01218802|79326482|FG001|Overall Study|Lost to Follow-up|6|||
44321625|NCT01218802|79326481|FG000|Overall Study|Withdrawal by Subject|3|||
44321626|NCT01218802|79326482|FG001|Overall Study|Withdrawal by Subject|10|||
44321627|NCT01218802|79326481|FG000|Overall Study|Adverse Event|0|||
44321628|NCT01218802|79326482|FG001|Overall Study|Adverse Event|2|||
44321629|NCT01218802|79326481|FG000|Overall Study|Incarcerated|2|||
44321630|NCT01218802|79326482|FG001|Overall Study|Incarcerated|0|||
44321631|NCT01218646|79326492|FG000|Overall Study|Adverse Event|0|||
44321632|NCT01218646|79326493|FG001|Overall Study|Adverse Event|0|||
44321633|NCT01218646|79326494|FG002|Overall Study|Adverse Event|1|||
44321634|NCT01218646|79326495|FG003|Overall Study|Adverse Event|0|||
44321635|NCT01218646|79326492|FG000|Overall Study|Lost to Follow-up|1|||
44321636|NCT01218646|79326493|FG001|Overall Study|Lost to Follow-up|0|||
44321637|NCT01218646|79326494|FG002|Overall Study|Lost to Follow-up|0|||
44321638|NCT01218646|79326495|FG003|Overall Study|Lost to Follow-up|0|||
44321639|NCT01218646|79326492|FG000|Overall Study|Protocol Violation|0|||
44321640|NCT01218646|79326493|FG001|Overall Study|Protocol Violation|0|||
44321641|NCT01218646|79326494|FG002|Overall Study|Protocol Violation|1|||
44321642|NCT01218646|79326495|FG003|Overall Study|Protocol Violation|1|||
44321643|NCT01188772|79326509|FG000|Overall Study|Randomized but Not Treated|0|||
44321644|NCT01188772|79326510|FG001|Overall Study|Randomized but Not Treated|1|||
44321645|NCT01188772|79326511|FG002|Overall Study|Randomized but Not Treated|0|||
44321646|NCT01188772|79326512|FG003|Overall Study|Randomized but Not Treated|0|||
44321647|NCT01188772|79326509|FG000|Overall Study|Adverse Event|0|||
44321648|NCT01188772|79326510|FG001|Overall Study|Adverse Event|1|||
44321649|NCT01188772|79326511|FG002|Overall Study|Adverse Event|2|||
44321650|NCT01188772|79326512|FG003|Overall Study|Adverse Event|0|||
44321651|NCT01188772|79326509|FG000|Overall Study|Lost to Follow-up|4|||
44321652|NCT01188772|79326510|FG001|Overall Study|Lost to Follow-up|1|||
44321653|NCT01188772|79326511|FG002|Overall Study|Lost to Follow-up|1|||
44321654|NCT01188772|79326512|FG003|Overall Study|Lost to Follow-up|1|||
44321655|NCT01188772|79326509|FG000|Overall Study|Non-responder|0|||
44321656|NCT01188772|79326510|FG001|Overall Study|Non-responder|0|||
44321657|NCT01188772|79326511|FG002|Overall Study|Non-responder|3|||
44321658|NCT01188772|79326512|FG003|Overall Study|Non-responder|0|||
44321659|NCT01188772|79326509|FG000|Overall Study|Physician Decision|0|||
44321660|NCT01188772|79326510|FG001|Overall Study|Physician Decision|0|||
44321661|NCT01188772|79326511|FG002|Overall Study|Physician Decision|1|||
44321662|NCT01188772|79326512|FG003|Overall Study|Physician Decision|0|||
44321663|NCT01188772|79326509|FG000|Overall Study|Terminated by Sponsor|0|||
44321664|NCT01188772|79326510|FG001|Overall Study|Terminated by Sponsor|0|||
44321665|NCT01188772|79326511|FG002|Overall Study|Terminated by Sponsor|1|||
44321666|NCT01188772|79326512|FG003|Overall Study|Terminated by Sponsor|0|||
44321667|NCT01188772|79326509|FG000|Overall Study|Treatment Failure|0|||
44321668|NCT01188772|79326510|FG001|Overall Study|Treatment Failure|0|||
44321669|NCT01188772|79326511|FG002|Overall Study|Treatment Failure|1|||
44321670|NCT01188772|79326512|FG003|Overall Study|Treatment Failure|0|||
44321671|NCT01188772|79326509|FG000|Overall Study|Virologic Failure|1|||
44321672|NCT01188772|79326510|FG001|Overall Study|Virologic Failure|0|||
44321673|NCT01188772|79326511|FG002|Overall Study|Virologic Failure|0|||
44321674|NCT01188772|79326512|FG003|Overall Study|Virologic Failure|0|||
44321675|NCT01188772|79326509|FG000|Overall Study|Withdrawal by Subject|0|||
44321676|NCT01188772|79326510|FG001|Overall Study|Withdrawal by Subject|0|||
44321677|NCT01188772|79326511|FG002|Overall Study|Withdrawal by Subject|2|||
44321678|NCT01188772|79326512|FG003|Overall Study|Withdrawal by Subject|0|||
44321679|NCT01188655|79326525|FG000|Overall Study|Lack of Efficacy|1|||
44321680|NCT01188655|79326525|FG000|Overall Study|Lost to Follow-up|1|||
44321681|NCT01188655|79326525|FG000|Overall Study|Other|11|||
44321682|NCT01188538|79326531|FG000|Overall Study|Lost to Follow-up|0|||
44321683|NCT01188538|79326532|FG001|Overall Study|Lost to Follow-up|1|||
44321684|NCT01188343|79326543|FG000|Overall Study|Not vaccinated|0|||
44321685|NCT01188343|79326544|FG001|Overall Study|Not vaccinated|2|||
44321686|NCT01188343|79326545|FG002|Overall Study|Not vaccinated|1|||
44321687|NCT01188343|79326543|FG000|Overall Study|Withdrawal by Subject|1|||
44321688|NCT01188343|79326544|FG001|Overall Study|Withdrawal by Subject|24|||
44321689|NCT01188343|79326545|FG002|Overall Study|Withdrawal by Subject|0|||
44321690|NCT01188226|79326556|FG000|Overall Study|Withdrawal by Subject|4|||
44321691|NCT01218100|79326574|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
44321692|NCT01218100|79326575|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
44321693|NCT01218100|79326576|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
44321694|NCT01218100|79326577|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
44321695|NCT01218100|79326574|FG000|Overall Study|Adverse Event|4|||
44321696|NCT01218100|79326575|FG001|Overall Study|Adverse Event|6|||
44321697|NCT01218100|79326576|FG002|Overall Study|Adverse Event|6|||
44321698|NCT01218100|79326577|FG003|Overall Study|Adverse Event|7|||
44321699|NCT01218100|79326574|FG000|Overall Study|Lack of Efficacy|9|||
44321700|NCT01218100|79326575|FG001|Overall Study|Lack of Efficacy|6|||
44321701|NCT01218100|79326576|FG002|Overall Study|Lack of Efficacy|5|||
44321702|NCT01218100|79326577|FG003|Overall Study|Lack of Efficacy|12|||
44321703|NCT01218100|79326574|FG000|Overall Study|Protocol Violation|0|||
44321704|NCT01218100|79326575|FG001|Overall Study|Protocol Violation|0|||
44321705|NCT01218100|79326576|FG002|Overall Study|Protocol Violation|1|||
44321706|NCT01218100|79326577|FG003|Overall Study|Protocol Violation|1|||
44321707|NCT01218100|79326574|FG000|Overall Study|Withdrawal by Subject|5|||
44321708|NCT01218100|79326575|FG001|Overall Study|Withdrawal by Subject|2|||
44321709|NCT01218100|79326576|FG002|Overall Study|Withdrawal by Subject|6|||
44321710|NCT01218100|79326577|FG003|Overall Study|Withdrawal by Subject|7|||
44321711|NCT01218100|79326574|FG000|Overall Study|Lost to Follow-up|3|||
44321712|NCT01218100|79326575|FG001|Overall Study|Lost to Follow-up|8|||
44321713|NCT01218100|79326576|FG002|Overall Study|Lost to Follow-up|2|||
44321714|NCT01218100|79326577|FG003|Overall Study|Lost to Follow-up|1|||
44321715|NCT01218100|79326574|FG000|Overall Study|Other Reason|2|||
44321716|NCT01218100|79326575|FG001|Overall Study|Other Reason|2|||
44321717|NCT01218100|79326576|FG002|Overall Study|Other Reason|6|||
44321718|NCT01218100|79326577|FG003|Overall Study|Other Reason|4|||
44536702|NCT03529773|79547243|FG009|Overall Study|Screen Failure|0|||
44536703|NCT03529773|79547244|FG010|Overall Study|Screen Failure|0|||
44155786|NCT01946152|78947281|FG001|Overall Study|Physician Decision|0|||
44155787|NCT01946152|78947282|FG002|Overall Study|Physician Decision|1|||
44155788|NCT01946152|78947283|FG003|Overall Study|Physician Decision|0|||
44155789|NCT01946152|78947280|FG000|Overall Study|Second malignancy|0|||
44155790|NCT01946152|78947281|FG001|Overall Study|Second malignancy|0|||
44155791|NCT01946152|78947282|FG002|Overall Study|Second malignancy|1|||
44321719|NCT02956850|79326605|FG000|Overall Study|Withdrawal by Subject|0|||
44321720|NCT02956850|79326606|FG001|Overall Study|Withdrawal by Subject|0|||
44321721|NCT02956850|79326607|FG002|Overall Study|Withdrawal by Subject|0|||
44321722|NCT02956850|79326608|FG003|Overall Study|Withdrawal by Subject|0|||
44321723|NCT02956850|79326609|FG004|Overall Study|Withdrawal by Subject|0|||
44321724|NCT02956850|79326610|FG005|Overall Study|Withdrawal by Subject|0|||
44321725|NCT02956850|79326611|FG006|Overall Study|Withdrawal by Subject|0|||
44321726|NCT02956850|79326612|FG007|Overall Study|Withdrawal by Subject|0|||
44321727|NCT02956850|79326613|FG008|Overall Study|Withdrawal by Subject|0|||
44321728|NCT02956850|79326614|FG009|Overall Study|Withdrawal by Subject|0|||
44155792|NCT01946152|78947283|FG003|Overall Study|Second malignancy|0|||
44155793|NCT01946152|78947280|FG000|Overall Study|Adverse Event|0|||
44155794|NCT01946152|78947281|FG001|Overall Study|Adverse Event|0|||
44155795|NCT01946152|78947282|FG002|Overall Study|Adverse Event|0|||
44321729|NCT02956850|79326615|FG010|Overall Study|Withdrawal by Subject|0|||
44321730|NCT02956850|79326616|FG011|Overall Study|Withdrawal by Subject|0|||
44321731|NCT02956850|79326617|FG012|Overall Study|Withdrawal by Subject|0|||
44321732|NCT02956850|79326618|FG013|Overall Study|Withdrawal by Subject|0|||
44321733|NCT02956850|79326619|FG014|Overall Study|Withdrawal by Subject|0|||
44321734|NCT02956850|79326620|FG015|Overall Study|Withdrawal by Subject|0|||
44321735|NCT02956850|79326621|FG016|Overall Study|Withdrawal by Subject|0|||
44321736|NCT02956850|79326622|FG017|Overall Study|Withdrawal by Subject|1|||
44321737|NCT01187953|79326718|FG000|Overall Study|Death|11|||
44321738|NCT01187953|79326719|FG001|Overall Study|Death|13|||
44321739|NCT01187953|79326718|FG000|Overall Study|Adverse Event|1|||
44321740|NCT01187953|79326719|FG001|Overall Study|Adverse Event|2|||
44321741|NCT01187953|79326718|FG000|Overall Study|Lost to Follow-up|0|||
44321742|NCT01187953|79326719|FG001|Overall Study|Lost to Follow-up|3|||
44321743|NCT01187953|79326718|FG000|Overall Study|Withdrawal by Subject|3|||
44321744|NCT01187953|79326719|FG001|Overall Study|Withdrawal by Subject|3|||
44321745|NCT01217944|79326735|FG000|Overall Study|Protocol Violation|1|||
44321746|NCT01217944|79326736|FG001|Overall Study|Protocol Violation|1|||
44321747|NCT01217944|79326737|FG002|Overall Study|Protocol Violation|0|||
44321748|NCT01217944|79326735|FG000|Overall Study|Lost to Follow-up|3|||
44321749|NCT01217944|79326736|FG001|Overall Study|Lost to Follow-up|1|||
44321750|NCT01217944|79326737|FG002|Overall Study|Lost to Follow-up|0|||
44321751|NCT01217944|79326735|FG000|Overall Study|Withdrawal by Subject|1|||
44321752|NCT01217944|79326736|FG001|Overall Study|Withdrawal by Subject|2|||
44321753|NCT01217944|79326737|FG002|Overall Study|Withdrawal by Subject|0|||
44321754|NCT01217944|79326735|FG000|Overall Study|Lack of Efficacy|1|||
44321755|NCT01217944|79326736|FG001|Overall Study|Lack of Efficacy|0|||
44321756|NCT01217944|79326737|FG002|Overall Study|Lack of Efficacy|0|||
44321757|NCT01187446|79326749|FG000|Overall Study|Patient started non-protocol therapy|0|||
44321758|NCT01187446|79326750|FG001|Overall Study|Patient started non-protocol therapy|1|||
44321759|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
44321760|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44321761|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44321762|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44321763|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44321764|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
44321765|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44321766|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44321767|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44321768|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44321769|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
44321770|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44321771|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44321772|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44321773|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44321774|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
44321775|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44321776|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44321777|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44321778|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44321779|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
44321780|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44321781|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44321782|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44321783|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44321784|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
44321785|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44421702|NCT00792701|79429581|FG001|Overall Study|Withdrawal by Subject|19|||
44421703|NCT00792701|79429580|FG000|Overall Study|Not protocol specified|17|||
44421704|NCT00792701|79429581|FG001|Overall Study|Not protocol specified|0|||
44536704|NCT03529773|79547245|FG011|Overall Study|Screen Failure|0|||
44536705|NCT03529773|79547246|FG012|Overall Study|Screen Failure|0|||
44536706|NCT03529773|79547247|FG013|Overall Study|Screen Failure|0|||
44536707|NCT03529773|79547248|FG014|Overall Study|Screen Failure|0|||
44536708|NCT03529773|79547249|FG015|Overall Study|Screen Failure|0|||
44155796|NCT01946152|78947283|FG003|Overall Study|Adverse Event|1|||
44321786|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44321787|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44321788|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44321789|NCT01187407|79326760|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
44536709|NCT03529773|79547250|FG016|Overall Study|Screen Failure|0|||
44321790|NCT01187407|79326761|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44321791|NCT01187407|79326762|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44321792|NCT01187407|79326763|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44321793|NCT01187407|79326764|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44321794|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
44321795|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
44321796|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
44321797|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
44321798|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
44321799|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
44321800|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
44321801|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
44321802|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
44321803|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
44321804|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
44321805|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
44321806|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
44321807|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
44321808|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
44321809|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44321810|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44321811|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44321812|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
44321813|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
44321814|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
44321815|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
44321816|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
44321817|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
44321818|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
44321819|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
44321820|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
44321821|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
44321822|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
44321823|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
44321824|NCT01187407|79326760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
44321825|NCT01187407|79326761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
44321826|NCT01187407|79326762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
44321827|NCT01187407|79326763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
44321828|NCT01187407|79326764|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
44321829|NCT01186978|79326781|FG000|Overall Study|Withdrawal by Subject|1|||
44321830|NCT01186939|79326785|FG000|Overall Study|Death|7|||
44321831|NCT01186939|79326785|FG000|Overall Study|Withdrawal by Subject|2|||
44321832|NCT01186939|79326785|FG000|Overall Study|No longer receiving clinical benefit|17|||
44321833|NCT01186939|79326785|FG000|Overall Study|Program closed|5|||
44321834|NCT01186939|79326785|FG000|Overall Study|Sponsor decision|4|||
44321835|NCT01186939|79326785|FG000|Overall Study|Started additional treatment|1|||
44321836|NCT01186939|79326785|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
44321837|NCT01186939|79326785|FG000|Overall Study|Myocardial infarction|1|||
44321838|NCT01186939|79326785|FG000|Overall Study|Bone marrow transplant|1|||
44321839|NCT01186939|79326785|FG000|Overall Study|Transformation to AML|1|||
44321840|NCT04938648|79326810|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
44321841|NCT04938648|79326811|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
44421705|NCT00777296|79429593|FG000|Overall Study|Adverse Event|0|||
44421706|NCT00777296|79429594|FG001|Overall Study|Adverse Event|1|||
44421707|NCT00777296|79429595|FG002|Overall Study|Adverse Event|0|||
44421708|NCT00777296|79429596|FG003|Overall Study|Adverse Event|1|||
44421709|NCT00777296|79429593|FG000|Overall Study|Withdrawal by Subject|1|||
44536710|NCT03529773|79547251|FG017|Overall Study|Screen Failure|0|||
44536711|NCT03529773|79547252|FG018|Overall Study|Screen Failure|0|||
44321842|NCT04938648|79326810|FG000|Overall Study|Patient too ill|0|||
44321843|NCT04938648|79326811|FG001|Overall Study|Patient too ill|1|||
44321844|NCT04938648|79326810|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
44321845|NCT04938648|79326811|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
44321846|NCT04938648|79326810|FG000|Overall Study|Patient did not have memory problems|1|||
44321847|NCT04938648|79326811|FG001|Overall Study|Patient did not have memory problems|1|||
44421710|NCT00777296|79429594|FG001|Overall Study|Withdrawal by Subject|0|||
44421711|NCT00777296|79429595|FG002|Overall Study|Withdrawal by Subject|0|||
44421712|NCT00777296|79429596|FG003|Overall Study|Withdrawal by Subject|0|||
44321848|NCT04938648|79326810|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
44321849|NCT04938648|79326811|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
44321850|NCT04938648|79326810|FG000|Overall Study|Care partner could not be reached|0|||
44321851|NCT04938648|79326811|FG001|Overall Study|Care partner could not be reached|1|||
44321852|NCT04938648|79326810|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
44321853|NCT04938648|79326811|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
44321854|NCT04938648|79326810|FG000|Overall Study|Withdrawal by Subject|2|||
44321855|NCT04938648|79326811|FG001|Overall Study|Withdrawal by Subject|1|||
44321856|NCT04564092|79326818|FG000|Overall Study|Withdrawal by Subject|1|||
44321857|NCT01658826|79326859|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
44321858|NCT01658826|79326860|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
44321859|NCT01658826|79326859|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
44321860|NCT01658826|79326860|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
44421713|NCT00777296|79429593|FG000|Overall Study|CRF form not completed|0|||
44421714|NCT00777296|79429594|FG001|Overall Study|CRF form not completed|0|||
44421715|NCT00777296|79429595|FG002|Overall Study|CRF form not completed|2|||
44421716|NCT00777296|79429596|FG003|Overall Study|CRF form not completed|0|||
44421717|NCT00756470|79429618|FG000|Overall Study|Withdrawal by Subject|1|||
44421718|NCT00756470|79429618|FG000|Overall Study|Adverse Event|4|||
44421719|NCT00792623|79429622|FG000|Overall Study|Adverse Event|2|||
44421720|NCT00792623|79429622|FG000|Overall Study|Withdrawal by Subject|5|||
44421721|NCT00756314|79429629|FG000|Overall Study|Lost to Follow-up|2|||
44421722|NCT00756314|79429630|FG001|Overall Study|Lost to Follow-up|59|||
44421723|NCT00727506|79429642|FG000|Overall Study|Adverse Event|0|||
44421724|NCT00727506|79429643|FG001|Overall Study|Adverse Event|0|||
44421725|NCT00727506|79429644|FG002|Overall Study|Adverse Event|4|||
44421726|NCT00727506|79429645|FG003|Overall Study|Adverse Event|4|||
44421727|NCT00727506|79429646|FG004|Overall Study|Adverse Event|1|||
44421728|NCT00727506|79429647|FG005|Overall Study|Adverse Event|8|||
44421729|NCT00727506|79429642|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
44421730|NCT00727506|79429643|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44536712|NCT03529773|79547253|FG019|Overall Study|Screen Failure|0|||
44536713|NCT03529773|79547254|FG020|Overall Study|Screen Failure|0|||
44536714|NCT03529773|79547255|FG021|Overall Study|Screen Failure|0|||
44536715|NCT03529773|79547256|FG022|Overall Study|Screen Failure|0|||
44536716|NCT03529773|79547257|FG023|Overall Study|Screen Failure|0|||
44536717|NCT03529773|79547258|FG024|Overall Study|Screen Failure|0|||
44155797|NCT01945996|78947297|FG000|Overall Study|Lost to Follow-up|3|||
44155798|NCT01945996|78947298|FG001|Overall Study|Lost to Follow-up|5|||
44321861|NCT01658826|79326859|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
44421731|NCT00727506|79429644|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
44421732|NCT00727506|79429645|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44421733|NCT00727506|79429646|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44421734|NCT00727506|79429647|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
44421735|NCT00727506|79429642|FG000|Overall Study|Progressive disease|4|||
44421736|NCT00727506|79429643|FG001|Overall Study|Progressive disease|7|||
44421737|NCT00727506|79429644|FG002|Overall Study|Progressive disease|9|||
44536718|NCT03529773|79547259|FG025|Overall Study|Screen Failure|0|||
44321862|NCT01658826|79326860|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
44321863|NCT01658826|79326859|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
44321864|NCT01658826|79326860|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
44321865|NCT01658826|79326859|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
44321866|NCT01658826|79326860|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
44321867|NCT01658826|79326859|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
44421738|NCT00727506|79429645|FG003|Overall Study|Progressive disease|28|||
44421739|NCT00727506|79429646|FG004|Overall Study|Progressive disease|38|||
44421740|NCT00727506|79429647|FG005|Overall Study|Progressive disease|28|||
44421741|NCT00727506|79429642|FG000|Overall Study|Refused to continue medication|0|||
44536719|NCT03529773|79547260|FG026|Overall Study|Screen Failure|0|||
44536720|NCT03529773|79547261|FG027|Overall Study|Screen Failure|0|||
44536721|NCT03529773|79547262|FG028|Overall Study|Screen Failure|0|||
44536722|NCT03529773|79547263|FG029|Overall Study|Screen Failure|0|||
44536723|NCT03529773|79547264|FG030|Overall Study|Screen Failure|0|||
44536724|NCT03529773|79547265|FG031|Overall Study|Screen Failure|0|||
44536725|NCT03529773|79547266|FG032|Overall Study|Screen Failure|0|||
44536726|NCT03529773|79547267|FG033|Overall Study|Screen Failure|0|||
44536727|NCT03529773|79547268|FG034|Overall Study|Screen Failure|0|||
44536728|NCT03529773|79547269|FG035|Overall Study|Screen Failure|0|||
44536729|NCT03529773|79547270|FG036|Overall Study|Screen Failure|1|||
44536730|NCT03529773|79547271|FG037|Overall Study|Screen Failure|1|||
44536731|NCT03529773|79547272|FG038|Overall Study|Screen Failure|0|||
44155799|NCT01971346|78947306|FG000|Overall Study|Protocol Violation|3|||
44321868|NCT01658826|79326860|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
44321869|NCT01658826|79326859|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
44321870|NCT01658826|79326860|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
44321871|NCT01658826|79326859|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
44321872|NCT01658826|79326860|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
44321873|NCT01658826|79326859|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
44321874|NCT01658826|79326860|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
44321875|NCT01186744|79326876|FG000|Overall Study|Lack of Efficacy|156|||
44321876|NCT01186744|79326877|FG001|Overall Study|Lack of Efficacy|99|||
44321877|NCT01186744|79326878|FG002|Overall Study|Lack of Efficacy|0|||
44321878|NCT01186744|79326879|FG003|Overall Study|Lack of Efficacy|2|||
44321879|NCT01186744|79326880|FG004|Overall Study|Lack of Efficacy|2|||
44321880|NCT01186744|79326881|FG005|Overall Study|Lack of Efficacy|5|||
44321881|NCT01186744|79326876|FG000|Overall Study|Protocol Violation|1|||
44321882|NCT01186744|79326877|FG001|Overall Study|Protocol Violation|2|||
44321883|NCT01186744|79326878|FG002|Overall Study|Protocol Violation|0|||
44321884|NCT01186744|79326879|FG003|Overall Study|Protocol Violation|1|||
44321885|NCT01186744|79326880|FG004|Overall Study|Protocol Violation|1|||
44321886|NCT01186744|79326881|FG005|Overall Study|Protocol Violation|2|||
44321887|NCT01186744|79326876|FG000|Overall Study|Lost to Follow-up|15|||
44321888|NCT01186744|79326877|FG001|Overall Study|Lost to Follow-up|16|||
44321889|NCT01186744|79326878|FG002|Overall Study|Lost to Follow-up|2|||
44321890|NCT01186744|79326879|FG003|Overall Study|Lost to Follow-up|1|||
44321891|NCT01186744|79326880|FG004|Overall Study|Lost to Follow-up|1|||
44321892|NCT01186744|79326881|FG005|Overall Study|Lost to Follow-up|4|||
44321893|NCT01186744|79326876|FG000|Overall Study|Screen failure|1|||
44321894|NCT01186744|79326877|FG001|Overall Study|Screen failure|1|||
44321895|NCT01186744|79326878|FG002|Overall Study|Screen failure|0|||
44321896|NCT01186744|79326879|FG003|Overall Study|Screen failure|1|||
44321897|NCT01186744|79326880|FG004|Overall Study|Screen failure|0|||
44321898|NCT01186744|79326881|FG005|Overall Study|Screen failure|0|||
44321899|NCT01186744|79326876|FG000|Overall Study|Withdrawal by Subject|14|||
44321900|NCT01186744|79326877|FG001|Overall Study|Withdrawal by Subject|10|||
44321901|NCT01186744|79326878|FG002|Overall Study|Withdrawal by Subject|2|||
44321902|NCT01186744|79326879|FG003|Overall Study|Withdrawal by Subject|5|||
44321903|NCT01186744|79326880|FG004|Overall Study|Withdrawal by Subject|0|||
44321904|NCT01186744|79326881|FG005|Overall Study|Withdrawal by Subject|6|||
44321905|NCT01186744|79326876|FG000|Overall Study|Study terminated by Sponsor|1|||
44321906|NCT01186744|79326877|FG001|Overall Study|Study terminated by Sponsor|0|||
44321907|NCT01186744|79326878|FG002|Overall Study|Study terminated by Sponsor|0|||
44321908|NCT01186744|79326879|FG003|Overall Study|Study terminated by Sponsor|0|||
44321909|NCT01186744|79326880|FG004|Overall Study|Study terminated by Sponsor|0|||
44321910|NCT01186744|79326881|FG005|Overall Study|Study terminated by Sponsor|0|||
44321911|NCT01186744|79326876|FG000|Overall Study|Other|9|||
44321912|NCT01186744|79326877|FG001|Overall Study|Other|10|||
44321913|NCT01186744|79326878|FG002|Overall Study|Other|1|||
44321914|NCT01186744|79326879|FG003|Overall Study|Other|2|||
44321915|NCT01186744|79326880|FG004|Overall Study|Other|1|||
44321916|NCT01186744|79326881|FG005|Overall Study|Other|5|||
44321917|NCT01186744|79326876|FG000|Overall Study|Adverse Event|10|||
44321918|NCT01186744|79326877|FG001|Overall Study|Adverse Event|14|||
44321919|NCT01186744|79326878|FG002|Overall Study|Adverse Event|1|||
44321920|NCT01186744|79326879|FG003|Overall Study|Adverse Event|0|||
44321921|NCT01186744|79326880|FG004|Overall Study|Adverse Event|1|||
44321922|NCT01186744|79326881|FG005|Overall Study|Adverse Event|4|||
44321923|NCT01186744|79326876|FG000|Overall Study|Death|1|||
44321924|NCT01186744|79326877|FG001|Overall Study|Death|0|||
44321925|NCT01186744|79326878|FG002|Overall Study|Death|0|||
44321926|NCT01186744|79326879|FG003|Overall Study|Death|0|||
44321927|NCT01186744|79326880|FG004|Overall Study|Death|0|||
44321928|NCT01186744|79326881|FG005|Overall Study|Death|0|||
44321929|NCT01185964|79326919|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
44321930|NCT01185964|79326920|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
44321931|NCT01185964|79326921|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
44321932|NCT01185964|79326922|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
44321933|NCT01185964|79326919|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
44321934|NCT01185964|79326920|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
44321935|NCT01185964|79326921|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
44321936|NCT01185964|79326922|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
44321937|NCT01185964|79326919|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
44321938|NCT01185964|79326920|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
44321939|NCT01185964|79326921|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
44321940|NCT01185964|79326922|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
44321941|NCT01185964|79326919|FG000|Phase 1b and Phase 2|Adverse Event|1|||
44321942|NCT01185964|79326920|FG001|Phase 1b and Phase 2|Adverse Event|0|||
44321943|NCT01185964|79326921|FG002|Phase 1b and Phase 2|Adverse Event|2|||
44321944|NCT01185964|79326922|FG003|Phase 1b and Phase 2|Adverse Event|0|||
44321945|NCT01185964|79326919|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
44321946|NCT01185964|79326920|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
44321947|NCT01185964|79326921|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
44321948|NCT01185964|79326922|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
44321949|NCT01185964|79326919|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
44321950|NCT01185964|79326920|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
44321951|NCT01185964|79326921|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
44321952|NCT01185964|79326922|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
44321953|NCT01185964|79326919|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
44321954|NCT01185964|79326920|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
44321955|NCT01185964|79326921|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
44321956|NCT01185964|79326922|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
44321957|NCT01185964|79326919|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
44321958|NCT01185964|79326920|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
44321959|NCT01185964|79326921|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
44321960|NCT01185964|79326922|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
44321961|NCT01217476|79326940|FG000|Overall Study|Adverse Event|6|||
44321962|NCT01217476|79326941|FG001|Overall Study|Adverse Event|1|||
44321963|NCT01217476|79326940|FG000|Overall Study|Physician Decision|0|||
44321964|NCT01217476|79326941|FG001|Overall Study|Physician Decision|1|||
44321965|NCT01217476|79326940|FG000|Overall Study|Withdrawal by Subject|3|||
44321966|NCT01217476|79326941|FG001|Overall Study|Withdrawal by Subject|3|||
44321967|NCT01217476|79326940|FG000|Overall Study|Surgery on the Target Limb|0|||
44321968|NCT01217476|79326941|FG001|Overall Study|Surgery on the Target Limb|2|||
44321969|NCT01217476|79326940|FG000|Overall Study|Protocol Deviation|1|||
44321970|NCT01217476|79326941|FG001|Overall Study|Protocol Deviation|0|||
44321971|NCT01217476|79326940|FG000|Overall Study|Other|2|||
44321972|NCT01217476|79326941|FG001|Overall Study|Other|0|||
44321973|NCT01217437|79326962|FG000|Overall Study|Adverse Event|0|||
44421742|NCT00727506|79429643|FG001|Overall Study|Refused to continue medication|1|||
44421743|NCT00727506|79429644|FG002|Overall Study|Refused to continue medication|2|||
44421744|NCT00727506|79429645|FG003|Overall Study|Refused to continue medication|3|||
44421745|NCT00727506|79429646|FG004|Overall Study|Refused to continue medication|1|||
44421746|NCT00727506|79429647|FG005|Overall Study|Refused to continue medication|2|||
44421747|NCT00727506|79429642|FG000|Overall Study|Other reason not described above|0|||
44421748|NCT00727506|79429643|FG001|Overall Study|Other reason not described above|0|||
44421749|NCT00727506|79429644|FG002|Overall Study|Other reason not described above|1|||
44421750|NCT00727506|79429645|FG003|Overall Study|Other reason not described above|4|||
44321974|NCT01217437|79326963|FG001|Overall Study|Adverse Event|8|||
44421751|NCT00727506|79429646|FG004|Overall Study|Other reason not described above|1|||
44421752|NCT00727506|79429647|FG005|Overall Study|Other reason not described above|1|||
44421753|NCT00789815|79429669|FG000|Overall Study|Protocol Violation|6|||
44421754|NCT00789815|79429670|FG001|Overall Study|Protocol Violation|1|||
44421755|NCT00789815|79429669|FG000|Overall Study|Intubation due to massive bleeding|1|||
44421756|NCT00789815|79429670|FG001|Overall Study|Intubation due to massive bleeding|0|||
44421757|NCT00721578|79429676|FG000|Overall Study|Death|1|||
44421758|NCT00721578|79429677|FG001|Overall Study|Death|1|||
44421759|NCT00721578|79429676|FG000|Overall Study|Withdrawal by Subject|1|||
44421760|NCT00721578|79429677|FG001|Overall Study|Withdrawal by Subject|1|||
44421761|NCT00789737|79429685|FG000|Overall Study|Withdrawal by Subject|13|||
44421762|NCT00789737|79429686|FG001|Overall Study|Withdrawal by Subject|22|||
44421763|NCT00789737|79429685|FG000|Overall Study|Lost to Follow-up|10|||
44421764|NCT00789737|79429686|FG001|Overall Study|Lost to Follow-up|14|||
44421765|NCT00789737|79429685|FG000|Overall Study|Adverse Event|8|||
44421766|NCT00789737|79429686|FG001|Overall Study|Adverse Event|8|||
44421767|NCT00789737|79429685|FG000|Overall Study|Protocol Violation|3|||
44321975|NCT01217437|79326962|FG000|Overall Study|Death|5|||
44321976|NCT01217437|79326963|FG001|Overall Study|Death|0|||
44321977|NCT01217437|79326962|FG000|Overall Study|Lack of Efficacy|29|||
44321978|NCT01217437|79326963|FG001|Overall Study|Lack of Efficacy|25|||
44321979|NCT01217437|79326962|FG000|Overall Study|Physician Decision|8|||
44321980|NCT01217437|79326963|FG001|Overall Study|Physician Decision|5|||
44321981|NCT01217437|79326962|FG000|Overall Study|Withdrawal by Subject|0|||
44321982|NCT01217437|79326963|FG001|Overall Study|Withdrawal by Subject|2|||
44321983|NCT01217437|79326962|FG000|Overall Study|Ineligible|1|||
44321984|NCT01217437|79326963|FG001|Overall Study|Ineligible|1|||
44321985|NCT04531904|79326987|FG000|Overall Study|Lost to Follow-up|1|||
44321986|NCT04531904|79326987|FG000|Overall Study|Death|14|||
44421768|NCT00789737|79429686|FG001|Overall Study|Protocol Violation|0|||
44421769|NCT00789737|79429685|FG000|Overall Study|Lack of Efficacy|3|||
44421770|NCT00789737|79429686|FG001|Overall Study|Lack of Efficacy|0|||
44321987|NCT04137380|79326998|FG000|Overall Study|Physician Decision|0|||
44321988|NCT04137380|79326999|FG001|Overall Study|Physician Decision|0|||
44321989|NCT04137380|79327000|FG002|Overall Study|Physician Decision|0|||
44321990|NCT04137380|79327001|FG003|Overall Study|Physician Decision|1|||
44321991|NCT04137380|79327002|FG004|Overall Study|Physician Decision|0|||
44321992|NCT04137380|79327003|FG005|Overall Study|Physician Decision|0|||
44421771|NCT00789737|79429685|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
44421772|NCT00789737|79429686|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
44421773|NCT00789737|79429685|FG000|Overall Study|Other|11|||
44421774|NCT00789737|79429686|FG001|Overall Study|Other|7|||
44421775|NCT00792467|79429692|FG000|Overall Study|progression of disease|17|||
44421776|NCT00792467|79429692|FG000|Overall Study|Adverse Event|1|||
44421777|NCT00792467|79429692|FG000|Overall Study|patient request|1|||
44421778|NCT00792467|79429692|FG000|Overall Study|Lost to Follow-up|1|||
44421779|NCT00792467|79429692|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
44421780|NCT00792467|79429692|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
44421781|NCT00585468|79429697|FG000|First Intervention|Withdrawal by Subject|1|||
44421782|NCT00585468|79429698|FG001|First Intervention|Withdrawal by Subject|1|||
44421783|NCT00724152|79429711|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
44421784|NCT00724152|79429712|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
44421785|NCT00724152|79429713|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
44421786|NCT00724152|79429711|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
44421787|NCT00724152|79429712|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
44421788|NCT00724152|79429713|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
44421789|NCT00721110|79429727|FG000|Overall Study|Ultram use|1|||
44421790|NCT00721110|79429728|FG001|Overall Study|Ultram use|0|||
44421791|NCT00721110|79429729|FG002|Overall Study|Ultram use|0|||
44421792|NCT00721110|79429730|FG003|Overall Study|Ultram use|0|||
44421793|NCT00721110|79429727|FG000|Overall Study|vertical incision|0|||
44421794|NCT00721110|79429728|FG001|Overall Study|vertical incision|0|||
44421795|NCT00721110|79429729|FG002|Overall Study|vertical incision|1|||
44421796|NCT00721110|79429730|FG003|Overall Study|vertical incision|0|||
44421797|NCT00791999|79429744|FG000|Overall Study|Protocol planed withdrawal|14|||
44421798|NCT00791999|79429745|FG001|Overall Study|Protocol planed withdrawal|11|||
44421799|NCT00791999|79429746|FG002|Overall Study|Protocol planed withdrawal|11|||
44421800|NCT00791999|79429747|FG003|Overall Study|Protocol planed withdrawal|45|||
44421801|NCT00791999|79429744|FG000|Overall Study|Withdrawal by Subject|0|||
44421802|NCT00791999|79429745|FG001|Overall Study|Withdrawal by Subject|1|||
44421803|NCT00791999|79429746|FG002|Overall Study|Withdrawal by Subject|0|||
44421804|NCT00791999|79429747|FG003|Overall Study|Withdrawal by Subject|2|||
44421805|NCT00791999|79429744|FG000|Overall Study|Protocol Violation|3|||
44421806|NCT00791999|79429745|FG001|Overall Study|Protocol Violation|0|||
44421807|NCT00791999|79429746|FG002|Overall Study|Protocol Violation|1|||
44421808|NCT00791999|79429747|FG003|Overall Study|Protocol Violation|0|||
44421809|NCT00791999|79429744|FG000|Overall Study|Adverse Event|3|||
44421810|NCT00791999|79429745|FG001|Overall Study|Adverse Event|3|||
44421811|NCT00791999|79429746|FG002|Overall Study|Adverse Event|7|||
44421812|NCT00791999|79429747|FG003|Overall Study|Adverse Event|3|||
44421813|NCT00791999|79429744|FG000|Overall Study|Lack of Efficacy|0|||
44421814|NCT00791999|79429745|FG001|Overall Study|Lack of Efficacy|1|||
44421815|NCT00791999|79429746|FG002|Overall Study|Lack of Efficacy|0|||
44421816|NCT00791999|79429747|FG003|Overall Study|Lack of Efficacy|2|||
44421817|NCT00791999|79429744|FG000|Overall Study|Reason other than those above|1|||
44421818|NCT00791999|79429745|FG001|Overall Study|Reason other than those above|0|||
44421819|NCT00791999|79429746|FG002|Overall Study|Reason other than those above|1|||
44421820|NCT00791999|79429747|FG003|Overall Study|Reason other than those above|0|||
44421821|NCT00585078|79429761|FG000|Overall Study|Withdrawal by Subject|4|||
44421822|NCT00585078|79429761|FG000|Overall Study|Poor performance status|1|||
44421823|NCT00585078|79429761|FG000|Overall Study|Disease Progression|24|||
44421824|NCT00585078|79429761|FG000|Overall Study|Adverse Event|10|||
44421825|NCT00585078|79429761|FG000|Overall Study|Death|1|||
44421826|NCT00720876|79429765|FG000|Overall Study|found to be ineligible after starting tx|2|||
44421827|NCT00723840|79429769|FG000|Overall Study|Lost to Follow-up|2|||
44536732|NCT03529773|79547273|FG039|Overall Study|Screen Failure|1|||
44155800|NCT01971346|78947306|FG000|Overall Study|Lost to Follow-up|2|||
44155801|NCT01971346|78947306|FG000|Overall Study|Withdrawal by Subject|2|||
44421828|NCT00723840|79429769|FG000|Overall Study|Failure to return|18|||
44421829|NCT00723840|79429769|FG000|Overall Study|Withdrawal by Subject|55|||
44421830|NCT00723840|79429769|FG000|Overall Study|Serious Adverse Events|3|||
44155802|NCT01971346|78947306|FG000|Overall Study|Physician Decision|1|||
44421831|NCT00723840|79429769|FG000|Overall Study|Other Medical Event|2|||
44421832|NCT00723840|79429769|FG000|Overall Study|Unspecified reason|2|||
44421833|NCT00789581|79429782|FG000|AC Therapy|Adverse Event|2|||
44421834|NCT00789581|79429783|FG001|AC Therapy|Adverse Event|3|||
44421835|NCT00789581|79429782|FG000|AC Therapy|Withdrawal by Subject|4|||
44421836|NCT00789581|79429783|FG001|AC Therapy|Withdrawal by Subject|7|||
44421837|NCT00789581|79429782|FG000|AC Therapy|Disease recurrence|3|||
44321993|NCT04137380|79327004|FG006|Overall Study|Physician Decision|0|||
44321994|NCT02927301|79327028|FG000|Overall Study|Adverse Event|7|||
44321995|NCT02927301|79327028|FG000|Overall Study|Withdrawal by Subject|1|||
44321996|NCT02927301|79327028|FG000|Overall Study|Physician Decision|2|||
44321997|NCT02653976|79327032|FG000|Overall Study|Withdrawal by Subject|5|||
44321998|NCT02653976|79327032|FG000|Overall Study|Death|4|||
44321999|NCT02611037|79327036|FG000|Overall Study|Withdrawal prior to treatment|2|||
44322000|NCT02611037|79327037|FG001|Overall Study|Withdrawal prior to treatment|0|||
44322001|NCT01566695|79327044|FG000|Overall Study|Lack of Efficacy|18|||
44322002|NCT01566695|79327045|FG001|Overall Study|Lack of Efficacy|45|||
44322003|NCT01566695|79327044|FG000|Overall Study|Adverse Event|28|||
44322004|NCT01566695|79327045|FG001|Overall Study|Adverse Event|27|||
44322005|NCT01566695|79327044|FG000|Overall Study|Death|20|||
44322006|NCT01566695|79327045|FG001|Overall Study|Death|8|||
44322007|NCT01566695|79327044|FG000|Overall Study|Withdrawal by Subject|14|||
44322008|NCT01566695|79327045|FG001|Overall Study|Withdrawal by Subject|7|||
44322009|NCT01566695|79327044|FG000|Overall Study|Progressive Disease|11|||
44322010|NCT01566695|79327045|FG001|Overall Study|Progressive Disease|6|||
44322011|NCT01566695|79327044|FG000|Overall Study|Miscellaneous|4|||
44322012|NCT01566695|79327045|FG001|Overall Study|Miscellaneous|6|||
44322013|NCT01081951|79327053|FG000|Overall Study|Death|54|||
44322014|NCT01081951|79327054|FG001|Overall Study|Death|47|||
44322015|NCT01081951|79327053|FG000|Overall Study|Withdrawal by Subject|2|||
44322016|NCT01081951|79327054|FG001|Overall Study|Withdrawal by Subject|6|||
44322017|NCT01081951|79327053|FG000|Overall Study|Allocated treatment but did not take it|0|||
44322018|NCT01081951|79327054|FG001|Overall Study|Allocated treatment but did not take it|1|||
44322019|NCT01081951|79327053|FG000|Overall Study|Lost to Follow-up|0|||
44322020|NCT01081951|79327054|FG001|Overall Study|Lost to Follow-up|1|||
44322021|NCT00736385|79327062|FG000|Overall Study|Withdrawal by Subject|2|||
44322022|NCT00736385|79327063|FG001|Overall Study|Withdrawal by Subject|2|||
44322023|NCT00736385|79327062|FG000|Overall Study|Adverse Event|0|||
44322024|NCT00736385|79327063|FG001|Overall Study|Adverse Event|1|||
44322025|NCT00392327|79327077|FG000|Overall Study|Death|1|||
44322026|NCT00392327|79327078|FG001|Overall Study|Death|0|||
44322027|NCT00392327|79327079|FG002|Overall Study|Death|1|||
44322028|NCT00392327|79327080|FG003|Overall Study|Death|0|||
44322029|NCT00392327|79327081|FG004|Overall Study|Death|0|||
44322030|NCT00392327|79327082|FG005|Overall Study|Death|0|||
44322031|NCT00392327|79327083|FG006|Overall Study|Death|0|||
44322032|NCT00392327|79327084|FG007|Overall Study|Death|0|||
44322033|NCT00392327|79327077|FG000|Overall Study|Lack of Efficacy|8|||
44322034|NCT00392327|79327078|FG001|Overall Study|Lack of Efficacy|8|||
44322035|NCT00392327|79327079|FG002|Overall Study|Lack of Efficacy|9|||
44322036|NCT00392327|79327080|FG003|Overall Study|Lack of Efficacy|6|||
44322037|NCT00392327|79327081|FG004|Overall Study|Lack of Efficacy|3|||
44322038|NCT00392327|79327082|FG005|Overall Study|Lack of Efficacy|3|||
44322039|NCT00392327|79327083|FG006|Overall Study|Lack of Efficacy|3|||
44322040|NCT00392327|79327084|FG007|Overall Study|Lack of Efficacy|3|||
44322041|NCT00392327|79327077|FG000|Overall Study|Physician Decision|3|||
44322042|NCT00392327|79327078|FG001|Overall Study|Physician Decision|5|||
44322043|NCT00392327|79327079|FG002|Overall Study|Physician Decision|2|||
44322044|NCT00392327|79327080|FG003|Overall Study|Physician Decision|2|||
44322045|NCT00392327|79327081|FG004|Overall Study|Physician Decision|0|||
44322046|NCT00392327|79327082|FG005|Overall Study|Physician Decision|1|||
44322047|NCT00392327|79327083|FG006|Overall Study|Physician Decision|5|||
44322048|NCT00392327|79327084|FG007|Overall Study|Physician Decision|3|||
44322049|NCT00392327|79327077|FG000|Overall Study|Protocol Violation|0|||
44322050|NCT00392327|79327078|FG001|Overall Study|Protocol Violation|0|||
44322051|NCT00392327|79327079|FG002|Overall Study|Protocol Violation|1|||
44322052|NCT00392327|79327080|FG003|Overall Study|Protocol Violation|0|||
44322053|NCT00392327|79327081|FG004|Overall Study|Protocol Violation|0|||
44322054|NCT00392327|79327082|FG005|Overall Study|Protocol Violation|0|||
44322055|NCT00392327|79327083|FG006|Overall Study|Protocol Violation|0|||
44322056|NCT00392327|79327084|FG007|Overall Study|Protocol Violation|0|||
44322057|NCT00392327|79327077|FG000|Overall Study|Withdrawal by Subject|3|||
44322058|NCT00392327|79327078|FG001|Overall Study|Withdrawal by Subject|2|||
44322059|NCT00392327|79327079|FG002|Overall Study|Withdrawal by Subject|4|||
44322060|NCT00392327|79327080|FG003|Overall Study|Withdrawal by Subject|6|||
44322061|NCT00392327|79327081|FG004|Overall Study|Withdrawal by Subject|0|||
44322062|NCT00392327|79327082|FG005|Overall Study|Withdrawal by Subject|1|||
44322063|NCT00392327|79327083|FG006|Overall Study|Withdrawal by Subject|1|||
44322064|NCT00392327|79327084|FG007|Overall Study|Withdrawal by Subject|5|||
44322065|NCT00392327|79327077|FG000|Overall Study|Ineligible|0|||
44322066|NCT00392327|79327078|FG001|Overall Study|Ineligible|4|||
44322067|NCT00392327|79327079|FG002|Overall Study|Ineligible|3|||
44155803|NCT01945216|78947321|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
44155804|NCT01945216|78947321|FG000|Overall Study|Protocol Violation|42|||
44155805|NCT01945216|78947321|FG000|Overall Study|CRF not assured by investigators|5|||
44155806|NCT02641379|78947340|FG000|Overall Study|Exclusion criterion during screening|1|||
44155807|NCT02641379|78947341|FG001|Overall Study|Exclusion criterion during screening|0|||
44421838|NCT00789581|79429783|FG001|AC Therapy|Disease recurrence|1|||
44421839|NCT00789581|79429782|FG000|AC Therapy|Intercurrent Illness|1|||
44421840|NCT00789581|79429783|FG001|AC Therapy|Intercurrent Illness|0|||
44421841|NCT00789581|79429782|FG000|AC Therapy|Never Treated|1|||
44421842|NCT00789581|79429783|FG001|AC Therapy|Never Treated|4|||
44421843|NCT00789581|79429782|FG000|AC Therapy|Other|0|||
44421844|NCT00789581|79429783|FG001|AC Therapy|Other|2|||
44421845|NCT00789581|79429782|FG000|Adjuvant Therapy|Never treated|2|||
44421846|NCT00789581|79429783|FG001|Adjuvant Therapy|Never treated|2|||
44421847|NCT00789581|79429782|FG000|Adjuvant Therapy|Adverse Event|20|||
44421848|NCT00789581|79429783|FG001|Adjuvant Therapy|Adverse Event|44|||
44421849|NCT00789581|79429782|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
44421850|NCT00789581|79429783|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
44421851|NCT00789581|79429782|FG000|Adjuvant Therapy|Disease recurrence|2|||
44421852|NCT00789581|79429783|FG001|Adjuvant Therapy|Disease recurrence|1|||
44421853|NCT00789581|79429782|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
44421854|NCT00789581|79429783|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
44421855|NCT00789581|79429782|FG000|Adjuvant Therapy|Protocol Violation|1|||
44421856|NCT00789581|79429783|FG001|Adjuvant Therapy|Protocol Violation|1|||
44421857|NCT00789581|79429782|FG000|Adjuvant Therapy|Other|0|||
44421858|NCT00789581|79429783|FG001|Adjuvant Therapy|Other|1|||
44421859|NCT00717756|79429790|FG000|Overall Study|Withdrawal by Subject|1|||
44421860|NCT00717522|79429794|FG000|Overall Study|Disease Progression|5|||
44421861|NCT00717522|79429794|FG000|Overall Study|Adverse Event|1|||
44421862|NCT00717522|79429794|FG000|Overall Study|Death|1|||
44421863|NCT00791921|79429800|FG000|Overall Study|Protocol planed|24|||
44421864|NCT00791921|79429801|FG001|Overall Study|Protocol planed|88|||
44421865|NCT00791921|79429800|FG000|Overall Study|Withdrawal by Subject|1|||
44421866|NCT00791921|79429801|FG001|Overall Study|Withdrawal by Subject|2|||
44421867|NCT00791921|79429800|FG000|Overall Study|Adverse Event|8|||
44421868|NCT00791921|79429801|FG001|Overall Study|Adverse Event|2|||
44421869|NCT00791921|79429800|FG000|Overall Study|Lack of Efficacy|0|||
44421870|NCT00791921|79429801|FG001|Overall Study|Lack of Efficacy|2|||
44421871|NCT00791921|79429800|FG000|Overall Study|Lack of study drug administration|1|||
44421872|NCT00791921|79429801|FG001|Overall Study|Lack of study drug administration|1|||
44421873|NCT00791921|79429800|FG000|Overall Study|Reason other than those above|0|||
44421874|NCT00791921|79429801|FG001|Overall Study|Reason other than those above|1|||
44421875|NCT00582933|79429807|FG000|Overall Study|Physician Decision|3|||
44421876|NCT00791765|79429813|FG000|Weeks 1 to 12|Adverse Event|0|||
44421877|NCT00791765|79429814|FG001|Weeks 1 to 12|Adverse Event|1|||
44421878|NCT00791765|79429813|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
44536733|NCT03529773|79547234|FG000|Overall Study|Randomized but not vaccinated|0|||
44536734|NCT03529773|79547235|FG001|Overall Study|Randomized but not vaccinated|0|||
44536735|NCT03529773|79547236|FG002|Overall Study|Randomized but not vaccinated|0|||
44536736|NCT03529773|79547237|FG003|Overall Study|Randomized but not vaccinated|0|||
44536737|NCT03529773|79547238|FG004|Overall Study|Randomized but not vaccinated|0|||
44536738|NCT03529773|79547239|FG005|Overall Study|Randomized but not vaccinated|0|||
44536739|NCT03529773|79547240|FG006|Overall Study|Randomized but not vaccinated|0|||
44536740|NCT03529773|79547241|FG007|Overall Study|Randomized but not vaccinated|0|||
44536741|NCT03529773|79547242|FG008|Overall Study|Randomized but not vaccinated|0|||
44536742|NCT03529773|79547243|FG009|Overall Study|Randomized but not vaccinated|0|||
44536743|NCT03529773|79547244|FG010|Overall Study|Randomized but not vaccinated|0|||
44536744|NCT03529773|79547245|FG011|Overall Study|Randomized but not vaccinated|0|||
44536745|NCT03529773|79547246|FG012|Overall Study|Randomized but not vaccinated|0|||
44536746|NCT03529773|79547247|FG013|Overall Study|Randomized but not vaccinated|0|||
44536747|NCT03529773|79547248|FG014|Overall Study|Randomized but not vaccinated|0|||
44536748|NCT03529773|79547249|FG015|Overall Study|Randomized but not vaccinated|0|||
44536749|NCT03529773|79547250|FG016|Overall Study|Randomized but not vaccinated|0|||
44536750|NCT03529773|79547251|FG017|Overall Study|Randomized but not vaccinated|1|||
44536751|NCT03529773|79547252|FG018|Overall Study|Randomized but not vaccinated|0|||
44536752|NCT03529773|79547253|FG019|Overall Study|Randomized but not vaccinated|0|||
44536753|NCT03529773|79547254|FG020|Overall Study|Randomized but not vaccinated|0|||
44536754|NCT03529773|79547255|FG021|Overall Study|Randomized but not vaccinated|0|||
44536755|NCT03529773|79547256|FG022|Overall Study|Randomized but not vaccinated|0|||
44536756|NCT03529773|79547257|FG023|Overall Study|Randomized but not vaccinated|0|||
44536757|NCT03529773|79547258|FG024|Overall Study|Randomized but not vaccinated|0|||
44536758|NCT03529773|79547259|FG025|Overall Study|Randomized but not vaccinated|0|||
44421879|NCT00791765|79429814|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
44421880|NCT00791765|79429813|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
44421881|NCT00791765|79429814|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
44322068|NCT00392327|79327080|FG003|Overall Study|Ineligible|2|||
44322069|NCT00392327|79327081|FG004|Overall Study|Ineligible|0|||
44322070|NCT00392327|79327082|FG005|Overall Study|Ineligible|0|||
44421882|NCT00791765|79429813|FG000|Weeks 1 to 12|Physician Decision|1|||
44421883|NCT00791765|79429814|FG001|Weeks 1 to 12|Physician Decision|0|||
44421884|NCT00791765|79429813|FG000|Weeks 1 to 12|Disease progression|3|||
44421885|NCT00791765|79429814|FG001|Weeks 1 to 12|Disease progression|0|||
44421886|NCT00791765|79429813|FG000|Weeks 1 to 12|Ineligibility determined|0|||
44421887|NCT00791765|79429814|FG001|Weeks 1 to 12|Ineligibility determined|3|||
44421888|NCT00791765|79429813|FG000|Weeks 13 to 24|Protocol deviation|2|||
44421889|NCT00791765|79429814|FG001|Weeks 13 to 24|Protocol deviation|0|||
44421890|NCT00791765|79429813|FG000|Weeks 13 to 24|Adverse Event|0|||
44421891|NCT00791765|79429814|FG001|Weeks 13 to 24|Adverse Event|3|||
44421892|NCT00791765|79429813|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
44421893|NCT00791765|79429814|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
44421894|NCT00791765|79429813|FG000|Weeks 13 to 24|Disease progression|0|||
44421895|NCT00791765|79429814|FG001|Weeks 13 to 24|Disease progression|1|||
44155808|NCT02641379|78947342|FG002|Overall Study|Exclusion criterion during screening|0|||
44421896|NCT00791765|79429813|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
44536759|NCT03529773|79547260|FG026|Overall Study|Randomized but not vaccinated|0|||
44536760|NCT03529773|79547261|FG027|Overall Study|Randomized but not vaccinated|1|||
44536761|NCT03529773|79547262|FG028|Overall Study|Randomized but not vaccinated|0|||
44536762|NCT03529773|79547263|FG029|Overall Study|Randomized but not vaccinated|0|||
44536763|NCT03529773|79547264|FG030|Overall Study|Randomized but not vaccinated|0|||
44536764|NCT03529773|79547265|FG031|Overall Study|Randomized but not vaccinated|0|||
44536765|NCT03529773|79547266|FG032|Overall Study|Randomized but not vaccinated|0|||
44536766|NCT03529773|79547267|FG033|Overall Study|Randomized but not vaccinated|0|||
44536767|NCT03529773|79547268|FG034|Overall Study|Randomized but not vaccinated|0|||
44536768|NCT03529773|79547269|FG035|Overall Study|Randomized but not vaccinated|0|||
44536769|NCT03529773|79547270|FG036|Overall Study|Randomized but not vaccinated|0|||
44536770|NCT03529773|79547271|FG037|Overall Study|Randomized but not vaccinated|0|||
44536771|NCT03529773|79547272|FG038|Overall Study|Randomized but not vaccinated|0|||
44536772|NCT03529773|79547273|FG039|Overall Study|Randomized but not vaccinated|0|||
44421897|NCT00791765|79429814|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
44421898|NCT00791765|79429813|FG000|Weeks 13 to 24|Other|0|||
44421899|NCT00791765|79429814|FG001|Weeks 13 to 24|Other|1|||
44421900|NCT00789191|79429822|FG000|Overall Study|Adverse Event|2|||
44421901|NCT00789191|79429823|FG001|Overall Study|Adverse Event|4|||
44421902|NCT00789191|79429822|FG000|Overall Study|Lack of Efficacy|0|||
44421903|NCT00789191|79429823|FG001|Overall Study|Lack of Efficacy|5|||
44421904|NCT00789191|79429822|FG000|Overall Study|Protocol Violation|5|||
44421905|NCT00789191|79429823|FG001|Overall Study|Protocol Violation|3|||
44421906|NCT00789191|79429822|FG000|Overall Study|Withdrawal Criteria|2|||
44421907|NCT00789191|79429823|FG001|Overall Study|Withdrawal Criteria|4|||
44421908|NCT00789191|79429822|FG000|Overall Study|Unclassified|5|||
44421909|NCT00789191|79429823|FG001|Overall Study|Unclassified|3|||
44421910|NCT00789035|79429834|FG000|Overall Study|Adverse Event|0|||
44421911|NCT00789035|79429835|FG001|Overall Study|Adverse Event|2|||
44421912|NCT00789035|79429836|FG002|Overall Study|Adverse Event|0|||
44421913|NCT00789035|79429837|FG003|Overall Study|Adverse Event|1|||
44421914|NCT00789035|79429838|FG004|Overall Study|Adverse Event|3|||
44421915|NCT00789035|79429834|FG000|Overall Study|Lack of Efficacy|3|||
44421916|NCT00789035|79429835|FG001|Overall Study|Lack of Efficacy|0|||
44421917|NCT00789035|79429836|FG002|Overall Study|Lack of Efficacy|0|||
44421918|NCT00789035|79429837|FG003|Overall Study|Lack of Efficacy|0|||
44421919|NCT00789035|79429838|FG004|Overall Study|Lack of Efficacy|2|||
44421920|NCT00789035|79429834|FG000|Overall Study|Protocol Violation|1|||
44421921|NCT00789035|79429835|FG001|Overall Study|Protocol Violation|0|||
44421922|NCT00789035|79429836|FG002|Overall Study|Protocol Violation|0|||
44421923|NCT00789035|79429837|FG003|Overall Study|Protocol Violation|0|||
44421924|NCT00789035|79429838|FG004|Overall Study|Protocol Violation|0|||
44421925|NCT00789035|79429834|FG000|Overall Study|Withdrawal by Subject|0|||
44421926|NCT00789035|79429835|FG001|Overall Study|Withdrawal by Subject|2|||
44421927|NCT00789035|79429836|FG002|Overall Study|Withdrawal by Subject|0|||
44421928|NCT00789035|79429837|FG003|Overall Study|Withdrawal by Subject|0|||
44421929|NCT00789035|79429838|FG004|Overall Study|Withdrawal by Subject|0|||
44421930|NCT00789035|79429834|FG000|Overall Study|Other reason not defined above|2|||
44421931|NCT00789035|79429835|FG001|Overall Study|Other reason not defined above|3|||
44421932|NCT00789035|79429836|FG002|Overall Study|Other reason not defined above|1|||
44536773|NCT03799211|79547378|FG000|Overall Study|Lost to Follow-up|2|||
44536774|NCT03799211|79547379|FG001|Overall Study|Lost to Follow-up|13|||
44536775|NCT03799211|79547378|FG000|Overall Study|Withdrawal by Subject|2|||
44322071|NCT00392327|79327083|FG006|Overall Study|Ineligible|0|||
44421933|NCT00789035|79429837|FG003|Overall Study|Other reason not defined above|0|||
44421934|NCT00789035|79429838|FG004|Overall Study|Other reason not defined above|1|||
44421935|NCT03326193|79429862|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
44421936|NCT03326193|79429862|FG000|Overall Study|Death|19|||
44322072|NCT00392327|79327084|FG007|Overall Study|Ineligible|0|||
44322073|NCT00352534|79327104|FG000|Initial Staging|Ineligible|8|||
44322074|NCT00352534|79327105|FG001|Initial Staging|Ineligible|9|||
44322075|NCT00352534|79327106|FG002|Initial Staging|Ineligible|0|||
44322076|NCT00352534|79327107|FG003|Initial Staging|Ineligible|0|||
44322077|NCT00352534|79327108|FG004|Initial Staging|Ineligible|0|||
44322078|NCT00352534|79327109|FG005|Initial Staging|Ineligible|0|||
44421937|NCT03326193|79429862|FG000|Overall Study|Withdrawal by Subject|8|||
44421938|NCT00437203|79429885|FG000|Overall Study|Death|0|||
44421939|NCT00437203|79429886|FG001|Overall Study|Death|0|||
44421940|NCT00437203|79429887|FG002|Overall Study|Death|1|||
44421941|NCT00437203|79429888|FG003|Overall Study|Death|0|||
44421942|NCT00437203|79429889|FG004|Overall Study|Death|0|||
44421943|NCT00437203|79429890|FG005|Overall Study|Death|0|||
44421944|NCT00437203|79429891|FG006|Overall Study|Death|0|||
44421945|NCT00437203|79429892|FG007|Overall Study|Death|1|||
44421946|NCT00437203|79429893|FG008|Overall Study|Death|0|||
44421947|NCT00437203|79429894|FG009|Overall Study|Death|1|||
44258071|NCT01405820|79112184|FG002|Open-Label Treatment Period|Physician Decision|1|||
44258072|NCT01405820|79112185|FG003|Open-Label Treatment Period|Physician Decision|2|||
44258073|NCT01405820|79112186|FG004|Open-Label Treatment Period|Physician Decision|1|||
44258074|NCT01405820|79112187|FG005|Open-Label Treatment Period|Physician Decision|0|||
44258075|NCT01405820|79112182|FG000|Open-Label Treatment Period|Adverse Event|0|||
44258076|NCT01405820|79112183|FG001|Open-Label Treatment Period|Adverse Event|0|||
44258077|NCT01405820|79112184|FG002|Open-Label Treatment Period|Adverse Event|0|||
44258078|NCT01405820|79112185|FG003|Open-Label Treatment Period|Adverse Event|1|||
44258079|NCT01405820|79112186|FG004|Open-Label Treatment Period|Adverse Event|0|||
44322079|NCT00352534|79327110|FG006|Initial Staging|Ineligible|0|||
44322080|NCT00352534|79327104|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
44322081|NCT00352534|79327105|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
44322082|NCT00352534|79327106|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
44322083|NCT00352534|79327107|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
44322084|NCT00352534|79327108|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
44322085|NCT00352534|79327109|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
44322086|NCT00352534|79327110|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
44322087|NCT00352534|79327104|FG000|Final Risk Group Assignment|Physician Decision|0|||
44322088|NCT00352534|79327105|FG001|Final Risk Group Assignment|Physician Decision|0|||
44322089|NCT00352534|79327106|FG002|Final Risk Group Assignment|Physician Decision|0|||
44322090|NCT00352534|79327107|FG003|Final Risk Group Assignment|Physician Decision|0|||
44322091|NCT00352534|79327108|FG004|Final Risk Group Assignment|Physician Decision|0|||
44322092|NCT00352534|79327109|FG005|Final Risk Group Assignment|Physician Decision|8|||
44322093|NCT00352534|79327110|FG006|Final Risk Group Assignment|Physician Decision|0|||
44322094|NCT00352534|79327104|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
44322095|NCT00352534|79327105|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
44322096|NCT00352534|79327106|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
44322097|NCT00352534|79327107|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
44322098|NCT00352534|79327108|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
44322099|NCT00352534|79327109|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
44322100|NCT00352534|79327110|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
44322101|NCT00352534|79327104|FG000|Final Risk Group Assignment|Ineligible|0|||
44421948|NCT00437203|79429885|FG000|Overall Study|Adverse Event|1|||
44421949|NCT00437203|79429886|FG001|Overall Study|Adverse Event|1|||
44421950|NCT00437203|79429887|FG002|Overall Study|Adverse Event|0|||
44421951|NCT00437203|79429888|FG003|Overall Study|Adverse Event|0|||
44322102|NCT00352534|79327105|FG001|Final Risk Group Assignment|Ineligible|0|||
44322103|NCT00352534|79327106|FG002|Final Risk Group Assignment|Ineligible|3|||
44322104|NCT00352534|79327107|FG003|Final Risk Group Assignment|Ineligible|1|||
44322105|NCT00352534|79327108|FG004|Final Risk Group Assignment|Ineligible|0|||
44322106|NCT00352534|79327109|FG005|Final Risk Group Assignment|Ineligible|13|||
44322107|NCT00352534|79327110|FG006|Final Risk Group Assignment|Ineligible|0|||
44322108|NCT00352534|79327104|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
44322109|NCT00352534|79327105|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
44322110|NCT00352534|79327106|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
44322111|NCT00352534|79327107|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
44322112|NCT00352534|79327108|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
44322113|NCT00352534|79327109|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
44322114|NCT00352534|79327110|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
44322115|NCT00352534|79327104|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
44322116|NCT00352534|79327105|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
44322117|NCT00352534|79327106|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
44322118|NCT00352534|79327107|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
44322119|NCT00352534|79327108|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
44322120|NCT00352534|79327109|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
44322121|NCT00352534|79327110|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
44322122|NCT00352534|79327104|FG000|Final Risk Group Assignment|Death|0|||
44322123|NCT00352534|79327105|FG001|Final Risk Group Assignment|Death|0|||
44322124|NCT00352534|79327106|FG002|Final Risk Group Assignment|Death|0|||
44322125|NCT00352534|79327107|FG003|Final Risk Group Assignment|Death|0|||
44322126|NCT00352534|79327108|FG004|Final Risk Group Assignment|Death|0|||
44322127|NCT00352534|79327109|FG005|Final Risk Group Assignment|Death|2|||
44322128|NCT00352534|79327110|FG006|Final Risk Group Assignment|Death|0|||
44322129|NCT01217047|79327124|FG000|Overall Study|Lost to Follow-up|0|||
44322130|NCT01217047|79327125|FG001|Overall Study|Lost to Follow-up|1|||
44322131|NCT01217047|79327126|FG002|Overall Study|Lost to Follow-up|0|||
44322132|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
44322133|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44322134|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44322135|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44322136|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
44322137|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44322138|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44322139|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44322140|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
44322141|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44322142|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44258080|NCT01405820|79112187|FG005|Open-Label Treatment Period|Adverse Event|0|||
44258081|NCT01405742|79112216|FG000|Overall Study|Lost to Follow-up|1|||
44258082|NCT01405742|79112217|FG001|Overall Study|Lost to Follow-up|0|||
44258083|NCT01425632|79112246|FG000|Overall Study|Adverse Event|0|||
44258084|NCT01425632|79112247|FG001|Overall Study|Adverse Event|1|||
44258085|NCT01425632|79112248|FG002|Overall Study|Adverse Event|1|||
44258086|NCT01425632|79112246|FG000|Overall Study|Physician Decision|1|||
44258087|NCT01425632|79112247|FG001|Overall Study|Physician Decision|0|||
44322143|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44322144|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
44322145|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44322146|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44322147|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44322148|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
44322149|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44322150|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44322151|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44322152|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
44322153|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44322154|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44322155|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44322156|NCT01185340|79327138|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
44322157|NCT01185340|79327139|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44322158|NCT01185340|79327140|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44322159|NCT01185340|79327141|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44322160|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
44322161|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
44322162|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
44322163|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
44322164|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
44322165|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
44322166|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
44322167|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
44322168|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
44322169|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
44322170|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
44322171|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
44322172|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44322173|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
44421952|NCT00437203|79429889|FG004|Overall Study|Adverse Event|0|||
44421953|NCT00437203|79429890|FG005|Overall Study|Adverse Event|0|||
44421954|NCT00437203|79429891|FG006|Overall Study|Adverse Event|0|||
44421955|NCT00437203|79429892|FG007|Overall Study|Adverse Event|1|||
44421956|NCT00437203|79429893|FG008|Overall Study|Adverse Event|0|||
44421957|NCT00437203|79429894|FG009|Overall Study|Adverse Event|1|||
44536776|NCT03799211|79547379|FG001|Overall Study|Withdrawal by Subject|0|||
44155809|NCT02641379|78947343|FG003|Overall Study|Exclusion criterion during screening|1|||
44155810|NCT02641379|78947344|FG004|Overall Study|Exclusion criterion during screening|2|||
44155811|NCT02641379|78947345|FG005|Overall Study|Exclusion criterion during screening|0|||
44536777|NCT03349710|79547391|FG000|Treatment Period|Death|0|||
44536778|NCT03349710|79547392|FG001|Treatment Period|Death|0|||
44536779|NCT03349710|79547393|FG002|Treatment Period|Death|1|||
44536780|NCT03349710|79547394|FG003|Treatment Period|Death|0|||
44536781|NCT03349710|79547391|FG000|Treatment Period|Disease Progression|0|||
44536782|NCT03349710|79547392|FG001|Treatment Period|Disease Progression|2|||
44536783|NCT03349710|79547393|FG002|Treatment Period|Disease Progression|0|||
44322174|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44322175|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
44322176|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
44536784|NCT03349710|79547394|FG003|Treatment Period|Disease Progression|1|||
44536785|NCT03349710|79547391|FG000|Treatment Period|Study Drug Toxicity|1|||
44155812|NCT02641379|78947346|FG006|Overall Study|Exclusion criterion during screening|0|||
44421958|NCT00437203|79429885|FG000|Overall Study|Study terminated by sponsor|0|||
44536786|NCT03349710|79547392|FG001|Treatment Period|Study Drug Toxicity|0|||
44536787|NCT03349710|79547393|FG002|Treatment Period|Study Drug Toxicity|1|||
44322177|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
44322178|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
44322179|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
44322180|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
44322181|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
44322182|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
44322183|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
44322184|NCT01185340|79327138|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
44322185|NCT01185340|79327139|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
44322186|NCT01185340|79327140|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
44322187|NCT01185340|79327141|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
44322188|NCT01216189|79327155|FG000|Overall Study|Lost to Follow-up|21|||
44322189|NCT01216189|79327156|FG001|Overall Study|Lost to Follow-up|3|||
44322190|NCT01216189|79327155|FG000|Overall Study|Death|4|||
44322191|NCT01216189|79327156|FG001|Overall Study|Death|2|||
44322192|NCT01185301|79327166|FG000|Overall Study|Adverse Event|3|||
44322193|NCT01185301|79327167|FG001|Overall Study|Adverse Event|0|||
44322194|NCT01185301|79327168|FG002|Overall Study|Adverse Event|2|||
44322195|NCT01185301|79327169|FG003|Overall Study|Adverse Event|3|||
44322196|NCT01185301|79327166|FG000|Overall Study|Withdrawal by Subject|7|||
44322197|NCT01185301|79327167|FG001|Overall Study|Withdrawal by Subject|5|||
44322198|NCT01185301|79327168|FG002|Overall Study|Withdrawal by Subject|2|||
44322199|NCT01185301|79327169|FG003|Overall Study|Withdrawal by Subject|3|||
44322200|NCT01185301|79327166|FG000|Overall Study|Lost to Follow-up|2|||
44322201|NCT01185301|79327167|FG001|Overall Study|Lost to Follow-up|0|||
44322202|NCT01185301|79327168|FG002|Overall Study|Lost to Follow-up|0|||
44322203|NCT01185301|79327169|FG003|Overall Study|Lost to Follow-up|1|||
44322204|NCT01185301|79327166|FG000|Overall Study|Other Reason|3|||
44322205|NCT01185301|79327167|FG001|Overall Study|Other Reason|2|||
44322206|NCT01185301|79327168|FG002|Overall Study|Other Reason|2|||
44322207|NCT01185301|79327169|FG003|Overall Study|Other Reason|2|||
44322208|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
44322209|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
44322210|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
44322211|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
44322212|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
44322213|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
44322214|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
44322215|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
44322216|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
44322217|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
44322218|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
44322219|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
44322220|NCT01216072|79327181|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
44322221|NCT01216072|79327182|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
44322222|NCT01216072|79327181|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
44322223|NCT01216072|79327182|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
44322224|NCT01216072|79327181|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
44322225|NCT01216072|79327182|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
44322226|NCT01216072|79327181|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
44322227|NCT01216072|79327182|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
44322228|NCT01184989|79327191|FG000|Overall Study|Adverse Event|11|||
44322229|NCT01184989|79327191|FG000|Overall Study|Withdrawal by Subject|1|||
44322230|NCT01215955|79327199|FG000|Overall Study|Adverse Event|1|||
44322231|NCT01215955|79327200|FG001|Overall Study|Adverse Event|4|||
44322232|NCT01215955|79327201|FG002|Overall Study|Adverse Event|2|||
44322233|NCT01215955|79327202|FG003|Overall Study|Adverse Event|3|||
44322234|NCT01215955|79327199|FG000|Overall Study|Death|2|||
44322235|NCT01215955|79327200|FG001|Overall Study|Death|0|||
44322236|NCT01215955|79327201|FG002|Overall Study|Death|1|||
44536788|NCT03349710|79547394|FG003|Treatment Period|Study Drug Toxicity|1|||
44536789|NCT03349710|79547391|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
44536790|NCT03349710|79547392|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
44536791|NCT03349710|79547393|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
44536792|NCT03349710|79547394|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
44536793|NCT03349710|79547391|FG000|Treatment Period|admin reason by sponsor|0|||
44322237|NCT01215955|79327202|FG003|Overall Study|Death|3|||
44322238|NCT01215955|79327199|FG000|Overall Study|Entry Criteria Not Met|1|||
44322239|NCT01215955|79327200|FG001|Overall Study|Entry Criteria Not Met|3|||
44322240|NCT01215955|79327201|FG002|Overall Study|Entry Criteria Not Met|4|||
44322241|NCT01215955|79327202|FG003|Overall Study|Entry Criteria Not Met|7|||
44322242|NCT01215955|79327199|FG000|Overall Study|Lack of Efficacy|1|||
44322243|NCT01215955|79327200|FG001|Overall Study|Lack of Efficacy|2|||
44322244|NCT01215955|79327201|FG002|Overall Study|Lack of Efficacy|1|||
44322245|NCT01215955|79327202|FG003|Overall Study|Lack of Efficacy|0|||
44322246|NCT01215955|79327199|FG000|Overall Study|Lost to Follow-up|4|||
44322247|NCT01215955|79327200|FG001|Overall Study|Lost to Follow-up|4|||
44322248|NCT01215955|79327201|FG002|Overall Study|Lost to Follow-up|8|||
44322249|NCT01215955|79327202|FG003|Overall Study|Lost to Follow-up|9|||
44322250|NCT01215955|79327199|FG000|Overall Study|Physician Decision|4|||
44322251|NCT01215955|79327200|FG001|Overall Study|Physician Decision|10|||
44322252|NCT01215955|79327201|FG002|Overall Study|Physician Decision|8|||
44322253|NCT01215955|79327202|FG003|Overall Study|Physician Decision|11|||
44322254|NCT01215955|79327199|FG000|Overall Study|Protocol Violation|17|||
44322255|NCT01215955|79327200|FG001|Overall Study|Protocol Violation|13|||
44322256|NCT01215955|79327201|FG002|Overall Study|Protocol Violation|8|||
44322257|NCT01215955|79327202|FG003|Overall Study|Protocol Violation|8|||
44322258|NCT01215955|79327199|FG000|Overall Study|Sponsor Decision|1|||
44322259|NCT01215955|79327200|FG001|Overall Study|Sponsor Decision|2|||
44322260|NCT01215955|79327201|FG002|Overall Study|Sponsor Decision|0|||
44322261|NCT01215955|79327202|FG003|Overall Study|Sponsor Decision|1|||
44322262|NCT01215955|79327199|FG000|Overall Study|Withdrawal by Subject|14|||
44322263|NCT01215955|79327200|FG001|Overall Study|Withdrawal by Subject|15|||
44322264|NCT01215955|79327201|FG002|Overall Study|Withdrawal by Subject|13|||
44322265|NCT01215955|79327202|FG003|Overall Study|Withdrawal by Subject|9|||
44322266|NCT01215955|79327199|FG000|Overall Study|Quality Issues|0|||
44322267|NCT01215955|79327200|FG001|Overall Study|Quality Issues|0|||
44322268|NCT01215955|79327201|FG002|Overall Study|Quality Issues|3|||
44322269|NCT01215955|79327202|FG003|Overall Study|Quality Issues|2|||
44322270|NCT04676763|79327231|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
44322271|NCT04676763|79327232|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
44322272|NCT04676763|79327233|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
44322273|NCT04676763|79327231|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
44322274|NCT04676763|79327232|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
44322275|NCT04676763|79327233|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
44421959|NCT00437203|79429886|FG001|Overall Study|Study terminated by sponsor|0|||
44421960|NCT00437203|79429887|FG002|Overall Study|Study terminated by sponsor|0|||
44421961|NCT00437203|79429888|FG003|Overall Study|Study terminated by sponsor|0|||
44421962|NCT00437203|79429889|FG004|Overall Study|Study terminated by sponsor|0|||
44421963|NCT00437203|79429890|FG005|Overall Study|Study terminated by sponsor|0|||
44421964|NCT00437203|79429891|FG006|Overall Study|Study terminated by sponsor|0|||
44421965|NCT00437203|79429892|FG007|Overall Study|Study terminated by sponsor|0|||
44421966|NCT00437203|79429893|FG008|Overall Study|Study terminated by sponsor|1|||
44421967|NCT00437203|79429894|FG009|Overall Study|Study terminated by sponsor|0|||
44421968|NCT00437203|79429885|FG000|Overall Study|Objective progression or relapse|5|||
44421969|NCT00437203|79429886|FG001|Overall Study|Objective progression or relapse|6|||
44421970|NCT00437203|79429887|FG002|Overall Study|Objective progression or relapse|2|||
44421971|NCT00437203|79429888|FG003|Overall Study|Objective progression or relapse|3|||
44421972|NCT00437203|79429889|FG004|Overall Study|Objective progression or relapse|3|||
44421973|NCT00437203|79429890|FG005|Overall Study|Objective progression or relapse|3|||
44421974|NCT00437203|79429891|FG006|Overall Study|Objective progression or relapse|6|||
44421975|NCT00437203|79429892|FG007|Overall Study|Objective progression or relapse|1|||
44421976|NCT00437203|79429893|FG008|Overall Study|Objective progression or relapse|2|||
44421977|NCT00437203|79429894|FG009|Overall Study|Objective progression or relapse|2|||
44421978|NCT00437203|79429885|FG000|Overall Study|Other|0|||
44421979|NCT00437203|79429886|FG001|Overall Study|Other|1|||
44421980|NCT00437203|79429887|FG002|Overall Study|Other|0|||
44421981|NCT00437203|79429888|FG003|Overall Study|Other|0|||
44322276|NCT04676763|79327231|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
44322277|NCT04676763|79327232|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
44322278|NCT04676763|79327233|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
44322279|NCT01215916|79327248|FG000|Overall Study|Progressive Disease|0|||
44322280|NCT01215916|79327249|FG001|Overall Study|Progressive Disease|2|||
44322281|NCT01215916|79327250|FG002|Overall Study|Progressive Disease|1|||
44322282|NCT01215916|79327251|FG003|Overall Study|Progressive Disease|2|||
44322283|NCT01215916|79327252|FG004|Overall Study|Progressive Disease|5|||
44322284|NCT01215916|79327253|FG005|Overall Study|Progressive Disease|4|||
44322285|NCT01215916|79327254|FG006|Overall Study|Progressive Disease|5|||
44421982|NCT00437203|79429889|FG004|Overall Study|Other|0|||
44421983|NCT00437203|79429890|FG005|Overall Study|Other|0|||
44421984|NCT00437203|79429891|FG006|Overall Study|Other|1|||
44322286|NCT01215916|79327255|FG007|Overall Study|Progressive Disease|3|||
44322287|NCT01215916|79327256|FG008|Overall Study|Progressive Disease|1|||
44322288|NCT01215916|79327248|FG000|Overall Study|Adverse Event|1|||
44421985|NCT00437203|79429892|FG007|Overall Study|Other|0|||
44421986|NCT00437203|79429893|FG008|Overall Study|Other|0|||
44421987|NCT00437203|79429894|FG009|Overall Study|Other|0|||
44322289|NCT01215916|79327249|FG001|Overall Study|Adverse Event|1|||
44322290|NCT01215916|79327250|FG002|Overall Study|Adverse Event|0|||
44322291|NCT01215916|79327251|FG003|Overall Study|Adverse Event|1|||
44322292|NCT01215916|79327252|FG004|Overall Study|Adverse Event|0|||
44322293|NCT01215916|79327253|FG005|Overall Study|Adverse Event|0|||
44322294|NCT01215916|79327254|FG006|Overall Study|Adverse Event|3|||
44322295|NCT01215916|79327255|FG007|Overall Study|Adverse Event|0|||
44322296|NCT01215916|79327256|FG008|Overall Study|Adverse Event|0|||
44322297|NCT01215916|79327248|FG000|Overall Study|Withdrawal by Subject|0|||
44322298|NCT01215916|79327249|FG001|Overall Study|Withdrawal by Subject|1|||
44322299|NCT01215916|79327250|FG002|Overall Study|Withdrawal by Subject|1|||
44322300|NCT01215916|79327251|FG003|Overall Study|Withdrawal by Subject|2|||
44322301|NCT01215916|79327252|FG004|Overall Study|Withdrawal by Subject|0|||
44155813|NCT02641379|78947347|FG007|Overall Study|Exclusion criterion during screening|0|||
44322302|NCT01215916|79327253|FG005|Overall Study|Withdrawal by Subject|0|||
44322303|NCT01215916|79327254|FG006|Overall Study|Withdrawal by Subject|1|||
44322304|NCT01215916|79327255|FG007|Overall Study|Withdrawal by Subject|0|||
44322305|NCT01215916|79327256|FG008|Overall Study|Withdrawal by Subject|0|||
44322306|NCT01215916|79327248|FG000|Overall Study|Death|0|||
44322307|NCT01215916|79327249|FG001|Overall Study|Death|1|||
44322308|NCT01215916|79327250|FG002|Overall Study|Death|0|||
44322309|NCT01215916|79327251|FG003|Overall Study|Death|0|||
44322310|NCT01215916|79327252|FG004|Overall Study|Death|1|||
44322311|NCT01215916|79327253|FG005|Overall Study|Death|0|||
44322312|NCT01215916|79327254|FG006|Overall Study|Death|0|||
44322313|NCT01215916|79327255|FG007|Overall Study|Death|0|||
44322314|NCT01215916|79327256|FG008|Overall Study|Death|1|||
44322315|NCT01215916|79327248|FG000|Overall Study|Physician Decision|0|||
44322316|NCT01215916|79327249|FG001|Overall Study|Physician Decision|0|||
44322317|NCT01215916|79327250|FG002|Overall Study|Physician Decision|1|||
44322318|NCT01215916|79327251|FG003|Overall Study|Physician Decision|1|||
44322319|NCT01215916|79327252|FG004|Overall Study|Physician Decision|0|||
44322320|NCT01215916|79327253|FG005|Overall Study|Physician Decision|0|||
44322321|NCT01215916|79327254|FG006|Overall Study|Physician Decision|0|||
44322322|NCT01215916|79327255|FG007|Overall Study|Physician Decision|0|||
44322323|NCT01215916|79327256|FG008|Overall Study|Physician Decision|0|||
44322324|NCT01184872|79327282|FG000|Overall Study|Adverse Event|3|||
44322325|NCT01184872|79327283|FG001|Overall Study|Adverse Event|4|||
44322326|NCT01184872|79327282|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
44322327|NCT01184872|79327283|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44322328|NCT01184872|79327282|FG000|Overall Study|Withdrawal by Subject|2|||
44322329|NCT01184872|79327283|FG001|Overall Study|Withdrawal by Subject|0|||
44322330|NCT01184872|79327282|FG000|Overall Study|Lost to Follow-up|0|||
44322331|NCT01184872|79327283|FG001|Overall Study|Lost to Follow-up|1|||
44322332|NCT01184872|79327282|FG000|Overall Study|Administrative problems|1|||
44322333|NCT01184872|79327283|FG001|Overall Study|Administrative problems|1|||
44322334|NCT01184872|79327282|FG000|Overall Study|Protocol deviation|1|||
44322335|NCT01184872|79327283|FG001|Overall Study|Protocol deviation|0|||
44421988|NCT00753272|79429927|FG000|Overall Study|Adverse Event|878|||
44421989|NCT00753272|79429928|FG001|Overall Study|Adverse Event|869|||
44421990|NCT00753272|79429927|FG000|Overall Study|Protocol Violation|28|||
44421991|NCT00753272|79429928|FG001|Overall Study|Protocol Violation|46|||
44536794|NCT03349710|79547392|FG001|Treatment Period|admin reason by sponsor|7|||
44536795|NCT03349710|79547393|FG002|Treatment Period|admin reason by sponsor|0|||
44536796|NCT03349710|79547394|FG003|Treatment Period|admin reason by sponsor|19|||
44536797|NCT03349710|79547391|FG000|Treatment Period|Other Reason|2|||
44536798|NCT03349710|79547392|FG001|Treatment Period|Other Reason|0|||
44536799|NCT03349710|79547393|FG002|Treatment Period|Other Reason|2|||
44155814|NCT02641379|78947348|FG008|Overall Study|Exclusion criterion during screening|0|||
44322336|NCT01215721|79327289|FG000|Overall Study|Adverse Event|2|||
44322337|NCT01184326|79327296|FG000|Overall Study|Adverse Event|1|||
44322338|NCT01184326|79327297|FG001|Overall Study|Adverse Event|2|||
44322339|NCT01184326|79327298|FG002|Overall Study|Adverse Event|0|||
44322340|NCT01184326|79327296|FG000|Overall Study|Death|0|||
44155815|NCT02641379|78947349|FG009|Overall Study|Exclusion criterion during screening|0|||
44322341|NCT01184326|79327297|FG001|Overall Study|Death|0|||
44322342|NCT01184326|79327298|FG002|Overall Study|Death|1|||
44322343|NCT01184326|79327296|FG000|Overall Study|Withdrawal by Subject|0|||
44322344|NCT01184326|79327297|FG001|Overall Study|Withdrawal by Subject|0|||
44322345|NCT01184326|79327298|FG002|Overall Study|Withdrawal by Subject|1|||
44322346|NCT01184326|79327296|FG000|Overall Study|Physician Decision|1|||
44322347|NCT01184326|79327297|FG001|Overall Study|Physician Decision|1|||
44322348|NCT01184326|79327298|FG002|Overall Study|Physician Decision|0|||
44536800|NCT03349710|79547394|FG003|Treatment Period|Other Reason|1|||
44421992|NCT00753272|79429927|FG000|Overall Study|Withdrawal by Subject|2481|||
44322349|NCT01184326|79327296|FG000|Overall Study|Disease Progression|1|||
44322350|NCT01184326|79327297|FG001|Overall Study|Disease Progression|3|||
44322351|NCT01184326|79327298|FG002|Overall Study|Disease Progression|12|||
44322352|NCT01215253|79327311|FG000|Overall Study|Withdrawal by Subject|57|||
44322353|NCT01215253|79327312|FG001|Overall Study|Withdrawal by Subject|35|||
44322354|NCT01215253|79327311|FG000|Overall Study|Physician Decision|9|||
44322355|NCT01215253|79327312|FG001|Overall Study|Physician Decision|12|||
44322356|NCT01215253|79327311|FG000|Overall Study|Lost to Follow-up|6|||
44322357|NCT01215253|79327312|FG001|Overall Study|Lost to Follow-up|4|||
44322358|NCT01215253|79327311|FG000|Overall Study|Other|14|||
44322359|NCT01215253|79327312|FG001|Overall Study|Other|12|||
44322360|NCT01184053|79327319|FG000|Overall Study|progression while on treatment|3|||
44322361|NCT01183975|79327324|FG000|Overall Study|Lost to Follow-up|73|||
44322362|NCT01183858|79327330|FG000|Overall Study|Death not related to Progressive Disease|5|||
44322363|NCT01183858|79327331|FG001|Overall Study|Death not related to Progressive Disease|6|||
44322364|NCT01183858|79327330|FG000|Overall Study|Adverse Event|14|||
44322365|NCT01183858|79327331|FG001|Overall Study|Adverse Event|11|||
44322366|NCT01183858|79327330|FG000|Overall Study|Investigator's Decision|0|||
44322367|NCT01183858|79327331|FG001|Overall Study|Investigator's Decision|3|||
44322368|NCT01183858|79327330|FG000|Overall Study|Insufficient Therapeutic Response|2|||
44322369|NCT01183858|79327331|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44322370|NCT01183858|79327330|FG000|Overall Study|Refused Treatment|1|||
44322371|NCT01183858|79327331|FG001|Overall Study|Refused Treatment|4|||
44322372|NCT01183858|79327330|FG000|Overall Study|Withdrew Consent|4|||
44322373|NCT01183858|79327331|FG001|Overall Study|Withdrew Consent|4|||
44322374|NCT01183858|79327330|FG000|Overall Study|Discontinued Smoking|3|||
44322375|NCT01183858|79327331|FG001|Overall Study|Discontinued Smoking|1|||
44322376|NCT01183858|79327330|FG000|Overall Study|Protocol Violation|1|||
44322377|NCT01183858|79327331|FG001|Overall Study|Protocol Violation|0|||
44322378|NCT01183858|79327330|FG000|Overall Study|Administrative/Other|6|||
44322379|NCT01183858|79327331|FG001|Overall Study|Administrative/Other|6|||
44322380|NCT01183858|79327330|FG000|Overall Study|Progressive Disease|112|||
44322381|NCT01183858|79327331|FG001|Overall Study|Progressive Disease|115|||
44322382|NCT01183858|79327330|FG000|Overall Study|Death related to Progressive Disease|4|||
44421993|NCT00753272|79429928|FG001|Overall Study|Withdrawal by Subject|2407|||
44421994|NCT00753272|79429927|FG000|Overall Study|Lost to Follow-up|491|||
44421995|NCT00753272|79429928|FG001|Overall Study|Lost to Follow-up|497|||
44421996|NCT00753272|79429927|FG000|Overall Study|Other|1104|||
44421997|NCT00753272|79429928|FG001|Overall Study|Other|1088|||
44421998|NCT00437125|79429937|FG000|Overall Study|Adverse Event|12|||
44421999|NCT00437125|79429937|FG000|Overall Study|Death|1|||
44422000|NCT00437125|79429937|FG000|Overall Study|Clinical Relapse|1|||
44422001|NCT00437125|79429937|FG000|Overall Study|Lack of Efficacy|1|||
44422002|NCT00437125|79429937|FG000|Overall Study|Lost to Follow-up|1|||
44422003|NCT00437125|79429937|FG000|Overall Study|Withdrawal by Subject|13|||
44422004|NCT00437125|79429937|FG000|Overall Study|Withdrawal by Caregiver|2|||
44422005|NCT00437125|79429937|FG000|Overall Study|Physician Decision|1|||
44422006|NCT00582309|79429953|FG000|Overall Study|Protocol Violation|0|||
44422007|NCT00582309|79429954|FG001|Overall Study|Protocol Violation|0|||
44536801|NCT03349710|79547391|FG000|Treatment Period|completed|6|||
44536802|NCT03349710|79547392|FG001|Treatment Period|completed|0|||
44536803|NCT03349710|79547393|FG002|Treatment Period|completed|18|||
44536804|NCT03349710|79547394|FG003|Treatment Period|completed|1|||
44536805|NCT03349710|79547391|FG000|Treatment Period|participant request to discontinue|0|||
44536806|NCT03349710|79547392|FG001|Treatment Period|participant request to discontinue|0|||
44536807|NCT03349710|79547393|FG002|Treatment Period|participant request to discontinue|4|||
44322383|NCT01183858|79327331|FG001|Overall Study|Death related to Progressive Disease|5|||
44322384|NCT01183858|79327330|FG000|Overall Study|Lost to Follow-up|1|||
44322385|NCT01183858|79327331|FG001|Overall Study|Lost to Follow-up|1|||
44322386|NCT01215175|79327342|FG000|Overall Study|Lost to Follow-up|0|||
44322387|NCT01215175|79327343|FG001|Overall Study|Lost to Follow-up|1|||
44322388|NCT01215175|79327344|FG002|Overall Study|Lost to Follow-up|0|||
44322389|NCT01215175|79327345|FG003|Overall Study|Lost to Follow-up|1|||
44322390|NCT01215175|79327346|FG004|Overall Study|Lost to Follow-up|0|||
44322391|NCT01215097|79327360|FG000|Overall Study|Adverse Event|1|||
44536808|NCT03349710|79547394|FG003|Treatment Period|participant request to discontinue|0|||
44536809|NCT03349710|79547391|FG000|Treatment Period|participant withdrew consent|1|||
44322392|NCT01215097|79327361|FG001|Overall Study|Adverse Event|3|||
44322393|NCT01215097|79327360|FG000|Overall Study|Protocol Violation|0|||
44322394|NCT01215097|79327361|FG001|Overall Study|Protocol Violation|2|||
44322395|NCT01215097|79327360|FG000|Overall Study|Lost to Follow-up|2|||
44322396|NCT01215097|79327361|FG001|Overall Study|Lost to Follow-up|0|||
44322397|NCT01215097|79327360|FG000|Overall Study|Withdrawal by Subject|6|||
44422008|NCT00582309|79429955|FG002|Overall Study|Protocol Violation|2|||
44422009|NCT00443053|79429965|FG000|Overall Study|Adverse Event|2|||
44422010|NCT00443053|79429966|FG001|Overall Study|Adverse Event|1|||
44322398|NCT01215097|79327361|FG001|Overall Study|Withdrawal by Subject|3|||
44322399|NCT01215097|79327360|FG000|Overall Study|Lack of Efficacy|0|||
44422011|NCT00443053|79429965|FG000|Overall Study|Withdrawal by Subject|9|||
44422012|NCT00443053|79429966|FG001|Overall Study|Withdrawal by Subject|18|||
44322400|NCT01215097|79327361|FG001|Overall Study|Lack of Efficacy|3|||
44422013|NCT00443053|79429965|FG000|Overall Study|Lost to Follow-up|4|||
44322401|NCT01215097|79327360|FG000|Overall Study|patient's refusal to come|2|||
44322402|NCT01215097|79327361|FG001|Overall Study|patient's refusal to come|2|||
44322403|NCT01215097|79327360|FG000|Overall Study|patient's private reason|1|||
44322404|NCT01215097|79327361|FG001|Overall Study|patient's private reason|1|||
44322405|NCT03303339|79327379|FG000|Overall Study|Death|2|||
44322406|NCT03303339|79327380|FG001|Overall Study|Death|2|||
44322407|NCT03303339|79327381|FG002|Overall Study|Death|2|||
44322408|NCT03303339|79327382|FG003|Overall Study|Death|1|||
44322409|NCT03303339|79327383|FG004|Overall Study|Death|4|||
44322410|NCT03303339|79327384|FG005|Overall Study|Death|2|||
44322411|NCT03303339|79327385|FG006|Overall Study|Death|2|||
44322412|NCT03303339|79327386|FG007|Overall Study|Death|2|||
44322413|NCT03303339|79327387|FG008|Overall Study|Death|3|||
44322414|NCT03303339|79327388|FG009|Overall Study|Death|3|||
44322415|NCT03303339|79327389|FG010|Overall Study|Death|4|||
44322416|NCT03303339|79327390|FG011|Overall Study|Death|24|||
44322417|NCT03303339|79327379|FG000|Overall Study|Study Terminated by Sponsor|0|||
44322418|NCT03303339|79327380|FG001|Overall Study|Study Terminated by Sponsor|0|||
44322419|NCT03303339|79327381|FG002|Overall Study|Study Terminated by Sponsor|0|||
44322420|NCT03303339|79327382|FG003|Overall Study|Study Terminated by Sponsor|0|||
44322421|NCT03303339|79327383|FG004|Overall Study|Study Terminated by Sponsor|0|||
44322422|NCT03303339|79327384|FG005|Overall Study|Study Terminated by Sponsor|0|||
44322423|NCT03303339|79327385|FG006|Overall Study|Study Terminated by Sponsor|0|||
44322424|NCT03303339|79327386|FG007|Overall Study|Study Terminated by Sponsor|0|||
44322425|NCT03303339|79327387|FG008|Overall Study|Study Terminated by Sponsor|1|||
44322426|NCT03303339|79327388|FG009|Overall Study|Study Terminated by Sponsor|0|||
44322427|NCT03303339|79327389|FG010|Overall Study|Study Terminated by Sponsor|1|||
44322428|NCT03303339|79327390|FG011|Overall Study|Study Terminated by Sponsor|1|||
44322429|NCT03303339|79327379|FG000|Overall Study|Withdrawal by Subject|1|||
44322430|NCT03303339|79327380|FG001|Overall Study|Withdrawal by Subject|0|||
44322431|NCT03303339|79327381|FG002|Overall Study|Withdrawal by Subject|0|||
44322432|NCT03303339|79327382|FG003|Overall Study|Withdrawal by Subject|0|||
44322433|NCT03303339|79327383|FG004|Overall Study|Withdrawal by Subject|0|||
44322434|NCT03303339|79327384|FG005|Overall Study|Withdrawal by Subject|1|||
44322435|NCT03303339|79327385|FG006|Overall Study|Withdrawal by Subject|1|||
44322436|NCT03303339|79327386|FG007|Overall Study|Withdrawal by Subject|0|||
44322437|NCT03303339|79327387|FG008|Overall Study|Withdrawal by Subject|0|||
44322438|NCT03303339|79327388|FG009|Overall Study|Withdrawal by Subject|0|||
44322439|NCT03303339|79327389|FG010|Overall Study|Withdrawal by Subject|0|||
44322440|NCT03303339|79327390|FG011|Overall Study|Withdrawal by Subject|2|||
44322441|NCT03303339|79327379|FG000|Overall Study|Physician Decision|0|||
44322442|NCT03303339|79327380|FG001|Overall Study|Physician Decision|0|||
44322443|NCT03303339|79327381|FG002|Overall Study|Physician Decision|0|||
44322444|NCT03303339|79327382|FG003|Overall Study|Physician Decision|0|||
44322445|NCT03303339|79327383|FG004|Overall Study|Physician Decision|1|||
44322446|NCT03303339|79327384|FG005|Overall Study|Physician Decision|0|||
44322447|NCT03303339|79327385|FG006|Overall Study|Physician Decision|0|||
44322448|NCT03303339|79327386|FG007|Overall Study|Physician Decision|0|||
44322449|NCT03303339|79327387|FG008|Overall Study|Physician Decision|0|||
44322450|NCT03303339|79327388|FG009|Overall Study|Physician Decision|0|||
44322451|NCT03303339|79327389|FG010|Overall Study|Physician Decision|0|||
44322452|NCT03303339|79327390|FG011|Overall Study|Physician Decision|0|||
44322453|NCT03303339|79327379|FG000|Overall Study|Safety/Non-compliance|0|||
44322454|NCT03303339|79327380|FG001|Overall Study|Safety/Non-compliance|0|||
44322455|NCT03303339|79327381|FG002|Overall Study|Safety/Non-compliance|0|||
44322456|NCT03303339|79327382|FG003|Overall Study|Safety/Non-compliance|0|||
44322457|NCT03303339|79327383|FG004|Overall Study|Safety/Non-compliance|0|||
44322458|NCT03303339|79327384|FG005|Overall Study|Safety/Non-compliance|0|||
44322459|NCT03303339|79327385|FG006|Overall Study|Safety/Non-compliance|0|||
44322460|NCT03303339|79327386|FG007|Overall Study|Safety/Non-compliance|0|||
44322461|NCT03303339|79327387|FG008|Overall Study|Safety/Non-compliance|0|||
44322462|NCT03303339|79327388|FG009|Overall Study|Safety/Non-compliance|0|||
44322463|NCT03303339|79327389|FG010|Overall Study|Safety/Non-compliance|0|||
44322464|NCT03303339|79327390|FG011|Overall Study|Safety/Non-compliance|1|||
44322465|NCT01183780|79327435|FG000|Overall Study|Withdrawal by Subject|25|||
44322466|NCT01183780|79327436|FG001|Overall Study|Withdrawal by Subject|14|||
44322467|NCT01183780|79327435|FG000|Overall Study|Lost to Follow-up|6|||
44322468|NCT01183780|79327436|FG001|Overall Study|Lost to Follow-up|11|||
44322469|NCT01183468|79327446|FG000|Overall Study|Lost to Follow-up|2|||
44322470|NCT01183468|79327447|FG001|Overall Study|Lost to Follow-up|1|||
44322471|NCT01183468|79327448|FG002|Overall Study|Lost to Follow-up|0|||
44322472|NCT01183468|79327449|FG003|Overall Study|Lost to Follow-up|0|||
44322473|NCT01183468|79327446|FG000|Overall Study|Physician Decision|1|||
44322474|NCT01183468|79327447|FG001|Overall Study|Physician Decision|0|||
44322475|NCT01183468|79327448|FG002|Overall Study|Physician Decision|0|||
44322476|NCT01183468|79327449|FG003|Overall Study|Physician Decision|0|||
44322477|NCT01183468|79327446|FG000|Overall Study|Withdrawal by Subject|0|||
44322478|NCT01183468|79327447|FG001|Overall Study|Withdrawal by Subject|1|||
44322479|NCT01183468|79327448|FG002|Overall Study|Withdrawal by Subject|0|||
44322480|NCT01183468|79327449|FG003|Overall Study|Withdrawal by Subject|0|||
44322481|NCT01183390|79327459|FG000|First Intervention|Adverse Event|0|||
44322482|NCT01183390|79327460|FG001|First Intervention|Adverse Event|1|||
44322483|NCT01214668|79327472|FG000|Overall Study|Adverse Event|0|||
44322484|NCT01214668|79327473|FG001|Overall Study|Adverse Event|1|||
44322485|NCT01214668|79327474|FG002|Overall Study|Adverse Event|0|||
44322486|NCT01214668|79327475|FG003|Overall Study|Adverse Event|2|||
44322487|NCT01214668|79327476|FG004|Overall Study|Adverse Event|1|||
44322488|NCT01214668|79327477|FG005|Overall Study|Adverse Event|1|||
44322489|NCT01214668|79327472|FG000|Overall Study|Death|0|||
44322490|NCT01214668|79327473|FG001|Overall Study|Death|0|||
44322491|NCT01214668|79327474|FG002|Overall Study|Death|1|||
44322492|NCT01214668|79327475|FG003|Overall Study|Death|0|||
44322493|NCT01214668|79327476|FG004|Overall Study|Death|0|||
44322494|NCT01214668|79327477|FG005|Overall Study|Death|0|||
44322495|NCT01214668|79327472|FG000|Overall Study|Progressive Disease|4|||
44322496|NCT01214668|79327473|FG001|Overall Study|Progressive Disease|2|||
44322497|NCT01214668|79327474|FG002|Overall Study|Progressive Disease|5|||
44322498|NCT01214668|79327475|FG003|Overall Study|Progressive Disease|4|||
44322499|NCT01214668|79327476|FG004|Overall Study|Progressive Disease|4|||
44322500|NCT01214668|79327477|FG005|Overall Study|Progressive Disease|5|||
44322501|NCT01214668|79327472|FG000|Overall Study|Withdrawal by Subject|0|||
44322502|NCT01214668|79327473|FG001|Overall Study|Withdrawal by Subject|0|||
44322503|NCT01214668|79327474|FG002|Overall Study|Withdrawal by Subject|0|||
44322504|NCT01214668|79327475|FG003|Overall Study|Withdrawal by Subject|0|||
44322505|NCT01214668|79327476|FG004|Overall Study|Withdrawal by Subject|1|||
44322506|NCT01214668|79327477|FG005|Overall Study|Withdrawal by Subject|0|||
44322507|NCT03456713|79327496|FG000|Overall Study|Lost to Follow-up|1|||
44322508|NCT03456713|79327497|FG001|Overall Study|Lost to Follow-up|0|||
44322509|NCT03456713|79327498|FG002|Overall Study|Lost to Follow-up|0|||
44322510|NCT03456713|79327499|FG003|Overall Study|Lost to Follow-up|0|||
44536810|NCT03349710|79547392|FG001|Treatment Period|participant withdrew consent|0|||
44536811|NCT03349710|79547393|FG002|Treatment Period|participant withdrew consent|0|||
44322511|NCT01191268|79327518|FG000|Overall Study|Withdrawal by Subject|19|||
44322512|NCT01191268|79327519|FG001|Overall Study|Withdrawal by Subject|25|||
44322513|NCT01191268|79327520|FG002|Overall Study|Withdrawal by Subject|21|||
44322514|NCT01191268|79327518|FG000|Overall Study|Adverse Event|21|||
44322515|NCT01191268|79327519|FG001|Overall Study|Adverse Event|13|||
44322516|NCT01191268|79327520|FG002|Overall Study|Adverse Event|8|||
44322517|NCT01191268|79327518|FG000|Overall Study|Physician Decision|6|||
44322518|NCT01191268|79327519|FG001|Overall Study|Physician Decision|8|||
44322519|NCT01191268|79327520|FG002|Overall Study|Physician Decision|9|||
44322520|NCT01191268|79327518|FG000|Overall Study|Lost to Follow-up|8|||
44322521|NCT01191268|79327519|FG001|Overall Study|Lost to Follow-up|5|||
44322522|NCT01191268|79327520|FG002|Overall Study|Lost to Follow-up|9|||
44322523|NCT01191268|79327518|FG000|Overall Study|Entry Criteria Not Met|3|||
44322524|NCT01191268|79327519|FG001|Overall Study|Entry Criteria Not Met|1|||
44322525|NCT01191268|79327520|FG002|Overall Study|Entry Criteria Not Met|1|||
44322526|NCT01191268|79327518|FG000|Overall Study|Death|0|||
44536812|NCT03349710|79547394|FG003|Treatment Period|participant withdrew consent|0|||
44536813|NCT03511053|79547404|FG000|Overall Study|Withdrawal by Subject|1|||
44536814|NCT03377634|79547410|FG000|Study Period|Adverse Event|1|||
44536815|NCT03377634|79547411|FG001|Study Period|Adverse Event|0|||
44536816|NCT03377634|79547410|FG000|Study Period|Withdrawal by Subject|1|||
44536817|NCT03377634|79547411|FG001|Study Period|Withdrawal by Subject|0|||
44322527|NCT01191268|79327519|FG001|Overall Study|Death|1|||
44322528|NCT01191268|79327520|FG002|Overall Study|Death|3|||
44322529|NCT01191268|79327518|FG000|Overall Study|Protocol Violation|1|||
44322530|NCT01191268|79327519|FG001|Overall Study|Protocol Violation|0|||
44322531|NCT01191268|79327520|FG002|Overall Study|Protocol Violation|1|||
44536818|NCT03528369|79547420|FG000|Overall Study|Withdrawal by Subject|2|||
44322532|NCT01191268|79327518|FG000|Overall Study|Sponsor Decision|0|||
44322533|NCT01191268|79327519|FG001|Overall Study|Sponsor Decision|2|||
44322534|NCT01191268|79327520|FG002|Overall Study|Sponsor Decision|0|||
44322535|NCT01191190|79327529|FG000|Overall Study|Withdrawal by Subject|1|||
44322536|NCT05751629|79327533|FG000|Overall Study|Withdrawal by Subject|6|||
44322537|NCT05751629|79327533|FG000|Overall Study|Death|25|||
44322538|NCT05751629|79327533|FG000|Overall Study|Study Site Closed|9|||
44322539|NCT05751629|79327533|FG000|Overall Study|Physician Decision|1|||
44322540|NCT05306977|79327537|FG000|Overall Study|Withdrawal by Subject|1|||
44322541|NCT05086276|79327543|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
44322542|NCT05086276|79327544|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
44322543|NCT04870710|79327550|FG000|Overall Study|Lost to Follow-up|3|||
44322544|NCT04858802|79327556|FG000|Overall Study|Lost to Follow-up|1|||
44322545|NCT04858802|79327557|FG001|Overall Study|Lost to Follow-up|1|||
44322546|NCT04858802|79327556|FG000|Overall Study|Withdrawal by Subject|1|||
44322547|NCT04858802|79327557|FG001|Overall Study|Withdrawal by Subject|1|||
44322548|NCT04562090|79327575|FG000|Overall Study|Withdrawal by Subject|3|||
44322549|NCT04562090|79327576|FG001|Overall Study|Withdrawal by Subject|4|||
44322550|NCT04562090|79327575|FG000|Overall Study|Protocol Violation|2|||
44322551|NCT04562090|79327576|FG001|Overall Study|Protocol Violation|0|||
44322552|NCT04562090|79327575|FG000|Overall Study|Lack of Efficacy|0|||
44322553|NCT04562090|79327576|FG001|Overall Study|Lack of Efficacy|1|||
44322554|NCT04562090|79327575|FG000|Overall Study|Adverse Event|1|||
44322555|NCT04562090|79327576|FG001|Overall Study|Adverse Event|4|||
44322556|NCT04562090|79327575|FG000|Overall Study|Miscellaneous|0|||
44322557|NCT04562090|79327576|FG001|Overall Study|Miscellaneous|3|||
44322558|NCT04557189|79327587|FG000|Overall Study|Adverse Event|0|||
44322559|NCT04557189|79327588|FG001|Overall Study|Adverse Event|1|||
44322560|NCT04557189|79327587|FG000|Overall Study|Lost to Follow-up|1|||
44322561|NCT04557189|79327588|FG001|Overall Study|Lost to Follow-up|1|||
44322562|NCT04557189|79327587|FG000|Overall Study|Withdrawal by Subject|2|||
44322563|NCT04557189|79327588|FG001|Overall Study|Withdrawal by Subject|1|||
44322564|NCT04557189|79327587|FG000|Overall Study|Reason not Specified|3|||
44322565|NCT04557189|79327588|FG001|Overall Study|Reason not Specified|6|||
44422014|NCT00443053|79429966|FG001|Overall Study|Lost to Follow-up|5|||
44536819|NCT03528369|79547421|FG001|Overall Study|Withdrawal by Subject|0|||
44536820|NCT03528369|79547422|FG002|Overall Study|Withdrawal by Subject|0|||
44536821|NCT03528369|79547420|FG000|Overall Study|Lost to Follow-up|1|||
44536822|NCT03528369|79547421|FG001|Overall Study|Lost to Follow-up|0|||
44536823|NCT03528369|79547422|FG002|Overall Study|Lost to Follow-up|0|||
44536824|NCT03528369|79547420|FG000|Overall Study|Adverse Event|0|||
44536825|NCT03528369|79547421|FG001|Overall Study|Adverse Event|1|||
44536826|NCT03528369|79547422|FG002|Overall Study|Adverse Event|0|||
44155816|NCT02641379|78947350|FG010|Overall Study|Exclusion criterion during screening|0|||
44155817|NCT02641379|78947340|FG000|Overall Study|Withdrawal of informed consent|0|||
44155818|NCT02641379|78947341|FG001|Overall Study|Withdrawal of informed consent|1|||
44155819|NCT02641379|78947342|FG002|Overall Study|Withdrawal of informed consent|0|||
44322566|NCT04530838|79327601|FG000|Overall Study|Other|2|||
44322567|NCT04530838|79327602|FG001|Overall Study|Other|1|||
44422015|NCT00443053|79429965|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
44322568|NCT04530838|79327603|FG002|Overall Study|Other|0|||
44322569|NCT04530838|79327601|FG000|Overall Study|Physician Decision|0|||
44322570|NCT04530838|79327602|FG001|Overall Study|Physician Decision|0|||
44422016|NCT00443053|79429966|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
44322571|NCT04530838|79327603|FG002|Overall Study|Physician Decision|1|||
44322572|NCT04530838|79327601|FG000|Overall Study|Death|0|||
44322573|NCT04530838|79327602|FG001|Overall Study|Death|0|||
44322574|NCT04530838|79327603|FG002|Overall Study|Death|1|||
44322575|NCT04530838|79327601|FG000|Overall Study|Adverse Event|0|||
44322576|NCT04530838|79327602|FG001|Overall Study|Adverse Event|1|||
44322577|NCT04530838|79327603|FG002|Overall Study|Adverse Event|0|||
44322578|NCT04530838|79327601|FG000|Overall Study|No longer meets eligibility criteria|1|||
44322579|NCT04530838|79327602|FG001|Overall Study|No longer meets eligibility criteria|0|||
44322580|NCT04530838|79327603|FG002|Overall Study|No longer meets eligibility criteria|2|||
44322581|NCT04530838|79327601|FG000|Overall Study|Withdrawal by parent/guardian|5|||
44322582|NCT04530838|79327602|FG001|Overall Study|Withdrawal by parent/guardian|2|||
44322583|NCT04530838|79327603|FG002|Overall Study|Withdrawal by parent/guardian|2|||
44322584|NCT04424901|79327617|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
44322585|NCT04424901|79327618|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
44322586|NCT04410445|79327626|FG000|Overall Study|Lost to Follow-up|3|||
44322587|NCT04410445|79327627|FG001|Overall Study|Lost to Follow-up|9|||
44322588|NCT04410445|79327626|FG000|Overall Study|Withdrawal by Subject|27|||
44322589|NCT04410445|79327627|FG001|Overall Study|Withdrawal by Subject|15|||
44322590|NCT04062448|79327651|FG000|Overall Study|Lost to Follow-up|1|||
44322591|NCT04062448|79327651|FG000|Overall Study|Withdrawal by Subject|1|||
44322592|NCT04062448|79327651|FG000|Overall Study|Ongoing|14|||
44322593|NCT03970733|79327658|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
44322594|NCT03970733|79327659|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
44322595|NCT03970733|79327660|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
44322596|NCT03970733|79327661|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
44322597|NCT03970733|79327662|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
44322598|NCT03970733|79327658|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
44322599|NCT03970733|79327659|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
44322600|NCT03970733|79327660|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
44322601|NCT03970733|79327661|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
44322602|NCT03970733|79327662|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
44322603|NCT03970733|79327658|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
44322604|NCT03970733|79327659|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
44322605|NCT03970733|79327660|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
44322606|NCT03970733|79327661|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
44322607|NCT03970733|79327662|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
44322608|NCT03970733|79327658|FG000|Main Study Phase (18 Months)|Other|1|||
44322609|NCT03970733|79327659|FG001|Main Study Phase (18 Months)|Other|1|||
44322610|NCT03970733|79327660|FG002|Main Study Phase (18 Months)|Other|0|||
44322611|NCT03970733|79327661|FG003|Main Study Phase (18 Months)|Other|0|||
44322612|NCT03970733|79327662|FG004|Main Study Phase (18 Months)|Other|0|||
44322613|NCT03970733|79327658|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
44322614|NCT03970733|79327659|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
44322615|NCT03970733|79327660|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
44322616|NCT03970733|79327661|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
44322617|NCT03970733|79327662|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
44322618|NCT03921411|79327674|FG000|Overall Study|Withdrawal by Subject|1|||
44322619|NCT03921411|79327674|FG000|Overall Study|Protocol Deviation|2|||
44322620|NCT03921411|79327674|FG000|Overall Study|Enrolled, but never treated|2|||
44322621|NCT03728582|79327678|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
44322622|NCT03728582|79327679|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
44322623|NCT03728582|79327678|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
44322624|NCT03728582|79327679|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
44322625|NCT03416179|79327698|FG000|Overall Study|Death|90|||
44322626|NCT03416179|79327699|FG001|Overall Study|Death|87|||
44322627|NCT03416179|79327700|FG002|Overall Study|Death|117|||
44322628|NCT03416179|79327701|FG003|Overall Study|Death|113|||
44322629|NCT03416179|79327698|FG000|Overall Study|Withdrawal by Subject|15|||
44322630|NCT03416179|79327699|FG001|Overall Study|Withdrawal by Subject|20|||
44322631|NCT03416179|79327700|FG002|Overall Study|Withdrawal by Subject|6|||
44322632|NCT03416179|79327701|FG003|Overall Study|Withdrawal by Subject|9|||
44322633|NCT03416179|79327698|FG000|Overall Study|Lost to Follow-up|1|||
44322634|NCT03416179|79327699|FG001|Overall Study|Lost to Follow-up|1|||
44322635|NCT03416179|79327700|FG002|Overall Study|Lost to Follow-up|0|||
44322636|NCT03416179|79327701|FG003|Overall Study|Lost to Follow-up|3|||
44422017|NCT00443053|79429965|FG000|Overall Study|Noncompliance|2|||
44422018|NCT00443053|79429966|FG001|Overall Study|Noncompliance|1|||
44422019|NCT00443053|79429965|FG000|Overall Study|Other|3|||
44422020|NCT00443053|79429966|FG001|Overall Study|Other|4|||
44422021|NCT00443053|79429965|FG000|Overall Study|Physician Decision|0|||
44422022|NCT00443053|79429966|FG001|Overall Study|Physician Decision|4|||
44422023|NCT00720798|79429972|FG000|Overall Study|Adverse Event|304|||
44422024|NCT00720798|79429972|FG000|Overall Study|Death|39|||
44422025|NCT00720798|79429972|FG000|Overall Study|Insufficient Therapeutic Response|129|||
44422026|NCT00720798|79429972|FG000|Overall Study|Protocol Violation|4|||
44422027|NCT00720798|79429972|FG000|Overall Study|Refused Treatment|151|||
44422028|NCT00720798|79429972|FG000|Overall Study|Failure to Return|46|||
44422029|NCT00720798|79429972|FG000|Overall Study|Reason not Specified|83|||
44422030|NCT00756002|79429982|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
44422031|NCT00756002|79429983|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
44422032|NCT00756002|79429982|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44422033|NCT00756002|79429983|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
44422034|NCT00756002|79429982|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
44422035|NCT00756002|79429983|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
44422036|NCT00756002|79429982|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
44422037|NCT00756002|79429983|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
44422038|NCT00756002|79429982|FG000|Double-Blind Treatment Period|Other|2|||
44422039|NCT00756002|79429983|FG001|Double-Blind Treatment Period|Other|2|||
44422040|NCT00717366|79429991|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
44422041|NCT00717366|79429992|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
44155820|NCT02641379|78947343|FG003|Overall Study|Withdrawal of informed consent|0|||
44155821|NCT02641379|78947344|FG004|Overall Study|Withdrawal of informed consent|0|||
44155822|NCT02641379|78947345|FG005|Overall Study|Withdrawal of informed consent|0|||
44155823|NCT02641379|78947346|FG006|Overall Study|Withdrawal of informed consent|0|||
44155824|NCT02641379|78947347|FG007|Overall Study|Withdrawal of informed consent|1|||
44155825|NCT02641379|78947348|FG008|Overall Study|Withdrawal of informed consent|0|||
44322637|NCT03416179|79327698|FG000|Overall Study|Study participation terminated by Sponsor|93|||
44322638|NCT03416179|79327699|FG001|Overall Study|Study participation terminated by Sponsor|91|||
44322639|NCT03416179|79327700|FG002|Overall Study|Study participation terminated by Sponsor|26|||
44322640|NCT03416179|79327701|FG003|Overall Study|Study participation terminated by Sponsor|31|||
44322641|NCT03416179|79327698|FG000|Overall Study|Other|2|||
44322642|NCT03416179|79327699|FG001|Overall Study|Other|3|||
44322643|NCT03416179|79327700|FG002|Overall Study|Other|1|||
44322644|NCT03416179|79327701|FG003|Overall Study|Other|0|||
44322645|NCT02932332|79327728|FG000|Overall Study|Withdrawal by Subject|1|||
44322646|NCT02932332|79327729|FG001|Overall Study|Withdrawal by Subject|1|||
44322647|NCT02932332|79327730|FG002|Overall Study|Withdrawal by Subject|0|||
44322648|NCT02932332|79327731|FG003|Overall Study|Withdrawal by Subject|1|||
44322649|NCT02932332|79327728|FG000|Overall Study|Chest pain|0|||
44322650|NCT02932332|79327729|FG001|Overall Study|Chest pain|0|||
44322651|NCT02932332|79327730|FG002|Overall Study|Chest pain|0|||
44322652|NCT02932332|79327731|FG003|Overall Study|Chest pain|1|||
44322653|NCT02932332|79327728|FG000|Overall Study|Not Dyspneic cough|1|||
44322654|NCT02932332|79327729|FG001|Overall Study|Not Dyspneic cough|2|||
44322655|NCT02932332|79327730|FG002|Overall Study|Not Dyspneic cough|1|||
44322656|NCT02932332|79327731|FG003|Overall Study|Not Dyspneic cough|0|||
44322657|NCT02820623|79327765|FG000|Overall Study|Withdrawal by Subject|1|||
44322658|NCT02820623|79327766|FG001|Overall Study|Withdrawal by Subject|3|||
44322659|NCT02820623|79327767|FG002|Overall Study|Withdrawal by Subject|3|||
44322660|NCT02820623|79327765|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
44322661|NCT02820623|79327766|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
44322662|NCT02820623|79327767|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
44322663|NCT02820623|79327765|FG000|Overall Study|Therapist unable to enroll clients|1|||
44322664|NCT02820623|79327766|FG001|Overall Study|Therapist unable to enroll clients|1|||
44322665|NCT02820623|79327767|FG002|Overall Study|Therapist unable to enroll clients|3|||
44322666|NCT02820623|79327765|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
44322667|NCT02820623|79327766|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
44322668|NCT02820623|79327767|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
44322669|NCT02774005|79327775|FG000|Overall Study|Adverse Event|8|||
44322670|NCT02774005|79327775|FG000|Overall Study|Withdrawal by Subject|23|||
44322671|NCT02774005|79327775|FG000|Overall Study|Lost to Follow-up|7|||
44322672|NCT02774005|79327775|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
44322673|NCT02774005|79327775|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
44322674|NCT02774005|79327775|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
44322675|NCT02774005|79327775|FG000|Overall Study|Death|1|||
44322676|NCT02774005|79327775|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
44322677|NCT02774005|79327775|FG000|Overall Study|Lack of compliance with study medication|4|||
44322678|NCT02774005|79327775|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
44322679|NCT02774005|79327775|FG000|Overall Study|another study|1|||
44322680|NCT02774005|79327775|FG000|Overall Study|cardiologist imposed travel restriction|1|||
44322681|NCT01975428|79327805|FG000|Overall Study|Lost to Follow-up|17|||
44322682|NCT01975428|79327806|FG001|Overall Study|Lost to Follow-up|4|||
44322683|NCT01975428|79327805|FG000|Overall Study|Withdrawal by Subject|3|||
44322684|NCT01975428|79327806|FG001|Overall Study|Withdrawal by Subject|10|||
44322685|NCT01047540|79327847|FG000|Overall Study|Protocol Violation|1|||
44322686|NCT01047540|79327848|FG001|Overall Study|Protocol Violation|0|||
44322687|NCT01047540|79327849|FG002|Overall Study|Protocol Violation|0|||
44322688|NCT01047540|79327850|FG003|Overall Study|Protocol Violation|0|||
44322689|NCT01047540|79327851|FG004|Overall Study|Protocol Violation|0|||
44322690|NCT01047540|79327847|FG000|Overall Study|Lost to Follow-up|1|||
44322691|NCT01047540|79327848|FG001|Overall Study|Lost to Follow-up|0|||
44322692|NCT01047540|79327849|FG002|Overall Study|Lost to Follow-up|0|||
44322693|NCT01047540|79327850|FG003|Overall Study|Lost to Follow-up|0|||
44322694|NCT01047540|79327851|FG004|Overall Study|Lost to Follow-up|0|||
44322695|NCT01047540|79327847|FG000|Overall Study|Withdrawal by Subject|1|||
44322696|NCT01047540|79327848|FG001|Overall Study|Withdrawal by Subject|0|||
44322697|NCT01047540|79327849|FG002|Overall Study|Withdrawal by Subject|3|||
44322698|NCT01047540|79327850|FG003|Overall Study|Withdrawal by Subject|0|||
44322699|NCT01047540|79327851|FG004|Overall Study|Withdrawal by Subject|1|||
44322700|NCT01047540|79327847|FG000|Overall Study|Pregnancy|1|||
44322701|NCT01047540|79327848|FG001|Overall Study|Pregnancy|0|||
44322702|NCT01047540|79327849|FG002|Overall Study|Pregnancy|0|||
44322703|NCT01047540|79327850|FG003|Overall Study|Pregnancy|0|||
44322704|NCT01047540|79327851|FG004|Overall Study|Pregnancy|0|||
44322705|NCT01047540|79327847|FG000|Overall Study|Adverse Event|1|||
44422042|NCT00717366|79429991|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
44422043|NCT00717366|79429992|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
44155826|NCT02641379|78947349|FG009|Overall Study|Withdrawal of informed consent|0|||
44322706|NCT01047540|79327848|FG001|Overall Study|Adverse Event|0|||
44322707|NCT01047540|79327849|FG002|Overall Study|Adverse Event|0|||
44322708|NCT01047540|79327850|FG003|Overall Study|Adverse Event|0|||
44322709|NCT01047540|79327851|FG004|Overall Study|Adverse Event|0|||
44322710|NCT00521222|79327867|FG000|Overall Study|Lost to Follow-up|0|||
44322711|NCT00521222|79327868|FG001|Overall Study|Lost to Follow-up|0|||
44322712|NCT00521222|79327869|FG002|Overall Study|Lost to Follow-up|1|||
44322713|NCT00521222|79327870|FG003|Overall Study|Lost to Follow-up|1|||
44322714|NCT00521222|79327867|FG000|Overall Study|Withdrawal by Subject|0|||
44322715|NCT00521222|79327868|FG001|Overall Study|Withdrawal by Subject|0|||
44322716|NCT00521222|79327869|FG002|Overall Study|Withdrawal by Subject|2|||
44322717|NCT00521222|79327870|FG003|Overall Study|Withdrawal by Subject|0|||
44322718|NCT00521222|79327867|FG000|Overall Study|Physician Decision|0|||
44322719|NCT00521222|79327868|FG001|Overall Study|Physician Decision|1|||
44322720|NCT00521222|79327869|FG002|Overall Study|Physician Decision|0|||
44322721|NCT00521222|79327870|FG003|Overall Study|Physician Decision|1|||
44322722|NCT01214629|79327904|FG000|Overall Study|Progressive Disease|1|||
44322723|NCT01214629|79327905|FG001|Overall Study|Progressive Disease|1|||
44322724|NCT01214629|79327906|FG002|Overall Study|Progressive Disease|0|||
44322725|NCT01214629|79327907|FG003|Overall Study|Progressive Disease|1|||
44322726|NCT01214629|79327908|FG004|Overall Study|Progressive Disease|2|||
44322727|NCT01214629|79327909|FG005|Overall Study|Progressive Disease|3|||
44322728|NCT01214629|79327910|FG006|Overall Study|Progressive Disease|1|||
44322729|NCT01214629|79327911|FG007|Overall Study|Progressive Disease|1|||
44322730|NCT01214629|79327912|FG008|Overall Study|Progressive Disease|1|||
44322731|NCT01214629|79327913|FG009|Overall Study|Progressive Disease|5|||
44322732|NCT01214629|79327914|FG010|Overall Study|Progressive Disease|1|||
44322733|NCT01214629|79327904|FG000|Overall Study|Adverse Event|0|||
44322734|NCT01214629|79327905|FG001|Overall Study|Adverse Event|0|||
44322735|NCT01214629|79327906|FG002|Overall Study|Adverse Event|0|||
44322736|NCT01214629|79327907|FG003|Overall Study|Adverse Event|1|||
44322737|NCT01214629|79327908|FG004|Overall Study|Adverse Event|0|||
44322738|NCT01214629|79327909|FG005|Overall Study|Adverse Event|1|||
44322739|NCT01214629|79327910|FG006|Overall Study|Adverse Event|0|||
44322740|NCT01214629|79327911|FG007|Overall Study|Adverse Event|0|||
44322741|NCT01214629|79327912|FG008|Overall Study|Adverse Event|0|||
44322742|NCT01214629|79327913|FG009|Overall Study|Adverse Event|1|||
44322743|NCT01214629|79327914|FG010|Overall Study|Adverse Event|0|||
44322744|NCT01214629|79327904|FG000|Overall Study|Physician Decision|0|||
44322745|NCT01214629|79327905|FG001|Overall Study|Physician Decision|0|||
44322746|NCT01214629|79327906|FG002|Overall Study|Physician Decision|0|||
44322747|NCT01214629|79327907|FG003|Overall Study|Physician Decision|0|||
44322748|NCT01214629|79327908|FG004|Overall Study|Physician Decision|0|||
44322749|NCT01214629|79327909|FG005|Overall Study|Physician Decision|0|||
44322750|NCT01214629|79327910|FG006|Overall Study|Physician Decision|0|||
44322751|NCT01214629|79327911|FG007|Overall Study|Physician Decision|0|||
44322752|NCT01214629|79327912|FG008|Overall Study|Physician Decision|0|||
44322753|NCT01214629|79327913|FG009|Overall Study|Physician Decision|0|||
44322754|NCT01214629|79327914|FG010|Overall Study|Physician Decision|1|||
44322755|NCT01214629|79327904|FG000|Overall Study|Withdrawal by Subject|0|||
44322756|NCT01214629|79327905|FG001|Overall Study|Withdrawal by Subject|0|||
44322757|NCT01214629|79327906|FG002|Overall Study|Withdrawal by Subject|0|||
44322758|NCT01214629|79327907|FG003|Overall Study|Withdrawal by Subject|0|||
44322759|NCT01214629|79327908|FG004|Overall Study|Withdrawal by Subject|0|||
44322760|NCT01214629|79327909|FG005|Overall Study|Withdrawal by Subject|0|||
44322761|NCT01214629|79327910|FG006|Overall Study|Withdrawal by Subject|0|||
44322762|NCT01214629|79327911|FG007|Overall Study|Withdrawal by Subject|0|||
44322763|NCT01214629|79327912|FG008|Overall Study|Withdrawal by Subject|0|||
44322764|NCT01214629|79327913|FG009|Overall Study|Withdrawal by Subject|1|||
44322765|NCT01214629|79327914|FG010|Overall Study|Withdrawal by Subject|0|||
44322766|NCT01214434|79327954|FG000|Overall Study|Withdrawal by Subject|1|||
44322767|NCT01214434|79327955|FG001|Overall Study|Withdrawal by Subject|0|||
44322768|NCT01214434|79327954|FG000|Overall Study|Lost to Follow-up|2|||
44322769|NCT01214434|79327955|FG001|Overall Study|Lost to Follow-up|2|||
44322770|NCT01214434|79327954|FG000|Overall Study|Site error|1|||
44322771|NCT01214434|79327955|FG001|Overall Study|Site error|0|||
44322772|NCT01214395|79327961|FG000|Overall Study|All patients had infection|5|||
44322773|NCT01214239|79327968|FG000|Overall Study|Adverse Event|3|||
44322774|NCT01214239|79327969|FG001|Overall Study|Adverse Event|4|||
44322775|NCT01214239|79327968|FG000|Overall Study|Protocol Violation|2|||
44422044|NCT00717366|79429991|FG000|Core Study Period (20 Weeks)|Death|0|||
44322776|NCT01214239|79327969|FG001|Overall Study|Protocol Violation|1|||
44322777|NCT01214239|79327968|FG000|Overall Study|Lost to Follow-up|1|||
44322778|NCT01214239|79327969|FG001|Overall Study|Lost to Follow-up|1|||
44322779|NCT01214239|79327968|FG000|Overall Study|Withdrawal by Subject|4|||
44322780|NCT01214239|79327969|FG001|Overall Study|Withdrawal by Subject|9|||
44322781|NCT01214239|79327968|FG000|Overall Study|Lack of Efficacy|1|||
44422045|NCT00717366|79429992|FG001|Core Study Period (20 Weeks)|Death|1|||
44322782|NCT01214239|79327969|FG001|Overall Study|Lack of Efficacy|2|||
44322783|NCT01214239|79327968|FG000|Overall Study|patient's private reason|1|||
44322784|NCT01214239|79327969|FG001|Overall Study|patient's private reason|1|||
44322785|NCT01214200|79327975|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
44322786|NCT01214200|79327975|FG000|Overall Study|Withdrawal by Subject|2|||
44322787|NCT01214044|79327981|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
44322788|NCT01214044|79327981|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
44322789|NCT01214044|79327981|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
44322790|NCT01214044|79327981|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
44322791|NCT01214044|79327981|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
44322792|NCT01214044|79327981|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
44322793|NCT01213966|79327993|FG000|Overall Study|Protocol Violation|1|||
44322794|NCT01213966|79327994|FG001|Overall Study|Protocol Violation|0|||
44322795|NCT01213966|79327995|FG002|Overall Study|Protocol Violation|3|||
44322796|NCT01213966|79327996|FG003|Overall Study|Protocol Violation|1|||
44322797|NCT01213264|79328009|FG000|Overall Study|Adverse Event|1|||
44322798|NCT01213264|79328010|FG001|Overall Study|Adverse Event|0|||
44322799|NCT01213264|79328011|FG002|Overall Study|Adverse Event|0|||
44322800|NCT01213264|79328009|FG000|Overall Study|Lost to Follow-up|1|||
44322801|NCT01213264|79328010|FG001|Overall Study|Lost to Follow-up|2|||
44322802|NCT01213264|79328011|FG002|Overall Study|Lost to Follow-up|6|||
44322803|NCT01212991|79328024|FG000|Double-blind|Lost to Follow-up|8|||
44322804|NCT01212991|79328025|FG001|Double-blind|Lost to Follow-up|4|||
44322805|NCT01212991|79328026|FG002|Double-blind|Lost to Follow-up|0|||
44322806|NCT01212991|79328024|FG000|Double-blind|Death|699|||
44322807|NCT01212991|79328025|FG001|Double-blind|Death|550|||
44322808|NCT01212991|79328026|FG002|Double-blind|Death|0|||
44322809|NCT01212991|79328024|FG000|Double-blind|Withdrawal by Subject|16|||
44322810|NCT01212991|79328025|FG001|Double-blind|Withdrawal by Subject|19|||
44322811|NCT01212991|79328026|FG002|Double-blind|Withdrawal by Subject|0|||
44322812|NCT01212991|79328024|FG000|Double-blind|Other|7|||
44322813|NCT01212991|79328025|FG001|Double-blind|Other|0|||
44322814|NCT01212991|79328026|FG002|Double-blind|Other|0|||
44322815|NCT01212991|79328024|FG000|Double-blind|Sponsor decision|142|||
44322816|NCT01212991|79328025|FG001|Double-blind|Sponsor decision|38|||
44322817|NCT01212991|79328026|FG002|Double-blind|Sponsor decision|0|||
44322818|NCT01212991|79328024|FG000|Open-label|Death|0|||
44322819|NCT01212991|79328025|FG001|Open-label|Death|0|||
44322820|NCT01212991|79328026|FG002|Open-label|Death|166|||
44322821|NCT01212991|79328024|FG000|Open-label|Lost to Follow-up|0|||
44322822|NCT01212991|79328025|FG001|Open-label|Lost to Follow-up|0|||
44322823|NCT01212991|79328026|FG002|Open-label|Lost to Follow-up|5|||
44322824|NCT01212991|79328024|FG000|Open-label|Withdrawal by Subject|0|||
44322825|NCT01212991|79328025|FG001|Open-label|Withdrawal by Subject|0|||
44322826|NCT01212991|79328026|FG002|Open-label|Withdrawal by Subject|7|||
44322827|NCT01212991|79328024|FG000|Open-label|Sponsor decision|0|||
44322828|NCT01212991|79328025|FG001|Open-label|Sponsor decision|0|||
44322829|NCT01212991|79328026|FG002|Open-label|Sponsor decision|53|||
44322830|NCT01212991|79328024|FG000|Open-label|Other|0|||
44322831|NCT01212991|79328025|FG001|Open-label|Other|0|||
44322832|NCT01212991|79328026|FG002|Open-label|Other|3|||
44322833|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
44322834|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
44322835|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
44322836|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44322837|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44322838|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44322839|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44322840|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44322841|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
44322842|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
44322843|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
44322844|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
44322845|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44322846|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44322847|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44322848|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44322849|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44322850|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
44322851|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
44322852|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
44322853|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
44322854|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44322855|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44322856|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44422046|NCT00717366|79429991|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
44322857|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44322858|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44322859|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
44536827|NCT00006011|79547433|FG000|Overall Study|Disease progression|13|||
44536828|NCT00006011|79547434|FG001|Overall Study|Disease progression|6|||
44322860|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
44322861|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44322862|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
44322863|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44322864|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44322865|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44322866|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44322867|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44322868|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
44422047|NCT00717366|79429992|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
44422048|NCT00717366|79429991|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
44422049|NCT00717366|79429992|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
44422050|NCT00717366|79429991|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
44422051|NCT00717366|79429992|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
44422052|NCT00717366|79429991|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
44422053|NCT00717366|79429992|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
44422054|NCT00723606|79430011|FG000|Overall Study|Adverse Event|2|||
44422055|NCT00723606|79430012|FG001|Overall Study|Adverse Event|5|||
44422056|NCT00723606|79430011|FG000|Overall Study|Other|2|||
44422057|NCT00723606|79430012|FG001|Overall Study|Other|0|||
44422058|NCT00723606|79430011|FG000|Overall Study|Withdrawal by Subject|0|||
44422059|NCT00723606|79430012|FG001|Overall Study|Withdrawal by Subject|2|||
44422060|NCT00442351|79430020|FG000|Overall Study|Administrative|6|||
44422061|NCT00442351|79430021|FG001|Overall Study|Administrative|5|||
44422062|NCT00442351|79430020|FG000|Overall Study|Did not meet protocol eligibility|1|||
44422063|NCT00442351|79430021|FG001|Overall Study|Did not meet protocol eligibility|0|||
44422064|NCT00442351|79430020|FG000|Overall Study|Other|0|||
44422065|NCT00442351|79430021|FG001|Overall Study|Other|1|||
44422066|NCT00436501|79430029|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
44422067|NCT00436501|79430030|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
44422068|NCT00436501|79430029|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
44422069|NCT00436501|79430030|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
44422070|NCT00755846|79430043|FG000|Overall Study|Adverse Event|0|||
44422071|NCT00755846|79430044|FG001|Overall Study|Adverse Event|0|||
44322869|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
44322870|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
44322871|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
44322872|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44322873|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44322874|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44322875|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44322876|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44322877|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
44322878|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322879|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
44322880|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
44322881|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322882|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322883|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322884|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322885|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322886|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
44322887|NCT01212757|79328037|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
44322888|NCT01212757|79328038|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
44322889|NCT01212757|79328039|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322890|NCT01212757|79328040|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322891|NCT01212757|79328041|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322892|NCT01212757|79328042|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322893|NCT01212757|79328043|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322894|NCT01212757|79328044|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322895|NCT01212757|79328045|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
44322896|NCT01212757|79328037|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
44322897|NCT01212757|79328038|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
44322898|NCT01212757|79328039|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
44322899|NCT01212757|79328040|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
44322900|NCT01212757|79328041|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
44322901|NCT01212757|79328042|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
44322902|NCT01212757|79328043|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
44422072|NCT00755846|79430045|FG002|Overall Study|Adverse Event|0|||
44422073|NCT00755846|79430046|FG003|Overall Study|Adverse Event|1|||
44422074|NCT00755846|79430047|FG004|Overall Study|Adverse Event|3|||
44422075|NCT00755846|79430048|FG005|Overall Study|Adverse Event|2|||
44322903|NCT01212757|79328044|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
44322904|NCT01212757|79328045|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
44322905|NCT01212757|79328037|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
44322906|NCT01212757|79328038|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
44322907|NCT01212757|79328039|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
44322908|NCT01212757|79328040|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
44322909|NCT01212757|79328041|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
44322910|NCT01212757|79328042|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
44322911|NCT01212757|79328043|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
44322912|NCT01212757|79328044|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
44322913|NCT01212757|79328045|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
44322914|NCT01212757|79328037|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322915|NCT01212757|79328038|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322916|NCT01212757|79328039|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
44322917|NCT01212757|79328040|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322918|NCT01212757|79328041|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322919|NCT01212757|79328042|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322920|NCT01212757|79328043|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322921|NCT01212757|79328044|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322922|NCT01212757|79328045|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
44322923|NCT01212757|79328037|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44322924|NCT01212757|79328038|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
44322925|NCT01212757|79328039|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
44322926|NCT01212757|79328040|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
44322927|NCT01212757|79328041|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
44322928|NCT01212757|79328042|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
44322929|NCT01212757|79328043|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44322930|NCT01212757|79328044|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44322931|NCT01212757|79328045|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
44322932|NCT01212757|79328037|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322933|NCT01212757|79328038|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
44322934|NCT01212757|79328039|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322935|NCT01212757|79328040|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322936|NCT01212757|79328041|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
44322937|NCT01212757|79328042|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322938|NCT01212757|79328043|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322939|NCT01212757|79328044|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322940|NCT01212757|79328045|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
44322941|NCT01212757|79328037|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322942|NCT01212757|79328038|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
44322943|NCT01212757|79328039|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
44322944|NCT01212757|79328040|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322945|NCT01212757|79328041|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322946|NCT01212757|79328042|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322947|NCT01212757|79328043|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322948|NCT01212757|79328044|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322949|NCT01212757|79328045|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
44322950|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322951|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322952|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322953|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322954|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322955|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322956|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322957|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
44322958|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
44322959|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
44322960|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
44322961|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
44322962|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
44322963|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
44322964|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
44322965|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
44322966|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
44322967|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
44422076|NCT00755846|79430043|FG000|Overall Study|Protocol Violation|1|||
44322968|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
44322969|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
44322970|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
44322971|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
44322972|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
44322973|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
44322974|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
44322975|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
44322976|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
44322977|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44322978|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
44322979|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
44322980|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44322981|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44322982|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44322983|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
44322984|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
44322985|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
44322986|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322987|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322988|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
44322989|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322990|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322991|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322992|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322993|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322994|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
44322995|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
44322996|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
44322997|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
44322998|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
44322999|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
44323000|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
44323001|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
44323002|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
44323003|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
44323004|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
44323005|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
44323006|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
44323007|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
44155827|NCT02641379|78947350|FG010|Overall Study|Withdrawal of informed consent|0|||
44155828|NCT02641379|78947340|FG000|Overall Study|Adverse Event|7|||
44155829|NCT02641379|78947341|FG001|Overall Study|Adverse Event|8|||
44155830|NCT02641379|78947342|FG002|Overall Study|Adverse Event|2|||
44323008|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
44323009|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
44323010|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
44323011|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
44323012|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
44323013|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323014|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323015|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
44323016|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323017|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323018|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323019|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44422077|NCT00755846|79430044|FG001|Overall Study|Protocol Violation|1|||
44155831|NCT02641379|78947343|FG003|Overall Study|Adverse Event|2|||
44258088|NCT01425632|79112248|FG002|Overall Study|Physician Decision|0|||
44258089|NCT01425632|79112246|FG000|Overall Study|Protocol Violation|0|||
44258090|NCT01425632|79112247|FG001|Overall Study|Protocol Violation|0|||
44258091|NCT01425632|79112248|FG002|Overall Study|Protocol Violation|2|||
44258092|NCT01425632|79112246|FG000|Overall Study|Withdrawal by Subject|0|||
44258093|NCT01425632|79112247|FG001|Overall Study|Withdrawal by Subject|0|||
44258094|NCT01425632|79112248|FG002|Overall Study|Withdrawal by Subject|1|||
44258095|NCT01405508|79112285|FG000|Overall Study|AE, non-serious non-fatal|1|||
44258096|NCT01405508|79112286|FG001|Overall Study|AE, non-serious non-fatal|1|||
44258097|NCT01405508|79112287|FG002|Overall Study|AE, non-serious non-fatal|0|||
44258098|NCT01405508|79112288|FG003|Overall Study|AE, non-serious non-fatal|0|||
44258099|NCT01405196|79112424|FG000|Overall Study|Study Terminated by Sponsor|0|||
44323020|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323021|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
44323022|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44323023|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
44323024|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
44323025|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44323026|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44323027|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44323028|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
44323029|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
44323030|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
44323031|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323032|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323033|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323034|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323035|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323036|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323037|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323038|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
44323039|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
44323040|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323041|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
44323042|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323043|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323044|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323045|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323046|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323047|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323048|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
44323049|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44323050|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44323051|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
44323052|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44323053|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44323054|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44155832|NCT02641379|78947344|FG004|Overall Study|Adverse Event|5|||
44155833|NCT02641379|78947345|FG005|Overall Study|Adverse Event|1|||
44155834|NCT02641379|78947346|FG006|Overall Study|Adverse Event|5|||
44155835|NCT02641379|78947347|FG007|Overall Study|Adverse Event|0|||
44155836|NCT02641379|78947348|FG008|Overall Study|Adverse Event|1|||
44155837|NCT02641379|78947349|FG009|Overall Study|Adverse Event|1|||
44155838|NCT02641379|78947350|FG010|Overall Study|Adverse Event|5|||
44155839|NCT02641379|78947340|FG000|Overall Study|Lack of Efficacy|0|||
44155840|NCT02641379|78947341|FG001|Overall Study|Lack of Efficacy|0|||
44155841|NCT02641379|78947342|FG002|Overall Study|Lack of Efficacy|2|||
44155842|NCT02641379|78947343|FG003|Overall Study|Lack of Efficacy|0|||
44155843|NCT02641379|78947344|FG004|Overall Study|Lack of Efficacy|0|||
44258100|NCT01405196|79112425|FG001|Overall Study|Study Terminated by Sponsor|0|||
44258101|NCT01405196|79112426|FG002|Overall Study|Study Terminated by Sponsor|9|||
44258102|NCT01405196|79112427|FG003|Overall Study|Study Terminated by Sponsor|0|||
44258103|NCT01405196|79112424|FG000|Overall Study|Other|2|||
44258104|NCT01405196|79112425|FG001|Overall Study|Other|2|||
44258105|NCT01405196|79112426|FG002|Overall Study|Other|5|||
44258106|NCT01405196|79112427|FG003|Overall Study|Other|0|||
44258107|NCT01405196|79112424|FG000|Overall Study|Withdrawal by Subject|4|||
44258108|NCT01405196|79112425|FG001|Overall Study|Withdrawal by Subject|6|||
44258109|NCT01405196|79112426|FG002|Overall Study|Withdrawal by Subject|3|||
44258110|NCT01405196|79112427|FG003|Overall Study|Withdrawal by Subject|6|||
44258111|NCT01405196|79112424|FG000|Overall Study|Adverse Event|2|||
44258112|NCT01405196|79112425|FG001|Overall Study|Adverse Event|2|||
44258113|NCT01405196|79112426|FG002|Overall Study|Adverse Event|0|||
44258114|NCT01405196|79112427|FG003|Overall Study|Adverse Event|2|||
44258115|NCT01405196|79112424|FG000|Overall Study|Death|1|||
44258116|NCT01405196|79112425|FG001|Overall Study|Death|0|||
44258117|NCT01405196|79112426|FG002|Overall Study|Death|3|||
44258118|NCT01405196|79112427|FG003|Overall Study|Death|0|||
44258119|NCT01405196|79112424|FG000|Overall Study|Lost to Follow-up|2|||
44258120|NCT01405196|79112425|FG001|Overall Study|Lost to Follow-up|2|||
44258121|NCT01405196|79112426|FG002|Overall Study|Lost to Follow-up|3|||
44258122|NCT01405196|79112427|FG003|Overall Study|Lost to Follow-up|1|||
44155844|NCT02641379|78947345|FG005|Overall Study|Lack of Efficacy|2|||
44258123|NCT01402700|79112477|FG000|Overall Study|Death|3|||
44258124|NCT01402700|79112477|FG000|Overall Study|Withdrawal by Subject|3|||
44258125|NCT01402700|79112477|FG000|Overall Study|Missed Visit|1|||
44155845|NCT02641379|78947346|FG006|Overall Study|Lack of Efficacy|0|||
44155846|NCT02641379|78947347|FG007|Overall Study|Lack of Efficacy|5|||
44155847|NCT02641379|78947348|FG008|Overall Study|Lack of Efficacy|0|||
44155848|NCT02641379|78947349|FG009|Overall Study|Lack of Efficacy|0|||
44155849|NCT02641379|78947350|FG010|Overall Study|Lack of Efficacy|0|||
44323055|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44323056|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
44323057|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
44323058|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323059|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
44323060|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323061|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323062|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323063|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323064|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323065|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
44323066|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
44323067|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
44422078|NCT00755846|79430045|FG002|Overall Study|Protocol Violation|1|||
44422079|NCT00755846|79430046|FG003|Overall Study|Protocol Violation|1|||
44422080|NCT00755846|79430047|FG004|Overall Study|Protocol Violation|1|||
44422081|NCT00755846|79430048|FG005|Overall Study|Protocol Violation|1|||
44422082|NCT00755846|79430043|FG000|Overall Study|Lost to Follow-up|0|||
44422083|NCT00755846|79430044|FG001|Overall Study|Lost to Follow-up|2|||
44422084|NCT00755846|79430045|FG002|Overall Study|Lost to Follow-up|1|||
44422085|NCT00755846|79430046|FG003|Overall Study|Lost to Follow-up|0|||
44422086|NCT00755846|79430047|FG004|Overall Study|Lost to Follow-up|4|||
44422087|NCT00755846|79430048|FG005|Overall Study|Lost to Follow-up|2|||
44422088|NCT00755846|79430043|FG000|Overall Study|Withdrawal by Subject|2|||
44422089|NCT00755846|79430044|FG001|Overall Study|Withdrawal by Subject|3|||
44422090|NCT00755846|79430045|FG002|Overall Study|Withdrawal by Subject|5|||
44422091|NCT00755846|79430046|FG003|Overall Study|Withdrawal by Subject|2|||
44422092|NCT00755846|79430047|FG004|Overall Study|Withdrawal by Subject|0|||
44422093|NCT00755846|79430048|FG005|Overall Study|Withdrawal by Subject|1|||
44422094|NCT00755846|79430043|FG000|Overall Study|Hyperglycemic Rescue|21|||
44422095|NCT00755846|79430044|FG001|Overall Study|Hyperglycemic Rescue|7|||
44422096|NCT00755846|79430045|FG002|Overall Study|Hyperglycemic Rescue|5|||
44422097|NCT00755846|79430046|FG003|Overall Study|Hyperglycemic Rescue|8|||
44422098|NCT00755846|79430047|FG004|Overall Study|Hyperglycemic Rescue|8|||
44536829|NCT00006011|79547435|FG002|Overall Study|Disease progression|26|||
44536830|NCT00006011|79547433|FG000|Overall Study|Refused further treatment|15|||
44536831|NCT00006011|79547434|FG001|Overall Study|Refused further treatment|13|||
44536832|NCT00006011|79547435|FG002|Overall Study|Refused further treatment|26|||
44536833|NCT00006011|79547433|FG000|Overall Study|Adverse Event|15|||
44536834|NCT00006011|79547434|FG001|Overall Study|Adverse Event|39|||
44536835|NCT00006011|79547435|FG002|Overall Study|Adverse Event|5|||
44536836|NCT00006011|79547433|FG000|Overall Study|Death|0|||
44536837|NCT00006011|79547434|FG001|Overall Study|Death|1|||
44536838|NCT00006011|79547435|FG002|Overall Study|Death|2|||
44536839|NCT00006011|79547433|FG000|Overall Study|Other|4|||
44536840|NCT00006011|79547434|FG001|Overall Study|Other|2|||
44536841|NCT00006011|79547435|FG002|Overall Study|Other|5|||
44536842|NCT00006011|79547433|FG000|Overall Study|Ineligible|18|||
44536843|NCT00006011|79547434|FG001|Overall Study|Ineligible|16|||
44536844|NCT00006011|79547435|FG002|Overall Study|Ineligible|9|||
44536845|NCT03377556|79547441|FG000|Overall Study|Adverse Event|5|||
44536846|NCT03377556|79547441|FG000|Overall Study|Refusal unrelated to adverse events|1|||
44536847|NCT03377556|79547441|FG000|Overall Study|Progression/relapse|38|||
44536848|NCT03377556|79547441|FG000|Overall Study|Death|3|||
44536849|NCT03750955|79547447|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
44536850|NCT03750955|79547448|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
44536851|NCT03750955|79547447|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
44536852|NCT03750955|79547448|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
44536853|NCT00005879|79547458|FG000|Overall Study|Withdrawal by Subject|8|||
44536854|NCT00005879|79547459|FG001|Overall Study|Withdrawal by Subject|10|||
44536855|NCT03510663|79547473|FG000|Overall Study|Withdrawal by Subject|0|||
44536856|NCT03510663|79547474|FG001|Overall Study|Withdrawal by Subject|1|||
44536857|NCT03510663|79547475|FG002|Overall Study|Withdrawal by Subject|0|||
44536858|NCT03510663|79547476|FG003|Overall Study|Withdrawal by Subject|0|||
44536859|NCT03510663|79547477|FG004|Overall Study|Withdrawal by Subject|0|||
44155850|NCT02641379|78947340|FG000|Overall Study|Participant unable to attend study visit|4|||
44155851|NCT02641379|78947341|FG001|Overall Study|Participant unable to attend study visit|10|||
44258126|NCT01424930|79112599|FG000|Overall Study|Adverse Event|0|||
44258127|NCT01424930|79112600|FG001|Overall Study|Adverse Event|1|||
44258128|NCT01424930|79112599|FG000|Overall Study|Death|1|||
44258129|NCT01424930|79112600|FG001|Overall Study|Death|0|||
44323068|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
44323069|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
44323070|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
44323071|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
44323072|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
44323073|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
44323074|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
44323075|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
44323076|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
44323077|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
44323078|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
44422099|NCT00755846|79430048|FG005|Overall Study|Hyperglycemic Rescue|7|||
44422100|NCT00755846|79430043|FG000|Overall Study|Physician Decision|1|||
44422101|NCT00755846|79430044|FG001|Overall Study|Physician Decision|3|||
44155852|NCT02641379|78947342|FG002|Overall Study|Participant unable to attend study visit|1|||
44155853|NCT02641379|78947343|FG003|Overall Study|Participant unable to attend study visit|2|||
44155854|NCT02641379|78947344|FG004|Overall Study|Participant unable to attend study visit|5|||
44155855|NCT02641379|78947345|FG005|Overall Study|Participant unable to attend study visit|1|||
44155856|NCT02641379|78947346|FG006|Overall Study|Participant unable to attend study visit|1|||
44155857|NCT02641379|78947347|FG007|Overall Study|Participant unable to attend study visit|1|||
44155858|NCT02641379|78947348|FG008|Overall Study|Participant unable to attend study visit|0|||
44155859|NCT02641379|78947349|FG009|Overall Study|Participant unable to attend study visit|2|||
44155860|NCT02641379|78947350|FG010|Overall Study|Participant unable to attend study visit|0|||
44155861|NCT02641379|78947340|FG000|Overall Study|Participant's compliance|0|||
44155862|NCT02641379|78947341|FG001|Overall Study|Participant's compliance|1|||
44155863|NCT02641379|78947342|FG002|Overall Study|Participant's compliance|0|||
44155864|NCT02641379|78947343|FG003|Overall Study|Participant's compliance|1|||
44155865|NCT02641379|78947344|FG004|Overall Study|Participant's compliance|0|||
44155866|NCT02641379|78947345|FG005|Overall Study|Participant's compliance|2|||
44422102|NCT00755846|79430045|FG002|Overall Study|Physician Decision|0|||
44422103|NCT00755846|79430046|FG003|Overall Study|Physician Decision|1|||
44422104|NCT00755846|79430047|FG004|Overall Study|Physician Decision|0|||
44422105|NCT00755846|79430048|FG005|Overall Study|Physician Decision|1|||
44422106|NCT00755846|79430043|FG000|Overall Study|Administrative Error|0|||
44422107|NCT00755846|79430044|FG001|Overall Study|Administrative Error|1|||
44422108|NCT00755846|79430045|FG002|Overall Study|Administrative Error|0|||
44422109|NCT00755846|79430046|FG003|Overall Study|Administrative Error|0|||
44422110|NCT00755846|79430047|FG004|Overall Study|Administrative Error|0|||
44422111|NCT00755846|79430048|FG005|Overall Study|Administrative Error|0|||
44422112|NCT00755846|79430043|FG000|Overall Study|Participant Non-compliance|0|||
44422113|NCT00755846|79430044|FG001|Overall Study|Participant Non-compliance|0|||
44422114|NCT00755846|79430045|FG002|Overall Study|Participant Non-compliance|0|||
44422115|NCT00755846|79430046|FG003|Overall Study|Participant Non-compliance|0|||
44422116|NCT00755846|79430047|FG004|Overall Study|Participant Non-compliance|1|||
44155867|NCT02641379|78947346|FG006|Overall Study|Participant's compliance|0|||
44155868|NCT02641379|78947347|FG007|Overall Study|Participant's compliance|0|||
44155869|NCT02641379|78947348|FG008|Overall Study|Participant's compliance|1|||
44155870|NCT02641379|78947349|FG009|Overall Study|Participant's compliance|1|||
44155871|NCT02641379|78947350|FG010|Overall Study|Participant's compliance|1|||
44155872|NCT02641379|78947340|FG000|Overall Study|Participant cannot be reached|4|||
44155873|NCT02641379|78947341|FG001|Overall Study|Participant cannot be reached|4|||
44155874|NCT02641379|78947342|FG002|Overall Study|Participant cannot be reached|0|||
44422117|NCT00755846|79430048|FG005|Overall Study|Participant Non-compliance|0|||
44422118|NCT03850093|79430065|FG000|Overall Study|Withdrawal by Subject|1|||
44422119|NCT03850093|79430066|FG001|Overall Study|Withdrawal by Subject|0|||
44422120|NCT03850093|79430067|FG002|Overall Study|Withdrawal by Subject|2|||
44536860|NCT03510663|79547478|FG005|Overall Study|Withdrawal by Subject|0|||
44536861|NCT03510663|79547479|FG006|Overall Study|Withdrawal by Subject|0|||
44155875|NCT02641379|78947343|FG003|Overall Study|Participant cannot be reached|8|||
44155876|NCT02641379|78947344|FG004|Overall Study|Participant cannot be reached|2|||
44155877|NCT02641379|78947345|FG005|Overall Study|Participant cannot be reached|1|||
44155878|NCT02641379|78947346|FG006|Overall Study|Participant cannot be reached|0|||
44155879|NCT02641379|78947347|FG007|Overall Study|Participant cannot be reached|1|||
44155880|NCT02641379|78947348|FG008|Overall Study|Participant cannot be reached|0|||
44155881|NCT02641379|78947349|FG009|Overall Study|Participant cannot be reached|2|||
44155882|NCT02641379|78947350|FG010|Overall Study|Participant cannot be reached|1|||
44422121|NCT00442117|79430077|FG000|Overall Study|Adverse Event|3|||
44422122|NCT00442117|79430078|FG001|Overall Study|Adverse Event|2|||
44422123|NCT00442117|79430077|FG000|Overall Study|Lack of Efficacy|2|||
44422124|NCT00442117|79430078|FG001|Overall Study|Lack of Efficacy|6|||
44536862|NCT03510663|79547480|FG007|Overall Study|Withdrawal by Subject|0|||
44155883|NCT02641379|78947340|FG000|Overall Study|PCR positive at Week 24|15|||
44155884|NCT02641379|78947341|FG001|Overall Study|PCR positive at Week 24|21|||
44422125|NCT00442117|79430077|FG000|Overall Study|Lost to Follow-up|1|||
44422126|NCT00442117|79430078|FG001|Overall Study|Lost to Follow-up|2|||
44422127|NCT00442117|79430077|FG000|Overall Study|Withdrawal by Subject|2|||
44422128|NCT00442117|79430078|FG001|Overall Study|Withdrawal by Subject|2|||
44422129|NCT00442117|79430077|FG000|Overall Study|Major Deviation|25|||
44422130|NCT00442117|79430078|FG001|Overall Study|Major Deviation|20|||
44422131|NCT00442117|79430077|FG000|Overall Study|Non compliance with protocol|3|||
44155885|NCT02641379|78947342|FG002|Overall Study|PCR positive at Week 24|62|||
44155886|NCT02641379|78947343|FG003|Overall Study|PCR positive at Week 24|0|||
44155887|NCT02641379|78947344|FG004|Overall Study|PCR positive at Week 24|0|||
44155888|NCT02641379|78947345|FG005|Overall Study|PCR positive at Week 24|6|||
44155889|NCT02641379|78947346|FG006|Overall Study|PCR positive at Week 24|3|||
44155890|NCT02641379|78947347|FG007|Overall Study|PCR positive at Week 24|8|||
44155891|NCT02641379|78947348|FG008|Overall Study|PCR positive at Week 24|0|||
44155892|NCT02641379|78947349|FG009|Overall Study|PCR positive at Week 24|1|||
44155893|NCT02641379|78947350|FG010|Overall Study|PCR positive at Week 24|0|||
44155894|NCT02641379|78947340|FG000|Overall Study|PCR positive at follow up 2|1|||
44155895|NCT02641379|78947341|FG001|Overall Study|PCR positive at follow up 2|0|||
44155896|NCT02641379|78947342|FG002|Overall Study|PCR positive at follow up 2|0|||
44155897|NCT02641379|78947343|FG003|Overall Study|PCR positive at follow up 2|0|||
44155898|NCT02641379|78947344|FG004|Overall Study|PCR positive at follow up 2|0|||
44155899|NCT02641379|78947345|FG005|Overall Study|PCR positive at follow up 2|0|||
44155900|NCT02641379|78947346|FG006|Overall Study|PCR positive at follow up 2|0|||
44155901|NCT02641379|78947347|FG007|Overall Study|PCR positive at follow up 2|0|||
44155902|NCT02641379|78947348|FG008|Overall Study|PCR positive at follow up 2|0|||
44155903|NCT02641379|78947349|FG009|Overall Study|PCR positive at follow up 2|0|||
44155904|NCT02641379|78947350|FG010|Overall Study|PCR positive at follow up 2|0|||
44155905|NCT02641379|78947340|FG000|Overall Study|Participant showed relapse|1|||
44422132|NCT00442117|79430078|FG001|Overall Study|Non compliance with protocol|5|||
44422133|NCT00442117|79430077|FG000|Overall Study|Met Withdrawal Criteria|2|||
44422134|NCT00442117|79430078|FG001|Overall Study|Met Withdrawal Criteria|1|||
44422135|NCT00752726|79430086|FG000|Overall Study|Lost to Follow-up|2|||
44155906|NCT02641379|78947341|FG001|Overall Study|Participant showed relapse|0|||
44155907|NCT02641379|78947342|FG002|Overall Study|Participant showed relapse|0|||
44155908|NCT02641379|78947343|FG003|Overall Study|Participant showed relapse|0|||
44155909|NCT02641379|78947344|FG004|Overall Study|Participant showed relapse|0|||
44155910|NCT02641379|78947345|FG005|Overall Study|Participant showed relapse|0|||
44155911|NCT02641379|78947346|FG006|Overall Study|Participant showed relapse|1|||
44155912|NCT02641379|78947347|FG007|Overall Study|Participant showed relapse|0|||
44155913|NCT02641379|78947348|FG008|Overall Study|Participant showed relapse|0|||
44155914|NCT02641379|78947349|FG009|Overall Study|Participant showed relapse|0|||
44155915|NCT02641379|78947350|FG010|Overall Study|Participant showed relapse|0|||
44155916|NCT02641379|78947340|FG000|Overall Study|Participant stopped study/treatment|1|||
44155917|NCT02641379|78947341|FG001|Overall Study|Participant stopped study/treatment|3|||
44155918|NCT02641379|78947342|FG002|Overall Study|Participant stopped study/treatment|1|||
44323079|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
44323080|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
44323081|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
44323082|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
44323083|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
44323084|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
44323085|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44323086|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
44323087|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
44323088|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44323089|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44323090|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44323091|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
44323092|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
44422136|NCT00752726|79430087|FG001|Overall Study|Lost to Follow-up|1|||
44422137|NCT00752726|79430086|FG000|Overall Study|Adverse Event|3|||
44422138|NCT00752726|79430087|FG001|Overall Study|Adverse Event|0|||
44422139|NCT00752726|79430086|FG000|Overall Study|Withdrawal by Subject|5|||
44536863|NCT03510273|79547490|FG000|Overall Study|Withdrawal by Subject|2|||
44536864|NCT03510273|79547490|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
44155919|NCT02641379|78947343|FG003|Overall Study|Participant stopped study/treatment|0|||
44155920|NCT02641379|78947344|FG004|Overall Study|Participant stopped study/treatment|0|||
44155921|NCT02641379|78947345|FG005|Overall Study|Participant stopped study/treatment|1|||
44155922|NCT02641379|78947346|FG006|Overall Study|Participant stopped study/treatment|2|||
44155923|NCT02641379|78947347|FG007|Overall Study|Participant stopped study/treatment|0|||
44155924|NCT02641379|78947348|FG008|Overall Study|Participant stopped study/treatment|1|||
44422140|NCT00752726|79430087|FG001|Overall Study|Withdrawal by Subject|10|||
44155925|NCT02641379|78947349|FG009|Overall Study|Participant stopped study/treatment|0|||
44323093|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
44323094|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
44323095|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
44323096|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
44323097|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
44323098|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
44323099|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
44323100|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
44323101|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
44323102|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
44323103|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44422141|NCT00752726|79430086|FG000|Overall Study|Other Reason|1|||
44422142|NCT00752726|79430087|FG001|Overall Study|Other Reason|2|||
44422143|NCT00755222|79430095|FG000|Overall Study|Withdrawal by Subject|4|||
44422144|NCT00755222|79430096|FG001|Overall Study|Withdrawal by Subject|2|||
44422145|NCT00755222|79430095|FG000|Overall Study|Adverse Event|2|||
44422146|NCT00755222|79430096|FG001|Overall Study|Adverse Event|0|||
44422147|NCT00755222|79430095|FG000|Overall Study|Protocol Violation|2|||
44422148|NCT00755222|79430096|FG001|Overall Study|Protocol Violation|0|||
44422149|NCT00441727|79430105|FG000|Overall Study|Protocol Violation|19|||
44422150|NCT00441727|79430106|FG001|Overall Study|Protocol Violation|28|||
44422151|NCT00441727|79430107|FG002|Overall Study|Protocol Violation|32|||
44422152|NCT00441727|79430105|FG000|Overall Study|Adverse Event|26|||
44422153|NCT00441727|79430106|FG001|Overall Study|Adverse Event|33|||
44422154|NCT00441727|79430107|FG002|Overall Study|Adverse Event|28|||
44422155|NCT00441727|79430105|FG000|Overall Study|Lack of Efficacy|7|||
44422156|NCT00441727|79430106|FG001|Overall Study|Lack of Efficacy|8|||
44422157|NCT00441727|79430107|FG002|Overall Study|Lack of Efficacy|48|||
44422158|NCT00441727|79430105|FG000|Overall Study|Withdrawal by Subject|40|||
44422159|NCT00441727|79430106|FG001|Overall Study|Withdrawal by Subject|34|||
44422160|NCT00441727|79430107|FG002|Overall Study|Withdrawal by Subject|47|||
44422161|NCT00441727|79430105|FG000|Overall Study|Lost to Follow-up|5|||
44422162|NCT00441727|79430106|FG001|Overall Study|Lost to Follow-up|6|||
44422163|NCT00441727|79430107|FG002|Overall Study|Lost to Follow-up|5|||
44422164|NCT00441727|79430105|FG000|Overall Study|Safety Reasons|3|||
44422165|NCT00441727|79430106|FG001|Overall Study|Safety Reasons|1|||
44422166|NCT00441727|79430107|FG002|Overall Study|Safety Reasons|3|||
44422167|NCT00441727|79430105|FG000|Overall Study|Various reason specified|6|||
44422168|NCT00441727|79430106|FG001|Overall Study|Various reason specified|8|||
44422169|NCT00441727|79430107|FG002|Overall Study|Various reason specified|5|||
44422170|NCT00770120|79430129|FG000|Overall Study|Progression|31|||
44422171|NCT00770120|79430129|FG000|Overall Study|Adverse Event|11|||
44422172|NCT00770120|79430129|FG000|Overall Study|Not Protocol Specified|11|||
44422173|NCT00770120|79430129|FG000|Overall Study|Death|3|||
44536865|NCT03510273|79547490|FG000|Overall Study|Moved away from study area|4|||
44258130|NCT01424930|79112599|FG000|Overall Study|Progressive Disease|3|||
44323104|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44422174|NCT00770120|79430129|FG000|Overall Study|Withdrawal by Subject|2|||
44422175|NCT00770120|79430129|FG000|Overall Study|Ineligible|1|||
44422176|NCT00770120|79430129|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
44536866|NCT03582813|79547500|FG000|Overall Study|Lost to Follow-up|18|||
44258131|NCT01424930|79112600|FG001|Overall Study|Progressive Disease|6|||
44258132|NCT01424930|79112599|FG000|Overall Study|Screen Failure|0|||
44258133|NCT01424930|79112600|FG001|Overall Study|Screen Failure|1|||
44258134|NCT01424930|79112599|FG000|Overall Study|Reason not specified|0|||
44258135|NCT01424930|79112600|FG001|Overall Study|Reason not specified|6|||
44258136|NCT01424306|79112615|FG000|Overall Study|Protocol Violation|0|||
44258137|NCT01424306|79112616|FG001|Overall Study|Protocol Violation|0|||
44258138|NCT01424306|79112617|FG002|Overall Study|Protocol Violation|0|||
44258139|NCT01424306|79112618|FG003|Overall Study|Protocol Violation|0|||
44258140|NCT01424306|79112619|FG004|Overall Study|Protocol Violation|1|||
44258141|NCT01424306|79112620|FG005|Overall Study|Protocol Violation|0|||
44258142|NCT01424228|79112664|FG000|Overall Study|Withdrawal by Subject|27|||
44258143|NCT01424228|79112665|FG001|Overall Study|Withdrawal by Subject|11|||
44258144|NCT01424228|79112664|FG000|Overall Study|Adverse Event|10|||
44258145|NCT01424228|79112665|FG001|Overall Study|Adverse Event|14|||
44258146|NCT01424228|79112664|FG000|Overall Study|Sponsor's decision|9|||
44258147|NCT01424228|79112665|FG001|Overall Study|Sponsor's decision|12|||
44258148|NCT01424228|79112664|FG000|Overall Study|Lack of Efficacy|5|||
44258149|NCT01424228|79112665|FG001|Overall Study|Lack of Efficacy|7|||
44258150|NCT01424228|79112664|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
44258151|NCT01424228|79112665|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
44258152|NCT01424228|79112664|FG000|Overall Study|Non-compliance|2|||
44258153|NCT01424228|79112665|FG001|Overall Study|Non-compliance|0|||
44258154|NCT01424228|79112664|FG000|Overall Study|Worsening of symptoms|1|||
44258155|NCT01424228|79112665|FG001|Overall Study|Worsening of symptoms|0|||
44258156|NCT01424228|79112664|FG000|Overall Study|Unplanned journey|0|||
44323105|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44323106|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44323107|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44323108|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44323109|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44323110|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
44323111|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
44323112|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44323113|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
44323114|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
44323115|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44323116|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44323117|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44323118|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
44323119|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
44323120|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
44323121|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
44323122|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
44323123|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
44323124|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
44323125|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
44323126|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
44323127|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
44323128|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
44323129|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
44323130|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
44323131|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
44323132|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
44323133|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
44323134|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
44323135|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
44323136|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
44323137|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
44323138|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
44323139|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323140|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
44323141|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44422177|NCT00770120|79430129|FG000|Overall Study|Reason under Review|1|||
44422178|NCT00436345|79430136|FG000|Overall Study|ICU resident beyond follow-up period|3|||
44422179|NCT00436345|79430137|FG001|Overall Study|ICU resident beyond follow-up period|0|||
44422180|NCT00769184|79430144|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
44422181|NCT00769184|79430145|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
44422182|NCT00769184|79430144|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
44422183|NCT00769184|79430145|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
44422184|NCT00769184|79430144|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
44422185|NCT00769184|79430145|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
44422186|NCT00768560|79430159|FG000|Intervention Set 1|Adverse Event|0|||
44422187|NCT00768560|79430160|FG001|Intervention Set 1|Adverse Event|1|||
44422188|NCT00768560|79430161|FG002|Intervention Set 1|Adverse Event|0|||
44422189|NCT00768560|79430162|FG003|Intervention Set 1|Adverse Event|0|||
44422190|NCT00768560|79430163|FG004|Intervention Set 1|Adverse Event|0|||
44422191|NCT00768560|79430164|FG005|Intervention Set 1|Adverse Event|0|||
44422192|NCT00468559|79430174|FG000|Open-label Treatment Phase|Adverse Event|5|||
44422193|NCT00468559|79430175|FG001|Open-label Treatment Phase|Adverse Event|0|||
44422194|NCT00468559|79430176|FG002|Open-label Treatment Phase|Adverse Event|0|||
44422195|NCT00468559|79430174|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
44422196|NCT00468559|79430175|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
44422197|NCT00468559|79430176|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
44422198|NCT00468559|79430174|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
44422199|NCT00468559|79430175|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
44422200|NCT00468559|79430176|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
44422201|NCT00468559|79430174|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
44422202|NCT00468559|79430175|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
44422203|NCT00468559|79430176|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
44422204|NCT00468559|79430174|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
44422205|NCT00468559|79430175|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
44422206|NCT00468559|79430176|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
44422207|NCT00754442|79430186|FG000|Overall Study|Withdrawal by Subject|5|||
44323142|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323143|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323144|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323145|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323146|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323147|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
44323148|NCT01212757|79328037|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323149|NCT01212757|79328038|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
44323150|NCT01212757|79328039|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
44323151|NCT01212757|79328040|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323152|NCT01212757|79328041|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323153|NCT01212757|79328042|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323154|NCT01212757|79328043|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323155|NCT01212757|79328044|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323156|NCT01212757|79328045|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
44323157|NCT01190410|79328065|FG000|Overall Study|Adverse Event|0|||
44323158|NCT01190410|79328066|FG001|Overall Study|Adverse Event|3|||
44323159|NCT01190410|79328065|FG000|Overall Study|Lack of Efficacy|0|||
44323160|NCT01190410|79328066|FG001|Overall Study|Lack of Efficacy|2|||
44323161|NCT01190410|79328065|FG000|Overall Study|Withdrawal by Subject|0|||
44323162|NCT01190410|79328066|FG001|Overall Study|Withdrawal by Subject|2|||
44323163|NCT01190410|79328065|FG000|Overall Study|Administrative decision|1|||
44323164|NCT01190410|79328066|FG001|Overall Study|Administrative decision|0|||
44323165|NCT01190410|79328065|FG000|Overall Study|PI discretion|0|||
44323166|NCT01190410|79328066|FG001|Overall Study|PI discretion|2|||
44323167|NCT01190254|79328081|FG000|Overall Study|Adverse Event|3|||
44323168|NCT01190254|79328082|FG001|Overall Study|Adverse Event|6|||
44323169|NCT01190254|79328083|FG002|Overall Study|Adverse Event|8|||
44323170|NCT01190254|79328081|FG000|Overall Study|Lack of Efficacy|7|||
44155926|NCT02641379|78947350|FG010|Overall Study|Participant stopped study/treatment|0|||
44323171|NCT01190254|79328082|FG001|Overall Study|Lack of Efficacy|4|||
44323172|NCT01190254|79328083|FG002|Overall Study|Lack of Efficacy|5|||
44323173|NCT01190254|79328081|FG000|Overall Study|Lost to Follow-up|4|||
44323174|NCT01190254|79328082|FG001|Overall Study|Lost to Follow-up|2|||
44323175|NCT01190254|79328083|FG002|Overall Study|Lost to Follow-up|0|||
44323176|NCT01190254|79328081|FG000|Overall Study|Withdrawal by Subject|4|||
44323177|NCT01190254|79328082|FG001|Overall Study|Withdrawal by Subject|5|||
44323178|NCT01190254|79328083|FG002|Overall Study|Withdrawal by Subject|7|||
44323179|NCT01190254|79328081|FG000|Overall Study|Protocol Violation|2|||
44323180|NCT01190254|79328082|FG001|Overall Study|Protocol Violation|0|||
44323181|NCT01190254|79328083|FG002|Overall Study|Protocol Violation|2|||
44323182|NCT01190254|79328081|FG000|Overall Study|Did not meet protocol eligibility|1|||
44323183|NCT01190254|79328082|FG001|Overall Study|Did not meet protocol eligibility|0|||
44323184|NCT01190254|79328083|FG002|Overall Study|Did not meet protocol eligibility|0|||
44323185|NCT01190839|79328093|FG000|Overall Study|Adverse Event|32|||
44323186|NCT01190839|79328094|FG001|Overall Study|Adverse Event|41|||
44323187|NCT01190839|79328093|FG000|Overall Study|Protocol Violation|2|||
44323188|NCT01190839|79328094|FG001|Overall Study|Protocol Violation|2|||
44323189|NCT01190839|79328093|FG000|Overall Study|Lost to Follow-up|7|||
44323190|NCT01190839|79328094|FG001|Overall Study|Lost to Follow-up|1|||
44323191|NCT01190839|79328093|FG000|Overall Study|Death|1|||
44323192|NCT01190839|79328094|FG001|Overall Study|Death|0|||
44323193|NCT01190839|79328093|FG000|Overall Study|Trial stopped by Sponsor|71|||
44323194|NCT01190839|79328094|FG001|Overall Study|Trial stopped by Sponsor|68|||
44323195|NCT01190839|79328093|FG000|Overall Study|Undefined|35|||
44323196|NCT01190839|79328094|FG001|Overall Study|Undefined|31|||
44323197|NCT01190839|79328093|FG000|Overall Study|Randomized but not treated|2|||
44323198|NCT01190839|79328094|FG001|Overall Study|Randomized but not treated|4|||
44323199|NCT01190215|79328104|FG000|Up to Month 6|Lost to Follow-up|2|||
44323200|NCT01190215|79328105|FG001|Up to Month 6|Lost to Follow-up|0|||
44323201|NCT01190449|79328113|FG000|Overall Study|Ineligible|0|||
44323202|NCT01190449|79328114|FG001|Overall Study|Ineligible|4|||
44323203|NCT01190176|79328120|FG000|Overall Study|Withdrawal by Subject|1|||
44323204|NCT01190176|79328120|FG000|Overall Study|Lost to Follow-up|1|||
44323205|NCT01190098|79328126|FG000|Overall Study|Adverse Event|2|||
44323206|NCT01190098|79328127|FG001|Overall Study|Adverse Event|0|||
44323207|NCT01190098|79328126|FG000|Overall Study|Patient coomorbidity|0|||
44323208|NCT01190098|79328127|FG001|Overall Study|Patient coomorbidity|1|||
44323209|NCT01190098|79328126|FG000|Overall Study|Lack of transportation|1|||
44323210|NCT01190098|79328127|FG001|Overall Study|Lack of transportation|0|||
44323211|NCT01190098|79328126|FG000|Overall Study|Other|0|||
44323212|NCT01190098|79328127|FG001|Overall Study|Other|1|||
44323213|NCT01190020|79328135|FG000|Overall Study|Adverse Event|2|||
44323214|NCT01190020|79328136|FG001|Overall Study|Adverse Event|0|||
44323215|NCT01190020|79328135|FG000|Overall Study|Lost to Follow-up|2|||
44323216|NCT01190020|79328136|FG001|Overall Study|Lost to Follow-up|0|||
44323217|NCT01190020|79328135|FG000|Overall Study|Withdrawal by Subject|3|||
44323218|NCT01190020|79328136|FG001|Overall Study|Withdrawal by Subject|0|||
44323219|NCT01189435|79328142|FG000|Overall Study|Withdrawal by Subject|1|||
44323220|NCT01189435|79328142|FG000|Overall Study|Physician Decision|1|||
44323221|NCT01165996|79328146|FG000|Overall Study|Death|1|||
44323222|NCT01165996|79328146|FG000|Overall Study|Physician Decision|1|||
44323223|NCT01165684|79328153|FG000|Overall Study|Adverse Event|1|||
44323224|NCT01165684|79328154|FG001|Overall Study|Adverse Event|1|||
44323225|NCT01165684|79328153|FG000|Overall Study|Lack of Efficacy|2|||
44323226|NCT01165684|79328154|FG001|Overall Study|Lack of Efficacy|1|||
44323227|NCT01165684|79328153|FG000|Overall Study|Protocol Violation|7|||
44323228|NCT01165684|79328154|FG001|Overall Study|Protocol Violation|15|||
44323229|NCT01165684|79328153|FG000|Overall Study|Withdrawal Criteria|2|||
44323230|NCT01165684|79328154|FG001|Overall Study|Withdrawal Criteria|13|||
44422208|NCT00754442|79430187|FG001|Overall Study|Withdrawal by Subject|3|||
44323231|NCT01165684|79328153|FG000|Overall Study|Unclassified|16|||
44323232|NCT01165684|79328154|FG001|Overall Study|Unclassified|22|||
44323233|NCT01189201|79328160|FG000|Overall Study|Adverse Event|1|||
44323234|NCT01188967|79328177|FG000|Overall Study|Withdrawal by Subject|1|||
44323235|NCT01188967|79328178|FG001|Overall Study|Withdrawal by Subject|1|||
44323236|NCT01188967|79328177|FG000|Overall Study|Physician Decision|1|||
44323237|NCT01188967|79328178|FG001|Overall Study|Physician Decision|1|||
44323238|NCT01188967|79328177|FG000|Overall Study|Lost to Follow-up|3|||
44323239|NCT01188967|79328178|FG001|Overall Study|Lost to Follow-up|2|||
44323240|NCT01188811|79328188|FG000|Overall Study|Withdrawal by Subject|0|||
44155927|NCT02641379|78947340|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
44155928|NCT02641379|78947341|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
44155929|NCT02641379|78947342|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
44323241|NCT01188811|79328189|FG001|Overall Study|Withdrawal by Subject|2|||
44323242|NCT01188811|79328188|FG000|Overall Study|Adverse Event|6|||
44323243|NCT01188811|79328189|FG001|Overall Study|Adverse Event|0|||
44323244|NCT01183234|79328197|FG000|First Intervention|Adverse Event|1|||
44323245|NCT01183234|79328198|FG001|First Intervention|Adverse Event|0|||
44323246|NCT01165216|79328206|FG000|Overall Study|Adverse Event|6|||
44323247|NCT01165216|79328207|FG001|Overall Study|Adverse Event|3|||
44323248|NCT01165216|79328206|FG000|Overall Study|Withdrawal by Subject|1|||
44323249|NCT01165216|79328207|FG001|Overall Study|Withdrawal by Subject|1|||
44323250|NCT01165216|79328206|FG000|Overall Study|Disease progression|1|||
44323251|NCT01165216|79328207|FG001|Overall Study|Disease progression|3|||
44323252|NCT04545476|79328232|FG000|Overall Study|Lost to Follow-up|1|||
44323253|NCT04545476|79328233|FG001|Overall Study|Lost to Follow-up|1|||
44323254|NCT04545476|79328234|FG002|Overall Study|Lost to Follow-up|0|||
44323255|NCT04545476|79328235|FG003|Overall Study|Lost to Follow-up|0|||
44323256|NCT01969838|79328250|FG000|Double-blind Phase|Adverse Event|10|||
44323257|NCT01969838|79328251|FG001|Double-blind Phase|Adverse Event|4|||
44155930|NCT02641379|78947343|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
44155931|NCT02641379|78947344|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
44323258|NCT01969838|79328252|FG002|Double-blind Phase|Adverse Event|0|||
44323259|NCT01969838|79328253|FG003|Double-blind Phase|Adverse Event|0|||
44323260|NCT01969838|79328250|FG000|Double-blind Phase|Death|5|||
44323261|NCT01969838|79328251|FG001|Double-blind Phase|Death|2|||
44323262|NCT01969838|79328252|FG002|Double-blind Phase|Death|0|||
44323263|NCT01969838|79328253|FG003|Double-blind Phase|Death|0|||
44323264|NCT01969838|79328250|FG000|Double-blind Phase|Physician Decision|5|||
44323265|NCT01969838|79328251|FG001|Double-blind Phase|Physician Decision|1|||
44323266|NCT01969838|79328252|FG002|Double-blind Phase|Physician Decision|0|||
44323267|NCT01969838|79328253|FG003|Double-blind Phase|Physician Decision|0|||
44323268|NCT01969838|79328250|FG000|Double-blind Phase|Subject Decision|4|||
44323269|NCT01969838|79328251|FG001|Double-blind Phase|Subject Decision|2|||
44323270|NCT01969838|79328252|FG002|Double-blind Phase|Subject Decision|0|||
44323271|NCT01969838|79328253|FG003|Double-blind Phase|Subject Decision|0|||
44323272|NCT01969838|79328250|FG000|Double-blind Phase|Disease Progression|2|||
44323273|NCT01969838|79328251|FG001|Double-blind Phase|Disease Progression|0|||
44323274|NCT01969838|79328252|FG002|Double-blind Phase|Disease Progression|0|||
44323275|NCT01969838|79328253|FG003|Double-blind Phase|Disease Progression|0|||
44323276|NCT01969838|79328250|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
44323277|NCT01969838|79328251|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
44323278|NCT01969838|79328252|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
44323279|NCT01969838|79328253|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
44323280|NCT01969838|79328250|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
44323281|NCT01969838|79328251|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
44323282|NCT01969838|79328252|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
44323283|NCT01969838|79328253|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
44323284|NCT01969838|79328250|FG000|Open-label Phase|Adverse Event|0|||
44323285|NCT01969838|79328251|FG001|Open-label Phase|Adverse Event|0|||
44323286|NCT01969838|79328252|FG002|Open-label Phase|Adverse Event|37|||
44323287|NCT01969838|79328253|FG003|Open-label Phase|Adverse Event|49|||
44323288|NCT01969838|79328250|FG000|Open-label Phase|Disease Progression|0|||
44323289|NCT01969838|79328251|FG001|Open-label Phase|Disease Progression|0|||
44323290|NCT01969838|79328252|FG002|Open-label Phase|Disease Progression|26|||
44323291|NCT01969838|79328253|FG003|Open-label Phase|Disease Progression|27|||
44323292|NCT01969838|79328250|FG000|Open-label Phase|Lack of Efficacy|0|||
44323293|NCT01969838|79328251|FG001|Open-label Phase|Lack of Efficacy|0|||
44323294|NCT01969838|79328252|FG002|Open-label Phase|Lack of Efficacy|17|||
44323295|NCT01969838|79328253|FG003|Open-label Phase|Lack of Efficacy|19|||
44323296|NCT01969838|79328250|FG000|Open-label Phase|Subject Decision|0|||
44323297|NCT01969838|79328251|FG001|Open-label Phase|Subject Decision|0|||
44323298|NCT01969838|79328252|FG002|Open-label Phase|Subject Decision|14|||
44323299|NCT01969838|79328253|FG003|Open-label Phase|Subject Decision|15|||
44323300|NCT01969838|79328250|FG000|Open-label Phase|Death|0|||
44323301|NCT01969838|79328251|FG001|Open-label Phase|Death|0|||
44323302|NCT01969838|79328252|FG002|Open-label Phase|Death|13|||
44323303|NCT01969838|79328253|FG003|Open-label Phase|Death|11|||
44323304|NCT01969838|79328250|FG000|Open-label Phase|Physician Decision|0|||
44323305|NCT01969838|79328251|FG001|Open-label Phase|Physician Decision|0|||
44323306|NCT01969838|79328252|FG002|Open-label Phase|Physician Decision|9|||
44323307|NCT01969838|79328253|FG003|Open-label Phase|Physician Decision|14|||
44323308|NCT01969838|79328250|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
44323309|NCT01969838|79328251|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
44323310|NCT01969838|79328252|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
44323311|NCT01969838|79328253|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
44323312|NCT01165177|79328264|FG000|Overall Study|Serious Adverse Event|227|||
44323313|NCT01165177|79328265|FG001|Overall Study|Serious Adverse Event|235|||
44323314|NCT01165177|79328264|FG000|Overall Study|Withdrawal by Subject|368|||
44323315|NCT01165177|79328265|FG001|Overall Study|Withdrawal by Subject|354|||
44323316|NCT01165177|79328264|FG000|Overall Study|Protocol Violation|19|||
44323317|NCT01165177|79328265|FG001|Overall Study|Protocol Violation|21|||
44536867|NCT03582813|79547501|FG001|Overall Study|Lost to Follow-up|21|||
44536868|NCT03582813|79547500|FG000|Overall Study|Withdrawal by Subject|1|||
44536869|NCT03582813|79547501|FG001|Overall Study|Withdrawal by Subject|0|||
44536870|NCT03480009|79547511|FG000|Overall Study|Lost to Follow-up|4|||
44536871|NCT03480009|79547512|FG001|Overall Study|Lost to Follow-up|5|||
44155932|NCT02641379|78947345|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
44155933|NCT02641379|78947346|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
44155934|NCT02641379|78947347|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
44323318|NCT01165177|79328264|FG000|Overall Study|Non-serious adverse event|30|||
44323319|NCT01165177|79328265|FG001|Overall Study|Non-serious adverse event|18|||
44323320|NCT01165177|79328264|FG000|Overall Study|Other unspecified reasons|47|||
44323321|NCT01165177|79328265|FG001|Overall Study|Other unspecified reasons|35|||
44155935|NCT02641379|78947348|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
44155936|NCT02641379|78947349|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
44155937|NCT02641379|78947350|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
44155938|NCT02641379|78947340|FG000|Overall Study|Financial problems|0|||
44323322|NCT01165177|79328264|FG000|Overall Study|Suspected HZ episode|0|||
44323323|NCT01165177|79328265|FG001|Overall Study|Suspected HZ episode|2|||
44323324|NCT01165177|79328264|FG000|Overall Study|Lost to Follow-up|183|||
44323325|NCT01165177|79328265|FG001|Overall Study|Lost to Follow-up|194|||
44323326|NCT01165177|79328264|FG000|Overall Study|Migrated/ moved from study area|48|||
44323327|NCT01165177|79328265|FG001|Overall Study|Migrated/ moved from study area|43|||
44323328|NCT01165138|79328282|FG000|Overall Study|Adverse Event|0|||
44323329|NCT01165138|79328283|FG001|Overall Study|Adverse Event|1|||
44323330|NCT01165138|79328284|FG002|Overall Study|Adverse Event|0|||
44155939|NCT02641379|78947341|FG001|Overall Study|Financial problems|1|||
44323331|NCT01165138|79328285|FG003|Overall Study|Adverse Event|2|||
44323332|NCT01165138|79328282|FG000|Overall Study|Lack of Efficacy|0|||
44323333|NCT01165138|79328283|FG001|Overall Study|Lack of Efficacy|32|||
44323334|NCT01165138|79328284|FG002|Overall Study|Lack of Efficacy|6|||
44323335|NCT01165138|79328285|FG003|Overall Study|Lack of Efficacy|7|||
44323336|NCT01165138|79328282|FG000|Overall Study|Protocol Violation|0|||
44323337|NCT01165138|79328283|FG001|Overall Study|Protocol Violation|7|||
44323338|NCT01165138|79328284|FG002|Overall Study|Protocol Violation|0|||
44323339|NCT01165138|79328285|FG003|Overall Study|Protocol Violation|2|||
44323340|NCT01165138|79328282|FG000|Overall Study|Lost to Follow-up|0|||
44323341|NCT01165138|79328283|FG001|Overall Study|Lost to Follow-up|0|||
44323342|NCT01165138|79328284|FG002|Overall Study|Lost to Follow-up|1|||
44323343|NCT01165138|79328285|FG003|Overall Study|Lost to Follow-up|2|||
44323344|NCT01165138|79328282|FG000|Overall Study|Physician Decision|0|||
44323345|NCT01165138|79328283|FG001|Overall Study|Physician Decision|6|||
44323346|NCT01165138|79328284|FG002|Overall Study|Physician Decision|7|||
44323347|NCT01165138|79328285|FG003|Overall Study|Physician Decision|6|||
44323348|NCT01165138|79328282|FG000|Overall Study|Withdrawal by Subject|0|||
44323349|NCT01165138|79328283|FG001|Overall Study|Withdrawal by Subject|6|||
44323350|NCT01165138|79328284|FG002|Overall Study|Withdrawal by Subject|6|||
44536872|NCT03480009|79547513|FG002|Overall Study|Lost to Follow-up|4|||
44536873|NCT03480009|79547514|FG003|Overall Study|Lost to Follow-up|0|||
44536874|NCT03399786|79547529|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
44536875|NCT03399786|79547530|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
44155940|NCT02641379|78947342|FG002|Overall Study|Financial problems|0|||
44155941|NCT02641379|78947343|FG003|Overall Study|Financial problems|0|||
44323351|NCT01165138|79328285|FG003|Overall Study|Withdrawal by Subject|3|||
44323352|NCT01165021|79328293|FG000|Overall Study|Death|1|||
44323353|NCT01182844|79328299|FG000|Overall Study|Withdrawal by Subject|0|||
44323354|NCT01182844|79328300|FG001|Overall Study|Withdrawal by Subject|2|||
44323355|NCT01164865|79328308|FG000|Overall Study|Lost to Follow-up|2|||
44323356|NCT01164865|79328309|FG001|Overall Study|Lost to Follow-up|1|||
44536876|NCT03399786|79547531|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
44536877|NCT03399786|79547532|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
44536878|NCT03399786|79547529|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
44155942|NCT02641379|78947344|FG004|Overall Study|Financial problems|0|||
44323357|NCT01164475|79328317|FG000|Overall Study|Lack of Efficacy|1|||
44323358|NCT01164475|79328318|FG001|Overall Study|Lack of Efficacy|0|||
44323359|NCT01164475|79328317|FG000|Overall Study|Other|0|||
44323360|NCT01164475|79328318|FG001|Overall Study|Other|1|||
44323361|NCT01164475|79328317|FG000|Overall Study|Progressive disease|0|||
44323362|NCT01164475|79328318|FG001|Overall Study|Progressive disease|1|||
44323363|NCT01164475|79328317|FG000|Overall Study|Protocol Violation|1|||
44323364|NCT01164475|79328318|FG001|Overall Study|Protocol Violation|0|||
44323365|NCT01164007|79328324|FG000|Overall Study|Adverse Event|5|||
44323366|NCT01164007|79328324|FG000|Overall Study|Progression of Disease|30|||
44323367|NCT01164007|79328324|FG000|Overall Study|Protocol Violation|1|||
44323368|NCT01164007|79328324|FG000|Overall Study|Withdrawal by Subject|1|||
44323369|NCT01164007|79328324|FG000|Overall Study|Medical Decision|3|||
44323370|NCT01163851|79328330|FG000|Overall Study|Site Closure|0|||
44323371|NCT01163851|79328331|FG001|Overall Study|Site Closure|1|||
44323372|NCT01163851|79328330|FG000|Overall Study|Enrolled but not treated|1|||
44323373|NCT01163851|79328331|FG001|Overall Study|Enrolled but not treated|0|||
44323374|NCT01163617|79328337|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323375|NCT01163617|79328338|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
44323376|NCT01163617|79328339|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323377|NCT01163617|79328340|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323378|NCT01163617|79328341|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323379|NCT01163617|79328342|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323380|NCT01163617|79328343|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323381|NCT01163617|79328344|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
44323382|NCT01163617|79328337|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323383|NCT01163617|79328338|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
44323384|NCT01163617|79328339|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323385|NCT01163617|79328340|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323386|NCT01163617|79328341|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323387|NCT01163617|79328342|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323388|NCT01163617|79328343|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323389|NCT01163617|79328344|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
44323390|NCT01163617|79328337|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323391|NCT01163617|79328338|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323392|NCT01163617|79328339|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
44323393|NCT01163617|79328340|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323394|NCT01163617|79328341|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323395|NCT01163617|79328342|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323396|NCT01163617|79328343|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323397|NCT01163617|79328344|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
44323398|NCT01182337|79328366|FG000|Overall Study|Withdrawal by Subject|3|||
44323399|NCT01182337|79328367|FG001|Overall Study|Withdrawal by Subject|1|||
44323400|NCT01182337|79328366|FG000|Overall Study|Lost to Follow-up|0|||
44323401|NCT01182337|79328367|FG001|Overall Study|Lost to Follow-up|1|||
44323402|NCT01182298|79328374|FG000|Overall Study|Lack of Efficacy|4|||
44323403|NCT01182298|79328374|FG000|Overall Study|Withdrawal by Subject|2|||
44323404|NCT01163266|79328381|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
44323405|NCT01163266|79328382|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
44323406|NCT01163266|79328383|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
44323407|NCT01163266|79328381|FG000|Overall Study|Lack of Efficacy|1|||
44323408|NCT01163266|79328382|FG001|Overall Study|Lack of Efficacy|3|||
44323409|NCT01163266|79328383|FG002|Overall Study|Lack of Efficacy|1|||
44323410|NCT01163266|79328381|FG000|Overall Study|Noncompliance with Study Drug|0|||
44323411|NCT01163266|79328382|FG001|Overall Study|Noncompliance with Study Drug|2|||
44323412|NCT01163266|79328383|FG002|Overall Study|Noncompliance with Study Drug|0|||
44323413|NCT01163266|79328381|FG000|Overall Study|Protocol Deviations|2|||
44323414|NCT01163266|79328382|FG001|Overall Study|Protocol Deviations|2|||
44323415|NCT01163266|79328383|FG002|Overall Study|Protocol Deviations|5|||
44323416|NCT01163266|79328381|FG000|Overall Study|Withdrawal of Consent|5|||
44323417|NCT01163266|79328382|FG001|Overall Study|Withdrawal of Consent|7|||
44323418|NCT01163266|79328383|FG002|Overall Study|Withdrawal of Consent|3|||
44323419|NCT01163266|79328381|FG000|Overall Study|Lost to Follow-up|7|||
44323420|NCT01163266|79328382|FG001|Overall Study|Lost to Follow-up|7|||
44323421|NCT01163266|79328383|FG002|Overall Study|Lost to Follow-up|10|||
44323422|NCT01163266|79328381|FG000|Overall Study|Other|1|||
44323423|NCT01163266|79328382|FG001|Overall Study|Other|1|||
44323424|NCT01163266|79328383|FG002|Overall Study|Other|2|||
44323425|NCT01163149|79328441|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
44323426|NCT01163149|79328442|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
44323427|NCT01163149|79328443|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
44323428|NCT01163149|79328441|FG000|Extension Treatment Period|Adverse Event|0|||
44323429|NCT01163149|79328442|FG001|Extension Treatment Period|Adverse Event|1|||
44323430|NCT01163149|79328443|FG002|Extension Treatment Period|Adverse Event|0|||
44323431|NCT01163149|79328441|FG000|Extension Treatment Period|Noncompliance|0|||
44323432|NCT01163149|79328442|FG001|Extension Treatment Period|Noncompliance|0|||
44323433|NCT01163149|79328443|FG002|Extension Treatment Period|Noncompliance|1|||
44323434|NCT01163032|79328468|FG000|Randomization Phase|Withdrawal by Subject|2|||
44323435|NCT01163032|79328469|FG001|Randomization Phase|Withdrawal by Subject|3|||
44323436|NCT01163032|79328470|FG002|Randomization Phase|Withdrawal by Subject|0|||
44323437|NCT01163032|79328468|FG000|Randomization Phase|Adverse Event|3|||
44323438|NCT01163032|79328469|FG001|Randomization Phase|Adverse Event|3|||
44323439|NCT01163032|79328470|FG002|Randomization Phase|Adverse Event|0|||
44323440|NCT01163032|79328468|FG000|Randomization Phase|Protocol Violation|0|||
44323441|NCT01163032|79328469|FG001|Randomization Phase|Protocol Violation|1|||
44323442|NCT01163032|79328470|FG002|Randomization Phase|Protocol Violation|0|||
44323443|NCT01163032|79328468|FG000|Randomization Phase|Various*|5|||
44323444|NCT01163032|79328469|FG001|Randomization Phase|Various*|4|||
44323445|NCT01163032|79328470|FG002|Randomization Phase|Various*|0|||
44323446|NCT01163032|79328468|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
44323447|NCT01163032|79328469|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
44323448|NCT01163032|79328470|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
44323449|NCT01163032|79328468|FG000|Open Label Extension Phase|Adverse Event|0|||
44323450|NCT01163032|79328469|FG001|Open Label Extension Phase|Adverse Event|0|||
44323451|NCT01163032|79328470|FG002|Open Label Extension Phase|Adverse Event|3|||
44323452|NCT01163032|79328468|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
44323453|NCT01163032|79328469|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
44323454|NCT01163032|79328470|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
44323455|NCT01163032|79328468|FG000|Open Label Extension Phase|Protocol Violation|0|||
44323456|NCT01163032|79328469|FG001|Open Label Extension Phase|Protocol Violation|0|||
44323457|NCT01163032|79328470|FG002|Open Label Extension Phase|Protocol Violation|1|||
44323458|NCT01163032|79328468|FG000|Open Label Extension Phase|Study Termination|0|||
44323459|NCT01163032|79328469|FG001|Open Label Extension Phase|Study Termination|0|||
44323460|NCT01163032|79328470|FG002|Open Label Extension Phase|Study Termination|7|||
44323461|NCT01163032|79328468|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
44323462|NCT01163032|79328469|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
44323463|NCT01163032|79328470|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
44323464|NCT01162486|79328483|FG000|Overall Study|low ANC|1|||
44323465|NCT01162486|79328484|FG001|Overall Study|low ANC|0|||
44323466|NCT01162486|79328485|FG002|Overall Study|low ANC|0|||
44323467|NCT01162486|79328486|FG003|Overall Study|low ANC|0|||
44323468|NCT01162486|79328487|FG004|Overall Study|low ANC|0|||
44323469|NCT01162486|79328483|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
44323470|NCT01162486|79328484|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
44323471|NCT01162486|79328485|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
44323472|NCT01162486|79328486|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
44323473|NCT01162486|79328487|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
44323474|NCT01162486|79328483|FG000|Overall Study|elevated LFTs|0|||
44323475|NCT01162486|79328484|FG001|Overall Study|elevated LFTs|0|||
44323476|NCT01162486|79328485|FG002|Overall Study|elevated LFTs|1|||
44323477|NCT01162486|79328486|FG003|Overall Study|elevated LFTs|0|||
44323478|NCT01162486|79328487|FG004|Overall Study|elevated LFTs|0|||
44323479|NCT01162486|79328483|FG000|Overall Study|Pregnancy|0|||
44323480|NCT01162486|79328484|FG001|Overall Study|Pregnancy|0|||
44323481|NCT01162486|79328485|FG002|Overall Study|Pregnancy|0|||
44323482|NCT01162486|79328486|FG003|Overall Study|Pregnancy|1|||
44323483|NCT01162486|79328487|FG004|Overall Study|Pregnancy|0|||
44323484|NCT01162135|79328503|FG000|Overall Study|Withdrawal by Subject|1|||
44323485|NCT01162135|79328503|FG000|Overall Study|Severe back pain|1|||
44323486|NCT01162135|79328503|FG000|Overall Study|Ineligible|1|||
44323487|NCT01161628|79328507|FG000|Overall Study|Death|6|||
44323488|NCT01161628|79328507|FG000|Overall Study|Lack of Efficacy|2|||
44323489|NCT01161472|79328511|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
44323490|NCT01161472|79328512|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
44323491|NCT01161472|79328513|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
44323492|NCT01161472|79328514|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
44323493|NCT01161043|79328524|FG000|Overall Study|Withdrawal by Subject|3|||
44323494|NCT01160770|79328528|FG000|Overall Study|Adverse Event|10|||
44155943|NCT02641379|78947345|FG005|Overall Study|Financial problems|0|||
44323495|NCT01160770|79328528|FG000|Overall Study|Protocol Violation|2|||
44323496|NCT01160770|79328528|FG000|Overall Study|Subject/parent/caregiver request|33|||
44323497|NCT01160770|79328528|FG000|Overall Study|Physician Decision|1|||
44323498|NCT01160770|79328528|FG000|Overall Study|Lost to Follow-up|7|||
44323499|NCT01160770|79328528|FG000|Overall Study|Study termination or sponsor request|1|||
44323500|NCT01160770|79328528|FG000|Overall Study|Death|9|||
44323501|NCT01160770|79328528|FG000|Overall Study|Lack of Efficacy|15|||
44323502|NCT01160770|79328528|FG000|Overall Study|Other Reasons|1|||
44323503|NCT01160614|79328534|FG000|Overall Study|Withdrawal by Subject|0|||
44323504|NCT01160614|79328535|FG001|Overall Study|Withdrawal by Subject|2|||
44323505|NCT01159912|79328562|FG000|Overall Study|Adverse Event|2|||
44323506|NCT01159912|79328563|FG001|Overall Study|Adverse Event|2|||
44323507|NCT01159912|79328564|FG002|Overall Study|Adverse Event|3|||
44323508|NCT01159912|79328562|FG000|Overall Study|Lack of Efficacy|23|||
44323509|NCT01159912|79328563|FG001|Overall Study|Lack of Efficacy|15|||
44323510|NCT01159912|79328564|FG002|Overall Study|Lack of Efficacy|14|||
44323511|NCT01159912|79328562|FG000|Overall Study|Protocol Violation|1|||
44323512|NCT01159912|79328563|FG001|Overall Study|Protocol Violation|2|||
44323513|NCT01159912|79328564|FG002|Overall Study|Protocol Violation|3|||
44323514|NCT01159912|79328562|FG000|Overall Study|Lost to Follow-up|4|||
44323515|NCT01159912|79328563|FG001|Overall Study|Lost to Follow-up|0|||
44323516|NCT01159912|79328564|FG002|Overall Study|Lost to Follow-up|0|||
44323517|NCT01159912|79328562|FG000|Overall Study|Physician Decision|0|||
44323518|NCT01159912|79328563|FG001|Overall Study|Physician Decision|0|||
44323519|NCT01159912|79328564|FG002|Overall Study|Physician Decision|3|||
44323520|NCT01159912|79328562|FG000|Overall Study|Withdrawal by Subject|10|||
44323521|NCT01159912|79328563|FG001|Overall Study|Withdrawal by Subject|3|||
44323522|NCT01159912|79328564|FG002|Overall Study|Withdrawal by Subject|3|||
44258157|NCT01424228|79112665|FG001|Overall Study|Unplanned journey|1|||
44258158|NCT01423916|79112674|FG000|Overall Study|Adverse Event|5|||
44258159|NCT01423916|79112675|FG001|Overall Study|Adverse Event|9|||
44258160|NCT01423916|79112676|FG002|Overall Study|Adverse Event|2|||
44258161|NCT01423916|79112674|FG000|Overall Study|Met Withdrawal Criteria|1|||
44258162|NCT01423916|79112675|FG001|Overall Study|Met Withdrawal Criteria|1|||
44258163|NCT01423916|79112676|FG002|Overall Study|Met Withdrawal Criteria|1|||
44258164|NCT01423916|79112674|FG000|Overall Study|Physician Decision|1|||
44258165|NCT01423916|79112675|FG001|Overall Study|Physician Decision|0|||
44258166|NCT01423916|79112676|FG002|Overall Study|Physician Decision|1|||
44258167|NCT01423916|79112674|FG000|Overall Study|Withdrawal by Subject|3|||
44258168|NCT01423916|79112675|FG001|Overall Study|Withdrawal by Subject|10|||
44258169|NCT01423916|79112676|FG002|Overall Study|Withdrawal by Subject|3|||
44258170|NCT01423916|79112674|FG000|Overall Study|Protocol Deviation|1|||
44258171|NCT01423916|79112675|FG001|Overall Study|Protocol Deviation|0|||
44258172|NCT01423916|79112676|FG002|Overall Study|Protocol Deviation|0|||
44258173|NCT01423604|79112795|FG000|Safety Run-In|Adverse Event|3|||
44258174|NCT01423604|79112796|FG001|Safety Run-In|Adverse Event|0|||
44258175|NCT01423604|79112795|FG000|Safety Run-In|Death|1|||
44258176|NCT01423604|79112796|FG001|Safety Run-In|Death|0|||
44258177|NCT01423604|79112795|FG000|Safety Run-In|Physician Decision|1|||
44258178|NCT01423604|79112796|FG001|Safety Run-In|Physician Decision|0|||
44258179|NCT01423604|79112795|FG000|Safety Run-In|Disease progression|3|||
44258180|NCT01423604|79112796|FG001|Safety Run-In|Disease progression|0|||
44258181|NCT01423604|79112795|FG000|Safety Run-In|Patient decision|1|||
44258182|NCT01423604|79112796|FG001|Safety Run-In|Patient decision|0|||
44258183|NCT01423604|79112795|FG000|Randomized|Adverse Event|4|||
44258184|NCT01423604|79112796|FG001|Randomized|Adverse Event|10|||
44258185|NCT01423604|79112795|FG000|Randomized|Death|1|||
44258186|NCT01423604|79112796|FG001|Randomized|Death|0|||
44258187|NCT01423604|79112795|FG000|Randomized|Physician Decision|16|||
44258188|NCT01423604|79112796|FG001|Randomized|Physician Decision|13|||
44258189|NCT01423604|79112795|FG000|Randomized|Other - unspecified|37|||
44258190|NCT01423604|79112796|FG001|Randomized|Other - unspecified|31|||
44258191|NCT01423604|79112795|FG000|Randomized|Patient decision|5|||
44258192|NCT01423604|79112796|FG001|Randomized|Patient decision|9|||
44258193|NCT01402544|79112812|FG000|Overall Study|Withdrawal by Subject|6|||
44258194|NCT01401842|79112818|FG000|Overall Study|Withdrawal by Subject|3|||
44258195|NCT01401842|79112819|FG001|Overall Study|Withdrawal by Subject|2|||
44258196|NCT01401842|79112818|FG000|Overall Study|academic reason|4|||
44258197|NCT01401842|79112819|FG001|Overall Study|academic reason|1|||
44258198|NCT01401842|79112818|FG000|Overall Study|changed companies|20|||
44258199|NCT01401842|79112819|FG001|Overall Study|changed companies|34|||
44258200|NCT01401842|79112818|FG000|Overall Study|discharged from US Army|3|||
44258201|NCT01401842|79112819|FG001|Overall Study|discharged from US Army|4|||
44258202|NCT01401842|79112818|FG000|Overall Study|invalid follow-up strength data|1|||
44258203|NCT01401842|79112819|FG001|Overall Study|invalid follow-up strength data|4|||
44258204|NCT01401842|79112818|FG000|Overall Study|on profile|9|||
44258205|NCT01401842|79112819|FG001|Overall Study|on profile|5|||
44258206|NCT01401842|79112818|FG000|Overall Study|other/unknown|28|||
44258207|NCT01401842|79112819|FG001|Overall Study|other/unknown|17|||
44258208|NCT01422824|79112825|FG000|Overall Study|Case record form not evaluated|1|||
44258209|NCT01422824|79112825|FG000|Overall Study|Lost to Follow-up|37|||
44323523|NCT01159600|79328580|FG000|Overall Study|Not treated|0|||
44323524|NCT01159600|79328581|FG001|Overall Study|Not treated|0|||
44323525|NCT01159600|79328582|FG002|Overall Study|Not treated|1|||
44258210|NCT01401530|79112888|FG000|Overall Study|Disease Progression|1|||
44258211|NCT01401530|79112889|FG001|Overall Study|Disease Progression|2|||
44258212|NCT01401530|79112890|FG002|Overall Study|Disease Progression|1|||
44258213|NCT01401530|79112888|FG000|Overall Study|Adverse Event|1|||
44258214|NCT01401530|79112889|FG001|Overall Study|Adverse Event|1|||
44258215|NCT01401530|79112890|FG002|Overall Study|Adverse Event|1|||
44258216|NCT01401530|79112888|FG000|Overall Study|Participant Choice|1|||
44323526|NCT01159600|79328583|FG003|Overall Study|Not treated|0|||
44323527|NCT01159600|79328584|FG004|Overall Study|Not treated|0|||
44323528|NCT01159600|79328585|FG005|Overall Study|Not treated|1|||
44323529|NCT01159600|79328586|FG006|Overall Study|Not treated|2|||
44323530|NCT01159600|79328587|FG007|Overall Study|Not treated|2|||
44323531|NCT01159600|79328580|FG000|Overall Study|Adverse Event|7|||
44323532|NCT01159600|79328581|FG001|Overall Study|Adverse Event|2|||
44323533|NCT01159600|79328582|FG002|Overall Study|Adverse Event|5|||
44323534|NCT01159600|79328583|FG003|Overall Study|Adverse Event|1|||
44323535|NCT01159600|79328584|FG004|Overall Study|Adverse Event|8|||
44323536|NCT01159600|79328585|FG005|Overall Study|Adverse Event|6|||
44323537|NCT01159600|79328586|FG006|Overall Study|Adverse Event|7|||
44323538|NCT01159600|79328587|FG007|Overall Study|Adverse Event|5|||
44323539|NCT01159600|79328580|FG000|Overall Study|Lack of Efficacy|0|||
44323540|NCT01159600|79328581|FG001|Overall Study|Lack of Efficacy|0|||
44323541|NCT01159600|79328582|FG002|Overall Study|Lack of Efficacy|0|||
44323542|NCT01159600|79328583|FG003|Overall Study|Lack of Efficacy|0|||
44323543|NCT01159600|79328584|FG004|Overall Study|Lack of Efficacy|2|||
44323544|NCT01159600|79328585|FG005|Overall Study|Lack of Efficacy|0|||
44323545|NCT01159600|79328586|FG006|Overall Study|Lack of Efficacy|0|||
44323546|NCT01159600|79328587|FG007|Overall Study|Lack of Efficacy|1|||
44323547|NCT01159600|79328580|FG000|Overall Study|Non compliant with protocol|2|||
44323548|NCT01159600|79328581|FG001|Overall Study|Non compliant with protocol|1|||
44323549|NCT01159600|79328582|FG002|Overall Study|Non compliant with protocol|0|||
44323550|NCT01159600|79328583|FG003|Overall Study|Non compliant with protocol|0|||
44323551|NCT01159600|79328584|FG004|Overall Study|Non compliant with protocol|2|||
44323552|NCT01159600|79328585|FG005|Overall Study|Non compliant with protocol|0|||
44323553|NCT01159600|79328586|FG006|Overall Study|Non compliant with protocol|2|||
44323554|NCT01159600|79328587|FG007|Overall Study|Non compliant with protocol|0|||
44323555|NCT01159600|79328580|FG000|Overall Study|Lost to Follow-up|2|||
44323556|NCT01159600|79328581|FG001|Overall Study|Lost to Follow-up|3|||
44323557|NCT01159600|79328582|FG002|Overall Study|Lost to Follow-up|4|||
44323558|NCT01159600|79328583|FG003|Overall Study|Lost to Follow-up|3|||
44323559|NCT01159600|79328584|FG004|Overall Study|Lost to Follow-up|3|||
44323560|NCT01159600|79328585|FG005|Overall Study|Lost to Follow-up|0|||
44323561|NCT01159600|79328586|FG006|Overall Study|Lost to Follow-up|3|||
44323562|NCT01159600|79328587|FG007|Overall Study|Lost to Follow-up|2|||
44323563|NCT01159600|79328580|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
44323564|NCT01159600|79328581|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
44323565|NCT01159600|79328582|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
44323566|NCT01159600|79328583|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
44323567|NCT01159600|79328584|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
44323568|NCT01159600|79328585|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
44323569|NCT01159600|79328586|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
44323570|NCT01159600|79328587|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
44155944|NCT02641379|78947346|FG006|Overall Study|Financial problems|0|||
44323571|NCT01159600|79328580|FG000|Overall Study|Other reason not defined above|3|||
44323572|NCT01159600|79328581|FG001|Overall Study|Other reason not defined above|0|||
44323573|NCT01159600|79328582|FG002|Overall Study|Other reason not defined above|4|||
44323574|NCT01159600|79328583|FG003|Overall Study|Other reason not defined above|2|||
44323575|NCT01159600|79328584|FG004|Overall Study|Other reason not defined above|5|||
44323576|NCT01159600|79328585|FG005|Overall Study|Other reason not defined above|7|||
44323577|NCT01159600|79328586|FG006|Overall Study|Other reason not defined above|3|||
44323578|NCT01159600|79328587|FG007|Overall Study|Other reason not defined above|3|||
44323579|NCT01159171|79328606|FG000|Overall Study|Adverse Event|11|||
44323580|NCT01159171|79328606|FG000|Overall Study|Progression of Disease|28|||
44323581|NCT01159171|79328606|FG000|Overall Study|Protocol Violation|1|||
44323582|NCT01159171|79328606|FG000|Overall Study|Need for Surgery|5|||
44323583|NCT01159171|79328606|FG000|Overall Study|Medical Decision|4|||
44323584|NCT01159171|79328606|FG000|Overall Study|Death|1|||
44323585|NCT01158118|79328613|FG000|Overall Study|Screen failure|1|||
44323586|NCT01158118|79328614|FG001|Overall Study|Screen failure|0|||
44323587|NCT01158118|79328613|FG000|Overall Study|Donor match was a screen failure|0|||
44323588|NCT01158118|79328614|FG001|Overall Study|Donor match was a screen failure|1|||
44323589|NCT01158118|79328613|FG000|Overall Study|Suffered stroke prior to transplant|0|||
44323590|NCT01158118|79328614|FG001|Overall Study|Suffered stroke prior to transplant|1|||
44155945|NCT02641379|78947347|FG007|Overall Study|Financial problems|0|||
44155946|NCT02641379|78947348|FG008|Overall Study|Financial problems|0|||
44155947|NCT02641379|78947349|FG009|Overall Study|Financial problems|0|||
44155948|NCT02641379|78947350|FG010|Overall Study|Financial problems|0|||
44323591|NCT01158118|79328613|FG000|Overall Study|Death|0|||
44323592|NCT01158118|79328614|FG001|Overall Study|Death|1|||
44323593|NCT01157845|79328620|FG000|Overall Study|Lost to Follow-up|5|||
44323594|NCT01157845|79328620|FG000|Overall Study|Withdrawal by Subject|12|||
44323595|NCT01157845|79328620|FG000|Overall Study|Physician Decision|3|||
44323596|NCT01157845|79328620|FG000|Overall Study|Protocol Violation|13|||
44323597|NCT01157845|79328620|FG000|Overall Study|Study was ended|1|||
44323598|NCT01157845|79328620|FG000|Overall Study|Device malfunction|1|||
44323599|NCT01157377|79328631|FG000|Overall Study|Lost to Follow-up|0|||
44323600|NCT01157377|79328632|FG001|Overall Study|Lost to Follow-up|0|||
44323601|NCT01157377|79328633|FG002|Overall Study|Lost to Follow-up|1|||
44323602|NCT01157377|79328634|FG003|Overall Study|Lost to Follow-up|0|||
44323603|NCT01157377|79328635|FG004|Overall Study|Lost to Follow-up|1|||
44323604|NCT01157377|79328636|FG005|Overall Study|Lost to Follow-up|1|||
44323605|NCT01157377|79328637|FG006|Overall Study|Lost to Follow-up|0|||
44323606|NCT01157377|79328631|FG000|Overall Study|Personal Reasons|2|||
44323607|NCT01157377|79328632|FG001|Overall Study|Personal Reasons|1|||
44155949|NCT02641379|78947340|FG000|Overall Study|PCR positive at Week 68|0|||
44155950|NCT02641379|78947341|FG001|Overall Study|PCR positive at Week 68|1|||
44323608|NCT01157377|79328633|FG002|Overall Study|Personal Reasons|0|||
44323609|NCT01157377|79328634|FG003|Overall Study|Personal Reasons|1|||
44323610|NCT01157377|79328635|FG004|Overall Study|Personal Reasons|0|||
44323611|NCT01157377|79328636|FG005|Overall Study|Personal Reasons|0|||
44323612|NCT01157377|79328637|FG006|Overall Study|Personal Reasons|0|||
44155951|NCT02641379|78947342|FG002|Overall Study|PCR positive at Week 68|0|||
44323613|NCT01157377|79328631|FG000|Overall Study|Protocol Violation|0|||
44323614|NCT01157377|79328632|FG001|Overall Study|Protocol Violation|0|||
44323615|NCT01157377|79328633|FG002|Overall Study|Protocol Violation|0|||
44323616|NCT01157377|79328634|FG003|Overall Study|Protocol Violation|0|||
44323617|NCT01157377|79328635|FG004|Overall Study|Protocol Violation|0|||
44323618|NCT01157377|79328636|FG005|Overall Study|Protocol Violation|1|||
44323619|NCT01157377|79328637|FG006|Overall Study|Protocol Violation|0|||
44323620|NCT01157377|79328631|FG000|Overall Study|Lack of Efficacy|0|||
44323621|NCT01157377|79328632|FG001|Overall Study|Lack of Efficacy|0|||
44323622|NCT01157377|79328633|FG002|Overall Study|Lack of Efficacy|0|||
44323623|NCT01157377|79328634|FG003|Overall Study|Lack of Efficacy|0|||
44323624|NCT01157377|79328635|FG004|Overall Study|Lack of Efficacy|0|||
44323625|NCT01157377|79328636|FG005|Overall Study|Lack of Efficacy|0|||
44323626|NCT01157377|79328637|FG006|Overall Study|Lack of Efficacy|1|||
44323627|NCT01157377|79328631|FG000|Overall Study|Other Miscellaneous Reasons|0|||
44323628|NCT01157377|79328632|FG001|Overall Study|Other Miscellaneous Reasons|2|||
44323629|NCT01157377|79328633|FG002|Overall Study|Other Miscellaneous Reasons|0|||
44323630|NCT01157377|79328634|FG003|Overall Study|Other Miscellaneous Reasons|0|||
44323631|NCT01157377|79328635|FG004|Overall Study|Other Miscellaneous Reasons|1|||
44323632|NCT01157377|79328636|FG005|Overall Study|Other Miscellaneous Reasons|1|||
44323633|NCT01157377|79328637|FG006|Overall Study|Other Miscellaneous Reasons|1|||
44323634|NCT01157182|79328655|FG000|Washout of 28 Days|Adverse Event|2|||
44323635|NCT01157182|79328656|FG001|Washout of 28 Days|Adverse Event|0|||
44323636|NCT01157065|79328664|FG000|Overall Study|Death|0|||
44323637|NCT01157065|79328665|FG001|Overall Study|Death|1|||
44536879|NCT03399786|79547530|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
44536880|NCT03399786|79547531|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
44536881|NCT03399786|79547532|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
44536882|NCT03399786|79547529|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
44536883|NCT03399786|79547530|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
44536884|NCT03399786|79547531|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
44536885|NCT03399786|79547532|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
44536886|NCT03505593|79547540|FG000|Overall Study|Withdrawal by Subject|1|||
44536887|NCT03505593|79547540|FG000|Overall Study|Died before procedure|1|||
44536888|NCT03505593|79547540|FG000|Overall Study|Anatomical abnormality|1|||
44536889|NCT03505593|79547540|FG000|Overall Study|Unable to pass through esophagus|1|||
44536890|NCT03505593|79547540|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
44536891|NCT03504189|79547544|FG000|Overall Study|Withdrawal by Subject|1|||
44258217|NCT01401530|79112889|FG001|Overall Study|Participant Choice|2|||
44258218|NCT01401530|79112890|FG002|Overall Study|Participant Choice|1|||
44258219|NCT01401530|79112888|FG000|Overall Study|Physician Decision|0|||
44258220|NCT01401530|79112889|FG001|Overall Study|Physician Decision|1|||
44258221|NCT01401530|79112890|FG002|Overall Study|Physician Decision|0|||
44258222|NCT01387022|79112902|FG000|Overall Study|Death|1|||
44258223|NCT01387022|79112903|FG001|Overall Study|Death|1|||
44258224|NCT01387022|79112902|FG000|Overall Study|Lost to Follow-up|0|||
44258225|NCT01387022|79112903|FG001|Overall Study|Lost to Follow-up|3|||
44323638|NCT01156792|79328671|FG000|Overall Study|Adverse Event|1|||
44258226|NCT01386944|79112929|FG000|Overall Study|Adverse Event|26|||
44258227|NCT01386944|79112929|FG000|Overall Study|Lack of Efficacy|14|||
44323639|NCT01156792|79328671|FG000|Overall Study|Lack of Efficacy|36|||
44323640|NCT01156792|79328671|FG000|Overall Study|Protocol Violation|6|||
44323641|NCT01156792|79328671|FG000|Overall Study|Lost to Follow-up|3|||
44323642|NCT01156792|79328671|FG000|Overall Study|Physician Decision|3|||
44323643|NCT01156792|79328671|FG000|Overall Study|Withdrawal by Subject|9|||
44323644|NCT01156792|79328671|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
44323645|NCT01156714|79328689|FG000|Overall Study|Withdrawal by Subject|9|||
44323646|NCT01156714|79328690|FG001|Overall Study|Withdrawal by Subject|4|||
44323647|NCT01156714|79328691|FG002|Overall Study|Withdrawal by Subject|3|||
44323648|NCT01156675|79328705|FG000|Overall Study|Death|5|||
44323649|NCT01156675|79328706|FG001|Overall Study|Death|3|||
44323650|NCT01156675|79328707|FG002|Overall Study|Death|0|||
44323651|NCT01156675|79328705|FG000|Overall Study|No data|29|||
44323652|NCT01156675|79328706|FG001|Overall Study|No data|22|||
44323653|NCT01156675|79328707|FG002|Overall Study|No data|2|||
44323654|NCT01156480|79328718|FG000|Overall Study|change in diagnosis|0|||
44323655|NCT01156480|79328719|FG001|Overall Study|change in diagnosis|1|||
44323656|NCT01156363|79328727|FG000|Overall Study|Adverse Event|6|||
44323657|NCT01156363|79328727|FG000|Overall Study|Insufficient Therapeutic Response|5|||
44258228|NCT01386944|79112929|FG000|Overall Study|Lost to Follow-up|8|||
44258229|NCT01386944|79112929|FG000|Overall Study|Unspecified reason|8|||
44258230|NCT01386788|79112940|FG000|Overall Study|Lost to Follow-up|2|||
44258231|NCT01386554|79113005|FG000|Overall Study|Lost to Follow-up|0|||
44258232|NCT01386554|79113006|FG001|Overall Study|Lost to Follow-up|0|||
44258233|NCT01386554|79113007|FG002|Overall Study|Lost to Follow-up|1|||
44258234|NCT01386554|79113005|FG000|Overall Study|Adverse Event|2|||
44258235|NCT01386554|79113006|FG001|Overall Study|Adverse Event|5|||
44258236|NCT01386554|79113007|FG002|Overall Study|Adverse Event|2|||
44258237|NCT01386554|79113005|FG000|Overall Study|Progressive disease|1|||
44258238|NCT01386554|79113006|FG001|Overall Study|Progressive disease|2|||
44258239|NCT01386554|79113007|FG002|Overall Study|Progressive disease|2|||
44258240|NCT01386554|79113005|FG000|Overall Study|Administration of live vaccines|0|||
44258241|NCT01386554|79113006|FG001|Overall Study|Administration of live vaccines|1|||
44258242|NCT01386554|79113007|FG002|Overall Study|Administration of live vaccines|0|||
44258243|NCT01386554|79113005|FG000|Overall Study|Investigator discretion|0|||
44258244|NCT01386554|79113006|FG001|Overall Study|Investigator discretion|0|||
44323658|NCT01156363|79328727|FG000|Overall Study|Failure to Return|1|||
44323659|NCT01156363|79328727|FG000|Overall Study|Refused Treatment|4|||
44323660|NCT01156363|79328727|FG000|Overall Study|Other|6|||
44323661|NCT01156051|79328740|FG000|Overall Study|Lost to Follow-up|1|||
44323662|NCT01156051|79328741|FG001|Overall Study|Lost to Follow-up|0|||
44323663|NCT01156051|79328740|FG000|Overall Study|patient not compliant with protocol|0|||
44323664|NCT01156051|79328741|FG001|Overall Study|patient not compliant with protocol|1|||
44323665|NCT01156012|79328749|FG000|Overall Study|Adverse Event|3|||
44323666|NCT01156012|79328750|FG001|Overall Study|Adverse Event|1|||
44323667|NCT01156012|79328749|FG000|Overall Study|Lost to Follow-up|1|||
44323668|NCT01156012|79328750|FG001|Overall Study|Lost to Follow-up|0|||
44323669|NCT01156012|79328749|FG000|Overall Study|Withdrawal by Subject|1|||
44323670|NCT01156012|79328750|FG001|Overall Study|Withdrawal by Subject|0|||
44323671|NCT01156012|79328749|FG000|Overall Study|use of commercial drug instead of study|0|||
44323672|NCT01156012|79328750|FG001|Overall Study|use of commercial drug instead of study|1|||
44323673|NCT01156012|79328749|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
44323674|NCT01156012|79328750|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
44323675|NCT01155661|79328756|FG000|Overall Study|Adverse Event|101|||
44323676|NCT01155661|79328756|FG000|Overall Study|Death|1|||
44323677|NCT01155661|79328756|FG000|Overall Study|Lack of Efficacy|32|||
44323678|NCT01155661|79328756|FG000|Overall Study|Lost to Follow-up|22|||
44323679|NCT01155661|79328756|FG000|Overall Study|Physician Decision|3|||
44323680|NCT01155661|79328756|FG000|Overall Study|Protocol Violation|35|||
44323681|NCT01155661|79328756|FG000|Overall Study|Withdrawal by Subject|73|||
44323682|NCT01155661|79328756|FG000|Overall Study|Sponsor Decision|13|||
44323683|NCT01155583|79328771|FG000|Phase I|Screen failure - did not start treatment|0|||
44323684|NCT01155583|79328772|FG001|Phase I|Screen failure - did not start treatment|0|||
44323685|NCT01155583|79328773|FG002|Phase I|Screen failure - did not start treatment|0|||
44323686|NCT01155583|79328774|FG003|Phase I|Screen failure - did not start treatment|0|||
44323687|NCT01155583|79328775|FG004|Phase I|Screen failure - did not start treatment|1|||
44323688|NCT01155583|79328776|FG005|Phase I|Screen failure - did not start treatment|0|||
44258245|NCT01386554|79113007|FG002|Overall Study|Investigator discretion|1|||
44258246|NCT01386554|79113005|FG000|Overall Study|Reason not collected|0|||
44323689|NCT01155583|79328777|FG006|Phase I|Screen failure - did not start treatment|0|||
44323690|NCT01155583|79328778|FG007|Phase I|Screen failure - did not start treatment|2|||
44323691|NCT01155583|79328779|FG008|Phase I|Screen failure - did not start treatment|0|||
44323692|NCT01155583|79328771|FG000|Phase I|Withdrawal by Subject|0|||
44323693|NCT01155583|79328772|FG001|Phase I|Withdrawal by Subject|0|||
44323694|NCT01155583|79328773|FG002|Phase I|Withdrawal by Subject|0|||
44258247|NCT01386554|79113006|FG001|Overall Study|Reason not collected|1|||
44258248|NCT01386554|79113007|FG002|Overall Study|Reason not collected|0|||
44155952|NCT02641379|78947343|FG003|Overall Study|PCR positive at Week 68|0|||
44155953|NCT02641379|78947344|FG004|Overall Study|PCR positive at Week 68|0|||
44155954|NCT02641379|78947345|FG005|Overall Study|PCR positive at Week 68|0|||
44155955|NCT02641379|78947346|FG006|Overall Study|PCR positive at Week 68|0|||
44155956|NCT02641379|78947347|FG007|Overall Study|PCR positive at Week 68|0|||
44155957|NCT02641379|78947348|FG008|Overall Study|PCR positive at Week 68|0|||
44155958|NCT02641379|78947349|FG009|Overall Study|PCR positive at Week 68|0|||
44155959|NCT02641379|78947350|FG010|Overall Study|PCR positive at Week 68|0|||
44155960|NCT02641379|78947340|FG000|Overall Study|PCR positive at Week 48|0|||
44155961|NCT02641379|78947341|FG001|Overall Study|PCR positive at Week 48|1|||
44155962|NCT02641379|78947342|FG002|Overall Study|PCR positive at Week 48|0|||
44155963|NCT02641379|78947343|FG003|Overall Study|PCR positive at Week 48|0|||
44155964|NCT02641379|78947344|FG004|Overall Study|PCR positive at Week 48|0|||
44155965|NCT02641379|78947345|FG005|Overall Study|PCR positive at Week 48|0|||
44155966|NCT02641379|78947346|FG006|Overall Study|PCR positive at Week 48|0|||
44155967|NCT02641379|78947347|FG007|Overall Study|PCR positive at Week 48|0|||
44155968|NCT02641379|78947348|FG008|Overall Study|PCR positive at Week 48|0|||
44155969|NCT02641379|78947349|FG009|Overall Study|PCR positive at Week 48|0|||
44155970|NCT02641379|78947350|FG010|Overall Study|PCR positive at Week 48|0|||
44155971|NCT02641379|78947340|FG000|Overall Study|PCR not performed at Week 12|0|||
44155972|NCT02641379|78947341|FG001|Overall Study|PCR not performed at Week 12|0|||
44155973|NCT02641379|78947342|FG002|Overall Study|PCR not performed at Week 12|1|||
44155974|NCT02641379|78947343|FG003|Overall Study|PCR not performed at Week 12|0|||
44155975|NCT02641379|78947344|FG004|Overall Study|PCR not performed at Week 12|0|||
44155976|NCT02641379|78947345|FG005|Overall Study|PCR not performed at Week 12|0|||
44155977|NCT02641379|78947346|FG006|Overall Study|PCR not performed at Week 12|0|||
44536892|NCT03504189|79547544|FG000|Overall Study|Screening Failure|1|||
44536893|NCT03504189|79547544|FG000|Overall Study|Device Failure|2|||
44155978|NCT02641379|78947347|FG007|Overall Study|PCR not performed at Week 12|0|||
44155979|NCT02641379|78947348|FG008|Overall Study|PCR not performed at Week 12|0|||
44155980|NCT02641379|78947349|FG009|Overall Study|PCR not performed at Week 12|0|||
44155981|NCT02641379|78947350|FG010|Overall Study|PCR not performed at Week 12|0|||
44155982|NCT02641379|78947340|FG000|Overall Study|No PCR at baseline|0|||
44155983|NCT02641379|78947341|FG001|Overall Study|No PCR at baseline|0|||
44155984|NCT02641379|78947342|FG002|Overall Study|No PCR at baseline|1|||
44155985|NCT02641379|78947343|FG003|Overall Study|No PCR at baseline|0|||
44155986|NCT02641379|78947344|FG004|Overall Study|No PCR at baseline|0|||
44155987|NCT02641379|78947345|FG005|Overall Study|No PCR at baseline|0|||
44155988|NCT02641379|78947346|FG006|Overall Study|No PCR at baseline|0|||
44155989|NCT02641379|78947347|FG007|Overall Study|No PCR at baseline|0|||
44155990|NCT02641379|78947348|FG008|Overall Study|No PCR at baseline|0|||
44536894|NCT03374358|79547555|FG000|Overall Study|Withdrawal by Subject|0|||
44536895|NCT03374358|79547556|FG001|Overall Study|Withdrawal by Subject|2|||
44536896|NCT03372096|79547562|FG000|Overall Study|Study Closed|8|||
44536897|NCT00004859|79547571|FG000|Overall Study|Lack of Efficacy|43|||
44536898|NCT00004859|79547572|FG001|Overall Study|Lack of Efficacy|113|||
44536899|NCT00004859|79547571|FG000|Overall Study|Adverse Event|31|||
44536900|NCT00004859|79547572|FG001|Overall Study|Adverse Event|93|||
44536901|NCT00004859|79547571|FG000|Overall Study|Death|5|||
44536902|NCT00004859|79547572|FG001|Overall Study|Death|5|||
44155991|NCT02641379|78947349|FG009|Overall Study|No PCR at baseline|0|||
44155992|NCT02641379|78947350|FG010|Overall Study|No PCR at baseline|0|||
44155993|NCT02641379|78947340|FG000|Overall Study|PCR positive at Week 28|0|||
44155994|NCT02641379|78947341|FG001|Overall Study|PCR positive at Week 28|0|||
44155995|NCT02641379|78947342|FG002|Overall Study|PCR positive at Week 28|1|||
44155996|NCT02641379|78947343|FG003|Overall Study|PCR positive at Week 28|0|||
44536903|NCT00004859|79547571|FG000|Overall Study|Withdrawal by Subject|7|||
44155997|NCT02641379|78947344|FG004|Overall Study|PCR positive at Week 28|0|||
44155998|NCT02641379|78947345|FG005|Overall Study|PCR positive at Week 28|0|||
44155999|NCT02641379|78947346|FG006|Overall Study|PCR positive at Week 28|0|||
44156000|NCT02641379|78947347|FG007|Overall Study|PCR positive at Week 28|0|||
44156001|NCT02641379|78947348|FG008|Overall Study|PCR positive at Week 28|0|||
44156002|NCT02641379|78947349|FG009|Overall Study|PCR positive at Week 28|0|||
44156003|NCT02641379|78947350|FG010|Overall Study|PCR positive at Week 28|0|||
44536904|NCT00004859|79547572|FG001|Overall Study|Withdrawal by Subject|33|||
44536905|NCT00004859|79547571|FG000|Overall Study|Protocol Violation|2|||
44156004|NCT02641379|78947340|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
44156005|NCT02641379|78947341|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
44156006|NCT02641379|78947342|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
44156007|NCT02641379|78947343|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
44156008|NCT02641379|78947344|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
44156009|NCT02641379|78947345|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
44156010|NCT02641379|78947346|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
44156011|NCT02641379|78947347|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
44536906|NCT00004859|79547572|FG001|Overall Study|Protocol Violation|2|||
44156012|NCT02641379|78947348|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
44156013|NCT02641379|78947349|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
44156014|NCT02641379|78947350|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
44156015|NCT02641379|78947340|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
44156016|NCT02641379|78947341|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
44156017|NCT02641379|78947342|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
44156018|NCT02641379|78947343|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
44156019|NCT02641379|78947344|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
44156020|NCT02641379|78947345|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
44156021|NCT02641379|78947346|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
44156022|NCT02641379|78947347|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
44156023|NCT02641379|78947348|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
44156024|NCT02641379|78947349|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
44156025|NCT02641379|78947350|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
44156026|NCT02641379|78947340|FG000|Overall Study|Baseline viral load unavailable|0|||
44536907|NCT00004859|79547571|FG000|Overall Study|other disease|0|||
44156027|NCT02641379|78947341|FG001|Overall Study|Baseline viral load unavailable|0|||
44156028|NCT02641379|78947342|FG002|Overall Study|Baseline viral load unavailable|0|||
44156029|NCT02641379|78947343|FG003|Overall Study|Baseline viral load unavailable|1|||
44156030|NCT02641379|78947344|FG004|Overall Study|Baseline viral load unavailable|0|||
44156031|NCT02641379|78947345|FG005|Overall Study|Baseline viral load unavailable|0|||
44156032|NCT02641379|78947346|FG006|Overall Study|Baseline viral load unavailable|0|||
44156033|NCT02641379|78947347|FG007|Overall Study|Baseline viral load unavailable|0|||
44156034|NCT02641379|78947348|FG008|Overall Study|Baseline viral load unavailable|0|||
44156035|NCT02641379|78947349|FG009|Overall Study|Baseline viral load unavailable|0|||
44156036|NCT02641379|78947350|FG010|Overall Study|Baseline viral load unavailable|0|||
44156037|NCT02641379|78947340|FG000|Overall Study|Blood could not be drawn|0|||
44156038|NCT02641379|78947341|FG001|Overall Study|Blood could not be drawn|0|||
44156039|NCT02641379|78947342|FG002|Overall Study|Blood could not be drawn|0|||
44156040|NCT02641379|78947343|FG003|Overall Study|Blood could not be drawn|0|||
44156041|NCT02641379|78947344|FG004|Overall Study|Blood could not be drawn|1|||
44156042|NCT02641379|78947345|FG005|Overall Study|Blood could not be drawn|0|||
44156043|NCT02641379|78947346|FG006|Overall Study|Blood could not be drawn|0|||
44156044|NCT02641379|78947347|FG007|Overall Study|Blood could not be drawn|0|||
44156045|NCT02641379|78947348|FG008|Overall Study|Blood could not be drawn|0|||
44156046|NCT02641379|78947349|FG009|Overall Study|Blood could not be drawn|0|||
44156047|NCT02641379|78947350|FG010|Overall Study|Blood could not be drawn|0|||
44156048|NCT02641379|78947340|FG000|Overall Study|Protocol Violation|0|||
44156049|NCT02641379|78947341|FG001|Overall Study|Protocol Violation|0|||
44156050|NCT02641379|78947342|FG002|Overall Study|Protocol Violation|0|||
44156051|NCT02641379|78947343|FG003|Overall Study|Protocol Violation|0|||
44156052|NCT02641379|78947344|FG004|Overall Study|Protocol Violation|2|||
44156053|NCT02641379|78947345|FG005|Overall Study|Protocol Violation|0|||
44156054|NCT02641379|78947346|FG006|Overall Study|Protocol Violation|0|||
44156055|NCT02641379|78947347|FG007|Overall Study|Protocol Violation|0|||
44156056|NCT02641379|78947348|FG008|Overall Study|Protocol Violation|1|||
44156057|NCT02641379|78947349|FG009|Overall Study|Protocol Violation|0|||
44156058|NCT02641379|78947350|FG010|Overall Study|Protocol Violation|0|||
44156059|NCT02641379|78947340|FG000|Overall Study|Participation in sili rescue study|0|||
44156060|NCT02641379|78947341|FG001|Overall Study|Participation in sili rescue study|0|||
44156061|NCT02641379|78947342|FG002|Overall Study|Participation in sili rescue study|0|||
44536908|NCT00004859|79547572|FG001|Overall Study|other disease|3|||
44536909|NCT00004859|79547571|FG000|Overall Study|error|3|||
44156062|NCT02641379|78947343|FG003|Overall Study|Participation in sili rescue study|0|||
44156063|NCT02641379|78947344|FG004|Overall Study|Participation in sili rescue study|0|||
44156064|NCT02641379|78947345|FG005|Overall Study|Participation in sili rescue study|1|||
44156065|NCT02641379|78947346|FG006|Overall Study|Participation in sili rescue study|0|||
44156066|NCT02641379|78947347|FG007|Overall Study|Participation in sili rescue study|0|||
44156067|NCT02641379|78947348|FG008|Overall Study|Participation in sili rescue study|0|||
44156068|NCT02641379|78947349|FG009|Overall Study|Participation in sili rescue study|0|||
44156069|NCT02641379|78947350|FG010|Overall Study|Participation in sili rescue study|0|||
44536910|NCT00004859|79547572|FG001|Overall Study|error|1|||
44536911|NCT00004859|79547571|FG000|Overall Study|missing data|14|||
44536912|NCT00004859|79547572|FG001|Overall Study|missing data|11|||
44536913|NCT00004859|79547571|FG000|Overall Study|Other|13|||
44156070|NCT02641379|78947340|FG000|Overall Study|Lost to Follow-up|0|||
44156071|NCT02641379|78947341|FG001|Overall Study|Lost to Follow-up|0|||
44156072|NCT02641379|78947342|FG002|Overall Study|Lost to Follow-up|0|||
44156073|NCT02641379|78947343|FG003|Overall Study|Lost to Follow-up|0|||
44156074|NCT02641379|78947344|FG004|Overall Study|Lost to Follow-up|0|||
44156075|NCT02641379|78947345|FG005|Overall Study|Lost to Follow-up|0|||
44156076|NCT02641379|78947346|FG006|Overall Study|Lost to Follow-up|0|||
44156077|NCT02641379|78947347|FG007|Overall Study|Lost to Follow-up|0|||
44156078|NCT02641379|78947348|FG008|Overall Study|Lost to Follow-up|1|||
44156079|NCT02641379|78947349|FG009|Overall Study|Lost to Follow-up|0|||
44156080|NCT02641379|78947350|FG010|Overall Study|Lost to Follow-up|0|||
44156081|NCT02641379|78947340|FG000|Overall Study|Source data not found|0|||
44156082|NCT02641379|78947341|FG001|Overall Study|Source data not found|0|||
44156083|NCT02641379|78947342|FG002|Overall Study|Source data not found|0|||
44156084|NCT02641379|78947343|FG003|Overall Study|Source data not found|0|||
44156085|NCT02641379|78947344|FG004|Overall Study|Source data not found|0|||
44156086|NCT02641379|78947345|FG005|Overall Study|Source data not found|1|||
44156087|NCT02641379|78947346|FG006|Overall Study|Source data not found|0|||
44156088|NCT02641379|78947347|FG007|Overall Study|Source data not found|0|||
44156089|NCT02641379|78947348|FG008|Overall Study|Source data not found|0|||
44156090|NCT02641379|78947349|FG009|Overall Study|Source data not found|0|||
44156091|NCT02641379|78947350|FG010|Overall Study|Source data not found|0|||
44156092|NCT02641379|78947340|FG000|Overall Study|Participant showed weight reduction|0|||
44156093|NCT02641379|78947341|FG001|Overall Study|Participant showed weight reduction|0|||
44156094|NCT02641379|78947342|FG002|Overall Study|Participant showed weight reduction|0|||
44156095|NCT02641379|78947343|FG003|Overall Study|Participant showed weight reduction|0|||
44156096|NCT02641379|78947344|FG004|Overall Study|Participant showed weight reduction|0|||
44156097|NCT02641379|78947345|FG005|Overall Study|Participant showed weight reduction|0|||
44156098|NCT02641379|78947346|FG006|Overall Study|Participant showed weight reduction|0|||
44156099|NCT02641379|78947347|FG007|Overall Study|Participant showed weight reduction|1|||
44156100|NCT02641379|78947348|FG008|Overall Study|Participant showed weight reduction|0|||
44156101|NCT02641379|78947349|FG009|Overall Study|Participant showed weight reduction|0|||
44156102|NCT02641379|78947350|FG010|Overall Study|Participant showed weight reduction|0|||
44156103|NCT02641379|78947340|FG000|Overall Study|Non-response Week 12|0|||
44156104|NCT02641379|78947341|FG001|Overall Study|Non-response Week 12|0|||
44156105|NCT02641379|78947342|FG002|Overall Study|Non-response Week 12|0|||
44156106|NCT02641379|78947343|FG003|Overall Study|Non-response Week 12|0|||
44156107|NCT02641379|78947344|FG004|Overall Study|Non-response Week 12|0|||
44156108|NCT02641379|78947345|FG005|Overall Study|Non-response Week 12|0|||
44156109|NCT02641379|78947346|FG006|Overall Study|Non-response Week 12|0|||
44156110|NCT02641379|78947347|FG007|Overall Study|Non-response Week 12|1|||
44156111|NCT02641379|78947348|FG008|Overall Study|Non-response Week 12|0|||
44156112|NCT02641379|78947349|FG009|Overall Study|Non-response Week 12|0|||
44156113|NCT02641379|78947350|FG010|Overall Study|Non-response Week 12|0|||
44156114|NCT02641379|78947340|FG000|Overall Study|No 2 Log drop at Week 12|0|||
44156115|NCT02641379|78947341|FG001|Overall Study|No 2 Log drop at Week 12|0|||
44156116|NCT02641379|78947342|FG002|Overall Study|No 2 Log drop at Week 12|0|||
44156117|NCT02641379|78947343|FG003|Overall Study|No 2 Log drop at Week 12|0|||
44156118|NCT02641379|78947344|FG004|Overall Study|No 2 Log drop at Week 12|0|||
44156119|NCT02641379|78947345|FG005|Overall Study|No 2 Log drop at Week 12|0|||
44156120|NCT02641379|78947346|FG006|Overall Study|No 2 Log drop at Week 12|0|||
44156121|NCT02641379|78947347|FG007|Overall Study|No 2 Log drop at Week 12|0|||
44156122|NCT02641379|78947348|FG008|Overall Study|No 2 Log drop at Week 12|0|||
44156123|NCT02641379|78947349|FG009|Overall Study|No 2 Log drop at Week 12|0|||
44156124|NCT02641379|78947350|FG010|Overall Study|No 2 Log drop at Week 12|1|||
44156125|NCT02641379|78947340|FG000|Overall Study|Negative PCR result|0|||
44156126|NCT02641379|78947341|FG001|Overall Study|Negative PCR result|0|||
44156127|NCT02641379|78947342|FG002|Overall Study|Negative PCR result|0|||
44156128|NCT02641379|78947343|FG003|Overall Study|Negative PCR result|0|||
44156129|NCT02641379|78947344|FG004|Overall Study|Negative PCR result|0|||
44156130|NCT02641379|78947345|FG005|Overall Study|Negative PCR result|0|||
44156131|NCT02641379|78947346|FG006|Overall Study|Negative PCR result|0|||
44156132|NCT02641379|78947347|FG007|Overall Study|Negative PCR result|0|||
44156133|NCT02641379|78947348|FG008|Overall Study|Negative PCR result|0|||
44156134|NCT02641379|78947349|FG009|Overall Study|Negative PCR result|1|||
44156135|NCT02641379|78947350|FG010|Overall Study|Negative PCR result|0|||
44156136|NCT02641379|78947340|FG000|Overall Study|Participant's PCR high|0|||
44156137|NCT02641379|78947341|FG001|Overall Study|Participant's PCR high|0|||
44156138|NCT02641379|78947342|FG002|Overall Study|Participant's PCR high|0|||
44156139|NCT02641379|78947343|FG003|Overall Study|Participant's PCR high|0|||
44156140|NCT02641379|78947344|FG004|Overall Study|Participant's PCR high|0|||
44156141|NCT02641379|78947345|FG005|Overall Study|Participant's PCR high|0|||
44156142|NCT02641379|78947346|FG006|Overall Study|Participant's PCR high|0|||
44156143|NCT02641379|78947347|FG007|Overall Study|Participant's PCR high|1|||
44156144|NCT02641379|78947348|FG008|Overall Study|Participant's PCR high|0|||
44156145|NCT02641379|78947349|FG009|Overall Study|Participant's PCR high|0|||
44156146|NCT02641379|78947350|FG010|Overall Study|Participant's PCR high|0|||
44156147|NCT02641379|78947340|FG000|Overall Study|Participant treated after Week 24|0|||
44156148|NCT02641379|78947341|FG001|Overall Study|Participant treated after Week 24|0|||
44156149|NCT02641379|78947342|FG002|Overall Study|Participant treated after Week 24|0|||
44156150|NCT02641379|78947343|FG003|Overall Study|Participant treated after Week 24|0|||
44156151|NCT02641379|78947344|FG004|Overall Study|Participant treated after Week 24|0|||
44156152|NCT02641379|78947345|FG005|Overall Study|Participant treated after Week 24|0|||
44156153|NCT02641379|78947346|FG006|Overall Study|Participant treated after Week 24|0|||
44156154|NCT02641379|78947347|FG007|Overall Study|Participant treated after Week 24|0|||
44156155|NCT02641379|78947348|FG008|Overall Study|Participant treated after Week 24|1|||
44156156|NCT02641379|78947349|FG009|Overall Study|Participant treated after Week 24|0|||
44156157|NCT02641379|78947350|FG010|Overall Study|Participant treated after Week 24|0|||
44156158|NCT02641379|78947340|FG000|Overall Study|Missing PCR result at Week 8|0|||
44156159|NCT02641379|78947341|FG001|Overall Study|Missing PCR result at Week 8|0|||
44156160|NCT02641379|78947342|FG002|Overall Study|Missing PCR result at Week 8|0|||
44156161|NCT02641379|78947343|FG003|Overall Study|Missing PCR result at Week 8|0|||
44156162|NCT02641379|78947344|FG004|Overall Study|Missing PCR result at Week 8|0|||
44156163|NCT02641379|78947345|FG005|Overall Study|Missing PCR result at Week 8|0|||
44156164|NCT02641379|78947346|FG006|Overall Study|Missing PCR result at Week 8|0|||
44156165|NCT02641379|78947347|FG007|Overall Study|Missing PCR result at Week 8|0|||
44156166|NCT02641379|78947348|FG008|Overall Study|Missing PCR result at Week 8|0|||
44156167|NCT02641379|78947349|FG009|Overall Study|Missing PCR result at Week 8|1|||
44156168|NCT02641379|78947350|FG010|Overall Study|Missing PCR result at Week 8|0|||
44156169|NCT02641379|78947340|FG000|Overall Study|PCR positive|0|||
44156170|NCT02641379|78947341|FG001|Overall Study|PCR positive|0|||
44156171|NCT02641379|78947342|FG002|Overall Study|PCR positive|0|||
44156172|NCT02641379|78947343|FG003|Overall Study|PCR positive|0|||
44156173|NCT02641379|78947344|FG004|Overall Study|PCR positive|0|||
44156174|NCT02641379|78947345|FG005|Overall Study|PCR positive|0|||
44156175|NCT02641379|78947346|FG006|Overall Study|PCR positive|1|||
44156176|NCT02641379|78947347|FG007|Overall Study|PCR positive|0|||
44156177|NCT02641379|78947348|FG008|Overall Study|PCR positive|0|||
44156178|NCT02641379|78947349|FG009|Overall Study|PCR positive|0|||
44156179|NCT02641379|78947350|FG010|Overall Study|PCR positive|0|||
44156180|NCT02660983|78947381|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
44156181|NCT02660983|78947382|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
44156182|NCT02660983|78947381|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
44156183|NCT02660983|78947382|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
44422209|NCT00754052|79430196|FG000|Overall Study|Study terminated by Sponsor|5|||
44156184|NCT02660983|78947381|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
44156185|NCT02660983|78947382|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
44156186|NCT02660983|78947381|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
44156187|NCT02660983|78947382|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
44156188|NCT02660983|78947381|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
44156189|NCT02660983|78947382|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
44156190|NCT02660983|78947381|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
44156191|NCT02660983|78947382|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
44156192|NCT02660983|78947381|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
44156193|NCT02660983|78947382|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
44156194|NCT01953328|78947397|FG000|Overall Study|Withdrawal by Subject|0|||
44156195|NCT01953328|78947398|FG001|Overall Study|Withdrawal by Subject|0|||
44156196|NCT01953328|78947399|FG002|Overall Study|Withdrawal by Subject|0|||
44156197|NCT01953328|78947400|FG003|Overall Study|Withdrawal by Subject|0|||
44422210|NCT00754052|79430197|FG001|Overall Study|Study terminated by Sponsor|3|||
44422211|NCT00747812|79430205|FG000|Overall Study|Research Site Staff Relocation|5|||
44422212|NCT00747812|79430206|FG001|Overall Study|Research Site Staff Relocation|3|||
44422213|NCT02927067|79430214|FG000|Overall Study|Withdrawn Consent|20|||
44536914|NCT00004859|79547572|FG001|Overall Study|Other|21|||
44536915|NCT03500679|79547582|FG000|Overall Study|Lost to Follow-up|6|||
44156198|NCT01953328|78947401|FG004|Overall Study|Withdrawal by Subject|1|||
44156199|NCT01953328|78947402|FG005|Overall Study|Withdrawal by Subject|0|||
44156200|NCT01953328|78947403|FG006|Overall Study|Withdrawal by Subject|0|||
44422214|NCT02927067|79430215|FG001|Overall Study|Withdrawn Consent|12|||
44536916|NCT03500679|79547583|FG001|Overall Study|Lost to Follow-up|3|||
44536917|NCT03500679|79547582|FG000|Overall Study|Withdrawal by Subject|3|||
44156201|NCT01953328|78947404|FG007|Overall Study|Withdrawal by Subject|0|||
44156202|NCT01953328|78947397|FG000|Overall Study|Lost to Follow-up|0|||
44156203|NCT01953328|78947398|FG001|Overall Study|Lost to Follow-up|0|||
44156204|NCT01953328|78947399|FG002|Overall Study|Lost to Follow-up|0|||
44156205|NCT01953328|78947400|FG003|Overall Study|Lost to Follow-up|0|||
44156206|NCT01953328|78947401|FG004|Overall Study|Lost to Follow-up|1|||
44156207|NCT01953328|78947402|FG005|Overall Study|Lost to Follow-up|0|||
44536918|NCT03500679|79547583|FG001|Overall Study|Withdrawal by Subject|0|||
44156208|NCT01953328|78947403|FG006|Overall Study|Lost to Follow-up|0|||
44156209|NCT01953328|78947404|FG007|Overall Study|Lost to Follow-up|0|||
44156210|NCT02640755|78947424|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
44156211|NCT02640755|78947425|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
44156212|NCT02640755|78947424|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
44156213|NCT02640755|78947425|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
44156214|NCT02640755|78947424|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
44156215|NCT02640755|78947425|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
44156216|NCT02640677|78947432|FG000|Overall Study|Lost to Follow-up|1|||
44156217|NCT02640677|78947432|FG000|Overall Study|Withdrawal by Subject|1|||
44156218|NCT02643251|78947438|FG000|Overall Study|Adverse Event|3|||
44156219|NCT02643251|78947439|FG001|Overall Study|Adverse Event|1|||
44156220|NCT02643251|78947438|FG000|Overall Study|Withdrawal by Subject|2|||
44156221|NCT02643251|78947439|FG001|Overall Study|Withdrawal by Subject|0|||
44156222|NCT02643251|78947438|FG000|Overall Study|Lost to Follow-up|4|||
44156223|NCT02643251|78947439|FG001|Overall Study|Lost to Follow-up|1|||
44156224|NCT02643251|78947438|FG000|Overall Study|Protocol Violation|1|||
44156225|NCT02643251|78947439|FG001|Overall Study|Protocol Violation|0|||
44156226|NCT02643251|78947438|FG000|Overall Study|PI Decision to terminate patient|1|||
44156227|NCT02643251|78947439|FG001|Overall Study|PI Decision to terminate patient|0|||
44156228|NCT01970878|78947449|FG000|Overall Study|Withdrawal by Subject|11|||
44156229|NCT01970878|78947450|FG001|Overall Study|Withdrawal by Subject|10|||
44156230|NCT01970878|78947451|FG002|Overall Study|Withdrawal by Subject|14|||
44156231|NCT01970878|78947452|FG003|Overall Study|Withdrawal by Subject|7|||
44156232|NCT01970878|78947449|FG000|Overall Study|Lost to Follow-up|1|||
44156233|NCT01970878|78947450|FG001|Overall Study|Lost to Follow-up|3|||
44156234|NCT01970878|78947451|FG002|Overall Study|Lost to Follow-up|2|||
44156235|NCT01970878|78947452|FG003|Overall Study|Lost to Follow-up|4|||
44156236|NCT01970878|78947449|FG000|Overall Study|Administrative Reasons|1|||
44156237|NCT01970878|78947450|FG001|Overall Study|Administrative Reasons|0|||
44156238|NCT01970878|78947451|FG002|Overall Study|Administrative Reasons|0|||
44156239|NCT01970878|78947452|FG003|Overall Study|Administrative Reasons|4|||
44156240|NCT01970878|78947449|FG000|Overall Study|Lack of Efficacy|2|||
44156241|NCT01970878|78947450|FG001|Overall Study|Lack of Efficacy|1|||
44156242|NCT01970878|78947451|FG002|Overall Study|Lack of Efficacy|2|||
44156243|NCT01970878|78947452|FG003|Overall Study|Lack of Efficacy|0|||
44156244|NCT01970878|78947449|FG000|Overall Study|Adverse Event|12|||
44156245|NCT01970878|78947450|FG001|Overall Study|Adverse Event|7|||
44156246|NCT01970878|78947451|FG002|Overall Study|Adverse Event|4|||
44156247|NCT01970878|78947452|FG003|Overall Study|Adverse Event|3|||
44156248|NCT01970878|78947449|FG000|Overall Study|Protocol Specified Criteria|10|||
44156249|NCT01970878|78947450|FG001|Overall Study|Protocol Specified Criteria|4|||
44156250|NCT01970878|78947451|FG002|Overall Study|Protocol Specified Criteria|3|||
44156251|NCT01970878|78947452|FG003|Overall Study|Protocol Specified Criteria|6|||
44156252|NCT01970878|78947449|FG000|Overall Study|Physician Decision|0|||
44156253|NCT01970878|78947450|FG001|Overall Study|Physician Decision|1|||
44156254|NCT01970878|78947451|FG002|Overall Study|Physician Decision|1|||
44156255|NCT01970878|78947452|FG003|Overall Study|Physician Decision|0|||
44156256|NCT01970878|78947449|FG000|Overall Study|No Completion Status|0|||
44156257|NCT01970878|78947450|FG001|Overall Study|No Completion Status|1|||
44156258|NCT01970878|78947451|FG002|Overall Study|No Completion Status|0|||
44156259|NCT01970878|78947452|FG003|Overall Study|No Completion Status|0|||
44156260|NCT01970488|78947464|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
44156261|NCT01970488|78947465|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
44156262|NCT01970488|78947466|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
44156263|NCT01970488|78947467|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
44156264|NCT01970488|78947468|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
44422215|NCT02927067|79430214|FG000|Overall Study|Death|18|||
44156265|NCT01970488|78947464|FG000|Part 1: Through Week 16|Protocol Violation|1|||
44156266|NCT01970488|78947465|FG001|Part 1: Through Week 16|Protocol Violation|2|||
44156267|NCT01970488|78947466|FG002|Part 1: Through Week 16|Protocol Violation|0|||
44156268|NCT01970488|78947467|FG003|Part 1: Through Week 16|Protocol Violation|0|||
44422216|NCT02927067|79430215|FG001|Overall Study|Death|31|||
44422217|NCT02927067|79430214|FG000|Overall Study|Adverse Event|13|||
44422218|NCT02927067|79430215|FG001|Overall Study|Adverse Event|10|||
44156269|NCT01970488|78947468|FG004|Part 1: Through Week 16|Protocol Violation|0|||
44156270|NCT01970488|78947464|FG000|Part 1: Through Week 16|Adverse Event|6|||
44156271|NCT01970488|78947465|FG001|Part 1: Through Week 16|Adverse Event|5|||
44156272|NCT01970488|78947466|FG002|Part 1: Through Week 16|Adverse Event|0|||
44156273|NCT01970488|78947467|FG003|Part 1: Through Week 16|Adverse Event|0|||
44156274|NCT01970488|78947468|FG004|Part 1: Through Week 16|Adverse Event|0|||
44156275|NCT01970488|78947464|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
44156276|NCT01970488|78947465|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
44156277|NCT01970488|78947466|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
44422219|NCT02927067|79430214|FG000|Overall Study|Noncompliance|5|||
44156278|NCT01970488|78947467|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
44156279|NCT01970488|78947468|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
44156280|NCT01970488|78947464|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
44156281|NCT01970488|78947465|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
44156282|NCT01970488|78947466|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
44156283|NCT01970488|78947467|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
44156284|NCT01970488|78947468|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
44156285|NCT01970488|78947464|FG000|Part 2: Post Week 16|Physician Decision|0|||
44156286|NCT01970488|78947465|FG001|Part 2: Post Week 16|Physician Decision|0|||
44156287|NCT01970488|78947466|FG002|Part 2: Post Week 16|Physician Decision|0|||
44156288|NCT01970488|78947467|FG003|Part 2: Post Week 16|Physician Decision|0|||
44156289|NCT01970488|78947468|FG004|Part 2: Post Week 16|Physician Decision|1|||
44156290|NCT01970488|78947464|FG000|Part 2: Post Week 16|Non-compliance|0|||
44156291|NCT01970488|78947465|FG001|Part 2: Post Week 16|Non-compliance|0|||
44156292|NCT01970488|78947466|FG002|Part 2: Post Week 16|Non-compliance|1|||
44258249|NCT01386008|79113032|FG000|Overall Study|exited w/o incident /study discontinued|17|||
44258250|NCT01386008|79113032|FG000|Overall Study|Adverse Event|3|||
44258251|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
44258252|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
44258253|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
44323695|NCT01155583|79328774|FG003|Phase I|Withdrawal by Subject|0|||
44323696|NCT01155583|79328775|FG004|Phase I|Withdrawal by Subject|0|||
44323697|NCT01155583|79328776|FG005|Phase I|Withdrawal by Subject|0|||
44323698|NCT01155583|79328777|FG006|Phase I|Withdrawal by Subject|0|||
44323699|NCT01155583|79328778|FG007|Phase I|Withdrawal by Subject|1|||
44323700|NCT01155583|79328779|FG008|Phase I|Withdrawal by Subject|0|||
44323701|NCT01155466|79328800|FG000|Overall Study|Adverse Event|13|||
44422220|NCT02927067|79430215|FG001|Overall Study|Noncompliance|2|||
44422221|NCT02927067|79430214|FG000|Overall Study|Reason not Specified|4|||
44422222|NCT02927067|79430215|FG001|Overall Study|Reason not Specified|6|||
44422223|NCT01751685|79430225|FG000|6-mo Followup|Missed study visit|1|||
44422224|NCT01751685|79430226|FG001|6-mo Followup|Missed study visit|0|||
44422225|NCT01751685|79430225|FG000|6-mo Followup|Withdrawal by Subject|2|||
44422226|NCT01751685|79430226|FG001|6-mo Followup|Withdrawal by Subject|2|||
44422227|NCT01751685|79430225|FG000|6-mo Followup|Lost to Follow-up|0|||
44422228|NCT01751685|79430226|FG001|6-mo Followup|Lost to Follow-up|1|||
44422229|NCT01751685|79430225|FG000|12-mo Followup|Lost to Follow-up|5|||
44422230|NCT01751685|79430226|FG001|12-mo Followup|Lost to Follow-up|0|||
44422231|NCT00586508|79430234|FG000|Overall Study|Progressive disease|52|||
44422232|NCT00586508|79430235|FG001|Overall Study|Progressive disease|8|||
44422233|NCT00586508|79430234|FG000|Overall Study|Death|0|||
44422234|NCT00586508|79430235|FG001|Overall Study|Death|1|||
44422235|NCT00586508|79430234|FG000|Overall Study|Adverse Event|12|||
44422236|NCT00586508|79430235|FG001|Overall Study|Adverse Event|4|||
44422237|NCT00586508|79430234|FG000|Overall Study|Withdrawal by Subject|4|||
44422238|NCT00586508|79430235|FG001|Overall Study|Withdrawal by Subject|0|||
44422239|NCT00581919|79430241|FG000|Overall Study|Adverse Event|8|||
44422240|NCT00581919|79430241|FG000|Overall Study|Death|1|||
44422241|NCT00581919|79430241|FG000|Overall Study|Disease Progression|10|||
44422242|NCT00581919|79430241|FG000|Overall Study|Physician Decision|1|||
44422243|NCT00581919|79430241|FG000|Overall Study|Other Complicating Disease|1|||
44422244|NCT00581919|79430241|FG000|Overall Study|Started Non-Protocol Therapy|2|||
44422245|NCT00581919|79430241|FG000|Overall Study|Withdrawal by Subject|1|||
44422246|NCT00723528|79430249|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
44422247|NCT00723528|79430250|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
44422248|NCT00723528|79430251|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
44422249|NCT00723528|79430252|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
44422250|NCT00723528|79430253|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
44422251|NCT00723528|79430254|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
44422252|NCT00723528|79430255|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
44536919|NCT03348930|79547589|FG000|Washout (1 Week)|Lost to Follow-up|1|||
44536920|NCT03348930|79547590|FG001|Washout (1 Week)|Lost to Follow-up|1|||
44536921|NCT03500211|79547598|FG000|Overall Study|Withdrawal by Subject|1|||
44258254|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
44258255|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
44323702|NCT01155466|79328801|FG001|Overall Study|Adverse Event|15|||
44422253|NCT00723528|79430249|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
44422254|NCT00723528|79430250|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
44422255|NCT00723528|79430251|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
44422256|NCT00723528|79430252|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
44536922|NCT03500211|79547599|FG001|Overall Study|Withdrawal by Subject|1|||
44156293|NCT01970488|78947467|FG003|Part 2: Post Week 16|Non-compliance|0|||
44156294|NCT01970488|78947468|FG004|Part 2: Post Week 16|Non-compliance|0|||
44156295|NCT01970488|78947464|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
44156296|NCT01970488|78947465|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
44323703|NCT01155466|79328802|FG002|Overall Study|Adverse Event|6|||
44323704|NCT01155466|79328803|FG003|Overall Study|Adverse Event|17|||
44323705|NCT01155466|79328804|FG004|Overall Study|Adverse Event|18|||
44323706|NCT01155466|79328800|FG000|Overall Study|Lost to Follow-up|0|||
44323707|NCT01155466|79328801|FG001|Overall Study|Lost to Follow-up|0|||
44323708|NCT01155466|79328802|FG002|Overall Study|Lost to Follow-up|0|||
44323709|NCT01155466|79328803|FG003|Overall Study|Lost to Follow-up|0|||
44323710|NCT01155466|79328804|FG004|Overall Study|Lost to Follow-up|2|||
44323711|NCT01155466|79328800|FG000|Overall Study|Withdrawal by Subject|7|||
44323712|NCT01155466|79328801|FG001|Overall Study|Withdrawal by Subject|5|||
44323713|NCT01155466|79328802|FG002|Overall Study|Withdrawal by Subject|9|||
44323714|NCT01155466|79328803|FG003|Overall Study|Withdrawal by Subject|4|||
44323715|NCT01155466|79328804|FG004|Overall Study|Withdrawal by Subject|4|||
44323716|NCT01155466|79328800|FG000|Overall Study|Protocol Violation|0|||
44323717|NCT01155466|79328801|FG001|Overall Study|Protocol Violation|0|||
44323718|NCT01155466|79328802|FG002|Overall Study|Protocol Violation|2|||
44323719|NCT01155466|79328803|FG003|Overall Study|Protocol Violation|0|||
44323720|NCT01155466|79328804|FG004|Overall Study|Protocol Violation|1|||
44323721|NCT01155466|79328800|FG000|Overall Study|Administrative|0|||
44323722|NCT01155466|79328801|FG001|Overall Study|Administrative|3|||
44323723|NCT01155466|79328802|FG002|Overall Study|Administrative|0|||
44323724|NCT01155466|79328803|FG003|Overall Study|Administrative|0|||
44323725|NCT01155466|79328804|FG004|Overall Study|Administrative|0|||
44323726|NCT01155466|79328800|FG000|Overall Study|Randomized not treated|2|||
44323727|NCT01155466|79328801|FG001|Overall Study|Randomized not treated|2|||
44323728|NCT01155466|79328802|FG002|Overall Study|Randomized not treated|3|||
44323729|NCT01155466|79328803|FG003|Overall Study|Randomized not treated|0|||
44323730|NCT01155466|79328804|FG004|Overall Study|Randomized not treated|2|||
44323731|NCT01155388|79328818|FG000|Overall Study|Adverse Event|1|||
44323732|NCT01155388|79328819|FG001|Overall Study|Adverse Event|0|||
44323733|NCT01154452|79328830|FG000|Phase Ib|Not Treated|1|||
44323734|NCT01154452|79328831|FG001|Phase Ib|Not Treated|0|||
44323735|NCT01154452|79328832|FG002|Phase Ib|Not Treated|0|||
44323736|NCT01154452|79328833|FG003|Phase Ib|Not Treated|0|||
44323737|NCT01154452|79328830|FG000|Phase Ib|Adverse Event|2|||
44323738|NCT01154452|79328831|FG001|Phase Ib|Adverse Event|1|||
44323739|NCT01154452|79328832|FG002|Phase Ib|Adverse Event|0|||
44323740|NCT01154452|79328833|FG003|Phase Ib|Adverse Event|0|||
44323741|NCT01154452|79328830|FG000|Phase II|Withdrawal by Subject|0|||
44323742|NCT01154452|79328831|FG001|Phase II|Withdrawal by Subject|0|||
44323743|NCT01154452|79328832|FG002|Phase II|Withdrawal by Subject|1|||
44323744|NCT01154452|79328833|FG003|Phase II|Withdrawal by Subject|2|||
44323745|NCT01154452|79328830|FG000|Phase II|Adverse Event|0|||
44323746|NCT01154452|79328831|FG001|Phase II|Adverse Event|0|||
44323747|NCT01154452|79328832|FG002|Phase II|Adverse Event|4|||
44422257|NCT00723528|79430253|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
44422258|NCT00723528|79430254|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
44422259|NCT00723528|79430255|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
44422260|NCT00723528|79430249|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
44422261|NCT00723528|79430250|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
44422262|NCT00723528|79430251|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
44422263|NCT00723528|79430252|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
44422264|NCT00723528|79430253|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
44422265|NCT00723528|79430254|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
44422266|NCT00723528|79430255|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
44422267|NCT00723528|79430249|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
44422268|NCT00723528|79430250|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
44422269|NCT00723528|79430251|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
44422270|NCT00723528|79430252|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
44422271|NCT00723528|79430253|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
44422272|NCT00723528|79430254|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
44323748|NCT01154452|79328833|FG003|Phase II|Adverse Event|4|||
44323749|NCT01154296|79328848|FG000|Randomization and Intervention|Decided to decline|1|||
44323750|NCT01154296|79328849|FG001|Randomization and Intervention|Decided to decline|1|||
44323751|NCT01154296|79328848|FG000|Randomization and Intervention|Declined by staff|1|||
44323752|NCT01154296|79328849|FG001|Randomization and Intervention|Declined by staff|0|||
44323753|NCT01154296|79328848|FG000|Randomization and Intervention|Did not return|1|||
44323754|NCT01154296|79328849|FG001|Randomization and Intervention|Did not return|0|||
44323755|NCT01154296|79328848|FG000|Randomization and Intervention|Left before test|0|||
44323756|NCT01154296|79328849|FG001|Randomization and Intervention|Left before test|1|||
44422273|NCT00723528|79430255|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
44422274|NCT00723528|79430249|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
44422275|NCT00723528|79430250|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
44422276|NCT00723528|79430251|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
44422277|NCT00723528|79430252|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
44422278|NCT00723528|79430253|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
44422279|NCT00723528|79430254|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
44422280|NCT00723528|79430255|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
44422281|NCT00723528|79430249|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
44422282|NCT00723528|79430250|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
44422283|NCT00723528|79430251|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
44422284|NCT00723528|79430252|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
44422285|NCT00723528|79430253|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
44422286|NCT00723528|79430254|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
44422287|NCT00723528|79430255|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
44422288|NCT00723528|79430249|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
44422289|NCT00723528|79430250|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
44422290|NCT00723528|79430251|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
44422291|NCT00723528|79430252|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
44422292|NCT00723528|79430253|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
44422293|NCT00723528|79430254|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
44422294|NCT00723528|79430255|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
44422295|NCT00723528|79430249|FG000|Period 2: After Controlled Period|Other|0|||
44422296|NCT00723528|79430250|FG001|Period 2: After Controlled Period|Other|0|||
44422297|NCT00723528|79430251|FG002|Period 2: After Controlled Period|Other|0|||
44422298|NCT00723528|79430252|FG003|Period 2: After Controlled Period|Other|0|||
44422299|NCT00723528|79430253|FG004|Period 2: After Controlled Period|Other|1|||
44422300|NCT00723528|79430254|FG005|Period 2: After Controlled Period|Other|4|||
44422301|NCT00723528|79430255|FG006|Period 2: After Controlled Period|Other|0|||
44422302|NCT00723528|79430249|FG000|Period 2: After Controlled Period|Adverse Event|0|||
44422303|NCT00723528|79430250|FG001|Period 2: After Controlled Period|Adverse Event|0|||
44422304|NCT00723528|79430251|FG002|Period 2: After Controlled Period|Adverse Event|0|||
44422305|NCT00723528|79430252|FG003|Period 2: After Controlled Period|Adverse Event|0|||
44422306|NCT00723528|79430253|FG004|Period 2: After Controlled Period|Adverse Event|1|||
44422307|NCT00723528|79430254|FG005|Period 2: After Controlled Period|Adverse Event|0|||
44422308|NCT00723528|79430255|FG006|Period 2: After Controlled Period|Adverse Event|1|||
44422309|NCT00723528|79430249|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
44422310|NCT00723528|79430250|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
44422311|NCT00723528|79430251|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
44422312|NCT00723528|79430252|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
44422313|NCT00723528|79430253|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
44422314|NCT00723528|79430254|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
44422315|NCT00723528|79430255|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
44422316|NCT00723528|79430249|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
44422317|NCT00723528|79430250|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
44422318|NCT00723528|79430251|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
44422319|NCT00723528|79430252|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
44422320|NCT00723528|79430253|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
44258256|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
44258257|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
44258258|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
44323757|NCT01154296|79328848|FG000|Randomization and Intervention|Left clinic early|2|||
44323758|NCT01154296|79328849|FG001|Randomization and Intervention|Left clinic early|0|||
44258259|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
44258260|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
44258261|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
44258262|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
44258263|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
44323759|NCT01154296|79328848|FG000|6-month Follow-up|Lost contact|269|||
44323760|NCT01154296|79328849|FG001|6-month Follow-up|Lost contact|275|||
44323761|NCT01154296|79328848|FG000|6-month Follow-up|Incarcerated|37|||
44323762|NCT01154296|79328849|FG001|6-month Follow-up|Incarcerated|32|||
44323763|NCT01154296|79328848|FG000|6-month Follow-up|Withdrew consent|14|||
44323764|NCT01154296|79328849|FG001|6-month Follow-up|Withdrew consent|15|||
44323765|NCT01154296|79328848|FG000|6-month Follow-up|Death|3|||
44323766|NCT01154296|79328849|FG001|6-month Follow-up|Death|2|||
44323767|NCT01154296|79328848|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
44323768|NCT01154296|79328849|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
44323769|NCT01154218|79328855|FG000|Third Intervention Period|Adverse Event|0|||
44323770|NCT01154218|79328856|FG001|Third Intervention Period|Adverse Event|1|||
44323771|NCT01154218|79328857|FG002|Third Intervention Period|Adverse Event|0|||
44323772|NCT01154218|79328858|FG003|Third Intervention Period|Adverse Event|0|||
44323773|NCT01154218|79328855|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44323774|NCT01154218|79328856|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44422321|NCT00723528|79430254|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
44422322|NCT00723528|79430255|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
44422323|NCT00751790|79430271|FG000|Overall Study|Lost to Follow-up|1|||
44422324|NCT00751790|79430271|FG000|Overall Study|Death|3|||
44422325|NCT00751790|79430271|FG000|Overall Study|Withdrawal by Subject|1|||
44422326|NCT00723450|79430277|FG000|Open-Label Phase|Adverse Event|26|||
44422327|NCT00723450|79430278|FG001|Open-Label Phase|Adverse Event|0|||
44422328|NCT00723450|79430279|FG002|Open-Label Phase|Adverse Event|0|||
44422329|NCT00723450|79430277|FG000|Open-Label Phase|Lack of Efficacy|18|||
44422330|NCT00723450|79430278|FG001|Open-Label Phase|Lack of Efficacy|0|||
44422331|NCT00723450|79430279|FG002|Open-Label Phase|Lack of Efficacy|0|||
44422332|NCT00723450|79430277|FG000|Open-Label Phase|Protocol Violation|35|||
44323775|NCT01154218|79328857|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
44323776|NCT01154218|79328858|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
44323777|NCT01154218|79328855|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
44323778|NCT01154218|79328856|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
44323779|NCT01154218|79328857|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
44323780|NCT01154218|79328858|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
44323781|NCT01154140|79328883|FG000|Overall Study|Death|71|||
44323782|NCT01154140|79328884|FG001|Overall Study|Death|81|||
44323783|NCT01154140|79328883|FG000|Overall Study|Lost to Follow-up|4|||
44323784|NCT01154140|79328884|FG001|Overall Study|Lost to Follow-up|5|||
44323785|NCT01154140|79328883|FG000|Overall Study|Withdrawal by Subject|12|||
44323786|NCT01154140|79328884|FG001|Overall Study|Withdrawal by Subject|13|||
44323787|NCT01154140|79328883|FG000|Overall Study|Other|3|||
44323788|NCT01154140|79328884|FG001|Overall Study|Other|1|||
44323789|NCT01154140|79328883|FG000|Overall Study|Randomized but not treated|1|||
44323790|NCT01154140|79328884|FG001|Overall Study|Randomized but not treated|2|||
44323791|NCT01154101|79328895|FG000|Overall Study|Adverse Event|0|||
44323792|NCT01154101|79328896|FG001|Overall Study|Adverse Event|2|||
44323793|NCT01154101|79328897|FG002|Overall Study|Adverse Event|1|||
44323794|NCT01154101|79328898|FG003|Overall Study|Adverse Event|1|||
44323795|NCT01154101|79328899|FG004|Overall Study|Adverse Event|0|||
44323796|NCT01154101|79328895|FG000|Overall Study|Lost to Follow-up|0|||
44323797|NCT01154101|79328896|FG001|Overall Study|Lost to Follow-up|1|||
44323798|NCT01154101|79328897|FG002|Overall Study|Lost to Follow-up|0|||
44323799|NCT01154101|79328898|FG003|Overall Study|Lost to Follow-up|1|||
44323800|NCT01154101|79328899|FG004|Overall Study|Lost to Follow-up|0|||
44323801|NCT01154101|79328895|FG000|Overall Study|Withdrawal by Subject|0|||
44323802|NCT01154101|79328896|FG001|Overall Study|Withdrawal by Subject|1|||
44323803|NCT01154101|79328897|FG002|Overall Study|Withdrawal by Subject|2|||
44323804|NCT01154101|79328898|FG003|Overall Study|Withdrawal by Subject|0|||
44323805|NCT01154101|79328899|FG004|Overall Study|Withdrawal by Subject|1|||
44323806|NCT01153984|79328916|FG000|Overall Study|Withdrawal by Subject|1|||
44323807|NCT01153984|79328916|FG000|Overall Study|Adverse Event|1|||
44323808|NCT01153633|79328922|FG000|Overall Study|Protocol Violation|1|||
44323809|NCT01153633|79328923|FG001|Overall Study|Protocol Violation|1|||
44323810|NCT01153633|79328922|FG000|Overall Study|Therapeutic failure|3|||
44323811|NCT01153633|79328923|FG001|Overall Study|Therapeutic failure|3|||
44323812|NCT01153516|79328933|FG000|Overall Study|Both subjects refused surgery|2|||
44323813|NCT01153516|79328934|FG001|Overall Study|Both subjects refused surgery|0|||
44323814|NCT01153321|79328942|FG000|Overall Study|Development of study withdrawal criteria|0|||
44323815|NCT01153321|79328943|FG001|Overall Study|Development of study withdrawal criteria|1|||
44323816|NCT01153321|79328942|FG000|Overall Study|Withdrawal by Subject|0|||
44323817|NCT01153321|79328943|FG001|Overall Study|Withdrawal by Subject|1|||
44323818|NCT01153321|79328942|FG000|Overall Study|Adverse Event|1|||
44536923|NCT03478683|79547607|FG000|Overall Study|Adverse Event|5|||
44323819|NCT01153321|79328943|FG001|Overall Study|Adverse Event|1|||
44422333|NCT00723450|79430278|FG001|Open-Label Phase|Protocol Violation|0|||
44422334|NCT00723450|79430279|FG002|Open-Label Phase|Protocol Violation|0|||
44323820|NCT01153009|79328953|FG000|Overall Study|Adverse Event|4|||
44323821|NCT01153009|79328954|FG001|Overall Study|Adverse Event|14|||
44323822|NCT01153009|79328955|FG002|Overall Study|Adverse Event|14|||
44323823|NCT01153009|79328956|FG003|Overall Study|Adverse Event|10|||
44323824|NCT01153009|79328953|FG000|Overall Study|Lack of Efficacy|9|||
44323825|NCT01153009|79328954|FG001|Overall Study|Lack of Efficacy|0|||
44323826|NCT01153009|79328955|FG002|Overall Study|Lack of Efficacy|2|||
44323827|NCT01153009|79328956|FG003|Overall Study|Lack of Efficacy|1|||
44323828|NCT01153009|79328953|FG000|Overall Study|Noncompliance with Study Medication|1|||
44323829|NCT01153009|79328954|FG001|Overall Study|Noncompliance with Study Medication|3|||
44323830|NCT01153009|79328955|FG002|Overall Study|Noncompliance with Study Medication|4|||
44323831|NCT01153009|79328956|FG003|Overall Study|Noncompliance with Study Medication|1|||
44323832|NCT01153009|79328953|FG000|Overall Study|Protocol Deviations|4|||
44323833|NCT01153009|79328954|FG001|Overall Study|Protocol Deviations|3|||
44323834|NCT01153009|79328955|FG002|Overall Study|Protocol Deviations|3|||
44323835|NCT01153009|79328956|FG003|Overall Study|Protocol Deviations|2|||
44323836|NCT01153009|79328953|FG000|Overall Study|Withdrawal of Consent|5|||
44323837|NCT01153009|79328954|FG001|Overall Study|Withdrawal of Consent|5|||
44323838|NCT01153009|79328955|FG002|Overall Study|Withdrawal of Consent|4|||
44323839|NCT01153009|79328956|FG003|Overall Study|Withdrawal of Consent|6|||
44323840|NCT01153009|79328953|FG000|Overall Study|Lost to Follow-up|8|||
44323841|NCT01153009|79328954|FG001|Overall Study|Lost to Follow-up|8|||
44323842|NCT01153009|79328955|FG002|Overall Study|Lost to Follow-up|11|||
44323843|NCT01153009|79328956|FG003|Overall Study|Lost to Follow-up|15|||
44323844|NCT01153009|79328953|FG000|Overall Study|Other|1|||
44323845|NCT01153009|79328954|FG001|Overall Study|Other|1|||
44323846|NCT01153009|79328955|FG002|Overall Study|Other|3|||
44323847|NCT01153009|79328956|FG003|Overall Study|Other|2|||
44323848|NCT01152814|79328966|FG000|Overall Study|Lost to Follow-up|2|||
44323849|NCT01152580|79328972|FG000|Overall Study|Withdrawal by Subject|0|||
44323850|NCT01152580|79328973|FG001|Overall Study|Withdrawal by Subject|1|||
44323851|NCT01152385|79328983|FG000|Overall Study|Withdrawal by Subject|3|||
44323852|NCT01152385|79328984|FG001|Overall Study|Withdrawal by Subject|1|||
44323853|NCT01152385|79328985|FG002|Overall Study|Withdrawal by Subject|1|||
44323854|NCT01152385|79328986|FG003|Overall Study|Withdrawal by Subject|1|||
44323855|NCT01152385|79328983|FG000|Overall Study|Protocol Violation|0|||
44323856|NCT01152385|79328984|FG001|Overall Study|Protocol Violation|0|||
44323857|NCT01152385|79328985|FG002|Overall Study|Protocol Violation|0|||
44323858|NCT01152385|79328986|FG003|Overall Study|Protocol Violation|1|||
44323859|NCT01152385|79328983|FG000|Overall Study|Adverse Event|1|||
44323860|NCT01152385|79328984|FG001|Overall Study|Adverse Event|1|||
44323861|NCT01152385|79328985|FG002|Overall Study|Adverse Event|0|||
44323862|NCT01152385|79328986|FG003|Overall Study|Adverse Event|0|||
44323863|NCT01152385|79328983|FG000|Overall Study|Study-specific withdrawal criteria|1|||
44323864|NCT01152385|79328984|FG001|Overall Study|Study-specific withdrawal criteria|1|||
44323865|NCT01152385|79328985|FG002|Overall Study|Study-specific withdrawal criteria|2|||
44323866|NCT01152385|79328986|FG003|Overall Study|Study-specific withdrawal criteria|0|||
44323867|NCT01152385|79328983|FG000|Overall Study|Other|4|||
44323868|NCT01152385|79328984|FG001|Overall Study|Other|3|||
44323869|NCT01152385|79328985|FG002|Overall Study|Other|2|||
44323870|NCT01152385|79328986|FG003|Overall Study|Other|3|||
44323871|NCT01152190|79329002|FG000|Overall Study|Adverse Event|2|||
44323872|NCT01152190|79329003|FG001|Overall Study|Adverse Event|4|||
44323873|NCT01152190|79329002|FG000|Overall Study|Death|1|||
44323874|NCT01152190|79329003|FG001|Overall Study|Death|0|||
44323875|NCT01152190|79329002|FG000|Overall Study|Protocol Violation|1|||
44323876|NCT01152190|79329003|FG001|Overall Study|Protocol Violation|1|||
44323877|NCT01152190|79329002|FG000|Overall Study|Withdrawal by Subject|1|||
44323878|NCT01152190|79329003|FG001|Overall Study|Withdrawal by Subject|3|||
44323879|NCT01151410|79329011|FG000|Overall Study|Withdrawal by Subject|3|||
44323880|NCT01151410|79329012|FG001|Overall Study|Withdrawal by Subject|5|||
44323881|NCT01151410|79329011|FG000|Overall Study|Lost to Follow-up|3|||
44323882|NCT01151410|79329012|FG001|Overall Study|Lost to Follow-up|4|||
44323883|NCT01151410|79329011|FG000|Overall Study|Adverse Event|1|||
44323884|NCT01151410|79329012|FG001|Overall Study|Adverse Event|2|||
44323885|NCT01151410|79329011|FG000|Overall Study|Protocol deviation|2|||
44323886|NCT01151410|79329012|FG001|Overall Study|Protocol deviation|1|||
44323887|NCT01151410|79329011|FG000|Overall Study|Administrative problems|1|||
44323888|NCT01151410|79329012|FG001|Overall Study|Administrative problems|1|||
44323889|NCT01151410|79329011|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44323890|NCT01151410|79329012|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
44323891|NCT01151410|79329011|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44323892|NCT01151410|79329012|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44323893|NCT01151215|79329021|FG000|Overall Study|Worsening of condition under study|1|||
44323894|NCT01151215|79329022|FG001|Overall Study|Worsening of condition under study|1|||
44323895|NCT01151215|79329023|FG002|Overall Study|Worsening of condition under study|1|||
44323896|NCT01151215|79329021|FG000|Overall Study|Death|16|||
44323897|NCT01151215|79329022|FG001|Overall Study|Death|20|||
44323898|NCT01151215|79329023|FG002|Overall Study|Death|11|||
44323899|NCT01151215|79329021|FG000|Overall Study|Lost to Follow-up|0|||
44323900|NCT01151215|79329022|FG001|Overall Study|Lost to Follow-up|0|||
44323901|NCT01151215|79329023|FG002|Overall Study|Lost to Follow-up|3|||
44323902|NCT01151215|79329021|FG000|Overall Study|Withdrawal by Subject|3|||
44323903|NCT01151215|79329022|FG001|Overall Study|Withdrawal by Subject|1|||
44323904|NCT01151215|79329023|FG002|Overall Study|Withdrawal by Subject|2|||
44323905|NCT01151215|79329021|FG000|Overall Study|Disease progression|0|||
44323906|NCT01151215|79329022|FG001|Overall Study|Disease progression|1|||
44323907|NCT01151215|79329023|FG002|Overall Study|Disease progression|1|||
44323908|NCT01151215|79329021|FG000|Overall Study|Safety as judged by the investigator|0|||
44323909|NCT01151215|79329022|FG001|Overall Study|Safety as judged by the investigator|0|||
44323910|NCT01151215|79329023|FG002|Overall Study|Safety as judged by the investigator|1|||
44323911|NCT01151137|79329033|FG000|Overall Study|Death|15|||
44323912|NCT01151137|79329034|FG001|Overall Study|Death|27|||
44323913|NCT01151137|79329033|FG000|Overall Study|Lost to Follow-up|1|||
44323914|NCT01151137|79329034|FG001|Overall Study|Lost to Follow-up|1|||
44323915|NCT01151098|79329040|FG000|Overall Study|Adverse Event|82|||
44323916|NCT01151098|79329040|FG000|Overall Study|Lost to Follow-up|6|||
44323917|NCT01151098|79329040|FG000|Overall Study|Lack of Efficacy|15|||
44323918|NCT01151098|79329040|FG000|Overall Study|Protocol Violation|1|||
44323919|NCT01151098|79329040|FG000|Overall Study|Miscellaneous|13|||
44323920|NCT01151020|79329044|FG000|Overall Study|Death|25|||
44323921|NCT01151020|79329044|FG000|Overall Study|Conversion to open repair|1|||
44323922|NCT01151020|79329044|FG000|Overall Study|Lost to Follow-up|4|||
44323923|NCT01151020|79329044|FG000|Overall Study|Withdrawal by Subject|22|||
44323924|NCT01151020|79329044|FG000|Overall Study|Patients did not receive the device|2|||
44323925|NCT01150474|79329050|FG000|Overall Study|Withdrawal by Subject|5|||
44323926|NCT01150474|79329051|FG001|Overall Study|Withdrawal by Subject|2|||
44323927|NCT01150474|79329050|FG000|Overall Study|Cancer found|1|||
44323928|NCT01150474|79329051|FG001|Overall Study|Cancer found|0|||
44323929|NCT01150474|79329050|FG000|Overall Study|Multiple Studies|0|||
44323930|NCT01150474|79329051|FG001|Overall Study|Multiple Studies|1|||
44323931|NCT01150474|79329050|FG000|Overall Study|Rectotomy|1|||
44323932|NCT01150474|79329051|FG001|Overall Study|Rectotomy|0|||
44323933|NCT01150474|79329050|FG000|Overall Study|Drug did not arrive in time|1|||
44323934|NCT01150474|79329051|FG001|Overall Study|Drug did not arrive in time|0|||
44323935|NCT01150474|79329050|FG000|Overall Study|Drug not administered|1|||
44323936|NCT01150474|79329051|FG001|Overall Study|Drug not administered|0|||
44323937|NCT01150474|79329050|FG000|Overall Study|Surgery Changed|1|||
44323938|NCT01150474|79329051|FG001|Overall Study|Surgery Changed|0|||
44323939|NCT01150357|79329060|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
44323940|NCT01150357|79329061|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
44323941|NCT01150357|79329062|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
44323942|NCT01150357|79329060|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
44422335|NCT00723450|79430277|FG000|Open-Label Phase|Lost to Follow-up|7|||
44422336|NCT00723450|79430278|FG001|Open-Label Phase|Lost to Follow-up|0|||
44422337|NCT00723450|79430279|FG002|Open-Label Phase|Lost to Follow-up|0|||
44422338|NCT00723450|79430277|FG000|Open-Label Phase|Physician Decision|2|||
44422339|NCT00723450|79430278|FG001|Open-Label Phase|Physician Decision|0|||
44422340|NCT00723450|79430279|FG002|Open-Label Phase|Physician Decision|0|||
44422341|NCT00723450|79430277|FG000|Open-Label Phase|Withdrawal by Subject|37|||
44422342|NCT00723450|79430278|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44422343|NCT00723450|79430279|FG002|Open-Label Phase|Withdrawal by Subject|0|||
44422344|NCT00723450|79430277|FG000|Randomized Phase|Adverse Event|0|||
44422345|NCT00723450|79430278|FG001|Randomized Phase|Adverse Event|26|||
44422346|NCT00723450|79430279|FG002|Randomized Phase|Adverse Event|17|||
44422347|NCT00723450|79430277|FG000|Randomized Phase|Lack of Efficacy|0|||
44422348|NCT00723450|79430278|FG001|Randomized Phase|Lack of Efficacy|11|||
44422349|NCT00723450|79430279|FG002|Randomized Phase|Lack of Efficacy|11|||
44422350|NCT00723450|79430277|FG000|Randomized Phase|Protocol Violation|0|||
44323943|NCT01150357|79329061|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
44323944|NCT01150357|79329062|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
44323945|NCT01150357|79329060|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
44323946|NCT01150357|79329061|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
44323947|NCT01150357|79329062|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
44422351|NCT00723450|79430278|FG001|Randomized Phase|Protocol Violation|9|||
44422352|NCT00723450|79430279|FG002|Randomized Phase|Protocol Violation|13|||
44422353|NCT00723450|79430277|FG000|Randomized Phase|Lost to Follow-up|0|||
44323948|NCT01150357|79329060|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
44323949|NCT01150357|79329061|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
44323950|NCT01150357|79329062|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
44422354|NCT00723450|79430278|FG001|Randomized Phase|Lost to Follow-up|2|||
44422355|NCT00723450|79430279|FG002|Randomized Phase|Lost to Follow-up|3|||
44323951|NCT01150357|79329060|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
44422356|NCT00723450|79430277|FG000|Randomized Phase|Physician Decision|0|||
44422357|NCT00723450|79430278|FG001|Randomized Phase|Physician Decision|3|||
44323952|NCT01150357|79329061|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
44323953|NCT01150357|79329062|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
44323954|NCT01150357|79329060|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
44323955|NCT01150357|79329061|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
44323956|NCT01150357|79329062|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
44323957|NCT01150357|79329060|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
44323958|NCT01150357|79329061|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
44323959|NCT01150357|79329062|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
44323960|NCT01150123|79329112|FG000|Overall Study|Withdrawal by Subject|1|||
44323961|NCT01150123|79329113|FG001|Overall Study|Withdrawal by Subject|1|||
44323962|NCT01150123|79329114|FG002|Overall Study|Withdrawal by Subject|2|||
44323963|NCT01150123|79329115|FG003|Overall Study|Withdrawal by Subject|1|||
44323964|NCT01150123|79329116|FG004|Overall Study|Withdrawal by Subject|1|||
44323965|NCT01150123|79329117|FG005|Overall Study|Withdrawal by Subject|1|||
44323966|NCT01150123|79329118|FG006|Overall Study|Withdrawal by Subject|0|||
44323967|NCT01150123|79329119|FG007|Overall Study|Withdrawal by Subject|3|||
44323968|NCT01150123|79329120|FG008|Overall Study|Withdrawal by Subject|2|||
44323969|NCT01150123|79329121|FG009|Overall Study|Withdrawal by Subject|0|||
44323970|NCT01150123|79329122|FG010|Overall Study|Withdrawal by Subject|1|||
44323971|NCT01150123|79329123|FG011|Overall Study|Withdrawal by Subject|0|||
44323972|NCT01150123|79329124|FG012|Overall Study|Withdrawal by Subject|1|||
44323973|NCT01150123|79329125|FG013|Overall Study|Withdrawal by Subject|0|||
44323974|NCT01150123|79329126|FG014|Overall Study|Withdrawal by Subject|0|||
44323975|NCT01150123|79329127|FG015|Overall Study|Withdrawal by Subject|1|||
44323976|NCT01150123|79329128|FG016|Overall Study|Withdrawal by Subject|0|||
44323977|NCT01150123|79329129|FG017|Overall Study|Withdrawal by Subject|1|||
44323978|NCT01150123|79329112|FG000|Overall Study|Lost to Follow-up|2|||
44323979|NCT01150123|79329113|FG001|Overall Study|Lost to Follow-up|1|||
44323980|NCT01150123|79329114|FG002|Overall Study|Lost to Follow-up|2|||
44323981|NCT01150123|79329115|FG003|Overall Study|Lost to Follow-up|2|||
44323982|NCT01150123|79329116|FG004|Overall Study|Lost to Follow-up|2|||
44323983|NCT01150123|79329117|FG005|Overall Study|Lost to Follow-up|5|||
44323984|NCT01150123|79329118|FG006|Overall Study|Lost to Follow-up|0|||
44323985|NCT01150123|79329119|FG007|Overall Study|Lost to Follow-up|0|||
44323986|NCT01150123|79329120|FG008|Overall Study|Lost to Follow-up|3|||
44323987|NCT01150123|79329121|FG009|Overall Study|Lost to Follow-up|1|||
44323988|NCT01150123|79329122|FG010|Overall Study|Lost to Follow-up|1|||
44323989|NCT01150123|79329123|FG011|Overall Study|Lost to Follow-up|1|||
44323990|NCT01150123|79329124|FG012|Overall Study|Lost to Follow-up|2|||
44323991|NCT01150123|79329125|FG013|Overall Study|Lost to Follow-up|0|||
44323992|NCT01150123|79329126|FG014|Overall Study|Lost to Follow-up|0|||
44323993|NCT01150123|79329127|FG015|Overall Study|Lost to Follow-up|0|||
44323994|NCT01150123|79329128|FG016|Overall Study|Lost to Follow-up|0|||
44323995|NCT01150123|79329129|FG017|Overall Study|Lost to Follow-up|0|||
44323996|NCT01149655|79329188|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
44323997|NCT01149655|79329189|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
44323998|NCT01149655|79329190|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
44323999|NCT01149655|79329191|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
44324000|NCT01149655|79329188|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
44324001|NCT01149655|79329189|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
44324002|NCT01149655|79329190|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
44324003|NCT01149655|79329191|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
44324004|NCT01149655|79329188|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
44324005|NCT01149655|79329189|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
44324006|NCT01149655|79329190|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
44324007|NCT01149655|79329191|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
44324008|NCT01149655|79329188|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
44324009|NCT01149655|79329189|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
44324010|NCT01149655|79329190|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
44324011|NCT01149655|79329191|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
44324012|NCT01149655|79329188|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
44324013|NCT01149655|79329189|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
44324014|NCT01149655|79329190|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
44324015|NCT01149655|79329191|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
44324016|NCT01149655|79329188|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
44324017|NCT01149655|79329189|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
44324018|NCT01149655|79329190|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
44324019|NCT01149655|79329191|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
44324020|NCT01149655|79329188|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
44324021|NCT01149655|79329189|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
44324022|NCT01149655|79329190|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
44324023|NCT01149655|79329191|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
44324024|NCT01149655|79329188|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
44324025|NCT01149655|79329189|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
44324026|NCT01149655|79329190|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
44324027|NCT01149655|79329191|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
44324028|NCT01149655|79329188|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
44324029|NCT01149655|79329189|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
44324030|NCT01149655|79329190|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
44324031|NCT01149655|79329191|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
44324032|NCT01149655|79329188|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
44324033|NCT01149655|79329189|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
44324034|NCT01149655|79329190|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
44324035|NCT01149655|79329191|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
44324036|NCT01149655|79329188|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
44324037|NCT01149655|79329189|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
44324038|NCT01149655|79329190|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
44324039|NCT01149655|79329191|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
44324040|NCT01149655|79329188|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
44324041|NCT01149655|79329189|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
44324042|NCT01149655|79329190|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
44324043|NCT01149655|79329191|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
44324044|NCT01149655|79329188|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
44324045|NCT01149655|79329189|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
44156297|NCT01970488|78947466|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
44156298|NCT01970488|78947467|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
44156299|NCT01970488|78947468|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
44156300|NCT01970488|78947464|FG000|Part 2: Post Week 16|Adverse Event|0|||
44156301|NCT01970488|78947465|FG001|Part 2: Post Week 16|Adverse Event|0|||
44156302|NCT01970488|78947466|FG002|Part 2: Post Week 16|Adverse Event|5|||
44156303|NCT01970488|78947467|FG003|Part 2: Post Week 16|Adverse Event|1|||
44324046|NCT01149655|79329190|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
44324047|NCT01149655|79329191|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
44324048|NCT01149655|79329188|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
44324049|NCT01149655|79329189|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
44324050|NCT01149655|79329190|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
44324051|NCT01149655|79329191|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
44324052|NCT01149655|79329188|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
44324053|NCT01149655|79329189|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
44324054|NCT01149655|79329190|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
44324055|NCT01149655|79329191|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
44324056|NCT01149655|79329188|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
44324057|NCT01149655|79329189|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
44324058|NCT01149655|79329190|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
44324059|NCT01149655|79329191|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
44324060|NCT01149538|79329201|FG000|Overall Study|Lost to Follow-up|0|||
44324061|NCT01149538|79329202|FG001|Overall Study|Lost to Follow-up|1|||
44324062|NCT01149538|79329201|FG000|Overall Study|Withdrawal by Subject|5|||
44324063|NCT01149538|79329202|FG001|Overall Study|Withdrawal by Subject|3|||
44324064|NCT01149460|79329210|FG000|Overall Study|Withdrawal by Subject|0|||
44324065|NCT01149460|79329211|FG001|Overall Study|Withdrawal by Subject|2|||
44324066|NCT01149421|79329220|FG000|Overall Study|Adverse Event|22|||
44324067|NCT01149421|79329221|FG001|Overall Study|Adverse Event|6|||
44324068|NCT01149421|79329222|FG002|Overall Study|Adverse Event|11|||
44324069|NCT01149421|79329220|FG000|Overall Study|Withdrawal by Subject|20|||
44324070|NCT01149421|79329221|FG001|Overall Study|Withdrawal by Subject|12|||
44324071|NCT01149421|79329222|FG002|Overall Study|Withdrawal by Subject|13|||
44324072|NCT01149421|79329220|FG000|Overall Study|Sponsor Decision|0|||
44324073|NCT01149421|79329221|FG001|Overall Study|Sponsor Decision|1|||
44324074|NCT01149421|79329222|FG002|Overall Study|Sponsor Decision|1|||
44324075|NCT01149421|79329220|FG000|Overall Study|Lost to Follow-up|2|||
44324076|NCT01149421|79329221|FG001|Overall Study|Lost to Follow-up|4|||
44422358|NCT00723450|79430279|FG002|Randomized Phase|Physician Decision|1|||
44422359|NCT00723450|79430277|FG000|Randomized Phase|Withdrawal by Subject|0|||
44422360|NCT00723450|79430278|FG001|Randomized Phase|Withdrawal by Subject|14|||
44536924|NCT03478683|79547608|FG001|Overall Study|Adverse Event|3|||
44536925|NCT03478683|79547607|FG000|Overall Study|Lost to Follow-up|0|||
44536926|NCT03478683|79547608|FG001|Overall Study|Lost to Follow-up|5|||
44156304|NCT01970488|78947468|FG004|Part 2: Post Week 16|Adverse Event|1|||
44156305|NCT01970488|78947464|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
44324077|NCT01149421|79329222|FG002|Overall Study|Lost to Follow-up|5|||
44324078|NCT01149421|79329220|FG000|Overall Study|Physician Decision|5|||
44324079|NCT01149421|79329221|FG001|Overall Study|Physician Decision|3|||
44324080|NCT01149421|79329222|FG002|Overall Study|Physician Decision|6|||
44324081|NCT01149421|79329220|FG000|Overall Study|Entry Criteria Not Met|1|||
44324082|NCT01149421|79329221|FG001|Overall Study|Entry Criteria Not Met|1|||
44324083|NCT01149421|79329222|FG002|Overall Study|Entry Criteria Not Met|2|||
44324084|NCT01149421|79329220|FG000|Overall Study|Protocol Violation|2|||
44324085|NCT01149421|79329221|FG001|Overall Study|Protocol Violation|2|||
44324086|NCT01149421|79329222|FG002|Overall Study|Protocol Violation|6|||
44324087|NCT01149343|79329240|FG000|Overall Study|Withdrawal by Subject|1|||
44324088|NCT01149343|79329241|FG001|Overall Study|Withdrawal by Subject|1|||
44324089|NCT01149343|79329242|FG002|Overall Study|Withdrawal by Subject|1|||
44324090|NCT01149343|79329243|FG003|Overall Study|Withdrawal by Subject|5|||
44324091|NCT01149343|79329240|FG000|Overall Study|Death|10|||
44324092|NCT01149343|79329241|FG001|Overall Study|Death|13|||
44324093|NCT01149343|79329242|FG002|Overall Study|Death|18|||
44324094|NCT01149343|79329243|FG003|Overall Study|Death|18|||
44324095|NCT01149343|79329240|FG000|Overall Study|Lost to Follow-up|1|||
44324096|NCT01149343|79329241|FG001|Overall Study|Lost to Follow-up|0|||
44324097|NCT01149343|79329242|FG002|Overall Study|Lost to Follow-up|0|||
44324098|NCT01149343|79329243|FG003|Overall Study|Lost to Follow-up|1|||
44324099|NCT01149343|79329240|FG000|Overall Study|Other|8|||
44324100|NCT01149343|79329241|FG001|Overall Study|Other|10|||
44324101|NCT01149343|79329242|FG002|Overall Study|Other|2|||
44324102|NCT01149343|79329243|FG003|Overall Study|Other|14|||
44324103|NCT01149343|79329240|FG000|Overall Study|Sponsor study termination|0|||
44324104|NCT01149343|79329241|FG001|Overall Study|Sponsor study termination|0|||
44324105|NCT01149343|79329242|FG002|Overall Study|Sponsor study termination|0|||
44324106|NCT01149343|79329243|FG003|Overall Study|Sponsor study termination|2|||
44324107|NCT01149343|79329240|FG000|Overall Study|Recurrence / Progressive disease|0|||
44324108|NCT01149343|79329241|FG001|Overall Study|Recurrence / Progressive disease|0|||
44324109|NCT01149343|79329242|FG002|Overall Study|Recurrence / Progressive disease|1|||
44324110|NCT01149343|79329243|FG003|Overall Study|Recurrence / Progressive disease|0|||
44324111|NCT01149148|79329259|FG000|Overall Study|Lost to Follow-up|1|||
44324112|NCT01149148|79329260|FG001|Overall Study|Lost to Follow-up|2|||
44324113|NCT01149148|79329259|FG000|Overall Study|Death|1|||
44324114|NCT01149148|79329260|FG001|Overall Study|Death|0|||
44324115|NCT01148017|79329271|FG000|Overall Study|Withdrawal by Subject|31|||
44324116|NCT01148017|79329272|FG001|Overall Study|Withdrawal by Subject|14|||
44324117|NCT01148017|79329273|FG002|Overall Study|Withdrawal by Subject|0|||
44324118|NCT01148017|79329274|FG003|Overall Study|Withdrawal by Subject|0|||
44324119|NCT01148017|79329271|FG000|Overall Study|Lost to Follow-up|23|||
44324120|NCT01148017|79329272|FG001|Overall Study|Lost to Follow-up|10|||
44324121|NCT01148017|79329273|FG002|Overall Study|Lost to Follow-up|0|||
44324122|NCT01148017|79329274|FG003|Overall Study|Lost to Follow-up|0|||
44324123|NCT01148017|79329271|FG000|Overall Study|Inappropriate enrollment|1|||
44324124|NCT01148017|79329272|FG001|Overall Study|Inappropriate enrollment|0|||
44324125|NCT01148017|79329273|FG002|Overall Study|Inappropriate enrollment|0|||
44324126|NCT01148017|79329274|FG003|Overall Study|Inappropriate enrollment|0|||
44324127|NCT01148017|79329271|FG000|Overall Study|Administrative reason|22|||
44324128|NCT01148017|79329272|FG001|Overall Study|Administrative reason|9|||
44324129|NCT01148017|79329273|FG002|Overall Study|Administrative reason|0|||
44324130|NCT01148017|79329274|FG003|Overall Study|Administrative reason|0|||
44422361|NCT00723450|79430279|FG002|Randomized Phase|Withdrawal by Subject|22|||
44422362|NCT00751400|79430288|FG000|Overall Study|Lost to Follow-up|10|||
44422363|NCT00585312|79430294|FG000|Overall Study|Adverse Event|3|||
44422364|NCT00585312|79430295|FG001|Overall Study|Adverse Event|0|||
44422365|NCT00585312|79430294|FG000|Overall Study|Lack of Efficacy|6|||
44422366|NCT00585312|79430295|FG001|Overall Study|Lack of Efficacy|11|||
44422367|NCT00585312|79430294|FG000|Overall Study|Lost to Follow-up|1|||
44422368|NCT00585312|79430295|FG001|Overall Study|Lost to Follow-up|1|||
44422369|NCT00585312|79430294|FG000|Overall Study|Reason not specified|2|||
44156306|NCT01970488|78947465|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
44156307|NCT01970488|78947466|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
44324131|NCT01148017|79329271|FG000|Overall Study|Unable to classify|3|||
44324132|NCT01148017|79329272|FG001|Overall Study|Unable to classify|1|||
44324133|NCT01148017|79329273|FG002|Overall Study|Unable to classify|0|||
44324134|NCT01148017|79329274|FG003|Overall Study|Unable to classify|0|||
44324135|NCT01147900|79329288|FG000|At Year 10|Lost to Follow-up|0|||
44324136|NCT01147900|79329289|FG001|At Year 10|Lost to Follow-up|1|||
44324137|NCT01147900|79329290|FG002|At Year 10|Lost to Follow-up|0|||
44422370|NCT00585312|79430295|FG001|Overall Study|Reason not specified|0|||
44324138|NCT01147744|79329305|FG000|Overall Study|Protocol Violation|1|||
44324139|NCT01147744|79329306|FG001|Overall Study|Protocol Violation|0|||
44324140|NCT01147744|79329307|FG002|Overall Study|Protocol Violation|1|||
44422371|NCT00585312|79430294|FG000|Overall Study|Withdrawal by Subject|5|||
44324141|NCT01147744|79329308|FG003|Overall Study|Protocol Violation|0|||
44324142|NCT01147744|79329309|FG004|Overall Study|Protocol Violation|1|||
44324143|NCT01147744|79329310|FG005|Overall Study|Protocol Violation|3|||
44324144|NCT01147744|79329311|FG006|Overall Study|Protocol Violation|1|||
44422372|NCT00585312|79430295|FG001|Overall Study|Withdrawal by Subject|1|||
44422373|NCT00585312|79430294|FG000|Overall Study|Study terminated by the sponsor|34|||
44422374|NCT00585312|79430295|FG001|Overall Study|Study terminated by the sponsor|31|||
44422375|NCT00753506|79430303|FG000|Overall Study|Withdrawal by Subject|4|||
44422376|NCT00753506|79430304|FG001|Overall Study|Withdrawal by Subject|1|||
44422377|NCT00753506|79430303|FG000|Overall Study|Lost to Follow-up|2|||
44422378|NCT00753506|79430304|FG001|Overall Study|Lost to Follow-up|0|||
44422379|NCT00753506|79430303|FG000|Overall Study|Other reason|1|||
44422380|NCT00753506|79430304|FG001|Overall Study|Other reason|1|||
44422381|NCT00720096|79430312|FG000|Overall Study|Withdrawal by Subject|0|||
44422382|NCT00720096|79430313|FG001|Overall Study|Withdrawal by Subject|2|||
44536927|NCT03478683|79547607|FG000|Overall Study|Physician Decision|1|||
44324145|NCT01147744|79329305|FG000|Overall Study|Physician Decision|0|||
44324146|NCT01147744|79329306|FG001|Overall Study|Physician Decision|1|||
44324147|NCT01147744|79329307|FG002|Overall Study|Physician Decision|1|||
44324148|NCT01147744|79329308|FG003|Overall Study|Physician Decision|0|||
44324149|NCT01147744|79329309|FG004|Overall Study|Physician Decision|0|||
44324150|NCT01147744|79329310|FG005|Overall Study|Physician Decision|0|||
44324151|NCT01147744|79329311|FG006|Overall Study|Physician Decision|1|||
44324152|NCT01147744|79329305|FG000|Overall Study|Lack of Efficacy|11|||
44324153|NCT01147744|79329306|FG001|Overall Study|Lack of Efficacy|11|||
44324154|NCT01147744|79329307|FG002|Overall Study|Lack of Efficacy|9|||
44324155|NCT01147744|79329308|FG003|Overall Study|Lack of Efficacy|11|||
44324156|NCT01147744|79329309|FG004|Overall Study|Lack of Efficacy|13|||
44324157|NCT01147744|79329310|FG005|Overall Study|Lack of Efficacy|8|||
44324158|NCT01147744|79329311|FG006|Overall Study|Lack of Efficacy|7|||
44324159|NCT01147744|79329305|FG000|Overall Study|Adverse Event|1|||
44324160|NCT01147744|79329306|FG001|Overall Study|Adverse Event|2|||
44324161|NCT01147744|79329307|FG002|Overall Study|Adverse Event|3|||
44324162|NCT01147744|79329308|FG003|Overall Study|Adverse Event|0|||
44324163|NCT01147744|79329309|FG004|Overall Study|Adverse Event|2|||
44324164|NCT01147744|79329310|FG005|Overall Study|Adverse Event|1|||
44324165|NCT01147744|79329311|FG006|Overall Study|Adverse Event|2|||
44324166|NCT01147744|79329305|FG000|Overall Study|Withdrawal by Subject|8|||
44324167|NCT01147744|79329306|FG001|Overall Study|Withdrawal by Subject|4|||
44324168|NCT01147744|79329307|FG002|Overall Study|Withdrawal by Subject|2|||
44324169|NCT01147744|79329308|FG003|Overall Study|Withdrawal by Subject|2|||
44324170|NCT01147744|79329309|FG004|Overall Study|Withdrawal by Subject|2|||
44324171|NCT01147744|79329310|FG005|Overall Study|Withdrawal by Subject|5|||
44324172|NCT01147744|79329311|FG006|Overall Study|Withdrawal by Subject|2|||
44324173|NCT01147744|79329305|FG000|Overall Study|Lost to Follow-up|0|||
44324174|NCT01147744|79329306|FG001|Overall Study|Lost to Follow-up|1|||
44324175|NCT01147744|79329307|FG002|Overall Study|Lost to Follow-up|0|||
44324176|NCT01147744|79329308|FG003|Overall Study|Lost to Follow-up|0|||
44324177|NCT01147744|79329309|FG004|Overall Study|Lost to Follow-up|0|||
44324178|NCT01147744|79329310|FG005|Overall Study|Lost to Follow-up|0|||
44324179|NCT01147744|79329311|FG006|Overall Study|Lost to Follow-up|0|||
44324180|NCT01147744|79329305|FG000|Overall Study|Sponsor decision to amend protocol|7|||
44324181|NCT01147744|79329306|FG001|Overall Study|Sponsor decision to amend protocol|4|||
44324182|NCT01147744|79329307|FG002|Overall Study|Sponsor decision to amend protocol|2|||
44324183|NCT01147744|79329308|FG003|Overall Study|Sponsor decision to amend protocol|5|||
44324184|NCT01147744|79329309|FG004|Overall Study|Sponsor decision to amend protocol|7|||
44324185|NCT01147744|79329310|FG005|Overall Study|Sponsor decision to amend protocol|2|||
44324186|NCT01147744|79329311|FG006|Overall Study|Sponsor decision to amend protocol|6|||
44324187|NCT01147744|79329305|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44324188|NCT01147744|79329306|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44324189|NCT01147744|79329307|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44324190|NCT01147744|79329308|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44324191|NCT01147744|79329309|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44324192|NCT01147744|79329310|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
44324193|NCT01147744|79329311|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
44354750|NCT01186770|79359154|FG001|Overall Study|Withdrawal by Subject|13|||
44354751|NCT01186770|79359155|FG002|Overall Study|Withdrawal by Subject|11|||
44354752|NCT01186770|79359156|FG003|Overall Study|Withdrawal by Subject|17|||
44354753|NCT01186770|79359153|FG000|Overall Study|Lost to Follow-up|10|||
44354754|NCT01186770|79359154|FG001|Overall Study|Lost to Follow-up|6|||
44354755|NCT01186770|79359155|FG002|Overall Study|Lost to Follow-up|14|||
44354756|NCT01186770|79359156|FG003|Overall Study|Lost to Follow-up|9|||
44354757|NCT01186770|79359153|FG000|Overall Study|Insufficient response to treatment|7|||
44354758|NCT01186770|79359154|FG001|Overall Study|Insufficient response to treatment|8|||
44354759|NCT01186770|79359155|FG002|Overall Study|Insufficient response to treatment|5|||
44354760|NCT01186770|79359156|FG003|Overall Study|Insufficient response to treatment|7|||
44354761|NCT01186770|79359153|FG000|Overall Study|Other than specified|0|||
44324194|NCT01147471|79329335|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
44324195|NCT01147471|79329336|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
44324196|NCT01147471|79329335|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
44324197|NCT01147471|79329336|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
44324198|NCT01147471|79329335|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
44324199|NCT01147471|79329336|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
44324200|NCT01147471|79329335|FG000|3 Month Follow Up|Lost to Follow-up|1|||
44324201|NCT01147471|79329336|FG001|3 Month Follow Up|Lost to Follow-up|1|||
44324202|NCT01147471|79329335|FG000|3 Month Follow Up|Physician Decision|0|||
44324203|NCT01147471|79329336|FG001|3 Month Follow Up|Physician Decision|1|||
44324204|NCT01147471|79329335|FG000|6 Month Follow Up|Lost to Follow-up|4|||
44324205|NCT01147471|79329336|FG001|6 Month Follow Up|Lost to Follow-up|2|||
44324206|NCT01147393|79329342|FG000|Dose Level 1|Dose limiting Toxicity|2|||
44324207|NCT01147393|79329342|FG000|Dose Level -1|Dose Limited Toxicity|1|||
44324208|NCT01146652|79329349|FG000|Overall Study|Adverse Event|506|||
44324209|NCT01146652|79329350|FG001|Overall Study|Adverse Event|15|||
44324210|NCT01146652|79329349|FG000|Overall Study|Lack of Efficacy|91|||
44324211|NCT01146652|79329350|FG001|Overall Study|Lack of Efficacy|7|||
44324212|NCT01146652|79329349|FG000|Overall Study|Poor compliance to protocol|38|||
44324213|NCT01146652|79329350|FG001|Overall Study|Poor compliance to protocol|1|||
44324214|NCT01146652|79329349|FG000|Overall Study|Other unspecified reasons|314|||
44324215|NCT01146652|79329350|FG001|Overall Study|Other unspecified reasons|22|||
44324216|NCT01146652|79329349|FG000|Overall Study|Enrolled but not treated|2|||
44324217|NCT01146652|79329350|FG001|Overall Study|Enrolled but not treated|0|||
44324218|NCT01146613|79329365|FG000|Overall Study|Lost to Follow-up|3|||
44324219|NCT01146613|79329366|FG001|Overall Study|Lost to Follow-up|8|||
44324220|NCT01146613|79329365|FG000|Overall Study|Lack of Efficacy|0|||
44324221|NCT01146613|79329366|FG001|Overall Study|Lack of Efficacy|1|||
44324222|NCT01146613|79329365|FG000|Overall Study|Death|1|||
44324223|NCT01146613|79329366|FG001|Overall Study|Death|0|||
44324224|NCT01146613|79329365|FG000|Overall Study|Physician Decision|1|||
44324225|NCT01146613|79329366|FG001|Overall Study|Physician Decision|0|||
44324226|NCT01146613|79329365|FG000|Overall Study|Withdrawal by Subject|0|||
44324227|NCT01146613|79329366|FG001|Overall Study|Withdrawal by Subject|3|||
44324228|NCT01146613|79329365|FG000|Overall Study|schedule conflict|1|||
44324229|NCT01146613|79329366|FG001|Overall Study|schedule conflict|0|||
44324230|NCT01146613|79329365|FG000|Overall Study|Outpatient detox|1|||
44156308|NCT01970488|78947467|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
44156309|NCT01970488|78947468|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
44156310|NCT01970488|78947464|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
44156311|NCT01970488|78947465|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
44156312|NCT01970488|78947466|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
44156313|NCT01970488|78947467|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
44156314|NCT01970488|78947468|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
44156315|NCT02661217|78947485|FG000|Overall Study|Physician Decision|12|||
44324231|NCT01146613|79329366|FG001|Overall Study|Outpatient detox|0|||
44324232|NCT01145755|79329375|FG000|Overall Study|Adverse Event|2|||
44324233|NCT01145755|79329376|FG001|Overall Study|Adverse Event|4|||
44324234|NCT01145755|79329377|FG002|Overall Study|Adverse Event|2|||
44324235|NCT01145755|79329375|FG000|Overall Study|Withdrawal by Subject|2|||
44324236|NCT01145755|79329376|FG001|Overall Study|Withdrawal by Subject|2|||
44324237|NCT01145755|79329377|FG002|Overall Study|Withdrawal by Subject|2|||
44324238|NCT01145755|79329375|FG000|Overall Study|Lost to Follow-up|2|||
44324239|NCT01145755|79329376|FG001|Overall Study|Lost to Follow-up|3|||
44324240|NCT01145755|79329377|FG002|Overall Study|Lost to Follow-up|1|||
44324241|NCT01145755|79329375|FG000|Overall Study|Protocol Violation|0|||
44324242|NCT01145755|79329376|FG001|Overall Study|Protocol Violation|3|||
44324243|NCT01145755|79329377|FG002|Overall Study|Protocol Violation|1|||
44324244|NCT01145755|79329375|FG000|Overall Study|Study Closure|14|||
44324245|NCT01145755|79329376|FG001|Overall Study|Study Closure|14|||
44324246|NCT01145755|79329377|FG002|Overall Study|Study Closure|17|||
44324247|NCT01145755|79329375|FG000|Overall Study|Lack of Efficacy|0|||
44324248|NCT01145755|79329376|FG001|Overall Study|Lack of Efficacy|1|||
44324249|NCT01145755|79329377|FG002|Overall Study|Lack of Efficacy|0|||
44324250|NCT01145755|79329375|FG000|Overall Study|Patient could not swollow medication|0|||
44324251|NCT01145755|79329376|FG001|Overall Study|Patient could not swollow medication|0|||
44324252|NCT01145755|79329377|FG002|Overall Study|Patient could not swollow medication|1|||
44324253|NCT01145755|79329375|FG000|Overall Study|Withdrawal by Subject|0|||
44324254|NCT01145755|79329376|FG001|Overall Study|Withdrawal by Subject|0|||
44324255|NCT01145755|79329377|FG002|Overall Study|Withdrawal by Subject|1|||
44156316|NCT02661217|78947486|FG001|Overall Study|Physician Decision|15|||
44324256|NCT01145755|79329375|FG000|Overall Study|Positive urine ethanol|0|||
44324257|NCT01145755|79329376|FG001|Overall Study|Positive urine ethanol|1|||
44324258|NCT01145755|79329377|FG002|Overall Study|Positive urine ethanol|0|||
44324259|NCT01145560|79329388|FG000|Overall Study|Withdrawal by Subject|2|||
44324260|NCT01145560|79329389|FG001|Overall Study|Withdrawal by Subject|1|||
44324261|NCT01145560|79329390|FG002|Overall Study|Withdrawal by Subject|0|||
44324262|NCT01145560|79329388|FG000|Overall Study|Lost to Follow-up|1|||
44324263|NCT01145560|79329389|FG001|Overall Study|Lost to Follow-up|1|||
44324264|NCT01145560|79329390|FG002|Overall Study|Lost to Follow-up|1|||
44324265|NCT01145560|79329388|FG000|Overall Study|No study drug by 24h after organ failure|1|||
44324266|NCT01145560|79329389|FG001|Overall Study|No study drug by 24h after organ failure|0|||
44324267|NCT01145560|79329390|FG002|Overall Study|No study drug by 24h after organ failure|0|||
44324268|NCT01145560|79329388|FG000|Overall Study|Accidental unblinding of study treatment|0|||
44324269|NCT01145560|79329389|FG001|Overall Study|Accidental unblinding of study treatment|1|||
44324270|NCT01145560|79329390|FG002|Overall Study|Accidental unblinding of study treatment|0|||
44324271|NCT01145560|79329388|FG000|Overall Study|False insurance information|0|||
44422383|NCT00723294|79430319|FG000|Overall Study|Lobular histology|2|||
44422384|NCT00723294|79430319|FG000|Overall Study|>25% intraductal component|1|||
44422385|NCT00723294|79430319|FG000|Overall Study|No MRI tumor enhancement|1|||
44422386|NCT00723294|79430319|FG000|Overall Study|1.0-Tesla MRI|1|||
44422387|NCT00723294|79430319|FG000|Overall Study|No cryoabalation|2|||
44422388|NCT00723294|79430319|FG000|Overall Study|Did not undergo surgery|1|||
44422389|NCT00723294|79430319|FG000|Overall Study|Treated prior to registration|1|||
44422390|NCT00723294|79430319|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
44422391|NCT00723294|79430319|FG000|Overall Study|Benign lesion|1|||
44324272|NCT01145560|79329389|FG001|Overall Study|False insurance information|1|||
44324273|NCT01145560|79329390|FG002|Overall Study|False insurance information|0|||
44324274|NCT01145560|79329388|FG000|Overall Study|Withdrawal of therapy|0|||
44324275|NCT01145560|79329389|FG001|Overall Study|Withdrawal of therapy|0|||
44324276|NCT01145560|79329390|FG002|Overall Study|Withdrawal of therapy|1|||
44324277|NCT01145482|79329400|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
44324278|NCT01145482|79329401|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
44324279|NCT01145053|79329407|FG000|Overall Study|Adverse Event|22|||
44324280|NCT01145053|79329407|FG000|Overall Study|Lost to Follow-up|28|||
44324281|NCT01145053|79329407|FG000|Overall Study|Withdrawal by Subject|25|||
44324282|NCT01145053|79329407|FG000|Overall Study|Other|18|||
44324283|NCT01144663|79329415|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
44324284|NCT01144663|79329416|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
44324285|NCT01144663|79329417|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
44324286|NCT01144663|79329418|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
44324287|NCT01144663|79329415|FG000|Primary Vaccination Phase|Adverse Event|1|||
44324288|NCT01144663|79329416|FG001|Primary Vaccination Phase|Adverse Event|0|||
44324289|NCT01144663|79329417|FG002|Primary Vaccination Phase|Adverse Event|0|||
44324290|NCT01144663|79329418|FG003|Primary Vaccination Phase|Adverse Event|1|||
44324291|NCT01144663|79329415|FG000|Primary Vaccination Phase|Protocol Violation|2|||
44324292|NCT01144663|79329416|FG001|Primary Vaccination Phase|Protocol Violation|0|||
44422392|NCT00723294|79430319|FG000|Overall Study|Withdrawal by Subject|1|||
44422393|NCT00723294|79430319|FG000|Overall Study|No treatment due to probe failure|1|||
44422394|NCT00747344|79430325|FG000|Controlled Period|Adverse Event|3|||
44422395|NCT00747344|79430326|FG001|Controlled Period|Adverse Event|0|||
44422396|NCT00747344|79430327|FG002|Controlled Period|Adverse Event|0|||
44422397|NCT00747344|79430328|FG003|Controlled Period|Adverse Event|0|||
44422398|NCT00747344|79430325|FG000|Controlled Period|Lack of Efficacy|2|||
44422399|NCT00747344|79430326|FG001|Controlled Period|Lack of Efficacy|1|||
44422400|NCT00747344|79430327|FG002|Controlled Period|Lack of Efficacy|0|||
44422401|NCT00747344|79430328|FG003|Controlled Period|Lack of Efficacy|0|||
44422402|NCT00747344|79430325|FG000|Controlled Period|Other|0|||
44422403|NCT00747344|79430326|FG001|Controlled Period|Other|3|||
44422404|NCT00747344|79430327|FG002|Controlled Period|Other|0|||
44422405|NCT00747344|79430328|FG003|Controlled Period|Other|0|||
44422406|NCT00747344|79430325|FG000|After Controlled Period|Adverse Event|0|||
44422407|NCT00747344|79430326|FG001|After Controlled Period|Adverse Event|0|||
44422408|NCT00747344|79430327|FG002|After Controlled Period|Adverse Event|0|||
44422409|NCT00747344|79430328|FG003|After Controlled Period|Adverse Event|1|||
44422410|NCT00580983|79430336|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
44422411|NCT00753896|79430340|FG000|Overall Study|Adverse Event|4|||
44422412|NCT00753896|79430340|FG000|Overall Study|Death|1|||
44324293|NCT01144663|79329417|FG002|Primary Vaccination Phase|Protocol Violation|1|||
44422413|NCT00753896|79430340|FG000|Overall Study|Lost to Follow-up|2|||
44422414|NCT00753896|79430340|FG000|Overall Study|Protocol Violation|1|||
44422415|NCT00753896|79430340|FG000|Overall Study|Withdrawal by Subject|4|||
44422416|NCT00753896|79430340|FG000|Overall Study|Entry Criteria Not Met|4|||
44422417|NCT00743444|79430344|FG000|First Intervention|Catheter placement problems|0|||
44422418|NCT00743444|79430345|FG001|First Intervention|Catheter placement problems|1|||
44324294|NCT01144663|79329418|FG003|Primary Vaccination Phase|Protocol Violation|0|||
44324295|NCT01144663|79329415|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
44422419|NCT00743444|79430344|FG000|Washout Period|Adverse Event|0|||
44422420|NCT00743444|79430345|FG001|Washout Period|Adverse Event|1|||
44422421|NCT00743366|79430351|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
44324296|NCT01144663|79329416|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
44324297|NCT01144663|79329417|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
44324298|NCT01144663|79329418|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
44324299|NCT01144663|79329415|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
44324300|NCT01144663|79329416|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
44324301|NCT01144663|79329417|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
44324302|NCT01144663|79329418|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
44324303|NCT01144663|79329415|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
44324304|NCT01144663|79329416|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
44324305|NCT01144663|79329417|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
44324306|NCT01144663|79329418|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
44324307|NCT01144663|79329415|FG000|Primary Vaccination Phase|Other|0|||
44324308|NCT01144663|79329416|FG001|Primary Vaccination Phase|Other|1|||
44324309|NCT01144663|79329417|FG002|Primary Vaccination Phase|Other|0|||
44324310|NCT01144663|79329418|FG003|Primary Vaccination Phase|Other|2|||
44324311|NCT01144663|79329415|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
44324312|NCT01144663|79329416|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
44324313|NCT01144663|79329417|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
44324314|NCT01144663|79329418|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
44324315|NCT01144663|79329415|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
44324316|NCT01144663|79329416|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
44324317|NCT01144663|79329417|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
44324318|NCT01144663|79329418|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
44324319|NCT01144663|79329415|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
44324320|NCT01144663|79329416|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
44324321|NCT01144663|79329417|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
44324322|NCT01144663|79329418|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
44324323|NCT01144663|79329415|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
44324324|NCT01144663|79329416|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
44324325|NCT01144663|79329417|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
44324326|NCT01144663|79329418|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
44324327|NCT01144663|79329415|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
44156317|NCT02661217|78947485|FG000|Overall Study|Lost to Follow-up|1|||
44156318|NCT02661217|78947486|FG001|Overall Study|Lost to Follow-up|4|||
44324328|NCT01144663|79329416|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
44324329|NCT01144663|79329417|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
44422422|NCT00743366|79430352|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
44324330|NCT01144663|79329418|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
44324331|NCT01144663|79329415|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
44324332|NCT01144663|79329416|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
44324333|NCT01144663|79329417|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
44324334|NCT01144663|79329418|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
44324335|NCT01143337|79329430|FG000|Overall Study|Adverse Event|3|||
44324336|NCT01143337|79329431|FG001|Overall Study|Adverse Event|9|||
44324337|NCT01143337|79329432|FG002|Overall Study|Adverse Event|5|||
44324338|NCT01143337|79329430|FG000|Overall Study|Lack of Efficacy|6|||
44324339|NCT01143337|79329431|FG001|Overall Study|Lack of Efficacy|2|||
44324340|NCT01143337|79329432|FG002|Overall Study|Lack of Efficacy|1|||
44324341|NCT01143337|79329430|FG000|Overall Study|Protocol Violation|1|||
44324342|NCT01143337|79329431|FG001|Overall Study|Protocol Violation|0|||
44324343|NCT01143337|79329432|FG002|Overall Study|Protocol Violation|0|||
44324344|NCT01143337|79329430|FG000|Overall Study|Withdrawal by Subject|0|||
44324345|NCT01143337|79329431|FG001|Overall Study|Withdrawal by Subject|0|||
44324346|NCT01143337|79329432|FG002|Overall Study|Withdrawal by Subject|1|||
44324347|NCT01143337|79329430|FG000|Overall Study|Other reason|0|||
44324348|NCT01143337|79329431|FG001|Overall Study|Other reason|0|||
44324349|NCT01143337|79329432|FG002|Overall Study|Other reason|5|||
44324350|NCT01143259|79329449|FG000|Overall Study|Withdrawal by Subject|3|||
44324351|NCT01143259|79329450|FG001|Overall Study|Withdrawal by Subject|2|||
44324352|NCT01143259|79329449|FG000|Overall Study|Protocol Violation|13|||
44536928|NCT03478683|79547608|FG001|Overall Study|Physician Decision|3|||
44324353|NCT01143259|79329450|FG001|Overall Study|Protocol Violation|9|||
44324354|NCT01143259|79329449|FG000|Overall Study|Screen Failure|7|||
44324355|NCT01143259|79329450|FG001|Overall Study|Screen Failure|9|||
44324356|NCT01142791|79329456|FG000|Overall Study|Alternative Treatment|1|||
44324357|NCT01142791|79329457|FG001|Overall Study|Alternative Treatment|0|||
44324358|NCT01142791|79329456|FG000|Overall Study|Lost to Follow-up|1|||
44536929|NCT03478683|79547607|FG000|Overall Study|Withdrawal by Subject|7|||
44324359|NCT01142791|79329457|FG001|Overall Study|Lost to Follow-up|0|||
44324360|NCT01142791|79329456|FG000|Overall Study|Withdrawal by Subject|5|||
44324361|NCT01142791|79329457|FG001|Overall Study|Withdrawal by Subject|0|||
44536930|NCT03478683|79547608|FG001|Overall Study|Withdrawal by Subject|7|||
44536931|NCT03478371|79547614|FG000|Overall Study|non-compliance|1|||
44324362|NCT01142791|79329456|FG000|Overall Study|Received only 1 sonication|0|||
44324363|NCT01142791|79329457|FG001|Overall Study|Received only 1 sonication|6|||
44324364|NCT01142596|79329463|FG000|Overall Study|Withdrawal by Subject|9|||
44324365|NCT01142596|79329464|FG001|Overall Study|Withdrawal by Subject|35|||
44324366|NCT01142596|79329463|FG000|Overall Study|Adverse Event|8|||
44324367|NCT01142596|79329464|FG001|Overall Study|Adverse Event|35|||
44324368|NCT01142596|79329463|FG000|Overall Study|Lack of Efficacy|5|||
44324369|NCT01142596|79329464|FG001|Overall Study|Lack of Efficacy|9|||
44324370|NCT01142596|79329463|FG000|Overall Study|Lost to Follow-up|2|||
44324371|NCT01142596|79329464|FG001|Overall Study|Lost to Follow-up|3|||
44324372|NCT01142596|79329463|FG000|Overall Study|Other reason (not specified)|5|||
44324373|NCT01142596|79329464|FG001|Overall Study|Other reason (not specified)|4|||
44324374|NCT01142128|79329474|FG000|Overall Study|Physician Decision|1|||
44324375|NCT01142128|79329474|FG000|Overall Study|Lost to Follow-up|1|||
44324376|NCT01142128|79329474|FG000|Overall Study|Withdrawal by Subject|2|||
44324377|NCT01142089|79329486|FG000|Overall Study|Physician Decision|1|||
44324378|NCT01142089|79329487|FG001|Overall Study|Physician Decision|0|||
44324379|NCT01142089|79329486|FG000|Overall Study|Withdrawal by Subject|1|||
44324380|NCT01142089|79329487|FG001|Overall Study|Withdrawal by Subject|2|||
44324381|NCT01142089|79329486|FG000|Overall Study|Use of prohibited medications|0|||
44324382|NCT01142089|79329487|FG001|Overall Study|Use of prohibited medications|1|||
44324383|NCT01142089|79329486|FG000|Overall Study|Noncompliance with study procedures|2|||
44324384|NCT01142089|79329487|FG001|Overall Study|Noncompliance with study procedures|1|||
44324385|NCT01142089|79329486|FG000|Overall Study|Patient required rescue medication|8|||
44324386|NCT01142089|79329487|FG001|Overall Study|Patient required rescue medication|17|||
44324387|NCT01141660|79329495|FG000|Overall Study|Physician Decision|0|||
44422423|NCT00721968|79430360|FG000|Overall Study|Lost to Follow-up|2|||
44422424|NCT00721968|79430361|FG001|Overall Study|Lost to Follow-up|0|||
44422425|NCT00743288|79430367|FG000|Overall Study|Adverse Event|1|||
44422426|NCT00743288|79430368|FG001|Overall Study|Adverse Event|1|||
44324388|NCT01141660|79329496|FG001|Overall Study|Physician Decision|12|||
44324389|NCT01140880|79329504|FG000|Overall Study|Death|0|||
44324390|NCT01140880|79329505|FG001|Overall Study|Death|1|||
44324391|NCT01140880|79329504|FG000|Overall Study|Withdrawal by Subject|6|||
44324392|NCT01140880|79329505|FG001|Overall Study|Withdrawal by Subject|3|||
44324393|NCT01140880|79329504|FG000|Overall Study|Lost to Follow-up|8|||
44324394|NCT01140880|79329505|FG001|Overall Study|Lost to Follow-up|10|||
44324395|NCT01140880|79329504|FG000|Overall Study|Protocol Violation|0|||
44324396|NCT01140880|79329505|FG001|Overall Study|Protocol Violation|30|||
44324397|NCT01140646|79329511|FG000|Overall Study|Adverse Event|4|||
44324398|NCT01140646|79329511|FG000|Overall Study|Refused Further Treatment|5|||
44324399|NCT01140568|79329515|FG000|Overall Study|disease progression|31|||
44324400|NCT01140568|79329515|FG000|Overall Study|Withdrawal by Subject|1|||
44324401|NCT01140568|79329515|FG000|Overall Study|Screen Fail|4|||
44324402|NCT01140451|79329521|FG000|Overall Study|Withdrawal by Subject|26|||
44324403|NCT01140451|79329522|FG001|Overall Study|Withdrawal by Subject|33|||
44324404|NCT01140451|79329521|FG000|Overall Study|Adverse Event|2|||
44324405|NCT01140451|79329522|FG001|Overall Study|Adverse Event|6|||
44324406|NCT01140451|79329521|FG000|Overall Study|Physician Decision|5|||
44324407|NCT01140451|79329522|FG001|Overall Study|Physician Decision|3|||
44324408|NCT01140451|79329521|FG000|Overall Study|Lost to Follow-up|2|||
44324409|NCT01140451|79329522|FG001|Overall Study|Lost to Follow-up|0|||
44324410|NCT01140451|79329521|FG000|Overall Study|Participants Planning Pregnancy|3|||
44324411|NCT01140451|79329522|FG001|Overall Study|Participants Planning Pregnancy|0|||
44324412|NCT01140061|79329539|FG000|Part I|Adverse Event|1|||
44324413|NCT01140061|79329540|FG001|Part I|Adverse Event|0|||
44324414|NCT01140061|79329541|FG002|Part I|Adverse Event|0|||
44324415|NCT01140061|79329542|FG003|Part I|Adverse Event|0|||
44324416|NCT01140061|79329543|FG004|Part I|Adverse Event|0|||
44324417|NCT01140061|79329544|FG005|Part I|Adverse Event|0|||
44324418|NCT01140061|79329545|FG006|Part I|Adverse Event|0|||
44324419|NCT01140061|79329546|FG007|Part I|Adverse Event|0|||
44324420|NCT01140061|79329547|FG008|Part I|Adverse Event|0|||
44324421|NCT01140061|79329548|FG009|Part I|Adverse Event|0|||
44422427|NCT00743288|79430369|FG002|Overall Study|Adverse Event|2|||
44324422|NCT01140061|79329539|FG000|Extension|Laboratory Adverse Event|0|||
44324423|NCT01140061|79329540|FG001|Extension|Laboratory Adverse Event|0|||
44324424|NCT01140061|79329541|FG002|Extension|Laboratory Adverse Event|0|||
44324425|NCT01140061|79329542|FG003|Extension|Laboratory Adverse Event|0|||
44324426|NCT01140061|79329543|FG004|Extension|Laboratory Adverse Event|0|||
44324427|NCT01140061|79329544|FG005|Extension|Laboratory Adverse Event|0|||
44324428|NCT01140061|79329545|FG006|Extension|Laboratory Adverse Event|0|||
44324429|NCT01140061|79329546|FG007|Extension|Laboratory Adverse Event|0|||
44324430|NCT01140061|79329547|FG008|Extension|Laboratory Adverse Event|0|||
44324431|NCT01140061|79329548|FG009|Extension|Laboratory Adverse Event|1|||
44324432|NCT01139164|79329566|FG000|Overall Study|Withdrawn prior to study start|0|||
44324433|NCT01139164|79329567|FG001|Overall Study|Withdrawn prior to study start|2|||
44324434|NCT01139164|79329568|FG002|Overall Study|Withdrawn prior to study start|0|||
44324435|NCT01139125|79329576|FG000|Overall Study|Withdrawal by Subject|1|||
44324436|NCT01139047|79329580|FG000|Overall Study|Withdrawal by Subject|1|||
44324437|NCT01139008|79329587|FG000|Overall Study|Withdrawal by Subject|5|||
44324438|NCT01139008|79329587|FG000|Overall Study|Non-compliant, lost product|1|||
44324439|NCT01138657|79329596|FG000|Overall Study|Adverse Event|3|||
44324440|NCT01138657|79329597|FG001|Overall Study|Adverse Event|10|||
44324441|NCT01138657|79329596|FG000|Overall Study|Lack of Efficacy|2|||
44324442|NCT01138657|79329597|FG001|Overall Study|Lack of Efficacy|1|||
44324443|NCT01138657|79329596|FG000|Overall Study|Lost to Follow-up|0|||
44324444|NCT01138657|79329597|FG001|Overall Study|Lost to Follow-up|3|||
44324445|NCT01138657|79329596|FG000|Overall Study|Miscellaneous Reasons|3|||
44324446|NCT01138657|79329597|FG001|Overall Study|Miscellaneous Reasons|4|||
44324447|NCT01138501|79329605|FG000|Overall Study|Protocol Violation|2|||
44324448|NCT01138501|79329605|FG000|Overall Study|Withdrawal by Subject|3|||
44324449|NCT01138150|79329611|FG000|Overall Study|blood unable to be processed|0|||
44324450|NCT01138150|79329612|FG001|Overall Study|blood unable to be processed|1|||
44324451|NCT01138150|79329611|FG000|Overall Study|Physician Decision|1|||
44324452|NCT01138150|79329612|FG001|Overall Study|Physician Decision|0|||
44324453|NCT01138111|79329628|FG000|Overall Study|Withdrawal by Subject|5|||
44324454|NCT01138111|79329628|FG000|Overall Study|Adverse Event|1|||
44324455|NCT01138111|79329628|FG000|Overall Study|Death|1|||
44324456|NCT01138111|79329628|FG000|Overall Study|Lost to Follow-up|2|||
44324457|NCT01137955|79329659|FG000|Overall Study|Withdrawal by Subject|5|||
44324458|NCT01137955|79329660|FG001|Overall Study|Withdrawal by Subject|4|||
44324459|NCT01137682|79329670|FG000|Overall Study|Adverse Event-CORE|2|||
44324460|NCT01137682|79329671|FG001|Overall Study|Adverse Event-CORE|4|||
44324461|NCT01137682|79329672|FG002|Overall Study|Adverse Event-CORE|0|||
44324462|NCT01137682|79329670|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
44324463|NCT01137682|79329671|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
44324464|NCT01137682|79329672|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
44324465|NCT01137682|79329670|FG000|Overall Study|Administrative problems-CORE|2|||
44324466|NCT01137682|79329671|FG001|Overall Study|Administrative problems-CORE|1|||
44324467|NCT01137682|79329672|FG002|Overall Study|Administrative problems-CORE|0|||
44324468|NCT01137682|79329670|FG000|Overall Study|Protocol Violation-CORE|0|||
44324469|NCT01137682|79329671|FG001|Overall Study|Protocol Violation-CORE|1|||
44324470|NCT01137682|79329672|FG002|Overall Study|Protocol Violation-CORE|1|||
44324471|NCT01137682|79329670|FG000|Overall Study|Adverse Event-Extension|4|||
44324472|NCT01137682|79329671|FG001|Overall Study|Adverse Event-Extension|8|||
44324473|NCT01137682|79329672|FG002|Overall Study|Adverse Event-Extension|7|||
44324474|NCT01137682|79329670|FG000|Overall Study|Lack of Efficacy-Extension|15|||
44324475|NCT01137682|79329671|FG001|Overall Study|Lack of Efficacy-Extension|9|||
44324476|NCT01137682|79329672|FG002|Overall Study|Lack of Efficacy-Extension|13|||
44324477|NCT01137682|79329670|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
44324478|NCT01137682|79329671|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
44324479|NCT01137682|79329672|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
44324480|NCT01137682|79329670|FG000|Overall Study|Lost to Follow Up-Extension|0|||
44324481|NCT01137682|79329671|FG001|Overall Study|Lost to Follow Up-Extension|1|||
44324482|NCT01137682|79329672|FG002|Overall Study|Lost to Follow Up-Extension|0|||
44324483|NCT01137682|79329670|FG000|Overall Study|Administrative problems-Extension|0|||
44324484|NCT01137682|79329671|FG001|Overall Study|Administrative problems-Extension|2|||
44324485|NCT01137682|79329672|FG002|Overall Study|Administrative problems-Extension|0|||
44324486|NCT01137682|79329670|FG000|Overall Study|Death-Extension|2|||
44324487|NCT01137682|79329671|FG001|Overall Study|Death-Extension|0|||
44324488|NCT01137682|79329672|FG002|Overall Study|Death-Extension|0|||
44324489|NCT01137682|79329670|FG000|Overall Study|Protocol Violation-Extension|2|||
44324490|NCT01137682|79329671|FG001|Overall Study|Protocol Violation-Extension|1|||
44324491|NCT01137682|79329672|FG002|Overall Study|Protocol Violation-Extension|0|||
44324492|NCT01137682|79329670|FG000|Overall Study|Did not enter extension|2|||
44324493|NCT01137682|79329671|FG001|Overall Study|Did not enter extension|3|||
44324494|NCT01137682|79329672|FG002|Overall Study|Did not enter extension|2|||
44324495|NCT01137682|79329670|FG000|Overall Study|Did not receive treatment in extension|0|||
44324496|NCT01137682|79329671|FG001|Overall Study|Did not receive treatment in extension|0|||
44324497|NCT01137682|79329672|FG002|Overall Study|Did not receive treatment in extension|1|||
44324498|NCT03452397|79329688|FG000|Overall Study|Adverse Event|1|||
44324499|NCT03452397|79329689|FG001|Overall Study|Adverse Event|0|||
44324500|NCT03452397|79329690|FG002|Overall Study|Adverse Event|0|||
44324501|NCT03452397|79329691|FG003|Overall Study|Adverse Event|0|||
44324502|NCT03452397|79329688|FG000|Overall Study|Administrative reason|0|||
44324503|NCT03452397|79329689|FG001|Overall Study|Administrative reason|0|||
44324504|NCT03452397|79329690|FG002|Overall Study|Administrative reason|1|||
44324505|NCT03452397|79329691|FG003|Overall Study|Administrative reason|1|||
44324506|NCT03452397|79329688|FG000|Overall Study|Withdrawal by Subject|0|||
44324507|NCT03452397|79329689|FG001|Overall Study|Withdrawal by Subject|0|||
44324508|NCT03452397|79329690|FG002|Overall Study|Withdrawal by Subject|1|||
44324509|NCT03452397|79329691|FG003|Overall Study|Withdrawal by Subject|0|||
44324510|NCT00199875|79329725|FG000|Overall Study|Withdrawal by Subject|0|||
44324511|NCT00199875|79329726|FG001|Overall Study|Withdrawal by Subject|0|||
44324512|NCT00199875|79329727|FG002|Overall Study|Withdrawal by Subject|0|||
44324513|NCT00199875|79329728|FG003|Overall Study|Withdrawal by Subject|0|||
44324514|NCT00199875|79329729|FG004|Overall Study|Withdrawal by Subject|1|||
44324515|NCT00199836|79329741|FG000|Overall Study|Progressive Disease|5|||
44324516|NCT00199836|79329741|FG000|Overall Study|Death|1|||
44324517|NCT00199797|79329746|FG000|Overall Study|Progressive Disease|1|||
44324518|NCT00199797|79329746|FG000|Overall Study|Adverse Event|1|||
44324519|NCT00199797|79329746|FG000|Overall Study|Physician Decision|1|||
44324520|NCT01137604|79329755|FG000|Overall Study|Adverse Event|3|||
44324521|NCT01137604|79329756|FG001|Overall Study|Adverse Event|6|||
44324522|NCT01137604|79329757|FG002|Overall Study|Adverse Event|9|||
44324523|NCT01137604|79329758|FG003|Overall Study|Adverse Event|9|||
44324524|NCT01137604|79329755|FG000|Overall Study|Participant Choice|0|||
44324525|NCT01137604|79329756|FG001|Overall Study|Participant Choice|2|||
44324526|NCT01137604|79329757|FG002|Overall Study|Participant Choice|2|||
44324527|NCT01137604|79329758|FG003|Overall Study|Participant Choice|0|||
44324528|NCT01137604|79329755|FG000|Overall Study|Withdrawal of consent|0|||
44324529|NCT01137604|79329756|FG001|Overall Study|Withdrawal of consent|0|||
44324530|NCT01137604|79329757|FG002|Overall Study|Withdrawal of consent|0|||
44324531|NCT01137604|79329758|FG003|Overall Study|Withdrawal of consent|2|||
44324532|NCT01137604|79329755|FG000|Overall Study|Clinical progression/deterioration|1|||
44324533|NCT01137604|79329756|FG001|Overall Study|Clinical progression/deterioration|2|||
44324534|NCT01137604|79329757|FG002|Overall Study|Clinical progression/deterioration|2|||
44324535|NCT01137604|79329758|FG003|Overall Study|Clinical progression/deterioration|0|||
44324536|NCT00198822|79329771|FG000|Overall Study|Lost to Follow-up|14|||
44324537|NCT00198822|79329772|FG001|Overall Study|Lost to Follow-up|20|||
44324538|NCT00198822|79329773|FG002|Overall Study|Lost to Follow-up|21|||
44324539|NCT01137292|79329781|FG000|Overall Study|Death|30|||
44324540|NCT01137292|79329781|FG000|Overall Study|Adverse Event|3|||
44324541|NCT01137292|79329781|FG000|Overall Study|Lack of Efficacy|13|||
44324542|NCT01137292|79329781|FG000|Overall Study|Lost to Follow-up|1|||
44324543|NCT01137292|79329781|FG000|Overall Study|Other|7|||
44324544|NCT00197496|79329787|FG000|Baseline to Discharge|not interested|1|||
44324545|NCT00197496|79329788|FG001|Baseline to Discharge|not interested|0|||
44324546|NCT00197496|79329787|FG000|Baseline to Discharge|MRSA|1|||
44324547|NCT00197496|79329788|FG001|Baseline to Discharge|MRSA|0|||
44324548|NCT00197496|79329787|FG000|Baseline to Discharge|Physician Decision|0|||
44324549|NCT00197496|79329788|FG001|Baseline to Discharge|Physician Decision|1|||
44324550|NCT00197496|79329787|FG000|Baseline to Discharge|Protocol Violation|0|||
44324551|NCT00197496|79329788|FG001|Baseline to Discharge|Protocol Violation|1|||
44324552|NCT00197496|79329787|FG000|Follow-up|Lost to Follow-up|2|||
44324553|NCT00197496|79329788|FG001|Follow-up|Lost to Follow-up|1|||
44324554|NCT00197145|79329796|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
44324555|NCT00197145|79329797|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
44324556|NCT00197145|79329796|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
44324557|NCT00197145|79329797|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
44324558|NCT00197145|79329796|FG000|Period 1: Randomized Treatment Phase|Other|2|||
44324559|NCT00197145|79329797|FG001|Period 1: Randomized Treatment Phase|Other|2|||
44324560|NCT00197145|79329796|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
44324561|NCT00197145|79329797|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
44324562|NCT00197145|79329796|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
44536932|NCT03478371|79547614|FG000|Overall Study|Lost to Follow-up|4|||
44536933|NCT03477903|79547624|FG000|Overall Study|Study Terminated by Sponsor|1|||
44536934|NCT03475875|79547628|FG000|Period 1|Lost to Follow-up|1|||
44536935|NCT03475875|79547629|FG001|Period 1|Lost to Follow-up|0|||
44536936|NCT03475875|79547628|FG000|Period 1|Adverse Event|2|||
44536937|NCT03475875|79547629|FG001|Period 1|Adverse Event|1|||
44258264|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
44258265|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
44258266|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
44258267|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
44258268|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
44258269|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
44258270|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
44258271|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
44258272|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
44258273|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
44258274|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
44324563|NCT00197145|79329797|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
44536938|NCT03475875|79547628|FG000|Period 2|Adverse Event|3|||
44536939|NCT03475875|79547629|FG001|Period 2|Adverse Event|0|||
44156319|NCT02661217|78947485|FG000|Overall Study|Protocol Deviation|0|||
44156320|NCT02661217|78947486|FG001|Overall Study|Protocol Deviation|4|||
44156321|NCT02661217|78947485|FG000|Overall Study|Non-compliance with study treatment|5|||
44156322|NCT02661217|78947486|FG001|Overall Study|Non-compliance with study treatment|5|||
44156323|NCT02661217|78947485|FG000|Overall Study|Death|21|||
44156324|NCT02661217|78947486|FG001|Overall Study|Death|15|||
44156325|NCT02661217|78947485|FG000|Overall Study|Adverse Event|10|||
44156326|NCT02661217|78947486|FG001|Overall Study|Adverse Event|8|||
44156327|NCT02661217|78947485|FG000|Overall Study|Withdrawal by Subject|15|||
44156328|NCT02661217|78947486|FG001|Overall Study|Withdrawal by Subject|19|||
44156329|NCT02661217|78947485|FG000|Overall Study|Did not enter follow-up epoch|7|||
44156330|NCT02661217|78947486|FG001|Overall Study|Did not enter follow-up epoch|10|||
44156331|NCT02661217|78947485|FG000|Overall Study|Death - no study drug received|1|||
44156332|NCT02661217|78947486|FG001|Overall Study|Death - no study drug received|2|||
44156333|NCT02661217|78947485|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
44156334|NCT02661217|78947486|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
44156335|NCT01952080|78947497|FG000|Overall Study|Withdrawal by Subject|0|||
44156336|NCT01952080|78947498|FG001|Overall Study|Withdrawal by Subject|0|||
44156337|NCT01952080|78947499|FG002|Overall Study|Withdrawal by Subject|0|||
44156338|NCT01952080|78947500|FG003|Overall Study|Withdrawal by Subject|1|||
44156339|NCT01952080|78947497|FG000|Overall Study|Protocol Non-compliance|0|||
44156340|NCT01952080|78947498|FG001|Overall Study|Protocol Non-compliance|1|||
44156341|NCT01952080|78947499|FG002|Overall Study|Protocol Non-compliance|0|||
44156342|NCT01952080|78947500|FG003|Overall Study|Protocol Non-compliance|0|||
44156343|NCT01951378|78947512|FG000|Overall Study|Study Terminated-Not completed|23|||
44156344|NCT01951378|78947513|FG001|Overall Study|Study Terminated-Not completed|17|||
44156345|NCT01944670|78947519|FG000|Overall Study|Lost to Follow-up|2|||
44156346|NCT01361009|78947523|FG000|Overall Study|Protocol Violation|116|||
44156347|NCT01944046|78947529|FG000|Randomized to DB|Adverse Event|5|||
44156348|NCT01944046|78947530|FG001|Randomized to DB|Adverse Event|2|||
44156349|NCT01944046|78947529|FG000|Randomized to DB|Clinical Worsening|3|||
44156350|NCT01944046|78947530|FG001|Randomized to DB|Clinical Worsening|2|||
44156351|NCT01944046|78947529|FG000|Randomized to DB|Lost to Follow-up|3|||
44156352|NCT01944046|78947530|FG001|Randomized to DB|Lost to Follow-up|3|||
44324564|NCT00197145|79329796|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
44324565|NCT00197145|79329797|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
44324566|NCT00197145|79329796|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
44324567|NCT00197145|79329797|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
44324568|NCT00197145|79329796|FG000|Period 2 : Open Label Phase|Other|1|||
44324569|NCT00197145|79329797|FG001|Period 2 : Open Label Phase|Other|0|||
44324570|NCT01136785|79329806|FG000|Overall Study|Protocol Violation|2|||
44324571|NCT01136785|79329807|FG001|Overall Study|Protocol Violation|1|||
44324572|NCT00197106|79329819|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
44324573|NCT00197106|79329820|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
44324574|NCT00197106|79329821|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
44324575|NCT00197106|79329819|FG000|Overall Treatment Period|Lack of Efficacy|0|||
44324576|NCT00197106|79329820|FG001|Overall Treatment Period|Lack of Efficacy|1|||
44324577|NCT00197106|79329821|FG002|Overall Treatment Period|Lack of Efficacy|0|||
44324578|NCT00197106|79329819|FG000|Overall Treatment Period|Lost to Follow-up|0|||
44324579|NCT00197106|79329820|FG001|Overall Treatment Period|Lost to Follow-up|0|||
44324580|NCT00197106|79329821|FG002|Overall Treatment Period|Lost to Follow-up|2|||
44324581|NCT00197106|79329819|FG000|Overall Treatment Period|Protocol Violation|0|||
44324582|NCT00197106|79329820|FG001|Overall Treatment Period|Protocol Violation|0|||
44324583|NCT00197106|79329821|FG002|Overall Treatment Period|Protocol Violation|2|||
44324584|NCT00197106|79329819|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
44324585|NCT00197106|79329820|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
44324586|NCT00197106|79329821|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
44324587|NCT01136746|79329829|FG000|Overall Study|Lost to Follow-up|0|||
44324588|NCT01136746|79329830|FG001|Overall Study|Lost to Follow-up|2|||
44324589|NCT01136746|79329829|FG000|Overall Study|Protocol Violation|2|||
44422428|NCT00743288|79430370|FG003|Overall Study|Adverse Event|2|||
44422429|NCT00743288|79430371|FG004|Overall Study|Adverse Event|1|||
44422430|NCT00743288|79430372|FG005|Overall Study|Adverse Event|1|||
44422431|NCT00743288|79430373|FG006|Overall Study|Adverse Event|2|||
44422432|NCT00743288|79430367|FG000|Overall Study|Withdrawal by Subject|0|||
44422433|NCT00743288|79430368|FG001|Overall Study|Withdrawal by Subject|0|||
44422434|NCT00743288|79430369|FG002|Overall Study|Withdrawal by Subject|1|||
44422435|NCT00743288|79430370|FG003|Overall Study|Withdrawal by Subject|0|||
44156353|NCT01944046|78947529|FG000|Randomized to DB|Withdrawal by Subject|2|||
44156354|NCT01944046|78947530|FG001|Randomized to DB|Withdrawal by Subject|4|||
44156355|NCT01944046|78947529|FG000|Randomized to DB|Physician Decision|1|||
44156356|NCT01944046|78947530|FG001|Randomized to DB|Physician Decision|2|||
44156357|NCT01944046|78947529|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
44156358|NCT01944046|78947530|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
44324590|NCT01136746|79329830|FG001|Overall Study|Protocol Violation|1|||
44324591|NCT01136746|79329829|FG000|Overall Study|Death|1|||
44324592|NCT01136746|79329830|FG001|Overall Study|Death|0|||
44324593|NCT01136356|79329836|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
44324594|NCT01136356|79329837|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
44324595|NCT01136356|79329836|FG000|First 18-day Withdrawal|Physician Decision|1|||
44324596|NCT01136356|79329837|FG001|First 18-day Withdrawal|Physician Decision|0|||
44324597|NCT01136356|79329836|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
44156359|NCT01944046|78947529|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
44156360|NCT01944046|78947530|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
44156361|NCT01944046|78947529|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
44156362|NCT01944046|78947530|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
44156363|NCT01944046|78947529|FG000|Open Label Eligible and Consented|Adverse Event|6|||
44156364|NCT01944046|78947530|FG001|Open Label Eligible and Consented|Adverse Event|1|||
44156365|NCT01944046|78947529|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
44156366|NCT01944046|78947530|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
44156367|NCT01944046|78947529|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
44156368|NCT01944046|78947530|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
44156369|NCT01969084|78947542|FG000|Overall Study|Adverse Event|0|||
44324598|NCT01136356|79329837|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
44324599|NCT00196326|79329842|FG000|Overall Study|Did not meet protocol requirements|64|||
44324600|NCT00196326|79329842|FG000|Overall Study|Non-compliance with the protocol|81|||
44324601|NCT00196326|79329842|FG000|Overall Study|Physician Decision|3|||
44324602|NCT00196326|79329842|FG000|Overall Study|Withdrawal by Subject|225|||
44324603|NCT00196326|79329842|FG000|Overall Study|Adverse Event|253|||
44324604|NCT00196326|79329842|FG000|Overall Study|Pregnancy|34|||
44324605|NCT00196326|79329842|FG000|Overall Study|Lost to Follow-up|304|||
44324606|NCT00196326|79329842|FG000|Overall Study|Other|22|||
44324607|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
44422436|NCT00743288|79430371|FG004|Overall Study|Withdrawal by Subject|0|||
44422437|NCT00743288|79430372|FG005|Overall Study|Withdrawal by Subject|1|||
44422438|NCT00743288|79430373|FG006|Overall Study|Withdrawal by Subject|1|||
44422439|NCT00743288|79430367|FG000|Overall Study|Progressive disease (PD)|2|||
44422440|NCT00743288|79430368|FG001|Overall Study|Progressive disease (PD)|0|||
44422441|NCT00743288|79430369|FG002|Overall Study|Progressive disease (PD)|1|||
44324608|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
44324609|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
44324610|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Death|0|||
44422442|NCT00743288|79430370|FG003|Overall Study|Progressive disease (PD)|4|||
44422443|NCT00743288|79430371|FG004|Overall Study|Progressive disease (PD)|5|||
44422444|NCT00743288|79430372|FG005|Overall Study|Progressive disease (PD)|3|||
44422445|NCT00743288|79430373|FG006|Overall Study|Progressive disease (PD)|6|||
44422446|NCT00743288|79430367|FG000|Overall Study|Worsening of condition (Not PD)|0|||
44422447|NCT00743288|79430368|FG001|Overall Study|Worsening of condition (Not PD)|2|||
44422448|NCT00743288|79430369|FG002|Overall Study|Worsening of condition (Not PD)|1|||
44422449|NCT00743288|79430370|FG003|Overall Study|Worsening of condition (Not PD)|1|||
44422450|NCT00743288|79430371|FG004|Overall Study|Worsening of condition (Not PD)|0|||
44422451|NCT00743288|79430372|FG005|Overall Study|Worsening of condition (Not PD)|0|||
44422452|NCT00743288|79430373|FG006|Overall Study|Worsening of condition (Not PD)|0|||
44422453|NCT00750308|79430384|FG000|First Treatment|Adverse Event|0|||
44422454|NCT00750308|79430385|FG001|First Treatment|Adverse Event|1|||
44422455|NCT00750308|79430386|FG002|First Treatment|Adverse Event|0|||
44422456|NCT00750308|79430387|FG003|First Treatment|Adverse Event|0|||
44422457|NCT00750308|79430388|FG004|First Treatment|Adverse Event|0|||
44422458|NCT00750308|79430389|FG005|First Treatment|Adverse Event|0|||
44422459|NCT00750308|79430390|FG006|First Treatment|Adverse Event|0|||
44422460|NCT00750308|79430391|FG007|First Treatment|Adverse Event|0|||
44422461|NCT00750308|79430392|FG008|First Treatment|Adverse Event|0|||
44422462|NCT00750308|79430393|FG009|First Treatment|Adverse Event|0|||
44422463|NCT00750308|79430394|FG010|First Treatment|Adverse Event|1|||
44422464|NCT00750308|79430395|FG011|First Treatment|Adverse Event|1|||
44422465|NCT00750308|79430384|FG000|First Treatment|Withdrawal by Subject|0|||
44536940|NCT03475875|79547628|FG000|Period 2|Protocol Violation|0|||
44536941|NCT03475875|79547629|FG001|Period 2|Protocol Violation|1|||
44536942|NCT03474081|79547637|FG000|Overall Study|Adverse Event|6|||
44536943|NCT03474081|79547638|FG001|Overall Study|Adverse Event|3|||
44536944|NCT03474081|79547637|FG000|Overall Study|Lost to Follow-up|2|||
44536945|NCT03474081|79547638|FG001|Overall Study|Lost to Follow-up|1|||
44536946|NCT03474081|79547637|FG000|Overall Study|Physician Decision|3|||
44536947|NCT03474081|79547638|FG001|Overall Study|Physician Decision|2|||
44536948|NCT03474081|79547637|FG000|Overall Study|Withdrawal by Subject|5|||
44536949|NCT03474081|79547638|FG001|Overall Study|Withdrawal by Subject|7|||
44422466|NCT00750308|79430385|FG001|First Treatment|Withdrawal by Subject|0|||
44422467|NCT00750308|79430386|FG002|First Treatment|Withdrawal by Subject|0|||
44536950|NCT03474081|79547637|FG000|Overall Study|Investigator site closed|1|||
44156370|NCT01969084|78947543|FG001|Overall Study|Adverse Event|1|||
44156371|NCT01942486|78947553|FG000|Overall Study|Lost to Follow-up|27|||
44156372|NCT01941940|78947557|FG000|Overall Study|Adverse Event|11|||
44156373|NCT01941940|78947557|FG000|Overall Study|Lost to Follow-up|2|||
44156374|NCT01941940|78947557|FG000|Overall Study|Physician Decision|2|||
44156375|NCT01941940|78947557|FG000|Overall Study|Withdrawal by Subject|15|||
44156376|NCT01941940|78947557|FG000|Overall Study|Death|1|||
44156377|NCT01941940|78947557|FG000|Overall Study|Other|1|||
44156378|NCT01941940|78947557|FG000|Overall Study|Other|1|||
44156379|NCT01968694|78947563|FG000|Washout (1 Month)|Lost to Follow-up|0|||
44156380|NCT01968694|78947564|FG001|Washout (1 Month)|Lost to Follow-up|1|||
44156381|NCT01968226|78947572|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
44156382|NCT02640053|78947578|FG000|Overall Study|Withdrawal by Subject|2|||
44156383|NCT02640053|78947579|FG001|Overall Study|Withdrawal by Subject|1|||
44156384|NCT02640053|78947578|FG000|Overall Study|Adverse Event|1|||
44156385|NCT02640053|78947579|FG001|Overall Study|Adverse Event|1|||
44156386|NCT02640053|78947578|FG000|Overall Study|Alternative Therapy|1|||
44156387|NCT02640053|78947579|FG001|Overall Study|Alternative Therapy|1|||
44156388|NCT02640053|78947578|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
44324611|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Death|2|||
44324612|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Death|0|||
44324613|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
44324614|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
44324615|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
44324616|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
44324617|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
44324618|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
44324619|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
44324620|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
44324621|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
44324622|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
44324623|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
44324624|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
44324625|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
44324626|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
44324627|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
44324628|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Recovery|1|||
44324629|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Recovery|0|||
44324630|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Recovery|1|||
44324631|NCT00195663|79329849|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
44324632|NCT00195663|79329850|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
44324633|NCT00195663|79329851|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
44324634|NCT00195663|79329849|FG000|Open-Label Extension Period|Adverse Event|21|||
44324635|NCT00195663|79329850|FG001|Open-Label Extension Period|Adverse Event|32|||
44324636|NCT00195663|79329851|FG002|Open-Label Extension Period|Adverse Event|36|||
44324637|NCT00195663|79329849|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
44324638|NCT00195663|79329850|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
44324639|NCT00195663|79329851|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
44324640|NCT00195663|79329849|FG000|Open-Label Extension Period|Recovery|0|||
44324641|NCT00195663|79329850|FG001|Open-Label Extension Period|Recovery|2|||
44324642|NCT00195663|79329851|FG002|Open-Label Extension Period|Recovery|2|||
44324643|NCT00195663|79329849|FG000|Open-Label Extension Period|Protocol Violation|3|||
44324644|NCT00195663|79329850|FG001|Open-Label Extension Period|Protocol Violation|4|||
44324645|NCT00195663|79329851|FG002|Open-Label Extension Period|Protocol Violation|4|||
44324646|NCT00195663|79329849|FG000|Open-Label Extension Period|Death|2|||
44324647|NCT00195663|79329850|FG001|Open-Label Extension Period|Death|2|||
44324648|NCT00195663|79329851|FG002|Open-Label Extension Period|Death|2|||
44324649|NCT00195663|79329849|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
44324650|NCT00195663|79329850|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
44324651|NCT00195663|79329851|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
44324652|NCT00195663|79329849|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
44324653|NCT00195663|79329850|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
44324654|NCT00195663|79329851|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
44324655|NCT00195663|79329849|FG000|Open-Label Extension Period|Administrative reasons|11|||
44156389|NCT02640053|78947579|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
44324656|NCT00195663|79329850|FG001|Open-Label Extension Period|Administrative reasons|11|||
44536951|NCT03474081|79547638|FG001|Overall Study|Investigator site closed|0|||
44156390|NCT01950364|78947587|FG000|Overall Study|Adverse Event|3|||
44156391|NCT01950364|78947588|FG001|Overall Study|Adverse Event|0|||
44156392|NCT01950364|78947587|FG000|Overall Study|Stem Cell Transplant|2|||
44156393|NCT01950364|78947588|FG001|Overall Study|Stem Cell Transplant|6|||
44324657|NCT00195663|79329851|FG002|Open-Label Extension Period|Administrative reasons|13|||
44324658|NCT01135498|79329869|FG000|Overall Study|Adverse Event|20|||
44324659|NCT01135498|79329869|FG000|Overall Study|Progressive disease|38|||
44324660|NCT01135498|79329869|FG000|Overall Study|Investigator judgement|25|||
44324661|NCT01135498|79329869|FG000|Overall Study|Withdrawal by Subject|4|||
44324662|NCT01135498|79329869|FG000|Overall Study|Death|1|||
44324663|NCT01135498|79329869|FG000|Overall Study|Ongoing at time of analysis|2|||
44324664|NCT00195507|79329876|FG000|Overall Study|Adverse Event|24|||
44324665|NCT00195507|79329877|FG001|Overall Study|Adverse Event|13|||
44324666|NCT00195507|79329876|FG000|Overall Study|Death|0|||
44324667|NCT00195507|79329877|FG001|Overall Study|Death|1|||
44324668|NCT00195507|79329876|FG000|Overall Study|Failed to Return|4|||
44324669|NCT00195507|79329877|FG001|Overall Study|Failed to Return|3|||
44324670|NCT00195507|79329876|FG000|Overall Study|Physician Decision|1|||
44324671|NCT00195507|79329877|FG001|Overall Study|Physician Decision|2|||
44324672|NCT00195507|79329876|FG000|Overall Study|Lost to Follow-up|3|||
44324673|NCT00195507|79329877|FG001|Overall Study|Lost to Follow-up|2|||
44324674|NCT00195507|79329876|FG000|Overall Study|Protocol Violation|5|||
44324675|NCT00195507|79329877|FG001|Overall Study|Protocol Violation|4|||
44324676|NCT00195507|79329876|FG000|Overall Study|Lack of Efficacy|40|||
44324677|NCT00195507|79329877|FG001|Overall Study|Lack of Efficacy|67|||
44324678|NCT00195507|79329876|FG000|Overall Study|Withdrawal by Subject|16|||
44324679|NCT00195507|79329877|FG001|Overall Study|Withdrawal by Subject|23|||
44324680|NCT00195507|79329876|FG000|Overall Study|Protocol Deviation|6|||
44324681|NCT00195507|79329877|FG001|Overall Study|Protocol Deviation|3|||
44324682|NCT01134562|79329888|FG000|Overall Study|Adverse Event|0|||
44156394|NCT01950364|78947587|FG000|Overall Study|Disease Progression|5|||
44156395|NCT01950364|78947588|FG001|Overall Study|Disease Progression|2|||
44324683|NCT01134562|79329889|FG001|Overall Study|Adverse Event|1|||
44324684|NCT01134562|79329890|FG002|Overall Study|Adverse Event|0|||
44324685|NCT01134562|79329891|FG003|Overall Study|Adverse Event|0|||
44324686|NCT01134562|79329892|FG004|Overall Study|Adverse Event|0|||
44324687|NCT00195351|79329919|FG000|Overall Study|Lost to Follow-up|9|||
44324688|NCT00195351|79329920|FG001|Overall Study|Lost to Follow-up|9|||
44324689|NCT00195351|79329919|FG000|Overall Study|Withdrawal by Subject|6|||
44324690|NCT00195351|79329920|FG001|Overall Study|Withdrawal by Subject|3|||
44324691|NCT00195351|79329919|FG000|Overall Study|Protocol Deviation|3|||
44324692|NCT00195351|79329920|FG001|Overall Study|Protocol Deviation|2|||
44324693|NCT00195351|79329919|FG000|Overall Study|Death|3|||
44324694|NCT00195351|79329920|FG001|Overall Study|Death|1|||
44324695|NCT00195351|79329919|FG000|Overall Study|Lack of Efficacy|0|||
44324696|NCT00195351|79329920|FG001|Overall Study|Lack of Efficacy|1|||
44324697|NCT00195273|79329928|FG000|Overall Study|Adverse Event|9|||
44324698|NCT00195273|79329929|FG001|Overall Study|Adverse Event|9|||
44324699|NCT00195273|79329928|FG000|Overall Study|Protocol deviation|0|||
44324700|NCT00195273|79329929|FG001|Overall Study|Protocol deviation|1|||
44324701|NCT00195273|79329928|FG000|Overall Study|Lack of Efficacy|3|||
44324702|NCT00195273|79329929|FG001|Overall Study|Lack of Efficacy|1|||
44324703|NCT00195273|79329928|FG000|Overall Study|Procedural complications|9|||
44422468|NCT00750308|79430387|FG003|First Treatment|Withdrawal by Subject|1|||
44422469|NCT00750308|79430388|FG004|First Treatment|Withdrawal by Subject|0|||
44422470|NCT00750308|79430389|FG005|First Treatment|Withdrawal by Subject|0|||
44422471|NCT00750308|79430390|FG006|First Treatment|Withdrawal by Subject|0|||
44422472|NCT00750308|79430391|FG007|First Treatment|Withdrawal by Subject|1|||
44422473|NCT00750308|79430392|FG008|First Treatment|Withdrawal by Subject|0|||
44422474|NCT00750308|79430393|FG009|First Treatment|Withdrawal by Subject|0|||
44422475|NCT00750308|79430394|FG010|First Treatment|Withdrawal by Subject|0|||
44422476|NCT00750308|79430395|FG011|First Treatment|Withdrawal by Subject|0|||
44422477|NCT00750308|79430384|FG000|Second Treatment|Adverse Event|0|||
44422478|NCT00750308|79430385|FG001|Second Treatment|Adverse Event|0|||
44422479|NCT00750308|79430386|FG002|Second Treatment|Adverse Event|0|||
44422480|NCT00750308|79430387|FG003|Second Treatment|Adverse Event|0|||
44422481|NCT00750308|79430388|FG004|Second Treatment|Adverse Event|0|||
44422482|NCT00750308|79430389|FG005|Second Treatment|Adverse Event|1|||
44156396|NCT01950364|78947587|FG000|Overall Study|Withdrawal by Subject|0|||
44324704|NCT00195273|79329929|FG001|Overall Study|Procedural complications|3|||
44324705|NCT00193479|79329935|FG000|Induction Chemotherapy|Adverse Event|2|||
44324706|NCT00193479|79329935|FG000|Induction Chemotherapy|Disease Progression|1|||
44324707|NCT00193479|79329935|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
44422483|NCT00750308|79430390|FG006|Second Treatment|Adverse Event|0|||
44324708|NCT00193479|79329935|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
44324709|NCT00193206|79329939|FG000|Preoperative Therapy|Lack of Efficacy|2|||
44324710|NCT00193206|79329939|FG000|Preoperative Therapy|Adverse Event|2|||
44324711|NCT00193206|79329939|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
44422484|NCT00750308|79430391|FG007|Second Treatment|Adverse Event|0|||
44422485|NCT00750308|79430392|FG008|Second Treatment|Adverse Event|1|||
44324712|NCT00193206|79329939|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
44156397|NCT01950364|78947588|FG001|Overall Study|Withdrawal by Subject|1|||
44324713|NCT00193206|79329939|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
44324714|NCT00193206|79329939|FG000|Postoperative Therapy|Physician Decision|3|||
44324715|NCT00193206|79329939|FG000|Postoperative Therapy|Intercurrent Illness|2|||
44156398|NCT01950364|78947587|FG000|Overall Study|Protocol Violation|0|||
44324716|NCT00193206|79329939|FG000|Postoperative Therapy|Lack of Efficacy|1|||
44324717|NCT00193206|79329939|FG000|Postoperative Therapy|Protocol Violation|1|||
44324718|NCT00193050|79329943|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
44324719|NCT00193050|79329943|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
44324720|NCT00193050|79329943|FG000|Neoadjuvant Treatment|Physician Decision|2|||
44324721|NCT00193050|79329943|FG000|Neoadjuvant Treatment|Adverse Event|2|||
44324722|NCT00193050|79329943|FG000|Adjuvant|Physician Decision|5|||
44324723|NCT00193050|79329943|FG000|Adjuvant|Intercurrent Hospitalization|3|||
44324724|NCT00193050|79329943|FG000|Adjuvant|Lack of Efficacy|2|||
44324725|NCT00192504|79329952|FG000|Overall Study|Lost to Follow-up|1|||
44324726|NCT00192504|79329953|FG001|Overall Study|Lost to Follow-up|0|||
44324727|NCT00192504|79329954|FG002|Overall Study|Lost to Follow-up|0|||
44324728|NCT00192504|79329955|FG003|Overall Study|Lost to Follow-up|0|||
44324729|NCT00192504|79329952|FG000|Overall Study|Dosing window missed|0|||
44324730|NCT00192504|79329953|FG001|Overall Study|Dosing window missed|0|||
44324731|NCT00192504|79329954|FG002|Overall Study|Dosing window missed|1|||
44324732|NCT00192504|79329955|FG003|Overall Study|Dosing window missed|0|||
44324733|NCT00192114|79329965|FG000|Overall Study|Objective Tumor Progression|19|||
44156399|NCT01950364|78947588|FG001|Overall Study|Protocol Violation|1|||
44156400|NCT01968070|78947612|FG000|Period 1|Withdrawal by Subject|0|||
44156401|NCT01968070|78947613|FG001|Period 1|Withdrawal by Subject|1|||
44156402|NCT01968070|78947614|FG002|Period 1|Withdrawal by Subject|0|||
44156403|NCT01968070|78947615|FG003|Period 1|Withdrawal by Subject|0|||
44156404|NCT01968070|78947616|FG004|Period 1|Withdrawal by Subject|0|||
44156405|NCT01968070|78947617|FG005|Period 1|Withdrawal by Subject|0|||
44156406|NCT01968070|78947618|FG006|Period 1|Withdrawal by Subject|1|||
44156407|NCT01968070|78947619|FG007|Period 1|Withdrawal by Subject|0|||
44156408|NCT01968070|78947620|FG008|Period 1|Withdrawal by Subject|0|||
44156409|NCT01968070|78947621|FG009|Period 1|Withdrawal by Subject|0|||
44324734|NCT00192114|79329965|FG000|Overall Study|Adverse Event|2|||
44324735|NCT00192114|79329965|FG000|Overall Study|Clinical Progression|2|||
44324736|NCT00192114|79329965|FG000|Overall Study|Death|1|||
44324737|NCT00192075|79329971|FG000|Overall Study|Disease Progression|23|||
44324738|NCT00192075|79329972|FG001|Overall Study|Disease Progression|6|||
44324739|NCT00192075|79329971|FG000|Overall Study|Adverse Event|1|||
44324740|NCT00192075|79329972|FG001|Overall Study|Adverse Event|3|||
44324741|NCT00192075|79329971|FG000|Overall Study|Death|0|||
44324742|NCT00192075|79329972|FG001|Overall Study|Death|1|||
44324743|NCT00192075|79329971|FG000|Overall Study|Lack of Efficacy|0|||
44324744|NCT00192075|79329972|FG001|Overall Study|Lack of Efficacy|0|||
44324745|NCT00192075|79329971|FG000|Overall Study|Physician Decision|3|||
44324746|NCT00192075|79329972|FG001|Overall Study|Physician Decision|0|||
44324747|NCT00192075|79329971|FG000|Overall Study|Withdrawal by Subject|5|||
44324748|NCT00192075|79329972|FG001|Overall Study|Withdrawal by Subject|5|||
44324749|NCT00192075|79329971|FG000|Overall Study|Patient Non-Compliance|0|||
44324750|NCT00192075|79329972|FG001|Overall Study|Patient Non-Compliance|1|||
44324751|NCT00192075|79329971|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
44324752|NCT00192075|79329972|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
44324753|NCT00192075|79329971|FG000|Overall Study|Other|5|||
44324754|NCT00192075|79329972|FG001|Overall Study|Other|2|||
44324755|NCT00192036|79329983|FG000|Overall Study|Protocol Violation|3|||
44422486|NCT00750308|79430393|FG009|Second Treatment|Adverse Event|0|||
44156410|NCT01968070|78947622|FG010|Period 1|Withdrawal by Subject|0|||
44156411|NCT01968070|78947623|FG011|Period 1|Withdrawal by Subject|0|||
44156412|NCT01968070|78947624|FG012|Period 1|Withdrawal by Subject|0|||
44258275|NCT01421342|79113180|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
44258276|NCT01421342|79113181|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
44258277|NCT01421342|79113182|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
44258278|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
44258279|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
44258280|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
44258281|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
44258282|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
44258283|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
44258284|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
44258285|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
44258286|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
44258287|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
44258288|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
44324756|NCT00192036|79329983|FG000|Overall Study|Adverse Event|6|||
44324757|NCT00192036|79329983|FG000|Overall Study|Patient/Physician Perception|1|||
44324758|NCT00192036|79329983|FG000|Overall Study|Objective Tumor Progression|4|||
44324759|NCT00192036|79329983|FG000|Overall Study|Clinical Disease Progression|1|||
44422487|NCT00750308|79430394|FG010|Second Treatment|Adverse Event|0|||
44422488|NCT00750308|79430395|FG011|Second Treatment|Adverse Event|0|||
44422489|NCT00750308|79430384|FG000|Second Treatment|Withdrawal by Subject|0|||
44422490|NCT00750308|79430385|FG001|Second Treatment|Withdrawal by Subject|0|||
44156413|NCT01968070|78947625|FG013|Period 1|Withdrawal by Subject|0|||
44422491|NCT00750308|79430386|FG002|Second Treatment|Withdrawal by Subject|0|||
44422492|NCT00750308|79430387|FG003|Second Treatment|Withdrawal by Subject|0|||
44422493|NCT00750308|79430388|FG004|Second Treatment|Withdrawal by Subject|1|||
44422494|NCT00750308|79430389|FG005|Second Treatment|Withdrawal by Subject|0|||
44422495|NCT00750308|79430390|FG006|Second Treatment|Withdrawal by Subject|0|||
44422496|NCT00750308|79430391|FG007|Second Treatment|Withdrawal by Subject|0|||
44324760|NCT00192036|79329983|FG000|Overall Study|Death|1|||
44324761|NCT00192036|79329983|FG000|Overall Study|Unknown or Not Specified|5|||
44324762|NCT00191724|79329992|FG000|Overall Study|Adverse Event|0|||
44422497|NCT00750308|79430392|FG008|Second Treatment|Withdrawal by Subject|0|||
44324763|NCT00191724|79329993|FG001|Overall Study|Adverse Event|0|||
44324764|NCT00191724|79329994|FG002|Overall Study|Adverse Event|1|||
44324765|NCT00191724|79329995|FG003|Overall Study|Adverse Event|0|||
44324766|NCT00191724|79329996|FG004|Overall Study|Adverse Event|0|||
44324767|NCT00191724|79329992|FG000|Overall Study|Lost to Follow-up|1|||
44324768|NCT00191724|79329993|FG001|Overall Study|Lost to Follow-up|1|||
44324769|NCT00191724|79329994|FG002|Overall Study|Lost to Follow-up|0|||
44324770|NCT00191724|79329995|FG003|Overall Study|Lost to Follow-up|2|||
44324771|NCT00191724|79329996|FG004|Overall Study|Lost to Follow-up|3|||
44324772|NCT00191724|79329992|FG000|Overall Study|Withdrawal by Subject|0|||
44324773|NCT00191724|79329993|FG001|Overall Study|Withdrawal by Subject|0|||
44324774|NCT00191724|79329994|FG002|Overall Study|Withdrawal by Subject|0|||
44324775|NCT00191724|79329995|FG003|Overall Study|Withdrawal by Subject|1|||
44324776|NCT00191724|79329996|FG004|Overall Study|Withdrawal by Subject|0|||
44324777|NCT00191646|79330010|FG000|Overall Study|Toxicity|26|||
44324778|NCT00191646|79330011|FG001|Overall Study|Toxicity|37|||
44324779|NCT00191646|79330010|FG000|Overall Study|Disease Progression|5|||
44324780|NCT00191646|79330011|FG001|Overall Study|Disease Progression|6|||
44324781|NCT00191646|79330010|FG000|Overall Study|Physician Decision|20|||
44324782|NCT00191646|79330011|FG001|Overall Study|Physician Decision|11|||
44324783|NCT00191646|79330010|FG000|Overall Study|Withdrawal by Subject|58|||
44324784|NCT00191646|79330011|FG001|Overall Study|Withdrawal by Subject|39|||
44324785|NCT00191646|79330010|FG000|Overall Study|Protocol Violation|5|||
44324786|NCT00191646|79330011|FG001|Overall Study|Protocol Violation|7|||
44324787|NCT00191646|79330010|FG000|Overall Study|Death|6|||
44324788|NCT00191646|79330011|FG001|Overall Study|Death|8|||
44324789|NCT00191646|79330010|FG000|Overall Study|Other|33|||
44324790|NCT00191646|79330011|FG001|Overall Study|Other|34|||
44324791|NCT00191646|79330010|FG000|Overall Study|Missing Data|18|||
44324792|NCT00191646|79330011|FG001|Overall Study|Missing Data|11|||
44324793|NCT00191451|79330028|FG000|Overall Study|Withdrawal by Subject|2|||
44324794|NCT00191451|79330029|FG001|Overall Study|Withdrawal by Subject|3|||
44324795|NCT00191451|79330030|FG002|Overall Study|Withdrawal by Subject|5|||
44324796|NCT00191451|79330028|FG000|Overall Study|Physician Decision|2|||
44324797|NCT00191451|79330029|FG001|Overall Study|Physician Decision|9|||
44324798|NCT00191451|79330030|FG002|Overall Study|Physician Decision|6|||
44324799|NCT00191451|79330028|FG000|Overall Study|Sponsor Decision|1|||
44324800|NCT00191451|79330029|FG001|Overall Study|Sponsor Decision|0|||
44324801|NCT00191451|79330030|FG002|Overall Study|Sponsor Decision|0|||
44324802|NCT00191451|79330028|FG000|Overall Study|Ineligible|0|||
44324803|NCT00191451|79330029|FG001|Overall Study|Ineligible|1|||
44422498|NCT00750308|79430393|FG009|Second Treatment|Withdrawal by Subject|0|||
44324804|NCT00191451|79330030|FG002|Overall Study|Ineligible|0|||
44422499|NCT00750308|79430394|FG010|Second Treatment|Withdrawal by Subject|0|||
44324805|NCT00191451|79330028|FG000|Overall Study|Reason Not Specified|2|||
44422500|NCT00750308|79430395|FG011|Second Treatment|Withdrawal by Subject|0|||
44324806|NCT00191451|79330029|FG001|Overall Study|Reason Not Specified|1|||
44324807|NCT00191451|79330030|FG002|Overall Study|Reason Not Specified|3|||
44324808|NCT00191334|79330038|FG000|Overall Study|Adverse Event|4|||
44324809|NCT00191334|79330038|FG000|Overall Study|Disease Progression or Relapse|8|||
44324810|NCT00191334|79330038|FG000|Overall Study|Physician Decision|1|||
44324811|NCT00191334|79330038|FG000|Overall Study|Withdrawal by Subject|4|||
44324812|NCT00191139|79330044|FG000|Overall Study|Adverse Event|2|||
44324813|NCT00191139|79330045|FG001|Overall Study|Adverse Event|6|||
44324814|NCT00191139|79330044|FG000|Overall Study|Death|2|||
44324815|NCT00191139|79330045|FG001|Overall Study|Death|0|||
44324816|NCT00191139|79330044|FG000|Overall Study|Withdrawal by Subject|0|||
44324817|NCT00191139|79330045|FG001|Overall Study|Withdrawal by Subject|3|||
44324818|NCT00191139|79330044|FG000|Overall Study|Disease Progression|0|||
44422501|NCT00750308|79430384|FG000|Third Treatment|Withdrawal by Subject|0|||
44324819|NCT00191139|79330045|FG001|Overall Study|Disease Progression|1|||
44324820|NCT00191139|79330044|FG000|Overall Study|Other|1|||
44324821|NCT00191139|79330045|FG001|Overall Study|Other|2|||
44324822|NCT00190983|79330051|FG000|Overall Study|Inevaluable (never treated)|2|||
44324823|NCT00190749|79330057|FG000|Overall Study|Lost to Follow-up|8|||
44324824|NCT00190749|79330058|FG001|Overall Study|Lost to Follow-up|11|||
44324825|NCT00190749|79330057|FG000|Overall Study|Withdrawal by Subject|10|||
44324826|NCT00190749|79330058|FG001|Overall Study|Withdrawal by Subject|6|||
44324827|NCT00190749|79330057|FG000|Overall Study|Protocol Violation|5|||
44324828|NCT00190749|79330058|FG001|Overall Study|Protocol Violation|4|||
44324829|NCT00190749|79330057|FG000|Overall Study|Adverse Event|0|||
44324830|NCT00190749|79330058|FG001|Overall Study|Adverse Event|5|||
44422502|NCT00750308|79430385|FG001|Third Treatment|Withdrawal by Subject|1|||
44422503|NCT00750308|79430386|FG002|Third Treatment|Withdrawal by Subject|0|||
44324831|NCT00190749|79330057|FG000|Overall Study|Lack of Efficacy|2|||
44324832|NCT00190749|79330058|FG001|Overall Study|Lack of Efficacy|3|||
44324833|NCT00190749|79330057|FG000|Overall Study|Reason Not Specified|0|||
44324834|NCT00190749|79330058|FG001|Overall Study|Reason Not Specified|2|||
44324835|NCT00190749|79330057|FG000|Overall Study|Sponsor Decision|1|||
44324836|NCT00190749|79330058|FG001|Overall Study|Sponsor Decision|0|||
44324837|NCT00190671|79330066|FG000|Overall Study|Satisfactory Response|4|||
44324838|NCT00190671|79330067|FG001|Overall Study|Satisfactory Response|7|||
44324839|NCT00190671|79330066|FG000|Overall Study|Lack of Efficacy|19|||
44324840|NCT00190671|79330067|FG001|Overall Study|Lack of Efficacy|24|||
44324841|NCT00190671|79330066|FG000|Overall Study|Death from Study Disease|1|||
44324842|NCT00190671|79330067|FG001|Overall Study|Death from Study Disease|1|||
44324843|NCT00190671|79330066|FG000|Overall Study|Adverse Event|3|||
44324844|NCT00190671|79330067|FG001|Overall Study|Adverse Event|2|||
44324845|NCT00190671|79330066|FG000|Overall Study|Clinical Relapse|0|||
44324846|NCT00190671|79330067|FG001|Overall Study|Clinical Relapse|1|||
44324847|NCT00190671|79330066|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
44324848|NCT00190671|79330067|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
44324849|NCT00190671|79330066|FG000|Overall Study|Death from Other Causes|0|||
44324850|NCT00190671|79330067|FG001|Overall Study|Death from Other Causes|2|||
44324851|NCT00190671|79330066|FG000|Overall Study|Protocol Violation|0|||
44324852|NCT00190671|79330067|FG001|Overall Study|Protocol Violation|1|||
44324853|NCT00190671|79330066|FG000|Overall Study|Withdrawal by Subject|0|||
44324854|NCT00190671|79330067|FG001|Overall Study|Withdrawal by Subject|2|||
44324855|NCT00477165|79330089|FG000|Overall Study|Adverse Event|7|||
44324856|NCT00477165|79330090|FG001|Overall Study|Adverse Event|2|||
44324857|NCT00476229|79330096|FG000|Overall Study|Progressive shortness of breath|1|||
44324858|NCT00476151|79330102|FG000|Overall Study|Adverse Event|0|||
44324859|NCT00476151|79330103|FG001|Overall Study|Adverse Event|2|||
44324860|NCT00476151|79330102|FG000|Overall Study|Protocol Violation|1|||
44324861|NCT00476151|79330103|FG001|Overall Study|Protocol Violation|3|||
44324862|NCT00476151|79330102|FG000|Overall Study|Withdrawal by Subject|2|||
44324863|NCT00476151|79330103|FG001|Overall Study|Withdrawal by Subject|0|||
44324864|NCT00476151|79330102|FG000|Overall Study|Physician Decision|0|||
44536952|NCT03346434|79547650|FG000|Overall Study|Randomized in Error|0|||
44324865|NCT00476151|79330103|FG001|Overall Study|Physician Decision|2|||
44324866|NCT00475644|79330109|FG000|Overall Study|Protocol Violation|13|||
44324867|NCT00474903|79330116|FG000|Overall Study|Protocol Violation|1|||
44324868|NCT00474903|79330117|FG001|Overall Study|Protocol Violation|5|||
44324869|NCT00474903|79330118|FG002|Overall Study|Protocol Violation|2|||
44324870|NCT01134055|79330133|FG000|Overall Study|Adverse Event|5|||
44324871|NCT01134055|79330134|FG001|Overall Study|Adverse Event|2|||
44324872|NCT01134055|79330135|FG002|Overall Study|Adverse Event|2|||
44324873|NCT01134055|79330136|FG003|Overall Study|Adverse Event|2|||
44324874|NCT01134055|79330137|FG004|Overall Study|Adverse Event|5|||
44324875|NCT01134055|79330138|FG005|Overall Study|Adverse Event|7|||
44156414|NCT01968070|78947626|FG014|Period 1|Withdrawal by Subject|0|||
44324876|NCT01134055|79330139|FG006|Overall Study|Adverse Event|2|||
44536953|NCT03346434|79547651|FG001|Overall Study|Randomized in Error|0|||
44156415|NCT01968070|78947627|FG015|Period 1|Withdrawal by Subject|1|||
44324877|NCT01134055|79330133|FG000|Overall Study|Lost to Follow-up|0|||
44324878|NCT01134055|79330134|FG001|Overall Study|Lost to Follow-up|1|||
44324879|NCT01134055|79330135|FG002|Overall Study|Lost to Follow-up|0|||
44324880|NCT01134055|79330136|FG003|Overall Study|Lost to Follow-up|1|||
44324881|NCT01134055|79330137|FG004|Overall Study|Lost to Follow-up|0|||
44324882|NCT01134055|79330138|FG005|Overall Study|Lost to Follow-up|0|||
44324883|NCT01134055|79330139|FG006|Overall Study|Lost to Follow-up|0|||
44324884|NCT01134055|79330133|FG000|Overall Study|Withdrawal by Subject|3|||
44422504|NCT00750308|79430387|FG003|Third Treatment|Withdrawal by Subject|0|||
44536954|NCT03346434|79547652|FG002|Overall Study|Randomized in Error|0|||
44324885|NCT01134055|79330134|FG001|Overall Study|Withdrawal by Subject|3|||
44324886|NCT01134055|79330135|FG002|Overall Study|Withdrawal by Subject|1|||
44324887|NCT01134055|79330136|FG003|Overall Study|Withdrawal by Subject|2|||
44422505|NCT00750308|79430388|FG004|Third Treatment|Withdrawal by Subject|0|||
44324888|NCT01134055|79330137|FG004|Overall Study|Withdrawal by Subject|0|||
44422506|NCT00750308|79430389|FG005|Third Treatment|Withdrawal by Subject|0|||
44422507|NCT00750308|79430390|FG006|Third Treatment|Withdrawal by Subject|0|||
44422508|NCT00750308|79430391|FG007|Third Treatment|Withdrawal by Subject|0|||
44422509|NCT00750308|79430392|FG008|Third Treatment|Withdrawal by Subject|0|||
44422510|NCT00750308|79430393|FG009|Third Treatment|Withdrawal by Subject|0|||
44422511|NCT00750308|79430394|FG010|Third Treatment|Withdrawal by Subject|0|||
44422512|NCT00750308|79430395|FG011|Third Treatment|Withdrawal by Subject|0|||
44422513|NCT04942366|79430446|FG000|Overall Study|Withdrawal by Subject|5|||
44324889|NCT01134055|79330138|FG005|Overall Study|Withdrawal by Subject|0|||
44324890|NCT01134055|79330139|FG006|Overall Study|Withdrawal by Subject|8|||
44324891|NCT01134055|79330133|FG000|Overall Study|Protocol Violation|0|||
44324892|NCT01134055|79330134|FG001|Overall Study|Protocol Violation|0|||
44324893|NCT01134055|79330135|FG002|Overall Study|Protocol Violation|0|||
44324894|NCT01134055|79330136|FG003|Overall Study|Protocol Violation|1|||
44324895|NCT01134055|79330137|FG004|Overall Study|Protocol Violation|1|||
44324896|NCT01134055|79330138|FG005|Overall Study|Protocol Violation|0|||
44324897|NCT01134055|79330139|FG006|Overall Study|Protocol Violation|0|||
44324898|NCT01134055|79330133|FG000|Overall Study|Physician Decision|0|||
44324899|NCT01134055|79330134|FG001|Overall Study|Physician Decision|0|||
44324900|NCT01134055|79330135|FG002|Overall Study|Physician Decision|0|||
44324901|NCT01134055|79330136|FG003|Overall Study|Physician Decision|0|||
44324902|NCT01134055|79330137|FG004|Overall Study|Physician Decision|0|||
44324903|NCT01134055|79330138|FG005|Overall Study|Physician Decision|0|||
44324904|NCT01134055|79330139|FG006|Overall Study|Physician Decision|1|||
44324905|NCT00474708|79330163|FG000|Overall Study|Lack of Efficacy|11|||
44324906|NCT00474708|79330164|FG001|Overall Study|Lack of Efficacy|5|||
44324907|NCT00474708|79330163|FG000|Overall Study|Suicide ideation/behavior|0|||
44324908|NCT00474708|79330164|FG001|Overall Study|Suicide ideation/behavior|1|||
44324909|NCT00474708|79330163|FG000|Overall Study|Withdrawal by Subject|7|||
44324910|NCT00474708|79330164|FG001|Overall Study|Withdrawal by Subject|0|||
44324911|NCT00474708|79330163|FG000|Overall Study|Lack of compliance|12|||
44324912|NCT00474708|79330164|FG001|Overall Study|Lack of compliance|4|||
44324913|NCT00474708|79330163|FG000|Overall Study|Lost to Follow-up|18|||
44324914|NCT00474708|79330164|FG001|Overall Study|Lost to Follow-up|9|||
44324915|NCT00474708|79330163|FG000|Overall Study|Physician Decision|9|||
44324916|NCT00474708|79330164|FG001|Overall Study|Physician Decision|6|||
44324917|NCT00474240|79330176|FG000|Overall Study|Withdrawal by Subject|1|||
44324918|NCT00474240|79330177|FG001|Overall Study|Withdrawal by Subject|1|||
44324919|NCT00474240|79330178|FG002|Overall Study|Withdrawal by Subject|0|||
44324920|NCT00474240|79330179|FG003|Overall Study|Withdrawal by Subject|2|||
44324921|NCT00474240|79330180|FG004|Overall Study|Withdrawal by Subject|3|||
44324922|NCT00474240|79330181|FG005|Overall Study|Withdrawal by Subject|1|||
44324923|NCT00474240|79330176|FG000|Overall Study|Adverse Event|0|||
44324924|NCT00474240|79330177|FG001|Overall Study|Adverse Event|0|||
44324925|NCT00474240|79330178|FG002|Overall Study|Adverse Event|9|||
44324926|NCT00474240|79330179|FG003|Overall Study|Adverse Event|14|||
44324927|NCT00474240|79330180|FG004|Overall Study|Adverse Event|5|||
44324928|NCT00474240|79330181|FG005|Overall Study|Adverse Event|16|||
44324929|NCT00474240|79330176|FG000|Overall Study|Removed due to lab value|0|||
44324930|NCT00474240|79330177|FG001|Overall Study|Removed due to lab value|0|||
44324931|NCT00474240|79330178|FG002|Overall Study|Removed due to lab value|0|||
44324932|NCT00474240|79330179|FG003|Overall Study|Removed due to lab value|0|||
44324933|NCT00474240|79330180|FG004|Overall Study|Removed due to lab value|0|||
44324934|NCT00474240|79330181|FG005|Overall Study|Removed due to lab value|1|||
44324935|NCT00473889|79330197|FG000|Overall Study|Did not receive study medication|1|||
44324936|NCT00473889|79330198|FG001|Overall Study|Did not receive study medication|4|||
44324937|NCT00473889|79330197|FG000|Overall Study|Adverse Event|30|||
44422514|NCT04942366|79430447|FG001|Overall Study|Withdrawal by Subject|5|||
44422515|NCT04840615|79430453|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
44422516|NCT04840615|79430454|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
44422517|NCT04840615|79430455|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
44422518|NCT04830215|79430460|FG000|Overall Study|Adverse Event|6|||
44156416|NCT01968070|78947628|FG016|Period 1|Withdrawal by Subject|0|||
44156417|NCT01968070|78947629|FG017|Period 1|Withdrawal by Subject|0|||
44324938|NCT00473889|79330198|FG001|Overall Study|Adverse Event|17|||
44324939|NCT00473889|79330197|FG000|Overall Study|Protocol Violation|4|||
44324940|NCT00473889|79330198|FG001|Overall Study|Protocol Violation|2|||
44324941|NCT00473889|79330197|FG000|Overall Study|Lack of Efficacy|28|||
44324942|NCT00473889|79330198|FG001|Overall Study|Lack of Efficacy|29|||
44422519|NCT04830215|79430460|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
44324943|NCT00473889|79330197|FG000|Overall Study|Lost to Follow-up|2|||
44324944|NCT00473889|79330198|FG001|Overall Study|Lost to Follow-up|1|||
44324945|NCT00473889|79330197|FG000|Overall Study|Physician Decision|10|||
44324946|NCT00473889|79330198|FG001|Overall Study|Physician Decision|5|||
44324947|NCT00473889|79330197|FG000|Overall Study|Trial Terminated|3|||
44324948|NCT00473889|79330198|FG001|Overall Study|Trial Terminated|6|||
44324949|NCT00473889|79330197|FG000|Overall Study|Withdrawal by Subject|5|||
44422520|NCT04830215|79430460|FG000|Overall Study|Withdrawal by Subject|3|||
44422521|NCT04830215|79430460|FG000|Overall Study|Protocol Deviation|1|||
44422522|NCT04825912|79430464|FG000|Overall Study|Death|3|||
44422523|NCT04825912|79430464|FG000|Overall Study|Withdrawal by Subject|1|||
44422524|NCT04327934|79430498|FG000|Overall Study|Did not qualify|7|||
44324950|NCT00473889|79330198|FG001|Overall Study|Withdrawal by Subject|0|||
44324951|NCT00473694|79330208|FG000|Overall Study|Adverse Event|0|||
44324952|NCT00473694|79330209|FG001|Overall Study|Adverse Event|1|||
44324953|NCT00473694|79330210|FG002|Overall Study|Adverse Event|0|||
44324954|NCT00473694|79330211|FG003|Overall Study|Adverse Event|0|||
44324955|NCT00473694|79330208|FG000|Overall Study|Participants did not receive treatment|11|||
44324956|NCT00473694|79330209|FG001|Overall Study|Participants did not receive treatment|3|||
44324957|NCT00473694|79330210|FG002|Overall Study|Participants did not receive treatment|5|||
44422525|NCT04327934|79430499|FG001|Overall Study|Did not qualify|4|||
44422526|NCT04327934|79430498|FG000|Overall Study|Physician Decision|0|||
44324958|NCT00473694|79330211|FG003|Overall Study|Participants did not receive treatment|6|||
44324959|NCT00473694|79330208|FG000|Overall Study|Lost to Follow-up|0|||
44324960|NCT00473694|79330209|FG001|Overall Study|Lost to Follow-up|0|||
44324961|NCT00473694|79330210|FG002|Overall Study|Lost to Follow-up|0|||
44324962|NCT00473694|79330211|FG003|Overall Study|Lost to Follow-up|1|||
44422527|NCT04327934|79430499|FG001|Overall Study|Physician Decision|1|||
44422528|NCT04101331|79430507|FG000|Overall Study|Adverse Event|7|||
44422529|NCT04101331|79430507|FG000|Overall Study|Disease progression|79|||
44422530|NCT04101331|79430507|FG000|Overall Study|Withdrawal by Subject|1|||
44422531|NCT04101331|79430507|FG000|Overall Study|Investigator decision|6|||
44422532|NCT04101331|79430507|FG000|Overall Study|Death|6|||
44422533|NCT04101331|79430507|FG000|Overall Study|Allogenic transplant|1|||
44422534|NCT03834519|79430517|FG000|Overall Study|Ongoing|234|||
44422535|NCT03834519|79430518|FG001|Overall Study|Ongoing|111|||
44422536|NCT03834519|79430517|FG000|Overall Study|Withdrawal by Subject|4|||
44422537|NCT03834519|79430518|FG001|Overall Study|Withdrawal by Subject|7|||
44422538|NCT03834519|79430517|FG000|Overall Study|Death|291|||
44422539|NCT03834519|79430518|FG001|Overall Study|Death|146|||
44324963|NCT00473655|79330227|FG000|Overall Study|Lost to Follow-up|9|||
44324964|NCT00473655|79330228|FG001|Overall Study|Lost to Follow-up|5|||
44324965|NCT00473655|79330229|FG002|Overall Study|Lost to Follow-up|8|||
44324966|NCT00473382|79330240|FG000|Core Study|Adverse Event|3|||
44324967|NCT00473382|79330241|FG001|Core Study|Adverse Event|1|||
44324968|NCT00473382|79330242|FG002|Core Study|Adverse Event|1|||
44324969|NCT00473382|79330240|FG000|Core Study|Death|3|||
44324970|NCT00473382|79330241|FG001|Core Study|Death|5|||
44324971|NCT00473382|79330242|FG002|Core Study|Death|10|||
44324972|NCT00473382|79330240|FG000|Core Study|Lost to Follow-up|3|||
44324973|NCT00473382|79330241|FG001|Core Study|Lost to Follow-up|3|||
44324974|NCT00473382|79330242|FG002|Core Study|Lost to Follow-up|3|||
44324975|NCT00473382|79330240|FG000|Core Study|Physician Decision|1|||
44324976|NCT00473382|79330241|FG001|Core Study|Physician Decision|2|||
44324977|NCT00473382|79330242|FG002|Core Study|Physician Decision|2|||
44324978|NCT00473382|79330240|FG000|Core Study|Subject non-compliance|5|||
44156418|NCT01968070|78947612|FG000|Period 1|Protocol Violation|0|||
44324979|NCT00473382|79330241|FG001|Core Study|Subject non-compliance|2|||
44324980|NCT00473382|79330242|FG002|Core Study|Subject non-compliance|1|||
44422540|NCT03693170|79430524|FG000|Overall Study|Disease Progression|48|||
44422541|NCT03693170|79430524|FG000|Overall Study|Adverse Event|16|||
44422542|NCT03693170|79430524|FG000|Overall Study|Physician Decision|6|||
44422543|NCT03693170|79430524|FG000|Overall Study|Protocol Violation|2|||
44422544|NCT03693170|79430524|FG000|Overall Study|Death|1|||
44156419|NCT01968070|78947613|FG001|Period 1|Protocol Violation|0|||
44422545|NCT03693170|79430524|FG000|Overall Study|Non compliance with study drug|1|||
44422546|NCT03693170|79430524|FG000|Overall Study|Withdrawal by Subject|1|||
44536955|NCT03346434|79547653|FG003|Overall Study|Randomized in Error|0|||
44536956|NCT03346434|79547654|FG004|Overall Study|Randomized in Error|1|||
44536957|NCT03346434|79547655|FG005|Overall Study|Randomized in Error|0|||
44156420|NCT01968070|78947614|FG002|Period 1|Protocol Violation|0|||
44156421|NCT01968070|78947615|FG003|Period 1|Protocol Violation|1|||
44536958|NCT03346434|79547650|FG000|Overall Study|Withdrawal by Subject|0|||
44536959|NCT03346434|79547651|FG001|Overall Study|Withdrawal by Subject|0|||
44156422|NCT01968070|78947616|FG004|Period 1|Protocol Violation|1|||
44324981|NCT00473382|79330240|FG000|Core Study|Subject needed other treatment|1|||
44324982|NCT00473382|79330241|FG001|Core Study|Subject needed other treatment|3|||
44324983|NCT00473382|79330242|FG002|Core Study|Subject needed other treatment|2|||
44324984|NCT00473382|79330240|FG000|Core Study|Subject's decision|12|||
44324985|NCT00473382|79330241|FG001|Core Study|Subject's decision|11|||
44324986|NCT00473382|79330242|FG002|Core Study|Subject's decision|10|||
44324987|NCT00473382|79330240|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
44324988|NCT00473382|79330241|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
44324989|NCT00473382|79330242|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
44422547|NCT03655262|79430532|FG000|Overall Study|Withdrawal by Subject|0|||
44422548|NCT03655262|79430533|FG001|Overall Study|Withdrawal by Subject|0|||
44324990|NCT00473382|79330240|FG000|Open-label Extension Through Month 48|Death|1|||
44422549|NCT03655262|79430534|FG002|Overall Study|Withdrawal by Subject|1|||
44422550|NCT03580044|79430547|FG000|Overall Study|Death|2|||
44422551|NCT03580044|79430548|FG001|Overall Study|Death|1|||
44422552|NCT03580044|79430547|FG000|Overall Study|Withdrawal by Subject|1|||
44422553|NCT03580044|79430548|FG001|Overall Study|Withdrawal by Subject|1|||
44422554|NCT03520400|79430556|FG000|Overall Study|Physician Decision|15|||
44324991|NCT00473382|79330241|FG001|Open-label Extension Through Month 48|Death|3|||
44422555|NCT03520400|79430557|FG001|Overall Study|Physician Decision|7|||
44422556|NCT03474107|79430565|FG000|Overall Study|Adverse Event|42|||
44156423|NCT01968070|78947617|FG005|Period 1|Protocol Violation|0|||
44156424|NCT01968070|78947618|FG006|Period 1|Protocol Violation|0|||
44156425|NCT01968070|78947619|FG007|Period 1|Protocol Violation|0|||
44156426|NCT01968070|78947620|FG008|Period 1|Protocol Violation|0|||
44156427|NCT01968070|78947621|FG009|Period 1|Protocol Violation|0|||
44156428|NCT01968070|78947622|FG010|Period 1|Protocol Violation|0|||
44156429|NCT01968070|78947623|FG011|Period 1|Protocol Violation|0|||
44324992|NCT00473382|79330242|FG002|Open-label Extension Through Month 48|Death|3|||
44324993|NCT00473382|79330240|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
44324994|NCT00473382|79330241|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
44324995|NCT00473382|79330242|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
44324996|NCT00473382|79330240|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
44324997|NCT00473382|79330241|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
44324998|NCT00473382|79330242|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
44324999|NCT00473382|79330240|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
44325000|NCT00473382|79330241|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
44325001|NCT00473382|79330242|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
44325002|NCT00473382|79330240|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
44325003|NCT00473382|79330241|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
44325004|NCT00473382|79330242|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
44325005|NCT00473382|79330240|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
44325006|NCT00473382|79330241|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
44325007|NCT00473382|79330242|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
44325008|NCT00473382|79330240|FG000|Open-label Extension Through Month 60|Death|1|||
44325009|NCT00473382|79330241|FG001|Open-label Extension Through Month 60|Death|7|||
44325010|NCT00473382|79330242|FG002|Open-label Extension Through Month 60|Death|4|||
44422557|NCT03474107|79430566|FG001|Overall Study|Adverse Event|46|||
44422558|NCT03474107|79430565|FG000|Overall Study|Death|2|||
44422559|NCT03474107|79430566|FG001|Overall Study|Death|2|||
44422560|NCT03474107|79430565|FG000|Overall Study|Lost to Follow-up|0|||
44422561|NCT03474107|79430566|FG001|Overall Study|Lost to Follow-up|1|||
44422562|NCT03474107|79430565|FG000|Overall Study|Progressive Disease|177|||
44536960|NCT03346434|79547652|FG002|Overall Study|Withdrawal by Subject|1|||
44156430|NCT01968070|78947624|FG012|Period 1|Protocol Violation|0|||
44156431|NCT01968070|78947625|FG013|Period 1|Protocol Violation|0|||
44156432|NCT01968070|78947626|FG014|Period 1|Protocol Violation|0|||
44156433|NCT01968070|78947627|FG015|Period 1|Protocol Violation|0|||
44156434|NCT01968070|78947628|FG016|Period 1|Protocol Violation|0|||
44156435|NCT01968070|78947629|FG017|Period 1|Protocol Violation|0|||
44156436|NCT01968070|78947612|FG000|Period 1|Lost to Follow-up|0|||
44156437|NCT01968070|78947613|FG001|Period 1|Lost to Follow-up|0|||
44156438|NCT01968070|78947614|FG002|Period 1|Lost to Follow-up|0|||
44156439|NCT01968070|78947615|FG003|Period 1|Lost to Follow-up|1|||
44156440|NCT01968070|78947616|FG004|Period 1|Lost to Follow-up|0|||
44156441|NCT01968070|78947617|FG005|Period 1|Lost to Follow-up|0|||
44156442|NCT01968070|78947618|FG006|Period 1|Lost to Follow-up|0|||
44156443|NCT01968070|78947619|FG007|Period 1|Lost to Follow-up|0|||
44258289|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
44258290|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
44258291|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
44258292|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
44258293|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
44258294|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
44258295|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
44258296|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
44258297|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
44258298|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
44258299|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
44258300|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
44258301|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
44258302|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
44325011|NCT00473382|79330240|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
44325012|NCT00473382|79330241|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
44325013|NCT00473382|79330242|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
44325014|NCT00473382|79330240|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
44325015|NCT00473382|79330241|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
44325016|NCT00473382|79330242|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
44325017|NCT00473382|79330240|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
44325018|NCT00473382|79330241|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
44422563|NCT03474107|79430566|FG001|Overall Study|Progressive Disease|180|||
44422564|NCT03474107|79430565|FG000|Overall Study|Protocol Violation|1|||
44422565|NCT03474107|79430566|FG001|Overall Study|Protocol Violation|1|||
44422566|NCT03474107|79430565|FG000|Overall Study|Withdrawal by Subject|15|||
44422567|NCT03474107|79430566|FG001|Overall Study|Withdrawal by Subject|27|||
44422568|NCT03474107|79430565|FG000|Overall Study|Physician Decision|7|||
44422569|NCT03474107|79430566|FG001|Overall Study|Physician Decision|22|||
44422570|NCT03474107|79430565|FG000|Overall Study|Miscellaneous|1|||
44422571|NCT03474107|79430566|FG001|Overall Study|Miscellaneous|6|||
44422572|NCT03019185|79430598|FG000|Overall Study|Lost to Follow-up|3|||
44422573|NCT03019185|79430599|FG001|Overall Study|Lost to Follow-up|0|||
44422574|NCT03019185|79430600|FG002|Overall Study|Lost to Follow-up|2|||
44422575|NCT03019185|79430598|FG000|Overall Study|Withdrawal by Subject|1|||
44422576|NCT03019185|79430599|FG001|Overall Study|Withdrawal by Subject|1|||
44422577|NCT03019185|79430600|FG002|Overall Study|Withdrawal by Subject|0|||
44422578|NCT03019185|79430598|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
44422579|NCT03019185|79430599|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
44422580|NCT03019185|79430600|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
44422581|NCT03019185|79430598|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
44422582|NCT03019185|79430599|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
44422583|NCT03019185|79430600|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
44422584|NCT02974621|79430610|FG000|Overall Study|Didn't receive study treatment|1|||
44422585|NCT02974621|79430611|FG001|Overall Study|Didn't receive study treatment|10|||
44422586|NCT02961881|79430622|FG000|Overall Study|Adverse Event|1|||
44422587|NCT02961881|79430623|FG001|Overall Study|Adverse Event|2|||
44422588|NCT02961881|79430624|FG002|Overall Study|Adverse Event|2|||
44422589|NCT02961881|79430625|FG003|Overall Study|Adverse Event|0|||
44422590|NCT02961881|79430626|FG004|Overall Study|Adverse Event|1|||
44422591|NCT02961881|79430622|FG000|Overall Study|Participant request|0|||
44422592|NCT02961881|79430623|FG001|Overall Study|Participant request|2|||
44422593|NCT02961881|79430624|FG002|Overall Study|Participant request|0|||
44422594|NCT02961881|79430625|FG003|Overall Study|Participant request|0|||
44422595|NCT02961881|79430626|FG004|Overall Study|Participant request|0|||
44422596|NCT02961881|79430622|FG000|Overall Study|Disease progression|1|||
44422597|NCT02961881|79430623|FG001|Overall Study|Disease progression|0|||
44422598|NCT02961881|79430624|FG002|Overall Study|Disease progression|1|||
44422599|NCT02961881|79430625|FG003|Overall Study|Disease progression|0|||
44422600|NCT02961881|79430626|FG004|Overall Study|Disease progression|0|||
44422601|NCT02891382|79430660|FG000|Overall Study|Lost to Follow-up|3|||
44422602|NCT02891382|79430661|FG001|Overall Study|Lost to Follow-up|4|||
44422603|NCT02891382|79430662|FG002|Overall Study|Lost to Follow-up|5|||
44422604|NCT02891382|79430663|FG003|Overall Study|Lost to Follow-up|3|||
44422605|NCT02891382|79430664|FG004|Overall Study|Lost to Follow-up|4|||
44422606|NCT02860039|79430674|FG000|Overall Study|Death|4|||
44422607|NCT02860039|79430675|FG001|Overall Study|Death|0|||
44422608|NCT02860039|79430674|FG000|Overall Study|Lost to Follow-up|2|||
44422609|NCT02860039|79430675|FG001|Overall Study|Lost to Follow-up|2|||
44422610|NCT02860039|79430674|FG000|Overall Study|Protocol Violation|3|||
44422611|NCT02860039|79430675|FG001|Overall Study|Protocol Violation|1|||
44422612|NCT02860039|79430674|FG000|Overall Study|Withdrawal by Subject|1|||
44422613|NCT02860039|79430675|FG001|Overall Study|Withdrawal by Subject|0|||
44422614|NCT02860039|79430674|FG000|Overall Study|Not otherwise eligible|1|||
44156444|NCT01968070|78947620|FG008|Period 1|Lost to Follow-up|0|||
44156445|NCT01968070|78947621|FG009|Period 1|Lost to Follow-up|0|||
44258303|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
44258304|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
44258305|NCT01421342|79113180|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
44258306|NCT01421342|79113181|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
44258307|NCT01421342|79113182|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
44258308|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
44258309|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
44258310|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
44258311|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
44258312|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
44258313|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
44325019|NCT00473382|79330242|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
44325020|NCT00473382|79330240|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
44325021|NCT00473382|79330241|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
44325022|NCT00473382|79330242|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
44325023|NCT00473265|79330268|FG000|Overall Study|Unrelated adverse event|5|||
44325024|NCT00473265|79330268|FG000|Overall Study|Off treatment early|15|||
44325025|NCT00472641|79330272|FG000|Overall Study|Lack of Efficacy|3|||
44325026|NCT00472641|79330272|FG000|Overall Study|Adverse Event|3|||
44325027|NCT00472641|79330272|FG000|Overall Study|Lost to Follow-up|1|||
44325028|NCT01133977|79330281|FG000|Overall Study|Adverse Event|0|||
44325029|NCT01133977|79330282|FG001|Overall Study|Adverse Event|0|||
44325030|NCT01133977|79330283|FG002|Overall Study|Adverse Event|1|||
44325031|NCT01133977|79330284|FG003|Overall Study|Adverse Event|0|||
44325032|NCT01133977|79330285|FG004|Overall Study|Adverse Event|0|||
44325033|NCT01133977|79330281|FG000|Overall Study|Death|1|||
44325034|NCT01133977|79330282|FG001|Overall Study|Death|1|||
44325035|NCT01133977|79330283|FG002|Overall Study|Death|1|||
44325036|NCT01133977|79330284|FG003|Overall Study|Death|7|||
44325037|NCT01133977|79330285|FG004|Overall Study|Death|3|||
44325038|NCT01133977|79330281|FG000|Overall Study|Started a New Line of Therapy|2|||
44325039|NCT01133977|79330282|FG001|Overall Study|Started a New Line of Therapy|6|||
44325040|NCT01133977|79330283|FG002|Overall Study|Started a New Line of Therapy|4|||
44325041|NCT01133977|79330284|FG003|Overall Study|Started a New Line of Therapy|25|||
44325042|NCT01133977|79330285|FG004|Overall Study|Started a New Line of Therapy|33|||
44325043|NCT01133977|79330281|FG000|Overall Study|Lost to Follow-up|0|||
44325044|NCT01133977|79330282|FG001|Overall Study|Lost to Follow-up|0|||
44325045|NCT01133977|79330283|FG002|Overall Study|Lost to Follow-up|0|||
44325046|NCT01133977|79330284|FG003|Overall Study|Lost to Follow-up|2|||
44325047|NCT01133977|79330285|FG004|Overall Study|Lost to Follow-up|1|||
44325048|NCT01133977|79330281|FG000|Overall Study|Withdrawal by Subject|0|||
44325049|NCT01133977|79330282|FG001|Overall Study|Withdrawal by Subject|0|||
44325050|NCT01133977|79330283|FG002|Overall Study|Withdrawal by Subject|0|||
44325051|NCT01133977|79330284|FG003|Overall Study|Withdrawal by Subject|5|||
44325052|NCT01133977|79330285|FG004|Overall Study|Withdrawal by Subject|1|||
44325053|NCT01133821|79330302|FG000|Overall Study|Lost to Follow-up|8|||
44325054|NCT01133821|79330303|FG001|Overall Study|Lost to Follow-up|11|||
44325055|NCT01133821|79330302|FG000|Overall Study|Withdrawal by Subject|8|||
44325056|NCT01133821|79330303|FG001|Overall Study|Withdrawal by Subject|3|||
44325057|NCT01133821|79330302|FG000|Overall Study|preferred other treatment|1|||
44325058|NCT01133821|79330303|FG001|Overall Study|preferred other treatment|1|||
44325059|NCT01133821|79330302|FG000|Overall Study|Protocol Violation|0|||
44325060|NCT01133821|79330303|FG001|Overall Study|Protocol Violation|1|||
44325061|NCT01133821|79330302|FG000|Overall Study|Refused participation|1|||
44325062|NCT01133821|79330303|FG001|Overall Study|Refused participation|3|||
44325063|NCT00472446|79330313|FG000|Overall Study|Protocol Violation|0|||
44325064|NCT00472446|79330314|FG001|Overall Study|Protocol Violation|0|||
44422615|NCT02860039|79430675|FG001|Overall Study|Not otherwise eligible|1|||
44422616|NCT02807636|79430684|FG000|Overall Study|Lost to Follow-up|9|||
44422617|NCT02807636|79430685|FG001|Overall Study|Lost to Follow-up|12|||
44422618|NCT02807636|79430686|FG002|Overall Study|Lost to Follow-up|6|||
44422619|NCT02807636|79430684|FG000|Overall Study|Protocol Deviation|2|||
44422620|NCT02807636|79430685|FG001|Overall Study|Protocol Deviation|0|||
44422621|NCT02807636|79430686|FG002|Overall Study|Protocol Deviation|0|||
44422622|NCT02807636|79430684|FG000|Overall Study|Symptomatic Deterioration|0|||
44422623|NCT02807636|79430685|FG001|Overall Study|Symptomatic Deterioration|1|||
44422624|NCT02807636|79430686|FG002|Overall Study|Symptomatic Deterioration|0|||
44422625|NCT02807636|79430684|FG000|Overall Study|Withdrawal by Subject|39|||
44422626|NCT02807636|79430685|FG001|Overall Study|Withdrawal by Subject|27|||
44422627|NCT02807636|79430686|FG002|Overall Study|Withdrawal by Subject|23|||
44422628|NCT02807636|79430684|FG000|Overall Study|Death|298|||
44325065|NCT00472446|79330315|FG002|Overall Study|Protocol Violation|0|||
44422629|NCT02807636|79430685|FG001|Overall Study|Death|327|||
44422630|NCT02807636|79430686|FG002|Overall Study|Death|266|||
44422631|NCT02807636|79430684|FG000|Overall Study|Ongoing in Study|52|||
44422632|NCT02807636|79430685|FG001|Overall Study|Ongoing in Study|84|||
44422633|NCT02807636|79430686|FG002|Overall Study|Ongoing in Study|67|||
44422634|NCT02654587|79430697|FG000|Overall Study|patient alive at end of study|22|||
44325066|NCT00472446|79330316|FG003|Overall Study|Protocol Violation|1|||
44325067|NCT00472446|79330313|FG000|Overall Study|Reintervention|0|||
44325068|NCT00472446|79330314|FG001|Overall Study|Reintervention|0|||
44325069|NCT00472446|79330315|FG002|Overall Study|Reintervention|1|||
44325070|NCT00472446|79330316|FG003|Overall Study|Reintervention|1|||
44325071|NCT00472446|79330313|FG000|Overall Study|Questionnaires not returned|5|||
44325072|NCT00472446|79330314|FG001|Overall Study|Questionnaires not returned|6|||
44325073|NCT00472446|79330315|FG002|Overall Study|Questionnaires not returned|6|||
44325074|NCT00472446|79330316|FG003|Overall Study|Questionnaires not returned|4|||
44325075|NCT00472290|79330326|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
44325076|NCT00472290|79330326|FG000|Overall Study|Protocol Specified Criteria|7|||
44325077|NCT00472290|79330326|FG000|Overall Study|Administrative Decision|37|||
44325078|NCT00472290|79330326|FG000|Overall Study|Death|3|||
44325079|NCT00472290|79330326|FG000|Overall Study|Lost to Follow-up|1|||
44325080|NCT00472290|79330326|FG000|Overall Study|Lack of Efficacy|1|||
44325081|NCT00472290|79330326|FG000|Overall Study|Disease Progression|4|||
44325082|NCT00472290|79330326|FG000|Overall Study|Withdrawal by Subject|5|||
44325083|NCT00472290|79330326|FG000|Overall Study|Adverse Event|6|||
44325084|NCT00472290|79330326|FG000|Overall Study|Requirement for alternative therapy|7|||
44422635|NCT02654587|79430698|FG001|Overall Study|patient alive at end of study|8|||
44422636|NCT02654587|79430697|FG000|Overall Study|Withdrawal by Subject|1|||
44325085|NCT01133704|79330332|FG000|Overall Study|Death|44|||
44325086|NCT01133704|79330333|FG001|Overall Study|Death|26|||
44325087|NCT01133704|79330332|FG000|Overall Study|Patient refused to continue|4|||
44325088|NCT01133704|79330333|FG001|Overall Study|Patient refused to continue|0|||
44325089|NCT01133704|79330332|FG000|Overall Study|Study Closure|1|||
44325090|NCT01133704|79330333|FG001|Overall Study|Study Closure|0|||
44325091|NCT01133665|79330339|FG000|Overall Study|Physician Decision|2|||
44325092|NCT01133626|79330346|FG000|Overall Study|Adverse Event|0|||
44325093|NCT01133626|79330347|FG001|Overall Study|Adverse Event|1|||
44325094|NCT01133626|79330348|FG002|Overall Study|Adverse Event|0|||
44325095|NCT01133626|79330346|FG000|Overall Study|Withdrawal by Subject|1|||
44325096|NCT01133626|79330347|FG001|Overall Study|Withdrawal by Subject|2|||
44325097|NCT01133626|79330348|FG002|Overall Study|Withdrawal by Subject|2|||
44325098|NCT01133626|79330346|FG000|Overall Study|Other|0|||
44325099|NCT01133626|79330347|FG001|Overall Study|Other|2|||
44325100|NCT01133626|79330348|FG002|Overall Study|Other|0|||
44325101|NCT01133392|79330358|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
44325102|NCT01133392|79330359|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
44325103|NCT01133392|79330358|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
44325104|NCT01133392|79330359|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
44325105|NCT00471354|79330365|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
44325106|NCT00471354|79330365|FG000|Overall Study|Adverse Event|13|||
44325107|NCT00471354|79330365|FG000|Overall Study|Protocol Violation|12|||
44325108|NCT00471354|79330365|FG000|Overall Study|Withdrawal by Subject|1|||
44325109|NCT00471354|79330365|FG000|Overall Study|Physician Decision|4|||
44325110|NCT00471354|79330365|FG000|Overall Study|Sponsor Decision|1|||
44325111|NCT00471354|79330365|FG000|Overall Study|Lost to Follow-up|3|||
44325112|NCT00471354|79330365|FG000|Overall Study|Lack of Efficacy|5|||
44325113|NCT00471354|79330365|FG000|Overall Study|Patient/Caregiver Decision|12|||
44325114|NCT00471315|79330369|FG000|Overall Study|Adverse Event|7|||
44325115|NCT00471315|79330369|FG000|Overall Study|Withdrawal by Subject|1|||
44325116|NCT00471237|79330380|FG000|Overall Study|Adverse Event|6|||
44325117|NCT00471237|79330381|FG001|Overall Study|Adverse Event|5|||
44325118|NCT00471237|79330382|FG002|Overall Study|Adverse Event|4|||
44325119|NCT00471237|79330383|FG003|Overall Study|Adverse Event|8|||
44325120|NCT00471237|79330384|FG004|Overall Study|Adverse Event|7|||
44325121|NCT00471237|79330385|FG005|Overall Study|Adverse Event|5|||
44325122|NCT00471237|79330386|FG006|Overall Study|Adverse Event|0|||
44325123|NCT00471237|79330380|FG000|Overall Study|Lost to Follow-up|1|||
44325124|NCT00471237|79330381|FG001|Overall Study|Lost to Follow-up|1|||
44325125|NCT00471237|79330382|FG002|Overall Study|Lost to Follow-up|0|||
44422637|NCT02654587|79430698|FG001|Overall Study|Withdrawal by Subject|7|||
44422638|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
44422639|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
44422640|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
44422641|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
44422642|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
44422643|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
44156446|NCT01968070|78947622|FG010|Period 1|Lost to Follow-up|0|||
44156447|NCT01968070|78947623|FG011|Period 1|Lost to Follow-up|0|||
44325126|NCT00471237|79330383|FG003|Overall Study|Lost to Follow-up|2|||
44325127|NCT00471237|79330384|FG004|Overall Study|Lost to Follow-up|3|||
44422644|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
44422645|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
44422646|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
44156448|NCT01968070|78947624|FG012|Period 1|Lost to Follow-up|0|||
44156449|NCT01968070|78947625|FG013|Period 1|Lost to Follow-up|0|||
44156450|NCT01968070|78947626|FG014|Period 1|Lost to Follow-up|0|||
44156451|NCT01968070|78947627|FG015|Period 1|Lost to Follow-up|0|||
44156452|NCT01968070|78947628|FG016|Period 1|Lost to Follow-up|0|||
44156453|NCT01968070|78947629|FG017|Period 1|Lost to Follow-up|0|||
44156454|NCT01968070|78947612|FG000|Period 1|Adverse Event|0|||
44156455|NCT01968070|78947613|FG001|Period 1|Adverse Event|0|||
44325128|NCT00471237|79330385|FG005|Overall Study|Lost to Follow-up|0|||
44325129|NCT00471237|79330386|FG006|Overall Study|Lost to Follow-up|0|||
44325130|NCT00471237|79330380|FG000|Overall Study|Protocol Violation|3|||
44422647|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
44422648|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
44422649|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
44422650|NCT02288247|79430710|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
44422651|NCT02288247|79430711|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
44422652|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
44422653|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
44325131|NCT00471237|79330381|FG001|Overall Study|Protocol Violation|6|||
44325132|NCT00471237|79330382|FG002|Overall Study|Protocol Violation|3|||
44325133|NCT00471237|79330383|FG003|Overall Study|Protocol Violation|2|||
44325134|NCT00471237|79330384|FG004|Overall Study|Protocol Violation|2|||
44325135|NCT00471237|79330385|FG005|Overall Study|Protocol Violation|4|||
44325136|NCT00471237|79330386|FG006|Overall Study|Protocol Violation|1|||
44325137|NCT00471237|79330380|FG000|Overall Study|Withdrawal by Subject|8|||
44325138|NCT00471237|79330381|FG001|Overall Study|Withdrawal by Subject|6|||
44325139|NCT00471237|79330382|FG002|Overall Study|Withdrawal by Subject|5|||
44422654|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
44422655|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
44422656|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
44422657|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
44422658|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
44422659|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
44422660|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
44422661|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
44422662|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
44325140|NCT00471237|79330383|FG003|Overall Study|Withdrawal by Subject|8|||
44325141|NCT00471237|79330384|FG004|Overall Study|Withdrawal by Subject|7|||
44325142|NCT00471237|79330385|FG005|Overall Study|Withdrawal by Subject|4|||
44325143|NCT00471237|79330386|FG006|Overall Study|Withdrawal by Subject|2|||
44325144|NCT00471237|79330380|FG000|Overall Study|Sponsor terminated study|20|||
44325145|NCT00471237|79330381|FG001|Overall Study|Sponsor terminated study|23|||
44325146|NCT00471237|79330382|FG002|Overall Study|Sponsor terminated study|19|||
44325147|NCT00471237|79330383|FG003|Overall Study|Sponsor terminated study|22|||
44325148|NCT00471237|79330384|FG004|Overall Study|Sponsor terminated study|18|||
44325149|NCT00471237|79330385|FG005|Overall Study|Sponsor terminated study|24|||
44325150|NCT00471237|79330386|FG006|Overall Study|Sponsor terminated study|0|||
44325151|NCT00471237|79330380|FG000|Overall Study|Non-compliance|0|||
44325152|NCT00471237|79330381|FG001|Overall Study|Non-compliance|1|||
44325153|NCT00471237|79330382|FG002|Overall Study|Non-compliance|0|||
44325154|NCT00471237|79330383|FG003|Overall Study|Non-compliance|1|||
44325155|NCT00471237|79330384|FG004|Overall Study|Non-compliance|0|||
44325156|NCT00471237|79330385|FG005|Overall Study|Non-compliance|0|||
44325157|NCT00471237|79330386|FG006|Overall Study|Non-compliance|0|||
44325158|NCT00471237|79330380|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
44325159|NCT00471237|79330381|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
44325160|NCT00471237|79330382|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
44325161|NCT00471237|79330383|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
44325162|NCT00471237|79330384|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
44325163|NCT00471237|79330385|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
44325164|NCT00471237|79330386|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
44325165|NCT00471237|79330380|FG000|Overall Study|Early stopping due to non-efficacy|1|||
44325166|NCT00471237|79330381|FG001|Overall Study|Early stopping due to non-efficacy|0|||
44325167|NCT00471237|79330382|FG002|Overall Study|Early stopping due to non-efficacy|0|||
44325168|NCT00471237|79330383|FG003|Overall Study|Early stopping due to non-efficacy|0|||
44325169|NCT00471237|79330384|FG004|Overall Study|Early stopping due to non-efficacy|1|||
44325170|NCT00471237|79330385|FG005|Overall Study|Early stopping due to non-efficacy|0|||
44325171|NCT00471237|79330386|FG006|Overall Study|Early stopping due to non-efficacy|0|||
44325172|NCT00471237|79330380|FG000|Overall Study|Participant planned to travel to abraod|1|||
44325173|NCT00471237|79330381|FG001|Overall Study|Participant planned to travel to abraod|0|||
44422663|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
44536961|NCT03346434|79547653|FG003|Overall Study|Withdrawal by Subject|0|||
44156456|NCT01968070|78947614|FG002|Period 1|Adverse Event|0|||
44325174|NCT00471237|79330382|FG002|Overall Study|Participant planned to travel to abraod|0|||
44536962|NCT03346434|79547654|FG004|Overall Study|Withdrawal by Subject|1|||
44325175|NCT00471237|79330383|FG003|Overall Study|Participant planned to travel to abraod|0|||
44325176|NCT00471237|79330384|FG004|Overall Study|Participant planned to travel to abraod|0|||
44325177|NCT00471237|79330385|FG005|Overall Study|Participant planned to travel to abraod|1|||
44325178|NCT00471237|79330386|FG006|Overall Study|Participant planned to travel to abraod|0|||
44325179|NCT00471237|79330380|FG000|Overall Study|High parathyroid hormone|0|||
44325180|NCT00471237|79330381|FG001|Overall Study|High parathyroid hormone|0|||
44422664|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
44325181|NCT00471237|79330382|FG002|Overall Study|High parathyroid hormone|1|||
44325182|NCT00471237|79330383|FG003|Overall Study|High parathyroid hormone|0|||
44325183|NCT00471237|79330384|FG004|Overall Study|High parathyroid hormone|0|||
44325184|NCT00471237|79330385|FG005|Overall Study|High parathyroid hormone|0|||
44536963|NCT03346434|79547655|FG005|Overall Study|Withdrawal by Subject|0|||
44156457|NCT01968070|78947615|FG003|Period 1|Adverse Event|0|||
44156458|NCT01968070|78947616|FG004|Period 1|Adverse Event|0|||
44156459|NCT01968070|78947617|FG005|Period 1|Adverse Event|0|||
44325185|NCT00471237|79330386|FG006|Overall Study|High parathyroid hormone|0|||
44325186|NCT00471237|79330380|FG000|Overall Study|Participant lost medication|0|||
44536964|NCT03346434|79547650|FG000|Overall Study|Lost to Follow-up|0|||
44156460|NCT01968070|78947618|FG006|Period 1|Adverse Event|1|||
44156461|NCT01968070|78947619|FG007|Period 1|Adverse Event|0|||
44156462|NCT01968070|78947620|FG008|Period 1|Adverse Event|0|||
44156463|NCT01968070|78947621|FG009|Period 1|Adverse Event|0|||
44156464|NCT01968070|78947622|FG010|Period 1|Adverse Event|0|||
44156465|NCT01968070|78947623|FG011|Period 1|Adverse Event|0|||
44156466|NCT01968070|78947624|FG012|Period 1|Adverse Event|0|||
44156467|NCT01968070|78947625|FG013|Period 1|Adverse Event|0|||
44156468|NCT01968070|78947626|FG014|Period 1|Adverse Event|0|||
44156469|NCT01968070|78947627|FG015|Period 1|Adverse Event|0|||
44156470|NCT01968070|78947628|FG016|Period 1|Adverse Event|0|||
44325187|NCT00471237|79330381|FG001|Overall Study|Participant lost medication|0|||
44536965|NCT03346434|79547651|FG001|Overall Study|Lost to Follow-up|0|||
44536966|NCT03346434|79547652|FG002|Overall Study|Lost to Follow-up|0|||
44536967|NCT03346434|79547653|FG003|Overall Study|Lost to Follow-up|0|||
44536968|NCT03346434|79547654|FG004|Overall Study|Lost to Follow-up|1|||
44536969|NCT03346434|79547655|FG005|Overall Study|Lost to Follow-up|1|||
44536970|NCT03346434|79547650|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
44536971|NCT03346434|79547651|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
44536972|NCT03346434|79547652|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
44536973|NCT03346434|79547653|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
44536974|NCT03346434|79547654|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
44536975|NCT03346434|79547655|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
44536976|NCT03393000|79547673|FG000|Overall Study|Death|11|||
44536977|NCT03393000|79547673|FG000|Overall Study|Withdrawal by Subject|2|||
44536978|NCT03393000|79547673|FG000|Overall Study|Physician Decision|1|||
44156471|NCT01968070|78947629|FG017|Period 1|Adverse Event|0|||
44156472|NCT01968070|78947612|FG000|Period 1|Physician Decision|0|||
44156473|NCT01968070|78947613|FG001|Period 1|Physician Decision|0|||
44156474|NCT01968070|78947614|FG002|Period 1|Physician Decision|0|||
44156475|NCT01968070|78947615|FG003|Period 1|Physician Decision|0|||
44156476|NCT01968070|78947616|FG004|Period 1|Physician Decision|0|||
44156477|NCT01968070|78947617|FG005|Period 1|Physician Decision|0|||
44156478|NCT01968070|78947618|FG006|Period 1|Physician Decision|0|||
44156479|NCT01968070|78947619|FG007|Period 1|Physician Decision|0|||
44156480|NCT01968070|78947620|FG008|Period 1|Physician Decision|0|||
44156481|NCT01968070|78947621|FG009|Period 1|Physician Decision|0|||
44156482|NCT01968070|78947622|FG010|Period 1|Physician Decision|0|||
44156483|NCT01968070|78947623|FG011|Period 1|Physician Decision|1|||
44156484|NCT01968070|78947624|FG012|Period 1|Physician Decision|0|||
44156485|NCT01968070|78947625|FG013|Period 1|Physician Decision|0|||
44156486|NCT01968070|78947626|FG014|Period 1|Physician Decision|0|||
44422665|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
44422666|NCT02288247|79430710|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
44422667|NCT02288247|79430711|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
44422668|NCT02283177|79430721|FG000|Overall Study|Withdrawal by Subject|1|||
44422669|NCT02283177|79430722|FG001|Overall Study|Withdrawal by Subject|1|||
44422670|NCT02259231|79430736|FG000|Overall Study|Adverse Event|1|||
44422671|NCT02259231|79430737|FG001|Overall Study|Adverse Event|1|||
44422672|NCT02259231|79430738|FG002|Overall Study|Adverse Event|2|||
44156487|NCT01968070|78947627|FG015|Period 1|Physician Decision|0|||
44156488|NCT01968070|78947628|FG016|Period 1|Physician Decision|0|||
44156489|NCT01968070|78947629|FG017|Period 1|Physician Decision|0|||
44156490|NCT01968070|78947612|FG000|Period 2|Withdrawal by Subject|0|||
44325188|NCT00471237|79330382|FG002|Overall Study|Participant lost medication|0|||
44325189|NCT00471237|79330383|FG003|Overall Study|Participant lost medication|0|||
44325190|NCT00471237|79330384|FG004|Overall Study|Participant lost medication|1|||
44325191|NCT00471237|79330385|FG005|Overall Study|Participant lost medication|0|||
44325192|NCT00471237|79330386|FG006|Overall Study|Participant lost medication|0|||
44325193|NCT00471237|79330380|FG000|Overall Study|Administration of prohibited medicine|0|||
44325194|NCT00471237|79330381|FG001|Overall Study|Administration of prohibited medicine|0|||
44325195|NCT00471237|79330382|FG002|Overall Study|Administration of prohibited medicine|0|||
44325196|NCT00471237|79330383|FG003|Overall Study|Administration of prohibited medicine|0|||
44325197|NCT00471237|79330384|FG004|Overall Study|Administration of prohibited medicine|1|||
44325198|NCT00471237|79330385|FG005|Overall Study|Administration of prohibited medicine|0|||
44325199|NCT00471237|79330386|FG006|Overall Study|Administration of prohibited medicine|0|||
44325200|NCT00471237|79330380|FG000|Overall Study|Participant shifted residence|0|||
44325201|NCT00471237|79330381|FG001|Overall Study|Participant shifted residence|0|||
44325202|NCT00471237|79330382|FG002|Overall Study|Participant shifted residence|0|||
44325203|NCT00471237|79330383|FG003|Overall Study|Participant shifted residence|0|||
44325204|NCT00471237|79330384|FG004|Overall Study|Participant shifted residence|1|||
44325205|NCT00471237|79330385|FG005|Overall Study|Participant shifted residence|0|||
44325206|NCT00471237|79330386|FG006|Overall Study|Participant shifted residence|0|||
44325207|NCT00471237|79330380|FG000|Overall Study|Participant's decision|0|||
44325208|NCT00471237|79330381|FG001|Overall Study|Participant's decision|0|||
44325209|NCT00471237|79330382|FG002|Overall Study|Participant's decision|0|||
44325210|NCT00471237|79330383|FG003|Overall Study|Participant's decision|0|||
44325211|NCT00471237|79330384|FG004|Overall Study|Participant's decision|0|||
44325212|NCT00471237|79330385|FG005|Overall Study|Participant's decision|1|||
44325213|NCT00471237|79330386|FG006|Overall Study|Participant's decision|0|||
44325214|NCT00471081|79330408|FG000|Active Phase|Protocol Violation|1|||
44422673|NCT02259231|79430739|FG003|Overall Study|Adverse Event|0|||
44536979|NCT03370770|79547677|FG000|Overall Study|Patient was followed in another hospital center|1|||
44536980|NCT03370770|79547677|FG000|Overall Study|Progressive Disease|98|||
44536981|NCT03370770|79547677|FG000|Overall Study|Adverse Event|2|||
44536982|NCT03370770|79547677|FG000|Overall Study|Death|5|||
44536983|NCT03473301|79547684|FG000|Overall Study|Protocol Violation|4|||
44536984|NCT03473301|79547685|FG001|Overall Study|Protocol Violation|0|||
44536985|NCT03473301|79547686|FG002|Overall Study|Protocol Violation|0|||
44536986|NCT03473301|79547684|FG000|Overall Study|Withdrawal by Subject|0|||
44536987|NCT03473301|79547685|FG001|Overall Study|Withdrawal by Subject|1|||
44536988|NCT03473301|79547686|FG002|Overall Study|Withdrawal by Subject|0|||
44422674|NCT02259231|79430740|FG004|Overall Study|Adverse Event|0|||
44422675|NCT02259231|79430741|FG005|Overall Study|Adverse Event|0|||
44422676|NCT02259231|79430742|FG006|Overall Study|Adverse Event|0|||
44536989|NCT03473301|79547684|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
44536990|NCT03473301|79547685|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
44536991|NCT03473301|79547686|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
44156491|NCT01968070|78947613|FG001|Period 2|Withdrawal by Subject|0|||
44156492|NCT01968070|78947614|FG002|Period 2|Withdrawal by Subject|0|||
44156493|NCT01968070|78947615|FG003|Period 2|Withdrawal by Subject|0|||
44156494|NCT01968070|78947616|FG004|Period 2|Withdrawal by Subject|1|||
44325215|NCT00471081|79330409|FG001|Active Phase|Protocol Violation|1|||
44325216|NCT00471081|79330408|FG000|Active Phase|Withdrawal by Subject|0|||
44422677|NCT02259231|79430736|FG000|Overall Study|Progressive Disease|4|||
44325217|NCT00471081|79330409|FG001|Active Phase|Withdrawal by Subject|3|||
44325218|NCT00471081|79330408|FG000|Active Phase|Lost to Follow-up|0|||
44325219|NCT00471081|79330409|FG001|Active Phase|Lost to Follow-up|1|||
44325220|NCT00471081|79330408|FG000|Active Phase|Lost health plan/insurance|1|||
44325221|NCT00471081|79330409|FG001|Active Phase|Lost health plan/insurance|8|||
44325222|NCT00471081|79330408|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
44325223|NCT00471081|79330409|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
44325224|NCT00471081|79330408|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
44325225|NCT00471081|79330409|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
44325226|NCT00471081|79330408|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
44325227|NCT00471081|79330409|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
44325228|NCT00470847|79330416|FG000|Overall Study|Pt still receiving treatment|1|||
44325229|NCT00470535|79330422|FG000|Overall Study|Disease Progression|13|||
44325230|NCT00470535|79330422|FG000|Overall Study|Withdrawal by Subject|1|||
44325231|NCT00470535|79330422|FG000|Overall Study|Adverse Event|1|||
44325232|NCT00470535|79330422|FG000|Overall Study|Death|1|||
44325233|NCT00470535|79330422|FG000|Overall Study|Other|2|||
44325234|NCT00470418|79330428|FG000|Overall Study|Withdrawal by Subject|1|||
44325235|NCT00470418|79330429|FG001|Overall Study|Withdrawal by Subject|0|||
44325236|NCT01133275|79330435|FG000|Overall Study|Withdrawal by Subject|1|||
44325237|NCT01133275|79330435|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
44325238|NCT00470184|79330439|FG000|Overall Study|Not Treated(became ineligible)|4|||
44325239|NCT00470184|79330439|FG000|Overall Study|Not treated (other)|1|||
44325240|NCT00470184|79330439|FG000|Overall Study|disease Progression|4|||
44325241|NCT00470184|79330439|FG000|Overall Study|Adverse Event|3|||
44325242|NCT00470184|79330439|FG000|Overall Study|Withdrawal by Subject|4|||
44325243|NCT00470184|79330439|FG000|Overall Study|other|5|||
44325244|NCT00470184|79330439|FG000|Overall Study|recurrence|1|||
44325245|NCT00470067|79330444|FG000|Overall Study|Death|1|||
44325246|NCT00470067|79330444|FG000|Overall Study|Disease Progression|6|||
44325247|NCT00475020|79330448|FG000|Overall Study|Physician Decision|3|||
44325248|NCT00475020|79330448|FG000|Overall Study|Insurance Denial|1|||
44325249|NCT00475020|79330448|FG000|Overall Study|Donor not able to donate the last minute|1|||
44325250|NCT02484456|79330454|FG000|Washout Period|Withdrawal by Subject|0|||
44325251|NCT02484456|79330455|FG001|Washout Period|Withdrawal by Subject|1|||
44325252|NCT02484456|79330454|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
44325253|NCT02484456|79330455|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
44325254|NCT02484456|79330454|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
44325255|NCT02484456|79330455|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
44325256|NCT02484456|79330454|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
44325257|NCT02484456|79330455|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
44422678|NCT02259231|79430737|FG001|Overall Study|Progressive Disease|5|||
44536992|NCT03390426|79547698|FG000|Overall Study|Protocol Violation|0|||
44325258|NCT01132807|79330462|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
44325259|NCT01132807|79330463|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
44325260|NCT01132807|79330464|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
44325261|NCT01132807|79330462|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
44325262|NCT01132807|79330463|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
44325263|NCT01132807|79330464|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
44325264|NCT01132651|79330474|FG000|Overall Study|Lost to Follow-up|1|||
44325265|NCT01132651|79330475|FG001|Overall Study|Lost to Follow-up|1|||
44325266|NCT01089543|79330485|FG000|Overall Study|Withdrawal by Subject|2|||
44325267|NCT01089543|79330486|FG001|Overall Study|Withdrawal by Subject|3|||
44325268|NCT01089543|79330487|FG002|Overall Study|Withdrawal by Subject|3|||
44422679|NCT02259231|79430738|FG002|Overall Study|Progressive Disease|4|||
44422680|NCT02259231|79430739|FG003|Overall Study|Progressive Disease|5|||
44422681|NCT02259231|79430740|FG004|Overall Study|Progressive Disease|4|||
44422682|NCT02259231|79430741|FG005|Overall Study|Progressive Disease|5|||
44422683|NCT02259231|79430742|FG006|Overall Study|Progressive Disease|4|||
44422684|NCT02259231|79430736|FG000|Overall Study|Sponsor termination of study|1|||
44422685|NCT02259231|79430737|FG001|Overall Study|Sponsor termination of study|0|||
44422686|NCT02259231|79430738|FG002|Overall Study|Sponsor termination of study|0|||
44422687|NCT02259231|79430739|FG003|Overall Study|Sponsor termination of study|1|||
44422688|NCT02259231|79430740|FG004|Overall Study|Sponsor termination of study|2|||
44422689|NCT02259231|79430741|FG005|Overall Study|Sponsor termination of study|1|||
44422690|NCT02259231|79430742|FG006|Overall Study|Sponsor termination of study|1|||
44325269|NCT01089543|79330488|FG003|Overall Study|Withdrawal by Subject|1|||
44325270|NCT01089543|79330485|FG000|Overall Study|Physician Decision|1|||
44325271|NCT01089543|79330486|FG001|Overall Study|Physician Decision|0|||
44536993|NCT03390426|79547699|FG001|Overall Study|Protocol Violation|1|||
44325272|NCT01089543|79330487|FG002|Overall Study|Physician Decision|0|||
44325273|NCT01089543|79330488|FG003|Overall Study|Physician Decision|1|||
44325274|NCT01089543|79330485|FG000|Overall Study|Adverse Event|0|||
44422691|NCT02062827|79430770|FG000|Overall Study|Death|1|||
44422692|NCT02062827|79430771|FG001|Overall Study|Death|0|||
44422693|NCT02062827|79430772|FG002|Overall Study|Death|0|||
44325275|NCT01089543|79330486|FG001|Overall Study|Adverse Event|1|||
44325276|NCT01089543|79330487|FG002|Overall Study|Adverse Event|0|||
44325277|NCT01089543|79330488|FG003|Overall Study|Adverse Event|0|||
44422694|NCT02062827|79430773|FG003|Overall Study|Death|0|||
44422695|NCT02062827|79430774|FG004|Overall Study|Death|0|||
44422696|NCT02062827|79430775|FG005|Overall Study|Death|0|||
44325278|NCT01089504|79330500|FG000|Overall Study|Lost to Follow-up|1|||
44325279|NCT01089504|79330501|FG001|Overall Study|Lost to Follow-up|1|||
44325280|NCT01089504|79330500|FG000|Overall Study|Withdrawal by Subject|2|||
44325281|NCT01089504|79330501|FG001|Overall Study|Withdrawal by Subject|0|||
44325282|NCT01088997|79330509|FG000|Overall Study|Physician Decision|1|||
44325283|NCT01088997|79330510|FG001|Overall Study|Physician Decision|1|||
44325284|NCT01088997|79330509|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
44325285|NCT01088997|79330510|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
44325286|NCT01088997|79330509|FG000|Overall Study|Excluded prior to receiving drug|1|||
44325287|NCT01088997|79330510|FG001|Overall Study|Excluded prior to receiving drug|1|||
44325288|NCT01088529|79330521|FG000|Overall Study|Did not receive study treatment|0|||
44325289|NCT01088529|79330522|FG001|Overall Study|Did not receive study treatment|1|||
44422697|NCT02062827|79430776|FG006|Overall Study|Death|0|||
44422698|NCT02062827|79430777|FG007|Overall Study|Death|0|||
44422699|NCT02062827|79430770|FG000|Overall Study|Withdrawal by Subject|3|||
44422700|NCT02062827|79430771|FG001|Overall Study|Withdrawal by Subject|1|||
44422701|NCT02062827|79430772|FG002|Overall Study|Withdrawal by Subject|1|||
44422702|NCT02062827|79430773|FG003|Overall Study|Withdrawal by Subject|2|||
44422703|NCT02062827|79430774|FG004|Overall Study|Withdrawal by Subject|6|||
44422704|NCT02062827|79430775|FG005|Overall Study|Withdrawal by Subject|0|||
44422705|NCT02062827|79430776|FG006|Overall Study|Withdrawal by Subject|5|||
44422706|NCT02062827|79430777|FG007|Overall Study|Withdrawal by Subject|0|||
44422707|NCT02062827|79430770|FG000|Overall Study|Screen Fail|0|||
44422708|NCT02062827|79430771|FG001|Overall Study|Screen Fail|0|||
44422709|NCT02062827|79430772|FG002|Overall Study|Screen Fail|0|||
44422710|NCT02062827|79430773|FG003|Overall Study|Screen Fail|0|||
44422711|NCT02062827|79430774|FG004|Overall Study|Screen Fail|0|||
44422712|NCT02062827|79430775|FG005|Overall Study|Screen Fail|0|||
44422713|NCT02062827|79430776|FG006|Overall Study|Screen Fail|0|||
44422714|NCT02062827|79430777|FG007|Overall Study|Screen Fail|8|||
44422715|NCT01467427|79430810|FG000|Overall Study|Withdrawal by Subject|1|||
44422716|NCT01467427|79430811|FG001|Overall Study|Withdrawal by Subject|0|||
44422717|NCT01467427|79430810|FG000|Overall Study|Entered extension phase|11|||
44422718|NCT01467427|79430811|FG001|Overall Study|Entered extension phase|11|||
44422719|NCT01467427|79430810|FG000|Overall Study|Not continuing in extension phase|0|||
44422720|NCT01467427|79430811|FG001|Overall Study|Not continuing in extension phase|2|||
44422721|NCT00750152|79430819|FG000|Overall Study|Adverse Event|2|||
44422722|NCT00750152|79430820|FG001|Overall Study|Adverse Event|1|||
44325290|NCT01087944|79330528|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
44325291|NCT01087944|79330529|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
44325292|NCT01087944|79330528|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
44325293|NCT01087944|79330529|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
44325294|NCT01132612|79330538|FG000|Overall Study|Death|0|||
44325295|NCT01132612|79330539|FG001|Overall Study|Death|0|||
44422723|NCT00750152|79430819|FG000|Overall Study|Lost to Follow-up|8|||
44325296|NCT01132612|79330540|FG002|Overall Study|Death|1|||
44325297|NCT01132612|79330538|FG000|Overall Study|Protocol deviation|0|||
44325298|NCT01132612|79330539|FG001|Overall Study|Protocol deviation|0|||
44325299|NCT01132612|79330540|FG002|Overall Study|Protocol deviation|3|||
44325300|NCT01132612|79330538|FG000|Overall Study|Lost to Follow-up|2|||
44325301|NCT01132612|79330539|FG001|Overall Study|Lost to Follow-up|2|||
44325302|NCT01132612|79330540|FG002|Overall Study|Lost to Follow-up|7|||
44325303|NCT01132612|79330538|FG000|Overall Study|Adverse Event|5|||
44325304|NCT01132612|79330539|FG001|Overall Study|Adverse Event|2|||
44422724|NCT00750152|79430820|FG001|Overall Study|Lost to Follow-up|13|||
44422725|NCT00750152|79430819|FG000|Overall Study|Withdrawal by Subject|3|||
44422726|NCT00750152|79430820|FG001|Overall Study|Withdrawal by Subject|3|||
44422727|NCT00750152|79430819|FG000|Overall Study|Physician Decision|1|||
44422728|NCT00750152|79430820|FG001|Overall Study|Physician Decision|1|||
44422729|NCT00750152|79430819|FG000|Overall Study|Non-compliance|0|||
44422730|NCT00750152|79430820|FG001|Overall Study|Non-compliance|1|||
44325305|NCT01132612|79330540|FG002|Overall Study|Adverse Event|15|||
44325306|NCT01132612|79330538|FG000|Overall Study|Withdrawal by Subject|5|||
44325307|NCT01132612|79330539|FG001|Overall Study|Withdrawal by Subject|8|||
44325308|NCT01132612|79330540|FG002|Overall Study|Withdrawal by Subject|19|||
44422731|NCT00750152|79430819|FG000|Overall Study|Termination by sponsor|1|||
44422732|NCT00750152|79430820|FG001|Overall Study|Termination by sponsor|0|||
44422733|NCT00750152|79430819|FG000|Overall Study|Other|7|||
44422734|NCT00750152|79430820|FG001|Overall Study|Other|8|||
44536994|NCT03472521|79547707|FG000|Overall Study|Lost to Follow-up|3|||
44536995|NCT03472521|79547708|FG001|Overall Study|Lost to Follow-up|2|||
44325309|NCT01132612|79330538|FG000|Overall Study|Administrative problems|5|||
44325310|NCT01132612|79330539|FG001|Overall Study|Administrative problems|1|||
44325311|NCT01132612|79330540|FG002|Overall Study|Administrative problems|52|||
44422735|NCT00749996|79430828|FG000|Overall Study|Lost to Follow-up|7|||
44422736|NCT00749996|79430829|FG001|Overall Study|Lost to Follow-up|4|||
44325312|NCT01132612|79330538|FG000|Overall Study|Lack of Efficacy|23|||
44325313|NCT01132612|79330539|FG001|Overall Study|Lack of Efficacy|22|||
44325314|NCT01132612|79330540|FG002|Overall Study|Lack of Efficacy|73|||
44325315|NCT01132495|79330552|FG000|Overall Study|Various reasons|40|||
44325316|NCT01132495|79330553|FG001|Overall Study|Various reasons|38|||
44325317|NCT01132495|79330554|FG002|Overall Study|Various reasons|20|||
44325318|NCT01132495|79330555|FG003|Overall Study|Various reasons|12|||
44325319|NCT01087905|79330574|FG000|Overall Study|Lost to Follow-up|24|||
44325320|NCT01087905|79330575|FG001|Overall Study|Lost to Follow-up|28|||
44325321|NCT01087905|79330576|FG002|Overall Study|Lost to Follow-up|18|||
44325322|NCT01087905|79330577|FG003|Overall Study|Lost to Follow-up|31|||
44325323|NCT01087905|79330578|FG004|Overall Study|Lost to Follow-up|27|||
44325324|NCT01087905|79330579|FG005|Overall Study|Lost to Follow-up|25|||
44325325|NCT01087905|79330580|FG006|Overall Study|Lost to Follow-up|20|||
44325326|NCT01087905|79330581|FG007|Overall Study|Lost to Follow-up|24|||
44325327|NCT01087905|79330574|FG000|Overall Study|Withdrawal by Subject|5|||
44325328|NCT01087905|79330575|FG001|Overall Study|Withdrawal by Subject|4|||
44422737|NCT00749996|79430828|FG000|Overall Study|Withdrawal by Subject|5|||
44422738|NCT00749996|79430829|FG001|Overall Study|Withdrawal by Subject|4|||
44422739|NCT00749996|79430828|FG000|Overall Study|Protocol Violation|2|||
44422740|NCT00749996|79430829|FG001|Overall Study|Protocol Violation|3|||
44422741|NCT00749996|79430828|FG000|Overall Study|Physician Decision|2|||
44422742|NCT00749996|79430829|FG001|Overall Study|Physician Decision|0|||
44422743|NCT00749996|79430828|FG000|Overall Study|Pregnancy|0|||
44422744|NCT00749996|79430829|FG001|Overall Study|Pregnancy|2|||
44422745|NCT00749996|79430828|FG000|Overall Study|Adverse Event|1|||
44422746|NCT00749996|79430829|FG001|Overall Study|Adverse Event|0|||
44422747|NCT00749996|79430828|FG000|Overall Study|Death|1|||
44422748|NCT00749996|79430829|FG001|Overall Study|Death|0|||
44422749|NCT00749684|79430835|FG000|Overall Study|Death|1|||
44422750|NCT00749684|79430835|FG000|Overall Study|Adverse Event|27|||
44422751|NCT00749684|79430835|FG000|Overall Study|Participant's Wish|10|||
44422752|NCT00749684|79430835|FG000|Overall Study|Not Documented|1|||
44422753|NCT00749684|79430835|FG000|Overall Study|Progressive Desease|31|||
44258314|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
44422754|NCT00749684|79430835|FG000|Overall Study|Therapy according to protocol + AE|2|||
44422755|NCT00749684|79430835|FG000|Overall Study|AE+discontinuation on participants wish|1|||
44422756|NCT00749684|79430835|FG000|Overall Study|Missing|9|||
44422757|NCT00746798|79430843|FG000|Overall Study|Protocol Violation|0|||
44258315|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
44156495|NCT01968070|78947617|FG005|Period 2|Withdrawal by Subject|0|||
44156496|NCT01968070|78947618|FG006|Period 2|Withdrawal by Subject|0|||
44156497|NCT01968070|78947619|FG007|Period 2|Withdrawal by Subject|0|||
44156498|NCT01968070|78947620|FG008|Period 2|Withdrawal by Subject|0|||
44156499|NCT01968070|78947621|FG009|Period 2|Withdrawal by Subject|0|||
44156500|NCT01968070|78947622|FG010|Period 2|Withdrawal by Subject|0|||
44156501|NCT01968070|78947623|FG011|Period 2|Withdrawal by Subject|0|||
44258316|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
44258317|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
44258318|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
44258319|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
44258320|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
44258321|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
44258322|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
44258323|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
44258324|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
44258325|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
44325329|NCT01087905|79330576|FG002|Overall Study|Withdrawal by Subject|4|||
44325330|NCT01087905|79330577|FG003|Overall Study|Withdrawal by Subject|5|||
44325331|NCT01087905|79330578|FG004|Overall Study|Withdrawal by Subject|4|||
44156502|NCT01968070|78947624|FG012|Period 2|Withdrawal by Subject|0|||
44156503|NCT01968070|78947625|FG013|Period 2|Withdrawal by Subject|0|||
44325332|NCT01087905|79330579|FG005|Overall Study|Withdrawal by Subject|3|||
44325333|NCT01087905|79330580|FG006|Overall Study|Withdrawal by Subject|3|||
44325334|NCT01087905|79330581|FG007|Overall Study|Withdrawal by Subject|5|||
44325335|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
44325336|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
44325337|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
44325338|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
44325339|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
44325340|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
44325341|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
44422758|NCT00746798|79430844|FG001|Overall Study|Protocol Violation|1|||
44422759|NCT00746798|79430845|FG002|Overall Study|Protocol Violation|0|||
44422760|NCT00746798|79430846|FG003|Overall Study|Protocol Violation|0|||
44422761|NCT00746798|79430843|FG000|Overall Study|Withdrawal by Subject|0|||
44422762|NCT00746798|79430844|FG001|Overall Study|Withdrawal by Subject|1|||
44422763|NCT00746798|79430845|FG002|Overall Study|Withdrawal by Subject|1|||
44422764|NCT00746798|79430846|FG003|Overall Study|Withdrawal by Subject|0|||
44422765|NCT00746798|79430843|FG000|Overall Study|Death|0|||
44422766|NCT00746798|79430844|FG001|Overall Study|Death|0|||
44422767|NCT00746798|79430845|FG002|Overall Study|Death|2|||
44422768|NCT00746798|79430846|FG003|Overall Study|Death|0|||
44422769|NCT00746798|79430843|FG000|Overall Study|Participant unable to return for visit|1|||
44422770|NCT00746798|79430844|FG001|Overall Study|Participant unable to return for visit|0|||
44422771|NCT00746798|79430845|FG002|Overall Study|Participant unable to return for visit|0|||
44422772|NCT00746798|79430846|FG003|Overall Study|Participant unable to return for visit|0|||
44422773|NCT00716274|79430859|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
44422774|NCT00716274|79430860|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
44156504|NCT01968070|78947626|FG014|Period 2|Withdrawal by Subject|0|||
44156505|NCT01968070|78947627|FG015|Period 2|Withdrawal by Subject|0|||
44156506|NCT01968070|78947628|FG016|Period 2|Withdrawal by Subject|0|||
44156507|NCT01968070|78947629|FG017|Period 2|Withdrawal by Subject|0|||
44156508|NCT01918774|78947667|FG000|Overall Study|Lost prior to first CBTw session|4|||
44156509|NCT01918774|78947667|FG000|Overall Study|Lost to Follow-up|1|||
44258326|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
44258327|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
44258328|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
44258329|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
44258330|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
44258331|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
44258332|NCT01421342|79113180|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
44258333|NCT01421342|79113181|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
44258334|NCT01421342|79113182|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
44258335|NCT01384760|79113205|FG000|Overall Study|Lost to Follow-up|0|||
44258336|NCT01384760|79113206|FG001|Overall Study|Lost to Follow-up|6|||
44258337|NCT01384760|79113205|FG000|Overall Study|Protocol Violation|16|||
44258338|NCT01384760|79113206|FG001|Overall Study|Protocol Violation|0|||
44258339|NCT01384292|79113246|FG000|Part B|Severe non-compliance to protocol|1|||
44258340|NCT01384292|79113247|FG001|Part B|Severe non-compliance to protocol|0|||
44258341|NCT01384292|79113248|FG002|Part B|Severe non-compliance to protocol|0|||
44258342|NCT01401452|79113258|FG000|Overall Study|Adverse reaction|9|||
44258343|NCT01401452|79113258|FG000|Overall Study|Lost to Follow-up|12|||
44258344|NCT01401452|79113258|FG000|Overall Study|Lack of Efficacy|30|||
44258345|NCT01401452|79113258|FG000|Overall Study|Participant developed breast cancer|1|||
44258346|NCT01401452|79113258|FG000|Overall Study|Tx stopped due to financial reasons|1|||
44258347|NCT01401452|79113258|FG000|Overall Study|Tx stopped by psychiatrist|1|||
44258348|NCT01401452|79113258|FG000|Overall Study|No more visits within the 36 wk followup|4|||
44258349|NCT01401452|79113258|FG000|Overall Study|Subject did not come to follow up visits|2|||
44258350|NCT01401452|79113258|FG000|Overall Study|Subject didn't return for routine visits|1|||
44258351|NCT01401452|79113258|FG000|Overall Study|Subject moved to another city|1|||
44258352|NCT01401452|79113258|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
44258353|NCT01401452|79113258|FG000|Overall Study|Psoriatic arthritis|1|||
44258354|NCT01401452|79113258|FG000|Overall Study|Participant stopped Tx|2|||
44258355|NCT01401452|79113258|FG000|Overall Study|Discontinuation for personal reasons|1|||
44258356|NCT01401452|79113258|FG000|Overall Study|Treatment failure|1|||
44258357|NCT01401452|79113258|FG000|Overall Study|Unsatisfactory output|1|||
44258358|NCT01401452|79113258|FG000|Overall Study|Subject withdrew because of Tx success|1|||
44325342|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
44422775|NCT00716274|79430861|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
44258359|NCT01401452|79113258|FG000|Overall Study|Subject chose to discontinue treatment|1|||
44258360|NCT01401452|79113258|FG000|Overall Study|Participant withdrew consent|1|||
44258361|NCT01401062|79113293|FG000|Overall Study|Death|9|||
44325343|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
44325344|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
44325345|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
44325346|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
44325347|NCT01087788|79330600|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
44325348|NCT01087788|79330601|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
44325349|NCT01087788|79330602|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
44325350|NCT01087788|79330600|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
44325351|NCT01087788|79330601|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
44325352|NCT01087788|79330602|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
44325353|NCT01087788|79330600|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
44422776|NCT00716274|79430862|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
44422777|NCT00716274|79430863|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
44422778|NCT00716274|79430864|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
44422779|NCT00716274|79430859|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
44325354|NCT01087788|79330601|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
44325355|NCT01087788|79330602|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
44325356|NCT01087788|79330600|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
44422780|NCT00716274|79430860|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
44422781|NCT00716274|79430861|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
44422782|NCT00716274|79430862|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
44422783|NCT00716274|79430863|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
44422784|NCT00716274|79430864|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
44258362|NCT01401062|79113294|FG001|Overall Study|Death|7|||
44258363|NCT01401062|79113293|FG000|Overall Study|Physician Decision|1|||
44325357|NCT01087788|79330601|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
44325358|NCT01087788|79330602|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
44325359|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
44325360|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
44325361|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
44325362|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
44422785|NCT00716274|79430859|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
44422786|NCT00716274|79430860|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
44422787|NCT00716274|79430861|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
44422788|NCT00716274|79430862|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
44258364|NCT01401062|79113294|FG001|Overall Study|Physician Decision|0|||
44258365|NCT01401062|79113293|FG000|Overall Study|Withdrawal by Subject|1|||
44258366|NCT01401062|79113294|FG001|Overall Study|Withdrawal by Subject|1|||
44258367|NCT01400516|79113327|FG000|Primary Trial|Withdrawal by Subject|0|||
44258368|NCT01400516|79113328|FG001|Primary Trial|Withdrawal by Subject|2|||
44258369|NCT01383356|79113334|FG000|Period 1|Adverse Event|5|||
44258370|NCT01383356|79113335|FG001|Period 1|Adverse Event|3|||
44258371|NCT01383356|79113334|FG000|Period 1|Non-compliance|3|||
44258372|NCT01383356|79113335|FG001|Period 1|Non-compliance|0|||
44258373|NCT01383356|79113334|FG000|Period 1|Out of Range Mid-study-Test|0|||
44258374|NCT01383356|79113335|FG001|Period 1|Out of Range Mid-study-Test|1|||
44258375|NCT01383356|79113334|FG000|Period 1|Personal|0|||
44258376|NCT01383356|79113335|FG001|Period 1|Personal|2|||
44258377|NCT05740098|79113361|FG000|Overall Study|Lost to Follow-up|26|||
44258378|NCT05740098|79113362|FG001|Overall Study|Lost to Follow-up|17|||
44258379|NCT05740098|79113363|FG002|Overall Study|Lost to Follow-up|21|||
44258380|NCT05059080|79113374|FG000|Overall Study|Withdrawal by Subject|3|||
44258381|NCT05059080|79113374|FG000|Overall Study|Study Terminated by Sponsor|64|||
44258382|NCT05012163|79113382|FG000|Overall Study|Protocol Violation|0|||
44258383|NCT05012163|79113383|FG001|Overall Study|Protocol Violation|0|||
44258384|NCT05012163|79113384|FG002|Overall Study|Protocol Violation|1|||
44258385|NCT05012163|79113385|FG003|Overall Study|Protocol Violation|1|||
44258386|NCT05009251|79113400|FG000|Overall Study|Protocol Violation|100|||
44258387|NCT05009251|79113401|FG001|Overall Study|Protocol Violation|105|||
44258388|NCT05009251|79113402|FG002|Overall Study|Protocol Violation|119|||
44258389|NCT05009251|79113403|FG003|Overall Study|Protocol Violation|120|||
44258390|NCT05009251|79113404|FG004|Overall Study|Protocol Violation|119|||
44258391|NCT05009251|79113400|FG000|Overall Study|Death|25|||
44258392|NCT05009251|79113401|FG001|Overall Study|Death|22|||
44258393|NCT05009251|79113402|FG002|Overall Study|Death|24|||
44258394|NCT05009251|79113403|FG003|Overall Study|Death|19|||
44258395|NCT05009251|79113404|FG004|Overall Study|Death|15|||
44422789|NCT00716274|79430863|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
44258396|NCT04839692|79113418|FG000|Overall Study|Withdrawal by Subject|0|||
44258397|NCT04839692|79113419|FG001|Overall Study|Withdrawal by Subject|3|||
44258398|NCT04839692|79113418|FG000|Overall Study|Physician Decision|1|||
44258399|NCT04839692|79113419|FG001|Overall Study|Physician Decision|0|||
44258400|NCT04476017|79113447|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
44258401|NCT04476017|79113448|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
44325363|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
44325364|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
44325365|NCT01087788|79330600|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
44325366|NCT01087788|79330601|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
44325367|NCT01087788|79330602|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
44325368|NCT01087788|79330600|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
44325369|NCT01087788|79330601|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
44325370|NCT01087788|79330602|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
44325371|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
44325372|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
44325373|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
44325374|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
44325375|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
44325376|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
44325377|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
44325378|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
44325379|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
44325380|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
44325381|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
44325382|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
44325383|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
44325384|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
44325385|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
44325386|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
44422790|NCT00716274|79430864|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
44422791|NCT00716274|79430859|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
44422792|NCT00716274|79430860|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
44422793|NCT00716274|79430861|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
44422794|NCT00716274|79430862|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
44422795|NCT00716274|79430863|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
44325387|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
44325388|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
44325389|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
44325390|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
44325391|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
44325392|NCT01087788|79330600|FG000|24-weeks Dose-blind Period|Patient moved|0|||
44325393|NCT01087788|79330601|FG001|24-weeks Dose-blind Period|Patient moved|0|||
44325394|NCT01087788|79330602|FG002|24-weeks Dose-blind Period|Patient moved|1|||
44325395|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
44325396|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
44325397|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
44325398|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
44325399|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
44325400|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
44325401|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
44325402|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
44325403|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
44422796|NCT00716274|79430864|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
44422797|NCT00716274|79430859|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
44422798|NCT00716274|79430860|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
44422799|NCT00716274|79430861|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
44422800|NCT00716274|79430862|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
44325404|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
44325405|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
44325406|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
44325407|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
44325408|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
44325409|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
44422801|NCT00716274|79430863|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
44325410|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
44325411|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
44325412|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
44325413|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
44325414|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
44325415|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
44325416|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
44156510|NCT01949116|78947673|FG000|Overall Study|Death|2|||
44325417|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
44325418|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
44325419|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
44325420|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
44325421|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
44325422|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
44325423|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
44325424|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
44325425|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
44325426|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
44325427|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
44325428|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
44325429|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
44325430|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
44325431|NCT01087788|79330600|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
44325432|NCT01087788|79330601|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
44325433|NCT01087788|79330602|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
44325434|NCT01086969|79330614|FG000|Overall Study|Withdrawal by Subject|1|||
44325435|NCT01086969|79330615|FG001|Overall Study|Withdrawal by Subject|2|||
44325436|NCT01086969|79330616|FG002|Overall Study|Withdrawal by Subject|0|||
44325437|NCT01086423|79330627|FG000|Overall Study|Protocol Violation|0|||
44325438|NCT01086423|79330628|FG001|Overall Study|Protocol Violation|0|||
44325439|NCT01086423|79330629|FG002|Overall Study|Protocol Violation|1|||
44325440|NCT01086423|79330627|FG000|Overall Study|Migrated/moved from study area|2|||
44325441|NCT01086423|79330628|FG001|Overall Study|Migrated/moved from study area|0|||
44325442|NCT01086423|79330629|FG002|Overall Study|Migrated/moved from study area|4|||
44325443|NCT01086423|79330627|FG000|Overall Study|Adverse event, fatal|1|||
44325444|NCT01086423|79330628|FG001|Overall Study|Adverse event, fatal|1|||
44325445|NCT01086423|79330629|FG002|Overall Study|Adverse event, fatal|0|||
44325446|NCT01086423|79330627|FG000|Overall Study|Adverse event, non-fatal|2|||
44325447|NCT01086423|79330628|FG001|Overall Study|Adverse event, non-fatal|1|||
44325448|NCT01086423|79330629|FG002|Overall Study|Adverse event, non-fatal|0|||
44325449|NCT01086423|79330627|FG000|Overall Study|Withdrawal by Subject|5|||
44325450|NCT01086423|79330628|FG001|Overall Study|Withdrawal by Subject|1|||
44325451|NCT01086423|79330629|FG002|Overall Study|Withdrawal by Subject|3|||
44325452|NCT01086423|79330627|FG000|Overall Study|Lost to Follow-up|0|||
44325453|NCT01086423|79330628|FG001|Overall Study|Lost to Follow-up|0|||
44325454|NCT01086423|79330629|FG002|Overall Study|Lost to Follow-up|1|||
44325455|NCT01086150|79330640|FG000|Overall Study|Withdrawal by Subject|0|||
44325456|NCT01086150|79330641|FG001|Overall Study|Withdrawal by Subject|4|||
44325457|NCT01086150|79330642|FG002|Overall Study|Withdrawal by Subject|1|||
44325458|NCT01086150|79330640|FG000|Overall Study|Lost to Follow-up|0|||
44325459|NCT01086150|79330641|FG001|Overall Study|Lost to Follow-up|1|||
44325460|NCT01086150|79330642|FG002|Overall Study|Lost to Follow-up|0|||
44325461|NCT01086150|79330640|FG000|Overall Study|Screen Failure|0|||
44325462|NCT01086150|79330641|FG001|Overall Study|Screen Failure|1|||
44325463|NCT01086150|79330642|FG002|Overall Study|Screen Failure|0|||
44325464|NCT01086033|79330650|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
44325465|NCT01086033|79330650|FG000|Overall Study|Lost to Follow-up|86|||
44325466|NCT01086033|79330650|FG000|Overall Study|Adverse Event|42|||
44325467|NCT01086033|79330650|FG000|Overall Study|Withdrawal by Subject|41|||
44325468|NCT01086033|79330650|FG000|Overall Study|Other|14|||
44325469|NCT01086033|79330650|FG000|Overall Study|Other|13|||
44325470|NCT01086033|79330650|FG000|Overall Study|AE and Withdrew Consent|5|||
44325471|NCT01086033|79330650|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
44422802|NCT00716274|79430864|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
44422803|NCT00716274|79430859|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
44422804|NCT00716274|79430860|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
44422805|NCT00716274|79430861|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
44422806|NCT00716274|79430862|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
44156511|NCT01949116|78947674|FG001|Overall Study|Death|0|||
44156512|NCT01949116|78947673|FG000|Overall Study|Lost to Follow-up|1|||
44156513|NCT01949116|78947674|FG001|Overall Study|Lost to Follow-up|3|||
44156514|NCT01949116|78947673|FG000|Overall Study|Withdrawal by Subject|5|||
44325472|NCT01086033|79330650|FG000|Overall Study|Withdrew consent and Other Reason|4|||
44325473|NCT01086033|79330650|FG000|Overall Study|AE and Lack of Efficacy|4|||
44422807|NCT00716274|79430863|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
44156515|NCT01949116|78947674|FG001|Overall Study|Withdrawal by Subject|3|||
44156516|NCT01673009|78947684|FG000|Overall Study|Physician Decision|5|||
44325474|NCT01086033|79330650|FG000|Overall Study|Death|1|||
44325475|NCT01086033|79330650|FG000|Overall Study|AE and Lost to Follow-up|1|||
44325476|NCT01086033|79330650|FG000|Overall Study|AE and Other Reason|1|||
44325477|NCT01086033|79330650|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
44325478|NCT01085682|79330659|FG000|Overall Study|Withdrawal by Subject|25|||
44422808|NCT00716274|79430864|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
44422809|NCT00716274|79430859|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
44422810|NCT00716274|79430860|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
44422811|NCT00716274|79430861|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
44422812|NCT00716274|79430862|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
44422813|NCT00716274|79430863|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
44422814|NCT00716274|79430864|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
44422815|NCT00716274|79430859|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
44422816|NCT00716274|79430860|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
44422817|NCT00716274|79430861|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
44422818|NCT00716274|79430862|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
44422819|NCT00716274|79430863|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
44422820|NCT00716274|79430864|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
44422821|NCT00716274|79430859|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
44422822|NCT00716274|79430860|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
44422823|NCT00716274|79430861|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
44325479|NCT01085682|79330660|FG001|Overall Study|Withdrawal by Subject|25|||
44325480|NCT01085214|79330666|FG000|Overall Study|Alternate treatment required|1|||
44422824|NCT00716274|79430862|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
44422825|NCT00716274|79430863|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
44325481|NCT01085136|79330670|FG000|Part A|Other Adverse event|223|||
44325482|NCT01085136|79330671|FG001|Part A|Other Adverse event|0|||
44325483|NCT01085136|79330672|FG002|Part A|Other Adverse event|0|||
44325484|NCT01085136|79330670|FG000|Part A|Protocol Violation|3|||
44325485|NCT01085136|79330671|FG001|Part A|Protocol Violation|0|||
44325486|NCT01085136|79330672|FG002|Part A|Protocol Violation|0|||
44325487|NCT01085136|79330670|FG000|Part A|Lost to Follow-up|3|||
44325488|NCT01085136|79330671|FG001|Part A|Lost to Follow-up|0|||
44325489|NCT01085136|79330672|FG002|Part A|Lost to Follow-up|0|||
44325490|NCT01085136|79330670|FG000|Part A|Refusal to continue trial medication|64|||
44325491|NCT01085136|79330671|FG001|Part A|Refusal to continue trial medication|0|||
44325492|NCT01085136|79330672|FG002|Part A|Refusal to continue trial medication|0|||
44422826|NCT00716274|79430864|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
44422827|NCT00716274|79430859|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
44422828|NCT00716274|79430860|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
44422829|NCT00716274|79430861|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
44422830|NCT00716274|79430862|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
44422831|NCT00716274|79430863|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
44422832|NCT00716274|79430864|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
44422833|NCT00746564|79430881|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
44422834|NCT01298193|79430887|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
44156517|NCT01673009|78947684|FG000|Overall Study|Withdrawal by Subject|8|||
44156518|NCT01939366|78947693|FG000|Overall Study|Adverse Event|8|||
44325493|NCT01085136|79330670|FG000|Part A|Other reason not defined above|30|||
44325494|NCT01085136|79330671|FG001|Part A|Other reason not defined above|0|||
44325495|NCT01085136|79330672|FG002|Part A|Other reason not defined above|0|||
44325496|NCT01085136|79330670|FG000|Part B|Other AE|0|||
44325497|NCT01085136|79330671|FG001|Part B|Other AE|29|||
44325498|NCT01085136|79330672|FG002|Part B|Other AE|8|||
44325499|NCT01085136|79330670|FG000|Part B|Refusal to continue trial medication|0|||
44325500|NCT01085136|79330671|FG001|Part B|Refusal to continue trial medication|12|||
44325501|NCT01085136|79330672|FG002|Part B|Refusal to continue trial medication|7|||
44325502|NCT01085136|79330670|FG000|Part B|Not treated|0|||
44156519|NCT01939366|78947694|FG001|Overall Study|Adverse Event|17|||
44325503|NCT01085136|79330671|FG001|Part B|Not treated|4|||
44325504|NCT01085136|79330672|FG002|Part B|Not treated|8|||
44325505|NCT01085136|79330670|FG000|Part B|Other reason not defined above|0|||
44325506|NCT01085136|79330671|FG001|Part B|Other reason not defined above|6|||
44325507|NCT01085136|79330672|FG002|Part B|Other reason not defined above|3|||
44325508|NCT01084707|79330682|FG000|Overall Study|Withdrawal by Subject|6|||
44156520|NCT01939366|78947695|FG002|Overall Study|Adverse Event|30|||
44156521|NCT01939366|78947696|FG003|Overall Study|Adverse Event|8|||
44325509|NCT01084668|79330694|FG000|Overall Study|Lack of Efficacy|5|||
44325510|NCT01084668|79330694|FG000|Overall Study|Withdrawal by Subject|2|||
44325511|NCT01084668|79330694|FG000|Overall Study|Pregnancy|1|||
44325512|NCT01084668|79330694|FG000|Overall Study|Non-compliance|1|||
44325513|NCT01084551|79330703|FG000|Overall Study|Adverse Event|2|||
44325514|NCT01084551|79330704|FG001|Overall Study|Adverse Event|9|||
44325515|NCT01084551|79330705|FG002|Overall Study|Adverse Event|4|||
44422835|NCT01298193|79430887|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
44422836|NCT01298193|79430887|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
44422837|NCT01298193|79430887|FG000|Efficacy Phase (Second Cycle)|Death|1|||
44422838|NCT00719862|79430896|FG000|Overall Study|Adverse Event|1|||
44325516|NCT01084551|79330703|FG000|Overall Study|Lack of Efficacy|2|||
44325517|NCT01084551|79330704|FG001|Overall Study|Lack of Efficacy|0|||
44325518|NCT01084551|79330705|FG002|Overall Study|Lack of Efficacy|1|||
44325519|NCT01084551|79330703|FG000|Overall Study|Withdrawal by Subject|2|||
44325520|NCT01084551|79330704|FG001|Overall Study|Withdrawal by Subject|1|||
44422839|NCT00719862|79430897|FG001|Overall Study|Adverse Event|2|||
44422840|NCT00719862|79430896|FG000|Overall Study|Lack of Efficacy|3|||
44325521|NCT01084551|79330705|FG002|Overall Study|Withdrawal by Subject|0|||
44422841|NCT00719862|79430897|FG001|Overall Study|Lack of Efficacy|0|||
44422842|NCT00719862|79430896|FG000|Overall Study|Non-Compliance|1|||
44422843|NCT00719862|79430897|FG001|Overall Study|Non-Compliance|0|||
44422844|NCT00719862|79430896|FG000|Overall Study|Withdrawal by Subject|1|||
44422845|NCT00719862|79430897|FG001|Overall Study|Withdrawal by Subject|0|||
44422846|NCT00719862|79430896|FG000|Overall Study|Lost to Follow-up|0|||
44422847|NCT00719862|79430897|FG001|Overall Study|Lost to Follow-up|1|||
44422848|NCT00719862|79430896|FG000|Overall Study|Other|2|||
44422849|NCT00719862|79430897|FG001|Overall Study|Other|3|||
44422850|NCT00742508|79430905|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
44422851|NCT00742508|79430906|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
44422852|NCT00742508|79430905|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
44422853|NCT00742508|79430906|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
44422854|NCT00742508|79430905|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
44422855|NCT00742508|79430906|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
44422856|NCT00742508|79430905|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
44422857|NCT00742508|79430906|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
44422858|NCT00742508|79430905|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
44422859|NCT00742508|79430906|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
44422860|NCT00719706|79430914|FG000|Overall Study|Adverse Event|5|||
44422861|NCT00719706|79430915|FG001|Overall Study|Adverse Event|4|||
44422862|NCT00719706|79430914|FG000|Overall Study|Withdrawal by Subject|1|||
44156522|NCT01939366|78947697|FG004|Overall Study|Adverse Event|5|||
44156523|NCT01939366|78947693|FG000|Overall Study|Lack of Efficacy|2|||
44325522|NCT01084551|79330703|FG000|Overall Study|Protocol Violation|2|||
44325523|NCT01084551|79330704|FG001|Overall Study|Protocol Violation|4|||
44325524|NCT01084551|79330705|FG002|Overall Study|Protocol Violation|0|||
44325525|NCT01084551|79330703|FG000|Overall Study|Lost to Follow-up|0|||
44325526|NCT01084551|79330704|FG001|Overall Study|Lost to Follow-up|0|||
44325527|NCT01084551|79330705|FG002|Overall Study|Lost to Follow-up|3|||
44325528|NCT01084551|79330703|FG000|Overall Study|Physician Decision|1|||
44325529|NCT01084551|79330704|FG001|Overall Study|Physician Decision|0|||
44422863|NCT00719706|79430915|FG001|Overall Study|Withdrawal by Subject|2|||
44156524|NCT01939366|78947694|FG001|Overall Study|Lack of Efficacy|1|||
44156525|NCT01939366|78947695|FG002|Overall Study|Lack of Efficacy|1|||
44156526|NCT01939366|78947696|FG003|Overall Study|Lack of Efficacy|1|||
44156527|NCT01939366|78947697|FG004|Overall Study|Lack of Efficacy|3|||
44156528|NCT01939366|78947693|FG000|Overall Study|Lost to Follow-up|1|||
44156529|NCT01939366|78947694|FG001|Overall Study|Lost to Follow-up|1|||
44156530|NCT01939366|78947695|FG002|Overall Study|Lost to Follow-up|0|||
44156531|NCT01939366|78947696|FG003|Overall Study|Lost to Follow-up|0|||
44156532|NCT01939366|78947697|FG004|Overall Study|Lost to Follow-up|0|||
44156533|NCT01939366|78947693|FG000|Overall Study|Withdrawal by Subject|1|||
44156534|NCT01939366|78947694|FG001|Overall Study|Withdrawal by Subject|0|||
44156535|NCT01939366|78947695|FG002|Overall Study|Withdrawal by Subject|2|||
44325530|NCT01084551|79330705|FG002|Overall Study|Physician Decision|0|||
44156536|NCT01939366|78947696|FG003|Overall Study|Withdrawal by Subject|2|||
44156537|NCT01939366|78947697|FG004|Overall Study|Withdrawal by Subject|3|||
44325531|NCT01084005|79330715|FG000|Overall Study|Adverse Event|1|||
44422864|NCT00719706|79430914|FG000|Overall Study|Protocol Violation|3|||
44422865|NCT00719706|79430915|FG001|Overall Study|Protocol Violation|0|||
44325532|NCT01084005|79330716|FG001|Overall Study|Adverse Event|8|||
44325533|NCT01084005|79330715|FG000|Overall Study|Protocol Violation|3|||
44325534|NCT01084005|79330716|FG001|Overall Study|Protocol Violation|7|||
44325535|NCT01084005|79330715|FG000|Overall Study|Withdrawal by Subject|1|||
44325536|NCT01084005|79330716|FG001|Overall Study|Withdrawal by Subject|1|||
44325537|NCT01083810|79330725|FG000|Overall Study|Lost to Follow-up|23|||
44325538|NCT01083810|79330726|FG001|Overall Study|Lost to Follow-up|11|||
44325539|NCT01083810|79330727|FG002|Overall Study|Lost to Follow-up|4|||
44325540|NCT01083810|79330725|FG000|Overall Study|Adverse Event|15|||
44325541|NCT01083810|79330726|FG001|Overall Study|Adverse Event|11|||
44325542|NCT01083810|79330727|FG002|Overall Study|Adverse Event|4|||
44325543|NCT01083810|79330725|FG000|Overall Study|Withdrawal by Subject|7|||
44325544|NCT01083810|79330726|FG001|Overall Study|Withdrawal by Subject|2|||
44325545|NCT01083810|79330727|FG002|Overall Study|Withdrawal by Subject|4|||
44325546|NCT01083810|79330725|FG000|Overall Study|Reason not reported|6|||
44325547|NCT01083810|79330726|FG001|Overall Study|Reason not reported|1|||
44325548|NCT01083810|79330727|FG002|Overall Study|Reason not reported|1|||
44325549|NCT01083810|79330725|FG000|Overall Study|Non-compliance|4|||
44325550|NCT01083810|79330726|FG001|Overall Study|Non-compliance|7|||
44325551|NCT01083810|79330727|FG002|Overall Study|Non-compliance|2|||
44325552|NCT01083810|79330725|FG000|Overall Study|Simplification|4|||
44325553|NCT01083810|79330726|FG001|Overall Study|Simplification|1|||
44325554|NCT01083810|79330727|FG002|Overall Study|Simplification|0|||
44325555|NCT01083810|79330725|FG000|Overall Study|Death|2|||
44325556|NCT01083810|79330726|FG001|Overall Study|Death|2|||
44325557|NCT01083810|79330727|FG002|Overall Study|Death|3|||
44325558|NCT01083810|79330725|FG000|Overall Study|Co-morbidities|1|||
44325559|NCT01083810|79330726|FG001|Overall Study|Co-morbidities|0|||
44325560|NCT01083810|79330727|FG002|Overall Study|Co-morbidities|0|||
44325561|NCT01083810|79330725|FG000|Overall Study|Participation in study|1|||
44325562|NCT01083810|79330726|FG001|Overall Study|Participation in study|0|||
44325563|NCT01083810|79330727|FG002|Overall Study|Participation in study|0|||
44325564|NCT01083810|79330725|FG000|Overall Study|Therapy break|1|||
44422866|NCT00742274|79430923|FG000|Overall Study|Death|1|||
44422867|NCT00742274|79430924|FG001|Overall Study|Death|0|||
44422868|NCT00742274|79430923|FG000|Overall Study|Withdrawal by Subject|1|||
44422869|NCT00742274|79430924|FG001|Overall Study|Withdrawal by Subject|2|||
44422870|NCT00742274|79430923|FG000|Overall Study|Removed for medical reasons|1|||
44422871|NCT00742274|79430924|FG001|Overall Study|Removed for medical reasons|1|||
44422872|NCT00719472|79430930|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
44422873|NCT00719472|79430930|FG000|Enrolled in Study|Subject decision to withdraw|8|||
44422874|NCT00719472|79430930|FG000|Enrolled in Study|Various Reasons|17|||
44422875|NCT00719472|79430930|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
44422876|NCT00719472|79430930|FG000|Received Cycle 1 Treatment|Death|5|||
44422877|NCT00719472|79430930|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
44422878|NCT00719472|79430930|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
44422879|NCT00719472|79430930|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
44422880|NCT00719472|79430930|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
44422881|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
44422882|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Death|6|||
44422883|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Disease progression|3|||
44422884|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
44422885|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
44422886|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
44422887|NCT00719472|79430930|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
44422888|NCT00579501|79430934|FG000|Overall Study|Death|1|||
44422889|NCT00579501|79430934|FG000|Overall Study|End of neoadjuvant therapy|25|||
44422890|NCT00579501|79430934|FG000|Overall Study|toxicity|1|||
44422891|NCT00579501|79430934|FG000|Overall Study|Secondary lesion|1|||
44422892|NCT00579501|79430934|FG000|Overall Study|Radiation therapy before surgery|1|||
44422893|NCT00741338|79430940|FG000|Overall Study|Adverse Event|0|||
44422894|NCT00741338|79430941|FG001|Overall Study|Adverse Event|1|||
44325565|NCT01083810|79330726|FG001|Overall Study|Therapy break|2|||
44325566|NCT01083810|79330727|FG002|Overall Study|Therapy break|2|||
44325567|NCT01083810|79330725|FG000|Overall Study|Virologic failure|1|||
44325568|NCT01083810|79330726|FG001|Overall Study|Virologic failure|8|||
44325569|NCT01083810|79330727|FG002|Overall Study|Virologic failure|0|||
44325570|NCT01083771|79330733|FG000|Overall Study|non-compliant|2|||
44422895|NCT00746330|79430951|FG000|Period 1|Abnormal test procedure result|0|||
44422896|NCT00746330|79430952|FG001|Period 1|Abnormal test procedure result|0|||
44422897|NCT00746330|79430953|FG002|Period 1|Abnormal test procedure result|1|||
44422898|NCT00746330|79430954|FG003|Period 1|Abnormal test procedure result|0|||
44422899|NCT00746252|79430967|FG000|Overall Study|weight gain >7.5 %|1|||
44422900|NCT00746252|79430968|FG001|Overall Study|weight gain >7.5 %|2|||
44422901|NCT00718770|79430974|FG000|Overall Study|Adverse Event|1|||
44325571|NCT01083771|79330733|FG000|Overall Study|Withdrawal by Subject|3|||
44325572|NCT01083693|79330740|FG000|Overall Study|Adverse Event|1|||
44325573|NCT01083693|79330741|FG001|Overall Study|Adverse Event|1|||
44325574|NCT01083693|79330742|FG002|Overall Study|Adverse Event|0|||
44325575|NCT01083693|79330740|FG000|Overall Study|Lost to Follow-up|2|||
44325576|NCT01083693|79330741|FG001|Overall Study|Lost to Follow-up|0|||
44422902|NCT00718770|79430974|FG000|Overall Study|Lack of Efficacy|1|||
44422903|NCT00718770|79430974|FG000|Overall Study|Lack of Efficacy|1|||
44422904|NCT00718770|79430974|FG000|Overall Study|Adverse Event|1|||
44422905|NCT00718770|79430974|FG000|Overall Study|Lack of Efficacy|1|||
44422906|NCT00718770|79430974|FG000|Overall Study|Adverse Event|1|||
44422907|NCT00718770|79430974|FG000|Overall Study|Lack of Efficacy|1|||
44325577|NCT01083693|79330742|FG002|Overall Study|Lost to Follow-up|2|||
44325578|NCT01083693|79330740|FG000|Overall Study|Lack of effectiveness|13|||
44325579|NCT01083693|79330741|FG001|Overall Study|Lack of effectiveness|2|||
44325580|NCT01083693|79330742|FG002|Overall Study|Lack of effectiveness|2|||
44325581|NCT01083693|79330740|FG000|Overall Study|Patient Moved|0|||
44325582|NCT01083693|79330741|FG001|Overall Study|Patient Moved|1|||
44325583|NCT01083693|79330742|FG002|Overall Study|Patient Moved|0|||
44325584|NCT01083693|79330740|FG000|Overall Study|Complete remission|0|||
44325585|NCT01083693|79330741|FG001|Overall Study|Complete remission|1|||
44325586|NCT01083693|79330742|FG002|Overall Study|Complete remission|0|||
44325587|NCT01083693|79330740|FG000|Overall Study|Other medical condition/surgery|1|||
44325588|NCT01083693|79330741|FG001|Overall Study|Other medical condition/surgery|1|||
44325589|NCT01083693|79330742|FG002|Overall Study|Other medical condition/surgery|0|||
44325590|NCT01083693|79330740|FG000|Overall Study|Withdrawal by Subject|3|||
44325591|NCT01083693|79330741|FG001|Overall Study|Withdrawal by Subject|0|||
44325592|NCT01083693|79330742|FG002|Overall Study|Withdrawal by Subject|2|||
44325593|NCT01083693|79330740|FG000|Overall Study|Reason unknown|0|||
44325594|NCT01083693|79330741|FG001|Overall Study|Reason unknown|0|||
44325595|NCT01083693|79330742|FG002|Overall Study|Reason unknown|1|||
44325596|NCT01083576|79330756|FG000|Overall Study|Treatment Failure|6|||
44325597|NCT01083576|79330757|FG001|Overall Study|Treatment Failure|1|||
44325598|NCT01083186|79330764|FG000|Overall Study|Lost to Follow-up|48|||
44325599|NCT01083186|79330764|FG000|Overall Study|Consent Withdrawal|7|||
44325600|NCT01083186|79330764|FG000|Overall Study|Death|3|||
44325601|NCT01083186|79330764|FG000|Overall Study|Adverse Event|3|||
44325602|NCT01083186|79330764|FG000|Overall Study|Lack of Efficacy|2|||
44325603|NCT01083186|79330764|FG000|Overall Study|Hemodialysis Initiation|28|||
44325604|NCT01083186|79330764|FG000|Overall Study|Administrative Reasons|2|||
44325605|NCT01083186|79330764|FG000|Overall Study|Non-compliance to Study Treatment|1|||
44325606|NCT01082640|79330791|FG000|Overall Study|Adverse Event|9|||
44325607|NCT01082640|79330792|FG001|Overall Study|Adverse Event|5|||
44325608|NCT01082640|79330793|FG002|Overall Study|Adverse Event|3|||
44325609|NCT01082640|79330791|FG000|Overall Study|Withdrawal by Subject|3|||
44325610|NCT01082640|79330792|FG001|Overall Study|Withdrawal by Subject|3|||
44325611|NCT01082640|79330793|FG002|Overall Study|Withdrawal by Subject|2|||
44325612|NCT01082640|79330791|FG000|Overall Study|Major protocol deviation|3|||
44325613|NCT01082640|79330792|FG001|Overall Study|Major protocol deviation|3|||
44325614|NCT01082640|79330793|FG002|Overall Study|Major protocol deviation|0|||
44325615|NCT01082640|79330791|FG000|Overall Study|Lost to Follow-up|0|||
44325616|NCT01082640|79330792|FG001|Overall Study|Lost to Follow-up|3|||
44325617|NCT01082640|79330793|FG002|Overall Study|Lost to Follow-up|0|||
44325618|NCT01082640|79330791|FG000|Overall Study|Other|2|||
44325619|NCT01082640|79330792|FG001|Overall Study|Other|1|||
44325620|NCT01082640|79330793|FG002|Overall Study|Other|3|||
44325621|NCT01082367|79330806|FG000|Double-blind Period|Administrative problems|0|||
44325622|NCT01082367|79330807|FG001|Double-blind Period|Administrative problems|1|||
44325623|NCT01082367|79330806|FG000|Double-blind Period|Lack of Efficacy|5|||
44325624|NCT01082367|79330807|FG001|Double-blind Period|Lack of Efficacy|11|||
44156538|NCT01939366|78947693|FG000|Overall Study|Inclusion criteria not met|0|||
44156539|NCT01939366|78947694|FG001|Overall Study|Inclusion criteria not met|1|||
44156540|NCT01939366|78947695|FG002|Overall Study|Inclusion criteria not met|1|||
44156541|NCT01939366|78947696|FG003|Overall Study|Inclusion criteria not met|0|||
44156542|NCT01939366|78947697|FG004|Overall Study|Inclusion criteria not met|1|||
44325625|NCT01082367|79330806|FG000|Double-blind Period|Adverse Event|0|||
44325626|NCT01082367|79330807|FG001|Double-blind Period|Adverse Event|1|||
44325627|NCT01082367|79330806|FG000|Follow-up (F-U) Period|Administrative problems|1|||
44325628|NCT01082367|79330807|FG001|Follow-up (F-U) Period|Administrative problems|0|||
44325629|NCT01082367|79330806|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
44325630|NCT01082367|79330807|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
44156543|NCT01939366|78947693|FG000|Overall Study|Other|0|||
44325631|NCT01082367|79330806|FG000|Follow-up (F-U) Period|Adverse Event|0|||
44325632|NCT01082367|79330807|FG001|Follow-up (F-U) Period|Adverse Event|1|||
44325633|NCT01082211|79330817|FG000|Overall Study|Protocol Violation|4|||
44325634|NCT01082211|79330817|FG000|Overall Study|No protocol treatment received|3|||
44325635|NCT01081665|79330824|FG000|Overall Study|Death|41|||
44325636|NCT01081665|79330824|FG000|Overall Study|Lost to Follow-up|18|||
44325637|NCT01081665|79330824|FG000|Overall Study|Withdrawal by Subject|17|||
44156544|NCT01939366|78947694|FG001|Overall Study|Other|0|||
44422908|NCT00718770|79430974|FG000|Overall Study|Adverse Event|1|||
44422909|NCT00746096|79430980|FG000|Overall Study|Adverse Event|1|||
44422910|NCT00746096|79430981|FG001|Overall Study|Adverse Event|0|||
44422911|NCT00746096|79430980|FG000|Overall Study|Withdrawal by Subject|5|||
44422912|NCT00746096|79430981|FG001|Overall Study|Withdrawal by Subject|1|||
44422913|NCT00746096|79430980|FG000|Overall Study|Lost to Follow-up|2|||
44422914|NCT00746096|79430981|FG001|Overall Study|Lost to Follow-up|1|||
44422915|NCT00746096|79430980|FG000|Overall Study|Protocol Violation|1|||
44422916|NCT00746096|79430981|FG001|Overall Study|Protocol Violation|0|||
44422917|NCT00746096|79430980|FG000|Overall Study|No study drug treatment|1|||
44422918|NCT00746096|79430981|FG001|Overall Study|No study drug treatment|1|||
44422919|NCT00715026|79430987|FG000|Overall Study|Withdrawal by Subject|5|||
44422920|NCT00715026|79430987|FG000|Overall Study|Lost to Follow-up|3|||
44422921|NCT00715026|79430987|FG000|Overall Study|Protocol Violation|1|||
44422922|NCT00715026|79430987|FG000|Overall Study|Surgery done on non-study consented hip|1|||
44422923|NCT00714948|79430991|FG000|Overall Study|Adverse Event|2|||
44422924|NCT00714870|79430997|FG000|Overall Study|Lost to Follow-up|22|||
44422925|NCT00714870|79430998|FG001|Overall Study|Lost to Follow-up|5|||
44422926|NCT00714870|79430997|FG000|Overall Study|patient unable to come b/c back pain|1|||
44422927|NCT00714870|79430998|FG001|Overall Study|patient unable to come b/c back pain|0|||
44422928|NCT00714870|79430997|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
44325638|NCT01081665|79330824|FG000|Overall Study|Change of dialysis unit|10|||
44325639|NCT01081665|79330824|FG000|Overall Study|Regulation of iPTH|5|||
44422929|NCT00714870|79430998|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
44156545|NCT01939366|78947695|FG002|Overall Study|Other|2|||
44156546|NCT01939366|78947696|FG003|Overall Study|Other|2|||
44422930|NCT00714714|79431004|FG000|Overall Study|Adverse Event|1|||
44422931|NCT00441337|79431014|FG000|Overall Study|Disease Progression|6|||
44422932|NCT00441337|79431015|FG001|Overall Study|Disease Progression|6|||
44422933|NCT00441337|79431016|FG002|Overall Study|Disease Progression|4|||
44422934|NCT00441337|79431017|FG003|Overall Study|Disease Progression|18|||
44422935|NCT00441337|79431014|FG000|Overall Study|Lost to Follow-up|0|||
44422936|NCT00441337|79431015|FG001|Overall Study|Lost to Follow-up|0|||
44422937|NCT00441337|79431016|FG002|Overall Study|Lost to Follow-up|0|||
44422938|NCT00441337|79431017|FG003|Overall Study|Lost to Follow-up|1|||
44422939|NCT00441337|79431014|FG000|Overall Study|Sponsor Decision|0|||
44422940|NCT00441337|79431015|FG001|Overall Study|Sponsor Decision|0|||
44422941|NCT00441337|79431016|FG002|Overall Study|Sponsor Decision|1|||
44422942|NCT00441337|79431017|FG003|Overall Study|Sponsor Decision|2|||
44422943|NCT00441337|79431014|FG000|Overall Study|Did not meet inclusion criteria|0|||
44422944|NCT00441337|79431015|FG001|Overall Study|Did not meet inclusion criteria|0|||
44422945|NCT00441337|79431016|FG002|Overall Study|Did not meet inclusion criteria|1|||
44422946|NCT00441337|79431017|FG003|Overall Study|Did not meet inclusion criteria|0|||
44325640|NCT01081665|79330824|FG000|Overall Study|Change in renal replacement therapy|2|||
44325641|NCT01081665|79330824|FG000|Overall Study|Adverse Event|1|||
44325642|NCT01081665|79330824|FG000|Overall Study|Lack of Efficacy|1|||
44325643|NCT01081626|79330830|FG000|Overall Study|Dosing error|1|||
44325644|NCT01081626|79330831|FG001|Overall Study|Dosing error|1|||
44325645|NCT01081626|79330830|FG000|Overall Study|Missing Estradiol|25|||
44325646|NCT01081626|79330831|FG001|Overall Study|Missing Estradiol|28|||
44325647|NCT01081626|79330830|FG000|Overall Study|Low antral follicle count|1|||
44325648|NCT01081626|79330831|FG001|Overall Study|Low antral follicle count|0|||
44325649|NCT01081626|79330830|FG000|Overall Study|Overstimulation|0|||
44325650|NCT01081626|79330831|FG001|Overall Study|Overstimulation|1|||
44325651|NCT01081626|79330830|FG000|Overall Study|Lost to Follow-up|0|||
44325652|NCT01081626|79330831|FG001|Overall Study|Lost to Follow-up|1|||
44325653|NCT01081626|79330830|FG000|Overall Study|Other|33|||
44325654|NCT01081626|79330831|FG001|Overall Study|Other|30|||
44325655|NCT01080768|79330839|FG000|Overall Study|Protocol Deviation|2|||
44325656|NCT01080768|79330840|FG001|Overall Study|Protocol Deviation|1|||
44422947|NCT00578877|79431037|FG000|Overall Study|Lost to Follow-up|8|||
44422948|NCT00578877|79431038|FG001|Overall Study|Lost to Follow-up|10|||
44422949|NCT00578877|79431037|FG000|Overall Study|early discontinue|61|||
44422950|NCT00578877|79431038|FG001|Overall Study|early discontinue|101|||
44422951|NCT00578877|79431037|FG000|Overall Study|did not provide follow-up data|12|||
44422952|NCT00578877|79431038|FG001|Overall Study|did not provide follow-up data|17|||
44422953|NCT00468481|79431046|FG000|Overall Study|Adverse Event|13|||
44422954|NCT00468481|79431047|FG001|Overall Study|Adverse Event|3|||
44422955|NCT00468481|79431046|FG000|Overall Study|Lost to Follow-up|25|||
44325657|NCT01080300|79330848|FG000|Overall Study|Adverse Event|49|||
44325658|NCT01080300|79330849|FG001|Overall Study|Adverse Event|35|||
44325659|NCT01080300|79330848|FG000|Overall Study|Lack of Efficacy|12|||
44325660|NCT01080300|79330849|FG001|Overall Study|Lack of Efficacy|15|||
44325661|NCT01080300|79330848|FG000|Overall Study|Protocol Violation|7|||
44325662|NCT01080300|79330849|FG001|Overall Study|Protocol Violation|13|||
44325663|NCT01080300|79330848|FG000|Overall Study|Lost to Follow-up|10|||
44325664|NCT01080300|79330849|FG001|Overall Study|Lost to Follow-up|6|||
44325665|NCT01080300|79330848|FG000|Overall Study|Death|0|||
44325666|NCT01080300|79330849|FG001|Overall Study|Death|1|||
44325667|NCT01080300|79330848|FG000|Overall Study|Withdrawal by Subject|12|||
44325668|NCT01080300|79330849|FG001|Overall Study|Withdrawal by Subject|28|||
44325669|NCT01080300|79330848|FG000|Overall Study|Reasons not specified|4|||
44325670|NCT01080300|79330849|FG001|Overall Study|Reasons not specified|6|||
44325671|NCT01085097|79330860|FG000|Overall Study|Adverse Event|0|||
44325672|NCT01085097|79330861|FG001|Overall Study|Adverse Event|0|||
44325673|NCT01085097|79330862|FG002|Overall Study|Adverse Event|2|||
44325674|NCT01085097|79330860|FG000|Overall Study|Treatment failure|2|||
44325675|NCT01085097|79330861|FG001|Overall Study|Treatment failure|0|||
44325676|NCT01085097|79330862|FG002|Overall Study|Treatment failure|0|||
44325677|NCT03450629|79330876|FG000|Overall Study|Adverse Event|15|||
44325678|NCT03450629|79330877|FG001|Overall Study|Adverse Event|14|||
44325679|NCT03450629|79330876|FG000|Overall Study|Physician Decision|2|||
44325680|NCT03450629|79330877|FG001|Overall Study|Physician Decision|2|||
44325681|NCT03450629|79330876|FG000|Overall Study|Lack of Efficacy|2|||
44325682|NCT03450629|79330877|FG001|Overall Study|Lack of Efficacy|0|||
44325683|NCT03450629|79330876|FG000|Overall Study|Lost to Follow-up|4|||
44325684|NCT03450629|79330877|FG001|Overall Study|Lost to Follow-up|2|||
44325685|NCT03450629|79330876|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
44325686|NCT03450629|79330877|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
44325687|NCT03450629|79330876|FG000|Overall Study|Non-Compliance With Study Drug|2|||
44325688|NCT03450629|79330877|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44325689|NCT03450629|79330876|FG000|Overall Study|Protocol Violation|11|||
44325690|NCT03450629|79330877|FG001|Overall Study|Protocol Violation|8|||
44325691|NCT03450629|79330876|FG000|Overall Study|Withdrawal by Subject|12|||
44325692|NCT03450629|79330877|FG001|Overall Study|Withdrawal by Subject|6|||
44325693|NCT00198029|79330883|FG000|Overall Study|Withdrawal by Subject|4|||
44325694|NCT00197054|79330890|FG000|Overall Study|Withdrawal by Subject|9|||
44325695|NCT00197054|79330891|FG001|Overall Study|Withdrawal by Subject|3|||
44325696|NCT00197054|79330892|FG002|Overall Study|Withdrawal by Subject|3|||
44325697|NCT00197054|79330890|FG000|Overall Study|Moved from area|7|||
44325698|NCT00197054|79330891|FG001|Overall Study|Moved from area|14|||
44325699|NCT00197054|79330892|FG002|Overall Study|Moved from area|9|||
44325700|NCT00197054|79330890|FG000|Overall Study|Lost to Follow-up|1|||
44422956|NCT00468481|79431047|FG001|Overall Study|Lost to Follow-up|8|||
44422957|NCT00468481|79431046|FG000|Overall Study|Pregnancy|2|||
44325701|NCT00197054|79330891|FG001|Overall Study|Lost to Follow-up|4|||
44422958|NCT00468481|79431047|FG001|Overall Study|Pregnancy|0|||
44325702|NCT00197054|79330892|FG002|Overall Study|Lost to Follow-up|0|||
44325703|NCT00197015|79330913|FG000|Overall Study|Adverse Event|3|||
44325704|NCT00197015|79330914|FG001|Overall Study|Adverse Event|0|||
44325705|NCT00197015|79330915|FG002|Overall Study|Adverse Event|1|||
44422959|NCT00468481|79431046|FG000|Overall Study|Protocol Violation|18|||
44325706|NCT00197015|79330913|FG000|Overall Study|Protocol Violation|0|||
44325707|NCT00197015|79330914|FG001|Overall Study|Protocol Violation|3|||
44325708|NCT00197015|79330915|FG002|Overall Study|Protocol Violation|3|||
44325709|NCT00197015|79330913|FG000|Overall Study|Withdrawal by Subject|17|||
44325710|NCT00197015|79330914|FG001|Overall Study|Withdrawal by Subject|37|||
44325711|NCT00197015|79330915|FG002|Overall Study|Withdrawal by Subject|34|||
44325712|NCT00197015|79330913|FG000|Overall Study|Lost to Follow-up|28|||
44325713|NCT00197015|79330914|FG001|Overall Study|Lost to Follow-up|46|||
44325714|NCT00197015|79330915|FG002|Overall Study|Lost to Follow-up|37|||
44325715|NCT00197015|79330913|FG000|Overall Study|Other|2|||
44325716|NCT00197015|79330914|FG001|Overall Study|Other|3|||
44325717|NCT00197015|79330915|FG002|Overall Study|Other|2|||
44325718|NCT00196976|79330937|FG000|Primary Study|Migrated from study area|0|||
44325719|NCT00196976|79330938|FG001|Primary Study|Migrated from study area|0|||
44325720|NCT00196976|79330939|FG002|Primary Study|Migrated from study area|0|||
44325721|NCT00196976|79330940|FG003|Primary Study|Migrated from study area|0|||
44325722|NCT00196976|79330941|FG004|Primary Study|Migrated from study area|0|||
44325723|NCT00196976|79330942|FG005|Primary Study|Migrated from study area|0|||
44325724|NCT00196976|79330943|FG006|Primary Study|Migrated from study area|0|||
44325725|NCT00196976|79330944|FG007|Primary Study|Migrated from study area|1|||
44325726|NCT00196976|79330945|FG008|Primary Study|Migrated from study area|0|||
44325727|NCT00196976|79330946|FG009|Primary Study|Migrated from study area|0|||
44325728|NCT00196976|79330947|FG010|Primary Study|Migrated from study area|0|||
44325729|NCT00196976|79330948|FG011|Primary Study|Migrated from study area|0|||
44325730|NCT00196976|79330949|FG012|Primary Study|Migrated from study area|0|||
44325731|NCT00196976|79330950|FG013|Primary Study|Migrated from study area|0|||
44325732|NCT00196976|79330937|FG000|Primary Study|Protocol Violation|0|||
44325733|NCT00196976|79330938|FG001|Primary Study|Protocol Violation|1|||
44325734|NCT00196976|79330939|FG002|Primary Study|Protocol Violation|1|||
44325735|NCT00196976|79330940|FG003|Primary Study|Protocol Violation|0|||
44325736|NCT00196976|79330941|FG004|Primary Study|Protocol Violation|0|||
44325737|NCT00196976|79330942|FG005|Primary Study|Protocol Violation|0|||
44325738|NCT00196976|79330943|FG006|Primary Study|Protocol Violation|0|||
44325739|NCT00196976|79330944|FG007|Primary Study|Protocol Violation|0|||
44325740|NCT00196976|79330945|FG008|Primary Study|Protocol Violation|0|||
44325741|NCT00196976|79330946|FG009|Primary Study|Protocol Violation|0|||
44325742|NCT00196976|79330947|FG010|Primary Study|Protocol Violation|0|||
44325743|NCT00196976|79330948|FG011|Primary Study|Protocol Violation|0|||
44325744|NCT00196976|79330949|FG012|Primary Study|Protocol Violation|0|||
44325745|NCT00196976|79330950|FG013|Primary Study|Protocol Violation|0|||
44325746|NCT00196976|79330937|FG000|Primary Study|Withdrawal by Subject|1|||
44325747|NCT00196976|79330938|FG001|Primary Study|Withdrawal by Subject|0|||
44325748|NCT00196976|79330939|FG002|Primary Study|Withdrawal by Subject|1|||
44325749|NCT00196976|79330940|FG003|Primary Study|Withdrawal by Subject|1|||
44325750|NCT00196976|79330941|FG004|Primary Study|Withdrawal by Subject|2|||
44325751|NCT00196976|79330942|FG005|Primary Study|Withdrawal by Subject|1|||
44325752|NCT00196976|79330943|FG006|Primary Study|Withdrawal by Subject|0|||
44325753|NCT00196976|79330944|FG007|Primary Study|Withdrawal by Subject|0|||
44325754|NCT00196976|79330945|FG008|Primary Study|Withdrawal by Subject|0|||
44325755|NCT00196976|79330946|FG009|Primary Study|Withdrawal by Subject|1|||
44325756|NCT00196976|79330947|FG010|Primary Study|Withdrawal by Subject|0|||
44325757|NCT00196976|79330948|FG011|Primary Study|Withdrawal by Subject|0|||
44325758|NCT00196976|79330949|FG012|Primary Study|Withdrawal by Subject|0|||
44325759|NCT00196976|79330950|FG013|Primary Study|Withdrawal by Subject|0|||
44325760|NCT00196976|79330937|FG000|Primary Study|Lost to Follow-up|0|||
44325761|NCT00196976|79330938|FG001|Primary Study|Lost to Follow-up|0|||
44325762|NCT00196976|79330939|FG002|Primary Study|Lost to Follow-up|0|||
44325763|NCT00196976|79330940|FG003|Primary Study|Lost to Follow-up|0|||
44325764|NCT00196976|79330941|FG004|Primary Study|Lost to Follow-up|1|||
44325765|NCT00196976|79330942|FG005|Primary Study|Lost to Follow-up|1|||
44325766|NCT00196976|79330943|FG006|Primary Study|Lost to Follow-up|0|||
44325767|NCT00196976|79330944|FG007|Primary Study|Lost to Follow-up|2|||
44325768|NCT00196976|79330945|FG008|Primary Study|Lost to Follow-up|0|||
44325769|NCT00196976|79330946|FG009|Primary Study|Lost to Follow-up|0|||
44325770|NCT00196976|79330947|FG010|Primary Study|Lost to Follow-up|0|||
44325771|NCT00196976|79330948|FG011|Primary Study|Lost to Follow-up|0|||
44325772|NCT00196976|79330949|FG012|Primary Study|Lost to Follow-up|0|||
44325773|NCT00196976|79330950|FG013|Primary Study|Lost to Follow-up|0|||
44325774|NCT00196976|79330937|FG000|Primary Study|Other|0|||
44325775|NCT00196976|79330938|FG001|Primary Study|Other|0|||
44325776|NCT00196976|79330939|FG002|Primary Study|Other|2|||
44325777|NCT00196976|79330940|FG003|Primary Study|Other|0|||
44325778|NCT00196976|79330941|FG004|Primary Study|Other|0|||
44325779|NCT00196976|79330942|FG005|Primary Study|Other|0|||
44325780|NCT00196976|79330943|FG006|Primary Study|Other|0|||
44325781|NCT00196976|79330944|FG007|Primary Study|Other|0|||
44325782|NCT00196976|79330945|FG008|Primary Study|Other|0|||
44325783|NCT00196976|79330946|FG009|Primary Study|Other|0|||
44325784|NCT00196976|79330947|FG010|Primary Study|Other|0|||
44325785|NCT00196976|79330948|FG011|Primary Study|Other|0|||
44325786|NCT00196976|79330949|FG012|Primary Study|Other|0|||
44325787|NCT00196976|79330950|FG013|Primary Study|Other|0|||
44325788|NCT00196976|79330937|FG000|Booster Study|Withdrawal by Subject|0|||
44325789|NCT00196976|79330938|FG001|Booster Study|Withdrawal by Subject|0|||
44325790|NCT00196976|79330939|FG002|Booster Study|Withdrawal by Subject|0|||
44325791|NCT00196976|79330940|FG003|Booster Study|Withdrawal by Subject|0|||
44325792|NCT00196976|79330941|FG004|Booster Study|Withdrawal by Subject|0|||
44325793|NCT00196976|79330942|FG005|Booster Study|Withdrawal by Subject|0|||
44325794|NCT00196976|79330943|FG006|Booster Study|Withdrawal by Subject|0|||
44325795|NCT00196976|79330944|FG007|Booster Study|Withdrawal by Subject|0|||
44325796|NCT00196976|79330945|FG008|Booster Study|Withdrawal by Subject|0|||
44325797|NCT00196976|79330946|FG009|Booster Study|Withdrawal by Subject|0|||
44325798|NCT00196976|79330947|FG010|Booster Study|Withdrawal by Subject|1|||
44325799|NCT00196976|79330948|FG011|Booster Study|Withdrawal by Subject|0|||
44325800|NCT00196976|79330949|FG012|Booster Study|Withdrawal by Subject|0|||
44325801|NCT00196976|79330950|FG013|Booster Study|Withdrawal by Subject|0|||
44325802|NCT00196976|79330937|FG000|Booster Study|Lost to Follow-up|0|||
44325803|NCT00196976|79330938|FG001|Booster Study|Lost to Follow-up|0|||
44325804|NCT00196976|79330939|FG002|Booster Study|Lost to Follow-up|0|||
44325805|NCT00196976|79330940|FG003|Booster Study|Lost to Follow-up|0|||
44325806|NCT00196976|79330941|FG004|Booster Study|Lost to Follow-up|0|||
44325807|NCT00196976|79330942|FG005|Booster Study|Lost to Follow-up|0|||
44325808|NCT00196976|79330943|FG006|Booster Study|Lost to Follow-up|0|||
44325809|NCT00196976|79330944|FG007|Booster Study|Lost to Follow-up|0|||
44325810|NCT00196976|79330945|FG008|Booster Study|Lost to Follow-up|0|||
44325811|NCT00196976|79330946|FG009|Booster Study|Lost to Follow-up|0|||
44325812|NCT00196976|79330947|FG010|Booster Study|Lost to Follow-up|1|||
44325813|NCT00196976|79330948|FG011|Booster Study|Lost to Follow-up|2|||
44422960|NCT00468481|79431047|FG001|Overall Study|Protocol Violation|8|||
44422961|NCT00468481|79431046|FG000|Overall Study|Withdrawal by Subject|12|||
44422962|NCT00468481|79431047|FG001|Overall Study|Withdrawal by Subject|3|||
44325814|NCT00196976|79330949|FG012|Booster Study|Lost to Follow-up|0|||
44325815|NCT00196976|79330950|FG013|Booster Study|Lost to Follow-up|0|||
44325816|NCT00196313|79330992|FG000|Overall Study|Protocol Violation|2|||
44325817|NCT00196313|79330993|FG001|Overall Study|Protocol Violation|3|||
44325818|NCT00196313|79330992|FG000|Overall Study|Withdrawal by Subject|3|||
44422963|NCT00468481|79431046|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
44422964|NCT00468481|79431047|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
44422965|NCT00468481|79431046|FG000|Overall Study|Prohibited Medication|1|||
44422966|NCT00468481|79431047|FG001|Overall Study|Prohibited Medication|1|||
44422967|NCT00468481|79431046|FG000|Overall Study|Egg Donor|1|||
44422968|NCT00468481|79431047|FG001|Overall Study|Egg Donor|0|||
44422969|NCT00468481|79431046|FG000|Overall Study|Moved out of area|4|||
44422970|NCT00468481|79431047|FG001|Overall Study|Moved out of area|1|||
44422971|NCT00468481|79431046|FG000|Overall Study|Non-Compliance|5|||
44156547|NCT01939366|78947697|FG004|Overall Study|Other|1|||
44156548|NCT01939366|78947693|FG000|Overall Study|Protocol Violation|0|||
44156549|NCT01939366|78947694|FG001|Overall Study|Protocol Violation|0|||
44325819|NCT00196313|79330993|FG001|Overall Study|Withdrawal by Subject|1|||
44156550|NCT01939366|78947695|FG002|Overall Study|Protocol Violation|0|||
44325820|NCT00196313|79330992|FG000|Overall Study|Adverse Event|3|||
44325821|NCT00196313|79330993|FG001|Overall Study|Adverse Event|1|||
44325822|NCT00196313|79330992|FG000|Overall Study|Subject Pregnant|1|||
44325823|NCT00196313|79330993|FG001|Overall Study|Subject Pregnant|1|||
44325824|NCT00196313|79330992|FG000|Overall Study|Lost to Follow-up|2|||
44325825|NCT00196313|79330993|FG001|Overall Study|Lost to Follow-up|2|||
44325826|NCT00196196|79331000|FG000|Overall Study|Withdrawal by Subject|2|||
44325827|NCT00196196|79331000|FG000|Overall Study|Did not have required condition (hydroce|5|||
44325828|NCT00195650|79331004|FG000|Overall Study|Adverse Event|194|||
44325829|NCT00195650|79331004|FG000|Overall Study|Lack of Efficacy|99|||
44325830|NCT00195650|79331004|FG000|Overall Study|Withdrawal by Subject|67|||
44325831|NCT00195650|79331004|FG000|Overall Study|Lost to Follow-up|44|||
44325832|NCT00195650|79331004|FG000|Overall Study|Death|23|||
44325833|NCT00195650|79331004|FG000|Overall Study|Protocol Violation|15|||
44422972|NCT00468481|79431047|FG001|Overall Study|Non-Compliance|0|||
44422973|NCT00468481|79431046|FG000|Overall Study|Other|6|||
44156551|NCT01939366|78947696|FG003|Overall Study|Protocol Violation|1|||
44325834|NCT00195650|79331004|FG000|Overall Study|Administrative reasons|83|||
44325835|NCT00195494|79331010|FG000|Year 1|Adverse Event|0|||
44325836|NCT00195494|79331011|FG001|Year 1|Adverse Event|0|||
44422974|NCT00468481|79431047|FG001|Overall Study|Other|0|||
44422975|NCT00714168|79431055|FG000|Overall Study|Pregnancy|5|||
44422976|NCT00714168|79431056|FG001|Overall Study|Pregnancy|4|||
44422977|NCT00714168|79431055|FG000|Overall Study|Lost to Follow-up|32|||
44422978|NCT00714168|79431056|FG001|Overall Study|Lost to Follow-up|50|||
44422979|NCT00714168|79431055|FG000|Overall Study|Relocation|4|||
44422980|NCT00714168|79431056|FG001|Overall Study|Relocation|3|||
44422981|NCT00714168|79431055|FG000|Overall Study|Non-study medical condition|3|||
44325837|NCT00195494|79331012|FG002|Year 1|Adverse Event|0|||
44325838|NCT00195494|79331013|FG003|Year 1|Adverse Event|0|||
44325839|NCT00195494|79331014|FG004|Year 1|Adverse Event|34|||
44422982|NCT00714168|79431056|FG001|Overall Study|Non-study medical condition|2|||
44422983|NCT00713700|79431062|FG000|Overall Study|Lost to Follow-up|3|||
44422984|NCT00713700|79431062|FG000|Overall Study|Withdrawal by Subject|1|||
44422985|NCT00468169|79431068|FG000|Overall Study|Withdrawal by Subject|1|||
44422986|NCT00468169|79431069|FG001|Overall Study|Withdrawal by Subject|0|||
44422987|NCT00435487|79431079|FG000|Overall Study|Death|3|||
44422988|NCT00435487|79431080|FG001|Overall Study|Death|4|||
44422989|NCT00435487|79431079|FG000|Overall Study|Adverse Event|0|||
44422990|NCT00435487|79431080|FG001|Overall Study|Adverse Event|3|||
44422991|NCT00435487|79431079|FG000|Overall Study|Lost to Follow-up|2|||
44422992|NCT00435487|79431080|FG001|Overall Study|Lost to Follow-up|2|||
44422993|NCT00435487|79431079|FG000|Overall Study|Other|5|||
44422994|NCT00435487|79431080|FG001|Overall Study|Other|2|||
44422995|NCT00435487|79431079|FG000|Overall Study|Withdrawal by Subject|2|||
44422996|NCT00435487|79431080|FG001|Overall Study|Withdrawal by Subject|1|||
44422997|NCT00435487|79431079|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
44422998|NCT00435487|79431080|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
44422999|NCT00435487|79431079|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
44423000|NCT00435487|79431080|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
44423001|NCT00579345|79431094|FG000|Overall Study|Withdrawal by Subject|2|||
44423002|NCT00579345|79431095|FG001|Overall Study|Withdrawal by Subject|0|||
44423003|NCT00579345|79431096|FG002|Overall Study|Withdrawal by Subject|0|||
44423004|NCT00579345|79431097|FG003|Overall Study|Withdrawal by Subject|0|||
44258402|NCT04422639|79113457|FG000|Overall Study|Death|1|||
44325840|NCT00195494|79331015|FG005|Year 1|Adverse Event|27|||
44325841|NCT00195494|79331010|FG000|Year 1|System Toxicity|0|||
44325842|NCT00195494|79331011|FG001|Year 1|System Toxicity|0|||
44325843|NCT00195494|79331012|FG002|Year 1|System Toxicity|0|||
44325844|NCT00195494|79331013|FG003|Year 1|System Toxicity|0|||
44325845|NCT00195494|79331014|FG004|Year 1|System Toxicity|0|||
44325846|NCT00195494|79331015|FG005|Year 1|System Toxicity|1|||
44325847|NCT00195494|79331010|FG000|Year 1|Lack of Efficacy|0|||
44325848|NCT00195494|79331011|FG001|Year 1|Lack of Efficacy|0|||
44325849|NCT00195494|79331012|FG002|Year 1|Lack of Efficacy|0|||
44325850|NCT00195494|79331013|FG003|Year 1|Lack of Efficacy|0|||
44325851|NCT00195494|79331014|FG004|Year 1|Lack of Efficacy|24|||
44423005|NCT00579345|79431098|FG004|Overall Study|Withdrawal by Subject|0|||
44423006|NCT00579345|79431099|FG005|Overall Study|Withdrawal by Subject|0|||
44423007|NCT00579345|79431100|FG006|Overall Study|Withdrawal by Subject|0|||
44258403|NCT04422639|79113458|FG001|Overall Study|Death|0|||
44258404|NCT04422639|79113457|FG000|Overall Study|study closed prior to completion of FU visits|0|||
44258405|NCT04422639|79113458|FG001|Overall Study|study closed prior to completion of FU visits|2|||
44258406|NCT04384107|79113466|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
44258407|NCT04384107|79113467|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
44258408|NCT04384107|79113466|FG000|Overall Study|Lost to Follow-up|1|||
44258409|NCT04384107|79113467|FG001|Overall Study|Lost to Follow-up|0|||
44258410|NCT04275089|79113473|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
44258411|NCT04096326|79113508|FG000|Overall Study|Withdrawal by Subject|0|||
44258412|NCT04096326|79113509|FG001|Overall Study|Withdrawal by Subject|0|||
44258413|NCT04096326|79113510|FG002|Overall Study|Withdrawal by Subject|0|||
44258414|NCT04096326|79113511|FG003|Overall Study|Withdrawal by Subject|0|||
44258415|NCT04096326|79113512|FG004|Overall Study|Withdrawal by Subject|0|||
44258416|NCT04096326|79113513|FG005|Overall Study|Withdrawal by Subject|0|||
44258417|NCT04096326|79113514|FG006|Overall Study|Withdrawal by Subject|1|||
44258418|NCT04096326|79113515|FG007|Overall Study|Withdrawal by Subject|0|||
44325852|NCT00195494|79331015|FG005|Year 1|Lack of Efficacy|9|||
44325853|NCT00195494|79331010|FG000|Year 1|Compliance|0|||
44325854|NCT00195494|79331011|FG001|Year 1|Compliance|0|||
44325855|NCT00195494|79331012|FG002|Year 1|Compliance|0|||
44423008|NCT00579345|79431101|FG007|Overall Study|Withdrawal by Subject|1|||
44325856|NCT00195494|79331013|FG003|Year 1|Compliance|0|||
44423009|NCT00579345|79431094|FG000|Overall Study|Lost to Follow-up|1|||
44423010|NCT00579345|79431095|FG001|Overall Study|Lost to Follow-up|0|||
44423011|NCT00579345|79431096|FG002|Overall Study|Lost to Follow-up|0|||
44423012|NCT00579345|79431097|FG003|Overall Study|Lost to Follow-up|0|||
44156552|NCT01939366|78947697|FG004|Overall Study|Protocol Violation|0|||
44325857|NCT00195494|79331014|FG004|Year 1|Compliance|5|||
44325858|NCT00195494|79331015|FG005|Year 1|Compliance|1|||
44325859|NCT00195494|79331010|FG000|Year 1|Lost to Follow-up|0|||
44325860|NCT00195494|79331011|FG001|Year 1|Lost to Follow-up|0|||
44423013|NCT00579345|79431098|FG004|Overall Study|Lost to Follow-up|0|||
44423014|NCT00579345|79431099|FG005|Overall Study|Lost to Follow-up|0|||
44423015|NCT00579345|79431100|FG006|Overall Study|Lost to Follow-up|0|||
44423016|NCT00579345|79431101|FG007|Overall Study|Lost to Follow-up|0|||
44423017|NCT00579345|79431094|FG000|Overall Study|Adverse Event|0|||
44423018|NCT00579345|79431095|FG001|Overall Study|Adverse Event|0|||
44423019|NCT00579345|79431096|FG002|Overall Study|Adverse Event|1|||
44423020|NCT00579345|79431097|FG003|Overall Study|Adverse Event|0|||
44423021|NCT00579345|79431098|FG004|Overall Study|Adverse Event|0|||
44423022|NCT00579345|79431099|FG005|Overall Study|Adverse Event|0|||
44423023|NCT00579345|79431100|FG006|Overall Study|Adverse Event|0|||
44423024|NCT00579345|79431101|FG007|Overall Study|Adverse Event|0|||
44423025|NCT00579345|79431094|FG000|Overall Study|Protocol Violation|1|||
44423026|NCT00579345|79431095|FG001|Overall Study|Protocol Violation|0|||
44423027|NCT00579345|79431096|FG002|Overall Study|Protocol Violation|0|||
44423028|NCT00579345|79431097|FG003|Overall Study|Protocol Violation|0|||
44423029|NCT00579345|79431098|FG004|Overall Study|Protocol Violation|0|||
44423030|NCT00579345|79431099|FG005|Overall Study|Protocol Violation|0|||
44423031|NCT00579345|79431100|FG006|Overall Study|Protocol Violation|0|||
44423032|NCT00579345|79431101|FG007|Overall Study|Protocol Violation|1|||
44423033|NCT00579345|79431094|FG000|Overall Study|Death|1|||
44423034|NCT00579345|79431095|FG001|Overall Study|Death|1|||
44423035|NCT00579345|79431096|FG002|Overall Study|Death|1|||
44423036|NCT00579345|79431097|FG003|Overall Study|Death|1|||
44423037|NCT00579345|79431098|FG004|Overall Study|Death|0|||
44423038|NCT00579345|79431099|FG005|Overall Study|Death|0|||
44423039|NCT00579345|79431100|FG006|Overall Study|Death|0|||
44423040|NCT00579345|79431101|FG007|Overall Study|Death|0|||
44423041|NCT00795821|79431149|FG000|Acute Treatment Phase|Adverse Event|23|||
44423042|NCT00795821|79431150|FG001|Acute Treatment Phase|Adverse Event|4|||
44423043|NCT00795821|79431149|FG000|Acute Treatment Phase|Death|1|||
44423044|NCT00795821|79431150|FG001|Acute Treatment Phase|Death|0|||
44325861|NCT00195494|79331012|FG002|Year 1|Lost to Follow-up|0|||
44325862|NCT00195494|79331013|FG003|Year 1|Lost to Follow-up|0|||
44325863|NCT00195494|79331014|FG004|Year 1|Lost to Follow-up|1|||
44325864|NCT00195494|79331015|FG005|Year 1|Lost to Follow-up|0|||
44325865|NCT00195494|79331010|FG000|Year 1|Missed >4 consecutive doses|0|||
44325866|NCT00195494|79331011|FG001|Year 1|Missed >4 consecutive doses|0|||
44325867|NCT00195494|79331012|FG002|Year 1|Missed >4 consecutive doses|0|||
44325868|NCT00195494|79331013|FG003|Year 1|Missed >4 consecutive doses|0|||
44325869|NCT00195494|79331014|FG004|Year 1|Missed >4 consecutive doses|3|||
44325870|NCT00195494|79331015|FG005|Year 1|Missed >4 consecutive doses|2|||
44325871|NCT00195494|79331010|FG000|Year 1|Protocol deviation|0|||
44325872|NCT00195494|79331011|FG001|Year 1|Protocol deviation|0|||
44325873|NCT00195494|79331012|FG002|Year 1|Protocol deviation|0|||
44325874|NCT00195494|79331013|FG003|Year 1|Protocol deviation|0|||
44325875|NCT00195494|79331014|FG004|Year 1|Protocol deviation|2|||
44325876|NCT00195494|79331015|FG005|Year 1|Protocol deviation|3|||
44325877|NCT00195494|79331010|FG000|Year 1|Physician Decision|0|||
44325878|NCT00195494|79331011|FG001|Year 1|Physician Decision|0|||
44325879|NCT00195494|79331012|FG002|Year 1|Physician Decision|0|||
44325880|NCT00195494|79331013|FG003|Year 1|Physician Decision|0|||
44325881|NCT00195494|79331014|FG004|Year 1|Physician Decision|1|||
44325882|NCT00195494|79331015|FG005|Year 1|Physician Decision|0|||
44325883|NCT00195494|79331010|FG000|Year 1|Withdrawal by Subject|0|||
44325884|NCT00195494|79331011|FG001|Year 1|Withdrawal by Subject|0|||
44325885|NCT00195494|79331012|FG002|Year 1|Withdrawal by Subject|0|||
44325886|NCT00195494|79331013|FG003|Year 1|Withdrawal by Subject|0|||
44325887|NCT00195494|79331014|FG004|Year 1|Withdrawal by Subject|8|||
44423045|NCT00795821|79431149|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
44423046|NCT00795821|79431150|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
44423047|NCT00795821|79431149|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
44423048|NCT00795821|79431150|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
44423049|NCT00795821|79431149|FG000|Acute Treatment Phase|Physician Decision|1|||
44423050|NCT00795821|79431150|FG001|Acute Treatment Phase|Physician Decision|1|||
44423051|NCT00795821|79431149|FG000|Acute Treatment Phase|Protocol Violation|1|||
44423052|NCT00795821|79431150|FG001|Acute Treatment Phase|Protocol Violation|2|||
44423053|NCT00795821|79431149|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
44423054|NCT00795821|79431150|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
44325888|NCT00195494|79331015|FG005|Year 1|Withdrawal by Subject|9|||
44325889|NCT00195494|79331010|FG000|Year 1|Protocol Violation|0|||
44325890|NCT00195494|79331011|FG001|Year 1|Protocol Violation|0|||
44325891|NCT00195494|79331012|FG002|Year 1|Protocol Violation|0|||
44325892|NCT00195494|79331013|FG003|Year 1|Protocol Violation|0|||
44325893|NCT00195494|79331014|FG004|Year 1|Protocol Violation|1|||
44325894|NCT00195494|79331015|FG005|Year 1|Protocol Violation|1|||
44325895|NCT00195494|79331010|FG000|Year 2|Adverse Event|3|||
44423055|NCT00795821|79431149|FG000|Long-term Extension Phase|Adverse Event|25|||
44325896|NCT00195494|79331011|FG001|Year 2|Adverse Event|7|||
44325897|NCT00195494|79331012|FG002|Year 2|Adverse Event|5|||
44325898|NCT00195494|79331013|FG003|Year 2|Adverse Event|9|||
44325899|NCT00195494|79331014|FG004|Year 2|Adverse Event|0|||
44325900|NCT00195494|79331015|FG005|Year 2|Adverse Event|0|||
44325901|NCT00195494|79331010|FG000|Year 2|Lack of Efficacy|0|||
44423056|NCT00795821|79431150|FG001|Long-term Extension Phase|Adverse Event|32|||
44423057|NCT00795821|79431149|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
44423058|NCT00795821|79431150|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
44423059|NCT00795821|79431149|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
44423060|NCT00795821|79431150|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
44423061|NCT00795821|79431149|FG000|Long-term Extension Phase|Physician Decision|1|||
44423062|NCT00795821|79431150|FG001|Long-term Extension Phase|Physician Decision|2|||
44423063|NCT00795821|79431149|FG000|Long-term Extension Phase|Protocol Violation|3|||
44423064|NCT00795821|79431150|FG001|Long-term Extension Phase|Protocol Violation|5|||
44423065|NCT00795821|79431149|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
44423066|NCT00795821|79431150|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
44423067|NCT00795821|79431149|FG000|Taper Phase|Adverse Event|2|||
44423068|NCT00795821|79431150|FG001|Taper Phase|Adverse Event|0|||
44423069|NCT00795821|79431149|FG000|Taper Phase|Lost to Follow-up|1|||
44423070|NCT00795821|79431150|FG001|Taper Phase|Lost to Follow-up|0|||
44423071|NCT00795821|79431149|FG000|Taper Phase|Physician Decision|2|||
44423072|NCT00795821|79431150|FG001|Taper Phase|Physician Decision|0|||
44423073|NCT00795821|79431149|FG000|Taper Phase|Withdrawal by Subject|4|||
44423074|NCT00795821|79431150|FG001|Taper Phase|Withdrawal by Subject|0|||
44423075|NCT00578643|79431166|FG000|Overall Study|Death|1|||
44423076|NCT00578643|79431166|FG000|Overall Study|Lost to Follow-up|1|||
44423077|NCT00578565|79431170|FG000|Overall Study|Adverse Event|3|||
44423078|NCT00741260|79431182|FG000|Overall Study|Disease Progression|3|||
44423079|NCT00741260|79431183|FG001|Overall Study|Disease Progression|5|||
44423080|NCT00741260|79431184|FG002|Overall Study|Disease Progression|3|||
44423081|NCT00741260|79431185|FG003|Overall Study|Disease Progression|3|||
44423082|NCT00741260|79431186|FG004|Overall Study|Disease Progression|5|||
44423083|NCT00741260|79431187|FG005|Overall Study|Disease Progression|37|||
44423084|NCT00741260|79431188|FG006|Overall Study|Disease Progression|4|||
44423085|NCT00741260|79431182|FG000|Overall Study|Death|0|||
44423086|NCT00741260|79431183|FG001|Overall Study|Death|1|||
44423087|NCT00741260|79431184|FG002|Overall Study|Death|0|||
44423088|NCT00741260|79431185|FG003|Overall Study|Death|1|||
44423089|NCT00741260|79431186|FG004|Overall Study|Death|2|||
44423090|NCT00741260|79431187|FG005|Overall Study|Death|2|||
44423091|NCT00741260|79431188|FG006|Overall Study|Death|1|||
44423092|NCT00741260|79431182|FG000|Overall Study|Withdrawal by Subject|0|||
44423093|NCT00741260|79431183|FG001|Overall Study|Withdrawal by Subject|0|||
44423094|NCT00741260|79431184|FG002|Overall Study|Withdrawal by Subject|0|||
44423095|NCT00741260|79431185|FG003|Overall Study|Withdrawal by Subject|0|||
44423096|NCT00741260|79431186|FG004|Overall Study|Withdrawal by Subject|1|||
44423097|NCT00741260|79431187|FG005|Overall Study|Withdrawal by Subject|3|||
44423098|NCT00741260|79431188|FG006|Overall Study|Withdrawal by Subject|1|||
44156553|NCT01939366|78947693|FG000|Overall Study|Sponsor decision|0|||
44156554|NCT01939366|78947694|FG001|Overall Study|Sponsor decision|0|||
44156555|NCT01939366|78947695|FG002|Overall Study|Sponsor decision|0|||
44156556|NCT01939366|78947696|FG003|Overall Study|Sponsor decision|0|||
44156557|NCT01939366|78947697|FG004|Overall Study|Sponsor decision|2|||
44156558|NCT01939366|78947693|FG000|Overall Study|GCP non-compliance at site|2|||
44325902|NCT00195494|79331011|FG001|Year 2|Lack of Efficacy|1|||
44325903|NCT00195494|79331012|FG002|Year 2|Lack of Efficacy|7|||
44423099|NCT00741260|79431182|FG000|Overall Study|Physician Decision|1|||
44423100|NCT00741260|79431183|FG001|Overall Study|Physician Decision|1|||
44423101|NCT00741260|79431184|FG002|Overall Study|Physician Decision|0|||
44423102|NCT00741260|79431185|FG003|Overall Study|Physician Decision|0|||
44156559|NCT01939366|78947694|FG001|Overall Study|GCP non-compliance at site|3|||
44325904|NCT00195494|79331013|FG003|Year 2|Lack of Efficacy|7|||
44423103|NCT00741260|79431186|FG004|Overall Study|Physician Decision|0|||
44156560|NCT01939366|78947695|FG002|Overall Study|GCP non-compliance at site|2|||
44325905|NCT00195494|79331014|FG004|Year 2|Lack of Efficacy|0|||
44423104|NCT00741260|79431187|FG005|Overall Study|Physician Decision|0|||
44423105|NCT00741260|79431188|FG006|Overall Study|Physician Decision|0|||
44325906|NCT00195494|79331015|FG005|Year 2|Lack of Efficacy|0|||
44325907|NCT00195494|79331010|FG000|Year 2|Compliance|1|||
44423106|NCT00741260|79431182|FG000|Overall Study|Other|2|||
44423107|NCT00741260|79431183|FG001|Overall Study|Other|1|||
44423108|NCT00741260|79431184|FG002|Overall Study|Other|1|||
44423109|NCT00741260|79431185|FG003|Overall Study|Other|2|||
44423110|NCT00741260|79431186|FG004|Overall Study|Other|1|||
44156561|NCT01939366|78947696|FG003|Overall Study|GCP non-compliance at site|3|||
44325908|NCT00195494|79331011|FG001|Year 2|Compliance|0|||
44325909|NCT00195494|79331012|FG002|Year 2|Compliance|0|||
44423111|NCT00741260|79431187|FG005|Overall Study|Other|3|||
44423112|NCT00741260|79431188|FG006|Overall Study|Other|1|||
44423113|NCT00740870|79431209|FG000|Overall Study|Not Catheterized|4|||
44325910|NCT00195494|79331013|FG003|Year 2|Compliance|2|||
44325911|NCT00195494|79331014|FG004|Year 2|Compliance|0|||
44325912|NCT00195494|79331015|FG005|Year 2|Compliance|0|||
44325913|NCT00195494|79331010|FG000|Year 2|Lost to Follow-up|0|||
44325914|NCT00195494|79331011|FG001|Year 2|Lost to Follow-up|0|||
44325915|NCT00195494|79331012|FG002|Year 2|Lost to Follow-up|1|||
44325916|NCT00195494|79331013|FG003|Year 2|Lost to Follow-up|1|||
44325917|NCT00195494|79331014|FG004|Year 2|Lost to Follow-up|0|||
44325918|NCT00195494|79331015|FG005|Year 2|Lost to Follow-up|0|||
44423114|NCT00740870|79431209|FG000|Overall Study|Further testing contraindicated implant|17|||
44423115|NCT00740792|79431220|FG000|Overall Study|Adverse Event|3|||
44423116|NCT00740792|79431221|FG001|Overall Study|Adverse Event|1|||
44423117|NCT00740792|79431222|FG002|Overall Study|Adverse Event|1|||
44423118|NCT00740792|79431223|FG003|Overall Study|Adverse Event|3|||
44423119|NCT00740792|79431220|FG000|Overall Study|Lack of Efficacy|1|||
44423120|NCT00740792|79431221|FG001|Overall Study|Lack of Efficacy|1|||
44423121|NCT00740792|79431222|FG002|Overall Study|Lack of Efficacy|0|||
44423122|NCT00740792|79431223|FG003|Overall Study|Lack of Efficacy|3|||
44423123|NCT00740792|79431220|FG000|Overall Study|Lost to Follow-up|2|||
44423124|NCT00740792|79431221|FG001|Overall Study|Lost to Follow-up|1|||
44423125|NCT00740792|79431222|FG002|Overall Study|Lost to Follow-up|0|||
44423126|NCT00740792|79431223|FG003|Overall Study|Lost to Follow-up|0|||
44423127|NCT00740792|79431220|FG000|Overall Study|Protocol Violation|0|||
44423128|NCT00740792|79431221|FG001|Overall Study|Protocol Violation|1|||
44423129|NCT00740792|79431222|FG002|Overall Study|Protocol Violation|0|||
44423130|NCT00740792|79431223|FG003|Overall Study|Protocol Violation|2|||
44423131|NCT00740792|79431220|FG000|Overall Study|Withdrawal by Subject|1|||
44423132|NCT00740792|79431221|FG001|Overall Study|Withdrawal by Subject|1|||
44423133|NCT00740792|79431222|FG002|Overall Study|Withdrawal by Subject|0|||
44423134|NCT00740792|79431223|FG003|Overall Study|Withdrawal by Subject|0|||
44423135|NCT00740792|79431220|FG000|Overall Study|administrative|3|||
44423136|NCT00740792|79431221|FG001|Overall Study|administrative|3|||
44423137|NCT00740792|79431222|FG002|Overall Study|administrative|8|||
44423138|NCT00740792|79431223|FG003|Overall Study|administrative|2|||
44423139|NCT00740714|79431236|FG000|Overall Study|Withdrawal by Subject|17|||
44423140|NCT00740714|79431237|FG001|Overall Study|Withdrawal by Subject|19|||
44423141|NCT00740714|79431238|FG002|Overall Study|Withdrawal by Subject|29|||
44423142|NCT00788957|79431250|FG000|Part 1|Death|8|||
44423143|NCT00788957|79431251|FG001|Part 1|Death|0|||
44258419|NCT04096326|79113516|FG008|Overall Study|Withdrawal by Subject|0|||
44258420|NCT04096326|79113517|FG009|Overall Study|Withdrawal by Subject|0|||
44258421|NCT04096326|79113508|FG000|Overall Study|Lost to Follow-up|0|||
44258422|NCT04096326|79113509|FG001|Overall Study|Lost to Follow-up|1|||
44258423|NCT04096326|79113510|FG002|Overall Study|Lost to Follow-up|0|||
44258424|NCT04096326|79113511|FG003|Overall Study|Lost to Follow-up|0|||
44258425|NCT04096326|79113512|FG004|Overall Study|Lost to Follow-up|0|||
44258426|NCT04096326|79113513|FG005|Overall Study|Lost to Follow-up|0|||
44258427|NCT04096326|79113514|FG006|Overall Study|Lost to Follow-up|0|||
44258428|NCT04096326|79113515|FG007|Overall Study|Lost to Follow-up|0|||
44258429|NCT04096326|79113516|FG008|Overall Study|Lost to Follow-up|0|||
44258430|NCT04096326|79113517|FG009|Overall Study|Lost to Follow-up|0|||
44258431|NCT04096326|79113508|FG000|Overall Study|COVID-19-related reasons|0|||
44258432|NCT04096326|79113509|FG001|Overall Study|COVID-19-related reasons|0|||
44258433|NCT04096326|79113510|FG002|Overall Study|COVID-19-related reasons|0|||
44258434|NCT04096326|79113511|FG003|Overall Study|COVID-19-related reasons|0|||
44258435|NCT04096326|79113512|FG004|Overall Study|COVID-19-related reasons|1|||
44258436|NCT04096326|79113513|FG005|Overall Study|COVID-19-related reasons|5|||
44258437|NCT04096326|79113514|FG006|Overall Study|COVID-19-related reasons|0|||
44258438|NCT04096326|79113515|FG007|Overall Study|COVID-19-related reasons|0|||
44258439|NCT04096326|79113516|FG008|Overall Study|COVID-19-related reasons|0|||
44258440|NCT04096326|79113517|FG009|Overall Study|COVID-19-related reasons|0|||
44258441|NCT04072822|79113541|FG000|Treatment|Adverse Event|9|||
44258442|NCT04072822|79113542|FG001|Treatment|Adverse Event|5|||
44258443|NCT04072822|79113541|FG000|Treatment|Met Stopping Criteria|13|||
44258444|NCT04072822|79113542|FG001|Treatment|Met Stopping Criteria|24|||
44325919|NCT00195494|79331010|FG000|Year 2|Missed >4 consecutive doses|1|||
44325920|NCT00195494|79331011|FG001|Year 2|Missed >4 consecutive doses|1|||
44325921|NCT00195494|79331012|FG002|Year 2|Missed >4 consecutive doses|1|||
44258445|NCT04072822|79113541|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
44258446|NCT04072822|79113542|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
44258447|NCT04072822|79113541|FG000|Treatment|Withdrawal by Subject|0|||
44258448|NCT04072822|79113542|FG001|Treatment|Withdrawal by Subject|2|||
44258449|NCT04072822|79113541|FG000|Treatment|Death|0|||
44258450|NCT04072822|79113542|FG001|Treatment|Death|2|||
44258451|NCT04072822|79113541|FG000|Treatment|Lost to Follow-up|11|||
44325922|NCT00195494|79331013|FG003|Year 2|Missed >4 consecutive doses|0|||
44423144|NCT00788957|79431252|FG002|Part 1|Death|0|||
44423145|NCT00788957|79431253|FG003|Part 1|Death|0|||
44423146|NCT00788957|79431254|FG004|Part 1|Death|0|||
44423147|NCT00788957|79431255|FG005|Part 1|Death|0|||
44423148|NCT00788957|79431250|FG000|Part 1|Lost to Follow-up|1|||
44423149|NCT00788957|79431251|FG001|Part 1|Lost to Follow-up|0|||
44423150|NCT00788957|79431252|FG002|Part 1|Lost to Follow-up|0|||
44423151|NCT00788957|79431253|FG003|Part 1|Lost to Follow-up|0|||
44423152|NCT00788957|79431254|FG004|Part 1|Lost to Follow-up|0|||
44325923|NCT00195494|79331014|FG004|Year 2|Missed >4 consecutive doses|0|||
44325924|NCT00195494|79331015|FG005|Year 2|Missed >4 consecutive doses|0|||
44325925|NCT00195494|79331010|FG000|Year 2|Protocol deviation|0|||
44325926|NCT00195494|79331011|FG001|Year 2|Protocol deviation|1|||
44325927|NCT00195494|79331012|FG002|Year 2|Protocol deviation|0|||
44325928|NCT00195494|79331013|FG003|Year 2|Protocol deviation|0|||
44325929|NCT00195494|79331014|FG004|Year 2|Protocol deviation|0|||
44325930|NCT00195494|79331015|FG005|Year 2|Protocol deviation|0|||
44325931|NCT00195494|79331010|FG000|Year 2|Physician Decision|1|||
44325932|NCT00195494|79331011|FG001|Year 2|Physician Decision|1|||
44423153|NCT00788957|79431255|FG005|Part 1|Lost to Follow-up|0|||
44423154|NCT00788957|79431250|FG000|Part 2|Withdrawal by Subject|0|||
44325933|NCT00195494|79331012|FG002|Year 2|Physician Decision|0|||
44325934|NCT00195494|79331013|FG003|Year 2|Physician Decision|0|||
44325935|NCT00195494|79331014|FG004|Year 2|Physician Decision|0|||
44423155|NCT00788957|79431251|FG001|Part 2|Withdrawal by Subject|9|||
44423156|NCT00788957|79431252|FG002|Part 2|Withdrawal by Subject|5|||
44423157|NCT00788957|79431253|FG003|Part 2|Withdrawal by Subject|3|||
44423158|NCT00788957|79431254|FG004|Part 2|Withdrawal by Subject|0|||
44423159|NCT00788957|79431255|FG005|Part 2|Withdrawal by Subject|0|||
44423160|NCT00788957|79431250|FG000|Part 2|Death|0|||
44423161|NCT00788957|79431251|FG001|Part 2|Death|32|||
44423162|NCT00788957|79431252|FG002|Part 2|Death|35|||
44423163|NCT00788957|79431253|FG003|Part 2|Death|37|||
44325936|NCT00195494|79331015|FG005|Year 2|Physician Decision|0|||
44325937|NCT00195494|79331010|FG000|Year 2|Withdrawal by Subject|1|||
44325938|NCT00195494|79331011|FG001|Year 2|Withdrawal by Subject|5|||
44156562|NCT01939366|78947697|FG004|Overall Study|GCP non-compliance at site|3|||
44156563|NCT01918306|78947711|FG000|Overall Study|progresive disease|4|||
44156564|NCT01918306|78947712|FG001|Overall Study|progresive disease|0|||
44156565|NCT01918306|78947713|FG002|Overall Study|progresive disease|1|||
44156566|NCT01918306|78947714|FG003|Overall Study|progresive disease|1|||
44156567|NCT01918306|78947711|FG000|Overall Study|Withdrawal by Subject|0|||
44156568|NCT01918306|78947712|FG001|Overall Study|Withdrawal by Subject|0|||
44156569|NCT01918306|78947713|FG002|Overall Study|Withdrawal by Subject|0|||
44325939|NCT00195494|79331012|FG002|Year 2|Withdrawal by Subject|4|||
44325940|NCT00195494|79331013|FG003|Year 2|Withdrawal by Subject|3|||
44325941|NCT00195494|79331014|FG004|Year 2|Withdrawal by Subject|0|||
44325942|NCT00195494|79331015|FG005|Year 2|Withdrawal by Subject|0|||
44325943|NCT00195494|79331010|FG000|Year 2|System toxicity|0|||
44325944|NCT00195494|79331011|FG001|Year 2|System toxicity|0|||
44325945|NCT00195494|79331012|FG002|Year 2|System toxicity|0|||
44325946|NCT00195494|79331013|FG003|Year 2|System toxicity|1|||
44325947|NCT00195494|79331014|FG004|Year 2|System toxicity|0|||
44325948|NCT00195494|79331015|FG005|Year 2|System toxicity|0|||
44325949|NCT00194987|79331033|FG000|Overall Study|Withdrawal by Subject|0|||
44325950|NCT00194987|79331034|FG001|Overall Study|Withdrawal by Subject|3|||
44325951|NCT00194792|79331042|FG000|Overall Study|Withdrawal by Subject|1|||
44325952|NCT00194675|79331057|FG000|Overall Study|Lost to Follow-up|1|||
44325953|NCT00194675|79331058|FG001|Overall Study|Lost to Follow-up|1|||
44325954|NCT00194675|79331057|FG000|Overall Study|lack of interest|1|||
44325955|NCT00194675|79331058|FG001|Overall Study|lack of interest|1|||
44325956|NCT00194675|79331057|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
44325957|NCT00194675|79331058|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
44325958|NCT00194675|79331057|FG000|Overall Study|Protocol Violation|1|||
44325959|NCT00194675|79331058|FG001|Overall Study|Protocol Violation|0|||
44423164|NCT00788957|79431254|FG004|Part 2|Death|0|||
44325960|NCT00194675|79331057|FG000|Overall Study|Death|1|||
44325961|NCT00194675|79331058|FG001|Overall Study|Death|0|||
44325962|NCT00194012|79331068|FG000|Randomized Phase|Lack of Efficacy|8|||
44325963|NCT00194012|79331069|FG001|Randomized Phase|Lack of Efficacy|18|||
44325964|NCT00194012|79331068|FG000|Randomized Phase|Study nonadherence|2|||
44325965|NCT00194012|79331069|FG001|Randomized Phase|Study nonadherence|1|||
44325966|NCT00194012|79331068|FG000|Randomized Phase|Withdrawal by Subject|3|||
44325967|NCT00194012|79331069|FG001|Randomized Phase|Withdrawal by Subject|3|||
44325968|NCT00194012|79331068|FG000|Randomized Phase|Adverse Event|2|||
44325969|NCT00194012|79331069|FG001|Randomized Phase|Adverse Event|1|||
44325970|NCT00194012|79331068|FG000|Randomized Phase|Participant reported having a rash|1|||
44325971|NCT00194012|79331069|FG001|Randomized Phase|Participant reported having a rash|0|||
44325972|NCT00194012|79331068|FG000|Randomized Phase|Emesis and enuresis|0|||
44325973|NCT00194012|79331069|FG001|Randomized Phase|Emesis and enuresis|1|||
44325974|NCT00194012|79331068|FG000|Randomized Phase|Oral/nasal twitching|0|||
44325975|NCT00194012|79331069|FG001|Randomized Phase|Oral/nasal twitching|1|||
44325976|NCT00194012|79331068|FG000|Open Label Extension (OLE)|Weight Gain|1|||
44325977|NCT00194012|79331069|FG001|Open Label Extension (OLE)|Weight Gain|0|||
44423165|NCT00788957|79431255|FG005|Part 2|Death|0|||
44423166|NCT00788957|79431250|FG000|Part 2|Lost to Follow-up|0|||
44423167|NCT00788957|79431251|FG001|Part 2|Lost to Follow-up|0|||
44325978|NCT00194012|79331068|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
44325979|NCT00194012|79331069|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
44325980|NCT00194012|79331068|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
44325981|NCT00194012|79331069|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
44325982|NCT00194012|79331068|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
44325983|NCT00194012|79331069|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
44325984|NCT00192647|79331083|FG000|Overall Study|Death|1|||
44423168|NCT00788957|79431252|FG002|Part 2|Lost to Follow-up|3|||
44325985|NCT00192647|79331084|FG001|Overall Study|Death|1|||
44325986|NCT00192647|79331083|FG000|Overall Study|Adverse Event|35|||
44325987|NCT00192647|79331084|FG001|Overall Study|Adverse Event|29|||
44325988|NCT00192647|79331083|FG000|Overall Study|Laboratory Test Abnormality|4|||
44325989|NCT00192647|79331084|FG001|Overall Study|Laboratory Test Abnormality|2|||
44325990|NCT00192647|79331083|FG000|Overall Study|Insufficient Therapeutic Response|53|||
44325991|NCT00192647|79331084|FG001|Overall Study|Insufficient Therapeutic Response|83|||
44325992|NCT00192647|79331083|FG000|Overall Study|Entry Criteria Violation|6|||
44325993|NCT00192647|79331084|FG001|Overall Study|Entry Criteria Violation|6|||
44325994|NCT00192647|79331083|FG000|Overall Study|Protocol Violation|3|||
44325995|NCT00192647|79331084|FG001|Overall Study|Protocol Violation|1|||
44325996|NCT00192647|79331083|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
44325997|NCT00192647|79331084|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
44325998|NCT00192647|79331083|FG000|Overall Study|Failure to Return|11|||
44325999|NCT00192647|79331084|FG001|Overall Study|Failure to Return|13|||
44326000|NCT00192647|79331083|FG000|Overall Study|Other/Administrative|5|||
44326001|NCT00192647|79331084|FG001|Overall Study|Other/Administrative|3|||
44326002|NCT00192296|79331094|FG000|Overall Study|Withdrawal by Subject|0|||
44326003|NCT00192296|79331095|FG001|Overall Study|Withdrawal by Subject|1|||
44326004|NCT00192296|79331096|FG002|Overall Study|Withdrawal by Subject|0|||
44326005|NCT00192296|79331097|FG003|Overall Study|Withdrawal by Subject|0|||
44326006|NCT00192023|79331109|FG000|Period III - Double-Blind|Adverse Event|3|||
44326007|NCT00192023|79331110|FG001|Period III - Double-Blind|Adverse Event|0|||
44326008|NCT00192023|79331109|FG000|Period III - Double-Blind|Physician Decision|2|||
44326009|NCT00192023|79331110|FG001|Period III - Double-Blind|Physician Decision|0|||
44326010|NCT00192023|79331109|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
44326011|NCT00192023|79331110|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
44326012|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
44326013|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
44326014|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
44326015|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
44423169|NCT00788957|79431253|FG003|Part 2|Lost to Follow-up|0|||
44423170|NCT00788957|79431254|FG004|Part 2|Lost to Follow-up|0|||
44423171|NCT00788957|79431255|FG005|Part 2|Lost to Follow-up|0|||
44423172|NCT00788957|79431250|FG000|Part 2|On-study at time of data cut-off|0|||
44423173|NCT00788957|79431251|FG001|Part 2|On-study at time of data cut-off|1|||
44423174|NCT00788957|79431252|FG002|Part 2|On-study at time of data cut-off|1|||
44423175|NCT00788957|79431253|FG003|Part 2|On-study at time of data cut-off|1|||
44423176|NCT00788957|79431254|FG004|Part 2|On-study at time of data cut-off|0|||
44423177|NCT00788957|79431255|FG005|Part 2|On-study at time of data cut-off|0|||
44423178|NCT00788957|79431250|FG000|Part 3|Withdrawal by Subject|0|||
44423179|NCT00788957|79431251|FG001|Part 3|Withdrawal by Subject|0|||
44423180|NCT00788957|79431252|FG002|Part 3|Withdrawal by Subject|0|||
44423181|NCT00788957|79431253|FG003|Part 3|Withdrawal by Subject|0|||
44423182|NCT00788957|79431254|FG004|Part 3|Withdrawal by Subject|0|||
44326016|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
44326017|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
44326018|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
44326019|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
44326020|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
44326021|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
44326022|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
44423183|NCT00788957|79431255|FG005|Part 3|Withdrawal by Subject|2|||
44423184|NCT00788957|79431250|FG000|Part 3|Death|0|||
44423185|NCT00788957|79431251|FG001|Part 3|Death|0|||
44423186|NCT00788957|79431252|FG002|Part 3|Death|0|||
44423187|NCT00788957|79431253|FG003|Part 3|Death|0|||
44423188|NCT00788957|79431254|FG004|Part 3|Death|8|||
44423189|NCT00788957|79431255|FG005|Part 3|Death|9|||
44423190|NCT00788957|79431250|FG000|Part 3|On-study at time of data cut-off|0|||
44423191|NCT00788957|79431251|FG001|Part 3|On-study at time of data cut-off|0|||
44423192|NCT00788957|79431252|FG002|Part 3|On-study at time of data cut-off|0|||
44326023|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
44423193|NCT00788957|79431253|FG003|Part 3|On-study at time of data cut-off|0|||
44423194|NCT00788957|79431254|FG004|Part 3|On-study at time of data cut-off|1|||
44423195|NCT00788957|79431255|FG005|Part 3|On-study at time of data cut-off|0|||
44423196|NCT00740636|79431274|FG000|Overall Study|Adverse Event|0|||
44423197|NCT00740636|79431275|FG001|Overall Study|Adverse Event|2|||
44326024|NCT00192023|79331109|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
44326025|NCT00192023|79331110|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
44326026|NCT00191984|79331116|FG000|Overall Study|Disease Progression|21|||
44326027|NCT00191984|79331116|FG000|Overall Study|Adverse Event|4|||
44326028|NCT00191984|79331116|FG000|Overall Study|Death|2|||
44326029|NCT00191984|79331116|FG000|Overall Study|Entry Criteria Exclusion|1|||
44326030|NCT00191984|79331116|FG000|Overall Study|Withdrawal by Subject|7|||
44326031|NCT00191984|79331116|FG000|Overall Study|Physician Decision|4|||
44326032|NCT00191906|79331124|FG000|Study Period II|Adverse Event|0|||
44326033|NCT00191906|79331125|FG001|Study Period II|Adverse Event|1|||
44326034|NCT00191906|79331126|FG002|Study Period II|Adverse Event|0|||
44423198|NCT00740636|79431274|FG000|Overall Study|Patient Ineligible|0|||
44423199|NCT00740636|79431275|FG001|Overall Study|Patient Ineligible|1|||
44423200|NCT00740636|79431274|FG000|Overall Study|Patient Not Treated|0|||
44423201|NCT00740636|79431275|FG001|Overall Study|Patient Not Treated|1|||
44423202|NCT00740636|79431274|FG000|Overall Study|Progressive Disease|1|||
44423203|NCT00740636|79431275|FG001|Overall Study|Progressive Disease|0|||
44423204|NCT00740636|79431274|FG000|Overall Study|Death|1|||
44423205|NCT00740636|79431275|FG001|Overall Study|Death|0|||
44423206|NCT00735254|79431285|FG000|Overall Study|Protocol Violation|1|||
44423207|NCT00735254|79431286|FG001|Overall Study|Protocol Violation|1|||
44423208|NCT00735254|79431287|FG002|Overall Study|Protocol Violation|1|||
44423209|NCT00735254|79431288|FG003|Overall Study|Protocol Violation|0|||
44423210|NCT00795509|79431298|FG000|Overall Study|Protocol Violation|31|||
44423211|NCT00787787|79431302|FG000|Overall Study|Lack of Efficacy|4|||
44423212|NCT00787787|79431302|FG000|Overall Study|Adverse Event|3|||
44423213|NCT00787319|79431306|FG000|Overall Study|Lost to Follow-up|2|||
44423214|NCT00787319|79431306|FG000|Overall Study|Withdrawal by Subject|15|||
44423215|NCT00787319|79431306|FG000|Overall Study|Adverse Event|3|||
44423216|NCT00787319|79431306|FG000|Overall Study|Objective progression or relapse|30|||
44423217|NCT00787319|79431306|FG000|Overall Study|Lack of Efficacy|1|||
44423218|NCT00787319|79431306|FG000|Overall Study|Budget exhausted/exceeded|1|||
44423219|NCT00787319|79431306|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
44423220|NCT00787319|79431306|FG000|Overall Study|No health insurance reimbursement|2|||
44423221|NCT00787319|79431306|FG000|Overall Study|Stabilized disease findings|3|||
44423222|NCT00787319|79431306|FG000|Overall Study|Inactive disease|5|||
44423223|NCT00794963|79431312|FG000|Overall Study|Withdrawal by Subject|1|||
44423224|NCT00794963|79431313|FG001|Overall Study|Withdrawal by Subject|4|||
44423225|NCT00794573|79431321|FG000|Overall Study|Death|3|||
44423226|NCT00794573|79431322|FG001|Overall Study|Death|0|||
44423227|NCT00794573|79431321|FG000|Overall Study|Withdrawal by Subject|9|||
44423228|NCT00794573|79431322|FG001|Overall Study|Withdrawal by Subject|12|||
44423229|NCT00794573|79431321|FG000|Overall Study|Lost to Follow-up|26|||
44423230|NCT00794573|79431322|FG001|Overall Study|Lost to Follow-up|33|||
44326035|NCT00191906|79331127|FG003|Study Period II|Adverse Event|0|||
44326036|NCT00191906|79331124|FG000|Study Period II|Withdrawal by Subject|0|||
44423231|NCT00584844|79431328|FG000|Overall Study|Withdrawal by Subject|59|||
44423232|NCT00584844|79431328|FG000|Overall Study|Screen Failure|20|||
44423233|NCT00739934|79431336|FG000|Voriconazole IV|Adverse Event|6|||
44423234|NCT00739934|79431336|FG000|Voriconazole Oral|Other|3|||
44423235|NCT00739310|79431345|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
44423236|NCT00739310|79431345|FG000|Overall Study|Withdrawal by Subject|1|||
44423237|NCT00739310|79431345|FG000|Overall Study|Lost to Follow-up|2|||
44423238|NCT00734630|79431352|FG000|Overall Study|Lack of Efficacy|4|||
44423239|NCT00734630|79431353|FG001|Overall Study|Lack of Efficacy|4|||
44326037|NCT00191906|79331125|FG001|Study Period II|Withdrawal by Subject|3|||
44326038|NCT00191906|79331126|FG002|Study Period II|Withdrawal by Subject|0|||
44423240|NCT00734630|79431352|FG000|Overall Study|Withdrawal by Subject|7|||
44423241|NCT00734630|79431353|FG001|Overall Study|Withdrawal by Subject|9|||
44423242|NCT00734630|79431352|FG000|Overall Study|Lost to Follow-up|13|||
44423243|NCT00734630|79431353|FG001|Overall Study|Lost to Follow-up|7|||
44423244|NCT00734630|79431352|FG000|Overall Study|Protocol Violation|0|||
44423245|NCT00734630|79431353|FG001|Overall Study|Protocol Violation|3|||
44423246|NCT00734630|79431352|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
44423247|NCT00734630|79431353|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
44423248|NCT00734630|79431352|FG000|Overall Study|Adverse Event|3|||
44423249|NCT00734630|79431353|FG001|Overall Study|Adverse Event|6|||
44423250|NCT00734630|79431352|FG000|Overall Study|Randomized in Error|0|||
44423251|NCT00734630|79431353|FG001|Overall Study|Randomized in Error|1|||
44326039|NCT00191906|79331127|FG003|Study Period II|Withdrawal by Subject|0|||
44326040|NCT00191906|79331124|FG000|Study Period II|Parent/Caregiver Decision|0|||
44326041|NCT00191906|79331125|FG001|Study Period II|Parent/Caregiver Decision|1|||
44326042|NCT00191906|79331126|FG002|Study Period II|Parent/Caregiver Decision|0|||
44423252|NCT00734630|79431352|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
44423253|NCT00734630|79431353|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
44423254|NCT00734630|79431352|FG000|Overall Study|Poor Compliance|1|||
44423255|NCT00734630|79431353|FG001|Overall Study|Poor Compliance|1|||
44423256|NCT00584454|79431359|FG000|Overall Study|Adverse Event|1|||
44423257|NCT00584454|79431359|FG000|Overall Study|Relocation|1|||
44423258|NCT00584454|79431359|FG000|Overall Study|Clinical Hold|2|||
44423259|NCT00578175|79431366|FG000|Overall Study|Adverse Event|0|||
44423260|NCT00578175|79431367|FG001|Overall Study|Adverse Event|1|||
44423261|NCT00578175|79431368|FG002|Overall Study|Adverse Event|1|||
44423262|NCT00578175|79431366|FG000|Overall Study|Other reasons|70|||
44423263|NCT00578175|79431367|FG001|Overall Study|Other reasons|42|||
44423264|NCT00578175|79431368|FG002|Overall Study|Other reasons|23|||
44326043|NCT00191906|79331127|FG003|Study Period II|Parent/Caregiver Decision|0|||
44326044|NCT00191906|79331124|FG000|Study Period II|Entry Criteria Exclusion|0|||
44326045|NCT00191906|79331125|FG001|Study Period II|Entry Criteria Exclusion|0|||
44326046|NCT00191906|79331126|FG002|Study Period II|Entry Criteria Exclusion|1|||
44423265|NCT00435409|79431380|FG000|Overall Study|Protocol Violation|1|||
44423266|NCT00435409|79431381|FG001|Overall Study|Protocol Violation|2|||
44423267|NCT00435409|79431382|FG002|Overall Study|Protocol Violation|0|||
44423268|NCT00435409|79431380|FG000|Overall Study|Lost to Follow-up|1|||
44423269|NCT00435409|79431381|FG001|Overall Study|Lost to Follow-up|2|||
44423270|NCT00435409|79431382|FG002|Overall Study|Lost to Follow-up|0|||
44423271|NCT00435409|79431380|FG000|Overall Study|Death|8|||
44423272|NCT00435409|79431381|FG001|Overall Study|Death|6|||
44423273|NCT00435409|79431382|FG002|Overall Study|Death|6|||
44423274|NCT00435409|79431380|FG000|Overall Study|Objective progression or relapse|158|||
44423275|NCT00435409|79431381|FG001|Overall Study|Objective progression or relapse|93|||
44423276|NCT00435409|79431382|FG002|Overall Study|Objective progression or relapse|58|||
44423277|NCT00435409|79431380|FG000|Overall Study|Global deterioration of health status|0|||
44423278|NCT00435409|79431381|FG001|Overall Study|Global deterioration of health status|0|||
44423279|NCT00435409|79431382|FG002|Overall Study|Global deterioration of health status|4|||
44423280|NCT00435409|79431380|FG000|Overall Study|Withdrawal by Subject|8|||
44423281|NCT00435409|79431381|FG001|Overall Study|Withdrawal by Subject|7|||
44326047|NCT00191906|79331127|FG003|Study Period II|Entry Criteria Exclusion|0|||
44326048|NCT00191906|79331124|FG000|Study Period III|Adverse Event|1|||
44326049|NCT00191906|79331125|FG001|Study Period III|Adverse Event|0|||
44326050|NCT00191906|79331126|FG002|Study Period III|Adverse Event|0|||
44326051|NCT00191906|79331127|FG003|Study Period III|Adverse Event|0|||
44326052|NCT00191906|79331124|FG000|Study Period III|Lost to Follow-up|0|||
44326053|NCT00191906|79331125|FG001|Study Period III|Lost to Follow-up|1|||
44326054|NCT00191906|79331126|FG002|Study Period III|Lost to Follow-up|0|||
44326055|NCT00191906|79331127|FG003|Study Period III|Lost to Follow-up|0|||
44326056|NCT00191906|79331124|FG000|Study Period III|Parent/Caregiver Decision|1|||
44326057|NCT00191906|79331125|FG001|Study Period III|Parent/Caregiver Decision|0|||
44326058|NCT00191906|79331126|FG002|Study Period III|Parent/Caregiver Decision|0|||
44326059|NCT00191906|79331127|FG003|Study Period III|Parent/Caregiver Decision|0|||
44326060|NCT00191906|79331124|FG000|Study Period III|Lack of Efficacy|3|||
44326061|NCT00191906|79331125|FG001|Study Period III|Lack of Efficacy|3|||
44326062|NCT00191906|79331126|FG002|Study Period III|Lack of Efficacy|0|||
44326063|NCT00191906|79331127|FG003|Study Period III|Lack of Efficacy|0|||
44326064|NCT00191789|79331143|FG000|Overall Study|Adverse Event|5|||
44326065|NCT00191789|79331143|FG000|Overall Study|Patient: Satisfactory Response|5|||
44326066|NCT00191789|79331143|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
44326067|NCT00191789|79331143|FG000|Overall Study|Withdrawal by Subject|4|||
44326068|NCT00191789|79331143|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
44326069|NCT00191789|79331143|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
44326070|NCT00191789|79331143|FG000|Overall Study|Death - Not Study-Drug Related|1|||
44326071|NCT00191282|79331149|FG000|Overall Study|Adverse Event|5|||
44326072|NCT00191282|79331150|FG001|Overall Study|Adverse Event|6|||
44326073|NCT00191282|79331149|FG000|Overall Study|Death|51|||
44326074|NCT00191282|79331150|FG001|Overall Study|Death|51|||
44326075|NCT00191282|79331149|FG000|Overall Study|Lack of Efficacy|11|||
44326076|NCT00191282|79331150|FG001|Overall Study|Lack of Efficacy|6|||
44326077|NCT00191282|79331149|FG000|Overall Study|Noncompliance|14|||
44326078|NCT00191282|79331150|FG001|Overall Study|Noncompliance|17|||
44423282|NCT00435409|79431382|FG002|Overall Study|Withdrawal by Subject|1|||
44423283|NCT00435409|79431380|FG000|Overall Study|Other|45|||
44423284|NCT00435409|79431381|FG001|Overall Study|Other|30|||
44423285|NCT00435409|79431382|FG002|Overall Study|Other|1|||
44423286|NCT00435409|79431380|FG000|Overall Study|Adverse Event|0|||
44423287|NCT00435409|79431381|FG001|Overall Study|Adverse Event|0|||
44423288|NCT00435409|79431382|FG002|Overall Study|Adverse Event|8|||
44326079|NCT00191282|79331149|FG000|Overall Study|Patient moved|11|||
44326080|NCT00191282|79331150|FG001|Overall Study|Patient moved|14|||
44326081|NCT00191282|79331149|FG000|Overall Study|Withdrawal by Subject|59|||
44326082|NCT00191282|79331150|FG001|Overall Study|Withdrawal by Subject|44|||
44326083|NCT00191282|79331149|FG000|Overall Study|Physician Decision|18|||
44326084|NCT00191282|79331150|FG001|Overall Study|Physician Decision|15|||
44423289|NCT00435409|79431380|FG000|Overall Study|Sponsor decision|0|||
44423290|NCT00435409|79431381|FG001|Overall Study|Sponsor decision|3|||
44326085|NCT00191282|79331149|FG000|Overall Study|Protocol entry criteria not met|14|||
44423291|NCT00435409|79431382|FG002|Overall Study|Sponsor decision|0|||
44326086|NCT00191282|79331150|FG001|Overall Study|Protocol entry criteria not met|9|||
44326087|NCT00191282|79331149|FG000|Overall Study|Protocol Violation|9|||
44326088|NCT00191282|79331150|FG001|Overall Study|Protocol Violation|12|||
44326089|NCT00191282|79331149|FG000|Overall Study|Severity of outcome|2|||
44326090|NCT00191282|79331150|FG001|Overall Study|Severity of outcome|5|||
44326091|NCT00191282|79331149|FG000|Overall Study|Sponsor's decision|2|||
44326092|NCT00191282|79331150|FG001|Overall Study|Sponsor's decision|2|||
44326093|NCT00191282|79331149|FG000|Overall Study|Lost to Follow-up|24|||
44326094|NCT00191282|79331150|FG001|Overall Study|Lost to Follow-up|31|||
44326095|NCT00191165|79331158|FG000|Overall Study|Adverse Event|2|||
44326096|NCT00191165|79331159|FG001|Overall Study|Adverse Event|0|||
44258452|NCT04072822|79113542|FG001|Treatment|Lost to Follow-up|3|||
44258453|NCT04072822|79113541|FG000|Treatment|Physician Decision|1|||
44423292|NCT00467857|79431399|FG000|Overall Study|Adverse Event|1|||
44423293|NCT00467857|79431400|FG001|Overall Study|Adverse Event|0|||
44258454|NCT04072822|79113542|FG001|Treatment|Physician Decision|0|||
44258455|NCT04072822|79113541|FG000|Treatment|Other|7|||
44258456|NCT04072822|79113542|FG001|Treatment|Other|9|||
44258457|NCT04072822|79113541|FG000|Follow-up|Withdrawal by Subject|1|||
44258458|NCT04072822|79113542|FG001|Follow-up|Withdrawal by Subject|0|||
44258459|NCT04072822|79113541|FG000|Follow-up|Lost to Follow-up|5|||
44326097|NCT00191165|79331158|FG000|Overall Study|Protocol Violation|0|||
44326098|NCT00191165|79331159|FG001|Overall Study|Protocol Violation|1|||
44326099|NCT00191165|79331158|FG000|Overall Study|Participant Moved Away|0|||
44326100|NCT00191165|79331159|FG001|Overall Study|Participant Moved Away|1|||
44326101|NCT00190775|79331167|FG000|Overall Study|Adverse Event|57|||
44326102|NCT00190775|79331168|FG001|Overall Study|Adverse Event|22|||
44326103|NCT00190775|79331167|FG000|Overall Study|Satisfactory Response|1|||
44326104|NCT00190775|79331168|FG001|Overall Study|Satisfactory Response|0|||
44326105|NCT00190775|79331167|FG000|Overall Study|Lack of Efficacy|28|||
44326106|NCT00190775|79331168|FG001|Overall Study|Lack of Efficacy|32|||
44326107|NCT00190775|79331167|FG000|Overall Study|Lost to Follow-up|31|||
44326108|NCT00190775|79331168|FG001|Overall Study|Lost to Follow-up|23|||
44326109|NCT00190775|79331167|FG000|Overall Study|Participant Moved|0|||
44326110|NCT00190775|79331168|FG001|Overall Study|Participant Moved|1|||
44326111|NCT00190775|79331167|FG000|Overall Study|Withdrawal by Subject|24|||
44326112|NCT00190775|79331168|FG001|Overall Study|Withdrawal by Subject|13|||
44326113|NCT00190775|79331167|FG000|Overall Study|Sponsor Decision|1|||
44326114|NCT00190775|79331168|FG001|Overall Study|Sponsor Decision|0|||
44326115|NCT00190775|79331167|FG000|Overall Study|Physician Decision|3|||
44326116|NCT00190775|79331168|FG001|Overall Study|Physician Decision|0|||
44326117|NCT00190775|79331167|FG000|Overall Study|Noncompliance|3|||
44326118|NCT00190775|79331168|FG001|Overall Study|Noncompliance|5|||
44326119|NCT00190775|79331167|FG000|Overall Study|Protocol Violation|0|||
44326120|NCT00190775|79331168|FG001|Overall Study|Protocol Violation|1|||
44326121|NCT00190775|79331167|FG000|Overall Study|Exclusion Criteria Met|1|||
44326122|NCT00190775|79331168|FG001|Overall Study|Exclusion Criteria Met|3|||
44326123|NCT00199901|79331183|FG000|Overall Study|Protocol Violation|2|||
44326124|NCT00199901|79331184|FG001|Overall Study|Protocol Violation|0|||
44326125|NCT00199901|79331183|FG000|Overall Study|Withdrawal by Subject|1|||
44326126|NCT00199901|79331184|FG001|Overall Study|Withdrawal by Subject|0|||
44326127|NCT00199901|79331183|FG000|Overall Study|Progressive Disease|24|||
44326128|NCT00199901|79331184|FG001|Overall Study|Progressive Disease|24|||
44326129|NCT00198107|79331194|FG000|Double-Blind Period|Adverse Event|1|||
44326130|NCT00198107|79331195|FG001|Double-Blind Period|Adverse Event|1|||
44326131|NCT00198107|79331196|FG002|Double-Blind Period|Adverse Event|0|||
44326132|NCT00198107|79331194|FG000|Double-Blind Period|Lack of Efficacy|2|||
44326133|NCT00198107|79331195|FG001|Double-Blind Period|Lack of Efficacy|0|||
44326134|NCT00198107|79331196|FG002|Double-Blind Period|Lack of Efficacy|0|||
44326135|NCT00198107|79331194|FG000|Double-Blind Period|Lost to Follow-up|2|||
44326136|NCT00198107|79331195|FG001|Double-Blind Period|Lost to Follow-up|1|||
44326137|NCT00198107|79331196|FG002|Double-Blind Period|Lost to Follow-up|0|||
44326138|NCT00198107|79331194|FG000|Double-Blind Period|Physician Decision|1|||
44326139|NCT00198107|79331195|FG001|Double-Blind Period|Physician Decision|0|||
44326140|NCT00198107|79331196|FG002|Double-Blind Period|Physician Decision|0|||
44326141|NCT00198107|79331194|FG000|Double-Blind Period|Withdrawal by Subject|0|||
44326142|NCT00198107|79331195|FG001|Double-Blind Period|Withdrawal by Subject|1|||
44423294|NCT00467857|79431399|FG000|Overall Study|Withdrew consent|2|||
44326143|NCT00198107|79331196|FG002|Double-Blind Period|Withdrawal by Subject|0|||
44326144|NCT00198107|79331194|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
44326145|NCT00198107|79331195|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
44326146|NCT00198107|79331196|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
44326147|NCT00179660|79331204|FG000|Overall Study|Adverse Event|7|||
44326148|NCT00179660|79331204|FG000|Overall Study|Lack of therapeutic effect|28|||
44326149|NCT00179660|79331204|FG000|Overall Study|Withdrawal by Subject|2|||
44326150|NCT00179660|79331204|FG000|Overall Study|Lost to Follow-up|1|||
44326151|NCT00179660|79331204|FG000|Overall Study|Death|3|||
44423295|NCT00467857|79431400|FG001|Overall Study|Withdrew consent|0|||
44423296|NCT00467857|79431399|FG000|Overall Study|Death|0|||
44423297|NCT00467857|79431400|FG001|Overall Study|Death|1|||
44423298|NCT00467857|79431399|FG000|Overall Study|Discharged from court service|0|||
44423299|NCT00467857|79431400|FG001|Overall Study|Discharged from court service|1|||
44423300|NCT00467857|79431399|FG000|Overall Study|Emergency care required|0|||
44423301|NCT00467857|79431400|FG001|Overall Study|Emergency care required|1|||
44423302|NCT00467857|79431399|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
44423303|NCT00467857|79431400|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
44423304|NCT00467857|79431399|FG000|Overall Study|Discontinuation reason missing|0|||
44423305|NCT00467857|79431400|FG001|Overall Study|Discontinuation reason missing|3|||
44423306|NCT00435019|79431408|FG000|Overall Study|Adverse Event|1|||
44423307|NCT00435019|79431409|FG001|Overall Study|Adverse Event|0|||
44423308|NCT00435019|79431408|FG000|Overall Study|Lack of Efficacy|1|||
44423309|NCT00435019|79431409|FG001|Overall Study|Lack of Efficacy|2|||
44423310|NCT00435019|79431408|FG000|Overall Study|Protocol Violation|3|||
44423311|NCT00435019|79431409|FG001|Overall Study|Protocol Violation|1|||
44423312|NCT00435019|79431408|FG000|Overall Study|Personal reasons for withdrawal|8|||
44423313|NCT00435019|79431409|FG001|Overall Study|Personal reasons for withdrawal|7|||
44423314|NCT00577863|79431417|FG000|Overall Study|Adverse Event|4|||
44423315|NCT00577863|79431418|FG001|Overall Study|Adverse Event|2|||
44423316|NCT00577863|79431417|FG000|Overall Study|Death|1|||
44423317|NCT00577863|79431418|FG001|Overall Study|Death|0|||
44423318|NCT00577863|79431417|FG000|Overall Study|Lost to Follow-up|2|||
44423319|NCT00577863|79431418|FG001|Overall Study|Lost to Follow-up|2|||
44423320|NCT00577863|79431417|FG000|Overall Study|Entry Criteria Exclusion|1|||
44423321|NCT00577863|79431418|FG001|Overall Study|Entry Criteria Exclusion|0|||
44423322|NCT00577863|79431417|FG000|Overall Study|Withdrawal by Subject|0|||
44423323|NCT00577863|79431418|FG001|Overall Study|Withdrawal by Subject|2|||
44423324|NCT00577863|79431417|FG000|Overall Study|Sponsor Decision|2|||
44423325|NCT00577863|79431418|FG001|Overall Study|Sponsor Decision|7|||
44423326|NCT00577863|79431417|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
44423327|NCT00577863|79431418|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
44423328|NCT00794417|79431428|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
44326152|NCT00179660|79331204|FG000|Overall Study|Other - Unspecified|9|||
44326153|NCT00178256|79331208|FG000|Overall Study|Adverse Event|2|||
44326154|NCT00178256|79331209|FG001|Overall Study|Adverse Event|0|||
44326155|NCT00178256|79331210|FG002|Overall Study|Adverse Event|0|||
44326156|NCT00178256|79331211|FG003|Overall Study|Adverse Event|0|||
44326157|NCT00178256|79331208|FG000|Overall Study|Death|0|||
44326158|NCT00178256|79331209|FG001|Overall Study|Death|1|||
44326159|NCT00178256|79331210|FG002|Overall Study|Death|0|||
44326160|NCT00178256|79331211|FG003|Overall Study|Death|1|||
44326161|NCT00178256|79331208|FG000|Overall Study|Cancer progression|2|||
44326162|NCT00178256|79331209|FG001|Overall Study|Cancer progression|0|||
44326163|NCT00178256|79331210|FG002|Overall Study|Cancer progression|0|||
44326164|NCT00178256|79331211|FG003|Overall Study|Cancer progression|1|||
44326165|NCT00177164|79331220|FG000|Overall Study|Protocol Violation|0|||
44326166|NCT00177164|79331221|FG001|Overall Study|Protocol Violation|7|||
44326167|NCT00177164|79331220|FG000|Overall Study|Lost to Follow-up|4|||
44326168|NCT00177164|79331221|FG001|Overall Study|Lost to Follow-up|5|||
44326169|NCT00177164|79331220|FG000|Overall Study|increase in alcohol and drug use|1|||
44326170|NCT00177164|79331221|FG001|Overall Study|increase in alcohol and drug use|2|||
44326171|NCT00177164|79331220|FG000|Overall Study|Adverse Event|1|||
44326172|NCT00177164|79331221|FG001|Overall Study|Adverse Event|0|||
44326173|NCT00177164|79331220|FG000|Overall Study|discharge from hospital|1|||
44326174|NCT00177164|79331221|FG001|Overall Study|discharge from hospital|0|||
44326175|NCT00177164|79331220|FG000|Overall Study|Lack of Efficacy|2|||
44326176|NCT00177164|79331221|FG001|Overall Study|Lack of Efficacy|1|||
44423329|NCT00794417|79431429|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
44423330|NCT00794417|79431430|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
44423331|NCT00794417|79431431|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
44423332|NCT00794417|79431428|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
44423333|NCT00794417|79431429|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
44423334|NCT00794417|79431430|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
44423335|NCT00794417|79431431|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
44423336|NCT00794417|79431428|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
44423337|NCT00794417|79431429|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
44423338|NCT00794417|79431430|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
44326177|NCT00177164|79331220|FG000|Overall Study|Pregnancy|0|||
44423339|NCT00794417|79431431|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
44423340|NCT00794417|79431428|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
44326178|NCT00177164|79331221|FG001|Overall Study|Pregnancy|1|||
44326179|NCT02489942|79331244|FG000|Overall Study|Request by patient|602|||
44326180|NCT02489942|79331244|FG000|Overall Study|Improvement/remission|157|||
44326181|NCT02489942|79331244|FG000|Overall Study|No change/Progressive disease|263|||
44423341|NCT00794417|79431429|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
44423342|NCT00794417|79431430|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
44423343|NCT00794417|79431431|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
44423344|NCT00794417|79431428|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
44423345|NCT00794417|79431429|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
44423346|NCT00794417|79431430|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
44423347|NCT00794417|79431431|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
44326182|NCT02489942|79331244|FG000|Overall Study|Adverse Event|522|||
44326183|NCT02489942|79331244|FG000|Overall Study|Other personal reasons|1218|||
44326184|NCT02489942|79331244|FG000|Overall Study|Lost to Follow-up|456|||
44326185|NCT02489942|79331244|FG000|Overall Study|Not continuously investigated|7|||
44326186|NCT02489942|79331244|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
44326187|NCT02489942|79331244|FG000|Overall Study|Multiple registration|1|||
44326188|NCT02489942|79331244|FG000|Overall Study|No patient visit after entry|100|||
44326189|NCT02489942|79331244|FG000|Overall Study|No treatment with Jardiance|2|||
44423348|NCT00794417|79431428|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
44423349|NCT00794417|79431429|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
44423350|NCT00794417|79431430|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
44423351|NCT00794417|79431431|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
44423352|NCT00790907|79431446|FG000|Overall Study|Adverse Event|9|||
44423353|NCT00790907|79431447|FG001|Overall Study|Adverse Event|7|||
44423354|NCT00790907|79431448|FG002|Overall Study|Adverse Event|6|||
44423355|NCT00790907|79431446|FG000|Overall Study|Physician Decision|304|||
44423356|NCT00790907|79431447|FG001|Overall Study|Physician Decision|271|||
44423357|NCT00790907|79431448|FG002|Overall Study|Physician Decision|255|||
44423358|NCT00790907|79431446|FG000|Overall Study|Withdrawal by Subject|1|||
44423359|NCT00790907|79431447|FG001|Overall Study|Withdrawal by Subject|7|||
44423360|NCT00790907|79431448|FG002|Overall Study|Withdrawal by Subject|5|||
44423361|NCT00790907|79431446|FG000|Overall Study|Bleeding Event|11|||
44423362|NCT00790907|79431447|FG001|Overall Study|Bleeding Event|16|||
44423363|NCT00790907|79431448|FG002|Overall Study|Bleeding Event|21|||
44423364|NCT00790907|79431446|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
44423365|NCT00790907|79431447|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
44423366|NCT00790907|79431448|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
44423367|NCT00790907|79431446|FG000|Overall Study|Qualifying Condition Not Present|29|||
44423368|NCT00790907|79431447|FG001|Overall Study|Qualifying Condition Not Present|14|||
44423369|NCT00790907|79431448|FG002|Overall Study|Qualifying Condition Not Present|16|||
44423370|NCT00790907|79431446|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
44423371|NCT00790907|79431447|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
44423372|NCT00790907|79431448|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
44423373|NCT00790907|79431446|FG000|Overall Study|Did Not Receive Study Drug|10|||
44423374|NCT00790907|79431447|FG001|Overall Study|Did Not Receive Study Drug|0|||
44156570|NCT01918306|78947714|FG003|Overall Study|Withdrawal by Subject|2|||
44156571|NCT01918306|78947711|FG000|Overall Study|neutropenia|1|||
44156572|NCT01918306|78947712|FG001|Overall Study|neutropenia|0|||
44156573|NCT01918306|78947713|FG002|Overall Study|neutropenia|0|||
44156574|NCT01918306|78947714|FG003|Overall Study|neutropenia|0|||
44156575|NCT01918306|78947711|FG000|Overall Study|Lack of Efficacy|1|||
44156576|NCT01918306|78947712|FG001|Overall Study|Lack of Efficacy|0|||
44156577|NCT01918306|78947713|FG002|Overall Study|Lack of Efficacy|0|||
44156578|NCT01918306|78947714|FG003|Overall Study|Lack of Efficacy|0|||
44326190|NCT02489942|79331244|FG000|Overall Study|Patient received Jardiance before registration|1|||
44423375|NCT00790907|79431448|FG002|Overall Study|Did Not Receive Study Drug|0|||
44423376|NCT00793871|79431466|FG000|Overall Study|Death|50|||
44423377|NCT00793871|79431466|FG000|Overall Study|Lost to Follow-up|3|||
44423378|NCT00793871|79431466|FG000|Overall Study|Study terminated by the Sponsor|7|||
44423379|NCT00577707|79431474|FG000|Overall Study|Withdrawal by Subject|3|||
44423380|NCT00713349|79431478|FG000|Overall Study|Protocol Violation|1|||
44423381|NCT00712959|79431486|FG000|Overall Study|Protocol Violation|3|||
44423382|NCT00712959|79431487|FG001|Overall Study|Protocol Violation|1|||
44423383|NCT00712959|79431486|FG000|Overall Study|Lost to Follow-up|13|||
44423384|NCT00712959|79431487|FG001|Overall Study|Lost to Follow-up|2|||
44423385|NCT00712959|79431486|FG000|Overall Study|Withdrawal by Subject|3|||
44423386|NCT00712959|79431487|FG001|Overall Study|Withdrawal by Subject|0|||
44423387|NCT00712725|79431501|FG000|Overall Study|Adverse Event|1|||
44423388|NCT00712725|79431502|FG001|Overall Study|Adverse Event|0|||
44423389|NCT00712725|79431503|FG002|Overall Study|Adverse Event|0|||
44423390|NCT00712725|79431504|FG003|Overall Study|Adverse Event|1|||
44423391|NCT00712725|79431505|FG004|Overall Study|Adverse Event|0|||
44423392|NCT00712725|79431506|FG005|Overall Study|Adverse Event|0|||
44156579|NCT01918306|78947711|FG000|Overall Study|progress disease, crossover|0|||
44156580|NCT01918306|78947712|FG001|Overall Study|progress disease, crossover|0|||
44326191|NCT02489942|79331244|FG000|Overall Study|No CRF collected|86|||
44423393|NCT00712725|79431507|FG006|Overall Study|Adverse Event|0|||
44423394|NCT00712725|79431508|FG007|Overall Study|Adverse Event|0|||
44423395|NCT00712725|79431501|FG000|Overall Study|Lost to Follow-up|3|||
44423396|NCT00712725|79431502|FG001|Overall Study|Lost to Follow-up|2|||
44423397|NCT00712725|79431503|FG002|Overall Study|Lost to Follow-up|1|||
44423398|NCT00712725|79431504|FG003|Overall Study|Lost to Follow-up|1|||
44423399|NCT00712725|79431505|FG004|Overall Study|Lost to Follow-up|2|||
44423400|NCT00712725|79431506|FG005|Overall Study|Lost to Follow-up|2|||
44423401|NCT00712725|79431507|FG006|Overall Study|Lost to Follow-up|3|||
44423402|NCT00712725|79431508|FG007|Overall Study|Lost to Follow-up|1|||
44423403|NCT00712725|79431501|FG000|Overall Study|Physician Decision|2|||
44423404|NCT00712725|79431502|FG001|Overall Study|Physician Decision|0|||
44423405|NCT00712725|79431503|FG002|Overall Study|Physician Decision|0|||
44423406|NCT00712725|79431504|FG003|Overall Study|Physician Decision|0|||
44423407|NCT00712725|79431505|FG004|Overall Study|Physician Decision|1|||
44423408|NCT00712725|79431506|FG005|Overall Study|Physician Decision|0|||
44423409|NCT00712725|79431507|FG006|Overall Study|Physician Decision|2|||
44423410|NCT00712725|79431508|FG007|Overall Study|Physician Decision|0|||
44423411|NCT00712725|79431501|FG000|Overall Study|Pregnancy|0|||
44423412|NCT00712725|79431502|FG001|Overall Study|Pregnancy|1|||
44326192|NCT00176462|79331250|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
44326193|NCT00176462|79331251|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
44423413|NCT00712725|79431503|FG002|Overall Study|Pregnancy|0|||
44423414|NCT00712725|79431504|FG003|Overall Study|Pregnancy|0|||
44423415|NCT00712725|79431505|FG004|Overall Study|Pregnancy|1|||
44423416|NCT00712725|79431506|FG005|Overall Study|Pregnancy|0|||
44326194|NCT00176462|79331250|FG000|Induction (4 Weeks)|Death|1|||
44326195|NCT00176462|79331251|FG001|Induction (4 Weeks)|Death|2|||
44326196|NCT00176462|79331250|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
44326197|NCT00176462|79331251|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
44326198|NCT00176462|79331250|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
44326199|NCT00176462|79331251|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
44326200|NCT00176462|79331250|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
44326201|NCT00176462|79331251|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
44326202|NCT00176462|79331250|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
44326203|NCT00176462|79331251|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
44326204|NCT00176462|79331250|FG000|Consolidation (12 Weeks)|Not documented|0|||
44326205|NCT00176462|79331251|FG001|Consolidation (12 Weeks)|Not documented|1|||
44326206|NCT00176462|79331250|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
44326207|NCT00176462|79331251|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
44326208|NCT00176462|79331250|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
44326209|NCT00176462|79331251|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
44326210|NCT00175019|79331261|FG000|Overall Study|Adverse Event|54|||
44326211|NCT00175019|79331262|FG001|Overall Study|Adverse Event|22|||
44326212|NCT00175019|79331263|FG002|Overall Study|Adverse Event|2|||
44326213|NCT00175019|79331261|FG000|Overall Study|Protocol Violation|6|||
44326214|NCT00175019|79331262|FG001|Overall Study|Protocol Violation|3|||
44326215|NCT00175019|79331263|FG002|Overall Study|Protocol Violation|3|||
44326216|NCT00175019|79331261|FG000|Overall Study|Lost to Follow-up|42|||
44326217|NCT00175019|79331262|FG001|Overall Study|Lost to Follow-up|39|||
44326218|NCT00175019|79331263|FG002|Overall Study|Lost to Follow-up|9|||
44326219|NCT00175019|79331261|FG000|Overall Study|Did not continue under Amendment 4|1|||
44326220|NCT00175019|79331262|FG001|Overall Study|Did not continue under Amendment 4|1|||
44326221|NCT00175019|79331263|FG002|Overall Study|Did not continue under Amendment 4|2|||
44326222|NCT00175019|79331261|FG000|Overall Study|Personal Reason(s)|39|||
44326223|NCT00175019|79331262|FG001|Overall Study|Personal Reason(s)|31|||
44326224|NCT00175019|79331263|FG002|Overall Study|Personal Reason(s)|8|||
44423417|NCT00712725|79431507|FG006|Overall Study|Pregnancy|2|||
44156581|NCT01918306|78947713|FG002|Overall Study|progress disease, crossover|1|||
44326225|NCT00175019|79331261|FG000|Overall Study|Therapeutic Failure|10|||
44423418|NCT00712725|79431508|FG007|Overall Study|Pregnancy|0|||
44423419|NCT00712725|79431501|FG000|Overall Study|Protocol Violation|2|||
44423420|NCT00712725|79431502|FG001|Overall Study|Protocol Violation|0|||
44423421|NCT00712725|79431503|FG002|Overall Study|Protocol Violation|1|||
44423422|NCT00712725|79431504|FG003|Overall Study|Protocol Violation|3|||
44423423|NCT00712725|79431505|FG004|Overall Study|Protocol Violation|2|||
44423424|NCT00712725|79431506|FG005|Overall Study|Protocol Violation|0|||
44423425|NCT00712725|79431507|FG006|Overall Study|Protocol Violation|1|||
44423426|NCT00712725|79431508|FG007|Overall Study|Protocol Violation|1|||
44423427|NCT00712725|79431501|FG000|Overall Study|Withdrawal by Subject|2|||
44423428|NCT00712725|79431502|FG001|Overall Study|Withdrawal by Subject|1|||
44423429|NCT00712725|79431503|FG002|Overall Study|Withdrawal by Subject|1|||
44423430|NCT00712725|79431504|FG003|Overall Study|Withdrawal by Subject|2|||
44326226|NCT00175019|79331262|FG001|Overall Study|Therapeutic Failure|38|||
44423431|NCT00712725|79431505|FG004|Overall Study|Withdrawal by Subject|1|||
44326227|NCT00175019|79331263|FG002|Overall Study|Therapeutic Failure|22|||
44326228|NCT00175019|79331261|FG000|Overall Study|Gout Flare|2|||
44326229|NCT00175019|79331262|FG001|Overall Study|Gout Flare|3|||
44423432|NCT00712725|79431506|FG005|Overall Study|Withdrawal by Subject|1|||
44326230|NCT00175019|79331263|FG002|Overall Study|Gout Flare|0|||
44326231|NCT00175019|79331261|FG000|Overall Study|Reason Not Specified|40|||
44326232|NCT00175019|79331262|FG001|Overall Study|Reason Not Specified|34|||
44326233|NCT00175019|79331263|FG002|Overall Study|Reason Not Specified|11|||
44326234|NCT00174941|79331274|FG000|Overall Study|Adverse Event|1|||
44326235|NCT00174941|79331275|FG001|Overall Study|Adverse Event|10|||
44326236|NCT00174941|79331276|FG002|Overall Study|Adverse Event|2|||
44326237|NCT00174941|79331277|FG003|Overall Study|Adverse Event|13|||
44326238|NCT00174941|79331274|FG000|Overall Study|Protocol Violation|0|||
44326239|NCT00174941|79331275|FG001|Overall Study|Protocol Violation|1|||
44326240|NCT00174941|79331276|FG002|Overall Study|Protocol Violation|0|||
44326241|NCT00174941|79331277|FG003|Overall Study|Protocol Violation|1|||
44326242|NCT00174941|79331274|FG000|Overall Study|Lost to Follow-up|0|||
44326243|NCT00174941|79331275|FG001|Overall Study|Lost to Follow-up|3|||
44326244|NCT00174941|79331276|FG002|Overall Study|Lost to Follow-up|2|||
44326245|NCT00174941|79331277|FG003|Overall Study|Lost to Follow-up|5|||
44326246|NCT00174941|79331274|FG000|Overall Study|Personal Reason(s)|0|||
44326247|NCT00174941|79331275|FG001|Overall Study|Personal Reason(s)|14|||
44326248|NCT00174941|79331276|FG002|Overall Study|Personal Reason(s)|8|||
44326249|NCT00174941|79331277|FG003|Overall Study|Personal Reason(s)|22|||
44326250|NCT00174941|79331274|FG000|Overall Study|Gout Flare|0|||
44326251|NCT00174941|79331275|FG001|Overall Study|Gout Flare|4|||
44326252|NCT00174941|79331276|FG002|Overall Study|Gout Flare|4|||
44326253|NCT00174941|79331277|FG003|Overall Study|Gout Flare|8|||
44326254|NCT00174941|79331274|FG000|Overall Study|Reason Not Specified|1|||
44326255|NCT00174941|79331275|FG001|Overall Study|Reason Not Specified|6|||
44326256|NCT00174941|79331276|FG002|Overall Study|Reason Not Specified|2|||
44326257|NCT00174941|79331277|FG003|Overall Study|Reason Not Specified|9|||
44326258|NCT00171704|79331289|FG000|Overall Study|Adverse Event|24|||
44326259|NCT00171704|79331290|FG001|Overall Study|Adverse Event|33|||
44326260|NCT00171704|79331289|FG000|Overall Study|Disease Progression|14|||
44326261|NCT00171704|79331290|FG001|Overall Study|Disease Progression|9|||
44326262|NCT00171704|79331289|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
44326263|NCT00171704|79331290|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
44326264|NCT00171704|79331289|FG000|Overall Study|Administrative Problems|2|||
44326265|NCT00171704|79331290|FG001|Overall Study|Administrative Problems|1|||
44326266|NCT00171704|79331289|FG000|Overall Study|Death|2|||
44326267|NCT00171704|79331290|FG001|Overall Study|Death|2|||
44326268|NCT00171704|79331289|FG000|Overall Study|Withdrawal by Subject|1|||
44326269|NCT00171704|79331290|FG001|Overall Study|Withdrawal by Subject|3|||
44326270|NCT00171704|79331289|FG000|Overall Study|Protocol Violation|0|||
44326271|NCT00171704|79331290|FG001|Overall Study|Protocol Violation|1|||
44326272|NCT00171314|79331298|FG000|Overall Study|Adverse Event|44|||
44326273|NCT00171314|79331299|FG001|Overall Study|Adverse Event|41|||
44326274|NCT00171314|79331298|FG000|Overall Study|Lack of Efficacy|19|||
44326275|NCT00171314|79331299|FG001|Overall Study|Lack of Efficacy|14|||
44326276|NCT00171314|79331298|FG000|Overall Study|Withdrawal by Subject|9|||
44326277|NCT00171314|79331299|FG001|Overall Study|Withdrawal by Subject|6|||
44326278|NCT00171314|79331298|FG000|Overall Study|Abnormal Test Procedure Results|9|||
44326279|NCT00171314|79331299|FG001|Overall Study|Abnormal Test Procedure Results|3|||
44326280|NCT00171314|79331298|FG000|Overall Study|Protocol Violation|3|||
44326281|NCT00171314|79331299|FG001|Overall Study|Protocol Violation|7|||
44326282|NCT00171314|79331298|FG000|Overall Study|Administrative Problems|4|||
44423433|NCT00712725|79431507|FG006|Overall Study|Withdrawal by Subject|1|||
44423434|NCT00712725|79431508|FG007|Overall Study|Withdrawal by Subject|2|||
44423435|NCT00712725|79431501|FG000|Overall Study|Lack of Qualifying Event|16|||
44423436|NCT00712725|79431502|FG001|Overall Study|Lack of Qualifying Event|2|||
44423437|NCT00712725|79431503|FG002|Overall Study|Lack of Qualifying Event|6|||
44423438|NCT00712725|79431504|FG003|Overall Study|Lack of Qualifying Event|8|||
44423439|NCT00712725|79431505|FG004|Overall Study|Lack of Qualifying Event|11|||
44326283|NCT00171314|79331299|FG001|Overall Study|Administrative Problems|3|||
44326284|NCT00171314|79331298|FG000|Overall Study|Lost to Follow-up|1|||
44423440|NCT00712725|79431506|FG005|Overall Study|Lack of Qualifying Event|13|||
44326285|NCT00171314|79331299|FG001|Overall Study|Lost to Follow-up|3|||
44326286|NCT00171314|79331298|FG000|Overall Study|Death|2|||
44423441|NCT00712725|79431507|FG006|Overall Study|Lack of Qualifying Event|11|||
44423442|NCT00712725|79431508|FG007|Overall Study|Lack of Qualifying Event|6|||
44326287|NCT00171314|79331299|FG001|Overall Study|Death|1|||
44326288|NCT00171158|79331305|FG000|Core Study|Death|27|||
44326289|NCT00171158|79331305|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
44326290|NCT00171158|79331305|FG000|Core Study|Protocol Violation|4|||
44326291|NCT00171158|79331305|FG000|Core Study|Administrative problems|1|||
44326292|NCT00171158|79331305|FG000|Core Study|Adverse event, non-fatal|21|||
44326293|NCT00171158|79331305|FG000|Core Study|Consent withdrawn by subject|6|||
44326294|NCT00171158|79331305|FG000|Core Study|No longer required drug (BMT)|14|||
44326295|NCT00171158|79331305|FG000|Core Study|Abnormal Laboratory Values|2|||
44326296|NCT00171158|79331305|FG000|Core Study|Lost to Follow-up|1|||
44326297|NCT00171158|79331305|FG000|E2 Extension|Other|7|||
44423443|NCT00712725|79431501|FG000|Overall Study|Protocol Specified Criteria|3|||
44423444|NCT00712725|79431502|FG001|Overall Study|Protocol Specified Criteria|0|||
44423445|NCT00712725|79431503|FG002|Overall Study|Protocol Specified Criteria|1|||
44423446|NCT00712725|79431504|FG003|Overall Study|Protocol Specified Criteria|2|||
44423447|NCT00712725|79431505|FG004|Overall Study|Protocol Specified Criteria|1|||
44423448|NCT00712725|79431506|FG005|Overall Study|Protocol Specified Criteria|0|||
44423449|NCT00712725|79431507|FG006|Overall Study|Protocol Specified Criteria|2|||
44423450|NCT00712725|79431508|FG007|Overall Study|Protocol Specified Criteria|1|||
44423451|NCT00712335|79431531|FG000|Overall Study|Withdrawal by Subject|0|||
44423452|NCT00712335|79431532|FG001|Overall Study|Withdrawal by Subject|7|||
44423453|NCT00712335|79431533|FG002|Overall Study|Withdrawal by Subject|2|||
44423454|NCT00712335|79431534|FG003|Overall Study|Withdrawal by Subject|3|||
44423455|NCT00712335|79431535|FG004|Overall Study|Withdrawal by Subject|0|||
44423456|NCT00712335|79431531|FG000|Overall Study|Lost to Follow-up|2|||
44423457|NCT00712335|79431532|FG001|Overall Study|Lost to Follow-up|5|||
44423458|NCT00712335|79431533|FG002|Overall Study|Lost to Follow-up|0|||
44423459|NCT00712335|79431534|FG003|Overall Study|Lost to Follow-up|1|||
44423460|NCT00712335|79431535|FG004|Overall Study|Lost to Follow-up|0|||
44423461|NCT00712335|79431531|FG000|Overall Study|Protocol Violation|1|||
44423462|NCT00712335|79431532|FG001|Overall Study|Protocol Violation|2|||
44326298|NCT00170846|79331312|FG000|Overall Study|Subject withdrew Informed Consent|5|||
44326299|NCT00170846|79331313|FG001|Overall Study|Subject withdrew Informed Consent|12|||
44258460|NCT04072822|79113542|FG001|Follow-up|Lost to Follow-up|4|||
44258461|NCT04031846|79113550|FG000|Overall Study|Lost to Follow-up|4|||
44258462|NCT04031846|79113551|FG001|Overall Study|Lost to Follow-up|4|||
44258463|NCT04031846|79113550|FG000|Overall Study|Physician Decision|0|||
44258464|NCT04031846|79113551|FG001|Overall Study|Physician Decision|1|||
44258465|NCT04031846|79113550|FG000|Overall Study|Protocol Violation|1|||
44258466|NCT04031846|79113551|FG001|Overall Study|Protocol Violation|1|||
44326300|NCT00170846|79331314|FG002|Overall Study|Subject withdrew Informed Consent|8|||
44326301|NCT00170846|79331312|FG000|Overall Study|Lost to Follow-up|6|||
44326302|NCT00170846|79331313|FG001|Overall Study|Lost to Follow-up|3|||
44326303|NCT00170846|79331314|FG002|Overall Study|Lost to Follow-up|2|||
44326304|NCT00170846|79331312|FG000|Overall Study|Death|0|||
44326305|NCT00170846|79331313|FG001|Overall Study|Death|3|||
44326306|NCT00170846|79331314|FG002|Overall Study|Death|3|||
44326307|NCT00170846|79331312|FG000|Overall Study|Reason Missing|0|||
44326308|NCT00170846|79331313|FG001|Overall Study|Reason Missing|1|||
44326309|NCT00170846|79331314|FG002|Overall Study|Reason Missing|0|||
44326310|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
44326311|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
44326312|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
44326313|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
44326314|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
44326315|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
44326316|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
44423463|NCT00712335|79431533|FG002|Overall Study|Protocol Violation|1|||
44423464|NCT00712335|79431534|FG003|Overall Study|Protocol Violation|0|||
44423465|NCT00712335|79431535|FG004|Overall Study|Protocol Violation|0|||
44423466|NCT00712335|79431531|FG000|Overall Study|Lack of Efficacy|0|||
44423467|NCT00712335|79431532|FG001|Overall Study|Lack of Efficacy|0|||
44423468|NCT00712335|79431533|FG002|Overall Study|Lack of Efficacy|1|||
44423469|NCT00712335|79431534|FG003|Overall Study|Lack of Efficacy|1|||
44423470|NCT00712335|79431535|FG004|Overall Study|Lack of Efficacy|0|||
44423471|NCT00712335|79431531|FG000|Overall Study|Other Reason|0|||
44423472|NCT00712335|79431532|FG001|Overall Study|Other Reason|3|||
44536996|NCT03472521|79547707|FG000|Overall Study|Discontinued intervention|3|||
44536997|NCT03472521|79547708|FG001|Overall Study|Discontinued intervention|1|||
44536998|NCT02906020|79547724|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
44536999|NCT02906020|79547725|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
44258467|NCT04031846|79113550|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
44326317|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
44326318|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
44423473|NCT00712335|79431533|FG002|Overall Study|Other Reason|1|||
44423474|NCT00712335|79431534|FG003|Overall Study|Other Reason|0|||
44423475|NCT00712335|79431535|FG004|Overall Study|Other Reason|0|||
44423476|NCT00577629|79431547|FG000|Treatment Period|Death|1|||
44537000|NCT02906020|79547726|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
44537001|NCT02906020|79547727|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
44537002|NCT02906020|79547728|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
44258468|NCT04031846|79113551|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
44258469|NCT03893448|79113560|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
44423477|NCT00577629|79431547|FG000|Long Term Follow-Up|Death|15|||
44423478|NCT00577629|79431547|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
44423479|NCT00577629|79431547|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
44423480|NCT00577629|79431547|FG000|Long Term Follow-Up|Physician Decision|1|||
44423481|NCT00710385|79431553|FG000|Overall Study|Did not qualify|1|||
44423482|NCT00710385|79431553|FG000|Overall Study|Withdrawal by Subject|1|||
44156582|NCT01918306|78947714|FG003|Overall Study|progress disease, crossover|0|||
44156583|NCT01917526|78947736|FG000|Overall Study|Protocol Violation|1|||
44156584|NCT01917526|78947737|FG001|Overall Study|Protocol Violation|1|||
44326319|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
44423483|NCT00710385|79431553|FG000|Overall Study|Undisclosed back pain|1|||
44423484|NCT00710385|79431553|FG000|Overall Study|Physician Decision|1|||
44423485|NCT00710385|79431553|FG000|Overall Study|Undisclosed excessive methadone use|1|||
44423486|NCT00701415|79431565|FG000|Overall Study|Adverse Event|0|||
44423487|NCT00701415|79431566|FG001|Overall Study|Adverse Event|1|||
44423488|NCT00701415|79431565|FG000|Overall Study|Social/family issues and needle phobia|1|||
44423489|NCT00701415|79431566|FG001|Overall Study|Social/family issues and needle phobia|0|||
44423490|NCT00700011|79431574|FG000|Overall Study|Death|0|||
44423491|NCT00700011|79431575|FG001|Overall Study|Death|1|||
44423492|NCT00707031|79431583|FG000|Overall Study|Adverse Event|45|||
44423493|NCT00707031|79431584|FG001|Overall Study|Adverse Event|45|||
44423494|NCT00707031|79431583|FG000|Overall Study|Lack of Efficacy|19|||
44423495|NCT00707031|79431584|FG001|Overall Study|Lack of Efficacy|6|||
44423496|NCT00707031|79431583|FG000|Overall Study|Lost to Follow-up|2|||
44423497|NCT00707031|79431584|FG001|Overall Study|Lost to Follow-up|1|||
44423498|NCT00707031|79431583|FG000|Overall Study|Protocol Violation|1|||
44423499|NCT00707031|79431584|FG001|Overall Study|Protocol Violation|0|||
44423500|NCT00707031|79431583|FG000|Overall Study|Withdrawal by Subject|7|||
44423501|NCT00707031|79431584|FG001|Overall Study|Withdrawal by Subject|8|||
44423502|NCT00707031|79431583|FG000|Overall Study|Poor Compliance to Protocol|7|||
44423503|NCT00707031|79431584|FG001|Overall Study|Poor Compliance to Protocol|13|||
44423504|NCT00707031|79431583|FG000|Overall Study|Familial or Personal Reasons|12|||
44423505|NCT00707031|79431584|FG001|Overall Study|Familial or Personal Reasons|15|||
44423506|NCT00707031|79431583|FG000|Overall Study|Serious Noncompliance|2|||
44423507|NCT00707031|79431584|FG001|Overall Study|Serious Noncompliance|3|||
44423508|NCT00707031|79431583|FG000|Overall Study|Sponsor Decision|9|||
44423509|NCT00707031|79431584|FG001|Overall Study|Sponsor Decision|8|||
44423510|NCT00711477|79431593|FG000|Overall Study|Adverse Event|3|||
44423511|NCT00711477|79431594|FG001|Overall Study|Adverse Event|1|||
44423512|NCT00711477|79431593|FG000|Overall Study|Lost to Follow-up|0|||
44423513|NCT00711477|79431594|FG001|Overall Study|Lost to Follow-up|1|||
44326320|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
44326321|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
44326322|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
44326323|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
44326324|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
44326325|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
44326326|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
44326327|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
44326328|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
44326329|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
44423514|NCT00711477|79431593|FG000|Overall Study|Noncompliance|0|||
44423515|NCT00711477|79431594|FG001|Overall Study|Noncompliance|1|||
44326330|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
44326331|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
44326332|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
44423516|NCT00699699|79431602|FG000|Overall Study|Adverse Event|36|||
44423517|NCT00699699|79431602|FG000|Overall Study|Individual different reasons|21|||
44423518|NCT00734474|79431615|FG000|Overall Study|Entry Criteria Not Met|0|||
44423519|NCT00734474|79431616|FG001|Overall Study|Entry Criteria Not Met|0|||
44423520|NCT00734474|79431617|FG002|Overall Study|Entry Criteria Not Met|5|||
44423521|NCT00734474|79431618|FG003|Overall Study|Entry Criteria Not Met|0|||
44423522|NCT00734474|79431619|FG004|Overall Study|Entry Criteria Not Met|3|||
44423523|NCT00734474|79431620|FG005|Overall Study|Entry Criteria Not Met|1|||
44423524|NCT00734474|79431621|FG006|Overall Study|Entry Criteria Not Met|0|||
44423525|NCT00734474|79431622|FG007|Overall Study|Entry Criteria Not Met|1|||
44423526|NCT00734474|79431623|FG008|Overall Study|Entry Criteria Not Met|1|||
44423527|NCT00734474|79431615|FG000|Overall Study|Lost to Follow-up|1|||
44423528|NCT00734474|79431616|FG001|Overall Study|Lost to Follow-up|0|||
44423529|NCT00734474|79431617|FG002|Overall Study|Lost to Follow-up|13|||
44423530|NCT00734474|79431618|FG003|Overall Study|Lost to Follow-up|0|||
44423531|NCT00734474|79431619|FG004|Overall Study|Lost to Follow-up|11|||
44423532|NCT00734474|79431620|FG005|Overall Study|Lost to Follow-up|1|||
44423533|NCT00734474|79431621|FG006|Overall Study|Lost to Follow-up|0|||
44423534|NCT00734474|79431622|FG007|Overall Study|Lost to Follow-up|9|||
44423535|NCT00734474|79431623|FG008|Overall Study|Lost to Follow-up|4|||
44156585|NCT01948258|78947743|FG000|Overall Study|Pregnancy|41|||
44423536|NCT00734474|79431615|FG000|Overall Study|Withdrawal by Subject|2|||
44423537|NCT00734474|79431616|FG001|Overall Study|Withdrawal by Subject|1|||
44423538|NCT00734474|79431617|FG002|Overall Study|Withdrawal by Subject|18|||
44326333|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
44326334|NCT00479882|79331326|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
44326335|NCT00479882|79331327|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
44326336|NCT00479882|79331328|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
44326337|NCT00479882|79331329|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
44326338|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
44326339|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
44326340|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
44326341|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
44326342|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
44326343|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
44326344|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
44326345|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
44326346|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
44326347|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
44326348|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
44326349|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
44326350|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
44326351|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
44326352|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
44326353|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
44326354|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
44326355|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
44326356|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
44326357|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
44326358|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
44326359|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
44326360|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
44326361|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
44326362|NCT00479882|79331326|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
44326363|NCT00479882|79331327|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
44326364|NCT00479882|79331328|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
44326365|NCT00479882|79331329|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
44326366|NCT00479765|79331355|FG000|Overall Study|study terminated|4|||
44326367|NCT00479687|79331361|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
44326368|NCT00479687|79331362|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
44326369|NCT00479687|79331363|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
44326370|NCT00479687|79331361|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
44326371|NCT00479687|79331362|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
44326372|NCT00479687|79331363|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
44326373|NCT00479687|79331361|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
44326374|NCT00479687|79331362|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
44326375|NCT00479687|79331363|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
44326376|NCT00479687|79331361|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
44326377|NCT00479687|79331362|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
44326378|NCT00479687|79331363|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
44326379|NCT00479687|79331361|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
44326380|NCT00479687|79331362|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
44326381|NCT00479687|79331363|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
44326382|NCT00479687|79331361|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
44326383|NCT00479687|79331362|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
44326384|NCT00479687|79331363|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
44326385|NCT00479687|79331361|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
44326386|NCT00479687|79331362|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
44326387|NCT00479687|79331363|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
44423539|NCT00734474|79431618|FG003|Overall Study|Withdrawal by Subject|0|||
44423540|NCT00734474|79431619|FG004|Overall Study|Withdrawal by Subject|24|||
44423541|NCT00734474|79431620|FG005|Overall Study|Withdrawal by Subject|2|||
44326388|NCT00479687|79331361|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
44326389|NCT00479687|79331362|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
44423542|NCT00734474|79431621|FG006|Overall Study|Withdrawal by Subject|0|||
44423543|NCT00734474|79431622|FG007|Overall Study|Withdrawal by Subject|36|||
44423544|NCT00734474|79431623|FG008|Overall Study|Withdrawal by Subject|21|||
44423545|NCT00734474|79431615|FG000|Overall Study|Physician Decision|0|||
44423546|NCT00734474|79431616|FG001|Overall Study|Physician Decision|0|||
44423547|NCT00734474|79431617|FG002|Overall Study|Physician Decision|4|||
44423548|NCT00734474|79431618|FG003|Overall Study|Physician Decision|1|||
44423549|NCT00734474|79431619|FG004|Overall Study|Physician Decision|11|||
44423550|NCT00734474|79431620|FG005|Overall Study|Physician Decision|0|||
44423551|NCT00734474|79431621|FG006|Overall Study|Physician Decision|0|||
44423552|NCT00734474|79431622|FG007|Overall Study|Physician Decision|9|||
44423553|NCT00734474|79431623|FG008|Overall Study|Physician Decision|9|||
44326390|NCT00479687|79331363|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
44326391|NCT00479687|79331361|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
44326392|NCT00479687|79331362|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
44326393|NCT00479687|79331363|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
44326394|NCT00479336|79331374|FG000|Overall Study|Adverse Event|1|||
44326395|NCT00479336|79331375|FG001|Overall Study|Adverse Event|1|||
44326396|NCT00479336|79331376|FG002|Overall Study|Adverse Event|1|||
44326397|NCT00479336|79331377|FG003|Overall Study|Adverse Event|3|||
44326398|NCT00479336|79331374|FG000|Overall Study|Lack of Efficacy|1|||
44326399|NCT00479336|79331375|FG001|Overall Study|Lack of Efficacy|0|||
44423554|NCT00734474|79431615|FG000|Overall Study|Adverse Event|4|||
44423555|NCT00734474|79431616|FG001|Overall Study|Adverse Event|4|||
44423556|NCT00734474|79431617|FG002|Overall Study|Adverse Event|63|||
44423557|NCT00734474|79431618|FG003|Overall Study|Adverse Event|1|||
44156586|NCT01948258|78947743|FG000|Overall Study|Did not complete by cut-off date|35|||
44156587|NCT01948258|78947743|FG000|Overall Study|Lost to Follow-up|27|||
44156588|NCT01948258|78947743|FG000|Overall Study|Withdrawal by SPD|8|||
44156589|NCT01948258|78947743|FG000|Overall Study|Withdrawal by Subject|6|||
44156590|NCT01948258|78947743|FG000|Overall Study|Health Care Professional|43|||
44156591|NCT01948258|78947743|FG000|Overall Study|Removed from statistical analysis|2|||
44156592|NCT01916980|78947749|FG000|Overall Study|Adverse Event|4|||
44156593|NCT01916980|78947750|FG001|Overall Study|Adverse Event|2|||
44156594|NCT01916980|78947749|FG000|Overall Study|Lack of Efficacy|2|||
44156595|NCT01916980|78947750|FG001|Overall Study|Lack of Efficacy|2|||
44156596|NCT01916980|78947749|FG000|Overall Study|Withdrawal by Subject|1|||
44156597|NCT01916980|78947750|FG001|Overall Study|Withdrawal by Subject|0|||
44156598|NCT05940077|78947756|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
44156599|NCT05011513|78947770|FG000|Overall Study|Death|0|||
44156600|NCT05011513|78947771|FG001|Overall Study|Death|1|||
44156601|NCT05011513|78947770|FG000|Overall Study|Lost to Follow-up|4|||
44156602|NCT05011513|78947771|FG001|Overall Study|Lost to Follow-up|0|||
44156603|NCT05011513|78947770|FG000|Overall Study|Withdrawal by Subject|18|||
44156604|NCT05011513|78947771|FG001|Overall Study|Withdrawal by Subject|17|||
44156605|NCT05011513|78947770|FG000|Overall Study|Other|4|||
44156606|NCT05011513|78947771|FG001|Overall Study|Other|2|||
44156607|NCT04750239|78947777|FG000|Overall Study|Withdrawal by Subject|2|||
44156608|NCT04750239|78947777|FG000|Overall Study|Trial terminated by sponsor|1|||
44156609|NCT04590248|78947782|FG000|Overall Study|Lost to Follow-up|1|||
44326400|NCT00479336|79331376|FG002|Overall Study|Lack of Efficacy|0|||
44326401|NCT00479336|79331377|FG003|Overall Study|Lack of Efficacy|0|||
44326402|NCT00479336|79331374|FG000|Overall Study|Protocol Violation|0|||
44326403|NCT00479336|79331375|FG001|Overall Study|Protocol Violation|1|||
44156610|NCT04590248|78947782|FG000|Overall Study|Withdrawal by Subject|16|||
44326404|NCT00479336|79331376|FG002|Overall Study|Protocol Violation|0|||
44326405|NCT00479336|79331377|FG003|Overall Study|Protocol Violation|0|||
44326406|NCT00479336|79331374|FG000|Overall Study|Withdrawal by Subject|1|||
44326407|NCT00479336|79331375|FG001|Overall Study|Withdrawal by Subject|2|||
44326408|NCT00479336|79331376|FG002|Overall Study|Withdrawal by Subject|0|||
44326409|NCT00479336|79331377|FG003|Overall Study|Withdrawal by Subject|0|||
44326410|NCT00479336|79331374|FG000|Overall Study|Physician Decision|0|||
44326411|NCT00479336|79331375|FG001|Overall Study|Physician Decision|1|||
44423558|NCT00734474|79431619|FG004|Overall Study|Adverse Event|64|||
44423559|NCT00734474|79431620|FG005|Overall Study|Adverse Event|0|||
44423560|NCT00734474|79431621|FG006|Overall Study|Adverse Event|1|||
44423561|NCT00734474|79431622|FG007|Overall Study|Adverse Event|65|||
44423562|NCT00734474|79431623|FG008|Overall Study|Adverse Event|39|||
44423563|NCT00734474|79431615|FG000|Overall Study|Protocol Violation|0|||
44423564|NCT00734474|79431616|FG001|Overall Study|Protocol Violation|0|||
44156611|NCT04590248|78947782|FG000|Overall Study|Other|2|||
44156612|NCT04560816|78947786|FG000|Overall Study|Withdrawal by Subject|1|||
44156613|NCT04560816|78947787|FG001|Overall Study|Withdrawal by Subject|1|||
44326412|NCT00479336|79331376|FG002|Overall Study|Physician Decision|0|||
44326413|NCT00479336|79331377|FG003|Overall Study|Physician Decision|2|||
44423565|NCT00734474|79431617|FG002|Overall Study|Protocol Violation|4|||
44423566|NCT00734474|79431618|FG003|Overall Study|Protocol Violation|0|||
44423567|NCT00734474|79431619|FG004|Overall Study|Protocol Violation|3|||
44156614|NCT04560816|78947788|FG002|Overall Study|Withdrawal by Subject|1|||
44156615|NCT04560816|78947789|FG003|Overall Study|Withdrawal by Subject|0|||
44423568|NCT00734474|79431620|FG005|Overall Study|Protocol Violation|0|||
44423569|NCT00734474|79431621|FG006|Overall Study|Protocol Violation|0|||
44423570|NCT00734474|79431622|FG007|Overall Study|Protocol Violation|3|||
44423571|NCT00734474|79431623|FG008|Overall Study|Protocol Violation|1|||
44423572|NCT00734474|79431615|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
44423573|NCT00734474|79431616|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
44423574|NCT00734474|79431617|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
44423575|NCT00734474|79431618|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
44423576|NCT00734474|79431619|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
44423577|NCT00734474|79431620|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
44423578|NCT00734474|79431621|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
44423579|NCT00734474|79431622|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
44423580|NCT00734474|79431623|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
44423581|NCT00734474|79431615|FG000|Overall Study|Sponsor Decision|0|||
44423582|NCT00734474|79431616|FG001|Overall Study|Sponsor Decision|0|||
44423583|NCT00734474|79431617|FG002|Overall Study|Sponsor Decision|0|||
44423584|NCT00734474|79431618|FG003|Overall Study|Sponsor Decision|0|||
44423585|NCT00734474|79431619|FG004|Overall Study|Sponsor Decision|2|||
44423586|NCT00734474|79431620|FG005|Overall Study|Sponsor Decision|0|||
44423587|NCT00734474|79431621|FG006|Overall Study|Sponsor Decision|0|||
44423588|NCT00734474|79431622|FG007|Overall Study|Sponsor Decision|0|||
44423589|NCT00734474|79431623|FG008|Overall Study|Sponsor Decision|0|||
44423590|NCT00734474|79431615|FG000|Overall Study|Death|0|||
44423591|NCT00734474|79431616|FG001|Overall Study|Death|0|||
44423592|NCT00734474|79431617|FG002|Overall Study|Death|1|||
44423593|NCT00734474|79431618|FG003|Overall Study|Death|0|||
44423594|NCT00734474|79431619|FG004|Overall Study|Death|0|||
44423595|NCT00734474|79431620|FG005|Overall Study|Death|0|||
44423596|NCT00734474|79431621|FG006|Overall Study|Death|0|||
44423597|NCT00734474|79431622|FG007|Overall Study|Death|2|||
44423598|NCT00734474|79431623|FG008|Overall Study|Death|1|||
44326414|NCT00479336|79331374|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
44326415|NCT00479336|79331375|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
44326416|NCT00479336|79331376|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
44326417|NCT00479336|79331377|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
44326418|NCT00478244|79331387|FG000|Overall Study|Did not receive transplant|1|||
44326419|NCT00478205|79331393|FG000|Overall Study|Adverse Event|182|||
44326420|NCT00478205|79331394|FG001|Overall Study|Adverse Event|39|||
44326421|NCT00478205|79331393|FG000|Overall Study|Medication Non-compliance|9|||
44326422|NCT00478205|79331394|FG001|Overall Study|Medication Non-compliance|4|||
44326423|NCT00478205|79331393|FG000|Overall Study|Protocol Violation|15|||
44326424|NCT00478205|79331394|FG001|Overall Study|Protocol Violation|5|||
44326425|NCT00478205|79331393|FG000|Overall Study|Request of Investigator or Sponsor|4|||
44326426|NCT00478205|79331394|FG001|Overall Study|Request of Investigator or Sponsor|5|||
44326427|NCT00478205|79331393|FG000|Overall Study|Withdrawal by Subject|61|||
44326428|NCT00478205|79331394|FG001|Overall Study|Withdrawal by Subject|22|||
44326429|NCT00478205|79331393|FG000|Overall Study|Lack of Efficacy|1|||
44423599|NCT00734474|79431615|FG000|Overall Study|Lack of Efficacy|0|||
44423600|NCT00734474|79431616|FG001|Overall Study|Lack of Efficacy|0|||
44423601|NCT00734474|79431617|FG002|Overall Study|Lack of Efficacy|4|||
44423602|NCT00734474|79431618|FG003|Overall Study|Lack of Efficacy|0|||
44423603|NCT00734474|79431619|FG004|Overall Study|Lack of Efficacy|0|||
44423604|NCT00734474|79431620|FG005|Overall Study|Lack of Efficacy|0|||
44423605|NCT00734474|79431621|FG006|Overall Study|Lack of Efficacy|0|||
44423606|NCT00734474|79431622|FG007|Overall Study|Lack of Efficacy|4|||
44156616|NCT04560816|78947790|FG004|Overall Study|Withdrawal by Subject|3|||
44156617|NCT04560816|78947791|FG005|Overall Study|Withdrawal by Subject|0|||
44258470|NCT03893448|79113561|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
44258471|NCT03893448|79113560|FG000|Overall Study|Physician Decision|8|||
44258472|NCT03893448|79113561|FG001|Overall Study|Physician Decision|14|||
44258473|NCT03893448|79113560|FG000|Overall Study|Lost to Follow-up|34|||
44258474|NCT03893448|79113561|FG001|Overall Study|Lost to Follow-up|27|||
44258475|NCT03893448|79113560|FG000|Overall Study|Death|1|||
44258476|NCT03893448|79113561|FG001|Overall Study|Death|0|||
44258477|NCT03692871|79113584|FG000|Overall Study|Death|1|||
44258478|NCT03692871|79113585|FG001|Overall Study|Death|1|||
44258479|NCT03692871|79113584|FG000|Overall Study|Lost to Follow-up|24|||
44258480|NCT03692871|79113585|FG001|Overall Study|Lost to Follow-up|9|||
44258481|NCT03692871|79113584|FG000|Overall Study|Physician Decision|22|||
44423607|NCT00734474|79431623|FG008|Overall Study|Lack of Efficacy|6|||
44258482|NCT03692871|79113585|FG001|Overall Study|Physician Decision|7|||
44326430|NCT00478205|79331394|FG001|Overall Study|Lack of Efficacy|0|||
44326431|NCT00478205|79331393|FG000|Overall Study|Other|24|||
44326432|NCT00478205|79331394|FG001|Overall Study|Other|12|||
44326433|NCT00477971|79331402|FG000|Overall Study|Disease progression|6|||
44423608|NCT00583362|79431649|FG000|Overall Study|Adverse Event|44|||
44423609|NCT00583362|79431649|FG000|Overall Study|Lack of Efficacy|22|||
44258483|NCT03692871|79113584|FG000|Overall Study|Protocol Deviation|1|||
44258484|NCT03692871|79113585|FG001|Overall Study|Protocol Deviation|0|||
44326434|NCT00477971|79331403|FG001|Overall Study|Disease progression|0|||
44326435|NCT00477971|79331402|FG000|Overall Study|Withdrawal by Subject|3|||
44326436|NCT00477971|79331403|FG001|Overall Study|Withdrawal by Subject|1|||
44326437|NCT00477971|79331402|FG000|Overall Study|Adverse Event|3|||
44326438|NCT00477971|79331403|FG001|Overall Study|Adverse Event|0|||
44326439|NCT00477971|79331402|FG000|Overall Study|Death|2|||
44326440|NCT00477971|79331403|FG001|Overall Study|Death|4|||
44326441|NCT00477971|79331402|FG000|Overall Study|Alternative treatment|3|||
44326442|NCT00477971|79331403|FG001|Overall Study|Alternative treatment|1|||
44326443|NCT00477464|79331409|FG000|Overall Study|Lost to Follow-up|1|||
44423610|NCT00583362|79431649|FG000|Overall Study|Lost to Follow-up|4|||
44423611|NCT00583362|79431649|FG000|Overall Study|Non-compliance with study drug|28|||
44423612|NCT00583362|79431649|FG000|Overall Study|Pregnancy|7|||
44423613|NCT00583362|79431649|FG000|Overall Study|Miscommunication of visit window|5|||
44423614|NCT00583362|79431649|FG000|Overall Study|Current site closed|7|||
44423615|NCT00583362|79431649|FG000|Overall Study|Subject not dosed in LBSL99|1|||
44423616|NCT00583362|79431649|FG000|Overall Study|Subject moved out of the country/state|2|||
44423617|NCT00583362|79431649|FG000|Overall Study|Missed visits due to staff changes|1|||
44423618|NCT00583362|79431649|FG000|Overall Study|Misunderstanding of protocol|1|||
44423619|NCT00583362|79431649|FG000|Overall Study|Behavioral problems and non-compliance|1|||
44423620|NCT00583362|79431649|FG000|Overall Study|Sponsor request due to missed doses|1|||
44423621|NCT00583362|79431649|FG000|Overall Study|Physician Decision|19|||
44423622|NCT00583362|79431649|FG000|Overall Study|Protocol Violation|2|||
44423623|NCT00583362|79431649|FG000|Overall Study|Withdrawal by Subject|57|||
44423624|NCT00577473|79431655|FG000|Overall Study|Protocol Violation|1|||
44423625|NCT00577473|79431656|FG001|Overall Study|Protocol Violation|4|||
44423626|NCT00577473|79431655|FG000|Overall Study|Adverse Event|8|||
44423627|NCT00577473|79431656|FG001|Overall Study|Adverse Event|5|||
44423628|NCT00577473|79431655|FG000|Overall Study|Withdrawal by Subject|2|||
44423629|NCT00577473|79431656|FG001|Overall Study|Withdrawal by Subject|6|||
44423630|NCT00577473|79431655|FG000|Overall Study|Physician Decision|2|||
44423631|NCT00577473|79431656|FG001|Overall Study|Physician Decision|2|||
44423632|NCT00577473|79431655|FG000|Overall Study|Lack of Efficacy|8|||
44326444|NCT00477464|79331409|FG000|Overall Study|Death|36|||
44326445|NCT00477464|79331409|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
44326446|NCT00477386|79331417|FG000|Overall Study|Adverse Event|4|||
44326447|NCT00477386|79331418|FG001|Overall Study|Adverse Event|8|||
44326448|NCT00477386|79331417|FG000|Overall Study|Disease progression, relapse|3|||
44326449|NCT00477386|79331418|FG001|Overall Study|Disease progression, relapse|4|||
44326450|NCT00477386|79331417|FG000|Overall Study|Disease progression, refractory|1|||
44326451|NCT00477386|79331418|FG001|Overall Study|Disease progression, refractory|3|||
44326452|NCT00477386|79331417|FG000|Overall Study|Other|1|||
44423633|NCT00577473|79431656|FG001|Overall Study|Lack of Efficacy|7|||
44423634|NCT00785291|79431665|FG000|Overall Study|Never began treatment|8|||
44423635|NCT00785291|79431666|FG001|Overall Study|Never began treatment|4|||
44423636|NCT00785291|79431667|FG002|Overall Study|Never began treatment|4|||
44423637|NCT00785291|79431665|FG000|Overall Study|Adverse Event|39|||
44423638|NCT00785291|79431666|FG001|Overall Study|Adverse Event|70|||
44423639|NCT00785291|79431667|FG002|Overall Study|Adverse Event|56|||
44423640|NCT00785291|79431665|FG000|Overall Study|Death|7|||
44423641|NCT00785291|79431666|FG001|Overall Study|Death|4|||
44423642|NCT00785291|79431667|FG002|Overall Study|Death|3|||
44423643|NCT00785291|79431665|FG000|Overall Study|Withdrawal by Subject|35|||
44423644|NCT00785291|79431666|FG001|Overall Study|Withdrawal by Subject|36|||
44423645|NCT00785291|79431667|FG002|Overall Study|Withdrawal by Subject|17|||
44423646|NCT00785291|79431665|FG000|Overall Study|Alternative Therapy|12|||
44423647|NCT00785291|79431666|FG001|Overall Study|Alternative Therapy|6|||
44423648|NCT00785291|79431667|FG002|Overall Study|Alternative Therapy|7|||
44156618|NCT04560816|78947786|FG000|Overall Study|Lost to Follow-up|1|||
44156619|NCT04560816|78947787|FG001|Overall Study|Lost to Follow-up|0|||
44258485|NCT03692871|79113584|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
44258486|NCT03692871|79113585|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
44258487|NCT03565900|79113593|FG000|Overall Study|Disposition Unknown|4|||
44258488|NCT03565900|79113594|FG001|Overall Study|Disposition Unknown|1|||
44258489|NCT03565900|79113593|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
44258490|NCT03565900|79113594|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
44258491|NCT03565900|79113593|FG000|Overall Study|Withdrawal by Subject|4|||
44258492|NCT03565900|79113594|FG001|Overall Study|Withdrawal by Subject|5|||
44258493|NCT03565900|79113593|FG000|Overall Study|Randomized By Mistake|0|||
44258494|NCT03565900|79113594|FG001|Overall Study|Randomized By Mistake|2|||
44258495|NCT03565900|79113593|FG000|Overall Study|Physician Decision|7|||
44258496|NCT03565900|79113594|FG001|Overall Study|Physician Decision|11|||
44326453|NCT00477386|79331418|FG001|Overall Study|Other|2|||
44326454|NCT00477386|79331417|FG000|Overall Study|Physician Decision|1|||
44326455|NCT00477386|79331418|FG001|Overall Study|Physician Decision|0|||
44258497|NCT03565900|79113593|FG000|Overall Study|Death|9|||
44423649|NCT00785291|79431665|FG000|Overall Study|Complicating illness|6|||
44423650|NCT00785291|79431666|FG001|Overall Study|Complicating illness|4|||
44423651|NCT00785291|79431667|FG002|Overall Study|Complicating illness|4|||
44423652|NCT00785291|79431665|FG000|Overall Study|Other Medical Reasons|29|||
44423653|NCT00785291|79431666|FG001|Overall Study|Other Medical Reasons|25|||
44423654|NCT00785291|79431667|FG002|Overall Study|Other Medical Reasons|15|||
44423655|NCT00705939|79431678|FG000|Overall Study|Protocol Violation|0|||
44423656|NCT00705939|79431679|FG001|Overall Study|Protocol Violation|0|||
44423657|NCT00705939|79431680|FG002|Overall Study|Protocol Violation|1|||
44423658|NCT00705939|79431678|FG000|Overall Study|Withdrawal by Subject|0|||
44423659|NCT00705939|79431679|FG001|Overall Study|Withdrawal by Subject|1|||
44423660|NCT00705939|79431680|FG002|Overall Study|Withdrawal by Subject|3|||
44326456|NCT00477386|79331417|FG000|Overall Study|Withdrawal by Subject|1|||
44326457|NCT00477386|79331418|FG001|Overall Study|Withdrawal by Subject|0|||
44326458|NCT00477269|79331426|FG000|Core Study|Adverse Event|6|||
44326459|NCT00477269|79331427|FG001|Core Study|Adverse Event|4|||
44423661|NCT00705939|79431678|FG000|Overall Study|Physician Decision|0|||
44423662|NCT00705939|79431679|FG001|Overall Study|Physician Decision|1|||
44423663|NCT00705939|79431680|FG002|Overall Study|Physician Decision|0|||
44423664|NCT00785213|79431689|FG000|Quinine Sulfate Alone|Adverse Event|4|||
44423665|NCT00785213|79431689|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
44423666|NCT00577317|79431698|FG000|Overall Study|Study Terminated|0|||
44423667|NCT00577317|79431699|FG001|Overall Study|Study Terminated|2|||
44423668|NCT00734162|79431709|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
44423669|NCT00734162|79431710|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
44423670|NCT00734162|79431711|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
44423671|NCT00734162|79431712|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
44423672|NCT00734162|79431709|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
44423673|NCT00734162|79431710|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
44423674|NCT00734162|79431711|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
44326460|NCT00477269|79331428|FG002|Core Study|Adverse Event|0|||
44326461|NCT00477269|79331426|FG000|Core Study|Death|3|||
44326462|NCT00477269|79331427|FG001|Core Study|Death|3|||
44326463|NCT00477269|79331428|FG002|Core Study|Death|0|||
44326464|NCT00477269|79331426|FG000|Core Study|Withdrawn Consent|0|||
44326465|NCT00477269|79331427|FG001|Core Study|Withdrawn Consent|1|||
44326466|NCT00477269|79331428|FG002|Core Study|Withdrawn Consent|0|||
44326467|NCT00477269|79331426|FG000|Open Label Extension|Adverse Event|0|||
44326468|NCT00477269|79331427|FG001|Open Label Extension|Adverse Event|0|||
44326469|NCT00477269|79331428|FG002|Open Label Extension|Adverse Event|4|||
44326470|NCT00477269|79331426|FG000|Open Label Extension|Abnormal laboratory values|0|||
44326471|NCT00477269|79331427|FG001|Open Label Extension|Abnormal laboratory values|0|||
44326472|NCT00477269|79331428|FG002|Open Label Extension|Abnormal laboratory values|1|||
44326473|NCT00477269|79331426|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
44326474|NCT00477269|79331427|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
44326475|NCT00477269|79331428|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
44326476|NCT00477269|79331426|FG000|Open Label Extension|Adminiatrative problems|0|||
44326477|NCT00477269|79331427|FG001|Open Label Extension|Adminiatrative problems|0|||
44326478|NCT00477269|79331428|FG002|Open Label Extension|Adminiatrative problems|2|||
44326479|NCT00477269|79331426|FG000|Open Label Extension|Death|0|||
44326480|NCT00477269|79331427|FG001|Open Label Extension|Death|0|||
44326481|NCT00477269|79331428|FG002|Open Label Extension|Death|4|||
44326482|NCT00477152|79331436|FG000|Overall Study|Parent withdrew consent|2|||
44326483|NCT00477152|79331436|FG000|Overall Study|Adverse Event|1|||
44326484|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
44326485|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
44326486|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
44326487|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
44326488|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
44326489|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
44326490|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
44326491|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
44326492|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
44326493|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
44423675|NCT00734162|79431712|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
44537003|NCT02906020|79547729|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
44326494|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
44326495|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
44537004|NCT02906020|79547730|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
44326496|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
44326497|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
44423676|NCT00734162|79431709|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
44423677|NCT00734162|79431710|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
44326498|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
44326499|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
44326500|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
44326501|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
44326502|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
44326503|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
44326504|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
44326505|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
44326506|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
44326507|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
44326508|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
44326509|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
44326510|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
44326511|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
44326512|NCT00476996|79331443|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
44423678|NCT00734162|79431711|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
44423679|NCT00734162|79431712|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
44423680|NCT00734162|79431709|FG000|Open-Label Phase|Withdrew Consent|1|||
44423681|NCT00734162|79431710|FG001|Open-Label Phase|Withdrew Consent|0|||
44423682|NCT00734162|79431711|FG002|Open-Label Phase|Withdrew Consent|1|||
44423683|NCT00734162|79431712|FG003|Open-Label Phase|Withdrew Consent|1|||
44326513|NCT00476996|79331444|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
44326514|NCT00476996|79331445|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
44326515|NCT00476996|79331446|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
44326516|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
44326517|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
44326518|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
44326519|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
44326520|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
44326521|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
44326522|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
44326523|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
44326524|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Death|0|||
44423684|NCT00734162|79431709|FG000|Open-Label Phase|Lost to Follow-up|1|||
44423685|NCT00734162|79431710|FG001|Open-Label Phase|Lost to Follow-up|2|||
44423686|NCT00734162|79431711|FG002|Open-Label Phase|Lost to Follow-up|0|||
44423687|NCT00734162|79431712|FG003|Open-Label Phase|Lost to Follow-up|1|||
44423688|NCT00734162|79431709|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
44423689|NCT00734162|79431710|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
44423690|NCT00734162|79431711|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
44423691|NCT00734162|79431712|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
44423692|NCT00790751|79431730|FG000|Overall Study|Protocol non-compliance|16|||
44423693|NCT00790751|79431731|FG001|Overall Study|Protocol non-compliance|16|||
44423694|NCT00790751|79431732|FG002|Overall Study|Protocol non-compliance|10|||
44423695|NCT00790751|79431733|FG003|Overall Study|Protocol non-compliance|11|||
44423696|NCT00790751|79431730|FG000|Overall Study|Lost to Follow-up|4|||
44423697|NCT00790751|79431731|FG001|Overall Study|Lost to Follow-up|9|||
44423698|NCT00790751|79431732|FG002|Overall Study|Lost to Follow-up|4|||
44423699|NCT00790751|79431733|FG003|Overall Study|Lost to Follow-up|5|||
44423700|NCT00790751|79431730|FG000|Overall Study|Adverse Event|5|||
44423701|NCT00790751|79431731|FG001|Overall Study|Adverse Event|3|||
44423702|NCT00790751|79431732|FG002|Overall Study|Adverse Event|5|||
44423703|NCT00790751|79431733|FG003|Overall Study|Adverse Event|4|||
44423704|NCT00790751|79431730|FG000|Overall Study|Requirement for restricted medication|0|||
44423705|NCT00790751|79431731|FG001|Overall Study|Requirement for restricted medication|2|||
44423706|NCT00790751|79431732|FG002|Overall Study|Requirement for restricted medication|0|||
44423707|NCT00790751|79431733|FG003|Overall Study|Requirement for restricted medication|0|||
44423708|NCT00790751|79431730|FG000|Overall Study|Death|0|||
44423709|NCT00790751|79431731|FG001|Overall Study|Death|0|||
44423710|NCT00790751|79431732|FG002|Overall Study|Death|1|||
44423711|NCT00790751|79431733|FG003|Overall Study|Death|0|||
44423712|NCT00790751|79431730|FG000|Overall Study|Physician Decision|0|||
44423713|NCT00790751|79431731|FG001|Overall Study|Physician Decision|0|||
44423714|NCT00790751|79431732|FG002|Overall Study|Physician Decision|0|||
44423715|NCT00790751|79431733|FG003|Overall Study|Physician Decision|1|||
44423716|NCT00784979|79431743|FG000|Overall Study|incomplete data|6|||
44423717|NCT00738920|79431750|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
44423718|NCT00738920|79431751|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
44423719|NCT00738920|79431752|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
44423720|NCT00738920|79431750|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
44423721|NCT00738920|79431751|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
44423722|NCT00738920|79431752|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
44423723|NCT00738920|79431750|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
44423724|NCT00738920|79431751|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
44423725|NCT00738920|79431752|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
44423726|NCT00738920|79431750|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
44423727|NCT00738920|79431751|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
44423728|NCT00738920|79431752|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
44423729|NCT00738920|79431750|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
44423730|NCT00738920|79431751|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
44423731|NCT00738920|79431752|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
44423732|NCT00738920|79431750|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
44423733|NCT00738920|79431751|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
44423734|NCT00738920|79431752|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
44326525|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Death|0|||
44326526|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Death|0|||
44326527|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Death|7|||
44326528|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
44326529|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
44326530|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
44326531|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
44326532|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
44326533|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
44326534|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
44326535|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
44326536|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
44326537|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
44326538|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
44326539|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
44326540|NCT00476996|79331443|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
44326541|NCT00476996|79331444|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
44326542|NCT00476996|79331445|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
44326543|NCT00476996|79331446|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
44326544|NCT00476957|79331457|FG000|Overall Study|Lost to Follow-up|176|||
44423735|NCT00738920|79431750|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
44423736|NCT00738920|79431751|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
44423737|NCT00738920|79431752|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
44423738|NCT00738920|79431750|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
44423739|NCT00738920|79431751|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
44423740|NCT00738920|79431752|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
44423741|NCT00738920|79431750|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
44423742|NCT00738920|79431751|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
44423743|NCT00738920|79431752|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
44423744|NCT00738920|79431750|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
44423745|NCT00738920|79431751|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
44156620|NCT04560816|78947788|FG002|Overall Study|Lost to Follow-up|0|||
44326545|NCT00476957|79331458|FG001|Overall Study|Lost to Follow-up|193|||
44326546|NCT00475865|79331467|FG000|Overall Study|Adverse Event|0|||
44326547|NCT00475865|79331468|FG001|Overall Study|Adverse Event|3|||
44326548|NCT00475865|79331469|FG002|Overall Study|Adverse Event|4|||
44326549|NCT00475865|79331467|FG000|Overall Study|Lack of Efficacy|1|||
44326550|NCT00475865|79331468|FG001|Overall Study|Lack of Efficacy|0|||
44326551|NCT00475865|79331469|FG002|Overall Study|Lack of Efficacy|0|||
44326552|NCT00475865|79331467|FG000|Overall Study|Progressive disease|0|||
44326553|NCT00475865|79331468|FG001|Overall Study|Progressive disease|1|||
44326554|NCT00475865|79331469|FG002|Overall Study|Progressive disease|2|||
44326555|NCT00475865|79331467|FG000|Overall Study|Participant did not wish to continue|1|||
44326556|NCT00475865|79331468|FG001|Overall Study|Participant did not wish to continue|0|||
44326557|NCT00475865|79331469|FG002|Overall Study|Participant did not wish to continue|0|||
44326558|NCT00475865|79331467|FG000|Overall Study|Other than above|0|||
44423746|NCT00738920|79431752|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
44423747|NCT00582972|79431760|FG000|Overall Study|Protocol Violation|2|||
44156621|NCT04560816|78947789|FG003|Overall Study|Lost to Follow-up|0|||
44156622|NCT04560816|78947790|FG004|Overall Study|Lost to Follow-up|0|||
44156623|NCT04560816|78947791|FG005|Overall Study|Lost to Follow-up|0|||
44326559|NCT00475865|79331468|FG001|Overall Study|Other than above|1|||
44326560|NCT00475865|79331469|FG002|Overall Study|Other than above|0|||
44326561|NCT00475709|79331479|FG000|Overall Study|Did not meet eligibility criteria|8|||
44326562|NCT00475709|79331479|FG000|Overall Study|Death|41|||
44156624|NCT04560816|78947786|FG000|Overall Study|Protocol Violation|1|||
44156625|NCT04560816|78947787|FG001|Overall Study|Protocol Violation|0|||
44156626|NCT04560816|78947788|FG002|Overall Study|Protocol Violation|0|||
44156627|NCT04560816|78947789|FG003|Overall Study|Protocol Violation|0|||
44156628|NCT04560816|78947790|FG004|Overall Study|Protocol Violation|0|||
44156629|NCT04560816|78947791|FG005|Overall Study|Protocol Violation|0|||
44156630|NCT04092582|78947805|FG000|Overall Study|Death|1|||
44156631|NCT04092582|78947806|FG001|Overall Study|Death|1|||
44156632|NCT04092582|78947805|FG000|Overall Study|Withdrawal by Subject|4|||
44156633|NCT04092582|78947806|FG001|Overall Study|Withdrawal by Subject|1|||
44156634|NCT04092582|78947805|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
44537005|NCT02906020|79547731|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
44537006|NCT02906020|79547732|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
44537007|NCT02906020|79547733|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
44537008|NCT02906020|79547734|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
44537009|NCT02906020|79547735|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
44537010|NCT02906020|79547736|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
44156635|NCT04092582|78947806|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
44156636|NCT03636256|78947842|FG000|Overall Study|Lost to Follow-up|3|||
44156637|NCT03636256|78947843|FG001|Overall Study|Lost to Follow-up|0|||
44156638|NCT03636256|78947844|FG002|Overall Study|Lost to Follow-up|2|||
44156639|NCT03636256|78947845|FG003|Overall Study|Lost to Follow-up|1|||
44156640|NCT03636256|78947846|FG004|Overall Study|Lost to Follow-up|0|||
44156641|NCT03636256|78947847|FG005|Overall Study|Lost to Follow-up|4|||
44156642|NCT03636256|78947848|FG006|Overall Study|Lost to Follow-up|2|||
44156643|NCT03636256|78947849|FG007|Overall Study|Lost to Follow-up|0|||
44156644|NCT03636256|78947850|FG008|Overall Study|Lost to Follow-up|4|||
44156645|NCT03636256|78947842|FG000|Overall Study|Withdrawal by Subject|0|||
44156646|NCT03636256|78947843|FG001|Overall Study|Withdrawal by Subject|0|||
44156647|NCT03636256|78947844|FG002|Overall Study|Withdrawal by Subject|0|||
44156648|NCT03636256|78947845|FG003|Overall Study|Withdrawal by Subject|0|||
44326563|NCT00475709|79331479|FG000|Overall Study|Device Explant|6|||
44326564|NCT00475709|79331479|FG000|Overall Study|Lost to Follow-up|21|||
44326565|NCT00475670|79331485|FG000|Overall Study|Death|0|||
44326566|NCT00475670|79331486|FG001|Overall Study|Death|1|||
44326567|NCT00475670|79331485|FG000|Overall Study|Lack of Efficacy|3|||
44326568|NCT00475670|79331486|FG001|Overall Study|Lack of Efficacy|34|||
44326569|NCT00475670|79331485|FG000|Overall Study|Refused treatment|0|||
44326570|NCT00475670|79331486|FG001|Overall Study|Refused treatment|2|||
44326571|NCT00475670|79331485|FG000|Overall Study|Failure to Return|0|||
44326572|NCT00475670|79331486|FG001|Overall Study|Failure to Return|1|||
44326573|NCT00475670|79331485|FG000|Overall Study|Other|0|||
44326574|NCT00475670|79331486|FG001|Overall Study|Other|3|||
44326575|NCT00474968|79331494|FG000|Overall Study|Withdrawal by Subject|8|||
44326576|NCT00474968|79331495|FG001|Overall Study|Withdrawal by Subject|7|||
44326577|NCT00474968|79331494|FG000|Overall Study|Protocol Violation|9|||
44326578|NCT00474968|79331495|FG001|Overall Study|Protocol Violation|8|||
44326579|NCT00474968|79331494|FG000|Overall Study|Sample not collected|1|||
44326580|NCT00474968|79331495|FG001|Overall Study|Sample not collected|1|||
44326581|NCT00474929|79331506|FG000|Overall Study|Withdrawal by Subject|0|||
44326582|NCT00474929|79331507|FG001|Overall Study|Withdrawal by Subject|1|||
44326583|NCT00474929|79331508|FG002|Overall Study|Withdrawal by Subject|0|||
44326584|NCT00474929|79331509|FG003|Overall Study|Withdrawal by Subject|0|||
44326585|NCT00474929|79331510|FG004|Overall Study|Withdrawal by Subject|0|||
44326586|NCT00474929|79331506|FG000|Overall Study|Unrelated medical condition|0|||
44326587|NCT00474929|79331507|FG001|Overall Study|Unrelated medical condition|0|||
44326588|NCT00474929|79331508|FG002|Overall Study|Unrelated medical condition|1|||
44326589|NCT00474929|79331509|FG003|Overall Study|Unrelated medical condition|0|||
44326590|NCT00474929|79331510|FG004|Overall Study|Unrelated medical condition|0|||
44326591|NCT00474929|79331506|FG000|Overall Study|Physician Decision|0|||
44326592|NCT00474929|79331507|FG001|Overall Study|Physician Decision|0|||
44326593|NCT00474929|79331508|FG002|Overall Study|Physician Decision|1|||
44326594|NCT00474929|79331509|FG003|Overall Study|Physician Decision|2|||
44326595|NCT00474929|79331510|FG004|Overall Study|Physician Decision|0|||
44326596|NCT00474812|79331523|FG000|Overall Study|Withdrawal by Subject|5|||
44156649|NCT03636256|78947846|FG004|Overall Study|Withdrawal by Subject|0|||
44537011|NCT02906020|79547737|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
44537012|NCT02906020|79547738|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
44156650|NCT03636256|78947847|FG005|Overall Study|Withdrawal by Subject|0|||
44326597|NCT00474812|79331523|FG000|Overall Study|No Initiation of treatment|2|||
44326598|NCT00474383|79331527|FG000|Main Study|Adverse Event|11|||
44326599|NCT00474383|79331528|FG001|Main Study|Adverse Event|0|||
44423748|NCT04319718|79431767|FG000|Overall Study|Adverse Event|0|||
44156651|NCT03636256|78947848|FG006|Overall Study|Withdrawal by Subject|0|||
44156652|NCT03636256|78947849|FG007|Overall Study|Withdrawal by Subject|0|||
44156653|NCT03636256|78947850|FG008|Overall Study|Withdrawal by Subject|1|||
44326600|NCT00474383|79331527|FG000|Main Study|Symptomatic Deterioration|1|||
44326601|NCT00474383|79331528|FG001|Main Study|Symptomatic Deterioration|0|||
44423749|NCT04319718|79431768|FG001|Overall Study|Adverse Event|2|||
44423750|NCT04319718|79431767|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
44423751|NCT04319718|79431768|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
44423752|NCT04372602|79431776|FG000|Overall Study|Withdrawal by Subject|1|||
44423753|NCT04372602|79431777|FG001|Overall Study|Withdrawal by Subject|1|||
44423754|NCT04372602|79431776|FG000|Overall Study|Adverse Event|0|||
44423755|NCT04372602|79431777|FG001|Overall Study|Adverse Event|1|||
44423756|NCT04372602|79431776|FG000|Overall Study|Transitioned to comfort care|0|||
44423757|NCT04372602|79431777|FG001|Overall Study|Transitioned to comfort care|1|||
44423758|NCT00733304|79431786|FG000|Overall Study|Adverse Event|3|||
44423759|NCT00733304|79431787|FG001|Overall Study|Adverse Event|0|||
44423760|NCT00733304|79431788|FG002|Overall Study|Adverse Event|0|||
44423761|NCT00733304|79431786|FG000|Overall Study|Lack of Efficacy|0|||
44423762|NCT00733304|79431787|FG001|Overall Study|Lack of Efficacy|0|||
44423763|NCT00733304|79431788|FG002|Overall Study|Lack of Efficacy|2|||
44423764|NCT00733304|79431786|FG000|Overall Study|Lost to Follow-up|0|||
44423765|NCT00733304|79431787|FG001|Overall Study|Lost to Follow-up|1|||
44326602|NCT00474383|79331527|FG000|Main Study|Progressive Disease|23|||
44326603|NCT00474383|79331528|FG001|Main Study|Progressive Disease|0|||
44326604|NCT00474383|79331527|FG000|Main Study|Other|1|||
44326605|NCT00474383|79331528|FG001|Main Study|Other|0|||
44326606|NCT00474383|79331527|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
44326607|NCT00474383|79331528|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
44326608|NCT00474383|79331527|FG000|Extension|Progressive Disease|0|||
44326609|NCT00474383|79331528|FG001|Extension|Progressive Disease|5|||
44326610|NCT00474266|79331536|FG000|Overall Study|Withdrawal by Subject|7|||
44326611|NCT00474266|79331537|FG001|Overall Study|Withdrawal by Subject|20|||
44423766|NCT00733304|79431788|FG002|Overall Study|Lost to Follow-up|0|||
44423767|NCT00733304|79431786|FG000|Overall Study|Physician Decision|3|||
44423768|NCT00733304|79431787|FG001|Overall Study|Physician Decision|1|||
44423769|NCT00733304|79431788|FG002|Overall Study|Physician Decision|3|||
44423770|NCT00733304|79431786|FG000|Overall Study|Withdrawal by Subject|1|||
44423771|NCT00733304|79431787|FG001|Overall Study|Withdrawal by Subject|1|||
44423772|NCT00733304|79431788|FG002|Overall Study|Withdrawal by Subject|0|||
44423773|NCT00711243|79431802|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
44423774|NCT00711243|79431803|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
44423775|NCT00711243|79431804|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
44423776|NCT00711243|79431805|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
44423777|NCT00711243|79431806|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
44423778|NCT00711243|79431807|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
44423779|NCT00711243|79431802|FG000|Reached First Response/4 Cycles|Death|0|||
44423780|NCT00711243|79431803|FG001|Reached First Response/4 Cycles|Death|0|||
44423781|NCT00711243|79431804|FG002|Reached First Response/4 Cycles|Death|0|||
44423782|NCT00711243|79431805|FG003|Reached First Response/4 Cycles|Death|0|||
44423783|NCT00711243|79431806|FG004|Reached First Response/4 Cycles|Death|0|||
44423784|NCT00711243|79431807|FG005|Reached First Response/4 Cycles|Death|2|||
44423785|NCT00711243|79431802|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
44423786|NCT00711243|79431803|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
44423787|NCT00711243|79431804|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
44423788|NCT00711243|79431805|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
44423789|NCT00711243|79431806|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
44423790|NCT00711243|79431807|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
44423791|NCT00711243|79431802|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
44423792|NCT00711243|79431803|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
44423793|NCT00711243|79431804|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
44423794|NCT00711243|79431805|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
44423795|NCT00711243|79431806|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
44423796|NCT00711243|79431807|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
44423797|NCT00711243|79431802|FG000|Treated Cycle 5 After First Response|Death|0|||
44423798|NCT00711243|79431803|FG001|Treated Cycle 5 After First Response|Death|0|||
44326612|NCT00474266|79331538|FG002|Overall Study|Withdrawal by Subject|4|||
44326613|NCT00474266|79331539|FG003|Overall Study|Withdrawal by Subject|7|||
44423799|NCT00711243|79431804|FG002|Treated Cycle 5 After First Response|Death|0|||
44156654|NCT03614676|78947881|FG000|Overall Study|Delivery before planned visit|2|||
44326614|NCT00473564|79331552|FG000|Overall Study|robot surgery aborted in OR|23|||
44326615|NCT00472199|79331558|FG000|Overall Study|Adverse Event|19|||
44423800|NCT00711243|79431805|FG003|Treated Cycle 5 After First Response|Death|0|||
44326616|NCT00472199|79331559|FG001|Overall Study|Adverse Event|23|||
44326617|NCT00472199|79331558|FG000|Overall Study|Lack of Efficacy|4|||
44326618|NCT00472199|79331559|FG001|Overall Study|Lack of Efficacy|25|||
44423801|NCT00711243|79431806|FG004|Treated Cycle 5 After First Response|Death|0|||
44423802|NCT00711243|79431807|FG005|Treated Cycle 5 After First Response|Death|2|||
44326619|NCT00472199|79331558|FG000|Overall Study|Lost to Follow-up|2|||
44326620|NCT00472199|79331559|FG001|Overall Study|Lost to Follow-up|4|||
44326621|NCT00472199|79331558|FG000|Overall Study|Protocol Violation|3|||
44326622|NCT00472199|79331559|FG001|Overall Study|Protocol Violation|2|||
44326623|NCT00472199|79331558|FG000|Overall Study|Withdrawal by Subject|6|||
44326624|NCT00472199|79331559|FG001|Overall Study|Withdrawal by Subject|5|||
44423803|NCT00711243|79431802|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
44423804|NCT00711243|79431803|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
44423805|NCT00711243|79431804|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
44423806|NCT00711243|79431805|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
44326625|NCT00472199|79331558|FG000|Overall Study|personal reason|0|||
44326626|NCT00472199|79331559|FG001|Overall Study|personal reason|1|||
44326627|NCT00472199|79331558|FG000|Overall Study|patient was asymptomatic|1|||
44326628|NCT00472199|79331559|FG001|Overall Study|patient was asymptomatic|0|||
44326629|NCT00472082|79331565|FG000|Overall Study|Study prematurely terminated|5|||
44326630|NCT00471887|79331569|FG000|Overall Study|Adverse Event|9|||
44326631|NCT00471536|79331573|FG000|Overall Study|Withdrawal by Subject|1|||
44326632|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
44326633|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
44326634|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Adverse Event|7|||
44423807|NCT00711243|79431806|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
44423808|NCT00711243|79431807|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
44423809|NCT00711243|79431802|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
44423810|NCT00711243|79431803|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
44423811|NCT00711243|79431804|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
44423812|NCT00711243|79431805|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
44423813|NCT00711243|79431806|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
44423814|NCT00711243|79431807|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
44423815|NCT00733226|79431825|FG000|Overall Study|Withdrawal by Subject|1|||
44423816|NCT00733226|79431826|FG001|Overall Study|Withdrawal by Subject|0|||
44423817|NCT00733226|79431825|FG000|Overall Study|Lost to Follow-up|2|||
44423818|NCT00733226|79431826|FG001|Overall Study|Lost to Follow-up|0|||
44423819|NCT00733226|79431825|FG000|Overall Study|moved to another place|2|||
44423820|NCT00733226|79431826|FG001|Overall Study|moved to another place|0|||
44423821|NCT00732992|79431834|FG000|Overall Study|Adverse Event|1|||
44423822|NCT00732992|79431835|FG001|Overall Study|Adverse Event|1|||
44423823|NCT00732992|79431834|FG000|Overall Study|Objective Progression or Relapse|3|||
44423824|NCT00732992|79431835|FG001|Overall Study|Objective Progression or Relapse|5|||
44423825|NCT00732992|79431834|FG000|Overall Study|Global Deterioration of Health Status|1|||
44423826|NCT00732992|79431835|FG001|Overall Study|Global Deterioration of Health Status|0|||
44423827|NCT00732992|79431834|FG000|Overall Study|Withdrawal by Subject|1|||
44423828|NCT00732992|79431835|FG001|Overall Study|Withdrawal by Subject|0|||
44423829|NCT00732758|79431844|FG000|Overall Study|Lost to Follow-up|8|||
44423830|NCT00732758|79431845|FG001|Overall Study|Lost to Follow-up|16|||
44423831|NCT00699153|79431853|FG000|Overall Study|Lost to Follow-up|1|||
44423832|NCT00699153|79431854|FG001|Overall Study|Lost to Follow-up|0|||
44423833|NCT00699153|79431853|FG000|Overall Study|Adverse Event|0|||
44423834|NCT00699153|79431854|FG001|Overall Study|Adverse Event|2|||
44423835|NCT00699153|79431853|FG000|Overall Study|Protocol Violation|1|||
44423836|NCT00699153|79431854|FG001|Overall Study|Protocol Violation|0|||
44423837|NCT00699153|79431853|FG000|Overall Study|Travel Problem|1|||
44423838|NCT00699153|79431854|FG001|Overall Study|Travel Problem|0|||
44423839|NCT00698997|79431862|FG000|Overall Study|Lost to Follow-up|3|||
44423840|NCT00698997|79431863|FG001|Overall Study|Lost to Follow-up|0|||
44423841|NCT00698997|79431862|FG000|Overall Study|Withdrawal by Subject|7|||
44423842|NCT00698997|79431863|FG001|Overall Study|Withdrawal by Subject|27|||
44423843|NCT00711087|79431872|FG000|Overall Study|Lost to Follow-up|1|||
44423844|NCT00711087|79431873|FG001|Overall Study|Lost to Follow-up|0|||
44423845|NCT00738530|79431881|FG000|Overall Study|Death|220|||
44423846|NCT00738530|79431882|FG001|Overall Study|Death|224|||
44326635|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Adverse Event|6|||
44326636|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
44326637|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
44326638|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Physician Decision|4|||
44326639|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Physician Decision|4|||
44423847|NCT00738530|79431881|FG000|Overall Study|Lost to Follow-up|8|||
44423848|NCT00738530|79431882|FG001|Overall Study|Lost to Follow-up|6|||
44423849|NCT00738530|79431881|FG000|Overall Study|Withdrawal by Subject|6|||
44326640|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
44423850|NCT00738530|79431882|FG001|Overall Study|Withdrawal by Subject|8|||
44423851|NCT00711009|79431890|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
44423852|NCT00711009|79431891|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
44423853|NCT00711009|79431890|FG000|Overall Study|Withdrawal by Subject|4|||
44423854|NCT00711009|79431891|FG001|Overall Study|Withdrawal by Subject|2|||
44423855|NCT00711009|79431890|FG000|Overall Study|Lost to Follow-up|3|||
44423856|NCT00711009|79431891|FG001|Overall Study|Lost to Follow-up|9|||
44423857|NCT00711009|79431890|FG000|Overall Study|Participant Noncompliant|0|||
44423858|NCT00711009|79431891|FG001|Overall Study|Participant Noncompliant|1|||
44423859|NCT00711009|79431890|FG000|Overall Study|Virologic Failure|2|||
44423860|NCT00711009|79431891|FG001|Overall Study|Virologic Failure|1|||
44423861|NCT00711009|79431890|FG000|Overall Study|Pregnancy|1|||
44423862|NCT00711009|79431891|FG001|Overall Study|Pregnancy|0|||
44423863|NCT00711009|79431890|FG000|Overall Study|Site closing|0|||
44423864|NCT00711009|79431891|FG001|Overall Study|Site closing|1|||
44423865|NCT00711009|79431890|FG000|Overall Study|Dose adjustment|1|||
44423866|NCT00711009|79431891|FG001|Overall Study|Dose adjustment|0|||
44423867|NCT00577005|79431899|FG000|Overall Study|Lost to Follow-up|3|||
44423868|NCT00577005|79431900|FG001|Overall Study|Lost to Follow-up|2|||
44423869|NCT00577005|79431899|FG000|Overall Study|Withdrawal by Subject|2|||
44423870|NCT00577005|79431900|FG001|Overall Study|Withdrawal by Subject|1|||
44423871|NCT00576927|79431911|FG000|Clinical Assessment|Lack of Efficacy|24|||
44423872|NCT00576927|79431911|FG000|Clinical Assessment|Death|1|||
44423873|NCT00576927|79431911|FG000|Clinical Assessment|Withdrawal by Subject|10|||
44423874|NCT00576927|79431911|FG000|Clinical Assessment|Physician Decision|1|||
44423875|NCT00576927|79431911|FG000|Baseline|Physician Decision|9|||
44423876|NCT00576927|79431911|FG000|Baseline|Medication Change by PCP of subject|1|||
44423877|NCT00576927|79431911|FG000|Baseline|Withdrawal by Subject|3|||
44423878|NCT00576927|79431911|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
44423879|NCT00576927|79431911|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
44423880|NCT00576927|79431911|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
44423881|NCT00576927|79431911|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
44423882|NCT00576927|79431911|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
44423883|NCT00698841|79431917|FG000|Overall Study|Withdrawal by Subject|2|||
44423884|NCT00698841|79431917|FG000|Overall Study|Adverse Event|3|||
44423885|NCT00698841|79431917|FG000|Overall Study|Disease progression|7|||
44423886|NCT00698841|79431917|FG000|Overall Study|Failure to meet eligibility criteria|2|||
44423887|NCT00698841|79431917|FG000|Overall Study|Study drug toxicity|2|||
44537013|NCT02906020|79547739|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
44537014|NCT02906020|79547724|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44326641|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
44326642|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
44326643|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
44326644|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
44326645|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
44326646|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Non-compliance|1|||
44326647|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Non-compliance|0|||
44326648|NCT00470834|79331579|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
44326649|NCT00470834|79331580|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
44326650|NCT00470834|79331579|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
44326651|NCT00470834|79331580|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
44326652|NCT00470834|79331579|FG000|Extension Period (24 Months)|Adverse Event|3|||
44326653|NCT00470834|79331580|FG001|Extension Period (24 Months)|Adverse Event|4|||
44326654|NCT00470834|79331579|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
44326655|NCT00470834|79331580|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
44326656|NCT00470834|79331579|FG000|Extension Period (24 Months)|Physician Decision|4|||
44326657|NCT00470834|79331580|FG001|Extension Period (24 Months)|Physician Decision|3|||
44326658|NCT00470834|79331579|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
44326659|NCT00470834|79331580|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
44326660|NCT00470834|79331579|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
44326661|NCT00470834|79331580|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
44326662|NCT00470834|79331579|FG000|Extension Period (24 Months)|Non-compliance|0|||
44326663|NCT00470834|79331580|FG001|Extension Period (24 Months)|Non-compliance|1|||
44326664|NCT00470834|79331579|FG000|Extension Period (24 Months)|Disease Progression|0|||
44326665|NCT00470834|79331580|FG001|Extension Period (24 Months)|Disease Progression|1|||
44423888|NCT00698841|79431917|FG000|Overall Study|Other|2|||
44537015|NCT02906020|79547725|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537016|NCT02906020|79547726|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44326666|NCT00470366|79331586|FG000|Overall Study|Adverse Event|3|||
44326667|NCT00470366|79331586|FG000|Overall Study|Poor compliance|1|||
44423889|NCT00577395|79431923|FG000|Overall Study|Study was terminated early by Sponsor|7|||
44423890|NCT00577395|79431924|FG001|Overall Study|Study was terminated early by Sponsor|6|||
44326668|NCT00470093|79331590|FG000|Overall Study|Adverse Event|2|||
44326669|NCT00470054|79331594|FG000|Overall Study|Ineligible|1|||
44326670|NCT00474188|79331598|FG000|Overall Study|Withdrawal by Subject|1|||
44326671|NCT00474188|79331598|FG000|Overall Study|Study discontinued by sponsor|5|||
44326672|NCT00475982|79331603|FG000|Overall Study|surgery rescheduled|7|||
44326673|NCT00475982|79331604|FG001|Overall Study|surgery rescheduled|3|||
44326674|NCT01089647|79331612|FG000|Overall Study|Lost to Follow-up|2|||
44326675|NCT01089647|79331613|FG001|Overall Study|Lost to Follow-up|2|||
44326676|NCT01089647|79331612|FG000|Overall Study|Withdrawal by Subject|2|||
44326677|NCT01089647|79331613|FG001|Overall Study|Withdrawal by Subject|1|||
44326678|NCT01089647|79331612|FG000|Overall Study|Adverse Event|0|||
44326679|NCT01089647|79331613|FG001|Overall Study|Adverse Event|1|||
44326680|NCT01089608|79331621|FG000|Overall Study|Adverse Event|0|||
44326681|NCT01089608|79331622|FG001|Overall Study|Adverse Event|4|||
44326682|NCT01089608|79331621|FG000|Overall Study|Lost to Follow-up|0|||
44326683|NCT01089608|79331622|FG001|Overall Study|Lost to Follow-up|2|||
44326684|NCT01089413|79331631|FG000|Overall Study|Lost to Follow-up|1|||
44326685|NCT01089413|79331631|FG000|Overall Study|Progressive Disease|93|||
44326686|NCT01089413|79331631|FG000|Overall Study|Participant Withdrew Consent|1|||
44326687|NCT01089413|79331631|FG000|Overall Study|Unacceptable Toxicity|12|||
44326688|NCT01089413|79331631|FG000|Overall Study|Death|10|||
44326689|NCT01089413|79331631|FG000|Overall Study|Metastasectomy|13|||
44326690|NCT01089413|79331631|FG000|Overall Study|Other|71|||
44326691|NCT01089023|79331641|FG000|Overall Study|Lost to Follow-up|3|||
44326692|NCT01089023|79331641|FG000|Overall Study|Adverse Event|1|||
44326693|NCT01089023|79331641|FG000|Overall Study|Withdrawal by Subject|1|||
44326694|NCT01089023|79331641|FG000|Overall Study|Protocol Violation|1|||
44326695|NCT01089023|79331641|FG000|Overall Study|Lack of Efficacy|1|||
44326696|NCT01088984|79331647|FG000|Phase 1|Death|2|||
44326697|NCT01088984|79331648|FG001|Phase 1|Death|1|||
44326698|NCT01088984|79331647|FG000|Phase 1|Disease Progression|2|||
44326699|NCT01088984|79331648|FG001|Phase 1|Disease Progression|4|||
44326700|NCT01088984|79331647|FG000|Phase 1|Other|1|||
44326701|NCT01088984|79331648|FG001|Phase 1|Other|1|||
44326702|NCT01088984|79331647|FG000|Phase 2|Death|0|||
44423891|NCT00738374|79431933|FG000|Induction Treatment Phase|Adverse Event|14|||
44423892|NCT00738374|79431934|FG001|Induction Treatment Phase|Adverse Event|0|||
44423893|NCT00738374|79431935|FG002|Induction Treatment Phase|Adverse Event|0|||
44423894|NCT00738374|79431936|FG003|Induction Treatment Phase|Adverse Event|0|||
44423895|NCT00738374|79431933|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
44423896|NCT00738374|79431934|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
44423897|NCT00738374|79431935|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
44423898|NCT00738374|79431936|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
44423899|NCT00738374|79431933|FG000|Induction Treatment Phase|Physician Decision|2|||
44423900|NCT00738374|79431934|FG001|Induction Treatment Phase|Physician Decision|0|||
44423901|NCT00738374|79431935|FG002|Induction Treatment Phase|Physician Decision|0|||
44423902|NCT00738374|79431936|FG003|Induction Treatment Phase|Physician Decision|0|||
44423903|NCT00738374|79431933|FG000|Induction Treatment Phase|Protocol Violation|2|||
44423904|NCT00738374|79431934|FG001|Induction Treatment Phase|Protocol Violation|0|||
44423905|NCT00738374|79431935|FG002|Induction Treatment Phase|Protocol Violation|0|||
44423906|NCT00738374|79431936|FG003|Induction Treatment Phase|Protocol Violation|0|||
44423907|NCT00738374|79431933|FG000|Induction Treatment Phase|Non-compliance|1|||
44423908|NCT00738374|79431934|FG001|Induction Treatment Phase|Non-compliance|0|||
44423909|NCT00738374|79431935|FG002|Induction Treatment Phase|Non-compliance|0|||
44423910|NCT00738374|79431936|FG003|Induction Treatment Phase|Non-compliance|0|||
44423911|NCT00738374|79431933|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
44423912|NCT00738374|79431934|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
44423913|NCT00738374|79431935|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
44423914|NCT00738374|79431936|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
44423915|NCT00738374|79431933|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
44423916|NCT00738374|79431934|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
44423917|NCT00738374|79431935|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
44423918|NCT00738374|79431936|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
44423919|NCT00738374|79431933|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
44423920|NCT00738374|79431934|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
44537017|NCT02906020|79547727|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44326703|NCT01088984|79331648|FG001|Phase 2|Death|5|||
44326704|NCT01088984|79331647|FG000|Phase 2|Withdrawal by Subject|0|||
44326705|NCT01088984|79331648|FG001|Phase 2|Withdrawal by Subject|1|||
44326706|NCT01088984|79331647|FG000|Phase 2|DIsease Progression|0|||
44326707|NCT01088984|79331648|FG001|Phase 2|DIsease Progression|25|||
44326708|NCT01088984|79331647|FG000|Phase 2|Other|0|||
44326709|NCT01088984|79331648|FG001|Phase 2|Other|1|||
44326710|NCT01088438|79331659|FG000|Overall Study|Withdrawal by Subject|11|||
44326711|NCT01088438|79331660|FG001|Overall Study|Withdrawal by Subject|6|||
44423921|NCT00738374|79431935|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
44423922|NCT00738374|79431936|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
44326712|NCT01088438|79331659|FG000|Overall Study|Lost to Follow-up|18|||
44326713|NCT01088438|79331660|FG001|Overall Study|Lost to Follow-up|30|||
44326714|NCT01088243|79331668|FG000|Overall Study|Adverse Event|1|||
44326715|NCT01088243|79331669|FG001|Overall Study|Adverse Event|0|||
44326716|NCT01088048|79331685|FG000|Overall Study|Adverse Event|7|||
44326717|NCT01088048|79331686|FG001|Overall Study|Adverse Event|9|||
44326718|NCT01088048|79331687|FG002|Overall Study|Adverse Event|7|||
44326719|NCT01088048|79331688|FG003|Overall Study|Adverse Event|5|||
44326720|NCT01088048|79331689|FG004|Overall Study|Adverse Event|6|||
44326721|NCT01088048|79331690|FG005|Overall Study|Adverse Event|3|||
44326722|NCT01088048|79331691|FG006|Overall Study|Adverse Event|3|||
44326723|NCT01088048|79331692|FG007|Overall Study|Adverse Event|0|||
44326724|NCT01088048|79331693|FG008|Overall Study|Adverse Event|2|||
44326725|NCT01088048|79331694|FG009|Overall Study|Adverse Event|2|||
44423923|NCT00738374|79431933|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
44423924|NCT00738374|79431934|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
44326726|NCT01088048|79331685|FG000|Overall Study|Withdrew Consent|1|||
44423925|NCT00738374|79431935|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
44423926|NCT00738374|79431936|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
44423927|NCT00738374|79431933|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
44423928|NCT00738374|79431934|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
44423929|NCT00738374|79431935|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
44423930|NCT00738374|79431936|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
44423931|NCT00738374|79431933|FG000|Maintenance Treatment/Observation Phase|Other|0|||
44326727|NCT01088048|79331686|FG001|Overall Study|Withdrew Consent|1|||
44326728|NCT01088048|79331687|FG002|Overall Study|Withdrew Consent|1|||
44423932|NCT00738374|79431934|FG001|Maintenance Treatment/Observation Phase|Other|1|||
44423933|NCT00738374|79431935|FG002|Maintenance Treatment/Observation Phase|Other|0|||
44423934|NCT00738374|79431936|FG003|Maintenance Treatment/Observation Phase|Other|0|||
44423935|NCT00697593|79431945|FG000|Overall Study|Adverse Event|3|||
44423936|NCT00697593|79431945|FG000|Overall Study|Protocol Violation|1|||
44423937|NCT00697593|79431945|FG000|Overall Study|Lack of Efficacy|3|||
44423938|NCT00697593|79431945|FG000|Overall Study|Suspension of the study by sponsor|12|||
44423939|NCT00697515|79431949|FG000|Dose Optimization Period|Adverse Event|4|||
44423940|NCT00697515|79431950|FG001|Dose Optimization Period|Adverse Event|0|||
44423941|NCT00697515|79431949|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
44423942|NCT00697515|79431950|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
44423943|NCT00697515|79431949|FG000|Dose Optimization Period|Lost to Follow-up|2|||
44423944|NCT00697515|79431950|FG001|Dose Optimization Period|Lost to Follow-up|0|||
44423945|NCT00697515|79431949|FG000|Dose Optimization Period|sponsor request|2|||
44423946|NCT00697515|79431950|FG001|Dose Optimization Period|sponsor request|0|||
44423947|NCT00697515|79431949|FG000|Dose Optimization Period|called to active duty|1|||
44423948|NCT00697515|79431950|FG001|Dose Optimization Period|called to active duty|0|||
44423949|NCT00697515|79431949|FG000|Dose Optimization Period|elevated QTc|1|||
44423950|NCT00697515|79431950|FG001|Dose Optimization Period|elevated QTc|0|||
44537018|NCT02906020|79547728|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537019|NCT02906020|79547729|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537020|NCT02906020|79547730|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537021|NCT02906020|79547731|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537022|NCT02906020|79547732|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
44326729|NCT01088048|79331688|FG003|Overall Study|Withdrew Consent|1|||
44326730|NCT01088048|79331689|FG004|Overall Study|Withdrew Consent|2|||
44326731|NCT01088048|79331690|FG005|Overall Study|Withdrew Consent|1|||
44326732|NCT01088048|79331691|FG006|Overall Study|Withdrew Consent|0|||
44326733|NCT01088048|79331692|FG007|Overall Study|Withdrew Consent|2|||
44326734|NCT01088048|79331693|FG008|Overall Study|Withdrew Consent|2|||
44326735|NCT01088048|79331694|FG009|Overall Study|Withdrew Consent|1|||
44326736|NCT01088048|79331685|FG000|Overall Study|Concomitant Medication Prohibited|1|||
44326737|NCT01088048|79331686|FG001|Overall Study|Concomitant Medication Prohibited|0|||
44326738|NCT01088048|79331687|FG002|Overall Study|Concomitant Medication Prohibited|0|||
44423951|NCT00697515|79431949|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
44537023|NCT02906020|79547733|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
44156655|NCT03614676|78947882|FG001|Overall Study|Delivery before planned visit|0|||
44423952|NCT00697515|79431950|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
44167845|NCT02528357|78961056|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
44326739|NCT01088048|79331688|FG003|Overall Study|Concomitant Medication Prohibited|0|||
44326740|NCT01088048|79331689|FG004|Overall Study|Concomitant Medication Prohibited|0|||
44326741|NCT01088048|79331690|FG005|Overall Study|Concomitant Medication Prohibited|0|||
44326742|NCT01088048|79331691|FG006|Overall Study|Concomitant Medication Prohibited|0|||
44326743|NCT01088048|79331692|FG007|Overall Study|Concomitant Medication Prohibited|0|||
44423953|NCT00697515|79431949|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
44423954|NCT00697515|79431950|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
44326744|NCT01088048|79331693|FG008|Overall Study|Concomitant Medication Prohibited|0|||
44423955|NCT00697515|79431949|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
44423956|NCT00697515|79431950|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
44326745|NCT01088048|79331694|FG009|Overall Study|Concomitant Medication Prohibited|0|||
44326746|NCT01088048|79331685|FG000|Overall Study|Investigator Request|2|||
44326747|NCT01088048|79331686|FG001|Overall Study|Investigator Request|2|||
44423957|NCT00697515|79431949|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
44423958|NCT00697515|79431950|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
44423959|NCT00738062|79431959|FG000|Open Label Treatment|Lack of Efficacy|5|||
44423960|NCT00738062|79431960|FG001|Open Label Treatment|Lack of Efficacy|0|||
44423961|NCT00738062|79431961|FG002|Open Label Treatment|Lack of Efficacy|0|||
44423962|NCT00738062|79431959|FG000|Open Label Treatment|Adverse Event|11|||
44423963|NCT00738062|79431960|FG001|Open Label Treatment|Adverse Event|0|||
44423964|NCT00738062|79431961|FG002|Open Label Treatment|Adverse Event|0|||
44423965|NCT00738062|79431959|FG000|Open Label Treatment|Protocol Violation|2|||
44326748|NCT01088048|79331687|FG002|Overall Study|Investigator Request|0|||
44326749|NCT01088048|79331688|FG003|Overall Study|Investigator Request|0|||
44326750|NCT01088048|79331689|FG004|Overall Study|Investigator Request|3|||
44326751|NCT01088048|79331690|FG005|Overall Study|Investigator Request|1|||
44326752|NCT01088048|79331691|FG006|Overall Study|Investigator Request|1|||
44326753|NCT01088048|79331692|FG007|Overall Study|Investigator Request|0|||
44326754|NCT01088048|79331693|FG008|Overall Study|Investigator Request|0|||
44326755|NCT01088048|79331694|FG009|Overall Study|Investigator Request|0|||
44326756|NCT01088048|79331685|FG000|Overall Study|Patient Non-compliance|0|||
44326757|NCT01088048|79331686|FG001|Overall Study|Patient Non-compliance|1|||
44423966|NCT00738062|79431960|FG001|Open Label Treatment|Protocol Violation|0|||
44423967|NCT00738062|79431961|FG002|Open Label Treatment|Protocol Violation|0|||
44423968|NCT00738062|79431959|FG000|Open Label Treatment|Withdrawal by Subject|9|||
44423969|NCT00738062|79431960|FG001|Open Label Treatment|Withdrawal by Subject|0|||
44423970|NCT00738062|79431961|FG002|Open Label Treatment|Withdrawal by Subject|0|||
44423971|NCT00738062|79431959|FG000|Open Label Treatment|Investigator Decision|1|||
44423972|NCT00738062|79431960|FG001|Open Label Treatment|Investigator Decision|0|||
44423973|NCT00738062|79431961|FG002|Open Label Treatment|Investigator Decision|0|||
44423974|NCT00738062|79431959|FG000|Open-Label Extension|Adverse Event|5|||
44423975|NCT00738062|79431960|FG001|Open-Label Extension|Adverse Event|0|||
44423976|NCT00738062|79431961|FG002|Open-Label Extension|Adverse Event|0|||
44423977|NCT00738062|79431959|FG000|Open-Label Extension|Physician Decision|1|||
44423978|NCT00738062|79431960|FG001|Open-Label Extension|Physician Decision|0|||
44326758|NCT01088048|79331687|FG002|Overall Study|Patient Non-compliance|0|||
44326759|NCT01088048|79331688|FG003|Overall Study|Patient Non-compliance|0|||
44326760|NCT01088048|79331689|FG004|Overall Study|Patient Non-compliance|0|||
44326761|NCT01088048|79331690|FG005|Overall Study|Patient Non-compliance|0|||
44326762|NCT01088048|79331691|FG006|Overall Study|Patient Non-compliance|0|||
44326763|NCT01088048|79331692|FG007|Overall Study|Patient Non-compliance|0|||
44326764|NCT01088048|79331693|FG008|Overall Study|Patient Non-compliance|0|||
44326765|NCT01088048|79331694|FG009|Overall Study|Patient Non-compliance|0|||
44326766|NCT01088048|79331685|FG000|Overall Study|Disease Progression|7|||
44326767|NCT01088048|79331686|FG001|Overall Study|Disease Progression|4|||
44326768|NCT01088048|79331687|FG002|Overall Study|Disease Progression|3|||
44326769|NCT01088048|79331688|FG003|Overall Study|Disease Progression|5|||
44326770|NCT01088048|79331689|FG004|Overall Study|Disease Progression|3|||
44326771|NCT01088048|79331690|FG005|Overall Study|Disease Progression|3|||
44326772|NCT01088048|79331691|FG006|Overall Study|Disease Progression|2|||
44326773|NCT01088048|79331692|FG007|Overall Study|Disease Progression|1|||
44326774|NCT01088048|79331693|FG008|Overall Study|Disease Progression|0|||
44423979|NCT00738062|79431961|FG002|Open-Label Extension|Physician Decision|0|||
44423980|NCT00738062|79431959|FG000|Open-Label Extension|Lack of Efficacy|2|||
44423981|NCT00738062|79431960|FG001|Open-Label Extension|Lack of Efficacy|0|||
44423982|NCT00738062|79431961|FG002|Open-Label Extension|Lack of Efficacy|0|||
44423983|NCT00738062|79431959|FG000|Open-Label Extension|Withdrawal by Subject|6|||
44423984|NCT00738062|79431960|FG001|Open-Label Extension|Withdrawal by Subject|0|||
44258498|NCT03565900|79113594|FG001|Overall Study|Death|7|||
44258499|NCT03443869|79113633|FG000|Overall Study|Death|3|||
44258500|NCT03443869|79113634|FG001|Overall Study|Death|3|||
44258501|NCT03443869|79113633|FG000|Overall Study|Withdrawal by Subject|34|||
44258502|NCT03443869|79113634|FG001|Overall Study|Withdrawal by Subject|22|||
44258503|NCT03443869|79113633|FG000|Overall Study|Lost to Follow-up|1|||
44258504|NCT03443869|79113634|FG001|Overall Study|Lost to Follow-up|2|||
44258505|NCT03443869|79113633|FG000|Overall Study|Physician Decision|3|||
44258506|NCT03443869|79113634|FG001|Overall Study|Physician Decision|3|||
44258507|NCT03443869|79113633|FG000|Overall Study|Other|4|||
44326775|NCT01088048|79331694|FG009|Overall Study|Disease Progression|0|||
44326776|NCT01088048|79331685|FG000|Overall Study|Death|1|||
44326777|NCT01088048|79331686|FG001|Overall Study|Death|5|||
44326778|NCT01088048|79331687|FG002|Overall Study|Death|3|||
44326779|NCT01088048|79331688|FG003|Overall Study|Death|3|||
44326780|NCT01088048|79331689|FG004|Overall Study|Death|1|||
44326781|NCT01088048|79331690|FG005|Overall Study|Death|3|||
44326782|NCT01088048|79331691|FG006|Overall Study|Death|0|||
44326783|NCT01088048|79331692|FG007|Overall Study|Death|0|||
44326784|NCT01088048|79331693|FG008|Overall Study|Death|3|||
44326785|NCT01088048|79331694|FG009|Overall Study|Death|1|||
44326786|NCT01088048|79331685|FG000|Overall Study|Other|3|||
44326787|NCT01088048|79331686|FG001|Overall Study|Other|5|||
44326788|NCT01088048|79331687|FG002|Overall Study|Other|0|||
44326789|NCT01088048|79331688|FG003|Overall Study|Other|0|||
44326790|NCT01088048|79331689|FG004|Overall Study|Other|2|||
44326791|NCT01088048|79331690|FG005|Overall Study|Other|0|||
44326792|NCT01088048|79331691|FG006|Overall Study|Other|0|||
44326793|NCT01088048|79331692|FG007|Overall Study|Other|2|||
44326794|NCT01088048|79331693|FG008|Overall Study|Other|0|||
44326795|NCT01088048|79331694|FG009|Overall Study|Other|0|||
44326796|NCT01087970|79331727|FG000|Overall Study|Protocol Violation|2|||
44326797|NCT01087814|79331734|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
44326798|NCT01087814|79331735|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
44326799|NCT01087814|79331734|FG000|Second Intervention (5 Days)|Physician Decision|1|||
44326800|NCT01087814|79331735|FG001|Second Intervention (5 Days)|Physician Decision|0|||
44326801|NCT01087775|79331741|FG000|Overall Study|failed inclusion criteria|2|||
44326802|NCT01087502|79331748|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
44326803|NCT01087502|79331749|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
44326804|NCT01087502|79331748|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
44326805|NCT01087502|79331749|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
44326806|NCT01087502|79331748|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
44326807|NCT01087502|79331749|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
44326808|NCT01087502|79331748|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
44326809|NCT01087502|79331749|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
44326810|NCT01087502|79331748|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
44326811|NCT01087502|79331749|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
44326812|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
44326813|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
44326814|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
44326815|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
44326816|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
44326817|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
44326818|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
44326819|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
44326820|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
44326821|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
44326822|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
44326823|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
44326824|NCT01087502|79331748|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
44326825|NCT01087502|79331749|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
44326826|NCT01086410|79331761|FG000|Overall Study|Adverse Event|1|||
44326827|NCT01086410|79331762|FG001|Overall Study|Adverse Event|0|||
44326828|NCT01086410|79331763|FG002|Overall Study|Adverse Event|0|||
44326829|NCT01086410|79331764|FG003|Overall Study|Adverse Event|2|||
44326830|NCT01086410|79331761|FG000|Overall Study|Lack of Efficacy|1|||
44326831|NCT01086410|79331762|FG001|Overall Study|Lack of Efficacy|1|||
44423985|NCT00738062|79431961|FG002|Open-Label Extension|Withdrawal by Subject|0|||
44423986|NCT00738062|79431959|FG000|Open-Label Extension|Protocol Violation|1|||
44258508|NCT03443869|79113634|FG001|Overall Study|Other|4|||
44258509|NCT03260140|79113642|FG000|Overall Study|Death|4|||
44258510|NCT03260140|79113643|FG001|Overall Study|Death|1|||
44258511|NCT03260140|79113642|FG000|Overall Study|Withdrawal by Subject|1|||
44258512|NCT03260140|79113643|FG001|Overall Study|Withdrawal by Subject|4|||
44258513|NCT03253796|79113654|FG000|Period 1: Run-In|Adverse Event|4|||
44258514|NCT03253796|79113655|FG001|Period 1: Run-In|Adverse Event|0|||
44258515|NCT03253796|79113656|FG002|Period 1: Run-In|Adverse Event|0|||
44258516|NCT03253796|79113657|FG003|Period 1: Run-In|Adverse Event|0|||
44258517|NCT03253796|79113658|FG004|Period 1: Run-In|Adverse Event|0|||
44258518|NCT03253796|79113654|FG000|Period 1: Run-In|Lack of Efficacy|1|||
44258519|NCT03253796|79113655|FG001|Period 1: Run-In|Lack of Efficacy|0|||
44258520|NCT03253796|79113656|FG002|Period 1: Run-In|Lack of Efficacy|0|||
44258521|NCT03253796|79113657|FG003|Period 1: Run-In|Lack of Efficacy|0|||
44258522|NCT03253796|79113658|FG004|Period 1: Run-In|Lack of Efficacy|0|||
44258523|NCT03253796|79113654|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
44258524|NCT03253796|79113655|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
44326832|NCT01086410|79331763|FG002|Overall Study|Lack of Efficacy|0|||
44326833|NCT01086410|79331764|FG003|Overall Study|Lack of Efficacy|0|||
44326834|NCT01086410|79331761|FG000|Overall Study|Protocol Violation|1|||
44326835|NCT01086410|79331762|FG001|Overall Study|Protocol Violation|1|||
44326836|NCT01086410|79331763|FG002|Overall Study|Protocol Violation|0|||
44326837|NCT01086410|79331764|FG003|Overall Study|Protocol Violation|0|||
44326838|NCT01086410|79331761|FG000|Overall Study|Lost to Follow-up|0|||
44326839|NCT01086410|79331762|FG001|Overall Study|Lost to Follow-up|0|||
44326840|NCT01086410|79331763|FG002|Overall Study|Lost to Follow-up|1|||
44326841|NCT01086410|79331764|FG003|Overall Study|Lost to Follow-up|0|||
44326842|NCT04553679|79331776|FG000|Overall Study|Withdrawal by Subject|2|||
44326843|NCT04553679|79331777|FG001|Overall Study|Withdrawal by Subject|0|||
44326844|NCT04553679|79331776|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
44326845|NCT04553679|79331777|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
44326846|NCT01086215|79331791|FG000|Overall Study|Death|14|||
44326847|NCT01086215|79331792|FG001|Overall Study|Death|8|||
44326848|NCT01086215|79331793|FG002|Overall Study|Death|8|||
44423987|NCT00738062|79431960|FG001|Open-Label Extension|Protocol Violation|0|||
44423988|NCT00738062|79431961|FG002|Open-Label Extension|Protocol Violation|0|||
44423989|NCT00738062|79431959|FG000|Open-Label Extension|Study Terminated|2|||
44423990|NCT00738062|79431960|FG001|Open-Label Extension|Study Terminated|0|||
44423991|NCT00738062|79431961|FG002|Open-Label Extension|Study Terminated|0|||
44423992|NCT04245345|79431970|FG000|Overall Study|Death|1|||
44423993|NCT04245345|79431970|FG000|Overall Study|Exited prior to implant|5|||
44423994|NCT04245345|79431970|FG000|Overall Study|Exited prior to 1-month|9|||
44423995|NCT04245345|79431970|FG000|Overall Study|Missed 1-month visit|3|||
44423996|NCT04245345|79431970|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
44423997|NCT04245345|79431970|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
44423998|NCT00698685|79431976|FG000|Overall Study|Sister withdrew as donor|1|||
44423999|NCT00698685|79431976|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
44424000|NCT00737672|79431982|FG000|Overall Study|Graft Abandonment|48|||
44424001|NCT00737672|79431983|FG001|Overall Study|Graft Abandonment|56|||
44424002|NCT00737672|79431982|FG000|Overall Study|Death|23|||
44424003|NCT00737672|79431983|FG001|Overall Study|Death|22|||
44424004|NCT00737672|79431982|FG000|Overall Study|Withdrawal by Subject|1|||
44424005|NCT00737672|79431983|FG001|Overall Study|Withdrawal by Subject|2|||
44424006|NCT00737672|79431982|FG000|Overall Study|Lost to Follow-up|1|||
44424007|NCT00737672|79431983|FG001|Overall Study|Lost to Follow-up|0|||
44424008|NCT00737672|79431982|FG000|Overall Study|Miscellaneous|7|||
44424009|NCT00737672|79431983|FG001|Overall Study|Miscellaneous|1|||
44424010|NCT00737672|79431982|FG000|Overall Study|Physician Decision|0|||
44424011|NCT00737672|79431983|FG001|Overall Study|Physician Decision|2|||
44424012|NCT00737438|79431989|FG000|Overall Study|Withdrawal by Subject|2|||
44424013|NCT00737438|79431989|FG000|Overall Study|Patient ineligible|1|||
44424014|NCT00737282|79431995|FG000|Overall Study|Study prematurely terminated|175|||
44424015|NCT03884478|79432004|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
44424016|NCT03884478|79432005|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
44424017|NCT03884478|79432006|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
44326849|NCT01086215|79331794|FG003|Overall Study|Death|1|||
44326850|NCT01086215|79331791|FG000|Overall Study|Lost to Follow-up|22|||
44326851|NCT01086215|79331792|FG001|Overall Study|Lost to Follow-up|39|||
44326852|NCT01086215|79331793|FG002|Overall Study|Lost to Follow-up|18|||
44326853|NCT01086215|79331794|FG003|Overall Study|Lost to Follow-up|2|||
44326854|NCT01085591|79331807|FG000|Overall Study|Adverse Event|0|||
44326855|NCT01085591|79331808|FG001|Overall Study|Adverse Event|1|||
44326856|NCT01085591|79331809|FG002|Overall Study|Adverse Event|3|||
44326857|NCT01085591|79331807|FG000|Overall Study|Physician Decision|1|||
44326858|NCT01085591|79331808|FG001|Overall Study|Physician Decision|0|||
44326859|NCT01085591|79331809|FG002|Overall Study|Physician Decision|1|||
44326860|NCT01085591|79331807|FG000|Overall Study|Withdrawal by Subject|0|||
44326861|NCT01085591|79331808|FG001|Overall Study|Withdrawal by Subject|2|||
44326862|NCT01085591|79331809|FG002|Overall Study|Withdrawal by Subject|1|||
44424018|NCT03884478|79432004|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
44424019|NCT03884478|79432005|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
44424020|NCT03884478|79432006|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
44156656|NCT03614676|78947881|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
44326863|NCT01085591|79331807|FG000|Overall Study|Lost to Follow-up|0|||
44326864|NCT01085591|79331808|FG001|Overall Study|Lost to Follow-up|1|||
44326865|NCT01085591|79331809|FG002|Overall Study|Lost to Follow-up|1|||
44326866|NCT01085591|79331807|FG000|Overall Study|Protocol Violation|1|||
44326867|NCT01085591|79331808|FG001|Overall Study|Protocol Violation|1|||
44424021|NCT03884478|79432004|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
44424022|NCT03884478|79432005|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
44326868|NCT01085591|79331809|FG002|Overall Study|Protocol Violation|1|||
44326869|NCT01085591|79331807|FG000|Overall Study|Other|0|||
44326870|NCT01085591|79331808|FG001|Overall Study|Other|1|||
44326871|NCT01085591|79331809|FG002|Overall Study|Other|0|||
44326872|NCT01085591|79331807|FG000|Overall Study|Not Properly Consented|1|||
44326873|NCT01085591|79331808|FG001|Overall Study|Not Properly Consented|0|||
44326874|NCT01085591|79331809|FG002|Overall Study|Not Properly Consented|0|||
44326875|NCT01085357|79331820|FG000|Overall Study|Adverse Event|1|||
44326876|NCT01085357|79331821|FG001|Overall Study|Adverse Event|1|||
44326877|NCT01085357|79331820|FG000|Overall Study|Subject Decision|4|||
44326878|NCT01085357|79331821|FG001|Overall Study|Subject Decision|3|||
44326879|NCT01085357|79331820|FG000|Overall Study|Investigator Decision|1|||
44326880|NCT01085357|79331821|FG001|Overall Study|Investigator Decision|1|||
44326881|NCT01085357|79331820|FG000|Overall Study|Death|11|||
44326882|NCT01085357|79331821|FG001|Overall Study|Death|1|||
44424023|NCT03884478|79432006|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
44424024|NCT03884478|79432004|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
44326883|NCT01085357|79331820|FG000|Overall Study|Lost to Follow-up|2|||
44326884|NCT01085357|79331821|FG001|Overall Study|Lost to Follow-up|0|||
44326885|NCT01085201|79331832|FG000|Overall Study|Scheduling conflict|1|||
44326886|NCT01085201|79331833|FG001|Overall Study|Scheduling conflict|0|||
44326887|NCT01085201|79331834|FG002|Overall Study|Scheduling conflict|1|||
44326888|NCT01085201|79331835|FG003|Overall Study|Scheduling conflict|0|||
44326889|NCT01085201|79331836|FG004|Overall Study|Scheduling conflict|0|||
44326890|NCT01085201|79331832|FG000|Overall Study|Unknown- no study drug|2|||
44326891|NCT01085201|79331833|FG001|Overall Study|Unknown- no study drug|0|||
44326892|NCT01085201|79331834|FG002|Overall Study|Unknown- no study drug|0|||
44326893|NCT01085201|79331835|FG003|Overall Study|Unknown- no study drug|0|||
44326894|NCT01085201|79331836|FG004|Overall Study|Unknown- no study drug|0|||
44326895|NCT01085201|79331832|FG000|Overall Study|Fond ineligible after consent|0|||
44326896|NCT01085201|79331833|FG001|Overall Study|Fond ineligible after consent|1|||
44326897|NCT01085201|79331834|FG002|Overall Study|Fond ineligible after consent|1|||
44326898|NCT01085201|79331835|FG003|Overall Study|Fond ineligible after consent|0|||
44326899|NCT01085201|79331836|FG004|Overall Study|Fond ineligible after consent|0|||
44326900|NCT01085084|79331856|FG000|Overall Study|Withdrawal by Subject|1|||
44326901|NCT01085084|79331857|FG001|Overall Study|Withdrawal by Subject|0|||
44326902|NCT01085084|79331858|FG002|Overall Study|Withdrawal by Subject|0|||
44326903|NCT01085084|79331856|FG000|Overall Study|Lost to Follow-up|2|||
44326904|NCT01085084|79331857|FG001|Overall Study|Lost to Follow-up|1|||
44326905|NCT01085084|79331858|FG002|Overall Study|Lost to Follow-up|1|||
44326906|NCT01085084|79331856|FG000|Overall Study|Adverse Event|4|||
44326907|NCT01085084|79331857|FG001|Overall Study|Adverse Event|3|||
44326908|NCT01085084|79331858|FG002|Overall Study|Adverse Event|6|||
44326909|NCT01085084|79331856|FG000|Overall Study|Treatment Failure|0|||
44326910|NCT01085084|79331857|FG001|Overall Study|Treatment Failure|1|||
44326911|NCT01085084|79331858|FG002|Overall Study|Treatment Failure|2|||
44326912|NCT01085045|79331866|FG000|Part A|Withdrawal by Subject|4|||
44326913|NCT01085045|79331866|FG000|Part A|Adverse Event|6|||
44326914|NCT01085045|79331866|FG000|Part A|Protocol Violation|1|||
44326915|NCT01085045|79331866|FG000|Part A|Protocol Specified Criteria|7|||
44326916|NCT01085045|79331866|FG000|Part B|Withdrawal by Subject|2|||
44326917|NCT01085045|79331866|FG000|Part B|Protocol Specified Criteria|6|||
44326918|NCT01085045|79331866|FG000|Part B|Lost to Follow-up|1|||
44326919|NCT01085045|79331866|FG000|Part B|Adverse Event|6|||
44326920|NCT01084772|79331888|FG000|Baseline|Withdrawal by Subject|7|||
44326921|NCT01084772|79331889|FG001|Baseline|Withdrawal by Subject|6|||
44326922|NCT01084772|79331888|FG000|3 Months|Death|1|||
44326923|NCT01084772|79331889|FG001|3 Months|Death|0|||
44326924|NCT01084772|79331888|FG000|3 Months|Study Termination|2|||
44326925|NCT01084772|79331889|FG001|3 Months|Study Termination|2|||
44326926|NCT01084772|79331888|FG000|1 Year|Withdrawal by Subject|0|||
44326927|NCT01084772|79331889|FG001|1 Year|Withdrawal by Subject|1|||
44326928|NCT01084772|79331888|FG000|1 Year|Lost to Follow-up|3|||
44326929|NCT01084772|79331889|FG001|1 Year|Lost to Follow-up|0|||
44326930|NCT01084772|79331888|FG000|1 Year|Study Termination|0|||
44326931|NCT01084772|79331889|FG001|1 Year|Study Termination|7|||
44326932|NCT01084772|79331888|FG000|2 Years|Withdrawal by Subject|1|||
44326933|NCT01084772|79331889|FG001|2 Years|Withdrawal by Subject|0|||
44326934|NCT01084772|79331888|FG000|2 Years|Lost to Follow-up|5|||
44326935|NCT01084772|79331889|FG001|2 Years|Lost to Follow-up|2|||
44326936|NCT01084772|79331888|FG000|2 Years|Study Termination|3|||
44326937|NCT01084772|79331889|FG001|2 Years|Study Termination|2|||
44326938|NCT00179673|79331895|FG000|Overall Study|Adverse Event|7|||
44326939|NCT00179673|79331895|FG000|Overall Study|Lack of Efficacy|15|||
44326940|NCT00179673|79331895|FG000|Overall Study|Withdrawal by Subject|3|||
44326941|NCT00179673|79331895|FG000|Overall Study|Death|4|||
44326942|NCT00179673|79331895|FG000|Overall Study|Other Observations and options|14|||
44326943|NCT01084655|79331902|FG000|Overall Study|Radiographic disease progression|3|||
44326944|NCT01084655|79331903|FG001|Overall Study|Radiographic disease progression|2|||
44326945|NCT01084655|79331904|FG002|Overall Study|Radiographic disease progression|8|||
44326946|NCT01084655|79331902|FG000|Overall Study|Withdrawal by Subject|1|||
44326947|NCT01084655|79331903|FG001|Overall Study|Withdrawal by Subject|0|||
44326948|NCT01084655|79331904|FG002|Overall Study|Withdrawal by Subject|4|||
44326949|NCT01084655|79331902|FG000|Overall Study|Adverse Event|2|||
44326950|NCT01084655|79331903|FG001|Overall Study|Adverse Event|1|||
44326951|NCT01084655|79331904|FG002|Overall Study|Adverse Event|2|||
44326952|NCT01084655|79331902|FG000|Overall Study|Other|0|||
44326953|NCT01084655|79331903|FG001|Overall Study|Other|3|||
44326954|NCT01084655|79331904|FG002|Overall Study|Other|2|||
44326955|NCT01084655|79331902|FG000|Overall Study|Symptomatic deterioration|0|||
44326956|NCT01084655|79331903|FG001|Overall Study|Symptomatic deterioration|0|||
44326957|NCT01084655|79331904|FG002|Overall Study|Symptomatic deterioration|2|||
44326958|NCT01084655|79331902|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
44326959|NCT01084655|79331903|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
44326960|NCT01084655|79331904|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
44326961|NCT01084538|79331916|FG000|Overall Study|Drug not available|30|||
44326962|NCT01084538|79331916|FG000|Overall Study|Adverse Event|9|||
44326963|NCT01084538|79331916|FG000|Overall Study|Kidney transplant|6|||
44326964|NCT01084538|79331916|FG000|Overall Study|Serious Adverse Event|3|||
44326965|NCT01084538|79331916|FG000|Overall Study|Lack of effectiveness|2|||
44326966|NCT01084538|79331916|FG000|Overall Study|Patient noncompliance|2|||
44326967|NCT01084538|79331916|FG000|Overall Study|Hyperphosphatemia|2|||
44326968|NCT01084538|79331916|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
44326969|NCT01084538|79331916|FG000|Overall Study|Change of residence|2|||
44326970|NCT01084538|79331916|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
44326971|NCT01084538|79331916|FG000|Overall Study|Reason unknown|8|||
44326972|NCT01083680|79331920|FG000|Overall Study|Lost to Follow-up|2758|||
44326973|NCT01083680|79331920|FG000|Overall Study|Withdrawal by Subject|1086|||
44326974|NCT00179517|79331926|FG000|Overall Study|Withdrawal by Subject|2|||
44326975|NCT00179517|79331927|FG001|Overall Study|Withdrawal by Subject|1|||
44326976|NCT01083641|79331933|FG000|Overall Study|Withdrawal by Subject|2|||
44326977|NCT00179010|79331939|FG000|Overall Study|Muscle probe defective|1|||
44326978|NCT00179010|79331940|FG001|Overall Study|Muscle probe defective|1|||
44326979|NCT00179010|79331939|FG000|Overall Study|Failure to place arterial line|0|||
44326980|NCT00179010|79331940|FG001|Overall Study|Failure to place arterial line|1|||
44326981|NCT01083602|79331947|FG000|Overall Study|Adverse Event|11|||
44326982|NCT01083602|79331947|FG000|Overall Study|New Cancer Therapy|2|||
44326983|NCT01083602|79331947|FG000|Overall Study|Death|1|||
44326984|NCT01083602|79331947|FG000|Overall Study|Withdrawal by Subject|5|||
44424025|NCT03884478|79432005|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
44424026|NCT03884478|79432006|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
44424027|NCT00582816|79432027|FG000|Overall Study|Engraftment Failure|3|||
44424028|NCT00737048|79432034|FG000|Overall Study|Physician Decision|0|||
44424029|NCT00737048|79432035|FG001|Overall Study|Physician Decision|0|||
44424030|NCT00737048|79432036|FG002|Overall Study|Physician Decision|1|||
44424031|NCT00737048|79432034|FG000|Overall Study|Adverse Event|0|||
44424032|NCT00737048|79432035|FG001|Overall Study|Adverse Event|1|||
44424033|NCT00737048|79432036|FG002|Overall Study|Adverse Event|0|||
44424034|NCT00737048|79432034|FG000|Overall Study|Worsening of the symptoms|3|||
44424035|NCT00737048|79432035|FG001|Overall Study|Worsening of the symptoms|5|||
44424036|NCT00737048|79432036|FG002|Overall Study|Worsening of the symptoms|3|||
44424037|NCT00731822|79432046|FG000|Overall Study|Adverse Event|2|||
44424038|NCT00731822|79432047|FG001|Overall Study|Adverse Event|1|||
44424039|NCT00731822|79432046|FG000|Overall Study|Protocol Violation|1|||
44424040|NCT00731822|79432047|FG001|Overall Study|Protocol Violation|0|||
44424041|NCT00731822|79432046|FG000|Overall Study|Lost to Follow-up|1|||
44424042|NCT00731822|79432047|FG001|Overall Study|Lost to Follow-up|0|||
44424043|NCT00731666|79432053|FG000|Overall Study|Adverse Event|2|||
44424044|NCT00731666|79432053|FG000|Overall Study|Lost to Follow-up|8|||
44326985|NCT01083602|79331947|FG000|Overall Study|Lack of Efficacy|36|||
44326986|NCT00178464|79331951|FG000|Overall Study|Withdrawal by Subject|1|||
44326987|NCT00178464|79331951|FG000|Overall Study|Physician Decision|1|||
44326988|NCT01083485|79331957|FG000|Overall Study|Adverse Event|0|||
44326989|NCT01083485|79331958|FG001|Overall Study|Adverse Event|1|||
44326990|NCT01083485|79331957|FG000|Overall Study|Protocol Violation|1|||
44326991|NCT01083485|79331958|FG001|Overall Study|Protocol Violation|0|||
44326992|NCT01083485|79331957|FG000|Overall Study|Withdrawal by Subject|5|||
44326993|NCT01083485|79331958|FG001|Overall Study|Withdrawal by Subject|2|||
44326994|NCT01083485|79331957|FG000|Overall Study|Other|1|||
44424045|NCT00731666|79432053|FG000|Overall Study|Withdrawal by Subject|2|||
44424046|NCT00731120|79432060|FG000|Overall Study|Adverse Event|7|||
44326995|NCT01083485|79331958|FG001|Overall Study|Other|0|||
44326996|NCT01083173|79331966|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
44424047|NCT00731120|79432061|FG001|Overall Study|Adverse Event|6|||
44424048|NCT00731120|79432062|FG002|Overall Study|Adverse Event|8|||
44424049|NCT00731120|79432060|FG000|Overall Study|Lack of Efficacy|4|||
44424050|NCT00731120|79432061|FG001|Overall Study|Lack of Efficacy|5|||
44326997|NCT01083173|79331967|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
44326998|NCT01083173|79331966|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
44326999|NCT01083173|79331967|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
44327000|NCT01083173|79331966|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
44327001|NCT01083173|79331967|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
44424051|NCT00731120|79432062|FG002|Overall Study|Lack of Efficacy|4|||
44424052|NCT00731120|79432060|FG000|Overall Study|Noncompliance with Study Drug|3|||
44424053|NCT00731120|79432061|FG001|Overall Study|Noncompliance with Study Drug|3|||
44424054|NCT00731120|79432062|FG002|Overall Study|Noncompliance with Study Drug|1|||
44424055|NCT00731120|79432060|FG000|Overall Study|Protocol Deviations|1|||
44424056|NCT00731120|79432061|FG001|Overall Study|Protocol Deviations|6|||
44327002|NCT01083173|79331966|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
44327003|NCT01083173|79331967|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
44327004|NCT01083173|79331966|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
44327005|NCT01083173|79331967|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
44327006|NCT01083173|79331966|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
44327007|NCT01083173|79331967|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
44424057|NCT00731120|79432062|FG002|Overall Study|Protocol Deviations|1|||
44424058|NCT00731120|79432060|FG000|Overall Study|Withdrawal of Consent|13|||
44424059|NCT00731120|79432061|FG001|Overall Study|Withdrawal of Consent|8|||
44424060|NCT00731120|79432062|FG002|Overall Study|Withdrawal of Consent|4|||
44424061|NCT00731120|79432060|FG000|Overall Study|Lost to Follow-up|10|||
44424062|NCT00731120|79432061|FG001|Overall Study|Lost to Follow-up|15|||
44424063|NCT00731120|79432062|FG002|Overall Study|Lost to Follow-up|17|||
44424064|NCT00731120|79432060|FG000|Overall Study|Other|4|||
44424065|NCT00731120|79432061|FG001|Overall Study|Other|0|||
44424066|NCT00731120|79432062|FG002|Overall Study|Other|1|||
44424067|NCT00731042|79432072|FG000|Second Intervention|Did not meet inclusion criteria|0|||
44424068|NCT00731042|79432073|FG001|Second Intervention|Did not meet inclusion criteria|2|||
44424069|NCT00726986|79432079|FG000|Induction Phase|Adverse Event|4|||
44424070|NCT00726986|79432079|FG000|Induction Phase|Withdrawal by Subject|2|||
44424071|NCT00726986|79432079|FG000|Induction Phase|Death|2|||
44424072|NCT00726986|79432079|FG000|Induction Phase|Lack of Efficacy|5|||
44424073|NCT00726986|79432079|FG000|Induction Phase|Secondary Disease|2|||
44424074|NCT00726986|79432079|FG000|Maintenance Phase|Adverse Event|1|||
44424075|NCT00726986|79432079|FG000|Maintenance Phase|Lack of Efficacy|2|||
44424076|NCT00696657|79432092|FG000|Overall Study|Protocol Violation|0|||
44424077|NCT00696657|79432093|FG001|Overall Study|Protocol Violation|0|||
44424078|NCT00696657|79432094|FG002|Overall Study|Protocol Violation|0|||
44424079|NCT00696657|79432095|FG003|Overall Study|Protocol Violation|0|||
44424080|NCT00696657|79432096|FG004|Overall Study|Protocol Violation|0|||
44424081|NCT00696657|79432097|FG005|Overall Study|Protocol Violation|1|||
44424082|NCT00696657|79432098|FG006|Overall Study|Protocol Violation|0|||
44424083|NCT00696657|79432099|FG007|Overall Study|Protocol Violation|0|||
44424084|NCT00696657|79432100|FG008|Overall Study|Protocol Violation|1|||
44424085|NCT00696657|79432092|FG000|Overall Study|Lack of Efficacy|0|||
44424086|NCT00696657|79432093|FG001|Overall Study|Lack of Efficacy|1|||
44424087|NCT00696657|79432094|FG002|Overall Study|Lack of Efficacy|0|||
44424088|NCT00696657|79432095|FG003|Overall Study|Lack of Efficacy|0|||
44327008|NCT01083173|79331966|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
44327009|NCT01083173|79331967|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
44327010|NCT01083173|79331966|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
44327011|NCT01083173|79331967|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
44327012|NCT01083173|79331966|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
44327013|NCT01083173|79331967|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
44327014|NCT01083173|79331966|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
44327015|NCT01083173|79331967|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
44327016|NCT01083173|79331966|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
44424089|NCT00696657|79432096|FG004|Overall Study|Lack of Efficacy|0|||
44424090|NCT00696657|79432097|FG005|Overall Study|Lack of Efficacy|0|||
44424091|NCT00696657|79432098|FG006|Overall Study|Lack of Efficacy|0|||
44424092|NCT00696657|79432099|FG007|Overall Study|Lack of Efficacy|0|||
44424093|NCT00696657|79432100|FG008|Overall Study|Lack of Efficacy|0|||
44424094|NCT00696657|79432092|FG000|Overall Study|Withdrawal criteria|1|||
44424095|NCT00696657|79432093|FG001|Overall Study|Withdrawal criteria|3|||
44424096|NCT00696657|79432094|FG002|Overall Study|Withdrawal criteria|2|||
44424097|NCT00696657|79432095|FG003|Overall Study|Withdrawal criteria|2|||
44424098|NCT00696657|79432096|FG004|Overall Study|Withdrawal criteria|0|||
44424099|NCT00696657|79432097|FG005|Overall Study|Withdrawal criteria|0|||
44424100|NCT00696657|79432098|FG006|Overall Study|Withdrawal criteria|1|||
44424101|NCT00696657|79432099|FG007|Overall Study|Withdrawal criteria|1|||
44424102|NCT00696657|79432100|FG008|Overall Study|Withdrawal criteria|2|||
44327017|NCT01083173|79331967|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
44327018|NCT00177294|79331978|FG000|Overall Study|Withdrawal by Subject|7|||
44327019|NCT00177294|79331979|FG001|Overall Study|Withdrawal by Subject|5|||
44327020|NCT01082081|79331988|FG000|Overall Study|Lost to Follow-up|0|||
44327021|NCT01082081|79331989|FG001|Overall Study|Lost to Follow-up|0|||
44327022|NCT01082081|79331990|FG002|Overall Study|Lost to Follow-up|1|||
44327023|NCT01082081|79331988|FG000|Overall Study|Withdrawal by Subject|0|||
44327024|NCT01082081|79331989|FG001|Overall Study|Withdrawal by Subject|0|||
44327025|NCT01082081|79331990|FG002|Overall Study|Withdrawal by Subject|1|||
44327026|NCT01082081|79331988|FG000|Overall Study|Other Reason|0|||
44327027|NCT01082081|79331989|FG001|Overall Study|Other Reason|1|||
44327028|NCT01082081|79331990|FG002|Overall Study|Other Reason|0|||
44327029|NCT00177216|79332001|FG000|Overall Study|Withdrawal by Subject|6|||
44327030|NCT00177216|79332002|FG001|Overall Study|Withdrawal by Subject|3|||
44327031|NCT00177216|79332003|FG002|Overall Study|Withdrawal by Subject|1|||
44327032|NCT01081886|79332017|FG000|Overall Study|Study termination|11|||
44327033|NCT01081886|79332018|FG001|Overall Study|Study termination|13|||
44327034|NCT01081769|79332026|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
44327035|NCT01081769|79332027|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
44327036|NCT01081769|79332026|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
44327037|NCT01081769|79332027|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
44327038|NCT01081769|79332026|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
44327039|NCT01081769|79332027|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
44327040|NCT01081769|79332026|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
44327041|NCT01081769|79332027|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
44327042|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Adverse Event|14|||
44327043|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Adverse Event|11|||
44327044|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Death|1|||
44327045|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Death|1|||
44327046|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
44327047|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
44327048|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
44327049|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
44327050|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Pregnancy|1|||
44327051|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Pregnancy|0|||
44327052|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
44327053|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
44327054|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
44327055|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
44327056|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Other|0|||
44327057|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Other|1|||
44327058|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Ineligibility|3|||
44327059|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Ineligibility|4|||
44327060|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
44327061|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
44327062|NCT01081769|79332026|FG000|CORE Intent-To-Treat|Patient Moved|2|||
44327063|NCT01081769|79332027|FG001|CORE Intent-To-Treat|Patient Moved|2|||
44327064|NCT01081301|79332033|FG000|Overall Study|Bereaved|3|||
44327065|NCT01081301|79332033|FG000|Overall Study|Too busy|5|||
44327066|NCT01081301|79332033|FG000|Overall Study|Patient too ill|2|||
44327067|NCT01081301|79332033|FG000|Overall Study|Lost to Follow-up|4|||
44327068|NCT00174954|79332054|FG000|Overall Study|Adverse Event|2|||
44327069|NCT00174954|79332054|FG000|Overall Study|No tophi found in MRI|1|||
44327070|NCT00174954|79332054|FG000|Overall Study|Physician Decision|1|||
44327071|NCT01081145|79332058|FG000|Open-Label Phase|Lack of Efficacy|56|||
44327072|NCT01081145|79332059|FG001|Open-Label Phase|Lack of Efficacy|0|||
44327073|NCT01081145|79332058|FG000|Open-Label Phase|Response criteria not met|46|||
44424103|NCT00696657|79432092|FG000|Overall Study|Unclassified|0|||
44424104|NCT00696657|79432093|FG001|Overall Study|Unclassified|1|||
44424105|NCT00696657|79432094|FG002|Overall Study|Unclassified|3|||
44327074|NCT01081145|79332059|FG001|Open-Label Phase|Response criteria not met|0|||
44327075|NCT01081145|79332058|FG000|Open-Label Phase|Adverse Event|42|||
44327076|NCT01081145|79332059|FG001|Open-Label Phase|Adverse Event|0|||
44327077|NCT01081145|79332058|FG000|Open-Label Phase|Withdrawal by Subject|41|||
44327078|NCT01081145|79332059|FG001|Open-Label Phase|Withdrawal by Subject|0|||
44537024|NCT02906020|79547734|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44327079|NCT01081145|79332058|FG000|Open-Label Phase|Other|12|||
44327080|NCT01081145|79332059|FG001|Open-Label Phase|Other|0|||
44327081|NCT01081145|79332058|FG000|Open-Label Phase|Lost to Follow-up|11|||
44327082|NCT01081145|79332059|FG001|Open-Label Phase|Lost to Follow-up|0|||
44327083|NCT01081145|79332058|FG000|Open-Label Phase|Protocol Violation|4|||
44327084|NCT01081145|79332059|FG001|Open-Label Phase|Protocol Violation|0|||
44327085|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
44424106|NCT00696657|79432095|FG003|Overall Study|Unclassified|2|||
44327086|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
44327087|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
44327088|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
44327089|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
44327090|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
44327091|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
44327092|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
44327093|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
44327094|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
44327095|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
44327096|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
44327097|NCT01081145|79332058|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
44327098|NCT01081145|79332059|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
44327099|NCT00174915|79332072|FG000|Overall Study|Lost to Follow-up|19|||
44327100|NCT00174915|79332073|FG001|Overall Study|Lost to Follow-up|17|||
44327101|NCT00174915|79332074|FG002|Overall Study|Lost to Follow-up|9|||
44327102|NCT00174915|79332075|FG003|Overall Study|Lost to Follow-up|17|||
44327103|NCT00174915|79332076|FG004|Overall Study|Lost to Follow-up|10|||
44327104|NCT00174915|79332072|FG000|Overall Study|Adverse Event|18|||
44327105|NCT00174915|79332073|FG001|Overall Study|Adverse Event|16|||
44327106|NCT00174915|79332074|FG002|Overall Study|Adverse Event|11|||
44327107|NCT00174915|79332075|FG003|Overall Study|Adverse Event|18|||
44327108|NCT00174915|79332076|FG004|Overall Study|Adverse Event|5|||
44327109|NCT00174915|79332072|FG000|Overall Study|Personal Reason(s)|16|||
44327110|NCT00174915|79332073|FG001|Overall Study|Personal Reason(s)|16|||
44327111|NCT00174915|79332074|FG002|Overall Study|Personal Reason(s)|9|||
44424107|NCT00696657|79432096|FG004|Overall Study|Unclassified|4|||
44424108|NCT00696657|79432097|FG005|Overall Study|Unclassified|2|||
44424109|NCT00696657|79432098|FG006|Overall Study|Unclassified|0|||
44424110|NCT00696657|79432099|FG007|Overall Study|Unclassified|0|||
44424111|NCT00696657|79432100|FG008|Overall Study|Unclassified|1|||
44424112|NCT00696657|79432092|FG000|Overall Study|Adverse Event|0|||
44424113|NCT00696657|79432093|FG001|Overall Study|Adverse Event|0|||
44424114|NCT00696657|79432094|FG002|Overall Study|Adverse Event|3|||
44424115|NCT00696657|79432095|FG003|Overall Study|Adverse Event|7|||
44424116|NCT00696657|79432096|FG004|Overall Study|Adverse Event|6|||
44424117|NCT00696657|79432097|FG005|Overall Study|Adverse Event|9|||
44424118|NCT00696657|79432098|FG006|Overall Study|Adverse Event|14|||
44424119|NCT00696657|79432099|FG007|Overall Study|Adverse Event|2|||
44424120|NCT00696657|79432100|FG008|Overall Study|Adverse Event|5|||
44424121|NCT00730886|79432122|FG000|Overall Study|Lost to Follow-up|1|||
44424122|NCT00730886|79432123|FG001|Overall Study|Lost to Follow-up|0|||
44424123|NCT00730886|79432122|FG000|Overall Study|Physician Decision|1|||
44424124|NCT00730886|79432123|FG001|Overall Study|Physician Decision|0|||
44424125|NCT00726752|79432129|FG000|Overall Study|Lack of Efficacy|6|||
44156657|NCT03614676|78947882|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
44258525|NCT03253796|79113656|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
44258526|NCT03253796|79113657|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
44258527|NCT03253796|79113658|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
44258528|NCT03253796|79113654|FG000|Period 1: Run-In|Protocol Violation|5|||
44258529|NCT03253796|79113655|FG001|Period 1: Run-In|Protocol Violation|0|||
44258530|NCT03253796|79113656|FG002|Period 1: Run-In|Protocol Violation|0|||
44258531|NCT03253796|79113657|FG003|Period 1: Run-In|Protocol Violation|0|||
44258532|NCT03253796|79113658|FG004|Period 1: Run-In|Protocol Violation|0|||
44258533|NCT03253796|79113654|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
44258534|NCT03253796|79113655|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
44258535|NCT03253796|79113656|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
44258536|NCT03253796|79113657|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
44258537|NCT03253796|79113658|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
44258538|NCT03253796|79113654|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
44258539|NCT03253796|79113655|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
44258540|NCT03253796|79113656|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
44327112|NCT00174915|79332075|FG003|Overall Study|Personal Reason(s)|9|||
44327113|NCT00174915|79332076|FG004|Overall Study|Personal Reason(s)|9|||
44327114|NCT00174915|79332072|FG000|Overall Study|Other|15|||
44327115|NCT00174915|79332073|FG001|Overall Study|Other|8|||
44327116|NCT00174915|79332074|FG002|Overall Study|Other|6|||
44327117|NCT00174915|79332075|FG003|Overall Study|Other|5|||
44327118|NCT00174915|79332076|FG004|Overall Study|Other|3|||
44327119|NCT00174915|79332072|FG000|Overall Study|Gout Flare|13|||
44327120|NCT00174915|79332073|FG001|Overall Study|Gout Flare|6|||
44327121|NCT00174915|79332074|FG002|Overall Study|Gout Flare|8|||
44327122|NCT00174915|79332075|FG003|Overall Study|Gout Flare|1|||
44424126|NCT00730028|79432147|FG000|Overall Study|Adverse Event|23|||
44424127|NCT00730028|79432148|FG001|Overall Study|Adverse Event|26|||
44424128|NCT00730028|79432149|FG002|Overall Study|Adverse Event|16|||
44327123|NCT00174915|79332076|FG004|Overall Study|Gout Flare|0|||
44327124|NCT00174915|79332072|FG000|Overall Study|Protocol Violation|6|||
44327125|NCT00174915|79332073|FG001|Overall Study|Protocol Violation|3|||
44327126|NCT00174915|79332074|FG002|Overall Study|Protocol Violation|3|||
44327127|NCT00174915|79332075|FG003|Overall Study|Protocol Violation|6|||
44327128|NCT00174915|79332076|FG004|Overall Study|Protocol Violation|3|||
44327129|NCT00174915|79332072|FG000|Overall Study|Therapeutic Failure|6|||
44327130|NCT00174915|79332073|FG001|Overall Study|Therapeutic Failure|3|||
44327131|NCT00174915|79332074|FG002|Overall Study|Therapeutic Failure|2|||
44327132|NCT00174915|79332075|FG003|Overall Study|Therapeutic Failure|1|||
44327133|NCT00174915|79332076|FG004|Overall Study|Therapeutic Failure|3|||
44327134|NCT01080716|79332092|FG000|Part 1|Physician Decision|1|||
44327135|NCT01080716|79332093|FG001|Part 1|Physician Decision|0|||
44327136|NCT01080716|79332094|FG002|Part 1|Physician Decision|0|||
44327137|NCT01080716|79332095|FG003|Part 1|Physician Decision|0|||
44327138|NCT00172185|79332113|FG000|Overall Study|Adverse Event|0|||
44327139|NCT00172185|79332114|FG001|Overall Study|Adverse Event|1|||
44327140|NCT00172185|79332115|FG002|Overall Study|Adverse Event|3|||
44327141|NCT00172185|79332116|FG003|Overall Study|Adverse Event|4|||
44327142|NCT00172185|79332113|FG000|Overall Study|Physician Decision|0|||
44327143|NCT00172185|79332114|FG001|Overall Study|Physician Decision|0|||
44537025|NCT02906020|79547735|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537026|NCT02906020|79547736|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537027|NCT02906020|79547737|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44327144|NCT00172185|79332115|FG002|Overall Study|Physician Decision|1|||
44327145|NCT00172185|79332116|FG003|Overall Study|Physician Decision|0|||
44327146|NCT00172185|79332113|FG000|Overall Study|SPONSOR Decision|0|||
44327147|NCT00172185|79332114|FG001|Overall Study|SPONSOR Decision|1|||
44327148|NCT00172185|79332115|FG002|Overall Study|SPONSOR Decision|0|||
44327149|NCT00172185|79332116|FG003|Overall Study|SPONSOR Decision|0|||
44327150|NCT00172185|79332113|FG000|Overall Study|Withdrawal by Subject|0|||
44327151|NCT00172185|79332114|FG001|Overall Study|Withdrawal by Subject|0|||
44327152|NCT00172185|79332115|FG002|Overall Study|Withdrawal by Subject|1|||
44327153|NCT00172185|79332116|FG003|Overall Study|Withdrawal by Subject|0|||
44327154|NCT01080326|79332130|FG000|Overall Study|Patient deterioration prior to procedure|3|||
44327155|NCT01080326|79332130|FG000|Overall Study|Surgeon decision|1|||
44327156|NCT00171951|79332134|FG000|Overall Study|Adverse Event|1|||
44327157|NCT00171951|79332134|FG000|Overall Study|Abnormal Laboratory Values|2|||
44327158|NCT00171951|79332134|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44327159|NCT00171951|79332134|FG000|Overall Study|Participants Withdrew Consent|3|||
44327160|NCT00171951|79332134|FG000|Overall Study|New Cancer Therapy|5|||
44327161|NCT00171951|79332134|FG000|Overall Study|Reason not Specified|2|||
44424129|NCT00730028|79432150|FG003|Overall Study|Adverse Event|20|||
44424130|NCT00730028|79432151|FG004|Overall Study|Adverse Event|43|||
44424131|NCT00730028|79432147|FG000|Overall Study|Lost to Follow-up|13|||
44424132|NCT00730028|79432148|FG001|Overall Study|Lost to Follow-up|26|||
44424133|NCT00730028|79432149|FG002|Overall Study|Lost to Follow-up|22|||
44424134|NCT00730028|79432150|FG003|Overall Study|Lost to Follow-up|26|||
44424135|NCT00730028|79432151|FG004|Overall Study|Lost to Follow-up|25|||
44424136|NCT00730028|79432147|FG000|Overall Study|Protocol Violation|6|||
44424137|NCT00730028|79432148|FG001|Overall Study|Protocol Violation|1|||
44424138|NCT00730028|79432149|FG002|Overall Study|Protocol Violation|1|||
44537028|NCT02906020|79547738|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44327162|NCT01080131|79332143|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
44327163|NCT01080131|79332144|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
44327164|NCT01080131|79332143|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
44327165|NCT01080131|79332144|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
44327166|NCT01080131|79332143|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
44327167|NCT01080131|79332144|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
44327168|NCT01080131|79332143|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
44327169|NCT01080131|79332144|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
44327170|NCT01080131|79332143|FG000|Core Study (0- 12 Weeks)|Death|1|||
44327171|NCT01080131|79332144|FG001|Core Study (0- 12 Weeks)|Death|0|||
44327172|NCT01080131|79332143|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
44327173|NCT01080131|79332144|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
44327174|NCT01080131|79332143|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
44327175|NCT01080131|79332144|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
44327176|NCT01080131|79332143|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
44327177|NCT01080131|79332144|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
44327178|NCT01080131|79332143|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
44327179|NCT01080131|79332144|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
44327180|NCT01080131|79332143|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
44327181|NCT01080131|79332144|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
44327182|NCT01080131|79332143|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
44424139|NCT00730028|79432150|FG003|Overall Study|Protocol Violation|2|||
44424140|NCT00730028|79432151|FG004|Overall Study|Protocol Violation|0|||
44327183|NCT01080131|79332144|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
44327184|NCT01080131|79332143|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
44327185|NCT01080131|79332144|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
44327186|NCT01080131|79332143|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
44327187|NCT01080131|79332144|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
44327188|NCT00171873|79332170|FG000|Overall Study|Withdrawal by Subject|4|||
44327189|NCT00171873|79332171|FG001|Overall Study|Withdrawal by Subject|2|||
44327190|NCT00171873|79332170|FG000|Overall Study|Adverse Event|5|||
44327191|NCT00171873|79332171|FG001|Overall Study|Adverse Event|0|||
44327192|NCT00171873|79332170|FG000|Overall Study|Switched to Octreotide|0|||
44424141|NCT00730028|79432147|FG000|Overall Study|Withdrawal by Subject|9|||
44327193|NCT00171873|79332171|FG001|Overall Study|Switched to Octreotide|1|||
44327194|NCT00171834|79332184|FG000|Overall Study|Adverse Event|2|||
44327195|NCT00171834|79332185|FG001|Overall Study|Adverse Event|1|||
44327196|NCT00171834|79332186|FG002|Overall Study|Adverse Event|3|||
44327197|NCT00171834|79332187|FG003|Overall Study|Adverse Event|2|||
44327198|NCT00171834|79332188|FG004|Overall Study|Adverse Event|2|||
44327199|NCT00171834|79332189|FG005|Overall Study|Adverse Event|15|||
44327200|NCT00171834|79332190|FG006|Overall Study|Adverse Event|1|||
44327201|NCT00171834|79332184|FG000|Overall Study|Withdrawal by Subject|0|||
44327202|NCT00171834|79332185|FG001|Overall Study|Withdrawal by Subject|2|||
44327203|NCT00171834|79332186|FG002|Overall Study|Withdrawal by Subject|0|||
44327204|NCT00171834|79332187|FG003|Overall Study|Withdrawal by Subject|1|||
44327205|NCT00171834|79332188|FG004|Overall Study|Withdrawal by Subject|1|||
44327206|NCT00171834|79332189|FG005|Overall Study|Withdrawal by Subject|1|||
44327207|NCT00171834|79332190|FG006|Overall Study|Withdrawal by Subject|0|||
44424142|NCT00730028|79432148|FG001|Overall Study|Withdrawal by Subject|5|||
44424143|NCT00730028|79432149|FG002|Overall Study|Withdrawal by Subject|4|||
44424144|NCT00730028|79432150|FG003|Overall Study|Withdrawal by Subject|5|||
44424145|NCT00730028|79432151|FG004|Overall Study|Withdrawal by Subject|9|||
44424146|NCT00730028|79432147|FG000|Overall Study|Physician Decision|3|||
44424147|NCT00730028|79432148|FG001|Overall Study|Physician Decision|3|||
44424148|NCT00730028|79432149|FG002|Overall Study|Physician Decision|2|||
44424149|NCT00730028|79432150|FG003|Overall Study|Physician Decision|3|||
44424150|NCT00730028|79432151|FG004|Overall Study|Physician Decision|2|||
44424151|NCT00730028|79432147|FG000|Overall Study|Treatment Failure|5|||
44424152|NCT00730028|79432148|FG001|Overall Study|Treatment Failure|5|||
44424153|NCT00730028|79432149|FG002|Overall Study|Treatment Failure|0|||
44424154|NCT00730028|79432150|FG003|Overall Study|Treatment Failure|0|||
44424155|NCT00730028|79432151|FG004|Overall Study|Treatment Failure|1|||
44424156|NCT00730028|79432147|FG000|Overall Study|Randomization Error|1|||
44424157|NCT00730028|79432148|FG001|Overall Study|Randomization Error|0|||
44424158|NCT00730028|79432149|FG002|Overall Study|Randomization Error|0|||
44424159|NCT00730028|79432150|FG003|Overall Study|Randomization Error|0|||
44424160|NCT00730028|79432151|FG004|Overall Study|Randomization Error|2|||
44424161|NCT00736502|79432163|FG000|Overall Study|Adverse Event|22|||
44424162|NCT00736502|79432163|FG000|Overall Study|Lack of Efficacy|16|||
44424163|NCT00736502|79432163|FG000|Overall Study|Lost to Follow-up|27|||
44424164|NCT00729560|79432167|FG000|Overall Study|Withdrawal by Subject|3|||
44424165|NCT00736190|79432171|FG000|Overall Study|Pregnancy|1|||
44424166|NCT00736190|79432171|FG000|Overall Study|Withdrawal by Subject|1|||
44424167|NCT00736190|79432171|FG000|Overall Study|Adverse Event|1|||
44424168|NCT00729326|79432177|FG000|Overall Study|Lost to Follow-up|2|||
44424169|NCT00729326|79432178|FG001|Overall Study|Lost to Follow-up|0|||
44424170|NCT00729326|79432177|FG000|Overall Study|Physician Decision|0|||
44424171|NCT00729326|79432178|FG001|Overall Study|Physician Decision|1|||
44424172|NCT00729326|79432177|FG000|Overall Study|Protocol Violation|3|||
44424173|NCT00729326|79432178|FG001|Overall Study|Protocol Violation|2|||
44424174|NCT00729326|79432177|FG000|Overall Study|Subject Decision|4|||
44424175|NCT00729326|79432178|FG001|Overall Study|Subject Decision|4|||
44424176|NCT00729326|79432177|FG000|Overall Study|Sponsor Decision|1|||
44424177|NCT00729326|79432178|FG001|Overall Study|Sponsor Decision|2|||
44327208|NCT00171834|79332184|FG000|Overall Study|Death from study indication|0|||
44327209|NCT00171834|79332185|FG001|Overall Study|Death from study indication|1|||
44327210|NCT00171834|79332186|FG002|Overall Study|Death from study indication|0|||
44327211|NCT00171834|79332187|FG003|Overall Study|Death from study indication|0|||
44327212|NCT00171834|79332188|FG004|Overall Study|Death from study indication|1|||
44327213|NCT00171834|79332189|FG005|Overall Study|Death from study indication|0|||
44327214|NCT00171834|79332190|FG006|Overall Study|Death from study indication|0|||
44424178|NCT00729248|79432184|FG000|Overall Study|Physician Decision|2|||
44424179|NCT00696423|79432191|FG000|Overall Study|Lost to Follow-up|0|||
44327215|NCT00171834|79332184|FG000|Overall Study|Disease Progression|4|||
44327216|NCT00171834|79332185|FG001|Overall Study|Disease Progression|8|||
44327217|NCT00171834|79332186|FG002|Overall Study|Disease Progression|8|||
44327218|NCT00171834|79332187|FG003|Overall Study|Disease Progression|9|||
44327219|NCT00171834|79332188|FG004|Overall Study|Disease Progression|2|||
44327220|NCT00171834|79332189|FG005|Overall Study|Disease Progression|18|||
44327221|NCT00171834|79332190|FG006|Overall Study|Disease Progression|3|||
44327222|NCT00171834|79332184|FG000|Overall Study|Treatment Duration Completed|0|||
44327223|NCT00171834|79332185|FG001|Overall Study|Treatment Duration Completed|0|||
44327224|NCT00171834|79332186|FG002|Overall Study|Treatment Duration Completed|1|||
44327225|NCT00171834|79332187|FG003|Overall Study|Treatment Duration Completed|0|||
44327226|NCT00171834|79332188|FG004|Overall Study|Treatment Duration Completed|2|||
44327227|NCT00171834|79332189|FG005|Overall Study|Treatment Duration Completed|1|||
44327228|NCT00171834|79332190|FG006|Overall Study|Treatment Duration Completed|0|||
44327229|NCT00171249|79332220|FG000|Overall Study|Withdrawal by Subject|2|||
44327230|NCT00171249|79332221|FG001|Overall Study|Withdrawal by Subject|0|||
44327231|NCT00171249|79332222|FG002|Overall Study|Withdrawal by Subject|0|||
44327232|NCT00171249|79332223|FG003|Overall Study|Withdrawal by Subject|6|||
44327233|NCT00171249|79332224|FG004|Overall Study|Withdrawal by Subject|0|||
44327234|NCT00171249|79332225|FG005|Overall Study|Withdrawal by Subject|0|||
44327235|NCT00171249|79332226|FG006|Overall Study|Withdrawal by Subject|0|||
44327236|NCT00171249|79332220|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
44327237|NCT00171249|79332221|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44327238|NCT00171249|79332222|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
44327239|NCT00171249|79332223|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
44327240|NCT00171249|79332224|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44327241|NCT00171249|79332225|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
44327242|NCT00171249|79332226|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
44327243|NCT00171249|79332220|FG000|Overall Study|Death|7|||
44327244|NCT00171249|79332221|FG001|Overall Study|Death|1|||
44327245|NCT00171249|79332222|FG002|Overall Study|Death|0|||
44327246|NCT00171249|79332223|FG003|Overall Study|Death|4|||
44327247|NCT00171249|79332224|FG004|Overall Study|Death|0|||
44327248|NCT00171249|79332225|FG005|Overall Study|Death|3|||
44537029|NCT02906020|79547739|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
44537030|NCT02906020|79547724|FG000|Part 2: Double-blind Treatment Period|Other|0|||
44537031|NCT02906020|79547725|FG001|Part 2: Double-blind Treatment Period|Other|0|||
44537032|NCT02906020|79547726|FG002|Part 2: Double-blind Treatment Period|Other|0|||
44537033|NCT02906020|79547727|FG003|Part 2: Double-blind Treatment Period|Other|0|||
44537034|NCT02906020|79547728|FG004|Part 2: Double-blind Treatment Period|Other|0|||
44537035|NCT02906020|79547729|FG005|Part 2: Double-blind Treatment Period|Other|0|||
44327249|NCT00171249|79332226|FG006|Overall Study|Death|1|||
44327250|NCT00171249|79332220|FG000|Overall Study|Other|10|||
44327251|NCT00171249|79332221|FG001|Overall Study|Other|0|||
44327252|NCT00171249|79332222|FG002|Overall Study|Other|0|||
44327253|NCT00171249|79332223|FG003|Overall Study|Other|43|||
44327254|NCT00171249|79332224|FG004|Overall Study|Other|0|||
44327255|NCT00171249|79332225|FG005|Overall Study|Other|2|||
44327256|NCT00171249|79332226|FG006|Overall Study|Other|0|||
44327257|NCT00171249|79332220|FG000|Overall Study|No Longer Requires Study Drug|4|||
44327258|NCT00171249|79332221|FG001|Overall Study|No Longer Requires Study Drug|0|||
44327259|NCT00171249|79332222|FG002|Overall Study|No Longer Requires Study Drug|0|||
44327260|NCT00171249|79332223|FG003|Overall Study|No Longer Requires Study Drug|3|||
44327261|NCT00171249|79332224|FG004|Overall Study|No Longer Requires Study Drug|0|||
44327262|NCT00171249|79332225|FG005|Overall Study|No Longer Requires Study Drug|5|||
44327263|NCT00171249|79332226|FG006|Overall Study|No Longer Requires Study Drug|0|||
44327264|NCT00171249|79332220|FG000|Overall Study|Administrative Problems|1|||
44327265|NCT00171249|79332221|FG001|Overall Study|Administrative Problems|0|||
44327266|NCT00171249|79332222|FG002|Overall Study|Administrative Problems|0|||
44327267|NCT00171249|79332223|FG003|Overall Study|Administrative Problems|2|||
44537036|NCT02906020|79547730|FG006|Part 2: Double-blind Treatment Period|Other|0|||
44537037|NCT02906020|79547731|FG007|Part 2: Double-blind Treatment Period|Other|0|||
44537038|NCT02906020|79547732|FG008|Part 2: Double-blind Treatment Period|Other|6|||
44537039|NCT02906020|79547733|FG009|Part 2: Double-blind Treatment Period|Other|10|||
44537040|NCT02906020|79547734|FG010|Part 2: Double-blind Treatment Period|Other|0|||
44537041|NCT02906020|79547735|FG011|Part 2: Double-blind Treatment Period|Other|0|||
44537042|NCT02906020|79547736|FG012|Part 2: Double-blind Treatment Period|Other|0|||
44537043|NCT02906020|79547737|FG013|Part 2: Double-blind Treatment Period|Other|0|||
44537044|NCT02906020|79547738|FG014|Part 2: Double-blind Treatment Period|Other|0|||
44537045|NCT02906020|79547739|FG015|Part 2: Double-blind Treatment Period|Other|0|||
44537046|NCT02906020|79547724|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44156658|NCT03614676|78947881|FG000|Overall Study|Migrated / moved from the study area|30|||
44156659|NCT03614676|78947882|FG001|Overall Study|Migrated / moved from the study area|22|||
44156660|NCT03614676|78947881|FG000|Overall Study|Lost to Follow-up|17|||
44156661|NCT03614676|78947882|FG001|Overall Study|Lost to Follow-up|42|||
44156662|NCT03614676|78947881|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
44156663|NCT03614676|78947882|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
44156664|NCT03614676|78947881|FG000|Overall Study|Other|16|||
44156665|NCT03614676|78947882|FG001|Overall Study|Other|47|||
44156666|NCT03614676|78947881|FG000|Overall Study|Protocol Violation|0|||
44156667|NCT03614676|78947882|FG001|Overall Study|Protocol Violation|2|||
44156668|NCT03614676|78947881|FG000|Overall Study|Neonatal event of interest|0|||
44156669|NCT03614676|78947882|FG001|Overall Study|Neonatal event of interest|6|||
44156670|NCT03614676|78947881|FG000|Overall Study|Death in infant greater than 28 days old|0|||
44156671|NCT03614676|78947882|FG001|Overall Study|Death in infant greater than 28 days old|12|||
44156672|NCT03614676|78947881|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
44156673|NCT03614676|78947882|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
44156674|NCT02727478|78947894|FG000|Overall Study|Withdrawal by Subject|8|||
44156675|NCT02727478|78947895|FG001|Overall Study|Withdrawal by Subject|10|||
44156676|NCT02614794|78947903|FG000|Overall Study|Death|258|||
44537047|NCT02906020|79547725|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537048|NCT02906020|79547726|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537049|NCT02906020|79547727|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537050|NCT02906020|79547728|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537051|NCT02906020|79547729|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537052|NCT02906020|79547730|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537053|NCT02906020|79547731|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537054|NCT02906020|79547732|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537055|NCT02906020|79547733|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537056|NCT02906020|79547734|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537057|NCT02906020|79547735|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537058|NCT02906020|79547736|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
44537059|NCT02906020|79547737|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
44537060|NCT02906020|79547738|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537061|NCT02906020|79547739|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
44537062|NCT02906020|79547724|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537063|NCT02906020|79547725|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44156677|NCT02614794|78947904|FG001|Overall Study|Death|151|||
44156678|NCT02614794|78947903|FG000|Overall Study|Study closure by Sponsor|119|||
44258541|NCT03253796|79113657|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
44258542|NCT03253796|79113658|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
44258543|NCT03253796|79113654|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
44258544|NCT03253796|79113655|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
44258545|NCT03253796|79113656|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
44258546|NCT03253796|79113657|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
44327268|NCT00171249|79332224|FG004|Overall Study|Administrative Problems|0|||
44327269|NCT00171249|79332225|FG005|Overall Study|Administrative Problems|0|||
44327270|NCT00171249|79332226|FG006|Overall Study|Administrative Problems|0|||
44327271|NCT00171249|79332220|FG000|Overall Study|Adverse Event|3|||
44327272|NCT00171249|79332221|FG001|Overall Study|Adverse Event|1|||
44327273|NCT00171249|79332222|FG002|Overall Study|Adverse Event|0|||
44327274|NCT00171249|79332223|FG003|Overall Study|Adverse Event|15|||
44327275|NCT00171249|79332224|FG004|Overall Study|Adverse Event|0|||
44327276|NCT00171249|79332225|FG005|Overall Study|Adverse Event|2|||
44327277|NCT00171249|79332226|FG006|Overall Study|Adverse Event|0|||
44327278|NCT00171249|79332220|FG000|Overall Study|Lost to Follow-up|5|||
44327279|NCT00171249|79332221|FG001|Overall Study|Lost to Follow-up|0|||
44327280|NCT00171249|79332222|FG002|Overall Study|Lost to Follow-up|0|||
44327281|NCT00171249|79332223|FG003|Overall Study|Lost to Follow-up|9|||
44327282|NCT00171249|79332224|FG004|Overall Study|Lost to Follow-up|0|||
44327283|NCT00171249|79332225|FG005|Overall Study|Lost to Follow-up|0|||
44327284|NCT00171249|79332226|FG006|Overall Study|Lost to Follow-up|0|||
44327285|NCT01085630|79332237|FG000|Overall Study|Insufficient data|1|||
44327286|NCT01085630|79332238|FG001|Overall Study|Insufficient data|0|||
44327287|NCT01085630|79332237|FG000|Overall Study|Ineligible|3|||
44327288|NCT01085630|79332238|FG001|Overall Study|Ineligible|0|||
44327289|NCT00171210|79332246|FG000|Overall Study|Adverse Event|16|||
44327290|NCT00171210|79332247|FG001|Overall Study|Adverse Event|27|||
44327291|NCT00171210|79332246|FG000|Overall Study|Abnormal laboratory value(s)|6|||
44327292|NCT00171210|79332247|FG001|Overall Study|Abnormal laboratory value(s)|3|||
44327293|NCT00171210|79332246|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44327294|NCT00171210|79332247|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44327295|NCT00171210|79332246|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
44327296|NCT00171210|79332247|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
44327297|NCT00171210|79332246|FG000|Overall Study|Protocol Violation|0|||
44327298|NCT00171210|79332247|FG001|Overall Study|Protocol Violation|2|||
44327299|NCT00171210|79332246|FG000|Overall Study|Withdrawal by Subject|32|||
44327300|NCT00171210|79332247|FG001|Overall Study|Withdrawal by Subject|30|||
44537064|NCT02906020|79547726|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537065|NCT02906020|79547727|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537066|NCT02906020|79547728|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537067|NCT02906020|79547729|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537068|NCT02906020|79547730|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537069|NCT02906020|79547731|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537070|NCT02906020|79547732|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537071|NCT02906020|79547733|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537072|NCT02906020|79547734|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537073|NCT02906020|79547735|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537074|NCT02906020|79547736|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
44537075|NCT02906020|79547737|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
44537076|NCT02906020|79547738|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
44537077|NCT02906020|79547739|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
44537078|NCT02906020|79547724|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537079|NCT02906020|79547725|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537080|NCT02906020|79547726|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537081|NCT02906020|79547727|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537082|NCT02906020|79547728|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537083|NCT02906020|79547729|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537084|NCT02906020|79547730|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537085|NCT02906020|79547731|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537086|NCT02906020|79547732|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537087|NCT02906020|79547733|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44156679|NCT02614794|78947904|FG001|Overall Study|Study closure by Sponsor|45|||
44156680|NCT02614794|78947903|FG000|Overall Study|Withdrawal by Subject|24|||
44156681|NCT02614794|78947904|FG001|Overall Study|Withdrawal by Subject|5|||
44156682|NCT02614794|78947903|FG000|Overall Study|Lost to Follow-up|7|||
44156683|NCT02614794|78947904|FG001|Overall Study|Lost to Follow-up|0|||
44156684|NCT02614794|78947903|FG000|Overall Study|Physician Decision|1|||
44156685|NCT02614794|78947904|FG001|Overall Study|Physician Decision|1|||
44156686|NCT02614794|78947903|FG000|Overall Study|Hospital closure|1|||
44156687|NCT02614794|78947904|FG001|Overall Study|Hospital closure|0|||
44156688|NCT01649232|78947917|FG000|Overall Study|Physician Decision|2|||
44537088|NCT02906020|79547734|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44327301|NCT00171210|79332246|FG000|Overall Study|Lost to Follow-up|1|||
44327302|NCT00171210|79332247|FG001|Overall Study|Lost to Follow-up|0|||
44327303|NCT00171210|79332246|FG000|Overall Study|Administrative problems|1|||
44156689|NCT01649232|78947918|FG001|Overall Study|Physician Decision|0|||
44327304|NCT00171210|79332247|FG001|Overall Study|Administrative problems|1|||
44327305|NCT00171210|79332246|FG000|Overall Study|Death|2|||
44327306|NCT00171210|79332247|FG001|Overall Study|Death|3|||
44327307|NCT00171210|79332246|FG000|Overall Study|Stopped at end of core|0|||
44327308|NCT00171210|79332247|FG001|Overall Study|Stopped at end of core|32|||
44327309|NCT00171210|79332246|FG000|Overall Study|Stopped at end of extension 1|0|||
44327310|NCT00171210|79332247|FG001|Overall Study|Stopped at end of extension 1|1|||
44327311|NCT00171054|79332255|FG000|Overall Study|Protocol Violation|1|||
44327312|NCT00171054|79332256|FG001|Overall Study|Protocol Violation|2|||
44327313|NCT00171054|79332255|FG000|Overall Study|Patient withdrew consent|1|||
44327314|NCT00171054|79332256|FG001|Overall Study|Patient withdrew consent|0|||
44327315|NCT00171054|79332255|FG000|Overall Study|Lost to Follow-up|0|||
44327316|NCT00171054|79332256|FG001|Overall Study|Lost to Follow-up|1|||
44327317|NCT00171054|79332255|FG000|Overall Study|Adverse Event|8|||
44327318|NCT00171054|79332256|FG001|Overall Study|Adverse Event|8|||
44327319|NCT00171054|79332255|FG000|Overall Study|Condition no longer required study drug|0|||
44424180|NCT00696423|79432192|FG001|Overall Study|Lost to Follow-up|5|||
44424181|NCT00736034|79432198|FG000|Overall Study|Adverse Event|2|||
44424182|NCT00576693|79432204|FG000|Overall Study|Lost to Follow-up|7|||
44424183|NCT00576693|79432205|FG001|Overall Study|Lost to Follow-up|11|||
44424184|NCT00576693|79432204|FG000|Overall Study|Withdrawal by Subject|3|||
44424185|NCT00576693|79432205|FG001|Overall Study|Withdrawal by Subject|13|||
44424186|NCT00698451|79432211|FG000|Overall Study|Adverse Event|22|||
44424187|NCT00698451|79432211|FG000|Overall Study|Physician Decision|2|||
44424188|NCT00698451|79432211|FG000|Overall Study|Protocol Violation|6|||
44424189|NCT00698451|79432211|FG000|Overall Study|Withdrawal by Subject|6|||
44424190|NCT00698451|79432211|FG000|Overall Study|Disease progression|3|||
44424191|NCT00697827|79432217|FG000|Overall Study|enrolled but not treated|2|||
44424192|NCT00697827|79432218|FG001|Overall Study|enrolled but not treated|1|||
44424193|NCT00728936|79432231|FG000|Overall Study|Withdrawal by Subject|0|||
44424194|NCT00728936|79432232|FG001|Overall Study|Withdrawal by Subject|0|||
44424195|NCT00728936|79432233|FG002|Overall Study|Withdrawal by Subject|0|||
44424196|NCT00728936|79432234|FG003|Overall Study|Withdrawal by Subject|0|||
44424197|NCT00728936|79432235|FG004|Overall Study|Withdrawal by Subject|0|||
44424198|NCT00728936|79432236|FG005|Overall Study|Withdrawal by Subject|1|||
44424199|NCT00728936|79432237|FG006|Overall Study|Withdrawal by Subject|0|||
44424200|NCT00693693|79432256|FG000|Overall Study|Lost to Follow-up|1|||
44424201|NCT00693693|79432257|FG001|Overall Study|Lost to Follow-up|1|||
44424202|NCT00693693|79432258|FG002|Overall Study|Lost to Follow-up|2|||
44424203|NCT00728468|79432266|FG000|Overall Study|Enrolled but not treated|1|||
44424204|NCT00728468|79432266|FG000|Overall Study|Death|1|||
44424205|NCT00728468|79432266|FG000|Overall Study|Protocol Violation|4|||
44156690|NCT00955968|78947932|FG000|Overall Study|Death|2|||
44327320|NCT00171054|79332256|FG001|Overall Study|Condition no longer required study drug|1|||
44327321|NCT01084694|79332264|FG000|Overall Study|Withdrawal by Subject|2|||
44424206|NCT00728468|79432266|FG000|Overall Study|Objective progression or relapse|9|||
44424207|NCT00728468|79432266|FG000|Overall Study|Study terminated by sponsor|1|||
44424208|NCT00727844|79432272|FG000|Initial Randomization|Physician Decision|2|||
44424209|NCT00727844|79432273|FG001|Initial Randomization|Physician Decision|0|||
44424210|NCT00727844|79432274|FG002|Initial Randomization|Physician Decision|0|||
44424211|NCT00727844|79432275|FG003|Initial Randomization|Physician Decision|0|||
44424212|NCT00735878|79432283|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
44424213|NCT00735878|79432284|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
44424214|NCT00735878|79432285|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
44424215|NCT00695955|79432296|FG000|Cohort 1|Adverse Event|26|||
44424216|NCT00695955|79432296|FG000|Cohort 1|Protocol Violation|2|||
44424217|NCT00695955|79432296|FG000|Cohort 1|Lost to Follow-up|30|||
44424218|NCT00695955|79432296|FG000|Cohort 1|Withdrawal by Subject|25|||
44424219|NCT00695955|79432296|FG000|Cohort 1|Lack of Efficacy|3|||
44424220|NCT00695955|79432296|FG000|Cohort 1|Other|16|||
44424221|NCT00695955|79432296|FG000|Cohort 2|Adverse Event|24|||
44424222|NCT00695955|79432296|FG000|Cohort 2|Protocol Violation|5|||
44424223|NCT00695955|79432296|FG000|Cohort 2|Lost to Follow-up|38|||
44424224|NCT00695955|79432296|FG000|Cohort 2|Withdrawal by Subject|28|||
44327322|NCT01084694|79332265|FG001|Overall Study|Withdrawal by Subject|1|||
44327323|NCT01084694|79332264|FG000|Overall Study|Death|2|||
44327324|NCT01084694|79332265|FG001|Overall Study|Death|12|||
44327325|NCT01084694|79332264|FG000|Overall Study|eligibility not maintained|2|||
44327326|NCT01084694|79332265|FG001|Overall Study|eligibility not maintained|7|||
44327327|NCT00479856|79332279|FG000|Overall Study|Adverse Event|1|||
44327328|NCT00479856|79332279|FG000|Overall Study|Withdrawal by Subject|1|||
44327329|NCT00479856|79332279|FG000|Overall Study|Physician Decision|1|||
44424225|NCT00695955|79432296|FG000|Cohort 2|Lack of Efficacy|4|||
44424226|NCT00695955|79432296|FG000|Cohort 2|Other|5|||
44424227|NCT00693225|79432304|FG000|Overall Study|Lost to Follow-up|1|||
44424228|NCT00693225|79432305|FG001|Overall Study|Lost to Follow-up|2|||
44424229|NCT00693225|79432304|FG000|Overall Study|Adverse Event|1|||
44424230|NCT00693225|79432305|FG001|Overall Study|Adverse Event|3|||
44424231|NCT00735644|79432316|FG000|Overall Study|Did not receive study vaccine|0|||
44424232|NCT00735644|79432317|FG001|Overall Study|Did not receive study vaccine|1|||
44424233|NCT00735644|79432318|FG002|Overall Study|Did not receive study vaccine|0|||
44327330|NCT00479466|79332289|FG000|Overall Study|Adverse Event|5|||
44327331|NCT00479466|79332290|FG001|Overall Study|Adverse Event|1|||
44327332|NCT00479466|79332291|FG002|Overall Study|Adverse Event|0|||
44327333|NCT00479466|79332292|FG003|Overall Study|Adverse Event|1|||
44327334|NCT00479466|79332293|FG004|Overall Study|Adverse Event|2|||
44327335|NCT00479466|79332294|FG005|Overall Study|Adverse Event|0|||
44327336|NCT00479466|79332289|FG000|Overall Study|Hyperglycemia|0|||
44327337|NCT00479466|79332290|FG001|Overall Study|Hyperglycemia|0|||
44327338|NCT00479466|79332291|FG002|Overall Study|Hyperglycemia|0|||
44327339|NCT00479466|79332292|FG003|Overall Study|Hyperglycemia|0|||
44327340|NCT00479466|79332293|FG004|Overall Study|Hyperglycemia|0|||
44327341|NCT00479466|79332294|FG005|Overall Study|Hyperglycemia|1|||
44327342|NCT00479466|79332289|FG000|Overall Study|Lack of Efficacy|2|||
44327343|NCT00479466|79332290|FG001|Overall Study|Lack of Efficacy|0|||
44327344|NCT00479466|79332291|FG002|Overall Study|Lack of Efficacy|1|||
44327345|NCT00479466|79332292|FG003|Overall Study|Lack of Efficacy|0|||
44327346|NCT00479466|79332293|FG004|Overall Study|Lack of Efficacy|0|||
44327347|NCT00479466|79332294|FG005|Overall Study|Lack of Efficacy|0|||
44327348|NCT00479466|79332289|FG000|Overall Study|Lost to Follow-up|0|||
44327349|NCT00479466|79332290|FG001|Overall Study|Lost to Follow-up|1|||
44327350|NCT00479466|79332291|FG002|Overall Study|Lost to Follow-up|1|||
44327351|NCT00479466|79332292|FG003|Overall Study|Lost to Follow-up|0|||
44327352|NCT00479466|79332293|FG004|Overall Study|Lost to Follow-up|2|||
44327353|NCT00479466|79332294|FG005|Overall Study|Lost to Follow-up|2|||
44327354|NCT00479466|79332289|FG000|Overall Study|Physician Decision|2|||
44327355|NCT00479466|79332290|FG001|Overall Study|Physician Decision|1|||
44327356|NCT00479466|79332291|FG002|Overall Study|Physician Decision|1|||
44327357|NCT00479466|79332292|FG003|Overall Study|Physician Decision|0|||
44327358|NCT00479466|79332293|FG004|Overall Study|Physician Decision|0|||
44327359|NCT00479466|79332294|FG005|Overall Study|Physician Decision|0|||
44327360|NCT00479466|79332289|FG000|Overall Study|Pregnancy|0|||
44424234|NCT00735644|79432319|FG003|Overall Study|Did not receive study vaccine|0|||
44424235|NCT00735644|79432320|FG004|Overall Study|Did not receive study vaccine|0|||
44327361|NCT00479466|79332290|FG001|Overall Study|Pregnancy|0|||
44327362|NCT00479466|79332291|FG002|Overall Study|Pregnancy|0|||
44327363|NCT00479466|79332292|FG003|Overall Study|Pregnancy|0|||
44424236|NCT00735644|79432316|FG000|Overall Study|Withdrawal by Subject|0|||
44424237|NCT00735644|79432317|FG001|Overall Study|Withdrawal by Subject|1|||
44424238|NCT00735644|79432318|FG002|Overall Study|Withdrawal by Subject|1|||
44424239|NCT00735644|79432319|FG003|Overall Study|Withdrawal by Subject|1|||
44424240|NCT00735644|79432320|FG004|Overall Study|Withdrawal by Subject|0|||
44424241|NCT03718299|79432339|FG000|Overall Study|Adverse Event|1|||
44327364|NCT00479466|79332293|FG004|Overall Study|Pregnancy|1|||
44327365|NCT00479466|79332294|FG005|Overall Study|Pregnancy|0|||
44327366|NCT00479466|79332289|FG000|Overall Study|Protocol Violation|1|||
44327367|NCT00479466|79332290|FG001|Overall Study|Protocol Violation|0|||
44327368|NCT00479466|79332291|FG002|Overall Study|Protocol Violation|0|||
44327369|NCT00479466|79332292|FG003|Overall Study|Protocol Violation|0|||
44327370|NCT00479466|79332293|FG004|Overall Study|Protocol Violation|0|||
44327371|NCT00479466|79332294|FG005|Overall Study|Protocol Violation|0|||
44327372|NCT00479466|79332289|FG000|Overall Study|Withdrawal by Subject|3|||
44327373|NCT00479466|79332290|FG001|Overall Study|Withdrawal by Subject|5|||
44327374|NCT00479466|79332291|FG002|Overall Study|Withdrawal by Subject|0|||
44327375|NCT00479466|79332292|FG003|Overall Study|Withdrawal by Subject|2|||
44327376|NCT00479466|79332293|FG004|Overall Study|Withdrawal by Subject|3|||
44327377|NCT00479466|79332294|FG005|Overall Study|Withdrawal by Subject|1|||
44327378|NCT00479388|79332310|FG000|Overall Study|Adverse Event|90|||
44327379|NCT00479388|79332311|FG001|Overall Study|Adverse Event|45|||
44327380|NCT00479388|79332310|FG000|Overall Study|Lost to Follow-up|0|||
44327381|NCT00479388|79332311|FG001|Overall Study|Lost to Follow-up|2|||
44327382|NCT00479388|79332310|FG000|Overall Study|Protocol Violation|10|||
44327383|NCT00479388|79332311|FG001|Overall Study|Protocol Violation|9|||
44327384|NCT00479388|79332310|FG000|Overall Study|Withdrawal by Subject|32|||
44327385|NCT00479388|79332311|FG001|Overall Study|Withdrawal by Subject|17|||
44327386|NCT00479232|79332319|FG000|Overall Study|Adverse Event|0|||
44327387|NCT00479232|79332320|FG001|Overall Study|Adverse Event|0|||
44327388|NCT00479232|79332321|FG002|Overall Study|Adverse Event|5|||
44327389|NCT00479232|79332322|FG003|Overall Study|Adverse Event|0|||
44327390|NCT00479232|79332323|FG004|Overall Study|Adverse Event|0|||
44327391|NCT00479232|79332324|FG005|Overall Study|Adverse Event|10|||
44327392|NCT00479232|79332319|FG000|Overall Study|Deviation from Protocol|0|||
44327393|NCT00479232|79332320|FG001|Overall Study|Deviation from Protocol|0|||
44327394|NCT00479232|79332321|FG002|Overall Study|Deviation from Protocol|1|||
44327395|NCT00479232|79332322|FG003|Overall Study|Deviation from Protocol|0|||
44327396|NCT00479232|79332323|FG004|Overall Study|Deviation from Protocol|0|||
44327397|NCT00479232|79332324|FG005|Overall Study|Deviation from Protocol|0|||
44327398|NCT00479232|79332319|FG000|Overall Study|Lack of Efficacy|0|||
44327399|NCT00479232|79332320|FG001|Overall Study|Lack of Efficacy|0|||
44327400|NCT00479232|79332321|FG002|Overall Study|Lack of Efficacy|2|||
44327401|NCT00479232|79332322|FG003|Overall Study|Lack of Efficacy|0|||
44327402|NCT00479232|79332323|FG004|Overall Study|Lack of Efficacy|0|||
44327403|NCT00479232|79332324|FG005|Overall Study|Lack of Efficacy|4|||
44327404|NCT00479232|79332319|FG000|Overall Study|Physician Decision|0|||
44327405|NCT00479232|79332320|FG001|Overall Study|Physician Decision|0|||
44327406|NCT00479232|79332321|FG002|Overall Study|Physician Decision|2|||
44327407|NCT00479232|79332322|FG003|Overall Study|Physician Decision|0|||
44327408|NCT00479232|79332323|FG004|Overall Study|Physician Decision|0|||
44327409|NCT00479232|79332324|FG005|Overall Study|Physician Decision|1|||
44327410|NCT00479232|79332319|FG000|Overall Study|Progressive Disease|3|||
44327411|NCT00479232|79332320|FG001|Overall Study|Progressive Disease|1|||
44327412|NCT00479232|79332321|FG002|Overall Study|Progressive Disease|12|||
44327413|NCT00479232|79332322|FG003|Overall Study|Progressive Disease|3|||
44327414|NCT00479232|79332323|FG004|Overall Study|Progressive Disease|3|||
44327415|NCT00479232|79332324|FG005|Overall Study|Progressive Disease|12|||
44327416|NCT00479232|79332319|FG000|Overall Study|Withdrew Consent|0|||
44327417|NCT00479232|79332320|FG001|Overall Study|Withdrew Consent|2|||
44327418|NCT00479232|79332321|FG002|Overall Study|Withdrew Consent|6|||
44327419|NCT00479232|79332322|FG003|Overall Study|Withdrew Consent|0|||
44327420|NCT00479232|79332323|FG004|Overall Study|Withdrew Consent|1|||
44327421|NCT00479232|79332324|FG005|Overall Study|Withdrew Consent|3|||
44327422|NCT00478881|79332344|FG000|Overall Study|Adverse Event|31|||
44327423|NCT00478881|79332345|FG001|Overall Study|Adverse Event|12|||
44327424|NCT00478881|79332344|FG000|Overall Study|Lack of Efficacy|0|||
44327425|NCT00478881|79332345|FG001|Overall Study|Lack of Efficacy|3|||
44327426|NCT00478881|79332344|FG000|Overall Study|Lost to Follow-up|0|||
44327427|NCT00478881|79332345|FG001|Overall Study|Lost to Follow-up|1|||
44327428|NCT00478881|79332344|FG000|Overall Study|Protocol Violation|2|||
44327429|NCT00478881|79332345|FG001|Overall Study|Protocol Violation|2|||
44327430|NCT00478881|79332344|FG000|Overall Study|Withdrawal by Subject|6|||
44327431|NCT00478881|79332345|FG001|Overall Study|Withdrawal by Subject|2|||
44327432|NCT00478881|79332344|FG000|Overall Study|Non-Compliance with Study Medication|0|||
44327433|NCT00478881|79332345|FG001|Overall Study|Non-Compliance with Study Medication|2|||
44327434|NCT00478647|79332351|FG000|Overall Study|Adverse Event|1|||
44327435|NCT00478647|79332351|FG000|Overall Study|Withdrawal by Subject|1|||
44327436|NCT00478608|79332355|FG000|Overall Study|Adverse Event|1|||
44327437|NCT00478608|79332355|FG000|Overall Study|Serious Adverse Event|14|||
44327438|NCT00478608|79332355|FG000|Overall Study|Withdrawal by Subject|2|||
44327439|NCT00478608|79332355|FG000|Overall Study|Protocol Violation|3|||
44327440|NCT00478257|79332361|FG000|Overall Study|Withdrawal by Subject|8|||
44327441|NCT00478257|79332362|FG001|Overall Study|Withdrawal by Subject|3|||
44424242|NCT03718299|79432339|FG000|Overall Study|Withdrawal by Subject|6|||
44424243|NCT03718299|79432339|FG000|Overall Study|Physician Decision|2|||
44424244|NCT03718299|79432339|FG000|Overall Study|Lost to Follow-up|1|||
44424245|NCT00724958|79432343|FG000|Overall Study|Adverse Event|28|||
44537089|NCT02906020|79547735|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537090|NCT02906020|79547736|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
44537091|NCT02906020|79547737|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
44537092|NCT02906020|79547738|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537093|NCT02906020|79547739|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
44537094|NCT02906020|79547724|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537095|NCT02906020|79547725|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537096|NCT02906020|79547726|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537097|NCT02906020|79547727|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537098|NCT02906020|79547728|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537099|NCT02906020|79547729|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537100|NCT02906020|79547730|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537101|NCT02906020|79547731|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537102|NCT02906020|79547732|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537103|NCT02906020|79547733|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537104|NCT02906020|79547734|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537105|NCT02906020|79547735|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537106|NCT02906020|79547736|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
44537107|NCT02906020|79547737|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
44537108|NCT02906020|79547738|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537109|NCT02906020|79547739|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
44537110|NCT02906020|79547724|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537111|NCT02906020|79547725|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537112|NCT02906020|79547726|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537113|NCT02906020|79547727|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537114|NCT02906020|79547728|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537115|NCT02906020|79547729|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537116|NCT02906020|79547730|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537117|NCT02906020|79547731|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537118|NCT02906020|79547732|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537119|NCT02906020|79547733|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537120|NCT02906020|79547734|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537121|NCT02906020|79547735|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
44537122|NCT02906020|79547736|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
44537123|NCT02906020|79547737|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
44537124|NCT02906020|79547738|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
44537125|NCT02906020|79547739|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
44537126|NCT02906020|79547724|FG000|Part 2: Long-term Follow-up Period|Other|0|||
44537127|NCT02906020|79547725|FG001|Part 2: Long-term Follow-up Period|Other|0|||
44537128|NCT02906020|79547726|FG002|Part 2: Long-term Follow-up Period|Other|0|||
44537129|NCT02906020|79547727|FG003|Part 2: Long-term Follow-up Period|Other|0|||
44537130|NCT02906020|79547728|FG004|Part 2: Long-term Follow-up Period|Other|0|||
44537131|NCT02906020|79547729|FG005|Part 2: Long-term Follow-up Period|Other|0|||
44537132|NCT02906020|79547730|FG006|Part 2: Long-term Follow-up Period|Other|0|||
44537133|NCT02906020|79547731|FG007|Part 2: Long-term Follow-up Period|Other|0|||
44537134|NCT02906020|79547732|FG008|Part 2: Long-term Follow-up Period|Other|0|||
44537135|NCT02906020|79547733|FG009|Part 2: Long-term Follow-up Period|Other|0|||
44424246|NCT00724958|79432343|FG000|Overall Study|Loss of Response|40|||
44424247|NCT00724958|79432343|FG000|Overall Study|No Response|18|||
44424248|NCT00724958|79432343|FG000|Overall Study|Remission|7|||
44258547|NCT03253796|79113658|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
44156691|NCT00955968|78947933|FG001|Overall Study|Death|4|||
44258548|NCT03253796|79113654|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
44258549|NCT03253796|79113655|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
44258550|NCT03253796|79113656|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
44258551|NCT03253796|79113657|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
44327442|NCT00478140|79332368|FG000|Overall Study|Clinical Disease Progression|1|||
44327443|NCT00478023|79332377|FG000|Overall Study|Adverse Event|11|||
44327444|NCT00478023|79332378|FG001|Overall Study|Adverse Event|7|||
44327445|NCT00478023|79332379|FG002|Overall Study|Adverse Event|8|||
44327446|NCT00478023|79332380|FG003|Overall Study|Adverse Event|14|||
44327447|NCT00478023|79332381|FG004|Overall Study|Adverse Event|6|||
44327448|NCT00478023|79332377|FG000|Overall Study|Death|1|||
44327449|NCT00478023|79332378|FG001|Overall Study|Death|0|||
44327450|NCT00478023|79332379|FG002|Overall Study|Death|0|||
44327451|NCT00478023|79332380|FG003|Overall Study|Death|0|||
44327452|NCT00478023|79332381|FG004|Overall Study|Death|0|||
44327453|NCT00478023|79332377|FG000|Overall Study|Lack of Efficacy|11|||
44327454|NCT00478023|79332378|FG001|Overall Study|Lack of Efficacy|10|||
44327455|NCT00478023|79332379|FG002|Overall Study|Lack of Efficacy|4|||
44327456|NCT00478023|79332380|FG003|Overall Study|Lack of Efficacy|5|||
44327457|NCT00478023|79332381|FG004|Overall Study|Lack of Efficacy|41|||
44327458|NCT00478023|79332377|FG000|Overall Study|Lost to Follow-up|3|||
44327459|NCT00478023|79332378|FG001|Overall Study|Lost to Follow-up|1|||
44424249|NCT00724958|79432343|FG000|Overall Study|Other Reason|76|||
44424250|NCT00724958|79432343|FG000|Overall Study|No documentation for end of therapy|13|||
44424251|NCT00695565|79432349|FG000|Overall Study|Lost to Follow-up|4|||
44424252|NCT00695565|79432350|FG001|Overall Study|Lost to Follow-up|4|||
44424253|NCT00695565|79432349|FG000|Overall Study|Adverse Event|3|||
44424254|NCT00695565|79432350|FG001|Overall Study|Adverse Event|1|||
44327460|NCT00478023|79332379|FG002|Overall Study|Lost to Follow-up|1|||
44327461|NCT00478023|79332380|FG003|Overall Study|Lost to Follow-up|1|||
44327462|NCT00478023|79332381|FG004|Overall Study|Lost to Follow-up|0|||
44327463|NCT00478023|79332377|FG000|Overall Study|Withdrawal by Subject|2|||
44327464|NCT00478023|79332378|FG001|Overall Study|Withdrawal by Subject|3|||
44327465|NCT00478023|79332379|FG002|Overall Study|Withdrawal by Subject|2|||
44327466|NCT00478023|79332380|FG003|Overall Study|Withdrawal by Subject|4|||
44327467|NCT00478023|79332381|FG004|Overall Study|Withdrawal by Subject|5|||
44327468|NCT00478023|79332377|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
44327469|NCT00478023|79332378|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
44327470|NCT00478023|79332379|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
44327471|NCT00478023|79332380|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
44327472|NCT00478023|79332381|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
44327473|NCT00477750|79332393|FG000|Overall Study|Currently Receiving Treatment|11|||
44327474|NCT00477672|79332402|FG000|Overall Study|Adverse Event|3|||
44327475|NCT00477672|79332403|FG001|Overall Study|Adverse Event|5|||
44327476|NCT00477672|79332404|FG002|Overall Study|Adverse Event|6|||
44327477|NCT00477672|79332402|FG000|Overall Study|Death|0|||
44327478|NCT00477672|79332403|FG001|Overall Study|Death|1|||
44327479|NCT00477672|79332404|FG002|Overall Study|Death|0|||
44327480|NCT00477672|79332402|FG000|Overall Study|Disease progression|0|||
44327481|NCT00477672|79332403|FG001|Overall Study|Disease progression|1|||
44327482|NCT00477672|79332404|FG002|Overall Study|Disease progression|0|||
44327483|NCT00477672|79332402|FG000|Overall Study|Physician Decision|1|||
44327484|NCT00477672|79332403|FG001|Overall Study|Physician Decision|0|||
44327485|NCT00477672|79332404|FG002|Overall Study|Physician Decision|0|||
44327486|NCT00477672|79332402|FG000|Overall Study|Protocol noncompliance|0|||
44327487|NCT00477672|79332403|FG001|Overall Study|Protocol noncompliance|2|||
44327488|NCT00477672|79332404|FG002|Overall Study|Protocol noncompliance|0|||
44327489|NCT00477672|79332402|FG000|Overall Study|Consent withdrawn|2|||
44327490|NCT00477672|79332403|FG001|Overall Study|Consent withdrawn|5|||
44327491|NCT00477672|79332404|FG002|Overall Study|Consent withdrawn|10|||
44327492|NCT00477672|79332402|FG000|Overall Study|Discretion of Sponsor|1|||
44327493|NCT00477672|79332403|FG001|Overall Study|Discretion of Sponsor|2|||
44327494|NCT00477672|79332404|FG002|Overall Study|Discretion of Sponsor|0|||
44327495|NCT00477633|79332412|FG000|Overall Study|Did not receive treatment|23|||
44327496|NCT00477633|79332412|FG000|Overall Study|Adverse Event|143|||
44327497|NCT00477633|79332412|FG000|Overall Study|Pregnancy|23|||
44327498|NCT00477633|79332412|FG000|Overall Study|Lost to Follow-up|271|||
44156692|NCT00955968|78947932|FG000|Overall Study|Withdrawal by Subject|35|||
44327499|NCT00477633|79332412|FG000|Overall Study|Withdrawal by Subject|149|||
44327500|NCT00477633|79332412|FG000|Overall Study|Protocol Violation|25|||
44327501|NCT00477633|79332412|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
44327502|NCT01131676|79332428|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
44327503|NCT01131676|79332429|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
44327504|NCT01131676|79332430|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
44327505|NCT01131676|79332428|FG000|Discontinuation From Treatment|Not treated|4|||
44327506|NCT01131676|79332429|FG001|Discontinuation From Treatment|Not treated|2|||
44424255|NCT00695565|79432349|FG000|Overall Study|Protocol Violation|3|||
44327507|NCT01131676|79332430|FG002|Discontinuation From Treatment|Not treated|2|||
44327508|NCT01131676|79332428|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
44537136|NCT02906020|79547734|FG010|Part 2: Long-term Follow-up Period|Other|0|||
44537137|NCT02906020|79547735|FG011|Part 2: Long-term Follow-up Period|Other|0|||
44537138|NCT02906020|79547736|FG012|Part 2: Long-term Follow-up Period|Other|13|||
44424256|NCT00695565|79432350|FG001|Overall Study|Protocol Violation|1|||
44424257|NCT00695565|79432349|FG000|Overall Study|Withdrawal by Subject|1|||
44424258|NCT00695565|79432350|FG001|Overall Study|Withdrawal by Subject|1|||
44424259|NCT00695565|79432349|FG000|Overall Study|Lack of Efficacy|1|||
44424260|NCT00695565|79432350|FG001|Overall Study|Lack of Efficacy|1|||
44424261|NCT00695565|79432349|FG000|Overall Study|Subject did not follow instructions|1|||
44424262|NCT00695565|79432350|FG001|Overall Study|Subject did not follow instructions|1|||
44424263|NCT00727532|79432356|FG000|Overall Study|Adverse Event|1|||
44424264|NCT00727532|79432356|FG000|Overall Study|Withdrawal by Subject|1|||
44424265|NCT00721214|79432360|FG000|Overall Study|Chose another center for transplant|1|||
44424266|NCT00721214|79432360|FG000|Overall Study|Death|3|||
44424267|NCT00720902|79432366|FG000|Overall Study|Withdrawal by Subject|1|||
44424268|NCT00720902|79432367|FG001|Overall Study|Withdrawal by Subject|0|||
44424269|NCT00720902|79432366|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
44424270|NCT00720902|79432367|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
44424271|NCT00695019|79432376|FG000|Overall Study|Withdrawal by Subject|8|||
44424272|NCT00695019|79432377|FG001|Overall Study|Withdrawal by Subject|6|||
44424273|NCT00695019|79432378|FG002|Overall Study|Withdrawal by Subject|4|||
44424274|NCT00695019|79432376|FG000|Overall Study|Protocol Violation|1|||
44424275|NCT00695019|79432377|FG001|Overall Study|Protocol Violation|3|||
44424276|NCT00695019|79432378|FG002|Overall Study|Protocol Violation|1|||
44424277|NCT00695019|79432376|FG000|Overall Study|Lack of Efficacy|0|||
44424278|NCT00695019|79432377|FG001|Overall Study|Lack of Efficacy|0|||
44424279|NCT00695019|79432378|FG002|Overall Study|Lack of Efficacy|1|||
44424280|NCT00695019|79432376|FG000|Overall Study|Various|4|||
44424281|NCT00695019|79432377|FG001|Overall Study|Various|5|||
44424282|NCT00695019|79432378|FG002|Overall Study|Various|4|||
44424283|NCT00694707|79432391|FG000|Overall Study|Did Not Receive Treatment|0|||
44424284|NCT00694707|79432392|FG001|Overall Study|Did Not Receive Treatment|0|||
44424285|NCT00694707|79432393|FG002|Overall Study|Did Not Receive Treatment|1|||
44424286|NCT00694707|79432394|FG003|Overall Study|Did Not Receive Treatment|1|||
44424287|NCT00694707|79432395|FG004|Overall Study|Did Not Receive Treatment|1|||
44537139|NCT02906020|79547737|FG013|Part 2: Long-term Follow-up Period|Other|8|||
44537140|NCT02906020|79547738|FG014|Part 2: Long-term Follow-up Period|Other|3|||
44537141|NCT02906020|79547739|FG015|Part 2: Long-term Follow-up Period|Other|2|||
44537142|NCT03499353|79547767|FG000|Treatment|Adverse Event|3|||
44537143|NCT03499353|79547767|FG000|Treatment|Progressive Disease|10|||
44537144|NCT03499353|79547767|FG000|Treatment|Other|1|||
44327509|NCT01131676|79332429|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
44327510|NCT01131676|79332430|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
44327511|NCT01131676|79332428|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
44327512|NCT01131676|79332429|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
44327513|NCT01131676|79332430|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
44327514|NCT01131676|79332428|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
44327515|NCT01131676|79332429|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
44327516|NCT01131676|79332430|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
44327517|NCT01131676|79332428|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
44327518|NCT01131676|79332429|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
44327519|NCT01131676|79332430|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
44327520|NCT01131676|79332428|FG000|Discontinuation From Treatment|Other than those specified|162|||
44327521|NCT01131676|79332429|FG001|Discontinuation From Treatment|Other than those specified|142|||
44327522|NCT01131676|79332430|FG002|Discontinuation From Treatment|Other than those specified|125|||
44327523|NCT01131676|79332428|FG000|Discontinuation From Treatment|Adverse Event|303|||
44327524|NCT01131676|79332429|FG001|Discontinuation From Treatment|Adverse Event|267|||
44327525|NCT01131676|79332430|FG002|Discontinuation From Treatment|Adverse Event|273|||
44327526|NCT01131676|79332428|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
44327527|NCT01131676|79332429|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
44327528|NCT01131676|79332430|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
44327529|NCT01131676|79332428|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
44327530|NCT01131676|79332429|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
44424288|NCT00694707|79432391|FG000|Overall Study|Adverse Event|22|||
44424289|NCT00694707|79432392|FG001|Overall Study|Adverse Event|14|||
44537145|NCT03499353|79547767|FG000|Treatment|Withdrawal by Subject|2|||
44424290|NCT00694707|79432393|FG002|Overall Study|Adverse Event|8|||
44424291|NCT00694707|79432394|FG003|Overall Study|Adverse Event|12|||
44424292|NCT00694707|79432395|FG004|Overall Study|Adverse Event|13|||
44537146|NCT03499353|79547767|FG000|Long-Term Follow-up|Death|2|||
44327531|NCT01131676|79332430|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
44327532|NCT01131676|79332428|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
44327533|NCT01131676|79332429|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
44327534|NCT01131676|79332430|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
44327535|NCT01131676|79332428|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
44327536|NCT01131676|79332429|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
44327537|NCT01131676|79332430|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
44327538|NCT01131676|79332428|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
44327539|NCT01131676|79332429|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
44424293|NCT00694707|79432391|FG000|Overall Study|Insufficient Therapeutic Response|33|||
44424294|NCT00694707|79432392|FG001|Overall Study|Insufficient Therapeutic Response|18|||
44424295|NCT00694707|79432393|FG002|Overall Study|Insufficient Therapeutic Response|17|||
44424296|NCT00694707|79432394|FG003|Overall Study|Insufficient Therapeutic Response|15|||
44424297|NCT00694707|79432395|FG004|Overall Study|Insufficient Therapeutic Response|10|||
44424298|NCT00694707|79432391|FG000|Overall Study|Protocol Violation|1|||
44424299|NCT00694707|79432392|FG001|Overall Study|Protocol Violation|2|||
44424300|NCT00694707|79432393|FG002|Overall Study|Protocol Violation|1|||
44424301|NCT00694707|79432394|FG003|Overall Study|Protocol Violation|3|||
44424302|NCT00694707|79432395|FG004|Overall Study|Protocol Violation|1|||
44424303|NCT00694707|79432391|FG000|Overall Study|Withdrawal of Consent|14|||
44424304|NCT00694707|79432392|FG001|Overall Study|Withdrawal of Consent|18|||
44424305|NCT00694707|79432393|FG002|Overall Study|Withdrawal of Consent|22|||
44424306|NCT00694707|79432394|FG003|Overall Study|Withdrawal of Consent|16|||
44424307|NCT00694707|79432395|FG004|Overall Study|Withdrawal of Consent|15|||
44424308|NCT00694707|79432391|FG000|Overall Study|Lost to Follow-up|0|||
44424309|NCT00694707|79432392|FG001|Overall Study|Lost to Follow-up|1|||
44327540|NCT01131676|79332430|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
44327541|NCT01131676|79332428|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
44327542|NCT01131676|79332429|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
44327543|NCT01131676|79332430|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
44327544|NCT01131520|79332452|FG000|Overall Study|Computer problem|1|||
44327545|NCT01131520|79332453|FG001|Overall Study|Computer problem|0|||
44424310|NCT00694707|79432393|FG002|Overall Study|Lost to Follow-up|2|||
44424311|NCT00694707|79432394|FG003|Overall Study|Lost to Follow-up|0|||
44327546|NCT01131520|79332452|FG000|Overall Study|Counselor not available|0|||
44327547|NCT01131520|79332453|FG001|Overall Study|Counselor not available|3|||
44327548|NCT01131520|79332452|FG000|Overall Study|Subject changed history after enrollment|0|||
44327549|NCT01131520|79332453|FG001|Overall Study|Subject changed history after enrollment|1|||
44327550|NCT01131325|79332459|FG000|Overall Study|Adverse Event|1|||
44327551|NCT01131325|79332459|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
44327552|NCT01131130|79332463|FG000|Period 1 - Baseline|Pregnancy|1|||
44327553|NCT01131130|79332463|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
44327554|NCT01130974|79332473|FG000|Overall Study|Protocol Violation|10|||
44327555|NCT01130974|79332474|FG001|Overall Study|Protocol Violation|10|||
44327556|NCT01130974|79332473|FG000|Overall Study|Withdrawal by Subject|0|||
44327557|NCT01130974|79332474|FG001|Overall Study|Withdrawal by Subject|1|||
44327558|NCT01130974|79332473|FG000|Overall Study|Ineligibility criteria|5|||
44327559|NCT01130974|79332474|FG001|Overall Study|Ineligibility criteria|2|||
44327560|NCT01130272|79332486|FG000|Overall Study|Adverse Event|2|||
44327561|NCT01130272|79332487|FG001|Overall Study|Adverse Event|5|||
44424312|NCT00694707|79432395|FG004|Overall Study|Lost to Follow-up|0|||
44424313|NCT00694707|79432391|FG000|Overall Study|Jeopardizing Parole Status|1|||
44424314|NCT00694707|79432392|FG001|Overall Study|Jeopardizing Parole Status|0|||
44424315|NCT00694707|79432393|FG002|Overall Study|Jeopardizing Parole Status|0|||
44424316|NCT00694707|79432394|FG003|Overall Study|Jeopardizing Parole Status|0|||
44424317|NCT00694707|79432395|FG004|Overall Study|Jeopardizing Parole Status|0|||
44424318|NCT00694707|79432391|FG000|Overall Study|Death in the Family|1|||
44424319|NCT00694707|79432392|FG001|Overall Study|Death in the Family|0|||
44424320|NCT00694707|79432393|FG002|Overall Study|Death in the Family|0|||
44424321|NCT00694707|79432394|FG003|Overall Study|Death in the Family|0|||
44424322|NCT00694707|79432395|FG004|Overall Study|Death in the Family|0|||
44424323|NCT00694707|79432391|FG000|Overall Study|Arrest by Police|0|||
44424324|NCT00694707|79432392|FG001|Overall Study|Arrest by Police|1|||
44424325|NCT00694707|79432393|FG002|Overall Study|Arrest by Police|0|||
44424326|NCT00694707|79432394|FG003|Overall Study|Arrest by Police|0|||
44424327|NCT00694707|79432395|FG004|Overall Study|Arrest by Police|0|||
44424328|NCT00694707|79432391|FG000|Overall Study|Administrative Reasons|0|||
44424329|NCT00694707|79432392|FG001|Overall Study|Administrative Reasons|1|||
44424330|NCT00694707|79432393|FG002|Overall Study|Administrative Reasons|0|||
44424331|NCT00694707|79432394|FG003|Overall Study|Administrative Reasons|2|||
44424332|NCT00694707|79432395|FG004|Overall Study|Administrative Reasons|0|||
44424333|NCT00694707|79432391|FG000|Overall Study|Notification of Past Head Injury|0|||
44327562|NCT01130272|79332488|FG002|Overall Study|Adverse Event|6|||
44327563|NCT01130272|79332489|FG003|Overall Study|Adverse Event|22|||
44327564|NCT01130272|79332490|FG004|Overall Study|Adverse Event|7|||
44327565|NCT01130272|79332486|FG000|Overall Study|IVRS-confirmed constipation|0|||
44327566|NCT01130272|79332487|FG001|Overall Study|IVRS-confirmed constipation|1|||
44327567|NCT01130272|79332488|FG002|Overall Study|IVRS-confirmed constipation|1|||
44327568|NCT01130272|79332489|FG003|Overall Study|IVRS-confirmed constipation|2|||
44327569|NCT01130272|79332490|FG004|Overall Study|IVRS-confirmed constipation|0|||
44327570|NCT01130272|79332486|FG000|Overall Study|Rescue medications due to diarrhea|3|||
44327571|NCT01130272|79332487|FG001|Overall Study|Rescue medications due to diarrhea|5|||
44327572|NCT01130272|79332488|FG002|Overall Study|Rescue medications due to diarrhea|8|||
44327573|NCT01130272|79332489|FG003|Overall Study|Rescue medications due to diarrhea|8|||
44424334|NCT00694707|79432392|FG001|Overall Study|Notification of Past Head Injury|0|||
44424335|NCT00694707|79432393|FG002|Overall Study|Notification of Past Head Injury|0|||
44424336|NCT00694707|79432394|FG003|Overall Study|Notification of Past Head Injury|1|||
44327574|NCT01130272|79332490|FG004|Overall Study|Rescue medications due to diarrhea|6|||
44327575|NCT01130272|79332486|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
44327576|NCT01130272|79332487|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
44424337|NCT00694707|79432395|FG004|Overall Study|Notification of Past Head Injury|0|||
44424338|NCT00692913|79432409|FG000|Overall Study|Adverse Event|8|||
44424339|NCT00692913|79432410|FG001|Overall Study|Adverse Event|4|||
44424340|NCT00692913|79432409|FG000|Overall Study|Lost to Follow-up|3|||
44424341|NCT00692913|79432410|FG001|Overall Study|Lost to Follow-up|5|||
44424342|NCT00692913|79432409|FG000|Overall Study|Physician Decision|2|||
44424343|NCT00692913|79432410|FG001|Overall Study|Physician Decision|0|||
44424344|NCT00692913|79432409|FG000|Overall Study|Protocol Violation|1|||
44424345|NCT00692913|79432410|FG001|Overall Study|Protocol Violation|1|||
44424346|NCT00692913|79432409|FG000|Overall Study|Withdrawal by Subject|15|||
44424347|NCT00692913|79432410|FG001|Overall Study|Withdrawal by Subject|20|||
44424348|NCT00694551|79432419|FG000|Overall Study|Disease Progression|1|||
44424349|NCT00694551|79432420|FG001|Overall Study|Disease Progression|0|||
44424350|NCT00694551|79432421|FG002|Overall Study|Disease Progression|1|||
44424351|NCT00689871|79432434|FG000|Overall Study|Lost to Follow-up|123|||
44424352|NCT00689871|79432435|FG001|Overall Study|Lost to Follow-up|13|||
44424353|NCT00689871|79432436|FG002|Overall Study|Lost to Follow-up|37|||
44424354|NCT00689871|79432437|FG003|Overall Study|Lost to Follow-up|1|||
44424355|NCT00689871|79432434|FG000|Overall Study|Explanted of All Study Devices|36|||
44424356|NCT00689871|79432435|FG001|Overall Study|Explanted of All Study Devices|25|||
44424357|NCT00689871|79432436|FG002|Overall Study|Explanted of All Study Devices|29|||
44424358|NCT00689871|79432437|FG003|Overall Study|Explanted of All Study Devices|3|||
44424359|NCT00689871|79432434|FG000|Overall Study|Withdrawal by Subject|13|||
44424360|NCT00689871|79432435|FG001|Overall Study|Withdrawal by Subject|3|||
44327577|NCT01130272|79332488|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
44327578|NCT01130272|79332489|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
44327579|NCT01130272|79332490|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
44537147|NCT03499353|79547767|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
44327580|NCT01130272|79332486|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
44327581|NCT01130272|79332487|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
44327582|NCT01130272|79332488|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
44327583|NCT01130272|79332489|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
44327584|NCT01130272|79332490|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
44327585|NCT01130272|79332486|FG000|Overall Study|Protocol Violation|0|||
44327586|NCT01130272|79332487|FG001|Overall Study|Protocol Violation|0|||
44327587|NCT01130272|79332488|FG002|Overall Study|Protocol Violation|3|||
44327588|NCT01130272|79332489|FG003|Overall Study|Protocol Violation|5|||
44327589|NCT01130272|79332490|FG004|Overall Study|Protocol Violation|5|||
44327590|NCT01130272|79332486|FG000|Overall Study|Lost to Follow-up|4|||
44327591|NCT01130272|79332487|FG001|Overall Study|Lost to Follow-up|3|||
44327592|NCT01130272|79332488|FG002|Overall Study|Lost to Follow-up|4|||
44327593|NCT01130272|79332489|FG003|Overall Study|Lost to Follow-up|7|||
44424361|NCT00689871|79432436|FG002|Overall Study|Withdrawal by Subject|4|||
44537148|NCT03499353|79547767|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
44537149|NCT00004259|79547775|FG000|Overall Study|Protocol Violation|1|||
44537150|NCT00004259|79547776|FG001|Overall Study|Protocol Violation|2|||
44327594|NCT01130272|79332490|FG004|Overall Study|Lost to Follow-up|6|||
44327595|NCT01130272|79332486|FG000|Overall Study|Withdrawal by Subject|4|||
44327596|NCT01130272|79332487|FG001|Overall Study|Withdrawal by Subject|11|||
44327597|NCT01130272|79332488|FG002|Overall Study|Withdrawal by Subject|10|||
44424362|NCT00689871|79432437|FG003|Overall Study|Withdrawal by Subject|1|||
44424363|NCT00689871|79432434|FG000|Overall Study|Death|1|||
44424364|NCT00689871|79432435|FG001|Overall Study|Death|10|||
44424365|NCT00689871|79432436|FG002|Overall Study|Death|2|||
44424366|NCT00689871|79432437|FG003|Overall Study|Death|2|||
44327598|NCT01130272|79332489|FG003|Overall Study|Withdrawal by Subject|9|||
44424367|NCT00689871|79432434|FG000|Overall Study|Physician Decision|2|||
44424368|NCT00689871|79432435|FG001|Overall Study|Physician Decision|1|||
44327599|NCT01130272|79332490|FG004|Overall Study|Withdrawal by Subject|8|||
44327600|NCT01130272|79332486|FG000|Overall Study|Physician Decision|1|||
44327601|NCT01130272|79332487|FG001|Overall Study|Physician Decision|1|||
44327602|NCT01130272|79332488|FG002|Overall Study|Physician Decision|0|||
44327603|NCT01130272|79332489|FG003|Overall Study|Physician Decision|1|||
44327604|NCT01130272|79332490|FG004|Overall Study|Physician Decision|2|||
44537151|NCT00004259|79547777|FG002|Overall Study|Protocol Violation|0|||
44537152|NCT00004259|79547778|FG003|Overall Study|Protocol Violation|0|||
44537153|NCT00004259|79547775|FG000|Overall Study|Withdrawal by Subject|0|||
44537154|NCT00004259|79547776|FG001|Overall Study|Withdrawal by Subject|2|||
44537155|NCT00004259|79547777|FG002|Overall Study|Withdrawal by Subject|0|||
44537156|NCT00004259|79547778|FG003|Overall Study|Withdrawal by Subject|0|||
44537157|NCT03365934|79547802|FG000|Overall Study|Adverse Event|1|||
44537158|NCT03365934|79547802|FG000|Overall Study|Withdrawal by Subject|1|||
44537159|NCT03468855|79547811|FG000|Overall Study|Adverse Event|2|||
44537160|NCT03468855|79547811|FG000|Overall Study|Lost to Follow-up|5|||
44537161|NCT03468855|79547811|FG000|Overall Study|Withdrawal by Subject|3|||
44537162|NCT03468855|79547811|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
44156693|NCT00955968|78947933|FG001|Overall Study|Withdrawal by Subject|31|||
44327605|NCT01130272|79332486|FG000|Overall Study|Sponsor decision|6|||
44327606|NCT01130272|79332487|FG001|Overall Study|Sponsor decision|15|||
44327607|NCT01130272|79332488|FG002|Overall Study|Sponsor decision|16|||
44327608|NCT01130272|79332489|FG003|Overall Study|Sponsor decision|13|||
44327609|NCT01130272|79332490|FG004|Overall Study|Sponsor decision|16|||
44327610|NCT01130272|79332486|FG000|Overall Study|Study arm discontinued|38|||
44327611|NCT01130272|79332487|FG001|Overall Study|Study arm discontinued|0|||
44327612|NCT01130272|79332488|FG002|Overall Study|Study arm discontinued|0|||
44327613|NCT01130272|79332489|FG003|Overall Study|Study arm discontinued|0|||
44327614|NCT01130272|79332490|FG004|Overall Study|Study arm discontinued|0|||
44327615|NCT01129960|79332506|FG000|Overall Study|Withdrawal by Subject|3|||
44327616|NCT01129960|79332507|FG001|Overall Study|Withdrawal by Subject|0|||
44327617|NCT01129960|79332508|FG002|Overall Study|Withdrawal by Subject|3|||
44327618|NCT01129960|79332509|FG003|Overall Study|Withdrawal by Subject|2|||
44327619|NCT01129960|79332506|FG000|Overall Study|Lack of Efficacy|1|||
44327620|NCT01129960|79332507|FG001|Overall Study|Lack of Efficacy|1|||
44327621|NCT01129960|79332508|FG002|Overall Study|Lack of Efficacy|1|||
44327622|NCT01129960|79332509|FG003|Overall Study|Lack of Efficacy|1|||
44327623|NCT01129960|79332506|FG000|Overall Study|Adverse Event|23|||
44327624|NCT01129960|79332507|FG001|Overall Study|Adverse Event|16|||
44327625|NCT01129960|79332508|FG002|Overall Study|Adverse Event|16|||
44327626|NCT01129960|79332509|FG003|Overall Study|Adverse Event|7|||
44327627|NCT01129960|79332506|FG000|Overall Study|Protocol Violation|1|||
44327628|NCT01129960|79332507|FG001|Overall Study|Protocol Violation|2|||
44327629|NCT01129960|79332508|FG002|Overall Study|Protocol Violation|3|||
44327630|NCT01129960|79332509|FG003|Overall Study|Protocol Violation|0|||
44327631|NCT01129960|79332506|FG000|Overall Study|Lost to Follow-up|0|||
44327632|NCT01129960|79332507|FG001|Overall Study|Lost to Follow-up|2|||
44327633|NCT01129960|79332508|FG002|Overall Study|Lost to Follow-up|3|||
44327634|NCT01129960|79332509|FG003|Overall Study|Lost to Follow-up|3|||
44327635|NCT01129960|79332506|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
44327636|NCT01129960|79332507|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
44424369|NCT00689871|79432436|FG002|Overall Study|Physician Decision|1|||
44424370|NCT00689871|79432437|FG003|Overall Study|Physician Decision|0|||
44424371|NCT00793793|79432459|FG000|Overall Study|Adverse Event|0|||
44424372|NCT00793793|79432460|FG001|Overall Study|Adverse Event|0|||
44424373|NCT00793793|79432461|FG002|Overall Study|Adverse Event|1|||
44424374|NCT00793793|79432462|FG003|Overall Study|Adverse Event|1|||
44424375|NCT00793793|79432463|FG004|Overall Study|Adverse Event|0|||
44424376|NCT00793793|79432464|FG005|Overall Study|Adverse Event|1|||
44424377|NCT00793793|79432465|FG006|Overall Study|Adverse Event|2|||
44424378|NCT00793793|79432466|FG007|Overall Study|Adverse Event|0|||
44424379|NCT00793793|79432467|FG008|Overall Study|Adverse Event|0|||
44424380|NCT00793793|79432468|FG009|Overall Study|Adverse Event|0|||
44156694|NCT00955968|78947932|FG000|Overall Study|Lost to Follow-up|45|||
44327637|NCT01129960|79332508|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
44327638|NCT01129960|79332509|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
44327639|NCT01129960|79332506|FG000|Overall Study|Physician Decision|1|||
44327640|NCT01129960|79332507|FG001|Overall Study|Physician Decision|0|||
44327641|NCT01129960|79332508|FG002|Overall Study|Physician Decision|0|||
44327642|NCT01129960|79332509|FG003|Overall Study|Physician Decision|0|||
44537163|NCT03738865|79547817|FG000|Overall Study|Withdrawal by Subject|3|||
44537164|NCT03738865|79547818|FG001|Overall Study|Withdrawal by Subject|3|||
44537165|NCT03738865|79547817|FG000|Overall Study|Adverse Event|2|||
44327643|NCT01129960|79332506|FG000|Overall Study|Pregnancy|1|||
44424381|NCT00793793|79432469|FG010|Overall Study|Adverse Event|0|||
44424382|NCT00793793|79432470|FG011|Overall Study|Adverse Event|2|||
44424383|NCT00793793|79432459|FG000|Overall Study|Protocol Violation|0|||
44424384|NCT00793793|79432460|FG001|Overall Study|Protocol Violation|0|||
44537166|NCT03738865|79547818|FG001|Overall Study|Adverse Event|0|||
44327644|NCT01129960|79332507|FG001|Overall Study|Pregnancy|0|||
44327645|NCT01129960|79332508|FG002|Overall Study|Pregnancy|0|||
44327646|NCT01129960|79332509|FG003|Overall Study|Pregnancy|0|||
44327647|NCT01129921|79332521|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
44327648|NCT01129921|79332522|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
44327649|NCT01129921|79332521|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
44327650|NCT01129921|79332522|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
44327651|NCT01129921|79332521|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
44327652|NCT01129921|79332522|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
44327653|NCT01129921|79332521|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
44327654|NCT01129921|79332522|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
44327655|NCT01129882|79332541|FG000|Overall Study|Adverse Event|39|||
44327656|NCT01129882|79332541|FG000|Overall Study|Death|6|||
44327657|NCT01129882|79332541|FG000|Overall Study|Lack of Efficacy|5|||
44327658|NCT01129882|79332541|FG000|Overall Study|Lost to Follow-up|13|||
44327659|NCT01129882|79332541|FG000|Overall Study|Physician Decision|27|||
44327660|NCT01129882|79332541|FG000|Overall Study|Protocol Deviation|3|||
44327661|NCT01129882|79332541|FG000|Overall Study|Withdrawal Criteria Met|19|||
44327662|NCT01129882|79332541|FG000|Overall Study|Trial Termination by Sponsor|6|||
44327663|NCT01129882|79332541|FG000|Overall Study|Withdrawal by Subject|160|||
44327664|NCT01129102|79332548|FG000|Overall Study|No study drug treatment|2|||
44327665|NCT01129102|79332549|FG001|Overall Study|No study drug treatment|3|||
44327666|NCT01129102|79332550|FG002|Overall Study|No study drug treatment|1|||
44327667|NCT01129102|79332548|FG000|Overall Study|Withdrawal by Subject|2|||
44327668|NCT01129102|79332549|FG001|Overall Study|Withdrawal by Subject|0|||
44327669|NCT01129102|79332550|FG002|Overall Study|Withdrawal by Subject|3|||
44327670|NCT01129102|79332548|FG000|Overall Study|Protocol Violation|0|||
44327671|NCT01129102|79332549|FG001|Overall Study|Protocol Violation|1|||
44327672|NCT01129102|79332550|FG002|Overall Study|Protocol Violation|1|||
44327673|NCT01129102|79332548|FG000|Overall Study|Pregnancy|0|||
44424385|NCT00793793|79432461|FG002|Overall Study|Protocol Violation|0|||
44424386|NCT00793793|79432462|FG003|Overall Study|Protocol Violation|1|||
44424387|NCT00793793|79432463|FG004|Overall Study|Protocol Violation|0|||
44424388|NCT00793793|79432464|FG005|Overall Study|Protocol Violation|0|||
44424389|NCT00793793|79432465|FG006|Overall Study|Protocol Violation|0|||
44424390|NCT00793793|79432466|FG007|Overall Study|Protocol Violation|0|||
44424391|NCT00793793|79432467|FG008|Overall Study|Protocol Violation|0|||
44424392|NCT00793793|79432468|FG009|Overall Study|Protocol Violation|0|||
44424393|NCT00793793|79432469|FG010|Overall Study|Protocol Violation|0|||
44424394|NCT00793793|79432470|FG011|Overall Study|Protocol Violation|0|||
44424395|NCT00793793|79432459|FG000|Overall Study|Lost to Follow-up|0|||
44424396|NCT00793793|79432460|FG001|Overall Study|Lost to Follow-up|0|||
44424397|NCT00793793|79432461|FG002|Overall Study|Lost to Follow-up|1|||
44424398|NCT00793793|79432462|FG003|Overall Study|Lost to Follow-up|0|||
44424399|NCT00793793|79432463|FG004|Overall Study|Lost to Follow-up|0|||
44424400|NCT00793793|79432464|FG005|Overall Study|Lost to Follow-up|0|||
44424401|NCT00793793|79432465|FG006|Overall Study|Lost to Follow-up|0|||
44424402|NCT00793793|79432466|FG007|Overall Study|Lost to Follow-up|0|||
44424403|NCT00793793|79432467|FG008|Overall Study|Lost to Follow-up|1|||
44424404|NCT00793793|79432468|FG009|Overall Study|Lost to Follow-up|3|||
44424405|NCT00793793|79432469|FG010|Overall Study|Lost to Follow-up|1|||
44424406|NCT00793793|79432470|FG011|Overall Study|Lost to Follow-up|0|||
44424407|NCT00793793|79432459|FG000|Overall Study|Withdrawal by Subject|0|||
44424408|NCT00793793|79432460|FG001|Overall Study|Withdrawal by Subject|0|||
44424409|NCT00793793|79432461|FG002|Overall Study|Withdrawal by Subject|0|||
44424410|NCT00793793|79432462|FG003|Overall Study|Withdrawal by Subject|0|||
44327674|NCT01129102|79332549|FG001|Overall Study|Pregnancy|0|||
44327675|NCT01129102|79332550|FG002|Overall Study|Pregnancy|1|||
44327676|NCT01129102|79332548|FG000|Overall Study|Adverse Event|2|||
44327677|NCT01129102|79332549|FG001|Overall Study|Adverse Event|2|||
44327678|NCT01129102|79332550|FG002|Overall Study|Adverse Event|1|||
44327679|NCT01129102|79332548|FG000|Overall Study|Lost to Follow-up|2|||
44327680|NCT01129102|79332549|FG001|Overall Study|Lost to Follow-up|0|||
44327681|NCT01129102|79332550|FG002|Overall Study|Lost to Follow-up|0|||
44327682|NCT01129024|79332557|FG000|Overall Study|Physician Decision|5|||
44424411|NCT00793793|79432463|FG004|Overall Study|Withdrawal by Subject|1|||
44424412|NCT00793793|79432464|FG005|Overall Study|Withdrawal by Subject|0|||
44424413|NCT00793793|79432465|FG006|Overall Study|Withdrawal by Subject|0|||
44156695|NCT00955968|78947933|FG001|Overall Study|Lost to Follow-up|39|||
44424414|NCT00793793|79432466|FG007|Overall Study|Withdrawal by Subject|0|||
44424415|NCT00793793|79432467|FG008|Overall Study|Withdrawal by Subject|1|||
44424416|NCT00793793|79432468|FG009|Overall Study|Withdrawal by Subject|0|||
44327683|NCT01129024|79332557|FG000|Overall Study|Study Terminated by Sponsor|8|||
44327684|NCT01129024|79332557|FG000|Overall Study|Withdrawal by Subject|2|||
44327685|NCT01129024|79332557|FG000|Overall Study|Lack of Efficacy|3|||
44327686|NCT01129024|79332557|FG000|Overall Study|Needed a Platelet Transfusion|1|||
44327687|NCT01128946|79332561|FG000|Period I|Protocol Violation|0|||
44327688|NCT01128946|79332562|FG001|Period I|Protocol Violation|1|||
44327689|NCT01128946|79332563|FG002|Period I|Protocol Violation|0|||
44327690|NCT01128946|79332564|FG003|Period I|Protocol Violation|0|||
44327691|NCT01128946|79332561|FG000|Period I|Withdrawal by Subject|0|||
44327692|NCT01128946|79332562|FG001|Period I|Withdrawal by Subject|0|||
44327693|NCT01128946|79332563|FG002|Period I|Withdrawal by Subject|1|||
44327694|NCT01128946|79332564|FG003|Period I|Withdrawal by Subject|1|||
44327695|NCT01128946|79332561|FG000|Period II|Protocol Violation|0|||
44327696|NCT01128946|79332562|FG001|Period II|Protocol Violation|1|||
44327697|NCT01128946|79332563|FG002|Period II|Protocol Violation|0|||
44327698|NCT01128946|79332564|FG003|Period II|Protocol Violation|0|||
44327699|NCT01128946|79332561|FG000|Period II|Withdrawal by Subject|0|||
44327700|NCT01128946|79332562|FG001|Period II|Withdrawal by Subject|0|||
44327701|NCT01128946|79332563|FG002|Period II|Withdrawal by Subject|0|||
44327702|NCT01128946|79332564|FG003|Period II|Withdrawal by Subject|1|||
44327703|NCT01128946|79332561|FG000|Period III|Protocol Violation|1|||
44327704|NCT01128946|79332562|FG001|Period III|Protocol Violation|0|||
44327705|NCT01128946|79332563|FG002|Period III|Protocol Violation|0|||
44327706|NCT01128946|79332564|FG003|Period III|Protocol Violation|0|||
44327707|NCT01128595|79332575|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44327708|NCT01128595|79332576|FG001|Treatment Period 3|Withdrawal by Subject|1|||
44327709|NCT01128595|79332577|FG002|Treatment Period 3|Withdrawal by Subject|0|||
44327710|NCT01128595|79332578|FG003|Treatment Period 3|Withdrawal by Subject|0|||
44327711|NCT01129336|79332591|FG000|Overall Study|Protocol Violation|1|||
44424417|NCT00793793|79432469|FG010|Overall Study|Withdrawal by Subject|0|||
44424418|NCT00793793|79432470|FG011|Overall Study|Withdrawal by Subject|0|||
44424419|NCT00793793|79432459|FG000|Overall Study|reason not specified|0|||
44424420|NCT00793793|79432460|FG001|Overall Study|reason not specified|1|||
44424421|NCT00793793|79432461|FG002|Overall Study|reason not specified|0|||
44424422|NCT00793793|79432462|FG003|Overall Study|reason not specified|1|||
44424423|NCT00793793|79432463|FG004|Overall Study|reason not specified|1|||
44424424|NCT00793793|79432464|FG005|Overall Study|reason not specified|1|||
44424425|NCT00793793|79432465|FG006|Overall Study|reason not specified|2|||
44424426|NCT00793793|79432466|FG007|Overall Study|reason not specified|0|||
44424427|NCT00793793|79432467|FG008|Overall Study|reason not specified|7|||
44424428|NCT00793793|79432468|FG009|Overall Study|reason not specified|6|||
44424429|NCT00793793|79432469|FG010|Overall Study|reason not specified|2|||
44424430|NCT00793793|79432470|FG011|Overall Study|reason not specified|4|||
44424431|NCT00776789|79432518|FG000|Overall Study|Consent refusal|2|||
44424432|NCT00776789|79432519|FG001|Overall Study|Consent refusal|2|||
44424433|NCT00776789|79432518|FG000|Overall Study|Poor quality video|1|||
44424434|NCT00776789|79432519|FG001|Overall Study|Poor quality video|1|||
44424435|NCT00776555|79432529|FG000|Overall Study|Study terminated|3|||
44424436|NCT00776555|79432530|FG001|Overall Study|Study terminated|0|||
44424437|NCT00720434|79432540|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
44424438|NCT00720434|79432541|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
44424439|NCT00720434|79432542|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
44424440|NCT00720434|79432543|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
44424441|NCT00720434|79432540|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
44424442|NCT00720434|79432541|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
44424443|NCT00720434|79432542|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
44424444|NCT00720434|79432543|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
44424445|NCT00720434|79432540|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
44424446|NCT00720434|79432541|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
44537167|NCT03738865|79547817|FG000|Overall Study|Physician Decision|0|||
44537168|NCT03738865|79547818|FG001|Overall Study|Physician Decision|1|||
44327712|NCT01129336|79332592|FG001|Overall Study|Protocol Violation|0|||
44327713|NCT01129336|79332591|FG000|Overall Study|Disease Progression|1|||
44327714|NCT01129336|79332592|FG001|Overall Study|Disease Progression|4|||
44327715|NCT01129336|79332591|FG000|Overall Study|Lost to Follow-up|1|||
44327716|NCT01129336|79332592|FG001|Overall Study|Lost to Follow-up|0|||
44327717|NCT01129336|79332591|FG000|Overall Study|Withdrawal by Subject|7|||
44327718|NCT01129336|79332592|FG001|Overall Study|Withdrawal by Subject|4|||
44424447|NCT00720434|79432542|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
44424448|NCT00720434|79432543|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
44424449|NCT00720434|79432540|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
44424450|NCT00720434|79432541|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
44424451|NCT00720434|79432542|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
44424452|NCT00720434|79432543|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
44424453|NCT00720434|79432540|FG000|Open-Label Period (Week 5-72)|Other|4|||
44156696|NCT00955968|78947932|FG000|Overall Study|Site closed|55|||
44424454|NCT00720434|79432541|FG001|Open-Label Period (Week 5-72)|Other|3|||
44327719|NCT01129336|79332591|FG000|Overall Study|Adverse Event|0|||
44327720|NCT01129336|79332592|FG001|Overall Study|Adverse Event|1|||
44327721|NCT01129336|79332591|FG000|Overall Study|Missing Study Completion Status|2|||
44327722|NCT01129336|79332592|FG001|Overall Study|Missing Study Completion Status|3|||
44327723|NCT01129336|79332591|FG000|Overall Study|Death|0|||
44327724|NCT01129336|79332592|FG001|Overall Study|Death|4|||
44327725|NCT01128400|79332601|FG000|Overall Study|Lost to Follow-up|1|||
44327726|NCT01128400|79332602|FG001|Overall Study|Lost to Follow-up|0|||
44327727|NCT01128400|79332603|FG002|Overall Study|Lost to Follow-up|1|||
44327728|NCT01128400|79332601|FG000|Overall Study|Screening failure|1|||
44327729|NCT01128400|79332602|FG001|Overall Study|Screening failure|0|||
44327730|NCT01128400|79332603|FG002|Overall Study|Screening failure|0|||
44327731|NCT01128400|79332601|FG000|Overall Study|were not invited to participate on taste|0|||
44327732|NCT01128400|79332602|FG001|Overall Study|were not invited to participate on taste|0|||
44327733|NCT01128400|79332603|FG002|Overall Study|were not invited to participate on taste|15|||
44327734|NCT01128400|79332601|FG000|Overall Study|Excluded due to sinus problems|0|||
44327735|NCT01128400|79332602|FG001|Overall Study|Excluded due to sinus problems|1|||
44327736|NCT01128400|79332603|FG002|Overall Study|Excluded due to sinus problems|0|||
44327737|NCT01128361|79332613|FG000|Overall Study|Lost to Follow-up|0|||
44327738|NCT01128361|79332614|FG001|Overall Study|Lost to Follow-up|1|||
44327739|NCT01128361|79332613|FG000|Overall Study|Withdrawal by Subject|5|||
44327740|NCT01128361|79332614|FG001|Overall Study|Withdrawal by Subject|2|||
44327741|NCT01128244|79332620|FG000|Overall Study|Adverse Event|1|||
44327742|NCT01128244|79332620|FG000|Overall Study|Scheduling conflict|2|||
44327743|NCT01127893|79332628|FG000|Overall Study|Study Termination by the Sponsor|1|||
44327744|NCT01126879|79332634|FG000|Overall Study|Progressive Disease|3|||
44327745|NCT01126879|79332635|FG001|Overall Study|Progressive Disease|1|||
44327746|NCT01126879|79332634|FG000|Overall Study|Withdrawal by Subject|1|||
44327747|NCT01126879|79332635|FG001|Overall Study|Withdrawal by Subject|0|||
44327748|NCT01126879|79332634|FG000|Overall Study|Adverse Event|0|||
44327749|NCT01126879|79332635|FG001|Overall Study|Adverse Event|1|||
44327750|NCT01126879|79332634|FG000|Overall Study|Physician Decision|1|||
44327751|NCT01126879|79332635|FG001|Overall Study|Physician Decision|0|||
44327752|NCT01126060|79332643|FG000|Overall Study|Protocol Violation|0|||
44327753|NCT01126060|79332644|FG001|Overall Study|Protocol Violation|2|||
44327754|NCT01125748|79332652|FG000|Overall Study|Adverse Event|0|||
44327755|NCT01125748|79332653|FG001|Overall Study|Adverse Event|2|||
44327756|NCT01125748|79332652|FG000|Overall Study|Lost to Follow-up|0|||
44327757|NCT01125748|79332653|FG001|Overall Study|Lost to Follow-up|1|||
44327758|NCT01125748|79332652|FG000|Overall Study|Physician Decision|8|||
44327759|NCT01125748|79332653|FG001|Overall Study|Physician Decision|7|||
44327760|NCT01125748|79332652|FG000|Overall Study|Patient Decision to Withdraw|2|||
44327761|NCT01125748|79332653|FG001|Overall Study|Patient Decision to Withdraw|4|||
44424455|NCT00720434|79432542|FG002|Open-Label Period (Week 5-72)|Other|3|||
44424456|NCT00720434|79432543|FG003|Open-Label Period (Week 5-72)|Other|2|||
44424457|NCT00776009|79432559|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
44424458|NCT00776009|79432560|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
44327762|NCT01125514|79332659|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
44327763|NCT01125514|79332659|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
44327764|NCT01125514|79332659|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
44327765|NCT01125514|79332659|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
44327766|NCT01125514|79332659|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
44327767|NCT01125514|79332659|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
44537169|NCT03524157|79547827|FG000|Overall Study|cytology not readable|0|||
44156697|NCT00955968|78947933|FG001|Overall Study|Site closed|52|||
44258552|NCT03253796|79113658|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
44258553|NCT03253796|79113654|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
44327768|NCT01125358|79332677|FG000|Overall Study|Adverse Event|3|||
44258554|NCT03253796|79113655|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
44258555|NCT03253796|79113656|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
44258556|NCT03253796|79113657|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
44258557|NCT03253796|79113658|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
44258558|NCT03253796|79113654|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
44327769|NCT01125358|79332678|FG001|Overall Study|Adverse Event|0|||
44327770|NCT01125358|79332679|FG002|Overall Study|Adverse Event|0|||
44327771|NCT01125358|79332680|FG003|Overall Study|Adverse Event|2|||
44327772|NCT01125358|79332677|FG000|Overall Study|Perceived Lack of Efficacy|6|||
44327773|NCT01125358|79332678|FG001|Overall Study|Perceived Lack of Efficacy|3|||
44327774|NCT01125358|79332679|FG002|Overall Study|Perceived Lack of Efficacy|7|||
44424459|NCT00776009|79432561|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
44327775|NCT01125358|79332680|FG003|Overall Study|Perceived Lack of Efficacy|4|||
44327776|NCT01125358|79332677|FG000|Overall Study|Protocol Violation|1|||
44327777|NCT01125358|79332678|FG001|Overall Study|Protocol Violation|0|||
44327778|NCT01125358|79332679|FG002|Overall Study|Protocol Violation|0|||
44327779|NCT01125358|79332680|FG003|Overall Study|Protocol Violation|0|||
44327780|NCT01125358|79332677|FG000|Overall Study|Sponsor Decision|0|||
44327781|NCT01125358|79332678|FG001|Overall Study|Sponsor Decision|0|||
44327782|NCT01125358|79332679|FG002|Overall Study|Sponsor Decision|1|||
44327783|NCT01125358|79332680|FG003|Overall Study|Sponsor Decision|1|||
44327784|NCT01125358|79332677|FG000|Overall Study|Withdrawal by Subject|2|||
44327785|NCT01125358|79332678|FG001|Overall Study|Withdrawal by Subject|1|||
44327786|NCT01125358|79332679|FG002|Overall Study|Withdrawal by Subject|1|||
44327787|NCT01125358|79332680|FG003|Overall Study|Withdrawal by Subject|1|||
44327788|NCT01125046|79332690|FG000|First 6 Months of Treatment|Death|1|||
44327789|NCT01125046|79332690|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
44327790|NCT01125046|79332690|FG000|First 6 Months of Treatment|Non-compliance|1|||
44327791|NCT01125046|79332690|FG000|First 6 Months of Treatment|Surgery|1|||
44327792|NCT01125046|79332690|FG000|First 6 Months of Treatment|Progressive Disease|7|||
44327793|NCT01125046|79332690|FG000|First 6 Months of Treatment|Adverse Event|2|||
44327794|NCT01125046|79332690|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
44327795|NCT01125046|79332690|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
44327796|NCT01125046|79332690|FG000|Follow-up/Data Cut Off Point|Death|29|||
44327797|NCT01125046|79332690|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
44327798|NCT01124734|79332694|FG000|Overall Study|Disease progression|13|||
44327799|NCT01124734|79332694|FG000|Overall Study|Adverse Event|1|||
44327800|NCT01124734|79332694|FG000|Overall Study|Withdrawal by Subject|1|||
44327801|NCT01124734|79332694|FG000|Overall Study|Elected for alternative treatment|2|||
44327802|NCT01124617|79332705|FG000|Overall Study|Adverse Event|5|||
44327803|NCT01124617|79332706|FG001|Overall Study|Adverse Event|2|||
44327804|NCT01124617|79332705|FG000|Overall Study|Lack of Efficacy|2|||
44327805|NCT01124617|79332706|FG001|Overall Study|Lack of Efficacy|1|||
44327806|NCT01124617|79332705|FG000|Overall Study|Protocol Violation|1|||
44327807|NCT01124617|79332706|FG001|Overall Study|Protocol Violation|1|||
44327808|NCT01124617|79332705|FG000|Overall Study|Withdrawal by Subject|9|||
44327809|NCT01124617|79332706|FG001|Overall Study|Withdrawal by Subject|1|||
44327810|NCT01124617|79332705|FG000|Overall Study|Other|2|||
44327811|NCT01124617|79332706|FG001|Overall Study|Other|1|||
44327812|NCT01124422|79332714|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
44327813|NCT01124422|79332715|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
44327814|NCT01124422|79332716|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
44327815|NCT01124422|79332714|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
44327816|NCT01124422|79332715|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
44327817|NCT01124422|79332716|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
44327818|NCT01124422|79332714|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
44327819|NCT01124422|79332715|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
44327820|NCT01124422|79332716|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
44424460|NCT00776009|79432562|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
44424461|NCT00776009|79432563|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
44424462|NCT00776009|79432564|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
44537170|NCT03524157|79547828|FG001|Overall Study|cytology not readable|0|||
44537171|NCT03524157|79547829|FG002|Overall Study|cytology not readable|1|||
44156698|NCT05062759|78947957|FG000|Overall Study|Death|0|||
44327821|NCT01124422|79332714|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
44327822|NCT01124422|79332715|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
44327823|NCT01124422|79332716|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
44327824|NCT01124422|79332714|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
44327825|NCT01124422|79332715|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
44327826|NCT01124422|79332716|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
44327827|NCT01124422|79332714|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
44327828|NCT01124422|79332715|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
44327829|NCT01124422|79332716|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
44327830|NCT01124422|79332714|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
44327831|NCT01124422|79332715|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
44327832|NCT01124422|79332716|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
44327833|NCT01124422|79332714|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
44327834|NCT01124422|79332715|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
44327835|NCT01124422|79332716|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
44327836|NCT01124422|79332714|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
44327837|NCT01124422|79332715|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
44327838|NCT01124422|79332716|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
44327839|NCT01124422|79332714|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
44327840|NCT01124422|79332715|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
44327841|NCT01124422|79332716|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
44537172|NCT03437733|79547843|FG000|Overall Study|Eligibility criteria not met|0|||
44327842|NCT01124149|79332723|FG000|Acute Phase|Withdrawal by Subject|22|||
44327843|NCT01124149|79332723|FG000|Acute Phase|Adverse Event|21|||
44327844|NCT01124149|79332723|FG000|Acute Phase|Lack of Efficacy|17|||
44327845|NCT01124149|79332723|FG000|Acute Phase|Protocol Violation|14|||
44327846|NCT01124149|79332723|FG000|Acute Phase|Lost to Follow-up|2|||
44327847|NCT01124149|79332723|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
44327848|NCT01124149|79332723|FG000|Acute Phase|Sponsor request|1|||
44327849|NCT01124149|79332723|FG000|Acute Phase|UC symptoms not ameliorated|1|||
44327850|NCT01124149|79332723|FG000|Acute Phase|Non-compliance|1|||
44327851|NCT01124149|79332723|FG000|Acute Phase|Low hemoglobin|1|||
44327852|NCT01124149|79332723|FG000|Acute Phase|Travelling to another country|1|||
44327853|NCT01124149|79332723|FG000|Acute Phase|Sponsor decision|1|||
44327854|NCT01124149|79332723|FG000|Maintenance Phase|Lack of Efficacy|40|||
44327855|NCT01124149|79332723|FG000|Maintenance Phase|Adverse Event|24|||
44424463|NCT00776009|79432559|FG000|Period 1: First Intervention|Protocol Violation|0|||
44424464|NCT00776009|79432560|FG001|Period 1: First Intervention|Protocol Violation|1|||
44424465|NCT00776009|79432561|FG002|Period 1: First Intervention|Protocol Violation|0|||
44424466|NCT00776009|79432562|FG003|Period 1: First Intervention|Protocol Violation|0|||
44424467|NCT00776009|79432563|FG004|Period 1: First Intervention|Protocol Violation|1|||
44424468|NCT00776009|79432564|FG005|Period 1: First Intervention|Protocol Violation|0|||
44424469|NCT00776009|79432559|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
44424470|NCT00776009|79432560|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
44424471|NCT00776009|79432561|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
44424472|NCT00776009|79432562|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
44424473|NCT00776009|79432563|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
44424474|NCT00776009|79432564|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
44424475|NCT00776009|79432559|FG000|Period 2: Second Intervention|Protocol Violation|1|||
44424476|NCT00776009|79432560|FG001|Period 2: Second Intervention|Protocol Violation|0|||
44424477|NCT00776009|79432561|FG002|Period 2: Second Intervention|Protocol Violation|1|||
44424478|NCT00776009|79432562|FG003|Period 2: Second Intervention|Protocol Violation|0|||
44424479|NCT00776009|79432563|FG004|Period 2: Second Intervention|Protocol Violation|0|||
44424480|NCT00776009|79432564|FG005|Period 2: Second Intervention|Protocol Violation|0|||
44258559|NCT03253796|79113655|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
44258560|NCT03253796|79113656|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
44258561|NCT03253796|79113657|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
44258562|NCT03253796|79113658|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
44258563|NCT03253796|79113654|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
44258564|NCT03253796|79113655|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
44258565|NCT03253796|79113656|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
44258566|NCT03253796|79113657|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
44258567|NCT03253796|79113658|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
44258568|NCT03073733|79113676|FG000|Overall Study|Lost to Follow-up|1|||
44258569|NCT03073733|79113677|FG001|Overall Study|Lost to Follow-up|0|||
44258570|NCT03073733|79113678|FG002|Overall Study|Lost to Follow-up|0|||
44258571|NCT03073733|79113676|FG000|Overall Study|Physician Decision|0|||
44258572|NCT03073733|79113677|FG001|Overall Study|Physician Decision|1|||
44258573|NCT03073733|79113678|FG002|Overall Study|Physician Decision|0|||
44258574|NCT03073733|79113676|FG000|Overall Study|Withdrawal by Subject|0|||
44258575|NCT03073733|79113677|FG001|Overall Study|Withdrawal by Subject|0|||
44258576|NCT03073733|79113678|FG002|Overall Study|Withdrawal by Subject|1|||
44258577|NCT03029143|79113688|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
44258578|NCT03029143|79113689|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
44258579|NCT03029143|79113690|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
44258580|NCT03029143|79113688|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
44258581|NCT03029143|79113689|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
44258582|NCT03029143|79113690|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
44258583|NCT03029143|79113688|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
44258584|NCT03029143|79113689|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
44258585|NCT03029143|79113690|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
44258586|NCT03029143|79113688|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
44258587|NCT03029143|79113689|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
44258588|NCT03029143|79113690|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
44258589|NCT03029143|79113688|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
44258590|NCT03029143|79113689|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
44258591|NCT03029143|79113690|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
44258592|NCT03029143|79113688|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
44258593|NCT03029143|79113689|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
44327856|NCT01124149|79332723|FG000|Maintenance Phase|Lost to Follow-up|15|||
44424481|NCT00776009|79432559|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
44424482|NCT00776009|79432560|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
44424483|NCT00776009|79432561|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
44424484|NCT00776009|79432562|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
44424485|NCT00776009|79432563|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
44424486|NCT00776009|79432564|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
44424487|NCT00694161|79432572|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
44424488|NCT00694161|79432572|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
44424489|NCT00694161|79432572|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
44424490|NCT00720356|79432576|FG000|Registration to Study|Determined to have methylated MGMT|67|||
44424491|NCT00720356|79432576|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
44424492|NCT00720356|79432576|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
44424493|NCT00720356|79432576|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
44424494|NCT00720356|79432576|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
44424495|NCT00720356|79432576|FG000|Follow up Until Death|Withdrawal by Subject|1|||
44424496|NCT00720356|79432576|FG000|Follow up Until Death|Alive at last data collection|4|||
44424497|NCT00720278|79432583|FG000|Overall Study|Adverse Event|5|||
44424498|NCT00720278|79432584|FG001|Overall Study|Adverse Event|3|||
44424499|NCT00720278|79432585|FG002|Overall Study|Adverse Event|4|||
44424500|NCT00720278|79432583|FG000|Overall Study|Withdrawal by Subject|0|||
44424501|NCT00720278|79432584|FG001|Overall Study|Withdrawal by Subject|1|||
44424502|NCT00720278|79432585|FG002|Overall Study|Withdrawal by Subject|0|||
44424503|NCT00720278|79432583|FG000|Overall Study|Lost to Follow-up|0|||
44424504|NCT00720278|79432584|FG001|Overall Study|Lost to Follow-up|0|||
44424505|NCT00720278|79432585|FG002|Overall Study|Lost to Follow-up|1|||
44424506|NCT00720278|79432583|FG000|Overall Study|Non-compliance|1|||
44424507|NCT00720278|79432584|FG001|Overall Study|Non-compliance|0|||
44424508|NCT00720278|79432585|FG002|Overall Study|Non-compliance|0|||
44424509|NCT00720278|79432583|FG000|Overall Study|eligibility criteria violation|1|||
44424510|NCT00720278|79432584|FG001|Overall Study|eligibility criteria violation|0|||
44424511|NCT00720278|79432585|FG002|Overall Study|eligibility criteria violation|1|||
44424512|NCT00720122|79432593|FG000|Overall Study|Lost to Follow-up|1|||
44327857|NCT01124149|79332723|FG000|Maintenance Phase|Withdrawal by Subject|10|||
44424513|NCT00720122|79432593|FG000|Overall Study|Physician Decision|1|||
44424514|NCT00720122|79432593|FG000|Overall Study|Withdrawal by Subject|7|||
44424515|NCT00717860|79432599|FG000|Overall Study|Clinical adverse experience|5|||
44537173|NCT03437733|79547844|FG001|Overall Study|Eligibility criteria not met|3|||
44537174|NCT03468543|79547852|FG000|Overall Study|Protocol stopping rules met|3|||
44537175|NCT03467763|79547856|FG000|Overall Study|Lost to Follow-up|1|||
44537176|NCT03467763|79547856|FG000|Overall Study|Protocol Violation|2|||
44537177|NCT00004031|79547864|FG000|Overall Study|Adverse Event|5|||
44537178|NCT00004031|79547865|FG001|Overall Study|Adverse Event|0|||
44537179|NCT00004031|79547864|FG000|Overall Study|Refusal unrelated to adverse events|2|||
44537180|NCT00004031|79547865|FG001|Overall Study|Refusal unrelated to adverse events|11|||
44537181|NCT00004031|79547864|FG000|Overall Study|Progression/relapse|9|||
44537182|NCT00004031|79547865|FG001|Overall Study|Progression/relapse|4|||
44258594|NCT03029143|79113690|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
44258595|NCT03029143|79113688|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
44258596|NCT03029143|79113689|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
44258597|NCT03029143|79113690|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
44258598|NCT03029143|79113688|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44258599|NCT03029143|79113689|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
44258600|NCT03029143|79113690|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
44258601|NCT03029143|79113688|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
44327858|NCT01124149|79332723|FG000|Maintenance Phase|Protocol Violation|5|||
44327859|NCT01124149|79332723|FG000|Maintenance Phase|Coordinator error|1|||
44327860|NCT01124149|79332723|FG000|Maintenance Phase|Non-compliance|1|||
44327861|NCT01123642|79332730|FG000|Overall Study|Lost to Follow-up|23|||
44327862|NCT01123642|79332730|FG000|Overall Study|Withdrawal by Subject|9|||
44327863|NCT01123642|79332730|FG000|Overall Study|ineligible at baseline assessment|36|||
44327864|NCT01122862|79332735|FG000|Period 1|Protocol Violation|0|||
44327865|NCT01122862|79332736|FG001|Period 1|Protocol Violation|1|||
44327866|NCT01122862|79332737|FG002|Period 1|Protocol Violation|0|||
44327867|NCT01122862|79332735|FG000|Period 2|Adverse Event|0|||
44327868|NCT01122862|79332736|FG001|Period 2|Adverse Event|0|||
44327869|NCT01122862|79332737|FG002|Period 2|Adverse Event|1|||
44327870|NCT01122394|79332748|FG000|Overall Study|Withdrawal by Subject|1|||
44424516|NCT00717860|79432600|FG001|Overall Study|Clinical adverse experience|9|||
44424517|NCT00717860|79432599|FG000|Overall Study|Laboratory adverse experience|2|||
44424518|NCT00717860|79432600|FG001|Overall Study|Laboratory adverse experience|2|||
44424519|NCT00717860|79432599|FG000|Overall Study|Lack of Efficacy|7|||
44424520|NCT00717860|79432600|FG001|Overall Study|Lack of Efficacy|13|||
44424521|NCT00717860|79432599|FG000|Overall Study|Discontinued for other reason|6|||
44424522|NCT00717860|79432600|FG001|Overall Study|Discontinued for other reason|1|||
44327871|NCT01122394|79332749|FG001|Overall Study|Withdrawal by Subject|1|||
44327872|NCT01122394|79332748|FG000|Overall Study|Lost to Follow-up|2|||
44327873|NCT01122394|79332749|FG001|Overall Study|Lost to Follow-up|2|||
44327874|NCT01122394|79332748|FG000|Overall Study|Adverse Event|0|||
44327875|NCT01122394|79332749|FG001|Overall Study|Adverse Event|1|||
44327876|NCT01121926|79332757|FG000|First Intervention Period|Adverse Event|1|||
44327877|NCT01121926|79332758|FG001|First Intervention Period|Adverse Event|0|||
44327878|NCT01121926|79332757|FG000|Washout Period|Adverse Event|0|||
44327879|NCT01121926|79332758|FG001|Washout Period|Adverse Event|1|||
44327880|NCT01121926|79332757|FG000|Washout Period|Positive pregnancy test|0|||
44327881|NCT01121926|79332758|FG001|Washout Period|Positive pregnancy test|1|||
44327882|NCT01121575|79332779|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
44327883|NCT01121575|79332780|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
44327884|NCT01121575|79332781|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
44327885|NCT01121575|79332782|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
44327886|NCT01121575|79332783|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
44327887|NCT01121575|79332784|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
44327888|NCT01121575|79332779|FG000|Overall Study|Unspecified Reasons|8|||
44327889|NCT01121575|79332780|FG001|Overall Study|Unspecified Reasons|6|||
44327890|NCT01121575|79332781|FG002|Overall Study|Unspecified Reasons|7|||
44327891|NCT01121575|79332782|FG003|Overall Study|Unspecified Reasons|5|||
44327892|NCT01121575|79332783|FG004|Overall Study|Unspecified Reasons|13|||
44327893|NCT01121575|79332784|FG005|Overall Study|Unspecified Reasons|10|||
44327894|NCT01121575|79332779|FG000|Overall Study|Death|6|||
44424523|NCT00717860|79432599|FG000|Overall Study|Withdrew consent|7|||
44424524|NCT00717860|79432600|FG001|Overall Study|Withdrew consent|3|||
44424525|NCT00717314|79432608|FG000|Overall Study|Adverse Event|3|||
44424526|NCT00717314|79432609|FG001|Overall Study|Adverse Event|2|||
44424527|NCT00717314|79432608|FG000|Overall Study|Protocol Violation|1|||
44424528|NCT00717314|79432609|FG001|Overall Study|Protocol Violation|0|||
44424529|NCT00717314|79432608|FG000|Overall Study|Lost to Follow-up|1|||
44424530|NCT00717314|79432609|FG001|Overall Study|Lost to Follow-up|5|||
44424531|NCT00717314|79432608|FG000|Overall Study|Withdrawal by Subject|1|||
44424532|NCT00717314|79432609|FG001|Overall Study|Withdrawal by Subject|3|||
44424533|NCT00689793|79432617|FG000|Overall Study|Lost to Follow-up|4|||
44424534|NCT00689793|79432618|FG001|Overall Study|Lost to Follow-up|5|||
44424535|NCT00723944|79432628|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
44424536|NCT00723944|79432629|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
44424537|NCT00723944|79432628|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
44424538|NCT00723944|79432629|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
44424539|NCT00723944|79432628|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
44327895|NCT01121575|79332780|FG001|Overall Study|Death|0|||
44327896|NCT01121575|79332781|FG002|Overall Study|Death|0|||
44327897|NCT01121575|79332782|FG003|Overall Study|Death|1|||
44327898|NCT01121575|79332783|FG004|Overall Study|Death|7|||
44327899|NCT01121575|79332784|FG005|Overall Study|Death|1|||
44327900|NCT01121536|79332807|FG000|Overall Study|Adverse Event|63|||
44424540|NCT00723944|79432629|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
44424541|NCT00689481|79432637|FG000|Overall Study|Adverse Event|7|||
44537183|NCT00004031|79547864|FG000|Overall Study|Death|3|||
44537184|NCT00004031|79547865|FG001|Overall Study|Death|1|||
44537185|NCT00004031|79547864|FG000|Overall Study|Other- not protocol specified|3|||
44537186|NCT00004031|79547865|FG001|Overall Study|Other- not protocol specified|3|||
44424542|NCT00689481|79432638|FG001|Overall Study|Adverse Event|1|||
44537187|NCT00004031|79547864|FG000|Overall Study|Reason under review|3|||
44537188|NCT00004031|79547865|FG001|Overall Study|Reason under review|2|||
44537189|NCT03467217|79547875|FG000|Overall Study|Trial stopped early|5|||
44537190|NCT03467217|79547876|FG001|Overall Study|Trial stopped early|2|||
44537191|NCT03467217|79547875|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
44537192|NCT03467217|79547876|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
44537193|NCT03467217|79547875|FG000|Overall Study|Lost to Follow-up|0|||
44327901|NCT01121536|79332807|FG000|Overall Study|Lack of Efficacy|35|||
44327902|NCT01121536|79332807|FG000|Overall Study|Withdrawal by Subject|65|||
44327903|NCT01121536|79332807|FG000|Overall Study|Protocol Violation|20|||
44327904|NCT01121536|79332807|FG000|Overall Study|Noncompliance with study medication|12|||
44424543|NCT00689481|79432637|FG000|Overall Study|Lost to Follow-up|4|||
44424544|NCT00689481|79432638|FG001|Overall Study|Lost to Follow-up|3|||
44424545|NCT00689481|79432637|FG000|Overall Study|Lack of Efficacy|4|||
44424546|NCT00689481|79432638|FG001|Overall Study|Lack of Efficacy|3|||
44424547|NCT00689481|79432637|FG000|Overall Study|Non-compliance with study treatment|1|||
44424548|NCT00689481|79432638|FG001|Overall Study|Non-compliance with study treatment|1|||
44424549|NCT00689481|79432637|FG000|Overall Study|Withdrawal by Subject|8|||
44424550|NCT00689481|79432638|FG001|Overall Study|Withdrawal by Subject|4|||
44424551|NCT00689481|79432637|FG000|Overall Study|Excluded medication started during study|0|||
44424552|NCT00689481|79432638|FG001|Overall Study|Excluded medication started during study|1|||
44424553|NCT00689481|79432637|FG000|Overall Study|Subject early term, left on vacation|0|||
44424554|NCT00689481|79432638|FG001|Overall Study|Subject early term, left on vacation|1|||
44424555|NCT00688701|79432647|FG000|Overall Study|Adverse Event|1|||
44424556|NCT00688701|79432648|FG001|Overall Study|Adverse Event|0|||
44424557|NCT00688701|79432649|FG002|Overall Study|Adverse Event|5|||
44424558|NCT00688701|79432650|FG003|Overall Study|Adverse Event|3|||
44424559|NCT00688701|79432647|FG000|Overall Study|Lack of Efficacy|0|||
44424560|NCT00688701|79432648|FG001|Overall Study|Lack of Efficacy|1|||
44327905|NCT01121536|79332807|FG000|Overall Study|Noncompliance with study procedures|9|||
44424561|NCT00688701|79432649|FG002|Overall Study|Lack of Efficacy|0|||
44424562|NCT00688701|79432650|FG003|Overall Study|Lack of Efficacy|0|||
44424563|NCT00688701|79432647|FG000|Overall Study|Withdrawal by Subject|3|||
44424564|NCT00688701|79432648|FG001|Overall Study|Withdrawal by Subject|3|||
44424565|NCT00688701|79432649|FG002|Overall Study|Withdrawal by Subject|4|||
44424566|NCT00688701|79432650|FG003|Overall Study|Withdrawal by Subject|8|||
44424567|NCT00688701|79432647|FG000|Overall Study|Poor compliance to protocol|0|||
44424568|NCT00688701|79432648|FG001|Overall Study|Poor compliance to protocol|1|||
44424569|NCT00688701|79432649|FG002|Overall Study|Poor compliance to protocol|1|||
44424570|NCT00688701|79432650|FG003|Overall Study|Poor compliance to protocol|0|||
44424571|NCT00688623|79432670|FG000|Overall Study|Adverse Event|22|||
44424572|NCT00688623|79432670|FG000|Overall Study|abnormal lab value|1|||
44424573|NCT00688623|79432670|FG000|Overall Study|Withdrawal by Subject|4|||
44424574|NCT00688623|79432670|FG000|Overall Study|Death|3|||
44424575|NCT00688623|79432670|FG000|Overall Study|disease progression|23|||
44424576|NCT00688623|79432670|FG000|Overall Study|Protocol Violation|2|||
44424577|NCT00717236|79432676|FG000|Double-Blind Period|Adverse Event|33|||
44424578|NCT00717236|79432677|FG001|Double-Blind Period|Adverse Event|6|||
44424579|NCT00717236|79432676|FG000|Double-Blind Period|Lack of Efficacy|6|||
44537194|NCT03467217|79547876|FG001|Overall Study|Lost to Follow-up|2|||
44537195|NCT00003875|79547882|FG000|Overall Study|Screen Failed|1|||
44327906|NCT01121536|79332807|FG000|Overall Study|Lost to Follow-up|39|||
44327907|NCT01121536|79332807|FG000|Overall Study|Other|118|||
44327908|NCT01121263|79332813|FG000|Overall Study|Death|3|||
44327909|NCT01121263|79332814|FG001|Overall Study|Death|2|||
44327910|NCT01121263|79332813|FG000|Overall Study|Lost to Follow-up|22|||
44327911|NCT01121263|79332814|FG001|Overall Study|Lost to Follow-up|12|||
44327912|NCT01121263|79332813|FG000|Overall Study|Withdrawal by Subject|0|||
44327913|NCT01121263|79332814|FG001|Overall Study|Withdrawal by Subject|1|||
44327914|NCT01121185|79332824|FG000|Overall Study|Not infused|0|||
44327915|NCT01121185|79332825|FG001|Overall Study|Not infused|1|||
44327916|NCT01121185|79332824|FG000|Overall Study|Not transplanted|1|||
44327917|NCT01121185|79332825|FG001|Overall Study|Not transplanted|0|||
44327918|NCT01121146|79332833|FG000|Overall Study|Death|17|||
44327919|NCT01121146|79332834|FG001|Overall Study|Death|15|||
44327920|NCT01121146|79332833|FG000|Overall Study|Adverse Event|2|||
44424580|NCT00717236|79432677|FG001|Double-Blind Period|Lack of Efficacy|6|||
44537196|NCT03364686|79547886|FG000|Overall Study|Physician Decision|2|||
44537197|NCT03437577|79547893|FG000|Pre-Randomization|Withdrawal by Subject|0|||
44537198|NCT03437577|79547894|FG001|Pre-Randomization|Withdrawal by Subject|0|||
44537199|NCT03437577|79547895|FG002|Pre-Randomization|Withdrawal by Subject|10|||
44327921|NCT01121146|79332834|FG001|Overall Study|Adverse Event|11|||
44327922|NCT01121146|79332833|FG000|Overall Study|Lost to Follow-up|7|||
44327923|NCT01121146|79332834|FG001|Overall Study|Lost to Follow-up|16|||
44327924|NCT01120756|79332843|FG000|Overall Study|Withdrawal by Subject|1|||
44424581|NCT00717236|79432676|FG000|Double-Blind Period|Lost to Follow-up|3|||
44424582|NCT00717236|79432677|FG001|Double-Blind Period|Lost to Follow-up|5|||
44424583|NCT00717236|79432676|FG000|Double-Blind Period|Withdrawal by Subject|10|||
44424584|NCT00717236|79432677|FG001|Double-Blind Period|Withdrawal by Subject|2|||
44424585|NCT00717236|79432676|FG000|Double-Blind Period|Loss of efficacy|3|||
44424586|NCT00717236|79432677|FG001|Double-Blind Period|Loss of efficacy|0|||
44424587|NCT00717236|79432676|FG000|Double-Blind Period|Other: Death|1|||
44424588|NCT00717236|79432677|FG001|Double-Blind Period|Other: Death|0|||
44424589|NCT00717236|79432676|FG000|Double-Blind Period|Other: Pregnancy|1|||
44424590|NCT00717236|79432677|FG001|Double-Blind Period|Other: Pregnancy|0|||
44424591|NCT00717236|79432676|FG000|Double-Blind Period|Other: Protocol Violation|2|||
44424592|NCT00717236|79432677|FG001|Double-Blind Period|Other: Protocol Violation|0|||
44424593|NCT00717236|79432676|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
44424594|NCT00717236|79432677|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
44424595|NCT00717236|79432676|FG000|Double-Blind Period|Other: Site withdrew|2|||
44424596|NCT00717236|79432677|FG001|Double-Blind Period|Other: Site withdrew|0|||
44424597|NCT00717236|79432676|FG000|Double-Blind Period|Other: Screening failure|1|||
44424598|NCT00717236|79432677|FG001|Double-Blind Period|Other: Screening failure|0|||
44424599|NCT00717236|79432676|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
44424600|NCT00717236|79432677|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
44424601|NCT00717236|79432676|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
44424602|NCT00717236|79432677|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
44424603|NCT00717236|79432676|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
44424604|NCT00717236|79432677|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
44424605|NCT00717236|79432676|FG000|Double-Blind Period|Other: History of cancer|1|||
44424606|NCT00717236|79432677|FG001|Double-Blind Period|Other: History of cancer|0|||
44424607|NCT00717236|79432676|FG000|Double-Blind Period|Other: Sponsor request|1|||
44537200|NCT03437577|79547893|FG000|Post-Randomization|Physician Decision|0|||
44327925|NCT01120756|79332844|FG001|Overall Study|Withdrawal by Subject|1|||
44327926|NCT01120717|79332852|FG000|Overall Study|Withdrawal by Subject|11|||
44327927|NCT01120717|79332853|FG001|Overall Study|Withdrawal by Subject|6|||
44327928|NCT01120717|79332852|FG000|Overall Study|Adverse Event|10|||
44327929|NCT01120717|79332853|FG001|Overall Study|Adverse Event|6|||
44327930|NCT01120717|79332852|FG000|Overall Study|Protocol Deviation|2|||
44327931|NCT01120717|79332853|FG001|Overall Study|Protocol Deviation|5|||
44327932|NCT01120717|79332852|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44327933|NCT01120717|79332853|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44327934|NCT01120717|79332852|FG000|Overall Study|Lost to Follow-up|2|||
44327935|NCT01120717|79332853|FG001|Overall Study|Lost to Follow-up|3|||
44327936|NCT01120717|79332852|FG000|Overall Study|Death|3|||
44327937|NCT01120717|79332853|FG001|Overall Study|Death|1|||
44327938|NCT01120717|79332852|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
44327939|NCT01120717|79332853|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
44327940|NCT01120600|79332861|FG000|Overall Study|Adverse Event|7|||
44327941|NCT01120600|79332862|FG001|Overall Study|Adverse Event|7|||
44327942|NCT01120600|79332861|FG000|Overall Study|Excessive Bone Loss|0|||
44327943|NCT01120600|79332862|FG001|Overall Study|Excessive Bone Loss|4|||
44327944|NCT01120600|79332861|FG000|Overall Study|Lost to Follow-up|1|||
44327945|NCT01120600|79332862|FG001|Overall Study|Lost to Follow-up|3|||
44327946|NCT01120600|79332861|FG000|Overall Study|Physician Decision|1|||
44327947|NCT01120600|79332862|FG001|Overall Study|Physician Decision|3|||
44327948|NCT01120600|79332861|FG000|Overall Study|Protocol Violation|0|||
44327949|NCT01120600|79332862|FG001|Overall Study|Protocol Violation|4|||
44327950|NCT01120600|79332861|FG000|Overall Study|Withdrawal by Subject|10|||
44327951|NCT01120600|79332862|FG001|Overall Study|Withdrawal by Subject|11|||
44327952|NCT01120210|79332870|FG000|MAIN INFUSION|Adverse Event|1|||
44327953|NCT01120210|79332871|FG001|MAIN INFUSION|Adverse Event|0|||
44327954|NCT01120210|79332870|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
44327955|NCT01120210|79332871|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
44327956|NCT01120093|79332877|FG000|Treatment Period 1|Adverse Event|0|||
44327957|NCT01120093|79332878|FG001|Treatment Period 1|Adverse Event|0|||
44327958|NCT01120093|79332879|FG002|Treatment Period 1|Adverse Event|1|||
44327959|NCT01120093|79332880|FG003|Treatment Period 1|Adverse Event|0|||
44327960|NCT01120093|79332881|FG004|Treatment Period 1|Adverse Event|1|||
44327961|NCT01120093|79332877|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44327962|NCT01120093|79332878|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44327963|NCT01120093|79332879|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44327964|NCT01120093|79332880|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44327965|NCT01120093|79332881|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44327966|NCT01120093|79332877|FG000|Treatment Period 2|Adverse Event|0|||
44424608|NCT00717236|79432677|FG001|Double-Blind Period|Other: Sponsor request|0|||
44424609|NCT00717236|79432676|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
44424610|NCT00717236|79432677|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
44424611|NCT00717236|79432676|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
44424612|NCT00717236|79432677|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
44537201|NCT03437577|79547894|FG001|Post-Randomization|Physician Decision|2|||
44537202|NCT03437577|79547895|FG002|Post-Randomization|Physician Decision|0|||
44537203|NCT03336528|79547903|FG000|Overall Study|Protocol Violation|1|||
44156699|NCT05062759|78947958|FG001|Overall Study|Death|1|||
44327967|NCT01120093|79332878|FG001|Treatment Period 2|Adverse Event|0|||
44327968|NCT01120093|79332879|FG002|Treatment Period 2|Adverse Event|0|||
44327969|NCT01120093|79332880|FG003|Treatment Period 2|Adverse Event|1|||
44327970|NCT01120093|79332881|FG004|Treatment Period 2|Adverse Event|0|||
44424613|NCT00717236|79432676|FG000|Double-Blind Period|Other: Subject moved|1|||
44424614|NCT00717236|79432677|FG001|Double-Blind Period|Other: Subject moved|1|||
44327971|NCT01120093|79332877|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44424615|NCT00717236|79432676|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
44424616|NCT00717236|79432677|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
44424617|NCT00717236|79432676|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
44424618|NCT00717236|79432677|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
44327972|NCT01120093|79332878|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44327973|NCT01120093|79332879|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44327974|NCT01120093|79332880|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44327975|NCT01120093|79332881|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44327976|NCT01120093|79332877|FG000|Treatment Period 3|Lack of Efficacy|0|||
44327977|NCT01120093|79332878|FG001|Treatment Period 3|Lack of Efficacy|0|||
44327978|NCT01120093|79332879|FG002|Treatment Period 3|Lack of Efficacy|0|||
44327979|NCT01120093|79332880|FG003|Treatment Period 3|Lack of Efficacy|1|||
44327980|NCT01120093|79332881|FG004|Treatment Period 3|Lack of Efficacy|0|||
44327981|NCT01120093|79332877|FG000|Treatment Period 3|Adverse Event|0|||
44327982|NCT01120093|79332878|FG001|Treatment Period 3|Adverse Event|0|||
44327983|NCT01120093|79332879|FG002|Treatment Period 3|Adverse Event|0|||
44327984|NCT01120093|79332880|FG003|Treatment Period 3|Adverse Event|0|||
44327985|NCT01120093|79332881|FG004|Treatment Period 3|Adverse Event|1|||
44327986|NCT01120093|79332877|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44327987|NCT01120093|79332878|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44327988|NCT01120093|79332879|FG002|Treatment Period 3|Withdrawal by Subject|1|||
44327989|NCT01120093|79332880|FG003|Treatment Period 3|Withdrawal by Subject|0|||
44327990|NCT01120093|79332881|FG004|Treatment Period 3|Withdrawal by Subject|0|||
44327991|NCT01120093|79332877|FG000|Treatment Period 4|Adverse Event|1|||
44327992|NCT01120093|79332878|FG001|Treatment Period 4|Adverse Event|0|||
44327993|NCT01120093|79332879|FG002|Treatment Period 4|Adverse Event|0|||
44327994|NCT01120093|79332880|FG003|Treatment Period 4|Adverse Event|0|||
44424619|NCT00717236|79432676|FG000|Double-Blind Period|Other: Transportation problems|0|||
44424620|NCT00717236|79432677|FG001|Double-Blind Period|Other: Transportation problems|1|||
44424621|NCT00717236|79432676|FG000|Double-Blind Period|Other: Investigator Decision|0|||
44424622|NCT00717236|79432677|FG001|Double-Blind Period|Other: Investigator Decision|1|||
44424623|NCT00717236|79432676|FG000|Open-Label Period|Adverse Event|29|||
44424624|NCT00717236|79432677|FG001|Open-Label Period|Adverse Event|4|||
44424625|NCT00717236|79432676|FG000|Open-Label Period|Lack of Efficacy|30|||
44424626|NCT00717236|79432677|FG001|Open-Label Period|Lack of Efficacy|8|||
44424627|NCT00717236|79432676|FG000|Open-Label Period|Lost to Follow-up|28|||
44424628|NCT00717236|79432677|FG001|Open-Label Period|Lost to Follow-up|4|||
44424629|NCT00717236|79432676|FG000|Open-Label Period|Withdrawal by Subject|20|||
44424630|NCT00717236|79432677|FG001|Open-Label Period|Withdrawal by Subject|2|||
44424631|NCT00717236|79432676|FG000|Open-Label Period|Loss of Efficacy|6|||
44424632|NCT00717236|79432677|FG001|Open-Label Period|Loss of Efficacy|1|||
44424633|NCT00717236|79432676|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
44424634|NCT00717236|79432677|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
44537204|NCT03336528|79547904|FG001|Overall Study|Protocol Violation|1|||
44156700|NCT05062759|78947957|FG000|Overall Study|Lost to Follow-up|1|||
44156701|NCT05062759|78947958|FG001|Overall Study|Lost to Follow-up|0|||
44156702|NCT05033262|78947977|FG000|Overall Study|Lost to Follow-up|1|||
44327995|NCT01120093|79332881|FG004|Treatment Period 4|Adverse Event|0|||
44327996|NCT01120093|79332877|FG000|Treatment Period 5|Adverse Event|0|||
44327997|NCT01120093|79332878|FG001|Treatment Period 5|Adverse Event|1|||
44327998|NCT01120093|79332879|FG002|Treatment Period 5|Adverse Event|0|||
44327999|NCT01120093|79332880|FG003|Treatment Period 5|Adverse Event|1|||
44328000|NCT01120093|79332881|FG004|Treatment Period 5|Adverse Event|0|||
44328001|NCT01119937|79332895|FG000|Overall Study|Adverse Event|11|||
44328002|NCT01119937|79332896|FG001|Overall Study|Adverse Event|5|||
44328003|NCT01119937|79332895|FG000|Overall Study|Protocol deviation|3|||
44328004|NCT01119937|79332896|FG001|Overall Study|Protocol deviation|1|||
44328005|NCT01119937|79332895|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
44328006|NCT01119937|79332896|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44328007|NCT01119937|79332895|FG000|Overall Study|Withdrawal by Subject|2|||
44328008|NCT01119937|79332896|FG001|Overall Study|Withdrawal by Subject|1|||
44328009|NCT01119898|79332904|FG000|Overall Study|Adverse Event|4|||
44328010|NCT01119898|79332905|FG001|Overall Study|Adverse Event|5|||
44328011|NCT01119898|79332904|FG000|Overall Study|Withdrawal by Subject|1|||
44328012|NCT01119898|79332905|FG001|Overall Study|Withdrawal by Subject|4|||
44328013|NCT01119898|79332904|FG000|Overall Study|Lack of Efficacy|0|||
44328014|NCT01119898|79332905|FG001|Overall Study|Lack of Efficacy|2|||
44424635|NCT00717236|79432676|FG000|Open-Label Period|Other: Lack of Compliance|1|||
44424636|NCT00717236|79432677|FG001|Open-Label Period|Other: Lack of Compliance|1|||
44424637|NCT00717236|79432676|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
44424638|NCT00717236|79432677|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
44424639|NCT00717236|79432676|FG000|Open-Label Period|Other: Moved|1|||
44424640|NCT00717236|79432677|FG001|Open-Label Period|Other: Moved|0|||
44424641|NCT00717236|79432676|FG000|Open-Label Period|Other: Investigator Decision|1|||
44424642|NCT00717236|79432677|FG001|Open-Label Period|Other: Investigator Decision|0|||
44424643|NCT00717236|79432676|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
44424644|NCT00717236|79432677|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
44424645|NCT00717236|79432676|FG000|Open-Label Period|Other: Sponsor Request|3|||
44424646|NCT00717236|79432677|FG001|Open-Label Period|Other: Sponsor Request|0|||
44424647|NCT00717236|79432676|FG000|Open-Label Period|Other: Cataract Surgery|1|||
44424648|NCT00717236|79432677|FG001|Open-Label Period|Other: Cataract Surgery|0|||
44424649|NCT00717236|79432676|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
44328015|NCT01119898|79332904|FG000|Overall Study|Protocol Violation|1|||
44328016|NCT01119898|79332905|FG001|Overall Study|Protocol Violation|1|||
44328017|NCT01119898|79332904|FG000|Overall Study|Medical procedure|1|||
44328018|NCT01119898|79332905|FG001|Overall Study|Medical procedure|0|||
44328019|NCT01119898|79332904|FG000|Overall Study|Randomized in error did not participate|1|||
44328020|NCT01119898|79332905|FG001|Overall Study|Randomized in error did not participate|0|||
44328021|NCT01119859|79332913|FG000|Overall Study|Adverse Event|9|||
44328022|NCT01119859|79332914|FG001|Overall Study|Adverse Event|10|||
44424650|NCT00717236|79432677|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
44424651|NCT00717236|79432676|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
44424652|NCT00717236|79432677|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
44424653|NCT00717236|79432676|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
44424654|NCT00717236|79432677|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
44424655|NCT00719810|79432688|FG000|Overall Study|Adverse Event|0|||
44328023|NCT01119859|79332913|FG000|Overall Study|Death|2|||
44328024|NCT01119859|79332914|FG001|Overall Study|Death|0|||
44328025|NCT01119859|79332913|FG000|Overall Study|Insufficient therapeutic response|7|||
44328026|NCT01119859|79332914|FG001|Overall Study|Insufficient therapeutic response|14|||
44328027|NCT01119859|79332913|FG000|Overall Study|Refused treatment|3|||
44328028|NCT01119859|79332914|FG001|Overall Study|Refused treatment|6|||
44328029|NCT01119859|79332913|FG000|Overall Study|Failure to return|3|||
44328030|NCT01119859|79332914|FG001|Overall Study|Failure to return|0|||
44328031|NCT01119703|79332922|FG000|Overall Study|Adverse Event|0|||
44328032|NCT01119703|79332923|FG001|Overall Study|Adverse Event|1|||
44328033|NCT01119625|79332930|FG000|Overall Study|Lost to Follow-up|1|||
44328034|NCT01119625|79332931|FG001|Overall Study|Lost to Follow-up|2|||
44328035|NCT01119625|79332930|FG000|Overall Study|Withdrawal by Subject|2|||
44328036|NCT01119625|79332931|FG001|Overall Study|Withdrawal by Subject|1|||
44328037|NCT01119625|79332930|FG000|Overall Study|Other|0|||
44328038|NCT01119625|79332931|FG001|Overall Study|Other|1|||
44424656|NCT00719810|79432689|FG001|Overall Study|Adverse Event|2|||
44424657|NCT00719810|79432690|FG002|Overall Study|Adverse Event|3|||
44424658|NCT00719810|79432688|FG000|Overall Study|Lost to Follow-up|2|||
44424659|NCT00719810|79432689|FG001|Overall Study|Lost to Follow-up|0|||
44424660|NCT00719810|79432690|FG002|Overall Study|Lost to Follow-up|3|||
44424661|NCT00719810|79432688|FG000|Overall Study|Physician Decision|0|||
44424662|NCT00719810|79432689|FG001|Overall Study|Physician Decision|1|||
44424663|NCT00719810|79432690|FG002|Overall Study|Physician Decision|0|||
44424664|NCT00719810|79432688|FG000|Overall Study|Withdrawal by Subject|1|||
44424665|NCT00719810|79432689|FG001|Overall Study|Withdrawal by Subject|1|||
44424666|NCT00719810|79432690|FG002|Overall Study|Withdrawal by Subject|2|||
44424667|NCT00719732|79432698|FG000|Overall Study|Lost to Follow-up|20|||
44424668|NCT00719732|79432698|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
44424669|NCT00719732|79432698|FG000|Overall Study|Illness not associated with device|1|||
44424670|NCT00723710|79432702|FG000|Overall Study|Disease progression|48|||
44424671|NCT00723710|79432702|FG000|Overall Study|Adverse Event|88|||
44424672|NCT00723710|79432702|FG000|Overall Study|Withdrawal by Subject|36|||
44424673|NCT00723710|79432702|FG000|Overall Study|Physician Decision|2|||
44424674|NCT00688545|79432708|FG000|Overall Study|Lost to Follow-up|1|||
44424675|NCT00688545|79432709|FG001|Overall Study|Lost to Follow-up|4|||
44424676|NCT00688545|79432708|FG000|Overall Study|Insurance/cost of drug|0|||
44424677|NCT00688545|79432709|FG001|Overall Study|Insurance/cost of drug|1|||
44424678|NCT00688545|79432708|FG000|Overall Study|Withdrawal by Subject|2|||
44424679|NCT00688545|79432709|FG001|Overall Study|Withdrawal by Subject|3|||
44328039|NCT01119118|79332937|FG000|Overall Study|Adverse Event|1|||
44424680|NCT00688545|79432708|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
44424681|NCT00688545|79432709|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
44424682|NCT00688467|79432719|FG000|Treatment Period 1|Adverse Event|2|||
44424683|NCT00688467|79432720|FG001|Treatment Period 1|Adverse Event|1|||
44537205|NCT03336528|79547903|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
44328040|NCT01119001|79332941|FG000|Overall Study|Withdrawal by Subject|2|||
44424684|NCT00688467|79432719|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
44328041|NCT01118962|79332947|FG000|Overall Study|Adverse Event|2|||
44328042|NCT01118962|79332947|FG000|Overall Study|Lack of Efficacy|1|||
44328043|NCT01118962|79332947|FG000|Overall Study|Protocol Violation|1|||
44328044|NCT01118962|79332947|FG000|Overall Study|Withdrawal by Subject|4|||
44424685|NCT00688467|79432720|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
44424686|NCT00688467|79432719|FG000|Treatment Period 2|Protocol Violation|0|||
44424687|NCT00688467|79432720|FG001|Treatment Period 2|Protocol Violation|1|||
44424688|NCT00688467|79432719|FG000|Treatment Period 2|Adverse Event|0|||
44328045|NCT01118962|79332947|FG000|Overall Study|Pregnancy|1|||
44328046|NCT01118962|79332947|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
44424689|NCT00688467|79432720|FG001|Treatment Period 2|Adverse Event|1|||
44424690|NCT00688155|79432730|FG000|Overall Study|Withdrawal by Subject|2|||
44424691|NCT00688155|79432731|FG001|Overall Study|Withdrawal by Subject|2|||
44424692|NCT00688155|79432732|FG002|Overall Study|Withdrawal by Subject|1|||
44424693|NCT00688155|79432733|FG003|Overall Study|Withdrawal by Subject|1|||
44424694|NCT00690573|79432743|FG000|Overall Study|Lack of Efficacy|8|||
44424695|NCT00690573|79432743|FG000|Overall Study|Withdrawal by Subject|1|||
44424696|NCT00719264|79432749|FG000|Overall Study|Adverse Event|41|||
44424697|NCT00719264|79432750|FG001|Overall Study|Adverse Event|49|||
44424698|NCT00719264|79432749|FG000|Overall Study|Death|13|||
44424699|NCT00719264|79432750|FG001|Overall Study|Death|10|||
44424700|NCT00719264|79432749|FG000|Overall Study|Administrative Problems|6|||
44424701|NCT00719264|79432750|FG001|Overall Study|Administrative Problems|4|||
44424702|NCT00719264|79432749|FG000|Overall Study|Lost to Follow-up|1|||
44424703|NCT00719264|79432750|FG001|Overall Study|Lost to Follow-up|1|||
44424704|NCT00719264|79432749|FG000|Overall Study|Withdrawal by Subject|12|||
44424705|NCT00719264|79432750|FG001|Overall Study|Withdrawal by Subject|7|||
44424706|NCT00719264|79432749|FG000|Overall Study|Protocol Deviation|1|||
44424707|NCT00719264|79432750|FG001|Overall Study|Protocol Deviation|3|||
44424708|NCT00719264|79432749|FG000|Overall Study|New Cancer Therapy|4|||
44424709|NCT00719264|79432750|FG001|Overall Study|New Cancer Therapy|2|||
44424710|NCT00719264|79432749|FG000|Overall Study|Disease Progression|104|||
44424711|NCT00719264|79432750|FG001|Overall Study|Disease Progression|107|||
44424712|NCT00687609|79432756|FG000|Overall Study|Physician Decision|1|||
44328047|NCT01118728|79332951|FG000|Overall Study|Adverse Event|17|||
44328048|NCT01118728|79332951|FG000|Overall Study|Lack of Efficacy|27|||
44328049|NCT01118728|79332951|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
44424713|NCT00687609|79432756|FG000|Overall Study|Withdrawal by Subject|2|||
44424714|NCT00723554|79432760|FG000|Overall Study|Adverse Event|12|||
44424715|NCT00723554|79432760|FG000|Overall Study|Investigator's judgement|5|||
44424716|NCT00723554|79432760|FG000|Overall Study|Inhaled medication other than iloprost|4|||
44424717|NCT00723554|79432760|FG000|Overall Study|Withdrawal of consent|3|||
44424718|NCT00723554|79432760|FG000|Overall Study|Other|3|||
44424719|NCT00723554|79432760|FG000|Overall Study|Lost to Follow-up|1|||
44424720|NCT00723554|79432760|FG000|Overall Study|Non-compliance|1|||
44328050|NCT01118728|79332951|FG000|Overall Study|Withdrawal by Subject|3|||
44328051|NCT01118728|79332951|FG000|Overall Study|Lost to Follow-up|4|||
44328052|NCT01118455|79332957|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
44328053|NCT01118455|79332958|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
44328054|NCT01118377|79332972|FG000|Overall Study|Did Not Receive Study Medication|1|||
44328055|NCT01118377|79332972|FG000|Overall Study|Death|38|||
44328056|NCT01118377|79332972|FG000|Overall Study|Failure to Return|3|||
44328057|NCT01118299|79332978|FG000|Overall Study|Death|7|||
44328058|NCT01118299|79332979|FG001|Overall Study|Death|5|||
44328059|NCT01118299|79332978|FG000|Overall Study|Withdrawal by Subject|8|||
44328060|NCT01118299|79332979|FG001|Overall Study|Withdrawal by Subject|8|||
44328061|NCT01118299|79332978|FG000|Overall Study|Lost to Follow-up|2|||
44328062|NCT01118299|79332979|FG001|Overall Study|Lost to Follow-up|1|||
44328063|NCT01118299|79332978|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
44328064|NCT01118299|79332979|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
44328065|NCT01118143|79332986|FG000|Overall Study|Withdrawal by Subject|2|||
44328066|NCT01118143|79332987|FG001|Overall Study|Withdrawal by Subject|5|||
44328067|NCT01117987|79332997|FG000|Overall Study|Protocol deviation|0|||
44328068|NCT01117987|79332998|FG001|Overall Study|Protocol deviation|1|||
44424721|NCT00687219|79432766|FG000|Overall Study|Adverse Event|8|||
44424722|NCT00687219|79432766|FG000|Overall Study|Discontinuance criteria met|7|||
44424723|NCT00687219|79432766|FG000|Overall Study|HCV-RNA positive conversion|34|||
44424724|NCT00687219|79432766|FG000|Overall Study|Withdrawal by Subject|1|||
44424725|NCT00687219|79432766|FG000|Overall Study|Lack of Efficacy|1|||
44424726|NCT00723398|79432775|FG000|Overall Study|Withdrawal by Subject|2|||
44424727|NCT00723398|79432776|FG001|Overall Study|Withdrawal by Subject|6|||
44156703|NCT05033262|78947978|FG001|Overall Study|Lost to Follow-up|0|||
44424728|NCT00723398|79432777|FG002|Overall Study|Withdrawal by Subject|4|||
44424729|NCT00723398|79432778|FG003|Overall Study|Withdrawal by Subject|4|||
44424730|NCT00723398|79432779|FG004|Overall Study|Withdrawal by Subject|4|||
44424731|NCT00723398|79432775|FG000|Overall Study|Protocol Violation|2|||
44424732|NCT00723398|79432776|FG001|Overall Study|Protocol Violation|1|||
44328069|NCT01117987|79332997|FG000|Overall Study|Subject no longer requires study drug|1|||
44328070|NCT01117987|79332998|FG001|Overall Study|Subject no longer requires study drug|0|||
44328071|NCT01117987|79332997|FG000|Overall Study|Lost to Follow-up|1|||
44328072|NCT01117987|79332998|FG001|Overall Study|Lost to Follow-up|1|||
44328073|NCT01117987|79332997|FG000|Overall Study|Abnormal test procedure result|2|||
44328074|NCT01117987|79332998|FG001|Overall Study|Abnormal test procedure result|0|||
44328075|NCT01117987|79332997|FG000|Overall Study|Lack of Efficacy|3|||
44328076|NCT01117987|79332998|FG001|Overall Study|Lack of Efficacy|4|||
44328077|NCT01117987|79332997|FG000|Overall Study|Death|5|||
44328078|NCT01117987|79332998|FG001|Overall Study|Death|10|||
44328079|NCT01117987|79332997|FG000|Overall Study|Withdrawal by Subject|5|||
44328080|NCT01117987|79332998|FG001|Overall Study|Withdrawal by Subject|10|||
44328081|NCT01117987|79332997|FG000|Overall Study|Adverse Event|19|||
44328082|NCT01117987|79332998|FG001|Overall Study|Adverse Event|26|||
44328083|NCT01117987|79332997|FG000|Overall Study|Administrative problems|25|||
44328084|NCT01117987|79332998|FG001|Overall Study|Administrative problems|22|||
44328085|NCT01117870|79333006|FG000|Overall Study|Inability to place needle|1|||
44328086|NCT01117870|79333007|FG001|Overall Study|Inability to place needle|0|||
44328087|NCT01117792|79333017|FG000|Overall Study|Death|1|||
44328088|NCT01117792|79333017|FG000|Overall Study|Adverse Event|3|||
44328089|NCT02219490|79333021|FG000|Overall Study|Adverse Event|24|||
44328090|NCT02219490|79333021|FG000|Overall Study|Withdrew consent|96|||
44328091|NCT02219490|79333021|FG000|Overall Study|Lost to Follow-up|126|||
44328092|NCT02219490|79333021|FG000|Overall Study|COVID-19 infection|2|||
44328093|NCT02219490|79333021|FG000|Overall Study|COVID-19 logistical restrictions|33|||
44328094|NCT02219490|79333021|FG000|Overall Study|Other, not specified|57|||
44328095|NCT01117480|79333029|FG000|Overall Study|Protocol Violation|8|||
44328096|NCT01117480|79333029|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
44328097|NCT01117051|79333035|FG000|Overall Study|Withdrawal by Subject|5|||
44328098|NCT01117051|79333036|FG001|Overall Study|Withdrawal by Subject|3|||
44328099|NCT01117051|79333035|FG000|Overall Study|Adverse Event|4|||
44328100|NCT01117051|79333036|FG001|Overall Study|Adverse Event|3|||
44328101|NCT01117051|79333035|FG000|Overall Study|Lost to Follow-up|0|||
44328102|NCT01117051|79333036|FG001|Overall Study|Lost to Follow-up|1|||
44328103|NCT01117051|79333035|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
44424733|NCT00723398|79432777|FG002|Overall Study|Protocol Violation|5|||
44156704|NCT05033262|78947979|FG002|Overall Study|Lost to Follow-up|0|||
44156705|NCT05033262|78947980|FG003|Overall Study|Lost to Follow-up|1|||
44156706|NCT04963062|78947994|FG000|Overall Study|withdrew by the study team|4|||
44156707|NCT04963062|78947995|FG001|Overall Study|withdrew by the study team|2|||
44156708|NCT04900220|78948007|FG000|Overall Study|Lost to Follow-up|1|||
44156709|NCT04900220|78948008|FG001|Overall Study|Lost to Follow-up|1|||
44156710|NCT04599062|78948020|FG000|Overall Study|Physician Decision|1|||
44156711|NCT04599062|78948021|FG001|Overall Study|Physician Decision|0|||
44156712|NCT04537208|78948038|FG000|Overall Study|Adverse Event|0|||
44156713|NCT04537208|78948039|FG001|Overall Study|Adverse Event|0|||
44156714|NCT04537208|78948040|FG002|Overall Study|Adverse Event|0|||
44156715|NCT04537208|78948041|FG003|Overall Study|Adverse Event|0|||
44156716|NCT04537208|78948042|FG004|Overall Study|Adverse Event|0|||
44156717|NCT04537208|78948043|FG005|Overall Study|Adverse Event|0|||
44156718|NCT04537208|78948044|FG006|Overall Study|Adverse Event|0|||
44156719|NCT04537208|78948045|FG007|Overall Study|Adverse Event|0|||
44156720|NCT04537208|78948046|FG008|Overall Study|Adverse Event|1|||
44156721|NCT04537208|78948047|FG009|Overall Study|Adverse Event|0|||
44156722|NCT04537208|78948048|FG010|Overall Study|Adverse Event|0|||
44156723|NCT04537208|78948038|FG000|Overall Study|Protocol deviation|0|||
44156724|NCT04537208|78948039|FG001|Overall Study|Protocol deviation|0|||
44156725|NCT04537208|78948040|FG002|Overall Study|Protocol deviation|2|||
44156726|NCT04537208|78948041|FG003|Overall Study|Protocol deviation|0|||
44156727|NCT04537208|78948042|FG004|Overall Study|Protocol deviation|0|||
44156728|NCT04537208|78948043|FG005|Overall Study|Protocol deviation|2|||
44156729|NCT04537208|78948044|FG006|Overall Study|Protocol deviation|4|||
44156730|NCT04537208|78948045|FG007|Overall Study|Protocol deviation|0|||
44156731|NCT04537208|78948046|FG008|Overall Study|Protocol deviation|1|||
44156732|NCT04537208|78948047|FG009|Overall Study|Protocol deviation|0|||
44156733|NCT04537208|78948048|FG010|Overall Study|Protocol deviation|2|||
44156734|NCT04537208|78948038|FG000|Overall Study|Withdrawal by Subject|4|||
44156735|NCT04537208|78948039|FG001|Overall Study|Withdrawal by Subject|2|||
44156736|NCT04537208|78948040|FG002|Overall Study|Withdrawal by Subject|1|||
44156737|NCT04537208|78948041|FG003|Overall Study|Withdrawal by Subject|3|||
44156738|NCT04537208|78948042|FG004|Overall Study|Withdrawal by Subject|5|||
44156739|NCT04537208|78948043|FG005|Overall Study|Withdrawal by Subject|1|||
44328104|NCT01117051|79333036|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
44328105|NCT01117051|79333035|FG000|Overall Study|Sponsor's decision|3|||
44156740|NCT04537208|78948044|FG006|Overall Study|Withdrawal by Subject|6|||
44156741|NCT04537208|78948045|FG007|Overall Study|Withdrawal by Subject|1|||
44328106|NCT01117051|79333036|FG001|Overall Study|Sponsor's decision|1|||
44328107|NCT01117051|79333035|FG000|Overall Study|Surgical procedure|0|||
44328108|NCT01117051|79333036|FG001|Overall Study|Surgical procedure|1|||
44328109|NCT01117051|79333035|FG000|Overall Study|Randomized by mistake|0|||
44328110|NCT01117051|79333036|FG001|Overall Study|Randomized by mistake|1|||
44328111|NCT01117051|79333035|FG000|Overall Study|Convenience issue|1|||
44328112|NCT01117051|79333036|FG001|Overall Study|Convenience issue|0|||
44328113|NCT02211417|79333045|FG000|Overall Study|Withdrawal by Subject|11|||
44156742|NCT04537208|78948046|FG008|Overall Study|Withdrawal by Subject|7|||
44328114|NCT02211417|79333046|FG001|Overall Study|Withdrawal by Subject|8|||
44424734|NCT00723398|79432778|FG003|Overall Study|Protocol Violation|0|||
44424735|NCT00723398|79432779|FG004|Overall Study|Protocol Violation|0|||
44424736|NCT00723398|79432775|FG000|Overall Study|Physician Decision|2|||
44424737|NCT00723398|79432776|FG001|Overall Study|Physician Decision|2|||
44424738|NCT00723398|79432777|FG002|Overall Study|Physician Decision|5|||
44424739|NCT00723398|79432778|FG003|Overall Study|Physician Decision|0|||
44424740|NCT00723398|79432779|FG004|Overall Study|Physician Decision|1|||
44424741|NCT00723398|79432775|FG000|Overall Study|Adverse Event|0|||
44424742|NCT00723398|79432776|FG001|Overall Study|Adverse Event|5|||
44424743|NCT00723398|79432777|FG002|Overall Study|Adverse Event|3|||
44424744|NCT00723398|79432778|FG003|Overall Study|Adverse Event|1|||
44424745|NCT00723398|79432779|FG004|Overall Study|Adverse Event|4|||
44424746|NCT00723398|79432775|FG000|Overall Study|Lost to Follow-up|0|||
44424747|NCT00723398|79432776|FG001|Overall Study|Lost to Follow-up|1|||
44424748|NCT00723398|79432777|FG002|Overall Study|Lost to Follow-up|0|||
44424749|NCT00723398|79432778|FG003|Overall Study|Lost to Follow-up|0|||
44424750|NCT00723398|79432779|FG004|Overall Study|Lost to Follow-up|0|||
44424751|NCT00716456|79432794|FG000|Overall Study|Adverse Event|0|||
44328115|NCT02211417|79333045|FG000|Overall Study|Protocol Violation|1|||
44328116|NCT02211417|79333046|FG001|Overall Study|Protocol Violation|0|||
44424752|NCT00716456|79432795|FG001|Overall Study|Adverse Event|2|||
44424753|NCT00716456|79432796|FG002|Overall Study|Adverse Event|0|||
44424754|NCT00684645|79432804|FG000|Overall Study|Death|2|||
44424755|NCT00684645|79432804|FG000|Overall Study|Progressive disease|67|||
44424756|NCT00684645|79432804|FG000|Overall Study|Adverse Event|27|||
44328117|NCT02211417|79333045|FG000|Overall Study|Pregnancy|0|||
44328118|NCT02211417|79333046|FG001|Overall Study|Pregnancy|1|||
44328119|NCT02211417|79333045|FG000|Overall Study|Lost to Follow-up|2|||
44328120|NCT02211417|79333046|FG001|Overall Study|Lost to Follow-up|3|||
44328121|NCT02211417|79333045|FG000|Overall Study|Adverse Event|1|||
44328122|NCT02211417|79333046|FG001|Overall Study|Adverse Event|4|||
44328123|NCT01117012|79333059|FG000|Overall Study|Adverse Event|0|||
44328124|NCT01117012|79333060|FG001|Overall Study|Adverse Event|1|||
44328125|NCT01117012|79333059|FG000|Overall Study|Death|1|||
44328126|NCT01117012|79333060|FG001|Overall Study|Death|1|||
44328127|NCT01117012|79333059|FG000|Overall Study|Withdrawal by Subject|3|||
44328128|NCT01117012|79333060|FG001|Overall Study|Withdrawal by Subject|0|||
44328129|NCT01117012|79333059|FG000|Overall Study|Undefined|4|||
44328130|NCT01117012|79333060|FG001|Overall Study|Undefined|3|||
44328131|NCT01116739|79333068|FG000|Overall Study|Child had 2 years of HS|110|||
44328132|NCT01116739|79333069|FG001|Overall Study|Child had 2 years of HS|128|||
44328133|NCT01116739|79333068|FG000|Overall Study|Withdrawal by Subject|6|||
44328134|NCT01116739|79333069|FG001|Overall Study|Withdrawal by Subject|0|||
44328135|NCT01116739|79333068|FG000|Overall Study|child too young|2|||
44328136|NCT01116739|79333069|FG001|Overall Study|child too young|6|||
44328137|NCT01116739|79333068|FG000|Overall Study|child not enrolled in head start|10|||
44328138|NCT01116739|79333069|FG001|Overall Study|child not enrolled in head start|2|||
44328139|NCT01116739|79333068|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
44328140|NCT01116739|79333069|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
44328141|NCT01116544|79333077|FG000|Overall Study|Protocol Violation|1|||
44328142|NCT01116544|79333078|FG001|Overall Study|Protocol Violation|0|||
44328143|NCT01116544|79333077|FG000|Overall Study|Withdrawal by Subject|1|||
44328144|NCT01116544|79333078|FG001|Overall Study|Withdrawal by Subject|1|||
44328145|NCT01116427|79333086|FG000|Core Phase|Adverse Event|0|||
44328146|NCT01116427|79333087|FG001|Core Phase|Adverse Event|1|||
44328147|NCT01116427|79333086|FG000|Core Phase|Lost to Follow-up|1|||
44328148|NCT01116427|79333087|FG001|Core Phase|Lost to Follow-up|0|||
44328149|NCT01116427|79333086|FG000|Core Phase|Withdrawal by Subject|3|||
44328150|NCT01116427|79333087|FG001|Core Phase|Withdrawal by Subject|0|||
44328151|NCT01116427|79333086|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
44328152|NCT01116427|79333087|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
44328153|NCT01116427|79333086|FG000|Extension Phase|Adverse Event|1|||
44328154|NCT01116427|79333087|FG001|Extension Phase|Adverse Event|1|||
44328155|NCT01116427|79333086|FG000|Extension Phase|Lost to Follow-up|2|||
44328156|NCT01116427|79333087|FG001|Extension Phase|Lost to Follow-up|0|||
44328157|NCT01116427|79333086|FG000|Extension Phase|Withdrawal by Subject|5|||
44328158|NCT01116427|79333087|FG001|Extension Phase|Withdrawal by Subject|1|||
44328159|NCT01116427|79333086|FG000|Extension Phase|Not using appropriate birth control|1|||
44328160|NCT01116427|79333087|FG001|Extension Phase|Not using appropriate birth control|0|||
44328161|NCT01116232|79333097|FG000|Overall Study|Progressive diease|4|||
44328162|NCT01115998|79333106|FG000|Overall Study|Lost to Follow-up|6|||
44328163|NCT01115998|79333107|FG001|Overall Study|Lost to Follow-up|6|||
44424757|NCT00684645|79432804|FG000|Overall Study|Lost to Follow-up|3|||
44424758|NCT00684645|79432804|FG000|Overall Study|Other|15|||
44424759|NCT00716144|79432812|FG000|Overall Study|Withdrawal by Subject|4|||
44424760|NCT00716144|79432813|FG001|Overall Study|Withdrawal by Subject|2|||
44424761|NCT00716144|79432814|FG002|Overall Study|Withdrawal by Subject|6|||
44424762|NCT00716144|79432815|FG003|Overall Study|Withdrawal by Subject|6|||
44424763|NCT00716144|79432812|FG000|Overall Study|Lost to Follow-up|2|||
44424764|NCT00716144|79432813|FG001|Overall Study|Lost to Follow-up|2|||
44424765|NCT00716144|79432814|FG002|Overall Study|Lost to Follow-up|1|||
44424766|NCT00716144|79432815|FG003|Overall Study|Lost to Follow-up|2|||
44424767|NCT00716144|79432812|FG000|Overall Study|Adverse Event|0|||
44424768|NCT00716144|79432813|FG001|Overall Study|Adverse Event|0|||
44424769|NCT00716144|79432814|FG002|Overall Study|Adverse Event|0|||
44424770|NCT00716144|79432815|FG003|Overall Study|Adverse Event|2|||
44424771|NCT00716144|79432812|FG000|Overall Study|Non-compliance|1|||
44424772|NCT00716144|79432813|FG001|Overall Study|Non-compliance|0|||
44424773|NCT00716144|79432814|FG002|Overall Study|Non-compliance|0|||
44424774|NCT00716144|79432815|FG003|Overall Study|Non-compliance|0|||
44424775|NCT00716144|79432812|FG000|Overall Study|Protocol Violation|2|||
44424776|NCT00716144|79432813|FG001|Overall Study|Protocol Violation|0|||
44424777|NCT00716144|79432814|FG002|Overall Study|Protocol Violation|1|||
44424778|NCT00716144|79432815|FG003|Overall Study|Protocol Violation|0|||
44424779|NCT00716144|79432812|FG000|Overall Study|Physician Decision|0|||
44424780|NCT00716144|79432813|FG001|Overall Study|Physician Decision|1|||
44328164|NCT01205230|79333115|FG000|Overall Study|Adverse Event|4|||
44328165|NCT01205230|79333116|FG001|Overall Study|Adverse Event|0|||
44328166|NCT01205230|79333115|FG000|Overall Study|Physician Decision|1|||
44328167|NCT01205230|79333116|FG001|Overall Study|Physician Decision|0|||
44328168|NCT01205152|79333127|FG000|Overall Study|Death|1|||
44328169|NCT01205035|79333135|FG000|Overall Study|Withdrawal by Subject|1|||
44328170|NCT01205035|79333136|FG001|Overall Study|Withdrawal by Subject|0|||
44328171|NCT01205035|79333135|FG000|Overall Study|Physician Decision|1|||
44328172|NCT01205035|79333136|FG001|Overall Study|Physician Decision|0|||
44328173|NCT01204918|79333145|FG000|Overall Study|Withdrawal by Subject|4|||
44328174|NCT01204918|79333146|FG001|Overall Study|Withdrawal by Subject|10|||
44328175|NCT01204918|79333147|FG002|Overall Study|Withdrawal by Subject|5|||
44328176|NCT01204294|79333162|FG000|Overall Study|Adverse Event|2|||
44328177|NCT01204294|79333163|FG001|Overall Study|Adverse Event|6|||
44328178|NCT01204294|79333164|FG002|Overall Study|Adverse Event|0|||
44328179|NCT01204294|79333165|FG003|Overall Study|Adverse Event|7|||
44328180|NCT01204294|79333166|FG004|Overall Study|Adverse Event|1|||
44328181|NCT01204294|79333167|FG005|Overall Study|Adverse Event|4|||
44328182|NCT01204294|79333168|FG006|Overall Study|Adverse Event|0|||
44328183|NCT01204294|79333162|FG000|Overall Study|Protocol Violation|1|||
44328184|NCT01204294|79333163|FG001|Overall Study|Protocol Violation|0|||
44328185|NCT01204294|79333164|FG002|Overall Study|Protocol Violation|2|||
44328186|NCT01204294|79333165|FG003|Overall Study|Protocol Violation|1|||
44328187|NCT01204294|79333166|FG004|Overall Study|Protocol Violation|0|||
44424781|NCT00716144|79432814|FG002|Overall Study|Physician Decision|2|||
44424782|NCT00716144|79432815|FG003|Overall Study|Physician Decision|2|||
44424783|NCT00716144|79432812|FG000|Overall Study|Intercurrent illness|0|||
44424784|NCT00716144|79432813|FG001|Overall Study|Intercurrent illness|0|||
44424785|NCT00716144|79432814|FG002|Overall Study|Intercurrent illness|1|||
44424786|NCT00716144|79432815|FG003|Overall Study|Intercurrent illness|0|||
44424787|NCT00716144|79432812|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
44424788|NCT00716144|79432813|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
44424789|NCT00716144|79432814|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
44424790|NCT00716144|79432815|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
44424791|NCT00716144|79432812|FG000|Overall Study|Adverse event: left foot pain|0|||
44424792|NCT00716144|79432813|FG001|Overall Study|Adverse event: left foot pain|1|||
44424793|NCT00716144|79432814|FG002|Overall Study|Adverse event: left foot pain|0|||
44424794|NCT00716144|79432815|FG003|Overall Study|Adverse event: left foot pain|0|||
44424795|NCT00716144|79432812|FG000|Overall Study|Clinical Depression|0|||
44424796|NCT00716144|79432813|FG001|Overall Study|Clinical Depression|1|||
44424797|NCT00716144|79432814|FG002|Overall Study|Clinical Depression|0|||
44424798|NCT00716144|79432815|FG003|Overall Study|Clinical Depression|0|||
44537206|NCT03336528|79547904|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
44537207|NCT03336528|79547903|FG000|Overall Study|Did not receive study medication|1|||
44537208|NCT03336528|79547904|FG001|Overall Study|Did not receive study medication|2|||
44537209|NCT03364608|79547912|FG000|Overall Study|Withdrawal by Subject|4|||
44537210|NCT03364608|79547912|FG000|Overall Study|Protocol Violation|2|||
44328188|NCT01204294|79333167|FG005|Overall Study|Protocol Violation|0|||
44328189|NCT01204294|79333168|FG006|Overall Study|Protocol Violation|0|||
44328190|NCT01204294|79333162|FG000|Overall Study|Withdrawal by Subject|0|||
44328191|NCT01204294|79333163|FG001|Overall Study|Withdrawal by Subject|2|||
44328192|NCT01204294|79333164|FG002|Overall Study|Withdrawal by Subject|2|||
44328193|NCT01204294|79333165|FG003|Overall Study|Withdrawal by Subject|1|||
44424799|NCT00576381|79432825|FG000|Overall Study|Reoperation|3|||
44424800|NCT00576381|79432825|FG000|Overall Study|Adverse Event|4|||
44424801|NCT00684567|79432829|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
44424802|NCT00684567|79432829|FG000|Monotherapy Period|Adverse Event|2|||
44424803|NCT00684567|79432829|FG000|Monotherapy Period|Death|1|||
44424804|NCT00684567|79432829|FG000|Monotherapy Period|Progression of primary disease|11|||
44424805|NCT00684411|79432833|FG000|Overall Study|New Primary Cancer|1|||
44424806|NCT00684411|79432833|FG000|Overall Study|Disease Progression|10|||
44424807|NCT00684411|79432833|FG000|Overall Study|Adverse Event|1|||
44424808|NCT00686829|79432837|FG000|Overall Study|Adverse Event|5|||
44424809|NCT00686829|79432837|FG000|Overall Study|Lack of Efficacy|6|||
44424810|NCT00686829|79432837|FG000|Overall Study|Lost to Follow-up|4|||
44424811|NCT00686829|79432837|FG000|Overall Study|Withdrawal by Subject|14|||
44424812|NCT00686829|79432837|FG000|Overall Study|Protocol Violation|3|||
44424813|NCT00686829|79432837|FG000|Overall Study|Sponsor discontinued VCV|47|||
44424814|NCT00687297|79432843|FG000|Randomization|Withdrawal by Subject|2|||
44424815|NCT00687297|79432844|FG001|Randomization|Withdrawal by Subject|0|||
44424816|NCT00687297|79432843|FG000|Randomization|Withdrew before treatment, ineligible|1|||
44424817|NCT00687297|79432844|FG001|Randomization|Withdrew before treatment, ineligible|1|||
44424818|NCT00687297|79432843|FG000|Induction|Withdrawal by Subject|4|||
44424819|NCT00687297|79432844|FG001|Induction|Withdrawal by Subject|4|||
44424820|NCT00687297|79432843|FG000|Induction|Adverse Event|16|||
44424821|NCT00687297|79432844|FG001|Induction|Adverse Event|15|||
44424822|NCT00687297|79432843|FG000|Induction|Death|7|||
44424823|NCT00687297|79432844|FG001|Induction|Death|11|||
44424824|NCT00687297|79432843|FG000|Induction|Lack of Efficacy|17|||
44424825|NCT00687297|79432844|FG001|Induction|Lack of Efficacy|21|||
44424826|NCT00687297|79432843|FG000|Induction|Ineligible|0|||
44424827|NCT00687297|79432844|FG001|Induction|Ineligible|1|||
44424828|NCT00687297|79432843|FG000|Induction|Patient Noncompliance|1|||
44424829|NCT00687297|79432844|FG001|Induction|Patient Noncompliance|0|||
44424830|NCT00687297|79432843|FG000|Induction|Physician Decision|0|||
44424831|NCT00687297|79432844|FG001|Induction|Physician Decision|2|||
44424832|NCT00687297|79432843|FG000|Induction|Other|0|||
44424833|NCT00687297|79432844|FG001|Induction|Other|1|||
44424834|NCT00684177|79432854|FG000|Overall Study|Adverse Event|4|||
44424835|NCT00684177|79432855|FG001|Overall Study|Adverse Event|3|||
44424836|NCT00684177|79432854|FG000|Overall Study|Lack of Efficacy|10|||
44424837|NCT00684177|79432855|FG001|Overall Study|Lack of Efficacy|15|||
44424838|NCT00684177|79432854|FG000|Overall Study|Protocol Violation|1|||
44424839|NCT00684177|79432855|FG001|Overall Study|Protocol Violation|0|||
44424840|NCT00684177|79432854|FG000|Overall Study|Lost to Follow-up|2|||
44424841|NCT00684177|79432855|FG001|Overall Study|Lost to Follow-up|1|||
44424842|NCT00684177|79432854|FG000|Overall Study|Physician Decision|2|||
44424843|NCT00684177|79432855|FG001|Overall Study|Physician Decision|0|||
44424844|NCT00684177|79432854|FG000|Overall Study|Withdrawal by Subject|1|||
44424845|NCT00684177|79432855|FG001|Overall Study|Withdrawal by Subject|2|||
44424846|NCT00684177|79432854|FG000|Overall Study|Other|1|||
44424847|NCT00684177|79432855|FG001|Overall Study|Other|2|||
44156743|NCT04537208|78948047|FG009|Overall Study|Withdrawal by Subject|2|||
44156744|NCT04537208|78948048|FG010|Overall Study|Withdrawal by Subject|4|||
44328194|NCT01204294|79333166|FG004|Overall Study|Withdrawal by Subject|1|||
44328195|NCT01204294|79333167|FG005|Overall Study|Withdrawal by Subject|1|||
44328196|NCT01204294|79333168|FG006|Overall Study|Withdrawal by Subject|2|||
44328197|NCT01204294|79333162|FG000|Overall Study|Lack of Efficacy|0|||
44328198|NCT01204294|79333163|FG001|Overall Study|Lack of Efficacy|0|||
44328199|NCT01204294|79333164|FG002|Overall Study|Lack of Efficacy|0|||
44328200|NCT01204294|79333165|FG003|Overall Study|Lack of Efficacy|2|||
44328201|NCT01204294|79333166|FG004|Overall Study|Lack of Efficacy|0|||
44328202|NCT01204294|79333167|FG005|Overall Study|Lack of Efficacy|0|||
44328203|NCT01204294|79333168|FG006|Overall Study|Lack of Efficacy|0|||
44328204|NCT01204294|79333162|FG000|Overall Study|Other (house moving)|0|||
44328205|NCT01204294|79333163|FG001|Overall Study|Other (house moving)|0|||
44328206|NCT01204294|79333164|FG002|Overall Study|Other (house moving)|1|||
44328207|NCT01204294|79333165|FG003|Overall Study|Other (house moving)|0|||
44328208|NCT01204294|79333166|FG004|Overall Study|Other (house moving)|0|||
44328209|NCT01204294|79333167|FG005|Overall Study|Other (house moving)|0|||
44328210|NCT01204294|79333168|FG006|Overall Study|Other (house moving)|0|||
44328211|NCT01182181|79333186|FG000|First Intervention|Adverse Event|1|||
44328212|NCT01182181|79333187|FG001|First Intervention|Adverse Event|0|||
44328213|NCT01182181|79333186|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
44424848|NCT00684021|79432865|FG000|Overall Study|MRI Contraindicated|1|||
44424849|NCT00684021|79432866|FG001|Overall Study|MRI Contraindicated|1|||
44424850|NCT00684021|79432867|FG002|Overall Study|MRI Contraindicated|1|||
44424851|NCT00684021|79432868|FG003|Overall Study|MRI Contraindicated|0|||
44424852|NCT00684021|79432865|FG000|Overall Study|MRI not performed|0|||
44424853|NCT00684021|79432866|FG001|Overall Study|MRI not performed|1|||
44424854|NCT00684021|79432867|FG002|Overall Study|MRI not performed|1|||
44424855|NCT00684021|79432868|FG003|Overall Study|MRI not performed|2|||
44424856|NCT00684021|79432865|FG000|Overall Study|Death|1|||
44424857|NCT00684021|79432866|FG001|Overall Study|Death|0|||
44424858|NCT00684021|79432867|FG002|Overall Study|Death|0|||
44424859|NCT00684021|79432868|FG003|Overall Study|Death|0|||
44424860|NCT00576303|79432878|FG000|Dose Titration Period|Early withdrawal|17|||
44424861|NCT00576303|79432878|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
44424862|NCT00576303|79432878|FG000|Long Term Safety Period|Early withdrawal|16|||
44424863|NCT00686517|79432885|FG000|Treatment|Serious Adverse Event|1|||
44328214|NCT01182181|79333187|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
44328215|NCT01181986|79333195|FG000|Phase 1|Lost to Follow-up|0|||
44328216|NCT01181986|79333196|FG001|Phase 1|Lost to Follow-up|1|||
44328217|NCT01181986|79333197|FG002|Phase 1|Lost to Follow-up|1|||
44328218|NCT01181986|79333195|FG000|Phase 1|Adverse Event|0|||
44424864|NCT00686517|79432886|FG001|Treatment|Serious Adverse Event|2|||
44424865|NCT00686517|79432887|FG002|Treatment|Serious Adverse Event|1|||
44424866|NCT00686517|79432885|FG000|Treatment|Adverse Event|2|||
44424867|NCT00686517|79432886|FG001|Treatment|Adverse Event|0|||
44424868|NCT00686517|79432887|FG002|Treatment|Adverse Event|0|||
44424869|NCT00686517|79432885|FG000|Treatment|Poor Protocol Compliance|1|||
44424870|NCT00686517|79432886|FG001|Treatment|Poor Protocol Compliance|0|||
44424871|NCT00686517|79432887|FG002|Treatment|Poor Protocol Compliance|0|||
44424872|NCT00686517|79432885|FG000|Treatment|Protocol Violation|2|||
44424873|NCT00686517|79432886|FG001|Treatment|Protocol Violation|1|||
44424874|NCT00686517|79432887|FG002|Treatment|Protocol Violation|0|||
44537211|NCT03364608|79547912|FG000|Overall Study|Lost to Follow-up|2|||
44328219|NCT01181986|79333196|FG001|Phase 1|Adverse Event|0|||
44328220|NCT01181986|79333197|FG002|Phase 1|Adverse Event|1|||
44328221|NCT01181986|79333195|FG000|Phase 1|Protocol Violation|1|||
44328222|NCT01181986|79333196|FG001|Phase 1|Protocol Violation|0|||
44328223|NCT01181986|79333197|FG002|Phase 1|Protocol Violation|0|||
44328224|NCT01181986|79333195|FG000|Phase 2|Adverse Event|0|||
44328225|NCT01181986|79333196|FG001|Phase 2|Adverse Event|3|||
44328226|NCT01181986|79333197|FG002|Phase 2|Adverse Event|0|||
44328227|NCT01181986|79333195|FG000|Phase 2|Medical condition|0|||
44328228|NCT01181986|79333196|FG001|Phase 2|Medical condition|1|||
44328229|NCT01181986|79333197|FG002|Phase 2|Medical condition|0|||
44328230|NCT01181167|79333213|FG000|Overall Study|Adverse Event|11|||
44328231|NCT01181167|79333214|FG001|Overall Study|Adverse Event|21|||
44328232|NCT01181167|79333213|FG000|Overall Study|Lost to Follow-up|1|||
44328233|NCT01181167|79333214|FG001|Overall Study|Lost to Follow-up|0|||
44328234|NCT01181167|79333213|FG000|Overall Study|Physician Decision|2|||
44328235|NCT01181167|79333214|FG001|Overall Study|Physician Decision|3|||
44328236|NCT01181167|79333213|FG000|Overall Study|Protocol Violation|3|||
44328237|NCT01181167|79333214|FG001|Overall Study|Protocol Violation|0|||
44328238|NCT01181167|79333213|FG000|Overall Study|Withdrawal by Subject|6|||
44328239|NCT01181167|79333214|FG001|Overall Study|Withdrawal by Subject|8|||
44328240|NCT01181128|79333223|FG000|Overall Study|Withdrawal by Subject|2|||
44328241|NCT01181128|79333224|FG001|Overall Study|Withdrawal by Subject|2|||
44328242|NCT01181128|79333225|FG002|Overall Study|Withdrawal by Subject|0|||
44328243|NCT01181128|79333223|FG000|Overall Study|Death|1|||
44328244|NCT01181128|79333224|FG001|Overall Study|Death|0|||
44328245|NCT01181128|79333225|FG002|Overall Study|Death|0|||
44328246|NCT01181128|79333223|FG000|Overall Study|Physician Decision|2|||
44328247|NCT01181128|79333224|FG001|Overall Study|Physician Decision|0|||
44328248|NCT01181128|79333225|FG002|Overall Study|Physician Decision|0|||
44328249|NCT01181128|79333223|FG000|Overall Study|Adverse Event|0|||
44328250|NCT01181128|79333224|FG001|Overall Study|Adverse Event|2|||
44328251|NCT01181128|79333225|FG002|Overall Study|Adverse Event|0|||
44328252|NCT01181128|79333223|FG000|Overall Study|Other|1|||
44328253|NCT01181128|79333224|FG001|Overall Study|Other|1|||
44328254|NCT01181128|79333225|FG002|Overall Study|Other|1|||
44328255|NCT01203787|79333247|FG000|Overall Study|Death|12|||
44328256|NCT01203787|79333248|FG001|Overall Study|Death|10|||
44328257|NCT01203787|79333247|FG000|Overall Study|Withdrawal by Subject|6|||
44328258|NCT01203787|79333248|FG001|Overall Study|Withdrawal by Subject|2|||
44328259|NCT01203787|79333247|FG000|Overall Study|Lost to Follow-up|2|||
44328260|NCT01203787|79333248|FG001|Overall Study|Lost to Follow-up|0|||
44328261|NCT01203787|79333247|FG000|Overall Study|Adverse Event|11|||
44328262|NCT01203787|79333248|FG001|Overall Study|Adverse Event|15|||
44328263|NCT01181011|79333256|FG000|Overall Study|Adverse Event|2|||
44328264|NCT01181011|79333256|FG000|Overall Study|Lost to Follow-up|1|||
44328265|NCT01180777|79333265|FG000|Overall Study|Protocol Violation|6|||
44328266|NCT01180777|79333265|FG000|Overall Study|Poor lens fit|4|||
44328267|NCT01180777|79333265|FG000|Overall Study|Lost to Follow-up|1|||
44328268|NCT01180777|79333265|FG000|Overall Study|Adverse Event|1|||
44328269|NCT01648023|79333273|FG000|Overall Study|Screen Fail Post Randomization|1|||
44328270|NCT01648023|79333274|FG001|Overall Study|Screen Fail Post Randomization|2|||
44328271|NCT02756208|79333288|FG000|Overall Study|Withdrawal by Subject|1|||
44328272|NCT02756208|79333289|FG001|Overall Study|Withdrawal by Subject|0|||
44328273|NCT02756208|79333290|FG002|Overall Study|Withdrawal by Subject|1|||
44328274|NCT02756208|79333291|FG003|Overall Study|Withdrawal by Subject|3|||
44328275|NCT02756208|79333288|FG000|Overall Study|Lost to Follow-up|3|||
44328276|NCT02756208|79333289|FG001|Overall Study|Lost to Follow-up|1|||
44328277|NCT02756208|79333290|FG002|Overall Study|Lost to Follow-up|1|||
44328278|NCT02756208|79333291|FG003|Overall Study|Lost to Follow-up|1|||
44328279|NCT02756208|79333288|FG000|Overall Study|Physician Decision|1|||
44424875|NCT00686205|79432897|FG000|Overall Study|Protocol Violation|127|||
44424876|NCT00686205|79432898|FG001|Overall Study|Protocol Violation|0|||
44424877|NCT00686205|79432897|FG000|Overall Study|Withdrawal by Subject|2|||
44328280|NCT02756208|79333289|FG001|Overall Study|Physician Decision|0|||
44328281|NCT02756208|79333290|FG002|Overall Study|Physician Decision|0|||
44328282|NCT02756208|79333291|FG003|Overall Study|Physician Decision|0|||
44328283|NCT02756208|79333288|FG000|Overall Study|Protocol Violation|0|||
44328284|NCT02756208|79333289|FG001|Overall Study|Protocol Violation|1|||
44328285|NCT02756208|79333290|FG002|Overall Study|Protocol Violation|0|||
44328286|NCT02756208|79333291|FG003|Overall Study|Protocol Violation|0|||
44328287|NCT02756013|79333301|FG000|Overall Study|Adverse Event|1|||
44328288|NCT02756013|79333301|FG000|Overall Study|Hypersensitivity|1|||
44328289|NCT01202773|79333308|FG000|Overall Study|Adverse Event|4|||
44424878|NCT00686205|79432898|FG001|Overall Study|Withdrawal by Subject|0|||
44424879|NCT00686205|79432897|FG000|Overall Study|Specimen handling procedure altered|5878|||
44328290|NCT01202773|79333309|FG001|Overall Study|Adverse Event|5|||
44328291|NCT01202773|79333310|FG002|Overall Study|Adverse Event|5|||
44424880|NCT00686205|79432898|FG001|Overall Study|Specimen handling procedure altered|0|||
44424881|NCT00686205|79432897|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
44424882|NCT00686205|79432898|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
44424883|NCT00571701|79432906|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
44424884|NCT00571701|79432907|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
44424885|NCT00571701|79432906|FG000|First Intervention 12 Months|Death|1|||
44424886|NCT00571701|79432907|FG001|First Intervention 12 Months|Death|0|||
44424887|NCT00571701|79432906|FG000|Second Intervention 12 Months|Adverse Event|0|||
44424888|NCT00571701|79432907|FG001|Second Intervention 12 Months|Adverse Event|1|||
44424889|NCT00571701|79432906|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
44424890|NCT00571701|79432907|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
44424891|NCT00686127|79432933|FG000|Overall Study|Withdrawal by Subject|14|||
44424892|NCT00686127|79432934|FG001|Overall Study|Withdrawal by Subject|6|||
44424893|NCT00718718|79432947|FG000|Prior to Week 12|Adverse Event|0|||
44424894|NCT00718718|79432948|FG001|Prior to Week 12|Adverse Event|0|||
44424895|NCT00718718|79432949|FG002|Prior to Week 12|Adverse Event|0|||
44424896|NCT00718718|79432950|FG003|Prior to Week 12|Adverse Event|0|||
44424897|NCT00718718|79432951|FG004|Prior to Week 12|Adverse Event|0|||
44424898|NCT00718718|79432952|FG005|Prior to Week 12|Adverse Event|0|||
44424899|NCT00718718|79432953|FG006|Prior to Week 12|Adverse Event|0|||
44424900|NCT00718718|79432954|FG007|Prior to Week 12|Adverse Event|1|||
44424901|NCT00718718|79432955|FG008|Prior to Week 12|Adverse Event|1|||
44424902|NCT00718718|79432956|FG009|Prior to Week 12|Adverse Event|0|||
44424903|NCT00718718|79432947|FG000|Prior to Week 12|Withdrawal by Subject|0|||
44424904|NCT00718718|79432948|FG001|Prior to Week 12|Withdrawal by Subject|0|||
44424905|NCT00718718|79432949|FG002|Prior to Week 12|Withdrawal by Subject|0|||
44424906|NCT00718718|79432950|FG003|Prior to Week 12|Withdrawal by Subject|0|||
44424907|NCT00718718|79432951|FG004|Prior to Week 12|Withdrawal by Subject|3|||
44424908|NCT00718718|79432952|FG005|Prior to Week 12|Withdrawal by Subject|0|||
44424909|NCT00718718|79432953|FG006|Prior to Week 12|Withdrawal by Subject|1|||
44328292|NCT01202773|79333308|FG000|Overall Study|Lack of Efficacy|5|||
44328293|NCT01202773|79333309|FG001|Overall Study|Lack of Efficacy|4|||
44328294|NCT01202773|79333310|FG002|Overall Study|Lack of Efficacy|9|||
44328295|NCT01202773|79333308|FG000|Overall Study|Entry Criteria Not Met|2|||
44328296|NCT01202773|79333309|FG001|Overall Study|Entry Criteria Not Met|0|||
44328297|NCT01202773|79333310|FG002|Overall Study|Entry Criteria Not Met|1|||
44328298|NCT01202773|79333308|FG000|Overall Study|Lost to Follow-up|1|||
44328299|NCT01202773|79333309|FG001|Overall Study|Lost to Follow-up|2|||
44328300|NCT01202773|79333310|FG002|Overall Study|Lost to Follow-up|2|||
44328301|NCT01202773|79333308|FG000|Overall Study|Withdrawal by Subject|13|||
44328302|NCT01202773|79333309|FG001|Overall Study|Withdrawal by Subject|6|||
44328303|NCT01202773|79333310|FG002|Overall Study|Withdrawal by Subject|5|||
44424910|NCT00718718|79432954|FG007|Prior to Week 12|Withdrawal by Subject|1|||
44424911|NCT00718718|79432955|FG008|Prior to Week 12|Withdrawal by Subject|1|||
44424912|NCT00718718|79432956|FG009|Prior to Week 12|Withdrawal by Subject|0|||
44424913|NCT00718718|79432947|FG000|Prior to Week 12|Other|1|||
44424914|NCT00718718|79432948|FG001|Prior to Week 12|Other|0|||
44424915|NCT00718718|79432949|FG002|Prior to Week 12|Other|1|||
44424916|NCT00718718|79432950|FG003|Prior to Week 12|Other|0|||
44424917|NCT00718718|79432951|FG004|Prior to Week 12|Other|0|||
44424918|NCT00718718|79432952|FG005|Prior to Week 12|Other|0|||
44328304|NCT01202773|79333308|FG000|Overall Study|Physician Decision|2|||
44328305|NCT01202773|79333309|FG001|Overall Study|Physician Decision|0|||
44328306|NCT01202773|79333310|FG002|Overall Study|Physician Decision|0|||
44328307|NCT01202773|79333308|FG000|Overall Study|Protocol Violation|11|||
44424919|NCT00718718|79432953|FG006|Prior to Week 12|Other|0|||
44424920|NCT00718718|79432954|FG007|Prior to Week 12|Other|0|||
44328308|NCT01202773|79333309|FG001|Overall Study|Protocol Violation|6|||
44328309|NCT01202773|79333310|FG002|Overall Study|Protocol Violation|10|||
44328310|NCT01202773|79333308|FG000|Overall Study|Sponsor Decision|19|||
44328311|NCT01202773|79333309|FG001|Overall Study|Sponsor Decision|20|||
44328312|NCT01202773|79333310|FG002|Overall Study|Sponsor Decision|23|||
44424921|NCT00718718|79432955|FG008|Prior to Week 12|Other|0|||
44424922|NCT00718718|79432956|FG009|Prior to Week 12|Other|0|||
44424923|NCT00718718|79432947|FG000|Week 12 to End of Study|Adverse Event|0|||
44424924|NCT00718718|79432948|FG001|Week 12 to End of Study|Adverse Event|0|||
44424925|NCT00718718|79432949|FG002|Week 12 to End of Study|Adverse Event|0|||
44424926|NCT00718718|79432950|FG003|Week 12 to End of Study|Adverse Event|0|||
44424927|NCT00718718|79432951|FG004|Week 12 to End of Study|Adverse Event|0|||
44424928|NCT00718718|79432952|FG005|Week 12 to End of Study|Adverse Event|0|||
44424929|NCT00718718|79432953|FG006|Week 12 to End of Study|Adverse Event|0|||
44424930|NCT00718718|79432954|FG007|Week 12 to End of Study|Adverse Event|1|||
44424931|NCT00718718|79432955|FG008|Week 12 to End of Study|Adverse Event|0|||
44424932|NCT00718718|79432956|FG009|Week 12 to End of Study|Adverse Event|0|||
44424933|NCT00718718|79432947|FG000|Week 12 to End of Study|Death|0|||
44328313|NCT01180660|79333330|FG000|Overall Study|Changed to open surgery|1|||
44424934|NCT00718718|79432948|FG001|Week 12 to End of Study|Death|0|||
44424935|NCT00718718|79432949|FG002|Week 12 to End of Study|Death|0|||
44424936|NCT00718718|79432950|FG003|Week 12 to End of Study|Death|0|||
44424937|NCT00718718|79432951|FG004|Week 12 to End of Study|Death|0|||
44424938|NCT00718718|79432952|FG005|Week 12 to End of Study|Death|1|||
44424939|NCT00718718|79432953|FG006|Week 12 to End of Study|Death|0|||
44424940|NCT00718718|79432954|FG007|Week 12 to End of Study|Death|0|||
44424941|NCT00718718|79432955|FG008|Week 12 to End of Study|Death|0|||
44424942|NCT00718718|79432956|FG009|Week 12 to End of Study|Death|0|||
44424943|NCT00718718|79432947|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
44424944|NCT00718718|79432948|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
44424945|NCT00718718|79432949|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
44424946|NCT00718718|79432950|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
44424947|NCT00718718|79432951|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
44424948|NCT00718718|79432952|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
44424949|NCT00718718|79432953|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
44424950|NCT00718718|79432954|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
44424951|NCT00718718|79432955|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
44424952|NCT00718718|79432956|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
44424953|NCT00718718|79432947|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
44424954|NCT00718718|79432948|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
44424955|NCT00718718|79432949|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
44424956|NCT00718718|79432950|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
44424957|NCT00718718|79432951|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
44424958|NCT00718718|79432952|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
44424959|NCT00718718|79432953|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
44424960|NCT00718718|79432954|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
44424961|NCT00718718|79432955|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
44328314|NCT01180660|79333331|FG001|Overall Study|Changed to open surgery|0|||
44328315|NCT01202227|79333337|FG000|Overall Study|Adverse Event|16|||
44328316|NCT01202227|79333337|FG000|Overall Study|Withdrawal by Subject|2|||
44328317|NCT01202227|79333337|FG000|Overall Study|Lack of Efficacy|1|||
44328318|NCT01202188|79333346|FG000|Overall Study|Protocol deviation|14|||
44328319|NCT01202188|79333347|FG001|Overall Study|Protocol deviation|8|||
44328320|NCT01202188|79333348|FG002|Overall Study|Protocol deviation|12|||
44424962|NCT00718718|79432956|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
44424963|NCT00718718|79432947|FG000|Week 12 to End of Study|Other|0|||
44424964|NCT00718718|79432948|FG001|Week 12 to End of Study|Other|1|||
44424965|NCT00718718|79432949|FG002|Week 12 to End of Study|Other|0|||
44424966|NCT00718718|79432950|FG003|Week 12 to End of Study|Other|1|||
44424967|NCT00718718|79432951|FG004|Week 12 to End of Study|Other|0|||
44424968|NCT00718718|79432952|FG005|Week 12 to End of Study|Other|0|||
44424969|NCT00718718|79432953|FG006|Week 12 to End of Study|Other|1|||
44424970|NCT00718718|79432954|FG007|Week 12 to End of Study|Other|0|||
44424971|NCT00718718|79432955|FG008|Week 12 to End of Study|Other|0|||
44424972|NCT00718718|79432956|FG009|Week 12 to End of Study|Other|0|||
44424973|NCT00683787|79432985|FG000|Overall Study|Progression|3|||
44424974|NCT00683787|79432986|FG001|Overall Study|Progression|3|||
44424975|NCT00683787|79432987|FG002|Overall Study|Progression|0|||
44424976|NCT00683787|79432985|FG000|Overall Study|Adverse Event|0|||
44328321|NCT01202188|79333349|FG003|Overall Study|Protocol deviation|10|||
44424977|NCT00683787|79432986|FG001|Overall Study|Adverse Event|0|||
44424978|NCT00683787|79432987|FG002|Overall Study|Adverse Event|2|||
44424979|NCT00723008|79432997|FG000|Enrollment|Lost to Follow-up|1|||
44424980|NCT00723008|79432998|FG001|Enrollment|Lost to Follow-up|0|||
44424981|NCT00723008|79432997|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
44424982|NCT00723008|79432998|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
44424983|NCT00723008|79432997|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
44424984|NCT00723008|79432998|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
44424985|NCT00723008|79432997|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
44424986|NCT00723008|79432998|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
44424987|NCT00723008|79432997|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
44424988|NCT00723008|79432998|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
44156745|NCT04537208|78948038|FG000|Overall Study|Lost to Follow-up|4|||
44156746|NCT04537208|78948039|FG001|Overall Study|Lost to Follow-up|1|||
44156747|NCT04537208|78948040|FG002|Overall Study|Lost to Follow-up|3|||
44156748|NCT04537208|78948041|FG003|Overall Study|Lost to Follow-up|4|||
44156749|NCT04537208|78948042|FG004|Overall Study|Lost to Follow-up|3|||
44156750|NCT04537208|78948043|FG005|Overall Study|Lost to Follow-up|2|||
44156751|NCT04537208|78948044|FG006|Overall Study|Lost to Follow-up|3|||
44156752|NCT04537208|78948045|FG007|Overall Study|Lost to Follow-up|2|||
44156753|NCT04537208|78948046|FG008|Overall Study|Lost to Follow-up|7|||
44156754|NCT04537208|78948047|FG009|Overall Study|Lost to Follow-up|2|||
44156755|NCT04537208|78948048|FG010|Overall Study|Lost to Follow-up|2|||
44156756|NCT04502433|78948077|FG000|Overall Study|Death|2|||
44156757|NCT04502433|78948078|FG001|Overall Study|Death|4|||
44156758|NCT04502433|78948077|FG000|Overall Study|Lost to Follow-up|1|||
44328322|NCT01202188|79333350|FG004|Overall Study|Protocol deviation|11|||
44328323|NCT01202188|79333346|FG000|Overall Study|Subject withdrew consent|12|||
44328324|NCT01202188|79333347|FG001|Overall Study|Subject withdrew consent|13|||
44328325|NCT01202188|79333348|FG002|Overall Study|Subject withdrew consent|22|||
44328326|NCT01202188|79333349|FG003|Overall Study|Subject withdrew consent|11|||
44328327|NCT01202188|79333350|FG004|Overall Study|Subject withdrew consent|13|||
44328328|NCT01202188|79333346|FG000|Overall Study|Adverse Event|5|||
44328329|NCT01202188|79333347|FG001|Overall Study|Adverse Event|23|||
44328330|NCT01202188|79333348|FG002|Overall Study|Adverse Event|13|||
44328331|NCT01202188|79333349|FG003|Overall Study|Adverse Event|10|||
44328332|NCT01202188|79333350|FG004|Overall Study|Adverse Event|10|||
44328333|NCT01202188|79333346|FG000|Overall Study|Administrative problems|3|||
44328334|NCT01202188|79333347|FG001|Overall Study|Administrative problems|2|||
44328335|NCT01202188|79333348|FG002|Overall Study|Administrative problems|1|||
44328336|NCT01202188|79333349|FG003|Overall Study|Administrative problems|1|||
44328337|NCT01202188|79333350|FG004|Overall Study|Administrative problems|2|||
44328338|NCT01202188|79333346|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44328339|NCT01202188|79333347|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
44328340|NCT01202188|79333348|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
44328341|NCT01202188|79333349|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
44328342|NCT01202188|79333350|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
44328343|NCT01202188|79333346|FG000|Overall Study|Lost to Follow-up|1|||
44328344|NCT01202188|79333347|FG001|Overall Study|Lost to Follow-up|1|||
44328345|NCT01202188|79333348|FG002|Overall Study|Lost to Follow-up|0|||
44328346|NCT01202188|79333349|FG003|Overall Study|Lost to Follow-up|4|||
44328347|NCT01202188|79333350|FG004|Overall Study|Lost to Follow-up|1|||
44328348|NCT01202188|79333346|FG000|Overall Study|Death|1|||
44424989|NCT00723008|79432997|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
44156759|NCT04502433|78948078|FG001|Overall Study|Lost to Follow-up|0|||
44424990|NCT00723008|79432998|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
44424991|NCT00718640|79433012|FG000|Overall Study|Adverse Event|4|||
44424992|NCT00718640|79433012|FG000|Overall Study|Death|1|||
44424993|NCT00718640|79433012|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
44424994|NCT00715910|79433020|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
44424995|NCT00715910|79433021|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
44156760|NCT04502433|78948077|FG000|Overall Study|Physician Decision|0|||
44156761|NCT04502433|78948078|FG001|Overall Study|Physician Decision|1|||
44156762|NCT04411914|78948086|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
44424996|NCT00715910|79433022|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
44424997|NCT00715910|79433023|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
44424998|NCT00715910|79433024|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
44424999|NCT00715910|79433025|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
44156763|NCT04411914|78948087|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
44328349|NCT01202188|79333347|FG001|Overall Study|Death|1|||
44328350|NCT01202188|79333348|FG002|Overall Study|Death|1|||
44425000|NCT00715910|79433020|FG000|Booster and ESFU Phase|Other|0|||
44156764|NCT04389671|78948106|FG000|Overall Study|Death|7|||
44328351|NCT01202188|79333349|FG003|Overall Study|Death|1|||
44328352|NCT01202188|79333350|FG004|Overall Study|Death|0|||
44328353|NCT01202188|79333346|FG000|Overall Study|Abnormal test procedure result (s)|0|||
44328354|NCT01202188|79333347|FG001|Overall Study|Abnormal test procedure result (s)|0|||
44328355|NCT01202188|79333348|FG002|Overall Study|Abnormal test procedure result (s)|2|||
44328356|NCT01202188|79333349|FG003|Overall Study|Abnormal test procedure result (s)|0|||
44328357|NCT01202188|79333350|FG004|Overall Study|Abnormal test procedure result (s)|0|||
44328358|NCT01201915|79333371|FG000|Overall Study|Adverse Event|2|||
44328359|NCT01201915|79333372|FG001|Overall Study|Adverse Event|1|||
44328360|NCT01201915|79333373|FG002|Overall Study|Adverse Event|1|||
44328361|NCT01201915|79333371|FG000|Overall Study|Lost to Follow-up|0|||
44328362|NCT01201915|79333372|FG001|Overall Study|Lost to Follow-up|4|||
44328363|NCT01201915|79333373|FG002|Overall Study|Lost to Follow-up|0|||
44328364|NCT01201915|79333371|FG000|Overall Study|Physician Decision|3|||
44328365|NCT01201915|79333372|FG001|Overall Study|Physician Decision|0|||
44425001|NCT00715910|79433021|FG001|Booster and ESFU Phase|Other|0|||
44425002|NCT00715910|79433022|FG002|Booster and ESFU Phase|Other|0|||
44425003|NCT00715910|79433023|FG003|Booster and ESFU Phase|Other|5|||
44425004|NCT00715910|79433024|FG004|Booster and ESFU Phase|Other|1|||
44425005|NCT00715910|79433025|FG005|Booster and ESFU Phase|Other|0|||
44425006|NCT00715676|79433044|FG000|Overall Study|Adverse Event|3|||
44425007|NCT00715676|79433045|FG001|Overall Study|Adverse Event|5|||
44425008|NCT00715676|79433046|FG002|Overall Study|Adverse Event|21|||
44425009|NCT00715676|79433044|FG000|Overall Study|Withdrawal by Subject|1|||
44425010|NCT00715676|79433045|FG001|Overall Study|Withdrawal by Subject|3|||
44425011|NCT00715676|79433046|FG002|Overall Study|Withdrawal by Subject|8|||
44328366|NCT01201915|79333373|FG002|Overall Study|Physician Decision|0|||
44328367|NCT01201915|79333371|FG000|Overall Study|Subject Decision|3|||
44328368|NCT01201915|79333372|FG001|Overall Study|Subject Decision|3|||
44328369|NCT01201915|79333373|FG002|Overall Study|Subject Decision|5|||
44328370|NCT01201915|79333371|FG000|Overall Study|Target Lesion Progression|0|||
44328371|NCT01201915|79333372|FG001|Overall Study|Target Lesion Progression|3|||
44328372|NCT01201915|79333373|FG002|Overall Study|Target Lesion Progression|0|||
44328373|NCT01179919|79333381|FG000|Overall Study|Protocol Violation|1|||
44328374|NCT01179919|79333381|FG000|Overall Study|Adverse Event|1|||
44328375|NCT01201798|79333387|FG000|Overall Study|Adverse Event|2|||
44328376|NCT01201798|79333388|FG001|Overall Study|Adverse Event|0|||
44328377|NCT01201798|79333387|FG000|Overall Study|Lost to Follow-up|3|||
44328378|NCT01201798|79333388|FG001|Overall Study|Lost to Follow-up|5|||
44328379|NCT01201798|79333387|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
44328380|NCT01201798|79333388|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
44328381|NCT01201798|79333387|FG000|Overall Study|Noncompliance|1|||
44328382|NCT01201798|79333388|FG001|Overall Study|Noncompliance|0|||
44328383|NCT01201798|79333387|FG000|Overall Study|Protocol Violation|1|||
44328384|NCT01201798|79333388|FG001|Overall Study|Protocol Violation|1|||
44328385|NCT01201798|79333387|FG000|Overall Study|Treatment Failure|1|||
44328386|NCT01201798|79333388|FG001|Overall Study|Treatment Failure|8|||
44328387|NCT01201759|79333396|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
44328388|NCT01201759|79333397|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
44328389|NCT01201759|79333396|FG000|Visit 3 - Washout|Adverse Event|0|||
44328390|NCT01201759|79333397|FG001|Visit 3 - Washout|Adverse Event|3|||
44328391|NCT01201759|79333396|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
44328392|NCT01201759|79333397|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
44328393|NCT01201759|79333396|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
44328394|NCT01201759|79333397|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
44328395|NCT01200589|79333407|FG000|Overall Study|Withdrawal by Subject|13|||
44328396|NCT01200589|79333408|FG001|Overall Study|Withdrawal by Subject|11|||
44328397|NCT01200589|79333407|FG000|Overall Study|Physician Decision|2|||
44328398|NCT01200589|79333408|FG001|Overall Study|Physician Decision|2|||
44328399|NCT01200589|79333407|FG000|Overall Study|Lost to Follow-up|5|||
44328400|NCT01200589|79333408|FG001|Overall Study|Lost to Follow-up|4|||
44328401|NCT01200589|79333407|FG000|Overall Study|Study terminated|170|||
44425012|NCT00715676|79433044|FG000|Overall Study|Lost to Follow-up|1|||
44425013|NCT00715676|79433045|FG001|Overall Study|Lost to Follow-up|2|||
44425014|NCT00715676|79433046|FG002|Overall Study|Lost to Follow-up|1|||
44156765|NCT04381494|78948110|FG000|Overall Study|Early termination of trial|19|||
44156766|NCT04381494|78948110|FG000|Overall Study|Investigator's discretion|1|||
44156767|NCT04381494|78948110|FG000|Overall Study|Withdrawal by Subject|9|||
44156768|NCT04381494|78948110|FG000|Overall Study|NSCLC disease progression|4|||
44156769|NCT04381494|78948110|FG000|Overall Study|Device-Related Adverse Event|2|||
44156770|NCT04094584|78948165|FG000|Overall Study|No interest in study|88|||
44328402|NCT01200589|79333408|FG001|Overall Study|Study terminated|172|||
44328403|NCT01200511|79333414|FG000|Overall Study|Lost to Follow-up|3|||
44328404|NCT01200511|79333414|FG000|Overall Study|Withdrawal by Subject|1|||
44328405|NCT01200511|79333414|FG000|Overall Study|Adverse Event|1|||
44328406|NCT01179334|79333422|FG000|Treatment Period|Adverse Event|1|||
44328407|NCT01179334|79333423|FG001|Treatment Period|Adverse Event|0|||
44328408|NCT01179334|79333422|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
44328409|NCT01179334|79333423|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
44425015|NCT00715676|79433044|FG000|Overall Study|Terminated by Sponsor|1|||
44425016|NCT00715676|79433045|FG001|Overall Study|Terminated by Sponsor|0|||
44425017|NCT00715676|79433046|FG002|Overall Study|Terminated by Sponsor|0|||
44425018|NCT00715676|79433044|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
44328410|NCT01179334|79333422|FG000|Long-term Extension (LTE) Period|Death|3|||
44328411|NCT01179334|79333423|FG001|Long-term Extension (LTE) Period|Death|0|||
44328412|NCT01179334|79333422|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
44328413|NCT01179334|79333423|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
44328414|NCT01178671|79333431|FG000|Overall Study|Adverse Event|4|||
44328415|NCT01178671|79333432|FG001|Overall Study|Adverse Event|6|||
44328416|NCT01178671|79333431|FG000|Overall Study|Protocol Violation|1|||
44328417|NCT01178671|79333432|FG001|Overall Study|Protocol Violation|1|||
44425019|NCT00715676|79433045|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
44425020|NCT00715676|79433046|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
44425021|NCT00715676|79433044|FG000|Overall Study|Use of Exclusionary Medication|0|||
44425022|NCT00715676|79433045|FG001|Overall Study|Use of Exclusionary Medication|0|||
44425023|NCT00715676|79433046|FG002|Overall Study|Use of Exclusionary Medication|1|||
44425024|NCT00715676|79433044|FG000|Overall Study|Elevated Blood Glucose|0|||
44425025|NCT00715676|79433045|FG001|Overall Study|Elevated Blood Glucose|1|||
44425026|NCT00715676|79433046|FG002|Overall Study|Elevated Blood Glucose|0|||
44425027|NCT00718328|79433056|FG000|Overall Study|Lost to Follow-up|1|||
44425028|NCT00718328|79433057|FG001|Overall Study|Lost to Follow-up|0|||
44425029|NCT00715520|79433066|FG000|Overall Study|Screen failure|8|||
44425030|NCT00715520|79433067|FG001|Overall Study|Screen failure|1|||
44425031|NCT00715520|79433068|FG002|Overall Study|Screen failure|1|||
44425032|NCT00715520|79433066|FG000|Overall Study|Withdrawal by Subject|2|||
44425033|NCT00715520|79433067|FG001|Overall Study|Withdrawal by Subject|0|||
44425034|NCT00715520|79433068|FG002|Overall Study|Withdrawal by Subject|1|||
44425035|NCT00790205|79433078|FG000|Overall Study|Lost to Follow-up|61|||
44425036|NCT00790205|79433079|FG001|Overall Study|Lost to Follow-up|71|||
44425037|NCT00790205|79433078|FG000|Overall Study|Withdrawal by Subject|299|||
44425038|NCT00790205|79433079|FG001|Overall Study|Withdrawal by Subject|363|||
44425039|NCT00715208|79433087|FG000|Overall Study|Withdrawal by Subject|1|||
44425040|NCT00715208|79433088|FG001|Overall Study|Withdrawal by Subject|1|||
44425041|NCT00715208|79433087|FG000|Overall Study|Adverse Event|0|||
44425042|NCT00715208|79433088|FG001|Overall Study|Adverse Event|6|||
44425043|NCT00715208|79433087|FG000|Overall Study|Lack of Efficacy|0|||
44425044|NCT00715208|79433088|FG001|Overall Study|Lack of Efficacy|2|||
44425045|NCT00587795|79433096|FG000|Overall Study|Withdrawal by Subject|1|||
44425046|NCT00587795|79433097|FG001|Overall Study|Withdrawal by Subject|0|||
44425047|NCT00587639|79433103|FG000|Overall Study|Withdrawal by Subject|1|||
44425048|NCT00774995|79433111|FG000|Overall Study|Protocol Violation|0|||
44425049|NCT00774995|79433112|FG001|Overall Study|Protocol Violation|0|||
44425050|NCT00774995|79433113|FG002|Overall Study|Protocol Violation|1|||
44425051|NCT00774995|79433114|FG003|Overall Study|Protocol Violation|0|||
44425052|NCT00713648|79433124|FG000|Overall Study|Adverse Event|1|||
44425053|NCT00713648|79433124|FG000|Overall Study|Unclassified|2|||
44425054|NCT00713648|79433124|FG000|Overall Study|According to Protocol|2|||
44425055|NCT00713648|79433124|FG000|Overall Study|Development of antibodies|3|||
44425056|NCT00768053|79433128|FG000|Overall Study|Adverse Event|10|||
44425057|NCT00768053|79433128|FG000|Overall Study|Lost to Follow-up|1|||
44425058|NCT00683475|79433134|FG000|Overall Study|Withdrawal by Subject|1|||
44425059|NCT00683475|79433135|FG001|Overall Study|Withdrawal by Subject|0|||
44425060|NCT00683475|79433134|FG000|Overall Study|Never Treated: Adverse Event|2|||
44425061|NCT00683475|79433135|FG001|Overall Study|Never Treated: Adverse Event|3|||
44425062|NCT00683475|79433134|FG000|Overall Study|Never Treated: Progressive Disease|1|||
44425063|NCT00683475|79433135|FG001|Overall Study|Never Treated: Progressive Disease|0|||
44425064|NCT00685035|79433142|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
44425065|NCT00685035|79433143|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
44425066|NCT00773747|79433169|FG000|Overall Study|Lack of Efficacy|112|||
44425067|NCT00773747|79433170|FG001|Overall Study|Lack of Efficacy|144|||
44425068|NCT00773747|79433169|FG000|Overall Study|Physician Decision|26|||
44425069|NCT00773747|79433170|FG001|Overall Study|Physician Decision|18|||
44328418|NCT01178671|79333431|FG000|Overall Study|Lack of Efficacy|0|||
44328419|NCT01178671|79333432|FG001|Overall Study|Lack of Efficacy|1|||
44328420|NCT01178671|79333431|FG000|Overall Study|Lost to Follow-up|3|||
44328421|NCT01178671|79333432|FG001|Overall Study|Lost to Follow-up|1|||
44328422|NCT01178671|79333431|FG000|Overall Study|Physician Decision|4|||
44425070|NCT00773747|79433169|FG000|Overall Study|Lost to Follow-up|0|||
44328423|NCT01178671|79333432|FG001|Overall Study|Physician Decision|6|||
44328424|NCT01178125|79333438|FG000|Overall Study|Lost to Follow-up|397|||
44425071|NCT00773747|79433170|FG001|Overall Study|Lost to Follow-up|1|||
44425072|NCT00773747|79433169|FG000|Overall Study|Protocol Violation|2|||
44425073|NCT00773747|79433170|FG001|Overall Study|Protocol Violation|2|||
44425074|NCT00773747|79433169|FG000|Overall Study|Withdrawal by Subject|89|||
44537212|NCT00003869|79547926|FG000|Overall Study|Adverse Event|14|||
44328425|NCT01178125|79333438|FG000|Overall Study|Adverse Event|244|||
44425075|NCT00773747|79433170|FG001|Overall Study|Withdrawal by Subject|61|||
44425076|NCT00773747|79433169|FG000|Overall Study|Adverse Event|61|||
44425077|NCT00773747|79433170|FG001|Overall Study|Adverse Event|62|||
44425078|NCT00773747|79433169|FG000|Overall Study|Death|5|||
44328426|NCT01178125|79333438|FG000|Overall Study|Withdrawal by Subject|209|||
44328427|NCT01178125|79333438|FG000|Overall Study|Noncompliance|184|||
44328428|NCT01178125|79333438|FG000|Overall Study|Pregnancy|55|||
44328429|NCT01178125|79333438|FG000|Overall Study|Other Reason|39|||
44328430|NCT01178125|79333438|FG000|Overall Study|Sponsor Decision|28|||
44328431|NCT01178125|79333438|FG000|Overall Study|Protocol Violation|17|||
44328432|NCT01178125|79333438|FG000|Overall Study|Investigator Decision|5|||
44328433|NCT01178086|79333460|FG000|Overall Study|Participant refusal|7|||
44328434|NCT01178086|79333460|FG000|Overall Study|Physician Decision|44|||
44328435|NCT01178086|79333460|FG000|Overall Study|Switch to other CLL therapy|113|||
44328436|NCT01178086|79333460|FG000|Overall Study|Death|59|||
44328437|NCT01178086|79333460|FG000|Overall Study|Other unspecified|89|||
44328438|NCT01178086|79333460|FG000|Overall Study|Excluded from EAS|20|||
44328439|NCT01177969|79333468|FG000|Overall Study|Protocol Violation|2|||
44328440|NCT01177969|79333469|FG001|Overall Study|Protocol Violation|1|||
44328441|NCT01177969|79333468|FG000|Overall Study|Withdrawal by Subject|1|||
44328442|NCT01177969|79333469|FG001|Overall Study|Withdrawal by Subject|2|||
44328443|NCT01177813|79333480|FG000|Overall Study|Adverse Event|8|||
44328444|NCT01177813|79333481|FG001|Overall Study|Adverse Event|2|||
44328445|NCT01177813|79333482|FG002|Overall Study|Adverse Event|4|||
44328446|NCT01177813|79333483|FG003|Overall Study|Adverse Event|6|||
44328447|NCT01177813|79333484|FG004|Overall Study|Adverse Event|3|||
44328448|NCT01177813|79333480|FG000|Overall Study|Lack of Efficacy|1|||
44328449|NCT01177813|79333481|FG001|Overall Study|Lack of Efficacy|0|||
44328450|NCT01177813|79333482|FG002|Overall Study|Lack of Efficacy|0|||
44328451|NCT01177813|79333483|FG003|Overall Study|Lack of Efficacy|0|||
44328452|NCT01177813|79333484|FG004|Overall Study|Lack of Efficacy|0|||
44328453|NCT01177813|79333480|FG000|Overall Study|Protocol Violation|3|||
44328454|NCT01177813|79333481|FG001|Overall Study|Protocol Violation|2|||
44328455|NCT01177813|79333482|FG002|Overall Study|Protocol Violation|2|||
44328456|NCT01177813|79333483|FG003|Overall Study|Protocol Violation|0|||
44328457|NCT01177813|79333484|FG004|Overall Study|Protocol Violation|1|||
44328458|NCT01177813|79333480|FG000|Overall Study|Lost to Follow-up|12|||
44328459|NCT01177813|79333481|FG001|Overall Study|Lost to Follow-up|5|||
44328460|NCT01177813|79333482|FG002|Overall Study|Lost to Follow-up|6|||
44328461|NCT01177813|79333483|FG003|Overall Study|Lost to Follow-up|3|||
44328462|NCT01177813|79333484|FG004|Overall Study|Lost to Follow-up|0|||
44328463|NCT01177813|79333480|FG000|Overall Study|Withdrawal by Subject|12|||
44328464|NCT01177813|79333481|FG001|Overall Study|Withdrawal by Subject|7|||
44328465|NCT01177813|79333482|FG002|Overall Study|Withdrawal by Subject|6|||
44328466|NCT01177813|79333483|FG003|Overall Study|Withdrawal by Subject|5|||
44328467|NCT01177813|79333484|FG004|Overall Study|Withdrawal by Subject|3|||
44328468|NCT01177813|79333480|FG000|Overall Study|Other reason not defined above|5|||
44328469|NCT01177813|79333481|FG001|Overall Study|Other reason not defined above|2|||
44328470|NCT01177813|79333482|FG002|Overall Study|Other reason not defined above|2|||
44328471|NCT01177813|79333483|FG003|Overall Study|Other reason not defined above|3|||
44328472|NCT01177813|79333484|FG004|Overall Study|Other reason not defined above|2|||
44328473|NCT01200394|79333498|FG000|Overall Study|Adverse Event|0|||
44328474|NCT01200394|79333499|FG001|Overall Study|Adverse Event|14|||
44328475|NCT01200394|79333498|FG000|Overall Study|Death|1|||
44328476|NCT01200394|79333499|FG001|Overall Study|Death|0|||
44328477|NCT01200394|79333498|FG000|Overall Study|Lost to Follow-up|0|||
44425079|NCT00773747|79433170|FG001|Overall Study|Death|8|||
44425080|NCT00773747|79433169|FG000|Overall Study|Not Treated|2|||
44425081|NCT00773747|79433170|FG001|Overall Study|Not Treated|0|||
44425082|NCT00784277|79433180|FG000|IR Treatment|Adverse Event|4|||
44425083|NCT00784277|79433181|FG001|IR Treatment|Adverse Event|8|||
44425084|NCT00784277|79433182|FG002|IR Treatment|Adverse Event|19|||
44425085|NCT00784277|79433183|FG003|IR Treatment|Adverse Event|35|||
44425086|NCT00784277|79433184|FG004|IR Treatment|Adverse Event|0|||
44425087|NCT00784277|79433185|FG005|IR Treatment|Adverse Event|0|||
44425088|NCT00784277|79433186|FG006|IR Treatment|Adverse Event|0|||
44425089|NCT00784277|79433180|FG000|IR Treatment|Lack of Efficacy|4|||
44425090|NCT00784277|79433181|FG001|IR Treatment|Lack of Efficacy|4|||
44425091|NCT00784277|79433182|FG002|IR Treatment|Lack of Efficacy|1|||
44425092|NCT00784277|79433183|FG003|IR Treatment|Lack of Efficacy|0|||
44425093|NCT00784277|79433184|FG004|IR Treatment|Lack of Efficacy|0|||
44425094|NCT00784277|79433185|FG005|IR Treatment|Lack of Efficacy|0|||
44537213|NCT00003869|79547927|FG001|Overall Study|Adverse Event|3|||
44537214|NCT00003869|79547926|FG000|Overall Study|Withdrawal by Subject|21|||
44328478|NCT01200394|79333499|FG001|Overall Study|Lost to Follow-up|1|||
44328479|NCT01200394|79333498|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
44328480|NCT01200394|79333499|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
44328481|NCT01200394|79333498|FG000|Overall Study|Protocol Violation|0|||
44328482|NCT01200394|79333499|FG001|Overall Study|Protocol Violation|3|||
44328483|NCT01200394|79333498|FG000|Overall Study|Withdrawal by Subject|0|||
44425095|NCT00784277|79433186|FG006|IR Treatment|Lack of Efficacy|0|||
44425096|NCT00784277|79433180|FG000|IR Treatment|Lost to Follow-up|1|||
44425097|NCT00784277|79433181|FG001|IR Treatment|Lost to Follow-up|0|||
44425098|NCT00784277|79433182|FG002|IR Treatment|Lost to Follow-up|1|||
44328484|NCT01200394|79333499|FG001|Overall Study|Withdrawal by Subject|5|||
44328485|NCT01200394|79333498|FG000|Overall Study|Other|0|||
44328486|NCT01200394|79333499|FG001|Overall Study|Other|1|||
44328487|NCT01200355|79333508|FG000|Overall Study|Death|7|||
44328488|NCT01200355|79333509|FG001|Overall Study|Death|2|||
44328489|NCT01200238|79333517|FG000|Overall Study|Adverse Event|2|||
44328490|NCT01200238|79333518|FG001|Overall Study|Adverse Event|1|||
44328491|NCT01200238|79333517|FG000|Overall Study|Progressive Disease|5|||
44328492|NCT01200238|79333518|FG001|Overall Study|Progressive Disease|8|||
44328493|NCT01200238|79333517|FG000|Overall Study|Withdrawal by Subject|0|||
44328494|NCT01200238|79333518|FG001|Overall Study|Withdrawal by Subject|1|||
44328495|NCT01199731|79333527|FG000|Overall Study|Adverse Event|0|||
44328496|NCT01199731|79333528|FG001|Overall Study|Adverse Event|1|||
44328497|NCT01199731|79333529|FG002|Overall Study|Adverse Event|0|||
44328498|NCT01199731|79333527|FG000|Overall Study|Study closed/terminated|7|||
44328499|NCT01199731|79333528|FG001|Overall Study|Study closed/terminated|9|||
44328500|NCT01199731|79333529|FG002|Overall Study|Study closed/terminated|7|||
44425099|NCT00784277|79433183|FG003|IR Treatment|Lost to Follow-up|0|||
44425100|NCT00784277|79433184|FG004|IR Treatment|Lost to Follow-up|0|||
44425101|NCT00784277|79433185|FG005|IR Treatment|Lost to Follow-up|0|||
44425102|NCT00784277|79433186|FG006|IR Treatment|Lost to Follow-up|0|||
44425103|NCT00784277|79433180|FG000|IR Treatment|Withdrawal by Subject|5|||
44425104|NCT00784277|79433181|FG001|IR Treatment|Withdrawal by Subject|1|||
44425105|NCT00784277|79433182|FG002|IR Treatment|Withdrawal by Subject|4|||
44425106|NCT00784277|79433183|FG003|IR Treatment|Withdrawal by Subject|6|||
44425107|NCT00784277|79433184|FG004|IR Treatment|Withdrawal by Subject|0|||
44425108|NCT00784277|79433185|FG005|IR Treatment|Withdrawal by Subject|0|||
44425109|NCT00784277|79433186|FG006|IR Treatment|Withdrawal by Subject|0|||
44425110|NCT00784277|79433180|FG000|IR Treatment|Resolution Of Pain|0|||
44425111|NCT00784277|79433181|FG001|IR Treatment|Resolution Of Pain|1|||
44425112|NCT00784277|79433182|FG002|IR Treatment|Resolution Of Pain|0|||
44425113|NCT00784277|79433183|FG003|IR Treatment|Resolution Of Pain|0|||
44425114|NCT00784277|79433184|FG004|IR Treatment|Resolution Of Pain|0|||
44425115|NCT00784277|79433185|FG005|IR Treatment|Resolution Of Pain|0|||
44425116|NCT00784277|79433186|FG006|IR Treatment|Resolution Of Pain|0|||
44425117|NCT00784277|79433180|FG000|IR Treatment|Other|2|||
44425118|NCT00784277|79433181|FG001|IR Treatment|Other|3|||
44425119|NCT00784277|79433182|FG002|IR Treatment|Other|3|||
44425120|NCT00784277|79433183|FG003|IR Treatment|Other|2|||
44425121|NCT00784277|79433184|FG004|IR Treatment|Other|0|||
44425122|NCT00784277|79433185|FG005|IR Treatment|Other|0|||
44425123|NCT00784277|79433186|FG006|IR Treatment|Other|0|||
44425124|NCT00784277|79433180|FG000|ER Treatment|Adverse Event|0|||
44425125|NCT00784277|79433181|FG001|ER Treatment|Adverse Event|0|||
44425126|NCT00784277|79433182|FG002|ER Treatment|Adverse Event|0|||
44425127|NCT00784277|79433183|FG003|ER Treatment|Adverse Event|0|||
44425128|NCT00784277|79433184|FG004|ER Treatment|Adverse Event|1|||
44425129|NCT00784277|79433185|FG005|ER Treatment|Adverse Event|7|||
44425130|NCT00784277|79433186|FG006|ER Treatment|Adverse Event|7|||
44425131|NCT00784277|79433180|FG000|ER Treatment|Lack of Efficacy|0|||
44425132|NCT00784277|79433181|FG001|ER Treatment|Lack of Efficacy|0|||
44425133|NCT00784277|79433182|FG002|ER Treatment|Lack of Efficacy|0|||
44425134|NCT00784277|79433183|FG003|ER Treatment|Lack of Efficacy|0|||
44425135|NCT00784277|79433184|FG004|ER Treatment|Lack of Efficacy|3|||
44425136|NCT00784277|79433185|FG005|ER Treatment|Lack of Efficacy|4|||
44425137|NCT00784277|79433186|FG006|ER Treatment|Lack of Efficacy|0|||
44425138|NCT00784277|79433180|FG000|ER Treatment|Lost to Follow-up|0|||
44328501|NCT01199731|79333527|FG000|Overall Study|Lost to Follow-up|0|||
44328502|NCT01199731|79333528|FG001|Overall Study|Lost to Follow-up|0|||
44328503|NCT01199731|79333529|FG002|Overall Study|Lost to Follow-up|2|||
44328504|NCT01199731|79333527|FG000|Overall Study|Physician Decision|0|||
44328505|NCT01199731|79333528|FG001|Overall Study|Physician Decision|1|||
44328506|NCT01199731|79333529|FG002|Overall Study|Physician Decision|1|||
44328507|NCT01199731|79333527|FG000|Overall Study|Withdrawal by Subject|2|||
44425139|NCT00784277|79433181|FG001|ER Treatment|Lost to Follow-up|0|||
44425140|NCT00784277|79433182|FG002|ER Treatment|Lost to Follow-up|0|||
44328508|NCT01199731|79333528|FG001|Overall Study|Withdrawal by Subject|0|||
44425141|NCT00784277|79433183|FG003|ER Treatment|Lost to Follow-up|0|||
44425142|NCT00784277|79433184|FG004|ER Treatment|Lost to Follow-up|0|||
44425143|NCT00784277|79433185|FG005|ER Treatment|Lost to Follow-up|2|||
44425144|NCT00784277|79433186|FG006|ER Treatment|Lost to Follow-up|0|||
44425145|NCT00784277|79433180|FG000|ER Treatment|Withdrawal by Subject|0|||
44328509|NCT01199731|79333529|FG002|Overall Study|Withdrawal by Subject|0|||
44425146|NCT00784277|79433181|FG001|ER Treatment|Withdrawal by Subject|0|||
44425147|NCT00784277|79433182|FG002|ER Treatment|Withdrawal by Subject|0|||
44425148|NCT00784277|79433183|FG003|ER Treatment|Withdrawal by Subject|0|||
44328510|NCT01199263|79333539|FG000|Overall Study|Ineligible|0|||
44328511|NCT01199263|79333540|FG001|Overall Study|Ineligible|2|||
44328512|NCT01199263|79333539|FG000|Overall Study|Never Treated|6|||
44328513|NCT01199263|79333540|FG001|Overall Study|Never Treated|0|||
44425149|NCT00784277|79433184|FG004|ER Treatment|Withdrawal by Subject|2|||
44425150|NCT00784277|79433185|FG005|ER Treatment|Withdrawal by Subject|5|||
44425151|NCT00784277|79433186|FG006|ER Treatment|Withdrawal by Subject|3|||
44425152|NCT00784277|79433180|FG000|ER Treatment|Study Medication Non-Compliant|0|||
44156771|NCT04094584|78948165|FG000|Overall Study|Unwilling to undergo screening tests|36|||
44156772|NCT04094584|78948165|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
44156773|NCT04094584|78948165|FG000|Overall Study|Opioid use|7|||
44328514|NCT01199068|79333551|FG000|Overall Study|Unacceptable toxicity|0|||
44328515|NCT01199068|79333552|FG001|Overall Study|Unacceptable toxicity|0|||
44328516|NCT01199068|79333553|FG002|Overall Study|Unacceptable toxicity|2|||
44328517|NCT01199068|79333551|FG000|Overall Study|Progressive disease|3|||
44328518|NCT01199068|79333552|FG001|Overall Study|Progressive disease|3|||
44328519|NCT01199068|79333553|FG002|Overall Study|Progressive disease|6|||
44328520|NCT01199068|79333551|FG000|Overall Study|Withdrawal by Subject|0|||
44328521|NCT01199068|79333552|FG001|Overall Study|Withdrawal by Subject|0|||
44328522|NCT01199068|79333553|FG002|Overall Study|Withdrawal by Subject|1|||
44328523|NCT01198873|79333570|FG000|Overall Study|Adverse Event|4|||
44328524|NCT01198873|79333571|FG001|Overall Study|Adverse Event|7|||
44328525|NCT01198873|79333570|FG000|Overall Study|Study closure|29|||
44328526|NCT01198873|79333571|FG001|Overall Study|Study closure|23|||
44328527|NCT01198873|79333570|FG000|Overall Study|Other than above|4|||
44328528|NCT01198873|79333571|FG001|Overall Study|Other than above|2|||
44328529|NCT01198795|79333577|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
44328530|NCT01198795|79333577|FG000|Overall Study|Withdrawal by Subject|17|||
44328531|NCT01198795|79333577|FG000|Overall Study|Lost to Follow-up|15|||
44328532|NCT01198795|79333577|FG000|Overall Study|Adverse Event|9|||
44328533|NCT01198795|79333577|FG000|Overall Study|Lack of Efficacy|5|||
44328534|NCT01198795|79333577|FG000|Overall Study|Protocol Violation|2|||
44328535|NCT01198795|79333577|FG000|Overall Study|Other Reason|4|||
44328536|NCT01198756|79333585|FG000|Overall Study|Adverse Event|0|||
44328537|NCT01198756|79333586|FG001|Overall Study|Adverse Event|0|||
44328538|NCT01198756|79333587|FG002|Overall Study|Adverse Event|0|||
44328539|NCT01198756|79333588|FG003|Overall Study|Adverse Event|1|||
44328540|NCT01198756|79333585|FG000|Overall Study|Protocol Violation|0|||
44156774|NCT04094584|78948165|FG000|Overall Study|Need for major surgery in study period|4|||
44156775|NCT04094584|78948165|FG000|Overall Study|eligible but declined enrollment|4|||
44156776|NCT04094584|78948165|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
44156777|NCT04094584|78948165|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
44156778|NCT04094584|78948165|FG000|Overall Study|Lost to Follow-up|3|||
44156779|NCT04094584|78948165|FG000|Overall Study|Withdrawal by Subject|2|||
44156780|NCT04020341|78948180|FG000|Overall Study|Adverse Event|8|||
44156781|NCT04020341|78948181|FG001|Overall Study|Adverse Event|6|||
44156782|NCT04020341|78948180|FG000|Overall Study|Lost to Follow-up|8|||
44156783|NCT04020341|78948181|FG001|Overall Study|Lost to Follow-up|2|||
44156784|NCT04020341|78948180|FG000|Overall Study|Withdrawal by Subject|16|||
44156785|NCT04020341|78948181|FG001|Overall Study|Withdrawal by Subject|16|||
44156786|NCT04020341|78948180|FG000|Overall Study|Participant not able to swallow the tablet|1|||
44156787|NCT04020341|78948181|FG001|Overall Study|Participant not able to swallow the tablet|0|||
44156788|NCT04020341|78948180|FG000|Overall Study|Physician Decision|0|||
44156789|NCT04020341|78948181|FG001|Overall Study|Physician Decision|2|||
44156790|NCT04020341|78948180|FG000|Overall Study|Protocol Deviation|0|||
44156791|NCT04020341|78948181|FG001|Overall Study|Protocol Deviation|2|||
44156792|NCT03868891|78948203|FG000|Overall Study|Adverse Event|1|||
44156793|NCT03868891|78948204|FG001|Overall Study|Adverse Event|0|||
44156794|NCT03868891|78948203|FG000|Overall Study|Lost to Follow-up|2|||
44156795|NCT03868891|78948204|FG001|Overall Study|Lost to Follow-up|1|||
44156796|NCT03868891|78948203|FG000|Overall Study|COVID-19 Restrictions|1|||
44156797|NCT03868891|78948204|FG001|Overall Study|COVID-19 Restrictions|2|||
44156798|NCT03827655|78948215|FG000|Overall Study|Death|0|||
44156799|NCT03827655|78948216|FG001|Overall Study|Death|0|||
44156800|NCT03827655|78948217|FG002|Overall Study|Death|0|||
44156801|NCT03827655|78948218|FG003|Overall Study|Death|0|||
44425153|NCT00784277|79433181|FG001|ER Treatment|Study Medication Non-Compliant|0|||
44425154|NCT00784277|79433182|FG002|ER Treatment|Study Medication Non-Compliant|0|||
44156802|NCT03827655|78948219|FG004|Overall Study|Death|1|||
44156803|NCT03827655|78948215|FG000|Overall Study|Protocol Deviation|1|||
44156804|NCT03827655|78948216|FG001|Overall Study|Protocol Deviation|0|||
44156805|NCT03827655|78948217|FG002|Overall Study|Protocol Deviation|1|||
44156806|NCT03827655|78948218|FG003|Overall Study|Protocol Deviation|1|||
44156807|NCT03827655|78948219|FG004|Overall Study|Protocol Deviation|0|||
44156808|NCT03827655|78948215|FG000|Overall Study|Withdrawal by Subject|3|||
44156809|NCT03827655|78948216|FG001|Overall Study|Withdrawal by Subject|2|||
44328541|NCT01198756|79333586|FG001|Overall Study|Protocol Violation|0|||
44328542|NCT01198756|79333587|FG002|Overall Study|Protocol Violation|0|||
44328543|NCT01198756|79333588|FG003|Overall Study|Protocol Violation|2|||
44328544|NCT01198756|79333585|FG000|Overall Study|Withdrawal by Subject|9|||
44425155|NCT00784277|79433183|FG003|ER Treatment|Study Medication Non-Compliant|0|||
44425156|NCT00784277|79433184|FG004|ER Treatment|Study Medication Non-Compliant|2|||
44425157|NCT00784277|79433185|FG005|ER Treatment|Study Medication Non-Compliant|3|||
44425158|NCT00784277|79433186|FG006|ER Treatment|Study Medication Non-Compliant|3|||
44425159|NCT00784277|79433180|FG000|ER Treatment|Other|0|||
44425160|NCT00784277|79433181|FG001|ER Treatment|Other|0|||
44258602|NCT03029143|79113689|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
44258603|NCT03029143|79113690|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
44425161|NCT00784277|79433182|FG002|ER Treatment|Other|0|||
44537215|NCT00003869|79547927|FG001|Overall Study|Withdrawal by Subject|3|||
44258604|NCT03029143|79113688|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
44258605|NCT03029143|79113689|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
44258606|NCT03029143|79113690|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
44258607|NCT03029143|79113688|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
44258608|NCT03029143|79113689|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
44258609|NCT03029143|79113690|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
44258610|NCT02971137|79113701|FG000|Overall Study|Lost to Follow-up|44|||
44258611|NCT02971137|79113702|FG001|Overall Study|Lost to Follow-up|56|||
44258612|NCT02953262|79113712|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
44258613|NCT02953262|79113713|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
44258614|NCT02953262|79113714|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
44258615|NCT02953262|79113715|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
44258616|NCT02763579|79113731|FG000|Global Period|Death|167|||
44258617|NCT02763579|79113732|FG001|Global Period|Death|151|||
44258618|NCT02763579|79113733|FG002|Global Period|Death|0|||
44258619|NCT02763579|79113734|FG003|Global Period|Death|0|||
44537216|NCT00003869|79547926|FG000|Overall Study|Death|1|||
44537217|NCT00003869|79547927|FG001|Overall Study|Death|2|||
44537218|NCT00003869|79547926|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
44537219|NCT00003869|79547927|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
44537220|NCT03344640|79547935|FG000|Overall Study|Adverse Event|1|||
44537221|NCT03344640|79547936|FG001|Overall Study|Adverse Event|0|||
44537222|NCT03344640|79547935|FG000|Overall Study|Physician Decision|1|||
44258620|NCT02763579|79113731|FG000|Global Period|Lost to Follow-up|2|||
44258621|NCT02763579|79113732|FG001|Global Period|Lost to Follow-up|4|||
44258622|NCT02763579|79113733|FG002|Global Period|Lost to Follow-up|0|||
44258623|NCT02763579|79113734|FG003|Global Period|Lost to Follow-up|0|||
44258624|NCT02763579|79113731|FG000|Global Period|Physician Decision|0|||
44258625|NCT02763579|79113732|FG001|Global Period|Physician Decision|2|||
44258626|NCT02763579|79113733|FG002|Global Period|Physician Decision|0|||
44258627|NCT02763579|79113734|FG003|Global Period|Physician Decision|0|||
44258628|NCT02763579|79113731|FG000|Global Period|Study Terminated By Sponsor|21|||
44258629|NCT02763579|79113732|FG001|Global Period|Study Terminated By Sponsor|26|||
44258630|NCT02763579|79113733|FG002|Global Period|Study Terminated By Sponsor|0|||
44258631|NCT02763579|79113734|FG003|Global Period|Study Terminated By Sponsor|0|||
44258632|NCT02763579|79113731|FG000|Global Period|Withdrawal by Subject|12|||
44258633|NCT02763579|79113732|FG001|Global Period|Withdrawal by Subject|18|||
44258634|NCT02763579|79113733|FG002|Global Period|Withdrawal by Subject|0|||
44258635|NCT02763579|79113734|FG003|Global Period|Withdrawal by Subject|0|||
44258636|NCT02763579|79113731|FG000|China Period|Death|0|||
44258637|NCT02763579|79113732|FG001|China Period|Death|0|||
44328545|NCT01198756|79333586|FG001|Overall Study|Withdrawal by Subject|4|||
44425162|NCT00784277|79433183|FG003|ER Treatment|Other|0|||
44425163|NCT00784277|79433184|FG004|ER Treatment|Other|1|||
44537223|NCT03344640|79547936|FG001|Overall Study|Physician Decision|1|||
44328546|NCT01198756|79333587|FG002|Overall Study|Withdrawal by Subject|7|||
44328547|NCT01198756|79333588|FG003|Overall Study|Withdrawal by Subject|5|||
44328548|NCT01198756|79333585|FG000|Overall Study|Lost to Follow-up|29|||
44328549|NCT01198756|79333586|FG001|Overall Study|Lost to Follow-up|36|||
44328550|NCT01198756|79333587|FG002|Overall Study|Lost to Follow-up|23|||
44328551|NCT01198756|79333588|FG003|Overall Study|Lost to Follow-up|18|||
44328552|NCT01198600|79333605|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
44425164|NCT00784277|79433185|FG005|ER Treatment|Other|3|||
44425165|NCT00784277|79433186|FG006|ER Treatment|Other|2|||
44425166|NCT00682929|79433202|FG000|Overall Study|Adverse Event|4|||
44425167|NCT00682929|79433203|FG001|Overall Study|Adverse Event|1|||
44425168|NCT00682929|79433204|FG002|Overall Study|Adverse Event|1|||
44328553|NCT01198600|79333606|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
44328554|NCT01198600|79333607|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
44328555|NCT01198600|79333608|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
44328556|NCT01198600|79333605|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
44328557|NCT01198600|79333606|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
44328558|NCT01198600|79333607|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
44328559|NCT01198600|79333608|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
44328560|NCT01198600|79333605|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
44328561|NCT01198600|79333606|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
44328562|NCT01198600|79333607|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
44328563|NCT01198600|79333608|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
44328564|NCT01198600|79333605|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
44328565|NCT01198600|79333606|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
44328566|NCT01198600|79333607|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
44328567|NCT01198600|79333608|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
44328568|NCT01198600|79333605|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
44328569|NCT01198600|79333606|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
44328570|NCT01198600|79333607|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
44328571|NCT01198600|79333608|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
44328572|NCT01198600|79333605|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
44328573|NCT01198600|79333606|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
44328574|NCT01198600|79333607|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
44328575|NCT01198600|79333608|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
44328576|NCT01198600|79333605|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
44328577|NCT01198600|79333606|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
44328578|NCT01198600|79333607|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
44328579|NCT01198600|79333608|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
44328580|NCT01198132|79333618|FG000|Overall Study|Withdrawal by Subject|4|||
44328581|NCT01198132|79333619|FG001|Overall Study|Withdrawal by Subject|5|||
44328582|NCT01198132|79333618|FG000|Overall Study|Physician Decision|5|||
44328583|NCT01198132|79333619|FG001|Overall Study|Physician Decision|4|||
44328584|NCT01198132|79333618|FG000|Overall Study|Other Unspecified|3|||
44328585|NCT01198132|79333619|FG001|Overall Study|Other Unspecified|6|||
44328586|NCT01198132|79333618|FG000|Overall Study|Lack of Efficacy|2|||
44328587|NCT01198132|79333619|FG001|Overall Study|Lack of Efficacy|3|||
44328588|NCT01198132|79333618|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
44328589|NCT01198132|79333619|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
44328590|NCT01198132|79333618|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
44328591|NCT01198132|79333619|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
44328592|NCT01198132|79333618|FG000|Overall Study|Adverse Event|0|||
44328593|NCT01198132|79333619|FG001|Overall Study|Adverse Event|1|||
44425169|NCT00682929|79433202|FG000|Overall Study|Withdrawal by Subject|1|||
44425170|NCT00682929|79433203|FG001|Overall Study|Withdrawal by Subject|2|||
44425171|NCT00682929|79433204|FG002|Overall Study|Withdrawal by Subject|1|||
44425172|NCT00682929|79433202|FG000|Overall Study|dosing compliance < 80%|0|||
44328594|NCT01198132|79333618|FG000|Overall Study|Protocol Violation|1|||
44328595|NCT01198132|79333619|FG001|Overall Study|Protocol Violation|0|||
44328596|NCT01197508|79333631|FG000|Overall Study|Withdrawal by Subject|8|||
44425173|NCT00682929|79433203|FG001|Overall Study|dosing compliance < 80%|2|||
44425174|NCT00682929|79433204|FG002|Overall Study|dosing compliance < 80%|0|||
44328597|NCT01197508|79333632|FG001|Overall Study|Withdrawal by Subject|7|||
44328598|NCT01197508|79333633|FG002|Overall Study|Withdrawal by Subject|15|||
44328599|NCT01197508|79333634|FG003|Overall Study|Withdrawal by Subject|4|||
44328600|NCT01197508|79333631|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
44425175|NCT00682929|79433202|FG000|Overall Study|lag in DEA renewal|1|||
44425176|NCT00682929|79433203|FG001|Overall Study|lag in DEA renewal|0|||
44425177|NCT00682929|79433204|FG002|Overall Study|lag in DEA renewal|0|||
44328601|NCT01197508|79333632|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
44328602|NCT01197508|79333633|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
44328603|NCT01197508|79333634|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
44328604|NCT01197508|79333631|FG000|Overall Study|Adverse Event|10|||
44328605|NCT01197508|79333632|FG001|Overall Study|Adverse Event|13|||
44328606|NCT01197508|79333633|FG002|Overall Study|Adverse Event|23|||
44328607|NCT01197508|79333634|FG003|Overall Study|Adverse Event|3|||
44328608|NCT01197508|79333631|FG000|Overall Study|Severe non-compliance to protocol|0|||
44328609|NCT01197508|79333632|FG001|Overall Study|Severe non-compliance to protocol|3|||
44328610|NCT01197508|79333633|FG002|Overall Study|Severe non-compliance to protocol|1|||
44328611|NCT01197508|79333634|FG003|Overall Study|Severe non-compliance to protocol|3|||
44328612|NCT01197508|79333631|FG000|Overall Study|Condition under investigation worsened|1|||
44328613|NCT01197508|79333632|FG001|Overall Study|Condition under investigation worsened|1|||
44328614|NCT01197508|79333633|FG002|Overall Study|Condition under investigation worsened|1|||
44328615|NCT01197508|79333634|FG003|Overall Study|Condition under investigation worsened|1|||
44328616|NCT01197508|79333631|FG000|Overall Study|Lack of Efficacy|1|||
44328617|NCT01197508|79333632|FG001|Overall Study|Lack of Efficacy|2|||
44328618|NCT01197508|79333633|FG002|Overall Study|Lack of Efficacy|2|||
44328619|NCT01197508|79333634|FG003|Overall Study|Lack of Efficacy|1|||
44328620|NCT01197508|79333631|FG000|Overall Study|Study-specific withdrawal criteria|0|||
44328621|NCT01197508|79333632|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44328622|NCT01197508|79333633|FG002|Overall Study|Study-specific withdrawal criteria|1|||
44328623|NCT01197508|79333634|FG003|Overall Study|Study-specific withdrawal criteria|2|||
44328624|NCT01197508|79333631|FG000|Overall Study|Lost to Follow-up|1|||
44328625|NCT01197508|79333632|FG001|Overall Study|Lost to Follow-up|1|||
44328626|NCT01197508|79333633|FG002|Overall Study|Lost to Follow-up|2|||
44328627|NCT01197508|79333634|FG003|Overall Study|Lost to Follow-up|0|||
44328628|NCT01197508|79333631|FG000|Overall Study|Other|2|||
44328629|NCT01197508|79333632|FG001|Overall Study|Other|3|||
44328630|NCT01197508|79333633|FG002|Overall Study|Other|2|||
44425178|NCT00680745|79433216|FG000|Overall Study|Withdrawal by Subject|8|||
44425179|NCT00680745|79433217|FG001|Overall Study|Withdrawal by Subject|3|||
44425180|NCT00680745|79433218|FG002|Overall Study|Withdrawal by Subject|2|||
44425181|NCT00680745|79433219|FG003|Overall Study|Withdrawal by Subject|8|||
44537224|NCT03344640|79547935|FG000|Overall Study|Withdrawal by Subject|1|||
44537225|NCT03344640|79547936|FG001|Overall Study|Withdrawal by Subject|2|||
44537226|NCT03344640|79547935|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
44537227|NCT03344640|79547936|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
44537228|NCT03344562|79547944|FG000|Overall Study|Withdrawal by Subject|2|||
44537229|NCT03344562|79547945|FG001|Overall Study|Withdrawal by Subject|0|||
44537230|NCT00003659|79547951|FG000|Overall Study|Withdrawal by Subject|3|||
44537231|NCT03494985|79547959|FG000|Overall Study|Adverse Event|3|||
44537232|NCT03494985|79547960|FG001|Overall Study|Adverse Event|2|||
44537233|NCT03494985|79547961|FG002|Overall Study|Adverse Event|3|||
44537234|NCT03494985|79547962|FG003|Overall Study|Adverse Event|0|||
44537235|NCT03494985|79547959|FG000|Overall Study|Other (Withdrawal of consent)|2|||
44537236|NCT03494985|79547960|FG001|Overall Study|Other (Withdrawal of consent)|3|||
44537237|NCT03494985|79547961|FG002|Overall Study|Other (Withdrawal of consent)|2|||
44537238|NCT03494985|79547962|FG003|Overall Study|Other (Withdrawal of consent)|5|||
44537239|NCT03494985|79547959|FG000|Overall Study|Other (Not specified)|0|||
44537240|NCT03494985|79547960|FG001|Overall Study|Other (Not specified)|1|||
44537241|NCT03494985|79547961|FG002|Overall Study|Other (Not specified)|1|||
44537242|NCT03494985|79547962|FG003|Overall Study|Other (Not specified)|0|||
44537243|NCT00003509|79547972|FG000|Overall Study|Not evaluable|5|||
44537244|NCT03344172|79547978|FG000|Overall Study|Received <1 dose of treatment|1|||
44537245|NCT03344172|79547979|FG001|Overall Study|Received <1 dose of treatment|0|||
44537246|NCT03465891|79547987|FG000|Overall Study|Withdrawal by Subject|0|||
44156810|NCT03827655|78948217|FG002|Overall Study|Withdrawal by Subject|2|||
44156811|NCT03827655|78948218|FG003|Overall Study|Withdrawal by Subject|0|||
44537247|NCT03465891|79547988|FG001|Overall Study|Withdrawal by Subject|1|||
44537248|NCT03465891|79547987|FG000|Overall Study|Disease progression|1|||
44156812|NCT03827655|78948219|FG004|Overall Study|Withdrawal by Subject|1|||
44156813|NCT03827655|78948215|FG000|Overall Study|Reason not Specified|3|||
44328631|NCT01197508|79333634|FG003|Overall Study|Other|2|||
44328632|NCT01196416|79333651|FG000|Overall Study|Withdrawal by Subject|2|||
44328633|NCT01196104|79333657|FG000|Overall Study|Lost to Follow-up|1|||
44328634|NCT01196104|79333658|FG001|Overall Study|Lost to Follow-up|0|||
44328635|NCT01196104|79333657|FG000|Overall Study|Physician Decision|0|||
44328636|NCT01196104|79333658|FG001|Overall Study|Physician Decision|1|||
44328637|NCT01196104|79333657|FG000|Overall Study|Withdrawal by Subject|3|||
44328638|NCT01196104|79333658|FG001|Overall Study|Withdrawal by Subject|3|||
44425182|NCT00680745|79433216|FG000|Overall Study|Lost to Follow-up|0|||
44537249|NCT03465891|79547988|FG001|Overall Study|Disease progression|0|||
44537250|NCT03363906|79547994|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
44537251|NCT03363906|79547995|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
44425183|NCT00680745|79433217|FG001|Overall Study|Lost to Follow-up|1|||
44425184|NCT00680745|79433218|FG002|Overall Study|Lost to Follow-up|1|||
44425185|NCT00680745|79433219|FG003|Overall Study|Lost to Follow-up|0|||
44425186|NCT00680745|79433216|FG000|Overall Study|Death|1|||
44425187|NCT00680745|79433217|FG001|Overall Study|Death|0|||
44425188|NCT00680745|79433218|FG002|Overall Study|Death|1|||
44425189|NCT00680745|79433219|FG003|Overall Study|Death|0|||
44425190|NCT00680745|79433216|FG000|Overall Study|Adverse Event|5|||
44425191|NCT00680745|79433217|FG001|Overall Study|Adverse Event|3|||
44425192|NCT00680745|79433218|FG002|Overall Study|Adverse Event|3|||
44425193|NCT00680745|79433219|FG003|Overall Study|Adverse Event|3|||
44425194|NCT00680745|79433216|FG000|Overall Study|Poor/Non-compliance|0|||
44425195|NCT00680745|79433217|FG001|Overall Study|Poor/Non-compliance|3|||
44425196|NCT00680745|79433218|FG002|Overall Study|Poor/Non-compliance|0|||
44425197|NCT00680745|79433219|FG003|Overall Study|Poor/Non-compliance|0|||
44425198|NCT00680745|79433216|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
44425199|NCT00680745|79433217|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
44425200|NCT00680745|79433218|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
44425201|NCT00680745|79433219|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
44425202|NCT00680745|79433216|FG000|Overall Study|False Treatment|0|||
44425203|NCT00680745|79433217|FG001|Overall Study|False Treatment|1|||
44425204|NCT00680745|79433218|FG002|Overall Study|False Treatment|3|||
44425205|NCT00680745|79433219|FG003|Overall Study|False Treatment|0|||
44425206|NCT00680121|79433232|FG000|Overall Study|Lost to Follow-up|27|||
44425207|NCT00680121|79433233|FG001|Overall Study|Lost to Follow-up|23|||
44425208|NCT00767819|79433242|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
44425209|NCT00767819|79433243|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
44425210|NCT00767819|79433244|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
44425211|NCT00767819|79433242|FG000|Overall Study|Withdrawal by Subject|1|||
44425212|NCT00767819|79433243|FG001|Overall Study|Withdrawal by Subject|1|||
44425213|NCT00767819|79433244|FG002|Overall Study|Withdrawal by Subject|0|||
44425214|NCT00767819|79433242|FG000|Overall Study|Administrative problems|0|||
44425215|NCT00767819|79433243|FG001|Overall Study|Administrative problems|1|||
44425216|NCT00767819|79433244|FG002|Overall Study|Administrative problems|0|||
44425217|NCT00767819|79433242|FG000|Overall Study|Death|2|||
44425218|NCT00767819|79433243|FG001|Overall Study|Death|3|||
44328639|NCT01196104|79333657|FG000|Overall Study|Various|0|||
44328640|NCT01196104|79333658|FG001|Overall Study|Various|1|||
44328641|NCT01196026|79333676|FG000|Overall Study|Withdrawal by Subject|1|||
44328642|NCT01196026|79333677|FG001|Overall Study|Withdrawal by Subject|4|||
44328643|NCT01196026|79333678|FG002|Overall Study|Withdrawal by Subject|0|||
44328644|NCT01196026|79333679|FG003|Overall Study|Withdrawal by Subject|0|||
44328645|NCT01196026|79333680|FG004|Overall Study|Withdrawal by Subject|0|||
44328646|NCT01196026|79333681|FG005|Overall Study|Withdrawal by Subject|0|||
44328647|NCT01196026|79333676|FG000|Overall Study|Lost to Follow-up|0|||
44328648|NCT01196026|79333677|FG001|Overall Study|Lost to Follow-up|3|||
44328649|NCT01196026|79333678|FG002|Overall Study|Lost to Follow-up|0|||
44328650|NCT01196026|79333679|FG003|Overall Study|Lost to Follow-up|0|||
44328651|NCT01196026|79333680|FG004|Overall Study|Lost to Follow-up|1|||
44328652|NCT01196026|79333681|FG005|Overall Study|Lost to Follow-up|0|||
44328653|NCT01196026|79333676|FG000|Overall Study|Other|0|||
44328654|NCT01196026|79333677|FG001|Overall Study|Other|1|||
44328655|NCT01196026|79333678|FG002|Overall Study|Other|0|||
44328656|NCT01196026|79333679|FG003|Overall Study|Other|0|||
44328657|NCT01196026|79333680|FG004|Overall Study|Other|0|||
44328658|NCT01196026|79333681|FG005|Overall Study|Other|0|||
44328659|NCT01195948|79333700|FG000|Overall Study|Lost to Follow-up|0|||
44328660|NCT01195948|79333701|FG001|Overall Study|Lost to Follow-up|1|||
44328661|NCT01195948|79333702|FG002|Overall Study|Lost to Follow-up|2|||
44328662|NCT01195831|79333715|FG000|Overall Study|Lost to Follow-up|2|||
44328663|NCT01195831|79333716|FG001|Overall Study|Lost to Follow-up|4|||
44328664|NCT01195831|79333715|FG000|Overall Study|Withdrawal by Subject|2|||
44425219|NCT00767819|79433244|FG002|Overall Study|Death|0|||
44425220|NCT00767819|79433242|FG000|Overall Study|Adverse Event|2|||
44425221|NCT00767819|79433243|FG001|Overall Study|Adverse Event|0|||
44328665|NCT01195831|79333716|FG001|Overall Study|Withdrawal by Subject|2|||
44328666|NCT01195831|79333715|FG000|Overall Study|Adverse Event|4|||
44328667|NCT01195831|79333716|FG001|Overall Study|Adverse Event|2|||
44328668|NCT01195831|79333715|FG000|Overall Study|Protocol Violation|0|||
44328669|NCT01195831|79333716|FG001|Overall Study|Protocol Violation|2|||
44328670|NCT01195675|79333722|FG000|Overall Study|Adverse Event|1|||
44328671|NCT01195675|79333722|FG000|Overall Study|Withdrawal by Subject|2|||
44425222|NCT00767819|79433244|FG002|Overall Study|Adverse Event|0|||
44425223|NCT00767819|79433242|FG000|Overall Study|Abnormal lab values|1|||
44425224|NCT00767819|79433243|FG001|Overall Study|Abnormal lab values|0|||
44425225|NCT00767819|79433244|FG002|Overall Study|Abnormal lab values|0|||
44425226|NCT00767819|79433242|FG000|Overall Study|Lost to Follow-up|1|||
44425227|NCT00767819|79433243|FG001|Overall Study|Lost to Follow-up|0|||
44425228|NCT00767819|79433244|FG002|Overall Study|Lost to Follow-up|0|||
44425229|NCT00584870|79433255|FG000|Overall Study|Adverse Event|4|||
44328672|NCT01195636|79333739|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
44328673|NCT01195636|79333740|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
44328674|NCT01195636|79333739|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
44328675|NCT01195636|79333740|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
44328676|NCT01195636|79333739|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
44328677|NCT01195636|79333740|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
44328678|NCT01195636|79333739|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
44328679|NCT01195636|79333740|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
44328680|NCT01195636|79333739|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
44328681|NCT01195636|79333740|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
44328682|NCT01195636|79333739|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
44425230|NCT00584870|79433256|FG001|Overall Study|Adverse Event|3|||
44425231|NCT00584870|79433257|FG002|Overall Study|Adverse Event|2|||
44425232|NCT00584870|79433255|FG000|Overall Study|Lost to Follow-up|4|||
44425233|NCT00584870|79433256|FG001|Overall Study|Lost to Follow-up|1|||
44425234|NCT00584870|79433257|FG002|Overall Study|Lost to Follow-up|1|||
44156814|NCT03827655|78948216|FG001|Overall Study|Reason not Specified|1|||
44156815|NCT03827655|78948217|FG002|Overall Study|Reason not Specified|1|||
44156816|NCT03827655|78948218|FG003|Overall Study|Reason not Specified|1|||
44156817|NCT03827655|78948219|FG004|Overall Study|Reason not Specified|1|||
44156818|NCT03782064|78948254|FG000|Overall Study|Lack of Efficacy|2|||
44156819|NCT03782064|78948254|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
44156820|NCT03772522|78948260|FG000|Pre-intervention|Withdrawal by Subject|3|||
44156821|NCT03772522|78948261|FG001|Pre-intervention|Withdrawal by Subject|4|||
44156822|NCT03772522|78948260|FG000|Intervention|Withdrawal by Subject|1|||
44156823|NCT03772522|78948261|FG001|Intervention|Withdrawal by Subject|0|||
44156824|NCT03772522|78948260|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
44156825|NCT03772522|78948261|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
44156826|NCT03755518|78948271|FG000|Overall Study|Adverse Event|6|||
44156827|NCT03755518|78948271|FG000|Overall Study|Lack of Efficacy|6|||
44156828|NCT03755518|78948271|FG000|Overall Study|Bone Marrow Transplant|4|||
44156829|NCT03755518|78948271|FG000|Overall Study|Withdrawal by participant|4|||
44156830|NCT03755518|78948271|FG000|Overall Study|Progressive Disease|2|||
44156831|NCT03755518|78948271|FG000|Overall Study|Death|1|||
44425235|NCT00584870|79433255|FG000|Overall Study|Lack of Efficacy|7|||
44425236|NCT00584870|79433256|FG001|Overall Study|Lack of Efficacy|14|||
44425237|NCT00584870|79433257|FG002|Overall Study|Lack of Efficacy|8|||
44425238|NCT00584870|79433255|FG000|Overall Study|Withdrawal by Subject|10|||
44425239|NCT00584870|79433256|FG001|Overall Study|Withdrawal by Subject|5|||
44425240|NCT00584870|79433257|FG002|Overall Study|Withdrawal by Subject|3|||
44328683|NCT01195636|79333740|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
44328684|NCT01195636|79333739|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
44425241|NCT00584870|79433255|FG000|Overall Study|Protocol Violation|1|||
44425242|NCT00584870|79433256|FG001|Overall Study|Protocol Violation|1|||
44425243|NCT00584870|79433257|FG002|Overall Study|Protocol Violation|2|||
44425244|NCT00584870|79433255|FG000|Overall Study|Did not met entrance criteria|1|||
44425245|NCT00584870|79433256|FG001|Overall Study|Did not met entrance criteria|0|||
44425246|NCT00584870|79433257|FG002|Overall Study|Did not met entrance criteria|0|||
44156832|NCT03755518|78948271|FG000|Overall Study|Physician Decision|1|||
44156833|NCT03755518|78948271|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
44156834|NCT03739112|78948277|FG000|Overall Study|Adverse Event|2|||
44156835|NCT03739112|78948278|FG001|Overall Study|Adverse Event|2|||
44156836|NCT03739112|78948277|FG000|Overall Study|Withdrawal by Subject|38|||
44156837|NCT03739112|78948278|FG001|Overall Study|Withdrawal by Subject|19|||
44156838|NCT03739112|78948277|FG000|Overall Study|Lost to Follow-up|31|||
44156839|NCT03739112|78948278|FG001|Overall Study|Lost to Follow-up|33|||
44156840|NCT03739112|78948277|FG000|Overall Study|Protocol Deviation|12|||
44156841|NCT03739112|78948278|FG001|Overall Study|Protocol Deviation|9|||
44156842|NCT03739112|78948277|FG000|Overall Study|Physician Decision|1|||
44156843|NCT03739112|78948278|FG001|Overall Study|Physician Decision|0|||
44156844|NCT03739112|78948277|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
44156845|NCT03739112|78948278|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
44156846|NCT03739112|78948277|FG000|Overall Study|Site went on hold|65|||
44425247|NCT00584870|79433255|FG000|Overall Study|Other|2|||
44156847|NCT03739112|78948278|FG001|Overall Study|Site went on hold|67|||
44156848|NCT03739112|78948277|FG000|Overall Study|Other than specified|8|||
44156849|NCT03739112|78948278|FG001|Overall Study|Other than specified|5|||
44328685|NCT01195636|79333740|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
44328686|NCT01195636|79333739|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
44328687|NCT01195636|79333740|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
44328688|NCT01195363|79333748|FG000|Overall Study|Lost to Follow-up|7|||
44425248|NCT00584870|79433256|FG001|Overall Study|Other|0|||
44425249|NCT00584870|79433257|FG002|Overall Study|Other|0|||
44156850|NCT03739112|78948277|FG000|Overall Study|Randomized but not vaccinated|31|||
44156851|NCT03739112|78948278|FG001|Overall Study|Randomized but not vaccinated|25|||
44156852|NCT03622593|78948287|FG000|Overall Study|Withdrawal by Subject|11|||
44156853|NCT03622593|78948288|FG001|Overall Study|Withdrawal by Subject|9|||
44156854|NCT03622593|78948289|FG002|Overall Study|Withdrawal by Subject|13|||
44156855|NCT03622593|78948287|FG000|Overall Study|Death|12|||
44156856|NCT03622593|78948288|FG001|Overall Study|Death|9|||
44156857|NCT03622593|78948289|FG002|Overall Study|Death|10|||
44328689|NCT01195363|79333749|FG001|Overall Study|Lost to Follow-up|4|||
44328690|NCT01195363|79333748|FG000|Overall Study|Adverse Event|3|||
44328691|NCT01195363|79333749|FG001|Overall Study|Adverse Event|1|||
44328692|NCT01195363|79333748|FG000|Overall Study|Lack of Efficacy|0|||
44328693|NCT01195363|79333749|FG001|Overall Study|Lack of Efficacy|4|||
44328694|NCT01195363|79333748|FG000|Overall Study|incarceration|1|||
44328695|NCT01195363|79333749|FG001|Overall Study|incarceration|0|||
44328696|NCT01195090|79333757|FG000|Overall Study|Adverse Event|1|||
44328697|NCT01195090|79333758|FG001|Overall Study|Adverse Event|2|||
44328698|NCT01195090|79333757|FG000|Overall Study|Lost to Follow-up|2|||
44328699|NCT01195090|79333758|FG001|Overall Study|Lost to Follow-up|2|||
44328700|NCT01195090|79333757|FG000|Overall Study|Protocol Violation|3|||
44328701|NCT01195090|79333758|FG001|Overall Study|Protocol Violation|4|||
44328702|NCT01194973|79333764|FG000|Screening Period|Screen Failure|3|||
44328703|NCT01194973|79333764|FG000|26 Week Treatment Period|Adverse Event|1|||
44328704|NCT01194973|79333764|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
44328705|NCT01194973|79333764|FG000|26 Week Treatment Period|Pregnancy|1|||
44328706|NCT02218697|79333770|FG000|Overall Study|Adverse Event|0|||
44328707|NCT02218697|79333771|FG001|Overall Study|Adverse Event|2|||
44328708|NCT02218697|79333770|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
44328709|NCT02218697|79333771|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
44328710|NCT02218697|79333770|FG000|Overall Study|Withdrawal by Subject|2|||
44328711|NCT02218697|79333771|FG001|Overall Study|Withdrawal by Subject|3|||
44328712|NCT01177540|79333779|FG000|Overall Study|Adverse Event|1|||
44328713|NCT01177540|79333780|FG001|Overall Study|Adverse Event|0|||
44328714|NCT01177384|79333788|FG000|Overall Study|Adverse Event|6|||
44328715|NCT01177384|79333789|FG001|Overall Study|Adverse Event|4|||
44328716|NCT01177384|79333788|FG000|Overall Study|Lack of Efficacy|0|||
44328717|NCT01177384|79333789|FG001|Overall Study|Lack of Efficacy|1|||
44328718|NCT01177384|79333788|FG000|Overall Study|Lost to Follow-up|3|||
44328719|NCT01177384|79333789|FG001|Overall Study|Lost to Follow-up|4|||
44328720|NCT01177384|79333788|FG000|Overall Study|Physician Decision|0|||
44328721|NCT01177384|79333789|FG001|Overall Study|Physician Decision|3|||
44328722|NCT01177384|79333788|FG000|Overall Study|Protocol Violation|0|||
44328723|NCT01177384|79333789|FG001|Overall Study|Protocol Violation|2|||
44328724|NCT01177384|79333788|FG000|Overall Study|Withdrawal by Subject|5|||
44328725|NCT01177384|79333789|FG001|Overall Study|Withdrawal by Subject|12|||
44328726|NCT01194154|79333797|FG000|Overall Study|Adverse Event|12|||
44328727|NCT01194154|79333798|FG001|Overall Study|Adverse Event|7|||
44328728|NCT01194154|79333797|FG000|Overall Study|Lost to Follow-up|2|||
44425250|NCT00584870|79433255|FG000|Overall Study|Randomized but not treated|0|||
44425251|NCT00584870|79433256|FG001|Overall Study|Randomized but not treated|1|||
44425252|NCT00584870|79433257|FG002|Overall Study|Randomized but not treated|2|||
44425253|NCT00679341|79433267|FG000|Overall Study|Disease progression|42|||
44425254|NCT00679341|79433268|FG001|Overall Study|Disease progression|36|||
44156858|NCT03622593|78948287|FG000|Overall Study|Lost to Follow-up|11|||
44156859|NCT03622593|78948288|FG001|Overall Study|Lost to Follow-up|5|||
44156860|NCT03622593|78948289|FG002|Overall Study|Lost to Follow-up|8|||
44156861|NCT03622593|78948287|FG000|Overall Study|Adverse Event|4|||
44156862|NCT03622593|78948288|FG001|Overall Study|Adverse Event|5|||
44156863|NCT03622593|78948289|FG002|Overall Study|Adverse Event|6|||
44328729|NCT01194154|79333798|FG001|Overall Study|Lost to Follow-up|3|||
44328730|NCT01194154|79333797|FG000|Overall Study|Protocol Violation|0|||
44328731|NCT01194154|79333798|FG001|Overall Study|Protocol Violation|1|||
44328732|NCT01194154|79333797|FG000|Overall Study|Withdrawal by Subject|5|||
44328733|NCT01194154|79333798|FG001|Overall Study|Withdrawal by Subject|6|||
44328734|NCT01194154|79333797|FG000|Overall Study|Blood pressure increase|5|||
44328735|NCT01194154|79333798|FG001|Overall Study|Blood pressure increase|3|||
44328736|NCT01194154|79333797|FG000|Overall Study|Hemoglobin decrease|0|||
44328737|NCT01194154|79333798|FG001|Overall Study|Hemoglobin decrease|1|||
44328738|NCT01194154|79333797|FG000|Overall Study|Hemoglobin increase|12|||
44328739|NCT01194154|79333798|FG001|Overall Study|Hemoglobin increase|3|||
44328740|NCT01194154|79333797|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
44328741|NCT01194154|79333798|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
44328742|NCT01194154|79333797|FG000|Overall Study|Treatment with prohibited medication|4|||
44328743|NCT01194154|79333798|FG001|Overall Study|Treatment with prohibited medication|5|||
44328744|NCT01194154|79333797|FG000|Overall Study|Other|4|||
44328745|NCT01194154|79333798|FG001|Overall Study|Other|0|||
44328746|NCT01194154|79333797|FG000|Overall Study|Did not receive study medication|2|||
44328747|NCT01194154|79333798|FG001|Overall Study|Did not receive study medication|4|||
44328748|NCT05034731|79333820|FG000|Overall Study|Screen fail|1|||
44328749|NCT05034731|79333821|FG001|Overall Study|Screen fail|1|||
44328750|NCT04984993|79333831|FG000|Overall Study|Withdrawal by Subject|8|||
44328751|NCT04984993|79333832|FG001|Overall Study|Withdrawal by Subject|2|||
44328752|NCT04984993|79333831|FG000|Overall Study|Lost to Follow-up|2|||
44328753|NCT04984993|79333832|FG001|Overall Study|Lost to Follow-up|2|||
44328754|NCT04984993|79333831|FG000|Overall Study|Both patients moved to another country|4|||
44328755|NCT04984993|79333832|FG001|Overall Study|Both patients moved to another country|0|||
44328756|NCT04880161|79333839|FG000|Overall Study|Withdrawal by Subject|1|||
44328757|NCT04880161|79333840|FG001|Overall Study|Withdrawal by Subject|0|||
44328758|NCT04880161|79333839|FG000|Overall Study|Lack of Compliance|1|||
44328759|NCT04880161|79333840|FG001|Overall Study|Lack of Compliance|1|||
44328760|NCT04880161|79333839|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
44328761|NCT04880161|79333840|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
44328762|NCT04880161|79333839|FG000|Overall Study|Screen Failure|0|||
44328763|NCT04880161|79333840|FG001|Overall Study|Screen Failure|1|||
44328764|NCT04809220|79333848|FG000|Overall Study|Adverse Event|4|||
44328765|NCT04809220|79333849|FG001|Overall Study|Adverse Event|0|||
44328766|NCT04809220|79333848|FG000|Overall Study|Death|1|||
44328767|NCT04809220|79333849|FG001|Overall Study|Death|0|||
44328768|NCT04809220|79333848|FG000|Overall Study|Lost to Follow-up|3|||
44328769|NCT04809220|79333849|FG001|Overall Study|Lost to Follow-up|0|||
44328770|NCT04809220|79333848|FG000|Overall Study|Physician Decision|0|||
44328771|NCT04809220|79333849|FG001|Overall Study|Physician Decision|1|||
44328772|NCT04809220|79333848|FG000|Overall Study|Withdrawal by Subject|9|||
44328773|NCT04809220|79333849|FG001|Overall Study|Withdrawal by Subject|5|||
44328774|NCT04809220|79333848|FG000|Overall Study|Due to long-term overseas business trips|1|||
44328775|NCT04809220|79333849|FG001|Overall Study|Due to long-term overseas business trips|0|||
44328776|NCT04740827|79333858|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
44328777|NCT04740827|79333859|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
44328778|NCT04740827|79333858|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
44328779|NCT04740827|79333859|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
44328780|NCT04740827|79333858|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
44328781|NCT04740827|79333859|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
44328782|NCT04740827|79333858|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
44328783|NCT04740827|79333859|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
44328784|NCT04740827|79333858|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
44328785|NCT04740827|79333859|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
44328786|NCT04740827|79333858|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
44328787|NCT04740827|79333859|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
44328788|NCT04725240|79333865|FG000|Overall Study|Adverse Event|2|||
44328789|NCT04620746|79333880|FG000|Overall Study|Adverse Event|2|||
44328790|NCT04620746|79333881|FG001|Overall Study|Adverse Event|0|||
44328791|NCT04620746|79333880|FG000|Overall Study|Uniterpretable skin test|1|||
44328792|NCT04620746|79333881|FG001|Overall Study|Uniterpretable skin test|0|||
44328793|NCT04620746|79333880|FG000|Overall Study|Withdrawal by Subject|0|||
44328794|NCT04620746|79333881|FG001|Overall Study|Withdrawal by Subject|1|||
44328795|NCT04524858|79333912|FG000|Overall Study|Adverse Event|1|||
44328796|NCT04464265|79333916|FG000|Overall Study|Physician Decision|2|||
44328797|NCT04326231|79333929|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
44328798|NCT04275336|79333936|FG000|Overall Study|First venipuncture failed|4|||
44328799|NCT04275336|79333937|FG001|Overall Study|First venipuncture failed|6|||
44425255|NCT00679341|79433267|FG000|Overall Study|Adverse Event|5|||
44425256|NCT00679341|79433268|FG001|Overall Study|Adverse Event|6|||
44425257|NCT00679341|79433267|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
44425258|NCT00679341|79433268|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
44425259|NCT00679341|79433267|FG000|Overall Study|Death|1|||
44425260|NCT00679341|79433268|FG001|Overall Study|Death|1|||
44425261|NCT00679341|79433267|FG000|Overall Study|Other|1|||
44425262|NCT00679341|79433268|FG001|Overall Study|Other|0|||
44425263|NCT00679341|79433267|FG000|Overall Study|Physician Decision|1|||
44425264|NCT00679341|79433268|FG001|Overall Study|Physician Decision|0|||
44425265|NCT00679341|79433267|FG000|Overall Study|Not treated|0|||
44425266|NCT00679341|79433268|FG001|Overall Study|Not treated|2|||
44425267|NCT00679341|79433267|FG000|Overall Study|Physician/patient decision to withdraw|0|||
44328800|NCT04275336|79333938|FG002|Overall Study|First venipuncture failed|5|||
44328801|NCT04275336|79333936|FG000|Overall Study|Unscheduled venipuncture|9|||
44328802|NCT04275336|79333937|FG001|Overall Study|Unscheduled venipuncture|13|||
44425268|NCT00679341|79433268|FG001|Overall Study|Physician/patient decision to withdraw|6|||
44425269|NCT00679263|79433278|FG000|Visit 2/Dose 1|Adverse Event|1|||
44425270|NCT00679263|79433279|FG001|Visit 2/Dose 1|Adverse Event|0|||
44328803|NCT04275336|79333938|FG002|Overall Study|Unscheduled venipuncture|7|||
44328804|NCT04275336|79333936|FG000|Overall Study|Failed specimen of saliva|4|||
44328805|NCT04275336|79333937|FG001|Overall Study|Failed specimen of saliva|3|||
44425271|NCT00679263|79433280|FG002|Visit 2/Dose 1|Adverse Event|0|||
44425272|NCT00679263|79433278|FG000|Visit 2/Dose 1|subject not compliance|1|||
44425273|NCT00679263|79433279|FG001|Visit 2/Dose 1|subject not compliance|1|||
44425274|NCT00679263|79433280|FG002|Visit 2/Dose 1|subject not compliance|0|||
44425275|NCT00680043|79433291|FG000|Overall Study|Withdrawal by Subject|1|||
44425276|NCT00680043|79433292|FG001|Overall Study|Withdrawal by Subject|0|||
44425277|NCT00680043|79433293|FG002|Overall Study|Withdrawal by Subject|0|||
44425278|NCT00680043|79433291|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
44425279|NCT00680043|79433292|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
44425280|NCT00680043|79433293|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
44425281|NCT00680043|79433291|FG000|Overall Study|Renal Transplant|1|||
44425282|NCT00680043|79433292|FG001|Overall Study|Renal Transplant|0|||
44425283|NCT00680043|79433293|FG002|Overall Study|Renal Transplant|4|||
44425284|NCT00682539|79433304|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
44425285|NCT00682539|79433305|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
44425286|NCT00682539|79433306|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
44425287|NCT00682539|79433304|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
44425288|NCT00682539|79433305|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
44425289|NCT00682539|79433306|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
44425290|NCT00682461|79433316|FG000|Overall Study|Adverse Event|5|||
44425291|NCT00682461|79433317|FG001|Overall Study|Adverse Event|7|||
44328806|NCT04275336|79333938|FG002|Overall Study|Failed specimen of saliva|4|||
44328807|NCT04251910|79333964|FG000|Overall Study|Covid 19 lockdown|0|||
44328808|NCT04251910|79333965|FG001|Overall Study|Covid 19 lockdown|5|||
44328809|NCT04251910|79333966|FG002|Overall Study|Covid 19 lockdown|0|||
44328810|NCT04251910|79333967|FG003|Overall Study|Covid 19 lockdown|4|||
44328811|NCT04251910|79333968|FG004|Overall Study|Covid 19 lockdown|0|||
44328812|NCT04251910|79333969|FG005|Overall Study|Covid 19 lockdown|0|||
44425292|NCT00682461|79433316|FG000|Overall Study|Lost to Follow-up|8|||
44425293|NCT00682461|79433317|FG001|Overall Study|Lost to Follow-up|5|||
44425294|NCT00682461|79433316|FG000|Overall Study|Withdrawal by Subject|12|||
44425295|NCT00682461|79433317|FG001|Overall Study|Withdrawal by Subject|19|||
44425296|NCT00677235|79433326|FG000|Overall Study|Withdrawal by Subject|1|||
44328813|NCT04251910|79333964|FG000|Overall Study|Assisted living facility was closed|0|||
44328814|NCT04251910|79333965|FG001|Overall Study|Assisted living facility was closed|0|||
44328815|NCT04251910|79333966|FG002|Overall Study|Assisted living facility was closed|0|||
44328816|NCT04251910|79333967|FG003|Overall Study|Assisted living facility was closed|0|||
44328817|NCT04251910|79333968|FG004|Overall Study|Assisted living facility was closed|1|||
44328818|NCT04251910|79333969|FG005|Overall Study|Assisted living facility was closed|0|||
44328819|NCT04248491|79333988|FG000|Overall Study|Lost to Follow-up|1|||
44328820|NCT04248491|79333989|FG001|Overall Study|Lost to Follow-up|0|||
44328821|NCT04101318|79334003|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
44328822|NCT04101318|79334004|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
44425297|NCT00677235|79433327|FG001|Overall Study|Withdrawal by Subject|1|||
44425298|NCT00677235|79433326|FG000|Overall Study|Lost to Follow-up|2|||
44425299|NCT00677235|79433327|FG001|Overall Study|Lost to Follow-up|1|||
44425300|NCT00677235|79433326|FG000|Overall Study|Death|37|||
44425301|NCT00677235|79433327|FG001|Overall Study|Death|36|||
44425302|NCT00677235|79433326|FG000|Overall Study|Adverse Experience|1|||
44425303|NCT00677235|79433327|FG001|Overall Study|Adverse Experience|0|||
44425304|NCT00676689|79433333|FG000|Overall Study|Screen Failure|2|||
44425305|NCT00676689|79433333|FG000|Overall Study|Death|2|||
44425306|NCT00676689|79433333|FG000|Overall Study|Lost to Follow-up|4|||
44425307|NCT00676689|79433333|FG000|Overall Study|Physician Decision|1|||
44425308|NCT00676689|79433333|FG000|Overall Study|Withdrawal by Subject|3|||
44425309|NCT00676689|79433333|FG000|Overall Study|Continuing FU|49|||
44425310|NCT00678795|79433339|FG000|Overall Study|Adverse Event|7|||
44425311|NCT00678795|79433340|FG001|Overall Study|Adverse Event|3|||
44425312|NCT00678795|79433339|FG000|Overall Study|Withdrawal by Subject|3|||
44425313|NCT00678795|79433340|FG001|Overall Study|Withdrawal by Subject|0|||
44328823|NCT04101318|79334003|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
44328824|NCT04101318|79334004|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
44328825|NCT04101318|79334003|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
44328826|NCT04101318|79334004|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
44328827|NCT04091672|79334012|FG000|Overall Study|Death|6|||
44328828|NCT04091672|79334013|FG001|Overall Study|Death|6|||
44425314|NCT00678795|79433339|FG000|Overall Study|Protocol Violation|0|||
44425315|NCT00678795|79433340|FG001|Overall Study|Protocol Violation|1|||
44425316|NCT00678795|79433339|FG000|Overall Study|Lost to Follow-up|0|||
44425317|NCT00678795|79433340|FG001|Overall Study|Lost to Follow-up|1|||
44425318|NCT00678795|79433339|FG000|Overall Study|Lack of Efficacy|1|||
44425319|NCT00678795|79433340|FG001|Overall Study|Lack of Efficacy|1|||
44425320|NCT00678639|79433348|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
44425321|NCT00678639|79433349|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
44156864|NCT03622593|78948287|FG000|Overall Study|Physician Decision|2|||
44328829|NCT04091672|79334012|FG000|Overall Study|Lost to Follow-up|7|||
44425322|NCT00678561|79433399|FG000|Overall Study|Adverse Event|0|||
44425323|NCT00678561|79433400|FG001|Overall Study|Adverse Event|1|||
44328830|NCT04091672|79334013|FG001|Overall Study|Lost to Follow-up|7|||
44328831|NCT04091672|79334012|FG000|Overall Study|Withdrawal by Subject|3|||
44156865|NCT03622593|78948288|FG001|Overall Study|Physician Decision|1|||
44156866|NCT03622593|78948289|FG002|Overall Study|Physician Decision|6|||
44156867|NCT03622593|78948287|FG000|Overall Study|Other|2|||
44156868|NCT03622593|78948288|FG001|Overall Study|Other|2|||
44156869|NCT03622593|78948289|FG002|Overall Study|Other|3|||
44156870|NCT03622593|78948287|FG000|Overall Study|Protocol Violation|0|||
44156871|NCT03622593|78948288|FG001|Overall Study|Protocol Violation|0|||
44156872|NCT03622593|78948289|FG002|Overall Study|Protocol Violation|1|||
44156873|NCT03622593|78948287|FG000|Overall Study|Pregnancy|0|||
44156874|NCT03622593|78948288|FG001|Overall Study|Pregnancy|0|||
44156875|NCT03622593|78948289|FG002|Overall Study|Pregnancy|1|||
44156876|NCT03593655|78948300|FG000|First Product Use Period|Withdrawal by Subject|1|||
44156877|NCT03593655|78948301|FG001|First Product Use Period|Withdrawal by Subject|1|||
44156878|NCT03593655|78948300|FG000|First Product Use Period|Lost to Follow-up|1|||
44328832|NCT04091672|79334013|FG001|Overall Study|Withdrawal by Subject|3|||
44328833|NCT04091672|79334012|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
44328834|NCT04091672|79334013|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
44328835|NCT04003389|79334029|FG000|Overall Study|Adverse Event|27|||
44425324|NCT00678561|79433401|FG002|Overall Study|Adverse Event|1|||
44425325|NCT00678561|79433402|FG003|Overall Study|Adverse Event|0|||
44425326|NCT00678561|79433403|FG004|Overall Study|Adverse Event|1|||
44425327|NCT00678561|79433404|FG005|Overall Study|Adverse Event|0|||
44425328|NCT00678561|79433405|FG006|Overall Study|Adverse Event|0|||
44425329|NCT00678561|79433406|FG007|Overall Study|Adverse Event|0|||
44425330|NCT00678561|79433399|FG000|Overall Study|Protocol Violation|0|||
44425331|NCT00678561|79433400|FG001|Overall Study|Protocol Violation|0|||
44425332|NCT00678561|79433401|FG002|Overall Study|Protocol Violation|0|||
44425333|NCT00678561|79433402|FG003|Overall Study|Protocol Violation|0|||
44425334|NCT00678561|79433403|FG004|Overall Study|Protocol Violation|1|||
44425335|NCT00678561|79433404|FG005|Overall Study|Protocol Violation|1|||
44425336|NCT00678561|79433405|FG006|Overall Study|Protocol Violation|0|||
44425337|NCT00678561|79433406|FG007|Overall Study|Protocol Violation|0|||
44425338|NCT00678561|79433399|FG000|Overall Study|Withdrawal by Subject|0|||
44425339|NCT00678561|79433400|FG001|Overall Study|Withdrawal by Subject|0|||
44425340|NCT00678561|79433401|FG002|Overall Study|Withdrawal by Subject|0|||
44425341|NCT00678561|79433402|FG003|Overall Study|Withdrawal by Subject|0|||
44425342|NCT00678561|79433403|FG004|Overall Study|Withdrawal by Subject|0|||
44425343|NCT00678561|79433404|FG005|Overall Study|Withdrawal by Subject|0|||
44425344|NCT00678561|79433405|FG006|Overall Study|Withdrawal by Subject|0|||
44425345|NCT00678561|79433406|FG007|Overall Study|Withdrawal by Subject|1|||
44425346|NCT00676143|79433433|FG000|Overall Study|Adverse Event|34|||
44425347|NCT00676143|79433434|FG001|Overall Study|Adverse Event|60|||
44425348|NCT00676143|79433433|FG000|Overall Study|Death|4|||
44425349|NCT00676143|79433434|FG001|Overall Study|Death|4|||
44425350|NCT00676143|79433433|FG000|Overall Study|Lack of Efficacy|0|||
44425351|NCT00676143|79433434|FG001|Overall Study|Lack of Efficacy|6|||
44425352|NCT00676143|79433433|FG000|Overall Study|Lost to Follow-up|0|||
44425353|NCT00676143|79433434|FG001|Overall Study|Lost to Follow-up|13|||
44425354|NCT00676143|79433433|FG000|Overall Study|Physician Decision|5|||
44328836|NCT04003389|79334030|FG001|Overall Study|Adverse Event|34|||
44328837|NCT04003389|79334031|FG002|Overall Study|Adverse Event|28|||
44328838|NCT04003389|79334029|FG000|Overall Study|Lost to Follow-up|39|||
44328839|NCT04003389|79334030|FG001|Overall Study|Lost to Follow-up|30|||
44328840|NCT04003389|79334031|FG002|Overall Study|Lost to Follow-up|33|||
44328841|NCT04003389|79334029|FG000|Overall Study|Protocol Violation|1|||
44328842|NCT04003389|79334030|FG001|Overall Study|Protocol Violation|6|||
44328843|NCT04003389|79334031|FG002|Overall Study|Protocol Violation|5|||
44328844|NCT04003389|79334029|FG000|Overall Study|Withdrawal by Subject|119|||
44328845|NCT04003389|79334030|FG001|Overall Study|Withdrawal by Subject|79|||
44425355|NCT00676143|79433434|FG001|Overall Study|Physician Decision|8|||
44425356|NCT00676143|79433433|FG000|Overall Study|Protocol Violation|4|||
44425357|NCT00676143|79433434|FG001|Overall Study|Protocol Violation|8|||
44425358|NCT00676143|79433433|FG000|Overall Study|Withdrawal by Subject|24|||
44425359|NCT00676143|79433434|FG001|Overall Study|Withdrawal by Subject|42|||
44156879|NCT03593655|78948301|FG001|First Product Use Period|Lost to Follow-up|3|||
44328846|NCT04003389|79334031|FG002|Overall Study|Withdrawal by Subject|85|||
44328847|NCT04003389|79334029|FG000|Overall Study|Miscellaneous|14|||
44328848|NCT04003389|79334030|FG001|Overall Study|Miscellaneous|11|||
44328849|NCT04003389|79334031|FG002|Overall Study|Miscellaneous|14|||
44328850|NCT04003389|79334029|FG000|Overall Study|Participant did not receive study drug|1|||
44425360|NCT00676143|79433433|FG000|Overall Study|Discontinuation of study by sponsor|65|||
44425361|NCT00676143|79433434|FG001|Overall Study|Discontinuation of study by sponsor|88|||
44425362|NCT00676143|79433433|FG000|Overall Study|Failed to return|2|||
44425363|NCT00676143|79433434|FG001|Overall Study|Failed to return|1|||
44425364|NCT00676143|79433433|FG000|Overall Study|Loss of caregiver|5|||
44425365|NCT00676143|79433434|FG001|Overall Study|Loss of caregiver|3|||
44425366|NCT00676143|79433433|FG000|Overall Study|Other|11|||
44425367|NCT00676143|79433434|FG001|Overall Study|Other|20|||
44425368|NCT00676143|79433433|FG000|Overall Study|Participant participation unknown|1|||
44425369|NCT00676143|79433434|FG001|Overall Study|Participant participation unknown|4|||
44425370|NCT00676143|79433433|FG000|Overall Study|Vasogenic edema recurrence|1|||
44425371|NCT00676143|79433434|FG001|Overall Study|Vasogenic edema recurrence|3|||
44425372|NCT00675597|79433459|FG000|Overall Study|Withdrawal by Subject|3|||
44328851|NCT04003389|79334030|FG001|Overall Study|Participant did not receive study drug|0|||
44328852|NCT04003389|79334031|FG002|Overall Study|Participant did not receive study drug|0|||
44425373|NCT00675441|79433467|FG000|Overall Study|Withdrawal by Subject|2|||
44425374|NCT00675441|79433467|FG000|Overall Study|Death|1|||
44425375|NCT00674973|79433482|FG000|Overall Study|Insufficient Therapeutic Response|77|||
44425376|NCT00674973|79433483|FG001|Overall Study|Insufficient Therapeutic Response|72|||
44425377|NCT00674973|79433482|FG000|Overall Study|Refused Treatment|1|||
44425378|NCT00674973|79433483|FG001|Overall Study|Refused Treatment|5|||
44425379|NCT00674973|79433482|FG000|Overall Study|Failure to Return|1|||
44425380|NCT00674973|79433483|FG001|Overall Study|Failure to Return|0|||
44425381|NCT00674973|79433482|FG000|Overall Study|Adverse Event|2|||
44425382|NCT00674973|79433483|FG001|Overall Study|Adverse Event|9|||
44425383|NCT00674973|79433482|FG000|Overall Study|Death|19|||
44425384|NCT00674973|79433483|FG001|Overall Study|Death|15|||
44425385|NCT00674973|79433482|FG000|Overall Study|Protocol Violation|0|||
44425386|NCT00674973|79433483|FG001|Overall Study|Protocol Violation|1|||
44425387|NCT00673179|79433491|FG000|Overall Study|Toxicity/Complications|3|||
44425388|NCT00673179|79433492|FG001|Overall Study|Toxicity/Complications|0|||
44425389|NCT00584012|79433498|FG000|Overall Study|Withdrawal by Subject|1|||
44425390|NCT00674817|79433502|FG000|Period 1|Withdrawal by Subject|2|||
44425391|NCT00674817|79433502|FG000|Period 1|Protocol Violation|1|||
44425392|NCT00674817|79433502|FG000|Period 3|Adverse Event|1|||
44425393|NCT00674817|79433502|FG000|Period 3|Protocol Violation|1|||
44425394|NCT00674817|79433502|FG000|Period 4|Adverse Event|1|||
44425395|NCT00672633|79433518|FG000|Overall Study|Withdrawal by Subject|0|||
44425396|NCT00672633|79433519|FG001|Overall Study|Withdrawal by Subject|1|||
44425397|NCT00672555|79433525|FG000|Overall Study|Lost to Follow-up|4|||
44425398|NCT00672555|79433525|FG000|Overall Study|Did not want to answer questionnaire|2|||
44425399|NCT00672477|79433531|FG000|Overall Study|Adverse Event|10|||
44425400|NCT00672477|79433532|FG001|Overall Study|Adverse Event|7|||
44328853|NCT03960437|79334039|FG000|Overall Study|Removed by PI|4|||
44328854|NCT03960437|79334039|FG000|Overall Study|Lost to Follow-up|2|||
44328855|NCT03960437|79334039|FG000|Overall Study|Withdrawal by Subject|1|||
44328856|NCT03960437|79334039|FG000|Overall Study|Death|2|||
44328857|NCT03959488|79334048|FG000|Season 1|Other|6|||
44328858|NCT03959488|79334049|FG001|Season 1|Other|7|||
44328859|NCT03959488|79334050|FG002|Season 1|Other|0|||
44328860|NCT03959488|79334051|FG003|Season 1|Other|0|||
44328861|NCT03959488|79334052|FG004|Season 1|Other|0|||
44328862|NCT03959488|79334048|FG000|Season 1|Withdrawal by parent/guardian|43|||
44328863|NCT03959488|79334049|FG001|Season 1|Withdrawal by parent/guardian|28|||
44328864|NCT03959488|79334050|FG002|Season 1|Withdrawal by parent/guardian|0|||
44328865|NCT03959488|79334051|FG003|Season 1|Withdrawal by parent/guardian|0|||
44328866|NCT03959488|79334052|FG004|Season 1|Withdrawal by parent/guardian|0|||
44328867|NCT03959488|79334048|FG000|Season 1|Due to COVID-19 pandemic|2|||
44328868|NCT03959488|79334049|FG001|Season 1|Due to COVID-19 pandemic|3|||
44328869|NCT03959488|79334050|FG002|Season 1|Due to COVID-19 pandemic|0|||
44328870|NCT03959488|79334051|FG003|Season 1|Due to COVID-19 pandemic|0|||
44328871|NCT03959488|79334052|FG004|Season 1|Due to COVID-19 pandemic|0|||
44328872|NCT03959488|79334048|FG000|Season 1|Lost to Follow-up|17|||
44328873|NCT03959488|79334049|FG001|Season 1|Lost to Follow-up|7|||
44328874|NCT03959488|79334050|FG002|Season 1|Lost to Follow-up|0|||
44328875|NCT03959488|79334051|FG003|Season 1|Lost to Follow-up|0|||
44425401|NCT00672477|79433531|FG000|Overall Study|Death|7|||
44425402|NCT00672477|79433532|FG001|Overall Study|Death|11|||
44425403|NCT00672477|79433531|FG000|Overall Study|Physician Decision|2|||
44425404|NCT00672477|79433532|FG001|Overall Study|Physician Decision|0|||
44425405|NCT00672477|79433531|FG000|Overall Study|Protocol Violation|1|||
44328876|NCT03959488|79334052|FG004|Season 1|Lost to Follow-up|0|||
44425406|NCT00672477|79433532|FG001|Overall Study|Protocol Violation|1|||
44537252|NCT03363906|79547994|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
44328877|NCT03959488|79334048|FG000|Season 1|Death|5|||
44328878|NCT03959488|79334049|FG001|Season 1|Death|1|||
44328879|NCT03959488|79334050|FG002|Season 1|Death|0|||
44328880|NCT03959488|79334051|FG003|Season 1|Death|0|||
44328881|NCT03959488|79334052|FG004|Season 1|Death|0|||
44328882|NCT03959488|79334048|FG000|Season 2|Other|0|||
44425407|NCT00672477|79433531|FG000|Overall Study|Withdrawal by Subject|5|||
44425408|NCT00672477|79433532|FG001|Overall Study|Withdrawal by Subject|3|||
44425409|NCT00672477|79433531|FG000|Overall Study|Lack of Efficacy|1|||
44425410|NCT00672477|79433532|FG001|Overall Study|Lack of Efficacy|1|||
44328883|NCT03959488|79334049|FG001|Season 2|Other|0|||
44328884|NCT03959488|79334050|FG002|Season 2|Other|2|||
44328885|NCT03959488|79334051|FG003|Season 2|Other|0|||
44328886|NCT03959488|79334052|FG004|Season 2|Other|0|||
44328887|NCT03959488|79334048|FG000|Season 2|Withdrawal by parent/guardian|0|||
44328888|NCT03959488|79334049|FG001|Season 2|Withdrawal by parent/guardian|0|||
44328889|NCT03959488|79334050|FG002|Season 2|Withdrawal by parent/guardian|3|||
44328890|NCT03959488|79334051|FG003|Season 2|Withdrawal by parent/guardian|1|||
44328891|NCT03959488|79334052|FG004|Season 2|Withdrawal by parent/guardian|1|||
44328892|NCT03959488|79334048|FG000|Season 2|Lost to Follow-up|0|||
44328893|NCT03959488|79334049|FG001|Season 2|Lost to Follow-up|0|||
44328894|NCT03959488|79334050|FG002|Season 2|Lost to Follow-up|1|||
44328895|NCT03959488|79334051|FG003|Season 2|Lost to Follow-up|0|||
44328896|NCT03959488|79334052|FG004|Season 2|Lost to Follow-up|1|||
44328897|NCT03847194|79334073|FG000|Overall Study|Lost to Follow-up|2|||
44328898|NCT03847194|79334074|FG001|Overall Study|Lost to Follow-up|5|||
44328899|NCT03847194|79334073|FG000|Overall Study|Withdrawal by Subject|1|||
44328900|NCT03847194|79334074|FG001|Overall Study|Withdrawal by Subject|2|||
44328901|NCT03847194|79334073|FG000|Overall Study|Death|0|||
44328902|NCT03847194|79334074|FG001|Overall Study|Death|1|||
44328903|NCT03828747|79334082|FG000|Double-Blind Treatment Period|Adverse Event|6|||
44328904|NCT03828747|79334083|FG001|Double-Blind Treatment Period|Adverse Event|6|||
44425411|NCT00672477|79433531|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
44425412|NCT00672477|79433532|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
44425413|NCT00674661|79433540|FG000|Overall Study|Other|5|||
44425414|NCT00674661|79433541|FG001|Overall Study|Other|7|||
44425415|NCT00674661|79433540|FG000|Overall Study|Lost to Follow-up|6|||
44425416|NCT00674661|79433541|FG001|Overall Study|Lost to Follow-up|3|||
44425417|NCT00674661|79433540|FG000|Overall Study|Withdrawal by Subject|0|||
44425418|NCT00674661|79433541|FG001|Overall Study|Withdrawal by Subject|5|||
44425419|NCT00671931|79433552|FG000|Overall Study|Physician Decision|1|||
44425420|NCT00671931|79433553|FG001|Overall Study|Physician Decision|0|||
44425421|NCT00671931|79433554|FG002|Overall Study|Physician Decision|0|||
44425422|NCT00671931|79433555|FG003|Overall Study|Physician Decision|2|||
44425423|NCT00671931|79433556|FG004|Overall Study|Physician Decision|1|||
44425424|NCT00673881|79433572|FG000|Overall Study|Withdrawal by Subject|1|||
44425425|NCT00671853|79433578|FG000|Overall Study|Lack of Efficacy|3|||
44425426|NCT00671853|79433579|FG001|Overall Study|Lack of Efficacy|7|||
44425427|NCT00671853|79433578|FG000|Overall Study|Adverse Event|7|||
44425428|NCT00671853|79433579|FG001|Overall Study|Adverse Event|1|||
44425429|NCT00671853|79433578|FG000|Overall Study|Withdrawal by Subject|1|||
44425430|NCT00671853|79433579|FG001|Overall Study|Withdrawal by Subject|5|||
44425431|NCT00671853|79433578|FG000|Overall Study|Lost to Follow-up|8|||
44425432|NCT00671853|79433579|FG001|Overall Study|Lost to Follow-up|8|||
44425433|NCT00671853|79433578|FG000|Overall Study|Physician Decision|0|||
44425434|NCT00671853|79433579|FG001|Overall Study|Physician Decision|2|||
44425435|NCT00671853|79433578|FG000|Overall Study|Non-adherence with study procedures|1|||
44425436|NCT00671853|79433579|FG001|Overall Study|Non-adherence with study procedures|4|||
44425437|NCT00570921|79433587|FG000|Overall Study|Protocol Violation|1|||
44425438|NCT00570921|79433587|FG000|Overall Study|Physician Decision|1|||
44425439|NCT00670449|79433595|FG000|Overall Study|Adverse Event|6|||
44425440|NCT00670449|79433596|FG001|Overall Study|Adverse Event|2|||
44425441|NCT00670449|79433597|FG002|Overall Study|Adverse Event|8|||
44425442|NCT00670449|79433598|FG003|Overall Study|Adverse Event|5|||
44425443|NCT00670449|79433595|FG000|Overall Study|Protocol Deviation|1|||
44425444|NCT00670449|79433596|FG001|Overall Study|Protocol Deviation|2|||
44425445|NCT00670449|79433597|FG002|Overall Study|Protocol Deviation|0|||
44425446|NCT00670449|79433598|FG003|Overall Study|Protocol Deviation|1|||
44425447|NCT00670449|79433595|FG000|Overall Study|Administrative Problems|0|||
44425448|NCT00670449|79433596|FG001|Overall Study|Administrative Problems|2|||
44425449|NCT00670449|79433597|FG002|Overall Study|Administrative Problems|0|||
44425450|NCT00670449|79433598|FG003|Overall Study|Administrative Problems|1|||
44425451|NCT00670449|79433595|FG000|Overall Study|Subject Withdrew Consent|0|||
44425452|NCT00670449|79433596|FG001|Overall Study|Subject Withdrew Consent|2|||
44425453|NCT00670449|79433597|FG002|Overall Study|Subject Withdrew Consent|0|||
44425454|NCT00670449|79433598|FG003|Overall Study|Subject Withdrew Consent|1|||
44328905|NCT03828747|79334082|FG000|Double-Blind Treatment Period|Death|1|||
44425455|NCT00670449|79433595|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
44425456|NCT00670449|79433596|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44425457|NCT00670449|79433597|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
44425458|NCT00670449|79433598|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
44328906|NCT03828747|79334083|FG001|Double-Blind Treatment Period|Death|2|||
44425459|NCT00670449|79433595|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
44425460|NCT00670449|79433596|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
44425461|NCT00670449|79433597|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
44425462|NCT00670449|79433598|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
44425463|NCT00668733|79433609|FG000|Overall Study|Lost to Follow-up|2|||
44425464|NCT00668733|79433610|FG001|Overall Study|Lost to Follow-up|3|||
44328907|NCT03828747|79334082|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44425465|NCT00668733|79433609|FG000|Overall Study|Withdrawal by Subject|0|||
44328908|NCT03828747|79334083|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
44425466|NCT00668733|79433610|FG001|Overall Study|Withdrawal by Subject|4|||
44425467|NCT00673257|79433616|FG000|Overall Study|Withdrawal by Subject|4|||
44425468|NCT00673257|79433616|FG000|Overall Study|Unable to obtain specimen|1|||
44328909|NCT03828747|79334082|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
44328910|NCT03828747|79334083|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
44425469|NCT00667875|79433623|FG000|Overall Study|Adverse Event|0|||
44425470|NCT00667875|79433624|FG001|Overall Study|Adverse Event|2|||
44328911|NCT03828747|79334082|FG000|Double-Blind Treatment Period|Physician Decision|0|||
44328912|NCT03828747|79334083|FG001|Double-Blind Treatment Period|Physician Decision|3|||
44328913|NCT03828747|79334082|FG000|Double-Blind Treatment Period|Various reasons|5|||
44328914|NCT03828747|79334083|FG001|Double-Blind Treatment Period|Various reasons|3|||
44328915|NCT03828747|79334082|FG000|Open-Label Extension|Continuing on Study|77|||
44328916|NCT03828747|79334083|FG001|Open-Label Extension|Continuing on Study|72|||
44328917|NCT03828747|79334082|FG000|Open-Label Extension|Adverse Event|3|||
44328918|NCT03828747|79334083|FG001|Open-Label Extension|Adverse Event|4|||
44328919|NCT03828747|79334082|FG000|Open-Label Extension|Death|0|||
44328920|NCT03828747|79334083|FG001|Open-Label Extension|Death|2|||
44328921|NCT03828747|79334082|FG000|Open-Label Extension|Lost to Follow-up|4|||
44328922|NCT03828747|79334083|FG001|Open-Label Extension|Lost to Follow-up|0|||
44328923|NCT03828747|79334082|FG000|Open-Label Extension|Withdrawal by Subject|19|||
44328924|NCT03828747|79334083|FG001|Open-Label Extension|Withdrawal by Subject|16|||
44328925|NCT03828747|79334082|FG000|Open-Label Extension|Various reasons|1|||
44328926|NCT03828747|79334083|FG001|Open-Label Extension|Various reasons|1|||
44328927|NCT03816176|79334121|FG000|Overall Study|Miscellaneous|5|||
44328928|NCT03816176|79334121|FG000|Overall Study|Lack of Efficacy|4|||
44328929|NCT03816176|79334121|FG000|Overall Study|Adverse Event|3|||
44328930|NCT03712098|79334133|FG000|Overall Study|Lost to Follow-up|3|||
44328931|NCT03712098|79334134|FG001|Overall Study|Lost to Follow-up|7|||
44328932|NCT03712098|79334133|FG000|Overall Study|Withdrawal by Subject|9|||
44328933|NCT03712098|79334134|FG001|Overall Study|Withdrawal by Subject|4|||
44328934|NCT03712098|79334133|FG000|Overall Study|Protocol Violation|2|||
44328935|NCT03712098|79334134|FG001|Overall Study|Protocol Violation|1|||
44328936|NCT03704688|79334146|FG000|Overall Study|Adverse Event|0|||
44328937|NCT03704688|79334147|FG001|Overall Study|Adverse Event|0|||
44328938|NCT03704688|79334148|FG002|Overall Study|Adverse Event|0|||
44328939|NCT03704688|79334149|FG003|Overall Study|Adverse Event|4|||
44328940|NCT03704688|79334150|FG004|Overall Study|Adverse Event|1|||
44328941|NCT03704688|79334151|FG005|Overall Study|Adverse Event|0|||
44328942|NCT03704688|79334146|FG000|Overall Study|Disease Progression|0|||
44328943|NCT03704688|79334147|FG001|Overall Study|Disease Progression|0|||
44328944|NCT03704688|79334148|FG002|Overall Study|Disease Progression|0|||
44328945|NCT03704688|79334149|FG003|Overall Study|Disease Progression|3|||
44328946|NCT03704688|79334150|FG004|Overall Study|Disease Progression|1|||
44328947|NCT03704688|79334151|FG005|Overall Study|Disease Progression|0|||
44328948|NCT03704688|79334146|FG000|Overall Study|Death|0|||
44328949|NCT03704688|79334147|FG001|Overall Study|Death|0|||
44328950|NCT03704688|79334148|FG002|Overall Study|Death|0|||
44328951|NCT03704688|79334149|FG003|Overall Study|Death|0|||
44328952|NCT03704688|79334150|FG004|Overall Study|Death|3|||
44328953|NCT03704688|79334151|FG005|Overall Study|Death|0|||
44425471|NCT00667875|79433625|FG002|Overall Study|Adverse Event|6|||
44425472|NCT00667875|79433623|FG000|Overall Study|Withdrawal by Subject|10|||
44425473|NCT00667875|79433624|FG001|Overall Study|Withdrawal by Subject|9|||
44425474|NCT00667875|79433625|FG002|Overall Study|Withdrawal by Subject|7|||
44156880|NCT03593655|78948300|FG000|Second Product Use Period|Withdrawal by Subject|1|||
44156881|NCT03593655|78948301|FG001|Second Product Use Period|Withdrawal by Subject|1|||
44156882|NCT03593655|78948300|FG000|Second Product Use Period|Lost to Follow-up|1|||
44328954|NCT03683394|79334168|FG000|Overall Study|Withdrawal by Subject|4|||
44328955|NCT03683394|79334169|FG001|Overall Study|Withdrawal by Subject|8|||
44328956|NCT03683394|79334168|FG000|Overall Study|Lost to Follow-up|7|||
44328957|NCT03683394|79334169|FG001|Overall Study|Lost to Follow-up|0|||
44328958|NCT03683394|79334168|FG000|Overall Study|Death|3|||
44328959|NCT03683394|79334169|FG001|Overall Study|Death|1|||
44328960|NCT03656510|79334181|FG000|Overall Study|Lost to Follow-up|1|||
44328961|NCT03656510|79334182|FG001|Overall Study|Lost to Follow-up|0|||
44328962|NCT03656510|79334183|FG002|Overall Study|Lost to Follow-up|0|||
44328963|NCT03656510|79334184|FG003|Overall Study|Lost to Follow-up|0|||
44328964|NCT03656510|79334185|FG004|Overall Study|Lost to Follow-up|0|||
44328965|NCT03656510|79334186|FG005|Overall Study|Lost to Follow-up|0|||
44425475|NCT03468998|79433645|FG000|Overall Study|Withdrawal by Subject|1|||
44425476|NCT03468998|79433646|FG001|Overall Study|Withdrawal by Subject|1|||
44425477|NCT03468998|79433647|FG002|Overall Study|Withdrawal by Subject|0|||
44425478|NCT03468998|79433648|FG003|Overall Study|Withdrawal by Subject|4|||
44425479|NCT03468998|79433649|FG004|Overall Study|Withdrawal by Subject|1|||
44156883|NCT03593655|78948301|FG001|Second Product Use Period|Lost to Follow-up|0|||
44156884|NCT03593655|78948300|FG000|Third Product Use Period|Lost to Follow-up|1|||
44156885|NCT03593655|78948301|FG001|Third Product Use Period|Lost to Follow-up|2|||
44328966|NCT03656510|79334181|FG000|Overall Study|Withdrawal by Subject|1|||
44328967|NCT03656510|79334182|FG001|Overall Study|Withdrawal by Subject|1|||
44328968|NCT03656510|79334183|FG002|Overall Study|Withdrawal by Subject|0|||
44328969|NCT03656510|79334184|FG003|Overall Study|Withdrawal by Subject|1|||
44328970|NCT03656510|79334185|FG004|Overall Study|Withdrawal by Subject|0|||
44328971|NCT03656510|79334186|FG005|Overall Study|Withdrawal by Subject|0|||
44328972|NCT03539081|79334215|FG000|Overall Study|Withdrawal by Subject|2|||
44328973|NCT03539081|79334216|FG001|Overall Study|Withdrawal by Subject|3|||
44328974|NCT03539081|79334217|FG002|Overall Study|Withdrawal by Subject|0|||
44328975|NCT03539081|79334215|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
44328976|NCT03539081|79334216|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
44328977|NCT03539081|79334217|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
44328978|NCT03518203|79334228|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
44328979|NCT03518203|79334228|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
44328980|NCT03500172|79334242|FG000|Period 1: Baseline Randomization|Death|0|||
44328981|NCT03500172|79334243|FG001|Period 1: Baseline Randomization|Death|0|||
44328982|NCT03500172|79334244|FG002|Period 1: Baseline Randomization|Death|0|||
44328983|NCT03500172|79334245|FG003|Period 1: Baseline Randomization|Death|0|||
44328984|NCT03500172|79334246|FG004|Period 1: Baseline Randomization|Death|0|||
44328985|NCT03500172|79334247|FG005|Period 1: Baseline Randomization|Death|0|||
44328986|NCT03500172|79334248|FG006|Period 1: Baseline Randomization|Death|0|||
44328987|NCT03500172|79334249|FG007|Period 1: Baseline Randomization|Death|0|||
44328988|NCT03500172|79334250|FG008|Period 1: Baseline Randomization|Death|0|||
44328989|NCT03500172|79334251|FG009|Period 1: Baseline Randomization|Death|2|||
44328990|NCT03500172|79334252|FG010|Period 1: Baseline Randomization|Death|0|||
44328991|NCT03500172|79334242|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
44328992|NCT03500172|79334243|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
44328993|NCT03500172|79334244|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
44328994|NCT03500172|79334245|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
44328995|NCT03500172|79334246|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
44328996|NCT03500172|79334247|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
44328997|NCT03500172|79334248|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
44328998|NCT03500172|79334249|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
44328999|NCT03500172|79334250|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
44329000|NCT03500172|79334251|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
44329001|NCT03500172|79334252|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
44329002|NCT03500172|79334242|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
44329003|NCT03500172|79334243|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
44329004|NCT03500172|79334244|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
44329005|NCT03500172|79334245|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
44329006|NCT03500172|79334246|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
44329007|NCT03500172|79334247|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
44329008|NCT03500172|79334248|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
44329009|NCT03500172|79334249|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
44329010|NCT03500172|79334250|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
44329011|NCT03500172|79334251|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
44329012|NCT03500172|79334252|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
44329013|NCT03500172|79334242|FG000|Period 2: Re-Randomization|Death|0|||
44329014|NCT03500172|79334243|FG001|Period 2: Re-Randomization|Death|0|||
44329015|NCT03500172|79334244|FG002|Period 2: Re-Randomization|Death|0|||
44329016|NCT03500172|79334245|FG003|Period 2: Re-Randomization|Death|4|||
44329017|NCT03500172|79334246|FG004|Period 2: Re-Randomization|Death|2|||
44329018|NCT03500172|79334247|FG005|Period 2: Re-Randomization|Death|0|||
44329019|NCT03500172|79334248|FG006|Period 2: Re-Randomization|Death|5|||
44329020|NCT03500172|79334249|FG007|Period 2: Re-Randomization|Death|2|||
44329021|NCT03500172|79334250|FG008|Period 2: Re-Randomization|Death|0|||
44329022|NCT03500172|79334251|FG009|Period 2: Re-Randomization|Death|0|||
44329023|NCT03500172|79334252|FG010|Period 2: Re-Randomization|Death|0|||
44329024|NCT03470922|79334270|FG000|Overall Study|Death|107|||
44329025|NCT03470922|79334271|FG001|Overall Study|Death|118|||
44329026|NCT03470922|79334270|FG000|Overall Study|Lost to Follow-up|5|||
44329027|NCT03470922|79334271|FG001|Overall Study|Lost to Follow-up|5|||
44329028|NCT03470922|79334270|FG000|Overall Study|Participant Withdrew Consent|4|||
44425480|NCT03468998|79433650|FG005|Overall Study|Withdrawal by Subject|0|||
44425481|NCT00667251|79433664|FG000|Overall Study|Adverse Event|13|||
44425482|NCT00667251|79433665|FG001|Overall Study|Adverse Event|4|||
44425483|NCT00667251|79433664|FG000|Overall Study|Withdrawal by Subject|6|||
44425484|NCT00667251|79433665|FG001|Overall Study|Withdrawal by Subject|2|||
44425485|NCT00667251|79433664|FG000|Overall Study|Other/missing|46|||
44425486|NCT00667251|79433665|FG001|Overall Study|Other/missing|84|||
44425487|NCT00667251|79433664|FG000|Overall Study|Intercurrent Illness|4|||
44425488|NCT00667251|79433665|FG001|Overall Study|Intercurrent Illness|3|||
44425489|NCT00667251|79433664|FG000|Overall Study|Symptomatic progression|1|||
44425490|NCT00667251|79433665|FG001|Overall Study|Symptomatic progression|2|||
44425491|NCT00669903|79433683|FG000|Overall Study|Adverse Event|0|||
44425492|NCT00669903|79433684|FG001|Overall Study|Adverse Event|1|||
44425493|NCT00669903|79433685|FG002|Overall Study|Adverse Event|3|||
44425494|NCT00669903|79433686|FG003|Overall Study|Adverse Event|1|||
44425495|NCT00669903|79433683|FG000|Overall Study|Withdrawal by Subject|0|||
44425496|NCT00669903|79433684|FG001|Overall Study|Withdrawal by Subject|2|||
44329029|NCT03470922|79334271|FG001|Overall Study|Participant Withdrew Consent|9|||
44329030|NCT03470922|79334270|FG000|Overall Study|Other reasons|1|||
44329031|NCT03470922|79334271|FG001|Overall Study|Other reasons|0|||
44425497|NCT00669903|79433685|FG002|Overall Study|Withdrawal by Subject|2|||
44329032|NCT03470922|79334270|FG000|Overall Study|Not reported|1|||
44329033|NCT03470922|79334271|FG001|Overall Study|Not reported|0|||
44329034|NCT03440814|79334279|FG000|Overall Study|Adverse Event|2|||
44425498|NCT00669903|79433686|FG003|Overall Study|Withdrawal by Subject|2|||
44425499|NCT00669903|79433683|FG000|Overall Study|Lost to Follow-up|1|||
44425500|NCT00669903|79433684|FG001|Overall Study|Lost to Follow-up|1|||
44425501|NCT00669903|79433685|FG002|Overall Study|Lost to Follow-up|0|||
44425502|NCT00669903|79433686|FG003|Overall Study|Lost to Follow-up|1|||
44425503|NCT00669903|79433683|FG000|Overall Study|Protocol Violation|0|||
44425504|NCT00669903|79433684|FG001|Overall Study|Protocol Violation|1|||
44425505|NCT00669903|79433685|FG002|Overall Study|Protocol Violation|0|||
44425506|NCT00669903|79433686|FG003|Overall Study|Protocol Violation|0|||
44425507|NCT03759392|79433698|FG000|Overall Study|Adverse Event|12|||
44425508|NCT03759392|79433699|FG001|Overall Study|Adverse Event|4|||
44156886|NCT03593655|78948300|FG000|Third Product Use Period|Physician Decision|0|||
44156887|NCT03593655|78948301|FG001|Third Product Use Period|Physician Decision|1|||
44156888|NCT03593655|78948300|FG000|Third Product Use Period|Withdrawal by Subject|0|||
44329035|NCT03440814|79334280|FG001|Overall Study|Adverse Event|1|||
44329036|NCT03440814|79334279|FG000|Overall Study|Lost to Follow-up|2|||
44329037|NCT03440814|79334280|FG001|Overall Study|Lost to Follow-up|0|||
44329038|NCT03440814|79334279|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
44329039|NCT03440814|79334280|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
44329040|NCT03427814|79334288|FG000|Overall Study|Withdrawal by Subject|4|||
44329041|NCT03427814|79334289|FG001|Overall Study|Withdrawal by Subject|4|||
44329042|NCT03427814|79334288|FG000|Overall Study|Lost to Follow-up|0|||
44329043|NCT03427814|79334289|FG001|Overall Study|Lost to Follow-up|2|||
44329044|NCT03427814|79334288|FG000|Overall Study|Death|42|||
44329045|NCT03427814|79334289|FG001|Overall Study|Death|31|||
44329046|NCT03427814|79334288|FG000|Overall Study|Sponsor's Decision|1|||
44329047|NCT03427814|79334289|FG001|Overall Study|Sponsor's Decision|0|||
44329048|NCT03427814|79334288|FG000|Overall Study|Investigator's Decision|1|||
44329049|NCT03427814|79334289|FG001|Overall Study|Investigator's Decision|2|||
44329050|NCT03427814|79334288|FG000|Overall Study|Disease progression|1|||
44329051|NCT03427814|79334289|FG001|Overall Study|Disease progression|0|||
44329052|NCT03427814|79334288|FG000|Overall Study|Treatment Completed|0|||
44329053|NCT03427814|79334289|FG001|Overall Study|Treatment Completed|1|||
44329054|NCT03427814|79334288|FG000|Overall Study|Sponsor's Decision to End study|21|||
44329055|NCT03427814|79334289|FG001|Overall Study|Sponsor's Decision to End study|25|||
44329056|NCT03427814|79334288|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
44329057|NCT03427814|79334289|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
44329058|NCT03418493|79334306|FG000|Overall Study|Adverse Event|1|||
44425509|NCT03759392|79433698|FG000|Overall Study|Death|2|||
44425510|NCT03759392|79433699|FG001|Overall Study|Death|1|||
44425511|NCT03759392|79433698|FG000|Overall Study|Withdrawal by Subject|2|||
44329059|NCT03418493|79334307|FG001|Overall Study|Adverse Event|0|||
44425512|NCT03759392|79433699|FG001|Overall Study|Withdrawal by Subject|0|||
44425513|NCT03759392|79433698|FG000|Overall Study|Protocol Violation|2|||
44425514|NCT03759392|79433699|FG001|Overall Study|Protocol Violation|0|||
44425515|NCT03759392|79433698|FG000|Overall Study|Physician Decision|0|||
44425516|NCT03759392|79433699|FG001|Overall Study|Physician Decision|1|||
44425517|NCT03759392|79433698|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
44329060|NCT03418493|79334308|FG002|Overall Study|Adverse Event|0|||
44329061|NCT03418493|79334309|FG003|Overall Study|Adverse Event|0|||
44329062|NCT03418493|79334310|FG004|Overall Study|Adverse Event|0|||
44425518|NCT03759392|79433699|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
44425519|NCT03759392|79433698|FG000|Overall Study|No longer able to take medicines|1|||
44329063|NCT03418493|79334311|FG005|Overall Study|Adverse Event|0|||
44329064|NCT03418493|79334312|FG006|Overall Study|Adverse Event|0|||
44329065|NCT03418493|79334313|FG007|Overall Study|Adverse Event|0|||
44329066|NCT03418493|79334314|FG008|Overall Study|Adverse Event|0|||
44329067|NCT03418493|79334315|FG009|Overall Study|Adverse Event|0|||
44329068|NCT03418493|79334316|FG010|Overall Study|Adverse Event|0|||
44329069|NCT03418493|79334306|FG000|Overall Study|Protocol Violation|0|||
44329070|NCT03418493|79334307|FG001|Overall Study|Protocol Violation|0|||
44329071|NCT03418493|79334308|FG002|Overall Study|Protocol Violation|0|||
44329072|NCT03418493|79334309|FG003|Overall Study|Protocol Violation|0|||
44329073|NCT03418493|79334310|FG004|Overall Study|Protocol Violation|0|||
44329074|NCT03418493|79334311|FG005|Overall Study|Protocol Violation|0|||
44329075|NCT03418493|79334312|FG006|Overall Study|Protocol Violation|0|||
44329076|NCT03418493|79334313|FG007|Overall Study|Protocol Violation|0|||
44329077|NCT03418493|79334314|FG008|Overall Study|Protocol Violation|0|||
44329078|NCT03418493|79334315|FG009|Overall Study|Protocol Violation|1|||
44329079|NCT03418493|79334316|FG010|Overall Study|Protocol Violation|0|||
44329080|NCT03368664|79334349|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
44329081|NCT03368664|79334349|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
44329082|NCT03368664|79334349|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
44329083|NCT03368664|79334349|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
44329084|NCT03343054|79334360|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
44329085|NCT03343054|79334361|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
44329086|NCT03343054|79334362|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
44329087|NCT03343054|79334360|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
44329088|NCT03343054|79334361|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
44329089|NCT03343054|79334362|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
44329090|NCT03343054|79334360|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
44329091|NCT03343054|79334361|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
44329092|NCT03343054|79334362|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
44329093|NCT03343054|79334360|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
44329094|NCT03343054|79334361|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
44329095|NCT03343054|79334362|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
44329096|NCT03309878|79334400|FG000|Overall Study|Adverse Event|1|||
44329097|NCT03309878|79334401|FG001|Overall Study|Adverse Event|0|||
44329098|NCT03309878|79334402|FG002|Overall Study|Adverse Event|0|||
44329099|NCT03309878|79334403|FG003|Overall Study|Adverse Event|0|||
44329100|NCT03309878|79334400|FG000|Overall Study|Did not maintain eligibility|2|||
44329101|NCT03309878|79334401|FG001|Overall Study|Did not maintain eligibility|1|||
44329102|NCT03309878|79334402|FG002|Overall Study|Did not maintain eligibility|0|||
44329103|NCT03309878|79334403|FG003|Overall Study|Did not maintain eligibility|0|||
44329104|NCT03309878|79334400|FG000|Overall Study|Withdrawal by Subject|0|||
44329105|NCT03309878|79334401|FG001|Overall Study|Withdrawal by Subject|1|||
44329106|NCT03309878|79334402|FG002|Overall Study|Withdrawal by Subject|0|||
44329107|NCT03309878|79334403|FG003|Overall Study|Withdrawal by Subject|0|||
44329108|NCT03200704|79334421|FG000|Overall Study|Withdrawal by Subject|1|||
44329109|NCT03176472|79334427|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
44329110|NCT03176472|79334428|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
44329111|NCT03176472|79334427|FG000|Double Blind Treatment Period|Adverse Event|0|||
44329112|NCT03176472|79334428|FG001|Double Blind Treatment Period|Adverse Event|5|||
44329113|NCT03176472|79334427|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
44329114|NCT03176472|79334428|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
44329115|NCT03176472|79334427|FG000|Double Blind Treatment Period|Physician Decision|0|||
44329116|NCT03176472|79334428|FG001|Double Blind Treatment Period|Physician Decision|1|||
44425520|NCT03759392|79433699|FG001|Overall Study|No longer able to take medicines|0|||
44425521|NCT03759392|79433698|FG000|Overall Study|Stopped taking study drug|1|||
44425522|NCT03759392|79433699|FG001|Overall Study|Stopped taking study drug|0|||
44425523|NCT00667719|79433705|FG000|Overall Study|Adverse Event|39|||
44425524|NCT00667719|79433705|FG000|Overall Study|Abnormal Test Procedure|1|||
44425525|NCT00667719|79433705|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
44425526|NCT00667719|79433705|FG000|Overall Study|Protocol Violation|3|||
44425527|NCT00667719|79433705|FG000|Overall Study|Withdrawal by Subject|17|||
44425528|NCT00667719|79433705|FG000|Overall Study|Lost to Follow-up|8|||
44329117|NCT03176472|79334427|FG000|Double Blind Treatment Period|Protocol Violation|1|||
44329118|NCT03176472|79334428|FG001|Double Blind Treatment Period|Protocol Violation|0|||
44329119|NCT03176472|79334427|FG000|Double Blind Treatment Period|Not Provided|1|||
44329120|NCT03176472|79334428|FG001|Double Blind Treatment Period|Not Provided|0|||
44329121|NCT03176472|79334427|FG000|Open Label Extension|Withdrawal by Subject|3|||
44329122|NCT03176472|79334428|FG001|Open Label Extension|Withdrawal by Subject|4|||
44425529|NCT00669669|79433714|FG000|Overall Study|To late to start treatment|1|||
44425530|NCT00467779|79433733|FG000|Stage 1|Adverse Event|1|||
44329123|NCT03176472|79334427|FG000|Open Label Extension|Adverse Event|2|||
44329124|NCT03176472|79334428|FG001|Open Label Extension|Adverse Event|4|||
44329125|NCT03176472|79334427|FG000|Open Label Extension|Lost to Follow-up|1|||
44329126|NCT03176472|79334428|FG001|Open Label Extension|Lost to Follow-up|2|||
44329127|NCT03176472|79334427|FG000|Open Label Extension|Protocol Violation|0|||
44329128|NCT03176472|79334428|FG001|Open Label Extension|Protocol Violation|1|||
44329129|NCT03176472|79334427|FG000|Open Label Extension|Not Provided|2|||
44329130|NCT03176472|79334428|FG001|Open Label Extension|Not Provided|1|||
44329131|NCT04876599|79334479|FG000|Overall Study|Missed|2|||
44329132|NCT04876599|79334480|FG001|Overall Study|Missed|0|||
44329133|NCT04876599|79334479|FG000|Overall Study|Declined|2|||
44329134|NCT04876599|79334480|FG001|Overall Study|Declined|3|||
44329135|NCT04730947|79334489|FG000|Overall Study|Withdrawal by Subject|0|||
44329136|NCT04730947|79334490|FG001|Overall Study|Withdrawal by Subject|1|||
44329137|NCT04660799|79334498|FG000|Overall Study|Progressive Disease|1|||
44329138|NCT04660799|79334499|FG001|Overall Study|Progressive Disease|1|||
44329139|NCT04660799|79334498|FG000|Overall Study|Death|2|||
44329140|NCT04660799|79334499|FG001|Overall Study|Death|1|||
44329141|NCT04660799|79334498|FG000|Overall Study|Adverse Event|2|||
44329142|NCT04660799|79334499|FG001|Overall Study|Adverse Event|1|||
44329143|NCT04660799|79334498|FG000|Overall Study|Withdrawal by Subject|2|||
44329144|NCT04660799|79334499|FG001|Overall Study|Withdrawal by Subject|5|||
44329145|NCT04553471|79334514|FG000|Overall Study|Did not start treatment on protocol|3|||
44329146|NCT04553471|79334514|FG000|Overall Study|Death|1|||
44329147|NCT04484831|79334520|FG000|Overall Study|Withdrawal by Subject|1|||
44329148|NCT04484831|79334521|FG001|Overall Study|Withdrawal by Subject|0|||
44329149|NCT04063787|79334559|FG000|Overall Study|Inadequate Doppler data|4|||
44329150|NCT04063787|79334559|FG000|Overall Study|Lost to Follow-up|2|||
44329151|NCT04063787|79334559|FG000|Overall Study|Death|3|||
44329152|NCT03995316|79334573|FG000|Overall Study|Lost to Follow-up|10|||
44329153|NCT03995316|79334574|FG001|Overall Study|Lost to Follow-up|3|||
44329154|NCT03927690|79334583|FG000|Overall Study|Withdrawal by Subject|3|||
44329155|NCT03927690|79334584|FG001|Overall Study|Withdrawal by Subject|1|||
44329156|NCT03927690|79334585|FG002|Overall Study|Withdrawal by Subject|1|||
44329157|NCT03927690|79334583|FG000|Overall Study|Adverse Event|1|||
44329158|NCT03927690|79334584|FG001|Overall Study|Adverse Event|0|||
44329159|NCT03927690|79334585|FG002|Overall Study|Adverse Event|0|||
44329160|NCT03927690|79334583|FG000|Overall Study|Death|1|||
44329161|NCT03927690|79334584|FG001|Overall Study|Death|0|||
44329162|NCT03927690|79334585|FG002|Overall Study|Death|0|||
44329163|NCT03927690|79334583|FG000|Overall Study|Lost to Follow-up|2|||
44329164|NCT03927690|79334584|FG001|Overall Study|Lost to Follow-up|2|||
44425531|NCT00467779|79433734|FG001|Stage 1|Adverse Event|0|||
44425532|NCT00467779|79433735|FG002|Stage 1|Adverse Event|0|||
44425533|NCT00467779|79433736|FG003|Stage 1|Adverse Event|0|||
44425534|NCT00467779|79433737|FG004|Stage 1|Adverse Event|0|||
44425535|NCT00467779|79433738|FG005|Stage 1|Adverse Event|1|||
44425536|NCT00467779|79433739|FG006|Stage 1|Adverse Event|2|||
44156889|NCT03593655|78948301|FG001|Third Product Use Period|Withdrawal by Subject|1|||
44156890|NCT03577106|78948310|FG000|Overall Study|Withdrawal by Subject|3|||
44329165|NCT03927690|79334585|FG002|Overall Study|Lost to Follow-up|1|||
44329166|NCT03793842|79334597|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
44329167|NCT03793842|79334598|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
44329168|NCT03793842|79334597|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
44329169|NCT03793842|79334598|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
44329170|NCT03555695|79334608|FG000|Overall Study|Withdrawal by Subject|1|||
44329171|NCT03555695|79334608|FG000|Overall Study|Lost to Follow-up|1|||
44329172|NCT03555695|79334608|FG000|Overall Study|appendicitis (unrelated)|1|||
44329173|NCT03555695|79334608|FG000|Overall Study|pre-existing sciatica|1|||
44329174|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
44329175|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
44329176|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
44329177|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
44329178|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
44329179|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
44329180|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
44425537|NCT00467779|79433740|FG007|Stage 1|Adverse Event|1|||
44329181|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
44329182|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
44329183|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
44329184|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
44425538|NCT00467779|79433741|FG008|Stage 1|Adverse Event|0|||
44329185|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
44329186|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
44425539|NCT00467779|79433742|FG009|Stage 1|Adverse Event|0|||
44425540|NCT00467779|79433743|FG010|Stage 1|Adverse Event|0|||
44329187|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
44329188|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
44329189|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
44329190|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
44329191|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
44329192|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
44329193|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
44329194|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
44329195|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
44329196|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
44329197|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
44329198|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
44329199|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
44329200|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
44329201|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
44329202|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
44425541|NCT00467779|79433744|FG011|Stage 1|Adverse Event|0|||
44425542|NCT00467779|79433745|FG012|Stage 1|Adverse Event|0|||
44425543|NCT00467779|79433746|FG013|Stage 1|Adverse Event|0|||
44425544|NCT00467779|79433747|FG014|Stage 1|Adverse Event|0|||
44425545|NCT00467779|79433733|FG000|Stage 1|Disease Progression|2|||
44425546|NCT00467779|79433734|FG001|Stage 1|Disease Progression|2|||
44425547|NCT00467779|79433735|FG002|Stage 1|Disease Progression|2|||
44425548|NCT00467779|79433736|FG003|Stage 1|Disease Progression|3|||
44425549|NCT00467779|79433737|FG004|Stage 1|Disease Progression|2|||
44425550|NCT00467779|79433738|FG005|Stage 1|Disease Progression|2|||
44425551|NCT00467779|79433739|FG006|Stage 1|Disease Progression|4|||
44425552|NCT00467779|79433740|FG007|Stage 1|Disease Progression|5|||
44156891|NCT03364231|78948320|FG000|Overall Study|Adverse Event|1|||
44258638|NCT02763579|79113733|FG002|China Period|Death|46|||
44329203|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
44329204|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
44329205|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
44329206|NCT03538691|79334612|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
44329207|NCT03538691|79334613|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
44329208|NCT03538691|79334614|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
44329209|NCT03538691|79334615|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
44329210|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
44329211|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
44329212|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
44329213|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
44329214|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
44329215|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
44329216|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
44329217|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
44329218|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
44329219|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
44329220|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
44329221|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
44329222|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
44329223|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
44329224|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
44329225|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
44329226|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
44329227|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
44329228|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
44425553|NCT00467779|79433741|FG008|Stage 1|Disease Progression|0|||
44425554|NCT00467779|79433742|FG009|Stage 1|Disease Progression|0|||
44425555|NCT00467779|79433743|FG010|Stage 1|Disease Progression|0|||
44258639|NCT02763579|79113734|FG003|China Period|Death|48|||
44258640|NCT02763579|79113731|FG000|China Period|Lost to Follow-up|0|||
44258641|NCT02763579|79113732|FG001|China Period|Lost to Follow-up|0|||
44258642|NCT02763579|79113733|FG002|China Period|Lost to Follow-up|1|||
44258643|NCT02763579|79113734|FG003|China Period|Lost to Follow-up|1|||
44258644|NCT02763579|79113731|FG000|China Period|Physician Decision|0|||
44258645|NCT02763579|79113732|FG001|China Period|Physician Decision|0|||
44258646|NCT02763579|79113733|FG002|China Period|Physician Decision|0|||
44329229|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
44329230|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
44329231|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
44329232|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
44329233|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
44329234|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
44329235|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
44329236|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
44329237|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
44329238|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
44329239|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
44329240|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
44329241|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
44329242|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
44329243|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
44329244|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
44329245|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
44329246|NCT03538691|79334612|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
44329247|NCT03538691|79334613|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
44425556|NCT00467779|79433744|FG011|Stage 1|Disease Progression|0|||
44425557|NCT00467779|79433745|FG012|Stage 1|Disease Progression|0|||
44425558|NCT00467779|79433746|FG013|Stage 1|Disease Progression|0|||
44425559|NCT00467779|79433747|FG014|Stage 1|Disease Progression|0|||
44425560|NCT00467779|79433733|FG000|Stage 1|Unspecified Reason|1|||
44425561|NCT00467779|79433734|FG001|Stage 1|Unspecified Reason|0|||
44329248|NCT03538691|79334614|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
44425562|NCT00467779|79433735|FG002|Stage 1|Unspecified Reason|1|||
44425563|NCT00467779|79433736|FG003|Stage 1|Unspecified Reason|0|||
44425564|NCT00467779|79433737|FG004|Stage 1|Unspecified Reason|1|||
44425565|NCT00467779|79433738|FG005|Stage 1|Unspecified Reason|2|||
44425566|NCT00467779|79433739|FG006|Stage 1|Unspecified Reason|0|||
44425567|NCT00467779|79433740|FG007|Stage 1|Unspecified Reason|0|||
44425568|NCT00467779|79433741|FG008|Stage 1|Unspecified Reason|0|||
44425569|NCT00467779|79433742|FG009|Stage 1|Unspecified Reason|0|||
44425570|NCT00467779|79433743|FG010|Stage 1|Unspecified Reason|0|||
44425571|NCT00467779|79433744|FG011|Stage 1|Unspecified Reason|0|||
44425572|NCT00467779|79433745|FG012|Stage 1|Unspecified Reason|0|||
44156892|NCT03364231|78948321|FG001|Overall Study|Adverse Event|4|||
44156893|NCT03364231|78948320|FG000|Overall Study|Death|1|||
44329249|NCT03538691|79334615|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
44329250|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
44329251|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
44329252|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
44329253|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
44329254|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
44329255|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
44329256|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
44329257|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
44329258|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
44329259|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
44329260|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
44329261|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
44329262|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
44329263|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
44329264|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
44329265|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
44329266|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
44329267|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
44329268|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
44425573|NCT00467779|79433746|FG013|Stage 1|Unspecified Reason|0|||
44425574|NCT00467779|79433747|FG014|Stage 1|Unspecified Reason|0|||
44425575|NCT00467779|79433733|FG000|Stage 1|Physician Decision|0|||
44425576|NCT00467779|79433734|FG001|Stage 1|Physician Decision|1|||
44425577|NCT00467779|79433735|FG002|Stage 1|Physician Decision|0|||
44425578|NCT00467779|79433736|FG003|Stage 1|Physician Decision|0|||
44537253|NCT03363906|79547995|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
44156894|NCT03364231|78948321|FG001|Overall Study|Death|0|||
44425579|NCT00467779|79433737|FG004|Stage 1|Physician Decision|0|||
44425580|NCT00467779|79433738|FG005|Stage 1|Physician Decision|0|||
44329269|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
44329270|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
44329271|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
44329272|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
44329273|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
44329274|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
44329275|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
44329276|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
44329277|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
44329278|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
44329279|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
44329280|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
44329281|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
44329282|NCT03538691|79334612|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
44329283|NCT03538691|79334613|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
44329284|NCT03538691|79334614|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
44329285|NCT03538691|79334615|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
44425581|NCT00467779|79433739|FG006|Stage 1|Physician Decision|0|||
44425582|NCT00467779|79433740|FG007|Stage 1|Physician Decision|0|||
44425583|NCT00467779|79433741|FG008|Stage 1|Physician Decision|0|||
44425584|NCT00467779|79433742|FG009|Stage 1|Physician Decision|0|||
44425585|NCT00467779|79433743|FG010|Stage 1|Physician Decision|0|||
44425586|NCT00467779|79433744|FG011|Stage 1|Physician Decision|0|||
44425587|NCT00467779|79433745|FG012|Stage 1|Physician Decision|0|||
44425588|NCT00467779|79433746|FG013|Stage 1|Physician Decision|0|||
44329286|NCT03120949|79334634|FG000|Overall Study|randomized in error|1|||
44329287|NCT03120949|79334635|FG001|Overall Study|randomized in error|0|||
44329288|NCT03120949|79334634|FG000|Overall Study|Death|13|||
44329289|NCT03120949|79334635|FG001|Overall Study|Death|13|||
44329290|NCT03120949|79334634|FG000|Overall Study|Lost to Follow-up|23|||
44329291|NCT03120949|79334635|FG001|Overall Study|Lost to Follow-up|13|||
44329292|NCT03120949|79334634|FG000|Overall Study|Withdrawal by Subject|139|||
44329293|NCT03120949|79334635|FG001|Overall Study|Withdrawal by Subject|124|||
44329294|NCT03120949|79334634|FG000|Overall Study|Covid-19|43|||
44329295|NCT03120949|79334635|FG001|Overall Study|Covid-19|34|||
44329296|NCT03120949|79334634|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
44329297|NCT03120949|79334635|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
44329298|NCT03120949|79334634|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
44329299|NCT03120949|79334635|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
44329300|NCT03120949|79334634|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
44329301|NCT03120949|79334635|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
44329302|NCT03120949|79334634|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
44329303|NCT03120949|79334635|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
44329304|NCT03120949|79334634|FG000|Overall Study|Site was closed|2|||
44329305|NCT03120949|79334635|FG001|Overall Study|Site was closed|3|||
44329306|NCT03120949|79334634|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
44329307|NCT03120949|79334635|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
44329308|NCT03120949|79334634|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
44329309|NCT03120949|79334635|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
44329310|NCT03120949|79334634|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
44329311|NCT03120949|79334635|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
44329312|NCT03120949|79334634|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
44329313|NCT03120949|79334635|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
44329314|NCT03120949|79334634|FG000|Overall Study|Other: Adverse Event|0|||
44425589|NCT00467779|79433747|FG014|Stage 1|Physician Decision|0|||
44425590|NCT00467779|79433733|FG000|Stage 1|Withdrawal by Subject|0|||
44425591|NCT00467779|79433734|FG001|Stage 1|Withdrawal by Subject|0|||
44425592|NCT00467779|79433735|FG002|Stage 1|Withdrawal by Subject|0|||
44425593|NCT00467779|79433736|FG003|Stage 1|Withdrawal by Subject|0|||
44425594|NCT00467779|79433737|FG004|Stage 1|Withdrawal by Subject|0|||
44425595|NCT00467779|79433738|FG005|Stage 1|Withdrawal by Subject|0|||
44156895|NCT03364231|78948320|FG000|Overall Study|Investigator Decision|2|||
44329315|NCT03120949|79334635|FG001|Overall Study|Other: Adverse Event|1|||
44329316|NCT03120949|79334634|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
44329317|NCT03120949|79334635|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
44329318|NCT03120949|79334634|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
44329319|NCT03120949|79334635|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
44425596|NCT00467779|79433739|FG006|Stage 1|Withdrawal by Subject|1|||
44425597|NCT00467779|79433740|FG007|Stage 1|Withdrawal by Subject|1|||
44329320|NCT03120949|79334634|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
44425598|NCT00467779|79433741|FG008|Stage 1|Withdrawal by Subject|0|||
44425599|NCT00467779|79433742|FG009|Stage 1|Withdrawal by Subject|0|||
44425600|NCT00467779|79433743|FG010|Stage 1|Withdrawal by Subject|0|||
44425601|NCT00467779|79433744|FG011|Stage 1|Withdrawal by Subject|0|||
44329321|NCT03120949|79334635|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
44329322|NCT03120949|79334634|FG000|Overall Study|Personal Reasons|0|||
44329323|NCT03120949|79334635|FG001|Overall Study|Personal Reasons|1|||
44329324|NCT03120949|79334634|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
44329325|NCT03120949|79334635|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
44329326|NCT03120949|79334634|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
44425602|NCT00467779|79433745|FG012|Stage 1|Withdrawal by Subject|0|||
44425603|NCT00467779|79433746|FG013|Stage 1|Withdrawal by Subject|0|||
44425604|NCT00467779|79433747|FG014|Stage 1|Withdrawal by Subject|0|||
44425605|NCT00467779|79433733|FG000|Stage 1A|Adverse Event|0|||
44425606|NCT00467779|79433734|FG001|Stage 1A|Adverse Event|0|||
44425607|NCT00467779|79433735|FG002|Stage 1A|Adverse Event|0|||
44425608|NCT00467779|79433736|FG003|Stage 1A|Adverse Event|0|||
44425609|NCT00467779|79433737|FG004|Stage 1A|Adverse Event|0|||
44425610|NCT00467779|79433738|FG005|Stage 1A|Adverse Event|0|||
44425611|NCT00467779|79433739|FG006|Stage 1A|Adverse Event|0|||
44156896|NCT03364231|78948321|FG001|Overall Study|Investigator Decision|2|||
44156897|NCT03364231|78948320|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
44329327|NCT03120949|79334635|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
44329328|NCT03120949|79334634|FG000|Overall Study|Compliance With Medication|0|||
44329329|NCT03120949|79334635|FG001|Overall Study|Compliance With Medication|1|||
44329330|NCT03120949|79334634|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
44329331|NCT03120949|79334635|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
44329332|NCT03120949|79334634|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
44329333|NCT03120949|79334635|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
44329334|NCT03120949|79334634|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
44329335|NCT03120949|79334635|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
44329336|NCT02921256|79334658|FG000|Arm 1a v. Arm II|Adverse Event|6|||
44329337|NCT02921256|79334659|FG001|Arm 1a v. Arm II|Adverse Event|15|||
44329338|NCT02921256|79334660|FG002|Arm 1a v. Arm II|Adverse Event|0|||
44329339|NCT02921256|79334658|FG000|Arm 1a v. Arm II|Death|0|||
44329340|NCT02921256|79334659|FG001|Arm 1a v. Arm II|Death|2|||
44329341|NCT02921256|79334660|FG002|Arm 1a v. Arm II|Death|0|||
44329342|NCT02921256|79334658|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
44329343|NCT02921256|79334659|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
44329344|NCT02921256|79334660|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
44329345|NCT02921256|79334658|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
44329346|NCT02921256|79334659|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
44329347|NCT02921256|79334660|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
44329348|NCT02921256|79334658|FG000|Arm 1a v. Arm II|Physician Decision|1|||
44329349|NCT02921256|79334659|FG001|Arm 1a v. Arm II|Physician Decision|1|||
44329350|NCT02921256|79334660|FG002|Arm 1a v. Arm II|Physician Decision|0|||
44329351|NCT02921256|79334658|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
44329352|NCT02921256|79334659|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
44425612|NCT00467779|79433740|FG007|Stage 1A|Adverse Event|0|||
44156898|NCT03364231|78948321|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
44156899|NCT03364231|78948320|FG000|Overall Study|Withdrawal of Subject Consent|1|||
44156900|NCT03364231|78948321|FG001|Overall Study|Withdrawal of Subject Consent|0|||
44156901|NCT03364231|78948320|FG000|Overall Study|Reason Not Specified|1|||
44156902|NCT03364231|78948321|FG001|Overall Study|Reason Not Specified|0|||
44156903|NCT03364231|78948320|FG000|Overall Study|Disease Progression|0|||
44425613|NCT00467779|79433741|FG008|Stage 1A|Adverse Event|0|||
44425614|NCT00467779|79433742|FG009|Stage 1A|Adverse Event|0|||
44425615|NCT00467779|79433743|FG010|Stage 1A|Adverse Event|0|||
44425616|NCT00467779|79433744|FG011|Stage 1A|Adverse Event|0|||
44425617|NCT00467779|79433745|FG012|Stage 1A|Adverse Event|1|||
44425618|NCT00467779|79433746|FG013|Stage 1A|Adverse Event|0|||
44425619|NCT00467779|79433747|FG014|Stage 1A|Adverse Event|0|||
44425620|NCT00467779|79433733|FG000|Stage 1A|Death|0|||
44425621|NCT00467779|79433734|FG001|Stage 1A|Death|0|||
44425622|NCT00467779|79433735|FG002|Stage 1A|Death|0|||
44425623|NCT00467779|79433736|FG003|Stage 1A|Death|0|||
44329353|NCT02921256|79334660|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
44329354|NCT02921256|79334658|FG000|Arm Ib v Arm III|Adverse Event|9|||
44329355|NCT02921256|79334659|FG001|Arm Ib v Arm III|Adverse Event|0|||
44329356|NCT02921256|79334660|FG002|Arm Ib v Arm III|Adverse Event|4|||
44329357|NCT02921256|79334658|FG000|Arm Ib v Arm III|Death|1|||
44329358|NCT02921256|79334659|FG001|Arm Ib v Arm III|Death|0|||
44425624|NCT00467779|79433737|FG004|Stage 1A|Death|0|||
44425625|NCT00467779|79433738|FG005|Stage 1A|Death|0|||
44425626|NCT00467779|79433739|FG006|Stage 1A|Death|0|||
44425627|NCT00467779|79433740|FG007|Stage 1A|Death|0|||
44425628|NCT00467779|79433741|FG008|Stage 1A|Death|0|||
44425629|NCT00467779|79433742|FG009|Stage 1A|Death|0|||
44425630|NCT00467779|79433743|FG010|Stage 1A|Death|0|||
44425631|NCT00467779|79433744|FG011|Stage 1A|Death|1|||
44425632|NCT00467779|79433745|FG012|Stage 1A|Death|1|||
44425633|NCT00467779|79433746|FG013|Stage 1A|Death|0|||
44425634|NCT00467779|79433747|FG014|Stage 1A|Death|0|||
44425635|NCT00467779|79433733|FG000|Stage 1A|Disease Progression|0|||
44425636|NCT00467779|79433734|FG001|Stage 1A|Disease Progression|0|||
44425637|NCT00467779|79433735|FG002|Stage 1A|Disease Progression|0|||
44425638|NCT00467779|79433736|FG003|Stage 1A|Disease Progression|0|||
44425639|NCT00467779|79433737|FG004|Stage 1A|Disease Progression|0|||
44425640|NCT00467779|79433738|FG005|Stage 1A|Disease Progression|0|||
44425641|NCT00467779|79433739|FG006|Stage 1A|Disease Progression|0|||
44425642|NCT00467779|79433740|FG007|Stage 1A|Disease Progression|0|||
44425643|NCT00467779|79433741|FG008|Stage 1A|Disease Progression|0|||
44425644|NCT00467779|79433742|FG009|Stage 1A|Disease Progression|2|||
44425645|NCT00467779|79433743|FG010|Stage 1A|Disease Progression|2|||
44425646|NCT00467779|79433744|FG011|Stage 1A|Disease Progression|5|||
44425647|NCT00467779|79433745|FG012|Stage 1A|Disease Progression|2|||
44425648|NCT00467779|79433746|FG013|Stage 1A|Disease Progression|0|||
44156904|NCT03364231|78948321|FG001|Overall Study|Disease Progression|6|||
44156905|NCT03303625|78948332|FG000|Overall Study|Withdrawal by Subject|2|||
44329359|NCT02921256|79334660|FG002|Arm Ib v Arm III|Death|1|||
44329360|NCT02921256|79334658|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
44329361|NCT02921256|79334659|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
44329362|NCT02921256|79334660|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
44329363|NCT02921256|79334658|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
44329364|NCT02921256|79334659|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
44329365|NCT02921256|79334660|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
44329366|NCT02921256|79334658|FG000|Arm Ib v Arm III|Physician Decision|4|||
44329367|NCT02921256|79334659|FG001|Arm Ib v Arm III|Physician Decision|0|||
44329368|NCT02921256|79334660|FG002|Arm Ib v Arm III|Physician Decision|1|||
44329369|NCT02921256|79334658|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
44329370|NCT02921256|79334659|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
44329371|NCT02921256|79334660|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
44329372|NCT02757885|79334674|FG000|Overall Study|Screen Failures|4|||
44329373|NCT02635867|79334692|FG000|Overall Study|Lost to Follow-up|4|||
44329374|NCT02635867|79334693|FG001|Overall Study|Lost to Follow-up|3|||
44329375|NCT02635867|79334694|FG002|Overall Study|Lost to Follow-up|3|||
44329376|NCT02635867|79334695|FG003|Overall Study|Lost to Follow-up|4|||
44329377|NCT02635867|79334696|FG004|Overall Study|Lost to Follow-up|1|||
44329378|NCT02426658|79334713|FG000|Overall Study|Withdrawal by Subject|1|||
44329379|NCT02426658|79334713|FG000|Overall Study|Patient expired before treatment|2|||
44329380|NCT02158091|79334720|FG000|Overall Study|DLT|2|||
44425649|NCT00467779|79433747|FG014|Stage 1A|Disease Progression|0|||
44425650|NCT00467779|79433733|FG000|Stage 1A|Physician Decision|0|||
44425651|NCT00467779|79433734|FG001|Stage 1A|Physician Decision|0|||
44425652|NCT00467779|79433735|FG002|Stage 1A|Physician Decision|0|||
44537254|NCT03363906|79547994|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
44425653|NCT00467779|79433736|FG003|Stage 1A|Physician Decision|0|||
44425654|NCT00467779|79433737|FG004|Stage 1A|Physician Decision|0|||
44425655|NCT00467779|79433738|FG005|Stage 1A|Physician Decision|0|||
44425656|NCT00467779|79433739|FG006|Stage 1A|Physician Decision|0|||
44425657|NCT00467779|79433740|FG007|Stage 1A|Physician Decision|0|||
44425658|NCT00467779|79433741|FG008|Stage 1A|Physician Decision|0|||
44425659|NCT00467779|79433742|FG009|Stage 1A|Physician Decision|1|||
44425660|NCT00467779|79433743|FG010|Stage 1A|Physician Decision|0|||
44425661|NCT00467779|79433744|FG011|Stage 1A|Physician Decision|0|||
44425662|NCT00467779|79433745|FG012|Stage 1A|Physician Decision|0|||
44425663|NCT00467779|79433746|FG013|Stage 1A|Physician Decision|0|||
44425664|NCT00467779|79433747|FG014|Stage 1A|Physician Decision|0|||
44425665|NCT00467779|79433733|FG000|Stage 1A|Withdrawal by Subject|0|||
44537255|NCT03363906|79547995|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
44537256|NCT03363906|79547994|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
44537257|NCT03363906|79547995|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
44425666|NCT00467779|79433734|FG001|Stage 1A|Withdrawal by Subject|0|||
44425667|NCT00467779|79433735|FG002|Stage 1A|Withdrawal by Subject|0|||
44425668|NCT00467779|79433736|FG003|Stage 1A|Withdrawal by Subject|0|||
44425669|NCT00467779|79433737|FG004|Stage 1A|Withdrawal by Subject|0|||
44425670|NCT00467779|79433738|FG005|Stage 1A|Withdrawal by Subject|0|||
44425671|NCT00467779|79433739|FG006|Stage 1A|Withdrawal by Subject|0|||
44425672|NCT00467779|79433740|FG007|Stage 1A|Withdrawal by Subject|0|||
44425673|NCT00467779|79433741|FG008|Stage 1A|Withdrawal by Subject|0|||
44156906|NCT03303625|78948333|FG001|Overall Study|Withdrawal by Subject|0|||
44156907|NCT03303625|78948334|FG002|Overall Study|Withdrawal by Subject|0|||
44156908|NCT03303625|78948335|FG003|Overall Study|Withdrawal by Subject|0|||
44156909|NCT03299816|78948347|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
44329381|NCT02158091|79334721|FG001|Overall Study|DLT|1|||
44425674|NCT00467779|79433742|FG009|Stage 1A|Withdrawal by Subject|0|||
44425675|NCT00467779|79433743|FG010|Stage 1A|Withdrawal by Subject|1|||
44425676|NCT00467779|79433744|FG011|Stage 1A|Withdrawal by Subject|1|||
44425677|NCT00467779|79433745|FG012|Stage 1A|Withdrawal by Subject|1|||
44425678|NCT00467779|79433746|FG013|Stage 1A|Withdrawal by Subject|0|||
44156910|NCT03299816|78948348|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
44156911|NCT03299816|78948347|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
44156912|NCT03299816|78948348|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
44156913|NCT03299816|78948347|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
44156914|NCT03299816|78948348|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
44156915|NCT03288493|78948361|FG000|Overall Study|Withdrawal by Subject|4|||
44156916|NCT03288493|78948362|FG001|Overall Study|Withdrawal by Subject|0|||
44156917|NCT03288493|78948363|FG002|Overall Study|Withdrawal by Subject|0|||
44156918|NCT03288493|78948364|FG003|Overall Study|Withdrawal by Subject|0|||
44156919|NCT03288493|78948365|FG004|Overall Study|Withdrawal by Subject|0|||
44156920|NCT03288493|78948366|FG005|Overall Study|Withdrawal by Subject|2|||
44156921|NCT03288493|78948367|FG006|Overall Study|Withdrawal by Subject|0|||
44156922|NCT03288493|78948361|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
44156923|NCT03288493|78948362|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
44156924|NCT03288493|78948363|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
44156925|NCT03288493|78948364|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
44156926|NCT03288493|78948365|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
44156927|NCT03288493|78948366|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
44258647|NCT02763579|79113734|FG003|China Period|Physician Decision|1|||
44258648|NCT02763579|79113731|FG000|China Period|Study Terminated By Sponsor|0|||
44258649|NCT02763579|79113732|FG001|China Period|Study Terminated By Sponsor|0|||
44258650|NCT02763579|79113733|FG002|China Period|Study Terminated By Sponsor|3|||
44329382|NCT02158091|79334722|FG002|Overall Study|DLT|0|||
44329383|NCT02903420|79334752|FG000|Overall Study|Death|3|||
44425679|NCT00467779|79433747|FG014|Stage 1A|Withdrawal by Subject|0|||
44537258|NCT00003473|79548001|FG000|Overall Study|Three patients were not evaluable.|3|||
44537259|NCT03343626|79548013|FG000|Overall Study|Lost to Follow-up|4|||
44537260|NCT03343626|79548014|FG001|Overall Study|Lost to Follow-up|3|||
44537261|NCT03343626|79548015|FG002|Overall Study|Lost to Follow-up|2|||
44537262|NCT03343626|79548016|FG003|Overall Study|Lost to Follow-up|5|||
44537263|NCT03343626|79548017|FG004|Overall Study|Lost to Follow-up|4|||
44537264|NCT03343626|79548018|FG005|Overall Study|Lost to Follow-up|4|||
44537265|NCT03343626|79548019|FG006|Overall Study|Lost to Follow-up|4|||
44537266|NCT03343626|79548020|FG007|Overall Study|Lost to Follow-up|7|||
44537267|NCT03343626|79548013|FG000|Overall Study|Withdrawal of Consent|2|||
44537268|NCT03343626|79548014|FG001|Overall Study|Withdrawal of Consent|1|||
44537269|NCT03343626|79548015|FG002|Overall Study|Withdrawal of Consent|0|||
44537270|NCT03343626|79548016|FG003|Overall Study|Withdrawal of Consent|3|||
44537271|NCT03343626|79548017|FG004|Overall Study|Withdrawal of Consent|3|||
44258651|NCT02763579|79113734|FG003|China Period|Study Terminated By Sponsor|4|||
44537272|NCT03343626|79548018|FG005|Overall Study|Withdrawal of Consent|1|||
44537273|NCT03343626|79548019|FG006|Overall Study|Withdrawal of Consent|1|||
44258652|NCT02763579|79113731|FG000|China Period|Withdrawal by Subject|0|||
44258653|NCT02763579|79113732|FG001|China Period|Withdrawal by Subject|0|||
44258654|NCT02763579|79113733|FG002|China Period|Withdrawal by Subject|3|||
44258655|NCT02763579|79113734|FG003|China Period|Withdrawal by Subject|3|||
44258656|NCT02623699|79113778|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258657|NCT02623699|79113779|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
44329384|NCT02831933|79334756|FG000|Overall Study|Physician Decision|11|||
44329385|NCT02813668|79334760|FG000|Overall Study|Death|4|||
44329386|NCT02813668|79334760|FG000|Overall Study|Lost to Follow-up|509|||
44329387|NCT02813668|79334760|FG000|Overall Study|Withdrawal by Subject|148|||
44329388|NCT02813668|79334760|FG000|Overall Study|No longer at worksite|85|||
44329389|NCT02813668|79334760|FG000|Overall Study|Medical reasons not related to the study|4|||
44329390|NCT02763566|79334768|FG000|Overall Study|Lost to Follow-up|1|||
44329391|NCT02763566|79334769|FG001|Overall Study|Lost to Follow-up|4|||
44329392|NCT02763566|79334770|FG002|Overall Study|Lost to Follow-up|0|||
44425680|NCT00467779|79433733|FG000|Stage 1A|Unspecified Reason|0|||
44329393|NCT02763566|79334771|FG003|Overall Study|Lost to Follow-up|1|||
44329394|NCT02763566|79334768|FG000|Overall Study|On study treatment at study conclusion|114|||
44329395|NCT02763566|79334769|FG001|Overall Study|On study treatment at study conclusion|34|||
44425681|NCT00467779|79433734|FG001|Stage 1A|Unspecified Reason|0|||
44425682|NCT00467779|79433735|FG002|Stage 1A|Unspecified Reason|0|||
44425683|NCT00467779|79433736|FG003|Stage 1A|Unspecified Reason|0|||
44425684|NCT00467779|79433737|FG004|Stage 1A|Unspecified Reason|0|||
44425685|NCT00467779|79433738|FG005|Stage 1A|Unspecified Reason|0|||
44425686|NCT00467779|79433739|FG006|Stage 1A|Unspecified Reason|0|||
44425687|NCT00467779|79433740|FG007|Stage 1A|Unspecified Reason|0|||
44425688|NCT00467779|79433741|FG008|Stage 1A|Unspecified Reason|0|||
44425689|NCT00467779|79433742|FG009|Stage 1A|Unspecified Reason|0|||
44425690|NCT00467779|79433743|FG010|Stage 1A|Unspecified Reason|0|||
44425691|NCT00467779|79433744|FG011|Stage 1A|Unspecified Reason|1|||
44425692|NCT00467779|79433745|FG012|Stage 1A|Unspecified Reason|1|||
44425693|NCT00467779|79433746|FG013|Stage 1A|Unspecified Reason|0|||
44425694|NCT00467779|79433747|FG014|Stage 1A|Unspecified Reason|0|||
44425695|NCT00467779|79433733|FG000|Stage 2|Adverse Event|0|||
44425696|NCT00467779|79433734|FG001|Stage 2|Adverse Event|0|||
44425697|NCT00467779|79433735|FG002|Stage 2|Adverse Event|0|||
44425698|NCT00467779|79433736|FG003|Stage 2|Adverse Event|0|||
44425699|NCT00467779|79433737|FG004|Stage 2|Adverse Event|0|||
44425700|NCT00467779|79433738|FG005|Stage 2|Adverse Event|0|||
44425701|NCT00467779|79433739|FG006|Stage 2|Adverse Event|0|||
44425702|NCT00467779|79433740|FG007|Stage 2|Adverse Event|0|||
44425703|NCT00467779|79433741|FG008|Stage 2|Adverse Event|1|||
44425704|NCT00467779|79433742|FG009|Stage 2|Adverse Event|0|||
44425705|NCT00467779|79433743|FG010|Stage 2|Adverse Event|0|||
44425706|NCT00467779|79433744|FG011|Stage 2|Adverse Event|0|||
44425707|NCT00467779|79433745|FG012|Stage 2|Adverse Event|0|||
44425708|NCT00467779|79433746|FG013|Stage 2|Adverse Event|0|||
44425709|NCT00467779|79433747|FG014|Stage 2|Adverse Event|0|||
44425710|NCT00467779|79433733|FG000|Stage 2|Death|0|||
44425711|NCT00467779|79433734|FG001|Stage 2|Death|0|||
44425712|NCT00467779|79433735|FG002|Stage 2|Death|0|||
44425713|NCT00467779|79433736|FG003|Stage 2|Death|0|||
44425714|NCT00467779|79433737|FG004|Stage 2|Death|0|||
44425715|NCT00467779|79433738|FG005|Stage 2|Death|0|||
44425716|NCT00467779|79433739|FG006|Stage 2|Death|0|||
44425717|NCT00467779|79433740|FG007|Stage 2|Death|0|||
44425718|NCT00467779|79433741|FG008|Stage 2|Death|1|||
44425719|NCT00467779|79433742|FG009|Stage 2|Death|0|||
44537274|NCT03343626|79548020|FG007|Overall Study|Withdrawal of Consent|2|||
44537275|NCT03343626|79548013|FG000|Overall Study|Reason not Specified|0|||
44537276|NCT03343626|79548014|FG001|Overall Study|Reason not Specified|1|||
44329396|NCT02763566|79334770|FG002|Overall Study|On study treatment at study conclusion|54|||
44329397|NCT02763566|79334771|FG003|Overall Study|On study treatment at study conclusion|13|||
44329398|NCT02763566|79334768|FG000|Overall Study|Withdrawal by Subject|3|||
44329399|NCT02763566|79334769|FG001|Overall Study|Withdrawal by Subject|1|||
44329400|NCT02763566|79334770|FG002|Overall Study|Withdrawal by Subject|0|||
44329401|NCT02763566|79334771|FG003|Overall Study|Withdrawal by Subject|0|||
44329402|NCT02760433|79334790|FG000|Overall Study|Lost to Follow-up|1|||
44329403|NCT02760433|79334791|FG001|Overall Study|Lost to Follow-up|0|||
44329404|NCT02760433|79334792|FG002|Overall Study|Lost to Follow-up|1|||
44425720|NCT00467779|79433743|FG010|Stage 2|Death|0|||
44425721|NCT00467779|79433744|FG011|Stage 2|Death|0|||
44425722|NCT00467779|79433745|FG012|Stage 2|Death|0|||
44425723|NCT00467779|79433746|FG013|Stage 2|Death|0|||
44425724|NCT00467779|79433747|FG014|Stage 2|Death|0|||
44425725|NCT00467779|79433733|FG000|Stage 2|Disease Progression|0|||
44425726|NCT00467779|79433734|FG001|Stage 2|Disease Progression|0|||
44425727|NCT00467779|79433735|FG002|Stage 2|Disease Progression|0|||
44425728|NCT00467779|79433736|FG003|Stage 2|Disease Progression|0|||
44425729|NCT00467779|79433737|FG004|Stage 2|Disease Progression|0|||
44425730|NCT00467779|79433738|FG005|Stage 2|Disease Progression|0|||
44425731|NCT00467779|79433739|FG006|Stage 2|Disease Progression|0|||
44425732|NCT00467779|79433740|FG007|Stage 2|Disease Progression|0|||
44425733|NCT00467779|79433741|FG008|Stage 2|Disease Progression|16|||
44425734|NCT00467779|79433742|FG009|Stage 2|Disease Progression|0|||
44425735|NCT00467779|79433743|FG010|Stage 2|Disease Progression|0|||
44425736|NCT00467779|79433744|FG011|Stage 2|Disease Progression|0|||
44537277|NCT03343626|79548015|FG002|Overall Study|Reason not Specified|0|||
44425737|NCT00467779|79433745|FG012|Stage 2|Disease Progression|0|||
44329405|NCT02760433|79334793|FG003|Overall Study|Lost to Follow-up|0|||
44425738|NCT00467779|79433746|FG013|Stage 2|Disease Progression|0|||
44425739|NCT00467779|79433747|FG014|Stage 2|Disease Progression|0|||
44425740|NCT00467779|79433733|FG000|Stage 2|Unspecified Reason|0|||
44425741|NCT00467779|79433734|FG001|Stage 2|Unspecified Reason|0|||
44425742|NCT00467779|79433735|FG002|Stage 2|Unspecified Reason|0|||
44425743|NCT00467779|79433736|FG003|Stage 2|Unspecified Reason|0|||
44425744|NCT00467779|79433737|FG004|Stage 2|Unspecified Reason|0|||
44425745|NCT00467779|79433738|FG005|Stage 2|Unspecified Reason|0|||
44425746|NCT00467779|79433739|FG006|Stage 2|Unspecified Reason|0|||
44425747|NCT00467779|79433740|FG007|Stage 2|Unspecified Reason|0|||
44425748|NCT00467779|79433741|FG008|Stage 2|Unspecified Reason|3|||
44425749|NCT00467779|79433742|FG009|Stage 2|Unspecified Reason|0|||
44537278|NCT03343626|79548016|FG003|Overall Study|Reason not Specified|0|||
44537279|NCT03343626|79548017|FG004|Overall Study|Reason not Specified|0|||
44537280|NCT03343626|79548018|FG005|Overall Study|Reason not Specified|0|||
44537281|NCT03343626|79548019|FG006|Overall Study|Reason not Specified|0|||
44537282|NCT03343626|79548020|FG007|Overall Study|Reason not Specified|1|||
44537283|NCT03343626|79548013|FG000|Overall Study|Data Entry Error|0|||
44537284|NCT03343626|79548014|FG001|Overall Study|Data Entry Error|0|||
44537285|NCT03343626|79548015|FG002|Overall Study|Data Entry Error|0|||
44537286|NCT03343626|79548016|FG003|Overall Study|Data Entry Error|0|||
44537287|NCT03343626|79548017|FG004|Overall Study|Data Entry Error|0|||
44537288|NCT03343626|79548018|FG005|Overall Study|Data Entry Error|0|||
44537289|NCT03343626|79548019|FG006|Overall Study|Data Entry Error|0|||
44537290|NCT03343626|79548020|FG007|Overall Study|Data Entry Error|1|||
44537291|NCT03334422|79548045|FG000|Overall Study|Adverse Event|1|||
44537292|NCT03334422|79548046|FG001|Overall Study|Adverse Event|3|||
44537293|NCT03334422|79548047|FG002|Overall Study|Adverse Event|2|||
44537294|NCT03334422|79548048|FG003|Overall Study|Adverse Event|2|||
44329406|NCT02760433|79334794|FG004|Overall Study|Lost to Follow-up|0|||
44329407|NCT02760433|79334790|FG000|Overall Study|Withdrawal by Subject|23|||
44329408|NCT02760433|79334791|FG001|Overall Study|Withdrawal by Subject|9|||
44329409|NCT02760433|79334792|FG002|Overall Study|Withdrawal by Subject|0|||
44329410|NCT02760433|79334793|FG003|Overall Study|Withdrawal by Subject|2|||
44329411|NCT02760433|79334794|FG004|Overall Study|Withdrawal by Subject|9|||
44329412|NCT02760433|79334790|FG000|Overall Study|Lack of Response At Week 14|0|||
44329413|NCT02760433|79334791|FG001|Overall Study|Lack of Response At Week 14|0|||
44329414|NCT02760433|79334792|FG002|Overall Study|Lack of Response At Week 14|0|||
44329415|NCT02760433|79334793|FG003|Overall Study|Lack of Response At Week 14|0|||
44425750|NCT00467779|79433743|FG010|Stage 2|Unspecified Reason|0|||
44425751|NCT00467779|79433744|FG011|Stage 2|Unspecified Reason|0|||
44425752|NCT00467779|79433745|FG012|Stage 2|Unspecified Reason|0|||
44425753|NCT00467779|79433746|FG013|Stage 2|Unspecified Reason|0|||
44425754|NCT00467779|79433747|FG014|Stage 2|Unspecified Reason|0|||
44425755|NCT00467779|79433733|FG000|Stage 2A|Adverse Event|0|||
44425756|NCT00467779|79433734|FG001|Stage 2A|Adverse Event|0|||
44425757|NCT00467779|79433735|FG002|Stage 2A|Adverse Event|0|||
44425758|NCT00467779|79433736|FG003|Stage 2A|Adverse Event|0|||
44425759|NCT00467779|79433737|FG004|Stage 2A|Adverse Event|0|||
44425760|NCT00467779|79433738|FG005|Stage 2A|Adverse Event|0|||
44425761|NCT00467779|79433739|FG006|Stage 2A|Adverse Event|0|||
44425762|NCT00467779|79433740|FG007|Stage 2A|Adverse Event|0|||
44425763|NCT00467779|79433741|FG008|Stage 2A|Adverse Event|0|||
44425764|NCT00467779|79433742|FG009|Stage 2A|Adverse Event|0|||
44537295|NCT03334422|79548045|FG000|Overall Study|Lack of Efficacy|10|||
44537296|NCT03334422|79548046|FG001|Overall Study|Lack of Efficacy|2|||
44537297|NCT03334422|79548047|FG002|Overall Study|Lack of Efficacy|7|||
44425765|NCT00467779|79433743|FG010|Stage 2A|Adverse Event|0|||
44425766|NCT00467779|79433744|FG011|Stage 2A|Adverse Event|0|||
44425767|NCT00467779|79433745|FG012|Stage 2A|Adverse Event|0|||
44425768|NCT00467779|79433746|FG013|Stage 2A|Adverse Event|2|||
44425769|NCT00467779|79433747|FG014|Stage 2A|Adverse Event|0|||
44425770|NCT00467779|79433733|FG000|Stage 2A|Death|0|||
44425771|NCT00467779|79433734|FG001|Stage 2A|Death|0|||
44425772|NCT00467779|79433735|FG002|Stage 2A|Death|0|||
44425773|NCT00467779|79433736|FG003|Stage 2A|Death|0|||
44425774|NCT00467779|79433737|FG004|Stage 2A|Death|0|||
44425775|NCT00467779|79433738|FG005|Stage 2A|Death|0|||
44425776|NCT00467779|79433739|FG006|Stage 2A|Death|0|||
44425777|NCT00467779|79433740|FG007|Stage 2A|Death|0|||
44425778|NCT00467779|79433741|FG008|Stage 2A|Death|0|||
44425779|NCT00467779|79433742|FG009|Stage 2A|Death|0|||
44425780|NCT00467779|79433743|FG010|Stage 2A|Death|0|||
44425781|NCT00467779|79433744|FG011|Stage 2A|Death|0|||
44425782|NCT00467779|79433745|FG012|Stage 2A|Death|0|||
44425783|NCT00467779|79433746|FG013|Stage 2A|Death|1|||
44329416|NCT02760433|79334794|FG004|Overall Study|Lack of Response At Week 14|1|||
44329417|NCT02760433|79334790|FG000|Overall Study|Subject refused to continue the study|1|||
44425784|NCT00467779|79433747|FG014|Stage 2A|Death|0|||
44425785|NCT00467779|79433733|FG000|Stage 2A|Disease Progression|0|||
44425786|NCT00467779|79433734|FG001|Stage 2A|Disease Progression|0|||
44425787|NCT00467779|79433735|FG002|Stage 2A|Disease Progression|0|||
44537298|NCT03334422|79548048|FG003|Overall Study|Lack of Efficacy|3|||
44537299|NCT03334422|79548045|FG000|Overall Study|Withdrawal by Subject|8|||
44537300|NCT03334422|79548046|FG001|Overall Study|Withdrawal by Subject|3|||
44537301|NCT03334422|79548047|FG002|Overall Study|Withdrawal by Subject|1|||
44537302|NCT03334422|79548048|FG003|Overall Study|Withdrawal by Subject|0|||
44537303|NCT03334422|79548045|FG000|Overall Study|Lost to Follow-up|0|||
44537304|NCT03334422|79548046|FG001|Overall Study|Lost to Follow-up|0|||
44537305|NCT03334422|79548047|FG002|Overall Study|Lost to Follow-up|0|||
44537306|NCT03334422|79548048|FG003|Overall Study|Lost to Follow-up|1|||
44329418|NCT02760433|79334791|FG001|Overall Study|Subject refused to continue the study|0|||
44329419|NCT02760433|79334792|FG002|Overall Study|Subject refused to continue the study|0|||
44329420|NCT02760433|79334793|FG003|Overall Study|Subject refused to continue the study|0|||
44329421|NCT02760433|79334794|FG004|Overall Study|Subject refused to continue the study|0|||
44329422|NCT02760433|79334790|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
44329423|NCT02760433|79334791|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
44329424|NCT02760433|79334792|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
44329425|NCT02760433|79334793|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
44329426|NCT02760433|79334794|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
44329427|NCT02760433|79334790|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
44329428|NCT02760433|79334791|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
44329429|NCT02760433|79334792|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
44329430|NCT02760433|79334793|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
44329431|NCT02760433|79334794|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
44329432|NCT02760407|79334814|FG000|Overall Study|Death|2|||
44329433|NCT02760407|79334815|FG001|Overall Study|Death|3|||
44329434|NCT02760407|79334816|FG002|Overall Study|Death|1|||
44329435|NCT02760407|79334817|FG003|Overall Study|Death|1|||
44537307|NCT03334422|79548045|FG000|Overall Study|Inability to obtain laboratory samples|0|||
44537308|NCT03334422|79548046|FG001|Overall Study|Inability to obtain laboratory samples|1|||
44329436|NCT02760407|79334814|FG000|Overall Study|Lost to Follow-up|1|||
44329437|NCT02760407|79334815|FG001|Overall Study|Lost to Follow-up|7|||
44329438|NCT02760407|79334816|FG002|Overall Study|Lost to Follow-up|4|||
44329439|NCT02760407|79334817|FG003|Overall Study|Lost to Follow-up|6|||
44329440|NCT02760407|79334814|FG000|Overall Study|Withdrawal by Subject|25|||
44329441|NCT02760407|79334815|FG001|Overall Study|Withdrawal by Subject|31|||
44329442|NCT02760407|79334816|FG002|Overall Study|Withdrawal by Subject|37|||
44329443|NCT02760407|79334817|FG003|Overall Study|Withdrawal by Subject|25|||
44329444|NCT02760407|79334814|FG000|Overall Study|Violation of Eligibility criteria|0|||
44329445|NCT02760407|79334815|FG001|Overall Study|Violation of Eligibility criteria|0|||
44329446|NCT02760407|79334816|FG002|Overall Study|Violation of Eligibility criteria|1|||
44329447|NCT02760407|79334817|FG003|Overall Study|Violation of Eligibility criteria|1|||
44329448|NCT02760407|79334814|FG000|Overall Study|Personal reasons|0|||
44329449|NCT02760407|79334815|FG001|Overall Study|Personal reasons|0|||
44329450|NCT02760407|79334816|FG002|Overall Study|Personal reasons|0|||
44425788|NCT00467779|79433736|FG003|Stage 2A|Disease Progression|0|||
44425789|NCT00467779|79433737|FG004|Stage 2A|Disease Progression|0|||
44425790|NCT00467779|79433738|FG005|Stage 2A|Disease Progression|0|||
44537309|NCT03334422|79548047|FG002|Overall Study|Inability to obtain laboratory samples|0|||
44537310|NCT03334422|79548048|FG003|Overall Study|Inability to obtain laboratory samples|0|||
44329451|NCT02760407|79334817|FG003|Overall Study|Personal reasons|1|||
44329452|NCT02760407|79334814|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
44329453|NCT02760407|79334815|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
44329454|NCT02760407|79334816|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
44329455|NCT02760407|79334817|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
44329456|NCT02760407|79334814|FG000|Overall Study|Use of prohibited Medication|0|||
44329457|NCT02760407|79334815|FG001|Overall Study|Use of prohibited Medication|0|||
44329458|NCT02760407|79334816|FG002|Overall Study|Use of prohibited Medication|1|||
44425791|NCT00467779|79433739|FG006|Stage 2A|Disease Progression|0|||
44425792|NCT00467779|79433740|FG007|Stage 2A|Disease Progression|0|||
44425793|NCT00467779|79433741|FG008|Stage 2A|Disease Progression|0|||
44425794|NCT00467779|79433742|FG009|Stage 2A|Disease Progression|0|||
44425795|NCT00467779|79433743|FG010|Stage 2A|Disease Progression|0|||
44425796|NCT00467779|79433744|FG011|Stage 2A|Disease Progression|0|||
44425797|NCT00467779|79433745|FG012|Stage 2A|Disease Progression|0|||
44425798|NCT00467779|79433746|FG013|Stage 2A|Disease Progression|10|||
44425799|NCT00467779|79433747|FG014|Stage 2A|Disease Progression|0|||
44425800|NCT00467779|79433733|FG000|Stage 2A|Unspecified Reason|0|||
44425801|NCT00467779|79433734|FG001|Stage 2A|Unspecified Reason|0|||
44425802|NCT00467779|79433735|FG002|Stage 2A|Unspecified Reason|0|||
44425803|NCT00467779|79433736|FG003|Stage 2A|Unspecified Reason|0|||
44425804|NCT00467779|79433737|FG004|Stage 2A|Unspecified Reason|0|||
44537311|NCT03334422|79548045|FG000|Overall Study|Pregnancy|0|||
44537312|NCT03334422|79548046|FG001|Overall Study|Pregnancy|1|||
44537313|NCT03334422|79548047|FG002|Overall Study|Pregnancy|0|||
44537314|NCT03334422|79548048|FG003|Overall Study|Pregnancy|0|||
44537315|NCT02323126|79548066|FG000|Overall Study|Patient / guardian decision|0|||
44537316|NCT02323126|79548067|FG001|Overall Study|Patient / guardian decision|1|||
44537317|NCT02323126|79548068|FG002|Overall Study|Patient / guardian decision|2|||
44537318|NCT02323126|79548066|FG000|Overall Study|Progressive disease|14|||
44537319|NCT02323126|79548067|FG001|Overall Study|Progressive disease|8|||
44537320|NCT02323126|79548068|FG002|Overall Study|Progressive disease|14|||
44537321|NCT02323126|79548066|FG000|Overall Study|Physician Decision|0|||
44537322|NCT02323126|79548067|FG001|Overall Study|Physician Decision|1|||
44329459|NCT02760407|79334817|FG003|Overall Study|Use of prohibited Medication|0|||
44537323|NCT02323126|79548068|FG002|Overall Study|Physician Decision|3|||
44537324|NCT02323126|79548066|FG000|Overall Study|Death|1|||
44537325|NCT02323126|79548067|FG001|Overall Study|Death|1|||
44329460|NCT02760407|79334814|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
44329461|NCT02760407|79334815|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
44329462|NCT02760407|79334816|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
44329463|NCT02760407|79334817|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
44329464|NCT02760407|79334814|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
44329465|NCT02760407|79334815|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
44329466|NCT02760407|79334816|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
44329467|NCT02760407|79334817|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
44329468|NCT02760407|79334814|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
44329469|NCT02760407|79334815|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
44329470|NCT02760407|79334816|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
44329471|NCT02760407|79334817|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
44329472|NCT02760407|79334814|FG000|Overall Study|Inadequately Enrolled|0|||
44329473|NCT02760407|79334815|FG001|Overall Study|Inadequately Enrolled|0|||
44329474|NCT02760407|79334816|FG002|Overall Study|Inadequately Enrolled|0|||
44329475|NCT02760407|79334817|FG003|Overall Study|Inadequately Enrolled|1|||
44329476|NCT02760407|79334814|FG000|Overall Study|Withdrawal By PI's Decision|0|||
44329477|NCT02760407|79334815|FG001|Overall Study|Withdrawal By PI's Decision|1|||
44329478|NCT02760407|79334816|FG002|Overall Study|Withdrawal By PI's Decision|0|||
44329479|NCT02760407|79334817|FG003|Overall Study|Withdrawal By PI's Decision|0|||
44329480|NCT02760407|79334814|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
44329481|NCT02760407|79334815|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
44329482|NCT02760407|79334816|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
44354762|NCT01186770|79359154|FG001|Overall Study|Other than specified|1|||
44425805|NCT00467779|79433738|FG005|Stage 2A|Unspecified Reason|0|||
44425806|NCT00467779|79433739|FG006|Stage 2A|Unspecified Reason|0|||
44537326|NCT02323126|79548068|FG002|Overall Study|Death|4|||
44537327|NCT02323126|79548066|FG000|Overall Study|Adverse Event|3|||
44537328|NCT02323126|79548067|FG001|Overall Study|Adverse Event|5|||
44537329|NCT02323126|79548068|FG002|Overall Study|Adverse Event|7|||
44537330|NCT03491553|79548085|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
44537331|NCT03491553|79548086|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
44329483|NCT02760407|79334817|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
44329484|NCT02760407|79334814|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
44329485|NCT02760407|79334815|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
44329486|NCT02760407|79334816|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
44329487|NCT02760407|79334817|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
44329488|NCT02760407|79334814|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
44329489|NCT02760407|79334815|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
44329490|NCT02760407|79334816|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
44329491|NCT02760407|79334817|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
44329492|NCT02760407|79334814|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
44329493|NCT02760407|79334815|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
44329494|NCT02760407|79334816|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
44329495|NCT02760407|79334817|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
44329496|NCT02760407|79334814|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
44329497|NCT02760407|79334815|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
44329498|NCT02760407|79334816|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
44329499|NCT02760407|79334817|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
44329500|NCT02760407|79334814|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
44329501|NCT02760407|79334815|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
44329502|NCT02760407|79334816|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
44329503|NCT02760407|79334817|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
44329504|NCT02760407|79334814|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
44329505|NCT02760407|79334815|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
44329506|NCT02760407|79334816|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
44329507|NCT02760407|79334817|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
44329508|NCT02760407|79334814|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
44329509|NCT02760407|79334815|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
44425807|NCT00467779|79433740|FG007|Stage 2A|Unspecified Reason|0|||
44425808|NCT00467779|79433741|FG008|Stage 2A|Unspecified Reason|0|||
44425809|NCT00467779|79433742|FG009|Stage 2A|Unspecified Reason|0|||
44425810|NCT00467779|79433743|FG010|Stage 2A|Unspecified Reason|0|||
44425811|NCT00467779|79433744|FG011|Stage 2A|Unspecified Reason|0|||
44425812|NCT00467779|79433745|FG012|Stage 2A|Unspecified Reason|0|||
44425813|NCT00467779|79433746|FG013|Stage 2A|Unspecified Reason|7|||
44425814|NCT00467779|79433747|FG014|Stage 2A|Unspecified Reason|0|||
44425815|NCT00467779|79433733|FG000|Stage 2A|Withdrawal by Subject|0|||
44425816|NCT00467779|79433734|FG001|Stage 2A|Withdrawal by Subject|0|||
44425817|NCT00467779|79433735|FG002|Stage 2A|Withdrawal by Subject|0|||
44425818|NCT00467779|79433736|FG003|Stage 2A|Withdrawal by Subject|0|||
44425819|NCT00467779|79433737|FG004|Stage 2A|Withdrawal by Subject|0|||
44425820|NCT00467779|79433738|FG005|Stage 2A|Withdrawal by Subject|0|||
44425821|NCT00467779|79433739|FG006|Stage 2A|Withdrawal by Subject|0|||
44425822|NCT00467779|79433740|FG007|Stage 2A|Withdrawal by Subject|0|||
44425823|NCT00467779|79433741|FG008|Stage 2A|Withdrawal by Subject|0|||
44425824|NCT00467779|79433742|FG009|Stage 2A|Withdrawal by Subject|0|||
44425825|NCT00467779|79433743|FG010|Stage 2A|Withdrawal by Subject|0|||
44425826|NCT00467779|79433744|FG011|Stage 2A|Withdrawal by Subject|0|||
44425827|NCT00467779|79433745|FG012|Stage 2A|Withdrawal by Subject|0|||
44425828|NCT00467779|79433746|FG013|Stage 2A|Withdrawal by Subject|1|||
44425829|NCT00467779|79433747|FG014|Stage 2A|Withdrawal by Subject|0|||
44329510|NCT02760407|79334816|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
44329511|NCT02760407|79334817|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
44329512|NCT02760407|79334814|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
44329513|NCT02760407|79334815|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
44329514|NCT02760407|79334816|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
44425830|NCT00467779|79433733|FG000|Stage 3|Adverse Event|0|||
44425831|NCT00467779|79433734|FG001|Stage 3|Adverse Event|0|||
44425832|NCT00467779|79433735|FG002|Stage 3|Adverse Event|0|||
44425833|NCT00467779|79433736|FG003|Stage 3|Adverse Event|0|||
44425834|NCT00467779|79433737|FG004|Stage 3|Adverse Event|0|||
44425835|NCT00467779|79433738|FG005|Stage 3|Adverse Event|0|||
44329515|NCT02760407|79334817|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
44329516|NCT02760368|79334833|FG000|Overall Study|Withdrawal by Subject|8|||
44329517|NCT02760368|79334834|FG001|Overall Study|Withdrawal by Subject|12|||
44329518|NCT02760368|79334835|FG002|Overall Study|Withdrawal by Subject|9|||
44329519|NCT02760368|79334833|FG000|Overall Study|Screen Failure|0|||
44329520|NCT02760368|79334834|FG001|Overall Study|Screen Failure|0|||
44329521|NCT02760368|79334835|FG002|Overall Study|Screen Failure|1|||
44329522|NCT02760368|79334833|FG000|Overall Study|Death|0|||
44329523|NCT02760368|79334834|FG001|Overall Study|Death|1|||
44329524|NCT02760368|79334835|FG002|Overall Study|Death|0|||
44329525|NCT02760368|79334833|FG000|Overall Study|Withdrawal by Sponsor|0|||
44329526|NCT02760368|79334834|FG001|Overall Study|Withdrawal by Sponsor|0|||
44329527|NCT02760368|79334835|FG002|Overall Study|Withdrawal by Sponsor|1|||
44329528|NCT02747004|79334849|FG000|Overall Study|Withdrawal by Subject|8|||
44329529|NCT02747004|79334850|FG001|Overall Study|Withdrawal by Subject|5|||
44329530|NCT02747004|79334851|FG002|Overall Study|Withdrawal by Subject|4|||
44329531|NCT02747004|79334849|FG000|Overall Study|Lost to Follow-up|1|||
44329532|NCT02747004|79334850|FG001|Overall Study|Lost to Follow-up|2|||
44329533|NCT02747004|79334851|FG002|Overall Study|Lost to Follow-up|2|||
44329534|NCT02747004|79334849|FG000|Overall Study|on study treatment/follow-up|48|||
44329535|NCT02747004|79334850|FG001|Overall Study|on study treatment/follow-up|42|||
44329536|NCT02747004|79334851|FG002|Overall Study|on study treatment/follow-up|41|||
44329537|NCT02741570|79334861|FG000|Pre-Treatment Period|Other reasons|0|||
44329538|NCT02741570|79334862|FG001|Pre-Treatment Period|Other reasons|3|||
44329539|NCT02741570|79334861|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
44156928|NCT03288493|78948367|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
44329540|NCT02741570|79334862|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
44329541|NCT02741570|79334861|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
44329542|NCT02741570|79334862|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
44329543|NCT02741570|79334861|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
44329544|NCT02741570|79334862|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
44329545|NCT02741570|79334861|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
44329546|NCT02741570|79334862|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
44329547|NCT02741570|79334861|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
44329548|NCT02741570|79334862|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
44329549|NCT02741570|79334861|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
44329550|NCT02741570|79334862|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
44329551|NCT02741570|79334861|FG000|Pre-Treatment Period|Death|0|||
44425836|NCT00467779|79433739|FG006|Stage 3|Adverse Event|0|||
44425837|NCT00467779|79433740|FG007|Stage 3|Adverse Event|0|||
44425838|NCT00467779|79433741|FG008|Stage 3|Adverse Event|0|||
44425839|NCT00467779|79433742|FG009|Stage 3|Adverse Event|0|||
44425840|NCT00467779|79433743|FG010|Stage 3|Adverse Event|0|||
44425841|NCT00467779|79433744|FG011|Stage 3|Adverse Event|0|||
44425842|NCT00467779|79433745|FG012|Stage 3|Adverse Event|0|||
44156929|NCT03288493|78948361|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
44329552|NCT02741570|79334862|FG001|Pre-Treatment Period|Death|1|||
44329553|NCT02741570|79334861|FG000|Pre-Treatment Period|Disease progression|0|||
44329554|NCT02741570|79334862|FG001|Pre-Treatment Period|Disease progression|1|||
44329555|NCT02741570|79334861|FG000|Treatment Period|Other reasons|47|||
44329556|NCT02741570|79334862|FG001|Treatment Period|Other reasons|12|||
44329557|NCT02741570|79334861|FG000|Treatment Period|Poor/non-compliance|0|||
44329558|NCT02741570|79334862|FG001|Treatment Period|Poor/non-compliance|2|||
44329559|NCT02741570|79334861|FG000|Treatment Period|Maximum clinical benefit|4|||
44329560|NCT02741570|79334862|FG001|Treatment Period|Maximum clinical benefit|6|||
44329561|NCT02741570|79334861|FG000|Treatment Period|Lost to Follow-up|1|||
44425843|NCT00467779|79433746|FG013|Stage 3|Adverse Event|0|||
44156930|NCT03288493|78948362|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
44329562|NCT02741570|79334862|FG001|Treatment Period|Lost to Follow-up|3|||
44329563|NCT02741570|79334861|FG000|Treatment Period|Participant withdrew consent|9|||
44329564|NCT02741570|79334862|FG001|Treatment Period|Participant withdrew consent|13|||
44329565|NCT02741570|79334861|FG000|Treatment Period|Participant request to discontinue treatment|8|||
44329566|NCT02741570|79334862|FG001|Treatment Period|Participant request to discontinue treatment|23|||
44329567|NCT02741570|79334861|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
44329568|NCT02741570|79334862|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
44329569|NCT02741570|79334861|FG000|Treatment Period|Death|9|||
44329570|NCT02741570|79334862|FG001|Treatment Period|Death|7|||
44329571|NCT02741570|79334861|FG000|Treatment Period|Study drug toxicity|55|||
44329572|NCT02741570|79334862|FG001|Treatment Period|Study drug toxicity|47|||
44329573|NCT02741570|79334861|FG000|Treatment Period|Disease progression|294|||
44425844|NCT00467779|79433747|FG014|Stage 3|Adverse Event|2|||
44425845|NCT00467779|79433733|FG000|Stage 3|Death|0|||
44425846|NCT00467779|79433734|FG001|Stage 3|Death|0|||
44425847|NCT00467779|79433735|FG002|Stage 3|Death|0|||
44329574|NCT02741570|79334862|FG001|Treatment Period|Disease progression|301|||
44329575|NCT02741570|79334861|FG000|Treatment Period|Administrative reason by sponsor|0|||
44329576|NCT02741570|79334862|FG001|Treatment Period|Administrative reason by sponsor|1|||
44329577|NCT02675231|79334889|FG000|Overall Study|Withdrawal by Subject|1|||
44329578|NCT02675231|79334890|FG001|Overall Study|Withdrawal by Subject|3|||
44329579|NCT02675231|79334891|FG002|Overall Study|Withdrawal by Subject|1|||
44329580|NCT02675231|79334889|FG000|Overall Study|Lost to Follow-up|2|||
44329581|NCT02675231|79334890|FG001|Overall Study|Lost to Follow-up|2|||
44329582|NCT02675231|79334891|FG002|Overall Study|Lost to Follow-up|2|||
44329583|NCT02675231|79334889|FG000|Overall Study|On study treatment/follow up|23|||
44329584|NCT02675231|79334890|FG001|Overall Study|On study treatment/follow up|31|||
44329585|NCT02675231|79334891|FG002|Overall Study|On study treatment/follow up|23|||
44329586|NCT02603887|79334904|FG000|Stage 1|Adverse Event|4|||
44329587|NCT02603887|79334904|FG000|Stage 1|Disease progression|1|||
44329588|NCT02603887|79334904|FG000|Stage 2|FDA guidance|1|||
44329589|NCT02554279|79334910|FG000|Overall Study|Adverse Event|2|||
44329590|NCT02554279|79334911|FG001|Overall Study|Adverse Event|5|||
44329591|NCT02554279|79334910|FG000|Overall Study|Lost to Follow-up|3|||
44329592|NCT02554279|79334911|FG001|Overall Study|Lost to Follow-up|2|||
44329593|NCT02554279|79334910|FG000|Overall Study|Withdrawal by Subject|6|||
44329594|NCT02554279|79334911|FG001|Overall Study|Withdrawal by Subject|4|||
44329595|NCT02554279|79334910|FG000|Overall Study|Protocol Violation|2|||
44329596|NCT02554279|79334911|FG001|Overall Study|Protocol Violation|1|||
44329597|NCT02554279|79334910|FG000|Overall Study|Other reason|19|||
44329598|NCT02554279|79334911|FG001|Overall Study|Other reason|6|||
44329599|NCT02439450|79334939|FG000|Overall Study|Adverse Event|4|||
44425848|NCT00467779|79433736|FG003|Stage 3|Death|0|||
44425849|NCT00467779|79433737|FG004|Stage 3|Death|0|||
44425850|NCT00467779|79433738|FG005|Stage 3|Death|0|||
44425851|NCT00467779|79433739|FG006|Stage 3|Death|0|||
44425852|NCT00467779|79433740|FG007|Stage 3|Death|0|||
44425853|NCT00467779|79433741|FG008|Stage 3|Death|0|||
44425854|NCT00467779|79433742|FG009|Stage 3|Death|0|||
44425855|NCT00467779|79433743|FG010|Stage 3|Death|0|||
44425856|NCT00467779|79433744|FG011|Stage 3|Death|0|||
44425857|NCT00467779|79433745|FG012|Stage 3|Death|0|||
44425858|NCT00467779|79433746|FG013|Stage 3|Death|0|||
44425859|NCT00467779|79433747|FG014|Stage 3|Death|1|||
44425860|NCT00467779|79433733|FG000|Stage 3|Disease Progression|0|||
44425861|NCT00467779|79433734|FG001|Stage 3|Disease Progression|0|||
44425862|NCT00467779|79433735|FG002|Stage 3|Disease Progression|0|||
44425863|NCT00467779|79433736|FG003|Stage 3|Disease Progression|0|||
44425864|NCT00467779|79433737|FG004|Stage 3|Disease Progression|0|||
44425865|NCT00467779|79433738|FG005|Stage 3|Disease Progression|0|||
44425866|NCT00467779|79433739|FG006|Stage 3|Disease Progression|0|||
44425867|NCT00467779|79433740|FG007|Stage 3|Disease Progression|0|||
44425868|NCT00467779|79433741|FG008|Stage 3|Disease Progression|0|||
44425869|NCT00467779|79433742|FG009|Stage 3|Disease Progression|0|||
44425870|NCT00467779|79433743|FG010|Stage 3|Disease Progression|0|||
44425871|NCT00467779|79433744|FG011|Stage 3|Disease Progression|0|||
44425872|NCT00467779|79433745|FG012|Stage 3|Disease Progression|0|||
44425873|NCT00467779|79433746|FG013|Stage 3|Disease Progression|0|||
44425874|NCT00467779|79433747|FG014|Stage 3|Disease Progression|9|||
44425875|NCT00467779|79433733|FG000|Stage 3|Unspecified Reason|0|||
44425876|NCT00467779|79433734|FG001|Stage 3|Unspecified Reason|0|||
44425877|NCT00467779|79433735|FG002|Stage 3|Unspecified Reason|0|||
44425878|NCT00467779|79433736|FG003|Stage 3|Unspecified Reason|0|||
44425879|NCT00467779|79433737|FG004|Stage 3|Unspecified Reason|0|||
44425880|NCT00467779|79433738|FG005|Stage 3|Unspecified Reason|0|||
44425881|NCT00467779|79433739|FG006|Stage 3|Unspecified Reason|0|||
44425882|NCT00467779|79433740|FG007|Stage 3|Unspecified Reason|0|||
44425883|NCT00467779|79433741|FG008|Stage 3|Unspecified Reason|0|||
44425884|NCT00467779|79433742|FG009|Stage 3|Unspecified Reason|0|||
44425885|NCT00467779|79433743|FG010|Stage 3|Unspecified Reason|0|||
44537332|NCT03491553|79548087|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
44329600|NCT02439450|79334940|FG001|Overall Study|Adverse Event|1|||
44329601|NCT02439450|79334941|FG002|Overall Study|Adverse Event|0|||
44329602|NCT02439450|79334942|FG003|Overall Study|Adverse Event|0|||
44329603|NCT02439450|79334939|FG000|Overall Study|Withdrawal by Subject|1|||
44329604|NCT02439450|79334940|FG001|Overall Study|Withdrawal by Subject|2|||
44329605|NCT02439450|79334941|FG002|Overall Study|Withdrawal by Subject|0|||
44425886|NCT00467779|79433744|FG011|Stage 3|Unspecified Reason|0|||
44425887|NCT00467779|79433745|FG012|Stage 3|Unspecified Reason|0|||
44425888|NCT00467779|79433746|FG013|Stage 3|Unspecified Reason|0|||
44425889|NCT00467779|79433747|FG014|Stage 3|Unspecified Reason|5|||
44425890|NCT00570687|79433787|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425891|NCT00570687|79433788|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425892|NCT00570687|79433789|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425893|NCT00570687|79433790|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44537333|NCT03491553|79548088|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
44537334|NCT03491553|79548089|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
44537335|NCT03491553|79548090|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
44537336|NCT03491553|79548085|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
44537337|NCT03491553|79548086|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
44537338|NCT03491553|79548087|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
44537339|NCT03491553|79548088|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
44537340|NCT03491553|79548089|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
44537341|NCT03491553|79548090|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
44537342|NCT00003377|79548111|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
44537343|NCT00003377|79548112|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
44537344|NCT00003377|79548113|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
44537345|NCT00003377|79548114|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
44537346|NCT00003377|79548115|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
44537347|NCT00003377|79548111|FG000|Period II|Ureteral stent complications|0|||
44537348|NCT00003377|79548112|FG001|Period II|Ureteral stent complications|0|||
44537349|NCT00003377|79548113|FG002|Period II|Ureteral stent complications|0|||
44537350|NCT00003377|79548114|FG003|Period II|Ureteral stent complications|0|||
44537351|NCT00003377|79548115|FG004|Period II|Ureteral stent complications|1|||
44537352|NCT00651742|79548128|FG000|Overall Study|Objective Disease Progression|22|||
44537353|NCT00651742|79548128|FG000|Overall Study|Toxicity|3|||
44537354|NCT00651742|79548128|FG000|Overall Study|Investigator Judgment|1|||
44537355|NCT00651742|79548128|FG000|Overall Study|Withdrawal of Consent|1|||
44537356|NCT00651742|79548128|FG000|Overall Study|Enrolled but not treated|1|||
44537357|NCT00002651|79548134|FG000|Induction|Adverse Event|44|||
44537358|NCT00002651|79548135|FG001|Induction|Adverse Event|0|||
44537359|NCT00002651|79548136|FG002|Induction|Adverse Event|0|||
44537360|NCT00002651|79548134|FG000|Induction|Refusal unrelated to adverse event|50|||
44537361|NCT00002651|79548135|FG001|Induction|Refusal unrelated to adverse event|0|||
44329606|NCT02439450|79334942|FG003|Overall Study|Withdrawal by Subject|0|||
44329607|NCT02439450|79334939|FG000|Overall Study|Death|3|||
44329608|NCT02439450|79334940|FG001|Overall Study|Death|0|||
44329609|NCT02439450|79334941|FG002|Overall Study|Death|0|||
44329610|NCT02439450|79334942|FG003|Overall Study|Death|1|||
44329611|NCT02439450|79334939|FG000|Overall Study|Progressive Disease|18|||
44329612|NCT02439450|79334940|FG001|Overall Study|Progressive Disease|41|||
44329613|NCT02439450|79334941|FG002|Overall Study|Progressive Disease|2|||
44329614|NCT02439450|79334942|FG003|Overall Study|Progressive Disease|3|||
44329615|NCT02312258|79334963|FG000|Overall Study|Lost to Follow-up|8|||
44329616|NCT02312258|79334964|FG001|Overall Study|Lost to Follow-up|8|||
44329617|NCT02312258|79334963|FG000|Overall Study|Withdrawal by Patient|49|||
44425894|NCT00570687|79433791|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
44537362|NCT00002651|79548136|FG002|Induction|Refusal unrelated to adverse event|0|||
44537363|NCT00002651|79548134|FG000|Induction|Progression/relapse|274|||
44537364|NCT00002651|79548135|FG001|Induction|Progression/relapse|0|||
44537365|NCT00002651|79548136|FG002|Induction|Progression/relapse|0|||
44329618|NCT02312258|79334964|FG001|Overall Study|Withdrawal by Patient|76|||
44537366|NCT00002651|79548134|FG000|Induction|Death|62|||
44537367|NCT00002651|79548135|FG001|Induction|Death|0|||
44537368|NCT00002651|79548136|FG002|Induction|Death|0|||
44537369|NCT00002651|79548134|FG000|Induction|Other|823|||
44537370|NCT00002651|79548135|FG001|Induction|Other|0|||
44537371|NCT00002651|79548136|FG002|Induction|Other|0|||
44329619|NCT02312258|79334963|FG000|Overall Study|Reason not Specified|107|||
44329620|NCT02312258|79334964|FG001|Overall Study|Reason not Specified|159|||
44329621|NCT02312258|79334963|FG000|Overall Study|Missing|2|||
44329622|NCT02312258|79334964|FG001|Overall Study|Missing|1|||
44329623|NCT02312258|79334963|FG000|Overall Study|Death|115|||
44329624|NCT02312258|79334964|FG001|Overall Study|Death|181|||
44329625|NCT02049515|79335001|FG000|Overall Study|Adverse Event|46|||
44329626|NCT02049515|79335002|FG001|Overall Study|Adverse Event|2|||
44329627|NCT02049515|79335001|FG000|Overall Study|Protocol-specified Disease Progression|23|||
44329628|NCT02049515|79335002|FG001|Overall Study|Protocol-specified Disease Progression|2|||
44329629|NCT02049515|79335001|FG000|Overall Study|Death|6|||
44329630|NCT02049515|79335002|FG001|Overall Study|Death|0|||
44329631|NCT02049515|79335001|FG000|Overall Study|Physician Decision|5|||
44329632|NCT02049515|79335002|FG001|Overall Study|Physician Decision|1|||
44329633|NCT02049515|79335001|FG000|Overall Study|Withdrawal by Subject|3|||
44329634|NCT02049515|79335002|FG001|Overall Study|Withdrawal by Subject|0|||
44329635|NCT02049515|79335001|FG000|Overall Study|Termination of the Study by Sponsor|2|||
44329636|NCT02049515|79335002|FG001|Overall Study|Termination of the Study by Sponsor|0|||
44329637|NCT02049515|79335001|FG000|Overall Study|Protocol Violation|1|||
44329638|NCT02049515|79335002|FG001|Overall Study|Protocol Violation|1|||
44329639|NCT02049515|79335001|FG000|Overall Study|Clinical Deterioration|1|||
44329640|NCT02049515|79335002|FG001|Overall Study|Clinical Deterioration|0|||
44329641|NCT02049515|79335001|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
44425895|NCT00570687|79433792|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
44425896|NCT00570687|79433793|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
44425897|NCT00570687|79433794|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
44425898|NCT00570687|79433795|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
44425899|NCT00570687|79433796|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
44425900|NCT00570687|79433787|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425901|NCT00570687|79433788|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425902|NCT00570687|79433789|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425903|NCT00570687|79433790|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425904|NCT00570687|79433791|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425905|NCT00570687|79433792|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425906|NCT00570687|79433793|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425907|NCT00570687|79433794|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425908|NCT00570687|79433795|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
44425909|NCT00570687|79433796|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425910|NCT00570687|79433787|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425911|NCT00570687|79433788|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425912|NCT00570687|79433789|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425913|NCT00570687|79433790|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425914|NCT00570687|79433791|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425915|NCT00570687|79433792|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425916|NCT00570687|79433793|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
44425917|NCT00570687|79433794|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425918|NCT00570687|79433795|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425919|NCT00570687|79433796|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
44425920|NCT03836677|79433810|FG000|Period 1|Adverse Event|0|||
44425921|NCT03836677|79433811|FG001|Period 1|Adverse Event|1|||
44425922|NCT03836677|79433810|FG000|Period 2|Severe non-compliance to protocol|1|||
44425923|NCT03836677|79433811|FG001|Period 2|Severe non-compliance to protocol|0|||
44425924|NCT00434161|79433842|FG000|Overall Study|Adverse Event|5|||
44425925|NCT00434161|79433843|FG001|Overall Study|Adverse Event|1|||
44425926|NCT00434161|79433844|FG002|Overall Study|Adverse Event|4|||
44425927|NCT00434161|79433842|FG000|Overall Study|Lost to Follow-up|0|||
44425928|NCT00434161|79433843|FG001|Overall Study|Lost to Follow-up|1|||
44425929|NCT00434161|79433844|FG002|Overall Study|Lost to Follow-up|0|||
44425930|NCT00434161|79433842|FG000|Overall Study|Death|1|||
44425931|NCT00434161|79433843|FG001|Overall Study|Death|0|||
44537372|NCT00002651|79548134|FG000|Induction|not eligible|90|||
44537373|NCT00002651|79548135|FG001|Induction|not eligible|0|||
44537374|NCT00002651|79548136|FG002|Induction|not eligible|0|||
44537375|NCT00002651|79548134|FG000|Consolidation and Randomization|Adverse Event|0|||
44537376|NCT00002651|79548135|FG001|Consolidation and Randomization|Adverse Event|36|||
44537377|NCT00002651|79548136|FG002|Consolidation and Randomization|Adverse Event|14|||
44537378|NCT00002651|79548134|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
44537379|NCT00002651|79548135|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
44329642|NCT02049515|79335002|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
44537380|NCT00002651|79548136|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
44329643|NCT02049515|79335001|FG000|Overall Study|Treatment Interruption >42 Days|1|||
44329644|NCT02049515|79335002|FG001|Overall Study|Treatment Interruption >42 Days|0|||
44329645|NCT02049515|79335001|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
44329646|NCT02049515|79335002|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
44425932|NCT00434161|79433844|FG002|Overall Study|Death|1|||
44425933|NCT00434161|79433842|FG000|Overall Study|Non-Compliance|1|||
44425934|NCT00434161|79433843|FG001|Overall Study|Non-Compliance|1|||
44425935|NCT00434161|79433844|FG002|Overall Study|Non-Compliance|0|||
44425936|NCT00434161|79433842|FG000|Overall Study|Withdrawal by Subject|2|||
44425937|NCT00434161|79433843|FG001|Overall Study|Withdrawal by Subject|0|||
44425938|NCT00434161|79433844|FG002|Overall Study|Withdrawal by Subject|3|||
44425939|NCT00434161|79433842|FG000|Overall Study|Logistical error study assessments|1|||
44425940|NCT00434161|79433843|FG001|Overall Study|Logistical error study assessments|0|||
44425941|NCT00434161|79433844|FG002|Overall Study|Logistical error study assessments|3|||
44425942|NCT00441103|79433861|FG000|Overall Study|Adverse Event|2|||
44425943|NCT00441103|79433862|FG001|Overall Study|Adverse Event|1|||
44425944|NCT00441103|79433861|FG000|Overall Study|Death|1|||
44425945|NCT00441103|79433862|FG001|Overall Study|Death|0|||
44425946|NCT00441103|79433861|FG000|Overall Study|Disease Progression|2|||
44425947|NCT00441103|79433862|FG001|Overall Study|Disease Progression|0|||
44425948|NCT00441103|79433861|FG000|Overall Study|Lost to Follow-up|1|||
44329647|NCT02039401|79335010|FG000|Overall Study|Adverse Event|0|||
44329648|NCT02039401|79335011|FG001|Overall Study|Adverse Event|1|||
44425949|NCT00441103|79433862|FG001|Overall Study|Lost to Follow-up|0|||
44425950|NCT00441103|79433861|FG000|Overall Study|Protocol Violation|1|||
44425951|NCT00441103|79433862|FG001|Overall Study|Protocol Violation|0|||
44425952|NCT00441103|79433861|FG000|Overall Study|Participant unable to use Rebiject II|1|||
44425953|NCT00441103|79433862|FG001|Overall Study|Participant unable to use Rebiject II|0|||
44425954|NCT00441103|79433861|FG000|Overall Study|Participant refused MRI|1|||
44425955|NCT00441103|79433862|FG001|Overall Study|Participant refused MRI|0|||
44425956|NCT00441103|79433861|FG000|Overall Study|Inclusion criteria absent|1|||
44425957|NCT00441103|79433862|FG001|Overall Study|Inclusion criteria absent|0|||
44425958|NCT00441103|79433861|FG000|Overall Study|Non-compliant|0|||
44329649|NCT02004522|79335020|FG000|Overall Study|Adverse Event|55|||
44329650|NCT02004522|79335021|FG001|Overall Study|Adverse Event|6|||
44329651|NCT02004522|79335020|FG000|Overall Study|Withdrawal by Subject|13|||
44329652|NCT02004522|79335021|FG001|Overall Study|Withdrawal by Subject|7|||
44329653|NCT02004522|79335020|FG000|Overall Study|Death|12|||
44329654|NCT02004522|79335021|FG001|Overall Study|Death|3|||
44425959|NCT00441103|79433862|FG001|Overall Study|Non-compliant|1|||
44425960|NCT00441103|79433861|FG000|Overall Study|Participant decided to withdraw|1|||
44425961|NCT00441103|79433862|FG001|Overall Study|Participant decided to withdraw|0|||
44425962|NCT00441103|79433861|FG000|Overall Study|Participant's reason|0|||
44425963|NCT00441103|79433862|FG001|Overall Study|Participant's reason|1|||
44425964|NCT00441103|79433861|FG000|Overall Study|Participant decided to stop|0|||
44425965|NCT00441103|79433862|FG001|Overall Study|Participant decided to stop|1|||
44425966|NCT00433771|79433869|FG000|Overall Study|screen fail|14|||
44425967|NCT00433771|79433869|FG000|Overall Study|Treated and later found to be ineligible|2|||
44425968|NCT00433771|79433869|FG000|Overall Study|Death|2|||
44329655|NCT02004522|79335020|FG000|Overall Study|Physician Decision|3|||
44329656|NCT02004522|79335021|FG001|Overall Study|Physician Decision|4|||
44329657|NCT02004522|79335020|FG000|Overall Study|Protocol Violation|1|||
44329658|NCT02004522|79335021|FG001|Overall Study|Protocol Violation|0|||
44329659|NCT02004522|79335020|FG000|Overall Study|Other is reason listed by PI|4|||
44329660|NCT02004522|79335021|FG001|Overall Study|Other is reason listed by PI|1|||
44329661|NCT02004522|79335020|FG000|Overall Study|Never Dosed|2|||
44329662|NCT02004522|79335021|FG001|Overall Study|Never Dosed|4|||
44329663|NCT02004522|79335020|FG000|Overall Study|Disease Progression|35|||
44329664|NCT02004522|79335021|FG001|Overall Study|Disease Progression|31|||
44329665|NCT02004522|79335020|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
44329666|NCT02004522|79335021|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
44329667|NCT01932697|79335029|FG000|Overall Study|Received a different amount of tx|1|||
44329668|NCT01932697|79335030|FG001|Overall Study|Received a different amount of tx|0|||
44329669|NCT01932697|79335029|FG000|Overall Study|Ineligible|1|||
44329670|NCT01932697|79335030|FG001|Overall Study|Ineligible|0|||
44425969|NCT00433771|79433869|FG000|Overall Study|Failure to deploy stent|1|||
44425970|NCT00433537|79433873|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
44329671|NCT01739309|79335076|FG000|Overall Study|Adverse Event|1|||
44329672|NCT01739309|79335076|FG000|Overall Study|Withdrawal by Subject|1|||
44425971|NCT00433537|79433874|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
44329673|NCT01659658|79335087|FG000|Overall Study|Withdrawal by Patient|18|||
44425972|NCT00433537|79433875|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
44425973|NCT00433537|79433873|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
44329674|NCT01659658|79335088|FG001|Overall Study|Withdrawal by Patient|4|||
44329675|NCT01659658|79335089|FG002|Overall Study|Withdrawal by Patient|2|||
44329676|NCT01659658|79335090|FG003|Overall Study|Withdrawal by Patient|0|||
44329677|NCT01659658|79335091|FG004|Overall Study|Withdrawal by Patient|11|||
44425974|NCT00433537|79433874|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
44425975|NCT00433537|79433875|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
44425976|NCT00433537|79433873|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
44156931|NCT03288493|78948363|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
44156932|NCT03288493|78948364|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
44156933|NCT03288493|78948365|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
44156934|NCT03288493|78948366|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
44156935|NCT03288493|78948367|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
44329678|NCT01659658|79335087|FG000|Overall Study|Study Terminated by Sponsor|9|||
44329679|NCT01659658|79335088|FG001|Overall Study|Study Terminated by Sponsor|7|||
44329680|NCT01659658|79335089|FG002|Overall Study|Study Terminated by Sponsor|0|||
44329681|NCT01659658|79335090|FG003|Overall Study|Study Terminated by Sponsor|1|||
44425977|NCT00433537|79433874|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
44425978|NCT00433537|79433875|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
44425979|NCT00433537|79433873|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
44425980|NCT00433537|79433874|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
44425981|NCT00433537|79433875|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
44425982|NCT00433537|79433873|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
44425983|NCT00433537|79433874|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
44425984|NCT00433537|79433875|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
44425985|NCT00433537|79433873|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
44425986|NCT00433537|79433874|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
44425987|NCT00433537|79433875|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
44425988|NCT00433537|79433873|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
44425989|NCT00433537|79433874|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
44425990|NCT00433537|79433875|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
44425991|NCT00433537|79433873|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
44329682|NCT01659658|79335091|FG004|Overall Study|Study Terminated by Sponsor|4|||
44329683|NCT01659658|79335087|FG000|Overall Study|Reason not Specified|61|||
44329684|NCT01659658|79335088|FG001|Overall Study|Reason not Specified|15|||
44329685|NCT01659658|79335089|FG002|Overall Study|Reason not Specified|8|||
44329686|NCT01659658|79335090|FG003|Overall Study|Reason not Specified|1|||
44329687|NCT01659658|79335091|FG004|Overall Study|Reason not Specified|34|||
44329688|NCT01659658|79335087|FG000|Overall Study|Lost to Follow-up|2|||
44329689|NCT01659658|79335088|FG001|Overall Study|Lost to Follow-up|0|||
44329690|NCT01659658|79335089|FG002|Overall Study|Lost to Follow-up|0|||
44329691|NCT01659658|79335090|FG003|Overall Study|Lost to Follow-up|0|||
44329692|NCT01659658|79335091|FG004|Overall Study|Lost to Follow-up|0|||
44329693|NCT01357161|79335111|FG000|Part 1 (Open Label Run-in)|Death|5|||
44329694|NCT01357161|79335112|FG001|Part 1 (Open Label Run-in)|Death|0|||
44329695|NCT01357161|79335113|FG002|Part 1 (Open Label Run-in)|Death|0|||
44329696|NCT01357161|79335111|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
44329697|NCT01357161|79335112|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
44329698|NCT01357161|79335113|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
44329699|NCT01357161|79335111|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
44425992|NCT00433537|79433874|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
44425993|NCT00433537|79433875|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
44425994|NCT00433537|79433873|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
44425995|NCT00433537|79433874|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
44425996|NCT00433537|79433875|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
44425997|NCT00570765|79433885|FG000|DB Phase|Withdrawal by Subject|1|||
44425998|NCT00570765|79433886|FG001|DB Phase|Withdrawal by Subject|0|||
44425999|NCT00570765|79433887|FG002|DB Phase|Withdrawal by Subject|0|||
44426000|NCT00570765|79433888|FG003|DB Phase|Withdrawal by Subject|0|||
44426001|NCT00570765|79433885|FG000|DB Phase|Protocol Violation|0|||
44329700|NCT01357161|79335112|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
44329701|NCT01357161|79335113|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
44329702|NCT01357161|79335111|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
44329703|NCT01357161|79335112|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
44329704|NCT01357161|79335113|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
44329705|NCT01357161|79335111|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
44329706|NCT01357161|79335112|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
44426002|NCT00570765|79433886|FG001|DB Phase|Protocol Violation|1|||
44426003|NCT00570765|79433887|FG002|DB Phase|Protocol Violation|0|||
44426004|NCT00570765|79433888|FG003|DB Phase|Protocol Violation|0|||
44426005|NCT00570765|79433885|FG000|DB Phase|Adverse Event|3|||
44426006|NCT00570765|79433886|FG001|DB Phase|Adverse Event|6|||
44426007|NCT00570765|79433887|FG002|DB Phase|Adverse Event|0|||
44426008|NCT00570765|79433888|FG003|DB Phase|Adverse Event|0|||
44329707|NCT01357161|79335113|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
44329708|NCT01357161|79335111|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
44329709|NCT01357161|79335112|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
44329710|NCT01357161|79335113|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
44329711|NCT01357161|79335111|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
44329712|NCT01357161|79335112|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
44329713|NCT01357161|79335113|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
44329714|NCT01357161|79335111|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
44426009|NCT00570765|79433885|FG000|DB Phase|Did Not Receive Study Drug|0|||
44426010|NCT00570765|79433886|FG001|DB Phase|Did Not Receive Study Drug|0|||
44426011|NCT00570765|79433887|FG002|DB Phase|Did Not Receive Study Drug|1|||
44426012|NCT00570765|79433888|FG003|DB Phase|Did Not Receive Study Drug|0|||
44329715|NCT01357161|79335112|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
44329716|NCT01357161|79335113|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
44329717|NCT01357161|79335111|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
44329718|NCT01357161|79335112|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
44329719|NCT01357161|79335113|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
44329720|NCT01357161|79335111|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
44329721|NCT01357161|79335112|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
44329722|NCT01357161|79335113|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
44329723|NCT01357161|79335111|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
44329724|NCT01357161|79335112|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
44329725|NCT01357161|79335113|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
44329726|NCT01321073|79335121|FG000|Overall Study|Did not attempt implant|4|||
44329727|NCT01321073|79335121|FG000|Overall Study|Death|3|||
44329728|NCT01276704|79335127|FG000|Overall Study|Lost to Follow-up|2|||
44329729|NCT01276704|79335128|FG001|Overall Study|Lost to Follow-up|3|||
44329730|NCT01276704|79335127|FG000|Overall Study|Non-compliant|2|||
44426013|NCT00570765|79433885|FG000|LTSE Phase|Withdrawal by Subject|0|||
44426014|NCT00570765|79433886|FG001|LTSE Phase|Withdrawal by Subject|0|||
44426015|NCT00570765|79433887|FG002|LTSE Phase|Withdrawal by Subject|0|||
44426016|NCT00570765|79433888|FG003|LTSE Phase|Withdrawal by Subject|1|||
44426017|NCT00570765|79433885|FG000|LTSE Phase|Adverse Event|0|||
44426018|NCT00570765|79433886|FG001|LTSE Phase|Adverse Event|0|||
44426019|NCT00570765|79433887|FG002|LTSE Phase|Adverse Event|0|||
44426020|NCT00570765|79433888|FG003|LTSE Phase|Adverse Event|7|||
44426021|NCT00570765|79433885|FG000|LTSE Phase|Physician Decision|0|||
44426022|NCT00570765|79433886|FG001|LTSE Phase|Physician Decision|0|||
44426023|NCT00570765|79433887|FG002|LTSE Phase|Physician Decision|0|||
44426024|NCT00570765|79433888|FG003|LTSE Phase|Physician Decision|4|||
44426025|NCT00667563|79433899|FG000|Overall Study|Protocol Violation|24|||
44426026|NCT00667095|79433905|FG000|Overall Study|Withdrawal by Subject|0|||
44329731|NCT01276704|79335128|FG001|Overall Study|Non-compliant|2|||
44329732|NCT01276704|79335127|FG000|Overall Study|Withdrawal by Subject|7|||
44329733|NCT01276704|79335128|FG001|Overall Study|Withdrawal by Subject|1|||
44329734|NCT01276704|79335127|FG000|Overall Study|Physician Decision|3|||
44329735|NCT01276704|79335128|FG001|Overall Study|Physician Decision|5|||
44329736|NCT01190930|79335136|FG000|Induction|Adverse Event|17|||
44329737|NCT01190930|79335137|FG001|Induction|Adverse Event|0|||
44329738|NCT01190930|79335138|FG002|Induction|Adverse Event|0|||
44329739|NCT01190930|79335139|FG003|Induction|Adverse Event|0|||
44329740|NCT01190930|79335140|FG004|Induction|Adverse Event|0|||
44329741|NCT01190930|79335141|FG005|Induction|Adverse Event|0|||
44426027|NCT00667095|79433906|FG001|Overall Study|Withdrawal by Subject|1|||
44426028|NCT00433381|79433914|FG000|Overall Study|Ineligible / no protocol treatment|3|||
44426029|NCT00433381|79433915|FG001|Overall Study|Ineligible / no protocol treatment|3|||
44426030|NCT00667017|79433929|FG000|Overall Study|Withdrawal by Subject|1|||
44426031|NCT00666705|79433933|FG000|Overall Study|Withdrawal by Subject|1|||
44426032|NCT00433147|79433946|FG000|Overall Study|Adverse Event|0|||
44426033|NCT00433147|79433947|FG001|Overall Study|Adverse Event|1|||
44426034|NCT00433147|79433948|FG002|Overall Study|Adverse Event|0|||
44426035|NCT00433147|79433949|FG003|Overall Study|Adverse Event|0|||
44426036|NCT00666237|79433961|FG000|Overall Study|Death|5|||
44426037|NCT00666237|79433962|FG001|Overall Study|Death|5|||
44426038|NCT00666237|79433961|FG000|Overall Study|Lost to Follow-up|29|||
44426039|NCT00666237|79433962|FG001|Overall Study|Lost to Follow-up|25|||
44426040|NCT00662025|79433968|FG000|Overall Study|Objective progression or relapse|51|||
44426041|NCT00662025|79433968|FG000|Overall Study|Adverse Event|7|||
44426042|NCT00662025|79433968|FG000|Overall Study|Withdrawal by Subject|1|||
44426043|NCT00662025|79433968|FG000|Overall Study|Results of other clinical study|2|||
44426044|NCT00662025|79433968|FG000|Overall Study|Target lesion cannot be evaluated|1|||
44426045|NCT00662025|79433968|FG000|Overall Study|Domestic circumstances|1|||
44426046|NCT00440947|79433972|FG000|36-Week Induction Phase|Adverse Event|16|||
44426047|NCT00440947|79433973|FG001|36-Week Induction Phase|Adverse Event|0|||
44426048|NCT00440947|79433974|FG002|36-Week Induction Phase|Adverse Event|0|||
44426049|NCT00440947|79433975|FG003|36-Week Induction Phase|Adverse Event|0|||
44329742|NCT01190930|79335142|FG006|Induction|Adverse Event|0|||
44329743|NCT01190930|79335143|FG007|Induction|Adverse Event|0|||
44329744|NCT01190930|79335144|FG008|Induction|Adverse Event|0|||
44329745|NCT01190930|79335145|FG009|Induction|Adverse Event|0|||
44329746|NCT01190930|79335136|FG000|Induction|Death|34|||
44329747|NCT01190930|79335137|FG001|Induction|Death|0|||
44329748|NCT01190930|79335138|FG002|Induction|Death|0|||
44329749|NCT01190930|79335139|FG003|Induction|Death|0|||
44329750|NCT01190930|79335140|FG004|Induction|Death|0|||
44329751|NCT01190930|79335141|FG005|Induction|Death|0|||
44329752|NCT01190930|79335142|FG006|Induction|Death|0|||
44329753|NCT01190930|79335143|FG007|Induction|Death|0|||
44329754|NCT01190930|79335144|FG008|Induction|Death|0|||
44329755|NCT01190930|79335145|FG009|Induction|Death|0|||
44426050|NCT00440947|79433976|FG004|36-Week Induction Phase|Adverse Event|0|||
44426051|NCT00440947|79433972|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
44426052|NCT00440947|79433973|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
44426053|NCT00440947|79433974|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
44426054|NCT00440947|79433975|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
44426055|NCT00440947|79433976|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
44426056|NCT00440947|79433972|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
44426057|NCT00440947|79433973|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
44426058|NCT00440947|79433974|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
44426059|NCT00440947|79433975|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
44426060|NCT00440947|79433976|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
44426061|NCT00440947|79433972|FG000|36-Week Induction Phase|Non-compliance|10|||
44426062|NCT00440947|79433973|FG001|36-Week Induction Phase|Non-compliance|0|||
44426063|NCT00440947|79433974|FG002|36-Week Induction Phase|Non-compliance|0|||
44426064|NCT00440947|79433975|FG003|36-Week Induction Phase|Non-compliance|0|||
44426065|NCT00440947|79433976|FG004|36-Week Induction Phase|Non-compliance|0|||
44426066|NCT00440947|79433972|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
44426067|NCT00440947|79433973|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
44426068|NCT00440947|79433974|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
44426069|NCT00440947|79433975|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
44426070|NCT00440947|79433976|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
44426071|NCT00440947|79433972|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
44426072|NCT00440947|79433973|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
44426073|NCT00440947|79433974|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
44426074|NCT00440947|79433975|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
44426075|NCT00440947|79433976|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
44426076|NCT00440947|79433972|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
44426077|NCT00440947|79433973|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
44426078|NCT00440947|79433974|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
44426079|NCT00440947|79433975|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
44426080|NCT00440947|79433976|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
44329756|NCT01190930|79335136|FG000|Induction|Lost to Follow-up|1|||
44426081|NCT00440947|79433972|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
44426082|NCT00440947|79433973|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
44426083|NCT00440947|79433974|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
44426084|NCT00440947|79433975|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
44426085|NCT00440947|79433976|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
44426086|NCT00440947|79433972|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
44426087|NCT00440947|79433973|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
44426088|NCT00440947|79433974|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
44426089|NCT00440947|79433975|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
44426090|NCT00440947|79433976|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
44426091|NCT00440947|79433972|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
44426092|NCT00440947|79433973|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
44426093|NCT00440947|79433974|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
44426094|NCT00440947|79433975|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
44426095|NCT00440947|79433976|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
44426096|NCT00440947|79433972|FG000|36-Week Induction Phase|Incarceration|3|||
44426097|NCT00440947|79433973|FG001|36-Week Induction Phase|Incarceration|0|||
44537381|NCT00002651|79548134|FG000|Consolidation and Randomization|Progression/relapse|0|||
44537382|NCT00002651|79548135|FG001|Consolidation and Randomization|Progression/relapse|295|||
44537383|NCT00002651|79548136|FG002|Consolidation and Randomization|Progression/relapse|298|||
44537384|NCT00002651|79548134|FG000|Consolidation and Randomization|Death|0|||
44537385|NCT00002651|79548135|FG001|Consolidation and Randomization|Death|38|||
44537386|NCT00002651|79548136|FG002|Consolidation and Randomization|Death|48|||
44537387|NCT00002651|79548134|FG000|Consolidation and Randomization|Other|0|||
44537388|NCT00002651|79548135|FG001|Consolidation and Randomization|Other|314|||
44156936|NCT03288493|78948361|FG000|Overall Study|Death|2|||
44329757|NCT01190930|79335137|FG001|Induction|Lost to Follow-up|0|||
44329758|NCT01190930|79335138|FG002|Induction|Lost to Follow-up|0|||
44329759|NCT01190930|79335139|FG003|Induction|Lost to Follow-up|0|||
44329760|NCT01190930|79335140|FG004|Induction|Lost to Follow-up|0|||
44329761|NCT01190930|79335141|FG005|Induction|Lost to Follow-up|0|||
44329762|NCT01190930|79335142|FG006|Induction|Lost to Follow-up|0|||
44329763|NCT01190930|79335143|FG007|Induction|Lost to Follow-up|0|||
44329764|NCT01190930|79335144|FG008|Induction|Lost to Follow-up|0|||
44329765|NCT01190930|79335145|FG009|Induction|Lost to Follow-up|0|||
44329766|NCT01190930|79335136|FG000|Induction|Physician Decision|125|||
44329767|NCT01190930|79335137|FG001|Induction|Physician Decision|3|||
44329768|NCT01190930|79335138|FG002|Induction|Physician Decision|0|||
44329769|NCT01190930|79335139|FG003|Induction|Physician Decision|0|||
44329770|NCT01190930|79335140|FG004|Induction|Physician Decision|0|||
44329771|NCT01190930|79335141|FG005|Induction|Physician Decision|0|||
44329772|NCT01190930|79335142|FG006|Induction|Physician Decision|0|||
44329773|NCT01190930|79335143|FG007|Induction|Physician Decision|0|||
44329774|NCT01190930|79335144|FG008|Induction|Physician Decision|0|||
44329775|NCT01190930|79335145|FG009|Induction|Physician Decision|0|||
44329776|NCT01190930|79335136|FG000|Induction|Withdrawal by Subject|9|||
44329777|NCT01190930|79335137|FG001|Induction|Withdrawal by Subject|0|||
44329778|NCT01190930|79335138|FG002|Induction|Withdrawal by Subject|0|||
44329779|NCT01190930|79335139|FG003|Induction|Withdrawal by Subject|0|||
44329780|NCT01190930|79335140|FG004|Induction|Withdrawal by Subject|0|||
44329781|NCT01190930|79335141|FG005|Induction|Withdrawal by Subject|0|||
44329782|NCT01190930|79335142|FG006|Induction|Withdrawal by Subject|0|||
44329783|NCT01190930|79335143|FG007|Induction|Withdrawal by Subject|0|||
44329784|NCT01190930|79335144|FG008|Induction|Withdrawal by Subject|0|||
44329785|NCT01190930|79335145|FG009|Induction|Withdrawal by Subject|0|||
44329786|NCT01190930|79335136|FG000|Induction|Refusal|235|||
44329787|NCT01190930|79335137|FG001|Induction|Refusal|0|||
44329788|NCT01190930|79335138|FG002|Induction|Refusal|0|||
44329789|NCT01190930|79335139|FG003|Induction|Refusal|0|||
44537389|NCT00002651|79548136|FG002|Consolidation and Randomization|Other|313|||
44537390|NCT00002651|79548134|FG000|Consolidation and Randomization|not eligible|0|||
44537391|NCT00002651|79548135|FG001|Consolidation and Randomization|not eligible|102|||
44537392|NCT00002651|79548136|FG002|Consolidation and Randomization|not eligible|112|||
44537393|NCT00002597|79548146|FG000|Overall Study|Protocol Violation|19|||
44537394|NCT00002597|79548147|FG001|Overall Study|Protocol Violation|17|||
44537395|NCT00002597|79548146|FG000|Overall Study|Withdrawal by Subject|7|||
44329790|NCT01190930|79335140|FG004|Induction|Refusal|0|||
44329791|NCT01190930|79335141|FG005|Induction|Refusal|0|||
44329792|NCT01190930|79335142|FG006|Induction|Refusal|0|||
44329793|NCT01190930|79335143|FG007|Induction|Refusal|0|||
44329794|NCT01190930|79335144|FG008|Induction|Refusal|0|||
44329795|NCT01190930|79335145|FG009|Induction|Refusal|0|||
44329796|NCT01190930|79335136|FG000|Induction|Inevaluable|23|||
44537396|NCT00002597|79548147|FG001|Overall Study|Withdrawal by Subject|6|||
44537397|NCT03435081|79548156|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
44537398|NCT03435081|79548157|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
44537399|NCT03435081|79548158|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
44537400|NCT03435081|79548156|FG000|Week 0 to Week 16|Adverse Event|2|||
44329797|NCT01190930|79335137|FG001|Induction|Inevaluable|1|||
44329798|NCT01190930|79335138|FG002|Induction|Inevaluable|0|||
44329799|NCT01190930|79335139|FG003|Induction|Inevaluable|0|||
44329800|NCT01190930|79335140|FG004|Induction|Inevaluable|0|||
44329801|NCT01190930|79335141|FG005|Induction|Inevaluable|0|||
44329802|NCT01190930|79335142|FG006|Induction|Inevaluable|0|||
44537401|NCT03435081|79548157|FG001|Week 0 to Week 16|Adverse Event|2|||
44537402|NCT03435081|79548158|FG002|Week 0 to Week 16|Adverse Event|2|||
44329803|NCT01190930|79335143|FG007|Induction|Inevaluable|0|||
44329804|NCT01190930|79335144|FG008|Induction|Inevaluable|0|||
44329805|NCT01190930|79335145|FG009|Induction|Inevaluable|0|||
44426098|NCT00440947|79433974|FG002|36-Week Induction Phase|Incarceration|0|||
44329806|NCT01190930|79335136|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
44329807|NCT01190930|79335137|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329808|NCT01190930|79335138|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329809|NCT01190930|79335139|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329810|NCT01190930|79335140|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329811|NCT01190930|79335141|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329812|NCT01190930|79335142|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329813|NCT01190930|79335143|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44426099|NCT00440947|79433975|FG003|36-Week Induction Phase|Incarceration|0|||
44426100|NCT00440947|79433976|FG004|36-Week Induction Phase|Incarceration|0|||
44426101|NCT00440947|79433972|FG000|36-Week Induction Phase|Pregnancy|1|||
44426102|NCT00440947|79433973|FG001|36-Week Induction Phase|Pregnancy|0|||
44426103|NCT00440947|79433974|FG002|36-Week Induction Phase|Pregnancy|0|||
44426104|NCT00440947|79433975|FG003|36-Week Induction Phase|Pregnancy|0|||
44329814|NCT01190930|79335144|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44329815|NCT01190930|79335145|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
44426105|NCT00440947|79433976|FG004|36-Week Induction Phase|Pregnancy|0|||
44426106|NCT00440947|79433972|FG000|48-Week Randomization Phase|Adverse Event|0|||
44426107|NCT00440947|79433973|FG001|48-Week Randomization Phase|Adverse Event|2|||
44426108|NCT00440947|79433974|FG002|48-Week Randomization Phase|Adverse Event|5|||
44426109|NCT00440947|79433975|FG003|48-Week Randomization Phase|Adverse Event|0|||
44426110|NCT00440947|79433976|FG004|48-Week Randomization Phase|Adverse Event|0|||
44426111|NCT00440947|79433972|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
44426112|NCT00440947|79433973|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
44426113|NCT00440947|79433974|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
44426114|NCT00440947|79433975|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
44426115|NCT00440947|79433976|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
44426116|NCT00440947|79433972|FG000|48-Week Randomization Phase|Non-compliance|0|||
44426117|NCT00440947|79433973|FG001|48-Week Randomization Phase|Non-compliance|3|||
44426118|NCT00440947|79433974|FG002|48-Week Randomization Phase|Non-compliance|4|||
44426119|NCT00440947|79433975|FG003|48-Week Randomization Phase|Non-compliance|0|||
44426120|NCT00440947|79433976|FG004|48-Week Randomization Phase|Non-compliance|0|||
44426121|NCT00440947|79433972|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
44426122|NCT00440947|79433973|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
44426123|NCT00440947|79433974|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
44426124|NCT00440947|79433975|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
44426125|NCT00440947|79433976|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
44426126|NCT00440947|79433972|FG000|48-Week Randomization Phase|Protocol Violation|0|||
44426127|NCT00440947|79433973|FG001|48-Week Randomization Phase|Protocol Violation|0|||
44426128|NCT00440947|79433974|FG002|48-Week Randomization Phase|Protocol Violation|1|||
44426129|NCT00440947|79433975|FG003|48-Week Randomization Phase|Protocol Violation|0|||
44426130|NCT00440947|79433976|FG004|48-Week Randomization Phase|Protocol Violation|0|||
44426131|NCT00440947|79433972|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
44537403|NCT03435081|79548156|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
44537404|NCT03435081|79548157|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
44537405|NCT03435081|79548158|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
44537406|NCT03435081|79548156|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
44537407|NCT03435081|79548157|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
44537408|NCT03435081|79548158|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
44537409|NCT03435081|79548156|FG000|Week 0 to Week 16|Pregnancy|1|||
44537410|NCT03435081|79548157|FG001|Week 0 to Week 16|Pregnancy|0|||
44537411|NCT03435081|79548158|FG002|Week 0 to Week 16|Pregnancy|0|||
44537412|NCT03435081|79548156|FG000|Week 0 to Week 16|Non-compliance|1|||
44537413|NCT03435081|79548157|FG001|Week 0 to Week 16|Non-compliance|0|||
44329816|NCT01190930|79335136|FG000|Induction|High Risk Downs|80|||
44329817|NCT01190930|79335137|FG001|Induction|High Risk Downs|0|||
44329818|NCT01190930|79335138|FG002|Induction|High Risk Downs|0|||
44329819|NCT01190930|79335139|FG003|Induction|High Risk Downs|0|||
44329820|NCT01190930|79335140|FG004|Induction|High Risk Downs|0|||
44329821|NCT01190930|79335141|FG005|Induction|High Risk Downs|0|||
44329822|NCT01190930|79335142|FG006|Induction|High Risk Downs|0|||
44329823|NCT01190930|79335143|FG007|Induction|High Risk Downs|0|||
44329824|NCT01190930|79335144|FG008|Induction|High Risk Downs|0|||
44329825|NCT01190930|79335145|FG009|Induction|High Risk Downs|0|||
44329826|NCT01190930|79335136|FG000|Induction|Enrollment onto another COG Protocol|1|||
44329827|NCT01190930|79335137|FG001|Induction|Enrollment onto another COG Protocol|0|||
44329828|NCT01190930|79335138|FG002|Induction|Enrollment onto another COG Protocol|0|||
44329829|NCT01190930|79335139|FG003|Induction|Enrollment onto another COG Protocol|0|||
44329830|NCT01190930|79335140|FG004|Induction|Enrollment onto another COG Protocol|0|||
44329831|NCT01190930|79335141|FG005|Induction|Enrollment onto another COG Protocol|0|||
44329832|NCT01190930|79335142|FG006|Induction|Enrollment onto another COG Protocol|0|||
44329833|NCT01190930|79335143|FG007|Induction|Enrollment onto another COG Protocol|0|||
44329834|NCT01190930|79335144|FG008|Induction|Enrollment onto another COG Protocol|0|||
44426132|NCT00440947|79433973|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
44537414|NCT03435081|79548158|FG002|Week 0 to Week 16|Non-compliance|2|||
44537415|NCT03435081|79548156|FG000|Week 0 to Week 16|Inadequate Response|0|||
44537416|NCT03435081|79548157|FG001|Week 0 to Week 16|Inadequate Response|1|||
44537417|NCT03435081|79548158|FG002|Week 0 to Week 16|Inadequate Response|0|||
44329835|NCT01190930|79335145|FG009|Induction|Enrollment onto another COG Protocol|0|||
44156937|NCT03288493|78948362|FG001|Overall Study|Death|0|||
44156938|NCT03288493|78948363|FG002|Overall Study|Death|0|||
44426133|NCT00440947|79433974|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
44426134|NCT00440947|79433975|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
44426135|NCT00440947|79433976|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
44426136|NCT00440947|79433972|FG000|48-Week Randomization Phase|Pregnancy|0|||
44426137|NCT00440947|79433973|FG001|48-Week Randomization Phase|Pregnancy|0|||
44426138|NCT00440947|79433974|FG002|48-Week Randomization Phase|Pregnancy|1|||
44426139|NCT00440947|79433975|FG003|48-Week Randomization Phase|Pregnancy|0|||
44426140|NCT00440947|79433976|FG004|48-Week Randomization Phase|Pregnancy|0|||
44426141|NCT00440947|79433972|FG000|48-Week Randomization Phase|Incarceration|0|||
44426142|NCT00440947|79433973|FG001|48-Week Randomization Phase|Incarceration|3|||
44426143|NCT00440947|79433974|FG002|48-Week Randomization Phase|Incarceration|0|||
44426144|NCT00440947|79433975|FG003|48-Week Randomization Phase|Incarceration|0|||
44426145|NCT00440947|79433976|FG004|48-Week Randomization Phase|Incarceration|0|||
44426146|NCT00440947|79433972|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
44426147|NCT00440947|79433973|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
44426148|NCT00440947|79433974|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
44426149|NCT00440947|79433975|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
44426150|NCT00440947|79433976|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
44426151|NCT00440947|79433972|FG000|48-Week Randomization Phase|Physician Decision|0|||
44426152|NCT00440947|79433973|FG001|48-Week Randomization Phase|Physician Decision|2|||
44426153|NCT00440947|79433974|FG002|48-Week Randomization Phase|Physician Decision|0|||
44426154|NCT00440947|79433975|FG003|48-Week Randomization Phase|Physician Decision|0|||
44537418|NCT03435081|79548156|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
44537419|NCT03435081|79548157|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
44537420|NCT03435081|79548158|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
44537421|NCT03435081|79548156|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
44537422|NCT03435081|79548157|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
44537423|NCT03435081|79548158|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
44537424|NCT03435081|79548156|FG000|Week 16 to Week 104|Adverse Event|1|||
44537425|NCT03435081|79548157|FG001|Week 16 to Week 104|Adverse Event|0|||
44537426|NCT03435081|79548158|FG002|Week 16 to Week 104|Adverse Event|2|||
44537427|NCT03435081|79548156|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
44537428|NCT03435081|79548157|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
44537429|NCT03435081|79548158|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
44426155|NCT00440947|79433976|FG004|48-Week Randomization Phase|Physician Decision|0|||
44426156|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
44537430|NCT03435081|79548156|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
44426157|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
44426158|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
44156939|NCT03288493|78948364|FG003|Overall Study|Death|0|||
44156940|NCT03288493|78948365|FG004|Overall Study|Death|0|||
44329836|NCT01190930|79335136|FG000|Induction|Average Risk|1847|||
44329837|NCT01190930|79335137|FG001|Induction|Average Risk|0|||
44329838|NCT01190930|79335138|FG002|Induction|Average Risk|0|||
44329839|NCT01190930|79335139|FG003|Induction|Average Risk|0|||
44537431|NCT03435081|79548157|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
44426159|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
44426160|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
44426161|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
44426162|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
44537432|NCT03435081|79548158|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
44537433|NCT03435081|79548156|FG000|Week 16 to Week 104|Non--Compliance|0|||
44537434|NCT03435081|79548157|FG001|Week 16 to Week 104|Non--Compliance|0|||
44537435|NCT03435081|79548158|FG002|Week 16 to Week 104|Non--Compliance|1|||
44537436|NCT02738008|79548173|FG000|Overall Study|Study Terminated by Sponsor|1|||
44537437|NCT02738008|79548174|FG001|Overall Study|Study Terminated by Sponsor|5|||
44537438|NCT02738008|79548175|FG002|Overall Study|Study Terminated by Sponsor|3|||
44537439|NCT02738008|79548173|FG000|Overall Study|Adverse Event|0|||
44329840|NCT01190930|79335140|FG004|Induction|Average Risk|0|||
44329841|NCT01190930|79335141|FG005|Induction|Average Risk|0|||
44426163|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
44426164|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
44426165|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
44426166|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
44426167|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
44426168|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
44426169|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
44426170|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
44426171|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
44329842|NCT01190930|79335142|FG006|Induction|Average Risk|0|||
44329843|NCT01190930|79335143|FG007|Induction|Average Risk|0|||
44426172|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
44426173|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
44426174|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
44426175|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
44426176|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
44426177|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
44426178|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
44426179|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
44426180|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
44426181|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
44426182|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
44426183|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
44537440|NCT02738008|79548174|FG001|Overall Study|Adverse Event|1|||
44537441|NCT02738008|79548175|FG002|Overall Study|Adverse Event|2|||
44537442|NCT03489369|79548187|FG000|Overall Study|Documented Progressive Disease|3|||
44537443|NCT03489369|79548188|FG001|Overall Study|Documented Progressive Disease|2|||
44537444|NCT03489369|79548189|FG002|Overall Study|Documented Progressive Disease|3|||
44537445|NCT03489369|79548190|FG003|Overall Study|Documented Progressive Disease|6|||
44329844|NCT01190930|79335144|FG008|Induction|Average Risk|0|||
44329845|NCT01190930|79335145|FG009|Induction|Average Risk|0|||
44329846|NCT01190930|79335136|FG000|Induction|High Risk|1227|||
44329847|NCT01190930|79335137|FG001|Induction|High Risk|0|||
44329848|NCT01190930|79335138|FG002|Induction|High Risk|0|||
44329849|NCT01190930|79335139|FG003|Induction|High Risk|0|||
44329850|NCT01190930|79335140|FG004|Induction|High Risk|0|||
44329851|NCT01190930|79335141|FG005|Induction|High Risk|0|||
44329852|NCT01190930|79335142|FG006|Induction|High Risk|0|||
44156941|NCT03288493|78948366|FG005|Overall Study|Death|0|||
44426184|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
44426185|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
44426186|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
44426187|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
44426188|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
44426189|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
44426190|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
44426191|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
44426192|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
44426193|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
44426194|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
44426195|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
44426196|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
44426197|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
44426198|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
44426199|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
44426200|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
44426201|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
44426202|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
44426203|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
44426204|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
44426205|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
44426206|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
44426207|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
44426208|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
44426209|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
44426210|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
44426211|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Other|0|||
44426212|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Other|0|||
44426213|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Other|0|||
44426214|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Other|1|||
44426215|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Other|0|||
44426216|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
44426217|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
44426218|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
44426219|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
44426220|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
44426221|NCT00440947|79433972|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
44426222|NCT00440947|79433973|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
44426223|NCT00440947|79433974|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
44426224|NCT00440947|79433975|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
44426225|NCT00440947|79433976|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
44426226|NCT00664521|79433999|FG000|Overall Study|Adverse Event|4|||
44426227|NCT00664521|79434000|FG001|Overall Study|Adverse Event|1|||
44426228|NCT00664521|79433999|FG000|Overall Study|Lost to Follow-up|1|||
44426229|NCT00664521|79434000|FG001|Overall Study|Lost to Follow-up|0|||
44426230|NCT00664521|79433999|FG000|Overall Study|Other|1|||
44426231|NCT00664521|79434000|FG001|Overall Study|Other|0|||
44426232|NCT00664209|79434006|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
44426233|NCT00664209|79434006|FG000|Study Treatment Period|Physician Decision|4|||
44426234|NCT00664209|79434006|FG000|Study Treatment Period|Withdrawal by Subject|2|||
44426235|NCT00440557|79434014|FG000|Overall Study|Withdrawal by Subject|10|||
44426236|NCT00440557|79434015|FG001|Overall Study|Withdrawal by Subject|5|||
44426237|NCT00440557|79434016|FG002|Overall Study|Withdrawal by Subject|11|||
44426238|NCT00440557|79434014|FG000|Overall Study|Lost to Follow-up|1|||
44426239|NCT00440557|79434015|FG001|Overall Study|Lost to Follow-up|2|||
44426240|NCT00440557|79434016|FG002|Overall Study|Lost to Follow-up|6|||
44426241|NCT00440557|79434014|FG000|Overall Study|Adverse Event|3|||
44426242|NCT00440557|79434015|FG001|Overall Study|Adverse Event|3|||
44426243|NCT00440557|79434016|FG002|Overall Study|Adverse Event|5|||
44426244|NCT00440557|79434014|FG000|Overall Study|Death|2|||
44426245|NCT00440557|79434015|FG001|Overall Study|Death|6|||
44426246|NCT00440557|79434016|FG002|Overall Study|Death|3|||
44426247|NCT00440557|79434014|FG000|Overall Study|Began Dialysis|4|||
44426248|NCT00440557|79434015|FG001|Overall Study|Began Dialysis|1|||
44426249|NCT00440557|79434016|FG002|Overall Study|Began Dialysis|4|||
44426250|NCT00440557|79434014|FG000|Overall Study|Principal Investigator decision|0|||
44426251|NCT00440557|79434015|FG001|Overall Study|Principal Investigator decision|3|||
44426252|NCT00440557|79434016|FG002|Overall Study|Principal Investigator decision|1|||
44537446|NCT03489369|79548187|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
44537447|NCT03489369|79548188|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
44537448|NCT03489369|79548189|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
44537449|NCT03489369|79548190|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
44537450|NCT03257254|79548200|FG000|Overall Study|Withdrawal by Subject|7|||
44537451|NCT03257254|79548200|FG000|Overall Study|Lost to Follow-up|9|||
44537452|NCT03257254|79548200|FG000|Overall Study|Study discontinued by sponsor|5|||
44537453|NCT03738475|79548206|FG000|Overall Study|Participant Non-Compliance|1|||
44537454|NCT03738475|79548207|FG001|Overall Study|Participant Non-Compliance|0|||
44537455|NCT03084718|79548218|FG000|Overall Study|Withdrawal by Subject|4|||
44537456|NCT03084718|79548219|FG001|Overall Study|Withdrawal by Subject|3|||
44537457|NCT03084718|79548220|FG002|Overall Study|Withdrawal by Subject|4|||
44156942|NCT03288493|78948367|FG006|Overall Study|Death|0|||
44329853|NCT01190930|79335143|FG007|Induction|High Risk|0|||
44329854|NCT01190930|79335144|FG008|Induction|High Risk|0|||
44329855|NCT01190930|79335145|FG009|Induction|High Risk|0|||
44329856|NCT01190930|79335136|FG000|Induction|Low Risk|443|||
44329857|NCT01190930|79335137|FG001|Induction|Low Risk|0|||
44329858|NCT01190930|79335138|FG002|Induction|Low Risk|0|||
44329859|NCT01190930|79335139|FG003|Induction|Low Risk|0|||
44329860|NCT01190930|79335140|FG004|Induction|Low Risk|0|||
44329861|NCT01190930|79335141|FG005|Induction|Low Risk|0|||
44329862|NCT01190930|79335142|FG006|Induction|Low Risk|0|||
44329863|NCT01190930|79335143|FG007|Induction|Low Risk|0|||
44329864|NCT01190930|79335144|FG008|Induction|Low Risk|0|||
44329865|NCT01190930|79335145|FG009|Induction|Low Risk|0|||
44329866|NCT01190930|79335136|FG000|Induction|Very High Risk|1012|||
44329867|NCT01190930|79335137|FG001|Induction|Very High Risk|0|||
44329868|NCT01190930|79335138|FG002|Induction|Very High Risk|0|||
44329869|NCT01190930|79335139|FG003|Induction|Very High Risk|0|||
44329870|NCT01190930|79335140|FG004|Induction|Very High Risk|0|||
44329871|NCT01190930|79335141|FG005|Induction|Very High Risk|0|||
44329872|NCT01190930|79335142|FG006|Induction|Very High Risk|0|||
44329873|NCT01190930|79335143|FG007|Induction|Very High Risk|0|||
44329874|NCT01190930|79335144|FG008|Induction|Very High Risk|0|||
44329875|NCT01190930|79335145|FG009|Induction|Very High Risk|0|||
44329876|NCT01190930|79335136|FG000|Induction|Philadelphia chromosome-positive|99|||
44329877|NCT01190930|79335137|FG001|Induction|Philadelphia chromosome-positive|0|||
44329878|NCT01190930|79335138|FG002|Induction|Philadelphia chromosome-positive|0|||
44329879|NCT01190930|79335139|FG003|Induction|Philadelphia chromosome-positive|0|||
44329880|NCT01190930|79335140|FG004|Induction|Philadelphia chromosome-positive|0|||
44329881|NCT01190930|79335141|FG005|Induction|Philadelphia chromosome-positive|0|||
44329882|NCT01190930|79335142|FG006|Induction|Philadelphia chromosome-positive|0|||
44329883|NCT01190930|79335143|FG007|Induction|Philadelphia chromosome-positive|0|||
44329884|NCT01190930|79335144|FG008|Induction|Philadelphia chromosome-positive|0|||
44329885|NCT01190930|79335145|FG009|Induction|Philadelphia chromosome-positive|0|||
44329886|NCT01190930|79335136|FG000|Induction|Incomplete Induction data|63|||
44329887|NCT01190930|79335137|FG001|Induction|Incomplete Induction data|0|||
44329888|NCT01190930|79335138|FG002|Induction|Incomplete Induction data|0|||
44426253|NCT00440557|79434014|FG000|Overall Study|Patient moved|1|||
44426254|NCT00440557|79434015|FG001|Overall Study|Patient moved|2|||
44426255|NCT00440557|79434016|FG002|Overall Study|Patient moved|1|||
44426256|NCT00440557|79434014|FG000|Overall Study|Principal Investigator's office closed|3|||
44426257|NCT00440557|79434015|FG001|Overall Study|Principal Investigator's office closed|6|||
44537458|NCT03084718|79548221|FG003|Overall Study|Withdrawal by Subject|0|||
44537459|NCT03084718|79548222|FG004|Overall Study|Withdrawal by Subject|0|||
44537460|NCT03084718|79548218|FG000|Overall Study|Physician Decision|1|||
44426258|NCT00440557|79434016|FG002|Overall Study|Principal Investigator's office closed|4|||
44426259|NCT00440557|79434014|FG000|Overall Study|Patient transferred to nursing home|0|||
44426260|NCT00440557|79434015|FG001|Overall Study|Patient transferred to nursing home|1|||
44426261|NCT00440557|79434016|FG002|Overall Study|Patient transferred to nursing home|0|||
44329889|NCT01190930|79335139|FG003|Induction|Incomplete Induction data|0|||
44426262|NCT00440557|79434014|FG000|Overall Study|Patient had surgery|1|||
44426263|NCT00440557|79434015|FG001|Overall Study|Patient had surgery|0|||
44426264|NCT00440557|79434016|FG002|Overall Study|Patient had surgery|0|||
44426265|NCT00582608|79434076|FG000|Overall Study|Not Treated|7|||
44426266|NCT00582608|79434076|FG000|Overall Study|Patient Ineligible|1|||
44426267|NCT00582608|79434076|FG000|Overall Study|Lack of accrual|4|||
44426268|NCT03014570|79434082|FG000|Overall Study|COVID-19 Restrictions|38|||
44426269|NCT03014570|79434083|FG001|Overall Study|COVID-19 Restrictions|24|||
44426270|NCT03014570|79434082|FG000|Overall Study|Death|70|||
44426271|NCT03014570|79434083|FG001|Overall Study|Death|79|||
44426272|NCT03014570|79434082|FG000|Overall Study|Transfer from facility|11|||
44426273|NCT03014570|79434083|FG001|Overall Study|Transfer from facility|14|||
44426274|NCT03014570|79434082|FG000|Overall Study|Hospitalized|5|||
44426275|NCT03014570|79434083|FG001|Overall Study|Hospitalized|3|||
44426276|NCT03014570|79434082|FG000|Overall Study|Transfer within facility|1|||
44426277|NCT03014570|79434083|FG001|Overall Study|Transfer within facility|0|||
44426278|NCT03014570|79434082|FG000|Overall Study|Site refusal|0|||
44426279|NCT03014570|79434083|FG001|Overall Study|Site refusal|11|||
44426280|NCT00427999|79434090|FG000|Overall Study|Adverse Event|6|||
44426281|NCT00427999|79434090|FG000|Overall Study|Abnormal laboratory values|1|||
44426282|NCT00427999|79434090|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
44426283|NCT00427999|79434090|FG000|Overall Study|Protocol Violation|2|||
44426284|NCT00427999|79434090|FG000|Overall Study|Withdrawal by Subject|9|||
44426285|NCT00427999|79434090|FG000|Overall Study|Death|1|||
44426286|NCT00661713|79434103|FG000|Overall Study|Death|1|||
44537461|NCT03084718|79548219|FG001|Overall Study|Physician Decision|0|||
44537462|NCT03084718|79548220|FG002|Overall Study|Physician Decision|0|||
44537463|NCT03084718|79548221|FG003|Overall Study|Physician Decision|0|||
44537464|NCT03084718|79548222|FG004|Overall Study|Physician Decision|0|||
44537465|NCT03084718|79548218|FG000|Overall Study|Adverse Event|3|||
44537466|NCT03084718|79548219|FG001|Overall Study|Adverse Event|5|||
44537467|NCT03084718|79548220|FG002|Overall Study|Adverse Event|5|||
44329890|NCT01190930|79335140|FG004|Induction|Incomplete Induction data|0|||
44329891|NCT01190930|79335141|FG005|Induction|Incomplete Induction data|0|||
44329892|NCT01190930|79335142|FG006|Induction|Incomplete Induction data|0|||
44329893|NCT01190930|79335143|FG007|Induction|Incomplete Induction data|0|||
44329894|NCT01190930|79335144|FG008|Induction|Incomplete Induction data|0|||
44329895|NCT01190930|79335145|FG009|Induction|Incomplete Induction data|0|||
44329896|NCT01190930|79335136|FG000|Induction|Progressive disease|0|||
44329897|NCT01190930|79335137|FG001|Induction|Progressive disease|1|||
44329898|NCT01190930|79335138|FG002|Induction|Progressive disease|0|||
44329899|NCT01190930|79335139|FG003|Induction|Progressive disease|0|||
44329900|NCT01190930|79335140|FG004|Induction|Progressive disease|0|||
44329901|NCT01190930|79335141|FG005|Induction|Progressive disease|0|||
44329902|NCT01190930|79335142|FG006|Induction|Progressive disease|0|||
44329903|NCT01190930|79335143|FG007|Induction|Progressive disease|0|||
44329904|NCT01190930|79335144|FG008|Induction|Progressive disease|0|||
44329905|NCT01190930|79335145|FG009|Induction|Progressive disease|0|||
44156943|NCT03288493|78948361|FG000|Overall Study|other reason not listed above|2|||
44329906|NCT01190930|79335136|FG000|Induction|No treatment|3|||
44329907|NCT01190930|79335137|FG001|Induction|No treatment|0|||
44329908|NCT01190930|79335138|FG002|Induction|No treatment|0|||
44426287|NCT00661713|79434104|FG001|Overall Study|Death|0|||
44426288|NCT00661713|79434105|FG002|Overall Study|Death|0|||
44426289|NCT00661713|79434106|FG003|Overall Study|Death|0|||
44426290|NCT00661713|79434107|FG004|Overall Study|Death|1|||
44426291|NCT00661713|79434108|FG005|Overall Study|Death|0|||
44426292|NCT00661713|79434109|FG006|Overall Study|Death|0|||
44426293|NCT00661713|79434110|FG007|Overall Study|Death|0|||
44426294|NCT00661713|79434103|FG000|Overall Study|Unable to Classify|1|||
44537468|NCT03084718|79548221|FG003|Overall Study|Adverse Event|8|||
44537469|NCT03084718|79548222|FG004|Overall Study|Adverse Event|2|||
44329909|NCT01190930|79335139|FG003|Induction|No treatment|0|||
44329910|NCT01190930|79335140|FG004|Induction|No treatment|0|||
44537470|NCT03084718|79548218|FG000|Overall Study|Lack of Efficacy|2|||
44537471|NCT03084718|79548219|FG001|Overall Study|Lack of Efficacy|0|||
44537472|NCT03084718|79548220|FG002|Overall Study|Lack of Efficacy|1|||
44537473|NCT03084718|79548221|FG003|Overall Study|Lack of Efficacy|4|||
44329911|NCT01190930|79335141|FG005|Induction|No treatment|0|||
44329912|NCT01190930|79335142|FG006|Induction|No treatment|0|||
44329913|NCT01190930|79335143|FG007|Induction|No treatment|0|||
44329914|NCT01190930|79335144|FG008|Induction|No treatment|0|||
44329915|NCT01190930|79335145|FG009|Induction|No treatment|0|||
44329916|NCT01190930|79335136|FG000|Induction|Ineligible|69|||
44329917|NCT01190930|79335137|FG001|Induction|Ineligible|4|||
44329918|NCT01190930|79335138|FG002|Induction|Ineligible|0|||
44329919|NCT01190930|79335139|FG003|Induction|Ineligible|0|||
44329920|NCT01190930|79335140|FG004|Induction|Ineligible|0|||
44329921|NCT01190930|79335141|FG005|Induction|Ineligible|0|||
44329922|NCT01190930|79335142|FG006|Induction|Ineligible|0|||
44329923|NCT01190930|79335143|FG007|Induction|Ineligible|0|||
44329924|NCT01190930|79335144|FG008|Induction|Ineligible|0|||
44329925|NCT01190930|79335145|FG009|Induction|Ineligible|0|||
44329926|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
44329927|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
44329928|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
44329929|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
44537474|NCT03084718|79548222|FG004|Overall Study|Lack of Efficacy|0|||
44537475|NCT03084718|79548218|FG000|Overall Study|Lost to Follow-up|0|||
44537476|NCT03084718|79548219|FG001|Overall Study|Lost to Follow-up|1|||
44537477|NCT03084718|79548220|FG002|Overall Study|Lost to Follow-up|0|||
44537478|NCT03084718|79548221|FG003|Overall Study|Lost to Follow-up|0|||
44537479|NCT03084718|79548222|FG004|Overall Study|Lost to Follow-up|2|||
44329930|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
44329931|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
44329932|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
44329933|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
44329934|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
44329935|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
44329936|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Death|0|||
44329937|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Death|0|||
44329938|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Death|8|||
44329939|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Death|4|||
44329940|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Death|0|||
44329941|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Death|0|||
44329942|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Death|0|||
44329943|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Death|0|||
44329944|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Death|0|||
44329945|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Death|0|||
44329946|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
44329947|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
44329948|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
44329949|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
44329950|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
44426295|NCT00661713|79434104|FG001|Overall Study|Unable to Classify|0|||
44426296|NCT00661713|79434105|FG002|Overall Study|Unable to Classify|0|||
44426297|NCT00661713|79434106|FG003|Overall Study|Unable to Classify|0|||
44426298|NCT00661713|79434107|FG004|Overall Study|Unable to Classify|0|||
44426299|NCT00661713|79434108|FG005|Overall Study|Unable to Classify|0|||
44426300|NCT00661713|79434109|FG006|Overall Study|Unable to Classify|0|||
44426301|NCT00661713|79434110|FG007|Overall Study|Unable to Classify|0|||
44329951|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
44329952|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
44329953|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
44426302|NCT00661713|79434103|FG000|Overall Study|Protocol Violation|1|||
44329954|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
44329955|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
44329956|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44426303|NCT00661713|79434104|FG001|Overall Study|Protocol Violation|6|||
44329957|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
44329958|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
44426304|NCT00661713|79434105|FG002|Overall Study|Protocol Violation|3|||
44537480|NCT03084718|79548218|FG000|Overall Study|Protocol Violation|0|||
44537481|NCT03084718|79548219|FG001|Overall Study|Protocol Violation|0|||
44537482|NCT03084718|79548220|FG002|Overall Study|Protocol Violation|1|||
44329959|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
44329960|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44329961|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44329962|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44329963|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44329964|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44329965|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
44329966|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Refusal|0|||
44329967|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Refusal|2|||
44329968|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Refusal|694|||
44329969|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Refusal|4|||
44329970|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Refusal|0|||
44329971|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Refusal|3|||
44329972|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Refusal|0|||
44329973|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Refusal|0|||
44329974|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Refusal|0|||
44329975|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Refusal|0|||
44329976|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
44329977|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
44329978|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
44329979|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
44329980|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
44329981|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
44329982|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
44329983|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
44329984|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
44329985|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
44329986|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329987|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
44329988|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329989|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329990|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329991|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329992|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329993|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329994|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329995|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
44329996|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
44329997|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
44329998|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
44329999|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
44330000|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
44330001|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
44330002|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
44330003|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
44330004|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
44330005|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
44330006|NCT01190930|79335136|FG000|Post Induction Pre-Maintenance|Relapse|0|||
44330007|NCT01190930|79335137|FG001|Post Induction Pre-Maintenance|Relapse|0|||
44426305|NCT00661713|79434106|FG003|Overall Study|Protocol Violation|3|||
44426306|NCT00661713|79434107|FG004|Overall Study|Protocol Violation|0|||
44426307|NCT00661713|79434108|FG005|Overall Study|Protocol Violation|2|||
44426308|NCT00661713|79434109|FG006|Overall Study|Protocol Violation|2|||
44426309|NCT00661713|79434110|FG007|Overall Study|Protocol Violation|1|||
44426310|NCT00661713|79434103|FG000|Overall Study|Withdrawal by Subject|11|||
44426311|NCT00661713|79434104|FG001|Overall Study|Withdrawal by Subject|25|||
44426312|NCT00661713|79434105|FG002|Overall Study|Withdrawal by Subject|12|||
44426313|NCT00661713|79434106|FG003|Overall Study|Withdrawal by Subject|21|||
44426314|NCT00661713|79434107|FG004|Overall Study|Withdrawal by Subject|12|||
44426315|NCT00661713|79434108|FG005|Overall Study|Withdrawal by Subject|26|||
44426316|NCT00661713|79434109|FG006|Overall Study|Withdrawal by Subject|45|||
44426317|NCT00661713|79434110|FG007|Overall Study|Withdrawal by Subject|9|||
44426318|NCT00661713|79434103|FG000|Overall Study|Lost to Follow-up|2|||
44426319|NCT00661713|79434104|FG001|Overall Study|Lost to Follow-up|7|||
44426320|NCT00661713|79434105|FG002|Overall Study|Lost to Follow-up|2|||
44330008|NCT01190930|79335138|FG002|Post Induction Pre-Maintenance|Relapse|1|||
44330009|NCT01190930|79335139|FG003|Post Induction Pre-Maintenance|Relapse|0|||
44426321|NCT00661713|79434106|FG003|Overall Study|Lost to Follow-up|2|||
44426322|NCT00661713|79434107|FG004|Overall Study|Lost to Follow-up|5|||
44426323|NCT00661713|79434108|FG005|Overall Study|Lost to Follow-up|7|||
44330010|NCT01190930|79335140|FG004|Post Induction Pre-Maintenance|Relapse|0|||
44330011|NCT01190930|79335141|FG005|Post Induction Pre-Maintenance|Relapse|0|||
44330012|NCT01190930|79335142|FG006|Post Induction Pre-Maintenance|Relapse|0|||
44330013|NCT01190930|79335143|FG007|Post Induction Pre-Maintenance|Relapse|0|||
44330014|NCT01190930|79335144|FG008|Post Induction Pre-Maintenance|Relapse|0|||
44330015|NCT01190930|79335145|FG009|Post Induction Pre-Maintenance|Relapse|0|||
44330016|NCT01190930|79335136|FG000|Maintenance|Adverse Event|0|||
44330017|NCT01190930|79335137|FG001|Maintenance|Adverse Event|0|||
44330018|NCT01190930|79335138|FG002|Maintenance|Adverse Event|0|||
44330019|NCT01190930|79335139|FG003|Maintenance|Adverse Event|0|||
44330020|NCT01190930|79335140|FG004|Maintenance|Adverse Event|0|||
44330021|NCT01190930|79335141|FG005|Maintenance|Adverse Event|1|||
44330022|NCT01190930|79335142|FG006|Maintenance|Adverse Event|1|||
44330023|NCT01190930|79335143|FG007|Maintenance|Adverse Event|3|||
44330024|NCT01190930|79335144|FG008|Maintenance|Adverse Event|3|||
44330025|NCT01190930|79335145|FG009|Maintenance|Adverse Event|0|||
44330026|NCT01190930|79335136|FG000|Maintenance|Death|0|||
44330027|NCT01190930|79335137|FG001|Maintenance|Death|0|||
44330028|NCT01190930|79335138|FG002|Maintenance|Death|0|||
44330029|NCT01190930|79335139|FG003|Maintenance|Death|1|||
44330030|NCT01190930|79335140|FG004|Maintenance|Death|0|||
44330031|NCT01190930|79335141|FG005|Maintenance|Death|0|||
44330032|NCT01190930|79335142|FG006|Maintenance|Death|2|||
44330033|NCT01190930|79335143|FG007|Maintenance|Death|2|||
44330034|NCT01190930|79335144|FG008|Maintenance|Death|2|||
44330035|NCT01190930|79335145|FG009|Maintenance|Death|2|||
44330036|NCT01190930|79335136|FG000|Maintenance|Lost to Follow-up|0|||
44426324|NCT00661713|79434109|FG006|Overall Study|Lost to Follow-up|14|||
44426325|NCT00661713|79434110|FG007|Overall Study|Lost to Follow-up|1|||
44426326|NCT00661713|79434103|FG000|Overall Study|Administrative Reason|0|||
44426327|NCT00661713|79434104|FG001|Overall Study|Administrative Reason|1|||
44426328|NCT00661713|79434105|FG002|Overall Study|Administrative Reason|0|||
44426329|NCT00661713|79434106|FG003|Overall Study|Administrative Reason|2|||
44426330|NCT00661713|79434107|FG004|Overall Study|Administrative Reason|2|||
44426331|NCT00661713|79434108|FG005|Overall Study|Administrative Reason|2|||
44426332|NCT00661713|79434109|FG006|Overall Study|Administrative Reason|1|||
44426333|NCT00661713|79434110|FG007|Overall Study|Administrative Reason|0|||
44426334|NCT00661713|79434103|FG000|Overall Study|Adverse Event|0|||
44426335|NCT00661713|79434104|FG001|Overall Study|Adverse Event|0|||
44426336|NCT00661713|79434105|FG002|Overall Study|Adverse Event|0|||
44426337|NCT00661713|79434106|FG003|Overall Study|Adverse Event|0|||
44426338|NCT00661713|79434107|FG004|Overall Study|Adverse Event|0|||
44426339|NCT00661713|79434108|FG005|Overall Study|Adverse Event|0|||
44426340|NCT00661713|79434109|FG006|Overall Study|Adverse Event|1|||
44426341|NCT00661713|79434110|FG007|Overall Study|Adverse Event|0|||
44426342|NCT00661713|79434103|FG000|Overall Study|Inappropriate Enrollment|0|||
44426343|NCT00661713|79434104|FG001|Overall Study|Inappropriate Enrollment|0|||
44426344|NCT00661713|79434105|FG002|Overall Study|Inappropriate Enrollment|0|||
44426345|NCT00661713|79434106|FG003|Overall Study|Inappropriate Enrollment|0|||
44426346|NCT00661713|79434107|FG004|Overall Study|Inappropriate Enrollment|0|||
44426347|NCT00661713|79434108|FG005|Overall Study|Inappropriate Enrollment|0|||
44426348|NCT00661713|79434109|FG006|Overall Study|Inappropriate Enrollment|1|||
44426349|NCT00661713|79434110|FG007|Overall Study|Inappropriate Enrollment|0|||
44330037|NCT01190930|79335137|FG001|Maintenance|Lost to Follow-up|0|||
44330038|NCT01190930|79335138|FG002|Maintenance|Lost to Follow-up|0|||
44330039|NCT01190930|79335139|FG003|Maintenance|Lost to Follow-up|0|||
44330040|NCT01190930|79335140|FG004|Maintenance|Lost to Follow-up|0|||
44330041|NCT01190930|79335141|FG005|Maintenance|Lost to Follow-up|0|||
44330042|NCT01190930|79335142|FG006|Maintenance|Lost to Follow-up|1|||
44330043|NCT01190930|79335143|FG007|Maintenance|Lost to Follow-up|1|||
44330044|NCT01190930|79335144|FG008|Maintenance|Lost to Follow-up|1|||
44156944|NCT03288493|78948362|FG001|Overall Study|other reason not listed above|0|||
44330045|NCT01190930|79335145|FG009|Maintenance|Lost to Follow-up|0|||
44330046|NCT01190930|79335136|FG000|Maintenance|Physician Decision|0|||
44330047|NCT01190930|79335137|FG001|Maintenance|Physician Decision|1|||
44330048|NCT01190930|79335138|FG002|Maintenance|Physician Decision|0|||
44330049|NCT01190930|79335139|FG003|Maintenance|Physician Decision|5|||
44426350|NCT03835975|79434135|FG000|Overall Study|Lost to Follow-up|1|||
44426351|NCT03835975|79434136|FG001|Overall Study|Lost to Follow-up|1|||
44156945|NCT03288493|78948363|FG002|Overall Study|other reason not listed above|0|||
44426352|NCT03835975|79434137|FG002|Overall Study|Lost to Follow-up|0|||
44426353|NCT03835975|79434138|FG003|Overall Study|Lost to Follow-up|0|||
44426354|NCT03835975|79434139|FG004|Overall Study|Lost to Follow-up|0|||
44330050|NCT01190930|79335140|FG004|Maintenance|Physician Decision|9|||
44330051|NCT01190930|79335141|FG005|Maintenance|Physician Decision|4|||
44330052|NCT01190930|79335142|FG006|Maintenance|Physician Decision|8|||
44330053|NCT01190930|79335143|FG007|Maintenance|Physician Decision|8|||
44330054|NCT01190930|79335144|FG008|Maintenance|Physician Decision|10|||
44330055|NCT01190930|79335145|FG009|Maintenance|Physician Decision|17|||
44330056|NCT01190930|79335136|FG000|Maintenance|Withdrawal by Subject|0|||
44330057|NCT01190930|79335137|FG001|Maintenance|Withdrawal by Subject|0|||
44330058|NCT01190930|79335138|FG002|Maintenance|Withdrawal by Subject|0|||
44330059|NCT01190930|79335139|FG003|Maintenance|Withdrawal by Subject|0|||
44330060|NCT01190930|79335140|FG004|Maintenance|Withdrawal by Subject|0|||
44330061|NCT01190930|79335141|FG005|Maintenance|Withdrawal by Subject|0|||
44330062|NCT01190930|79335142|FG006|Maintenance|Withdrawal by Subject|2|||
44330063|NCT01190930|79335143|FG007|Maintenance|Withdrawal by Subject|1|||
44330064|NCT01190930|79335144|FG008|Maintenance|Withdrawal by Subject|4|||
44330065|NCT01190930|79335145|FG009|Maintenance|Withdrawal by Subject|1|||
44330066|NCT01190930|79335136|FG000|Maintenance|Refusal|0|||
44330067|NCT01190930|79335137|FG001|Maintenance|Refusal|1|||
44330068|NCT01190930|79335138|FG002|Maintenance|Refusal|0|||
44330069|NCT01190930|79335139|FG003|Maintenance|Refusal|2|||
44330070|NCT01190930|79335140|FG004|Maintenance|Refusal|0|||
44330071|NCT01190930|79335141|FG005|Maintenance|Refusal|4|||
44426355|NCT03835975|79434135|FG000|Overall Study|No longer met eligibility criteria|0|||
44426356|NCT03835975|79434136|FG001|Overall Study|No longer met eligibility criteria|1|||
44426357|NCT03835975|79434137|FG002|Overall Study|No longer met eligibility criteria|0|||
44426358|NCT03835975|79434138|FG003|Overall Study|No longer met eligibility criteria|0|||
44426359|NCT03835975|79434139|FG004|Overall Study|No longer met eligibility criteria|0|||
44426360|NCT03835975|79434135|FG000|Overall Study|Protocol Violation|1|||
44426361|NCT03835975|79434136|FG001|Overall Study|Protocol Violation|1|||
44426362|NCT03835975|79434137|FG002|Overall Study|Protocol Violation|2|||
44426363|NCT03835975|79434138|FG003|Overall Study|Protocol Violation|0|||
44426364|NCT03835975|79434139|FG004|Overall Study|Protocol Violation|0|||
44426365|NCT03835975|79434135|FG000|Overall Study|Withdrawal by Subject|1|||
44426366|NCT03835975|79434136|FG001|Overall Study|Withdrawal by Subject|0|||
44426367|NCT03835975|79434137|FG002|Overall Study|Withdrawal by Subject|1|||
44426368|NCT03835975|79434138|FG003|Overall Study|Withdrawal by Subject|1|||
44537483|NCT03084718|79548221|FG003|Overall Study|Protocol Violation|0|||
44537484|NCT03084718|79548222|FG004|Overall Study|Protocol Violation|0|||
44537485|NCT03084718|79548218|FG000|Overall Study|Death|0|||
44537486|NCT03084718|79548219|FG001|Overall Study|Death|1|||
44426369|NCT03835975|79434139|FG004|Overall Study|Withdrawal by Subject|0|||
44426370|NCT00427921|79434153|FG000|Overall Study|Adverse Event|26|||
44426371|NCT00427921|79434153|FG000|Overall Study|Withdrawal by Subject|4|||
44426372|NCT00427921|79434153|FG000|Overall Study|Lost to Follow-up|2|||
44426373|NCT00427921|79434153|FG000|Overall Study|Other reason not specified|10|||
44426374|NCT00427921|79434153|FG000|Overall Study|Adverse Event + Hospitalization|1|||
44426375|NCT00427921|79434153|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
44426376|NCT00427921|79434153|FG000|Overall Study|Adverse Event + No Response|1|||
44426377|NCT00427921|79434153|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
44426378|NCT00427921|79434153|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
44426379|NCT00427921|79434153|FG000|Overall Study|Adverse Event + Lost Response|1|||
44426380|NCT00427921|79434153|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
44426381|NCT00427921|79434153|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
44426382|NCT00432991|79434159|FG000|Overall Study|Protocol Violation|7|||
44426383|NCT00432991|79434160|FG001|Overall Study|Protocol Violation|12|||
44426384|NCT00432835|79434168|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
44426385|NCT00432835|79434169|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
44426386|NCT00580970|79434177|FG000|Pre-treatment|Non-compliance|1|||
44426387|NCT00580970|79434177|FG000|Treatment (Lovastatin)|Non-compliance|6|||
44426388|NCT00580970|79434177|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
44426389|NCT00580970|79434177|FG000|Treatment (Lovastatin)|Physician Decision|4|||
44426390|NCT00580970|79434177|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
44426391|NCT00580970|79434177|FG000|Treatment (Lovastatin)|Death|1|||
44426392|NCT00665925|79434185|FG000|Overall Study|Lack of Efficacy|10|||
44426393|NCT00665925|79434186|FG001|Overall Study|Lack of Efficacy|8|||
44426394|NCT00665925|79434187|FG002|Overall Study|Lack of Efficacy|9|||
44156946|NCT03288493|78948364|FG003|Overall Study|other reason not listed above|0|||
44156947|NCT03288493|78948365|FG004|Overall Study|other reason not listed above|0|||
44330072|NCT01190930|79335142|FG006|Maintenance|Refusal|5|||
44330073|NCT01190930|79335143|FG007|Maintenance|Refusal|17|||
44330074|NCT01190930|79335144|FG008|Maintenance|Refusal|13|||
44330075|NCT01190930|79335145|FG009|Maintenance|Refusal|6|||
44426395|NCT00665925|79434188|FG003|Overall Study|Lack of Efficacy|8|||
44426396|NCT00665925|79434185|FG000|Overall Study|Lost to Follow-up|1|||
44426397|NCT00665925|79434186|FG001|Overall Study|Lost to Follow-up|2|||
44426398|NCT00665925|79434187|FG002|Overall Study|Lost to Follow-up|2|||
44426399|NCT00665925|79434188|FG003|Overall Study|Lost to Follow-up|2|||
44426400|NCT00665925|79434185|FG000|Overall Study|Withdrawal by Subject|2|||
44426401|NCT00665925|79434186|FG001|Overall Study|Withdrawal by Subject|2|||
44426402|NCT00665925|79434187|FG002|Overall Study|Withdrawal by Subject|3|||
44330076|NCT01190930|79335136|FG000|Maintenance|second malignant neoplasm|0|||
44426403|NCT00665925|79434188|FG003|Overall Study|Withdrawal by Subject|2|||
44537487|NCT03084718|79548220|FG002|Overall Study|Death|0|||
44330077|NCT01190930|79335137|FG001|Maintenance|second malignant neoplasm|0|||
44330078|NCT01190930|79335138|FG002|Maintenance|second malignant neoplasm|0|||
44426404|NCT00665925|79434185|FG000|Overall Study|Physician Decision|0|||
44426405|NCT00665925|79434186|FG001|Overall Study|Physician Decision|0|||
44426406|NCT00665925|79434187|FG002|Overall Study|Physician Decision|1|||
44426407|NCT00665925|79434188|FG003|Overall Study|Physician Decision|2|||
44426408|NCT00665925|79434185|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
44426409|NCT00665925|79434186|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
44426410|NCT00665925|79434187|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
44426411|NCT00665925|79434188|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
44426412|NCT00665925|79434185|FG000|Overall Study|Adverse Event|1|||
44426413|NCT00665925|79434186|FG001|Overall Study|Adverse Event|5|||
44426414|NCT00665925|79434187|FG002|Overall Study|Adverse Event|10|||
44426415|NCT00665925|79434188|FG003|Overall Study|Adverse Event|5|||
44426416|NCT00665925|79434185|FG000|Overall Study|Enrolled by mistake|0|||
44426417|NCT00665925|79434186|FG001|Overall Study|Enrolled by mistake|0|||
44330079|NCT01190930|79335139|FG003|Maintenance|second malignant neoplasm|1|||
44330080|NCT01190930|79335140|FG004|Maintenance|second malignant neoplasm|0|||
44330081|NCT01190930|79335141|FG005|Maintenance|second malignant neoplasm|1|||
44330082|NCT01190930|79335142|FG006|Maintenance|second malignant neoplasm|0|||
44426418|NCT00665925|79434187|FG002|Overall Study|Enrolled by mistake|0|||
44426419|NCT00665925|79434188|FG003|Overall Study|Enrolled by mistake|1|||
44426420|NCT00665925|79434185|FG000|Overall Study|Due to exclusion criteria|1|||
44426421|NCT00665925|79434186|FG001|Overall Study|Due to exclusion criteria|0|||
44426422|NCT00665925|79434187|FG002|Overall Study|Due to exclusion criteria|0|||
44426423|NCT00665925|79434188|FG003|Overall Study|Due to exclusion criteria|0|||
44426424|NCT00426751|79434201|FG000|Overall Study|Adverse Event|8|||
44330083|NCT01190930|79335143|FG007|Maintenance|second malignant neoplasm|0|||
44330084|NCT01190930|79335144|FG008|Maintenance|second malignant neoplasm|1|||
44330085|NCT01190930|79335145|FG009|Maintenance|second malignant neoplasm|0|||
44330086|NCT01190930|79335136|FG000|Maintenance|Inevaluable|0|||
44330087|NCT01190930|79335137|FG001|Maintenance|Inevaluable|0|||
44330088|NCT01190930|79335138|FG002|Maintenance|Inevaluable|0|||
44330089|NCT01190930|79335139|FG003|Maintenance|Inevaluable|0|||
44330090|NCT01190930|79335140|FG004|Maintenance|Inevaluable|0|||
44330091|NCT01190930|79335141|FG005|Maintenance|Inevaluable|1|||
44330092|NCT01190930|79335142|FG006|Maintenance|Inevaluable|1|||
44330093|NCT01190930|79335143|FG007|Maintenance|Inevaluable|1|||
44330094|NCT01190930|79335144|FG008|Maintenance|Inevaluable|0|||
44330095|NCT01190930|79335145|FG009|Maintenance|Inevaluable|0|||
44330096|NCT01190930|79335136|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
44330097|NCT01190930|79335137|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
44330098|NCT01190930|79335138|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
44330099|NCT01190930|79335139|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
44426425|NCT00426751|79434202|FG001|Overall Study|Adverse Event|1|||
44426426|NCT00426751|79434201|FG000|Overall Study|Lost to Follow-up|7|||
44426427|NCT00426751|79434202|FG001|Overall Study|Lost to Follow-up|6|||
44426428|NCT00426751|79434201|FG000|Overall Study|Consent Withdrawn|0|||
44426429|NCT00426751|79434202|FG001|Overall Study|Consent Withdrawn|1|||
44426430|NCT00426751|79434201|FG000|Overall Study|Other Reasons|7|||
44426431|NCT00426751|79434202|FG001|Overall Study|Other Reasons|12|||
44426432|NCT00440401|79434210|FG000|Overall Study|Adverse Event|2|||
44426433|NCT00440401|79434211|FG001|Overall Study|Adverse Event|1|||
44426434|NCT00440401|79434210|FG000|Overall Study|Other|2|||
44330100|NCT01190930|79335140|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
44426435|NCT00440401|79434211|FG001|Overall Study|Other|5|||
44426436|NCT02598960|79434230|FG000|Treatment Period|Disease Progression|4|||
44426437|NCT02598960|79434231|FG001|Treatment Period|Disease Progression|4|||
44426438|NCT02598960|79434232|FG002|Treatment Period|Disease Progression|4|||
44426439|NCT02598960|79434233|FG003|Treatment Period|Disease Progression|6|||
44537488|NCT03084718|79548221|FG003|Overall Study|Death|0|||
44537489|NCT03084718|79548222|FG004|Overall Study|Death|0|||
44537490|NCT03084718|79548218|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
44330101|NCT01190930|79335141|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
44330102|NCT01190930|79335142|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
44330103|NCT01190930|79335143|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
44330104|NCT01190930|79335144|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
44330105|NCT01190930|79335145|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
44426440|NCT02598960|79434234|FG004|Treatment Period|Disease Progression|8|||
44426441|NCT02598960|79434235|FG005|Treatment Period|Disease Progression|2|||
44426442|NCT02598960|79434236|FG006|Treatment Period|Disease Progression|2|||
44426443|NCT02598960|79434237|FG007|Treatment Period|Disease Progression|3|||
44426444|NCT02598960|79434238|FG008|Treatment Period|Disease Progression|7|||
44426445|NCT02598960|79434239|FG009|Treatment Period|Disease Progression|9|||
44426446|NCT02598960|79434240|FG010|Treatment Period|Disease Progression|7|||
44426447|NCT02598960|79434241|FG011|Treatment Period|Disease Progression|143|||
44537491|NCT03084718|79548219|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
44330106|NCT01190930|79335136|FG000|Maintenance|Relapse|0|||
44426448|NCT02598960|79434242|FG012|Treatment Period|Disease Progression|23|||
44330107|NCT01190930|79335137|FG001|Maintenance|Relapse|0|||
44426449|NCT02598960|79434230|FG000|Treatment Period|Study drug toxicity|0|||
44426450|NCT02598960|79434231|FG001|Treatment Period|Study drug toxicity|0|||
44426451|NCT02598960|79434232|FG002|Treatment Period|Study drug toxicity|0|||
44426452|NCT02598960|79434233|FG003|Treatment Period|Study drug toxicity|0|||
44426453|NCT02598960|79434234|FG004|Treatment Period|Study drug toxicity|0|||
44426454|NCT02598960|79434235|FG005|Treatment Period|Study drug toxicity|0|||
44426455|NCT02598960|79434236|FG006|Treatment Period|Study drug toxicity|0|||
44426456|NCT02598960|79434237|FG007|Treatment Period|Study drug toxicity|0|||
44426457|NCT02598960|79434238|FG008|Treatment Period|Study drug toxicity|0|||
44426458|NCT02598960|79434239|FG009|Treatment Period|Study drug toxicity|1|||
44426459|NCT02598960|79434240|FG010|Treatment Period|Study drug toxicity|0|||
44330108|NCT01190930|79335138|FG002|Maintenance|Relapse|0|||
44330109|NCT01190930|79335139|FG003|Maintenance|Relapse|2|||
44330110|NCT01190930|79335140|FG004|Maintenance|Relapse|0|||
44330111|NCT01190930|79335141|FG005|Maintenance|Relapse|1|||
44330112|NCT01190930|79335142|FG006|Maintenance|Relapse|6|||
44330113|NCT01190930|79335143|FG007|Maintenance|Relapse|13|||
44330114|NCT01190930|79335144|FG008|Maintenance|Relapse|11|||
44330115|NCT01190930|79335145|FG009|Maintenance|Relapse|11|||
44330116|NCT01190930|79335136|FG000|Maintenance|Still on therapy|0|||
44330117|NCT01190930|79335137|FG001|Maintenance|Still on therapy|8|||
44330118|NCT01190930|79335138|FG002|Maintenance|Still on therapy|0|||
44330119|NCT01190930|79335139|FG003|Maintenance|Still on therapy|29|||
44330120|NCT01190930|79335140|FG004|Maintenance|Still on therapy|0|||
44330121|NCT01190930|79335141|FG005|Maintenance|Still on therapy|0|||
44330122|NCT01190930|79335142|FG006|Maintenance|Still on therapy|0|||
44330123|NCT01190930|79335143|FG007|Maintenance|Still on therapy|0|||
44330124|NCT01190930|79335144|FG008|Maintenance|Still on therapy|0|||
44330125|NCT01190930|79335145|FG009|Maintenance|Still on therapy|0|||
44330126|NCT01163682|79335194|FG000|Overall Study|Lost to Follow-up|6|||
44330127|NCT01163682|79335195|FG001|Overall Study|Lost to Follow-up|9|||
44330128|NCT01047007|79335205|FG000|Overall Study|Adverse Event|0|||
44330129|NCT01047007|79335206|FG001|Overall Study|Adverse Event|2|||
44330130|NCT01047007|79335207|FG002|Overall Study|Adverse Event|1|||
44330131|NCT01047007|79335208|FG003|Overall Study|Adverse Event|0|||
44330132|NCT01047007|79335205|FG000|Overall Study|Progressive Disease|2|||
44330133|NCT01047007|79335206|FG001|Overall Study|Progressive Disease|4|||
44330134|NCT01047007|79335207|FG002|Overall Study|Progressive Disease|1|||
44330135|NCT01047007|79335208|FG003|Overall Study|Progressive Disease|0|||
44330136|NCT00546351|79335348|FG000|Overall Study|Adverse Event|76|||
44330137|NCT00546351|79335348|FG000|Overall Study|Lack of Efficacy|15|||
44330138|NCT00546351|79335348|FG000|Overall Study|Withdrawal by Subject|109|||
44330139|NCT00546351|79335348|FG000|Overall Study|Lost to Follow-up|9|||
44330140|NCT00546351|79335348|FG000|Overall Study|Protocol Deviation|1|||
44330141|NCT00546351|79335348|FG000|Overall Study|Unsatisfactory compliance|9|||
44330142|NCT00546351|79335348|FG000|Overall Study|Other reasons for premature termination|17|||
44330143|NCT00003838|79335364|FG000|Overall Study|Death|0|||
44330144|NCT00003838|79335365|FG001|Overall Study|Death|12|||
44330145|NCT00003838|79335366|FG002|Overall Study|Death|7|||
44330146|NCT00003838|79335364|FG000|Overall Study|Lost to Follow-up|0|||
44330147|NCT00003838|79335365|FG001|Overall Study|Lost to Follow-up|1|||
44330148|NCT00003838|79335366|FG002|Overall Study|Lost to Follow-up|1|||
44330149|NCT00003838|79335364|FG000|Overall Study|Disease Progression|0|||
44330150|NCT00003838|79335365|FG001|Overall Study|Disease Progression|12|||
44330151|NCT00003838|79335366|FG002|Overall Study|Disease Progression|0|||
44330152|NCT04276883|79335398|FG000|Overall Study|Withdrawal by Subject|2|||
44330153|NCT04276883|79335399|FG001|Overall Study|Withdrawal by Subject|3|||
44330154|NCT04276883|79335400|FG002|Overall Study|Withdrawal by Subject|6|||
44330155|NCT04276883|79335398|FG000|Overall Study|Lost to Follow-up|1|||
44330156|NCT04276883|79335399|FG001|Overall Study|Lost to Follow-up|3|||
44426460|NCT02598960|79434241|FG011|Treatment Period|Study drug toxicity|3|||
44426461|NCT02598960|79434242|FG012|Treatment Period|Study drug toxicity|0|||
44426462|NCT02598960|79434230|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
44426463|NCT02598960|79434231|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
44330157|NCT04276883|79335400|FG002|Overall Study|Lost to Follow-up|0|||
44330158|NCT04276883|79335398|FG000|Overall Study|Adverse Event|0|||
44330159|NCT04276883|79335399|FG001|Overall Study|Adverse Event|1|||
44426464|NCT02598960|79434232|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
44426465|NCT02598960|79434233|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
44330160|NCT04276883|79335400|FG002|Overall Study|Adverse Event|0|||
44330161|NCT04276883|79335398|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
44330162|NCT04276883|79335399|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
44330163|NCT04276883|79335400|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
44330164|NCT04099888|79335410|FG000|Overall Study|Study terminated by sponsor|9|||
44330165|NCT04099888|79335411|FG001|Overall Study|Study terminated by sponsor|11|||
44330166|NCT04099888|79335410|FG000|Overall Study|Lost to Follow-up|1|||
44330167|NCT04099888|79335411|FG001|Overall Study|Lost to Follow-up|1|||
44330168|NCT04099888|79335410|FG000|Overall Study|Withdrawal by Subject|5|||
44426466|NCT02598960|79434234|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
44426467|NCT02598960|79434235|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
44426468|NCT02598960|79434236|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
44426469|NCT02598960|79434237|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
44426470|NCT02598960|79434238|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
44426471|NCT02598960|79434239|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
44426472|NCT02598960|79434240|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
44426473|NCT02598960|79434241|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
44426474|NCT02598960|79434242|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
44426475|NCT02598960|79434230|FG000|Treatment Period|participant request to discontinue|0|||
44426476|NCT02598960|79434231|FG001|Treatment Period|participant request to discontinue|1|||
44426477|NCT02598960|79434232|FG002|Treatment Period|participant request to discontinue|0|||
44426478|NCT02598960|79434233|FG003|Treatment Period|participant request to discontinue|0|||
44426479|NCT02598960|79434234|FG004|Treatment Period|participant request to discontinue|1|||
44426480|NCT02598960|79434235|FG005|Treatment Period|participant request to discontinue|0|||
44426481|NCT02598960|79434236|FG006|Treatment Period|participant request to discontinue|0|||
44426482|NCT02598960|79434237|FG007|Treatment Period|participant request to discontinue|0|||
44426483|NCT02598960|79434238|FG008|Treatment Period|participant request to discontinue|0|||
44426484|NCT02598960|79434239|FG009|Treatment Period|participant request to discontinue|0|||
44426485|NCT02598960|79434240|FG010|Treatment Period|participant request to discontinue|1|||
44426486|NCT02598960|79434241|FG011|Treatment Period|participant request to discontinue|4|||
44426487|NCT02598960|79434242|FG012|Treatment Period|participant request to discontinue|0|||
44426488|NCT02598960|79434230|FG000|Treatment Period|participant withdrew consent|0|||
44426489|NCT02598960|79434231|FG001|Treatment Period|participant withdrew consent|0|||
44426490|NCT02598960|79434232|FG002|Treatment Period|participant withdrew consent|0|||
44426491|NCT02598960|79434233|FG003|Treatment Period|participant withdrew consent|0|||
44426492|NCT02598960|79434234|FG004|Treatment Period|participant withdrew consent|0|||
44426493|NCT02598960|79434235|FG005|Treatment Period|participant withdrew consent|0|||
44426494|NCT02598960|79434236|FG006|Treatment Period|participant withdrew consent|0|||
44426495|NCT02598960|79434237|FG007|Treatment Period|participant withdrew consent|0|||
44426496|NCT02598960|79434238|FG008|Treatment Period|participant withdrew consent|0|||
44426497|NCT02598960|79434239|FG009|Treatment Period|participant withdrew consent|0|||
44426498|NCT02598960|79434240|FG010|Treatment Period|participant withdrew consent|0|||
44426499|NCT02598960|79434241|FG011|Treatment Period|participant withdrew consent|3|||
44426500|NCT02598960|79434242|FG012|Treatment Period|participant withdrew consent|0|||
44426501|NCT02598960|79434230|FG000|Treatment Period|No longer meets study criteria|0|||
44426502|NCT02598960|79434231|FG001|Treatment Period|No longer meets study criteria|0|||
44426503|NCT02598960|79434232|FG002|Treatment Period|No longer meets study criteria|0|||
44426504|NCT02598960|79434233|FG003|Treatment Period|No longer meets study criteria|0|||
44426505|NCT02598960|79434234|FG004|Treatment Period|No longer meets study criteria|0|||
44426506|NCT02598960|79434235|FG005|Treatment Period|No longer meets study criteria|0|||
44426507|NCT02598960|79434236|FG006|Treatment Period|No longer meets study criteria|0|||
44426508|NCT02598960|79434237|FG007|Treatment Period|No longer meets study criteria|0|||
44426509|NCT02598960|79434238|FG008|Treatment Period|No longer meets study criteria|0|||
44426510|NCT02598960|79434239|FG009|Treatment Period|No longer meets study criteria|0|||
44426511|NCT02598960|79434240|FG010|Treatment Period|No longer meets study criteria|0|||
44426512|NCT02598960|79434241|FG011|Treatment Period|No longer meets study criteria|1|||
44426513|NCT02598960|79434242|FG012|Treatment Period|No longer meets study criteria|0|||
44330169|NCT04099888|79335411|FG001|Overall Study|Withdrawal by Subject|6|||
44330170|NCT04099888|79335410|FG000|Overall Study|Death|5|||
44330171|NCT04099888|79335411|FG001|Overall Study|Death|2|||
44330172|NCT04099888|79335410|FG000|Overall Study|Other|1|||
44330173|NCT04099888|79335411|FG001|Overall Study|Other|0|||
44330174|NCT04081389|79335421|FG000|Overall Study|Withdrawal by Subject|0|||
44330175|NCT04081389|79335422|FG001|Overall Study|Withdrawal by Subject|0|||
44330176|NCT04081389|79335423|FG002|Overall Study|Withdrawal by Subject|1|||
44330177|NCT04081389|79335424|FG003|Overall Study|Withdrawal by Subject|0|||
44330178|NCT04032080|79335434|FG000|Overall Study|Death|6|||
44330179|NCT03781323|79335448|FG000|Overall Study|Withdrawal by Subject|1|||
44330180|NCT03729362|79335454|FG000|Overall Study|Withdrawal by Subject|2|||
44330181|NCT03729362|79335455|FG001|Overall Study|Withdrawal by Subject|0|||
44330182|NCT03729362|79335454|FG000|Overall Study|Physician Decision|1|||
44330183|NCT03729362|79335455|FG001|Overall Study|Physician Decision|0|||
44330184|NCT03729362|79335454|FG000|Overall Study|COVID-19 Pandemic|1|||
44330185|NCT03729362|79335455|FG001|Overall Study|COVID-19 Pandemic|0|||
44330186|NCT03729362|79335454|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
44330187|NCT03729362|79335455|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
44330188|NCT03729362|79335454|FG000|Overall Study|Adverse Event|0|||
44330189|NCT03729362|79335455|FG001|Overall Study|Adverse Event|1|||
44426514|NCT02598960|79434230|FG000|Treatment Period|Other Reasons|0|||
44426515|NCT02598960|79434231|FG001|Treatment Period|Other Reasons|0|||
44426516|NCT02598960|79434232|FG002|Treatment Period|Other Reasons|0|||
44426517|NCT02598960|79434233|FG003|Treatment Period|Other Reasons|0|||
44426518|NCT02598960|79434234|FG004|Treatment Period|Other Reasons|0|||
44426519|NCT02598960|79434235|FG005|Treatment Period|Other Reasons|0|||
44426520|NCT02598960|79434236|FG006|Treatment Period|Other Reasons|0|||
44426521|NCT02598960|79434237|FG007|Treatment Period|Other Reasons|0|||
44426522|NCT02598960|79434238|FG008|Treatment Period|Other Reasons|0|||
44426523|NCT02598960|79434239|FG009|Treatment Period|Other Reasons|0|||
44426524|NCT02598960|79434240|FG010|Treatment Period|Other Reasons|0|||
44426525|NCT02598960|79434241|FG011|Treatment Period|Other Reasons|0|||
44426526|NCT02598960|79434242|FG012|Treatment Period|Other Reasons|1|||
44426527|NCT02598960|79434230|FG000|Participants Entering Follow Up Period|Death|1|||
44426528|NCT02598960|79434231|FG001|Participants Entering Follow Up Period|Death|0|||
44426529|NCT02598960|79434232|FG002|Participants Entering Follow Up Period|Death|0|||
44426530|NCT02598960|79434233|FG003|Participants Entering Follow Up Period|Death|0|||
44426531|NCT02598960|79434234|FG004|Participants Entering Follow Up Period|Death|0|||
44426532|NCT02598960|79434235|FG005|Participants Entering Follow Up Period|Death|0|||
44426533|NCT02598960|79434236|FG006|Participants Entering Follow Up Period|Death|0|||
44426534|NCT02598960|79434237|FG007|Participants Entering Follow Up Period|Death|0|||
44426535|NCT02598960|79434238|FG008|Participants Entering Follow Up Period|Death|0|||
44426536|NCT02598960|79434239|FG009|Participants Entering Follow Up Period|Death|1|||
44426537|NCT02598960|79434240|FG010|Participants Entering Follow Up Period|Death|0|||
44426538|NCT02598960|79434241|FG011|Participants Entering Follow Up Period|Death|11|||
44426539|NCT02598960|79434242|FG012|Participants Entering Follow Up Period|Death|2|||
44156948|NCT03288493|78948366|FG005|Overall Study|other reason not listed above|0|||
44156949|NCT03288493|78948367|FG006|Overall Study|other reason not listed above|0|||
44156950|NCT03238300|78948387|FG000|Baseline (Before Intervention)|Physician Decision|0|||
44156951|NCT03238300|78948388|FG001|Baseline (Before Intervention)|Physician Decision|1|||
44156952|NCT03238300|78948387|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
44330190|NCT03729362|79335454|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
44330191|NCT03729362|79335455|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
44330192|NCT03340766|79335482|FG000|Overall Study|Death|6|||
44330193|NCT03340766|79335483|FG001|Overall Study|Death|6|||
44330194|NCT03340766|79335484|FG002|Overall Study|Death|2|||
44330195|NCT03340766|79335482|FG000|Overall Study|Withdrawal by Subject|2|||
44330196|NCT03340766|79335483|FG001|Overall Study|Withdrawal by Subject|1|||
44330197|NCT03340766|79335484|FG002|Overall Study|Withdrawal by Subject|2|||
44330198|NCT03340766|79335482|FG000|Overall Study|Continuing Study|3|||
44330199|NCT03340766|79335483|FG001|Overall Study|Continuing Study|3|||
44330200|NCT03340766|79335484|FG002|Overall Study|Continuing Study|5|||
44330201|NCT02711852|79335520|FG000|Overall Study|Death|5|||
44330202|NCT02711852|79335520|FG000|Overall Study|Lost to Follow-up|1|||
44330203|NCT02711852|79335520|FG000|Overall Study|Completed follow-up|3|||
44330204|NCT02711852|79335520|FG000|Overall Study|Withdrawal by Subject|1|||
44330205|NCT01977417|79335549|FG000|Overall Study|Adverse Event|1|||
44330206|NCT01977417|79335550|FG001|Overall Study|Adverse Event|0|||
44330207|NCT01977417|79335549|FG000|Overall Study|Withdrawal by Subject|2|||
44330208|NCT01977417|79335550|FG001|Overall Study|Withdrawal by Subject|4|||
44330209|NCT01977417|79335549|FG000|Overall Study|Female enrollment goal met|0|||
44330210|NCT01977417|79335550|FG001|Overall Study|Female enrollment goal met|2|||
44330211|NCT01951885|79335558|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
44330212|NCT01951885|79335559|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
44330213|NCT01951885|79335558|FG000|Overall Study|Adverse Event|1|||
44330214|NCT01951885|79335559|FG001|Overall Study|Adverse Event|0|||
44330215|NCT01951885|79335558|FG000|Overall Study|Withdrawal by Subject|0|||
44330216|NCT01951885|79335559|FG001|Overall Study|Withdrawal by Subject|1|||
44330217|NCT01951885|79335558|FG000|Overall Study|ineligible due to a change in donor|0|||
44330218|NCT01951885|79335559|FG001|Overall Study|ineligible due to a change in donor|1|||
44330219|NCT01951885|79335558|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
44330220|NCT01951885|79335559|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
44330221|NCT00626990|79335569|FG000|Overall Study|Lack of Efficacy|6|||
44330222|NCT00626990|79335570|FG001|Overall Study|Lack of Efficacy|7|||
44330223|NCT00626990|79335571|FG002|Overall Study|Lack of Efficacy|49|||
44330224|NCT00626990|79335572|FG003|Overall Study|Lack of Efficacy|40|||
44330225|NCT00626990|79335569|FG000|Overall Study|Adverse Event|1|||
44330226|NCT00626990|79335570|FG001|Overall Study|Adverse Event|7|||
44330227|NCT00626990|79335571|FG002|Overall Study|Adverse Event|14|||
44330228|NCT00626990|79335572|FG003|Overall Study|Adverse Event|28|||
44330229|NCT00626990|79335569|FG000|Overall Study|Death|0|||
44330230|NCT00626990|79335570|FG001|Overall Study|Death|1|||
44426540|NCT02598960|79434230|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
44330231|NCT00626990|79335571|FG002|Overall Study|Death|0|||
44330232|NCT00626990|79335572|FG003|Overall Study|Death|0|||
44426541|NCT02598960|79434231|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426542|NCT02598960|79434232|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426543|NCT02598960|79434233|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426544|NCT02598960|79434234|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426545|NCT02598960|79434235|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426546|NCT02598960|79434236|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426547|NCT02598960|79434237|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426548|NCT02598960|79434238|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426549|NCT02598960|79434239|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426550|NCT02598960|79434240|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426551|NCT02598960|79434241|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
44426552|NCT02598960|79434242|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
44426553|NCT02598960|79434230|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
44426554|NCT02598960|79434231|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
44426555|NCT02598960|79434232|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
44426556|NCT02598960|79434233|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
44426557|NCT02598960|79434234|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
44426558|NCT02598960|79434235|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
44426559|NCT02598960|79434236|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
44426560|NCT02598960|79434237|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
44426561|NCT02598960|79434238|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
44426562|NCT02598960|79434239|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
44426563|NCT02598960|79434240|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
44426564|NCT02598960|79434241|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
44330233|NCT00626990|79335569|FG000|Overall Study|Withdrawal by Subject|3|||
44330234|NCT00626990|79335570|FG001|Overall Study|Withdrawal by Subject|1|||
44330235|NCT00626990|79335571|FG002|Overall Study|Withdrawal by Subject|5|||
44330236|NCT00626990|79335572|FG003|Overall Study|Withdrawal by Subject|11|||
44330237|NCT00626990|79335569|FG000|Overall Study|Protocol Violation|0|||
44330238|NCT00626990|79335570|FG001|Overall Study|Protocol Violation|1|||
44330239|NCT00626990|79335571|FG002|Overall Study|Protocol Violation|1|||
44330240|NCT00626990|79335572|FG003|Overall Study|Protocol Violation|0|||
44426565|NCT02598960|79434242|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
44426566|NCT02598960|79434230|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426567|NCT02598960|79434231|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426568|NCT02598960|79434232|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426569|NCT02598960|79434233|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426570|NCT02598960|79434234|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44537492|NCT03084718|79548220|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
44537493|NCT03084718|79548221|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
44537494|NCT03084718|79548222|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
44537495|NCT04321252|79548246|FG000|Overall Study|Withdrawal by Subject|0|||
44537496|NCT04321252|79548247|FG001|Overall Study|Withdrawal by Subject|0|||
44537497|NCT04321252|79548248|FG002|Overall Study|Withdrawal by Subject|0|||
44537498|NCT04321252|79548249|FG003|Overall Study|Withdrawal by Subject|0|||
44537499|NCT04321252|79548250|FG004|Overall Study|Withdrawal by Subject|0|||
44537500|NCT04321252|79548251|FG005|Overall Study|Withdrawal by Subject|1|||
44537501|NCT04321252|79548252|FG006|Overall Study|Withdrawal by Subject|0|||
44537502|NCT04321252|79548253|FG007|Overall Study|Withdrawal by Subject|0|||
44537503|NCT04321252|79548254|FG008|Overall Study|Withdrawal by Subject|0|||
44537504|NCT03433677|79548286|FG000|Period 1|Protocol Violation|1|||
44426571|NCT02598960|79434235|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426572|NCT02598960|79434236|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426573|NCT02598960|79434237|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426574|NCT02598960|79434238|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426575|NCT02598960|79434239|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426576|NCT02598960|79434240|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44537505|NCT03433677|79548287|FG001|Period 1|Protocol Violation|0|||
44330241|NCT00626990|79335569|FG000|Overall Study|Various different reasons/missing|4|||
44330242|NCT00626990|79335570|FG001|Overall Study|Various different reasons/missing|8|||
44330243|NCT00626990|79335571|FG002|Overall Study|Various different reasons/missing|8|||
44330244|NCT00626990|79335572|FG003|Overall Study|Various different reasons/missing|16|||
44330245|NCT00107198|79335586|FG000|Overall Study|Lack of Efficacy|28|||
44330246|NCT00107198|79335586|FG000|Overall Study|Lost to Follow-up|12|||
44330247|NCT00107198|79335586|FG000|Overall Study|Protocol Violation|1|||
44330248|NCT00107198|79335586|FG000|Overall Study|Withdrawal by Subject|6|||
44330249|NCT00107198|79335586|FG000|Overall Study|Ineligible|5|||
44330250|NCT01193920|79335609|FG000|Overall Study|Withdrawal by Subject|1|||
44330251|NCT01193920|79335610|FG001|Overall Study|Withdrawal by Subject|0|||
44330252|NCT01193920|79335611|FG002|Overall Study|Withdrawal by Subject|5|||
44330253|NCT01193920|79335612|FG003|Overall Study|Withdrawal by Subject|1|||
44330254|NCT01193920|79335613|FG004|Overall Study|Withdrawal by Subject|3|||
44330255|NCT01193920|79335614|FG005|Overall Study|Withdrawal by Subject|1|||
44330256|NCT01193920|79335615|FG006|Overall Study|Withdrawal by Subject|3|||
44330257|NCT01193920|79335616|FG007|Overall Study|Withdrawal by Subject|0|||
44426577|NCT02598960|79434241|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
44426578|NCT02598960|79434242|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
44426579|NCT02598960|79434230|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
44426580|NCT02598960|79434231|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
44426581|NCT02598960|79434232|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
44426582|NCT02598960|79434233|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
44426583|NCT02598960|79434234|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
44426584|NCT02598960|79434235|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
44426585|NCT02598960|79434236|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
44426586|NCT02598960|79434237|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
44426587|NCT02598960|79434238|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
44426588|NCT02598960|79434239|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
44426589|NCT02598960|79434240|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
44426590|NCT02598960|79434241|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
44426591|NCT02598960|79434242|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
44426592|NCT00426361|79434273|FG000|Overall Study|Lost to Follow-up|3|||
44426593|NCT00426361|79434274|FG001|Overall Study|Lost to Follow-up|2|||
44426594|NCT00426361|79434275|FG002|Overall Study|Lost to Follow-up|5|||
44426595|NCT00426361|79434273|FG000|Overall Study|Withdrawal by Subject|1|||
44426596|NCT00426361|79434274|FG001|Overall Study|Withdrawal by Subject|3|||
44426597|NCT00426361|79434275|FG002|Overall Study|Withdrawal by Subject|0|||
44426598|NCT00665847|79434283|FG000|Overall Study|Adverse Event|8|||
44426599|NCT00665847|79434283|FG000|Overall Study|Withdrawal by Subject|2|||
44426600|NCT00665847|79434283|FG000|Overall Study|Subject non-compliant|8|||
44426601|NCT00665847|79434283|FG000|Overall Study|Subject reached a virologic endpoint|4|||
44426602|NCT00665847|79434283|FG000|Overall Study|Resistance to TMC125|1|||
44426603|NCT00665847|79434283|FG000|Overall Study|Subject ineligible to continue the trial|1|||
44330258|NCT01193920|79335617|FG008|Overall Study|Withdrawal by Subject|1|||
44330259|NCT01193920|79335618|FG009|Overall Study|Withdrawal by Subject|0|||
44330260|NCT01193920|79335609|FG000|Overall Study|Lost to Follow-up|1|||
44426604|NCT00665847|79434283|FG000|Overall Study|Switch to Commercial Medication|1|||
44426605|NCT00426127|79434287|FG000|Overall Study|Adverse Event|1|||
44426606|NCT00426127|79434287|FG000|Overall Study|Removed due to disease progression|1|||
44426607|NCT00425503|79434291|FG000|Overall Study|Adverse Event|2|||
44426608|NCT00425503|79434291|FG000|Overall Study|Protocol Violation|1|||
44426609|NCT00425269|79434297|FG000|Overall Study|Pregnancy|5|||
44426610|NCT00425269|79434298|FG001|Overall Study|Pregnancy|7|||
44426611|NCT00425269|79434297|FG000|Overall Study|Lost to Follow-up|9|||
44426612|NCT00425269|79434298|FG001|Overall Study|Lost to Follow-up|9|||
44426613|NCT00425269|79434297|FG000|Overall Study|moved or medical reason|5|||
44426614|NCT00425269|79434298|FG001|Overall Study|moved or medical reason|4|||
44426615|NCT00430573|79434304|FG000|Overall Study|Withdrawal by Subject|5|||
44426616|NCT00430495|79434330|FG000|Overall Study|Adverse Event|2|||
44426617|NCT00430495|79434331|FG001|Overall Study|Adverse Event|3|||
44426618|NCT00430495|79434332|FG002|Overall Study|Adverse Event|2|||
44537506|NCT03433677|79548286|FG000|Period 2|Withdrawal by Subject|1|||
44537507|NCT03433677|79548287|FG001|Period 2|Withdrawal by Subject|1|||
44537508|NCT02492711|79548297|FG000|Overall Study|Adverse Event|9|||
44537509|NCT02492711|79548298|FG001|Overall Study|Adverse Event|9|||
44426619|NCT00430495|79434333|FG003|Overall Study|Adverse Event|0|||
44426620|NCT00430495|79434330|FG000|Overall Study|Death|0|||
44426621|NCT00430495|79434331|FG001|Overall Study|Death|0|||
44426622|NCT00430495|79434332|FG002|Overall Study|Death|1|||
44426623|NCT00430495|79434333|FG003|Overall Study|Death|0|||
44426624|NCT00430495|79434330|FG000|Overall Study|Lost to Follow-up|0|||
44426625|NCT00430495|79434331|FG001|Overall Study|Lost to Follow-up|1|||
44537510|NCT02492711|79548299|FG002|Overall Study|Adverse Event|2|||
44537511|NCT02492711|79548297|FG000|Overall Study|Death|3|||
44537512|NCT02492711|79548298|FG001|Overall Study|Death|3|||
44330261|NCT01193920|79335610|FG001|Overall Study|Lost to Follow-up|0|||
44330262|NCT01193920|79335611|FG002|Overall Study|Lost to Follow-up|1|||
44330263|NCT01193920|79335612|FG003|Overall Study|Lost to Follow-up|1|||
44426626|NCT00430495|79434332|FG002|Overall Study|Lost to Follow-up|4|||
44426627|NCT00430495|79434333|FG003|Overall Study|Lost to Follow-up|0|||
44330264|NCT01193920|79335613|FG004|Overall Study|Lost to Follow-up|3|||
44330265|NCT01193920|79335614|FG005|Overall Study|Lost to Follow-up|3|||
44330266|NCT01193920|79335615|FG006|Overall Study|Lost to Follow-up|1|||
44330267|NCT01193920|79335616|FG007|Overall Study|Lost to Follow-up|0|||
44330268|NCT01193920|79335617|FG008|Overall Study|Lost to Follow-up|2|||
44330269|NCT01193920|79335618|FG009|Overall Study|Lost to Follow-up|3|||
44330270|NCT01193920|79335609|FG000|Overall Study|Protocol Violation|1|||
44330271|NCT01193920|79335610|FG001|Overall Study|Protocol Violation|0|||
44426628|NCT00430495|79434330|FG000|Overall Study|Protocol Violation|1|||
44426629|NCT00430495|79434331|FG001|Overall Study|Protocol Violation|0|||
44426630|NCT00430495|79434332|FG002|Overall Study|Protocol Violation|1|||
44426631|NCT00430495|79434333|FG003|Overall Study|Protocol Violation|0|||
44426632|NCT00430495|79434330|FG000|Overall Study|Disease Progression|1|||
44426633|NCT00430495|79434331|FG001|Overall Study|Disease Progression|1|||
44426634|NCT00430495|79434332|FG002|Overall Study|Disease Progression|0|||
44426635|NCT00430495|79434333|FG003|Overall Study|Disease Progression|0|||
44426636|NCT00430495|79434330|FG000|Overall Study|Other|8|||
44426637|NCT00430495|79434331|FG001|Overall Study|Other|2|||
44426638|NCT00430495|79434332|FG002|Overall Study|Other|5|||
44426639|NCT00430495|79434333|FG003|Overall Study|Other|4|||
44426640|NCT00430495|79434330|FG000|Overall Study|Randomized but not Treated|2|||
44426641|NCT00430495|79434331|FG001|Overall Study|Randomized but not Treated|0|||
44426642|NCT00430495|79434332|FG002|Overall Study|Randomized but not Treated|0|||
44426643|NCT00430495|79434333|FG003|Overall Study|Randomized but not Treated|0|||
44426644|NCT00425113|79434345|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
44426645|NCT00425113|79434346|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
44426646|NCT00425113|79434345|FG000|Overall Study|diagnosis of abdominal TB|0|||
44426647|NCT00425113|79434346|FG001|Overall Study|diagnosis of abdominal TB|1|||
44426648|NCT00425113|79434345|FG000|Overall Study|missing study drug more than 14 days|0|||
44426649|NCT00425113|79434346|FG001|Overall Study|missing study drug more than 14 days|1|||
44426650|NCT00425113|79434345|FG000|Overall Study|Withdrawal by Subject|1|||
44426651|NCT00425113|79434346|FG001|Overall Study|Withdrawal by Subject|0|||
44426652|NCT00440011|79434355|FG000|Overall Study|Adverse Event|2|||
44426653|NCT00440011|79434356|FG001|Overall Study|Adverse Event|0|||
44426654|NCT00440011|79434355|FG000|Overall Study|Lost to Follow-up|0|||
44426655|NCT00440011|79434356|FG001|Overall Study|Lost to Follow-up|2|||
44426656|NCT00440011|79434355|FG000|Overall Study|Protocol Violation|1|||
44426657|NCT00440011|79434356|FG001|Overall Study|Protocol Violation|1|||
44426658|NCT00440011|79434355|FG000|Overall Study|Withdrawal by Subject|1|||
44426659|NCT00440011|79434356|FG001|Overall Study|Withdrawal by Subject|0|||
44426660|NCT00663117|79434393|FG000|Overall Study|Lack of Efficacy|1|||
44426661|NCT00663117|79434394|FG001|Overall Study|Lack of Efficacy|0|||
44426662|NCT00570141|79434415|FG000|Overall Study|Adverse Event|1|||
44426663|NCT00570141|79434415|FG000|Overall Study|Missed visits|1|||
44426664|NCT00570141|79434415|FG000|Overall Study|Lost to Follow-up|1|||
44426665|NCT00579254|79434419|FG000|Overall Study|Lost to Follow-up|39|||
44426666|NCT00579254|79434419|FG000|Overall Study|Discontinued when study terminated|73|||
44426667|NCT00661089|79434425|FG000|Overall Study|1 subject withdrawal|0|||
44426668|NCT00661089|79434426|FG001|Overall Study|1 subject withdrawal|1|||
44426669|NCT00661089|79434425|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
44426670|NCT00661089|79434426|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
44426671|NCT00582426|79434439|FG000|Overall Study|Lost to Follow-up|0|||
44426672|NCT00582426|79434440|FG001|Overall Study|Lost to Follow-up|2|||
44426673|NCT00582426|79434439|FG000|Overall Study|Adverse Event|4|||
44426674|NCT00582426|79434440|FG001|Overall Study|Adverse Event|2|||
44426675|NCT00582426|79434439|FG000|Overall Study|Protocol Violation|6|||
44426676|NCT00582426|79434440|FG001|Overall Study|Protocol Violation|2|||
44426677|NCT00582426|79434439|FG000|Overall Study|Death|4|||
44426678|NCT00582426|79434440|FG001|Overall Study|Death|3|||
44426679|NCT00582426|79434439|FG000|Overall Study|Withdrawal by Subject|3|||
44426680|NCT00582426|79434440|FG001|Overall Study|Withdrawal by Subject|2|||
44426681|NCT00582426|79434439|FG000|Overall Study|Disease Progression|2|||
44426682|NCT00582426|79434440|FG001|Overall Study|Disease Progression|2|||
44426683|NCT00582426|79434439|FG000|Overall Study|Use of illicit drugs|1|||
44426684|NCT00582426|79434440|FG001|Overall Study|Use of illicit drugs|0|||
44330272|NCT01193920|79335611|FG002|Overall Study|Protocol Violation|0|||
44426685|NCT02387970|79434448|FG000|Overall Study|Did not complete 1-year follow up|1|||
44426686|NCT02387970|79434449|FG001|Overall Study|Did not complete 1-year follow up|2|||
44330273|NCT01193920|79335612|FG003|Overall Study|Protocol Violation|0|||
44330274|NCT01193920|79335613|FG004|Overall Study|Protocol Violation|0|||
44330275|NCT01193920|79335614|FG005|Overall Study|Protocol Violation|0|||
44426687|NCT00580034|79434455|FG000|Overall Study|Toxicity|10|||
44426688|NCT00580034|79434456|FG001|Overall Study|Toxicity|0|||
44426689|NCT00773513|79434462|FG000|Overall Study|Renal Transplant|254|||
44426690|NCT00773513|79434463|FG001|Overall Study|Renal Transplant|263|||
44426691|NCT00773513|79434462|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
44537513|NCT02492711|79548299|FG002|Overall Study|Death|0|||
44330276|NCT01193920|79335615|FG006|Overall Study|Protocol Violation|0|||
44426692|NCT00773513|79434463|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
44426693|NCT00773513|79434462|FG000|Overall Study|Withdrew Consent|68|||
44426694|NCT00773513|79434463|FG001|Overall Study|Withdrew Consent|69|||
44426695|NCT00773513|79434462|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
44426696|NCT00773513|79434463|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
44426697|NCT00773513|79434462|FG000|Overall Study|Failure to Return|22|||
44426698|NCT00773513|79434463|FG001|Overall Study|Failure to Return|8|||
44426699|NCT00773513|79434462|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44426700|NCT00773513|79434463|FG001|Overall Study|Insufficient Therapeutic Response|18|||
44426701|NCT00773513|79434462|FG000|Overall Study|Reason Not Specified|159|||
44426702|NCT00773513|79434463|FG001|Overall Study|Reason Not Specified|126|||
44426703|NCT00773513|79434462|FG000|Overall Study|Death|531|||
44426704|NCT00773513|79434463|FG001|Overall Study|Death|545|||
44426705|NCT00767039|79434471|FG000|Overall Study|Death|5|||
44426706|NCT00767039|79434472|FG001|Overall Study|Death|2|||
44426707|NCT00662649|79434482|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
44426708|NCT00662649|79434483|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
44426709|NCT00662649|79434484|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
44426710|NCT00662649|79434485|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
44426711|NCT00662649|79434486|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
44537514|NCT02492711|79548297|FG000|Overall Study|Withdrawal by Subject|10|||
44537515|NCT02492711|79548298|FG001|Overall Study|Withdrawal by Subject|16|||
44537516|NCT02492711|79548299|FG002|Overall Study|Withdrawal by Subject|5|||
44537517|NCT02492711|79548297|FG000|Overall Study|Physician Decision|10|||
44537518|NCT02492711|79548298|FG001|Overall Study|Physician Decision|6|||
44537519|NCT02492711|79548299|FG002|Overall Study|Physician Decision|4|||
44537520|NCT02492711|79548297|FG000|Overall Study|Lost to Follow-up|0|||
44537521|NCT02492711|79548298|FG001|Overall Study|Lost to Follow-up|0|||
44537522|NCT02492711|79548299|FG002|Overall Study|Lost to Follow-up|1|||
44537523|NCT02492711|79548297|FG000|Overall Study|study treatment delay|2|||
44330277|NCT01193920|79335616|FG007|Overall Study|Protocol Violation|0|||
44330278|NCT01193920|79335617|FG008|Overall Study|Protocol Violation|0|||
44330279|NCT01193920|79335618|FG009|Overall Study|Protocol Violation|0|||
44330280|NCT01193920|79335609|FG000|Overall Study|Death|0|||
44330281|NCT01193920|79335610|FG001|Overall Study|Death|0|||
44330282|NCT01193920|79335611|FG002|Overall Study|Death|0|||
44330283|NCT01193920|79335612|FG003|Overall Study|Death|1|||
44330284|NCT01193920|79335613|FG004|Overall Study|Death|0|||
44330285|NCT01193920|79335614|FG005|Overall Study|Death|0|||
44330286|NCT01193920|79335615|FG006|Overall Study|Death|2|||
44330287|NCT01193920|79335616|FG007|Overall Study|Death|3|||
44330288|NCT01193920|79335617|FG008|Overall Study|Death|2|||
44330289|NCT01193920|79335618|FG009|Overall Study|Death|4|||
44330290|NCT01193920|79335609|FG000|Overall Study|Unable to classify|0|||
44330291|NCT01193920|79335610|FG001|Overall Study|Unable to classify|0|||
44330292|NCT01193920|79335611|FG002|Overall Study|Unable to classify|0|||
44330293|NCT01193920|79335612|FG003|Overall Study|Unable to classify|1|||
44330294|NCT01193920|79335613|FG004|Overall Study|Unable to classify|0|||
44330295|NCT01193920|79335614|FG005|Overall Study|Unable to classify|0|||
44330296|NCT01193920|79335615|FG006|Overall Study|Unable to classify|0|||
44330297|NCT01193920|79335616|FG007|Overall Study|Unable to classify|1|||
44330298|NCT01193920|79335617|FG008|Overall Study|Unable to classify|0|||
44330299|NCT01193920|79335618|FG009|Overall Study|Unable to classify|0|||
44330300|NCT01193686|79335643|FG000|Overall Study|Withdrawal by Subject|4|||
44330301|NCT01193686|79335644|FG001|Overall Study|Withdrawal by Subject|1|||
44330302|NCT01193686|79335643|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
44330303|NCT01193686|79335644|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
44330304|NCT01193608|79335657|FG000|Overall Study|Other|0|||
44330305|NCT01193608|79335658|FG001|Overall Study|Other|1|||
44330306|NCT01193608|79335659|FG002|Overall Study|Other|0|||
44330307|NCT01193608|79335660|FG003|Overall Study|Other|0|||
44537524|NCT02492711|79548298|FG001|Overall Study|study treatment delay|1|||
44537525|NCT02492711|79548299|FG002|Overall Study|study treatment delay|0|||
44537526|NCT02492711|79548297|FG000|Overall Study|change in chemotherapy|0|||
44156953|NCT03238300|78948388|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
44330308|NCT01193608|79335661|FG004|Overall Study|Other|0|||
44330309|NCT01193608|79335662|FG005|Overall Study|Other|0|||
44330310|NCT01193608|79335657|FG000|Overall Study|Withdrawal by Subject|0|||
44330311|NCT01193608|79335658|FG001|Overall Study|Withdrawal by Subject|1|||
44330312|NCT01193608|79335659|FG002|Overall Study|Withdrawal by Subject|2|||
44330313|NCT01193608|79335660|FG003|Overall Study|Withdrawal by Subject|3|||
44330314|NCT01193608|79335661|FG004|Overall Study|Withdrawal by Subject|3|||
44330315|NCT01193608|79335662|FG005|Overall Study|Withdrawal by Subject|0|||
44330316|NCT01193608|79335657|FG000|Overall Study|Lost to Follow-up|0|||
44426712|NCT00662649|79434482|FG000|Core Study (24 Months)|Adverse Event|22|||
44426713|NCT00662649|79434483|FG001|Core Study (24 Months)|Adverse Event|13|||
44426714|NCT00662649|79434484|FG002|Core Study (24 Months)|Adverse Event|18|||
44426715|NCT00662649|79434485|FG003|Core Study (24 Months)|Adverse Event|0|||
44426716|NCT00662649|79434486|FG004|Core Study (24 Months)|Adverse Event|0|||
44426717|NCT00662649|79434482|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
44426718|NCT00662649|79434483|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
44426719|NCT00662649|79434484|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
44426720|NCT00662649|79434485|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
44426721|NCT00662649|79434486|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
44426722|NCT00662649|79434482|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
44426723|NCT00662649|79434483|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
44426724|NCT00662649|79434484|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
44426725|NCT00662649|79434485|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
44426726|NCT00662649|79434486|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
44426727|NCT00662649|79434482|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
44426728|NCT00662649|79434483|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
44426729|NCT00662649|79434484|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
44426730|NCT00662649|79434485|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
44426731|NCT00662649|79434486|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
44426732|NCT00662649|79434482|FG000|Core Study (24 Months)|Protocol Violation|5|||
44426733|NCT00662649|79434483|FG001|Core Study (24 Months)|Protocol Violation|5|||
44426734|NCT00662649|79434484|FG002|Core Study (24 Months)|Protocol Violation|4|||
44426735|NCT00662649|79434485|FG003|Core Study (24 Months)|Protocol Violation|0|||
44426736|NCT00662649|79434486|FG004|Core Study (24 Months)|Protocol Violation|0|||
44426737|NCT00662649|79434482|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
44426738|NCT00662649|79434483|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
44426739|NCT00662649|79434484|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
44426740|NCT00662649|79434485|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
44426741|NCT00662649|79434486|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
44426742|NCT00662649|79434482|FG000|Core Study (24 Months)|Death|1|||
44426743|NCT00662649|79434483|FG001|Core Study (24 Months)|Death|0|||
44426744|NCT00662649|79434484|FG002|Core Study (24 Months)|Death|2|||
44426745|NCT00662649|79434485|FG003|Core Study (24 Months)|Death|0|||
44426746|NCT00662649|79434486|FG004|Core Study (24 Months)|Death|0|||
44426747|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
44426748|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
44426749|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
44426750|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
44426751|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
44426752|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
44426753|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
44426754|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
44426755|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
44426756|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
44426757|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
44426758|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
44426759|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
44426760|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
44426761|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
44426762|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
44426763|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
44426764|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
44426765|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
44426766|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
44426767|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
44426768|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
44426769|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
44426770|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
44426771|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
44426772|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
44426773|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
44426774|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
44426775|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
44426776|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
44426777|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
44426778|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
44426779|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
44426780|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
44330317|NCT01193608|79335658|FG001|Overall Study|Lost to Follow-up|0|||
44426781|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
44426782|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
44426783|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
44426784|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
44426785|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
44426786|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
44426787|NCT00662649|79434482|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
44426788|NCT00662649|79434483|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
44426789|NCT00662649|79434484|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
44426790|NCT00662649|79434485|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
44426791|NCT00662649|79434486|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
44426792|NCT00766493|79434500|FG000|30 Days Post-Procedure|Discontinued|7|||
44426793|NCT00766493|79434500|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
44426794|NCT00766493|79434500|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
44330318|NCT01193608|79335659|FG002|Overall Study|Lost to Follow-up|0|||
44330319|NCT01193608|79335660|FG003|Overall Study|Lost to Follow-up|0|||
44330320|NCT01193608|79335661|FG004|Overall Study|Lost to Follow-up|1|||
44426795|NCT03070392|79434506|FG000|Overall Study|Not Treated|7|||
44426796|NCT03070392|79434507|FG001|Overall Study|Not Treated|0|||
44426797|NCT03070392|79434508|FG002|Overall Study|Not Treated|3|||
44426798|NCT03070392|79434509|FG003|Overall Study|Not Treated|12|||
44426799|NCT03070392|79434506|FG000|Overall Study|Death|3|||
44426800|NCT03070392|79434507|FG001|Overall Study|Death|0|||
44426801|NCT03070392|79434508|FG002|Overall Study|Death|0|||
44426802|NCT03070392|79434509|FG003|Overall Study|Death|1|||
44426803|NCT03070392|79434506|FG000|Overall Study|Withdrawal by Subject|7|||
44426804|NCT03070392|79434507|FG001|Overall Study|Withdrawal by Subject|0|||
44426805|NCT03070392|79434508|FG002|Overall Study|Withdrawal by Subject|0|||
44426806|NCT03070392|79434509|FG003|Overall Study|Withdrawal by Subject|3|||
44426807|NCT03070392|79434506|FG000|Overall Study|Physician Decision|1|||
44426808|NCT03070392|79434507|FG001|Overall Study|Physician Decision|0|||
44426809|NCT03070392|79434508|FG002|Overall Study|Physician Decision|0|||
44426810|NCT03070392|79434509|FG003|Overall Study|Physician Decision|2|||
44426811|NCT03070392|79434506|FG000|Overall Study|Progressive Disease|154|||
44426812|NCT03070392|79434507|FG001|Overall Study|Progressive Disease|6|||
44330321|NCT01193608|79335662|FG005|Overall Study|Lost to Follow-up|2|||
44330322|NCT01193608|79335657|FG000|Overall Study|Adverse Event|0|||
44330323|NCT01193608|79335658|FG001|Overall Study|Adverse Event|0|||
44330324|NCT01193608|79335659|FG002|Overall Study|Adverse Event|0|||
44330325|NCT01193608|79335660|FG003|Overall Study|Adverse Event|0|||
44330326|NCT01193608|79335661|FG004|Overall Study|Adverse Event|1|||
44330327|NCT01193608|79335662|FG005|Overall Study|Adverse Event|0|||
44330328|NCT01177228|79335685|FG000|Overall Study|Positive tuberculosis test|0|||
44330329|NCT01177228|79335686|FG001|Overall Study|Positive tuberculosis test|1|||
44330330|NCT01177228|79335687|FG002|Overall Study|Positive tuberculosis test|0|||
44330331|NCT01177228|79335688|FG003|Overall Study|Positive tuberculosis test|0|||
44330332|NCT01177228|79335685|FG000|Overall Study|Worsening disease activity|1|||
44330333|NCT01177228|79335686|FG001|Overall Study|Worsening disease activity|0|||
44330334|NCT01177228|79335687|FG002|Overall Study|Worsening disease activity|0|||
44330335|NCT01177228|79335688|FG003|Overall Study|Worsening disease activity|0|||
44330336|NCT01177228|79335685|FG000|Overall Study|Withdrawal by Subject|0|||
44330337|NCT01177228|79335686|FG001|Overall Study|Withdrawal by Subject|1|||
44330338|NCT01177228|79335687|FG002|Overall Study|Withdrawal by Subject|0|||
44330339|NCT01177228|79335688|FG003|Overall Study|Withdrawal by Subject|0|||
44330340|NCT01193530|79335705|FG000|Overall Study|Withdrawal by Subject|2|||
44330341|NCT01193530|79335706|FG001|Overall Study|Withdrawal by Subject|2|||
44426813|NCT03070392|79434508|FG002|Overall Study|Progressive Disease|2|||
44426814|NCT03070392|79434509|FG003|Overall Study|Progressive Disease|70|||
44426815|NCT03070392|79434506|FG000|Overall Study|Adverse Event|6|||
44426816|NCT03070392|79434507|FG001|Overall Study|Adverse Event|1|||
44537527|NCT02492711|79548298|FG001|Overall Study|change in chemotherapy|1|||
44330342|NCT01193530|79335705|FG000|Overall Study|Began Contraindicated Therapy|1|||
44330343|NCT01193530|79335706|FG001|Overall Study|Began Contraindicated Therapy|0|||
44330344|NCT01193530|79335705|FG000|Overall Study|Lost Light Box|0|||
44426817|NCT03070392|79434508|FG002|Overall Study|Adverse Event|1|||
44426818|NCT03070392|79434509|FG003|Overall Study|Adverse Event|3|||
44426819|NCT03070392|79434506|FG000|Overall Study|Alternate anticancer treatment|1|||
44426820|NCT03070392|79434507|FG001|Overall Study|Alternate anticancer treatment|0|||
44426821|NCT03070392|79434508|FG002|Overall Study|Alternate anticancer treatment|0|||
44330345|NCT01193530|79335706|FG001|Overall Study|Lost Light Box|1|||
44330346|NCT01193530|79335705|FG000|Overall Study|Returned home - out of state|0|||
44330347|NCT01193530|79335706|FG001|Overall Study|Returned home - out of state|1|||
44426822|NCT03070392|79434509|FG003|Overall Study|Alternate anticancer treatment|1|||
44426823|NCT03070392|79434506|FG000|Overall Study|Ongoing|73|||
44426824|NCT03070392|79434507|FG001|Overall Study|Ongoing|0|||
44426825|NCT03070392|79434508|FG002|Overall Study|Ongoing|0|||
44426826|NCT03070392|79434509|FG003|Overall Study|Ongoing|11|||
44426827|NCT00784043|79434517|FG000|Overall Study|Withdrawal by Subject|8|||
44426828|NCT00784043|79434518|FG001|Overall Study|Withdrawal by Subject|5|||
44426829|NCT00784043|79434517|FG000|Overall Study|Protocol Terminated|23|||
44426830|NCT00784043|79434518|FG001|Overall Study|Protocol Terminated|1|||
44426831|NCT00773279|79434524|FG000|Period 1|Adverse Event|2|||
44426832|NCT00773279|79434525|FG001|Period 1|Adverse Event|1|||
44426833|NCT00773279|79434524|FG000|Period 1|Lack of Efficacy|0|||
44426834|NCT00773279|79434525|FG001|Period 1|Lack of Efficacy|2|||
44426835|NCT00773279|79434524|FG000|Period 1|Unclassified|5|||
44330348|NCT01193530|79335705|FG000|Overall Study|Non-Compliance|0|||
44330349|NCT01193530|79335706|FG001|Overall Study|Non-Compliance|1|||
44330350|NCT00107172|79335714|FG000|Overall Study|Withdrawal by Subject|1|||
44330351|NCT00107172|79335715|FG001|Overall Study|Withdrawal by Subject|0|||
44330352|NCT00107172|79335714|FG000|Overall Study|Death|0|||
44330353|NCT00107172|79335715|FG001|Overall Study|Death|2|||
44330354|NCT00107172|79335714|FG000|Overall Study|Other Reason|4|||
44330355|NCT00107172|79335715|FG001|Overall Study|Other Reason|3|||
44330356|NCT01680965|79335729|FG000|Overall Study|Death|0|||
44330357|NCT01680965|79335730|FG001|Overall Study|Death|0|||
44330358|NCT01680965|79335731|FG002|Overall Study|Death|0|||
44330359|NCT01680965|79335732|FG003|Overall Study|Death|6|||
44330360|NCT01339923|79335747|FG000|Overall Study|Adverse Event|1|||
44330361|NCT01339923|79335748|FG001|Overall Study|Adverse Event|1|||
44330362|NCT01339923|79335749|FG002|Overall Study|Adverse Event|1|||
44330363|NCT01339923|79335750|FG003|Overall Study|Adverse Event|0|||
44330364|NCT01339923|79335751|FG004|Overall Study|Adverse Event|0|||
44330365|NCT01339923|79335752|FG005|Overall Study|Adverse Event|0|||
44330366|NCT01339923|79335753|FG006|Overall Study|Adverse Event|1|||
44330367|NCT01339923|79335747|FG000|Overall Study|Inappropriate Enrollment|1|||
44330368|NCT01339923|79335748|FG001|Overall Study|Inappropriate Enrollment|0|||
44330369|NCT01339923|79335749|FG002|Overall Study|Inappropriate Enrollment|0|||
44330370|NCT01339923|79335750|FG003|Overall Study|Inappropriate Enrollment|0|||
44330371|NCT01339923|79335751|FG004|Overall Study|Inappropriate Enrollment|0|||
44330372|NCT01339923|79335752|FG005|Overall Study|Inappropriate Enrollment|1|||
44330373|NCT01339923|79335753|FG006|Overall Study|Inappropriate Enrollment|0|||
44330374|NCT01339923|79335747|FG000|Overall Study|Lost to Follow-up|4|||
44330375|NCT01339923|79335748|FG001|Overall Study|Lost to Follow-up|4|||
44330376|NCT01339923|79335749|FG002|Overall Study|Lost to Follow-up|0|||
44330377|NCT01339923|79335750|FG003|Overall Study|Lost to Follow-up|3|||
44330378|NCT01339923|79335751|FG004|Overall Study|Lost to Follow-up|1|||
44330379|NCT01339923|79335752|FG005|Overall Study|Lost to Follow-up|1|||
44330380|NCT01339923|79335753|FG006|Overall Study|Lost to Follow-up|5|||
44330381|NCT01339923|79335747|FG000|Overall Study|Protocol Violation|0|||
44330382|NCT01339923|79335748|FG001|Overall Study|Protocol Violation|0|||
44330383|NCT01339923|79335749|FG002|Overall Study|Protocol Violation|0|||
44330384|NCT01339923|79335750|FG003|Overall Study|Protocol Violation|0|||
44330385|NCT01339923|79335751|FG004|Overall Study|Protocol Violation|0|||
44330386|NCT01339923|79335752|FG005|Overall Study|Protocol Violation|3|||
44330387|NCT01339923|79335753|FG006|Overall Study|Protocol Violation|1|||
44330388|NCT01339923|79335747|FG000|Overall Study|Unable to Classify|1|||
44330389|NCT01339923|79335748|FG001|Overall Study|Unable to Classify|0|||
44330390|NCT01339923|79335749|FG002|Overall Study|Unable to Classify|1|||
44330391|NCT01339923|79335750|FG003|Overall Study|Unable to Classify|0|||
44330392|NCT01339923|79335751|FG004|Overall Study|Unable to Classify|0|||
44330393|NCT01339923|79335752|FG005|Overall Study|Unable to Classify|1|||
44330394|NCT01339923|79335753|FG006|Overall Study|Unable to Classify|5|||
44330395|NCT01339923|79335747|FG000|Overall Study|Withdrawal by Subject|7|||
44330396|NCT01339923|79335748|FG001|Overall Study|Withdrawal by Subject|11|||
44330397|NCT01339923|79335749|FG002|Overall Study|Withdrawal by Subject|6|||
44330398|NCT01339923|79335750|FG003|Overall Study|Withdrawal by Subject|1|||
44330399|NCT01339923|79335751|FG004|Overall Study|Withdrawal by Subject|4|||
44330400|NCT01339923|79335752|FG005|Overall Study|Withdrawal by Subject|3|||
44330401|NCT01339923|79335753|FG006|Overall Study|Withdrawal by Subject|2|||
44330402|NCT01380093|79335786|FG000|Naloxone Challenge Phase|Screen failures|21|||
44330403|NCT01380093|79335787|FG001|Naloxone Challenge Phase|Screen failures|0|||
44330404|NCT01380093|79335788|FG002|Naloxone Challenge Phase|Screen failures|0|||
44330405|NCT01380093|79335789|FG003|Naloxone Challenge Phase|Screen failures|0|||
44330406|NCT01380093|79335790|FG004|Naloxone Challenge Phase|Screen failures|0|||
44330407|NCT01380093|79335791|FG005|Naloxone Challenge Phase|Screen failures|0|||
44330408|NCT01380093|79335792|FG006|Naloxone Challenge Phase|Screen failures|0|||
44330409|NCT01380093|79335793|FG007|Naloxone Challenge Phase|Screen failures|0|||
44330410|NCT01380093|79335794|FG008|Naloxone Challenge Phase|Screen failures|0|||
44426836|NCT00773279|79434525|FG001|Period 1|Unclassified|1|||
44426837|NCT00773279|79434524|FG000|Period 2|Adverse Event|0|||
44426838|NCT00773279|79434525|FG001|Period 2|Adverse Event|1|||
44426839|NCT00773279|79434524|FG000|Period 2|Lack of Efficacy|1|||
44426840|NCT00773279|79434525|FG001|Period 2|Lack of Efficacy|0|||
44426841|NCT00773279|79434524|FG000|Period 2|Protocol Violation|0|||
44426842|NCT00773279|79434525|FG001|Period 2|Protocol Violation|3|||
44426843|NCT00773279|79434524|FG000|Period 2|Unclassified|2|||
44426844|NCT00773279|79434525|FG001|Period 2|Unclassified|2|||
44426845|NCT00766415|79434534|FG000|Overall Study|Withdrawal by Subject|0|||
44426846|NCT00766415|79434535|FG001|Overall Study|Withdrawal by Subject|1|||
44426847|NCT00772967|79434541|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
44426848|NCT00772967|79434542|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
44426849|NCT00772967|79434543|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
44426850|NCT00772967|79434544|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
44426851|NCT00772967|79434545|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
44426852|NCT00772967|79434546|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
44426853|NCT00772967|79434541|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
44426854|NCT00772967|79434542|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
44426855|NCT00772967|79434543|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
44426856|NCT00772967|79434544|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
44426857|NCT00772967|79434545|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
44426858|NCT00772967|79434546|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
44426859|NCT00772967|79434541|FG000|Crossover Treatment 3|Adverse Event|0|||
44426860|NCT00772967|79434542|FG001|Crossover Treatment 3|Adverse Event|0|||
44426861|NCT00772967|79434543|FG002|Crossover Treatment 3|Adverse Event|0|||
44426862|NCT00772967|79434544|FG003|Crossover Treatment 3|Adverse Event|0|||
44426863|NCT00772967|79434545|FG004|Crossover Treatment 3|Adverse Event|1|||
44426864|NCT00772967|79434546|FG005|Crossover Treatment 3|Adverse Event|0|||
44426865|NCT00662259|79434569|FG000|Overall Study|Adverse Event|2|||
44426866|NCT00662259|79434570|FG001|Overall Study|Adverse Event|0|||
44426867|NCT00660699|79434576|FG000|Overall Study|Withdrawal by Subject|2|||
44426868|NCT00582114|79434582|FG000|Overall Study|Death|4|||
44426869|NCT00582114|79434583|FG001|Overall Study|Death|4|||
44426870|NCT00582114|79434582|FG000|Overall Study|Kidney Transplant|3|||
44426871|NCT00582114|79434583|FG001|Overall Study|Kidney Transplant|1|||
44426872|NCT00582114|79434582|FG000|Overall Study|Lost to Follow-up|7|||
44426873|NCT00582114|79434583|FG001|Overall Study|Lost to Follow-up|6|||
44426874|NCT00582114|79434582|FG000|Overall Study|Withdrawal by Subject|8|||
44426875|NCT00582114|79434583|FG001|Overall Study|Withdrawal by Subject|16|||
44426876|NCT00582114|79434582|FG000|Overall Study|Adverse Event|1|||
44426877|NCT00582114|79434583|FG001|Overall Study|Adverse Event|1|||
44426878|NCT00582114|79434582|FG000|Overall Study|Physician Decision|0|||
44330411|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330412|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
44330413|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330414|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330415|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330416|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330417|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330418|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330419|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
44330420|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44330421|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
44330422|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
44330423|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44330424|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44330425|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44330426|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44426879|NCT00582114|79434583|FG001|Overall Study|Physician Decision|6|||
44330427|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44330428|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
44330429|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330430|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
44330431|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330432|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330433|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330434|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330435|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330436|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44426880|NCT00582114|79434582|FG000|Overall Study|Stopped by data safety monitoring board|19|||
44426881|NCT00582114|79434583|FG001|Overall Study|Stopped by data safety monitoring board|20|||
44426882|NCT00582036|79434591|FG000|Overall Study|Withdrawal by Subject|0|||
44426883|NCT00582036|79434592|FG001|Overall Study|Withdrawal by Subject|1|||
44426884|NCT00581360|79434598|FG000|Overall Study|Withdrawal by Subject|1|||
44426885|NCT00660387|79434604|FG000|Overall Study|Adverse Event|1|||
44426886|NCT00660387|79434605|FG001|Overall Study|Adverse Event|2|||
44426887|NCT00660387|79434604|FG000|Overall Study|Lack of Efficacy|0|||
44426888|NCT00660387|79434605|FG001|Overall Study|Lack of Efficacy|1|||
44426889|NCT00660387|79434604|FG000|Overall Study|Protocol Violation|1|||
44330437|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
44330438|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44330439|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
44330440|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
44330441|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44330442|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44330443|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44330444|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44330445|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44426890|NCT00660387|79434605|FG001|Overall Study|Protocol Violation|0|||
44426891|NCT00582738|79434613|FG000|Overall Study|Administrative Problems|7|||
44426892|NCT00582738|79434614|FG001|Overall Study|Administrative Problems|8|||
44426893|NCT00582738|79434613|FG000|Overall Study|Adverse Event|0|||
44426894|NCT00582738|79434614|FG001|Overall Study|Adverse Event|5|||
44426895|NCT00582738|79434613|FG000|Overall Study|Graft Lost|0|||
44426896|NCT00582738|79434614|FG001|Overall Study|Graft Lost|1|||
44426897|NCT00582738|79434613|FG000|Overall Study|Other|1|||
44426898|NCT00582738|79434614|FG001|Overall Study|Other|0|||
44426899|NCT00582738|79434613|FG000|Overall Study|Protocol Violation|1|||
44330446|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
44330447|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330448|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
44330449|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
44330450|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330451|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330452|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330453|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330454|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330455|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
44330456|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330457|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330458|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
44330459|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
44426900|NCT00582738|79434614|FG001|Overall Study|Protocol Violation|1|||
44426901|NCT00582738|79434613|FG000|Overall Study|Withdrawal by Subject|0|||
44426902|NCT00582738|79434614|FG001|Overall Study|Withdrawal by Subject|3|||
44426903|NCT00772889|79434629|FG000|Overall Study|Adverse Event|7|||
44426904|NCT00772889|79434630|FG001|Overall Study|Adverse Event|4|||
44426905|NCT00772889|79434631|FG002|Overall Study|Adverse Event|0|||
44426906|NCT00772889|79434629|FG000|Overall Study|Withdrawal by Subject|9|||
44426907|NCT00772889|79434630|FG001|Overall Study|Withdrawal by Subject|8|||
44426908|NCT00772889|79434631|FG002|Overall Study|Withdrawal by Subject|9|||
44426909|NCT00772889|79434629|FG000|Overall Study|Lost to Follow-up|6|||
44426910|NCT00772889|79434630|FG001|Overall Study|Lost to Follow-up|6|||
44330460|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330461|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330462|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330463|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330464|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
44330465|NCT01380093|79335786|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330466|NCT01380093|79335787|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330467|NCT01380093|79335788|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
44330468|NCT01380093|79335789|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330469|NCT01380093|79335790|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330470|NCT01380093|79335791|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330471|NCT01380093|79335792|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330472|NCT01380093|79335793|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330473|NCT01380093|79335794|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
44330474|NCT01380093|79335786|FG000|Treatment Phase: Second Intervention|Other|0|||
44330475|NCT01380093|79335787|FG001|Treatment Phase: Second Intervention|Other|0|||
44426911|NCT00772889|79434631|FG002|Overall Study|Lost to Follow-up|7|||
44426912|NCT01247324|79434641|FG000|Overall Study|Death|1|||
44426913|NCT01247324|79434642|FG001|Overall Study|Death|0|||
44426914|NCT01247324|79434641|FG000|Overall Study|Physician Decision|0|||
44426915|NCT01247324|79434642|FG001|Overall Study|Physician Decision|1|||
44426916|NCT01247324|79434641|FG000|Overall Study|Non-compliance with study drug|3|||
44426917|NCT01247324|79434642|FG001|Overall Study|Non-compliance with study drug|0|||
44426918|NCT01247324|79434641|FG000|Overall Study|Lack of Efficacy|12|||
44426919|NCT01247324|79434642|FG001|Overall Study|Lack of Efficacy|8|||
44426920|NCT01247324|79434641|FG000|Overall Study|Non-compliance|2|||
44426921|NCT01247324|79434642|FG001|Overall Study|Non-compliance|0|||
44426922|NCT01247324|79434641|FG000|Overall Study|Pregnancy|2|||
44426923|NCT01247324|79434642|FG001|Overall Study|Pregnancy|3|||
44426924|NCT01247324|79434641|FG000|Overall Study|Protocol Violation|1|||
44426925|NCT01247324|79434642|FG001|Overall Study|Protocol Violation|2|||
44426926|NCT01247324|79434641|FG000|Overall Study|Reason not specified|11|||
44426927|NCT01247324|79434642|FG001|Overall Study|Reason not specified|8|||
44426928|NCT01247324|79434641|FG000|Overall Study|Consent withdrawn by participant|13|||
44426929|NCT01247324|79434642|FG001|Overall Study|Consent withdrawn by participant|8|||
44426930|NCT01247324|79434641|FG000|Overall Study|Adverse Event|25|||
44426931|NCT01247324|79434642|FG001|Overall Study|Adverse Event|13|||
44426932|NCT01247324|79434641|FG000|Overall Study|Lost to Follow-up|1|||
44426933|NCT01247324|79434642|FG001|Overall Study|Lost to Follow-up|1|||
44537528|NCT02492711|79548299|FG002|Overall Study|change in chemotherapy|0|||
44537529|NCT02492711|79548297|FG000|Overall Study|never treated|2|||
44537530|NCT02492711|79548298|FG001|Overall Study|never treated|4|||
44537531|NCT02492711|79548299|FG002|Overall Study|never treated|0|||
44156954|NCT03238300|78948387|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
44330476|NCT01380093|79335788|FG002|Treatment Phase: Second Intervention|Other|0|||
44330477|NCT01380093|79335789|FG003|Treatment Phase: Second Intervention|Other|1|||
44330478|NCT01380093|79335790|FG004|Treatment Phase: Second Intervention|Other|0|||
44330479|NCT01380093|79335791|FG005|Treatment Phase: Second Intervention|Other|0|||
44330480|NCT01380093|79335792|FG006|Treatment Phase: Second Intervention|Other|0|||
44330481|NCT01380093|79335793|FG007|Treatment Phase: Second Intervention|Other|0|||
44330482|NCT01380093|79335794|FG008|Treatment Phase: Second Intervention|Other|0|||
44330483|NCT01380093|79335786|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
44330484|NCT01380093|79335787|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
44330485|NCT01380093|79335788|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
44330486|NCT01380093|79335789|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
44330487|NCT01380093|79335790|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
44330488|NCT01380093|79335791|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
44330489|NCT01380093|79335792|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
44330490|NCT01380093|79335793|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
44330491|NCT01380093|79335794|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
44330492|NCT01380093|79335786|FG000|Treatment Phase: Third Intervention|Other|0|||
44330493|NCT01380093|79335787|FG001|Treatment Phase: Third Intervention|Other|0|||
44330494|NCT01380093|79335788|FG002|Treatment Phase: Third Intervention|Other|0|||
44330495|NCT01380093|79335789|FG003|Treatment Phase: Third Intervention|Other|0|||
44330496|NCT01380093|79335790|FG004|Treatment Phase: Third Intervention|Other|0|||
44330497|NCT01380093|79335791|FG005|Treatment Phase: Third Intervention|Other|0|||
44330498|NCT01380093|79335792|FG006|Treatment Phase: Third Intervention|Other|0|||
44330499|NCT01380093|79335793|FG007|Treatment Phase: Third Intervention|Other|0|||
44330500|NCT01380093|79335794|FG008|Treatment Phase: Third Intervention|Other|1|||
44330501|NCT01379937|79335812|FG000|Overall Study|Protocol Violation|0|||
44330502|NCT01379937|79335813|FG001|Overall Study|Protocol Violation|0|||
44330503|NCT01379937|79335814|FG002|Overall Study|Protocol Violation|0|||
44330504|NCT01379937|79335815|FG003|Overall Study|Protocol Violation|1|||
44330505|NCT01379937|79335812|FG000|Overall Study|Consent withdrawal|0|||
44330506|NCT01379937|79335813|FG001|Overall Study|Consent withdrawal|1|||
44330507|NCT01379937|79335814|FG002|Overall Study|Consent withdrawal|0|||
44330508|NCT01379937|79335815|FG003|Overall Study|Consent withdrawal|0|||
44330509|NCT01379937|79335812|FG000|Overall Study|Lost to Follow-up|1|||
44330510|NCT01379937|79335813|FG001|Overall Study|Lost to Follow-up|2|||
44330511|NCT01379937|79335814|FG002|Overall Study|Lost to Follow-up|2|||
44330512|NCT01379937|79335815|FG003|Overall Study|Lost to Follow-up|0|||
44330513|NCT01379781|79335841|FG000|Overall Study|Lost to Follow-up|11|||
44330514|NCT01379781|79335842|FG001|Overall Study|Lost to Follow-up|8|||
44330515|NCT01379703|79335848|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
44330516|NCT01379703|79335849|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
44330517|NCT01379703|79335850|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
44330518|NCT01379703|79335848|FG000|Study Start Through 9 Months|Adverse Event|0|||
44330519|NCT01379703|79335849|FG001|Study Start Through 9 Months|Adverse Event|14|||
44330520|NCT01379703|79335850|FG002|Study Start Through 9 Months|Adverse Event|10|||
44330521|NCT01379703|79335848|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
44330522|NCT01379703|79335849|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
44330523|NCT01379703|79335850|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
44330524|NCT01379703|79335848|FG000|Study Start Through 9 Months|Treatment Failure|0|||
44330525|NCT01379703|79335849|FG001|Study Start Through 9 Months|Treatment Failure|2|||
44330526|NCT01379703|79335850|FG002|Study Start Through 9 Months|Treatment Failure|2|||
44330527|NCT01379703|79335848|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
44426934|NCT00772577|79434651|FG000|Overall Study|Adverse Event|6|||
44426935|NCT00772577|79434652|FG001|Overall Study|Adverse Event|3|||
44426936|NCT00772577|79434651|FG000|Overall Study|Abnormal laboratory values|0|||
44426937|NCT00772577|79434652|FG001|Overall Study|Abnormal laboratory values|1|||
44426938|NCT00772577|79434651|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44426939|NCT00772577|79434652|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
44426940|NCT00772577|79434651|FG000|Overall Study|Patient withdrew consent|8|||
44426941|NCT00772577|79434652|FG001|Overall Study|Patient withdrew consent|5|||
44426942|NCT00772577|79434651|FG000|Overall Study|Lost to Follow-up|4|||
44426943|NCT00772577|79434652|FG001|Overall Study|Lost to Follow-up|3|||
44426944|NCT00772577|79434651|FG000|Overall Study|Administrative problems|2|||
44426945|NCT00772577|79434652|FG001|Overall Study|Administrative problems|1|||
44426946|NCT00772577|79434651|FG000|Overall Study|Protocol Deviation|3|||
44426947|NCT00772577|79434652|FG001|Overall Study|Protocol Deviation|2|||
44426948|NCT02345850|79434661|FG000|Overall Study|Not transplanted|10|||
44426949|NCT02345850|79434662|FG001|Overall Study|Not transplanted|5|||
44426950|NCT02345850|79434663|FG002|Overall Study|Not transplanted|4|||
44426951|NCT02345850|79434661|FG000|Overall Study|Lost to Follow-up|2|||
44330528|NCT01379703|79335849|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
44330529|NCT01379703|79335850|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
44330530|NCT01379703|79335848|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
44426952|NCT02345850|79434662|FG001|Overall Study|Lost to Follow-up|3|||
44426953|NCT02345850|79434663|FG002|Overall Study|Lost to Follow-up|2|||
44426954|NCT02345850|79434661|FG000|Overall Study|Withdrawal by Subject|1|||
44426955|NCT02345850|79434662|FG001|Overall Study|Withdrawal by Subject|0|||
44330531|NCT01379703|79335849|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
44330532|NCT01379703|79335850|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
44330533|NCT01379703|79335848|FG000|Study Start Through 9 Months|Medication not available|0|||
44330534|NCT01379703|79335849|FG001|Study Start Through 9 Months|Medication not available|2|||
44330535|NCT01379703|79335850|FG002|Study Start Through 9 Months|Medication not available|1|||
44330536|NCT01379703|79335848|FG000|Study Start Through 9 Months|Poor general condition|0|||
44330537|NCT01379703|79335849|FG001|Study Start Through 9 Months|Poor general condition|1|||
44330538|NCT01379703|79335850|FG002|Study Start Through 9 Months|Poor general condition|0|||
44330539|NCT01379703|79335848|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
44330540|NCT01379703|79335849|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
44330541|NCT01379703|79335850|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
44330542|NCT01379703|79335848|FG000|Study Start Through 9 Months|Reason unknown|2|||
44330543|NCT01379703|79335849|FG001|Study Start Through 9 Months|Reason unknown|31|||
44330544|NCT01379703|79335850|FG002|Study Start Through 9 Months|Reason unknown|24|||
44426956|NCT02345850|79434663|FG002|Overall Study|Withdrawal by Subject|0|||
44426957|NCT00659607|79434671|FG000|Overall Study|No blood pressure recorded|147|||
44330545|NCT01379703|79335848|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
44330546|NCT01379703|79335849|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
44330547|NCT01379703|79335850|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
44330548|NCT01379703|79335848|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
44330549|NCT01379703|79335849|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
44330550|NCT01379703|79335850|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
44426958|NCT00659607|79434671|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
44426959|NCT00659607|79434671|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
44426960|NCT00659607|79434671|FG000|Overall Study|No recorded efficacy data|15|||
44426961|NCT00659607|79434671|FG000|Overall Study|Inconsistent BP measuring date|2|||
44426962|NCT02848092|79434679|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
44426963|NCT02848092|79434680|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
44426964|NCT02848092|79434679|FG000|1-month Post-training Follow-up|Adverse Event|2|||
44426965|NCT02848092|79434680|FG001|1-month Post-training Follow-up|Adverse Event|1|||
44426966|NCT02848092|79434679|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
44426967|NCT02848092|79434680|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
44426968|NCT02848092|79434679|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
44426969|NCT02848092|79434680|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
44426970|NCT02848092|79434679|FG000|1-month Post-training Follow-up|fatigue|0|||
44330551|NCT01379703|79335848|FG000|9 Months Through 18 Months|Adverse Event|0|||
44330552|NCT01379703|79335849|FG001|9 Months Through 18 Months|Adverse Event|6|||
44537532|NCT02492711|79548297|FG000|Overall Study|Other|0|||
44537533|NCT02492711|79548298|FG001|Overall Study|Other|0|||
44537534|NCT02492711|79548299|FG002|Overall Study|Other|1|||
44330553|NCT01379703|79335850|FG002|9 Months Through 18 Months|Adverse Event|0|||
44537535|NCT01147822|79548314|FG000|Overall Study|Death|66|||
44537536|NCT01147822|79548315|FG001|Overall Study|Death|59|||
44330554|NCT01379703|79335848|FG000|9 Months Through 18 Months|Treatment failure|0|||
44426971|NCT02848092|79434680|FG001|1-month Post-training Follow-up|fatigue|1|||
44426972|NCT02848092|79434679|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
44426973|NCT02848092|79434680|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
44426974|NCT02848092|79434679|FG000|6-month Post-training Follow-up|Adverse Event|1|||
44537537|NCT01147822|79548314|FG000|Overall Study|Protocol Violation|0|||
44426975|NCT02848092|79434680|FG001|6-month Post-training Follow-up|Adverse Event|1|||
44426976|NCT02848092|79434679|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
44426977|NCT02848092|79434680|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
44426978|NCT02848092|79434679|FG000|6-month Post-training Follow-up|frustrated with task|1|||
44426979|NCT02848092|79434680|FG001|6-month Post-training Follow-up|frustrated with task|0|||
44426980|NCT02848092|79434679|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
44426981|NCT02848092|79434680|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
44426982|NCT02848092|79434679|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
44426983|NCT02848092|79434680|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
44426984|NCT00660309|79434688|FG000|Overall Study|Adverse Event|2|||
44426985|NCT00660309|79434689|FG001|Overall Study|Adverse Event|0|||
44426986|NCT00660309|79434688|FG000|Overall Study|Withdrawal by Subject|0|||
44426987|NCT00660309|79434689|FG001|Overall Study|Withdrawal by Subject|3|||
44426988|NCT00581100|79434698|FG000|Overall Study|Death|1|||
44426989|NCT00581100|79434699|FG001|Overall Study|Death|0|||
44426990|NCT00581100|79434698|FG000|Overall Study|Adverse Event|2|||
44426991|NCT00581100|79434699|FG001|Overall Study|Adverse Event|1|||
44426992|NCT00581100|79434698|FG000|Overall Study|Withdrawal by Subject|1|||
44426993|NCT00581100|79434699|FG001|Overall Study|Withdrawal by Subject|4|||
44426994|NCT00581100|79434698|FG000|Overall Study|Other|3|||
44426995|NCT00581100|79434699|FG001|Overall Study|Other|0|||
44426996|NCT00579098|79434707|FG000|Overall Study|Lost to Follow-up|2|||
44426997|NCT00579098|79434708|FG001|Overall Study|Lost to Follow-up|0|||
44426998|NCT00579098|79434707|FG000|Overall Study|Adverse Event|2|||
44426999|NCT00579098|79434708|FG001|Overall Study|Adverse Event|3|||
44427000|NCT00579098|79434707|FG000|Overall Study|Withdrawal by Subject|2|||
44427001|NCT00579098|79434708|FG001|Overall Study|Withdrawal by Subject|3|||
44427002|NCT00579098|79434707|FG000|Overall Study|AF returned after ablation|3|||
44427003|NCT00579098|79434708|FG001|Overall Study|AF returned after ablation|2|||
44427004|NCT00772109|79434718|FG000|Overall Study|Serious adverse event|1|||
44427005|NCT00772109|79434719|FG001|Overall Study|Serious adverse event|0|||
44427006|NCT00772109|79434720|FG002|Overall Study|Serious adverse event|1|||
44427007|NCT00772109|79434721|FG003|Overall Study|Serious adverse event|0|||
44427008|NCT00772109|79434718|FG000|Overall Study|Protocol Violation|5|||
44427009|NCT00772109|79434719|FG001|Overall Study|Protocol Violation|8|||
44427010|NCT00772109|79434720|FG002|Overall Study|Protocol Violation|7|||
44427011|NCT00772109|79434721|FG003|Overall Study|Protocol Violation|6|||
44427012|NCT00772109|79434718|FG000|Overall Study|Lost to Follow-up|7|||
44427013|NCT00772109|79434719|FG001|Overall Study|Lost to Follow-up|3|||
44427014|NCT00772109|79434720|FG002|Overall Study|Lost to Follow-up|5|||
44427015|NCT00772109|79434721|FG003|Overall Study|Lost to Follow-up|9|||
44427016|NCT00772109|79434718|FG000|Overall Study|Withdrawal by Subject|8|||
44427017|NCT00772109|79434719|FG001|Overall Study|Withdrawal by Subject|8|||
44427018|NCT00772109|79434720|FG002|Overall Study|Withdrawal by Subject|6|||
44427019|NCT00772109|79434721|FG003|Overall Study|Withdrawal by Subject|16|||
44537538|NCT01147822|79548315|FG001|Overall Study|Protocol Violation|1|||
44330555|NCT01379703|79335849|FG001|9 Months Through 18 Months|Treatment failure|5|||
44330556|NCT01379703|79335850|FG002|9 Months Through 18 Months|Treatment failure|0|||
44330557|NCT01379703|79335848|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
44330558|NCT01379703|79335849|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
44330559|NCT01379703|79335850|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
44330560|NCT01379703|79335848|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
44330561|NCT01379703|79335849|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
44330562|NCT01379703|79335850|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
44330563|NCT01379703|79335848|FG000|9 Months Through 18 Months|Fatigue|0|||
44330564|NCT01379703|79335849|FG001|9 Months Through 18 Months|Fatigue|1|||
44330565|NCT01379703|79335850|FG002|9 Months Through 18 Months|Fatigue|0|||
44330566|NCT01379703|79335848|FG000|9 Months Through 18 Months|Reason Unknown|0|||
44330567|NCT01379703|79335849|FG001|9 Months Through 18 Months|Reason Unknown|23|||
44537539|NCT01147822|79548314|FG000|Overall Study|Lost to Follow-up|3|||
44537540|NCT01147822|79548315|FG001|Overall Study|Lost to Follow-up|2|||
44537541|NCT01147822|79548314|FG000|Overall Study|Physician Decision|0|||
44537542|NCT01147822|79548315|FG001|Overall Study|Physician Decision|2|||
44330568|NCT01379703|79335850|FG002|9 Months Through 18 Months|Reason Unknown|0|||
44330569|NCT01335477|79335861|FG000|Overall Study|Adverse Event|30|||
44330570|NCT01335477|79335862|FG001|Overall Study|Adverse Event|42|||
44427020|NCT00772031|79434733|FG000|Overall Study|Early termination of trial|12|||
44427021|NCT00772031|79434734|FG001|Overall Study|Early termination of trial|10|||
44427022|NCT00772031|79434733|FG000|Overall Study|Lost to Follow-up|20|||
44427023|NCT00772031|79434734|FG001|Overall Study|Lost to Follow-up|33|||
44427024|NCT00580866|79434748|FG000|Overall Study|Lost to Follow-up|2|||
44427025|NCT00580866|79434749|FG001|Overall Study|Lost to Follow-up|2|||
44427026|NCT00771953|79434757|FG000|Overall Study|Adverse Event|5|||
44427027|NCT00771953|79434758|FG001|Overall Study|Adverse Event|3|||
44537543|NCT01147822|79548314|FG000|Overall Study|Withdrawal by Subject|8|||
44537544|NCT01147822|79548315|FG001|Overall Study|Withdrawal by Subject|13|||
44427028|NCT00771953|79434757|FG000|Overall Study|Death|2|||
44427029|NCT00771953|79434758|FG001|Overall Study|Death|2|||
44427030|NCT00771953|79434757|FG000|Overall Study|Progression before active Tx|1|||
44427031|NCT00771953|79434758|FG001|Overall Study|Progression before active Tx|2|||
44427032|NCT00771953|79434757|FG000|Overall Study|Sponsor decision|1|||
44427033|NCT00771953|79434758|FG001|Overall Study|Sponsor decision|0|||
44427034|NCT00771953|79434757|FG000|Overall Study|Other complicating disease|1|||
44427035|NCT00771953|79434758|FG001|Overall Study|Other complicating disease|0|||
44427036|NCT00771953|79434757|FG000|Overall Study|Withdrawal by Subject|0|||
44427037|NCT00771953|79434758|FG001|Overall Study|Withdrawal by Subject|3|||
44427038|NCT00621244|79434770|FG000|Overall Study|Withdrawal by Subject|7|||
44427039|NCT00621244|79434771|FG001|Overall Study|Withdrawal by Subject|3|||
44427040|NCT00621244|79434772|FG002|Overall Study|Withdrawal by Subject|3|||
44427041|NCT00621244|79434773|FG003|Overall Study|Withdrawal by Subject|3|||
44427042|NCT00621244|79434770|FG000|Overall Study|Disease progression|44|||
44427043|NCT00621244|79434771|FG001|Overall Study|Disease progression|20|||
44427044|NCT00621244|79434772|FG002|Overall Study|Disease progression|20|||
44427045|NCT00621244|79434773|FG003|Overall Study|Disease progression|15|||
44427046|NCT00621244|79434770|FG000|Overall Study|Death|3|||
44427047|NCT00621244|79434771|FG001|Overall Study|Death|3|||
44427048|NCT00621244|79434772|FG002|Overall Study|Death|1|||
44427049|NCT00621244|79434773|FG003|Overall Study|Death|1|||
44427050|NCT00621244|79434770|FG000|Overall Study|Adverse Event|27|||
44427051|NCT00621244|79434771|FG001|Overall Study|Adverse Event|7|||
44427052|NCT00621244|79434772|FG002|Overall Study|Adverse Event|9|||
44427053|NCT00621244|79434773|FG003|Overall Study|Adverse Event|2|||
44427054|NCT00621244|79434770|FG000|Overall Study|Administrative problems|5|||
44427055|NCT00621244|79434771|FG001|Overall Study|Administrative problems|1|||
44427056|NCT00621244|79434772|FG002|Overall Study|Administrative problems|0|||
44427057|NCT00621244|79434773|FG003|Overall Study|Administrative problems|2|||
44427058|NCT00659529|79434847|FG000|Overall Study|Withdrawal by Subject|4|||
44427059|NCT00659529|79434847|FG000|Overall Study|Protocol Violation|3|||
44427060|NCT00659529|79434847|FG000|Overall Study|Screen failure|9|||
44330571|NCT01335477|79335861|FG000|Overall Study|Non compliant with protocol|0|||
44427061|NCT00578942|79434851|FG000|Overall Study|Lost to Follow-up|1|||
44427062|NCT00765245|79434857|FG000|Overall Study|disease progression|3|||
44427063|NCT00765245|79434858|FG001|Overall Study|disease progression|2|||
44427064|NCT00765245|79434857|FG000|Overall Study|Withdrawal by Subject|3|||
44427065|NCT00765245|79434858|FG001|Overall Study|Withdrawal by Subject|0|||
44427066|NCT00765245|79434857|FG000|Overall Study|Adverse Event|5|||
44427067|NCT00765245|79434858|FG001|Overall Study|Adverse Event|0|||
44427068|NCT00765245|79434857|FG000|Overall Study|Physician Decision|1|||
44537545|NCT01147822|79548314|FG000|Overall Study|Not Completed/Ongoing|111|||
44537546|NCT01147822|79548315|FG001|Overall Study|Not Completed/Ongoing|102|||
44537547|NCT03431337|79548323|FG000|Overall Study|Lost to Follow-up|21|||
44330572|NCT01335477|79335862|FG001|Overall Study|Non compliant with protocol|2|||
44330573|NCT01335477|79335861|FG000|Overall Study|Lost to Follow-up|1|||
44330574|NCT01335477|79335862|FG001|Overall Study|Lost to Follow-up|2|||
44330575|NCT01335477|79335861|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
44330576|NCT01335477|79335862|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
44330577|NCT01335477|79335861|FG000|Overall Study|Not treated|1|||
44330578|NCT01335477|79335862|FG001|Overall Study|Not treated|2|||
44330579|NCT01335477|79335861|FG000|Overall Study|Reason other than those stated above|2|||
44330580|NCT01335477|79335862|FG001|Overall Study|Reason other than those stated above|2|||
44330581|NCT01371825|79335868|FG000|Overall Study|Death|4|||
44330582|NCT01371747|79335878|FG000|Overall Study|Adverse Event|4|||
44330583|NCT01371747|79335879|FG001|Overall Study|Adverse Event|2|||
44330584|NCT01371747|79335880|FG002|Overall Study|Adverse Event|7|||
44330585|NCT01371747|79335881|FG003|Overall Study|Adverse Event|2|||
44537548|NCT03431337|79548324|FG001|Overall Study|Lost to Follow-up|19|||
44537549|NCT03431337|79548323|FG000|Overall Study|Withdrawal by Subject|8|||
44537550|NCT03431337|79548324|FG001|Overall Study|Withdrawal by Subject|3|||
44330586|NCT01371747|79335882|FG004|Overall Study|Adverse Event|2|||
44330587|NCT01371747|79335883|FG005|Overall Study|Adverse Event|2|||
44330588|NCT01371747|79335878|FG000|Overall Study|Death|1|||
44330589|NCT01371747|79335879|FG001|Overall Study|Death|0|||
44330590|NCT01371747|79335880|FG002|Overall Study|Death|4|||
44330591|NCT01371747|79335881|FG003|Overall Study|Death|1|||
44427069|NCT00765245|79434858|FG001|Overall Study|Physician Decision|0|||
44427070|NCT00765245|79434857|FG000|Overall Study|Death|1|||
44427071|NCT00765245|79434858|FG001|Overall Study|Death|0|||
44427072|NCT00782795|79434866|FG000|Overall Study|Withdrawal by Subject|1|||
44427073|NCT00782795|79434867|FG001|Overall Study|Withdrawal by Subject|2|||
44427074|NCT00656799|79434873|FG000|Overall Study|Death|2|||
44427075|NCT00764699|79434877|FG000|Overall Study|PI left and study terminated|3|||
44427076|NCT00782717|79434883|FG000|Overall Study|Adverse Event|2|||
44427077|NCT00782717|79434884|FG001|Overall Study|Adverse Event|5|||
44427078|NCT00782717|79434883|FG000|Overall Study|Patient decision unrelated to AE|6|||
44537551|NCT03738241|79548344|FG000|Overall Study|Withdrawal by Subject|0|||
44330592|NCT01371747|79335882|FG004|Overall Study|Death|2|||
44330593|NCT01371747|79335883|FG005|Overall Study|Death|0|||
44330594|NCT01371747|79335878|FG000|Overall Study|Abnormal Renal Function|0|||
44330595|NCT01371747|79335879|FG001|Overall Study|Abnormal Renal Function|2|||
44427079|NCT00782717|79434884|FG001|Overall Study|Patient decision unrelated to AE|3|||
44427080|NCT00782717|79434883|FG000|Overall Study|Noncompliance|2|||
44427081|NCT00782717|79434884|FG001|Overall Study|Noncompliance|1|||
44427082|NCT00782717|79434883|FG000|Overall Study|Treatment failure|3|||
44427083|NCT00782717|79434884|FG001|Overall Study|Treatment failure|14|||
44427084|NCT00782717|79434883|FG000|Overall Study|Enrollment close prior to surgery|1|||
44427085|NCT00782717|79434884|FG001|Overall Study|Enrollment close prior to surgery|0|||
44427086|NCT00782717|79434883|FG000|Overall Study|Did not meet entrance criteria|1|||
44427087|NCT00782717|79434884|FG001|Overall Study|Did not meet entrance criteria|3|||
44427088|NCT00782717|79434883|FG000|Overall Study|Exited in error|0|||
44427089|NCT00782717|79434884|FG001|Overall Study|Exited in error|2|||
44427090|NCT00656175|79434892|FG000|Overall Study|Adverse Event|1|||
44427091|NCT00656175|79434893|FG001|Overall Study|Adverse Event|0|||
44427092|NCT00656175|79434892|FG000|Overall Study|Transportation issues|0|||
44427093|NCT00656175|79434893|FG001|Overall Study|Transportation issues|1|||
44427094|NCT00620776|79434901|FG000|Overall Study|Did not receive treatment|3|||
44427095|NCT00620776|79434902|FG001|Overall Study|Did not receive treatment|5|||
44427096|NCT00620776|79434901|FG000|Overall Study|Adverse Event|2|||
44427097|NCT00620776|79434902|FG001|Overall Study|Adverse Event|3|||
44427098|NCT00620776|79434901|FG000|Overall Study|Lack of Efficacy|2|||
44427099|NCT00620776|79434902|FG001|Overall Study|Lack of Efficacy|1|||
44427100|NCT00620776|79434901|FG000|Overall Study|Lost to Follow-up|2|||
44427101|NCT00620776|79434902|FG001|Overall Study|Lost to Follow-up|5|||
44427102|NCT00620776|79434901|FG000|Overall Study|Withdrawal by Subject|3|||
44427103|NCT00620776|79434902|FG001|Overall Study|Withdrawal by Subject|2|||
44427104|NCT00656019|79434912|FG000|Overall Study|Not Eligible|10|||
44427105|NCT00656019|79434913|FG001|Overall Study|Not Eligible|0|||
44427106|NCT00656019|79434914|FG002|Overall Study|Not Eligible|0|||
44427107|NCT00656019|79434915|FG003|Overall Study|Not Eligible|0|||
44427108|NCT00656019|79434912|FG000|Overall Study|Withdrawal by Subject|2|||
44427109|NCT00656019|79434913|FG001|Overall Study|Withdrawal by Subject|0|||
44427110|NCT00656019|79434914|FG002|Overall Study|Withdrawal by Subject|0|||
44427111|NCT00656019|79434915|FG003|Overall Study|Withdrawal by Subject|0|||
44427112|NCT00656019|79434912|FG000|Overall Study|Lost to Follow-up|2|||
44427113|NCT00656019|79434913|FG001|Overall Study|Lost to Follow-up|1|||
44427114|NCT00656019|79434914|FG002|Overall Study|Lost to Follow-up|0|||
44427115|NCT00656019|79434915|FG003|Overall Study|Lost to Follow-up|0|||
44427116|NCT00782483|79434925|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
44427117|NCT00782171|79434931|FG000|Overall Study|Lost to Follow-up|2|||
44427118|NCT00782171|79434932|FG001|Overall Study|Lost to Follow-up|2|||
44427119|NCT00782171|79434931|FG000|Overall Study|Withdrawal by Subject|2|||
44427120|NCT00782171|79434932|FG001|Overall Study|Withdrawal by Subject|1|||
44330596|NCT01371747|79335880|FG002|Overall Study|Abnormal Renal Function|0|||
44330597|NCT01371747|79335881|FG003|Overall Study|Abnormal Renal Function|1|||
44330598|NCT01371747|79335882|FG004|Overall Study|Abnormal Renal Function|0|||
44330599|NCT01371747|79335883|FG005|Overall Study|Abnormal Renal Function|1|||
44330600|NCT01371747|79335878|FG000|Overall Study|High Serum Potassium Results|1|||
44330601|NCT01371747|79335879|FG001|Overall Study|High Serum Potassium Results|1|||
44330602|NCT01371747|79335880|FG002|Overall Study|High Serum Potassium Results|1|||
44330603|NCT01371747|79335881|FG003|Overall Study|High Serum Potassium Results|2|||
44330604|NCT01371747|79335882|FG004|Overall Study|High Serum Potassium Results|0|||
44330605|NCT01371747|79335883|FG005|Overall Study|High Serum Potassium Results|2|||
44330606|NCT01371747|79335878|FG000|Overall Study|Low Serum Potassium Results|1|||
44330607|NCT01371747|79335879|FG001|Overall Study|Low Serum Potassium Results|1|||
44427121|NCT00782171|79434931|FG000|Overall Study|complications|3|||
44427122|NCT00782171|79434932|FG001|Overall Study|complications|1|||
44427123|NCT00782171|79434931|FG000|Overall Study|others|7|||
44537552|NCT03738241|79548345|FG001|Overall Study|Withdrawal by Subject|0|||
44537553|NCT03738241|79548346|FG002|Overall Study|Withdrawal by Subject|0|||
44537554|NCT03738241|79548347|FG003|Overall Study|Withdrawal by Subject|0|||
44330608|NCT01371747|79335880|FG002|Overall Study|Low Serum Potassium Results|1|||
44427124|NCT00782171|79434932|FG001|Overall Study|others|9|||
44330609|NCT01371747|79335881|FG003|Overall Study|Low Serum Potassium Results|1|||
44330610|NCT01371747|79335882|FG004|Overall Study|Low Serum Potassium Results|0|||
44427125|NCT00782171|79434931|FG000|Overall Study|not eligible|8|||
44427126|NCT00782171|79434932|FG001|Overall Study|not eligible|6|||
44427127|NCT00764465|79434944|FG000|Overall Study|Adverse Event|2|||
44427128|NCT00764465|79434945|FG001|Overall Study|Adverse Event|0|||
44427129|NCT00764465|79434946|FG002|Overall Study|Adverse Event|0|||
44427130|NCT00764465|79434947|FG003|Overall Study|Adverse Event|1|||
44427131|NCT00764465|79434948|FG004|Overall Study|Adverse Event|1|||
44427132|NCT00764465|79434949|FG005|Overall Study|Adverse Event|1|||
44427133|NCT00764465|79434944|FG000|Overall Study|Withdrawal by Subject|0|||
44427134|NCT00764465|79434945|FG001|Overall Study|Withdrawal by Subject|1|||
44427135|NCT00764465|79434946|FG002|Overall Study|Withdrawal by Subject|1|||
44427136|NCT00764465|79434947|FG003|Overall Study|Withdrawal by Subject|0|||
44427137|NCT00764465|79434948|FG004|Overall Study|Withdrawal by Subject|0|||
44427138|NCT00764465|79434949|FG005|Overall Study|Withdrawal by Subject|0|||
44427139|NCT00655863|79434969|FG000|Overall Study|Lost to Follow-up|0|||
44427140|NCT00655863|79434970|FG001|Overall Study|Lost to Follow-up|0|||
44427141|NCT00655863|79434971|FG002|Overall Study|Lost to Follow-up|1|||
44427142|NCT00781937|79434981|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
44427143|NCT00781937|79434982|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
44427144|NCT00781937|79434981|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
44427145|NCT00781937|79434982|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
44427146|NCT00781937|79434981|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
44330611|NCT01371747|79335883|FG005|Overall Study|Low Serum Potassium Results|3|||
44330612|NCT01371747|79335878|FG000|Overall Study|Protocol Violation|0|||
44330613|NCT01371747|79335879|FG001|Overall Study|Protocol Violation|0|||
44330614|NCT01371747|79335880|FG002|Overall Study|Protocol Violation|1|||
44330615|NCT01371747|79335881|FG003|Overall Study|Protocol Violation|0|||
44330616|NCT01371747|79335882|FG004|Overall Study|Protocol Violation|0|||
44330617|NCT01371747|79335883|FG005|Overall Study|Protocol Violation|0|||
44427147|NCT00781937|79434982|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
44427148|NCT00781937|79434981|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
44427149|NCT00781937|79434982|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
44427150|NCT00781937|79434981|FG000|Main Trial Period Through Week 56|Unclassified|10|||
44427151|NCT00781937|79434982|FG001|Main Trial Period Through Week 56|Unclassified|15|||
44427152|NCT00781937|79434981|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
44427153|NCT00781937|79434982|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
44427154|NCT00781937|79434981|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
44427155|NCT00781937|79434982|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
44537555|NCT03738241|79548348|FG004|Overall Study|Withdrawal by Subject|0|||
44537556|NCT03738241|79548349|FG005|Overall Study|Withdrawal by Subject|0|||
44537557|NCT03738241|79548350|FG006|Overall Study|Withdrawal by Subject|0|||
44537558|NCT03738241|79548351|FG007|Overall Study|Withdrawal by Subject|0|||
44537559|NCT03738241|79548352|FG008|Overall Study|Withdrawal by Subject|0|||
44537560|NCT03738241|79548353|FG009|Overall Study|Withdrawal by Subject|1|||
44537561|NCT03738241|79548344|FG000|Overall Study|Physician Decision|0|||
44537562|NCT03738241|79548345|FG001|Overall Study|Physician Decision|0|||
44537563|NCT03738241|79548346|FG002|Overall Study|Physician Decision|0|||
44537564|NCT03738241|79548347|FG003|Overall Study|Physician Decision|0|||
44330618|NCT01371747|79335878|FG000|Overall Study|Non-Compliance|3|||
44330619|NCT01371747|79335879|FG001|Overall Study|Non-Compliance|4|||
44330620|NCT01371747|79335880|FG002|Overall Study|Non-Compliance|3|||
44330621|NCT01371747|79335881|FG003|Overall Study|Non-Compliance|0|||
44330622|NCT01371747|79335882|FG004|Overall Study|Non-Compliance|0|||
44330623|NCT01371747|79335883|FG005|Overall Study|Non-Compliance|1|||
44330624|NCT01371747|79335878|FG000|Overall Study|Physician Decision|0|||
44330625|NCT01371747|79335879|FG001|Overall Study|Physician Decision|0|||
44330626|NCT01371747|79335880|FG002|Overall Study|Physician Decision|0|||
44330627|NCT01371747|79335881|FG003|Overall Study|Physician Decision|0|||
44330628|NCT01371747|79335882|FG004|Overall Study|Physician Decision|1|||
44330629|NCT01371747|79335883|FG005|Overall Study|Physician Decision|0|||
44330630|NCT01371747|79335878|FG000|Overall Study|Withdrawal by Subject|6|||
44330631|NCT01371747|79335879|FG001|Overall Study|Withdrawal by Subject|12|||
44330632|NCT01371747|79335880|FG002|Overall Study|Withdrawal by Subject|5|||
44330633|NCT01371747|79335881|FG003|Overall Study|Withdrawal by Subject|2|||
44330634|NCT01371747|79335882|FG004|Overall Study|Withdrawal by Subject|2|||
44330635|NCT01371747|79335883|FG005|Overall Study|Withdrawal by Subject|4|||
44330636|NCT01371747|79335878|FG000|Overall Study|Other Reasons|2|||
44330637|NCT01371747|79335879|FG001|Overall Study|Other Reasons|1|||
44330638|NCT01371747|79335880|FG002|Overall Study|Other Reasons|2|||
44330639|NCT01371747|79335881|FG003|Overall Study|Other Reasons|0|||
44427156|NCT00659373|79434990|FG000|Overall Study|Withdrawal by Subject|3|||
44427157|NCT00659373|79434991|FG001|Overall Study|Withdrawal by Subject|5|||
44427158|NCT00659373|79434990|FG000|Overall Study|Assessment Missed|2|||
44427159|NCT00659373|79434991|FG001|Overall Study|Assessment Missed|2|||
44330640|NCT01371747|79335882|FG004|Overall Study|Other Reasons|0|||
44427160|NCT00439777|79434999|FG000|Treatment Period|Death|29|||
44330641|NCT01371747|79335883|FG005|Overall Study|Other Reasons|1|||
44330642|NCT01371708|79335918|FG000|Overall Study|Insufficient clinical response|3|||
44427161|NCT00439777|79435000|FG001|Treatment Period|Death|21|||
44427162|NCT00439777|79434999|FG000|Treatment Period|Study terminated by sponsor|125|||
44427163|NCT00439777|79435000|FG001|Treatment Period|Study terminated by sponsor|132|||
44537565|NCT03738241|79548348|FG004|Overall Study|Physician Decision|0|||
44537566|NCT03738241|79548349|FG005|Overall Study|Physician Decision|0|||
44537567|NCT03738241|79548350|FG006|Overall Study|Physician Decision|0|||
44537568|NCT03738241|79548351|FG007|Overall Study|Physician Decision|0|||
44427164|NCT00439777|79434999|FG000|Treatment Period|Site closed by investigator|0|||
44427165|NCT00439777|79435000|FG001|Treatment Period|Site closed by investigator|1|||
44427166|NCT00439777|79434999|FG000|Treatment Period|Did not take study treatment|7|||
44427167|NCT00439777|79435000|FG001|Treatment Period|Did not take study treatment|8|||
44427168|NCT00439777|79434999|FG000|Treatment Period|Adverse Event|111|||
44427169|NCT00439777|79435000|FG001|Treatment Period|Adverse Event|92|||
44427170|NCT00439777|79434999|FG000|Treatment Period|Protocol Violation|23|||
44427171|NCT00439777|79435000|FG001|Treatment Period|Protocol Violation|30|||
44427172|NCT00439777|79434999|FG000|Treatment Period|Withdrawal by Subject|66|||
44427173|NCT00439777|79435000|FG001|Treatment Period|Withdrawal by Subject|118|||
44427174|NCT00439777|79434999|FG000|Treatment Period|Lack of Efficacy|1|||
44427175|NCT00439777|79435000|FG001|Treatment Period|Lack of Efficacy|4|||
44427176|NCT00439777|79434999|FG000|Treatment Period|Lost to Follow-up|8|||
44427177|NCT00439777|79435000|FG001|Treatment Period|Lost to Follow-up|10|||
44427178|NCT00439777|79434999|FG000|Treatment Period|Protocol driven decision point|1|||
44427179|NCT00439777|79435000|FG001|Treatment Period|Protocol driven decision point|3|||
44427180|NCT00439777|79434999|FG000|Treatment Period|Physician Decision|7|||
44427181|NCT00439777|79435000|FG001|Treatment Period|Physician Decision|18|||
44427182|NCT00439777|79434999|FG000|Treatment Period|Clinical endpoint reached|26|||
44427183|NCT00439777|79435000|FG001|Treatment Period|Clinical endpoint reached|13|||
44427184|NCT00439777|79434999|FG000|Treatment Period|Technical problems|3|||
44427185|NCT00439777|79435000|FG001|Treatment Period|Technical problems|1|||
44427186|NCT00439777|79434999|FG000|Treatment Period|Participant convenience|12|||
44427187|NCT00439777|79435000|FG001|Treatment Period|Participant convenience|8|||
44427188|NCT00439777|79434999|FG000|Observational Period|Protocol Violation|0|||
44427189|NCT00439777|79435000|FG001|Observational Period|Protocol Violation|2|||
44427190|NCT00439777|79434999|FG000|Observational Period|Withdrawal by Subject|9|||
44427191|NCT00439777|79435000|FG001|Observational Period|Withdrawal by Subject|5|||
44427192|NCT00439777|79434999|FG000|Observational Period|Lost to Follow-up|1|||
44427193|NCT00439777|79435000|FG001|Observational Period|Lost to Follow-up|11|||
44427194|NCT00439777|79434999|FG000|Observational Period|Death|27|||
44427195|NCT00439777|79435000|FG001|Observational Period|Death|20|||
44427196|NCT00439777|79434999|FG000|Observational Period|Study terminated by sponsor|3|||
44427197|NCT00439777|79435000|FG001|Observational Period|Study terminated by sponsor|1|||
44427198|NCT00439777|79434999|FG000|Observational Period|Protocol driven decision point|0|||
44427199|NCT00439777|79435000|FG001|Observational Period|Protocol driven decision point|1|||
44427200|NCT00439777|79434999|FG000|Observational Period|Lack of Efficacy|1|||
44427201|NCT00439777|79435000|FG001|Observational Period|Lack of Efficacy|0|||
44427202|NCT00439777|79434999|FG000|Observational Period|Technical problems|0|||
44427203|NCT00439777|79435000|FG001|Observational Period|Technical problems|1|||
44427204|NCT00620854|79435012|FG000|Washout 1|Withdrawal by Subject|0|||
44427205|NCT00620854|79435013|FG001|Washout 1|Withdrawal by Subject|0|||
44156955|NCT03238300|78948388|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
44330643|NCT01371708|79335919|FG001|Overall Study|Insufficient clinical response|2|||
44330644|NCT01371708|79335920|FG002|Overall Study|Insufficient clinical response|0|||
44330645|NCT01371708|79335918|FG000|Overall Study|Lost to Follow-up|5|||
44330646|NCT01371708|79335919|FG001|Overall Study|Lost to Follow-up|9|||
44330647|NCT01371708|79335920|FG002|Overall Study|Lost to Follow-up|7|||
44330648|NCT01371708|79335918|FG000|Overall Study|Protocol Violation|2|||
44330649|NCT01371708|79335919|FG001|Overall Study|Protocol Violation|1|||
44156956|NCT03238300|78948387|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
44156957|NCT03238300|78948388|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
44330650|NCT01371708|79335920|FG002|Overall Study|Protocol Violation|2|||
44330651|NCT01371708|79335918|FG000|Overall Study|No longer willing to participate|7|||
44330652|NCT01371708|79335919|FG001|Overall Study|No longer willing to participate|7|||
44330653|NCT01371708|79335920|FG002|Overall Study|No longer willing to participate|13|||
44330654|NCT01371708|79335918|FG000|Overall Study|Medication error/not related to AE|0|||
44330655|NCT01371708|79335919|FG001|Overall Study|Medication error/not related to AE|1|||
44427206|NCT00620854|79435014|FG002|Washout 1|Withdrawal by Subject|1|||
44156958|NCT03178045|78948400|FG000|Overall Study|Withdrawal by Subject|5|||
44156959|NCT03178045|78948401|FG001|Overall Study|Withdrawal by Subject|7|||
44156960|NCT03178045|78948400|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
44330656|NCT01371708|79335920|FG002|Overall Study|Medication error/not related to AE|0|||
44330657|NCT01371708|79335918|FG000|Overall Study|Other|3|||
44330658|NCT01371708|79335919|FG001|Overall Study|Other|2|||
44330659|NCT01371708|79335920|FG002|Overall Study|Other|4|||
44330660|NCT01371708|79335918|FG000|Overall Study|Adverse Event|5|||
44330661|NCT01371708|79335919|FG001|Overall Study|Adverse Event|8|||
44427207|NCT00620854|79435015|FG003|Washout 1|Withdrawal by Subject|1|||
44427208|NCT00620854|79435016|FG004|Washout 1|Withdrawal by Subject|0|||
44427209|NCT00620854|79435017|FG005|Washout 1|Withdrawal by Subject|0|||
44427210|NCT00430027|79435028|FG000|Overall Study|Study terminated|8|||
44427211|NCT00429793|79435032|FG000|Overall Study|Improper pre-protocol treatment|3|||
44427212|NCT00429793|79435032|FG000|Overall Study|Required test not done|1|||
44427213|NCT00429793|79435032|FG000|Overall Study|Never treated|1|||
44427214|NCT00429793|79435032|FG000|Overall Study|Non-measurable|1|||
44427215|NCT00424645|79435043|FG000|Overall Study|Death|1|||
44427216|NCT00424645|79435044|FG001|Overall Study|Death|0|||
44427217|NCT00763451|79435054|FG000|Overall Study|Adverse Event|4|||
44427218|NCT00763451|79435055|FG001|Overall Study|Adverse Event|6|||
44427219|NCT00763451|79435056|FG002|Overall Study|Adverse Event|19|||
44427220|NCT00763451|79435057|FG003|Overall Study|Adverse Event|14|||
44427221|NCT00763451|79435054|FG000|Overall Study|Lack of Efficacy|1|||
44427222|NCT00763451|79435055|FG001|Overall Study|Lack of Efficacy|4|||
44427223|NCT00763451|79435056|FG002|Overall Study|Lack of Efficacy|3|||
44427224|NCT00763451|79435057|FG003|Overall Study|Lack of Efficacy|2|||
44427225|NCT00763451|79435054|FG000|Overall Study|Withdrawal by Subject|1|||
44427226|NCT00763451|79435055|FG001|Overall Study|Withdrawal by Subject|6|||
44427227|NCT00763451|79435056|FG002|Overall Study|Withdrawal by Subject|9|||
44427228|NCT00763451|79435057|FG003|Overall Study|Withdrawal by Subject|7|||
44427229|NCT00763451|79435054|FG000|Overall Study|Protocol Violation|0|||
44427230|NCT00763451|79435055|FG001|Overall Study|Protocol Violation|0|||
44427231|NCT00763451|79435056|FG002|Overall Study|Protocol Violation|1|||
44330662|NCT01371708|79335920|FG002|Overall Study|Adverse Event|12|||
44330663|NCT01371708|79335918|FG000|Overall Study|Started but did not receive treatment|1|||
44330664|NCT01371708|79335919|FG001|Overall Study|Started but did not receive treatment|0|||
44330665|NCT01371708|79335920|FG002|Overall Study|Started but did not receive treatment|1|||
44330666|NCT01335399|79335932|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
44330667|NCT01335399|79335933|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
44330668|NCT01335399|79335932|FG000|Pre-treatment Period|Participant request to discontinue|0|||
44330669|NCT01335399|79335933|FG001|Pre-treatment Period|Participant request to discontinue|1|||
44330670|NCT01335399|79335932|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
44330671|NCT01335399|79335933|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
44330672|NCT01335399|79335932|FG000|Pre-treatment Period|Consent withdrawal|3|||
44330673|NCT01335399|79335933|FG001|Pre-treatment Period|Consent withdrawal|0|||
44330674|NCT01335399|79335932|FG000|Treatment Period|Disease progression|117|||
44330675|NCT01335399|79335933|FG001|Treatment Period|Disease progression|145|||
44427232|NCT00763451|79435057|FG003|Overall Study|Protocol Violation|0|||
44427233|NCT00763451|79435054|FG000|Overall Study|Poor Compliance to Protocol|1|||
44427234|NCT00763451|79435055|FG001|Overall Study|Poor Compliance to Protocol|1|||
44427235|NCT00763451|79435056|FG002|Overall Study|Poor Compliance to Protocol|2|||
44427236|NCT00763451|79435057|FG003|Overall Study|Poor Compliance to Protocol|2|||
44427237|NCT00763451|79435054|FG000|Overall Study|Familial and Personal Reasons|5|||
44330676|NCT01335399|79335932|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
44330677|NCT01335399|79335933|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
44330678|NCT01335399|79335932|FG000|Treatment Period|Study drug toxicity|52|||
44330679|NCT01335399|79335933|FG001|Treatment Period|Study drug toxicity|64|||
44330680|NCT01335399|79335932|FG000|Treatment Period|Participant request to discontinue|30|||
44330681|NCT01335399|79335933|FG001|Treatment Period|Participant request to discontinue|22|||
44330682|NCT01335399|79335932|FG000|Treatment Period|Other reasons|30|||
44330683|NCT01335399|79335933|FG001|Treatment Period|Other reasons|30|||
44330684|NCT01335399|79335932|FG000|Treatment Period|Consent withdrawal|10|||
44330685|NCT01335399|79335933|FG001|Treatment Period|Consent withdrawal|7|||
44330686|NCT01335399|79335932|FG000|Treatment Period|Death|7|||
44330687|NCT01335399|79335933|FG001|Treatment Period|Death|6|||
44330688|NCT01335399|79335932|FG000|Treatment Period|Poor/Non-compliance|3|||
44330689|NCT01335399|79335933|FG001|Treatment Period|Poor/Non-compliance|4|||
44330690|NCT01335399|79335932|FG000|Treatment Period|Lost to Follow-up|2|||
44330691|NCT01335399|79335933|FG001|Treatment Period|Lost to Follow-up|2|||
44330692|NCT01335399|79335932|FG000|Treatment Period|Maximum clinical benefit|1|||
44330693|NCT01335399|79335933|FG001|Treatment Period|Maximum clinical benefit|1|||
44330694|NCT01335399|79335932|FG000|Treatment Period|No longer meet study criteria|1|||
44330695|NCT01335399|79335933|FG001|Treatment Period|No longer meet study criteria|1|||
44427238|NCT00763451|79435055|FG001|Overall Study|Familial and Personal Reasons|3|||
44427239|NCT00763451|79435056|FG002|Overall Study|Familial and Personal Reasons|5|||
44427240|NCT00763451|79435057|FG003|Overall Study|Familial and Personal Reasons|4|||
44427241|NCT00763451|79435054|FG000|Overall Study|Randomized but not Treated|1|||
44427242|NCT00763451|79435055|FG001|Overall Study|Randomized but not Treated|1|||
44330696|NCT01335399|79335932|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
44330697|NCT01335399|79335933|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
44330698|NCT01366521|79335943|FG000|Overall Study|Adverse Event|1|||
44330699|NCT01366521|79335944|FG001|Overall Study|Adverse Event|0|||
44427243|NCT00763451|79435056|FG002|Overall Study|Randomized but not Treated|0|||
44427244|NCT00763451|79435057|FG003|Overall Study|Randomized but not Treated|0|||
44427245|NCT00763451|79435054|FG000|Overall Study|Study Site Reason|0|||
44427246|NCT00763451|79435055|FG001|Overall Study|Study Site Reason|1|||
44427247|NCT00763451|79435056|FG002|Overall Study|Study Site Reason|1|||
44427248|NCT00763451|79435057|FG003|Overall Study|Study Site Reason|1|||
44427249|NCT00762762|79435070|FG000|Overall Study|Did not return for appointments|6|||
44427250|NCT00762762|79435071|FG001|Overall Study|Did not return for appointments|8|||
44427251|NCT00424489|79435079|FG000|Overall Study|Death|3|||
44427252|NCT00578864|79435085|FG000|Overall Study|Death|1|||
44427253|NCT00578864|79435086|FG001|Overall Study|Death|0|||
44427254|NCT00770315|79435109|FG000|Overall Study|Adverse Event|11|||
44427255|NCT00770315|79435110|FG001|Overall Study|Adverse Event|17|||
44427256|NCT00770315|79435111|FG002|Overall Study|Adverse Event|16|||
44427257|NCT00770315|79435112|FG003|Overall Study|Adverse Event|6|||
44427258|NCT00770315|79435109|FG000|Overall Study|Lost to Follow-up|9|||
44427259|NCT00770315|79435110|FG001|Overall Study|Lost to Follow-up|5|||
44427260|NCT00770315|79435111|FG002|Overall Study|Lost to Follow-up|10|||
44427261|NCT00770315|79435112|FG003|Overall Study|Lost to Follow-up|3|||
44427262|NCT00770315|79435109|FG000|Overall Study|Withdrawal by Subject|13|||
44427263|NCT00770315|79435110|FG001|Overall Study|Withdrawal by Subject|17|||
44427264|NCT00770315|79435111|FG002|Overall Study|Withdrawal by Subject|24|||
44427265|NCT00770315|79435112|FG003|Overall Study|Withdrawal by Subject|20|||
44427266|NCT00770315|79435109|FG000|Overall Study|Noncompliance with Protocol|7|||
44427267|NCT00770315|79435110|FG001|Overall Study|Noncompliance with Protocol|4|||
44427268|NCT00770315|79435111|FG002|Overall Study|Noncompliance with Protocol|7|||
44427269|NCT00770315|79435112|FG003|Overall Study|Noncompliance with Protocol|9|||
44427270|NCT00587171|79435124|FG000|Overall Study|Lost to Follow-up|1|||
44427271|NCT00587171|79435125|FG001|Overall Study|Lost to Follow-up|1|||
44537569|NCT03738241|79548352|FG008|Overall Study|Physician Decision|1|||
44330700|NCT01366521|79335945|FG002|Overall Study|Adverse Event|0|||
44330701|NCT01366521|79335946|FG003|Overall Study|Adverse Event|0|||
44330702|NCT01366521|79335943|FG000|Overall Study|Protocol Violation|0|||
44330703|NCT01366521|79335944|FG001|Overall Study|Protocol Violation|0|||
44330704|NCT01366521|79335945|FG002|Overall Study|Protocol Violation|1|||
44330705|NCT01366521|79335946|FG003|Overall Study|Protocol Violation|0|||
44330706|NCT01366521|79335943|FG000|Overall Study|Physician Decision|0|||
44330707|NCT01366521|79335944|FG001|Overall Study|Physician Decision|0|||
44330708|NCT01366521|79335945|FG002|Overall Study|Physician Decision|1|||
44330709|NCT01366521|79335946|FG003|Overall Study|Physician Decision|0|||
44330710|NCT01366521|79335943|FG000|Overall Study|Withdrawal by Subject|0|||
44330711|NCT01366521|79335944|FG001|Overall Study|Withdrawal by Subject|1|||
44330712|NCT01366521|79335945|FG002|Overall Study|Withdrawal by Subject|0|||
44330713|NCT01366521|79335946|FG003|Overall Study|Withdrawal by Subject|0|||
44330714|NCT01335009|79335960|FG000|Overall Study|Too ill to travel to study sites|1|||
44330715|NCT01335009|79335961|FG001|Overall Study|Too ill to travel to study sites|0|||
44427272|NCT00763139|79435131|FG000|Overall Study|Adverse Event|4|||
44427273|NCT00763139|79435132|FG001|Overall Study|Adverse Event|2|||
44427274|NCT00763139|79435131|FG000|Overall Study|Withdrawal by Subject|0|||
44427275|NCT00763139|79435132|FG001|Overall Study|Withdrawal by Subject|1|||
44427276|NCT00763139|79435131|FG000|Overall Study|med change not allowed by protocol|1|||
44427277|NCT00763139|79435132|FG001|Overall Study|med change not allowed by protocol|0|||
44427278|NCT00781859|79435145|FG000|Overall Study|Adverse Event|2|||
44537570|NCT03738241|79548353|FG009|Overall Study|Physician Decision|0|||
44258658|NCT02623699|79113780|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258659|NCT02623699|79113781|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258660|NCT02623699|79113782|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258661|NCT02623699|79113783|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44537571|NCT03738241|79548344|FG000|Overall Study|Adverse Event|1|||
44537572|NCT03738241|79548345|FG001|Overall Study|Adverse Event|0|||
44258662|NCT02623699|79113784|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258663|NCT02623699|79113785|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258664|NCT02623699|79113786|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258665|NCT02623699|79113787|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258666|NCT02623699|79113788|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258667|NCT02623699|79113789|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
44258668|NCT02623699|79113778|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258669|NCT02623699|79113779|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258670|NCT02623699|79113780|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258671|NCT02623699|79113781|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258672|NCT02623699|79113782|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258673|NCT02623699|79113783|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258674|NCT02623699|79113784|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
44258675|NCT02623699|79113785|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44330716|NCT01335009|79335960|FG000|Overall Study|Death|28|||
44330717|NCT01335009|79335961|FG001|Overall Study|Death|32|||
44330718|NCT01335009|79335960|FG000|Overall Study|Withdrawal by Subject|1|||
44330719|NCT01335009|79335961|FG001|Overall Study|Withdrawal by Subject|1|||
44427279|NCT00781859|79435146|FG001|Overall Study|Adverse Event|2|||
44427280|NCT00781859|79435145|FG000|Overall Study|Withdrawal by Subject|8|||
44427281|NCT00781859|79435146|FG001|Overall Study|Withdrawal by Subject|4|||
44427282|NCT00781859|79435145|FG000|Overall Study|Lost to Follow-up|6|||
44427283|NCT00781859|79435146|FG001|Overall Study|Lost to Follow-up|3|||
44427284|NCT00781859|79435145|FG000|Overall Study|Death|3|||
44537573|NCT03738241|79548346|FG002|Overall Study|Adverse Event|0|||
44330720|NCT01335009|79335960|FG000|Overall Study|Lost to Follow-up|1|||
44330721|NCT01335009|79335961|FG001|Overall Study|Lost to Follow-up|0|||
44330722|NCT01366443|79335976|FG000|Overall Study|Lost to Follow-up|2|||
44330723|NCT01366443|79335976|FG000|Overall Study|Under 18 yo|1|||
44330724|NCT01332630|79335981|FG000|Overall Study|Withdrawal by Subject|3|||
44330725|NCT01366209|79335987|FG000|Overall Study|Adverse Event|6|||
44330726|NCT01366209|79335988|FG001|Overall Study|Adverse Event|7|||
44427285|NCT00781859|79435146|FG001|Overall Study|Death|0|||
44427286|NCT00580788|79435156|FG000|Overall Study|Adverse Event|0|||
44427287|NCT00580788|79435157|FG001|Overall Study|Adverse Event|0|||
44427288|NCT00580788|79435158|FG002|Overall Study|Adverse Event|0|||
44427289|NCT00580788|79435159|FG003|Overall Study|Adverse Event|1|||
44537574|NCT03738241|79548347|FG003|Overall Study|Adverse Event|0|||
44537575|NCT03738241|79548348|FG004|Overall Study|Adverse Event|0|||
44537576|NCT03738241|79548349|FG005|Overall Study|Adverse Event|0|||
44537577|NCT03738241|79548350|FG006|Overall Study|Adverse Event|0|||
44258676|NCT02623699|79113786|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258677|NCT02623699|79113787|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258678|NCT02623699|79113788|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258679|NCT02623699|79113789|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
44258680|NCT02623699|79113778|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258681|NCT02623699|79113779|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258682|NCT02623699|79113780|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258683|NCT02623699|79113781|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258684|NCT02623699|79113782|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258685|NCT02623699|79113783|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
44258686|NCT02623699|79113784|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258687|NCT02623699|79113785|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258688|NCT02623699|79113786|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258689|NCT02623699|79113787|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258690|NCT02623699|79113788|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258691|NCT02623699|79113789|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
44258692|NCT02623699|79113778|FG000|Part B (Up to 289 Days)|Death|0|||
44258693|NCT02623699|79113779|FG001|Part B (Up to 289 Days)|Death|0|||
44258694|NCT02623699|79113780|FG002|Part B (Up to 289 Days)|Death|0|||
44258695|NCT02623699|79113781|FG003|Part B (Up to 289 Days)|Death|0|||
44258696|NCT02623699|79113782|FG004|Part B (Up to 289 Days)|Death|0|||
44258697|NCT02623699|79113783|FG005|Part B (Up to 289 Days)|Death|1|||
44258698|NCT02623699|79113784|FG006|Part B (Up to 289 Days)|Death|1|||
44258699|NCT02623699|79113785|FG007|Part B (Up to 289 Days)|Death|0|||
44258700|NCT02623699|79113786|FG008|Part B (Up to 289 Days)|Death|1|||
44258701|NCT02623699|79113787|FG009|Part B (Up to 289 Days)|Death|0|||
44258702|NCT02623699|79113788|FG010|Part B (Up to 289 Days)|Death|0|||
44258703|NCT02623699|79113789|FG011|Part B (Up to 289 Days)|Death|0|||
44258704|NCT02623699|79113778|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
44258705|NCT02623699|79113779|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
44258706|NCT02623699|79113780|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
44258707|NCT02623699|79113781|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
44258708|NCT02623699|79113782|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
44258709|NCT02623699|79113783|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
44258710|NCT02623699|79113784|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
44258711|NCT02623699|79113785|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
44258712|NCT02623699|79113786|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
44258713|NCT02623699|79113787|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
44258714|NCT02623699|79113788|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
44258715|NCT02623699|79113789|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
44258716|NCT02623699|79113778|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258717|NCT02623699|79113779|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258718|NCT02623699|79113780|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258719|NCT02623699|79113781|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258720|NCT02623699|79113782|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258721|NCT02623699|79113783|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258722|NCT02623699|79113784|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258723|NCT02623699|79113785|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258724|NCT02623699|79113786|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258725|NCT02623699|79113787|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
44258726|NCT02623699|79113788|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
44258727|NCT02623699|79113789|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
44258728|NCT02623699|79113778|FG000|Part C (Up to 236 Days)|Death|0|||
44258729|NCT02623699|79113779|FG001|Part C (Up to 236 Days)|Death|0|||
44258730|NCT02623699|79113780|FG002|Part C (Up to 236 Days)|Death|0|||
44258731|NCT02623699|79113781|FG003|Part C (Up to 236 Days)|Death|0|||
44258732|NCT02623699|79113782|FG004|Part C (Up to 236 Days)|Death|0|||
44258733|NCT02623699|79113783|FG005|Part C (Up to 236 Days)|Death|0|||
44330727|NCT01366209|79335987|FG000|Overall Study|Withdrawal by Subject|4|||
44330728|NCT01366209|79335988|FG001|Overall Study|Withdrawal by Subject|4|||
44427290|NCT00417079|79435178|FG000|Overall Study|Disease progression|267|||
44537578|NCT03738241|79548351|FG007|Overall Study|Adverse Event|0|||
44427291|NCT00417079|79435179|FG001|Overall Study|Disease progression|180|||
44427292|NCT00417079|79435178|FG000|Overall Study|Adverse Event|32|||
44427293|NCT00417079|79435179|FG001|Overall Study|Adverse Event|67|||
44427294|NCT00417079|79435178|FG000|Overall Study|Non-compliance to protocol|0|||
44427295|NCT00417079|79435179|FG001|Overall Study|Non-compliance to protocol|1|||
44427296|NCT00417079|79435178|FG000|Overall Study|Lost to Follow-up|2|||
44427297|NCT00417079|79435179|FG001|Overall Study|Lost to Follow-up|0|||
44427298|NCT00417079|79435178|FG000|Overall Study|Withdrawal by Subject|17|||
44330729|NCT01366209|79335987|FG000|Overall Study|Death|12|||
44330730|NCT01366209|79335988|FG001|Overall Study|Death|19|||
44330731|NCT01366209|79335987|FG000|Overall Study|Lung transplantation|6|||
44330732|NCT01366209|79335988|FG001|Overall Study|Lung transplantation|1|||
44330733|NCT01366209|79335987|FG000|Overall Study|Lost to Follow-up|2|||
44330734|NCT01366209|79335988|FG001|Overall Study|Lost to Follow-up|1|||
44330735|NCT01366209|79335987|FG000|Overall Study|Physician Decision|1|||
44330736|NCT01366209|79335988|FG001|Overall Study|Physician Decision|0|||
44330737|NCT01366209|79335987|FG000|Overall Study|Sponsors decision|0|||
44330738|NCT01366209|79335988|FG001|Overall Study|Sponsors decision|1|||
44330739|NCT01366209|79335987|FG000|Overall Study|Withdrew consent|4|||
44330740|NCT01366209|79335988|FG001|Overall Study|Withdrew consent|3|||
44330741|NCT01365546|79335994|FG000|Overall Study|Withdrawal by Subject|1|||
44330742|NCT01365546|79335994|FG000|Overall Study|Screen failure|9|||
44330743|NCT01365546|79335994|FG000|Overall Study|Study termination|1|||
44330744|NCT01365507|79336004|FG000|Overall Study|Withdrawal Criteria|8|||
44330745|NCT01365507|79336005|FG001|Overall Study|Withdrawal Criteria|5|||
44330746|NCT01365507|79336004|FG000|Overall Study|Unclassified|1|||
44330747|NCT01365507|79336005|FG001|Overall Study|Unclassified|4|||
44330748|NCT01365468|79336029|FG000|Overall Study|Physician Decision|1|||
44330749|NCT01365468|79336030|FG001|Overall Study|Physician Decision|0|||
44330750|NCT01365468|79336029|FG000|Overall Study|Disease progression|1|||
44330751|NCT01365468|79336030|FG001|Overall Study|Disease progression|0|||
44330752|NCT01365468|79336029|FG000|Overall Study|Lost to Follow-up|2|||
44330753|NCT01365468|79336030|FG001|Overall Study|Lost to Follow-up|0|||
44330754|NCT01357980|79336041|FG000|Overall Study|Lack of Efficacy|0|||
44330755|NCT01357980|79336042|FG001|Overall Study|Lack of Efficacy|1|||
44330756|NCT01357980|79336043|FG002|Overall Study|Lack of Efficacy|0|||
44330757|NCT01357980|79336044|FG003|Overall Study|Lack of Efficacy|0|||
44330758|NCT01357980|79336041|FG000|Overall Study|Consent withdrawn|0|||
44330759|NCT01357980|79336042|FG001|Overall Study|Consent withdrawn|0|||
44427299|NCT00417079|79435179|FG001|Overall Study|Withdrawal by Subject|8|||
44427300|NCT00417079|79435178|FG000|Overall Study|Not treated|6|||
44427301|NCT00417079|79435179|FG001|Overall Study|Not treated|7|||
44427302|NCT00417079|79435178|FG000|Overall Study|Screened failure|2|||
44427303|NCT00417079|79435179|FG001|Overall Study|Screened failure|1|||
44537579|NCT03738241|79548352|FG008|Overall Study|Adverse Event|0|||
44537580|NCT03738241|79548353|FG009|Overall Study|Adverse Event|0|||
44537581|NCT03430245|79548375|FG000|Overall Study|Withdrawal by Subject|6|||
44537582|NCT03430245|79548375|FG000|Overall Study|Lost to Follow-up|1|||
44537583|NCT03461289|79548379|FG000|Overall Study|Death|1|||
44537584|NCT03452943|79548385|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
44537585|NCT03452943|79548386|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
44537586|NCT03452943|79548385|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
44537587|NCT03452943|79548386|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
44537588|NCT03452943|79548385|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
44537589|NCT03452943|79548386|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
44537590|NCT03452943|79548385|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
44537591|NCT03452943|79548386|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
44537592|NCT03452943|79548385|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
44537593|NCT03452943|79548386|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
44537594|NCT03452943|79548385|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
44330760|NCT01357980|79336043|FG002|Overall Study|Consent withdrawn|1|||
44330761|NCT01357980|79336044|FG003|Overall Study|Consent withdrawn|0|||
44330762|NCT01332318|79336058|FG000|Overall Study|Adverse Event|0|||
44330763|NCT01332318|79336059|FG001|Overall Study|Adverse Event|3|||
44330764|NCT01332318|79336060|FG002|Overall Study|Adverse Event|0|||
44330765|NCT01332318|79336061|FG003|Overall Study|Adverse Event|0|||
44330766|NCT01332318|79336058|FG000|Overall Study|Withdrawal by Subject|1|||
44330767|NCT01332318|79336059|FG001|Overall Study|Withdrawal by Subject|1|||
44427304|NCT00417079|79435178|FG000|Overall Study|Investigator's decision|1|||
44330768|NCT01332318|79336060|FG002|Overall Study|Withdrawal by Subject|0|||
44330769|NCT01332318|79336061|FG003|Overall Study|Withdrawal by Subject|1|||
44330770|NCT01332318|79336058|FG000|Overall Study|Protocol Violation|1|||
44330771|NCT01332318|79336059|FG001|Overall Study|Protocol Violation|0|||
44330772|NCT01332318|79336060|FG002|Overall Study|Protocol Violation|1|||
44330773|NCT01332318|79336061|FG003|Overall Study|Protocol Violation|1|||
44330774|NCT01331109|79336076|FG000|Overall Study|Adverse Event|6|||
44427305|NCT00417079|79435179|FG001|Overall Study|Investigator's decision|4|||
44537595|NCT03452943|79548386|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
44427306|NCT00417079|79435178|FG000|Overall Study|Non-confirmed Disease progression|1|||
44427307|NCT00417079|79435179|FG001|Overall Study|Non-confirmed Disease progression|1|||
44427308|NCT00417079|79435178|FG000|Overall Study|Clinical deterioration|1|||
44427309|NCT00417079|79435179|FG001|Overall Study|Clinical deterioration|0|||
44427310|NCT00417079|79435178|FG000|Overall Study|Screening error|2|||
44427311|NCT00417079|79435179|FG001|Overall Study|Screening error|1|||
44427312|NCT00417079|79435178|FG000|Overall Study|Withdrawal by subject's family|0|||
44427313|NCT00417079|79435179|FG001|Overall Study|Withdrawal by subject's family|1|||
44427314|NCT00417079|79435178|FG000|Overall Study|Patient unable to come to the clinic|0|||
44427315|NCT00417079|79435179|FG001|Overall Study|Patient unable to come to the clinic|1|||
44427316|NCT00417079|79435178|FG000|Overall Study|abnormal liver function tests|0|||
44427317|NCT00417079|79435179|FG001|Overall Study|abnormal liver function tests|1|||
44427318|NCT00429169|79435187|FG000|Overall Study|Lost to Follow-up|0|||
44427319|NCT00429169|79435188|FG001|Overall Study|Lost to Follow-up|1|||
44427320|NCT00429169|79435187|FG000|Overall Study|Ineligibility discovered after entry|2|||
44537596|NCT03481725|79548394|FG000|Overall Study|Withdrawal by Subject|1|||
44537597|NCT03481725|79548395|FG001|Overall Study|Withdrawal by Subject|0|||
44537598|NCT03480243|79548403|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
44537599|NCT03480243|79548403|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
44537600|NCT03426345|79548418|FG000|Overall Study|Adverse Event|4|||
44537601|NCT03426345|79548419|FG001|Overall Study|Adverse Event|4|||
44537602|NCT03426345|79548418|FG000|Overall Study|Lack of Efficacy|1|||
44258734|NCT02623699|79113784|FG006|Part C (Up to 236 Days)|Death|0|||
44258735|NCT02623699|79113785|FG007|Part C (Up to 236 Days)|Death|0|||
44258736|NCT02623699|79113786|FG008|Part C (Up to 236 Days)|Death|0|||
44330775|NCT01331109|79336076|FG000|Overall Study|Lack of Efficacy|2|||
44330776|NCT01331109|79336076|FG000|Overall Study|Protocol Violation|3|||
44330777|NCT01331109|79336076|FG000|Overall Study|Withdrawal by Subject|7|||
44330778|NCT01331109|79336076|FG000|Overall Study|Lost to Follow-up|1|||
44330779|NCT01331109|79336076|FG000|Overall Study|Study Terminated by Sponsor|38|||
44330780|NCT01357551|79336082|FG000|Overall Study|Withdrawal by Subject|6|||
44258737|NCT02623699|79113787|FG009|Part C (Up to 236 Days)|Death|0|||
44258738|NCT02623699|79113788|FG010|Part C (Up to 236 Days)|Death|0|||
44258739|NCT02623699|79113789|FG011|Part C (Up to 236 Days)|Death|1|||
44258740|NCT02623699|79113778|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
44258741|NCT02623699|79113779|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
44258742|NCT02623699|79113780|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
44258743|NCT02623699|79113781|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
44258744|NCT02623699|79113782|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
44258745|NCT02623699|79113783|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
44258746|NCT02623699|79113784|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
44330781|NCT01357551|79336083|FG001|Overall Study|Withdrawal by Subject|4|||
44330782|NCT01357551|79336082|FG000|Overall Study|Death|0|||
44330783|NCT01357551|79336083|FG001|Overall Study|Death|1|||
44330784|NCT01357551|79336082|FG000|Overall Study|Lost to Follow-up|16|||
44330785|NCT01357551|79336083|FG001|Overall Study|Lost to Follow-up|6|||
44330786|NCT01357239|79336096|FG000|Stratum: All Patients|Adverse Event|0|||
44330787|NCT01357239|79336097|FG001|Stratum: All Patients|Adverse Event|0|||
44330788|NCT01357239|79336098|FG002|Stratum: All Patients|Adverse Event|1|||
44330789|NCT01357239|79336099|FG003|Stratum: All Patients|Adverse Event|1|||
44258747|NCT02623699|79113785|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
44258748|NCT02623699|79113786|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
44258749|NCT02623699|79113787|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
44258750|NCT02623699|79113788|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
44258751|NCT02623699|79113789|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
44258752|NCT02501642|79113830|FG000|Overall Study|Lost to Follow-up|7|||
44258753|NCT02501642|79113831|FG001|Overall Study|Lost to Follow-up|11|||
44537603|NCT03426345|79548419|FG001|Overall Study|Lack of Efficacy|0|||
44537604|NCT03426345|79548418|FG000|Overall Study|Withdrawal by Subject|5|||
44537605|NCT03426345|79548419|FG001|Overall Study|Withdrawal by Subject|6|||
44258754|NCT02475954|79113839|FG000|Overall Study|Withdrawal by Subject|2|||
44258755|NCT02475954|79113840|FG001|Overall Study|Withdrawal by Subject|2|||
44258756|NCT02475954|79113839|FG000|Overall Study|Lost to Follow-up|11|||
44258757|NCT02475954|79113840|FG001|Overall Study|Lost to Follow-up|9|||
44258758|NCT02475954|79113839|FG000|Overall Study|Death|1|||
44330790|NCT01357239|79336096|FG000|Stratum: All Patients|Subject withdrew consent|0|||
44330791|NCT01357239|79336097|FG001|Stratum: All Patients|Subject withdrew consent|0|||
44330792|NCT01357239|79336098|FG002|Stratum: All Patients|Subject withdrew consent|1|||
44330793|NCT01357239|79336099|FG003|Stratum: All Patients|Subject withdrew consent|1|||
44330794|NCT01357239|79336096|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
44330795|NCT01357239|79336097|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
44330796|NCT01357239|79336098|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
44427321|NCT00429169|79435188|FG001|Overall Study|Ineligibility discovered after entry|1|||
44537606|NCT03426345|79548418|FG000|Overall Study|Lost to Follow-up|3|||
44537607|NCT03426345|79548419|FG001|Overall Study|Lost to Follow-up|1|||
44330797|NCT01357239|79336099|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
44330798|NCT01357239|79336096|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
44330799|NCT01357239|79336097|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
44330800|NCT01357239|79336098|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
44330801|NCT01357239|79336099|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
44330802|NCT01357239|79336096|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
44330803|NCT01357239|79336097|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
44330804|NCT01357239|79336098|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
44330805|NCT01357239|79336099|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
44330806|NCT01351350|79336117|FG000|Overall Study|Disease Progression|5|||
44330807|NCT01351350|79336118|FG001|Overall Study|Disease Progression|13|||
44330808|NCT01351350|79336119|FG002|Overall Study|Disease Progression|6|||
44330809|NCT01351350|79336120|FG003|Overall Study|Disease Progression|8|||
44330810|NCT01351350|79336121|FG004|Overall Study|Disease Progression|5|||
44330811|NCT01351350|79336117|FG000|Overall Study|Adverse Event|1|||
44330812|NCT01351350|79336118|FG001|Overall Study|Adverse Event|10|||
44330813|NCT01351350|79336119|FG002|Overall Study|Adverse Event|1|||
44330814|NCT01351350|79336120|FG003|Overall Study|Adverse Event|2|||
44330815|NCT01351350|79336121|FG004|Overall Study|Adverse Event|0|||
44330816|NCT01351350|79336117|FG000|Overall Study|Participant Decision|2|||
44427322|NCT00416455|79435198|FG000|Overall Study|PET / CT not done|3|||
44427323|NCT00416455|79435199|FG001|Overall Study|PET / CT not done|5|||
44427324|NCT00416455|79435198|FG000|Overall Study|PET / CT poor quality|2|||
44427325|NCT00416455|79435199|FG001|Overall Study|PET / CT poor quality|1|||
44427326|NCT00416455|79435198|FG000|Overall Study|Inadequate pathology|11|||
44427327|NCT00416455|79435199|FG001|Overall Study|Inadequate pathology|2|||
44427328|NCT00415909|79435216|FG000|Overall Study|Withdrawal by Subject|2|||
44427329|NCT00415909|79435216|FG000|Overall Study|Death|1|||
44427330|NCT00415597|79435220|FG000|Enrollment|Withdrawal by Subject|1|||
44427331|NCT00415597|79435220|FG000|Enrollment|Protocol Violation|1|||
44427332|NCT00415597|79435220|FG000|Treatment|Adverse Event|110|||
44427333|NCT00415597|79435220|FG000|Treatment|Lack of Efficacy|39|||
44537608|NCT03426345|79548418|FG000|Overall Study|Protocol Deviation|3|||
44537609|NCT03426345|79548419|FG001|Overall Study|Protocol Deviation|4|||
44537610|NCT03426345|79548418|FG000|Overall Study|Reason Not Specified|1|||
44537611|NCT03426345|79548419|FG001|Overall Study|Reason Not Specified|2|||
44537612|NCT03426345|79548418|FG000|Overall Study|Missing Completion Status|1|||
44537613|NCT03426345|79548419|FG001|Overall Study|Missing Completion Status|0|||
44537614|NCT03426267|79548428|FG000|Overall Study|Physician Decision|1|||
44537615|NCT03426267|79548429|FG001|Overall Study|Physician Decision|4|||
44537616|NCT03426267|79548428|FG000|Overall Study|Lost to Follow-up|1|||
44537617|NCT03426267|79548429|FG001|Overall Study|Lost to Follow-up|0|||
44537618|NCT03426267|79548428|FG000|Overall Study|Withdrawal by Subject|4|||
44537619|NCT03426267|79548429|FG001|Overall Study|Withdrawal by Subject|10|||
44537620|NCT03426267|79548428|FG000|Overall Study|Protocol Violation|1|||
44537621|NCT03426267|79548429|FG001|Overall Study|Protocol Violation|3|||
44537622|NCT03426267|79548428|FG000|Overall Study|Adverse Event|9|||
44537623|NCT03426267|79548429|FG001|Overall Study|Adverse Event|27|||
44537624|NCT03426267|79548428|FG000|Overall Study|Prohibited Treatment Intake|2|||
44537625|NCT03426267|79548429|FG001|Overall Study|Prohibited Treatment Intake|3|||
44537626|NCT03426267|79548428|FG000|Overall Study|Lack of Efficacy|0|||
44537627|NCT03426267|79548429|FG001|Overall Study|Lack of Efficacy|25|||
44537628|NCT03426267|79548428|FG000|Overall Study|other|3|||
44537629|NCT03426267|79548429|FG001|Overall Study|other|0|||
44537630|NCT03412929|79548435|FG000|Overall Study|Protocol Violation|3|||
44537631|NCT03451773|79548441|FG000|Overall Study|Death on study|1|||
44330817|NCT01351350|79336118|FG001|Overall Study|Participant Decision|6|||
44427334|NCT00415597|79435220|FG000|Treatment|Protocol Violation|67|||
44330818|NCT01351350|79336119|FG002|Overall Study|Participant Decision|3|||
44330819|NCT01351350|79336120|FG003|Overall Study|Participant Decision|3|||
44330820|NCT01351350|79336121|FG004|Overall Study|Participant Decision|2|||
44330821|NCT01351350|79336117|FG000|Overall Study|Enrolled but not Treated|0|||
44427335|NCT00415597|79435220|FG000|Treatment|Physician Decision|3|||
44537632|NCT03451773|79548442|FG001|Overall Study|Death on study|5|||
44537633|NCT03451773|79548441|FG000|Overall Study|Death during follow-up period|0|||
44537634|NCT03451773|79548442|FG001|Overall Study|Death during follow-up period|1|||
44537635|NCT03425253|79548449|FG000|Overall Study|Adverse Event|2|||
44537636|NCT03425253|79548449|FG000|Overall Study|Lost to Follow-up|3|||
44427336|NCT00415597|79435220|FG000|Treatment|Withdrawal by Subject|51|||
44427337|NCT00415597|79435220|FG000|Treatment|Lost to Follow-up|28|||
44427338|NCT00415597|79435220|FG000|Treatment|Drug Screen|2|||
44427339|NCT00415597|79435220|FG000|Treatment|Administrative|3|||
44427340|NCT00415597|79435220|FG000|Treatment|Sponsor Decision|1|||
44427341|NCT00415597|79435220|FG000|Treatment|Multiple Reasons|1|||
44427342|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
44427343|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
44427344|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
44427345|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
44427346|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
44427347|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
44427348|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
44427349|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
44427350|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
44427351|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
44427352|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
44330822|NCT01351350|79336118|FG001|Overall Study|Enrolled but not Treated|0|||
44330823|NCT01351350|79336119|FG002|Overall Study|Enrolled but not Treated|1|||
44330824|NCT01351350|79336120|FG003|Overall Study|Enrolled but not Treated|0|||
44330825|NCT01351350|79336121|FG004|Overall Study|Enrolled but not Treated|0|||
44427353|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
44427354|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
44537637|NCT03425253|79548449|FG000|Overall Study|Withdrew Consent|6|||
44537638|NCT03425253|79548449|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
44537639|NCT03424239|79548454|FG000|Overall Study|Withdrawal by Subject|2|||
44537640|NCT03451071|79548458|FG000|First Vaccine|Withdrawal by Subject|1|||
44537641|NCT03451071|79548458|FG000|Second Vaccine|Lost to Follow-up|19|||
44537642|NCT03451071|79548458|FG000|Third Vaccine|Lost to Follow-up|22|||
44537643|NCT03451071|79548458|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
44537644|NCT03449979|79548466|FG000|Overall Study|Technical difficulty|0|||
44537645|NCT03449979|79548467|FG001|Overall Study|Technical difficulty|0|||
44537646|NCT03449979|79548468|FG002|Overall Study|Technical difficulty|0|||
44537647|NCT03449979|79548469|FG003|Overall Study|Technical difficulty|1|||
44537648|NCT03449199|79548482|FG000|Overall Study|Lost to Follow-up|1|||
44537649|NCT03449199|79548483|FG001|Overall Study|Lost to Follow-up|1|||
44537650|NCT03449199|79548484|FG002|Overall Study|Lost to Follow-up|0|||
44537651|NCT03449199|79548482|FG000|Overall Study|Protocol Deviation|0|||
44537652|NCT03449199|79548483|FG001|Overall Study|Protocol Deviation|0|||
44537653|NCT03449199|79548484|FG002|Overall Study|Protocol Deviation|1|||
44537654|NCT03449199|79548482|FG000|Overall Study|Withdrawal by Subject|0|||
44537655|NCT03449199|79548483|FG001|Overall Study|Withdrawal by Subject|0|||
44537656|NCT03449199|79548484|FG002|Overall Study|Withdrawal by Subject|1|||
44537657|NCT03421431|79548498|FG000|Overall Study|Adverse Event|2|||
44537658|NCT03421431|79548499|FG001|Overall Study|Adverse Event|1|||
44537659|NCT03421431|79548500|FG002|Overall Study|Adverse Event|12|||
44537660|NCT03421431|79548498|FG000|Overall Study|Lost to Follow-up|1|||
44537661|NCT03421431|79548499|FG001|Overall Study|Lost to Follow-up|1|||
44537662|NCT03421431|79548500|FG002|Overall Study|Lost to Follow-up|1|||
44330826|NCT01350999|79336149|FG000|Overall Study|Adverse Event|4|||
44330827|NCT01350999|79336150|FG001|Overall Study|Adverse Event|9|||
44330828|NCT01350999|79336151|FG002|Overall Study|Adverse Event|10|||
44330829|NCT01350999|79336149|FG000|Overall Study|Voluntary withdrawal|3|||
44330830|NCT01350999|79336150|FG001|Overall Study|Voluntary withdrawal|4|||
44330831|NCT01350999|79336151|FG002|Overall Study|Voluntary withdrawal|6|||
44330832|NCT01350999|79336149|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
44537663|NCT03421431|79548498|FG000|Overall Study|Withdrawal by Subject|3|||
44537664|NCT03421431|79548499|FG001|Overall Study|Withdrawal by Subject|2|||
44537665|NCT03421431|79548500|FG002|Overall Study|Withdrawal by Subject|1|||
44537666|NCT03421431|79548498|FG000|Overall Study|Protocol Violation|0|||
44537667|NCT03421431|79548499|FG001|Overall Study|Protocol Violation|1|||
44537668|NCT03421431|79548500|FG002|Overall Study|Protocol Violation|0|||
44537669|NCT03421431|79548498|FG000|Overall Study|Participant met Stopping Rules|0|||
44537670|NCT03421431|79548499|FG001|Overall Study|Participant met Stopping Rules|1|||
44537671|NCT03421431|79548500|FG002|Overall Study|Participant met Stopping Rules|0|||
44537672|NCT03448419|79548512|FG000|Overall Study|Adverse Event|10|||
44537673|NCT03448419|79548513|FG001|Overall Study|Adverse Event|9|||
44156961|NCT03178045|78948401|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
44330833|NCT01350999|79336150|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
44427355|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
44537674|NCT03448419|79548512|FG000|Overall Study|Lost to Follow-up|0|||
44537675|NCT03448419|79548513|FG001|Overall Study|Lost to Follow-up|2|||
44330834|NCT01350999|79336151|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
44537676|NCT03448419|79548512|FG000|Overall Study|Withdrawal by Subject|3|||
44537677|NCT03448419|79548513|FG001|Overall Study|Withdrawal by Subject|1|||
44537678|NCT03448419|79548512|FG000|Overall Study|Not treated|0|||
44427356|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
44427357|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
44427358|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
44427359|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
44427360|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
44427361|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
44427362|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
44427363|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
44427364|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
44427365|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
44427366|NCT00620542|79435226|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
44427367|NCT00620542|79435227|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
44427368|NCT00620542|79435228|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
44427369|NCT00620542|79435229|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
44427370|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
44427371|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
44427372|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
44427373|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
44427374|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
44427375|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
44427376|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
44427377|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
44427378|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
44427379|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
44427380|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
44427381|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
44427382|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
44427383|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
44427384|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
44427385|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
44427386|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
44427387|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
44427388|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
44427389|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
44427390|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
44427391|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
44427392|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
44427393|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
44427394|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
44427395|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
44427396|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
44427397|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
44427398|NCT00620542|79435226|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
44427399|NCT00620542|79435227|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
44427400|NCT00620542|79435228|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
44427401|NCT00620542|79435229|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
44427402|NCT05096208|79435241|FG000|Overall Study|Lost to Follow-up|3|||
44427403|NCT05096208|79435242|FG001|Overall Study|Lost to Follow-up|5|||
44427404|NCT05096208|79435243|FG002|Overall Study|Lost to Follow-up|5|||
44427405|NCT05096208|79435244|FG003|Overall Study|Lost to Follow-up|2|||
44427406|NCT05096208|79435241|FG000|Overall Study|Withdrawal by Subject|0|||
44427407|NCT05096208|79435242|FG001|Overall Study|Withdrawal by Subject|1|||
44427408|NCT05096208|79435243|FG002|Overall Study|Withdrawal by Subject|2|||
44330835|NCT01330914|79336170|FG000|Overall Study|Withdrawal by Subject|4|||
44330836|NCT01330914|79336170|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
44330837|NCT01350804|79336178|FG000|Core Study|Withdrawal by Subject|11|||
44330838|NCT01350804|79336179|FG001|Core Study|Withdrawal by Subject|17|||
44330839|NCT01350804|79336180|FG002|Core Study|Withdrawal by Subject|16|||
44330840|NCT01350804|79336181|FG003|Core Study|Withdrawal by Subject|7|||
44330841|NCT01350804|79336178|FG000|Core Study|Study terminated by Sponsor|0|||
44330842|NCT01350804|79336179|FG001|Core Study|Study terminated by Sponsor|0|||
44330843|NCT01350804|79336180|FG002|Core Study|Study terminated by Sponsor|0|||
44427409|NCT05096208|79435244|FG003|Overall Study|Withdrawal by Subject|3|||
44427410|NCT05096208|79435241|FG000|Overall Study|No longer met eligibility criteria|1|||
44330844|NCT01350804|79336181|FG003|Core Study|Study terminated by Sponsor|2|||
44427411|NCT05096208|79435242|FG001|Overall Study|No longer met eligibility criteria|0|||
44427412|NCT05096208|79435243|FG002|Overall Study|No longer met eligibility criteria|0|||
44427413|NCT05096208|79435244|FG003|Overall Study|No longer met eligibility criteria|0|||
44427414|NCT05096208|79435241|FG000|Overall Study|Other|0|||
44330845|NCT01350804|79336178|FG000|Core Study|Protocol deviation|1|||
44330846|NCT01350804|79336179|FG001|Core Study|Protocol deviation|0|||
44330847|NCT01350804|79336180|FG002|Core Study|Protocol deviation|1|||
44427415|NCT05096208|79435242|FG001|Overall Study|Other|0|||
44427416|NCT05096208|79435243|FG002|Overall Study|Other|1|||
44427417|NCT05096208|79435244|FG003|Overall Study|Other|0|||
44427418|NCT04555616|79435263|FG000|Overall Study|Death|1|||
44427419|NCT04555616|79435264|FG001|Overall Study|Death|0|||
44427420|NCT04555616|79435265|FG002|Overall Study|Death|1|||
44427421|NCT04555616|79435263|FG000|Overall Study|Withdrawal by Subject|2|||
44427422|NCT04555616|79435264|FG001|Overall Study|Withdrawal by Subject|1|||
44427423|NCT04555616|79435265|FG002|Overall Study|Withdrawal by Subject|0|||
44427424|NCT04177758|79435289|FG000|Overall Study|Lost to Follow-up|19|||
44427425|NCT04177758|79435290|FG001|Overall Study|Lost to Follow-up|11|||
44427426|NCT04003103|79435299|FG000|Overall Study|Death|1|||
44427427|NCT04003103|79435300|FG001|Overall Study|Death|0|||
44427428|NCT04003103|79435301|FG002|Overall Study|Death|0|||
44427429|NCT04003103|79435299|FG000|Overall Study|Lost to Follow-up|4|||
44537679|NCT03448419|79548513|FG001|Overall Study|Not treated|1|||
44537680|NCT03448419|79548512|FG000|Overall Study|Patient did not attend all visits|0|||
44330848|NCT01350804|79336181|FG003|Core Study|Protocol deviation|0|||
44427430|NCT04003103|79435300|FG001|Overall Study|Lost to Follow-up|3|||
44427431|NCT04003103|79435301|FG002|Overall Study|Lost to Follow-up|2|||
44427432|NCT04003103|79435299|FG000|Overall Study|Withdrawal by Subject|10|||
44427433|NCT04003103|79435300|FG001|Overall Study|Withdrawal by Subject|1|||
44427434|NCT04003103|79435301|FG002|Overall Study|Withdrawal by Subject|1|||
44427435|NCT04003103|79435299|FG000|Overall Study|Status not recorded|0|||
44427436|NCT04003103|79435300|FG001|Overall Study|Status not recorded|2|||
44427437|NCT04003103|79435301|FG002|Overall Study|Status not recorded|0|||
44427438|NCT03921528|79435350|FG000|Overall Study|Withdrawal by Subject|0|||
44427439|NCT03921528|79435351|FG001|Overall Study|Withdrawal by Subject|1|||
44427440|NCT03921528|79435352|FG002|Overall Study|Withdrawal by Subject|0|||
44427441|NCT03921528|79435353|FG003|Overall Study|Withdrawal by Subject|0|||
44427442|NCT03921528|79435354|FG004|Overall Study|Withdrawal by Subject|0|||
44427443|NCT03832322|79435372|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
44427444|NCT03832322|79435373|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
44427445|NCT03642990|79435389|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
44427446|NCT03642990|79435389|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
44427447|NCT03639311|79435395|FG000|Overall Study|Ongoing at the time of analysis|88|||
44427448|NCT03639311|79435396|FG001|Overall Study|Ongoing at the time of analysis|0|||
44427449|NCT03639311|79435395|FG000|Overall Study|Lost to Follow-up|1|||
44427450|NCT03639311|79435396|FG001|Overall Study|Lost to Follow-up|0|||
44427451|NCT03639311|79435395|FG000|Overall Study|Adverse Event|1|||
44427452|NCT03639311|79435396|FG001|Overall Study|Adverse Event|0|||
44427453|NCT03633825|79435407|FG000|Enrollment|Did not post on network|5066|||
44427454|NCT03633825|79435408|FG001|Enrollment|Did not post on network|5080|||
44427455|NCT03633825|79435407|FG000|Enrollment|Post not classified as crisis|13967|||
44537681|NCT03448419|79548513|FG001|Overall Study|Patient did not attend all visits|2|||
44330849|NCT01350804|79336178|FG000|Core Study|Physician Decision|1|||
44330850|NCT01350804|79336179|FG001|Core Study|Physician Decision|0|||
44330851|NCT01350804|79336180|FG002|Core Study|Physician Decision|1|||
44258759|NCT02475954|79113840|FG001|Overall Study|Death|1|||
44258760|NCT02459587|79113849|FG000|3-Month Follow-up Assessment|Death|0|||
44258761|NCT02459587|79113850|FG001|3-Month Follow-up Assessment|Death|2|||
44258762|NCT02459587|79113849|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
44258763|NCT02459587|79113850|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
44258764|NCT02459587|79113849|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
44258765|NCT02459587|79113850|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
44258766|NCT02459587|79113849|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
44258767|NCT02459587|79113850|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
44258768|NCT02459587|79113849|FG000|6-month Follow-up Assessment|Death|2|||
44258769|NCT02459587|79113850|FG001|6-month Follow-up Assessment|Death|1|||
44330852|NCT01350804|79336181|FG003|Core Study|Physician Decision|3|||
44330853|NCT01350804|79336178|FG000|Core Study|Lost to Follow-up|3|||
44330854|NCT01350804|79336179|FG001|Core Study|Lost to Follow-up|0|||
44330855|NCT01350804|79336180|FG002|Core Study|Lost to Follow-up|2|||
44330856|NCT01350804|79336181|FG003|Core Study|Lost to Follow-up|1|||
44427456|NCT03633825|79435408|FG001|Enrollment|Post not classified as crisis|13757|||
44427457|NCT03633825|79435407|FG000|Follow up|Lost to Follow-up|478|||
44330857|NCT01350804|79336178|FG000|Core Study|Lack of Efficacy|16|||
44427458|NCT03633825|79435408|FG001|Follow up|Lost to Follow-up|450|||
44427459|NCT05427539|79435414|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
44427460|NCT05427539|79435415|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
44427461|NCT05427539|79435414|FG000|Period 1|Withdrawal by Subject|1|||
44427462|NCT05427539|79435415|FG001|Period 1|Withdrawal by Subject|0|||
44427463|NCT05144945|79435423|FG000|Overall Study|Withdrawal by Subject|1|||
44427464|NCT05144945|79435424|FG001|Overall Study|Withdrawal by Subject|0|||
44330858|NCT01350804|79336179|FG001|Core Study|Lack of Efficacy|19|||
44330859|NCT01350804|79336180|FG002|Core Study|Lack of Efficacy|18|||
44427465|NCT03768336|79435468|FG000|Overall Study|Lost to Follow-up|3|||
44427466|NCT03768336|79435469|FG001|Overall Study|Lost to Follow-up|2|||
44427467|NCT03768336|79435468|FG000|Overall Study|Became Ineligible|2|||
44427468|NCT03768336|79435469|FG001|Overall Study|Became Ineligible|0|||
44427469|NCT03768336|79435468|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
44427470|NCT03768336|79435469|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
44427471|NCT03768336|79435468|FG000|Overall Study|Missed final survey (post-treatment|0|||
44427472|NCT03768336|79435469|FG001|Overall Study|Missed final survey (post-treatment|1|||
44427473|NCT03742141|79435476|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
44427474|NCT02968849|79435482|FG000|Overall Study|Death|8|||
44427475|NCT02968849|79435483|FG001|Overall Study|Death|10|||
44427476|NCT02968849|79435482|FG000|Overall Study|Lost to Follow-up|31|||
44427477|NCT02968849|79435483|FG001|Overall Study|Lost to Follow-up|29|||
44427478|NCT02968849|79435482|FG000|Overall Study|Withdrawal by Subject|73|||
44427479|NCT02968849|79435483|FG001|Overall Study|Withdrawal by Subject|64|||
44427480|NCT02968849|79435482|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
44427481|NCT02968849|79435483|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
44427482|NCT02968849|79435482|FG000|Overall Study|Physician Decision|6|||
44427483|NCT02968849|79435483|FG001|Overall Study|Physician Decision|9|||
44427484|NCT02968849|79435482|FG000|Overall Study|Other|16|||
44427485|NCT02968849|79435483|FG001|Overall Study|Other|10|||
44427486|NCT02795104|79435495|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
44427487|NCT02795104|79435496|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
44427488|NCT02795104|79435497|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
44427489|NCT02795104|79435495|FG000|Overall Study|Withdrawal by Subject|0|||
44427490|NCT02795104|79435496|FG001|Overall Study|Withdrawal by Subject|2|||
44427491|NCT02795104|79435497|FG002|Overall Study|Withdrawal by Subject|0|||
44427492|NCT02795104|79435495|FG000|Overall Study|Lost to Follow-up|0|||
44427493|NCT02795104|79435496|FG001|Overall Study|Lost to Follow-up|0|||
44427494|NCT02795104|79435497|FG002|Overall Study|Lost to Follow-up|1|||
44427495|NCT02675244|79435510|FG000|Overall Study|Death|9|||
44330860|NCT01350804|79336181|FG003|Core Study|Lack of Efficacy|5|||
44258770|NCT02459587|79113849|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
44258771|NCT02459587|79113850|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
44258772|NCT02459587|79113849|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
44427496|NCT02675244|79435511|FG001|Overall Study|Death|6|||
44427497|NCT02675244|79435510|FG000|Overall Study|Withdrawal by Subject|3|||
44427498|NCT02675244|79435511|FG001|Overall Study|Withdrawal by Subject|6|||
44427499|NCT02675244|79435510|FG000|Overall Study|Lost to Follow-up|1|||
44427500|NCT02675244|79435511|FG001|Overall Study|Lost to Follow-up|1|||
44427501|NCT02675244|79435510|FG000|Overall Study|Ongoing at 2 Years|190|||
44427502|NCT02675244|79435511|FG001|Overall Study|Ongoing at 2 Years|185|||
44427503|NCT01298323|79435581|FG000|Overall Study|Adverse Event|2|||
44427504|NCT01298323|79435582|FG001|Overall Study|Adverse Event|4|||
44427505|NCT01298323|79435581|FG000|Overall Study|Death|11|||
44427506|NCT01298323|79435582|FG001|Overall Study|Death|16|||
44427507|NCT01298323|79435581|FG000|Overall Study|Lost to Follow-up|1|||
44427508|NCT01298323|79435582|FG001|Overall Study|Lost to Follow-up|0|||
44427509|NCT01298323|79435581|FG000|Overall Study|Withdrawal by Subject|6|||
44427510|NCT01298323|79435582|FG001|Overall Study|Withdrawal by Subject|3|||
44156962|NCT03178045|78948400|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
44156963|NCT03178045|78948401|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
44156964|NCT02924727|78948442|FG000|Overall Study|Withdrawal by Subject|2|||
44156965|NCT02924727|78948443|FG001|Overall Study|Withdrawal by Subject|4|||
44156966|NCT02924727|78948442|FG000|Overall Study|Lost to Follow-up|2|||
44156967|NCT02924727|78948443|FG001|Overall Study|Lost to Follow-up|5|||
44156968|NCT02924727|78948442|FG000|Overall Study|Death|221|||
44156969|NCT02924727|78948443|FG001|Overall Study|Death|247|||
44258773|NCT02459587|79113850|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
44258774|NCT02459587|79113849|FG000|12-month Follow-up Assessment|Death|2|||
44258775|NCT02459587|79113850|FG001|12-month Follow-up Assessment|Death|0|||
44258776|NCT02459587|79113849|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
44258777|NCT02459587|79113850|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
44258778|NCT02459587|79113849|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
44258779|NCT02459587|79113850|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
44258780|NCT02459587|79113849|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
44427511|NCT01298323|79435581|FG000|Overall Study|Protocol Violation|1|||
44427512|NCT01298323|79435582|FG001|Overall Study|Protocol Violation|0|||
44427513|NCT01298323|79435581|FG000|Overall Study|Other|10|||
44427514|NCT01298323|79435582|FG001|Overall Study|Other|9|||
44427515|NCT01298323|79435581|FG000|Overall Study|Ongoing|55|||
44427516|NCT01298323|79435582|FG001|Overall Study|Ongoing|55|||
44427517|NCT01298323|79435581|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44427518|NCT01298323|79435582|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44427519|NCT01268579|79435588|FG000|Overall Study|Adverse Event|1|||
44427520|NCT01268579|79435588|FG000|Overall Study|Withdrawal by Subject|2|||
44427521|NCT01056523|79435592|FG000|Overall Study|Death|1|||
44427522|NCT01056523|79435593|FG001|Overall Study|Death|0|||
44427523|NCT01056523|79435594|FG002|Overall Study|Death|2|||
44427524|NCT01056523|79435595|FG003|Overall Study|Death|3|||
44427525|NCT01056523|79435596|FG004|Overall Study|Death|0|||
44427526|NCT01056523|79435597|FG005|Overall Study|Death|0|||
44427527|NCT01056523|79435598|FG006|Overall Study|Death|1|||
44427528|NCT00554788|79435619|FG000|Overall Study|Adverse Event|0|||
44427529|NCT00554788|79435620|FG001|Overall Study|Adverse Event|1|||
44427530|NCT00554788|79435621|FG002|Overall Study|Adverse Event|2|||
44427531|NCT00554788|79435619|FG000|Overall Study|Lost to Follow-up|4|||
44427532|NCT00554788|79435620|FG001|Overall Study|Lost to Follow-up|3|||
44427533|NCT00554788|79435621|FG002|Overall Study|Lost to Follow-up|3|||
44427534|NCT00554788|79435619|FG000|Overall Study|Physician Decision|1|||
44427535|NCT00554788|79435620|FG001|Overall Study|Physician Decision|1|||
44427536|NCT00554788|79435621|FG002|Overall Study|Physician Decision|3|||
44427537|NCT00554788|79435619|FG000|Overall Study|Withdrawal by Subject|0|||
44427538|NCT00554788|79435620|FG001|Overall Study|Withdrawal by Subject|0|||
44427539|NCT00554788|79435621|FG002|Overall Study|Withdrawal by Subject|1|||
44427540|NCT00554788|79435619|FG000|Overall Study|Refusal of further protocol therapy|0|||
44427541|NCT00554788|79435620|FG001|Overall Study|Refusal of further protocol therapy|1|||
44427542|NCT00554788|79435621|FG002|Overall Study|Refusal of further protocol therapy|1|||
44427543|NCT00554788|79435619|FG000|Overall Study|Progressive disease|0|||
44427544|NCT00554788|79435620|FG001|Overall Study|Progressive disease|0|||
44427545|NCT00554788|79435621|FG002|Overall Study|Progressive disease|3|||
44427546|NCT00554788|79435619|FG000|Overall Study|Ineligible|2|||
44427547|NCT00554788|79435620|FG001|Overall Study|Ineligible|0|||
44427548|NCT00554788|79435621|FG002|Overall Study|Ineligible|1|||
44427549|NCT00410761|79435632|FG000|Overall Study|Adverse Event|29|||
44427550|NCT00410761|79435633|FG001|Overall Study|Adverse Event|3|||
44427551|NCT00410761|79435632|FG000|Overall Study|objective disease progression|71|||
44427552|NCT00410761|79435633|FG001|Overall Study|objective disease progression|55|||
44427553|NCT00410761|79435632|FG000|Overall Study|Withdrawal by Subject|8|||
44427554|NCT00410761|79435633|FG001|Overall Study|Withdrawal by Subject|4|||
44427555|NCT00410761|79435632|FG000|Overall Study|Other|12|||
44427556|NCT00410761|79435633|FG001|Overall Study|Other|9|||
44427557|NCT00410761|79435632|FG000|Overall Study|Never received randomised treatment|0|||
44427558|NCT00410761|79435633|FG001|Overall Study|Never received randomised treatment|1|||
44427559|NCT00374595|79435639|FG000|Overall Study|Death|23|||
44427560|NCT00374595|79435639|FG000|Overall Study|Withdrawal by Subject|39|||
44427561|NCT00374595|79435639|FG000|Overall Study|Lost to Follow-up|3|||
44427562|NCT00374595|79435639|FG000|Overall Study|too much time commitment|1|||
44427563|NCT00374595|79435639|FG000|Overall Study|transfer care to other clinical site|1|||
44427564|NCT00374595|79435639|FG000|Overall Study|relocation|3|||
44427565|NCT03465540|79435649|FG000|Overall Study|Withdrawal by Subject|0|||
44427566|NCT03465540|79435650|FG001|Overall Study|Withdrawal by Subject|0|||
44427567|NCT03465540|79435651|FG002|Overall Study|Withdrawal by Subject|1|||
44427568|NCT03465540|79435652|FG003|Overall Study|Withdrawal by Subject|1|||
44427569|NCT03465540|79435653|FG004|Overall Study|Withdrawal by Subject|1|||
44427570|NCT03465540|79435654|FG005|Overall Study|Withdrawal by Subject|0|||
44427571|NCT03465540|79435649|FG000|Overall Study|Lost to Follow-up|0|||
44427572|NCT03465540|79435650|FG001|Overall Study|Lost to Follow-up|1|||
44427573|NCT03465540|79435651|FG002|Overall Study|Lost to Follow-up|0|||
44427574|NCT03465540|79435652|FG003|Overall Study|Lost to Follow-up|0|||
44427575|NCT03465540|79435653|FG004|Overall Study|Lost to Follow-up|1|||
44427576|NCT03465540|79435654|FG005|Overall Study|Lost to Follow-up|0|||
44427577|NCT03465540|79435649|FG000|Overall Study|Death|1|||
44427578|NCT03465540|79435650|FG001|Overall Study|Death|1|||
44427579|NCT03465540|79435651|FG002|Overall Study|Death|0|||
44427580|NCT03465540|79435652|FG003|Overall Study|Death|2|||
44427581|NCT03465540|79435653|FG004|Overall Study|Death|0|||
44427582|NCT03465540|79435654|FG005|Overall Study|Death|2|||
44258781|NCT02459587|79113850|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
44427583|NCT03465540|79435649|FG000|Overall Study|Protocol specified criteria|0|||
44427584|NCT03465540|79435650|FG001|Overall Study|Protocol specified criteria|2|||
44427585|NCT03465540|79435651|FG002|Overall Study|Protocol specified criteria|2|||
44427586|NCT03465540|79435652|FG003|Overall Study|Protocol specified criteria|0|||
44427587|NCT03465540|79435653|FG004|Overall Study|Protocol specified criteria|2|||
44427588|NCT03465540|79435654|FG005|Overall Study|Protocol specified criteria|0|||
44427589|NCT03055832|79435702|FG000|Week 2|Withdrawal by Subject|1|||
44427590|NCT03055832|79435703|FG001|Week 2|Withdrawal by Subject|0|||
44427591|NCT02768870|79435744|FG000|Overall Study|Death|1|||
44427592|NCT02768870|79435744|FG000|Overall Study|Reoperation|6|||
44427593|NCT02768870|79435744|FG000|Overall Study|Lost to Follow-up|1|||
44427594|NCT02768870|79435744|FG000|Overall Study|Exit|4|||
44427595|NCT02750618|79435748|FG000|Overall Study|Withdrawal by Subject|1|||
44427596|NCT02537431|79435752|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
44427597|NCT02526160|79435758|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
44427598|NCT02526160|79435759|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
44427599|NCT02526160|79435758|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
44427600|NCT02526160|79435759|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
44427601|NCT02526160|79435758|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
44427602|NCT02526160|79435759|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
44427603|NCT02526160|79435758|FG000|Open-Label Treatment Extension Period I|Death|0|||
44427604|NCT02526160|79435759|FG001|Open-Label Treatment Extension Period I|Death|1|||
44427605|NCT02526160|79435758|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
44427606|NCT02526160|79435759|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
44427607|NCT02526160|79435758|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
44427608|NCT02526160|79435759|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
44427609|NCT02526160|79435758|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
44427610|NCT02526160|79435759|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
44427611|NCT02526160|79435758|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
44427612|NCT02526160|79435759|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
44427613|NCT02157610|79435781|FG000|Overall Study|Death|4|||
44427614|NCT02157610|79435782|FG001|Overall Study|Death|4|||
44427615|NCT01511250|79435816|FG000|Overall Study|Withdrawal of Consent|1|||
44427616|NCT01511250|79435817|FG001|Overall Study|Withdrawal of Consent|0|||
44427617|NCT01511250|79435818|FG002|Overall Study|Withdrawal of Consent|0|||
44427618|NCT01511250|79435819|FG003|Overall Study|Withdrawal of Consent|0|||
44427619|NCT01511250|79435820|FG004|Overall Study|Withdrawal of Consent|0|||
44427620|NCT01511250|79435821|FG005|Overall Study|Withdrawal of Consent|0|||
44537682|NCT03448419|79548512|FG000|Overall Study|Withdrawn by Sponsor|0|||
44537683|NCT03448419|79548513|FG001|Overall Study|Withdrawn by Sponsor|1|||
44537684|NCT04816214|79548535|FG000|Overall Study|Progressive Disease|4|||
44537685|NCT04816214|79548536|FG001|Overall Study|Progressive Disease|0|||
44537686|NCT04816214|79548537|FG002|Overall Study|Progressive Disease|0|||
44537687|NCT04816214|79548535|FG000|Overall Study|Death|1|||
44537688|NCT04816214|79548536|FG001|Overall Study|Death|0|||
44537689|NCT04816214|79548537|FG002|Overall Study|Death|0|||
44156970|NCT02924727|78948442|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
44330861|NCT01350804|79336178|FG000|Core Study|Death|1|||
44330862|NCT01350804|79336179|FG001|Core Study|Death|1|||
44330863|NCT01350804|79336180|FG002|Core Study|Death|1|||
44330864|NCT01350804|79336181|FG003|Core Study|Death|0|||
44330865|NCT01350804|79336178|FG000|Core Study|Adverse Event|8|||
44330866|NCT01350804|79336179|FG001|Core Study|Adverse Event|10|||
44330867|NCT01350804|79336180|FG002|Core Study|Adverse Event|8|||
44330868|NCT01350804|79336181|FG003|Core Study|Adverse Event|8|||
44330869|NCT01350804|79336178|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
44330870|NCT01350804|79336179|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
44330871|NCT01350804|79336180|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
44427621|NCT01511250|79435822|FG006|Overall Study|Withdrawal of Consent|0|||
44427622|NCT01511250|79435823|FG007|Overall Study|Withdrawal of Consent|1|||
44427623|NCT01511250|79435824|FG008|Overall Study|Withdrawal of Consent|1|||
44537690|NCT04816214|79548535|FG000|Overall Study|Study Terminated by Sponsor|1|||
44537691|NCT04816214|79548536|FG001|Overall Study|Study Terminated by Sponsor|0|||
44537692|NCT04816214|79548537|FG002|Overall Study|Study Terminated by Sponsor|0|||
44330872|NCT01350804|79336181|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
44427624|NCT01511250|79435825|FG009|Overall Study|Withdrawal of Consent|0|||
44427625|NCT01511250|79435816|FG000|Overall Study|Sponsor/Investigator Decision|1|||
44427626|NCT01511250|79435817|FG001|Overall Study|Sponsor/Investigator Decision|0|||
44427627|NCT01511250|79435818|FG002|Overall Study|Sponsor/Investigator Decision|0|||
44427628|NCT01511250|79435819|FG003|Overall Study|Sponsor/Investigator Decision|0|||
44427629|NCT01511250|79435820|FG004|Overall Study|Sponsor/Investigator Decision|0|||
44427630|NCT01511250|79435821|FG005|Overall Study|Sponsor/Investigator Decision|0|||
44427631|NCT01511250|79435822|FG006|Overall Study|Sponsor/Investigator Decision|0|||
44427632|NCT01511250|79435823|FG007|Overall Study|Sponsor/Investigator Decision|0|||
44427633|NCT01511250|79435824|FG008|Overall Study|Sponsor/Investigator Decision|0|||
44427634|NCT01511250|79435825|FG009|Overall Study|Sponsor/Investigator Decision|0|||
44427635|NCT01511250|79435816|FG000|Overall Study|Lost to Follow-up|7|||
44427636|NCT01511250|79435817|FG001|Overall Study|Lost to Follow-up|3|||
44427637|NCT01511250|79435818|FG002|Overall Study|Lost to Follow-up|3|||
44427638|NCT01511250|79435819|FG003|Overall Study|Lost to Follow-up|3|||
44427639|NCT01511250|79435820|FG004|Overall Study|Lost to Follow-up|0|||
44427640|NCT01511250|79435821|FG005|Overall Study|Lost to Follow-up|0|||
44427641|NCT01511250|79435822|FG006|Overall Study|Lost to Follow-up|2|||
44427642|NCT01511250|79435823|FG007|Overall Study|Lost to Follow-up|3|||
44427643|NCT01511250|79435824|FG008|Overall Study|Lost to Follow-up|13|||
44427644|NCT01511250|79435825|FG009|Overall Study|Lost to Follow-up|5|||
44427645|NCT01511250|79435816|FG000|Overall Study|Protocol Violation|0|||
44427646|NCT01511250|79435817|FG001|Overall Study|Protocol Violation|2|||
44427647|NCT01511250|79435818|FG002|Overall Study|Protocol Violation|1|||
44427648|NCT01511250|79435819|FG003|Overall Study|Protocol Violation|0|||
44427649|NCT01511250|79435820|FG004|Overall Study|Protocol Violation|0|||
44427650|NCT01511250|79435821|FG005|Overall Study|Protocol Violation|0|||
44427651|NCT01511250|79435822|FG006|Overall Study|Protocol Violation|0|||
44427652|NCT01511250|79435823|FG007|Overall Study|Protocol Violation|0|||
44427653|NCT01511250|79435824|FG008|Overall Study|Protocol Violation|0|||
44427654|NCT01511250|79435825|FG009|Overall Study|Protocol Violation|0|||
44427655|NCT01424566|79435847|FG000|Single-blind Treatment|Adverse Event|71|||
44427656|NCT01424566|79435848|FG001|Single-blind Treatment|Adverse Event|0|||
44427657|NCT01424566|79435849|FG002|Single-blind Treatment|Adverse Event|0|||
44427658|NCT01424566|79435847|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
44427659|NCT01424566|79435848|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
44427660|NCT01424566|79435849|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
44427661|NCT01424566|79435847|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
44537693|NCT04350827|79548582|FG000|Overall Study|Lost to Follow-up|1|||
44537694|NCT04350827|79548583|FG001|Overall Study|Lost to Follow-up|2|||
44537695|NCT04303000|79548591|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
44537696|NCT04303000|79548592|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
44537697|NCT04303000|79548593|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
44537698|NCT04212650|79548614|FG000|Overall Study|Withdrawal by Subject|1|||
44537699|NCT04212650|79548615|FG001|Overall Study|Withdrawal by Subject|0|||
44537700|NCT03992196|79548636|FG000|Enrollment|lost to follow-up prior dosing|1|||
44537701|NCT03992196|79548637|FG001|Enrollment|lost to follow-up prior dosing|0|||
44537702|NCT03992196|79548638|FG002|Enrollment|lost to follow-up prior dosing|0|||
44537703|NCT03992196|79548636|FG000|Treatment|Protocol Violation|0|||
44537704|NCT03992196|79548637|FG001|Treatment|Protocol Violation|0|||
44537705|NCT03992196|79548638|FG002|Treatment|Protocol Violation|1|||
44537706|NCT03992196|79548636|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
44537707|NCT03992196|79548637|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
44537708|NCT03992196|79548638|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
44537709|NCT03992196|79548636|FG000|Treatment|Withdrawal due to non-compliance|0|||
44537710|NCT03992196|79548637|FG001|Treatment|Withdrawal due to non-compliance|0|||
44537711|NCT03992196|79548638|FG002|Treatment|Withdrawal due to non-compliance|1|||
44537712|NCT03992196|79548636|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
44537713|NCT03992196|79548637|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
44537714|NCT03992196|79548638|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
44537715|NCT03992196|79548636|FG000|Treatment|Withdrawal by parent/guardian|0|||
44537716|NCT03992196|79548637|FG001|Treatment|Withdrawal by parent/guardian|0|||
44537717|NCT03992196|79548638|FG002|Treatment|Withdrawal by parent/guardian|2|||
44537718|NCT03970200|79548647|FG000|Overall Study|Death|2|||
44537719|NCT03970200|79548648|FG001|Overall Study|Death|2|||
44537720|NCT03970200|79548649|FG002|Overall Study|Death|1|||
44537721|NCT03970200|79548647|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
44427662|NCT01424566|79435848|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
44427663|NCT01424566|79435849|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
44427664|NCT01424566|79435847|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
44427665|NCT01424566|79435848|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
44427666|NCT01424566|79435849|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
44427667|NCT01424566|79435847|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
44427668|NCT01424566|79435848|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
44427669|NCT01424566|79435849|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
44427670|NCT01424566|79435847|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
44427671|NCT01424566|79435848|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
44427672|NCT01424566|79435849|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
44427673|NCT01424566|79435847|FG000|Double-blind Treatment|Adverse Event|0|||
44427674|NCT01424566|79435848|FG001|Double-blind Treatment|Adverse Event|21|||
44427675|NCT01424566|79435849|FG002|Double-blind Treatment|Adverse Event|13|||
44427676|NCT01424566|79435847|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
44427677|NCT01424566|79435848|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
44427678|NCT01424566|79435849|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
44427679|NCT01424566|79435847|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
44427680|NCT01424566|79435848|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
44427681|NCT01424566|79435849|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
44427682|NCT01424566|79435847|FG000|Double-blind Treatment|Lack of Efficacy|0|||
44427683|NCT01424566|79435848|FG001|Double-blind Treatment|Lack of Efficacy|1|||
44427684|NCT01424566|79435849|FG002|Double-blind Treatment|Lack of Efficacy|1|||
44427685|NCT01361607|79435858|FG000|Overall Study|Adverse Event|38|||
44427686|NCT01361607|79435859|FG001|Overall Study|Adverse Event|29|||
44427687|NCT01361607|79435858|FG000|Overall Study|Withdrawal by Subject|19|||
44427688|NCT01361607|79435859|FG001|Overall Study|Withdrawal by Subject|8|||
44427689|NCT01361607|79435858|FG000|Overall Study|Withdrawal by Investigator|5|||
44427690|NCT01361607|79435859|FG001|Overall Study|Withdrawal by Investigator|3|||
44427691|NCT01361607|79435858|FG000|Overall Study|Lost to Follow-up|1|||
44427692|NCT01361607|79435859|FG001|Overall Study|Lost to Follow-up|0|||
44427693|NCT01361607|79435858|FG000|Overall Study|Met Withdrawal Criteria|1|||
44537722|NCT03970200|79548648|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
44537723|NCT03970200|79548649|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
44537724|NCT03840200|79548661|FG000|Overall Study|Death|6|||
44537725|NCT03840200|79548662|FG001|Overall Study|Death|3|||
44537726|NCT03840200|79548663|FG002|Overall Study|Death|6|||
44537727|NCT03840200|79548664|FG003|Overall Study|Death|10|||
44537728|NCT03840200|79548661|FG000|Overall Study|Reason Not Specified|2|||
44537729|NCT03840200|79548662|FG001|Overall Study|Reason Not Specified|2|||
44537730|NCT03840200|79548663|FG002|Overall Study|Reason Not Specified|1|||
44537731|NCT03840200|79548664|FG003|Overall Study|Reason Not Specified|15|||
44537732|NCT03840200|79548661|FG000|Overall Study|Physician Decision|0|||
44537733|NCT03840200|79548662|FG001|Overall Study|Physician Decision|0|||
44537734|NCT03840200|79548663|FG002|Overall Study|Physician Decision|0|||
44537735|NCT03840200|79548664|FG003|Overall Study|Physician Decision|2|||
44537736|NCT03840200|79548661|FG000|Overall Study|Progressive Disease|0|||
44537737|NCT03840200|79548662|FG001|Overall Study|Progressive Disease|0|||
44537738|NCT03840200|79548663|FG002|Overall Study|Progressive Disease|0|||
44537739|NCT03840200|79548664|FG003|Overall Study|Progressive Disease|1|||
44537740|NCT03840200|79548661|FG000|Overall Study|Withdrawal by Subject|0|||
44537741|NCT03840200|79548662|FG001|Overall Study|Withdrawal by Subject|1|||
44537742|NCT03840200|79548663|FG002|Overall Study|Withdrawal by Subject|0|||
44537743|NCT03840200|79548664|FG003|Overall Study|Withdrawal by Subject|2|||
44537744|NCT03334851|79548697|FG000|Overall Study|Other|0|||
44537745|NCT03334851|79548698|FG001|Overall Study|Other|0|||
44537746|NCT03334851|79548699|FG002|Overall Study|Other|0|||
44537747|NCT03334851|79548700|FG003|Overall Study|Other|0|||
44537748|NCT03334851|79548701|FG004|Overall Study|Other|0|||
44537749|NCT03334851|79548702|FG005|Overall Study|Other|0|||
44537750|NCT03334851|79548703|FG006|Overall Study|Other|0|||
44537751|NCT03334851|79548704|FG007|Overall Study|Other|1|||
44537752|NCT03334851|79548705|FG008|Overall Study|Other|0|||
44537753|NCT03334851|79548706|FG009|Overall Study|Other|0|||
44537754|NCT03334851|79548707|FG010|Overall Study|Other|0|||
44537755|NCT03334851|79548708|FG011|Overall Study|Other|0|||
44537756|NCT03334851|79548709|FG012|Overall Study|Other|0|||
44537757|NCT03334851|79548697|FG000|Overall Study|Adverse Event|0|||
44537758|NCT03334851|79548698|FG001|Overall Study|Adverse Event|0|||
44537759|NCT03334851|79548699|FG002|Overall Study|Adverse Event|0|||
44537760|NCT03334851|79548700|FG003|Overall Study|Adverse Event|0|||
44537761|NCT03334851|79548701|FG004|Overall Study|Adverse Event|0|||
44537762|NCT03334851|79548702|FG005|Overall Study|Adverse Event|0|||
44427694|NCT01361607|79435859|FG001|Overall Study|Met Withdrawal Criteria|1|||
44427695|NCT01337089|79435866|FG000|Overall Study|Adverse Event|237|||
44427696|NCT01337089|79435866|FG000|Overall Study|Withdrawal by Subject|129|||
44427697|NCT01337089|79435866|FG000|Overall Study|Withdrawal by Investigator|33|||
44537763|NCT03334851|79548703|FG006|Overall Study|Adverse Event|0|||
44537764|NCT03334851|79548704|FG007|Overall Study|Adverse Event|1|||
44537765|NCT03334851|79548705|FG008|Overall Study|Adverse Event|0|||
44537766|NCT03334851|79548706|FG009|Overall Study|Adverse Event|0|||
44537767|NCT03334851|79548707|FG010|Overall Study|Adverse Event|0|||
44537768|NCT03334851|79548708|FG011|Overall Study|Adverse Event|0|||
44537769|NCT03334851|79548709|FG012|Overall Study|Adverse Event|0|||
44537770|NCT03334851|79548697|FG000|Overall Study|Withdrawal by Subject|0|||
44537771|NCT03334851|79548698|FG001|Overall Study|Withdrawal by Subject|0|||
44537772|NCT03334851|79548699|FG002|Overall Study|Withdrawal by Subject|0|||
44537773|NCT03334851|79548700|FG003|Overall Study|Withdrawal by Subject|0|||
44537774|NCT03334851|79548701|FG004|Overall Study|Withdrawal by Subject|0|||
44537775|NCT03334851|79548702|FG005|Overall Study|Withdrawal by Subject|0|||
44537776|NCT03334851|79548703|FG006|Overall Study|Withdrawal by Subject|0|||
44427698|NCT01337089|79435866|FG000|Overall Study|Met Withdrawal Criteria|3|||
44427699|NCT01337089|79435866|FG000|Overall Study|Lost to Follow-up|2|||
44427700|NCT00114530|79435880|FG000|Overall Study|Death|3|||
44427701|NCT00114530|79435881|FG001|Overall Study|Death|11|||
44427702|NCT00114530|79435880|FG000|Overall Study|Lost to Follow-up|1|||
44427703|NCT00114530|79435881|FG001|Overall Study|Lost to Follow-up|1|||
44427704|NCT00114530|79435880|FG000|Overall Study|Physician Decision|1|||
44427705|NCT00114530|79435881|FG001|Overall Study|Physician Decision|1|||
44427706|NCT00114530|79435880|FG000|Overall Study|Withdrawal by Subject|2|||
44427707|NCT00114530|79435881|FG001|Overall Study|Withdrawal by Subject|6|||
44427708|NCT00114530|79435880|FG000|Overall Study|Breast Cancer|1|||
44427709|NCT00114530|79435881|FG001|Overall Study|Breast Cancer|0|||
44427710|NCT00114530|79435880|FG000|Overall Study|Subject decision after endpoint failure|0|||
44427711|NCT00114530|79435881|FG001|Overall Study|Subject decision after endpoint failure|1|||
44427712|NCT00114530|79435880|FG000|Overall Study|Ineligible|1|||
44427713|NCT00114530|79435881|FG001|Overall Study|Ineligible|0|||
44427714|NCT00618982|79435904|FG000|Overall Study|Adverse Event|23|||
44427715|NCT00618982|79435904|FG000|Overall Study|Withdrawal by Subject|1|||
44427716|NCT00618982|79435904|FG000|Overall Study|Protocol Violation|1|||
44427717|NCT00618982|79435904|FG000|Overall Study|ongoing, still treated with study med.|25|||
44427718|NCT00578786|79435914|FG000|Overall Study|Adverse Event|27|||
44427719|NCT00578786|79435915|FG001|Overall Study|Adverse Event|37|||
44427720|NCT00578786|79435916|FG002|Overall Study|Adverse Event|17|||
44427721|NCT00578786|79435914|FG000|Overall Study|Lack of Efficacy|2|||
44427722|NCT00578786|79435915|FG001|Overall Study|Lack of Efficacy|5|||
44427723|NCT00578786|79435916|FG002|Overall Study|Lack of Efficacy|2|||
44427724|NCT00578786|79435914|FG000|Overall Study|Early Escape from Prior Study|2|||
44427725|NCT00578786|79435915|FG001|Overall Study|Early Escape from Prior Study|1|||
44427726|NCT00578786|79435916|FG002|Overall Study|Early Escape from Prior Study|2|||
44427727|NCT00578786|79435914|FG000|Overall Study|Withdrawal by Subject|7|||
44427728|NCT00578786|79435915|FG001|Overall Study|Withdrawal by Subject|8|||
44427729|NCT00578786|79435916|FG002|Overall Study|Withdrawal by Subject|5|||
44427730|NCT00578786|79435914|FG000|Overall Study|Protocol Violation|0|||
44427731|NCT00578786|79435915|FG001|Overall Study|Protocol Violation|3|||
44427732|NCT00578786|79435916|FG002|Overall Study|Protocol Violation|1|||
44427733|NCT00578786|79435914|FG000|Overall Study|Physician Decision|1|||
44427734|NCT00578786|79435915|FG001|Overall Study|Physician Decision|0|||
44427735|NCT00578786|79435916|FG002|Overall Study|Physician Decision|1|||
44427736|NCT00578786|79435914|FG000|Overall Study|Sponsor Decision|0|||
44427737|NCT00578786|79435915|FG001|Overall Study|Sponsor Decision|0|||
44537777|NCT03334851|79548704|FG007|Overall Study|Withdrawal by Subject|0|||
44537778|NCT03334851|79548705|FG008|Overall Study|Withdrawal by Subject|0|||
44537779|NCT03334851|79548706|FG009|Overall Study|Withdrawal by Subject|0|||
44537780|NCT03334851|79548707|FG010|Overall Study|Withdrawal by Subject|1|||
44427738|NCT00578786|79435916|FG002|Overall Study|Sponsor Decision|1|||
44427739|NCT00578786|79435914|FG000|Overall Study|Lost to Follow-up|0|||
44427740|NCT00578786|79435915|FG001|Overall Study|Lost to Follow-up|4|||
44427741|NCT00578786|79435916|FG002|Overall Study|Lost to Follow-up|0|||
44427742|NCT00578786|79435914|FG000|Overall Study|Pregnancy|0|||
44427743|NCT00578786|79435915|FG001|Overall Study|Pregnancy|1|||
44427744|NCT00578786|79435916|FG002|Overall Study|Pregnancy|0|||
44427745|NCT00578786|79435914|FG000|Overall Study|Not Otherwise Specified|0|||
44427746|NCT00578786|79435915|FG001|Overall Study|Not Otherwise Specified|4|||
44427747|NCT00578786|79435916|FG002|Overall Study|Not Otherwise Specified|1|||
44427748|NCT00578786|79435914|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
44427749|NCT00578786|79435915|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
44427750|NCT00578786|79435916|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
44427751|NCT00424255|79435936|FG000|Overall Study|Death|115|||
44427752|NCT00424255|79435937|FG001|Overall Study|Death|111|||
44427753|NCT00424255|79435936|FG000|Overall Study|Lost to Follow-up|26|||
44427754|NCT00424255|79435937|FG001|Overall Study|Lost to Follow-up|20|||
44427755|NCT00424255|79435936|FG000|Overall Study|Protocol Violation|0|||
44427756|NCT00424255|79435937|FG001|Overall Study|Protocol Violation|1|||
44427757|NCT00424255|79435936|FG000|Overall Study|Withdrawal by Subject|34|||
44427758|NCT00424255|79435937|FG001|Overall Study|Withdrawal by Subject|38|||
44427759|NCT00424255|79435936|FG000|Overall Study|Physician Decision|3|||
44427760|NCT00424255|79435937|FG001|Overall Study|Physician Decision|7|||
44427761|NCT00424255|79435936|FG000|Overall Study|Cognitive Disturbance|1|||
44427762|NCT00424255|79435937|FG001|Overall Study|Cognitive Disturbance|0|||
44427763|NCT00424255|79435936|FG000|Overall Study|Non-compliance by Participants|1|||
44427764|NCT00424255|79435937|FG001|Overall Study|Non-compliance by Participants|0|||
44427765|NCT00424255|79435936|FG000|Overall Study|Fatigue|1|||
44427766|NCT00424255|79435937|FG001|Overall Study|Fatigue|0|||
44427767|NCT00424255|79435936|FG000|Overall Study|Disease Progression|0|||
44427768|NCT00424255|79435937|FG001|Overall Study|Disease Progression|2|||
44427769|NCT00424255|79435936|FG000|Overall Study|Sponsor Terminated Study|161|||
44427770|NCT00424255|79435937|FG001|Overall Study|Sponsor Terminated Study|167|||
44427771|NCT00620074|79435943|FG000|Overall Study|Adverse Event|1|||
44427772|NCT00424177|79435947|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
44427773|NCT00424177|79435947|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
44427774|NCT00424177|79435947|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
44427775|NCT00424177|79435947|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
44427776|NCT00424177|79435947|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
44427777|NCT00424177|79435947|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
44427778|NCT00424177|79435947|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
44537781|NCT03334851|79548708|FG011|Overall Study|Withdrawal by Subject|0|||
44537782|NCT03334851|79548709|FG012|Overall Study|Withdrawal by Subject|1|||
44537783|NCT03334851|79548697|FG000|Overall Study|Lost to Follow-up|0|||
44537784|NCT03334851|79548698|FG001|Overall Study|Lost to Follow-up|0|||
44537785|NCT03334851|79548699|FG002|Overall Study|Lost to Follow-up|0|||
44537786|NCT03334851|79548700|FG003|Overall Study|Lost to Follow-up|0|||
44537787|NCT03334851|79548701|FG004|Overall Study|Lost to Follow-up|0|||
44537788|NCT03334851|79548702|FG005|Overall Study|Lost to Follow-up|0|||
44537789|NCT03334851|79548703|FG006|Overall Study|Lost to Follow-up|0|||
44537790|NCT03334851|79548704|FG007|Overall Study|Lost to Follow-up|0|||
44537791|NCT03334851|79548705|FG008|Overall Study|Lost to Follow-up|0|||
44537792|NCT03334851|79548706|FG009|Overall Study|Lost to Follow-up|0|||
44537793|NCT03334851|79548707|FG010|Overall Study|Lost to Follow-up|2|||
44537794|NCT03334851|79548708|FG011|Overall Study|Lost to Follow-up|1|||
44537795|NCT03334851|79548709|FG012|Overall Study|Lost to Follow-up|0|||
44537796|NCT02717507|79548771|FG000|Overall Study|Lost to Follow-up|5|||
44537797|NCT02717507|79548772|FG001|Overall Study|Lost to Follow-up|8|||
44537798|NCT02717507|79548771|FG000|Overall Study|Pregnancy|1|||
44537799|NCT02717507|79548772|FG001|Overall Study|Pregnancy|1|||
44537800|NCT02717507|79548771|FG000|Overall Study|Protocol Violation|2|||
44537801|NCT02717507|79548772|FG001|Overall Study|Protocol Violation|2|||
44537802|NCT02717507|79548771|FG000|Overall Study|Withdrawal by Subject|20|||
44537803|NCT02717507|79548772|FG001|Overall Study|Withdrawal by Subject|20|||
44537804|NCT02717507|79548771|FG000|Overall Study|Relapse|1|||
44537805|NCT02717507|79548772|FG001|Overall Study|Relapse|1|||
44537806|NCT02717507|79548771|FG000|Overall Study|Cardiac Event|2|||
44537807|NCT02717507|79548772|FG001|Overall Study|Cardiac Event|6|||
44537808|NCT02470585|79548795|FG000|Overall Study|Death|82|||
44537809|NCT02470585|79548796|FG001|Overall Study|Death|87|||
44537810|NCT02470585|79548797|FG002|Overall Study|Death|86|||
44537811|NCT02470585|79548795|FG000|Overall Study|Withdrawal by Subject|19|||
44537812|NCT02470585|79548796|FG001|Overall Study|Withdrawal by Subject|21|||
44537813|NCT02470585|79548797|FG002|Overall Study|Withdrawal by Subject|29|||
44537814|NCT02470585|79548795|FG000|Overall Study|Lost to Follow-up|2|||
44537815|NCT02470585|79548796|FG001|Overall Study|Lost to Follow-up|5|||
44537816|NCT02470585|79548797|FG002|Overall Study|Lost to Follow-up|4|||
44537817|NCT02470585|79548795|FG000|Overall Study|Other|4|||
44427779|NCT00424177|79435947|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
44427780|NCT00424177|79435947|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
44427781|NCT00424177|79435947|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
44427782|NCT00618826|79435959|FG000|Overall Study|Adverse Event|1|||
44537818|NCT02470585|79548796|FG001|Overall Study|Other|4|||
44537819|NCT02470585|79548797|FG002|Overall Study|Other|6|||
44537820|NCT02199080|79548822|FG000|Overall Study|Protocol Violation|12|||
44427783|NCT00578448|79435964|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
44427784|NCT00578448|79435964|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
44427785|NCT00578448|79435964|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
44427786|NCT00578448|79435964|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
44427787|NCT00578318|79435972|FG000|Overall Study|Lost to Follow-up|2|||
44427788|NCT00578318|79435973|FG001|Overall Study|Lost to Follow-up|0|||
44427789|NCT00578318|79435972|FG000|Overall Study|Physician Decision|1|||
44427790|NCT00578318|79435973|FG001|Overall Study|Physician Decision|0|||
44427791|NCT00618748|79435982|FG000|Overall Study|Adverse Event|4|||
44427792|NCT00618748|79435983|FG001|Overall Study|Adverse Event|3|||
44427793|NCT00618748|79435984|FG002|Overall Study|Adverse Event|8|||
44427794|NCT00618748|79435982|FG000|Overall Study|Physician Decision|3|||
44427795|NCT00618748|79435983|FG001|Overall Study|Physician Decision|1|||
44427796|NCT00618748|79435984|FG002|Overall Study|Physician Decision|1|||
44427797|NCT00618748|79435982|FG000|Overall Study|Withdrawal by Subject|4|||
44427798|NCT00618748|79435983|FG001|Overall Study|Withdrawal by Subject|1|||
44427799|NCT00618748|79435984|FG002|Overall Study|Withdrawal by Subject|5|||
44427800|NCT00658359|79435995|FG000|Overall Study|Death|3|||
44427801|NCT00658359|79435996|FG001|Overall Study|Death|1|||
44427802|NCT00658359|79435997|FG002|Overall Study|Death|2|||
44427803|NCT00658359|79435995|FG000|Overall Study|Adverse Event|13|||
44427804|NCT00658359|79435996|FG001|Overall Study|Adverse Event|6|||
44427805|NCT00658359|79435997|FG002|Overall Study|Adverse Event|9|||
44427806|NCT00658359|79435995|FG000|Overall Study|Protocol Violation|1|||
44427807|NCT00658359|79435996|FG001|Overall Study|Protocol Violation|0|||
44427808|NCT00658359|79435997|FG002|Overall Study|Protocol Violation|0|||
44427809|NCT00658359|79435995|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
44427810|NCT00658359|79435996|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
44427811|NCT00658359|79435997|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
44427812|NCT00658359|79435995|FG000|Overall Study|Withdrawal by Subject|7|||
44427813|NCT00658359|79435996|FG001|Overall Study|Withdrawal by Subject|4|||
44427814|NCT00658359|79435997|FG002|Overall Study|Withdrawal by Subject|2|||
44427815|NCT00658359|79435995|FG000|Overall Study|Lost to Follow-up|2|||
44427816|NCT00658359|79435996|FG001|Overall Study|Lost to Follow-up|2|||
44427817|NCT00658359|79435997|FG002|Overall Study|Lost to Follow-up|4|||
44427818|NCT00658359|79435995|FG000|Overall Study|Lack of Efficacy|0|||
44427819|NCT00658359|79435996|FG001|Overall Study|Lack of Efficacy|1|||
44427820|NCT00658359|79435997|FG002|Overall Study|Lack of Efficacy|0|||
44427821|NCT00619918|79436009|FG000|Overall Study|Withdrawal by Subject|4|||
44427822|NCT00619918|79436010|FG001|Overall Study|Withdrawal by Subject|3|||
44427823|NCT00619918|79436009|FG000|Overall Study|Physician Decision|8|||
44427824|NCT00619918|79436010|FG001|Overall Study|Physician Decision|8|||
44427825|NCT00619918|79436009|FG000|Overall Study|Transfer to outside facility|3|||
44427826|NCT00619918|79436010|FG001|Overall Study|Transfer to outside facility|3|||
44427827|NCT00619918|79436009|FG000|Overall Study|Left before receiving first dose|5|||
44427828|NCT00619918|79436010|FG001|Overall Study|Left before receiving first dose|8|||
44537821|NCT02173379|79548830|FG000|Overall Study|Lost to Follow-up|89|||
44537822|NCT02173379|79548831|FG001|Overall Study|Lost to Follow-up|81|||
44537823|NCT02173379|79548830|FG000|Overall Study|Withdrawal by Subject|24|||
44537824|NCT02173379|79548831|FG001|Overall Study|Withdrawal by Subject|29|||
44537825|NCT02173379|79548830|FG000|Overall Study|Physician Decision|8|||
44537826|NCT02173379|79548831|FG001|Overall Study|Physician Decision|8|||
44537827|NCT02173379|79548830|FG000|Overall Study|Death|75|||
44427829|NCT01005914|79436016|FG000|Overall Study|Adverse Event|4|||
44427830|NCT01005914|79436016|FG000|Overall Study|Death|4|||
44427831|NCT01005914|79436016|FG000|Overall Study|Lack of Efficacy|1|||
44537828|NCT02173379|79548831|FG001|Overall Study|Death|72|||
44537829|NCT02173379|79548830|FG000|Overall Study|Other Reason|1|||
44537830|NCT02173379|79548831|FG001|Overall Study|Other Reason|0|||
44427832|NCT01005914|79436016|FG000|Overall Study|Withdrawal by Subject|1|||
44427833|NCT00618514|79436027|FG000|Overall Study|Lost to Follow-up|11|||
44427834|NCT00618514|79436028|FG001|Overall Study|Lost to Follow-up|12|||
44427835|NCT00618514|79436029|FG002|Overall Study|Lost to Follow-up|4|||
44427836|NCT00655629|79436037|FG000|Overall Study|Adverse Event|4|||
44427837|NCT00655629|79436038|FG001|Overall Study|Adverse Event|1|||
44537831|NCT02134925|79548842|FG000|Overall Study|Withdrawal by Subject|1|||
44537832|NCT02134925|79548843|FG001|Overall Study|Withdrawal by Subject|0|||
44537833|NCT02134925|79548842|FG000|Overall Study|Cancel|1|||
44537834|NCT02134925|79548843|FG001|Overall Study|Cancel|6|||
44537835|NCT01849874|79548851|FG000|Overall Study|Death|89|||
44537836|NCT01849874|79548852|FG001|Overall Study|Death|42|||
44537837|NCT01849874|79548851|FG000|Overall Study|Withdrawal by Subject|17|||
44537838|NCT01849874|79548852|FG001|Overall Study|Withdrawal by Subject|16|||
44537839|NCT01849874|79548851|FG000|Overall Study|Lost to Follow-up|3|||
44427838|NCT00655629|79436037|FG000|Overall Study|Lack of Efficacy|2|||
44427839|NCT00655629|79436038|FG001|Overall Study|Lack of Efficacy|12|||
44427840|NCT00655629|79436037|FG000|Overall Study|Lost to Follow-up|4|||
44427841|NCT00655629|79436038|FG001|Overall Study|Lost to Follow-up|3|||
44427842|NCT00655629|79436037|FG000|Overall Study|Protocol Violation|5|||
44427843|NCT00655629|79436038|FG001|Overall Study|Protocol Violation|3|||
44427844|NCT00655629|79436037|FG000|Overall Study|consent withdrawn|6|||
44537840|NCT01849874|79548852|FG001|Overall Study|Lost to Follow-up|2|||
44537841|NCT01849874|79548851|FG000|Overall Study|Study Termination By Sponsor|93|||
44537842|NCT01849874|79548852|FG001|Overall Study|Study Termination By Sponsor|48|||
44537843|NCT01849874|79548851|FG000|Overall Study|Completed as per protocol amendment 6|3|||
44537844|NCT01849874|79548852|FG001|Overall Study|Completed as per protocol amendment 6|0|||
44537845|NCT01849874|79548851|FG000|Overall Study|Physician Decision|7|||
44537846|NCT01849874|79548852|FG001|Overall Study|Physician Decision|1|||
44537847|NCT01849874|79548851|FG000|Overall Study|Other|16|||
44537848|NCT01849874|79548852|FG001|Overall Study|Other|4|||
44537849|NCT01771107|79548865|FG000|Overall Study|Adverse Event|1|||
44537850|NCT01771107|79548866|FG001|Overall Study|Adverse Event|3|||
44537851|NCT01771107|79548865|FG000|Overall Study|Withdrawal by Subject|0|||
44537852|NCT01771107|79548866|FG001|Overall Study|Withdrawal by Subject|2|||
44537853|NCT01771107|79548865|FG000|Overall Study|Lost to Follow-up|0|||
44537854|NCT01771107|79548866|FG001|Overall Study|Lost to Follow-up|1|||
44537855|NCT01771107|79548865|FG000|Overall Study|participant moved|0|||
44537856|NCT01771107|79548866|FG001|Overall Study|participant moved|1|||
44537857|NCT01771107|79548865|FG000|Overall Study|Other|0|||
44537858|NCT01771107|79548866|FG001|Overall Study|Other|1|||
44537859|NCT01375114|79548877|FG000|Overall Study|Lost to Follow-up|1|||
44537860|NCT01375114|79548878|FG001|Overall Study|Lost to Follow-up|0|||
44537861|NCT01375114|79548879|FG002|Overall Study|Lost to Follow-up|1|||
44427845|NCT00655629|79436038|FG001|Overall Study|consent withdrawn|4|||
44427846|NCT00578292|79436044|FG000|Overall Study|Death|1|||
44537862|NCT01375114|79548877|FG000|Overall Study|Disease Progression|3|||
44537863|NCT01375114|79548878|FG001|Overall Study|Disease Progression|2|||
44537864|NCT01375114|79548879|FG002|Overall Study|Disease Progression|2|||
44537865|NCT01375114|79548877|FG000|Overall Study|Patient Changed Mind|0|||
44537866|NCT01375114|79548878|FG001|Overall Study|Patient Changed Mind|0|||
44427847|NCT00578292|79436044|FG000|Overall Study|Graft failure|2|||
44537867|NCT01375114|79548879|FG002|Overall Study|Patient Changed Mind|2|||
44537868|NCT01375114|79548877|FG000|Overall Study|Pruritus|0|||
44537869|NCT01375114|79548878|FG001|Overall Study|Pruritus|0|||
44537870|NCT01375114|79548879|FG002|Overall Study|Pruritus|1|||
44427848|NCT00570063|79436050|FG000|Overall Study|Adverse Event|4|||
44427849|NCT00570063|79436051|FG001|Overall Study|Adverse Event|1|||
44330873|NCT01350804|79336178|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
44330874|NCT01350804|79336179|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
44330875|NCT01350804|79336180|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
44330876|NCT01350804|79336181|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
44330877|NCT01350804|79336178|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
44330878|NCT01350804|79336179|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
44330879|NCT01350804|79336180|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
44330880|NCT01350804|79336181|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
44330881|NCT01350804|79336178|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
44330882|NCT01350804|79336179|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
44330883|NCT01350804|79336180|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
44330884|NCT01350804|79336181|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
44330885|NCT01350804|79336178|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
44330886|NCT01350804|79336179|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
44427850|NCT00570063|79436050|FG000|Overall Study|Lack of Efficacy|0|||
44427851|NCT00570063|79436051|FG001|Overall Study|Lack of Efficacy|1|||
44427852|NCT00570063|79436050|FG000|Overall Study|Withdrawal by Subject|4|||
44427853|NCT00570063|79436051|FG001|Overall Study|Withdrawal by Subject|3|||
44427854|NCT00570063|79436050|FG000|Overall Study|Sponsor's Decision|7|||
44427855|NCT00570063|79436051|FG001|Overall Study|Sponsor's Decision|3|||
44427856|NCT00577772|79436068|FG000|Overall Study|Lost to Follow-up|0|||
44427857|NCT00577772|79436069|FG001|Overall Study|Lost to Follow-up|1|||
44427858|NCT00578136|79436077|FG000|Overall Study|Not given intervention|1|||
44427859|NCT00578136|79436078|FG001|Overall Study|Not given intervention|1|||
44427860|NCT00655551|79436087|FG000|All Periods Combined|Adverse Event|0|||
44427861|NCT00655551|79436088|FG001|All Periods Combined|Adverse Event|3|||
44427862|NCT00655551|79436089|FG002|All Periods Combined|Adverse Event|4|||
44427863|NCT00655551|79436087|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
44427864|NCT00655551|79436088|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
44427865|NCT00655551|79436089|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
44427866|NCT00655551|79436087|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
44427867|NCT00655551|79436088|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
44537871|NCT01375114|79548877|FG000|Overall Study|Restlessness|0|||
44537872|NCT01375114|79548878|FG001|Overall Study|Restlessness|0|||
44537873|NCT01375114|79548879|FG002|Overall Study|Restlessness|1|||
44537874|NCT01375114|79548877|FG000|Overall Study|Diarrhea|0|||
44537875|NCT01375114|79548878|FG001|Overall Study|Diarrhea|0|||
44537876|NCT01375114|79548879|FG002|Overall Study|Diarrhea|1|||
44537877|NCT01375114|79548877|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
44537878|NCT01375114|79548878|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
44537879|NCT01375114|79548879|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
44537880|NCT01375114|79548877|FG000|Overall Study|Nausea|0|||
44537881|NCT01375114|79548878|FG001|Overall Study|Nausea|1|||
44537882|NCT01375114|79548879|FG002|Overall Study|Nausea|0|||
44537883|NCT01375114|79548877|FG000|Overall Study|Increased AST/ALT|0|||
44258798|NCT01966120|79113885|FG000|Overall Study|Withdrawal by Subject|0|||
44258799|NCT01966120|79113886|FG001|Overall Study|Withdrawal by Subject|5|||
44258800|NCT01966120|79113885|FG000|Overall Study|Lost to Follow-up|1|||
44258801|NCT01966120|79113886|FG001|Overall Study|Lost to Follow-up|1|||
44330887|NCT01350804|79336180|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
44427868|NCT00655551|79436089|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
44537884|NCT01375114|79548878|FG001|Overall Study|Increased AST/ALT|1|||
44537885|NCT01375114|79548879|FG002|Overall Study|Increased AST/ALT|0|||
44537886|NCT01375114|79548877|FG000|Overall Study|Vaginal Hemorrhage|0|||
44537887|NCT01375114|79548878|FG001|Overall Study|Vaginal Hemorrhage|1|||
44537888|NCT01375114|79548879|FG002|Overall Study|Vaginal Hemorrhage|0|||
44537889|NCT01375114|79548877|FG000|Overall Study|Family problem|0|||
44537890|NCT01375114|79548878|FG001|Overall Study|Family problem|1|||
44537891|NCT01375114|79548879|FG002|Overall Study|Family problem|0|||
44537892|NCT01375114|79548877|FG000|Overall Study|Protocol Violation|2|||
44537893|NCT01375114|79548878|FG001|Overall Study|Protocol Violation|0|||
44537894|NCT01375114|79548879|FG002|Overall Study|Protocol Violation|0|||
44537895|NCT01009645|79548893|FG000|Overall Study|Lost to Follow-up|2|||
44537896|NCT01009645|79548894|FG001|Overall Study|Lost to Follow-up|8|||
44537897|NCT01009645|79548895|FG002|Overall Study|Lost to Follow-up|4|||
44537898|NCT01009645|79548896|FG003|Overall Study|Lost to Follow-up|5|||
44537899|NCT00950846|79548906|FG000|Overall Study|Death|6|||
44537900|NCT00950846|79548906|FG000|Overall Study|Lost to Follow-up|3|||
44537901|NCT00950846|79548906|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
44537902|NCT03419403|79548913|FG000|Overall Study|Withdrawal by Subject|5|||
44537903|NCT03419403|79548914|FG001|Overall Study|Withdrawal by Subject|2|||
44537904|NCT03419403|79548915|FG002|Overall Study|Withdrawal by Subject|5|||
44537905|NCT03419403|79548916|FG003|Overall Study|Withdrawal by Subject|1|||
44537906|NCT03419403|79548913|FG000|Overall Study|Progressive disease (per protocol)|0|||
44330888|NCT01350804|79336181|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
44330889|NCT01350804|79336178|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
44330890|NCT01350804|79336179|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
44330891|NCT01350804|79336180|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
44330892|NCT01350804|79336181|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
44330893|NCT01350492|79336203|FG000|Intervention|Lost to Follow-up|2|||
44330894|NCT01350492|79336204|FG001|Intervention|Lost to Follow-up|5|||
44330895|NCT01350492|79336203|FG000|Intervention|Withdrawal by Subject|3|||
44330896|NCT01350492|79336204|FG001|Intervention|Withdrawal by Subject|1|||
44330897|NCT01350492|79336203|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
44330898|NCT01350492|79336204|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
44330899|NCT01350492|79336203|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
44330900|NCT01350492|79336204|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
44330901|NCT02270957|79336212|FG000|Overall Study|Lack of Efficacy|2|||
44537907|NCT03419403|79548914|FG001|Overall Study|Progressive disease (per protocol)|2|||
44537908|NCT03419403|79548915|FG002|Overall Study|Progressive disease (per protocol)|2|||
44537909|NCT03419403|79548916|FG003|Overall Study|Progressive disease (per protocol)|0|||
44537910|NCT03419403|79548913|FG000|Overall Study|Other, not specified|6|||
44537911|NCT03419403|79548914|FG001|Overall Study|Other, not specified|4|||
44537912|NCT03419403|79548915|FG002|Overall Study|Other, not specified|5|||
44537913|NCT03419403|79548916|FG003|Overall Study|Other, not specified|1|||
44537914|NCT03419403|79548913|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
44537915|NCT03419403|79548914|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
44537916|NCT03419403|79548915|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
44330902|NCT02270957|79336213|FG001|Overall Study|Lack of Efficacy|4|||
44330903|NCT02270957|79336212|FG000|Overall Study|Adverse Event|2|||
44330904|NCT02270957|79336213|FG001|Overall Study|Adverse Event|0|||
44330905|NCT01350414|79336220|FG000|Overall Study|Lost to Follow-up|13|||
44330906|NCT01350414|79336220|FG000|Overall Study|Withdrawal by Subject|4|||
44330907|NCT01350414|79336220|FG000|Overall Study|Physician Decision|2|||
44330908|NCT01350336|79336230|FG000|Overall Study|Lost to Follow-up|31|||
44330909|NCT01350336|79336230|FG000|Overall Study|Withdrawal by Subject|14|||
44330910|NCT01350336|79336230|FG000|Overall Study|Physician Decision|8|||
44330911|NCT01350336|79336230|FG000|Overall Study|Death|4|||
44330912|NCT01349049|79336288|FG000|Overall Study|Disease progression|3|||
44330913|NCT01349049|79336289|FG001|Overall Study|Disease progression|5|||
44330914|NCT01349049|79336290|FG002|Overall Study|Disease progression|3|||
44330915|NCT01349049|79336291|FG003|Overall Study|Disease progression|2|||
44330916|NCT01349049|79336292|FG004|Overall Study|Disease progression|2|||
44330917|NCT01349049|79336293|FG005|Overall Study|Disease progression|2|||
44427869|NCT00655551|79436087|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
44537917|NCT03419403|79548916|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
44167846|NCT02528357|78961057|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
44427870|NCT00655551|79436088|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
44537918|NCT03447249|79548926|FG000|Overall Study|Adverse Event|1|||
44537919|NCT03447249|79548927|FG001|Overall Study|Adverse Event|0|||
44330918|NCT01349049|79336294|FG006|Overall Study|Disease progression|3|||
44330919|NCT01349049|79336295|FG007|Overall Study|Disease progression|2|||
44330920|NCT01349049|79336296|FG008|Overall Study|Disease progression|33|||
44330921|NCT01349049|79336288|FG000|Overall Study|Adverse Event|0|||
44330922|NCT01349049|79336289|FG001|Overall Study|Adverse Event|1|||
44330923|NCT01349049|79336290|FG002|Overall Study|Adverse Event|0|||
44537920|NCT03447249|79548926|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
44427871|NCT00655551|79436089|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
44427872|NCT00312728|79436097|FG000|Overall Study|Progressive disease|53|||
44427873|NCT00312728|79436097|FG000|Overall Study|Adverse Event|32|||
44427874|NCT00312728|79436097|FG000|Overall Study|Withdrawal by Subject|10|||
44427875|NCT00312728|79436097|FG000|Overall Study|Required non-protocol cancer treatment|2|||
44427876|NCT00312728|79436097|FG000|Overall Study|Protocol Violation|2|||
44427877|NCT00312728|79436097|FG000|Overall Study|Other|10|||
44427878|NCT00312728|79436097|FG000|Overall Study|Other|1|||
44427879|NCT00577824|79436104|FG000|Overall Study|Adverse Event|6|||
44427880|NCT00577824|79436105|FG001|Overall Study|Adverse Event|18|||
44427881|NCT00577824|79436106|FG002|Overall Study|Adverse Event|1|||
44427882|NCT00577824|79436104|FG000|Overall Study|Patient decision|0|||
44427883|NCT00577824|79436105|FG001|Overall Study|Patient decision|1|||
44427884|NCT00577824|79436106|FG002|Overall Study|Patient decision|1|||
44427885|NCT00577824|79436104|FG000|Overall Study|Protocol Violation|1|||
44427886|NCT00577824|79436105|FG001|Overall Study|Protocol Violation|1|||
44427887|NCT00577824|79436106|FG002|Overall Study|Protocol Violation|0|||
44427888|NCT00617344|79436117|FG000|Overall Study|Serious adverse event|1|||
44427889|NCT00617344|79436118|FG001|Overall Study|Serious adverse event|0|||
44427890|NCT00617344|79436119|FG002|Overall Study|Serious adverse event|0|||
44427891|NCT00617344|79436117|FG000|Overall Study|Other Adverse Event|1|||
44427892|NCT00617344|79436118|FG001|Overall Study|Other Adverse Event|1|||
44427893|NCT00617344|79436119|FG002|Overall Study|Other Adverse Event|0|||
44427894|NCT00617344|79436117|FG000|Overall Study|Protocol Violation|10|||
44427895|NCT00617344|79436118|FG001|Overall Study|Protocol Violation|8|||
44427896|NCT00617344|79436119|FG002|Overall Study|Protocol Violation|5|||
44427897|NCT00617344|79436117|FG000|Overall Study|Lost to Follow-up|5|||
44427898|NCT00617344|79436118|FG001|Overall Study|Lost to Follow-up|4|||
44427899|NCT00617344|79436119|FG002|Overall Study|Lost to Follow-up|1|||
44427900|NCT00617344|79436117|FG000|Overall Study|Withdrawal by Subject|8|||
44427901|NCT00617344|79436118|FG001|Overall Study|Withdrawal by Subject|9|||
44427902|NCT00617344|79436119|FG002|Overall Study|Withdrawal by Subject|2|||
44427903|NCT00654381|79436152|FG000|1st Stage|Adverse Event|3|||
44427904|NCT00654381|79436153|FG001|1st Stage|Adverse Event|3|||
44427905|NCT00654381|79436154|FG002|1st Stage|Adverse Event|3|||
44427906|NCT00654381|79436155|FG003|1st Stage|Adverse Event|3|||
44427907|NCT00654381|79436156|FG004|1st Stage|Adverse Event|2|||
44427908|NCT00654381|79436157|FG005|1st Stage|Adverse Event|1|||
44427909|NCT00654381|79436152|FG000|1st Stage|Withdrawal by Subject|0|||
44427910|NCT00654381|79436153|FG001|1st Stage|Withdrawal by Subject|0|||
44427911|NCT00654381|79436154|FG002|1st Stage|Withdrawal by Subject|0|||
44427912|NCT00654381|79436155|FG003|1st Stage|Withdrawal by Subject|1|||
44427913|NCT00654381|79436156|FG004|1st Stage|Withdrawal by Subject|0|||
44427914|NCT00654381|79436157|FG005|1st Stage|Withdrawal by Subject|1|||
44427915|NCT00654381|79436152|FG000|1st Stage|Investigator's decision|0|||
44427916|NCT00654381|79436153|FG001|1st Stage|Investigator's decision|0|||
44427917|NCT00654381|79436154|FG002|1st Stage|Investigator's decision|0|||
44537921|NCT03447249|79548927|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
44330924|NCT01349049|79336291|FG003|Overall Study|Adverse Event|0|||
44330925|NCT01349049|79336292|FG004|Overall Study|Adverse Event|0|||
44330926|NCT01349049|79336293|FG005|Overall Study|Adverse Event|3|||
44330927|NCT01349049|79336294|FG006|Overall Study|Adverse Event|1|||
44330928|NCT01349049|79336295|FG007|Overall Study|Adverse Event|0|||
44330929|NCT01349049|79336296|FG008|Overall Study|Adverse Event|4|||
44330930|NCT01349049|79336288|FG000|Overall Study|Physician Decision|0|||
44330931|NCT01349049|79336289|FG001|Overall Study|Physician Decision|1|||
44330932|NCT01349049|79336290|FG002|Overall Study|Physician Decision|0|||
44330933|NCT01349049|79336291|FG003|Overall Study|Physician Decision|0|||
44330934|NCT01349049|79336292|FG004|Overall Study|Physician Decision|0|||
44330935|NCT01349049|79336293|FG005|Overall Study|Physician Decision|0|||
44330936|NCT01349049|79336294|FG006|Overall Study|Physician Decision|0|||
44427918|NCT00654381|79436155|FG003|1st Stage|Investigator's decision|1|||
44427919|NCT00654381|79436156|FG004|1st Stage|Investigator's decision|0|||
44427920|NCT00654381|79436157|FG005|1st Stage|Investigator's decision|0|||
44427921|NCT00654381|79436152|FG000|2nd Stage|Adverse Event|2|||
44427922|NCT00654381|79436153|FG001|2nd Stage|Adverse Event|0|||
44427923|NCT00654381|79436154|FG002|2nd Stage|Adverse Event|2|||
44427924|NCT00654381|79436155|FG003|2nd Stage|Adverse Event|3|||
44427925|NCT00654381|79436156|FG004|2nd Stage|Adverse Event|7|||
44427926|NCT00654381|79436157|FG005|2nd Stage|Adverse Event|2|||
44427927|NCT00654381|79436152|FG000|2nd Stage|Withdrawal by Subject|0|||
44537922|NCT03447249|79548926|FG000|Overall Study|Other|3|||
44330937|NCT01349049|79336295|FG007|Overall Study|Physician Decision|0|||
44427928|NCT00654381|79436153|FG001|2nd Stage|Withdrawal by Subject|0|||
44427929|NCT00654381|79436154|FG002|2nd Stage|Withdrawal by Subject|0|||
44427930|NCT00654381|79436155|FG003|2nd Stage|Withdrawal by Subject|0|||
44330938|NCT01349049|79336296|FG008|Overall Study|Physician Decision|2|||
44330939|NCT01349049|79336288|FG000|Overall Study|Protocol Violation|0|||
44330940|NCT01349049|79336289|FG001|Overall Study|Protocol Violation|0|||
44330941|NCT01349049|79336290|FG002|Overall Study|Protocol Violation|0|||
44427931|NCT00654381|79436156|FG004|2nd Stage|Withdrawal by Subject|1|||
44427932|NCT00654381|79436157|FG005|2nd Stage|Withdrawal by Subject|1|||
44427933|NCT00654381|79436152|FG000|2nd Stage|Investigator's decision|0|||
44427934|NCT00654381|79436153|FG001|2nd Stage|Investigator's decision|0|||
44427935|NCT00654381|79436154|FG002|2nd Stage|Investigator's decision|1|||
44427936|NCT00654381|79436155|FG003|2nd Stage|Investigator's decision|1|||
44330942|NCT01349049|79336291|FG003|Overall Study|Protocol Violation|0|||
44330943|NCT01349049|79336292|FG004|Overall Study|Protocol Violation|0|||
44330944|NCT01349049|79336293|FG005|Overall Study|Protocol Violation|0|||
44330945|NCT01349049|79336294|FG006|Overall Study|Protocol Violation|0|||
44330946|NCT01349049|79336295|FG007|Overall Study|Protocol Violation|0|||
44330947|NCT01349049|79336296|FG008|Overall Study|Protocol Violation|1|||
44330948|NCT01349049|79336288|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
44330949|NCT01349049|79336289|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
44330950|NCT01349049|79336290|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
44330951|NCT01349049|79336291|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
44330952|NCT01349049|79336292|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
44330953|NCT01349049|79336293|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
44330954|NCT01349049|79336294|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
44330955|NCT01349049|79336295|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
44330956|NCT01349049|79336296|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
44330957|NCT01349049|79336288|FG000|Overall Study|Other|0|||
44330958|NCT01349049|79336289|FG001|Overall Study|Other|0|||
44330959|NCT01349049|79336290|FG002|Overall Study|Other|0|||
44427937|NCT00654381|79436156|FG004|2nd Stage|Investigator's decision|0|||
44427938|NCT00654381|79436157|FG005|2nd Stage|Investigator's decision|0|||
44427939|NCT00654381|79436152|FG000|Extension Stage|Adverse Event|1|||
44427940|NCT00654381|79436153|FG001|Extension Stage|Adverse Event|2|||
44427941|NCT00654381|79436154|FG002|Extension Stage|Adverse Event|9|||
44427942|NCT00654381|79436155|FG003|Extension Stage|Adverse Event|7|||
44427943|NCT00654381|79436156|FG004|Extension Stage|Adverse Event|1|||
44427944|NCT00654381|79436157|FG005|Extension Stage|Adverse Event|1|||
44427945|NCT00654381|79436152|FG000|Extension Stage|Protocol Violation|0|||
44427946|NCT00654381|79436153|FG001|Extension Stage|Protocol Violation|0|||
44427947|NCT00654381|79436154|FG002|Extension Stage|Protocol Violation|0|||
44427948|NCT00654381|79436155|FG003|Extension Stage|Protocol Violation|1|||
44427949|NCT00654381|79436156|FG004|Extension Stage|Protocol Violation|0|||
44427950|NCT00654381|79436157|FG005|Extension Stage|Protocol Violation|0|||
44427951|NCT00654381|79436152|FG000|Extension Stage|Lack of Efficacy|0|||
44427952|NCT00654381|79436153|FG001|Extension Stage|Lack of Efficacy|0|||
44427953|NCT00654381|79436154|FG002|Extension Stage|Lack of Efficacy|1|||
44427954|NCT00654381|79436155|FG003|Extension Stage|Lack of Efficacy|0|||
44427955|NCT00654381|79436156|FG004|Extension Stage|Lack of Efficacy|0|||
44427956|NCT00654381|79436157|FG005|Extension Stage|Lack of Efficacy|0|||
44427957|NCT00654381|79436152|FG000|Extension Stage|Withdrawal by Subject|0|||
44427958|NCT00654381|79436153|FG001|Extension Stage|Withdrawal by Subject|0|||
44427959|NCT00654381|79436154|FG002|Extension Stage|Withdrawal by Subject|1|||
44427960|NCT00654381|79436155|FG003|Extension Stage|Withdrawal by Subject|1|||
44537923|NCT03447249|79548927|FG001|Overall Study|Other|0|||
44537924|NCT03418545|79548937|FG000|Overall Study|Withdrawal by Participant|2|||
44537925|NCT03418545|79548938|FG001|Overall Study|Withdrawal by Participant|4|||
44330960|NCT01349049|79336291|FG003|Overall Study|Other|0|||
44537926|NCT03418545|79548937|FG000|Overall Study|Lost to Follow-up|3|||
44537927|NCT03418545|79548938|FG001|Overall Study|Lost to Follow-up|5|||
44537928|NCT03418545|79548937|FG000|Overall Study|Reason Not Specified|0|||
44537929|NCT03418545|79548938|FG001|Overall Study|Reason Not Specified|1|||
44330961|NCT01349049|79336292|FG004|Overall Study|Other|0|||
44330962|NCT01349049|79336293|FG005|Overall Study|Other|1|||
44330963|NCT01349049|79336294|FG006|Overall Study|Other|0|||
44330964|NCT01349049|79336295|FG007|Overall Study|Other|0|||
44330965|NCT01349049|79336296|FG008|Overall Study|Other|4|||
44330966|NCT01349049|79336288|FG000|Overall Study|Death|0|||
44330967|NCT01349049|79336289|FG001|Overall Study|Death|0|||
44330968|NCT01349049|79336290|FG002|Overall Study|Death|0|||
44330969|NCT01349049|79336291|FG003|Overall Study|Death|0|||
44330970|NCT01349049|79336292|FG004|Overall Study|Death|0|||
44427961|NCT00654381|79436156|FG004|Extension Stage|Withdrawal by Subject|1|||
44427962|NCT00654381|79436157|FG005|Extension Stage|Withdrawal by Subject|1|||
44427963|NCT00654381|79436152|FG000|Extension Stage|Closure of the trial site|0|||
44427964|NCT00654381|79436153|FG001|Extension Stage|Closure of the trial site|0|||
44427965|NCT00654381|79436154|FG002|Extension Stage|Closure of the trial site|0|||
44427966|NCT00654381|79436155|FG003|Extension Stage|Closure of the trial site|0|||
44427967|NCT00654381|79436156|FG004|Extension Stage|Closure of the trial site|1|||
44330971|NCT01349049|79336293|FG005|Overall Study|Death|0|||
44330972|NCT01349049|79336294|FG006|Overall Study|Death|0|||
44330973|NCT01349049|79336295|FG007|Overall Study|Death|1|||
44427968|NCT00654381|79436157|FG005|Extension Stage|Closure of the trial site|1|||
44427969|NCT00657267|79436187|FG000|Overall Study|Progressive disease|45|||
44330974|NCT01349049|79336296|FG008|Overall Study|Death|5|||
44330975|NCT01349049|79336288|FG000|Overall Study|Non-compliance|0|||
44427970|NCT00657267|79436187|FG000|Overall Study|Adverse Event|9|||
44427971|NCT00653991|79436195|FG000|3 Month Follow-up|Participant would not respond|150|||
44427972|NCT00653991|79436196|FG001|3 Month Follow-up|Participant would not respond|157|||
44427973|NCT00653991|79436195|FG000|6 Month Follow-up|Participant would not respond|133|||
44427974|NCT00653991|79436196|FG001|6 Month Follow-up|Participant would not respond|141|||
44427975|NCT00652899|79436204|FG000|Overall Study|Death|1|||
44427976|NCT00652899|79436204|FG000|Overall Study|Treating physician decision|1|||
44427977|NCT00617890|79436216|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
44427978|NCT00617890|79436217|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
44427979|NCT00617890|79436218|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
44427980|NCT00617890|79436219|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
44427981|NCT00617890|79436216|FG000|Overall Study|Lack of Efficacy|23|||
44427982|NCT00617890|79436217|FG001|Overall Study|Lack of Efficacy|26|||
44427983|NCT00617890|79436218|FG002|Overall Study|Lack of Efficacy|30|||
44427984|NCT00617890|79436219|FG003|Overall Study|Lack of Efficacy|97|||
44427985|NCT00617890|79436216|FG000|Overall Study|Lost to Follow-up|0|||
44258802|NCT01399736|79113929|FG000|Overall Study|Withdrawal by Subject|4|||
44258803|NCT01399736|79113930|FG001|Overall Study|Withdrawal by Subject|2|||
44258804|NCT01399736|79113929|FG000|Overall Study|Lost to Follow-up|0|||
44258805|NCT01399736|79113930|FG001|Overall Study|Lost to Follow-up|2|||
44258806|NCT04372927|79114060|FG000|Overall Study|Death|1|||
44258807|NCT01381874|79114067|FG000|Overall Study|Lost to Follow-up|1|||
44258808|NCT01381874|79114068|FG001|Overall Study|Lost to Follow-up|1|||
44258809|NCT01381874|79114069|FG002|Overall Study|Lost to Follow-up|0|||
44330976|NCT01349049|79336289|FG001|Overall Study|Non-compliance|0|||
44330977|NCT01349049|79336290|FG002|Overall Study|Non-compliance|0|||
44330978|NCT01349049|79336291|FG003|Overall Study|Non-compliance|1|||
44330979|NCT01349049|79336292|FG004|Overall Study|Non-compliance|0|||
44330980|NCT01349049|79336293|FG005|Overall Study|Non-compliance|0|||
44330981|NCT01349049|79336294|FG006|Overall Study|Non-compliance|0|||
44330982|NCT01349049|79336295|FG007|Overall Study|Non-compliance|0|||
44330983|NCT01349049|79336296|FG008|Overall Study|Non-compliance|0|||
44330984|NCT01349049|79336288|FG000|Overall Study|Withdrawal by Subject|0|||
44330985|NCT01349049|79336289|FG001|Overall Study|Withdrawal by Subject|0|||
44330986|NCT01349049|79336290|FG002|Overall Study|Withdrawal by Subject|0|||
44330987|NCT01349049|79336291|FG003|Overall Study|Withdrawal by Subject|0|||
44330988|NCT01349049|79336292|FG004|Overall Study|Withdrawal by Subject|0|||
44330989|NCT01349049|79336293|FG005|Overall Study|Withdrawal by Subject|0|||
44330990|NCT01349049|79336294|FG006|Overall Study|Withdrawal by Subject|0|||
44330991|NCT01349049|79336295|FG007|Overall Study|Withdrawal by Subject|0|||
44330992|NCT01349049|79336296|FG008|Overall Study|Withdrawal by Subject|6|||
44330993|NCT01348854|79336330|FG000|Overall Study|Lost to Follow-up|2|||
44330994|NCT01348854|79336331|FG001|Overall Study|Lost to Follow-up|1|||
44330995|NCT01348854|79336330|FG000|Overall Study|Withdrawal by Subject|1|||
44330996|NCT01348854|79336331|FG001|Overall Study|Withdrawal by Subject|0|||
44330997|NCT01348776|79336337|FG000|Overall Study|Lost to Follow-up|3|||
44330998|NCT01348698|79336350|FG000|Overall Study|Does not meet lesion size criteria|1|||
44330999|NCT01348698|79336350|FG000|Overall Study|Death|3|||
44331000|NCT01348698|79336350|FG000|Overall Study|PI decision to close study|68|||
44331001|NCT01348542|79336356|FG000|Overall Study|Withdrawal by Subject|3|||
44331002|NCT01348542|79336357|FG001|Overall Study|Withdrawal by Subject|0|||
44331003|NCT01346709|79336363|FG000|Overall Study|Protocol Violation|35|||
44331004|NCT01346709|79336363|FG000|Overall Study|Lost to Follow-up|31|||
44331005|NCT01346709|79336363|FG000|Overall Study|Missing data in candidate risk factor|285|||
44331006|NCT01346592|79336370|FG000|Overall Study|Lost to Follow-up|62|||
44331007|NCT01346592|79336371|FG001|Overall Study|Lost to Follow-up|29|||
44331008|NCT01346592|79336372|FG002|Overall Study|Lost to Follow-up|29|||
44331009|NCT01346592|79336370|FG000|Overall Study|Protocol Violation|2|||
44331010|NCT01346592|79336371|FG001|Overall Study|Protocol Violation|1|||
44331011|NCT01346592|79336372|FG002|Overall Study|Protocol Violation|0|||
44331012|NCT01346592|79336370|FG000|Overall Study|Death|1|||
44331013|NCT01346592|79336371|FG001|Overall Study|Death|3|||
44331014|NCT01346592|79336372|FG002|Overall Study|Death|4|||
44331015|NCT01346592|79336370|FG000|Overall Study|Adverse Event|0|||
44427986|NCT00617890|79436217|FG001|Overall Study|Lost to Follow-up|0|||
44427987|NCT00617890|79436218|FG002|Overall Study|Lost to Follow-up|1|||
44427988|NCT00617890|79436219|FG003|Overall Study|Lost to Follow-up|2|||
44427989|NCT00617890|79436216|FG000|Overall Study|Withdrawal by Subject|4|||
44427990|NCT00617890|79436217|FG001|Overall Study|Withdrawal by Subject|1|||
44258810|NCT01381874|79114067|FG000|Overall Study|Withdrawal by Subject|9|||
44331016|NCT01346592|79336371|FG001|Overall Study|Adverse Event|1|||
44331017|NCT01346592|79336372|FG002|Overall Study|Adverse Event|0|||
44331018|NCT01346592|79336370|FG000|Overall Study|Withdrawal by Subject|77|||
44331019|NCT01346592|79336371|FG001|Overall Study|Withdrawal by Subject|51|||
44331020|NCT01346592|79336372|FG002|Overall Study|Withdrawal by Subject|38|||
44331021|NCT01346592|79336370|FG000|Overall Study|Inappropriate enrollment|3|||
44331022|NCT01346592|79336371|FG001|Overall Study|Inappropriate enrollment|1|||
44427991|NCT00617890|79436218|FG002|Overall Study|Withdrawal by Subject|0|||
44427992|NCT00617890|79436219|FG003|Overall Study|Withdrawal by Subject|2|||
44427993|NCT00617890|79436216|FG000|Overall Study|Protocol Violation|2|||
44427994|NCT00617890|79436217|FG001|Overall Study|Protocol Violation|1|||
44427995|NCT00617890|79436218|FG002|Overall Study|Protocol Violation|0|||
44427996|NCT00617890|79436219|FG003|Overall Study|Protocol Violation|0|||
44427997|NCT00617890|79436216|FG000|Overall Study|Adverse Event|1|||
44427998|NCT00617890|79436217|FG001|Overall Study|Adverse Event|0|||
44427999|NCT00617890|79436218|FG002|Overall Study|Adverse Event|3|||
44428000|NCT00617890|79436219|FG003|Overall Study|Adverse Event|8|||
44428001|NCT00617890|79436216|FG000|Overall Study|Not treated|1|||
44428002|NCT00617890|79436217|FG001|Overall Study|Not treated|0|||
44428003|NCT00617890|79436218|FG002|Overall Study|Not treated|1|||
44428004|NCT00617890|79436219|FG003|Overall Study|Not treated|1|||
44428005|NCT00712166|79436234|FG000|Overall Study|Noncompliance|0|||
44428006|NCT00712166|79436235|FG001|Overall Study|Noncompliance|1|||
44258811|NCT01381874|79114068|FG001|Overall Study|Withdrawal by Subject|10|||
44258812|NCT01381874|79114069|FG002|Overall Study|Withdrawal by Subject|9|||
44258813|NCT01381874|79114067|FG000|Overall Study|Other|67|||
44258814|NCT01381874|79114068|FG001|Overall Study|Other|52|||
44258815|NCT01381874|79114069|FG002|Overall Study|Other|67|||
44428007|NCT00652743|79436246|FG000|Months 12-18|Lost to Follow-up|1|||
44428008|NCT00652743|79436247|FG001|Months 12-18|Lost to Follow-up|2|||
44428009|NCT00652743|79436248|FG002|Months 12-18|Lost to Follow-up|7|||
44428010|NCT00652743|79436246|FG000|Months 24-30|Other|5|||
44428011|NCT00652743|79436247|FG001|Months 24-30|Other|1|||
44428012|NCT00652743|79436248|FG002|Months 24-30|Other|11|||
44428013|NCT00652743|79436246|FG000|Months 36-42|Serious Adverse Events|0|||
44428014|NCT00652743|79436247|FG001|Months 36-42|Serious Adverse Events|1|||
44428015|NCT00652743|79436248|FG002|Months 36-42|Serious Adverse Events|1|||
44428016|NCT00652743|79436246|FG000|Months 36-42|Withdrawal by Subject|1|||
44428017|NCT00652743|79436247|FG001|Months 36-42|Withdrawal by Subject|1|||
44428018|NCT00652743|79436248|FG002|Months 36-42|Withdrawal by Subject|0|||
44428019|NCT00652743|79436246|FG000|Months 36-42|Lost to Follow-up|0|||
44428020|NCT00652743|79436247|FG001|Months 36-42|Lost to Follow-up|1|||
44428021|NCT00652743|79436248|FG002|Months 36-42|Lost to Follow-up|0|||
44428022|NCT00652743|79436246|FG000|Months 36-42|Migrated/moved from study area|1|||
44428023|NCT00652743|79436247|FG001|Months 36-42|Migrated/moved from study area|0|||
44428024|NCT00652743|79436248|FG002|Months 36-42|Migrated/moved from study area|0|||
44428025|NCT00652743|79436246|FG000|Months 36-42|Other|4|||
44258816|NCT01399190|79114077|FG000|Overall Study|Not Eligible for Final Analysis|5|||
44258817|NCT01399190|79114077|FG000|Overall Study|Adverse Event|8|||
44258818|NCT01399190|79114077|FG000|Overall Study|Participant's Request|5|||
44258819|NCT01399190|79114077|FG000|Overall Study|Physician Decision|2|||
44258820|NCT01381718|79114095|FG000|Overall Study|Withdrawal by Subject|2|||
44258821|NCT01381718|79114096|FG001|Overall Study|Withdrawal by Subject|5|||
44258822|NCT01381718|79114095|FG000|Overall Study|Lost to Follow-up|3|||
44258823|NCT01381718|79114096|FG001|Overall Study|Lost to Follow-up|5|||
44258824|NCT01381718|79114095|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
44258825|NCT01381718|79114096|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
44258826|NCT01398956|79114115|FG000|Overall Study|Withdrawal by Subject|4|||
44258827|NCT01398956|79114115|FG000|Overall Study|AE, non-serious non-fatal|4|||
44258828|NCT01398956|79114115|FG000|Overall Study|Withdrawal Criteria No.3|1|||
44258829|NCT01398956|79114115|FG000|Overall Study|Subject moved a long distance|1|||
44331023|NCT01346592|79336372|FG002|Overall Study|Inappropriate enrollment|1|||
44331024|NCT01346592|79336370|FG000|Overall Study|Administrative reason|1|||
44331025|NCT01346592|79336371|FG001|Overall Study|Administrative reason|0|||
44331026|NCT01346592|79336372|FG002|Overall Study|Administrative reason|0|||
44331027|NCT01346592|79336370|FG000|Overall Study|Unable to Classify|7|||
44331028|NCT01346592|79336371|FG001|Overall Study|Unable to Classify|3|||
44331029|NCT01346592|79336372|FG002|Overall Study|Unable to Classify|6|||
44331030|NCT01346514|79336399|FG000|Overall Study|Lost to Follow-up|19|||
44331031|NCT01346514|79336400|FG001|Overall Study|Lost to Follow-up|30|||
44331032|NCT01346514|79336399|FG000|Overall Study|Withdrawal by Subject|7|||
44331033|NCT01346514|79336400|FG001|Overall Study|Withdrawal by Subject|3|||
44331034|NCT01346514|79336399|FG000|Overall Study|Death|3|||
44331035|NCT01346514|79336400|FG001|Overall Study|Death|4|||
44428026|NCT00652743|79436247|FG001|Months 36-42|Other|2|||
44428027|NCT00652743|79436248|FG002|Months 36-42|Other|8|||
44428028|NCT00712010|79436259|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
44428029|NCT00653523|79436275|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
44428030|NCT00653523|79436275|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
44428031|NCT00653523|79436275|FG000|Overall Study|Adverse Event|7|||
44258830|NCT01381562|79114141|FG000|Overall Study|Adverse Event|0|||
44258831|NCT01381562|79114142|FG001|Overall Study|Adverse Event|1|||
44331036|NCT01193335|79336410|FG000|After Infant Series|Lost to Follow-up|1|||
44331037|NCT01193335|79336411|FG001|After Infant Series|Lost to Follow-up|2|||
44331038|NCT01193335|79336410|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
44331039|NCT01193335|79336411|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
44331040|NCT01193335|79336410|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
44331041|NCT01193335|79336411|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
44331042|NCT01193335|79336410|FG000|1-Year Follow-up|Lost to Follow-up|4|||
44331043|NCT01193335|79336411|FG001|1-Year Follow-up|Lost to Follow-up|0|||
44331044|NCT01193335|79336410|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
44331045|NCT01193335|79336411|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
44428032|NCT00653523|79436275|FG000|Overall Study|Withdrawal by Subject|6|||
44428033|NCT00653523|79436275|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
44428034|NCT00653523|79436275|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
44428035|NCT02717442|79436281|FG000|Overall Study|Study Terminated by Sponsor|31|||
44428036|NCT02717442|79436282|FG001|Overall Study|Study Terminated by Sponsor|29|||
44428037|NCT02717442|79436281|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
44428038|NCT02717442|79436282|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
44331046|NCT01193335|79336410|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
44331047|NCT01193335|79336411|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
44331048|NCT01342887|79336433|FG000|Overall Study|Death|2|||
44331049|NCT01342341|79336439|FG000|Overall Study|Lost to Follow-up|4|||
44331050|NCT01342341|79336440|FG001|Overall Study|Lost to Follow-up|4|||
44331051|NCT01340664|79336449|FG000|Overall Study|Adverse Event|0|||
44331052|NCT01340664|79336450|FG001|Overall Study|Adverse Event|1|||
44331053|NCT01340664|79336451|FG002|Overall Study|Adverse Event|7|||
44331054|NCT01340664|79336449|FG000|Overall Study|Lost to Follow-up|2|||
44428039|NCT02717442|79436281|FG000|Overall Study|Other - Not Specified|2|||
44428040|NCT02717442|79436282|FG001|Overall Study|Other - Not Specified|0|||
44428041|NCT05233085|79436307|FG000|Overall Study|Adverse Event|1|||
44428042|NCT05233085|79436308|FG001|Overall Study|Adverse Event|0|||
44428043|NCT05233085|79436309|FG002|Overall Study|Adverse Event|0|||
44428044|NCT05233085|79436310|FG003|Overall Study|Adverse Event|0|||
44428045|NCT04738734|79436328|FG000|Overall Study|Withdrawal by Subject|2|||
44428046|NCT04738734|79436329|FG001|Overall Study|Withdrawal by Subject|4|||
44428047|NCT04738734|79436328|FG000|Overall Study|Lost to Follow-up|5|||
44428048|NCT04738734|79436329|FG001|Overall Study|Lost to Follow-up|2|||
44428049|NCT04738734|79436328|FG000|Overall Study|Physician Decision|0|||
44428050|NCT04738734|79436329|FG001|Overall Study|Physician Decision|1|||
44428051|NCT04738734|79436328|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
44428052|NCT04738734|79436329|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
44428053|NCT04707196|79436337|FG000|Overall Study|Withdrawal by Subject|9|||
44428054|NCT04707196|79436338|FG001|Overall Study|Withdrawal by Subject|6|||
44428055|NCT04707196|79436337|FG000|Overall Study|Lost to Follow-up|1|||
44428056|NCT04707196|79436338|FG001|Overall Study|Lost to Follow-up|0|||
44428057|NCT04707196|79436337|FG000|Overall Study|Protocol Violation|4|||
44428058|NCT04707196|79436338|FG001|Overall Study|Protocol Violation|1|||
44428059|NCT04707196|79436337|FG000|Overall Study|Adverse Event|2|||
44428060|NCT04707196|79436338|FG001|Overall Study|Adverse Event|2|||
44428061|NCT04707196|79436337|FG000|Overall Study|Death|3|||
44428062|NCT04707196|79436338|FG001|Overall Study|Death|1|||
44428063|NCT04707196|79436337|FG000|Overall Study|Non-compliance with study drug|1|||
44428064|NCT04707196|79436338|FG001|Overall Study|Non-compliance with study drug|0|||
44428065|NCT04707196|79436337|FG000|Overall Study|Progressive disease|9|||
44428066|NCT04707196|79436338|FG001|Overall Study|Progressive disease|10|||
44428067|NCT04551963|79436356|FG000|Overall Study|Physician Decision|1|||
44428068|NCT04551963|79436357|FG001|Overall Study|Physician Decision|1|||
44428069|NCT04551963|79436356|FG000|Overall Study|Death|1|||
44537930|NCT03418545|79548937|FG000|Overall Study|Missing Completion Status|0|||
44537931|NCT03418545|79548938|FG001|Overall Study|Missing Completion Status|1|||
44537932|NCT03446781|79548949|FG000|Overall Study|Lost to Follow-up|11|||
44331055|NCT01340664|79336450|FG001|Overall Study|Lost to Follow-up|0|||
44331056|NCT01340664|79336451|FG002|Overall Study|Lost to Follow-up|2|||
44331057|NCT01340664|79336449|FG000|Overall Study|Withdrawal by Subject|2|||
44331058|NCT01340664|79336450|FG001|Overall Study|Withdrawal by Subject|4|||
44428070|NCT04551963|79436357|FG001|Overall Study|Death|0|||
44428071|NCT04416555|79436367|FG000|Overall Study|Withdrawal by Subject|0|||
44428072|NCT04416555|79436368|FG001|Overall Study|Withdrawal by Subject|3|||
44428073|NCT04102007|79436374|FG000|Overall Study|Adverse Event|4|||
44428074|NCT04102007|79436374|FG000|Overall Study|Lost to Follow-up|3|||
44428075|NCT04102007|79436374|FG000|Overall Study|Withdrawal by Subject|12|||
44428076|NCT04102007|79436374|FG000|Overall Study|Eligibility Violation|5|||
44428077|NCT04102007|79436374|FG000|Overall Study|Lack of Efficacy|6|||
44428078|NCT04102007|79436374|FG000|Overall Study|Protocol Deviation|5|||
44428079|NCT04102007|79436374|FG000|Overall Study|Protocol Compliance|1|||
44428080|NCT04102007|79436374|FG000|Overall Study|Withdrew Treatment|2|||
44331059|NCT01340664|79336451|FG002|Overall Study|Withdrawal by Subject|0|||
44428081|NCT04102007|79436374|FG000|Overall Study|Pregnancy|1|||
44331060|NCT01340664|79336449|FG000|Overall Study|Glycemic withdrawal criteria|2|||
44331061|NCT01340664|79336450|FG001|Overall Study|Glycemic withdrawal criteria|0|||
44428082|NCT03898960|79436378|FG000|Overall Study|Death|10|||
44428083|NCT03734237|79436394|FG000|Overall Study|Lost to Follow-up|1|||
44428084|NCT03734237|79436395|FG001|Overall Study|Lost to Follow-up|3|||
44428085|NCT03734237|79436396|FG002|Overall Study|Lost to Follow-up|0|||
44428086|NCT03734237|79436394|FG000|Overall Study|Withdrawal by Subject|7|||
44428087|NCT03734237|79436395|FG001|Overall Study|Withdrawal by Subject|9|||
44428088|NCT03734237|79436396|FG002|Overall Study|Withdrawal by Subject|10|||
44428089|NCT03496623|79436456|FG000|Run-In Period (2 Weeks)|Death|1|||
44428090|NCT03496623|79436457|FG001|Run-In Period (2 Weeks)|Death|0|||
44428091|NCT03496623|79436458|FG002|Run-In Period (2 Weeks)|Death|0|||
44428092|NCT03496623|79436459|FG003|Run-In Period (2 Weeks)|Death|0|||
44428093|NCT03496623|79436460|FG004|Run-In Period (2 Weeks)|Death|0|||
44428094|NCT03496623|79436456|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
44428095|NCT03496623|79436457|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
44428096|NCT03496623|79436458|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
44331062|NCT01340664|79336451|FG002|Overall Study|Glycemic withdrawal criteria|0|||
44331063|NCT01340664|79336449|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
44331064|NCT01340664|79336450|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
44331065|NCT01340664|79336451|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
44331066|NCT01340664|79336449|FG000|Overall Study|Other|1|||
44331067|NCT01340664|79336450|FG001|Overall Study|Other|2|||
44537933|NCT03446781|79548950|FG001|Overall Study|Lost to Follow-up|5|||
44537934|NCT03446781|79548949|FG000|Overall Study|Withdrawal by Subject|9|||
44537935|NCT03446781|79548950|FG001|Overall Study|Withdrawal by Subject|7|||
44537936|NCT03446781|79548949|FG000|Overall Study|Adverse Event|8|||
44537937|NCT03446781|79548950|FG001|Overall Study|Adverse Event|2|||
44537938|NCT03446781|79548949|FG000|Overall Study|Protocol Violation|0|||
44537939|NCT03446781|79548950|FG001|Overall Study|Protocol Violation|3|||
44537940|NCT03445065|79548982|FG000|Overall Study|Withdrawal by Subject|3|||
44331068|NCT01340664|79336451|FG002|Overall Study|Other|2|||
44331069|NCT01340625|79336461|FG000|First Intervention|Adverse Event|1|||
44331070|NCT01340625|79336462|FG001|First Intervention|Adverse Event|0|||
44331071|NCT01340625|79336461|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
44331072|NCT01340625|79336462|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
44331073|NCT01340196|79336468|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
44331074|NCT01327599|79336477|FG000|Overall Study|Adverse Event|1|||
44331075|NCT01327599|79336477|FG000|Overall Study|Could Not Attend Visit|1|||
44331076|NCT01327599|79336477|FG000|Overall Study|Withdrawal of Consent|1|||
44331077|NCT01193257|79336483|FG000|Overall Study|Death|202|||
44331078|NCT01193257|79336484|FG001|Overall Study|Death|391|||
44331079|NCT01193257|79336483|FG000|Overall Study|Study termination by sponsor|0|||
44331080|NCT01193257|79336484|FG001|Overall Study|Study termination by sponsor|3|||
44331081|NCT01193257|79336483|FG000|Overall Study|Withdrawal by Subject|26|||
44331082|NCT01193257|79336484|FG001|Overall Study|Withdrawal by Subject|86|||
44331083|NCT01193257|79336483|FG000|Overall Study|Lost to Follow-up|2|||
44331084|NCT01193257|79336484|FG001|Overall Study|Lost to Follow-up|3|||
44331085|NCT01193257|79336483|FG000|Overall Study|Unblinded due to futility|135|||
44331086|NCT01193257|79336484|FG001|Overall Study|Unblinded due to futility|251|||
44331087|NCT01193218|79336495|FG000|0-12 Weeks|Adverse Event|6|||
44331088|NCT01193218|79336496|FG001|0-12 Weeks|Adverse Event|0|||
44331089|NCT01193218|79336497|FG002|0-12 Weeks|Adverse Event|1|||
44331090|NCT01193218|79336498|FG003|0-12 Weeks|Adverse Event|0|||
44331091|NCT01193218|79336499|FG004|0-12 Weeks|Adverse Event|0|||
44331092|NCT01193218|79336500|FG005|0-12 Weeks|Adverse Event|2|||
44331093|NCT01193218|79336501|FG006|0-12 Weeks|Adverse Event|2|||
44331094|NCT01193218|79336502|FG007|0-12 Weeks|Adverse Event|0|||
44428097|NCT03496623|79436459|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
44428098|NCT03496623|79436460|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
44428099|NCT03496623|79436456|FG000|Period 1 (12 Weeks)|Death|0|||
44331095|NCT01193218|79336495|FG000|0-12 Weeks|Protocol Violation|0|||
44331096|NCT01193218|79336496|FG001|0-12 Weeks|Protocol Violation|0|||
44331097|NCT01193218|79336497|FG002|0-12 Weeks|Protocol Violation|0|||
44428100|NCT03496623|79436457|FG001|Period 1 (12 Weeks)|Death|3|||
44331098|NCT01193218|79336498|FG003|0-12 Weeks|Protocol Violation|0|||
44331099|NCT01193218|79336499|FG004|0-12 Weeks|Protocol Violation|1|||
44428101|NCT03496623|79436458|FG002|Period 1 (12 Weeks)|Death|0|||
44428102|NCT03496623|79436459|FG003|Period 1 (12 Weeks)|Death|0|||
44537941|NCT03445065|79548983|FG001|Overall Study|Withdrawal by Subject|6|||
44428103|NCT03496623|79436460|FG004|Period 1 (12 Weeks)|Death|0|||
44428104|NCT03496623|79436456|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
44428105|NCT03496623|79436457|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
44331100|NCT01193218|79336500|FG005|0-12 Weeks|Protocol Violation|1|||
44331101|NCT01193218|79336501|FG006|0-12 Weeks|Protocol Violation|0|||
44331102|NCT01193218|79336502|FG007|0-12 Weeks|Protocol Violation|0|||
44331103|NCT01193218|79336495|FG000|0-12 Weeks|Withdrawal by Subject|3|||
44331104|NCT01193218|79336496|FG001|0-12 Weeks|Withdrawal by Subject|0|||
44331105|NCT01193218|79336497|FG002|0-12 Weeks|Withdrawal by Subject|2|||
44331106|NCT01193218|79336498|FG003|0-12 Weeks|Withdrawal by Subject|0|||
44428106|NCT03496623|79436458|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
44428107|NCT03496623|79436459|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
44428108|NCT03496623|79436460|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
44428109|NCT03496623|79436456|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44428110|NCT03496623|79436457|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
44428111|NCT03496623|79436458|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
44428112|NCT03496623|79436459|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44428113|NCT03496623|79436460|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44428114|NCT03496623|79436456|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
44428115|NCT03496623|79436457|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
44428116|NCT03496623|79436458|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
44428117|NCT03496623|79436459|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
44428118|NCT03496623|79436460|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
44428119|NCT03496623|79436456|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44428120|NCT03496623|79436457|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44428121|NCT03496623|79436458|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
44428122|NCT03496623|79436459|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44428123|NCT03496623|79436460|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
44428124|NCT03496623|79436456|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
44428125|NCT03496623|79436457|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
44428126|NCT03496623|79436458|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
44428127|NCT03496623|79436459|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
44156971|NCT02924727|78948443|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
44156972|NCT02901626|78948453|FG000|Overall Study|Lost to Follow-up|1|||
44156973|NCT02901626|78948454|FG001|Overall Study|Lost to Follow-up|1|||
44156974|NCT02720692|78948493|FG000|Overall Study|Withdrawal by Subject|3|||
44156975|NCT02720692|78948494|FG001|Overall Study|Withdrawal by Subject|0|||
44156976|NCT02720692|78948493|FG000|Overall Study|Physician Decision|1|||
44156977|NCT02720692|78948494|FG001|Overall Study|Physician Decision|0|||
44331107|NCT01193218|79336499|FG004|0-12 Weeks|Withdrawal by Subject|0|||
44331108|NCT01193218|79336500|FG005|0-12 Weeks|Withdrawal by Subject|0|||
44331109|NCT01193218|79336501|FG006|0-12 Weeks|Withdrawal by Subject|1|||
44331110|NCT01193218|79336502|FG007|0-12 Weeks|Withdrawal by Subject|0|||
44331111|NCT01193218|79336495|FG000|12-52 Weeks|Adverse Event|1|||
44428128|NCT03496623|79436460|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
44428129|NCT03496623|79436456|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44428130|NCT03496623|79436457|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
44428131|NCT03496623|79436458|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44428132|NCT03496623|79436459|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44428133|NCT03496623|79436460|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44428134|NCT03224507|79436492|FG000|Overall Study|Death|3|||
44428135|NCT03224507|79436493|FG001|Overall Study|Death|0|||
44428136|NCT03224507|79436492|FG000|Overall Study|Lack of Efficacy|6|||
44428137|NCT03224507|79436493|FG001|Overall Study|Lack of Efficacy|0|||
44428138|NCT03224507|79436492|FG000|Overall Study|Withdrawal by Subject|6|||
44428139|NCT03224507|79436493|FG001|Overall Study|Withdrawal by Subject|0|||
44428140|NCT02720094|79436535|FG000|Overall Study|Scheduled exit visit/end of study|2|||
44428141|NCT02720094|79436536|FG001|Overall Study|Scheduled exit visit/end of study|1|||
44428142|NCT02720094|79436535|FG000|Overall Study|Death|4|||
44428143|NCT02720094|79436536|FG001|Overall Study|Death|7|||
44428144|NCT02720094|79436535|FG000|Overall Study|Withdrawal by Subject|55|||
44428145|NCT02720094|79436536|FG001|Overall Study|Withdrawal by Subject|56|||
44428146|NCT02720094|79436535|FG000|Overall Study|Lost to Follow-up|2|||
44428147|NCT02720094|79436536|FG001|Overall Study|Lost to Follow-up|7|||
44428148|NCT02720094|79436535|FG000|Overall Study|Physician Decision|1|||
44428149|NCT02720094|79436536|FG001|Overall Study|Physician Decision|3|||
44428150|NCT02720094|79436535|FG000|Overall Study|Inappropriate enrollment|1|||
44331112|NCT01193218|79336496|FG001|12-52 Weeks|Adverse Event|0|||
44331113|NCT01193218|79336497|FG002|12-52 Weeks|Adverse Event|1|||
44331114|NCT01193218|79336498|FG003|12-52 Weeks|Adverse Event|2|||
44331115|NCT01193218|79336499|FG004|12-52 Weeks|Adverse Event|3|||
44428151|NCT02720094|79436536|FG001|Overall Study|Inappropriate enrollment|3|||
44331116|NCT01193218|79336500|FG005|12-52 Weeks|Adverse Event|3|||
44428152|NCT02720094|79436535|FG000|Overall Study|Ongoing|2210|||
44428153|NCT02720094|79436536|FG001|Overall Study|Ongoing|2203|||
44428154|NCT02720094|79436535|FG000|Overall Study|Relocation|1|||
44428155|NCT02720094|79436536|FG001|Overall Study|Relocation|1|||
44428156|NCT02646618|79436564|FG000|Overall Study|Lost to Follow-up|10|||
44156978|NCT02720692|78948493|FG000|Overall Study|Lost to Follow-up|8|||
44331117|NCT01193218|79336501|FG006|12-52 Weeks|Adverse Event|1|||
44331118|NCT01193218|79336502|FG007|12-52 Weeks|Adverse Event|2|||
44331119|NCT01193218|79336495|FG000|12-52 Weeks|Lack of Efficacy|0|||
44331120|NCT01193218|79336496|FG001|12-52 Weeks|Lack of Efficacy|0|||
44428157|NCT02646618|79436565|FG001|Overall Study|Lost to Follow-up|14|||
44428161|NCT02285114|79436589|FG000|Overall Study|Investigator's Discretion|0|||
44428162|NCT02285114|79436590|FG001|Overall Study|Investigator's Discretion|2|||
44428163|NCT02285114|79436591|FG002|Overall Study|Investigator's Discretion|0|||
44428164|NCT02285114|79436589|FG000|Overall Study|Withdrew Consent|0|||
44428165|NCT02285114|79436590|FG001|Overall Study|Withdrew Consent|0|||
44428166|NCT02285114|79436591|FG002|Overall Study|Withdrew Consent|1|||
44428167|NCT02285114|79436589|FG000|Overall Study|Enrolled but not treated|1|||
44428168|NCT02285114|79436590|FG001|Overall Study|Enrolled but not treated|0|||
44428169|NCT02285114|79436591|FG002|Overall Study|Enrolled but not treated|0|||
44428170|NCT02285114|79436589|FG000|Overall Study|Still on study|21|||
44428171|NCT02285114|79436590|FG001|Overall Study|Still on study|5|||
44428172|NCT02285114|79436591|FG002|Overall Study|Still on study|2|||
44428173|NCT01952366|79436605|FG000|Overall Study|Death|22|||
44428174|NCT01952366|79436605|FG000|Overall Study|Withdrawal by Subject|9|||
44428175|NCT01626079|79436615|FG000|Overall Study|Death|167|||
44428176|NCT01626079|79436616|FG001|Overall Study|Death|192|||
44428177|NCT01626079|79436617|FG002|Overall Study|Death|39|||
44428178|NCT01626079|79436615|FG000|Overall Study|Withdrawal by Subject|23|||
44428179|NCT01626079|79436616|FG001|Overall Study|Withdrawal by Subject|37|||
44428180|NCT01626079|79436617|FG002|Overall Study|Withdrawal by Subject|5|||
44428181|NCT01626079|79436615|FG000|Overall Study|Lost to Follow-up|7|||
44428182|NCT01626079|79436616|FG001|Overall Study|Lost to Follow-up|4|||
44428183|NCT01626079|79436617|FG002|Overall Study|Lost to Follow-up|2|||
44428184|NCT01626079|79436615|FG000|Overall Study|Missed Visits|1|||
44428185|NCT01626079|79436616|FG001|Overall Study|Missed Visits|4|||
44428186|NCT01626079|79436617|FG002|Overall Study|Missed Visits|6|||
44428187|NCT01349959|79436628|FG000|Overall Study|Adverse Event|7|||
44428188|NCT01331681|79436635|FG000|Overall Study|Adverse Event|10|||
44428189|NCT01331681|79436636|FG001|Overall Study|Adverse Event|13|||
44428190|NCT01331681|79436637|FG002|Overall Study|Adverse Event|10|||
44428191|NCT01331681|79436635|FG000|Overall Study|Death|6|||
44428192|NCT01331681|79436636|FG001|Overall Study|Death|6|||
44428193|NCT01331681|79436637|FG002|Overall Study|Death|2|||
44428194|NCT01331681|79436635|FG000|Overall Study|Lack of Efficacy|0|||
44428195|NCT01331681|79436636|FG001|Overall Study|Lack of Efficacy|1|||
44428196|NCT01331681|79436637|FG002|Overall Study|Lack of Efficacy|0|||
44428197|NCT01331681|79436635|FG000|Overall Study|Withdrawal by Subject|12|||
44428198|NCT01331681|79436636|FG001|Overall Study|Withdrawal by Subject|8|||
44428199|NCT01331681|79436637|FG002|Overall Study|Withdrawal by Subject|15|||
44428200|NCT01331681|79436635|FG000|Overall Study|Protocol Violation|1|||
44428201|NCT01331681|79436636|FG001|Overall Study|Protocol Violation|1|||
44428202|NCT01331681|79436637|FG002|Overall Study|Protocol Violation|0|||
44428203|NCT01331681|79436635|FG000|Overall Study|Lost to Follow-up|2|||
44428204|NCT01331681|79436636|FG001|Overall Study|Lost to Follow-up|4|||
44428205|NCT01331681|79436637|FG002|Overall Study|Lost to Follow-up|1|||
44428206|NCT01331681|79436635|FG000|Overall Study|Physician Decision|2|||
44428207|NCT01331681|79436636|FG001|Overall Study|Physician Decision|0|||
44331121|NCT01193218|79336497|FG002|12-52 Weeks|Lack of Efficacy|0|||
44331122|NCT01193218|79336498|FG003|12-52 Weeks|Lack of Efficacy|0|||
44331123|NCT01193218|79336499|FG004|12-52 Weeks|Lack of Efficacy|0|||
44331124|NCT01193218|79336500|FG005|12-52 Weeks|Lack of Efficacy|0|||
44331125|NCT01193218|79336501|FG006|12-52 Weeks|Lack of Efficacy|1|||
44331126|NCT01193218|79336502|FG007|12-52 Weeks|Lack of Efficacy|0|||
44331127|NCT01193218|79336495|FG000|12-52 Weeks|Withdrawal by Subject|3|||
44331128|NCT01193218|79336496|FG001|12-52 Weeks|Withdrawal by Subject|0|||
44331129|NCT01193218|79336497|FG002|12-52 Weeks|Withdrawal by Subject|3|||
44331130|NCT01193218|79336498|FG003|12-52 Weeks|Withdrawal by Subject|0|||
44331131|NCT01193218|79336499|FG004|12-52 Weeks|Withdrawal by Subject|0|||
44331132|NCT01193218|79336500|FG005|12-52 Weeks|Withdrawal by Subject|2|||
44428208|NCT01331681|79436637|FG002|Overall Study|Physician Decision|4|||
44428209|NCT01331681|79436635|FG000|Overall Study|Therapeutic procedure required|1|||
44428210|NCT01331681|79436636|FG001|Overall Study|Therapeutic procedure required|0|||
44428211|NCT01331681|79436637|FG002|Overall Study|Therapeutic procedure required|0|||
44428212|NCT01331681|79436635|FG000|Overall Study|Sponsor decision|1|||
44428213|NCT01331681|79436636|FG001|Overall Study|Sponsor decision|1|||
44428214|NCT01331681|79436637|FG002|Overall Study|Sponsor decision|0|||
44428215|NCT01331681|79436635|FG000|Overall Study|Switching to other therapy|0|||
44428216|NCT01331681|79436636|FG001|Overall Study|Switching to other therapy|0|||
44428217|NCT01331681|79436637|FG002|Overall Study|Switching to other therapy|1|||
44428218|NCT01331681|79436635|FG000|Overall Study|Not Received Study Treatment|0|||
44428219|NCT01331681|79436636|FG001|Overall Study|Not Received Study Treatment|0|||
44331133|NCT01193218|79336501|FG006|12-52 Weeks|Withdrawal by Subject|1|||
44331134|NCT01193218|79336502|FG007|12-52 Weeks|Withdrawal by Subject|2|||
44331135|NCT01193218|79336495|FG000|12-52 Weeks|Other reason than above|1|||
44428220|NCT01331681|79436637|FG002|Overall Study|Not Received Study Treatment|2|||
44428221|NCT01286272|79436647|FG000|Overall Study|Ineligible after beginning treatment|1|||
44428222|NCT01286272|79436648|FG001|Overall Study|Ineligible after beginning treatment|3|||
44428223|NCT01215136|79436656|FG000|Overall Study|Adverse Event|2|||
44428224|NCT01215136|79436657|FG001|Overall Study|Adverse Event|9|||
44428225|NCT01215136|79436656|FG000|Overall Study|Disease Progression|3|||
44428226|NCT01215136|79436657|FG001|Overall Study|Disease Progression|14|||
44331136|NCT01193218|79336496|FG001|12-52 Weeks|Other reason than above|0|||
44331137|NCT01193218|79336497|FG002|12-52 Weeks|Other reason than above|0|||
44331138|NCT01193218|79336498|FG003|12-52 Weeks|Other reason than above|1|||
44331139|NCT01193218|79336499|FG004|12-52 Weeks|Other reason than above|1|||
44331140|NCT01193218|79336500|FG005|12-52 Weeks|Other reason than above|0|||
44331141|NCT01193218|79336501|FG006|12-52 Weeks|Other reason than above|0|||
44428227|NCT01215136|79436656|FG000|Overall Study|Symptomatic Deterioration|1|||
44428228|NCT01215136|79436657|FG001|Overall Study|Symptomatic Deterioration|1|||
44428229|NCT01215136|79436656|FG000|Overall Study|Death|0|||
44428230|NCT01215136|79436657|FG001|Overall Study|Death|2|||
44428231|NCT01215136|79436656|FG000|Overall Study|Withdrawal by Subject|0|||
44428232|NCT01215136|79436657|FG001|Overall Study|Withdrawal by Subject|1|||
44428233|NCT00616018|79436688|FG000|Overall Study|Protocol Violation|3|||
44428234|NCT00424021|79436697|FG000|NCT00046319 Study Period|Adverse Event|1|||
44428235|NCT00424021|79436698|FG001|NCT00046319 Study Period|Adverse Event|0|||
44428236|NCT00424021|79436699|FG002|NCT00046319 Study Period|Adverse Event|1|||
44428237|NCT00424021|79436700|FG003|NCT00046319 Study Period|Adverse Event|1|||
44428238|NCT00424021|79436697|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
44428239|NCT00424021|79436698|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
44428240|NCT00424021|79436699|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
44428241|NCT00424021|79436700|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
44428242|NCT00424021|79436697|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
44428243|NCT00424021|79436698|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
44428244|NCT00424021|79436699|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
44428245|NCT00424021|79436700|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
44428246|NCT00424021|79436697|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
44428247|NCT00424021|79436698|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
44428248|NCT00424021|79436699|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
44428249|NCT00424021|79436700|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
44428250|NCT00424021|79436697|FG000|AMB-220-E Study Period|Adverse Event|1|||
44428251|NCT00424021|79436698|FG001|AMB-220-E Study Period|Adverse Event|1|||
44428252|NCT00424021|79436699|FG002|AMB-220-E Study Period|Adverse Event|3|||
44428253|NCT00424021|79436700|FG003|AMB-220-E Study Period|Adverse Event|7|||
44428254|NCT00424021|79436697|FG000|AMB-220-E Study Period|Death|0|||
44428255|NCT00424021|79436698|FG001|AMB-220-E Study Period|Death|0|||
44428256|NCT00424021|79436699|FG002|AMB-220-E Study Period|Death|1|||
44428257|NCT00424021|79436700|FG003|AMB-220-E Study Period|Death|1|||
44428258|NCT00424021|79436697|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
44428259|NCT00424021|79436698|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
44428260|NCT00424021|79436699|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
44428261|NCT00424021|79436700|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
44428262|NCT00424021|79436697|FG000|AMB-220-E Study Period|Physician Decision|0|||
44428263|NCT00424021|79436698|FG001|AMB-220-E Study Period|Physician Decision|0|||
44428264|NCT00424021|79436699|FG002|AMB-220-E Study Period|Physician Decision|0|||
44428265|NCT00424021|79436700|FG003|AMB-220-E Study Period|Physician Decision|1|||
44428266|NCT00617734|79436719|FG000|Overall Study|Withdrew Consent|2|||
44428267|NCT00617734|79436720|FG001|Overall Study|Withdrew Consent|0|||
44428268|NCT00617734|79436719|FG000|Overall Study|Adverse Event|4|||
44428269|NCT00617734|79436720|FG001|Overall Study|Adverse Event|1|||
44428270|NCT00617734|79436719|FG000|Overall Study|Protocol Violation|1|||
44428271|NCT00617734|79436720|FG001|Overall Study|Protocol Violation|0|||
44428272|NCT00617734|79436719|FG000|Overall Study|Found Ineligible After Randomization|1|||
44331142|NCT01193218|79336502|FG007|12-52 Weeks|Other reason than above|0|||
44331143|NCT01193101|79336522|FG000|Overall Study|Adverse Event|0|||
44331144|NCT01193101|79336523|FG001|Overall Study|Adverse Event|1|||
44331145|NCT01193101|79336524|FG002|Overall Study|Adverse Event|1|||
44331146|NCT01193101|79336525|FG003|Overall Study|Adverse Event|3|||
44428273|NCT00617734|79436720|FG001|Overall Study|Found Ineligible After Randomization|4|||
44428274|NCT00617734|79436719|FG000|Overall Study|Lost to Follow-up|0|||
44428275|NCT00617734|79436720|FG001|Overall Study|Lost to Follow-up|1|||
44428276|NCT00577460|79436729|FG000|Overall Study|Adverse Event|11|||
44428277|NCT00577460|79436730|FG001|Overall Study|Adverse Event|7|||
44428278|NCT00577460|79436731|FG002|Overall Study|Adverse Event|14|||
44428279|NCT00577460|79436729|FG000|Overall Study|Protocol Violation|0|||
44428280|NCT00577460|79436730|FG001|Overall Study|Protocol Violation|1|||
44428281|NCT00577460|79436731|FG002|Overall Study|Protocol Violation|1|||
44428282|NCT00577460|79436729|FG000|Overall Study|Lost to Follow-up|0|||
44428283|NCT00577460|79436730|FG001|Overall Study|Lost to Follow-up|3|||
44428284|NCT00577460|79436731|FG002|Overall Study|Lost to Follow-up|4|||
44331147|NCT01193101|79336522|FG000|Overall Study|Lack of Efficacy|3|||
44331148|NCT01193101|79336523|FG001|Overall Study|Lack of Efficacy|1|||
44428285|NCT00577460|79436729|FG000|Overall Study|Withdrawal by Subject|5|||
44428286|NCT00577460|79436730|FG001|Overall Study|Withdrawal by Subject|5|||
44428287|NCT00577460|79436731|FG002|Overall Study|Withdrawal by Subject|6|||
44428288|NCT00577460|79436729|FG000|Overall Study|Other|0|||
44331149|NCT01193101|79336524|FG002|Overall Study|Lack of Efficacy|0|||
44331150|NCT01193101|79336525|FG003|Overall Study|Lack of Efficacy|8|||
44331151|NCT01193101|79336522|FG000|Overall Study|Withdrawal by Subject|2|||
44331152|NCT01193101|79336523|FG001|Overall Study|Withdrawal by Subject|4|||
44331153|NCT01193101|79336524|FG002|Overall Study|Withdrawal by Subject|1|||
44331154|NCT01193101|79336525|FG003|Overall Study|Withdrawal by Subject|1|||
44331155|NCT01193101|79336522|FG000|Overall Study|Administrative problems|0|||
44331156|NCT01193101|79336523|FG001|Overall Study|Administrative problems|0|||
44331157|NCT01193101|79336524|FG002|Overall Study|Administrative problems|1|||
44331158|NCT01193101|79336525|FG003|Overall Study|Administrative problems|0|||
44428289|NCT00577460|79436730|FG001|Overall Study|Other|3|||
44428290|NCT00577460|79436731|FG002|Overall Study|Other|2|||
44428291|NCT00415519|79436748|FG000|Overall Study|Adverse Event|1|||
44428292|NCT00415519|79436749|FG001|Overall Study|Adverse Event|0|||
44428293|NCT00415519|79436748|FG000|Overall Study|Withdrawal by Subject|2|||
44428294|NCT00415519|79436749|FG001|Overall Study|Withdrawal by Subject|0|||
44428295|NCT00415519|79436748|FG000|Overall Study|Patient's convenience|1|||
44428296|NCT00415519|79436749|FG001|Overall Study|Patient's convenience|0|||
44428297|NCT00423943|79436757|FG000|Overall Study|Withdrawal by Subject|3|||
44428298|NCT00423943|79436758|FG001|Overall Study|Withdrawal by Subject|1|||
44428299|NCT00428389|79436766|FG000|Core Phase|Adverse Event|6|||
44428300|NCT00428389|79436767|FG001|Core Phase|Adverse Event|4|||
44428301|NCT00428389|79436766|FG000|Core Phase|Lack of Efficacy|2|||
44428302|NCT00428389|79436767|FG001|Core Phase|Lack of Efficacy|0|||
44428303|NCT00428389|79436766|FG000|Core Phase|Abnormal test procedure result(s)|0|||
44428304|NCT00428389|79436767|FG001|Core Phase|Abnormal test procedure result(s)|1|||
44428305|NCT00428389|79436766|FG000|Core Phase|Withdrawal by Subject|3|||
44428306|NCT00428389|79436767|FG001|Core Phase|Withdrawal by Subject|4|||
44428307|NCT00428389|79436766|FG000|Core Phase|Protocol deviation|0|||
44428308|NCT00428389|79436767|FG001|Core Phase|Protocol deviation|2|||
44428309|NCT00428389|79436766|FG000|Extension Phase|Adverse Event|17|||
44428310|NCT00428389|79436767|FG001|Extension Phase|Adverse Event|11|||
44428311|NCT00428389|79436766|FG000|Extension Phase|Lack of Efficacy|4|||
44428312|NCT00428389|79436767|FG001|Extension Phase|Lack of Efficacy|3|||
44428313|NCT00428389|79436766|FG000|Extension Phase|Withdrawal by Subject|6|||
44428314|NCT00428389|79436767|FG001|Extension Phase|Withdrawal by Subject|6|||
44331159|NCT01193101|79336522|FG000|Overall Study|Abnormal test procedure results|0|||
44331160|NCT01193101|79336523|FG001|Overall Study|Abnormal test procedure results|1|||
44331161|NCT01193101|79336524|FG002|Overall Study|Abnormal test procedure results|0|||
44331162|NCT01193101|79336525|FG003|Overall Study|Abnormal test procedure results|0|||
44331163|NCT01192516|79336538|FG000|Overall Study|Lost to Follow-up|7|||
44331164|NCT01192516|79336539|FG001|Overall Study|Lost to Follow-up|10|||
44331165|NCT01192516|79336540|FG002|Overall Study|Lost to Follow-up|7|||
44331166|NCT01192516|79336538|FG000|Overall Study|Withdrawal by Subject|4|||
44331167|NCT01192516|79336539|FG001|Overall Study|Withdrawal by Subject|4|||
44331168|NCT01192516|79336540|FG002|Overall Study|Withdrawal by Subject|1|||
44331169|NCT01192516|79336538|FG000|Overall Study|started new treatment|5|||
44331170|NCT01192516|79336539|FG001|Overall Study|started new treatment|1|||
44331171|NCT01192516|79336540|FG002|Overall Study|started new treatment|0|||
44331172|NCT01192516|79336538|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
44331173|NCT01192516|79336539|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
44331174|NCT01192516|79336540|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
44331175|NCT01192399|79336552|FG000|Overall Study|Lack of Efficacy|2|||
44331176|NCT01176916|79336556|FG000|Overall Study|Adverse Event|61|||
44331177|NCT01176916|79336556|FG000|Overall Study|Death|1|||
44331178|NCT01176916|79336556|FG000|Overall Study|Lost to Follow-up|15|||
44428315|NCT00428389|79436766|FG000|Extension Phase|Lost to Follow-up|0|||
44428316|NCT00428389|79436767|FG001|Extension Phase|Lost to Follow-up|3|||
44428317|NCT00428389|79436766|FG000|Extension Phase|Death|1|||
44428318|NCT00428389|79436767|FG001|Extension Phase|Death|0|||
44428319|NCT00428389|79436766|FG000|Extension Phase|Protocol Violation|3|||
44428320|NCT00428389|79436767|FG001|Extension Phase|Protocol Violation|2|||
44428321|NCT00428389|79436766|FG000|Extension Phase|Administrative problems|1|||
44537942|NCT03445065|79548984|FG002|Overall Study|Withdrawal by Subject|2|||
44537943|NCT03445065|79548985|FG003|Overall Study|Withdrawal by Subject|2|||
44537944|NCT03445065|79548982|FG000|Overall Study|Other|4|||
44331179|NCT01176916|79336556|FG000|Overall Study|Objective progression or relapse|17|||
44331180|NCT01176916|79336556|FG000|Overall Study|Protocol Violation|24|||
44331181|NCT01176916|79336556|FG000|Overall Study|Withdrawal by Subject|37|||
44331182|NCT01176916|79336556|FG000|Overall Study|Other|6|||
44331183|NCT01176916|79336556|FG000|Overall Study|Withdrawal prior to Treatment|6|||
44331184|NCT01192204|79336562|FG000|Overall Study|could not keep recall appointments|1|||
44428322|NCT00428389|79436767|FG001|Extension Phase|Administrative problems|1|||
44428323|NCT00616642|79436775|FG000|Overall Study|Withdrawal by Subject|0|||
44331185|NCT01192204|79336563|FG001|Overall Study|could not keep recall appointments|0|||
44331186|NCT01192126|79336570|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
44331187|NCT01192126|79336571|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
44331188|NCT01192126|79336570|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
44331189|NCT01192126|79336571|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
44331190|NCT01327482|79336577|FG000|Overall Study|Adverse Event|1|||
44331191|NCT01176565|79336583|FG000|Overall Study|Lost to Follow-up|12|||
44331192|NCT01176565|79336584|FG001|Overall Study|Lost to Follow-up|16|||
44331193|NCT01176565|79336583|FG000|Overall Study|Withdrawal by Subject|7|||
44331194|NCT01176565|79336584|FG001|Overall Study|Withdrawal by Subject|1|||
44331195|NCT01176565|79336583|FG000|Overall Study|Not Analyzed (any other reason)|1|||
44331196|NCT01176565|79336584|FG001|Overall Study|Not Analyzed (any other reason)|2|||
44331197|NCT01176292|79336592|FG000|Overall Study|Lost to Follow-up|2|||
44428324|NCT00616642|79436776|FG001|Overall Study|Withdrawal by Subject|1|||
44428325|NCT00406315|79436782|FG000|Overall Study|Death|1|||
44428326|NCT00406315|79436782|FG000|Overall Study|Adverse Event|39|||
44428327|NCT00406315|79436782|FG000|Overall Study|Laboratory Abnormality|4|||
44428328|NCT00406315|79436782|FG000|Overall Study|Lack of Efficacy|13|||
44428329|NCT00406315|79436782|FG000|Overall Study|Other|33|||
44428330|NCT00406315|79436782|FG000|Overall Study|Lost to Follow-up|21|||
44428331|NCT00406315|79436782|FG000|Overall Study|Withdrawal by Subject|30|||
44428332|NCT00711594|79436790|FG000|Overall Study|Progressive disease|2|||
44428333|NCT00711594|79436791|FG001|Overall Study|Progressive disease|2|||
44428334|NCT00711594|79436792|FG002|Overall Study|Progressive disease|6|||
44428335|NCT00711594|79436793|FG003|Overall Study|Progressive disease|44|||
44428336|NCT00711594|79436790|FG000|Overall Study|Other Adverse Event|1|||
44428337|NCT00711594|79436791|FG001|Overall Study|Other Adverse Event|0|||
44428338|NCT00711594|79436792|FG002|Overall Study|Other Adverse Event|0|||
44428339|NCT00711594|79436793|FG003|Overall Study|Other Adverse Event|16|||
44428340|NCT00711594|79436790|FG000|Overall Study|Withdrawal by Subject|0|||
44428341|NCT00711594|79436791|FG001|Overall Study|Withdrawal by Subject|1|||
44428342|NCT00711594|79436792|FG002|Overall Study|Withdrawal by Subject|0|||
44428343|NCT00711594|79436793|FG003|Overall Study|Withdrawal by Subject|2|||
44428344|NCT00710762|79436807|FG000|Overall Study|Progressive disease|27|||
44428345|NCT00710762|79436808|FG001|Overall Study|Progressive disease|30|||
44537945|NCT03445065|79548983|FG001|Overall Study|Other|3|||
44537946|NCT03445065|79548984|FG002|Overall Study|Other|3|||
44537947|NCT03445065|79548985|FG003|Overall Study|Other|1|||
44428346|NCT00710762|79436807|FG000|Overall Study|Adverse Event other disease worsening|2|||
44428347|NCT00710762|79436808|FG001|Overall Study|Adverse Event other disease worsening|1|||
44428348|NCT00710762|79436807|FG000|Overall Study|Other Adverse Event|7|||
44428349|NCT00710762|79436808|FG001|Overall Study|Other Adverse Event|7|||
44428350|NCT00710762|79436807|FG000|Overall Study|Lost to Follow-up|1|||
44428351|NCT00710762|79436808|FG001|Overall Study|Lost to Follow-up|0|||
44428352|NCT00710762|79436807|FG000|Overall Study|Reason other than listed above|2|||
44428353|NCT00710762|79436808|FG001|Overall Study|Reason other than listed above|2|||
44428354|NCT00573430|79436817|FG000|Overall Study|Incorrect enrollment of randomization|0|||
44428355|NCT00573430|79436818|FG001|Overall Study|Incorrect enrollment of randomization|4|||
44428356|NCT00573430|79436819|FG002|Overall Study|Incorrect enrollment of randomization|3|||
44428357|NCT00573430|79436817|FG000|Overall Study|Adverse Event|0|||
44428358|NCT00573430|79436818|FG001|Overall Study|Adverse Event|0|||
44428359|NCT00573430|79436819|FG002|Overall Study|Adverse Event|2|||
44428360|NCT00573430|79436817|FG000|Overall Study|Withdrawal by Subject|1|||
44428361|NCT00573430|79436818|FG001|Overall Study|Withdrawal by Subject|0|||
44428362|NCT00573430|79436819|FG002|Overall Study|Withdrawal by Subject|1|||
44428363|NCT00573430|79436817|FG000|Overall Study|Protocol Violation|0|||
44428364|NCT00573430|79436818|FG001|Overall Study|Protocol Violation|1|||
44428365|NCT00573430|79436819|FG002|Overall Study|Protocol Violation|1|||
44428366|NCT00573430|79436817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44428367|NCT00573430|79436818|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44537948|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Death|3|||
44537949|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Death|0|||
44537950|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Death|0|||
44537951|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Death|0|||
44331198|NCT01176292|79336593|FG001|Overall Study|Lost to Follow-up|4|||
44537952|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Death|0|||
44331199|NCT01176292|79336592|FG000|Overall Study|Adverse Event|1|||
44331200|NCT01176292|79336593|FG001|Overall Study|Adverse Event|1|||
44428368|NCT00573430|79436819|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
44428369|NCT00711516|79436829|FG000|Overall Study|Adverse Event|1|||
44428370|NCT00711516|79436830|FG001|Overall Study|Adverse Event|1|||
44428371|NCT00711516|79436829|FG000|Overall Study|Withdrawal by Subject|0|||
44428372|NCT00711516|79436830|FG001|Overall Study|Withdrawal by Subject|1|||
44537953|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
44331201|NCT01176292|79336592|FG000|Overall Study|Physician Decision|0|||
44331202|NCT01176292|79336593|FG001|Overall Study|Physician Decision|2|||
44331203|NCT01176292|79336592|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
44331204|NCT01176292|79336593|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
44331205|NCT01113541|79336599|FG000|Overall Study|Withdrawal by Subject|1|||
44331206|NCT01113541|79336599|FG000|Overall Study|Protocol Violation|1|||
44331207|NCT01113541|79336599|FG000|Overall Study|Study Terminated by Sponsor|7|||
44331208|NCT01113541|79336599|FG000|Overall Study|Adverse Event|4|||
44331209|NCT01113502|79336612|FG000|Overall Study|Withdrawal by Subject|1|||
44331210|NCT01113502|79336613|FG001|Overall Study|Withdrawal by Subject|0|||
44331211|NCT01113502|79336614|FG002|Overall Study|Withdrawal by Subject|1|||
44331212|NCT01113502|79336615|FG003|Overall Study|Withdrawal by Subject|1|||
44331213|NCT01113502|79336616|FG004|Overall Study|Withdrawal by Subject|0|||
44331214|NCT01113502|79336612|FG000|Overall Study|Adverse Event|0|||
44331215|NCT01113502|79336613|FG001|Overall Study|Adverse Event|0|||
44331216|NCT01113502|79336614|FG002|Overall Study|Adverse Event|3|||
44331217|NCT01113502|79336615|FG003|Overall Study|Adverse Event|2|||
44331218|NCT01113502|79336616|FG004|Overall Study|Adverse Event|0|||
44331219|NCT01113463|79336629|FG000|Overall Study|Physician Decision|5|||
44331220|NCT01112917|79336633|FG000|Overall Study|Death|2|||
44331221|NCT01112917|79336634|FG001|Overall Study|Death|11|||
44331222|NCT01112917|79336633|FG000|Overall Study|Lost to Follow-up|1|||
44331223|NCT01112917|79336634|FG001|Overall Study|Lost to Follow-up|1|||
44331224|NCT01112917|79336633|FG000|Overall Study|Withdrawal by Subject|1|||
44428373|NCT00711516|79436829|FG000|Overall Study|Protocol Violation|0|||
44428374|NCT00711516|79436830|FG001|Overall Study|Protocol Violation|1|||
44428375|NCT00615550|79436838|FG000|Overall Study|Lost to Follow-up|6|||
44428376|NCT00615550|79436839|FG001|Overall Study|Lost to Follow-up|1|||
44428377|NCT00577382|79436847|FG000|Overall Study|Adverse Event|0|||
44428378|NCT00577382|79436848|FG001|Overall Study|Adverse Event|6|||
44428379|NCT00577382|79436847|FG000|Overall Study|Withdrawal by Subject|0|||
44428380|NCT00577382|79436848|FG001|Overall Study|Withdrawal by Subject|1|||
44428381|NCT00577382|79436847|FG000|Overall Study|Progressive Disease|17|||
44428382|NCT00577382|79436848|FG001|Overall Study|Progressive Disease|19|||
44428383|NCT00577382|79436847|FG000|Overall Study|Intercurrent Illness|1|||
44428384|NCT00577382|79436848|FG001|Overall Study|Intercurrent Illness|2|||
44428385|NCT00577382|79436847|FG000|Overall Study|Death|1|||
44428386|NCT00577382|79436848|FG001|Overall Study|Death|1|||
44428387|NCT00577382|79436847|FG000|Overall Study|Lost to Follow-up|2|||
44428388|NCT00577382|79436848|FG001|Overall Study|Lost to Follow-up|2|||
44428389|NCT00614926|79436856|FG000|Overall Study|Burden of travel|1|||
44428390|NCT00614926|79436857|FG001|Overall Study|Burden of travel|0|||
44428391|NCT00614926|79436856|FG000|Overall Study|Adverse Event|3|||
44428392|NCT00614926|79436857|FG001|Overall Study|Adverse Event|0|||
44428393|NCT00423319|79436865|FG000|Overall Study|Death|2|||
44428394|NCT00423319|79436866|FG001|Overall Study|Death|0|||
44428395|NCT00423319|79436865|FG000|Overall Study|Adverse Event|93|||
44428396|NCT00423319|79436866|FG001|Overall Study|Adverse Event|112|||
44428397|NCT00423319|79436865|FG000|Overall Study|Withdrawal by Subject|86|||
44428398|NCT00423319|79436866|FG001|Overall Study|Withdrawal by Subject|99|||
44428399|NCT00423319|79436865|FG000|Overall Study|Lost to Follow-up|4|||
44428400|NCT00423319|79436866|FG001|Overall Study|Lost to Follow-up|3|||
44428401|NCT00423319|79436865|FG000|Overall Study|Poor compliance or noncompliance|1|||
44428402|NCT00423319|79436866|FG001|Overall Study|Poor compliance or noncompliance|1|||
44428403|NCT00423319|79436865|FG000|Overall Study|No longer meets study criteria|15|||
44428404|NCT00423319|79436866|FG001|Overall Study|No longer meets study criteria|15|||
44428405|NCT00423319|79436865|FG000|Overall Study|Other|23|||
44537954|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
44537955|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
44537956|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
44537957|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
44537958|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
44537959|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
44331225|NCT01112917|79336634|FG001|Overall Study|Withdrawal by Subject|3|||
44331226|NCT01112917|79336633|FG000|Overall Study|Unable to Convert Filter|3|||
44331227|NCT01112917|79336634|FG001|Overall Study|Unable to Convert Filter|0|||
44428406|NCT00423319|79436866|FG001|Overall Study|Other|22|||
44428407|NCT00710684|79436876|FG000|Overall Study|Adverse Event|11|||
44428408|NCT00710684|79436877|FG001|Overall Study|Adverse Event|19|||
44428409|NCT00710684|79436878|FG002|Overall Study|Adverse Event|16|||
44537960|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
44428410|NCT00710684|79436876|FG000|Overall Study|Lack of Efficacy|4|||
44428411|NCT00710684|79436877|FG001|Overall Study|Lack of Efficacy|3|||
44331228|NCT01176058|79336640|FG000|Overall Study|Adverse Event|1|||
44331229|NCT01176058|79336641|FG001|Overall Study|Adverse Event|0|||
44331230|NCT01176058|79336640|FG000|Overall Study|Insufficient clinical response|2|||
44331231|NCT01176058|79336641|FG001|Overall Study|Insufficient clinical response|2|||
44428412|NCT00710684|79436878|FG002|Overall Study|Lack of Efficacy|5|||
44428413|NCT00710684|79436876|FG000|Overall Study|Protocol Violation|5|||
44428414|NCT00710684|79436877|FG001|Overall Study|Protocol Violation|5|||
44428415|NCT00710684|79436878|FG002|Overall Study|Protocol Violation|5|||
44428416|NCT00710684|79436876|FG000|Overall Study|Lost to Follow-up|4|||
44428417|NCT00710684|79436877|FG001|Overall Study|Lost to Follow-up|6|||
44428418|NCT00710684|79436878|FG002|Overall Study|Lost to Follow-up|7|||
44428419|NCT00710684|79436876|FG000|Overall Study|Physician Decision|0|||
44428420|NCT00710684|79436877|FG001|Overall Study|Physician Decision|2|||
44428421|NCT00710684|79436878|FG002|Overall Study|Physician Decision|4|||
44428422|NCT00710684|79436876|FG000|Overall Study|Withdrawal by Subject|24|||
44428423|NCT00710684|79436877|FG001|Overall Study|Withdrawal by Subject|18|||
44428424|NCT00710684|79436878|FG002|Overall Study|Withdrawal by Subject|11|||
44428425|NCT00710684|79436876|FG000|Overall Study|Missing|1|||
44428426|NCT00710684|79436877|FG001|Overall Study|Missing|0|||
44428427|NCT00710684|79436878|FG002|Overall Study|Missing|0|||
44428428|NCT00710684|79436876|FG000|Overall Study|Did not continue after week 24|25|||
44428429|NCT00710684|79436877|FG001|Overall Study|Did not continue after week 24|21|||
44428430|NCT00710684|79436878|FG002|Overall Study|Did not continue after week 24|16|||
44428431|NCT00710606|79436894|FG000|Overall Study|Adverse Event|0|||
44428432|NCT00710606|79436895|FG001|Overall Study|Adverse Event|2|||
44428433|NCT00713544|79436909|FG000|Overall Study|Adverse Event|5|||
44428434|NCT00713544|79436910|FG001|Overall Study|Adverse Event|3|||
44428435|NCT00713544|79436911|FG002|Overall Study|Adverse Event|7|||
44428436|NCT00713544|79436912|FG003|Overall Study|Adverse Event|7|||
44428437|NCT00713544|79436913|FG004|Overall Study|Adverse Event|3|||
44428438|NCT00713544|79436914|FG005|Overall Study|Adverse Event|5|||
44428439|NCT00713544|79436909|FG000|Overall Study|Withdrawal by Subject|2|||
44428440|NCT00713544|79436910|FG001|Overall Study|Withdrawal by Subject|0|||
44428441|NCT00713544|79436911|FG002|Overall Study|Withdrawal by Subject|3|||
44428442|NCT00713544|79436912|FG003|Overall Study|Withdrawal by Subject|2|||
44428443|NCT00713544|79436913|FG004|Overall Study|Withdrawal by Subject|3|||
44428444|NCT00713544|79436914|FG005|Overall Study|Withdrawal by Subject|1|||
44428445|NCT00713544|79436909|FG000|Overall Study|Protocol Violation|0|||
44428446|NCT00713544|79436910|FG001|Overall Study|Protocol Violation|0|||
44428447|NCT00713544|79436911|FG002|Overall Study|Protocol Violation|0|||
44428448|NCT00713544|79436912|FG003|Overall Study|Protocol Violation|0|||
44428449|NCT00713544|79436913|FG004|Overall Study|Protocol Violation|0|||
44428450|NCT00713544|79436914|FG005|Overall Study|Protocol Violation|1|||
44428451|NCT00713544|79436909|FG000|Overall Study|Physician Decision|0|||
44428452|NCT00713544|79436910|FG001|Overall Study|Physician Decision|0|||
44428453|NCT00713544|79436911|FG002|Overall Study|Physician Decision|0|||
44428454|NCT00713544|79436912|FG003|Overall Study|Physician Decision|0|||
44428455|NCT00713544|79436913|FG004|Overall Study|Physician Decision|0|||
44428456|NCT00713544|79436914|FG005|Overall Study|Physician Decision|2|||
44428457|NCT00713544|79436909|FG000|Overall Study|Lack of Efficacy|0|||
44428458|NCT00713544|79436910|FG001|Overall Study|Lack of Efficacy|1|||
44428459|NCT00713544|79436911|FG002|Overall Study|Lack of Efficacy|0|||
44428460|NCT00713544|79436912|FG003|Overall Study|Lack of Efficacy|1|||
44428461|NCT00713544|79436913|FG004|Overall Study|Lack of Efficacy|1|||
44428462|NCT00713544|79436914|FG005|Overall Study|Lack of Efficacy|0|||
44331232|NCT01176058|79336640|FG000|Overall Study|Insufficient mycological response|0|||
44331233|NCT01176058|79336641|FG001|Overall Study|Insufficient mycological response|1|||
44331234|NCT01176058|79336640|FG000|Overall Study|Withdrawal by Subject|1|||
44331235|NCT01176058|79336641|FG001|Overall Study|Withdrawal by Subject|0|||
44331236|NCT01175824|79336649|FG000|Overall Study|Adverse Event|2|||
44331237|NCT01175824|79336650|FG001|Overall Study|Adverse Event|1|||
44331238|NCT01175824|79336649|FG000|Overall Study|Lack of Efficacy|2|||
44331239|NCT01175824|79336650|FG001|Overall Study|Lack of Efficacy|0|||
44331240|NCT01175824|79336649|FG000|Overall Study|Lost to Follow-up|0|||
44331241|NCT01175824|79336650|FG001|Overall Study|Lost to Follow-up|1|||
44331242|NCT01175824|79336649|FG000|Overall Study|Physician Decision|0|||
44331243|NCT01175824|79336650|FG001|Overall Study|Physician Decision|4|||
44428463|NCT00713544|79436909|FG000|Overall Study|Lost to Follow-up|0|||
44428464|NCT00713544|79436910|FG001|Overall Study|Lost to Follow-up|0|||
44428465|NCT00713544|79436911|FG002|Overall Study|Lost to Follow-up|1|||
44428466|NCT00713544|79436912|FG003|Overall Study|Lost to Follow-up|0|||
44428467|NCT00713544|79436913|FG004|Overall Study|Lost to Follow-up|0|||
44428468|NCT00713544|79436914|FG005|Overall Study|Lost to Follow-up|0|||
44428469|NCT00713544|79436909|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
44428470|NCT00713544|79436910|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
44428471|NCT00713544|79436911|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
44428472|NCT00713544|79436912|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
44428473|NCT00713544|79436913|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
44428474|NCT00713544|79436914|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
44331244|NCT01175824|79336649|FG000|Overall Study|Protocol Violation|2|||
44331245|NCT01175824|79336650|FG001|Overall Study|Protocol Violation|5|||
44331246|NCT01175824|79336649|FG000|Overall Study|Withdrawal by Subject|3|||
44428475|NCT00713544|79436909|FG000|Overall Study|Incorrect enrollment|0|||
44428476|NCT00713544|79436910|FG001|Overall Study|Incorrect enrollment|1|||
44428477|NCT00713544|79436911|FG002|Overall Study|Incorrect enrollment|0|||
44428478|NCT00713544|79436912|FG003|Overall Study|Incorrect enrollment|0|||
44428479|NCT00713544|79436913|FG004|Overall Study|Incorrect enrollment|0|||
44428480|NCT00713544|79436914|FG005|Overall Study|Incorrect enrollment|0|||
44428481|NCT00713544|79436909|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
44428482|NCT00713544|79436910|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
44428483|NCT00713544|79436911|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
44428484|NCT00713544|79436912|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
44428485|NCT00713544|79436913|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
44428486|NCT00713544|79436914|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
44428487|NCT00415363|79436930|FG000|Overall Study|Withdrawal by Subject|4|||
44428488|NCT00415363|79436931|FG001|Overall Study|Withdrawal by Subject|4|||
44428489|NCT00415363|79436930|FG000|Overall Study|Adverse Event|4|||
44428490|NCT00415363|79436931|FG001|Overall Study|Adverse Event|4|||
44428491|NCT00415363|79436930|FG000|Overall Study|Lost to Follow-up|2|||
44428492|NCT00415363|79436931|FG001|Overall Study|Lost to Follow-up|1|||
44428493|NCT00415363|79436930|FG000|Overall Study|Physician Decision|3|||
44428494|NCT00415363|79436931|FG001|Overall Study|Physician Decision|1|||
44428495|NCT00415363|79436930|FG000|Overall Study|Death|16|||
44428496|NCT00415363|79436931|FG001|Overall Study|Death|12|||
44428497|NCT00415363|79436930|FG000|Overall Study|Progressive disease|26|||
44428498|NCT00415363|79436931|FG001|Overall Study|Progressive disease|32|||
44428499|NCT00415051|79436938|FG000|Overall Study|Protocol Violation|1|||
44428500|NCT00713258|79436944|FG000|Overall Study|Adverse Event|2|||
44428501|NCT00713258|79436945|FG001|Overall Study|Adverse Event|4|||
44428502|NCT00713258|79436944|FG000|Overall Study|Non-Compliance|2|||
44428503|NCT00713258|79436945|FG001|Overall Study|Non-Compliance|1|||
44428504|NCT00713258|79436944|FG000|Overall Study|Other|1|||
44428505|NCT00713258|79436945|FG001|Overall Study|Other|1|||
44428506|NCT00710034|79436953|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
44428507|NCT00710034|79436954|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
44428508|NCT00710034|79436953|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
44428509|NCT00710034|79436954|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
44428510|NCT00710034|79436953|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
44428511|NCT00710034|79436954|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
44428512|NCT00710034|79436953|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
44428513|NCT00710034|79436954|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
44428514|NCT00710034|79436953|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
44428515|NCT00710034|79436954|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
44428516|NCT00710034|79436953|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
44428517|NCT00710034|79436954|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
44428518|NCT00710034|79436953|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
44428519|NCT00710034|79436954|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
44428520|NCT00710034|79436953|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
44428521|NCT00710034|79436954|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
44428522|NCT00710034|79436953|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
44428523|NCT00710034|79436954|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
44428524|NCT00710034|79436953|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
44428525|NCT00710034|79436954|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
44428526|NCT00710034|79436953|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
44428527|NCT00710034|79436954|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
44428528|NCT00414973|79436964|FG000|Overall Study|Withdrawal by Subject|14|||
44331247|NCT01175824|79336650|FG001|Overall Study|Withdrawal by Subject|7|||
44331248|NCT01175824|79336649|FG000|Overall Study|Sponsor Decision|1|||
44331249|NCT01175824|79336650|FG001|Overall Study|Sponsor Decision|0|||
44331250|NCT01175824|79336649|FG000|Overall Study|Entry Criteria Not Met|6|||
44331251|NCT01175824|79336650|FG001|Overall Study|Entry Criteria Not Met|4|||
44331252|NCT01175707|79336658|FG000|Overall Study|Adverse Event|4|||
44331253|NCT01175707|79336659|FG001|Overall Study|Adverse Event|6|||
44331254|NCT01112059|79336668|FG000|Overall Study|Withdrawal by Subject|1|||
44331255|NCT01112059|79336669|FG001|Overall Study|Withdrawal by Subject|0|||
44331256|NCT01175668|79336680|FG000|Overall Study|Withdrawal by Subject|2|||
44331257|NCT01175668|79336681|FG001|Overall Study|Withdrawal by Subject|0|||
44331258|NCT01111825|79336691|FG000|Overall Study|Withdrawal by Subject|0|||
44428529|NCT00414973|79436965|FG001|Overall Study|Withdrawal by Subject|4|||
44428530|NCT00414973|79436966|FG002|Overall Study|Withdrawal by Subject|1|||
44428531|NCT00414973|79436967|FG003|Overall Study|Withdrawal by Subject|0|||
44331259|NCT01111825|79336692|FG001|Overall Study|Withdrawal by Subject|0|||
44331260|NCT01111825|79336693|FG002|Overall Study|Withdrawal by Subject|1|||
44331261|NCT01111825|79336694|FG003|Overall Study|Withdrawal by Subject|0|||
44331262|NCT01111825|79336691|FG000|Overall Study|Lost to Follow-up|0|||
44428532|NCT00414973|79436964|FG000|Overall Study|Adverse Event|10|||
44428533|NCT00414973|79436965|FG001|Overall Study|Adverse Event|0|||
44428534|NCT00414973|79436966|FG002|Overall Study|Adverse Event|1|||
44428535|NCT00414973|79436967|FG003|Overall Study|Adverse Event|0|||
44428536|NCT00414973|79436964|FG000|Overall Study|Protocol Violation|3|||
44331263|NCT01111825|79336692|FG001|Overall Study|Lost to Follow-up|0|||
44331264|NCT01111825|79336693|FG002|Overall Study|Lost to Follow-up|3|||
44331265|NCT01111825|79336694|FG003|Overall Study|Lost to Follow-up|1|||
44331266|NCT01111825|79336691|FG000|Overall Study|Adverse Event|2|||
44331267|NCT01111825|79336692|FG001|Overall Study|Adverse Event|1|||
44331268|NCT01111825|79336693|FG002|Overall Study|Adverse Event|4|||
44331269|NCT01111825|79336694|FG003|Overall Study|Adverse Event|0|||
44331270|NCT01111825|79336691|FG000|Overall Study|Disease Progression|1|||
44331271|NCT01111825|79336692|FG001|Overall Study|Disease Progression|0|||
44331272|NCT01111825|79336693|FG002|Overall Study|Disease Progression|0|||
44331273|NCT01111825|79336694|FG003|Overall Study|Disease Progression|0|||
44331274|NCT01111825|79336691|FG000|Overall Study|Discontinuation by Sponsor|0|||
44331275|NCT01111825|79336692|FG001|Overall Study|Discontinuation by Sponsor|0|||
44331276|NCT01111825|79336693|FG002|Overall Study|Discontinuation by Sponsor|0|||
44331277|NCT01111825|79336694|FG003|Overall Study|Discontinuation by Sponsor|20|||
44331278|NCT01175590|79336706|FG000|Overall Study|Lost to Follow-up|1|||
44428537|NCT00414973|79436965|FG001|Overall Study|Protocol Violation|4|||
44428538|NCT00414973|79436966|FG002|Overall Study|Protocol Violation|0|||
44428539|NCT00414973|79436967|FG003|Overall Study|Protocol Violation|0|||
44428540|NCT00414973|79436964|FG000|Overall Study|Lost to Follow-up|0|||
44428541|NCT00414973|79436965|FG001|Overall Study|Lost to Follow-up|2|||
44428542|NCT00414973|79436966|FG002|Overall Study|Lost to Follow-up|0|||
44428543|NCT00414973|79436967|FG003|Overall Study|Lost to Follow-up|0|||
44428544|NCT00414973|79436964|FG000|Overall Study|Sponsor Decision|1|||
44428545|NCT00414973|79436965|FG001|Overall Study|Sponsor Decision|0|||
44537961|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
44537962|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
44537963|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Other|0|||
44537964|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Other|0|||
44537965|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Other|1|||
44537966|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Other|0|||
44537967|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Other|0|||
44537968|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
44537969|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
44537970|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
44537971|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
44537972|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
44428546|NCT00414973|79436966|FG002|Overall Study|Sponsor Decision|0|||
44428547|NCT00414973|79436967|FG003|Overall Study|Sponsor Decision|0|||
44428548|NCT00414973|79436964|FG000|Overall Study|Death|0|||
44428549|NCT00414973|79436965|FG001|Overall Study|Death|0|||
44428550|NCT00414973|79436966|FG002|Overall Study|Death|1|||
44428551|NCT00414973|79436967|FG003|Overall Study|Death|0|||
44428552|NCT00423085|79436980|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
44428553|NCT00423085|79436981|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
44428554|NCT00423085|79436982|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
44428555|NCT00423085|79436983|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
44428556|NCT00423085|79436980|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
44428557|NCT00423085|79436981|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
44428558|NCT00423085|79436982|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
44428559|NCT00423085|79436983|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44428560|NCT00423085|79436980|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
44428561|NCT00423085|79436981|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
44428562|NCT00423085|79436982|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
44428563|NCT00423085|79436983|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
44428564|NCT00423085|79436980|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
44428565|NCT00423085|79436981|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
44258832|NCT01381562|79114143|FG002|Overall Study|Adverse Event|0|||
44258833|NCT01381016|79114166|FG000|Overall Study|Lost to Follow-up|1|||
44258834|NCT01381016|79114167|FG001|Overall Study|Lost to Follow-up|1|||
44258835|NCT01381016|79114166|FG000|Overall Study|Screen Failure|2|||
44258836|NCT01381016|79114167|FG001|Overall Study|Screen Failure|2|||
44258837|NCT01381016|79114166|FG000|Overall Study|Withdrawal by Subject|0|||
44258838|NCT01381016|79114167|FG001|Overall Study|Withdrawal by Subject|1|||
44258839|NCT01381016|79114166|FG000|Overall Study|Physician Decision|0|||
44258840|NCT01381016|79114167|FG001|Overall Study|Physician Decision|2|||
44331279|NCT01175590|79336707|FG001|Overall Study|Lost to Follow-up|0|||
44331280|NCT01175590|79336706|FG000|Overall Study|Withdrawal by Subject|0|||
44258841|NCT01398410|79114194|FG000|Overall Study|Adverse Event|12|||
44331281|NCT01175590|79336707|FG001|Overall Study|Withdrawal by Subject|2|||
44331282|NCT01175590|79336706|FG000|Overall Study|Adverse Event|4|||
44428566|NCT00423085|79436982|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
44428567|NCT00423085|79436983|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
44331283|NCT01175590|79336707|FG001|Overall Study|Adverse Event|0|||
44331284|NCT01175590|79336706|FG000|Overall Study|Physician Decision|1|||
44331285|NCT01175590|79336707|FG001|Overall Study|Physician Decision|4|||
44331286|NCT01175590|79336706|FG000|Overall Study|Lack of Efficacy|1|||
44331287|NCT01175590|79336707|FG001|Overall Study|Lack of Efficacy|1|||
44331288|NCT01175590|79336706|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
44331289|NCT01175590|79336707|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
44331290|NCT01175590|79336706|FG000|Overall Study|Treated not as randomized|3|||
44331291|NCT01175590|79336707|FG001|Overall Study|Treated not as randomized|2|||
44331292|NCT01175590|79336706|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
44331293|NCT01175590|79336707|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
44331294|NCT01175590|79336706|FG000|Overall Study|Protocol Violation|0|||
44331295|NCT01175590|79336707|FG001|Overall Study|Protocol Violation|1|||
44331296|NCT01175473|79336716|FG000|Overall Study|Adverse Event|2|||
44331297|NCT01175473|79336717|FG001|Overall Study|Adverse Event|2|||
44331298|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
44331299|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44331300|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44331301|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44331302|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44331303|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
44331304|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44331305|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44331306|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44331307|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44331308|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
44331309|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44331310|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44331311|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44331312|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44331313|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
44331314|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
44331315|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
44331316|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
44331317|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
44331318|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
44331319|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
44331320|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
44331321|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
44331322|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
44331323|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
44331324|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
44428568|NCT00423085|79436980|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
44428569|NCT00423085|79436981|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
44428570|NCT00423085|79436982|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
44428571|NCT00423085|79436983|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
44428572|NCT00423085|79436980|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
44428573|NCT00423085|79436981|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
44428574|NCT00423085|79436982|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
44428575|NCT00423085|79436983|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
44428576|NCT00423085|79436980|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
44428577|NCT00423085|79436981|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
44258842|NCT01398410|79114195|FG001|Overall Study|Adverse Event|16|||
44258843|NCT01398410|79114194|FG000|Overall Study|Participants Choice|8|||
44258844|NCT01398410|79114195|FG001|Overall Study|Participants Choice|11|||
44258845|NCT01398410|79114194|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
44258846|NCT01398410|79114195|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
44258847|NCT01398410|79114194|FG000|Overall Study|Other|36|||
44258848|NCT01398410|79114195|FG001|Overall Study|Other|29|||
44258849|NCT01380782|79114261|FG000|Overall Study|Adverse Event|0|||
44258850|NCT01380782|79114262|FG001|Overall Study|Adverse Event|1|||
44258851|NCT01380782|79114263|FG002|Overall Study|Adverse Event|0|||
44258852|NCT01380782|79114264|FG003|Overall Study|Adverse Event|0|||
44258853|NCT01380782|79114261|FG000|Overall Study|Death|1|||
44258854|NCT01380782|79114262|FG001|Overall Study|Death|0|||
44258855|NCT01380782|79114263|FG002|Overall Study|Death|0|||
44331325|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
44331326|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
44331327|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
44331328|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
44258856|NCT01380782|79114264|FG003|Overall Study|Death|0|||
44428578|NCT00423085|79436982|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
44428579|NCT00423085|79436983|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
44428580|NCT00423085|79436980|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
44428581|NCT00423085|79436981|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
44428582|NCT00423085|79436982|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
44428583|NCT00423085|79436983|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
44428584|NCT00423085|79436980|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
44428585|NCT00423085|79436981|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
44428586|NCT00423085|79436982|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
44428587|NCT00423085|79436983|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
44428588|NCT00423085|79436980|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
44428589|NCT00423085|79436981|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
44428590|NCT00423085|79436982|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
44428591|NCT00423085|79436983|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
44428592|NCT00423085|79436980|FG000|52-Week Open-Label Extension Phase|Death|0|||
44428593|NCT00423085|79436981|FG001|52-Week Open-Label Extension Phase|Death|0|||
44428594|NCT00423085|79436982|FG002|52-Week Open-Label Extension Phase|Death|0|||
44428595|NCT00423085|79436983|FG003|52-Week Open-Label Extension Phase|Death|2|||
44428596|NCT00414661|79436997|FG000|Overall Study|Death|2|||
44428597|NCT00414661|79436998|FG001|Overall Study|Death|5|||
44428598|NCT00414661|79436999|FG002|Overall Study|Death|0|||
44428599|NCT00414661|79437000|FG003|Overall Study|Death|0|||
44428600|NCT00414661|79436997|FG000|Overall Study|Lost to Follow-up|1|||
44428601|NCT00414661|79436998|FG001|Overall Study|Lost to Follow-up|4|||
44428602|NCT00414661|79436999|FG002|Overall Study|Lost to Follow-up|0|||
44428603|NCT00414661|79437000|FG003|Overall Study|Lost to Follow-up|1|||
44428604|NCT00414661|79436997|FG000|Overall Study|Withdrawal by Subject|5|||
44428605|NCT00414661|79436998|FG001|Overall Study|Withdrawal by Subject|2|||
44428606|NCT00414661|79436999|FG002|Overall Study|Withdrawal by Subject|2|||
44428607|NCT00414661|79437000|FG003|Overall Study|Withdrawal by Subject|2|||
44428608|NCT00414661|79436997|FG000|Overall Study|Other|6|||
44428609|NCT00414661|79436998|FG001|Overall Study|Other|3|||
44428610|NCT00414661|79436999|FG002|Overall Study|Other|0|||
44428611|NCT00414661|79437000|FG003|Overall Study|Other|0|||
44428612|NCT00405067|79437013|FG000|Overall Study|Adverse Event|4|||
44428613|NCT00405067|79437014|FG001|Overall Study|Adverse Event|9|||
44428614|NCT00405067|79437015|FG002|Overall Study|Adverse Event|4|||
44428615|NCT00405067|79437013|FG000|Overall Study|Lost to Follow-up|0|||
44428616|NCT00405067|79437014|FG001|Overall Study|Lost to Follow-up|0|||
44428617|NCT00405067|79437015|FG002|Overall Study|Lost to Follow-up|1|||
44428618|NCT00708708|79437023|FG000|Overall Study|Another therapy instead of Enbrel|141|||
44428619|NCT00708708|79437023|FG000|Overall Study|Lost to Follow-up|52|||
44428620|NCT00708708|79437023|FG000|Overall Study|Withdrawal by Subject|51|||
44428621|NCT00708708|79437023|FG000|Overall Study|Intolerance|42|||
44428622|NCT00708708|79437023|FG000|Overall Study|Another therapy along with Enbrel|15|||
44428623|NCT00708708|79437023|FG000|Overall Study|Other unspecified|11|||
44428624|NCT00708708|79437023|FG000|Overall Study|Good effectiveness|9|||
44428625|NCT00708708|79437023|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
44428626|NCT00708708|79437023|FG000|Overall Study|Administrative reasons|7|||
44428627|NCT00708708|79437023|FG000|Overall Study|Lack of effectiveness|4|||
44428628|NCT00708708|79437023|FG000|Overall Study|Lack of compliance|3|||
44428629|NCT00708708|79437023|FG000|Overall Study|Pregnancy|3|||
44428630|NCT00708708|79437023|FG000|Overall Study|Adverse Event|3|||
44428631|NCT00708708|79437023|FG000|Overall Study|Missing values|392|||
44428632|NCT00404755|79437030|FG000|Phase I (Bupropion)|Adverse Event|3|||
44428633|NCT00404755|79437030|FG000|Phase I (Bupropion)|Other|1|||
44428634|NCT00404755|79437030|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
44428635|NCT00614614|79437040|FG000|Primary Vaccination Phase|Adverse Event|6|||
44428636|NCT00614614|79437041|FG001|Primary Vaccination Phase|Adverse Event|0|||
44428637|NCT00614614|79437042|FG002|Primary Vaccination Phase|Adverse Event|0|||
44428638|NCT00614614|79437043|FG003|Primary Vaccination Phase|Adverse Event|0|||
44428639|NCT00614614|79437044|FG004|Primary Vaccination Phase|Adverse Event|0|||
44156979|NCT02720692|78948494|FG001|Overall Study|Lost to Follow-up|3|||
44258857|NCT01380782|79114261|FG000|Overall Study|Lack of Efficacy|10|||
44428640|NCT00614614|79437040|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
44258858|NCT01380782|79114262|FG001|Overall Study|Lack of Efficacy|9|||
44258859|NCT01380782|79114263|FG002|Overall Study|Lack of Efficacy|10|||
44258860|NCT01380782|79114264|FG003|Overall Study|Lack of Efficacy|3|||
44258861|NCT01380782|79114261|FG000|Overall Study|Physician Decision|1|||
44258862|NCT01380782|79114262|FG001|Overall Study|Physician Decision|0|||
44258863|NCT01380782|79114263|FG002|Overall Study|Physician Decision|0|||
44258864|NCT01380782|79114264|FG003|Overall Study|Physician Decision|0|||
44428641|NCT00614614|79437041|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
44428642|NCT00614614|79437042|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
44428643|NCT00614614|79437043|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
44428644|NCT00614614|79437044|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
44428645|NCT00614614|79437040|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
44428646|NCT00614614|79437041|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
44428647|NCT00614614|79437042|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
44428648|NCT00614614|79437043|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
44428649|NCT00614614|79437044|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
44428650|NCT00614614|79437040|FG000|Primary Vaccination Phase|Protocol Violation|9|||
44428651|NCT00614614|79437041|FG001|Primary Vaccination Phase|Protocol Violation|3|||
44331329|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44428652|NCT00614614|79437042|FG002|Primary Vaccination Phase|Protocol Violation|0|||
44428653|NCT00614614|79437043|FG003|Primary Vaccination Phase|Protocol Violation|0|||
44156980|NCT02720692|78948493|FG000|Overall Study|Subject unable to return for visit|1|||
44428654|NCT00614614|79437044|FG004|Primary Vaccination Phase|Protocol Violation|0|||
44428655|NCT00614614|79437040|FG000|Primary Vaccination Phase|Other|4|||
44428656|NCT00614614|79437041|FG001|Primary Vaccination Phase|Other|0|||
44428657|NCT00614614|79437042|FG002|Primary Vaccination Phase|Other|0|||
44428658|NCT00614614|79437043|FG003|Primary Vaccination Phase|Other|0|||
44428659|NCT00614614|79437044|FG004|Primary Vaccination Phase|Other|0|||
44428660|NCT00614614|79437040|FG000|Booster Vaccination Phase|Adverse Event|0|||
44428661|NCT00614614|79437041|FG001|Booster Vaccination Phase|Adverse Event|0|||
44428662|NCT00614614|79437042|FG002|Booster Vaccination Phase|Adverse Event|1|||
44428663|NCT00614614|79437043|FG003|Booster Vaccination Phase|Adverse Event|1|||
44428664|NCT00614614|79437044|FG004|Booster Vaccination Phase|Adverse Event|0|||
44428665|NCT00614614|79437040|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
44428666|NCT00614614|79437041|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
44428667|NCT00614614|79437042|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
44428668|NCT00614614|79437043|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
44428669|NCT00614614|79437044|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
44428670|NCT00614614|79437040|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
44428671|NCT00614614|79437041|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
44428672|NCT00614614|79437042|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
44428673|NCT00614614|79437043|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
44156981|NCT02720692|78948494|FG001|Overall Study|Subject unable to return for visit|0|||
44428674|NCT00614614|79437044|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
44428675|NCT00614614|79437040|FG000|Booster Vaccination Phase|Protocol Violation|0|||
44428676|NCT00614614|79437041|FG001|Booster Vaccination Phase|Protocol Violation|0|||
44428677|NCT00614614|79437042|FG002|Booster Vaccination Phase|Protocol Violation|2|||
44428678|NCT00614614|79437043|FG003|Booster Vaccination Phase|Protocol Violation|3|||
44428679|NCT00614614|79437044|FG004|Booster Vaccination Phase|Protocol Violation|0|||
44428680|NCT00614614|79437040|FG000|Booster Vaccination Phase|Other|0|||
44428681|NCT00614614|79437041|FG001|Booster Vaccination Phase|Other|1|||
44428682|NCT00614614|79437042|FG002|Booster Vaccination Phase|Other|3|||
44156982|NCT02656303|78948503|FG000|Overall Study|Adverse Event|3|||
44156983|NCT02656303|78948504|FG001|Overall Study|Adverse Event|2|||
44156984|NCT02656303|78948505|FG002|Overall Study|Adverse Event|0|||
44156985|NCT02656303|78948503|FG000|Overall Study|Death|12|||
44258865|NCT01380782|79114261|FG000|Overall Study|Withdrawal by Subject|0|||
44428683|NCT00614614|79437043|FG003|Booster Vaccination Phase|Other|2|||
44428684|NCT00614614|79437044|FG004|Booster Vaccination Phase|Other|1|||
44428685|NCT00713310|79437061|FG000|Overall Study|Adverse Event|5|||
44428686|NCT00713310|79437062|FG001|Overall Study|Adverse Event|2|||
44428687|NCT00713310|79437061|FG000|Overall Study|Lack of Efficacy|0|||
44428688|NCT00713310|79437062|FG001|Overall Study|Lack of Efficacy|2|||
44428689|NCT00713310|79437061|FG000|Overall Study|Withdrawal by Subject|0|||
44428690|NCT00713310|79437062|FG001|Overall Study|Withdrawal by Subject|2|||
44428691|NCT00422461|79437072|FG000|Overall Study|Adverse Event|1|||
44428692|NCT00422461|79437073|FG001|Overall Study|Adverse Event|2|||
44428693|NCT00422461|79437074|FG002|Overall Study|Adverse Event|1|||
44156986|NCT02656303|78948504|FG001|Overall Study|Death|4|||
44258866|NCT01380782|79114262|FG001|Overall Study|Withdrawal by Subject|0|||
44258867|NCT01380782|79114263|FG002|Overall Study|Withdrawal by Subject|1|||
44258868|NCT01380782|79114264|FG003|Overall Study|Withdrawal by Subject|1|||
44258869|NCT01398176|79114278|FG000|Overall Study|Lost to Follow-up|1|||
44258870|NCT01398176|79114279|FG001|Overall Study|Lost to Follow-up|3|||
44258871|NCT01398176|79114278|FG000|Overall Study|Physician Decision|2|||
44258872|NCT01398176|79114279|FG001|Overall Study|Physician Decision|3|||
44258873|NCT01397786|79114332|FG000|Phase A|Lost to Follow-up|0|||
44258874|NCT01397786|79114333|FG001|Phase A|Lost to Follow-up|0|||
44258875|NCT01397786|79114334|FG002|Phase A|Lost to Follow-up|6|||
44258876|NCT01397786|79114332|FG000|Phase A|Adverse Event|0|||
44258877|NCT01397786|79114333|FG001|Phase A|Adverse Event|0|||
44258878|NCT01397786|79114334|FG002|Phase A|Adverse Event|8|||
44156987|NCT02656303|78948505|FG002|Overall Study|Death|1|||
44156988|NCT02656303|78948503|FG000|Overall Study|Lack of Efficacy|1|||
44156989|NCT02656303|78948504|FG001|Overall Study|Lack of Efficacy|0|||
44258879|NCT01397786|79114332|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
44258880|NCT01397786|79114333|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
44258881|NCT01397786|79114334|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
44156990|NCT02656303|78948505|FG002|Overall Study|Lack of Efficacy|0|||
44156991|NCT02656303|78948503|FG000|Overall Study|Non-Compliance with Study|1|||
44156992|NCT02656303|78948504|FG001|Overall Study|Non-Compliance with Study|1|||
44331330|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44331331|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44331332|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44331333|NCT01111552|79336723|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
44331334|NCT01111552|79336724|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
44331335|NCT01111552|79336725|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
44331336|NCT01111552|79336726|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
44428694|NCT00422461|79437075|FG003|Overall Study|Adverse Event|1|||
44428695|NCT00422461|79437072|FG000|Overall Study|Other|0|||
44428696|NCT00422461|79437073|FG001|Overall Study|Other|0|||
44428697|NCT00422461|79437074|FG002|Overall Study|Other|0|||
44428698|NCT00422461|79437075|FG003|Overall Study|Other|2|||
44428699|NCT00422461|79437072|FG000|Overall Study|Participants no longer willing to participate in study|1|||
44428700|NCT00422461|79437073|FG001|Overall Study|Participants no longer willing to participate in study|0|||
44428701|NCT00422461|79437074|FG002|Overall Study|Participants no longer willing to participate in study|0|||
44428702|NCT00422461|79437075|FG003|Overall Study|Participants no longer willing to participate in study|0|||
44428703|NCT00422461|79437072|FG000|Overall Study|Randomized but not treated|1|||
44428704|NCT00422461|79437073|FG001|Overall Study|Randomized but not treated|1|||
44428705|NCT00422461|79437074|FG002|Overall Study|Randomized but not treated|0|||
44428706|NCT00422461|79437075|FG003|Overall Study|Randomized but not treated|0|||
44428707|NCT00712920|79437088|FG000|Overall Study|Adverse Event|3|||
44428708|NCT00712920|79437089|FG001|Overall Study|Adverse Event|4|||
44428709|NCT00712920|79437090|FG002|Overall Study|Adverse Event|7|||
44428710|NCT00712920|79437088|FG000|Overall Study|Withdrawal by Subject|4|||
44428711|NCT00712920|79437089|FG001|Overall Study|Withdrawal by Subject|2|||
44428712|NCT00712920|79437090|FG002|Overall Study|Withdrawal by Subject|1|||
44428713|NCT00712920|79437088|FG000|Overall Study|Lost to Follow-up|1|||
44428714|NCT00712920|79437089|FG001|Overall Study|Lost to Follow-up|4|||
44428715|NCT00712920|79437090|FG002|Overall Study|Lost to Follow-up|0|||
44428716|NCT00712920|79437088|FG000|Overall Study|Lack of Efficacy|1|||
44428717|NCT00712920|79437089|FG001|Overall Study|Lack of Efficacy|0|||
44428718|NCT00712920|79437090|FG002|Overall Study|Lack of Efficacy|1|||
44428719|NCT00712920|79437088|FG000|Overall Study|Other|5|||
44428720|NCT00712920|79437089|FG001|Overall Study|Other|7|||
44428721|NCT00712920|79437090|FG002|Overall Study|Other|3|||
44428722|NCT00712920|79437088|FG000|Overall Study|Non-compliance|3|||
44428723|NCT00712920|79437089|FG001|Overall Study|Non-compliance|0|||
44428724|NCT00712920|79437090|FG002|Overall Study|Non-compliance|0|||
44428725|NCT00612586|79437109|FG000|Overall Study|Adverse Event|6|||
44428726|NCT00612586|79437110|FG001|Overall Study|Adverse Event|2|||
44428727|NCT00612586|79437109|FG000|Overall Study|Death|1|||
44428728|NCT00612586|79437110|FG001|Overall Study|Death|0|||
44428729|NCT00612586|79437109|FG000|Overall Study|Entry Criteria Not Met|0|||
44428730|NCT00612586|79437110|FG001|Overall Study|Entry Criteria Not Met|2|||
44428731|NCT00612586|79437109|FG000|Overall Study|Withdrawal by Subject|7|||
44428732|NCT00612586|79437110|FG001|Overall Study|Withdrawal by Subject|9|||
44428733|NCT00612586|79437109|FG000|Overall Study|Physician Decision|1|||
44258882|NCT01397786|79114332|FG000|Phase A|Physician Decision|0|||
44156993|NCT02656303|78948505|FG002|Overall Study|Non-Compliance with Study|0|||
44156994|NCT02656303|78948503|FG000|Overall Study|Investigator Decision|2|||
44156995|NCT02656303|78948504|FG001|Overall Study|Investigator Decision|1|||
44156996|NCT02656303|78948505|FG002|Overall Study|Investigator Decision|0|||
44156997|NCT02656303|78948503|FG000|Overall Study|Progressive Disease|25|||
44258883|NCT01397786|79114333|FG001|Phase A|Physician Decision|0|||
44258884|NCT01397786|79114334|FG002|Phase A|Physician Decision|1|||
44428734|NCT00612586|79437110|FG001|Overall Study|Physician Decision|2|||
44428735|NCT00612586|79437109|FG000|Overall Study|Sponsor Decision|1|||
44428736|NCT00612586|79437110|FG001|Overall Study|Sponsor Decision|1|||
44428737|NCT00612586|79437109|FG000|Overall Study|Progressive Disease|26|||
44428738|NCT00612586|79437110|FG001|Overall Study|Progressive Disease|24|||
44428739|NCT00612586|79437109|FG000|Overall Study|Randomized and Not Treated|1|||
44258885|NCT01397786|79114332|FG000|Phase A|Withdrawal by Subject|0|||
44258886|NCT01397786|79114333|FG001|Phase A|Withdrawal by Subject|0|||
44258887|NCT01397786|79114334|FG002|Phase A|Withdrawal by Subject|5|||
44258888|NCT01397786|79114332|FG000|Phase A|Lack of Efficacy|0|||
44258889|NCT01397786|79114333|FG001|Phase A|Lack of Efficacy|0|||
44258890|NCT01397786|79114334|FG002|Phase A|Lack of Efficacy|1|||
44258891|NCT01397786|79114332|FG000|Phase B|Lost to Follow-up|22|||
44156998|NCT02656303|78948504|FG001|Overall Study|Progressive Disease|14|||
44156999|NCT02656303|78948505|FG002|Overall Study|Progressive Disease|10|||
44157000|NCT02656303|78948503|FG000|Overall Study|Study Terminated by Sponsor|20|||
44258892|NCT01397786|79114333|FG001|Phase B|Lost to Follow-up|12|||
44258893|NCT01397786|79114334|FG002|Phase B|Lost to Follow-up|22|||
44258894|NCT01397786|79114332|FG000|Phase B|Adverse Event|109|||
44157001|NCT02656303|78948504|FG001|Overall Study|Study Terminated by Sponsor|7|||
44157002|NCT02656303|78948505|FG002|Overall Study|Study Terminated by Sponsor|5|||
44258895|NCT01397786|79114333|FG001|Phase B|Adverse Event|23|||
44331337|NCT01111552|79336727|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
44331338|NCT01111552|79336723|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44428740|NCT00612586|79437110|FG001|Overall Study|Randomized and Not Treated|1|||
44331339|NCT01111552|79336724|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44331340|NCT01111552|79336725|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44331341|NCT01111552|79336726|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
44331342|NCT01111552|79336727|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44331343|NCT01111552|79336723|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
44331344|NCT01111552|79336724|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
44331345|NCT01111552|79336725|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
44331346|NCT01111552|79336726|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
44331347|NCT01111552|79336727|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
44331348|NCT01111552|79336723|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
44331349|NCT01111552|79336724|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
44331350|NCT01111552|79336725|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
44428741|NCT00614380|79437121|FG000|Overall Study|Adverse Event|14|||
44428742|NCT00614380|79437122|FG001|Overall Study|Adverse Event|4|||
44428743|NCT00614380|79437123|FG002|Overall Study|Adverse Event|0|||
44428744|NCT00614380|79437124|FG003|Overall Study|Adverse Event|0|||
44428745|NCT00614380|79437121|FG000|Overall Study|Lost to Follow-up|6|||
44428746|NCT00614380|79437122|FG001|Overall Study|Lost to Follow-up|1|||
44428747|NCT00614380|79437123|FG002|Overall Study|Lost to Follow-up|0|||
44428748|NCT00614380|79437124|FG003|Overall Study|Lost to Follow-up|0|||
44428749|NCT00614380|79437121|FG000|Overall Study|Non compliant with the protocol|12|||
44428750|NCT00614380|79437122|FG001|Overall Study|Non compliant with the protocol|2|||
44428751|NCT00614380|79437123|FG002|Overall Study|Non compliant with the protocol|1|||
44428752|NCT00614380|79437124|FG003|Overall Study|Non compliant with the protocol|2|||
44428753|NCT00614380|79437121|FG000|Overall Study|Consent withdrawn|3|||
44428754|NCT00614380|79437122|FG001|Overall Study|Consent withdrawn|1|||
44428755|NCT00614380|79437123|FG002|Overall Study|Consent withdrawn|0|||
44428756|NCT00614380|79437124|FG003|Overall Study|Consent withdrawn|0|||
44428757|NCT00612508|79437141|FG000|Overall Study|Withdrawal by Subject|3|||
44428758|NCT00612508|79437142|FG001|Overall Study|Withdrawal by Subject|4|||
44428759|NCT00613834|79437152|FG000|Overall Study|Withdrawal by Subject|0|||
44428760|NCT00613834|79437153|FG001|Overall Study|Withdrawal by Subject|3|||
44428761|NCT00613366|79437167|FG000|Overall Study|Withdrawal by Subject|3|||
44428762|NCT00613366|79437168|FG001|Overall Study|Withdrawal by Subject|2|||
44428763|NCT00612352|79437176|FG000|Overall Study|Adverse Event|1|||
44428764|NCT00612352|79437177|FG001|Overall Study|Adverse Event|0|||
44428765|NCT00612352|79437176|FG000|Overall Study|Withdrawal by Subject|3|||
44428766|NCT00612352|79437177|FG001|Overall Study|Withdrawal by Subject|5|||
44428767|NCT00612352|79437176|FG000|Overall Study|moved out of state|1|||
44428768|NCT00612352|79437177|FG001|Overall Study|moved out of state|0|||
44428769|NCT00612352|79437176|FG000|Overall Study|didn't return calls/show up on test date|4|||
44258896|NCT01397786|79114334|FG002|Phase B|Adverse Event|27|||
44258897|NCT01397786|79114332|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
44258898|NCT01397786|79114333|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
44258899|NCT01397786|79114334|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
44428770|NCT00612352|79437177|FG001|Overall Study|didn't return calls/show up on test date|1|||
44428771|NCT00704730|79437185|FG000|Overall Study|Adverse Event|35|||
44428772|NCT00704730|79437186|FG001|Overall Study|Adverse Event|9|||
44428773|NCT00704730|79437185|FG000|Overall Study|Death|11|||
44428774|NCT00704730|79437186|FG001|Overall Study|Death|5|||
44428775|NCT00704730|79437185|FG000|Overall Study|Physician Decision|2|||
44428776|NCT00704730|79437186|FG001|Overall Study|Physician Decision|0|||
44428777|NCT00704730|79437185|FG000|Overall Study|Did not receive drug|5|||
44428778|NCT00704730|79437186|FG001|Overall Study|Did not receive drug|2|||
44428779|NCT00704730|79437185|FG000|Overall Study|Disease progression per PI|58|||
44428780|NCT00704730|79437186|FG001|Overall Study|Disease progression per PI|67|||
44258900|NCT01397786|79114332|FG000|Phase B|Physician Decision|9|||
44428781|NCT00704730|79437185|FG000|Overall Study|data unavailable|1|||
44258901|NCT01397786|79114333|FG001|Phase B|Physician Decision|1|||
44258902|NCT01397786|79114334|FG002|Phase B|Physician Decision|3|||
44258903|NCT01397786|79114332|FG000|Phase B|Withdrawal by Subject|102|||
44258904|NCT01397786|79114333|FG001|Phase B|Withdrawal by Subject|45|||
44258905|NCT01397786|79114334|FG002|Phase B|Withdrawal by Subject|30|||
44258906|NCT01397786|79114332|FG000|Phase B|Protocol Deviation|1|||
44258907|NCT01397786|79114333|FG001|Phase B|Protocol Deviation|2|||
44258908|NCT01397786|79114334|FG002|Phase B|Protocol Deviation|4|||
44428782|NCT00704730|79437186|FG001|Overall Study|data unavailable|0|||
44258909|NCT01397786|79114332|FG000|Phase B|Lack of Efficacy|22|||
44258910|NCT01397786|79114333|FG001|Phase B|Lack of Efficacy|7|||
44331351|NCT01111552|79336726|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
44331352|NCT01111552|79336727|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
44428783|NCT00704730|79437185|FG000|Overall Study|Withdrawal by Subject|9|||
44428784|NCT00704730|79437186|FG001|Overall Study|Withdrawal by Subject|13|||
44428785|NCT00651261|79437195|FG000|Overall Study|Adverse Event|32|||
44428786|NCT00651261|79437196|FG001|Overall Study|Adverse Event|22|||
44428787|NCT00651261|79437195|FG000|Overall Study|Death|18|||
44428788|NCT00651261|79437196|FG001|Overall Study|Death|18|||
44428789|NCT00651261|79437195|FG000|Overall Study|Withdrawal by Subject|22|||
44428790|NCT00651261|79437196|FG001|Overall Study|Withdrawal by Subject|40|||
44428791|NCT00651261|79437195|FG000|Overall Study|Induction failure|24|||
44331353|NCT01111552|79336723|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
44331354|NCT01111552|79336724|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
44331355|NCT01111552|79336725|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
44331356|NCT01111552|79336726|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
44331357|NCT01111552|79336727|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
44331358|NCT01111552|79336723|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
44331359|NCT01111552|79336724|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
44331360|NCT01111552|79336725|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
44537973|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
44537974|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
44537975|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
44537976|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
44537977|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
44537978|NCT01224106|79549010|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
44537979|NCT01224106|79549011|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44537980|NCT01224106|79549012|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
44537981|NCT01224106|79549013|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44537982|NCT01224106|79549014|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44537983|NCT01224106|79549010|FG000|Open-Label Extension (OLE) Phase|Death|0|||
44331361|NCT01111552|79336726|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
44331362|NCT01111552|79336727|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
44331363|NCT01111552|79336723|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44331364|NCT01111552|79336724|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44537984|NCT01224106|79549011|FG001|Open-Label Extension (OLE) Phase|Death|0|||
44537985|NCT01224106|79549012|FG002|Open-Label Extension (OLE) Phase|Death|0|||
44537986|NCT01224106|79549013|FG003|Open-Label Extension (OLE) Phase|Death|1|||
44537987|NCT01224106|79549014|FG004|Open-Label Extension (OLE) Phase|Death|3|||
44537988|NCT01224106|79549010|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
44537989|NCT01224106|79549011|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
44537990|NCT01224106|79549012|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
44537991|NCT01224106|79549013|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
44157003|NCT02656303|78948503|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
44157004|NCT02656303|78948504|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
44331365|NCT01111552|79336725|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
44331366|NCT01111552|79336726|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44331367|NCT01111552|79336727|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44331368|NCT01175083|79336743|FG000|Primary Epoch|Withdrawal by Subject|0|||
44331369|NCT01175083|79336744|FG001|Primary Epoch|Withdrawal by Subject|0|||
44331370|NCT01175083|79336745|FG002|Primary Epoch|Withdrawal by Subject|0|||
44428792|NCT00651261|79437196|FG001|Overall Study|Induction failure|35|||
44428793|NCT00651261|79437195|FG000|Overall Study|Disease progression|58|||
44537992|NCT01224106|79549014|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
44537993|NCT01224106|79549010|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
44537994|NCT01224106|79549011|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
44537995|NCT01224106|79549012|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
44537996|NCT01224106|79549013|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
44537997|NCT01224106|79549014|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
44157005|NCT02656303|78948505|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
44157006|NCT02656303|78948503|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
44157007|NCT02656303|78948504|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
44157008|NCT02656303|78948505|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
44157009|NCT02656303|78948503|FG000|Overall Study|Reason not Specified|1|||
44157010|NCT02656303|78948504|FG001|Overall Study|Reason not Specified|1|||
44157011|NCT02656303|78948505|FG002|Overall Study|Reason not Specified|2|||
44157012|NCT02628626|78948515|FG000|Overall Study|Withdrawal by Subject|2|||
44157013|NCT02628626|78948516|FG001|Overall Study|Withdrawal by Subject|2|||
44157014|NCT02527707|78948548|FG000|Overall Study|Adverse Event|1|||
44331371|NCT01175083|79336746|FG003|Primary Epoch|Withdrawal by Subject|0|||
44331372|NCT01175083|79336747|FG004|Primary Epoch|Withdrawal by Subject|0|||
44331373|NCT01175083|79336748|FG005|Primary Epoch|Withdrawal by Subject|2|||
44331374|NCT01175083|79336743|FG000|Primary Epoch|Lost to Follow-up|0|||
44331375|NCT01175083|79336744|FG001|Primary Epoch|Lost to Follow-up|0|||
44331376|NCT01175083|79336745|FG002|Primary Epoch|Lost to Follow-up|0|||
44331377|NCT01175083|79336746|FG003|Primary Epoch|Lost to Follow-up|0|||
44428794|NCT00651261|79437196|FG001|Overall Study|Disease progression|58|||
44428795|NCT00651261|79437195|FG000|Overall Study|Alternative therapy|109|||
44428796|NCT00651261|79437196|FG001|Overall Study|Alternative therapy|107|||
44428797|NCT00651261|79437195|FG000|Overall Study|Other disease or participant decisions|23|||
44428798|NCT00651261|79437196|FG001|Overall Study|Other disease or participant decisions|23|||
44428799|NCT00651261|79437195|FG000|Overall Study|Never treated|5|||
44428800|NCT00651261|79437196|FG001|Overall Study|Never treated|3|||
44537998|NCT01224106|79549010|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
44537999|NCT01224106|79549011|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
44538000|NCT01224106|79549012|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
44538001|NCT01224106|79549013|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
44538002|NCT01224106|79549014|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
44538003|NCT01224106|79549010|FG000|Open-Label Extension (OLE) Phase|Other|0|||
44538004|NCT01224106|79549011|FG001|Open-Label Extension (OLE) Phase|Other|0|||
44538005|NCT01224106|79549012|FG002|Open-Label Extension (OLE) Phase|Other|0|||
44538006|NCT01224106|79549013|FG003|Open-Label Extension (OLE) Phase|Other|5|||
44538007|NCT01224106|79549014|FG004|Open-Label Extension (OLE) Phase|Other|3|||
44538008|NCT03409107|79549034|FG000|Overall Study|Withdrawal by Subject|4|||
44538009|NCT03409107|79549035|FG001|Overall Study|Withdrawal by Subject|2|||
44538010|NCT03409107|79549034|FG000|Overall Study|Physician Decision|1|||
44538011|NCT03409107|79549035|FG001|Overall Study|Physician Decision|0|||
44538012|NCT03409107|79549034|FG000|Overall Study|Lost to Follow-up|7|||
44538013|NCT03409107|79549035|FG001|Overall Study|Lost to Follow-up|2|||
44538014|NCT03409107|79549034|FG000|Overall Study|Adverse Event|5|||
44538015|NCT03409107|79549035|FG001|Overall Study|Adverse Event|3|||
44538016|NCT03408873|79549049|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
44538017|NCT03408873|79549049|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
44538018|NCT03408873|79549049|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
44538019|NCT03408873|79549049|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
44538020|NCT03408873|79549049|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
44538021|NCT03408873|79549049|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
44538022|NCT03780959|79549056|FG000|Part 1|Adverse Event|1|||
44538023|NCT03780959|79549057|FG001|Part 1|Adverse Event|0|||
44538024|NCT03780959|79549058|FG002|Part 1|Adverse Event|0|||
44538025|NCT03780959|79549056|FG000|Part 1|Withdrawal by Subject|1|||
44538026|NCT03780959|79549057|FG001|Part 1|Withdrawal by Subject|0|||
44538027|NCT03780959|79549058|FG002|Part 1|Withdrawal by Subject|0|||
44538028|NCT03780959|79549056|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
44538029|NCT03780959|79549057|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
44538030|NCT03780959|79549058|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
44538031|NCT03780959|79549056|FG000|Part 1|Response Status|2|||
44538032|NCT03780959|79549057|FG001|Part 1|Response Status|0|||
44538033|NCT03780959|79549058|FG002|Part 1|Response Status|0|||
44538034|NCT03780959|79549056|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
44538035|NCT03780959|79549057|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
44538036|NCT03780959|79549058|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
44538037|NCT03780959|79549056|FG000|Part 2|Response Status|0|||
44538038|NCT03780959|79549057|FG001|Part 2|Response Status|18|||
44538039|NCT03780959|79549058|FG002|Part 2|Response Status|6|||
44538040|NCT03408639|79549070|FG000|Overall Study|Death|5|||
44538041|NCT03408639|79549071|FG001|Overall Study|Death|5|||
44538042|NCT03408639|79549070|FG000|Overall Study|Lost to Follow-up|1|||
44538043|NCT03408639|79549071|FG001|Overall Study|Lost to Follow-up|4|||
44538044|NCT03408639|79549070|FG000|Overall Study|Withdrawal by Subject|2|||
44538045|NCT03408639|79549071|FG001|Overall Study|Withdrawal by Subject|7|||
44331378|NCT01175083|79336747|FG004|Primary Epoch|Lost to Follow-up|0|||
44331379|NCT01175083|79336748|FG005|Primary Epoch|Lost to Follow-up|1|||
44331380|NCT01175083|79336743|FG000|Booster Epoch|Death|0|||
44331381|NCT01175083|79336744|FG001|Booster Epoch|Death|0|||
44331382|NCT01175083|79336745|FG002|Booster Epoch|Death|1|||
44331383|NCT01175083|79336746|FG003|Booster Epoch|Death|0|||
44331384|NCT01175083|79336747|FG004|Booster Epoch|Death|0|||
44538046|NCT03408639|79549070|FG000|Overall Study|Physician Decision|3|||
44538047|NCT03408639|79549071|FG001|Overall Study|Physician Decision|6|||
44331385|NCT01175083|79336748|FG005|Booster Epoch|Death|0|||
44331386|NCT01175083|79336743|FG000|Booster Epoch|Withdrawal by Subject|0|||
44331387|NCT01175083|79336744|FG001|Booster Epoch|Withdrawal by Subject|0|||
44331388|NCT01175083|79336745|FG002|Booster Epoch|Withdrawal by Subject|0|||
44331389|NCT01175083|79336746|FG003|Booster Epoch|Withdrawal by Subject|1|||
44428801|NCT00651183|79437204|FG000|Overall Study|Lack of Efficacy|1|||
44428802|NCT00651183|79437205|FG001|Overall Study|Lack of Efficacy|0|||
44331390|NCT01175083|79336747|FG004|Booster Epoch|Withdrawal by Subject|0|||
44331391|NCT01175083|79336748|FG005|Booster Epoch|Withdrawal by Subject|0|||
44331392|NCT01174459|79336766|FG000|Overall Study|case report form (CRF) not collected|5|||
44331393|NCT01174342|79336770|FG000|Overall Study|Conversion to cesarean section|4|||
44331394|NCT01111474|79336774|FG000|Overall Study|Lost to Follow-up|12|||
44428803|NCT00651183|79437204|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
44428804|NCT00651183|79437205|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
44428805|NCT00651183|79437204|FG000|Overall Study|Tolerability insufficient|5|||
44428806|NCT00651183|79437205|FG001|Overall Study|Tolerability insufficient|2|||
44428807|NCT00651183|79437204|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
44428808|NCT00651183|79437205|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
44428809|NCT00651183|79437204|FG000|Overall Study|Withdrawal by Subject|6|||
44428810|NCT00651183|79437205|FG001|Overall Study|Withdrawal by Subject|3|||
44331395|NCT01174264|79336783|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
44331396|NCT01174264|79336784|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
44331397|NCT01174264|79336785|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
44331398|NCT01174264|79336783|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
44331399|NCT01174264|79336784|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
44331400|NCT01174264|79336785|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
44331401|NCT01174264|79336783|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
44331402|NCT01174264|79336784|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
44331403|NCT01174264|79336785|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
44331404|NCT01174186|79336795|FG000|Overall Study|Lost to Follow-up|0|||
44331405|NCT01174186|79336796|FG001|Overall Study|Lost to Follow-up|1|||
44331406|NCT01174186|79336795|FG000|Overall Study|Withdrawal by Subject|0|||
44331407|NCT01174186|79336796|FG001|Overall Study|Withdrawal by Subject|2|||
44331408|NCT01173718|79336802|FG000|Overall Study|Death|17|||
44428811|NCT00651183|79437204|FG000|Overall Study|Lost to Follow-up|3|||
44428812|NCT00651183|79437205|FG001|Overall Study|Lost to Follow-up|1|||
44428813|NCT00651183|79437204|FG000|Overall Study|Other reasons|4|||
44428814|NCT00651183|79437205|FG001|Overall Study|Other reasons|2|||
44428815|NCT00651183|79437204|FG000|Overall Study|missing|1|||
44428816|NCT00651183|79437205|FG001|Overall Study|missing|0|||
44428817|NCT00699972|79437214|FG000|Overall Study|Adverse Event|7|||
44428818|NCT00699972|79437215|FG001|Overall Study|Adverse Event|9|||
44428819|NCT00699972|79437216|FG002|Overall Study|Adverse Event|24|||
44538048|NCT03810235|79549079|FG000|Overall Study|Withdrawal by Subject|2|||
44538049|NCT03810235|79549080|FG001|Overall Study|Withdrawal by Subject|0|||
44538050|NCT03408483|79549089|FG000|Overall Study|Physician Decision|3|||
44538051|NCT03408483|79549090|FG001|Overall Study|Physician Decision|3|||
44538052|NCT03408483|79549089|FG000|Overall Study|Lost to Follow-up|3|||
44538053|NCT03408483|79549090|FG001|Overall Study|Lost to Follow-up|0|||
44538054|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
44538055|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
44157015|NCT02527707|78948548|FG000|Overall Study|Adverse Event|1|||
44538056|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
44538057|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
44538058|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
44538059|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
44538060|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
44538061|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
44538062|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
44538063|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
44538064|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
44538065|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
44538066|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
44538067|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
44538068|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
44538069|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
44538070|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
44331409|NCT01173718|79336802|FG000|Overall Study|Abandonment of study graft|27|||
44331410|NCT01111240|79336806|FG000|Overall Study|Adverse Event|190|||
44331411|NCT01111240|79336806|FG000|Overall Study|Lack of Efficacy|545|||
44428820|NCT00699972|79437214|FG000|Overall Study|Lost to Follow-up|0|||
44428821|NCT00699972|79437215|FG001|Overall Study|Lost to Follow-up|2|||
44428822|NCT00699972|79437216|FG002|Overall Study|Lost to Follow-up|0|||
44428823|NCT00699972|79437214|FG000|Overall Study|Withdrawal by Subject|3|||
44331412|NCT01111240|79336806|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
44331413|NCT01111240|79336806|FG000|Overall Study|Other|312|||
44331414|NCT01111123|79336812|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
44331415|NCT01111123|79336813|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
44331416|NCT01111123|79336812|FG000|Maintenance Phase|Lost to Follow-up|0|||
44331417|NCT01111123|79336813|FG001|Maintenance Phase|Lost to Follow-up|2|||
44331418|NCT01173679|79336821|FG000|Overall Study|Death|1|||
44331419|NCT01110382|79336828|FG000|Overall Study|Withdrawal by Subject|0|||
44331420|NCT01110382|79336829|FG001|Overall Study|Withdrawal by Subject|1|||
44331421|NCT01110382|79336828|FG000|Overall Study|Protocol Violation|0|||
44331422|NCT01110382|79336829|FG001|Overall Study|Protocol Violation|1|||
44331423|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
44331424|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44331425|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44428824|NCT00699972|79437215|FG001|Overall Study|Withdrawal by Subject|7|||
44428825|NCT00699972|79437216|FG002|Overall Study|Withdrawal by Subject|4|||
44428826|NCT00699972|79437214|FG000|Overall Study|Lack of Efficacy|2|||
44428827|NCT00699972|79437215|FG001|Overall Study|Lack of Efficacy|0|||
44428828|NCT00699972|79437216|FG002|Overall Study|Lack of Efficacy|2|||
44428829|NCT00699972|79437214|FG000|Overall Study|Administrative/Other|3|||
44428830|NCT00699972|79437215|FG001|Overall Study|Administrative/Other|1|||
44428831|NCT00699972|79437216|FG002|Overall Study|Administrative/Other|4|||
44428832|NCT00699972|79437214|FG000|Overall Study|Randomized, Not Treated|1|||
44428833|NCT00699972|79437215|FG001|Overall Study|Randomized, Not Treated|0|||
44428834|NCT00699972|79437216|FG002|Overall Study|Randomized, Not Treated|1|||
44428835|NCT00642759|79437224|FG000|Overall Study|Protocol Violation|1|||
44428836|NCT00611026|79437232|FG000|Randomized to Double-blind Treatment|Not treated|2|||
44428837|NCT00611026|79437233|FG001|Randomized to Double-blind Treatment|Not treated|1|||
44428838|NCT00611026|79437234|FG002|Randomized to Double-blind Treatment|Not treated|3|||
44428839|NCT00611026|79437232|FG000|Double-blind Treatment Period|Death|1|||
44428840|NCT00611026|79437233|FG001|Double-blind Treatment Period|Death|0|||
44428841|NCT00611026|79437234|FG002|Double-blind Treatment Period|Death|0|||
44428842|NCT00611026|79437232|FG000|Double-blind Treatment Period|Adverse Event|9|||
44428843|NCT00611026|79437233|FG001|Double-blind Treatment Period|Adverse Event|28|||
44428844|NCT00611026|79437234|FG002|Double-blind Treatment Period|Adverse Event|46|||
44428845|NCT00611026|79437232|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
44428846|NCT00611026|79437233|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
44331426|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44331427|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
44331428|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
44331429|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44428847|NCT00611026|79437234|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
44428848|NCT00611026|79437232|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
44428849|NCT00611026|79437233|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
44428850|NCT00611026|79437234|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
44428851|NCT00611026|79437232|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
44428852|NCT00611026|79437233|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
44428853|NCT00611026|79437234|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
44428854|NCT00611026|79437232|FG000|Double-blind Treatment Period|Other|13|||
44428855|NCT00611026|79437233|FG001|Double-blind Treatment Period|Other|20|||
44331430|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44331431|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44331432|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
44331433|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
44331434|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44331435|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44331436|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44331437|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
44331438|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
44331439|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44331440|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44331441|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44331442|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
44331443|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
44331444|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44331445|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44331446|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44331447|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
44331448|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
44331449|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44331450|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44331451|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44331452|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
44331453|NCT01173601|79336839|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
44331454|NCT01173601|79336840|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44331455|NCT01173601|79336841|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44331456|NCT01173601|79336842|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44331457|NCT01173601|79336843|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
44331458|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
44331459|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
44331460|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
44331461|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
44331462|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
44331463|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
44331464|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
44331465|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
44331466|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
44428856|NCT00611026|79437234|FG002|Double-blind Treatment Period|Other|18|||
44428857|NCT00646113|79437244|FG000|Overall Study|Lost to Follow-up|5|||
44428858|NCT00646113|79437244|FG000|Overall Study|Adverse Event|3|||
44428859|NCT00422383|79437253|FG000|Overall Study|Adverse Event|5|||
44428860|NCT00422383|79437254|FG001|Overall Study|Adverse Event|3|||
44428861|NCT00422383|79437255|FG002|Overall Study|Adverse Event|1|||
44428862|NCT00422383|79437256|FG003|Overall Study|Adverse Event|1|||
44428863|NCT00422383|79437257|FG004|Overall Study|Adverse Event|0|||
44428864|NCT00422383|79437253|FG000|Overall Study|Lack of Efficacy|4|||
44428865|NCT00422383|79437254|FG001|Overall Study|Lack of Efficacy|4|||
44428866|NCT00422383|79437255|FG002|Overall Study|Lack of Efficacy|2|||
44428867|NCT00422383|79437256|FG003|Overall Study|Lack of Efficacy|1|||
44428868|NCT00422383|79437257|FG004|Overall Study|Lack of Efficacy|1|||
44428869|NCT00422383|79437253|FG000|Overall Study|Lost to Follow-up|0|||
44428870|NCT00422383|79437254|FG001|Overall Study|Lost to Follow-up|1|||
44428871|NCT00422383|79437255|FG002|Overall Study|Lost to Follow-up|0|||
44428872|NCT00422383|79437256|FG003|Overall Study|Lost to Follow-up|0|||
44428873|NCT00422383|79437257|FG004|Overall Study|Lost to Follow-up|1|||
44428874|NCT00422383|79437253|FG000|Overall Study|Protocol Violation|1|||
44428875|NCT00422383|79437254|FG001|Overall Study|Protocol Violation|1|||
44428876|NCT00422383|79437255|FG002|Overall Study|Protocol Violation|1|||
44428877|NCT00422383|79437256|FG003|Overall Study|Protocol Violation|0|||
44428878|NCT00422383|79437257|FG004|Overall Study|Protocol Violation|0|||
44428879|NCT00422383|79437253|FG000|Overall Study|Withdrawal by Subject|5|||
44428880|NCT00422383|79437254|FG001|Overall Study|Withdrawal by Subject|5|||
44428881|NCT00422383|79437255|FG002|Overall Study|Withdrawal by Subject|0|||
44428882|NCT00422383|79437256|FG003|Overall Study|Withdrawal by Subject|0|||
44428883|NCT00422383|79437257|FG004|Overall Study|Withdrawal by Subject|1|||
44428884|NCT00612040|79437278|FG000|Overall Study|Adverse Event|0|||
44428885|NCT00612040|79437279|FG001|Overall Study|Adverse Event|2|||
44428886|NCT00612040|79437280|FG002|Overall Study|Adverse Event|1|||
44428887|NCT00612040|79437278|FG000|Overall Study|Protocol Violation|1|||
44428888|NCT00612040|79437279|FG001|Overall Study|Protocol Violation|2|||
44428889|NCT00612040|79437280|FG002|Overall Study|Protocol Violation|1|||
44428890|NCT00612040|79437278|FG000|Overall Study|Lack of Efficacy|2|||
44331467|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
44331468|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
44331469|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
44331470|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
44331471|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
44331472|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
44331473|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44331474|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
44331475|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
44331476|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
44331477|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
44428891|NCT00612040|79437279|FG001|Overall Study|Lack of Efficacy|1|||
44428892|NCT00612040|79437280|FG002|Overall Study|Lack of Efficacy|0|||
44428893|NCT00612040|79437278|FG000|Overall Study|Unclassified|2|||
44428894|NCT00612040|79437279|FG001|Overall Study|Unclassified|2|||
44428895|NCT00612040|79437280|FG002|Overall Study|Unclassified|5|||
44428896|NCT00422227|79437290|FG000|Overall Study|Adverse Event|3|||
44428897|NCT00422227|79437291|FG001|Overall Study|Adverse Event|8|||
44428898|NCT00422227|79437290|FG000|Overall Study|Lost to Follow-up|1|||
44428899|NCT00422227|79437291|FG001|Overall Study|Lost to Follow-up|3|||
44428900|NCT00422227|79437290|FG000|Overall Study|Withdrawal by Subject|0|||
44428901|NCT00422227|79437291|FG001|Overall Study|Withdrawal by Subject|4|||
44428902|NCT00421993|79437301|FG000|Overall Study|Withdrawal by Subject|22|||
44428903|NCT00421993|79437302|FG001|Overall Study|Withdrawal by Subject|23|||
44428904|NCT00421993|79437303|FG002|Overall Study|Withdrawal by Subject|23|||
44428905|NCT00421993|79437304|FG003|Overall Study|Withdrawal by Subject|24|||
44428906|NCT00421993|79437301|FG000|Overall Study|Lost to Follow-up|18|||
44428907|NCT00421993|79437302|FG001|Overall Study|Lost to Follow-up|19|||
44428908|NCT00421993|79437303|FG002|Overall Study|Lost to Follow-up|22|||
44428909|NCT00421993|79437304|FG003|Overall Study|Lost to Follow-up|20|||
44428910|NCT00421993|79437301|FG000|Overall Study|Adverse Event|11|||
44428911|NCT00421993|79437302|FG001|Overall Study|Adverse Event|1|||
44428912|NCT00421993|79437303|FG002|Overall Study|Adverse Event|6|||
44428913|NCT00421993|79437304|FG003|Overall Study|Adverse Event|4|||
44428914|NCT00421993|79437301|FG000|Overall Study|Protocol Violation|2|||
44428915|NCT00421993|79437302|FG001|Overall Study|Protocol Violation|2|||
44428916|NCT00421993|79437303|FG002|Overall Study|Protocol Violation|0|||
44428917|NCT00421993|79437304|FG003|Overall Study|Protocol Violation|1|||
44428918|NCT00421993|79437301|FG000|Overall Study|Lack of Efficacy|0|||
44428919|NCT00421993|79437302|FG001|Overall Study|Lack of Efficacy|3|||
44428920|NCT00421993|79437303|FG002|Overall Study|Lack of Efficacy|0|||
44428921|NCT00421993|79437304|FG003|Overall Study|Lack of Efficacy|5|||
44428922|NCT00421993|79437301|FG000|Overall Study|Pregnancy|0|||
44428923|NCT00421993|79437302|FG001|Overall Study|Pregnancy|1|||
44428924|NCT00421993|79437303|FG002|Overall Study|Pregnancy|1|||
44428925|NCT00421993|79437304|FG003|Overall Study|Pregnancy|2|||
44428926|NCT00421993|79437301|FG000|Overall Study|Subject transportation issues|0|||
44428927|NCT00421993|79437302|FG001|Overall Study|Subject transportation issues|0|||
44428928|NCT00421993|79437303|FG002|Overall Study|Subject transportation issues|0|||
44428929|NCT00421993|79437304|FG003|Overall Study|Subject transportation issues|1|||
44428930|NCT00413959|79437314|FG000|Overall Study|Pt had only one cycle.|1|||
44428931|NCT00645567|79437318|FG000|Overall Study|Adverse Event|1|||
44428932|NCT00611884|79437330|FG000|Overall Study|Adverse Event|1|||
44428933|NCT00611884|79437331|FG001|Overall Study|Adverse Event|0|||
44428934|NCT00611884|79437332|FG002|Overall Study|Adverse Event|0|||
44428935|NCT00611884|79437333|FG003|Overall Study|Adverse Event|1|||
44331478|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
44331479|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
44331480|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
44331481|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
44331482|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
44331483|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
44331484|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
44331485|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
44428936|NCT00611884|79437330|FG000|Overall Study|Non-Compliance|1|||
44428937|NCT00611884|79437331|FG001|Overall Study|Non-Compliance|4|||
44428938|NCT00611884|79437332|FG002|Overall Study|Non-Compliance|2|||
44428939|NCT00611884|79437333|FG003|Overall Study|Non-Compliance|2|||
44428940|NCT00611884|79437330|FG000|Overall Study|Lack of Efficacy|0|||
44428941|NCT00611884|79437331|FG001|Overall Study|Lack of Efficacy|1|||
44428942|NCT00611884|79437332|FG002|Overall Study|Lack of Efficacy|0|||
44428943|NCT00611884|79437333|FG003|Overall Study|Lack of Efficacy|0|||
44428944|NCT00611884|79437330|FG000|Overall Study|Unclassified|7|||
44428945|NCT00611884|79437331|FG001|Overall Study|Unclassified|4|||
44331486|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
44331487|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
44331488|NCT01173601|79336839|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
44331489|NCT01173601|79336840|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
44331490|NCT01173601|79336841|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
44331491|NCT01173601|79336842|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
44331492|NCT01173601|79336843|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
44428946|NCT00611884|79437332|FG002|Overall Study|Unclassified|2|||
44428947|NCT00611884|79437333|FG003|Overall Study|Unclassified|3|||
44428948|NCT00420745|79437345|FG000|Overall Study|Adverse Event|2|||
44428949|NCT00420745|79437346|FG001|Overall Study|Adverse Event|2|||
44428950|NCT00420745|79437345|FG000|Overall Study|Lost to Follow-up|10|||
44428951|NCT00420745|79437346|FG001|Overall Study|Lost to Follow-up|2|||
44428952|NCT00420745|79437345|FG000|Overall Study|Protocol Violation|1|||
44428953|NCT00420745|79437346|FG001|Overall Study|Protocol Violation|0|||
44428954|NCT00420745|79437345|FG000|Overall Study|Physician Decision|1|||
44428955|NCT00420745|79437346|FG001|Overall Study|Physician Decision|1|||
44428956|NCT00420745|79437345|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
44428957|NCT00420745|79437346|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
44428958|NCT00420745|79437345|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
44428959|NCT00420745|79437346|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
44428960|NCT00611806|79437354|FG000|Overall Study|Withdrawal by Subject|8|||
44428961|NCT00611806|79437355|FG001|Overall Study|Withdrawal by Subject|2|||
44428962|NCT00611806|79437354|FG000|Overall Study|Adverse Event|2|||
44428963|NCT00611806|79437355|FG001|Overall Study|Adverse Event|1|||
44428964|NCT00611806|79437354|FG000|Overall Study|Lost to Follow-up|6|||
44428965|NCT00611806|79437355|FG001|Overall Study|Lost to Follow-up|0|||
44428966|NCT00413413|79437364|FG000|Single-Blind|Adverse Event|0|||
44428967|NCT00413413|79437365|FG001|Single-Blind|Adverse Event|9|||
44428968|NCT00413413|79437366|FG002|Single-Blind|Adverse Event|0|||
44428969|NCT00413413|79437364|FG000|Single-Blind|Lack of Efficacy|0|||
44428970|NCT00413413|79437365|FG001|Single-Blind|Lack of Efficacy|5|||
44428971|NCT00413413|79437366|FG002|Single-Blind|Lack of Efficacy|0|||
44428972|NCT00413413|79437364|FG000|Single-Blind|Subject no longer requires study drug|0|||
44428973|NCT00413413|79437365|FG001|Single-Blind|Subject no longer requires study drug|151|||
44428974|NCT00413413|79437366|FG002|Single-Blind|Subject no longer requires study drug|0|||
44428975|NCT00413413|79437364|FG000|Single-Blind|Protocol Violation|0|||
44428976|NCT00413413|79437365|FG001|Single-Blind|Protocol Violation|16|||
44428977|NCT00413413|79437366|FG002|Single-Blind|Protocol Violation|0|||
44428978|NCT00413413|79437364|FG000|Single-Blind|Withdrawal by Subject|0|||
44428979|NCT00413413|79437365|FG001|Single-Blind|Withdrawal by Subject|27|||
44428980|NCT00413413|79437366|FG002|Single-Blind|Withdrawal by Subject|0|||
44428981|NCT00413413|79437364|FG000|Single-Blind|Lost to Follow-up|0|||
44428982|NCT00413413|79437365|FG001|Single-Blind|Lost to Follow-up|8|||
44428983|NCT00413413|79437366|FG002|Single-Blind|Lost to Follow-up|0|||
44428984|NCT00413413|79437364|FG000|Double-Blind|Adverse Event|6|||
44428985|NCT00413413|79437365|FG001|Double-Blind|Adverse Event|0|||
44428986|NCT00413413|79437366|FG002|Double-Blind|Adverse Event|5|||
44157016|NCT02453191|78948559|FG000|Overall Study|Withdrawal by Subject|1|||
44157017|NCT02352090|78948567|FG000|Overall Study|general malaise|1|||
44157018|NCT02352090|78948568|FG001|Overall Study|general malaise|0|||
44157019|NCT02352090|78948569|FG002|Overall Study|general malaise|0|||
44157020|NCT02352090|78948567|FG000|Overall Study|non-specified mild side-effects|0|||
44157021|NCT02352090|78948568|FG001|Overall Study|non-specified mild side-effects|0|||
44258911|NCT01397786|79114334|FG002|Phase B|Lack of Efficacy|14|||
44258912|NCT01397162|79114396|FG000|Overall Study|Adverse Event|4|||
44258913|NCT01397162|79114397|FG001|Overall Study|Adverse Event|0|||
44258914|NCT01397162|79114398|FG002|Overall Study|Adverse Event|0|||
44258915|NCT01397162|79114399|FG003|Overall Study|Adverse Event|0|||
44258916|NCT01397162|79114400|FG004|Overall Study|Adverse Event|0|||
44258917|NCT01397162|79114396|FG000|Overall Study|Not yet defined|3|||
44258918|NCT01397162|79114397|FG001|Overall Study|Not yet defined|4|||
44258919|NCT01397162|79114398|FG002|Overall Study|Not yet defined|3|||
44258920|NCT01397162|79114399|FG003|Overall Study|Not yet defined|5|||
44258921|NCT01397162|79114400|FG004|Overall Study|Not yet defined|3|||
44258922|NCT01397084|79114433|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
44258923|NCT01397084|79114433|FG000|Overall Study|Protocol Violation|2|||
44258924|NCT01397084|79114433|FG000|Overall Study|Adverse Event|2|||
44428987|NCT00413413|79437364|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
44428988|NCT00413413|79437365|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
44428989|NCT00413413|79437366|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
44428990|NCT00413413|79437364|FG000|Double-Blind|Protocol deviation|1|||
44428991|NCT00413413|79437365|FG001|Double-Blind|Protocol deviation|2|||
44428992|NCT00413413|79437366|FG002|Double-Blind|Protocol deviation|1|||
44258925|NCT01397084|79114433|FG000|Overall Study|Withdrawal by Subject|1|||
44258926|NCT01397084|79114433|FG000|Overall Study|Lost to Follow-up|1|||
44428993|NCT00413413|79437364|FG000|Double-Blind|Subject withdrew consent|4|||
44428994|NCT00413413|79437365|FG001|Double-Blind|Subject withdrew consent|6|||
44428995|NCT00413413|79437366|FG002|Double-Blind|Subject withdrew consent|9|||
44428996|NCT00413413|79437364|FG000|Double-Blind|Lost to Follow-up|3|||
44428997|NCT00413413|79437365|FG001|Double-Blind|Lost to Follow-up|4|||
44428998|NCT00413413|79437366|FG002|Double-Blind|Lost to Follow-up|2|||
44428999|NCT00610714|79437376|FG000|Overall Study|Adverse Event|3|||
44429000|NCT00610714|79437377|FG001|Overall Study|Adverse Event|1|||
44429001|NCT00610714|79437376|FG000|Overall Study|Death|12|||
44429002|NCT00610714|79437377|FG001|Overall Study|Death|18|||
44429003|NCT00610714|79437376|FG000|Overall Study|Withdrawal by Subject|9|||
44429004|NCT00610714|79437377|FG001|Overall Study|Withdrawal by Subject|3|||
44429005|NCT00610714|79437376|FG000|Overall Study|Study completion at 120 PFS events|2|||
44429006|NCT00610714|79437377|FG001|Overall Study|Study completion at 120 PFS events|2|||
44538071|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
44538072|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
44538073|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
44538074|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
44538075|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
44538076|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
44157022|NCT02352090|78948569|FG002|Overall Study|non-specified mild side-effects|2|||
44157023|NCT02135107|78948579|FG000|Treatment Period|Withdrawal by Subject|11|||
44157024|NCT02135107|78948580|FG001|Treatment Period|Withdrawal by Subject|0|||
44157025|NCT02135107|78948581|FG002|Treatment Period|Withdrawal by Subject|0|||
44157026|NCT02135107|78948582|FG003|Treatment Period|Withdrawal by Subject|0|||
44157027|NCT02135107|78948579|FG000|Treatment Period|Adverse Event|5|||
44157028|NCT02135107|78948580|FG001|Treatment Period|Adverse Event|2|||
44157029|NCT02135107|78948581|FG002|Treatment Period|Adverse Event|0|||
44157030|NCT02135107|78948582|FG003|Treatment Period|Adverse Event|0|||
44157031|NCT02135107|78948579|FG000|Treatment Period|Pregnancy|1|||
44157032|NCT02135107|78948580|FG001|Treatment Period|Pregnancy|0|||
44157033|NCT02135107|78948581|FG002|Treatment Period|Pregnancy|0|||
44157034|NCT02135107|78948582|FG003|Treatment Period|Pregnancy|0|||
44157035|NCT02135107|78948579|FG000|Treatment Period|Other|115|||
44157036|NCT02135107|78948580|FG001|Treatment Period|Other|24|||
44157037|NCT02135107|78948581|FG002|Treatment Period|Other|0|||
44157038|NCT02135107|78948582|FG003|Treatment Period|Other|0|||
44157039|NCT02135107|78948579|FG000|Maintenance Therapy Period|Adverse Event|0|||
44157040|NCT02135107|78948580|FG001|Maintenance Therapy Period|Adverse Event|0|||
44157041|NCT02135107|78948581|FG002|Maintenance Therapy Period|Adverse Event|3|||
44331493|NCT01173523|79336863|FG000|Overall Study|Clinical Progression|1|||
44331494|NCT01173523|79336864|FG001|Overall Study|Clinical Progression|1|||
44331495|NCT01173523|79336863|FG000|Overall Study|Progressive Disease|10|||
44331496|NCT01173523|79336864|FG001|Overall Study|Progressive Disease|8|||
44331497|NCT01173523|79336863|FG000|Overall Study|Other|2|||
44331498|NCT01173523|79336864|FG001|Overall Study|Other|3|||
44538077|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
44538078|NCT03777059|79549100|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
44538079|NCT03777059|79549101|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
44538080|NCT03777059|79549102|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
44538081|NCT03777059|79549103|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
44538082|NCT03777059|79549100|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
44538083|NCT03777059|79549101|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
44331499|NCT01173055|79336872|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
44331500|NCT01173055|79336873|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
44331501|NCT01173055|79336872|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
44331502|NCT01173055|79336873|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
44331503|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
44331504|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
44331505|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
44331506|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44429007|NCT00403585|79437383|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
44429008|NCT00403585|79437383|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
44429009|NCT00403585|79437383|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
44429010|NCT00645411|79437391|FG000|Overall Study|Adverse Event|0|||
44429011|NCT00645411|79437392|FG001|Overall Study|Adverse Event|0|||
44157042|NCT02135107|78948582|FG003|Maintenance Therapy Period|Adverse Event|7|||
44157043|NCT02135107|78948579|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
44157044|NCT02135107|78948580|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
44157045|NCT02135107|78948581|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
44157046|NCT02135107|78948582|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
44157047|NCT02135107|78948579|FG000|Maintenance Therapy Period|Pregnancy|0|||
44331507|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44331508|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44331509|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44331510|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44331511|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
44331512|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
44331513|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
44331514|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
44331515|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44331516|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44331517|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44331518|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44331519|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44331520|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
44331521|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331522|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
44331523|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
44331524|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331525|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331526|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331527|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331528|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331529|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
44331530|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
44331531|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
44331532|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
44331533|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44331534|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44331535|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44331536|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44331537|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44331538|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
44331539|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331540|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
44331541|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331542|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331543|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331544|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331545|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331546|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331547|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
44331548|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
44331549|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331550|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331551|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331552|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331553|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331554|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331555|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44429012|NCT00645411|79437393|FG002|Overall Study|Adverse Event|0|||
44429013|NCT00645411|79437394|FG003|Overall Study|Adverse Event|2|||
44429014|NCT00645411|79437391|FG000|Overall Study|Withdrawal by Subject|2|||
44429015|NCT00645411|79437392|FG001|Overall Study|Withdrawal by Subject|1|||
44429016|NCT00645411|79437393|FG002|Overall Study|Withdrawal by Subject|19|||
44429017|NCT00645411|79437394|FG003|Overall Study|Withdrawal by Subject|21|||
44429018|NCT00645411|79437391|FG000|Overall Study|Lost to Follow-up|10|||
44429019|NCT00645411|79437392|FG001|Overall Study|Lost to Follow-up|5|||
44429020|NCT00645411|79437393|FG002|Overall Study|Lost to Follow-up|124|||
44429021|NCT00645411|79437394|FG003|Overall Study|Lost to Follow-up|75|||
44157048|NCT02135107|78948580|FG001|Maintenance Therapy Period|Pregnancy|0|||
44157049|NCT02135107|78948581|FG002|Maintenance Therapy Period|Pregnancy|0|||
44429022|NCT00645411|79437391|FG000|Overall Study|Protocol Violation|1|||
44429023|NCT00645411|79437392|FG001|Overall Study|Protocol Violation|0|||
44429024|NCT00645411|79437393|FG002|Overall Study|Protocol Violation|1|||
44429025|NCT00645411|79437394|FG003|Overall Study|Protocol Violation|0|||
44429026|NCT00645411|79437391|FG000|Overall Study|Inappropriate enrollment|0|||
44429027|NCT00645411|79437392|FG001|Overall Study|Inappropriate enrollment|0|||
44429028|NCT00645411|79437393|FG002|Overall Study|Inappropriate enrollment|4|||
44429029|NCT00645411|79437394|FG003|Overall Study|Inappropriate enrollment|1|||
44429030|NCT00645411|79437391|FG000|Overall Study|Unable to classify|0|||
44429031|NCT00645411|79437392|FG001|Overall Study|Unable to classify|0|||
44429032|NCT00645411|79437393|FG002|Overall Study|Unable to classify|3|||
44429033|NCT00645411|79437394|FG003|Overall Study|Unable to classify|4|||
44429034|NCT00403273|79437413|FG000|Overall Study|Lost to Follow-up|3|||
44331556|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
44331557|NCT01172938|79336882|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331558|NCT01172938|79336883|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
44429035|NCT00403273|79437414|FG001|Overall Study|Lost to Follow-up|2|||
44429036|NCT00403273|79437413|FG000|Overall Study|Physician Decision|0|||
44429037|NCT00403273|79437414|FG001|Overall Study|Physician Decision|1|||
44429038|NCT00403273|79437413|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
44429039|NCT00403273|79437414|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
44429040|NCT00402727|79437437|FG000|Overall Study|Adverse Event|10|||
44429041|NCT00402727|79437438|FG001|Overall Study|Adverse Event|6|||
44429042|NCT00402727|79437437|FG000|Overall Study|Death|1|||
44429043|NCT00402727|79437438|FG001|Overall Study|Death|0|||
44429044|NCT00402727|79437437|FG000|Overall Study|Lack of Efficacy|1|||
44538084|NCT03777059|79549102|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
44538085|NCT03777059|79549103|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
44538086|NCT03777059|79549100|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
44538087|NCT03777059|79549101|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
44538088|NCT03777059|79549102|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
44538089|NCT03777059|79549103|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
44538090|NCT03777059|79549100|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
44538091|NCT03777059|79549101|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
44538092|NCT03777059|79549102|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
44538093|NCT03777059|79549103|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
44538094|NCT03777059|79549100|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
44538095|NCT03777059|79549101|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
44538096|NCT03777059|79549102|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
44538097|NCT03777059|79549103|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
44331559|NCT01172938|79336884|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
44538098|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44538099|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44538100|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
44538101|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
44538102|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
44538103|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44538104|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
44538105|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
44538106|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
44538107|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44538108|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44331560|NCT01172938|79336885|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331561|NCT01172938|79336886|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331562|NCT01172938|79336887|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331563|NCT01172938|79336888|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331564|NCT01172938|79336889|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331565|NCT01172938|79336890|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
44331566|NCT01172938|79336882|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
44331567|NCT01172938|79336883|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
44331568|NCT01172938|79336884|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
44331569|NCT01172938|79336885|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
44331570|NCT01172938|79336886|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
44331571|NCT01172938|79336887|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
44331572|NCT01172938|79336888|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
44331573|NCT01172938|79336889|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
44331574|NCT01172938|79336890|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
44331575|NCT01172938|79336882|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
44331576|NCT01172938|79336883|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
44331577|NCT01172938|79336884|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
44331578|NCT01172938|79336885|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
44429045|NCT00402727|79437438|FG001|Overall Study|Lack of Efficacy|3|||
44429046|NCT00402727|79437437|FG000|Overall Study|Lost to Follow-up|24|||
44429047|NCT00402727|79437438|FG001|Overall Study|Lost to Follow-up|11|||
44429048|NCT00402727|79437437|FG000|Overall Study|Physician Decision|1|||
44331579|NCT01172938|79336886|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
44331580|NCT01172938|79336887|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
44331581|NCT01172938|79336888|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
44331582|NCT01172938|79336889|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
44331583|NCT01172938|79336890|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
44331584|NCT01172938|79336882|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331585|NCT01172938|79336883|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331586|NCT01172938|79336884|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
44331587|NCT01172938|79336885|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331588|NCT01172938|79336886|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331589|NCT01172938|79336887|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331590|NCT01172938|79336888|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331591|NCT01172938|79336889|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44331592|NCT01172938|79336890|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
44429049|NCT00402727|79437438|FG001|Overall Study|Physician Decision|1|||
44429050|NCT00402727|79437437|FG000|Overall Study|Protocol Violation|0|||
44429051|NCT00402727|79437438|FG001|Overall Study|Protocol Violation|4|||
44429052|NCT00402727|79437437|FG000|Overall Study|Withdrawal by Subject|3|||
44429053|NCT00402727|79437438|FG001|Overall Study|Withdrawal by Subject|7|||
44429054|NCT00402727|79437437|FG000|Overall Study|supply problems|2|||
44429055|NCT00402727|79437438|FG001|Overall Study|supply problems|1|||
44429056|NCT00402727|79437437|FG000|Overall Study|non-compliance|0|||
44429057|NCT00402727|79437438|FG001|Overall Study|non-compliance|1|||
44429058|NCT00402649|79437444|FG000|Overall Study|Lost to Follow-up|1|||
44429059|NCT00402649|79437444|FG000|Overall Study|Withdrawal by Subject|1|||
44429060|NCT00402337|79437453|FG000|Overall Study|Adverse Event|0|||
44429061|NCT00402337|79437454|FG001|Overall Study|Adverse Event|2|||
44429062|NCT00402337|79437455|FG002|Overall Study|Adverse Event|2|||
44429063|NCT00402337|79437456|FG003|Overall Study|Adverse Event|3|||
44429064|NCT00402337|79437457|FG004|Overall Study|Adverse Event|2|||
44429065|NCT00402337|79437453|FG000|Overall Study|Noncompliance|0|||
44429066|NCT00402337|79437454|FG001|Overall Study|Noncompliance|0|||
44429067|NCT00402337|79437455|FG002|Overall Study|Noncompliance|0|||
44429068|NCT00402337|79437456|FG003|Overall Study|Noncompliance|0|||
44429069|NCT00402337|79437457|FG004|Overall Study|Noncompliance|2|||
44429070|NCT00402337|79437453|FG000|Overall Study|Withdrawal by Subject|5|||
44429071|NCT00402337|79437454|FG001|Overall Study|Withdrawal by Subject|3|||
44429072|NCT00402337|79437455|FG002|Overall Study|Withdrawal by Subject|1|||
44429073|NCT00402337|79437456|FG003|Overall Study|Withdrawal by Subject|6|||
44429074|NCT00402337|79437457|FG004|Overall Study|Withdrawal by Subject|4|||
44429075|NCT00402337|79437453|FG000|Overall Study|Lost to Follow-up|0|||
44429076|NCT00402337|79437454|FG001|Overall Study|Lost to Follow-up|0|||
44429077|NCT00402337|79437455|FG002|Overall Study|Lost to Follow-up|1|||
44429078|NCT00402337|79437456|FG003|Overall Study|Lost to Follow-up|2|||
44429079|NCT00402337|79437457|FG004|Overall Study|Lost to Follow-up|0|||
44429080|NCT00402337|79437453|FG000|Overall Study|Physician Decision|0|||
44538109|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44538110|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
44538111|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
44538112|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
44538113|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
44538114|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
44538115|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
44538116|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
44538117|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
44538118|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
44538119|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
44157050|NCT02135107|78948582|FG003|Maintenance Therapy Period|Pregnancy|1|||
44157051|NCT02135107|78948579|FG000|Maintenance Therapy Period|Other|0|||
44157052|NCT02135107|78948580|FG001|Maintenance Therapy Period|Other|0|||
44157053|NCT02135107|78948581|FG002|Maintenance Therapy Period|Other|7|||
44157054|NCT02135107|78948582|FG003|Maintenance Therapy Period|Other|8|||
44157055|NCT02030847|78948594|FG000|Overall Study|Death|10|||
44157056|NCT02030847|78948594|FG000|Overall Study|Disease Progression|15|||
44157057|NCT02030847|78948594|FG000|Overall Study|New Cancer Therapy|8|||
44157058|NCT02030847|78948594|FG000|Overall Study|Physician Decision|3|||
44157059|NCT02030847|78948594|FG000|Overall Study|Withdrawal by Subject|1|||
44157060|NCT02030834|78948602|FG000|Overall Study|Death|4|||
44157061|NCT02030834|78948603|FG001|Overall Study|Death|0|||
44429081|NCT00402337|79437454|FG001|Overall Study|Physician Decision|0|||
44429082|NCT00402337|79437455|FG002|Overall Study|Physician Decision|0|||
44331593|NCT01172938|79336882|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
44331594|NCT01172938|79336883|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
44331595|NCT01172938|79336884|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
44331596|NCT01172938|79336885|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
44331597|NCT01172938|79336886|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
44331598|NCT01172938|79336887|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
44331599|NCT01172938|79336888|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
44331600|NCT01172938|79336889|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
44331601|NCT01172938|79336890|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
44331602|NCT01172938|79336882|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
44331603|NCT01172938|79336883|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
44331604|NCT01172938|79336884|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
44429083|NCT00402337|79437456|FG003|Overall Study|Physician Decision|1|||
44429084|NCT00402337|79437457|FG004|Overall Study|Physician Decision|0|||
44429085|NCT00402337|79437453|FG000|Overall Study|Other Reason|0|||
44429086|NCT00402337|79437454|FG001|Overall Study|Other Reason|1|||
44331605|NCT01172938|79336885|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
44331606|NCT01172938|79336886|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
44331607|NCT01172938|79336887|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
44429087|NCT00402337|79437455|FG002|Overall Study|Other Reason|0|||
44429088|NCT00402337|79437456|FG003|Overall Study|Other Reason|0|||
44331608|NCT01172938|79336888|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
44331609|NCT01172938|79336889|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
44331610|NCT01172938|79336890|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
44331611|NCT01172938|79336882|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331612|NCT01172938|79336883|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331613|NCT01172938|79336884|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331614|NCT01172938|79336885|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331615|NCT01172938|79336886|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331616|NCT01172938|79336887|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
44331617|NCT01172938|79336888|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
44429089|NCT00402337|79437457|FG004|Overall Study|Other Reason|0|||
44429090|NCT00650091|79437471|FG000|Amended Study Design|Withdrawal by Subject|12|||
44429091|NCT00650091|79437472|FG001|Amended Study Design|Withdrawal by Subject|11|||
44429092|NCT00650091|79437473|FG002|Amended Study Design|Withdrawal by Subject|0|||
44429093|NCT00650091|79437471|FG000|Amended Study Design|Physician Decision|5|||
44429094|NCT00650091|79437472|FG001|Amended Study Design|Physician Decision|0|||
44429095|NCT00650091|79437473|FG002|Amended Study Design|Physician Decision|0|||
44429096|NCT00650091|79437471|FG000|Amended Study Design|Adverse Event|1|||
44429097|NCT00650091|79437472|FG001|Amended Study Design|Adverse Event|4|||
44429098|NCT00650091|79437473|FG002|Amended Study Design|Adverse Event|0|||
44429099|NCT00650091|79437471|FG000|Amended Study Design|Lung transplantation|4|||
44429100|NCT00650091|79437472|FG001|Amended Study Design|Lung transplantation|2|||
44429101|NCT00650091|79437473|FG002|Amended Study Design|Lung transplantation|0|||
44429102|NCT00650091|79437471|FG000|Amended Study Design|Other|1|||
44429103|NCT00650091|79437472|FG001|Amended Study Design|Other|3|||
44429104|NCT00650091|79437473|FG002|Amended Study Design|Other|0|||
44429105|NCT00642369|79437483|FG000|Overall Study|Adverse Event|2|||
44429106|NCT00642369|79437484|FG001|Overall Study|Adverse Event|3|||
44429107|NCT00642369|79437483|FG000|Overall Study|Withdrawal by Subject|1|||
44429108|NCT00642369|79437484|FG001|Overall Study|Withdrawal by Subject|0|||
44429109|NCT00642369|79437483|FG000|Overall Study|misdiagnosis|0|||
44429110|NCT00642369|79437484|FG001|Overall Study|misdiagnosis|1|||
44429111|NCT00642369|79437483|FG000|Overall Study|Lack of Efficacy|2|||
44429112|NCT00642369|79437484|FG001|Overall Study|Lack of Efficacy|2|||
44429113|NCT00645099|79437509|FG000|Overall Study|Lack of Efficacy|15|||
44429114|NCT00645099|79437510|FG001|Overall Study|Lack of Efficacy|6|||
44429115|NCT00645099|79437509|FG000|Overall Study|Withdrawal by Subject|30|||
44429116|NCT00645099|79437510|FG001|Overall Study|Withdrawal by Subject|22|||
44538120|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
44538121|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
44538122|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
44538123|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
44538124|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44429117|NCT00645099|79437509|FG000|Overall Study|Lost to Follow-up|6|||
44429118|NCT00645099|79437510|FG001|Overall Study|Lost to Follow-up|4|||
44429119|NCT00645099|79437509|FG000|Overall Study|Adverse Event|11|||
44429120|NCT00645099|79437510|FG001|Overall Study|Adverse Event|5|||
44429121|NCT00645099|79437509|FG000|Overall Study|Other|9|||
44429122|NCT00645099|79437510|FG001|Overall Study|Other|5|||
44538125|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
44538126|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
44429123|NCT00420511|79437518|FG000|Overall Study|Adverse Event|1|||
44429124|NCT00420511|79437519|FG001|Overall Study|Adverse Event|1|||
44429125|NCT00420511|79437518|FG000|Overall Study|Lost to Follow-up|1|||
44429126|NCT00420511|79437519|FG001|Overall Study|Lost to Follow-up|0|||
44429127|NCT00420199|79437529|FG000|Overall Study|Participant no longer met study criteria|1|||
44429128|NCT00420199|79437530|FG001|Overall Study|Participant no longer met study criteria|0|||
44429129|NCT00649389|79437545|FG000|Overall Study|Adverse Event|22|||
44429130|NCT00649389|79437546|FG001|Overall Study|Adverse Event|46|||
44429131|NCT00649389|79437547|FG002|Overall Study|Adverse Event|38|||
44331618|NCT01172938|79336889|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331619|NCT01172938|79336890|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
44331620|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
44331621|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
44331622|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
44331623|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
44331624|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
44331625|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
44331626|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
44331627|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
44331628|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
44331629|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
44331630|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
44331631|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
44331632|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
44331633|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
44331634|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
44331635|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
44429132|NCT00649389|79437548|FG003|Overall Study|Adverse Event|48|||
44429133|NCT00649389|79437545|FG000|Overall Study|Lost to Follow-up|15|||
44429134|NCT00649389|79437546|FG001|Overall Study|Lost to Follow-up|17|||
44429135|NCT00649389|79437547|FG002|Overall Study|Lost to Follow-up|21|||
44429136|NCT00649389|79437548|FG003|Overall Study|Lost to Follow-up|26|||
44429137|NCT00649389|79437545|FG000|Overall Study|Protocol Violation|11|||
44429138|NCT00649389|79437546|FG001|Overall Study|Protocol Violation|13|||
44429139|NCT00649389|79437547|FG002|Overall Study|Protocol Violation|9|||
44331636|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
44331637|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
44331638|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44331639|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44331640|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
44331641|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44331642|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44429140|NCT00649389|79437548|FG003|Overall Study|Protocol Violation|8|||
44429141|NCT00649389|79437545|FG000|Overall Study|Withdrawal by Subject|20|||
44429142|NCT00649389|79437546|FG001|Overall Study|Withdrawal by Subject|21|||
44157062|NCT02030834|78948604|FG002|Overall Study|Death|0|||
44157063|NCT02030834|78948602|FG000|Overall Study|Manufacturing failure|2|||
44157064|NCT02030834|78948603|FG001|Overall Study|Manufacturing failure|0|||
44157065|NCT02030834|78948604|FG002|Overall Study|Manufacturing failure|1|||
44157066|NCT02030834|78948602|FG000|Overall Study|Disease progression|2|||
44429143|NCT00649389|79437547|FG002|Overall Study|Withdrawal by Subject|19|||
44429144|NCT00649389|79437548|FG003|Overall Study|Withdrawal by Subject|23|||
44429145|NCT00649389|79437545|FG000|Overall Study|Other|3|||
44429146|NCT00649389|79437546|FG001|Overall Study|Other|9|||
44429147|NCT00649389|79437547|FG002|Overall Study|Other|1|||
44429148|NCT00649389|79437548|FG003|Overall Study|Other|6|||
44429149|NCT00402103|79437560|FG000|Overall Study|Adverse Event|60|||
44429150|NCT00402103|79437561|FG001|Overall Study|Adverse Event|7|||
44538127|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538128|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538129|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
44538130|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
44157067|NCT02030834|78948603|FG001|Overall Study|Disease progression|0|||
44157068|NCT02030834|78948604|FG002|Overall Study|Disease progression|2|||
44157069|NCT02030834|78948602|FG000|Overall Study|Lost to Follow-up|1|||
44157070|NCT02030834|78948603|FG001|Overall Study|Lost to Follow-up|0|||
44157071|NCT02030834|78948604|FG002|Overall Study|Lost to Follow-up|0|||
44157072|NCT02030834|78948602|FG000|Overall Study|Withdrawal by Subject|1|||
44157073|NCT02030834|78948603|FG001|Overall Study|Withdrawal by Subject|0|||
44157074|NCT02030834|78948604|FG002|Overall Study|Withdrawal by Subject|0|||
44429151|NCT00402103|79437560|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44157075|NCT02030834|78948602|FG000|Overall Study|Lack of funding|1|||
44429152|NCT00402103|79437561|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44429153|NCT00402103|79437560|FG000|Overall Study|Condition no longer requires study drug|2|||
44429154|NCT00402103|79437561|FG001|Overall Study|Condition no longer requires study drug|0|||
44429155|NCT00402103|79437560|FG000|Overall Study|Protocol Deviation|8|||
44429156|NCT00402103|79437561|FG001|Overall Study|Protocol Deviation|0|||
44429157|NCT00402103|79437560|FG000|Overall Study|Patient withdrew consent|12|||
44429158|NCT00402103|79437561|FG001|Overall Study|Patient withdrew consent|1|||
44429159|NCT00402103|79437560|FG000|Overall Study|Lost to Follow-up|6|||
44429160|NCT00402103|79437561|FG001|Overall Study|Lost to Follow-up|3|||
44429161|NCT00402103|79437560|FG000|Overall Study|Administrative problems|2|||
44429162|NCT00402103|79437561|FG001|Overall Study|Administrative problems|0|||
44429163|NCT00641667|79437571|FG000|Overall Study|Withdrawal by Subject|1|||
44429164|NCT00641667|79437571|FG000|Overall Study|Adverse Event|1|||
44429165|NCT00641667|79437571|FG000|Overall Study|Physician Decision|1|||
44429166|NCT00641667|79437571|FG000|Overall Study|Worsening of underlying disease|3|||
44429167|NCT00704184|79437580|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
44429168|NCT00704184|79437581|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
44429169|NCT00704184|79437582|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
44429170|NCT00704184|79437583|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
44429171|NCT00704184|79437584|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
44331643|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44331644|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44429172|NCT00704184|79437580|FG000|Open-Label Treatment|Adverse Event|0|||
44331645|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44331646|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
44331647|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
44331648|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
44331649|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
44331650|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
44331651|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
44331652|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
44331653|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
44331654|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
44331655|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
44331656|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331657|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331658|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
44331659|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331660|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331661|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331662|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331663|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331664|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
44331665|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
44331666|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
44331667|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
44331668|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
44331669|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
44331670|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
44331671|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
44331672|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
44331673|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
44331674|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44331675|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
44331676|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44331677|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44331678|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44331679|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44331680|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44429173|NCT00704184|79437581|FG001|Open-Label Treatment|Adverse Event|0|||
44429174|NCT00704184|79437582|FG002|Open-Label Treatment|Adverse Event|2|||
44429175|NCT00704184|79437583|FG003|Open-Label Treatment|Adverse Event|0|||
44157076|NCT02030834|78948603|FG001|Overall Study|Lack of funding|0|||
44157077|NCT02030834|78948604|FG002|Overall Study|Lack of funding|0|||
44331681|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
44331682|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
44331683|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331684|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
44331685|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331686|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331687|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331688|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331689|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331690|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331691|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
44331692|NCT01172938|79336882|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331693|NCT01172938|79336883|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331694|NCT01172938|79336884|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331695|NCT01172938|79336885|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331696|NCT01172938|79336886|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331697|NCT01172938|79336887|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331698|NCT01172938|79336888|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44331699|NCT01172938|79336889|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
44429176|NCT00704184|79437584|FG004|Open-Label Treatment|Adverse Event|1|||
44429177|NCT00704184|79437580|FG000|Open-Label Treatment|Lack of Efficacy|0|||
44429178|NCT00704184|79437581|FG001|Open-Label Treatment|Lack of Efficacy|2|||
44429179|NCT00704184|79437582|FG002|Open-Label Treatment|Lack of Efficacy|2|||
44429180|NCT00704184|79437583|FG003|Open-Label Treatment|Lack of Efficacy|2|||
44429181|NCT00704184|79437584|FG004|Open-Label Treatment|Lack of Efficacy|1|||
44429182|NCT00704184|79437580|FG000|Open-Label Treatment|Physician Decision|0|||
44429183|NCT00704184|79437581|FG001|Open-Label Treatment|Physician Decision|0|||
44429184|NCT00704184|79437582|FG002|Open-Label Treatment|Physician Decision|0|||
44429185|NCT00704184|79437583|FG003|Open-Label Treatment|Physician Decision|0|||
44429186|NCT00704184|79437584|FG004|Open-Label Treatment|Physician Decision|1|||
44429187|NCT00704184|79437580|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
44429188|NCT00704184|79437581|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
44429189|NCT00704184|79437582|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
44429190|NCT00704184|79437583|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
44429191|NCT00704184|79437584|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
44429192|NCT00641043|79437598|FG000|Overall Study|Adverse Event|6|||
44429193|NCT00641043|79437599|FG001|Overall Study|Adverse Event|4|||
44429194|NCT00641043|79437598|FG000|Overall Study|Protocol Violation|2|||
44429195|NCT00641043|79437599|FG001|Overall Study|Protocol Violation|3|||
44331700|NCT01172938|79336890|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
44331701|NCT01172938|79336882|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
44429196|NCT00641043|79437598|FG000|Overall Study|Lost to Follow-up|3|||
44429197|NCT00641043|79437599|FG001|Overall Study|Lost to Follow-up|2|||
44429198|NCT00641043|79437598|FG000|Overall Study|Withdrawal by Subject|4|||
44429199|NCT00641043|79437599|FG001|Overall Study|Withdrawal by Subject|4|||
44429200|NCT00641043|79437598|FG000|Overall Study|Other incl. lack of efficacy|4|||
44429201|NCT00641043|79437599|FG001|Overall Study|Other incl. lack of efficacy|2|||
44429202|NCT00402025|79437608|FG000|Overall Study|Adverse Event|0|||
44429203|NCT00402025|79437609|FG001|Overall Study|Adverse Event|0|||
44538131|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538132|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538133|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538134|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538135|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538136|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
44538137|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538138|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
44538139|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
44538140|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538141|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538142|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538143|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
44429204|NCT00402025|79437610|FG002|Overall Study|Adverse Event|2|||
44429205|NCT00402025|79437608|FG000|Overall Study|Death|0|||
44538144|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44331702|NCT01172938|79336883|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
44429206|NCT00402025|79437609|FG001|Overall Study|Death|1|||
44429207|NCT00402025|79437610|FG002|Overall Study|Death|5|||
44429208|NCT00402025|79437608|FG000|Overall Study|Disease Progression|1|||
44429209|NCT00402025|79437609|FG001|Overall Study|Disease Progression|1|||
44429210|NCT00402025|79437610|FG002|Overall Study|Disease Progression|2|||
44429211|NCT00402025|79437608|FG000|Overall Study|Physician Decision|1|||
44429212|NCT00402025|79437609|FG001|Overall Study|Physician Decision|1|||
44429213|NCT00402025|79437610|FG002|Overall Study|Physician Decision|0|||
44429214|NCT00402025|79437608|FG000|Overall Study|Participant Decision|0|||
44429215|NCT00402025|79437609|FG001|Overall Study|Participant Decision|0|||
44538145|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
44538146|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538147|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538148|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538149|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
44538150|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538151|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538152|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538153|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
44538154|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538155|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538156|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538157|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
44538158|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538159|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538160|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538161|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44331703|NCT01172938|79336884|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
44331704|NCT01172938|79336885|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
44331705|NCT01172938|79336886|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
44331706|NCT01172938|79336887|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
44331707|NCT01172938|79336888|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
44331708|NCT01172938|79336889|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
44331709|NCT01172938|79336890|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
44331710|NCT01172938|79336882|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
44331711|NCT01172938|79336883|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
44331712|NCT01172938|79336884|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
44331713|NCT01172938|79336885|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
44331714|NCT01172938|79336886|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
44331715|NCT01172938|79336887|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
44331716|NCT01172938|79336888|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
44331717|NCT01172938|79336889|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
44331718|NCT01172938|79336890|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
44331719|NCT01172938|79336882|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331720|NCT01172938|79336883|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331721|NCT01172938|79336884|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331722|NCT01172938|79336885|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331723|NCT01172938|79336886|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331724|NCT01172938|79336887|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331725|NCT01172938|79336888|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331726|NCT01172938|79336889|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
44331727|NCT01172938|79336890|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
44331728|NCT01172938|79336882|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331729|NCT01172938|79336883|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
44331730|NCT01172938|79336884|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331731|NCT01172938|79336885|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331732|NCT01172938|79336886|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331733|NCT01172938|79336887|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331734|NCT01172938|79336888|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331735|NCT01172938|79336889|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331736|NCT01172938|79336890|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
44331737|NCT01172938|79336882|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44429216|NCT00402025|79437610|FG002|Overall Study|Participant Decision|1|||
44429217|NCT00609622|79437620|FG000|Overall Study|Adverse Event|14|||
44538162|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
44538163|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538164|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538165|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44429218|NCT00609622|79437621|FG001|Overall Study|Adverse Event|10|||
44331738|NCT01172938|79336883|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331739|NCT01172938|79336884|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
44331740|NCT01172938|79336885|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331741|NCT01172938|79336886|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331742|NCT01172938|79336887|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331743|NCT01172938|79336888|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331744|NCT01172938|79336889|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331745|NCT01172938|79336890|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
44331746|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
44331747|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
44331748|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
44331749|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
44331750|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
44331751|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
44331752|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
44331753|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
44331754|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
44331755|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
44331756|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
44331757|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
44331758|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
44331759|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
44331760|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
44331761|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
44331762|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
44331763|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
44331764|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
44331765|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
44331766|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
44331767|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
44331768|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
44331769|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
44331770|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
44331771|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
44331772|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
44429219|NCT00609622|79437620|FG000|Overall Study|Withdrawal by Subject|4|||
44429220|NCT00609622|79437621|FG001|Overall Study|Withdrawal by Subject|20|||
44429221|NCT00609622|79437620|FG000|Overall Study|Death|1|||
44429222|NCT00609622|79437621|FG001|Overall Study|Death|4|||
44429223|NCT00609622|79437620|FG000|Overall Study|Protocol Violation|1|||
44429224|NCT00609622|79437621|FG001|Overall Study|Protocol Violation|1|||
44429225|NCT00609622|79437620|FG000|Overall Study|Objective progression or relapse|47|||
44538166|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
44538167|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538168|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538169|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
44429226|NCT00609622|79437621|FG001|Overall Study|Objective progression or relapse|41|||
44538170|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538171|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44429227|NCT00609622|79437620|FG000|Overall Study|Study terminated by sponsor|16|||
44429228|NCT00609622|79437621|FG001|Overall Study|Study terminated by sponsor|3|||
44429229|NCT00609622|79437620|FG000|Overall Study|Other|7|||
44429230|NCT00609622|79437621|FG001|Overall Study|Other|14|||
44429231|NCT00609622|79437620|FG000|Overall Study|Global deterioration of health status|6|||
44429232|NCT00609622|79437621|FG001|Overall Study|Global deterioration of health status|2|||
44429233|NCT00699660|79437629|FG000|Overall Study|Lost to Follow-up|4|||
44429234|NCT00699660|79437630|FG001|Overall Study|Lost to Follow-up|2|||
44429235|NCT00699660|79437629|FG000|Overall Study|missing reports and recording failures|10|||
44429236|NCT00699660|79437630|FG001|Overall Study|missing reports and recording failures|6|||
44538172|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538173|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538174|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44331773|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44429237|NCT00627705|79437638|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
44429238|NCT00627705|79437639|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
44429239|NCT00627705|79437638|FG000|Overall Study|Adverse Event|1|||
44538175|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
44538176|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44331774|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44331775|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
44331776|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44331777|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44331778|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44331779|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44331780|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
44331781|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
44331782|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331783|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331784|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331785|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331786|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331787|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331788|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331789|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
44331790|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
44331791|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
44331792|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
44331793|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
44331794|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
44331795|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
44331796|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
44331797|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
44331798|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
44331799|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
44331800|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331801|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331802|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
44331803|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331804|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331805|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331806|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331807|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331808|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
44331809|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331810|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
44331811|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331812|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331813|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331814|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331815|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331816|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
44331817|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
44331818|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
44331819|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
44331820|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
44331821|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
44331822|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
44331823|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
44538177|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
44538178|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538179|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538180|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538181|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538182|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538183|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538184|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538185|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538186|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44331824|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
44538187|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538188|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
44538189|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
44538190|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538191|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44429240|NCT00627705|79437639|FG001|Overall Study|Adverse Event|0|||
44429241|NCT00627705|79437638|FG000|Overall Study|Withdrawal by Subject|0|||
44429242|NCT00627705|79437639|FG001|Overall Study|Withdrawal by Subject|2|||
44429243|NCT00627705|79437638|FG000|Overall Study|Lost to Follow-up|0|||
44429244|NCT00627705|79437639|FG001|Overall Study|Lost to Follow-up|1|||
44429245|NCT00610168|79437647|FG000|Overall Study|Withdrawal by Subject|2|||
44429246|NCT00610168|79437648|FG001|Overall Study|Withdrawal by Subject|0|||
44429247|NCT00644787|79437654|FG000|Period 1: Titration Phase|Adverse Event|11|||
44429248|NCT00644787|79437655|FG001|Period 1: Titration Phase|Adverse Event|0|||
44429249|NCT00644787|79437656|FG002|Period 1: Titration Phase|Adverse Event|0|||
44429250|NCT00644787|79437654|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
44429251|NCT00644787|79437655|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
44429252|NCT00644787|79437656|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
44429253|NCT00644787|79437654|FG000|Period 1: Titration Phase|Physician Decision|1|||
44429254|NCT00644787|79437655|FG001|Period 1: Titration Phase|Physician Decision|0|||
44429255|NCT00644787|79437656|FG002|Period 1: Titration Phase|Physician Decision|0|||
44331825|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
44331826|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
44331827|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331828|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331829|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
44331830|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331831|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331832|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331833|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44429256|NCT00644787|79437654|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
44429257|NCT00644787|79437655|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
44429258|NCT00644787|79437656|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
44429259|NCT00644787|79437654|FG000|Period 1: Titration Phase|Worsening of complications|1|||
44429260|NCT00644787|79437655|FG001|Period 1: Titration Phase|Worsening of complications|0|||
44429261|NCT00644787|79437656|FG002|Period 1: Titration Phase|Worsening of complications|0|||
44429262|NCT00644787|79437654|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
44429263|NCT00644787|79437655|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
44429264|NCT00644787|79437656|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
44429265|NCT00644787|79437654|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
44429266|NCT00644787|79437655|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
44429267|NCT00644787|79437656|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
44429268|NCT00644787|79437654|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
44429269|NCT00644787|79437655|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
44429270|NCT00644787|79437656|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
44429271|NCT00644787|79437654|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
44331834|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331835|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
44331836|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44429272|NCT00644787|79437655|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
44429273|NCT00644787|79437656|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
44429274|NCT00644787|79437654|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
44429275|NCT00644787|79437655|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
44538192|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538193|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538194|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538195|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538196|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538197|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538198|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538199|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538200|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538201|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
44538202|NCT03100058|79549122|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538203|NCT03100058|79549123|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44429276|NCT00644787|79437656|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
44429277|NCT00644787|79437654|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
44429278|NCT00644787|79437655|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
44429279|NCT00644787|79437656|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
44429280|NCT00644787|79437654|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
44429281|NCT00644787|79437655|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
44538204|NCT03100058|79549124|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538205|NCT03100058|79549125|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538206|NCT03100058|79549126|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44331837|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331838|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
44429282|NCT00644787|79437656|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
44429283|NCT00699582|79437667|FG000|Overall Study|Adverse Event|4|||
44429284|NCT00699582|79437668|FG001|Overall Study|Adverse Event|11|||
44429285|NCT00699582|79437669|FG002|Overall Study|Adverse Event|23|||
44429286|NCT00699582|79437667|FG000|Overall Study|Withdrawal by Subject|6|||
44429287|NCT00699582|79437668|FG001|Overall Study|Withdrawal by Subject|7|||
44429288|NCT00699582|79437669|FG002|Overall Study|Withdrawal by Subject|4|||
44429289|NCT00699582|79437667|FG000|Overall Study|Lack of Efficacy|1|||
44429290|NCT00699582|79437668|FG001|Overall Study|Lack of Efficacy|0|||
44429291|NCT00699582|79437669|FG002|Overall Study|Lack of Efficacy|1|||
44429292|NCT00699582|79437667|FG000|Overall Study|Progressive Disease|1|||
44429293|NCT00699582|79437668|FG001|Overall Study|Progressive Disease|0|||
44429294|NCT00699582|79437669|FG002|Overall Study|Progressive Disease|0|||
44429295|NCT00699582|79437667|FG000|Overall Study|Administrative/Other|4|||
44429296|NCT00699582|79437668|FG001|Overall Study|Administrative/Other|3|||
44429297|NCT00699582|79437669|FG002|Overall Study|Administrative/Other|0|||
44538207|NCT03100058|79549127|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538208|NCT03100058|79549128|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
44331839|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331840|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331841|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331842|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331843|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331844|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
44331845|NCT01172938|79336882|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331846|NCT01172938|79336883|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44538209|NCT03100058|79549129|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538210|NCT03100058|79549130|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538211|NCT03100058|79549131|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538212|NCT03100058|79549132|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538213|NCT03100058|79549133|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538214|NCT03100058|79549134|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
44538215|NCT03100058|79549122|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538216|NCT03100058|79549123|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538217|NCT03100058|79549124|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538218|NCT03100058|79549125|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538219|NCT03100058|79549126|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538220|NCT03100058|79549127|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538221|NCT03100058|79549128|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44331847|NCT01172938|79336884|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331848|NCT01172938|79336885|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331849|NCT01172938|79336886|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331850|NCT01172938|79336887|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331851|NCT01172938|79336888|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331852|NCT01172938|79336889|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
44331853|NCT01172938|79336890|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
44331854|NCT01109992|79336910|FG000|Overall Study|Withdrawal by Subject|0|||
44331855|NCT01109992|79336911|FG001|Overall Study|Withdrawal by Subject|1|||
44331856|NCT01109992|79336910|FG000|Overall Study|Movement during rest scan.|0|||
44331857|NCT01109992|79336911|FG001|Overall Study|Movement during rest scan.|1|||
44331858|NCT01109524|79336920|FG000|Overall Study|Disease Progression|29|||
44331859|NCT01109524|79336920|FG000|Overall Study|Study Drug toxicity|6|||
44331860|NCT01109524|79336920|FG000|Overall Study|Adverse Event|4|||
44331861|NCT01109524|79336920|FG000|Overall Study|Withdrawal by Subject|2|||
44331862|NCT01109524|79336920|FG000|Overall Study|Maximum clinical benefit|3|||
44331863|NCT01109524|79336920|FG000|Overall Study|Death|2|||
44331864|NCT01109524|79336920|FG000|Overall Study|No longer meets criteria|2|||
44331865|NCT01109524|79336920|FG000|Overall Study|Participant requested to end treatment|4|||
44331866|NCT01109524|79336920|FG000|Overall Study|Other|5|||
44331867|NCT01109173|79336935|FG000|Overall Study|Adverse Event|15|||
44331868|NCT01109173|79336936|FG001|Overall Study|Adverse Event|17|||
44331869|NCT01109173|79336937|FG002|Overall Study|Adverse Event|9|||
44331870|NCT01109173|79336938|FG003|Overall Study|Adverse Event|6|||
44331871|NCT01109173|79336935|FG000|Overall Study|Lost to Follow-up|0|||
44331872|NCT01109173|79336936|FG001|Overall Study|Lost to Follow-up|1|||
44331873|NCT01109173|79336937|FG002|Overall Study|Lost to Follow-up|0|||
44331874|NCT01109173|79336938|FG003|Overall Study|Lost to Follow-up|0|||
44429298|NCT00699582|79437667|FG000|Overall Study|Randomized, Not Treated|2|||
44429299|NCT00699582|79437668|FG001|Overall Study|Randomized, Not Treated|1|||
44429300|NCT00699582|79437669|FG002|Overall Study|Randomized, Not Treated|0|||
44429301|NCT00640341|79437680|FG000|Overall Study|Adverse Event|0|||
44429302|NCT00640341|79437681|FG001|Overall Study|Adverse Event|0|||
44429303|NCT00640341|79437682|FG002|Overall Study|Adverse Event|1|||
44429304|NCT00640341|79437680|FG000|Overall Study|Positive Slit Lamp Findings|0|||
44429305|NCT00640341|79437681|FG001|Overall Study|Positive Slit Lamp Findings|0|||
44429306|NCT00640341|79437682|FG002|Overall Study|Positive Slit Lamp Findings|1|||
44538222|NCT03100058|79549129|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538223|NCT03100058|79549130|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538224|NCT03100058|79549131|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
44538225|NCT03100058|79549132|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
44538226|NCT03100058|79549133|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
44538227|NCT03100058|79549134|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
44538228|NCT03100058|79549122|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44258927|NCT01397084|79114433|FG000|Overall Study|Used other proton pump inhibitor|1|||
44258928|NCT01396148|79114473|FG000|Overall Study|Patient Decision|1|||
44258929|NCT01396070|79114506|FG000|Overall Study|Withdrawal by Subject|2|||
44258930|NCT01396070|79114506|FG000|Overall Study|Death|2|||
44258931|NCT01396070|79114506|FG000|Overall Study|Adverse Event|8|||
44258932|NCT01396070|79114506|FG000|Overall Study|Physician Decision|3|||
44258933|NCT01396070|79114506|FG000|Overall Study|Lack of Efficacy|4|||
44258934|NCT01395914|79114523|FG000|Overall Study|Unrelated to study drug AE|6|||
44258935|NCT01395914|79114524|FG001|Overall Study|Unrelated to study drug AE|1|||
44258936|NCT01395914|79114523|FG000|Overall Study|Death|23|||
44331875|NCT01109173|79336935|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
44331876|NCT01109173|79336936|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
44331877|NCT01109173|79336937|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
44331878|NCT01109173|79336938|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
44331879|NCT01109173|79336935|FG000|Overall Study|Noncompliance|0|||
44331880|NCT01109173|79336936|FG001|Overall Study|Noncompliance|1|||
44331881|NCT01109173|79336937|FG002|Overall Study|Noncompliance|0|||
44258937|NCT01395914|79114524|FG001|Overall Study|Death|17|||
44258938|NCT01395914|79114523|FG000|Overall Study|Other|9|||
44258939|NCT01395914|79114524|FG001|Overall Study|Other|3|||
44258940|NCT01395914|79114523|FG000|Overall Study|Withdrawal by patient|27|||
44258941|NCT01395914|79114524|FG001|Overall Study|Withdrawal by patient|14|||
44258942|NCT01395914|79114523|FG000|Overall Study|Study drug-related AE|1|||
44258943|NCT01395914|79114524|FG001|Overall Study|Study drug-related AE|0|||
44331882|NCT01109173|79336938|FG003|Overall Study|Noncompliance|0|||
44331883|NCT01109173|79336935|FG000|Overall Study|Treatment Failure|25|||
44331884|NCT01109173|79336936|FG001|Overall Study|Treatment Failure|32|||
44331885|NCT01109173|79336937|FG002|Overall Study|Treatment Failure|69|||
44331886|NCT01109173|79336938|FG003|Overall Study|Treatment Failure|64|||
44331887|NCT01109173|79336935|FG000|Overall Study|Protocol Violation|4|||
44331888|NCT01109173|79336936|FG001|Overall Study|Protocol Violation|5|||
44331889|NCT01109173|79336937|FG002|Overall Study|Protocol Violation|1|||
44331890|NCT01109173|79336938|FG003|Overall Study|Protocol Violation|2|||
44331891|NCT01109173|79336935|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
44331892|NCT01109173|79336936|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
44331893|NCT01109173|79336937|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
44429307|NCT00640341|79437680|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
44429308|NCT00640341|79437681|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
44538229|NCT03100058|79549123|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538230|NCT03100058|79549124|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538231|NCT03100058|79549125|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538232|NCT03100058|79549126|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44429309|NCT00640341|79437682|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
44429310|NCT00640341|79437680|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
44429311|NCT00640341|79437681|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
44429312|NCT00640341|79437682|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
44429313|NCT00640341|79437680|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
44331894|NCT01109173|79336938|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
44331895|NCT01109173|79336935|FG000|Overall Study|Not Specifiied|5|||
44331896|NCT01109173|79336936|FG001|Overall Study|Not Specifiied|4|||
44331897|NCT01109173|79336937|FG002|Overall Study|Not Specifiied|9|||
44331898|NCT01109173|79336938|FG003|Overall Study|Not Specifiied|14|||
44331899|NCT01172821|79336952|FG000|Overall Study|Adverse Event|5|||
44331900|NCT01172821|79336953|FG001|Overall Study|Adverse Event|2|||
44331901|NCT01172821|79336954|FG002|Overall Study|Adverse Event|2|||
44331902|NCT01172821|79336955|FG003|Overall Study|Adverse Event|7|||
44331903|NCT01172821|79336952|FG000|Overall Study|Protocol Violation|0|||
44331904|NCT01172821|79336953|FG001|Overall Study|Protocol Violation|2|||
44429314|NCT00640341|79437681|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
44429315|NCT00640341|79437682|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
44429316|NCT00640341|79437680|FG000|Overall Study|Lost to Follow-up|2|||
44429317|NCT00640341|79437681|FG001|Overall Study|Lost to Follow-up|0|||
44429318|NCT00640341|79437682|FG002|Overall Study|Lost to Follow-up|0|||
44429319|NCT00640341|79437680|FG000|Overall Study|Withdrawal by Subject|4|||
44429320|NCT00640341|79437681|FG001|Overall Study|Withdrawal by Subject|0|||
44429321|NCT00640341|79437682|FG002|Overall Study|Withdrawal by Subject|1|||
44429322|NCT00640341|79437680|FG000|Overall Study|Unacceptable Lens Movement|1|||
44429323|NCT00640341|79437681|FG001|Overall Study|Unacceptable Lens Movement|0|||
44429324|NCT00640341|79437682|FG002|Overall Study|Unacceptable Lens Movement|0|||
44429325|NCT00640341|79437680|FG000|Overall Study|Poor fit/Uncomfortable|4|||
44429326|NCT00640341|79437681|FG001|Overall Study|Poor fit/Uncomfortable|0|||
44429327|NCT00640341|79437682|FG002|Overall Study|Poor fit/Uncomfortable|0|||
44429328|NCT00640341|79437680|FG000|Overall Study|Ineligable at Baseline|5|||
44429329|NCT00640341|79437681|FG001|Overall Study|Ineligable at Baseline|3|||
44429330|NCT00640341|79437682|FG002|Overall Study|Ineligable at Baseline|2|||
44429331|NCT00640341|79437680|FG000|Overall Study|Adverse event and positive slit lamp|1|||
44429332|NCT00640341|79437681|FG001|Overall Study|Adverse event and positive slit lamp|0|||
44429333|NCT00640341|79437682|FG002|Overall Study|Adverse event and positive slit lamp|0|||
44429334|NCT00699348|79437690|FG000|Overall Study|Death|6|||
44429335|NCT00699348|79437690|FG000|Overall Study|Adverse Event|15|||
44429336|NCT00699348|79437690|FG000|Overall Study|Withdrawal by Subject|11|||
44429337|NCT00699348|79437690|FG000|Overall Study|Protocol Violation|10|||
44429338|NCT00699348|79437690|FG000|Overall Study|Lack of Efficacy|8|||
44429339|NCT00699348|79437690|FG000|Overall Study|Failure to return|1|||
44429340|NCT00699348|79437690|FG000|Overall Study|Blood transfusion|24|||
44429341|NCT00699348|79437690|FG000|Overall Study|Renal transplantation|10|||
44429342|NCT00699348|79437690|FG000|Overall Study|Other|5|||
44429343|NCT00643851|79437697|FG000|Overall Study|Death|0|||
44429344|NCT00643851|79437698|FG001|Overall Study|Death|1|||
44429345|NCT00643851|79437699|FG002|Overall Study|Death|0|||
44429346|NCT00643851|79437697|FG000|Overall Study|Lack of Efficacy|0|||
44429347|NCT00643851|79437698|FG001|Overall Study|Lack of Efficacy|1|||
44429348|NCT00643851|79437699|FG002|Overall Study|Lack of Efficacy|0|||
44538233|NCT03100058|79549127|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538234|NCT03100058|79549128|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538235|NCT03100058|79549129|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538236|NCT03100058|79549130|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538237|NCT03100058|79549131|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44331905|NCT01172821|79336954|FG002|Overall Study|Protocol Violation|1|||
44331906|NCT01172821|79336955|FG003|Overall Study|Protocol Violation|2|||
44538238|NCT03100058|79549132|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
44538239|NCT03100058|79549133|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
44331907|NCT01172821|79336952|FG000|Overall Study|Lost to Follow-up|4|||
44429349|NCT00643851|79437697|FG000|Overall Study|Adverse Event|2|||
44429350|NCT00643851|79437698|FG001|Overall Study|Adverse Event|6|||
44429351|NCT00643851|79437699|FG002|Overall Study|Adverse Event|6|||
44538240|NCT03100058|79549134|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
44538241|NCT03100058|79549122|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538242|NCT03100058|79549123|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538243|NCT03100058|79549124|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44331908|NCT01172821|79336953|FG001|Overall Study|Lost to Follow-up|1|||
44429352|NCT00643851|79437697|FG000|Overall Study|Lost to Follow-up|4|||
44429353|NCT00643851|79437698|FG001|Overall Study|Lost to Follow-up|6|||
44429354|NCT00643851|79437699|FG002|Overall Study|Lost to Follow-up|9|||
44429355|NCT00643851|79437697|FG000|Overall Study|Withdrawal by Subject|8|||
44429356|NCT00643851|79437698|FG001|Overall Study|Withdrawal by Subject|15|||
44331909|NCT01172821|79336954|FG002|Overall Study|Lost to Follow-up|2|||
44331910|NCT01172821|79336955|FG003|Overall Study|Lost to Follow-up|2|||
44429357|NCT00643851|79437699|FG002|Overall Study|Withdrawal by Subject|9|||
44429358|NCT00643851|79437697|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
44429359|NCT00643851|79437698|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
44429360|NCT00643851|79437699|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
44429361|NCT03667690|79437709|FG000|Overall Study|Adverse Event|0|||
44429362|NCT03667690|79437710|FG001|Overall Study|Adverse Event|3|||
44429363|NCT03667690|79437709|FG000|Overall Study|Death|22|||
44429364|NCT03667690|79437710|FG001|Overall Study|Death|21|||
44429365|NCT03667690|79437709|FG000|Overall Study|Lost to Follow-up|4|||
44429366|NCT03667690|79437710|FG001|Overall Study|Lost to Follow-up|5|||
44429367|NCT03667690|79437709|FG000|Overall Study|Withdrawal by Subject|7|||
44429368|NCT03667690|79437710|FG001|Overall Study|Withdrawal by Subject|8|||
44429369|NCT03667690|79437709|FG000|Overall Study|Subject could not return for additional investigational product|1|||
44429370|NCT03667690|79437710|FG001|Overall Study|Subject could not return for additional investigational product|0|||
44429371|NCT03667690|79437709|FG000|Overall Study|Subject discharged to hospice care|2|||
44331911|NCT01172821|79336952|FG000|Overall Study|Withdrawal by Subject|2|||
44331912|NCT01172821|79336953|FG001|Overall Study|Withdrawal by Subject|3|||
44331913|NCT01172821|79336954|FG002|Overall Study|Withdrawal by Subject|3|||
44331914|NCT01172821|79336955|FG003|Overall Study|Withdrawal by Subject|3|||
44331915|NCT01172821|79336952|FG000|Overall Study|Other|3|||
44331916|NCT01172821|79336953|FG001|Overall Study|Other|4|||
44331917|NCT01172821|79336954|FG002|Overall Study|Other|5|||
44331918|NCT01172821|79336955|FG003|Overall Study|Other|3|||
44331919|NCT01172275|79336967|FG000|Overall Study|Lost to Follow-up|1|||
44331920|NCT01172275|79336968|FG001|Overall Study|Lost to Follow-up|0|||
44331921|NCT01172275|79336967|FG000|Overall Study|Protocol Violation|1|||
44331922|NCT01172275|79336968|FG001|Overall Study|Protocol Violation|0|||
44331923|NCT01108510|79336976|FG000|Overall Study|Randomized but Not Treated|5|||
44331924|NCT01108510|79336977|FG001|Overall Study|Randomized but Not Treated|1|||
44331925|NCT01108510|79336976|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
44331926|NCT01108510|79336977|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
44331927|NCT01108510|79336976|FG000|Overall Study|Adverse Event|26|||
44331928|NCT01108510|79336977|FG001|Overall Study|Adverse Event|19|||
44331929|NCT01108510|79336976|FG000|Overall Study|Lost to Follow-up|20|||
44331930|NCT01108510|79336977|FG001|Overall Study|Lost to Follow-up|17|||
44331931|NCT01108510|79336976|FG000|Overall Study|Withdrew Consent|21|||
44331932|NCT01108510|79336977|FG001|Overall Study|Withdrew Consent|15|||
44331933|NCT01108510|79336976|FG000|Overall Study|Investigator's Discretion|12|||
44331934|NCT01108510|79336977|FG001|Overall Study|Investigator's Discretion|10|||
44331935|NCT01108510|79336976|FG000|Overall Study|Participant Noncompliance|5|||
44331936|NCT01108510|79336977|FG001|Overall Study|Participant Noncompliance|7|||
44331937|NCT01108510|79336976|FG000|Overall Study|Lack of Efficacy|3|||
44331938|NCT01108510|79336977|FG001|Overall Study|Lack of Efficacy|0|||
44429372|NCT03667690|79437710|FG001|Overall Study|Subject discharged to hospice care|0|||
44429373|NCT03667690|79437709|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
44429374|NCT03667690|79437710|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
44429375|NCT03667690|79437709|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
44429376|NCT03667690|79437710|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
44429377|NCT03667690|79437709|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
44429378|NCT03667690|79437710|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
44429379|NCT03667690|79437709|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
44429380|NCT03667690|79437710|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
44429381|NCT03667690|79437709|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
44429382|NCT03667690|79437710|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
44429383|NCT00627393|79437718|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
44331939|NCT01108510|79336976|FG000|Overall Study|Pregnancy|0|||
44331940|NCT01108510|79336977|FG001|Overall Study|Pregnancy|3|||
44331941|NCT01108510|79336976|FG000|Overall Study|Death|1|||
44331942|NCT01108510|79336977|FG001|Overall Study|Death|1|||
44331943|NCT01340027|79336995|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
44331944|NCT01340027|79336996|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
44331945|NCT01340027|79336997|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
44331946|NCT01340027|79336998|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
44331947|NCT01340027|79336999|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
44331948|NCT01340027|79337000|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
44331949|NCT01340027|79337001|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
44331950|NCT01340027|79337002|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
44331951|NCT01340027|79337003|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
44331952|NCT01340027|79337004|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
44331953|NCT01340027|79337005|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
44429384|NCT00627393|79437719|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
44429385|NCT00627393|79437718|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
44429386|NCT00627393|79437719|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
44429387|NCT00627393|79437718|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
44429388|NCT00627393|79437719|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
44429389|NCT00627393|79437718|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
44429390|NCT00627393|79437719|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
44429391|NCT00696774|79437730|FG000|Period II|Adverse Event|0|||
44331954|NCT01340027|79337006|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
44331955|NCT01340027|79336995|FG000|Overall Study|Adverse Event|0|||
44331956|NCT01340027|79336996|FG001|Overall Study|Adverse Event|1|||
44331957|NCT01340027|79336997|FG002|Overall Study|Adverse Event|2|||
44331958|NCT01340027|79336998|FG003|Overall Study|Adverse Event|0|||
44331959|NCT01340027|79336999|FG004|Overall Study|Adverse Event|1|||
44331960|NCT01340027|79337000|FG005|Overall Study|Adverse Event|2|||
44429392|NCT00696774|79437731|FG001|Period II|Adverse Event|0|||
44429393|NCT00696774|79437732|FG002|Period II|Adverse Event|15|||
44429394|NCT00696774|79437730|FG000|Period II|Lost to Follow-up|0|||
44429395|NCT00696774|79437731|FG001|Period II|Lost to Follow-up|0|||
44429396|NCT00696774|79437732|FG002|Period II|Lost to Follow-up|4|||
44429397|NCT00696774|79437730|FG000|Period II|Protocol Violation|0|||
44429398|NCT00696774|79437731|FG001|Period II|Protocol Violation|0|||
44429399|NCT00696774|79437732|FG002|Period II|Protocol Violation|11|||
44429400|NCT00696774|79437730|FG000|Period II|Withdrawal by Subject|0|||
44538244|NCT03100058|79549125|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538245|NCT03100058|79549126|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538246|NCT03100058|79549127|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538247|NCT03100058|79549128|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538248|NCT03100058|79549129|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538249|NCT03100058|79549130|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538250|NCT03100058|79549131|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
44538251|NCT03100058|79549132|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
44538252|NCT03100058|79549133|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
44538253|NCT03100058|79549134|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
44538254|NCT03100058|79549122|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538255|NCT03100058|79549123|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538256|NCT03100058|79549124|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538257|NCT03100058|79549125|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44258944|NCT01395914|79114523|FG000|Overall Study|Lost to Follow-up|6|||
44258945|NCT01395914|79114524|FG001|Overall Study|Lost to Follow-up|2|||
44258946|NCT01395758|79114765|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
44258947|NCT01395758|79114766|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
44258948|NCT01395758|79114767|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
44258949|NCT01395524|79114825|FG000|Overall Study|Non-compliance with study schedule|1|||
44258950|NCT01395524|79114826|FG001|Overall Study|Non-compliance with study schedule|0|||
44258951|NCT01395524|79114827|FG002|Overall Study|Non-compliance with study schedule|1|||
44258952|NCT01395524|79114825|FG000|Overall Study|Lost to Follow-up|3|||
44258953|NCT01395524|79114826|FG001|Overall Study|Lost to Follow-up|1|||
44258954|NCT01395524|79114827|FG002|Overall Study|Lost to Follow-up|1|||
44258955|NCT01395524|79114825|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
44258956|NCT01395524|79114826|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
44331961|NCT01340027|79337001|FG006|Overall Study|Adverse Event|2|||
44331962|NCT01340027|79337002|FG007|Overall Study|Adverse Event|1|||
44331963|NCT01340027|79337003|FG008|Overall Study|Adverse Event|4|||
44331964|NCT01340027|79337004|FG009|Overall Study|Adverse Event|1|||
44331965|NCT01340027|79337005|FG010|Overall Study|Adverse Event|1|||
44331966|NCT01340027|79337006|FG011|Overall Study|Adverse Event|3|||
44331967|NCT01340027|79336995|FG000|Overall Study|Lack of Efficacy|0|||
44331968|NCT01340027|79336996|FG001|Overall Study|Lack of Efficacy|0|||
44331969|NCT01340027|79336997|FG002|Overall Study|Lack of Efficacy|0|||
44331970|NCT01340027|79336998|FG003|Overall Study|Lack of Efficacy|0|||
44331971|NCT01340027|79336999|FG004|Overall Study|Lack of Efficacy|0|||
44331972|NCT01340027|79337000|FG005|Overall Study|Lack of Efficacy|0|||
44331973|NCT01340027|79337001|FG006|Overall Study|Lack of Efficacy|1|||
44331974|NCT01340027|79337002|FG007|Overall Study|Lack of Efficacy|1|||
44331975|NCT01340027|79337003|FG008|Overall Study|Lack of Efficacy|1|||
44331976|NCT01340027|79337004|FG009|Overall Study|Lack of Efficacy|0|||
44331977|NCT01340027|79337005|FG010|Overall Study|Lack of Efficacy|0|||
44331978|NCT01340027|79337006|FG011|Overall Study|Lack of Efficacy|0|||
44331979|NCT01340027|79336995|FG000|Overall Study|Lost to Follow-up|0|||
44331980|NCT01340027|79336996|FG001|Overall Study|Lost to Follow-up|1|||
44331981|NCT01340027|79336997|FG002|Overall Study|Lost to Follow-up|0|||
44538258|NCT03100058|79549126|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538259|NCT03100058|79549127|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538260|NCT03100058|79549128|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538261|NCT03100058|79549129|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538262|NCT03100058|79549130|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538263|NCT03100058|79549131|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538264|NCT03100058|79549132|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
44538265|NCT03100058|79549133|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538266|NCT03100058|79549134|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
44538267|NCT03100058|79549122|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44429401|NCT00696774|79437731|FG001|Period II|Withdrawal by Subject|0|||
44429402|NCT00696774|79437732|FG002|Period II|Withdrawal by Subject|4|||
44429403|NCT00696774|79437730|FG000|Period II|Sponsor Decision|0|||
44429404|NCT00696774|79437731|FG001|Period II|Sponsor Decision|0|||
44429405|NCT00696774|79437732|FG002|Period II|Sponsor Decision|0|||
44429406|NCT00696774|79437730|FG000|Period II|Lack of Efficacy|0|||
44429407|NCT00696774|79437731|FG001|Period II|Lack of Efficacy|0|||
44429408|NCT00696774|79437732|FG002|Period II|Lack of Efficacy|2|||
44538268|NCT03100058|79549123|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538269|NCT03100058|79549124|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44331982|NCT01340027|79336998|FG003|Overall Study|Lost to Follow-up|0|||
44331983|NCT01340027|79336999|FG004|Overall Study|Lost to Follow-up|0|||
44331984|NCT01340027|79337000|FG005|Overall Study|Lost to Follow-up|0|||
44331985|NCT01340027|79337001|FG006|Overall Study|Lost to Follow-up|1|||
44331986|NCT01340027|79337002|FG007|Overall Study|Lost to Follow-up|0|||
44331987|NCT01340027|79337003|FG008|Overall Study|Lost to Follow-up|0|||
44331988|NCT01340027|79337004|FG009|Overall Study|Lost to Follow-up|1|||
44331989|NCT01340027|79337005|FG010|Overall Study|Lost to Follow-up|0|||
44331990|NCT01340027|79337006|FG011|Overall Study|Lost to Follow-up|0|||
44331991|NCT01340027|79336995|FG000|Overall Study|Protocol Violation|1|||
44331992|NCT01340027|79336996|FG001|Overall Study|Protocol Violation|2|||
44331993|NCT01340027|79336997|FG002|Overall Study|Protocol Violation|0|||
44331994|NCT01340027|79336998|FG003|Overall Study|Protocol Violation|0|||
44331995|NCT01340027|79336999|FG004|Overall Study|Protocol Violation|6|||
44331996|NCT01340027|79337000|FG005|Overall Study|Protocol Violation|0|||
44331997|NCT01340027|79337001|FG006|Overall Study|Protocol Violation|0|||
44331998|NCT01340027|79337002|FG007|Overall Study|Protocol Violation|1|||
44331999|NCT01340027|79337003|FG008|Overall Study|Protocol Violation|2|||
44332000|NCT01340027|79337004|FG009|Overall Study|Protocol Violation|2|||
44332001|NCT01340027|79337005|FG010|Overall Study|Protocol Violation|0|||
44332002|NCT01340027|79337006|FG011|Overall Study|Protocol Violation|0|||
44332003|NCT01340027|79336995|FG000|Overall Study|Withdrawal by Subject|4|||
44332004|NCT01340027|79336996|FG001|Overall Study|Withdrawal by Subject|3|||
44332005|NCT01340027|79336997|FG002|Overall Study|Withdrawal by Subject|1|||
44332006|NCT01340027|79336998|FG003|Overall Study|Withdrawal by Subject|3|||
44332007|NCT01340027|79336999|FG004|Overall Study|Withdrawal by Subject|3|||
44332008|NCT01340027|79337000|FG005|Overall Study|Withdrawal by Subject|2|||
44429409|NCT00696774|79437730|FG000|Period III|Adverse Event|1|||
44429410|NCT00696774|79437731|FG001|Period III|Adverse Event|1|||
44429411|NCT00696774|79437732|FG002|Period III|Adverse Event|0|||
44429412|NCT00696774|79437730|FG000|Period III|Lost to Follow-up|2|||
44429413|NCT00696774|79437731|FG001|Period III|Lost to Follow-up|1|||
44429414|NCT00696774|79437732|FG002|Period III|Lost to Follow-up|0|||
44429415|NCT00696774|79437730|FG000|Period III|Protocol Violation|1|||
44429416|NCT00696774|79437731|FG001|Period III|Protocol Violation|1|||
44429417|NCT00696774|79437732|FG002|Period III|Protocol Violation|0|||
44429418|NCT00696774|79437730|FG000|Period III|Withdrawal by Subject|1|||
44429419|NCT00696774|79437731|FG001|Period III|Withdrawal by Subject|2|||
44429420|NCT00696774|79437732|FG002|Period III|Withdrawal by Subject|0|||
44538270|NCT03100058|79549125|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538271|NCT03100058|79549126|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538272|NCT03100058|79549127|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44157078|NCT01982448|78948614|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
44429421|NCT00696774|79437730|FG000|Period III|Sponsor Decision|2|||
44429422|NCT00696774|79437731|FG001|Period III|Sponsor Decision|0|||
44538273|NCT03100058|79549128|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44157079|NCT01982448|78948615|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
44157080|NCT01982448|78948614|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
44332009|NCT01340027|79337001|FG006|Overall Study|Withdrawal by Subject|3|||
44332010|NCT01340027|79337002|FG007|Overall Study|Withdrawal by Subject|4|||
44332011|NCT01340027|79337003|FG008|Overall Study|Withdrawal by Subject|1|||
44332012|NCT01340027|79337004|FG009|Overall Study|Withdrawal by Subject|2|||
44332013|NCT01340027|79337005|FG010|Overall Study|Withdrawal by Subject|0|||
44332014|NCT01340027|79337006|FG011|Overall Study|Withdrawal by Subject|1|||
44332015|NCT01340027|79336995|FG000|Overall Study|Miscellaneous|0|||
44429423|NCT00696774|79437732|FG002|Period III|Sponsor Decision|0|||
44429424|NCT00696774|79437730|FG000|Period III|Lack of Efficacy|0|||
44332016|NCT01340027|79336996|FG001|Overall Study|Miscellaneous|0|||
44332017|NCT01340027|79336997|FG002|Overall Study|Miscellaneous|0|||
44332018|NCT01340027|79336998|FG003|Overall Study|Miscellaneous|1|||
44332019|NCT01340027|79336999|FG004|Overall Study|Miscellaneous|0|||
44332020|NCT01340027|79337000|FG005|Overall Study|Miscellaneous|0|||
44332021|NCT01340027|79337001|FG006|Overall Study|Miscellaneous|0|||
44429425|NCT00696774|79437731|FG001|Period III|Lack of Efficacy|2|||
44429426|NCT00696774|79437732|FG002|Period III|Lack of Efficacy|0|||
44429427|NCT00608842|79437744|FG000|Overall Study|Participant's Request|0|||
44538274|NCT03100058|79549129|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538275|NCT03100058|79549130|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538276|NCT03100058|79549131|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44332022|NCT01340027|79337002|FG007|Overall Study|Miscellaneous|0|||
44332023|NCT01340027|79337003|FG008|Overall Study|Miscellaneous|0|||
44332024|NCT01340027|79337004|FG009|Overall Study|Miscellaneous|0|||
44332025|NCT01340027|79337005|FG010|Overall Study|Miscellaneous|1|||
44332026|NCT01340027|79337006|FG011|Overall Study|Miscellaneous|0|||
44332027|NCT01327053|79337034|FG000|Overall Study|Adverse Event|23|||
44332028|NCT01327053|79337035|FG001|Overall Study|Adverse Event|57|||
44332029|NCT01327053|79337034|FG000|Overall Study|Patient/guardian decision|11|||
44332030|NCT01327053|79337035|FG001|Overall Study|Patient/guardian decision|35|||
44332031|NCT01327053|79337034|FG000|Overall Study|Physician Decision|10|||
44332032|NCT01327053|79337035|FG001|Overall Study|Physician Decision|14|||
44332033|NCT01327053|79337034|FG000|Overall Study|Death|1|||
44332034|NCT01327053|79337035|FG001|Overall Study|Death|5|||
44332035|NCT01327053|79337034|FG000|Overall Study|Lost to Follow-up|2|||
44332036|NCT01327053|79337035|FG001|Overall Study|Lost to Follow-up|4|||
44332037|NCT01327053|79337034|FG000|Overall Study|Non-compliance with study treatment|0|||
44332038|NCT01327053|79337035|FG001|Overall Study|Non-compliance with study treatment|5|||
44332039|NCT01327053|79337034|FG000|Overall Study|Study terminated by Sponsor|1|||
44332040|NCT01327053|79337035|FG001|Overall Study|Study terminated by Sponsor|3|||
44332041|NCT01327053|79337034|FG000|Overall Study|Progressive disease|31|||
44332042|NCT01327053|79337035|FG001|Overall Study|Progressive disease|26|||
44332043|NCT01327053|79337034|FG000|Overall Study|Protocol Violation|0|||
44332044|NCT01327053|79337035|FG001|Overall Study|Protocol Violation|1|||
44429428|NCT00608842|79437745|FG001|Overall Study|Participant's Request|1|||
44429429|NCT00608842|79437746|FG002|Overall Study|Participant's Request|2|||
44429430|NCT00608842|79437747|FG003|Overall Study|Participant's Request|1|||
44429431|NCT00608842|79437744|FG000|Overall Study|Lost to Follow-up|1|||
44429432|NCT00608842|79437745|FG001|Overall Study|Lost to Follow-up|0|||
44429433|NCT00608842|79437746|FG002|Overall Study|Lost to Follow-up|0|||
44429434|NCT00608842|79437747|FG003|Overall Study|Lost to Follow-up|0|||
44429435|NCT00626925|79437759|FG000|Overall Study|Lost to Follow-up|1|||
44429436|NCT00626925|79437760|FG001|Overall Study|Lost to Follow-up|2|||
44429437|NCT00626925|79437759|FG000|Overall Study|relapse|1|||
44429438|NCT00626925|79437760|FG001|Overall Study|relapse|0|||
44429439|NCT00626925|79437759|FG000|Overall Study|Adverse effect|6|||
44429440|NCT00626925|79437760|FG001|Overall Study|Adverse effect|2|||
44429441|NCT00626925|79437759|FG000|Overall Study|Lack of Efficacy|1|||
44429442|NCT00626925|79437760|FG001|Overall Study|Lack of Efficacy|4|||
44429443|NCT00626925|79437759|FG000|Overall Study|Time constraints|3|||
44429444|NCT00626925|79437760|FG001|Overall Study|Time constraints|1|||
44429445|NCT00698646|79437783|FG000|Overall Study|Adverse Event|8|||
44429446|NCT00698646|79437784|FG001|Overall Study|Adverse Event|7|||
44429447|NCT00698646|79437785|FG002|Overall Study|Adverse Event|8|||
44429448|NCT00698646|79437783|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
44429449|NCT00698646|79437784|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
44538277|NCT03100058|79549132|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538278|NCT03100058|79549133|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
44538279|NCT03100058|79549134|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
44538280|NCT03100058|79549122|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538281|NCT03100058|79549123|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44429450|NCT00698646|79437785|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
44429451|NCT00698646|79437783|FG000|Overall Study|Protocol Deviation|6|||
44429452|NCT00698646|79437784|FG001|Overall Study|Protocol Deviation|2|||
44538282|NCT03100058|79549124|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44429453|NCT00698646|79437785|FG002|Overall Study|Protocol Deviation|3|||
44429454|NCT00698646|79437783|FG000|Overall Study|Withdrawal by Subject|10|||
44429455|NCT00698646|79437784|FG001|Overall Study|Withdrawal by Subject|11|||
44429456|NCT00698646|79437785|FG002|Overall Study|Withdrawal by Subject|8|||
44332045|NCT01327053|79337034|FG000|Overall Study|Untreated|0|||
44332046|NCT01327053|79337035|FG001|Overall Study|Untreated|1|||
44332047|NCT01107925|79337049|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
44332048|NCT01107925|79337050|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
44332049|NCT01107925|79337051|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
44429457|NCT00698646|79437783|FG000|Overall Study|Lost to Follow-up|0|||
44332050|NCT01107925|79337052|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
44332051|NCT01107925|79337053|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
44332052|NCT01107925|79337054|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
44332053|NCT01107925|79337049|FG000|Period 2|Withdrawal by Subject|0|||
44332054|NCT01107925|79337050|FG001|Period 2|Withdrawal by Subject|1|||
44332055|NCT01107925|79337051|FG002|Period 2|Withdrawal by Subject|0|||
44332056|NCT01107925|79337052|FG003|Period 2|Withdrawal by Subject|0|||
44332057|NCT01107925|79337053|FG004|Period 2|Withdrawal by Subject|0|||
44332058|NCT01107925|79337054|FG005|Period 2|Withdrawal by Subject|1|||
44332059|NCT01339832|79337082|FG000|Overall Study|Lost to Follow-up|3|||
44332060|NCT01339832|79337082|FG000|Overall Study|Death|11|||
44332061|NCT01339559|79337086|FG000|Overall Study|Adverse Event|92|||
44332062|NCT01339559|79337086|FG000|Overall Study|Death|5|||
44332063|NCT01339559|79337086|FG000|Overall Study|Lack of Efficacy|164|||
44332064|NCT01339559|79337086|FG000|Overall Study|Lost to Follow-up|22|||
44332065|NCT01339559|79337086|FG000|Overall Study|Subject choice|89|||
44429458|NCT00698646|79437784|FG001|Overall Study|Lost to Follow-up|0|||
44429459|NCT00698646|79437785|FG002|Overall Study|Lost to Follow-up|2|||
44429460|NCT00698646|79437783|FG000|Overall Study|Administrative problems|1|||
44429461|NCT00698646|79437784|FG001|Overall Study|Administrative problems|0|||
44429462|NCT00698646|79437785|FG002|Overall Study|Administrative problems|1|||
44429463|NCT00609466|79437796|FG000|Overall Study|Withdrawal by Subject|0|||
44429464|NCT00609466|79437797|FG001|Overall Study|Withdrawal by Subject|1|||
44429465|NCT00609466|79437798|FG002|Overall Study|Withdrawal by Subject|1|||
44429466|NCT00609466|79437796|FG000|Overall Study|Adverse Event|2|||
44429467|NCT00609466|79437797|FG001|Overall Study|Adverse Event|3|||
44429468|NCT00609466|79437798|FG002|Overall Study|Adverse Event|1|||
44429469|NCT00609466|79437796|FG000|Overall Study|Lack of Efficacy|0|||
44332066|NCT01339559|79337086|FG000|Overall Study|Protocol Violation|15|||
44332067|NCT01339559|79337086|FG000|Overall Study|Study closure at site|1|||
44332068|NCT01339559|79337086|FG000|Overall Study|Incarcerated|2|||
44332069|NCT01339559|79337086|FG000|Overall Study|Epilepsy surgery|1|||
44332070|NCT01339559|79337086|FG000|Overall Study|Pregnancy planned|2|||
44332071|NCT01339559|79337086|FG000|Overall Study|Left the country|1|||
44332072|NCT01339559|79337086|FG000|Overall Study|Investigator decision|2|||
44332073|NCT01339559|79337086|FG000|Overall Study|Patient didn't wish to continue|1|||
44332074|NCT01339559|79337086|FG000|Overall Study|PI decision|1|||
44332075|NCT00107900|79337097|FG000|Overall Study|Adverse Event|3|||
44332076|NCT00107900|79337098|FG001|Overall Study|Adverse Event|2|||
44332077|NCT00107900|79337099|FG002|Overall Study|Adverse Event|10|||
44332078|NCT00107900|79337100|FG003|Overall Study|Adverse Event|3|||
44332079|NCT00107900|79337101|FG004|Overall Study|Adverse Event|5|||
44332080|NCT00107900|79337102|FG005|Overall Study|Adverse Event|3|||
44332081|NCT00107900|79337097|FG000|Overall Study|Death|0|||
44332082|NCT00107900|79337098|FG001|Overall Study|Death|0|||
44332083|NCT00107900|79337099|FG002|Overall Study|Death|0|||
44332084|NCT00107900|79337100|FG003|Overall Study|Death|0|||
44332085|NCT00107900|79337101|FG004|Overall Study|Death|1|||
44332086|NCT00107900|79337102|FG005|Overall Study|Death|0|||
44332087|NCT00107900|79337097|FG000|Overall Study|Lost to Follow-up|4|||
44332088|NCT00107900|79337098|FG001|Overall Study|Lost to Follow-up|1|||
44332089|NCT00107900|79337099|FG002|Overall Study|Lost to Follow-up|3|||
44332090|NCT00107900|79337100|FG003|Overall Study|Lost to Follow-up|2|||
44332091|NCT00107900|79337101|FG004|Overall Study|Lost to Follow-up|5|||
44429470|NCT00609466|79437797|FG001|Overall Study|Lack of Efficacy|2|||
44429471|NCT00609466|79437798|FG002|Overall Study|Lack of Efficacy|2|||
44429472|NCT00608530|79437810|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
44429473|NCT00608530|79437811|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
44429474|NCT00608530|79437812|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
44429475|NCT00608530|79437813|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
44429476|NCT00608530|79437810|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
44429477|NCT00608530|79437811|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
44538283|NCT03100058|79549125|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538284|NCT03100058|79549126|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538285|NCT03100058|79549127|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538286|NCT03100058|79549128|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538287|NCT03100058|79549129|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44332092|NCT00107900|79337102|FG005|Overall Study|Lost to Follow-up|5|||
44332093|NCT00107900|79337097|FG000|Overall Study|Protocol Violation|1|||
44332094|NCT00107900|79337098|FG001|Overall Study|Protocol Violation|0|||
44332095|NCT00107900|79337099|FG002|Overall Study|Protocol Violation|5|||
44332096|NCT00107900|79337100|FG003|Overall Study|Protocol Violation|5|||
44332097|NCT00107900|79337101|FG004|Overall Study|Protocol Violation|7|||
44332098|NCT00107900|79337102|FG005|Overall Study|Protocol Violation|0|||
44429478|NCT00608530|79437812|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
44429479|NCT00608530|79437813|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
44429480|NCT00608530|79437810|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
44429481|NCT00608530|79437811|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
44429482|NCT00608530|79437812|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
44429483|NCT00608530|79437813|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
44429484|NCT00608530|79437810|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
44429485|NCT00608530|79437811|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
44332099|NCT00107900|79337097|FG000|Overall Study|Withdrawal by Subject|1|||
44332100|NCT00107900|79337098|FG001|Overall Study|Withdrawal by Subject|0|||
44332101|NCT00107900|79337099|FG002|Overall Study|Withdrawal by Subject|5|||
44332102|NCT00107900|79337100|FG003|Overall Study|Withdrawal by Subject|0|||
44332103|NCT00107900|79337101|FG004|Overall Study|Withdrawal by Subject|1|||
44332104|NCT00107900|79337102|FG005|Overall Study|Withdrawal by Subject|1|||
44332105|NCT00107900|79337097|FG000|Overall Study|Administrative Reasons|1|||
44332106|NCT00107900|79337098|FG001|Overall Study|Administrative Reasons|0|||
44332107|NCT00107900|79337099|FG002|Overall Study|Administrative Reasons|2|||
44332108|NCT00107900|79337100|FG003|Overall Study|Administrative Reasons|2|||
44332109|NCT00107900|79337101|FG004|Overall Study|Administrative Reasons|2|||
44332110|NCT00107900|79337102|FG005|Overall Study|Administrative Reasons|0|||
44332111|NCT01339052|79337118|FG000|Overall Study|Disease progression|13|||
44332112|NCT01339052|79337119|FG001|Overall Study|Disease progression|46|||
44332113|NCT01339052|79337118|FG000|Overall Study|Adverse Event|1|||
44332114|NCT01339052|79337119|FG001|Overall Study|Adverse Event|1|||
44332115|NCT01339052|79337118|FG000|Overall Study|Withdrawal by Subject|0|||
44332116|NCT01339052|79337119|FG001|Overall Study|Withdrawal by Subject|3|||
44332117|NCT01339052|79337118|FG000|Overall Study|Physician Decision|1|||
44332118|NCT01339052|79337119|FG001|Overall Study|Physician Decision|0|||
44332119|NCT00107315|79337128|FG000|Overall Study|Disease Progression|9|||
44332120|NCT00107315|79337128|FG000|Overall Study|Adverse Event|4|||
44332121|NCT00107315|79337128|FG000|Overall Study|Withdrawal by Subject|2|||
44332122|NCT01335971|79337135|FG000|Overall Study|Withdrawal by Subject|1|||
44332123|NCT01335971|79337136|FG001|Overall Study|Withdrawal by Subject|0|||
44332124|NCT01335971|79337137|FG002|Overall Study|Withdrawal by Subject|0|||
44332125|NCT01335971|79337135|FG000|Overall Study|Did not complete bronchoscopy|1|||
44332126|NCT01335971|79337136|FG001|Overall Study|Did not complete bronchoscopy|1|||
44332127|NCT01335971|79337137|FG002|Overall Study|Did not complete bronchoscopy|1|||
44332128|NCT00107276|79337145|FG000|Overall Study|Progression|46|||
44332129|NCT00107276|79337145|FG000|Overall Study|Adverse Event|6|||
44332130|NCT00107276|79337145|FG000|Overall Study|M.D. decision|2|||
44332131|NCT00107276|79337145|FG000|Overall Study|Patient refusal|1|||
44332132|NCT00107276|79337145|FG000|Overall Study|Death|1|||
44332133|NCT00107276|79337145|FG000|Overall Study|Ineligible|16|||
44332134|NCT01335698|79337155|FG000|Treatment Stage 1|Lack of Efficacy|3|||
44332135|NCT01335698|79337156|FG001|Treatment Stage 1|Lack of Efficacy|1|||
44332136|NCT01335698|79337157|FG002|Treatment Stage 1|Lack of Efficacy|3|||
44332137|NCT01335698|79337158|FG003|Treatment Stage 1|Lack of Efficacy|3|||
44332138|NCT01335698|79337159|FG004|Treatment Stage 1|Lack of Efficacy|1|||
44332139|NCT01335698|79337155|FG000|Treatment Stage 1|Adverse Event|1|||
44429486|NCT00608530|79437812|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
44429487|NCT00608530|79437813|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
44429488|NCT00608530|79437810|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
44429489|NCT00608530|79437811|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
44429490|NCT00608530|79437812|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
44429491|NCT00608530|79437813|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
44429492|NCT00608530|79437810|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
44429493|NCT00608530|79437811|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
44332140|NCT01335698|79337156|FG001|Treatment Stage 1|Adverse Event|2|||
44332141|NCT01335698|79337157|FG002|Treatment Stage 1|Adverse Event|2|||
44429494|NCT00608530|79437812|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
44429495|NCT00608530|79437813|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
44429496|NCT00642993|79437830|FG000|Overall Study|Adverse Event|85|||
44429497|NCT00642993|79437831|FG001|Overall Study|Adverse Event|4|||
44429498|NCT00642993|79437830|FG000|Overall Study|Lost to Follow-up|8|||
44538288|NCT03100058|79549130|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538289|NCT03100058|79549131|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
44332142|NCT01335698|79337158|FG003|Treatment Stage 1|Adverse Event|1|||
44332143|NCT01335698|79337159|FG004|Treatment Stage 1|Adverse Event|1|||
44332144|NCT01335698|79337155|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
44332145|NCT01335698|79337156|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
44429499|NCT00642993|79437831|FG001|Overall Study|Lost to Follow-up|4|||
44429500|NCT00642993|79437830|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
44332146|NCT01335698|79337157|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
44332147|NCT01335698|79337158|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
44332148|NCT01335698|79337159|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
44332149|NCT01335698|79337155|FG000|Treatment Stage 1|Lost to Follow-up|1|||
44332150|NCT01335698|79337156|FG001|Treatment Stage 1|Lost to Follow-up|1|||
44332151|NCT01335698|79337157|FG002|Treatment Stage 1|Lost to Follow-up|0|||
44429501|NCT00642993|79437831|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
44429502|NCT00642993|79437830|FG000|Overall Study|Protocol Violation|1|||
44429503|NCT00642993|79437831|FG001|Overall Study|Protocol Violation|4|||
44429504|NCT00642993|79437830|FG000|Overall Study|Did not meet protocol eligibility|0|||
44429505|NCT00642993|79437831|FG001|Overall Study|Did not meet protocol eligibility|1|||
44429506|NCT00642993|79437830|FG000|Overall Study|Administrative|1|||
44332152|NCT01335698|79337158|FG003|Treatment Stage 1|Lost to Follow-up|0|||
44332153|NCT01335698|79337159|FG004|Treatment Stage 1|Lost to Follow-up|0|||
44332154|NCT01335698|79337155|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
44332155|NCT01335698|79337156|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
44332156|NCT01335698|79337157|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
44429507|NCT00642993|79437831|FG001|Overall Study|Administrative|0|||
44429508|NCT00696696|79437837|FG000|Overall Study|Adverse Event|5|||
44429509|NCT00696696|79437837|FG000|Overall Study|Withdrawal by Subject|8|||
44429510|NCT00696696|79437837|FG000|Overall Study|Physician Decision|2|||
44429511|NCT00696696|79437837|FG000|Overall Study|Death|3|||
44429512|NCT00699192|79437844|FG000|Overall Study|Missing|1|||
44429513|NCT00699192|79437845|FG001|Overall Study|Missing|1|||
44429514|NCT00699192|79437846|FG002|Overall Study|Missing|1|||
44429515|NCT00699192|79437844|FG000|Overall Study|Adverse Event|9|||
44429516|NCT00699192|79437845|FG001|Overall Study|Adverse Event|4|||
44429517|NCT00699192|79437846|FG002|Overall Study|Adverse Event|3|||
44429518|NCT00699192|79437844|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44429519|NCT00699192|79437845|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44429520|NCT00699192|79437846|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44429521|NCT00699192|79437844|FG000|Overall Study|Lack of Efficacy|0|||
44429522|NCT00699192|79437845|FG001|Overall Study|Lack of Efficacy|0|||
44429523|NCT00699192|79437846|FG002|Overall Study|Lack of Efficacy|1|||
44429524|NCT00699192|79437844|FG000|Overall Study|Withdrawal by Subject|3|||
44429525|NCT00699192|79437845|FG001|Overall Study|Withdrawal by Subject|2|||
44429526|NCT00699192|79437846|FG002|Overall Study|Withdrawal by Subject|4|||
44429527|NCT00699192|79437844|FG000|Overall Study|Administrative problems|1|||
44429528|NCT00699192|79437845|FG001|Overall Study|Administrative problems|3|||
44429529|NCT00699192|79437846|FG002|Overall Study|Administrative problems|1|||
44429530|NCT00699192|79437844|FG000|Overall Study|Protocol Violation|2|||
44429531|NCT00699192|79437845|FG001|Overall Study|Protocol Violation|2|||
44429532|NCT00699192|79437846|FG002|Overall Study|Protocol Violation|0|||
44429533|NCT00401245|79437858|FG000|Double Blind Titration Phase|Adverse Event|3|||
44429534|NCT00401245|79437859|FG001|Double Blind Titration Phase|Adverse Event|2|||
44429535|NCT00401245|79437860|FG002|Double Blind Titration Phase|Adverse Event|5|||
44429536|NCT00401245|79437861|FG003|Double Blind Titration Phase|Adverse Event|12|||
44429537|NCT00401245|79437862|FG004|Double Blind Titration Phase|Adverse Event|0|||
44429538|NCT00401245|79437863|FG005|Double Blind Titration Phase|Adverse Event|0|||
44429539|NCT00401245|79437864|FG006|Double Blind Titration Phase|Adverse Event|0|||
44429540|NCT00401245|79437865|FG007|Double Blind Titration Phase|Adverse Event|0|||
44429541|NCT00401245|79437858|FG000|Double Blind Titration Phase|Other|0|||
44429542|NCT00401245|79437859|FG001|Double Blind Titration Phase|Other|0|||
44429543|NCT00401245|79437860|FG002|Double Blind Titration Phase|Other|1|||
44429544|NCT00401245|79437861|FG003|Double Blind Titration Phase|Other|0|||
44429545|NCT00401245|79437862|FG004|Double Blind Titration Phase|Other|0|||
44429546|NCT00401245|79437863|FG005|Double Blind Titration Phase|Other|0|||
44429547|NCT00401245|79437864|FG006|Double Blind Titration Phase|Other|0|||
44429548|NCT00401245|79437865|FG007|Double Blind Titration Phase|Other|0|||
44429549|NCT00401245|79437858|FG000|Double Blind Titration Phase|Protocol Violation|0|||
44429550|NCT00401245|79437859|FG001|Double Blind Titration Phase|Protocol Violation|0|||
44429551|NCT00401245|79437860|FG002|Double Blind Titration Phase|Protocol Violation|0|||
44429552|NCT00401245|79437861|FG003|Double Blind Titration Phase|Protocol Violation|1|||
44429553|NCT00401245|79437862|FG004|Double Blind Titration Phase|Protocol Violation|0|||
44429554|NCT00401245|79437863|FG005|Double Blind Titration Phase|Protocol Violation|0|||
44429555|NCT00401245|79437864|FG006|Double Blind Titration Phase|Protocol Violation|0|||
44429556|NCT00401245|79437865|FG007|Double Blind Titration Phase|Protocol Violation|0|||
44429557|NCT00401245|79437858|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
44429558|NCT00401245|79437859|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
44429559|NCT00401245|79437860|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
44429560|NCT00401245|79437861|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
44429561|NCT00401245|79437862|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
44429562|NCT00401245|79437863|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
44429563|NCT00401245|79437864|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
44429564|NCT00401245|79437865|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
44429565|NCT00401245|79437858|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
44429566|NCT00401245|79437859|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
44429567|NCT00401245|79437860|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
44429568|NCT00401245|79437861|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
44429569|NCT00401245|79437862|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
44429570|NCT00401245|79437863|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
44429571|NCT00401245|79437864|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
44429572|NCT00401245|79437865|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
44429573|NCT00401245|79437858|FG000|Open Label Phase|Adverse Event|5|||
44429574|NCT00401245|79437859|FG001|Open Label Phase|Adverse Event|14|||
44429575|NCT00401245|79437860|FG002|Open Label Phase|Adverse Event|6|||
44429576|NCT00401245|79437861|FG003|Open Label Phase|Adverse Event|7|||
44429577|NCT00401245|79437862|FG004|Open Label Phase|Adverse Event|0|||
44429578|NCT00401245|79437863|FG005|Open Label Phase|Adverse Event|0|||
44429579|NCT00401245|79437864|FG006|Open Label Phase|Adverse Event|0|||
44429580|NCT00401245|79437865|FG007|Open Label Phase|Adverse Event|0|||
44429581|NCT00401245|79437858|FG000|Open Label Phase|Lost to Follow-up|5|||
44429582|NCT00401245|79437859|FG001|Open Label Phase|Lost to Follow-up|7|||
44429583|NCT00401245|79437860|FG002|Open Label Phase|Lost to Follow-up|5|||
44429584|NCT00401245|79437861|FG003|Open Label Phase|Lost to Follow-up|4|||
44429585|NCT00401245|79437862|FG004|Open Label Phase|Lost to Follow-up|0|||
44429586|NCT00401245|79437863|FG005|Open Label Phase|Lost to Follow-up|0|||
44429587|NCT00401245|79437864|FG006|Open Label Phase|Lost to Follow-up|0|||
44429588|NCT00401245|79437865|FG007|Open Label Phase|Lost to Follow-up|0|||
44429589|NCT00401245|79437858|FG000|Open Label Phase|Other|4|||
44429590|NCT00401245|79437859|FG001|Open Label Phase|Other|8|||
44429591|NCT00401245|79437860|FG002|Open Label Phase|Other|7|||
44429592|NCT00401245|79437861|FG003|Open Label Phase|Other|8|||
44429593|NCT00401245|79437862|FG004|Open Label Phase|Other|0|||
44429594|NCT00401245|79437863|FG005|Open Label Phase|Other|0|||
44429595|NCT00401245|79437864|FG006|Open Label Phase|Other|0|||
44429596|NCT00401245|79437865|FG007|Open Label Phase|Other|0|||
44429597|NCT00401245|79437858|FG000|Open Label Phase|Protocol Violation|0|||
44429598|NCT00401245|79437859|FG001|Open Label Phase|Protocol Violation|1|||
44429599|NCT00401245|79437860|FG002|Open Label Phase|Protocol Violation|0|||
44429600|NCT00401245|79437861|FG003|Open Label Phase|Protocol Violation|1|||
44429601|NCT00401245|79437862|FG004|Open Label Phase|Protocol Violation|0|||
44429602|NCT00401245|79437863|FG005|Open Label Phase|Protocol Violation|0|||
44429603|NCT00401245|79437864|FG006|Open Label Phase|Protocol Violation|0|||
44429604|NCT00401245|79437865|FG007|Open Label Phase|Protocol Violation|0|||
44429605|NCT00401245|79437858|FG000|Open Label Phase|Withdrawal by Subject|3|||
44538290|NCT03100058|79549132|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538291|NCT03100058|79549133|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44429606|NCT00401245|79437859|FG001|Open Label Phase|Withdrawal by Subject|3|||
44538292|NCT03100058|79549134|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
44538293|NCT02871778|79549180|FG000|Part A: Treatment Period 1|Adverse Event|1|||
44538294|NCT02871778|79549181|FG001|Part A: Treatment Period 1|Adverse Event|1|||
44538295|NCT02871778|79549182|FG002|Part A: Treatment Period 1|Adverse Event|1|||
44157081|NCT01982448|78948615|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
44429607|NCT00401245|79437860|FG002|Open Label Phase|Withdrawal by Subject|2|||
44429608|NCT00401245|79437861|FG003|Open Label Phase|Withdrawal by Subject|1|||
44429609|NCT00401245|79437862|FG004|Open Label Phase|Withdrawal by Subject|0|||
44538296|NCT02871778|79549183|FG003|Part A: Treatment Period 1|Adverse Event|0|||
44429610|NCT00401245|79437863|FG005|Open Label Phase|Withdrawal by Subject|0|||
44429611|NCT00401245|79437864|FG006|Open Label Phase|Withdrawal by Subject|0|||
44429612|NCT00401245|79437865|FG007|Open Label Phase|Withdrawal by Subject|0|||
44429613|NCT00401245|79437858|FG000|Open Label Phase|Lack of Efficacy|4|||
44429614|NCT00401245|79437859|FG001|Open Label Phase|Lack of Efficacy|2|||
44429615|NCT00401245|79437860|FG002|Open Label Phase|Lack of Efficacy|3|||
44157082|NCT01982448|78948614|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
44157083|NCT01982448|78948615|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
44157084|NCT01982448|78948614|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
44157085|NCT01982448|78948615|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
44157086|NCT01773421|78948629|FG000|Treatment Phase|Other|0|||
44429616|NCT00401245|79437861|FG003|Open Label Phase|Lack of Efficacy|0|||
44429617|NCT00401245|79437862|FG004|Open Label Phase|Lack of Efficacy|0|||
44429618|NCT00401245|79437863|FG005|Open Label Phase|Lack of Efficacy|0|||
44429619|NCT00401245|79437864|FG006|Open Label Phase|Lack of Efficacy|0|||
44429620|NCT00401245|79437865|FG007|Open Label Phase|Lack of Efficacy|0|||
44429621|NCT00401245|79437858|FG000|Double Blind Tapering Phase|Adverse Event|0|||
44157087|NCT01773421|78948630|FG001|Treatment Phase|Other|0|||
44157088|NCT01773421|78948631|FG002|Treatment Phase|Other|2|||
44157089|NCT01773421|78948632|FG003|Treatment Phase|Other|0|||
44157090|NCT01773421|78948633|FG004|Treatment Phase|Other|0|||
44157091|NCT01773421|78948634|FG005|Treatment Phase|Other|0|||
44157092|NCT01773421|78948635|FG006|Treatment Phase|Other|0|||
44157093|NCT01773421|78948629|FG000|Treatment Phase|Adverse Event|0|||
44157094|NCT01773421|78948630|FG001|Treatment Phase|Adverse Event|0|||
44429622|NCT00401245|79437859|FG001|Double Blind Tapering Phase|Adverse Event|0|||
44429623|NCT00401245|79437860|FG002|Double Blind Tapering Phase|Adverse Event|0|||
44429624|NCT00401245|79437861|FG003|Double Blind Tapering Phase|Adverse Event|0|||
44429625|NCT00401245|79437862|FG004|Double Blind Tapering Phase|Adverse Event|1|||
44429626|NCT00401245|79437863|FG005|Double Blind Tapering Phase|Adverse Event|1|||
44429627|NCT00401245|79437864|FG006|Double Blind Tapering Phase|Adverse Event|2|||
44429628|NCT00401245|79437865|FG007|Double Blind Tapering Phase|Adverse Event|4|||
44429629|NCT00401245|79437858|FG000|Double Blind Tapering Phase|Investigator request|0|||
44429630|NCT00401245|79437859|FG001|Double Blind Tapering Phase|Investigator request|0|||
44429631|NCT00401245|79437860|FG002|Double Blind Tapering Phase|Investigator request|0|||
44429632|NCT00401245|79437861|FG003|Double Blind Tapering Phase|Investigator request|0|||
44429633|NCT00401245|79437862|FG004|Double Blind Tapering Phase|Investigator request|0|||
44429634|NCT00401245|79437863|FG005|Double Blind Tapering Phase|Investigator request|0|||
44429635|NCT00401245|79437864|FG006|Double Blind Tapering Phase|Investigator request|0|||
44429636|NCT00401245|79437865|FG007|Double Blind Tapering Phase|Investigator request|1|||
44429637|NCT00401245|79437858|FG000|Double Blind Tapering Phase|Other|0|||
44429638|NCT00401245|79437859|FG001|Double Blind Tapering Phase|Other|0|||
44429639|NCT00401245|79437860|FG002|Double Blind Tapering Phase|Other|0|||
44429640|NCT00401245|79437861|FG003|Double Blind Tapering Phase|Other|0|||
44429641|NCT00401245|79437862|FG004|Double Blind Tapering Phase|Other|1|||
44429642|NCT00401245|79437863|FG005|Double Blind Tapering Phase|Other|0|||
44429643|NCT00401245|79437864|FG006|Double Blind Tapering Phase|Other|2|||
44429644|NCT00401245|79437865|FG007|Double Blind Tapering Phase|Other|2|||
44429645|NCT00401245|79437858|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
44429646|NCT00401245|79437859|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
44429647|NCT00401245|79437860|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
44429648|NCT00401245|79437861|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
44429649|NCT00401245|79437862|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
44538297|NCT02871778|79549184|FG004|Part A: Treatment Period 1|Adverse Event|0|||
44538298|NCT02871778|79549185|FG005|Part A: Treatment Period 1|Adverse Event|0|||
44157095|NCT01773421|78948631|FG002|Treatment Phase|Adverse Event|3|||
44157096|NCT01773421|78948632|FG003|Treatment Phase|Adverse Event|1|||
44538299|NCT02871778|79549186|FG006|Part A: Treatment Period 1|Adverse Event|0|||
44538300|NCT02871778|79549187|FG007|Part A: Treatment Period 1|Adverse Event|0|||
44538301|NCT02871778|79549180|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
44157097|NCT01773421|78948633|FG004|Treatment Phase|Adverse Event|0|||
44157098|NCT01773421|78948634|FG005|Treatment Phase|Adverse Event|0|||
44157099|NCT01773421|78948635|FG006|Treatment Phase|Adverse Event|0|||
44157100|NCT01773421|78948629|FG000|Treatment Phase|Withdrawal by Subject|0|||
44157101|NCT01773421|78948630|FG001|Treatment Phase|Withdrawal by Subject|0|||
44157102|NCT01773421|78948631|FG002|Treatment Phase|Withdrawal by Subject|1|||
44157103|NCT01773421|78948632|FG003|Treatment Phase|Withdrawal by Subject|1|||
44429650|NCT00401245|79437863|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
44429651|NCT00401245|79437864|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
44429652|NCT00401245|79437865|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
44429653|NCT00401245|79437858|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
44429654|NCT00401245|79437859|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
44538302|NCT02871778|79549181|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
44429655|NCT00401245|79437860|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
44429656|NCT00401245|79437861|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
44157104|NCT01773421|78948633|FG004|Treatment Phase|Withdrawal by Subject|0|||
44157105|NCT01773421|78948634|FG005|Treatment Phase|Withdrawal by Subject|0|||
44258957|NCT01395524|79114827|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
44332157|NCT01335698|79337158|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
44429657|NCT00401245|79437862|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
44429658|NCT00401245|79437863|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
44429659|NCT00401245|79437864|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
44429660|NCT00401245|79437865|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
44429661|NCT00696384|79437885|FG000|Open Label Phase|Adverse Event|27|||
44429662|NCT00696384|79437886|FG001|Open Label Phase|Adverse Event|0|||
44538303|NCT02871778|79549182|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
44538304|NCT02871778|79549183|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
44429663|NCT00696384|79437887|FG002|Open Label Phase|Adverse Event|0|||
44429664|NCT00696384|79437885|FG000|Open Label Phase|Protocol Violation|18|||
44429665|NCT00696384|79437886|FG001|Open Label Phase|Protocol Violation|0|||
44429666|NCT00696384|79437887|FG002|Open Label Phase|Protocol Violation|0|||
44429667|NCT00696384|79437885|FG000|Open Label Phase|Lost to Follow-up|24|||
44429668|NCT00696384|79437886|FG001|Open Label Phase|Lost to Follow-up|0|||
44429669|NCT00696384|79437887|FG002|Open Label Phase|Lost to Follow-up|0|||
44429670|NCT00696384|79437885|FG000|Open Label Phase|Withdrawal by Subject|37|||
44429671|NCT00696384|79437886|FG001|Open Label Phase|Withdrawal by Subject|0|||
44429672|NCT00696384|79437887|FG002|Open Label Phase|Withdrawal by Subject|0|||
44429673|NCT00696384|79437885|FG000|Open Label Phase|Other|6|||
44429674|NCT00696384|79437886|FG001|Open Label Phase|Other|0|||
44429675|NCT00696384|79437887|FG002|Open Label Phase|Other|0|||
44429676|NCT00696384|79437885|FG000|Open Label Phase|Lack of Efficacy|3|||
44538305|NCT02871778|79549184|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
44538306|NCT02871778|79549185|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
44538307|NCT02871778|79549186|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
44538308|NCT02871778|79549187|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
44538309|NCT02871778|79549180|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538310|NCT02871778|79549181|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538311|NCT02871778|79549182|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
44538312|NCT02871778|79549183|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538313|NCT02871778|79549184|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538314|NCT02871778|79549185|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538315|NCT02871778|79549186|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538316|NCT02871778|79549187|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
44538317|NCT02871778|79549180|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44538318|NCT02871778|79549181|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44332158|NCT01335698|79337159|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
44332159|NCT01335698|79337155|FG000|Treatment Stage 1|No longer meets study criteria|1|||
44332160|NCT01335698|79337156|FG001|Treatment Stage 1|No longer meets study criteria|1|||
44332161|NCT01335698|79337157|FG002|Treatment Stage 1|No longer meets study criteria|0|||
44332162|NCT01335698|79337158|FG003|Treatment Stage 1|No longer meets study criteria|1|||
44332163|NCT01335698|79337159|FG004|Treatment Stage 1|No longer meets study criteria|0|||
44332164|NCT01335698|79337155|FG000|Treatment Stage 1|Other|1|||
44332165|NCT01335698|79337156|FG001|Treatment Stage 1|Other|0|||
44332166|NCT01335698|79337157|FG002|Treatment Stage 1|Other|0|||
44332167|NCT01335698|79337158|FG003|Treatment Stage 1|Other|1|||
44332168|NCT01335698|79337159|FG004|Treatment Stage 1|Other|0|||
44332169|NCT01335698|79337155|FG000|Treatment Stage 2|Lack of Efficacy|2|||
44157106|NCT01773421|78948635|FG006|Treatment Phase|Withdrawal by Subject|0|||
44258958|NCT01395524|79114825|FG000|Overall Study|Severe noncompliance with protocol|1|||
44258959|NCT01395524|79114826|FG001|Overall Study|Severe noncompliance with protocol|0|||
44258960|NCT01395524|79114827|FG002|Overall Study|Severe noncompliance with protocol|0|||
44258961|NCT01395524|79114825|FG000|Overall Study|Adverse Event|4|||
44258962|NCT01395524|79114826|FG001|Overall Study|Adverse Event|4|||
44258963|NCT01395524|79114827|FG002|Overall Study|Adverse Event|3|||
44258964|NCT01395524|79114825|FG000|Overall Study|Death|1|||
44258965|NCT01395524|79114826|FG001|Overall Study|Death|0|||
44258966|NCT01395524|79114827|FG002|Overall Study|Death|0|||
44258967|NCT01395524|79114825|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
44258968|NCT01395524|79114826|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44332170|NCT01335698|79337156|FG001|Treatment Stage 2|Lack of Efficacy|1|||
44332171|NCT01335698|79337157|FG002|Treatment Stage 2|Lack of Efficacy|3|||
44332172|NCT01335698|79337158|FG003|Treatment Stage 2|Lack of Efficacy|1|||
44429677|NCT00696384|79437886|FG001|Open Label Phase|Lack of Efficacy|0|||
44429678|NCT00696384|79437887|FG002|Open Label Phase|Lack of Efficacy|0|||
44429679|NCT00696384|79437885|FG000|Open Label Phase|Physician Decision|4|||
44429680|NCT00696384|79437886|FG001|Open Label Phase|Physician Decision|0|||
44429681|NCT00696384|79437887|FG002|Open Label Phase|Physician Decision|0|||
44429682|NCT00696384|79437885|FG000|Double Blind Phase|Adverse Event|0|||
44429683|NCT00696384|79437886|FG001|Double Blind Phase|Adverse Event|2|||
44429684|NCT00696384|79437887|FG002|Double Blind Phase|Adverse Event|2|||
44429685|NCT00696384|79437885|FG000|Double Blind Phase|Lost to Follow-up|0|||
44429686|NCT00696384|79437886|FG001|Double Blind Phase|Lost to Follow-up|2|||
44429687|NCT00696384|79437887|FG002|Double Blind Phase|Lost to Follow-up|1|||
44429688|NCT00696384|79437885|FG000|Double Blind Phase|Withdrawal by Subject|0|||
44429689|NCT00696384|79437886|FG001|Double Blind Phase|Withdrawal by Subject|4|||
44429690|NCT00696384|79437887|FG002|Double Blind Phase|Withdrawal by Subject|3|||
44429691|NCT00696384|79437885|FG000|Double Blind Phase|Lack of Efficacy|0|||
44429692|NCT00696384|79437886|FG001|Double Blind Phase|Lack of Efficacy|1|||
44429693|NCT00696384|79437887|FG002|Double Blind Phase|Lack of Efficacy|0|||
44429694|NCT00696384|79437885|FG000|Double Blind Phase|Physician Decision|0|||
44429695|NCT00696384|79437886|FG001|Double Blind Phase|Physician Decision|2|||
44429696|NCT00696384|79437887|FG002|Double Blind Phase|Physician Decision|0|||
44429697|NCT00636675|79437898|FG000|Overall Study|Lost to Follow-up|121|||
44429698|NCT00636675|79437899|FG001|Overall Study|Lost to Follow-up|31|||
44429699|NCT00636675|79437898|FG000|Overall Study|Withdrawal by Subject|19|||
44429700|NCT00636675|79437899|FG001|Overall Study|Withdrawal by Subject|10|||
44429701|NCT00699998|79437909|FG000|Overall Study|Withdrawal by Subject|194|||
44429702|NCT00699998|79437910|FG001|Overall Study|Withdrawal by Subject|83|||
44429703|NCT00699998|79437911|FG002|Overall Study|Withdrawal by Subject|202|||
44429704|NCT00699998|79437912|FG003|Overall Study|Withdrawal by Subject|80|||
44429705|NCT00699998|79437909|FG000|Overall Study|Physician Decision|3|||
44429706|NCT00699998|79437910|FG001|Overall Study|Physician Decision|2|||
44429707|NCT00699998|79437911|FG002|Overall Study|Physician Decision|1|||
44429708|NCT00699998|79437912|FG003|Overall Study|Physician Decision|1|||
44429709|NCT00699998|79437909|FG000|Overall Study|Lost to Follow-up|2|||
44429710|NCT00699998|79437910|FG001|Overall Study|Lost to Follow-up|1|||
44429711|NCT00699998|79437911|FG002|Overall Study|Lost to Follow-up|3|||
44429712|NCT00699998|79437912|FG003|Overall Study|Lost to Follow-up|1|||
44429713|NCT00696072|79437929|FG000|Overall Study|continuing active treatment|10|||
44429714|NCT00696072|79437930|FG001|Overall Study|continuing active treatment|13|||
44429715|NCT00696072|79437929|FG000|Overall Study|Adverse Event|10|||
44429716|NCT00696072|79437930|FG001|Overall Study|Adverse Event|6|||
44429717|NCT00696072|79437929|FG000|Overall Study|Patient Request|3|||
44429718|NCT00696072|79437930|FG001|Overall Study|Patient Request|7|||
44429719|NCT00696072|79437929|FG000|Overall Study|Investigator Request|1|||
44429720|NCT00696072|79437930|FG001|Overall Study|Investigator Request|4|||
44429721|NCT00696072|79437929|FG000|Overall Study|Sponsor Request|0|||
44429722|NCT00696072|79437930|FG001|Overall Study|Sponsor Request|1|||
44429723|NCT00696072|79437929|FG000|Overall Study|Disease Progression|32|||
44429724|NCT00696072|79437930|FG001|Overall Study|Disease Progression|30|||
44429725|NCT00696072|79437929|FG000|Overall Study|Non-specified|1|||
44429726|NCT00696072|79437930|FG001|Overall Study|Non-specified|2|||
44429727|NCT00634647|79437937|FG000|Overall Study|death on study|3|||
44429728|NCT00634647|79437937|FG000|Overall Study|refused further treatment|3|||
44429729|NCT00634647|79437937|FG000|Overall Study|declined to participate before treatment|1|||
44429730|NCT00576732|79437944|FG000|DOUBLE BLIND|Adverse Event|0|||
44429731|NCT00576732|79437945|FG001|DOUBLE BLIND|Adverse Event|0|||
44429732|NCT00576732|79437946|FG002|DOUBLE BLIND|Adverse Event|1|||
44429733|NCT00576732|79437947|FG003|DOUBLE BLIND|Adverse Event|0|||
44429734|NCT00576732|79437948|FG004|DOUBLE BLIND|Adverse Event|0|||
44429735|NCT00576732|79437949|FG005|DOUBLE BLIND|Adverse Event|0|||
44429736|NCT00576732|79437944|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
44429737|NCT00576732|79437945|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
44429738|NCT00576732|79437946|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
44429739|NCT00576732|79437947|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
44429740|NCT00576732|79437948|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
44429741|NCT00576732|79437949|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
44429742|NCT00576732|79437944|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
44429743|NCT00576732|79437945|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
44429744|NCT00576732|79437946|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
44429745|NCT00576732|79437947|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
44429746|NCT00576732|79437948|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
44429747|NCT00576732|79437949|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
44429748|NCT00576732|79437944|FG000|DOUBLE BLIND|OTHER|0|||
44429749|NCT00576732|79437945|FG001|DOUBLE BLIND|OTHER|2|||
44429750|NCT00576732|79437946|FG002|DOUBLE BLIND|OTHER|1|||
44429751|NCT00576732|79437947|FG003|DOUBLE BLIND|OTHER|0|||
44429752|NCT00576732|79437948|FG004|DOUBLE BLIND|OTHER|0|||
44429753|NCT00576732|79437949|FG005|DOUBLE BLIND|OTHER|0|||
44429754|NCT00576732|79437944|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
44429755|NCT00576732|79437945|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
44429756|NCT00576732|79437946|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
44429757|NCT00576732|79437947|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
44429758|NCT00576732|79437948|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
44429759|NCT00576732|79437949|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
44429760|NCT00576732|79437944|FG000|DOUBLE BLIND|Protocol Violation|1|||
44429761|NCT00576732|79437945|FG001|DOUBLE BLIND|Protocol Violation|0|||
44332173|NCT01335698|79337159|FG004|Treatment Stage 2|Lack of Efficacy|0|||
44332174|NCT01335698|79337155|FG000|Treatment Stage 2|Adverse Event|2|||
44332175|NCT01335698|79337156|FG001|Treatment Stage 2|Adverse Event|0|||
44332176|NCT01335698|79337157|FG002|Treatment Stage 2|Adverse Event|0|||
44332177|NCT01335698|79337158|FG003|Treatment Stage 2|Adverse Event|3|||
44332178|NCT01335698|79337159|FG004|Treatment Stage 2|Adverse Event|0|||
44332179|NCT01335698|79337155|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
44332180|NCT01335698|79337156|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
44332181|NCT01335698|79337157|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
44332182|NCT01335698|79337158|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
44429762|NCT00576732|79437946|FG002|DOUBLE BLIND|Protocol Violation|0|||
44429763|NCT00576732|79437947|FG003|DOUBLE BLIND|Protocol Violation|0|||
44429764|NCT00576732|79437948|FG004|DOUBLE BLIND|Protocol Violation|0|||
44429765|NCT00576732|79437949|FG005|DOUBLE BLIND|Protocol Violation|0|||
44429766|NCT00576732|79437944|FG000|OPEN LABEL|Adverse Event|0|||
44429767|NCT00576732|79437945|FG001|OPEN LABEL|Adverse Event|0|||
44429768|NCT00576732|79437946|FG002|OPEN LABEL|Adverse Event|0|||
44429769|NCT00576732|79437947|FG003|OPEN LABEL|Adverse Event|4|||
44429770|NCT00576732|79437948|FG004|OPEN LABEL|Adverse Event|0|||
44429771|NCT00576732|79437949|FG005|OPEN LABEL|Adverse Event|1|||
44429772|NCT00576732|79437944|FG000|OPEN LABEL|Lost to Follow-up|0|||
44429773|NCT00576732|79437945|FG001|OPEN LABEL|Lost to Follow-up|0|||
44429774|NCT00576732|79437946|FG002|OPEN LABEL|Lost to Follow-up|0|||
44429775|NCT00576732|79437947|FG003|OPEN LABEL|Lost to Follow-up|2|||
44429776|NCT00576732|79437948|FG004|OPEN LABEL|Lost to Follow-up|1|||
44429777|NCT00576732|79437949|FG005|OPEN LABEL|Lost to Follow-up|1|||
44429778|NCT00576732|79437944|FG000|OPEN LABEL|Withdrawal by Subject|0|||
44429779|NCT00576732|79437945|FG001|OPEN LABEL|Withdrawal by Subject|0|||
44429780|NCT00576732|79437946|FG002|OPEN LABEL|Withdrawal by Subject|0|||
44429781|NCT00576732|79437947|FG003|OPEN LABEL|Withdrawal by Subject|1|||
44429782|NCT00576732|79437948|FG004|OPEN LABEL|Withdrawal by Subject|0|||
44429783|NCT00576732|79437949|FG005|OPEN LABEL|Withdrawal by Subject|1|||
44429784|NCT00576732|79437944|FG000|OPEN LABEL|OTHER|0|||
44429785|NCT00576732|79437945|FG001|OPEN LABEL|OTHER|0|||
44429786|NCT00576732|79437946|FG002|OPEN LABEL|OTHER|0|||
44429787|NCT00576732|79437947|FG003|OPEN LABEL|OTHER|0|||
44429788|NCT00576732|79437948|FG004|OPEN LABEL|OTHER|0|||
44429789|NCT00576732|79437949|FG005|OPEN LABEL|OTHER|2|||
44429790|NCT00576732|79437944|FG000|OPEN LABEL|Lack of Efficacy|0|||
44429791|NCT00576732|79437945|FG001|OPEN LABEL|Lack of Efficacy|0|||
44429792|NCT00576732|79437946|FG002|OPEN LABEL|Lack of Efficacy|0|||
44429793|NCT00576732|79437947|FG003|OPEN LABEL|Lack of Efficacy|2|||
44429794|NCT00576732|79437948|FG004|OPEN LABEL|Lack of Efficacy|2|||
44429795|NCT00576732|79437949|FG005|OPEN LABEL|Lack of Efficacy|3|||
44429796|NCT00576732|79437944|FG000|OPEN LABEL|Protocol Violation|0|||
44429797|NCT00576732|79437945|FG001|OPEN LABEL|Protocol Violation|0|||
44429798|NCT00576732|79437946|FG002|OPEN LABEL|Protocol Violation|0|||
44429799|NCT00576732|79437947|FG003|OPEN LABEL|Protocol Violation|2|||
44429800|NCT00576732|79437948|FG004|OPEN LABEL|Protocol Violation|1|||
44429801|NCT00576732|79437949|FG005|OPEN LABEL|Protocol Violation|0|||
44429802|NCT00697788|79437961|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44429803|NCT00697788|79437962|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
44429804|NCT00697788|79437963|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44429805|NCT00697788|79437964|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44538319|NCT02871778|79549182|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
44538320|NCT02871778|79549183|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44429806|NCT00697788|79437965|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44429807|NCT00697788|79437966|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44429808|NCT00697788|79437967|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44429809|NCT00697788|79437968|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
44429810|NCT00697788|79437961|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44429811|NCT00697788|79437962|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44429812|NCT00697788|79437963|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44538321|NCT02871778|79549184|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44538322|NCT02871778|79549185|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44538323|NCT02871778|79549186|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44332183|NCT01335698|79337159|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
44429813|NCT00697788|79437964|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44429814|NCT00697788|79437965|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
44538324|NCT02871778|79549187|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
44429815|NCT00697788|79437966|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44429816|NCT00697788|79437967|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44332184|NCT01335698|79337155|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
44429817|NCT00697788|79437968|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
44429818|NCT00400153|79437998|FG000|Overall Study|AE due to study disease worsening|14|||
44429819|NCT00400153|79437999|FG001|Overall Study|AE due to study disease worsening|19|||
44429820|NCT00400153|79438000|FG002|Overall Study|AE due to study disease worsening|20|||
44429821|NCT00400153|79437998|FG000|Overall Study|AE due to other disease worsening|2|||
44429822|NCT00400153|79437999|FG001|Overall Study|AE due to other disease worsening|1|||
44429823|NCT00400153|79438000|FG002|Overall Study|AE due to other disease worsening|0|||
44429824|NCT00400153|79437998|FG000|Overall Study|AE due to other condition|3|||
44429825|NCT00400153|79437999|FG001|Overall Study|AE due to other condition|14|||
44429826|NCT00400153|79438000|FG002|Overall Study|AE due to other condition|15|||
44429827|NCT00400153|79437998|FG000|Overall Study|Protocol Violation|7|||
44429828|NCT00400153|79437999|FG001|Overall Study|Protocol Violation|4|||
44429829|NCT00400153|79438000|FG002|Overall Study|Protocol Violation|9|||
44429830|NCT00400153|79437998|FG000|Overall Study|Lost to Follow-up|2|||
44429831|NCT00400153|79437999|FG001|Overall Study|Lost to Follow-up|1|||
44429832|NCT00400153|79438000|FG002|Overall Study|Lost to Follow-up|4|||
44429833|NCT00400153|79437998|FG000|Overall Study|Withdrawal by Subject|12|||
44429834|NCT00400153|79437999|FG001|Overall Study|Withdrawal by Subject|11|||
44429835|NCT00400153|79438000|FG002|Overall Study|Withdrawal by Subject|10|||
44429836|NCT00400153|79437998|FG000|Overall Study|Other reasons - not mentioned above|8|||
44538325|NCT02871778|79549180|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
44538326|NCT02871778|79549181|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
44538327|NCT02871778|79549182|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
44538328|NCT02871778|79549183|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
44538329|NCT02871778|79549184|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
44538330|NCT02871778|79549185|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
44429837|NCT00400153|79437999|FG001|Overall Study|Other reasons - not mentioned above|5|||
44429838|NCT00400153|79438000|FG002|Overall Study|Other reasons - not mentioned above|3|||
44429839|NCT00631917|79438015|FG000|Overall Study|Adverse Event|34|||
44429840|NCT00631917|79438016|FG001|Overall Study|Adverse Event|45|||
44429841|NCT00631917|79438015|FG000|Overall Study|Abnormal laboratory value(s)|2|||
44429842|NCT00631917|79438016|FG001|Overall Study|Abnormal laboratory value(s)|1|||
44429843|NCT00631917|79438015|FG000|Overall Study|Abnormal test procedure result(s)|3|||
44429844|NCT00631917|79438016|FG001|Overall Study|Abnormal test procedure result(s)|2|||
44429845|NCT00631917|79438015|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
44429846|NCT00631917|79438016|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
44429847|NCT00631917|79438015|FG000|Overall Study|No longer required study drug|0|||
44429848|NCT00631917|79438016|FG001|Overall Study|No longer required study drug|1|||
44429849|NCT00631917|79438015|FG000|Overall Study|Protocol deviation|6|||
44429850|NCT00631917|79438016|FG001|Overall Study|Protocol deviation|5|||
44429851|NCT00631917|79438015|FG000|Overall Study|Subject withdrew consent|25|||
44538331|NCT02871778|79549186|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
44538332|NCT02871778|79549187|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
44538333|NCT02871778|79549180|FG000|Part A: Treatment Period 2|Adverse Event|2|||
44538334|NCT02871778|79549181|FG001|Part A: Treatment Period 2|Adverse Event|2|||
44538335|NCT02871778|79549182|FG002|Part A: Treatment Period 2|Adverse Event|0|||
44538336|NCT02871778|79549183|FG003|Part A: Treatment Period 2|Adverse Event|0|||
44538337|NCT02871778|79549184|FG004|Part A: Treatment Period 2|Adverse Event|0|||
44538338|NCT02871778|79549185|FG005|Part A: Treatment Period 2|Adverse Event|0|||
44538339|NCT02871778|79549186|FG006|Part A: Treatment Period 2|Adverse Event|0|||
44538340|NCT02871778|79549187|FG007|Part A: Treatment Period 2|Adverse Event|0|||
44538341|NCT02871778|79549180|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
44538342|NCT02871778|79549181|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
44538343|NCT02871778|79549182|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
44538344|NCT02871778|79549183|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
44157107|NCT01773421|78948629|FG000|Extension Phase|Other|0|||
44332185|NCT01335698|79337156|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
44332186|NCT01335698|79337157|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
44332187|NCT01335698|79337158|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
44332188|NCT01335698|79337159|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
44332189|NCT01335698|79337155|FG000|Treatment Stage 2|Lost to Follow-up|1|||
44258969|NCT01395524|79114827|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44258970|NCT01395524|79114825|FG000|Overall Study|Withdrawal by Subject|4|||
44429852|NCT00631917|79438016|FG001|Overall Study|Subject withdrew consent|33|||
44258971|NCT01395524|79114826|FG001|Overall Study|Withdrawal by Subject|8|||
44258972|NCT01395524|79114827|FG002|Overall Study|Withdrawal by Subject|8|||
44258973|NCT01395524|79114825|FG000|Overall Study|Did not receive treatment|1|||
44258974|NCT01395524|79114826|FG001|Overall Study|Did not receive treatment|1|||
44258975|NCT01395524|79114827|FG002|Overall Study|Did not receive treatment|3|||
44258976|NCT01395524|79114825|FG000|Overall Study|Subject had spinal surgery|0|||
44429853|NCT00631917|79438015|FG000|Overall Study|Lost to Follow-up|7|||
44429854|NCT00631917|79438016|FG001|Overall Study|Lost to Follow-up|7|||
44429855|NCT00631917|79438015|FG000|Overall Study|Administrative problems|2|||
44429856|NCT00631917|79438016|FG001|Overall Study|Administrative problems|0|||
44429857|NCT00631917|79438015|FG000|Overall Study|Death|1|||
44538345|NCT02871778|79549184|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
44429858|NCT00631917|79438016|FG001|Overall Study|Death|0|||
44429859|NCT00419341|79438033|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
44429860|NCT00419341|79438033|FG000|Wash in/Wash Out Period|Adverse Event|2|||
44429861|NCT00419341|79438033|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
44429862|NCT00419341|79438033|FG000|Efficacy Period|Withdrawal by Subject|6|||
44429863|NCT00419341|79438033|FG000|Efficacy Period|Protocol Violation|1|||
44429864|NCT00419341|79438033|FG000|Efficacy Period|Lost to Follow-up|1|||
44429865|NCT00419341|79438033|FG000|Efficacy Period|Non-compliance|1|||
44429866|NCT00419341|79438033|FG000|Efficacy Period|Termination of study site|1|||
44429867|NCT00694122|79438039|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
44429868|NCT00694122|79438040|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
44429869|NCT00694122|79438039|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
44429870|NCT00694122|79438040|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
44429871|NCT00694122|79438039|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
44429872|NCT00694122|79438040|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
44429873|NCT03922620|79438053|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
44429874|NCT03922620|79438054|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
44429875|NCT00419263|79438063|FG000|Overall Study|Lost to Follow-up|2|||
44429876|NCT00419263|79438064|FG001|Overall Study|Lost to Follow-up|1|||
44429877|NCT00419263|79438065|FG002|Overall Study|Lost to Follow-up|1|||
44429878|NCT00419263|79438063|FG000|Overall Study|Randomized in Error, Not Treated|1|||
44429879|NCT00419263|79438064|FG001|Overall Study|Randomized in Error, Not Treated|1|||
44429880|NCT00419263|79438065|FG002|Overall Study|Randomized in Error, Not Treated|0|||
44429881|NCT00419263|79438063|FG000|Overall Study|Adverse Event|0|||
44258977|NCT01395524|79114826|FG001|Overall Study|Subject had spinal surgery|0|||
44258978|NCT01395524|79114827|FG002|Overall Study|Subject had spinal surgery|1|||
44258979|NCT01395368|79114835|FG000|Overall Study|Physician Decision|14|||
44258980|NCT01395368|79114835|FG000|Overall Study|Withdrawal by Subject|2|||
44258981|NCT01394978|79114842|FG000|Overall Study|Withdrawal by Subject|2|||
44258982|NCT01394978|79114843|FG001|Overall Study|Withdrawal by Subject|4|||
44258983|NCT01394978|79114842|FG000|Overall Study|Lost to Follow-up|13|||
44258984|NCT01394978|79114843|FG001|Overall Study|Lost to Follow-up|20|||
44258985|NCT01394978|79114842|FG000|Overall Study|Death|6|||
44258986|NCT01394978|79114843|FG001|Overall Study|Death|7|||
44258987|NCT01394276|79114850|FG000|Overall Study|Related Adverse event (AEs)|15|||
44258988|NCT01394276|79114850|FG000|Overall Study|Not related AEs|9|||
44258989|NCT01394276|79114850|FG000|Overall Study|Remission of disease|2|||
44258990|NCT01394276|79114850|FG000|Overall Study|Insufficient therapeutic effect|17|||
44258991|NCT01394276|79114850|FG000|Overall Study|Insufficient compliance|9|||
44332190|NCT01335698|79337156|FG001|Treatment Stage 2|Lost to Follow-up|0|||
44332191|NCT01335698|79337157|FG002|Treatment Stage 2|Lost to Follow-up|0|||
44332192|NCT01335698|79337158|FG003|Treatment Stage 2|Lost to Follow-up|0|||
44332193|NCT01335698|79337159|FG004|Treatment Stage 2|Lost to Follow-up|0|||
44332194|NCT01335698|79337155|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
44332195|NCT01335698|79337156|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
44332196|NCT01335698|79337157|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
44332197|NCT01335698|79337158|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
44332198|NCT01335698|79337159|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
44332199|NCT01335698|79337155|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
44332200|NCT01335698|79337156|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
44332201|NCT01335698|79337157|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
44332202|NCT01335698|79337158|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
44332203|NCT01335698|79337159|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
44332204|NCT01335698|79337155|FG000|Treatment Stage 2|Switched to another formulation|1|||
44332205|NCT01335698|79337156|FG001|Treatment Stage 2|Switched to another formulation|1|||
44332206|NCT01335698|79337157|FG002|Treatment Stage 2|Switched to another formulation|0|||
44332207|NCT01335698|79337158|FG003|Treatment Stage 2|Switched to another formulation|0|||
44332208|NCT01335698|79337159|FG004|Treatment Stage 2|Switched to another formulation|0|||
44332209|NCT00107120|79337175|FG000|Overall Study|Adverse Event|4|||
44332210|NCT00107120|79337176|FG001|Overall Study|Adverse Event|1|||
44332211|NCT00107120|79337175|FG000|Overall Study|Lack of Efficacy|5|||
44332212|NCT00107120|79337176|FG001|Overall Study|Lack of Efficacy|5|||
44332213|NCT00107120|79337175|FG000|Overall Study|Protocol Violation|3|||
44332214|NCT00107120|79337176|FG001|Overall Study|Protocol Violation|0|||
44332215|NCT00107120|79337175|FG000|Overall Study|Withdrawal by Subject|8|||
44332216|NCT00107120|79337176|FG001|Overall Study|Withdrawal by Subject|9|||
44332217|NCT00107120|79337175|FG000|Overall Study|Lost to Follow-up|8|||
44332218|NCT00107120|79337176|FG001|Overall Study|Lost to Follow-up|6|||
44332219|NCT00107120|79337175|FG000|Overall Study|Pregnancy|0|||
44332220|NCT00107120|79337176|FG001|Overall Study|Pregnancy|1|||
44332221|NCT00107120|79337175|FG000|Overall Study|moving away from site|1|||
44332222|NCT00107120|79337176|FG001|Overall Study|moving away from site|1|||
44258992|NCT01394276|79114850|FG000|Overall Study|Lost to Follow-up|5|||
44429882|NCT00419263|79438064|FG001|Overall Study|Adverse Event|0|||
44429883|NCT00419263|79438065|FG002|Overall Study|Adverse Event|1|||
44429884|NCT00419263|79438063|FG000|Overall Study|Withdrawal by Subject|0|||
44429885|NCT00419263|79438064|FG001|Overall Study|Withdrawal by Subject|0|||
44429886|NCT00419263|79438065|FG002|Overall Study|Withdrawal by Subject|1|||
44429887|NCT00399763|79438076|FG000|Overall Study|Lost to Follow-up|2|||
44429888|NCT00399763|79438077|FG001|Overall Study|Lost to Follow-up|3|||
44429889|NCT00699842|79438086|FG000|Overall Study|Death|0|||
44429890|NCT00699842|79438087|FG001|Overall Study|Death|1|||
44429891|NCT00699842|79438088|FG002|Overall Study|Death|0|||
44429892|NCT00399529|79438096|FG000|Overall Study|Off Study Prior to Treatment|2|||
44429893|NCT00712712|79438101|FG000|Overall Study|Protocol Violation|11|||
44429894|NCT00712712|79438101|FG000|Overall Study|Radiofrequency not done|3|||
44429895|NCT00712712|79438101|FG000|Overall Study|Death|8|||
44429896|NCT00712712|79438101|FG000|Overall Study|Withdrawal by Subject|1|||
44332223|NCT00107120|79337175|FG000|Overall Study|death of parent|0|||
44332224|NCT00107120|79337176|FG001|Overall Study|death of parent|1|||
44332225|NCT01335464|79337184|FG000|Overall Study|Adverse Event|15|||
44332226|NCT01335464|79337185|FG001|Overall Study|Adverse Event|25|||
44332227|NCT01335464|79337184|FG000|Overall Study|Non compliant with protocol|2|||
44332228|NCT01335464|79337185|FG001|Overall Study|Non compliant with protocol|0|||
44332229|NCT01335464|79337184|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
44429897|NCT00411151|79438105|FG000|Overall Study|Death|38|||
44429898|NCT00411151|79438105|FG000|Overall Study|Withdrawal by Subject|2|||
44429899|NCT00411151|79438105|FG000|Overall Study|Lost to Follow-up|2|||
44429900|NCT00411151|79438105|FG000|Overall Study|Protocol Violation|1|||
44332230|NCT01335464|79337185|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
44332231|NCT01335464|79337184|FG000|Overall Study|Not treated|2|||
44429901|NCT00411151|79438105|FG000|Overall Study|Trial prematurely closed|4|||
44429902|NCT00607048|79438111|FG000|Overall Study|Adverse Event|0|||
44429903|NCT00607048|79438112|FG001|Overall Study|Adverse Event|1|||
44429904|NCT00607048|79438113|FG002|Overall Study|Adverse Event|0|||
44429905|NCT00607048|79438114|FG003|Overall Study|Adverse Event|0|||
44429906|NCT00607048|79438115|FG004|Overall Study|Adverse Event|4|||
44429907|NCT00607048|79438116|FG005|Overall Study|Adverse Event|0|||
44429908|NCT00607048|79438111|FG000|Overall Study|Global deterioration of health|1|||
44429909|NCT00607048|79438112|FG001|Overall Study|Global deterioration of health|0|||
44429910|NCT00607048|79438113|FG002|Overall Study|Global deterioration of health|0|||
44429911|NCT00607048|79438114|FG003|Overall Study|Global deterioration of health|0|||
44429912|NCT00607048|79438115|FG004|Overall Study|Global deterioration of health|0|||
44429913|NCT00607048|79438116|FG005|Overall Study|Global deterioration of health|0|||
44429914|NCT00607048|79438111|FG000|Overall Study|Objective disease progression - relapse|1|||
44429915|NCT00607048|79438112|FG001|Overall Study|Objective disease progression - relapse|2|||
44429916|NCT00607048|79438113|FG002|Overall Study|Objective disease progression - relapse|4|||
44429917|NCT00607048|79438114|FG003|Overall Study|Objective disease progression - relapse|2|||
44429918|NCT00607048|79438115|FG004|Overall Study|Objective disease progression - relapse|2|||
44429919|NCT00607048|79438116|FG005|Overall Study|Objective disease progression - relapse|2|||
44429920|NCT00607048|79438111|FG000|Overall Study|Withdrawal by Subject|0|||
44429921|NCT00607048|79438112|FG001|Overall Study|Withdrawal by Subject|0|||
44429922|NCT00607048|79438113|FG002|Overall Study|Withdrawal by Subject|0|||
44429923|NCT00607048|79438114|FG003|Overall Study|Withdrawal by Subject|1|||
44429924|NCT00607048|79438115|FG004|Overall Study|Withdrawal by Subject|0|||
44429925|NCT00607048|79438116|FG005|Overall Study|Withdrawal by Subject|2|||
44429926|NCT00607048|79438111|FG000|Overall Study|Other|1|||
44429927|NCT00607048|79438112|FG001|Overall Study|Other|1|||
44538346|NCT02871778|79549185|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
44538347|NCT02871778|79549186|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
44538348|NCT02871778|79549187|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
44538349|NCT02871778|79549180|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
44332232|NCT01335464|79337185|FG001|Overall Study|Not treated|0|||
44332233|NCT01335464|79337184|FG000|Overall Study|Reason other than those stated above|1|||
44332234|NCT01335464|79337185|FG001|Overall Study|Reason other than those stated above|1|||
44332235|NCT00107042|79337193|FG000|Overall Study|Lost to Follow-up|9|||
44332236|NCT00107042|79337194|FG001|Overall Study|Lost to Follow-up|7|||
44332237|NCT00107042|79337193|FG000|Overall Study|Withdrawal by Subject|6|||
44429928|NCT00607048|79438113|FG002|Overall Study|Other|0|||
44538350|NCT02871778|79549181|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
44538351|NCT02871778|79549182|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
44332238|NCT00107042|79337194|FG001|Overall Study|Withdrawal by Subject|1|||
44332239|NCT00107042|79337193|FG000|Overall Study|Moved out of area|5|||
44332240|NCT00107042|79337194|FG001|Overall Study|Moved out of area|3|||
44332241|NCT00107042|79337193|FG000|Overall Study|Pregnancy|1|||
44429929|NCT00607048|79438114|FG003|Overall Study|Other|0|||
44429930|NCT00607048|79438115|FG004|Overall Study|Other|0|||
44429931|NCT00607048|79438116|FG005|Overall Study|Other|1|||
44429932|NCT00699608|79438132|FG000|First Intervention|Withdrawal by Subject|0|||
44332242|NCT00107042|79337194|FG001|Overall Study|Pregnancy|1|||
44332243|NCT00107042|79337193|FG000|Overall Study|Inadvertent enrollment|0|||
44332244|NCT00107042|79337194|FG001|Overall Study|Inadvertent enrollment|1|||
44332245|NCT00107042|79337193|FG000|Overall Study|vaccinated outside window|1|||
44332246|NCT00107042|79337194|FG001|Overall Study|vaccinated outside window|1|||
44332247|NCT00107042|79337193|FG000|Overall Study|Disallowed medications|0|||
44332248|NCT00107042|79337194|FG001|Overall Study|Disallowed medications|2|||
44332249|NCT00106964|79337245|FG000|Overall Study|Lost to Follow-up|8|||
44332250|NCT00106964|79337246|FG001|Overall Study|Lost to Follow-up|6|||
44332251|NCT00106964|79337247|FG002|Overall Study|Lost to Follow-up|2|||
44332252|NCT00106964|79337245|FG000|Overall Study|Pregnancy|2|||
44332253|NCT00106964|79337246|FG001|Overall Study|Pregnancy|3|||
44332254|NCT00106964|79337247|FG002|Overall Study|Pregnancy|2|||
44332255|NCT00106964|79337245|FG000|Overall Study|Death|1|||
44332256|NCT00106964|79337246|FG001|Overall Study|Death|1|||
44332257|NCT00106964|79337247|FG002|Overall Study|Death|0|||
44332258|NCT00106964|79337245|FG000|Overall Study|Incarceration|0|||
44332259|NCT00106964|79337246|FG001|Overall Study|Incarceration|1|||
44332260|NCT00106964|79337247|FG002|Overall Study|Incarceration|0|||
44332261|NCT00106964|79337245|FG000|Overall Study|Site Funding Terminated|0|||
44332262|NCT00106964|79337246|FG001|Overall Study|Site Funding Terminated|1|||
44332263|NCT00106964|79337247|FG002|Overall Study|Site Funding Terminated|1|||
44332264|NCT00106964|79337245|FG000|Overall Study|Failure to adhere|2|||
44332265|NCT00106964|79337246|FG001|Overall Study|Failure to adhere|0|||
44332266|NCT00106964|79337247|FG002|Overall Study|Failure to adhere|0|||
44332267|NCT00106964|79337245|FG000|Overall Study|Did not meet eligibility criteria|0|||
44332268|NCT00106964|79337246|FG001|Overall Study|Did not meet eligibility criteria|2|||
44332269|NCT00106964|79337247|FG002|Overall Study|Did not meet eligibility criteria|2|||
44332270|NCT00106964|79337245|FG000|Overall Study|Required disallowed medication|0|||
44332271|NCT00106964|79337246|FG001|Overall Study|Required disallowed medication|1|||
44332272|NCT00106964|79337247|FG002|Overall Study|Required disallowed medication|0|||
44332273|NCT00106184|79337266|FG000|Overall Study|Withdrawal by Subject|3|||
44332274|NCT00106184|79337267|FG001|Overall Study|Withdrawal by Subject|2|||
44332275|NCT01334918|79337277|FG000|Overall Study|Did not receive study drug|6|||
44332276|NCT01334918|79337278|FG001|Overall Study|Did not receive study drug|0|||
44332277|NCT01334918|79337277|FG000|Overall Study|Adverse Event|2|||
44332278|NCT01334918|79337278|FG001|Overall Study|Adverse Event|0|||
44332279|NCT01334918|79337277|FG000|Overall Study|Withdrawal by Subject|0|||
44332280|NCT01334918|79337278|FG001|Overall Study|Withdrawal by Subject|1|||
44332281|NCT01332968|79337297|FG000|Induction Period|Adverse Event|23|||
44332282|NCT01332968|79337298|FG001|Induction Period|Adverse Event|26|||
44332283|NCT01332968|79337299|FG002|Induction Period|Adverse Event|0|||
44332284|NCT01332968|79337300|FG003|Induction Period|Adverse Event|0|||
44332285|NCT01332968|79337301|FG004|Induction Period|Adverse Event|0|||
44332286|NCT01332968|79337302|FG005|Induction Period|Adverse Event|0|||
44332287|NCT01332968|79337303|FG006|Induction Period|Adverse Event|0|||
44332288|NCT01332968|79337304|FG007|Induction Period|Adverse Event|0|||
44332289|NCT01332968|79337297|FG000|Induction Period|Death|1|||
44332290|NCT01332968|79337298|FG001|Induction Period|Death|4|||
44332291|NCT01332968|79337299|FG002|Induction Period|Death|0|||
44332292|NCT01332968|79337300|FG003|Induction Period|Death|0|||
44332293|NCT01332968|79337301|FG004|Induction Period|Death|0|||
44332294|NCT01332968|79337302|FG005|Induction Period|Death|0|||
44332295|NCT01332968|79337303|FG006|Induction Period|Death|0|||
44332296|NCT01332968|79337304|FG007|Induction Period|Death|0|||
44332297|NCT01332968|79337297|FG000|Induction Period|Non-compliance|1|||
44332298|NCT01332968|79337298|FG001|Induction Period|Non-compliance|0|||
44332299|NCT01332968|79337299|FG002|Induction Period|Non-compliance|0|||
44429933|NCT00699608|79438133|FG001|First Intervention|Withdrawal by Subject|0|||
44429934|NCT00699608|79438134|FG002|First Intervention|Withdrawal by Subject|1|||
44429935|NCT00699608|79438135|FG003|First Intervention|Withdrawal by Subject|0|||
44258993|NCT01394276|79114850|FG000|Overall Study|Participant moved to another site|1|||
44258994|NCT01394276|79114850|FG000|Overall Study|Pregnancy|1|||
44258995|NCT01394276|79114850|FG000|Overall Study|unavailability of drug at the Hospital|2|||
44258996|NCT01394276|79114850|FG000|Overall Study|Symptoms of concurrent diseases|1|||
44258997|NCT00211172|79114950|FG000|Overall Study|Died or lost health plan eligibility|39|||
44258998|NCT00211172|79114951|FG001|Overall Study|Died or lost health plan eligibility|32|||
44258999|NCT00210626|79115002|FG000|Overall Study|Adverse Event|1|||
44332300|NCT01332968|79337300|FG003|Induction Period|Non-compliance|0|||
44332301|NCT01332968|79337301|FG004|Induction Period|Non-compliance|0|||
44332302|NCT01332968|79337302|FG005|Induction Period|Non-compliance|0|||
44332303|NCT01332968|79337303|FG006|Induction Period|Non-compliance|0|||
44332304|NCT01332968|79337304|FG007|Induction Period|Non-compliance|0|||
44332305|NCT01332968|79337297|FG000|Induction Period|Other|2|||
44332306|NCT01332968|79337298|FG001|Induction Period|Other|2|||
44332307|NCT01332968|79337299|FG002|Induction Period|Other|0|||
44332308|NCT01332968|79337300|FG003|Induction Period|Other|0|||
44332309|NCT01332968|79337301|FG004|Induction Period|Other|0|||
44332310|NCT01332968|79337302|FG005|Induction Period|Other|0|||
44332311|NCT01332968|79337303|FG006|Induction Period|Other|0|||
44332312|NCT01332968|79337304|FG007|Induction Period|Other|0|||
44332313|NCT01332968|79337297|FG000|Induction Period|Physician Decision|6|||
44332314|NCT01332968|79337298|FG001|Induction Period|Physician Decision|1|||
44332315|NCT01332968|79337299|FG002|Induction Period|Physician Decision|0|||
44332316|NCT01332968|79337300|FG003|Induction Period|Physician Decision|0|||
44332317|NCT01332968|79337301|FG004|Induction Period|Physician Decision|0|||
44332318|NCT01332968|79337302|FG005|Induction Period|Physician Decision|0|||
44332319|NCT01332968|79337303|FG006|Induction Period|Physician Decision|0|||
44332320|NCT01332968|79337304|FG007|Induction Period|Physician Decision|0|||
44332321|NCT01332968|79337297|FG000|Induction Period|Progressive Disease|15|||
44332322|NCT01332968|79337298|FG001|Induction Period|Progressive Disease|7|||
44332323|NCT01332968|79337299|FG002|Induction Period|Progressive Disease|0|||
44332324|NCT01332968|79337300|FG003|Induction Period|Progressive Disease|0|||
44332325|NCT01332968|79337301|FG004|Induction Period|Progressive Disease|0|||
44332326|NCT01332968|79337302|FG005|Induction Period|Progressive Disease|0|||
44332327|NCT01332968|79337303|FG006|Induction Period|Progressive Disease|0|||
44332328|NCT01332968|79337304|FG007|Induction Period|Progressive Disease|0|||
44332329|NCT01332968|79337297|FG000|Induction Period|Protocol Violation|3|||
44332330|NCT01332968|79337298|FG001|Induction Period|Protocol Violation|4|||
44332331|NCT01332968|79337299|FG002|Induction Period|Protocol Violation|0|||
44332332|NCT01332968|79337300|FG003|Induction Period|Protocol Violation|0|||
44332333|NCT01332968|79337301|FG004|Induction Period|Protocol Violation|0|||
44332334|NCT01332968|79337302|FG005|Induction Period|Protocol Violation|0|||
44332335|NCT01332968|79337303|FG006|Induction Period|Protocol Violation|0|||
44332336|NCT01332968|79337304|FG007|Induction Period|Protocol Violation|0|||
44332337|NCT01332968|79337297|FG000|Induction Period|Withdrawal by Subject|3|||
44332338|NCT01332968|79337298|FG001|Induction Period|Withdrawal by Subject|5|||
44332339|NCT01332968|79337299|FG002|Induction Period|Withdrawal by Subject|0|||
44332340|NCT01332968|79337300|FG003|Induction Period|Withdrawal by Subject|0|||
44332341|NCT01332968|79337301|FG004|Induction Period|Withdrawal by Subject|0|||
44332342|NCT01332968|79337302|FG005|Induction Period|Withdrawal by Subject|0|||
44332343|NCT01332968|79337303|FG006|Induction Period|Withdrawal by Subject|0|||
44332344|NCT01332968|79337304|FG007|Induction Period|Withdrawal by Subject|0|||
44429936|NCT00699608|79438136|FG004|First Intervention|Withdrawal by Subject|0|||
44429937|NCT00699608|79438137|FG005|First Intervention|Withdrawal by Subject|0|||
44429938|NCT00699608|79438132|FG000|First Intervention|Protocol Violation|0|||
44429939|NCT00699608|79438133|FG001|First Intervention|Protocol Violation|0|||
44429940|NCT00699608|79438134|FG002|First Intervention|Protocol Violation|0|||
44429941|NCT00699608|79438135|FG003|First Intervention|Protocol Violation|0|||
44429942|NCT00699608|79438136|FG004|First Intervention|Protocol Violation|1|||
44429943|NCT00699608|79438137|FG005|First Intervention|Protocol Violation|0|||
44429944|NCT00699608|79438132|FG000|Second Intervention|Adverse Event|0|||
44429945|NCT00699608|79438133|FG001|Second Intervention|Adverse Event|0|||
44429946|NCT00699608|79438134|FG002|Second Intervention|Adverse Event|1|||
44429947|NCT00699608|79438135|FG003|Second Intervention|Adverse Event|0|||
44429948|NCT00699608|79438136|FG004|Second Intervention|Adverse Event|0|||
44429949|NCT00699608|79438137|FG005|Second Intervention|Adverse Event|0|||
44429950|NCT00699608|79438132|FG000|Second Intervention|Withdrawal by Subject|0|||
44429951|NCT00699608|79438133|FG001|Second Intervention|Withdrawal by Subject|0|||
44332345|NCT01332968|79337297|FG000|Induction Period|Randomised but not treated|4|||
44332346|NCT01332968|79337298|FG001|Induction Period|Randomised but not treated|7|||
44332347|NCT01332968|79337299|FG002|Induction Period|Randomised but not treated|0|||
44429952|NCT00699608|79438134|FG002|Second Intervention|Withdrawal by Subject|0|||
44429953|NCT00699608|79438135|FG003|Second Intervention|Withdrawal by Subject|1|||
44429954|NCT00699608|79438136|FG004|Second Intervention|Withdrawal by Subject|0|||
44429955|NCT00699608|79438137|FG005|Second Intervention|Withdrawal by Subject|0|||
44429956|NCT03823404|79438148|FG000|Overall Study|Lost to Follow-up|1|||
44429957|NCT03823404|79438149|FG001|Overall Study|Lost to Follow-up|2|||
44429958|NCT03823404|79438150|FG002|Overall Study|Lost to Follow-up|3|||
44429959|NCT03823404|79438148|FG000|Overall Study|Protocol Violation|2|||
44429960|NCT03823404|79438149|FG001|Overall Study|Protocol Violation|0|||
44429961|NCT03823404|79438150|FG002|Overall Study|Protocol Violation|2|||
44429962|NCT03823404|79438148|FG000|Overall Study|Adverse Event|35|||
44332348|NCT01332968|79337300|FG003|Induction Period|Randomised but not treated|0|||
44429963|NCT03823404|79438149|FG001|Overall Study|Adverse Event|38|||
44429964|NCT03823404|79438150|FG002|Overall Study|Adverse Event|8|||
44332349|NCT01332968|79337301|FG004|Induction Period|Randomised but not treated|0|||
44157108|NCT01773421|78948630|FG001|Extension Phase|Other|0|||
44332350|NCT01332968|79337302|FG005|Induction Period|Randomised but not treated|0|||
44332351|NCT01332968|79337303|FG006|Induction Period|Randomised but not treated|0|||
44429965|NCT03823404|79438148|FG000|Overall Study|Withdrawal by Subject|38|||
44429966|NCT03823404|79438149|FG001|Overall Study|Withdrawal by Subject|40|||
44429967|NCT03823404|79438150|FG002|Overall Study|Withdrawal by Subject|35|||
44332352|NCT01332968|79337304|FG007|Induction Period|Randomised but not treated|0|||
44157109|NCT01773421|78948631|FG002|Extension Phase|Other|0|||
44332353|NCT01332968|79337297|FG000|Maintenance/Observation Period|Adverse Event|0|||
44332354|NCT01332968|79337298|FG001|Maintenance/Observation Period|Adverse Event|0|||
44332355|NCT01332968|79337299|FG002|Maintenance/Observation Period|Adverse Event|53|||
44332356|NCT01332968|79337300|FG003|Maintenance/Observation Period|Adverse Event|66|||
44332357|NCT01332968|79337301|FG004|Maintenance/Observation Period|Adverse Event|0|||
44332358|NCT01332968|79337302|FG005|Maintenance/Observation Period|Adverse Event|0|||
44332359|NCT01332968|79337303|FG006|Maintenance/Observation Period|Adverse Event|0|||
44332360|NCT01332968|79337304|FG007|Maintenance/Observation Period|Adverse Event|0|||
44332361|NCT01332968|79337297|FG000|Maintenance/Observation Period|Death|0|||
44332362|NCT01332968|79337298|FG001|Maintenance/Observation Period|Death|0|||
44332363|NCT01332968|79337299|FG002|Maintenance/Observation Period|Death|5|||
44332364|NCT01332968|79337300|FG003|Maintenance/Observation Period|Death|6|||
44332365|NCT01332968|79337301|FG004|Maintenance/Observation Period|Death|0|||
44332366|NCT01332968|79337302|FG005|Maintenance/Observation Period|Death|0|||
44332367|NCT01332968|79337303|FG006|Maintenance/Observation Period|Death|0|||
44332368|NCT01332968|79337304|FG007|Maintenance/Observation Period|Death|0|||
44332369|NCT01332968|79337297|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
44332370|NCT01332968|79337298|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
44429968|NCT03823404|79438148|FG000|Overall Study|Death|4|||
44429969|NCT03823404|79438149|FG001|Overall Study|Death|0|||
44429970|NCT03823404|79438150|FG002|Overall Study|Death|0|||
44429971|NCT03823404|79438148|FG000|Overall Study|Other: Various reasons provided|5|||
44429972|NCT03823404|79438149|FG001|Overall Study|Other: Various reasons provided|5|||
44429973|NCT03823404|79438150|FG002|Overall Study|Other: Various reasons provided|6|||
44429974|NCT00706706|79438158|FG000|Overall Study|Death|53|||
44429975|NCT00706706|79438158|FG000|Overall Study|Lost to Follow-up|7|||
44429976|NCT00706706|79438158|FG000|Overall Study|Study endpoint had reached|45|||
44429977|NCT00410605|79438162|FG000|Overall Study|Adverse Event|12|||
44429978|NCT00410605|79438162|FG000|Overall Study|Physician Decision|3|||
44429979|NCT00410605|79438162|FG000|Overall Study|Withdrawal by Subject|5|||
44429980|NCT00410605|79438162|FG000|Overall Study|Started Non-Protocol Therapy|3|||
44429981|NCT00410605|79438162|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
44429982|NCT00410605|79438162|FG000|Overall Study|Transferred to another Institution|1|||
44429983|NCT00418717|79438166|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
44429984|NCT00418717|79438166|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
44429985|NCT00572572|79438172|FG000|Overall Study|Withdrawal by Subject|3|||
44429986|NCT00572572|79438173|FG001|Overall Study|Withdrawal by Subject|6|||
44429987|NCT00418561|79438182|FG000|Overall Study|Participant's (guardian's) decision|0|||
44429988|NCT00418561|79438183|FG001|Overall Study|Participant's (guardian's) decision|1|||
44429989|NCT00418561|79438184|FG002|Overall Study|Participant's (guardian's) decision|0|||
44429990|NCT00398047|79438192|FG000|Overall Study|all patient progressed before completion|3|||
44429991|NCT00631371|79438199|FG000|Overall Study|Lost to Follow-up|24|||
44429992|NCT00631371|79438200|FG001|Overall Study|Lost to Follow-up|19|||
44429993|NCT00631371|79438199|FG000|Overall Study|Other reason|5|||
44429994|NCT00631371|79438200|FG001|Overall Study|Other reason|12|||
44429995|NCT00631371|79438199|FG000|Overall Study|subject request|38|||
44429996|NCT00631371|79438200|FG001|Overall Study|subject request|45|||
44538352|NCT02871778|79549183|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
44538353|NCT02871778|79549184|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
44538354|NCT02871778|79549185|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
44538355|NCT02871778|79549186|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
44538356|NCT02871778|79549187|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
44538357|NCT02871778|79549180|FG000|Part B: Treatment Period 3|Adverse Event|0|||
44538358|NCT02871778|79549181|FG001|Part B: Treatment Period 3|Adverse Event|0|||
44538359|NCT02871778|79549182|FG002|Part B: Treatment Period 3|Adverse Event|0|||
44538360|NCT02871778|79549183|FG003|Part B: Treatment Period 3|Adverse Event|0|||
44538361|NCT02871778|79549184|FG004|Part B: Treatment Period 3|Adverse Event|1|||
44538362|NCT02871778|79549185|FG005|Part B: Treatment Period 3|Adverse Event|1|||
44538363|NCT02871778|79549186|FG006|Part B: Treatment Period 3|Adverse Event|1|||
44259000|NCT00210626|79115003|FG001|Overall Study|Adverse Event|2|||
44259001|NCT00210626|79115002|FG000|Overall Study|Protocol Violation|1|||
44259002|NCT00210626|79115003|FG001|Overall Study|Protocol Violation|5|||
44259003|NCT00210626|79115002|FG000|Overall Study|Lost to Follow-up|11|||
44259004|NCT00210626|79115003|FG001|Overall Study|Lost to Follow-up|11|||
44259005|NCT00210626|79115002|FG000|Overall Study|Death|1|||
44259006|NCT00210626|79115003|FG001|Overall Study|Death|0|||
44538364|NCT02871778|79549187|FG007|Part B: Treatment Period 3|Adverse Event|0|||
44538365|NCT01471444|79549220|FG000|Overall Study|Physician Decision|3|||
44259007|NCT00210626|79115002|FG000|Overall Study|Withdrawal by Subject|29|||
44259008|NCT00210626|79115003|FG001|Overall Study|Withdrawal by Subject|20|||
44259009|NCT00210626|79115002|FG000|Overall Study|Physician Decision|0|||
44259010|NCT00210626|79115003|FG001|Overall Study|Physician Decision|2|||
44259011|NCT00210626|79115002|FG000|Overall Study|Sponser Request|1|||
44429997|NCT00631371|79438199|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
44429998|NCT00631371|79438200|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
44429999|NCT00631371|79438199|FG000|Overall Study|Death|263|||
44430000|NCT00631371|79438200|FG001|Overall Study|Death|239|||
44430001|NCT00409747|79438206|FG000|Overall Study|Withdrawal by Subject|1|||
44430002|NCT00630747|79438210|FG000|Overall Study|Death|1|||
44430003|NCT00630747|79438210|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
44430004|NCT00630747|79438210|FG000|Overall Study|Returned to country of origin|1|||
44430005|NCT00397891|79438219|FG000|Overall Study|Withdrawal by Subject|1|||
44430006|NCT00397891|79438220|FG001|Overall Study|Withdrawal by Subject|0|||
44430007|NCT00397891|79438221|FG002|Overall Study|Withdrawal by Subject|0|||
44430008|NCT00397891|79438222|FG003|Overall Study|Withdrawal by Subject|0|||
44430009|NCT00397891|79438223|FG004|Overall Study|Withdrawal by Subject|1|||
44430010|NCT00397189|79438237|FG000|3 Weeks Period|Lost to Follow-up|5|||
44430011|NCT00397189|79438238|FG001|3 Weeks Period|Lost to Follow-up|4|||
44430012|NCT00397189|79438237|FG000|3 Weeks Period|Adverse Event|3|||
44430013|NCT00397189|79438238|FG001|3 Weeks Period|Adverse Event|2|||
44430014|NCT00397189|79438237|FG000|3 Weeks Period|Withdrawal by Subject|13|||
44430015|NCT00397189|79438238|FG001|3 Weeks Period|Withdrawal by Subject|9|||
44430016|NCT00397189|79438237|FG000|3 Weeks Period|Physician Decision|0|||
44430017|NCT00397189|79438238|FG001|3 Weeks Period|Physician Decision|2|||
44430018|NCT00397189|79438237|FG000|3 Weeks Period|Protocol Violation|0|||
44430019|NCT00397189|79438238|FG001|3 Weeks Period|Protocol Violation|3|||
44430020|NCT00397189|79438237|FG000|3 Weeks Period|Other|0|||
44430021|NCT00397189|79438238|FG001|3 Weeks Period|Other|2|||
44430022|NCT00606034|79438246|FG000|Overall Study|incarceration|1|||
44430023|NCT00397033|79438255|FG000|Overall Study|Adverse Event|7|||
44430024|NCT00397033|79438256|FG001|Overall Study|Adverse Event|10|||
44430025|NCT00397033|79438257|FG002|Overall Study|Adverse Event|4|||
44430026|NCT00397033|79438255|FG000|Overall Study|Lack of Efficacy|22|||
44430027|NCT00397033|79438256|FG001|Overall Study|Lack of Efficacy|12|||
44430028|NCT00397033|79438257|FG002|Overall Study|Lack of Efficacy|9|||
44430029|NCT00397033|79438255|FG000|Overall Study|Lost to Follow-up|3|||
44430030|NCT00397033|79438256|FG001|Overall Study|Lost to Follow-up|3|||
44430031|NCT00397033|79438257|FG002|Overall Study|Lost to Follow-up|3|||
44430032|NCT00397033|79438255|FG000|Overall Study|Withdrawal by Subject|12|||
44430033|NCT00397033|79438256|FG001|Overall Study|Withdrawal by Subject|7|||
44430034|NCT00397033|79438257|FG002|Overall Study|Withdrawal by Subject|5|||
44430035|NCT00397033|79438255|FG000|Overall Study|Other|0|||
44430036|NCT00397033|79438256|FG001|Overall Study|Other|5|||
44430037|NCT00397033|79438257|FG002|Overall Study|Other|2|||
44430038|NCT00572728|79438265|FG000|Overall Study|Withdrawal by Subject|10|||
44430039|NCT00572728|79438265|FG000|Overall Study|Ineligible|3|||
44430040|NCT00572728|79438265|FG000|Overall Study|Enrolled under Amendment 4|5|||
44430041|NCT00572728|79438265|FG000|Overall Study|Offstudy due to complicating disease|1|||
44430042|NCT00572728|79438265|FG000|Overall Study|FLT1 not completed|4|||
44430043|NCT00572728|79438265|FG000|Overall Study|First Chemotherapy not initiated|2|||
44430044|NCT00572728|79438265|FG000|Overall Study|FLT2 not completed|5|||
44430045|NCT00572728|79438265|FG000|Overall Study|Second chemotherapy not initiated|1|||
44430046|NCT00572728|79438265|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
44430047|NCT00572728|79438265|FG000|Overall Study|Pathology missing|1|||
44430048|NCT00699374|79438273|FG000|Overall Study|Death|93|||
44430049|NCT00699374|79438274|FG001|Overall Study|Death|83|||
44430050|NCT00699374|79438273|FG000|Overall Study|Adverse Event|70|||
44430051|NCT00699374|79438274|FG001|Overall Study|Adverse Event|67|||
44430052|NCT00699374|79438273|FG000|Overall Study|Global deterioration of health status|7|||
44430053|NCT00699374|79438274|FG001|Overall Study|Global deterioration of health status|8|||
44430054|NCT00699374|79438273|FG000|Overall Study|Lost to Follow-up|3|||
44430055|NCT00699374|79438274|FG001|Overall Study|Lost to Follow-up|5|||
44430056|NCT00699374|79438273|FG000|Overall Study|Withdrawal by Subject|34|||
44430057|NCT00699374|79438274|FG001|Overall Study|Withdrawal by Subject|44|||
44430058|NCT00699374|79438273|FG000|Overall Study|Objective progression or relapse|281|||
44430059|NCT00699374|79438274|FG001|Overall Study|Objective progression or relapse|277|||
44430060|NCT00699374|79438273|FG000|Overall Study|Other|18|||
44430061|NCT00699374|79438274|FG001|Overall Study|Other|15|||
44430062|NCT00699374|79438273|FG000|Overall Study|Protocol Violation|2|||
44430063|NCT00699374|79438274|FG001|Overall Study|Protocol Violation|6|||
44430064|NCT00699374|79438273|FG000|Overall Study|Study terminated by sponsor|13|||
44430065|NCT00699374|79438274|FG001|Overall Study|Study terminated by sponsor|28|||
44430066|NCT00699374|79438273|FG000|Overall Study|Randomized but not treated|4|||
44430067|NCT00699374|79438274|FG001|Overall Study|Randomized but not treated|2|||
44430068|NCT00699374|79438273|FG000|Overall Study|Died 28 days after last dose|5|||
44430069|NCT00699374|79438274|FG001|Overall Study|Died 28 days after last dose|9|||
44430070|NCT00606892|79438280|FG000|First Intervention|Protocol Violation|1|||
44430071|NCT00606892|79438281|FG001|First Intervention|Protocol Violation|4|||
44430072|NCT00625443|79438316|FG000|Overall Study|Adverse Event|1|||
44430073|NCT00625443|79438317|FG001|Overall Study|Adverse Event|4|||
44332371|NCT01332968|79337299|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
44332372|NCT01332968|79337300|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
44332373|NCT01332968|79337301|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
44332374|NCT01332968|79337302|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
44332375|NCT01332968|79337303|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
44332376|NCT01332968|79337304|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
44332377|NCT01332968|79337297|FG000|Maintenance/Observation Period|Non-compliance|0|||
44332378|NCT01332968|79337298|FG001|Maintenance/Observation Period|Non-compliance|0|||
44332379|NCT01332968|79337299|FG002|Maintenance/Observation Period|Non-compliance|4|||
44332380|NCT01332968|79337300|FG003|Maintenance/Observation Period|Non-compliance|3|||
44332381|NCT01332968|79337301|FG004|Maintenance/Observation Period|Non-compliance|0|||
44332382|NCT01332968|79337302|FG005|Maintenance/Observation Period|Non-compliance|0|||
44332383|NCT01332968|79337303|FG006|Maintenance/Observation Period|Non-compliance|0|||
44332384|NCT01332968|79337304|FG007|Maintenance/Observation Period|Non-compliance|0|||
44430074|NCT00625443|79438318|FG002|Overall Study|Adverse Event|0|||
44430075|NCT00625443|79438316|FG000|Overall Study|Non-compliance with protocol|0|||
44430076|NCT00625443|79438317|FG001|Overall Study|Non-compliance with protocol|1|||
44430077|NCT00625443|79438318|FG002|Overall Study|Non-compliance with protocol|0|||
44430078|NCT00625443|79438316|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
44430079|NCT00625443|79438317|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
44430080|NCT00625443|79438318|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
44430081|NCT00625443|79438316|FG000|Overall Study|Withdrawal by Subject|0|||
44430082|NCT00625443|79438317|FG001|Overall Study|Withdrawal by Subject|1|||
44430083|NCT00625443|79438318|FG002|Overall Study|Withdrawal by Subject|2|||
44430084|NCT00625443|79438316|FG000|Overall Study|Physician Decision|0|||
44430085|NCT00625443|79438317|FG001|Overall Study|Physician Decision|4|||
44430086|NCT00625443|79438318|FG002|Overall Study|Physician Decision|2|||
44430087|NCT00625443|79438316|FG000|Overall Study|Other|0|||
44430088|NCT00625443|79438317|FG001|Overall Study|Other|1|||
44430089|NCT00625443|79438318|FG002|Overall Study|Other|1|||
44430090|NCT00625365|79438329|FG000|Overall Study|Withdrawal by Subject|1|||
44430091|NCT00625365|79438329|FG000|Overall Study|No IV access|5|||
44430092|NCT00625365|79438329|FG000|Overall Study|VSD|1|||
44430093|NCT00606580|79438336|FG000|Overall Study|Lost to Follow-up|1|||
44430094|NCT00606580|79438337|FG001|Overall Study|Lost to Follow-up|1|||
44430095|NCT00606580|79438338|FG002|Overall Study|Lost to Follow-up|4|||
44430096|NCT00606580|79438336|FG000|Overall Study|Clinical failures|1|||
44430097|NCT00606580|79438337|FG001|Overall Study|Clinical failures|0|||
44538366|NCT01471444|79549221|FG001|Overall Study|Physician Decision|2|||
44538367|NCT01471444|79549220|FG000|Overall Study|Withdrawal by Subject|0|||
44538368|NCT01471444|79549221|FG001|Overall Study|Withdrawal by Subject|1|||
44538369|NCT03443427|79549239|FG000|Overall Study|Adverse Event|2|||
44538370|NCT03443427|79549240|FG001|Overall Study|Adverse Event|3|||
44538371|NCT03443427|79549239|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
44538372|NCT03443427|79549240|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
44538373|NCT03443427|79549239|FG000|Overall Study|Other|4|||
44538374|NCT03443427|79549240|FG001|Overall Study|Other|6|||
44538375|NCT03417219|79549248|FG000|Overall Study|Lost to Follow-up|0|||
44538376|NCT03417219|79549249|FG001|Overall Study|Lost to Follow-up|3|||
44538377|NCT02953821|79549257|FG000|Overall Study|Adverse Event|0|||
44430098|NCT00606580|79438338|FG002|Overall Study|Clinical failures|12|||
44430099|NCT00606580|79438336|FG000|Overall Study|Withdrawal by investigator|0|||
44430100|NCT00606580|79438337|FG001|Overall Study|Withdrawal by investigator|1|||
44538378|NCT02953821|79549258|FG001|Overall Study|Adverse Event|4|||
44538379|NCT02953821|79549257|FG000|Overall Study|Death|1|||
44538380|NCT02953821|79549258|FG001|Overall Study|Death|0|||
44157110|NCT01773421|78948632|FG003|Extension Phase|Other|0|||
44332385|NCT01332968|79337297|FG000|Maintenance/Observation Period|Other|0|||
44332386|NCT01332968|79337298|FG001|Maintenance/Observation Period|Other|0|||
44332387|NCT01332968|79337299|FG002|Maintenance/Observation Period|Other|4|||
44332388|NCT01332968|79337300|FG003|Maintenance/Observation Period|Other|7|||
44430101|NCT00606580|79438338|FG002|Overall Study|Withdrawal by investigator|6|||
44430102|NCT00606580|79438336|FG000|Overall Study|Withdrawal by Subject|0|||
44332389|NCT01332968|79337301|FG004|Maintenance/Observation Period|Other|0|||
44430103|NCT00606580|79438337|FG001|Overall Study|Withdrawal by Subject|1|||
44430104|NCT00606580|79438338|FG002|Overall Study|Withdrawal by Subject|0|||
44430105|NCT00629265|79438348|FG000|Overall Study|Lost to Follow-up|4|||
44430106|NCT00629265|79438349|FG001|Overall Study|Lost to Follow-up|5|||
44538381|NCT02953821|79549257|FG000|Overall Study|Progressive Disease|5|||
44157111|NCT01773421|78948633|FG004|Extension Phase|Other|1|||
44157112|NCT01773421|78948634|FG005|Extension Phase|Other|2|||
44157113|NCT01773421|78948635|FG006|Extension Phase|Other|0|||
44430107|NCT00629265|79438348|FG000|Overall Study|Withdrawal by Subject|11|||
44430108|NCT00629265|79438349|FG001|Overall Study|Withdrawal by Subject|8|||
44538382|NCT02953821|79549258|FG001|Overall Study|Progressive Disease|1|||
44430109|NCT00629265|79438348|FG000|Overall Study|Death|1|||
44430110|NCT00629265|79438349|FG001|Overall Study|Death|0|||
44430111|NCT00629265|79438348|FG000|Overall Study|Adverse Event|2|||
44430112|NCT00629265|79438349|FG001|Overall Study|Adverse Event|0|||
44430113|NCT00629265|79438348|FG000|Overall Study|HNC Recurrence|4|||
44430114|NCT00629265|79438349|FG001|Overall Study|HNC Recurrence|0|||
44430115|NCT00629265|79438348|FG000|Overall Study|Other CA Requiring Treatment|1|||
44430116|NCT00629265|79438349|FG001|Overall Study|Other CA Requiring Treatment|3|||
44430117|NCT00629265|79438348|FG000|Overall Study|Needed Esophageal Dilation|4|||
44430118|NCT00629265|79438349|FG001|Overall Study|Needed Esophageal Dilation|1|||
44430119|NCT00629265|79438348|FG000|Overall Study|Unrelated Medical Complications|3|||
44430120|NCT00629265|79438349|FG001|Overall Study|Unrelated Medical Complications|1|||
44430121|NCT00629265|79438348|FG000|Overall Study|Unknown Reason|2|||
44430122|NCT00629265|79438349|FG001|Overall Study|Unknown Reason|2|||
44430123|NCT00606502|79438357|FG000|Randomization|Randomized but not treated|3|||
44430124|NCT00606502|79438358|FG001|Randomization|Randomized but not treated|0|||
44430125|NCT00606502|79438357|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
44430126|NCT00606502|79438358|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
44430127|NCT00605722|79438364|FG000|Overall Study|Adverse Event|6|||
44430128|NCT00605722|79438364|FG000|Overall Study|Insufficient therapeutic response|44|||
44430129|NCT00605722|79438364|FG000|Overall Study|Failure to return|1|||
44430130|NCT00605566|79438368|FG000|Overall Study|Adverse Event|1|||
44430131|NCT00605566|79438368|FG000|Overall Study|Clinical deterioration|1|||
44430132|NCT00605566|79438368|FG000|Overall Study|Poor compliance in run-in period|1|||
44430133|NCT00396877|79438374|FG000|Overall Study|Lost to Follow-up|2|||
44430134|NCT00396877|79438375|FG001|Overall Study|Lost to Follow-up|1|||
44430135|NCT00396877|79438374|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
44430136|NCT00396877|79438375|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
44430137|NCT00628251|79438384|FG000|Randomised Part|Withdrawal by Subject|0|||
44430138|NCT00628251|79438385|FG001|Randomised Part|Withdrawal by Subject|0|||
44430139|NCT00628251|79438386|FG002|Randomised Part|Withdrawal by Subject|1|||
44430140|NCT00628251|79438384|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
44430141|NCT00628251|79438385|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
44430142|NCT00628251|79438386|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
44430143|NCT00628251|79438384|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
44430144|NCT00628251|79438385|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
44430145|NCT00628251|79438386|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
44538383|NCT02953821|79549257|FG000|Overall Study|Lost to Follow-up|2|||
44157114|NCT01773421|78948629|FG000|Extension Phase|Adverse Event|0|||
44157115|NCT01773421|78948630|FG001|Extension Phase|Adverse Event|0|||
44157116|NCT01773421|78948631|FG002|Extension Phase|Adverse Event|0|||
44157117|NCT01773421|78948632|FG003|Extension Phase|Adverse Event|0|||
44157118|NCT01773421|78948633|FG004|Extension Phase|Adverse Event|2|||
44157119|NCT01773421|78948634|FG005|Extension Phase|Adverse Event|0|||
44157120|NCT01773421|78948635|FG006|Extension Phase|Adverse Event|0|||
44157121|NCT01747486|78948653|FG000|Stage 1|Physician Decision|3|||
44157122|NCT01747486|78948654|FG001|Stage 1|Physician Decision|0|||
44157123|NCT01747486|78948653|FG000|Stage 1|Withdrawal by Subject|4|||
44157124|NCT01747486|78948654|FG001|Stage 1|Withdrawal by Subject|3|||
44157125|NCT01747486|78948653|FG000|Stage 1|Disease progression|4|||
44157126|NCT01747486|78948654|FG001|Stage 1|Disease progression|9|||
44157127|NCT01747486|78948653|FG000|Stage 1|Death|1|||
44157128|NCT01747486|78948654|FG001|Stage 1|Death|1|||
44157129|NCT01747486|78948653|FG000|Stage 2|Physician Decision|2|||
44157130|NCT01747486|78948654|FG001|Stage 2|Physician Decision|0|||
44157131|NCT01747486|78948653|FG000|Stage 2|Withdrawal by Subject|1|||
44157132|NCT01747486|78948654|FG001|Stage 2|Withdrawal by Subject|0|||
44157133|NCT01747486|78948653|FG000|Stage 2|New Cancer Therapy|3|||
44157134|NCT01747486|78948654|FG001|Stage 2|New Cancer Therapy|0|||
44157135|NCT01747486|78948653|FG000|Stage 2|Disease Progression|3|||
44157136|NCT01747486|78948654|FG001|Stage 2|Disease Progression|0|||
44157137|NCT01593254|78948666|FG000|Overall Study|Disease progression|2|||
44157138|NCT01593254|78948667|FG001|Overall Study|Disease progression|7|||
44157139|NCT01593254|78948666|FG000|Overall Study|Study drug toxicity|6|||
44157140|NCT01593254|78948667|FG001|Overall Study|Study drug toxicity|20|||
44157141|NCT01593254|78948666|FG000|Overall Study|Death|3|||
44157142|NCT01593254|78948667|FG001|Overall Study|Death|3|||
44157143|NCT01593254|78948666|FG000|Overall Study|AE unrelated to study drug|0|||
44157144|NCT01593254|78948667|FG001|Overall Study|AE unrelated to study drug|1|||
44157145|NCT01593254|78948666|FG000|Overall Study|participant request to discontinue study treatment|1|||
44430146|NCT00628251|79438384|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
44430147|NCT00628251|79438385|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
44538384|NCT02953821|79549258|FG001|Overall Study|Lost to Follow-up|0|||
44157146|NCT01593254|78948667|FG001|Overall Study|participant request to discontinue study treatment|3|||
44157147|NCT01593254|78948666|FG000|Overall Study|participant withdrew consent|0|||
44430148|NCT00628251|79438386|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
44430149|NCT00628251|79438384|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
44430150|NCT00628251|79438385|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
44430151|NCT00628251|79438386|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
44430152|NCT00628251|79438384|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
44430153|NCT00628251|79438385|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
44430154|NCT00628251|79438386|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
44430155|NCT00625131|79438398|FG000|Overall Study|Lost to Follow-up|3|||
44430156|NCT00625131|79438399|FG001|Overall Study|Lost to Follow-up|2|||
44430157|NCT00625131|79438400|FG002|Overall Study|Lost to Follow-up|0|||
44430158|NCT00625131|79438398|FG000|Overall Study|Withdrawal by Subject|1|||
44430159|NCT00625131|79438399|FG001|Overall Study|Withdrawal by Subject|0|||
44430160|NCT00625131|79438400|FG002|Overall Study|Withdrawal by Subject|5|||
44430161|NCT00408499|79438406|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
44430162|NCT00408499|79438407|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
44430163|NCT00408499|79438408|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
44430164|NCT00408499|79438409|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
44430165|NCT00408499|79438410|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
44430166|NCT00408499|79438406|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
44332390|NCT01332968|79337302|FG005|Maintenance/Observation Period|Other|0|||
44332391|NCT01332968|79337303|FG006|Maintenance/Observation Period|Other|0|||
44332392|NCT01332968|79337304|FG007|Maintenance/Observation Period|Other|0|||
44430167|NCT00408499|79438407|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
44430168|NCT00408499|79438408|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
44430169|NCT00408499|79438409|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
44332393|NCT01332968|79337297|FG000|Maintenance/Observation Period|Physician Decision|0|||
44332394|NCT01332968|79337298|FG001|Maintenance/Observation Period|Physician Decision|0|||
44332395|NCT01332968|79337299|FG002|Maintenance/Observation Period|Physician Decision|14|||
44332396|NCT01332968|79337300|FG003|Maintenance/Observation Period|Physician Decision|19|||
44332397|NCT01332968|79337301|FG004|Maintenance/Observation Period|Physician Decision|0|||
44332398|NCT01332968|79337302|FG005|Maintenance/Observation Period|Physician Decision|1|||
44332399|NCT01332968|79337303|FG006|Maintenance/Observation Period|Physician Decision|0|||
44332400|NCT01332968|79337304|FG007|Maintenance/Observation Period|Physician Decision|0|||
44332401|NCT01332968|79337297|FG000|Maintenance/Observation Period|Progressive Disease|0|||
44332402|NCT01332968|79337298|FG001|Maintenance/Observation Period|Progressive Disease|0|||
44332403|NCT01332968|79337299|FG002|Maintenance/Observation Period|Progressive Disease|72|||
44332404|NCT01332968|79337300|FG003|Maintenance/Observation Period|Progressive Disease|40|||
44332405|NCT01332968|79337301|FG004|Maintenance/Observation Period|Progressive Disease|0|||
44332406|NCT01332968|79337302|FG005|Maintenance/Observation Period|Progressive Disease|0|||
44332407|NCT01332968|79337303|FG006|Maintenance/Observation Period|Progressive Disease|0|||
44332408|NCT01332968|79337304|FG007|Maintenance/Observation Period|Progressive Disease|0|||
44332409|NCT01332968|79337297|FG000|Maintenance/Observation Period|Protocol Violation|0|||
44332410|NCT01332968|79337298|FG001|Maintenance/Observation Period|Protocol Violation|0|||
44332411|NCT01332968|79337299|FG002|Maintenance/Observation Period|Protocol Violation|1|||
44332412|NCT01332968|79337300|FG003|Maintenance/Observation Period|Protocol Violation|1|||
44332413|NCT01332968|79337301|FG004|Maintenance/Observation Period|Protocol Violation|0|||
44332414|NCT01332968|79337302|FG005|Maintenance/Observation Period|Protocol Violation|0|||
44332415|NCT01332968|79337303|FG006|Maintenance/Observation Period|Protocol Violation|0|||
44332416|NCT01332968|79337304|FG007|Maintenance/Observation Period|Protocol Violation|0|||
44332417|NCT01332968|79337297|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
44332418|NCT01332968|79337298|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
44332419|NCT01332968|79337299|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
44332420|NCT01332968|79337300|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
44332421|NCT01332968|79337301|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
44332422|NCT01332968|79337302|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
44332423|NCT01332968|79337303|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
44332424|NCT01332968|79337304|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
44332425|NCT01332968|79337297|FG000|Follow-Up Period|Adverse Event|0|||
44332426|NCT01332968|79337298|FG001|Follow-Up Period|Adverse Event|0|||
44430170|NCT00408499|79438410|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
44430171|NCT00408499|79438406|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
44157148|NCT01593254|78948667|FG001|Overall Study|participant withdrew consent|9|||
44430172|NCT00408499|79438407|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
44157149|NCT01593254|78948666|FG000|Overall Study|lost to follow up|1|||
44157150|NCT01593254|78948667|FG001|Overall Study|lost to follow up|6|||
44430173|NCT00408499|79438408|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
44430174|NCT00408499|79438409|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
44430175|NCT00408499|79438410|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
44430176|NCT00408499|79438406|FG000|Phase II- MTD Expansion|Adverse Event|0|||
44430177|NCT00408499|79438407|FG001|Phase II- MTD Expansion|Adverse Event|0|||
44430178|NCT00408499|79438408|FG002|Phase II- MTD Expansion|Adverse Event|0|||
44430179|NCT00408499|79438409|FG003|Phase II- MTD Expansion|Adverse Event|0|||
44430180|NCT00408499|79438410|FG004|Phase II- MTD Expansion|Adverse Event|9|||
44430181|NCT00408499|79438406|FG000|Phase II- MTD Expansion|Death|0|||
44430182|NCT00408499|79438407|FG001|Phase II- MTD Expansion|Death|0|||
44430183|NCT00408499|79438408|FG002|Phase II- MTD Expansion|Death|0|||
44430184|NCT00408499|79438409|FG003|Phase II- MTD Expansion|Death|0|||
44430185|NCT00408499|79438410|FG004|Phase II- MTD Expansion|Death|2|||
44430186|NCT00408499|79438406|FG000|Phase II- MTD Expansion|Physician Decision|0|||
44430187|NCT00408499|79438407|FG001|Phase II- MTD Expansion|Physician Decision|0|||
44430188|NCT00408499|79438408|FG002|Phase II- MTD Expansion|Physician Decision|0|||
44538385|NCT02953821|79549257|FG000|Overall Study|Physician Decision|1|||
44538386|NCT02953821|79549258|FG001|Overall Study|Physician Decision|1|||
44538387|NCT02953821|79549257|FG000|Overall Study|Withdrawal by Subject|3|||
44538388|NCT02953821|79549258|FG001|Overall Study|Withdrawal by Subject|3|||
44538389|NCT02953821|79549257|FG000|Overall Study|Change of address|0|||
44538390|NCT02953821|79549258|FG001|Overall Study|Change of address|1|||
44538391|NCT02953821|79549257|FG000|Overall Study|Lack of Efficacy|1|||
44538392|NCT02953821|79549258|FG001|Overall Study|Lack of Efficacy|0|||
44538393|NCT02953821|79549257|FG000|Overall Study|Out of state for indeterminate time|0|||
44538394|NCT02953821|79549258|FG001|Overall Study|Out of state for indeterminate time|1|||
44538395|NCT02953821|79549257|FG000|Overall Study|No improvement|0|||
44538396|NCT02953821|79549258|FG001|Overall Study|No improvement|1|||
44538397|NCT02953821|79549257|FG000|Overall Study|Refused follow-up visit|2|||
44538398|NCT02953821|79549258|FG001|Overall Study|Refused follow-up visit|1|||
44538399|NCT03783923|79549268|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
44332427|NCT01332968|79337299|FG002|Follow-Up Period|Adverse Event|0|||
44332428|NCT01332968|79337300|FG003|Follow-Up Period|Adverse Event|0|||
44332429|NCT01332968|79337301|FG004|Follow-Up Period|Adverse Event|0|||
44332430|NCT01332968|79337302|FG005|Follow-Up Period|Adverse Event|0|||
44332431|NCT01332968|79337303|FG006|Follow-Up Period|Adverse Event|0|||
44332432|NCT01332968|79337304|FG007|Follow-Up Period|Adverse Event|4|||
44332433|NCT01332968|79337297|FG000|Follow-Up Period|Death|0|||
44332434|NCT01332968|79337298|FG001|Follow-Up Period|Death|0|||
44332435|NCT01332968|79337299|FG002|Follow-Up Period|Death|0|||
44332436|NCT01332968|79337300|FG003|Follow-Up Period|Death|0|||
44332437|NCT01332968|79337301|FG004|Follow-Up Period|Death|0|||
44332438|NCT01332968|79337302|FG005|Follow-Up Period|Death|0|||
44332439|NCT01332968|79337303|FG006|Follow-Up Period|Death|27|||
44332440|NCT01332968|79337304|FG007|Follow-Up Period|Death|30|||
44332441|NCT01332968|79337297|FG000|Follow-Up Period|Lost to Follow-up|0|||
44332442|NCT01332968|79337298|FG001|Follow-Up Period|Lost to Follow-up|0|||
44332443|NCT01332968|79337299|FG002|Follow-Up Period|Lost to Follow-up|0|||
44332444|NCT01332968|79337300|FG003|Follow-Up Period|Lost to Follow-up|0|||
44332445|NCT01332968|79337301|FG004|Follow-Up Period|Lost to Follow-up|0|||
44538400|NCT03783923|79549269|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
44538401|NCT03783923|79549268|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
44538402|NCT03783923|79549269|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
44538403|NCT03783923|79549268|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
44332446|NCT01332968|79337302|FG005|Follow-Up Period|Lost to Follow-up|0|||
44332447|NCT01332968|79337303|FG006|Follow-Up Period|Lost to Follow-up|11|||
44332448|NCT01332968|79337304|FG007|Follow-Up Period|Lost to Follow-up|15|||
44430189|NCT00408499|79438409|FG003|Phase II- MTD Expansion|Physician Decision|0|||
44430190|NCT00408499|79438410|FG004|Phase II- MTD Expansion|Physician Decision|1|||
44430191|NCT00408499|79438406|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
44430192|NCT00408499|79438407|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
44157151|NCT01593254|78948666|FG000|Overall Study|maximum clinical benefit|1|||
44157152|NCT01593254|78948667|FG001|Overall Study|maximum clinical benefit|2|||
44157153|NCT01593254|78948666|FG000|Overall Study|Poor/non compliance|1|||
44157154|NCT01593254|78948667|FG001|Overall Study|Poor/non compliance|1|||
44332449|NCT01332968|79337297|FG000|Follow-Up Period|Non-compliance|0|||
44332450|NCT01332968|79337298|FG001|Follow-Up Period|Non-compliance|0|||
44430193|NCT00408499|79438408|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
44430194|NCT00408499|79438409|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
44430195|NCT00408499|79438410|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
44430196|NCT00408499|79438406|FG000|Phase II- MTD Expansion|treatment delay|0|||
44430197|NCT00408499|79438407|FG001|Phase II- MTD Expansion|treatment delay|0|||
44430198|NCT00408499|79438408|FG002|Phase II- MTD Expansion|treatment delay|0|||
44430199|NCT00408499|79438409|FG003|Phase II- MTD Expansion|treatment delay|0|||
44430200|NCT00408499|79438410|FG004|Phase II- MTD Expansion|treatment delay|3|||
44430201|NCT00621777|79438430|FG000|Open Phase|Adverse Event|20|||
44430202|NCT00621777|79438431|FG001|Open Phase|Adverse Event|0|||
44430203|NCT00621777|79438430|FG000|Open Phase|Did not abstain during open phase|56|||
44430204|NCT00621777|79438431|FG001|Open Phase|Did not abstain during open phase|0|||
44430205|NCT00621777|79438430|FG000|Open Phase|Withdrawal by Subject|17|||
44430206|NCT00621777|79438431|FG001|Open Phase|Withdrawal by Subject|0|||
44430207|NCT00621777|79438430|FG000|Open Phase|administrative|13|||
44430208|NCT00621777|79438431|FG001|Open Phase|administrative|0|||
44430209|NCT00621777|79438430|FG000|Open Phase|Lost to Follow-up|10|||
44430210|NCT00621777|79438431|FG001|Open Phase|Lost to Follow-up|0|||
44430211|NCT00621777|79438430|FG000|Randomized Phase|Adverse Event|3|||
44430212|NCT00621777|79438431|FG001|Randomized Phase|Adverse Event|3|||
44430213|NCT00621777|79438430|FG000|Randomized Phase|Lost to Follow-up|3|||
44430214|NCT00621777|79438431|FG001|Randomized Phase|Lost to Follow-up|3|||
44430215|NCT00621777|79438430|FG000|Randomized Phase|Withdrawal by Subject|1|||
44430216|NCT00621777|79438431|FG001|Randomized Phase|Withdrawal by Subject|9|||
44430217|NCT00621777|79438430|FG000|Randomized Phase|administrative|0|||
44430218|NCT00621777|79438431|FG001|Randomized Phase|administrative|3|||
44430219|NCT00621777|79438430|FG000|Randomized Phase|Death|0|||
44430220|NCT00621777|79438431|FG001|Randomized Phase|Death|1|||
44430221|NCT00408421|79438441|FG000|Treatment Initial Randomization|Adverse Event|5|||
44430222|NCT00408421|79438442|FG001|Treatment Initial Randomization|Adverse Event|9|||
44538404|NCT03783923|79549269|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
44157155|NCT01593254|78948666|FG000|Overall Study|Pregnancy|0|||
44157156|NCT01593254|78948667|FG001|Overall Study|Pregnancy|3|||
44332451|NCT01332968|79337299|FG002|Follow-Up Period|Non-compliance|0|||
44332452|NCT01332968|79337300|FG003|Follow-Up Period|Non-compliance|0|||
44332453|NCT01332968|79337301|FG004|Follow-Up Period|Non-compliance|0|||
44332454|NCT01332968|79337302|FG005|Follow-Up Period|Non-compliance|0|||
44332455|NCT01332968|79337303|FG006|Follow-Up Period|Non-compliance|4|||
44332456|NCT01332968|79337304|FG007|Follow-Up Period|Non-compliance|9|||
44332457|NCT01332968|79337297|FG000|Follow-Up Period|Other|0|||
44332458|NCT01332968|79337298|FG001|Follow-Up Period|Other|0|||
44332459|NCT01332968|79337299|FG002|Follow-Up Period|Other|0|||
44332460|NCT01332968|79337300|FG003|Follow-Up Period|Other|0|||
44332461|NCT01332968|79337301|FG004|Follow-Up Period|Other|0|||
44332462|NCT01332968|79337302|FG005|Follow-Up Period|Other|0|||
44332463|NCT01332968|79337303|FG006|Follow-Up Period|Other|18|||
44332464|NCT01332968|79337304|FG007|Follow-Up Period|Other|21|||
44332465|NCT01332968|79337297|FG000|Follow-Up Period|Physician Decision|0|||
44332466|NCT01332968|79337298|FG001|Follow-Up Period|Physician Decision|0|||
44332467|NCT01332968|79337299|FG002|Follow-Up Period|Physician Decision|0|||
44332468|NCT01332968|79337300|FG003|Follow-Up Period|Physician Decision|0|||
44332469|NCT01332968|79337301|FG004|Follow-Up Period|Physician Decision|0|||
44332470|NCT01332968|79337302|FG005|Follow-Up Period|Physician Decision|0|||
44332471|NCT01332968|79337303|FG006|Follow-Up Period|Physician Decision|12|||
44430223|NCT00408421|79438443|FG002|Treatment Initial Randomization|Adverse Event|0|||
44430224|NCT00408421|79438441|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
44430225|NCT00408421|79438442|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
44430226|NCT00408421|79438443|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
44430227|NCT00408421|79438441|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
44430228|NCT00408421|79438442|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
44430229|NCT00408421|79438443|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
44430230|NCT00408421|79438441|FG000|Treatment Initial Randomization|Physician Decision|1|||
44430231|NCT00408421|79438442|FG001|Treatment Initial Randomization|Physician Decision|0|||
44332472|NCT01332968|79337304|FG007|Follow-Up Period|Physician Decision|15|||
44332473|NCT01332968|79337297|FG000|Follow-Up Period|Progressive Disease|0|||
44332474|NCT01332968|79337298|FG001|Follow-Up Period|Progressive Disease|0|||
44332475|NCT01332968|79337299|FG002|Follow-Up Period|Progressive Disease|0|||
44332476|NCT01332968|79337300|FG003|Follow-Up Period|Progressive Disease|0|||
44332477|NCT01332968|79337301|FG004|Follow-Up Period|Progressive Disease|0|||
44332478|NCT01332968|79337302|FG005|Follow-Up Period|Progressive Disease|0|||
44332479|NCT01332968|79337303|FG006|Follow-Up Period|Progressive Disease|126|||
44332480|NCT01332968|79337304|FG007|Follow-Up Period|Progressive Disease|106|||
44332481|NCT01332968|79337297|FG000|Follow-Up Period|Protocol Violation|0|||
44332482|NCT01332968|79337298|FG001|Follow-Up Period|Protocol Violation|0|||
44332483|NCT01332968|79337299|FG002|Follow-Up Period|Protocol Violation|0|||
44332484|NCT01332968|79337300|FG003|Follow-Up Period|Protocol Violation|0|||
44332485|NCT01332968|79337301|FG004|Follow-Up Period|Protocol Violation|0|||
44332486|NCT01332968|79337302|FG005|Follow-Up Period|Protocol Violation|0|||
44332487|NCT01332968|79337303|FG006|Follow-Up Period|Protocol Violation|1|||
44332488|NCT01332968|79337304|FG007|Follow-Up Period|Protocol Violation|0|||
44332489|NCT01332968|79337297|FG000|Follow-Up Period|Withdrawal by Subject|0|||
44332490|NCT01332968|79337298|FG001|Follow-Up Period|Withdrawal by Subject|0|||
44332491|NCT01332968|79337299|FG002|Follow-Up Period|Withdrawal by Subject|0|||
44332492|NCT01332968|79337300|FG003|Follow-Up Period|Withdrawal by Subject|0|||
44332493|NCT01332968|79337301|FG004|Follow-Up Period|Withdrawal by Subject|0|||
44430232|NCT00408421|79438443|FG002|Treatment Initial Randomization|Physician Decision|0|||
44430233|NCT00408421|79438441|FG000|Treatment Initial Randomization|Protocol Violation|0|||
44430234|NCT00408421|79438442|FG001|Treatment Initial Randomization|Protocol Violation|1|||
44430235|NCT00408421|79438443|FG002|Treatment Initial Randomization|Protocol Violation|0|||
44430236|NCT00408421|79438441|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
44430237|NCT00408421|79438442|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
44430238|NCT00408421|79438443|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
44430239|NCT00408421|79438441|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
44430240|NCT00408421|79438442|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
44430241|NCT00408421|79438443|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
44430242|NCT00408421|79438441|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
44430243|NCT00408421|79438442|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
44430244|NCT00408421|79438443|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
44430245|NCT00408421|79438441|FG000|Treatment Re-Randomization|Adverse Event|2|||
44430246|NCT00408421|79438442|FG001|Treatment Re-Randomization|Adverse Event|2|||
44430247|NCT00408421|79438443|FG002|Treatment Re-Randomization|Adverse Event|4|||
44430248|NCT00408421|79438441|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
44430249|NCT00408421|79438442|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
44332494|NCT01332968|79337302|FG005|Follow-Up Period|Withdrawal by Subject|0|||
44430250|NCT00408421|79438443|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
44430251|NCT00408421|79438441|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
44430252|NCT00408421|79438442|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
44430253|NCT00408421|79438443|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
44430254|NCT00408421|79438441|FG000|Treatment Re-Randomization|Physician Decision|1|||
44430255|NCT00408421|79438442|FG001|Treatment Re-Randomization|Physician Decision|3|||
44430256|NCT00408421|79438443|FG002|Treatment Re-Randomization|Physician Decision|0|||
44430257|NCT00408421|79438441|FG000|Treatment Re-Randomization|Protocol Violation|1|||
44430258|NCT00408421|79438442|FG001|Treatment Re-Randomization|Protocol Violation|1|||
44430259|NCT00408421|79438443|FG002|Treatment Re-Randomization|Protocol Violation|0|||
44430260|NCT00408421|79438441|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
44430261|NCT00408421|79438442|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
44430262|NCT00408421|79438443|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
44332495|NCT01332968|79337303|FG006|Follow-Up Period|Withdrawal by Subject|29|||
44332496|NCT01332968|79337304|FG007|Follow-Up Period|Withdrawal by Subject|32|||
44332497|NCT01332968|79337297|FG000|Follow-Up Period|No reason provided|0|||
44332498|NCT01332968|79337298|FG001|Follow-Up Period|No reason provided|0|||
44332499|NCT01332968|79337299|FG002|Follow-Up Period|No reason provided|0|||
44332500|NCT01332968|79337300|FG003|Follow-Up Period|No reason provided|0|||
44332501|NCT01332968|79337301|FG004|Follow-Up Period|No reason provided|0|||
44332502|NCT01332968|79337302|FG005|Follow-Up Period|No reason provided|0|||
44332503|NCT01332968|79337303|FG006|Follow-Up Period|No reason provided|2|||
44332504|NCT01332968|79337304|FG007|Follow-Up Period|No reason provided|3|||
44332505|NCT01332851|79337314|FG000|Overall Study|Withdrawal by Subject|4|||
44332506|NCT01332851|79337315|FG001|Overall Study|Withdrawal by Subject|2|||
44332507|NCT01332851|79337314|FG000|Overall Study|Lost to Follow-up|7|||
44430263|NCT00604786|79438453|FG000|Overall Study|Lost to Follow-up|2|||
44430264|NCT00604786|79438454|FG001|Overall Study|Lost to Follow-up|0|||
44538405|NCT03783923|79549268|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
44538406|NCT03783923|79549269|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
44332508|NCT01332851|79337315|FG001|Overall Study|Lost to Follow-up|11|||
44430265|NCT00604708|79438462|FG000|Overall Study|Withdrawal by Subject|9|||
44332509|NCT01332305|79337330|FG000|Overall Study|Adverse Event|1|||
44332510|NCT01332305|79337331|FG001|Overall Study|Adverse Event|4|||
44332511|NCT01332305|79337332|FG002|Overall Study|Adverse Event|6|||
44332512|NCT01332305|79337333|FG003|Overall Study|Adverse Event|3|||
44430266|NCT00604708|79438463|FG001|Overall Study|Withdrawal by Subject|10|||
44430267|NCT00604708|79438462|FG000|Overall Study|Protocol Violation|2|||
44332513|NCT01332305|79337334|FG004|Overall Study|Adverse Event|5|||
44332514|NCT01332305|79337330|FG000|Overall Study|Withdrawal by Subject|6|||
44332515|NCT01332305|79337331|FG001|Overall Study|Withdrawal by Subject|5|||
44332516|NCT01332305|79337332|FG002|Overall Study|Withdrawal by Subject|4|||
44332517|NCT01332305|79337333|FG003|Overall Study|Withdrawal by Subject|1|||
44332518|NCT01332305|79337334|FG004|Overall Study|Withdrawal by Subject|0|||
44332519|NCT01332305|79337330|FG000|Overall Study|Lost to Follow-up|0|||
44332520|NCT01332305|79337331|FG001|Overall Study|Lost to Follow-up|2|||
44332521|NCT01332305|79337332|FG002|Overall Study|Lost to Follow-up|3|||
44332522|NCT01332305|79337333|FG003|Overall Study|Lost to Follow-up|2|||
44332523|NCT01332305|79337334|FG004|Overall Study|Lost to Follow-up|3|||
44332524|NCT01332305|79337330|FG000|Overall Study|Protocol Violation|1|||
44332525|NCT01332305|79337331|FG001|Overall Study|Protocol Violation|2|||
44332526|NCT01332305|79337332|FG002|Overall Study|Protocol Violation|1|||
44332527|NCT01332305|79337333|FG003|Overall Study|Protocol Violation|0|||
44332528|NCT01332305|79337334|FG004|Overall Study|Protocol Violation|3|||
44332529|NCT01332305|79337330|FG000|Overall Study|Withdrawal by Sponsor|1|||
44332530|NCT01332305|79337331|FG001|Overall Study|Withdrawal by Sponsor|0|||
44332531|NCT01332305|79337332|FG002|Overall Study|Withdrawal by Sponsor|0|||
44430268|NCT00604708|79438463|FG001|Overall Study|Protocol Violation|8|||
44430269|NCT00604708|79438462|FG000|Overall Study|Lost to Follow-up|5|||
44430270|NCT00604708|79438463|FG001|Overall Study|Lost to Follow-up|5|||
44430271|NCT00604708|79438462|FG000|Overall Study|administrative reasons|9|||
44430272|NCT00604708|79438463|FG001|Overall Study|administrative reasons|11|||
44538407|NCT03783923|79549268|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
44538408|NCT03783923|79549269|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
44538409|NCT03417141|79549273|FG000|Overall Study|Withdrawal by Subject|1|||
44538410|NCT03417141|79549273|FG000|Overall Study|Protocol Violation|3|||
44332532|NCT01332305|79337333|FG003|Overall Study|Withdrawal by Sponsor|1|||
44332533|NCT01332305|79337334|FG004|Overall Study|Withdrawal by Sponsor|1|||
44332534|NCT01332305|79337330|FG000|Overall Study|Treatment Failure|1|||
44332535|NCT01332305|79337331|FG001|Overall Study|Treatment Failure|1|||
44332536|NCT01332305|79337332|FG002|Overall Study|Treatment Failure|0|||
44332537|NCT01332305|79337333|FG003|Overall Study|Treatment Failure|0|||
44332538|NCT01332305|79337334|FG004|Overall Study|Treatment Failure|0|||
44332539|NCT01332305|79337330|FG000|Overall Study|Physician Decision|0|||
44332540|NCT01332305|79337331|FG001|Overall Study|Physician Decision|0|||
44332541|NCT01332305|79337332|FG002|Overall Study|Physician Decision|0|||
44332542|NCT01332305|79337333|FG003|Overall Study|Physician Decision|1|||
44332543|NCT01332305|79337334|FG004|Overall Study|Physician Decision|0|||
44332544|NCT01332227|79337348|FG000|Overall Study|Adverse Event|4|||
44332545|NCT01332227|79337349|FG001|Overall Study|Adverse Event|1|||
44332546|NCT01332227|79337348|FG000|Overall Study|Withdrawal by Subject|5|||
44332547|NCT01332227|79337349|FG001|Overall Study|Withdrawal by Subject|1|||
44332548|NCT01332227|79337348|FG000|Overall Study|Lost to Follow-up|2|||
44332549|NCT01332227|79337349|FG001|Overall Study|Lost to Follow-up|0|||
44332550|NCT01332227|79337348|FG000|Overall Study|Lack of Efficacy|3|||
44332551|NCT01332227|79337349|FG001|Overall Study|Lack of Efficacy|1|||
44332552|NCT01332227|79337348|FG000|Overall Study|Poor compliance/noncompliance|1|||
44332553|NCT01332227|79337349|FG001|Overall Study|Poor compliance/noncompliance|1|||
44332554|NCT01332227|79337348|FG000|Overall Study|Patient moved from area|1|||
44332555|NCT01332227|79337349|FG001|Overall Study|Patient moved from area|0|||
44332556|NCT01332227|79337348|FG000|Overall Study|Patient began prohibited medication|0|||
44332557|NCT01332227|79337349|FG001|Overall Study|Patient began prohibited medication|1|||
44332558|NCT01332149|79337357|FG000|Overall Study|Adverse Event|11|||
44332559|NCT01332149|79337358|FG001|Overall Study|Adverse Event|9|||
44332560|NCT01332149|79337357|FG000|Overall Study|Other unspecified|5|||
44332561|NCT01332149|79337358|FG001|Overall Study|Other unspecified|7|||
44538411|NCT03724981|79549281|FG000|First Device|Protocol Violation|1|||
44538412|NCT03724981|79549282|FG001|First Device|Protocol Violation|1|||
44332562|NCT01332149|79337357|FG000|Overall Study|Protocol Violation|1|||
44430273|NCT00604708|79438462|FG000|Overall Study|Adverse Event|6|||
44332563|NCT01332149|79337358|FG001|Overall Study|Protocol Violation|3|||
44538413|NCT01347879|79549292|FG000|Overall Study|Adverse Event|0|||
44538414|NCT01347879|79549293|FG001|Overall Study|Adverse Event|12|||
44332564|NCT01332149|79337357|FG000|Overall Study|Withdrawal by Subject|4|||
44332565|NCT01332149|79337358|FG001|Overall Study|Withdrawal by Subject|5|||
44332566|NCT01332149|79337357|FG000|Overall Study|Lost to Follow-up|1|||
44332567|NCT01332149|79337358|FG001|Overall Study|Lost to Follow-up|1|||
44332568|NCT01332149|79337357|FG000|Overall Study|Insufficient clinical response|4|||
44332569|NCT01332149|79337358|FG001|Overall Study|Insufficient clinical response|7|||
44430274|NCT00604708|79438463|FG001|Overall Study|Adverse Event|6|||
44430275|NCT00407797|79438469|FG000|Overall Study|Lost to Follow-up|2|||
44430276|NCT00407797|79438469|FG000|Overall Study|Adverse Event|6|||
44332570|NCT01332149|79337357|FG000|Overall Study|Did not meet entrance criteria|3|||
44332571|NCT01332149|79337358|FG001|Overall Study|Did not meet entrance criteria|4|||
44430277|NCT00407797|79438469|FG000|Overall Study|Other|7|||
44430278|NCT00407797|79438469|FG000|Overall Study|Withdrawal by Subject|3|||
44430279|NCT00568126|79438475|FG000|Overall Study|Adverse Event|3|||
44430280|NCT00568126|79438476|FG001|Overall Study|Adverse Event|0|||
44430281|NCT00568126|79438475|FG000|Overall Study|Withdrawal by Subject|2|||
44538415|NCT01347879|79549292|FG000|Overall Study|Lost to Follow-up|2|||
44538416|NCT01347879|79549293|FG001|Overall Study|Lost to Follow-up|0|||
44538417|NCT01347879|79549292|FG000|Overall Study|Withdrawal by Subject|3|||
44538418|NCT01347879|79549293|FG001|Overall Study|Withdrawal by Subject|2|||
44538419|NCT01347879|79549292|FG000|Overall Study|Other|2|||
44538420|NCT01347879|79549293|FG001|Overall Study|Other|3|||
44538421|NCT03441789|79549310|FG000|Overall Study|Withdrawal by Subject|1|||
44538422|NCT03441789|79549311|FG001|Overall Study|Withdrawal by Subject|1|||
44538423|NCT03441789|79549310|FG000|Overall Study|Adverse Event|0|||
44538424|NCT03441789|79549311|FG001|Overall Study|Adverse Event|1|||
44538425|NCT03441789|79549310|FG000|Overall Study|Protocol Violation|0|||
44332572|NCT01332149|79337357|FG000|Overall Study|Randomized but not treated|1|||
44332573|NCT01332149|79337358|FG001|Overall Study|Randomized but not treated|2|||
44332574|NCT01330628|79337366|FG000|Overall Study|Death|2|||
44332575|NCT01330628|79337367|FG001|Overall Study|Death|3|||
44332576|NCT01330628|79337366|FG000|Overall Study|Lost to Follow-up|5|||
44332577|NCT01330628|79337367|FG001|Overall Study|Lost to Follow-up|6|||
44332578|NCT01330628|79337366|FG000|Overall Study|Adverse Event|44|||
44332579|NCT01330628|79337367|FG001|Overall Study|Adverse Event|25|||
44332580|NCT01330628|79337366|FG000|Overall Study|Withdrawn|18|||
44332581|NCT01330628|79337367|FG001|Overall Study|Withdrawn|6|||
44430282|NCT00568126|79438476|FG001|Overall Study|Withdrawal by Subject|3|||
44430283|NCT00568126|79438475|FG000|Overall Study|Lost to Follow-up|4|||
44430284|NCT00568126|79438476|FG001|Overall Study|Lost to Follow-up|3|||
44430285|NCT00568126|79438475|FG000|Overall Study|Lack of Efficacy|0|||
44430286|NCT00568126|79438476|FG001|Overall Study|Lack of Efficacy|1|||
44430287|NCT00568126|79438475|FG000|Overall Study|Physician Decision|2|||
44430288|NCT00568126|79438476|FG001|Overall Study|Physician Decision|2|||
44430289|NCT00407563|79438482|FG000|Overall Study|Patient continues on treatment|1|||
44430290|NCT00567892|79438488|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
44430291|NCT00567892|79438489|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
44430292|NCT00567892|79438490|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
44430293|NCT00567892|79438491|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
44430294|NCT00567892|79438488|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
44430295|NCT00567892|79438489|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
44430296|NCT00567892|79438490|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
44430297|NCT00567892|79438491|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
44430298|NCT00623103|79438505|FG000|Overall Study|Adverse Event|70|||
44430299|NCT00623103|79438506|FG001|Overall Study|Adverse Event|60|||
44430300|NCT00623103|79438505|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44430301|NCT00623103|79438506|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
44430302|NCT00623103|79438505|FG000|Overall Study|Withdrawal by Subject|18|||
44430303|NCT00623103|79438506|FG001|Overall Study|Withdrawal by Subject|24|||
44430304|NCT00623103|79438505|FG000|Overall Study|Lost to Follow-up|4|||
44430305|NCT00623103|79438506|FG001|Overall Study|Lost to Follow-up|1|||
44430306|NCT00623103|79438505|FG000|Overall Study|Administrative problems|2|||
44430307|NCT00623103|79438506|FG001|Overall Study|Administrative problems|4|||
44430308|NCT00623103|79438505|FG000|Overall Study|Death|11|||
44430309|NCT00623103|79438506|FG001|Overall Study|Death|11|||
44430310|NCT00623103|79438505|FG000|Overall Study|Protocol deviation|2|||
44430311|NCT00623103|79438506|FG001|Overall Study|Protocol deviation|1|||
44430312|NCT00396565|79438515|FG000|Overall Study|Physician Decision|3|||
44430313|NCT00396565|79438516|FG001|Overall Study|Physician Decision|1|||
44430314|NCT00396565|79438517|FG002|Overall Study|Physician Decision|2|||
44430315|NCT00396565|79438515|FG000|Overall Study|Adverse Event|5|||
44430316|NCT00396565|79438516|FG001|Overall Study|Adverse Event|13|||
44430317|NCT00396565|79438517|FG002|Overall Study|Adverse Event|3|||
44538426|NCT03441789|79549311|FG001|Overall Study|Protocol Violation|1|||
44538427|NCT03441789|79549310|FG000|Overall Study|Lost to Follow-up|0|||
44538428|NCT03441789|79549311|FG001|Overall Study|Lost to Follow-up|1|||
44538429|NCT03387735|79549323|FG000|Overall Study|Lost to Follow-up|4|||
44430318|NCT00396565|79438515|FG000|Overall Study|Withdrawal by Subject|8|||
44538430|NCT03387735|79549324|FG001|Overall Study|Lost to Follow-up|8|||
44538431|NCT03387735|79549323|FG000|Overall Study|Death|4|||
44332582|NCT01330628|79337366|FG000|Overall Study|Didn't receive study treatment|1|||
44430319|NCT00396565|79438516|FG001|Overall Study|Withdrawal by Subject|13|||
44430320|NCT00396565|79438517|FG002|Overall Study|Withdrawal by Subject|1|||
44430321|NCT00396565|79438515|FG000|Overall Study|Lack of Efficacy|32|||
44430322|NCT00396565|79438516|FG001|Overall Study|Lack of Efficacy|64|||
44430323|NCT00396565|79438517|FG002|Overall Study|Lack of Efficacy|11|||
44332583|NCT01330628|79337367|FG001|Overall Study|Didn't receive study treatment|0|||
44430324|NCT00394771|79438529|FG000|Overall Study|Did not meet protocol requirements|1|||
44538432|NCT03387735|79549324|FG001|Overall Study|Death|8|||
44430325|NCT00394771|79438530|FG001|Overall Study|Did not meet protocol requirements|0|||
44430326|NCT00394771|79438531|FG002|Overall Study|Did not meet protocol requirements|2|||
44430327|NCT00394771|79438532|FG003|Overall Study|Did not meet protocol requirements|0|||
44430328|NCT00394771|79438529|FG000|Overall Study|Protocol Violation|2|||
44430329|NCT00394771|79438530|FG001|Overall Study|Protocol Violation|4|||
44430330|NCT00394771|79438531|FG002|Overall Study|Protocol Violation|9|||
44430331|NCT00394771|79438532|FG003|Overall Study|Protocol Violation|7|||
44430332|NCT00394771|79438529|FG000|Overall Study|Withdrawal by Subject|10|||
44430333|NCT00394771|79438530|FG001|Overall Study|Withdrawal by Subject|6|||
44332584|NCT01330433|79337375|FG000|Overall Study|Death|1|||
44332585|NCT01330433|79337376|FG001|Overall Study|Death|3|||
44332586|NCT01330433|79337375|FG000|Overall Study|Lost to Follow-up|1|||
44332587|NCT01330433|79337376|FG001|Overall Study|Lost to Follow-up|0|||
44332588|NCT01330316|79337384|FG000|Overall Study|Adverse Event|2|||
44332589|NCT01330316|79337385|FG001|Overall Study|Adverse Event|2|||
44332590|NCT01330316|79337384|FG000|Overall Study|Lack of Efficacy|0|||
44332591|NCT01330316|79337385|FG001|Overall Study|Lack of Efficacy|10|||
44332592|NCT01330316|79337384|FG000|Overall Study|Lost to Follow-up|0|||
44538433|NCT04055090|79549332|FG000|Overall Study|screen failure|1|||
44538434|NCT04055090|79549333|FG001|Overall Study|screen failure|0|||
44538435|NCT04055090|79549332|FG000|Overall Study|Withdrawal by Subject|1|||
44538436|NCT04055090|79549333|FG001|Overall Study|Withdrawal by Subject|0|||
44538437|NCT03403413|79549356|FG000|Overall Study|Lack of Efficacy|2|||
44538438|NCT03721705|79549373|FG000|Overall Study|Adverse Event|2|||
44538439|NCT03721705|79549374|FG001|Overall Study|Adverse Event|0|||
44538440|NCT03721705|79549373|FG000|Overall Study|Withdrawal by Subject|4|||
44538441|NCT03721705|79549374|FG001|Overall Study|Withdrawal by Subject|10|||
44538442|NCT03721705|79549373|FG000|Overall Study|No Suitable Study Partner|1|||
44538443|NCT03721705|79549374|FG001|Overall Study|No Suitable Study Partner|0|||
44538444|NCT03721705|79549373|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
44538445|NCT03721705|79549374|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
44538446|NCT03721705|79549373|FG000|Overall Study|Death|0|||
44538447|NCT03721705|79549374|FG001|Overall Study|Death|1|||
44538448|NCT03720847|79549380|FG000|Washout|Physician Decision|1|||
44538449|NCT03720847|79549381|FG001|Washout|Physician Decision|2|||
44538450|NCT02631070|79549390|FG000|Overall Study|Withdrawal by Subject|35|||
44538451|NCT02631070|79549391|FG001|Overall Study|Withdrawal by Subject|13|||
44538452|NCT02631070|79549390|FG000|Overall Study|Death|45|||
44538453|NCT02631070|79549391|FG001|Overall Study|Death|24|||
44538454|NCT02631070|79549390|FG000|Overall Study|Lost to Follow-up|5|||
44538455|NCT02631070|79549391|FG001|Overall Study|Lost to Follow-up|1|||
44538456|NCT02631070|79549390|FG000|Overall Study|Transition to rollover protocol|52|||
44538457|NCT02631070|79549391|FG001|Overall Study|Transition to rollover protocol|21|||
44538458|NCT02631070|79549390|FG000|Overall Study|Other reasons|12|||
44538459|NCT02631070|79549391|FG001|Overall Study|Other reasons|5|||
44538460|NCT00741988|79549399|FG000|Overall Study|Adverse Event|2|||
44538461|NCT00741988|79549400|FG001|Overall Study|Adverse Event|4|||
44538462|NCT00741988|79549399|FG000|Overall Study|Lack of Efficacy|2|||
44538463|NCT00741988|79549400|FG001|Overall Study|Lack of Efficacy|0|||
44538464|NCT03354429|79549408|FG000|Overall Study|Withdrawal by Subject|8|||
44538465|NCT03354429|79549409|FG001|Overall Study|Withdrawal by Subject|7|||
44538466|NCT03354429|79549408|FG000|Overall Study|Lost to Follow-up|1|||
44538467|NCT03354429|79549409|FG001|Overall Study|Lost to Follow-up|0|||
44538468|NCT03352713|79549415|FG000|Overall Study|Lost to Follow-up|8|||
44538469|NCT03352713|79549415|FG000|Overall Study|Withdrawn by investigator|5|||
44538470|NCT03352713|79549415|FG000|Overall Study|Completed 0 EMAs|8|||
44538471|NCT03352713|79549415|FG000|Overall Study|Device incompatible/stolen|5|||
44538472|NCT03901144|79549419|FG000|Overall Study|Lost to Follow-up|1|||
44538473|NCT03901144|79549420|FG001|Overall Study|Lost to Follow-up|1|||
44538474|NCT03901144|79549421|FG002|Overall Study|Lost to Follow-up|1|||
44538475|NCT03901144|79549422|FG003|Overall Study|Lost to Follow-up|1|||
44538476|NCT02952261|79549434|FG000|Overall Study|Withdrawal by Subject|4|||
44538477|NCT02952261|79549435|FG001|Overall Study|Withdrawal by Subject|5|||
44538478|NCT02952261|79549434|FG000|Overall Study|Protocol Violation|1|||
44538479|NCT02952261|79549435|FG001|Overall Study|Protocol Violation|0|||
44538480|NCT03384693|79549441|FG000|Overall Study|Adverse Event|3|||
44538481|NCT03718429|79549453|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
44538482|NCT03718429|79549454|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
44538483|NCT03718429|79549455|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
44538484|NCT03718429|79549456|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
44332593|NCT01330316|79337385|FG001|Overall Study|Lost to Follow-up|1|||
44332594|NCT01330316|79337384|FG000|Overall Study|Withdrawal by Subject|0|||
44430334|NCT00394771|79438531|FG002|Overall Study|Withdrawal by Subject|8|||
44430335|NCT00394771|79438532|FG003|Overall Study|Withdrawal by Subject|12|||
44332595|NCT01330316|79337385|FG001|Overall Study|Withdrawal by Subject|1|||
44332596|NCT01330316|79337384|FG000|Overall Study|other than above|0|||
44332597|NCT01330316|79337385|FG001|Overall Study|other than above|1|||
44332598|NCT01326702|79337398|FG000|Overall Study|Other|1|||
44332599|NCT01326702|79337399|FG001|Overall Study|Other|0|||
44332600|NCT01326702|79337400|FG002|Overall Study|Other|0|||
44332601|NCT01326702|79337401|FG003|Overall Study|Other|0|||
44332602|NCT01326702|79337402|FG004|Overall Study|Other|0|||
44332603|NCT01326702|79337403|FG005|Overall Study|Other|1|||
44332604|NCT01326702|79337404|FG006|Overall Study|Other|0|||
44332605|NCT01326702|79337398|FG000|Overall Study|progressive disease|1|||
44430336|NCT00394771|79438529|FG000|Overall Study|Adverse Event|10|||
44430337|NCT00394771|79438530|FG001|Overall Study|Adverse Event|5|||
44430338|NCT00394771|79438531|FG002|Overall Study|Adverse Event|12|||
44430339|NCT00394771|79438532|FG003|Overall Study|Adverse Event|8|||
44538485|NCT01285102|79549476|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
44538486|NCT03382899|79549510|FG000|Overall Study|Ineligibility Determined|0|||
44538487|NCT03382899|79549511|FG001|Overall Study|Ineligibility Determined|1|||
44538488|NCT03382899|79549510|FG000|Overall Study|Lost to Follow-up|0|||
44538489|NCT03382899|79549511|FG001|Overall Study|Lost to Follow-up|1|||
44538490|NCT03382899|79549510|FG000|Overall Study|Sponsor's decision|31|||
44538491|NCT03382899|79549511|FG001|Overall Study|Sponsor's decision|28|||
44538492|NCT03382899|79549510|FG000|Overall Study|Withdrawal by Subject|0|||
44538493|NCT03382899|79549511|FG001|Overall Study|Withdrawal by Subject|5|||
44538494|NCT00709852|79549517|FG000|Period 1|Adverse Event|2|||
44538495|NCT00709852|79549518|FG001|Period 1|Adverse Event|0|||
44538496|NCT00709852|79549517|FG000|Period 1|Withdrawal by Subject|4|||
44430340|NCT00394771|79438529|FG000|Overall Study|Participant pregnant|0|||
44430341|NCT00394771|79438530|FG001|Overall Study|Participant pregnant|1|||
44430342|NCT00394771|79438531|FG002|Overall Study|Participant pregnant|2|||
44430343|NCT00394771|79438532|FG003|Overall Study|Participant pregnant|2|||
44430344|NCT00394771|79438529|FG000|Overall Study|Lost to Follow-up|15|||
44430345|NCT00394771|79438530|FG001|Overall Study|Lost to Follow-up|15|||
44430346|NCT00394771|79438531|FG002|Overall Study|Lost to Follow-up|13|||
44430347|NCT00394771|79438532|FG003|Overall Study|Lost to Follow-up|10|||
44430348|NCT00394771|79438529|FG000|Overall Study|Other|3|||
44430349|NCT00394771|79438530|FG001|Overall Study|Other|3|||
44430350|NCT00394771|79438531|FG002|Overall Study|Other|1|||
44430351|NCT00394771|79438532|FG003|Overall Study|Other|0|||
44430352|NCT00396409|79438544|FG000|Period 1 - 2007|Adverse Event|0|||
44538497|NCT00709852|79549518|FG001|Period 1|Withdrawal by Subject|2|||
44538498|NCT00709852|79549517|FG000|Period 1|Protocol Violation|1|||
44538499|NCT00709852|79549518|FG001|Period 1|Protocol Violation|0|||
44430353|NCT00396409|79438545|FG001|Period 1 - 2007|Adverse Event|1|||
44430354|NCT00396409|79438544|FG000|Period 1 - 2007|Lack of Efficacy|0|||
44430355|NCT00396409|79438545|FG001|Period 1 - 2007|Lack of Efficacy|1|||
44430356|NCT00396409|79438544|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
44430357|NCT00396409|79438545|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
44430358|NCT00396409|79438544|FG000|Period 1 - 2007|Lost to Follow-up|2|||
44538500|NCT00709852|79549517|FG000|Period 1|Defective scanner|0|||
44332606|NCT01326702|79337399|FG001|Overall Study|progressive disease|1|||
44332607|NCT01326702|79337400|FG002|Overall Study|progressive disease|3|||
44430359|NCT00396409|79438545|FG001|Period 1 - 2007|Lost to Follow-up|3|||
44430360|NCT00396409|79438544|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
44430361|NCT00396409|79438545|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
44430362|NCT00396409|79438544|FG000|Period 2 - 2008|Protocol Violation|1|||
44430363|NCT00396409|79438545|FG001|Period 2 - 2008|Protocol Violation|0|||
44430364|NCT00396409|79438544|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
44430365|NCT00396409|79438545|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
44538501|NCT00709852|79549518|FG001|Period 1|Defective scanner|1|||
44538502|NCT00709852|79549517|FG000|Period 1|Lost to Follow-up|1|||
44538503|NCT00709852|79549518|FG001|Period 1|Lost to Follow-up|0|||
44538504|NCT00709852|79549517|FG000|Period 2|Protocol Violation|4|||
44538505|NCT00709852|79549518|FG001|Period 2|Protocol Violation|1|||
44538506|NCT00709852|79549517|FG000|Period 2|Adverse Event|1|||
44538507|NCT00709852|79549518|FG001|Period 2|Adverse Event|1|||
44538508|NCT00709852|79549517|FG000|Period 2|Lost to Follow-up|1|||
44538509|NCT00709852|79549518|FG001|Period 2|Lost to Follow-up|0|||
44538510|NCT00709852|79549517|FG000|Period 2|No 72-hour follow-up|3|||
44538511|NCT00709852|79549518|FG001|Period 2|No 72-hour follow-up|0|||
44538512|NCT03382041|79549535|FG000|Overall Study|Consent Form Lost|2|||
44538513|NCT03382041|79549536|FG001|Overall Study|Consent Form Lost|1|||
44538514|NCT03382041|79549535|FG000|Overall Study|Withdrawal by Subject|1|||
44538515|NCT03382041|79549536|FG001|Overall Study|Withdrawal by Subject|4|||
44538516|NCT03382041|79549535|FG000|Overall Study|Lost to Follow-up|1|||
44538517|NCT03382041|79549536|FG001|Overall Study|Lost to Follow-up|4|||
44538518|NCT03351231|79549542|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
44332608|NCT01326702|79337401|FG003|Overall Study|progressive disease|1|||
44332609|NCT01326702|79337402|FG004|Overall Study|progressive disease|3|||
44332610|NCT01326702|79337403|FG005|Overall Study|progressive disease|2|||
44332611|NCT01326702|79337404|FG006|Overall Study|progressive disease|3|||
44332612|NCT01326702|79337398|FG000|Overall Study|Death|0|||
44332613|NCT01326702|79337399|FG001|Overall Study|Death|1|||
44332614|NCT01326702|79337400|FG002|Overall Study|Death|0|||
44332615|NCT01326702|79337401|FG003|Overall Study|Death|0|||
44332616|NCT01326702|79337402|FG004|Overall Study|Death|0|||
44332617|NCT01326702|79337403|FG005|Overall Study|Death|0|||
44430366|NCT00396409|79438544|FG000|Period 2 - 2008|Lost to Follow-up|3|||
44430367|NCT00396409|79438545|FG001|Period 2 - 2008|Lost to Follow-up|1|||
44430368|NCT02924376|79438557|FG000|Overall Study|Progressive Disease|4|||
44430369|NCT02924376|79438558|FG001|Overall Study|Progressive Disease|0|||
44430370|NCT02924376|79438559|FG002|Overall Study|Progressive Disease|1|||
44430371|NCT02924376|79438560|FG003|Overall Study|Progressive Disease|0|||
44430372|NCT02924376|79438557|FG000|Overall Study|Death|73|||
44430373|NCT02924376|79438558|FG001|Overall Study|Death|18|||
44430374|NCT02924376|79438559|FG002|Overall Study|Death|15|||
44430375|NCT02924376|79438560|FG003|Overall Study|Death|2|||
44430376|NCT02924376|79438557|FG000|Overall Study|Lost to Follow-up|3|||
44430377|NCT02924376|79438558|FG001|Overall Study|Lost to Follow-up|0|||
44430378|NCT02924376|79438559|FG002|Overall Study|Lost to Follow-up|0|||
44430379|NCT02924376|79438560|FG003|Overall Study|Lost to Follow-up|0|||
44430380|NCT02924376|79438557|FG000|Overall Study|Study Terminated by Sponsor|19|||
44538519|NCT03351231|79549542|FG000|Combination Therapy Period|Disease progression|2|||
44538520|NCT03351231|79549542|FG000|Combination Therapy Period|Study drug toxicity|1|||
44538521|NCT03351231|79549542|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
44538522|NCT03351231|79549542|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
44538523|NCT03351231|79549542|FG000|Safety Follow-Up Period|Other reason|2|||
44538524|NCT03381339|79549548|FG000|Overall Study|Protocol Violation|4|||
44157157|NCT01593254|78948666|FG000|Overall Study|participant no longer meets study criteria|1|||
44430381|NCT02924376|79438558|FG001|Overall Study|Study Terminated by Sponsor|0|||
44430382|NCT02924376|79438559|FG002|Overall Study|Study Terminated by Sponsor|0|||
44430383|NCT02924376|79438560|FG003|Overall Study|Study Terminated by Sponsor|0|||
44430384|NCT02924376|79438557|FG000|Overall Study|Physician Decision|1|||
44332618|NCT01326702|79337404|FG006|Overall Study|Death|0|||
44332619|NCT01326702|79337398|FG000|Overall Study|Adverse Event|0|||
44430385|NCT02924376|79438558|FG001|Overall Study|Physician Decision|0|||
44430386|NCT02924376|79438559|FG002|Overall Study|Physician Decision|0|||
44430387|NCT02924376|79438560|FG003|Overall Study|Physician Decision|0|||
44430388|NCT02924376|79438557|FG000|Overall Study|Withdrawal by Subject|7|||
44430389|NCT02924376|79438558|FG001|Overall Study|Withdrawal by Subject|2|||
44430390|NCT02924376|79438559|FG002|Overall Study|Withdrawal by Subject|1|||
44430391|NCT02924376|79438560|FG003|Overall Study|Withdrawal by Subject|0|||
44430392|NCT02924376|79438557|FG000|Overall Study|Rolled Over to Another Study|1|||
44430393|NCT02924376|79438558|FG001|Overall Study|Rolled Over to Another Study|0|||
44430394|NCT02924376|79438559|FG002|Overall Study|Rolled Over to Another Study|0|||
44430395|NCT02924376|79438560|FG003|Overall Study|Rolled Over to Another Study|0|||
44430396|NCT00693420|79438575|FG000|Overall Study|Adverse Event|4|||
44430397|NCT00693420|79438576|FG001|Overall Study|Adverse Event|4|||
44430398|NCT00693420|79438575|FG000|Overall Study|Lost to Follow-up|0|||
44430399|NCT00693420|79438576|FG001|Overall Study|Lost to Follow-up|3|||
44332620|NCT01326702|79337399|FG001|Overall Study|Adverse Event|0|||
44332621|NCT01326702|79337400|FG002|Overall Study|Adverse Event|1|||
44332622|NCT01326702|79337401|FG003|Overall Study|Adverse Event|1|||
44332623|NCT01326702|79337402|FG004|Overall Study|Adverse Event|0|||
44332624|NCT01326702|79337403|FG005|Overall Study|Adverse Event|3|||
44332625|NCT01326702|79337404|FG006|Overall Study|Adverse Event|1|||
44430400|NCT00693420|79438575|FG000|Overall Study|Withdrawal by Subject|1|||
44430401|NCT00693420|79438576|FG001|Overall Study|Withdrawal by Subject|0|||
44430402|NCT00693420|79438575|FG000|Overall Study|Protocol Violation|0|||
44430403|NCT00693420|79438576|FG001|Overall Study|Protocol Violation|2|||
44430404|NCT00693420|79438575|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
44430405|NCT00693420|79438576|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
44430406|NCT00693420|79438575|FG000|Overall Study|Personal Reasons|1|||
44430407|NCT00693420|79438576|FG001|Overall Study|Personal Reasons|4|||
44430408|NCT00695136|79438582|FG000|Overall Study|Withdrawal by Subject|1|||
44430409|NCT00695136|79438582|FG000|Overall Study|unrelated adverse event|1|||
44430410|NCT00605176|79438598|FG000|Overall Study|Adverse Event|2|||
44430411|NCT00605176|79438599|FG001|Overall Study|Adverse Event|1|||
44430412|NCT00605176|79438600|FG002|Overall Study|Adverse Event|3|||
44332626|NCT01326702|79337398|FG000|Overall Study|Withdrawal by Subject|0|||
44430413|NCT00605176|79438598|FG000|Overall Study|Withdrawal by Subject|4|||
44430414|NCT00605176|79438599|FG001|Overall Study|Withdrawal by Subject|2|||
44430415|NCT00605176|79438600|FG002|Overall Study|Withdrawal by Subject|4|||
44430416|NCT00605176|79438598|FG000|Overall Study|Lost to Follow-up|2|||
44430417|NCT00605176|79438599|FG001|Overall Study|Lost to Follow-up|2|||
44430418|NCT00605176|79438600|FG002|Overall Study|Lost to Follow-up|1|||
44430419|NCT00605176|79438598|FG000|Overall Study|Non-complicance with study procedures|1|||
44430420|NCT00605176|79438599|FG001|Overall Study|Non-complicance with study procedures|0|||
44430421|NCT00605176|79438600|FG002|Overall Study|Non-complicance with study procedures|0|||
44430422|NCT00605176|79438598|FG000|Overall Study|Use of concomitant therapy|1|||
44430423|NCT00605176|79438599|FG001|Overall Study|Use of concomitant therapy|0|||
44430424|NCT00605176|79438600|FG002|Overall Study|Use of concomitant therapy|1|||
44430425|NCT00605176|79438598|FG000|Overall Study|Other (not due to AE)|1|||
44430426|NCT00605176|79438599|FG001|Overall Study|Other (not due to AE)|1|||
44430427|NCT00605176|79438600|FG002|Overall Study|Other (not due to AE)|0|||
44430428|NCT00694356|79438611|FG000|Overall Study|Adverse Event|1|||
44430429|NCT00694356|79438612|FG001|Overall Study|Adverse Event|0|||
44430430|NCT00694356|79438613|FG002|Overall Study|Adverse Event|0|||
44430431|NCT00694356|79438611|FG000|Overall Study|Progressive Disease|2|||
44332627|NCT01326702|79337399|FG001|Overall Study|Withdrawal by Subject|0|||
44332628|NCT01326702|79337400|FG002|Overall Study|Withdrawal by Subject|1|||
44332629|NCT01326702|79337401|FG003|Overall Study|Withdrawal by Subject|0|||
44332630|NCT01326702|79337402|FG004|Overall Study|Withdrawal by Subject|1|||
44332631|NCT01326702|79337403|FG005|Overall Study|Withdrawal by Subject|1|||
44332632|NCT01326702|79337404|FG006|Overall Study|Withdrawal by Subject|3|||
44332633|NCT01326702|79337398|FG000|Overall Study|Not Treated|0|||
44332634|NCT01326702|79337399|FG001|Overall Study|Not Treated|0|||
44332635|NCT01326702|79337400|FG002|Overall Study|Not Treated|0|||
44430432|NCT00694356|79438612|FG001|Overall Study|Progressive Disease|6|||
44430433|NCT00694356|79438613|FG002|Overall Study|Progressive Disease|6|||
44430434|NCT00692406|79438621|FG000|Overall Study|PI dropped, bad data|57|||
44430435|NCT00567502|79438638|FG000|Overall Study|Lost to Follow-up|91|||
44430436|NCT00567502|79438639|FG001|Overall Study|Lost to Follow-up|14|||
44430437|NCT00567502|79438640|FG002|Overall Study|Lost to Follow-up|351|||
44430438|NCT00567502|79438641|FG003|Overall Study|Lost to Follow-up|2|||
44430439|NCT00567502|79438638|FG000|Overall Study|Death|65|||
44430440|NCT00567502|79438639|FG001|Overall Study|Death|16|||
44430441|NCT00567502|79438640|FG002|Overall Study|Death|360|||
44332636|NCT01326702|79337401|FG003|Overall Study|Not Treated|1|||
44430442|NCT00567502|79438641|FG003|Overall Study|Death|5|||
44430443|NCT00567502|79438638|FG000|Overall Study|Other|64|||
44430444|NCT00567502|79438639|FG001|Overall Study|Other|2|||
44430445|NCT00567502|79438640|FG002|Overall Study|Other|134|||
44430446|NCT00567502|79438641|FG003|Overall Study|Other|6|||
44430447|NCT00567502|79438638|FG000|Overall Study|Participant request|12|||
44430448|NCT00567502|79438639|FG001|Overall Study|Participant request|1|||
44430449|NCT00567502|79438640|FG002|Overall Study|Participant request|33|||
44430450|NCT00567502|79438641|FG003|Overall Study|Participant request|1|||
44430451|NCT00567502|79438638|FG000|Overall Study|Sponsor request|9|||
44538525|NCT03381339|79549549|FG001|Overall Study|Protocol Violation|3|||
44538526|NCT03381339|79549548|FG000|Overall Study|Lost to Follow-up|0|||
44538527|NCT03381339|79549549|FG001|Overall Study|Lost to Follow-up|1|||
44538528|NCT03401229|79549557|FG000|Overall Study|Lost to Follow-up|2|||
44538529|NCT03401229|79549558|FG001|Overall Study|Lost to Follow-up|1|||
44157158|NCT01593254|78948667|FG001|Overall Study|participant no longer meets study criteria|1|||
44157159|NCT01593254|78948666|FG000|Overall Study|Admin reason by sponsor|7|||
44157160|NCT01593254|78948667|FG001|Overall Study|Admin reason by sponsor|3|||
44157161|NCT01593254|78948666|FG000|Overall Study|Imatinib treatment failure|2|||
44157162|NCT01593254|78948667|FG001|Overall Study|Imatinib treatment failure|0|||
44157163|NCT01593254|78948666|FG000|Overall Study|Other Reasons|61|||
44157164|NCT01593254|78948667|FG001|Overall Study|Other Reasons|115|||
44332637|NCT01326702|79337402|FG004|Overall Study|Not Treated|0|||
44332638|NCT01326702|79337403|FG005|Overall Study|Not Treated|1|||
44332639|NCT01326702|79337404|FG006|Overall Study|Not Treated|0|||
44332640|NCT01327703|79337423|FG000|Second Treatment Period|Adverse Event|1|||
44332641|NCT01327703|79337424|FG001|Second Treatment Period|Adverse Event|1|||
44332642|NCT01327703|79337423|FG000|Second Treatment Period|Protocol Violation|0|||
44332643|NCT01327703|79337424|FG001|Second Treatment Period|Protocol Violation|1|||
44332644|NCT01380080|79337435|FG000|Overall Study|Death|36|||
44332645|NCT01380080|79337436|FG001|Overall Study|Death|44|||
44332646|NCT01380080|79337435|FG000|Overall Study|Site is closing|28|||
44332647|NCT01380080|79337436|FG001|Overall Study|Site is closing|31|||
44332648|NCT01380080|79337435|FG000|Overall Study|Not able to get to clinic|7|||
44332649|NCT01380080|79337436|FG001|Overall Study|Not able to get to clinic|1|||
44332650|NCT01380080|79337435|FG000|Overall Study|Not willing to adhere to requirements|6|||
44332651|NCT01380080|79337436|FG001|Overall Study|Not willing to adhere to requirements|2|||
44332652|NCT01380080|79337435|FG000|Overall Study|Withdrawal by Subject|5|||
44332653|NCT01380080|79337436|FG001|Overall Study|Withdrawal by Subject|2|||
44332654|NCT01380080|79337435|FG000|Overall Study|Lost to Follow-up|3|||
44332655|NCT01380080|79337436|FG001|Overall Study|Lost to Follow-up|3|||
44332656|NCT01379768|79337445|FG000|Overall Study|Adverse Event|1|||
44332657|NCT01379768|79337446|FG001|Overall Study|Adverse Event|1|||
44332658|NCT01379768|79337447|FG002|Overall Study|Adverse Event|0|||
44332659|NCT01379768|79337445|FG000|Overall Study|Lost to Follow-up|2|||
44332660|NCT01379768|79337446|FG001|Overall Study|Lost to Follow-up|0|||
44332661|NCT01379768|79337447|FG002|Overall Study|Lost to Follow-up|0|||
44332662|NCT01379573|79337455|FG000|Overall Study|Lost to Follow-up|1|||
44332663|NCT01379573|79337455|FG000|Overall Study|Screen Failure|10|||
44332664|NCT01379534|79337461|FG000|Treatment Phase|Withdrawal by Subject|2|||
44332665|NCT01379534|79337462|FG001|Treatment Phase|Withdrawal by Subject|2|||
44332666|NCT01379534|79337461|FG000|Treatment Phase|Progressive disease|13|||
44332667|NCT01379534|79337462|FG001|Treatment Phase|Progressive disease|22|||
44332668|NCT01379534|79337461|FG000|Treatment Phase|Adverse Event|7|||
44332669|NCT01379534|79337462|FG001|Treatment Phase|Adverse Event|7|||
44332670|NCT01379534|79337461|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
44332671|NCT01379534|79337462|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
44332672|NCT01379534|79337461|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
44332673|NCT01379534|79337462|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
44332674|NCT01379534|79337461|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
44332675|NCT01379534|79337462|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
44332676|NCT01379534|79337461|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
44332677|NCT01379534|79337462|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
44332678|NCT01371851|79337470|FG000|Overall Study|Lost to Follow-up|5|||
44332679|NCT01371851|79337471|FG001|Overall Study|Lost to Follow-up|8|||
44332680|NCT01371851|79337470|FG000|Overall Study|was arrested and put in jail|0|||
44332681|NCT01371851|79337471|FG001|Overall Study|was arrested and put in jail|1|||
44332682|NCT01371851|79337470|FG000|Overall Study|non study related adverse event|1|||
44332683|NCT01371851|79337471|FG001|Overall Study|non study related adverse event|0|||
44332684|NCT01371851|79337470|FG000|Overall Study|Blood Pressure outside study parameters|2|||
44332685|NCT01371851|79337471|FG001|Overall Study|Blood Pressure outside study parameters|0|||
44332686|NCT01371734|79337480|FG000|Overall Study|Other|2|||
44538530|NCT03401229|79549557|FG000|Overall Study|Other|1|||
44332687|NCT01371734|79337481|FG001|Overall Study|Other|1|||
44332688|NCT01371734|79337482|FG002|Overall Study|Other|2|||
44430452|NCT00567502|79438639|FG001|Overall Study|Sponsor request|0|||
44430453|NCT00567502|79438640|FG002|Overall Study|Sponsor request|30|||
44538531|NCT03401229|79549558|FG001|Overall Study|Other|3|||
44332689|NCT01371734|79337480|FG000|Overall Study|Withdrawal by Subject|3|||
44332690|NCT01371734|79337481|FG001|Overall Study|Withdrawal by Subject|4|||
44332691|NCT01371734|79337482|FG002|Overall Study|Withdrawal by Subject|9|||
44332692|NCT01371734|79337480|FG000|Overall Study|Lost to Follow-up|5|||
44332693|NCT01371734|79337481|FG001|Overall Study|Lost to Follow-up|3|||
44332694|NCT01371734|79337482|FG002|Overall Study|Lost to Follow-up|1|||
44332695|NCT01371734|79337480|FG000|Overall Study|Protocol Violation|3|||
44430454|NCT00567502|79438641|FG003|Overall Study|Sponsor request|1|||
44430455|NCT00567502|79438638|FG000|Overall Study|Never Initiated Treatment|0|||
44430456|NCT00567502|79438639|FG001|Overall Study|Never Initiated Treatment|0|||
44430457|NCT00567502|79438640|FG002|Overall Study|Never Initiated Treatment|0|||
44430458|NCT00567502|79438641|FG003|Overall Study|Never Initiated Treatment|72|||
44430459|NCT00396331|79438666|FG000|Overall Study|Failed to mobilize - no transplant|8|||
44430460|NCT00396331|79438666|FG000|Overall Study|Did not go on to transplant|5|||
44430461|NCT00396331|79438666|FG000|Overall Study|Lost to Follow-up|3|||
44430462|NCT00396331|79438666|FG000|Overall Study|Death|16|||
44430463|NCT00396253|79438678|FG000|Overall Study|Protocol Violation|1|||
44430464|NCT00396253|79438678|FG000|Overall Study|Withdrawal by Subject|7|||
44430465|NCT00396253|79438678|FG000|Overall Study|Death|3|||
44430466|NCT00396253|79438678|FG000|Overall Study|Physician Decision|1|||
44430467|NCT00396253|79438678|FG000|Overall Study|Change in eligibility status|1|||
44430468|NCT00604162|79438682|FG000|Overall Study|Physician Decision|3|||
44430469|NCT00604162|79438682|FG000|Overall Study|Withdrawal by Subject|1|||
44430470|NCT00396097|79438691|FG000|Overall Study|Withdrawal by Subject|17|||
44430471|NCT00396097|79438692|FG001|Overall Study|Withdrawal by Subject|17|||
44430472|NCT00396097|79438691|FG000|Overall Study|Lost to Follow-up|4|||
44430473|NCT00396097|79438692|FG001|Overall Study|Lost to Follow-up|9|||
44430474|NCT00396097|79438691|FG000|Overall Study|Other|3|||
44430475|NCT00396097|79438692|FG001|Overall Study|Other|5|||
44538532|NCT03401229|79549557|FG000|Overall Study|Adverse Event|8|||
44538533|NCT03401229|79549558|FG001|Overall Study|Adverse Event|6|||
44538534|NCT03401229|79549557|FG000|Overall Study|Withdrawal by Subject|29|||
44538535|NCT03401229|79549558|FG001|Overall Study|Withdrawal by Subject|26|||
44538536|NCT03401229|79549557|FG000|Overall Study|COVID-19|0|||
44538537|NCT03401229|79549558|FG001|Overall Study|COVID-19|1|||
44538538|NCT03349515|79549566|FG000|Overall Study|Lack of Efficacy|2|||
44538539|NCT03349515|79549567|FG001|Overall Study|Lack of Efficacy|0|||
44538540|NCT03349515|79549566|FG000|Overall Study|Physician Decision|3|||
44538541|NCT03349515|79549567|FG001|Overall Study|Physician Decision|1|||
44538542|NCT03349437|79549573|FG000|Screening|Screen Fail|4|||
44538543|NCT03349437|79549574|FG001|Screening|Screen Fail|0|||
44538544|NCT03349437|79549575|FG002|Screening|Screen Fail|0|||
44538545|NCT03349437|79549573|FG000|Screening|Withdrawn|1|||
44538546|NCT03349437|79549574|FG001|Screening|Withdrawn|0|||
44538547|NCT03349437|79549575|FG002|Screening|Withdrawn|0|||
44538548|NCT03380091|79549584|FG000|Overall Study|Withdrawal by Subject|2|||
44538549|NCT03380091|79549585|FG001|Overall Study|Withdrawal by Subject|1|||
44538550|NCT03379233|79549595|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
44538551|NCT03379233|79549596|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
44538552|NCT01377922|79549604|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
44538553|NCT01377922|79549605|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
44538554|NCT03372603|79549611|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
44538555|NCT03372603|79549612|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
44538556|NCT03372603|79549611|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
44538557|NCT03372603|79549612|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
44538558|NCT01377844|79549620|FG000|Overall Study|Withdrawal by Subject|25|||
44538559|NCT01377844|79549621|FG001|Overall Study|Withdrawal by Subject|28|||
44538560|NCT01377844|79549620|FG000|Overall Study|Protocol Violation|2|||
44332696|NCT01371734|79337481|FG001|Overall Study|Protocol Violation|1|||
44332697|NCT01371734|79337482|FG002|Overall Study|Protocol Violation|2|||
44430476|NCT00396097|79438691|FG000|Overall Study|Protocol Violation|0|||
44430477|NCT00396097|79438692|FG001|Overall Study|Protocol Violation|6|||
44538561|NCT01377844|79549621|FG001|Overall Study|Protocol Violation|3|||
44538562|NCT01377844|79549620|FG000|Overall Study|Adverse Event|3|||
44538563|NCT01377844|79549621|FG001|Overall Study|Adverse Event|0|||
44538564|NCT01377844|79549620|FG000|Overall Study|Physician Decision|6|||
44157165|NCT01559818|78948674|FG000|Overall Study|Physician Decision|1|||
44430478|NCT00396097|79438691|FG000|Overall Study|Adverse Event|1|||
44538565|NCT01377844|79549621|FG001|Overall Study|Physician Decision|3|||
44430479|NCT00396097|79438692|FG001|Overall Study|Adverse Event|5|||
44430480|NCT00396097|79438691|FG000|Overall Study|Insufficient Clinical Response|1|||
44430481|NCT00396097|79438692|FG001|Overall Study|Insufficient Clinical Response|4|||
44430482|NCT00375505|79438704|FG000|Overall Study|Adverse Event|1|||
44430483|NCT00375505|79438705|FG001|Overall Study|Adverse Event|2|||
44332698|NCT01371734|79337480|FG000|Overall Study|Adverse Event|8|||
44332699|NCT01371734|79337481|FG001|Overall Study|Adverse Event|8|||
44430484|NCT00375427|79438713|FG000|Overall Study|Adverse Event|21|||
44538566|NCT01377844|79549620|FG000|Overall Study|Study terminated by Sponsor|0|||
44430485|NCT00375427|79438714|FG001|Overall Study|Adverse Event|27|||
44430486|NCT00375427|79438713|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44430487|NCT00375427|79438714|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44430488|NCT00375427|79438713|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44430489|NCT00375427|79438714|FG001|Overall Study|Abnormal laboratory value(s)|2|||
44430490|NCT00375427|79438713|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44430491|NCT00375427|79438714|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
44430492|NCT00375427|79438713|FG000|Overall Study|Patient no longer requires study drug|3|||
44430493|NCT00375427|79438714|FG001|Overall Study|Patient no longer requires study drug|7|||
44430494|NCT00375427|79438713|FG000|Overall Study|Protocol Violation|10|||
44430495|NCT00375427|79438714|FG001|Overall Study|Protocol Violation|8|||
44430496|NCT00375427|79438713|FG000|Overall Study|Withdrawal by Subject|9|||
44430497|NCT00375427|79438714|FG001|Overall Study|Withdrawal by Subject|13|||
44430498|NCT00375427|79438713|FG000|Overall Study|Lost to Follow-up|1|||
44430499|NCT00375427|79438714|FG001|Overall Study|Lost to Follow-up|1|||
44430500|NCT00375427|79438713|FG000|Overall Study|Administrative reasons|0|||
44430501|NCT00375427|79438714|FG001|Overall Study|Administrative reasons|1|||
44430502|NCT00375427|79438713|FG000|Overall Study|Death|11|||
44430503|NCT00375427|79438714|FG001|Overall Study|Death|10|||
44430504|NCT00393913|79438720|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
44430505|NCT00393913|79438720|FG000|Initial Assessment|Withdrawal by Subject|16|||
44430506|NCT00393913|79438720|FG000|CPAP|Withdrawal by Subject|3|||
44430507|NCT00393913|79438720|FG000|CPAP|Physician Decision|1|||
44430508|NCT00393913|79438720|FG000|CPAP|TEchnical problem with CPAP|3|||
44430509|NCT00567268|79438725|FG000|Overall Study|Protocol Violation|7|||
44430510|NCT00567268|79438725|FG000|Overall Study|Lost to Follow-up|36|||
44430511|NCT00567268|79438725|FG000|Overall Study|No Visit After First Day of Treatment|2|||
44430512|NCT00567268|79438725|FG000|Overall Study|No Drug Administration|4|||
44430513|NCT00567268|79438725|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
44430514|NCT03976648|79438766|FG000|Overall Study|Adverse Event|0|||
44430515|NCT03976648|79438767|FG001|Overall Study|Adverse Event|2|||
44430516|NCT03976648|79438766|FG000|Overall Study|Study terminated by sponsor|21|||
44430517|NCT03976648|79438767|FG001|Overall Study|Study terminated by sponsor|8|||
44430518|NCT00566254|79438775|FG000|Overall Study|Adverse Event|3|||
44430519|NCT00566254|79438776|FG001|Overall Study|Adverse Event|1|||
44430520|NCT00566254|79438775|FG000|Overall Study|Protocol Violation|1|||
44430521|NCT00566254|79438776|FG001|Overall Study|Protocol Violation|3|||
44430522|NCT00566254|79438775|FG000|Overall Study|Withdrawal by Subject|1|||
44430523|NCT00566254|79438776|FG001|Overall Study|Withdrawal by Subject|2|||
44430524|NCT00566254|79438775|FG000|Overall Study|Lack of Efficacy|5|||
44430525|NCT00566254|79438776|FG001|Overall Study|Lack of Efficacy|6|||
44430526|NCT00566254|79438775|FG000|Overall Study|Other|0|||
44430527|NCT00566254|79438776|FG001|Overall Study|Other|2|||
44430528|NCT00393523|79438787|FG000|Overall Study|Lost to Follow-up|0|||
44430529|NCT00393523|79438788|FG001|Overall Study|Lost to Follow-up|0|||
44538567|NCT01377844|79549621|FG001|Overall Study|Study terminated by Sponsor|1|||
44538568|NCT03372369|79549630|FG000|Qualification Period|Withdrawal by Subject|16|||
44157166|NCT01559818|78948674|FG000|Overall Study|Pregnancy|1|||
44157167|NCT01559818|78948674|FG000|Overall Study|Study terminated by Sponsor|4|||
44332700|NCT01371734|79337482|FG002|Overall Study|Adverse Event|3|||
44332701|NCT01371734|79337480|FG000|Overall Study|Lack of Efficacy|2|||
44332702|NCT01371734|79337481|FG001|Overall Study|Lack of Efficacy|2|||
44332703|NCT01371734|79337482|FG002|Overall Study|Lack of Efficacy|0|||
44332704|NCT01365494|79337492|FG000|Overall Study|Adverse Event|1|||
44332705|NCT01365494|79337493|FG001|Overall Study|Adverse Event|0|||
44332706|NCT01365494|79337492|FG000|Overall Study|Withdrawal by Subject|0|||
44332707|NCT01365494|79337493|FG001|Overall Study|Withdrawal by Subject|1|||
44332708|NCT01365494|79337492|FG000|Overall Study|Lost to Follow-up|1|||
44332709|NCT01365494|79337493|FG001|Overall Study|Lost to Follow-up|2|||
44332710|NCT01357889|79337502|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
44332711|NCT01357889|79337503|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
44332712|NCT01357889|79337502|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
44332713|NCT01357889|79337503|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
44332714|NCT01357889|79337502|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
44332715|NCT01357889|79337503|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
44538569|NCT03372369|79549631|FG001|Qualification Period|Withdrawal by Subject|13|||
44332716|NCT01357889|79337502|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
44430530|NCT00393523|79438789|FG002|Overall Study|Lost to Follow-up|0|||
44430531|NCT00393523|79438790|FG003|Overall Study|Lost to Follow-up|2|||
44430532|NCT00393523|79438791|FG004|Overall Study|Lost to Follow-up|1|||
44430533|NCT00393523|79438787|FG000|Overall Study|Protocol Violation|6|||
44430534|NCT00393523|79438788|FG001|Overall Study|Protocol Violation|2|||
44430535|NCT00393523|79438789|FG002|Overall Study|Protocol Violation|0|||
44430536|NCT00393523|79438790|FG003|Overall Study|Protocol Violation|1|||
44430537|NCT00393523|79438791|FG004|Overall Study|Protocol Violation|0|||
44430538|NCT00393523|79438787|FG000|Overall Study|Withdrawal by Subject|6|||
44430539|NCT00393523|79438788|FG001|Overall Study|Withdrawal by Subject|7|||
44430540|NCT00393523|79438789|FG002|Overall Study|Withdrawal by Subject|2|||
44430541|NCT00393523|79438790|FG003|Overall Study|Withdrawal by Subject|3|||
44430542|NCT00393523|79438791|FG004|Overall Study|Withdrawal by Subject|0|||
44430543|NCT00393523|79438787|FG000|Overall Study|Difficulties in specimen collection|0|||
44430544|NCT00393523|79438788|FG001|Overall Study|Difficulties in specimen collection|0|||
44430545|NCT00393523|79438789|FG002|Overall Study|Difficulties in specimen collection|1|||
44430546|NCT00393523|79438790|FG003|Overall Study|Difficulties in specimen collection|0|||
44430547|NCT00393523|79438791|FG004|Overall Study|Difficulties in specimen collection|0|||
44430548|NCT00393523|79438787|FG000|Overall Study|Vaccine supply issue|0|||
44430549|NCT00393523|79438788|FG001|Overall Study|Vaccine supply issue|0|||
44430550|NCT00393523|79438789|FG002|Overall Study|Vaccine supply issue|1|||
44430551|NCT00393523|79438790|FG003|Overall Study|Vaccine supply issue|0|||
44430552|NCT00393523|79438791|FG004|Overall Study|Vaccine supply issue|0|||
44430553|NCT00393367|79438804|FG000|Overall Study|Protocol Violation|2|||
44430554|NCT00393367|79438805|FG001|Overall Study|Protocol Violation|5|||
44430555|NCT00393367|79438804|FG000|Overall Study|Withdrawal by Subject|0|||
44430556|NCT00393367|79438805|FG001|Overall Study|Withdrawal by Subject|2|||
44430557|NCT00395863|79438815|FG000|Overall Study|Patients did not complete both exams|2|||
44430558|NCT00395863|79438816|FG001|Overall Study|Patients did not complete both exams|3|||
44430559|NCT00395629|79438828|FG000|Core Study|Adverse Event|0|||
44430560|NCT00395629|79438829|FG001|Core Study|Adverse Event|3|||
44430561|NCT00395629|79438830|FG002|Core Study|Adverse Event|4|||
44430562|NCT00395629|79438828|FG000|Core Study|Abnormal laboratory value(s)|0|||
44430563|NCT00395629|79438829|FG001|Core Study|Abnormal laboratory value(s)|0|||
44430564|NCT00395629|79438830|FG002|Core Study|Abnormal laboratory value(s)|1|||
44332717|NCT01357889|79337503|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
44332718|NCT01357889|79337502|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
44332719|NCT01357889|79337503|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
44332720|NCT01357889|79337502|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
44332721|NCT01357889|79337503|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
44332722|NCT01357889|79337502|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
44332723|NCT01357889|79337503|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
44332724|NCT01357889|79337502|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
44332725|NCT01357889|79337503|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
44332726|NCT01357889|79337502|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
44332727|NCT01357889|79337503|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
44332728|NCT01357889|79337502|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
44332729|NCT01357889|79337503|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
44332730|NCT01357889|79337502|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
44332731|NCT01357889|79337503|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
44332732|NCT01357889|79337502|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
44332733|NCT01357889|79337503|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
44332734|NCT01357889|79337502|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
44332735|NCT01357889|79337503|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
44332736|NCT01357850|79337515|FG000|Overall Study|Lost to Follow-up|1|||
44332737|NCT01357850|79337516|FG001|Overall Study|Lost to Follow-up|0|||
44332738|NCT01357850|79337517|FG002|Overall Study|Lost to Follow-up|0|||
44332739|NCT01357850|79337518|FG003|Overall Study|Lost to Follow-up|0|||
44332740|NCT01357655|79337531|FG000|Overall Study|Administrative Reason by Sponsor|45|||
44332741|NCT01357655|79337532|FG001|Overall Study|Administrative Reason by Sponsor|0|||
44430565|NCT00395629|79438828|FG000|Core Study|Protocol Violation|1|||
44430566|NCT00395629|79438829|FG001|Core Study|Protocol Violation|0|||
44430567|NCT00395629|79438830|FG002|Core Study|Protocol Violation|0|||
44332742|NCT01357655|79337531|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
44332743|NCT01357655|79337532|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
44332744|NCT01357655|79337531|FG000|Overall Study|Disease Progression|1|||
44332745|NCT01357655|79337532|FG001|Overall Study|Disease Progression|0|||
44430568|NCT00395629|79438828|FG000|Core Study|Withdrawal by Subject|0|||
44430569|NCT00395629|79438829|FG001|Core Study|Withdrawal by Subject|1|||
44430570|NCT00395629|79438830|FG002|Core Study|Withdrawal by Subject|1|||
44332746|NCT01357655|79337531|FG000|Overall Study|Lost to Follow-up|2|||
44332747|NCT01357655|79337532|FG001|Overall Study|Lost to Follow-up|0|||
44332748|NCT01357655|79337531|FG000|Overall Study|Maximum Clinical Benefit|2|||
44332749|NCT01357655|79337532|FG001|Overall Study|Maximum Clinical Benefit|0|||
44332750|NCT01357655|79337531|FG000|Overall Study|Reason Unspecified|1|||
44332751|NCT01357655|79337532|FG001|Overall Study|Reason Unspecified|0|||
44332752|NCT01357655|79337531|FG000|Overall Study|Study Drug Toxicity|11|||
44332753|NCT01357655|79337532|FG001|Overall Study|Study Drug Toxicity|0|||
44430571|NCT00395629|79438828|FG000|Core Study|Lost to Follow-up|0|||
44430572|NCT00395629|79438829|FG001|Core Study|Lost to Follow-up|0|||
44430573|NCT00395629|79438830|FG002|Core Study|Lost to Follow-up|1|||
44430574|NCT00395629|79438828|FG000|Extension Study|Adverse Event|0|||
44430575|NCT00395629|79438829|FG001|Extension Study|Adverse Event|0|||
44430576|NCT00395629|79438830|FG002|Extension Study|Adverse Event|2|||
44430577|NCT00395629|79438828|FG000|Extension Study|Administrative problems|0|||
44430578|NCT00395629|79438829|FG001|Extension Study|Administrative problems|0|||
44430579|NCT00395629|79438830|FG002|Extension Study|Administrative problems|1|||
44430580|NCT00392665|79438843|FG000|Overall Study|Death|16|||
44430581|NCT00392665|79438844|FG001|Overall Study|Death|14|||
44430582|NCT00392665|79438843|FG000|Overall Study|Lost to Follow-up|1|||
44430583|NCT00392665|79438844|FG001|Overall Study|Lost to Follow-up|1|||
44430584|NCT00622869|79438853|FG000|Overall Study|Subject Withdrew Consent|13|||
44430585|NCT00622869|79438854|FG001|Overall Study|Subject Withdrew Consent|17|||
44430586|NCT00622869|79438855|FG002|Overall Study|Subject Withdrew Consent|11|||
44430587|NCT00622869|79438853|FG000|Overall Study|Administrative Problems|11|||
44430588|NCT00622869|79438854|FG001|Overall Study|Administrative Problems|17|||
44430589|NCT00622869|79438855|FG002|Overall Study|Administrative Problems|13|||
44430590|NCT00622869|79438853|FG000|Overall Study|Death|12|||
44430591|NCT00622869|79438854|FG001|Overall Study|Death|15|||
44430592|NCT00622869|79438855|FG002|Overall Study|Death|10|||
44430593|NCT00622869|79438853|FG000|Overall Study|Lost to Follow-up|2|||
44430594|NCT00622869|79438854|FG001|Overall Study|Lost to Follow-up|4|||
44430595|NCT00622869|79438855|FG002|Overall Study|Lost to Follow-up|2|||
44430596|NCT00622869|79438853|FG000|Overall Study|Graft Loss|5|||
44430597|NCT00622869|79438854|FG001|Overall Study|Graft Loss|3|||
44430598|NCT00622869|79438855|FG002|Overall Study|Graft Loss|2|||
44430599|NCT00622869|79438853|FG000|Overall Study|Missing|0|||
44430600|NCT00622869|79438854|FG001|Overall Study|Missing|1|||
44430601|NCT00622869|79438855|FG002|Overall Study|Missing|1|||
44430602|NCT00395083|79438865|FG000|Overall Study|Withdrawal by Subject|6|||
44430603|NCT00395083|79438866|FG001|Overall Study|Withdrawal by Subject|5|||
44430604|NCT00395083|79438865|FG000|Overall Study|Developed another disease|4|||
44430605|NCT00395083|79438866|FG001|Overall Study|Developed another disease|3|||
44430606|NCT00366457|79438872|FG000|Overall Study|never began study therapy|2|||
44430607|NCT00624819|79438880|FG000|Follow-up Period: Year 4|Parents decision|0|||
44430608|NCT00624819|79438881|FG001|Follow-up Period: Year 4|Parents decision|0|||
44430609|NCT00624819|79438882|FG002|Follow-up Period: Year 4|Parents decision|1|||
44538570|NCT03372369|79549630|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
44538571|NCT03372369|79549631|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
44538572|NCT03372369|79549630|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
44332754|NCT01357655|79337531|FG000|Overall Study|Subject Withdrew Consent|1|||
44332755|NCT01357655|79337532|FG001|Overall Study|Subject Withdrew Consent|0|||
44538573|NCT03372369|79549631|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
44538574|NCT03371355|79549641|FG000|Overall Study|Investigator judgment|0|||
44538575|NCT03371355|79549642|FG001|Overall Study|Investigator judgment|0|||
44538576|NCT03371355|79549643|FG002|Overall Study|Investigator judgment|1|||
44538577|NCT03371355|79549644|FG003|Overall Study|Investigator judgment|1|||
44538578|NCT03371355|79549641|FG000|Overall Study|Voluntary withdrawal|1|||
44538579|NCT03371355|79549642|FG001|Overall Study|Voluntary withdrawal|0|||
44538580|NCT03371355|79549643|FG002|Overall Study|Voluntary withdrawal|1|||
44538581|NCT03371355|79549644|FG003|Overall Study|Voluntary withdrawal|2|||
44538582|NCT03371355|79549641|FG000|Overall Study|Adverse Event|0|||
44538583|NCT03371355|79549642|FG001|Overall Study|Adverse Event|1|||
44332756|NCT01357616|79337539|FG000|Overall Study|Adverse Event|1|||
44538584|NCT03371355|79549643|FG002|Overall Study|Adverse Event|2|||
44538585|NCT03371355|79549644|FG003|Overall Study|Adverse Event|3|||
44538586|NCT03371355|79549641|FG000|Overall Study|Reason not Specified|0|||
44332757|NCT01357616|79337540|FG001|Overall Study|Adverse Event|1|||
44430610|NCT00624819|79438883|FG003|Follow-up Period: Year 4|Parents decision|0|||
44430611|NCT00624819|79438880|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
44430612|NCT00624819|79438881|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
44430613|NCT00624819|79438882|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
44430614|NCT00624819|79438883|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
44430615|NCT03832387|79438895|FG000|Overall Study|Protocol Violation|2|||
44332758|NCT01357616|79337539|FG000|Overall Study|Lost to Follow-up|4|||
44332759|NCT01357616|79337540|FG001|Overall Study|Lost to Follow-up|3|||
44430616|NCT03832387|79438896|FG001|Overall Study|Protocol Violation|6|||
44430617|NCT03832387|79438895|FG000|Overall Study|EXCLUSION CRITERIA|3|||
44332760|NCT01357616|79337539|FG000|Overall Study|Protocol Violation|0|||
44332761|NCT01357616|79337540|FG001|Overall Study|Protocol Violation|2|||
44332762|NCT01357616|79337539|FG000|Overall Study|Inadequate Control of IOP|1|||
44332763|NCT01357616|79337540|FG001|Overall Study|Inadequate Control of IOP|2|||
44332764|NCT01357616|79337539|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
44332765|NCT01357616|79337540|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
44332766|NCT01357616|79337539|FG000|Overall Study|Withdrawal by Subject|1|||
44332767|NCT01357616|79337540|FG001|Overall Study|Withdrawal by Subject|0|||
44332768|NCT01357577|79337548|FG000|Overall Study|Lost to Follow-up|20|||
44332769|NCT01357577|79337549|FG001|Overall Study|Lost to Follow-up|16|||
44332770|NCT01357577|79337548|FG000|Overall Study|Withdrawal by Subject|16|||
44332771|NCT01357577|79337549|FG001|Overall Study|Withdrawal by Subject|8|||
44332772|NCT01357577|79337548|FG000|Overall Study|look at data in database?|1|||
44332773|NCT01357577|79337549|FG001|Overall Study|look at data in database?|2|||
44332774|NCT01351025|79337558|FG000|Week 0 - 20|Lost to Follow-up|2|||
44332775|NCT01351025|79337559|FG001|Week 0 - 20|Lost to Follow-up|1|||
44332776|NCT01351025|79337558|FG000|Week 0 - 20|Withdrawal by Subject|1|||
44332777|NCT01351025|79337559|FG001|Week 0 - 20|Withdrawal by Subject|0|||
44332778|NCT01351025|79337558|FG000|Week 24 - 44|Lost to Follow-up|0|||
44332779|NCT01351025|79337559|FG001|Week 24 - 44|Lost to Follow-up|2|||
44332780|NCT01351025|79337558|FG000|Week 24 - 44|Site closed|0|||
44332781|NCT01351025|79337559|FG001|Week 24 - 44|Site closed|1|||
44332782|NCT01351025|79337558|FG000|Week 24 - 44|unable to get to clinic|1|||
44332783|NCT01351025|79337559|FG001|Week 24 - 44|unable to get to clinic|1|||
44332784|NCT01349036|79337573|FG000|Overall Study|Disease progression|13|||
44332785|NCT01349036|79337574|FG001|Overall Study|Disease progression|22|||
44332786|NCT01349036|79337573|FG000|Overall Study|Other|1|||
44332787|NCT01349036|79337574|FG001|Overall Study|Other|0|||
44332788|NCT01349036|79337573|FG000|Overall Study|Withdrawal by Subject|0|||
44332789|NCT01349036|79337574|FG001|Overall Study|Withdrawal by Subject|2|||
44332790|NCT01348763|79337584|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
44332791|NCT01348763|79337584|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
44538587|NCT03371355|79549642|FG001|Overall Study|Reason not Specified|1|||
44538588|NCT03371355|79549643|FG002|Overall Study|Reason not Specified|0|||
44538589|NCT03371355|79549644|FG003|Overall Study|Reason not Specified|1|||
44538590|NCT03370419|79549658|FG000|Overall Study|Lost to Follow-up|16|||
44538591|NCT03369951|79549666|FG000|Overall Study|Withdrawal by Subject|3|||
44538592|NCT03369951|79549666|FG000|Overall Study|Death|1|||
44538593|NCT03369951|79549666|FG000|Overall Study|Lost to Follow-up|1|||
44538594|NCT03369951|79549666|FG000|Overall Study|Protocol Violation|1|||
44538595|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
44538596|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
44538597|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
44538598|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
44538599|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
44538600|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
44538601|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
44538602|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
44538603|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
44538604|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
44538605|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
44538606|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
44332792|NCT01346969|79337592|FG000|Overall Study|Withdrawal by Subject|0|||
44332793|NCT01346969|79337593|FG001|Overall Study|Withdrawal by Subject|0|||
44332794|NCT01346969|79337594|FG002|Overall Study|Withdrawal by Subject|1|||
44332795|NCT01346969|79337595|FG003|Overall Study|Withdrawal by Subject|0|||
44332796|NCT01346969|79337592|FG000|Overall Study|Lost to Follow-up|1|||
44332797|NCT01346969|79337593|FG001|Overall Study|Lost to Follow-up|0|||
44332798|NCT01346969|79337594|FG002|Overall Study|Lost to Follow-up|2|||
44332799|NCT01346969|79337595|FG003|Overall Study|Lost to Follow-up|0|||
44538607|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
44538608|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
44332800|NCT01346969|79337592|FG000|Overall Study|Physician Decision|0|||
44332801|NCT01346969|79337593|FG001|Overall Study|Physician Decision|0|||
44332802|NCT01346969|79337594|FG002|Overall Study|Physician Decision|0|||
44332803|NCT01346969|79337595|FG003|Overall Study|Physician Decision|1|||
44332804|NCT01346969|79337592|FG000|Overall Study|Randomized but not treated|1|||
44332805|NCT01346969|79337593|FG001|Overall Study|Randomized but not treated|0|||
44332806|NCT01346969|79337594|FG002|Overall Study|Randomized but not treated|0|||
44332807|NCT01346969|79337595|FG003|Overall Study|Randomized but not treated|0|||
44332808|NCT01346774|79337607|FG000|Overall Study|Did not take a single dose|6|||
44332809|NCT01346774|79337608|FG001|Overall Study|Did not take a single dose|4|||
44332810|NCT01346774|79337607|FG000|Overall Study|Lost to Follow-up|3|||
44332811|NCT01346774|79337608|FG001|Overall Study|Lost to Follow-up|4|||
44332812|NCT01346774|79337607|FG000|Overall Study|Withdrawal by Subject|1|||
44332813|NCT01346774|79337608|FG001|Overall Study|Withdrawal by Subject|4|||
44332814|NCT01346774|79337607|FG000|Overall Study|Protocol Violation|2|||
44332815|NCT01346774|79337608|FG001|Overall Study|Protocol Violation|3|||
44332816|NCT01346774|79337607|FG000|Overall Study|Adverse Event|1|||
44332817|NCT01346774|79337608|FG001|Overall Study|Adverse Event|2|||
44332818|NCT01346696|79337614|FG000|Overall Study|Death|1|||
44332819|NCT01346540|79337620|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
44332820|NCT01346540|79337621|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
44332821|NCT01346540|79337620|FG000|Overall Study|Adverse Event|0|||
44332822|NCT01346540|79337621|FG001|Overall Study|Adverse Event|4|||
44332823|NCT01342913|79337630|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
44332824|NCT01342913|79337631|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44332825|NCT01342913|79337632|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
44332826|NCT01342913|79337630|FG000|2-week Run-in Period|Physician Decision|6|||
44332827|NCT01342913|79337631|FG001|2-week Run-in Period|Physician Decision|0|||
44332828|NCT01342913|79337632|FG002|2-week Run-in Period|Physician Decision|0|||
44332829|NCT01342913|79337630|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
44332830|NCT01342913|79337631|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44332831|NCT01342913|79337632|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44332832|NCT01342913|79337630|FG000|2-week Run-in Period|Adverse Event|2|||
44332833|NCT01342913|79337631|FG001|2-week Run-in Period|Adverse Event|0|||
44332834|NCT01342913|79337632|FG002|2-week Run-in Period|Adverse Event|0|||
44332835|NCT01342913|79337630|FG000|2-week Run-in Period|Protocol Violation|5|||
44332836|NCT01342913|79337631|FG001|2-week Run-in Period|Protocol Violation|0|||
44332837|NCT01342913|79337632|FG002|2-week Run-in Period|Protocol Violation|0|||
44332838|NCT01342913|79337630|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
44332839|NCT01342913|79337631|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
44332840|NCT01342913|79337632|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
44332841|NCT01342913|79337630|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44332842|NCT01342913|79337631|FG001|Double-Blind Treatment Period|Adverse Event|3|||
44332843|NCT01342913|79337632|FG002|Double-Blind Treatment Period|Adverse Event|6|||
44332844|NCT01342913|79337630|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
44332845|NCT01342913|79337631|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
44332846|NCT01342913|79337632|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
44332847|NCT01342913|79337630|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
44332848|NCT01342913|79337631|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
44332849|NCT01342913|79337632|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
44332850|NCT01342913|79337630|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44332851|NCT01342913|79337631|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
44332852|NCT01342913|79337632|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
44332853|NCT01342913|79337630|FG000|Double-Blind Treatment Period|Physician Decision|0|||
44332854|NCT01342913|79337631|FG001|Double-Blind Treatment Period|Physician Decision|2|||
44332855|NCT01342913|79337632|FG002|Double-Blind Treatment Period|Physician Decision|0|||
44332856|NCT01342913|79337630|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44332857|NCT01342913|79337631|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44332858|NCT01342913|79337632|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44332859|NCT01342796|79337640|FG000|Overall Study|Withdrawal by Subject|2|||
44332860|NCT01342796|79337641|FG001|Overall Study|Withdrawal by Subject|0|||
44332861|NCT01342796|79337640|FG000|Overall Study|Lost to Follow-up|0|||
44332862|NCT01342796|79337641|FG001|Overall Study|Lost to Follow-up|3|||
44332863|NCT01342796|79337640|FG000|Overall Study|Inappropriate enrollment|1|||
44332864|NCT01342796|79337641|FG001|Overall Study|Inappropriate enrollment|0|||
44538609|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
44538610|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
44332865|NCT01342640|79337647|FG000|Overall Study|Adverse Event|3|||
44332866|NCT01342640|79337647|FG000|Overall Study|Protocol Violation|16|||
44332867|NCT01342640|79337647|FG000|Overall Study|Lost to Follow-up|21|||
44332868|NCT01342640|79337647|FG000|Overall Study|Other|1|||
44332869|NCT01342484|79337654|FG000|Overall Study|Other Reasons|1|||
44332870|NCT01342484|79337655|FG001|Overall Study|Other Reasons|0|||
44332871|NCT01342484|79337656|FG002|Overall Study|Other Reasons|0|||
44332872|NCT01342484|79337654|FG000|Overall Study|Protocol Violation|0|||
44332873|NCT01342484|79337655|FG001|Overall Study|Protocol Violation|0|||
44332874|NCT01342484|79337656|FG002|Overall Study|Protocol Violation|1|||
44332875|NCT01342484|79337654|FG000|Overall Study|Withdrawal by Subject|1|||
44332876|NCT01342484|79337655|FG001|Overall Study|Withdrawal by Subject|0|||
44332877|NCT01342484|79337656|FG002|Overall Study|Withdrawal by Subject|0|||
44332878|NCT01342445|79337666|FG000|Overall Study|Experienced side effects|0|||
44332879|NCT01342445|79337667|FG001|Overall Study|Experienced side effects|2|||
44332880|NCT01342211|79337682|FG000|Overall Study|Lost to Follow-up|0|||
44332881|NCT01342211|79337683|FG001|Overall Study|Lost to Follow-up|0|||
44332882|NCT01342211|79337684|FG002|Overall Study|Lost to Follow-up|0|||
44332883|NCT01342211|79337685|FG003|Overall Study|Lost to Follow-up|1|||
44332884|NCT01342211|79337686|FG004|Overall Study|Lost to Follow-up|0|||
44332885|NCT01342211|79337682|FG000|Overall Study|Adverse Event|0|||
44332886|NCT01342211|79337683|FG001|Overall Study|Adverse Event|0|||
44332887|NCT01342211|79337684|FG002|Overall Study|Adverse Event|0|||
44332888|NCT01342211|79337685|FG003|Overall Study|Adverse Event|0|||
44332889|NCT01342211|79337686|FG004|Overall Study|Adverse Event|1|||
44332890|NCT01342211|79337682|FG000|Overall Study|Withdrawal by Subject|0|||
44332891|NCT01342211|79337683|FG001|Overall Study|Withdrawal by Subject|0|||
44332892|NCT01342211|79337684|FG002|Overall Study|Withdrawal by Subject|0|||
44332893|NCT01342211|79337685|FG003|Overall Study|Withdrawal by Subject|1|||
44332894|NCT01342211|79337686|FG004|Overall Study|Withdrawal by Subject|0|||
44332895|NCT01342211|79337682|FG000|Overall Study|Randomized, but not Treated|0|||
44332896|NCT01342211|79337683|FG001|Overall Study|Randomized, but not Treated|2|||
44332897|NCT01342211|79337684|FG002|Overall Study|Randomized, but not Treated|0|||
44332898|NCT01342211|79337685|FG003|Overall Study|Randomized, but not Treated|0|||
44332899|NCT01342211|79337686|FG004|Overall Study|Randomized, but not Treated|1|||
44332900|NCT01342094|79337704|FG000|Overall Study|Adverse Event|5|||
44332901|NCT01342094|79337705|FG001|Overall Study|Adverse Event|0|||
44332902|NCT01342094|79337704|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
44332903|NCT01342094|79337705|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
44332904|NCT01342094|79337704|FG000|Overall Study|Withdrawal by Subject|0|||
44332905|NCT01342094|79337705|FG001|Overall Study|Withdrawal by Subject|2|||
44332906|NCT01340768|79337713|FG000|Overall Study|Lost to Follow-up|10|||
44332907|NCT01340768|79337714|FG001|Overall Study|Lost to Follow-up|4|||
44332908|NCT01340768|79337713|FG000|Overall Study|Withdrawal by Subject|5|||
44332909|NCT01340768|79337714|FG001|Overall Study|Withdrawal by Subject|1|||
44332910|NCT01340768|79337713|FG000|Overall Study|Other|2|||
44332911|NCT01340768|79337714|FG001|Overall Study|Other|0|||
44332912|NCT01340651|79337720|FG000|Overall Study|Adverse Event|3|||
44332913|NCT01340651|79337720|FG000|Overall Study|Consent Withdrawn|2|||
44332914|NCT01340651|79337720|FG000|Overall Study|Commercial Supply per Sponsor|12|||
44332915|NCT01340495|79337726|FG000|Overall Study|Withdrawal by Subject|1|||
44332916|NCT01340300|79337734|FG000|Overall Study|Lost to Follow-up|3|||
44332917|NCT01340300|79337735|FG001|Overall Study|Lost to Follow-up|0|||
44332918|NCT01340300|79337736|FG002|Overall Study|Lost to Follow-up|5|||
44332919|NCT01340300|79337737|FG003|Overall Study|Lost to Follow-up|10|||
44332920|NCT01340300|79337734|FG000|Overall Study|Withdrawal by Subject|5|||
44332921|NCT01340300|79337735|FG001|Overall Study|Withdrawal by Subject|6|||
44332922|NCT01340300|79337736|FG002|Overall Study|Withdrawal by Subject|6|||
44332923|NCT01340300|79337737|FG003|Overall Study|Withdrawal by Subject|3|||
44332924|NCT01340300|79337734|FG000|Overall Study|Adverse Event|1|||
44332925|NCT01340300|79337735|FG001|Overall Study|Adverse Event|0|||
44332926|NCT01340300|79337736|FG002|Overall Study|Adverse Event|4|||
44332927|NCT01340300|79337737|FG003|Overall Study|Adverse Event|0|||
44332928|NCT01340300|79337734|FG000|Overall Study|Physician Decision|0|||
44332929|NCT01340300|79337735|FG001|Overall Study|Physician Decision|1|||
44332930|NCT01340300|79337736|FG002|Overall Study|Physician Decision|0|||
44332931|NCT01340300|79337737|FG003|Overall Study|Physician Decision|0|||
44332932|NCT01340300|79337734|FG000|Overall Study|Unrelated sickness|0|||
44332933|NCT01340300|79337735|FG001|Overall Study|Unrelated sickness|2|||
44332934|NCT01340300|79337736|FG002|Overall Study|Unrelated sickness|0|||
44332935|NCT01340300|79337737|FG003|Overall Study|Unrelated sickness|1|||
44332936|NCT01340066|79337749|FG000|Placebo Run in Period|Screen Failures|27|||
44332937|NCT01340066|79337750|FG001|Placebo Run in Period|Screen Failures|0|||
44430618|NCT03832387|79438896|FG001|Overall Study|EXCLUSION CRITERIA|1|||
44430619|NCT00366301|79438906|FG000|Overall Study|Lost to Follow-up|4|||
44332938|NCT01340066|79337751|FG002|Placebo Run in Period|Screen Failures|0|||
44332939|NCT01340066|79337749|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
44332940|NCT01340066|79337750|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
44332941|NCT01340066|79337751|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
44332942|NCT01340066|79337749|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
44332943|NCT01340066|79337750|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
44332944|NCT01340066|79337751|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
44332945|NCT01340066|79337749|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
44332946|NCT01340066|79337750|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
44332947|NCT01340066|79337751|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
44332948|NCT01107535|79337758|FG000|Overall Study|Death|5|||
44332949|NCT01326546|79337764|FG000|Overall Study|Lost to Follow-up|8|||
44332950|NCT01326546|79337765|FG001|Overall Study|Lost to Follow-up|7|||
44332951|NCT01326546|79337764|FG000|Overall Study|Protocol Violation|3|||
44332952|NCT01326546|79337765|FG001|Overall Study|Protocol Violation|4|||
44332953|NCT01326546|79337764|FG000|Overall Study|Pregnancy|0|||
44332954|NCT01326546|79337765|FG001|Overall Study|Pregnancy|1|||
44332955|NCT01326546|79337764|FG000|Overall Study|Adverse Event|1|||
44332956|NCT01326546|79337765|FG001|Overall Study|Adverse Event|0|||
44332957|NCT01326546|79337764|FG000|Overall Study|Withdrawal by Subject|5|||
44332958|NCT01326546|79337765|FG001|Overall Study|Withdrawal by Subject|1|||
44332959|NCT01325532|79337773|FG000|Overall Study|Withdrawal by Subject|2|||
44332960|NCT01325532|79337774|FG001|Overall Study|Withdrawal by Subject|0|||
44332961|NCT01171963|79337782|FG000|Overall Study|Adverse Event|10|||
44332962|NCT01171963|79337783|FG001|Overall Study|Adverse Event|15|||
44332963|NCT01171963|79337782|FG000|Overall Study|Lost to Follow-up|23|||
44332964|NCT01171963|79337783|FG001|Overall Study|Lost to Follow-up|24|||
44332965|NCT01171963|79337782|FG000|Overall Study|Other - diarrhoea|1|||
44332966|NCT01171963|79337783|FG001|Overall Study|Other - diarrhoea|0|||
44332967|NCT01171963|79337782|FG000|Overall Study|Withdrawal by Subject|114|||
44332968|NCT01171963|79337783|FG001|Overall Study|Withdrawal by Subject|129|||
44332969|NCT01171183|79337794|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
44332970|NCT01171183|79337795|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
44332971|NCT01171183|79337794|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
44332972|NCT01171183|79337795|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
44332973|NCT01171183|79337794|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
44332974|NCT01171183|79337795|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
44332975|NCT01171183|79337794|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
44332976|NCT01171183|79337795|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
44332977|NCT01171183|79337794|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
44332978|NCT01171183|79337795|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
44332979|NCT01171183|79337794|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
44332980|NCT01171183|79337795|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
44332981|NCT01170091|79337801|FG000|Overall Study|Missing efficacy evaluation|3|||
44332982|NCT01170091|79337801|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
44332983|NCT01169779|79337807|FG000|Overall Study|Adverse Event|3|||
44332984|NCT01169779|79337808|FG001|Overall Study|Adverse Event|11|||
44332985|NCT01169779|79337807|FG000|Overall Study|Lack of Efficacy|1|||
44332986|NCT01169779|79337808|FG001|Overall Study|Lack of Efficacy|0|||
44332987|NCT01169779|79337807|FG000|Overall Study|Protocol Violation|1|||
44332988|NCT01169779|79337808|FG001|Overall Study|Protocol Violation|1|||
44332989|NCT01169779|79337807|FG000|Overall Study|Withdrawal by Subject|3|||
44332990|NCT01169779|79337808|FG001|Overall Study|Withdrawal by Subject|2|||
44332991|NCT01169779|79337807|FG000|Overall Study|Familial and personal reasons|3|||
44332992|NCT01169779|79337808|FG001|Overall Study|Familial and personal reasons|3|||
44332993|NCT01169701|79337816|FG000|Overall Study|Lost to Follow-up|1|||
44332994|NCT01169701|79337817|FG001|Overall Study|Lost to Follow-up|1|||
44332995|NCT01169701|79337816|FG000|Overall Study|Withdrawal by Subject|1|||
44332996|NCT01169701|79337817|FG001|Overall Study|Withdrawal by Subject|3|||
44332997|NCT01169701|79337816|FG000|Overall Study|Adverse Event|1|||
44332998|NCT01169701|79337817|FG001|Overall Study|Adverse Event|2|||
44332999|NCT01169701|79337816|FG000|Overall Study|Exclusion criteria|2|||
44333000|NCT01169701|79337817|FG001|Overall Study|Exclusion criteria|0|||
44333001|NCT01169701|79337816|FG000|Overall Study|Death|0|||
44333002|NCT01169701|79337817|FG001|Overall Study|Death|1|||
44333003|NCT01169701|79337816|FG000|Overall Study|Administrative problems|0|||
44333004|NCT01169701|79337817|FG001|Overall Study|Administrative problems|1|||
44333005|NCT01169701|79337816|FG000|Overall Study|Serious adverse event|0|||
44333006|NCT01169701|79337817|FG001|Overall Study|Serious adverse event|1|||
44333007|NCT01169701|79337816|FG000|Overall Study|Sponsor decision|0|||
44333008|NCT01169701|79337817|FG001|Overall Study|Sponsor decision|1|||
44333009|NCT01168999|79337827|FG000|Overall Study|Lost to Follow-up|2|||
44333010|NCT01168999|79337828|FG001|Overall Study|Lost to Follow-up|1|||
44333011|NCT01168999|79337829|FG002|Overall Study|Lost to Follow-up|0|||
44333012|NCT01168999|79337830|FG003|Overall Study|Lost to Follow-up|0|||
44333013|NCT01167907|79337842|FG000|Overall Study|Protocol Violation|1|||
44333014|NCT01167907|79337843|FG001|Overall Study|Protocol Violation|0|||
44333015|NCT01167907|79337842|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
44333016|NCT01167907|79337843|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
44333017|NCT01166659|79337849|FG000|Overall Study|Subject Decision|8|||
44333018|NCT01166659|79337849|FG000|Overall Study|Investigator Decision|2|||
44333019|NCT01166659|79337849|FG000|Overall Study|Death|1|||
44333020|NCT01166659|79337849|FG000|Overall Study|Lost to Follow-up|1|||
44333021|NCT01166659|79337849|FG000|Overall Study|Study Closed at Site|1|||
44333022|NCT01115491|79337854|FG000|Overall Study|Death|22|||
44333023|NCT01115491|79337854|FG000|Overall Study|Adverse Event|3|||
44333024|NCT01115491|79337854|FG000|Overall Study|Lost to Follow-up|3|||
44333025|NCT01115491|79337854|FG000|Overall Study|Withdrawal by Subject|1|||
44333026|NCT01115491|79337854|FG000|Overall Study|Physician Decision|1|||
44333027|NCT01113931|79337860|FG000|Overall Study|Adverse Event|2|||
44333028|NCT01113931|79337861|FG001|Overall Study|Adverse Event|2|||
44333029|NCT01113931|79337860|FG000|Overall Study|Physician Decision|0|||
44333030|NCT01113931|79337861|FG001|Overall Study|Physician Decision|2|||
44333031|NCT01113931|79337860|FG000|Overall Study|Lost to Follow-up|12|||
44333032|NCT01113931|79337861|FG001|Overall Study|Lost to Follow-up|9|||
44333033|NCT01113931|79337860|FG000|Overall Study|Various|2|||
44333034|NCT01113931|79337861|FG001|Overall Study|Various|4|||
44333035|NCT01113931|79337860|FG000|Overall Study|Withdrawal by Subject|3|||
44333036|NCT01113931|79337861|FG001|Overall Study|Withdrawal by Subject|0|||
44333037|NCT01107379|79337867|FG000|Overall Study|Withdrawal by Subject|18|||
44333038|NCT01107379|79337867|FG000|Overall Study|Lost to Follow-up|3|||
44333039|NCT01106911|79337871|FG000|Overall Study|Physician Decision|2|||
44333040|NCT01106911|79337871|FG000|Overall Study|deemed ineligible after screening|3|||
44333041|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
44333042|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
44333043|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
44333044|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
44333045|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Death|0|||
44333046|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Death|0|||
44333047|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Death|1|||
44333048|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Death|0|||
44333049|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
44333050|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
44333051|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
44333052|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
44333053|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
44333054|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
44333055|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
44333056|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
44333057|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
44333058|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
44333059|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
44333060|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
44333061|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
44333062|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
44333063|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
44333064|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
44333065|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
44333066|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
44333067|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
44333068|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
44333069|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
44333070|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
44333071|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
44333072|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
44333073|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
44333074|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
44333075|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44333076|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44333077|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
44333078|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
44333079|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
44333080|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
44333081|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
44333082|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
44333083|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
44430620|NCT00366301|79438907|FG001|Overall Study|Lost to Follow-up|4|||
44430621|NCT00366301|79438908|FG002|Overall Study|Lost to Follow-up|3|||
44430622|NCT00366301|79438909|FG003|Overall Study|Lost to Follow-up|7|||
44430623|NCT00366301|79438906|FG000|Overall Study|Withdrawal by Subject|4|||
44333084|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
44333085|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Other|8|||
44333086|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Other|14|||
44333087|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Other|8|||
44430624|NCT00366301|79438907|FG001|Overall Study|Withdrawal by Subject|2|||
44430625|NCT00366301|79438908|FG002|Overall Study|Withdrawal by Subject|1|||
44333088|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Other|23|||
44333089|NCT01106677|79337879|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
44333090|NCT01106677|79337880|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
44333091|NCT01106677|79337881|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
44333092|NCT01106677|79337882|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
44333093|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
44333094|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
44333095|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
44538611|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
44538612|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
44538613|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
44538614|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
44538615|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
44259012|NCT00210626|79115003|FG001|Overall Study|Sponser Request|0|||
44259013|NCT00210626|79115002|FG000|Overall Study|Other|4|||
44259014|NCT00210626|79115003|FG001|Overall Study|Other|5|||
44259015|NCT00217022|79115025|FG000|Overall Study|Withdrawal by Subject|1|||
44538616|NCT04040192|79549670|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
44333096|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
44333097|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Death|0|||
44333098|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Death|0|||
44333099|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Death|0|||
44333100|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Death|1|||
44333101|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
44333102|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
44333103|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
44333104|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
44333105|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44333106|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
44333107|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
44333108|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
44333109|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
44333110|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
44430626|NCT00366301|79438909|FG003|Overall Study|Withdrawal by Subject|1|||
44430627|NCT00365989|79438919|FG000|Overall Study|Withdrawal by Subject|1|||
44430628|NCT00365989|79438919|FG000|Overall Study|Non-compliance|1|||
44430629|NCT00622713|79438924|FG000|Overall Study|Adverse Event|35|||
44430630|NCT00622713|79438924|FG000|Overall Study|Administrative problems|4|||
44430631|NCT00622713|79438924|FG000|Overall Study|Withdrawal by Subject|11|||
44430632|NCT00622713|79438924|FG000|Overall Study|Lost to Follow-up|5|||
44430633|NCT00622713|79438924|FG000|Overall Study|Death|2|||
44430634|NCT00622713|79438924|FG000|Overall Study|Subject no longer required study drug|1|||
44430635|NCT00622713|79438924|FG000|Overall Study|Did not meet eligibility criteria|1|||
44430636|NCT00392197|79438930|FG000|Overall Study|Adverse Event|4|||
44430637|NCT00392197|79438931|FG001|Overall Study|Adverse Event|12|||
44430638|NCT00392197|79438930|FG000|Overall Study|Lack of Efficacy|3|||
44430639|NCT00392197|79438931|FG001|Overall Study|Lack of Efficacy|4|||
44430640|NCT00392197|79438930|FG000|Overall Study|Lost to Follow-up|0|||
44430641|NCT00392197|79438931|FG001|Overall Study|Lost to Follow-up|1|||
44538617|NCT04040192|79549671|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
44538618|NCT04040192|79549672|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
44259016|NCT00217022|79115026|FG001|Overall Study|Withdrawal by Subject|1|||
44259017|NCT00219284|79115373|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
44259018|NCT00219284|79115374|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
44259019|NCT00219284|79115373|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
44259020|NCT00219284|79115374|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
44259021|NCT00219284|79115373|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
44259022|NCT00219284|79115374|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
44259023|NCT00219284|79115373|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
44333111|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
44333112|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
44333113|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
44333114|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44430642|NCT00392197|79438930|FG000|Overall Study|Physician Decision|3|||
44430643|NCT00392197|79438931|FG001|Overall Study|Physician Decision|2|||
44430644|NCT00392197|79438930|FG000|Overall Study|Protocol Violation|7|||
44430645|NCT00392197|79438931|FG001|Overall Study|Protocol Violation|5|||
44430646|NCT00392197|79438930|FG000|Overall Study|Withdrawal by Subject|4|||
44259024|NCT00219284|79115374|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
44430647|NCT00392197|79438931|FG001|Overall Study|Withdrawal by Subject|6|||
44430648|NCT00391807|79438937|FG000|Overall Study|Did not receive study medication|23|||
44430649|NCT00391807|79438937|FG000|Overall Study|Adverse Event|177|||
44430650|NCT00391807|79438937|FG000|Overall Study|Pregnancy|25|||
44430651|NCT00391807|79438937|FG000|Overall Study|Lost to Follow-up|227|||
44430652|NCT00391807|79438937|FG000|Overall Study|Withdrawal by Subject|147|||
44430653|NCT00391807|79438937|FG000|Overall Study|Protocol Violation|20|||
44430654|NCT00391807|79438937|FG000|Overall Study|Various|96|||
44430655|NCT00624585|79438941|FG000|Overall Study|Death|3|||
44430656|NCT00624585|79438941|FG000|Overall Study|Disease Progression|6|||
44430657|NCT00624585|79438941|FG000|Overall Study|Adverse Event|3|||
44430658|NCT00622635|79438945|FG000|Treatment Period 1|Adverse Event|0|||
44430659|NCT00622635|79438946|FG001|Treatment Period 1|Adverse Event|0|||
44430660|NCT00622635|79438947|FG002|Treatment Period 1|Adverse Event|1|||
44430661|NCT00622635|79438948|FG003|Treatment Period 1|Adverse Event|0|||
44430662|NCT00622635|79438949|FG004|Treatment Period 1|Adverse Event|0|||
44430663|NCT00622635|79438950|FG005|Treatment Period 1|Adverse Event|0|||
44333115|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44333116|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44333117|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44333118|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
44333119|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
44333120|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44333121|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
44333122|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
44333123|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
44333124|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
44333125|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44333126|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44333127|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44333128|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
44333129|NCT01106677|79337879|FG000|Extension Period: Week 26 to Week 52|Other|6|||
44333130|NCT01106677|79337880|FG001|Extension Period: Week 26 to Week 52|Other|5|||
44333131|NCT01106677|79337881|FG002|Extension Period: Week 26 to Week 52|Other|8|||
44333132|NCT01106677|79337882|FG003|Extension Period: Week 26 to Week 52|Other|5|||
44333133|NCT01106287|79337903|FG000|Overall Study|Adverse Event|1|||
44333134|NCT01106287|79337904|FG001|Overall Study|Adverse Event|0|||
44333135|NCT01106287|79337905|FG002|Overall Study|Adverse Event|0|||
44333136|NCT01106287|79337906|FG003|Overall Study|Adverse Event|0|||
44333137|NCT01104493|79337922|FG000|Overall Study|Lost to Follow-up|0|||
44333138|NCT01104493|79337923|FG001|Overall Study|Lost to Follow-up|2|||
44333139|NCT01104415|79337929|FG000|Core Phase|Consent withdrawn by subjects|1|||
44333140|NCT01104415|79337930|FG001|Core Phase|Consent withdrawn by subjects|0|||
44333141|NCT01104415|79337929|FG000|Extension Period|Progressive disease|0|||
44333142|NCT01104415|79337930|FG001|Extension Period|Progressive disease|4|||
44333143|NCT01104415|79337929|FG000|Extension Period|Death|0|||
44333144|NCT01104415|79337930|FG001|Extension Period|Death|1|||
44333145|NCT01104415|79337929|FG000|Extension Period|Physician Decision|0|||
44333146|NCT01104415|79337930|FG001|Extension Period|Physician Decision|1|||
44333147|NCT01104415|79337929|FG000|Extension Period|Transition to Study LX1606.302|0|||
44430664|NCT00622635|79438945|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44430665|NCT00622635|79438946|FG001|Treatment Period 1|Withdrawal by Subject|1|||
44430666|NCT00622635|79438947|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44430667|NCT00622635|79438948|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44538619|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
44538620|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
44259025|NCT00219284|79115373|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
44259026|NCT00219284|79115374|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
44259027|NCT00219284|79115373|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
44259028|NCT00219284|79115374|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
44259029|NCT00219284|79115373|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
44259030|NCT00219284|79115374|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
44259031|NCT00219284|79115373|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
44259032|NCT00219284|79115374|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
44333148|NCT01104415|79337930|FG001|Extension Period|Transition to Study LX1606.302|4|||
44333149|NCT01104415|79337929|FG000|Extension Period|Heart surgery/feeling miserable|0|||
44430668|NCT00622635|79438949|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44430669|NCT00622635|79438950|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44430670|NCT00622635|79438945|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
44430671|NCT00622635|79438946|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
44430672|NCT00622635|79438947|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
44333150|NCT01104415|79337930|FG001|Extension Period|Heart surgery/feeling miserable|1|||
44333151|NCT01099579|79337940|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
44333152|NCT01099579|79337941|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
44333153|NCT01099579|79337942|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
44333154|NCT01099579|79337940|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
44333155|NCT01099579|79337941|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
44430673|NCT00622635|79438948|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
44430674|NCT00622635|79438949|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
44430675|NCT00622635|79438950|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
44430676|NCT00622635|79438945|FG000|Treatment Period 2|Adverse Event|1|||
44430677|NCT00622635|79438946|FG001|Treatment Period 2|Adverse Event|0|||
44430678|NCT00622635|79438947|FG002|Treatment Period 2|Adverse Event|0|||
44430679|NCT00622635|79438948|FG003|Treatment Period 2|Adverse Event|0|||
44430680|NCT00622635|79438949|FG004|Treatment Period 2|Adverse Event|0|||
44430681|NCT00622635|79438950|FG005|Treatment Period 2|Adverse Event|0|||
44430682|NCT00622635|79438945|FG000|Treatment Period 3|Adverse Event|0|||
44430683|NCT00622635|79438946|FG001|Treatment Period 3|Adverse Event|0|||
44430684|NCT00622635|79438947|FG002|Treatment Period 3|Adverse Event|0|||
44430685|NCT00622635|79438948|FG003|Treatment Period 3|Adverse Event|2|||
44430686|NCT00622635|79438949|FG004|Treatment Period 3|Adverse Event|0|||
44430687|NCT00622635|79438950|FG005|Treatment Period 3|Adverse Event|0|||
44430688|NCT00622635|79438945|FG000|Treatment Period 3|Withdrawal by Subject|0|||
44430689|NCT00622635|79438946|FG001|Treatment Period 3|Withdrawal by Subject|0|||
44430690|NCT00622635|79438947|FG002|Treatment Period 3|Withdrawal by Subject|0|||
44430691|NCT00622635|79438948|FG003|Treatment Period 3|Withdrawal by Subject|1|||
44430692|NCT00622635|79438949|FG004|Treatment Period 3|Withdrawal by Subject|0|||
44430693|NCT00622635|79438950|FG005|Treatment Period 3|Withdrawal by Subject|0|||
44430694|NCT00391027|79438960|FG000|Overall Study|Adverse Event|8|||
44430695|NCT00391027|79438961|FG001|Overall Study|Adverse Event|8|||
44430696|NCT00391027|79438960|FG000|Overall Study|Lack of Efficacy|3|||
44430697|NCT00391027|79438961|FG001|Overall Study|Lack of Efficacy|0|||
44430698|NCT00391027|79438960|FG000|Overall Study|Withdrawal by Subject|10|||
44430699|NCT00391027|79438961|FG001|Overall Study|Withdrawal by Subject|1|||
44430700|NCT00391027|79438960|FG000|Overall Study|Other|4|||
44430701|NCT00391027|79438961|FG001|Overall Study|Other|3|||
44430702|NCT00622401|79438970|FG000|Overall Study|Disease progression prior to treatment|3|||
44430703|NCT00622401|79438971|FG001|Overall Study|Disease progression prior to treatment|2|||
44430704|NCT00622401|79438972|FG002|Overall Study|Disease progression prior to treatment|0|||
44430705|NCT00621621|79438982|FG000|Overall Study|Subjects were exited at EP study|30|||
44430706|NCT00621621|79438983|FG001|Overall Study|Subjects were exited at EP study|0|||
44430707|NCT00621543|79438991|FG000|Overall Study|Lost to Follow-up|23|||
44430708|NCT00623805|79438997|FG000|Overall Study|Adverse Event|9|||
44333156|NCT01099579|79337942|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
44333157|NCT01099579|79337940|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
44333158|NCT01099579|79337941|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
44333159|NCT01099579|79337942|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
44333160|NCT01099579|79337940|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
44333161|NCT01099579|79337941|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
44333162|NCT01099579|79337942|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
44333163|NCT01099579|79337940|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
44333164|NCT01099579|79337941|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
44333165|NCT01099579|79337942|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
44333166|NCT01099579|79337940|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
44333167|NCT01099579|79337941|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
44333168|NCT01099579|79337942|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
44333169|NCT01099579|79337940|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
44333170|NCT01099579|79337941|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
44333171|NCT01099579|79337942|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
44333172|NCT01099579|79337940|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
44333173|NCT01099579|79337941|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
44430709|NCT00623805|79438998|FG001|Overall Study|Adverse Event|6|||
44430710|NCT00623805|79438997|FG000|Overall Study|Death|2|||
44430711|NCT00623805|79438998|FG001|Overall Study|Death|0|||
44333174|NCT01099579|79337942|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
44333175|NCT01099579|79337940|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
44430712|NCT00623805|79438997|FG000|Overall Study|Lack of Efficacy|3|||
44430713|NCT00623805|79438998|FG001|Overall Study|Lack of Efficacy|7|||
44430714|NCT00623805|79438997|FG000|Overall Study|Lost to Follow-up|2|||
44430715|NCT00623805|79438998|FG001|Overall Study|Lost to Follow-up|2|||
44430716|NCT00623805|79438997|FG000|Overall Study|Protocol Violation|1|||
44430717|NCT00623805|79438998|FG001|Overall Study|Protocol Violation|1|||
44430718|NCT00623805|79438997|FG000|Overall Study|Reason not Specified|3|||
44430719|NCT00623805|79438998|FG001|Overall Study|Reason not Specified|6|||
44430720|NCT00621309|79439004|FG000|Overall Study|Withdrawal by Subject|2|||
44333176|NCT01099579|79337941|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
44333177|NCT01099579|79337942|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
44333178|NCT01099579|79337940|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
44333179|NCT01099579|79337941|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
44333180|NCT01099579|79337942|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
44333181|NCT01103713|79337952|FG000|Overall Study|Lost to Follow-up|2|||
44333182|NCT01103713|79337952|FG000|Overall Study|Withdrawal by Subject|8|||
44333183|NCT01103713|79337952|FG000|Overall Study|Study terminated by sponsor|2|||
44333184|NCT01103713|79337952|FG000|Overall Study|Other|1|||
44333185|NCT01103479|79337962|FG000|Overall Study|Up to date with CRC screening|1|||
44333186|NCT01103479|79337963|FG001|Overall Study|Up to date with CRC screening|9|||
44333187|NCT01103479|79337964|FG002|Overall Study|Up to date with CRC screening|12|||
44333188|NCT01103479|79337962|FG000|Overall Study|Family history of CRC|1|||
44333189|NCT01103479|79337963|FG001|Overall Study|Family history of CRC|0|||
44333190|NCT01103479|79337964|FG002|Overall Study|Family history of CRC|2|||
44333191|NCT01103479|79337962|FG000|Overall Study|Active cancer|1|||
44333192|NCT01103479|79337963|FG001|Overall Study|Active cancer|0|||
44333193|NCT01103479|79337964|FG002|Overall Study|Active cancer|0|||
44333194|NCT01103479|79337962|FG000|Overall Study|Saw non-study physician|2|||
44333195|NCT01103479|79337963|FG001|Overall Study|Saw non-study physician|0|||
44333196|NCT01103479|79337964|FG002|Overall Study|Saw non-study physician|0|||
44333197|NCT01103323|79337975|FG000|Without/Before Drug Switch|Adverse Event|50|||
44430721|NCT00621309|79439005|FG001|Overall Study|Withdrawal by Subject|0|||
44430722|NCT00621309|79439006|FG002|Overall Study|Withdrawal by Subject|1|||
44430723|NCT00621309|79439007|FG003|Overall Study|Withdrawal by Subject|1|||
44430724|NCT00621309|79439008|FG004|Overall Study|Withdrawal by Subject|1|||
44430725|NCT00621309|79439009|FG005|Overall Study|Withdrawal by Subject|1|||
44430726|NCT00567190|79439017|FG000|Overall Study|Death|235|||
44430727|NCT00567190|79439018|FG001|Overall Study|Death|280|||
44430728|NCT00567190|79439017|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
44430729|NCT00567190|79439018|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
44430730|NCT00691938|79439036|FG000|Overall Study|QTc prolongation|1|||
44430731|NCT00691938|79439037|FG001|Overall Study|QTc prolongation|0|||
44430732|NCT00691938|79439038|FG002|Overall Study|QTc prolongation|0|||
44430733|NCT00691938|79439039|FG003|Overall Study|QTc prolongation|0|||
44430734|NCT00691938|79439040|FG004|Overall Study|QTc prolongation|0|||
44430735|NCT00691938|79439041|FG005|Overall Study|QTc prolongation|0|||
44430736|NCT00691938|79439042|FG006|Overall Study|QTc prolongation|0|||
44430737|NCT00365365|79439056|FG000|Overall Study|Randomized but not treated|0|||
44430738|NCT00365365|79439057|FG001|Overall Study|Randomized but not treated|2|||
44430739|NCT00365365|79439058|FG002|Overall Study|Randomized but not treated|0|||
44430740|NCT00365365|79439056|FG000|Overall Study|Poor compliance to protocol|0|||
44430741|NCT00365365|79439057|FG001|Overall Study|Poor compliance to protocol|1|||
44430742|NCT00365365|79439058|FG002|Overall Study|Poor compliance to protocol|0|||
44430743|NCT00365365|79439056|FG000|Overall Study|Lost to Follow-up|3|||
44430744|NCT00365365|79439057|FG001|Overall Study|Lost to Follow-up|3|||
44430745|NCT00365365|79439058|FG002|Overall Study|Lost to Follow-up|3|||
44430746|NCT00365365|79439056|FG000|Overall Study|Death|1|||
44430747|NCT00365365|79439057|FG001|Overall Study|Death|3|||
44430748|NCT00365365|79439058|FG002|Overall Study|Death|0|||
44430749|NCT00365365|79439056|FG000|Overall Study|Subject's request|11|||
44430750|NCT00365365|79439057|FG001|Overall Study|Subject's request|13|||
44430751|NCT00365365|79439058|FG002|Overall Study|Subject's request|1|||
44333198|NCT01103323|79337976|FG001|Without/Before Drug Switch|Adverse Event|7|||
44333199|NCT01103323|79337975|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
44333200|NCT01103323|79337976|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
44333201|NCT01103323|79337975|FG000|Without/Before Drug Switch|Protocol Violation|2|||
44430752|NCT00365365|79439056|FG000|Overall Study|Disease progression/relapse|9|||
44430753|NCT00365365|79439057|FG001|Overall Study|Disease progression/relapse|6|||
44430754|NCT00365365|79439058|FG002|Overall Study|Disease progression/relapse|7|||
44430755|NCT00365365|79439056|FG000|Overall Study|Adverse Event|6|||
44430756|NCT00365365|79439057|FG001|Overall Study|Adverse Event|6|||
44430757|NCT00365365|79439058|FG002|Overall Study|Adverse Event|3|||
44430758|NCT00365365|79439056|FG000|Overall Study|Moved|2|||
44430759|NCT00365365|79439057|FG001|Overall Study|Moved|0|||
44333202|NCT01103323|79337976|FG001|Without/Before Drug Switch|Protocol Violation|0|||
44430760|NCT00365365|79439058|FG002|Overall Study|Moved|0|||
44430761|NCT00365365|79439056|FG000|Overall Study|New cancer|1|||
44430762|NCT00365365|79439057|FG001|Overall Study|New cancer|0|||
44430763|NCT00365365|79439058|FG002|Overall Study|New cancer|0|||
44430764|NCT00365365|79439056|FG000|Overall Study|Withdrew consent|1|||
44430765|NCT00365365|79439057|FG001|Overall Study|Withdrew consent|1|||
44333203|NCT01103323|79337975|FG000|Without/Before Drug Switch|Physician Decision|2|||
44333204|NCT01103323|79337976|FG001|Without/Before Drug Switch|Physician Decision|0|||
44333205|NCT01103323|79337975|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
44430766|NCT00365365|79439058|FG002|Overall Study|Withdrew consent|0|||
44430767|NCT00365365|79439056|FG000|Overall Study|Second malignancy|0|||
44333206|NCT01103323|79337976|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
44333207|NCT01103323|79337975|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
44333208|NCT01103323|79337976|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
44333209|NCT01103323|79337975|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
44333210|NCT01103323|79337976|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
44333211|NCT01103245|79337987|FG000|Overall Study|Withdrawal by Subject|1|||
44333212|NCT01103245|79337988|FG001|Overall Study|Withdrawal by Subject|0|||
44333213|NCT01103245|79337989|FG002|Overall Study|Withdrawal by Subject|3|||
44333214|NCT01103245|79337990|FG003|Overall Study|Withdrawal by Subject|0|||
44333215|NCT01103245|79337987|FG000|Overall Study|Inadequate IV access|1|||
44333216|NCT01103245|79337988|FG001|Overall Study|Inadequate IV access|0|||
44333217|NCT01103245|79337989|FG002|Overall Study|Inadequate IV access|0|||
44333218|NCT01103245|79337990|FG003|Overall Study|Inadequate IV access|0|||
44333219|NCT01103245|79337987|FG000|Overall Study|Adverse Event|0|||
44333220|NCT01103245|79337988|FG001|Overall Study|Adverse Event|2|||
44333221|NCT01103245|79337989|FG002|Overall Study|Adverse Event|1|||
44333222|NCT01103245|79337990|FG003|Overall Study|Adverse Event|0|||
44333223|NCT01103245|79337987|FG000|Overall Study|Physician Decision|1|||
44333224|NCT01103245|79337988|FG001|Overall Study|Physician Decision|0|||
44333225|NCT01103245|79337989|FG002|Overall Study|Physician Decision|0|||
44333226|NCT01103245|79337990|FG003|Overall Study|Physician Decision|0|||
44333227|NCT01099267|79338000|FG000|MDS-003 Study|Adverse Event|37|||
44333228|NCT01099267|79338000|FG000|MDS-003 Study|Lack of Efficacy|52|||
44333229|NCT01099267|79338000|FG000|MDS-003 Study|Withdrawal by Subject|8|||
44333230|NCT01099267|79338000|FG000|MDS-003 Study|Lost to Follow-up|1|||
44333231|NCT01099267|79338000|FG000|MDS-003 Study|Death|11|||
44430768|NCT00365365|79439057|FG001|Overall Study|Second malignancy|1|||
44430769|NCT00365365|79439058|FG002|Overall Study|Second malignancy|0|||
44430770|NCT00365365|79439056|FG000|Overall Study|Patient/physician decision|0|||
44430771|NCT00365365|79439057|FG001|Overall Study|Patient/physician decision|0|||
44430772|NCT00365365|79439058|FG002|Overall Study|Patient/physician decision|1|||
44430773|NCT00623727|79439068|FG000|Double Blind (DB)|Adverse Event|1|||
44430774|NCT00623727|79439069|FG001|Double Blind (DB)|Adverse Event|3|||
44430775|NCT00623727|79439068|FG000|Double Blind (DB)|Physician Decision|0|||
44430776|NCT00623727|79439069|FG001|Double Blind (DB)|Physician Decision|1|||
44430777|NCT00623727|79439068|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
44430778|NCT00623727|79439069|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
44430779|NCT00623727|79439068|FG000|Double Blind (DB)|Lack of Efficacy|2|||
44430780|NCT00623727|79439069|FG001|Double Blind (DB)|Lack of Efficacy|2|||
44430781|NCT00623727|79439068|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
44430782|NCT00623727|79439069|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
44430783|NCT00623727|79439068|FG000|Double Blind (DB)|Lost to Follow-up|1|||
44430784|NCT00623727|79439069|FG001|Double Blind (DB)|Lost to Follow-up|1|||
44430785|NCT00623727|79439068|FG000|Double Blind (DB)|Protocol Violation|2|||
44430786|NCT00623727|79439069|FG001|Double Blind (DB)|Protocol Violation|2|||
44430787|NCT00623727|79439068|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
44430788|NCT00623727|79439069|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
44430789|NCT00623727|79439068|FG000|Open Label Follow-up|Study termination|0|||
44430790|NCT00623727|79439069|FG001|Open Label Follow-up|Study termination|6|||
44430791|NCT00623727|79439068|FG000|Open Label Follow-up|Participant convenience|0|||
44430792|NCT00623727|79439069|FG001|Open Label Follow-up|Participant convenience|1|||
44430793|NCT00372775|79439077|FG000|Overall Study|Adverse Event|8|||
44430794|NCT00372775|79439077|FG000|Overall Study|Death|15|||
44430795|NCT00372775|79439077|FG000|Overall Study|Objective progression or relapse|30|||
44430796|NCT00372775|79439077|FG000|Overall Study|Global deterioration of health status|6|||
44430797|NCT00372775|79439077|FG000|Overall Study|Withdrawal by Subject|1|||
44430798|NCT00372775|79439077|FG000|Overall Study|Other|1|||
44430799|NCT00372775|79439077|FG000|Overall Study|Not Treated|2|||
44430800|NCT00372697|79439083|FG000|Overall Study|Protocol Violation|1|||
44333232|NCT01099267|79338000|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
44333233|NCT01099267|79338000|FG000|MDS-003 Study|Disease Progression|7|||
44430801|NCT00372697|79439084|FG001|Overall Study|Protocol Violation|1|||
44333234|NCT01099267|79338000|FG000|MDS-003 Study|Investigator Decision|2|||
44333235|NCT01099267|79338000|FG000|MDS-003 Study|Non-Compliance|2|||
44333236|NCT01099267|79338000|FG000|MDS-003 Study|Loss of Response|1|||
44333237|NCT01099267|79338000|FG000|MDS-003 Study|Secondary Malign Disease|1|||
44333238|NCT01098487|79338004|FG000|Overall Study|Adverse Event|22|||
44333239|NCT01098487|79338004|FG000|Overall Study|Lack of Efficacy|11|||
44333240|NCT01098487|79338004|FG000|Overall Study|Withdrawal by Subject|7|||
44333241|NCT01098487|79338004|FG000|Overall Study|Lost to Follow-up|3|||
44333242|NCT01098487|79338004|FG000|Overall Study|Physician Decision|1|||
44430802|NCT00690378|79439092|FG000|Overall Study|Adverse Event|1|||
44430803|NCT00690378|79439093|FG001|Overall Study|Adverse Event|0|||
44430804|NCT00690378|79439092|FG000|Overall Study|Withdrawal by Subject|2|||
44430805|NCT00690378|79439093|FG001|Overall Study|Withdrawal by Subject|0|||
44430806|NCT00690378|79439092|FG000|Overall Study|Protocol Violation|1|||
44430807|NCT00690378|79439093|FG001|Overall Study|Protocol Violation|0|||
44430808|NCT00690378|79439092|FG000|Overall Study|Lost to Follow-up|2|||
44430809|NCT00690378|79439093|FG001|Overall Study|Lost to Follow-up|3|||
44430810|NCT00690378|79439092|FG000|Overall Study|Did not meet inc/exc criteria|13|||
44430811|NCT00690378|79439093|FG001|Overall Study|Did not meet inc/exc criteria|11|||
44430812|NCT00690378|79439092|FG000|Overall Study|Social problem|1|||
44430813|NCT00690378|79439093|FG001|Overall Study|Social problem|0|||
44430814|NCT00574275|79439101|FG000|Overall Study|Randomized but not treated|2|||
44430815|NCT00574275|79439102|FG001|Overall Study|Randomized but not treated|3|||
44430816|NCT00574275|79439101|FG000|Overall Study|Adverse Event|32|||
44430817|NCT00574275|79439102|FG001|Overall Study|Adverse Event|76|||
44430818|NCT00574275|79439101|FG000|Overall Study|Disease progression|160|||
44333243|NCT01098097|79338008|FG000|Overall Study|Adverse Event|17|||
44333244|NCT01098097|79338008|FG000|Overall Study|Lost to Follow-up|18|||
44430819|NCT00574275|79439102|FG001|Overall Study|Disease progression|146|||
44430820|NCT00574275|79439101|FG000|Overall Study|Lost to Follow-up|2|||
44430821|NCT00574275|79439102|FG001|Overall Study|Lost to Follow-up|1|||
44430822|NCT00574275|79439101|FG000|Overall Study|Study stopped based on DMC decision|62|||
44430823|NCT00574275|79439102|FG001|Overall Study|Study stopped based on DMC decision|23|||
44430824|NCT00574275|79439101|FG000|Overall Study|Withdrawal by Subject|15|||
44430825|NCT00574275|79439102|FG001|Overall Study|Withdrawal by Subject|17|||
44430826|NCT00574275|79439101|FG000|Overall Study|Error calculating tumor measurement|1|||
44430827|NCT00574275|79439102|FG001|Overall Study|Error calculating tumor measurement|0|||
44430828|NCT00574275|79439101|FG000|Overall Study|Physician Decision|1|||
44430829|NCT00574275|79439102|FG001|Overall Study|Physician Decision|1|||
44430830|NCT00574275|79439101|FG000|Overall Study|Protocol Violation|0|||
44430831|NCT00574275|79439102|FG001|Overall Study|Protocol Violation|1|||
44430832|NCT00574275|79439101|FG000|Overall Study|Patient and Investigator decision|0|||
44430833|NCT00574275|79439102|FG001|Overall Study|Patient and Investigator decision|1|||
44538621|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
44538622|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
44538623|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
44538624|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
44538625|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
44538626|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
44538627|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
44538628|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
44538629|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
44538630|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
44538631|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
44538632|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
44538633|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
44538634|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
44538635|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
44538636|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
44538637|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
44538638|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
44538639|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
44538640|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
44538641|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
44538642|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
44538643|NCT04040192|79549670|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
44538644|NCT04040192|79549671|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
44538645|NCT04040192|79549672|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
44538646|NCT03368859|79549696|FG000|Overall Study|Withdrew Consent|5|||
44538647|NCT03368859|79549697|FG001|Overall Study|Withdrew Consent|4|||
44538648|NCT03368859|79549696|FG000|Overall Study|Death|12|||
44333245|NCT01098097|79338008|FG000|Overall Study|Status unknown|16|||
44333246|NCT01098097|79338008|FG000|Overall Study|No reason reported|31|||
44333247|NCT01097863|79338015|FG000|Overall Study|Discomfort|1|||
44333248|NCT01097863|79338016|FG001|Overall Study|Discomfort|0|||
44333249|NCT01097863|79338017|FG002|Overall Study|Discomfort|1|||
44538649|NCT03368859|79549697|FG001|Overall Study|Death|6|||
44538650|NCT03368859|79549696|FG000|Overall Study|Study terminated by Sponsor|18|||
44538651|NCT03368859|79549697|FG001|Overall Study|Study terminated by Sponsor|23|||
44538652|NCT03368859|79549696|FG000|Overall Study|Other|1|||
44430834|NCT00574275|79439101|FG000|Overall Study|Insurance change|0|||
44430835|NCT00574275|79439102|FG001|Overall Study|Insurance change|1|||
44430836|NCT00574275|79439101|FG000|Overall Study|Operation for curative intent|0|||
44430837|NCT00574275|79439102|FG001|Overall Study|Operation for curative intent|1|||
44430838|NCT00567112|79439108|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
44430839|NCT00567112|79439109|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
44430840|NCT00567112|79439110|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
44430841|NCT00567112|79439108|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
44430842|NCT00567112|79439109|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
44430843|NCT00567112|79439110|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
44430844|NCT00567112|79439108|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
44430845|NCT00567112|79439109|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
44430846|NCT00567112|79439110|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
44430847|NCT01618656|79439130|FG000|Overall Study|Withdrawal by Subject|7|||
44333250|NCT01097863|79338015|FG000|Overall Study|Did not return for final visit|0|||
44333251|NCT01097863|79338016|FG001|Overall Study|Did not return for final visit|0|||
44333252|NCT01097863|79338017|FG002|Overall Study|Did not return for final visit|1|||
44333253|NCT01326962|79338025|FG000|Overall Study|Adverse Event|1|||
44333254|NCT01326962|79338025|FG000|Overall Study|Withdrawal by Subject|1|||
44333255|NCT01326962|79338025|FG000|Overall Study|Lost to Follow-up|3|||
44333256|NCT01326962|79338025|FG000|Overall Study|Other|2|||
44333257|NCT01326728|79338031|FG000|Overall Study|Death|13|||
44333258|NCT01326728|79338032|FG001|Overall Study|Death|0|||
44333259|NCT01326728|79338031|FG000|Overall Study|Early closure of study|34|||
44333260|NCT01326728|79338032|FG001|Overall Study|Early closure of study|9|||
44333261|NCT01097707|79338042|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44430848|NCT01618656|79439131|FG001|Overall Study|Withdrawal by Subject|3|||
44430849|NCT01618656|79439130|FG000|Overall Study|Physician Decision|1|||
44430850|NCT01618656|79439131|FG001|Overall Study|Physician Decision|1|||
44430851|NCT03978832|79439137|FG000|Overall Study|Adverse Event|1|||
44430852|NCT03978832|79439137|FG000|Overall Study|Lost to Follow-up|1|||
44430853|NCT03978832|79439137|FG000|Overall Study|Withdrawal by Subject|6|||
44430854|NCT03978832|79439137|FG000|Overall Study|Physician Decision|2|||
44430855|NCT03978832|79439137|FG000|Overall Study|did not pass screening criteria|44|||
44430856|NCT00566722|79439144|FG000|Overall Study|Adverse Event|0|||
44430857|NCT00566722|79439145|FG001|Overall Study|Adverse Event|1|||
44430858|NCT00566722|79439146|FG002|Overall Study|Adverse Event|0|||
44430859|NCT00566722|79439144|FG000|Overall Study|Withdrawal by Subject|0|||
44430860|NCT00566722|79439145|FG001|Overall Study|Withdrawal by Subject|0|||
44430861|NCT00566722|79439146|FG002|Overall Study|Withdrawal by Subject|1|||
44430862|NCT00566722|79439144|FG000|Overall Study|Lost to Follow-up|1|||
44430863|NCT00566722|79439145|FG001|Overall Study|Lost to Follow-up|1|||
44430864|NCT00566722|79439146|FG002|Overall Study|Lost to Follow-up|1|||
44430865|NCT00566722|79439144|FG000|Overall Study|Lack of Efficacy|1|||
44333262|NCT01097707|79338043|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
44333263|NCT01097707|79338044|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
44430866|NCT00566722|79439145|FG001|Overall Study|Lack of Efficacy|2|||
44430867|NCT00566722|79439146|FG002|Overall Study|Lack of Efficacy|4|||
44430868|NCT00566722|79439144|FG000|Overall Study|Did not meet exclusion criteria|0|||
44430869|NCT00566722|79439145|FG001|Overall Study|Did not meet exclusion criteria|0|||
44430870|NCT00566722|79439146|FG002|Overall Study|Did not meet exclusion criteria|2|||
44430871|NCT00566722|79439144|FG000|Overall Study|Serious adverse event|0|||
44430872|NCT00566722|79439145|FG001|Overall Study|Serious adverse event|1|||
44430873|NCT00566722|79439146|FG002|Overall Study|Serious adverse event|0|||
44430874|NCT00566722|79439144|FG000|Overall Study|Noncompliant with drug administration|0|||
44430875|NCT00566722|79439145|FG001|Overall Study|Noncompliant with drug administration|0|||
44430876|NCT00566722|79439146|FG002|Overall Study|Noncompliant with drug administration|1|||
44430877|NCT00691704|79439157|FG000|Induction Therapy|Disease Progression|1|||
44430878|NCT00691704|79439157|FG000|Induction Therapy|Active Hepatitis|1|||
44538653|NCT03368859|79549697|FG001|Overall Study|Other|1|||
44538654|NCT03096314|79549711|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
44538655|NCT03096314|79549712|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
44333264|NCT01097707|79338045|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
44333265|NCT01097707|79338046|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
44333266|NCT01097707|79338042|FG000|Overall Study|Adverse Event|4|||
44333267|NCT01097707|79338043|FG001|Overall Study|Adverse Event|2|||
44333268|NCT01097707|79338044|FG002|Overall Study|Adverse Event|3|||
44333269|NCT01097707|79338045|FG003|Overall Study|Adverse Event|1|||
44333270|NCT01097707|79338046|FG004|Overall Study|Adverse Event|3|||
44333271|NCT01097707|79338042|FG000|Overall Study|Entry Criteria Not Met|2|||
44333272|NCT01097707|79338043|FG001|Overall Study|Entry Criteria Not Met|1|||
44333273|NCT01097707|79338044|FG002|Overall Study|Entry Criteria Not Met|1|||
44333274|NCT01097707|79338045|FG003|Overall Study|Entry Criteria Not Met|0|||
44430879|NCT00691704|79439157|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
44430880|NCT00691704|79439157|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
44430881|NCT00691704|79439157|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
44430882|NCT00566020|79439161|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
44430883|NCT00566020|79439162|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
44333275|NCT01097707|79338046|FG004|Overall Study|Entry Criteria Not Met|1|||
44333276|NCT01097707|79338042|FG000|Overall Study|Lack of Efficacy|1|||
44430884|NCT00566020|79439161|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
44333277|NCT01097707|79338043|FG001|Overall Study|Lack of Efficacy|0|||
44333278|NCT01097707|79338044|FG002|Overall Study|Lack of Efficacy|0|||
44333279|NCT01097707|79338045|FG003|Overall Study|Lack of Efficacy|1|||
44333280|NCT01097707|79338046|FG004|Overall Study|Lack of Efficacy|0|||
44430885|NCT00566020|79439162|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
44430886|NCT00566020|79439161|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
44430887|NCT00566020|79439162|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
44430888|NCT00566020|79439161|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
44430889|NCT00566020|79439162|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
44430890|NCT00566020|79439161|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
44430891|NCT00566020|79439162|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
44430892|NCT00566020|79439161|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
44430893|NCT00566020|79439162|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
44430894|NCT00564070|79439169|FG000|Overall Study|Lost to Follow-up|9|||
44430895|NCT00564070|79439170|FG001|Overall Study|Lost to Follow-up|7|||
44430896|NCT00564070|79439169|FG000|Overall Study|Worsening depression, referred to care|3|||
44430897|NCT00564070|79439170|FG001|Overall Study|Worsening depression, referred to care|0|||
44430898|NCT00690612|79439176|FG000|Overall Study|Adverse Event|1|||
44430899|NCT00690612|79439176|FG000|Overall Study|Withdrawal by Subject|2|||
44430900|NCT00621153|79439182|FG000|Overall Study|Safety Reason|8|||
44430901|NCT00621153|79439183|FG001|Overall Study|Safety Reason|7|||
44333281|NCT01097707|79338042|FG000|Overall Study|Lost to Follow-up|1|||
44333282|NCT01097707|79338043|FG001|Overall Study|Lost to Follow-up|1|||
44333283|NCT01097707|79338044|FG002|Overall Study|Lost to Follow-up|2|||
44333284|NCT01097707|79338045|FG003|Overall Study|Lost to Follow-up|0|||
44430902|NCT00621153|79439182|FG000|Overall Study|Adverse Event|3|||
44430903|NCT00621153|79439183|FG001|Overall Study|Adverse Event|2|||
44430904|NCT00621153|79439182|FG000|Overall Study|Lost to Follow-up|5|||
44430905|NCT00621153|79439183|FG001|Overall Study|Lost to Follow-up|1|||
44430906|NCT00621153|79439182|FG000|Overall Study|Withdrawal by Subject|4|||
44430907|NCT00621153|79439183|FG001|Overall Study|Withdrawal by Subject|5|||
44430908|NCT00574119|79439189|FG000|Overall Study|Adverse Event|1|||
44430909|NCT00574119|79439189|FG000|Overall Study|Protocol Violation|1|||
44430910|NCT00574119|79439189|FG000|Overall Study|Withdrawal by Subject|1|||
44430911|NCT00574119|79439189|FG000|Overall Study|Physician Decision|1|||
44430912|NCT00705614|79439195|FG000|Initial Intervention|Adverse Event|40|||
44430913|NCT00705614|79439196|FG001|Initial Intervention|Adverse Event|21|||
44430914|NCT00705614|79439195|FG000|Initial Intervention|Lost to Follow-up|310|||
44430915|NCT00705614|79439196|FG001|Initial Intervention|Lost to Follow-up|191|||
44430916|NCT00705614|79439195|FG000|Initial Intervention|Withdrawal by Subject|114|||
44430917|NCT00705614|79439196|FG001|Initial Intervention|Withdrawal by Subject|71|||
44430918|NCT00705614|79439195|FG000|Initial Intervention|Administrative Reason|51|||
44430919|NCT00705614|79439196|FG001|Initial Intervention|Administrative Reason|38|||
44430920|NCT00705614|79439195|FG000|Initial Intervention|Status completion unknown|3|||
44430921|NCT00705614|79439196|FG001|Initial Intervention|Status completion unknown|0|||
44333285|NCT01097707|79338046|FG004|Overall Study|Lost to Follow-up|3|||
44333286|NCT01097707|79338042|FG000|Overall Study|Protocol Violation|2|||
44333287|NCT01097707|79338043|FG001|Overall Study|Protocol Violation|2|||
44333288|NCT01097707|79338044|FG002|Overall Study|Protocol Violation|3|||
44333289|NCT01097707|79338045|FG003|Overall Study|Protocol Violation|2|||
44333290|NCT01097707|79338046|FG004|Overall Study|Protocol Violation|2|||
44333291|NCT01097707|79338042|FG000|Overall Study|Sponsor Decision|31|||
44333292|NCT01097707|79338043|FG001|Overall Study|Sponsor Decision|31|||
44333293|NCT01097707|79338044|FG002|Overall Study|Sponsor Decision|34|||
44333294|NCT01097707|79338045|FG003|Overall Study|Sponsor Decision|35|||
44333295|NCT01097707|79338046|FG004|Overall Study|Sponsor Decision|36|||
44333296|NCT01097707|79338042|FG000|Overall Study|Withdrawal by Subject|3|||
44333297|NCT01097707|79338043|FG001|Overall Study|Withdrawal by Subject|6|||
44333298|NCT01097707|79338044|FG002|Overall Study|Withdrawal by Subject|1|||
44333299|NCT01097707|79338045|FG003|Overall Study|Withdrawal by Subject|4|||
44333300|NCT01097707|79338046|FG004|Overall Study|Withdrawal by Subject|3|||
44333301|NCT01097707|79338042|FG000|Overall Study|Reason unknown|0|||
44430922|NCT00705614|79439195|FG000|Switch to Remicade|Adverse Event|0|||
44430923|NCT00705614|79439196|FG001|Switch to Remicade|Adverse Event|5|||
44430924|NCT00705614|79439195|FG000|Switch to Remicade|Lost to Follow-up|0|||
44430925|NCT00705614|79439196|FG001|Switch to Remicade|Lost to Follow-up|23|||
44333302|NCT01097707|79338043|FG001|Overall Study|Reason unknown|0|||
44333303|NCT01097707|79338044|FG002|Overall Study|Reason unknown|0|||
44333304|NCT01097707|79338045|FG003|Overall Study|Reason unknown|0|||
44333305|NCT01097707|79338046|FG004|Overall Study|Reason unknown|1|||
44333306|NCT01326026|79338060|FG000|Overall Study|Adverse Event|4|||
44430926|NCT00705614|79439195|FG000|Switch to Remicade|Withdrawal by Subject|0|||
44430927|NCT00705614|79439196|FG001|Switch to Remicade|Withdrawal by Subject|12|||
44430928|NCT00705614|79439195|FG000|Switch to Remicade|Administrative Reason|0|||
44430929|NCT00705614|79439196|FG001|Switch to Remicade|Administrative Reason|9|||
44430930|NCT00620763|79439204|FG000|Period: First Intervention|Withdrawal by Subject|0|||
44333307|NCT01326026|79338061|FG001|Overall Study|Adverse Event|3|||
44333308|NCT01326026|79338060|FG000|Overall Study|Withdrawal Criteria|5|||
44333309|NCT01326026|79338061|FG001|Overall Study|Withdrawal Criteria|7|||
44333310|NCT01326026|79338060|FG000|Overall Study|Other|3|||
44333311|NCT01326026|79338061|FG001|Overall Study|Other|3|||
44333312|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
44333313|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
44333314|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
44333315|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44333316|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44333317|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44333318|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44333319|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
44333320|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
44333321|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
44333322|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
44333323|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44430931|NCT00620763|79439205|FG001|Period: First Intervention|Withdrawal by Subject|2|||
44430932|NCT00620763|79439204|FG000|Period: First Intervention|Protocol Violation|0|||
44430933|NCT00620763|79439205|FG001|Period: First Intervention|Protocol Violation|3|||
44430934|NCT00620763|79439204|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
44430935|NCT00620763|79439205|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
44430936|NCT00562978|79439213|FG000|Overall Study|Patient had imaging dose only|1|||
44333324|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44333325|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44430937|NCT00562978|79439214|FG001|Overall Study|Patient had imaging dose only|11|||
44430938|NCT00620373|79439220|FG000|Overall Study|Unverified cancer status|33|||
44430939|NCT00372619|79439234|FG000|Overall Study|Ineligible|0|||
44430940|NCT00372619|79439235|FG001|Overall Study|Ineligible|0|||
44430941|NCT00372619|79439236|FG002|Overall Study|Ineligible|0|||
44430942|NCT00372619|79439237|FG003|Overall Study|Ineligible|0|||
44430943|NCT00372619|79439238|FG004|Overall Study|Ineligible|0|||
44430944|NCT00372619|79439239|FG005|Overall Study|Ineligible|2|||
44430945|NCT00372619|79439240|FG006|Overall Study|Ineligible|0|||
44430946|NCT00372619|79439234|FG000|Overall Study|Inevaluable|0|||
44430947|NCT00372619|79439235|FG001|Overall Study|Inevaluable|0|||
44430948|NCT00372619|79439236|FG002|Overall Study|Inevaluable|0|||
44430949|NCT00372619|79439237|FG003|Overall Study|Inevaluable|0|||
44157168|NCT01559818|78948674|FG000|Overall Study|Withdrawal by Subject|1|||
44333326|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44333327|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
44333328|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
44333329|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
44333330|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
44333331|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44333332|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44333333|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44333334|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44430950|NCT00372619|79439238|FG004|Overall Study|Inevaluable|0|||
44157169|NCT01454934|78948681|FG000|Overall Study|Clinical progression|28|||
44157170|NCT01454934|78948682|FG001|Overall Study|Clinical progression|25|||
44157171|NCT01454934|78948681|FG000|Overall Study|Other|6|||
44157172|NCT01454934|78948682|FG001|Overall Study|Other|17|||
44157173|NCT01454934|78948681|FG000|Overall Study|Adverse Event|28|||
44157174|NCT01454934|78948682|FG001|Overall Study|Adverse Event|24|||
44157175|NCT01454934|78948681|FG000|Overall Study|Withdrawn consent|2|||
44157176|NCT01454934|78948682|FG001|Overall Study|Withdrawn consent|5|||
44157177|NCT01454934|78948681|FG000|Overall Study|Withdrawal by Subject|11|||
44157178|NCT01454934|78948682|FG001|Overall Study|Withdrawal by Subject|15|||
44157179|NCT01454934|78948681|FG000|Overall Study|Disease progression|194|||
44157180|NCT01454934|78948682|FG001|Overall Study|Disease progression|181|||
44157181|NCT01454934|78948681|FG000|Overall Study|Lost to Follow-up|0|||
44157182|NCT01454934|78948682|FG001|Overall Study|Lost to Follow-up|1|||
44157183|NCT01454934|78948681|FG000|Overall Study|Not treated|1|||
44157184|NCT01454934|78948682|FG001|Overall Study|Not treated|2|||
44157185|NCT01439282|78948690|FG000|Overall Study|Adverse Event|5|||
44430951|NCT00372619|79439239|FG005|Overall Study|Inevaluable|1|||
44430952|NCT00372619|79439240|FG006|Overall Study|Inevaluable|0|||
44430953|NCT00562588|79439258|FG000|Overall Study|Adverse Event|40|||
44430954|NCT00562588|79439259|FG001|Overall Study|Adverse Event|58|||
44430955|NCT00562588|79439258|FG000|Overall Study|Protocol Violation|30|||
44538656|NCT03335163|79549718|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
44157186|NCT01439282|78948691|FG001|Overall Study|Adverse Event|0|||
44157187|NCT01439282|78948690|FG000|Overall Study|Withdrawal by Subject|2|||
44430956|NCT00562588|79439259|FG001|Overall Study|Protocol Violation|26|||
44430957|NCT00562588|79439258|FG000|Overall Study|Lost to Follow-up|12|||
44430958|NCT00562588|79439259|FG001|Overall Study|Lost to Follow-up|4|||
44430959|NCT00562588|79439258|FG000|Overall Study|Withdrawal by Subject|10|||
44430960|NCT00562588|79439259|FG001|Overall Study|Withdrawal by Subject|9|||
44430961|NCT00562588|79439258|FG000|Overall Study|Other|0|||
44430962|NCT00562588|79439259|FG001|Overall Study|Other|2|||
44333335|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
44333336|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
44430963|NCT00622167|79439265|FG000|Overall Study|Did not meet angiographic criteria|20|||
44430964|NCT00562354|79439271|FG000|Overall Study|Physician Decision|0|||
44430965|NCT00562354|79439272|FG001|Overall Study|Physician Decision|1|||
44430966|NCT00562354|79439271|FG000|Overall Study|Lost to Follow-up|0|||
44430967|NCT00562354|79439272|FG001|Overall Study|Lost to Follow-up|1|||
44430968|NCT00372385|79439284|FG000|Overall Study|Adverse Event|6|||
44333337|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
44333338|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
44333339|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44333340|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44333341|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44333342|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44333343|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
44333344|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
44333345|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
44333346|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
44333347|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44333348|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44333349|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44333350|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44333351|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
44333352|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
44333353|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
44333354|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44333355|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44333356|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44333357|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44333358|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44333359|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
44333360|NCT01097629|79338070|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
44333361|NCT01097629|79338071|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
44333362|NCT01097629|79338072|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
44333363|NCT01097629|79338073|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44333364|NCT01097629|79338074|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44333365|NCT01097629|79338075|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44333366|NCT01097629|79338076|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44333367|NCT01097629|79338077|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
44333368|NCT01097629|79338070|FG000|DB RO Phase|Withdrawal by Subject|0|||
44333369|NCT01097629|79338071|FG001|DB RO Phase|Withdrawal by Subject|0|||
44430969|NCT00372385|79439285|FG001|Overall Study|Adverse Event|11|||
44430970|NCT00372385|79439286|FG002|Overall Study|Adverse Event|9|||
44430971|NCT00372385|79439287|FG003|Overall Study|Adverse Event|7|||
44430972|NCT00372385|79439284|FG000|Overall Study|Noncompliance|0|||
44430973|NCT00372385|79439285|FG001|Overall Study|Noncompliance|1|||
44430974|NCT00372385|79439286|FG002|Overall Study|Noncompliance|1|||
44430975|NCT00372385|79439287|FG003|Overall Study|Noncompliance|1|||
44430976|NCT00372385|79439284|FG000|Overall Study|Physician Decision|1|||
44430977|NCT00372385|79439285|FG001|Overall Study|Physician Decision|0|||
44430978|NCT00372385|79439286|FG002|Overall Study|Physician Decision|0|||
44538657|NCT03335163|79549718|FG000|Overall Study|Withdrawal by Subject|18|||
44538658|NCT03364335|79549744|FG000|Overall Study|Adverse Event|3|||
44538659|NCT03364335|79549745|FG001|Overall Study|Adverse Event|4|||
44333370|NCT01097629|79338072|FG002|DB RO Phase|Withdrawal by Subject|0|||
44333371|NCT01097629|79338073|FG003|DB RO Phase|Withdrawal by Subject|0|||
44333372|NCT01097629|79338074|FG004|DB RO Phase|Withdrawal by Subject|0|||
44333373|NCT01097629|79338075|FG005|DB RO Phase|Withdrawal by Subject|0|||
44430979|NCT00372385|79439287|FG003|Overall Study|Physician Decision|0|||
44430980|NCT00372385|79439284|FG000|Overall Study|Lost to Follow-up|2|||
44430981|NCT00372385|79439285|FG001|Overall Study|Lost to Follow-up|0|||
44430982|NCT00372385|79439286|FG002|Overall Study|Lost to Follow-up|0|||
44430983|NCT00372385|79439287|FG003|Overall Study|Lost to Follow-up|0|||
44538660|NCT03364335|79549746|FG002|Overall Study|Adverse Event|1|||
44430984|NCT00372385|79439284|FG000|Overall Study|Withdrawal by Subject|2|||
44333374|NCT01097629|79338076|FG006|DB RO Phase|Withdrawal by Subject|0|||
44333375|NCT01097629|79338077|FG007|DB RO Phase|Withdrawal by Subject|1|||
44333376|NCT01097629|79338070|FG000|DB RO Phase|Protocol Violation|0|||
44333377|NCT01097629|79338071|FG001|DB RO Phase|Protocol Violation|0|||
44333378|NCT01097629|79338072|FG002|DB RO Phase|Protocol Violation|0|||
44333379|NCT01097629|79338073|FG003|DB RO Phase|Protocol Violation|1|||
44430985|NCT00372385|79439285|FG001|Overall Study|Withdrawal by Subject|1|||
44430986|NCT00372385|79439286|FG002|Overall Study|Withdrawal by Subject|0|||
44430987|NCT00372385|79439287|FG003|Overall Study|Withdrawal by Subject|0|||
44430988|NCT00372385|79439284|FG000|Overall Study|Refusal of Treatment|3|||
44333380|NCT01097629|79338074|FG004|DB RO Phase|Protocol Violation|0|||
44333381|NCT01097629|79338075|FG005|DB RO Phase|Protocol Violation|1|||
44333382|NCT01097629|79338076|FG006|DB RO Phase|Protocol Violation|1|||
44430989|NCT00372385|79439285|FG001|Overall Study|Refusal of Treatment|6|||
44430990|NCT00372385|79439286|FG002|Overall Study|Refusal of Treatment|0|||
44430991|NCT00372385|79439287|FG003|Overall Study|Refusal of Treatment|0|||
44430992|NCT00372385|79439284|FG000|Overall Study|No Response|1|||
44430993|NCT00372385|79439285|FG001|Overall Study|No Response|1|||
44430994|NCT00372385|79439286|FG002|Overall Study|No Response|0|||
44430995|NCT00372385|79439287|FG003|Overall Study|No Response|0|||
44430996|NCT00372385|79439284|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
44430997|NCT00372385|79439285|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
44430998|NCT00372385|79439286|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
44430999|NCT00372385|79439287|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
44431000|NCT00372385|79439284|FG000|Overall Study|Virologic Stopping Rule|17|||
44431001|NCT00372385|79439285|FG001|Overall Study|Virologic Stopping Rule|0|||
44431002|NCT00372385|79439286|FG002|Overall Study|Virologic Stopping Rule|0|||
44431003|NCT00372385|79439287|FG003|Overall Study|Virologic Stopping Rule|0|||
44431004|NCT03830281|79439300|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
44431005|NCT03830281|79439301|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
44431006|NCT03830281|79439300|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
44431007|NCT03830281|79439301|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
44431008|NCT03830281|79439300|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
44431009|NCT03830281|79439301|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
44431010|NCT03830281|79439300|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
44431011|NCT03830281|79439301|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
44431012|NCT03830281|79439300|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
44431013|NCT03830281|79439301|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
44431014|NCT03830281|79439300|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
44431015|NCT03830281|79439301|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
44431016|NCT03830281|79439300|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
44431017|NCT03830281|79439301|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
44259033|NCT00219284|79115373|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
44259034|NCT00219284|79115374|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
44259035|NCT00216476|79115513|FG000|Overall Study|Withdrawal by Subject|59|||
44431018|NCT03830281|79439300|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
44431019|NCT03830281|79439301|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
44431020|NCT03830281|79439300|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
44431021|NCT03830281|79439301|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
44431022|NCT00563368|79439315|FG000|Overall Study|Lost to Follow-up|14|||
44431023|NCT00563368|79439316|FG001|Overall Study|Lost to Follow-up|14|||
44431024|NCT00563368|79439317|FG002|Overall Study|Lost to Follow-up|12|||
44431025|NCT00563368|79439318|FG003|Overall Study|Lost to Follow-up|6|||
44431026|NCT00563368|79439319|FG004|Overall Study|Lost to Follow-up|9|||
44431027|NCT00563368|79439320|FG005|Overall Study|Lost to Follow-up|8|||
44431028|NCT00563368|79439321|FG006|Overall Study|Lost to Follow-up|9|||
44259036|NCT00216476|79115514|FG001|Overall Study|Withdrawal by Subject|72|||
44259037|NCT00216476|79115515|FG002|Overall Study|Withdrawal by Subject|9|||
44259038|NCT00216476|79115513|FG000|Overall Study|Lost to Follow-up|10|||
44259039|NCT00216476|79115514|FG001|Overall Study|Lost to Follow-up|9|||
44259040|NCT00216476|79115515|FG002|Overall Study|Lost to Follow-up|1|||
44259041|NCT00216476|79115513|FG000|Overall Study|Adverse Event|6|||
44333383|NCT01097629|79338077|FG007|DB RO Phase|Protocol Violation|0|||
44333384|NCT01097629|79338070|FG000|DB RO Phase|Lost to Follow-up|0|||
44333385|NCT01097629|79338071|FG001|DB RO Phase|Lost to Follow-up|0|||
44431029|NCT00563368|79439315|FG000|Overall Study|Adverse Event|3|||
44431030|NCT00563368|79439316|FG001|Overall Study|Adverse Event|4|||
44431031|NCT00563368|79439317|FG002|Overall Study|Adverse Event|5|||
44431032|NCT00563368|79439318|FG003|Overall Study|Adverse Event|9|||
44431033|NCT00563368|79439319|FG004|Overall Study|Adverse Event|6|||
44333386|NCT01097629|79338072|FG002|DB RO Phase|Lost to Follow-up|0|||
44431034|NCT00563368|79439320|FG005|Overall Study|Adverse Event|10|||
44431035|NCT00563368|79439321|FG006|Overall Study|Adverse Event|17|||
44431036|NCT00563368|79439315|FG000|Overall Study|Withdrawal by Subject|11|||
44431037|NCT00563368|79439316|FG001|Overall Study|Withdrawal by Subject|6|||
44259042|NCT00216476|79115514|FG001|Overall Study|Adverse Event|10|||
44333387|NCT01097629|79338073|FG003|DB RO Phase|Lost to Follow-up|0|||
44333388|NCT01097629|79338074|FG004|DB RO Phase|Lost to Follow-up|0|||
44431038|NCT00563368|79439317|FG002|Overall Study|Withdrawal by Subject|5|||
44431039|NCT00563368|79439318|FG003|Overall Study|Withdrawal by Subject|7|||
44431040|NCT00563368|79439319|FG004|Overall Study|Withdrawal by Subject|8|||
44431041|NCT00563368|79439320|FG005|Overall Study|Withdrawal by Subject|5|||
44431042|NCT00563368|79439321|FG006|Overall Study|Withdrawal by Subject|4|||
44431043|NCT00563368|79439315|FG000|Overall Study|protocol non-compliance|1|||
44431044|NCT00563368|79439316|FG001|Overall Study|protocol non-compliance|1|||
44431045|NCT00563368|79439317|FG002|Overall Study|protocol non-compliance|2|||
44431046|NCT00563368|79439318|FG003|Overall Study|protocol non-compliance|1|||
44431047|NCT00563368|79439319|FG004|Overall Study|protocol non-compliance|0|||
44431048|NCT00563368|79439320|FG005|Overall Study|protocol non-compliance|1|||
44431049|NCT00563368|79439321|FG006|Overall Study|protocol non-compliance|3|||
44431050|NCT00563368|79439315|FG000|Overall Study|Pregnancy|1|||
44431051|NCT00563368|79439316|FG001|Overall Study|Pregnancy|0|||
44431052|NCT00563368|79439317|FG002|Overall Study|Pregnancy|1|||
44431053|NCT00563368|79439318|FG003|Overall Study|Pregnancy|2|||
44431054|NCT00563368|79439319|FG004|Overall Study|Pregnancy|1|||
44431055|NCT00563368|79439320|FG005|Overall Study|Pregnancy|2|||
44431056|NCT00563368|79439321|FG006|Overall Study|Pregnancy|0|||
44431057|NCT00563368|79439315|FG000|Overall Study|requirement for restricted medication|0|||
44431058|NCT00563368|79439316|FG001|Overall Study|requirement for restricted medication|0|||
44431059|NCT00563368|79439317|FG002|Overall Study|requirement for restricted medication|2|||
44431060|NCT00563368|79439318|FG003|Overall Study|requirement for restricted medication|0|||
44431061|NCT00563368|79439319|FG004|Overall Study|requirement for restricted medication|0|||
44431062|NCT00563368|79439320|FG005|Overall Study|requirement for restricted medication|0|||
44431063|NCT00563368|79439321|FG006|Overall Study|requirement for restricted medication|0|||
44431064|NCT00563368|79439315|FG000|Overall Study|Other|5|||
44431065|NCT00563368|79439316|FG001|Overall Study|Other|5|||
44431066|NCT00563368|79439317|FG002|Overall Study|Other|3|||
44431067|NCT00563368|79439318|FG003|Overall Study|Other|4|||
44431068|NCT00563368|79439319|FG004|Overall Study|Other|4|||
44431069|NCT00563368|79439320|FG005|Overall Study|Other|4|||
44431070|NCT00563368|79439321|FG006|Overall Study|Other|0|||
44431071|NCT00390013|79439340|FG000|Phase 1|tired|0|||
44431072|NCT00390013|79439341|FG001|Phase 1|tired|0|||
44431073|NCT00390013|79439342|FG002|Phase 1|tired|0|||
44431074|NCT00390013|79439343|FG003|Phase 1|tired|1|||
44431075|NCT00390013|79439340|FG000|Phase 2 First Treatment|tired|1|||
44538661|NCT03364335|79549747|FG003|Overall Study|Adverse Event|2|||
44333389|NCT01097629|79338075|FG005|DB RO Phase|Lost to Follow-up|0|||
44333390|NCT01097629|79338076|FG006|DB RO Phase|Lost to Follow-up|2|||
44333391|NCT01097629|79338077|FG007|DB RO Phase|Lost to Follow-up|0|||
44333392|NCT01324622|79338102|FG000|Overall Study|Lost to Follow-up|7|||
44333393|NCT01324622|79338103|FG001|Overall Study|Lost to Follow-up|7|||
44333394|NCT01324622|79338102|FG000|Overall Study|Death|1|||
44333395|NCT01324622|79338103|FG001|Overall Study|Death|0|||
44333396|NCT01324622|79338102|FG000|Overall Study|Lack of Efficacy|1|||
44333397|NCT01324622|79338103|FG001|Overall Study|Lack of Efficacy|0|||
44333398|NCT01097005|79338110|FG000|Overall Study|Case Report Form not collected|18|||
44333399|NCT01097005|79338110|FG000|Overall Study|Subjects cannot visit the hospital|1|||
44333400|NCT01097005|79338110|FG000|Overall Study|Poor medication compliance|1|||
44333401|NCT01097005|79338110|FG000|Overall Study|No examination data available|244|||
44333402|NCT01097005|79338110|FG000|Overall Study|Deviation from exclusion criteria|37|||
44333403|NCT01097005|79338110|FG000|Overall Study|Adverse Event|14|||
44333404|NCT01097005|79338110|FG000|Overall Study|Discontinuance by complication|50|||
44333405|NCT01096849|79338119|FG000|Overall Study|Consent Withdrawn|1|||
44333406|NCT01096849|79338120|FG001|Overall Study|Consent Withdrawn|4|||
44333407|NCT01096849|79338121|FG002|Overall Study|Consent Withdrawn|2|||
44333408|NCT01096849|79338119|FG000|Overall Study|Lack of Efficacy|0|||
44333409|NCT01096849|79338120|FG001|Overall Study|Lack of Efficacy|2|||
44431076|NCT00390013|79439341|FG001|Phase 2 First Treatment|tired|0|||
44431077|NCT00390013|79439342|FG002|Phase 2 First Treatment|tired|0|||
44431078|NCT00390013|79439343|FG003|Phase 2 First Treatment|tired|0|||
44431079|NCT00390013|79439340|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
44431080|NCT00390013|79439341|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
44431081|NCT00390013|79439342|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
44431082|NCT00390013|79439343|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
44333410|NCT01096849|79338121|FG002|Overall Study|Lack of Efficacy|0|||
44333411|NCT01096849|79338119|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
44333412|NCT01096849|79338120|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
44333413|NCT01096849|79338121|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
44333414|NCT01096849|79338119|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
44333415|NCT01096849|79338120|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
44431083|NCT00561652|79439351|FG000|Overall Study|Withdrawal by Subject|0|||
44431084|NCT00561652|79439352|FG001|Overall Study|Withdrawal by Subject|1|||
44431085|NCT00697346|79439361|FG000|Overall Study|Adverse Event|4|||
44431086|NCT00697346|79439362|FG001|Overall Study|Adverse Event|5|||
44431087|NCT00697346|79439363|FG002|Overall Study|Adverse Event|0|||
44431088|NCT00697346|79439361|FG000|Overall Study|Progressive Disease|19|||
44431089|NCT00697346|79439362|FG001|Overall Study|Progressive Disease|18|||
44431090|NCT00697346|79439363|FG002|Overall Study|Progressive Disease|0|||
44431091|NCT00697346|79439361|FG000|Overall Study|Symptomatic Deterioration|0|||
44431092|NCT00697346|79439362|FG001|Overall Study|Symptomatic Deterioration|1|||
44431093|NCT00697346|79439363|FG002|Overall Study|Symptomatic Deterioration|0|||
44431094|NCT00697346|79439361|FG000|Overall Study|Withdrawal by Subject|2|||
44431095|NCT00697346|79439362|FG001|Overall Study|Withdrawal by Subject|2|||
44431096|NCT00697346|79439363|FG002|Overall Study|Withdrawal by Subject|0|||
44431097|NCT00697346|79439361|FG000|Overall Study|Reason not Specified|3|||
44431098|NCT00697346|79439362|FG001|Overall Study|Reason not Specified|0|||
44431099|NCT00697346|79439363|FG002|Overall Study|Reason not Specified|1|||
44431100|NCT00562120|79439390|FG000|First Intervention Period|Adverse Event|1|||
44431101|NCT00562120|79439391|FG001|First Intervention Period|Adverse Event|0|||
44431102|NCT00562120|79439392|FG002|First Intervention Period|Adverse Event|0|||
44431103|NCT00562120|79439393|FG003|First Intervention Period|Adverse Event|0|||
44431104|NCT00562120|79439390|FG000|First Intervention Period|Randomized but not Treated|1|||
44431105|NCT00562120|79439391|FG001|First Intervention Period|Randomized but not Treated|0|||
44431106|NCT00562120|79439392|FG002|First Intervention Period|Randomized but not Treated|0|||
44431107|NCT00562120|79439393|FG003|First Intervention Period|Randomized but not Treated|0|||
44431108|NCT00561730|79439403|FG000|Overall Study|Adverse Event|2|||
44431109|NCT00561730|79439403|FG000|Overall Study|Handling of the drug|1|||
44431110|NCT00561730|79439403|FG000|Overall Study|Lost to Follow-up|5|||
44333416|NCT01096849|79338121|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
44333417|NCT01096849|79338119|FG000|Overall Study|Administrative Reasons|0|||
44333418|NCT01096849|79338120|FG001|Overall Study|Administrative Reasons|1|||
44333419|NCT01096849|79338121|FG002|Overall Study|Administrative Reasons|2|||
44333420|NCT01096849|79338119|FG000|Overall Study|Lost to Follow-up|1|||
44333421|NCT01096849|79338120|FG001|Overall Study|Lost to Follow-up|3|||
44333422|NCT01096849|79338121|FG002|Overall Study|Lost to Follow-up|1|||
44431111|NCT00561730|79439403|FG000|Overall Study|Not specified reasons|1|||
44538662|NCT03364335|79549748|FG004|Overall Study|Adverse Event|0|||
44538663|NCT03364335|79549744|FG000|Overall Study|Lost to Follow-up|7|||
44538664|NCT03364335|79549745|FG001|Overall Study|Lost to Follow-up|7|||
44538665|NCT03364335|79549746|FG002|Overall Study|Lost to Follow-up|10|||
44538666|NCT03364335|79549747|FG003|Overall Study|Lost to Follow-up|11|||
44538667|NCT03364335|79549748|FG004|Overall Study|Lost to Follow-up|11|||
44538668|NCT03334695|79549771|FG000|Overall Study|Lost to Follow-up|3|||
44538669|NCT03334695|79549772|FG001|Overall Study|Lost to Follow-up|3|||
44538670|NCT03334695|79549771|FG000|Overall Study|Physician Decision|1|||
44538671|NCT03334695|79549772|FG001|Overall Study|Physician Decision|2|||
44538672|NCT03334695|79549771|FG000|Overall Study|Protocol Violation|0|||
44538673|NCT03334695|79549772|FG001|Overall Study|Protocol Violation|1|||
44538674|NCT03364023|79549780|FG000|Overall Study|Lost to Follow-up|3|||
44538675|NCT03364023|79549780|FG000|Overall Study|Death|14|||
44538676|NCT03764813|79549804|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
44538677|NCT03764813|79549805|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
44538678|NCT03764813|79549806|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
44538679|NCT03764813|79549807|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
44538680|NCT03363321|79549828|FG000|Overall Study|Withdrawal by Subject|0|||
44538681|NCT03363321|79549829|FG001|Overall Study|Withdrawal by Subject|1|||
44538682|NCT03363321|79549830|FG002|Overall Study|Withdrawal by Subject|0|||
44538683|NCT03363321|79549831|FG003|Overall Study|Withdrawal by Subject|1|||
44538684|NCT03363321|79549832|FG004|Overall Study|Withdrawal by Subject|0|||
44538685|NCT03361605|79549845|FG000|Overall Study|Analyzable data not available|3|||
44538686|NCT03829046|79549851|FG000|Overall Study|Withdrawal by Subject|1|||
44538687|NCT03829046|79549852|FG001|Overall Study|Withdrawal by Subject|0|||
44538688|NCT03361293|79549860|FG000|Overall Study|Lost to Follow-up|0|||
44538689|NCT03361293|79549861|FG001|Overall Study|Lost to Follow-up|2|||
44157188|NCT01439282|78948691|FG001|Overall Study|Withdrawal by Subject|0|||
44333423|NCT01324388|79338132|FG000|Part 1 of Study|Adverse Event|2|||
44431112|NCT00697112|79439409|FG000|Overall Study|Adverse Event|8|||
44431113|NCT00697112|79439409|FG000|Overall Study|Lost to Follow-up|1|||
44431114|NCT00697112|79439409|FG000|Overall Study|Did not meet inclusion criteria|1|||
44431115|NCT00621855|79439418|FG000|Overall Study|Adverse Event|32|||
44431116|NCT00621855|79439419|FG001|Overall Study|Adverse Event|31|||
44431117|NCT00621855|79439420|FG002|Overall Study|Adverse Event|48|||
44333424|NCT01324388|79338133|FG001|Part 1 of Study|Adverse Event|0|||
44431118|NCT00621855|79439421|FG003|Overall Study|Adverse Event|34|||
44431119|NCT00621855|79439422|FG004|Overall Study|Adverse Event|31|||
44538690|NCT03361293|79549860|FG000|Overall Study|Withdrawal by Subject|1|||
44538691|NCT03361293|79549861|FG001|Overall Study|Withdrawal by Subject|3|||
44538692|NCT03361137|79549872|FG000|Overall Study|Reason not specified|1|||
44157189|NCT01439282|78948690|FG000|Overall Study|Other|1|||
44431120|NCT00621855|79439418|FG000|Overall Study|Lost to Follow-up|0|||
44431121|NCT00621855|79439419|FG001|Overall Study|Lost to Follow-up|1|||
44431122|NCT00621855|79439420|FG002|Overall Study|Lost to Follow-up|3|||
44431123|NCT00621855|79439421|FG003|Overall Study|Lost to Follow-up|4|||
44431124|NCT00621855|79439422|FG004|Overall Study|Lost to Follow-up|1|||
44431125|NCT00621855|79439418|FG000|Overall Study|Protocol Violation|16|||
44431126|NCT00621855|79439419|FG001|Overall Study|Protocol Violation|8|||
44431127|NCT00621855|79439420|FG002|Overall Study|Protocol Violation|6|||
44431128|NCT00621855|79439421|FG003|Overall Study|Protocol Violation|7|||
44431129|NCT00621855|79439422|FG004|Overall Study|Protocol Violation|8|||
44431130|NCT00621855|79439418|FG000|Overall Study|Withdrawal by Subject|16|||
44333425|NCT01324388|79338134|FG002|Part 1 of Study|Adverse Event|0|||
44333426|NCT01324388|79338135|FG003|Part 1 of Study|Adverse Event|0|||
44333427|NCT01324388|79338132|FG000|Part 1 of Study|Protocol Violation|1|||
44333428|NCT01324388|79338133|FG001|Part 1 of Study|Protocol Violation|2|||
44333429|NCT01324388|79338134|FG002|Part 1 of Study|Protocol Violation|0|||
44333430|NCT01324388|79338135|FG003|Part 1 of Study|Protocol Violation|0|||
44333431|NCT01324388|79338132|FG000|Part 1 of Study|Physician Decision|1|||
44333432|NCT01324388|79338133|FG001|Part 1 of Study|Physician Decision|0|||
44333433|NCT01324388|79338134|FG002|Part 1 of Study|Physician Decision|0|||
44333434|NCT01324388|79338135|FG003|Part 1 of Study|Physician Decision|0|||
44431131|NCT00621855|79439419|FG001|Overall Study|Withdrawal by Subject|11|||
44431132|NCT00621855|79439420|FG002|Overall Study|Withdrawal by Subject|13|||
44431133|NCT00621855|79439421|FG003|Overall Study|Withdrawal by Subject|13|||
44333435|NCT01324388|79338132|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
44431134|NCT00621855|79439422|FG004|Overall Study|Withdrawal by Subject|9|||
44431135|NCT00621855|79439418|FG000|Overall Study|Other|9|||
44431136|NCT00621855|79439419|FG001|Overall Study|Other|7|||
44431137|NCT00621855|79439420|FG002|Overall Study|Other|6|||
44431138|NCT00621855|79439421|FG003|Overall Study|Other|5|||
44431139|NCT00621855|79439422|FG004|Overall Study|Other|4|||
44431140|NCT00621855|79439418|FG000|Overall Study|Patients did not receive study drug|3|||
44431141|NCT00621855|79439419|FG001|Overall Study|Patients did not receive study drug|3|||
44431142|NCT00621855|79439420|FG002|Overall Study|Patients did not receive study drug|5|||
44431143|NCT00621855|79439421|FG003|Overall Study|Patients did not receive study drug|4|||
44431144|NCT00621855|79439422|FG004|Overall Study|Patients did not receive study drug|2|||
44431145|NCT00561574|79439436|FG000|Overall Study|Adverse Event|21|||
44431146|NCT00561574|79439437|FG001|Overall Study|Adverse Event|24|||
44431147|NCT00561574|79439436|FG000|Overall Study|Lack of Efficacy|11|||
44431148|NCT00561574|79439437|FG001|Overall Study|Lack of Efficacy|21|||
44431149|NCT00561574|79439436|FG000|Overall Study|Withdrawal by Subject|4|||
44431150|NCT00561574|79439437|FG001|Overall Study|Withdrawal by Subject|4|||
44431151|NCT00561574|79439436|FG000|Overall Study|Reason Unrelated to Trial|6|||
44431152|NCT00561574|79439437|FG001|Overall Study|Reason Unrelated to Trial|2|||
44431153|NCT00561574|79439436|FG000|Overall Study|Lost to Follow-up|1|||
44431154|NCT00561574|79439437|FG001|Overall Study|Lost to Follow-up|0|||
44157190|NCT01439282|78948691|FG001|Overall Study|Other|1|||
44157191|NCT01326312|78948701|FG000|Overall Study|Adverse Event|11|||
44157192|NCT01326312|78948702|FG001|Overall Study|Adverse Event|11|||
44157193|NCT01326312|78948703|FG002|Overall Study|Adverse Event|1|||
44157194|NCT01326312|78948701|FG000|Overall Study|Withdrawal by Subject|1|||
44157195|NCT01326312|78948702|FG001|Overall Study|Withdrawal by Subject|2|||
44157196|NCT01326312|78948703|FG002|Overall Study|Withdrawal by Subject|1|||
44157197|NCT01326312|78948701|FG000|Overall Study|Protocol Violation|0|||
44157198|NCT01326312|78948702|FG001|Overall Study|Protocol Violation|1|||
44157199|NCT01326312|78948703|FG002|Overall Study|Protocol Violation|0|||
44157200|NCT01326312|78948701|FG000|Overall Study|Lack of Efficacy|13|||
44157201|NCT01326312|78948702|FG001|Overall Study|Lack of Efficacy|7|||
44157202|NCT01326312|78948703|FG002|Overall Study|Lack of Efficacy|1|||
44157203|NCT01326312|78948701|FG000|Overall Study|Death|1|||
44157204|NCT01326312|78948702|FG001|Overall Study|Death|0|||
44333436|NCT01324388|79338133|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
44431155|NCT00561574|79439436|FG000|Overall Study|Other|5|||
44431156|NCT00561574|79439437|FG001|Overall Study|Other|7|||
44157205|NCT01326312|78948703|FG002|Overall Study|Death|1|||
44157206|NCT01326312|78948701|FG000|Overall Study|progressive disease|0|||
44333437|NCT01324388|79338134|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
44431157|NCT00619827|79439445|FG000|Overall Study|Adverse Event|1|||
44431158|NCT00619827|79439446|FG001|Overall Study|Adverse Event|2|||
44157207|NCT01326312|78948702|FG001|Overall Study|progressive disease|1|||
44431159|NCT00619827|79439445|FG000|Overall Study|Withdrawal by Subject|2|||
44431160|NCT00619827|79439446|FG001|Overall Study|Withdrawal by Subject|2|||
44431161|NCT00687804|79439455|FG000|Core Study|Adverse Event|5|||
44431162|NCT00687804|79439456|FG001|Core Study|Adverse Event|3|||
44431163|NCT00687804|79439457|FG002|Core Study|Adverse Event|3|||
44157208|NCT01326312|78948703|FG002|Overall Study|progressive disease|1|||
44157209|NCT01326312|78948701|FG000|Overall Study|Study terminated by Sponsor|8|||
44333438|NCT01324388|79338135|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
44431164|NCT00687804|79439455|FG000|Core Study|Abnormal laboratory value(s)|1|||
44431165|NCT00687804|79439456|FG001|Core Study|Abnormal laboratory value(s)|0|||
44431166|NCT00687804|79439457|FG002|Core Study|Abnormal laboratory value(s)|0|||
44431167|NCT00687804|79439455|FG000|Core Study|Lack of Efficacy|1|||
44431168|NCT00687804|79439456|FG001|Core Study|Lack of Efficacy|1|||
44431169|NCT00687804|79439457|FG002|Core Study|Lack of Efficacy|1|||
44431170|NCT00687804|79439455|FG000|Core Study|Withdrawal by Subject|4|||
44431171|NCT00687804|79439456|FG001|Core Study|Withdrawal by Subject|7|||
44431172|NCT00687804|79439457|FG002|Core Study|Withdrawal by Subject|7|||
44333439|NCT01324388|79338132|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
44333440|NCT01324388|79338133|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
44333441|NCT01324388|79338134|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
44333442|NCT01324388|79338135|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
44431173|NCT00687804|79439455|FG000|Core Study|Lost to Follow-up|0|||
44333443|NCT01102777|79338149|FG000|Overall Study|Death|2|||
44333444|NCT01102777|79338150|FG001|Overall Study|Death|6|||
44431174|NCT00687804|79439456|FG001|Core Study|Lost to Follow-up|1|||
44431175|NCT00687804|79439457|FG002|Core Study|Lost to Follow-up|0|||
44431176|NCT00687804|79439455|FG000|Core Study|Death|2|||
44431177|NCT00687804|79439456|FG001|Core Study|Death|2|||
44431178|NCT00687804|79439457|FG002|Core Study|Death|2|||
44431179|NCT00687804|79439455|FG000|Core Study|Protocol Violation|1|||
44431180|NCT00687804|79439456|FG001|Core Study|Protocol Violation|1|||
44431181|NCT00687804|79439457|FG002|Core Study|Protocol Violation|0|||
44431182|NCT00687804|79439455|FG000|Open-Label Extension Study|Adverse Event|2|||
44431183|NCT00687804|79439456|FG001|Open-Label Extension Study|Adverse Event|2|||
44431184|NCT00687804|79439457|FG002|Open-Label Extension Study|Adverse Event|2|||
44431185|NCT00687804|79439455|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
44431186|NCT00687804|79439456|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
44431187|NCT00687804|79439457|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
44431188|NCT00687804|79439455|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
44431189|NCT00687804|79439456|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
44431190|NCT00687804|79439457|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
44431191|NCT00687804|79439455|FG000|Open-Label Extension Study|Administrative problems|1|||
44431192|NCT00687804|79439456|FG001|Open-Label Extension Study|Administrative problems|1|||
44431193|NCT00687804|79439457|FG002|Open-Label Extension Study|Administrative problems|0|||
44431194|NCT00687804|79439455|FG000|Open-Label Extension Study|Death|2|||
44431195|NCT00687804|79439456|FG001|Open-Label Extension Study|Death|3|||
44431196|NCT00687804|79439457|FG002|Open-Label Extension Study|Death|3|||
44431197|NCT00689052|79439484|FG000|Overall Study|Adverse Event|4|||
44431198|NCT00689052|79439485|FG001|Overall Study|Adverse Event|6|||
44431199|NCT00689052|79439484|FG000|Overall Study|Protocol Violation|1|||
44431200|NCT00689052|79439485|FG001|Overall Study|Protocol Violation|0|||
44431201|NCT00689052|79439484|FG000|Overall Study|Lost to Follow-up|2|||
44431202|NCT00689052|79439485|FG001|Overall Study|Lost to Follow-up|0|||
44431203|NCT00689052|79439484|FG000|Overall Study|Withdrawal by Subject|2|||
44431204|NCT00689052|79439485|FG001|Overall Study|Withdrawal by Subject|0|||
44431205|NCT00689052|79439484|FG000|Overall Study|Early termination of the trial|22|||
44333445|NCT01102777|79338149|FG000|Overall Study|Lost to Follow-up|7|||
44333446|NCT01102777|79338150|FG001|Overall Study|Lost to Follow-up|10|||
44333447|NCT01324310|79338157|FG000|Overall Study|Adverse Event|1|||
44333448|NCT01324310|79338157|FG000|Overall Study|Disease Progression|1|||
44333449|NCT01102231|79338163|FG000|Overall Study|Protocol Violation|3|||
44333450|NCT01102231|79338163|FG000|Overall Study|Lack of Efficacy|2|||
44333451|NCT01102231|79338163|FG000|Overall Study|Death|2|||
44431206|NCT00689052|79439485|FG001|Overall Study|Early termination of the trial|24|||
44431207|NCT00560950|79439495|FG000|Overall Study|Lost to Follow-up|1|||
44431208|NCT00560950|79439496|FG001|Overall Study|Lost to Follow-up|0|||
44157210|NCT01326312|78948702|FG001|Overall Study|Study terminated by Sponsor|32|||
44157211|NCT01326312|78948703|FG002|Overall Study|Study terminated by Sponsor|46|||
44333452|NCT01102231|79338163|FG000|Overall Study|Adverse Event|3|||
44431209|NCT00576758|79439506|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
44431210|NCT00576758|79439507|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
44431211|NCT00576758|79439506|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
44333453|NCT01102231|79338163|FG000|Overall Study|Withdrawal by Subject|1|||
44431212|NCT00576758|79439507|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
44431213|NCT00576758|79439506|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
44431214|NCT00576758|79439507|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
44431215|NCT00576758|79439506|FG000|Induction Treatment Period|Death|1|||
44431216|NCT00576758|79439507|FG001|Induction Treatment Period|Death|0|||
44431217|NCT00576758|79439506|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
44333454|NCT01102231|79338163|FG000|Overall Study|Did not received the treatment|4|||
44333455|NCT01094743|79338168|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
44333456|NCT01095835|79338176|FG000|Overall Study|Adverse Event|8|||
44333457|NCT01095835|79338177|FG001|Overall Study|Adverse Event|6|||
44333458|NCT01095835|79338178|FG002|Overall Study|Adverse Event|6|||
44333459|NCT01095835|79338176|FG000|Overall Study|Lack of Efficacy|0|||
44333460|NCT01095835|79338177|FG001|Overall Study|Lack of Efficacy|1|||
44333461|NCT01095835|79338178|FG002|Overall Study|Lack of Efficacy|0|||
44333462|NCT01095835|79338176|FG000|Overall Study|Physician Decision|0|||
44333463|NCT01095835|79338177|FG001|Overall Study|Physician Decision|0|||
44333464|NCT01095835|79338178|FG002|Overall Study|Physician Decision|1|||
44333465|NCT01095835|79338176|FG000|Overall Study|Withdrawal by Subject|1|||
44333466|NCT01095835|79338177|FG001|Overall Study|Withdrawal by Subject|3|||
44333467|NCT01095835|79338178|FG002|Overall Study|Withdrawal by Subject|0|||
44333468|NCT01095835|79338176|FG000|Overall Study|Non study compliance|0|||
44333469|NCT01095835|79338177|FG001|Overall Study|Non study compliance|0|||
44333470|NCT01095835|79338178|FG002|Overall Study|Non study compliance|1|||
44431218|NCT00576758|79439507|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
44431219|NCT00576758|79439506|FG000|Induction Treatment Period|Withdrew consent|1|||
44431220|NCT00576758|79439507|FG001|Induction Treatment Period|Withdrew consent|0|||
44431221|NCT00576758|79439506|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
44431222|NCT00576758|79439507|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
44431223|NCT00576758|79439506|FG000|Extension Treatment Period|Death|1|||
44431224|NCT00576758|79439507|FG001|Extension Treatment Period|Death|1|||
44431225|NCT00576758|79439506|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
44333471|NCT01095835|79338176|FG000|Overall Study|Protocol Violation|1|||
44333472|NCT01095835|79338177|FG001|Overall Study|Protocol Violation|2|||
44333473|NCT01095835|79338178|FG002|Overall Study|Protocol Violation|0|||
44333474|NCT01324232|79338191|FG000|Overall Study|Protocol Violation|0|||
44333475|NCT01324232|79338192|FG001|Overall Study|Protocol Violation|0|||
44333476|NCT01324232|79338193|FG002|Overall Study|Protocol Violation|0|||
44333477|NCT01324232|79338194|FG003|Overall Study|Protocol Violation|2|||
44333478|NCT01324232|79338191|FG000|Overall Study|Missing|0|||
44333479|NCT01324232|79338192|FG001|Overall Study|Missing|0|||
44333480|NCT01324232|79338193|FG002|Overall Study|Missing|1|||
44333481|NCT01324232|79338194|FG003|Overall Study|Missing|0|||
44333482|NCT01324232|79338191|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
44333483|NCT01324232|79338192|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
44333484|NCT01324232|79338193|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
44333485|NCT01324232|79338194|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
44333486|NCT01324232|79338191|FG000|Overall Study|Lack of Efficacy|2|||
44431226|NCT00576758|79439507|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
44431227|NCT00576758|79439506|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
44333487|NCT01324232|79338192|FG001|Overall Study|Lack of Efficacy|1|||
44431228|NCT00576758|79439507|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
44431229|NCT00576758|79439506|FG000|Extension Treatment Period|Administrative/Other|3|||
44431230|NCT00576758|79439507|FG001|Extension Treatment Period|Administrative/Other|1|||
44431231|NCT00576758|79439506|FG000|Follow-up Period|Administrative/Other|6|||
44431232|NCT00576758|79439507|FG001|Follow-up Period|Administrative/Other|8|||
44431233|NCT00576758|79439506|FG000|Follow-up Period|Death|3|||
44431234|NCT00576758|79439507|FG001|Follow-up Period|Death|3|||
44431235|NCT00576758|79439506|FG000|Follow-up Period|Insufficient therapeutic response|16|||
44431236|NCT00576758|79439507|FG001|Follow-up Period|Insufficient therapeutic response|5|||
44431237|NCT00576758|79439506|FG000|Follow-up Period|Withdrew consent|2|||
44431238|NCT00576758|79439507|FG001|Follow-up Period|Withdrew consent|1|||
44431239|NCT00560794|79439514|FG000|Overall Study|Adverse Event|2|||
44431240|NCT00560794|79439514|FG000|Overall Study|Patient was not Compliant|1|||
44431241|NCT00560794|79439514|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
44431242|NCT00560794|79439514|FG000|Overall Study|Hematological Relapse|1|||
44431243|NCT00560794|79439514|FG000|Overall Study|Received Bone Marrow Transplant|6|||
44431244|NCT00619359|79439522|FG000|Overall Study|Adverse Event|32|||
44431245|NCT00619359|79439523|FG001|Overall Study|Adverse Event|36|||
44431246|NCT00619359|79439522|FG000|Overall Study|Lost to Follow-up|12|||
44431247|NCT00619359|79439523|FG001|Overall Study|Lost to Follow-up|16|||
44431248|NCT00619359|79439522|FG000|Overall Study|Physician Decision|0|||
44538693|NCT03361137|79549873|FG001|Overall Study|Reason not specified|0|||
44538694|NCT03361137|79549874|FG002|Overall Study|Reason not specified|0|||
44538695|NCT03361137|79549875|FG003|Overall Study|Reason not specified|0|||
44431249|NCT00619359|79439523|FG001|Overall Study|Physician Decision|7|||
44538696|NCT03361137|79549876|FG004|Overall Study|Reason not specified|0|||
44431250|NCT00619359|79439522|FG000|Overall Study|Protocol Violation|1|||
44431251|NCT00619359|79439523|FG001|Overall Study|Protocol Violation|1|||
44431252|NCT00619359|79439522|FG000|Overall Study|Withdrawal by Subject|19|||
44538697|NCT03360747|79549890|FG000|Overall Study|Voluntary Withdrawal|1|||
44333488|NCT01324232|79338193|FG002|Overall Study|Lack of Efficacy|2|||
44333489|NCT01324232|79338194|FG003|Overall Study|Lack of Efficacy|2|||
44333490|NCT01324232|79338191|FG000|Overall Study|Participant Refused Medication|0|||
44333491|NCT01324232|79338192|FG001|Overall Study|Participant Refused Medication|1|||
44333492|NCT01324232|79338193|FG002|Overall Study|Participant Refused Medication|0|||
44431253|NCT00619359|79439523|FG001|Overall Study|Withdrawal by Subject|20|||
44431254|NCT00619359|79439522|FG000|Overall Study|Progressive Disease|3|||
44431255|NCT00619359|79439523|FG001|Overall Study|Progressive Disease|1|||
44431256|NCT00372229|79439531|FG000|Study Phase|Graft loss|0|||
44431257|NCT00372229|79439532|FG001|Study Phase|Graft loss|3|||
44431258|NCT00372229|79439531|FG000|Study Phase|Protocol Violation|3|||
44431259|NCT00372229|79439532|FG001|Study Phase|Protocol Violation|4|||
44431260|NCT00372229|79439531|FG000|Study Phase|Consent withdrawn|16|||
44431261|NCT00372229|79439532|FG001|Study Phase|Consent withdrawn|14|||
44431262|NCT00372229|79439531|FG000|Study Phase|Refused treatment/did not cooperate|3|||
44431263|NCT00372229|79439532|FG001|Study Phase|Refused treatment/did not cooperate|1|||
44431264|NCT00372229|79439531|FG000|Study Phase|Death|3|||
44431265|NCT00372229|79439532|FG001|Study Phase|Death|2|||
44431266|NCT00372229|79439531|FG000|Study Phase|Reason not specified|3|||
44431267|NCT00372229|79439532|FG001|Study Phase|Reason not specified|2|||
44431268|NCT00372229|79439531|FG000|Study Phase|Lost to Follow-up|3|||
44431269|NCT00372229|79439532|FG001|Study Phase|Lost to Follow-up|3|||
44431270|NCT00372229|79439531|FG000|Follow-Up Phase|Graft loss|8|||
44431271|NCT00372229|79439532|FG001|Follow-Up Phase|Graft loss|7|||
44431272|NCT00372229|79439531|FG000|Follow-Up Phase|Consent withdrawn|13|||
44431273|NCT00372229|79439532|FG001|Follow-Up Phase|Consent withdrawn|19|||
44431274|NCT00372229|79439531|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
44431275|NCT00372229|79439532|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
44431276|NCT00372229|79439531|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
44431277|NCT00372229|79439532|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
44431278|NCT00372229|79439531|FG000|Follow-Up Phase|Death|9|||
44431279|NCT00372229|79439532|FG001|Follow-Up Phase|Death|12|||
44431280|NCT00372229|79439531|FG000|Follow-Up Phase|Administrative|1|||
44431281|NCT00372229|79439532|FG001|Follow-Up Phase|Administrative|0|||
44431282|NCT00372229|79439531|FG000|Follow-Up Phase|Reason not specified|2|||
44431283|NCT00372229|79439532|FG001|Follow-Up Phase|Reason not specified|3|||
44431284|NCT00372229|79439531|FG000|Follow-Up Phase|Lost to Follow-up|12|||
44431285|NCT00372229|79439532|FG001|Follow-Up Phase|Lost to Follow-up|10|||
44431286|NCT00698828|79439545|FG000|Overall Study|Adverse Event|3|||
44431287|NCT00698828|79439546|FG001|Overall Study|Adverse Event|4|||
44431288|NCT00698828|79439547|FG002|Overall Study|Adverse Event|4|||
44431289|NCT00698828|79439545|FG000|Overall Study|Death|0|||
44431290|NCT00698828|79439546|FG001|Overall Study|Death|0|||
44431291|NCT00698828|79439547|FG002|Overall Study|Death|1|||
44431292|NCT00698828|79439545|FG000|Overall Study|Exacerbation of COPD|1|||
44431293|NCT00698828|79439546|FG001|Overall Study|Exacerbation of COPD|3|||
44431294|NCT00698828|79439547|FG002|Overall Study|Exacerbation of COPD|0|||
44431295|NCT00698828|79439545|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
44431296|NCT00698828|79439546|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
44431297|NCT00698828|79439547|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
44431298|NCT00698828|79439545|FG000|Overall Study|Investigator/Sponsor decision|1|||
44431299|NCT00698828|79439546|FG001|Overall Study|Investigator/Sponsor decision|0|||
44333493|NCT01324232|79338194|FG003|Overall Study|Participant Refused Medication|0|||
44333494|NCT01324232|79338191|FG000|Overall Study|Intercurrent illness|0|||
44333495|NCT01324232|79338192|FG001|Overall Study|Intercurrent illness|0|||
44333496|NCT01324232|79338193|FG002|Overall Study|Intercurrent illness|0|||
44333497|NCT01324232|79338194|FG003|Overall Study|Intercurrent illness|1|||
44333498|NCT01324232|79338191|FG000|Overall Study|Adverse Event|2|||
44333499|NCT01324232|79338192|FG001|Overall Study|Adverse Event|5|||
44333500|NCT01324232|79338193|FG002|Overall Study|Adverse Event|6|||
44333501|NCT01324232|79338194|FG003|Overall Study|Adverse Event|6|||
44333502|NCT01324232|79338191|FG000|Overall Study|Withdrawal by Subject|0|||
44333503|NCT01324232|79338192|FG001|Overall Study|Withdrawal by Subject|3|||
44431300|NCT00698828|79439547|FG002|Overall Study|Investigator/Sponsor decision|2|||
44431301|NCT00698828|79439545|FG000|Overall Study|Lost to Follow-up|1|||
44431302|NCT00698828|79439546|FG001|Overall Study|Lost to Follow-up|1|||
44431303|NCT00698828|79439547|FG002|Overall Study|Lost to Follow-up|0|||
44431304|NCT00698828|79439545|FG000|Overall Study|Withdrew consent|0|||
44431305|NCT00698828|79439546|FG001|Overall Study|Withdrew consent|7|||
44431306|NCT00698828|79439547|FG002|Overall Study|Withdrew consent|4|||
44431307|NCT00698828|79439545|FG000|Overall Study|Withdrew consent (not treated)|2|||
44431308|NCT00698828|79439546|FG001|Overall Study|Withdrew consent (not treated)|0|||
44431309|NCT00698828|79439547|FG002|Overall Study|Withdrew consent (not treated)|0|||
44431310|NCT00619515|79439555|FG000|Overall Study|Study Termination by IRB|73|||
44431311|NCT03167606|79439561|FG000|Overall Study|Lost to Follow-up|73|||
44431312|NCT03167606|79439562|FG001|Overall Study|Lost to Follow-up|64|||
44431313|NCT03167606|79439561|FG000|Overall Study|Withdrawal by Subject|6|||
44431314|NCT03167606|79439562|FG001|Overall Study|Withdrawal by Subject|5|||
44431315|NCT03167606|79439561|FG000|Overall Study|Withdrawal by Investigator|0|||
44431316|NCT03167606|79439562|FG001|Overall Study|Withdrawal by Investigator|2|||
44333504|NCT01324232|79338193|FG002|Overall Study|Withdrawal by Subject|4|||
44333505|NCT01324232|79338194|FG003|Overall Study|Withdrawal by Subject|0|||
44431317|NCT00688740|79439570|FG000|Overall Study|Adverse Event|45|||
44333506|NCT01324232|79338191|FG000|Overall Study|Lost to Follow-up|1|||
44333507|NCT01324232|79338192|FG001|Overall Study|Lost to Follow-up|0|||
44333508|NCT01324232|79338193|FG002|Overall Study|Lost to Follow-up|0|||
44333509|NCT01324232|79338194|FG003|Overall Study|Lost to Follow-up|0|||
44333510|NCT01094119|79338211|FG000|Overall Study|Lack of Efficacy|2|||
44333511|NCT01094119|79338212|FG001|Overall Study|Lack of Efficacy|4|||
44333512|NCT01323920|79338218|FG000|Overall Study|Death|5|||
44333513|NCT01323920|79338218|FG000|Overall Study|Withdrawal by Subject|1|||
44333514|NCT01093885|79338222|FG000|Overall Study|Adverse Event|4|||
44333515|NCT01093885|79338222|FG000|Overall Study|Lost to Follow-up|1|||
44333516|NCT01101997|79338227|FG000|Overall Study|Withdrawal by Subject|2|||
44333517|NCT01324830|79338257|FG000|Overall Study|Progressive Disease|3|||
44333518|NCT01324830|79338258|FG001|Overall Study|Progressive Disease|2|||
44333519|NCT01324830|79338259|FG002|Overall Study|Progressive Disease|3|||
44333520|NCT01324830|79338260|FG003|Overall Study|Progressive Disease|3|||
44333521|NCT01324830|79338261|FG004|Overall Study|Progressive Disease|6|||
44333522|NCT01324830|79338262|FG005|Overall Study|Progressive Disease|6|||
44333523|NCT01324830|79338263|FG006|Overall Study|Progressive Disease|3|||
44333524|NCT01324830|79338264|FG007|Overall Study|Progressive Disease|3|||
44431318|NCT00688740|79439571|FG001|Overall Study|Adverse Event|8|||
44431319|NCT00688740|79439570|FG000|Overall Study|Death|2|||
44431320|NCT00688740|79439571|FG001|Overall Study|Death|2|||
44431321|NCT00688740|79439570|FG000|Overall Study|Lost to Follow-up|0|||
44431322|NCT00688740|79439571|FG001|Overall Study|Lost to Follow-up|1|||
44431323|NCT00688740|79439570|FG000|Overall Study|Consent Withdrawn|17|||
44431324|NCT00688740|79439571|FG001|Overall Study|Consent Withdrawn|17|||
44431325|NCT00688740|79439570|FG000|Overall Study|Breast Cancer Relapse|1|||
44431326|NCT00688740|79439571|FG001|Overall Study|Breast Cancer Relapse|4|||
44431327|NCT00688740|79439570|FG000|Overall Study|Violation of Inclusion Criteria|1|||
44431328|NCT00688740|79439571|FG001|Overall Study|Violation of Inclusion Criteria|3|||
44431329|NCT00552760|79439579|FG000|Overall Study|Adverse Event|3|||
44538698|NCT03359811|79549896|FG000|Overall Study|Protocol Violation|2|||
44538699|NCT03359811|79549897|FG001|Overall Study|Protocol Violation|0|||
44333525|NCT01324830|79338265|FG008|Overall Study|Progressive Disease|3|||
44333526|NCT01324830|79338266|FG009|Overall Study|Progressive Disease|6|||
44333527|NCT01324830|79338267|FG010|Overall Study|Progressive Disease|2|||
44333528|NCT01324830|79338268|FG011|Overall Study|Progressive Disease|1|||
44333529|NCT01324830|79338269|FG012|Overall Study|Progressive Disease|1|||
44333530|NCT01324830|79338270|FG013|Overall Study|Progressive Disease|1|||
44538700|NCT03728426|79549904|FG000|Overall Study|Death|3|||
44333531|NCT01324830|79338271|FG014|Overall Study|Progressive Disease|1|||
44333532|NCT01324830|79338272|FG015|Overall Study|Progressive Disease|3|||
44333533|NCT01324830|79338273|FG016|Overall Study|Progressive Disease|2|||
44333534|NCT01324830|79338274|FG017|Overall Study|Progressive Disease|3|||
44333535|NCT01324830|79338275|FG018|Overall Study|Progressive Disease|4|||
44333536|NCT01324830|79338257|FG000|Overall Study|Dose limiting toxicity|0|||
44333537|NCT01324830|79338258|FG001|Overall Study|Dose limiting toxicity|0|||
44333538|NCT01324830|79338259|FG002|Overall Study|Dose limiting toxicity|0|||
44333539|NCT01324830|79338260|FG003|Overall Study|Dose limiting toxicity|0|||
44333540|NCT01324830|79338261|FG004|Overall Study|Dose limiting toxicity|1|||
44333541|NCT01324830|79338262|FG005|Overall Study|Dose limiting toxicity|0|||
44333542|NCT01324830|79338263|FG006|Overall Study|Dose limiting toxicity|0|||
44333543|NCT01324830|79338264|FG007|Overall Study|Dose limiting toxicity|0|||
44333544|NCT01324830|79338265|FG008|Overall Study|Dose limiting toxicity|0|||
44333545|NCT01324830|79338266|FG009|Overall Study|Dose limiting toxicity|0|||
44333546|NCT01324830|79338267|FG010|Overall Study|Dose limiting toxicity|0|||
44333547|NCT01324830|79338268|FG011|Overall Study|Dose limiting toxicity|0|||
44333548|NCT01324830|79338269|FG012|Overall Study|Dose limiting toxicity|0|||
44333549|NCT01324830|79338270|FG013|Overall Study|Dose limiting toxicity|0|||
44333550|NCT01324830|79338271|FG014|Overall Study|Dose limiting toxicity|0|||
44333551|NCT01324830|79338272|FG015|Overall Study|Dose limiting toxicity|0|||
44333552|NCT01324830|79338273|FG016|Overall Study|Dose limiting toxicity|1|||
44431330|NCT00552760|79439580|FG001|Overall Study|Adverse Event|5|||
44431331|NCT00552760|79439579|FG000|Overall Study|Relapsed- Depressed Event|10|||
44538701|NCT02095678|79549910|FG000|Overall Study|Withdrawal by Subject|0|||
44333553|NCT01324830|79338274|FG017|Overall Study|Dose limiting toxicity|1|||
44333554|NCT01324830|79338275|FG018|Overall Study|Dose limiting toxicity|1|||
44333555|NCT01324830|79338257|FG000|Overall Study|Reason not mentioned above|0|||
44333556|NCT01324830|79338258|FG001|Overall Study|Reason not mentioned above|0|||
44333557|NCT01324830|79338259|FG002|Overall Study|Reason not mentioned above|0|||
44333558|NCT01324830|79338260|FG003|Overall Study|Reason not mentioned above|0|||
44333559|NCT01324830|79338261|FG004|Overall Study|Reason not mentioned above|0|||
44333560|NCT01324830|79338262|FG005|Overall Study|Reason not mentioned above|0|||
44333561|NCT01324830|79338263|FG006|Overall Study|Reason not mentioned above|0|||
44333562|NCT01324830|79338264|FG007|Overall Study|Reason not mentioned above|0|||
44333563|NCT01324830|79338265|FG008|Overall Study|Reason not mentioned above|0|||
44333564|NCT01324830|79338266|FG009|Overall Study|Reason not mentioned above|0|||
44431332|NCT00552760|79439580|FG001|Overall Study|Relapsed- Depressed Event|16|||
44333565|NCT01324830|79338267|FG010|Overall Study|Reason not mentioned above|0|||
44333566|NCT01324830|79338268|FG011|Overall Study|Reason not mentioned above|0|||
44333567|NCT01324830|79338269|FG012|Overall Study|Reason not mentioned above|0|||
44333568|NCT01324830|79338270|FG013|Overall Study|Reason not mentioned above|0|||
44333569|NCT01324830|79338271|FG014|Overall Study|Reason not mentioned above|0|||
44333570|NCT01324830|79338272|FG015|Overall Study|Reason not mentioned above|0|||
44333571|NCT01324830|79338273|FG016|Overall Study|Reason not mentioned above|0|||
44333572|NCT01324830|79338274|FG017|Overall Study|Reason not mentioned above|1|||
44333573|NCT01324830|79338275|FG018|Overall Study|Reason not mentioned above|0|||
44333574|NCT01324830|79338257|FG000|Overall Study|Adverse Event, serious fatal|0|||
44333575|NCT01324830|79338258|FG001|Overall Study|Adverse Event, serious fatal|1|||
44333576|NCT01324830|79338259|FG002|Overall Study|Adverse Event, serious fatal|0|||
44333577|NCT01324830|79338260|FG003|Overall Study|Adverse Event, serious fatal|0|||
44333578|NCT01324830|79338261|FG004|Overall Study|Adverse Event, serious fatal|0|||
44333579|NCT01324830|79338262|FG005|Overall Study|Adverse Event, serious fatal|0|||
44333580|NCT01324830|79338263|FG006|Overall Study|Adverse Event, serious fatal|0|||
44333581|NCT01324830|79338264|FG007|Overall Study|Adverse Event, serious fatal|0|||
44333582|NCT01324830|79338265|FG008|Overall Study|Adverse Event, serious fatal|0|||
44333583|NCT01324830|79338266|FG009|Overall Study|Adverse Event, serious fatal|0|||
44431333|NCT00552760|79439579|FG000|Overall Study|Relapse- Manic Event|3|||
44431334|NCT00552760|79439580|FG001|Overall Study|Relapse- Manic Event|3|||
44431335|NCT00552760|79439579|FG000|Overall Study|Relapsed- Mixed Event|3|||
44431336|NCT00552760|79439580|FG001|Overall Study|Relapsed- Mixed Event|5|||
44431337|NCT00552760|79439579|FG000|Overall Study|Protocol Violation|0|||
44431338|NCT00552760|79439580|FG001|Overall Study|Protocol Violation|1|||
44431339|NCT00552760|79439579|FG000|Overall Study|Lost to Follow-up|1|||
44431340|NCT00552760|79439580|FG001|Overall Study|Lost to Follow-up|1|||
44431341|NCT00552760|79439579|FG000|Overall Study|Non-compliance|1|||
44431342|NCT00552760|79439580|FG001|Overall Study|Non-compliance|1|||
44431343|NCT00552760|79439579|FG000|Overall Study|Medical Condition|1|||
44431344|NCT00552760|79439580|FG001|Overall Study|Medical Condition|1|||
44431345|NCT00552760|79439579|FG000|Overall Study|Withdrawal by Subject|3|||
44431346|NCT00552760|79439580|FG001|Overall Study|Withdrawal by Subject|0|||
44431347|NCT00552760|79439579|FG000|Overall Study|Medication Change|1|||
44431348|NCT00552760|79439580|FG001|Overall Study|Medication Change|0|||
44431349|NCT00686790|79439586|FG000|Overall Study|Adverse Event|2|||
44431350|NCT00686790|79439586|FG000|Overall Study|Withdrawal by Subject|1|||
44431351|NCT00686790|79439586|FG000|Overall Study|Death|1|||
44431352|NCT00686790|79439586|FG000|Overall Study|Lost to Follow-up|12|||
44431353|NCT00686712|79439593|FG000|Overall Study|Protocol Violation|8|||
44431354|NCT00686712|79439594|FG001|Overall Study|Protocol Violation|8|||
44431355|NCT00686712|79439595|FG002|Overall Study|Protocol Violation|10|||
44431356|NCT00686712|79439593|FG000|Overall Study|Lost to Follow-up|1|||
44431357|NCT00686712|79439594|FG001|Overall Study|Lost to Follow-up|2|||
44431358|NCT00686712|79439595|FG002|Overall Study|Lost to Follow-up|3|||
44431359|NCT00686712|79439593|FG000|Overall Study|Adverse Event|1|||
44431360|NCT00686712|79439594|FG001|Overall Study|Adverse Event|1|||
44431361|NCT00686712|79439595|FG002|Overall Study|Adverse Event|0|||
44431362|NCT00686634|79439606|FG000|Overall Study|Protocol Violation|6|||
44431363|NCT00560404|79439613|FG000|Overall Study|Adverse Event|2|||
44431364|NCT00560404|79439614|FG001|Overall Study|Adverse Event|3|||
44431365|NCT00560404|79439613|FG000|Overall Study|Death|3|||
44431366|NCT00560404|79439614|FG001|Overall Study|Death|3|||
44431367|NCT00560404|79439613|FG000|Overall Study|Protocol Violation|12|||
44431368|NCT00560404|79439614|FG001|Overall Study|Protocol Violation|7|||
44431369|NCT00560404|79439613|FG000|Overall Study|Administrative Reasons|1|||
44431370|NCT00560404|79439614|FG001|Overall Study|Administrative Reasons|1|||
44431371|NCT00560404|79439613|FG000|Overall Study|Withdrew Consent|4|||
44431372|NCT00560404|79439614|FG001|Overall Study|Withdrew Consent|0|||
44431373|NCT00560404|79439613|FG000|Overall Study|Failure to return|1|||
44431374|NCT00560404|79439614|FG001|Overall Study|Failure to return|2|||
44431375|NCT00560404|79439613|FG000|Overall Study|Other withdrawal reason|13|||
44431376|NCT00560404|79439614|FG001|Overall Study|Other withdrawal reason|5|||
44431377|NCT03967444|79439622|FG000|Overall Study|Lost to Follow-up|1|||
44431378|NCT03967444|79439623|FG001|Overall Study|Lost to Follow-up|2|||
44431379|NCT00619983|79439633|FG000|Test Drug Alone|Withdrawal by Subject|1|||
44431380|NCT00619983|79439634|FG001|Test Drug Alone|Withdrawal by Subject|0|||
44431381|NCT00619983|79439635|FG002|Test Drug Alone|Withdrawal by Subject|0|||
44431382|NCT00619983|79439636|FG003|Test Drug Alone|Withdrawal by Subject|1|||
44333584|NCT01324830|79338267|FG010|Overall Study|Adverse Event, serious fatal|0|||
44333585|NCT01324830|79338268|FG011|Overall Study|Adverse Event, serious fatal|0|||
44333586|NCT01324830|79338269|FG012|Overall Study|Adverse Event, serious fatal|0|||
44431383|NCT00619983|79439633|FG000|Test Drug Alone|Failure of daily diary device|1|||
44431384|NCT00619983|79439634|FG001|Test Drug Alone|Failure of daily diary device|1|||
44431385|NCT00619983|79439635|FG002|Test Drug Alone|Failure of daily diary device|2|||
44431386|NCT00619983|79439636|FG003|Test Drug Alone|Failure of daily diary device|2|||
44431387|NCT00576420|79439649|FG000|Overall Study|Death|0|||
44431388|NCT00576420|79439650|FG001|Overall Study|Death|0|||
44431389|NCT00576420|79439651|FG002|Overall Study|Death|1|||
44431390|NCT00364351|79439702|FG000|Overall Study|Adverse Event|90|||
44431391|NCT00364351|79439703|FG001|Overall Study|Adverse Event|44|||
44431392|NCT00364351|79439702|FG000|Overall Study|Condition under investigation worsened|469|||
44431393|NCT00364351|79439703|FG001|Overall Study|Condition under investigation worsened|497|||
44431394|NCT00364351|79439702|FG000|Overall Study|Prohibited concomitant medication|0|||
44431395|NCT00364351|79439703|FG001|Overall Study|Prohibited concomitant medication|2|||
44431396|NCT00364351|79439702|FG000|Overall Study|Lost to Follow-up|1|||
44431397|NCT00364351|79439703|FG001|Overall Study|Lost to Follow-up|1|||
44431398|NCT00364351|79439702|FG000|Overall Study|Withdrawal by Subject|30|||
44431399|NCT00364351|79439703|FG001|Overall Study|Withdrawal by Subject|29|||
44431400|NCT00364351|79439702|FG000|Overall Study|Incorrect enrollment|1|||
44431401|NCT00364351|79439703|FG001|Overall Study|Incorrect enrollment|1|||
44431402|NCT00364351|79439702|FG000|Overall Study|Sponsor decision|1|||
44431403|NCT00364351|79439703|FG001|Overall Study|Sponsor decision|0|||
44431404|NCT00364351|79439702|FG000|Overall Study|Poor treatment compliance|0|||
44431405|NCT00364351|79439703|FG001|Overall Study|Poor treatment compliance|3|||
44431406|NCT00364351|79439702|FG000|Overall Study|Investigator error|0|||
44431407|NCT00364351|79439703|FG001|Overall Study|Investigator error|2|||
44431408|NCT00364351|79439702|FG000|Overall Study|Patient could not travel to site|0|||
44431409|NCT00364351|79439703|FG001|Overall Study|Patient could not travel to site|1|||
44431410|NCT00364351|79439702|FG000|Overall Study|Randomised treatment not started|0|||
44431411|NCT00364351|79439703|FG001|Overall Study|Randomised treatment not started|3|||
44431412|NCT00388297|79439713|FG000|Overall Study|Lost to Follow-up|16|||
44431413|NCT00388297|79439714|FG001|Overall Study|Lost to Follow-up|12|||
44431414|NCT00388297|79439715|FG002|Overall Study|Lost to Follow-up|11|||
44431415|NCT00388297|79439716|FG003|Overall Study|Lost to Follow-up|8|||
44431416|NCT00686166|79439726|FG000|Overall Study|Adverse Event|7|||
44333587|NCT01324830|79338270|FG013|Overall Study|Adverse Event, serious fatal|0|||
44333588|NCT01324830|79338271|FG014|Overall Study|Adverse Event, serious fatal|0|||
44333589|NCT01324830|79338272|FG015|Overall Study|Adverse Event, serious fatal|0|||
44333590|NCT01324830|79338273|FG016|Overall Study|Adverse Event, serious fatal|0|||
44431417|NCT00686166|79439726|FG000|Overall Study|Withdrawal by Subject|1|||
44431418|NCT00686166|79439726|FG000|Overall Study|Progression/Relapse|1|||
44431419|NCT00686166|79439726|FG000|Overall Study|Death|1|||
44333591|NCT01324830|79338274|FG017|Overall Study|Adverse Event, serious fatal|0|||
44333592|NCT01324830|79338275|FG018|Overall Study|Adverse Event, serious fatal|0|||
44333593|NCT01324830|79338257|FG000|Overall Study|Adverse Event, non-fatal|0|||
44333594|NCT01324830|79338258|FG001|Overall Study|Adverse Event, non-fatal|0|||
44333595|NCT01324830|79338259|FG002|Overall Study|Adverse Event, non-fatal|0|||
44333596|NCT01324830|79338260|FG003|Overall Study|Adverse Event, non-fatal|0|||
44333597|NCT01324830|79338261|FG004|Overall Study|Adverse Event, non-fatal|0|||
44333598|NCT01324830|79338262|FG005|Overall Study|Adverse Event, non-fatal|0|||
44333599|NCT01324830|79338263|FG006|Overall Study|Adverse Event, non-fatal|0|||
44333600|NCT01324830|79338264|FG007|Overall Study|Adverse Event, non-fatal|0|||
44333601|NCT01324830|79338265|FG008|Overall Study|Adverse Event, non-fatal|2|||
44333602|NCT01324830|79338266|FG009|Overall Study|Adverse Event, non-fatal|0|||
44333603|NCT01324830|79338267|FG010|Overall Study|Adverse Event, non-fatal|1|||
44333604|NCT01324830|79338268|FG011|Overall Study|Adverse Event, non-fatal|0|||
44333605|NCT01324830|79338269|FG012|Overall Study|Adverse Event, non-fatal|0|||
44333606|NCT01324830|79338270|FG013|Overall Study|Adverse Event, non-fatal|0|||
44333607|NCT01324830|79338271|FG014|Overall Study|Adverse Event, non-fatal|0|||
44333608|NCT01324830|79338272|FG015|Overall Study|Adverse Event, non-fatal|0|||
44333609|NCT01324830|79338273|FG016|Overall Study|Adverse Event, non-fatal|0|||
44333610|NCT01324830|79338274|FG017|Overall Study|Adverse Event, non-fatal|1|||
44333611|NCT01324830|79338275|FG018|Overall Study|Adverse Event, non-fatal|0|||
44333612|NCT01324830|79338257|FG000|Overall Study|Withdrawal by Subject|0|||
44431420|NCT00686166|79439726|FG000|Overall Study|Not Protocol Specified|1|||
44431421|NCT00686166|79439726|FG000|Overall Study|Ineligible|5|||
44431422|NCT00686166|79439726|FG000|Overall Study|Did not begin protocol therapy|4|||
44431423|NCT00363649|79439737|FG000|Overall Study|Withdrawal by Subject|1|||
44431424|NCT00363649|79439738|FG001|Overall Study|Withdrawal by Subject|1|||
44157212|NCT01326312|78948701|FG000|Overall Study|Treatment arm terminated|19|||
44157213|NCT01326312|78948702|FG001|Overall Study|Treatment arm terminated|0|||
44431425|NCT00363649|79439737|FG000|Overall Study|Adverse Event|6|||
44431426|NCT00363649|79439738|FG001|Overall Study|Adverse Event|0|||
44431427|NCT00684060|79439746|FG000|Overall Study|Lost to Follow-up|1|||
44431428|NCT00684060|79439747|FG001|Overall Study|Lost to Follow-up|0|||
44431429|NCT00684060|79439746|FG000|Overall Study|New stenosis identified|1|||
44333613|NCT01324830|79338258|FG001|Overall Study|Withdrawal by Subject|0|||
44333614|NCT01324830|79338259|FG002|Overall Study|Withdrawal by Subject|0|||
44333615|NCT01324830|79338260|FG003|Overall Study|Withdrawal by Subject|0|||
44333616|NCT01324830|79338261|FG004|Overall Study|Withdrawal by Subject|0|||
44333617|NCT01324830|79338262|FG005|Overall Study|Withdrawal by Subject|1|||
44333618|NCT01324830|79338263|FG006|Overall Study|Withdrawal by Subject|0|||
44431430|NCT00684060|79439747|FG001|Overall Study|New stenosis identified|0|||
44431431|NCT00684060|79439746|FG000|Overall Study|Unable to collect MRI|1|||
44431432|NCT00684060|79439747|FG001|Overall Study|Unable to collect MRI|2|||
44431433|NCT00684060|79439746|FG000|Overall Study|Death|0|||
44431434|NCT00684060|79439747|FG001|Overall Study|Death|1|||
44431435|NCT03131648|79439755|FG000|Initial Treatment Period|Not dosed|2|||
44431436|NCT03131648|79439756|FG001|Initial Treatment Period|Not dosed|2|||
44431437|NCT03131648|79439757|FG002|Initial Treatment Period|Not dosed|0|||
44431438|NCT03131648|79439758|FG003|Initial Treatment Period|Not dosed|0|||
44431439|NCT03131648|79439759|FG004|Initial Treatment Period|Not dosed|0|||
44431440|NCT03131648|79439760|FG005|Initial Treatment Period|Not dosed|0|||
44431441|NCT03131648|79439761|FG006|Initial Treatment Period|Not dosed|0|||
44431442|NCT03131648|79439762|FG007|Initial Treatment Period|Not dosed|0|||
44431443|NCT03131648|79439755|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
44431444|NCT03131648|79439756|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
44431445|NCT03131648|79439757|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44431446|NCT03131648|79439758|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44431447|NCT03131648|79439759|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44431448|NCT03131648|79439760|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44431449|NCT03131648|79439761|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44431450|NCT03131648|79439762|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
44431451|NCT03131648|79439755|FG000|Open-label Treatment|Discontinued IMP|0|||
44431452|NCT03131648|79439756|FG001|Open-label Treatment|Discontinued IMP|0|||
44431453|NCT03131648|79439757|FG002|Open-label Treatment|Discontinued IMP|0|||
44431454|NCT03131648|79439758|FG003|Open-label Treatment|Discontinued IMP|0|||
44431455|NCT03131648|79439759|FG004|Open-label Treatment|Discontinued IMP|0|||
44431456|NCT03131648|79439760|FG005|Open-label Treatment|Discontinued IMP|0|||
44431457|NCT03131648|79439761|FG006|Open-label Treatment|Discontinued IMP|112|||
44431458|NCT03131648|79439762|FG007|Open-label Treatment|Discontinued IMP|0|||
44431459|NCT03131648|79439755|FG000|Open-label Treatment|Completed Week 50|0|||
44431460|NCT03131648|79439756|FG001|Open-label Treatment|Completed Week 50|0|||
44431461|NCT03131648|79439757|FG002|Open-label Treatment|Completed Week 50|0|||
44538702|NCT02095678|79549911|FG001|Overall Study|Withdrawal by Subject|1|||
44538703|NCT02095678|79549910|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
44538704|NCT02095678|79549911|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
44538705|NCT02095678|79549910|FG000|Overall Study|lesion impacted by previous treatment|1|||
44538706|NCT02095678|79549911|FG001|Overall Study|lesion impacted by previous treatment|1|||
44157214|NCT01326312|78948703|FG002|Overall Study|Treatment arm terminated|0|||
44157215|NCT01326312|78948701|FG000|Overall Study|QTc > 500|0|||
44333619|NCT01324830|79338264|FG007|Overall Study|Withdrawal by Subject|0|||
44333620|NCT01324830|79338265|FG008|Overall Study|Withdrawal by Subject|0|||
44333621|NCT01324830|79338266|FG009|Overall Study|Withdrawal by Subject|0|||
44333622|NCT01324830|79338267|FG010|Overall Study|Withdrawal by Subject|1|||
44333623|NCT01324830|79338268|FG011|Overall Study|Withdrawal by Subject|0|||
44333624|NCT01324830|79338269|FG012|Overall Study|Withdrawal by Subject|0|||
44333625|NCT01324830|79338270|FG013|Overall Study|Withdrawal by Subject|0|||
44333626|NCT01324830|79338271|FG014|Overall Study|Withdrawal by Subject|0|||
44333627|NCT01324830|79338272|FG015|Overall Study|Withdrawal by Subject|0|||
44333628|NCT01324830|79338273|FG016|Overall Study|Withdrawal by Subject|0|||
44333629|NCT01324830|79338274|FG017|Overall Study|Withdrawal by Subject|0|||
44333630|NCT01324830|79338275|FG018|Overall Study|Withdrawal by Subject|1|||
44333631|NCT01324440|79338323|FG000|Overall Study|Subject moved|0|||
44333632|NCT01324440|79338324|FG001|Overall Study|Subject moved|1|||
44333633|NCT01325493|79338332|FG000|Overall Study|Protocol Violation|0|||
44333634|NCT01325493|79338333|FG001|Overall Study|Protocol Violation|1|||
44333635|NCT01325493|79338332|FG000|Overall Study|loss of neuromonitoring signals|0|||
44333636|NCT01325493|79338333|FG001|Overall Study|loss of neuromonitoring signals|2|||
44333637|NCT01325493|79338332|FG000|Overall Study|Allergy|1|||
44333638|NCT01325493|79338333|FG001|Overall Study|Allergy|0|||
44333639|NCT01323972|79338343|FG000|Overall Study|Withdrawal by Subject|1|||
44333640|NCT01323972|79338344|FG001|Overall Study|Withdrawal by Subject|0|||
44431462|NCT03131648|79439758|FG003|Open-label Treatment|Completed Week 50|0|||
44431463|NCT03131648|79439759|FG004|Open-label Treatment|Completed Week 50|0|||
44431464|NCT03131648|79439760|FG005|Open-label Treatment|Completed Week 50|0|||
44431465|NCT03131648|79439761|FG006|Open-label Treatment|Completed Week 50|6|||
44431466|NCT03131648|79439762|FG007|Open-label Treatment|Completed Week 50|0|||
44431467|NCT03131648|79439755|FG000|Maintenance Treatment Period|Not dosed|0|||
44538707|NCT02095678|79549910|FG000|Overall Study|No Confirmed Diagnosis|0|||
44157216|NCT01326312|78948702|FG001|Overall Study|QTc > 500|1|||
44333641|NCT01323972|79338345|FG002|Overall Study|Withdrawal by Subject|1|||
44333642|NCT01323972|79338346|FG003|Overall Study|Withdrawal by Subject|0|||
44333643|NCT01323972|79338343|FG000|Overall Study|Migrated/moved from study area|1|||
44333644|NCT01323972|79338344|FG001|Overall Study|Migrated/moved from study area|2|||
44333645|NCT01323972|79338345|FG002|Overall Study|Migrated/moved from study area|0|||
44333646|NCT01323972|79338346|FG003|Overall Study|Migrated/moved from study area|0|||
44333647|NCT01323972|79338343|FG000|Overall Study|Lost to Follow-up|0|||
44333648|NCT01323972|79338344|FG001|Overall Study|Lost to Follow-up|1|||
44333649|NCT01323972|79338345|FG002|Overall Study|Lost to Follow-up|1|||
44333650|NCT01323972|79338346|FG003|Overall Study|Lost to Follow-up|1|||
44333651|NCT01325337|79338363|FG000|Overall Study|Adverse Event|0|||
44333652|NCT01325337|79338364|FG001|Overall Study|Adverse Event|2|||
44333653|NCT01325337|79338365|FG002|Overall Study|Adverse Event|2|||
44333654|NCT01325337|79338366|FG003|Overall Study|Adverse Event|1|||
44333655|NCT01325337|79338367|FG004|Overall Study|Adverse Event|2|||
44333656|NCT01325337|79338363|FG000|Overall Study|Lost to Follow-up|2|||
44333657|NCT01325337|79338364|FG001|Overall Study|Lost to Follow-up|2|||
44333658|NCT01325337|79338365|FG002|Overall Study|Lost to Follow-up|2|||
44333659|NCT01325337|79338366|FG003|Overall Study|Lost to Follow-up|1|||
44333660|NCT01325337|79338367|FG004|Overall Study|Lost to Follow-up|2|||
44333661|NCT01325337|79338363|FG000|Overall Study|Personal Reasons|2|||
44333662|NCT01325337|79338364|FG001|Overall Study|Personal Reasons|5|||
44333663|NCT01325337|79338365|FG002|Overall Study|Personal Reasons|4|||
44333664|NCT01325337|79338366|FG003|Overall Study|Personal Reasons|8|||
44333665|NCT01325337|79338367|FG004|Overall Study|Personal Reasons|3|||
44333666|NCT01325337|79338363|FG000|Overall Study|Withdrawal by Subject|1|||
44333667|NCT01325337|79338364|FG001|Overall Study|Withdrawal by Subject|0|||
44333668|NCT01325337|79338365|FG002|Overall Study|Withdrawal by Subject|1|||
44333669|NCT01325337|79338366|FG003|Overall Study|Withdrawal by Subject|0|||
44333670|NCT01325337|79338367|FG004|Overall Study|Withdrawal by Subject|1|||
44333671|NCT01324947|79338379|FG000|Overall Study|Adverse Event|7|||
44333672|NCT01324947|79338379|FG000|Overall Study|Death|10|||
44333673|NCT01324947|79338379|FG000|Overall Study|Other|3|||
44333674|NCT01324947|79338379|FG000|Overall Study|Progressive Disease|50|||
44333675|NCT01324947|79338379|FG000|Overall Study|Withdrawal by Subject|3|||
44333676|NCT01324947|79338379|FG000|Overall Study|1 discontinued before starting drug|1|||
44333677|NCT01101841|79338387|FG000|Overall Study|Adverse Event|15|||
44333678|NCT01101841|79338388|FG001|Overall Study|Adverse Event|15|||
44333679|NCT01101841|79338387|FG000|Overall Study|Lost to Follow-up|9|||
44333680|NCT01101841|79338388|FG001|Overall Study|Lost to Follow-up|3|||
44333681|NCT01101841|79338387|FG000|Overall Study|Withdrawal by Subject|21|||
44333682|NCT01101841|79338388|FG001|Overall Study|Withdrawal by Subject|40|||
44333683|NCT01101841|79338387|FG000|Overall Study|Protocol Violation|1|||
44333684|NCT01101841|79338388|FG001|Overall Study|Protocol Violation|1|||
44333685|NCT01101841|79338387|FG000|Overall Study|Physician Decision|0|||
44333686|NCT01101841|79338388|FG001|Overall Study|Physician Decision|2|||
44333687|NCT01101841|79338387|FG000|Overall Study|Lack of Efficacy|0|||
44333688|NCT01101841|79338388|FG001|Overall Study|Lack of Efficacy|2|||
44431468|NCT03131648|79439756|FG001|Maintenance Treatment Period|Not dosed|0|||
44431469|NCT03131648|79439757|FG002|Maintenance Treatment Period|Not dosed|3|||
44431470|NCT03131648|79439758|FG003|Maintenance Treatment Period|Not dosed|2|||
44431471|NCT03131648|79439759|FG004|Maintenance Treatment Period|Not dosed|1|||
44431472|NCT03131648|79439760|FG005|Maintenance Treatment Period|Not dosed|0|||
44431473|NCT03131648|79439761|FG006|Maintenance Treatment Period|Not dosed|0|||
44431474|NCT03131648|79439762|FG007|Maintenance Treatment Period|Not dosed|0|||
44431475|NCT03131648|79439755|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
44431476|NCT03131648|79439756|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
44431477|NCT03131648|79439757|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
44431478|NCT03131648|79439758|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
44431479|NCT03131648|79439759|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
44431480|NCT03131648|79439760|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
44431481|NCT03131648|79439761|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
44431482|NCT03131648|79439762|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
44538708|NCT02095678|79549911|FG001|Overall Study|No Confirmed Diagnosis|3|||
44538709|NCT02095678|79549910|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
44538710|NCT02095678|79549911|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
44538711|NCT02095678|79549910|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
44538712|NCT02095678|79549911|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
44538713|NCT03763877|79549924|FG000|Overall Study|Withdrawal by Subject|3|||
44538714|NCT03763877|79549925|FG001|Overall Study|Withdrawal by Subject|1|||
44333689|NCT01101841|79338387|FG000|Overall Study|Other|0|||
44333690|NCT01101841|79338388|FG001|Overall Study|Other|1|||
44333691|NCT01101841|79338387|FG000|Overall Study|Suicidality Tracking Scale|3|||
44333692|NCT01101841|79338388|FG001|Overall Study|Suicidality Tracking Scale|1|||
44333693|NCT01101841|79338387|FG000|Overall Study|Eligibility Criteria|1|||
44333694|NCT01101841|79338388|FG001|Overall Study|Eligibility Criteria|2|||
44333695|NCT01324401|79338397|FG000|Overall Study|Withdrawn before any treatment|0|||
44333696|NCT01324401|79338398|FG001|Overall Study|Withdrawn before any treatment|3|||
44333697|NCT01324401|79338397|FG000|Overall Study|Adverse Event|1|||
44333698|NCT01324401|79338398|FG001|Overall Study|Adverse Event|3|||
44538715|NCT03763877|79549926|FG002|Overall Study|Withdrawal by Subject|3|||
44333699|NCT01323660|79338404|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
44333700|NCT01323660|79338405|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
44333701|NCT01323660|79338406|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
44431483|NCT03131648|79439755|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44431484|NCT03131648|79439756|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44431485|NCT03131648|79439757|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
44431486|NCT03131648|79439758|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
44431487|NCT03131648|79439759|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
44431488|NCT03131648|79439760|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
44431489|NCT03131648|79439761|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44157217|NCT01326312|78948703|FG002|Overall Study|QTc > 500|0|||
44431490|NCT03131648|79439762|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
44431491|NCT03131648|79439755|FG000|Maintenance Treatment Period|Completed Week 50|0|||
44431492|NCT03131648|79439756|FG001|Maintenance Treatment Period|Completed Week 50|0|||
44431493|NCT03131648|79439757|FG002|Maintenance Treatment Period|Completed Week 50|0|||
44431494|NCT03131648|79439758|FG003|Maintenance Treatment Period|Completed Week 50|0|||
44431495|NCT03131648|79439759|FG004|Maintenance Treatment Period|Completed Week 50|1|||
44431496|NCT03131648|79439760|FG005|Maintenance Treatment Period|Completed Week 50|0|||
44538716|NCT03763877|79549927|FG003|Overall Study|Withdrawal by Subject|4|||
44538717|NCT03763877|79549924|FG000|Overall Study|Adverse Event|1|||
44538718|NCT03763877|79549925|FG001|Overall Study|Adverse Event|1|||
44538719|NCT03763877|79549926|FG002|Overall Study|Adverse Event|3|||
44538720|NCT03763877|79549927|FG003|Overall Study|Adverse Event|1|||
44538721|NCT03763877|79549924|FG000|Overall Study|Protocol Violation|1|||
44538722|NCT03763877|79549925|FG001|Overall Study|Protocol Violation|1|||
44538723|NCT03763877|79549926|FG002|Overall Study|Protocol Violation|0|||
44538724|NCT03763877|79549927|FG003|Overall Study|Protocol Violation|0|||
44538725|NCT03763877|79549924|FG000|Overall Study|Lost to Follow-up|0|||
44538726|NCT03763877|79549925|FG001|Overall Study|Lost to Follow-up|1|||
44538727|NCT03763877|79549926|FG002|Overall Study|Lost to Follow-up|1|||
44538728|NCT03763877|79549927|FG003|Overall Study|Lost to Follow-up|0|||
44538729|NCT03358407|79549960|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538730|NCT03358407|79549961|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538731|NCT03358407|79549962|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
44538732|NCT03358407|79549963|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538733|NCT03358407|79549964|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538734|NCT03358407|79549965|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538735|NCT03358407|79549966|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538736|NCT03358407|79549967|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538737|NCT03358407|79549968|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538738|NCT03358407|79549969|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
44538739|NCT03358407|79549960|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44333702|NCT01323660|79338407|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
44333703|NCT01323660|79338408|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
44333704|NCT01323660|79338409|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
44333705|NCT01323660|79338404|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
44333706|NCT01323660|79338405|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
44333707|NCT01323660|79338406|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
44333708|NCT01323660|79338407|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
44333709|NCT01323660|79338408|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
44333710|NCT01323660|79338409|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
44333711|NCT01323660|79338404|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
44333712|NCT01323660|79338405|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
44333713|NCT01323660|79338406|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
44333714|NCT01323660|79338407|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
44333715|NCT01323660|79338408|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
44333716|NCT01323660|79338409|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
44538740|NCT03358407|79549961|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538741|NCT03358407|79549962|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44431497|NCT03131648|79439761|FG006|Maintenance Treatment Period|Completed Week 50|0|||
44431498|NCT03131648|79439762|FG007|Maintenance Treatment Period|Completed Week 50|0|||
44431499|NCT03131648|79439755|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
44538742|NCT03358407|79549963|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538743|NCT03358407|79549964|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
44538744|NCT03358407|79549965|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44157218|NCT01269346|78948725|FG000|Treatment Phase|Disease progression|3|||
44354763|NCT01186770|79359155|FG002|Overall Study|Other than specified|1|||
44431500|NCT03131648|79439756|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
44431501|NCT03131648|79439757|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
44431502|NCT03131648|79439758|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
44431503|NCT03131648|79439759|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
44431504|NCT03131648|79439760|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
44431505|NCT03131648|79439761|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
44431506|NCT03131648|79439762|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
44431507|NCT00618813|79439779|FG000|Overall Study|Lack of Efficacy|1|||
44431508|NCT00618813|79439779|FG000|Overall Study|Physician Decision|2|||
44431509|NCT00618813|79439779|FG000|Overall Study|Withdrawal by Subject|1|||
44431510|NCT00685698|79439783|FG000|Overall Study|Withdrawal by Subject|1|||
44431511|NCT00685698|79439783|FG000|Overall Study|Protocol Violation|6|||
44431512|NCT00685698|79439783|FG000|Overall Study|Adverse Event|3|||
44431513|NCT00685698|79439783|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
44431514|NCT00685698|79439783|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
44431515|NCT00685698|79439783|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
44431516|NCT00549328|79439799|FG000|Overall Study|Adverse Event|2|||
44431517|NCT00549328|79439799|FG000|Overall Study|Disease Progression|10|||
44431518|NCT00549328|79439799|FG000|Overall Study|Death|1|||
44431519|NCT00549328|79439799|FG000|Overall Study|Use of Prohibited Medication|1|||
44431520|NCT00696410|79439805|FG000|Overall Study|Lost to Follow-up|2|||
44431521|NCT00696410|79439806|FG001|Overall Study|Lost to Follow-up|0|||
44431522|NCT00696410|79439805|FG000|Overall Study|Withdrawal by Subject|8|||
44431523|NCT00696410|79439806|FG001|Overall Study|Withdrawal by Subject|0|||
44431524|NCT00696410|79439805|FG000|Overall Study|Physician Decision|3|||
44431525|NCT00696410|79439806|FG001|Overall Study|Physician Decision|0|||
44431526|NCT00683904|79439819|FG000|Dose Level 1|Disease progression|2|||
44431527|NCT00683904|79439820|FG001|Dose Level 1|Disease progression|0|||
44431528|NCT00683904|79439819|FG000|Dose Level 1|Adverse Event|1|||
44333717|NCT01323660|79338404|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44333718|NCT01323660|79338405|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44333719|NCT01323660|79338406|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44333720|NCT01323660|79338407|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44333721|NCT01323660|79338408|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
44333722|NCT01323660|79338409|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
44333723|NCT01323660|79338404|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44333724|NCT01323660|79338405|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44333725|NCT01323660|79338406|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44333726|NCT01323660|79338407|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44333727|NCT01323660|79338408|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
44333728|NCT01323660|79338409|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44333729|NCT01323660|79338404|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
44431529|NCT00683904|79439820|FG001|Dose Level 1|Adverse Event|0|||
44431530|NCT00683904|79439819|FG000|Dose Level 2|Adverse Event|0|||
44431531|NCT00683904|79439820|FG001|Dose Level 2|Adverse Event|2|||
44431532|NCT00363415|79439834|FG000|Overall Study|Progressive Disease|196|||
44431533|NCT00363415|79439835|FG001|Overall Study|Progressive Disease|107|||
44431534|NCT00363415|79439834|FG000|Overall Study|Sponsor Decision|67|||
44431535|NCT00363415|79439835|FG001|Overall Study|Sponsor Decision|31|||
44431536|NCT00363415|79439834|FG000|Overall Study|Death|32|||
44431537|NCT00363415|79439835|FG001|Overall Study|Death|29|||
44431538|NCT00363415|79439834|FG000|Overall Study|Adverse Event|24|||
44431539|NCT00363415|79439835|FG001|Overall Study|Adverse Event|15|||
44431540|NCT00363415|79439834|FG000|Overall Study|Physician Decision|18|||
44538745|NCT03358407|79549966|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538746|NCT03358407|79549967|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538747|NCT03358407|79549968|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538748|NCT03358407|79549969|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538749|NCT03358407|79549960|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538750|NCT03358407|79549961|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538751|NCT03358407|79549962|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538752|NCT03358407|79549963|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538753|NCT03358407|79549964|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538754|NCT03358407|79549965|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
44538755|NCT03358407|79549966|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538756|NCT03358407|79549967|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
44538757|NCT03358407|79549968|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44538758|NCT03358407|79549969|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
44431541|NCT00363415|79439835|FG001|Overall Study|Physician Decision|35|||
44431542|NCT00363415|79439834|FG000|Overall Study|Entry Criteria Not Met|11|||
44431543|NCT00363415|79439835|FG001|Overall Study|Entry Criteria Not Met|10|||
44333730|NCT01323660|79338405|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44333731|NCT01323660|79338406|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
44333732|NCT01323660|79338407|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
44333733|NCT01323660|79338408|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
44333734|NCT01323660|79338409|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
44333735|NCT01323660|79338404|FG000|Washout Period (14 Days)|Adverse Event|0|||
44333736|NCT01323660|79338405|FG001|Washout Period (14 Days)|Adverse Event|0|||
44333737|NCT01323660|79338406|FG002|Washout Period (14 Days)|Adverse Event|0|||
44333738|NCT01323660|79338407|FG003|Washout Period (14 Days)|Adverse Event|0|||
44333739|NCT01323660|79338408|FG004|Washout Period (14 Days)|Adverse Event|1|||
44333740|NCT01323660|79338409|FG005|Washout Period (14 Days)|Adverse Event|0|||
44333741|NCT01323660|79338404|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
44431544|NCT00363415|79439834|FG000|Overall Study|Withdrawal by Subject|9|||
44431545|NCT00363415|79439835|FG001|Overall Study|Withdrawal by Subject|15|||
44431546|NCT00363415|79439834|FG000|Overall Study|Lost to Follow-up|3|||
44431547|NCT00363415|79439835|FG001|Overall Study|Lost to Follow-up|3|||
44431548|NCT00363415|79439834|FG000|Overall Study|Protocol Violation|1|||
44431549|NCT00363415|79439835|FG001|Overall Study|Protocol Violation|4|||
44431550|NCT00696020|79439845|FG000|Overall Study|Adverse Event|3|||
44431551|NCT00696020|79439846|FG001|Overall Study|Adverse Event|1|||
44431552|NCT00696020|79439847|FG002|Overall Study|Adverse Event|2|||
44431553|NCT00696020|79439848|FG003|Overall Study|Adverse Event|1|||
44431554|NCT00696020|79439845|FG000|Overall Study|Lack of Efficacy|1|||
44431555|NCT00696020|79439846|FG001|Overall Study|Lack of Efficacy|0|||
44431556|NCT00696020|79439847|FG002|Overall Study|Lack of Efficacy|0|||
44431557|NCT00696020|79439848|FG003|Overall Study|Lack of Efficacy|0|||
44431558|NCT00696020|79439845|FG000|Overall Study|Protocol Violation|0|||
44431559|NCT00696020|79439846|FG001|Overall Study|Protocol Violation|0|||
44431560|NCT00696020|79439847|FG002|Overall Study|Protocol Violation|0|||
44431561|NCT00696020|79439848|FG003|Overall Study|Protocol Violation|1|||
44431562|NCT00696020|79439845|FG000|Overall Study|Withdrawal by Subject|0|||
44431563|NCT00696020|79439846|FG001|Overall Study|Withdrawal by Subject|1|||
44431564|NCT00696020|79439847|FG002|Overall Study|Withdrawal by Subject|0|||
44431565|NCT00696020|79439848|FG003|Overall Study|Withdrawal by Subject|1|||
44431566|NCT00696020|79439845|FG000|Overall Study|Other not stated above|0|||
44431567|NCT00696020|79439846|FG001|Overall Study|Other not stated above|0|||
44431568|NCT00696020|79439847|FG002|Overall Study|Other not stated above|1|||
44431569|NCT00696020|79439848|FG003|Overall Study|Other not stated above|1|||
44431570|NCT00576576|79439860|FG000|Overall Study|Lost to Follow-up|6|||
44431571|NCT00576576|79439860|FG000|Overall Study|Protocol Violation|1|||
44431572|NCT00695864|79439879|FG000|Placebo|Withdrawal by Subject|1|||
44431573|NCT00695864|79439879|FG000|Placebo|Physician Decision|4|||
44431574|NCT00684996|79439885|FG000|Overall Study|Adverse Event|1|||
44431575|NCT00684996|79439885|FG000|Overall Study|Refusal unrelated to adverse event|1|||
44431576|NCT00684996|79439885|FG000|Overall Study|Progression/relapse|2|||
44431577|NCT00684996|79439885|FG000|Overall Study|Other reasons not protocol specified|1|||
44431578|NCT00684762|79439892|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
44431579|NCT00684762|79439893|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
44333742|NCT01323660|79338405|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
44333743|NCT01323660|79338406|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
44333744|NCT01323660|79338407|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
44333745|NCT01323660|79338408|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
44333746|NCT01323660|79338409|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
44333747|NCT01323660|79338404|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
44333748|NCT01323660|79338405|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
44333749|NCT01323660|79338406|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
44431580|NCT00695786|79439903|FG000|Overall Study|Adverse Event|0|||
44431581|NCT00695786|79439904|FG001|Overall Study|Adverse Event|3|||
44431582|NCT00695786|79439905|FG002|Overall Study|Adverse Event|4|||
44431583|NCT00695786|79439906|FG003|Overall Study|Adverse Event|2|||
44431584|NCT00695786|79439903|FG000|Overall Study|Lost to Follow-up|0|||
44431585|NCT00695786|79439904|FG001|Overall Study|Lost to Follow-up|5|||
44431586|NCT00695786|79439905|FG002|Overall Study|Lost to Follow-up|1|||
44431587|NCT00695786|79439906|FG003|Overall Study|Lost to Follow-up|1|||
44431588|NCT00695786|79439903|FG000|Overall Study|Withdrawal by Subject|0|||
44431589|NCT00695786|79439904|FG001|Overall Study|Withdrawal by Subject|4|||
44333750|NCT01323660|79338407|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
44431590|NCT00695786|79439905|FG002|Overall Study|Withdrawal by Subject|3|||
44431591|NCT00695786|79439906|FG003|Overall Study|Withdrawal by Subject|1|||
44538759|NCT03358407|79549960|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44538760|NCT03358407|79549961|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44333751|NCT01323660|79338408|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
44333752|NCT01323660|79338409|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
44431592|NCT00695786|79439903|FG000|Overall Study|Deemed Ineligible|1|||
44431593|NCT00695786|79439904|FG001|Overall Study|Deemed Ineligible|0|||
44431594|NCT00695786|79439905|FG002|Overall Study|Deemed Ineligible|0|||
44333753|NCT01323660|79338404|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
44333754|NCT01323660|79338405|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
44333755|NCT01323660|79338406|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
44333756|NCT01323660|79338407|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
44333757|NCT01323660|79338408|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
44333758|NCT01323660|79338409|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
44333759|NCT01323660|79338404|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
44333760|NCT01323660|79338405|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
44333761|NCT01323660|79338406|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
44333762|NCT01323660|79338407|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
44333763|NCT01323660|79338408|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
44333764|NCT01323660|79338409|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
44333765|NCT01323660|79338404|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
44431595|NCT00695786|79439906|FG003|Overall Study|Deemed Ineligible|0|||
44431596|NCT00695786|79439903|FG000|Overall Study|Lack of Efficacy|0|||
44431597|NCT00695786|79439904|FG001|Overall Study|Lack of Efficacy|0|||
44333766|NCT01323660|79338405|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
44333767|NCT01323660|79338406|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
44431598|NCT00695786|79439905|FG002|Overall Study|Lack of Efficacy|0|||
44431599|NCT00695786|79439906|FG003|Overall Study|Lack of Efficacy|4|||
44431600|NCT00387127|79439918|FG000|Overall Study|Lost to Follow-up|0|||
44431601|NCT00387127|79439919|FG001|Overall Study|Lost to Follow-up|4|||
44538761|NCT03358407|79549962|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44538762|NCT03358407|79549963|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44538763|NCT03358407|79549964|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44157219|NCT01269346|78948725|FG000|Treatment Phase|Adverse Event|3|||
44157220|NCT01269346|78948725|FG000|Treatment Phase|Withdrawal by Subject|1|||
44157221|NCT01269346|78948725|FG000|Treatment Phase|Other|2|||
44157222|NCT01269346|78948725|FG000|Extension Phase|Adverse Event|6|||
44157223|NCT01269346|78948725|FG000|Extension Phase|Withdrawal by Subject|4|||
44538764|NCT03358407|79549965|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
44538765|NCT03358407|79549966|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44538766|NCT03358407|79549967|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
44538767|NCT03358407|79549968|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44538768|NCT03358407|79549969|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
44157224|NCT01269346|78948725|FG000|Extension Phase|Disease progression|22|||
44157225|NCT01269346|78948725|FG000|Extension Phase|Physician decision or participant choice|9|||
44157226|NCT01269346|78948725|FG000|Extension Phase|Clinical progression|1|||
44157227|NCT01269346|78948725|FG000|Extension Phase|Started a prohibited con med|1|||
44157228|NCT01268293|78948730|FG000|Overall Study|Disease progression|7|||
44157229|NCT01268293|78948730|FG000|Overall Study|Adverse Event|1|||
44157230|NCT01268293|78948730|FG000|Overall Study|Subject choice|1|||
44157231|NCT01268150|78948734|FG000|Treatment Phase|Progression of disease|18|||
44157232|NCT01268150|78948734|FG000|Treatment Phase|Adverse Event|3|||
44157233|NCT01268150|78948734|FG000|Treatment Phase|Withdrawal by Subject|3|||
44157234|NCT01268150|78948734|FG000|Treatment Phase|Other|4|||
44157235|NCT01268150|78948734|FG000|Extension Phase|Adverse Event|3|||
44157236|NCT01268150|78948734|FG000|Extension Phase|Disease progression|18|||
44157237|NCT01268150|78948734|FG000|Extension Phase|Other|6|||
44538769|NCT03358407|79549960|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538770|NCT03358407|79549961|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538771|NCT03358407|79549962|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538772|NCT03358407|79549963|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538773|NCT03358407|79549964|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44157238|NCT01267175|78948738|FG000|Overall Study|Withdrawal by Subject|1|||
44157239|NCT01267175|78948738|FG000|Overall Study|Lost to Follow-up|1|||
44157240|NCT01133756|78948749|FG000|Overall Study|Adverse Event|1|||
44157241|NCT01133756|78948750|FG001|Overall Study|Adverse Event|2|||
44157242|NCT01133756|78948751|FG002|Overall Study|Adverse Event|1|||
44333768|NCT01323660|79338407|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
44333769|NCT01323660|79338408|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
44333770|NCT01323660|79338409|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
44157243|NCT01133756|78948749|FG000|Overall Study|Investigator Decision|1|||
44333771|NCT01323660|79338404|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44157244|NCT01133756|78948750|FG001|Overall Study|Investigator Decision|0|||
44157245|NCT01133756|78948751|FG002|Overall Study|Investigator Decision|0|||
44431602|NCT00387127|79439918|FG000|Overall Study|Death|16|||
44333772|NCT01323660|79338405|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44333773|NCT01323660|79338406|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
44333774|NCT01323660|79338407|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44333775|NCT01323660|79338408|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
44333776|NCT01323660|79338409|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
44333777|NCT01092637|79338425|FG000|Overall Study|Death|47|||
44333778|NCT01092637|79338426|FG001|Overall Study|Death|49|||
44333779|NCT01324323|79338433|FG000|Overall Study|Withdrawal by Subject|1|||
44333780|NCT01323582|79338447|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
44333781|NCT01323582|79338448|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
44333782|NCT01323582|79338447|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
44333783|NCT01323582|79338448|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
44333784|NCT01323582|79338447|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
44333785|NCT01323582|79338448|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
44333786|NCT01323621|79338458|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
44333787|NCT01323621|79338459|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
44333788|NCT01323621|79338460|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
44333789|NCT01323621|79338458|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
44333790|NCT01323621|79338459|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
44333791|NCT01323621|79338460|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
44333792|NCT01323621|79338458|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
44333793|NCT01323621|79338459|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
44333794|NCT01323621|79338460|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
44333795|NCT01323621|79338458|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
44333796|NCT01323621|79338459|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
44333797|NCT01323621|79338460|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
44333798|NCT01323621|79338458|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
44333799|NCT01323621|79338459|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
44333800|NCT01323621|79338460|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
44333801|NCT01323621|79338458|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
44333802|NCT01323621|79338459|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
44333803|NCT01323621|79338460|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
44333804|NCT01323621|79338458|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
44333805|NCT01323621|79338459|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
44333806|NCT01323621|79338460|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
44333807|NCT01323621|79338458|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
44333808|NCT01323621|79338459|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
44333809|NCT01323621|79338460|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
44333810|NCT01323621|79338458|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
44333811|NCT01323621|79338459|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
44333812|NCT01323621|79338460|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
44333813|NCT01323621|79338458|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44333814|NCT01323621|79338459|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
44333815|NCT01323621|79338460|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44333816|NCT01323621|79338458|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
44333817|NCT01323621|79338459|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
44333818|NCT01323621|79338460|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
44333819|NCT01323621|79338458|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44333820|NCT01323621|79338459|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
44333821|NCT01323621|79338460|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
44259043|NCT00216476|79115515|FG002|Overall Study|Adverse Event|1|||
44259044|NCT00216476|79115513|FG000|Overall Study|Lack of Efficacy|4|||
44259045|NCT00216476|79115514|FG001|Overall Study|Lack of Efficacy|3|||
44259046|NCT00216476|79115515|FG002|Overall Study|Lack of Efficacy|0|||
44259047|NCT00216476|79115513|FG000|Overall Study|Death|2|||
44259048|NCT00216476|79115514|FG001|Overall Study|Death|0|||
44259049|NCT00216476|79115515|FG002|Overall Study|Death|0|||
44259050|NCT00216476|79115513|FG000|Overall Study|Pregnancy|0|||
44259051|NCT00216476|79115514|FG001|Overall Study|Pregnancy|1|||
44259052|NCT00216476|79115515|FG002|Overall Study|Pregnancy|1|||
44259053|NCT00216476|79115513|FG000|Overall Study|Other|0|||
44259054|NCT00216476|79115514|FG001|Overall Study|Other|0|||
44259055|NCT00216476|79115515|FG002|Overall Study|Other|1|||
44259056|NCT00216476|79115513|FG000|Overall Study|Refuses Injection|11|||
44259057|NCT00216476|79115514|FG001|Overall Study|Refuses Injection|0|||
44259058|NCT00216476|79115515|FG002|Overall Study|Refuses Injection|0|||
44333822|NCT01323192|79338468|FG000|Overall Study|Adverse Event|6|||
44259059|NCT00216476|79115513|FG000|Overall Study|No Further Need for Treatment|3|||
44259060|NCT00216476|79115514|FG001|Overall Study|No Further Need for Treatment|4|||
44333823|NCT01323192|79338469|FG001|Overall Study|Adverse Event|1|||
44333824|NCT01323192|79338468|FG000|Overall Study|Withdrawal by Subject|3|||
44333825|NCT01323192|79338469|FG001|Overall Study|Withdrawal by Subject|1|||
44333826|NCT01323192|79338468|FG000|Overall Study|Noncompliance with study medication|0|||
44333827|NCT01323192|79338469|FG001|Overall Study|Noncompliance with study medication|3|||
44333828|NCT01323192|79338468|FG000|Overall Study|Nonmedical reasons|0|||
44333829|NCT01323192|79338469|FG001|Overall Study|Nonmedical reasons|1|||
44333830|NCT01323387|79338475|FG000|Overall Study|Withdrawal by Subject|41|||
44333831|NCT01323387|79338475|FG000|Overall Study|Radiographic Data Unavailable|1|||
44333832|NCT01323387|79338475|FG000|Overall Study|Revision|14|||
44333833|NCT01323387|79338475|FG000|Overall Study|Protocol Violation|12|||
44333834|NCT01323387|79338475|FG000|Overall Study|Randomized but Never Treated|16|||
44431603|NCT00387127|79439919|FG001|Overall Study|Death|16|||
44333835|NCT01321749|79338483|FG000|Overall Study|Lost to Follow-up|4|||
44333836|NCT01321749|79338484|FG001|Overall Study|Lost to Follow-up|11|||
44333837|NCT01321749|79338483|FG000|Overall Study|Protocol Violation|4|||
44333838|NCT01321749|79338484|FG001|Overall Study|Protocol Violation|7|||
44431604|NCT00387127|79439918|FG000|Overall Study|Physician Decision|0|||
44431605|NCT00387127|79439919|FG001|Overall Study|Physician Decision|1|||
44431606|NCT00387127|79439918|FG000|Overall Study|Withdrawal by Subject|3|||
44431607|NCT00387127|79439919|FG001|Overall Study|Withdrawal by Subject|2|||
44431608|NCT00387127|79439918|FG000|Overall Study|Required by Protocol Amendment #4|12|||
44431609|NCT00387127|79439919|FG001|Overall Study|Required by Protocol Amendment #4|10|||
44431610|NCT00387127|79439918|FG000|Overall Study|Serious Adverse Event|1|||
44431611|NCT00387127|79439919|FG001|Overall Study|Serious Adverse Event|1|||
44333839|NCT01321749|79338483|FG000|Overall Study|Withdrawal by Subject|5|||
44333840|NCT01321749|79338484|FG001|Overall Study|Withdrawal by Subject|4|||
44333841|NCT01320735|79338490|FG000|Overall Study|Adverse Event|3|||
44333842|NCT01320735|79338490|FG000|Overall Study|Withdrawal by Subject|3|||
44333843|NCT01320735|79338490|FG000|Overall Study|Lost to Follow-up|13|||
44333844|NCT01320735|79338490|FG000|Overall Study|Administrative Reason|6|||
44333845|NCT01320735|79338490|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
44333846|NCT01320735|79338490|FG000|Overall Study|Protocol Violation|1|||
44333847|NCT01320735|79338490|FG000|Overall Study|Other|1|||
44333848|NCT01320735|79338490|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
44333849|NCT01320735|79338490|FG000|Overall Study|Investigator Unable to be Contacted|17|||
44333850|NCT01320033|79338497|FG000|Overall Study|Lack of Efficacy|0|||
44333851|NCT01320033|79338498|FG001|Overall Study|Lack of Efficacy|0|||
44333852|NCT01320033|79338499|FG002|Overall Study|Lack of Efficacy|1|||
44333853|NCT01320033|79338497|FG000|Overall Study|Adverse Event|9|||
44333854|NCT01320033|79338498|FG001|Overall Study|Adverse Event|7|||
44333855|NCT01320033|79338499|FG002|Overall Study|Adverse Event|8|||
44431612|NCT00387127|79439918|FG000|Overall Study|Sponsor Unblinded|1|||
44431613|NCT00387127|79439919|FG001|Overall Study|Sponsor Unblinded|0|||
44431614|NCT00683592|79439929|FG000|Overall Study|Adverse Event|12|||
44431615|NCT00683592|79439930|FG001|Overall Study|Adverse Event|4|||
44431616|NCT00683592|79439929|FG000|Overall Study|Withdrawal by Subject|11|||
44431617|NCT00683592|79439930|FG001|Overall Study|Withdrawal by Subject|11|||
44431618|NCT00683592|79439929|FG000|Overall Study|Lost to Follow-up|17|||
44431619|NCT00683592|79439930|FG001|Overall Study|Lost to Follow-up|17|||
44333856|NCT01320033|79338497|FG000|Overall Study|Withdrawal by Subject|22|||
44333857|NCT01320033|79338498|FG001|Overall Study|Withdrawal by Subject|23|||
44333858|NCT01320033|79338499|FG002|Overall Study|Withdrawal by Subject|23|||
44333859|NCT01320033|79338497|FG000|Overall Study|Protocol Violation|3|||
44333860|NCT01320033|79338498|FG001|Overall Study|Protocol Violation|5|||
44333861|NCT01320033|79338499|FG002|Overall Study|Protocol Violation|3|||
44333862|NCT01320033|79338497|FG000|Overall Study|Lost to Follow-up|22|||
44333863|NCT01320033|79338498|FG001|Overall Study|Lost to Follow-up|26|||
44333864|NCT01320033|79338499|FG002|Overall Study|Lost to Follow-up|17|||
44333865|NCT01320033|79338497|FG000|Overall Study|Other|2|||
44333866|NCT01320033|79338498|FG001|Overall Study|Other|3|||
44333867|NCT01320033|79338499|FG002|Overall Study|Other|1|||
44431620|NCT00683592|79439929|FG000|Overall Study|Lack of Efficacy|3|||
44431621|NCT00683592|79439930|FG001|Overall Study|Lack of Efficacy|7|||
44431622|NCT00683592|79439929|FG000|Overall Study|Physician Decision|0|||
44431623|NCT00683592|79439930|FG001|Overall Study|Physician Decision|1|||
44333868|NCT01101061|79338513|FG000|Overall Study|Adverse Event|0|||
44333869|NCT01101061|79338514|FG001|Overall Study|Adverse Event|0|||
44333870|NCT01101061|79338515|FG002|Overall Study|Adverse Event|1|||
44333871|NCT01101061|79338516|FG003|Overall Study|Adverse Event|0|||
44333872|NCT01101061|79338517|FG004|Overall Study|Adverse Event|0|||
44333873|NCT01101061|79338518|FG005|Overall Study|Adverse Event|0|||
44333874|NCT01317615|79338536|FG000|Overall Study|Disease progression|25|||
44333875|NCT01317615|79338536|FG000|Overall Study|New cancer therapy|5|||
44333876|NCT01317615|79338536|FG000|Overall Study|Death|6|||
44333877|NCT01317615|79338536|FG000|Overall Study|Withdrawal by Subject|5|||
44333878|NCT01317615|79338536|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44333879|NCT01317615|79338536|FG000|Overall Study|Adverse Event|7|||
44431624|NCT00683592|79439929|FG000|Overall Study|Non-compliance|3|||
44333880|NCT01078675|79338542|FG000|Overall Study|Withdrawal by Subject|7|||
44333881|NCT01078675|79338543|FG001|Overall Study|Withdrawal by Subject|3|||
44333882|NCT01078675|79338542|FG000|Overall Study|Protocol Violation|56|||
44333883|NCT01078675|79338543|FG001|Overall Study|Protocol Violation|0|||
44333884|NCT01078675|79338542|FG000|Overall Study|Provided in CRF for specific reasons|2|||
44333885|NCT01078675|79338543|FG001|Overall Study|Provided in CRF for specific reasons|3|||
44333886|NCT01078675|79338542|FG000|Overall Study|Adverse Event|3|||
44333887|NCT01078675|79338543|FG001|Overall Study|Adverse Event|0|||
44333888|NCT01100437|79338549|FG000|Titration/Stabilization|Adverse Event|0|||
44333889|NCT01100437|79338550|FG001|Titration/Stabilization|Adverse Event|0|||
44333890|NCT01100437|79338551|FG002|Titration/Stabilization|Adverse Event|4|||
44333891|NCT01100437|79338549|FG000|Titration/Stabilization|Non-compliance|0|||
44333892|NCT01100437|79338550|FG001|Titration/Stabilization|Non-compliance|0|||
44333893|NCT01100437|79338551|FG002|Titration/Stabilization|Non-compliance|1|||
44333894|NCT01100437|79338549|FG000|Titration/Stabilization|Sponsor canceled study|0|||
44333895|NCT01100437|79338550|FG001|Titration/Stabilization|Sponsor canceled study|0|||
44333896|NCT01100437|79338551|FG002|Titration/Stabilization|Sponsor canceled study|1|||
44333897|NCT01100437|79338549|FG000|Maintenance|Withdrawal by Subject|0|||
44333898|NCT01100437|79338550|FG001|Maintenance|Withdrawal by Subject|0|||
44333899|NCT01100437|79338551|FG002|Maintenance|Withdrawal by Subject|1|||
44333900|NCT01100437|79338549|FG000|Maintenance|Sponsor termination of study|0|||
44333901|NCT01100437|79338550|FG001|Maintenance|Sponsor termination of study|0|||
44333902|NCT01100437|79338551|FG002|Maintenance|Sponsor termination of study|1|||
44333903|NCT01322490|79338563|FG000|Treatment Period|Adverse Event|12|||
44333904|NCT01322490|79338564|FG001|Treatment Period|Adverse Event|18|||
44333905|NCT01322490|79338565|FG002|Treatment Period|Adverse Event|15|||
44333906|NCT01322490|79338563|FG000|Treatment Period|Death|5|||
44333907|NCT01322490|79338564|FG001|Treatment Period|Death|7|||
44333908|NCT01322490|79338565|FG002|Treatment Period|Death|3|||
44333909|NCT01322490|79338563|FG000|Treatment Period|Lack of Efficacy|89|||
44333910|NCT01322490|79338564|FG001|Treatment Period|Lack of Efficacy|100|||
44333911|NCT01322490|79338565|FG002|Treatment Period|Lack of Efficacy|112|||
44333912|NCT01322490|79338563|FG000|Treatment Period|Physician Decision|0|||
44431625|NCT00683592|79439930|FG001|Overall Study|Non-compliance|5|||
44431626|NCT00683592|79439929|FG000|Overall Study|Other|1|||
44431627|NCT00683592|79439930|FG001|Overall Study|Other|1|||
44431628|NCT00695396|79439939|FG000|Overall Study|Study Closed Prematurely|5|||
44333913|NCT01322490|79338564|FG001|Treatment Period|Physician Decision|2|||
44431629|NCT00695396|79439940|FG001|Overall Study|Study Closed Prematurely|6|||
44431630|NCT00695396|79439941|FG002|Overall Study|Study Closed Prematurely|8|||
44431631|NCT00695396|79439939|FG000|Overall Study|Withdrawal by Subject|2|||
44431632|NCT00695396|79439940|FG001|Overall Study|Withdrawal by Subject|2|||
44431633|NCT00695396|79439941|FG002|Overall Study|Withdrawal by Subject|0|||
44431634|NCT02656706|79439949|FG000|Overall Study|Insurance Denial|1|||
44431635|NCT00575328|79439955|FG000|Overall Study|Adverse Event|1|||
44431636|NCT00575328|79439956|FG001|Overall Study|Adverse Event|1|||
44431637|NCT00575328|79439955|FG000|Overall Study|Lost to Follow-up|2|||
44431638|NCT00575328|79439956|FG001|Overall Study|Lost to Follow-up|1|||
44431639|NCT00575094|79439962|FG000|Overall Study|Adverse Event|2|||
44431640|NCT00575094|79439962|FG000|Overall Study|Withdrawal by Subject|1|||
44431641|NCT00553696|79439970|FG000|Overall Study|Adverse Event|2|||
44431642|NCT00553696|79439971|FG001|Overall Study|Adverse Event|4|||
44431643|NCT00553696|79439972|FG002|Overall Study|Adverse Event|0|||
44431644|NCT00553696|79439973|FG003|Overall Study|Adverse Event|1|||
44431645|NCT00553696|79439970|FG000|Overall Study|Global deterioration of health status|0|||
44431646|NCT00553696|79439971|FG001|Overall Study|Global deterioration of health status|2|||
44431647|NCT00553696|79439972|FG002|Overall Study|Global deterioration of health status|0|||
44431648|NCT00553696|79439973|FG003|Overall Study|Global deterioration of health status|0|||
44431649|NCT00553696|79439970|FG000|Overall Study|Objective progression or relapse|2|||
44431650|NCT00553696|79439971|FG001|Overall Study|Objective progression or relapse|9|||
44431651|NCT00553696|79439972|FG002|Overall Study|Objective progression or relapse|6|||
44431652|NCT00553696|79439973|FG003|Overall Study|Objective progression or relapse|0|||
44431653|NCT00553696|79439970|FG000|Overall Study|Withdrawal by Subject|0|||
44431654|NCT00553696|79439971|FG001|Overall Study|Withdrawal by Subject|1|||
44431655|NCT00553696|79439972|FG002|Overall Study|Withdrawal by Subject|0|||
44538774|NCT03358407|79549965|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
44538775|NCT03358407|79549966|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
44333914|NCT01322490|79338565|FG002|Treatment Period|Physician Decision|1|||
44333915|NCT01322490|79338563|FG000|Treatment Period|Protocol Violation|7|||
44333916|NCT01322490|79338564|FG001|Treatment Period|Protocol Violation|5|||
44333917|NCT01322490|79338565|FG002|Treatment Period|Protocol Violation|4|||
44333918|NCT01322490|79338563|FG000|Treatment Period|Withdrawal by Subject|14|||
44333919|NCT01322490|79338564|FG001|Treatment Period|Withdrawal by Subject|16|||
44333920|NCT01322490|79338565|FG002|Treatment Period|Withdrawal by Subject|11|||
44333921|NCT01322490|79338563|FG000|Treatment Period|Non-compliance with study drug|0|||
44431656|NCT00553696|79439973|FG003|Overall Study|Withdrawal by Subject|0|||
44333922|NCT01322490|79338564|FG001|Treatment Period|Non-compliance with study drug|0|||
44431657|NCT00553540|79439988|FG000|Overall Study|discharged after first visit|2|||
44431658|NCT00553540|79439989|FG001|Overall Study|discharged after first visit|5|||
44431659|NCT00617409|79439998|FG000|Overall Study|Withdrawal by Subject|4|||
44431660|NCT00617409|79439999|FG001|Overall Study|Withdrawal by Subject|1|||
44431661|NCT00617409|79440000|FG002|Overall Study|Withdrawal by Subject|2|||
44431662|NCT00617409|79439998|FG000|Overall Study|Adverse Event|0|||
44431663|NCT00617409|79439999|FG001|Overall Study|Adverse Event|2|||
44431664|NCT00617409|79440000|FG002|Overall Study|Adverse Event|3|||
44431665|NCT00617409|79439998|FG000|Overall Study|Disease Progression|8|||
44431666|NCT00617409|79439999|FG001|Overall Study|Disease Progression|8|||
44431667|NCT00617409|79440000|FG002|Overall Study|Disease Progression|18|||
44431668|NCT00617409|79439998|FG000|Overall Study|Death|3|||
44431669|NCT00617409|79439999|FG001|Overall Study|Death|5|||
44431670|NCT00617409|79440000|FG002|Overall Study|Death|4|||
44431671|NCT00617409|79439998|FG000|Overall Study|Alternative Therapy|1|||
44431672|NCT00617409|79439999|FG001|Overall Study|Alternative Therapy|2|||
44431673|NCT00617409|79440000|FG002|Overall Study|Alternative Therapy|0|||
44431674|NCT00695318|79440011|FG000|Overall Study|Lost to Follow-up|1|||
44431675|NCT00695318|79440012|FG001|Overall Study|Lost to Follow-up|0|||
44431676|NCT00695318|79440011|FG000|Overall Study|Withdrawal by Subject|2|||
44431677|NCT00695318|79440012|FG001|Overall Study|Withdrawal by Subject|0|||
44431678|NCT00695318|79440011|FG000|Overall Study|Death|1|||
44431679|NCT00695318|79440012|FG001|Overall Study|Death|1|||
44431680|NCT00695318|79440011|FG000|Overall Study|Study Terminated|1|||
44333923|NCT01322490|79338565|FG002|Treatment Period|Non-compliance with study drug|1|||
44333924|NCT01322490|79338563|FG000|Treatment Period|Other per report|2|||
44333925|NCT01322490|79338564|FG001|Treatment Period|Other per report|2|||
44333926|NCT01322490|79338565|FG002|Treatment Period|Other per report|1|||
44333927|NCT01322490|79338563|FG000|Treatment Period|Randomized but Not Treated|3|||
44333928|NCT01322490|79338564|FG001|Treatment Period|Randomized but Not Treated|3|||
44333929|NCT01322490|79338565|FG002|Treatment Period|Randomized but Not Treated|5|||
44333930|NCT01322490|79338563|FG000|Long Term Follow-up Period|Death|235|||
44333931|NCT01322490|79338564|FG001|Long Term Follow-up Period|Death|239|||
44333932|NCT01322490|79338565|FG002|Long Term Follow-up Period|Death|236|||
44431681|NCT00695318|79440012|FG001|Overall Study|Study Terminated|0|||
44431682|NCT00386425|79440026|FG000|Overall Study|Physician Decision|3|||
44431683|NCT00386425|79440027|FG001|Overall Study|Physician Decision|0|||
44431684|NCT00386425|79440028|FG002|Overall Study|Physician Decision|0|||
44431685|NCT00386425|79440026|FG000|Overall Study|Withdrawal by Subject|0|||
44431686|NCT00386425|79440027|FG001|Overall Study|Withdrawal by Subject|1|||
44431687|NCT00386425|79440028|FG002|Overall Study|Withdrawal by Subject|0|||
44431688|NCT00694304|79440040|FG000|Overall Study|Adverse Event|42|||
44431689|NCT00694304|79440040|FG000|Overall Study|Lack of Efficacy|35|||
44431690|NCT00694304|79440040|FG000|Overall Study|Non-compliance With Study Product|16|||
44431691|NCT00694304|79440040|FG000|Overall Study|Protocol Violation|6|||
44431692|NCT00694304|79440040|FG000|Overall Study|Withdrawal of Consent|61|||
44431693|NCT00694304|79440040|FG000|Overall Study|Lost to Follow-up|15|||
44431694|NCT00694304|79440040|FG000|Overall Study|Administrative or Other Reasons|32|||
44431695|NCT00371839|79440047|FG000|Overall Study|Death|4|||
44431696|NCT00371839|79440048|FG001|Overall Study|Death|0|||
44431697|NCT00371839|79440049|FG002|Overall Study|Death|0|||
44431698|NCT00371839|79440047|FG000|Overall Study|Withdrawal by Subject|7|||
44431699|NCT00371839|79440048|FG001|Overall Study|Withdrawal by Subject|4|||
44431700|NCT00371839|79440049|FG002|Overall Study|Withdrawal by Subject|0|||
44431701|NCT00371839|79440047|FG000|Overall Study|Lost to Follow-up|6|||
44431702|NCT00371839|79440048|FG001|Overall Study|Lost to Follow-up|3|||
44431703|NCT00371839|79440049|FG002|Overall Study|Lost to Follow-up|2|||
44431704|NCT00682890|79440057|FG000|Overall Study|Lost to Follow-up|1|||
44431705|NCT00682890|79440058|FG001|Overall Study|Lost to Follow-up|1|||
44431706|NCT00682890|79440057|FG000|Overall Study|subject moved away|0|||
44431707|NCT00682890|79440058|FG001|Overall Study|subject moved away|1|||
44538776|NCT03358407|79549967|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44333933|NCT01322490|79338563|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
44431708|NCT00682890|79440057|FG000|Overall Study|heavy menstrual bleeding|1|||
44431709|NCT00682890|79440058|FG001|Overall Study|heavy menstrual bleeding|0|||
44333934|NCT01322490|79338564|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
44333935|NCT01322490|79338565|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
44431710|NCT00385723|79440067|FG000|Overall Study|Lost to Follow-up|1|||
44431711|NCT00385723|79440068|FG001|Overall Study|Lost to Follow-up|1|||
44431712|NCT00385723|79440069|FG002|Overall Study|Lost to Follow-up|0|||
44431713|NCT00385723|79440067|FG000|Overall Study|Withdrawal by Subject|1|||
44431714|NCT00385723|79440068|FG001|Overall Study|Withdrawal by Subject|0|||
44431715|NCT00385723|79440069|FG002|Overall Study|Withdrawal by Subject|2|||
44431716|NCT00698516|79440077|FG000|Overall Study|Study Termination|2|||
44431717|NCT00698516|79440077|FG000|Overall Study|Withdrawal by Subject|3|||
44431718|NCT00679302|79440087|FG000|Overall Study|Lost to Follow-up|8|||
44431719|NCT00679302|79440088|FG001|Overall Study|Lost to Follow-up|4|||
44431720|NCT00690482|79440117|FG000|Overall Study|Adverse Event|2|||
44431721|NCT00690482|79440118|FG001|Overall Study|Adverse Event|1|||
44431722|NCT00690482|79440117|FG000|Overall Study|Incorrect enrolment|0|||
44431723|NCT00690482|79440118|FG001|Overall Study|Incorrect enrolment|1|||
44431724|NCT00690482|79440117|FG000|Overall Study|Study-specific discontinuation criteria|1|||
44431725|NCT00690482|79440118|FG001|Overall Study|Study-specific discontinuation criteria|0|||
44333936|NCT01322490|79338563|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
44333937|NCT01322490|79338564|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
44333938|NCT01322490|79338565|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
44333939|NCT01322490|79338563|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
44333940|NCT01322490|79338564|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
44333941|NCT01322490|79338565|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
44333942|NCT01322490|79338563|FG000|Long Term Follow-up Period|Other per report|3|||
44333943|NCT01322490|79338564|FG001|Long Term Follow-up Period|Other per report|2|||
44333944|NCT01322490|79338565|FG002|Long Term Follow-up Period|Other per report|2|||
44333945|NCT01322490|79338563|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
44333946|NCT01322490|79338564|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
44333947|NCT01322490|79338565|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
44333948|NCT01314261|79338577|FG000|Overall Study|Adverse Event|1|||
44333949|NCT01314261|79338578|FG001|Overall Study|Adverse Event|0|||
44333950|NCT01314261|79338579|FG002|Overall Study|Adverse Event|0|||
44333951|NCT01314261|79338580|FG003|Overall Study|Adverse Event|0|||
44333952|NCT01314261|79338577|FG000|Overall Study|Withdrawal by Subject|0|||
44333953|NCT01314261|79338578|FG001|Overall Study|Withdrawal by Subject|3|||
44333954|NCT01314261|79338579|FG002|Overall Study|Withdrawal by Subject|1|||
44333955|NCT01314261|79338580|FG003|Overall Study|Withdrawal by Subject|0|||
44333956|NCT01314261|79338577|FG000|Overall Study|Lost to Follow-up|1|||
44333957|NCT01314261|79338578|FG001|Overall Study|Lost to Follow-up|0|||
44333958|NCT01314261|79338579|FG002|Overall Study|Lost to Follow-up|2|||
44333959|NCT01314261|79338580|FG003|Overall Study|Lost to Follow-up|2|||
44333960|NCT01314261|79338577|FG000|Overall Study|Virologic Failure|0|||
44431726|NCT00690482|79440117|FG000|Overall Study|Intake of prohibited medicine|1|||
44431727|NCT00690482|79440118|FG001|Overall Study|Intake of prohibited medicine|0|||
44431728|NCT00690482|79440117|FG000|Overall Study|withdrew consent at rand.day|0|||
44538777|NCT03358407|79549968|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538778|NCT03358407|79549969|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
44538779|NCT03358407|79549960|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538780|NCT03358407|79549961|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538781|NCT03358407|79549962|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538782|NCT03358407|79549963|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538783|NCT03358407|79549964|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538784|NCT03358407|79549965|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
44538785|NCT03358407|79549966|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
44538786|NCT03358407|79549967|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
44538787|NCT03358407|79549968|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538788|NCT03358407|79549969|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
44538789|NCT02950545|79550011|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
44538790|NCT02950545|79550012|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
44538791|NCT02950545|79550013|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
44538792|NCT02950545|79550014|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
44538793|NCT02950545|79550015|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
44538794|NCT02950545|79550016|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
44538795|NCT02950545|79550011|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
44538796|NCT02950545|79550012|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
44538797|NCT02950545|79550013|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
44538798|NCT02950545|79550014|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
44538799|NCT02950545|79550015|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
44538800|NCT02950545|79550016|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
44538801|NCT02950545|79550011|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
44538802|NCT02950545|79550012|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
44431729|NCT00690482|79440118|FG001|Overall Study|withdrew consent at rand.day|1|||
44431730|NCT00385255|79440126|FG000|Overall Study|Serious Adverse Event|1|||
44431731|NCT00385255|79440127|FG001|Overall Study|Serious Adverse Event|2|||
44538803|NCT02950545|79550013|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
44538804|NCT02950545|79550014|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
44333961|NCT01314261|79338578|FG001|Overall Study|Virologic Failure|1|||
44333962|NCT01314261|79338579|FG002|Overall Study|Virologic Failure|0|||
44333963|NCT01314261|79338580|FG003|Overall Study|Virologic Failure|1|||
44333964|NCT01321710|79338593|FG000|Overall Study|Lost to Follow-up|4|||
44333965|NCT01321710|79338594|FG001|Overall Study|Lost to Follow-up|5|||
44431732|NCT00385255|79440126|FG000|Overall Study|Protocol Violation|0|||
44333966|NCT01321710|79338595|FG002|Overall Study|Lost to Follow-up|0|||
44333967|NCT01321008|79338605|FG000|Overall Study|Early Study Termination|1|||
44333968|NCT01320150|79338611|FG000|Overall Study|Protocol Violation|15|||
44333969|NCT01320150|79338611|FG000|Overall Study|Withdrawal by Subject|5|||
44333970|NCT01320150|79338611|FG000|Overall Study|Death|2|||
44333971|NCT01320150|79338611|FG000|Overall Study|Lost to Follow-up|44|||
44333972|NCT01323530|79338622|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
44333973|NCT01323530|79338623|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44333974|NCT01323530|79338624|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44333975|NCT01323530|79338625|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44431733|NCT00385255|79440127|FG001|Overall Study|Protocol Violation|4|||
44431734|NCT00385255|79440126|FG000|Overall Study|Withdrawal by Subject|0|||
44431735|NCT00385255|79440127|FG001|Overall Study|Withdrawal by Subject|8|||
44431736|NCT00385255|79440126|FG000|Overall Study|Migrated/moved from study area|0|||
44431737|NCT00385255|79440127|FG001|Overall Study|Migrated/moved from study area|1|||
44431738|NCT00385255|79440126|FG000|Overall Study|Lost to Follow-up|20|||
44431739|NCT00385255|79440127|FG001|Overall Study|Lost to Follow-up|58|||
44431740|NCT00698204|79440139|FG000|Overall Study|Withdrawal by Subject|1|||
44431741|NCT00698204|79440140|FG001|Overall Study|Withdrawal by Subject|0|||
44431742|NCT00549718|79440152|FG000|Overall Study|Insufficient clinical response|20|||
44431743|NCT00549718|79440153|FG001|Overall Study|Insufficient clinical response|7|||
44431744|NCT00549718|79440154|FG002|Overall Study|Insufficient clinical response|18|||
44431745|NCT00549718|79440155|FG003|Overall Study|Insufficient clinical response|32|||
44431746|NCT00549718|79440152|FG000|Overall Study|Adverse Event|6|||
44431747|NCT00549718|79440153|FG001|Overall Study|Adverse Event|8|||
44431748|NCT00549718|79440154|FG002|Overall Study|Adverse Event|7|||
44431749|NCT00549718|79440155|FG003|Overall Study|Adverse Event|3|||
44431750|NCT00549718|79440152|FG000|Overall Study|Lost to Follow-up|4|||
44431751|NCT00549718|79440153|FG001|Overall Study|Lost to Follow-up|2|||
44431752|NCT00549718|79440154|FG002|Overall Study|Lost to Follow-up|0|||
44431753|NCT00549718|79440155|FG003|Overall Study|Lost to Follow-up|6|||
44431754|NCT00549718|79440152|FG000|Overall Study|Withdrawal by Subject|9|||
44431755|NCT00549718|79440153|FG001|Overall Study|Withdrawal by Subject|18|||
44431756|NCT00549718|79440154|FG002|Overall Study|Withdrawal by Subject|12|||
44431757|NCT00549718|79440155|FG003|Overall Study|Withdrawal by Subject|13|||
44431758|NCT00549718|79440152|FG000|Overall Study|Administrative|2|||
44431759|NCT00549718|79440153|FG001|Overall Study|Administrative|2|||
44431760|NCT00549718|79440154|FG002|Overall Study|Administrative|2|||
44431761|NCT00549718|79440155|FG003|Overall Study|Administrative|1|||
44333976|NCT01323530|79338626|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44333977|NCT01323530|79338627|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
44333978|NCT01323530|79338628|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
44333979|NCT01323530|79338622|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
44333980|NCT01323530|79338623|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
44333981|NCT01323530|79338624|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
44333982|NCT01323530|79338625|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44333983|NCT01323530|79338626|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
44333984|NCT01323530|79338627|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44333985|NCT01323530|79338628|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
44333986|NCT01323530|79338622|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
44333987|NCT01323530|79338623|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
44333988|NCT01323530|79338624|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
44333989|NCT01323530|79338625|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
44333990|NCT01323530|79338626|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
44431762|NCT00371761|79440167|FG000|Overall Study|Adverse Event|1|||
44431763|NCT00371761|79440168|FG001|Overall Study|Adverse Event|1|||
44431764|NCT00371761|79440167|FG000|Overall Study|Withdrawal by Subject|1|||
44431765|NCT00371761|79440168|FG001|Overall Study|Withdrawal by Subject|3|||
44333991|NCT01323530|79338627|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
44333992|NCT01323530|79338628|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
44333993|NCT01323530|79338622|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
44431766|NCT00371761|79440167|FG000|Overall Study|Investigator Judgment|2|||
44431767|NCT00371761|79440168|FG001|Overall Study|Investigator Judgment|3|||
44431768|NCT00371761|79440167|FG000|Overall Study|Study termination|4|||
44431769|NCT00371761|79440168|FG001|Overall Study|Study termination|3|||
44333994|NCT01323530|79338623|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
44333995|NCT01323530|79338624|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
44333996|NCT01323530|79338625|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
44333997|NCT01323530|79338626|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
44431770|NCT00549640|79440176|FG000|Overall Study|Withdrawal by Subject|6|||
44431771|NCT00549640|79440177|FG001|Overall Study|Withdrawal by Subject|12|||
44431772|NCT00549640|79440176|FG000|Overall Study|Adverse Event|5|||
44431773|NCT00549640|79440177|FG001|Overall Study|Adverse Event|0|||
44431774|NCT00549640|79440176|FG000|Overall Study|Lost to Follow-up|7|||
44431775|NCT00549640|79440177|FG001|Overall Study|Lost to Follow-up|4|||
44431776|NCT00549562|79440199|FG000|Overall Study|Adverse Event|1|||
44431777|NCT00549562|79440199|FG000|Overall Study|Lack of Efficacy|1|||
44431778|NCT00681564|79440205|FG000|Overall Study|Lost to Follow-up|6|||
44431779|NCT00681564|79440206|FG001|Overall Study|Lost to Follow-up|6|||
44431780|NCT00681564|79440205|FG000|Overall Study|Withdrawal by Subject|0|||
44431781|NCT00681564|79440206|FG001|Overall Study|Withdrawal by Subject|1|||
44431782|NCT00681564|79440205|FG000|Overall Study|Death|0|||
44431783|NCT00681564|79440206|FG001|Overall Study|Death|1|||
44431784|NCT00677352|79440214|FG000|Treatment Phase|Adverse Event|14|||
44431785|NCT00677352|79440215|FG001|Treatment Phase|Adverse Event|22|||
44431786|NCT00677352|79440214|FG000|Treatment Phase|Lack of Efficacy|2|||
44431787|NCT00677352|79440215|FG001|Treatment Phase|Lack of Efficacy|3|||
44431788|NCT00677352|79440214|FG000|Treatment Phase|Lost to Follow-up|0|||
44333998|NCT01323530|79338627|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
44333999|NCT01323530|79338628|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
44431789|NCT00677352|79440215|FG001|Treatment Phase|Lost to Follow-up|1|||
44431790|NCT00677352|79440214|FG000|Treatment Phase|Withdrawal by Subject|7|||
44431791|NCT00677352|79440215|FG001|Treatment Phase|Withdrawal by Subject|7|||
44431792|NCT00677352|79440214|FG000|Treatment Phase|Physician Decision|1|||
44431793|NCT00677352|79440215|FG001|Treatment Phase|Physician Decision|0|||
44431794|NCT00677352|79440214|FG000|Treatment Phase|Pregnancy|0|||
44334000|NCT01323530|79338622|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
44334001|NCT01323530|79338623|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
44334002|NCT01323530|79338624|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
44334003|NCT01323530|79338625|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
44334004|NCT01323530|79338626|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
44334005|NCT01323530|79338627|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
44334006|NCT01323530|79338628|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
44431795|NCT00677352|79440215|FG001|Treatment Phase|Pregnancy|1|||
44431796|NCT00677352|79440214|FG000|Treatment Phase|Protocol Violation|1|||
44334007|NCT01323530|79338622|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
44334008|NCT01323530|79338623|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
44334009|NCT01323530|79338624|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
44334010|NCT01323530|79338625|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
44334011|NCT01323530|79338626|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
44334012|NCT01323530|79338627|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
44334013|NCT01323530|79338628|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
44334014|NCT01323530|79338622|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
44334015|NCT01323530|79338623|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
44334016|NCT01323530|79338624|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
44431797|NCT00677352|79440215|FG001|Treatment Phase|Protocol Violation|1|||
44431798|NCT00677352|79440214|FG000|Treatment Phase|Transference or work related matter|0|||
44431799|NCT00677352|79440215|FG001|Treatment Phase|Transference or work related matter|5|||
44431800|NCT00677352|79440214|FG000|Treatment Phase|Not treated|0|||
44431801|NCT00677352|79440215|FG001|Treatment Phase|Not treated|2|||
44431802|NCT00677352|79440214|FG000|Tapering Phase|Adverse Event|1|||
44431803|NCT00677352|79440215|FG001|Tapering Phase|Adverse Event|5|||
44431804|NCT00677352|79440214|FG000|Tapering Phase|Withdrawal by Subject|5|||
44431805|NCT00677352|79440215|FG001|Tapering Phase|Withdrawal by Subject|3|||
44431806|NCT00677352|79440214|FG000|Tapering Phase|Pregnancy|0|||
44431807|NCT00677352|79440215|FG001|Tapering Phase|Pregnancy|1|||
44431808|NCT00677352|79440214|FG000|Tapering Phase|Job transfer|0|||
44431809|NCT00677352|79440215|FG001|Tapering Phase|Job transfer|1|||
44431810|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|Death|1|||
44431811|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|Death|1|||
44431812|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
44431813|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
44431814|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
44431815|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
44538805|NCT02950545|79550015|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
44538806|NCT02950545|79550016|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
44431816|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
44431817|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
44431818|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
44431819|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
44431820|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
44431821|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
44431822|NCT00371683|79440228|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
44431823|NCT00371683|79440229|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
44334017|NCT01323530|79338625|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
44431824|NCT00371683|79440228|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
44431825|NCT00371683|79440229|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
44431826|NCT00371683|79440228|FG000|Follow-Up Period - Randomized Patients|Death|0|||
44431827|NCT00371683|79440229|FG001|Follow-Up Period - Randomized Patients|Death|2|||
44431828|NCT00371683|79440228|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
44431829|NCT00371683|79440229|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
44431830|NCT00371683|79440228|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
44431831|NCT00371683|79440229|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
44431832|NCT03951766|79440245|FG000|Treatment Phase|Lost to Follow-up|1|||
44431833|NCT03951766|79440245|FG000|Follow-up Phase|Lost to Follow-up|10|||
44431834|NCT00371137|79440254|FG000|Overall Study|Adverse Event|20|||
44431835|NCT00371137|79440255|FG001|Overall Study|Adverse Event|35|||
44431836|NCT00371137|79440256|FG002|Overall Study|Adverse Event|42|||
44431837|NCT00371137|79440254|FG000|Overall Study|Withdrawal by Subject|11|||
44431838|NCT00371137|79440255|FG001|Overall Study|Withdrawal by Subject|10|||
44431839|NCT00371137|79440256|FG002|Overall Study|Withdrawal by Subject|15|||
44431840|NCT00371137|79440254|FG000|Overall Study|Lost to Follow-up|6|||
44431841|NCT00371137|79440255|FG001|Overall Study|Lost to Follow-up|3|||
44431842|NCT00371137|79440256|FG002|Overall Study|Lost to Follow-up|5|||
44431843|NCT00371137|79440254|FG000|Overall Study|Lack of Efficacy|30|||
44431844|NCT00371137|79440255|FG001|Overall Study|Lack of Efficacy|12|||
44431845|NCT00371137|79440256|FG002|Overall Study|Lack of Efficacy|13|||
44431846|NCT00371137|79440254|FG000|Overall Study|Sponsor Decision|2|||
44538807|NCT02950545|79550011|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
44538808|NCT02950545|79550012|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
44538809|NCT02950545|79550013|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
44538810|NCT02950545|79550014|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
44538811|NCT02950545|79550015|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
44538812|NCT02950545|79550016|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
44538813|NCT02950545|79550011|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
44538814|NCT02950545|79550012|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
44538815|NCT02950545|79550013|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
44538816|NCT02950545|79550014|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
44538817|NCT02950545|79550015|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
44538818|NCT02950545|79550016|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
44538819|NCT03358329|79550022|FG000|Overall Study|Lost to Follow-up|2|||
44538820|NCT03358329|79550022|FG000|Overall Study|Withdrawal by Subject|2|||
44538821|NCT03357471|79550038|FG000|Overall Study|Adverse Event|1|||
44538822|NCT03357471|79550039|FG001|Overall Study|Adverse Event|0|||
44334018|NCT01323530|79338626|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
44334019|NCT01323530|79338627|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
44334020|NCT01323530|79338628|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
44334021|NCT01323530|79338622|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
44334022|NCT01323530|79338623|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
44334023|NCT01323530|79338624|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
44334024|NCT01323530|79338625|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
44334025|NCT01323530|79338626|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
44334026|NCT01323530|79338627|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
44334027|NCT01323530|79338628|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
44334028|NCT01313637|79338649|FG000|Overall Study|Adverse Event|17|||
44334029|NCT01313637|79338650|FG001|Overall Study|Adverse Event|24|||
44334030|NCT01313637|79338651|FG002|Overall Study|Adverse Event|25|||
44334031|NCT01313637|79338652|FG003|Overall Study|Adverse Event|18|||
44334032|NCT01313637|79338649|FG000|Overall Study|Lack of Efficacy|44|||
44334033|NCT01313637|79338650|FG001|Overall Study|Lack of Efficacy|38|||
44334034|NCT01313637|79338651|FG002|Overall Study|Lack of Efficacy|37|||
44334035|NCT01313637|79338652|FG003|Overall Study|Lack of Efficacy|24|||
44334036|NCT01313637|79338649|FG000|Overall Study|Protocol Violation|4|||
44334037|NCT01313637|79338650|FG001|Overall Study|Protocol Violation|3|||
44334038|NCT01313637|79338651|FG002|Overall Study|Protocol Violation|11|||
44334039|NCT01313637|79338652|FG003|Overall Study|Protocol Violation|5|||
44431847|NCT00371137|79440255|FG001|Overall Study|Sponsor Decision|1|||
44431848|NCT00371137|79440256|FG002|Overall Study|Sponsor Decision|2|||
44334040|NCT01313637|79338649|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
44334041|NCT01313637|79338650|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
44334042|NCT01313637|79338651|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
44431849|NCT00371137|79440254|FG000|Overall Study|Physician Decision|1|||
44431850|NCT00371137|79440255|FG001|Overall Study|Physician Decision|1|||
44431851|NCT00371137|79440256|FG002|Overall Study|Physician Decision|1|||
44431852|NCT00371137|79440254|FG000|Overall Study|Protocol Violation|2|||
44334043|NCT01313637|79338652|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
44431853|NCT00371137|79440255|FG001|Overall Study|Protocol Violation|1|||
44431854|NCT00371137|79440256|FG002|Overall Study|Protocol Violation|1|||
44431855|NCT03753789|79440264|FG000|Overall Study|Withdrawal by Subject|2|||
44431856|NCT00616239|79440268|FG000|Overall Study|Withdrawal by Subject|2|||
44334044|NCT01313637|79338649|FG000|Overall Study|Lost to Follow-up|0|||
44334045|NCT01313637|79338650|FG001|Overall Study|Lost to Follow-up|2|||
44334046|NCT01313637|79338651|FG002|Overall Study|Lost to Follow-up|1|||
44334047|NCT01313637|79338652|FG003|Overall Study|Lost to Follow-up|3|||
44334048|NCT01313637|79338649|FG000|Overall Study|Withdrawal by Subject|11|||
44334049|NCT01313637|79338650|FG001|Overall Study|Withdrawal by Subject|13|||
44334050|NCT01313637|79338651|FG002|Overall Study|Withdrawal by Subject|18|||
44334051|NCT01313637|79338652|FG003|Overall Study|Withdrawal by Subject|15|||
44334052|NCT01320722|79338667|FG000|Overall Study|Did not Receive Intervention|3|||
44334053|NCT01320722|79338668|FG001|Overall Study|Did not Receive Intervention|2|||
44334054|NCT01320722|79338669|FG002|Overall Study|Did not Receive Intervention|1|||
44334055|NCT01320722|79338670|FG003|Overall Study|Did not Receive Intervention|1|||
44334056|NCT01320722|79338671|FG004|Overall Study|Did not Receive Intervention|2|||
44334057|NCT01320722|79338667|FG000|Overall Study|Lost to Follow-up|0|||
44334058|NCT01320722|79338668|FG001|Overall Study|Lost to Follow-up|1|||
44334059|NCT01320722|79338669|FG002|Overall Study|Lost to Follow-up|0|||
44334060|NCT01320722|79338670|FG003|Overall Study|Lost to Follow-up|1|||
44334061|NCT01320722|79338671|FG004|Overall Study|Lost to Follow-up|3|||
44334062|NCT01320722|79338667|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
44334063|NCT01320722|79338668|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
44431857|NCT00547534|79440272|FG000|Overall Study|Adverse Event|7|||
44431858|NCT00547534|79440272|FG000|Overall Study|Disease Progression|4|||
44431859|NCT00384397|79440280|FG000|Overall Study|Adverse Event|0|||
44431860|NCT00384397|79440281|FG001|Overall Study|Adverse Event|1|||
44431861|NCT00384397|79440282|FG002|Overall Study|Adverse Event|2|||
44431862|NCT00384397|79440280|FG000|Overall Study|Protocol Violation|7|||
44431863|NCT00384397|79440281|FG001|Overall Study|Protocol Violation|15|||
44431864|NCT00384397|79440282|FG002|Overall Study|Protocol Violation|13|||
44431865|NCT00384397|79440280|FG000|Overall Study|Lost to Follow-up|11|||
44431866|NCT00384397|79440281|FG001|Overall Study|Lost to Follow-up|13|||
44431867|NCT00384397|79440282|FG002|Overall Study|Lost to Follow-up|3|||
44431868|NCT00384397|79440280|FG000|Overall Study|Withdrawal by Subject|14|||
44538823|NCT03357471|79550038|FG000|Overall Study|Lost to Follow-up|1|||
44538824|NCT03357471|79550039|FG001|Overall Study|Lost to Follow-up|0|||
44538825|NCT03342963|79550049|FG000|Overall Study|Adverse Event|1|||
44538826|NCT03342963|79550050|FG001|Overall Study|Adverse Event|2|||
44538827|NCT03342963|79550051|FG002|Overall Study|Adverse Event|0|||
44538828|NCT03342963|79550052|FG003|Overall Study|Adverse Event|0|||
44334064|NCT01320722|79338669|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
44334065|NCT01320722|79338670|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
44334066|NCT01320722|79338671|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
44334067|NCT01320722|79338667|FG000|Overall Study|Participant Developed a Rash|0|||
44334068|NCT01320722|79338668|FG001|Overall Study|Participant Developed a Rash|0|||
44334069|NCT01320722|79338669|FG002|Overall Study|Participant Developed a Rash|2|||
44334070|NCT01320722|79338670|FG003|Overall Study|Participant Developed a Rash|1|||
44334071|NCT01320722|79338671|FG004|Overall Study|Participant Developed a Rash|1|||
44334072|NCT01320722|79338667|FG000|Overall Study|Non-compliant with Medication|0|||
44334073|NCT01320722|79338668|FG001|Overall Study|Non-compliant with Medication|0|||
44334074|NCT01320722|79338669|FG002|Overall Study|Non-compliant with Medication|1|||
44334075|NCT01320722|79338670|FG003|Overall Study|Non-compliant with Medication|0|||
44334076|NCT01320722|79338671|FG004|Overall Study|Non-compliant with Medication|0|||
44334077|NCT01320722|79338667|FG000|Overall Study|Adverse Event|0|||
44431869|NCT00384397|79440281|FG001|Overall Study|Withdrawal by Subject|17|||
44431870|NCT00384397|79440282|FG002|Overall Study|Withdrawal by Subject|15|||
44431871|NCT00384085|79440293|FG000|Overall Study|Adverse Event|5|||
44431872|NCT00384085|79440294|FG001|Overall Study|Adverse Event|5|||
44431873|NCT00384085|79440295|FG002|Overall Study|Adverse Event|4|||
44431874|NCT00384085|79440293|FG000|Overall Study|Lack of Efficacy|0|||
44431875|NCT00384085|79440294|FG001|Overall Study|Lack of Efficacy|3|||
44431876|NCT00384085|79440295|FG002|Overall Study|Lack of Efficacy|2|||
44431877|NCT00384085|79440293|FG000|Overall Study|No longer Requires Study Treatment|1|||
44431878|NCT00384085|79440294|FG001|Overall Study|No longer Requires Study Treatment|0|||
44431879|NCT00384085|79440295|FG002|Overall Study|No longer Requires Study Treatment|1|||
44431880|NCT00384085|79440293|FG000|Overall Study|Protocol Violation|2|||
44334078|NCT01320722|79338668|FG001|Overall Study|Adverse Event|0|||
44431881|NCT00384085|79440294|FG001|Overall Study|Protocol Violation|2|||
44431882|NCT00384085|79440295|FG002|Overall Study|Protocol Violation|2|||
44431883|NCT00384085|79440293|FG000|Overall Study|Lost to Follow-up|9|||
44334079|NCT01320722|79338669|FG002|Overall Study|Adverse Event|3|||
44334080|NCT01320722|79338670|FG003|Overall Study|Adverse Event|6|||
44334081|NCT01320722|79338671|FG004|Overall Study|Adverse Event|0|||
44431884|NCT00384085|79440294|FG001|Overall Study|Lost to Follow-up|9|||
44334082|NCT01320722|79338667|FG000|Overall Study|Not Compliant with Study Procedures|0|||
44334083|NCT01320722|79338668|FG001|Overall Study|Not Compliant with Study Procedures|0|||
44334084|NCT01320722|79338669|FG002|Overall Study|Not Compliant with Study Procedures|0|||
44334085|NCT01320722|79338670|FG003|Overall Study|Not Compliant with Study Procedures|4|||
44334086|NCT01320722|79338671|FG004|Overall Study|Not Compliant with Study Procedures|0|||
44334087|NCT01320722|79338667|FG000|Overall Study|Pregnancy|0|||
44334088|NCT01320722|79338668|FG001|Overall Study|Pregnancy|0|||
44334089|NCT01320722|79338669|FG002|Overall Study|Pregnancy|0|||
44334090|NCT01320722|79338670|FG003|Overall Study|Pregnancy|1|||
44334091|NCT01320722|79338671|FG004|Overall Study|Pregnancy|0|||
44334092|NCT01320722|79338667|FG000|Overall Study|Started an Exclusionary Medication|0|||
44334093|NCT01320722|79338668|FG001|Overall Study|Started an Exclusionary Medication|0|||
44431885|NCT00384085|79440295|FG002|Overall Study|Lost to Follow-up|10|||
44431886|NCT00384085|79440293|FG000|Overall Study|Progressive Disease|0|||
44431887|NCT00384085|79440294|FG001|Overall Study|Progressive Disease|1|||
44431888|NCT00384085|79440295|FG002|Overall Study|Progressive Disease|0|||
44431889|NCT00384085|79440293|FG000|Overall Study|Withdrawal by Subject|14|||
44431890|NCT00384085|79440294|FG001|Overall Study|Withdrawal by Subject|19|||
44431891|NCT00384085|79440295|FG002|Overall Study|Withdrawal by Subject|29|||
44431892|NCT00384085|79440293|FG000|Overall Study|Patient non-compliant|4|||
44431893|NCT00384085|79440294|FG001|Overall Study|Patient non-compliant|4|||
44431894|NCT00384085|79440295|FG002|Overall Study|Patient non-compliant|5|||
44431895|NCT00384085|79440293|FG000|Overall Study|Physician Decision|1|||
44431896|NCT00384085|79440294|FG001|Overall Study|Physician Decision|0|||
44431897|NCT00384085|79440295|FG002|Overall Study|Physician Decision|0|||
44538829|NCT03342963|79550049|FG000|Overall Study|Withdrawal by Subject|1|||
44538830|NCT03342963|79550050|FG001|Overall Study|Withdrawal by Subject|0|||
44538831|NCT03342963|79550051|FG002|Overall Study|Withdrawal by Subject|0|||
44538832|NCT03342963|79550052|FG003|Overall Study|Withdrawal by Subject|0|||
44538833|NCT03361956|79550067|FG000|Overall Study|Adverse Event|1|||
44538834|NCT03361956|79550068|FG001|Overall Study|Adverse Event|0|||
44538835|NCT03361956|79550069|FG002|Overall Study|Adverse Event|1|||
44538836|NCT03361956|79550070|FG003|Overall Study|Adverse Event|1|||
44538837|NCT03361956|79550071|FG004|Overall Study|Adverse Event|0|||
44538838|NCT03361956|79550067|FG000|Overall Study|Other|0|||
44538839|NCT03361956|79550068|FG001|Overall Study|Other|0|||
44538840|NCT03361956|79550069|FG002|Overall Study|Other|0|||
44538841|NCT03361956|79550070|FG003|Overall Study|Other|1|||
44538842|NCT03361956|79550071|FG004|Overall Study|Other|0|||
44259061|NCT00216476|79115515|FG002|Overall Study|No Further Need for Treatment|1|||
44259062|NCT00216476|79115513|FG000|Overall Study|Non-compliance|0|||
44259063|NCT00216476|79115514|FG001|Overall Study|Non-compliance|4|||
44259064|NCT00216476|79115515|FG002|Overall Study|Non-compliance|1|||
44259065|NCT00216476|79115513|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
44259066|NCT00216476|79115514|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
44259067|NCT00216476|79115515|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
44259068|NCT00216476|79115513|FG000|Overall Study|Administrative Reasons|1|||
44259069|NCT00216476|79115514|FG001|Overall Study|Administrative Reasons|1|||
44259070|NCT00216476|79115515|FG002|Overall Study|Administrative Reasons|0|||
44259071|NCT00216476|79115513|FG000|Overall Study|Protocol Deviation|5|||
44259072|NCT00216476|79115514|FG001|Overall Study|Protocol Deviation|1|||
44259073|NCT00216476|79115515|FG002|Overall Study|Protocol Deviation|0|||
44259074|NCT00216476|79115513|FG000|Overall Study|Patient Moved|2|||
44259075|NCT00216476|79115514|FG001|Overall Study|Patient Moved|2|||
44259076|NCT00216476|79115515|FG002|Overall Study|Patient Moved|0|||
44259077|NCT00216086|79115566|FG000|Overall Study|Protocol Violation|1|||
44259078|NCT00216086|79115566|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
44259079|NCT00216086|79115566|FG000|Overall Study|Social Reasons|2|||
44259080|NCT00215150|79115597|FG000|Open Label Phase|Lost to Follow-up|7|||
44259081|NCT00215150|79115597|FG000|Open Label Phase|Withdrawal by Subject|1|||
44259082|NCT00215150|79115597|FG000|Open Label Phase|Did not complete a post base visit|13|||
44334094|NCT01320722|79338669|FG002|Overall Study|Started an Exclusionary Medication|0|||
44334095|NCT01320722|79338670|FG003|Overall Study|Started an Exclusionary Medication|0|||
44431898|NCT00384085|79440293|FG000|Overall Study|Loss of site personnel|1|||
44431899|NCT00384085|79440294|FG001|Overall Study|Loss of site personnel|0|||
44431900|NCT00384085|79440295|FG002|Overall Study|Loss of site personnel|1|||
44431901|NCT00384085|79440293|FG000|Overall Study|Sponsor decision|1|||
44259083|NCT00215150|79115597|FG000|Open Label Phase|Did not meet randomization criteria|9|||
44259084|NCT00215150|79115597|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
44334096|NCT01320722|79338671|FG004|Overall Study|Started an Exclusionary Medication|1|||
44538843|NCT03361956|79550067|FG000|Overall Study|Withdrawal by Subject|2|||
44538844|NCT03361956|79550068|FG001|Overall Study|Withdrawal by Subject|2|||
44538845|NCT03361956|79550069|FG002|Overall Study|Withdrawal by Subject|2|||
44334097|NCT01320722|79338667|FG000|Overall Study|Withdrew due to Health Condition|0|||
44431902|NCT00384085|79440294|FG001|Overall Study|Sponsor decision|2|||
44431903|NCT00384085|79440295|FG002|Overall Study|Sponsor decision|1|||
44334098|NCT01320722|79338668|FG001|Overall Study|Withdrew due to Health Condition|0|||
44334099|NCT01320722|79338669|FG002|Overall Study|Withdrew due to Health Condition|0|||
44334100|NCT01320722|79338670|FG003|Overall Study|Withdrew due to Health Condition|0|||
44334101|NCT01320722|79338671|FG004|Overall Study|Withdrew due to Health Condition|1|||
44538846|NCT03361956|79550070|FG003|Overall Study|Withdrawal by Subject|0|||
44538847|NCT03361956|79550071|FG004|Overall Study|Withdrawal by Subject|3|||
44538848|NCT03361956|79550067|FG000|Overall Study|Disease Relapse|0|||
44538849|NCT03361956|79550068|FG001|Overall Study|Disease Relapse|0|||
44538850|NCT03361956|79550069|FG002|Overall Study|Disease Relapse|1|||
44538851|NCT03361956|79550070|FG003|Overall Study|Disease Relapse|0|||
44538852|NCT03361956|79550071|FG004|Overall Study|Disease Relapse|0|||
44538853|NCT03361956|79550067|FG000|Overall Study|Physician Decision|0|||
44538854|NCT03361956|79550068|FG001|Overall Study|Physician Decision|2|||
44538855|NCT03361956|79550069|FG002|Overall Study|Physician Decision|0|||
44538856|NCT03361956|79550070|FG003|Overall Study|Physician Decision|1|||
44538857|NCT03361956|79550071|FG004|Overall Study|Physician Decision|0|||
44538858|NCT03361956|79550067|FG000|Overall Study|Lost to Follow-up|0|||
44538859|NCT03361956|79550068|FG001|Overall Study|Lost to Follow-up|0|||
44538860|NCT03361956|79550069|FG002|Overall Study|Lost to Follow-up|1|||
44538861|NCT03361956|79550070|FG003|Overall Study|Lost to Follow-up|1|||
44538862|NCT03361956|79550071|FG004|Overall Study|Lost to Follow-up|2|||
44538863|NCT03361176|79550142|FG000|Overall Study|Lost to Follow-up|1|||
44538864|NCT03361176|79550143|FG001|Overall Study|Lost to Follow-up|2|||
44538865|NCT03361176|79550142|FG000|Overall Study|Adverse Event|0|||
44538866|NCT03361176|79550143|FG001|Overall Study|Adverse Event|2|||
44538867|NCT03361176|79550142|FG000|Overall Study|Withdrawal by Subject|0|||
44538868|NCT03361176|79550143|FG001|Overall Study|Withdrawal by Subject|1|||
44538869|NCT05283499|79550151|FG000|Overall Study|Did not receive intervention|1|||
44538870|NCT05283499|79550152|FG001|Overall Study|Did not receive intervention|2|||
44538871|NCT05271175|79550161|FG000|One Week Follow up|Lost to Follow-up|10|||
44538872|NCT05271175|79550162|FG001|One Week Follow up|Lost to Follow-up|7|||
44538873|NCT05271175|79550163|FG002|One Week Follow up|Lost to Follow-up|5|||
44538874|NCT05271175|79550161|FG000|One Month Follow up|Lost to Follow-up|12|||
44538875|NCT05271175|79550162|FG001|One Month Follow up|Lost to Follow-up|7|||
44538876|NCT05271175|79550163|FG002|One Month Follow up|Lost to Follow-up|9|||
44538877|NCT05271175|79550161|FG000|Six Months Follow up|Lost to Follow-up|8|||
44538878|NCT05271175|79550162|FG001|Six Months Follow up|Lost to Follow-up|2|||
44538879|NCT05271175|79550163|FG002|Six Months Follow up|Lost to Follow-up|2|||
44538880|NCT03098030|79550175|FG000|Overall Study|Death|10|||
44538881|NCT03098030|79550176|FG001|Overall Study|Death|156|||
44538882|NCT03098030|79550177|FG002|Overall Study|Death|156|||
44334102|NCT01313559|79338688|FG000|Overall Study|Withdrawal by Subject|1|||
44334103|NCT01313559|79338689|FG001|Overall Study|Withdrawal by Subject|2|||
44334104|NCT01313559|79338688|FG000|Overall Study|Disease progression|1|||
44334105|NCT01313559|79338689|FG001|Overall Study|Disease progression|0|||
44334106|NCT01313559|79338688|FG000|Overall Study|Rising PSA|2|||
44334107|NCT01313559|79338689|FG001|Overall Study|Rising PSA|0|||
44334108|NCT01312779|79338695|FG000|Overall Study|Withdrawal by Subject|2|||
44334109|NCT01312779|79338695|FG000|Overall Study|Death|3|||
44431904|NCT00384085|79440293|FG000|Overall Study|Patient moved|1|||
44431905|NCT00384085|79440294|FG001|Overall Study|Patient moved|0|||
44431906|NCT00384085|79440295|FG002|Overall Study|Patient moved|1|||
44431907|NCT00384085|79440293|FG000|Overall Study|Patient required surgery|0|||
44431908|NCT00384085|79440294|FG001|Overall Study|Patient required surgery|1|||
44431909|NCT00384085|79440295|FG002|Overall Study|Patient required surgery|0|||
44334110|NCT01312779|79338695|FG000|Overall Study|Not Implanted with Device|27|||
44538883|NCT03098030|79550178|FG003|Overall Study|Death|82|||
44334111|NCT01312467|79338708|FG000|Overall Study|Adverse Event|4|||
44334112|NCT01312467|79338708|FG000|Overall Study|Lost to Follow-up|1|||
44431910|NCT00361231|79440305|FG000|Overall Study|Physician Decision|3|||
44431911|NCT00361231|79440305|FG000|Overall Study|Symptomatic deterioration|5|||
44431912|NCT00361231|79440305|FG000|Overall Study|Radiographic disease progression|16|||
44538884|NCT03098030|79550175|FG000|Overall Study|Withdrawal by Subject|0|||
44538885|NCT03098030|79550176|FG001|Overall Study|Withdrawal by Subject|7|||
44334113|NCT01312467|79338708|FG000|Overall Study|Withdrawal by Subject|2|||
44334114|NCT01312467|79338708|FG000|Overall Study|Deported to country of origin|1|||
44334115|NCT01312467|79338708|FG000|Overall Study|Another medical condition|1|||
44431913|NCT00361231|79440305|FG000|Overall Study|Withdrawal by Subject|4|||
44431914|NCT00361231|79440305|FG000|Overall Study|Adverse Event|6|||
44538886|NCT03098030|79550177|FG002|Overall Study|Withdrawal by Subject|8|||
44538887|NCT03098030|79550178|FG003|Overall Study|Withdrawal by Subject|2|||
44538888|NCT03098030|79550175|FG000|Overall Study|Lost to Follow-up|0|||
44538889|NCT03098030|79550176|FG001|Overall Study|Lost to Follow-up|0|||
44538890|NCT03098030|79550177|FG002|Overall Study|Lost to Follow-up|2|||
44538891|NCT03098030|79550178|FG003|Overall Study|Lost to Follow-up|1|||
44334116|NCT01312467|79338708|FG000|Overall Study|Ineligible|4|||
44334117|NCT01310127|79338715|FG000|Overall Study|Protocol Violation|1|||
44334118|NCT01310127|79338716|FG001|Overall Study|Protocol Violation|1|||
44431915|NCT00676650|79440311|FG000|Overall Study|Death|45|||
44431916|NCT00676650|79440312|FG001|Overall Study|Death|14|||
44431917|NCT00676650|79440311|FG000|Overall Study|Adverse Event|159|||
44431918|NCT00676650|79440312|FG001|Overall Study|Adverse Event|21|||
44431919|NCT00676650|79440311|FG000|Overall Study|Global deterioration of health status|66|||
44431920|NCT00676650|79440312|FG001|Overall Study|Global deterioration of health status|31|||
44431921|NCT00676650|79440311|FG000|Overall Study|Lost to Follow-up|0|||
44431922|NCT00676650|79440312|FG001|Overall Study|Lost to Follow-up|1|||
44431923|NCT00676650|79440311|FG000|Overall Study|Objective progression or relapse|189|||
44431924|NCT00676650|79440312|FG001|Overall Study|Objective progression or relapse|140|||
44431925|NCT00676650|79440311|FG000|Overall Study|Other|14|||
44431926|NCT00676650|79440312|FG001|Overall Study|Other|10|||
44431927|NCT00676650|79440311|FG000|Overall Study|Protocol Violation|3|||
44431928|NCT00676650|79440312|FG001|Overall Study|Protocol Violation|1|||
44431929|NCT00676650|79440311|FG000|Overall Study|Study terminated by sponsor|57|||
44431930|NCT00676650|79440312|FG001|Overall Study|Study terminated by sponsor|43|||
44431931|NCT00676650|79440311|FG000|Overall Study|Withdrawal by Subject|48|||
44431932|NCT00676650|79440312|FG001|Overall Study|Withdrawal by Subject|24|||
44431933|NCT00676650|79440311|FG000|Overall Study|Randomized but not treated|3|||
44431934|NCT00676650|79440312|FG001|Overall Study|Randomized but not treated|4|||
44431935|NCT00573183|79440320|FG000|Overall Study|Lost to Follow-up|52|||
44431936|NCT00573183|79440321|FG001|Overall Study|Lost to Follow-up|50|||
44431937|NCT00573183|79440320|FG000|Overall Study|Withdrawal by Subject|8|||
44431938|NCT00573183|79440321|FG001|Overall Study|Withdrawal by Subject|2|||
44431939|NCT00573183|79440320|FG000|Overall Study|Death|0|||
44431940|NCT00573183|79440321|FG001|Overall Study|Death|1|||
44431941|NCT00573183|79440320|FG000|Overall Study|Adverse Event|2|||
44431942|NCT00573183|79440321|FG001|Overall Study|Adverse Event|0|||
44431943|NCT00573183|79440320|FG000|Overall Study|Incarceration|5|||
44431944|NCT00573183|79440321|FG001|Overall Study|Incarceration|8|||
44431945|NCT00573183|79440320|FG000|Overall Study|Other|5|||
44431946|NCT00573183|79440321|FG001|Overall Study|Other|2|||
44431947|NCT00615459|79440329|FG000|Period I|Adverse Event|2|||
44334119|NCT01310127|79338715|FG000|Overall Study|advanced psc cataract outlier|1|||
44334120|NCT01310127|79338716|FG001|Overall Study|advanced psc cataract outlier|0|||
44334121|NCT01309893|79338722|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
44334122|NCT01309893|79338723|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
44431948|NCT00615459|79440330|FG001|Period I|Adverse Event|0|||
44431949|NCT00615459|79440331|FG002|Period I|Adverse Event|1|||
44334123|NCT01309893|79338722|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
44334124|NCT01309893|79338723|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
44334125|NCT01318902|79338733|FG000|Overall Study|Symptomatic Deterioration|0|||
44334126|NCT01318902|79338734|FG001|Overall Study|Symptomatic Deterioration|1|||
44334127|NCT01318902|79338735|FG002|Overall Study|Symptomatic Deterioration|1|||
44334128|NCT01318902|79338736|FG003|Overall Study|Symptomatic Deterioration|2|||
44334129|NCT01318902|79338733|FG000|Overall Study|Withdrawal by Patient|0|||
44334130|NCT01318902|79338734|FG001|Overall Study|Withdrawal by Patient|1|||
44334131|NCT01318902|79338735|FG002|Overall Study|Withdrawal by Patient|0|||
44431950|NCT00615459|79440332|FG003|Period I|Adverse Event|0|||
44431951|NCT00615459|79440329|FG000|Period I|Subject withdrew consent|1|||
44334132|NCT01318902|79338736|FG003|Overall Study|Withdrawal by Patient|3|||
44334133|NCT01318902|79338733|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
44334134|NCT01318902|79338734|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
44431952|NCT00615459|79440330|FG001|Period I|Subject withdrew consent|0|||
44431953|NCT00615459|79440331|FG002|Period I|Subject withdrew consent|0|||
44431954|NCT00615459|79440332|FG003|Period I|Subject withdrew consent|1|||
44431955|NCT00615459|79440329|FG000|Period I|Abnormal test procedure results|1|||
44431956|NCT00615459|79440330|FG001|Period I|Abnormal test procedure results|1|||
44431957|NCT00615459|79440331|FG002|Period I|Abnormal test procedure results|1|||
44431958|NCT00615459|79440332|FG003|Period I|Abnormal test procedure results|0|||
44431959|NCT00615459|79440329|FG000|Period II|Adverse Event|1|||
44431960|NCT00615459|79440330|FG001|Period II|Adverse Event|0|||
44334135|NCT01318902|79338735|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
44334136|NCT01318902|79338736|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
44431961|NCT00615459|79440331|FG002|Period II|Adverse Event|0|||
44431962|NCT00615459|79440332|FG003|Period II|Adverse Event|0|||
44431963|NCT00615459|79440329|FG000|Period II|Lost to Follow-up|0|||
44431964|NCT00615459|79440330|FG001|Period II|Lost to Follow-up|0|||
44334137|NCT01318902|79338733|FG000|Overall Study|Adverse Event|0|||
44431965|NCT00615459|79440331|FG002|Period II|Lost to Follow-up|0|||
44431966|NCT00615459|79440332|FG003|Period II|Lost to Follow-up|1|||
44431967|NCT00615459|79440329|FG000|Period III|Adverse Event|0|||
44334138|NCT01318902|79338734|FG001|Overall Study|Adverse Event|1|||
44334139|NCT01318902|79338735|FG002|Overall Study|Adverse Event|0|||
44431968|NCT00615459|79440330|FG001|Period III|Adverse Event|1|||
44431969|NCT00615459|79440331|FG002|Period III|Adverse Event|0|||
44431970|NCT00615459|79440332|FG003|Period III|Adverse Event|0|||
44431971|NCT00615459|79440329|FG000|Period III|Administrative problems|0|||
44538892|NCT03341637|79550189|FG000|Overall Study|Lost to Follow-up|1|||
44334140|NCT01318902|79338736|FG003|Overall Study|Adverse Event|0|||
44334141|NCT01318902|79338733|FG000|Overall Study|Terminated by Sponsor|0|||
44334142|NCT01318902|79338734|FG001|Overall Study|Terminated by Sponsor|0|||
44334143|NCT01318902|79338735|FG002|Overall Study|Terminated by Sponsor|1|||
44334144|NCT01318902|79338736|FG003|Overall Study|Terminated by Sponsor|0|||
44334145|NCT01313858|79338751|FG000|Overall Study|Premature Treatment Termination|251|||
44334146|NCT01313858|79338752|FG001|Overall Study|Premature Treatment Termination|219|||
44334147|NCT01313858|79338753|FG002|Overall Study|Premature Treatment Termination|191|||
44334148|NCT01313858|79338751|FG000|Overall Study|Lost to Follow-up|35|||
44334149|NCT01313858|79338752|FG001|Overall Study|Lost to Follow-up|51|||
44334150|NCT01313858|79338753|FG002|Overall Study|Lost to Follow-up|47|||
44334151|NCT01090765|79338765|FG000|Overall Study|Patient withdrew consent|0|||
44431972|NCT00615459|79440330|FG001|Period III|Administrative problems|1|||
44431973|NCT00615459|79440331|FG002|Period III|Administrative problems|1|||
44431974|NCT00615459|79440332|FG003|Period III|Administrative problems|0|||
44431975|NCT00615459|79440329|FG000|Period III|Unsatisfactory therapeutic effect|0|||
44431976|NCT00615459|79440330|FG001|Period III|Unsatisfactory therapeutic effect|1|||
44431977|NCT00615459|79440331|FG002|Period III|Unsatisfactory therapeutic effect|0|||
44431978|NCT00615459|79440332|FG003|Period III|Unsatisfactory therapeutic effect|0|||
44431979|NCT00383149|79440346|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
44431980|NCT00383149|79440346|FG000|Overall Study|Death|2|||
44431981|NCT00383149|79440346|FG000|Overall Study|Disease Progression|38|||
44431982|NCT00383149|79440346|FG000|Overall Study|Lost to Follow-up|1|||
44431983|NCT00383149|79440346|FG000|Overall Study|Other|1|||
44431984|NCT00383149|79440346|FG000|Overall Study|Study Drug Toxicity|4|||
44431985|NCT00383149|79440346|FG000|Overall Study|Request to Discontinue Treatment|4|||
44431986|NCT00383149|79440346|FG000|Overall Study|Participant Withdrew Consent|1|||
44431987|NCT00382993|79440352|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
44431988|NCT00382993|79440353|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
44431989|NCT00382993|79440352|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
44431990|NCT00382993|79440353|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
44431991|NCT00382993|79440352|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
44431992|NCT00382993|79440353|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
44431993|NCT00382993|79440352|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
44431994|NCT00382993|79440353|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
44431995|NCT00382993|79440352|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
44431996|NCT00382993|79440353|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
44431997|NCT00382993|79440352|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
44431998|NCT00382993|79440353|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
44431999|NCT00382993|79440352|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
44432000|NCT00382993|79440353|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
44432001|NCT00382993|79440352|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
44432002|NCT00382993|79440353|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
44432003|NCT00382993|79440352|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
44432004|NCT00382993|79440353|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
44432005|NCT00382993|79440352|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
44432006|NCT00382993|79440353|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
44432007|NCT00369967|79440361|FG000|Overall Study|Lost to Follow-up|23|||
44432008|NCT00369967|79440362|FG001|Overall Study|Lost to Follow-up|12|||
44432009|NCT00616629|79440377|FG000|Overall Study|Protocol Violation|1|||
44432010|NCT00616629|79440378|FG001|Overall Study|Protocol Violation|2|||
44432011|NCT00616629|79440379|FG002|Overall Study|Protocol Violation|1|||
44432012|NCT00616629|79440380|FG003|Overall Study|Protocol Violation|0|||
44538893|NCT03341637|79550190|FG001|Overall Study|Lost to Follow-up|0|||
44538894|NCT03341637|79550189|FG000|Overall Study|Withdrawal by Subject|3|||
44538895|NCT03341637|79550190|FG001|Overall Study|Withdrawal by Subject|3|||
44538896|NCT03341637|79550189|FG000|Overall Study|Reason not Specified|1|||
44157246|NCT01133756|78948749|FG000|Overall Study|Withdrawal by Subject|0|||
44157247|NCT01133756|78948750|FG001|Overall Study|Withdrawal by Subject|1|||
44157248|NCT01133756|78948751|FG002|Overall Study|Withdrawal by Subject|0|||
44157249|NCT01133756|78948749|FG000|Overall Study|Progression of Disease|0|||
44157250|NCT01133756|78948750|FG001|Overall Study|Progression of Disease|0|||
44157251|NCT01133756|78948751|FG002|Overall Study|Progression of Disease|1|||
44157252|NCT01126736|78948764|FG000|Overall Study|Death|2|||
44157253|NCT01126736|78948765|FG001|Overall Study|Death|2|||
44157254|NCT01126736|78948766|FG002|Overall Study|Death|1|||
44157255|NCT01126736|78948767|FG003|Overall Study|Death|19|||
44157256|NCT01126736|78948768|FG004|Overall Study|Death|19|||
44157257|NCT01126736|78948764|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
44334152|NCT01090765|79338766|FG001|Overall Study|Patient withdrew consent|0|||
44334153|NCT01090765|79338767|FG002|Overall Study|Patient withdrew consent|0|||
44432013|NCT00616629|79440381|FG004|Overall Study|Protocol Violation|0|||
44432014|NCT00616629|79440377|FG000|Overall Study|AV-block|1|||
44157258|NCT01126736|78948765|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
44538897|NCT03341637|79550190|FG001|Overall Study|Reason not Specified|1|||
44538898|NCT01378858|79550198|FG000|Overall Study|Withdrawal by Subject|4|||
44538899|NCT01378858|79550199|FG001|Overall Study|Withdrawal by Subject|4|||
44538900|NCT02891850|79550207|FG000|Overall Study|Adverse Event|3|||
44538901|NCT02891850|79550208|FG001|Overall Study|Adverse Event|0|||
44538902|NCT02891850|79550207|FG000|Overall Study|Death|0|||
44538903|NCT02891850|79550208|FG001|Overall Study|Death|4|||
44538904|NCT02891850|79550207|FG000|Overall Study|Physician Decision|1|||
44538905|NCT02891850|79550208|FG001|Overall Study|Physician Decision|0|||
44538906|NCT02891850|79550207|FG000|Overall Study|Pregnancy|1|||
44538907|NCT02891850|79550208|FG001|Overall Study|Pregnancy|0|||
44538908|NCT02891850|79550207|FG000|Overall Study|Withdrawal by Subject|2|||
44538909|NCT02891850|79550208|FG001|Overall Study|Withdrawal by Subject|3|||
44538910|NCT05594173|79550214|FG000|Overall Study|Adverse Event|1|||
44538911|NCT05594173|79550214|FG000|Overall Study|COVID-19 Pandemic|2|||
44538912|NCT03339999|79550227|FG000|Overall Study|Adverse Event|1|||
44538913|NCT03339999|79550228|FG001|Overall Study|Adverse Event|2|||
44538914|NCT03339999|79550229|FG002|Overall Study|Adverse Event|2|||
44538915|NCT03339999|79550230|FG003|Overall Study|Adverse Event|1|||
44538916|NCT03339999|79550227|FG000|Overall Study|Lack of Efficacy|0|||
44538917|NCT03339999|79550228|FG001|Overall Study|Lack of Efficacy|1|||
44538918|NCT03339999|79550229|FG002|Overall Study|Lack of Efficacy|0|||
44538919|NCT03339999|79550230|FG003|Overall Study|Lack of Efficacy|0|||
44538920|NCT03339999|79550227|FG000|Overall Study|Lost to Follow-up|0|||
44538921|NCT03339999|79550228|FG001|Overall Study|Lost to Follow-up|0|||
44538922|NCT03339999|79550229|FG002|Overall Study|Lost to Follow-up|0|||
44538923|NCT03339999|79550230|FG003|Overall Study|Lost to Follow-up|1|||
44538924|NCT03339999|79550227|FG000|Overall Study|Study Terminated by Sponsor|6|||
44538925|NCT03339999|79550228|FG001|Overall Study|Study Terminated by Sponsor|3|||
44538926|NCT03339999|79550229|FG002|Overall Study|Study Terminated by Sponsor|4|||
44538927|NCT03339999|79550230|FG003|Overall Study|Study Terminated by Sponsor|3|||
44538928|NCT03339453|79550243|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
44538929|NCT03339453|79550244|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
44538930|NCT03359850|79550288|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
44538931|NCT03359850|79550289|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
44538932|NCT03359850|79550288|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
44538933|NCT03359850|79550289|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
44538934|NCT03359850|79550288|FG000|Extension Phase (Up to 28 Months)|Death|2|||
44538935|NCT03359850|79550289|FG001|Extension Phase (Up to 28 Months)|Death|4|||
44538936|NCT03359850|79550288|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
44538937|NCT03359850|79550289|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
44538938|NCT03359850|79550288|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
44538939|NCT03359850|79550289|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
44538940|NCT00114140|79550308|FG000|Overall Study|Protocol Violation|7|||
44538941|NCT03712345|79550322|FG000|Overall Study|Failure to meet randomization criteria|0|||
44538942|NCT03712345|79550323|FG001|Overall Study|Failure to meet randomization criteria|0|||
44538943|NCT03712345|79550324|FG002|Overall Study|Failure to meet randomization criteria|1|||
44538944|NCT03358290|79550337|FG000|Overall Study|Study discontinued by Sponsor|0|||
44538945|NCT03358290|79550338|FG001|Overall Study|Study discontinued by Sponsor|1|||
44334154|NCT01090765|79338768|FG003|Overall Study|Patient withdrew consent|0|||
44334155|NCT01090765|79338769|FG004|Overall Study|Patient withdrew consent|1|||
44334156|NCT01090765|79338770|FG005|Overall Study|Patient withdrew consent|1|||
44334157|NCT01090765|79338765|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
44334158|NCT01090765|79338766|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
44334159|NCT01090765|79338767|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
44334160|NCT01090765|79338768|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
44334161|NCT01090765|79338769|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
44334162|NCT01090765|79338770|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
44334163|NCT01090765|79338765|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
44334164|NCT01090765|79338766|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
44334165|NCT01090765|79338767|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
44157259|NCT01126736|78948766|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
44157260|NCT01126736|78948767|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
44538946|NCT03358290|79550339|FG002|Overall Study|Study discontinued by Sponsor|1|||
44538947|NCT03358290|79550340|FG003|Overall Study|Study discontinued by Sponsor|0|||
44538948|NCT03358290|79550341|FG004|Overall Study|Study discontinued by Sponsor|0|||
44538949|NCT03358290|79550337|FG000|Overall Study|Adverse Event|0|||
44538950|NCT03358290|79550338|FG001|Overall Study|Adverse Event|0|||
44538951|NCT03358290|79550339|FG002|Overall Study|Adverse Event|1|||
44538952|NCT03358290|79550340|FG003|Overall Study|Adverse Event|2|||
44538953|NCT03358290|79550341|FG004|Overall Study|Adverse Event|0|||
44538954|NCT03358290|79550337|FG000|Overall Study|Withdrawal by Subject|0|||
44334166|NCT01090765|79338768|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
44538955|NCT03358290|79550338|FG001|Overall Study|Withdrawal by Subject|0|||
44538956|NCT03358290|79550339|FG002|Overall Study|Withdrawal by Subject|0|||
44538957|NCT03358290|79550340|FG003|Overall Study|Withdrawal by Subject|0|||
44538958|NCT03358290|79550341|FG004|Overall Study|Withdrawal by Subject|1|||
44538959|NCT03089216|79550357|FG000|Overall Study|Adverse Event|0|||
44538960|NCT03089216|79550358|FG001|Overall Study|Adverse Event|0|||
44538961|NCT03089216|79550359|FG002|Overall Study|Adverse Event|0|||
44538962|NCT03089216|79550360|FG003|Overall Study|Adverse Event|1|||
44538963|NCT03339726|79550377|FG000|Overall Study|Withdrawal by Subject|1|||
44538964|NCT03339726|79550378|FG001|Overall Study|Withdrawal by Subject|0|||
44538965|NCT03339726|79550379|FG002|Overall Study|Withdrawal by Subject|0|||
44538966|NCT03339726|79550377|FG000|Overall Study|Lost to Follow-up|0|||
44538967|NCT03339726|79550378|FG001|Overall Study|Lost to Follow-up|1|||
44538968|NCT03339726|79550379|FG002|Overall Study|Lost to Follow-up|0|||
44157261|NCT01126736|78948768|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
44157262|NCT01126736|78948764|FG000|Overall Study|Lost to Follow-up|0|||
44157263|NCT01126736|78948765|FG001|Overall Study|Lost to Follow-up|0|||
44157264|NCT01126736|78948766|FG002|Overall Study|Lost to Follow-up|0|||
44334167|NCT01090765|79338769|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
44334168|NCT01090765|79338770|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
44334169|NCT01313780|79338787|FG000|Overall Study|Lack of Efficacy|4|||
44334170|NCT01313780|79338788|FG001|Overall Study|Lack of Efficacy|2|||
44334171|NCT01313780|79338787|FG000|Overall Study|Adverse Event|6|||
44334172|NCT01313780|79338788|FG001|Overall Study|Adverse Event|11|||
44334173|NCT01313780|79338787|FG000|Overall Study|Withdrawal by Subject|2|||
44334174|NCT01313780|79338788|FG001|Overall Study|Withdrawal by Subject|8|||
44538969|NCT03339297|79550389|FG000|Overall Study|Relapse of Hematologic Disease|1|||
44538970|NCT03339297|79550390|FG001|Overall Study|Relapse of Hematologic Disease|0|||
44157265|NCT01126736|78948767|FG003|Overall Study|Lost to Follow-up|1|||
44157266|NCT01126736|78948768|FG004|Overall Study|Lost to Follow-up|1|||
44157267|NCT01126736|78948764|FG000|Overall Study|Administrative reasons|0|||
44157268|NCT01126736|78948765|FG001|Overall Study|Administrative reasons|0|||
44157269|NCT01126736|78948766|FG002|Overall Study|Administrative reasons|0|||
44157270|NCT01126736|78948767|FG003|Overall Study|Administrative reasons|0|||
44157271|NCT01126736|78948768|FG004|Overall Study|Administrative reasons|1|||
44157272|NCT01126736|78948764|FG000|Overall Study|Progressive disease|0|||
44157273|NCT01126736|78948765|FG001|Overall Study|Progressive disease|0|||
44157274|NCT01126736|78948766|FG002|Overall Study|Progressive disease|0|||
44157275|NCT01126736|78948767|FG003|Overall Study|Progressive disease|2|||
44157276|NCT01126736|78948768|FG004|Overall Study|Progressive disease|1|||
44157277|NCT01126736|78948764|FG000|Overall Study|Withdrawal by Subject|0|||
44157278|NCT01126736|78948765|FG001|Overall Study|Withdrawal by Subject|0|||
44157279|NCT01126736|78948766|FG002|Overall Study|Withdrawal by Subject|0|||
44157280|NCT01126736|78948767|FG003|Overall Study|Withdrawal by Subject|1|||
44157281|NCT01126736|78948768|FG004|Overall Study|Withdrawal by Subject|1|||
44157282|NCT01126736|78948764|FG000|Overall Study|Other|2|||
44157283|NCT01126736|78948765|FG001|Overall Study|Other|4|||
44157284|NCT01126736|78948766|FG002|Overall Study|Other|4|||
44157285|NCT01126736|78948767|FG003|Overall Study|Other|16|||
44157286|NCT01126736|78948768|FG004|Overall Study|Other|15|||
44157287|NCT01111461|78948780|FG000|Overall Study|Adverse Event|32|||
44157288|NCT01111461|78948780|FG000|Overall Study|Participant choice|11|||
44157289|NCT01111461|78948780|FG000|Overall Study|Lost to Follow-up|1|||
44157290|NCT01111461|78948780|FG000|Overall Study|Withdrawal by Subject|1|||
44157291|NCT01111461|78948780|FG000|Overall Study|Other|6|||
44157292|NCT01104155|78948786|FG000|Overall Study|Adverse Event|15|||
44157293|NCT01104155|78948787|FG001|Overall Study|Adverse Event|8|||
44157294|NCT01104155|78948786|FG000|Overall Study|Participant choice|6|||
44157295|NCT01104155|78948787|FG001|Overall Study|Participant choice|5|||
44157296|NCT01104155|78948786|FG000|Overall Study|Withdrawal of consent|1|||
44432015|NCT00616629|79440378|FG001|Overall Study|AV-block|0|||
44432016|NCT00616629|79440379|FG002|Overall Study|AV-block|0|||
44432017|NCT00616629|79440380|FG003|Overall Study|AV-block|0|||
44432018|NCT00616629|79440381|FG004|Overall Study|AV-block|0|||
44432019|NCT00369655|79440393|FG000|Overall Study|Refusal of further treatment|2|||
44432020|NCT00615069|79440397|FG000|Overall Study|Death|10|||
44432021|NCT00615069|79440397|FG000|Overall Study|Physician Decision|2|||
44432022|NCT00615069|79440397|FG000|Overall Study|Withdrawal by Subject|4|||
44432023|NCT00676338|79440405|FG000|Overall Study|Adverse Event|6|||
44432024|NCT00676338|79440406|FG001|Overall Study|Adverse Event|6|||
44432025|NCT00676338|79440407|FG002|Overall Study|Adverse Event|5|||
44432026|NCT00676338|79440408|FG003|Overall Study|Adverse Event|1|||
44432027|NCT00676338|79440405|FG000|Overall Study|Lost to Follow-up|4|||
44432028|NCT00676338|79440406|FG001|Overall Study|Lost to Follow-up|1|||
44432029|NCT00676338|79440407|FG002|Overall Study|Lost to Follow-up|3|||
44432030|NCT00676338|79440408|FG003|Overall Study|Lost to Follow-up|4|||
44432031|NCT00676338|79440405|FG000|Overall Study|Physician Decision|3|||
44432032|NCT00676338|79440406|FG001|Overall Study|Physician Decision|3|||
44432033|NCT00676338|79440407|FG002|Overall Study|Physician Decision|2|||
44432034|NCT00676338|79440408|FG003|Overall Study|Physician Decision|3|||
44432035|NCT00676338|79440405|FG000|Overall Study|Protocol Violation|5|||
44432036|NCT00676338|79440406|FG001|Overall Study|Protocol Violation|9|||
44432037|NCT00676338|79440407|FG002|Overall Study|Protocol Violation|2|||
44432038|NCT00676338|79440408|FG003|Overall Study|Protocol Violation|5|||
44432039|NCT00676338|79440405|FG000|Overall Study|Withdrawal by Subject|17|||
44432040|NCT00676338|79440406|FG001|Overall Study|Withdrawal by Subject|9|||
44432041|NCT00676338|79440407|FG002|Overall Study|Withdrawal by Subject|12|||
44432042|NCT00676338|79440408|FG003|Overall Study|Withdrawal by Subject|6|||
44432043|NCT00676338|79440405|FG000|Overall Study|Entry Criteria Not Met|0|||
44432044|NCT00676338|79440406|FG001|Overall Study|Entry Criteria Not Met|2|||
44538971|NCT03339297|79550389|FG000|Overall Study|Death|10|||
44538972|NCT03339297|79550390|FG001|Overall Study|Death|7|||
44538973|NCT03339297|79550389|FG000|Overall Study|Hepatic Candidosis|1|||
44259085|NCT00215150|79115597|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
44259086|NCT00215150|79115597|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
44432045|NCT00676338|79440407|FG002|Overall Study|Entry Criteria Not Met|1|||
44432046|NCT00676338|79440408|FG003|Overall Study|Entry Criteria Not Met|1|||
44432047|NCT00676338|79440405|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
44432048|NCT00676338|79440406|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
44432049|NCT00676338|79440407|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
44432050|NCT00676338|79440408|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
44432051|NCT00382291|79440421|FG000|Overall Study|Adverse Event|1|||
44432052|NCT00382291|79440422|FG001|Overall Study|Adverse Event|2|||
44538974|NCT03339297|79550390|FG001|Overall Study|Hepatic Candidosis|0|||
44157297|NCT01104155|78948787|FG001|Overall Study|Withdrawal of consent|1|||
44157298|NCT01104155|78948786|FG000|Overall Study|Other|3|||
44157299|NCT01104155|78948787|FG001|Overall Study|Other|4|||
44432053|NCT00382291|79440423|FG002|Overall Study|Adverse Event|2|||
44432054|NCT00382291|79440421|FG000|Overall Study|Protocol Violation|1|||
44432055|NCT00382291|79440422|FG001|Overall Study|Protocol Violation|0|||
44432056|NCT00382291|79440423|FG002|Overall Study|Protocol Violation|0|||
44432057|NCT00382291|79440421|FG000|Overall Study|Temporary study suspension|2|||
44432058|NCT00382291|79440422|FG001|Overall Study|Temporary study suspension|2|||
44432059|NCT00382291|79440423|FG002|Overall Study|Temporary study suspension|5|||
44432060|NCT00382291|79440421|FG000|Overall Study|Withdrawal by Subject|0|||
44432061|NCT00382291|79440422|FG001|Overall Study|Withdrawal by Subject|2|||
44432062|NCT00382291|79440423|FG002|Overall Study|Withdrawal by Subject|0|||
44432063|NCT00382291|79440421|FG000|Overall Study|Physician Decision|0|||
44432064|NCT00382291|79440422|FG001|Overall Study|Physician Decision|1|||
44432065|NCT00382291|79440423|FG002|Overall Study|Physician Decision|0|||
44432066|NCT00382291|79440421|FG000|Overall Study|Lack of Efficacy|0|||
44432067|NCT00382291|79440422|FG001|Overall Study|Lack of Efficacy|0|||
44432068|NCT00382291|79440423|FG002|Overall Study|Lack of Efficacy|1|||
44432069|NCT00547378|79440445|FG000|Randomized Cohort|Withdrawal by Subject|7|||
44432070|NCT00547378|79440446|FG001|Randomized Cohort|Withdrawal by Subject|5|||
44432071|NCT00547378|79440447|FG002|Randomized Cohort|Withdrawal by Subject|0|||
44432072|NCT00547378|79440445|FG000|Randomized Cohort|Death|0|||
44432073|NCT00547378|79440446|FG001|Randomized Cohort|Death|1|||
44432074|NCT00547378|79440447|FG002|Randomized Cohort|Death|0|||
44432075|NCT00547378|79440445|FG000|Randomized Cohort|Lost to Follow-up|1|||
44432076|NCT00547378|79440446|FG001|Randomized Cohort|Lost to Follow-up|0|||
44432077|NCT00547378|79440447|FG002|Randomized Cohort|Lost to Follow-up|0|||
44432078|NCT00547378|79440445|FG000|Randomized Cohort|Adverse Event|1|||
44432079|NCT00547378|79440446|FG001|Randomized Cohort|Adverse Event|0|||
44538975|NCT03339297|79550389|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
44538976|NCT03339297|79550390|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
44538977|NCT03339297|79550389|FG000|Overall Study|Consent Withdrawn by Participant|3|||
44538978|NCT03339297|79550390|FG001|Overall Study|Consent Withdrawn by Participant|3|||
44538979|NCT03339297|79550389|FG000|Overall Study|Disease Relapse|2|||
44538980|NCT03339297|79550390|FG001|Overall Study|Disease Relapse|0|||
44538981|NCT03339297|79550389|FG000|Overall Study|Physician Decision|1|||
44538982|NCT03339297|79550390|FG001|Overall Study|Physician Decision|1|||
44538983|NCT03339297|79550389|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
44538984|NCT03339297|79550390|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
44538985|NCT03339297|79550389|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
44538986|NCT03339297|79550390|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
44538987|NCT03339297|79550389|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
44538988|NCT03339297|79550390|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
44538989|NCT03339297|79550389|FG000|Overall Study|Adverse Event, Non-fatal|1|||
44538990|NCT03339297|79550390|FG001|Overall Study|Adverse Event, Non-fatal|0|||
44538991|NCT03339297|79550389|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
44538992|NCT03339297|79550390|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
44538993|NCT03339297|79550389|FG000|Overall Study|Patient Was Not Eligible|1|||
44538994|NCT03339297|79550390|FG001|Overall Study|Patient Was Not Eligible|0|||
44538995|NCT03713281|79550416|FG000|Overall Study|Lens handling difficuluties|2|||
44538996|NCT03713281|79550416|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
44538997|NCT03339219|79550420|FG000|Overall Study|Death|12|||
44538998|NCT03339219|79550420|FG000|Overall Study|Site Terminated by Sponsor|22|||
44538999|NCT03339219|79550420|FG000|Overall Study|Withdrawal by Subject|1|||
44539000|NCT03338673|79550426|FG000|Overall Study|Lost to Follow-up|1|||
44539001|NCT03338673|79550427|FG001|Overall Study|Lost to Follow-up|1|||
44539002|NCT02949024|79550435|FG000|Overall Study|Withdrawal by Subject|0|||
44539003|NCT02949024|79550436|FG001|Overall Study|Withdrawal by Subject|1|||
44539004|NCT03093428|79550446|FG000|Overall Study|Not eligible for treatment|2|||
44539005|NCT03093428|79550447|FG001|Overall Study|Not eligible for treatment|1|||
44539006|NCT03093428|79550446|FG000|Overall Study|Progression|14|||
44539007|NCT03093428|79550447|FG001|Overall Study|Progression|4|||
44539008|NCT03093428|79550446|FG000|Overall Study|Death|1|||
44539009|NCT03093428|79550447|FG001|Overall Study|Death|0|||
44539010|NCT03093428|79550446|FG000|Overall Study|Adverse Event|1|||
44539011|NCT03093428|79550447|FG001|Overall Study|Adverse Event|0|||
44539012|NCT03093428|79550446|FG000|Overall Study|Withdrawal by Subject|1|||
44539013|NCT03093428|79550447|FG001|Overall Study|Withdrawal by Subject|1|||
44539014|NCT02735980|79550456|FG000|Overall Study|Adverse Event|0|||
44539015|NCT02735980|79550457|FG001|Overall Study|Adverse Event|4|||
44432080|NCT00547378|79440447|FG002|Randomized Cohort|Adverse Event|0|||
44432081|NCT00547378|79440445|FG000|Randomized Cohort|Other reasons|2|||
44432082|NCT00547378|79440446|FG001|Randomized Cohort|Other reasons|0|||
44432083|NCT00547378|79440447|FG002|Randomized Cohort|Other reasons|0|||
44539016|NCT02735980|79550458|FG002|Overall Study|Adverse Event|1|||
44539017|NCT02735980|79550456|FG000|Overall Study|Death|5|||
44539018|NCT02735980|79550457|FG001|Overall Study|Death|4|||
44539019|NCT02735980|79550458|FG002|Overall Study|Death|0|||
44539020|NCT02735980|79550456|FG000|Overall Study|Physician Decision|3|||
44432084|NCT00547378|79440445|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
44432085|NCT00547378|79440446|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
44432086|NCT00547378|79440447|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
44432087|NCT00547378|79440445|FG000|All Implanted Cohort|Adverse Event|4|||
44432088|NCT00547378|79440446|FG001|All Implanted Cohort|Adverse Event|10|||
44432089|NCT00547378|79440447|FG002|All Implanted Cohort|Adverse Event|17|||
44432090|NCT00547378|79440445|FG000|All Implanted Cohort|Lost to Follow-up|0|||
44432091|NCT00547378|79440446|FG001|All Implanted Cohort|Lost to Follow-up|1|||
44432092|NCT00547378|79440447|FG002|All Implanted Cohort|Lost to Follow-up|14|||
44432093|NCT00547378|79440445|FG000|All Implanted Cohort|Death|3|||
44432094|NCT00547378|79440446|FG001|All Implanted Cohort|Death|1|||
44432095|NCT00547378|79440447|FG002|All Implanted Cohort|Death|4|||
44432096|NCT00547378|79440445|FG000|All Implanted Cohort|Physician Decision|0|||
44432097|NCT00547378|79440446|FG001|All Implanted Cohort|Physician Decision|2|||
44432098|NCT00547378|79440447|FG002|All Implanted Cohort|Physician Decision|6|||
44432099|NCT00547378|79440445|FG000|All Implanted Cohort|Site closure|2|||
44432100|NCT00547378|79440446|FG001|All Implanted Cohort|Site closure|0|||
44432101|NCT00547378|79440447|FG002|All Implanted Cohort|Site closure|1|||
44432102|NCT00547378|79440445|FG000|All Implanted Cohort|Other reasons|1|||
44432103|NCT00547378|79440446|FG001|All Implanted Cohort|Other reasons|0|||
44539021|NCT02735980|79550457|FG001|Overall Study|Physician Decision|1|||
44539022|NCT02735980|79550458|FG002|Overall Study|Physician Decision|0|||
44539023|NCT02735980|79550456|FG000|Overall Study|Screen failure|1|||
44539024|NCT02735980|79550457|FG001|Overall Study|Screen failure|0|||
44539025|NCT02735980|79550458|FG002|Overall Study|Screen failure|0|||
44539026|NCT02735980|79550456|FG000|Overall Study|Withdrawal by Subject|1|||
44539027|NCT02735980|79550457|FG001|Overall Study|Withdrawal by Subject|2|||
44539028|NCT02735980|79550458|FG002|Overall Study|Withdrawal by Subject|0|||
44539029|NCT03338400|79550473|FG000|Overall Study|Lost to Follow-up|1|||
44539030|NCT03338400|79550474|FG001|Overall Study|Lost to Follow-up|2|||
44334175|NCT01313780|79338787|FG000|Overall Study|Protocol Violation|10|||
44334176|NCT01313780|79338788|FG001|Overall Study|Protocol Violation|4|||
44334177|NCT01313780|79338787|FG000|Overall Study|missing data|3|||
44334178|NCT01313780|79338788|FG001|Overall Study|missing data|3|||
44334179|NCT01090453|79338796|FG000|Overall Study|Withdrawal by Subject|1|||
44334180|NCT01090453|79338797|FG001|Overall Study|Withdrawal by Subject|2|||
44334181|NCT01090453|79338796|FG000|Overall Study|Lost to Follow-up|7|||
44334182|NCT01090453|79338797|FG001|Overall Study|Lost to Follow-up|7|||
44539031|NCT03337113|79550492|FG000|Overall Study|Adverse Event|1|||
44539032|NCT03337113|79550493|FG001|Overall Study|Adverse Event|1|||
44539033|NCT03337113|79550494|FG002|Overall Study|Adverse Event|0|||
44539034|NCT03337113|79550495|FG003|Overall Study|Adverse Event|1|||
44539035|NCT03337113|79550492|FG000|Overall Study|Physician Decision|0|||
44539036|NCT03337113|79550493|FG001|Overall Study|Physician Decision|2|||
44539037|NCT03337113|79550494|FG002|Overall Study|Physician Decision|0|||
44539038|NCT03337113|79550495|FG003|Overall Study|Physician Decision|1|||
44539039|NCT03337113|79550492|FG000|Overall Study|Withdrawal by Subject|0|||
44539040|NCT03337113|79550493|FG001|Overall Study|Withdrawal by Subject|0|||
44539041|NCT03337113|79550494|FG002|Overall Study|Withdrawal by Subject|1|||
44539042|NCT03337113|79550495|FG003|Overall Study|Withdrawal by Subject|0|||
44539043|NCT03092726|79550507|FG000|Overall Study|Adverse Event|3|||
44539044|NCT03092726|79550508|FG001|Overall Study|Adverse Event|10|||
44539045|NCT03092726|79550507|FG000|Overall Study|Lack of Efficacy|0|||
44539046|NCT03092726|79550508|FG001|Overall Study|Lack of Efficacy|1|||
44259087|NCT00214136|79115605|FG000|Overall Study|Death|5|||
44259088|NCT00213980|79115611|FG000|Overall Study|Withdrawal by Subject|3|||
44259089|NCT00213980|79115612|FG001|Overall Study|Withdrawal by Subject|1|||
44259090|NCT00213980|79115611|FG000|Overall Study|Adverse Event|1|||
44259091|NCT00213980|79115612|FG001|Overall Study|Adverse Event|1|||
44259092|NCT00213980|79115611|FG000|Overall Study|Disease progression|0|||
44259093|NCT00213980|79115612|FG001|Overall Study|Disease progression|2|||
44259094|NCT00213980|79115611|FG000|Overall Study|Developed ovarian cancer|1|||
44259095|NCT00213980|79115612|FG001|Overall Study|Developed ovarian cancer|0|||
44334183|NCT01090453|79338796|FG000|Overall Study|Non serious AEs|1|||
44334184|NCT01090453|79338797|FG001|Overall Study|Non serious AEs|0|||
44334185|NCT01090453|79338796|FG000|Overall Study|Protocol Violation|2|||
44334186|NCT01090453|79338797|FG001|Overall Study|Protocol Violation|0|||
44334187|NCT01090453|79338796|FG000|Overall Study|Other|2|||
44334188|NCT01090453|79338797|FG001|Overall Study|Other|4|||
44334189|NCT01090453|79338796|FG000|Overall Study|Eligibility Criteria|0|||
44334190|NCT01090453|79338797|FG001|Overall Study|Eligibility Criteria|1|||
44432104|NCT00547378|79440447|FG002|All Implanted Cohort|Other reasons|1|||
44334191|NCT01171612|79338803|FG000|Overall Study|Lost to Follow-up|51|||
44432105|NCT00381043|79440457|FG000|Overall Study|Lost to Follow-up|8|||
44539047|NCT03092726|79550507|FG000|Overall Study|Lost to Follow-up|1|||
44539048|NCT03092726|79550508|FG001|Overall Study|Lost to Follow-up|0|||
44539049|NCT03092726|79550507|FG000|Overall Study|Withdrawal by Subject|5|||
44539050|NCT03092726|79550508|FG001|Overall Study|Withdrawal by Subject|3|||
44334192|NCT01171534|79338812|FG000|Overall Study|Lost to Follow-up|0|||
44334193|NCT01171534|79338813|FG001|Overall Study|Lost to Follow-up|2|||
44334194|NCT01171534|79338812|FG000|Overall Study|screen failure|0|||
44432106|NCT00381043|79440458|FG001|Overall Study|Lost to Follow-up|6|||
44432107|NCT00381043|79440457|FG000|Overall Study|Withdrawal by Subject|3|||
44432108|NCT00381043|79440458|FG001|Overall Study|Withdrawal by Subject|1|||
44432109|NCT00381043|79440457|FG000|Overall Study|wanted more care|0|||
44432110|NCT00381043|79440458|FG001|Overall Study|wanted more care|1|||
44432111|NCT00381043|79440457|FG000|Overall Study|incarcerated|1|||
44432112|NCT00381043|79440458|FG001|Overall Study|incarcerated|0|||
44432113|NCT00614991|79440470|FG000|Overall Study|Adverse Event|3|||
44432114|NCT00614991|79440471|FG001|Overall Study|Adverse Event|3|||
44432115|NCT00614991|79440472|FG002|Overall Study|Adverse Event|0|||
44334195|NCT01171534|79338813|FG001|Overall Study|screen failure|1|||
44334196|NCT01170598|79338819|FG000|Overall Study|Withdrawal by Subject|1|||
44432116|NCT00614991|79440473|FG003|Overall Study|Adverse Event|0|||
44432117|NCT00614991|79440474|FG004|Overall Study|Adverse Event|1|||
44539051|NCT03338010|79550516|FG000|Overall Study|Withdrawal by Subject|14|||
44539052|NCT03338010|79550517|FG001|Overall Study|Withdrawal by Subject|8|||
44539053|NCT03338010|79550516|FG000|Overall Study|Lost to Follow-up|4|||
44539054|NCT03338010|79550517|FG001|Overall Study|Lost to Follow-up|2|||
44539055|NCT03338010|79550516|FG000|Overall Study|Adverse Event|3|||
44539056|NCT03338010|79550517|FG001|Overall Study|Adverse Event|2|||
44539057|NCT03338010|79550516|FG000|Overall Study|Physician Decision|2|||
44539058|NCT03338010|79550517|FG001|Overall Study|Physician Decision|2|||
44539059|NCT03338010|79550516|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44539060|NCT03338010|79550517|FG001|Overall Study|Non-Compliance with Study Drug|3|||
44539061|NCT03338010|79550516|FG000|Overall Study|Protocol Violation|0|||
44539062|NCT03338010|79550517|FG001|Overall Study|Protocol Violation|1|||
44539063|NCT03337542|79550523|FG000|Overall Study|Withdrew Consent|17|||
44539064|NCT03337542|79550523|FG000|Overall Study|Allergic Adverse Event|1|||
44539065|NCT03337542|79550523|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
44539066|NCT03337542|79550523|FG000|Overall Study|Lost to Follow-up|1|||
44539067|NCT03337542|79550523|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
44539068|NCT01328548|79550530|FG000|Overall Study|Death|3|||
44539069|NCT01328548|79550531|FG001|Overall Study|Death|0|||
44539070|NCT01328548|79550530|FG000|Overall Study|Protocol Violation|1|||
44539071|NCT01328548|79550531|FG001|Overall Study|Protocol Violation|0|||
44539072|NCT03337308|79550569|FG000|Overall Study|Adverse Event|2|||
44539073|NCT03337308|79550570|FG001|Overall Study|Adverse Event|3|||
44539074|NCT03337308|79550571|FG002|Overall Study|Adverse Event|3|||
44539075|NCT03337308|79550572|FG003|Overall Study|Adverse Event|1|||
44539076|NCT03337308|79550569|FG000|Overall Study|Lost to Follow-up|1|||
44539077|NCT03337308|79550570|FG001|Overall Study|Lost to Follow-up|2|||
44539078|NCT03337308|79550571|FG002|Overall Study|Lost to Follow-up|0|||
44259096|NCT00213980|79115611|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
44259097|NCT00213980|79115612|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
44259098|NCT05086289|79115671|FG000|Overall Study|Adverse Event|4|||
44259099|NCT05086289|79115672|FG001|Overall Study|Adverse Event|2|||
44259100|NCT05086289|79115671|FG000|Overall Study|Lost to Follow-up|2|||
44259101|NCT05086289|79115672|FG001|Overall Study|Lost to Follow-up|0|||
44259102|NCT05086289|79115671|FG000|Overall Study|Non-compliance with study drug|2|||
44259103|NCT05086289|79115672|FG001|Overall Study|Non-compliance with study drug|1|||
44259104|NCT05086289|79115671|FG000|Overall Study|Physician Decision|2|||
44259105|NCT05086289|79115672|FG001|Overall Study|Physician Decision|0|||
44334197|NCT01170598|79338819|FG000|Overall Study|Death|3|||
44334198|NCT01170598|79338819|FG000|Overall Study|Lost to Follow-up|1|||
44334199|NCT01170598|79338819|FG000|Overall Study|Refused|1|||
44334200|NCT01170364|79338825|FG000|Overall Study|Protocol Violation|4|||
44334201|NCT01170364|79338826|FG001|Overall Study|Protocol Violation|1|||
44334202|NCT01076179|79338832|FG000|Overall Study|Withdrawal by Subject|1|||
44334203|NCT01170208|79338840|FG000|Overall Study|Withdrawal by Subject|5|||
44334204|NCT01170208|79338841|FG001|Overall Study|Withdrawal by Subject|0|||
44432118|NCT00614991|79440475|FG005|Overall Study|Adverse Event|0|||
44432119|NCT00360529|79440497|FG000|Overall Study|Adverse Event|10|||
44539079|NCT03337308|79550572|FG003|Overall Study|Lost to Follow-up|0|||
44539080|NCT03337308|79550569|FG000|Overall Study|Withdrawal by Subject|2|||
44539081|NCT03337308|79550570|FG001|Overall Study|Withdrawal by Subject|1|||
44259106|NCT05086289|79115671|FG000|Overall Study|Withdrawal by Subject|5|||
44259107|NCT05086289|79115672|FG001|Overall Study|Withdrawal by Subject|2|||
44259108|NCT05045144|79115685|FG000|Overall Study|Lost to Follow-up|3|||
44259109|NCT05045144|79115686|FG001|Overall Study|Lost to Follow-up|2|||
44334205|NCT01170208|79338842|FG002|Overall Study|Withdrawal by Subject|1|||
44334206|NCT01170208|79338840|FG000|Overall Study|Protocol Violation|1|||
44432120|NCT00360529|79440498|FG001|Overall Study|Adverse Event|23|||
44432121|NCT00360529|79440499|FG002|Overall Study|Adverse Event|33|||
44539082|NCT03337308|79550571|FG002|Overall Study|Withdrawal by Subject|2|||
44539083|NCT03337308|79550572|FG003|Overall Study|Withdrawal by Subject|1|||
44539084|NCT03337308|79550569|FG000|Overall Study|Protocol Violation|0|||
44334207|NCT01170208|79338841|FG001|Overall Study|Protocol Violation|0|||
44334208|NCT01170208|79338842|FG002|Overall Study|Protocol Violation|1|||
44334209|NCT01313624|79338855|FG000|Double-Blind Phase|Adverse Event|27|||
44334210|NCT01313624|79338856|FG001|Double-Blind Phase|Adverse Event|4|||
44334211|NCT01313624|79338855|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
44334212|NCT01313624|79338856|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
44334213|NCT01313624|79338855|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44334214|NCT01313624|79338856|FG001|Double-Blind Phase|Lost to Follow-up|2|||
44334215|NCT01313624|79338855|FG000|Double-Blind Phase|Physician Decision|1|||
44334216|NCT01313624|79338856|FG001|Double-Blind Phase|Physician Decision|0|||
44432122|NCT00360529|79440497|FG000|Overall Study|Protocol Violation|3|||
44432123|NCT00360529|79440498|FG001|Overall Study|Protocol Violation|3|||
44432124|NCT00360529|79440499|FG002|Overall Study|Protocol Violation|11|||
44432125|NCT00360529|79440497|FG000|Overall Study|Lost to Follow-up|14|||
44432126|NCT00360529|79440498|FG001|Overall Study|Lost to Follow-up|10|||
44432127|NCT00360529|79440499|FG002|Overall Study|Lost to Follow-up|13|||
44432128|NCT00360529|79440497|FG000|Overall Study|Withdrawal by Subject|22|||
44432129|NCT00360529|79440498|FG001|Overall Study|Withdrawal by Subject|14|||
44432130|NCT00360529|79440499|FG002|Overall Study|Withdrawal by Subject|18|||
44432131|NCT00360529|79440497|FG000|Overall Study|Lack of Efficacy|8|||
44432132|NCT00360529|79440498|FG001|Overall Study|Lack of Efficacy|6|||
44432133|NCT00360529|79440499|FG002|Overall Study|Lack of Efficacy|5|||
44432134|NCT00360529|79440497|FG000|Overall Study|Reason discontinued not explained above|4|||
44432135|NCT00360529|79440498|FG001|Overall Study|Reason discontinued not explained above|9|||
44432136|NCT00360529|79440499|FG002|Overall Study|Reason discontinued not explained above|11|||
44432137|NCT00369577|79440510|FG000|Overall Study|Withdrawal by Subject|0|||
44432138|NCT00369577|79440511|FG001|Overall Study|Withdrawal by Subject|0|||
44432139|NCT00369577|79440512|FG002|Overall Study|Withdrawal by Subject|1|||
44432140|NCT00678288|79440522|FG000|Overall Study|Adverse Event|0|||
44432141|NCT00678288|79440523|FG001|Overall Study|Adverse Event|2|||
44432142|NCT00678288|79440522|FG000|Overall Study|Withdrawal by Subject|1|||
44432143|NCT00678288|79440523|FG001|Overall Study|Withdrawal by Subject|1|||
44432144|NCT00678288|79440522|FG000|Overall Study|Study terminated by the sponsor|2|||
44432145|NCT00678288|79440523|FG001|Overall Study|Study terminated by the sponsor|0|||
44432146|NCT00678288|79440522|FG000|Overall Study|Not compliant with study medication|0|||
44432147|NCT00678288|79440523|FG001|Overall Study|Not compliant with study medication|1|||
44432148|NCT00678288|79440522|FG000|Overall Study|Switch to commercial drug|0|||
44432149|NCT00678288|79440523|FG001|Overall Study|Switch to commercial drug|1|||
44432150|NCT00678288|79440522|FG000|Overall Study|Reason not reported|1|||
44432151|NCT00678288|79440523|FG001|Overall Study|Reason not reported|0|||
44432152|NCT00678288|79440522|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
44432153|NCT00678288|79440523|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
44432154|NCT00369343|79440531|FG000|Double-blind Phase|Adverse Event|19|||
44432155|NCT00369343|79440532|FG001|Double-blind Phase|Adverse Event|4|||
44432156|NCT00369343|79440531|FG000|Double-blind Phase|Failed to return|2|||
44432157|NCT00369343|79440532|FG001|Double-blind Phase|Failed to return|0|||
44334217|NCT01313624|79338855|FG000|Double-Blind Phase|Lack of Efficacy|1|||
44334218|NCT01313624|79338856|FG001|Double-Blind Phase|Lack of Efficacy|0|||
44334219|NCT01313624|79338855|FG000|Open-Label Phase|Adverse Event|1|||
44334220|NCT01313624|79338856|FG001|Open-Label Phase|Adverse Event|10|||
44334221|NCT01313624|79338855|FG000|Open-Label Phase|Withdrawal by Subject|2|||
44334222|NCT01313624|79338856|FG001|Open-Label Phase|Withdrawal by Subject|2|||
44334223|NCT01313624|79338855|FG000|Open-Label Phase|Lost to Follow-up|1|||
44334224|NCT01313624|79338856|FG001|Open-Label Phase|Lost to Follow-up|1|||
44334225|NCT01169350|79338864|FG000|Overall Study|Physician Decision|3|||
44334226|NCT01169350|79338864|FG000|Overall Study|Lost to Follow-up|2|||
44334227|NCT01169038|79338868|FG000|Overall Study|Death|1|||
44334228|NCT01169038|79338868|FG000|Overall Study|Adverse Event|5|||
44334229|NCT01169038|79338868|FG000|Overall Study|Required antibiotic administration|1|||
44334230|NCT01167634|79338876|FG000|Overall Study|Lost to Follow-up|1|||
44334231|NCT01167634|79338877|FG001|Overall Study|Lost to Follow-up|3|||
44334232|NCT01167634|79338878|FG002|Overall Study|Lost to Follow-up|3|||
44334233|NCT01167634|79338879|FG003|Overall Study|Lost to Follow-up|4|||
44334234|NCT01167634|79338876|FG000|Overall Study|Withdrawal by Subject|1|||
44334235|NCT01167634|79338877|FG001|Overall Study|Withdrawal by Subject|1|||
44334236|NCT01167634|79338878|FG002|Overall Study|Withdrawal by Subject|0|||
44432158|NCT00369343|79440531|FG000|Double-blind Phase|Lost to Follow-up|9|||
44432159|NCT00369343|79440532|FG001|Double-blind Phase|Lost to Follow-up|2|||
44432160|NCT00369343|79440531|FG000|Double-blind Phase|Protocol Violation|2|||
44432161|NCT00369343|79440532|FG001|Double-blind Phase|Protocol Violation|0|||
44432162|NCT00369343|79440531|FG000|Double-blind Phase|Withdrawal by Subject|8|||
44432163|NCT00369343|79440532|FG001|Double-blind Phase|Withdrawal by Subject|6|||
44432164|NCT00369343|79440531|FG000|Double-blind Phase|Lack of Efficacy|0|||
44432165|NCT00369343|79440532|FG001|Double-blind Phase|Lack of Efficacy|4|||
44432166|NCT00369343|79440531|FG000|Double-blind Phase|Protocol deviation|4|||
44334237|NCT01167634|79338879|FG003|Overall Study|Withdrawal by Subject|0|||
44432167|NCT00369343|79440532|FG001|Double-blind Phase|Protocol deviation|0|||
44432168|NCT00369343|79440531|FG000|Open-label Phase|Adverse Event|19|||
44432169|NCT00369343|79440532|FG001|Open-label Phase|Adverse Event|7|||
44432170|NCT00369343|79440531|FG000|Open-label Phase|Failed to return|4|||
44432171|NCT00369343|79440532|FG001|Open-label Phase|Failed to return|0|||
44432172|NCT00369343|79440531|FG000|Open-label Phase|Physician Decision|2|||
44432173|NCT00369343|79440532|FG001|Open-label Phase|Physician Decision|0|||
44432174|NCT00369343|79440531|FG000|Open-label Phase|Lost to Follow-up|5|||
44432175|NCT00369343|79440532|FG001|Open-label Phase|Lost to Follow-up|3|||
44432176|NCT00369343|79440531|FG000|Open-label Phase|inadvertently reported study completers|3|||
44334238|NCT01166386|79338891|FG000|Overall Study|Withdrawal by Subject|3|||
44334239|NCT01166386|79338892|FG001|Overall Study|Withdrawal by Subject|5|||
44334240|NCT01114828|79338900|FG000|Overall Study|Adverse Event|1|||
44334241|NCT01114828|79338901|FG001|Overall Study|Adverse Event|1|||
44334242|NCT01114828|79338900|FG000|Overall Study|Lack of Efficacy|0|||
44334243|NCT01114828|79338901|FG001|Overall Study|Lack of Efficacy|2|||
44334244|NCT01114828|79338900|FG000|Overall Study|Protocol Violation|2|||
44334245|NCT01114828|79338901|FG001|Overall Study|Protocol Violation|0|||
44432177|NCT00369343|79440532|FG001|Open-label Phase|inadvertently reported study completers|2|||
44432178|NCT00369343|79440531|FG000|Open-label Phase|Protocol Violation|1|||
44432179|NCT00369343|79440532|FG001|Open-label Phase|Protocol Violation|3|||
44432180|NCT00369343|79440531|FG000|Open-label Phase|Withdrawal by Subject|15|||
44432181|NCT00369343|79440532|FG001|Open-label Phase|Withdrawal by Subject|6|||
44432182|NCT00369343|79440531|FG000|Open-label Phase|Lack of Efficacy|4|||
44432183|NCT00369343|79440532|FG001|Open-label Phase|Lack of Efficacy|3|||
44432184|NCT00369343|79440531|FG000|Open-label Phase|Lack of continuance tolerability|3|||
44432185|NCT00369343|79440532|FG001|Open-label Phase|Lack of continuance tolerability|4|||
44432186|NCT00369343|79440531|FG000|Open-label Phase|did not take study drug|1|||
44432187|NCT00369343|79440532|FG001|Open-label Phase|did not take study drug|2|||
44432188|NCT00369265|79440547|FG000|Overall Study|Study terminated|4|||
44432189|NCT00369265|79440548|FG001|Overall Study|Study terminated|7|||
44432190|NCT00368875|79440554|FG000|Overall Study|Adverse Event|0|||
44432191|NCT00368875|79440555|FG001|Overall Study|Adverse Event|12|||
44432192|NCT00368875|79440554|FG000|Overall Study|Progressive disease|3|||
44432193|NCT00368875|79440555|FG001|Overall Study|Progressive disease|27|||
44432194|NCT00368875|79440554|FG000|Overall Study|Withdrawal by Subject|2|||
44432195|NCT00368875|79440555|FG001|Overall Study|Withdrawal by Subject|6|||
44432196|NCT00368875|79440554|FG000|Overall Study|Other Reason|0|||
44432197|NCT00368875|79440555|FG001|Overall Study|Other Reason|2|||
44432198|NCT00368875|79440554|FG000|Overall Study|Alternative Therapy|1|||
44432199|NCT00368875|79440555|FG001|Overall Study|Alternative Therapy|1|||
44539085|NCT03337308|79550570|FG001|Overall Study|Protocol Violation|1|||
44334246|NCT01114828|79338900|FG000|Overall Study|Withdrawal by Subject|0|||
44334247|NCT01114828|79338901|FG001|Overall Study|Withdrawal by Subject|1|||
44334248|NCT01313312|79338907|FG000|Overall Study|Adverse Event|5|||
44334249|NCT01313312|79338907|FG000|Overall Study|Withdrawal by Subject|18|||
44334250|NCT01313312|79338907|FG000|Overall Study|Lack of Efficacy|3|||
44334251|NCT01313312|79338907|FG000|Overall Study|Investigator Decision|1|||
44334252|NCT01313312|79338907|FG000|Overall Study|Observational Phase|1|||
44334253|NCT01313312|79338907|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
44334254|NCT01313312|79338907|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
44334255|NCT01114672|79338913|FG000|Overall Study|Death|0|||
44334256|NCT01114672|79338914|FG001|Overall Study|Death|1|||
44334257|NCT01114672|79338913|FG000|Overall Study|Withdrawal by Subject|2|||
44334258|NCT01114672|79338914|FG001|Overall Study|Withdrawal by Subject|1|||
44334259|NCT01114672|79338913|FG000|Overall Study|Lost to Follow-up|1|||
44334260|NCT01114672|79338914|FG001|Overall Study|Lost to Follow-up|0|||
44334261|NCT01114672|79338913|FG000|Overall Study|transplanted|1|||
44334262|NCT01114672|79338914|FG001|Overall Study|transplanted|0|||
44334263|NCT01114516|79338922|FG000|Overall Study|Lost to Follow-up|2|||
44432200|NCT00614055|79440564|FG000|Overall Study|Adverse Event|1|||
44432201|NCT00614055|79440565|FG001|Overall Study|Adverse Event|0|||
44432202|NCT00614055|79440566|FG002|Overall Study|Adverse Event|0|||
44432203|NCT00614055|79440564|FG000|Overall Study|Protocol Violation|2|||
44432204|NCT00614055|79440565|FG001|Overall Study|Protocol Violation|2|||
44432205|NCT00614055|79440566|FG002|Overall Study|Protocol Violation|1|||
44432206|NCT00614055|79440564|FG000|Overall Study|Lack of Efficacy|0|||
44432207|NCT00614055|79440565|FG001|Overall Study|Lack of Efficacy|0|||
44432208|NCT00614055|79440566|FG002|Overall Study|Lack of Efficacy|2|||
44432209|NCT00614055|79440564|FG000|Overall Study|Unclassified|1|||
44539086|NCT03337308|79550571|FG002|Overall Study|Protocol Violation|0|||
44539087|NCT03337308|79550572|FG003|Overall Study|Protocol Violation|0|||
44334264|NCT01114516|79338923|FG001|Overall Study|Lost to Follow-up|1|||
44334265|NCT01114438|79338929|FG000|Overall Study|Adverse Event|10|||
44334266|NCT01114438|79338929|FG000|Overall Study|concomitant medication|1|||
44334267|NCT01114438|79338929|FG000|Overall Study|Physician Decision|1|||
44432210|NCT00614055|79440565|FG001|Overall Study|Unclassified|4|||
44539088|NCT03337152|79550584|FG000|Overall Study|Physician Decision|1|||
44432211|NCT00614055|79440566|FG002|Overall Study|Unclassified|2|||
44432212|NCT00613821|79440579|FG000|Overall Study|Withdrawal by Subject|1|||
44432213|NCT00613821|79440580|FG001|Overall Study|Withdrawal by Subject|0|||
44432214|NCT00613821|79440579|FG000|Overall Study|Physician Decision|1|||
44432215|NCT00613821|79440580|FG001|Overall Study|Physician Decision|1|||
44432216|NCT00548548|79440588|FG000|Overall Study|Death|345|||
44432217|NCT00548548|79440589|FG001|Overall Study|Death|348|||
44432218|NCT00548548|79440588|FG000|Overall Study|Lost to Follow-up|17|||
44432219|NCT00548548|79440589|FG001|Overall Study|Lost to Follow-up|18|||
44432220|NCT00613509|79440597|FG000|Cycle 1|Adverse Event|2|||
44432221|NCT00613509|79440598|FG001|Cycle 1|Adverse Event|1|||
44432222|NCT00613509|79440597|FG000|Cycle 1|Disease Progression|2|||
44432223|NCT00613509|79440598|FG001|Cycle 1|Disease Progression|6|||
44432224|NCT00613509|79440597|FG000|Cycle 1|Unacceptable Toxicity|1|||
44539089|NCT03337152|79550585|FG001|Overall Study|Physician Decision|0|||
44539090|NCT03337152|79550584|FG000|Overall Study|Lost to Follow-up|1|||
44539091|NCT03337152|79550585|FG001|Overall Study|Lost to Follow-up|3|||
44539092|NCT03337152|79550584|FG000|Overall Study|Adverse Event|3|||
44157300|NCT01065597|78948793|FG000|Overall Study|Adverse Event|1|||
44157301|NCT01051856|78948799|FG000|Overall Study|Withdrawal by Subject|1|||
44157302|NCT01051856|78948800|FG001|Overall Study|Withdrawal by Subject|0|||
44157303|NCT01029366|78948808|FG000|Overall Study|Withdrawal by Subject|1|||
44259110|NCT05045144|79115687|FG002|Overall Study|Lost to Follow-up|3|||
44334268|NCT01114438|79338929|FG000|Overall Study|Withdrawal by Subject|2|||
44334269|NCT01313078|79338938|FG000|Overall Study|Death|1|||
44334270|NCT01313078|79338938|FG000|Overall Study|Discontinued study drug|1|||
44334271|NCT01313078|79338938|FG000|Overall Study|Withdrawal by Subject|1|||
44334272|NCT01114360|79338942|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
44539093|NCT03337152|79550585|FG001|Overall Study|Adverse Event|1|||
44539094|NCT03337152|79550584|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
44539095|NCT03337152|79550585|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
44259111|NCT05045144|79115688|FG003|Overall Study|Lost to Follow-up|5|||
44259112|NCT05045144|79115689|FG004|Overall Study|Lost to Follow-up|13|||
44259113|NCT05045144|79115685|FG000|Overall Study|Withdrawal by Subject|0|||
44259114|NCT05045144|79115686|FG001|Overall Study|Withdrawal by Subject|1|||
44259115|NCT05045144|79115687|FG002|Overall Study|Withdrawal by Subject|0|||
44259116|NCT05045144|79115688|FG003|Overall Study|Withdrawal by Subject|0|||
44259117|NCT05045144|79115689|FG004|Overall Study|Withdrawal by Subject|0|||
44259118|NCT05045144|79115685|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44259119|NCT05045144|79115686|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44259120|NCT05045144|79115687|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
44259121|NCT05045144|79115688|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44259122|NCT05045144|79115689|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
44259123|NCT05016765|79115705|FG000|Overall Study|Lost to Follow-up|4|||
44259124|NCT04982029|79115712|FG000|Overall Study|Lost to Follow-up|2|||
44259125|NCT04982029|79115713|FG001|Overall Study|Lost to Follow-up|3|||
44259126|NCT04897867|79115727|FG000|Overall Study|Withdrawal of Consent|1|||
44259127|NCT04897867|79115727|FG000|Overall Study|Pregnancy|1|||
44259128|NCT04897867|79115727|FG000|Overall Study|Lost to Follow-up|7|||
44259129|NCT04897867|79115727|FG000|Overall Study|Reason not Specified|2|||
44259130|NCT04161157|79115768|FG000|Overall Study|Lost to Follow-up|4|||
44259131|NCT04161157|79115768|FG000|Overall Study|Death|3|||
44259132|NCT04161157|79115768|FG000|Overall Study|Ineligible|2|||
44259133|NCT04161157|79115768|FG000|Overall Study|Withdrawal by Subject|4|||
44259134|NCT04035187|79115776|FG000|Overall Study|Withdrawal by Subject|2|||
44259135|NCT04035187|79115777|FG001|Overall Study|Withdrawal by Subject|1|||
44259136|NCT04035187|79115778|FG002|Overall Study|Withdrawal by Subject|0|||
44259137|NCT04035187|79115779|FG003|Overall Study|Withdrawal by Subject|0|||
44259138|NCT04035187|79115776|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
44259139|NCT04035187|79115777|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
44259140|NCT04035187|79115778|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
44259141|NCT04035187|79115779|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
44259142|NCT03852719|79115792|FG000|Overall Study|Still on study after Week 96|49|||
44259143|NCT03852719|79115793|FG001|Overall Study|Still on study after Week 96|47|||
44259144|NCT03852719|79115794|FG002|Overall Study|Still on study after Week 96|47|||
44259145|NCT03852719|79115792|FG000|Overall Study|Withdrawal of consent|0|||
44259146|NCT03852719|79115793|FG001|Overall Study|Withdrawal of consent|2|||
44259147|NCT03852719|79115794|FG002|Overall Study|Withdrawal of consent|2|||
44259148|NCT03852719|79115792|FG000|Overall Study|Physician Decision|0|||
44334273|NCT01114360|79338943|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
44334274|NCT01310036|79338963|FG000|Overall Study|Administrative/other|10|||
44432225|NCT00613509|79440598|FG001|Cycle 1|Unacceptable Toxicity|0|||
44432226|NCT00613509|79440597|FG000|Cycle 1|Other administrative reason|0|||
44432227|NCT00613509|79440598|FG001|Cycle 1|Other administrative reason|1|||
44157304|NCT01029366|78948809|FG001|Overall Study|Withdrawal by Subject|0|||
44157305|NCT01029366|78948808|FG000|Overall Study|Death|1|||
44157306|NCT01029366|78948809|FG001|Overall Study|Death|1|||
44157307|NCT01029366|78948808|FG000|Overall Study|disease progression|2|||
44157308|NCT01029366|78948809|FG001|Overall Study|disease progression|0|||
44157309|NCT01029366|78948808|FG000|Overall Study|manufacturing failure|0|||
44157310|NCT01029366|78948809|FG001|Overall Study|manufacturing failure|1|||
44157311|NCT00879086|78948818|FG000|Overall Study|Adverse Event|3|||
44157312|NCT00879086|78948819|FG001|Overall Study|Adverse Event|15|||
44157313|NCT00879086|78948818|FG000|Overall Study|Participant choice|2|||
44157314|NCT00879086|78948819|FG001|Overall Study|Participant choice|2|||
44157315|NCT00879086|78948818|FG000|Overall Study|Progression of disease|40|||
44157316|NCT00879086|78948819|FG001|Overall Study|Progression of disease|26|||
44157317|NCT00879086|78948818|FG000|Overall Study|Withdrawal of consent|2|||
44334275|NCT01310036|79338963|FG000|Overall Study|Withdrew Consent|11|||
44334276|NCT01310036|79338963|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
44334277|NCT01310036|79338963|FG000|Overall Study|Progression of Disease|164|||
44334278|NCT01310036|79338963|FG000|Overall Study|Death|1|||
44334279|NCT01310036|79338963|FG000|Overall Study|Adverse event or intercurrent illness|12|||
44334280|NCT01309100|79338967|FG000|Overall Study|Protocol Violation|1|||
44157318|NCT00879086|78948819|FG001|Overall Study|Withdrawal of consent|1|||
44157319|NCT00879086|78948818|FG000|Overall Study|Other|4|||
44157320|NCT00879086|78948819|FG001|Overall Study|Other|6|||
44157321|NCT00879086|78948818|FG000|Overall Study|Death|1|||
44157322|NCT00879086|78948819|FG001|Overall Study|Death|2|||
44157323|NCT00244933|78948835|FG000|Overall Study|Not response evaluable|2|||
44157324|NCT02637557|78948916|FG000|Overall Study|Adverse Event|3|||
44157325|NCT02637557|78948917|FG001|Overall Study|Adverse Event|1|||
44157326|NCT02637557|78948918|FG002|Overall Study|Adverse Event|3|||
44334281|NCT01309100|79338967|FG000|Overall Study|Positive Slit lamp finding|1|||
44334282|NCT01308788|79338976|FG000|2-year Treatment|medication change by treating physician|4|||
44334283|NCT01308788|79338977|FG001|2-year Treatment|medication change by treating physician|11|||
44432228|NCT00547300|79440623|FG000|Overall Study|Study was Administratively Terminated|25|||
44432229|NCT00547300|79440624|FG001|Overall Study|Study was Administratively Terminated|24|||
44432230|NCT00547300|79440623|FG000|Overall Study|Did not Meet Entry Criteria|0|||
44432231|NCT00547300|79440624|FG001|Overall Study|Did not Meet Entry Criteria|2|||
44432232|NCT00612807|79440632|FG000|Overall Study|Withdrawal by Subject|2|||
44432233|NCT00612807|79440633|FG001|Overall Study|Withdrawal by Subject|0|||
44432234|NCT00678210|79440643|FG000|Overall Study|Adverse Event|1|||
44432235|NCT00678210|79440644|FG001|Overall Study|Adverse Event|2|||
44432236|NCT00678210|79440645|FG002|Overall Study|Adverse Event|3|||
44432237|NCT00678210|79440646|FG003|Overall Study|Adverse Event|3|||
44432238|NCT00678210|79440643|FG000|Overall Study|Lack of Efficacy|2|||
44432239|NCT00678210|79440644|FG001|Overall Study|Lack of Efficacy|3|||
44432240|NCT00678210|79440645|FG002|Overall Study|Lack of Efficacy|1|||
44432241|NCT00678210|79440646|FG003|Overall Study|Lack of Efficacy|9|||
44432242|NCT00678210|79440643|FG000|Overall Study|Lost to Follow-up|4|||
44432243|NCT00678210|79440644|FG001|Overall Study|Lost to Follow-up|2|||
44432244|NCT00678210|79440645|FG002|Overall Study|Lost to Follow-up|0|||
44432245|NCT00678210|79440646|FG003|Overall Study|Lost to Follow-up|1|||
44432246|NCT00678210|79440643|FG000|Overall Study|Withdrawal by Subject|3|||
44432247|NCT00678210|79440644|FG001|Overall Study|Withdrawal by Subject|4|||
44432248|NCT00678210|79440645|FG002|Overall Study|Withdrawal by Subject|1|||
44432249|NCT00678210|79440646|FG003|Overall Study|Withdrawal by Subject|7|||
44157327|NCT02637557|78948919|FG003|Overall Study|Adverse Event|3|||
44432250|NCT00678210|79440643|FG000|Overall Study|Other|1|||
44432251|NCT00678210|79440644|FG001|Overall Study|Other|0|||
44432252|NCT00678210|79440645|FG002|Overall Study|Other|1|||
44432253|NCT00678210|79440646|FG003|Overall Study|Other|0|||
44432254|NCT00611715|79440658|FG000|Overall Study|Disease Progression|24|||
44432255|NCT00611715|79440659|FG001|Overall Study|Disease Progression|4|||
44432256|NCT00611715|79440658|FG000|Overall Study|Withdrawal by Subject|5|||
44334284|NCT01075321|79338983|FG000|Overall Study|Withdrawal by Subject|0|||
44432257|NCT00611715|79440659|FG001|Overall Study|Withdrawal by Subject|1|||
44432258|NCT00611715|79440658|FG000|Overall Study|Adverse Event|9|||
44432259|NCT00611715|79440659|FG001|Overall Study|Adverse Event|1|||
44432260|NCT00611715|79440658|FG000|Overall Study|Death|1|||
44157328|NCT02637557|78948916|FG000|Overall Study|Lost to Follow-up|1|||
44157329|NCT02637557|78948917|FG001|Overall Study|Lost to Follow-up|1|||
44157330|NCT02637557|78948918|FG002|Overall Study|Lost to Follow-up|0|||
44157331|NCT02637557|78948919|FG003|Overall Study|Lost to Follow-up|1|||
44157332|NCT02637557|78948916|FG000|Overall Study|Physician Decision|1|||
44157333|NCT02637557|78948917|FG001|Overall Study|Physician Decision|0|||
44157334|NCT02637557|78948918|FG002|Overall Study|Physician Decision|0|||
44432261|NCT00611715|79440659|FG001|Overall Study|Death|0|||
44432262|NCT00611715|79440658|FG000|Overall Study|two patients are still on treatment|2|||
44432263|NCT00611715|79440659|FG001|Overall Study|two patients are still on treatment|0|||
44432264|NCT00677820|79440673|FG000|Overall Study|Lost to Follow-up|1|||
44432265|NCT00677820|79440674|FG001|Overall Study|Lost to Follow-up|0|||
44432266|NCT00611559|79440683|FG000|Overall Study|Lost to Follow-up|0|||
44432267|NCT00611559|79440684|FG001|Overall Study|Lost to Follow-up|1|||
44432268|NCT00611559|79440685|FG002|Overall Study|Lost to Follow-up|0|||
44432269|NCT00611559|79440683|FG000|Overall Study|Protocol Violation|1|||
44432270|NCT00611559|79440684|FG001|Overall Study|Protocol Violation|0|||
44432271|NCT00611559|79440685|FG002|Overall Study|Protocol Violation|1|||
44432272|NCT00611247|79440695|FG000|Overall Study|Death|1|||
44432273|NCT00611247|79440696|FG001|Overall Study|Death|5|||
44432274|NCT00611247|79440695|FG000|Overall Study|Lack of Efficacy|1|||
44432275|NCT00611247|79440696|FG001|Overall Study|Lack of Efficacy|16|||
44432276|NCT00675948|79440705|FG000|Overall Study|Adverse Event|23|||
44432277|NCT00675948|79440706|FG001|Overall Study|Adverse Event|1|||
44432278|NCT00675948|79440705|FG000|Overall Study|Lack of Efficacy|3|||
44157335|NCT02637557|78948919|FG003|Overall Study|Physician Decision|0|||
44157336|NCT02637557|78948916|FG000|Overall Study|Protocol Violation|2|||
44157337|NCT02637557|78948917|FG001|Overall Study|Protocol Violation|0|||
44157338|NCT02637557|78948918|FG002|Overall Study|Protocol Violation|2|||
44157339|NCT02637557|78948919|FG003|Overall Study|Protocol Violation|1|||
44157340|NCT02637557|78948916|FG000|Overall Study|Withdrawal by Subject|1|||
44157341|NCT02637557|78948917|FG001|Overall Study|Withdrawal by Subject|3|||
44157342|NCT02637557|78948918|FG002|Overall Study|Withdrawal by Subject|4|||
44334285|NCT01075321|79338984|FG001|Overall Study|Withdrawal by Subject|0|||
44334286|NCT01075321|79338985|FG002|Overall Study|Withdrawal by Subject|1|||
44334287|NCT01075321|79338986|FG003|Overall Study|Withdrawal by Subject|1|||
44334288|NCT01075321|79338983|FG000|Overall Study|Protocol Violation|0|||
44334289|NCT01075321|79338984|FG001|Overall Study|Protocol Violation|0|||
44334290|NCT01075321|79338985|FG002|Overall Study|Protocol Violation|1|||
44334291|NCT01075321|79338986|FG003|Overall Study|Protocol Violation|0|||
44334292|NCT01075321|79338983|FG000|Overall Study|Treatment Incomplete due to progression|1|||
44334293|NCT01075321|79338984|FG001|Overall Study|Treatment Incomplete due to progression|0|||
44334294|NCT01075321|79338985|FG002|Overall Study|Treatment Incomplete due to progression|0|||
44334295|NCT01075321|79338986|FG003|Overall Study|Treatment Incomplete due to progression|0|||
44334296|NCT01075321|79338983|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
44334297|NCT01075321|79338984|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
44334298|NCT01075321|79338985|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
44334299|NCT01075321|79338986|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
44334300|NCT01114204|79339000|FG000|Overall Study|Adverse Event|3|||
44334301|NCT01114204|79339001|FG001|Overall Study|Adverse Event|2|||
44334302|NCT01114204|79339000|FG000|Overall Study|Lost to Follow-up|1|||
44334303|NCT01114204|79339001|FG001|Overall Study|Lost to Follow-up|0|||
44334304|NCT01114204|79339000|FG000|Overall Study|Withdrawal by Subject|10|||
44334305|NCT01114204|79339001|FG001|Overall Study|Withdrawal by Subject|6|||
44334306|NCT01114204|79339000|FG000|Overall Study|Death|1|||
44334307|NCT01114204|79339001|FG001|Overall Study|Death|0|||
44334308|NCT01114204|79339000|FG000|Overall Study|Other-Personal reasons|2|||
44334309|NCT01114204|79339001|FG001|Overall Study|Other-Personal reasons|0|||
44334310|NCT01114204|79339000|FG000|Overall Study|Other-Medical monitor request|1|||
44334311|NCT01114204|79339001|FG001|Overall Study|Other-Medical monitor request|0|||
44334312|NCT01114204|79339000|FG000|Overall Study|Other-Participant request|2|||
44334313|NCT01114204|79339001|FG001|Overall Study|Other-Participant request|0|||
44334314|NCT01114204|79339000|FG000|Overall Study|Other-Protocol Violation|1|||
44334315|NCT01114204|79339001|FG001|Overall Study|Other-Protocol Violation|0|||
44334316|NCT01075243|79339010|FG000|Overall Study|Lost to Follow-up|5|||
44334317|NCT01075243|79339011|FG001|Overall Study|Lost to Follow-up|2|||
44334318|NCT01075243|79339012|FG002|Overall Study|Lost to Follow-up|0|||
44432279|NCT00675948|79440706|FG001|Overall Study|Lack of Efficacy|0|||
44432280|NCT00675948|79440705|FG000|Overall Study|Withdrawal by Subject|7|||
44432281|NCT00675948|79440706|FG001|Overall Study|Withdrawal by Subject|0|||
44432282|NCT00675948|79440705|FG000|Overall Study|Lost to Follow-up|2|||
44432283|NCT00675948|79440706|FG001|Overall Study|Lost to Follow-up|0|||
44432284|NCT00675948|79440705|FG000|Overall Study|Protocol Violation|1|||
44432285|NCT00675948|79440706|FG001|Overall Study|Protocol Violation|0|||
44432286|NCT00675948|79440705|FG000|Overall Study|Pain under control|1|||
44432287|NCT00675948|79440706|FG001|Overall Study|Pain under control|0|||
44432288|NCT00675948|79440705|FG000|Overall Study|Sponsor decision|0|||
44334319|NCT01075243|79339010|FG000|Overall Study|Withdrawal by Subject|1|||
44334320|NCT01075243|79339011|FG001|Overall Study|Withdrawal by Subject|1|||
44432289|NCT00675948|79440706|FG001|Overall Study|Sponsor decision|1|||
44334321|NCT01075243|79339012|FG002|Overall Study|Withdrawal by Subject|0|||
44432290|NCT00675948|79440705|FG000|Overall Study|Patient died|1|||
44432291|NCT00675948|79440706|FG001|Overall Study|Patient died|0|||
44432292|NCT00675948|79440705|FG000|Overall Study|Patient unable to comply with diaries|1|||
44432293|NCT00675948|79440706|FG001|Overall Study|Patient unable to comply with diaries|0|||
44157343|NCT02637557|78948919|FG003|Overall Study|Withdrawal by Subject|2|||
44157344|NCT02638493|78948932|FG000|Overall Study|Inability to provide semen samples|2|||
44432294|NCT00675948|79440705|FG000|Overall Study|Patient feels unable to take medication|0|||
44432295|NCT00675948|79440706|FG001|Overall Study|Patient feels unable to take medication|1|||
44334322|NCT01308476|79339024|FG000|Overall Study|Lost to Follow-up|2|||
44334323|NCT01308476|79339025|FG001|Overall Study|Lost to Follow-up|2|||
44334324|NCT01308476|79339024|FG000|Overall Study|Other|1|||
44334325|NCT01308476|79339025|FG001|Overall Study|Other|0|||
44334326|NCT01078441|79339031|FG000|Overall Study|Withdrawal by Subject|1|||
44334327|NCT01308008|79339037|FG000|4 Weeks|Illness, disinterest, time|9|||
44334328|NCT01308008|79339038|FG001|4 Weeks|Illness, disinterest, time|2|||
44334329|NCT01113892|79339046|FG000|Overall Study|Lost to Follow-up|2|||
44432296|NCT00610935|79440715|FG000|Overall Study|Lost to Follow-up|0|||
44432297|NCT00610935|79440716|FG001|Overall Study|Lost to Follow-up|1|||
44432298|NCT00610935|79440715|FG000|Overall Study|Withdrawal by Subject|0|||
44432299|NCT00610935|79440716|FG001|Overall Study|Withdrawal by Subject|2|||
44432300|NCT00610935|79440715|FG000|Overall Study|Sponsor Discontinuation|1|||
44432301|NCT00610935|79440716|FG001|Overall Study|Sponsor Discontinuation|0|||
44432302|NCT00610857|79440731|FG000|Overall Study|Not evaluable for response|2|||
44432303|NCT00672984|79440738|FG000|First Intervention|Adverse Event|5|||
44432304|NCT00672984|79440739|FG001|First Intervention|Adverse Event|0|||
44432305|NCT00672984|79440740|FG002|First Intervention|Adverse Event|0|||
44432306|NCT00672984|79440738|FG000|First Intervention|Withdrawal by Subject|1|||
44432307|NCT00672984|79440739|FG001|First Intervention|Withdrawal by Subject|2|||
44432308|NCT00672984|79440740|FG002|First Intervention|Withdrawal by Subject|2|||
44334330|NCT01113892|79339047|FG001|Overall Study|Lost to Follow-up|2|||
44334331|NCT01113892|79339046|FG000|Overall Study|Withdrawal by Subject|1|||
44334332|NCT01113892|79339047|FG001|Overall Study|Withdrawal by Subject|1|||
44334333|NCT01113892|79339046|FG000|Overall Study|Death|2|||
44432309|NCT00672984|79440738|FG000|First Intervention|Sponsor decision|3|||
44432310|NCT00672984|79440739|FG001|First Intervention|Sponsor decision|0|||
44432311|NCT00672984|79440740|FG002|First Intervention|Sponsor decision|0|||
44432312|NCT00672984|79440738|FG000|Second Intervention|Non-compliance with facility policies|0|||
44432313|NCT00672984|79440739|FG001|Second Intervention|Non-compliance with facility policies|2|||
44432314|NCT00672984|79440740|FG002|Second Intervention|Non-compliance with facility policies|0|||
44432315|NCT00672984|79440738|FG000|Second Intervention|Withdrawal by Subject|0|||
44432316|NCT00672984|79440739|FG001|Second Intervention|Withdrawal by Subject|3|||
44432317|NCT00672984|79440740|FG002|Second Intervention|Withdrawal by Subject|0|||
44432318|NCT00672984|79440738|FG000|Second Intervention|Protocol Violation|0|||
44432319|NCT00672984|79440739|FG001|Second Intervention|Protocol Violation|1|||
44432320|NCT00672984|79440740|FG002|Second Intervention|Protocol Violation|1|||
44432321|NCT00672984|79440738|FG000|Third Intervention|Adverse Event|1|||
44334334|NCT01113892|79339047|FG001|Overall Study|Death|4|||
44334335|NCT01113892|79339046|FG000|Overall Study|Graft no longer evaluable|9|||
44334336|NCT01113892|79339047|FG001|Overall Study|Graft no longer evaluable|9|||
44334337|NCT01090063|79339053|FG000|Screen|Screen Failed|4|||
44334338|NCT01090063|79339053|FG000|Treatment|Withdrawal by Subject|4|||
44334339|NCT01113580|79339069|FG000|Overall Study|Protocol Violation|1|||
44539096|NCT03091400|79550599|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
44539097|NCT03091400|79550600|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
44539098|NCT01318993|79550606|FG000|Overall Study|Adverse Event|53|||
44334340|NCT01113580|79339070|FG001|Overall Study|Protocol Violation|0|||
44334341|NCT01306214|79339079|FG000|Overall Study|Death|0|||
44334342|NCT01306214|79339080|FG001|Overall Study|Death|0|||
44334343|NCT01306214|79339081|FG002|Overall Study|Death|1|||
44334344|NCT01306214|79339079|FG000|Overall Study|Lost to Follow-up|3|||
44432322|NCT00672984|79440739|FG001|Third Intervention|Adverse Event|0|||
44432323|NCT00672984|79440740|FG002|Third Intervention|Adverse Event|1|||
44432324|NCT00546364|79440753|FG000|Overall Study|Disease progression|5|||
44432325|NCT00546364|79440754|FG001|Overall Study|Disease progression|11|||
44539099|NCT01318993|79550606|FG000|Overall Study|Lack of Efficacy|121|||
44539100|NCT01318993|79550606|FG000|Overall Study|Protocol Violation|3|||
44539101|NCT01318993|79550606|FG000|Overall Study|Protocol based stopping criteria|6|||
44539102|NCT01318993|79550606|FG000|Overall Study|Study closed or terminated|174|||
44539103|NCT01318993|79550606|FG000|Overall Study|Lost to Follow-up|4|||
44432326|NCT00546364|79440755|FG002|Overall Study|Disease progression|8|||
44432327|NCT00546364|79440753|FG000|Overall Study|Completed and off treatment|1|||
44432328|NCT00546364|79440754|FG001|Overall Study|Completed and off treatment|0|||
44539104|NCT01318993|79550606|FG000|Overall Study|Physician Decision|13|||
44432329|NCT00546364|79440755|FG002|Overall Study|Completed and off treatment|2|||
44432330|NCT00546364|79440753|FG000|Overall Study|Administrative reason by sponsor|1|||
44432331|NCT00546364|79440754|FG001|Overall Study|Administrative reason by sponsor|0|||
44432332|NCT00546364|79440755|FG002|Overall Study|Administrative reason by sponsor|0|||
44539105|NCT01318993|79550606|FG000|Overall Study|Withdrawal by Subject|24|||
44157345|NCT02638493|78948933|FG001|Overall Study|Inability to provide semen samples|0|||
44157346|NCT02638493|78948934|FG002|Overall Study|Inability to provide semen samples|0|||
44157347|NCT02638337|78948944|FG000|Overall Study|Adverse Event|6|||
44334345|NCT01306214|79339080|FG001|Overall Study|Lost to Follow-up|5|||
44334346|NCT01306214|79339081|FG002|Overall Study|Lost to Follow-up|4|||
44157348|NCT02638337|78948945|FG001|Overall Study|Adverse Event|10|||
44334347|NCT01306214|79339079|FG000|Overall Study|Withdrawal by Subject|24|||
44334348|NCT01306214|79339080|FG001|Overall Study|Withdrawal by Subject|22|||
44334349|NCT01306214|79339081|FG002|Overall Study|Withdrawal by Subject|16|||
44334350|NCT01306214|79339079|FG000|Overall Study|Not treated|1|||
44432333|NCT00546364|79440753|FG000|Overall Study|Poor compliance/noncompliance|0|||
44432334|NCT00546364|79440754|FG001|Overall Study|Poor compliance/noncompliance|0|||
44432335|NCT00546364|79440755|FG002|Overall Study|Poor compliance/noncompliance|1|||
44432336|NCT00546364|79440753|FG000|Overall Study|No longer meets study criteria|1|||
44334351|NCT01306214|79339080|FG001|Overall Study|Not treated|1|||
44334352|NCT01306214|79339081|FG002|Overall Study|Not treated|1|||
44334353|NCT01077739|79339091|FG000|Overall Study|Premature withdrawal|1|||
44334354|NCT01077739|79339092|FG001|Overall Study|Premature withdrawal|3|||
44334355|NCT01077739|79339091|FG000|Overall Study|Withdrawal by Subject|1|||
44334356|NCT01077739|79339092|FG001|Overall Study|Withdrawal by Subject|0|||
44334357|NCT01077739|79339091|FG000|Overall Study|Death|0|||
44334358|NCT01077739|79339092|FG001|Overall Study|Death|3|||
44334359|NCT01077739|79339091|FG000|Overall Study|Unacceptable toxicity|1|||
44334360|NCT01077739|79339092|FG001|Overall Study|Unacceptable toxicity|2|||
44334361|NCT01077739|79339091|FG000|Overall Study|Other|2|||
44334362|NCT01077739|79339092|FG001|Overall Study|Other|2|||
44334363|NCT01306058|79339098|FG000|Overall Study|Death|1|||
44432337|NCT00546364|79440754|FG001|Overall Study|No longer meets study criteria|1|||
44432338|NCT00546364|79440755|FG002|Overall Study|No longer meets study criteria|0|||
44432339|NCT00546364|79440753|FG000|Overall Study|Withdrawal by Subject|5|||
44334364|NCT01306058|79339098|FG000|Overall Study|Enrolled but did not get treatment|1|||
44334365|NCT01305200|79339105|FG000|Overall Study|Physician Decision|4|||
44334366|NCT01305200|79339106|FG001|Overall Study|Physician Decision|6|||
44334367|NCT01305200|79339107|FG002|Overall Study|Physician Decision|1|||
44334368|NCT01305200|79339105|FG000|Overall Study|Withdrawal by Subject|24|||
44334369|NCT01305200|79339106|FG001|Overall Study|Withdrawal by Subject|21|||
44334370|NCT01305200|79339107|FG002|Overall Study|Withdrawal by Subject|1|||
44334371|NCT01305200|79339105|FG000|Overall Study|Ineligible|1|||
44334372|NCT01305200|79339106|FG001|Overall Study|Ineligible|2|||
44334373|NCT01305200|79339107|FG002|Overall Study|Ineligible|1|||
44334374|NCT01305200|79339105|FG000|Overall Study|Death|0|||
44334375|NCT01305200|79339106|FG001|Overall Study|Death|2|||
44432340|NCT00546364|79440754|FG001|Overall Study|Withdrawal by Subject|6|||
44334376|NCT01305200|79339107|FG002|Overall Study|Death|0|||
44334377|NCT01077271|79339117|FG000|Overall Study|Parental desire|8|||
44334378|NCT01077271|79339117|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
44334379|NCT01077271|79339117|FG000|Overall Study|Noncompliance|2|||
44334380|NCT01077271|79339117|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
44334381|NCT01077271|79339117|FG000|Overall Study|Changed doctors|2|||
44334382|NCT01077271|79339117|FG000|Overall Study|Parents thought too many injections|2|||
44334383|NCT01077271|79339117|FG000|Overall Study|End of RSV season nearly reached|1|||
44432341|NCT00546364|79440755|FG002|Overall Study|Withdrawal by Subject|3|||
44539106|NCT03090152|79550613|FG000|Overall Study|Withdrawal by Subject|0|||
44539107|NCT03090152|79550614|FG001|Overall Study|Withdrawal by Subject|2|||
44334384|NCT01077271|79339117|FG000|Overall Study|Mother unconvinced of the necessity|1|||
44334385|NCT01305044|79339131|FG000|Overall Study|Withdrawal by Subject|3|||
44334386|NCT01305044|79339132|FG001|Overall Study|Withdrawal by Subject|6|||
44334387|NCT01304498|79339140|FG000|Overall Study|Adverse Event|1|||
44334388|NCT01304498|79339141|FG001|Overall Study|Adverse Event|1|||
44334389|NCT01304498|79339140|FG000|Overall Study|Withdrawal by Subject|2|||
44334390|NCT01304498|79339141|FG001|Overall Study|Withdrawal by Subject|3|||
44334391|NCT01304498|79339140|FG000|Overall Study|Protocol Violation|1|||
44334392|NCT01304498|79339141|FG001|Overall Study|Protocol Violation|0|||
44334393|NCT01304498|79339140|FG000|Overall Study|Lost to Follow-up|2|||
44334394|NCT01304498|79339141|FG001|Overall Study|Lost to Follow-up|1|||
44432342|NCT00546364|79440753|FG000|Overall Study|Prior taxotere|1|||
44432343|NCT00546364|79440754|FG001|Overall Study|Prior taxotere|0|||
44539108|NCT03090152|79550615|FG002|Overall Study|Withdrawal by Subject|1|||
44157349|NCT02638337|78948944|FG000|Overall Study|Protocol Violation|3|||
44157350|NCT02638337|78948945|FG001|Overall Study|Protocol Violation|0|||
44334395|NCT01077193|79339147|FG000|Overall Study|Lost to Follow-up|1|||
44432344|NCT00546364|79440755|FG002|Overall Study|Prior taxotere|0|||
44157351|NCT02638337|78948944|FG000|Overall Study|Withdrawal by Subject|13|||
44334396|NCT01077193|79339147|FG000|Overall Study|Withdrawal by Subject|2|||
44334397|NCT01077193|79339147|FG000|Overall Study|Lack of Efficacy|1|||
44334398|NCT01077193|79339147|FG000|Overall Study|Study Terminated by Sponsor|40|||
44334399|NCT01074931|79339151|FG000|Overall Study|Economic reasons|1|||
44334400|NCT01074931|79339151|FG000|Overall Study|Death|5|||
44334401|NCT01303172|79339161|FG000|Overall Study|Physician Decision|9|||
44334402|NCT01303172|79339162|FG001|Overall Study|Physician Decision|6|||
44334403|NCT01303172|79339161|FG000|Overall Study|Adverse Event|5|||
44432345|NCT00546364|79440753|FG000|Overall Study|Mixed response|1|||
44432346|NCT00546364|79440754|FG001|Overall Study|Mixed response|0|||
44432347|NCT00546364|79440755|FG002|Overall Study|Mixed response|0|||
44334404|NCT01303172|79339162|FG001|Overall Study|Adverse Event|2|||
44432348|NCT00546364|79440753|FG000|Overall Study|Palliative treatment|1|||
44432349|NCT00546364|79440754|FG001|Overall Study|Palliative treatment|0|||
44432350|NCT00546364|79440755|FG002|Overall Study|Palliative treatment|1|||
44432351|NCT00546364|79440753|FG000|Overall Study|Target lesions resected|1|||
44432352|NCT00546364|79440754|FG001|Overall Study|Target lesions resected|0|||
44432353|NCT00546364|79440755|FG002|Overall Study|Target lesions resected|0|||
44432354|NCT00546364|79440753|FG000|Overall Study|Physician Decision|0|||
44432355|NCT00546364|79440754|FG001|Overall Study|Physician Decision|0|||
44334405|NCT01303172|79339161|FG000|Overall Study|Withdrawal by Subject|4|||
44334406|NCT01303172|79339162|FG001|Overall Study|Withdrawal by Subject|2|||
44334407|NCT01303172|79339161|FG000|Overall Study|Death|20|||
44334408|NCT01303172|79339162|FG001|Overall Study|Death|7|||
44334409|NCT01303172|79339161|FG000|Overall Study|Lack of Efficacy|25|||
44334410|NCT01303172|79339162|FG001|Overall Study|Lack of Efficacy|17|||
44334411|NCT01302938|79339171|FG000|Overall Study|Withdrawal by Subject|1|||
44334412|NCT01302938|79339172|FG001|Overall Study|Withdrawal by Subject|0|||
44334413|NCT01302938|79339171|FG000|Overall Study|Adverse Event|1|||
44334414|NCT01302938|79339172|FG001|Overall Study|Adverse Event|0|||
44334415|NCT01302548|79339181|FG000|Overall Study|Lost to Follow-up|2|||
44334416|NCT01302548|79339182|FG001|Overall Study|Lost to Follow-up|1|||
44432356|NCT00546364|79440755|FG002|Overall Study|Physician Decision|1|||
44432357|NCT00546364|79440753|FG000|Overall Study|Sponsor decision|0|||
44432358|NCT00546364|79440754|FG001|Overall Study|Sponsor decision|0|||
44432359|NCT00546364|79440755|FG002|Overall Study|Sponsor decision|1|||
44432360|NCT05020327|79440774|FG000|Overall Study|Physician Decision|3|||
44432361|NCT05020327|79440775|FG001|Overall Study|Physician Decision|0|||
44432362|NCT05020327|79440776|FG002|Overall Study|Physician Decision|0|||
44432363|NCT05020327|79440774|FG000|Overall Study|Withdrawal by Subject|1|||
44432364|NCT05020327|79440775|FG001|Overall Study|Withdrawal by Subject|1|||
44432365|NCT05020327|79440776|FG002|Overall Study|Withdrawal by Subject|0|||
44432366|NCT05020327|79440774|FG000|Overall Study|personal/cultural, ineligible|12|||
44432367|NCT05020327|79440775|FG001|Overall Study|personal/cultural, ineligible|0|||
44432368|NCT05020327|79440776|FG002|Overall Study|personal/cultural, ineligible|0|||
44432369|NCT04907032|79440790|FG000|Overall Study|Withdrawal by Subject|7|||
44432370|NCT04907032|79440791|FG001|Overall Study|Withdrawal by Subject|1|||
44432371|NCT04739709|79440812|FG000|Overall Study|Physician Decision|1|||
44432372|NCT04739709|79440813|FG001|Overall Study|Physician Decision|0|||
44432373|NCT04710927|79440830|FG000|Overall Study|Lost to Follow-up|7|||
44432374|NCT04710927|79440831|FG001|Overall Study|Lost to Follow-up|6|||
44432375|NCT04710927|79440832|FG002|Overall Study|Lost to Follow-up|5|||
44432376|NCT04657666|79440843|FG000|Period 1|Withdrawal of participant consent|2|||
44432377|NCT04657666|79440844|FG001|Period 1|Withdrawal of participant consent|1|||
44432378|NCT04657666|79440843|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
44432379|NCT04657666|79440844|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
44432380|NCT04657666|79440843|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
44432381|NCT04657666|79440844|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
44432382|NCT04657666|79440843|FG000|Period 2|Other|2|||
44432383|NCT04657666|79440844|FG001|Period 2|Other|0|||
44432384|NCT04657666|79440843|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
44432385|NCT04657666|79440844|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
44432386|NCT04495829|79440863|FG000|Overall Study|Lost to Follow-up|2|||
44432387|NCT04495829|79440863|FG000|Overall Study|Inclusion criterion not met|3|||
44432388|NCT04101721|79440878|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
44539109|NCT03090152|79550613|FG000|Overall Study|Surgery Canceled|1|||
44539110|NCT03090152|79550614|FG001|Overall Study|Surgery Canceled|0|||
44539111|NCT03090152|79550615|FG002|Overall Study|Surgery Canceled|0|||
44334417|NCT01076959|79339188|FG000|Overall Study|Adverse Event|767|||
44334418|NCT01076959|79339188|FG000|Overall Study|Lack of Efficacy|849|||
44334419|NCT01076959|79339188|FG000|Overall Study|Non-compliance|274|||
44334420|NCT01076959|79339188|FG000|Overall Study|Lost to Follow-up|241|||
44334421|NCT01076959|79339188|FG000|Overall Study|Other|119|||
44334422|NCT01302392|79339207|FG000|Overall Study|Lost to Follow-up|1|||
44334423|NCT01302392|79339208|FG001|Overall Study|Lost to Follow-up|0|||
44334424|NCT01302392|79339207|FG000|Overall Study|Withdrawal by Subject|6|||
44334425|NCT01302392|79339208|FG001|Overall Study|Withdrawal by Subject|1|||
44432389|NCT04101721|79440879|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
44432390|NCT04101721|79440878|FG000|Overall Study|Death|0|||
44334426|NCT01076647|79339216|FG000|Overall Study|Adverse Event|4|||
44334427|NCT01076647|79339217|FG001|Overall Study|Adverse Event|1|||
44432391|NCT04101721|79440879|FG001|Overall Study|Death|1|||
44432392|NCT04101721|79440878|FG000|Overall Study|Lost to Follow-up|0|||
44432393|NCT04101721|79440879|FG001|Overall Study|Lost to Follow-up|3|||
44432394|NCT03864926|79440887|FG000|Overall Study|Death|0|||
44432395|NCT03864926|79440888|FG001|Overall Study|Death|2|||
44432396|NCT03623243|79440903|FG000|Overall Study|Adverse Event|15|||
44432397|NCT03623243|79440903|FG000|Overall Study|Guardian Decision|1|||
44432398|NCT03623243|79440903|FG000|Overall Study|New Therapy for Study Indication|1|||
44432399|NCT03623243|79440903|FG000|Overall Study|Protocol Deviation|3|||
44432400|NCT03623243|79440903|FG000|Overall Study|Physician Decision|4|||
44432401|NCT03623243|79440903|FG000|Overall Study|Patient Decision|15|||
44334428|NCT01076647|79339216|FG000|Overall Study|Lack of Efficacy|0|||
44334429|NCT01076647|79339217|FG001|Overall Study|Lack of Efficacy|1|||
44432402|NCT03258853|79440909|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
44334430|NCT01076647|79339216|FG000|Overall Study|Protocol Violation|7|||
44334431|NCT01076647|79339217|FG001|Overall Study|Protocol Violation|9|||
44334432|NCT01076647|79339216|FG000|Overall Study|Withdrawal criteria|2|||
44334433|NCT01076647|79339217|FG001|Overall Study|Withdrawal criteria|2|||
44334434|NCT01076647|79339216|FG000|Overall Study|Unclassified|12|||
44334435|NCT01076647|79339217|FG001|Overall Study|Unclassified|12|||
44334436|NCT01074307|79339225|FG000|Overall Study|No primary endpoint evaluation|14|||
44432403|NCT03258853|79440910|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
44539112|NCT03090152|79550613|FG000|Overall Study|Epidural catheter could not be placed|0|||
44334437|NCT01074307|79339226|FG001|Overall Study|No primary endpoint evaluation|6|||
44334438|NCT01074307|79339225|FG000|Overall Study|Exclusion criterion|0|||
44334439|NCT01074307|79339226|FG001|Overall Study|Exclusion criterion|1|||
44334440|NCT01074307|79339225|FG000|Overall Study|Protocol Violation|8|||
44334441|NCT01074307|79339226|FG001|Overall Study|Protocol Violation|5|||
44334442|NCT01076335|79339232|FG000|Overall Study|Withdrawal by Subject|3|||
44334443|NCT01076335|79339232|FG000|Overall Study|Withdrawal without treatment|1|||
44334444|NCT01309737|79339239|FG000|Week 0 to 16|Death|1|||
44334445|NCT01309737|79339240|FG001|Week 0 to 16|Death|0|||
44334446|NCT01309737|79339241|FG002|Week 0 to 16|Death|1|||
44334447|NCT01309737|79339242|FG003|Week 0 to 16|Death|0|||
44334448|NCT01309737|79339243|FG004|Week 0 to 16|Death|0|||
44334449|NCT01309737|79339239|FG000|Week 0 to 16|Adverse Event|11|||
44334450|NCT01309737|79339240|FG001|Week 0 to 16|Adverse Event|10|||
44432404|NCT03006848|79440962|FG000|Overall Study|Adverse Event|1|||
44539113|NCT03090152|79550614|FG001|Overall Study|Epidural catheter could not be placed|2|||
44539114|NCT03090152|79550615|FG002|Overall Study|Epidural catheter could not be placed|0|||
44539115|NCT04252287|79550625|FG000|Overall Study|Death|5|||
44539116|NCT04252287|79550626|FG001|Overall Study|Death|3|||
44539117|NCT04252287|79550625|FG000|Overall Study|Lost to Follow-up|4|||
44539118|NCT04252287|79550626|FG001|Overall Study|Lost to Follow-up|6|||
44539119|NCT04252287|79550625|FG000|Overall Study|Withdrawal by Subject|19|||
44539120|NCT04252287|79550626|FG001|Overall Study|Withdrawal by Subject|16|||
44539121|NCT04252287|79550625|FG000|Overall Study|Protocol Violation|3|||
44539122|NCT04252287|79550626|FG001|Overall Study|Protocol Violation|4|||
44539123|NCT02735200|79550638|FG000|Overall Study|Lost to Follow-up|0|||
44539124|NCT02735200|79550639|FG001|Overall Study|Lost to Follow-up|5|||
44539125|NCT02735200|79550638|FG000|Overall Study|Withdrawal by Subject|8|||
44539126|NCT02735200|79550639|FG001|Overall Study|Withdrawal by Subject|0|||
44539127|NCT02946918|79550647|FG000|Overall Study|Patient unblinded himself|1|||
44539128|NCT02946918|79550648|FG001|Overall Study|Patient unblinded himself|0|||
44539129|NCT02946918|79550647|FG000|Overall Study|Physician Decision|0|||
44539130|NCT02946918|79550648|FG001|Overall Study|Physician Decision|2|||
44539131|NCT02946918|79550647|FG000|Overall Study|Ran out of study medication|0|||
44539132|NCT02946918|79550648|FG001|Overall Study|Ran out of study medication|1|||
44539133|NCT02734810|79550669|FG000|Overall Study|Adverse Event|1|||
44539134|NCT02734810|79550670|FG001|Overall Study|Adverse Event|0|||
44539135|NCT02734810|79550669|FG000|Overall Study|Lack of Efficacy|1|||
44539136|NCT02734810|79550670|FG001|Overall Study|Lack of Efficacy|0|||
44539137|NCT03656068|79550695|FG000|Overall Study|Withdrawal by Subject|4|||
44539138|NCT03656068|79550695|FG000|Overall Study|Adverse Event|1|||
44539139|NCT02944383|79550702|FG000|Overall Study|Lost to Follow-up|0|||
44539140|NCT02944383|79550703|FG001|Overall Study|Lost to Follow-up|0|||
44539141|NCT02944383|79550704|FG002|Overall Study|Lost to Follow-up|1|||
44539142|NCT02944383|79550702|FG000|Overall Study|Withdrawal by Subject|1|||
44539143|NCT02944383|79550703|FG001|Overall Study|Withdrawal by Subject|0|||
44334451|NCT01309737|79339241|FG002|Week 0 to 16|Adverse Event|5|||
44539144|NCT02944383|79550704|FG002|Overall Study|Withdrawal by Subject|0|||
44334452|NCT01309737|79339242|FG003|Week 0 to 16|Adverse Event|0|||
44539145|NCT03768089|79550732|FG000|Part A|Lost to Follow-up|0|||
44539146|NCT03768089|79550733|FG001|Part A|Lost to Follow-up|0|||
44539147|NCT03768089|79550734|FG002|Part A|Lost to Follow-up|0|||
44539148|NCT03768089|79550735|FG003|Part A|Lost to Follow-up|0|||
44539149|NCT03768089|79550736|FG004|Part A|Lost to Follow-up|1|||
44539150|NCT03768089|79550737|FG005|Part A|Lost to Follow-up|0|||
44539151|NCT03768089|79550738|FG006|Part A|Lost to Follow-up|0|||
44539152|NCT03768089|79550739|FG007|Part A|Lost to Follow-up|0|||
44539153|NCT03768089|79550740|FG008|Part A|Lost to Follow-up|0|||
44334453|NCT01309737|79339243|FG004|Week 0 to 16|Adverse Event|0|||
44334454|NCT01309737|79339239|FG000|Week 0 to 16|Lack of Efficacy|15|||
44334455|NCT01309737|79339240|FG001|Week 0 to 16|Lack of Efficacy|2|||
44334456|NCT01309737|79339241|FG002|Week 0 to 16|Lack of Efficacy|24|||
44334457|NCT01309737|79339242|FG003|Week 0 to 16|Lack of Efficacy|0|||
44334458|NCT01309737|79339243|FG004|Week 0 to 16|Lack of Efficacy|0|||
44432405|NCT03006848|79440962|FG000|Overall Study|Physician Decision|1|||
44432406|NCT03006848|79440962|FG000|Overall Study|Lack of Efficacy|16|||
44334459|NCT01309737|79339239|FG000|Week 0 to 16|Lost to Follow-up|7|||
44334460|NCT01309737|79339240|FG001|Week 0 to 16|Lost to Follow-up|8|||
44334461|NCT01309737|79339241|FG002|Week 0 to 16|Lost to Follow-up|3|||
44334462|NCT01309737|79339242|FG003|Week 0 to 16|Lost to Follow-up|0|||
44432407|NCT02810444|79441000|FG000|Overall Study|Screen Failures|14|||
44432408|NCT02810444|79441000|FG000|Overall Study|Withdrawal by Subject|4|||
44432409|NCT02810444|79441000|FG000|Overall Study|Adverse Event|3|||
44432410|NCT02501096|79441026|FG000|Overall Study|Lost to Follow-up|0|||
44432411|NCT02501096|79441027|FG001|Overall Study|Lost to Follow-up|0|||
44432412|NCT02501096|79441028|FG002|Overall Study|Lost to Follow-up|0|||
44432413|NCT02501096|79441029|FG003|Overall Study|Lost to Follow-up|0|||
44432414|NCT02501096|79441030|FG004|Overall Study|Lost to Follow-up|1|||
44432415|NCT02501096|79441031|FG005|Overall Study|Lost to Follow-up|1|||
44432416|NCT02501096|79441032|FG006|Overall Study|Lost to Follow-up|3|||
44432417|NCT02501096|79441033|FG007|Overall Study|Lost to Follow-up|0|||
44432418|NCT02501096|79441034|FG008|Overall Study|Lost to Follow-up|0|||
44334463|NCT01309737|79339243|FG004|Week 0 to 16|Lost to Follow-up|0|||
44334464|NCT01309737|79339239|FG000|Week 0 to 16|Withdrawal by Subject|7|||
44334465|NCT01309737|79339240|FG001|Week 0 to 16|Withdrawal by Subject|6|||
44334466|NCT01309737|79339241|FG002|Week 0 to 16|Withdrawal by Subject|7|||
44334467|NCT01309737|79339242|FG003|Week 0 to 16|Withdrawal by Subject|0|||
44334468|NCT01309737|79339243|FG004|Week 0 to 16|Withdrawal by Subject|0|||
44334469|NCT01309737|79339239|FG000|Week 0 to 16|Other|10|||
44334470|NCT01309737|79339240|FG001|Week 0 to 16|Other|14|||
44334471|NCT01309737|79339241|FG002|Week 0 to 16|Other|4|||
44334472|NCT01309737|79339242|FG003|Week 0 to 16|Other|0|||
44334473|NCT01309737|79339243|FG004|Week 0 to 16|Other|0|||
44334474|NCT01309737|79339239|FG000|Week 0 to 16|Randomized, but not treated|1|||
44334475|NCT01309737|79339240|FG001|Week 0 to 16|Randomized, but not treated|0|||
44334476|NCT01309737|79339241|FG002|Week 0 to 16|Randomized, but not treated|0|||
44334477|NCT01309737|79339242|FG003|Week 0 to 16|Randomized, but not treated|0|||
44334478|NCT01309737|79339243|FG004|Week 0 to 16|Randomized, but not treated|0|||
44432419|NCT02501096|79441026|FG000|Overall Study|Withdrawal by Subject|1|||
44432420|NCT02501096|79441027|FG001|Overall Study|Withdrawal by Subject|0|||
44432421|NCT02501096|79441028|FG002|Overall Study|Withdrawal by Subject|7|||
44432422|NCT02501096|79441029|FG003|Overall Study|Withdrawal by Subject|13|||
44432423|NCT02501096|79441030|FG004|Overall Study|Withdrawal by Subject|2|||
44432424|NCT02501096|79441031|FG005|Overall Study|Withdrawal by Subject|2|||
44334479|NCT01309737|79339239|FG000|Week 16 to 52|Death|0|||
44334480|NCT01309737|79339240|FG001|Week 16 to 52|Death|0|||
44334481|NCT01309737|79339241|FG002|Week 16 to 52|Death|0|||
44334482|NCT01309737|79339242|FG003|Week 16 to 52|Death|0|||
44432425|NCT02501096|79441032|FG006|Overall Study|Withdrawal by Subject|2|||
44432426|NCT02501096|79441033|FG007|Overall Study|Withdrawal by Subject|3|||
44432427|NCT02501096|79441034|FG008|Overall Study|Withdrawal by Subject|0|||
44432428|NCT02501096|79441026|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
44334483|NCT01309737|79339243|FG004|Week 16 to 52|Death|1|||
44334484|NCT01309737|79339239|FG000|Week 16 to 52|Adverse Event|7|||
44334485|NCT01309737|79339240|FG001|Week 16 to 52|Adverse Event|7|||
44334486|NCT01309737|79339241|FG002|Week 16 to 52|Adverse Event|0|||
44334487|NCT01309737|79339242|FG003|Week 16 to 52|Adverse Event|6|||
44334488|NCT01309737|79339243|FG004|Week 16 to 52|Adverse Event|5|||
44334489|NCT01309737|79339239|FG000|Week 16 to 52|Lack of Efficacy|107|||
44334490|NCT01309737|79339240|FG001|Week 16 to 52|Lack of Efficacy|76|||
44334491|NCT01309737|79339241|FG002|Week 16 to 52|Lack of Efficacy|0|||
44334492|NCT01309737|79339242|FG003|Week 16 to 52|Lack of Efficacy|25|||
44432429|NCT02501096|79441027|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
44432430|NCT02501096|79441028|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
44432431|NCT02501096|79441029|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
44432432|NCT02501096|79441030|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
44432433|NCT02501096|79441031|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
44432434|NCT02501096|79441032|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
44432435|NCT02501096|79441033|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
44432436|NCT02501096|79441034|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
44432437|NCT02501096|79441026|FG000|Overall Study|Death|1|||
44432438|NCT02501096|79441027|FG001|Overall Study|Death|1|||
44432439|NCT02501096|79441028|FG002|Overall Study|Death|88|||
44432440|NCT02501096|79441029|FG003|Overall Study|Death|74|||
44432441|NCT02501096|79441030|FG004|Overall Study|Death|15|||
44432442|NCT02501096|79441031|FG005|Overall Study|Death|16|||
44432443|NCT02501096|79441032|FG006|Overall Study|Death|15|||
44432444|NCT02501096|79441033|FG007|Overall Study|Death|16|||
44432445|NCT02501096|79441034|FG008|Overall Study|Death|1|||
44432446|NCT01633541|79441068|FG000|Overall Study|Death|1|||
44432447|NCT01633541|79441069|FG001|Overall Study|Death|0|||
44432448|NCT01466036|79441079|FG000|Overall Study|Death|1|||
44432449|NCT01466036|79441080|FG001|Overall Study|Death|1|||
44432450|NCT01466036|79441079|FG000|Overall Study|Physician Decision|0|||
44432451|NCT01466036|79441080|FG001|Overall Study|Physician Decision|4|||
44432452|NCT01466036|79441079|FG000|Overall Study|Adverse Event|2|||
44432453|NCT01466036|79441080|FG001|Overall Study|Adverse Event|6|||
44432454|NCT01466036|79441079|FG000|Overall Study|Withdrawal by Subject|2|||
44432455|NCT01466036|79441080|FG001|Overall Study|Withdrawal by Subject|8|||
44432456|NCT01466036|79441079|FG000|Overall Study|progression/relapse|14|||
44432457|NCT01466036|79441080|FG001|Overall Study|progression/relapse|21|||
44432458|NCT01466036|79441079|FG000|Overall Study|prolonged treatment delay|1|||
44432459|NCT01466036|79441080|FG001|Overall Study|prolonged treatment delay|1|||
44432460|NCT01399372|79441089|FG000|Overall Study|Protocol Violation|3|||
44432461|NCT01399372|79441090|FG001|Overall Study|Protocol Violation|1|||
44432462|NCT01063517|79441098|FG000|Overall Study|Consent withdrawal|1|||
44432463|NCT01063517|79441099|FG001|Overall Study|Consent withdrawal|0|||
44432464|NCT01063517|79441098|FG000|Overall Study|Study reached data cut-off|19|||
44432465|NCT01063517|79441099|FG001|Overall Study|Study reached data cut-off|7|||
44432466|NCT01063517|79441098|FG000|Overall Study|Lost to Follow-up|4|||
44432467|NCT01063517|79441099|FG001|Overall Study|Lost to Follow-up|3|||
44432468|NCT01063517|79441098|FG000|Overall Study|Withdrawal by Subject|1|||
44432469|NCT01063517|79441099|FG001|Overall Study|Withdrawal by Subject|2|||
44432470|NCT01063517|79441098|FG000|Overall Study|Death|33|||
44432471|NCT01063517|79441099|FG001|Overall Study|Death|48|||
44432472|NCT00920621|79441109|FG000|Overall Study|Lost to Follow-up|16|||
44432473|NCT00920621|79441110|FG001|Overall Study|Lost to Follow-up|17|||
44432474|NCT00920621|79441111|FG002|Overall Study|Lost to Follow-up|19|||
44432475|NCT00920621|79441112|FG003|Overall Study|Lost to Follow-up|21|||
44539154|NCT03768089|79550741|FG009|Part A|Lost to Follow-up|0|||
44539155|NCT03768089|79550742|FG010|Part A|Lost to Follow-up|0|||
44539156|NCT03768089|79550743|FG011|Part A|Lost to Follow-up|0|||
44539157|NCT03768089|79550744|FG012|Part A|Lost to Follow-up|0|||
44334493|NCT01309737|79339243|FG004|Week 16 to 52|Lack of Efficacy|21|||
44334494|NCT01309737|79339239|FG000|Week 16 to 52|Lost to Follow-up|4|||
44334495|NCT01309737|79339240|FG001|Week 16 to 52|Lost to Follow-up|2|||
44334496|NCT01309737|79339241|FG002|Week 16 to 52|Lost to Follow-up|0|||
44432476|NCT00920621|79441109|FG000|Overall Study|Fetal/neonatal deaths|16|||
44432477|NCT00920621|79441110|FG001|Overall Study|Fetal/neonatal deaths|14|||
44432478|NCT00920621|79441111|FG002|Overall Study|Fetal/neonatal deaths|16|||
44432479|NCT00920621|79441112|FG003|Overall Study|Fetal/neonatal deaths|14|||
44432480|NCT00920621|79441109|FG000|Overall Study|Blood sample not collected|22|||
44539158|NCT03768089|79550745|FG013|Part A|Lost to Follow-up|0|||
44334497|NCT01309737|79339242|FG003|Week 16 to 52|Lost to Follow-up|1|||
44334498|NCT01309737|79339243|FG004|Week 16 to 52|Lost to Follow-up|4|||
44432481|NCT00920621|79441110|FG001|Overall Study|Blood sample not collected|14|||
44432482|NCT00920621|79441111|FG002|Overall Study|Blood sample not collected|0|||
44432483|NCT00920621|79441112|FG003|Overall Study|Blood sample not collected|0|||
44432484|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
44432485|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
44432486|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
44432487|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
44432488|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
44432489|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
44432490|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
44432491|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
44432492|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
44432493|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
44432494|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
44432495|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
44432496|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
44432497|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
44432498|NCT00612105|79441125|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
44432499|NCT00612105|79441126|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
44432500|NCT00612105|79441125|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
44432501|NCT00612105|79441126|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
44432502|NCT00612105|79441125|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
44432503|NCT00612105|79441126|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
44432504|NCT00612105|79441125|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
44432505|NCT00612105|79441126|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
44432506|NCT00612105|79441125|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
44432507|NCT00612105|79441126|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
44432508|NCT00546052|79441132|FG000|Overall Study|Adverse Event|47|||
44432509|NCT00546052|79441132|FG000|Overall Study|Lost to Follow-up|144|||
44432510|NCT00546052|79441132|FG000|Overall Study|Protocol Violation|9|||
44432511|NCT00546052|79441132|FG000|Overall Study|Withdrawal by Subject|20|||
44432512|NCT00546052|79441132|FG000|Overall Study|Non Compliance|7|||
44432513|NCT00673920|79441147|FG000|Baseline up to Week 48|Withdrew consent|1|||
44432514|NCT00673920|79441148|FG001|Baseline up to Week 48|Withdrew consent|0|||
44432515|NCT00673920|79441149|FG002|Baseline up to Week 48|Withdrew consent|2|||
44432516|NCT00673920|79441150|FG003|Baseline up to Week 48|Withdrew consent|0|||
44432517|NCT00673920|79441151|FG004|Baseline up to Week 48|Withdrew consent|0|||
44432518|NCT00673920|79441152|FG005|Baseline up to Week 48|Withdrew consent|0|||
44432519|NCT00673920|79441153|FG006|Baseline up to Week 48|Withdrew consent|0|||
44432520|NCT00673920|79441154|FG007|Baseline up to Week 48|Withdrew consent|0|||
44432521|NCT00673920|79441147|FG000|Baseline up to Week 48|Refused treatment|1|||
44432522|NCT00673920|79441148|FG001|Baseline up to Week 48|Refused treatment|0|||
44432523|NCT00673920|79441149|FG002|Baseline up to Week 48|Refused treatment|0|||
44432524|NCT00673920|79441150|FG003|Baseline up to Week 48|Refused treatment|0|||
44432525|NCT00673920|79441151|FG004|Baseline up to Week 48|Refused treatment|0|||
44432526|NCT00673920|79441152|FG005|Baseline up to Week 48|Refused treatment|0|||
44432527|NCT00673920|79441153|FG006|Baseline up to Week 48|Refused treatment|0|||
44432528|NCT00673920|79441154|FG007|Baseline up to Week 48|Refused treatment|0|||
44539159|NCT03768089|79550746|FG014|Part A|Lost to Follow-up|0|||
44539160|NCT03768089|79550747|FG015|Part A|Lost to Follow-up|0|||
44334499|NCT01309737|79339239|FG000|Week 16 to 52|Withdrawal by Subject|5|||
44334500|NCT01309737|79339240|FG001|Week 16 to 52|Withdrawal by Subject|6|||
44334501|NCT01309737|79339241|FG002|Week 16 to 52|Withdrawal by Subject|0|||
44334502|NCT01309737|79339242|FG003|Week 16 to 52|Withdrawal by Subject|0|||
44334503|NCT01309737|79339243|FG004|Week 16 to 52|Withdrawal by Subject|2|||
44334504|NCT01309737|79339239|FG000|Week 16 to 52|Other|10|||
44334505|NCT01309737|79339240|FG001|Week 16 to 52|Other|12|||
44334506|NCT01309737|79339241|FG002|Week 16 to 52|Other|0|||
44334507|NCT01309737|79339242|FG003|Week 16 to 52|Other|2|||
44334508|NCT01309737|79339243|FG004|Week 16 to 52|Other|0|||
44334509|NCT01074229|79339269|FG000|Overall Study|Lost to Follow-up|1|||
44334510|NCT01074229|79339270|FG001|Overall Study|Lost to Follow-up|0|||
44334511|NCT01074229|79339271|FG002|Overall Study|Lost to Follow-up|0|||
44334512|NCT01074229|79339269|FG000|Overall Study|Change to open surgical procedure|1|||
44334513|NCT01074229|79339270|FG001|Overall Study|Change to open surgical procedure|3|||
44334514|NCT01074229|79339271|FG002|Overall Study|Change to open surgical procedure|4|||
44334515|NCT01106014|79339283|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
44334516|NCT01106014|79339284|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
44334517|NCT01106014|79339283|FG000|Overall Study|Adverse Event|78|||
44334518|NCT01106014|79339284|FG001|Overall Study|Adverse Event|42|||
44334519|NCT01106014|79339283|FG000|Overall Study|Withdrawal by Subject|43|||
44334520|NCT01106014|79339284|FG001|Overall Study|Withdrawal by Subject|37|||
44432529|NCT00673920|79441147|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
44432530|NCT00673920|79441148|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
44432531|NCT00673920|79441149|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
44334521|NCT01106014|79339283|FG000|Overall Study|Administrative reason|7|||
44334522|NCT01106014|79339284|FG001|Overall Study|Administrative reason|6|||
44334523|NCT01106014|79339283|FG000|Overall Study|Lost to Follow-up|2|||
44432532|NCT00673920|79441150|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
44432533|NCT00673920|79441151|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
44432534|NCT00673920|79441152|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
44432535|NCT00673920|79441153|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
44432536|NCT00673920|79441154|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
44432537|NCT00673920|79441147|FG000|Baseline up to Week 48|Protocol Violation|0|||
44432538|NCT00673920|79441148|FG001|Baseline up to Week 48|Protocol Violation|0|||
44432539|NCT00673920|79441149|FG002|Baseline up to Week 48|Protocol Violation|1|||
44432540|NCT00673920|79441150|FG003|Baseline up to Week 48|Protocol Violation|0|||
44432541|NCT00673920|79441151|FG004|Baseline up to Week 48|Protocol Violation|0|||
44432542|NCT00673920|79441152|FG005|Baseline up to Week 48|Protocol Violation|0|||
44432543|NCT00673920|79441153|FG006|Baseline up to Week 48|Protocol Violation|0|||
44539161|NCT03768089|79550748|FG016|Part A|Lost to Follow-up|0|||
44539162|NCT03768089|79550749|FG017|Part A|Lost to Follow-up|0|||
44539163|NCT03768089|79550732|FG000|Part C|Randomized, Never Dosed|0|||
44539164|NCT03768089|79550733|FG001|Part C|Randomized, Never Dosed|0|||
44334524|NCT01106014|79339284|FG001|Overall Study|Lost to Follow-up|3|||
44539165|NCT03768089|79550734|FG002|Part C|Randomized, Never Dosed|0|||
44334525|NCT01073605|79339293|FG000|Overall Study|Ongoing at Cutoff Date|1|||
44334526|NCT01073605|79339294|FG001|Overall Study|Ongoing at Cutoff Date|1|||
44334527|NCT01073605|79339295|FG002|Overall Study|Ongoing at Cutoff Date|0|||
44334528|NCT01073605|79339293|FG000|Overall Study|Adverse Event|2|||
44334529|NCT01073605|79339294|FG001|Overall Study|Adverse Event|1|||
44334530|NCT01073605|79339295|FG002|Overall Study|Adverse Event|0|||
44334531|NCT01073605|79339293|FG000|Overall Study|Lost to Follow-up|3|||
44334532|NCT01073605|79339294|FG001|Overall Study|Lost to Follow-up|4|||
44334533|NCT01073605|79339295|FG002|Overall Study|Lost to Follow-up|9|||
44334534|NCT01073605|79339293|FG000|Overall Study|Other|25|||
44334535|NCT01073605|79339294|FG001|Overall Study|Other|21|||
44334536|NCT01073605|79339295|FG002|Overall Study|Other|29|||
44334537|NCT01073605|79339293|FG000|Overall Study|Withdrawal by Subject|31|||
44334538|NCT01073605|79339294|FG001|Overall Study|Withdrawal by Subject|39|||
44334539|NCT01073605|79339295|FG002|Overall Study|Withdrawal by Subject|22|||
44334540|NCT01073605|79339293|FG000|Overall Study|Randomized But Not Treated|0|||
44334541|NCT01073605|79339294|FG001|Overall Study|Randomized But Not Treated|1|||
44334542|NCT01073605|79339295|FG002|Overall Study|Randomized But Not Treated|1|||
44334543|NCT01073293|79339305|FG000|Overall Study|Lost to Follow-up|0|||
44334544|NCT01073293|79339306|FG001|Overall Study|Lost to Follow-up|1|||
44334545|NCT01073293|79339305|FG000|Overall Study|Withdrawal by Subject|5|||
44334546|NCT01073293|79339306|FG001|Overall Study|Withdrawal by Subject|10|||
44334547|NCT01105936|79339312|FG000|Period 1|Adverse Event|0|||
44334548|NCT01105936|79339313|FG001|Period 1|Adverse Event|0|||
44334549|NCT01105936|79339314|FG002|Period 1|Adverse Event|0|||
44334550|NCT01105936|79339315|FG003|Period 1|Adverse Event|1|||
44334551|NCT01105936|79339312|FG000|Period 2|Adverse Event|1|||
44334552|NCT01105936|79339313|FG001|Period 2|Adverse Event|0|||
44334553|NCT01105936|79339314|FG002|Period 2|Adverse Event|0|||
44334554|NCT01105936|79339315|FG003|Period 2|Adverse Event|0|||
44334555|NCT01105936|79339312|FG000|Period 3|Protocol Violation|0|||
44334556|NCT01105936|79339313|FG001|Period 3|Protocol Violation|2|||
44334557|NCT01105936|79339314|FG002|Period 3|Protocol Violation|0|||
44334558|NCT01105936|79339315|FG003|Period 3|Protocol Violation|0|||
44334559|NCT01309659|79339326|FG000|Overall Study|Protocol Violation|0|||
44334560|NCT01309659|79339327|FG001|Overall Study|Protocol Violation|1|||
44334561|NCT01104766|79339337|FG000|Overall Study|Did not meet inc/exc criteria|1|||
44334562|NCT01104766|79339338|FG001|Overall Study|Did not meet inc/exc criteria|0|||
44334563|NCT01104766|79339339|FG002|Overall Study|Did not meet inc/exc criteria|0|||
44334564|NCT01104766|79339340|FG003|Overall Study|Did not meet inc/exc criteria|0|||
44334565|NCT01104766|79339337|FG000|Overall Study|Adverse Event|17|||
44334566|NCT01104766|79339338|FG001|Overall Study|Adverse Event|15|||
44334567|NCT01104766|79339339|FG002|Overall Study|Adverse Event|20|||
44334568|NCT01104766|79339340|FG003|Overall Study|Adverse Event|14|||
44334569|NCT01104766|79339337|FG000|Overall Study|Lack of Efficacy|20|||
44334570|NCT01104766|79339338|FG001|Overall Study|Lack of Efficacy|15|||
44334571|NCT01104766|79339339|FG002|Overall Study|Lack of Efficacy|14|||
44539166|NCT03768089|79550735|FG003|Part C|Randomized, Never Dosed|0|||
44539167|NCT03768089|79550736|FG004|Part C|Randomized, Never Dosed|0|||
44539168|NCT03768089|79550737|FG005|Part C|Randomized, Never Dosed|0|||
44334572|NCT01104766|79339340|FG003|Overall Study|Lack of Efficacy|8|||
44334573|NCT01104766|79339337|FG000|Overall Study|Protocol Violation|2|||
44334574|NCT01104766|79339338|FG001|Overall Study|Protocol Violation|0|||
44334575|NCT01104766|79339339|FG002|Overall Study|Protocol Violation|0|||
44334576|NCT01104766|79339340|FG003|Overall Study|Protocol Violation|0|||
44334577|NCT01104766|79339337|FG000|Overall Study|Withdrawal by Subject|17|||
44539169|NCT03768089|79550738|FG006|Part C|Randomized, Never Dosed|0|||
44334578|NCT01104766|79339338|FG001|Overall Study|Withdrawal by Subject|19|||
44334579|NCT01104766|79339339|FG002|Overall Study|Withdrawal by Subject|25|||
44334580|NCT01104766|79339340|FG003|Overall Study|Withdrawal by Subject|15|||
44334581|NCT01104766|79339337|FG000|Overall Study|Lost to Follow-up|1|||
44334582|NCT01104766|79339338|FG001|Overall Study|Lost to Follow-up|2|||
44334583|NCT01104766|79339339|FG002|Overall Study|Lost to Follow-up|1|||
44334584|NCT01104766|79339340|FG003|Overall Study|Lost to Follow-up|1|||
44334585|NCT01104376|79339350|FG000|Overall Study|Withdrawal by Subject|15|||
44334586|NCT01104376|79339350|FG000|Overall Study|Consented but excluded after labs|13|||
44334587|NCT01072357|79339356|FG000|Overall Study|Lost to Follow-up|0|||
44334588|NCT01072357|79339357|FG001|Overall Study|Lost to Follow-up|1|||
44432544|NCT00673920|79441154|FG007|Baseline up to Week 48|Protocol Violation|0|||
44432545|NCT00673920|79441147|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432546|NCT00673920|79441148|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432547|NCT00673920|79441149|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
44432548|NCT00673920|79441150|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432549|NCT00673920|79441151|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432550|NCT00673920|79441152|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432551|NCT00673920|79441153|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432552|NCT00673920|79441154|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
44432553|NCT00673920|79441147|FG000|Baseline up to Week 48|Administrative/Other|0|||
44432554|NCT00673920|79441148|FG001|Baseline up to Week 48|Administrative/Other|1|||
44432555|NCT00673920|79441149|FG002|Baseline up to Week 48|Administrative/Other|2|||
44432556|NCT00673920|79441150|FG003|Baseline up to Week 48|Administrative/Other|0|||
44432557|NCT00673920|79441151|FG004|Baseline up to Week 48|Administrative/Other|0|||
44432558|NCT00673920|79441152|FG005|Baseline up to Week 48|Administrative/Other|0|||
44432559|NCT00673920|79441153|FG006|Baseline up to Week 48|Administrative/Other|0|||
44432560|NCT00673920|79441154|FG007|Baseline up to Week 48|Administrative/Other|0|||
44432561|NCT00673920|79441147|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
44432562|NCT00673920|79441148|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
44432563|NCT00673920|79441149|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
44432564|NCT00673920|79441150|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
44432565|NCT00673920|79441151|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
44432566|NCT00673920|79441152|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
44432567|NCT00673920|79441153|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
44432568|NCT00673920|79441154|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
44432569|NCT00673920|79441147|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432570|NCT00673920|79441148|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432571|NCT00673920|79441149|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432572|NCT00673920|79441150|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432573|NCT00673920|79441151|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432574|NCT00673920|79441152|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432575|NCT00673920|79441153|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
44432576|NCT00673920|79441154|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
44432577|NCT00673920|79441147|FG000|Week 24 to Week 48|Failure to return|0|||
44432578|NCT00673920|79441148|FG001|Week 24 to Week 48|Failure to return|0|||
44432579|NCT00673920|79441149|FG002|Week 24 to Week 48|Failure to return|0|||
44432580|NCT00673920|79441150|FG003|Week 24 to Week 48|Failure to return|0|||
44432581|NCT00673920|79441151|FG004|Week 24 to Week 48|Failure to return|0|||
44432582|NCT00673920|79441152|FG005|Week 24 to Week 48|Failure to return|1|||
44432583|NCT00673920|79441153|FG006|Week 24 to Week 48|Failure to return|0|||
44432584|NCT00673920|79441154|FG007|Week 24 to Week 48|Failure to return|0|||
44432585|NCT00673920|79441147|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432586|NCT00673920|79441148|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432587|NCT00673920|79441149|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432588|NCT00673920|79441150|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432589|NCT00673920|79441151|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432590|NCT00673920|79441152|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
44432591|NCT00673920|79441153|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432592|NCT00673920|79441154|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
44432593|NCT00673920|79441147|FG000|Week 24 to Week 48|Death|0|||
44432594|NCT00673920|79441148|FG001|Week 24 to Week 48|Death|0|||
44432595|NCT00673920|79441149|FG002|Week 24 to Week 48|Death|0|||
44432596|NCT00673920|79441150|FG003|Week 24 to Week 48|Death|0|||
44334589|NCT01072201|79339365|FG000|Overall Study|Lost to Follow-up|0|||
44334590|NCT01072201|79339366|FG001|Overall Study|Lost to Follow-up|1|||
44334591|NCT01103362|79339372|FG000|Overall Study|study terminated|596|||
44432597|NCT00673920|79441151|FG004|Week 24 to Week 48|Death|0|||
44432598|NCT00673920|79441152|FG005|Week 24 to Week 48|Death|1|||
44432599|NCT00673920|79441153|FG006|Week 24 to Week 48|Death|0|||
44432600|NCT00673920|79441154|FG007|Week 24 to Week 48|Death|0|||
44334592|NCT01103284|79339378|FG000|Overall Study|Death|2|||
44334593|NCT01103284|79339379|FG001|Overall Study|Death|0|||
44334594|NCT01103284|79339378|FG000|Overall Study|Lost to Follow-up|9|||
44334595|NCT01103284|79339379|FG001|Overall Study|Lost to Follow-up|10|||
44432601|NCT00673920|79441147|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
44432602|NCT00673920|79441148|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
44432603|NCT00673920|79441149|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
44432604|NCT00673920|79441150|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
44432605|NCT00673920|79441151|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
44432606|NCT00673920|79441152|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
44432607|NCT00673920|79441153|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
44432608|NCT00673920|79441154|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
44432609|NCT00379795|79441181|FG000|Overall Study|Death|31|||
44432610|NCT00379795|79441182|FG001|Overall Study|Death|8|||
44432611|NCT00379795|79441183|FG002|Overall Study|Death|6|||
44432612|NCT00379795|79441184|FG003|Overall Study|Death|4|||
44432613|NCT00379795|79441185|FG004|Overall Study|Death|7|||
44432614|NCT00379795|79441181|FG000|Overall Study|Adverse Event|17|||
44432615|NCT00379795|79441182|FG001|Overall Study|Adverse Event|3|||
44432616|NCT00379795|79441183|FG002|Overall Study|Adverse Event|3|||
44432617|NCT00379795|79441184|FG003|Overall Study|Adverse Event|1|||
44432618|NCT00379795|79441185|FG004|Overall Study|Adverse Event|4|||
44432619|NCT00379795|79441181|FG000|Overall Study|Lost to Follow-up|8|||
44432620|NCT00379795|79441182|FG001|Overall Study|Lost to Follow-up|1|||
44334596|NCT01103284|79339378|FG000|Overall Study|Pregnancy|3|||
44334597|NCT01103284|79339379|FG001|Overall Study|Pregnancy|1|||
44334598|NCT01103284|79339378|FG000|Overall Study|Protocol Violation|12|||
44334599|NCT01103284|79339379|FG001|Overall Study|Protocol Violation|5|||
44334600|NCT01103284|79339378|FG000|Overall Study|Adverse Event|0|||
44334601|NCT01103284|79339379|FG001|Overall Study|Adverse Event|5|||
44334602|NCT01103284|79339378|FG000|Overall Study|Withdrawal by Subject|14|||
44432621|NCT00379795|79441183|FG002|Overall Study|Lost to Follow-up|2|||
44432622|NCT00379795|79441184|FG003|Overall Study|Lost to Follow-up|1|||
44432623|NCT00379795|79441185|FG004|Overall Study|Lost to Follow-up|4|||
44432624|NCT00379795|79441181|FG000|Overall Study|Physician Decision|25|||
44432625|NCT00379795|79441182|FG001|Overall Study|Physician Decision|0|||
44432626|NCT00379795|79441183|FG002|Overall Study|Physician Decision|2|||
44432627|NCT00379795|79441184|FG003|Overall Study|Physician Decision|2|||
44432628|NCT00379795|79441185|FG004|Overall Study|Physician Decision|2|||
44432629|NCT00379795|79441181|FG000|Overall Study|Withdrawal by Subject|94|||
44432630|NCT00379795|79441182|FG001|Overall Study|Withdrawal by Subject|11|||
44432631|NCT00379795|79441183|FG002|Overall Study|Withdrawal by Subject|19|||
44432632|NCT00379795|79441184|FG003|Overall Study|Withdrawal by Subject|7|||
44432633|NCT00379795|79441185|FG004|Overall Study|Withdrawal by Subject|14|||
44432634|NCT00379795|79441181|FG000|Overall Study|Subject non-compliance|7|||
44432635|NCT00379795|79441182|FG001|Overall Study|Subject non-compliance|2|||
44432636|NCT00379795|79441183|FG002|Overall Study|Subject non-compliance|0|||
44432637|NCT00379795|79441184|FG003|Overall Study|Subject non-compliance|0|||
44432638|NCT00379795|79441185|FG004|Overall Study|Subject non-compliance|1|||
44432639|NCT00379795|79441181|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
44432640|NCT00379795|79441182|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
44432641|NCT00379795|79441183|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
44334603|NCT01103284|79339379|FG001|Overall Study|Withdrawal by Subject|18|||
44432642|NCT00379795|79441184|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
44432643|NCT00379795|79441185|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
44432644|NCT00379795|79441181|FG000|Overall Study|Subjects condition mandated intervention|34|||
44432645|NCT00379795|79441182|FG001|Overall Study|Subjects condition mandated intervention|9|||
44432646|NCT00379795|79441183|FG002|Overall Study|Subjects condition mandated intervention|7|||
44432647|NCT00379795|79441184|FG003|Overall Study|Subjects condition mandated intervention|5|||
44432648|NCT00379795|79441185|FG004|Overall Study|Subjects condition mandated intervention|7|||
44432649|NCT00379795|79441181|FG000|Overall Study|Sponsor's decision|257|||
44539170|NCT03768089|79550739|FG007|Part C|Randomized, Never Dosed|0|||
44539171|NCT03768089|79550740|FG008|Part C|Randomized, Never Dosed|0|||
44539172|NCT03768089|79550741|FG009|Part C|Randomized, Never Dosed|0|||
44539173|NCT03768089|79550742|FG010|Part C|Randomized, Never Dosed|0|||
44539174|NCT03768089|79550743|FG011|Part C|Randomized, Never Dosed|0|||
44334604|NCT01103284|79339378|FG000|Overall Study|Dermal Hypersensitivity|0|||
44334605|NCT01103284|79339379|FG001|Overall Study|Dermal Hypersensitivity|1|||
44432650|NCT00379795|79441182|FG001|Overall Study|Sponsor's decision|17|||
44432651|NCT00379795|79441183|FG002|Overall Study|Sponsor's decision|54|||
44432652|NCT00379795|79441184|FG003|Overall Study|Sponsor's decision|47|||
44432653|NCT00379795|79441185|FG004|Overall Study|Sponsor's decision|10|||
44432654|NCT00610155|79441200|FG000|Period 1|Withdrawal by Subject|0|||
44539175|NCT03768089|79550744|FG012|Part C|Randomized, Never Dosed|0|||
44539176|NCT03768089|79550745|FG013|Part C|Randomized, Never Dosed|0|||
44432655|NCT00610155|79441201|FG001|Period 1|Withdrawal by Subject|0|||
44432656|NCT00610155|79441202|FG002|Period 1|Withdrawal by Subject|1|||
44432657|NCT00610155|79441203|FG003|Period 1|Withdrawal by Subject|0|||
44539177|NCT03768089|79550746|FG014|Part C|Randomized, Never Dosed|1|||
44539178|NCT03768089|79550747|FG015|Part C|Randomized, Never Dosed|0|||
44334606|NCT01103284|79339378|FG000|Overall Study|Termination by the Sponsor|0|||
44432658|NCT00610155|79441204|FG004|Period 1|Withdrawal by Subject|0|||
44432659|NCT00610155|79441205|FG005|Period 1|Withdrawal by Subject|0|||
44432660|NCT00610155|79441200|FG000|Period 3|Adverse Event|1|||
44432661|NCT00610155|79441201|FG001|Period 3|Adverse Event|0|||
44432662|NCT00610155|79441202|FG002|Period 3|Adverse Event|0|||
44432663|NCT00610155|79441203|FG003|Period 3|Adverse Event|0|||
44432664|NCT00610155|79441204|FG004|Period 3|Adverse Event|0|||
44432665|NCT00610155|79441205|FG005|Period 3|Adverse Event|0|||
44432666|NCT00674700|79441216|FG000|Year 1|Adverse Event|17|||
44432667|NCT00674700|79441217|FG001|Year 1|Adverse Event|20|||
44432668|NCT00674700|79441218|FG002|Year 1|Adverse Event|5|||
44432669|NCT00674700|79441216|FG000|Year 1|Withdrawal by Subject|7|||
44432670|NCT00674700|79441217|FG001|Year 1|Withdrawal by Subject|7|||
44432671|NCT00674700|79441218|FG002|Year 1|Withdrawal by Subject|6|||
44432672|NCT00674700|79441216|FG000|Year 1|Any other reason not above-mentioned|7|||
44432673|NCT00674700|79441217|FG001|Year 1|Any other reason not above-mentioned|7|||
44334607|NCT01103284|79339379|FG001|Overall Study|Termination by the Sponsor|1|||
44334608|NCT01103284|79339378|FG000|Overall Study|Not described|2|||
44334609|NCT01103284|79339379|FG001|Overall Study|Not described|1|||
44334610|NCT01103284|79339378|FG000|Overall Study|Missing CRF entries for study completion|0|||
44334611|NCT01103284|79339379|FG001|Overall Study|Missing CRF entries for study completion|2|||
44334612|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
44432674|NCT00674700|79441218|FG002|Year 1|Any other reason not above-mentioned|6|||
44432675|NCT00674700|79441216|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
44432676|NCT00674700|79441217|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
44432677|NCT00674700|79441218|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
44432678|NCT00674700|79441216|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
44432679|NCT00674700|79441217|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
44432680|NCT00674700|79441218|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
44432681|NCT00674700|79441216|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
44334613|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Off-label use|283|||
44334614|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
44334615|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
44334616|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
44334617|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
44334618|NCT01070953|79339385|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
44334619|NCT01070953|79339385|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
44334620|NCT01070953|79339385|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
44334621|NCT01070953|79339385|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
44334622|NCT01089361|79339397|FG000|Overall Study|Death|1|||
44334623|NCT01089361|79339398|FG001|Overall Study|Death|0|||
44334624|NCT01102972|79339408|FG000|Overall Study|Adverse Event|8|||
44432682|NCT00674700|79441217|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
44432683|NCT00674700|79441218|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
44432684|NCT00546910|79441228|FG000|Overall Study|Adverse Event|2|||
44432685|NCT00546910|79441229|FG001|Overall Study|Adverse Event|3|||
44334625|NCT01102972|79339409|FG001|Overall Study|Adverse Event|2|||
44334626|NCT01102972|79339408|FG000|Overall Study|Lack of Efficacy|2|||
44334627|NCT01102972|79339409|FG001|Overall Study|Lack of Efficacy|1|||
44334628|NCT01102972|79339408|FG000|Overall Study|Protocol Violation|1|||
44334629|NCT01102972|79339409|FG001|Overall Study|Protocol Violation|0|||
44334630|NCT01102972|79339408|FG000|Overall Study|Lost to Follow-up|10|||
44334631|NCT01102972|79339409|FG001|Overall Study|Lost to Follow-up|5|||
44334632|NCT01102972|79339408|FG000|Overall Study|Investigator Discretion|2|||
44334633|NCT01102972|79339409|FG001|Overall Study|Investigator Discretion|0|||
44334634|NCT01102972|79339408|FG000|Overall Study|Withdrawal by Subject|6|||
44432686|NCT00546910|79441228|FG000|Overall Study|Lack of Efficacy|5|||
44432687|NCT00546910|79441229|FG001|Overall Study|Lack of Efficacy|7|||
44432688|NCT00546910|79441228|FG000|Overall Study|Physician Decision|0|||
44432689|NCT00546910|79441229|FG001|Overall Study|Physician Decision|1|||
44432690|NCT00546910|79441228|FG000|Overall Study|Withdrawal by Subject|2|||
44432691|NCT00546910|79441229|FG001|Overall Study|Withdrawal by Subject|0|||
44432692|NCT00379639|79441240|FG000|Overall Study|Disease Progression|3|||
44432693|NCT00379639|79441241|FG001|Overall Study|Disease Progression|3|||
44432694|NCT00379639|79441242|FG002|Overall Study|Disease Progression|3|||
44432695|NCT00379639|79441243|FG003|Overall Study|Disease Progression|4|||
44432696|NCT00379639|79441244|FG004|Overall Study|Disease Progression|4|||
44432697|NCT00379639|79441240|FG000|Overall Study|Physician Decision|0|||
44432698|NCT00379639|79441241|FG001|Overall Study|Physician Decision|2|||
44432699|NCT00379639|79441242|FG002|Overall Study|Physician Decision|1|||
44432700|NCT00379639|79441243|FG003|Overall Study|Physician Decision|1|||
44432701|NCT00379639|79441244|FG004|Overall Study|Physician Decision|0|||
44432702|NCT00379639|79441240|FG000|Overall Study|Symptomatic Deterioration|0|||
44157352|NCT02638337|78948945|FG001|Overall Study|Withdrawal by Subject|16|||
44334635|NCT01102972|79339409|FG001|Overall Study|Withdrawal by Subject|6|||
44334636|NCT01309269|79339415|FG000|Overall Study|Adverse Event|56|||
44334637|NCT01309269|79339415|FG000|Overall Study|Withdrawal by Subject|25|||
44334638|NCT01309269|79339415|FG000|Overall Study|Lack of Acceptance|15|||
44334639|NCT01309269|79339415|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
44334640|NCT01309269|79339415|FG000|Overall Study|Kidney Transplant|25|||
44334641|NCT01309269|79339415|FG000|Overall Study|Administrative Problems|141|||
44334642|NCT01309269|79339415|FG000|Overall Study|Other|256|||
44334643|NCT01309269|79339415|FG000|Overall Study|Other|1|||
44334644|NCT01309269|79339415|FG000|Overall Study|Study Completion Data Not Recorded|95|||
44432703|NCT00379639|79441241|FG001|Overall Study|Symptomatic Deterioration|0|||
44432704|NCT00379639|79441242|FG002|Overall Study|Symptomatic Deterioration|1|||
44432705|NCT00379639|79441243|FG003|Overall Study|Symptomatic Deterioration|0|||
44432706|NCT00379639|79441244|FG004|Overall Study|Symptomatic Deterioration|1|||
44432707|NCT00379639|79441240|FG000|Overall Study|Adverse Event|0|||
44432708|NCT00379639|79441241|FG001|Overall Study|Adverse Event|0|||
44432709|NCT00379639|79441242|FG002|Overall Study|Adverse Event|1|||
44432710|NCT00379639|79441243|FG003|Overall Study|Adverse Event|0|||
44432711|NCT00379639|79441244|FG004|Overall Study|Adverse Event|1|||
44432712|NCT00379639|79441240|FG000|Overall Study|Lost to Follow-up|0|||
44432713|NCT00379639|79441241|FG001|Overall Study|Lost to Follow-up|0|||
44432714|NCT00379639|79441242|FG002|Overall Study|Lost to Follow-up|0|||
44432715|NCT00379639|79441243|FG003|Overall Study|Lost to Follow-up|1|||
44432716|NCT00379639|79441244|FG004|Overall Study|Lost to Follow-up|0|||
44432717|NCT00379639|79441240|FG000|Overall Study|Other|0|||
44432718|NCT00379639|79441241|FG001|Overall Study|Other|0|||
44432719|NCT00379639|79441242|FG002|Overall Study|Other|3|||
44539179|NCT03768089|79550748|FG016|Part C|Randomized, Never Dosed|0|||
44334645|NCT01309269|79339415|FG000|Overall Study|Enrolled but not Treated|107|||
44334646|NCT01088503|79339422|FG000|Overall Study|Withdrawal by Subject|118|||
44334647|NCT01088503|79339423|FG001|Overall Study|Withdrawal by Subject|327|||
44334648|NCT01088503|79339424|FG002|Overall Study|Withdrawal by Subject|10|||
44334649|NCT01088503|79339422|FG000|Overall Study|Death|64|||
44334650|NCT01088503|79339423|FG001|Overall Study|Death|358|||
44334651|NCT01088503|79339424|FG002|Overall Study|Death|7|||
44334652|NCT01087489|79339430|FG000|Overall Study|enrolled in another VA study|0|||
44334653|NCT01087489|79339431|FG001|Overall Study|enrolled in another VA study|1|||
44334654|NCT01087489|79339430|FG000|Overall Study|Death|0|||
44334655|NCT01087489|79339431|FG001|Overall Study|Death|1|||
44334656|NCT01087489|79339430|FG000|Overall Study|unable to survey by telephone|0|||
44334657|NCT01087489|79339431|FG001|Overall Study|unable to survey by telephone|1|||
44157353|NCT02638337|78948944|FG000|Overall Study|Lost to Follow-up|7|||
44334658|NCT01082965|79339439|FG000|Overall Study|Protocol Violation|0|||
44334659|NCT01082965|79339440|FG001|Overall Study|Protocol Violation|1|||
44334660|NCT01082965|79339439|FG000|Overall Study|Other|1|||
44334661|NCT01082965|79339440|FG001|Overall Study|Other|1|||
44334662|NCT01102426|79339448|FG000|Overall Study|Randomized but not treated|4|||
44334663|NCT01102426|79339449|FG001|Overall Study|Randomized but not treated|1|||
44334664|NCT01102426|79339448|FG000|Overall Study|Adverse Events (treatment-related)|15|||
44334665|NCT01102426|79339449|FG001|Overall Study|Adverse Events (treatment-related)|8|||
44334666|NCT01102426|79339448|FG000|Overall Study|Physician Decision|9|||
44334667|NCT01102426|79339449|FG001|Overall Study|Physician Decision|6|||
44334668|NCT01102426|79339448|FG000|Overall Study|Progressive Disease|85|||
44334669|NCT01102426|79339449|FG001|Overall Study|Progressive Disease|44|||
44334670|NCT01102426|79339448|FG000|Overall Study|Adverse Events (unrelated to|9|||
44334671|NCT01102426|79339449|FG001|Overall Study|Adverse Events (unrelated to|1|||
44334672|NCT01102426|79339448|FG000|Overall Study|Patient Refusal|24|||
44334673|NCT01102426|79339449|FG001|Overall Study|Patient Refusal|12|||
44334674|NCT01102426|79339448|FG000|Overall Study|Death (due to adverse events|0|||
44432720|NCT00379639|79441243|FG003|Overall Study|Other|0|||
44539180|NCT03768089|79550749|FG017|Part C|Randomized, Never Dosed|0|||
44539181|NCT03548584|79550807|FG000|Overall Study|Lost to Follow-up|0|||
44539182|NCT03548584|79550808|FG001|Overall Study|Lost to Follow-up|0|||
44539183|NCT03548584|79550809|FG002|Overall Study|Lost to Follow-up|1|||
44539184|NCT03548584|79550807|FG000|Overall Study|Adverse Event|1|||
44539185|NCT03548584|79550808|FG001|Overall Study|Adverse Event|11|||
44334675|NCT01102426|79339449|FG001|Overall Study|Death (due to adverse events|1|||
44334676|NCT01102426|79339448|FG000|Overall Study|Death (non-related to the study|19|||
44334677|NCT01102426|79339449|FG001|Overall Study|Death (non-related to the study|8|||
44334678|NCT01101334|79339457|FG000|Overall Study|Adverse Event|9|||
44334679|NCT01101334|79339458|FG001|Overall Study|Adverse Event|4|||
44432721|NCT00379639|79441244|FG004|Overall Study|Other|0|||
44432722|NCT03948334|79441258|FG000|Overall Study|Adverse Event|1|||
44539186|NCT03548584|79550809|FG002|Overall Study|Adverse Event|5|||
44334680|NCT01101334|79339457|FG000|Overall Study|Death|7|||
44539187|NCT03548584|79550807|FG000|Overall Study|Site Terminated by Sponsor|1|||
44334681|NCT01101334|79339458|FG001|Overall Study|Death|1|||
44432723|NCT03948334|79441259|FG001|Overall Study|Adverse Event|4|||
44432724|NCT03948334|79441258|FG000|Overall Study|Lack of Efficacy|2|||
44334682|NCT01101334|79339457|FG000|Overall Study|Withdrawal by Subject|4|||
44334683|NCT01101334|79339458|FG001|Overall Study|Withdrawal by Subject|3|||
44334684|NCT01101334|79339457|FG000|Overall Study|Withdrawal by Sponsor|1|||
44334685|NCT01101334|79339458|FG001|Overall Study|Withdrawal by Sponsor|1|||
44334686|NCT01101334|79339457|FG000|Overall Study|Progressive Disease|22|||
44334687|NCT01101334|79339458|FG001|Overall Study|Progressive Disease|35|||
44334688|NCT01101334|79339457|FG000|Overall Study|Other|2|||
44334689|NCT01101334|79339458|FG001|Overall Study|Other|1|||
44334690|NCT01327547|79339466|FG000|Overall Study|Adverse Event|4|||
44334691|NCT01327547|79339467|FG001|Overall Study|Adverse Event|1|||
44334692|NCT01327547|79339466|FG000|Overall Study|Death|1|||
44334693|NCT01327547|79339467|FG001|Overall Study|Death|2|||
44334694|NCT01327547|79339466|FG000|Overall Study|Lost to Follow-up|6|||
44432725|NCT03948334|79441259|FG001|Overall Study|Lack of Efficacy|0|||
44432726|NCT03948334|79441258|FG000|Overall Study|Lost to Follow-up|1|||
44539188|NCT03548584|79550808|FG001|Overall Study|Site Terminated by Sponsor|3|||
44334695|NCT01327547|79339467|FG001|Overall Study|Lost to Follow-up|6|||
44334696|NCT01327547|79339466|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
44334697|NCT01327547|79339467|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
44334698|NCT01327547|79339466|FG000|Overall Study|Withdrawal by Subject|3|||
44539189|NCT03548584|79550809|FG002|Overall Study|Site Terminated by Sponsor|2|||
44539190|NCT03548584|79550807|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
44539191|NCT03548584|79550808|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
44539192|NCT03548584|79550809|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
44539193|NCT03548584|79550807|FG000|Overall Study|Lack of Efficacy|0|||
44539194|NCT03548584|79550808|FG001|Overall Study|Lack of Efficacy|1|||
44539195|NCT03548584|79550809|FG002|Overall Study|Lack of Efficacy|0|||
44539196|NCT03548584|79550807|FG000|Overall Study|Non-compliance with Study Drug|0|||
44539197|NCT03548584|79550808|FG001|Overall Study|Non-compliance with Study Drug|1|||
44539198|NCT03548584|79550809|FG002|Overall Study|Non-compliance with Study Drug|0|||
44539199|NCT03548584|79550807|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
44539200|NCT03548584|79550808|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
44539201|NCT03548584|79550809|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
44539202|NCT03086330|79550822|FG000|Overall Study|Withdrawal by Subject|3|||
44539203|NCT03086330|79550823|FG001|Overall Study|Withdrawal by Subject|2|||
44539204|NCT03086330|79550822|FG000|Overall Study|Lost to Follow-up|1|||
44539205|NCT03086330|79550823|FG001|Overall Study|Lost to Follow-up|2|||
44539206|NCT02943993|79550855|FG000|Overall Study|Withdrawal by Subject|52|||
44539207|NCT02943993|79550855|FG000|Overall Study|Transfer to another institution|6|||
44539208|NCT02943993|79550855|FG000|Overall Study|Lost to Follow-up|135|||
44539209|NCT02943993|79550855|FG000|Overall Study|Death|98|||
44539210|NCT02943993|79550855|FG000|Overall Study|Other reason for premature termination|32|||
44539211|NCT02943993|79550855|FG000|Overall Study|Missing reason for termination|7|||
44539212|NCT02943447|79550879|FG000|Blinded Study Phase|Withdrew Consent|1|||
44539213|NCT02943447|79550880|FG001|Blinded Study Phase|Withdrew Consent|2|||
44539214|NCT02943447|79550881|FG002|Blinded Study Phase|Withdrew Consent|1|||
44539215|NCT02943447|79550879|FG000|Blinded Study Phase|Adverse Event|3|||
44539216|NCT02943447|79550880|FG001|Blinded Study Phase|Adverse Event|0|||
44539217|NCT02943447|79550881|FG002|Blinded Study Phase|Adverse Event|0|||
44539218|NCT02943447|79550879|FG000|Blinded Study Phase|Investigator's discretion|1|||
44539219|NCT02943447|79550880|FG001|Blinded Study Phase|Investigator's discretion|0|||
44539220|NCT02943447|79550881|FG002|Blinded Study Phase|Investigator's discretion|0|||
44539221|NCT02943447|79550879|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
44539222|NCT02943447|79550880|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
44539223|NCT02943447|79550881|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
44539224|NCT02943447|79550879|FG000|Open-Label Extension Phase|Adverse Event|4|||
44539225|NCT02943447|79550880|FG001|Open-Label Extension Phase|Adverse Event|7|||
44539226|NCT02943447|79550881|FG002|Open-Label Extension Phase|Adverse Event|3|||
44539227|NCT02943447|79550879|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
44539228|NCT02943447|79550880|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
44539229|NCT02943447|79550881|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
44334699|NCT01327547|79339467|FG001|Overall Study|Withdrawal by Subject|7|||
44539230|NCT02943447|79550879|FG000|Open-Label Extension Phase|Withdrew consent|1|||
44539231|NCT02943447|79550880|FG001|Open-Label Extension Phase|Withdrew consent|1|||
44539232|NCT02943447|79550881|FG002|Open-Label Extension Phase|Withdrew consent|1|||
44539233|NCT02943447|79550879|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
44539234|NCT02943447|79550880|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
44539235|NCT02943447|79550881|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
44334700|NCT01327547|79339466|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
44334701|NCT01327547|79339467|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
44432727|NCT03948334|79441259|FG001|Overall Study|Lost to Follow-up|0|||
44334702|NCT01327547|79339466|FG000|Overall Study|Protocol Violation|1|||
44334703|NCT01327547|79339467|FG001|Overall Study|Protocol Violation|0|||
44334704|NCT01327547|79339466|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
44334705|NCT01327547|79339467|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
44334706|NCT01327547|79339466|FG000|Overall Study|Required prohibited medication|2|||
44334707|NCT01327547|79339467|FG001|Overall Study|Required prohibited medication|0|||
44334708|NCT01327547|79339466|FG000|Overall Study|Non-compliance with study procedures|1|||
44334709|NCT01327547|79339467|FG001|Overall Study|Non-compliance with study procedures|0|||
44334710|NCT01327547|79339466|FG000|Overall Study|By investigator in subject's interest|0|||
44334711|NCT01327547|79339467|FG001|Overall Study|By investigator in subject's interest|1|||
44334712|NCT01308567|79339489|FG000|Overall Study|Lost to Follow-up|2|||
44334713|NCT01308567|79339490|FG001|Overall Study|Lost to Follow-up|4|||
44334714|NCT01308567|79339491|FG002|Overall Study|Lost to Follow-up|4|||
44334715|NCT01307319|79339502|FG000|Overall Study|Adverse Event|2|||
44334716|NCT01307319|79339503|FG001|Overall Study|Adverse Event|2|||
44334717|NCT01307319|79339504|FG002|Overall Study|Adverse Event|1|||
44334718|NCT01307319|79339502|FG000|Overall Study|Lost to Follow-up|1|||
44334719|NCT01307319|79339503|FG001|Overall Study|Lost to Follow-up|0|||
44334720|NCT01307319|79339504|FG002|Overall Study|Lost to Follow-up|1|||
44334721|NCT01307319|79339502|FG000|Overall Study|Protocol Violation|1|||
44334722|NCT01307319|79339503|FG001|Overall Study|Protocol Violation|1|||
44334723|NCT01307319|79339504|FG002|Overall Study|Protocol Violation|0|||
44334724|NCT01307319|79339502|FG000|Overall Study|Withdrawal by Subject|0|||
44432728|NCT03948334|79441258|FG000|Overall Study|Physician Decision|1|||
44432729|NCT03948334|79441259|FG001|Overall Study|Physician Decision|0|||
44432730|NCT03948334|79441258|FG000|Overall Study|Pregnancy|0|||
44432731|NCT03948334|79441259|FG001|Overall Study|Pregnancy|1|||
44432732|NCT03948334|79441258|FG000|Overall Study|Protocol Deviation|1|||
44432733|NCT03948334|79441259|FG001|Overall Study|Protocol Deviation|0|||
44432734|NCT03948334|79441258|FG000|Overall Study|Study terminated by Sponsor|50|||
44432735|NCT03948334|79441259|FG001|Overall Study|Study terminated by Sponsor|51|||
44432736|NCT03948334|79441258|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
44432737|NCT03948334|79441259|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
44432738|NCT00609765|79441273|FG000|Overall Study|Study ended prior to 12 months|1|||
44432739|NCT00608829|79441277|FG000|Overall Study|Death|6|||
44432740|NCT00608829|79441277|FG000|Overall Study|Withdrawal by Subject|4|||
44432741|NCT00608829|79441277|FG000|Overall Study|Subject refuses to follow up or return.|5|||
44432742|NCT00545818|79441283|FG000|Overall Study|Protocol Violation|1|||
44432743|NCT00545818|79441284|FG001|Overall Study|Protocol Violation|0|||
44432744|NCT00545818|79441283|FG000|Overall Study|Adverse Event|1|||
44432745|NCT00545818|79441284|FG001|Overall Study|Adverse Event|1|||
44334725|NCT01307319|79339503|FG001|Overall Study|Withdrawal by Subject|1|||
44334726|NCT01307319|79339504|FG002|Overall Study|Withdrawal by Subject|2|||
44334727|NCT01307319|79339502|FG000|Overall Study|Other|0|||
44334728|NCT01307319|79339503|FG001|Overall Study|Other|4|||
44432746|NCT00545818|79441283|FG000|Overall Study|Lost to Follow-up|1|||
44432747|NCT00545818|79441284|FG001|Overall Study|Lost to Follow-up|6|||
44432748|NCT00674154|79441292|FG000|Overall Study|Withdrawal by Subject|3|||
44432749|NCT00674154|79441293|FG001|Overall Study|Withdrawal by Subject|1|||
44539236|NCT02844777|79550910|FG000|Overall Study|Withdrawal by Subject|2|||
44539237|NCT02844777|79550911|FG001|Overall Study|Withdrawal by Subject|0|||
44539238|NCT02844777|79550912|FG002|Overall Study|Withdrawal by Subject|0|||
44539239|NCT02612337|79550922|FG000|Overall Study|Lack of Efficacy|1|||
44539240|NCT02612337|79550923|FG001|Overall Study|Lack of Efficacy|0|||
44539241|NCT02612337|79550922|FG000|Overall Study|Withdrawal by Subject|2|||
44539242|NCT02612337|79550923|FG001|Overall Study|Withdrawal by Subject|2|||
44539243|NCT02612337|79550922|FG000|Overall Study|Did not receive study drug|0|||
44539244|NCT02612337|79550923|FG001|Overall Study|Did not receive study drug|1|||
44539245|NCT03532451|79550937|FG000|Overall Study|Withdrawal by Subject|0|||
44539246|NCT03532451|79550938|FG001|Overall Study|Withdrawal by Subject|1|||
44539247|NCT03532451|79550937|FG000|Overall Study|Progression prior to the surgery|1|||
44539248|NCT03532451|79550938|FG001|Overall Study|Progression prior to the surgery|0|||
44539249|NCT03085238|79550944|FG000|Overall Study|Adverse Event|2|||
44157354|NCT02638337|78948945|FG001|Overall Study|Lost to Follow-up|7|||
44157355|NCT02638337|78948944|FG000|Overall Study|Other - Miscellaneous|4|||
44334729|NCT01307319|79339504|FG002|Overall Study|Other|3|||
44334730|NCT01080391|79339514|FG000|Overall Study|Randomized but not treated|7|||
44334731|NCT01080391|79339515|FG001|Overall Study|Randomized but not treated|4|||
44432750|NCT00674154|79441292|FG000|Overall Study|Did not want parathyroidectomy|0|||
44432751|NCT00674154|79441293|FG001|Overall Study|Did not want parathyroidectomy|2|||
44432752|NCT00608517|79441302|FG000|Overall Study|Death|1|||
44539250|NCT03085238|79550944|FG000|Overall Study|Death|2|||
44539251|NCT03383666|79550957|FG000|Overall Study|Withdrawal by Subject|2|||
44334732|NCT01070329|79339523|FG000|Overall Study|Adverse Event|13|||
44432753|NCT00608517|79441303|FG001|Overall Study|Death|0|||
44432754|NCT00608517|79441304|FG002|Overall Study|Death|0|||
44539252|NCT03383666|79550957|FG000|Overall Study|Lost to Follow-up|2|||
44334733|NCT01070329|79339524|FG001|Overall Study|Adverse Event|10|||
44334734|NCT01070329|79339523|FG000|Overall Study|Lost to Follow-up|22|||
44334735|NCT01070329|79339524|FG001|Overall Study|Lost to Follow-up|12|||
44334736|NCT01070329|79339523|FG000|Overall Study|Withdrawal by Subject|9|||
44334737|NCT01070329|79339524|FG001|Overall Study|Withdrawal by Subject|11|||
44334738|NCT01070329|79339523|FG000|Overall Study|Protocol Violation|3|||
44334739|NCT01070329|79339524|FG001|Overall Study|Protocol Violation|8|||
44334740|NCT01070329|79339523|FG000|Overall Study|Lack of Efficacy|2|||
44334741|NCT01070329|79339524|FG001|Overall Study|Lack of Efficacy|6|||
44334742|NCT01070329|79339523|FG000|Overall Study|Physician Decision|2|||
44334743|NCT01070329|79339524|FG001|Overall Study|Physician Decision|1|||
44334744|NCT01070329|79339523|FG000|Overall Study|Entry Criteria Not Met|1|||
44334745|NCT01070329|79339524|FG001|Overall Study|Entry Criteria Not Met|0|||
44334746|NCT01070329|79339523|FG000|Overall Study|Sponsor Decision|0|||
44334747|NCT01070329|79339524|FG001|Overall Study|Sponsor Decision|1|||
44334748|NCT01069861|79339530|FG000|Overall Study|Death|1|||
44334749|NCT01069861|79339530|FG000|Overall Study|Adverse Event|1|||
44334750|NCT01069861|79339530|FG000|Overall Study|Did not meet entrance criteria|1|||
44334751|NCT01306929|79339534|FG000|Overall Study|Withdrawal by Subject|23|||
44334752|NCT01306929|79339534|FG000|Overall Study|Adverse Event|21|||
44334753|NCT01306929|79339534|FG000|Overall Study|Physician Decision|13|||
44334754|NCT01306929|79339534|FG000|Overall Study|Death|8|||
44334755|NCT01306929|79339534|FG000|Overall Study|Withdrawal by parent/guardian|5|||
44334756|NCT01306929|79339534|FG000|Overall Study|Protocol Violation|3|||
44334757|NCT01306929|79339534|FG000|Overall Study|Non-compliance with study drug|2|||
44334758|NCT01306929|79339534|FG000|Overall Study|Lost to Follow-up|2|||
44334759|NCT01306929|79339534|FG000|Overall Study|Various|17|||
44334760|NCT01064401|79339540|FG000|Overall Study|Adverse Event|47|||
44334761|NCT01064401|79339541|FG001|Overall Study|Adverse Event|56|||
44334762|NCT01064401|79339540|FG000|Overall Study|Lack of Efficacy|46|||
44334763|NCT01064401|79339541|FG001|Overall Study|Lack of Efficacy|23|||
44334764|NCT01064401|79339540|FG000|Overall Study|Lost to Follow-up|12|||
44334765|NCT01064401|79339541|FG001|Overall Study|Lost to Follow-up|9|||
44334766|NCT01064401|79339540|FG000|Overall Study|Consent Withdrawn|98|||
44334767|NCT01064401|79339541|FG001|Overall Study|Consent Withdrawn|80|||
44334768|NCT01064401|79339540|FG000|Overall Study|Investigator Decision|4|||
44334769|NCT01064401|79339541|FG001|Overall Study|Investigator Decision|6|||
44334770|NCT01064401|79339540|FG000|Overall Study|Death|4|||
44334771|NCT01064401|79339541|FG001|Overall Study|Death|0|||
44334772|NCT01064401|79339540|FG000|Overall Study|Pregnancy|4|||
44334773|NCT01064401|79339541|FG001|Overall Study|Pregnancy|7|||
44334774|NCT01064401|79339540|FG000|Overall Study|Noncompliance|7|||
44334775|NCT01064401|79339541|FG001|Overall Study|Noncompliance|8|||
44334776|NCT01064401|79339540|FG000|Overall Study|Site Closure|4|||
44334777|NCT01064401|79339541|FG001|Overall Study|Site Closure|5|||
44334778|NCT01064401|79339540|FG000|Overall Study|Other|2|||
44334779|NCT01064401|79339541|FG001|Overall Study|Other|1|||
44334780|NCT01306617|79339551|FG000|Overall Study|Adverse Event|1|||
44334781|NCT01306617|79339552|FG001|Overall Study|Adverse Event|0|||
44334782|NCT01306617|79339553|FG002|Overall Study|Adverse Event|0|||
44334783|NCT01306617|79339551|FG000|Overall Study|Virologic Failure|0|||
44334784|NCT01306617|79339552|FG001|Overall Study|Virologic Failure|0|||
44334785|NCT01306617|79339553|FG002|Overall Study|Virologic Failure|5|||
44334786|NCT01306617|79339551|FG000|Overall Study|Non-compliance|0|||
44334787|NCT01306617|79339552|FG001|Overall Study|Non-compliance|1|||
44334788|NCT01306617|79339553|FG002|Overall Study|Non-compliance|0|||
44334789|NCT01306305|79339563|FG000|Overall Study|Lost to Follow-up|1|||
44334790|NCT01306305|79339564|FG001|Overall Study|Lost to Follow-up|0|||
44334791|NCT01306305|79339563|FG000|Overall Study|Withdrew consent|1|||
44334792|NCT01306305|79339564|FG001|Overall Study|Withdrew consent|0|||
44334793|NCT01038427|79339573|FG000|Overall Study|Lost to follow up|1|||
44539253|NCT03086018|79550961|FG000|Final Testing for End of Trial|Adverse Event|1|||
44334794|NCT01038427|79339574|FG001|Overall Study|Lost to follow up|1|||
44334795|NCT01038427|79339575|FG002|Overall Study|Lost to follow up|0|||
44334796|NCT01038427|79339573|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
44334797|NCT01038427|79339574|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
44334798|NCT01038427|79339575|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
44334799|NCT01038427|79339573|FG000|Overall Study|Withdrew consent|0|||
44334800|NCT01038427|79339574|FG001|Overall Study|Withdrew consent|0|||
44334801|NCT01038427|79339575|FG002|Overall Study|Withdrew consent|1|||
44334802|NCT01038427|79339573|FG000|Overall Study|Adverse Event|2|||
44334803|NCT01038427|79339574|FG001|Overall Study|Adverse Event|2|||
44334804|NCT01038427|79339575|FG002|Overall Study|Adverse Event|1|||
44334805|NCT01038427|79339573|FG000|Overall Study|Enrolled in error|0|||
44334806|NCT01038427|79339574|FG001|Overall Study|Enrolled in error|1|||
44334807|NCT01038427|79339575|FG002|Overall Study|Enrolled in error|1|||
44334808|NCT01038427|79339573|FG000|Overall Study|Other|0|||
44334809|NCT01038427|79339574|FG001|Overall Study|Other|2|||
44334810|NCT01038427|79339575|FG002|Overall Study|Other|0|||
44539254|NCT03086018|79550961|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
44334811|NCT01037413|79339583|FG000|Part A: Skin Testing|Adverse Event|1|||
44334812|NCT01037413|79339584|FG001|Part A: Skin Testing|Adverse Event|0|||
44432755|NCT00608205|79441315|FG000|Overall Study|Adverse Event|3|||
44432756|NCT00608205|79441316|FG001|Overall Study|Adverse Event|2|||
44432757|NCT00608205|79441315|FG000|Overall Study|Patient non-compliant|0|||
44432758|NCT00608205|79441316|FG001|Overall Study|Patient non-compliant|1|||
44432759|NCT00670800|79441326|FG000|Overall Study|2 controls were insulin resistant|0|||
44432760|NCT00670800|79441327|FG001|Overall Study|2 controls were insulin resistant|2|||
44432761|NCT00607893|79441337|FG000|Overall Study|Lost to Follow-up|4|||
44432762|NCT00607893|79441338|FG001|Overall Study|Lost to Follow-up|0|||
44432763|NCT00607893|79441337|FG000|Overall Study|withdrew due to loss of interest|0|||
44432764|NCT00607893|79441338|FG001|Overall Study|withdrew due to loss of interest|1|||
44432765|NCT00607893|79441337|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
44432766|NCT00607893|79441338|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
44432767|NCT00607893|79441337|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
44432768|NCT00607893|79441338|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
44432769|NCT00607893|79441337|FG000|Overall Study|Declined to be treated|1|||
44432770|NCT00607893|79441338|FG001|Overall Study|Declined to be treated|0|||
44432771|NCT00607893|79441337|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
44432772|NCT00607893|79441338|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
44432773|NCT00571038|79441348|FG000|Overall Study|Lost to Follow-up|1|||
44432774|NCT00571038|79441349|FG001|Overall Study|Lost to Follow-up|4|||
44432775|NCT00571038|79441348|FG000|Overall Study|Death|7|||
44432776|NCT00571038|79441349|FG001|Overall Study|Death|5|||
44432777|NCT00571038|79441348|FG000|Overall Study|Withdrawal by Subject|1|||
44432778|NCT00571038|79441349|FG001|Overall Study|Withdrawal by Subject|3|||
44432779|NCT00571038|79441348|FG000|Overall Study|Moved out of state|2|||
44432780|NCT00571038|79441349|FG001|Overall Study|Moved out of state|2|||
44432781|NCT00545740|79441359|FG000|Overall Study|Lack of Efficacy|34|||
44432782|NCT00545740|79441360|FG001|Overall Study|Lack of Efficacy|35|||
44432783|NCT00545740|79441361|FG002|Overall Study|Lack of Efficacy|47|||
44432784|NCT00545740|79441362|FG003|Overall Study|Lack of Efficacy|36|||
44432785|NCT00545740|79441359|FG000|Overall Study|Withdrawal by Subject|17|||
44432786|NCT00545740|79441360|FG001|Overall Study|Withdrawal by Subject|15|||
44432787|NCT00545740|79441361|FG002|Overall Study|Withdrawal by Subject|16|||
44432788|NCT00545740|79441362|FG003|Overall Study|Withdrawal by Subject|18|||
44432789|NCT00545740|79441359|FG000|Overall Study|Adverse Event|10|||
44432790|NCT00545740|79441360|FG001|Overall Study|Adverse Event|18|||
44432791|NCT00545740|79441361|FG002|Overall Study|Adverse Event|19|||
44432792|NCT00545740|79441362|FG003|Overall Study|Adverse Event|9|||
44432793|NCT00545740|79441359|FG000|Overall Study|Lost to Follow-up|7|||
44432794|NCT00545740|79441360|FG001|Overall Study|Lost to Follow-up|5|||
44432795|NCT00545740|79441361|FG002|Overall Study|Lost to Follow-up|5|||
44432796|NCT00545740|79441362|FG003|Overall Study|Lost to Follow-up|6|||
44432797|NCT00545740|79441359|FG000|Overall Study|Protocol Violation|1|||
44432798|NCT00545740|79441360|FG001|Overall Study|Protocol Violation|3|||
44432799|NCT00545740|79441361|FG002|Overall Study|Protocol Violation|1|||
44432800|NCT00545740|79441362|FG003|Overall Study|Protocol Violation|0|||
44432801|NCT00545740|79441359|FG000|Overall Study|Non-compliance|0|||
44432802|NCT00545740|79441360|FG001|Overall Study|Non-compliance|2|||
44432803|NCT00545740|79441361|FG002|Overall Study|Non-compliance|1|||
44432804|NCT00545740|79441362|FG003|Overall Study|Non-compliance|0|||
44432805|NCT00545740|79441359|FG000|Overall Study|Moved|2|||
44432806|NCT00545740|79441360|FG001|Overall Study|Moved|0|||
44259149|NCT03852719|79115793|FG001|Overall Study|Physician Decision|0|||
44334813|NCT01037413|79339583|FG000|Part A: Skin Testing|Protocol Violation|1|||
44334814|NCT01037413|79339584|FG001|Part A: Skin Testing|Protocol Violation|0|||
44432807|NCT00545740|79441361|FG002|Overall Study|Moved|1|||
44432808|NCT00545740|79441362|FG003|Overall Study|Moved|0|||
44432809|NCT00545740|79441359|FG000|Overall Study|Diverticulitis attack|0|||
44432810|NCT00545740|79441360|FG001|Overall Study|Diverticulitis attack|0|||
44432811|NCT00545740|79441361|FG002|Overall Study|Diverticulitis attack|1|||
44432812|NCT00545740|79441362|FG003|Overall Study|Diverticulitis attack|1|||
44432813|NCT00545740|79441359|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
44432814|NCT00545740|79441360|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
44432815|NCT00545740|79441361|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
44259150|NCT03852719|79115794|FG002|Overall Study|Physician Decision|1|||
44259151|NCT03852719|79115792|FG000|Overall Study|Pregnancy|1|||
44259152|NCT03852719|79115793|FG001|Overall Study|Pregnancy|0|||
44259153|NCT03852719|79115794|FG002|Overall Study|Pregnancy|0|||
44259154|NCT03852719|79115792|FG000|Overall Study|Death|1|||
44259155|NCT03852719|79115793|FG001|Overall Study|Death|0|||
44259156|NCT03852719|79115794|FG002|Overall Study|Death|0|||
44259157|NCT03785145|79115811|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
44259158|NCT03785145|79115812|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
44259159|NCT03785145|79115811|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
44259160|NCT03785145|79115812|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
44334815|NCT01037413|79339583|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
44334816|NCT01037413|79339584|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
44334817|NCT01037413|79339583|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
44334818|NCT01037413|79339584|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
44334819|NCT01326845|79339599|FG000|Overall Study|Administrative Problems|5|||
44334820|NCT01326845|79339600|FG001|Overall Study|Administrative Problems|2|||
44334821|NCT01326845|79339599|FG000|Overall Study|Adverse Event|1|||
44334822|NCT01326845|79339600|FG001|Overall Study|Adverse Event|0|||
44334823|NCT01326845|79339599|FG000|Overall Study|Misisng|1|||
44334824|NCT01326845|79339600|FG001|Overall Study|Misisng|3|||
44334825|NCT01062763|79339608|FG000|Overall Study|Adverse Event|3|||
44432816|NCT00545740|79441362|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
44432817|NCT00545740|79441359|FG000|Overall Study|Site closure|1|||
44432818|NCT00545740|79441360|FG001|Overall Study|Site closure|0|||
44432819|NCT00545740|79441361|FG002|Overall Study|Site closure|0|||
44432820|NCT00545740|79441362|FG003|Overall Study|Site closure|0|||
44432821|NCT00545740|79441359|FG000|Overall Study|Missed visit|1|||
44432822|NCT00545740|79441360|FG001|Overall Study|Missed visit|0|||
44432823|NCT00545740|79441361|FG002|Overall Study|Missed visit|0|||
44432824|NCT00545740|79441362|FG003|Overall Study|Missed visit|0|||
44432825|NCT00545740|79441359|FG000|Overall Study|Physician Decision|0|||
44432826|NCT00545740|79441360|FG001|Overall Study|Physician Decision|0|||
44432827|NCT00545740|79441361|FG002|Overall Study|Physician Decision|3|||
44432828|NCT00545740|79441362|FG003|Overall Study|Physician Decision|0|||
44432829|NCT00545740|79441359|FG000|Overall Study|Accepted only monthly telephone calls|1|||
44432830|NCT00545740|79441360|FG001|Overall Study|Accepted only monthly telephone calls|0|||
44432831|NCT00545740|79441361|FG002|Overall Study|Accepted only monthly telephone calls|0|||
44432832|NCT00545740|79441362|FG003|Overall Study|Accepted only monthly telephone calls|0|||
44432833|NCT00545740|79441359|FG000|Overall Study|Sponsor decision|0|||
44432834|NCT00545740|79441360|FG001|Overall Study|Sponsor decision|1|||
44432835|NCT00545740|79441361|FG002|Overall Study|Sponsor decision|0|||
44432836|NCT00545740|79441362|FG003|Overall Study|Sponsor decision|0|||
44432837|NCT00545740|79441359|FG000|Overall Study|Lack of time|0|||
44432838|NCT00545740|79441360|FG001|Overall Study|Lack of time|1|||
44432839|NCT00545740|79441361|FG002|Overall Study|Lack of time|0|||
44432840|NCT00545740|79441362|FG003|Overall Study|Lack of time|0|||
44432841|NCT00545740|79441359|FG000|Overall Study|Non-adherence to visits|0|||
44432842|NCT00545740|79441360|FG001|Overall Study|Non-adherence to visits|1|||
44432843|NCT00545740|79441361|FG002|Overall Study|Non-adherence to visits|0|||
44432844|NCT00545740|79441362|FG003|Overall Study|Non-adherence to visits|0|||
44432845|NCT00545740|79441359|FG000|Overall Study|Patient difficulties|0|||
44432846|NCT00545740|79441360|FG001|Overall Study|Patient difficulties|1|||
44432847|NCT00545740|79441361|FG002|Overall Study|Patient difficulties|0|||
44432848|NCT00545740|79441362|FG003|Overall Study|Patient difficulties|0|||
44432849|NCT00545740|79441359|FG000|Overall Study|Husband against study|0|||
44432850|NCT00545740|79441360|FG001|Overall Study|Husband against study|0|||
44432851|NCT00545740|79441361|FG002|Overall Study|Husband against study|1|||
44432852|NCT00545740|79441362|FG003|Overall Study|Husband against study|0|||
44432853|NCT00609609|79441374|FG000|Overall Study|Withdrawal by Subject|2|||
44432854|NCT00609609|79441375|FG001|Overall Study|Withdrawal by Subject|0|||
44432855|NCT00609609|79441374|FG000|Overall Study|Progression|4|||
44539255|NCT03319953|79550971|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
44157356|NCT02638337|78948945|FG001|Overall Study|Other - Miscellaneous|3|||
44334826|NCT01062763|79339609|FG001|Overall Study|Adverse Event|4|||
44334827|NCT01048099|79339615|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
44432856|NCT00609609|79441375|FG001|Overall Study|Progression|2|||
44432857|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Adverse Event|41|||
44432858|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Adverse Event|24|||
44432859|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
44432860|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
44432861|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
44432862|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
44432863|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Physician Decision|0|||
44432864|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Physician Decision|6|||
44432865|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
44432866|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
44432867|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
44432868|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
44432869|NCT00673452|79441383|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
44539256|NCT03319953|79550972|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
44157357|NCT02638259|78948953|FG000|Treatment Period 1|Adverse Event|1|||
44334828|NCT01048099|79339615|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
44432870|NCT00673452|79441384|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
44432871|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
44432872|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
44334829|NCT01303965|79339623|FG000|Overall Study|Adverse Event|1|||
44432873|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
44432874|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
44432875|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
44432876|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
44432877|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
44432878|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
44432879|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
44334830|NCT01303965|79339624|FG001|Overall Study|Adverse Event|1|||
44334831|NCT01303965|79339623|FG000|Overall Study|Death|0|||
44334832|NCT01303965|79339624|FG001|Overall Study|Death|3|||
44334833|NCT01303965|79339623|FG000|Overall Study|Withdrawal by Subject|1|||
44334834|NCT01303965|79339624|FG001|Overall Study|Withdrawal by Subject|0|||
44334835|NCT01303965|79339623|FG000|Overall Study|Disease Progression|1|||
44334836|NCT01303965|79339624|FG001|Overall Study|Disease Progression|6|||
44432880|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
44432881|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
44334837|NCT01045993|79339634|FG000|Overall Study|Treated-later found eligibility not met|0|||
44334838|NCT01045993|79339635|FG001|Overall Study|Treated-later found eligibility not met|1|||
44432882|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
44432883|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
44432884|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
44432885|NCT00673452|79441383|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
44432886|NCT00673452|79441384|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
44432887|NCT00545584|79441393|FG000|Overall Study|Only one reason for discontinuation|62|||
44432888|NCT00545584|79441394|FG001|Overall Study|Only one reason for discontinuation|61|||
44432889|NCT00545584|79441395|FG002|Overall Study|Only one reason for discontinuation|48|||
44432890|NCT00545584|79441393|FG000|Overall Study|Two or more reasons for discontinuation|17|||
44432891|NCT00545584|79441394|FG001|Overall Study|Two or more reasons for discontinuation|19|||
44432892|NCT00545584|79441395|FG002|Overall Study|Two or more reasons for discontinuation|8|||
44432893|NCT00378703|79441407|FG000|Overall Study|Disease progression|59|||
44432894|NCT00378703|79441408|FG001|Overall Study|Disease progression|43|||
44432895|NCT00378703|79441409|FG002|Overall Study|Disease progression|48|||
44432896|NCT00378703|79441410|FG003|Overall Study|Disease progression|49|||
44432897|NCT00378703|79441407|FG000|Overall Study|Adverse Event|11|||
44432898|NCT00378703|79441408|FG001|Overall Study|Adverse Event|17|||
44432899|NCT00378703|79441409|FG002|Overall Study|Adverse Event|20|||
44432900|NCT00378703|79441410|FG003|Overall Study|Adverse Event|18|||
44432901|NCT00378703|79441407|FG000|Overall Study|Death|2|||
44432902|NCT00378703|79441408|FG001|Overall Study|Death|2|||
44157358|NCT02638259|78948954|FG001|Treatment Period 1|Adverse Event|5|||
44157359|NCT02638259|78948953|FG000|Treatment Period 1|Death|0|||
44157360|NCT02638259|78948954|FG001|Treatment Period 1|Death|1|||
44157361|NCT02638259|78948953|FG000|Treatment Period 1|Lack of Efficacy|0|||
44157362|NCT02638259|78948954|FG001|Treatment Period 1|Lack of Efficacy|1|||
44157363|NCT02638259|78948953|FG000|Treatment Period 1|Protocol Violation|0|||
44157364|NCT02638259|78948954|FG001|Treatment Period 1|Protocol Violation|3|||
44157365|NCT02638259|78948953|FG000|Treatment Period 1|Withdrawal by Subject|4|||
44157366|NCT02638259|78948954|FG001|Treatment Period 1|Withdrawal by Subject|6|||
44157367|NCT02638259|78948953|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
44157368|NCT02638259|78948954|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
44334839|NCT01045993|79339636|FG002|Overall Study|Treated-later found eligibility not met|0|||
44334840|NCT01045993|79339637|FG003|Overall Study|Treated-later found eligibility not met|0|||
44334841|NCT01303419|79339647|FG000|Overall Study|Discontinuation of study|60|||
44334842|NCT01303419|79339647|FG000|Overall Study|Did not complete both imaging methods|5|||
44334843|NCT01303419|79339647|FG000|Overall Study|Did not meet all I/E after screening|31|||
44334844|NCT01326533|79339653|FG000|Overall Study|Lost to Follow-up|2|||
44334845|NCT01326533|79339654|FG001|Overall Study|Lost to Follow-up|0|||
44334846|NCT01326533|79339653|FG000|Overall Study|Withdrawal by Subject|1|||
44334847|NCT01326533|79339654|FG001|Overall Study|Withdrawal by Subject|0|||
44334848|NCT01326533|79339653|FG000|Overall Study|Adverse Event|1|||
44432903|NCT00378703|79441409|FG002|Overall Study|Death|4|||
44432904|NCT00378703|79441410|FG003|Overall Study|Death|3|||
44432905|NCT00378703|79441407|FG000|Overall Study|Withdrawal by Subject|4|||
44432906|NCT00378703|79441408|FG001|Overall Study|Withdrawal by Subject|8|||
44432907|NCT00378703|79441409|FG002|Overall Study|Withdrawal by Subject|5|||
44432908|NCT00378703|79441410|FG003|Overall Study|Withdrawal by Subject|7|||
44432909|NCT00378703|79441407|FG000|Overall Study|Physician Decision|1|||
44432910|NCT00378703|79441408|FG001|Overall Study|Physician Decision|4|||
44432911|NCT00378703|79441409|FG002|Overall Study|Physician Decision|1|||
44432912|NCT00378703|79441410|FG003|Overall Study|Physician Decision|0|||
44157369|NCT02638259|78948953|FG000|Treatment Period 2|Adverse Event|5|||
44157370|NCT02638259|78948954|FG001|Treatment Period 2|Adverse Event|4|||
44157371|NCT02638259|78948953|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44334849|NCT01326533|79339654|FG001|Overall Study|Adverse Event|0|||
44334850|NCT01045447|79339662|FG000|Overall Study|Adverse Event|0|||
44334851|NCT01045447|79339663|FG001|Overall Study|Adverse Event|1|||
44334852|NCT01045447|79339662|FG000|Overall Study|Lack of Efficacy|3|||
44334853|NCT01045447|79339663|FG001|Overall Study|Lack of Efficacy|1|||
44334854|NCT01045447|79339662|FG000|Overall Study|Protocol Violation|6|||
44334855|NCT01045447|79339663|FG001|Overall Study|Protocol Violation|3|||
44334856|NCT01045447|79339662|FG000|Overall Study|Withdrawal Criteria|10|||
44334857|NCT01045447|79339663|FG001|Overall Study|Withdrawal Criteria|10|||
44334858|NCT01045447|79339662|FG000|Overall Study|Unclassified|17|||
44334859|NCT01045447|79339663|FG001|Overall Study|Unclassified|13|||
44334860|NCT01301625|79339669|FG000|Overall Study|Death|5|||
44334861|NCT01301625|79339669|FG000|Overall Study|Not Due|21|||
44334862|NCT01301625|79339669|FG000|Overall Study|Expected|8|||
44334863|NCT01301625|79339669|FG000|Overall Study|Lost to Follow-up|1|||
44334864|NCT01301391|79339673|FG000|Overall Study|Death|13|||
44334865|NCT01301391|79339673|FG000|Overall Study|Lost to Follow-up|3|||
44334866|NCT01301391|79339673|FG000|Overall Study|Physician Decision|2|||
44334867|NCT01301391|79339673|FG000|Overall Study|Sponsor's decision|8|||
44334868|NCT01036321|79339679|FG000|Overall Study|Ineligible after randomization|0|||
44334869|NCT01036321|79339680|FG001|Overall Study|Ineligible after randomization|1|||
44334870|NCT01036321|79339679|FG000|Overall Study|Withdrawal by Subject|3|||
44334871|NCT01036321|79339680|FG001|Overall Study|Withdrawal by Subject|2|||
44334872|NCT01036321|79339679|FG000|Overall Study|Adverse Event|2|||
44334873|NCT01036321|79339680|FG001|Overall Study|Adverse Event|1|||
44334874|NCT01061359|79339686|FG000|Overall Study|Death|32|||
44334875|NCT01061359|79339686|FG000|Overall Study|Lost to Follow-up|1072|||
44334876|NCT01061359|79339686|FG000|Overall Study|Relapse|187|||
44334877|NCT01061359|79339686|FG000|Overall Study|Secondary neoplasm|11|||
44334878|NCT01301079|79339692|FG000|Overall Study|Lost to Follow-up|2|||
44334879|NCT01301079|79339693|FG001|Overall Study|Lost to Follow-up|2|||
44334880|NCT01036165|79339703|FG000|Overall Study|Adverse Event|6|||
44334881|NCT01036165|79339703|FG000|Overall Study|Lost to Follow-up|2|||
44334882|NCT01036165|79339703|FG000|Overall Study|Withdrawal by Subject|3|||
44334883|NCT01036165|79339703|FG000|Overall Study|Device Related Issues|3|||
44334884|NCT01036165|79339703|FG000|Overall Study|Problems finding proper area to inject|1|||
44334885|NCT01301001|79339707|FG000|First Intervention|Lost to Follow-up|4|||
44334886|NCT01301001|79339708|FG001|First Intervention|Lost to Follow-up|4|||
44334887|NCT01301001|79339707|FG000|First Intervention|Withdrawal by Subject|1|||
44334888|NCT01301001|79339708|FG001|First Intervention|Withdrawal by Subject|4|||
44334889|NCT01301001|79339707|FG000|First Intervention|Adverse Event|5|||
44334890|NCT01301001|79339708|FG001|First Intervention|Adverse Event|0|||
44334891|NCT01301001|79339707|FG000|First Intervention|Protocol Violation|0|||
44334892|NCT01301001|79339708|FG001|First Intervention|Protocol Violation|1|||
44432913|NCT00378703|79441407|FG000|Overall Study|Alternative therapy|4|||
44432914|NCT00378703|79441408|FG001|Overall Study|Alternative therapy|2|||
44539257|NCT03319953|79550973|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
44157372|NCT02638259|78948954|FG001|Treatment Period 2|Withdrawal by Subject|7|||
44157373|NCT02637323|78948966|FG000|Overall Study|Lost to Follow-up|2|||
44157374|NCT02637323|78948967|FG001|Overall Study|Lost to Follow-up|0|||
44157375|NCT02637323|78948966|FG000|Overall Study|Protocol Violation|0|||
44157376|NCT02637323|78948967|FG001|Overall Study|Protocol Violation|1|||
44157377|NCT05446142|78948991|FG000|Period 2|Adverse Event|1|||
44157378|NCT05446142|78948992|FG001|Period 2|Adverse Event|0|||
44157379|NCT05446142|78948993|FG002|Period 2|Adverse Event|0|||
44157380|NCT05446142|78948994|FG003|Period 2|Adverse Event|0|||
44157381|NCT05446142|78948995|FG004|Period 2|Adverse Event|0|||
44157382|NCT05446142|78948996|FG005|Period 2|Adverse Event|0|||
44157383|NCT04748445|78949008|FG000|Overall Study|No longer met eligibility criteria|12|||
44334893|NCT01301001|79339707|FG000|Second Intervention|Adverse Event|2|||
44539258|NCT03319953|79550974|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
44334894|NCT01301001|79339708|FG001|Second Intervention|Adverse Event|0|||
44539259|NCT03319953|79550971|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
44334895|NCT01301001|79339707|FG000|Second Intervention|Withdrawal by Subject|2|||
44334896|NCT01301001|79339708|FG001|Second Intervention|Withdrawal by Subject|0|||
44334897|NCT01300923|79339715|FG000|Overall Study|Physician Decision|0|||
44334898|NCT01300923|79339716|FG001|Overall Study|Physician Decision|2|||
44432915|NCT00378703|79441409|FG002|Overall Study|Alternative therapy|0|||
44157384|NCT04748445|78949008|FG000|Overall Study|Other|36|||
44334899|NCT01300767|79339721|FG000|Overall Study|Discomfort|2|||
44334900|NCT01300767|79339721|FG000|Overall Study|Biomicroscopy|1|||
44334901|NCT01300767|79339721|FG000|Overall Study|Unacceptable fit|1|||
44334902|NCT01300455|79339729|FG000|Washout|Withdrawal by Subject|1|||
44334903|NCT01300455|79339730|FG001|Washout|Withdrawal by Subject|0|||
44334904|NCT01107418|79339740|FG000|Overall Study|Disease Progression|45|||
44334905|NCT01107418|79339740|FG000|Overall Study|Adverse Event|3|||
44157385|NCT04748445|78949008|FG000|Overall Study|Withdrawal by Subject|553|||
44157386|NCT04748445|78949008|FG000|Overall Study|Lost to Follow-up|30|||
44334906|NCT01107418|79339740|FG000|Overall Study|Withdrawal by Subject|1|||
44539260|NCT03319953|79550972|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
44432916|NCT00378703|79441410|FG003|Overall Study|Alternative therapy|0|||
44432917|NCT00378703|79441407|FG000|Overall Study|Other complicated disease|0|||
44432918|NCT00378703|79441408|FG001|Overall Study|Other complicated disease|2|||
44432919|NCT00378703|79441409|FG002|Overall Study|Other complicated disease|2|||
44432920|NCT00378703|79441410|FG003|Overall Study|Other complicated disease|0|||
44432921|NCT00378703|79441407|FG000|Overall Study|Symptomatic deterioration|0|||
44432922|NCT00378703|79441408|FG001|Overall Study|Symptomatic deterioration|1|||
44432923|NCT00378703|79441409|FG002|Overall Study|Symptomatic deterioration|0|||
44432924|NCT00378703|79441410|FG003|Overall Study|Symptomatic deterioration|2|||
44432925|NCT00378703|79441407|FG000|Overall Study|Surgery|1|||
44432926|NCT00378703|79441408|FG001|Overall Study|Surgery|0|||
44432927|NCT00378703|79441409|FG002|Overall Study|Surgery|0|||
44432928|NCT00378703|79441410|FG003|Overall Study|Surgery|1|||
44432929|NCT00378703|79441407|FG000|Overall Study|Joint decision of physician and patient|1|||
44432930|NCT00378703|79441408|FG001|Overall Study|Joint decision of physician and patient|0|||
44432931|NCT00378703|79441409|FG002|Overall Study|Joint decision of physician and patient|0|||
44432932|NCT00378703|79441410|FG003|Overall Study|Joint decision of physician and patient|0|||
44432933|NCT00378703|79441407|FG000|Overall Study|Adverse events and progressive disease|0|||
44432934|NCT00378703|79441408|FG001|Overall Study|Adverse events and progressive disease|0|||
44432935|NCT00378703|79441409|FG002|Overall Study|Adverse events and progressive disease|0|||
44432936|NCT00378703|79441410|FG003|Overall Study|Adverse events and progressive disease|1|||
44432937|NCT00378703|79441407|FG000|Overall Study|Relocation|0|||
44432938|NCT00378703|79441408|FG001|Overall Study|Relocation|0|||
44432939|NCT00378703|79441409|FG002|Overall Study|Relocation|1|||
44432940|NCT00378703|79441410|FG003|Overall Study|Relocation|0|||
44432941|NCT00378703|79441407|FG000|Overall Study|Ineligible|4|||
44432942|NCT00378703|79441408|FG001|Overall Study|Ineligible|7|||
44432943|NCT00378703|79441409|FG002|Overall Study|Ineligible|7|||
44539261|NCT03319953|79550973|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
44539262|NCT03319953|79550974|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
44539263|NCT02927834|79550985|FG000|Overall Study|Lost to Follow-up|1|||
44539264|NCT02927834|79550986|FG001|Overall Study|Lost to Follow-up|2|||
44539265|NCT02927834|79550987|FG002|Overall Study|Lost to Follow-up|2|||
44334907|NCT01107418|79339740|FG000|Overall Study|Study Closing|1|||
44334908|NCT01107418|79339740|FG000|Overall Study|Started Other Therapy|1|||
44334909|NCT01107418|79339740|FG000|Overall Study|Entered Extension Study|1|||
44334910|NCT01101178|79339755|FG000|Period 1|Withdrawal by Subject|1|||
44539266|NCT01964547|79551001|FG000|Overall Study|Adverse Event|8|||
44539267|NCT01964547|79551002|FG001|Overall Study|Adverse Event|2|||
44539268|NCT01964547|79551001|FG000|Overall Study|Withdrawal by Subject|4|||
44539269|NCT01964547|79551002|FG001|Overall Study|Withdrawal by Subject|7|||
44539270|NCT01964547|79551001|FG000|Overall Study|Lost to Follow-up|0|||
44539271|NCT01964547|79551002|FG001|Overall Study|Lost to Follow-up|1|||
44539272|NCT01964547|79551001|FG000|Overall Study|Withdrawal by Investigator|0|||
44539273|NCT01964547|79551002|FG001|Overall Study|Withdrawal by Investigator|1|||
44539274|NCT03319719|79551008|FG000|Overall Study|Lost to Follow-up|1|||
44539275|NCT03318783|79551016|FG000|Overall Study|Withdrawal by Subject|0|||
44334911|NCT01101178|79339756|FG001|Period 1|Withdrawal by Subject|2|||
44334912|NCT01101178|79339755|FG000|Period 1|Positive drug screen|1|||
44334913|NCT01101178|79339756|FG001|Period 1|Positive drug screen|1|||
44334914|NCT01101178|79339755|FG000|Period 1|Adverse Event|2|||
44334915|NCT01101178|79339756|FG001|Period 1|Adverse Event|1|||
44334916|NCT01101178|79339755|FG000|Period 2|Withdrawal by Subject|0|||
44334917|NCT01101178|79339756|FG001|Period 2|Withdrawal by Subject|1|||
44334918|NCT01101022|79339765|FG000|Overall Study|Adverse Event|6|||
44334919|NCT01101022|79339766|FG001|Overall Study|Adverse Event|2|||
44334920|NCT01101022|79339765|FG000|Overall Study|Protocol Violation|4|||
44334921|NCT01101022|79339766|FG001|Overall Study|Protocol Violation|3|||
44432944|NCT00378703|79441410|FG003|Overall Study|Ineligible|7|||
44432945|NCT00378703|79441407|FG000|Overall Study|Never started treatment|1|||
44432946|NCT00378703|79441408|FG001|Overall Study|Never started treatment|4|||
44432947|NCT00378703|79441409|FG002|Overall Study|Never started treatment|0|||
44432948|NCT00378703|79441410|FG003|Overall Study|Never started treatment|0|||
44432949|NCT00378703|79441407|FG000|Overall Study|Other|1|||
44432950|NCT00378703|79441408|FG001|Overall Study|Other|1|||
44432951|NCT00378703|79441409|FG002|Overall Study|Other|2|||
44432952|NCT00378703|79441410|FG003|Overall Study|Other|3|||
44432953|NCT00368641|79441426|FG000|Overall Study|Adverse Event|2|||
44432954|NCT00368641|79441427|FG001|Overall Study|Adverse Event|1|||
44432955|NCT00368641|79441426|FG000|Overall Study|Death|1|||
44432956|NCT00368641|79441427|FG001|Overall Study|Death|0|||
44432957|NCT00368641|79441426|FG000|Overall Study|Withdrawal by Subject|1|||
44432958|NCT00368641|79441427|FG001|Overall Study|Withdrawal by Subject|0|||
44539276|NCT03318783|79551017|FG001|Overall Study|Withdrawal by Subject|1|||
44334922|NCT01101022|79339765|FG000|Overall Study|Withdrawal by Subject|3|||
44334923|NCT01101022|79339766|FG001|Overall Study|Withdrawal by Subject|8|||
44334924|NCT01101022|79339765|FG000|Overall Study|Lost to Follow-up|1|||
44539277|NCT03318783|79551016|FG000|Overall Study|Death|0|||
44539278|NCT03318783|79551017|FG001|Overall Study|Death|1|||
44432959|NCT00368641|79441426|FG000|Overall Study|Sponsor decision to terminate study|2|||
44334925|NCT01101022|79339766|FG001|Overall Study|Lost to Follow-up|4|||
44334926|NCT01101022|79339765|FG000|Overall Study|Lack of Efficacy|0|||
44334927|NCT01101022|79339766|FG001|Overall Study|Lack of Efficacy|7|||
44334928|NCT01101022|79339765|FG000|Overall Study|Sponsor decision|1|||
44334929|NCT01101022|79339766|FG001|Overall Study|Sponsor decision|1|||
44334930|NCT01101022|79339765|FG000|Overall Study|Non-compliance|1|||
44334931|NCT01101022|79339766|FG001|Overall Study|Non-compliance|0|||
44334932|NCT01101022|79339765|FG000|Overall Study|Work schedule|1|||
44334933|NCT01101022|79339766|FG001|Overall Study|Work schedule|1|||
44334934|NCT01101022|79339765|FG000|Overall Study|Vacation|0|||
44432960|NCT00368641|79441427|FG001|Overall Study|Sponsor decision to terminate study|5|||
44432961|NCT00608985|79441437|FG000|Overall Study|Adverse Event|2|||
44432962|NCT00608985|79441438|FG001|Overall Study|Adverse Event|7|||
44432963|NCT00608985|79441439|FG002|Overall Study|Adverse Event|4|||
44432964|NCT00608985|79441440|FG003|Overall Study|Adverse Event|6|||
44432965|NCT00608985|79441437|FG000|Overall Study|Administrative/Other|7|||
44432966|NCT00608985|79441438|FG001|Overall Study|Administrative/Other|4|||
44432967|NCT00608985|79441439|FG002|Overall Study|Administrative/Other|1|||
44432968|NCT00608985|79441440|FG003|Overall Study|Administrative/Other|2|||
44432969|NCT00608985|79441437|FG000|Overall Study|Withdrawal of Consent|5|||
44432970|NCT00608985|79441438|FG001|Overall Study|Withdrawal of Consent|1|||
44432971|NCT00608985|79441439|FG002|Overall Study|Withdrawal of Consent|1|||
44432972|NCT00608985|79441440|FG003|Overall Study|Withdrawal of Consent|1|||
44432973|NCT00608985|79441437|FG000|Overall Study|Lost to Follow-up|2|||
44432974|NCT00608985|79441438|FG001|Overall Study|Lost to Follow-up|1|||
44432975|NCT00608985|79441439|FG002|Overall Study|Lost to Follow-up|0|||
44432976|NCT00608985|79441440|FG003|Overall Study|Lost to Follow-up|0|||
44432977|NCT00368251|79441453|FG000|Overall Study|SAE, non-fatal|1|||
44432978|NCT00368251|79441454|FG001|Overall Study|SAE, non-fatal|0|||
44334935|NCT01101022|79339766|FG001|Overall Study|Vacation|1|||
44432979|NCT00368251|79441455|FG002|Overall Study|SAE, non-fatal|0|||
44432980|NCT00368251|79441453|FG000|Overall Study|AE, non-serious non-fatal|0|||
44432981|NCT00368251|79441454|FG001|Overall Study|AE, non-serious non-fatal|0|||
44432982|NCT00368251|79441455|FG002|Overall Study|AE, non-serious non-fatal|1|||
44432983|NCT00378079|79441466|FG000|Overall Study|Lost to Follow-up|6|||
44432984|NCT00378079|79441467|FG001|Overall Study|Lost to Follow-up|1|||
44432985|NCT00378079|79441468|FG002|Overall Study|Lost to Follow-up|0|||
44432986|NCT03936244|79441478|FG000|Overall Study|Lost to Follow-up|5|||
44432987|NCT03936244|79441479|FG001|Overall Study|Lost to Follow-up|1|||
44432988|NCT03936244|79441478|FG000|Overall Study|Physician Decision|7|||
44432989|NCT03936244|79441479|FG001|Overall Study|Physician Decision|3|||
44432990|NCT03923530|79441486|FG000|Overall Study|Withdrawal by Subject|1|||
44334936|NCT01299909|79339775|FG000|Overall Study|Lost to Follow-up|22|||
44432991|NCT03923530|79441486|FG000|Overall Study|screen failure|3|||
44432992|NCT00608907|79441493|FG000|Overall Study|Adverse Event|6|||
44432993|NCT00608907|79441494|FG001|Overall Study|Adverse Event|0|||
44432994|NCT00608907|79441495|FG002|Overall Study|Adverse Event|1|||
44432995|NCT00608907|79441493|FG000|Overall Study|Death|1|||
44432996|NCT00608907|79441494|FG001|Overall Study|Death|0|||
44432997|NCT00608907|79441495|FG002|Overall Study|Death|0|||
44432998|NCT00608907|79441493|FG000|Overall Study|Withdrawal by Subject|4|||
44432999|NCT00608907|79441494|FG001|Overall Study|Withdrawal by Subject|0|||
44433000|NCT00608907|79441495|FG002|Overall Study|Withdrawal by Subject|0|||
44334937|NCT01299909|79339776|FG001|Overall Study|Lost to Follow-up|18|||
44433001|NCT00608907|79441493|FG000|Overall Study|Progressive Disease|1|||
44433002|NCT00608907|79441494|FG001|Overall Study|Progressive Disease|0|||
44433003|NCT00608907|79441495|FG002|Overall Study|Progressive Disease|0|||
44157387|NCT04716881|78949012|FG000|Overall Study|Adverse Event|1|||
44334938|NCT01299909|79339777|FG002|Overall Study|Lost to Follow-up|17|||
44433004|NCT00377611|79441505|FG000|Overall Study|Adverse Event|2|||
44433005|NCT00377611|79441506|FG001|Overall Study|Adverse Event|9|||
44433006|NCT00377611|79441505|FG000|Overall Study|Protocol Violation|2|||
44433007|NCT00377611|79441506|FG001|Overall Study|Protocol Violation|0|||
44433008|NCT00377611|79441505|FG000|Overall Study|Withdrawal by Subject|0|||
44433009|NCT00377611|79441506|FG001|Overall Study|Withdrawal by Subject|5|||
44433010|NCT00377611|79441505|FG000|Overall Study|Lost to Follow-up|18|||
44433011|NCT00377611|79441506|FG001|Overall Study|Lost to Follow-up|16|||
44334939|NCT01298661|79339787|FG000|Overall Study|Withdrawal by Subject|2|||
44334940|NCT01298661|79339788|FG001|Overall Study|Withdrawal by Subject|0|||
44334941|NCT01298661|79339789|FG002|Overall Study|Withdrawal by Subject|2|||
44433012|NCT00377611|79441505|FG000|Overall Study|Other|0|||
44334942|NCT01100944|79339798|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
44433013|NCT00377611|79441506|FG001|Overall Study|Other|3|||
44433014|NCT00545272|79441519|FG000|Overall Study|Protocol deviation|0|||
44433015|NCT00545272|79441520|FG001|Overall Study|Protocol deviation|1|||
44433016|NCT00545272|79441521|FG002|Overall Study|Protocol deviation|0|||
44433017|NCT00545272|79441522|FG003|Overall Study|Protocol deviation|1|||
44433018|NCT00545272|79441523|FG004|Overall Study|Protocol deviation|0|||
44334943|NCT01100944|79339799|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
44334944|NCT01100944|79339800|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
44334945|NCT01100944|79339798|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
44334946|NCT01100944|79339799|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
44334947|NCT01100944|79339800|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
44334948|NCT01100944|79339798|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
44334949|NCT01100944|79339799|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
44334950|NCT01100944|79339800|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
44334951|NCT01100944|79339798|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
44334952|NCT01100944|79339799|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
44433019|NCT00545272|79441524|FG005|Overall Study|Protocol deviation|1|||
44433020|NCT00545272|79441519|FG000|Overall Study|Adverse Event|0|||
44433021|NCT00545272|79441520|FG001|Overall Study|Adverse Event|0|||
44433022|NCT00545272|79441521|FG002|Overall Study|Adverse Event|1|||
44433023|NCT00545272|79441522|FG003|Overall Study|Adverse Event|0|||
44433024|NCT00545272|79441523|FG004|Overall Study|Adverse Event|0|||
44433025|NCT00545272|79441524|FG005|Overall Study|Adverse Event|1|||
44433026|NCT00545272|79441519|FG000|Overall Study|Abnormal laboratory value(s)|0|||
44433027|NCT00545272|79441520|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44433028|NCT00545272|79441521|FG002|Overall Study|Abnormal laboratory value(s)|0|||
44433029|NCT00545272|79441522|FG003|Overall Study|Abnormal laboratory value(s)|0|||
44433030|NCT00545272|79441523|FG004|Overall Study|Abnormal laboratory value(s)|0|||
44433031|NCT00545272|79441524|FG005|Overall Study|Abnormal laboratory value(s)|1|||
44334953|NCT01100944|79339800|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
44334954|NCT01100320|79339821|FG000|Period 1|Withdrawal by Subject|2|||
44334955|NCT01100320|79339822|FG001|Period 1|Withdrawal by Subject|4|||
44334956|NCT01100320|79339821|FG000|Period 1|Positive Drug Screen|1|||
44334957|NCT01100320|79339822|FG001|Period 1|Positive Drug Screen|1|||
44334958|NCT01100320|79339821|FG000|Period 1|Adverse Event|2|||
44334959|NCT01100320|79339822|FG001|Period 1|Adverse Event|2|||
44334960|NCT01100320|79339821|FG000|Period 2|Withdrawal by Subject|1|||
44334961|NCT01100320|79339822|FG001|Period 2|Withdrawal by Subject|1|||
44334962|NCT01100086|79339828|FG000|Period 1|Withdrawal by Subject|1|||
44334963|NCT01100086|79339829|FG001|Period 1|Withdrawal by Subject|0|||
44334964|NCT01297959|79339837|FG000|Overall Study|Adverse Event|0|||
44334965|NCT01297959|79339838|FG001|Overall Study|Adverse Event|1|||
44334966|NCT01297959|79339837|FG000|Overall Study|Protocol Violation|2|||
44433032|NCT00545272|79441519|FG000|Overall Study|Abnormal test procedure result(s)|0|||
44433033|NCT00545272|79441520|FG001|Overall Study|Abnormal test procedure result(s)|0|||
44433034|NCT00545272|79441521|FG002|Overall Study|Abnormal test procedure result(s)|0|||
44433035|NCT00545272|79441522|FG003|Overall Study|Abnormal test procedure result(s)|0|||
44433036|NCT00545272|79441523|FG004|Overall Study|Abnormal test procedure result(s)|1|||
44433037|NCT00545272|79441524|FG005|Overall Study|Abnormal test procedure result(s)|0|||
44433038|NCT00545272|79441519|FG000|Overall Study|Lost to Follow-up|0|||
44334967|NCT01297959|79339838|FG001|Overall Study|Protocol Violation|1|||
44433039|NCT00545272|79441520|FG001|Overall Study|Lost to Follow-up|0|||
44433040|NCT00545272|79441521|FG002|Overall Study|Lost to Follow-up|0|||
44433041|NCT00545272|79441522|FG003|Overall Study|Lost to Follow-up|0|||
44433042|NCT00545272|79441523|FG004|Overall Study|Lost to Follow-up|1|||
44433043|NCT00545272|79441524|FG005|Overall Study|Lost to Follow-up|0|||
44433044|NCT00377455|79441538|FG000|Overall Study|Withdrawal by Subject|1|||
44433045|NCT00377299|79441544|FG000|Overall Study|Lost to Follow-up|14|||
44433046|NCT00377299|79441545|FG001|Overall Study|Lost to Follow-up|19|||
44334968|NCT01297959|79339837|FG000|Overall Study|Withdrawal by Subject|5|||
44334969|NCT01297959|79339838|FG001|Overall Study|Withdrawal by Subject|4|||
44539279|NCT01313689|79551028|FG000|24-Week Randomization 1|Adverse Event|10|||
44539280|NCT01313689|79551029|FG001|24-Week Randomization 1|Adverse Event|5|||
44334970|NCT01297959|79339837|FG000|Overall Study|Physician Decision|0|||
44334971|NCT01297959|79339838|FG001|Overall Study|Physician Decision|1|||
44433047|NCT00377299|79441544|FG000|Overall Study|Adverse Event|0|||
44433048|NCT00377299|79441545|FG001|Overall Study|Adverse Event|1|||
44539281|NCT01313689|79551030|FG002|24-Week Randomization 1|Adverse Event|0|||
44433049|NCT00377299|79441544|FG000|Overall Study|Withdrawal by Subject|5|||
44433050|NCT00377299|79441545|FG001|Overall Study|Withdrawal by Subject|4|||
44433051|NCT00376675|79441563|FG000|Overall Study|Withdrawal by Subject|9|||
44433052|NCT00376675|79441564|FG001|Overall Study|Withdrawal by Subject|2|||
44539282|NCT01313689|79551031|FG003|24-Week Randomization 1|Adverse Event|0|||
44539283|NCT01313689|79551032|FG004|24-Week Randomization 1|Adverse Event|0|||
44433053|NCT00376675|79441563|FG000|Overall Study|Adverse Event|10|||
44433054|NCT00376675|79441564|FG001|Overall Study|Adverse Event|5|||
44433055|NCT00376675|79441563|FG000|Overall Study|Other Reason|1|||
44433056|NCT00376675|79441564|FG001|Overall Study|Other Reason|7|||
44433057|NCT03931330|79441570|FG000|Overall Study|Physician Decision|1|||
44433058|NCT00367237|79441577|FG000|Overall Study|Adverse Event|7|||
44433059|NCT00367237|79441578|FG001|Overall Study|Adverse Event|2|||
44433060|NCT00367237|79441577|FG000|Overall Study|Lost to Follow-up|1|||
44433061|NCT00367237|79441578|FG001|Overall Study|Lost to Follow-up|0|||
44433062|NCT00367237|79441577|FG000|Overall Study|Withdrawal by Subject|0|||
44433063|NCT00367237|79441578|FG001|Overall Study|Withdrawal by Subject|4|||
44433064|NCT00367237|79441577|FG000|Overall Study|Protocol Violation|2|||
44433065|NCT00367237|79441578|FG001|Overall Study|Protocol Violation|5|||
44433066|NCT00544882|79441586|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
44433067|NCT00544882|79441587|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
44433068|NCT00544882|79441588|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
44433069|NCT00544882|79441586|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
44433070|NCT00544882|79441587|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
44433071|NCT00544882|79441588|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
44433072|NCT00544882|79441586|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
44433073|NCT00544882|79441587|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
44433074|NCT00544882|79441588|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
44433075|NCT00544882|79441586|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
44433076|NCT00544882|79441587|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
44433077|NCT00544882|79441588|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
44433078|NCT00544882|79441586|FG000|Cycle 3: Follow-up|Noncompliance|0|||
44433079|NCT00544882|79441587|FG001|Cycle 3: Follow-up|Noncompliance|1|||
44433080|NCT00544882|79441588|FG002|Cycle 3: Follow-up|Noncompliance|0|||
44433081|NCT00544882|79441586|FG000|Cycle 3: Follow-up|Pregnancy|0|||
44433082|NCT00544882|79441587|FG001|Cycle 3: Follow-up|Pregnancy|1|||
44433083|NCT00544882|79441588|FG002|Cycle 3: Follow-up|Pregnancy|0|||
44433084|NCT00606801|79441596|FG000|Intervention|Protocol Violation|3|||
44334972|NCT01297959|79339837|FG000|Overall Study|Unrelated medical illness / complication|0|||
44334973|NCT01297959|79339838|FG001|Overall Study|Unrelated medical illness / complication|2|||
44334974|NCT01297959|79339837|FG000|Overall Study|Other|13|||
44334975|NCT01297959|79339838|FG001|Overall Study|Other|7|||
44334976|NCT01035229|79339846|FG000|Overall Study|Adverse Event|61|||
44334977|NCT01035229|79339847|FG001|Overall Study|Adverse Event|14|||
44334978|NCT01035229|79339846|FG000|Overall Study|Withdrawal by Subject|20|||
44334979|NCT01035229|79339847|FG001|Overall Study|Withdrawal by Subject|7|||
44334980|NCT01035229|79339846|FG000|Overall Study|Lost to Follow-up|1|||
44334981|NCT01035229|79339847|FG001|Overall Study|Lost to Follow-up|0|||
44334982|NCT01035229|79339846|FG000|Overall Study|Administrative problems|1|||
44433085|NCT00606801|79441597|FG001|Intervention|Protocol Violation|3|||
44433086|NCT00606177|79441609|FG000|Overall Study|Adverse Event|9|||
44433087|NCT00606177|79441610|FG001|Overall Study|Adverse Event|5|||
44433088|NCT00606177|79441609|FG000|Overall Study|Lack of Efficacy|3|||
44433089|NCT00606177|79441610|FG001|Overall Study|Lack of Efficacy|7|||
44433090|NCT00606177|79441609|FG000|Overall Study|Physician Decision|1|||
44433091|NCT00606177|79441610|FG001|Overall Study|Physician Decision|0|||
44433092|NCT00606177|79441609|FG000|Overall Study|Protocol Violation|1|||
44433093|NCT00606177|79441610|FG001|Overall Study|Protocol Violation|4|||
44433094|NCT00606177|79441609|FG000|Overall Study|Withdrawal by Subject|5|||
44433095|NCT00606177|79441610|FG001|Overall Study|Withdrawal by Subject|6|||
44433096|NCT00606177|79441609|FG000|Overall Study|Progression to depressive phase|6|||
44433097|NCT00606177|79441610|FG001|Overall Study|Progression to depressive phase|1|||
44433098|NCT00606177|79441609|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
44334983|NCT01035229|79339847|FG001|Overall Study|Administrative problems|1|||
44334984|NCT01035229|79339846|FG000|Overall Study|Death|13|||
44334985|NCT01035229|79339847|FG001|Overall Study|Death|5|||
44334986|NCT01035229|79339846|FG000|Overall Study|New cancer therapy|2|||
44334987|NCT01035229|79339847|FG001|Overall Study|New cancer therapy|0|||
44334988|NCT01035229|79339846|FG000|Overall Study|Protocol Violation|0|||
44334989|NCT01035229|79339847|FG001|Overall Study|Protocol Violation|2|||
44334990|NCT01035229|79339846|FG000|Overall Study|Sponsor's decision to end study|3|||
44334991|NCT01035229|79339847|FG001|Overall Study|Sponsor's decision to end study|3|||
44334992|NCT01035229|79339846|FG000|Overall Study|Disease Progression|261|||
44334993|NCT01035229|79339847|FG001|Overall Study|Disease Progression|152|||
44334994|NCT01106404|79339857|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
44334995|NCT01106404|79339858|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
44539284|NCT01313689|79551028|FG000|24-Week Randomization 1|Physician Decision|4|||
44539285|NCT01313689|79551029|FG001|24-Week Randomization 1|Physician Decision|5|||
44539286|NCT01313689|79551030|FG002|24-Week Randomization 1|Physician Decision|0|||
44433099|NCT00606177|79441610|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
44433100|NCT00606177|79441609|FG000|Overall Study|Change of residence or other commitments|1|||
44433101|NCT00606177|79441610|FG001|Overall Study|Change of residence or other commitments|1|||
44433102|NCT00359281|79441625|FG000|Overall Study|Adverse Event|1|||
44433103|NCT00359281|79441626|FG001|Overall Study|Adverse Event|0|||
44433104|NCT00359281|79441627|FG002|Overall Study|Adverse Event|0|||
44433105|NCT00359281|79441628|FG003|Overall Study|Adverse Event|0|||
44539287|NCT01313689|79551031|FG003|24-Week Randomization 1|Physician Decision|0|||
44539288|NCT01313689|79551032|FG004|24-Week Randomization 1|Physician Decision|0|||
44539289|NCT01313689|79551028|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
44539290|NCT01313689|79551029|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
44539291|NCT01313689|79551030|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
44539292|NCT01313689|79551031|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
44539293|NCT01313689|79551032|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
44539294|NCT01313689|79551028|FG000|24-Week Randomization 2|Adverse Event|0|||
44539295|NCT01313689|79551029|FG001|24-Week Randomization 2|Adverse Event|0|||
44539296|NCT01313689|79551030|FG002|24-Week Randomization 2|Adverse Event|2|||
44539297|NCT01313689|79551031|FG003|24-Week Randomization 2|Adverse Event|0|||
44539298|NCT01313689|79551032|FG004|24-Week Randomization 2|Adverse Event|8|||
44539299|NCT01313689|79551028|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
44539300|NCT01313689|79551029|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
44539301|NCT01313689|79551030|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
44539302|NCT01313689|79551031|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
44539303|NCT01313689|79551032|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
44539304|NCT01313689|79551028|FG000|24-Week Randomization 2|Physician Decision|0|||
44539305|NCT01313689|79551029|FG001|24-Week Randomization 2|Physician Decision|0|||
44539306|NCT01313689|79551030|FG002|24-Week Randomization 2|Physician Decision|0|||
44539307|NCT01313689|79551031|FG003|24-Week Randomization 2|Physician Decision|0|||
44539308|NCT01313689|79551032|FG004|24-Week Randomization 2|Physician Decision|4|||
44539309|NCT03318315|79551054|FG000|Overall Study|Lost to Follow-up|3|||
44539310|NCT03318315|79551055|FG001|Overall Study|Lost to Follow-up|2|||
44539311|NCT03318315|79551056|FG002|Overall Study|Lost to Follow-up|1|||
44539312|NCT03318315|79551054|FG000|Overall Study|Protocol Violation|1|||
44539313|NCT03318315|79551055|FG001|Overall Study|Protocol Violation|1|||
44539314|NCT03318315|79551056|FG002|Overall Study|Protocol Violation|1|||
44539315|NCT03318315|79551054|FG000|Overall Study|Withdrawal by Subject|0|||
44539316|NCT03318315|79551055|FG001|Overall Study|Withdrawal by Subject|0|||
44539317|NCT03318315|79551056|FG002|Overall Study|Withdrawal by Subject|2|||
44539318|NCT04460183|79551067|FG000|Overall Study|Lost to Follow-up|3|||
44334996|NCT01106404|79339857|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
44334997|NCT01106404|79339858|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
44334998|NCT01106404|79339857|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
44157388|NCT04716881|78949012|FG000|Overall Study|Lost to Follow-up|1|||
44334999|NCT01106404|79339858|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
44433106|NCT00359281|79441629|FG004|Overall Study|Adverse Event|0|||
44433107|NCT00359281|79441630|FG005|Overall Study|Adverse Event|0|||
44433108|NCT00359281|79441631|FG006|Overall Study|Adverse Event|1|||
44539319|NCT04460183|79551068|FG001|Overall Study|Lost to Follow-up|1|||
44539320|NCT04460183|79551067|FG000|Overall Study|Withdrawal by Subject|1|||
44539321|NCT04460183|79551068|FG001|Overall Study|Withdrawal by Subject|0|||
44539322|NCT03710083|79551074|FG000|Overall Study|Withdrawal by Subject|2|||
44539323|NCT03710083|79551074|FG000|Overall Study|Unsuccessful Procedure|1|||
44335000|NCT01106404|79339857|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
44433109|NCT00359281|79441632|FG007|Overall Study|Adverse Event|0|||
44433110|NCT00359281|79441633|FG008|Overall Study|Adverse Event|0|||
44433111|NCT00359281|79441625|FG000|Overall Study|Withdrawal by Subject|0|||
44433112|NCT00359281|79441626|FG001|Overall Study|Withdrawal by Subject|0|||
44433113|NCT00359281|79441627|FG002|Overall Study|Withdrawal by Subject|0|||
44433114|NCT00359281|79441628|FG003|Overall Study|Withdrawal by Subject|0|||
44433115|NCT00359281|79441629|FG004|Overall Study|Withdrawal by Subject|0|||
44433116|NCT00359281|79441630|FG005|Overall Study|Withdrawal by Subject|0|||
44433117|NCT00359281|79441631|FG006|Overall Study|Withdrawal by Subject|1|||
44433118|NCT00359281|79441632|FG007|Overall Study|Withdrawal by Subject|0|||
44433119|NCT00359281|79441633|FG008|Overall Study|Withdrawal by Subject|0|||
44433120|NCT00366535|79441662|FG000|First Phase: 12 Weeks|Adverse Event|1|||
44433121|NCT00366535|79441663|FG001|First Phase: 12 Weeks|Adverse Event|3|||
44433122|NCT00366535|79441662|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
44433123|NCT00366535|79441663|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
44335001|NCT01106404|79339858|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
44335002|NCT01059799|79339872|FG000|Overall Study|Adverse Event|2|||
44335003|NCT01059799|79339873|FG001|Overall Study|Adverse Event|3|||
44335004|NCT01059799|79339872|FG000|Overall Study|Lack of Efficacy|1|||
44335005|NCT01059799|79339873|FG001|Overall Study|Lack of Efficacy|0|||
44335006|NCT01059799|79339872|FG000|Overall Study|Protocol Violation|3|||
44335007|NCT01059799|79339873|FG001|Overall Study|Protocol Violation|2|||
44335008|NCT01059799|79339872|FG000|Overall Study|Withdrawal criteria|13|||
44335009|NCT01059799|79339873|FG001|Overall Study|Withdrawal criteria|2|||
44335010|NCT01059799|79339872|FG000|Overall Study|Other|12|||
44335011|NCT01059799|79339873|FG001|Overall Study|Other|3|||
44335012|NCT01106248|79339879|FG000|Overall Study|Adverse Event|1|||
44433124|NCT00366535|79441662|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
44433125|NCT00366535|79441663|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
44433126|NCT00366535|79441662|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
44433127|NCT00366535|79441663|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
44433128|NCT00350545|79441677|FG000|Overall Study|Withdrawal by Subject|2|||
44433129|NCT00349921|79441685|FG000|First Spinal Injection|Physician Decision|1|||
44433130|NCT00349921|79441686|FG001|First Spinal Injection|Physician Decision|0|||
44433131|NCT00349921|79441687|FG002|First Spinal Injection|Physician Decision|0|||
44433132|NCT00349921|79441688|FG003|First Spinal Injection|Physician Decision|0|||
44433133|NCT00349921|79441685|FG000|First Spinal Injection|Adverse Event|0|||
44433134|NCT00349921|79441686|FG001|First Spinal Injection|Adverse Event|0|||
44433135|NCT00349921|79441687|FG002|First Spinal Injection|Adverse Event|1|||
44433136|NCT00349921|79441688|FG003|First Spinal Injection|Adverse Event|0|||
44433137|NCT00606021|79441699|FG000|Induction Phase|Death|73|||
44433138|NCT00606021|79441700|FG001|Induction Phase|Death|0|||
44433139|NCT00606021|79441701|FG002|Induction Phase|Death|0|||
44433140|NCT00606021|79441699|FG000|Induction Phase|Physician Decision|2|||
44335013|NCT01106248|79339879|FG000|Overall Study|Administrative|2|||
44335014|NCT01059175|79339885|FG000|Overall Study|Death|17|||
44335015|NCT01059175|79339886|FG001|Overall Study|Death|17|||
44335016|NCT01059175|79339885|FG000|Overall Study|Adverse Event|4|||
44335017|NCT01059175|79339886|FG001|Overall Study|Adverse Event|2|||
44335018|NCT01059175|79339885|FG000|Overall Study|Lost to Follow-up|0|||
44335019|NCT01059175|79339886|FG001|Overall Study|Lost to Follow-up|1|||
44335020|NCT01297491|79339894|FG000|Overall Study|Adverse Event|11|||
44335021|NCT01297491|79339895|FG001|Overall Study|Adverse Event|6|||
44335022|NCT01297491|79339894|FG000|Overall Study|Physician Decision|3|||
44335023|NCT01297491|79339895|FG001|Overall Study|Physician Decision|2|||
44335024|NCT01297491|79339894|FG000|Overall Study|Progressive disease|11|||
44335025|NCT01297491|79339895|FG001|Overall Study|Progressive disease|20|||
44335026|NCT01297491|79339894|FG000|Overall Study|Patient/Guardian decision|3|||
44335027|NCT01297491|79339895|FG001|Overall Study|Patient/Guardian decision|4|||
44335028|NCT01297491|79339894|FG000|Overall Study|Death|2|||
44335029|NCT01297491|79339895|FG001|Overall Study|Death|1|||
44433141|NCT00606021|79441700|FG001|Induction Phase|Physician Decision|0|||
44433142|NCT00606021|79441701|FG002|Induction Phase|Physician Decision|0|||
44433143|NCT00606021|79441699|FG000|Induction Phase|Withdrawal by Subject|2|||
44433144|NCT00606021|79441700|FG001|Induction Phase|Withdrawal by Subject|0|||
44433145|NCT00606021|79441701|FG002|Induction Phase|Withdrawal by Subject|0|||
44433146|NCT00606021|79441699|FG000|Induction Phase|Lost to Follow-up|10|||
44433147|NCT00606021|79441700|FG001|Induction Phase|Lost to Follow-up|0|||
44433148|NCT00606021|79441701|FG002|Induction Phase|Lost to Follow-up|0|||
44335030|NCT01106092|79339905|FG000|Overall Study|Withdrawal by Subject|0|||
44335031|NCT01106092|79339906|FG001|Overall Study|Withdrawal by Subject|0|||
44433149|NCT00606021|79441699|FG000|Maintenance Phase|Death|0|||
44433150|NCT00606021|79441700|FG001|Maintenance Phase|Death|17|||
44433151|NCT00606021|79441701|FG002|Maintenance Phase|Death|15|||
44433152|NCT00606021|79441699|FG000|Maintenance Phase|Physician Decision|0|||
44433153|NCT00606021|79441700|FG001|Maintenance Phase|Physician Decision|1|||
44433154|NCT00606021|79441701|FG002|Maintenance Phase|Physician Decision|0|||
44335032|NCT01106092|79339907|FG002|Overall Study|Withdrawal by Subject|0|||
44335033|NCT01106092|79339908|FG003|Overall Study|Withdrawal by Subject|1|||
44539324|NCT03318003|79551080|FG000|Overall Study|Withdrawal by Subject|1|||
44539325|NCT03318003|79551081|FG001|Overall Study|Withdrawal by Subject|1|||
44539326|NCT03318003|79551080|FG000|Overall Study|fetal loss|0|||
44433155|NCT00606021|79441699|FG000|Maintenance Phase|Lost to Follow-up|0|||
44433156|NCT00606021|79441700|FG001|Maintenance Phase|Lost to Follow-up|5|||
44433157|NCT00606021|79441701|FG002|Maintenance Phase|Lost to Follow-up|2|||
44433158|NCT00337675|79441712|FG000|Overall Study|Adverse Event|10|||
44433159|NCT00337675|79441713|FG001|Overall Study|Adverse Event|9|||
44433160|NCT00337675|79441714|FG002|Overall Study|Adverse Event|19|||
44433161|NCT00337675|79441712|FG000|Overall Study|Lack of Efficacy|10|||
44539327|NCT03318003|79551081|FG001|Overall Study|fetal loss|1|||
44539328|NCT03317379|79551090|FG000|Overall Study|Lost to Follow-up|0|||
44539329|NCT03317379|79551091|FG001|Overall Study|Lost to Follow-up|3|||
44539330|NCT03317379|79551092|FG002|Overall Study|Lost to Follow-up|2|||
44539331|NCT03316911|79551102|FG000|Overall Study|Lost to Follow-up|33|||
44539332|NCT03316911|79551103|FG001|Overall Study|Lost to Follow-up|29|||
44539333|NCT01106391|79551109|FG000|Overall Study|Death|12|||
44539334|NCT01106391|79551109|FG000|Overall Study|Withdrawal by Subject|7|||
44539335|NCT03316131|79551113|FG000|Treatment Period 2|Protocol deviation|1|||
44539336|NCT03316131|79551114|FG001|Treatment Period 2|Protocol deviation|0|||
44539337|NCT03301415|79551120|FG000|Overall Study|Lost to Follow-up|2|||
44539338|NCT03301415|79551120|FG000|Overall Study|Unable to comply with visit schedule|2|||
44335034|NCT01097668|79339920|FG000|Overall Study|Withdrawal by Subject|1|||
44335035|NCT01097668|79339921|FG001|Overall Study|Withdrawal by Subject|2|||
44335036|NCT01097668|79339920|FG000|Overall Study|Lost to Follow-up|1|||
44335037|NCT01097668|79339921|FG001|Overall Study|Lost to Follow-up|0|||
44335038|NCT01325207|79339937|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
44335039|NCT01325207|79339938|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
44335040|NCT01325207|79339939|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
44335041|NCT01325207|79339940|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
44335042|NCT01325207|79339941|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
44335043|NCT01325207|79339942|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
44335044|NCT01325207|79339937|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
44335045|NCT01325207|79339938|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
44335046|NCT01325207|79339939|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
44335047|NCT01325207|79339940|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
44335048|NCT01325207|79339941|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
44335049|NCT01325207|79339942|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
44335050|NCT01325207|79339937|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
44335051|NCT01325207|79339938|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
44335052|NCT01325207|79339939|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
44335053|NCT01325207|79339940|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
44335054|NCT01325207|79339941|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
44335055|NCT01325207|79339942|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
44335056|NCT01325207|79339937|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
44335057|NCT01325207|79339938|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
44335058|NCT01325207|79339939|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
44335059|NCT01325207|79339940|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
44335060|NCT01325207|79339941|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
44335061|NCT01325207|79339942|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
44335062|NCT01325207|79339937|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
44335063|NCT01325207|79339938|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
44335064|NCT01325207|79339939|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
44335065|NCT01325207|79339940|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
44335066|NCT01325207|79339941|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
44335067|NCT01325207|79339942|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
44335068|NCT01325207|79339937|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
44335069|NCT01325207|79339938|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
44335070|NCT01325207|79339939|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
44433162|NCT00337675|79441713|FG001|Overall Study|Lack of Efficacy|7|||
44433163|NCT00337675|79441714|FG002|Overall Study|Lack of Efficacy|9|||
44433164|NCT00337675|79441712|FG000|Overall Study|Lost to Follow-up|22|||
44433165|NCT00337675|79441713|FG001|Overall Study|Lost to Follow-up|19|||
44539339|NCT02732938|79551126|FG000|Overall Study|Death|0|||
44539340|NCT02732938|79551127|FG001|Overall Study|Death|11|||
44539341|NCT02732938|79551128|FG002|Overall Study|Death|0|||
44539342|NCT02732938|79551126|FG000|Overall Study|Randomized but did not receive treatment|0|||
44539343|NCT02732938|79551127|FG001|Overall Study|Randomized but did not receive treatment|1|||
44539344|NCT02732938|79551128|FG002|Overall Study|Randomized but did not receive treatment|0|||
44433166|NCT00337675|79441714|FG002|Overall Study|Lost to Follow-up|17|||
44433167|NCT00337675|79441712|FG000|Overall Study|Physician Decision|9|||
44433168|NCT00337675|79441713|FG001|Overall Study|Physician Decision|17|||
44433169|NCT00337675|79441714|FG002|Overall Study|Physician Decision|14|||
44433170|NCT00337675|79441712|FG000|Overall Study|Protocol Violation|21|||
44433171|NCT00337675|79441713|FG001|Overall Study|Protocol Violation|24|||
44433172|NCT00337675|79441714|FG002|Overall Study|Protocol Violation|19|||
44433173|NCT00337675|79441712|FG000|Overall Study|Withdrawal by Subject|25|||
44433174|NCT00337675|79441713|FG001|Overall Study|Withdrawal by Subject|25|||
44433175|NCT00337675|79441714|FG002|Overall Study|Withdrawal by Subject|19|||
44433176|NCT00337675|79441712|FG000|Overall Study|Progressive Disease|0|||
44433177|NCT00337675|79441713|FG001|Overall Study|Progressive Disease|2|||
44433178|NCT00337675|79441714|FG002|Overall Study|Progressive Disease|0|||
44433179|NCT00337675|79441712|FG000|Overall Study|Trial Terminated|0|||
44335071|NCT01325207|79339940|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
44335072|NCT01325207|79339941|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
44335073|NCT01325207|79339942|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
44335074|NCT01325207|79339937|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
44335075|NCT01325207|79339938|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
44335076|NCT01325207|79339939|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
44433180|NCT00337675|79441713|FG001|Overall Study|Trial Terminated|0|||
44433181|NCT00337675|79441714|FG002|Overall Study|Trial Terminated|2|||
44433182|NCT00337285|79441722|FG000|Overall Study|Withdrawal by Subject|42|||
44433183|NCT00337285|79441722|FG000|Overall Study|Lost to Follow-up|41|||
44433184|NCT00337285|79441722|FG000|Overall Study|Adverse Event|28|||
44433185|NCT00337285|79441722|FG000|Overall Study|Protocol Violation|27|||
44433186|NCT00337285|79441722|FG000|Overall Study|Lack of Efficacy|11|||
44433187|NCT00337285|79441722|FG000|Overall Study|Death|1|||
44433188|NCT00337285|79441722|FG000|Overall Study|Physician Decision|1|||
44433189|NCT00337285|79441722|FG000|Overall Study|Lack of protocol compliance|7|||
44433190|NCT00605865|79441726|FG000|Overall Study|Protocol Violation|115|||
44433191|NCT00348673|79441766|FG000|Stage 1|Randomized but not Treated|0|||
44433192|NCT00348673|79441767|FG001|Stage 1|Randomized but not Treated|0|||
44335077|NCT01325207|79339940|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
44335078|NCT01325207|79339941|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
44335079|NCT01325207|79339942|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
44335080|NCT01324349|79339959|FG000|Overall Study|Death|1|||
44335081|NCT01324349|79339960|FG001|Overall Study|Death|1|||
44335082|NCT01324349|79339959|FG000|Overall Study|Withdrawal by Subject|0|||
44335083|NCT01324349|79339960|FG001|Overall Study|Withdrawal by Subject|1|||
44335084|NCT01095250|79339970|FG000|Overall Study|administrative reasons|8|||
44335085|NCT01095250|79339971|FG001|Overall Study|administrative reasons|10|||
44335086|NCT01095250|79339972|FG002|Overall Study|administrative reasons|7|||
44335087|NCT01095250|79339973|FG003|Overall Study|administrative reasons|5|||
44335088|NCT01095250|79339970|FG000|Overall Study|Withdrawal by Subject|0|||
44335089|NCT01095250|79339971|FG001|Overall Study|Withdrawal by Subject|0|||
44335090|NCT01095250|79339972|FG002|Overall Study|Withdrawal by Subject|1|||
44335091|NCT01095250|79339973|FG003|Overall Study|Withdrawal by Subject|0|||
44335092|NCT01324271|79339983|FG000|Overall Study|Lost to Follow-up|3|||
44335093|NCT01324271|79339984|FG001|Overall Study|Lost to Follow-up|0|||
44335094|NCT01324271|79339983|FG000|Overall Study|Physician Decision|1|||
44335095|NCT01324271|79339984|FG001|Overall Study|Physician Decision|0|||
44433193|NCT00348673|79441768|FG002|Stage 1|Randomized but not Treated|1|||
44259161|NCT03785145|79115811|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
44259162|NCT03785145|79115812|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
44259163|NCT03785145|79115811|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
44259164|NCT03785145|79115812|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
44259165|NCT03785145|79115811|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
44259166|NCT03785145|79115812|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
44259167|NCT03785145|79115811|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
44259168|NCT03785145|79115812|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
44259169|NCT03785145|79115811|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
44259170|NCT03785145|79115812|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
44259171|NCT03785145|79115811|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
44259172|NCT03785145|79115812|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
44259173|NCT03785145|79115811|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
44259174|NCT03785145|79115812|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
44335096|NCT01095094|79339990|FG000|Overall Study|Withdrawal by Subject|1|||
44433194|NCT00348673|79441769|FG003|Stage 1|Randomized but not Treated|0|||
44433195|NCT00348673|79441770|FG004|Stage 1|Randomized but not Treated|0|||
44433196|NCT00348673|79441771|FG005|Stage 1|Randomized but not Treated|0|||
44433197|NCT00348673|79441772|FG006|Stage 1|Randomized but not Treated|0|||
44335097|NCT01095094|79339990|FG000|Overall Study|Death|1|||
44335098|NCT01095094|79339990|FG000|Overall Study|Physician Decision|1|||
44335099|NCT01323647|79339996|FG000|Overall Study|Migrated/moved from study area|2|||
44335100|NCT01323647|79339997|FG001|Overall Study|Migrated/moved from study area|0|||
44335101|NCT01323647|79339996|FG000|Overall Study|Withdrawal by Subject|5|||
44335102|NCT01323647|79339997|FG001|Overall Study|Withdrawal by Subject|0|||
44335103|NCT01323647|79339996|FG000|Overall Study|Lost to Follow-up|2|||
44335104|NCT01323647|79339997|FG001|Overall Study|Lost to Follow-up|0|||
44335105|NCT01094782|79340009|FG000|Overall Study|Withdrawal by Subject|5|||
44335106|NCT01094782|79340010|FG001|Overall Study|Withdrawal by Subject|5|||
44335107|NCT01094782|79340011|FG002|Overall Study|Withdrawal by Subject|1|||
44335108|NCT01094782|79340012|FG003|Overall Study|Withdrawal by Subject|5|||
44335109|NCT01094782|79340013|FG004|Overall Study|Withdrawal by Subject|5|||
44335110|NCT01094782|79340014|FG005|Overall Study|Withdrawal by Subject|0|||
44335111|NCT01094782|79340009|FG000|Overall Study|Lost to Follow-up|1|||
44335112|NCT01094782|79340010|FG001|Overall Study|Lost to Follow-up|0|||
44335113|NCT01094782|79340011|FG002|Overall Study|Lost to Follow-up|0|||
44335114|NCT01094782|79340012|FG003|Overall Study|Lost to Follow-up|2|||
44335115|NCT01094782|79340013|FG004|Overall Study|Lost to Follow-up|1|||
44335116|NCT01094782|79340014|FG005|Overall Study|Lost to Follow-up|4|||
44335117|NCT01094782|79340009|FG000|Overall Study|Positive Drug Screen|2|||
44335118|NCT01094782|79340010|FG001|Overall Study|Positive Drug Screen|2|||
44335119|NCT01094782|79340011|FG002|Overall Study|Positive Drug Screen|1|||
44335120|NCT01094782|79340012|FG003|Overall Study|Positive Drug Screen|1|||
44335121|NCT01094782|79340013|FG004|Overall Study|Positive Drug Screen|3|||
44335122|NCT01094782|79340014|FG005|Overall Study|Positive Drug Screen|2|||
44335123|NCT01094782|79340009|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
44335124|NCT01094782|79340010|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
44335125|NCT01094782|79340011|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
44335126|NCT01094782|79340012|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
44335127|NCT01094782|79340013|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
44335128|NCT01094782|79340014|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
44335129|NCT01094782|79340009|FG000|Overall Study|Unable to Complete Questionnaires|0|||
44335130|NCT01094782|79340010|FG001|Overall Study|Unable to Complete Questionnaires|1|||
44335131|NCT01094782|79340011|FG002|Overall Study|Unable to Complete Questionnaires|0|||
44335132|NCT01094782|79340012|FG003|Overall Study|Unable to Complete Questionnaires|0|||
44335133|NCT01094782|79340013|FG004|Overall Study|Unable to Complete Questionnaires|0|||
44335134|NCT01094782|79340014|FG005|Overall Study|Unable to Complete Questionnaires|0|||
44335135|NCT01094782|79340009|FG000|Overall Study|Healthy Subject Had Pain|0|||
44335136|NCT01094782|79340010|FG001|Overall Study|Healthy Subject Had Pain|1|||
44335137|NCT01094782|79340011|FG002|Overall Study|Healthy Subject Had Pain|0|||
44335138|NCT01094782|79340012|FG003|Overall Study|Healthy Subject Had Pain|0|||
44335139|NCT01094782|79340013|FG004|Overall Study|Healthy Subject Had Pain|0|||
44335140|NCT01094782|79340014|FG005|Overall Study|Healthy Subject Had Pain|0|||
44335141|NCT01094782|79340009|FG000|Overall Study|Hypertension|0|||
44335142|NCT01094782|79340010|FG001|Overall Study|Hypertension|0|||
44335143|NCT01094782|79340011|FG002|Overall Study|Hypertension|1|||
44335144|NCT01094782|79340012|FG003|Overall Study|Hypertension|0|||
44335145|NCT01094782|79340013|FG004|Overall Study|Hypertension|0|||
44335146|NCT01094782|79340014|FG005|Overall Study|Hypertension|0|||
44335147|NCT01094782|79340009|FG000|Overall Study|Wrong Pain Condition|0|||
44335148|NCT01094782|79340010|FG001|Overall Study|Wrong Pain Condition|0|||
44335149|NCT01094782|79340011|FG002|Overall Study|Wrong Pain Condition|0|||
44335150|NCT01094782|79340012|FG003|Overall Study|Wrong Pain Condition|2|||
44335151|NCT01094782|79340013|FG004|Overall Study|Wrong Pain Condition|1|||
44335152|NCT01094782|79340014|FG005|Overall Study|Wrong Pain Condition|1|||
44335153|NCT01094782|79340009|FG000|Overall Study|Recent Interventional Injection|0|||
44335154|NCT01094782|79340010|FG001|Overall Study|Recent Interventional Injection|0|||
44335155|NCT01094782|79340011|FG002|Overall Study|Recent Interventional Injection|0|||
44335156|NCT01094782|79340012|FG003|Overall Study|Recent Interventional Injection|0|||
44335157|NCT01094782|79340013|FG004|Overall Study|Recent Interventional Injection|0|||
44335158|NCT01094782|79340014|FG005|Overall Study|Recent Interventional Injection|1|||
44433198|NCT00348673|79441773|FG007|Stage 1|Randomized but not Treated|0|||
44433199|NCT00348673|79441774|FG008|Stage 1|Randomized but not Treated|0|||
44433200|NCT00337207|79441792|FG000|Overall Study|Withdrawal by Subject|3|||
44433201|NCT00604695|79441799|FG000|Overall Study|Did not receive first bolus.|0|||
44433202|NCT00604695|79441800|FG001|Overall Study|Did not receive first bolus.|4|||
44433203|NCT00348595|79441808|FG000|Overall Study|Adverse Event|5|||
44335159|NCT01094782|79340009|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
44335160|NCT01094782|79340010|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
44335161|NCT01094782|79340011|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
44335162|NCT01094782|79340012|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
44335163|NCT01094782|79340013|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
44433204|NCT00348595|79441809|FG001|Overall Study|Adverse Event|8|||
44433205|NCT00337129|79441815|FG000|Overall Study|Adverse Event|4|||
44335164|NCT01094782|79340014|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
44335165|NCT01094782|79340009|FG000|Overall Study|Noncompliance With Study Schedule|0|||
44335166|NCT01094782|79340010|FG001|Overall Study|Noncompliance With Study Schedule|0|||
44433206|NCT00337129|79441815|FG000|Overall Study|Withdrawal by Subject|1|||
44433207|NCT00337129|79441815|FG000|Overall Study|Lack of Efficacy|32|||
44433208|NCT00337129|79441815|FG000|Overall Study|Death|2|||
44433209|NCT00337129|79441815|FG000|Overall Study|not protocol specified|1|||
44433210|NCT00605085|79441821|FG000|Overall Study|Withdrawal by Subject|8|||
44433211|NCT00605085|79441822|FG001|Overall Study|Withdrawal by Subject|5|||
44433212|NCT00605085|79441821|FG000|Overall Study|Adverse Event|9|||
44433213|NCT00605085|79441822|FG001|Overall Study|Adverse Event|5|||
44433214|NCT00605085|79441821|FG000|Overall Study|Pregnancy|2|||
44433215|NCT00605085|79441822|FG001|Overall Study|Pregnancy|0|||
44433216|NCT00605085|79441821|FG000|Overall Study|Protocol Violation|3|||
44433217|NCT00605085|79441822|FG001|Overall Study|Protocol Violation|2|||
44433218|NCT00605085|79441821|FG000|Overall Study|Lost to Follow-up|10|||
44433219|NCT00605085|79441822|FG001|Overall Study|Lost to Follow-up|5|||
44157389|NCT04666922|78949023|FG000|Overall Study|Withdrawal by Subject|1|||
44157390|NCT04666922|78949024|FG001|Overall Study|Withdrawal by Subject|0|||
44157391|NCT04666922|78949025|FG002|Overall Study|Withdrawal by Subject|0|||
44157392|NCT04666922|78949026|FG003|Overall Study|Withdrawal by Subject|0|||
44157393|NCT04666922|78949027|FG004|Overall Study|Withdrawal by Subject|0|||
44157394|NCT04666922|78949028|FG005|Overall Study|Withdrawal by Subject|0|||
44157395|NCT04666922|78949029|FG006|Overall Study|Withdrawal by Subject|0|||
44157396|NCT04435366|78949059|FG000|Overall Study|Adverse Event|3|||
44157397|NCT04435366|78949060|FG001|Overall Study|Adverse Event|2|||
44157398|NCT04435366|78949059|FG000|Overall Study|Death|2|||
44157399|NCT04435366|78949060|FG001|Overall Study|Death|1|||
44157400|NCT04435366|78949059|FG000|Overall Study|Lost to Follow-up|2|||
44157401|NCT04435366|78949060|FG001|Overall Study|Lost to Follow-up|1|||
44157402|NCT04435366|78949059|FG000|Overall Study|Withdrawal by Subject|17|||
44335167|NCT01094782|79340011|FG002|Overall Study|Noncompliance With Study Schedule|0|||
44335168|NCT01094782|79340012|FG003|Overall Study|Noncompliance With Study Schedule|1|||
44433220|NCT00605085|79441821|FG000|Overall Study|administrative reasons|18|||
44433221|NCT00605085|79441822|FG001|Overall Study|administrative reasons|8|||
44433222|NCT00348283|79441830|FG000|Induction|Adverse Event|0|||
44433223|NCT00348283|79441831|FG001|Induction|Adverse Event|2|||
44433224|NCT00348283|79441830|FG000|Induction|Protocol Violation|0|||
44433225|NCT00348283|79441831|FG001|Induction|Protocol Violation|4|||
44433226|NCT00348283|79441830|FG000|Double Blind|Adverse Event|2|||
44433227|NCT00348283|79441831|FG001|Double Blind|Adverse Event|5|||
44433228|NCT00348283|79441830|FG000|Double Blind|Withdrawal by Subject|1|||
44433229|NCT00348283|79441831|FG001|Double Blind|Withdrawal by Subject|1|||
44433230|NCT00348283|79441830|FG000|Double Blind|Protocol Violation|0|||
44433231|NCT00348283|79441831|FG001|Double Blind|Protocol Violation|1|||
44433232|NCT00348283|79441830|FG000|Double Blind|Lack of Efficacy|2|||
44433233|NCT00348283|79441831|FG001|Double Blind|Lack of Efficacy|2|||
44433234|NCT00348283|79441830|FG000|Double Blind|Pregnancy|0|||
44433235|NCT00348283|79441831|FG001|Double Blind|Pregnancy|1|||
44433236|NCT00348283|79441830|FG000|Open Label|Adverse Event|0|||
44433237|NCT00348283|79441831|FG001|Open Label|Adverse Event|8|||
44433238|NCT00348283|79441830|FG000|Open Label|Withdrawal by Subject|0|||
44433239|NCT00348283|79441831|FG001|Open Label|Withdrawal by Subject|4|||
44433240|NCT00348283|79441830|FG000|Open Label|Lost to Follow-up|0|||
44539345|NCT02732938|79551126|FG000|Overall Study|Refused further follow-up|1|||
44335169|NCT01094782|79340013|FG004|Overall Study|Noncompliance With Study Schedule|0|||
44335170|NCT01094782|79340014|FG005|Overall Study|Noncompliance With Study Schedule|0|||
44335171|NCT01097044|79340030|FG000|Overall Study|Withdrawal by Subject|4|||
44335172|NCT01097044|79340031|FG001|Overall Study|Withdrawal by Subject|4|||
44335173|NCT01097044|79340030|FG000|Overall Study|Lost to Follow-up|1|||
44335174|NCT01097044|79340031|FG001|Overall Study|Lost to Follow-up|0|||
44335175|NCT01097044|79340030|FG000|Overall Study|Withdrawal by Sponsor|0|||
44433241|NCT00348283|79441831|FG001|Open Label|Lost to Follow-up|1|||
44433242|NCT00348283|79441830|FG000|Open Label|Lack of Efficacy|0|||
44433243|NCT00348283|79441831|FG001|Open Label|Lack of Efficacy|13|||
44433244|NCT00348283|79441830|FG000|Open Label|Administrative reasons|0|||
44433245|NCT00348283|79441831|FG001|Open Label|Administrative reasons|5|||
44433246|NCT00348283|79441830|FG000|Open Label|Subject moved to the United States|0|||
44433247|NCT00348283|79441831|FG001|Open Label|Subject moved to the United States|1|||
44433248|NCT00348283|79441830|FG000|Open Label|Pregnancy|0|||
44539346|NCT02732938|79551127|FG001|Overall Study|Refused further follow-up|0|||
44433249|NCT00348283|79441831|FG001|Open Label|Pregnancy|1|||
44433250|NCT00348283|79441830|FG000|Open Label|Sponsor decision|0|||
44433251|NCT00348283|79441831|FG001|Open Label|Sponsor decision|1|||
44433252|NCT00336895|79441837|FG000|Overall Study|diarrhea|1|||
44157403|NCT04435366|78949060|FG001|Overall Study|Withdrawal by Subject|13|||
44157404|NCT04435366|78949059|FG000|Overall Study|Patient non-compliance|1|||
44157405|NCT04435366|78949060|FG001|Overall Study|Patient non-compliance|0|||
44433253|NCT00336895|79441837|FG000|Overall Study|nausea and upset stomach|1|||
44433254|NCT00336895|79441837|FG000|Overall Study|Physician Decision|1|||
44433255|NCT00336895|79441837|FG000|Overall Study|screen failed|1|||
44433256|NCT00336583|79441841|FG000|Overall Study|Lost to Follow-up|1|||
44433257|NCT00336583|79441841|FG000|Overall Study|Death|1|||
44433258|NCT00336505|79441847|FG000|Overall Study|Adverse Event|10|||
44335176|NCT01097044|79340031|FG001|Overall Study|Withdrawal by Sponsor|1|||
44335177|NCT01322009|79340041|FG000|Overall Study|Death|0|||
44335178|NCT01322009|79340042|FG001|Overall Study|Death|1|||
44335179|NCT01322009|79340041|FG000|Overall Study|Adverse Event|0|||
44335180|NCT01322009|79340042|FG001|Overall Study|Adverse Event|1|||
44335181|NCT01322009|79340041|FG000|Overall Study|ng tube discontinued|0|||
44335182|NCT01322009|79340042|FG001|Overall Study|ng tube discontinued|1|||
44335183|NCT01321697|79340048|FG000|Overall Study|Study Terminated|7|||
44335184|NCT01320683|79340052|FG000|Overall Study|Positive antibody response|1|||
44335185|NCT01320293|79340056|FG000|Overall Study|Lack of Efficacy|1|||
44335186|NCT01320293|79340056|FG000|Overall Study|Adverse Event|1|||
44335187|NCT01318811|79340062|FG000|Overall Study|Physician Decision|1|||
44335188|NCT01318811|79340063|FG001|Overall Study|Physician Decision|1|||
44335189|NCT01318811|79340062|FG000|Overall Study|CRRT stopped for head CT|0|||
44335190|NCT01318811|79340063|FG001|Overall Study|CRRT stopped for head CT|1|||
44335191|NCT01318811|79340062|FG000|Overall Study|Death|0|||
44335192|NCT01318811|79340063|FG001|Overall Study|Death|1|||
44335193|NCT01318811|79340062|FG000|Overall Study|CRRT stopped for head MRI|0|||
44335194|NCT01318811|79340063|FG001|Overall Study|CRRT stopped for head MRI|1|||
44335195|NCT01093846|79340072|FG000|Overall Study|Adverse Event|0|||
44335196|NCT01093846|79340073|FG001|Overall Study|Adverse Event|0|||
44335197|NCT01093846|79340074|FG002|Overall Study|Adverse Event|1|||
44335198|NCT01093846|79340072|FG000|Overall Study|Lack of Efficacy|0|||
44335199|NCT01093846|79340073|FG001|Overall Study|Lack of Efficacy|0|||
44335200|NCT01093846|79340074|FG002|Overall Study|Lack of Efficacy|4|||
44335201|NCT01093846|79340072|FG000|Overall Study|Condition no longer required study drug|1|||
44539347|NCT02732938|79551128|FG002|Overall Study|Refused further follow-up|0|||
44539348|NCT02732938|79551126|FG000|Overall Study|Study terminated by sponsor|3|||
44335202|NCT01093846|79340073|FG001|Overall Study|Condition no longer required study drug|1|||
44335203|NCT01093846|79340074|FG002|Overall Study|Condition no longer required study drug|1|||
44335204|NCT01093846|79340072|FG000|Overall Study|Administrative Problems|18|||
44335205|NCT01093846|79340073|FG001|Overall Study|Administrative Problems|17|||
44335206|NCT01093846|79340074|FG002|Overall Study|Administrative Problems|15|||
44335207|NCT01315847|79340082|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
44335208|NCT01315847|79340083|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
44335209|NCT01315847|79340082|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
44335210|NCT01315847|79340083|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
44335211|NCT01093534|79340092|FG000|Overall Study|Adverse Event|2|||
44335212|NCT01093534|79340093|FG001|Overall Study|Adverse Event|5|||
44433259|NCT00336505|79441848|FG001|Overall Study|Adverse Event|9|||
44433260|NCT00336505|79441847|FG000|Overall Study|Lack of Efficacy|8|||
44433261|NCT00336505|79441848|FG001|Overall Study|Lack of Efficacy|4|||
44433262|NCT00336505|79441847|FG000|Overall Study|Lost to Follow-up|7|||
44433263|NCT00336505|79441848|FG001|Overall Study|Lost to Follow-up|4|||
44433264|NCT00336505|79441847|FG000|Overall Study|Withdrawal by Subject|5|||
44433265|NCT00336505|79441848|FG001|Overall Study|Withdrawal by Subject|3|||
44433266|NCT00336505|79441847|FG000|Overall Study|Other|7|||
44433267|NCT00336505|79441848|FG001|Overall Study|Other|7|||
44433268|NCT00357877|79441856|FG000|Overall Study|Death|2|||
44433269|NCT00357877|79441857|FG001|Overall Study|Death|1|||
44433270|NCT00357877|79441856|FG000|Overall Study|Lost to Follow-up|20|||
44433271|NCT00357877|79441857|FG001|Overall Study|Lost to Follow-up|23|||
44433272|NCT00357877|79441856|FG000|Overall Study|Withdrawal by Subject|3|||
44433273|NCT00357877|79441857|FG001|Overall Study|Withdrawal by Subject|3|||
44433274|NCT00357877|79441856|FG000|Overall Study|Administrative withdrawal|1|||
44433275|NCT00357877|79441857|FG001|Overall Study|Administrative withdrawal|1|||
44433276|NCT00357877|79441856|FG000|Overall Study|Other|0|||
44433277|NCT00357877|79441857|FG001|Overall Study|Other|2|||
44539349|NCT02732938|79551127|FG001|Overall Study|Study terminated by sponsor|6|||
44539350|NCT02732938|79551128|FG002|Overall Study|Study terminated by sponsor|0|||
44539351|NCT04647721|79551136|FG000|Overall Study|Withdrawal by Subject|0|||
44539352|NCT04647721|79551137|FG001|Overall Study|Withdrawal by Subject|2|||
44335213|NCT01093534|79340094|FG002|Overall Study|Adverse Event|2|||
44335214|NCT01093534|79340092|FG000|Overall Study|Lack of Efficacy|2|||
44335215|NCT01093534|79340093|FG001|Overall Study|Lack of Efficacy|1|||
44335216|NCT01093534|79340094|FG002|Overall Study|Lack of Efficacy|1|||
44433278|NCT00335959|79441865|FG000|Overall Study|Adverse Event|2|||
44433279|NCT00335959|79441865|FG000|Overall Study|Ineligible|1|||
44433280|NCT00670488|79441880|FG000|Overall Study|Adverse Event|0|||
44433281|NCT00670488|79441881|FG001|Overall Study|Adverse Event|7|||
44433282|NCT00670488|79441882|FG002|Overall Study|Adverse Event|0|||
44539353|NCT04647721|79551136|FG000|Overall Study|Lost to Follow-up|2|||
44433283|NCT00670488|79441883|FG003|Overall Study|Adverse Event|3|||
44433284|NCT00670488|79441884|FG004|Overall Study|Adverse Event|1|||
44433285|NCT00670488|79441885|FG005|Overall Study|Adverse Event|1|||
44433286|NCT00670488|79441886|FG006|Overall Study|Adverse Event|5|||
44433287|NCT00670488|79441887|FG007|Overall Study|Adverse Event|1|||
44433288|NCT00670488|79441888|FG008|Overall Study|Adverse Event|0|||
44433289|NCT00670488|79441889|FG009|Overall Study|Adverse Event|1|||
44433290|NCT00670488|79441880|FG000|Overall Study|Physician Decision|1|||
44433291|NCT00670488|79441881|FG001|Overall Study|Physician Decision|9|||
44433292|NCT00670488|79441882|FG002|Overall Study|Physician Decision|0|||
44433293|NCT00670488|79441883|FG003|Overall Study|Physician Decision|1|||
44433294|NCT00670488|79441884|FG004|Overall Study|Physician Decision|0|||
44433295|NCT00670488|79441885|FG005|Overall Study|Physician Decision|0|||
44433296|NCT00670488|79441886|FG006|Overall Study|Physician Decision|0|||
44433297|NCT00670488|79441887|FG007|Overall Study|Physician Decision|0|||
44433298|NCT00670488|79441888|FG008|Overall Study|Physician Decision|0|||
44433299|NCT00670488|79441889|FG009|Overall Study|Physician Decision|0|||
44433300|NCT00670488|79441880|FG000|Overall Study|Progressive Disease|2|||
44433301|NCT00670488|79441881|FG001|Overall Study|Progressive Disease|41|||
44433302|NCT00670488|79441882|FG002|Overall Study|Progressive Disease|3|||
44433303|NCT00670488|79441883|FG003|Overall Study|Progressive Disease|2|||
44433304|NCT00670488|79441884|FG004|Overall Study|Progressive Disease|2|||
44433305|NCT00670488|79441885|FG005|Overall Study|Progressive Disease|4|||
44433306|NCT00670488|79441886|FG006|Overall Study|Progressive Disease|11|||
44433307|NCT00670488|79441887|FG007|Overall Study|Progressive Disease|2|||
44433308|NCT00670488|79441888|FG008|Overall Study|Progressive Disease|2|||
44433309|NCT00670488|79441889|FG009|Overall Study|Progressive Disease|1|||
44433310|NCT00670488|79441880|FG000|Overall Study|Withdrawal by Subject|0|||
44433311|NCT00670488|79441881|FG001|Overall Study|Withdrawal by Subject|1|||
44433312|NCT00670488|79441882|FG002|Overall Study|Withdrawal by Subject|0|||
44433313|NCT00670488|79441883|FG003|Overall Study|Withdrawal by Subject|1|||
44433314|NCT00670488|79441884|FG004|Overall Study|Withdrawal by Subject|0|||
44433315|NCT00670488|79441885|FG005|Overall Study|Withdrawal by Subject|0|||
44433316|NCT00670488|79441886|FG006|Overall Study|Withdrawal by Subject|1|||
44433317|NCT00670488|79441887|FG007|Overall Study|Withdrawal by Subject|0|||
44433318|NCT00670488|79441888|FG008|Overall Study|Withdrawal by Subject|1|||
44433319|NCT00670488|79441889|FG009|Overall Study|Withdrawal by Subject|0|||
44433320|NCT00671658|79441911|FG000|Overall Study|Physician Decision|5|||
44433321|NCT00542386|79441921|FG000|Overall Study|Adverse Event|1|||
44433322|NCT00542386|79441922|FG001|Overall Study|Adverse Event|7|||
44433323|NCT00542386|79441923|FG002|Overall Study|Adverse Event|7|||
44433324|NCT00542386|79441924|FG003|Overall Study|Adverse Event|8|||
44335217|NCT01093534|79340092|FG000|Overall Study|Withdrawal by Subject|5|||
44335218|NCT01093534|79340093|FG001|Overall Study|Withdrawal by Subject|7|||
44335219|NCT01093534|79340094|FG002|Overall Study|Withdrawal by Subject|2|||
44335220|NCT01093534|79340092|FG000|Overall Study|Other|1|||
44335221|NCT01093534|79340093|FG001|Overall Study|Other|3|||
44335222|NCT01093534|79340094|FG002|Overall Study|Other|4|||
44335223|NCT01314911|79340105|FG000|Overall Study|Lost to Follow-up|3|||
44335224|NCT01314911|79340106|FG001|Overall Study|Lost to Follow-up|2|||
44335225|NCT01314911|79340105|FG000|Overall Study|Withdrawal by Subject|1|||
44335226|NCT01314911|79340106|FG001|Overall Study|Withdrawal by Subject|3|||
44335227|NCT01314911|79340105|FG000|Overall Study|Received Non-randomized Study Drug|0|||
44335228|NCT01314911|79340106|FG001|Overall Study|Received Non-randomized Study Drug|1|||
44335229|NCT01314911|79340105|FG000|Overall Study|Never Started Treatment|1|||
44335230|NCT01314911|79340106|FG001|Overall Study|Never Started Treatment|0|||
44335231|NCT01093222|79340112|FG000|Overall Study|Ineligible|6|||
44335232|NCT01093222|79340112|FG000|Overall Study|Adverse Event|7|||
44335233|NCT01093222|79340112|FG000|Overall Study|Progression/relapse|24|||
44335234|NCT01093222|79340112|FG000|Overall Study|Death|2|||
44335235|NCT01093222|79340112|FG000|Overall Study|Not protocol specified|1|||
44433325|NCT00542386|79441925|FG004|Overall Study|Adverse Event|13|||
44433326|NCT00542386|79441926|FG005|Overall Study|Adverse Event|4|||
44433327|NCT00542386|79441921|FG000|Overall Study|Death|0|||
44433328|NCT00542386|79441922|FG001|Overall Study|Death|0|||
44433329|NCT00542386|79441923|FG002|Overall Study|Death|1|||
44433330|NCT00542386|79441924|FG003|Overall Study|Death|2|||
44335236|NCT01313663|79340118|FG000|Overall Study|Study Closed/Terminated|2|||
44335237|NCT01313663|79340119|FG001|Overall Study|Study Closed/Terminated|4|||
44433331|NCT00542386|79441925|FG004|Overall Study|Death|1|||
44433332|NCT00542386|79441926|FG005|Overall Study|Death|2|||
44433333|NCT00542386|79441921|FG000|Overall Study|Lack of Efficacy|32|||
44433334|NCT00542386|79441922|FG001|Overall Study|Lack of Efficacy|12|||
44433335|NCT00542386|79441923|FG002|Overall Study|Lack of Efficacy|10|||
44433336|NCT00542386|79441924|FG003|Overall Study|Lack of Efficacy|13|||
44433337|NCT00542386|79441925|FG004|Overall Study|Lack of Efficacy|7|||
44433338|NCT00542386|79441926|FG005|Overall Study|Lack of Efficacy|31|||
44433339|NCT00542386|79441921|FG000|Overall Study|Physician Decision|1|||
44433340|NCT00542386|79441922|FG001|Overall Study|Physician Decision|0|||
44433341|NCT00542386|79441923|FG002|Overall Study|Physician Decision|0|||
44335238|NCT01313663|79340118|FG000|Overall Study|Lost to Follow-up|0|||
44335239|NCT01313663|79340119|FG001|Overall Study|Lost to Follow-up|1|||
44335240|NCT01313663|79340118|FG000|Overall Study|Physician Decision|0|||
44335241|NCT01313663|79340119|FG001|Overall Study|Physician Decision|2|||
44335242|NCT01313663|79340118|FG000|Overall Study|Withdrawal by Subject|2|||
44335243|NCT01313663|79340119|FG001|Overall Study|Withdrawal by Subject|1|||
44335244|NCT01092832|79340127|FG000|Overall Study|Other|1|||
44335245|NCT01092832|79340128|FG001|Overall Study|Other|0|||
44335246|NCT01313273|79340136|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
44335247|NCT01313273|79340137|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
44335248|NCT01313273|79340136|FG000|Overall Study|Withdrawal by Subject|1|||
44335249|NCT01313273|79340137|FG001|Overall Study|Withdrawal by Subject|0|||
44335250|NCT01313273|79340136|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
44335251|NCT01313273|79340137|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
44335252|NCT01091974|79340147|FG000|Overall Study|Did not start intervention|3|||
44335253|NCT01091974|79340148|FG001|Overall Study|Did not start intervention|1|||
44335254|NCT01091974|79340149|FG002|Overall Study|Did not start intervention|3|||
44335255|NCT01091974|79340150|FG003|Overall Study|Did not start intervention|1|||
44335256|NCT01091974|79340147|FG000|Overall Study|resumed sleep medication|0|||
44335257|NCT01091974|79340148|FG001|Overall Study|resumed sleep medication|0|||
44433342|NCT00542386|79441924|FG003|Overall Study|Physician Decision|1|||
44433343|NCT00542386|79441925|FG004|Overall Study|Physician Decision|0|||
44433344|NCT00542386|79441926|FG005|Overall Study|Physician Decision|0|||
44433345|NCT00542386|79441921|FG000|Overall Study|Protocol Violation|0|||
44433346|NCT00542386|79441922|FG001|Overall Study|Protocol Violation|0|||
44433347|NCT00542386|79441923|FG002|Overall Study|Protocol Violation|1|||
44433348|NCT00542386|79441924|FG003|Overall Study|Protocol Violation|0|||
44433349|NCT00542386|79441925|FG004|Overall Study|Protocol Violation|0|||
44433350|NCT00542386|79441926|FG005|Overall Study|Protocol Violation|4|||
44433351|NCT00542386|79441921|FG000|Overall Study|Withdrawal by Subject|5|||
44433352|NCT00542386|79441922|FG001|Overall Study|Withdrawal by Subject|8|||
44433353|NCT00542386|79441923|FG002|Overall Study|Withdrawal by Subject|10|||
44433354|NCT00542386|79441924|FG003|Overall Study|Withdrawal by Subject|11|||
44433355|NCT00542386|79441925|FG004|Overall Study|Withdrawal by Subject|15|||
44433356|NCT00542386|79441926|FG005|Overall Study|Withdrawal by Subject|7|||
44433357|NCT00542386|79441921|FG000|Overall Study|Other Reasons|4|||
44433358|NCT00542386|79441922|FG001|Overall Study|Other Reasons|1|||
44433359|NCT00542386|79441923|FG002|Overall Study|Other Reasons|4|||
44433360|NCT00542386|79441924|FG003|Overall Study|Other Reasons|3|||
44433361|NCT00542386|79441925|FG004|Overall Study|Other Reasons|4|||
44433362|NCT00542386|79441926|FG005|Overall Study|Other Reasons|2|||
44433363|NCT00604383|79441942|FG000|Overall Study|Withdrawal by Subject|33|||
44433364|NCT00604383|79441943|FG001|Overall Study|Withdrawal by Subject|31|||
44433365|NCT00604383|79441942|FG000|Overall Study|Lost to Follow-up|24|||
44433366|NCT00604383|79441943|FG001|Overall Study|Lost to Follow-up|19|||
44433367|NCT00604383|79441942|FG000|Overall Study|Death|14|||
44433368|NCT00604383|79441943|FG001|Overall Study|Death|22|||
44335258|NCT01091974|79340149|FG002|Overall Study|resumed sleep medication|1|||
44335259|NCT01091974|79340150|FG003|Overall Study|resumed sleep medication|2|||
44335260|NCT01091974|79340147|FG000|Overall Study|Withdrawal by Subject|1|||
44335261|NCT01091974|79340148|FG001|Overall Study|Withdrawal by Subject|3|||
44433369|NCT00604383|79441942|FG000|Overall Study|Adverse Event|16|||
44433370|NCT00604383|79441943|FG001|Overall Study|Adverse Event|9|||
44433371|NCT00604383|79441942|FG000|Overall Study|Physician Decision|0|||
44433372|NCT00604383|79441943|FG001|Overall Study|Physician Decision|3|||
44433373|NCT00333775|79441952|FG000|Overall Study|Death|144|||
44433374|NCT00333775|79441953|FG001|Overall Study|Death|149|||
44433375|NCT00333775|79441954|FG002|Overall Study|Death|143|||
44335262|NCT01091974|79340149|FG002|Overall Study|Withdrawal by Subject|2|||
44335263|NCT01091974|79340150|FG003|Overall Study|Withdrawal by Subject|2|||
44335264|NCT01091974|79340147|FG000|Overall Study|side-effects|1|||
44433376|NCT00333775|79441952|FG000|Overall Study|In Follow-up When Study Stopped|87|||
44433377|NCT00333775|79441953|FG001|Overall Study|In Follow-up When Study Stopped|92|||
44433378|NCT00333775|79441954|FG002|Overall Study|In Follow-up When Study Stopped|96|||
44433379|NCT00333775|79441952|FG000|Overall Study|Lost to Follow-up|10|||
44335265|NCT01091974|79340148|FG001|Overall Study|side-effects|1|||
44433380|NCT00333775|79441953|FG001|Overall Study|Lost to Follow-up|7|||
44433381|NCT00333775|79441954|FG002|Overall Study|Lost to Follow-up|8|||
44433382|NCT00605475|79441972|FG000|Overall Study|Abnormal Laboratory Values|0|||
44335266|NCT01091974|79340149|FG002|Overall Study|side-effects|0|||
44335267|NCT01091974|79340150|FG003|Overall Study|side-effects|2|||
44335268|NCT01313117|79340160|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
44433383|NCT00605475|79441973|FG001|Overall Study|Abnormal Laboratory Values|0|||
44433384|NCT00605475|79441974|FG002|Overall Study|Abnormal Laboratory Values|0|||
44433385|NCT00605475|79441975|FG003|Overall Study|Abnormal Laboratory Values|0|||
44433386|NCT00605475|79441976|FG004|Overall Study|Abnormal Laboratory Values|0|||
44433387|NCT00605475|79441977|FG005|Overall Study|Abnormal Laboratory Values|0|||
44433388|NCT00605475|79441978|FG006|Overall Study|Abnormal Laboratory Values|0|||
44335269|NCT01313117|79340160|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
44335270|NCT01313039|79340165|FG000|Overall Study|Physician Decision|1|||
44335271|NCT01313039|79340165|FG000|Overall Study|Adverse Event|1|||
44335272|NCT01091662|79340171|FG000|Overall Study|Adverse Event|1|||
44335273|NCT01091662|79340172|FG001|Overall Study|Adverse Event|9|||
44335274|NCT01091662|79340171|FG000|Overall Study|Physician Decision|1|||
44335275|NCT01091662|79340172|FG001|Overall Study|Physician Decision|1|||
44335276|NCT01091662|79340171|FG000|Overall Study|Withdrawal by Subject|7|||
44335277|NCT01091662|79340172|FG001|Overall Study|Withdrawal by Subject|6|||
44335278|NCT01091662|79340171|FG000|Overall Study|met exit criteria|7|||
44335279|NCT01091662|79340172|FG001|Overall Study|met exit criteria|13|||
44335280|NCT01091662|79340171|FG000|Overall Study|met exclusion criteria|1|||
44335281|NCT01091662|79340172|FG001|Overall Study|met exclusion criteria|0|||
44335282|NCT01091662|79340171|FG000|Overall Study|Lost to Follow-up|0|||
44335283|NCT01091662|79340172|FG001|Overall Study|Lost to Follow-up|1|||
44335284|NCT01091662|79340171|FG000|Overall Study|Pregnancy|0|||
44335285|NCT01091662|79340172|FG001|Overall Study|Pregnancy|1|||
44335286|NCT01091662|79340171|FG000|Overall Study|Protocol Violation|0|||
44335287|NCT01091662|79340172|FG001|Overall Study|Protocol Violation|2|||
44335288|NCT01091662|79340171|FG000|Overall Study|unable to swallow capsule|0|||
44335289|NCT01091662|79340172|FG001|Overall Study|unable to swallow capsule|1|||
44335290|NCT01312961|79340185|FG000|Overall Study|Adverse Event|3|||
44335291|NCT01312961|79340186|FG001|Overall Study|Adverse Event|3|||
44335292|NCT01312961|79340185|FG000|Overall Study|Lack of Efficacy|11|||
44335293|NCT01312961|79340186|FG001|Overall Study|Lack of Efficacy|1|||
44335294|NCT01312961|79340185|FG000|Overall Study|Poor compliance to protocol|1|||
44335295|NCT01312961|79340186|FG001|Overall Study|Poor compliance to protocol|0|||
44335296|NCT01312961|79340185|FG000|Overall Study|Other than specified above|2|||
44335297|NCT01312961|79340186|FG001|Overall Study|Other than specified above|3|||
44335298|NCT01311557|79340195|FG000|Overall Study|Serious adverse event|0|||
44335299|NCT01311557|79340196|FG001|Overall Study|Serious adverse event|1|||
44335300|NCT01311557|79340195|FG000|Overall Study|Protocol Violation|4|||
44335301|NCT01311557|79340196|FG001|Overall Study|Protocol Violation|2|||
44335302|NCT01311557|79340195|FG000|Overall Study|Lost to Follow-up|0|||
44335303|NCT01311557|79340196|FG001|Overall Study|Lost to Follow-up|1|||
44335304|NCT01311557|79340195|FG000|Overall Study|Withdrawal by Subject|1|||
44335305|NCT01311557|79340196|FG001|Overall Study|Withdrawal by Subject|2|||
44335306|NCT01310777|79340205|FG000|Overall Study|Adverse Event|23|||
44335307|NCT01310777|79340206|FG001|Overall Study|Adverse Event|1|||
44335308|NCT01310777|79340207|FG002|Overall Study|Adverse Event|15|||
44433389|NCT00605475|79441979|FG007|Overall Study|Abnormal Laboratory Values|0|||
44433390|NCT00605475|79441980|FG008|Overall Study|Abnormal Laboratory Values|1|||
44433391|NCT00605475|79441981|FG009|Overall Study|Abnormal Laboratory Values|0|||
44433392|NCT00605475|79441972|FG000|Overall Study|Administrative problems|0|||
44433393|NCT00605475|79441973|FG001|Overall Study|Administrative problems|0|||
44433394|NCT00605475|79441974|FG002|Overall Study|Administrative problems|0|||
44433395|NCT00605475|79441975|FG003|Overall Study|Administrative problems|0|||
44433396|NCT00605475|79441976|FG004|Overall Study|Administrative problems|0|||
44433397|NCT00605475|79441977|FG005|Overall Study|Administrative problems|0|||
44433398|NCT00605475|79441978|FG006|Overall Study|Administrative problems|1|||
44433399|NCT00605475|79441979|FG007|Overall Study|Administrative problems|0|||
44433400|NCT00605475|79441980|FG008|Overall Study|Administrative problems|0|||
44433401|NCT00605475|79441981|FG009|Overall Study|Administrative problems|0|||
44433402|NCT00605475|79441972|FG000|Overall Study|Lost to Follow-up|0|||
44433403|NCT00605475|79441973|FG001|Overall Study|Lost to Follow-up|0|||
44433404|NCT00605475|79441974|FG002|Overall Study|Lost to Follow-up|0|||
44433405|NCT00605475|79441975|FG003|Overall Study|Lost to Follow-up|0|||
44433406|NCT00605475|79441976|FG004|Overall Study|Lost to Follow-up|0|||
44433407|NCT00605475|79441977|FG005|Overall Study|Lost to Follow-up|0|||
44433408|NCT00605475|79441978|FG006|Overall Study|Lost to Follow-up|0|||
44433409|NCT00605475|79441979|FG007|Overall Study|Lost to Follow-up|0|||
44433410|NCT00605475|79441980|FG008|Overall Study|Lost to Follow-up|1|||
44433411|NCT00605475|79441981|FG009|Overall Study|Lost to Follow-up|1|||
44433412|NCT00605475|79441972|FG000|Overall Study|Protocol Violation|0|||
44433413|NCT00605475|79441973|FG001|Overall Study|Protocol Violation|0|||
44433414|NCT00605475|79441974|FG002|Overall Study|Protocol Violation|0|||
44433415|NCT00605475|79441975|FG003|Overall Study|Protocol Violation|0|||
44539354|NCT04647721|79551137|FG001|Overall Study|Lost to Follow-up|0|||
44539355|NCT03718000|79551158|FG000|Overall Study|Relocation|2|||
44539356|NCT03718000|79551159|FG001|Overall Study|Relocation|4|||
44433416|NCT00605475|79441976|FG004|Overall Study|Protocol Violation|1|||
44539357|NCT03718000|79551158|FG000|Overall Study|Pregnancy|0|||
44539358|NCT03718000|79551159|FG001|Overall Study|Pregnancy|1|||
44335309|NCT01310777|79340205|FG000|Overall Study|Lost to Follow-up|0|||
44335310|NCT01310777|79340206|FG001|Overall Study|Lost to Follow-up|4|||
44433417|NCT00605475|79441977|FG005|Overall Study|Protocol Violation|0|||
44433418|NCT00605475|79441978|FG006|Overall Study|Protocol Violation|0|||
44539359|NCT03063203|79551166|FG000|Overall Study|Chose alternative therapy|3|||
44433419|NCT00605475|79441979|FG007|Overall Study|Protocol Violation|0|||
44433420|NCT00605475|79441980|FG008|Overall Study|Protocol Violation|0|||
44433421|NCT00605475|79441981|FG009|Overall Study|Protocol Violation|0|||
44433422|NCT00605475|79441972|FG000|Overall Study|Withdrawal by Subject|0|||
44433423|NCT00605475|79441973|FG001|Overall Study|Withdrawal by Subject|0|||
44433424|NCT00605475|79441974|FG002|Overall Study|Withdrawal by Subject|0|||
44433425|NCT00605475|79441975|FG003|Overall Study|Withdrawal by Subject|0|||
44433426|NCT00605475|79441976|FG004|Overall Study|Withdrawal by Subject|0|||
44433427|NCT00605475|79441977|FG005|Overall Study|Withdrawal by Subject|2|||
44433428|NCT00605475|79441978|FG006|Overall Study|Withdrawal by Subject|0|||
44335311|NCT01310777|79340207|FG002|Overall Study|Lost to Follow-up|1|||
44335312|NCT01310777|79340205|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
44335313|NCT01310777|79340206|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
44335314|NCT01310777|79340207|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
44335315|NCT01310777|79340205|FG000|Overall Study|Inadequate Control of IOP|5|||
44335316|NCT01310777|79340206|FG001|Overall Study|Inadequate Control of IOP|7|||
44335317|NCT01310777|79340207|FG002|Overall Study|Inadequate Control of IOP|10|||
44433429|NCT00605475|79441979|FG007|Overall Study|Withdrawal by Subject|0|||
44433430|NCT00605475|79441980|FG008|Overall Study|Withdrawal by Subject|0|||
44433431|NCT00605475|79441981|FG009|Overall Study|Withdrawal by Subject|1|||
44433432|NCT00333619|79442026|FG000|Overall Study|Death|12|||
44433433|NCT00333619|79442027|FG001|Overall Study|Death|6|||
44433434|NCT00333619|79442026|FG000|Overall Study|Withdrawal by Subject|6|||
44539360|NCT03063203|79551166|FG000|Overall Study|Death|2|||
44539361|NCT03063203|79551166|FG000|Overall Study|Disease progression|4|||
44539362|NCT03063203|79551166|FG000|Overall Study|Physician Decision|5|||
44539363|NCT02891226|79551185|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
44539364|NCT02891226|79551186|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
44539365|NCT02891226|79551187|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
44539366|NCT02891226|79551188|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539367|NCT02891226|79551189|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539368|NCT02891226|79551190|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539369|NCT02891226|79551191|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539370|NCT02891226|79551192|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539371|NCT02891226|79551193|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539372|NCT02891226|79551194|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539373|NCT02891226|79551195|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539374|NCT02891226|79551196|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539375|NCT02891226|79551197|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539376|NCT02891226|79551198|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539377|NCT02891226|79551199|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539378|NCT02891226|79551200|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
44539379|NCT02891226|79551185|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
44539380|NCT02891226|79551186|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
44539381|NCT02891226|79551187|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539382|NCT02891226|79551188|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539383|NCT02891226|79551189|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539384|NCT02891226|79551190|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539385|NCT02891226|79551191|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539386|NCT02891226|79551192|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539387|NCT02891226|79551193|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539388|NCT02891226|79551194|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539389|NCT02891226|79551195|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539390|NCT02891226|79551196|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539391|NCT02891226|79551197|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44335318|NCT01310777|79340205|FG000|Overall Study|Other|4|||
44335319|NCT01310777|79340206|FG001|Overall Study|Other|1|||
44335320|NCT01310777|79340207|FG002|Overall Study|Other|2|||
44335321|NCT01310699|79340217|FG000|Overall Study|Patients did not complete tandem.|4|||
44433435|NCT00333619|79442027|FG001|Overall Study|Withdrawal by Subject|1|||
44433436|NCT00333619|79442026|FG000|Overall Study|Lost to Follow-up|3|||
44335322|NCT01310699|79340218|FG001|Overall Study|Patients did not complete tandem.|6|||
44335323|NCT01310075|79340228|FG000|Overall Study|Lost to Follow-up|1|||
44433437|NCT00333619|79442027|FG001|Overall Study|Lost to Follow-up|3|||
44433438|NCT00605319|79442035|FG000|Overall Study|Adverse Event|6|||
44433439|NCT00333229|79442047|FG000|Overall Study|Lack of Efficacy|0|||
44433440|NCT00333229|79442048|FG001|Overall Study|Lack of Efficacy|1|||
44433441|NCT00332839|79442056|FG000|Core (Months 0 - 12)|Administrative problems|1|||
44539392|NCT02891226|79551198|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539393|NCT02891226|79551199|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539394|NCT02891226|79551200|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
44539395|NCT02891226|79551185|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539396|NCT02891226|79551186|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539397|NCT02891226|79551187|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44335324|NCT01310075|79340229|FG001|Overall Study|Lost to Follow-up|0|||
44335325|NCT01310075|79340228|FG000|Overall Study|Physician Decision|10|||
44433442|NCT00332839|79442057|FG001|Core (Months 0 - 12)|Administrative problems|1|||
44433443|NCT00332839|79442056|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
44433444|NCT00332839|79442057|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
44433445|NCT00332839|79442056|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
44433446|NCT00332839|79442057|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
44433447|NCT00332839|79442056|FG000|Core (Months 0 - 12)|Adverse Event|5|||
44433448|NCT00332839|79442057|FG001|Core (Months 0 - 12)|Adverse Event|15|||
44433449|NCT00332839|79442056|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
44539398|NCT02891226|79551188|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
44539399|NCT02891226|79551189|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539400|NCT02891226|79551190|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539401|NCT02891226|79551191|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539402|NCT02891226|79551192|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539403|NCT02891226|79551193|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539404|NCT02891226|79551194|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539405|NCT02891226|79551195|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539406|NCT02891226|79551196|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539407|NCT02891226|79551197|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539408|NCT02891226|79551198|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539409|NCT02891226|79551199|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539410|NCT02891226|79551200|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
44539411|NCT02891226|79551185|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539412|NCT02891226|79551186|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539413|NCT02891226|79551187|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
44539414|NCT02891226|79551188|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539415|NCT02891226|79551189|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539416|NCT02891226|79551190|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539417|NCT02891226|79551191|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539418|NCT02891226|79551192|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539419|NCT02891226|79551193|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539420|NCT02891226|79551194|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539421|NCT02891226|79551195|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539422|NCT02891226|79551196|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539423|NCT02891226|79551197|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539424|NCT02891226|79551198|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539425|NCT02891226|79551199|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539426|NCT02891226|79551200|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
44539427|NCT02891226|79551185|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539428|NCT02891226|79551186|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539429|NCT02891226|79551187|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539430|NCT02891226|79551188|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
44539431|NCT02891226|79551189|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539432|NCT02891226|79551190|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539433|NCT02891226|79551191|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539434|NCT02891226|79551192|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44433450|NCT00332839|79442057|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
44433451|NCT00332839|79442056|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
44539435|NCT02891226|79551193|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539436|NCT02891226|79551194|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539437|NCT02891226|79551195|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44335326|NCT01310075|79340229|FG001|Overall Study|Physician Decision|7|||
44335327|NCT01310075|79340228|FG000|Overall Study|Protocol Violation|2|||
44335328|NCT01310075|79340229|FG001|Overall Study|Protocol Violation|2|||
44335329|NCT01310075|79340228|FG000|Overall Study|Withdrawal by Subject|1|||
44433452|NCT00332839|79442057|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
44433453|NCT00332839|79442056|FG000|Follow-up (Months 12 - 60)|Death|1|||
44433454|NCT00332839|79442057|FG001|Follow-up (Months 12 - 60)|Death|1|||
44433455|NCT00357097|79442065|FG000|Overall Study|Did not meet inclusion criteria|5|||
44433456|NCT00357097|79442066|FG001|Overall Study|Did not meet inclusion criteria|3|||
44539438|NCT02891226|79551196|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539439|NCT02891226|79551197|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44335330|NCT01310075|79340229|FG001|Overall Study|Withdrawal by Subject|1|||
44433457|NCT00357097|79442065|FG000|Overall Study|Adverse Event|34|||
44539440|NCT02891226|79551198|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44539441|NCT02891226|79551199|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44335331|NCT01309997|79340237|FG000|Overall Study|Adverse Event|1|||
44539442|NCT02891226|79551200|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
44433458|NCT00357097|79442066|FG001|Overall Study|Adverse Event|6|||
44433459|NCT00357097|79442065|FG000|Overall Study|Withdrawal by Subject|8|||
44433460|NCT00357097|79442066|FG001|Overall Study|Withdrawal by Subject|7|||
44433461|NCT00357097|79442065|FG000|Overall Study|Non-compliance|1|||
44433462|NCT00357097|79442066|FG001|Overall Study|Non-compliance|2|||
44433463|NCT00357097|79442065|FG000|Overall Study|Lack of Efficacy|2|||
44433464|NCT00357097|79442066|FG001|Overall Study|Lack of Efficacy|8|||
44433465|NCT00357097|79442065|FG000|Overall Study|Met Exclusion Criteria|3|||
44433466|NCT00357097|79442066|FG001|Overall Study|Met Exclusion Criteria|1|||
44433467|NCT00357097|79442065|FG000|Overall Study|Other|1|||
44433468|NCT00357097|79442066|FG001|Overall Study|Other|1|||
44335332|NCT01309997|79340238|FG001|Overall Study|Adverse Event|0|||
44335333|NCT01309997|79340237|FG000|Overall Study|Death|1|||
44335334|NCT01309997|79340238|FG001|Overall Study|Death|3|||
44335335|NCT01309997|79340237|FG000|Overall Study|Lack of Efficacy|2|||
44335336|NCT01309997|79340238|FG001|Overall Study|Lack of Efficacy|2|||
44335337|NCT01309997|79340237|FG000|Overall Study|Withdrawal by Subject|1|||
44335338|NCT01309997|79340238|FG001|Overall Study|Withdrawal by Subject|1|||
44335339|NCT01309919|79340257|FG000|Overall Study|Did not receive a postpartum IUD|17|||
44335340|NCT01309919|79340258|FG001|Overall Study|Did not receive a postpartum IUD|48|||
44335341|NCT01309841|79340267|FG000|Overall Study|Other|0|||
44335342|NCT01309841|79340268|FG001|Overall Study|Other|1|||
44335343|NCT01309841|79340269|FG002|Overall Study|Other|1|||
44335344|NCT01309841|79340267|FG000|Overall Study|Lost to Follow-up|7|||
44433469|NCT00357097|79442065|FG000|Overall Study|Increase of RLS Symptoms|0|||
44433470|NCT00357097|79442066|FG001|Overall Study|Increase of RLS Symptoms|1|||
44433471|NCT00356863|79442074|FG000|Overall Study|Death|16|||
44433472|NCT00356863|79442075|FG001|Overall Study|Death|32|||
44433473|NCT00356863|79442074|FG000|Overall Study|Lost to Follow-up|76|||
44433474|NCT00356863|79442075|FG001|Overall Study|Lost to Follow-up|43|||
44433475|NCT00355615|79442098|FG000|Randomized Double Blind Period|Adverse Event|1|||
44433476|NCT00355615|79442099|FG001|Randomized Double Blind Period|Adverse Event|0|||
44433477|NCT00355615|79442100|FG002|Randomized Double Blind Period|Adverse Event|0|||
44433478|NCT00355615|79442101|FG003|Randomized Double Blind Period|Adverse Event|0|||
44433479|NCT00355615|79442102|FG004|Randomized Double Blind Period|Adverse Event|0|||
44433480|NCT00355615|79442098|FG000|Randomized Double Blind Period|Protocol Violation|0|||
44433481|NCT00355615|79442099|FG001|Randomized Double Blind Period|Protocol Violation|0|||
44433482|NCT00355615|79442100|FG002|Randomized Double Blind Period|Protocol Violation|1|||
44433483|NCT00355615|79442101|FG003|Randomized Double Blind Period|Protocol Violation|1|||
44433484|NCT00355615|79442102|FG004|Randomized Double Blind Period|Protocol Violation|0|||
44433485|NCT00355615|79442098|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
44433486|NCT00355615|79442099|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
44433487|NCT00355615|79442100|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
44433488|NCT00355615|79442101|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
44433489|NCT00355615|79442102|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
44433490|NCT00355615|79442098|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
44433491|NCT00355615|79442099|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
44433492|NCT00355615|79442100|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
44433493|NCT00355615|79442101|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
44433494|NCT00355615|79442102|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
44433495|NCT00355615|79442098|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
44433496|NCT00355615|79442099|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
44433497|NCT00355615|79442100|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
44259175|NCT03785145|79115811|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
44259176|NCT03785145|79115812|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
44259177|NCT03785145|79115811|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
44259178|NCT03785145|79115812|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
44259179|NCT03320330|79115838|FG000|Overall Study|Lack of Efficacy|5|||
44259180|NCT03320330|79115839|FG001|Overall Study|Lack of Efficacy|5|||
44259181|NCT03320330|79115840|FG002|Overall Study|Lack of Efficacy|14|||
44259182|NCT03320330|79115838|FG000|Overall Study|Physician Decision|1|||
44259183|NCT03320330|79115839|FG001|Overall Study|Physician Decision|0|||
44259184|NCT03320330|79115840|FG002|Overall Study|Physician Decision|0|||
44259185|NCT03284788|79115873|FG000|Overall Study|Withdrawal by Subject|2|||
44259186|NCT03082612|79115879|FG000|Overall Study|Lost to Follow-up|2|||
44433498|NCT00355615|79442101|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
44433499|NCT00355615|79442102|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
44433500|NCT00355615|79442098|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
44259187|NCT03082612|79115880|FG001|Overall Study|Lost to Follow-up|0|||
44335345|NCT01309841|79340268|FG001|Overall Study|Lost to Follow-up|6|||
44335346|NCT01309841|79340269|FG002|Overall Study|Lost to Follow-up|4|||
44335347|NCT01309841|79340267|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
44335348|NCT01309841|79340268|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
44335349|NCT01309841|79340269|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
44335350|NCT01309841|79340267|FG000|Overall Study|Lack of Efficacy|0|||
44433501|NCT00355615|79442099|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
44433502|NCT00355615|79442100|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
44433503|NCT00355615|79442101|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
44433504|NCT00355615|79442102|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
44433505|NCT00347269|79442115|FG000|Overall Study|Lost to Follow-up|74|||
44433506|NCT00347269|79442116|FG001|Overall Study|Lost to Follow-up|65|||
44433507|NCT00347269|79442115|FG000|Overall Study|Withdrawal by Subject|18|||
44433508|NCT00347269|79442116|FG001|Overall Study|Withdrawal by Subject|38|||
44433509|NCT00347269|79442115|FG000|Overall Study|Death|2|||
44433510|NCT00347269|79442116|FG001|Overall Study|Death|3|||
44433511|NCT00544648|79442124|FG000|Overall Study|Withdrawal by Subject|1|||
44433512|NCT00544648|79442125|FG001|Overall Study|Withdrawal by Subject|0|||
44433513|NCT00544648|79442124|FG000|Overall Study|Adverse Event|1|||
44433514|NCT00544648|79442125|FG001|Overall Study|Adverse Event|1|||
44433515|NCT00544648|79442124|FG000|Overall Study|progression of disease|1|||
44433516|NCT00544648|79442125|FG001|Overall Study|progression of disease|0|||
44433517|NCT00346333|79442135|FG000|Overall Study|Death|1|||
44433518|NCT00346333|79442136|FG001|Overall Study|Death|0|||
44433519|NCT00346333|79442135|FG000|Overall Study|unwilling or unable to continue|4|||
44433520|NCT00346333|79442136|FG001|Overall Study|unwilling or unable to continue|8|||
44433521|NCT00330967|79442146|FG000|Overall Study|Withdrawal by Subject|0|||
44433522|NCT00330967|79442147|FG001|Overall Study|Withdrawal by Subject|5|||
44433523|NCT00330967|79442146|FG000|Overall Study|Physician Decision|0|||
44433524|NCT00330967|79442147|FG001|Overall Study|Physician Decision|9|||
44433525|NCT00330343|79442153|FG000|Overall Study|Lost to Follow-up|5|||
44433526|NCT00330187|79442161|FG000|Overall Study|Lost to Follow-up|12|||
44335351|NCT01309841|79340268|FG001|Overall Study|Lack of Efficacy|0|||
44335352|NCT01309841|79340269|FG002|Overall Study|Lack of Efficacy|2|||
44335353|NCT01309841|79340267|FG000|Overall Study|Adverse Event|9|||
44335354|NCT01309841|79340268|FG001|Overall Study|Adverse Event|22|||
44335355|NCT01309841|79340269|FG002|Overall Study|Adverse Event|11|||
44335356|NCT01309841|79340267|FG000|Overall Study|Death|1|||
44335357|NCT01309841|79340268|FG001|Overall Study|Death|0|||
44335358|NCT01309841|79340269|FG002|Overall Study|Death|0|||
44335359|NCT01309841|79340267|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44335360|NCT01309841|79340268|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44335361|NCT01309841|79340269|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
44335362|NCT01309841|79340267|FG000|Overall Study|Withdrawal by Subject|17|||
44335363|NCT01309841|79340268|FG001|Overall Study|Withdrawal by Subject|6|||
44335364|NCT01309841|79340269|FG002|Overall Study|Withdrawal by Subject|13|||
44335365|NCT01309841|79340267|FG000|Overall Study|Did Not Receive Treatment|2|||
44335366|NCT01309841|79340268|FG001|Overall Study|Did Not Receive Treatment|0|||
44433527|NCT00330187|79442162|FG001|Overall Study|Lost to Follow-up|13|||
44433528|NCT00330187|79442163|FG002|Overall Study|Lost to Follow-up|14|||
44433529|NCT00330187|79442164|FG003|Overall Study|Lost to Follow-up|10|||
44433530|NCT00330187|79442161|FG000|Overall Study|Withdrawal by Subject|8|||
44433531|NCT00330187|79442162|FG001|Overall Study|Withdrawal by Subject|5|||
44433532|NCT00330187|79442163|FG002|Overall Study|Withdrawal by Subject|4|||
44433533|NCT00330187|79442164|FG003|Overall Study|Withdrawal by Subject|4|||
44433534|NCT03914950|79442174|FG000|Overall Study|Physician Decision|54|||
44433535|NCT00329797|79442186|FG000|Overall Study|Protocol Violation|1|||
44335367|NCT01309841|79340269|FG002|Overall Study|Did Not Receive Treatment|1|||
44335368|NCT01309841|79340267|FG000|Overall Study|Severe non-compliance with protocol|0|||
44335369|NCT01309841|79340268|FG001|Overall Study|Severe non-compliance with protocol|5|||
44335370|NCT01309841|79340269|FG002|Overall Study|Severe non-compliance with protocol|2|||
44335371|NCT01308749|79340279|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
44335372|NCT01308749|79340280|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
44335373|NCT01308749|79340279|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
44433536|NCT00329797|79442187|FG001|Overall Study|Protocol Violation|0|||
44433537|NCT00329797|79442186|FG000|Overall Study|Withdrawal by Subject|6|||
44433538|NCT00329797|79442187|FG001|Overall Study|Withdrawal by Subject|6|||
44433539|NCT00541450|79442195|FG000|Phase A|Adverse Event|3|||
44433540|NCT00541450|79442196|FG001|Phase A|Adverse Event|0|||
44539443|NCT02891226|79551185|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539444|NCT02891226|79551186|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539445|NCT02891226|79551187|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539446|NCT02891226|79551188|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
44539447|NCT02891226|79551189|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44335374|NCT01308749|79340280|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
44335375|NCT01308749|79340279|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
44335376|NCT01308749|79340280|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
44335377|NCT01307891|79340302|FG000|Overall Study|Progressive Disease|3|||
44335378|NCT01307891|79340303|FG001|Overall Study|Progressive Disease|1|||
44433541|NCT00541450|79442195|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
44433542|NCT00541450|79442196|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
44433543|NCT00541450|79442195|FG000|Phase A|Hyperglycemia|0|||
44433544|NCT00541450|79442196|FG001|Phase A|Hyperglycemia|1|||
44433545|NCT00541450|79442195|FG000|Phase A|Lost to Follow-up|6|||
44433546|NCT00541450|79442196|FG001|Phase A|Lost to Follow-up|4|||
44433547|NCT00541450|79442195|FG000|Phase A|Physician Decision|2|||
44433548|NCT00541450|79442196|FG001|Phase A|Physician Decision|0|||
44433549|NCT00541450|79442195|FG000|Phase A|Protocol Violation|2|||
44433550|NCT00541450|79442196|FG001|Phase A|Protocol Violation|3|||
44433551|NCT00541450|79442195|FG000|Phase A|Withdrawal by Subject|7|||
44433552|NCT00541450|79442196|FG001|Phase A|Withdrawal by Subject|7|||
44433553|NCT00541450|79442195|FG000|Phase B|Adverse Event|6|||
44433554|NCT00541450|79442196|FG001|Phase B|Adverse Event|6|||
44433555|NCT00541450|79442195|FG000|Phase B|Hyperglycemia|10|||
44433556|NCT00541450|79442196|FG001|Phase B|Hyperglycemia|9|||
44433557|NCT00541450|79442195|FG000|Phase B|Lost to Follow-up|6|||
44433558|NCT00541450|79442196|FG001|Phase B|Lost to Follow-up|4|||
44433559|NCT00541450|79442195|FG000|Phase B|Physician Decision|4|||
44433560|NCT00541450|79442196|FG001|Phase B|Physician Decision|2|||
44433561|NCT00541450|79442195|FG000|Phase B|Pregnancy|0|||
44433562|NCT00541450|79442196|FG001|Phase B|Pregnancy|1|||
44433563|NCT00541450|79442195|FG000|Phase B|Protocol Violation|3|||
44433564|NCT00541450|79442196|FG001|Phase B|Protocol Violation|3|||
44433565|NCT00541450|79442195|FG000|Phase B|Withdrawal by Subject|8|||
44433566|NCT00541450|79442196|FG001|Phase B|Withdrawal by Subject|6|||
44433567|NCT00355147|79442208|FG000|Overall Study|Lost to Follow-up|10|||
44433568|NCT00355147|79442209|FG001|Overall Study|Lost to Follow-up|8|||
44433569|NCT00355147|79442208|FG000|Overall Study|Withdrawal by Subject|8|||
44433570|NCT00355147|79442209|FG001|Overall Study|Withdrawal by Subject|12|||
44433571|NCT00540124|79442222|FG000|Overall Study|Adverse Event|0|||
44433572|NCT00540124|79442223|FG001|Overall Study|Adverse Event|2|||
44433573|NCT00540124|79442224|FG002|Overall Study|Adverse Event|1|||
44433574|NCT00540124|79442222|FG000|Overall Study|Entry Criteria Not Met|2|||
44433575|NCT00540124|79442223|FG001|Overall Study|Entry Criteria Not Met|0|||
44433576|NCT00540124|79442224|FG002|Overall Study|Entry Criteria Not Met|0|||
44433577|NCT00540124|79442222|FG000|Overall Study|Lack of Efficacy|1|||
44433578|NCT00540124|79442223|FG001|Overall Study|Lack of Efficacy|0|||
44433579|NCT00540124|79442224|FG002|Overall Study|Lack of Efficacy|0|||
44433580|NCT00540124|79442222|FG000|Overall Study|Withdrawal by Subject|1|||
44433581|NCT00540124|79442223|FG001|Overall Study|Withdrawal by Subject|1|||
44433582|NCT00540124|79442224|FG002|Overall Study|Withdrawal by Subject|0|||
44433583|NCT00540046|79442234|FG000|Overall Study|Lost to Follow-up|33|||
44433584|NCT00540046|79442235|FG001|Overall Study|Lost to Follow-up|23|||
44433585|NCT00689936|79442246|FG000|Active Treatment Phase|Adverse Event|68|||
44433586|NCT00689936|79442247|FG001|Active Treatment Phase|Adverse Event|71|||
44433587|NCT00689936|79442248|FG002|Active Treatment Phase|Adverse Event|76|||
44433588|NCT00689936|79442246|FG000|Active Treatment Phase|Disease Progression|273|||
44433589|NCT00689936|79442247|FG001|Active Treatment Phase|Disease Progression|362|||
44433590|NCT00689936|79442248|FG002|Active Treatment Phase|Disease Progression|339|||
44433591|NCT00689936|79442246|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
44433592|NCT00689936|79442247|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
44433593|NCT00689936|79442248|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
44433594|NCT00689936|79442246|FG000|Active Treatment Phase|Death|60|||
44433595|NCT00689936|79442247|FG001|Active Treatment Phase|Death|28|||
44433596|NCT00689936|79442248|FG002|Active Treatment Phase|Death|37|||
44433597|NCT00689936|79442246|FG000|Active Treatment Phase|Lost to Follow-up|0|||
44433598|NCT00689936|79442247|FG001|Active Treatment Phase|Lost to Follow-up|2|||
44539448|NCT02891226|79551190|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539449|NCT02891226|79551191|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539450|NCT02891226|79551192|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539451|NCT02891226|79551193|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539452|NCT02891226|79551194|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539453|NCT02891226|79551195|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539454|NCT02891226|79551196|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539455|NCT02891226|79551197|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44433599|NCT00689936|79442248|FG002|Active Treatment Phase|Lost to Follow-up|2|||
44539456|NCT02891226|79551198|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539457|NCT02891226|79551199|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44539458|NCT02891226|79551200|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
44335379|NCT01307579|79340311|FG000|Overall Study|Death|3|||
44433600|NCT00689936|79442246|FG000|Active Treatment Phase|Protocol Violation|2|||
44433601|NCT00689936|79442247|FG001|Active Treatment Phase|Protocol Violation|2|||
44433602|NCT00689936|79442248|FG002|Active Treatment Phase|Protocol Violation|4|||
44433603|NCT00689936|79442246|FG000|Active Treatment Phase|Study Close Out|64|||
44433604|NCT00689936|79442247|FG001|Active Treatment Phase|Study Close Out|26|||
44433605|NCT00689936|79442248|FG002|Active Treatment Phase|Study Close Out|21|||
44335380|NCT01307579|79340312|FG001|Overall Study|Death|6|||
44539459|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44433606|NCT00689936|79442246|FG000|Active Treatment Phase|Miscellaneous|52|||
44433607|NCT00689936|79442247|FG001|Active Treatment Phase|Miscellaneous|34|||
44433608|NCT00689936|79442248|FG002|Active Treatment Phase|Miscellaneous|47|||
44433609|NCT00689936|79442246|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
44433610|NCT00689936|79442247|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
44433611|NCT00689936|79442248|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
44433612|NCT00671034|79442259|FG000|Overall Study|Adverse Event|5|||
44433613|NCT00671034|79442260|FG001|Overall Study|Adverse Event|7|||
44433614|NCT00671034|79442261|FG002|Overall Study|Adverse Event|1|||
44433615|NCT00671034|79442259|FG000|Overall Study|Death|3|||
44433616|NCT00671034|79442260|FG001|Overall Study|Death|2|||
44433617|NCT00671034|79442261|FG002|Overall Study|Death|1|||
44433618|NCT00671034|79442259|FG000|Overall Study|Physician Decision|12|||
44433619|NCT00671034|79442260|FG001|Overall Study|Physician Decision|4|||
44433620|NCT00671034|79442261|FG002|Overall Study|Physician Decision|5|||
44433621|NCT00671034|79442259|FG000|Overall Study|VHR ALL feature|8|||
44433622|NCT00671034|79442260|FG001|Overall Study|VHR ALL feature|3|||
44433623|NCT00671034|79442261|FG002|Overall Study|VHR ALL feature|5|||
44433624|NCT00671034|79442259|FG000|Overall Study|Refusal|5|||
44433625|NCT00671034|79442260|FG001|Overall Study|Refusal|3|||
44433626|NCT00671034|79442261|FG002|Overall Study|Refusal|5|||
44433627|NCT00671034|79442259|FG000|Overall Study|includes Alternative therapy, etc.|6|||
44433628|NCT00671034|79442260|FG001|Overall Study|includes Alternative therapy, etc.|1|||
44433629|NCT00671034|79442261|FG002|Overall Study|includes Alternative therapy, etc.|7|||
44433630|NCT02679508|79442272|FG000|Healing Phase|Protocol Violation|1|||
44433631|NCT02679508|79442273|FG001|Healing Phase|Protocol Violation|1|||
44433632|NCT02679508|79442272|FG000|Healing Phase|Lost to Follow-up|1|||
44433633|NCT02679508|79442273|FG001|Healing Phase|Lost to Follow-up|0|||
44433634|NCT02679508|79442272|FG000|Maintenance Phase|Adverse Event|12|||
44433635|NCT02679508|79442273|FG001|Maintenance Phase|Adverse Event|2|||
44433636|NCT02679508|79442272|FG000|Maintenance Phase|Lost to Follow-up|0|||
44433637|NCT02679508|79442273|FG001|Maintenance Phase|Lost to Follow-up|1|||
44433638|NCT02679508|79442272|FG000|Maintenance Phase|Withdrawal by Subject|15|||
44433639|NCT02679508|79442273|FG001|Maintenance Phase|Withdrawal by Subject|8|||
44433640|NCT02679508|79442272|FG000|Maintenance Phase|Other|5|||
44433641|NCT02679508|79442273|FG001|Maintenance Phase|Other|4|||
44433642|NCT04404478|79442281|FG000|Overall Study|Withdrawal by Subject|1|||
44433643|NCT04404478|79442282|FG001|Overall Study|Withdrawal by Subject|3|||
44433644|NCT00539734|79442290|FG000|Overall Study|Protocol Violation|1|||
44433645|NCT03907072|79442297|FG000|Overall Study|Study Terminated by Sponsor|2|||
44335381|NCT01307579|79340311|FG000|Overall Study|Physician Decision|26|||
44335382|NCT01307579|79340312|FG001|Overall Study|Physician Decision|29|||
44335383|NCT01307579|79340311|FG000|Overall Study|Withdrawal by Subject|7|||
44335384|NCT01307579|79340312|FG001|Overall Study|Withdrawal by Subject|3|||
44335385|NCT01307579|79340311|FG000|Overall Study|Institutional diagnosis of IFD|21|||
44335386|NCT01307579|79340312|FG001|Overall Study|Institutional diagnosis of IFD|36|||
44335387|NCT01307579|79340311|FG000|Overall Study|Begin conditioning for HSCT|42|||
44335388|NCT01307579|79340312|FG001|Overall Study|Begin conditioning for HSCT|44|||
44335389|NCT01307579|79340311|FG000|Overall Study|Refractory or relapsed AML|38|||
44335390|NCT01307579|79340312|FG001|Overall Study|Refractory or relapsed AML|23|||
44335391|NCT01307579|79340311|FG000|Overall Study|Ineligible|3|||
44335392|NCT01307579|79340312|FG001|Overall Study|Ineligible|4|||
44335393|NCT01057693|79340318|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
44335394|NCT01057693|79340319|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
44335395|NCT01057693|79340320|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
44335396|NCT01057693|79340318|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
44335397|NCT01057693|79340319|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
44335398|NCT01057693|79340320|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
44335399|NCT01057693|79340318|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
44335400|NCT01057693|79340319|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
44433646|NCT03907072|79442298|FG001|Overall Study|Study Terminated by Sponsor|2|||
44433647|NCT03907072|79442299|FG002|Overall Study|Study Terminated by Sponsor|2|||
44433648|NCT00329719|79442324|FG000|Overall Study|Lost to Follow-up|0|||
44433649|NCT00329719|79442325|FG001|Overall Study|Lost to Follow-up|0|||
44433650|NCT00329719|79442326|FG002|Overall Study|Lost to Follow-up|0|||
44433651|NCT00329719|79442327|FG003|Overall Study|Lost to Follow-up|1|||
44433652|NCT00329641|79442337|FG000|Overall Study|Did not start treatment|1|||
44539460|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44335401|NCT01057693|79340320|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
44335402|NCT01057693|79340318|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
44433653|NCT00329641|79442337|FG000|Overall Study|Not eligible|1|||
44433654|NCT00329641|79442337|FG000|Overall Study|Adverse Event|3|||
44433655|NCT00329641|79442337|FG000|Overall Study|Other reason, not protocol specified|1|||
44433656|NCT00329407|79442351|FG000|Overall Study|Withdrawal by Subject|1|||
44433657|NCT00328783|79442355|FG000|Overall Study|Could not tolerate ABC|21|||
44433658|NCT00328783|79442355|FG000|Overall Study|No heart in RT field|4|||
44433659|NCT00328783|79442355|FG000|Overall Study|Withdrawal by Subject|1|||
44433660|NCT00567489|79442363|FG000|Overall Study|Adverse Event|6|||
44433661|NCT00567489|79442364|FG001|Overall Study|Adverse Event|14|||
44433662|NCT00567489|79442363|FG000|Overall Study|Physician Decision|0|||
44433663|NCT00567489|79442364|FG001|Overall Study|Physician Decision|4|||
44433664|NCT00567489|79442363|FG000|Overall Study|Withdrawal by Subject|0|||
44433665|NCT00567489|79442364|FG001|Overall Study|Withdrawal by Subject|2|||
44433666|NCT00567489|79442363|FG000|Overall Study|Renal Transplantation|0|||
44433667|NCT00567489|79442364|FG001|Overall Study|Renal Transplantation|3|||
44433668|NCT00567489|79442363|FG000|Overall Study|Other|1|||
44433669|NCT00567489|79442364|FG001|Overall Study|Other|0|||
44433670|NCT00669942|79442382|FG000|Parts 2 and 3|Adverse Event|0|||
44433671|NCT00669942|79442383|FG001|Parts 2 and 3|Adverse Event|0|||
44539461|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539462|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539463|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539464|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539465|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
44539466|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
44539467|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
44539468|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
44539469|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539470|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539471|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539472|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539473|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539474|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
44539475|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539476|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539477|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539478|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539479|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539480|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
44539481|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539482|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539483|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539484|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
44539485|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539486|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539487|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539488|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539489|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539490|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
44539491|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539492|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539493|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539494|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44259188|NCT02824627|79115919|FG000|Overall Study|Adverse Event|1|||
44259189|NCT02824627|79115920|FG001|Overall Study|Adverse Event|2|||
44259190|NCT02824627|79115919|FG000|Overall Study|Lost to Follow-up|2|||
44259191|NCT02824627|79115920|FG001|Overall Study|Lost to Follow-up|1|||
44259192|NCT02743611|79115926|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
44259193|NCT02743611|79115927|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
44259194|NCT02743611|79115928|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
44335403|NCT01057693|79340319|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
44335404|NCT01057693|79340320|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
44335405|NCT01057693|79340318|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
44335406|NCT01057693|79340319|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
44259195|NCT02743611|79115929|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
44335407|NCT01057693|79340320|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
44335408|NCT01057693|79340318|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
44335409|NCT01057693|79340319|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
44335410|NCT01057693|79340320|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
44335411|NCT01057693|79340318|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
44335412|NCT01057693|79340319|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
44335413|NCT01057693|79340320|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
44433672|NCT00669942|79442384|FG002|Parts 2 and 3|Adverse Event|0|||
44433673|NCT00669942|79442385|FG003|Parts 2 and 3|Adverse Event|0|||
44539495|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44433674|NCT00669942|79442386|FG004|Parts 2 and 3|Adverse Event|0|||
44539496|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44433675|NCT00669942|79442387|FG005|Parts 2 and 3|Adverse Event|0|||
44433676|NCT00669942|79442388|FG006|Parts 2 and 3|Adverse Event|0|||
44433677|NCT00669942|79442389|FG007|Parts 2 and 3|Adverse Event|2|||
44433678|NCT00669942|79442390|FG008|Parts 2 and 3|Adverse Event|1|||
44433679|NCT00669942|79442391|FG009|Parts 2 and 3|Adverse Event|0|||
44433680|NCT00669942|79442392|FG010|Parts 2 and 3|Adverse Event|0|||
44433681|NCT00669942|79442393|FG011|Parts 2 and 3|Adverse Event|0|||
44433682|NCT00669942|79442382|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
44433683|NCT00669942|79442383|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
44433684|NCT00669942|79442384|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
44433685|NCT00669942|79442385|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
44433686|NCT00669942|79442386|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
44433687|NCT00669942|79442387|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
44433688|NCT00669942|79442388|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
44539497|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
44539498|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
44539499|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
44539500|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
44539501|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539502|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539503|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539504|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539505|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539506|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
44539507|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539508|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539509|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539510|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539511|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
44539512|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539513|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539514|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539515|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539516|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539517|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539518|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539519|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539520|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539521|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539522|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
44539523|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539524|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539525|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44335414|NCT01057693|79340318|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
44335415|NCT01057693|79340319|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
44335416|NCT01057693|79340320|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
44335417|NCT01057693|79340318|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
44335418|NCT01057693|79340319|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
44335419|NCT01057693|79340320|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
44335420|NCT01057693|79340318|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
44335421|NCT01057693|79340319|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
44335422|NCT01057693|79340320|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
44335423|NCT01057693|79340318|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
44335424|NCT01057693|79340319|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
44335425|NCT01057693|79340320|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
44335426|NCT01057693|79340318|FG000|Between Single-Blind and Double-Blind|Other|6|||
44433689|NCT00669942|79442389|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
44433690|NCT00669942|79442390|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
44433691|NCT00669942|79442391|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
44433692|NCT00669942|79442392|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
44433693|NCT00669942|79442393|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
44433694|NCT00669942|79442382|FG000|Parts 2 and 3|Protocol Violation|0|||
44433695|NCT00669942|79442383|FG001|Parts 2 and 3|Protocol Violation|0|||
44433696|NCT00669942|79442384|FG002|Parts 2 and 3|Protocol Violation|0|||
44433697|NCT00669942|79442385|FG003|Parts 2 and 3|Protocol Violation|0|||
44433698|NCT00669942|79442386|FG004|Parts 2 and 3|Protocol Violation|0|||
44335427|NCT01057693|79340319|FG001|Between Single-Blind and Double-Blind|Other|0|||
44335428|NCT01057693|79340320|FG002|Between Single-Blind and Double-Blind|Other|0|||
44433699|NCT00669942|79442387|FG005|Parts 2 and 3|Protocol Violation|1|||
44335429|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
44335430|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
44335431|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
44335432|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
44335433|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
44335434|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
44335435|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
44433700|NCT00669942|79442388|FG006|Parts 2 and 3|Protocol Violation|0|||
44433701|NCT00669942|79442389|FG007|Parts 2 and 3|Protocol Violation|0|||
44433702|NCT00669942|79442390|FG008|Parts 2 and 3|Protocol Violation|0|||
44433703|NCT00669942|79442391|FG009|Parts 2 and 3|Protocol Violation|0|||
44433704|NCT00669942|79442392|FG010|Parts 2 and 3|Protocol Violation|0|||
44433705|NCT00669942|79442393|FG011|Parts 2 and 3|Protocol Violation|0|||
44433706|NCT00669864|79442416|FG000|Overall Study|Lost to Follow-up|2|||
44433707|NCT00669864|79442416|FG000|Overall Study|Protocol Violation|2|||
44433708|NCT00669864|79442416|FG000|Overall Study|Withdrawal by Subject|3|||
44433709|NCT00669864|79442416|FG000|Overall Study|Other|2|||
44433710|NCT00668148|79442420|FG000|Overall Study|Adverse Event|5|||
44433711|NCT00668148|79442420|FG000|Overall Study|Subject Non-compliance|1|||
44433712|NCT00668148|79442420|FG000|Overall Study|Progressive Disease Before Treatment|2|||
44433713|NCT00668148|79442420|FG000|Overall Study|Withdrawal of Consent|2|||
44433714|NCT00667992|79442437|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
44433715|NCT00667992|79442438|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
44433716|NCT00667992|79442437|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
44433717|NCT00667992|79442438|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
44433718|NCT00667992|79442437|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
44433719|NCT00667992|79442438|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
44433720|NCT00667992|79442437|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
44433721|NCT00667992|79442438|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
44433722|NCT00667992|79442437|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
44335436|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
44335437|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
44335438|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
44335439|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
44335440|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
44335441|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
44335442|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
44335443|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
44335444|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
44335445|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
44335446|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
44335447|NCT01057693|79340318|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
44335448|NCT01057693|79340319|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
44335449|NCT01057693|79340320|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
44335450|NCT01307501|79340328|FG000|Overall Study|Treatment Failure|1|||
44335451|NCT01307501|79340328|FG000|Overall Study|Death|20|||
44335452|NCT01307501|79340328|FG000|Overall Study|Lost to Follow-up|1|||
44335453|NCT01307501|79340328|FG000|Overall Study|Starting Hospice|1|||
44335454|NCT01034137|79340335|FG000|Overall Study|Adverse Event|9|||
44335455|NCT01034137|79340336|FG001|Overall Study|Adverse Event|10|||
44335456|NCT01034137|79340337|FG002|Overall Study|Adverse Event|8|||
44335457|NCT01034137|79340335|FG000|Overall Study|Withdrawal by Subject|4|||
44335458|NCT01034137|79340336|FG001|Overall Study|Withdrawal by Subject|3|||
44335459|NCT01034137|79340337|FG002|Overall Study|Withdrawal by Subject|3|||
44335460|NCT01034137|79340335|FG000|Overall Study|Lack of Efficacy|9|||
44433723|NCT00667992|79442438|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
44433724|NCT00667992|79442437|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
44433725|NCT00667992|79442438|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
44433726|NCT00667992|79442437|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
44539526|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44433727|NCT00667992|79442438|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
44539527|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539528|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44335461|NCT01034137|79340336|FG001|Overall Study|Lack of Efficacy|4|||
44335462|NCT01034137|79340337|FG002|Overall Study|Lack of Efficacy|13|||
44335463|NCT01034137|79340335|FG000|Overall Study|Protocol Violation|2|||
44335464|NCT01034137|79340336|FG001|Overall Study|Protocol Violation|2|||
44335465|NCT01034137|79340337|FG002|Overall Study|Protocol Violation|1|||
44335466|NCT01034137|79340335|FG000|Overall Study|Refused treatment or did not cooperate|2|||
44335467|NCT01034137|79340336|FG001|Overall Study|Refused treatment or did not cooperate|0|||
44335468|NCT01034137|79340337|FG002|Overall Study|Refused treatment or did not cooperate|1|||
44335469|NCT01034137|79340335|FG000|Overall Study|Administrative or other|2|||
44335470|NCT01034137|79340336|FG001|Overall Study|Administrative or other|3|||
44335471|NCT01034137|79340337|FG002|Overall Study|Administrative or other|4|||
44335472|NCT01056289|79340346|FG000|Open-label Phase|Adverse Event|29|||
44335473|NCT01056289|79340347|FG001|Open-label Phase|Adverse Event|0|||
44335474|NCT01056289|79340348|FG002|Open-label Phase|Adverse Event|0|||
44335475|NCT01056289|79340349|FG003|Open-label Phase|Adverse Event|0|||
44335476|NCT01056289|79340346|FG000|Open-label Phase|Lost to Follow-up|30|||
44335477|NCT01056289|79340347|FG001|Open-label Phase|Lost to Follow-up|0|||
44335478|NCT01056289|79340348|FG002|Open-label Phase|Lost to Follow-up|0|||
44335479|NCT01056289|79340349|FG003|Open-label Phase|Lost to Follow-up|0|||
44335480|NCT01056289|79340346|FG000|Open-label Phase|Other|9|||
44335481|NCT01056289|79340347|FG001|Open-label Phase|Other|0|||
44335482|NCT01056289|79340348|FG002|Open-label Phase|Other|0|||
44335483|NCT01056289|79340349|FG003|Open-label Phase|Other|0|||
44335484|NCT01056289|79340346|FG000|Open-label Phase|Protocol Violation|6|||
44335485|NCT01056289|79340347|FG001|Open-label Phase|Protocol Violation|0|||
44335486|NCT01056289|79340348|FG002|Open-label Phase|Protocol Violation|0|||
44335487|NCT01056289|79340349|FG003|Open-label Phase|Protocol Violation|0|||
44335488|NCT01056289|79340346|FG000|Open-label Phase|Withdrawal by Subject|26|||
44335489|NCT01056289|79340347|FG001|Open-label Phase|Withdrawal by Subject|0|||
44335490|NCT01056289|79340348|FG002|Open-label Phase|Withdrawal by Subject|0|||
44335491|NCT01056289|79340349|FG003|Open-label Phase|Withdrawal by Subject|0|||
44335492|NCT01056289|79340346|FG000|Open-label Phase|Lack of Efficacy|18|||
44335493|NCT01056289|79340347|FG001|Open-label Phase|Lack of Efficacy|0|||
44335494|NCT01056289|79340348|FG002|Open-label Phase|Lack of Efficacy|0|||
44335495|NCT01056289|79340349|FG003|Open-label Phase|Lack of Efficacy|0|||
44335496|NCT01056289|79340346|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
44335497|NCT01056289|79340347|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
44335498|NCT01056289|79340348|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
44335499|NCT01056289|79340349|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
44335500|NCT01056289|79340346|FG000|Double-blind Phase|Adverse Event|0|||
44335501|NCT01056289|79340347|FG001|Double-blind Phase|Adverse Event|1|||
44335502|NCT01056289|79340348|FG002|Double-blind Phase|Adverse Event|2|||
44335503|NCT01056289|79340349|FG003|Double-blind Phase|Adverse Event|1|||
44335504|NCT01056289|79340346|FG000|Double-blind Phase|Lost to Follow-up|0|||
44335505|NCT01056289|79340347|FG001|Double-blind Phase|Lost to Follow-up|2|||
44335506|NCT01056289|79340348|FG002|Double-blind Phase|Lost to Follow-up|2|||
44433728|NCT00667992|79442437|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
44433729|NCT00667992|79442438|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
44433730|NCT00667992|79442437|FG000|Wash-out|Not within one doubling dilution|4|||
44433731|NCT00667992|79442438|FG001|Wash-out|Not within one doubling dilution|3|||
44433732|NCT00667992|79442437|FG000|Wash-out|Failure to wash-out|2|||
44433733|NCT00667992|79442438|FG001|Wash-out|Failure to wash-out|2|||
44433734|NCT00667992|79442437|FG000|Wash-out|Withdrawal by Subject|1|||
44433735|NCT00667992|79442438|FG001|Wash-out|Withdrawal by Subject|0|||
44433736|NCT00667992|79442437|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
44433737|NCT00667992|79442438|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
44433738|NCT00667992|79442437|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
44433739|NCT00667992|79442438|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
44433740|NCT00669396|79442456|FG000|Overall Study|Lost to Follow-up|10|||
44433741|NCT00669396|79442457|FG001|Overall Study|Lost to Follow-up|12|||
44433742|NCT00669318|79442463|FG000|Overall Study|Withdrawal by Subject|2|||
44433743|NCT00669240|79442467|FG000|Overall Study|Lack of Efficacy|33|||
44433744|NCT00669240|79442467|FG000|Overall Study|Withdrawal by Subject|42|||
44433745|NCT00669240|79442467|FG000|Overall Study|Lost to Follow-up|34|||
44433746|NCT00669240|79442467|FG000|Overall Study|Adverse Event|21|||
44433747|NCT00669240|79442467|FG000|Overall Study|Other|19|||
44433748|NCT00669240|79442467|FG000|Overall Study|Enrolled but not treated|15|||
44433749|NCT00669240|79442467|FG000|Overall Study|Enrolled but no dosing record|1|||
44433750|NCT00669162|79442471|FG000|Overall Study|Withdrawal by Subject|1|||
44335507|NCT01056289|79340349|FG003|Double-blind Phase|Lost to Follow-up|2|||
44335508|NCT01056289|79340346|FG000|Double-blind Phase|Other|0|||
44335509|NCT01056289|79340347|FG001|Double-blind Phase|Other|0|||
44335510|NCT01056289|79340348|FG002|Double-blind Phase|Other|1|||
44335511|NCT01056289|79340349|FG003|Double-blind Phase|Other|2|||
44335512|NCT01056289|79340346|FG000|Double-blind Phase|Protocol Violation|0|||
44335513|NCT01056289|79340347|FG001|Double-blind Phase|Protocol Violation|0|||
44335514|NCT01056289|79340348|FG002|Double-blind Phase|Protocol Violation|1|||
44433751|NCT00666588|79442488|FG000|Overall Study|ineligible|2|||
44433752|NCT00666588|79442489|FG001|Overall Study|ineligible|0|||
44433753|NCT00666588|79442490|FG002|Overall Study|ineligible|0|||
44433754|NCT00666588|79442491|FG003|Overall Study|ineligible|2|||
44433755|NCT00666588|79442488|FG000|Overall Study|inevaluable|2|||
44433756|NCT00666588|79442489|FG001|Overall Study|inevaluable|0|||
44433757|NCT00666588|79442490|FG002|Overall Study|inevaluable|0|||
44433758|NCT00666588|79442491|FG003|Overall Study|inevaluable|0|||
44433759|NCT00689390|79442503|FG000|Overall Study|Adverse Event|19|||
44433760|NCT00689390|79442504|FG001|Overall Study|Adverse Event|0|||
44433761|NCT00689390|79442503|FG000|Overall Study|Lost to Follow-up|179|||
44433762|NCT00689390|79442504|FG001|Overall Study|Lost to Follow-up|7|||
44335515|NCT01056289|79340349|FG003|Double-blind Phase|Protocol Violation|1|||
44433763|NCT00689390|79442503|FG000|Overall Study|Withdrawal by Subject|117|||
44433764|NCT00689390|79442504|FG001|Overall Study|Withdrawal by Subject|3|||
44433765|NCT00689390|79442503|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
44433766|NCT00689390|79442504|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
44433767|NCT00689390|79442503|FG000|Overall Study|Non-Compliance With Protocol|21|||
44433768|NCT00689390|79442504|FG001|Overall Study|Non-Compliance With Protocol|0|||
44433769|NCT00689390|79442503|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
44433770|NCT00689390|79442504|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
44433771|NCT00689390|79442503|FG000|Overall Study|Administrative|37|||
44433772|NCT00689390|79442504|FG001|Overall Study|Administrative|0|||
44539529|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
44539530|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539531|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539532|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539533|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539534|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539535|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539536|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539537|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539538|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
44539539|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539540|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539541|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539542|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539543|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539544|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539545|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539546|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
44539547|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
44539548|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
44539549|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539550|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539551|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539552|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539553|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539554|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
44539555|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539556|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539557|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44335516|NCT01056289|79340346|FG000|Double-blind Phase|Withdrawal by Subject|0|||
44335517|NCT01056289|79340347|FG001|Double-blind Phase|Withdrawal by Subject|0|||
44335518|NCT01056289|79340348|FG002|Double-blind Phase|Withdrawal by Subject|4|||
44335519|NCT01056289|79340349|FG003|Double-blind Phase|Withdrawal by Subject|2|||
44335520|NCT01056289|79340346|FG000|Double-blind Phase|Discontinuation symptom|0|||
44335521|NCT01056289|79340347|FG001|Double-blind Phase|Discontinuation symptom|1|||
44335522|NCT01056289|79340348|FG002|Double-blind Phase|Discontinuation symptom|2|||
44335523|NCT01056289|79340349|FG003|Double-blind Phase|Discontinuation symptom|2|||
44335524|NCT01056289|79340346|FG000|Double-blind Phase|Physician Decision|0|||
44335525|NCT01056289|79340347|FG001|Double-blind Phase|Physician Decision|0|||
44335526|NCT01056289|79340348|FG002|Double-blind Phase|Physician Decision|1|||
44433773|NCT00567879|79442521|FG000|Overall Study|Adverse Event|2|||
44433774|NCT00567879|79442522|FG001|Overall Study|Adverse Event|0|||
44433775|NCT00567879|79442523|FG002|Overall Study|Adverse Event|1|||
44433776|NCT00567879|79442524|FG003|Overall Study|Adverse Event|0|||
44433777|NCT00567879|79442525|FG004|Overall Study|Adverse Event|1|||
44433778|NCT00567879|79442526|FG005|Overall Study|Adverse Event|0|||
44433779|NCT00567879|79442521|FG000|Overall Study|Abnormal test procedure(s)|0|||
44433780|NCT00567879|79442522|FG001|Overall Study|Abnormal test procedure(s)|0|||
44335527|NCT01056289|79340349|FG003|Double-blind Phase|Physician Decision|0|||
44335528|NCT01039675|79340361|FG000|Overall Study|Adverse Event|0|||
44335529|NCT01039675|79340362|FG001|Overall Study|Adverse Event|2|||
44335530|NCT01039675|79340361|FG000|Overall Study|Lack of Efficacy|0|||
44335531|NCT01039675|79340362|FG001|Overall Study|Lack of Efficacy|2|||
44335532|NCT01039675|79340361|FG000|Overall Study|Withdrawal by Subject|0|||
44335533|NCT01039675|79340362|FG001|Overall Study|Withdrawal by Subject|1|||
44335534|NCT01039675|79340361|FG000|Overall Study|Lost to Follow-up|0|||
44335535|NCT01039675|79340362|FG001|Overall Study|Lost to Follow-up|1|||
44335536|NCT01039675|79340361|FG000|Overall Study|Physician Decision|0|||
44335537|NCT01039675|79340362|FG001|Overall Study|Physician Decision|1|||
44335538|NCT01033825|79340375|FG000|Overall Study|Withdrawal by Subject|2|||
44335539|NCT01033825|79340376|FG001|Overall Study|Withdrawal by Subject|3|||
44335540|NCT01033825|79340377|FG002|Overall Study|Withdrawal by Subject|2|||
44335541|NCT01033825|79340378|FG003|Overall Study|Withdrawal by Subject|1|||
44335542|NCT01033825|79340379|FG004|Overall Study|Withdrawal by Subject|1|||
44335543|NCT01033825|79340380|FG005|Overall Study|Withdrawal by Subject|0|||
44335544|NCT01033825|79340381|FG006|Overall Study|Withdrawal by Subject|0|||
44335545|NCT01033825|79340375|FG000|Overall Study|Adverse Event|0|||
44335546|NCT01033825|79340376|FG001|Overall Study|Adverse Event|0|||
44335547|NCT01033825|79340377|FG002|Overall Study|Adverse Event|0|||
44335548|NCT01033825|79340378|FG003|Overall Study|Adverse Event|1|||
44335549|NCT01033825|79340379|FG004|Overall Study|Adverse Event|0|||
44335550|NCT01033825|79340380|FG005|Overall Study|Adverse Event|0|||
44335551|NCT01033825|79340381|FG006|Overall Study|Adverse Event|0|||
44335552|NCT01033825|79340375|FG000|Overall Study|Protocol Violation|1|||
44335553|NCT01033825|79340376|FG001|Overall Study|Protocol Violation|0|||
44335554|NCT01033825|79340377|FG002|Overall Study|Protocol Violation|0|||
44335555|NCT01033825|79340378|FG003|Overall Study|Protocol Violation|0|||
44335556|NCT01033825|79340379|FG004|Overall Study|Protocol Violation|0|||
44335557|NCT01033825|79340380|FG005|Overall Study|Protocol Violation|0|||
44433781|NCT00567879|79442523|FG002|Overall Study|Abnormal test procedure(s)|1|||
44433782|NCT00567879|79442524|FG003|Overall Study|Abnormal test procedure(s)|0|||
44433783|NCT00567879|79442525|FG004|Overall Study|Abnormal test procedure(s)|0|||
44433784|NCT00567879|79442526|FG005|Overall Study|Abnormal test procedure(s)|0|||
44433785|NCT00567879|79442521|FG000|Overall Study|Withdrawal by Subject|0|||
44433786|NCT00567879|79442522|FG001|Overall Study|Withdrawal by Subject|0|||
44433787|NCT00567879|79442523|FG002|Overall Study|Withdrawal by Subject|3|||
44335558|NCT01033825|79340381|FG006|Overall Study|Protocol Violation|0|||
44335559|NCT01033825|79340375|FG000|Overall Study|Other|0|||
44335560|NCT01033825|79340376|FG001|Overall Study|Other|0|||
44335561|NCT01033825|79340377|FG002|Overall Study|Other|0|||
44335562|NCT01033825|79340378|FG003|Overall Study|Other|0|||
44335563|NCT01033825|79340379|FG004|Overall Study|Other|1|||
44335564|NCT01033825|79340380|FG005|Overall Study|Other|0|||
44433788|NCT00567879|79442524|FG003|Overall Study|Withdrawal by Subject|1|||
44433789|NCT00567879|79442525|FG004|Overall Study|Withdrawal by Subject|0|||
44433790|NCT00567879|79442526|FG005|Overall Study|Withdrawal by Subject|0|||
44433791|NCT00567879|79442521|FG000|Overall Study|New cancer therapy|0|||
44433792|NCT00567879|79442522|FG001|Overall Study|New cancer therapy|0|||
44433793|NCT00567879|79442523|FG002|Overall Study|New cancer therapy|1|||
44433794|NCT00567879|79442524|FG003|Overall Study|New cancer therapy|0|||
44433795|NCT00567879|79442525|FG004|Overall Study|New cancer therapy|0|||
44433796|NCT00567879|79442526|FG005|Overall Study|New cancer therapy|0|||
44433797|NCT00567879|79442521|FG000|Overall Study|Disease progression|5|||
44433798|NCT00567879|79442522|FG001|Overall Study|Disease progression|7|||
44335565|NCT01033825|79340381|FG006|Overall Study|Other|0|||
44433799|NCT00567879|79442523|FG002|Overall Study|Disease progression|15|||
44539558|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539559|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44335566|NCT01033747|79340401|FG000|Overall Study|Adverse Event|9|||
44335567|NCT01033747|79340402|FG001|Overall Study|Adverse Event|4|||
44335568|NCT01033747|79340401|FG000|Overall Study|Abnormal Laboratory Value|1|||
44335569|NCT01033747|79340402|FG001|Overall Study|Abnormal Laboratory Value|0|||
44335570|NCT01033747|79340401|FG000|Overall Study|Abnormal test procedure|0|||
44539560|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539561|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44335571|NCT01033747|79340402|FG001|Overall Study|Abnormal test procedure|1|||
44335572|NCT01033747|79340401|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
44335573|NCT01033747|79340402|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
44335574|NCT01033747|79340401|FG000|Overall Study|Protocol Violation|1|||
44433800|NCT00567879|79442524|FG003|Overall Study|Disease progression|5|||
44433801|NCT00567879|79442525|FG004|Overall Study|Disease progression|11|||
44433802|NCT00567879|79442526|FG005|Overall Study|Disease progression|3|||
44433803|NCT00603915|79442544|FG000|Overall Study|Physician Decision|1|||
44335575|NCT01033747|79340402|FG001|Overall Study|Protocol Violation|0|||
44335576|NCT01033747|79340401|FG000|Overall Study|Withdrawal by Subject|9|||
44335577|NCT01033747|79340402|FG001|Overall Study|Withdrawal by Subject|6|||
44433804|NCT00603837|79442550|FG000|Overall Study|Physician Decision|3|||
44433805|NCT00603837|79442551|FG001|Overall Study|Physician Decision|0|||
44433806|NCT00667602|79442560|FG000|Overall Study|Withdrawal by Subject|4|||
44433807|NCT00667602|79442561|FG001|Overall Study|Withdrawal by Subject|9|||
44433808|NCT00667602|79442562|FG002|Overall Study|Withdrawal by Subject|10|||
44539562|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
44539563|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539564|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539565|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539566|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539567|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539568|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539569|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539570|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
44539571|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539572|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539573|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539574|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44335578|NCT01033747|79340401|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
44335579|NCT01033747|79340402|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
44335580|NCT01033747|79340401|FG000|Overall Study|Stopped at end of Extension 1|2|||
44335581|NCT01033747|79340402|FG001|Overall Study|Stopped at end of Extension 1|0|||
44335582|NCT01091428|79340412|FG000|Phase 1|Progressive Disease|24|||
44335583|NCT01091428|79340413|FG001|Phase 1|Progressive Disease|8|||
44539575|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539576|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539577|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539578|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539579|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
44539580|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539581|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539582|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539583|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539584|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539585|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539586|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
44539587|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539588|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539589|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539590|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539591|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539592|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539593|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539594|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44335584|NCT01091428|79340414|FG002|Phase 1|Progressive Disease|0|||
44433809|NCT00667602|79442560|FG000|Overall Study|Lost to Follow-up|4|||
44433810|NCT00667602|79442561|FG001|Overall Study|Lost to Follow-up|5|||
44433811|NCT00667602|79442562|FG002|Overall Study|Lost to Follow-up|6|||
44433812|NCT00667602|79442560|FG000|Overall Study|Administrative reason|0|||
44433813|NCT00667602|79442561|FG001|Overall Study|Administrative reason|0|||
44539595|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539596|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
44157406|NCT03734679|78949111|FG000|Overall Study|Missed Visit|1|||
44157407|NCT03709706|78949121|FG000|Overall Study|Adverse Event|0|||
44157408|NCT03709706|78949122|FG001|Overall Study|Adverse Event|1|||
44157409|NCT03709706|78949121|FG000|Overall Study|Physician Decision|14|||
44157410|NCT03709706|78949122|FG001|Overall Study|Physician Decision|8|||
44157411|NCT03709706|78949121|FG000|Overall Study|Withdrawal by Subject|2|||
44157412|NCT03709706|78949122|FG001|Overall Study|Withdrawal by Subject|1|||
44157413|NCT03709706|78949121|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
44335585|NCT01091428|79340415|FG003|Phase 1|Progressive Disease|0|||
44335586|NCT01091428|79340412|FG000|Phase 1|Symptomatic Deterioration|3|||
44335587|NCT01091428|79340413|FG001|Phase 1|Symptomatic Deterioration|2|||
44433814|NCT00667602|79442562|FG002|Overall Study|Administrative reason|2|||
44157414|NCT03709706|78949122|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
44157415|NCT03429543|78949153|FG000|Overall Study|Adverse Event|1|||
44433815|NCT00667602|79442560|FG000|Overall Study|Protocol Violation|0|||
44433816|NCT00667602|79442561|FG001|Overall Study|Protocol Violation|1|||
44433817|NCT00667602|79442562|FG002|Overall Study|Protocol Violation|0|||
44433818|NCT00691028|79442578|FG000|Open-label Period|Adverse Event|0|||
44433819|NCT00691028|79442579|FG001|Open-label Period|Adverse Event|0|||
44433820|NCT00691028|79442580|FG002|Open-label Period|Adverse Event|0|||
44433821|NCT00691028|79442581|FG003|Open-label Period|Adverse Event|16|||
44433822|NCT00691028|79442578|FG000|Open-label Period|Withdrawal by Subject|0|||
44433823|NCT00691028|79442579|FG001|Open-label Period|Withdrawal by Subject|0|||
44433824|NCT00691028|79442580|FG002|Open-label Period|Withdrawal by Subject|0|||
44433825|NCT00691028|79442581|FG003|Open-label Period|Withdrawal by Subject|3|||
44433826|NCT00691028|79442578|FG000|Open-label Period|not come to a hospital|0|||
44335588|NCT01091428|79340414|FG002|Phase 1|Symptomatic Deterioration|0|||
44335589|NCT01091428|79340415|FG003|Phase 1|Symptomatic Deterioration|0|||
44433827|NCT00691028|79442579|FG001|Open-label Period|not come to a hospital|0|||
44433828|NCT00691028|79442580|FG002|Open-label Period|not come to a hospital|0|||
44433829|NCT00691028|79442581|FG003|Open-label Period|not come to a hospital|1|||
44433830|NCT00691028|79442578|FG000|Double-blind Period|Adverse Event|8|||
44433831|NCT00691028|79442579|FG001|Double-blind Period|Adverse Event|9|||
44433832|NCT00691028|79442580|FG002|Double-blind Period|Adverse Event|6|||
44335590|NCT01091428|79340412|FG000|Phase 1|Adverse Event|2|||
44335591|NCT01091428|79340413|FG001|Phase 1|Adverse Event|0|||
44335592|NCT01091428|79340414|FG002|Phase 1|Adverse Event|0|||
44335593|NCT01091428|79340415|FG003|Phase 1|Adverse Event|0|||
44335594|NCT01091428|79340412|FG000|Phase 1|Withdrawal by Subject|7|||
44335595|NCT01091428|79340413|FG001|Phase 1|Withdrawal by Subject|0|||
44335596|NCT01091428|79340414|FG002|Phase 1|Withdrawal by Subject|0|||
44335597|NCT01091428|79340415|FG003|Phase 1|Withdrawal by Subject|0|||
44335598|NCT01091428|79340412|FG000|Phase 1|Reason not specified|0|||
44335599|NCT01091428|79340413|FG001|Phase 1|Reason not specified|1|||
44335600|NCT01091428|79340414|FG002|Phase 1|Reason not specified|0|||
44335601|NCT01091428|79340415|FG003|Phase 1|Reason not specified|0|||
44335602|NCT01091428|79340412|FG000|Phase 1|Single-Patient IND|2|||
44335603|NCT01091428|79340413|FG001|Phase 1|Single-Patient IND|0|||
44335604|NCT01091428|79340414|FG002|Phase 1|Single-Patient IND|0|||
44335605|NCT01091428|79340415|FG003|Phase 1|Single-Patient IND|0|||
44335606|NCT01091428|79340412|FG000|Phase 2|Progressive Disease|0|||
44335607|NCT01091428|79340413|FG001|Phase 2|Progressive Disease|0|||
44335608|NCT01091428|79340414|FG002|Phase 2|Progressive Disease|44|||
44335609|NCT01091428|79340415|FG003|Phase 2|Progressive Disease|46|||
44335610|NCT01091428|79340412|FG000|Phase 2|Symptomatic Deterioration|0|||
44335611|NCT01091428|79340413|FG001|Phase 2|Symptomatic Deterioration|0|||
44335612|NCT01091428|79340414|FG002|Phase 2|Symptomatic Deterioration|1|||
44335613|NCT01091428|79340415|FG003|Phase 2|Symptomatic Deterioration|6|||
44433833|NCT00691028|79442581|FG003|Double-blind Period|Adverse Event|0|||
44433834|NCT00691028|79442578|FG000|Double-blind Period|Lack of Efficacy|4|||
44433835|NCT00691028|79442579|FG001|Double-blind Period|Lack of Efficacy|3|||
44433836|NCT00691028|79442580|FG002|Double-blind Period|Lack of Efficacy|2|||
44433837|NCT00691028|79442581|FG003|Double-blind Period|Lack of Efficacy|0|||
44433838|NCT00691028|79442578|FG000|Double-blind Period|Withdrawal by Subject|1|||
44433839|NCT00691028|79442579|FG001|Double-blind Period|Withdrawal by Subject|0|||
44433840|NCT00691028|79442580|FG002|Double-blind Period|Withdrawal by Subject|1|||
44433841|NCT00691028|79442581|FG003|Double-blind Period|Withdrawal by Subject|0|||
44433842|NCT00691028|79442578|FG000|Double-blind Period|not come to a hospital.|0|||
44433843|NCT00691028|79442579|FG001|Double-blind Period|not come to a hospital.|1|||
44433844|NCT00691028|79442580|FG002|Double-blind Period|not come to a hospital.|0|||
44433845|NCT00691028|79442581|FG003|Double-blind Period|not come to a hospital.|0|||
44433846|NCT00690794|79442595|FG000|Overall Study|Adverse Event|12|||
44433847|NCT00690794|79442596|FG001|Overall Study|Adverse Event|10|||
44433848|NCT00690794|79442595|FG000|Overall Study|Lost to Follow-up|1|||
44433849|NCT00690794|79442596|FG001|Overall Study|Lost to Follow-up|4|||
44433850|NCT00690794|79442595|FG000|Overall Study|Withdrawal by Subject|0|||
44433851|NCT00690794|79442596|FG001|Overall Study|Withdrawal by Subject|9|||
44335614|NCT01091428|79340412|FG000|Phase 2|Adverse Event|0|||
44335615|NCT01091428|79340413|FG001|Phase 2|Adverse Event|0|||
44335616|NCT01091428|79340414|FG002|Phase 2|Adverse Event|12|||
44335617|NCT01091428|79340415|FG003|Phase 2|Adverse Event|5|||
44335618|NCT01091428|79340412|FG000|Phase 2|Withdrawal by Subject|0|||
44433852|NCT00690794|79442595|FG000|Overall Study|Protocol Violation|6|||
44335619|NCT01091428|79340413|FG001|Phase 2|Withdrawal by Subject|0|||
44335620|NCT01091428|79340414|FG002|Phase 2|Withdrawal by Subject|9|||
44335621|NCT01091428|79340415|FG003|Phase 2|Withdrawal by Subject|8|||
44335622|NCT01091428|79340412|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
44433853|NCT00690794|79442596|FG001|Overall Study|Protocol Violation|7|||
44335623|NCT01091428|79340413|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
44433854|NCT00690794|79442595|FG000|Overall Study|Noncompliance|1|||
44433855|NCT00690794|79442596|FG001|Overall Study|Noncompliance|2|||
44433856|NCT00690794|79442595|FG000|Overall Study|Other not specified|1|||
44433857|NCT00690794|79442596|FG001|Overall Study|Other not specified|3|||
44433858|NCT00666276|79442602|FG000|Overall Study|Protocol Violation|34|||
44433859|NCT00567255|79442627|FG000|Overall Study|Adverse Event|241|||
44433860|NCT00567255|79442628|FG001|Overall Study|Adverse Event|68|||
44433861|NCT00567255|79442627|FG000|Overall Study|Lost to Follow-up|77|||
44433862|NCT00567255|79442628|FG001|Overall Study|Lost to Follow-up|48|||
44433863|NCT00567255|79442627|FG000|Overall Study|Withdrawal by Subject|75|||
44433864|NCT00567255|79442628|FG001|Overall Study|Withdrawal by Subject|56|||
44433865|NCT00567255|79442627|FG000|Overall Study|Lack of Efficacy|19|||
44433866|NCT00567255|79442628|FG001|Overall Study|Lack of Efficacy|33|||
44433867|NCT00567255|79442627|FG000|Overall Study|Protocol Violation|20|||
44433868|NCT00567255|79442628|FG001|Overall Study|Protocol Violation|8|||
44433869|NCT00567255|79442627|FG000|Overall Study|Pregnancy|6|||
44433870|NCT00567255|79442628|FG001|Overall Study|Pregnancy|0|||
44433871|NCT00567255|79442627|FG000|Overall Study|Drug noncompliance,moved,other|25|||
44433872|NCT00567255|79442628|FG001|Overall Study|Drug noncompliance,moved,other|15|||
44433873|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
44433874|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
44433875|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Other|2|||
44433876|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Other|2|||
44335624|NCT01091428|79340414|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
44335625|NCT01091428|79340415|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
44335626|NCT01091428|79340412|FG000|Phase 2|Reason not specified|0|||
44335627|NCT01091428|79340413|FG001|Phase 2|Reason not specified|0|||
44335628|NCT01091428|79340414|FG002|Phase 2|Reason not specified|4|||
44335629|NCT01091428|79340415|FG003|Phase 2|Reason not specified|3|||
44335630|NCT01091428|79340412|FG000|Phase 2|Physician Decision|0|||
44335631|NCT01091428|79340413|FG001|Phase 2|Physician Decision|0|||
44335632|NCT01091428|79340414|FG002|Phase 2|Physician Decision|2|||
44335633|NCT01091428|79340415|FG003|Phase 2|Physician Decision|0|||
44335634|NCT01096342|79340434|FG000|Overall Study|Protocol Violation|1|||
44335635|NCT01039519|79340438|FG000|Treatment|Progressive disease|20|||
44335636|NCT01039519|79340438|FG000|Treatment|Treatment failure|2|||
44433877|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Personal reasons|2|||
44433878|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Personal reasons|2|||
44433879|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
44433880|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
44433881|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
44433882|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
44433883|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
44433884|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
44433885|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
44433886|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
44433887|NCT00667446|79442636|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
44433888|NCT00667446|79442637|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
44433889|NCT00667446|79442636|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
44433890|NCT00667446|79442637|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
44433891|NCT00688844|79442643|FG000|Overall Study|Lost to Follow-up|10|||
44433892|NCT00667368|79442649|FG000|Overall Study|Lost to Follow-up|176|||
44433893|NCT00667368|79442650|FG001|Overall Study|Lost to Follow-up|155|||
44433894|NCT00667368|79442649|FG000|Overall Study|Discontinued early|24|||
44433895|NCT00667368|79442650|FG001|Overall Study|Discontinued early|17|||
44433896|NCT00567567|79442659|FG000|Overall Study|Adverse Event|0|||
44433897|NCT00567567|79442660|FG001|Overall Study|Adverse Event|2|||
44433898|NCT00567567|79442661|FG002|Overall Study|Adverse Event|5|||
44433899|NCT00567567|79442659|FG000|Overall Study|Death|8|||
44433900|NCT00567567|79442660|FG001|Overall Study|Death|1|||
44433901|NCT00567567|79442661|FG002|Overall Study|Death|5|||
44433902|NCT00567567|79442659|FG000|Overall Study|Lack of Efficacy|16|||
44433903|NCT00567567|79442660|FG001|Overall Study|Lack of Efficacy|17|||
44433904|NCT00567567|79442661|FG002|Overall Study|Lack of Efficacy|48|||
44335637|NCT01039519|79340438|FG000|Treatment|Adverse Event|3|||
44335638|NCT01039519|79340438|FG000|Treatment|Physician Decision|2|||
44433905|NCT00567567|79442659|FG000|Overall Study|Lost to Follow-up|0|||
44433906|NCT00567567|79442660|FG001|Overall Study|Lost to Follow-up|0|||
44433907|NCT00567567|79442661|FG002|Overall Study|Lost to Follow-up|1|||
44433908|NCT00567567|79442659|FG000|Overall Study|Physician Decision|16|||
44335639|NCT01039519|79340438|FG000|Survival Follow-up|Death|23|||
44335640|NCT01039519|79340438|FG000|Survival Follow-up|Sponsor decision|4|||
44335641|NCT01096186|79340442|FG000|Overall Study|Adverse Event|16|||
44433909|NCT00567567|79442660|FG001|Overall Study|Physician Decision|18|||
44433910|NCT00567567|79442661|FG002|Overall Study|Physician Decision|84|||
44433911|NCT00567567|79442659|FG000|Overall Study|Withdrawal by Subject|0|||
44433912|NCT00567567|79442660|FG001|Overall Study|Withdrawal by Subject|0|||
44335642|NCT01096186|79340442|FG000|Overall Study|Death|4|||
44335643|NCT01096186|79340442|FG000|Overall Study|Lack of Efficacy|4|||
44433913|NCT00567567|79442661|FG002|Overall Study|Withdrawal by Subject|2|||
44433914|NCT00567567|79442659|FG000|Overall Study|Ineligible|4|||
44433915|NCT00567567|79442660|FG001|Overall Study|Ineligible|0|||
44335644|NCT01096186|79340442|FG000|Overall Study|Lost to Follow-up|2|||
44335645|NCT01096186|79340442|FG000|Overall Study|Withdrawal by Subject|22|||
44335646|NCT01096186|79340442|FG000|Overall Study|Physician Decision|1|||
44433916|NCT00567567|79442661|FG002|Overall Study|Ineligible|9|||
44433917|NCT00567567|79442659|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
44433918|NCT00567567|79442660|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
44433919|NCT00567567|79442661|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
44433920|NCT00567567|79442659|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
44433921|NCT00567567|79442660|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
44433922|NCT00567567|79442661|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
44433923|NCT00567567|79442659|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
44433924|NCT00567567|79442660|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
44433925|NCT00567567|79442661|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
44433926|NCT00666198|79442671|FG000|Overall Study|Protocol Violation|10|||
44433927|NCT00666198|79442671|FG000|Overall Study|No Visit After First Day of Treatment|13|||
44433928|NCT00666198|79442671|FG000|Overall Study|Safety Not Assessable|6|||
44433929|NCT00666198|79442671|FG000|Overall Study|No Drug Administration|4|||
44433930|NCT00664560|79442678|FG000|Overall Study|Adverse Event|19|||
44433931|NCT00664560|79442679|FG001|Overall Study|Adverse Event|16|||
44433932|NCT00664560|79442680|FG002|Overall Study|Adverse Event|7|||
44433933|NCT00664560|79442678|FG000|Overall Study|Withdrawal by Subject|9|||
44433934|NCT00664560|79442679|FG001|Overall Study|Withdrawal by Subject|13|||
44433935|NCT00664560|79442680|FG002|Overall Study|Withdrawal by Subject|7|||
44433936|NCT00664560|79442678|FG000|Overall Study|Lost to Follow-up|0|||
44433937|NCT00664560|79442679|FG001|Overall Study|Lost to Follow-up|2|||
44433938|NCT00664560|79442680|FG002|Overall Study|Lost to Follow-up|0|||
44433939|NCT00664560|79442678|FG000|Overall Study|Other|11|||
44433940|NCT00664560|79442679|FG001|Overall Study|Other|4|||
44433941|NCT00664560|79442680|FG002|Overall Study|Other|5|||
44433942|NCT00566709|79442690|FG000|Overall Study|Protocol Violation|5|||
44433943|NCT00566709|79442691|FG001|Overall Study|Protocol Violation|0|||
44433944|NCT00688688|79442700|FG000|Overall Study|Eligibility criterion not met|7|||
44539597|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539598|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539599|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539600|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539601|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539602|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
44539603|NCT02891226|79551185|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539604|NCT02891226|79551186|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539605|NCT02891226|79551187|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539606|NCT02891226|79551188|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44335647|NCT01096186|79340442|FG000|Overall Study|Noncompliance with study drug|1|||
44335648|NCT01032889|79340449|FG000|Overall Study|Adverse Event|2|||
44539607|NCT02891226|79551189|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539608|NCT02891226|79551190|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539609|NCT02891226|79551191|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539610|NCT02891226|79551192|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539611|NCT02891226|79551193|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539612|NCT02891226|79551194|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
44539613|NCT02891226|79551195|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539614|NCT02891226|79551196|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539615|NCT02891226|79551197|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539616|NCT02891226|79551198|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539617|NCT02891226|79551199|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539618|NCT02891226|79551200|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
44539619|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539620|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44335649|NCT01032889|79340450|FG001|Overall Study|Adverse Event|2|||
44433945|NCT00688688|79442701|FG001|Overall Study|Eligibility criterion not met|7|||
44433946|NCT00688688|79442702|FG002|Overall Study|Eligibility criterion not met|10|||
44539621|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44433947|NCT00688688|79442700|FG000|Overall Study|Adverse Event|52|||
44433948|NCT00688688|79442701|FG001|Overall Study|Adverse Event|51|||
44433949|NCT00688688|79442702|FG002|Overall Study|Adverse Event|50|||
44433950|NCT00688688|79442700|FG000|Overall Study|Lack of Efficacy|34|||
44433951|NCT00688688|79442701|FG001|Overall Study|Lack of Efficacy|25|||
44433952|NCT00688688|79442702|FG002|Overall Study|Lack of Efficacy|45|||
44433953|NCT00688688|79442700|FG000|Overall Study|Withdrawal by Subject|66|||
44433954|NCT00688688|79442701|FG001|Overall Study|Withdrawal by Subject|75|||
44433955|NCT00688688|79442702|FG002|Overall Study|Withdrawal by Subject|65|||
44433956|NCT00688688|79442700|FG000|Overall Study|Lost to Follow-up|14|||
44433957|NCT00688688|79442701|FG001|Overall Study|Lost to Follow-up|7|||
44433958|NCT00688688|79442702|FG002|Overall Study|Lost to Follow-up|7|||
44433959|NCT00688688|79442700|FG000|Overall Study|Protocol Violation|6|||
44433960|NCT00688688|79442701|FG001|Overall Study|Protocol Violation|9|||
44433961|NCT00688688|79442702|FG002|Overall Study|Protocol Violation|11|||
44433962|NCT00688688|79442700|FG000|Overall Study|Randomized but never received study drug|1|||
44433963|NCT00688688|79442701|FG001|Overall Study|Randomized but never received study drug|0|||
44433964|NCT00688688|79442702|FG002|Overall Study|Randomized but never received study drug|0|||
44433965|NCT00688688|79442700|FG000|Overall Study|Non-compliance with study procedures|5|||
44433966|NCT00688688|79442701|FG001|Overall Study|Non-compliance with study procedures|3|||
44433967|NCT00688688|79442702|FG002|Overall Study|Non-compliance with study procedures|4|||
44433968|NCT00688688|79442700|FG000|Overall Study|Taking exclusionary medications|1|||
44539622|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539623|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539624|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539625|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539626|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539627|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539628|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539629|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
44539630|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539631|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539632|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539633|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539634|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
44539635|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539636|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539637|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539638|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539639|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539640|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539641|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539642|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539643|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539644|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539645|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
44539646|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539647|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539648|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44335650|NCT01032889|79340451|FG002|Overall Study|Adverse Event|0|||
44335651|NCT01032889|79340449|FG000|Overall Study|Withdrawal of Consent|1|||
44335652|NCT01032889|79340450|FG001|Overall Study|Withdrawal of Consent|2|||
44335653|NCT01032889|79340451|FG002|Overall Study|Withdrawal of Consent|1|||
44335654|NCT01032889|79340449|FG000|Overall Study|Patient Request|0|||
44335655|NCT01032889|79340450|FG001|Overall Study|Patient Request|1|||
44335656|NCT01032889|79340451|FG002|Overall Study|Patient Request|0|||
44433969|NCT00688688|79442701|FG001|Overall Study|Taking exclusionary medications|0|||
44433970|NCT00688688|79442702|FG002|Overall Study|Taking exclusionary medications|0|||
44433971|NCT00688688|79442700|FG000|Overall Study|Site closure|0|||
44335657|NCT01032889|79340449|FG000|Overall Study|Lost to Follow-up|1|||
44433972|NCT00688688|79442701|FG001|Overall Study|Site closure|1|||
44433973|NCT00688688|79442702|FG002|Overall Study|Site closure|0|||
44433974|NCT00688688|79442700|FG000|Overall Study|Violation of exclusion criterion|0|||
44433975|NCT00688688|79442701|FG001|Overall Study|Violation of exclusion criterion|1|||
44433976|NCT00688688|79442702|FG002|Overall Study|Violation of exclusion criterion|0|||
44539649|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44433977|NCT00664326|79442710|FG000|Overall Study|Adverse Event|14|||
44539650|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
44539651|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539652|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539653|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539654|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539655|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539656|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539657|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539658|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539659|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539660|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539661|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
44539662|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44259196|NCT01873833|79115947|FG000|Overall Study|Withdrawal by Subject|1|||
44259197|NCT04388527|79116384|FG000|Overall Study|Death|14|||
44259198|NCT04388527|79116384|FG000|Overall Study|Withdrawal by Subject|2|||
44259199|NCT04388527|79116384|FG000|Overall Study|Lost to Follow-up|1|||
44259200|NCT03649321|79116411|FG000|Overall Study|Withdrawal by Subject|1|||
44259201|NCT03649321|79116412|FG001|Overall Study|Withdrawal by Subject|0|||
44259202|NCT03649321|79116411|FG000|Overall Study|Death|1|||
44259203|NCT03649321|79116412|FG001|Overall Study|Death|0|||
44259204|NCT04149002|79116645|FG000|Overall Study|Lost to Follow-up|1|||
44259205|NCT04149002|79116646|FG001|Overall Study|Lost to Follow-up|0|||
44259206|NCT04149002|79116645|FG000|Overall Study|Withdrawal by Subject|1|||
44259207|NCT04149002|79116646|FG001|Overall Study|Withdrawal by Subject|0|||
44259208|NCT00555321|79116720|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
44335658|NCT01032889|79340450|FG001|Overall Study|Lost to Follow-up|1|||
44335659|NCT01032889|79340451|FG002|Overall Study|Lost to Follow-up|0|||
44335660|NCT01032889|79340449|FG000|Overall Study|Lack of Submental Fat|2|||
44259209|NCT00555321|79116721|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
44259210|NCT00555321|79116722|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
44259211|NCT00555321|79116723|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
44259212|NCT00555321|79116724|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
44259213|NCT00555321|79116720|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
44259214|NCT00555321|79116721|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
44259215|NCT00555321|79116722|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
44259216|NCT00555321|79116723|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
44259217|NCT00555321|79116724|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
44259218|NCT00555321|79116720|FG000|Treatment Phase up to 12-months|Death|2|||
44259219|NCT00555321|79116721|FG001|Treatment Phase up to 12-months|Death|1|||
44259220|NCT00555321|79116722|FG002|Treatment Phase up to 12-months|Death|4|||
44259221|NCT00555321|79116723|FG003|Treatment Phase up to 12-months|Death|0|||
44259222|NCT00555321|79116724|FG004|Treatment Phase up to 12-months|Death|0|||
44259223|NCT00555321|79116720|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
44259224|NCT00555321|79116721|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
44259225|NCT00555321|79116722|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
44259226|NCT00555321|79116723|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
44259227|NCT00555321|79116724|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
44259228|NCT00555321|79116720|FG000|Treatment Phase up to 12-months|Other Reason|1|||
44259229|NCT00555321|79116721|FG001|Treatment Phase up to 12-months|Other Reason|3|||
44259230|NCT00555321|79116722|FG002|Treatment Phase up to 12-months|Other Reason|2|||
44259231|NCT00555321|79116723|FG003|Treatment Phase up to 12-months|Other Reason|0|||
44259232|NCT00555321|79116724|FG004|Treatment Phase up to 12-months|Other Reason|0|||
44335661|NCT01032889|79340450|FG001|Overall Study|Lack of Submental Fat|8|||
44335662|NCT01032889|79340451|FG002|Overall Study|Lack of Submental Fat|1|||
44335663|NCT01032889|79340449|FG000|Overall Study|Miscellaneous Reasons|2|||
44335664|NCT01032889|79340450|FG001|Overall Study|Miscellaneous Reasons|1|||
44335665|NCT01032889|79340451|FG002|Overall Study|Miscellaneous Reasons|1|||
44335666|NCT01049503|79340465|FG000|Overall Study|Lost to Follow-up|11|||
44335667|NCT01049503|79340466|FG001|Overall Study|Lost to Follow-up|12|||
44335668|NCT01049503|79340467|FG002|Overall Study|Lost to Follow-up|24|||
44335669|NCT01049503|79340468|FG003|Overall Study|Lost to Follow-up|26|||
44335670|NCT01049503|79340469|FG004|Overall Study|Lost to Follow-up|27|||
44335671|NCT01049503|79340470|FG005|Overall Study|Lost to Follow-up|8|||
44335672|NCT01029925|79340493|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
44259233|NCT00555321|79116720|FG000|Treatment Phase up to 12-months|Never treated|2|||
44259234|NCT00555321|79116721|FG001|Treatment Phase up to 12-months|Never treated|3|||
44259235|NCT00555321|79116722|FG002|Treatment Phase up to 12-months|Never treated|1|||
44259236|NCT00555321|79116723|FG003|Treatment Phase up to 12-months|Never treated|0|||
44335673|NCT01029925|79340493|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
44335674|NCT01029925|79340493|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
44539663|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44335675|NCT01029691|79340500|FG000|Continued APAP to Delivery|Death|0|||
44335676|NCT01029691|79340501|FG001|Continued APAP to Delivery|Death|0|||
44433978|NCT00664326|79442710|FG000|Overall Study|Noncompliance with study medication|3|||
44433979|NCT00664326|79442710|FG000|Overall Study|Withdrawal by Subject|1|||
44433980|NCT00664326|79442710|FG000|Overall Study|Physician Decision|1|||
44335677|NCT01029691|79340502|FG002|Continued APAP to Delivery|Death|1|||
44335678|NCT01029535|79340511|FG000|Overall Study|Lost to Follow-up|24|||
44335679|NCT01029535|79340511|FG000|Overall Study|Protocol Violation|2|||
44335680|NCT01029535|79340511|FG000|Overall Study|Participant Withdrew Consent|2|||
44335681|NCT01029535|79340511|FG000|Overall Study|Adverse Event|1|||
44335682|NCT01029535|79340511|FG000|Overall Study|Use of Another Treatment|1|||
44335683|NCT01029535|79340511|FG000|Overall Study|Death|1|||
44335684|NCT01028053|79340516|FG000|Overall Study|Screen Failure|113|||
44335685|NCT01028053|79340516|FG000|Overall Study|Patient Request|11|||
44335686|NCT01028053|79340516|FG000|Overall Study|Protocol Violation|1|||
44335687|NCT01028053|79340516|FG000|Overall Study|Physician Decision|2|||
44335688|NCT01028053|79340516|FG000|Overall Study|Technical Problem|1|||
44335689|NCT01028053|79340516|FG000|Overall Study|Terminated by Sponsor|1|||
44335690|NCT01028053|79340516|FG000|Overall Study|Various reasons|4|||
44335691|NCT01023217|79340524|FG000|Overall Study|Withdrawal by Subject|1|||
44335692|NCT01023217|79340525|FG001|Overall Study|Withdrawal by Subject|0|||
44335693|NCT01095796|79340533|FG000|Overall Study|Randomized but Not Treated|5|||
44335694|NCT01095796|79340534|FG001|Overall Study|Randomized but Not Treated|2|||
44335695|NCT01095796|79340533|FG000|Overall Study|Adverse Event|9|||
44335696|NCT01095796|79340534|FG001|Overall Study|Adverse Event|19|||
44335697|NCT01095796|79340533|FG000|Overall Study|Death|3|||
44335698|NCT01095796|79340534|FG001|Overall Study|Death|2|||
44335699|NCT01095796|79340533|FG000|Overall Study|Pregnancy|2|||
44335700|NCT01095796|79340534|FG001|Overall Study|Pregnancy|0|||
44433981|NCT00664326|79442710|FG000|Overall Study|Other Reasons|3|||
44433982|NCT00664326|79442710|FG000|Overall Study|Death|2|||
44433983|NCT00664326|79442710|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
44433984|NCT00686972|79442714|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
44335701|NCT01095796|79340533|FG000|Overall Study|Lack of Efficacy|5|||
44335702|NCT01095796|79340534|FG001|Overall Study|Lack of Efficacy|3|||
44335703|NCT01095796|79340533|FG000|Overall Study|Investigator's Discretion|7|||
44335704|NCT01095796|79340534|FG001|Overall Study|Investigator's Discretion|2|||
44433985|NCT00665652|79442718|FG000|Overall Study|Adverse Event|4|||
44433986|NCT00665652|79442718|FG000|Overall Study|Death|1|||
44433987|NCT00665652|79442718|FG000|Overall Study|No longer met inclusion criteria.|1|||
44433988|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
44433989|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
44433990|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
44433991|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
44433992|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
44433993|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
44433994|NCT00566631|79442722|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
44433995|NCT00566631|79442722|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
44433996|NCT00566631|79442722|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
44433997|NCT00566631|79442722|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
44433998|NCT00566631|79442722|FG000|Part 2: Extension Phase|Adverse Event|11|||
44539664|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539665|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539666|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
44539667|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44335705|NCT01095796|79340533|FG000|Overall Study|Withdrew Consent|16|||
44539668|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539669|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539670|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539671|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539672|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539673|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44335706|NCT01095796|79340534|FG001|Overall Study|Withdrew Consent|22|||
44335707|NCT01095796|79340533|FG000|Overall Study|Lost to Follow-up|27|||
44335708|NCT01095796|79340534|FG001|Overall Study|Lost to Follow-up|29|||
44335709|NCT01095796|79340533|FG000|Overall Study|Participant Noncompliance|5|||
44335710|NCT01095796|79340534|FG001|Overall Study|Participant Noncompliance|10|||
44335711|NCT01095796|79340533|FG000|Overall Study|Protocol Violation|1|||
44433999|NCT00566631|79442722|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
44434000|NCT00566631|79442722|FG000|Part 2: Extension Phase|Death|1|||
44434001|NCT00566631|79442722|FG000|Part 2: Extension Phase|Other|5|||
44434002|NCT00661830|79442728|FG000|Overall Study|Death|37|||
44434003|NCT00661830|79442729|FG001|Overall Study|Death|33|||
44539674|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44335712|NCT01095796|79340534|FG001|Overall Study|Protocol Violation|0|||
44335713|NCT01095796|79340533|FG000|Overall Study|Participant Transferred to Another Study|215|||
44335714|NCT01095796|79340534|FG001|Overall Study|Participant Transferred to Another Study|200|||
44335715|NCT01023061|79340540|FG000|Overall Study|Withdrawal prior to treatment|2|||
44335716|NCT01027897|79340544|FG000|Overall Study|Protocol Violation|1|||
44335717|NCT01027897|79340544|FG000|Overall Study|Withdrawal by Subject|1|||
44335718|NCT01027351|79340554|FG000|Overall Study|Withdrawal by Subject|1|||
44335719|NCT01027351|79340555|FG001|Overall Study|Withdrawal by Subject|0|||
44335720|NCT01027351|79340556|FG002|Overall Study|Withdrawal by Subject|1|||
44335721|NCT01027351|79340557|FG003|Overall Study|Withdrawal by Subject|0|||
44335722|NCT01027351|79340558|FG004|Overall Study|Withdrawal by Subject|3|||
44335723|NCT01027351|79340559|FG005|Overall Study|Withdrawal by Subject|5|||
44335724|NCT01027351|79340554|FG000|Overall Study|Lost to Follow-up|1|||
44335725|NCT01027351|79340555|FG001|Overall Study|Lost to Follow-up|1|||
44335726|NCT01027351|79340556|FG002|Overall Study|Lost to Follow-up|0|||
44335727|NCT01027351|79340557|FG003|Overall Study|Lost to Follow-up|1|||
44335728|NCT01027351|79340558|FG004|Overall Study|Lost to Follow-up|6|||
44335729|NCT01027351|79340559|FG005|Overall Study|Lost to Follow-up|0|||
44335730|NCT01027351|79340554|FG000|Overall Study|Inappropriate enrollment|0|||
44335731|NCT01027351|79340555|FG001|Overall Study|Inappropriate enrollment|0|||
44335732|NCT01027351|79340556|FG002|Overall Study|Inappropriate enrollment|0|||
44335733|NCT01027351|79340557|FG003|Overall Study|Inappropriate enrollment|0|||
44335734|NCT01027351|79340558|FG004|Overall Study|Inappropriate enrollment|1|||
44335735|NCT01027351|79340559|FG005|Overall Study|Inappropriate enrollment|0|||
44335736|NCT01027351|79340554|FG000|Overall Study|Protocol Violation|1|||
44335737|NCT01027351|79340555|FG001|Overall Study|Protocol Violation|0|||
44335738|NCT01027351|79340556|FG002|Overall Study|Protocol Violation|0|||
44335739|NCT01027351|79340557|FG003|Overall Study|Protocol Violation|1|||
44335740|NCT01027351|79340558|FG004|Overall Study|Protocol Violation|1|||
44335741|NCT01027351|79340559|FG005|Overall Study|Protocol Violation|0|||
44335742|NCT01027273|79340582|FG000|Overall Study|Lost to Follow-up|57|||
44335743|NCT01027273|79340583|FG001|Overall Study|Lost to Follow-up|31|||
44335744|NCT01027273|79340582|FG000|Overall Study|Death|2|||
44335745|NCT01027273|79340583|FG001|Overall Study|Death|2|||
44335746|NCT01022203|79340591|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
44335747|NCT01022203|79340592|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
44335748|NCT01022203|79340591|FG000|Post Treatment Assessment|Physician Decision|2|||
44335749|NCT01022203|79340592|FG001|Post Treatment Assessment|Physician Decision|0|||
44335750|NCT01022203|79340591|FG000|Post Treatment Assessment|Adverse Event|0|||
44335751|NCT01022203|79340592|FG001|Post Treatment Assessment|Adverse Event|2|||
44335752|NCT01022203|79340591|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
44335753|NCT01022203|79340592|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
44335754|NCT01296711|79340609|FG000|Overall Study|Adverse Event|3|||
44335755|NCT01296711|79340610|FG001|Overall Study|Adverse Event|1|||
44335756|NCT01296711|79340611|FG002|Overall Study|Adverse Event|4|||
44335757|NCT01296711|79340612|FG003|Overall Study|Adverse Event|3|||
44335758|NCT01296711|79340613|FG004|Overall Study|Adverse Event|1|||
44335759|NCT01296711|79340614|FG005|Overall Study|Adverse Event|6|||
44335760|NCT01296711|79340615|FG006|Overall Study|Adverse Event|11|||
44335761|NCT01296711|79340616|FG007|Overall Study|Adverse Event|3|||
44335762|NCT01296711|79340609|FG000|Overall Study|Lack of Efficacy|1|||
44335763|NCT01296711|79340610|FG001|Overall Study|Lack of Efficacy|4|||
44335764|NCT01296711|79340611|FG002|Overall Study|Lack of Efficacy|1|||
44335765|NCT01296711|79340612|FG003|Overall Study|Lack of Efficacy|1|||
44335766|NCT01296711|79340613|FG004|Overall Study|Lack of Efficacy|1|||
44335767|NCT01296711|79340614|FG005|Overall Study|Lack of Efficacy|0|||
44335768|NCT01296711|79340615|FG006|Overall Study|Lack of Efficacy|2|||
44335769|NCT01296711|79340616|FG007|Overall Study|Lack of Efficacy|3|||
44335770|NCT01296711|79340609|FG000|Overall Study|Lost to Follow-up|0|||
44335771|NCT01296711|79340610|FG001|Overall Study|Lost to Follow-up|0|||
44539675|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44335772|NCT01296711|79340611|FG002|Overall Study|Lost to Follow-up|1|||
44335773|NCT01296711|79340612|FG003|Overall Study|Lost to Follow-up|1|||
44335774|NCT01296711|79340613|FG004|Overall Study|Lost to Follow-up|2|||
44335775|NCT01296711|79340614|FG005|Overall Study|Lost to Follow-up|0|||
44335776|NCT01296711|79340615|FG006|Overall Study|Lost to Follow-up|4|||
44335777|NCT01296711|79340616|FG007|Overall Study|Lost to Follow-up|2|||
44335778|NCT01296711|79340609|FG000|Overall Study|Protocol Violation|0|||
44335779|NCT01296711|79340610|FG001|Overall Study|Protocol Violation|0|||
44335780|NCT01296711|79340611|FG002|Overall Study|Protocol Violation|0|||
44335781|NCT01296711|79340612|FG003|Overall Study|Protocol Violation|1|||
44335782|NCT01296711|79340613|FG004|Overall Study|Protocol Violation|1|||
44335783|NCT01296711|79340614|FG005|Overall Study|Protocol Violation|0|||
44335784|NCT01296711|79340615|FG006|Overall Study|Protocol Violation|0|||
44335785|NCT01296711|79340616|FG007|Overall Study|Protocol Violation|0|||
44335786|NCT01296711|79340609|FG000|Overall Study|Withdrawal by Subject|4|||
44335787|NCT01296711|79340610|FG001|Overall Study|Withdrawal by Subject|2|||
44335788|NCT01296711|79340611|FG002|Overall Study|Withdrawal by Subject|2|||
44335789|NCT01296711|79340612|FG003|Overall Study|Withdrawal by Subject|1|||
44335790|NCT01296711|79340613|FG004|Overall Study|Withdrawal by Subject|1|||
44335791|NCT01296711|79340614|FG005|Overall Study|Withdrawal by Subject|1|||
44335792|NCT01296711|79340615|FG006|Overall Study|Withdrawal by Subject|2|||
44335793|NCT01296711|79340616|FG007|Overall Study|Withdrawal by Subject|1|||
44335794|NCT01296711|79340609|FG000|Overall Study|Study termination|8|||
44335795|NCT01296711|79340610|FG001|Overall Study|Study termination|1|||
44335796|NCT01296711|79340611|FG002|Overall Study|Study termination|5|||
44335797|NCT01296711|79340612|FG003|Overall Study|Study termination|4|||
44335798|NCT01296711|79340613|FG004|Overall Study|Study termination|4|||
44335799|NCT01296711|79340614|FG005|Overall Study|Study termination|4|||
44335800|NCT01296711|79340615|FG006|Overall Study|Study termination|8|||
44335801|NCT01296711|79340616|FG007|Overall Study|Study termination|10|||
44335802|NCT01296711|79340609|FG000|Overall Study|Continued elevated liver enzymes|0|||
44335803|NCT01296711|79340610|FG001|Overall Study|Continued elevated liver enzymes|0|||
44335804|NCT01296711|79340611|FG002|Overall Study|Continued elevated liver enzymes|0|||
44335805|NCT01296711|79340612|FG003|Overall Study|Continued elevated liver enzymes|1|||
44335806|NCT01296711|79340613|FG004|Overall Study|Continued elevated liver enzymes|0|||
44335807|NCT01296711|79340614|FG005|Overall Study|Continued elevated liver enzymes|0|||
44335808|NCT01296711|79340615|FG006|Overall Study|Continued elevated liver enzymes|0|||
44335809|NCT01296711|79340616|FG007|Overall Study|Continued elevated liver enzymes|0|||
44335810|NCT01296711|79340609|FG000|Overall Study|Methotrexate discontinued|0|||
44335811|NCT01296711|79340610|FG001|Overall Study|Methotrexate discontinued|0|||
44335812|NCT01296711|79340611|FG002|Overall Study|Methotrexate discontinued|0|||
44335813|NCT01296711|79340612|FG003|Overall Study|Methotrexate discontinued|1|||
44434004|NCT00661830|79442728|FG000|Overall Study|Lost to Follow-up|1|||
44434005|NCT00661830|79442729|FG001|Overall Study|Lost to Follow-up|3|||
44434006|NCT00661830|79442728|FG000|Overall Study|Withdrawal by Subject|1|||
44434007|NCT00661830|79442729|FG001|Overall Study|Withdrawal by Subject|1|||
44434008|NCT00661830|79442728|FG000|Overall Study|Other reason|1|||
44434009|NCT00661830|79442729|FG001|Overall Study|Other reason|5|||
44434010|NCT00540592|79442745|FG000|Overall Study|Adverse Event|0|||
44434011|NCT00540592|79442746|FG001|Overall Study|Adverse Event|1|||
44434012|NCT00540592|79442747|FG002|Overall Study|Adverse Event|0|||
44434013|NCT00540592|79442748|FG003|Overall Study|Adverse Event|0|||
44335814|NCT01296711|79340613|FG004|Overall Study|Methotrexate discontinued|0|||
44335815|NCT01296711|79340614|FG005|Overall Study|Methotrexate discontinued|0|||
44335816|NCT01296711|79340615|FG006|Overall Study|Methotrexate discontinued|0|||
44335817|NCT01296711|79340616|FG007|Overall Study|Methotrexate discontinued|0|||
44335818|NCT01296711|79340609|FG000|Overall Study|Investigator discretion|0|||
44335819|NCT01296711|79340610|FG001|Overall Study|Investigator discretion|0|||
44335820|NCT01296711|79340611|FG002|Overall Study|Investigator discretion|0|||
44335821|NCT01296711|79340612|FG003|Overall Study|Investigator discretion|0|||
44335822|NCT01296711|79340613|FG004|Overall Study|Investigator discretion|0|||
44335823|NCT01296711|79340614|FG005|Overall Study|Investigator discretion|0|||
44434014|NCT00540592|79442749|FG004|Overall Study|Adverse Event|1|||
44434015|NCT00540592|79442750|FG005|Overall Study|Adverse Event|0|||
44434016|NCT00540592|79442751|FG006|Overall Study|Adverse Event|0|||
44434017|NCT00540592|79442752|FG007|Overall Study|Adverse Event|1|||
44434018|NCT00540592|79442753|FG008|Overall Study|Adverse Event|1|||
44434019|NCT00540592|79442754|FG009|Overall Study|Adverse Event|2|||
44434020|NCT00540592|79442745|FG000|Overall Study|Lost to Follow-up|2|||
44434021|NCT00540592|79442746|FG001|Overall Study|Lost to Follow-up|0|||
44434022|NCT00540592|79442747|FG002|Overall Study|Lost to Follow-up|0|||
44434023|NCT00540592|79442748|FG003|Overall Study|Lost to Follow-up|0|||
44434024|NCT00540592|79442749|FG004|Overall Study|Lost to Follow-up|0|||
44434025|NCT00540592|79442750|FG005|Overall Study|Lost to Follow-up|0|||
44434026|NCT00540592|79442751|FG006|Overall Study|Lost to Follow-up|0|||
44434027|NCT00540592|79442752|FG007|Overall Study|Lost to Follow-up|0|||
44434028|NCT00540592|79442753|FG008|Overall Study|Lost to Follow-up|0|||
44434029|NCT00540592|79442754|FG009|Overall Study|Lost to Follow-up|0|||
44434030|NCT00540592|79442745|FG000|Overall Study|Withdrawal by Subject|0|||
44434031|NCT00540592|79442746|FG001|Overall Study|Withdrawal by Subject|0|||
44434032|NCT00540592|79442747|FG002|Overall Study|Withdrawal by Subject|1|||
44434033|NCT00540592|79442748|FG003|Overall Study|Withdrawal by Subject|1|||
44434034|NCT00540592|79442749|FG004|Overall Study|Withdrawal by Subject|0|||
44335824|NCT01296711|79340615|FG006|Overall Study|Investigator discretion|1|||
44434035|NCT00540592|79442750|FG005|Overall Study|Withdrawal by Subject|0|||
44434036|NCT00540592|79442751|FG006|Overall Study|Withdrawal by Subject|0|||
44335825|NCT01296711|79340616|FG007|Overall Study|Investigator discretion|0|||
44434037|NCT00540592|79442752|FG007|Overall Study|Withdrawal by Subject|0|||
44434038|NCT00540592|79442753|FG008|Overall Study|Withdrawal by Subject|0|||
44434039|NCT00540592|79442754|FG009|Overall Study|Withdrawal by Subject|0|||
44434040|NCT03970395|79442778|FG000|Overall Study|Withdrawal by Subject|3|||
44335826|NCT01296711|79340609|FG000|Overall Study|Other|0|||
44434041|NCT03970395|79442779|FG001|Overall Study|Withdrawal by Subject|4|||
44434042|NCT03970395|79442778|FG000|Overall Study|Lost to Follow-up|4|||
44434043|NCT03970395|79442779|FG001|Overall Study|Lost to Follow-up|8|||
44434044|NCT00565773|79442789|FG000|Overall Study|Withdrawal by Subject|1|||
44434045|NCT00565773|79442789|FG000|Overall Study|Physician Decision|1|||
44434046|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
44434047|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
44434048|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
44434049|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
44434050|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
44434051|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
44434052|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
44434053|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
44434054|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
44434055|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
44434056|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
44434057|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
44434058|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
44434059|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
44434060|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
44434061|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
44434062|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
44434063|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
44434064|NCT00570492|79442795|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
44434065|NCT00570492|79442796|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
44434066|NCT00570492|79442797|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
44434067|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44434068|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
44434069|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
44434070|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
44434071|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
44434072|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
44434073|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
44434074|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
44434075|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
44434076|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
44434077|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
44434078|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
44434079|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
44434080|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
44434081|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
44434082|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
44434083|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
44335827|NCT01296711|79340610|FG001|Overall Study|Other|0|||
44335828|NCT01296711|79340611|FG002|Overall Study|Other|0|||
44335829|NCT01296711|79340612|FG003|Overall Study|Other|0|||
44335830|NCT01296711|79340613|FG004|Overall Study|Other|0|||
44335831|NCT01296711|79340614|FG005|Overall Study|Other|0|||
44335832|NCT01296711|79340615|FG006|Overall Study|Other|1|||
44335833|NCT01296711|79340616|FG007|Overall Study|Other|0|||
44335834|NCT01296711|79340609|FG000|Overall Study|Required restricted steroid injections|0|||
44335835|NCT01296711|79340610|FG001|Overall Study|Required restricted steroid injections|0|||
44335836|NCT01296711|79340611|FG002|Overall Study|Required restricted steroid injections|0|||
44335837|NCT01296711|79340612|FG003|Overall Study|Required restricted steroid injections|0|||
44335838|NCT01296711|79340613|FG004|Overall Study|Required restricted steroid injections|0|||
44335839|NCT01296711|79340614|FG005|Overall Study|Required restricted steroid injections|0|||
44335840|NCT01296711|79340615|FG006|Overall Study|Required restricted steroid injections|1|||
44335841|NCT01296711|79340616|FG007|Overall Study|Required restricted steroid injections|0|||
44335842|NCT01296711|79340609|FG000|Overall Study|Ongoing missed appointments|0|||
44335843|NCT01296711|79340610|FG001|Overall Study|Ongoing missed appointments|0|||
44335844|NCT01296711|79340611|FG002|Overall Study|Ongoing missed appointments|0|||
44335845|NCT01296711|79340612|FG003|Overall Study|Ongoing missed appointments|0|||
44335846|NCT01296711|79340613|FG004|Overall Study|Ongoing missed appointments|0|||
44335847|NCT01296711|79340614|FG005|Overall Study|Ongoing missed appointments|0|||
44335848|NCT01296711|79340615|FG006|Overall Study|Ongoing missed appointments|1|||
44335849|NCT01296711|79340616|FG007|Overall Study|Ongoing missed appointments|0|||
44335850|NCT01296711|79340609|FG000|Overall Study|Failure to comply with visits|0|||
44335851|NCT01296711|79340610|FG001|Overall Study|Failure to comply with visits|0|||
44335852|NCT01296711|79340611|FG002|Overall Study|Failure to comply with visits|0|||
44335853|NCT01296711|79340612|FG003|Overall Study|Failure to comply with visits|0|||
44434084|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
44434085|NCT00570492|79442795|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
44434086|NCT00570492|79442796|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
44434087|NCT00570492|79442797|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
44434088|NCT00571922|79442805|FG000|Overall Study|Completion unknown|36|||
44434089|NCT00571922|79442806|FG001|Overall Study|Completion unknown|36|||
44434090|NCT00686894|79442812|FG000|Overall Study|Relapse|2|||
44434091|NCT00686894|79442812|FG000|Overall Study|Protocol Violation|4|||
44434092|NCT00328627|79442828|FG000|Overall Study|Hyperglycemic Rescue|41|||
44434093|NCT00328627|79442829|FG001|Overall Study|Hyperglycemic Rescue|18|||
44434094|NCT00328627|79442830|FG002|Overall Study|Hyperglycemic Rescue|16|||
44434095|NCT00328627|79442831|FG003|Overall Study|Hyperglycemic Rescue|13|||
44434096|NCT00328627|79442832|FG004|Overall Study|Hyperglycemic Rescue|6|||
44434097|NCT00328627|79442833|FG005|Overall Study|Hyperglycemic Rescue|5|||
44434098|NCT00328627|79442834|FG006|Overall Study|Hyperglycemic Rescue|19|||
44434099|NCT00328627|79442835|FG007|Overall Study|Hyperglycemic Rescue|6|||
44434100|NCT00328627|79442836|FG008|Overall Study|Hyperglycemic Rescue|6|||
44434101|NCT00328627|79442837|FG009|Overall Study|Hyperglycemic Rescue|11|||
44434102|NCT00328627|79442838|FG010|Overall Study|Hyperglycemic Rescue|3|||
44434103|NCT00328627|79442839|FG011|Overall Study|Hyperglycemic Rescue|2|||
44434104|NCT00328627|79442828|FG000|Overall Study|Adverse Event|3|||
44434105|NCT00328627|79442829|FG001|Overall Study|Adverse Event|1|||
44434106|NCT00328627|79442830|FG002|Overall Study|Adverse Event|2|||
44434107|NCT00328627|79442831|FG003|Overall Study|Adverse Event|3|||
44434108|NCT00328627|79442832|FG004|Overall Study|Adverse Event|1|||
44434109|NCT00328627|79442833|FG005|Overall Study|Adverse Event|2|||
44434110|NCT00328627|79442834|FG006|Overall Study|Adverse Event|1|||
44434111|NCT00328627|79442835|FG007|Overall Study|Adverse Event|2|||
44434112|NCT00328627|79442836|FG008|Overall Study|Adverse Event|0|||
44434113|NCT00328627|79442837|FG009|Overall Study|Adverse Event|7|||
44434114|NCT00328627|79442838|FG010|Overall Study|Adverse Event|5|||
44434115|NCT00328627|79442839|FG011|Overall Study|Adverse Event|4|||
44434116|NCT00328627|79442828|FG000|Overall Study|Protocol Violation|2|||
44434117|NCT00328627|79442829|FG001|Overall Study|Protocol Violation|2|||
44434118|NCT00328627|79442830|FG002|Overall Study|Protocol Violation|2|||
44434119|NCT00328627|79442831|FG003|Overall Study|Protocol Violation|8|||
44434120|NCT00328627|79442832|FG004|Overall Study|Protocol Violation|5|||
44434121|NCT00328627|79442833|FG005|Overall Study|Protocol Violation|5|||
44434122|NCT00328627|79442834|FG006|Overall Study|Protocol Violation|6|||
44434123|NCT00328627|79442835|FG007|Overall Study|Protocol Violation|2|||
44434124|NCT00328627|79442836|FG008|Overall Study|Protocol Violation|1|||
44434125|NCT00328627|79442837|FG009|Overall Study|Protocol Violation|4|||
44434126|NCT00328627|79442838|FG010|Overall Study|Protocol Violation|6|||
44434127|NCT00328627|79442839|FG011|Overall Study|Protocol Violation|2|||
44434128|NCT00328627|79442828|FG000|Overall Study|Lost to Follow-up|4|||
44335854|NCT01296711|79340613|FG004|Overall Study|Failure to comply with visits|0|||
44335855|NCT01296711|79340614|FG005|Overall Study|Failure to comply with visits|0|||
44335856|NCT01296711|79340615|FG006|Overall Study|Failure to comply with visits|0|||
44335857|NCT01296711|79340616|FG007|Overall Study|Failure to comply with visits|1|||
44335858|NCT01296711|79340609|FG000|Overall Study|Patient decision due to transport|0|||
44335859|NCT01296711|79340610|FG001|Overall Study|Patient decision due to transport|0|||
44335860|NCT01296711|79340611|FG002|Overall Study|Patient decision due to transport|0|||
44335861|NCT01296711|79340612|FG003|Overall Study|Patient decision due to transport|0|||
44335862|NCT01296711|79340613|FG004|Overall Study|Patient decision due to transport|0|||
44335863|NCT01296711|79340614|FG005|Overall Study|Patient decision due to transport|0|||
44335864|NCT01296711|79340615|FG006|Overall Study|Patient decision due to transport|0|||
44335865|NCT01296711|79340616|FG007|Overall Study|Patient decision due to transport|1|||
44335866|NCT01294917|79340634|FG000|Overall Study|Relocation|5|||
44335867|NCT01294917|79340634|FG000|Overall Study|Inconvenience|1|||
44335868|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
44335869|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
44335870|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
44335871|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
44434129|NCT00328627|79442829|FG001|Overall Study|Lost to Follow-up|2|||
44434130|NCT00328627|79442830|FG002|Overall Study|Lost to Follow-up|2|||
44434131|NCT00328627|79442831|FG003|Overall Study|Lost to Follow-up|4|||
44434132|NCT00328627|79442832|FG004|Overall Study|Lost to Follow-up|0|||
44335872|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
44335873|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
44335874|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
44434133|NCT00328627|79442833|FG005|Overall Study|Lost to Follow-up|2|||
44434134|NCT00328627|79442834|FG006|Overall Study|Lost to Follow-up|3|||
44434135|NCT00328627|79442835|FG007|Overall Study|Lost to Follow-up|0|||
44434136|NCT00328627|79442836|FG008|Overall Study|Lost to Follow-up|3|||
44434137|NCT00328627|79442837|FG009|Overall Study|Lost to Follow-up|2|||
44434138|NCT00328627|79442838|FG010|Overall Study|Lost to Follow-up|0|||
44434139|NCT00328627|79442839|FG011|Overall Study|Lost to Follow-up|1|||
44434140|NCT00328627|79442828|FG000|Overall Study|Withdrawal by Subject|5|||
44434141|NCT00328627|79442829|FG001|Overall Study|Withdrawal by Subject|4|||
44434142|NCT00328627|79442830|FG002|Overall Study|Withdrawal by Subject|5|||
44434143|NCT00328627|79442831|FG003|Overall Study|Withdrawal by Subject|6|||
44434144|NCT00328627|79442832|FG004|Overall Study|Withdrawal by Subject|2|||
44434145|NCT00328627|79442833|FG005|Overall Study|Withdrawal by Subject|5|||
44335875|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
44335876|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
44335877|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
44335878|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
44335879|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
44434146|NCT00328627|79442834|FG006|Overall Study|Withdrawal by Subject|4|||
44335880|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
44335881|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
44335882|NCT01294683|79340642|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
44335883|NCT01294683|79340643|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
44434147|NCT00328627|79442835|FG007|Overall Study|Withdrawal by Subject|4|||
44434148|NCT00328627|79442836|FG008|Overall Study|Withdrawal by Subject|4|||
44434149|NCT00328627|79442837|FG009|Overall Study|Withdrawal by Subject|5|||
44434150|NCT00328627|79442838|FG010|Overall Study|Withdrawal by Subject|2|||
44434151|NCT00328627|79442839|FG011|Overall Study|Withdrawal by Subject|7|||
44434152|NCT00328627|79442828|FG000|Overall Study|Pregnancy|0|||
44434153|NCT00328627|79442829|FG001|Overall Study|Pregnancy|1|||
44434154|NCT00328627|79442830|FG002|Overall Study|Pregnancy|0|||
44434155|NCT00328627|79442831|FG003|Overall Study|Pregnancy|0|||
44335884|NCT01294683|79340642|FG000|Post Crossover (Period III)|Adverse Event|6|||
44335885|NCT01294683|79340643|FG001|Post Crossover (Period III)|Adverse Event|6|||
44335886|NCT01294683|79340642|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
44434156|NCT00328627|79442832|FG004|Overall Study|Pregnancy|0|||
44434157|NCT00328627|79442833|FG005|Overall Study|Pregnancy|0|||
44434158|NCT00328627|79442834|FG006|Overall Study|Pregnancy|0|||
44434159|NCT00328627|79442835|FG007|Overall Study|Pregnancy|0|||
44434160|NCT00328627|79442836|FG008|Overall Study|Pregnancy|0|||
44434161|NCT00328627|79442837|FG009|Overall Study|Pregnancy|0|||
44434162|NCT00328627|79442838|FG010|Overall Study|Pregnancy|0|||
44434163|NCT00328627|79442839|FG011|Overall Study|Pregnancy|0|||
44434164|NCT00328627|79442828|FG000|Overall Study|Physician Decision|4|||
44434165|NCT00328627|79442829|FG001|Overall Study|Physician Decision|3|||
44434166|NCT00328627|79442830|FG002|Overall Study|Physician Decision|1|||
44434167|NCT00328627|79442831|FG003|Overall Study|Physician Decision|2|||
44434168|NCT00328627|79442832|FG004|Overall Study|Physician Decision|1|||
44434169|NCT00328627|79442833|FG005|Overall Study|Physician Decision|1|||
44434170|NCT00328627|79442834|FG006|Overall Study|Physician Decision|1|||
44434171|NCT00328627|79442835|FG007|Overall Study|Physician Decision|0|||
44434172|NCT00328627|79442836|FG008|Overall Study|Physician Decision|3|||
44434173|NCT00328627|79442837|FG009|Overall Study|Physician Decision|2|||
44434174|NCT00328627|79442838|FG010|Overall Study|Physician Decision|1|||
44434175|NCT00328627|79442839|FG011|Overall Study|Physician Decision|0|||
44434176|NCT00328627|79442828|FG000|Overall Study|Other|0|||
44434177|NCT00328627|79442829|FG001|Overall Study|Other|0|||
44434178|NCT00328627|79442830|FG002|Overall Study|Other|0|||
44434179|NCT00328627|79442831|FG003|Overall Study|Other|1|||
44434180|NCT00328627|79442832|FG004|Overall Study|Other|0|||
44434181|NCT00328627|79442833|FG005|Overall Study|Other|0|||
44539676|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539677|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
44539678|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539679|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539680|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539681|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44335887|NCT01294683|79340643|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
44434182|NCT00328627|79442834|FG006|Overall Study|Other|1|||
44434183|NCT00328627|79442835|FG007|Overall Study|Other|0|||
44434184|NCT00328627|79442836|FG008|Overall Study|Other|0|||
44539682|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
44539683|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539684|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44434185|NCT00328627|79442837|FG009|Overall Study|Other|1|||
44434186|NCT00328627|79442838|FG010|Overall Study|Other|1|||
44434187|NCT00328627|79442839|FG011|Overall Study|Other|0|||
44434188|NCT03977727|79442875|FG000|Second Treatment|Lost to Follow-up|0|||
44434189|NCT03977727|79442876|FG001|Second Treatment|Lost to Follow-up|3|||
44434190|NCT00663858|79442885|FG000|Overall Study|Adverse Event|9|||
44434191|NCT00663858|79442886|FG001|Overall Study|Adverse Event|1|||
44434192|NCT00663858|79442887|FG002|Overall Study|Adverse Event|6|||
44434193|NCT00663858|79442885|FG000|Overall Study|Lack of Efficacy|5|||
44434194|NCT00663858|79442886|FG001|Overall Study|Lack of Efficacy|1|||
44434195|NCT00663858|79442887|FG002|Overall Study|Lack of Efficacy|3|||
44434196|NCT00663858|79442885|FG000|Overall Study|Withdrawal by Subject|7|||
44434197|NCT00663858|79442886|FG001|Overall Study|Withdrawal by Subject|3|||
44434198|NCT00663858|79442887|FG002|Overall Study|Withdrawal by Subject|3|||
44434199|NCT00663858|79442885|FG000|Overall Study|Protocol Violation|5|||
44434200|NCT00663858|79442886|FG001|Overall Study|Protocol Violation|3|||
44434201|NCT00663858|79442887|FG002|Overall Study|Protocol Violation|4|||
44434202|NCT00663858|79442885|FG000|Overall Study|Other|8|||
44434203|NCT00663858|79442886|FG001|Overall Study|Other|2|||
44434204|NCT00663858|79442887|FG002|Overall Study|Other|4|||
44434205|NCT00659880|79442895|FG000|Overall Study|Lost to Follow-up|5|||
44434206|NCT00683774|79442902|FG000|Overall Study|Withdrawal by Subject|0|||
44434207|NCT00683774|79442903|FG001|Overall Study|Withdrawal by Subject|1|||
44434208|NCT00683774|79442902|FG000|Overall Study|Physician Decision|3|||
44434209|NCT00683774|79442903|FG001|Overall Study|Physician Decision|0|||
44434210|NCT00354679|79442909|FG000|Overall Study|Patient Not Treated|1|||
44434211|NCT00683696|79442915|FG000|Overall Study|Withdrawn due to study closure|337|||
44434212|NCT00683696|79442916|FG001|Overall Study|Withdrawn due to study closure|338|||
44434213|NCT00683696|79442915|FG000|Overall Study|Withdrawn prior to study closure|13|||
44434214|NCT00683696|79442916|FG001|Overall Study|Withdrawn prior to study closure|28|||
44434215|NCT00683696|79442915|FG000|Overall Study|Lost to Follow-up|5|||
44434216|NCT00683696|79442916|FG001|Overall Study|Lost to Follow-up|6|||
44434217|NCT00683696|79442915|FG000|Overall Study|Vital status follow-up only|3|||
44434218|NCT00683696|79442916|FG001|Overall Study|Vital status follow-up only|3|||
44434219|NCT00683696|79442915|FG000|Overall Study|Death|46|||
44434220|NCT00683696|79442916|FG001|Overall Study|Death|30|||
44434221|NCT00345631|79442926|FG000|Overall Study|Withdrawal by Subject|1|||
44434222|NCT00345631|79442927|FG001|Overall Study|Withdrawal by Subject|0|||
44434223|NCT00345631|79442928|FG002|Overall Study|Withdrawal by Subject|1|||
44434224|NCT00345631|79442926|FG000|Overall Study|Adverse Event|0|||
44434225|NCT00345631|79442927|FG001|Overall Study|Adverse Event|1|||
44434226|NCT00345631|79442928|FG002|Overall Study|Adverse Event|0|||
44434227|NCT00345631|79442926|FG000|Overall Study|Lost to Follow-up|3|||
44434228|NCT00345631|79442927|FG001|Overall Study|Lost to Follow-up|7|||
44434229|NCT00345631|79442928|FG002|Overall Study|Lost to Follow-up|4|||
44434230|NCT00345631|79442926|FG000|Overall Study|Other reasons|0|||
44434231|NCT00345631|79442927|FG001|Overall Study|Other reasons|0|||
44434232|NCT00345631|79442928|FG002|Overall Study|Other reasons|1|||
44434233|NCT00540514|79442940|FG000|Overall Study|Still on treatment|3|||
44434234|NCT00540514|79442941|FG001|Overall Study|Still on treatment|0|||
44434235|NCT00540514|79442940|FG000|Overall Study|Unacceptable Toxicity|61|||
44434236|NCT00540514|79442941|FG001|Overall Study|Unacceptable Toxicity|62|||
44434237|NCT00540514|79442940|FG000|Overall Study|Adverse Event|20|||
44434238|NCT00540514|79442941|FG001|Overall Study|Adverse Event|24|||
44335888|NCT01294683|79340642|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
44335889|NCT01294683|79340643|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
44335890|NCT01294683|79340642|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
44335891|NCT01294683|79340643|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
44335892|NCT01294449|79340657|FG000|Overall Study|Death|11|||
44335893|NCT01294449|79340658|FG001|Overall Study|Death|12|||
44335894|NCT01294449|79340657|FG000|Overall Study|Withdrawal by Subject|1|||
44335895|NCT01294449|79340658|FG001|Overall Study|Withdrawal by Subject|3|||
44335896|NCT01294371|79340664|FG000|Overall Study|Adverse Event|1|||
44335897|NCT01294371|79340664|FG000|Overall Study|Withdrawal by Subject|12|||
44335898|NCT01294371|79340664|FG000|Overall Study|Lost to Follow-up|6|||
44335899|NCT01294371|79340664|FG000|Overall Study|Administrative Reason|1|||
44335900|NCT01294371|79340664|FG000|Overall Study|Other|14|||
44335901|NCT01293123|79340673|FG000|Overall Study|Lost to Follow-up|0|||
44335902|NCT01293123|79340674|FG001|Overall Study|Lost to Follow-up|1|||
44335903|NCT01292187|79340682|FG000|Overall Study|Adverse Event|10|||
44335904|NCT01292187|79340683|FG001|Overall Study|Adverse Event|5|||
44335905|NCT01292187|79340682|FG000|Overall Study|Withdrawal by Subject|6|||
44335906|NCT01292187|79340683|FG001|Overall Study|Withdrawal by Subject|5|||
44335907|NCT01292187|79340682|FG000|Overall Study|All other reasons|1|||
44335908|NCT01292187|79340683|FG001|Overall Study|All other reasons|3|||
44335909|NCT01026493|79340698|FG000|Overall Study|Protocol Violation|0|||
44434239|NCT00540514|79442940|FG000|Overall Study|Physician Decision|86|||
44434240|NCT00540514|79442941|FG001|Overall Study|Physician Decision|99|||
44434241|NCT00540514|79442940|FG000|Overall Study|Protocol Deviation|3|||
44434242|NCT00540514|79442941|FG001|Overall Study|Protocol Deviation|4|||
44335910|NCT01026493|79340699|FG001|Overall Study|Protocol Violation|1|||
44335911|NCT01026493|79340700|FG002|Overall Study|Protocol Violation|0|||
44434243|NCT00540514|79442940|FG000|Overall Study|Lost to Follow-up|1|||
44434244|NCT00540514|79442941|FG001|Overall Study|Lost to Follow-up|1|||
44434245|NCT00540514|79442940|FG000|Overall Study|Withdrawal by Subject|65|||
44434246|NCT00540514|79442941|FG001|Overall Study|Withdrawal by Subject|67|||
44434247|NCT00540514|79442940|FG000|Overall Study|Excluded prior to treatment|7|||
44434248|NCT00540514|79442941|FG001|Overall Study|Excluded prior to treatment|7|||
44434249|NCT00540514|79442940|FG000|Overall Study|Paclitaxel not available|0|||
44434250|NCT00540514|79442941|FG001|Overall Study|Paclitaxel not available|2|||
44434251|NCT00663702|79442950|FG000|Overall Study|Adverse Event|8|||
44434252|NCT00663702|79442951|FG001|Overall Study|Adverse Event|4|||
44434253|NCT00663702|79442950|FG000|Overall Study|Withdrawal by Subject|3|||
44434254|NCT00663702|79442951|FG001|Overall Study|Withdrawal by Subject|1|||
44539685|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539686|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539687|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539688|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539689|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539690|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539691|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539692|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539693|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
44539694|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539695|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539696|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539697|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44539698|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
44335912|NCT01026493|79340701|FG003|Overall Study|Protocol Violation|0|||
44335913|NCT01026493|79340702|FG004|Overall Study|Protocol Violation|2|||
44335914|NCT01026493|79340703|FG005|Overall Study|Protocol Violation|3|||
44539699|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539700|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539701|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539702|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539703|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539704|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539705|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539706|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539707|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539708|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539709|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
44539710|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539711|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539712|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539713|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539714|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
44539715|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44335915|NCT01026493|79340704|FG006|Overall Study|Protocol Violation|4|||
44335916|NCT01026493|79340705|FG007|Overall Study|Protocol Violation|1|||
44335917|NCT01026103|79340723|FG000|Overall Study|Physician Decision|1|||
44335918|NCT01026103|79340723|FG000|Overall Study|did not receive study device bc of error|1|||
44335919|NCT01291173|79340731|FG000|Overall Study|Adverse Event|0|||
44335920|NCT01291173|79340732|FG001|Overall Study|Adverse Event|3|||
44335921|NCT01291173|79340733|FG002|Overall Study|Adverse Event|1|||
44335922|NCT01291173|79340734|FG003|Overall Study|Adverse Event|3|||
44335923|NCT01291173|79340731|FG000|Overall Study|Protocol Violation|7|||
44335924|NCT01291173|79340732|FG001|Overall Study|Protocol Violation|2|||
44335925|NCT01291173|79340733|FG002|Overall Study|Protocol Violation|2|||
44335926|NCT01291173|79340734|FG003|Overall Study|Protocol Violation|5|||
44335927|NCT01291173|79340731|FG000|Overall Study|Withdrawal by Subject|6|||
44335928|NCT01291173|79340732|FG001|Overall Study|Withdrawal by Subject|4|||
44335929|NCT01291173|79340733|FG002|Overall Study|Withdrawal by Subject|4|||
44335930|NCT01291173|79340734|FG003|Overall Study|Withdrawal by Subject|2|||
44335931|NCT01291173|79340731|FG000|Overall Study|Lost to Follow-up|4|||
44335932|NCT01291173|79340732|FG001|Overall Study|Lost to Follow-up|6|||
44434255|NCT00663702|79442950|FG000|Overall Study|Pregnancy|0|||
44434256|NCT00663702|79442951|FG001|Overall Study|Pregnancy|1|||
44434257|NCT00663702|79442950|FG000|Overall Study|Lost to Follow-up|3|||
44335933|NCT01291173|79340733|FG002|Overall Study|Lost to Follow-up|3|||
44157416|NCT03429543|78949154|FG001|Overall Study|Adverse Event|1|||
44335934|NCT01291173|79340734|FG003|Overall Study|Lost to Follow-up|2|||
44335935|NCT01291173|79340731|FG000|Overall Study|Unable to meet visit schedule|0|||
44434258|NCT00663702|79442951|FG001|Overall Study|Lost to Follow-up|0|||
44434259|NCT00663702|79442950|FG000|Overall Study|Death|1|||
44434260|NCT00663702|79442951|FG001|Overall Study|Death|1|||
44434261|NCT00663702|79442950|FG000|Overall Study|Lack of Efficacy|3|||
44434262|NCT00663702|79442951|FG001|Overall Study|Lack of Efficacy|3|||
44434263|NCT00683618|79442960|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
44434264|NCT00683618|79442961|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
44434265|NCT00683618|79442962|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
44434266|NCT00683618|79442960|FG000|Randomised Treatment Period|Protocol Violation|0|||
44434267|NCT00683618|79442961|FG001|Randomised Treatment Period|Protocol Violation|1|||
44434268|NCT00683618|79442962|FG002|Randomised Treatment Period|Protocol Violation|0|||
44434269|NCT00683618|79442960|FG000|Randomised Treatment Period|Adverse Event|2|||
44434270|NCT00683618|79442961|FG001|Randomised Treatment Period|Adverse Event|0|||
44434271|NCT00683618|79442962|FG002|Randomised Treatment Period|Adverse Event|2|||
44434272|NCT00683618|79442960|FG000|Randomised Treatment Period|Reason not provided|0|||
44434273|NCT00683618|79442961|FG001|Randomised Treatment Period|Reason not provided|0|||
44434274|NCT00683618|79442962|FG002|Randomised Treatment Period|Reason not provided|2|||
44434275|NCT00683618|79442960|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
44434276|NCT00683618|79442961|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
44434277|NCT00683618|79442962|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
44434278|NCT00683618|79442960|FG000|Extension Treatment Period|Adverse Event|1|||
44434279|NCT00683618|79442961|FG001|Extension Treatment Period|Adverse Event|0|||
44434280|NCT00683618|79442962|FG002|Extension Treatment Period|Adverse Event|0|||
44434281|NCT00683618|79442960|FG000|Extension Treatment Period|Protocol Violation|1|||
44434282|NCT00683618|79442961|FG001|Extension Treatment Period|Protocol Violation|0|||
44434283|NCT00683618|79442962|FG002|Extension Treatment Period|Protocol Violation|0|||
44434284|NCT00688064|79442974|FG000|Overall Study|Protocol Violation|0|||
44434285|NCT00688064|79442975|FG001|Overall Study|Protocol Violation|1|||
44434286|NCT00688064|79442974|FG000|Overall Study|Adverse Event|2|||
44434287|NCT00688064|79442975|FG001|Overall Study|Adverse Event|4|||
44434288|NCT00688064|79442974|FG000|Overall Study|Withdrawal by Subject|7|||
44434289|NCT00688064|79442975|FG001|Overall Study|Withdrawal by Subject|7|||
44434290|NCT00688064|79442974|FG000|Overall Study|Lost to Follow-up|10|||
44434291|NCT00688064|79442975|FG001|Overall Study|Lost to Follow-up|10|||
44434292|NCT00688064|79442974|FG000|Overall Study|Lack of Efficacy|0|||
44434293|NCT00688064|79442975|FG001|Overall Study|Lack of Efficacy|1|||
44434294|NCT00688064|79442974|FG000|Overall Study|Pregnancy|1|||
44434295|NCT00688064|79442975|FG001|Overall Study|Pregnancy|0|||
44434296|NCT00688064|79442974|FG000|Overall Study|Any other reasons|1|||
44434297|NCT00688064|79442975|FG001|Overall Study|Any other reasons|3|||
44335936|NCT01291173|79340732|FG001|Overall Study|Unable to meet visit schedule|0|||
44335937|NCT01291173|79340733|FG002|Overall Study|Unable to meet visit schedule|1|||
44335938|NCT01291173|79340734|FG003|Overall Study|Unable to meet visit schedule|0|||
44335939|NCT01291173|79340731|FG000|Overall Study|Lack of compliance|0|||
44335940|NCT01291173|79340732|FG001|Overall Study|Lack of compliance|0|||
44335941|NCT01291173|79340733|FG002|Overall Study|Lack of compliance|0|||
44335942|NCT01291173|79340734|FG003|Overall Study|Lack of compliance|1|||
44335943|NCT01291173|79340731|FG000|Overall Study|Subject was unblinded|0|||
44335944|NCT01291173|79340732|FG001|Overall Study|Subject was unblinded|0|||
44335945|NCT01291173|79340733|FG002|Overall Study|Subject was unblinded|1|||
44335946|NCT01291173|79340734|FG003|Overall Study|Subject was unblinded|0|||
44335947|NCT01291173|79340731|FG000|Overall Study|Excluded therapy|0|||
44335948|NCT01291173|79340732|FG001|Overall Study|Excluded therapy|0|||
44335949|NCT01291173|79340733|FG002|Overall Study|Excluded therapy|1|||
44335950|NCT01291173|79340734|FG003|Overall Study|Excluded therapy|0|||
44434298|NCT00663234|79442981|FG000|Overall Study|Not willing to adhere to requirements|1|||
44434299|NCT00683384|79442989|FG000|Overall Study|Death|1|||
44434300|NCT00683384|79442989|FG000|Overall Study|Adverse Event|1|||
44434301|NCT00326911|79442995|FG000|Overall Study|Hospitalization prior to treatment|0|||
44434302|NCT00326911|79442996|FG001|Overall Study|Hospitalization prior to treatment|1|||
44434303|NCT00326911|79442995|FG000|Overall Study|Physician decision prior to treatment|1|||
44434304|NCT00326911|79442996|FG001|Overall Study|Physician decision prior to treatment|0|||
44434305|NCT00326911|79442995|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
44434306|NCT00326911|79442996|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
44434307|NCT00540436|79443002|FG000|First 12-Week Treatment Period|Adverse Event|1|||
44434308|NCT00540436|79443002|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
44434309|NCT00540436|79443002|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
44434310|NCT00540436|79443002|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
44434311|NCT00687440|79443006|FG000|Overall Study|Adverse Event|3|||
44434312|NCT00687440|79443006|FG000|Overall Study|Lost to Follow-up|3|||
44434313|NCT00687440|79443006|FG000|Overall Study|Lack of Efficacy|2|||
44434314|NCT00687440|79443006|FG000|Overall Study|Death|2|||
44539716|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44335951|NCT01291017|79340744|FG000|Overall Study|Lost to Follow-up|2|||
44335952|NCT01291017|79340744|FG000|Overall Study|Withdrawal by Subject|3|||
44335953|NCT01290315|79340752|FG000|Overall Study|Adverse Event|0|||
44434315|NCT00687440|79443006|FG000|Overall Study|Other|1|||
44434316|NCT00687440|79443006|FG000|Overall Study|Missing|1|||
44434317|NCT00659490|79443013|FG000|Overall Study|Lost to Follow-up|2|||
44434318|NCT00659490|79443014|FG001|Overall Study|Lost to Follow-up|0|||
44434319|NCT00659490|79443015|FG002|Overall Study|Lost to Follow-up|1|||
44434320|NCT00539500|79443023|FG000|Overall Study|Disease Progression|1|||
44434321|NCT00539500|79443023|FG000|Overall Study|Lost to Follow-up|2|||
44434322|NCT00662532|79443029|FG000|Overall Study|Adverse Event|0|||
44434323|NCT00662532|79443030|FG001|Overall Study|Adverse Event|1|||
44434324|NCT00662532|79443029|FG000|Overall Study|Lost to Follow-up|0|||
44434325|NCT00662532|79443030|FG001|Overall Study|Lost to Follow-up|1|||
44434326|NCT00686036|79443038|FG000|Overall Study|Adverse Event|3|||
44434327|NCT00686036|79443039|FG001|Overall Study|Adverse Event|0|||
44434328|NCT00686036|79443038|FG000|Overall Study|Withdrawal by Subject|3|||
44434329|NCT00686036|79443039|FG001|Overall Study|Withdrawal by Subject|1|||
44434330|NCT00686036|79443038|FG000|Overall Study|Study terminated by AstraZeneca|2|||
44434331|NCT00686036|79443039|FG001|Overall Study|Study terminated by AstraZeneca|1|||
44434332|NCT00686036|79443038|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
44434333|NCT00686036|79443039|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
44434334|NCT00686036|79443038|FG000|Overall Study|Other reasons not identified|0|||
44434335|NCT00686036|79443039|FG001|Overall Study|Other reasons not identified|4|||
44434336|NCT00682448|79443047|FG000|Overall Study|Adverse Event|1|||
44434337|NCT00682448|79443048|FG001|Overall Study|Adverse Event|2|||
44434338|NCT00682448|79443047|FG000|Overall Study|Lack of Efficacy|1|||
44434339|NCT00682448|79443048|FG001|Overall Study|Lack of Efficacy|0|||
44434340|NCT00682448|79443047|FG000|Overall Study|Lost to Follow-up|1|||
44434341|NCT00682448|79443048|FG001|Overall Study|Lost to Follow-up|3|||
44434342|NCT00682448|79443047|FG000|Overall Study|Pregnancy|0|||
44434343|NCT00682448|79443048|FG001|Overall Study|Pregnancy|1|||
44434344|NCT00682448|79443047|FG000|Overall Study|Withdrawal by Subject|2|||
44434345|NCT00682448|79443048|FG001|Overall Study|Withdrawal by Subject|0|||
44434346|NCT00681824|79443057|FG000|Overall Study|withdrawn by investigator|0|||
44434347|NCT00681824|79443058|FG001|Overall Study|withdrawn by investigator|0|||
44434348|NCT00681824|79443059|FG002|Overall Study|withdrawn by investigator|1|||
44434349|NCT00681824|79443057|FG000|Overall Study|scheduling conflict|1|||
44434350|NCT00681824|79443058|FG001|Overall Study|scheduling conflict|0|||
44335954|NCT01290315|79340753|FG001|Overall Study|Adverse Event|0|||
44335955|NCT01290315|79340754|FG002|Overall Study|Adverse Event|0|||
44335956|NCT01290315|79340755|FG003|Overall Study|Adverse Event|3|||
44335957|NCT01290315|79340752|FG000|Overall Study|Selection criteria/compliance|2|||
44335958|NCT01290315|79340753|FG001|Overall Study|Selection criteria/compliance|1|||
44335959|NCT01290315|79340754|FG002|Overall Study|Selection criteria/compliance|0|||
44335960|NCT01290315|79340755|FG003|Overall Study|Selection criteria/compliance|2|||
44335961|NCT01290315|79340752|FG000|Overall Study|Lost to Follow-up|0|||
44335962|NCT01290315|79340753|FG001|Overall Study|Lost to Follow-up|1|||
44335963|NCT01290315|79340754|FG002|Overall Study|Lost to Follow-up|0|||
44335964|NCT01290315|79340755|FG003|Overall Study|Lost to Follow-up|0|||
44434351|NCT00681824|79443059|FG002|Overall Study|scheduling conflict|0|||
44434352|NCT00681824|79443057|FG000|Overall Study|Death|0|||
44434353|NCT00681824|79443058|FG001|Overall Study|Death|1|||
44434354|NCT00681824|79443059|FG002|Overall Study|Death|0|||
44434355|NCT00681668|79443067|FG000|Overall Study|Protocol Violation|1|||
44434356|NCT00681668|79443067|FG000|Overall Study|Withdrawal by Subject|1|||
44539717|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539718|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539719|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44335965|NCT01290315|79340752|FG000|Overall Study|Withdrawal by Subject|1|||
44335966|NCT01290315|79340753|FG001|Overall Study|Withdrawal by Subject|1|||
44335967|NCT01290315|79340754|FG002|Overall Study|Withdrawal by Subject|0|||
44335968|NCT01290315|79340755|FG003|Overall Study|Withdrawal by Subject|0|||
44335969|NCT01289847|79340764|FG000|Overall Study|Patient could not comply with visits|1|||
44335970|NCT01079182|79340768|FG000|Overall Study|Lost to Follow-up|1634|||
44335971|NCT01079182|79340768|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
44335972|NCT01079182|79340768|FG000|Overall Study|Lack of Efficacy|514|||
44335973|NCT01079182|79340768|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
44335974|NCT01079182|79340768|FG000|Overall Study|Reasons not Evaluated|271|||
44335975|NCT01021813|79340774|FG000|DB Treatment Phase|Adverse Event|60|||
44335976|NCT01021813|79340775|FG001|DB Treatment Phase|Adverse Event|22|||
44335977|NCT01021813|79340776|FG002|DB Treatment Phase|Adverse Event|0|||
44335978|NCT01021813|79340777|FG003|DB Treatment Phase|Adverse Event|0|||
44335979|NCT01021813|79340778|FG004|DB Treatment Phase|Adverse Event|0|||
44335980|NCT01021813|79340774|FG000|DB Treatment Phase|Lack of Efficacy|44|||
44434357|NCT00539188|79443073|FG000|Overall Study|Withdrawal by Subject|1|||
44434358|NCT00539188|79443074|FG001|Overall Study|Withdrawal by Subject|0|||
44434359|NCT00539188|79443073|FG000|Overall Study|Lost to Follow-up|2|||
44434360|NCT00539188|79443074|FG001|Overall Study|Lost to Follow-up|1|||
44434361|NCT00681590|79443082|FG000|Overall Study|Withdrawal by Subject|2|||
44434362|NCT00681590|79443083|FG001|Overall Study|Withdrawal by Subject|12|||
44335981|NCT01021813|79340775|FG001|DB Treatment Phase|Lack of Efficacy|28|||
44335982|NCT01021813|79340776|FG002|DB Treatment Phase|Lack of Efficacy|0|||
44335983|NCT01021813|79340777|FG003|DB Treatment Phase|Lack of Efficacy|0|||
44335984|NCT01021813|79340778|FG004|DB Treatment Phase|Lack of Efficacy|0|||
44335985|NCT01021813|79340774|FG000|DB Treatment Phase|Lost to Follow-up|14|||
44335986|NCT01021813|79340775|FG001|DB Treatment Phase|Lost to Follow-up|12|||
44335987|NCT01021813|79340776|FG002|DB Treatment Phase|Lost to Follow-up|0|||
44335988|NCT01021813|79340777|FG003|DB Treatment Phase|Lost to Follow-up|0|||
44335989|NCT01021813|79340778|FG004|DB Treatment Phase|Lost to Follow-up|0|||
44335990|NCT01021813|79340774|FG000|DB Treatment Phase|Physician Decision|17|||
44335991|NCT01021813|79340775|FG001|DB Treatment Phase|Physician Decision|8|||
44335992|NCT01021813|79340776|FG002|DB Treatment Phase|Physician Decision|0|||
44335993|NCT01021813|79340777|FG003|DB Treatment Phase|Physician Decision|0|||
44335994|NCT01021813|79340778|FG004|DB Treatment Phase|Physician Decision|0|||
44335995|NCT01021813|79340774|FG000|DB Treatment Phase|Pregnancy|1|||
44335996|NCT01021813|79340775|FG001|DB Treatment Phase|Pregnancy|0|||
44335997|NCT01021813|79340776|FG002|DB Treatment Phase|Pregnancy|0|||
44335998|NCT01021813|79340777|FG003|DB Treatment Phase|Pregnancy|0|||
44434363|NCT04980456|79443091|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
44434364|NCT04980456|79443092|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
44434365|NCT04980456|79443091|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
44434366|NCT04980456|79443092|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
44434367|NCT04980456|79443091|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
44434368|NCT04980456|79443092|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
44434369|NCT04980456|79443091|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
44434370|NCT04980456|79443092|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
44335999|NCT01021813|79340778|FG004|DB Treatment Phase|Pregnancy|0|||
44434371|NCT00326599|79443105|FG000|Overall Study|Withdrawal by Subject|1|||
44434372|NCT00326599|79443106|FG001|Overall Study|Withdrawal by Subject|0|||
44434373|NCT00326599|79443107|FG002|Overall Study|Withdrawal by Subject|5|||
44434374|NCT00326599|79443108|FG003|Overall Study|Withdrawal by Subject|2|||
44434375|NCT00326599|79443105|FG000|Overall Study|Adverse Event|1|||
44434376|NCT00326599|79443106|FG001|Overall Study|Adverse Event|0|||
44434377|NCT00326599|79443107|FG002|Overall Study|Adverse Event|32|||
44434378|NCT00326599|79443108|FG003|Overall Study|Adverse Event|3|||
44434379|NCT00326599|79443105|FG000|Overall Study|Disease Progression|3|||
44434380|NCT00326599|79443106|FG001|Overall Study|Disease Progression|1|||
44434381|NCT00326599|79443107|FG002|Overall Study|Disease Progression|13|||
44434382|NCT00326599|79443108|FG003|Overall Study|Disease Progression|11|||
44336000|NCT01021813|79340774|FG000|DB Treatment Phase|Protocol Violation|4|||
44336001|NCT01021813|79340775|FG001|DB Treatment Phase|Protocol Violation|3|||
44336002|NCT01021813|79340776|FG002|DB Treatment Phase|Protocol Violation|0|||
44336003|NCT01021813|79340777|FG003|DB Treatment Phase|Protocol Violation|0|||
44336004|NCT01021813|79340778|FG004|DB Treatment Phase|Protocol Violation|0|||
44336005|NCT01021813|79340774|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
44336006|NCT01021813|79340775|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
44434383|NCT00326599|79443105|FG000|Overall Study|Alternate Treatment|1|||
44434384|NCT00326599|79443106|FG001|Overall Study|Alternate Treatment|0|||
44434385|NCT00326599|79443107|FG002|Overall Study|Alternate Treatment|0|||
44434386|NCT00326599|79443108|FG003|Overall Study|Alternate Treatment|0|||
44434387|NCT00326599|79443105|FG000|Overall Study|Death|0|||
44434388|NCT00326599|79443106|FG001|Overall Study|Death|0|||
44434389|NCT00326599|79443107|FG002|Overall Study|Death|1|||
44434390|NCT00326599|79443108|FG003|Overall Study|Death|2|||
44434391|NCT00326599|79443105|FG000|Overall Study|Other Unspecified Reason|0|||
44434392|NCT00326599|79443106|FG001|Overall Study|Other Unspecified Reason|0|||
44434393|NCT00326599|79443107|FG002|Overall Study|Other Unspecified Reason|2|||
44434394|NCT00326599|79443108|FG003|Overall Study|Other Unspecified Reason|1|||
44434395|NCT00539032|79443119|FG000|Overall Study|Withdrawal by Subject|2|||
44434396|NCT00539032|79443120|FG001|Overall Study|Withdrawal by Subject|1|||
44434397|NCT00685802|79443126|FG000|Washout Period of 7 Days|Protocol Violation|2|||
44157417|NCT03429543|78949155|FG002|Overall Study|Adverse Event|0|||
44336007|NCT01021813|79340776|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
44336008|NCT01021813|79340777|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
44336009|NCT01021813|79340778|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
44336010|NCT01021813|79340774|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
44336011|NCT01021813|79340775|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
44336012|NCT01021813|79340776|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
44336013|NCT01021813|79340777|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
44336014|NCT01021813|79340778|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
44434398|NCT00685802|79443127|FG001|Washout Period of 7 Days|Protocol Violation|0|||
44434399|NCT00685802|79443126|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
44157418|NCT03429543|78949156|FG003|Overall Study|Adverse Event|0|||
44336015|NCT01021813|79340774|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
44434400|NCT00685802|79443127|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
44434401|NCT00354601|79443133|FG000|Overall Study|Protocol Violation|1|||
44434402|NCT00354601|79443133|FG000|Overall Study|progression|1|||
44434403|NCT03827473|79443139|FG000|Overall Study|Withdrawal by Subject|1|||
44434404|NCT03827473|79443140|FG001|Overall Study|Withdrawal by Subject|0|||
44434405|NCT00345397|79443146|FG000|Overall Study|Death|1|||
44434406|NCT00326209|79443151|FG000|Overall Study|Adverse Event|28|||
44434407|NCT00326209|79443151|FG000|Overall Study|Withdrawal by Subject|22|||
44434408|NCT00326209|79443151|FG000|Overall Study|Lack of Efficacy|31|||
44434409|NCT00326209|79443151|FG000|Overall Study|Lost to Follow-up|18|||
44434410|NCT00326209|79443151|FG000|Overall Study|Participant non-compliant|6|||
44434411|NCT00326209|79443151|FG000|Overall Study|Sponsor closed study|173|||
44434412|NCT00326209|79443151|FG000|Overall Study|Prohibited medication use|1|||
44434413|NCT00326209|79443151|FG000|Overall Study|Violation of entry criteria|1|||
44434414|NCT00326209|79443151|FG000|Overall Study|Withdrawn in error|1|||
44434415|NCT00326209|79443151|FG000|Overall Study|Pregnancy|1|||
44434416|NCT00537940|79443157|FG000|Overall Study|Adverse Event|20|||
44434417|NCT00537940|79443158|FG001|Overall Study|Adverse Event|19|||
44434418|NCT00537940|79443157|FG000|Overall Study|Lack of Efficacy|8|||
44434419|NCT00537940|79443158|FG001|Overall Study|Lack of Efficacy|16|||
44434420|NCT00537940|79443157|FG000|Overall Study|Lost to Follow-up|23|||
44434421|NCT00537940|79443158|FG001|Overall Study|Lost to Follow-up|29|||
44434422|NCT00537940|79443157|FG000|Overall Study|Withdrawal by Subject|113|||
44434423|NCT00537940|79443158|FG001|Overall Study|Withdrawal by Subject|95|||
44434424|NCT00537940|79443157|FG000|Overall Study|Protocol Violation|6|||
44434425|NCT00537940|79443158|FG001|Overall Study|Protocol Violation|4|||
44539720|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539721|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539722|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539723|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539724|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539725|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
44539726|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539727|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539728|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539729|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539730|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
44539731|NCT02891226|79551185|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539732|NCT02891226|79551186|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539733|NCT02891226|79551187|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539734|NCT02891226|79551188|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539735|NCT02891226|79551189|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539736|NCT02891226|79551190|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539737|NCT02891226|79551191|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539738|NCT02891226|79551192|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539739|NCT02891226|79551193|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539740|NCT02891226|79551194|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539741|NCT02891226|79551195|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
44539742|NCT02891226|79551196|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539743|NCT02891226|79551197|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539744|NCT02891226|79551198|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539745|NCT02891226|79551199|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44539746|NCT02891226|79551200|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
44336016|NCT01021813|79340775|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
44336017|NCT01021813|79340776|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
44336018|NCT01021813|79340777|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
44336019|NCT01021813|79340778|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
44336020|NCT01021813|79340774|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
44336021|NCT01021813|79340775|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
44336022|NCT01021813|79340776|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
44336023|NCT01021813|79340777|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
44434426|NCT00537940|79443157|FG000|Overall Study|Pregnancy|1|||
44434427|NCT00537940|79443158|FG001|Overall Study|Pregnancy|1|||
44336024|NCT01021813|79340778|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
44434428|NCT00537940|79443157|FG000|Overall Study|Study terminated by sponsor|2|||
44434429|NCT00537940|79443158|FG001|Overall Study|Study terminated by sponsor|3|||
44434430|NCT00537940|79443157|FG000|Overall Study|Other|10|||
44434431|NCT00537940|79443158|FG001|Overall Study|Other|12|||
44434432|NCT00661362|79443166|FG000|Overall Study|Adverse Event|5|||
44434433|NCT00661362|79443167|FG001|Overall Study|Adverse Event|4|||
44434434|NCT00661362|79443166|FG000|Overall Study|Incorrect enrollment|2|||
44434435|NCT00661362|79443167|FG001|Overall Study|Incorrect enrollment|0|||
44434436|NCT00661362|79443166|FG000|Overall Study|Study specific discontinuation criteria|4|||
44434437|NCT00661362|79443167|FG001|Overall Study|Study specific discontinuation criteria|11|||
44434438|NCT00661362|79443166|FG000|Overall Study|Withdrawal by Subject|13|||
44434439|NCT00661362|79443167|FG001|Overall Study|Withdrawal by Subject|23|||
44434440|NCT00661362|79443166|FG000|Overall Study|Lost to Follow-up|3|||
44336025|NCT01021813|79340774|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
44336026|NCT01021813|79340775|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
44336027|NCT01021813|79340776|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
44336028|NCT01021813|79340777|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
44336029|NCT01021813|79340778|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
44336030|NCT01021813|79340774|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
44336031|NCT01021813|79340775|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
44336032|NCT01021813|79340776|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
44336033|NCT01021813|79340777|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
44336034|NCT01021813|79340778|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
44336035|NCT01025635|79340797|FG000|Overall Study|Withdrawal by Subject|6|||
44336036|NCT01025635|79340798|FG001|Overall Study|Withdrawal by Subject|7|||
44336037|NCT01025635|79340797|FG000|Overall Study|Protocol Violation|4|||
44336038|NCT01025635|79340798|FG001|Overall Study|Protocol Violation|2|||
44336039|NCT01025635|79340797|FG000|Overall Study|Lack of Efficacy|0|||
44336040|NCT01025635|79340798|FG001|Overall Study|Lack of Efficacy|1|||
44336041|NCT01025635|79340797|FG000|Overall Study|Lost to Follow-up|9|||
44336042|NCT01025635|79340798|FG001|Overall Study|Lost to Follow-up|13|||
44336043|NCT01025635|79340797|FG000|Overall Study|Reason not known|4|||
44336044|NCT01025635|79340798|FG001|Overall Study|Reason not known|2|||
44336045|NCT01021423|79340806|FG000|Overall Study|Study terminated|4|||
44336046|NCT01021423|79340807|FG001|Overall Study|Study terminated|5|||
44336047|NCT01020877|79340815|FG000|Second Intervention|Withdrawal by Subject|1|||
44336048|NCT01020877|79340816|FG001|Second Intervention|Withdrawal by Subject|0|||
44336049|NCT01020799|79340825|FG000|Overall Study|Adverse Event|4|||
44336050|NCT01020799|79340826|FG001|Overall Study|Adverse Event|3|||
44336051|NCT01020799|79340827|FG002|Overall Study|Adverse Event|2|||
44336052|NCT01020799|79340825|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
44336053|NCT01020799|79340826|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
44336054|NCT01020799|79340827|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
44336055|NCT01020799|79340825|FG000|Overall Study|Protocol Violation|3|||
44336056|NCT01020799|79340826|FG001|Overall Study|Protocol Violation|2|||
44336057|NCT01020799|79340827|FG002|Overall Study|Protocol Violation|0|||
44336058|NCT01020799|79340825|FG000|Overall Study|Withdrawal by Subject|2|||
44336059|NCT01020799|79340826|FG001|Overall Study|Withdrawal by Subject|2|||
44336060|NCT01020799|79340827|FG002|Overall Study|Withdrawal by Subject|3|||
44336061|NCT01020799|79340825|FG000|Overall Study|Lost to Follow-up|6|||
44336062|NCT01020799|79340826|FG001|Overall Study|Lost to Follow-up|4|||
44336063|NCT01020799|79340827|FG002|Overall Study|Lost to Follow-up|2|||
44336064|NCT01288989|79340840|FG000|Overall Study|Death|0|||
44336065|NCT01288989|79340841|FG001|Overall Study|Death|0|||
44336066|NCT01288989|79340842|FG002|Overall Study|Death|0|||
44336067|NCT01288989|79340843|FG003|Overall Study|Death|1|||
44336068|NCT01288989|79340844|FG004|Overall Study|Death|0|||
44434441|NCT00661362|79443167|FG001|Overall Study|Lost to Follow-up|1|||
44434442|NCT00661362|79443166|FG000|Overall Study|Severe non-compliance to protocol|0|||
44434443|NCT00661362|79443167|FG001|Overall Study|Severe non-compliance to protocol|1|||
44434444|NCT00661362|79443166|FG000|Overall Study|Safety reasons|1|||
44434445|NCT00661362|79443167|FG001|Overall Study|Safety reasons|0|||
44434446|NCT00661362|79443166|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
44434447|NCT00661362|79443167|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
44434448|NCT00325897|79443175|FG000|Overall Study|Lost to Follow-up|12|||
44434449|NCT00325897|79443176|FG001|Overall Study|Lost to Follow-up|13|||
44434450|NCT00344773|79443185|FG000|Overall Study|Adverse Event|2|||
44434451|NCT00344773|79443185|FG000|Overall Study|Objective Disease Progression|16|||
44336069|NCT01288989|79340840|FG000|Overall Study|Dose limiting toxicity|1|||
44336070|NCT01288989|79340841|FG001|Overall Study|Dose limiting toxicity|0|||
44336071|NCT01288989|79340842|FG002|Overall Study|Dose limiting toxicity|0|||
44434452|NCT00344773|79443185|FG000|Overall Study|Withdrawal by Subject|1|||
44336072|NCT01288989|79340843|FG003|Overall Study|Dose limiting toxicity|0|||
44336073|NCT01288989|79340844|FG004|Overall Study|Dose limiting toxicity|0|||
44336074|NCT01288989|79340840|FG000|Overall Study|Adverse Event|0|||
44336075|NCT01288989|79340841|FG001|Overall Study|Adverse Event|0|||
44336076|NCT01288989|79340842|FG002|Overall Study|Adverse Event|0|||
44336077|NCT01288989|79340843|FG003|Overall Study|Adverse Event|0|||
44336078|NCT01288989|79340844|FG004|Overall Study|Adverse Event|2|||
44336079|NCT01288989|79340840|FG000|Overall Study|Physician Decision|0|||
44434453|NCT00344773|79443185|FG000|Overall Study|Not Eligible for the study|2|||
44336080|NCT01288989|79340841|FG001|Overall Study|Physician Decision|0|||
44336081|NCT01288989|79340842|FG002|Overall Study|Physician Decision|0|||
44336082|NCT01288989|79340843|FG003|Overall Study|Physician Decision|0|||
44336083|NCT01288989|79340844|FG004|Overall Study|Physician Decision|1|||
44336084|NCT01288989|79340840|FG000|Overall Study|Withdrawal by Subject|0|||
44336085|NCT01288989|79340841|FG001|Overall Study|Withdrawal by Subject|0|||
44336086|NCT01288989|79340842|FG002|Overall Study|Withdrawal by Subject|0|||
44336087|NCT01288989|79340843|FG003|Overall Study|Withdrawal by Subject|0|||
44336088|NCT01288989|79340844|FG004|Overall Study|Withdrawal by Subject|3|||
44434454|NCT00325819|79443191|FG000|Overall Study|Study product lost in mail|2|||
44434455|NCT00325819|79443192|FG001|Overall Study|Study product lost in mail|1|||
44434456|NCT00325819|79443191|FG000|Overall Study|Did not take a dose of study product|4|||
44434457|NCT00325819|79443192|FG001|Overall Study|Did not take a dose of study product|9|||
44434458|NCT00325819|79443191|FG000|Overall Study|Lost to Follow-up|3|||
44434459|NCT00325819|79443192|FG001|Overall Study|Lost to Follow-up|3|||
44434460|NCT00687362|79443200|FG000|Overall Study|Protocol Violation|2|||
44539747|NCT02891226|79551185|FG000|Follow-up Period|Withdrawal by Subject|0|||
44539748|NCT02891226|79551186|FG001|Follow-up Period|Withdrawal by Subject|0|||
44539749|NCT02891226|79551187|FG002|Follow-up Period|Withdrawal by Subject|0|||
44539750|NCT02891226|79551188|FG003|Follow-up Period|Withdrawal by Subject|0|||
44539751|NCT02891226|79551189|FG004|Follow-up Period|Withdrawal by Subject|0|||
44539752|NCT02891226|79551190|FG005|Follow-up Period|Withdrawal by Subject|0|||
44539753|NCT02891226|79551191|FG006|Follow-up Period|Withdrawal by Subject|0|||
44539754|NCT02891226|79551192|FG007|Follow-up Period|Withdrawal by Subject|0|||
44539755|NCT02891226|79551193|FG008|Follow-up Period|Withdrawal by Subject|0|||
44539756|NCT02891226|79551194|FG009|Follow-up Period|Withdrawal by Subject|0|||
44539757|NCT02891226|79551195|FG010|Follow-up Period|Withdrawal by Subject|0|||
44539758|NCT02891226|79551196|FG011|Follow-up Period|Withdrawal by Subject|1|||
44539759|NCT02891226|79551197|FG012|Follow-up Period|Withdrawal by Subject|0|||
44539760|NCT02891226|79551198|FG013|Follow-up Period|Withdrawal by Subject|0|||
44539761|NCT02891226|79551199|FG014|Follow-up Period|Withdrawal by Subject|1|||
44539762|NCT02891226|79551200|FG015|Follow-up Period|Withdrawal by Subject|1|||
44539763|NCT03612856|79551227|FG000|Pre-dose Period|Physician Decision|0|||
44539764|NCT03612856|79551228|FG001|Pre-dose Period|Physician Decision|1|||
44539765|NCT03612856|79551229|FG002|Pre-dose Period|Physician Decision|1|||
44539766|NCT03612856|79551227|FG000|Pre-dose Period|Withdrawal by Subject|0|||
44539767|NCT03612856|79551228|FG001|Pre-dose Period|Withdrawal by Subject|1|||
44539768|NCT03612856|79551229|FG002|Pre-dose Period|Withdrawal by Subject|0|||
44539769|NCT03333837|79551242|FG000|Overall Study|Adverse Event|2|||
44539770|NCT03333837|79551243|FG001|Overall Study|Adverse Event|1|||
44539771|NCT03333837|79551244|FG002|Overall Study|Adverse Event|1|||
44539772|NCT03333837|79551245|FG003|Overall Study|Adverse Event|1|||
44539773|NCT03333837|79551246|FG004|Overall Study|Adverse Event|0|||
44539774|NCT03333837|79551242|FG000|Overall Study|Caregiver withdrew|0|||
44539775|NCT03333837|79551243|FG001|Overall Study|Caregiver withdrew|2|||
44539776|NCT03333837|79551244|FG002|Overall Study|Caregiver withdrew|1|||
44539777|NCT03333837|79551245|FG003|Overall Study|Caregiver withdrew|0|||
44336089|NCT01020487|79340865|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
44336090|NCT01020487|79340866|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
44336091|NCT01020487|79340867|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
44336092|NCT01020487|79340865|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
44336093|NCT01020487|79340866|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
44336094|NCT01020487|79340867|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
44336095|NCT01020487|79340865|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
44336096|NCT01020487|79340866|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
44336097|NCT01020487|79340867|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
44336098|NCT01020487|79340865|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
44336099|NCT01020487|79340866|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
44336100|NCT01020487|79340867|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
44434461|NCT00687362|79443200|FG000|Overall Study|Withdrawal by Subject|1|||
44434462|NCT00325195|79443207|FG000|Randomized|Not dosed|5|||
44434463|NCT00325195|79443208|FG001|Randomized|Not dosed|5|||
44539778|NCT03333837|79551246|FG004|Overall Study|Caregiver withdrew|0|||
44539779|NCT03333837|79551242|FG000|Overall Study|Withdrawal by Subject|0|||
44434464|NCT00325195|79443209|FG002|Randomized|Not dosed|3|||
44434465|NCT00325195|79443207|FG000|Received Intervention: ITT Population|Adverse Event|15|||
44434466|NCT00325195|79443208|FG001|Received Intervention: ITT Population|Adverse Event|17|||
44539780|NCT03333837|79551243|FG001|Overall Study|Withdrawal by Subject|0|||
44539781|NCT03333837|79551244|FG002|Overall Study|Withdrawal by Subject|1|||
44539782|NCT03333837|79551245|FG003|Overall Study|Withdrawal by Subject|1|||
44539783|NCT03333837|79551246|FG004|Overall Study|Withdrawal by Subject|3|||
44539784|NCT03333837|79551242|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
44336101|NCT01020487|79340865|FG000|Part 2 Open-label Period|Adverse Event|0|||
44336102|NCT01020487|79340866|FG001|Part 2 Open-label Period|Adverse Event|4|||
44336103|NCT01020487|79340867|FG002|Part 2 Open-label Period|Adverse Event|1|||
44336104|NCT01024855|79340877|FG000|Overall Study|Inclusion/exclusion criteria|1|||
44336105|NCT01014013|79340884|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
44336106|NCT01014013|79340885|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
44336107|NCT01014013|79340884|FG000|Overall Study|Clinical adverse experience|4|||
44336108|NCT01014013|79340885|FG001|Overall Study|Clinical adverse experience|2|||
44336109|NCT01014013|79340884|FG000|Overall Study|Laboratory adverse experience|1|||
44336110|NCT01014013|79340885|FG001|Overall Study|Laboratory adverse experience|1|||
44336111|NCT01014013|79340884|FG000|Overall Study|Protocol Violation|1|||
44336112|NCT01014013|79340885|FG001|Overall Study|Protocol Violation|3|||
44336113|NCT01014013|79340884|FG000|Overall Study|Withdrawal by Subject|7|||
44336114|NCT01014013|79340885|FG001|Overall Study|Withdrawal by Subject|4|||
44336115|NCT01014013|79340884|FG000|Overall Study|Clinical/microbiologic failure|1|||
44336116|NCT01014013|79340885|FG001|Overall Study|Clinical/microbiologic failure|2|||
44336117|NCT01014013|79340884|FG000|Overall Study|Pathogen culture = no growth|26|||
44434467|NCT00325195|79443209|FG002|Received Intervention: ITT Population|Adverse Event|1|||
44434468|NCT00325195|79443207|FG000|Received Intervention: ITT Population|Death|3|||
44434469|NCT00325195|79443208|FG001|Received Intervention: ITT Population|Death|1|||
44434470|NCT00325195|79443209|FG002|Received Intervention: ITT Population|Death|0|||
44434471|NCT00325195|79443207|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
44434472|NCT00325195|79443208|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
44336118|NCT01014013|79340885|FG001|Overall Study|Pathogen culture = no growth|34|||
44336119|NCT01014013|79340884|FG000|Overall Study|Negative urine culture|2|||
44336120|NCT01014013|79340885|FG001|Overall Study|Negative urine culture|0|||
44336121|NCT01014013|79340884|FG000|Overall Study|Pathogen resistant|7|||
44336122|NCT01014013|79340885|FG001|Overall Study|Pathogen resistant|4|||
44336123|NCT01014013|79340884|FG000|Overall Study|Physician Decision|0|||
44336124|NCT01014013|79340885|FG001|Overall Study|Physician Decision|1|||
44336125|NCT01014013|79340884|FG000|Overall Study|Another antibiotic therapy required|0|||
44336126|NCT01014013|79340885|FG001|Overall Study|Another antibiotic therapy required|1|||
44336127|NCT01014013|79340884|FG000|Overall Study|Appendectomy|1|||
44336128|NCT01014013|79340885|FG001|Overall Study|Appendectomy|0|||
44336129|NCT01014013|79340884|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
44336130|NCT01014013|79340885|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
44434473|NCT00325195|79443209|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
44434474|NCT00325195|79443207|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
44434475|NCT00325195|79443208|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
44434476|NCT00325195|79443209|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
44434477|NCT00325195|79443207|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
44434478|NCT00325195|79443208|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
44434479|NCT00325195|79443209|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
44434480|NCT03976401|79443223|FG000|Overall Study|Adverse Event|2|||
44434481|NCT03976401|79443224|FG001|Overall Study|Adverse Event|0|||
44539785|NCT03333837|79551243|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
44539786|NCT03333837|79551244|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
44539787|NCT03333837|79551245|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
44434482|NCT03976401|79443225|FG002|Overall Study|Adverse Event|4|||
44434483|NCT03976401|79443226|FG003|Overall Study|Adverse Event|1|||
44434484|NCT03976401|79443227|FG004|Overall Study|Adverse Event|1|||
44434485|NCT03976401|79443228|FG005|Overall Study|Adverse Event|0|||
44434486|NCT03976401|79443223|FG000|Overall Study|Withdrawal by Subject|0|||
44434487|NCT03976401|79443224|FG001|Overall Study|Withdrawal by Subject|1|||
44434488|NCT03976401|79443225|FG002|Overall Study|Withdrawal by Subject|0|||
44434489|NCT03976401|79443226|FG003|Overall Study|Withdrawal by Subject|0|||
44539788|NCT03333837|79551246|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
44539789|NCT03708211|79551264|FG000|Overall Study|Progressive Disease|10|||
44539790|NCT03708211|79551265|FG001|Overall Study|Progressive Disease|7|||
44539791|NCT03708211|79551264|FG000|Overall Study|Withdrawal by Subject|0|||
44539792|NCT03708211|79551265|FG001|Overall Study|Withdrawal by Subject|1|||
44157419|NCT03429543|78949157|FG004|Overall Study|Adverse Event|0|||
44336131|NCT01013701|79340893|FG000|Overall Study|study prematurely terminated|7|||
44539793|NCT03708211|79551264|FG000|Overall Study|Other|2|||
44336132|NCT01020019|79340900|FG000|Overall Study|Lost to Follow-up|21|||
44336133|NCT01020019|79340901|FG001|Overall Study|Lost to Follow-up|18|||
44336134|NCT01020019|79340900|FG000|Overall Study|Adverse Event|1|||
44336135|NCT01020019|79340901|FG001|Overall Study|Adverse Event|5|||
44336136|NCT01020019|79340900|FG000|Overall Study|not interested in treatment|4|||
44336137|NCT01020019|79340901|FG001|Overall Study|not interested in treatment|4|||
44336138|NCT01020019|79340900|FG000|Overall Study|moving|0|||
44434490|NCT03976401|79443227|FG004|Overall Study|Withdrawal by Subject|0|||
44336139|NCT01020019|79340901|FG001|Overall Study|moving|2|||
44336140|NCT01024465|79340907|FG000|Overall Study|Adverse Event|2|||
44336141|NCT01024465|79340907|FG000|Overall Study|Physician Decision|1|||
44336142|NCT01024387|79340911|FG000|Overall Study|Radiographic Progression|29|||
44336143|NCT01024387|79340911|FG000|Overall Study|Symptomatic Progression|10|||
44336144|NCT01024387|79340911|FG000|Overall Study|Physician Decision|5|||
44434491|NCT03976401|79443228|FG005|Overall Study|Withdrawal by Subject|1|||
44539794|NCT03708211|79551265|FG001|Overall Study|Other|0|||
44539795|NCT02948634|79551275|FG000|Overall Study|Lack of efficacy and study suspended|10|||
44539796|NCT02948634|79551276|FG001|Overall Study|Lack of efficacy and study suspended|2|||
44539797|NCT02945046|79551285|FG000|Overall Study|Adverse Event|1|||
44539798|NCT02945046|79551286|FG001|Overall Study|Adverse Event|0|||
44539799|NCT02945046|79551287|FG002|Overall Study|Adverse Event|2|||
44539800|NCT02945046|79551285|FG000|Overall Study|Withdrawal by Subject|3|||
44539801|NCT02945046|79551286|FG001|Overall Study|Withdrawal by Subject|3|||
44539802|NCT02945046|79551287|FG002|Overall Study|Withdrawal by Subject|3|||
44539803|NCT02945046|79551285|FG000|Overall Study|Protocol Violation|2|||
44539804|NCT02945046|79551286|FG001|Overall Study|Protocol Violation|3|||
44539805|NCT02945046|79551287|FG002|Overall Study|Protocol Violation|2|||
44539806|NCT02945046|79551285|FG000|Overall Study|Lost to Follow-up|1|||
44539807|NCT02945046|79551286|FG001|Overall Study|Lost to Follow-up|1|||
44539808|NCT02945046|79551287|FG002|Overall Study|Lost to Follow-up|0|||
44539809|NCT02945046|79551285|FG000|Overall Study|Lack of Efficacy|1|||
44434492|NCT03976401|79443223|FG000|Overall Study|Physician Decision|0|||
44434493|NCT03976401|79443224|FG001|Overall Study|Physician Decision|0|||
44434494|NCT03976401|79443225|FG002|Overall Study|Physician Decision|1|||
44434495|NCT03976401|79443226|FG003|Overall Study|Physician Decision|0|||
44434496|NCT03976401|79443227|FG004|Overall Study|Physician Decision|0|||
44434497|NCT03976401|79443228|FG005|Overall Study|Physician Decision|0|||
44434498|NCT03976401|79443223|FG000|Overall Study|Lost to Follow-up|1|||
44434499|NCT03976401|79443224|FG001|Overall Study|Lost to Follow-up|2|||
44434500|NCT03976401|79443225|FG002|Overall Study|Lost to Follow-up|0|||
44434501|NCT03976401|79443226|FG003|Overall Study|Lost to Follow-up|0|||
44434502|NCT03976401|79443227|FG004|Overall Study|Lost to Follow-up|0|||
44434503|NCT03976401|79443228|FG005|Overall Study|Lost to Follow-up|0|||
44434504|NCT03976401|79443223|FG000|Overall Study|Protocol Violation|0|||
44434505|NCT03976401|79443224|FG001|Overall Study|Protocol Violation|1|||
44434506|NCT03976401|79443225|FG002|Overall Study|Protocol Violation|0|||
44434507|NCT03976401|79443226|FG003|Overall Study|Protocol Violation|0|||
44434508|NCT03976401|79443227|FG004|Overall Study|Protocol Violation|0|||
44434509|NCT03976401|79443228|FG005|Overall Study|Protocol Violation|0|||
44434510|NCT03976401|79443223|FG000|Overall Study|Withdrew Consent|0|||
44434511|NCT03976401|79443224|FG001|Overall Study|Withdrew Consent|0|||
44434512|NCT03976401|79443225|FG002|Overall Study|Withdrew Consent|0|||
44434513|NCT03976401|79443226|FG003|Overall Study|Withdrew Consent|1|||
44434514|NCT03976401|79443227|FG004|Overall Study|Withdrew Consent|0|||
44434515|NCT03976401|79443228|FG005|Overall Study|Withdrew Consent|0|||
44434516|NCT00685334|79443244|FG000|Overall Study|Withdrawal by Subject|5|||
44434517|NCT00685334|79443245|FG001|Overall Study|Withdrawal by Subject|6|||
44434518|NCT00685334|79443244|FG000|Overall Study|Lost to Follow-up|4|||
44434519|NCT00685334|79443245|FG001|Overall Study|Lost to Follow-up|0|||
44434520|NCT00685334|79443244|FG000|Overall Study|Chose to enter hospital|1|||
44434521|NCT00685334|79443245|FG001|Overall Study|Chose to enter hospital|1|||
44539810|NCT02945046|79551286|FG001|Overall Study|Lack of Efficacy|2|||
44539811|NCT02945046|79551287|FG002|Overall Study|Lack of Efficacy|1|||
44539812|NCT02945046|79551285|FG000|Overall Study|Other than specified|5|||
44539813|NCT02945046|79551286|FG001|Overall Study|Other than specified|4|||
44336145|NCT01024387|79340911|FG000|Overall Study|Withdrawal by Subject|5|||
44336146|NCT01024387|79340911|FG000|Overall Study|Death|2|||
44336147|NCT01024387|79340911|FG000|Overall Study|Prolonged Treatment Delay|1|||
44336148|NCT01024387|79340911|FG000|Overall Study|Adverse Event|3|||
44336149|NCT01024387|79340911|FG000|Overall Study|Other|5|||
44336150|NCT01019317|79340915|FG000|Overall Study|Not Eligible|4|||
44336151|NCT01024309|79340921|FG000|Overall Study|Physician Decision|4|||
44336152|NCT01024309|79340922|FG001|Overall Study|Physician Decision|0|||
44336153|NCT01024309|79340921|FG000|Overall Study|Withdrawal by Subject|4|||
44336154|NCT01024309|79340922|FG001|Overall Study|Withdrawal by Subject|4|||
44336155|NCT01090492|79340936|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
44434522|NCT00325039|79443253|FG000|Overall Study|Lost to Follow-up|18|||
44434523|NCT00325039|79443254|FG001|Overall Study|Lost to Follow-up|14|||
44434524|NCT00344461|79443260|FG000|Overall Study|Adverse Event|6|||
44434525|NCT00344461|79443260|FG000|Overall Study|Death|1|||
44434526|NCT00344461|79443260|FG000|Overall Study|Lack of Efficacy|2|||
44539814|NCT02945046|79551287|FG002|Overall Study|Other than specified|7|||
44539815|NCT03705793|79551297|FG000|Overall Study|Lost to Follow-up|3|||
44539816|NCT03705793|79551298|FG001|Overall Study|Lost to Follow-up|4|||
44539817|NCT03705793|79551297|FG000|Overall Study|Withdrawal by Subject|2|||
44434527|NCT00344461|79443260|FG000|Overall Study|Lost to Follow-up|2|||
44434528|NCT00344461|79443260|FG000|Overall Study|Physician Decision|2|||
44336156|NCT01090492|79340937|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
44336157|NCT01090492|79340938|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
44336158|NCT01090492|79340939|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
44336159|NCT01090492|79340940|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
44336160|NCT01090492|79340941|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
44336161|NCT01090492|79340942|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
44336162|NCT01090492|79340943|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
44434529|NCT00344461|79443260|FG000|Overall Study|Protocol Violation|6|||
44434530|NCT00344461|79443260|FG000|Overall Study|Withdrawal by Subject|2|||
44434531|NCT00685178|79443269|FG000|Overall Study|Adverse Event|1|||
44434532|NCT00685178|79443270|FG001|Overall Study|Adverse Event|5|||
44434533|NCT00685178|79443271|FG002|Overall Study|Adverse Event|2|||
44434534|NCT00685178|79443272|FG003|Overall Study|Adverse Event|4|||
44434535|NCT00685178|79443269|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
44434536|NCT00685178|79443270|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
44434537|NCT00685178|79443271|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
44434538|NCT00685178|79443272|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
44434539|NCT00685178|79443269|FG000|Overall Study|voluntary study discharge|4|||
44434540|NCT00685178|79443270|FG001|Overall Study|voluntary study discharge|5|||
44434541|NCT00685178|79443271|FG002|Overall Study|voluntary study discharge|1|||
44434542|NCT00685178|79443272|FG003|Overall Study|voluntary study discharge|1|||
44434543|NCT00685178|79443269|FG000|Overall Study|incarcerated|1|||
44434544|NCT00685178|79443270|FG001|Overall Study|incarcerated|3|||
44434545|NCT00685178|79443271|FG002|Overall Study|incarcerated|7|||
44434546|NCT00685178|79443272|FG003|Overall Study|incarcerated|0|||
44434547|NCT00685178|79443269|FG000|Overall Study|administrative (disciplinary) discharge|0|||
44434548|NCT00685178|79443270|FG001|Overall Study|administrative (disciplinary) discharge|1|||
44434549|NCT00685178|79443271|FG002|Overall Study|administrative (disciplinary) discharge|0|||
44434550|NCT00685178|79443272|FG003|Overall Study|administrative (disciplinary) discharge|2|||
44434551|NCT00685178|79443269|FG000|Overall Study|Pregnancy|0|||
44434552|NCT00685178|79443270|FG001|Overall Study|Pregnancy|0|||
44434553|NCT00685178|79443271|FG002|Overall Study|Pregnancy|0|||
44434554|NCT00685178|79443272|FG003|Overall Study|Pregnancy|1|||
44434555|NCT00537394|79443285|FG000|First Year of Follow-up|Death|7|||
44434556|NCT00537394|79443286|FG001|First Year of Follow-up|Death|0|||
44434557|NCT00537394|79443287|FG002|First Year of Follow-up|Death|0|||
44434558|NCT00537394|79443285|FG000|First Year of Follow-up|Severe debilitation|1|||
44434559|NCT00537394|79443286|FG001|First Year of Follow-up|Severe debilitation|0|||
44434560|NCT00537394|79443287|FG002|First Year of Follow-up|Severe debilitation|1|||
44434561|NCT00537394|79443285|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
44434562|NCT00537394|79443286|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
44434563|NCT00537394|79443287|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
44434564|NCT00537394|79443285|FG000|First Year of Follow-up|Lost to Follow-up|1|||
44434565|NCT00537394|79443286|FG001|First Year of Follow-up|Lost to Follow-up|5|||
44434566|NCT00537394|79443287|FG002|First Year of Follow-up|Lost to Follow-up|1|||
44434567|NCT00537394|79443285|FG000|2nd Year of Follow-up|Death|4|||
44434568|NCT00537394|79443286|FG001|2nd Year of Follow-up|Death|1|||
44434569|NCT00537394|79443287|FG002|2nd Year of Follow-up|Death|2|||
44434570|NCT00537394|79443285|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
44434571|NCT00537394|79443286|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
44434572|NCT00537394|79443287|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
44434573|NCT00537394|79443285|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
44434574|NCT00537394|79443286|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
44434575|NCT00537394|79443287|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
44434576|NCT00537394|79443285|FG000|2nd Year of Follow-up|Clinic site closure|1|||
44434577|NCT00537394|79443286|FG001|2nd Year of Follow-up|Clinic site closure|0|||
44539818|NCT03705793|79551298|FG001|Overall Study|Withdrawal by Subject|1|||
44539819|NCT02944968|79551317|FG000|Overall Study|Subject excluded before study procedure|1|||
44539820|NCT02944968|79551317|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
44539821|NCT03761797|79551321|FG000|Overall Study|Changing hospital|11|||
44539822|NCT03761797|79551321|FG000|Overall Study|Improvement/remission|6|||
44336163|NCT01090492|79340936|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
44336164|NCT01090492|79340937|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
44336165|NCT01090492|79340938|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
44336166|NCT01090492|79340939|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
44434578|NCT00537394|79443287|FG002|2nd Year of Follow-up|Clinic site closure|0|||
44434579|NCT00352885|79443295|FG000|Overall Study|Withdrawal by Subject|0|||
44434580|NCT00352885|79443296|FG001|Overall Study|Withdrawal by Subject|3|||
44434581|NCT00352885|79443295|FG000|Overall Study|Development of major depression|0|||
44434582|NCT00352885|79443296|FG001|Overall Study|Development of major depression|1|||
44434583|NCT00352885|79443295|FG000|Overall Study|Progression of metastatic melanoma|5|||
44539823|NCT03761797|79551321|FG000|Overall Study|Withdrawal by Subject|19|||
44336167|NCT01090492|79340940|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
44336168|NCT01090492|79340941|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
44336169|NCT01090492|79340942|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
44336170|NCT01090492|79340943|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
44336171|NCT01090492|79340936|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336172|NCT01090492|79340937|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336173|NCT01090492|79340938|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
44336174|NCT01090492|79340939|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336175|NCT01090492|79340940|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336176|NCT01090492|79340941|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336177|NCT01090492|79340942|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336178|NCT01090492|79340943|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336179|NCT01090492|79340936|FG000|First Intervention Period (4 Weeks)|Other|0|||
44336180|NCT01090492|79340937|FG001|First Intervention Period (4 Weeks)|Other|0|||
44434584|NCT00352885|79443296|FG001|Overall Study|Progression of metastatic melanoma|3|||
44434585|NCT00352885|79443295|FG000|Overall Study|Side effects of IL-2 administration|1|||
44434586|NCT00352885|79443296|FG001|Overall Study|Side effects of IL-2 administration|0|||
44434587|NCT00660660|79443304|FG000|Overall Study|Adverse Event|1|||
44434588|NCT00660660|79443305|FG001|Overall Study|Adverse Event|0|||
44434589|NCT00660660|79443304|FG000|Overall Study|Lost to Follow-up|0|||
44434590|NCT00660660|79443305|FG001|Overall Study|Lost to Follow-up|6|||
44434591|NCT00660660|79443304|FG000|Overall Study|Lack of Efficacy|0|||
44434592|NCT00660660|79443305|FG001|Overall Study|Lack of Efficacy|2|||
44434593|NCT00660660|79443304|FG000|Overall Study|Withdrawal by Subject|3|||
44434594|NCT00660660|79443305|FG001|Overall Study|Withdrawal by Subject|0|||
44434595|NCT00660660|79443304|FG000|Overall Study|Incorrect enrollment and other|0|||
44434596|NCT00660660|79443305|FG001|Overall Study|Incorrect enrollment and other|1|||
44434597|NCT00660660|79443304|FG000|Overall Study|New medication after randomization|1|||
44434598|NCT00660660|79443305|FG001|Overall Study|New medication after randomization|0|||
44434599|NCT00344305|79443313|FG000|Overall Study|Lost to Follow-up|2|||
44434600|NCT00344305|79443314|FG001|Overall Study|Lost to Follow-up|0|||
44434601|NCT00344305|79443313|FG000|Overall Study|Participant was not contacted in window|0|||
44434602|NCT00344305|79443314|FG001|Overall Study|Participant was not contacted in window|1|||
44434603|NCT00660816|79443323|FG000|Overall Study|Adverse Event|1|||
44434604|NCT00660816|79443324|FG001|Overall Study|Adverse Event|2|||
44434605|NCT00660816|79443323|FG000|Overall Study|Withdrawal by Subject|1|||
44434606|NCT00660816|79443324|FG001|Overall Study|Withdrawal by Subject|0|||
44434607|NCT00660816|79443323|FG000|Overall Study|Death|0|||
44434608|NCT00660816|79443324|FG001|Overall Study|Death|2|||
44434609|NCT00660816|79443323|FG000|Overall Study|Lack of Efficacy|1|||
44434610|NCT00660816|79443324|FG001|Overall Study|Lack of Efficacy|0|||
44434611|NCT00660816|79443323|FG000|Overall Study|Physician Decision|0|||
44434612|NCT00660816|79443324|FG001|Overall Study|Physician Decision|2|||
44434613|NCT00660816|79443323|FG000|Overall Study|Protocol Violation|1|||
44434614|NCT00660816|79443324|FG001|Overall Study|Protocol Violation|0|||
44434615|NCT00660816|79443323|FG000|Overall Study|Disease Progression|16|||
44434616|NCT00660816|79443324|FG001|Overall Study|Disease Progression|12|||
44434617|NCT00660816|79443323|FG000|Overall Study|Complicating Disease|0|||
44434618|NCT00660816|79443324|FG001|Overall Study|Complicating Disease|1|||
44434619|NCT00576056|79443330|FG000|Overall Study|Adverse Event|1|||
44434620|NCT00576056|79443330|FG000|Overall Study|Death|1|||
44434621|NCT00576056|79443330|FG000|Overall Study|Lack of Efficacy|1|||
44434622|NCT00576056|79443330|FG000|Overall Study|Withdrawal by Subject|2|||
44434623|NCT00576056|79443330|FG000|Overall Study|did not meet eligibility criteria|8|||
44434624|NCT00576056|79443330|FG000|Overall Study|Physician Decision|1|||
44434625|NCT00575510|79443337|FG000|Overall Study|Lost to Follow-up|4|||
44434626|NCT00575510|79443338|FG001|Overall Study|Lost to Follow-up|6|||
44434627|NCT00575510|79443339|FG002|Overall Study|Lost to Follow-up|9|||
44434628|NCT00575510|79443337|FG000|Overall Study|Withdrawal by Subject|1|||
44434629|NCT00575510|79443338|FG001|Overall Study|Withdrawal by Subject|0|||
44434630|NCT00575510|79443339|FG002|Overall Study|Withdrawal by Subject|0|||
44157420|NCT03429543|78949158|FG005|Overall Study|Adverse Event|2|||
44336181|NCT01090492|79340938|FG002|First Intervention Period (4 Weeks)|Other|1|||
44434631|NCT00575510|79443337|FG000|Overall Study|Clinic Called Patient|7|||
44434632|NCT00575510|79443338|FG001|Overall Study|Clinic Called Patient|7|||
44434633|NCT00575510|79443339|FG002|Overall Study|Clinic Called Patient|7|||
44434634|NCT00575510|79443337|FG000|Overall Study|Pregnancy|0|||
44434635|NCT00575510|79443338|FG001|Overall Study|Pregnancy|0|||
44434636|NCT00575510|79443339|FG002|Overall Study|Pregnancy|1|||
44434637|NCT02636439|79443350|FG000|Overall Study|Adverse Event|2|||
44434638|NCT02636439|79443351|FG001|Overall Study|Adverse Event|2|||
44434639|NCT02636439|79443350|FG000|Overall Study|Lost to Follow-up|1|||
44434640|NCT02636439|79443351|FG001|Overall Study|Lost to Follow-up|0|||
44434641|NCT02636439|79443350|FG000|Overall Study|Non-compliance|1|||
44434642|NCT02636439|79443351|FG001|Overall Study|Non-compliance|1|||
44434643|NCT02636439|79443350|FG000|Overall Study|Personal reasons|2|||
44434644|NCT02636439|79443351|FG001|Overall Study|Personal reasons|0|||
44336182|NCT01090492|79340939|FG003|First Intervention Period (4 Weeks)|Other|1|||
44336183|NCT01090492|79340940|FG004|First Intervention Period (4 Weeks)|Other|2|||
44336184|NCT01090492|79340941|FG005|First Intervention Period (4 Weeks)|Other|0|||
44336185|NCT01090492|79340942|FG006|First Intervention Period (4 Weeks)|Other|0|||
44336186|NCT01090492|79340943|FG007|First Intervention Period (4 Weeks)|Other|0|||
44336187|NCT01090492|79340936|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
44336188|NCT01090492|79340937|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
44336189|NCT01090492|79340938|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
44336190|NCT01090492|79340939|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
44434645|NCT00343915|79443359|FG000|Primary Study|Withdrawal by Subject|1|||
44434646|NCT00343915|79443360|FG001|Primary Study|Withdrawal by Subject|0|||
44434647|NCT00343915|79443359|FG000|Primary Study|Lost to Follow-up|2|||
44434648|NCT00343915|79443360|FG001|Primary Study|Lost to Follow-up|3|||
44434649|NCT00343915|79443359|FG000|Primary Study|Other|1|||
44434650|NCT00343915|79443360|FG001|Primary Study|Other|0|||
44434651|NCT00575666|79443371|FG000|Overall Study|Withdrawal by Subject|3|||
44434652|NCT00575666|79443372|FG001|Overall Study|Withdrawal by Subject|2|||
44434653|NCT00575666|79443371|FG000|Overall Study|Physician Decision|1|||
44434654|NCT00575666|79443372|FG001|Overall Study|Physician Decision|1|||
44434655|NCT00658632|79443380|FG000|Overall Study|Adverse Event|13|||
44434656|NCT00658632|79443381|FG001|Overall Study|Adverse Event|11|||
44434657|NCT00658632|79443380|FG000|Overall Study|Lost to Follow-up|25|||
44434658|NCT00658632|79443381|FG001|Overall Study|Lost to Follow-up|23|||
44434659|NCT00658632|79443380|FG000|Overall Study|Withdrawal by Subject|10|||
44434660|NCT00658632|79443381|FG001|Overall Study|Withdrawal by Subject|7|||
44434661|NCT00658632|79443380|FG000|Overall Study|Lack of Efficacy|0|||
44434662|NCT00658632|79443381|FG001|Overall Study|Lack of Efficacy|1|||
44434663|NCT00658632|79443380|FG000|Overall Study|Withdrawal of consent|8|||
44434664|NCT00658632|79443381|FG001|Overall Study|Withdrawal of consent|14|||
44434665|NCT00658632|79443380|FG000|Overall Study|Pregnancy|1|||
44434666|NCT00658632|79443381|FG001|Overall Study|Pregnancy|1|||
44434667|NCT00658632|79443380|FG000|Overall Study|Other|7|||
44434668|NCT00658632|79443381|FG001|Overall Study|Other|8|||
44434669|NCT00677534|79443387|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
44434670|NCT00677534|79443387|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
44434671|NCT00677534|79443387|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
44336191|NCT01090492|79340940|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
44336192|NCT01090492|79340941|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
44336193|NCT01090492|79340942|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
44336194|NCT01090492|79340943|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
44336195|NCT01090492|79340936|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
44336196|NCT01090492|79340937|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
44336197|NCT01090492|79340938|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
44336198|NCT01090492|79340939|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
44336199|NCT01090492|79340940|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
44336200|NCT01090492|79340941|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
44336201|NCT01090492|79340942|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
44336202|NCT01090492|79340943|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
44336203|NCT01090492|79340936|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
44336204|NCT01090492|79340937|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
44336205|NCT01090492|79340938|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
44336206|NCT01090492|79340939|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
44336207|NCT01090492|79340940|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
44336208|NCT01090492|79340941|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
44336209|NCT01090492|79340942|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
44336210|NCT01090492|79340943|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
44336211|NCT01090492|79340936|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44336212|NCT01090492|79340937|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
44434672|NCT00660348|79443393|FG000|Overall Study|Withdrawal by Subject|1|||
44434673|NCT00660348|79443394|FG001|Overall Study|Withdrawal by Subject|0|||
44336213|NCT01090492|79340938|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44336214|NCT01090492|79340939|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44336215|NCT01090492|79340940|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44434674|NCT00660192|79443402|FG000|Overall Study|Lost to Follow-up|2|||
44434675|NCT00660192|79443403|FG001|Overall Study|Lost to Follow-up|3|||
44434676|NCT00571688|79443411|FG000|Overall Study|Lost to Follow-up|3|||
44434677|NCT00571688|79443412|FG001|Overall Study|Lost to Follow-up|6|||
44434678|NCT00571688|79443411|FG000|Overall Study|subject did not tolerate Consta|1|||
44434679|NCT00571688|79443412|FG001|Overall Study|subject did not tolerate Consta|0|||
44434680|NCT00571688|79443411|FG000|Overall Study|subject moved out of the area|1|||
44434681|NCT00571688|79443412|FG001|Overall Study|subject moved out of the area|0|||
44157421|NCT03429543|78949159|FG006|Overall Study|Adverse Event|0|||
44434682|NCT00343291|79443420|FG000|Overall Study|Adverse Event|13|||
44434683|NCT00343291|79443421|FG001|Overall Study|Adverse Event|13|||
44434684|NCT00343291|79443420|FG000|Overall Study|Death|3|||
44434685|NCT00343291|79443421|FG001|Overall Study|Death|2|||
44539824|NCT03761797|79551321|FG000|Overall Study|Lost to Follow-up|33|||
44539825|NCT03761797|79551321|FG000|Overall Study|Adverse Event|37|||
44539826|NCT03761797|79551321|FG000|Overall Study|Case report form (CRF) not collected|5|||
44539827|NCT03761797|79551321|FG000|Overall Study|No patient visit after entry|13|||
44336216|NCT01090492|79340941|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44336217|NCT01090492|79340942|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44336218|NCT01090492|79340943|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
44336219|NCT01090492|79340936|FG000|Second Intervention Period (4 Weeks)|Other|0|||
44539828|NCT03761797|79551321|FG000|Overall Study|Switch to other diabetes medication|10|||
44539829|NCT03761797|79551321|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
44539830|NCT03761797|79551321|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
44539831|NCT03761797|79551321|FG000|Overall Study|Insufficient effectives|2|||
44539832|NCT03761797|79551321|FG000|Overall Study|Excessive alcohol intake|1|||
44539833|NCT02944656|79551327|FG000|Overall Study|No longer eligible|3|||
44539834|NCT02944656|79551328|FG001|Overall Study|No longer eligible|0|||
44539835|NCT02944656|79551327|FG000|Overall Study|Lost to Follow-up|7|||
44539836|NCT02944656|79551328|FG001|Overall Study|Lost to Follow-up|10|||
44539837|NCT02713529|79551341|FG000|Overall Study|Withdrawal by Subject|3|||
44539838|NCT02713529|79551342|FG001|Overall Study|Withdrawal by Subject|1|||
44539839|NCT02713529|79551343|FG002|Overall Study|Withdrawal by Subject|4|||
44539840|NCT02713529|79551344|FG003|Overall Study|Withdrawal by Subject|2|||
44539841|NCT02713529|79551345|FG004|Overall Study|Withdrawal by Subject|0|||
44539842|NCT02713529|79551346|FG005|Overall Study|Withdrawal by Subject|1|||
44539843|NCT02713529|79551347|FG006|Overall Study|Withdrawal by Subject|1|||
44539844|NCT02713529|79551341|FG000|Overall Study|Lost to Follow-up|1|||
44539845|NCT02713529|79551342|FG001|Overall Study|Lost to Follow-up|0|||
44539846|NCT02713529|79551343|FG002|Overall Study|Lost to Follow-up|1|||
44539847|NCT02713529|79551344|FG003|Overall Study|Lost to Follow-up|0|||
44539848|NCT02713529|79551345|FG004|Overall Study|Lost to Follow-up|0|||
44539849|NCT02713529|79551346|FG005|Overall Study|Lost to Follow-up|0|||
44539850|NCT02713529|79551347|FG006|Overall Study|Lost to Follow-up|0|||
44539851|NCT02713529|79551341|FG000|Overall Study|Death|3|||
44539852|NCT02713529|79551342|FG001|Overall Study|Death|3|||
44539853|NCT02713529|79551343|FG002|Overall Study|Death|26|||
44539854|NCT02713529|79551344|FG003|Overall Study|Death|27|||
44539855|NCT02713529|79551345|FG004|Overall Study|Death|3|||
44539856|NCT02713529|79551346|FG005|Overall Study|Death|13|||
44539857|NCT02713529|79551347|FG006|Overall Study|Death|3|||
44539858|NCT03707821|79551373|FG000|Overall Study|Protocol Violation|0|||
44539859|NCT03707821|79551374|FG001|Overall Study|Protocol Violation|1|||
44539860|NCT03707821|79551373|FG000|Overall Study|Unsatisfactory Visual Response|1|||
44539861|NCT03707821|79551374|FG001|Overall Study|Unsatisfactory Visual Response|0|||
44539862|NCT03707821|79551373|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
44539863|NCT03707821|79551374|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
44539864|NCT04546581|79551382|FG000|Overall Study|Adverse Event|9|||
44539865|NCT04546581|79551383|FG001|Overall Study|Adverse Event|3|||
44539866|NCT04546581|79551382|FG000|Overall Study|Physician Decision|0|||
44539867|NCT04546581|79551383|FG001|Overall Study|Physician Decision|1|||
44539868|NCT04546581|79551382|FG000|Overall Study|Protocol Violation|1|||
44539869|NCT04546581|79551383|FG001|Overall Study|Protocol Violation|2|||
44336220|NCT01090492|79340937|FG001|Second Intervention Period (4 Weeks)|Other|1|||
44336221|NCT01090492|79340938|FG002|Second Intervention Period (4 Weeks)|Other|1|||
44336222|NCT01090492|79340939|FG003|Second Intervention Period (4 Weeks)|Other|0|||
44336223|NCT01090492|79340940|FG004|Second Intervention Period (4 Weeks)|Other|0|||
44336224|NCT01090492|79340941|FG005|Second Intervention Period (4 Weeks)|Other|0|||
44336225|NCT01090492|79340942|FG006|Second Intervention Period (4 Weeks)|Other|0|||
44336226|NCT01090492|79340943|FG007|Second Intervention Period (4 Weeks)|Other|0|||
44336227|NCT01090492|79340936|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
44434686|NCT00343291|79443420|FG000|Overall Study|Progressive disease|33|||
44434687|NCT00343291|79443421|FG001|Overall Study|Progressive disease|34|||
44539870|NCT04546581|79551382|FG000|Overall Study|Withdrawal by Subject|3|||
44539871|NCT04546581|79551383|FG001|Overall Study|Withdrawal by Subject|7|||
44539872|NCT03707587|79551391|FG000|Overall Study|Death|0|||
44336228|NCT01090492|79340937|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
44434688|NCT00343291|79443420|FG000|Overall Study|Withdrawal by Subject|0|||
44539873|NCT03707587|79551392|FG001|Overall Study|Death|1|||
44539874|NCT03312933|79551402|FG000|Overall Study|Protocol Violation|15|||
44539875|NCT03312933|79551402|FG000|Overall Study|Lost to Follow-up|36|||
44539876|NCT03312933|79551402|FG000|Overall Study|Withdrawal by Subject|3|||
44539877|NCT03312543|79551408|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
44539878|NCT03312543|79551409|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
44539879|NCT03312543|79551408|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
44434689|NCT00343291|79443421|FG001|Overall Study|Withdrawal by Subject|2|||
44434690|NCT00343291|79443420|FG000|Overall Study|Other|8|||
44434691|NCT00343291|79443421|FG001|Overall Study|Other|5|||
44434692|NCT00658788|79443427|FG000|Overall Study|Adverse Event|11|||
44434693|NCT00658788|79443427|FG000|Overall Study|Withdrawal by Subject|13|||
44434694|NCT00658788|79443427|FG000|Overall Study|Lost to Follow-up|18|||
44434695|NCT00658788|79443427|FG000|Overall Study|Treatment Discontinuation|32|||
44434696|NCT04829214|79443442|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
44434697|NCT04829214|79443443|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
44434698|NCT04829214|79443442|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
44434699|NCT04829214|79443443|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
44434700|NCT00562965|79443453|FG000|Overall Study|Withdrawal by Subject|0|||
44434701|NCT00562965|79443454|FG001|Overall Study|Withdrawal by Subject|1|||
44434702|NCT00562965|79443453|FG000|Overall Study|Death|2|||
44434703|NCT00562965|79443454|FG001|Overall Study|Death|4|||
44434704|NCT00562965|79443453|FG000|Overall Study|Lost to Follow-up|1|||
44434705|NCT00562965|79443454|FG001|Overall Study|Lost to Follow-up|0|||
44434706|NCT00562965|79443453|FG000|Overall Study|Other|0|||
44434707|NCT00562965|79443454|FG001|Overall Study|Other|1|||
44434708|NCT00537082|79443463|FG000|Overall Study|Adverse Event|6|||
44434709|NCT00537082|79443464|FG001|Overall Study|Adverse Event|6|||
44434710|NCT00537082|79443465|FG002|Overall Study|Adverse Event|3|||
44434711|NCT00537082|79443463|FG000|Overall Study|Protocol Violation|0|||
44434712|NCT00537082|79443464|FG001|Overall Study|Protocol Violation|2|||
44434713|NCT00537082|79443465|FG002|Overall Study|Protocol Violation|1|||
44434714|NCT00537082|79443463|FG000|Overall Study|Lack of Efficacy|0|||
44434715|NCT00537082|79443464|FG001|Overall Study|Lack of Efficacy|0|||
44434716|NCT00537082|79443465|FG002|Overall Study|Lack of Efficacy|2|||
44434717|NCT00537082|79443463|FG000|Overall Study|Withdrawal by Subject|0|||
44434718|NCT00537082|79443464|FG001|Overall Study|Withdrawal by Subject|1|||
44434719|NCT00537082|79443465|FG002|Overall Study|Withdrawal by Subject|0|||
44434720|NCT00537082|79443463|FG000|Overall Study|Discontinued before initiating treatment|3|||
44434721|NCT00537082|79443464|FG001|Overall Study|Discontinued before initiating treatment|0|||
44434722|NCT00537082|79443465|FG002|Overall Study|Discontinued before initiating treatment|0|||
44434723|NCT03828487|79443473|FG000|Overall Study|Physician Decision|1|||
44434724|NCT00324961|79443477|FG000|Overall Study|Adverse Event|5|||
44434725|NCT00324961|79443477|FG000|Overall Study|Consent Withdrawn|11|||
44434726|NCT00324961|79443477|FG000|Overall Study|Lost to Follow-up|22|||
44336229|NCT01090492|79340938|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
44336230|NCT01090492|79340939|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
44336231|NCT01090492|79340940|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
44434727|NCT00324961|79443477|FG000|Overall Study|Protocol Violation|3|||
44434728|NCT00324961|79443477|FG000|Overall Study|Other|2|||
44539880|NCT03312543|79551409|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
44539881|NCT03312543|79551408|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
44539882|NCT03312543|79551409|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
44539883|NCT03312543|79551408|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
44539884|NCT03312543|79551409|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
44539885|NCT03312543|79551408|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
44539886|NCT03312543|79551409|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
44539887|NCT03312543|79551408|FG000|Regression (Week 12 to Week 24)|Death|0|||
44539888|NCT03312543|79551409|FG001|Regression (Week 12 to Week 24)|Death|1|||
44539889|NCT02392559|79551438|FG000|Overall Study|Withdrawal by Subject|0|||
44539890|NCT02392559|79551439|FG001|Overall Study|Withdrawal by Subject|1|||
44539891|NCT03332589|79551453|FG000|Overall Study|Lack of Efficacy|2|||
44539892|NCT03332589|79551454|FG001|Overall Study|Lack of Efficacy|0|||
44539893|NCT03332589|79551455|FG002|Overall Study|Lack of Efficacy|0|||
44539894|NCT03332589|79551453|FG000|Overall Study|Adverse Event|1|||
44336232|NCT01090492|79340941|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
44336233|NCT01090492|79340942|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
44336234|NCT01090492|79340943|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
44336235|NCT01090492|79340936|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44434729|NCT00324649|79443485|FG000|Overall Study|Adverse Event|1|||
44434730|NCT00324649|79443486|FG001|Overall Study|Adverse Event|4|||
44434731|NCT00324649|79443485|FG000|Overall Study|Withdrawal by Subject|0|||
44434732|NCT00324649|79443486|FG001|Overall Study|Withdrawal by Subject|1|||
44434733|NCT00324649|79443485|FG000|Overall Study|Noncompliance|1|||
44434734|NCT00324649|79443486|FG001|Overall Study|Noncompliance|0|||
44434735|NCT00656370|79443492|FG000|Overall Study|Screen Failures|7|||
44539895|NCT03332589|79551454|FG001|Overall Study|Adverse Event|0|||
44336236|NCT01090492|79340937|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336237|NCT01090492|79340938|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336238|NCT01090492|79340939|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336239|NCT01090492|79340940|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336240|NCT01090492|79340941|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336241|NCT01090492|79340942|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
44336242|NCT01090492|79340943|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
44336243|NCT01288911|79340964|FG000|Double-blind Period|Death|11|||
44336244|NCT01288911|79340965|FG001|Double-blind Period|Death|7|||
44336245|NCT01288911|79340964|FG000|Double-blind Period|Lost to Follow-up|0|||
44336246|NCT01288911|79340965|FG001|Double-blind Period|Lost to Follow-up|2|||
44336247|NCT01288911|79340964|FG000|Double-blind Period|Progressive Disease|75|||
44336248|NCT01288911|79340965|FG001|Double-blind Period|Progressive Disease|103|||
44336249|NCT01288911|79340964|FG000|Double-blind Period|Protocol Violation|1|||
44336250|NCT01288911|79340965|FG001|Double-blind Period|Protocol Violation|0|||
44336251|NCT01288911|79340964|FG000|Double-blind Period|Withdrawal by Subject|25|||
44336252|NCT01288911|79340965|FG001|Double-blind Period|Withdrawal by Subject|26|||
44336253|NCT01288911|79340964|FG000|Double-blind Period|Miscellaneous Reason|29|||
44336254|NCT01288911|79340965|FG001|Double-blind Period|Miscellaneous Reason|42|||
44336255|NCT01288911|79340964|FG000|Double-blind Period|Randomized but never received study drug|1|||
44336256|NCT01288911|79340965|FG001|Double-blind Period|Randomized but never received study drug|2|||
44336257|NCT01288911|79340964|FG000|Open-label Period (All Enzalutamide)|Death|0|||
44336258|NCT01288911|79340965|FG001|Open-label Period (All Enzalutamide)|Death|1|||
44336259|NCT01288911|79340964|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
44336260|NCT01288911|79340965|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
44336261|NCT01288911|79340964|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
44336262|NCT01288911|79340965|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
44336263|NCT01288911|79340964|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
44336264|NCT01288911|79340965|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
44336265|NCT01288911|79340964|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
44336266|NCT01288911|79340965|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
44336267|NCT01288911|79340964|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
44336268|NCT01288911|79340965|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
44336269|NCT01288443|79340980|FG000|Overall Study|Adverse Event|0|||
44336270|NCT01288443|79340981|FG001|Overall Study|Adverse Event|0|||
44336271|NCT01288443|79340982|FG002|Overall Study|Adverse Event|1|||
44336272|NCT01288443|79340983|FG003|Overall Study|Adverse Event|1|||
44336273|NCT01288443|79340984|FG004|Overall Study|Adverse Event|3|||
44336274|NCT01288443|79340985|FG005|Overall Study|Adverse Event|1|||
44336275|NCT01288443|79340980|FG000|Overall Study|Poor compliance to protocol|0|||
44336276|NCT01288443|79340981|FG001|Overall Study|Poor compliance to protocol|0|||
44336277|NCT01288443|79340982|FG002|Overall Study|Poor compliance to protocol|0|||
44336278|NCT01288443|79340983|FG003|Overall Study|Poor compliance to protocol|0|||
44336279|NCT01288443|79340984|FG004|Overall Study|Poor compliance to protocol|0|||
44336280|NCT01288443|79340985|FG005|Overall Study|Poor compliance to protocol|1|||
44336281|NCT01288443|79340980|FG000|Overall Study|Participant Moved|0|||
44336282|NCT01288443|79340981|FG001|Overall Study|Participant Moved|0|||
44336283|NCT01288443|79340982|FG002|Overall Study|Participant Moved|0|||
44336284|NCT01288443|79340983|FG003|Overall Study|Participant Moved|1|||
44336285|NCT01288443|79340984|FG004|Overall Study|Participant Moved|2|||
44336286|NCT01288443|79340985|FG005|Overall Study|Participant Moved|1|||
44336287|NCT01288443|79340980|FG000|Overall Study|Consent withdrawn by Participant|0|||
44336288|NCT01288443|79340981|FG001|Overall Study|Consent withdrawn by Participant|0|||
44336289|NCT01288443|79340982|FG002|Overall Study|Consent withdrawn by Participant|0|||
44336290|NCT01288443|79340983|FG003|Overall Study|Consent withdrawn by Participant|0|||
44336291|NCT01288443|79340984|FG004|Overall Study|Consent withdrawn by Participant|0|||
44336292|NCT01288443|79340985|FG005|Overall Study|Consent withdrawn by Participant|1|||
44336293|NCT01288443|79340980|FG000|Overall Study|Lost to Follow-up|0|||
44336294|NCT01288443|79340981|FG001|Overall Study|Lost to Follow-up|1|||
44336295|NCT01288443|79340982|FG002|Overall Study|Lost to Follow-up|0|||
44336296|NCT01288443|79340983|FG003|Overall Study|Lost to Follow-up|0|||
44336297|NCT01288443|79340984|FG004|Overall Study|Lost to Follow-up|0|||
44336298|NCT01288443|79340985|FG005|Overall Study|Lost to Follow-up|0|||
44336299|NCT01288443|79340980|FG000|Overall Study|Study drug auto-injector administration|0|||
44157422|NCT03429543|78949153|FG000|Overall Study|Lost to Follow-up|1|||
44336300|NCT01288443|79340981|FG001|Overall Study|Study drug auto-injector administration|0|||
44336301|NCT01288443|79340982|FG002|Overall Study|Study drug auto-injector administration|0|||
44336302|NCT01288443|79340983|FG003|Overall Study|Study drug auto-injector administration|0|||
44336303|NCT01288443|79340984|FG004|Overall Study|Study drug auto-injector administration|1|||
44336304|NCT01288443|79340985|FG005|Overall Study|Study drug auto-injector administration|1|||
44434736|NCT00656370|79443492|FG000|Overall Study|Alternates|3|||
44157423|NCT03429543|78949154|FG001|Overall Study|Lost to Follow-up|0|||
44336305|NCT01288443|79340980|FG000|Overall Study|Other than above|0|||
44336306|NCT01288443|79340981|FG001|Overall Study|Other than above|0|||
44336307|NCT01288443|79340982|FG002|Overall Study|Other than above|0|||
44336308|NCT01288443|79340983|FG003|Overall Study|Other than above|2|||
44336309|NCT01288443|79340984|FG004|Overall Study|Other than above|1|||
44336310|NCT01288443|79340985|FG005|Overall Study|Other than above|0|||
44336311|NCT01288287|79340999|FG000|Overall Study|Lost to Follow-up|8|||
44336312|NCT01288287|79340999|FG000|Overall Study|Withdrawal by Subject|4|||
44336313|NCT01288287|79340999|FG000|Overall Study|Lack of Efficacy|13|||
44336314|NCT01288287|79340999|FG000|Overall Study|Other Reason|13|||
44336315|NCT01288287|79340999|FG000|Overall Study|Unknown Reason|1|||
44336316|NCT01288287|79340999|FG000|Overall Study|Unknown Status|7|||
44336317|NCT01288209|79341006|FG000|Overall Study|Withdrawal by Subject|1|||
44336318|NCT01288209|79341007|FG001|Overall Study|Withdrawal by Subject|3|||
44336319|NCT01288209|79341006|FG000|Overall Study|Other|1|||
44336320|NCT01288209|79341007|FG001|Overall Study|Other|0|||
44434737|NCT00680186|79443500|FG000|Overall Study|Adverse Event|47|||
44434738|NCT00680186|79443501|FG001|Overall Study|Adverse Event|44|||
44434739|NCT00680186|79443500|FG000|Overall Study|Protocol Violation|31|||
44434740|NCT00680186|79443501|FG001|Overall Study|Protocol Violation|26|||
44434741|NCT00680186|79443500|FG000|Overall Study|Lost to Follow-up|11|||
44434742|NCT00680186|79443501|FG001|Overall Study|Lost to Follow-up|6|||
44434743|NCT00680186|79443500|FG000|Overall Study|Withdrawal by Subject|32|||
44434744|NCT00680186|79443501|FG001|Overall Study|Withdrawal by Subject|39|||
44434745|NCT00680186|79443500|FG000|Overall Study|Other|4|||
44434746|NCT00680186|79443501|FG001|Overall Study|Other|1|||
44434747|NCT00656292|79443509|FG000|Overall Study|Withdrawal by Subject|2|||
44434748|NCT00656292|79443510|FG001|Overall Study|Withdrawal by Subject|3|||
44336321|NCT01288053|79341013|FG000|Overall Study|Death|1|||
44336322|NCT01287195|79341017|FG000|Overall Study|Withdrawal by Subject|2|||
44336323|NCT01287117|79341025|FG000|Overall Study|Adverse Event|2|||
44336324|NCT01287117|79341026|FG001|Overall Study|Adverse Event|1|||
44434749|NCT00656292|79443509|FG000|Overall Study|Screen failure|1|||
44434750|NCT00656292|79443510|FG001|Overall Study|Screen failure|2|||
44434751|NCT00352417|79443518|FG000|Overall Study|Adverse Event|1|||
44434752|NCT00352417|79443519|FG001|Overall Study|Adverse Event|0|||
44434753|NCT00352417|79443518|FG000|Overall Study|Protocol Violation|0|||
44434754|NCT00352417|79443519|FG001|Overall Study|Protocol Violation|2|||
44434755|NCT00352417|79443518|FG000|Overall Study|Withdrawal by Subject|1|||
44434756|NCT00352417|79443519|FG001|Overall Study|Withdrawal by Subject|2|||
44434757|NCT00352417|79443518|FG000|Overall Study|Lost to Follow-up|1|||
44434758|NCT00352417|79443519|FG001|Overall Study|Lost to Follow-up|0|||
44434759|NCT00352417|79443518|FG000|Overall Study|Schedule Change|2|||
44434760|NCT00352417|79443519|FG001|Overall Study|Schedule Change|1|||
44434761|NCT00323869|79443525|FG000|Overall Study|Death|1|||
44434762|NCT00323557|79443531|FG000|Overall Study|Physician Decision|1|||
44434763|NCT00323557|79443532|FG001|Overall Study|Physician Decision|0|||
44336325|NCT01287117|79341027|FG002|Overall Study|Adverse Event|1|||
44336326|NCT01287117|79341028|FG003|Overall Study|Adverse Event|1|||
44336327|NCT01287117|79341025|FG000|Overall Study|Lost to Follow-up|1|||
44336328|NCT01287117|79341026|FG001|Overall Study|Lost to Follow-up|1|||
44336329|NCT01287117|79341027|FG002|Overall Study|Lost to Follow-up|0|||
44434764|NCT00558363|79443541|FG000|Overall Study|Physician Decision|18|||
44434765|NCT00558363|79443542|FG001|Overall Study|Physician Decision|4|||
44434766|NCT00558363|79443541|FG000|Overall Study|Withdrawal by Subject|11|||
44434767|NCT00558363|79443542|FG001|Overall Study|Withdrawal by Subject|4|||
44434768|NCT00558363|79443541|FG000|Overall Study|Adverse Event|5|||
44434769|NCT00558363|79443542|FG001|Overall Study|Adverse Event|5|||
44434770|NCT00558363|79443541|FG000|Overall Study|Lack of Efficacy|2|||
44434771|NCT00558363|79443542|FG001|Overall Study|Lack of Efficacy|2|||
44434772|NCT00558363|79443541|FG000|Overall Study|Protocol Violation|2|||
44434773|NCT00558363|79443542|FG001|Overall Study|Protocol Violation|1|||
44539896|NCT03332589|79551455|FG002|Overall Study|Adverse Event|0|||
44157424|NCT03429543|78949155|FG002|Overall Study|Lost to Follow-up|0|||
44157425|NCT03429543|78949156|FG003|Overall Study|Lost to Follow-up|0|||
44434774|NCT00558363|79443541|FG000|Overall Study|Lost to Follow-up|0|||
44434775|NCT00558363|79443542|FG001|Overall Study|Lost to Follow-up|1|||
44434776|NCT00558363|79443541|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
44434777|NCT00558363|79443542|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
44434778|NCT00558363|79443541|FG000|Overall Study|Randomized in Error|1|||
44336330|NCT01287117|79341028|FG003|Overall Study|Lost to Follow-up|0|||
44336331|NCT01287117|79341025|FG000|Overall Study|Physician Decision|0|||
44336332|NCT01287117|79341026|FG001|Overall Study|Physician Decision|1|||
44434779|NCT00558363|79443542|FG001|Overall Study|Randomized in Error|2|||
44434780|NCT00558363|79443541|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
44434781|NCT00558363|79443542|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
44434782|NCT00323479|79443548|FG000|Overall Study|Adverse Event|2|||
44434783|NCT00323479|79443548|FG000|Overall Study|Withdrawal by Subject|2|||
44336333|NCT01287117|79341027|FG002|Overall Study|Physician Decision|1|||
44336334|NCT01287117|79341028|FG003|Overall Study|Physician Decision|1|||
44434784|NCT00323479|79443548|FG000|Overall Study|Protocol Violation|3|||
44434785|NCT00323479|79443548|FG000|Overall Study|house moving|1|||
44434786|NCT00352105|79443552|FG000|Overall Study|Death|5|||
44434787|NCT00352105|79443552|FG000|Overall Study|Withdrawal by Subject|5|||
44434788|NCT00352105|79443552|FG000|Overall Study|Lack of Efficacy|9|||
44434789|NCT00352105|79443552|FG000|Overall Study|Adverse Event|19|||
44434790|NCT00352105|79443552|FG000|Overall Study|Protocol Violation|2|||
44434791|NCT00350779|79443558|FG000|Overall Study|Adverse Event|4|||
44434792|NCT00350779|79443559|FG001|Overall Study|Adverse Event|2|||
44434793|NCT00350779|79443558|FG000|Overall Study|Lack of Efficacy|0|||
44434794|NCT00350779|79443559|FG001|Overall Study|Lack of Efficacy|4|||
44434795|NCT00350779|79443558|FG000|Overall Study|Lost to Follow-up|2|||
44434796|NCT00350779|79443559|FG001|Overall Study|Lost to Follow-up|0|||
44434797|NCT00350779|79443558|FG000|Overall Study|Physician Decision|2|||
44434798|NCT00350779|79443559|FG001|Overall Study|Physician Decision|4|||
44434799|NCT00350779|79443558|FG000|Overall Study|Protocol Violation|3|||
44434800|NCT00350779|79443559|FG001|Overall Study|Protocol Violation|1|||
44434801|NCT00350779|79443558|FG000|Overall Study|Withdrawal by Subject|9|||
44434802|NCT00350779|79443559|FG001|Overall Study|Withdrawal by Subject|8|||
44434803|NCT00350779|79443558|FG000|Overall Study|Patient Moved|2|||
44434804|NCT00350779|79443559|FG001|Overall Study|Patient Moved|1|||
44434805|NCT00350779|79443558|FG000|Overall Study|Non-compliance with study procedures|0|||
44434806|NCT00350779|79443559|FG001|Overall Study|Non-compliance with study procedures|1|||
44434807|NCT00350623|79443570|FG000|Overall Study|Lost to Follow-up|8|||
44434808|NCT00350623|79443571|FG001|Overall Study|Lost to Follow-up|3|||
44434809|NCT00350623|79443572|FG002|Overall Study|Lost to Follow-up|4|||
44434810|NCT00350623|79443570|FG000|Overall Study|Withdrawal by Subject|0|||
44434811|NCT00350623|79443571|FG001|Overall Study|Withdrawal by Subject|1|||
44434812|NCT00350623|79443572|FG002|Overall Study|Withdrawal by Subject|1|||
44434813|NCT00350623|79443570|FG000|Overall Study|patient traveling outside the country|0|||
44434814|NCT00350623|79443571|FG001|Overall Study|patient traveling outside the country|0|||
44434815|NCT00350623|79443572|FG002|Overall Study|patient traveling outside the country|1|||
44434816|NCT00656136|79443582|FG000|Overall Study|Progressive disease|177|||
44434817|NCT00656136|79443583|FG001|Overall Study|Progressive disease|322|||
44434818|NCT00656136|79443582|FG000|Overall Study|Other Adverse Event|5|||
44434819|NCT00656136|79443583|FG001|Overall Study|Other Adverse Event|51|||
44539897|NCT03332589|79551453|FG000|Overall Study|Death|1|||
44336335|NCT01287117|79341025|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
44336336|NCT01287117|79341026|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
44336337|NCT01287117|79341027|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
44336338|NCT01287117|79341028|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
44336339|NCT01287117|79341025|FG000|Overall Study|Disease Progression|10|||
44336340|NCT01287117|79341026|FG001|Overall Study|Disease Progression|5|||
44336341|NCT01287117|79341027|FG002|Overall Study|Disease Progression|6|||
44336342|NCT01287117|79341028|FG003|Overall Study|Disease Progression|5|||
44336343|NCT01287039|79341040|FG000|Overall Study|Noncompliance with study procedures|0|||
44336344|NCT01287039|79341041|FG001|Overall Study|Noncompliance with study procedures|1|||
44336345|NCT01287039|79341040|FG000|Overall Study|Change of location/residence|0|||
44336346|NCT01287039|79341041|FG001|Overall Study|Change of location/residence|3|||
44336347|NCT01287039|79341040|FG000|Overall Study|Elective surgery|0|||
44336348|NCT01287039|79341041|FG001|Overall Study|Elective surgery|1|||
44336349|NCT01287039|79341040|FG000|Overall Study|Protocol Violation|2|||
44336350|NCT01287039|79341041|FG001|Overall Study|Protocol Violation|3|||
44336351|NCT01287039|79341040|FG000|Overall Study|Excluded medication taken|1|||
44336352|NCT01287039|79341041|FG001|Overall Study|Excluded medication taken|0|||
44336353|NCT01287039|79341040|FG000|Overall Study|Noncompliance with study medication|0|||
44336354|NCT01287039|79341041|FG001|Overall Study|Noncompliance with study medication|1|||
44336355|NCT01287039|79341040|FG000|Overall Study|Problem with travel|0|||
44336356|NCT01287039|79341041|FG001|Overall Study|Problem with travel|1|||
44336357|NCT01287039|79341040|FG000|Overall Study|Death|1|||
44336358|NCT01287039|79341041|FG001|Overall Study|Death|0|||
44434820|NCT00656136|79443582|FG000|Overall Study|Protocol Violation|2|||
44539898|NCT03332589|79551454|FG001|Overall Study|Death|0|||
44539899|NCT03332589|79551455|FG002|Overall Study|Death|0|||
44157426|NCT03429543|78949157|FG004|Overall Study|Lost to Follow-up|1|||
44336359|NCT01287039|79341040|FG000|Overall Study|Change of residence|1|||
44434821|NCT00656136|79443583|FG001|Overall Study|Protocol Violation|3|||
44434822|NCT00656136|79443582|FG000|Overall Study|Patient refused to take study medication|7|||
44434823|NCT00656136|79443583|FG001|Overall Study|Patient refused to take study medication|10|||
44157427|NCT03429543|78949158|FG005|Overall Study|Lost to Follow-up|0|||
44336360|NCT01287039|79341041|FG001|Overall Study|Change of residence|0|||
44336361|NCT01287039|79341040|FG000|Overall Study|Adverse Event|7|||
44336362|NCT01287039|79341041|FG001|Overall Study|Adverse Event|4|||
44434824|NCT00656136|79443582|FG000|Overall Study|Unknown and others|4|||
44434825|NCT00656136|79443583|FG001|Overall Study|Unknown and others|4|||
44434826|NCT00676520|79443589|FG000|Overall Study|Withdrawal by Subject|163|||
44336363|NCT01287039|79341040|FG000|Overall Study|Withdrawal by Subject|14|||
44434827|NCT00676520|79443589|FG000|Overall Study|Lost to Follow-up|162|||
44434828|NCT00676520|79443589|FG000|Overall Study|Death|159|||
44434829|NCT00676520|79443589|FG000|Overall Study|Physician Decision|20|||
44434830|NCT00676520|79443589|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
44434831|NCT00676520|79443589|FG000|Overall Study|Other Reason|18|||
44434832|NCT00652938|79443601|FG000|Overall Study|Adverse Event|1|||
44434833|NCT00652938|79443602|FG001|Overall Study|Adverse Event|0|||
44434834|NCT00652938|79443603|FG002|Overall Study|Adverse Event|2|||
44434835|NCT00652938|79443601|FG000|Overall Study|Withdrawal by Subject|0|||
44434836|NCT00652938|79443602|FG001|Overall Study|Withdrawal by Subject|6|||
44434837|NCT00652938|79443603|FG002|Overall Study|Withdrawal by Subject|1|||
44434838|NCT00652938|79443601|FG000|Overall Study|Lost to Follow-up|0|||
44434839|NCT00652938|79443602|FG001|Overall Study|Lost to Follow-up|0|||
44434840|NCT00652938|79443603|FG002|Overall Study|Lost to Follow-up|2|||
44157428|NCT03429543|78949159|FG006|Overall Study|Lost to Follow-up|0|||
44157429|NCT03429543|78949153|FG000|Overall Study|Withdrawal by Subject|5|||
44157430|NCT03429543|78949154|FG001|Overall Study|Withdrawal by Subject|0|||
44157431|NCT03429543|78949155|FG002|Overall Study|Withdrawal by Subject|1|||
44157432|NCT03429543|78949156|FG003|Overall Study|Withdrawal by Subject|2|||
44434841|NCT00652938|79443601|FG000|Overall Study|fear of blood sampling|0|||
44434842|NCT00652938|79443602|FG001|Overall Study|fear of blood sampling|1|||
44336364|NCT01287039|79341041|FG001|Overall Study|Withdrawal by Subject|11|||
44336365|NCT01287039|79341040|FG000|Overall Study|Lost to Follow-up|3|||
44336366|NCT01287039|79341041|FG001|Overall Study|Lost to Follow-up|2|||
44336367|NCT01285401|79341049|FG000|Overall Study|Prematurely withdrawn from the study|17|||
44336368|NCT01285401|79341050|FG001|Overall Study|Prematurely withdrawn from the study|29|||
44336369|NCT01285323|79341058|FG000|Overall Study|Adverse Event|9|||
44336370|NCT01285323|79341059|FG001|Overall Study|Adverse Event|8|||
44336371|NCT01285323|79341058|FG000|Overall Study|Lack of Efficacy|4|||
44434843|NCT00652938|79443603|FG002|Overall Study|fear of blood sampling|0|||
44434844|NCT00322621|79443611|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
44157433|NCT03429543|78949157|FG004|Overall Study|Withdrawal by Subject|6|||
44157434|NCT03429543|78949158|FG005|Overall Study|Withdrawal by Subject|3|||
44336372|NCT01285323|79341059|FG001|Overall Study|Lack of Efficacy|2|||
44336373|NCT01285323|79341058|FG000|Overall Study|Withdrawal by Subject|15|||
44434845|NCT00322621|79443612|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
44434846|NCT00322621|79443613|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
44434847|NCT00322621|79443611|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
44434848|NCT00322621|79443612|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
44336374|NCT01285323|79341059|FG001|Overall Study|Withdrawal by Subject|11|||
44336375|NCT01285323|79341058|FG000|Overall Study|Protocol Violation|1|||
44336376|NCT01285323|79341059|FG001|Overall Study|Protocol Violation|2|||
44336377|NCT01285323|79341058|FG000|Overall Study|Non-compliance with study procedures|2|||
44336378|NCT01285323|79341059|FG001|Overall Study|Non-compliance with study procedures|3|||
44336379|NCT01285323|79341058|FG000|Overall Study|Lost to Follow-up|1|||
44434849|NCT00322621|79443613|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
44434850|NCT00322621|79443611|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
44434851|NCT00322621|79443612|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
44434852|NCT00322621|79443613|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
44434853|NCT00322621|79443611|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
44434854|NCT00322621|79443612|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
44434855|NCT00322621|79443613|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
44434856|NCT00322621|79443611|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
44434857|NCT00322621|79443612|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
44434858|NCT00322621|79443613|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
44434859|NCT00322621|79443611|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
44434860|NCT00322621|79443612|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
44434861|NCT00322621|79443613|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
44434862|NCT00322621|79443611|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
44434863|NCT00322621|79443612|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
44434864|NCT00322621|79443613|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
44434865|NCT00322621|79443611|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
44157435|NCT03429543|78949159|FG006|Overall Study|Withdrawal by Subject|1|||
44157436|NCT03429543|78949153|FG000|Overall Study|Other reason than listed|0|||
44336380|NCT01285323|79341059|FG001|Overall Study|Lost to Follow-up|1|||
44336381|NCT01285323|79341058|FG000|Overall Study|Other|1|||
44336382|NCT01285323|79341059|FG001|Overall Study|Other|3|||
44434866|NCT00322621|79443612|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
44434867|NCT00322621|79443613|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
44434868|NCT00322621|79443611|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
44434869|NCT00322621|79443612|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
44434870|NCT00322621|79443613|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
44336383|NCT01284621|79341065|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
44336384|NCT01284621|79341066|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
44336385|NCT01284621|79341067|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
44336386|NCT01284621|79341068|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
44336387|NCT01284621|79341069|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
44336388|NCT01284621|79341070|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
44336389|NCT01283139|79341084|FG000|Overall Study|Lost to Follow-up|5|||
44336390|NCT01283139|79341085|FG001|Overall Study|Lost to Follow-up|2|||
44336391|NCT01283139|79341086|FG002|Overall Study|Lost to Follow-up|3|||
44336392|NCT01283139|79341087|FG003|Overall Study|Lost to Follow-up|1|||
44336393|NCT01283139|79341084|FG000|Overall Study|Withdrawal by Subject|8|||
44336394|NCT01283139|79341085|FG001|Overall Study|Withdrawal by Subject|8|||
44336395|NCT01283139|79341086|FG002|Overall Study|Withdrawal by Subject|6|||
44336396|NCT01283139|79341087|FG003|Overall Study|Withdrawal by Subject|8|||
44336397|NCT01283139|79341084|FG000|Overall Study|Death|2|||
44336398|NCT01283139|79341085|FG001|Overall Study|Death|0|||
44336399|NCT01283139|79341086|FG002|Overall Study|Death|2|||
44434871|NCT00322621|79443611|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
44434872|NCT00322621|79443612|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
44434873|NCT00322621|79443613|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
44434874|NCT00322621|79443611|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
44434875|NCT00322621|79443612|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
44434876|NCT00322621|79443613|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
44434877|NCT00575042|79443626|FG000|Overall Study|Adverse Event|2|||
44434878|NCT00575042|79443626|FG000|Overall Study|Lost to Follow-up|1|||
44434879|NCT00676208|79443633|FG000|Overall Study|Lost to Follow-up|0|||
44434880|NCT00676208|79443634|FG001|Overall Study|Lost to Follow-up|2|||
44434881|NCT00676208|79443633|FG000|Overall Study|Incomplete data|2|||
44434882|NCT00676208|79443634|FG001|Overall Study|Incomplete data|4|||
44434883|NCT00656058|79443642|FG000|Overall Study|Withdrawal by Subject|2|||
44434884|NCT00656058|79443642|FG000|Overall Study|Withdrawal by Subject|4|||
44434885|NCT00537316|79443652|FG000|Part 1|Adverse Event|7|||
44434886|NCT00537316|79443653|FG001|Part 1|Adverse Event|11|||
44434887|NCT00537316|79443654|FG002|Part 1|Adverse Event|8|||
44434888|NCT00537316|79443655|FG003|Part 1|Adverse Event|0|||
44434889|NCT00537316|79443656|FG004|Part 1|Adverse Event|0|||
44434890|NCT00537316|79443657|FG005|Part 1|Adverse Event|0|||
44434891|NCT00537316|79443658|FG006|Part 1|Adverse Event|0|||
44434892|NCT00537316|79443652|FG000|Part 1|Protocol defined clinical event|1|||
44434893|NCT00537316|79443653|FG001|Part 1|Protocol defined clinical event|0|||
44434894|NCT00537316|79443654|FG002|Part 1|Protocol defined clinical event|0|||
44434895|NCT00537316|79443655|FG003|Part 1|Protocol defined clinical event|0|||
44434896|NCT00537316|79443656|FG004|Part 1|Protocol defined clinical event|0|||
44434897|NCT00537316|79443657|FG005|Part 1|Protocol defined clinical event|0|||
44434898|NCT00537316|79443658|FG006|Part 1|Protocol defined clinical event|0|||
44434899|NCT00537316|79443652|FG000|Part 1|Lost to Follow-up|1|||
44434900|NCT00537316|79443653|FG001|Part 1|Lost to Follow-up|0|||
44434901|NCT00537316|79443654|FG002|Part 1|Lost to Follow-up|0|||
44434902|NCT00537316|79443655|FG003|Part 1|Lost to Follow-up|0|||
44434903|NCT00537316|79443656|FG004|Part 1|Lost to Follow-up|0|||
44434904|NCT00537316|79443657|FG005|Part 1|Lost to Follow-up|0|||
44434905|NCT00537316|79443658|FG006|Part 1|Lost to Follow-up|0|||
44434906|NCT00537316|79443652|FG000|Part 1|Withdrawal by Subject|3|||
44336400|NCT01283139|79341087|FG003|Overall Study|Death|2|||
44336401|NCT01283139|79341084|FG000|Overall Study|Lack of Efficacy|1|||
44336402|NCT01283139|79341085|FG001|Overall Study|Lack of Efficacy|2|||
44434907|NCT00537316|79443653|FG001|Part 1|Withdrawal by Subject|8|||
44434908|NCT00537316|79443654|FG002|Part 1|Withdrawal by Subject|4|||
44434909|NCT00537316|79443655|FG003|Part 1|Withdrawal by Subject|0|||
44434910|NCT00537316|79443656|FG004|Part 1|Withdrawal by Subject|0|||
44434911|NCT00537316|79443657|FG005|Part 1|Withdrawal by Subject|0|||
44434912|NCT00537316|79443658|FG006|Part 1|Withdrawal by Subject|0|||
44434913|NCT00537316|79443652|FG000|Part 1|Protocol Violation|1|||
44434914|NCT00537316|79443653|FG001|Part 1|Protocol Violation|5|||
44336403|NCT01283139|79341086|FG002|Overall Study|Lack of Efficacy|2|||
44336404|NCT01283139|79341087|FG003|Overall Study|Lack of Efficacy|1|||
44434915|NCT00537316|79443654|FG002|Part 1|Protocol Violation|1|||
44434916|NCT00537316|79443655|FG003|Part 1|Protocol Violation|0|||
44434917|NCT00537316|79443656|FG004|Part 1|Protocol Violation|0|||
44434918|NCT00537316|79443657|FG005|Part 1|Protocol Violation|0|||
44434919|NCT00537316|79443658|FG006|Part 1|Protocol Violation|0|||
44434920|NCT00537316|79443652|FG000|Part 1|Did not meet protocol eligibility|1|||
44434921|NCT00537316|79443653|FG001|Part 1|Did not meet protocol eligibility|3|||
44434922|NCT00537316|79443654|FG002|Part 1|Did not meet protocol eligibility|2|||
44336405|NCT01283139|79341084|FG000|Overall Study|Early termination due to AE/SAE|1|||
44434923|NCT00537316|79443655|FG003|Part 1|Did not meet protocol eligibility|0|||
44434924|NCT00537316|79443656|FG004|Part 1|Did not meet protocol eligibility|0|||
44434925|NCT00537316|79443657|FG005|Part 1|Did not meet protocol eligibility|0|||
44434926|NCT00537316|79443658|FG006|Part 1|Did not meet protocol eligibility|0|||
44434927|NCT00537316|79443652|FG000|Part 1|Administrative|0|||
44434928|NCT00537316|79443653|FG001|Part 1|Administrative|0|||
44434929|NCT00537316|79443654|FG002|Part 1|Administrative|2|||
44434930|NCT00537316|79443655|FG003|Part 1|Administrative|0|||
44434931|NCT00537316|79443656|FG004|Part 1|Administrative|0|||
44434932|NCT00537316|79443657|FG005|Part 1|Administrative|0|||
44434933|NCT00537316|79443658|FG006|Part 1|Administrative|0|||
44434934|NCT00537316|79443652|FG000|Part 2|Never entered follow-up|0|||
44336406|NCT01283139|79341085|FG001|Overall Study|Early termination due to AE/SAE|1|||
44336407|NCT01283139|79341086|FG002|Overall Study|Early termination due to AE/SAE|0|||
44434935|NCT00537316|79443653|FG001|Part 2|Never entered follow-up|0|||
44434936|NCT00537316|79443654|FG002|Part 2|Never entered follow-up|0|||
44434937|NCT00537316|79443655|FG003|Part 2|Never entered follow-up|0|||
44434938|NCT00537316|79443656|FG004|Part 2|Never entered follow-up|0|||
44434939|NCT00537316|79443657|FG005|Part 2|Never entered follow-up|0|||
44434940|NCT00537316|79443658|FG006|Part 2|Never entered follow-up|1|||
44434941|NCT00537316|79443652|FG000|Part 2|Adverse Event|4|||
44434942|NCT00537316|79443653|FG001|Part 2|Adverse Event|0|||
44434943|NCT00537316|79443654|FG002|Part 2|Adverse Event|2|||
44434944|NCT00537316|79443655|FG003|Part 2|Adverse Event|0|||
44434945|NCT00537316|79443656|FG004|Part 2|Adverse Event|0|||
44336408|NCT01283139|79341087|FG003|Overall Study|Early termination due to AE/SAE|0|||
44336409|NCT01283139|79341084|FG000|Overall Study|Participant's refusal to continue|0|||
44336410|NCT01283139|79341085|FG001|Overall Study|Participant's refusal to continue|3|||
44336411|NCT01283139|79341086|FG002|Overall Study|Participant's refusal to continue|1|||
44336412|NCT01283139|79341087|FG003|Overall Study|Participant's refusal to continue|1|||
44336413|NCT01283139|79341084|FG000|Overall Study|Pregnancy|0|||
44336414|NCT01283139|79341085|FG001|Overall Study|Pregnancy|1|||
44336415|NCT01283139|79341086|FG002|Overall Study|Pregnancy|1|||
44336416|NCT01283139|79341087|FG003|Overall Study|Pregnancy|0|||
44336417|NCT01283139|79341084|FG000|Overall Study|Missed follow-up visit|0|||
44336418|NCT01283139|79341085|FG001|Overall Study|Missed follow-up visit|1|||
44336419|NCT01283139|79341086|FG002|Overall Study|Missed follow-up visit|2|||
44336420|NCT01283139|79341087|FG003|Overall Study|Missed follow-up visit|2|||
44336421|NCT01283139|79341084|FG000|Overall Study|Participant randomized in error|0|||
44336422|NCT01283139|79341085|FG001|Overall Study|Participant randomized in error|0|||
44336423|NCT01283139|79341086|FG002|Overall Study|Participant randomized in error|1|||
44336424|NCT01283139|79341087|FG003|Overall Study|Participant randomized in error|0|||
44336425|NCT01282203|79341097|FG000|Overall Study|Adverse Event|1|||
44336426|NCT01281969|79341106|FG000|Overall Study|not randomized didn't meet criteria|0|||
44336427|NCT01281969|79341107|FG001|Overall Study|not randomized didn't meet criteria|0|||
44336428|NCT01281969|79341108|FG002|Overall Study|not randomized didn't meet criteria|7|||
44336429|NCT01281969|79341106|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
44336430|NCT01281969|79341107|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
44336431|NCT01281969|79341108|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
44336432|NCT01281969|79341106|FG000|Overall Study|not randomized, child consent not given|0|||
44336433|NCT01281969|79341107|FG001|Overall Study|not randomized, child consent not given|0|||
44336434|NCT01281969|79341108|FG002|Overall Study|not randomized, child consent not given|2|||
44336435|NCT01281813|79341119|FG000|Overall Study|Adverse Event|0|||
44336436|NCT01281813|79341120|FG001|Overall Study|Adverse Event|0|||
44336437|NCT01281813|79341121|FG002|Overall Study|Adverse Event|10|||
44336438|NCT01281813|79341119|FG000|Overall Study|Lost to Follow-up|0|||
44336439|NCT01281813|79341120|FG001|Overall Study|Lost to Follow-up|0|||
44336440|NCT01281813|79341121|FG002|Overall Study|Lost to Follow-up|31|||
44336441|NCT01281813|79341119|FG000|Overall Study|Withdrawal by Subject|0|||
44336442|NCT01281813|79341120|FG001|Overall Study|Withdrawal by Subject|0|||
44434946|NCT00537316|79443657|FG005|Part 2|Adverse Event|0|||
44434947|NCT00537316|79443658|FG006|Part 2|Adverse Event|0|||
44434948|NCT00537316|79443652|FG000|Part 2|Lost to Follow-up|1|||
44434949|NCT00537316|79443653|FG001|Part 2|Lost to Follow-up|0|||
44434950|NCT00537316|79443654|FG002|Part 2|Lost to Follow-up|2|||
44336443|NCT01281813|79341121|FG002|Overall Study|Withdrawal by Subject|13|||
44336444|NCT01281813|79341119|FG000|Overall Study|Subject Non-Compliant|0|||
44336445|NCT01281813|79341120|FG001|Overall Study|Subject Non-Compliant|0|||
44336446|NCT01281813|79341121|FG002|Overall Study|Subject Non-Compliant|6|||
44336447|NCT01281813|79341119|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
44336448|NCT01281813|79341120|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
44434951|NCT00537316|79443655|FG003|Part 2|Lost to Follow-up|0|||
44434952|NCT00537316|79443656|FG004|Part 2|Lost to Follow-up|0|||
44434953|NCT00537316|79443657|FG005|Part 2|Lost to Follow-up|0|||
44434954|NCT00537316|79443658|FG006|Part 2|Lost to Follow-up|0|||
44434955|NCT00537316|79443652|FG000|Part 2|Withdrawal by Subject|5|||
44434956|NCT00537316|79443653|FG001|Part 2|Withdrawal by Subject|1|||
44434957|NCT00537316|79443654|FG002|Part 2|Withdrawal by Subject|4|||
44434958|NCT00537316|79443655|FG003|Part 2|Withdrawal by Subject|0|||
44434959|NCT00537316|79443656|FG004|Part 2|Withdrawal by Subject|0|||
44434960|NCT00537316|79443657|FG005|Part 2|Withdrawal by Subject|0|||
44434961|NCT00537316|79443658|FG006|Part 2|Withdrawal by Subject|0|||
44434962|NCT00537316|79443652|FG000|Part 2|Administrative|16|||
44434963|NCT00537316|79443653|FG001|Part 2|Administrative|8|||
44434964|NCT00537316|79443654|FG002|Part 2|Administrative|24|||
44434965|NCT00537316|79443655|FG003|Part 2|Administrative|3|||
44434966|NCT00537316|79443656|FG004|Part 2|Administrative|1|||
44434967|NCT00537316|79443657|FG005|Part 2|Administrative|4|||
44434968|NCT00537316|79443658|FG006|Part 2|Administrative|1|||
44434969|NCT03827395|79443679|FG000|Overall Study|Lost to Follow-up|1|||
44434970|NCT03827395|79443680|FG001|Overall Study|Lost to Follow-up|0|||
44434971|NCT03827395|79443679|FG000|Overall Study|Protocol Violation|1|||
44434972|NCT03827395|79443680|FG001|Overall Study|Protocol Violation|0|||
44434973|NCT03827395|79443679|FG000|Overall Study|Became ineligible after enrollment|1|||
44434974|NCT03827395|79443680|FG001|Overall Study|Became ineligible after enrollment|2|||
44434975|NCT00655980|79443689|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
44336449|NCT01281813|79341121|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
44336450|NCT01281813|79341119|FG000|Overall Study|Sponsor's Decision|4|||
44336451|NCT01281813|79341120|FG001|Overall Study|Sponsor's Decision|3|||
44336452|NCT01281813|79341121|FG002|Overall Study|Sponsor's Decision|7|||
44434976|NCT00655980|79443690|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
44434977|NCT00655980|79443691|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
44434978|NCT00679172|79443707|FG000|Overall Study|Non-compliance|1|||
44434979|NCT00679172|79443708|FG001|Overall Study|Non-compliance|1|||
44434980|NCT00679172|79443709|FG002|Overall Study|Non-compliance|0|||
44434981|NCT00679172|79443710|FG003|Overall Study|Non-compliance|1|||
44434982|NCT00679172|79443711|FG004|Overall Study|Non-compliance|0|||
44434983|NCT00679172|79443707|FG000|Overall Study|Other not specified|0|||
44434984|NCT00679172|79443708|FG001|Overall Study|Other not specified|0|||
44434985|NCT00679172|79443709|FG002|Overall Study|Other not specified|1|||
44434986|NCT00679172|79443710|FG003|Overall Study|Other not specified|0|||
44157437|NCT03429543|78949154|FG001|Overall Study|Other reason than listed|1|||
44157438|NCT03429543|78949155|FG002|Overall Study|Other reason than listed|0|||
44157439|NCT03429543|78949156|FG003|Overall Study|Other reason than listed|0|||
44157440|NCT03429543|78949157|FG004|Overall Study|Other reason than listed|4|||
44157441|NCT03429543|78949158|FG005|Overall Study|Other reason than listed|4|||
44157442|NCT03429543|78949159|FG006|Overall Study|Other reason than listed|0|||
44157443|NCT03429543|78949153|FG000|Overall Study|Not treated|0|||
44157444|NCT03429543|78949154|FG001|Overall Study|Not treated|0|||
44157445|NCT03429543|78949155|FG002|Overall Study|Not treated|0|||
44157446|NCT03429543|78949156|FG003|Overall Study|Not treated|0|||
44157447|NCT03429543|78949157|FG004|Overall Study|Not treated|1|||
44157448|NCT03429543|78949158|FG005|Overall Study|Not treated|0|||
44157449|NCT03429543|78949159|FG006|Overall Study|Not treated|0|||
44157450|NCT03362190|78949189|FG000|Overall Study|Adverse Event|0|||
44157451|NCT03362190|78949190|FG001|Overall Study|Adverse Event|0|||
44157452|NCT03362190|78949191|FG002|Overall Study|Adverse Event|0|||
44157453|NCT03362190|78949192|FG003|Overall Study|Adverse Event|1|||
44157454|NCT03362190|78949189|FG000|Overall Study|Withdrawal by Subject|0|||
44157455|NCT03362190|78949190|FG001|Overall Study|Withdrawal by Subject|0|||
44157456|NCT03362190|78949191|FG002|Overall Study|Withdrawal by Subject|0|||
44157457|NCT03362190|78949192|FG003|Overall Study|Withdrawal by Subject|1|||
44157458|NCT03246061|78949207|FG000|Overall Study|Still in follow-up|15|||
44336453|NCT01281813|79341119|FG000|Overall Study|Switched to Commercially Available Medication|0|||
44336454|NCT01281813|79341120|FG001|Overall Study|Switched to Commercially Available Medication|0|||
44336455|NCT01281813|79341121|FG002|Overall Study|Switched to Commercially Available Medication|26|||
44336456|NCT01281813|79341119|FG000|Overall Study|Other|0|||
44336457|NCT01281813|79341120|FG001|Overall Study|Other|1|||
44336458|NCT01281813|79341121|FG002|Overall Study|Other|39|||
44336459|NCT01090414|79341133|FG000|Study 101-99|Progressive Disease|28|||
44336460|NCT01090414|79341134|FG001|Study 101-99|Progressive Disease|48|||
44336461|NCT01090414|79341135|FG002|Study 101-99|Progressive Disease|10|||
44434987|NCT00679172|79443711|FG004|Overall Study|Other not specified|0|||
44157459|NCT03246061|78949208|FG001|Overall Study|Still in follow-up|21|||
44157460|NCT02788006|78949246|FG000|Overall Study|Patient not treated|1|||
44434988|NCT00676130|79443728|FG000|Overall Study|Lost to Follow-up|0|||
44434989|NCT00676130|79443729|FG001|Overall Study|Lost to Follow-up|1|||
44434990|NCT00676130|79443728|FG000|Overall Study|Found ineligible|3|||
44336462|NCT01090414|79341136|FG003|Study 101-99|Progressive Disease|4|||
44434991|NCT00676130|79443729|FG001|Overall Study|Found ineligible|2|||
44434992|NCT00676130|79443728|FG000|Overall Study|Withdrawal by Subject|0|||
44434993|NCT00676130|79443729|FG001|Overall Study|Withdrawal by Subject|1|||
44434994|NCT00676052|79443741|FG000|Overall Study|Adverse Event|0|||
44434995|NCT00676052|79443742|FG001|Overall Study|Adverse Event|1|||
44434996|NCT00676052|79443743|FG002|Overall Study|Adverse Event|1|||
44434997|NCT00676052|79443744|FG003|Overall Study|Adverse Event|2|||
44434998|NCT00676052|79443745|FG004|Overall Study|Adverse Event|2|||
44336463|NCT01090414|79341133|FG000|Study 101-99|Adverse Event|10|||
44434999|NCT00676052|79443746|FG005|Overall Study|Adverse Event|2|||
44336464|NCT01090414|79341134|FG001|Study 101-99|Adverse Event|28|||
44336465|NCT01090414|79341135|FG002|Study 101-99|Adverse Event|18|||
44336466|NCT01090414|79341136|FG003|Study 101-99|Adverse Event|0|||
44336467|NCT01090414|79341133|FG000|Study 101-99|Investigator Request|1|||
44336468|NCT01090414|79341134|FG001|Study 101-99|Investigator Request|11|||
44336469|NCT01090414|79341135|FG002|Study 101-99|Investigator Request|4|||
44336470|NCT01090414|79341136|FG003|Study 101-99|Investigator Request|0|||
44435000|NCT00676052|79443741|FG000|Overall Study|Lack of Efficacy|2|||
44435001|NCT00676052|79443742|FG001|Overall Study|Lack of Efficacy|2|||
44435002|NCT00676052|79443743|FG002|Overall Study|Lack of Efficacy|1|||
44435003|NCT00676052|79443744|FG003|Overall Study|Lack of Efficacy|1|||
44435004|NCT00676052|79443745|FG004|Overall Study|Lack of Efficacy|2|||
44435005|NCT00676052|79443746|FG005|Overall Study|Lack of Efficacy|1|||
44435006|NCT00676052|79443741|FG000|Overall Study|Protocol Violation|5|||
44435007|NCT00676052|79443742|FG001|Overall Study|Protocol Violation|3|||
44435008|NCT00676052|79443743|FG002|Overall Study|Protocol Violation|2|||
44435009|NCT00676052|79443744|FG003|Overall Study|Protocol Violation|2|||
44435010|NCT00676052|79443745|FG004|Overall Study|Protocol Violation|1|||
44435011|NCT00676052|79443746|FG005|Overall Study|Protocol Violation|2|||
44435012|NCT00676052|79443741|FG000|Overall Study|Lost to Follow-up|0|||
44435013|NCT00676052|79443742|FG001|Overall Study|Lost to Follow-up|0|||
44539900|NCT00458003|79551465|FG000|Overall Study|Non protocol spinal anesthesia|1|||
44539901|NCT00458003|79551466|FG001|Overall Study|Non protocol spinal anesthesia|1|||
44539902|NCT02061293|79551476|FG000|Overall Study|Elevated Blood Pressure|1|||
44539903|NCT02061293|79551477|FG001|Overall Study|Elevated Blood Pressure|1|||
44539904|NCT02913612|79551487|FG000|Overall Study|Lost to Follow-up|6|||
44539905|NCT02913612|79551488|FG001|Overall Study|Lost to Follow-up|5|||
44539906|NCT02913612|79551489|FG002|Overall Study|Lost to Follow-up|2|||
44539907|NCT02913612|79551490|FG003|Overall Study|Lost to Follow-up|0|||
44539908|NCT02913612|79551487|FG000|Overall Study|Physician Decision|1|||
44539909|NCT02913612|79551488|FG001|Overall Study|Physician Decision|4|||
44539910|NCT02913612|79551489|FG002|Overall Study|Physician Decision|1|||
44539911|NCT02913612|79551490|FG003|Overall Study|Physician Decision|0|||
44539912|NCT02913612|79551487|FG000|Overall Study|Withdrawal by Subject|2|||
44539913|NCT02913612|79551488|FG001|Overall Study|Withdrawal by Subject|4|||
44539914|NCT02913612|79551489|FG002|Overall Study|Withdrawal by Subject|0|||
44539915|NCT02913612|79551490|FG003|Overall Study|Withdrawal by Subject|0|||
44539916|NCT02913612|79551487|FG000|Overall Study|Hemangioma resolved|1|||
44539917|NCT02913612|79551488|FG001|Overall Study|Hemangioma resolved|0|||
44539918|NCT02913612|79551489|FG002|Overall Study|Hemangioma resolved|0|||
44539919|NCT02913612|79551490|FG003|Overall Study|Hemangioma resolved|0|||
44539920|NCT02913612|79551487|FG000|Overall Study|Local IRB decision|1|||
44539921|NCT02913612|79551488|FG001|Overall Study|Local IRB decision|0|||
44539922|NCT02913612|79551489|FG002|Overall Study|Local IRB decision|0|||
44539923|NCT02913612|79551490|FG003|Overall Study|Local IRB decision|0|||
44539924|NCT02913612|79551487|FG000|Overall Study|Study drug non-compliance|1|||
44539925|NCT02913612|79551488|FG001|Overall Study|Study drug non-compliance|1|||
44539926|NCT02913612|79551489|FG002|Overall Study|Study drug non-compliance|0|||
44539927|NCT02913612|79551490|FG003|Overall Study|Study drug non-compliance|0|||
44539928|NCT02913612|79551487|FG000|Overall Study|Insurance issues|0|||
44157461|NCT02686658|78949257|FG000|Overall Study|Adverse Event|0|||
44259237|NCT00555321|79116724|FG004|Treatment Phase up to 12-months|Never treated|4|||
44259238|NCT00555321|79116720|FG000|Long-term Extension Phase|Adverse Event|2|||
44259239|NCT00555321|79116721|FG001|Long-term Extension Phase|Adverse Event|5|||
44259240|NCT00555321|79116722|FG002|Long-term Extension Phase|Adverse Event|2|||
44259241|NCT00555321|79116723|FG003|Long-term Extension Phase|Adverse Event|1|||
44259242|NCT00555321|79116724|FG004|Long-term Extension Phase|Adverse Event|0|||
44259243|NCT00555321|79116720|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
44259244|NCT00555321|79116721|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
44259245|NCT00555321|79116722|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
44259246|NCT00555321|79116723|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
44259247|NCT00555321|79116724|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
44259248|NCT00555321|79116720|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
44259249|NCT00555321|79116721|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
44336471|NCT01090414|79341133|FG000|Study 101-99|Death|3|||
44435014|NCT00676052|79443743|FG002|Overall Study|Lost to Follow-up|0|||
44435015|NCT00676052|79443744|FG003|Overall Study|Lost to Follow-up|0|||
44539929|NCT02913612|79551488|FG001|Overall Study|Insurance issues|1|||
44539930|NCT02913612|79551489|FG002|Overall Study|Insurance issues|0|||
44539931|NCT02913612|79551490|FG003|Overall Study|Insurance issues|0|||
44539932|NCT02913612|79551487|FG000|Overall Study|Needed to treat second hemangioma|0|||
44539933|NCT02913612|79551488|FG001|Overall Study|Needed to treat second hemangioma|1|||
44435016|NCT00676052|79443745|FG004|Overall Study|Lost to Follow-up|1|||
44435017|NCT00676052|79443746|FG005|Overall Study|Lost to Follow-up|0|||
44435018|NCT00676052|79443741|FG000|Overall Study|Physician Decision|1|||
44435019|NCT00676052|79443742|FG001|Overall Study|Physician Decision|1|||
44539934|NCT02913612|79551489|FG002|Overall Study|Needed to treat second hemangioma|0|||
44539935|NCT02913612|79551490|FG003|Overall Study|Needed to treat second hemangioma|0|||
44435020|NCT00676052|79443743|FG002|Overall Study|Physician Decision|1|||
44435021|NCT00676052|79443744|FG003|Overall Study|Physician Decision|0|||
44435022|NCT00676052|79443745|FG004|Overall Study|Physician Decision|0|||
44435023|NCT00676052|79443746|FG005|Overall Study|Physician Decision|1|||
44435024|NCT00676052|79443741|FG000|Overall Study|Withdrawal by Subject|1|||
44435025|NCT00676052|79443742|FG001|Overall Study|Withdrawal by Subject|0|||
44435026|NCT00676052|79443743|FG002|Overall Study|Withdrawal by Subject|1|||
44435027|NCT00676052|79443744|FG003|Overall Study|Withdrawal by Subject|0|||
44435028|NCT00676052|79443745|FG004|Overall Study|Withdrawal by Subject|0|||
44435029|NCT00676052|79443746|FG005|Overall Study|Withdrawal by Subject|0|||
44435030|NCT00535288|79443765|FG000|Overall Study|Adverse Event|20|||
44539936|NCT02913612|79551487|FG000|Overall Study|Study completion criteria not met|0|||
44539937|NCT02913612|79551488|FG001|Overall Study|Study completion criteria not met|1|||
44539938|NCT02913612|79551489|FG002|Overall Study|Study completion criteria not met|0|||
44539939|NCT02913612|79551490|FG003|Overall Study|Study completion criteria not met|0|||
44157462|NCT02686658|78949258|FG001|Overall Study|Adverse Event|0|||
44157463|NCT02686658|78949259|FG002|Overall Study|Adverse Event|1|||
44157464|NCT02686658|78949260|FG003|Overall Study|Adverse Event|1|||
44157465|NCT02686658|78949261|FG004|Overall Study|Adverse Event|2|||
44157466|NCT02686658|78949262|FG005|Overall Study|Adverse Event|1|||
44157467|NCT02686658|78949257|FG000|Overall Study|Investigator decision|0|||
44157468|NCT02686658|78949258|FG001|Overall Study|Investigator decision|0|||
44157469|NCT02686658|78949259|FG002|Overall Study|Investigator decision|0|||
44157470|NCT02686658|78949260|FG003|Overall Study|Investigator decision|1|||
44157471|NCT02686658|78949261|FG004|Overall Study|Investigator decision|2|||
44157472|NCT02686658|78949262|FG005|Overall Study|Investigator decision|1|||
44157473|NCT02686658|78949257|FG000|Overall Study|Sponsor decision|1|||
44157474|NCT02686658|78949258|FG001|Overall Study|Sponsor decision|2|||
44157475|NCT02686658|78949259|FG002|Overall Study|Sponsor decision|1|||
44157476|NCT02686658|78949260|FG003|Overall Study|Sponsor decision|5|||
44336472|NCT01090414|79341134|FG001|Study 101-99|Death|8|||
44336473|NCT01090414|79341135|FG002|Study 101-99|Death|1|||
44336474|NCT01090414|79341136|FG003|Study 101-99|Death|0|||
44336475|NCT01090414|79341133|FG000|Study 101-99|Sponsor Discontinued Study|0|||
44336476|NCT01090414|79341134|FG001|Study 101-99|Sponsor Discontinued Study|7|||
44336477|NCT01090414|79341135|FG002|Study 101-99|Sponsor Discontinued Study|5|||
44539940|NCT02913612|79551487|FG000|Overall Study|Ineligible|0|||
44539941|NCT02913612|79551488|FG001|Overall Study|Ineligible|1|||
44539942|NCT02913612|79551489|FG002|Overall Study|Ineligible|0|||
44539943|NCT02913612|79551490|FG003|Overall Study|Ineligible|0|||
44539944|NCT03323736|79551502|FG000|Overall Study|Screen Failure|14|||
44539945|NCT03323736|79551503|FG001|Overall Study|Screen Failure|9|||
44539946|NCT03323736|79551504|FG002|Overall Study|Screen Failure|1|||
44336478|NCT01090414|79341136|FG003|Study 101-99|Sponsor Discontinued Study|0|||
44336479|NCT01090414|79341133|FG000|Study 101-99|Other (Unknown Reasons)|3|||
44336480|NCT01090414|79341134|FG001|Study 101-99|Other (Unknown Reasons)|3|||
44336481|NCT01090414|79341135|FG002|Study 101-99|Other (Unknown Reasons)|0|||
44336482|NCT01090414|79341136|FG003|Study 101-99|Other (Unknown Reasons)|0|||
44336483|NCT01090414|79341133|FG000|Study 101-99|Withdrew Consent|0|||
44336484|NCT01090414|79341134|FG001|Study 101-99|Withdrew Consent|2|||
44336485|NCT01090414|79341135|FG002|Study 101-99|Withdrew Consent|3|||
44336486|NCT01090414|79341136|FG003|Study 101-99|Withdrew Consent|1|||
44336487|NCT01090414|79341133|FG000|Study 101-99|Participant Request|3|||
44336488|NCT01090414|79341134|FG001|Study 101-99|Participant Request|1|||
44336489|NCT01090414|79341135|FG002|Study 101-99|Participant Request|0|||
44336490|NCT01090414|79341136|FG003|Study 101-99|Participant Request|0|||
44157477|NCT02686658|78949261|FG004|Overall Study|Sponsor decision|13|||
44157478|NCT02686658|78949262|FG005|Overall Study|Sponsor decision|2|||
44157479|NCT02686658|78949257|FG000|Overall Study|Lost to Follow-up|0|||
44157480|NCT02686658|78949258|FG001|Overall Study|Lost to Follow-up|0|||
44157481|NCT02686658|78949259|FG002|Overall Study|Lost to Follow-up|2|||
44157482|NCT02686658|78949260|FG003|Overall Study|Lost to Follow-up|0|||
44157483|NCT02686658|78949261|FG004|Overall Study|Lost to Follow-up|0|||
44336491|NCT01090102|79341160|FG000|First 12 Weeks|Withdrawal by Subject|1|||
44539947|NCT03323736|79551502|FG000|Overall Study|Withdrawal Before Treatment|3|||
44539948|NCT03323736|79551503|FG001|Overall Study|Withdrawal Before Treatment|1|||
44157484|NCT02686658|78949262|FG005|Overall Study|Lost to Follow-up|1|||
44336492|NCT01090102|79341161|FG001|First 12 Weeks|Withdrawal by Subject|1|||
44336493|NCT01090102|79341160|FG000|First 12 Weeks|Adverse Event|2|||
44336494|NCT01090102|79341161|FG001|First 12 Weeks|Adverse Event|0|||
44336495|NCT01090102|79341160|FG000|First 12 Weeks|Death|1|||
44336496|NCT01090102|79341161|FG001|First 12 Weeks|Death|1|||
44336497|NCT01090102|79341160|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
44336498|NCT01090102|79341161|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
44435031|NCT00535288|79443766|FG001|Overall Study|Adverse Event|19|||
44435032|NCT00535288|79443767|FG002|Overall Study|Adverse Event|25|||
44539949|NCT03323736|79551504|FG002|Overall Study|Withdrawal Before Treatment|1|||
44157485|NCT02686658|78949257|FG000|Overall Study|Death|1|||
44336499|NCT01287897|79341171|FG000|Overall Study|Adverse Event|5|||
44336500|NCT01287897|79341172|FG001|Overall Study|Adverse Event|3|||
44336501|NCT01287897|79341173|FG002|Overall Study|Adverse Event|6|||
44336502|NCT01287897|79341174|FG003|Overall Study|Adverse Event|4|||
44336503|NCT01287897|79341171|FG000|Overall Study|Lack of Efficacy|2|||
44336504|NCT01287897|79341172|FG001|Overall Study|Lack of Efficacy|0|||
44336505|NCT01287897|79341173|FG002|Overall Study|Lack of Efficacy|0|||
44336506|NCT01287897|79341174|FG003|Overall Study|Lack of Efficacy|0|||
44336507|NCT01287897|79341171|FG000|Overall Study|Protocol Violation|1|||
44336508|NCT01287897|79341172|FG001|Overall Study|Protocol Violation|1|||
44435033|NCT00535288|79443768|FG003|Overall Study|Adverse Event|20|||
44435034|NCT00535288|79443769|FG004|Overall Study|Adverse Event|30|||
44435035|NCT00535288|79443765|FG000|Overall Study|Lost to Follow-up|0|||
44435036|NCT00535288|79443766|FG001|Overall Study|Lost to Follow-up|3|||
44435037|NCT00535288|79443767|FG002|Overall Study|Lost to Follow-up|0|||
44435038|NCT00535288|79443768|FG003|Overall Study|Lost to Follow-up|0|||
44435039|NCT00535288|79443769|FG004|Overall Study|Lost to Follow-up|0|||
44435040|NCT00535288|79443765|FG000|Overall Study|Lack of Efficacy|26|||
44435041|NCT00535288|79443766|FG001|Overall Study|Lack of Efficacy|3|||
44435042|NCT00535288|79443767|FG002|Overall Study|Lack of Efficacy|4|||
44336509|NCT01287897|79341173|FG002|Overall Study|Protocol Violation|0|||
44435043|NCT00535288|79443768|FG003|Overall Study|Lack of Efficacy|4|||
44435044|NCT00535288|79443769|FG004|Overall Study|Lack of Efficacy|7|||
44435045|NCT00535288|79443765|FG000|Overall Study|Unwilling to cooperate|6|||
44435046|NCT00535288|79443766|FG001|Overall Study|Unwilling to cooperate|6|||
44435047|NCT00535288|79443767|FG002|Overall Study|Unwilling to cooperate|3|||
44435048|NCT00535288|79443768|FG003|Overall Study|Unwilling to cooperate|3|||
44435049|NCT00535288|79443769|FG004|Overall Study|Unwilling to cooperate|4|||
44435050|NCT00535288|79443765|FG000|Overall Study|Other|2|||
44435051|NCT00535288|79443766|FG001|Overall Study|Other|1|||
44435052|NCT00535288|79443767|FG002|Overall Study|Other|1|||
44435053|NCT00535288|79443768|FG003|Overall Study|Other|2|||
44435054|NCT00535288|79443769|FG004|Overall Study|Other|1|||
44435055|NCT03904420|79443788|FG000|Overall Study|Study terminated|2|||
44435056|NCT03904420|79443789|FG001|Overall Study|Study terminated|2|||
44435057|NCT00675506|79443797|FG000|Overall Study|Lost to Follow-up|1|||
44435058|NCT00675506|79443798|FG001|Overall Study|Lost to Follow-up|5|||
44435059|NCT00675506|79443797|FG000|Overall Study|Lost interest|3|||
44435060|NCT00675506|79443798|FG001|Overall Study|Lost interest|5|||
44435061|NCT00675506|79443797|FG000|Overall Study|Elevated fasting glucose|2|||
44435062|NCT00675506|79443798|FG001|Overall Study|Elevated fasting glucose|1|||
44435063|NCT00675506|79443797|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
44435064|NCT00675506|79443798|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
44435065|NCT00675506|79443797|FG000|Overall Study|Elevated IGF-1|2|||
44435066|NCT00675506|79443798|FG001|Overall Study|Elevated IGF-1|0|||
44435067|NCT00675506|79443797|FG000|Overall Study|Hypersensitivity Reaction|1|||
44435068|NCT00675506|79443798|FG001|Overall Study|Hypersensitivity Reaction|0|||
44539950|NCT03323736|79551502|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
44539951|NCT03323736|79551503|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
44539952|NCT03323736|79551504|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
44539953|NCT03311841|79551519|FG000|14-day Wash-out|Adverse Event|0|||
44539954|NCT03311841|79551520|FG001|14-day Wash-out|Adverse Event|1|||
44539955|NCT03311841|79551521|FG002|14-day Wash-out|Adverse Event|0|||
44539956|NCT03311841|79551522|FG003|14-day Wash-out|Adverse Event|0|||
44539957|NCT03311841|79551523|FG004|14-day Wash-out|Adverse Event|0|||
44539958|NCT03311841|79551519|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
44539959|NCT03311841|79551520|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
44539960|NCT03311841|79551521|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
44259250|NCT00555321|79116722|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
44259251|NCT00555321|79116723|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
44259252|NCT00555321|79116724|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
44259253|NCT00555321|79116720|FG000|Long-term Extension Phase|Death|2|||
44259254|NCT00555321|79116721|FG001|Long-term Extension Phase|Death|0|||
44259255|NCT00555321|79116722|FG002|Long-term Extension Phase|Death|0|||
44259256|NCT00555321|79116723|FG003|Long-term Extension Phase|Death|3|||
44259257|NCT00555321|79116724|FG004|Long-term Extension Phase|Death|0|||
44259258|NCT00555321|79116720|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
44259259|NCT00555321|79116721|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
44259260|NCT00555321|79116722|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
44259261|NCT00555321|79116723|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
44336510|NCT01287897|79341174|FG003|Overall Study|Protocol Violation|1|||
44336511|NCT01287897|79341171|FG000|Overall Study|Lost to Follow-up|0|||
44435069|NCT00675506|79443797|FG000|Overall Study|Disclosed history of cancer|1|||
44435070|NCT00675506|79443798|FG001|Overall Study|Disclosed history of cancer|0|||
44435071|NCT00675506|79443797|FG000|Overall Study|Declined participation|1|||
44435072|NCT00675506|79443798|FG001|Overall Study|Declined participation|0|||
44435073|NCT00675506|79443797|FG000|Overall Study|Schedule conflict|0|||
44539961|NCT03311841|79551522|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
44435074|NCT00675506|79443798|FG001|Overall Study|Schedule conflict|1|||
44435075|NCT03895840|79443805|FG000|Overall Study|Withdrawal by Subject|21|||
44435076|NCT00310375|79443811|FG000|Primary Reporting Phase|Adverse Event|28|||
44435077|NCT00310375|79443812|FG001|Primary Reporting Phase|Adverse Event|22|||
44435078|NCT00310375|79443813|FG002|Primary Reporting Phase|Adverse Event|0|||
44435079|NCT00310375|79443811|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
44435080|NCT00310375|79443812|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
44435081|NCT00310375|79443813|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
44435082|NCT00310375|79443811|FG000|Primary Reporting Phase|Pregnancy|2|||
44435083|NCT00310375|79443812|FG001|Primary Reporting Phase|Pregnancy|2|||
44435084|NCT00310375|79443813|FG002|Primary Reporting Phase|Pregnancy|0|||
44435085|NCT00310375|79443811|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
44435086|NCT00310375|79443812|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
44435087|NCT00310375|79443813|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
44435088|NCT00310375|79443811|FG000|Primary Reporting Phase|Protocol Violation|8|||
44435089|NCT00310375|79443812|FG001|Primary Reporting Phase|Protocol Violation|5|||
44435090|NCT00310375|79443813|FG002|Primary Reporting Phase|Protocol Violation|0|||
44435091|NCT00310375|79443811|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
44435092|NCT00310375|79443812|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
44435093|NCT00310375|79443813|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
44435094|NCT00310375|79443811|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
44435095|NCT00310375|79443812|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
44435096|NCT00310375|79443813|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
44435097|NCT00310375|79443811|FG000|Primary Reporting Phase|Physician Decision|5|||
44435098|NCT00310375|79443812|FG001|Primary Reporting Phase|Physician Decision|3|||
44435099|NCT00310375|79443813|FG002|Primary Reporting Phase|Physician Decision|0|||
44435100|NCT00310375|79443811|FG000|Primary Reporting Phase|Request of the sponsor|2|||
44539962|NCT03311841|79551523|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
44539963|NCT03311373|79551556|FG000|Overall Study|Adverse Event|1|||
44539964|NCT03311373|79551556|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
44539965|NCT03311373|79551556|FG000|Overall Study|Lost to Follow-up|1|||
44539966|NCT03311373|79551556|FG000|Overall Study|Physician Decision|1|||
44539967|NCT03311373|79551556|FG000|Overall Study|Withdrawal by Subject|3|||
44539968|NCT01155375|79551568|FG000|Overall Study|Adverse Event|1|||
44539969|NCT01155375|79551569|FG001|Overall Study|Adverse Event|0|||
44539970|NCT00628095|79551587|FG000|Overall Study|Adverse Event|5|||
44539971|NCT00628095|79551588|FG001|Overall Study|Adverse Event|3|||
44539972|NCT00628095|79551587|FG000|Overall Study|Lack of Efficacy|0|||
44539973|NCT00628095|79551588|FG001|Overall Study|Lack of Efficacy|3|||
44539974|NCT00628095|79551587|FG000|Overall Study|Withdrawal by Subject|2|||
44539975|NCT00628095|79551588|FG001|Overall Study|Withdrawal by Subject|0|||
44539976|NCT00628095|79551587|FG000|Overall Study|Other|0|||
44539977|NCT00628095|79551588|FG001|Overall Study|Other|1|||
44539978|NCT02889861|79551596|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
44539979|NCT03325881|79551607|FG000|Overall Study|Protocol Violation|0|||
44539980|NCT03325881|79551608|FG001|Overall Study|Protocol Violation|1|||
44539981|NCT03325881|79551607|FG000|Overall Study|Withdrawal by Subject|0|||
44539982|NCT03325881|79551608|FG001|Overall Study|Withdrawal by Subject|2|||
44539983|NCT03325881|79551607|FG000|Overall Study|Lack of Efficacy|2|||
44539984|NCT03325881|79551608|FG001|Overall Study|Lack of Efficacy|0|||
44539985|NCT03325881|79551607|FG000|Overall Study|Not treated|1|||
44539986|NCT03325881|79551608|FG001|Overall Study|Not treated|0|||
44539987|NCT02887989|79551618|FG000|Overall Study|Withdrawal by Subject|8|||
44539988|NCT02887989|79551619|FG001|Overall Study|Withdrawal by Subject|11|||
44539989|NCT02887989|79551618|FG000|Overall Study|Death|1|||
44539990|NCT02887989|79551619|FG001|Overall Study|Death|0|||
44539991|NCT02887521|79551627|FG000|Overall Study|Withdrawal by Subject|0|||
44539992|NCT02887521|79551628|FG001|Overall Study|Withdrawal by Subject|3|||
44539993|NCT03305055|79551636|FG000|Overall Study|Withdrawal by Subject|0|||
44539994|NCT03305055|79551637|FG001|Overall Study|Withdrawal by Subject|1|||
44539995|NCT03305055|79551636|FG000|Overall Study|Adverse Event|1|||
44539996|NCT03305055|79551637|FG001|Overall Study|Adverse Event|1|||
44539997|NCT02763189|79551645|FG000|Overall Study|Device failure|0|||
44435101|NCT00310375|79443812|FG001|Primary Reporting Phase|Request of the sponsor|2|||
44435102|NCT00310375|79443813|FG002|Primary Reporting Phase|Request of the sponsor|0|||
44435103|NCT00310375|79443811|FG000|Primary Reporting Phase|Failed to return|1|||
44539998|NCT02763189|79551646|FG001|Overall Study|Device failure|2|||
44539999|NCT03273387|79551654|FG000|Overall Study|Death|2|||
44435104|NCT00310375|79443812|FG001|Primary Reporting Phase|Failed to return|3|||
44540000|NCT03273387|79551655|FG001|Overall Study|Death|2|||
44540001|NCT03273387|79551654|FG000|Overall Study|Withdrawal by Subject|1|||
44540002|NCT03273387|79551655|FG001|Overall Study|Withdrawal by Subject|1|||
44540003|NCT01328080|79551661|FG000|Overall Study|Lost to Follow-up|5|||
44540004|NCT02649946|79551680|FG000|Overall Study|Withdrawal by Subject|1|||
44540005|NCT02649946|79551681|FG001|Overall Study|Withdrawal by Subject|1|||
44540006|NCT02649946|79551680|FG000|Overall Study|Death|7|||
44435105|NCT00310375|79443813|FG002|Primary Reporting Phase|Failed to return|0|||
44435106|NCT00310375|79443811|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
44435107|NCT00310375|79443812|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
44435108|NCT00310375|79443813|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
44435109|NCT00310375|79443811|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
44435110|NCT00310375|79443812|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
44435111|NCT00310375|79443813|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
44435112|NCT00310375|79443811|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
44435113|NCT00310375|79443812|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
44435114|NCT00310375|79443813|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
44435115|NCT00310375|79443811|FG000|Primary Reporting Phase|Site closure|3|||
44540007|NCT02649946|79551681|FG001|Overall Study|Death|9|||
44540008|NCT02649946|79551680|FG000|Overall Study|Physician Decision|1|||
44540009|NCT02649946|79551681|FG001|Overall Study|Physician Decision|0|||
44540010|NCT02649946|79551680|FG000|Overall Study|Lost to Follow-up|2|||
44540011|NCT02649946|79551681|FG001|Overall Study|Lost to Follow-up|1|||
44540012|NCT02649946|79551680|FG000|Overall Study|Erroneously enrolled|1|||
44540013|NCT02649946|79551681|FG001|Overall Study|Erroneously enrolled|0|||
44540014|NCT02649946|79551680|FG000|Overall Study|Missed 6-month follow-up visit|0|||
44540015|NCT02649946|79551681|FG001|Overall Study|Missed 6-month follow-up visit|4|||
44540016|NCT03273153|79551689|FG000|Overall Study|Adverse Event|1|||
44540017|NCT03273153|79551690|FG001|Overall Study|Adverse Event|2|||
44540018|NCT03273153|79551689|FG000|Overall Study|Missing|0|||
44540019|NCT03273153|79551690|FG001|Overall Study|Missing|2|||
44540020|NCT03273153|79551689|FG000|Overall Study|Other|3|||
44540021|NCT03273153|79551690|FG001|Overall Study|Other|2|||
44540022|NCT03273153|79551689|FG000|Overall Study|Symptomatic Deterioration|0|||
44540023|NCT03273153|79551690|FG001|Overall Study|Symptomatic Deterioration|1|||
44540024|NCT03273153|79551689|FG000|Overall Study|Progressive Disease|6|||
44540025|NCT03273153|79551690|FG001|Overall Study|Progressive Disease|5|||
44540026|NCT03273153|79551689|FG000|Overall Study|Physician Decision|1|||
44540027|NCT03273153|79551690|FG001|Overall Study|Physician Decision|3|||
44540028|NCT03273153|79551689|FG000|Overall Study|Study Terminated by Sponsor|112|||
44540029|NCT03273153|79551690|FG001|Overall Study|Study Terminated by Sponsor|102|||
44540030|NCT03273153|79551689|FG000|Overall Study|Withdrawal by Subject|26|||
44540031|NCT03273153|79551690|FG001|Overall Study|Withdrawal by Subject|25|||
44540032|NCT03273153|79551689|FG000|Overall Study|Protocol Deviation|3|||
44540033|NCT03273153|79551690|FG001|Overall Study|Protocol Deviation|0|||
44540034|NCT03273153|79551689|FG000|Overall Study|Lost to Follow-up|6|||
44540035|NCT03273153|79551690|FG001|Overall Study|Lost to Follow-up|11|||
44540036|NCT03273153|79551689|FG000|Overall Study|Death|66|||
44540037|NCT03273153|79551690|FG001|Overall Study|Death|69|||
44540038|NCT03270657|79551715|FG000|Overall Study|Withdrawal by Subject|1|||
44540039|NCT03303417|79551719|FG000|Overall Study|Withdrawal by Subject|1|||
44540040|NCT03303417|79551720|FG001|Overall Study|Withdrawal by Subject|1|||
44540041|NCT02943564|79551738|FG000|Overall Study|Miscellaneous Reasons|0|||
44540042|NCT02943564|79551739|FG001|Overall Study|Miscellaneous Reasons|0|||
44540043|NCT02943564|79551740|FG002|Overall Study|Miscellaneous Reasons|3|||
44540044|NCT02943564|79551738|FG000|Overall Study|Site terminated by sponsor|0|||
44540045|NCT02943564|79551739|FG001|Overall Study|Site terminated by sponsor|1|||
44540046|NCT02943564|79551740|FG002|Overall Study|Site terminated by sponsor|0|||
44540047|NCT02943564|79551738|FG000|Overall Study|Non-compliance with study drug|0|||
44435116|NCT00310375|79443812|FG001|Primary Reporting Phase|Site closure|0|||
44435117|NCT00310375|79443813|FG002|Primary Reporting Phase|Site closure|0|||
44435118|NCT00310375|79443811|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
44435119|NCT00310375|79443812|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
44435120|NCT00310375|79443813|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
44435121|NCT00310375|79443811|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
44435122|NCT00310375|79443812|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
44540048|NCT02943564|79551739|FG001|Overall Study|Non-compliance with study drug|1|||
44540049|NCT02943564|79551740|FG002|Overall Study|Non-compliance with study drug|0|||
44157486|NCT02686658|78949258|FG001|Overall Study|Death|0|||
44435123|NCT00310375|79443813|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
44540050|NCT02943564|79551738|FG000|Overall Study|Pregnancy|0|||
44540051|NCT02943564|79551739|FG001|Overall Study|Pregnancy|1|||
44540052|NCT02943564|79551740|FG002|Overall Study|Pregnancy|1|||
44157487|NCT02686658|78949259|FG002|Overall Study|Death|0|||
44540053|NCT02943564|79551738|FG000|Overall Study|Protocol Violation|2|||
44540054|NCT02943564|79551739|FG001|Overall Study|Protocol Violation|2|||
44540055|NCT02943564|79551740|FG002|Overall Study|Protocol Violation|2|||
44540056|NCT02943564|79551738|FG000|Overall Study|Lost to Follow-up|1|||
44540057|NCT02943564|79551739|FG001|Overall Study|Lost to Follow-up|0|||
44540058|NCT02943564|79551740|FG002|Overall Study|Lost to Follow-up|0|||
44540059|NCT02943564|79551738|FG000|Overall Study|Withdrawal by Subject|6|||
44540060|NCT02943564|79551739|FG001|Overall Study|Withdrawal by Subject|5|||
44435124|NCT00310375|79443811|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
44435125|NCT00310375|79443812|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
44435126|NCT00310375|79443813|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
44435127|NCT00310375|79443811|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
44435128|NCT00310375|79443812|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
44435129|NCT00310375|79443813|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
44435130|NCT00309907|79443822|FG000|Overall Study|Death|4|||
44435131|NCT00309907|79443822|FG000|Overall Study|Physician Decision|1|||
44435132|NCT00309907|79443822|FG000|Overall Study|Ineligible|11|||
44435133|NCT00309907|79443822|FG000|Overall Study|Major infectious event|4|||
44435134|NCT00655824|79443827|FG000|Overall Study|Adverse Event|3|||
44435135|NCT00655824|79443827|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
44435136|NCT00655824|79443827|FG000|Overall Study|Protocol Violation|1|||
44435137|NCT00655824|79443827|FG000|Overall Study|Withdrawal by Subject|4|||
44435138|NCT00655824|79443827|FG000|Overall Study|Deterioration of Trial Disease|2|||
44435139|NCT00575588|79443833|FG000|Overall Study|Adverse Event|11|||
44435140|NCT00575588|79443834|FG001|Overall Study|Adverse Event|13|||
44435141|NCT00575588|79443833|FG000|Overall Study|Withdrawal by Subject|27|||
44435142|NCT00575588|79443834|FG001|Overall Study|Withdrawal by Subject|31|||
44435143|NCT00575588|79443833|FG000|Overall Study|Lost to Follow-up|1|||
44435144|NCT00575588|79443834|FG001|Overall Study|Lost to Follow-up|3|||
44435145|NCT00575588|79443833|FG000|Overall Study|Death|4|||
44435146|NCT00575588|79443834|FG001|Overall Study|Death|2|||
44435147|NCT00575588|79443833|FG000|Overall Study|Incorrect enrollment|8|||
44435148|NCT00575588|79443834|FG001|Overall Study|Incorrect enrollment|4|||
44435149|NCT00575588|79443833|FG000|Overall Study|Study specific discontinuation criteria|203|||
44435150|NCT00575588|79443834|FG001|Overall Study|Study specific discontinuation criteria|218|||
44435151|NCT00575588|79443833|FG000|Overall Study|Severe non-compliance to protocol|5|||
44435152|NCT00575588|79443834|FG001|Overall Study|Severe non-compliance to protocol|7|||
44435153|NCT00575588|79443833|FG000|Overall Study|Safety reasons|2|||
44435154|NCT00575588|79443834|FG001|Overall Study|Safety reasons|1|||
44435155|NCT00575588|79443833|FG000|Overall Study|Elevated triglyceride|1|||
44435156|NCT00575588|79443834|FG001|Overall Study|Elevated triglyceride|0|||
44435157|NCT00575588|79443833|FG000|Overall Study|Patient moved|1|||
44435158|NCT00575588|79443834|FG001|Overall Study|Patient moved|3|||
44435159|NCT00575588|79443833|FG000|Overall Study|Impossible to determine HbA1c|0|||
44435160|NCT00575588|79443834|FG001|Overall Study|Impossible to determine HbA1c|1|||
44435161|NCT00675428|79443842|FG000|Overall Study|Disease Progression|2|||
44435162|NCT00675428|79443843|FG001|Overall Study|Disease Progression|2|||
44435163|NCT00675428|79443842|FG000|Overall Study|No Disease Response After Cycle 6|0|||
44435164|NCT00675428|79443843|FG001|Overall Study|No Disease Response After Cycle 6|1|||
44435165|NCT00675428|79443842|FG000|Overall Study|Physician Decision|1|||
44435166|NCT00675428|79443843|FG001|Overall Study|Physician Decision|0|||
44435167|NCT00557505|79443867|FG000|Overall Study|Death|0|||
44435168|NCT00557505|79443868|FG001|Overall Study|Death|0|||
44435169|NCT00557505|79443869|FG002|Overall Study|Death|0|||
44435170|NCT00557505|79443870|FG003|Overall Study|Death|0|||
44336512|NCT01287897|79341172|FG001|Overall Study|Lost to Follow-up|0|||
44336513|NCT01287897|79341173|FG002|Overall Study|Lost to Follow-up|2|||
44336514|NCT01287897|79341174|FG003|Overall Study|Lost to Follow-up|0|||
44336515|NCT01287897|79341171|FG000|Overall Study|Withdrawal by Subject|1|||
44336516|NCT01287897|79341172|FG001|Overall Study|Withdrawal by Subject|5|||
44336517|NCT01287897|79341173|FG002|Overall Study|Withdrawal by Subject|3|||
44336518|NCT01287897|79341174|FG003|Overall Study|Withdrawal by Subject|2|||
44336519|NCT01287897|79341171|FG000|Overall Study|Not consented properly|0|||
44435171|NCT00557505|79443871|FG004|Overall Study|Death|0|||
44435172|NCT00557505|79443872|FG005|Overall Study|Death|0|||
44435173|NCT00557505|79443873|FG006|Overall Study|Death|0|||
44435174|NCT00557505|79443874|FG007|Overall Study|Death|0|||
44435175|NCT00557505|79443875|FG008|Overall Study|Death|1|||
44435176|NCT00557505|79443867|FG000|Overall Study|Adverse Event|0|||
44435177|NCT00557505|79443868|FG001|Overall Study|Adverse Event|0|||
44435178|NCT00557505|79443869|FG002|Overall Study|Adverse Event|1|||
44435179|NCT00557505|79443870|FG003|Overall Study|Adverse Event|0|||
44435180|NCT00557505|79443871|FG004|Overall Study|Adverse Event|0|||
44435181|NCT00557505|79443872|FG005|Overall Study|Adverse Event|0|||
44336520|NCT01287897|79341172|FG001|Overall Study|Not consented properly|1|||
44435182|NCT00557505|79443873|FG006|Overall Study|Adverse Event|1|||
44435183|NCT00557505|79443874|FG007|Overall Study|Adverse Event|0|||
44435184|NCT00557505|79443875|FG008|Overall Study|Adverse Event|0|||
44336521|NCT01287897|79341173|FG002|Overall Study|Not consented properly|0|||
44435185|NCT00557505|79443867|FG000|Overall Study|Global deterioration of health|1|||
44435186|NCT00557505|79443868|FG001|Overall Study|Global deterioration of health|0|||
44435187|NCT00557505|79443869|FG002|Overall Study|Global deterioration of health|0|||
44435188|NCT00557505|79443870|FG003|Overall Study|Global deterioration of health|0|||
44435189|NCT00557505|79443871|FG004|Overall Study|Global deterioration of health|0|||
44435190|NCT00557505|79443872|FG005|Overall Study|Global deterioration of health|0|||
44336522|NCT01287897|79341174|FG003|Overall Study|Not consented properly|0|||
44336523|NCT01287897|79341171|FG000|Overall Study|Not meeting entrance criteria|1|||
44336524|NCT01287897|79341172|FG001|Overall Study|Not meeting entrance criteria|1|||
44336525|NCT01287897|79341173|FG002|Overall Study|Not meeting entrance criteria|0|||
44336526|NCT01287897|79341174|FG003|Overall Study|Not meeting entrance criteria|0|||
44336527|NCT01287897|79341171|FG000|Overall Study|Other|1|||
44336528|NCT01287897|79341172|FG001|Overall Study|Other|0|||
44336529|NCT01287897|79341173|FG002|Overall Study|Other|1|||
44336530|NCT01287897|79341174|FG003|Overall Study|Other|0|||
44336531|NCT01090024|79341188|FG000|Period 1|Met exclusion criteria|0|||
44336532|NCT01090024|79341189|FG001|Period 1|Met exclusion criteria|0|||
44336533|NCT01090024|79341190|FG002|Period 1|Met exclusion criteria|0|||
44336534|NCT01090024|79341191|FG003|Period 1|Met exclusion criteria|0|||
44435191|NCT00557505|79443873|FG006|Overall Study|Global deterioration of health|0|||
44435192|NCT00557505|79443874|FG007|Overall Study|Global deterioration of health|0|||
44435193|NCT00557505|79443875|FG008|Overall Study|Global deterioration of health|0|||
44435194|NCT00557505|79443867|FG000|Overall Study|Objective progression or relapse|2|||
44435195|NCT00557505|79443868|FG001|Overall Study|Objective progression or relapse|3|||
44435196|NCT00557505|79443869|FG002|Overall Study|Objective progression or relapse|3|||
44435197|NCT00557505|79443870|FG003|Overall Study|Objective progression or relapse|2|||
44435198|NCT00557505|79443871|FG004|Overall Study|Objective progression or relapse|2|||
44435199|NCT00557505|79443872|FG005|Overall Study|Objective progression or relapse|3|||
44435200|NCT00557505|79443873|FG006|Overall Study|Objective progression or relapse|2|||
44435201|NCT00557505|79443874|FG007|Overall Study|Objective progression or relapse|5|||
44435202|NCT00557505|79443875|FG008|Overall Study|Objective progression or relapse|15|||
44435203|NCT00557505|79443867|FG000|Overall Study|Withdrawal by Subject|0|||
44435204|NCT00557505|79443868|FG001|Overall Study|Withdrawal by Subject|0|||
44435205|NCT00557505|79443869|FG002|Overall Study|Withdrawal by Subject|0|||
44435206|NCT00557505|79443870|FG003|Overall Study|Withdrawal by Subject|1|||
44435207|NCT00557505|79443871|FG004|Overall Study|Withdrawal by Subject|0|||
44435208|NCT00557505|79443872|FG005|Overall Study|Withdrawal by Subject|0|||
44435209|NCT00557505|79443873|FG006|Overall Study|Withdrawal by Subject|0|||
44435210|NCT00557505|79443874|FG007|Overall Study|Withdrawal by Subject|0|||
44435211|NCT00557505|79443875|FG008|Overall Study|Withdrawal by Subject|1|||
44435212|NCT00674570|79443901|FG000|Overall Study|Withdrawal by Subject|0|||
44435213|NCT00674570|79443902|FG001|Overall Study|Withdrawal by Subject|2|||
44435214|NCT00674570|79443903|FG002|Overall Study|Withdrawal by Subject|0|||
44435215|NCT00561951|79443914|FG000|Overall Study|Adverse Event|11|||
44435216|NCT00561951|79443915|FG001|Overall Study|Adverse Event|14|||
44435217|NCT00561951|79443916|FG002|Overall Study|Adverse Event|14|||
44435218|NCT00561951|79443914|FG000|Overall Study|Lack of Efficacy|5|||
44435219|NCT00561951|79443915|FG001|Overall Study|Lack of Efficacy|3|||
44435220|NCT00561951|79443916|FG002|Overall Study|Lack of Efficacy|2|||
44435221|NCT00561951|79443914|FG000|Overall Study|Lost to Follow-up|1|||
44435222|NCT00561951|79443915|FG001|Overall Study|Lost to Follow-up|1|||
44435223|NCT00561951|79443916|FG002|Overall Study|Lost to Follow-up|0|||
44336535|NCT01090024|79341192|FG004|Period 1|Met exclusion criteria|0|||
44336536|NCT01090024|79341193|FG005|Period 1|Met exclusion criteria|0|||
44435224|NCT00561951|79443914|FG000|Overall Study|Withdrawal by Subject|10|||
44435225|NCT00561951|79443915|FG001|Overall Study|Withdrawal by Subject|9|||
44435226|NCT00561951|79443916|FG002|Overall Study|Withdrawal by Subject|10|||
44435227|NCT00561951|79443914|FG000|Overall Study|Protocol Violation|4|||
44435228|NCT00561951|79443915|FG001|Overall Study|Protocol Violation|3|||
44435229|NCT00561951|79443916|FG002|Overall Study|Protocol Violation|4|||
44435230|NCT00561951|79443914|FG000|Overall Study|Physician Decision|1|||
44336537|NCT01090024|79341194|FG006|Period 1|Met exclusion criteria|0|||
44336538|NCT01090024|79341195|FG007|Period 1|Met exclusion criteria|0|||
44336539|NCT01090024|79341196|FG008|Period 1|Met exclusion criteria|0|||
44336540|NCT01090024|79341197|FG009|Period 1|Met exclusion criteria|0|||
44336541|NCT01090024|79341198|FG010|Period 1|Met exclusion criteria|0|||
44435231|NCT00561951|79443915|FG001|Overall Study|Physician Decision|0|||
44435232|NCT00561951|79443916|FG002|Overall Study|Physician Decision|0|||
44435233|NCT00561951|79443914|FG000|Overall Study|Pregnancy|0|||
44435234|NCT00561951|79443915|FG001|Overall Study|Pregnancy|1|||
44435235|NCT00561951|79443916|FG002|Overall Study|Pregnancy|0|||
44435236|NCT00561951|79443914|FG000|Overall Study|Meet Withdrawal Criterion|0|||
44435237|NCT00561951|79443915|FG001|Overall Study|Meet Withdrawal Criterion|1|||
44435238|NCT00561951|79443916|FG002|Overall Study|Meet Withdrawal Criterion|1|||
44435239|NCT00561951|79443914|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
44435240|NCT00561951|79443915|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
44435241|NCT00561951|79443916|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
44336542|NCT01090024|79341199|FG011|Period 1|Met exclusion criteria|0|||
44336543|NCT01090024|79341200|FG012|Period 1|Met exclusion criteria|0|||
44336544|NCT01090024|79341201|FG013|Period 1|Met exclusion criteria|0|||
44336545|NCT01090024|79341202|FG014|Period 1|Met exclusion criteria|1|||
44435242|NCT00322387|79443926|FG000|Treatment Period|Adverse Event|0|||
44435243|NCT00322387|79443927|FG001|Treatment Period|Adverse Event|1|||
44435244|NCT00322387|79443926|FG000|Follow-up Period|Final assessment not done|1|||
44435245|NCT00322387|79443927|FG001|Follow-up Period|Final assessment not done|3|||
44435246|NCT00322387|79443926|FG000|Follow-up Period|Death|1|||
44435247|NCT00322387|79443927|FG001|Follow-up Period|Death|0|||
44435248|NCT00561015|79443950|FG000|Overall Study|Adverse Event|0|||
44435249|NCT00561015|79443951|FG001|Overall Study|Adverse Event|0|||
44435250|NCT00561015|79443952|FG002|Overall Study|Adverse Event|0|||
44435251|NCT00561015|79443953|FG003|Overall Study|Adverse Event|0|||
44435252|NCT00561015|79443954|FG004|Overall Study|Adverse Event|1|||
44435253|NCT00561015|79443955|FG005|Overall Study|Adverse Event|0|||
44435254|NCT00561015|79443950|FG000|Overall Study|Lost to Follow-up|2|||
44435255|NCT00561015|79443951|FG001|Overall Study|Lost to Follow-up|0|||
44435256|NCT00561015|79443952|FG002|Overall Study|Lost to Follow-up|0|||
44435257|NCT00561015|79443953|FG003|Overall Study|Lost to Follow-up|1|||
44336546|NCT01090024|79341203|FG015|Period 1|Met exclusion criteria|0|||
44336547|NCT01090024|79341204|FG016|Period 1|Met exclusion criteria|0|||
44336548|NCT01090024|79341205|FG017|Period 1|Met exclusion criteria|0|||
44336549|NCT01090024|79341188|FG000|Period 1|Adverse Event|0|||
44336550|NCT01090024|79341189|FG001|Period 1|Adverse Event|0|||
44336551|NCT01090024|79341190|FG002|Period 1|Adverse Event|0|||
44336552|NCT01090024|79341191|FG003|Period 1|Adverse Event|0|||
44336553|NCT01090024|79341192|FG004|Period 1|Adverse Event|0|||
44336554|NCT01090024|79341193|FG005|Period 1|Adverse Event|0|||
44336555|NCT01090024|79341194|FG006|Period 1|Adverse Event|0|||
44336556|NCT01090024|79341195|FG007|Period 1|Adverse Event|0|||
44336557|NCT01090024|79341196|FG008|Period 1|Adverse Event|0|||
44435258|NCT00561015|79443954|FG004|Overall Study|Lost to Follow-up|0|||
44435259|NCT00561015|79443955|FG005|Overall Study|Lost to Follow-up|3|||
44435260|NCT00561015|79443950|FG000|Overall Study|Participant non-compliance|2|||
44435261|NCT00561015|79443951|FG001|Overall Study|Participant non-compliance|0|||
44435262|NCT00561015|79443952|FG002|Overall Study|Participant non-compliance|0|||
44435263|NCT00561015|79443953|FG003|Overall Study|Participant non-compliance|0|||
44435264|NCT00561015|79443954|FG004|Overall Study|Participant non-compliance|0|||
44435265|NCT00561015|79443955|FG005|Overall Study|Participant non-compliance|0|||
44435266|NCT00560937|79443975|FG000|Overall Study|Withdrawal by Subject|0|||
44435267|NCT00560937|79443976|FG001|Overall Study|Withdrawal by Subject|1|||
44435268|NCT00560937|79443975|FG000|Overall Study|Physician Decision|1|||
44435269|NCT00560937|79443976|FG001|Overall Study|Physician Decision|1|||
44435270|NCT00561795|79443984|FG000|Overall Study|Adverse Event|3|||
44435271|NCT00561795|79443985|FG001|Overall Study|Adverse Event|3|||
44435272|NCT00561795|79443986|FG002|Overall Study|Adverse Event|0|||
44435273|NCT00561795|79443987|FG003|Overall Study|Adverse Event|0|||
44435274|NCT00561795|79443984|FG000|Overall Study|Study Closed/Terminated|0|||
44435275|NCT00561795|79443985|FG001|Overall Study|Study Closed/Terminated|3|||
44336558|NCT01090024|79341197|FG009|Period 1|Adverse Event|1|||
44336559|NCT01090024|79341198|FG010|Period 1|Adverse Event|0|||
44336560|NCT01090024|79341199|FG011|Period 1|Adverse Event|1|||
44336561|NCT01090024|79341200|FG012|Period 1|Adverse Event|0|||
44336562|NCT01090024|79341201|FG013|Period 1|Adverse Event|0|||
44336563|NCT01090024|79341202|FG014|Period 1|Adverse Event|0|||
44336564|NCT01090024|79341203|FG015|Period 1|Adverse Event|0|||
44336565|NCT01090024|79341204|FG016|Period 1|Adverse Event|0|||
44336566|NCT01090024|79341205|FG017|Period 1|Adverse Event|1|||
44435276|NCT00561795|79443986|FG002|Overall Study|Study Closed/Terminated|0|||
44435277|NCT00561795|79443987|FG003|Overall Study|Study Closed/Terminated|0|||
44435278|NCT00561795|79443984|FG000|Overall Study|Physician Decision|1|||
44435279|NCT00561795|79443985|FG001|Overall Study|Physician Decision|0|||
44435280|NCT00561795|79443986|FG002|Overall Study|Physician Decision|0|||
44435281|NCT00561795|79443987|FG003|Overall Study|Physician Decision|0|||
44435282|NCT00652626|79444002|FG000|Initial Treatment Phase|Adverse Event|0|||
44435283|NCT00652626|79444003|FG001|Initial Treatment Phase|Adverse Event|0|||
44336567|NCT01090024|79341188|FG000|Period 1|Withdrawal by Subject|0|||
44435284|NCT00652626|79444004|FG002|Initial Treatment Phase|Adverse Event|0|||
44336568|NCT01090024|79341189|FG001|Period 1|Withdrawal by Subject|0|||
44336569|NCT01090024|79341190|FG002|Period 1|Withdrawal by Subject|0|||
44336570|NCT01090024|79341191|FG003|Period 1|Withdrawal by Subject|1|||
44336571|NCT01090024|79341192|FG004|Period 1|Withdrawal by Subject|0|||
44336572|NCT01090024|79341193|FG005|Period 1|Withdrawal by Subject|0|||
44336573|NCT01090024|79341194|FG006|Period 1|Withdrawal by Subject|0|||
44336574|NCT01090024|79341195|FG007|Period 1|Withdrawal by Subject|0|||
44336575|NCT01090024|79341196|FG008|Period 1|Withdrawal by Subject|0|||
44435285|NCT00652626|79444005|FG003|Initial Treatment Phase|Adverse Event|0|||
44435286|NCT00652626|79444006|FG004|Initial Treatment Phase|Adverse Event|1|||
44435287|NCT00652626|79444007|FG005|Initial Treatment Phase|Adverse Event|0|||
44435288|NCT00652626|79444008|FG006|Initial Treatment Phase|Adverse Event|0|||
44435289|NCT00652626|79444002|FG000|Initial Treatment Phase|Protocol Violation|0|||
44435290|NCT00652626|79444003|FG001|Initial Treatment Phase|Protocol Violation|0|||
44435291|NCT00652626|79444004|FG002|Initial Treatment Phase|Protocol Violation|0|||
44435292|NCT00652626|79444005|FG003|Initial Treatment Phase|Protocol Violation|1|||
44435293|NCT00652626|79444006|FG004|Initial Treatment Phase|Protocol Violation|0|||
44435294|NCT00652626|79444007|FG005|Initial Treatment Phase|Protocol Violation|0|||
44435295|NCT00652626|79444008|FG006|Initial Treatment Phase|Protocol Violation|0|||
44435296|NCT00652626|79444002|FG000|Initial Treatment Phase|Physician Decision|0|||
44435297|NCT00652626|79444003|FG001|Initial Treatment Phase|Physician Decision|0|||
44435298|NCT00652626|79444004|FG002|Initial Treatment Phase|Physician Decision|0|||
44435299|NCT00652626|79444005|FG003|Initial Treatment Phase|Physician Decision|0|||
44435300|NCT00652626|79444006|FG004|Initial Treatment Phase|Physician Decision|1|||
44435301|NCT00652626|79444007|FG005|Initial Treatment Phase|Physician Decision|0|||
44435302|NCT00652626|79444008|FG006|Initial Treatment Phase|Physician Decision|0|||
44435303|NCT00652626|79444002|FG000|Initial Treatment Phase|Sponsor Request|0|||
44435304|NCT00652626|79444003|FG001|Initial Treatment Phase|Sponsor Request|0|||
44435305|NCT00652626|79444004|FG002|Initial Treatment Phase|Sponsor Request|1|||
44435306|NCT00652626|79444005|FG003|Initial Treatment Phase|Sponsor Request|0|||
44435307|NCT00652626|79444006|FG004|Initial Treatment Phase|Sponsor Request|0|||
44435308|NCT00652626|79444007|FG005|Initial Treatment Phase|Sponsor Request|0|||
44435309|NCT00652626|79444008|FG006|Initial Treatment Phase|Sponsor Request|0|||
44435310|NCT00652626|79444002|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
44435311|NCT00652626|79444003|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
44435312|NCT00652626|79444004|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
44435313|NCT00652626|79444005|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
44435314|NCT00652626|79444006|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
44435315|NCT00652626|79444007|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
44435316|NCT00652626|79444008|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
44435317|NCT00652626|79444002|FG000|Extension Phase|Withdrawal by Subject|0|||
44435318|NCT00652626|79444003|FG001|Extension Phase|Withdrawal by Subject|0|||
44435319|NCT00652626|79444004|FG002|Extension Phase|Withdrawal by Subject|0|||
44435320|NCT00652626|79444005|FG003|Extension Phase|Withdrawal by Subject|0|||
44435321|NCT00652626|79444006|FG004|Extension Phase|Withdrawal by Subject|0|||
44435322|NCT00652626|79444007|FG005|Extension Phase|Withdrawal by Subject|2|||
44435323|NCT00652626|79444008|FG006|Extension Phase|Withdrawal by Subject|0|||
44435324|NCT00652626|79444002|FG000|Extension Phase|Adverse Event|0|||
44435325|NCT00652626|79444003|FG001|Extension Phase|Adverse Event|0|||
44435326|NCT00652626|79444004|FG002|Extension Phase|Adverse Event|0|||
44435327|NCT00652626|79444005|FG003|Extension Phase|Adverse Event|0|||
44435328|NCT00652626|79444006|FG004|Extension Phase|Adverse Event|0|||
44435329|NCT00652626|79444007|FG005|Extension Phase|Adverse Event|2|||
44435330|NCT00652626|79444008|FG006|Extension Phase|Adverse Event|1|||
44435331|NCT00652626|79444002|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
44435332|NCT00652626|79444003|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
44435333|NCT00652626|79444004|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
44435334|NCT00652626|79444005|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
44435335|NCT00652626|79444006|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
44435336|NCT00652626|79444007|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
44435337|NCT00652626|79444008|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
44435338|NCT00652626|79444002|FG000|Extension Phase|Physician Decision|0|||
44336576|NCT01090024|79341197|FG009|Period 1|Withdrawal by Subject|0|||
44336577|NCT01090024|79341198|FG010|Period 1|Withdrawal by Subject|0|||
44336578|NCT01090024|79341199|FG011|Period 1|Withdrawal by Subject|0|||
44336579|NCT01090024|79341200|FG012|Period 1|Withdrawal by Subject|0|||
44336580|NCT01090024|79341201|FG013|Period 1|Withdrawal by Subject|0|||
44336581|NCT01090024|79341202|FG014|Period 1|Withdrawal by Subject|0|||
44336582|NCT01090024|79341203|FG015|Period 1|Withdrawal by Subject|0|||
44336583|NCT01090024|79341204|FG016|Period 1|Withdrawal by Subject|0|||
44336584|NCT01090024|79341205|FG017|Period 1|Withdrawal by Subject|0|||
44336585|NCT01090024|79341188|FG000|Period 1|Lost to Follow-up|0|||
44336586|NCT01090024|79341189|FG001|Period 1|Lost to Follow-up|1|||
44336587|NCT01090024|79341190|FG002|Period 1|Lost to Follow-up|0|||
44435339|NCT00652626|79444003|FG001|Extension Phase|Physician Decision|0|||
44435340|NCT00652626|79444004|FG002|Extension Phase|Physician Decision|0|||
44435341|NCT00652626|79444005|FG003|Extension Phase|Physician Decision|0|||
44435342|NCT00652626|79444006|FG004|Extension Phase|Physician Decision|0|||
44435343|NCT00652626|79444007|FG005|Extension Phase|Physician Decision|1|||
44540061|NCT02943564|79551740|FG002|Overall Study|Withdrawal by Subject|2|||
44540062|NCT02943564|79551738|FG000|Overall Study|Adverse Event|1|||
44540063|NCT02943564|79551739|FG001|Overall Study|Adverse Event|2|||
44435344|NCT00652626|79444008|FG006|Extension Phase|Physician Decision|1|||
44336588|NCT01090024|79341191|FG003|Period 1|Lost to Follow-up|0|||
44336589|NCT01090024|79341192|FG004|Period 1|Lost to Follow-up|0|||
44336590|NCT01090024|79341193|FG005|Period 1|Lost to Follow-up|0|||
44435345|NCT00652626|79444002|FG000|Extension Phase|Death|0|||
44435346|NCT00652626|79444003|FG001|Extension Phase|Death|0|||
44435347|NCT00652626|79444004|FG002|Extension Phase|Death|0|||
44435348|NCT00652626|79444005|FG003|Extension Phase|Death|0|||
44435349|NCT00652626|79444006|FG004|Extension Phase|Death|0|||
44435350|NCT00652626|79444007|FG005|Extension Phase|Death|1|||
44336591|NCT01090024|79341194|FG006|Period 1|Lost to Follow-up|0|||
44336592|NCT01090024|79341195|FG007|Period 1|Lost to Follow-up|0|||
44336593|NCT01090024|79341196|FG008|Period 1|Lost to Follow-up|0|||
44336594|NCT01090024|79341197|FG009|Period 1|Lost to Follow-up|0|||
44336595|NCT01090024|79341198|FG010|Period 1|Lost to Follow-up|0|||
44336596|NCT01090024|79341199|FG011|Period 1|Lost to Follow-up|0|||
44336597|NCT01090024|79341200|FG012|Period 1|Lost to Follow-up|0|||
44336598|NCT01090024|79341201|FG013|Period 1|Lost to Follow-up|0|||
44435351|NCT00652626|79444008|FG006|Extension Phase|Death|1|||
44435352|NCT00560703|79444028|FG000|Overall Study|Adverse Event|0|||
44435353|NCT00560703|79444029|FG001|Overall Study|Adverse Event|2|||
44435354|NCT00560703|79444028|FG000|Overall Study|Protocol Violation|0|||
44435355|NCT00560703|79444029|FG001|Overall Study|Protocol Violation|2|||
44435356|NCT00560703|79444028|FG000|Overall Study|Withdrawal by Subject|0|||
44435357|NCT00560703|79444029|FG001|Overall Study|Withdrawal by Subject|1|||
44435358|NCT00560703|79444028|FG000|Overall Study|non-compliance|0|||
44435359|NCT00560703|79444029|FG001|Overall Study|non-compliance|1|||
44435360|NCT00308737|79444038|FG000|Overall Study|Adverse Event|104|||
44435361|NCT00308737|79444039|FG001|Overall Study|Adverse Event|9|||
44435362|NCT00308737|79444040|FG002|Overall Study|Adverse Event|0|||
44435363|NCT00308737|79444038|FG000|Overall Study|Death|4|||
44435364|NCT00308737|79444039|FG001|Overall Study|Death|3|||
44435365|NCT00308737|79444040|FG002|Overall Study|Death|0|||
44435366|NCT00308737|79444038|FG000|Overall Study|Lost to Follow-up|56|||
44435367|NCT00308737|79444039|FG001|Overall Study|Lost to Follow-up|80|||
44435368|NCT00308737|79444040|FG002|Overall Study|Lost to Follow-up|5|||
44435369|NCT00308737|79444038|FG000|Overall Study|Physician Decision|15|||
44435370|NCT00308737|79444039|FG001|Overall Study|Physician Decision|2|||
44435371|NCT00308737|79444040|FG002|Overall Study|Physician Decision|1|||
44435372|NCT00308737|79444038|FG000|Overall Study|Protocol Violation|34|||
44435373|NCT00308737|79444039|FG001|Overall Study|Protocol Violation|9|||
44435374|NCT00308737|79444040|FG002|Overall Study|Protocol Violation|5|||
44336599|NCT01090024|79341202|FG014|Period 1|Lost to Follow-up|0|||
44336600|NCT01090024|79341203|FG015|Period 1|Lost to Follow-up|0|||
44435375|NCT00308737|79444038|FG000|Overall Study|Withdrawal by Subject|218|||
44435376|NCT00308737|79444039|FG001|Overall Study|Withdrawal by Subject|166|||
44435377|NCT00308737|79444040|FG002|Overall Study|Withdrawal by Subject|18|||
44435378|NCT00308737|79444038|FG000|Overall Study|Various|32|||
44435379|NCT00308737|79444039|FG001|Overall Study|Various|20|||
44435380|NCT00308737|79444040|FG002|Overall Study|Various|8|||
44336601|NCT01090024|79341204|FG016|Period 1|Lost to Follow-up|0|||
44336602|NCT01090024|79341205|FG017|Period 1|Lost to Follow-up|0|||
44336603|NCT01090024|79341188|FG000|Period 2|Lost to Follow-up|0|||
44336604|NCT01090024|79341189|FG001|Period 2|Lost to Follow-up|0|||
44336605|NCT01090024|79341190|FG002|Period 2|Lost to Follow-up|0|||
44336606|NCT01090024|79341191|FG003|Period 2|Lost to Follow-up|1|||
44336607|NCT01090024|79341192|FG004|Period 2|Lost to Follow-up|0|||
44336608|NCT01090024|79341193|FG005|Period 2|Lost to Follow-up|0|||
44336609|NCT01090024|79341194|FG006|Period 2|Lost to Follow-up|0|||
44336610|NCT01090024|79341195|FG007|Period 2|Lost to Follow-up|0|||
44336611|NCT01090024|79341196|FG008|Period 2|Lost to Follow-up|0|||
44336612|NCT01090024|79341197|FG009|Period 2|Lost to Follow-up|0|||
44336613|NCT01090024|79341198|FG010|Period 2|Lost to Follow-up|0|||
44435381|NCT00655746|79444048|FG000|Overall Study|Withdrawal by Subject|1|||
44435382|NCT00338455|79444058|FG000|Overall Study|Death|2|||
44435383|NCT00338455|79444059|FG001|Overall Study|Death|1|||
44435384|NCT00338455|79444058|FG000|Overall Study|Physician Decision|1|||
44435385|NCT00338455|79444059|FG001|Overall Study|Physician Decision|0|||
44435386|NCT00651924|79444067|FG000|Overall Study|Withdrawal by PI|0|||
44435387|NCT00651924|79444068|FG001|Overall Study|Withdrawal by PI|2|||
44435388|NCT00651924|79444067|FG000|Overall Study|Withdrawal by Subject|0|||
44435389|NCT00651924|79444068|FG001|Overall Study|Withdrawal by Subject|5|||
44435390|NCT00678392|79444076|FG000|Overall Study|Adverse Event|0|||
44435391|NCT00678392|79444077|FG001|Overall Study|Adverse Event|6|||
44435392|NCT00678392|79444076|FG000|Overall Study|Death|280|||
44435393|NCT00678392|79444077|FG001|Overall Study|Death|269|||
44435394|NCT00678392|79444076|FG000|Overall Study|Lost to Follow-up|15|||
44336614|NCT01090024|79341199|FG011|Period 2|Lost to Follow-up|0|||
44336615|NCT01090024|79341200|FG012|Period 2|Lost to Follow-up|0|||
44336616|NCT01090024|79341201|FG013|Period 2|Lost to Follow-up|0|||
44435395|NCT00678392|79444077|FG001|Overall Study|Lost to Follow-up|13|||
44336617|NCT01090024|79341202|FG014|Period 2|Lost to Follow-up|0|||
44336618|NCT01090024|79341203|FG015|Period 2|Lost to Follow-up|0|||
44157488|NCT02686658|78949260|FG003|Overall Study|Death|1|||
44435396|NCT00678392|79444076|FG000|Overall Study|Objective Progression or Relapse|3|||
44540064|NCT02943564|79551740|FG002|Overall Study|Adverse Event|1|||
44540065|NCT02943564|79551738|FG000|Overall Study|Lack of Efficacy|0|||
44540066|NCT02943564|79551739|FG001|Overall Study|Lack of Efficacy|1|||
44540067|NCT02943564|79551740|FG002|Overall Study|Lack of Efficacy|0|||
44540068|NCT03268941|79551752|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
44435397|NCT00678392|79444077|FG001|Overall Study|Objective Progression or Relapse|8|||
44435398|NCT00678392|79444076|FG000|Overall Study|Sponsor's Decision|1|||
44435399|NCT00678392|79444077|FG001|Overall Study|Sponsor's Decision|2|||
44435400|NCT00678392|79444076|FG000|Overall Study|Withdrawal by Subject|4|||
44435401|NCT00678392|79444077|FG001|Overall Study|Withdrawal by Subject|4|||
44435402|NCT00678392|79444076|FG000|Overall Study|Randomized But Not Treated|2|||
44435403|NCT00678392|79444077|FG001|Overall Study|Randomized But Not Treated|7|||
44435404|NCT00678392|79444076|FG000|Overall Study|Other|56|||
44435405|NCT00678392|79444077|FG001|Overall Study|Other|53|||
44435406|NCT00308581|79444083|FG000|Induction Phase|Adverse Event|0|||
44435407|NCT00308581|79444084|FG001|Induction Phase|Adverse Event|0|||
44435408|NCT00308581|79444085|FG002|Induction Phase|Adverse Event|37|||
44435409|NCT00308581|79444083|FG000|Induction Phase|Lack of Efficacy|0|||
44435410|NCT00308581|79444084|FG001|Induction Phase|Lack of Efficacy|0|||
44435411|NCT00308581|79444085|FG002|Induction Phase|Lack of Efficacy|121|||
44435412|NCT00308581|79444083|FG000|Induction Phase|Withdrawal by Subject|0|||
44435413|NCT00308581|79444084|FG001|Induction Phase|Withdrawal by Subject|0|||
44435414|NCT00308581|79444085|FG002|Induction Phase|Withdrawal by Subject|5|||
44435415|NCT00308581|79444083|FG000|Induction Phase|Unknown reason|0|||
44435416|NCT00308581|79444084|FG001|Induction Phase|Unknown reason|0|||
44435417|NCT00308581|79444085|FG002|Induction Phase|Unknown reason|3|||
44435418|NCT00308581|79444083|FG000|Randomized Maintenance Phase|Adverse Event|10|||
44435419|NCT00308581|79444084|FG001|Randomized Maintenance Phase|Adverse Event|17|||
44435420|NCT00308581|79444085|FG002|Randomized Maintenance Phase|Adverse Event|0|||
44435421|NCT00308581|79444083|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
44435422|NCT00308581|79444084|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
44435423|NCT00308581|79444085|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
44435424|NCT00308581|79444083|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
44435425|NCT00308581|79444084|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
44435426|NCT00308581|79444085|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
44435427|NCT00308581|79444083|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
44435428|NCT00308581|79444084|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
44336619|NCT01090024|79341204|FG016|Period 2|Lost to Follow-up|0|||
44336620|NCT01090024|79341205|FG017|Period 2|Lost to Follow-up|0|||
44336621|NCT01090024|79341188|FG000|Period 2|Adverse Event|1|||
44435429|NCT00308581|79444085|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
44435430|NCT00308581|79444083|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
44435431|NCT00308581|79444084|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
44435432|NCT00308581|79444085|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
44435433|NCT00308581|79444083|FG000|Randomized Maintenance Phase|Unknown reason|3|||
44435434|NCT00308581|79444084|FG001|Randomized Maintenance Phase|Unknown reason|0|||
44435435|NCT00308581|79444085|FG002|Randomized Maintenance Phase|Unknown reason|0|||
44435436|NCT00678080|79444095|FG000|Overall Study|Physician Decision|2|||
44435437|NCT00678080|79444096|FG001|Overall Study|Physician Decision|0|||
44435438|NCT00678080|79444095|FG000|Overall Study|Lost to Follow-up|1|||
44435439|NCT00678080|79444096|FG001|Overall Study|Lost to Follow-up|0|||
44435440|NCT00678080|79444095|FG000|Overall Study|Withdrawal by Subject|0|||
44435441|NCT00678080|79444096|FG001|Overall Study|Withdrawal by Subject|1|||
44435442|NCT00658320|79444104|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
44435443|NCT00658320|79444105|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
44435444|NCT00658320|79444104|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
44435445|NCT00658320|79444105|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
44540069|NCT03268941|79551753|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
44540070|NCT03268941|79551754|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
44540071|NCT03268941|79551755|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
44540072|NCT03268941|79551756|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
44540073|NCT03268941|79551757|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
44336622|NCT01090024|79341189|FG001|Period 2|Adverse Event|0|||
44336623|NCT01090024|79341190|FG002|Period 2|Adverse Event|0|||
44336624|NCT01090024|79341191|FG003|Period 2|Adverse Event|0|||
44336625|NCT01090024|79341192|FG004|Period 2|Adverse Event|0|||
44336626|NCT01090024|79341193|FG005|Period 2|Adverse Event|0|||
44336627|NCT01090024|79341194|FG006|Period 2|Adverse Event|0|||
44435446|NCT00658320|79444104|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
44435447|NCT00658320|79444105|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
44435448|NCT00658320|79444104|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
44435449|NCT00658320|79444105|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
44435450|NCT00322153|79444115|FG000|Overall Study|Adverse Event|21|||
44435451|NCT00322153|79444116|FG001|Overall Study|Adverse Event|34|||
44435452|NCT00322153|79444115|FG000|Overall Study|Protocol Violation|6|||
44336628|NCT01090024|79341195|FG007|Period 2|Adverse Event|0|||
44435453|NCT00322153|79444116|FG001|Overall Study|Protocol Violation|14|||
44540074|NCT03268941|79551758|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
44336629|NCT01090024|79341196|FG008|Period 2|Adverse Event|0|||
44336630|NCT01090024|79341197|FG009|Period 2|Adverse Event|0|||
44336631|NCT01090024|79341198|FG010|Period 2|Adverse Event|0|||
44336632|NCT01090024|79341199|FG011|Period 2|Adverse Event|0|||
44336633|NCT01090024|79341200|FG012|Period 2|Adverse Event|0|||
44336634|NCT01090024|79341201|FG013|Period 2|Adverse Event|0|||
44336635|NCT01090024|79341202|FG014|Period 2|Adverse Event|0|||
44336636|NCT01090024|79341203|FG015|Period 2|Adverse Event|0|||
44435454|NCT00322153|79444115|FG000|Overall Study|Withdrawal by Subject|18|||
44540075|NCT03268941|79551752|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
44540076|NCT03268941|79551753|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
44540077|NCT03268941|79551754|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
44540078|NCT03268941|79551755|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
44540079|NCT03268941|79551756|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
44540080|NCT03268941|79551757|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
44540081|NCT03268941|79551758|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
44540082|NCT03268941|79551752|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
44540083|NCT03268941|79551753|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
44540084|NCT03268941|79551754|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
44540085|NCT03268941|79551755|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
44540086|NCT03268941|79551756|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
44540087|NCT03268941|79551757|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
44540088|NCT03268941|79551758|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
44540089|NCT03268941|79551752|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
44540090|NCT03268941|79551753|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
44540091|NCT03268941|79551754|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
44540092|NCT03268941|79551755|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
44540093|NCT03268941|79551756|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
44540094|NCT03268941|79551757|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
44540095|NCT03268941|79551758|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
44540096|NCT03268941|79551752|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
44540097|NCT03268941|79551753|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
44540098|NCT03268941|79551754|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
44540099|NCT03268941|79551755|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
44540100|NCT03268941|79551756|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
44540101|NCT03268941|79551757|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
44336637|NCT01090024|79341204|FG016|Period 2|Adverse Event|0|||
44336638|NCT01090024|79341205|FG017|Period 2|Adverse Event|0|||
44540102|NCT03268941|79551758|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
44540103|NCT03245619|79551835|FG000|Part A (Up to Day 22)|Physician Decision|4|||
44540104|NCT03245619|79551836|FG001|Part A (Up to Day 22)|Physician Decision|6|||
44540105|NCT03245619|79551837|FG002|Part A (Up to Day 22)|Physician Decision|6|||
44540106|NCT03245619|79551838|FG003|Part A (Up to Day 22)|Physician Decision|0|||
44540107|NCT03245619|79551839|FG004|Part A (Up to Day 22)|Physician Decision|0|||
44540108|NCT03245619|79551840|FG005|Part A (Up to Day 22)|Physician Decision|0|||
44540109|NCT03245619|79551841|FG006|Part A (Up to Day 22)|Physician Decision|0|||
44540110|NCT03245619|79551842|FG007|Part A (Up to Day 22)|Physician Decision|0|||
44540111|NCT03245619|79551843|FG008|Part A (Up to Day 22)|Physician Decision|0|||
44540112|NCT03245619|79551844|FG009|Part A (Up to Day 22)|Physician Decision|0|||
44540113|NCT03245619|79551845|FG010|Part A (Up to Day 22)|Physician Decision|0|||
44540114|NCT03245619|79551846|FG011|Part A (Up to Day 22)|Physician Decision|0|||
44540115|NCT03245619|79551847|FG012|Part A (Up to Day 22)|Physician Decision|0|||
44540116|NCT03245619|79551848|FG013|Part A (Up to Day 22)|Physician Decision|0|||
44540117|NCT03245619|79551849|FG014|Part A (Up to Day 22)|Physician Decision|0|||
44540118|NCT03245619|79551850|FG015|Part A (Up to Day 22)|Physician Decision|0|||
44540119|NCT03245619|79551851|FG016|Part A (Up to Day 22)|Physician Decision|0|||
44540120|NCT04472650|79551912|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
44336639|NCT01090024|79341188|FG000|Period 3|Withdrawal by Subject|0|||
44540121|NCT04472650|79551913|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
44540122|NCT02606461|79551925|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
44540123|NCT02606461|79551926|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
44540124|NCT02606461|79551927|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
44336640|NCT01090024|79341189|FG001|Period 3|Withdrawal by Subject|0|||
44540125|NCT02606461|79551928|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
44540126|NCT02606461|79551929|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
44336641|NCT01090024|79341190|FG002|Period 3|Withdrawal by Subject|0|||
44336642|NCT01090024|79341191|FG003|Period 3|Withdrawal by Subject|0|||
44540127|NCT02606461|79551930|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
44540128|NCT03321396|79551945|FG000|Overall Study|Physician Decision|1|||
44336643|NCT01090024|79341192|FG004|Period 3|Withdrawal by Subject|0|||
44540129|NCT03244917|79551951|FG000|Overall Study|Lost to Follow-up|2|||
44540130|NCT03244917|79551952|FG001|Overall Study|Lost to Follow-up|2|||
44540131|NCT03321006|79551960|FG000|Overall Study|Death|1|||
44540132|NCT03321006|79551961|FG001|Overall Study|Death|0|||
44336644|NCT01090024|79341193|FG005|Period 3|Withdrawal by Subject|0|||
44336645|NCT01090024|79341194|FG006|Period 3|Withdrawal by Subject|0|||
44336646|NCT01090024|79341195|FG007|Period 3|Withdrawal by Subject|0|||
44336647|NCT01090024|79341196|FG008|Period 3|Withdrawal by Subject|0|||
44540133|NCT03321006|79551960|FG000|Overall Study|Lack of Efficacy|1|||
44540134|NCT03321006|79551961|FG001|Overall Study|Lack of Efficacy|0|||
44259262|NCT00555321|79116724|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
44259263|NCT00555321|79116720|FG000|Long-term Extension Phase|Other Reason|1|||
44336648|NCT01090024|79341197|FG009|Period 3|Withdrawal by Subject|0|||
44336649|NCT01090024|79341198|FG010|Period 3|Withdrawal by Subject|0|||
44336650|NCT01090024|79341199|FG011|Period 3|Withdrawal by Subject|0|||
44336651|NCT01090024|79341200|FG012|Period 3|Withdrawal by Subject|0|||
44540135|NCT02593123|79551978|FG000|Overall Study|Physician Decision|2|||
44540136|NCT02593123|79551979|FG001|Overall Study|Physician Decision|1|||
44540137|NCT02593123|79551978|FG000|Overall Study|Relapse|1|||
44540138|NCT02593123|79551979|FG001|Overall Study|Relapse|1|||
44336652|NCT01090024|79341201|FG013|Period 3|Withdrawal by Subject|0|||
44336653|NCT01090024|79341202|FG014|Period 3|Withdrawal by Subject|0|||
44336654|NCT01090024|79341203|FG015|Period 3|Withdrawal by Subject|1|||
44336655|NCT01090024|79341204|FG016|Period 3|Withdrawal by Subject|0|||
44336656|NCT01090024|79341205|FG017|Period 3|Withdrawal by Subject|0|||
44435455|NCT00322153|79444116|FG001|Overall Study|Withdrawal by Subject|10|||
44435456|NCT00322153|79444115|FG000|Overall Study|Lack of Efficacy|8|||
44435457|NCT00322153|79444116|FG001|Overall Study|Lack of Efficacy|3|||
44435458|NCT00322153|79444115|FG000|Overall Study|Lost to Follow-up|5|||
44435459|NCT00322153|79444116|FG001|Overall Study|Lost to Follow-up|4|||
44435460|NCT00322153|79444115|FG000|Overall Study|Withdrawn for other reasons|5|||
44435461|NCT00322153|79444116|FG001|Overall Study|Withdrawn for other reasons|4|||
44435462|NCT00657618|79444122|FG000|Overall Study|Adverse Event|32|||
44540139|NCT03302559|79551987|FG000|Overall Study|Adverse Event|2|||
44540140|NCT03302559|79551987|FG000|Overall Study|Lost to Follow-up|1|||
44540141|NCT03302559|79551987|FG000|Overall Study|Withdrew Consent|3|||
44540142|NCT03302247|79551991|FG000|Overall Study|the study has closed prematurely|2|||
44540143|NCT03302247|79551991|FG000|Overall Study|Death|1|||
44540144|NCT04993339|79551997|FG000|Overall Study|Lost to Follow-up|0|||
44540145|NCT04993339|79551998|FG001|Overall Study|Lost to Follow-up|1|||
44259264|NCT00555321|79116721|FG001|Long-term Extension Phase|Other Reason|0|||
44259265|NCT00555321|79116722|FG002|Long-term Extension Phase|Other Reason|2|||
44259266|NCT00555321|79116723|FG003|Long-term Extension Phase|Other Reason|0|||
44259267|NCT00555321|79116724|FG004|Long-term Extension Phase|Other Reason|0|||
44259268|NCT03589976|79117236|FG000|Overall Study|Death|5|||
44259269|NCT03589976|79117237|FG001|Overall Study|Death|1|||
44336657|NCT01090024|79341188|FG000|Period 3|Protocol Violation|0|||
44336658|NCT01090024|79341189|FG001|Period 3|Protocol Violation|0|||
44336659|NCT01090024|79341190|FG002|Period 3|Protocol Violation|0|||
44336660|NCT01090024|79341191|FG003|Period 3|Protocol Violation|0|||
44336661|NCT01090024|79341192|FG004|Period 3|Protocol Violation|0|||
44435463|NCT00657618|79444122|FG000|Overall Study|Withdrawal by Subject|8|||
44540146|NCT04993339|79551997|FG000|Overall Study|no MRI scan|3|||
44435464|NCT00657618|79444122|FG000|Overall Study|negative for leishmaniasis|2|||
44540147|NCT04993339|79551998|FG001|Overall Study|no MRI scan|1|||
44336662|NCT01090024|79341193|FG005|Period 3|Protocol Violation|0|||
44435465|NCT00657618|79444122|FG000|Overall Study|didn't start due to schedule conflicts|1|||
44435466|NCT00657540|79444128|FG000|Overall Study|Lost to Follow-up|1|||
44435467|NCT00657540|79444129|FG001|Overall Study|Lost to Follow-up|4|||
44435468|NCT00672620|79444139|FG000|Overall Study|Adverse Event|7|||
44336663|NCT01090024|79341194|FG006|Period 3|Protocol Violation|0|||
44336664|NCT01090024|79341195|FG007|Period 3|Protocol Violation|0|||
44336665|NCT01090024|79341196|FG008|Period 3|Protocol Violation|1|||
44435469|NCT00672620|79444140|FG001|Overall Study|Adverse Event|7|||
44435470|NCT00672620|79444141|FG002|Overall Study|Adverse Event|12|||
44435471|NCT00672620|79444142|FG003|Overall Study|Adverse Event|17|||
44435472|NCT00672620|79444139|FG000|Overall Study|Lack of Efficacy|1|||
44435473|NCT00672620|79444140|FG001|Overall Study|Lack of Efficacy|2|||
44435474|NCT00672620|79444141|FG002|Overall Study|Lack of Efficacy|2|||
44435475|NCT00672620|79444142|FG003|Overall Study|Lack of Efficacy|0|||
44435476|NCT00672620|79444139|FG000|Overall Study|Noncompliance with Study Drug|3|||
44435477|NCT00672620|79444140|FG001|Overall Study|Noncompliance with Study Drug|4|||
44435478|NCT00672620|79444141|FG002|Overall Study|Noncompliance with Study Drug|0|||
44435479|NCT00672620|79444142|FG003|Overall Study|Noncompliance with Study Drug|2|||
44435480|NCT00672620|79444139|FG000|Overall Study|Protocol Deviations|5|||
44435481|NCT00672620|79444140|FG001|Overall Study|Protocol Deviations|7|||
44435482|NCT00672620|79444141|FG002|Overall Study|Protocol Deviations|2|||
44435483|NCT00672620|79444142|FG003|Overall Study|Protocol Deviations|5|||
44435484|NCT00672620|79444139|FG000|Overall Study|Withdrawal of Consent|6|||
44435485|NCT00672620|79444140|FG001|Overall Study|Withdrawal of Consent|12|||
44435486|NCT00672620|79444141|FG002|Overall Study|Withdrawal of Consent|5|||
44435487|NCT00672620|79444142|FG003|Overall Study|Withdrawal of Consent|6|||
44435488|NCT00672620|79444139|FG000|Overall Study|Lost to Follow-up|8|||
44435489|NCT00672620|79444140|FG001|Overall Study|Lost to Follow-up|19|||
44435490|NCT00672620|79444141|FG002|Overall Study|Lost to Follow-up|8|||
44435491|NCT00672620|79444142|FG003|Overall Study|Lost to Follow-up|11|||
44435492|NCT00672620|79444139|FG000|Overall Study|Reason not Specified|3|||
44435493|NCT00672620|79444140|FG001|Overall Study|Reason not Specified|3|||
44435494|NCT00672620|79444141|FG002|Overall Study|Reason not Specified|2|||
44435495|NCT00672620|79444142|FG003|Overall Study|Reason not Specified|1|||
44435496|NCT00673790|79444155|FG000|Overall Study|Adverse Event|23|||
44435497|NCT00673790|79444156|FG001|Overall Study|Adverse Event|14|||
44435498|NCT00673790|79444157|FG002|Overall Study|Adverse Event|2|||
44435499|NCT00673790|79444155|FG000|Overall Study|Lack of Efficacy|2|||
44435500|NCT00673790|79444156|FG001|Overall Study|Lack of Efficacy|2|||
44336666|NCT01090024|79341197|FG009|Period 3|Protocol Violation|0|||
44336667|NCT01090024|79341198|FG010|Period 3|Protocol Violation|0|||
44336668|NCT01090024|79341199|FG011|Period 3|Protocol Violation|0|||
44336669|NCT01090024|79341200|FG012|Period 3|Protocol Violation|0|||
44336670|NCT01090024|79341201|FG013|Period 3|Protocol Violation|0|||
44336671|NCT01090024|79341202|FG014|Period 3|Protocol Violation|0|||
44336672|NCT01090024|79341203|FG015|Period 3|Protocol Violation|0|||
44336673|NCT01090024|79341204|FG016|Period 3|Protocol Violation|0|||
44336674|NCT01090024|79341205|FG017|Period 3|Protocol Violation|0|||
44336675|NCT01090024|79341188|FG000|Period 3|Adverse Event|0|||
44336676|NCT01090024|79341189|FG001|Period 3|Adverse Event|0|||
44336677|NCT01090024|79341190|FG002|Period 3|Adverse Event|0|||
44336678|NCT01090024|79341191|FG003|Period 3|Adverse Event|0|||
44336679|NCT01090024|79341192|FG004|Period 3|Adverse Event|0|||
44336680|NCT01090024|79341193|FG005|Period 3|Adverse Event|1|||
44336681|NCT01090024|79341194|FG006|Period 3|Adverse Event|0|||
44336682|NCT01090024|79341195|FG007|Period 3|Adverse Event|0|||
44336683|NCT01090024|79341196|FG008|Period 3|Adverse Event|0|||
44336684|NCT01090024|79341197|FG009|Period 3|Adverse Event|0|||
44336685|NCT01090024|79341198|FG010|Period 3|Adverse Event|0|||
44336686|NCT01090024|79341199|FG011|Period 3|Adverse Event|0|||
44336687|NCT01090024|79341200|FG012|Period 3|Adverse Event|0|||
44540148|NCT04974697|79552006|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
44435501|NCT00673790|79444157|FG002|Overall Study|Lack of Efficacy|2|||
44540149|NCT04974697|79552006|FG000|Overall Study|Lens discomfort|1|||
44336688|NCT01090024|79341201|FG013|Period 3|Adverse Event|0|||
44435502|NCT00673790|79444155|FG000|Overall Study|Protocol Violation|6|||
44435503|NCT00673790|79444156|FG001|Overall Study|Protocol Violation|9|||
44435504|NCT00673790|79444157|FG002|Overall Study|Protocol Violation|1|||
44435505|NCT00673790|79444155|FG000|Overall Study|Withdrawal by Subject|7|||
44435506|NCT00673790|79444156|FG001|Overall Study|Withdrawal by Subject|4|||
44435507|NCT00673790|79444157|FG002|Overall Study|Withdrawal by Subject|1|||
44540150|NCT03265119|79552014|FG000|Overall Study|Adverse Event|2|||
44336689|NCT01090024|79341202|FG014|Period 3|Adverse Event|0|||
44336690|NCT01090024|79341203|FG015|Period 3|Adverse Event|0|||
44336691|NCT01090024|79341204|FG016|Period 3|Adverse Event|0|||
44435508|NCT00673790|79444155|FG000|Overall Study|Lost to Follow-up|6|||
44336692|NCT01090024|79341205|FG017|Period 3|Adverse Event|0|||
44540151|NCT03265119|79552015|FG001|Overall Study|Adverse Event|1|||
44336693|NCT04868890|79341217|FG000|Overall Study|Death|2|||
44336694|NCT04868890|79341218|FG001|Overall Study|Death|1|||
44435509|NCT00673790|79444156|FG001|Overall Study|Lost to Follow-up|6|||
44435510|NCT00673790|79444157|FG002|Overall Study|Lost to Follow-up|5|||
44435511|NCT00673790|79444155|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
44435512|NCT00673790|79444156|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
44435513|NCT00673790|79444157|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
44435514|NCT00673790|79444155|FG000|Overall Study|Poor compliance|1|||
44435515|NCT00673790|79444156|FG001|Overall Study|Poor compliance|0|||
44435516|NCT00673790|79444157|FG002|Overall Study|Poor compliance|0|||
44435517|NCT00673790|79444155|FG000|Overall Study|Participated in two Nebivolol studies|0|||
44435518|NCT00673790|79444156|FG001|Overall Study|Participated in two Nebivolol studies|0|||
44435519|NCT00673790|79444157|FG002|Overall Study|Participated in two Nebivolol studies|1|||
44435520|NCT00673790|79444155|FG000|Overall Study|Unconfirmed pregnancy|0|||
44435521|NCT00673790|79444156|FG001|Overall Study|Unconfirmed pregnancy|1|||
44435522|NCT00673790|79444157|FG002|Overall Study|Unconfirmed pregnancy|0|||
44435523|NCT00673790|79444155|FG000|Overall Study|Randomization criteria not met|0|||
44435524|NCT00673790|79444156|FG001|Overall Study|Randomization criteria not met|1|||
44435525|NCT00673790|79444157|FG002|Overall Study|Randomization criteria not met|0|||
44435526|NCT00657150|79444168|FG000|Overall Study|Adverse Event|19|||
44435527|NCT00657150|79444169|FG001|Overall Study|Adverse Event|10|||
44435528|NCT00657150|79444168|FG000|Overall Study|Non-compliant with protocol|5|||
44435529|NCT00657150|79444169|FG001|Overall Study|Non-compliant with protocol|9|||
44435530|NCT00657150|79444168|FG000|Overall Study|Lost to Follow-up|2|||
44435531|NCT00657150|79444169|FG001|Overall Study|Lost to Follow-up|0|||
44435532|NCT00657150|79444168|FG000|Overall Study|Withdrawal by Subject|51|||
44435533|NCT00657150|79444169|FG001|Overall Study|Withdrawal by Subject|36|||
44435534|NCT00657150|79444168|FG000|Overall Study|Other|38|||
44435535|NCT00657150|79444169|FG001|Overall Study|Other|38|||
44435536|NCT00657150|79444168|FG000|Treatment|Adverse Event|60|||
44435537|NCT00657150|79444169|FG001|Treatment|Adverse Event|53|||
44435538|NCT00657150|79444168|FG000|Treatment|Non-compliant with protocol|10|||
44435539|NCT00657150|79444169|FG001|Treatment|Non-compliant with protocol|9|||
44435540|NCT00657150|79444168|FG000|Treatment|Lost to Follow-up|1|||
44435541|NCT00657150|79444169|FG001|Treatment|Lost to Follow-up|0|||
44435542|NCT00657150|79444168|FG000|Treatment|Withdrawal by Subject|23|||
44435543|NCT00657150|79444169|FG001|Treatment|Withdrawal by Subject|20|||
44435544|NCT00657150|79444168|FG000|Treatment|Other|13|||
44435545|NCT00657150|79444169|FG001|Treatment|Other|15|||
44435546|NCT00670748|79444179|FG000|Overall Study|Death during treatment|1|||
44435547|NCT00670748|79444180|FG001|Overall Study|Death during treatment|1|||
44435548|NCT00670748|79444181|FG002|Overall Study|Death during treatment|1|||
44435549|NCT00670748|79444182|FG003|Overall Study|Death during treatment|0|||
44435550|NCT00670748|79444179|FG000|Overall Study|Not off study|2|||
44435551|NCT00670748|79444180|FG001|Overall Study|Not off study|1|||
44435552|NCT00670748|79444181|FG002|Overall Study|Not off study|1|||
44435553|NCT00670748|79444182|FG003|Overall Study|Not off study|1|||
44435554|NCT00646776|79444194|FG000|Overall Study|Adverse Event|1|||
44435555|NCT00646776|79444195|FG001|Overall Study|Adverse Event|9|||
44435556|NCT00646776|79444194|FG000|Overall Study|Investigator discretion|0|||
44435557|NCT00646776|79444195|FG001|Overall Study|Investigator discretion|4|||
44435558|NCT00655668|79444204|FG000|Overall Study|Adverse Event|6|||
44435559|NCT00655668|79444204|FG000|Overall Study|Death|5|||
44435560|NCT00655668|79444204|FG000|Overall Study|Disease Progression|27|||
44435561|NCT00655668|79444204|FG000|Overall Study|Study Terminated|9|||
44435562|NCT00655668|79444204|FG000|Overall Study|Other|1|||
44435563|NCT00655668|79444204|FG000|Overall Study|New Lymphoma Treatment Started|4|||
44435564|NCT00655668|79444204|FG000|Overall Study|Withdrawal by Subject|2|||
44435565|NCT00569166|79444211|FG000|Overall Study|Withdrawal by Subject|7|||
44435566|NCT00569166|79444212|FG001|Overall Study|Withdrawal by Subject|5|||
44435567|NCT00569166|79444213|FG002|Overall Study|Withdrawal by Subject|3|||
44435568|NCT00569166|79444211|FG000|Overall Study|Lost to Follow-up|2|||
44435569|NCT00569166|79444212|FG001|Overall Study|Lost to Follow-up|1|||
44435570|NCT00569166|79444213|FG002|Overall Study|Lost to Follow-up|1|||
44435571|NCT00655356|79444223|FG000|Overall Study|Withdrawal by Subject|3|||
44435572|NCT00655356|79444224|FG001|Overall Study|Withdrawal by Subject|4|||
44435573|NCT00655356|79444223|FG000|Overall Study|Sponsor Request|10|||
44435574|NCT00655356|79444224|FG001|Overall Study|Sponsor Request|4|||
44435575|NCT00655356|79444223|FG000|Overall Study|Adverse Event|1|||
44435576|NCT00655356|79444224|FG001|Overall Study|Adverse Event|1|||
44435577|NCT00655356|79444223|FG000|Overall Study|Protocol Violation|2|||
44435578|NCT00655356|79444224|FG001|Overall Study|Protocol Violation|1|||
44259270|NCT03589976|79117236|FG000|Overall Study|Adverse Event|5|||
44435579|NCT00655356|79444223|FG000|Overall Study|Other Reason|1|||
44435580|NCT00655356|79444224|FG001|Overall Study|Other Reason|0|||
44435581|NCT00571064|79444230|FG000|Overall Study|Adverse Event|13|||
44435582|NCT00571064|79444230|FG000|Overall Study|Protocol Violation|4|||
44435583|NCT00571064|79444230|FG000|Overall Study|Withdrawal by Subject|2|||
44435584|NCT00571064|79444230|FG000|Overall Study|Other|2|||
44435585|NCT03895372|79444243|FG000|Investigational Treatment Period|Adverse Event|1|||
44435586|NCT03895372|79444244|FG001|Investigational Treatment Period|Adverse Event|0|||
44435587|NCT03895372|79444245|FG002|Investigational Treatment Period|Adverse Event|0|||
44435588|NCT03895372|79444246|FG003|Investigational Treatment Period|Adverse Event|0|||
44435589|NCT03895372|79444247|FG004|Investigational Treatment Period|Adverse Event|0|||
44435590|NCT03895372|79444248|FG005|Investigational Treatment Period|Adverse Event|0|||
44435591|NCT03895372|79444249|FG006|Investigational Treatment Period|Adverse Event|4|||
44435592|NCT03895372|79444250|FG007|Investigational Treatment Period|Adverse Event|3|||
44435593|NCT03895372|79444243|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
44435594|NCT03895372|79444244|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
44435595|NCT03895372|79444245|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
44435596|NCT03895372|79444246|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
44435597|NCT03895372|79444247|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
44435598|NCT03895372|79444248|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
44435599|NCT03895372|79444249|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
44435600|NCT03895372|79444250|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
44435601|NCT03895372|79444243|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
44435602|NCT03895372|79444244|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
44435603|NCT03895372|79444245|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
44435604|NCT03895372|79444246|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
44435605|NCT03895372|79444247|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
44435606|NCT03895372|79444248|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
44435607|NCT03895372|79444249|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
44435608|NCT03895372|79444250|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
44435609|NCT03895372|79444243|FG000|Investigational Treatment Period|Other|0|||
44435610|NCT03895372|79444244|FG001|Investigational Treatment Period|Other|0|||
44435611|NCT03895372|79444245|FG002|Investigational Treatment Period|Other|0|||
44435612|NCT03895372|79444246|FG003|Investigational Treatment Period|Other|0|||
44435613|NCT03895372|79444247|FG004|Investigational Treatment Period|Other|0|||
44435614|NCT03895372|79444248|FG005|Investigational Treatment Period|Other|1|||
44435615|NCT03895372|79444249|FG006|Investigational Treatment Period|Other|0|||
44435616|NCT03895372|79444250|FG007|Investigational Treatment Period|Other|2|||
44435617|NCT03895372|79444243|FG000|Investigational Treatment Period|Protocol Violation|0|||
44435618|NCT03895372|79444244|FG001|Investigational Treatment Period|Protocol Violation|0|||
44435619|NCT03895372|79444245|FG002|Investigational Treatment Period|Protocol Violation|0|||
44435620|NCT03895372|79444246|FG003|Investigational Treatment Period|Protocol Violation|1|||
44435621|NCT03895372|79444247|FG004|Investigational Treatment Period|Protocol Violation|0|||
44435622|NCT03895372|79444248|FG005|Investigational Treatment Period|Protocol Violation|0|||
44435623|NCT03895372|79444249|FG006|Investigational Treatment Period|Protocol Violation|0|||
44336695|NCT04868890|79341217|FG000|Overall Study|Withdrawal by Subject|1|||
44336696|NCT04868890|79341218|FG001|Overall Study|Withdrawal by Subject|5|||
44336697|NCT01281189|79341226|FG000|Overall Study|Adverse Event|7|||
44336698|NCT01281189|79341227|FG001|Overall Study|Adverse Event|9|||
44435624|NCT03895372|79444250|FG007|Investigational Treatment Period|Protocol Violation|0|||
44435625|NCT03895372|79444243|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
44435626|NCT03895372|79444244|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
44435627|NCT03895372|79444245|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
44435628|NCT03895372|79444246|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
44435629|NCT03895372|79444247|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
44435630|NCT03895372|79444248|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
44540152|NCT03265119|79552014|FG000|Overall Study|Lack of Efficacy|3|||
44540153|NCT03265119|79552015|FG001|Overall Study|Lack of Efficacy|0|||
44336699|NCT01281189|79341226|FG000|Overall Study|Lost to Follow-up|6|||
44336700|NCT01281189|79341227|FG001|Overall Study|Lost to Follow-up|4|||
44336701|NCT01281189|79341226|FG000|Overall Study|Withdrawal by Subject|21|||
44336702|NCT01281189|79341227|FG001|Overall Study|Withdrawal by Subject|24|||
44336703|NCT01281189|79341226|FG000|Overall Study|Physician Decision|2|||
44435631|NCT03895372|79444249|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
44540154|NCT03265119|79552014|FG000|Overall Study|Protocol Violation|1|||
44540155|NCT03265119|79552015|FG001|Overall Study|Protocol Violation|2|||
44540156|NCT03265119|79552014|FG000|Overall Study|Withdrawal by Subject|2|||
44435632|NCT03895372|79444250|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
44435633|NCT03895372|79444243|FG000|Extension Treatment Period|Adverse Event|0|||
44435634|NCT03895372|79444244|FG001|Extension Treatment Period|Adverse Event|1|||
44540157|NCT03265119|79552015|FG001|Overall Study|Withdrawal by Subject|4|||
44540158|NCT03265119|79552014|FG000|Overall Study|Lost to Follow-up|1|||
44336704|NCT01281189|79341227|FG001|Overall Study|Physician Decision|3|||
44435635|NCT03895372|79444245|FG002|Extension Treatment Period|Adverse Event|0|||
44435636|NCT03895372|79444246|FG003|Extension Treatment Period|Adverse Event|1|||
44435637|NCT03895372|79444247|FG004|Extension Treatment Period|Adverse Event|0|||
44435638|NCT03895372|79444248|FG005|Extension Treatment Period|Adverse Event|0|||
44540159|NCT03265119|79552015|FG001|Overall Study|Lost to Follow-up|0|||
44540160|NCT03265119|79552014|FG000|Overall Study|Lack of Compliance|1|||
44540161|NCT03265119|79552015|FG001|Overall Study|Lack of Compliance|0|||
44540162|NCT04952701|79552021|FG000|Control Lens|Physician Decision|4|||
44540163|NCT04952701|79552021|FG000|Test Lens|Physician Decision|1|||
44540164|NCT04723173|79552027|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
44540165|NCT04919161|79552041|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
44540166|NCT04919161|79552042|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
44540167|NCT04919161|79552041|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
44540168|NCT04919161|79552042|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
44540169|NCT04919161|79552041|FG000|Overall Study|Acute ankle sprain after session 1|0|||
44540170|NCT04919161|79552042|FG001|Overall Study|Acute ankle sprain after session 1|1|||
44540171|NCT03262389|79552070|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
44540172|NCT03262389|79552070|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
44540173|NCT03262389|79552070|FG000|Overall Study|opted out of PET/MR|1|||
44540174|NCT03262233|79552078|FG000|Overall Study|Withdrawal by Subject|12|||
44540175|NCT03262233|79552079|FG001|Overall Study|Withdrawal by Subject|8|||
44540176|NCT03262233|79552080|FG002|Overall Study|Withdrawal by Subject|21|||
44540177|NCT03262233|79552081|FG003|Overall Study|Withdrawal by Subject|13|||
44540178|NCT03262233|79552078|FG000|Overall Study|Declined due to shock|1|||
44540179|NCT03262233|79552079|FG001|Overall Study|Declined due to shock|2|||
44540180|NCT03262233|79552080|FG002|Overall Study|Declined due to shock|2|||
44540181|NCT03262233|79552081|FG003|Overall Study|Declined due to shock|3|||
44540182|NCT03262233|79552078|FG000|Overall Study|Protocol Violation|5|||
44540183|NCT03262233|79552079|FG001|Overall Study|Protocol Violation|10|||
44540184|NCT03262233|79552080|FG002|Overall Study|Protocol Violation|2|||
44540185|NCT03262233|79552081|FG003|Overall Study|Protocol Violation|13|||
44540186|NCT03262233|79552078|FG000|Overall Study|data collection artifact|0|||
44540187|NCT03262233|79552079|FG001|Overall Study|data collection artifact|1|||
44540188|NCT03262233|79552080|FG002|Overall Study|data collection artifact|0|||
44540189|NCT03262233|79552081|FG003|Overall Study|data collection artifact|0|||
44540190|NCT03261531|79552092|FG000|Overall Study|Withdrawal by Subject|4|||
44540191|NCT04151290|79552096|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
44540192|NCT03260205|79552115|FG000|Overall Study|Adverse Event|2|||
44336705|NCT01281189|79341226|FG000|Overall Study|Death|103|||
44336706|NCT01281189|79341227|FG001|Overall Study|Death|91|||
44336707|NCT01281189|79341226|FG000|Overall Study|Other|8|||
44336708|NCT01281189|79341227|FG001|Overall Study|Other|12|||
44336709|NCT01280955|79341233|FG000|Overall Study|Death|2|||
44336710|NCT01280955|79341233|FG000|Overall Study|Withdrawal by Subject|1|||
44336711|NCT01280721|79341239|FG000|Overall Study|Adverse Event|4|||
44336712|NCT01280721|79341239|FG000|Overall Study|Physician Decision|3|||
44336713|NCT01280721|79341239|FG000|Overall Study|Withdrawal by Subject|6|||
44336714|NCT01280721|79341239|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
44336715|NCT01280721|79341239|FG000|Overall Study|No tolerability for the lowest dose|2|||
44336716|NCT01087762|79341257|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
44336717|NCT01087762|79341258|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
44336718|NCT01087762|79341259|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
44336719|NCT01087762|79341260|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
44336720|NCT01087762|79341261|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
44157489|NCT02686658|78949261|FG004|Overall Study|Death|1|||
44157490|NCT02686658|78949262|FG005|Overall Study|Death|1|||
44157491|NCT02686658|78949257|FG000|Overall Study|Withdrawal by Subject|2|||
44336721|NCT01087762|79341257|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
44336722|NCT01087762|79341258|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
44435639|NCT03895372|79444249|FG006|Extension Treatment Period|Adverse Event|3|||
44540193|NCT03260205|79552116|FG001|Overall Study|Adverse Event|0|||
44540194|NCT03260205|79552117|FG002|Overall Study|Adverse Event|2|||
44540195|NCT03260205|79552118|FG003|Overall Study|Adverse Event|2|||
44540196|NCT03260205|79552119|FG004|Overall Study|Adverse Event|4|||
44540197|NCT03260205|79552115|FG000|Overall Study|Lost to Follow-up|2|||
44540198|NCT03260205|79552116|FG001|Overall Study|Lost to Follow-up|2|||
44540199|NCT03260205|79552117|FG002|Overall Study|Lost to Follow-up|1|||
44336723|NCT01087762|79341259|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
44157492|NCT02686658|78949258|FG001|Overall Study|Withdrawal by Subject|5|||
44435640|NCT03895372|79444250|FG007|Extension Treatment Period|Adverse Event|3|||
44435641|NCT03895372|79444243|FG000|Extension Treatment Period|Other|1|||
44435642|NCT03895372|79444244|FG001|Extension Treatment Period|Other|3|||
44435643|NCT03895372|79444245|FG002|Extension Treatment Period|Other|0|||
44435644|NCT03895372|79444246|FG003|Extension Treatment Period|Other|0|||
44435645|NCT03895372|79444247|FG004|Extension Treatment Period|Other|1|||
44435646|NCT03895372|79444248|FG005|Extension Treatment Period|Other|0|||
44435647|NCT03895372|79444249|FG006|Extension Treatment Period|Other|0|||
44435648|NCT03895372|79444250|FG007|Extension Treatment Period|Other|2|||
44435649|NCT03895372|79444243|FG000|Extension Treatment Period|Pregnancy|0|||
44435650|NCT03895372|79444244|FG001|Extension Treatment Period|Pregnancy|0|||
44435651|NCT03895372|79444245|FG002|Extension Treatment Period|Pregnancy|0|||
44435652|NCT03895372|79444246|FG003|Extension Treatment Period|Pregnancy|0|||
44435653|NCT03895372|79444247|FG004|Extension Treatment Period|Pregnancy|1|||
44435654|NCT03895372|79444248|FG005|Extension Treatment Period|Pregnancy|0|||
44435655|NCT03895372|79444249|FG006|Extension Treatment Period|Pregnancy|0|||
44336724|NCT01087762|79341260|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
44336725|NCT01087762|79341261|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
44336726|NCT01087762|79341257|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
44336727|NCT01087762|79341258|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
44336728|NCT01087762|79341259|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
44435656|NCT03895372|79444250|FG007|Extension Treatment Period|Pregnancy|0|||
44435657|NCT03895372|79444243|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
44540200|NCT03260205|79552118|FG003|Overall Study|Lost to Follow-up|1|||
44336729|NCT01087762|79341260|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
44336730|NCT01087762|79341261|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
44336731|NCT01087762|79341257|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
44336732|NCT01087762|79341258|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
44336733|NCT01087762|79341259|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
44336734|NCT01087762|79341260|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
44336735|NCT01087762|79341261|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
44336736|NCT01087762|79341257|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
44336737|NCT01087762|79341258|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
44336738|NCT01087762|79341259|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
44336739|NCT01087762|79341260|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
44336740|NCT01087762|79341261|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
44336741|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
44336742|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
44336743|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
44157493|NCT02686658|78949259|FG002|Overall Study|Withdrawal by Subject|4|||
44157494|NCT02686658|78949260|FG003|Overall Study|Withdrawal by Subject|4|||
44336744|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
44336745|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
44336746|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
44336747|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
44336748|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
44336749|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
44336750|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
44336751|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
44336752|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
44336753|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
44336754|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
44336755|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
44336756|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
44336757|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
44336758|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
44336759|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
44336760|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
44336761|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
44336762|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
44336763|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
44336764|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
44336765|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
44336766|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
44336767|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
44336768|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
44336769|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
44336770|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
44336771|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
44336772|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
44336773|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
44336774|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
44336775|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
44540201|NCT03260205|79552119|FG004|Overall Study|Lost to Follow-up|5|||
44540202|NCT03260205|79552115|FG000|Overall Study|Protocol Violation|0|||
44540203|NCT03260205|79552116|FG001|Overall Study|Protocol Violation|0|||
44540204|NCT03260205|79552117|FG002|Overall Study|Protocol Violation|2|||
44540205|NCT03260205|79552118|FG003|Overall Study|Protocol Violation|0|||
44540206|NCT03260205|79552119|FG004|Overall Study|Protocol Violation|1|||
44540207|NCT03260205|79552115|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
44540208|NCT03260205|79552116|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
44540209|NCT03260205|79552117|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
44540210|NCT03260205|79552118|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
44540211|NCT03260205|79552119|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
44540212|NCT03260205|79552115|FG000|Overall Study|Other: Unspecified|0|||
44540213|NCT03260205|79552116|FG001|Overall Study|Other: Unspecified|0|||
44540214|NCT03260205|79552117|FG002|Overall Study|Other: Unspecified|3|||
44540215|NCT03260205|79552118|FG003|Overall Study|Other: Unspecified|1|||
44540216|NCT03260205|79552119|FG004|Overall Study|Other: Unspecified|1|||
44540217|NCT03260205|79552115|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
44540218|NCT03260205|79552116|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
44540219|NCT03260205|79552117|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
44336776|NCT01087762|79341257|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
44336777|NCT01087762|79341258|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
44336778|NCT01087762|79341259|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
44336779|NCT01087762|79341260|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
44336780|NCT01087762|79341261|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
44336781|NCT01078168|79341273|FG000|Overall Study|Physician Decision|0|||
44336782|NCT01078168|79341274|FG001|Overall Study|Physician Decision|1|||
44336783|NCT01086358|79341280|FG000|First Intervention|Lost to Follow-up|9|||
44435658|NCT03895372|79444244|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
44435659|NCT03895372|79444245|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
44435660|NCT03895372|79444246|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
44435661|NCT03895372|79444247|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
44435662|NCT03895372|79444248|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
44435663|NCT03895372|79444249|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
44435664|NCT03895372|79444250|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
44435665|NCT00669110|79444275|FG000|Overall Study|Adverse Event|4|||
44435666|NCT00669110|79444276|FG001|Overall Study|Adverse Event|3|||
44435667|NCT00669110|79444275|FG000|Overall Study|Caregiver request|3|||
44435668|NCT00669110|79444276|FG001|Overall Study|Caregiver request|2|||
44540220|NCT03260205|79552118|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
44540221|NCT03260205|79552119|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
44540222|NCT04666441|79552144|FG000|Overall Study|Lost to Follow-up|1|||
44540223|NCT04666441|79552145|FG001|Overall Study|Lost to Follow-up|4|||
44540224|NCT04666441|79552146|FG002|Overall Study|Lost to Follow-up|1|||
44540225|NCT04666441|79552147|FG003|Overall Study|Lost to Follow-up|3|||
44540226|NCT04666441|79552148|FG004|Overall Study|Lost to Follow-up|0|||
44540227|NCT04666441|79552149|FG005|Overall Study|Lost to Follow-up|2|||
44540228|NCT04666441|79552150|FG006|Overall Study|Lost to Follow-up|2|||
44540229|NCT04666441|79552151|FG007|Overall Study|Lost to Follow-up|2|||
44540230|NCT04666441|79552144|FG000|Overall Study|Subject Decision|1|||
44540231|NCT04666441|79552145|FG001|Overall Study|Subject Decision|1|||
44540232|NCT04666441|79552146|FG002|Overall Study|Subject Decision|3|||
44540233|NCT04666441|79552147|FG003|Overall Study|Subject Decision|1|||
44540234|NCT04666441|79552148|FG004|Overall Study|Subject Decision|0|||
44540235|NCT04666441|79552149|FG005|Overall Study|Subject Decision|1|||
44540236|NCT04666441|79552150|FG006|Overall Study|Subject Decision|3|||
44540237|NCT04666441|79552151|FG007|Overall Study|Subject Decision|2|||
44540238|NCT03320850|79552188|FG000|Overall Study|Lost to Follow-up|0|||
44540239|NCT03320850|79552189|FG001|Overall Study|Lost to Follow-up|0|||
44540240|NCT03320850|79552190|FG002|Overall Study|Lost to Follow-up|0|||
44540241|NCT03320850|79552191|FG003|Overall Study|Lost to Follow-up|0|||
44540242|NCT03320850|79552192|FG004|Overall Study|Lost to Follow-up|1|||
44336784|NCT01086358|79341281|FG001|First Intervention|Lost to Follow-up|4|||
44540243|NCT03320850|79552193|FG005|Overall Study|Lost to Follow-up|2|||
44336785|NCT01086358|79341280|FG000|First Intervention|Withdrawal by Subject|0|||
44336786|NCT01086358|79341281|FG001|First Intervention|Withdrawal by Subject|1|||
44336787|NCT01086358|79341280|FG000|Second Intervention|Lost to Follow-up|4|||
44435669|NCT00669110|79444275|FG000|Overall Study|Physician Decision|0|||
44540244|NCT03320850|79552194|FG006|Overall Study|Lost to Follow-up|2|||
44540245|NCT03320850|79552195|FG007|Overall Study|Lost to Follow-up|0|||
44540246|NCT03320850|79552196|FG008|Overall Study|Lost to Follow-up|6|||
44540247|NCT03320850|79552197|FG009|Overall Study|Lost to Follow-up|4|||
44336788|NCT01086358|79341281|FG001|Second Intervention|Lost to Follow-up|4|||
44336789|NCT01277601|79341291|FG000|Overall Study|Adverse Event|5|||
44336790|NCT01277601|79341292|FG001|Overall Study|Adverse Event|3|||
44336791|NCT01277601|79341293|FG002|Overall Study|Adverse Event|0|||
44336792|NCT01277601|79341294|FG003|Overall Study|Adverse Event|7|||
44336793|NCT01277601|79341291|FG000|Overall Study|Withdrawal by Subject|18|||
44336794|NCT01277601|79341292|FG001|Overall Study|Withdrawal by Subject|21|||
44336795|NCT01277601|79341293|FG002|Overall Study|Withdrawal by Subject|8|||
44336796|NCT01277601|79341294|FG003|Overall Study|Withdrawal by Subject|17|||
44336797|NCT01277601|79341291|FG000|Overall Study|Lost to Follow-up|7|||
44336798|NCT01277601|79341292|FG001|Overall Study|Lost to Follow-up|9|||
44336799|NCT01277601|79341293|FG002|Overall Study|Lost to Follow-up|4|||
44336800|NCT01277601|79341294|FG003|Overall Study|Lost to Follow-up|2|||
44336801|NCT01277601|79341291|FG000|Overall Study|Physician Decision|3|||
44336802|NCT01277601|79341292|FG001|Overall Study|Physician Decision|5|||
44435670|NCT00669110|79444276|FG001|Overall Study|Physician Decision|1|||
44435671|NCT00669110|79444275|FG000|Overall Study|Lost to Follow-up|1|||
44435672|NCT00669110|79444276|FG001|Overall Study|Lost to Follow-up|0|||
44435673|NCT00669110|79444275|FG000|Overall Study|Protocol Violation|0|||
44435674|NCT00669110|79444276|FG001|Overall Study|Protocol Violation|5|||
44435675|NCT00669110|79444275|FG000|Overall Study|Withdrawal by Subject|0|||
44435676|NCT00669110|79444276|FG001|Overall Study|Withdrawal by Subject|2|||
44435677|NCT00654732|79444284|FG000|Overall Study|Adverse Event|4|||
44435678|NCT00654732|79444285|FG001|Overall Study|Adverse Event|6|||
44435679|NCT00649428|79444293|FG000|Overall Study|Adverse Event|2|||
44435680|NCT00649428|79444294|FG001|Overall Study|Adverse Event|2|||
44435681|NCT00649428|79444293|FG000|Overall Study|Withdrawal by Subject|6|||
44435682|NCT00649428|79444294|FG001|Overall Study|Withdrawal by Subject|6|||
44435683|NCT00649428|79444293|FG000|Overall Study|Lost to Follow-up|1|||
44435684|NCT00649428|79444294|FG001|Overall Study|Lost to Follow-up|3|||
44435685|NCT00649428|79444293|FG000|Overall Study|Insufficient manufacturing yield|5|||
44435686|NCT00649428|79444294|FG001|Overall Study|Insufficient manufacturing yield|1|||
44435687|NCT00649428|79444293|FG000|Overall Study|Protocol Violation|6|||
44435688|NCT00649428|79444294|FG001|Overall Study|Protocol Violation|2|||
44435689|NCT00649428|79444293|FG000|Overall Study|Physician Decision|0|||
44435690|NCT00649428|79444294|FG001|Overall Study|Physician Decision|1|||
44435691|NCT00669032|79444303|FG000|Overall Study|Lost to Follow-up|6|||
44435692|NCT00669032|79444304|FG001|Overall Study|Lost to Follow-up|5|||
44435693|NCT00669032|79444303|FG000|Overall Study|Lack of Efficacy|8|||
44435694|NCT00669032|79444304|FG001|Overall Study|Lack of Efficacy|19|||
44435695|NCT00669032|79444303|FG000|Overall Study|Withdrawal by Subject|12|||
44435696|NCT00669032|79444304|FG001|Overall Study|Withdrawal by Subject|13|||
44435697|NCT00669032|79444303|FG000|Overall Study|Adverse Event|12|||
44435698|NCT00669032|79444304|FG001|Overall Study|Adverse Event|16|||
44435699|NCT00669032|79444303|FG000|Overall Study|Physician Decision|1|||
44435700|NCT00669032|79444304|FG001|Overall Study|Physician Decision|1|||
44435701|NCT00669032|79444303|FG000|Overall Study|No fulfilment of the selection criteria|5|||
44435702|NCT00669032|79444304|FG001|Overall Study|No fulfilment of the selection criteria|5|||
44435703|NCT00654498|79444312|FG000|Overall Study|Not Treated|1|||
44435704|NCT00654498|79444313|FG001|Overall Study|Not Treated|0|||
44435705|NCT00654498|79444312|FG000|Overall Study|Adverse Event|6|||
44435706|NCT00654498|79444313|FG001|Overall Study|Adverse Event|1|||
44435707|NCT00654498|79444312|FG000|Overall Study|Protocol Violation|1|||
44435708|NCT00654498|79444313|FG001|Overall Study|Protocol Violation|1|||
44435709|NCT00654498|79444312|FG000|Overall Study|Lost to Follow-up|1|||
44435710|NCT00654498|79444313|FG001|Overall Study|Lost to Follow-up|5|||
44435711|NCT00654498|79444312|FG000|Overall Study|Withdrawal by Subject|1|||
44435712|NCT00654498|79444313|FG001|Overall Study|Withdrawal by Subject|0|||
44435713|NCT00654498|79444312|FG000|Overall Study|Other reason not defined above|4|||
44435714|NCT00654498|79444313|FG001|Overall Study|Other reason not defined above|5|||
44435715|NCT00670046|79444321|FG000|Overall Study|Lost to Follow-up|1|||
44435716|NCT00670046|79444322|FG001|Overall Study|Lost to Follow-up|1|||
44435717|NCT00670046|79444321|FG000|Overall Study|Withdrawal by Subject|0|||
44336803|NCT01277601|79341293|FG002|Overall Study|Physician Decision|1|||
44336804|NCT01277601|79341294|FG003|Overall Study|Physician Decision|6|||
44336805|NCT01277601|79341291|FG000|Overall Study|Pregnancy|2|||
44336806|NCT01277601|79341292|FG001|Overall Study|Pregnancy|2|||
44336807|NCT01277601|79341293|FG002|Overall Study|Pregnancy|4|||
44336808|NCT01277601|79341294|FG003|Overall Study|Pregnancy|1|||
44336809|NCT01277601|79341291|FG000|Overall Study|Noncompliance with Study Drug|1|||
44435718|NCT00670046|79444322|FG001|Overall Study|Withdrawal by Subject|1|||
44336810|NCT01277601|79341292|FG001|Overall Study|Noncompliance with Study Drug|3|||
44336811|NCT01277601|79341293|FG002|Overall Study|Noncompliance with Study Drug|2|||
44336812|NCT01277601|79341294|FG003|Overall Study|Noncompliance with Study Drug|0|||
44336813|NCT01277601|79341291|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
44435719|NCT00560391|79444333|FG000|Overall Study|Still on treatment|0|||
44435720|NCT00560391|79444334|FG001|Overall Study|Still on treatment|0|||
44435721|NCT00560391|79444335|FG002|Overall Study|Still on treatment|0|||
44435722|NCT00560391|79444336|FG003|Overall Study|Still on treatment|1|||
44435723|NCT00560391|79444337|FG004|Overall Study|Still on treatment|2|||
44435724|NCT00537238|79444352|FG000|Overall Study|Death|1|||
44435725|NCT00537238|79444353|FG001|Overall Study|Death|2|||
44435726|NCT00537238|79444352|FG000|Overall Study|Adverse Event|31|||
44435727|NCT00537238|79444353|FG001|Overall Study|Adverse Event|22|||
44435728|NCT00537238|79444352|FG000|Overall Study|Lack of Efficacy|20|||
44435729|NCT00537238|79444353|FG001|Overall Study|Lack of Efficacy|21|||
44435730|NCT00537238|79444352|FG000|Overall Study|Lost to Follow-up|12|||
44435731|NCT00537238|79444353|FG001|Overall Study|Lost to Follow-up|8|||
44435732|NCT00537238|79444352|FG000|Overall Study|Withdrawal by Subject|51|||
44435733|NCT00537238|79444353|FG001|Overall Study|Withdrawal by Subject|47|||
44435734|NCT00537238|79444352|FG000|Overall Study|Protocol Violation|15|||
44435735|NCT00537238|79444353|FG001|Overall Study|Protocol Violation|19|||
44435736|NCT00537238|79444352|FG000|Overall Study|Does not meet entrance criteria|0|||
44435737|NCT00537238|79444353|FG001|Overall Study|Does not meet entrance criteria|2|||
44435738|NCT00537238|79444352|FG000|Overall Study|Other|44|||
44435739|NCT00537238|79444353|FG001|Overall Study|Other|52|||
44540248|NCT03320850|79552188|FG000|Overall Study|Withdrawal by Subject|0|||
44540249|NCT03320850|79552189|FG001|Overall Study|Withdrawal by Subject|0|||
44540250|NCT03320850|79552190|FG002|Overall Study|Withdrawal by Subject|0|||
44540251|NCT03320850|79552191|FG003|Overall Study|Withdrawal by Subject|0|||
44540252|NCT03320850|79552192|FG004|Overall Study|Withdrawal by Subject|1|||
44540253|NCT03320850|79552193|FG005|Overall Study|Withdrawal by Subject|2|||
44540254|NCT03320850|79552194|FG006|Overall Study|Withdrawal by Subject|4|||
44540255|NCT03320850|79552195|FG007|Overall Study|Withdrawal by Subject|5|||
44540256|NCT03320850|79552196|FG008|Overall Study|Withdrawal by Subject|2|||
44540257|NCT03320850|79552197|FG009|Overall Study|Withdrawal by Subject|1|||
44540258|NCT03320850|79552188|FG000|Overall Study|Lack of Efficacy|0|||
44540259|NCT03320850|79552189|FG001|Overall Study|Lack of Efficacy|0|||
44540260|NCT03320850|79552190|FG002|Overall Study|Lack of Efficacy|0|||
44540261|NCT03320850|79552191|FG003|Overall Study|Lack of Efficacy|1|||
44540262|NCT03320850|79552192|FG004|Overall Study|Lack of Efficacy|0|||
44540263|NCT03320850|79552193|FG005|Overall Study|Lack of Efficacy|1|||
44540264|NCT03320850|79552194|FG006|Overall Study|Lack of Efficacy|0|||
44540265|NCT03320850|79552195|FG007|Overall Study|Lack of Efficacy|2|||
44540266|NCT03320850|79552196|FG008|Overall Study|Lack of Efficacy|0|||
44540267|NCT03320850|79552197|FG009|Overall Study|Lack of Efficacy|3|||
44540268|NCT03320850|79552188|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
44540269|NCT03320850|79552189|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
44540270|NCT03320850|79552190|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
44540271|NCT03320850|79552191|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
44540272|NCT03320850|79552192|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
44540273|NCT03320850|79552193|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
44157495|NCT02686658|78949261|FG004|Overall Study|Withdrawal by Subject|17|||
44157496|NCT02686658|78949262|FG005|Overall Study|Withdrawal by Subject|8|||
44336814|NCT01277601|79341292|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
44336815|NCT01277601|79341293|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
44336816|NCT01277601|79341294|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
44336817|NCT01277601|79341291|FG000|Overall Study|Protocol Violation|0|||
44336818|NCT01277601|79341292|FG001|Overall Study|Protocol Violation|2|||
44336819|NCT01277601|79341293|FG002|Overall Study|Protocol Violation|5|||
44336820|NCT01277601|79341294|FG003|Overall Study|Protocol Violation|0|||
44336821|NCT01277601|79341291|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
44336822|NCT01277601|79341292|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
44435740|NCT03966885|79444361|FG000|Overall Study|Death|1|||
44540274|NCT03320850|79552194|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
44540275|NCT03320850|79552195|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
44540276|NCT03320850|79552196|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
44336823|NCT01277601|79341293|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
44336824|NCT01277601|79341294|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
44336825|NCT01277523|79341324|FG000|Overall Study|Adverse Event|1|||
44435741|NCT03966885|79444362|FG001|Overall Study|Death|0|||
44435742|NCT03966885|79444361|FG000|Overall Study|Lost to Follow-up|1|||
44336826|NCT01277523|79341325|FG001|Overall Study|Adverse Event|0|||
44435743|NCT03966885|79444362|FG001|Overall Study|Lost to Follow-up|2|||
44435744|NCT03966885|79444361|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
44435745|NCT03966885|79444362|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
44435746|NCT03966885|79444361|FG000|Overall Study|Moved from study area.|0|||
44435747|NCT03966885|79444362|FG001|Overall Study|Moved from study area.|2|||
44435748|NCT03965403|79444369|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
44435749|NCT00552669|79444375|FG000|Overall Study|Death|3|||
44435750|NCT00552669|79444376|FG001|Overall Study|Death|7|||
44435751|NCT00552513|79444384|FG000|Overall Study|Lost to Follow-up|5|||
44435752|NCT00552513|79444385|FG001|Overall Study|Lost to Follow-up|1|||
44435753|NCT00560313|79444393|FG000|Overall Study|Adverse Events or Death|2|||
44435754|NCT00560313|79444393|FG000|Overall Study|Withdrawal by Subject|2|||
44435755|NCT00560313|79444393|FG000|Overall Study|Lost to Follow-up|1|||
44435756|NCT00560313|79444393|FG000|Overall Study|Protocol Violation|1|||
44435757|NCT00667862|79444412|FG000|Overall Study|Adverse Event|9|||
44435758|NCT00667862|79444412|FG000|Overall Study|Death|1|||
44435759|NCT00667862|79444412|FG000|Overall Study|Disease Progression|22|||
44435760|NCT00667862|79444412|FG000|Overall Study|Withdrawal by Subject|3|||
44435761|NCT00535132|79444418|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
44435762|NCT00535132|79444419|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
44435763|NCT00535132|79444418|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
44435764|NCT00535132|79444419|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
44435765|NCT00570908|79444427|FG000|Overall Study|Adverse Event|5|||
44435766|NCT00570908|79444427|FG000|Overall Study|Withdrawal by Subject|2|||
44435767|NCT00321919|79444433|FG000|Overall Study|Adverse Event|17|||
44435768|NCT00321919|79444434|FG001|Overall Study|Adverse Event|10|||
44435769|NCT00321919|79444433|FG000|Overall Study|Death|21|||
44435770|NCT00321919|79444434|FG001|Overall Study|Death|17|||
44435771|NCT00321919|79444433|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44435772|NCT00321919|79444434|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44336827|NCT01277523|79341326|FG002|Overall Study|Adverse Event|0|||
44336828|NCT01277523|79341324|FG000|Overall Study|Protocol Violation|2|||
44336829|NCT01277523|79341325|FG001|Overall Study|Protocol Violation|0|||
44336830|NCT01277523|79341326|FG002|Overall Study|Protocol Violation|0|||
44336831|NCT01277523|79341324|FG000|Overall Study|Other Reason not Defined|0|||
44336832|NCT01277523|79341325|FG001|Overall Study|Other Reason not Defined|1|||
44336833|NCT01277523|79341326|FG002|Overall Study|Other Reason not Defined|0|||
44336834|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
44336835|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
44336836|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
44336837|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
44336838|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
44336839|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
44336840|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
44336841|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
44336842|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
44336843|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
44336844|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Death|1|||
44336845|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Death|0|||
44336846|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Death|0|||
44336847|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Death|0|||
44336848|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Death|0|||
44336849|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
44336850|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
44336851|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
44336852|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
44435773|NCT00321919|79444433|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
44435774|NCT00321919|79444434|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
44435775|NCT00321919|79444433|FG000|Overall Study|Refused Treatment|23|||
44435776|NCT00321919|79444434|FG001|Overall Study|Refused Treatment|14|||
44435777|NCT00321919|79444433|FG000|Overall Study|Other Protocol Violation|2|||
44435778|NCT00321919|79444434|FG001|Overall Study|Other Protocol Violation|3|||
44435779|NCT00321919|79444433|FG000|Overall Study|Failure to Return|3|||
44435780|NCT00321919|79444434|FG001|Overall Study|Failure to Return|1|||
44435781|NCT00321919|79444433|FG000|Overall Study|Other withdrawal reason|7|||
44336853|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
44336854|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
44336855|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
44336856|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
44336857|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
44336858|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
44336859|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
44336860|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
44435782|NCT00321919|79444434|FG001|Overall Study|Other withdrawal reason|6|||
44435783|NCT00781391|79444444|FG000|Overall Study|never received study drug|24|||
44435784|NCT00781391|79444445|FG001|Overall Study|never received study drug|23|||
44435785|NCT00781391|79444446|FG002|Overall Study|never received study drug|32|||
44435786|NCT00781391|79444444|FG000|Overall Study|Protocol Violation|19|||
44435787|NCT00781391|79444445|FG001|Overall Study|Protocol Violation|17|||
44435788|NCT00781391|79444446|FG002|Overall Study|Protocol Violation|20|||
44435789|NCT00781391|79444444|FG000|Overall Study|Death|789|||
44435790|NCT00781391|79444445|FG001|Overall Study|Death|730|||
44435791|NCT00781391|79444446|FG002|Overall Study|Death|706|||
44435792|NCT00781391|79444444|FG000|Overall Study|Withdrawal by Subject|47|||
44435793|NCT00781391|79444445|FG001|Overall Study|Withdrawal by Subject|37|||
44435794|NCT00781391|79444446|FG002|Overall Study|Withdrawal by Subject|25|||
44435795|NCT00781391|79444444|FG000|Overall Study|Lost to Follow-up|0|||
44435796|NCT00781391|79444445|FG001|Overall Study|Lost to Follow-up|0|||
44435797|NCT00781391|79444446|FG002|Overall Study|Lost to Follow-up|1|||
44435798|NCT00534976|79444456|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
44435799|NCT00534976|79444457|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
44435800|NCT00534976|79444456|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
44435801|NCT00534976|79444457|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
44435802|NCT00534976|79444456|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
44435803|NCT00534976|79444457|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
44435804|NCT00321763|79444467|FG000|Overall Study|Adverse Event|1|||
44435805|NCT00321763|79444468|FG001|Overall Study|Adverse Event|1|||
44435806|NCT00321763|79444469|FG002|Overall Study|Adverse Event|0|||
44435807|NCT00321763|79444470|FG003|Overall Study|Adverse Event|1|||
44435808|NCT00321763|79444467|FG000|Overall Study|Withdrawal by Subject|2|||
44435809|NCT00321763|79444468|FG001|Overall Study|Withdrawal by Subject|0|||
44435810|NCT00321763|79444469|FG002|Overall Study|Withdrawal by Subject|1|||
44435811|NCT00321763|79444470|FG003|Overall Study|Withdrawal by Subject|0|||
44435812|NCT00321763|79444467|FG000|Overall Study|Lost to Follow-up|3|||
44435813|NCT00321763|79444468|FG001|Overall Study|Lost to Follow-up|1|||
44435814|NCT00321763|79444469|FG002|Overall Study|Lost to Follow-up|5|||
44435815|NCT00321763|79444470|FG003|Overall Study|Lost to Follow-up|4|||
44435816|NCT00308113|79444486|FG000|Overall Study|Protocol closure|0|||
44435817|NCT00308113|79444487|FG001|Overall Study|Protocol closure|0|||
44435818|NCT00308113|79444488|FG002|Overall Study|Protocol closure|0|||
44435819|NCT00308113|79444489|FG003|Overall Study|Protocol closure|1|||
44435820|NCT00307801|79444505|FG000|Overall Study|Adverse Event|12|||
44435821|NCT00307801|79444506|FG001|Overall Study|Adverse Event|4|||
44435822|NCT00307801|79444505|FG000|Overall Study|Withdrawal by Subject|9|||
44435823|NCT00307801|79444506|FG001|Overall Study|Withdrawal by Subject|4|||
44435824|NCT00307801|79444505|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
44435825|NCT00307801|79444506|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
44540277|NCT03320850|79552197|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
44259271|NCT03589976|79117237|FG001|Overall Study|Adverse Event|1|||
44259272|NCT03589976|79117236|FG000|Overall Study|Withdrawal by Subject|4|||
44259273|NCT03589976|79117237|FG001|Overall Study|Withdrawal by Subject|1|||
44259274|NCT03589976|79117236|FG000|Overall Study|Lost to Follow-up|1|||
44259275|NCT03589976|79117237|FG001|Overall Study|Lost to Follow-up|0|||
44259276|NCT03589976|79117236|FG000|Overall Study|Other|4|||
44259277|NCT03589976|79117237|FG001|Overall Study|Other|3|||
44259278|NCT03029780|79117393|FG000|Overall Study|Disease Progression|20|||
44259279|NCT03029780|79117394|FG001|Overall Study|Disease Progression|22|||
44259280|NCT03029780|79117393|FG000|Overall Study|Study Drug Toxicity|15|||
44259281|NCT03029780|79117394|FG001|Overall Study|Study Drug Toxicity|11|||
44259282|NCT03029780|79117393|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
44259283|NCT03029780|79117394|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
44259284|NCT03029780|79117393|FG000|Overall Study|Participant request to discontinue study treatment|4|||
44259285|NCT03029780|79117394|FG001|Overall Study|Participant request to discontinue study treatment|1|||
44259286|NCT03029780|79117393|FG000|Overall Study|Maximum clinical benefit|1|||
44259287|NCT03029780|79117394|FG001|Overall Study|Maximum clinical benefit|0|||
44259288|NCT03029780|79117393|FG000|Overall Study|Participant no longer meets study criteria|0|||
44435826|NCT00307801|79444505|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
44435827|NCT00307801|79444506|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
44435828|NCT00307801|79444505|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
44435829|NCT00307801|79444506|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
44435830|NCT00307801|79444505|FG000|Overall Study|Wrong Randomization|1|||
44435831|NCT00307801|79444506|FG001|Overall Study|Wrong Randomization|0|||
44435832|NCT00307801|79444505|FG000|Overall Study|Lack of Efficacy|0|||
44435833|NCT00307801|79444506|FG001|Overall Study|Lack of Efficacy|2|||
44435834|NCT00307801|79444505|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
44435835|NCT00307801|79444506|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
44435836|NCT00307801|79444505|FG000|Overall Study|Frustration with e-diary|1|||
44435837|NCT00307801|79444506|FG001|Overall Study|Frustration with e-diary|0|||
44435838|NCT00307801|79444505|FG000|Overall Study|Protocol Violation|3|||
44435839|NCT00307801|79444506|FG001|Overall Study|Protocol Violation|2|||
44435840|NCT00307801|79444505|FG000|Overall Study|No reason specified|2|||
44435841|NCT00307801|79444506|FG001|Overall Study|No reason specified|0|||
44435842|NCT00307801|79444505|FG000|Overall Study|Pregnancy|0|||
44435843|NCT00307801|79444506|FG001|Overall Study|Pregnancy|1|||
44435844|NCT00671060|79444515|FG000|Overall Study|Protocol Violation|1|||
44435845|NCT00671060|79444516|FG001|Overall Study|Protocol Violation|0|||
44435846|NCT00671060|79444515|FG000|Overall Study|Physician Decision|0|||
44435847|NCT00671060|79444516|FG001|Overall Study|Physician Decision|1|||
44435848|NCT00654420|79444526|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
44435849|NCT00654420|79444527|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
44435850|NCT00654420|79444528|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
44435851|NCT00654420|79444529|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
44435852|NCT00654420|79444526|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
44540278|NCT03320850|79552188|FG000|Overall Study|Adverse Event|0|||
44540279|NCT03320850|79552189|FG001|Overall Study|Adverse Event|0|||
44540280|NCT03320850|79552190|FG002|Overall Study|Adverse Event|0|||
44540281|NCT03320850|79552191|FG003|Overall Study|Adverse Event|0|||
44540282|NCT03320850|79552192|FG004|Overall Study|Adverse Event|0|||
44540283|NCT03320850|79552193|FG005|Overall Study|Adverse Event|2|||
44540284|NCT03320850|79552194|FG006|Overall Study|Adverse Event|1|||
44540285|NCT03320850|79552195|FG007|Overall Study|Adverse Event|0|||
44540286|NCT03320850|79552196|FG008|Overall Study|Adverse Event|2|||
44540287|NCT03320850|79552197|FG009|Overall Study|Adverse Event|0|||
44540288|NCT03320850|79552188|FG000|Overall Study|Reason Not Specified|0|||
44336861|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
44336862|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
44336863|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
44336864|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
44336865|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
44336866|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
44540289|NCT03320850|79552189|FG001|Overall Study|Reason Not Specified|0|||
44540290|NCT03320850|79552190|FG002|Overall Study|Reason Not Specified|0|||
44540291|NCT03320850|79552191|FG003|Overall Study|Reason Not Specified|0|||
44540292|NCT03320850|79552192|FG004|Overall Study|Reason Not Specified|0|||
44540293|NCT03320850|79552193|FG005|Overall Study|Reason Not Specified|1|||
44540294|NCT03320850|79552194|FG006|Overall Study|Reason Not Specified|0|||
44540295|NCT03320850|79552195|FG007|Overall Study|Reason Not Specified|0|||
44336867|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
44336868|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44336869|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
44336870|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44336871|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44336872|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44336873|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44435853|NCT00654420|79444527|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
44540296|NCT03320850|79552196|FG008|Overall Study|Reason Not Specified|0|||
44540297|NCT03320850|79552197|FG009|Overall Study|Reason Not Specified|1|||
44540298|NCT03301623|79552226|FG000|Overall Study|Death|3|||
44540299|NCT03301623|79552227|FG001|Overall Study|Death|1|||
44540300|NCT03301623|79552226|FG000|Overall Study|Withdrawal by Subject|11|||
44540301|NCT03301623|79552227|FG001|Overall Study|Withdrawal by Subject|13|||
44259289|NCT03029780|79117394|FG001|Overall Study|Participant no longer meets study criteria|1|||
44259290|NCT03029780|79117393|FG000|Overall Study|Other reasons|6|||
44259291|NCT03029780|79117394|FG001|Overall Study|Other reasons|6|||
44259292|NCT03029780|79117393|FG000|Overall Study|Not reported|1|||
44259293|NCT03029780|79117394|FG001|Overall Study|Not reported|1|||
44259294|NCT03029780|79117393|FG000|Overall Study|Death|2|||
44259295|NCT03029780|79117394|FG001|Overall Study|Death|6|||
44259296|NCT03029234|79117454|FG000|Overall Study|Sponsor Decision|1|||
44259297|NCT03029234|79117454|FG000|Overall Study|Withdrawal by Subject|5|||
44259298|NCT03029234|79117454|FG000|Overall Study|Death|91|||
44259299|NCT03029234|79117454|FG000|Overall Study|Lost to Follow-up|2|||
44259300|NCT03991299|79118125|FG000|Overall Study|Study closed, sponsor decision|3|||
44336874|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Other|4|||
44336875|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Other|4|||
44336876|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Other|3|||
44435854|NCT00654420|79444528|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
44435855|NCT00654420|79444529|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
44435856|NCT00654420|79444526|FG000|Phase II|Adverse Event|0|||
44540302|NCT03301623|79552226|FG000|Overall Study|Lost to Follow-up|3|||
44435857|NCT00654420|79444527|FG001|Phase II|Adverse Event|0|||
44435858|NCT00654420|79444528|FG002|Phase II|Adverse Event|3|||
44435859|NCT00654420|79444529|FG003|Phase II|Adverse Event|3|||
44435860|NCT00654420|79444526|FG000|Phase II|Lost to Follow-up|0|||
44336877|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Other|1|||
44336878|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Other|0|||
44336879|NCT01081834|79341339|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
44336880|NCT01081834|79341340|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
44336881|NCT01081834|79341341|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
44336882|NCT01081834|79341342|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
44336883|NCT01081834|79341343|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
44336884|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
44336885|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
44435861|NCT00654420|79444527|FG001|Phase II|Lost to Follow-up|0|||
44435862|NCT00654420|79444528|FG002|Phase II|Lost to Follow-up|0|||
44435863|NCT00654420|79444529|FG003|Phase II|Lost to Follow-up|1|||
44435864|NCT00654420|79444526|FG000|Phase II|Physician Decision|0|||
44435865|NCT00654420|79444527|FG001|Phase II|Physician Decision|0|||
44435866|NCT00654420|79444528|FG002|Phase II|Physician Decision|0|||
44435867|NCT00654420|79444529|FG003|Phase II|Physician Decision|4|||
44435868|NCT00654420|79444526|FG000|Phase II|Progressive Disease|0|||
44435869|NCT00654420|79444527|FG001|Phase II|Progressive Disease|0|||
44435870|NCT00654420|79444528|FG002|Phase II|Progressive Disease|29|||
44435871|NCT00654420|79444529|FG003|Phase II|Progressive Disease|29|||
44435872|NCT00654420|79444526|FG000|Phase II|Withdrawal by Subject|0|||
44435873|NCT00654420|79444527|FG001|Phase II|Withdrawal by Subject|0|||
44435874|NCT00654420|79444528|FG002|Phase II|Withdrawal by Subject|4|||
44435875|NCT00654420|79444529|FG003|Phase II|Withdrawal by Subject|1|||
44435876|NCT00654420|79444526|FG000|Phase II|Missing Disposition Record|0|||
44435877|NCT00654420|79444527|FG001|Phase II|Missing Disposition Record|0|||
44435878|NCT00654420|79444528|FG002|Phase II|Missing Disposition Record|1|||
44435879|NCT00654420|79444529|FG003|Phase II|Missing Disposition Record|0|||
44435880|NCT00307489|79444541|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
44435881|NCT00307489|79444542|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
44435882|NCT00307489|79444541|FG000|Baseline Through Week 48|Physician Decision|1|||
44435883|NCT00307489|79444542|FG001|Baseline Through Week 48|Physician Decision|0|||
44435884|NCT00307489|79444541|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
44435885|NCT00307489|79444542|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
44435886|NCT00307489|79444541|FG000|Week 48 Through Week 168|Adverse Event|1|||
44435887|NCT00307489|79444542|FG001|Week 48 Through Week 168|Adverse Event|0|||
44435888|NCT00307489|79444541|FG000|Week 48 Through Week 168|Physician Decision|1|||
44435889|NCT00307489|79444542|FG001|Week 48 Through Week 168|Physician Decision|0|||
44435890|NCT00307489|79444541|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
44435891|NCT00307489|79444542|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
44435892|NCT00307489|79444541|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
44435893|NCT00307489|79444542|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
44435894|NCT00307489|79444541|FG000|Week 48 Through Week 168|Death|0|||
44435895|NCT00307489|79444542|FG001|Week 48 Through Week 168|Death|1|||
44435896|NCT00307489|79444541|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
44435897|NCT00307489|79444542|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
44435898|NCT00307489|79444541|FG000|Week 48 Through Week 168|Seroconversion|1|||
44435899|NCT00307489|79444542|FG001|Week 48 Through Week 168|Seroconversion|0|||
44157497|NCT02686658|78949257|FG000|Overall Study|Placed in hospice care|0|||
44157498|NCT02686658|78949258|FG001|Overall Study|Placed in hospice care|0|||
44157499|NCT02686658|78949259|FG002|Overall Study|Placed in hospice care|1|||
44336886|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
44336887|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
44336888|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
44336889|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Death|1|||
44336890|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Death|0|||
44336891|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Death|0|||
44435900|NCT00645840|79444548|FG000|Overall Study|Protocol Violation|3|||
44435901|NCT00307333|79444554|FG000|Overall Study|Lost to Follow-up|11|||
44435902|NCT00307333|79444555|FG001|Overall Study|Lost to Follow-up|3|||
44435903|NCT00762359|79444563|FG000|Overall Study|Adverse Event|20|||
44336892|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Death|0|||
44157500|NCT02686658|78949260|FG003|Overall Study|Placed in hospice care|0|||
44435904|NCT00762359|79444564|FG001|Overall Study|Adverse Event|23|||
44435905|NCT00762359|79444563|FG000|Overall Study|Protocol Violation|21|||
44435906|NCT00762359|79444564|FG001|Overall Study|Protocol Violation|13|||
44435907|NCT00762359|79444563|FG000|Overall Study|Withdrawal by Subject|13|||
44435908|NCT00762359|79444564|FG001|Overall Study|Withdrawal by Subject|10|||
44435909|NCT00762359|79444563|FG000|Overall Study|Lack of Efficacy|0|||
44435910|NCT00762359|79444564|FG001|Overall Study|Lack of Efficacy|4|||
44435911|NCT00762359|79444563|FG000|Overall Study|Institution closed|2|||
44435912|NCT00762359|79444564|FG001|Overall Study|Institution closed|3|||
44435913|NCT00762359|79444563|FG000|Overall Study|Physician Decision|2|||
44435914|NCT00762359|79444564|FG001|Overall Study|Physician Decision|3|||
44435915|NCT00762359|79444563|FG000|Overall Study|Removal|0|||
44435916|NCT00762359|79444564|FG001|Overall Study|Removal|1|||
44336893|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Death|0|||
44336894|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
44336895|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
44336896|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44336897|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44435917|NCT00762359|79444563|FG000|Overall Study|Withdrew consent|1|||
44435918|NCT00762359|79444564|FG001|Overall Study|Withdrew consent|0|||
44435919|NCT00654186|79444570|FG000|Overall Study|Withdrawal by Subject|5|||
44435920|NCT00761969|79444576|FG000|Overall Study|Death|112|||
44435921|NCT00761969|79444577|FG001|Overall Study|Death|47|||
44435922|NCT00761969|79444576|FG000|Overall Study|Lost to Follow-up|88|||
44435923|NCT00761969|79444577|FG001|Overall Study|Lost to Follow-up|93|||
44435924|NCT00761891|79444588|FG000|Overall Study|Withdrawal by Subject|10|||
44435925|NCT00321685|79444593|FG000|Overall Study|Adverse Event|18|||
44435926|NCT00321685|79444593|FG000|Overall Study|Death|2|||
44435927|NCT00321685|79444593|FG000|Overall Study|Withdrawal by Subject|8|||
44435928|NCT00321685|79444593|FG000|Overall Study|Alternative therapy|1|||
44435929|NCT00321685|79444593|FG000|Overall Study|Complicating disese|1|||
44435930|NCT00321685|79444593|FG000|Overall Study|Other|5|||
44435931|NCT00321685|79444593|FG000|Overall Study|Not start protocol therapy|2|||
44435932|NCT00321685|79444593|FG000|Overall Study|Ineligible|2|||
44435933|NCT03902392|79444599|FG000|Overall Study|Lost to Follow-up|7|||
44435934|NCT03902392|79444600|FG001|Overall Study|Lost to Follow-up|7|||
44435935|NCT00306787|79444608|FG000|Overall Study|Discontinued without taking study drug|208|||
44435936|NCT00306787|79444609|FG001|Overall Study|Discontinued without taking study drug|215|||
44435937|NCT00306787|79444608|FG000|Overall Study|Adverse Event|1|||
44435938|NCT00306787|79444609|FG001|Overall Study|Adverse Event|1|||
44435939|NCT00306787|79444608|FG000|Overall Study|Lack of Efficacy|1|||
44435940|NCT00306787|79444609|FG001|Overall Study|Lack of Efficacy|0|||
44435941|NCT00306787|79444608|FG000|Overall Study|Protocol Violation|8|||
44435942|NCT00306787|79444609|FG001|Overall Study|Protocol Violation|10|||
44435943|NCT00306787|79444608|FG000|Overall Study|Withdrawal by Subject|2|||
44435944|NCT00306787|79444609|FG001|Overall Study|Withdrawal by Subject|9|||
44435945|NCT00306787|79444608|FG000|Overall Study|Lost to Follow-up|9|||
44435946|NCT00306787|79444609|FG001|Overall Study|Lost to Follow-up|6|||
44435947|NCT00306787|79444608|FG000|Overall Study|Administrative problems|4|||
44435948|NCT00306787|79444609|FG001|Overall Study|Administrative problems|0|||
44435949|NCT00306787|79444608|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44435950|NCT00306787|79444609|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44435951|NCT00769067|79444617|FG000|Overall Study|Death|89|||
44435952|NCT00769067|79444618|FG001|Overall Study|Death|86|||
44435953|NCT00769067|79444617|FG000|Overall Study|Lost to Follow-up|3|||
44435954|NCT00769067|79444618|FG001|Overall Study|Lost to Follow-up|1|||
44435955|NCT00769067|79444617|FG000|Overall Study|Study terminated by sponsor|1|||
44435956|NCT00769067|79444618|FG001|Overall Study|Study terminated by sponsor|3|||
44435957|NCT00769067|79444617|FG000|Overall Study|Other|1|||
44435958|NCT00769067|79444618|FG001|Overall Study|Other|3|||
44435959|NCT00769067|79444617|FG000|Overall Study|Withdrawal by Subject|0|||
44435960|NCT00769067|79444618|FG001|Overall Study|Withdrawal by Subject|1|||
44259301|NCT03991299|79118125|FG000|Overall Study|Withdrawal by Subject|1|||
44259302|NCT03155373|79118143|FG000|Overall Study|No longer required surgery|1|||
44259303|NCT03155373|79118143|FG000|Overall Study|Protocol Violation|1|||
44259304|NCT03155373|79118143|FG000|Overall Study|Death|2|||
44259305|NCT03155373|79118143|FG000|Overall Study|Withdrawal by Subject|3|||
44259306|NCT05310084|79118561|FG000|Overall Study|Withdrawal by Subject|2|||
44259307|NCT05310084|79118562|FG001|Overall Study|Withdrawal by Subject|3|||
44259308|NCT05310084|79118561|FG000|Overall Study|Participant availability|0|||
44259309|NCT05310084|79118562|FG001|Overall Study|Participant availability|4|||
44259310|NCT05310084|79118561|FG000|Overall Study|Lost to Follow-up|1|||
44259311|NCT05310084|79118562|FG001|Overall Study|Lost to Follow-up|1|||
44259312|NCT05310084|79118561|FG000|Overall Study|Adverse Event|1|||
44259313|NCT05310084|79118562|FG001|Overall Study|Adverse Event|1|||
44259314|NCT05310084|79118561|FG000|Overall Study|Randomized but not vaccinated|4|||
44435961|NCT00321373|79444628|FG000|Overall Study|Adverse Event|0|||
44435962|NCT00321373|79444629|FG001|Overall Study|Adverse Event|0|||
44435963|NCT00321373|79444630|FG002|Overall Study|Adverse Event|1|||
44435964|NCT00321373|79444628|FG000|Overall Study|Lost to Follow-up|1|||
44435965|NCT00321373|79444629|FG001|Overall Study|Lost to Follow-up|0|||
44435966|NCT00321373|79444630|FG002|Overall Study|Lost to Follow-up|1|||
44435967|NCT00321373|79444628|FG000|Overall Study|Withdrawal by Subject|1|||
44435968|NCT00321373|79444629|FG001|Overall Study|Withdrawal by Subject|0|||
44435969|NCT00321373|79444630|FG002|Overall Study|Withdrawal by Subject|0|||
44435970|NCT00321373|79444628|FG000|Overall Study|Other|0|||
44435971|NCT00321373|79444629|FG001|Overall Study|Other|0|||
44435972|NCT00321373|79444630|FG002|Overall Study|Other|1|||
44435973|NCT00667394|79444640|FG000|Overall Study|Adverse Event|3|||
44435974|NCT00667394|79444641|FG001|Overall Study|Adverse Event|0|||
44435975|NCT00667394|79444640|FG000|Overall Study|Progressive disease|1|||
44435976|NCT00667394|79444641|FG001|Overall Study|Progressive disease|0|||
44435977|NCT00761735|79444647|FG000|Overall Study|Lost to Follow-up|6|||
44435978|NCT00761735|79444647|FG000|Overall Study|Withdrawal by Subject|6|||
44435979|NCT00761735|79444647|FG000|Overall Study|Non-compliance with protocol|1|||
44435980|NCT00761735|79444647|FG000|Overall Study|Administrative|1|||
44435981|NCT00569946|79444655|FG000|Overall Study|Adverse Event|16|||
44435982|NCT00569946|79444655|FG000|Overall Study|Objective Progression or Relapse|42|||
44435983|NCT00569946|79444655|FG000|Overall Study|Global Deterioration of Health Status|1|||
44435984|NCT00645528|79444659|FG000|Overall Study|Did not show up for Visit 2|7|||
44435985|NCT00295633|79444666|FG000|Overall Study|Lack of Efficacy|19|||
44435986|NCT00295633|79444667|FG001|Overall Study|Lack of Efficacy|7|||
44435987|NCT00295633|79444668|FG002|Overall Study|Lack of Efficacy|16|||
44435988|NCT00295633|79444666|FG000|Overall Study|Withdrawal of consent by subject|16|||
44435989|NCT00295633|79444667|FG001|Overall Study|Withdrawal of consent by subject|16|||
44435990|NCT00295633|79444668|FG002|Overall Study|Withdrawal of consent by subject|26|||
44435991|NCT00295633|79444666|FG000|Overall Study|Adverse Event|9|||
44435992|NCT00295633|79444667|FG001|Overall Study|Adverse Event|17|||
44435993|NCT00295633|79444668|FG002|Overall Study|Adverse Event|9|||
44435994|NCT00295633|79444666|FG000|Overall Study|Lost to Follow-up|6|||
44435995|NCT00295633|79444667|FG001|Overall Study|Lost to Follow-up|11|||
44435996|NCT00295633|79444668|FG002|Overall Study|Lost to Follow-up|7|||
44435997|NCT00295633|79444666|FG000|Overall Study|Physician Decision|9|||
44435998|NCT00295633|79444667|FG001|Overall Study|Physician Decision|10|||
44435999|NCT00295633|79444668|FG002|Overall Study|Physician Decision|8|||
44436000|NCT00295633|79444666|FG000|Overall Study|Poor/Noncompliance|2|||
44336898|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
44336899|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44336900|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
44336901|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44436001|NCT00295633|79444667|FG001|Overall Study|Poor/Noncompliance|2|||
44336902|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44336903|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44336904|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44336905|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
44436002|NCT00295633|79444668|FG002|Overall Study|Poor/Noncompliance|6|||
44436003|NCT00295633|79444666|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
44436004|NCT00295633|79444667|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
44436005|NCT00295633|79444668|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
44436006|NCT00295633|79444666|FG000|Overall Study|Death|1|||
44436007|NCT00295633|79444667|FG001|Overall Study|Death|1|||
44436008|NCT00295633|79444668|FG002|Overall Study|Death|0|||
44436009|NCT00295633|79444666|FG000|Overall Study|Administrative reason by sponsor|0|||
44436010|NCT00295633|79444667|FG001|Overall Study|Administrative reason by sponsor|0|||
44436011|NCT00295633|79444668|FG002|Overall Study|Administrative reason by sponsor|1|||
44436012|NCT00570674|79444676|FG000|Overall Study|Withdrawal by Subject|0|||
44436013|NCT00570674|79444677|FG001|Overall Study|Withdrawal by Subject|0|||
44436014|NCT00570674|79444678|FG002|Overall Study|Withdrawal by Subject|1|||
44436015|NCT00570674|79444679|FG003|Overall Study|Withdrawal by Subject|0|||
44436016|NCT00570674|79444680|FG004|Overall Study|Withdrawal by Subject|0|||
44540303|NCT03301623|79552227|FG001|Overall Study|Lost to Follow-up|1|||
44540304|NCT03319212|79552235|FG000|Overall Study|Discontinued as moving out of local area|0|||
44540305|NCT03319212|79552236|FG001|Overall Study|Discontinued as moving out of local area|1|||
44540306|NCT03319212|79552235|FG000|Overall Study|Adverse Event|2|||
44540307|NCT03319212|79552236|FG001|Overall Study|Adverse Event|2|||
44540308|NCT03319212|79552235|FG000|Overall Study|Withdrawal by Subject|0|||
44436017|NCT00570674|79444681|FG005|Overall Study|Withdrawal by Subject|0|||
44336906|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
44540309|NCT03319212|79552236|FG001|Overall Study|Withdrawal by Subject|1|||
44540310|NCT03319212|79552235|FG000|Overall Study|Lost to Follow-up|0|||
44540311|NCT03319212|79552236|FG001|Overall Study|Lost to Follow-up|1|||
44436018|NCT00570674|79444682|FG006|Overall Study|Withdrawal by Subject|0|||
44436019|NCT00768989|79444695|FG000|Prior to Week 24|Withdrawal by Subject|1|||
44436020|NCT00768989|79444696|FG001|Prior to Week 24|Withdrawal by Subject|0|||
44436021|NCT00768989|79444695|FG000|Prior to Week 24|Adverse Event|3|||
44436022|NCT00768989|79444696|FG001|Prior to Week 24|Adverse Event|0|||
44436023|NCT00768989|79444695|FG000|Prior to Week 24|Lost to Follow-up|0|||
44436024|NCT00768989|79444696|FG001|Prior to Week 24|Lost to Follow-up|1|||
44436025|NCT00768989|79444695|FG000|Prior to Week 24|Protocol Violation|0|||
44436026|NCT00768989|79444696|FG001|Prior to Week 24|Protocol Violation|2|||
44436027|NCT00768989|79444695|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
44436028|NCT00768989|79444696|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
44436029|NCT00768989|79444695|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
44436030|NCT00768989|79444696|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
44436031|NCT00768989|79444695|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
44436032|NCT00768989|79444696|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
44436033|NCT00768989|79444695|FG000|On or After Week 36|Lack of Efficacy|1|||
44436034|NCT00768989|79444696|FG001|On or After Week 36|Lack of Efficacy|0|||
44436035|NCT00768989|79444695|FG000|On or After Week 36|Adverse Event|0|||
44436036|NCT00768989|79444696|FG001|On or After Week 36|Adverse Event|1|||
44436037|NCT00768989|79444695|FG000|On or After Week 36|Lost to Follow-up|1|||
44436038|NCT00768989|79444696|FG001|On or After Week 36|Lost to Follow-up|0|||
44436039|NCT00768989|79444695|FG000|On or After Week 36|Poor Compliance|1|||
44436040|NCT00768989|79444696|FG001|On or After Week 36|Poor Compliance|0|||
44436041|NCT00768989|79444695|FG000|On or After Week 36|Protocol Violation|1|||
44436042|NCT00768989|79444696|FG001|On or After Week 36|Protocol Violation|0|||
44436043|NCT00768989|79444695|FG000|On or After Week 36|Did not attend termination visit|2|||
44436044|NCT00768989|79444696|FG001|On or After Week 36|Did not attend termination visit|0|||
44436045|NCT00768989|79444695|FG000|On or After Week 36|Sponsor Termination|45|||
44436046|NCT00768989|79444696|FG001|On or After Week 36|Sponsor Termination|26|||
44436047|NCT00305773|79444706|FG000|Overall Study|Death|3|||
44436048|NCT00305773|79444707|FG001|Overall Study|Death|2|||
44436049|NCT00305773|79444706|FG000|Overall Study|Adverse Event|1|||
44436050|NCT00305773|79444707|FG001|Overall Study|Adverse Event|2|||
44436051|NCT00305773|79444706|FG000|Overall Study|Alternative Treatment|4|||
44436052|NCT00305773|79444707|FG001|Overall Study|Alternative Treatment|4|||
44436053|NCT00305773|79444706|FG000|Overall Study|Physician Decision|1|||
44436054|NCT00305773|79444707|FG001|Overall Study|Physician Decision|1|||
44436055|NCT00305773|79444706|FG000|Overall Study|Withdrawal by Subject|1|||
44436056|NCT00305773|79444707|FG001|Overall Study|Withdrawal by Subject|4|||
44436057|NCT00305773|79444706|FG000|Overall Study|Disease Progression|1|||
44436058|NCT00305773|79444707|FG001|Overall Study|Disease Progression|3|||
44436059|NCT00305773|79444706|FG000|Overall Study|All other reasons|3|||
44436060|NCT00305773|79444707|FG001|Overall Study|All other reasons|2|||
44436061|NCT00305695|79444715|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
44436062|NCT00305695|79444716|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
44436063|NCT00305695|79444715|FG000|Overall Study|Did not have baseline scan|1|||
44436064|NCT00305695|79444716|FG001|Overall Study|Did not have baseline scan|1|||
44436065|NCT00647556|79444724|FG000|Overall Study|Adverse Event|0|||
44436066|NCT00647556|79444725|FG001|Overall Study|Adverse Event|1|||
44436067|NCT00647556|79444724|FG000|Overall Study|Lost to Follow-up|1|||
44436068|NCT00647556|79444725|FG001|Overall Study|Lost to Follow-up|0|||
44436069|NCT00647556|79444724|FG000|Overall Study|Protocol Violation|0|||
44436070|NCT00647556|79444725|FG001|Overall Study|Protocol Violation|1|||
44336907|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
44336908|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
44336909|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
44336910|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44336911|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
44336912|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44336913|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
44336914|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
44336915|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
44336916|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
44336917|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
44336918|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
44336919|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Other|4|||
44336920|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Other|5|||
44336921|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Other|4|||
44336922|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Other|0|||
44436071|NCT00647556|79444724|FG000|Overall Study|Withdrawal by Subject|1|||
44436072|NCT00647556|79444725|FG001|Overall Study|Withdrawal by Subject|0|||
44436073|NCT00647556|79444724|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
44436074|NCT00647556|79444725|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
44436075|NCT00320593|79444733|FG000|Overall Study|Lost to Follow-up|3|||
44436076|NCT00320593|79444734|FG001|Overall Study|Lost to Follow-up|0|||
44436077|NCT00320593|79444733|FG000|Overall Study|Moved to another state|1|||
44436078|NCT00320593|79444734|FG001|Overall Study|Moved to another state|0|||
44436079|NCT00320593|79444733|FG000|Overall Study|Withdrawal by Subject|2|||
44436080|NCT00320593|79444734|FG001|Overall Study|Withdrawal by Subject|1|||
44436081|NCT00320593|79444733|FG000|Overall Study|Withdrawal by clinical center|1|||
44436082|NCT00320593|79444734|FG001|Overall Study|Withdrawal by clinical center|0|||
44436083|NCT00320515|79444740|FG000|Overall Study|Death|33|||
44436084|NCT00320515|79444740|FG000|Overall Study|Lost to Follow-up|6|||
44436085|NCT00320515|79444740|FG000|Overall Study|Physician Decision|2|||
44436086|NCT00320515|79444740|FG000|Overall Study|Withdrawal by Subject|8|||
44436087|NCT00662012|79444744|FG000|Overall Study|Lost to Follow-up|85|||
44336923|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Other|0|||
44336924|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
44336925|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
44336926|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
44336927|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
44336928|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
44336929|NCT01081834|79341339|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44540312|NCT03319212|79552235|FG000|Overall Study|Physician Decision|1|||
44336930|NCT01081834|79341340|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
44336931|NCT01081834|79341341|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44336932|NCT01081834|79341342|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44336933|NCT01081834|79341343|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44336934|NCT01276509|79341366|FG000|Overall Study|Adverse Event|9|||
44336935|NCT01276509|79341367|FG001|Overall Study|Adverse Event|8|||
44336936|NCT01276509|79341368|FG002|Overall Study|Adverse Event|4|||
44336937|NCT01276509|79341369|FG003|Overall Study|Adverse Event|3|||
44336938|NCT01276509|79341366|FG000|Overall Study|Lack of Efficacy|2|||
44336939|NCT01276509|79341367|FG001|Overall Study|Lack of Efficacy|1|||
44336940|NCT01276509|79341368|FG002|Overall Study|Lack of Efficacy|1|||
44336941|NCT01276509|79341369|FG003|Overall Study|Lack of Efficacy|2|||
44436088|NCT00662012|79444744|FG000|Overall Study|Death|1|||
44436089|NCT00662012|79444744|FG000|Overall Study|Withdrawal by Subject|1|||
44436090|NCT00661778|79444748|FG000|Overall Study|Disease Progression|23|||
44436091|NCT00661778|79444748|FG000|Overall Study|Adverse Event|18|||
44436092|NCT00661778|79444748|FG000|Overall Study|Reason not Specified|6|||
44436093|NCT00661778|79444748|FG000|Overall Study|Protocol Violation|2|||
44436094|NCT00661778|79444748|FG000|Overall Study|Withdrawal of Consent|1|||
44436095|NCT00319735|79444752|FG000|Overall Study|Death|2|||
44336942|NCT01276509|79341366|FG000|Overall Study|Pregnancy|1|||
44336943|NCT01276509|79341367|FG001|Overall Study|Pregnancy|0|||
44336944|NCT01276509|79341368|FG002|Overall Study|Pregnancy|0|||
44336945|NCT01276509|79341369|FG003|Overall Study|Pregnancy|0|||
44336946|NCT01276509|79341366|FG000|Overall Study|Withdrawal by Subject|1|||
44336947|NCT01276509|79341367|FG001|Overall Study|Withdrawal by Subject|2|||
44336948|NCT01276509|79341368|FG002|Overall Study|Withdrawal by Subject|0|||
44336949|NCT01276509|79341369|FG003|Overall Study|Withdrawal by Subject|0|||
44336950|NCT01276509|79341366|FG000|Overall Study|Other|0|||
44336951|NCT01276509|79341367|FG001|Overall Study|Other|1|||
44336952|NCT01276509|79341368|FG002|Overall Study|Other|0|||
44336953|NCT01276509|79341369|FG003|Overall Study|Other|0|||
44336954|NCT01079962|79341381|FG000|Overall Study|Adverse Event|2|||
44336955|NCT01079962|79341382|FG001|Overall Study|Adverse Event|2|||
44336956|NCT01079962|79341381|FG000|Overall Study|Withdrawal by Subject|5|||
44336957|NCT01079962|79341382|FG001|Overall Study|Withdrawal by Subject|7|||
44336958|NCT01079962|79341381|FG000|Overall Study|Protocol Violation|2|||
44336959|NCT01079962|79341382|FG001|Overall Study|Protocol Violation|2|||
44336960|NCT01079962|79341381|FG000|Overall Study|No blood pressure (BP) control|3|||
44336961|NCT01079962|79341382|FG001|Overall Study|No blood pressure (BP) control|0|||
44336962|NCT01079962|79341381|FG000|Overall Study|Inclusion/exclusion criteria|1|||
44336963|NCT01079962|79341382|FG001|Overall Study|Inclusion/exclusion criteria|3|||
44336964|NCT01079962|79341381|FG000|Overall Study|Participant not returning for next visit|1|||
44336965|NCT01079962|79341382|FG001|Overall Study|Participant not returning for next visit|0|||
44336966|NCT01079962|79341381|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
44540313|NCT03319212|79552236|FG001|Overall Study|Physician Decision|0|||
44540314|NCT04656691|79552241|FG000|Overall Study|Adverse Event|1|||
44540315|NCT03301155|79552247|FG000|Overall Study|Сompliance with exclusion criteria|8|||
44540316|NCT03301155|79552248|FG001|Overall Study|Сompliance with exclusion criteria|7|||
44336967|NCT01079962|79341382|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
44336968|NCT01274637|79341390|FG000|Overall Study|Withdrawal by Subject|0|||
44336969|NCT01274637|79341391|FG001|Overall Study|Withdrawal by Subject|1|||
44336970|NCT01274637|79341390|FG000|Overall Study|Lost to Follow-up|0|||
44336971|NCT01274637|79341391|FG001|Overall Study|Lost to Follow-up|1|||
44336972|NCT01079806|79341399|FG000|Day 1 to Week 96|Adverse Event|0|||
44336973|NCT01079806|79341400|FG001|Day 1 to Week 96|Adverse Event|3|||
44336974|NCT01079806|79341399|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
44336975|NCT01079806|79341400|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
44436096|NCT00653328|79444757|FG000|Overall Study|Withdrawal by Subject|1|||
44436097|NCT00653328|79444757|FG000|Overall Study|Adverse Event|2|||
44436098|NCT00653328|79444757|FG000|Overall Study|Disease progression|10|||
44436099|NCT00653328|79444757|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
44436100|NCT00642642|79444770|FG000|Treatment & Follow Up|Adverse Event|2|||
44436101|NCT00642642|79444770|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
44436102|NCT00642642|79444770|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
44436103|NCT00534352|79444780|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
44436104|NCT00534352|79444780|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
44436105|NCT00534352|79444780|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
44436106|NCT00534352|79444780|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
44436107|NCT00534352|79444780|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
44436108|NCT00534352|79444780|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
44436109|NCT00642174|79444795|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
44436110|NCT00642174|79444796|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
44436111|NCT00665366|79444804|FG000|Overall Study|Lack of Efficacy|11|||
44436112|NCT00665366|79444805|FG001|Overall Study|Lack of Efficacy|10|||
44436113|NCT00665366|79444804|FG000|Overall Study|Adverse Event|25|||
44436114|NCT00665366|79444805|FG001|Overall Study|Adverse Event|23|||
44436115|NCT00665366|79444804|FG000|Overall Study|Withdrawal by Subject|11|||
44436116|NCT00665366|79444805|FG001|Overall Study|Withdrawal by Subject|14|||
44436117|NCT00665366|79444804|FG000|Overall Study|Lost to Follow-up|3|||
44436118|NCT00665366|79444805|FG001|Overall Study|Lost to Follow-up|5|||
44436119|NCT00665366|79444804|FG000|Overall Study|Poor compliance/noncompliance|3|||
44436120|NCT00665366|79444805|FG001|Overall Study|Poor compliance/noncompliance|5|||
44436121|NCT00665366|79444804|FG000|Overall Study|Pregnancy|1|||
44436122|NCT00665366|79444805|FG001|Overall Study|Pregnancy|0|||
44436123|NCT00665366|79444804|FG000|Overall Study|No longer meets study criteria|0|||
44436124|NCT00665366|79444805|FG001|Overall Study|No longer meets study criteria|1|||
44436125|NCT00665366|79444804|FG000|Overall Study|Other reasons|4|||
44436126|NCT00665366|79444805|FG001|Overall Study|Other reasons|1|||
44436127|NCT00642018|79444835|FG000|Overall Study|Adverse Event|11|||
44436128|NCT00642018|79444836|FG001|Overall Study|Adverse Event|36|||
44436129|NCT00642018|79444835|FG000|Overall Study|Withdrawal by Subject|4|||
44436130|NCT00642018|79444836|FG001|Overall Study|Withdrawal by Subject|10|||
44436131|NCT00642018|79444835|FG000|Overall Study|Progressive Disease|13|||
44436132|NCT00642018|79444836|FG001|Overall Study|Progressive Disease|18|||
44436133|NCT00642018|79444835|FG000|Overall Study|Physician Decision|0|||
44336976|NCT01079806|79341399|FG000|Day 1 to Week 96|Pregnancy|0|||
44336977|NCT01079806|79341400|FG001|Day 1 to Week 96|Pregnancy|1|||
44336978|NCT01079806|79341399|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
44336979|NCT01079806|79341400|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
44336980|NCT01079806|79341399|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
44336981|NCT01079806|79341400|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
44336982|NCT01079806|79341399|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
44436134|NCT00642018|79444836|FG001|Overall Study|Physician Decision|10|||
44436135|NCT00642018|79444835|FG000|Overall Study|Protocol Violation|0|||
44436136|NCT00642018|79444836|FG001|Overall Study|Protocol Violation|1|||
44436137|NCT00642018|79444835|FG000|Overall Study|Death|0|||
44436138|NCT00642018|79444836|FG001|Overall Study|Death|3|||
44436139|NCT00642018|79444835|FG000|Overall Study|Entry Criteria Not Met|0|||
44436140|NCT00642018|79444836|FG001|Overall Study|Entry Criteria Not Met|1|||
44436141|NCT00532948|79444846|FG000|Overall Study|Protocol Violation|1|||
44436142|NCT00532948|79444847|FG001|Overall Study|Protocol Violation|0|||
44436143|NCT00532948|79444848|FG002|Overall Study|Protocol Violation|0|||
44436144|NCT00532948|79444846|FG000|Overall Study|Death|3|||
44436145|NCT00532948|79444847|FG001|Overall Study|Death|3|||
44436146|NCT00532948|79444848|FG002|Overall Study|Death|4|||
44436147|NCT00532948|79444846|FG000|Overall Study|Violation of selection criteria at entry|0|||
44436148|NCT00532948|79444847|FG001|Overall Study|Violation of selection criteria at entry|1|||
44436149|NCT00532948|79444848|FG002|Overall Study|Violation of selection criteria at entry|0|||
44436150|NCT00532948|79444846|FG000|Overall Study|Failure to return|0|||
44436151|NCT00532948|79444847|FG001|Overall Study|Failure to return|1|||
44436152|NCT00532948|79444848|FG002|Overall Study|Failure to return|0|||
44436153|NCT00641706|79444862|FG000|Overall Study|Adverse Event|2|||
44259315|NCT05310084|79118562|FG001|Overall Study|Randomized but not vaccinated|2|||
44259316|NCT04581863|79118597|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
44259317|NCT04581863|79118598|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
44259318|NCT04349891|79118615|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
44259319|NCT04349891|79118616|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
44336983|NCT01079806|79341400|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
44336984|NCT01079806|79341399|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
44336985|NCT01079806|79341400|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
44436154|NCT00641706|79444863|FG001|Overall Study|Adverse Event|1|||
44436155|NCT00641706|79444862|FG000|Overall Study|Withdrawal by Subject|6|||
44436156|NCT00641706|79444863|FG001|Overall Study|Withdrawal by Subject|1|||
44436157|NCT00641706|79444862|FG000|Overall Study|Clinical Decline|1|||
44436158|NCT00641706|79444863|FG001|Overall Study|Clinical Decline|0|||
44436159|NCT00641706|79444862|FG000|Overall Study|Lead Investigator Decision|0|||
44436160|NCT00641706|79444863|FG001|Overall Study|Lead Investigator Decision|1|||
44336986|NCT01079806|79341399|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
44336987|NCT01079806|79341400|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
44336988|NCT01079806|79341399|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
44336989|NCT01079806|79341400|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
44336990|NCT01079806|79341399|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
44336991|NCT01079806|79341400|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
44336992|NCT01078090|79341408|FG000|Overall Study|Lost to Follow-up|2363|||
44336993|NCT01078090|79341408|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
44436161|NCT00644358|79444869|FG000|Overall Study|Adverse Event|124|||
44436162|NCT00644358|79444869|FG000|Overall Study|Lost to Follow-up|105|||
44436163|NCT00644358|79444869|FG000|Overall Study|Consent Withdrawal|64|||
44436164|NCT00644358|79444869|FG000|Overall Study|Lack of Effectiveness|39|||
44436165|NCT00644358|79444869|FG000|Overall Study|Protocol Violation|5|||
44436166|NCT00644358|79444869|FG000|Overall Study|Noncompliance|14|||
44436167|NCT00644358|79444869|FG000|Overall Study|Other Unspecified|11|||
44436168|NCT00640926|79444876|FG000|Overall Study|Adverse Event|2|||
44436169|NCT00640926|79444877|FG001|Overall Study|Adverse Event|3|||
44436170|NCT00640926|79444878|FG002|Overall Study|Adverse Event|2|||
44436171|NCT00640926|79444876|FG000|Overall Study|Lack of Efficacy|0|||
44436172|NCT00640926|79444877|FG001|Overall Study|Lack of Efficacy|2|||
44436173|NCT00640926|79444878|FG002|Overall Study|Lack of Efficacy|1|||
44436174|NCT00640926|79444876|FG000|Overall Study|Protocol Violation|2|||
44436175|NCT00640926|79444877|FG001|Overall Study|Protocol Violation|0|||
44436176|NCT00640926|79444878|FG002|Overall Study|Protocol Violation|2|||
44436177|NCT00640926|79444876|FG000|Overall Study|Lost to Follow-up|3|||
44436178|NCT00640926|79444877|FG001|Overall Study|Lost to Follow-up|1|||
44436179|NCT00640926|79444878|FG002|Overall Study|Lost to Follow-up|2|||
44436180|NCT00640926|79444876|FG000|Overall Study|Withdrawal by Subject|1|||
44436181|NCT00640926|79444877|FG001|Overall Study|Withdrawal by Subject|0|||
44436182|NCT00640926|79444878|FG002|Overall Study|Withdrawal by Subject|1|||
44436183|NCT03892564|79444886|FG000|Overall Study|Withdrawal by Subject|2|||
44436184|NCT03891862|79444893|FG000|Open-label Period|Adverse Event|2|||
44436185|NCT03891862|79444894|FG001|Open-label Period|Adverse Event|0|||
44336994|NCT01078090|79341408|FG000|Overall Study|Lack of Efficacy|1193|||
44336995|NCT01078090|79341408|FG000|Overall Study|ADR and lack of efficacy|61|||
44336996|NCT01078090|79341408|FG000|Overall Study|Other|523|||
44336997|NCT01077622|79341426|FG000|Overall Study|Physician Decision|2|||
44336998|NCT01077622|79341426|FG000|Overall Study|Withdrawal by Subject|1|||
44336999|NCT01313676|79341434|FG000|Overall Study|Adverse Event|395|||
44337000|NCT01313676|79341435|FG001|Overall Study|Adverse Event|365|||
44337001|NCT01313676|79341436|FG002|Overall Study|Adverse Event|372|||
44337002|NCT01313676|79341437|FG003|Overall Study|Adverse Event|333|||
44337003|NCT01313676|79341434|FG000|Overall Study|Lack of Efficacy|98|||
44337004|NCT01313676|79341435|FG001|Overall Study|Lack of Efficacy|90|||
44337005|NCT01313676|79341436|FG002|Overall Study|Lack of Efficacy|65|||
44337006|NCT01313676|79341437|FG003|Overall Study|Lack of Efficacy|46|||
44337007|NCT01313676|79341434|FG000|Overall Study|Protocol Violation|37|||
44337008|NCT01313676|79341435|FG001|Overall Study|Protocol Violation|44|||
44337009|NCT01313676|79341436|FG002|Overall Study|Protocol Violation|46|||
44337010|NCT01313676|79341437|FG003|Overall Study|Protocol Violation|44|||
44337011|NCT01313676|79341434|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
44337012|NCT01313676|79341435|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
44337013|NCT01313676|79341436|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
44337014|NCT01313676|79341437|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
44337015|NCT01313676|79341434|FG000|Overall Study|Study Closed/terminated|7|||
44337016|NCT01313676|79341435|FG001|Overall Study|Study Closed/terminated|6|||
44337017|NCT01313676|79341436|FG002|Overall Study|Study Closed/terminated|9|||
44337018|NCT01313676|79341437|FG003|Overall Study|Study Closed/terminated|9|||
44337019|NCT01313676|79341434|FG000|Overall Study|Lost to Follow-up|0|||
44337020|NCT01313676|79341435|FG001|Overall Study|Lost to Follow-up|0|||
44337021|NCT01313676|79341436|FG002|Overall Study|Lost to Follow-up|1|||
44337022|NCT01313676|79341437|FG003|Overall Study|Lost to Follow-up|0|||
44337023|NCT01313676|79341434|FG000|Overall Study|Physician Decision|53|||
44337024|NCT01313676|79341435|FG001|Overall Study|Physician Decision|64|||
44337025|NCT01313676|79341436|FG002|Overall Study|Physician Decision|62|||
44337026|NCT01313676|79341437|FG003|Overall Study|Physician Decision|48|||
44337027|NCT01313676|79341434|FG000|Overall Study|Decision by Participant or Proxy|643|||
44337028|NCT01313676|79341435|FG001|Overall Study|Decision by Participant or Proxy|527|||
44436186|NCT03891862|79444895|FG002|Open-label Period|Adverse Event|0|||
44436187|NCT03891862|79444893|FG000|Open-label Period|Protocol Violation|5|||
44436188|NCT03891862|79444894|FG001|Open-label Period|Protocol Violation|0|||
44436189|NCT03891862|79444895|FG002|Open-label Period|Protocol Violation|0|||
44436190|NCT03891862|79444893|FG000|Open-label Period|Withdrawal by Subject|6|||
44337029|NCT01313676|79341436|FG002|Overall Study|Decision by Participant or Proxy|515|||
44337030|NCT01313676|79341437|FG003|Overall Study|Decision by Participant or Proxy|492|||
44337031|NCT01313676|79341434|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
44337032|NCT01313676|79341435|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
44337033|NCT01313676|79341436|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
44337034|NCT01313676|79341437|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
44337035|NCT01313676|79341434|FG000|Overall Study|Investigator Site Closed|12|||
44337036|NCT01313676|79341435|FG001|Overall Study|Investigator Site Closed|11|||
44337037|NCT01313676|79341436|FG002|Overall Study|Investigator Site Closed|15|||
44337038|NCT01313676|79341437|FG003|Overall Study|Investigator Site Closed|10|||
44436191|NCT03891862|79444894|FG001|Open-label Period|Withdrawal by Subject|0|||
44436192|NCT03891862|79444895|FG002|Open-label Period|Withdrawal by Subject|0|||
44436193|NCT03891862|79444893|FG000|Open-label Period|Death|1|||
44436194|NCT03891862|79444894|FG001|Open-label Period|Death|0|||
44436195|NCT03891862|79444895|FG002|Open-label Period|Death|0|||
44436196|NCT03891862|79444893|FG000|Open-label Period|Lost to Follow-up|2|||
44436197|NCT03891862|79444894|FG001|Open-label Period|Lost to Follow-up|0|||
44436198|NCT03891862|79444895|FG002|Open-label Period|Lost to Follow-up|0|||
44436199|NCT03891862|79444893|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
44436200|NCT03891862|79444894|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
44436201|NCT03891862|79444895|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
44436202|NCT03891862|79444893|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
44436203|NCT03891862|79444894|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
44436204|NCT03891862|79444895|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
44436205|NCT03891862|79444893|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
44436206|NCT03891862|79444894|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
44337039|NCT01313676|79341434|FG000|Overall Study|Missing|1|||
44337040|NCT01313676|79341435|FG001|Overall Study|Missing|1|||
44337041|NCT01313676|79341436|FG002|Overall Study|Missing|1|||
44337042|NCT01313676|79341437|FG003|Overall Study|Missing|0|||
44337043|NCT01313286|79341448|FG000|Period 1|Withdrawal by Subject|2|||
44337044|NCT01313286|79341449|FG001|Period 1|Withdrawal by Subject|0|||
44436207|NCT03891862|79444895|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
44436208|NCT03891862|79444893|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
44436209|NCT03891862|79444894|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
44436210|NCT03891862|79444895|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
44436211|NCT00640614|79444904|FG000|Overall Study|Lost to Follow-up|1|||
44436212|NCT00640614|79444905|FG001|Overall Study|Lost to Follow-up|0|||
44436213|NCT00761657|79444943|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
44436214|NCT00761657|79444944|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
44436215|NCT00761657|79444945|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
44436216|NCT00761657|79444946|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
44436217|NCT00761657|79444947|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
44436218|NCT00761657|79444948|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
44436219|NCT00761657|79444949|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
44436220|NCT00761657|79444950|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
44436221|NCT00761657|79444951|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
44540317|NCT01952730|79552254|FG000|Overall Study|FDA shut down core lab used by study|1|||
44540318|NCT03316170|79552260|FG000|Overall Study|Death|1|||
44337045|NCT01313208|79341457|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
44337046|NCT01313208|79341458|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
44337047|NCT01313208|79341457|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
44337048|NCT01313208|79341458|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
44337049|NCT01313208|79341457|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
44436222|NCT00761657|79444943|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44436223|NCT00761657|79444944|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44436224|NCT00761657|79444945|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
44436225|NCT00761657|79444946|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
44436226|NCT00761657|79444947|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44436227|NCT00761657|79444948|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44540319|NCT03316170|79552261|FG001|Overall Study|Death|0|||
44540320|NCT03316170|79552260|FG000|Overall Study|Lost to Follow-up|6|||
44540321|NCT03316170|79552261|FG001|Overall Study|Lost to Follow-up|7|||
44540322|NCT03257865|79552270|FG000|Overall Study|Adverse Event|4|||
44540323|NCT03257865|79552271|FG001|Overall Study|Adverse Event|8|||
44337050|NCT01313208|79341458|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
44337051|NCT01313208|79341457|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
44337052|NCT01313208|79341458|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
44337053|NCT01313208|79341457|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
44337054|NCT01313208|79341458|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
44337055|NCT01313208|79341457|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
44337056|NCT01313208|79341458|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
44337057|NCT01313208|79341457|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
44337058|NCT01313208|79341458|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
44337059|NCT01313208|79341457|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
44337060|NCT01313208|79341458|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
44337061|NCT01313208|79341457|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
44337062|NCT01313208|79341458|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
44337063|NCT01312428|79341468|FG000|Overall Study|Study Termination|3|||
44337064|NCT01312428|79341469|FG001|Overall Study|Study Termination|4|||
44337065|NCT01075984|79341482|FG000|Treatment Phase|Adverse Event|0|||
44337066|NCT01075984|79341483|FG001|Treatment Phase|Adverse Event|1|||
44337067|NCT01075984|79341484|FG002|Treatment Phase|Adverse Event|3|||
44337068|NCT01075984|79341485|FG003|Treatment Phase|Adverse Event|7|||
44337069|NCT01075984|79341486|FG004|Treatment Phase|Adverse Event|35|||
44337070|NCT01075984|79341482|FG000|Treatment Phase|Protocol Violation|0|||
44337071|NCT01075984|79341483|FG001|Treatment Phase|Protocol Violation|0|||
44337072|NCT01075984|79341484|FG002|Treatment Phase|Protocol Violation|1|||
44337073|NCT01075984|79341485|FG003|Treatment Phase|Protocol Violation|0|||
44337074|NCT01075984|79341486|FG004|Treatment Phase|Protocol Violation|3|||
44337075|NCT01075984|79341482|FG000|Treatment Phase|Withdrawal by Subject|0|||
44337076|NCT01075984|79341483|FG001|Treatment Phase|Withdrawal by Subject|0|||
44337077|NCT01075984|79341484|FG002|Treatment Phase|Withdrawal by Subject|2|||
44337078|NCT01075984|79341485|FG003|Treatment Phase|Withdrawal by Subject|0|||
44337079|NCT01075984|79341486|FG004|Treatment Phase|Withdrawal by Subject|15|||
44337080|NCT01075984|79341482|FG000|Treatment Phase|Treatment Failure|0|||
44337081|NCT01075984|79341483|FG001|Treatment Phase|Treatment Failure|0|||
44337082|NCT01075984|79341484|FG002|Treatment Phase|Treatment Failure|1|||
44337083|NCT01075984|79341485|FG003|Treatment Phase|Treatment Failure|0|||
44337084|NCT01075984|79341486|FG004|Treatment Phase|Treatment Failure|5|||
44337085|NCT01075984|79341482|FG000|Treatment Phase|Progression of disease|0|||
44337086|NCT01075984|79341483|FG001|Treatment Phase|Progression of disease|0|||
44337087|NCT01075984|79341484|FG002|Treatment Phase|Progression of disease|0|||
44337088|NCT01075984|79341485|FG003|Treatment Phase|Progression of disease|0|||
44337089|NCT01075984|79341486|FG004|Treatment Phase|Progression of disease|2|||
44337090|NCT01075984|79341482|FG000|Follow-up Phase|Protocol Violation|0|||
44337091|NCT01075984|79341483|FG001|Follow-up Phase|Protocol Violation|0|||
44337092|NCT01075984|79341484|FG002|Follow-up Phase|Protocol Violation|1|||
44337093|NCT01075984|79341485|FG003|Follow-up Phase|Protocol Violation|0|||
44337094|NCT01075984|79341486|FG004|Follow-up Phase|Protocol Violation|3|||
44337095|NCT01075984|79341482|FG000|Follow-up Phase|Adverse Event|0|||
44337096|NCT01075984|79341483|FG001|Follow-up Phase|Adverse Event|0|||
44337097|NCT01075984|79341484|FG002|Follow-up Phase|Adverse Event|0|||
44337098|NCT01075984|79341485|FG003|Follow-up Phase|Adverse Event|2|||
44337099|NCT01075984|79341486|FG004|Follow-up Phase|Adverse Event|27|||
44337100|NCT01075984|79341482|FG000|Follow-up Phase|Administrative|0|||
44337101|NCT01075984|79341483|FG001|Follow-up Phase|Administrative|0|||
44337102|NCT01075984|79341484|FG002|Follow-up Phase|Administrative|0|||
44337103|NCT01075984|79341485|FG003|Follow-up Phase|Administrative|0|||
44337104|NCT01075984|79341486|FG004|Follow-up Phase|Administrative|1|||
44337105|NCT01075984|79341482|FG000|Follow-up Phase|Withdrawal by Subject|0|||
44337106|NCT01075984|79341483|FG001|Follow-up Phase|Withdrawal by Subject|0|||
44337107|NCT01075984|79341484|FG002|Follow-up Phase|Withdrawal by Subject|0|||
44337108|NCT01075984|79341485|FG003|Follow-up Phase|Withdrawal by Subject|0|||
44337109|NCT01075984|79341486|FG004|Follow-up Phase|Withdrawal by Subject|10|||
44337110|NCT01075984|79341482|FG000|Follow-up Phase|Progression of disease|0|||
44337111|NCT01075984|79341483|FG001|Follow-up Phase|Progression of disease|0|||
44337112|NCT01075984|79341484|FG002|Follow-up Phase|Progression of disease|0|||
44337113|NCT01075984|79341485|FG003|Follow-up Phase|Progression of disease|0|||
44337114|NCT01075984|79341486|FG004|Follow-up Phase|Progression of disease|2|||
44337115|NCT01075984|79341482|FG000|Follow-up Phase|Treatment failure|0|||
44337116|NCT01075984|79341483|FG001|Follow-up Phase|Treatment failure|0|||
44337117|NCT01075984|79341484|FG002|Follow-up Phase|Treatment failure|0|||
44337118|NCT01075984|79341485|FG003|Follow-up Phase|Treatment failure|0|||
44337119|NCT01075984|79341486|FG004|Follow-up Phase|Treatment failure|4|||
44337120|NCT01024231|79341505|FG000|Overall Study|Other Reasons|1|||
44337121|NCT01024231|79341506|FG001|Overall Study|Other Reasons|2|||
44337122|NCT01024231|79341507|FG002|Overall Study|Other Reasons|0|||
44337123|NCT01024231|79341508|FG003|Overall Study|Other Reasons|0|||
44337124|NCT01024231|79341509|FG004|Overall Study|Other Reasons|2|||
44337125|NCT01024231|79341510|FG005|Overall Study|Other Reasons|0|||
44337126|NCT01024231|79341511|FG006|Overall Study|Other Reasons|1|||
44337127|NCT01024231|79341505|FG000|Overall Study|Maximum Clinical Benefit|1|||
44337128|NCT01024231|79341506|FG001|Overall Study|Maximum Clinical Benefit|2|||
44337129|NCT01024231|79341507|FG002|Overall Study|Maximum Clinical Benefit|0|||
44337130|NCT01024231|79341508|FG003|Overall Study|Maximum Clinical Benefit|1|||
44337131|NCT01024231|79341509|FG004|Overall Study|Maximum Clinical Benefit|1|||
44436228|NCT00761657|79444949|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44436229|NCT00761657|79444950|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44436230|NCT00761657|79444951|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
44436231|NCT00761657|79444943|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
44436232|NCT00761657|79444944|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
44436233|NCT00761657|79444945|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
44436234|NCT00761657|79444946|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
44436235|NCT00761657|79444947|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
44436236|NCT00761657|79444948|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
44436237|NCT00761657|79444949|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
44436238|NCT00761657|79444950|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
44436239|NCT00761657|79444951|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
44436240|NCT00761657|79444943|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
44436241|NCT00761657|79444944|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
44436242|NCT00761657|79444945|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
44337132|NCT01024231|79341510|FG005|Overall Study|Maximum Clinical Benefit|0|||
44337133|NCT01024231|79341511|FG006|Overall Study|Maximum Clinical Benefit|0|||
44337134|NCT01024231|79341505|FG000|Overall Study|Disease Progression|3|||
44436243|NCT00761657|79444946|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
44436244|NCT00761657|79444947|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
44436245|NCT00761657|79444948|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
44436246|NCT00761657|79444949|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
44436247|NCT00761657|79444950|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
44436248|NCT00761657|79444951|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
44436249|NCT00319501|79444983|FG000|Double-blind Period|Withdrawal by Subject|0|||
44436250|NCT00319501|79444984|FG001|Double-blind Period|Withdrawal by Subject|3|||
44436251|NCT00319501|79444983|FG000|Double-blind Period|Sponsor Request|1|||
44436252|NCT00319501|79444984|FG001|Double-blind Period|Sponsor Request|0|||
44436253|NCT00319501|79444983|FG000|Double-blind Period|Did not receive treatment|42|||
44540324|NCT03257865|79552270|FG000|Overall Study|Lack of Efficacy|1|||
44540325|NCT03257865|79552271|FG001|Overall Study|Lack of Efficacy|2|||
44540326|NCT03257865|79552270|FG000|Overall Study|Non-compliance with Study Drug|0|||
44337135|NCT01024231|79341506|FG001|Overall Study|Disease Progression|1|||
44337136|NCT01024231|79341507|FG002|Overall Study|Disease Progression|3|||
44337137|NCT01024231|79341508|FG003|Overall Study|Disease Progression|0|||
44337138|NCT01024231|79341509|FG004|Overall Study|Disease Progression|4|||
44337139|NCT01024231|79341510|FG005|Overall Study|Disease Progression|11|||
44337140|NCT01024231|79341511|FG006|Overall Study|Disease Progression|6|||
44337141|NCT01024231|79341505|FG000|Overall Study|AE unrelated to Study Drug|0|||
44337142|NCT01024231|79341506|FG001|Overall Study|AE unrelated to Study Drug|1|||
44337143|NCT01024231|79341507|FG002|Overall Study|AE unrelated to Study Drug|0|||
44337144|NCT01024231|79341508|FG003|Overall Study|AE unrelated to Study Drug|0|||
44337145|NCT01024231|79341509|FG004|Overall Study|AE unrelated to Study Drug|0|||
44337146|NCT01024231|79341510|FG005|Overall Study|AE unrelated to Study Drug|0|||
44337147|NCT01024231|79341511|FG006|Overall Study|AE unrelated to Study Drug|0|||
44337148|NCT01024231|79341505|FG000|Overall Study|No longer meets criteria|0|||
44337149|NCT01024231|79341506|FG001|Overall Study|No longer meets criteria|0|||
44337150|NCT01024231|79341507|FG002|Overall Study|No longer meets criteria|0|||
44337151|NCT01024231|79341508|FG003|Overall Study|No longer meets criteria|0|||
44337152|NCT01024231|79341509|FG004|Overall Study|No longer meets criteria|1|||
44337153|NCT01024231|79341510|FG005|Overall Study|No longer meets criteria|0|||
44337154|NCT01024231|79341511|FG006|Overall Study|No longer meets criteria|1|||
44337155|NCT01024231|79341505|FG000|Overall Study|Study Drug Toxicity|1|||
44337156|NCT01024231|79341506|FG001|Overall Study|Study Drug Toxicity|6|||
44337157|NCT01024231|79341507|FG002|Overall Study|Study Drug Toxicity|6|||
44337158|NCT01024231|79341508|FG003|Overall Study|Study Drug Toxicity|4|||
44337159|NCT01024231|79341509|FG004|Overall Study|Study Drug Toxicity|2|||
44337160|NCT01024231|79341510|FG005|Overall Study|Study Drug Toxicity|0|||
44337161|NCT01024231|79341511|FG006|Overall Study|Study Drug Toxicity|7|||
44337162|NCT01024231|79341505|FG000|Overall Study|Death|6|||
44337163|NCT01024231|79341506|FG001|Overall Study|Death|2|||
44337164|NCT01024231|79341507|FG002|Overall Study|Death|1|||
44337165|NCT01024231|79341508|FG003|Overall Study|Death|0|||
44337166|NCT01024231|79341509|FG004|Overall Study|Death|4|||
44337167|NCT01024231|79341510|FG005|Overall Study|Death|3|||
44337168|NCT01024231|79341511|FG006|Overall Study|Death|5|||
44540327|NCT03257865|79552271|FG001|Overall Study|Non-compliance with Study Drug|2|||
44540328|NCT03257865|79552270|FG000|Overall Study|Withdrawal by Subject|23|||
44540329|NCT03257865|79552271|FG001|Overall Study|Withdrawal by Subject|17|||
44337169|NCT01024231|79341505|FG000|Overall Study|Lost to Follow-up|0|||
44337170|NCT01024231|79341506|FG001|Overall Study|Lost to Follow-up|0|||
44337171|NCT01024231|79341507|FG002|Overall Study|Lost to Follow-up|0|||
44337172|NCT01024231|79341508|FG003|Overall Study|Lost to Follow-up|0|||
44337173|NCT01024231|79341509|FG004|Overall Study|Lost to Follow-up|0|||
44337174|NCT01024231|79341510|FG005|Overall Study|Lost to Follow-up|0|||
44337175|NCT01024231|79341511|FG006|Overall Study|Lost to Follow-up|1|||
44337176|NCT01024231|79341505|FG000|Overall Study|Withdrew Consent|0|||
44337177|NCT01024231|79341506|FG001|Overall Study|Withdrew Consent|1|||
44436254|NCT00319501|79444984|FG001|Double-blind Period|Did not receive treatment|29|||
44436255|NCT00319501|79444983|FG000|Open-label Period|Adverse Event|5|||
44436256|NCT00319501|79444984|FG001|Open-label Period|Adverse Event|0|||
44436257|NCT00319501|79444983|FG000|Open-label Period|Protocol Violation|6|||
44157501|NCT02686658|78949261|FG004|Overall Study|Placed in hospice care|0|||
44157502|NCT02686658|78949262|FG005|Overall Study|Placed in hospice care|0|||
44157503|NCT02686658|78949257|FG000|Overall Study|Participant non-compliance|0|||
44157504|NCT02686658|78949258|FG001|Overall Study|Participant non-compliance|0|||
44157505|NCT02686658|78949259|FG002|Overall Study|Participant non-compliance|0|||
44157506|NCT02686658|78949260|FG003|Overall Study|Participant non-compliance|0|||
44337178|NCT01024231|79341507|FG002|Overall Study|Withdrew Consent|0|||
44337179|NCT01024231|79341508|FG003|Overall Study|Withdrew Consent|0|||
44337180|NCT01024231|79341509|FG004|Overall Study|Withdrew Consent|0|||
44337181|NCT01024231|79341510|FG005|Overall Study|Withdrew Consent|0|||
44337182|NCT01024231|79341511|FG006|Overall Study|Withdrew Consent|0|||
44337183|NCT01024231|79341505|FG000|Overall Study|Continuing on Treatment|0|||
44337184|NCT01024231|79341506|FG001|Overall Study|Continuing on Treatment|0|||
44337185|NCT01024231|79341507|FG002|Overall Study|Continuing on Treatment|0|||
44337186|NCT01024231|79341508|FG003|Overall Study|Continuing on Treatment|0|||
44337187|NCT01024231|79341509|FG004|Overall Study|Continuing on Treatment|3|||
44337188|NCT01024231|79341510|FG005|Overall Study|Continuing on Treatment|2|||
44337189|NCT01024231|79341511|FG006|Overall Study|Continuing on Treatment|0|||
44337190|NCT01077544|79341534|FG000|Overall Study|New Cancer Therapy|3|||
44337191|NCT01077544|79341535|FG001|Overall Study|New Cancer Therapy|3|||
44337192|NCT01077544|79341534|FG000|Overall Study|Adverse Event|0|||
44337193|NCT01077544|79341535|FG001|Overall Study|Adverse Event|1|||
44337194|NCT01077544|79341534|FG000|Overall Study|Disease Progression|0|||
44337195|NCT01077544|79341535|FG001|Overall Study|Disease Progression|1|||
44337196|NCT01075516|79341543|FG000|Overall Study|Death|5|||
44337197|NCT01075516|79341544|FG001|Overall Study|Death|9|||
44337198|NCT01075516|79341543|FG000|Overall Study|Lost to Follow-up|10|||
44337199|NCT01075516|79341544|FG001|Overall Study|Lost to Follow-up|2|||
44337200|NCT01075516|79341543|FG000|Overall Study|Withdrawal by Subject|3|||
44337201|NCT01075516|79341544|FG001|Overall Study|Withdrawal by Subject|5|||
44337202|NCT01012999|79341550|FG000|Overall Study|Protocol Violation|1|||
44337203|NCT01017601|79341556|FG000|Overall Study|Disease Progression|12|||
44337204|NCT01017601|79341557|FG001|Overall Study|Disease Progression|12|||
44337205|NCT01017601|79341556|FG000|Overall Study|Withdrawal by Subject|0|||
44337206|NCT01017601|79341557|FG001|Overall Study|Withdrawal by Subject|1|||
44337207|NCT01016977|79341565|FG000|Overall Study|Lost to Follow-up|1|||
44337208|NCT01016977|79341566|FG001|Overall Study|Lost to Follow-up|0|||
44337209|NCT01016977|79341565|FG000|Overall Study|Withdrawal by Subject|2|||
44337210|NCT01016977|79341566|FG001|Overall Study|Withdrawal by Subject|2|||
44337211|NCT01012765|79341575|FG000|Treatment Period 1|Adverse Event|1|||
44337212|NCT01012765|79341576|FG001|Treatment Period 1|Adverse Event|0|||
44337213|NCT01012765|79341577|FG002|Treatment Period 1|Adverse Event|1|||
44337214|NCT01012765|79341578|FG003|Treatment Period 1|Adverse Event|0|||
44337215|NCT01012765|79341579|FG004|Treatment Period 1|Adverse Event|0|||
44337216|NCT01012765|79341580|FG005|Treatment Period 1|Adverse Event|0|||
44337217|NCT01012765|79341575|FG000|Treatment Period 1|Withdrawal by Subject|2|||
44337218|NCT01012765|79341576|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44337219|NCT01012765|79341577|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44157507|NCT02686658|78949261|FG004|Overall Study|Participant non-compliance|0|||
44337220|NCT01012765|79341578|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44337221|NCT01012765|79341579|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44337222|NCT01012765|79341580|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44337223|NCT01012765|79341575|FG000|Treatment Period 1|Administrative problems|0|||
44337224|NCT01012765|79341576|FG001|Treatment Period 1|Administrative problems|0|||
44337225|NCT01012765|79341577|FG002|Treatment Period 1|Administrative problems|1|||
44337226|NCT01012765|79341578|FG003|Treatment Period 1|Administrative problems|1|||
44337227|NCT01012765|79341579|FG004|Treatment Period 1|Administrative problems|1|||
44337228|NCT01012765|79341580|FG005|Treatment Period 1|Administrative problems|0|||
44337229|NCT01012765|79341575|FG000|Treatment Period 1|Protocol Violation|0|||
44337230|NCT01012765|79341576|FG001|Treatment Period 1|Protocol Violation|0|||
44337231|NCT01012765|79341577|FG002|Treatment Period 1|Protocol Violation|0|||
44337232|NCT01012765|79341578|FG003|Treatment Period 1|Protocol Violation|2|||
44337233|NCT01012765|79341579|FG004|Treatment Period 1|Protocol Violation|1|||
44337234|NCT01012765|79341580|FG005|Treatment Period 1|Protocol Violation|0|||
44337235|NCT01012765|79341575|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
44337236|NCT01012765|79341576|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
44337237|NCT01012765|79341577|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
44436258|NCT00319501|79444984|FG001|Open-label Period|Protocol Violation|0|||
44337238|NCT01012765|79341578|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
44337239|NCT01012765|79341579|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
44436259|NCT00319501|79444983|FG000|Open-label Period|Withdrawal by Subject|38|||
44157508|NCT02686658|78949262|FG005|Overall Study|Participant non-compliance|1|||
44337240|NCT01012765|79341580|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
44337241|NCT01012765|79341575|FG000|Treatment Period 2|Withdrawal by Subject|1|||
44337242|NCT01012765|79341576|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44337243|NCT01012765|79341577|FG002|Treatment Period 2|Withdrawal by Subject|1|||
44337244|NCT01012765|79341578|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44337245|NCT01012765|79341579|FG004|Treatment Period 2|Withdrawal by Subject|1|||
44337246|NCT01012765|79341580|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44337247|NCT01012765|79341575|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
44337248|NCT01012765|79341576|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
44337249|NCT01012765|79341577|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
44337250|NCT01012765|79341578|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
44337251|NCT01012765|79341579|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
44337252|NCT01012765|79341580|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
44337253|NCT01012765|79341575|FG000|Treatment Period 2|Adverse Event|0|||
44337254|NCT01012765|79341576|FG001|Treatment Period 2|Adverse Event|1|||
44337255|NCT01012765|79341577|FG002|Treatment Period 2|Adverse Event|1|||
44337256|NCT01012765|79341578|FG003|Treatment Period 2|Adverse Event|0|||
44337257|NCT01012765|79341579|FG004|Treatment Period 2|Adverse Event|0|||
44337258|NCT01012765|79341580|FG005|Treatment Period 2|Adverse Event|0|||
44337259|NCT01012765|79341575|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
44337260|NCT01012765|79341576|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
44337261|NCT01012765|79341577|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
44337262|NCT01012765|79341578|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
44337263|NCT01012765|79341579|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
44337264|NCT01012765|79341580|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
44337265|NCT01010503|79341588|FG000|Overall Study|Adverse Event|1|||
44337266|NCT01010503|79341588|FG000|Overall Study|Death|1|||
44337267|NCT01006291|79341595|FG000|Overall Study|Adverse Event|2|||
44337268|NCT01006291|79341596|FG001|Overall Study|Adverse Event|1|||
44337269|NCT01006291|79341597|FG002|Overall Study|Adverse Event|2|||
44337270|NCT01006291|79341595|FG000|Overall Study|Lack of Efficacy|2|||
44337271|NCT01006291|79341596|FG001|Overall Study|Lack of Efficacy|2|||
44337272|NCT01006291|79341597|FG002|Overall Study|Lack of Efficacy|1|||
44337273|NCT01006291|79341595|FG000|Overall Study|Protocol Violation|3|||
44337274|NCT01006291|79341596|FG001|Overall Study|Protocol Violation|3|||
44337275|NCT01006291|79341597|FG002|Overall Study|Protocol Violation|3|||
44337276|NCT01006291|79341595|FG000|Overall Study|Withdrawal criteria|5|||
44337277|NCT01006291|79341596|FG001|Overall Study|Withdrawal criteria|4|||
44337278|NCT01006291|79341597|FG002|Overall Study|Withdrawal criteria|4|||
44337279|NCT01006291|79341595|FG000|Overall Study|Other|14|||
44337280|NCT01006291|79341596|FG001|Overall Study|Other|14|||
44337281|NCT01006291|79341597|FG002|Overall Study|Other|17|||
44337282|NCT01006135|79341605|FG000|Overall Study|Adverse Event|22|||
44436260|NCT00319501|79444984|FG001|Open-label Period|Withdrawal by Subject|0|||
44436261|NCT00319501|79444983|FG000|Open-label Period|Principal Investigator decision|6|||
44436262|NCT00319501|79444984|FG001|Open-label Period|Principal Investigator decision|0|||
44436263|NCT00319501|79444983|FG000|Open-label Period|Sponsor request|12|||
44436264|NCT00319501|79444984|FG001|Open-label Period|Sponsor request|0|||
44436265|NCT00319501|79444983|FG000|Open-label Period|Lost to Follow-up|5|||
44436266|NCT00319501|79444984|FG001|Open-label Period|Lost to Follow-up|0|||
44436267|NCT00319501|79444983|FG000|Open-label Period|Did not receive treatment|33|||
44540330|NCT03257865|79552270|FG000|Overall Study|Physician Decision|3|||
44540331|NCT03257865|79552271|FG001|Overall Study|Physician Decision|1|||
44540332|NCT03257865|79552270|FG000|Overall Study|Other|0|||
44540333|NCT03257865|79552271|FG001|Overall Study|Other|1|||
44337283|NCT01006135|79341605|FG000|Overall Study|Protocol Violation|14|||
44337284|NCT01006135|79341605|FG000|Overall Study|Lost to Follow-up|32|||
44337285|NCT01006135|79341605|FG000|Overall Study|Other|72|||
44337286|NCT01012609|79341611|FG000|Overall Study|Withdrawal by Subject|1|||
44337287|NCT01012609|79341612|FG001|Overall Study|Withdrawal by Subject|1|||
44337288|NCT01012219|79341619|FG000|Period 1|Withdrawal by Subject|1|||
44337289|NCT01012219|79341619|FG000|Period 2|Withdrawal by Subject|1|||
44337290|NCT01011907|79341628|FG000|Overall Study|Withdrawal by Subject|13|||
44337291|NCT01011907|79341629|FG001|Overall Study|Withdrawal by Subject|11|||
44337292|NCT01011907|79341628|FG000|Overall Study|Adverse Event|1|||
44337293|NCT01011907|79341629|FG001|Overall Study|Adverse Event|4|||
44337294|NCT01011673|79341637|FG000|Randomized|Secondary headache|2|||
44337295|NCT01011673|79341638|FG001|Randomized|Secondary headache|1|||
44337296|NCT01011673|79341637|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
44337297|NCT01011673|79341638|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
44337298|NCT01011439|79341644|FG000|Overall Study|Death|37|||
44337299|NCT01011439|79341644|FG000|Overall Study|Lost to Follow-up|4|||
44337300|NCT01011439|79341644|FG000|Overall Study|Withdrawal by Subject|1|||
44337301|NCT01011439|79341644|FG000|Overall Study|Sponsor's decision|15|||
44436268|NCT00319501|79444984|FG001|Open-label Period|Did not receive treatment|0|||
44337302|NCT01311024|79341651|FG000|Overall Study|Protocol Violation|35|||
44337303|NCT01311024|79341652|FG001|Overall Study|Protocol Violation|22|||
44337304|NCT01310868|79341658|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
44337305|NCT01273155|79341666|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
44337306|NCT01273155|79341667|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
44337307|NCT01273155|79341668|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
44337308|NCT01273155|79341669|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
44337309|NCT01273155|79341670|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
44337310|NCT01273155|79341671|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
44337311|NCT01273155|79341672|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
44337312|NCT01273155|79341666|FG000|Overall Study|Change in liver function/no longer eval.|0|||
44337313|NCT01273155|79341667|FG001|Overall Study|Change in liver function/no longer eval.|1|||
44337314|NCT01273155|79341668|FG002|Overall Study|Change in liver function/no longer eval.|0|||
44337315|NCT01273155|79341669|FG003|Overall Study|Change in liver function/no longer eval.|0|||
44337316|NCT01273155|79341670|FG004|Overall Study|Change in liver function/no longer eval.|1|||
44337317|NCT01273155|79341671|FG005|Overall Study|Change in liver function/no longer eval.|0|||
44337318|NCT01273155|79341672|FG006|Overall Study|Change in liver function/no longer eval.|0|||
44337319|NCT01273155|79341666|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
44337320|NCT01273155|79341667|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
44337321|NCT01273155|79341668|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
44337322|NCT01273155|79341669|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
44337323|NCT01273155|79341670|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
44337324|NCT01273155|79341671|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
44337325|NCT01273155|79341672|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
44337326|NCT01273155|79341666|FG000|Overall Study|Died during Cycle 1|0|||
44337327|NCT01273155|79341667|FG001|Overall Study|Died during Cycle 1|0|||
44337328|NCT01273155|79341668|FG002|Overall Study|Died during Cycle 1|1|||
44337329|NCT01273155|79341669|FG003|Overall Study|Died during Cycle 1|1|||
44337330|NCT01273155|79341670|FG004|Overall Study|Died during Cycle 1|0|||
44337331|NCT01273155|79341671|FG005|Overall Study|Died during Cycle 1|2|||
44337332|NCT01273155|79341672|FG006|Overall Study|Died during Cycle 1|2|||
44337333|NCT01273155|79341666|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
44337334|NCT01273155|79341667|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
44337335|NCT01273155|79341668|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
44337336|NCT01273155|79341669|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
44337337|NCT01273155|79341670|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
44337338|NCT01273155|79341671|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
44337339|NCT01273155|79341672|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
44436269|NCT00319501|79444983|FG000|Open-label Period|Other|11|||
44436270|NCT00319501|79444984|FG001|Open-label Period|Other|0|||
44436271|NCT00319501|79444983|FG000|Open-label Extension Period|Adverse Event|2|||
44436272|NCT00319501|79444984|FG001|Open-label Extension Period|Adverse Event|0|||
44436273|NCT00319501|79444983|FG000|Open-label Extension Period|Did not receive treatment|18|||
44436274|NCT00319501|79444984|FG001|Open-label Extension Period|Did not receive treatment|0|||
44436275|NCT00319501|79444983|FG000|Open-label Extension Period|Other|1|||
44436276|NCT00319501|79444984|FG001|Open-label Extension Period|Other|0|||
44436277|NCT00319501|79444983|FG000|Open-label Extension Period|Principal investigator decision|2|||
44436278|NCT00319501|79444984|FG001|Open-label Extension Period|Principal investigator decision|0|||
44436279|NCT00319501|79444983|FG000|Open-label Extension Period|Sponsor request|26|||
44436280|NCT00319501|79444984|FG001|Open-label Extension Period|Sponsor request|0|||
44436281|NCT00319501|79444983|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
44436282|NCT00319501|79444984|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
44436283|NCT00761579|79444995|FG000|Overall Study|Adverse Event|10|||
44436284|NCT00761579|79444995|FG000|Overall Study|Death|2|||
44436285|NCT00761579|79444995|FG000|Overall Study|Lack of Efficacy|21|||
44436286|NCT00761579|79444995|FG000|Overall Study|Lost to Follow-up|16|||
44436287|NCT00761579|79444995|FG000|Overall Study|Pregnancy|1|||
44436288|NCT00761579|79444995|FG000|Overall Study|Withdrawal by Subject|34|||
44436289|NCT00761579|79444995|FG000|Overall Study|Lack of compliance|2|||
44337340|NCT01005901|79341697|FG000|Overall Study|Withdrawal by Subject|38|||
44337341|NCT01005901|79341698|FG001|Overall Study|Withdrawal by Subject|14|||
44337342|NCT01005901|79341697|FG000|Overall Study|Adverse Event|30|||
44337343|NCT01005901|79341698|FG001|Overall Study|Adverse Event|16|||
44337344|NCT01005901|79341697|FG000|Overall Study|Administrative problems|21|||
44337345|NCT01005901|79341698|FG001|Overall Study|Administrative problems|13|||
44436290|NCT00761579|79444995|FG000|Overall Study|Protocol deviation|1|||
44436291|NCT00761579|79444995|FG000|Overall Study|Drug overdose|1|||
44436292|NCT00761579|79444995|FG000|Overall Study|Aggravation of depression|1|||
44436293|NCT00761579|79444995|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
44436294|NCT00761579|79444995|FG000|Overall Study|Lost survey form|1|||
44436295|NCT00761579|79444995|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
44157509|NCT02686658|78949257|FG000|Overall Study|Concern over coronavirus disease care|0|||
44436296|NCT00627042|79445001|FG000|Overall Study|Withdrawal by Subject|2|||
44436297|NCT00319111|79445005|FG000|Overall Study|Adverse Event|20|||
44436298|NCT00319111|79445005|FG000|Overall Study|Withdrawal of consent|11|||
44436299|NCT00319111|79445005|FG000|Overall Study|Death|9|||
44436300|NCT00319111|79445005|FG000|Overall Study|Lack of clinical improvement|4|||
44436301|NCT00319111|79445005|FG000|Overall Study|Administrative|2|||
44436302|NCT00319111|79445005|FG000|Overall Study|Treatment failure|1|||
44436303|NCT00640224|79445013|FG000|Overall Study|Lost to Follow-up|5|||
44436304|NCT00640224|79445014|FG001|Overall Study|Lost to Follow-up|2|||
44436305|NCT00640224|79445015|FG002|Overall Study|Lost to Follow-up|0|||
44436306|NCT00640224|79445016|FG003|Overall Study|Lost to Follow-up|0|||
44436307|NCT00640224|79445013|FG000|Overall Study|Withdrawal by Subject|1|||
44436308|NCT00640224|79445014|FG001|Overall Study|Withdrawal by Subject|0|||
44436309|NCT00640224|79445015|FG002|Overall Study|Withdrawal by Subject|0|||
44436310|NCT00640224|79445016|FG003|Overall Study|Withdrawal by Subject|0|||
44436311|NCT00640224|79445013|FG000|Overall Study|Headaches|0|||
44436312|NCT00640224|79445014|FG001|Overall Study|Headaches|1|||
44436313|NCT00640224|79445015|FG002|Overall Study|Headaches|0|||
44436314|NCT00640224|79445016|FG003|Overall Study|Headaches|0|||
44436315|NCT00318643|79445031|FG000|Overall Study|Adverse Event|0|||
44436316|NCT00318643|79445032|FG001|Overall Study|Adverse Event|0|||
44436317|NCT00318643|79445033|FG002|Overall Study|Adverse Event|0|||
44436318|NCT00318643|79445034|FG003|Overall Study|Adverse Event|0|||
44436319|NCT00318643|79445035|FG004|Overall Study|Adverse Event|1|||
44436320|NCT00318643|79445031|FG000|Overall Study|Participant's Decision|0|||
44436321|NCT00318643|79445032|FG001|Overall Study|Participant's Decision|0|||
44436322|NCT00318643|79445033|FG002|Overall Study|Participant's Decision|0|||
44436323|NCT00318643|79445034|FG003|Overall Study|Participant's Decision|0|||
44436324|NCT00318643|79445035|FG004|Overall Study|Participant's Decision|1|||
44436325|NCT00318643|79445031|FG000|Overall Study|Investigator's Decision|0|||
44436326|NCT00318643|79445032|FG001|Overall Study|Investigator's Decision|0|||
44436327|NCT00318643|79445033|FG002|Overall Study|Investigator's Decision|0|||
44436328|NCT00318643|79445034|FG003|Overall Study|Investigator's Decision|0|||
44436329|NCT00318643|79445035|FG004|Overall Study|Investigator's Decision|1|||
44436330|NCT00318565|79445048|FG000|Overall Study|Excluded per protocol|24|||
44436331|NCT00304915|79445054|FG000|Overall Study|Lost to Follow-up|11|||
44436332|NCT00304915|79445055|FG001|Overall Study|Lost to Follow-up|11|||
44436333|NCT00304915|79445054|FG000|Overall Study|Death|4|||
44436334|NCT00304915|79445055|FG001|Overall Study|Death|5|||
44436335|NCT00304915|79445054|FG000|Overall Study|Withdrawal by Subject|3|||
44436336|NCT00304915|79445055|FG001|Overall Study|Withdrawal by Subject|0|||
44436337|NCT03687970|79445063|FG000|Overall Study|visit scheduling conflicts|2|||
44436338|NCT03687970|79445064|FG001|Overall Study|visit scheduling conflicts|0|||
44436339|NCT00530920|79445075|FG000|Overall Study|Randomized but not treated|0|||
44436340|NCT00530920|79445076|FG001|Overall Study|Randomized but not treated|2|||
44436341|NCT00530920|79445077|FG002|Overall Study|Randomized but not treated|0|||
44436342|NCT00530920|79445075|FG000|Overall Study|Adverse Event|0|||
44436343|NCT00530920|79445076|FG001|Overall Study|Adverse Event|0|||
44436344|NCT00530920|79445077|FG002|Overall Study|Adverse Event|3|||
44436345|NCT00530920|79445075|FG000|Overall Study|Withdrawal by Subject|0|||
44436346|NCT00530920|79445076|FG001|Overall Study|Withdrawal by Subject|0|||
44436347|NCT00530920|79445077|FG002|Overall Study|Withdrawal by Subject|1|||
44436348|NCT03878758|79445086|FG000|Overall Study|Withdrawal by Subject|1|||
44436349|NCT03878758|79445086|FG000|Overall Study|Protocol defined|2|||
44436350|NCT03878758|79445086|FG000|Overall Study|Improper consent documentation|1|||
44436351|NCT03878602|79445101|FG000|Overall Study|cord blood donation|7|||
44436352|NCT03878602|79445102|FG001|Overall Study|cord blood donation|1|||
44436353|NCT03878602|79445101|FG000|Overall Study|incomplete data collection|2|||
44436354|NCT03878602|79445102|FG001|Overall Study|incomplete data collection|0|||
44436355|NCT00768755|79445114|FG000|Phase 1|Death|6|||
44436356|NCT00768755|79445115|FG001|Phase 1|Death|0|||
44436357|NCT00768755|79445116|FG002|Phase 1|Death|0|||
44436358|NCT00768755|79445117|FG003|Phase 1|Death|0|||
44436359|NCT00768755|79445114|FG000|Phase 1|Other|4|||
44436360|NCT00768755|79445115|FG001|Phase 1|Other|0|||
44436361|NCT00768755|79445116|FG002|Phase 1|Other|0|||
44436362|NCT00768755|79445117|FG003|Phase 1|Other|0|||
44436363|NCT00768755|79445114|FG000|Phase 2|Death|0|||
44436364|NCT00768755|79445115|FG001|Phase 2|Death|37|||
44436365|NCT00768755|79445116|FG002|Phase 2|Death|48|||
44436366|NCT00768755|79445117|FG003|Phase 2|Death|31|||
44436367|NCT00768755|79445114|FG000|Phase 2|Protocol Violation|0|||
44436368|NCT00768755|79445115|FG001|Phase 2|Protocol Violation|2|||
44436369|NCT00768755|79445116|FG002|Phase 2|Protocol Violation|0|||
44436370|NCT00768755|79445117|FG003|Phase 2|Protocol Violation|1|||
44436371|NCT00768755|79445114|FG000|Phase 2|Lost to Follow-up|0|||
44436372|NCT00768755|79445115|FG001|Phase 2|Lost to Follow-up|1|||
44436373|NCT00768755|79445116|FG002|Phase 2|Lost to Follow-up|1|||
44436374|NCT00768755|79445117|FG003|Phase 2|Lost to Follow-up|4|||
44436375|NCT00768755|79445114|FG000|Phase 2|Withdrawal by Subject|0|||
44436376|NCT00768755|79445115|FG001|Phase 2|Withdrawal by Subject|1|||
44436377|NCT00768755|79445116|FG002|Phase 2|Withdrawal by Subject|0|||
44436378|NCT00768755|79445117|FG003|Phase 2|Withdrawal by Subject|1|||
44436379|NCT00768755|79445114|FG000|Phase 2|Other|0|||
44436380|NCT00768755|79445115|FG001|Phase 2|Other|1|||
44436381|NCT00768755|79445116|FG002|Phase 2|Other|2|||
44436382|NCT00768755|79445117|FG003|Phase 2|Other|4|||
44436383|NCT00768755|79445114|FG000|Phase 2|Study Terminated by Sponsor|0|||
44436384|NCT00768755|79445115|FG001|Phase 2|Study Terminated by Sponsor|13|||
44436385|NCT00768755|79445116|FG002|Phase 2|Study Terminated by Sponsor|7|||
44436386|NCT00768755|79445117|FG003|Phase 2|Study Terminated by Sponsor|14|||
44436387|NCT00768755|79445114|FG000|Phase 2|Randomized but not treated|0|||
44436388|NCT00768755|79445115|FG001|Phase 2|Randomized but not treated|0|||
44436389|NCT00768755|79445116|FG002|Phase 2|Randomized but not treated|0|||
44436390|NCT00768755|79445117|FG003|Phase 2|Randomized but not treated|2|||
44436391|NCT00530842|79445128|FG000|Overall Study|Adverse Event|10|||
44436392|NCT00530842|79445129|FG001|Overall Study|Adverse Event|6|||
44436393|NCT00530842|79445128|FG000|Overall Study|Lack of Efficacy|2|||
44337346|NCT01005901|79341697|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
44337347|NCT01005901|79341698|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
44337348|NCT01005901|79341697|FG000|Overall Study|Protocol Violation|4|||
44337349|NCT01005901|79341698|FG001|Overall Study|Protocol Violation|3|||
44337350|NCT01005901|79341697|FG000|Overall Study|Death|2|||
44337351|NCT01005901|79341698|FG001|Overall Study|Death|3|||
44337352|NCT01005901|79341697|FG000|Overall Study|Lost to Follow-up|1|||
44337353|NCT01005901|79341698|FG001|Overall Study|Lost to Follow-up|2|||
44337354|NCT01005901|79341697|FG000|Overall Study|Patient's inability to use the device|1|||
44337355|NCT01005901|79341698|FG001|Overall Study|Patient's inability to use the device|1|||
44337356|NCT01005901|79341697|FG000|Overall Study|No longer requires study drug|0|||
44337357|NCT01005901|79341698|FG001|Overall Study|No longer requires study drug|1|||
44337358|NCT04968925|79341706|FG000|Phase I- Period 1|COVID-19 related|0|||
44337359|NCT04968925|79341707|FG001|Phase I- Period 1|COVID-19 related|1|||
44337360|NCT04968925|79341708|FG002|Phase I- Period 1|COVID-19 related|0|||
44337361|NCT04968925|79341709|FG003|Phase I- Period 1|COVID-19 related|0|||
44337362|NCT04968925|79341706|FG000|Phase I- Period 1|Subject enrolled in error|1|||
44337363|NCT04968925|79341707|FG001|Phase I- Period 1|Subject enrolled in error|1|||
44337364|NCT04968925|79341708|FG002|Phase I- Period 1|Subject enrolled in error|0|||
44337365|NCT04968925|79341709|FG003|Phase I- Period 1|Subject enrolled in error|0|||
44337366|NCT04968925|79341706|FG000|Phase II- Period 1|COVID-19 Related|0|||
44337367|NCT04968925|79341707|FG001|Phase II- Period 1|COVID-19 Related|0|||
44337368|NCT04968925|79341708|FG002|Phase II- Period 1|COVID-19 Related|6|||
44337369|NCT04968925|79341709|FG003|Phase II- Period 1|COVID-19 Related|6|||
44337370|NCT04968925|79341706|FG000|Phase II- Period 1|Subject enrolled in error|0|||
44337371|NCT04968925|79341707|FG001|Phase II- Period 1|Subject enrolled in error|0|||
44337372|NCT04968925|79341708|FG002|Phase II- Period 1|Subject enrolled in error|1|||
44436394|NCT00530842|79445129|FG001|Overall Study|Lack of Efficacy|1|||
44436395|NCT00530842|79445128|FG000|Overall Study|Lost to Follow-up|0|||
44436396|NCT00530842|79445129|FG001|Overall Study|Lost to Follow-up|4|||
44436397|NCT00530842|79445128|FG000|Overall Study|Protocol Violation|3|||
44337373|NCT04968925|79341709|FG003|Phase II- Period 1|Subject enrolled in error|0|||
44337374|NCT04968925|79341706|FG000|Phase II -Period 2|COVID-19 related|0|||
44337375|NCT04968925|79341707|FG001|Phase II -Period 2|COVID-19 related|0|||
44337376|NCT04968925|79341708|FG002|Phase II -Period 2|COVID-19 related|4|||
44337377|NCT04968925|79341709|FG003|Phase II -Period 2|COVID-19 related|3|||
44337378|NCT04968925|79341706|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
44337379|NCT04968925|79341707|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
44337380|NCT04968925|79341708|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
44337381|NCT04968925|79341709|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
44337382|NCT01266993|79341721|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
44337383|NCT01266993|79341722|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
44337384|NCT01266993|79341721|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
44337385|NCT01266993|79341722|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
44337386|NCT01309386|79341730|FG000|Overall Study|Other|2|||
44337387|NCT01309386|79341731|FG001|Overall Study|Other|0|||
44337388|NCT01309386|79341730|FG000|Overall Study|Withdrawal by Subject|2|||
44337389|NCT01309386|79341731|FG001|Overall Study|Withdrawal by Subject|0|||
44337390|NCT01309386|79341730|FG000|Overall Study|Progressive disease|9|||
44337391|NCT01309386|79341731|FG001|Overall Study|Progressive disease|11|||
44337392|NCT01309386|79341730|FG000|Overall Study|Physician Decision|1|||
44337393|NCT01309386|79341731|FG001|Overall Study|Physician Decision|1|||
44337394|NCT01309386|79341730|FG000|Overall Study|Lack of Efficacy|3|||
44337395|NCT01309386|79341731|FG001|Overall Study|Lack of Efficacy|1|||
44436398|NCT00530842|79445129|FG001|Overall Study|Protocol Violation|2|||
44436399|NCT00530842|79445128|FG000|Overall Study|Withdrawal by Subject|4|||
44436400|NCT00530842|79445129|FG001|Overall Study|Withdrawal by Subject|5|||
44436401|NCT00530842|79445128|FG000|Overall Study|Individual different reasons|4|||
44436402|NCT00530842|79445129|FG001|Overall Study|Individual different reasons|3|||
44436403|NCT00530842|79445128|FG000|Period 1|Adverse Event|7|||
44436404|NCT00530842|79445129|FG001|Period 1|Adverse Event|3|||
44436405|NCT00530842|79445128|FG000|Period 1|Lack of Efficacy|1|||
44436406|NCT00530842|79445129|FG001|Period 1|Lack of Efficacy|1|||
44436407|NCT00530842|79445128|FG000|Period 1|Protocol Violation|2|||
44436408|NCT00530842|79445129|FG001|Period 1|Protocol Violation|1|||
44436409|NCT00530842|79445128|FG000|Period 1|Withdrawal by Subject|2|||
44436410|NCT00530842|79445129|FG001|Period 1|Withdrawal by Subject|3|||
44436411|NCT00530842|79445128|FG000|Period 1|Individual different reasons|2|||
44436412|NCT00530842|79445129|FG001|Period 1|Individual different reasons|3|||
44436413|NCT00530842|79445128|FG000|Period 2|Adverse Event|3|||
44436414|NCT00530842|79445129|FG001|Period 2|Adverse Event|3|||
44436415|NCT00530842|79445128|FG000|Period 2|Lack of Efficacy|1|||
44436416|NCT00530842|79445129|FG001|Period 2|Lack of Efficacy|0|||
44436417|NCT00530842|79445128|FG000|Period 2|Lost to Follow-up|0|||
44436418|NCT00530842|79445129|FG001|Period 2|Lost to Follow-up|4|||
44436419|NCT00530842|79445128|FG000|Period 2|Protocol Violation|1|||
44436420|NCT00530842|79445129|FG001|Period 2|Protocol Violation|0|||
44436421|NCT00530842|79445128|FG000|Period 2|Withdrawal by Subject|1|||
44436422|NCT00530842|79445129|FG001|Period 2|Withdrawal by Subject|2|||
44436423|NCT00530842|79445128|FG000|Period 2|Individual different reasons|2|||
44436424|NCT00530842|79445129|FG001|Period 2|Individual different reasons|0|||
44436425|NCT03882424|79445140|FG000|Overall Study|Lost to Follow-up|3|||
44436426|NCT03882424|79445141|FG001|Overall Study|Lost to Follow-up|0|||
44337396|NCT01309386|79341730|FG000|Overall Study|Adverse Event|5|||
44337397|NCT01309386|79341731|FG001|Overall Study|Adverse Event|8|||
44337398|NCT01266603|79341737|FG000|Overall Study|Adverse Event|1|||
44337399|NCT01266603|79341737|FG000|Overall Study|Lack of Efficacy|14|||
44337400|NCT01266603|79341737|FG000|Overall Study|Withdrawal by Subject|1|||
44337401|NCT01266603|79341737|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
44436427|NCT03882424|79445142|FG002|Overall Study|Lost to Follow-up|0|||
44436428|NCT03882424|79445140|FG000|Overall Study|schedule conflict|1|||
44436429|NCT03882424|79445141|FG001|Overall Study|schedule conflict|0|||
44436430|NCT03882424|79445142|FG002|Overall Study|schedule conflict|0|||
44436431|NCT03879772|79445155|FG000|Overall Study|Adverse Event|2|||
44436432|NCT03879772|79445156|FG001|Overall Study|Adverse Event|2|||
44436433|NCT03879772|79445157|FG002|Overall Study|Adverse Event|3|||
44436434|NCT03879772|79445158|FG003|Overall Study|Adverse Event|4|||
44157510|NCT02686658|78949258|FG001|Overall Study|Concern over coronavirus disease care|0|||
44157511|NCT02686658|78949259|FG002|Overall Study|Concern over coronavirus disease care|0|||
44157512|NCT02686658|78949260|FG003|Overall Study|Concern over coronavirus disease care|0|||
44157513|NCT02686658|78949261|FG004|Overall Study|Concern over coronavirus disease care|2|||
44337402|NCT01309308|79341743|FG000|Overall Study|Lost to Follow-up|6|||
44436435|NCT03879772|79445159|FG004|Overall Study|Adverse Event|3|||
44436436|NCT03879772|79445155|FG000|Overall Study|Treatment Failure|1|||
44436437|NCT03879772|79445156|FG001|Overall Study|Treatment Failure|0|||
44436438|NCT03879772|79445157|FG002|Overall Study|Treatment Failure|0|||
44436439|NCT03879772|79445158|FG003|Overall Study|Treatment Failure|2|||
44436440|NCT03879772|79445159|FG004|Overall Study|Treatment Failure|1|||
44436441|NCT03879772|79445155|FG000|Overall Study|Lost to Follow-up|0|||
44157514|NCT02686658|78949262|FG005|Overall Study|Concern over coronavirus disease care|1|||
44157515|NCT02387957|78949305|FG000|Overall Study|The study was discontinued|21|||
44157516|NCT02387957|78949306|FG001|Overall Study|The study was discontinued|21|||
44157517|NCT02387957|78949307|FG002|Overall Study|The study was discontinued|20|||
44157518|NCT02163694|78949328|FG000|Overall Study|Adverse event- related to progression|3|||
44157519|NCT02163694|78949329|FG001|Overall Study|Adverse event- related to progression|8|||
44157520|NCT02163694|78949328|FG000|Overall Study|Adverse event- not related to progression|7|||
44157521|NCT02163694|78949329|FG001|Overall Study|Adverse event- not related to progression|17|||
44157522|NCT02163694|78949328|FG000|Overall Study|Withdrew consent|8|||
44157523|NCT02163694|78949329|FG001|Overall Study|Withdrew consent|21|||
44157524|NCT02163694|78949328|FG000|Overall Study|Lost to Follow-up|1|||
44157525|NCT02163694|78949329|FG001|Overall Study|Lost to Follow-up|2|||
44337403|NCT01309308|79341744|FG001|Overall Study|Lost to Follow-up|4|||
44436442|NCT03879772|79445156|FG001|Overall Study|Lost to Follow-up|0|||
44436443|NCT03879772|79445157|FG002|Overall Study|Lost to Follow-up|0|||
44540334|NCT03257865|79552270|FG000|Overall Study|Lost to Follow-up|4|||
44540335|NCT03257865|79552271|FG001|Overall Study|Lost to Follow-up|4|||
44157526|NCT02163694|78949328|FG000|Overall Study|Progressive disease per protocol|122|||
44436444|NCT03879772|79445158|FG003|Overall Study|Lost to Follow-up|0|||
44436445|NCT03879772|79445159|FG004|Overall Study|Lost to Follow-up|1|||
44337404|NCT01266291|79341750|FG000|Overall Study|Adverse Event|1|||
44436446|NCT03879772|79445155|FG000|Overall Study|Withdrawal by Subject|0|||
44436447|NCT03879772|79445156|FG001|Overall Study|Withdrawal by Subject|1|||
44436448|NCT03879772|79445157|FG002|Overall Study|Withdrawal by Subject|3|||
44436449|NCT03879772|79445158|FG003|Overall Study|Withdrawal by Subject|1|||
44436450|NCT03879772|79445159|FG004|Overall Study|Withdrawal by Subject|1|||
44436451|NCT03879772|79445155|FG000|Overall Study|Protocol Violation|0|||
44436452|NCT03879772|79445156|FG001|Overall Study|Protocol Violation|0|||
44436453|NCT03879772|79445157|FG002|Overall Study|Protocol Violation|3|||
44436454|NCT03879772|79445158|FG003|Overall Study|Protocol Violation|1|||
44436455|NCT03879772|79445159|FG004|Overall Study|Protocol Violation|2|||
44436456|NCT03879772|79445155|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
44436457|NCT03879772|79445156|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
44436458|NCT03879772|79445157|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
44436459|NCT03879772|79445158|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
44436460|NCT03879772|79445159|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
44436461|NCT00642954|79445176|FG000|Overall Study|Progressive Disease|3|||
44436462|NCT00642954|79445177|FG001|Overall Study|Progressive Disease|3|||
44436463|NCT00642954|79445178|FG002|Overall Study|Progressive Disease|3|||
44436464|NCT00642954|79445179|FG003|Overall Study|Progressive Disease|3|||
44157527|NCT02163694|78949329|FG001|Overall Study|Progressive disease per protocol|197|||
44157528|NCT02163694|78949328|FG000|Overall Study|Other, not specified|13|||
44157529|NCT02163694|78949329|FG001|Overall Study|Other, not specified|22|||
44157530|NCT01944839|78949348|FG000|Overall Study|Physician Decision|2|||
44337405|NCT01004263|79341754|FG000|Overall Study|Adverse Event|15|||
44337406|NCT01004263|79341754|FG000|Overall Study|Withdrawal by Subject|58|||
44337407|NCT01004263|79341754|FG000|Overall Study|Protocol Violation|10|||
44337408|NCT01004263|79341754|FG000|Overall Study|Lost to Follow-up|64|||
44337409|NCT01004263|79341754|FG000|Overall Study|Lack of Efficacy|13|||
44337410|NCT01004263|79341754|FG000|Overall Study|Pregnancy|2|||
44337411|NCT01004263|79341754|FG000|Overall Study|Physician Decision|15|||
44337412|NCT01004263|79341754|FG000|Overall Study|Lack of Qualifying Event|2|||
44337413|NCT01308762|79341761|FG000|Overall Study|Protocol Violation|0|||
44337414|NCT01308762|79341762|FG001|Overall Study|Protocol Violation|1|||
44337415|NCT01308762|79341763|FG002|Overall Study|Protocol Violation|0|||
44337416|NCT01265823|79341774|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
44337417|NCT01265823|79341774|FG000|Overall Study|Failure to Return|4|||
44337418|NCT01265823|79341774|FG000|Overall Study|Protocol Violation|1|||
44337419|NCT01265823|79341774|FG000|Overall Study|Participant Request|1|||
44337420|NCT01004185|79341784|FG000|Overall Study|Adverse Event|1|||
44337421|NCT01004185|79341785|FG001|Overall Study|Adverse Event|1|||
44337422|NCT01004185|79341784|FG000|Overall Study|Lost to Follow-up|0|||
44337423|NCT01004185|79341785|FG001|Overall Study|Lost to Follow-up|1|||
44337424|NCT01004185|79341784|FG000|Overall Study|Lack of Efficacy|2|||
44337425|NCT01004185|79341785|FG001|Overall Study|Lack of Efficacy|1|||
44337426|NCT01004185|79341784|FG000|Overall Study|Sponsor Terminated Study|4|||
44337427|NCT01004185|79341785|FG001|Overall Study|Sponsor Terminated Study|5|||
44337428|NCT01004185|79341784|FG000|Overall Study|Withdrawal by Subject|2|||
44337429|NCT01004185|79341785|FG001|Overall Study|Withdrawal by Subject|1|||
44337430|NCT01265511|79341793|FG000|Overall Study|Lack of Efficacy|2|||
44337431|NCT01265511|79341794|FG001|Overall Study|Lack of Efficacy|1|||
44337432|NCT01265511|79341793|FG000|Overall Study|Met stopping rules|0|||
44337433|NCT01265511|79341794|FG001|Overall Study|Met stopping rules|2|||
44337434|NCT01264965|79341800|FG000|Overall Study|Withdrawal by Subject|10|||
44337435|NCT01264887|79341804|FG000|Overall Study|Adverse Event|5|||
44337436|NCT01264887|79341804|FG000|Overall Study|Death|7|||
44337437|NCT01264887|79341804|FG000|Overall Study|Lack of Efficacy|5|||
44337438|NCT01264887|79341804|FG000|Overall Study|Physician Decision|4|||
44337439|NCT01264887|79341804|FG000|Overall Study|Withdrawal by Subject|6|||
44337440|NCT01264887|79341804|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
44337441|NCT01264887|79341804|FG000|Overall Study|Other|2|||
44337442|NCT01306968|79341814|FG000|Overall Study|Lost to Follow-up|1|||
44337443|NCT01306968|79341815|FG001|Overall Study|Lost to Follow-up|1|||
44337444|NCT01306968|79341816|FG002|Overall Study|Lost to Follow-up|0|||
44337445|NCT01306968|79341817|FG003|Overall Study|Lost to Follow-up|0|||
44337446|NCT01306968|79341814|FG000|Overall Study|Physician Decision|0|||
44337447|NCT01306968|79341815|FG001|Overall Study|Physician Decision|1|||
44337448|NCT01306968|79341816|FG002|Overall Study|Physician Decision|0|||
44337449|NCT01306968|79341817|FG003|Overall Study|Physician Decision|0|||
44337450|NCT01306968|79341814|FG000|Overall Study|Relocated and left active duty|0|||
44337451|NCT01306968|79341815|FG001|Overall Study|Relocated and left active duty|1|||
44337452|NCT01306968|79341816|FG002|Overall Study|Relocated and left active duty|1|||
44337453|NCT01306968|79341817|FG003|Overall Study|Relocated and left active duty|1|||
44337454|NCT01306968|79341814|FG000|Overall Study|Withdrew - time commitment|0|||
44337455|NCT01306968|79341815|FG001|Overall Study|Withdrew - time commitment|0|||
44337456|NCT01306968|79341816|FG002|Overall Study|Withdrew - time commitment|0|||
44337457|NCT01306968|79341817|FG003|Overall Study|Withdrew - time commitment|2|||
44337458|NCT01306968|79341814|FG000|Overall Study|Withdrew over privacy concerns|0|||
44337459|NCT01306968|79341815|FG001|Overall Study|Withdrew over privacy concerns|0|||
44436465|NCT00642954|79445180|FG004|Overall Study|Progressive Disease|9|||
44436466|NCT00642954|79445176|FG000|Overall Study|Withdrawal by Subject|0|||
44436467|NCT00642954|79445177|FG001|Overall Study|Withdrawal by Subject|0|||
44436468|NCT00642954|79445178|FG002|Overall Study|Withdrawal by Subject|0|||
44157531|NCT01944839|78949349|FG001|Overall Study|Physician Decision|2|||
44436469|NCT00642954|79445179|FG003|Overall Study|Withdrawal by Subject|0|||
44436470|NCT00642954|79445180|FG004|Overall Study|Withdrawal by Subject|1|||
44436471|NCT00642954|79445176|FG000|Overall Study|Adverse Event|1|||
44436472|NCT00642954|79445177|FG001|Overall Study|Adverse Event|1|||
44436473|NCT00642954|79445178|FG002|Overall Study|Adverse Event|0|||
44436474|NCT00642954|79445179|FG003|Overall Study|Adverse Event|0|||
44436475|NCT00642954|79445180|FG004|Overall Study|Adverse Event|6|||
44436476|NCT00640146|79445194|FG000|Overall Study|Adverse Event|2|||
44436477|NCT00640146|79445195|FG001|Overall Study|Adverse Event|0|||
44436478|NCT00640146|79445194|FG000|Overall Study|Lost to Follow-up|0|||
44436479|NCT00640146|79445195|FG001|Overall Study|Lost to Follow-up|1|||
44436480|NCT00640146|79445194|FG000|Overall Study|Lack of Efficacy|0|||
44337460|NCT01306968|79341816|FG002|Overall Study|Withdrew over privacy concerns|0|||
44337461|NCT01306968|79341817|FG003|Overall Study|Withdrew over privacy concerns|1|||
44337462|NCT01264419|79341829|FG000|Overall Study|Lost to Follow-up|3|||
44337463|NCT01263873|79341835|FG000|Overall Study|One provider unable to complete numbers|1|||
44337464|NCT01263873|79341836|FG001|Overall Study|One provider unable to complete numbers|1|||
44436481|NCT00640146|79445195|FG001|Overall Study|Lack of Efficacy|1|||
44436482|NCT00640146|79445194|FG000|Overall Study|Withdrawal by Subject|1|||
44436483|NCT00640146|79445195|FG001|Overall Study|Withdrawal by Subject|1|||
44436484|NCT00640146|79445194|FG000|Overall Study|Randomized but not treated|1|||
44436485|NCT00640146|79445195|FG001|Overall Study|Randomized but not treated|3|||
44436486|NCT00317473|79445207|FG000|Overall Study|Withdrawal by Subject|2|||
44436487|NCT00317473|79445208|FG001|Overall Study|Withdrawal by Subject|1|||
44436488|NCT00317473|79445209|FG002|Overall Study|Withdrawal by Subject|2|||
44436489|NCT00317473|79445210|FG003|Overall Study|Withdrawal by Subject|1|||
44436490|NCT00317473|79445211|FG004|Overall Study|Withdrawal by Subject|3|||
44436491|NCT00317473|79445212|FG005|Overall Study|Withdrawal by Subject|1|||
44436492|NCT00317473|79445207|FG000|Overall Study|Relocation|1|||
44436493|NCT00317473|79445208|FG001|Overall Study|Relocation|0|||
44436494|NCT00317473|79445209|FG002|Overall Study|Relocation|1|||
44436495|NCT00317473|79445210|FG003|Overall Study|Relocation|1|||
44436496|NCT00317473|79445211|FG004|Overall Study|Relocation|5|||
44436497|NCT00317473|79445212|FG005|Overall Study|Relocation|2|||
44436498|NCT00317473|79445207|FG000|Overall Study|Death|1|||
44436499|NCT00317473|79445208|FG001|Overall Study|Death|0|||
44436500|NCT00317473|79445209|FG002|Overall Study|Death|0|||
44436501|NCT00317473|79445210|FG003|Overall Study|Death|0|||
44436502|NCT00317473|79445211|FG004|Overall Study|Death|0|||
44436503|NCT00317473|79445212|FG005|Overall Study|Death|0|||
44436504|NCT00317473|79445207|FG000|Overall Study|Other|0|||
44259320|NCT04349891|79118615|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
44436505|NCT00317473|79445208|FG001|Overall Study|Other|2|||
44436506|NCT00317473|79445209|FG002|Overall Study|Other|0|||
44436507|NCT00317473|79445210|FG003|Overall Study|Other|0|||
44436508|NCT00317473|79445211|FG004|Overall Study|Other|0|||
44436509|NCT00317473|79445212|FG005|Overall Study|Other|0|||
44436510|NCT00530218|79445236|FG000|Overall Study|CMV Not Detected|13|||
44259321|NCT04349891|79118616|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
44259322|NCT04349891|79118615|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
44259323|NCT04349891|79118616|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
44259324|NCT04349891|79118615|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
44259325|NCT04349891|79118616|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
44259326|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
44259327|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
44259328|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
44259329|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
44259330|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
44259331|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
44259332|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
44259333|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
44259334|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to death|4|||
44259335|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to death|3|||
44259336|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
44259337|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
44259338|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
44259339|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
44259340|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
44436511|NCT00530218|79445236|FG000|Overall Study|Death|12|||
44436512|NCT00761267|79445246|FG000|Overall Study|Death|1|||
44436513|NCT00761267|79445247|FG001|Overall Study|Death|2|||
44436514|NCT00761267|79445248|FG002|Overall Study|Death|5|||
44436515|NCT00761267|79445246|FG000|Overall Study|Lost to Follow-up|0|||
44337465|NCT01263639|79341844|FG000|Overall Study|Lost to Follow-up|66|||
44436516|NCT00761267|79445247|FG001|Overall Study|Lost to Follow-up|0|||
44436517|NCT00761267|79445248|FG002|Overall Study|Lost to Follow-up|1|||
44436518|NCT00761267|79445246|FG000|Overall Study|Randomized but not treated|1|||
44436519|NCT00761267|79445247|FG001|Overall Study|Randomized but not treated|1|||
44436520|NCT00761267|79445248|FG002|Overall Study|Randomized but not treated|0|||
44436521|NCT00761267|79445246|FG000|Overall Study|Withdrawal by Subject|0|||
44436522|NCT00761267|79445247|FG001|Overall Study|Withdrawal by Subject|1|||
44436523|NCT00761267|79445248|FG002|Overall Study|Withdrawal by Subject|0|||
44436524|NCT00303667|79445269|FG000|Overall Study|Death|0|||
44436525|NCT00303667|79445270|FG001|Overall Study|Death|4|||
44436526|NCT00761189|79445276|FG000|Overall Study|Adverse Event|42|||
44436527|NCT00761189|79445276|FG000|Overall Study|Lack of Efficacy|45|||
44436528|NCT00761189|79445276|FG000|Overall Study|Lost to Follow-up|36|||
44436529|NCT00761189|79445276|FG000|Overall Study|Withdrawal by Subject|49|||
44436530|NCT00761189|79445276|FG000|Overall Study|Other|13|||
44436531|NCT00529516|79445283|FG000|Overall Study|Adverse Event|2|||
44436532|NCT00529516|79445284|FG001|Overall Study|Adverse Event|1|||
44436533|NCT00529516|79445285|FG002|Overall Study|Adverse Event|0|||
44436534|NCT00529516|79445283|FG000|Overall Study|Withdrawal by Subject|1|||
44436535|NCT00529516|79445284|FG001|Overall Study|Withdrawal by Subject|1|||
44436536|NCT00529516|79445285|FG002|Overall Study|Withdrawal by Subject|0|||
44436537|NCT00529516|79445283|FG000|Overall Study|Lost to Follow-up|0|||
44436538|NCT00529516|79445284|FG001|Overall Study|Lost to Follow-up|0|||
44436539|NCT00529516|79445285|FG002|Overall Study|Lost to Follow-up|1|||
44436540|NCT00316693|79445295|FG000|Overall Study|Adverse Event|6|||
44436541|NCT00316693|79445296|FG001|Overall Study|Adverse Event|1|||
44436542|NCT00316693|79445295|FG000|Overall Study|Protocol Violation|1|||
44436543|NCT00316693|79445296|FG001|Overall Study|Protocol Violation|0|||
44436544|NCT00316693|79445295|FG000|Overall Study|Withdrawal by Subject|6|||
44436545|NCT00316693|79445296|FG001|Overall Study|Withdrawal by Subject|6|||
44436546|NCT00316693|79445295|FG000|Overall Study|Lost to Follow-up|26|||
44436547|NCT00316693|79445296|FG001|Overall Study|Lost to Follow-up|34|||
44436548|NCT00316693|79445295|FG000|Overall Study|Other|38|||
44436549|NCT00316693|79445296|FG001|Overall Study|Other|44|||
44436550|NCT00316303|79445304|FG000|Overall Study|Lost to Follow-up|11|||
44436551|NCT00316303|79445305|FG001|Overall Study|Lost to Follow-up|16|||
44436552|NCT00760877|79445316|FG000|Overall Study|Protocol Violation|1|||
44436553|NCT00760877|79445317|FG001|Overall Study|Protocol Violation|0|||
44436554|NCT00760877|79445316|FG000|Overall Study|Non-compliance with protocol treatment|2|||
44436555|NCT00760877|79445317|FG001|Overall Study|Non-compliance with protocol treatment|1|||
44436556|NCT00760877|79445316|FG000|Overall Study|Pregnancy|1|||
44436557|NCT00760877|79445317|FG001|Overall Study|Pregnancy|4|||
44436558|NCT00760877|79445316|FG000|Overall Study|Death|2|||
44157532|NCT01944839|78949348|FG000|Overall Study|Protocol Violation|0|||
44157533|NCT01944839|78949349|FG001|Overall Study|Protocol Violation|1|||
44259341|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
44436559|NCT00760877|79445317|FG001|Overall Study|Death|1|||
44436560|NCT00760877|79445316|FG000|Overall Study|Withdrawal by Subject|7|||
44436561|NCT00760877|79445317|FG001|Overall Study|Withdrawal by Subject|3|||
44436562|NCT00760877|79445316|FG000|Overall Study|Adverse Event|19|||
44436563|NCT00760877|79445317|FG001|Overall Study|Adverse Event|12|||
44436564|NCT00760877|79445316|FG000|Overall Study|Participant diagnosed with AML|0|||
44436565|NCT00760877|79445317|FG001|Overall Study|Participant diagnosed with AML|1|||
44436566|NCT00760877|79445316|FG000|Overall Study|Participant not eligible to cross-over|0|||
44157534|NCT01944839|78949348|FG000|Overall Study|Adverse Event|10|||
44259342|NCT02258451|79118624|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
44259343|NCT02258451|79118625|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
44259344|NCT02258451|79118624|FG000|Overall Study|Other reason|1|||
44259345|NCT02258451|79118625|FG001|Overall Study|Other reason|1|||
44259346|NCT02258451|79118624|FG000|Overall Study|Never treated|2|||
44259347|NCT02258451|79118625|FG001|Overall Study|Never treated|3|||
44259348|NCT02168270|79118633|FG000|Overall Study|Lack of Efficacy|4|||
44259349|NCT02775903|79118934|FG000|Overall Study|Death|7|||
44259350|NCT02775903|79118935|FG001|Overall Study|Death|11|||
44259351|NCT02775903|79118936|FG002|Overall Study|Death|12|||
44259352|NCT02775903|79118937|FG003|Overall Study|Death|11|||
44259353|NCT02775903|79118934|FG000|Overall Study|Adverse Event|0|||
44259354|NCT02775903|79118935|FG001|Overall Study|Adverse Event|1|||
44436567|NCT00760877|79445317|FG001|Overall Study|Participant not eligible to cross-over|1|||
44436568|NCT00760877|79445316|FG000|Overall Study|Physician Decision|1|||
44157535|NCT01944839|78949349|FG001|Overall Study|Adverse Event|5|||
44436569|NCT00760877|79445317|FG001|Overall Study|Physician Decision|2|||
44436570|NCT00760877|79445316|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
44436571|NCT00760877|79445317|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
44436572|NCT00760877|79445316|FG000|Overall Study|Treatment failure|1|||
44436573|NCT00760877|79445317|FG001|Overall Study|Treatment failure|0|||
44436574|NCT00302731|79445328|FG000|Overall Study|Lost to Follow-up|1|||
44436575|NCT00302731|79445329|FG001|Overall Study|Lost to Follow-up|2|||
44436576|NCT00302731|79445330|FG002|Overall Study|Lost to Follow-up|0|||
44436577|NCT00302731|79445331|FG003|Overall Study|Lost to Follow-up|0|||
44436578|NCT00302731|79445328|FG000|Overall Study|Adverse Event|0|||
44436579|NCT00302731|79445329|FG001|Overall Study|Adverse Event|2|||
44436580|NCT00302731|79445330|FG002|Overall Study|Adverse Event|2|||
44436581|NCT00302731|79445331|FG003|Overall Study|Adverse Event|0|||
44436582|NCT00302731|79445328|FG000|Overall Study|Withdrawal by Subject|1|||
44436583|NCT00302731|79445329|FG001|Overall Study|Withdrawal by Subject|1|||
44436584|NCT00302731|79445330|FG002|Overall Study|Withdrawal by Subject|0|||
44436585|NCT00302731|79445331|FG003|Overall Study|Withdrawal by Subject|0|||
44436586|NCT00302731|79445328|FG000|Overall Study|Protocol Violation|1|||
44436587|NCT00302731|79445329|FG001|Overall Study|Protocol Violation|0|||
44436588|NCT00302731|79445330|FG002|Overall Study|Protocol Violation|0|||
44436589|NCT00302731|79445331|FG003|Overall Study|Protocol Violation|0|||
44436590|NCT00302731|79445328|FG000|Overall Study|cancer unrelated to study discovered|1|||
44436591|NCT00302731|79445329|FG001|Overall Study|cancer unrelated to study discovered|0|||
44436592|NCT00302731|79445330|FG002|Overall Study|cancer unrelated to study discovered|1|||
44436593|NCT00302731|79445331|FG003|Overall Study|cancer unrelated to study discovered|0|||
44436594|NCT00780143|79445341|FG000|Overall Study|Progressive disease|1|||
44436595|NCT00780143|79445341|FG000|Overall Study|Toxicity|1|||
44436596|NCT00780143|79445341|FG000|Overall Study|Adverse Event|1|||
44436597|NCT00779909|79445349|FG000|Overall Study|Lost to Follow-up|1|||
44436598|NCT00779909|79445350|FG001|Overall Study|Lost to Follow-up|0|||
44436599|NCT00779909|79445351|FG002|Overall Study|Lost to Follow-up|0|||
44436600|NCT00779909|79445352|FG003|Overall Study|Lost to Follow-up|1|||
44436601|NCT00779909|79445349|FG000|Overall Study|Withdrawal by Subject|0|||
44436602|NCT00779909|79445350|FG001|Overall Study|Withdrawal by Subject|1|||
44436603|NCT00779909|79445351|FG002|Overall Study|Withdrawal by Subject|0|||
44436604|NCT00779909|79445352|FG003|Overall Study|Withdrawal by Subject|0|||
44436605|NCT00302107|79445371|FG000|Overall Study|Lost to Follow-up|6|||
44436606|NCT00302107|79445372|FG001|Overall Study|Lost to Follow-up|5|||
44436607|NCT00302107|79445371|FG000|Overall Study|Protocol Violation|1|||
44436608|NCT00302107|79445372|FG001|Overall Study|Protocol Violation|0|||
44436609|NCT00302107|79445371|FG000|Overall Study|Relocation|0|||
44436610|NCT00302107|79445372|FG001|Overall Study|Relocation|1|||
44436611|NCT00302107|79445371|FG000|Overall Study|Withdrawal by Subject|0|||
44436612|NCT00302107|79445372|FG001|Overall Study|Withdrawal by Subject|3|||
44436613|NCT00302107|79445371|FG000|Overall Study|Adverse Event|1|||
44436614|NCT00302107|79445372|FG001|Overall Study|Adverse Event|0|||
44436615|NCT00760487|79445378|FG000|Overall Study|Unilateral implantation|3|||
44436616|NCT00316225|79445382|FG000|Overall Study|Adverse Event|2|||
44436617|NCT00316225|79445382|FG000|Overall Study|Physician Decision|3|||
44436618|NCT00316225|79445382|FG000|Overall Study|Progressive Disease|15|||
44436619|NCT00316225|79445382|FG000|Overall Study|Withdrawal by Subject|3|||
44540336|NCT04617847|79552279|FG000|Overall Study|Withdrawal by Subject|1|||
44540337|NCT04617847|79552280|FG001|Overall Study|Withdrawal by Subject|0|||
44540338|NCT04617847|79552279|FG000|Overall Study|Adverse Event|0|||
44540339|NCT04617847|79552280|FG001|Overall Study|Adverse Event|2|||
44540340|NCT04617847|79552279|FG000|Overall Study|Death|0|||
44540341|NCT04617847|79552280|FG001|Overall Study|Death|1|||
44540342|NCT04617847|79552279|FG000|Overall Study|Termination of Study by Sponsor|2|||
44540343|NCT04617847|79552280|FG001|Overall Study|Termination of Study by Sponsor|21|||
44540344|NCT04615507|79552290|FG000|Period 1|Covid-19 exposure|2|||
44436620|NCT00316225|79445382|FG000|Overall Study|Death|2|||
44436621|NCT00586703|79445386|FG000|Overall Study|Death|12|||
44436622|NCT00586625|79445392|FG000|Overall Study|Adverse Event|6|||
44436623|NCT00586625|79445393|FG001|Overall Study|Adverse Event|6|||
44436624|NCT00586625|79445392|FG000|Overall Study|Protocol Violation|3|||
44436625|NCT00586625|79445393|FG001|Overall Study|Protocol Violation|0|||
44436626|NCT00586625|79445392|FG000|Overall Study|Withdrawal by Subject|32|||
44436627|NCT00586625|79445393|FG001|Overall Study|Withdrawal by Subject|10|||
44436628|NCT00586625|79445392|FG000|Overall Study|Subject non-compliance|0|||
44436629|NCT00586625|79445393|FG001|Overall Study|Subject non-compliance|1|||
44436630|NCT00586625|79445392|FG000|Overall Study|Subject unable to return for visit|2|||
44436631|NCT00586625|79445393|FG001|Overall Study|Subject unable to return for visit|0|||
44436632|NCT00636168|79445401|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
44436633|NCT00636168|79445402|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
44436634|NCT00636168|79445401|FG000|Randomized to Study Drug|Adverse Event|1|||
44436635|NCT00636168|79445402|FG001|Randomized to Study Drug|Adverse Event|0|||
44436636|NCT00636168|79445401|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
44436637|NCT00636168|79445402|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
44540345|NCT04615507|79552291|FG001|Period 1|Covid-19 exposure|1|||
44540346|NCT04615507|79552290|FG000|Period 2|Covid-19 exposure|0|||
44436638|NCT00636168|79445401|FG000|Treated With Study Drug|Recurrence of disease|135|||
44436639|NCT00636168|79445402|FG001|Treated With Study Drug|Recurrence of disease|282|||
44436640|NCT00636168|79445401|FG000|Treated With Study Drug|Adverse Event|250|||
44436641|NCT00636168|79445402|FG001|Treated With Study Drug|Adverse Event|22|||
44436642|NCT00636168|79445401|FG000|Treated With Study Drug|Participant withdrew consent|16|||
44436643|NCT00636168|79445402|FG001|Treated With Study Drug|Participant withdrew consent|21|||
44436644|NCT00636168|79445401|FG000|Treated With Study Drug|Poor/non-compliance|1|||
44436645|NCT00636168|79445402|FG001|Treated With Study Drug|Poor/non-compliance|3|||
44436646|NCT00636168|79445401|FG000|Treated With Study Drug|Death|3|||
44436647|NCT00636168|79445402|FG001|Treated With Study Drug|Death|0|||
44436648|NCT00636168|79445401|FG000|Treated With Study Drug|Pregnancy|1|||
44436649|NCT00636168|79445402|FG001|Treated With Study Drug|Pregnancy|0|||
44436650|NCT00636168|79445401|FG000|Treated With Study Drug|No longer meets study criteria|1|||
44436651|NCT00636168|79445402|FG001|Treated With Study Drug|No longer meets study criteria|0|||
44436652|NCT00636168|79445401|FG000|Treated With Study Drug|Other reason|1|||
44436653|NCT00636168|79445402|FG001|Treated With Study Drug|Other reason|3|||
44436654|NCT00636168|79445401|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
44436655|NCT00636168|79445402|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
44436656|NCT00636168|79445401|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
44436657|NCT00636168|79445402|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
44436658|NCT00636168|79445401|FG000|Long Term Follow-Up|Death|8|||
44436659|NCT00636168|79445402|FG001|Long Term Follow-Up|Death|9|||
44436660|NCT00759941|79445410|FG000|Overall Study|Use of medication|1|||
44436661|NCT00759941|79445411|FG001|Overall Study|Use of medication|0|||
44436662|NCT00759941|79445410|FG000|Overall Study|Adverse Event|1|||
44337466|NCT01263639|79341845|FG001|Overall Study|Lost to Follow-up|70|||
44337467|NCT01263639|79341844|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
44337468|NCT01263639|79341845|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
44337469|NCT01011283|79341853|FG000|Overall Study|Adverse Event|4|||
44337470|NCT01011283|79341854|FG001|Overall Study|Adverse Event|2|||
44337471|NCT01011283|79341853|FG000|Overall Study|Progressive Disease|0|||
44436663|NCT00759941|79445411|FG001|Overall Study|Adverse Event|0|||
44436664|NCT00759941|79445410|FG000|Overall Study|Exited in error by site|1|||
44436665|NCT00759941|79445411|FG001|Overall Study|Exited in error by site|1|||
44436666|NCT00528424|79445417|FG000|Overall Study|Lost to Follow-up|13|||
44436667|NCT00528424|79445417|FG000|Overall Study|Withdrew consent|2|||
44436668|NCT00528424|79445417|FG000|Overall Study|Administrative reason|2|||
44436669|NCT00528424|79445417|FG000|Overall Study|Other|12|||
44436670|NCT00315445|79445424|FG000|Overall Study|Adverse Event|7|||
44436671|NCT00315445|79445425|FG001|Overall Study|Adverse Event|12|||
44436672|NCT00315445|79445426|FG002|Overall Study|Adverse Event|15|||
44436673|NCT00315445|79445424|FG000|Overall Study|Lack of Efficacy|16|||
44436674|NCT00315445|79445425|FG001|Overall Study|Lack of Efficacy|1|||
44436675|NCT00315445|79445426|FG002|Overall Study|Lack of Efficacy|7|||
44436676|NCT00315445|79445424|FG000|Overall Study|Lost to Follow-up|1|||
44337472|NCT01011283|79341854|FG001|Overall Study|Progressive Disease|2|||
44337473|NCT01011283|79341853|FG000|Overall Study|Terminated by Sponsor|5|||
44337474|NCT01011283|79341854|FG001|Overall Study|Terminated by Sponsor|5|||
44337475|NCT01011283|79341853|FG000|Overall Study|Other|2|||
44337476|NCT01011283|79341854|FG001|Overall Study|Other|2|||
44337477|NCT01263561|79341862|FG000|Overall Study|Death|1|||
44337478|NCT01263561|79341863|FG001|Overall Study|Death|2|||
44337479|NCT01009099|79341871|FG000|Overall Study|Lost to Follow-up|1|||
44337480|NCT01009099|79341872|FG001|Overall Study|Lost to Follow-up|0|||
44337481|NCT01009099|79341871|FG000|Overall Study|Physician Decision|3|||
44337482|NCT01009099|79341872|FG001|Overall Study|Physician Decision|2|||
44337483|NCT01009099|79341871|FG000|Overall Study|Withdrawal by Subject|1|||
44337484|NCT01009099|79341872|FG001|Overall Study|Withdrawal by Subject|1|||
44436677|NCT00315445|79445425|FG001|Overall Study|Lost to Follow-up|0|||
44436678|NCT00315445|79445426|FG002|Overall Study|Lost to Follow-up|1|||
44436679|NCT00315445|79445424|FG000|Overall Study|Protocol Violation|2|||
44337485|NCT01009099|79341871|FG000|Overall Study|Death|0|||
44337486|NCT01009099|79341872|FG001|Overall Study|Death|1|||
44337487|NCT01263483|79341881|FG000|Overall Study|Adverse Event|4|||
44337488|NCT01263483|79341882|FG001|Overall Study|Adverse Event|0|||
44337489|NCT01263483|79341883|FG002|Overall Study|Adverse Event|3|||
44337490|NCT01263483|79341881|FG000|Overall Study|Withdrawal by Subject|1|||
44436680|NCT00315445|79445425|FG001|Overall Study|Protocol Violation|0|||
44436681|NCT00315445|79445426|FG002|Overall Study|Protocol Violation|1|||
44436682|NCT00315445|79445424|FG000|Overall Study|Other|1|||
44436683|NCT00315445|79445425|FG001|Overall Study|Other|3|||
44436684|NCT00315445|79445426|FG002|Overall Study|Other|0|||
44436685|NCT03687736|79445434|FG000|Overall Study|Lost to Follow-up|7|||
44436686|NCT03687736|79445434|FG000|Overall Study|Withdrawal by Subject|3|||
44436687|NCT00779675|79445440|FG000|Treatment Period|Adverse Event|87|||
44337491|NCT01263483|79341882|FG001|Overall Study|Withdrawal by Subject|0|||
44337492|NCT01263483|79341883|FG002|Overall Study|Withdrawal by Subject|0|||
44337493|NCT01263483|79341881|FG000|Overall Study|Lack of Efficacy|2|||
44337494|NCT01263483|79341882|FG001|Overall Study|Lack of Efficacy|0|||
44337495|NCT01263483|79341883|FG002|Overall Study|Lack of Efficacy|0|||
44337496|NCT01263483|79341881|FG000|Overall Study|Protocol Violation|0|||
44337497|NCT01263483|79341882|FG001|Overall Study|Protocol Violation|1|||
44337498|NCT01263483|79341883|FG002|Overall Study|Protocol Violation|1|||
44337499|NCT01263483|79341881|FG000|Overall Study|Participant Unavailability|0|||
44337500|NCT01263483|79341882|FG001|Overall Study|Participant Unavailability|1|||
44436688|NCT00779675|79445440|FG000|Treatment Period|Treatment Failure|80|||
44436689|NCT00779675|79445440|FG000|Treatment Period|Transferred to Another Study|38|||
44337501|NCT01263483|79341883|FG002|Overall Study|Participant Unavailability|1|||
44337502|NCT01306890|79341891|FG000|Overall Study|Adverse Event|2|||
44337503|NCT01306890|79341891|FG000|Overall Study|Death|1223|||
44337504|NCT01306890|79341891|FG000|Overall Study|Lost to Follow-up|58|||
44337505|NCT01306890|79341891|FG000|Overall Study|Withdrawal by Subject|88|||
44337506|NCT01306890|79341891|FG000|Overall Study|Unspecified reasons|104|||
44337507|NCT01306890|79341891|FG000|Overall Study|Study Termination|3|||
44337508|NCT01306890|79341891|FG000|Overall Study|No discontinuation documentation|41|||
44337509|NCT01011049|79341899|FG000|Overall Study|Protocol Violation|0|||
44337510|NCT01011049|79341900|FG001|Overall Study|Protocol Violation|0|||
44337511|NCT01011049|79341901|FG002|Overall Study|Protocol Violation|2|||
44337512|NCT01011049|79341902|FG003|Overall Study|Protocol Violation|0|||
44337513|NCT01011049|79341899|FG000|Overall Study|Lost to Follow-up|1|||
44337514|NCT01011049|79341900|FG001|Overall Study|Lost to Follow-up|2|||
44337515|NCT01011049|79341901|FG002|Overall Study|Lost to Follow-up|1|||
44337516|NCT01011049|79341902|FG003|Overall Study|Lost to Follow-up|0|||
44337517|NCT01011049|79341899|FG000|Overall Study|Withdrawal by Subject|0|||
44337518|NCT01011049|79341900|FG001|Overall Study|Withdrawal by Subject|0|||
44337519|NCT01011049|79341901|FG002|Overall Study|Withdrawal by Subject|1|||
44337520|NCT01011049|79341902|FG003|Overall Study|Withdrawal by Subject|0|||
44337521|NCT01263093|79341914|FG000|Washout|Physician Decision|1|||
44337522|NCT01263093|79341915|FG001|Washout|Physician Decision|0|||
44337523|NCT01263093|79341914|FG000|Period 2|Adverse Event|1|||
44337524|NCT01263093|79341915|FG001|Period 2|Adverse Event|0|||
44337525|NCT01010971|79341925|FG000|Overall Study|Adverse Event|2|||
44337526|NCT01010971|79341926|FG001|Overall Study|Adverse Event|4|||
44337527|NCT01010971|79341927|FG002|Overall Study|Adverse Event|3|||
44337528|NCT01010971|79341925|FG000|Overall Study|Withdrawal by Subject|0|||
44337529|NCT01010971|79341926|FG001|Overall Study|Withdrawal by Subject|2|||
44337530|NCT01010971|79341927|FG002|Overall Study|Withdrawal by Subject|5|||
44436690|NCT00779675|79445440|FG000|Treatment Period|Lost to Follow-up|23|||
44436691|NCT00779675|79445440|FG000|Treatment Period|Withdrawal by Subject|46|||
44436692|NCT00779675|79445440|FG000|Treatment Period|Protocol Violation|54|||
44436693|NCT00779675|79445440|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
44436694|NCT00779675|79445440|FG000|Treatment Period|Administrative|3|||
44436695|NCT00779675|79445440|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
44436696|NCT00779675|79445440|FG000|Extended Treatment Period|Protocol Violation|13|||
44436697|NCT00779675|79445440|FG000|Extended Treatment Period|Adverse Event|6|||
44436698|NCT00779675|79445440|FG000|Extended Treatment Period|Treatment Failure|11|||
44436699|NCT00779675|79445440|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
44436700|NCT00779675|79445440|FG000|Extended Treatment Period|Lost to Follow-up|6|||
44436701|NCT00759863|79445450|FG000|Overall Study|Death, moved, or lost contact|20|||
44436702|NCT00759863|79445451|FG001|Overall Study|Death, moved, or lost contact|18|||
44436703|NCT00759785|79445459|FG000|Overall Study|Participant sample not evaluable|11|||
44436704|NCT00759785|79445460|FG001|Overall Study|Participant sample not evaluable|2|||
44436705|NCT00759785|79445459|FG000|Overall Study|Participant sample lost|0|||
44436706|NCT00759785|79445460|FG001|Overall Study|Participant sample lost|1|||
44436707|NCT00759785|79445459|FG000|Overall Study|Protocol Violation|1|||
44436708|NCT00759785|79445460|FG001|Overall Study|Protocol Violation|0|||
44436709|NCT00759785|79445459|FG000|Overall Study|Physician Decision|0|||
44157536|NCT01944839|78949348|FG000|Overall Study|Withdrawal by Subject|9|||
44337531|NCT01010971|79341925|FG000|Overall Study|Lost to Follow-up|0|||
44337532|NCT01010971|79341926|FG001|Overall Study|Lost to Follow-up|2|||
44337533|NCT01010971|79341927|FG002|Overall Study|Lost to Follow-up|3|||
44337534|NCT01010971|79341925|FG000|Overall Study|Other|1|||
44337535|NCT01010971|79341926|FG001|Overall Study|Other|0|||
44337536|NCT01010971|79341927|FG002|Overall Study|Other|2|||
44436710|NCT00759785|79445460|FG001|Overall Study|Physician Decision|1|||
44436711|NCT00759785|79445459|FG000|Overall Study|Withdrawal by Subject|0|||
44259355|NCT02775903|79118936|FG002|Overall Study|Adverse Event|12|||
44337537|NCT01306656|79341937|FG000|Overall Study|Lost to Follow-up|1|||
44337538|NCT01306656|79341938|FG001|Overall Study|Lost to Follow-up|0|||
44337539|NCT01008943|79341946|FG000|Overall Study|Withdrawal by Subject|1|||
44337540|NCT01003639|79341952|FG000|Overall Study|Lost to Follow-up|6|||
44337541|NCT01003639|79341953|FG001|Overall Study|Lost to Follow-up|9|||
44337542|NCT01003639|79341952|FG000|Overall Study|Withdrawal by Subject|9|||
44337543|NCT01003639|79341953|FG001|Overall Study|Withdrawal by Subject|5|||
44337544|NCT01003639|79341952|FG000|Overall Study|Lack of Efficacy|1|||
44436712|NCT00759785|79445460|FG001|Overall Study|Withdrawal by Subject|1|||
44436713|NCT00300781|79445468|FG000|Overall Study|Disease Progression|55|||
44436714|NCT00300781|79445469|FG001|Overall Study|Disease Progression|52|||
44436715|NCT00300781|79445468|FG000|Overall Study|Adverse Event|5|||
44436716|NCT00300781|79445469|FG001|Overall Study|Adverse Event|6|||
44436717|NCT00300781|79445468|FG000|Overall Study|Withdrawal by Subject|1|||
44436718|NCT00300781|79445469|FG001|Overall Study|Withdrawal by Subject|2|||
44337545|NCT01003639|79341953|FG001|Overall Study|Lack of Efficacy|6|||
44337546|NCT01003639|79341952|FG000|Overall Study|Adverse Event|0|||
44337547|NCT01003639|79341953|FG001|Overall Study|Adverse Event|1|||
44337548|NCT01003639|79341952|FG000|Overall Study|Protocol Violation|0|||
44337549|NCT01003639|79341953|FG001|Overall Study|Protocol Violation|1|||
44337550|NCT01003639|79341952|FG000|Overall Study|Physician Decision|1|||
44337551|NCT01003639|79341953|FG001|Overall Study|Physician Decision|0|||
44337552|NCT01003249|79341959|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
44337553|NCT01003249|79341960|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
44337554|NCT01003249|79341959|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
44337555|NCT01003249|79341960|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
44337556|NCT01003249|79341959|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
44337557|NCT01003249|79341960|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44337558|NCT01003249|79341959|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
44337559|NCT01003249|79341960|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
44337560|NCT01001767|79341972|FG000|Overall Study|no baseline study performed|1|||
44337561|NCT01001767|79341973|FG001|Overall Study|no baseline study performed|0|||
44337562|NCT01001767|79341972|FG000|Overall Study|Protocol Violation|1|||
44337563|NCT01001767|79341973|FG001|Overall Study|Protocol Violation|0|||
44337564|NCT01001767|79341972|FG000|Overall Study|Lost to Follow-up|1|||
44337565|NCT01001767|79341973|FG001|Overall Study|Lost to Follow-up|0|||
44337566|NCT01001767|79341972|FG000|Overall Study|Physician Decision|1|||
44337567|NCT01001767|79341973|FG001|Overall Study|Physician Decision|0|||
44337568|NCT01306032|79341985|FG000|First Intervention|Adverse Event|1|||
44337569|NCT01306032|79341986|FG001|First Intervention|Adverse Event|0|||
44337570|NCT01306032|79341987|FG002|First Intervention|Adverse Event|1|||
44337571|NCT01306032|79341988|FG003|First Intervention|Adverse Event|0|||
44337572|NCT01306032|79341989|FG004|First Intervention|Adverse Event|0|||
44337573|NCT01306032|79341990|FG005|First Intervention|Adverse Event|1|||
44337574|NCT01306032|79341985|FG000|First Intervention|Withdrawal by Subject|0|||
44337575|NCT01306032|79341986|FG001|First Intervention|Withdrawal by Subject|2|||
44337576|NCT01306032|79341987|FG002|First Intervention|Withdrawal by Subject|0|||
44337577|NCT01306032|79341988|FG003|First Intervention|Withdrawal by Subject|1|||
44337578|NCT01306032|79341989|FG004|First Intervention|Withdrawal by Subject|0|||
44337579|NCT01306032|79341990|FG005|First Intervention|Withdrawal by Subject|0|||
44337580|NCT01306032|79341985|FG000|First Intervention|Death|0|||
44337581|NCT01306032|79341986|FG001|First Intervention|Death|0|||
44337582|NCT01306032|79341987|FG002|First Intervention|Death|1|||
44337583|NCT01306032|79341988|FG003|First Intervention|Death|0|||
44337584|NCT01306032|79341989|FG004|First Intervention|Death|0|||
44337585|NCT01306032|79341990|FG005|First Intervention|Death|0|||
44337586|NCT01306032|79341985|FG000|First Intervention|Ineligible|0|||
44337587|NCT01306032|79341986|FG001|First Intervention|Ineligible|0|||
44337588|NCT01306032|79341987|FG002|First Intervention|Ineligible|0|||
44337589|NCT01306032|79341988|FG003|First Intervention|Ineligible|0|||
44337590|NCT01306032|79341989|FG004|First Intervention|Ineligible|0|||
44337591|NCT01306032|79341990|FG005|First Intervention|Ineligible|1|||
44337592|NCT01306032|79341985|FG000|First Intervention|Progressive disease|0|||
44337593|NCT01306032|79341986|FG001|First Intervention|Progressive disease|0|||
44337594|NCT01306032|79341987|FG002|First Intervention|Progressive disease|0|||
44337595|NCT01306032|79341988|FG003|First Intervention|Progressive disease|0|||
44337596|NCT01306032|79341989|FG004|First Intervention|Progressive disease|2|||
44337597|NCT01306032|79341990|FG005|First Intervention|Progressive disease|0|||
44436719|NCT00300781|79445468|FG000|Overall Study|Physician Decision|1|||
44436720|NCT00300781|79445469|FG001|Overall Study|Physician Decision|0|||
44436721|NCT00300781|79445468|FG000|Overall Study|Not Recorded|0|||
44259356|NCT02775903|79118937|FG003|Overall Study|Adverse Event|3|||
44259357|NCT02775903|79118934|FG000|Overall Study|Progressive disease|15|||
44259358|NCT02775903|79118935|FG001|Overall Study|Progressive disease|14|||
44259359|NCT02775903|79118936|FG002|Overall Study|Progressive disease|30|||
44259360|NCT02775903|79118937|FG003|Overall Study|Progressive disease|20|||
44259361|NCT02775903|79118934|FG000|Overall Study|Lack of Efficacy|2|||
44259362|NCT02775903|79118935|FG001|Overall Study|Lack of Efficacy|2|||
44259363|NCT02775903|79118936|FG002|Overall Study|Lack of Efficacy|2|||
44259364|NCT02775903|79118937|FG003|Overall Study|Lack of Efficacy|6|||
44337598|NCT01306032|79341985|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
44337599|NCT01306032|79341986|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
44337600|NCT01306032|79341987|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
44337601|NCT01306032|79341988|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
44337602|NCT01306032|79341989|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
44436722|NCT00300781|79445469|FG001|Overall Study|Not Recorded|1|||
44337603|NCT01306032|79341990|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
44436723|NCT00300781|79445468|FG000|Overall Study|Symptomatic Deterioration|1|||
44436724|NCT00300781|79445469|FG001|Overall Study|Symptomatic Deterioration|0|||
44436725|NCT00300781|79445468|FG000|Overall Study|Lost to Follow-up|0|||
44436726|NCT00300781|79445469|FG001|Overall Study|Lost to Follow-up|1|||
44540347|NCT04615507|79552291|FG001|Period 2|Covid-19 exposure|1|||
44540348|NCT04615507|79552290|FG000|Period 2|Protocol Violation|1|||
44540349|NCT04615507|79552291|FG001|Period 2|Protocol Violation|0|||
44540350|NCT04615507|79552290|FG000|Period 2|Withdrawal by Subject|1|||
44540351|NCT04615507|79552291|FG001|Period 2|Withdrawal by Subject|0|||
44540352|NCT04615507|79552290|FG000|Period 2|Adverse Event|0|||
44540353|NCT04615507|79552291|FG001|Period 2|Adverse Event|1|||
44540354|NCT04615507|79552290|FG000|Period 3|Covid-19 exposure|0|||
44540355|NCT04615507|79552291|FG001|Period 3|Covid-19 exposure|1|||
44540356|NCT04120233|79552303|FG000|Overall Study|Adverse Event|0|||
44540357|NCT04120233|79552304|FG001|Overall Study|Adverse Event|0|||
44540358|NCT04120233|79552305|FG002|Overall Study|Adverse Event|0|||
44540359|NCT04120233|79552306|FG003|Overall Study|Adverse Event|0|||
44540360|NCT04120233|79552307|FG004|Overall Study|Adverse Event|1|||
44540361|NCT04120233|79552308|FG005|Overall Study|Adverse Event|0|||
44540362|NCT01610700|79552324|FG000|Overall Study|Adverse Event|3|||
44540363|NCT01610700|79552325|FG001|Overall Study|Adverse Event|1|||
44540364|NCT01610700|79552324|FG000|Overall Study|Withdrawal by Subject|0|||
44540365|NCT01610700|79552325|FG001|Overall Study|Withdrawal by Subject|1|||
44540366|NCT01610700|79552324|FG000|Overall Study|subject took one dose of street cannabis|0|||
44540367|NCT01610700|79552325|FG001|Overall Study|subject took one dose of street cannabis|1|||
44540368|NCT03256851|79552334|FG000|Overall Study|Withdrawal by Subject|1|||
44540369|NCT03256851|79552335|FG001|Overall Study|Withdrawal by Subject|0|||
44540370|NCT04837807|79552341|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
44540371|NCT04837807|79552342|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
44540372|NCT03256695|79552348|FG000|Overall Study|Adverse Event|8|||
44540373|NCT03256695|79552348|FG000|Overall Study|Death|2|||
44540374|NCT03256695|79552348|FG000|Overall Study|Withdrawal by Subject|14|||
44540375|NCT03256695|79552348|FG000|Overall Study|Non-compliance with study drug|1|||
44540376|NCT03256695|79552348|FG000|Overall Study|Lost to Follow-up|3|||
44540377|NCT03256695|79552348|FG000|Overall Study|Lack of Efficacy|3|||
44540378|NCT03256695|79552348|FG000|Overall Study|Protocol Violation|5|||
44540379|NCT03256695|79552348|FG000|Overall Study|Other than specified|3|||
44540380|NCT03305016|79552352|FG000|Overall Study|Withdrawal by Subject|2|||
44540381|NCT03297021|79552359|FG000|Overall Study|Incomplete/illegible data sheet|4|||
44540382|NCT03297021|79552360|FG001|Overall Study|Incomplete/illegible data sheet|2|||
44540383|NCT03297021|79552361|FG002|Overall Study|Incomplete/illegible data sheet|3|||
44337604|NCT01306032|79341985|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
44337605|NCT01306032|79341986|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
44337606|NCT01306032|79341987|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
44337607|NCT01306032|79341988|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
44337608|NCT01306032|79341989|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
44337609|NCT01306032|79341990|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
44337610|NCT01263015|79342018|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
44337611|NCT01263015|79342019|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
44337612|NCT01263015|79342018|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
44337613|NCT01263015|79342019|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
44337614|NCT01263015|79342018|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
44337615|NCT01263015|79342019|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
44337616|NCT01263015|79342018|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
44337617|NCT01263015|79342019|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
44337618|NCT01263015|79342018|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
44337619|NCT01263015|79342019|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
44436727|NCT00315055|79445477|FG000|Overall Study|Protocol Violation|2|||
44436728|NCT00315055|79445478|FG001|Overall Study|Protocol Violation|4|||
44436729|NCT00315055|79445477|FG000|Overall Study|Lost to Follow-up|1|||
44436730|NCT00315055|79445478|FG001|Overall Study|Lost to Follow-up|1|||
44436731|NCT00528970|79445490|FG000|Overall Study|Adverse Event|6|||
44436732|NCT00528970|79445491|FG001|Overall Study|Adverse Event|8|||
44436733|NCT00528970|79445492|FG002|Overall Study|Adverse Event|5|||
44436734|NCT00528970|79445490|FG000|Overall Study|Lost to Follow-up|0|||
44436735|NCT00528970|79445491|FG001|Overall Study|Lost to Follow-up|0|||
44436736|NCT00528970|79445492|FG002|Overall Study|Lost to Follow-up|1|||
44540384|NCT03297021|79552359|FG000|Overall Study|Missing Post-Op Data|1|||
44540385|NCT03297021|79552360|FG001|Overall Study|Missing Post-Op Data|2|||
44540386|NCT03297021|79552361|FG002|Overall Study|Missing Post-Op Data|1|||
44540387|NCT04820491|79552371|FG000|Overall Study|Withdrawal by Subject|1|||
44540388|NCT04820491|79552372|FG001|Overall Study|Withdrawal by Subject|0|||
44436737|NCT00528970|79445490|FG000|Overall Study|Other than specified|2|||
44436738|NCT00528970|79445491|FG001|Overall Study|Other than specified|3|||
44337620|NCT01263015|79342018|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
44337621|NCT01263015|79342019|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
44436739|NCT00528970|79445492|FG002|Overall Study|Other than specified|3|||
44436740|NCT00528970|79445490|FG000|Overall Study|Protocol Violation|2|||
44436741|NCT00528970|79445491|FG001|Overall Study|Protocol Violation|1|||
44436742|NCT00528970|79445492|FG002|Overall Study|Protocol Violation|4|||
44436743|NCT00528970|79445490|FG000|Overall Study|Lack of Efficacy|0|||
44436744|NCT00528970|79445491|FG001|Overall Study|Lack of Efficacy|0|||
44436745|NCT00528970|79445492|FG002|Overall Study|Lack of Efficacy|1|||
44436746|NCT00528970|79445490|FG000|Overall Study|Withdrawal by Subject|4|||
44436747|NCT00528970|79445491|FG001|Overall Study|Withdrawal by Subject|3|||
44436748|NCT00528970|79445492|FG002|Overall Study|Withdrawal by Subject|5|||
44436749|NCT00528970|79445490|FG000|Overall Study|Randomized but not treated|0|||
44436750|NCT00528970|79445491|FG001|Overall Study|Randomized but not treated|0|||
44436751|NCT00528970|79445492|FG002|Overall Study|Randomized but not treated|1|||
44436752|NCT00759395|79445502|FG000|Overall Study|Adverse Event|1|||
44436753|NCT00759395|79445503|FG001|Overall Study|Adverse Event|0|||
44436754|NCT00759395|79445502|FG000|Overall Study|Withdrawal by Subject|1|||
44436755|NCT00759395|79445503|FG001|Overall Study|Withdrawal by Subject|0|||
44436756|NCT00759395|79445502|FG000|Overall Study|Lack of Efficacy|0|||
44157537|NCT01944839|78949349|FG001|Overall Study|Withdrawal by Subject|17|||
44157538|NCT01944839|78949348|FG000|Overall Study|Lost to Follow-up|1|||
44157539|NCT01944839|78949349|FG001|Overall Study|Lost to Follow-up|0|||
44157540|NCT01944839|78949348|FG000|Overall Study|Subject non-compliance|0|||
44157541|NCT01944839|78949349|FG001|Overall Study|Subject non-compliance|3|||
44157542|NCT01940900|78949357|FG000|Overall Study|Physician Decision|4|||
44157543|NCT01940900|78949358|FG001|Overall Study|Physician Decision|0|||
44157544|NCT01940900|78949357|FG000|Overall Study|Adverse Event|10|||
44337622|NCT01263015|79342018|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
44337623|NCT01263015|79342019|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
44337624|NCT01263015|79342018|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
44337625|NCT01263015|79342019|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
44436757|NCT00759395|79445503|FG001|Overall Study|Lack of Efficacy|2|||
44540389|NCT01988571|79552380|FG000|Overall Study|Death|3|||
44540390|NCT01988571|79552381|FG001|Overall Study|Death|1|||
44540391|NCT01988571|79552380|FG000|Overall Study|Physician Decision|2|||
44540392|NCT01988571|79552381|FG001|Overall Study|Physician Decision|1|||
44540393|NCT01988571|79552380|FG000|Overall Study|Lost to Follow-up|3|||
44540394|NCT01988571|79552381|FG001|Overall Study|Lost to Follow-up|0|||
44540395|NCT01988571|79552380|FG000|Overall Study|Withdrawal by Subject|31|||
44540396|NCT01988571|79552381|FG001|Overall Study|Withdrawal by Subject|33|||
44540397|NCT04794751|79552387|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
44540398|NCT04794751|79552388|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
44540399|NCT04794751|79552387|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
44540400|NCT04794751|79552388|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
44540401|NCT04794751|79552387|FG000|Period 1|Protocol Violation|0|||
44540402|NCT04794751|79552388|FG001|Period 1|Protocol Violation|2|||
44540403|NCT04794751|79552387|FG000|Period 1|Withdrawal by Subject|0|||
44540404|NCT04794751|79552388|FG001|Period 1|Withdrawal by Subject|1|||
44337626|NCT01263015|79342018|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
44337627|NCT01263015|79342019|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
44337628|NCT01263015|79342018|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
44337629|NCT01263015|79342019|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
44337630|NCT01263015|79342018|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
44540405|NCT04794751|79552387|FG000|Period 2|Withdrawal by Subject|0|||
44540406|NCT04794751|79552388|FG001|Period 2|Withdrawal by Subject|1|||
44540407|NCT04794751|79552387|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
44540408|NCT04794751|79552388|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
44157545|NCT01940900|78949358|FG001|Overall Study|Adverse Event|15|||
44436758|NCT00293293|79445511|FG000|Overall Study|Withdrawal by Subject|1|||
44436759|NCT00293293|79445512|FG001|Overall Study|Withdrawal by Subject|1|||
44540409|NCT04794751|79552387|FG000|Period 2|Protocol Violation|1|||
44540410|NCT04794751|79552388|FG001|Period 2|Protocol Violation|0|||
44540411|NCT04578457|79552394|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
44540412|NCT04578457|79552394|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
44540413|NCT04578457|79552394|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
44157546|NCT01940900|78949357|FG000|Overall Study|Withdrawal by Subject|11|||
44436760|NCT00293293|79445511|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
44436761|NCT00293293|79445512|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
44436762|NCT00293293|79445511|FG000|Overall Study|Patient discontinued chemotherapy|0|||
44157547|NCT01940900|78949358|FG001|Overall Study|Withdrawal by Subject|15|||
44157548|NCT01940900|78949357|FG000|Overall Study|Lost to Follow-up|1|||
44436763|NCT00293293|79445512|FG001|Overall Study|Patient discontinued chemotherapy|1|||
44436764|NCT04864639|79445519|FG000|Overall Study|Death|1|||
44436765|NCT04864639|79445519|FG000|Overall Study|Lost to Follow-up|1|||
44436766|NCT04245449|79445545|FG000|Overall Study|COVID shutdown|7|||
44436767|NCT03887221|79445555|FG000|Overall Study|Protocol Violation|1|||
44436768|NCT03887221|79445556|FG001|Overall Study|Protocol Violation|0|||
44436769|NCT02782741|79445576|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
44436770|NCT02782741|79445577|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
44436771|NCT02782741|79445576|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
44436772|NCT02782741|79445577|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
44436773|NCT02782741|79445576|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
44436774|NCT02782741|79445577|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
44337631|NCT01263015|79342019|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
44337632|NCT01263015|79342018|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
44337633|NCT01263015|79342019|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
44337634|NCT01305564|79342025|FG000|Overall Study|Death|21|||
44337635|NCT01305564|79342025|FG000|Overall Study|Lost to Follow-up|12|||
44337636|NCT01305564|79342025|FG000|Overall Study|Withdrawal by Subject|1|||
44337637|NCT01305564|79342025|FG000|Overall Study|Physician Decision|3|||
44337638|NCT01305408|79342042|FG000|Overall Study|Adverse Event|10|||
44337639|NCT01305408|79342043|FG001|Overall Study|Adverse Event|7|||
44337640|NCT01305408|79342042|FG000|Overall Study|Lack of Efficacy|3|||
44337641|NCT01305408|79342043|FG001|Overall Study|Lack of Efficacy|4|||
44337642|NCT01305408|79342042|FG000|Overall Study|Withdrawal by Subject|9|||
44337643|NCT01305408|79342043|FG001|Overall Study|Withdrawal by Subject|9|||
44337644|NCT01305408|79342042|FG000|Overall Study|Protocol Violation|4|||
44337645|NCT01305408|79342043|FG001|Overall Study|Protocol Violation|6|||
44337646|NCT01305408|79342042|FG000|Overall Study|Lost to Follow-up|5|||
44337647|NCT01305408|79342043|FG001|Overall Study|Lost to Follow-up|3|||
44337648|NCT01305408|79342042|FG000|Overall Study|Noncompliance with study medication|0|||
44337649|NCT01305408|79342043|FG001|Overall Study|Noncompliance with study medication|1|||
44337650|NCT01305408|79342042|FG000|Overall Study|Noncompliance with study procedures|0|||
44337651|NCT01305408|79342043|FG001|Overall Study|Noncompliance with study procedures|1|||
44337652|NCT01305408|79342042|FG000|Overall Study|Other|1|||
44337653|NCT01305408|79342043|FG001|Overall Study|Other|0|||
44337654|NCT01304940|79342051|FG000|Overall Study|not meet symptom severity requirement|3|||
44337655|NCT01304940|79342052|FG001|Overall Study|not meet symptom severity requirement|0|||
44337656|NCT01261611|79342061|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
44337657|NCT01261611|79342062|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
44337658|NCT01261611|79342063|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
44337659|NCT01261611|79342061|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
44337660|NCT01261611|79342062|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
44337661|NCT01261611|79342063|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
44337662|NCT01261611|79342061|FG000|Treatment Cycle 1|Adverse Event|0|||
44436775|NCT02782741|79445576|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
44436776|NCT02782741|79445577|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
44436777|NCT02782741|79445576|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
44436778|NCT02782741|79445577|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
44436779|NCT02771626|79445593|FG000|Overall Study|Adverse Event|1|||
44436780|NCT02771626|79445594|FG001|Overall Study|Adverse Event|5|||
44436781|NCT02771626|79445595|FG002|Overall Study|Adverse Event|3|||
44436782|NCT02771626|79445596|FG003|Overall Study|Adverse Event|0|||
44436783|NCT02771626|79445597|FG004|Overall Study|Adverse Event|1|||
44436784|NCT02771626|79445598|FG005|Overall Study|Adverse Event|1|||
44337663|NCT01261611|79342062|FG001|Treatment Cycle 1|Adverse Event|1|||
44337664|NCT01261611|79342063|FG002|Treatment Cycle 1|Adverse Event|0|||
44337665|NCT01261611|79342061|FG000|Treatment Cycle 1|Protocol Violation|0|||
44337666|NCT01261611|79342062|FG001|Treatment Cycle 1|Protocol Violation|0|||
44337667|NCT01261611|79342063|FG002|Treatment Cycle 1|Protocol Violation|2|||
44337668|NCT01261611|79342061|FG000|Treatment Cycle 2|Completed study|4|||
44337669|NCT01261611|79342062|FG001|Treatment Cycle 2|Completed study|0|||
44436785|NCT02771626|79445593|FG000|Overall Study|Radiologic Disease Progression|6|||
44436786|NCT02771626|79445594|FG001|Overall Study|Radiologic Disease Progression|13|||
44436787|NCT02771626|79445595|FG002|Overall Study|Radiologic Disease Progression|10|||
44436788|NCT02771626|79445596|FG003|Overall Study|Radiologic Disease Progression|7|||
44436789|NCT02771626|79445597|FG004|Overall Study|Radiologic Disease Progression|28|||
44436790|NCT02771626|79445598|FG005|Overall Study|Radiologic Disease Progression|15|||
44436791|NCT02771626|79445593|FG000|Overall Study|Symptomatic Deterioration|0|||
44436792|NCT02771626|79445594|FG001|Overall Study|Symptomatic Deterioration|4|||
44337670|NCT01261611|79342063|FG002|Treatment Cycle 2|Completed study|0|||
44337671|NCT01261611|79342061|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
44337672|NCT01261611|79342062|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
44337673|NCT01261611|79342063|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
44337674|NCT01261611|79342061|FG000|Treatment Cycle 2|Adverse Event|1|||
44436793|NCT02771626|79445595|FG002|Overall Study|Symptomatic Deterioration|2|||
44436794|NCT02771626|79445596|FG003|Overall Study|Symptomatic Deterioration|0|||
44436795|NCT02771626|79445597|FG004|Overall Study|Symptomatic Deterioration|5|||
44436796|NCT02771626|79445598|FG005|Overall Study|Symptomatic Deterioration|2|||
44436797|NCT02771626|79445593|FG000|Overall Study|Participant Request|0|||
44436798|NCT02771626|79445594|FG001|Overall Study|Participant Request|1|||
44436799|NCT02771626|79445595|FG002|Overall Study|Participant Request|0|||
44436800|NCT02771626|79445596|FG003|Overall Study|Participant Request|2|||
44436801|NCT02771626|79445597|FG004|Overall Study|Participant Request|0|||
44436802|NCT02771626|79445598|FG005|Overall Study|Participant Request|1|||
44436803|NCT02771626|79445593|FG000|Overall Study|Investigator Decision|0|||
44436804|NCT02771626|79445594|FG001|Overall Study|Investigator Decision|1|||
44436805|NCT02771626|79445595|FG002|Overall Study|Investigator Decision|0|||
44337675|NCT01261611|79342062|FG001|Treatment Cycle 2|Adverse Event|0|||
44337676|NCT01261611|79342063|FG002|Treatment Cycle 2|Adverse Event|0|||
44337677|NCT01261611|79342061|FG000|Treatment Cycle 2|Protocol Violation|2|||
44337678|NCT01261611|79342062|FG001|Treatment Cycle 2|Protocol Violation|0|||
44337679|NCT01261611|79342063|FG002|Treatment Cycle 2|Protocol Violation|0|||
44337680|NCT01261611|79342061|FG000|Treatment Cycle 2|Not otherwise specified|2|||
44337681|NCT01261611|79342062|FG001|Treatment Cycle 2|Not otherwise specified|0|||
44337682|NCT01261611|79342063|FG002|Treatment Cycle 2|Not otherwise specified|0|||
44337683|NCT01261611|79342061|FG000|Treatment Cycle 3|Completed study|24|||
44337684|NCT01261611|79342062|FG001|Treatment Cycle 3|Completed study|0|||
44337685|NCT01261611|79342063|FG002|Treatment Cycle 3|Completed study|0|||
44337686|NCT01261611|79342061|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
44337687|NCT01261611|79342062|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
44337688|NCT01261611|79342063|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
44337689|NCT01261611|79342061|FG000|Treatment Cycle 3|Adverse Event|1|||
44337690|NCT01261611|79342062|FG001|Treatment Cycle 3|Adverse Event|0|||
44337691|NCT01261611|79342063|FG002|Treatment Cycle 3|Adverse Event|0|||
44337692|NCT01261611|79342061|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
44337693|NCT01261611|79342062|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
44337694|NCT01261611|79342063|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
44337695|NCT01261611|79342061|FG000|Treatment Cycle 4|Completed study|87|||
44337696|NCT01261611|79342062|FG001|Treatment Cycle 4|Completed study|0|||
44337697|NCT01261611|79342063|FG002|Treatment Cycle 4|Completed study|0|||
44337698|NCT01261611|79342061|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
44337699|NCT01261611|79342062|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
44337700|NCT01261611|79342063|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
44337701|NCT01261611|79342061|FG000|Treatment Cycle 4|Adverse Event|1|||
44337702|NCT01261611|79342062|FG001|Treatment Cycle 4|Adverse Event|0|||
44337703|NCT01261611|79342063|FG002|Treatment Cycle 4|Adverse Event|0|||
44337704|NCT01261611|79342061|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
44337705|NCT01261611|79342062|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
44337706|NCT01261611|79342063|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
44337707|NCT01261611|79342061|FG000|Treatment Cycle 4|Not otherwise specified|3|||
44337708|NCT01261611|79342062|FG001|Treatment Cycle 4|Not otherwise specified|0|||
44337709|NCT01261611|79342063|FG002|Treatment Cycle 4|Not otherwise specified|0|||
44337710|NCT01261611|79342061|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
44337711|NCT01261611|79342062|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
44337712|NCT01261611|79342063|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
44337713|NCT01261611|79342061|FG000|Treatment Cycle 5|Adverse Event|1|||
44337714|NCT01261611|79342062|FG001|Treatment Cycle 5|Adverse Event|0|||
44337715|NCT01261611|79342063|FG002|Treatment Cycle 5|Adverse Event|0|||
44337716|NCT01261611|79342061|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
44337717|NCT01261611|79342062|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
44337718|NCT01261611|79342063|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
44337719|NCT01304706|79342075|FG000|Overall Study|Adverse Event|2|||
44337720|NCT01304706|79342075|FG000|Overall Study|Lack of Efficacy|1|||
44337721|NCT01304706|79342075|FG000|Overall Study|Death|3|||
44436806|NCT02771626|79445596|FG003|Overall Study|Investigator Decision|0|||
44436807|NCT02771626|79445597|FG004|Overall Study|Investigator Decision|1|||
44436808|NCT02771626|79445598|FG005|Overall Study|Investigator Decision|0|||
44337722|NCT01304706|79342075|FG000|Overall Study|Withdrawal by Subject|3|||
44337723|NCT01304706|79342075|FG000|Overall Study|Lost to Follow-up|7|||
44337724|NCT01304706|79342075|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
44337725|NCT01303380|79342079|FG000|Overall Study|Lack of compliance to study procedures|1|||
44337726|NCT01008553|79342083|FG000|Period 1 (Titration Period)|Physician Decision|2|||
44436809|NCT02771626|79445593|FG000|Overall Study|Study Termination by Sponsor|0|||
44436810|NCT02771626|79445594|FG001|Overall Study|Study Termination by Sponsor|2|||
44436811|NCT02771626|79445595|FG002|Overall Study|Study Termination by Sponsor|1|||
44337727|NCT01008553|79342084|FG001|Period 1 (Titration Period)|Physician Decision|0|||
44436812|NCT02771626|79445596|FG003|Overall Study|Study Termination by Sponsor|0|||
44337728|NCT01008553|79342085|FG002|Period 1 (Titration Period)|Physician Decision|0|||
44337729|NCT01008553|79342083|FG000|Period 1 (Titration Period)|Adverse Event|33|||
44337730|NCT01008553|79342084|FG001|Period 1 (Titration Period)|Adverse Event|0|||
44337731|NCT01008553|79342085|FG002|Period 1 (Titration Period)|Adverse Event|0|||
44337732|NCT01008553|79342083|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
44436813|NCT02771626|79445597|FG004|Overall Study|Study Termination by Sponsor|1|||
44436814|NCT02771626|79445598|FG005|Overall Study|Study Termination by Sponsor|0|||
44436815|NCT02771626|79445593|FG000|Overall Study|Informed Consent Withdrawn|0|||
44436816|NCT02771626|79445594|FG001|Overall Study|Informed Consent Withdrawn|0|||
44436817|NCT02771626|79445595|FG002|Overall Study|Informed Consent Withdrawn|1|||
44436818|NCT02771626|79445596|FG003|Overall Study|Informed Consent Withdrawn|0|||
44436819|NCT02771626|79445597|FG004|Overall Study|Informed Consent Withdrawn|1|||
44436820|NCT02771626|79445598|FG005|Overall Study|Informed Consent Withdrawn|1|||
44436821|NCT02771626|79445593|FG000|Overall Study|Other, Not Specified|1|||
44436822|NCT02771626|79445594|FG001|Overall Study|Other, Not Specified|0|||
44157549|NCT01940900|78949358|FG001|Overall Study|Lost to Follow-up|0|||
44157550|NCT01940900|78949357|FG000|Overall Study|Sponsor Decision|1|||
44337733|NCT01008553|79342084|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
44337734|NCT01008553|79342085|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
44337735|NCT01008553|79342083|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
44337736|NCT01008553|79342084|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
44337737|NCT01008553|79342085|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
44337738|NCT01008553|79342083|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
44337739|NCT01008553|79342084|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
44337740|NCT01008553|79342085|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
44337741|NCT01008553|79342083|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
44337742|NCT01008553|79342084|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
44337743|NCT01008553|79342085|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
44337744|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
44337745|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
44337746|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
44337747|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
44337748|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
44337749|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
44337750|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
44337751|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
44337752|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
44337753|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
44337754|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
44337755|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
44337756|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
44337757|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
44337758|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
44337759|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
44337760|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
44337761|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
44337762|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
44337763|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
44337764|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
44337765|NCT01008553|79342083|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
44337766|NCT01008553|79342084|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
44337767|NCT01008553|79342085|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
44337768|NCT01259115|79342094|FG000|Period 1|Adverse Event|1|||
44337769|NCT01259115|79342095|FG001|Period 1|Adverse Event|0|||
44337770|NCT01259115|79342094|FG000|Period 1|Protocol Violation|2|||
44337771|NCT01259115|79342095|FG001|Period 1|Protocol Violation|0|||
44337772|NCT01259115|79342094|FG000|Period 1|Lost to Follow-up|0|||
44337773|NCT01259115|79342095|FG001|Period 1|Lost to Follow-up|1|||
44337774|NCT01259115|79342094|FG000|Period 2|Adverse Event|1|||
44337775|NCT01259115|79342095|FG001|Period 2|Adverse Event|0|||
44337776|NCT01302366|79342106|FG000|Overall Study|patient choice or noncompliance|5|||
44337777|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
44337778|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
44337779|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
44337780|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
44337781|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
44337782|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
44337783|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
44337784|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
44436823|NCT02771626|79445595|FG002|Overall Study|Other, Not Specified|0|||
44436824|NCT02771626|79445596|FG003|Overall Study|Other, Not Specified|0|||
44436825|NCT02771626|79445597|FG004|Overall Study|Other, Not Specified|0|||
44436826|NCT02771626|79445598|FG005|Overall Study|Other, Not Specified|1|||
44436827|NCT01464164|79445619|FG000|Overall Study|Screen failure|0|||
44540414|NCT04578457|79552394|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
44540415|NCT03334188|79552404|FG000|Overall Study|Withdrawal by Subject|0|||
44540416|NCT03334188|79552405|FG001|Overall Study|Withdrawal by Subject|1|||
44540417|NCT03334188|79552404|FG000|Overall Study|Death|1|||
44540418|NCT03334188|79552405|FG001|Overall Study|Death|0|||
44540419|NCT03334188|79552404|FG000|Overall Study|Never had qualifying clinic visit|7|||
44540420|NCT03334188|79552405|FG001|Overall Study|Never had qualifying clinic visit|7|||
44540421|NCT03333876|79552414|FG000|Screening Period|Screen Failure|4|||
44337785|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
44337786|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
44337787|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
44337788|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
44337789|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
44337790|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
44337791|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
44337792|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
44337793|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
44337794|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
44337795|NCT01302054|79342110|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
44337796|NCT01302054|79342111|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
44337797|NCT01302054|79342112|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
44337798|NCT01302054|79342110|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
44337799|NCT01302054|79342111|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
44337800|NCT01302054|79342112|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
44337801|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44337802|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
44337803|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
44337804|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44337805|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
44337806|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
44337807|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44337808|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
44337809|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
44337810|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
44337811|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
44337812|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
44337813|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
44337814|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
44337815|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
44337816|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
44337817|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
44337818|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
44337819|NCT01302054|79342110|FG000|Double-Blind Treatment Phase|Other|0|||
44337820|NCT01302054|79342111|FG001|Double-Blind Treatment Phase|Other|4|||
44337821|NCT01302054|79342112|FG002|Double-Blind Treatment Phase|Other|9|||
44337822|NCT01301508|79342123|FG000|Overall Study|Withdrawal by Subject|1|||
44337823|NCT01301508|79342124|FG001|Overall Study|Withdrawal by Subject|2|||
44337824|NCT01301508|79342123|FG000|Overall Study|Lost to Follow-up|0|||
44337825|NCT01301508|79342124|FG001|Overall Study|Lost to Follow-up|1|||
44337826|NCT01301274|79342132|FG000|Overall Study|Physician Decision|2|||
44337827|NCT01301274|79342133|FG001|Overall Study|Physician Decision|1|||
44337828|NCT01300650|79342144|FG000|Overall Study|Adverse Event|1|||
44337829|NCT01300572|79342149|FG000|Overall Study|HAMA + post dosimetry|1|||
44337830|NCT01077154|79342156|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
44337831|NCT01077154|79342157|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
44337832|NCT01077154|79342156|FG000|Overall Study|Withdrawal by Subject|369|||
44337833|NCT01077154|79342157|FG001|Overall Study|Withdrawal by Subject|385|||
44337834|NCT01077154|79342156|FG000|Overall Study|Death|215|||
44337835|NCT01077154|79342157|FG001|Overall Study|Death|214|||
44337836|NCT01077154|79342156|FG000|Overall Study|Lost to Follow-up|43|||
44436828|NCT01464164|79445620|FG001|Overall Study|Screen failure|1|||
44436829|NCT01464164|79445621|FG002|Overall Study|Screen failure|2|||
44157551|NCT01940900|78949358|FG001|Overall Study|Sponsor Decision|0|||
44337837|NCT01077154|79342157|FG001|Overall Study|Lost to Follow-up|35|||
44337838|NCT01077154|79342156|FG000|Overall Study|Noncompliance|22|||
44337839|NCT01077154|79342157|FG001|Overall Study|Noncompliance|20|||
44337840|NCT01077154|79342156|FG000|Overall Study|Disease Progression|18|||
44436830|NCT01464164|79445622|FG003|Overall Study|Screen failure|0|||
44540422|NCT03333876|79552414|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
44436831|NCT01464164|79445623|FG004|Overall Study|Screen failure|0|||
44436832|NCT01464164|79445624|FG005|Overall Study|Screen failure|0|||
44436833|NCT01464164|79445625|FG006|Overall Study|Screen failure|0|||
44436834|NCT01464164|79445619|FG000|Overall Study|Physician Decision|0|||
44436835|NCT01464164|79445620|FG001|Overall Study|Physician Decision|1|||
44436836|NCT01464164|79445621|FG002|Overall Study|Physician Decision|0|||
44436837|NCT01464164|79445622|FG003|Overall Study|Physician Decision|0|||
44436838|NCT01464164|79445623|FG004|Overall Study|Physician Decision|0|||
44540423|NCT03333876|79552414|FG000|Mandibular Advancement|Adverse Event|2|||
44540424|NCT03333876|79552414|FG000|Mandibular Advancement|Product Damage|2|||
44540425|NCT03294681|79552427|FG000|Overall Study|Withdrawal by Subject|1|||
44540426|NCT01140867|79552431|FG000|Overall Study|Adverse Event|22|||
44540427|NCT01140867|79552431|FG000|Overall Study|Lack of Efficacy|3|||
44540428|NCT01140867|79552431|FG000|Overall Study|Lost to Follow-up|2|||
44540429|NCT01140867|79552431|FG000|Overall Study|Withdrawal by Subject|1|||
44540430|NCT01140867|79552431|FG000|Overall Study|Protocol Violation|1|||
44540431|NCT01140867|79552431|FG000|Overall Study|Uncooperative patient|2|||
44540432|NCT01140867|79552431|FG000|Overall Study|Medication Noncompliance|2|||
44540433|NCT04572997|79552435|FG000|Overall Study|Adverse Event|1|||
44540434|NCT02943096|79552445|FG000|Overall Study|Lack of Efficacy|0|||
44540435|NCT02943096|79552446|FG001|Overall Study|Lack of Efficacy|1|||
44540436|NCT04571515|79552457|FG000|Overall Study|Physician Decision|0|||
44540437|NCT04571515|79552458|FG001|Overall Study|Physician Decision|0|||
44540438|NCT04571515|79552459|FG002|Overall Study|Physician Decision|0|||
44540439|NCT04571515|79552460|FG003|Overall Study|Physician Decision|0|||
44540440|NCT04571515|79552461|FG004|Overall Study|Physician Decision|1|||
44540441|NCT04571515|79552457|FG000|Overall Study|Withdrawal by Subject|0|||
44540442|NCT04571515|79552458|FG001|Overall Study|Withdrawal by Subject|0|||
44540443|NCT04571515|79552459|FG002|Overall Study|Withdrawal by Subject|0|||
44540444|NCT04571515|79552460|FG003|Overall Study|Withdrawal by Subject|0|||
44540445|NCT04571515|79552461|FG004|Overall Study|Withdrawal by Subject|1|||
44540446|NCT04571515|79552457|FG000|Overall Study|insufficient pain|1|||
44540447|NCT04571515|79552458|FG001|Overall Study|insufficient pain|0|||
44540448|NCT04571515|79552459|FG002|Overall Study|insufficient pain|0|||
44540449|NCT04571515|79552460|FG003|Overall Study|insufficient pain|0|||
44540450|NCT04571515|79552461|FG004|Overall Study|insufficient pain|1|||
44540451|NCT03292653|79552476|FG000|Overall Study|Adverse Event|0|||
44540452|NCT03292653|79552477|FG001|Overall Study|Adverse Event|0|||
44540453|NCT03292653|79552478|FG002|Overall Study|Adverse Event|1|||
44540454|NCT03292653|79552476|FG000|Overall Study|Did not Receive Treatment|1|||
44540455|NCT03292653|79552477|FG001|Overall Study|Did not Receive Treatment|0|||
44540456|NCT03292653|79552478|FG002|Overall Study|Did not Receive Treatment|0|||
44540457|NCT03858634|79552489|FG000|Overall Study|Withdrawal by Subject|1|||
44540458|NCT03858634|79552490|FG001|Overall Study|Withdrawal by Subject|0|||
44540459|NCT03858634|79552489|FG000|Overall Study|Adverse Event|1|||
44540460|NCT03858634|79552490|FG001|Overall Study|Adverse Event|0|||
44540461|NCT03858634|79552489|FG000|Overall Study|Lost to Follow-up|0|||
44540462|NCT03858634|79552490|FG001|Overall Study|Lost to Follow-up|1|||
44540463|NCT03858634|79552489|FG000|Overall Study|Other, Not Specified|1|||
44540464|NCT03858634|79552490|FG001|Overall Study|Other, Not Specified|1|||
44540465|NCT02891070|79552506|FG000|Overall Study|Adverse Event|1|||
44540466|NCT02891070|79552507|FG001|Overall Study|Adverse Event|0|||
44540467|NCT02891070|79552506|FG000|Overall Study|Physician Decision|0|||
44540468|NCT02891070|79552507|FG001|Overall Study|Physician Decision|1|||
44540469|NCT02891070|79552506|FG000|Overall Study|Lost to Follow-up|4|||
44540470|NCT02891070|79552507|FG001|Overall Study|Lost to Follow-up|4|||
44540471|NCT02891070|79552506|FG000|Overall Study|Other|1|||
44540472|NCT02891070|79552507|FG001|Overall Study|Other|0|||
44436839|NCT01464164|79445624|FG005|Overall Study|Physician Decision|0|||
44436840|NCT01464164|79445625|FG006|Overall Study|Physician Decision|2|||
44436841|NCT00568776|79445668|FG000|Overall Study|Adverse Event|8|||
44540473|NCT02891070|79552506|FG000|Overall Study|Protocol Violation|0|||
44540474|NCT02891070|79552507|FG001|Overall Study|Protocol Violation|1|||
44540475|NCT02891070|79552506|FG000|Overall Study|Withdrawal by Subject|1|||
44540476|NCT02891070|79552507|FG001|Overall Study|Withdrawal by Subject|2|||
44540477|NCT02891070|79552506|FG000|Overall Study|Death|3|||
44540478|NCT02891070|79552507|FG001|Overall Study|Death|0|||
44540479|NCT03255291|79552519|FG000|Overall Study|Determined to be ineligible|10|||
44436842|NCT00568776|79445669|FG001|Overall Study|Adverse Event|8|||
44436843|NCT00568776|79445670|FG002|Overall Study|Adverse Event|10|||
44436844|NCT00568776|79445671|FG003|Overall Study|Adverse Event|8|||
44540480|NCT03255291|79552520|FG001|Overall Study|Determined to be ineligible|12|||
44540481|NCT03255291|79552521|FG002|Overall Study|Determined to be ineligible|6|||
44540482|NCT03255291|79552522|FG003|Overall Study|Determined to be ineligible|6|||
44540483|NCT03255291|79552523|FG004|Overall Study|Determined to be ineligible|5|||
44540484|NCT03255291|79552524|FG005|Overall Study|Determined to be ineligible|10|||
44540485|NCT03255291|79552519|FG000|Overall Study|Baseline data collection issues|3|||
44540486|NCT03255291|79552520|FG001|Overall Study|Baseline data collection issues|0|||
44540487|NCT03255291|79552521|FG002|Overall Study|Baseline data collection issues|0|||
44540488|NCT03255291|79552522|FG003|Overall Study|Baseline data collection issues|0|||
44540489|NCT03255291|79552523|FG004|Overall Study|Baseline data collection issues|2|||
44540490|NCT03255291|79552524|FG005|Overall Study|Baseline data collection issues|0|||
44540491|NCT00381381|79552542|FG000|Overall Study|Adverse Event|3|||
44540492|NCT00381381|79552542|FG000|Overall Study|Lost to Follow-up|52|||
44540493|NCT00381381|79552542|FG000|Overall Study|Withdrawal by Subject|9|||
44540494|NCT02939937|79552548|FG000|Overall Study|Adverse Event|5|||
44540495|NCT02939937|79552549|FG001|Overall Study|Adverse Event|0|||
44540496|NCT02939937|79552548|FG000|Overall Study|Lost to Follow-up|1|||
44540497|NCT02939937|79552549|FG001|Overall Study|Lost to Follow-up|3|||
44540498|NCT02939079|79552557|FG000|Overall Study|Adverse Event|2|||
44540499|NCT02939079|79552558|FG001|Overall Study|Adverse Event|1|||
44540500|NCT02939079|79552557|FG000|Overall Study|Lost to Follow-up|0|||
44540501|NCT02939079|79552558|FG001|Overall Study|Lost to Follow-up|2|||
44540502|NCT02939079|79552557|FG000|Overall Study|Protocol Violation|1|||
44540503|NCT02939079|79552558|FG001|Overall Study|Protocol Violation|0|||
44540504|NCT02939079|79552557|FG000|Overall Study|Withdrawal by Subject|0|||
44540505|NCT02939079|79552558|FG001|Overall Study|Withdrawal by Subject|1|||
44540506|NCT02939079|79552557|FG000|Overall Study|relapse during the study|1|||
44540507|NCT02939079|79552558|FG001|Overall Study|relapse during the study|1|||
44540508|NCT04562155|79552568|FG000|Overall Study|COVID-19 pandemic|0|||
44540509|NCT04562155|79552569|FG001|Overall Study|COVID-19 pandemic|0|||
44540510|NCT04562155|79552570|FG002|Overall Study|COVID-19 pandemic|0|||
44540511|NCT04562155|79552571|FG003|Overall Study|COVID-19 pandemic|1|||
44540512|NCT04562155|79552568|FG000|Overall Study|Adverse Event|7|||
44540513|NCT04562155|79552569|FG001|Overall Study|Adverse Event|3|||
44540514|NCT04562155|79552570|FG002|Overall Study|Adverse Event|8|||
44540515|NCT04562155|79552571|FG003|Overall Study|Adverse Event|1|||
44540516|NCT04562155|79552568|FG000|Overall Study|Withdrawal by Subject|3|||
44540517|NCT04562155|79552569|FG001|Overall Study|Withdrawal by Subject|6|||
44540518|NCT04562155|79552570|FG002|Overall Study|Withdrawal by Subject|3|||
44540519|NCT04562155|79552571|FG003|Overall Study|Withdrawal by Subject|3|||
44540520|NCT04562155|79552568|FG000|Overall Study|Participant personal reason|1|||
44540521|NCT04562155|79552569|FG001|Overall Study|Participant personal reason|0|||
44540522|NCT04562155|79552570|FG002|Overall Study|Participant personal reason|2|||
44540523|NCT04562155|79552571|FG003|Overall Study|Participant personal reason|1|||
44540524|NCT03313050|79552585|FG000|Stage 2: 12 Months|Adverse Event|0|||
44540525|NCT03313050|79552586|FG001|Stage 2: 12 Months|Adverse Event|0|||
44540526|NCT03313050|79552587|FG002|Stage 2: 12 Months|Adverse Event|0|||
44540527|NCT03313050|79552588|FG003|Stage 2: 12 Months|Adverse Event|1|||
44540528|NCT03313050|79552585|FG000|Stage 2: 12 Months|Death|0|||
44540529|NCT03313050|79552586|FG001|Stage 2: 12 Months|Death|0|||
44337841|NCT01077154|79342157|FG001|Overall Study|Disease Progression|20|||
44337842|NCT01077154|79342156|FG000|Overall Study|Ineligibility Determined|10|||
44337843|NCT01077154|79342157|FG001|Overall Study|Ineligibility Determined|14|||
44337844|NCT01077154|79342156|FG000|Overall Study|Other|14|||
44337845|NCT01077154|79342157|FG001|Overall Study|Other|11|||
44337846|NCT01077154|79342156|FG000|Overall Study|Adverse Event|9|||
44337847|NCT01077154|79342157|FG001|Overall Study|Adverse Event|9|||
44337848|NCT01077154|79342156|FG000|Overall Study|Administrative Decision|1|||
44337849|NCT01077154|79342157|FG001|Overall Study|Administrative Decision|6|||
44337850|NCT01077154|79342156|FG000|Overall Study|Protocol Deviation|1|||
44337851|NCT01077154|79342157|FG001|Overall Study|Protocol Deviation|0|||
44337852|NCT01258101|79342167|FG000|Overall Study|Adverse Event|5|||
44337853|NCT01258101|79342168|FG001|Overall Study|Adverse Event|6|||
44337854|NCT01258101|79342169|FG002|Overall Study|Adverse Event|0|||
44337855|NCT01258101|79342170|FG003|Overall Study|Adverse Event|0|||
44337856|NCT01258101|79342167|FG000|Overall Study|Extra exclusion criterion amended|2|||
44337857|NCT01258101|79342168|FG001|Overall Study|Extra exclusion criterion amended|1|||
44337858|NCT01258101|79342169|FG002|Overall Study|Extra exclusion criterion amended|1|||
44337859|NCT01258101|79342170|FG003|Overall Study|Extra exclusion criterion amended|1|||
44337860|NCT01258101|79342167|FG000|Overall Study|Informed consent has been withdrawn|2|||
44436845|NCT00568776|79445668|FG000|Overall Study|Death|0|||
44540530|NCT03313050|79552587|FG002|Stage 2: 12 Months|Death|3|||
44337861|NCT01258101|79342168|FG001|Overall Study|Informed consent has been withdrawn|2|||
44436846|NCT00568776|79445669|FG001|Overall Study|Death|1|||
44540531|NCT03313050|79552588|FG003|Stage 2: 12 Months|Death|0|||
44436847|NCT00568776|79445670|FG002|Overall Study|Death|4|||
44436848|NCT00568776|79445671|FG003|Overall Study|Death|3|||
44436849|NCT00568776|79445668|FG000|Overall Study|Physician Decision|0|||
44436850|NCT00568776|79445669|FG001|Overall Study|Physician Decision|2|||
44436851|NCT00568776|79445670|FG002|Overall Study|Physician Decision|0|||
44436852|NCT00568776|79445671|FG003|Overall Study|Physician Decision|0|||
44436853|NCT00568776|79445668|FG000|Overall Study|Lack of Efficacy|2|||
44436854|NCT00568776|79445669|FG001|Overall Study|Lack of Efficacy|2|||
44540532|NCT03313050|79552585|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
44540533|NCT03313050|79552586|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
44540534|NCT03313050|79552587|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
44540535|NCT03313050|79552588|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
44337862|NCT01258101|79342169|FG002|Overall Study|Informed consent has been withdrawn|1|||
44337863|NCT01258101|79342170|FG003|Overall Study|Informed consent has been withdrawn|1|||
44337864|NCT01258101|79342167|FG000|Overall Study|Patient is not able to attend visits|8|||
44337865|NCT01258101|79342168|FG001|Overall Study|Patient is not able to attend visits|9|||
44337866|NCT01258101|79342169|FG002|Overall Study|Patient is not able to attend visits|7|||
44337867|NCT01258101|79342170|FG003|Overall Study|Patient is not able to attend visits|6|||
44337868|NCT01258101|79342167|FG000|Overall Study|Patient´s compliance|4|||
44337869|NCT01258101|79342168|FG001|Overall Study|Patient´s compliance|3|||
44337870|NCT01258101|79342169|FG002|Overall Study|Patient´s compliance|1|||
44337871|NCT01258101|79342170|FG003|Overall Study|Patient´s compliance|2|||
44337872|NCT01258101|79342167|FG000|Overall Study|Lost to Follow-up|5|||
44337873|NCT01258101|79342168|FG001|Overall Study|Lost to Follow-up|5|||
44337874|NCT01258101|79342169|FG002|Overall Study|Lost to Follow-up|0|||
44337875|NCT01258101|79342170|FG003|Overall Study|Lost to Follow-up|6|||
44337876|NCT01258101|79342167|FG000|Overall Study|PCR positive at week 24|0|||
44337877|NCT01258101|79342168|FG001|Overall Study|PCR positive at week 24|0|||
44337878|NCT01258101|79342169|FG002|Overall Study|PCR positive at week 24|0|||
44337879|NCT01258101|79342170|FG003|Overall Study|PCR positive at week 24|1|||
44337880|NCT01258101|79342167|FG000|Overall Study|Other reason|7|||
44337881|NCT01258101|79342168|FG001|Overall Study|Other reason|8|||
44337882|NCT01258101|79342169|FG002|Overall Study|Other reason|1|||
44337883|NCT01258101|79342170|FG003|Overall Study|Other reason|8|||
44337884|NCT01300338|79342182|FG000|Overall Study|Lost to Follow-up|5|||
44337885|NCT01300338|79342183|FG001|Overall Study|Lost to Follow-up|0|||
44337886|NCT01300260|79342191|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
44337887|NCT01300260|79342192|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
44337888|NCT01300260|79342191|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
44337889|NCT01300260|79342192|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
44337890|NCT01300260|79342191|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
44337891|NCT01300260|79342192|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
44337892|NCT01256385|79342211|FG000|Overall Study|Physician Decision|1|||
44337893|NCT01256385|79342212|FG001|Overall Study|Physician Decision|1|||
44337894|NCT01256385|79342211|FG000|Overall Study|Withdrawal by Subject|2|||
44337895|NCT01256385|79342212|FG001|Overall Study|Withdrawal by Subject|2|||
44337896|NCT01298778|79342220|FG000|Overall Study|Lost to Follow-up|2|||
44337897|NCT01298778|79342221|FG001|Overall Study|Lost to Follow-up|3|||
44337898|NCT01298778|79342220|FG000|Overall Study|Incorrect use of VAS|1|||
44337899|NCT01298778|79342221|FG001|Overall Study|Incorrect use of VAS|0|||
44337900|NCT01298778|79342220|FG000|Overall Study|Withdrawal by Subject|0|||
44337901|NCT01298778|79342221|FG001|Overall Study|Withdrawal by Subject|1|||
44337902|NCT01298778|79342220|FG000|Overall Study|Protocol Violation|0|||
44337903|NCT01298778|79342221|FG001|Overall Study|Protocol Violation|1|||
44337904|NCT01298778|79342220|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
44337905|NCT01298778|79342221|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
44337906|NCT01298700|79342231|FG000|Overall Study|Adverse Event|50|||
44337907|NCT01298700|79342232|FG001|Overall Study|Adverse Event|51|||
44337908|NCT01298700|79342231|FG000|Overall Study|Lack of Efficacy|9|||
44337909|NCT01298700|79342232|FG001|Overall Study|Lack of Efficacy|14|||
44337910|NCT01298700|79342231|FG000|Overall Study|Lost to Follow-up|5|||
44337911|NCT01298700|79342232|FG001|Overall Study|Lost to Follow-up|2|||
44337912|NCT01298700|79342231|FG000|Overall Study|Withdrawal by Subject|12|||
44436855|NCT00568776|79445670|FG002|Overall Study|Lack of Efficacy|2|||
44436856|NCT00568776|79445671|FG003|Overall Study|Lack of Efficacy|4|||
44540536|NCT03313050|79552585|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
44540537|NCT03313050|79552586|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
44157552|NCT01940900|78949357|FG000|Overall Study|subject non-compliance|1|||
44337913|NCT01298700|79342232|FG001|Overall Study|Withdrawal by Subject|9|||
44337914|NCT01298700|79342231|FG000|Overall Study|Protocol Violation|6|||
44337915|NCT01298700|79342232|FG001|Overall Study|Protocol Violation|4|||
44337916|NCT01298700|79342231|FG000|Overall Study|Other Miscellaneous Reasons|16|||
44337917|NCT01298700|79342232|FG001|Overall Study|Other Miscellaneous Reasons|15|||
44337918|NCT01298700|79342231|FG000|Overall Study|Did not Receive Study Drug|3|||
44436857|NCT00568776|79445668|FG000|Overall Study|Lost to Follow-up|1|||
44436858|NCT00568776|79445669|FG001|Overall Study|Lost to Follow-up|1|||
44436859|NCT00568776|79445670|FG002|Overall Study|Lost to Follow-up|1|||
44436860|NCT00568776|79445671|FG003|Overall Study|Lost to Follow-up|1|||
44436861|NCT00568776|79445668|FG000|Overall Study|Protocol Violation|1|||
44436862|NCT00568776|79445669|FG001|Overall Study|Protocol Violation|0|||
44436863|NCT00568776|79445670|FG002|Overall Study|Protocol Violation|1|||
44436864|NCT00568776|79445671|FG003|Overall Study|Protocol Violation|1|||
44436865|NCT00568776|79445668|FG000|Overall Study|Withdrawal by Subject|13|||
44436866|NCT00568776|79445669|FG001|Overall Study|Withdrawal by Subject|15|||
44436867|NCT00568776|79445670|FG002|Overall Study|Withdrawal by Subject|13|||
44436868|NCT00568776|79445671|FG003|Overall Study|Withdrawal by Subject|7|||
44436869|NCT00568776|79445668|FG000|Overall Study|Loss of Caregiver|0|||
44436870|NCT00568776|79445669|FG001|Overall Study|Loss of Caregiver|2|||
44436871|NCT00568776|79445670|FG002|Overall Study|Loss of Caregiver|1|||
44436872|NCT00568776|79445671|FG003|Overall Study|Loss of Caregiver|2|||
44436873|NCT00568776|79445668|FG000|Overall Study|Sponsor Decision|2|||
44436874|NCT00568776|79445669|FG001|Overall Study|Sponsor Decision|2|||
44436875|NCT00568776|79445670|FG002|Overall Study|Sponsor Decision|41|||
44436876|NCT00568776|79445671|FG003|Overall Study|Sponsor Decision|42|||
44436877|NCT00568776|79445668|FG000|Overall Study|Miscellaeneous|3|||
44436878|NCT00568776|79445669|FG001|Overall Study|Miscellaeneous|3|||
44436879|NCT00568776|79445670|FG002|Overall Study|Miscellaeneous|1|||
44436880|NCT00568776|79445671|FG003|Overall Study|Miscellaeneous|4|||
44436881|NCT00758771|79445683|FG000|Overall Study|Withdrawal by Subject|1|||
44436882|NCT00758771|79445684|FG001|Overall Study|Withdrawal by Subject|1|||
44436883|NCT00758771|79445683|FG000|Overall Study|Did not meet eligibility criteria|2|||
44436884|NCT00758771|79445684|FG001|Overall Study|Did not meet eligibility criteria|4|||
44436885|NCT00635154|79445690|FG000|Overall Study|Alternative Treatment|8|||
44436886|NCT00635154|79445690|FG000|Overall Study|Other|4|||
44436887|NCT00635154|79445690|FG000|Overall Study|Still on treatment|21|||
44436888|NCT00778895|79445699|FG000|Active Phase|Adverse Event|3|||
44436889|NCT00778895|79445700|FG001|Active Phase|Adverse Event|1|||
44436890|NCT00778895|79445701|FG002|Active Phase|Adverse Event|0|||
44436891|NCT00778895|79445699|FG000|Active Phase|Withdrawal by Subject|1|||
44436892|NCT00778895|79445700|FG001|Active Phase|Withdrawal by Subject|4|||
44436893|NCT00778895|79445701|FG002|Active Phase|Withdrawal by Subject|0|||
44436894|NCT00778895|79445699|FG000|Active Phase|Lost to Follow-up|1|||
44436895|NCT00778895|79445700|FG001|Active Phase|Lost to Follow-up|1|||
44540538|NCT03313050|79552587|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
44540539|NCT03313050|79552588|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
44540540|NCT03313050|79552585|FG000|Stage 2: 12 Months|Protocol deviation|0|||
44540541|NCT03313050|79552586|FG001|Stage 2: 12 Months|Protocol deviation|0|||
44540542|NCT03313050|79552587|FG002|Stage 2: 12 Months|Protocol deviation|7|||
44540543|NCT03313050|79552588|FG003|Stage 2: 12 Months|Protocol deviation|7|||
44540544|NCT03313050|79552585|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
44540545|NCT03313050|79552586|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
44540546|NCT03313050|79552587|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
44540547|NCT03313050|79552588|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
44540548|NCT03313050|79552585|FG000|Stage 2: 12 Months|Other|0|||
44540549|NCT03313050|79552586|FG001|Stage 2: 12 Months|Other|0|||
44540550|NCT03313050|79552587|FG002|Stage 2: 12 Months|Other|0|||
44540551|NCT03313050|79552588|FG003|Stage 2: 12 Months|Other|1|||
44540552|NCT04755595|79552607|FG000|Overall Study|Lost to Follow-up|1|||
44540553|NCT04749745|79552612|FG000|Overall Study|Withdrawal by Subject|1|||
44436896|NCT00778895|79445701|FG002|Active Phase|Lost to Follow-up|0|||
44436897|NCT00778895|79445699|FG000|Active Phase|Other|2|||
44436898|NCT00778895|79445700|FG001|Active Phase|Other|0|||
44540554|NCT04749745|79552613|FG001|Overall Study|Withdrawal by Subject|0|||
44540555|NCT03257436|79552619|FG000|Overall Study|Withdrawal by Subject|76|||
44540556|NCT03257436|79552619|FG000|Overall Study|Death|19|||
44540557|NCT04748341|79552625|FG000|Overall Study|Lost to Follow-up|1|||
44540558|NCT04748341|79552626|FG001|Overall Study|Lost to Follow-up|1|||
44436899|NCT00778895|79445701|FG002|Active Phase|Other|0|||
44436900|NCT00778895|79445699|FG000|ESFU Phase|Adverse Event|2|||
44436901|NCT00778895|79445700|FG001|ESFU Phase|Adverse Event|1|||
44436902|NCT00778895|79445701|FG002|ESFU Phase|Adverse Event|0|||
44436903|NCT00778895|79445699|FG000|ESFU Phase|Withdrawal by Subject|1|||
44540559|NCT01328002|79552632|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
44540560|NCT01328002|79552633|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
44540561|NCT01328002|79552632|FG000|Open-Label Period|Adverse Event|8|||
44540562|NCT01328002|79552633|FG001|Open-Label Period|Adverse Event|0|||
44436904|NCT00778895|79445700|FG001|ESFU Phase|Withdrawal by Subject|4|||
44436905|NCT00778895|79445701|FG002|ESFU Phase|Withdrawal by Subject|0|||
44436906|NCT00778895|79445699|FG000|ESFU Phase|Lost to Follow-up|6|||
44436907|NCT00778895|79445700|FG001|ESFU Phase|Lost to Follow-up|7|||
44436908|NCT00778895|79445701|FG002|ESFU Phase|Lost to Follow-up|2|||
44540563|NCT01328002|79552632|FG000|Open-Label Period|Lack of Efficacy|3|||
44540564|NCT01328002|79552633|FG001|Open-Label Period|Lack of Efficacy|0|||
44436909|NCT00778895|79445699|FG000|ESFU Phase|Other|2|||
44436910|NCT00778895|79445700|FG001|ESFU Phase|Other|0|||
44436911|NCT00778895|79445701|FG002|ESFU Phase|Other|0|||
44436912|NCT00293215|79445712|FG000|Overall Study|Progressive disease|3|||
44436913|NCT00293215|79445713|FG001|Overall Study|Progressive disease|1|||
44436914|NCT00293215|79445712|FG000|Overall Study|Adverse Event|2|||
44436915|NCT00293215|79445713|FG001|Overall Study|Adverse Event|2|||
44436916|NCT00778817|79445719|FG000|Overall Study|Adverse Event|2|||
44436917|NCT00778817|79445719|FG000|Overall Study|Withdrawal by Subject|2|||
44436918|NCT00293059|79445725|FG000|Overall Study|Adverse Event|12|||
44436919|NCT00293059|79445726|FG001|Overall Study|Adverse Event|4|||
44436920|NCT00293059|79445725|FG000|Overall Study|Lack of Efficacy|2|||
44436921|NCT00293059|79445726|FG001|Overall Study|Lack of Efficacy|0|||
44436922|NCT00293059|79445725|FG000|Overall Study|Lost to Follow-up|2|||
44436923|NCT00293059|79445726|FG001|Overall Study|Lost to Follow-up|3|||
44436924|NCT00293059|79445725|FG000|Overall Study|Pregnancy|1|||
44436925|NCT00293059|79445726|FG001|Overall Study|Pregnancy|1|||
44436926|NCT00293059|79445725|FG000|Overall Study|Protocol Violation|2|||
44436927|NCT00293059|79445726|FG001|Overall Study|Protocol Violation|0|||
44157553|NCT01940900|78949358|FG001|Overall Study|subject non-compliance|1|||
44157554|NCT01940900|78949357|FG000|Overall Study|other|1|||
44157555|NCT01940900|78949358|FG001|Overall Study|other|0|||
44157556|NCT01940887|78949366|FG000|Year 1|Protocol Violation|0|||
44157557|NCT01940887|78949367|FG001|Year 1|Protocol Violation|1|||
44157558|NCT01940887|78949366|FG000|Year 1|Physician Decision|7|||
44157559|NCT01940887|78949367|FG001|Year 1|Physician Decision|3|||
44157560|NCT01940887|78949366|FG000|Year 1|Death|5|||
44157561|NCT01940887|78949367|FG001|Year 1|Death|3|||
44157562|NCT01940887|78949366|FG000|Year 1|Adverse Event|7|||
44157563|NCT01940887|78949367|FG001|Year 1|Adverse Event|6|||
44157564|NCT01940887|78949366|FG000|Year 1|Withdrawal by Subject|18|||
44157565|NCT01940887|78949367|FG001|Year 1|Withdrawal by Subject|9|||
44157566|NCT01940887|78949366|FG000|Year 1|Lost to Follow-up|2|||
44157567|NCT01940887|78949367|FG001|Year 1|Lost to Follow-up|1|||
44157568|NCT01940887|78949366|FG000|Year 2|Physician Decision|8|||
44436928|NCT00293059|79445725|FG000|Overall Study|Withdrawal by Subject|11|||
44436929|NCT00293059|79445726|FG001|Overall Study|Withdrawal by Subject|5|||
44436930|NCT00293059|79445725|FG000|Overall Study|Participant moved out of state|1|||
44436931|NCT00293059|79445726|FG001|Overall Study|Participant moved out of state|0|||
44436932|NCT00293059|79445725|FG000|Overall Study|Participant stopped study drug|1|||
44436933|NCT00293059|79445726|FG001|Overall Study|Participant stopped study drug|0|||
44436934|NCT00293059|79445725|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
44436935|NCT00293059|79445726|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
44540565|NCT01328002|79552632|FG000|Open-Label Period|Protocol Violation|2|||
44540566|NCT01328002|79552633|FG001|Open-Label Period|Protocol Violation|0|||
44540567|NCT01328002|79552632|FG000|Open-Label Period|Withdrawal by Subject|9|||
44540568|NCT01328002|79552633|FG001|Open-Label Period|Withdrawal by Subject|0|||
44540569|NCT01328002|79552632|FG000|Open-Label Period|Lost to Follow-up|6|||
44540570|NCT01328002|79552633|FG001|Open-Label Period|Lost to Follow-up|0|||
44540571|NCT01328002|79552632|FG000|Open-Label Period|Other Reason|2|||
44540572|NCT01328002|79552633|FG001|Open-Label Period|Other Reason|0|||
44540573|NCT01328002|79552632|FG000|Double-Blind Period|Adverse Event|1|||
44540574|NCT01328002|79552633|FG001|Double-Blind Period|Adverse Event|0|||
44540575|NCT01328002|79552632|FG000|Double-Blind Period|Lack of Efficacy|1|||
44540576|NCT01328002|79552633|FG001|Double-Blind Period|Lack of Efficacy|0|||
44540577|NCT02579265|79552642|FG000|Overall Study|Weaned off earlier than 28 days|44|||
44540578|NCT02579265|79552643|FG001|Overall Study|Weaned off earlier than 28 days|43|||
44540579|NCT02579265|79552642|FG000|Overall Study|Adverse Event|2|||
44540580|NCT02579265|79552643|FG001|Overall Study|Adverse Event|0|||
44540581|NCT02579265|79552642|FG000|Overall Study|Any other reason not specified|0|||
44157569|NCT01940887|78949367|FG001|Year 2|Physician Decision|1|||
44157570|NCT01940887|78949366|FG000|Year 2|Death|0|||
44540582|NCT02579265|79552643|FG001|Overall Study|Any other reason not specified|2|||
44540583|NCT02579265|79552642|FG000|Overall Study|Withdrawal by Subject|2|||
44157571|NCT01940887|78949367|FG001|Year 2|Death|2|||
44436936|NCT00293059|79445725|FG000|Overall Study|missing|3|||
44436937|NCT00293059|79445726|FG001|Overall Study|missing|5|||
44436938|NCT00756275|79445734|FG000|Overall Study|Lost to Follow-up|25|||
44436939|NCT00756275|79445735|FG001|Overall Study|Lost to Follow-up|21|||
44436940|NCT00756275|79445734|FG000|Overall Study|Withdrawal by Subject|4|||
44436941|NCT00756275|79445735|FG001|Overall Study|Withdrawal by Subject|7|||
44436942|NCT00758459|79445743|FG000|Overall Study|Adverse Event|3|||
44540584|NCT02579265|79552643|FG001|Overall Study|Withdrawal by Subject|0|||
44436943|NCT00758459|79445744|FG001|Overall Study|Adverse Event|2|||
44157572|NCT01940887|78949366|FG000|Year 2|Sponsor Decision, early termination|192|||
44157573|NCT01940887|78949367|FG001|Year 2|Sponsor Decision, early termination|203|||
44157574|NCT01940887|78949366|FG000|Year 2|Adverse Event|8|||
44436944|NCT00758459|79445743|FG000|Overall Study|Protocol Violation|0|||
44436945|NCT00758459|79445744|FG001|Overall Study|Protocol Violation|1|||
44436946|NCT00758459|79445743|FG000|Overall Study|Withdrawal by Subject|0|||
44436947|NCT00758459|79445744|FG001|Overall Study|Withdrawal by Subject|1|||
44436948|NCT00298831|79445750|FG000|Overall Study|Adverse Event|1|||
44436949|NCT00298831|79445750|FG000|Overall Study|Lost to Follow-up|3|||
44436950|NCT00298831|79445750|FG000|Overall Study|Withdrawal by Subject|1|||
44436951|NCT00298831|79445750|FG000|Overall Study|Participants did not receive treatment|27|||
44436952|NCT00758069|79445757|FG000|Overall Study|Lack of Efficacy|0|||
44436953|NCT00758069|79445758|FG001|Overall Study|Lack of Efficacy|0|||
44436954|NCT00758069|79445759|FG002|Overall Study|Lack of Efficacy|1|||
44436955|NCT00758069|79445757|FG000|Overall Study|Incorrect Study Drug|1|||
44436956|NCT00758069|79445758|FG001|Overall Study|Incorrect Study Drug|0|||
44436957|NCT00758069|79445759|FG002|Overall Study|Incorrect Study Drug|0|||
44436958|NCT00311623|79445770|FG000|Overall Study|Physician Decision|0|||
44436959|NCT00311623|79445771|FG001|Overall Study|Physician Decision|0|||
44436960|NCT00311623|79445772|FG002|Overall Study|Physician Decision|2|||
44436961|NCT00528112|79445783|FG000|Treatment up to 3 Years|Adverse Event|313|||
44436962|NCT00528112|79445784|FG001|Treatment up to 3 Years|Adverse Event|278|||
44436963|NCT00528112|79445783|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
44436964|NCT00528112|79445784|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
44436965|NCT00528112|79445783|FG000|Treatment up to 3 Years|Protocol Violation|16|||
44436966|NCT00528112|79445784|FG001|Treatment up to 3 Years|Protocol Violation|16|||
44436967|NCT00528112|79445783|FG000|Treatment up to 3 Years|Death|0|||
44436968|NCT00528112|79445784|FG001|Treatment up to 3 Years|Death|1|||
44436969|NCT00528112|79445783|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
44436970|NCT00528112|79445784|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
44436971|NCT00528112|79445783|FG000|Treatment up to 3 Years|Pregnancy|9|||
44436972|NCT00528112|79445784|FG001|Treatment up to 3 Years|Pregnancy|10|||
44436973|NCT00528112|79445783|FG000|Treatment up to 3 Years|Other reasons|186|||
44337919|NCT01298700|79342232|FG001|Overall Study|Did not Receive Study Drug|5|||
44337920|NCT01297920|79342241|FG000|Overall Study|Adverse Event|42|||
44337921|NCT01297920|79342242|FG001|Overall Study|Adverse Event|10|||
44337922|NCT01297920|79342243|FG002|Overall Study|Adverse Event|38|||
44337923|NCT01297920|79342241|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
44436974|NCT00528112|79445784|FG001|Treatment up to 3 Years|Other reasons|186|||
44436975|NCT00528112|79445783|FG000|Extension Phase|Withdrawal by Subject|0|||
44436976|NCT00528112|79445784|FG001|Extension Phase|Withdrawal by Subject|3|||
44436977|NCT00528112|79445783|FG000|Extension Phase|Other reasons|0|||
44436978|NCT00528112|79445784|FG001|Extension Phase|Other reasons|100|||
44436979|NCT00528112|79445783|FG000|Extension Phase|Pregnancy|0|||
44436980|NCT00528112|79445784|FG001|Extension Phase|Pregnancy|3|||
44436981|NCT00528112|79445783|FG000|Extension Phase|Lost to Follow-up|0|||
44436982|NCT00528112|79445784|FG001|Extension Phase|Lost to Follow-up|12|||
44436983|NCT00528112|79445783|FG000|Extension Phase|Death|0|||
44436984|NCT00528112|79445784|FG001|Extension Phase|Death|1|||
44436985|NCT00528112|79445783|FG000|Extension Phase|Adverse Event|0|||
44436986|NCT00528112|79445784|FG001|Extension Phase|Adverse Event|36|||
44436987|NCT00528112|79445783|FG000|Extension Phase|Protocol Violation|0|||
44436988|NCT00528112|79445784|FG001|Extension Phase|Protocol Violation|2|||
44436989|NCT00633594|79445795|FG000|Overall Study|Adverse Event|0|||
44436990|NCT00633594|79445796|FG001|Overall Study|Adverse Event|4|||
44436991|NCT00633594|79445797|FG002|Overall Study|Adverse Event|7|||
44436992|NCT00633594|79445795|FG000|Overall Study|Death|0|||
44436993|NCT00633594|79445796|FG001|Overall Study|Death|1|||
44436994|NCT00633594|79445797|FG002|Overall Study|Death|2|||
44436995|NCT00633594|79445795|FG000|Overall Study|Disease Progression|0|||
44436996|NCT00633594|79445796|FG001|Overall Study|Disease Progression|0|||
44436997|NCT00633594|79445797|FG002|Overall Study|Disease Progression|1|||
44436998|NCT00755807|79445810|FG000|Acute Phase|Adverse Event|16|||
44436999|NCT00755807|79445811|FG001|Acute Phase|Adverse Event|5|||
44437000|NCT00755807|79445810|FG000|Acute Phase|Protocol Violation|1|||
44437001|NCT00755807|79445811|FG001|Acute Phase|Protocol Violation|3|||
44437002|NCT00755807|79445810|FG000|Acute Phase|Withdrawal by Subject|1|||
44437003|NCT00755807|79445811|FG001|Acute Phase|Withdrawal by Subject|2|||
44437004|NCT00755807|79445810|FG000|Acute Phase|Lack of Efficacy|0|||
44437005|NCT00755807|79445811|FG001|Acute Phase|Lack of Efficacy|1|||
44437006|NCT00755807|79445810|FG000|Acute Phase|Physician Decision|0|||
44437007|NCT00755807|79445811|FG001|Acute Phase|Physician Decision|1|||
44437008|NCT00755807|79445810|FG000|Open-label Extension Phase|Adverse Event|7|||
44437009|NCT00755807|79445811|FG001|Open-label Extension Phase|Adverse Event|7|||
44437010|NCT00755807|79445810|FG000|Open-label Extension Phase|Protocol Violation|5|||
44437011|NCT00755807|79445811|FG001|Open-label Extension Phase|Protocol Violation|2|||
44437012|NCT00755807|79445810|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
44437013|NCT00755807|79445811|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
44437014|NCT00755807|79445810|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
44337924|NCT01297920|79342242|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
44437015|NCT00755807|79445811|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
44437016|NCT00755807|79445810|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
44437017|NCT00755807|79445811|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
44437018|NCT00755807|79445810|FG000|Open-label Extension Phase|Sponsor Decision|0|||
44437019|NCT00755807|79445811|FG001|Open-label Extension Phase|Sponsor Decision|1|||
44437020|NCT00631410|79445823|FG000|Overall Study|Adverse Event|1|||
44437021|NCT00631410|79445824|FG001|Overall Study|Adverse Event|3|||
44437022|NCT00631410|79445823|FG000|Overall Study|Objective Progression or Relapse|4|||
44437023|NCT00631410|79445824|FG001|Overall Study|Objective Progression or Relapse|3|||
44437024|NCT00631410|79445823|FG000|Overall Study|Surgery|1|||
44437025|NCT00631410|79445824|FG001|Overall Study|Surgery|0|||
44437026|NCT03686176|79445836|FG000|Overall Study|Procedure cancelled|1|||
44437027|NCT03686176|79445837|FG001|Overall Study|Procedure cancelled|0|||
44437028|NCT03686176|79445838|FG002|Overall Study|Procedure cancelled|0|||
44437029|NCT03686176|79445836|FG000|Overall Study|VR Malfunction|1|||
44437030|NCT03686176|79445837|FG001|Overall Study|VR Malfunction|0|||
44437031|NCT03686176|79445838|FG002|Overall Study|VR Malfunction|0|||
44437032|NCT00755417|79445849|FG000|Overall Study|Adverse Event|28|||
44437033|NCT00755417|79445850|FG001|Overall Study|Adverse Event|20|||
44437034|NCT00755417|79445851|FG002|Overall Study|Adverse Event|7|||
44437035|NCT00755417|79445849|FG000|Overall Study|Lack of Efficacy|8|||
44437036|NCT00755417|79445850|FG001|Overall Study|Lack of Efficacy|4|||
44437037|NCT00755417|79445851|FG002|Overall Study|Lack of Efficacy|9|||
44437038|NCT00755417|79445849|FG000|Overall Study|Protocol Violation|2|||
44437039|NCT00755417|79445850|FG001|Overall Study|Protocol Violation|1|||
44437040|NCT00755417|79445851|FG002|Overall Study|Protocol Violation|1|||
44437041|NCT00755417|79445849|FG000|Overall Study|Lost to Follow-up|3|||
44437042|NCT00755417|79445850|FG001|Overall Study|Lost to Follow-up|0|||
44437043|NCT00755417|79445851|FG002|Overall Study|Lost to Follow-up|1|||
44437044|NCT00755417|79445849|FG000|Overall Study|Withdrawal by Subject|12|||
44437045|NCT00755417|79445850|FG001|Overall Study|Withdrawal by Subject|12|||
44337925|NCT01297920|79342243|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
44337926|NCT01297920|79342241|FG000|Overall Study|Noncompliance|1|||
44337927|NCT01297920|79342242|FG001|Overall Study|Noncompliance|0|||
44337928|NCT01297920|79342243|FG002|Overall Study|Noncompliance|0|||
44337929|NCT01297920|79342241|FG000|Overall Study|Protocol Violation|1|||
44337930|NCT01297920|79342242|FG001|Overall Study|Protocol Violation|3|||
44437046|NCT00755417|79445851|FG002|Overall Study|Withdrawal by Subject|12|||
44437047|NCT00755417|79445849|FG000|Overall Study|Not specified or missing data|9|||
44437048|NCT00755417|79445850|FG001|Overall Study|Not specified or missing data|18|||
44437049|NCT00755417|79445851|FG002|Overall Study|Not specified or missing data|12|||
44437050|NCT03685708|79445862|FG000|Overall Study|Withdrawal by Subject|0|||
44437051|NCT03685708|79445863|FG001|Overall Study|Withdrawal by Subject|0|||
44437052|NCT03685708|79445864|FG002|Overall Study|Withdrawal by Subject|1|||
44437053|NCT03685708|79445862|FG000|Overall Study|Screen Fail|0|||
44437054|NCT03685708|79445863|FG001|Overall Study|Screen Fail|1|||
44437055|NCT03685708|79445864|FG002|Overall Study|Screen Fail|1|||
44437056|NCT03685708|79445862|FG000|Overall Study|COVID 19 Pandemic|1|||
44437057|NCT03685708|79445863|FG001|Overall Study|COVID 19 Pandemic|1|||
44437058|NCT03685708|79445864|FG002|Overall Study|COVID 19 Pandemic|6|||
44337931|NCT01297920|79342243|FG002|Overall Study|Protocol Violation|0|||
44337932|NCT01297920|79342241|FG000|Overall Study|Inadequate Control of IOP|7|||
44337933|NCT01297920|79342242|FG001|Overall Study|Inadequate Control of IOP|9|||
44337934|NCT01297920|79342243|FG002|Overall Study|Inadequate Control of IOP|17|||
44337935|NCT01297920|79342241|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
44337936|NCT01297920|79342242|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
44337937|NCT01297920|79342243|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
44337938|NCT01255761|79342253|FG000|Overall Study|Adverse Event|29|||
44337939|NCT01255761|79342254|FG001|Overall Study|Adverse Event|43|||
44337940|NCT01255761|79342253|FG000|Overall Study|Lack of Efficacy|86|||
44337941|NCT01255761|79342254|FG001|Overall Study|Lack of Efficacy|74|||
44337942|NCT01255761|79342253|FG000|Overall Study|Protocol Violation|9|||
44337943|NCT01255761|79342254|FG001|Overall Study|Protocol Violation|5|||
44337944|NCT01255761|79342253|FG000|Overall Study|Lost to Follow-up|10|||
44337945|NCT01255761|79342254|FG001|Overall Study|Lost to Follow-up|8|||
44337946|NCT01255761|79342253|FG000|Overall Study|Withdrawal by Subject|11|||
44337947|NCT01255761|79342254|FG001|Overall Study|Withdrawal by Subject|27|||
44337948|NCT01255761|79342253|FG000|Overall Study|Other Reasons|37|||
44437059|NCT03685708|79445862|FG000|Overall Study|Disease Progression|0|||
44437060|NCT03685708|79445863|FG001|Overall Study|Disease Progression|0|||
44437061|NCT03685708|79445864|FG002|Overall Study|Disease Progression|1|||
44437062|NCT03684928|79445872|FG000|First Intervention|Lost to Follow-up|0|||
44437063|NCT03684928|79445873|FG001|First Intervention|Lost to Follow-up|1|||
44437064|NCT03684928|79445872|FG000|First Intervention|Withdrawal by Subject|0|||
44437065|NCT03684928|79445873|FG001|First Intervention|Withdrawal by Subject|2|||
44437066|NCT03684928|79445872|FG000|Second Intervention|Soft Tissue Injury|1|||
44437067|NCT03684928|79445873|FG001|Second Intervention|Soft Tissue Injury|0|||
44437068|NCT00777803|79445881|FG000|Overall Study|Lost to Follow-up|12|||
44437069|NCT00777803|79445882|FG001|Overall Study|Lost to Follow-up|5|||
44437070|NCT00777803|79445881|FG000|Overall Study|Adverse Event|1|||
44437071|NCT00777803|79445882|FG001|Overall Study|Adverse Event|0|||
44437072|NCT00777803|79445881|FG000|Overall Study|Non-compliance|2|||
44437073|NCT00777803|79445882|FG001|Overall Study|Non-compliance|2|||
44437074|NCT00527488|79445892|FG000|Overall Study|Withdrawn prior to dosing|0|||
44437075|NCT00527488|79445893|FG001|Overall Study|Withdrawn prior to dosing|1|||
44437076|NCT00527488|79445894|FG002|Overall Study|Withdrawn prior to dosing|1|||
44437077|NCT00527488|79445895|FG003|Overall Study|Withdrawn prior to dosing|0|||
44437078|NCT00527332|79445907|FG000|Overall Study|Protocol Violation|4|||
44437079|NCT00527332|79445908|FG001|Overall Study|Protocol Violation|8|||
44437080|NCT00527332|79445907|FG000|Overall Study|Withdrew consent|5|||
44437081|NCT00527332|79445908|FG001|Overall Study|Withdrew consent|1|||
44437082|NCT00752609|79445916|FG000|Overall Study|Adverse Event|2|||
44437083|NCT00752609|79445917|FG001|Overall Study|Adverse Event|2|||
44437084|NCT00752609|79445916|FG000|Overall Study|Withdrawal by Subject|3|||
44437085|NCT00752609|79445917|FG001|Overall Study|Withdrawal by Subject|0|||
44437086|NCT00752609|79445916|FG000|Overall Study|Physician Decision|1|||
44437087|NCT00752609|79445917|FG001|Overall Study|Physician Decision|0|||
44437088|NCT00752609|79445916|FG000|Overall Study|Death|1|||
44437089|NCT00752609|79445917|FG001|Overall Study|Death|0|||
44337949|NCT01255761|79342254|FG001|Overall Study|Other Reasons|18|||
44337950|NCT01297062|79342266|FG000|Overall Study|Adverse Event|2|||
44337951|NCT01297062|79342267|FG001|Overall Study|Adverse Event|0|||
44337952|NCT01297062|79342268|FG002|Overall Study|Adverse Event|1|||
44337953|NCT01297062|79342269|FG003|Overall Study|Adverse Event|0|||
44337954|NCT01297062|79342270|FG004|Overall Study|Adverse Event|0|||
44337955|NCT01297062|79342271|FG005|Overall Study|Adverse Event|0|||
44337956|NCT01297062|79342272|FG006|Overall Study|Adverse Event|0|||
44337957|NCT01297062|79342266|FG000|Overall Study|Physician Decision|1|||
44337958|NCT01297062|79342267|FG001|Overall Study|Physician Decision|0|||
44337959|NCT01297062|79342268|FG002|Overall Study|Physician Decision|1|||
44337960|NCT01297062|79342269|FG003|Overall Study|Physician Decision|0|||
44337961|NCT01297062|79342270|FG004|Overall Study|Physician Decision|0|||
44337962|NCT01297062|79342271|FG005|Overall Study|Physician Decision|0|||
44337963|NCT01297062|79342272|FG006|Overall Study|Physician Decision|6|||
44337964|NCT01297062|79342266|FG000|Overall Study|Protocol Violation|0|||
44337965|NCT01297062|79342267|FG001|Overall Study|Protocol Violation|0|||
44337966|NCT01297062|79342268|FG002|Overall Study|Protocol Violation|0|||
44337967|NCT01297062|79342269|FG003|Overall Study|Protocol Violation|0|||
44337968|NCT01297062|79342270|FG004|Overall Study|Protocol Violation|1|||
44337969|NCT01297062|79342271|FG005|Overall Study|Protocol Violation|0|||
44337970|NCT01297062|79342272|FG006|Overall Study|Protocol Violation|0|||
44337971|NCT01297062|79342266|FG000|Overall Study|Subject Decision|1|||
44337972|NCT01297062|79342267|FG001|Overall Study|Subject Decision|1|||
44337973|NCT01297062|79342268|FG002|Overall Study|Subject Decision|0|||
44337974|NCT01297062|79342269|FG003|Overall Study|Subject Decision|1|||
44337975|NCT01297062|79342270|FG004|Overall Study|Subject Decision|1|||
44337976|NCT01297062|79342271|FG005|Overall Study|Subject Decision|1|||
44337977|NCT01297062|79342272|FG006|Overall Study|Subject Decision|2|||
44337978|NCT01254747|79342284|FG000|Overall Study|Unacceptable subjective vision|0|||
44337979|NCT01254747|79342285|FG001|Overall Study|Unacceptable subjective vision|0|||
44337980|NCT01254747|79342286|FG002|Overall Study|Unacceptable subjective vision|0|||
44337981|NCT01254747|79342287|FG003|Overall Study|Unacceptable subjective vision|2|||
44337982|NCT01254747|79342284|FG000|Overall Study|Difficult removal handling|0|||
44337983|NCT01254747|79342285|FG001|Overall Study|Difficult removal handling|0|||
44337984|NCT01254747|79342286|FG002|Overall Study|Difficult removal handling|1|||
44337985|NCT01254747|79342287|FG003|Overall Study|Difficult removal handling|0|||
44337986|NCT01254747|79342284|FG000|Overall Study|Symptoms and problems|0|||
44337987|NCT01254747|79342285|FG001|Overall Study|Symptoms and problems|2|||
44337988|NCT01254747|79342286|FG002|Overall Study|Symptoms and problems|1|||
44337989|NCT01254747|79342287|FG003|Overall Study|Symptoms and problems|0|||
44337990|NCT01254747|79342284|FG000|Overall Study|Lost to Follow-up|0|||
44337991|NCT01254747|79342285|FG001|Overall Study|Lost to Follow-up|0|||
44337992|NCT01254747|79342286|FG002|Overall Study|Lost to Follow-up|1|||
44337993|NCT01254747|79342287|FG003|Overall Study|Lost to Follow-up|0|||
44337994|NCT01254747|79342284|FG000|Overall Study|Biomicroscopy|0|||
44337995|NCT01254747|79342285|FG001|Overall Study|Biomicroscopy|0|||
44337996|NCT01254747|79342286|FG002|Overall Study|Biomicroscopy|1|||
44337997|NCT01254747|79342287|FG003|Overall Study|Biomicroscopy|0|||
44337998|NCT01254747|79342284|FG000|Overall Study|Discomfort|0|||
44337999|NCT01254747|79342285|FG001|Overall Study|Discomfort|4|||
44338000|NCT01254747|79342286|FG002|Overall Study|Discomfort|0|||
44338001|NCT01254747|79342287|FG003|Overall Study|Discomfort|0|||
44437090|NCT00752609|79445916|FG000|Overall Study|Met exclusion criteria|1|||
44437091|NCT00752609|79445917|FG001|Overall Study|Met exclusion criteria|0|||
44437092|NCT00752609|79445916|FG000|Overall Study|Received Aranesp in error|1|||
44437093|NCT00752609|79445917|FG001|Overall Study|Received Aranesp in error|0|||
44437094|NCT03684304|79445928|FG000|Overall Study|Lost to Follow-up|19|||
44437095|NCT03684304|79445929|FG001|Overall Study|Lost to Follow-up|17|||
44540585|NCT02579265|79552642|FG000|Overall Study|Physician Decision|1|||
44437096|NCT00629772|79445937|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
44437097|NCT00629772|79445938|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
44437098|NCT00629772|79445937|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
44437099|NCT00629772|79445938|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
44437100|NCT00526630|79445945|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
44437101|NCT00526630|79445946|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
44437102|NCT00526630|79445945|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
44437103|NCT00526630|79445946|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
44437104|NCT00755183|79445956|FG000|Overall Study|Adverse Event|5|||
44437105|NCT00755183|79445957|FG001|Overall Study|Adverse Event|2|||
44437106|NCT00755183|79445956|FG000|Overall Study|Protocol Violation|0|||
44437107|NCT00755183|79445957|FG001|Overall Study|Protocol Violation|1|||
44437108|NCT00755183|79445956|FG000|Overall Study|Withdrawal by Subject|0|||
44437109|NCT00755183|79445957|FG001|Overall Study|Withdrawal by Subject|2|||
44437110|NCT00755183|79445956|FG000|Overall Study|Administrative|2|||
44437111|NCT00755183|79445957|FG001|Overall Study|Administrative|1|||
44437112|NCT00755105|79445968|FG000|Overall Study|Withdrawal by Subject|9|||
44437113|NCT00755105|79445969|FG001|Overall Study|Withdrawal by Subject|11|||
44437114|NCT00755105|79445970|FG002|Overall Study|Withdrawal by Subject|4|||
44437115|NCT00526162|79445978|FG000|Overall Study|Device not implanted|3|||
44437116|NCT03875482|79445988|FG000|Overall Study|Adverse Event|0|||
44437117|NCT03875482|79445989|FG001|Overall Study|Adverse Event|1|||
44437118|NCT03875482|79445988|FG000|Overall Study|Withdrew consent|5|||
44437119|NCT03875482|79445989|FG001|Overall Study|Withdrew consent|6|||
44437120|NCT03875482|79445988|FG000|Overall Study|Lost to Follow-up|8|||
44437121|NCT03875482|79445989|FG001|Overall Study|Lost to Follow-up|2|||
44437122|NCT03875482|79445988|FG000|Overall Study|Lack of Efficacy|0|||
44437123|NCT03875482|79445989|FG001|Overall Study|Lack of Efficacy|11|||
44437124|NCT00754793|79445997|FG000|Overall Study|voluntary withdrawn from study|0|||
44437125|NCT00754793|79445998|FG001|Overall Study|voluntary withdrawn from study|1|||
44437126|NCT00586469|79446006|FG000|Overall Study|Adverse Event|0|||
44437127|NCT00586469|79446007|FG001|Overall Study|Adverse Event|1|||
44437128|NCT00626028|79446015|FG000|Overall Study|Adverse Event|1|||
44437129|NCT00626028|79446016|FG001|Overall Study|Adverse Event|1|||
44437130|NCT00626028|79446015|FG000|Overall Study|Device Failure|0|||
44437131|NCT00626028|79446016|FG001|Overall Study|Device Failure|1|||
44437132|NCT00626028|79446015|FG000|Overall Study|Physician Decision|2|||
44437133|NCT00626028|79446016|FG001|Overall Study|Physician Decision|1|||
44437134|NCT00626028|79446015|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
44338002|NCT01296672|79342299|FG000|Overall Study|Lost to Follow-up|73|||
44338003|NCT01296672|79342300|FG001|Overall Study|Lost to Follow-up|18|||
44338004|NCT01254669|79342310|FG000|Overall Study|Withdrawal by Subject|0|||
44338005|NCT01254669|79342311|FG001|Overall Study|Withdrawal by Subject|1|||
44338006|NCT01254669|79342310|FG000|Overall Study|time constraint|2|||
44338007|NCT01254669|79342311|FG001|Overall Study|time constraint|2|||
44338008|NCT01254669|79342310|FG000|Overall Study|called to clinic during intervention|1|||
44338009|NCT01254669|79342311|FG001|Overall Study|called to clinic during intervention|1|||
44338010|NCT01295814|79342321|FG000|Overall Study|Lack of Efficacy|0|||
44338011|NCT01295814|79342322|FG001|Overall Study|Lack of Efficacy|2|||
44338012|NCT01295814|79342321|FG000|Overall Study|Withdrawal by Subject|2|||
44338013|NCT01295814|79342322|FG001|Overall Study|Withdrawal by Subject|0|||
44338014|NCT01254045|79342328|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
44338015|NCT01254045|79342329|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
44338016|NCT01254045|79342330|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
44338017|NCT01254045|79342331|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
44338018|NCT01254045|79342332|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
44437135|NCT00626028|79446016|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
44437136|NCT00777257|79446025|FG000|Overall Study|Adverse Event|3|||
44437137|NCT00777257|79446026|FG001|Overall Study|Adverse Event|1|||
44437138|NCT00777257|79446027|FG002|Overall Study|Adverse Event|0|||
44437139|NCT00777257|79446025|FG000|Overall Study|Lost to Follow-up|3|||
44437140|NCT00777257|79446026|FG001|Overall Study|Lost to Follow-up|3|||
44437141|NCT00777257|79446027|FG002|Overall Study|Lost to Follow-up|2|||
44437142|NCT00777257|79446025|FG000|Overall Study|Protocol Violation|2|||
44437143|NCT00777257|79446026|FG001|Overall Study|Protocol Violation|2|||
44437144|NCT00777257|79446027|FG002|Overall Study|Protocol Violation|2|||
44437145|NCT00777257|79446025|FG000|Overall Study|Withdrawal by Subject|3|||
44437146|NCT00777257|79446026|FG001|Overall Study|Withdrawal by Subject|6|||
44437147|NCT00777257|79446027|FG002|Overall Study|Withdrawal by Subject|5|||
44437148|NCT00628758|79446037|FG000|Overall Study|Adverse Event|2|||
44437149|NCT00628758|79446038|FG001|Overall Study|Adverse Event|3|||
44157575|NCT01940887|78949367|FG001|Year 2|Adverse Event|2|||
44437150|NCT00628758|79446037|FG000|Overall Study|Withdrawal by Subject|6|||
44338019|NCT01254045|79342333|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
44338020|NCT01075282|79342346|FG000|Overall Study|Withdrawal by Subject|11|||
44338021|NCT01075282|79342347|FG001|Overall Study|Withdrawal by Subject|7|||
44437151|NCT00628758|79446038|FG001|Overall Study|Withdrawal by Subject|3|||
44437152|NCT00628758|79446037|FG000|Overall Study|Death|1|||
44437153|NCT00628758|79446038|FG001|Overall Study|Death|0|||
44437154|NCT00628758|79446037|FG000|Overall Study|Protocol Violation|5|||
44437155|NCT00628758|79446038|FG001|Overall Study|Protocol Violation|1|||
44437156|NCT00628758|79446037|FG000|Overall Study|Lost to Follow-up|25|||
44437157|NCT00628758|79446038|FG001|Overall Study|Lost to Follow-up|31|||
44437158|NCT00628758|79446037|FG000|Overall Study|Pregnancy|2|||
44437159|NCT00628758|79446038|FG001|Overall Study|Pregnancy|2|||
44437160|NCT00628758|79446037|FG000|Overall Study|Investigator Moved|3|||
44437161|NCT00628758|79446038|FG001|Overall Study|Investigator Moved|0|||
44437162|NCT00628758|79446037|FG000|Overall Study|Treatment Failure|0|||
44437163|NCT00628758|79446038|FG001|Overall Study|Treatment Failure|2|||
44437164|NCT04491604|79446046|FG000|Overall Study|Withdrawal by Subject|3|||
44437165|NCT00628446|79446051|FG000|Overall Study|Lost to Follow-up|3|||
44540586|NCT02579265|79552643|FG001|Overall Study|Physician Decision|0|||
44540587|NCT02579265|79552642|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
44540588|NCT02579265|79552643|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
44540589|NCT03289533|79552649|FG000|Overall Study|Death|12|||
44540590|NCT03289533|79552649|FG000|Overall Study|Terminated from study by sponsor|10|||
44540591|NCT04727749|79552655|FG000|Overall Study|Lost to Follow-up|10|||
44540592|NCT04727749|79552656|FG001|Overall Study|Lost to Follow-up|3|||
44540593|NCT04547023|79552666|FG000|Overall Study|Did Not Receive Intervention|3|||
44338022|NCT01075282|79342348|FG002|Overall Study|Withdrawal by Subject|11|||
44338023|NCT01075282|79342346|FG000|Overall Study|Adverse Event|9|||
44338024|NCT01075282|79342347|FG001|Overall Study|Adverse Event|8|||
44338025|NCT01075282|79342348|FG002|Overall Study|Adverse Event|5|||
44338026|NCT01075282|79342346|FG000|Overall Study|Entry Criteria Not Met|3|||
44338027|NCT01075282|79342347|FG001|Overall Study|Entry Criteria Not Met|2|||
44338028|NCT01075282|79342348|FG002|Overall Study|Entry Criteria Not Met|0|||
44338029|NCT01075282|79342346|FG000|Overall Study|Lost to Follow-up|3|||
44338030|NCT01075282|79342347|FG001|Overall Study|Lost to Follow-up|3|||
44338031|NCT01075282|79342348|FG002|Overall Study|Lost to Follow-up|3|||
44338032|NCT01075282|79342346|FG000|Overall Study|Physician Decision|3|||
44338033|NCT01075282|79342347|FG001|Overall Study|Physician Decision|3|||
44338034|NCT01075282|79342348|FG002|Overall Study|Physician Decision|3|||
44338035|NCT01075282|79342346|FG000|Overall Study|Lack of Efficacy|1|||
44338036|NCT01075282|79342347|FG001|Overall Study|Lack of Efficacy|1|||
44338037|NCT01075282|79342348|FG002|Overall Study|Lack of Efficacy|0|||
44338038|NCT01075282|79342346|FG000|Overall Study|Treatment Non-compliance|1|||
44338039|NCT01075282|79342347|FG001|Overall Study|Treatment Non-compliance|2|||
44338040|NCT01075282|79342348|FG002|Overall Study|Treatment Non-compliance|2|||
44338041|NCT01075282|79342346|FG000|Overall Study|Protocol Violation|0|||
44338042|NCT01075282|79342347|FG001|Overall Study|Protocol Violation|2|||
44338043|NCT01075282|79342348|FG002|Overall Study|Protocol Violation|1|||
44338044|NCT01075282|79342346|FG000|Overall Study|Death|0|||
44338045|NCT01075282|79342347|FG001|Overall Study|Death|1|||
44338046|NCT01075282|79342348|FG002|Overall Study|Death|2|||
44338047|NCT01253811|79342357|FG000|Overall Study|Withdrawal criteria|1|||
44338048|NCT01295580|79342363|FG000|Overall Study|Protocol Violation|4|||
44437166|NCT00628446|79446051|FG000|Overall Study|Withdrawal by Subject|1|||
44437167|NCT00628446|79446051|FG000|Overall Study|Protocol Violation|3|||
44437168|NCT00754559|79446056|FG000|Overall Study|Adverse Event|15|||
44437169|NCT00754559|79446056|FG000|Overall Study|Protocol Violation|11|||
44338049|NCT01295580|79342364|FG001|Overall Study|Protocol Violation|2|||
44338050|NCT01295580|79342363|FG000|Overall Study|Withdrawal by Subject|1|||
44338051|NCT01295580|79342364|FG001|Overall Study|Withdrawal by Subject|4|||
44338052|NCT01295580|79342363|FG000|Overall Study|Adverse Event|2|||
44338053|NCT01295580|79342364|FG001|Overall Study|Adverse Event|1|||
44338054|NCT01295580|79342363|FG000|Overall Study|Lost to Follow-up|1|||
44338055|NCT01295580|79342364|FG001|Overall Study|Lost to Follow-up|0|||
44338056|NCT01295580|79342363|FG000|Overall Study|Lack of Efficacy|1|||
44338057|NCT01295580|79342364|FG001|Overall Study|Lack of Efficacy|0|||
44437170|NCT00754559|79446056|FG000|Overall Study|Lack of Efficacy|10|||
44540594|NCT04547023|79552667|FG001|Overall Study|Did Not Receive Intervention|2|||
44540595|NCT04547023|79552666|FG000|Overall Study|Lost to Follow-up|1|||
44540596|NCT04547023|79552667|FG001|Overall Study|Lost to Follow-up|1|||
44540597|NCT03697993|79552677|FG000|Overall Study|Became Ineligible after Enrollment|1|||
44540598|NCT03697993|79552678|FG001|Overall Study|Became Ineligible after Enrollment|3|||
44540599|NCT03697993|79552677|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
44338058|NCT01295580|79342363|FG000|Overall Study|Other: inconvenience|1|||
44338059|NCT01295580|79342364|FG001|Overall Study|Other: inconvenience|0|||
44338060|NCT01295580|79342363|FG000|Overall Study|Other: family objection|0|||
44338061|NCT01295580|79342364|FG001|Overall Study|Other: family objection|1|||
44338062|NCT01253577|79342370|FG000|Overall Study|Lost to Follow-up|3|||
44338063|NCT01295034|79342378|FG000|Overall Study|Lost to Follow-up|5|||
44338064|NCT01295034|79342379|FG001|Overall Study|Lost to Follow-up|5|||
44338065|NCT01253421|79342390|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
44437171|NCT00754559|79446056|FG000|Overall Study|Lost to Follow-up|2|||
44437172|NCT00754559|79446056|FG000|Overall Study|Administrative reason|1|||
44437173|NCT00754559|79446056|FG000|Overall Study|Other|5|||
44437174|NCT00754559|79446056|FG000|Overall Study|Withdrawal by Subject|3|||
44338066|NCT01253421|79342391|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
44338067|NCT01253421|79342392|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
44338068|NCT01253421|79342393|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
44338069|NCT01253421|79342394|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
44338070|NCT01253421|79342390|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
44338071|NCT01253421|79342391|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
44338072|NCT01253421|79342392|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
44338073|NCT01253421|79342393|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
44338074|NCT01253421|79342394|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
44338075|NCT01253421|79342390|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
44338076|NCT01253421|79342391|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
44338077|NCT01253421|79342392|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
44338078|NCT01253421|79342393|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
44338079|NCT01253421|79342394|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
44338080|NCT01253421|79342390|FG000|Assessment and Scheduling|Physician Decision|1|||
44338081|NCT01253421|79342391|FG001|Assessment and Scheduling|Physician Decision|0|||
44338082|NCT01253421|79342392|FG002|Assessment and Scheduling|Physician Decision|0|||
44338083|NCT01253421|79342393|FG003|Assessment and Scheduling|Physician Decision|0|||
44338084|NCT01253421|79342394|FG004|Assessment and Scheduling|Physician Decision|0|||
44338085|NCT01253421|79342390|FG000|Drug+Scanning Visit|Physician Decision|0|||
44338086|NCT01253421|79342391|FG001|Drug+Scanning Visit|Physician Decision|0|||
44338087|NCT01253421|79342392|FG002|Drug+Scanning Visit|Physician Decision|0|||
44338088|NCT01253421|79342393|FG003|Drug+Scanning Visit|Physician Decision|0|||
44338089|NCT01253421|79342394|FG004|Drug+Scanning Visit|Physician Decision|1|||
44338090|NCT01077076|79342404|FG000|First Intervention|Withdrawal by Subject|1|||
44338091|NCT01077076|79342405|FG001|First Intervention|Withdrawal by Subject|0|||
44338092|NCT01077076|79342406|FG002|First Intervention|Withdrawal by Subject|0|||
44338093|NCT01077076|79342407|FG003|First Intervention|Withdrawal by Subject|0|||
44338094|NCT01077076|79342408|FG004|First Intervention|Withdrawal by Subject|0|||
44338095|NCT01077076|79342409|FG005|First Intervention|Withdrawal by Subject|0|||
44338096|NCT01077076|79342404|FG000|Third Intervention|Death in the participant's family|0|||
44338097|NCT01077076|79342405|FG001|Third Intervention|Death in the participant's family|0|||
44437175|NCT00525148|79446067|FG000|Overall Study|Other Adverse Event|3|||
44437176|NCT00525148|79446068|FG001|Overall Study|Other Adverse Event|5|||
44437177|NCT00525148|79446069|FG002|Overall Study|Other Adverse Event|1|||
44437178|NCT00525148|79446070|FG003|Overall Study|Other Adverse Event|8|||
44437179|NCT00525148|79446067|FG000|Overall Study|Progressive disease|18|||
44437180|NCT00525148|79446068|FG001|Overall Study|Progressive disease|30|||
44437181|NCT00525148|79446069|FG002|Overall Study|Progressive disease|6|||
44437182|NCT00525148|79446070|FG003|Overall Study|Progressive disease|49|||
44437183|NCT00525148|79446067|FG000|Overall Study|Refused continuation of study medication|0|||
44437184|NCT00525148|79446068|FG001|Overall Study|Refused continuation of study medication|2|||
44437185|NCT00525148|79446069|FG002|Overall Study|Refused continuation of study medication|0|||
44437186|NCT00525148|79446070|FG003|Overall Study|Refused continuation of study medication|1|||
44437187|NCT00525148|79446067|FG000|Overall Study|Other than stated|2|||
44437188|NCT00525148|79446068|FG001|Overall Study|Other than stated|1|||
44437189|NCT00525148|79446069|FG002|Overall Study|Other than stated|0|||
44437190|NCT00525148|79446070|FG003|Overall Study|Other than stated|3|||
44437191|NCT00754325|79446082|FG000|Initial Treatment|Continuing Active Treatment|4|||
44437192|NCT00754325|79446083|FG001|Initial Treatment|Continuing Active Treatment|5|||
44437193|NCT00754325|79446082|FG000|Initial Treatment|Adverse Event|7|||
44437194|NCT00754325|79446083|FG001|Initial Treatment|Adverse Event|6|||
44437195|NCT00754325|79446082|FG000|Initial Treatment|Withdrawal by Subject|2|||
44437196|NCT00754325|79446083|FG001|Initial Treatment|Withdrawal by Subject|2|||
44437197|NCT00754325|79446082|FG000|Initial Treatment|Physician Decision|2|||
44437198|NCT00754325|79446083|FG001|Initial Treatment|Physician Decision|0|||
44437199|NCT00754325|79446082|FG000|Initial Treatment|Sponsor Request|0|||
44437200|NCT00754325|79446083|FG001|Initial Treatment|Sponsor Request|1|||
44437201|NCT00754325|79446082|FG000|Initial Treatment|Disease Progression|35|||
44437202|NCT00754325|79446083|FG001|Initial Treatment|Disease Progression|35|||
44437203|NCT00524680|79446094|FG000|Overall Study|progression|0|||
44437204|NCT00524680|79446095|FG001|Overall Study|progression|0|||
44437205|NCT00524680|79446096|FG002|Overall Study|progression|0|||
44437206|NCT00524680|79446097|FG003|Overall Study|progression|1|||
44437207|NCT00524680|79446094|FG000|Overall Study|Adverse Event|2|||
44338098|NCT01077076|79342406|FG002|Third Intervention|Death in the participant's family|0|||
44338099|NCT01077076|79342407|FG003|Third Intervention|Death in the participant's family|0|||
44437208|NCT00524680|79446095|FG001|Overall Study|Adverse Event|0|||
44437209|NCT00524680|79446096|FG002|Overall Study|Adverse Event|0|||
44437210|NCT00524680|79446097|FG003|Overall Study|Adverse Event|1|||
44437211|NCT00524680|79446094|FG000|Overall Study|Other|0|||
44437212|NCT00524680|79446095|FG001|Overall Study|Other|1|||
44437213|NCT00524680|79446096|FG002|Overall Study|Other|2|||
44437214|NCT00524680|79446097|FG003|Overall Study|Other|3|||
44437215|NCT00524680|79446094|FG000|Overall Study|Withdrawal by Subject|1|||
44437216|NCT00524680|79446095|FG001|Overall Study|Withdrawal by Subject|0|||
44437217|NCT00524680|79446096|FG002|Overall Study|Withdrawal by Subject|1|||
44437218|NCT00524680|79446097|FG003|Overall Study|Withdrawal by Subject|1|||
44437219|NCT00628212|79446111|FG000|Overall Study|Adverse Event|2|||
44437220|NCT00628212|79446112|FG001|Overall Study|Adverse Event|0|||
44437221|NCT00628212|79446113|FG002|Overall Study|Adverse Event|1|||
44437222|NCT00628212|79446114|FG003|Overall Study|Adverse Event|2|||
44437223|NCT00628212|79446111|FG000|Overall Study|Physician Decision|1|||
44437224|NCT00628212|79446112|FG001|Overall Study|Physician Decision|1|||
44437225|NCT00628212|79446113|FG002|Overall Study|Physician Decision|2|||
44437226|NCT00628212|79446114|FG003|Overall Study|Physician Decision|3|||
44437227|NCT00298363|79446127|FG000|Overall Study|Lost to Follow-up|0|||
44437228|NCT00298363|79446128|FG001|Overall Study|Lost to Follow-up|0|||
44437229|NCT00298363|79446129|FG002|Overall Study|Lost to Follow-up|1|||
44437230|NCT00298363|79446127|FG000|Overall Study|Physician Decision|4|||
44437231|NCT00298363|79446128|FG001|Overall Study|Physician Decision|1|||
44437232|NCT00298363|79446129|FG002|Overall Study|Physician Decision|0|||
44437233|NCT00298363|79446127|FG000|Overall Study|Protocol Violation|1|||
44437234|NCT00298363|79446128|FG001|Overall Study|Protocol Violation|1|||
44437235|NCT00298363|79446129|FG002|Overall Study|Protocol Violation|0|||
44437236|NCT00298363|79446127|FG000|Overall Study|Withdrawal by Subject|5|||
44437237|NCT00298363|79446128|FG001|Overall Study|Withdrawal by Subject|1|||
44437238|NCT00298363|79446129|FG002|Overall Study|Withdrawal by Subject|3|||
44437239|NCT00298363|79446127|FG000|Overall Study|Adverse Event|5|||
44437240|NCT00298363|79446128|FG001|Overall Study|Adverse Event|2|||
44437241|NCT00298363|79446129|FG002|Overall Study|Adverse Event|2|||
44437242|NCT00298363|79446127|FG000|Overall Study|Lack of Efficacy|2|||
44437243|NCT00298363|79446128|FG001|Overall Study|Lack of Efficacy|3|||
44437244|NCT00298363|79446129|FG002|Overall Study|Lack of Efficacy|0|||
44437245|NCT00524368|79446145|FG000|Overall Study|Adverse Event|10|||
44437246|NCT00524368|79446146|FG001|Overall Study|Adverse Event|12|||
44437247|NCT00524368|79446145|FG000|Overall Study|Lost to Follow-up|9|||
44437248|NCT00524368|79446146|FG001|Overall Study|Lost to Follow-up|13|||
44437249|NCT00524368|79446145|FG000|Overall Study|Withdrawal by Subject|4|||
44338100|NCT01077076|79342408|FG004|Third Intervention|Death in the participant's family|0|||
44338101|NCT01077076|79342409|FG005|Third Intervention|Death in the participant's family|1|||
44338102|NCT01294800|79342421|FG000|Overall Study|Adverse Event|7|||
44338103|NCT01294800|79342422|FG001|Overall Study|Adverse Event|6|||
44338104|NCT01294800|79342423|FG002|Overall Study|Adverse Event|12|||
44338105|NCT01294800|79342424|FG003|Overall Study|Adverse Event|5|||
44338106|NCT01294800|79342421|FG000|Overall Study|Subject Withdrew Consent|2|||
44338107|NCT01294800|79342422|FG001|Overall Study|Subject Withdrew Consent|2|||
44338108|NCT01294800|79342423|FG002|Overall Study|Subject Withdrew Consent|2|||
44338109|NCT01294800|79342424|FG003|Overall Study|Subject Withdrew Consent|11|||
44338110|NCT01294800|79342421|FG000|Overall Study|Lost to Follow-up|0|||
44338111|NCT01294800|79342422|FG001|Overall Study|Lost to Follow-up|0|||
44338112|NCT01294800|79342423|FG002|Overall Study|Lost to Follow-up|1|||
44338113|NCT01294800|79342424|FG003|Overall Study|Lost to Follow-up|0|||
44338114|NCT01294800|79342421|FG000|Overall Study|Non-compliance With Protocol|0|||
44338115|NCT01294800|79342422|FG001|Overall Study|Non-compliance With Protocol|1|||
44338116|NCT01294800|79342423|FG002|Overall Study|Non-compliance With Protocol|1|||
44338117|NCT01294800|79342424|FG003|Overall Study|Non-compliance With Protocol|0|||
44437250|NCT00524368|79446146|FG001|Overall Study|Withdrawal by Subject|5|||
44437251|NCT00524368|79446145|FG000|Overall Study|Non-compliant|8|||
44437252|NCT00524368|79446146|FG001|Overall Study|Non-compliant|9|||
44437253|NCT00524368|79446145|FG000|Overall Study|Reached a Virologic Endpoint|3|||
44437254|NCT00524368|79446146|FG001|Overall Study|Reached a Virologic Endpoint|2|||
44437255|NCT00524368|79446145|FG000|Overall Study|Sponsor's Decision|2|||
44437256|NCT00524368|79446146|FG001|Overall Study|Sponsor's Decision|0|||
44259365|NCT02775903|79118934|FG000|Overall Study|Withdrawal by Subject|7|||
44259366|NCT02775903|79118935|FG001|Overall Study|Withdrawal by Subject|5|||
44259367|NCT02775903|79118936|FG002|Overall Study|Withdrawal by Subject|5|||
44259368|NCT02775903|79118937|FG003|Overall Study|Withdrawal by Subject|8|||
44259369|NCT02775903|79118934|FG000|Overall Study|Other reasons|7|||
44259370|NCT02775903|79118935|FG001|Overall Study|Other reasons|8|||
44259371|NCT02775903|79118936|FG002|Overall Study|Other reasons|2|||
44338118|NCT01294800|79342421|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
44338119|NCT01294800|79342422|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
44437257|NCT00524368|79446145|FG000|Overall Study|Ineligible to Continue the study|2|||
44437258|NCT00524368|79446146|FG001|Overall Study|Ineligible to Continue the study|5|||
44437259|NCT00524368|79446145|FG000|Overall Study|Other|3|||
44437260|NCT00524368|79446146|FG001|Overall Study|Other|2|||
44437261|NCT00777101|79446154|FG000|Overall Study|Death|48|||
44259372|NCT02775903|79118937|FG003|Overall Study|Other reasons|12|||
44437262|NCT00777101|79446155|FG001|Overall Study|Death|43|||
44338120|NCT01294800|79342423|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
44338121|NCT01294800|79342424|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
44338122|NCT01294644|79342437|FG000|Overall Study|Adverse Event|2|||
44338123|NCT01294644|79342438|FG001|Overall Study|Adverse Event|0|||
44338124|NCT01294644|79342439|FG002|Overall Study|Adverse Event|1|||
44338125|NCT01294644|79342437|FG000|Overall Study|Withdrawal by Subject|3|||
44338126|NCT01294644|79342438|FG001|Overall Study|Withdrawal by Subject|7|||
44437263|NCT00777101|79446154|FG000|Overall Study|Withdrawal by Subject|11|||
44437264|NCT00777101|79446155|FG001|Overall Study|Withdrawal by Subject|6|||
44437265|NCT00777101|79446154|FG000|Overall Study|Lost to Follow-up|2|||
44437266|NCT00777101|79446155|FG001|Overall Study|Lost to Follow-up|1|||
44437267|NCT00777101|79446154|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
44437268|NCT00777101|79446155|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
44437269|NCT00777101|79446154|FG000|Overall Study|Failed to Return|0|||
44437270|NCT00777101|79446155|FG001|Overall Study|Failed to Return|1|||
44437271|NCT00297427|79446164|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
44437272|NCT00297427|79446165|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
44437273|NCT00297427|79446164|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
44437274|NCT00297427|79446165|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
44437275|NCT00297427|79446164|FG000|Phase 1: Initial Intervention|Death|0|||
44437276|NCT00297427|79446165|FG001|Phase 1: Initial Intervention|Death|1|||
44437277|NCT00297427|79446164|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
44437278|NCT00297427|79446165|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
44437279|NCT00297427|79446164|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
44437280|NCT00297427|79446165|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
44437281|NCT00297427|79446164|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
44437282|NCT00297427|79446165|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
44437283|NCT00297427|79446164|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
44437284|NCT00297427|79446165|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
44437285|NCT00297427|79446164|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
44437286|NCT00297427|79446165|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
44437287|NCT00524134|79446179|FG000|Overall Study|Withdrawal by Subject|1|||
44437288|NCT00524134|79446179|FG000|Overall Study|Physician Decision|1|||
44437289|NCT00777023|79446186|FG000|Overall Study|Adverse Event|15|||
44437290|NCT00777023|79446187|FG001|Overall Study|Adverse Event|21|||
44437291|NCT00777023|79446188|FG002|Overall Study|Adverse Event|8|||
44437292|NCT00777023|79446186|FG000|Overall Study|Lack of Efficacy|1|||
44437293|NCT00777023|79446187|FG001|Overall Study|Lack of Efficacy|0|||
44437294|NCT00777023|79446188|FG002|Overall Study|Lack of Efficacy|14|||
44437295|NCT00777023|79446186|FG000|Overall Study|Protocol Violation|2|||
44437296|NCT00777023|79446187|FG001|Overall Study|Protocol Violation|1|||
44437297|NCT00777023|79446188|FG002|Overall Study|Protocol Violation|1|||
44437298|NCT00777023|79446186|FG000|Overall Study|Lost to Follow-up|2|||
44437299|NCT00777023|79446187|FG001|Overall Study|Lost to Follow-up|3|||
44437300|NCT00777023|79446188|FG002|Overall Study|Lost to Follow-up|3|||
44437301|NCT00777023|79446186|FG000|Overall Study|Death|0|||
44437302|NCT00777023|79446187|FG001|Overall Study|Death|1|||
44338127|NCT01294644|79342439|FG002|Overall Study|Withdrawal by Subject|4|||
44338128|NCT01294644|79342437|FG000|Overall Study|Lost to Follow-up|3|||
44338129|NCT01294644|79342438|FG001|Overall Study|Lost to Follow-up|2|||
44338130|NCT01294644|79342439|FG002|Overall Study|Lost to Follow-up|5|||
44338131|NCT01294644|79342437|FG000|Overall Study|Miscellaneous Reason|2|||
44338132|NCT01294644|79342438|FG001|Overall Study|Miscellaneous Reason|1|||
44338133|NCT01294644|79342439|FG002|Overall Study|Miscellaneous Reason|4|||
44338134|NCT01293240|79342447|FG000|Overall Study|Noncompliance|2|||
44338135|NCT01253265|79342456|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
44338136|NCT01253265|79342457|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
44338137|NCT01253265|79342458|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
44338138|NCT01253265|79342459|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
44338139|NCT01253265|79342460|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
44338140|NCT01253265|79342456|FG000|Overall Study|Withdrawal by Subject|0|||
44338141|NCT01253265|79342457|FG001|Overall Study|Withdrawal by Subject|0|||
44338142|NCT01253265|79342458|FG002|Overall Study|Withdrawal by Subject|0|||
44338143|NCT01253265|79342459|FG003|Overall Study|Withdrawal by Subject|0|||
44338144|NCT01253265|79342460|FG004|Overall Study|Withdrawal by Subject|1|||
44338145|NCT01293084|79342472|FG000|Overall Study|Physician Decision|3|||
44338146|NCT01293084|79342472|FG000|Overall Study|Withdrawal by Subject|2|||
44338147|NCT01293006|79342482|FG000|Period 2|Lost to Follow-up|1|||
44338148|NCT01293006|79342483|FG001|Period 2|Lost to Follow-up|0|||
44338149|NCT01293006|79342484|FG002|Period 2|Lost to Follow-up|0|||
44338150|NCT01293006|79342485|FG003|Period 2|Lost to Follow-up|0|||
44437303|NCT00777023|79446188|FG002|Overall Study|Death|0|||
44437304|NCT00777023|79446186|FG000|Overall Study|Withdrawal by Subject|7|||
44437305|NCT00777023|79446187|FG001|Overall Study|Withdrawal by Subject|7|||
44437306|NCT00777023|79446188|FG002|Overall Study|Withdrawal by Subject|8|||
44437307|NCT00777023|79446186|FG000|Overall Study|Missing data|1|||
44437308|NCT00777023|79446187|FG001|Overall Study|Missing data|1|||
44437309|NCT00777023|79446188|FG002|Overall Study|Missing data|0|||
44437310|NCT00777023|79446186|FG000|Overall Study|Reasons not specified|4|||
44437311|NCT00777023|79446187|FG001|Overall Study|Reasons not specified|4|||
44437312|NCT00777023|79446188|FG002|Overall Study|Reasons not specified|2|||
44437313|NCT00777023|79446186|FG000|Overall Study|Last dose date unknown|3|||
44437314|NCT00777023|79446187|FG001|Overall Study|Last dose date unknown|3|||
44437315|NCT00777023|79446188|FG002|Overall Study|Last dose date unknown|1|||
44437316|NCT00297037|79446198|FG000|Overall Study|Withdrawal by Subject|2|||
44437317|NCT00297037|79446199|FG001|Overall Study|Withdrawal by Subject|0|||
44437318|NCT00292981|79446207|FG000|Overall Study|Adverse Event|1|||
44437319|NCT00292981|79446207|FG000|Overall Study|Lost to Follow-up|13|||
44437320|NCT00292981|79446207|FG000|Overall Study|Withdrawal by Subject|22|||
44437321|NCT00292981|79446207|FG000|Overall Study|Other|3|||
44437322|NCT00296725|79446211|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
44437323|NCT00296725|79446211|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
44437324|NCT00296725|79446211|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
44437325|NCT00625872|79446219|FG000|Overall Study|Withdrawal by Subject|1|||
44437326|NCT00625872|79446220|FG001|Overall Study|Withdrawal by Subject|0|||
44338151|NCT01253187|79342504|FG000|Period 2|Withdrawal by Subject|0|||
44338152|NCT01253187|79342505|FG001|Period 2|Withdrawal by Subject|0|||
44338153|NCT01253187|79342506|FG002|Period 2|Withdrawal by Subject|0|||
44338154|NCT01253187|79342507|FG003|Period 2|Withdrawal by Subject|0|||
44338155|NCT01253187|79342508|FG004|Period 2|Withdrawal by Subject|1|||
44338156|NCT01253187|79342509|FG005|Period 2|Withdrawal by Subject|0|||
44338157|NCT01253187|79342504|FG000|Period 3|Pregnancy|1|||
44338158|NCT01253187|79342505|FG001|Period 3|Pregnancy|0|||
44338159|NCT01253187|79342506|FG002|Period 3|Pregnancy|0|||
44338160|NCT01253187|79342507|FG003|Period 3|Pregnancy|0|||
44338161|NCT01253187|79342508|FG004|Period 3|Pregnancy|0|||
44338162|NCT01253187|79342509|FG005|Period 3|Pregnancy|0|||
44338163|NCT01253187|79342504|FG000|Period 3|difficulty with blood sampling|0|||
44338164|NCT01253187|79342505|FG001|Period 3|difficulty with blood sampling|1|||
44437327|NCT00625872|79446219|FG000|Overall Study|Does not meet inclusion criteria|1|||
44437328|NCT00625872|79446220|FG001|Overall Study|Does not meet inclusion criteria|0|||
44437329|NCT00625872|79446219|FG000|Overall Study|Terminated by sponsor|2|||
44437330|NCT00625872|79446220|FG001|Overall Study|Terminated by sponsor|5|||
44437331|NCT00625872|79446219|FG000|Overall Study|Randomized but not treated|0|||
44437332|NCT00625872|79446220|FG001|Overall Study|Randomized but not treated|1|||
44437333|NCT00523978|79446228|FG000|Overall Study|Withdrawal by Subject|3|||
44437334|NCT00523978|79446229|FG001|Overall Study|Withdrawal by Subject|7|||
44437335|NCT00523978|79446228|FG000|Overall Study|Screen Failures|5|||
44437336|NCT00523978|79446229|FG001|Overall Study|Screen Failures|1|||
44437337|NCT00523978|79446228|FG000|Overall Study|Death|1|||
44437338|NCT00523978|79446229|FG001|Overall Study|Death|0|||
44437339|NCT00296647|79446241|FG000|Overall Study|Death|4|||
44437340|NCT00296647|79446242|FG001|Overall Study|Death|1|||
44437341|NCT00296647|79446243|FG002|Overall Study|Death|2|||
44437342|NCT00296647|79446244|FG003|Overall Study|Death|1|||
44437343|NCT00296647|79446245|FG004|Overall Study|Death|1|||
44437344|NCT00296647|79446241|FG000|Overall Study|Withdrawal by Subject|28|||
44437345|NCT00296647|79446242|FG001|Overall Study|Withdrawal by Subject|27|||
44437346|NCT00296647|79446243|FG002|Overall Study|Withdrawal by Subject|32|||
44437347|NCT00296647|79446244|FG003|Overall Study|Withdrawal by Subject|16|||
44437348|NCT00296647|79446245|FG004|Overall Study|Withdrawal by Subject|19|||
44437349|NCT00754013|79446259|FG000|Overall Study|Lost to Follow-up|1|||
44437350|NCT00754013|79446260|FG001|Overall Study|Lost to Follow-up|1|||
44338165|NCT01253187|79342506|FG002|Period 3|difficulty with blood sampling|0|||
44338166|NCT01253187|79342507|FG003|Period 3|difficulty with blood sampling|0|||
44338167|NCT01253187|79342508|FG004|Period 3|difficulty with blood sampling|0|||
44338168|NCT01253187|79342509|FG005|Period 3|difficulty with blood sampling|0|||
44437351|NCT00754013|79446259|FG000|Overall Study|didn't return after study termed|3|||
44437352|NCT00754013|79446260|FG001|Overall Study|didn't return after study termed|4|||
44437353|NCT00523744|79446266|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
44338169|NCT01253187|79342504|FG000|Period 3|non-compliance|0|||
44437354|NCT00523744|79446266|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
44338170|NCT01253187|79342505|FG001|Period 3|non-compliance|0|||
44437355|NCT00523744|79446266|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
44437356|NCT00523744|79446266|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
44437357|NCT00523744|79446266|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
44437358|NCT00523744|79446266|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
44437359|NCT00752219|79446284|FG000|Overall Study|Clinical failure|0|||
44437360|NCT00752219|79446285|FG001|Overall Study|Clinical failure|1|||
44437361|NCT00752219|79446284|FG000|Overall Study|Adverse Event|5|||
44437362|NCT00752219|79446285|FG001|Overall Study|Adverse Event|3|||
44437363|NCT00752219|79446284|FG000|Overall Study|Protocol deviation|1|||
44437364|NCT00752219|79446285|FG001|Overall Study|Protocol deviation|0|||
44437365|NCT00752219|79446284|FG000|Overall Study|Lost to Follow-up|1|||
44437366|NCT00752219|79446285|FG001|Overall Study|Lost to Follow-up|2|||
44437367|NCT00752219|79446284|FG000|Overall Study|Randomized but not treated|1|||
44437368|NCT00752219|79446285|FG001|Overall Study|Randomized but not treated|0|||
44437369|NCT00752219|79446284|FG000|Overall Study|Other|3|||
44437370|NCT00752219|79446285|FG001|Overall Study|Other|0|||
44437371|NCT00622908|79446293|FG000|Overall Study|Protocol Violation|1|||
44437372|NCT00622908|79446294|FG001|Overall Study|Protocol Violation|0|||
44437373|NCT00622908|79446293|FG000|Overall Study|Adverse Event|0|||
44437374|NCT00622908|79446294|FG001|Overall Study|Adverse Event|1|||
44437375|NCT00622908|79446293|FG000|Overall Study|Lack of Efficacy|1|||
44437376|NCT00622908|79446294|FG001|Overall Study|Lack of Efficacy|7|||
44437377|NCT00622908|79446293|FG000|Overall Study|Lost to Follow-up|1|||
44437378|NCT00622908|79446294|FG001|Overall Study|Lost to Follow-up|0|||
44437379|NCT00622908|79446293|FG000|Overall Study|Refusal|0|||
44437380|NCT00622908|79446294|FG001|Overall Study|Refusal|1|||
44437381|NCT00622908|79446293|FG000|Overall Study|Termination by study sponser|0|||
44437382|NCT00622908|79446294|FG001|Overall Study|Termination by study sponser|1|||
44437383|NCT00296491|79446304|FG000|Overall Study|Low Pollen Counts|18|||
44437384|NCT00296491|79446305|FG001|Overall Study|Low Pollen Counts|26|||
44437385|NCT00296491|79446306|FG002|Overall Study|Low Pollen Counts|25|||
44437386|NCT00296491|79446307|FG003|Overall Study|Low Pollen Counts|16|||
44437387|NCT00296491|79446304|FG000|Overall Study|Protocol Violation|4|||
44437388|NCT00296491|79446305|FG001|Overall Study|Protocol Violation|6|||
44437389|NCT00296491|79446306|FG002|Overall Study|Protocol Violation|2|||
44437390|NCT00296491|79446307|FG003|Overall Study|Protocol Violation|3|||
44437391|NCT00296491|79446304|FG000|Overall Study|Adverse Event|1|||
44437392|NCT00296491|79446305|FG001|Overall Study|Adverse Event|3|||
44437393|NCT00296491|79446306|FG002|Overall Study|Adverse Event|1|||
44437394|NCT00296491|79446307|FG003|Overall Study|Adverse Event|4|||
44437395|NCT00296491|79446304|FG000|Overall Study|Withdrawn due to Asthma|0|||
44437396|NCT00296491|79446305|FG001|Overall Study|Withdrawn due to Asthma|0|||
44437397|NCT00296491|79446306|FG002|Overall Study|Withdrawn due to Asthma|0|||
44437398|NCT00296491|79446307|FG003|Overall Study|Withdrawn due to Asthma|4|||
44437399|NCT00296491|79446304|FG000|Overall Study|Withdrawal by Subject|7|||
44437400|NCT00296491|79446305|FG001|Overall Study|Withdrawal by Subject|3|||
44437401|NCT00296491|79446306|FG002|Overall Study|Withdrawal by Subject|3|||
44437402|NCT00296491|79446307|FG003|Overall Study|Withdrawal by Subject|2|||
44437403|NCT00296491|79446304|FG000|Overall Study|Non-Compliance|12|||
44437404|NCT00296491|79446305|FG001|Overall Study|Non-Compliance|13|||
44437405|NCT00296491|79446306|FG002|Overall Study|Non-Compliance|10|||
44437406|NCT00296491|79446307|FG003|Overall Study|Non-Compliance|14|||
44437407|NCT00296491|79446304|FG000|Overall Study|Lost to Follow-up|0|||
44437408|NCT00296491|79446305|FG001|Overall Study|Lost to Follow-up|2|||
44437409|NCT00296491|79446306|FG002|Overall Study|Lost to Follow-up|2|||
44437410|NCT00296491|79446307|FG003|Overall Study|Lost to Follow-up|0|||
44437411|NCT00747617|79446326|FG000|Overall Study|Lost to Follow-up|3|||
44437412|NCT00747617|79446327|FG001|Overall Study|Lost to Follow-up|1|||
44437413|NCT00296335|79446335|FG000|Overall Study|Recurrence|3|||
44437414|NCT00296335|79446336|FG001|Overall Study|Recurrence|51|||
44437415|NCT00296335|79446335|FG000|Overall Study|Adverse Event|17|||
44338171|NCT01253187|79342506|FG002|Period 3|non-compliance|0|||
44338172|NCT01253187|79342507|FG003|Period 3|non-compliance|0|||
44338173|NCT01253187|79342508|FG004|Period 3|non-compliance|1|||
44338174|NCT01253187|79342509|FG005|Period 3|non-compliance|0|||
44338175|NCT01252563|79342520|FG000|Overall Study|Contract Deviation|41|||
44338176|NCT01252563|79342520|FG000|Overall Study|Centralized Registration Deviation|30|||
44338177|NCT01252563|79342520|FG000|Overall Study|Lost to Follow-up|161|||
44338178|NCT01252563|79342520|FG000|Overall Study|No visit after first day of treatment|194|||
44338179|NCT01252563|79342520|FG000|Overall Study|No drug administration|6|||
44437416|NCT00296335|79446336|FG001|Overall Study|Adverse Event|27|||
44437417|NCT00296335|79446335|FG000|Overall Study|Lost to Follow-up|7|||
44338180|NCT01292226|79342555|FG000|Overall Study|Adverse Event|5|||
44437418|NCT00296335|79446336|FG001|Overall Study|Lost to Follow-up|33|||
44437419|NCT00296335|79446335|FG000|Overall Study|Physician Decision|3|||
44437420|NCT00296335|79446336|FG001|Overall Study|Physician Decision|11|||
44437421|NCT00747461|79446344|FG000|Overall Study|study terminated by sponsor|5|||
44437422|NCT03683758|79446351|FG000|Overall Study|Non-study commitment conflict|1|||
44338181|NCT01292226|79342555|FG000|Overall Study|Death|1|||
44437423|NCT03683758|79446352|FG001|Overall Study|Non-study commitment conflict|3|||
44437424|NCT03683758|79446351|FG000|Overall Study|Illness preventing participation|1|||
44437425|NCT03683758|79446352|FG001|Overall Study|Illness preventing participation|0|||
44338182|NCT01292226|79342555|FG000|Overall Study|Graft loss|1|||
44437426|NCT03683758|79446351|FG000|Overall Study|Adverse Event|1|||
44437427|NCT03683758|79446352|FG001|Overall Study|Adverse Event|0|||
44437428|NCT00522418|79446360|FG000|Overall Study|Local IRB Consent Violation|5|||
44437429|NCT00522418|79446361|FG001|Overall Study|Local IRB Consent Violation|5|||
44437430|NCT00522418|79446360|FG000|Overall Study|Early Study Termination|46|||
44437431|NCT00522418|79446361|FG001|Overall Study|Early Study Termination|47|||
44437432|NCT00522418|79446360|FG000|Overall Study|Noncompliance|2|||
44437433|NCT00522418|79446361|FG001|Overall Study|Noncompliance|2|||
44437434|NCT00522418|79446360|FG000|Overall Study|Reason Not Specified|3|||
44437435|NCT00522418|79446361|FG001|Overall Study|Reason Not Specified|1|||
44437436|NCT00522418|79446360|FG000|Overall Study|Consent Withdraw|1|||
44437437|NCT00522418|79446361|FG001|Overall Study|Consent Withdraw|2|||
44437438|NCT00522418|79446360|FG000|Overall Study|Lack of Efficacy|0|||
44437439|NCT00522418|79446361|FG001|Overall Study|Lack of Efficacy|1|||
44437440|NCT00624780|79446375|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
44437441|NCT00624780|79446376|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
44437442|NCT00624780|79446377|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
44437443|NCT00624780|79446378|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
44437444|NCT00624780|79446379|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
44437445|NCT00624780|79446380|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
44338183|NCT01292226|79342555|FG000|Overall Study|Protocol Violation|3|||
44338184|NCT01292226|79342555|FG000|Overall Study|Withdrawal by Subject|1|||
44338185|NCT01292226|79342555|FG000|Overall Study|Other|2|||
44437446|NCT00624780|79446375|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
44437447|NCT00624780|79446376|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
44437448|NCT00624780|79446377|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
44437449|NCT00624780|79446378|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
44437450|NCT00624780|79446379|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
44437451|NCT00624780|79446380|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
44437452|NCT00624780|79446375|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
44437453|NCT00624780|79446376|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
44437454|NCT00624780|79446377|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
44437455|NCT00624780|79446378|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
44437456|NCT00624780|79446379|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
44437457|NCT00624780|79446380|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
44437458|NCT00624780|79446375|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
44437459|NCT00624780|79446376|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
44338186|NCT01290822|79342559|FG000|Overall Study|Withdrawal by Subject|1|||
44338187|NCT01290822|79342559|FG000|Overall Study|Physician Decision|10|||
44338188|NCT01075048|79342566|FG000|Overall Study|Death|4|||
44338189|NCT01075048|79342567|FG001|Overall Study|Death|17|||
44338190|NCT01075048|79342568|FG002|Overall Study|Death|12|||
44338191|NCT01075048|79342566|FG000|Overall Study|Start of other or new therapy|4|||
44338192|NCT01075048|79342567|FG001|Overall Study|Start of other or new therapy|36|||
44338193|NCT01075048|79342568|FG002|Overall Study|Start of other or new therapy|46|||
44338194|NCT01075048|79342566|FG000|Overall Study|Withdrawal by Subject|1|||
44338195|NCT01075048|79342567|FG001|Overall Study|Withdrawal by Subject|6|||
44338196|NCT01075048|79342568|FG002|Overall Study|Withdrawal by Subject|3|||
44338197|NCT01075048|79342566|FG000|Overall Study|Lost to Follow-up|0|||
44338198|NCT01075048|79342567|FG001|Overall Study|Lost to Follow-up|1|||
44338199|NCT01075048|79342568|FG002|Overall Study|Lost to Follow-up|1|||
44338200|NCT01290666|79342579|FG000|Overall Study|Lost to Follow-up|11|||
44338201|NCT01290666|79342579|FG000|Overall Study|Withdrawal by Subject|23|||
44338202|NCT01290666|79342579|FG000|Overall Study|Early Termination of Study|4|||
44338203|NCT01252251|79342583|FG000|Overall Study|Withdrawal by Subject|1|||
44338204|NCT01289574|79342590|FG000|Overall Study|Lack of Efficacy|4|||
44338205|NCT01289574|79342591|FG001|Overall Study|Lack of Efficacy|0|||
44338206|NCT01289574|79342592|FG002|Overall Study|Lack of Efficacy|1|||
44338207|NCT01289574|79342590|FG000|Overall Study|Lost to Follow-up|2|||
44338208|NCT01289574|79342591|FG001|Overall Study|Lost to Follow-up|0|||
44338209|NCT01289574|79342592|FG002|Overall Study|Lost to Follow-up|1|||
44338210|NCT01289574|79342590|FG000|Overall Study|Withdrawal by Subject|1|||
44338211|NCT01289574|79342591|FG001|Overall Study|Withdrawal by Subject|1|||
44338212|NCT01289574|79342592|FG002|Overall Study|Withdrawal by Subject|1|||
44338213|NCT01289574|79342590|FG000|Overall Study|Adverse Event|0|||
44338214|NCT01289574|79342591|FG001|Overall Study|Adverse Event|1|||
44338215|NCT01289574|79342592|FG002|Overall Study|Adverse Event|0|||
44338216|NCT01289574|79342590|FG000|Overall Study|Subject wanted alternate treatment|0|||
44338217|NCT01289574|79342591|FG001|Overall Study|Subject wanted alternate treatment|1|||
44338218|NCT01289574|79342592|FG002|Overall Study|Subject wanted alternate treatment|0|||
44338219|NCT01252095|79342603|FG000|Overall Study|Disease progression|1|||
44338220|NCT01252095|79342604|FG001|Overall Study|Disease progression|0|||
44338221|NCT01289418|79342613|FG000|Day 8 Survey|email address invalid|283|||
44338222|NCT01289418|79342613|FG000|Day 8 Survey|participants did not complete the survey|1935|||
44338223|NCT01289418|79342613|FG000|Day 29 Survey|email address invalid|283|||
44437460|NCT00624780|79446377|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
44437461|NCT00624780|79446378|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
44437462|NCT00624780|79446379|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
44437463|NCT00624780|79446380|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
44437464|NCT00624780|79446375|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
44437465|NCT00624780|79446376|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
44437466|NCT00624780|79446377|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
44437467|NCT00624780|79446378|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
44437468|NCT00624780|79446379|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
44437469|NCT00624780|79446380|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
44437470|NCT00624780|79446375|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
44437471|NCT00624780|79446376|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
44338224|NCT01289418|79342613|FG000|Day 29 Survey|participants did not complete the survey|2185|||
44338225|NCT01074658|79342619|FG000|Overall Study|No implant attempted|19|||
44338226|NCT01074502|79342623|FG000|Overall Study|Withdrawal by Subject|1|||
44338227|NCT01289028|79342627|FG000|Overall Study|Progressive Disease|49|||
44338228|NCT01289028|79342627|FG000|Overall Study|Adverse Event|14|||
44338229|NCT01289028|79342627|FG000|Overall Study|Withdrawal by Subject|6|||
44338230|NCT01289028|79342627|FG000|Overall Study|Death|4|||
44338231|NCT01289028|79342627|FG000|Overall Study|Lack of Efficacy|2|||
44338232|NCT01289028|79342627|FG000|Overall Study|No longer required|2|||
44437472|NCT00624780|79446377|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
44437473|NCT00624780|79446378|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
44437474|NCT00624780|79446379|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
44437475|NCT00624780|79446380|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
44437476|NCT00624780|79446375|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
44437477|NCT00624780|79446376|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
44437478|NCT00624780|79446377|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
44437479|NCT00624780|79446378|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
44437480|NCT00624780|79446379|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
44437481|NCT00624780|79446380|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
44437482|NCT00624780|79446375|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
44437483|NCT00624780|79446376|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
44437484|NCT00624780|79446377|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
44437485|NCT00624780|79446378|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
44437486|NCT00624780|79446379|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
44437487|NCT00624780|79446380|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
44437488|NCT00624780|79446375|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
44437489|NCT00624780|79446376|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
44437490|NCT00624780|79446377|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
44437491|NCT00624780|79446378|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
44437492|NCT00624780|79446379|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
44437493|NCT00624780|79446380|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
44437494|NCT00624780|79446375|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
44437495|NCT00624780|79446376|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
44437496|NCT00624780|79446377|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
44437497|NCT00624780|79446378|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
44338233|NCT01289028|79342627|FG000|Overall Study|Lost to Follow-up|2|||
44338234|NCT01289028|79342627|FG000|Overall Study|New Cancer Therapy|2|||
44338235|NCT01289028|79342627|FG000|Overall Study|Abnormal Lab Value|1|||
44338236|NCT01289028|79342627|FG000|Overall Study|Missing reason for discon|1|||
44437498|NCT00624780|79446379|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
44437499|NCT00624780|79446380|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
44540600|NCT03697993|79552678|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
44540601|NCT03697993|79552677|FG000|Overall Study|Lost to Follow-up|3|||
44540602|NCT03697993|79552678|FG001|Overall Study|Lost to Follow-up|0|||
44540603|NCT03697993|79552677|FG000|Overall Study|Physician Decision|4|||
44540604|NCT03697993|79552678|FG001|Overall Study|Physician Decision|0|||
44540605|NCT03697993|79552677|FG000|Overall Study|Initial Urine Culture Negative|0|||
44540606|NCT03697993|79552678|FG001|Overall Study|Initial Urine Culture Negative|1|||
44338237|NCT01250925|79342636|FG000|Overall Study|Lost to Follow-up|1|||
44338238|NCT01250925|79342637|FG001|Overall Study|Lost to Follow-up|1|||
44437500|NCT00624780|79446375|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
44437501|NCT00624780|79446376|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
44437502|NCT00624780|79446377|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
44437503|NCT00624780|79446378|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
44437504|NCT00624780|79446379|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
44540607|NCT03289455|79552688|FG000|Overall Study|Death|1|||
44338239|NCT01250925|79342638|FG002|Overall Study|Lost to Follow-up|0|||
44338240|NCT01250925|79342636|FG000|Overall Study|Withdrawal by Subject|2|||
44338241|NCT01250925|79342637|FG001|Overall Study|Withdrawal by Subject|0|||
44338242|NCT01250925|79342638|FG002|Overall Study|Withdrawal by Subject|0|||
44338243|NCT01250925|79342636|FG000|Overall Study|Protocol Violation|2|||
44338244|NCT01250925|79342637|FG001|Overall Study|Protocol Violation|0|||
44338245|NCT01250925|79342638|FG002|Overall Study|Protocol Violation|0|||
44338246|NCT01250925|79342636|FG000|Overall Study|Physician Decision|0|||
44338247|NCT01250925|79342637|FG001|Overall Study|Physician Decision|2|||
44338248|NCT01250925|79342638|FG002|Overall Study|Physician Decision|1|||
44338249|NCT01250925|79342636|FG000|Overall Study|Adverse Event|0|||
44338250|NCT01250925|79342637|FG001|Overall Study|Adverse Event|0|||
44437505|NCT00624780|79446380|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
44437506|NCT00624780|79446375|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
44338251|NCT01250925|79342638|FG002|Overall Study|Adverse Event|1|||
44437507|NCT00624780|79446376|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
44437508|NCT00624780|79446377|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
44437509|NCT00624780|79446378|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
44437510|NCT00624780|79446379|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
44437511|NCT00624780|79446380|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
44437512|NCT00624780|79446375|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
44437513|NCT00624780|79446376|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
44437514|NCT00624780|79446377|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
44437515|NCT00624780|79446378|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
44437516|NCT00624780|79446379|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
44437517|NCT00624780|79446380|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
44437518|NCT00624780|79446375|FG000|Follow-up (Week 26)|Death|0|||
44437519|NCT00624780|79446376|FG001|Follow-up (Week 26)|Death|0|||
44437520|NCT00624780|79446377|FG002|Follow-up (Week 26)|Death|1|||
44437521|NCT00624780|79446378|FG003|Follow-up (Week 26)|Death|0|||
44437522|NCT00624780|79446379|FG004|Follow-up (Week 26)|Death|0|||
44540608|NCT03289455|79552689|FG001|Overall Study|Death|0|||
44540609|NCT03289455|79552690|FG002|Overall Study|Death|0|||
44540610|NCT03289455|79552688|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
44540611|NCT03289455|79552689|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
44540612|NCT03289455|79552690|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
44540613|NCT03289455|79552688|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
44540614|NCT03289455|79552689|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
44540615|NCT03289455|79552690|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
44540616|NCT03289455|79552688|FG000|Overall Study|Progressive disease|3|||
44540617|NCT03289455|79552689|FG001|Overall Study|Progressive disease|4|||
44540618|NCT03289455|79552690|FG002|Overall Study|Progressive disease|5|||
44540619|NCT04484857|79552699|FG000|Overall Study|Adverse Event|2|||
44540620|NCT04484857|79552699|FG000|Overall Study|Death|10|||
44540621|NCT04484857|79552699|FG000|Overall Study|Withdrawal by Subject|3|||
44540622|NCT04484857|79552699|FG000|Overall Study|Transferred/Relocation|5|||
44540623|NCT04484857|79552699|FG000|Overall Study|Kidney Transplant|7|||
44540624|NCT04484857|79552699|FG000|Overall Study|Other than specified|4|||
44540625|NCT04484857|79552699|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
44540626|NCT04095793|79552703|FG000|Overall Study|Adverse Event|3|||
44540627|NCT04095793|79552703|FG000|Overall Study|Study Terminated by Sponsor|103|||
44540628|NCT04095793|79552703|FG000|Overall Study|Withdrawal by Subject|4|||
44540629|NCT04482439|79552707|FG000|Overall Study|Lost to Follow-up|1|||
44540630|NCT04482439|79552707|FG000|Overall Study|Unrelated illness|1|||
44540631|NCT04535947|79552714|FG000|Overall Study|Adverse Event|1|||
44540632|NCT04535947|79552715|FG001|Overall Study|Adverse Event|4|||
44540633|NCT04535947|79552714|FG000|Overall Study|Other reasons not specified|2|||
44540634|NCT04535947|79552715|FG001|Overall Study|Other reasons not specified|0|||
44540635|NCT04535947|79552714|FG000|Overall Study|Withdrawal by Subject|1|||
44540636|NCT04535947|79552715|FG001|Overall Study|Withdrawal by Subject|1|||
44540637|NCT04474405|79552727|FG000|Overall Study|Withdrawal by Subject|0|||
44540638|NCT04474405|79552728|FG001|Overall Study|Withdrawal by Subject|0|||
44437523|NCT00624780|79446380|FG005|Follow-up (Week 26)|Death|0|||
44437524|NCT00624780|79446375|FG000|Follow-up (Week 26)|Adverse Event|0|||
44437525|NCT00624780|79446376|FG001|Follow-up (Week 26)|Adverse Event|0|||
44540639|NCT04474405|79552729|FG002|Overall Study|Withdrawal by Subject|1|||
44540640|NCT04474405|79552730|FG003|Overall Study|Withdrawal by Subject|0|||
44540641|NCT04474405|79552731|FG004|Overall Study|Withdrawal by Subject|1|||
44540642|NCT04474405|79552732|FG005|Overall Study|Withdrawal by Subject|0|||
44540643|NCT04474405|79552727|FG000|Overall Study|Other|0|||
44437526|NCT00624780|79446377|FG002|Follow-up (Week 26)|Adverse Event|0|||
44437527|NCT00624780|79446378|FG003|Follow-up (Week 26)|Adverse Event|0|||
44540644|NCT04474405|79552728|FG001|Overall Study|Other|0|||
44338252|NCT01285908|79342646|FG000|Baseline Measurement|unable to insert catheter|1|||
44540645|NCT04474405|79552729|FG002|Overall Study|Other|0|||
44540646|NCT04474405|79552730|FG003|Overall Study|Other|0|||
44437528|NCT00624780|79446379|FG004|Follow-up (Week 26)|Adverse Event|1|||
44338253|NCT01285908|79342647|FG001|Baseline Measurement|unable to insert catheter|0|||
44338254|NCT01285908|79342648|FG002|Baseline Measurement|unable to insert catheter|0|||
44338255|NCT01285908|79342646|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
44338256|NCT01285908|79342647|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
44437529|NCT00624780|79446380|FG005|Follow-up (Week 26)|Adverse Event|0|||
44437530|NCT00624780|79446375|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
44437531|NCT00624780|79446376|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
44437532|NCT00624780|79446377|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
44437533|NCT00624780|79446378|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
44437534|NCT00624780|79446379|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
44437535|NCT00624780|79446380|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
44437536|NCT00624780|79446375|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
44437537|NCT00624780|79446376|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
44437538|NCT00624780|79446377|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
44437539|NCT00624780|79446378|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
44437540|NCT00624780|79446379|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
44437541|NCT00624780|79446380|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
44437542|NCT00624780|79446375|FG000|Follow-up (Week 26)|Other|1|||
44437543|NCT00624780|79446376|FG001|Follow-up (Week 26)|Other|1|||
44437544|NCT00624780|79446377|FG002|Follow-up (Week 26)|Other|0|||
44437545|NCT00624780|79446378|FG003|Follow-up (Week 26)|Other|0|||
44437546|NCT00624780|79446379|FG004|Follow-up (Week 26)|Other|0|||
44437547|NCT00624780|79446380|FG005|Follow-up (Week 26)|Other|0|||
44437548|NCT00750893|79446397|FG000|Overall Study|Adverse Event|5|||
44437549|NCT00750893|79446397|FG000|Overall Study|Withdrawal by Subject|10|||
44437550|NCT00750893|79446397|FG000|Overall Study|Lost to Follow-up|510|||
44437551|NCT00750893|79446397|FG000|Overall Study|Other|17|||
44437552|NCT00753623|79446403|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
44437553|NCT00753623|79446404|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
44437554|NCT00753623|79446403|FG000|Phase I (14 Days)|Physician Decision|1|||
44437555|NCT00753623|79446404|FG001|Phase I (14 Days)|Physician Decision|2|||
44437556|NCT00753623|79446403|FG000|Phase I (14 Days)|Adverse Event|0|||
44437557|NCT00753623|79446404|FG001|Phase I (14 Days)|Adverse Event|1|||
44437558|NCT00753623|79446403|FG000|Washout (7 Days)|Physician Decision|1|||
44437559|NCT00753623|79446404|FG001|Washout (7 Days)|Physician Decision|0|||
44437560|NCT00753623|79446403|FG000|Phase II (14 Days)|Physician Decision|0|||
44437561|NCT00753623|79446404|FG001|Phase II (14 Days)|Physician Decision|1|||
44437562|NCT00750737|79446412|FG000|Overall Study|Withdrawal by Subject|3|||
44437563|NCT00750737|79446413|FG001|Overall Study|Withdrawal by Subject|3|||
44437564|NCT00622440|79446421|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
44437565|NCT00622440|79446422|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
44437566|NCT00622440|79446421|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
44437567|NCT00622440|79446422|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
44437568|NCT00622440|79446421|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
44540647|NCT04474405|79552731|FG004|Overall Study|Other|3|||
44540648|NCT04474405|79552732|FG005|Overall Study|Other|0|||
44540649|NCT04531813|79552746|FG000|Overall Study|Protocol Violation|1|||
44540650|NCT04531813|79552746|FG000|Overall Study|Withdrawal by Subject|1|||
44540651|NCT03538444|79552752|FG000|Overall Study|opioid withdrawal|1|||
44540652|NCT03538444|79552753|FG001|Overall Study|opioid withdrawal|0|||
44540653|NCT01199302|79552763|FG000|Overall Study|Adverse Event|1|||
44540654|NCT01199302|79552764|FG001|Overall Study|Adverse Event|1|||
44540655|NCT01199302|79552765|FG002|Overall Study|Adverse Event|2|||
44540656|NCT01199302|79552766|FG003|Overall Study|Adverse Event|0|||
44540657|NCT01199302|79552763|FG000|Overall Study|Withdrawal by Subject|2|||
44540658|NCT01199302|79552764|FG001|Overall Study|Withdrawal by Subject|2|||
44540659|NCT01199302|79552765|FG002|Overall Study|Withdrawal by Subject|3|||
44540660|NCT01199302|79552766|FG003|Overall Study|Withdrawal by Subject|0|||
44338257|NCT01285908|79342648|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
44338258|NCT01285908|79342646|FG000|Baseline Measurement|unable to tolerate procedure|1|||
44338259|NCT01285908|79342647|FG001|Baseline Measurement|unable to tolerate procedure|0|||
44540661|NCT01199302|79552763|FG000|Overall Study|Disease Progression|3|||
44540662|NCT01199302|79552764|FG001|Overall Study|Disease Progression|4|||
44540663|NCT01199302|79552765|FG002|Overall Study|Disease Progression|4|||
44338260|NCT01285908|79342648|FG002|Baseline Measurement|unable to tolerate procedure|0|||
44338261|NCT01250769|79342682|FG000|Overall Study|Withdrawal by Subject|0|||
44437569|NCT00622440|79446422|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
44540664|NCT01199302|79552766|FG003|Overall Study|Disease Progression|2|||
44540665|NCT01199302|79552763|FG000|Overall Study|Study Termination|13|||
44437570|NCT00622440|79446421|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
44437571|NCT00622440|79446422|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
44437572|NCT00744653|79446428|FG000|Overall Study|antineoplastic treatment|11|||
44437573|NCT00744653|79446428|FG000|Overall Study|Death|1|||
44540666|NCT01199302|79552764|FG001|Overall Study|Study Termination|8|||
44338262|NCT01250769|79342683|FG001|Overall Study|Withdrawal by Subject|1|||
44338263|NCT01250769|79342684|FG002|Overall Study|Withdrawal by Subject|1|||
44338264|NCT01250769|79342685|FG003|Overall Study|Withdrawal by Subject|0|||
44338265|NCT01250769|79342682|FG000|Overall Study|Adverse Event|0|||
44338266|NCT01250769|79342683|FG001|Overall Study|Adverse Event|0|||
44338267|NCT01250769|79342684|FG002|Overall Study|Adverse Event|1|||
44338268|NCT01250769|79342685|FG003|Overall Study|Adverse Event|0|||
44338269|NCT01074268|79342697|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
44437574|NCT00744653|79446428|FG000|Overall Study|Lost to Follow-up|1|||
44437575|NCT00744653|79446428|FG000|Overall Study|Physician Decision|3|||
44437576|NCT00311311|79446435|FG000|Overall Study|Adverse Event|3|||
44437577|NCT00311311|79446436|FG001|Overall Study|Adverse Event|2|||
44437578|NCT00311311|79446435|FG000|Overall Study|Withdrawal by Subject|1|||
44437579|NCT00311311|79446436|FG001|Overall Study|Withdrawal by Subject|1|||
44338270|NCT01074268|79342698|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
44338271|NCT01074268|79342697|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
44338272|NCT01074268|79342698|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
44338273|NCT01074268|79342697|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
44338274|NCT01074268|79342698|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
44338275|NCT01074268|79342697|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
44338276|NCT01074268|79342698|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
44338277|NCT01074268|79342697|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
44338278|NCT01074268|79342698|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
44338279|NCT01074268|79342697|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
44338280|NCT01074268|79342698|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
44338281|NCT01074268|79342697|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
44437580|NCT00311311|79446435|FG000|Overall Study|Noncompliance|0|||
44540667|NCT01199302|79552765|FG002|Overall Study|Study Termination|11|||
44540668|NCT01199302|79552766|FG003|Overall Study|Study Termination|9|||
44540669|NCT01199302|79552763|FG000|Overall Study|Lost to Follow-up|0|||
44540670|NCT01199302|79552764|FG001|Overall Study|Lost to Follow-up|1|||
44540671|NCT01199302|79552765|FG002|Overall Study|Lost to Follow-up|0|||
44540672|NCT01199302|79552766|FG003|Overall Study|Lost to Follow-up|0|||
44540673|NCT01199302|79552763|FG000|Overall Study|Other|1|||
44540674|NCT01199302|79552764|FG001|Overall Study|Other|0|||
44540675|NCT01199302|79552765|FG002|Overall Study|Other|0|||
44540676|NCT01199302|79552766|FG003|Overall Study|Other|0|||
44540677|NCT03332784|79552793|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540678|NCT03332784|79552794|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
44540679|NCT03332784|79552795|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540680|NCT03332784|79552796|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540681|NCT03332784|79552797|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540682|NCT03332784|79552798|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540683|NCT03332784|79552799|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540684|NCT03332784|79552800|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540685|NCT03332784|79552801|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540686|NCT03332784|79552802|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540687|NCT03332784|79552803|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540688|NCT03332784|79552804|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540689|NCT03332784|79552805|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540690|NCT03332784|79552806|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540691|NCT03332784|79552807|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
44540692|NCT03332784|79552808|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540693|NCT03332784|79552809|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540694|NCT03332784|79552810|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540695|NCT03332784|79552811|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540696|NCT03332784|79552812|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
44540697|NCT04465357|79552876|FG000|Overall Study|Adverse Event|2|||
44338282|NCT01074268|79342698|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
44540698|NCT04465357|79552876|FG000|Overall Study|Lack of Efficacy|1|||
44540699|NCT04465357|79552876|FG000|Overall Study|Lost to Follow-up|2|||
44540700|NCT04465357|79552876|FG000|Overall Study|Withdrawal by Subject|6|||
44540701|NCT04465357|79552876|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
44540702|NCT03332628|79552880|FG000|Overall Study|Physician Decision|2|||
44540703|NCT04516759|79552887|FG000|Overall Study|Withdrawal by Subject|1|||
44540704|NCT04516759|79552888|FG001|Overall Study|Withdrawal by Subject|1|||
44540705|NCT04516759|79552887|FG000|Overall Study|Other|0|||
44540706|NCT04516759|79552888|FG001|Overall Study|Other|1|||
44338283|NCT01074268|79342697|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
44437581|NCT00311311|79446436|FG001|Overall Study|Noncompliance|1|||
44437582|NCT00311311|79446435|FG000|Overall Study|Study Termination by Sponsor|3|||
44437583|NCT00311311|79446436|FG001|Overall Study|Study Termination by Sponsor|4|||
44540707|NCT03332160|79552896|FG000|Overall Study|Withdrawal by Subject|1|||
44437584|NCT00311311|79446435|FG000|Overall Study|Death|1|||
44437585|NCT00311311|79446436|FG001|Overall Study|Death|0|||
44437586|NCT00311311|79446435|FG000|Overall Study|Lack of ancillary assistance|0|||
44437587|NCT00311311|79446436|FG001|Overall Study|Lack of ancillary assistance|1|||
44437588|NCT00521404|79446442|FG000|Overall Study|Adverse Event|13|||
44437589|NCT00521404|79446442|FG000|Overall Study|Disease Progression|33|||
44437590|NCT00521404|79446442|FG000|Overall Study|Investigator decision|5|||
44437591|NCT00521404|79446442|FG000|Overall Study|Withdrawal of consent|3|||
44437592|NCT00521404|79446442|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
44437593|NCT00521404|79446442|FG000|Overall Study|Other|7|||
44437594|NCT00311155|79446446|FG000|Overall Study|Adverse Event|21|||
44437595|NCT00311155|79446446|FG000|Overall Study|Withdrawal by Subject|17|||
44437596|NCT00311155|79446446|FG000|Overall Study|Did not meet entry criteria|55|||
44437597|NCT00274651|79446452|FG000|Overall Study|Adverse Event|6|||
44437598|NCT00274651|79446453|FG001|Overall Study|Adverse Event|3|||
44437599|NCT00274651|79446452|FG000|Overall Study|Lack of Efficacy|13|||
44437600|NCT00274651|79446453|FG001|Overall Study|Lack of Efficacy|6|||
44437601|NCT00274651|79446452|FG000|Overall Study|Death|1|||
44437602|NCT00274651|79446453|FG001|Overall Study|Death|3|||
44437603|NCT00274651|79446452|FG000|Overall Study|Withdrawal by Subject|0|||
44437604|NCT00274651|79446453|FG001|Overall Study|Withdrawal by Subject|1|||
44437605|NCT00274651|79446452|FG000|Overall Study|Physician Decision|8|||
44437606|NCT00274651|79446453|FG001|Overall Study|Physician Decision|7|||
44437607|NCT00274261|79446462|FG000|Overall Study|Adverse Event|19|||
44437608|NCT00274261|79446463|FG001|Overall Study|Adverse Event|11|||
44437609|NCT00274261|79446462|FG000|Overall Study|Pregnancy|114|||
44437610|NCT00274261|79446463|FG001|Overall Study|Pregnancy|83|||
44437611|NCT00274261|79446462|FG000|Overall Study|Withdrawal by Subject|179|||
44437612|NCT00274261|79446463|FG001|Overall Study|Withdrawal by Subject|126|||
44437613|NCT00274261|79446462|FG000|Overall Study|Protocol Violation|71|||
44437614|NCT00274261|79446463|FG001|Overall Study|Protocol Violation|42|||
44437615|NCT00274261|79446462|FG000|Overall Study|Lost to Follow-up|106|||
44437616|NCT00274261|79446463|FG001|Overall Study|Lost to Follow-up|75|||
44437617|NCT00624468|79446473|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
44437618|NCT00624468|79446474|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
44437619|NCT00624468|79446475|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
44259373|NCT02723019|79119006|FG000|Overall Study|Death|17|||
44259374|NCT02723019|79119007|FG001|Overall Study|Death|13|||
44540708|NCT03332160|79552897|FG001|Overall Study|Withdrawal by Subject|1|||
44157576|NCT01940887|78949366|FG000|Year 2|Withdrawal by Subject|8|||
44259375|NCT02723019|79119006|FG000|Overall Study|Withdrawal by Subject|11|||
44259376|NCT02723019|79119007|FG001|Overall Study|Withdrawal by Subject|7|||
44259377|NCT02723019|79119006|FG000|Overall Study|Lost to Follow-up|57|||
44338284|NCT01074268|79342698|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
44338285|NCT01074268|79342697|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
44338286|NCT01074268|79342698|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
44338287|NCT01074190|79342707|FG000|Overall Study|Emergency Cesarean Delivery|1|||
44338288|NCT01074190|79342708|FG001|Overall Study|Emergency Cesarean Delivery|2|||
44338289|NCT01074190|79342709|FG002|Overall Study|Emergency Cesarean Delivery|1|||
44338290|NCT01074190|79342707|FG000|Overall Study|Protocol Violation|2|||
44338291|NCT01074190|79342708|FG001|Overall Study|Protocol Violation|1|||
44259378|NCT02723019|79119007|FG001|Overall Study|Lost to Follow-up|70|||
44259379|NCT00088166|79119257|FG000|Overall Study|Adverse Event|11|||
44437620|NCT00624468|79446476|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
44437621|NCT00624468|79446473|FG000|Double-blind Period|Withdrew Prematurely|1|||
44540709|NCT03332160|79552896|FG000|Overall Study|Adverse Event|0|||
44157577|NCT01940887|78949367|FG001|Year 2|Withdrawal by Subject|8|||
44157578|NCT01940887|78949366|FG000|Year 2|Lost to Follow-up|1|||
44157579|NCT01940887|78949367|FG001|Year 2|Lost to Follow-up|6|||
44259380|NCT00088166|79119258|FG001|Overall Study|Adverse Event|9|||
44259381|NCT00088166|79119257|FG000|Overall Study|Death|3|||
44259382|NCT00088166|79119258|FG001|Overall Study|Death|1|||
44259383|NCT00088166|79119257|FG000|Overall Study|Lost to Follow-up|0|||
44338292|NCT01074190|79342709|FG002|Overall Study|Protocol Violation|0|||
44338293|NCT01074190|79342707|FG000|Overall Study|Delivered in under 90 minutes|0|||
44338294|NCT01074190|79342708|FG001|Overall Study|Delivered in under 90 minutes|2|||
44338295|NCT01074190|79342709|FG002|Overall Study|Delivered in under 90 minutes|1|||
44259384|NCT00088166|79119258|FG001|Overall Study|Lost to Follow-up|1|||
44437622|NCT00624468|79446474|FG001|Double-blind Period|Withdrew Prematurely|1|||
44437623|NCT00624468|79446475|FG002|Double-blind Period|Withdrew Prematurely|0|||
44437624|NCT00624468|79446476|FG003|Double-blind Period|Withdrew Prematurely|0|||
44437625|NCT00624468|79446473|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
44437626|NCT00624468|79446474|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
44157580|NCT01326104|78949375|FG000|Overall Study|progressed prior to vaccine|0|||
44259385|NCT00088166|79119257|FG000|Overall Study|Physician Decision|4|||
44259386|NCT00088166|79119258|FG001|Overall Study|Physician Decision|1|||
44259387|NCT00088166|79119257|FG000|Overall Study|Protocol Violation|1|||
44437627|NCT00624468|79446475|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
44437628|NCT00624468|79446476|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
44540710|NCT03332160|79552897|FG001|Overall Study|Adverse Event|1|||
44540711|NCT03332160|79552896|FG000|Overall Study|Developed Exclusion Criteria|0|||
44540712|NCT03332160|79552897|FG001|Overall Study|Developed Exclusion Criteria|1|||
44540713|NCT03332160|79552896|FG000|Overall Study|Non-adherence to treatment|0|||
44540714|NCT03332160|79552897|FG001|Overall Study|Non-adherence to treatment|2|||
44540715|NCT03312114|79552904|FG000|Overall Study|All the five enrolled dropped out of the|5|||
44540716|NCT03694327|79552911|FG000|Overall Study|Lost to Follow-up|13|||
44540717|NCT03694327|79552912|FG001|Overall Study|Lost to Follow-up|23|||
44540718|NCT03330288|79552920|FG000|Overall Study|Other reason|1|||
44540719|NCT03330288|79552921|FG001|Overall Study|Other reason|1|||
44540720|NCT03330288|79552920|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
44540721|NCT03330288|79552921|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
44540722|NCT03330288|79552920|FG000|Overall Study|Adverse Event|1|||
44540723|NCT03330288|79552921|FG001|Overall Study|Adverse Event|0|||
44540724|NCT03330288|79552920|FG000|Overall Study|Withdrawal by Subject|1|||
44540725|NCT03330288|79552921|FG001|Overall Study|Withdrawal by Subject|0|||
44540726|NCT03330288|79552920|FG000|Overall Study|Lost to Follow-up|26|||
44540727|NCT03330288|79552921|FG001|Overall Study|Lost to Follow-up|7|||
44540728|NCT03084536|79552930|FG000|Overall Study|Determined to be ineligible|0|||
44540729|NCT03084536|79552931|FG001|Overall Study|Determined to be ineligible|0|||
44540730|NCT03084536|79552932|FG002|Overall Study|Determined to be ineligible|16|||
44540731|NCT03084536|79552930|FG000|Overall Study|Withdrawal by Subject|0|||
44540732|NCT03084536|79552931|FG001|Overall Study|Withdrawal by Subject|0|||
44540733|NCT03084536|79552932|FG002|Overall Study|Withdrawal by Subject|4|||
44540734|NCT03084536|79552930|FG000|Overall Study|Physician Decision|0|||
44540735|NCT03084536|79552931|FG001|Overall Study|Physician Decision|0|||
44338296|NCT01074190|79342707|FG000|Overall Study|Subject withdrew consent|1|||
44338297|NCT01074190|79342708|FG001|Overall Study|Subject withdrew consent|1|||
44338298|NCT01074190|79342709|FG002|Overall Study|Subject withdrew consent|1|||
44338299|NCT01073566|79342722|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
44338300|NCT01073566|79342723|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
44338301|NCT01072396|79342731|FG000|Period One|Adverse Event|1|||
44338302|NCT01072396|79342732|FG001|Period One|Adverse Event|1|||
44338303|NCT01072396|79342731|FG000|Period One|Protocol Violation|2|||
44338304|NCT01072396|79342732|FG001|Period One|Protocol Violation|1|||
44338305|NCT01072396|79342731|FG000|Period One|Withdrawal by Subject|2|||
44540736|NCT03084536|79552932|FG002|Overall Study|Physician Decision|3|||
44540737|NCT03084536|79552930|FG000|Overall Study|Death|0|||
44540738|NCT03084536|79552931|FG001|Overall Study|Death|0|||
44540739|NCT03084536|79552932|FG002|Overall Study|Death|1|||
44540740|NCT03084536|79552930|FG000|Overall Study|Lost to Follow-up|0|||
44540741|NCT03084536|79552931|FG001|Overall Study|Lost to Follow-up|0|||
44540742|NCT03084536|79552932|FG002|Overall Study|Lost to Follow-up|1|||
44540743|NCT03084536|79552930|FG000|Overall Study|Protocol Violation|0|||
44540744|NCT03084536|79552931|FG001|Overall Study|Protocol Violation|0|||
44540745|NCT03084536|79552932|FG002|Overall Study|Protocol Violation|1|||
44540746|NCT03084536|79552930|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
44338306|NCT01072396|79342732|FG001|Period One|Withdrawal by Subject|0|||
44338307|NCT01072396|79342731|FG000|Washout Period|Missing termination information|0|||
44338308|NCT01072396|79342732|FG001|Washout Period|Missing termination information|1|||
44338309|NCT01072396|79342731|FG000|Period Two|Adverse Event|0|||
44338310|NCT01072396|79342732|FG001|Period Two|Adverse Event|3|||
44338311|NCT01072396|79342731|FG000|Period Two|Lost to Follow-up|1|||
44338312|NCT01072396|79342732|FG001|Period Two|Lost to Follow-up|0|||
44437629|NCT00624468|79446473|FG000|Safety Follow-up (SFU) Period|Other|0|||
44437630|NCT00624468|79446474|FG001|Safety Follow-up (SFU) Period|Other|0|||
44437631|NCT00624468|79446475|FG002|Safety Follow-up (SFU) Period|Other|1|||
44437632|NCT00624468|79446476|FG003|Safety Follow-up (SFU) Period|Other|1|||
44540747|NCT03084536|79552931|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
44540748|NCT03084536|79552932|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
44540749|NCT05291936|79552939|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
44540750|NCT05291936|79552940|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
44540751|NCT05291936|79552939|FG000|Period 1|Withdrew Consent during study|1|||
44540752|NCT05291936|79552940|FG001|Period 1|Withdrew Consent during study|0|||
44540753|NCT05291936|79552939|FG000|Period 2|Adverse Event|0|||
44540754|NCT05291936|79552940|FG001|Period 2|Adverse Event|1|||
44338313|NCT01045096|79342741|FG000|Overall Study|Withdrawal by Subject|2|||
44338314|NCT01045096|79342742|FG001|Overall Study|Withdrawal by Subject|0|||
44338315|NCT01045096|79342743|FG002|Overall Study|Withdrawal by Subject|0|||
44338316|NCT01045096|79342741|FG000|Overall Study|Other|1|||
44540755|NCT05291936|79552939|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
44540756|NCT05291936|79552940|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
44338317|NCT01045096|79342742|FG001|Overall Study|Other|0|||
44338318|NCT01045096|79342743|FG002|Overall Study|Other|0|||
44437633|NCT00521014|79446484|FG000|Overall Study|Inevaluable, not treated|1|||
44437634|NCT00560235|79446491|FG000|Phase 1|Discontinued|8|||
44437635|NCT00560235|79446492|FG001|Phase 1|Discontinued|0|||
44437636|NCT00560235|79446493|FG002|Phase 1|Discontinued|0|||
44437637|NCT00560235|79446491|FG000|Phase 1B|Discontinued|0|||
44437638|NCT00560235|79446492|FG001|Phase 1B|Discontinued|19|||
44437639|NCT00560235|79446493|FG002|Phase 1B|Discontinued|0|||
44437640|NCT00560235|79446491|FG000|Phase 2|Discontinued|0|||
44437641|NCT00560235|79446492|FG001|Phase 2|Discontinued|0|||
44437642|NCT00560235|79446493|FG002|Phase 2|Discontinued|96|||
44437643|NCT00560235|79446491|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
44437644|NCT00560235|79446492|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
44437645|NCT00560235|79446493|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
44437646|NCT00291577|79446511|FG000|Overall Study|Adverse Event|1|||
44437647|NCT00291577|79446511|FG000|Overall Study|Other|4|||
44437648|NCT00291577|79446511|FG000|Overall Study|Withdrawal by Subject|2|||
44437649|NCT00291577|79446511|FG000|Overall Study|Lack of Efficacy|14|||
44437650|NCT00520936|79446523|FG000|Overall Study|Physician Decision|0|||
44437651|NCT00520936|79446524|FG001|Overall Study|Physician Decision|2|||
44437652|NCT00520936|79446525|FG002|Overall Study|Physician Decision|1|||
44437653|NCT00520936|79446526|FG003|Overall Study|Physician Decision|0|||
44437654|NCT00520936|79446527|FG004|Overall Study|Physician Decision|0|||
44437655|NCT00520936|79446528|FG005|Overall Study|Physician Decision|0|||
44437656|NCT00520936|79446529|FG006|Overall Study|Physician Decision|0|||
44437657|NCT00520936|79446530|FG007|Overall Study|Physician Decision|0|||
44437658|NCT00520936|79446523|FG000|Overall Study|Withdrawal by Subject|0|||
44437659|NCT00520936|79446524|FG001|Overall Study|Withdrawal by Subject|0|||
44437660|NCT00520936|79446525|FG002|Overall Study|Withdrawal by Subject|0|||
44437661|NCT00520936|79446526|FG003|Overall Study|Withdrawal by Subject|0|||
44437662|NCT00520936|79446527|FG004|Overall Study|Withdrawal by Subject|0|||
44437663|NCT00520936|79446528|FG005|Overall Study|Withdrawal by Subject|0|||
44437664|NCT00520936|79446529|FG006|Overall Study|Withdrawal by Subject|0|||
44437665|NCT00520936|79446530|FG007|Overall Study|Withdrawal by Subject|1|||
44437666|NCT00520936|79446523|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
44437667|NCT00520936|79446524|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
44437668|NCT00520936|79446525|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
44437669|NCT00520936|79446526|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
44437670|NCT00520936|79446527|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
44437671|NCT00520936|79446528|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
44437672|NCT00520936|79446529|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
44437673|NCT00520936|79446530|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
44437674|NCT00520936|79446523|FG000|Overall Study|Death|0|||
44437675|NCT00520936|79446524|FG001|Overall Study|Death|0|||
44437676|NCT00520936|79446525|FG002|Overall Study|Death|0|||
44437677|NCT00520936|79446526|FG003|Overall Study|Death|0|||
44437678|NCT00520936|79446527|FG004|Overall Study|Death|0|||
44437679|NCT00520936|79446528|FG005|Overall Study|Death|0|||
44437680|NCT00520936|79446529|FG006|Overall Study|Death|1|||
44437681|NCT00520936|79446530|FG007|Overall Study|Death|0|||
44437682|NCT00520936|79446523|FG000|Overall Study|Protocol Violation|0|||
44437683|NCT00520936|79446524|FG001|Overall Study|Protocol Violation|1|||
44437684|NCT00520936|79446525|FG002|Overall Study|Protocol Violation|1|||
44437685|NCT00520936|79446526|FG003|Overall Study|Protocol Violation|0|||
44338319|NCT01285518|79342759|FG000|Overall Study|Lost to Follow-up|0|||
44338320|NCT01285518|79342760|FG001|Overall Study|Lost to Follow-up|0|||
44338321|NCT01285518|79342761|FG002|Overall Study|Lost to Follow-up|0|||
44338322|NCT01285518|79342762|FG003|Overall Study|Lost to Follow-up|0|||
44338323|NCT01285518|79342763|FG004|Overall Study|Lost to Follow-up|0|||
44338324|NCT01285518|79342764|FG005|Overall Study|Lost to Follow-up|1|||
44338325|NCT01285518|79342765|FG006|Overall Study|Lost to Follow-up|0|||
44437686|NCT00520936|79446527|FG004|Overall Study|Protocol Violation|1|||
44437687|NCT00520936|79446528|FG005|Overall Study|Protocol Violation|0|||
44437688|NCT00520936|79446529|FG006|Overall Study|Protocol Violation|1|||
44437689|NCT00520936|79446530|FG007|Overall Study|Protocol Violation|0|||
44437690|NCT03867760|79446543|FG000|Overall Study|Lost to Follow-up|2|||
44437691|NCT03867760|79446544|FG001|Overall Study|Lost to Follow-up|3|||
44437692|NCT03867760|79446543|FG000|Overall Study|Withdrawal by Subject|1|||
44437693|NCT03867760|79446544|FG001|Overall Study|Withdrawal by Subject|2|||
44338326|NCT01285518|79342766|FG007|Overall Study|Lost to Follow-up|0|||
44437694|NCT03867760|79446543|FG000|Overall Study|subject could not meet study logistics|3|||
44437695|NCT03867760|79446544|FG001|Overall Study|subject could not meet study logistics|3|||
44437696|NCT03865732|79446554|FG000|Overall Study|Adverse Event|0|||
44437697|NCT03865732|79446555|FG001|Overall Study|Adverse Event|1|||
44338327|NCT01073020|79342789|FG000|Overall Study|Withdrawal by Subject|6|||
44338328|NCT01073020|79342790|FG001|Overall Study|Withdrawal by Subject|4|||
44437698|NCT00520546|79446562|FG000|Overall Study|Withdrawal by Subject|1|||
44437699|NCT00520546|79446562|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
44437700|NCT00555009|79446573|FG000|Overall Study|Withdrawal by Subject|0|||
44338329|NCT01073020|79342791|FG002|Overall Study|Withdrawal by Subject|1|||
44338330|NCT01073020|79342792|FG003|Overall Study|Withdrawal by Subject|2|||
44437701|NCT00555009|79446574|FG001|Overall Study|Withdrawal by Subject|1|||
44437702|NCT00555009|79446573|FG000|Overall Study|Terminated by Sponsor|2|||
44437703|NCT00555009|79446574|FG001|Overall Study|Terminated by Sponsor|5|||
44437704|NCT00623766|79446582|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
44437705|NCT00623766|79446583|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
44437706|NCT00623766|79446582|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
44437707|NCT00623766|79446583|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
44437708|NCT00623766|79446582|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
44437709|NCT00623766|79446583|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
44437710|NCT00623766|79446582|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
44437711|NCT00623766|79446583|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
44437712|NCT00623766|79446582|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
44437713|NCT00623766|79446583|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
44437714|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
44437715|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
44437716|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
44437717|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
44437718|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
44437719|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
44437720|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
44437721|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
44437722|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
44437723|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
44437724|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
44437725|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
44437726|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
44437727|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
44437728|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
44437729|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
44437730|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
44437731|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
44437732|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
44437733|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
44437734|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
44437735|NCT00550407|79446595|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
44437736|NCT00550407|79446596|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
44437737|NCT00550407|79446597|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
44338331|NCT01073020|79342789|FG000|Overall Study|Physician Decision|1|||
44338332|NCT01073020|79342790|FG001|Overall Study|Physician Decision|0|||
44338333|NCT01073020|79342791|FG002|Overall Study|Physician Decision|2|||
44338334|NCT01073020|79342792|FG003|Overall Study|Physician Decision|0|||
44338335|NCT01073020|79342789|FG000|Overall Study|Death|0|||
44338336|NCT01073020|79342790|FG001|Overall Study|Death|1|||
44338337|NCT01073020|79342791|FG002|Overall Study|Death|0|||
44338338|NCT01073020|79342792|FG003|Overall Study|Death|0|||
44338339|NCT01284114|79342802|FG000|Overall Study|viral infection|1|||
44338340|NCT01284114|79342802|FG000|Overall Study|From the results of ALLTITUDE study|1|||
44338341|NCT01284114|79342802|FG000|Overall Study|Symptomatic hypotension|1|||
44338342|NCT01284114|79342802|FG000|Overall Study|dizziness|1|||
44338343|NCT01283334|79342807|FG000|Overall Study|Withdrawal by Subject|1|||
44338344|NCT01283334|79342807|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
44338345|NCT01283334|79342807|FG000|Overall Study|Adverse Event|4|||
44338346|NCT01283334|79342807|FG000|Overall Study|Physician Decision|1|||
44338347|NCT01282866|79342813|FG000|Overall Study|Adverse Event|1|||
44338348|NCT01071070|79342819|FG000|Overall Study|Adverse Event|0|||
44338349|NCT01071070|79342820|FG001|Overall Study|Adverse Event|3|||
44338350|NCT01071070|79342819|FG000|Overall Study|Withdrawal by Subject|1|||
44338351|NCT01071070|79342820|FG001|Overall Study|Withdrawal by Subject|0|||
44338352|NCT01071070|79342819|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
44437738|NCT00550407|79446595|FG000|26-Week Randomized Phase|Adverse Event|0|||
44437739|NCT00550407|79446596|FG001|26-Week Randomized Phase|Adverse Event|5|||
44437740|NCT00550407|79446597|FG002|26-Week Randomized Phase|Adverse Event|2|||
44338353|NCT01071070|79342820|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
44338354|NCT01071070|79342819|FG000|Overall Study|Hypercalcemia|1|||
44338355|NCT01071070|79342820|FG001|Overall Study|Hypercalcemia|0|||
44338356|NCT01282476|79342826|FG000|Overall Study|Death|11|||
44338357|NCT01282164|79342832|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
44540757|NCT03289143|79552950|FG000|Overall Study|Caregiver Unavailability|1|||
44540758|NCT03289143|79552951|FG001|Overall Study|Caregiver Unavailability|1|||
44540759|NCT03289143|79552952|FG002|Overall Study|Caregiver Unavailability|0|||
44540760|NCT03289143|79552953|FG003|Overall Study|Caregiver Unavailability|0|||
44540761|NCT03289143|79552950|FG000|Overall Study|Research Department Closure|0|||
44540762|NCT03289143|79552951|FG001|Overall Study|Research Department Closure|0|||
44540763|NCT03289143|79552952|FG002|Overall Study|Research Department Closure|1|||
44540764|NCT03289143|79552953|FG003|Overall Study|Research Department Closure|0|||
44540765|NCT03289143|79552950|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
44540766|NCT03289143|79552951|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
44540767|NCT03289143|79552952|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
44437741|NCT00550407|79446595|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
44437742|NCT00550407|79446596|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
44540768|NCT03289143|79552953|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
44540769|NCT03289143|79552950|FG000|Overall Study|Medical Monitor Decision|1|||
44540770|NCT03289143|79552951|FG001|Overall Study|Medical Monitor Decision|0|||
44437743|NCT00550407|79446597|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
44437744|NCT00550407|79446595|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
44540771|NCT03289143|79552952|FG002|Overall Study|Medical Monitor Decision|0|||
44540772|NCT03289143|79552953|FG003|Overall Study|Medical Monitor Decision|0|||
44540773|NCT03289143|79552950|FG000|Overall Study|Participant Non-Compliance|0|||
44540774|NCT03289143|79552951|FG001|Overall Study|Participant Non-Compliance|0|||
44540775|NCT03289143|79552952|FG002|Overall Study|Participant Non-Compliance|1|||
44540776|NCT03289143|79552953|FG003|Overall Study|Participant Non-Compliance|0|||
44540777|NCT03289143|79552950|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
44540778|NCT03289143|79552951|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
44540779|NCT03289143|79552952|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
44540780|NCT03289143|79552953|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
44540781|NCT03289143|79552950|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
44540782|NCT03289143|79552951|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
44540783|NCT03289143|79552952|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
44540784|NCT03289143|79552953|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
44540785|NCT03289143|79552950|FG000|Overall Study|Caregiver Passed Away|1|||
44540786|NCT03289143|79552951|FG001|Overall Study|Caregiver Passed Away|0|||
44540787|NCT03289143|79552952|FG002|Overall Study|Caregiver Passed Away|0|||
44540788|NCT03289143|79552953|FG003|Overall Study|Caregiver Passed Away|0|||
44540789|NCT03289143|79552950|FG000|Overall Study|Physician Decision|0|||
44540790|NCT03289143|79552951|FG001|Overall Study|Physician Decision|2|||
44540791|NCT03289143|79552952|FG002|Overall Study|Physician Decision|2|||
44540792|NCT03289143|79552953|FG003|Overall Study|Physician Decision|2|||
44540793|NCT03289143|79552950|FG000|Overall Study|Protocol Deviation|2|||
44540794|NCT03289143|79552951|FG001|Overall Study|Protocol Deviation|1|||
44338358|NCT01282164|79342833|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
44338359|NCT01250379|79342849|FG000|Overall Study|Death|141|||
44338360|NCT01250379|79342850|FG001|Overall Study|Death|148|||
44338361|NCT01250379|79342849|FG000|Overall Study|Withdrawal by Subject|32|||
44338362|NCT01250379|79342850|FG001|Overall Study|Withdrawal by Subject|20|||
44338363|NCT01250379|79342849|FG000|Overall Study|Physician Decision|11|||
44338364|NCT01250379|79342850|FG001|Overall Study|Physician Decision|3|||
44338365|NCT01250379|79342849|FG000|Overall Study|Protocol Violation|2|||
44338366|NCT01250379|79342850|FG001|Overall Study|Protocol Violation|8|||
44338367|NCT01250379|79342849|FG000|Overall Study|Lost to Follow-up|9|||
44437745|NCT00550407|79446596|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
44437746|NCT00550407|79446597|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
44437747|NCT00550407|79446595|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
44437748|NCT00550407|79446596|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
44437749|NCT00550407|79446597|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
44437750|NCT00531934|79446607|FG000|Overall Study|Adverse Event|4|||
44437751|NCT00531934|79446608|FG001|Overall Study|Adverse Event|8|||
44540795|NCT03289143|79552952|FG002|Overall Study|Protocol Deviation|3|||
44540796|NCT03289143|79552953|FG003|Overall Study|Protocol Deviation|1|||
44540797|NCT03289143|79552950|FG000|Overall Study|Study Terminated By Sponsor|101|||
44540798|NCT03289143|79552951|FG001|Overall Study|Study Terminated By Sponsor|75|||
44540799|NCT03289143|79552952|FG002|Overall Study|Study Terminated By Sponsor|100|||
44540800|NCT03289143|79552953|FG003|Overall Study|Study Terminated By Sponsor|69|||
44338368|NCT01250379|79342850|FG001|Overall Study|Lost to Follow-up|6|||
44338369|NCT01250379|79342849|FG000|Overall Study|Adverse Event|5|||
44338370|NCT01250379|79342850|FG001|Overall Study|Adverse Event|4|||
44338371|NCT01250379|79342849|FG000|Overall Study|Other|0|||
44338372|NCT01250379|79342850|FG001|Overall Study|Other|4|||
44338373|NCT01250379|79342849|FG000|Overall Study|Participant noncompliance|2|||
44338374|NCT01250379|79342850|FG001|Overall Study|Participant noncompliance|0|||
44338375|NCT01072630|79342859|FG000|Overall Study|Adverse Event|11|||
44338376|NCT01072630|79342860|FG001|Overall Study|Adverse Event|19|||
44338377|NCT01072630|79342861|FG002|Overall Study|Adverse Event|2|||
44437752|NCT00531934|79446607|FG000|Overall Study|Progression|52|||
44437753|NCT00531934|79446608|FG001|Overall Study|Progression|42|||
44437754|NCT00531934|79446607|FG000|Overall Study|Death|7|||
44437755|NCT00531934|79446608|FG001|Overall Study|Death|10|||
44437756|NCT00531934|79446607|FG000|Overall Study|Withdrawal by Subject|1|||
44437757|NCT00531934|79446608|FG001|Overall Study|Withdrawal by Subject|1|||
44437758|NCT00531934|79446607|FG000|Overall Study|Other|2|||
44437759|NCT00531934|79446608|FG001|Overall Study|Other|2|||
44437760|NCT00549939|79446617|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
44437761|NCT00549939|79446618|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
44338378|NCT01072630|79342859|FG000|Overall Study|Lack of Efficacy|10|||
44338379|NCT01072630|79342860|FG001|Overall Study|Lack of Efficacy|10|||
44437762|NCT00549939|79446619|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
44437763|NCT00549939|79446617|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
44437764|NCT00549939|79446618|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
44437765|NCT00549939|79446619|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
44437766|NCT00549939|79446617|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
44437767|NCT00549939|79446618|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
44437768|NCT00549939|79446619|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
44437769|NCT00549939|79446617|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
44437770|NCT00549939|79446618|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
44437771|NCT00549939|79446619|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
44437772|NCT00549939|79446617|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
44437773|NCT00549939|79446618|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
44437774|NCT00549939|79446619|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
44437775|NCT00549939|79446617|FG000|40-week Open Label Treatment Period|Other|0|||
44437776|NCT00549939|79446618|FG001|40-week Open Label Treatment Period|Other|1|||
44437777|NCT00549939|79446619|FG002|40-week Open Label Treatment Period|Other|4|||
44437778|NCT00272779|79446631|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
44437779|NCT00272779|79446632|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
44437780|NCT00272779|79446631|FG000|Baseline Through Week 48|Death before Week 48|4|||
44437781|NCT00272779|79446632|FG001|Baseline Through Week 48|Death before Week 48|4|||
44437782|NCT00272779|79446631|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
44437783|NCT00272779|79446632|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
44437784|NCT00272779|79446631|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
44437785|NCT00272779|79446632|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
44437786|NCT00272779|79446631|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
44437787|NCT00272779|79446632|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
44437788|NCT00272779|79446631|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
44437789|NCT00272779|79446632|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
44437790|NCT00272779|79446631|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
44437791|NCT00272779|79446632|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
44338380|NCT01072630|79342861|FG002|Overall Study|Lack of Efficacy|1|||
44338381|NCT01072630|79342859|FG000|Overall Study|Withdrawal by Subject|8|||
44338382|NCT01072630|79342860|FG001|Overall Study|Withdrawal by Subject|7|||
44157581|NCT01326104|78949376|FG001|Overall Study|progressed prior to vaccine|2|||
44157582|NCT01326104|78949375|FG000|Overall Study|unable to make vaccine|0|||
44157583|NCT01326104|78949376|FG001|Overall Study|unable to make vaccine|2|||
44157584|NCT00712881|78949410|FG000|Overall Study|Adverse Event|3|||
44157585|NCT00712881|78949411|FG001|Overall Study|Adverse Event|3|||
44338383|NCT01072630|79342861|FG002|Overall Study|Withdrawal by Subject|2|||
44338384|NCT01072630|79342859|FG000|Overall Study|Protocol Violation|10|||
44338385|NCT01072630|79342860|FG001|Overall Study|Protocol Violation|8|||
44338386|NCT01072630|79342861|FG002|Overall Study|Protocol Violation|4|||
44437792|NCT00272779|79446631|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
44437793|NCT00272779|79446632|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
44338387|NCT01072630|79342859|FG000|Overall Study|Lost to Follow-up|11|||
44338388|NCT01072630|79342860|FG001|Overall Study|Lost to Follow-up|11|||
44338389|NCT01072630|79342861|FG002|Overall Study|Lost to Follow-up|1|||
44338390|NCT01072630|79342859|FG000|Overall Study|Noncompliance with study medication|1|||
44338391|NCT01072630|79342860|FG001|Overall Study|Noncompliance with study medication|1|||
44437794|NCT00272779|79446631|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
44437795|NCT00272779|79446632|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
44338392|NCT01072630|79342861|FG002|Overall Study|Noncompliance with study medication|1|||
44157586|NCT00712881|78949410|FG000|Overall Study|Withdrawal by Subject|1|||
44259388|NCT00088166|79119258|FG001|Overall Study|Protocol Violation|5|||
44437796|NCT00272779|79446631|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
44437797|NCT00272779|79446632|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
44437798|NCT00272779|79446631|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
44437799|NCT00272779|79446632|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
44437800|NCT00272779|79446631|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
44437801|NCT00272779|79446632|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
44437802|NCT00272779|79446631|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
44437803|NCT00272779|79446632|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
44437804|NCT00272779|79446631|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
44437805|NCT00272779|79446632|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
44437806|NCT00272779|79446631|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
44437807|NCT00272779|79446632|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
44437808|NCT00272779|79446631|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
44437809|NCT00272779|79446632|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
44437810|NCT00272779|79446631|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
44437811|NCT00272779|79446632|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
44437812|NCT00272779|79446631|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
44437813|NCT00272779|79446632|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
44437814|NCT00272779|79446631|FG000|Baseline Through Week 48|Continuing treatment|385|||
44437815|NCT00272779|79446632|FG001|Baseline Through Week 48|Continuing treatment|368|||
44437816|NCT00272779|79446631|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
44437817|NCT00272779|79446632|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
44437818|NCT00272779|79446631|FG000|Baseline Through Week 48|Never treated|2|||
44437819|NCT00272779|79446632|FG001|Baseline Through Week 48|Never treated|3|||
44437820|NCT00272779|79446631|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
44437821|NCT00272779|79446632|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
44437822|NCT00272779|79446631|FG000|Baseline Through Week 96|Death before Week 96|6|||
44437823|NCT00272779|79446632|FG001|Baseline Through Week 96|Death before Week 96|5|||
44437824|NCT00272779|79446631|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
44437825|NCT00272779|79446632|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
44437826|NCT00272779|79446631|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
44437827|NCT00272779|79446632|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
44437828|NCT00272779|79446631|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
44437829|NCT00272779|79446632|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
44437830|NCT00272779|79446631|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
44437831|NCT00272779|79446632|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
44437832|NCT00272779|79446631|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
44437833|NCT00272779|79446632|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
44437834|NCT00272779|79446631|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
44437835|NCT00272779|79446632|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
44437836|NCT00272779|79446631|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
44437837|NCT00272779|79446632|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
44437838|NCT00272779|79446631|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
44437839|NCT00272779|79446632|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
44437840|NCT00272779|79446631|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
44437841|NCT00272779|79446632|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
44437842|NCT00272779|79446631|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
44437843|NCT00272779|79446632|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
44437844|NCT00272779|79446631|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
44437845|NCT00272779|79446632|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
44437846|NCT00272779|79446631|FG000|Baseline Through Week 96|Never treated|2|||
44437847|NCT00272779|79446632|FG001|Baseline Through Week 96|Never treated|3|||
44437848|NCT00272779|79446631|FG000|Baseline Through Week 96|Continuing on treatment|61|||
44437849|NCT00272779|79446632|FG001|Baseline Through Week 96|Continuing on treatment|38|||
44437850|NCT00511810|79446641|FG000|Overall Study|Lost to Follow-up|1|||
44437851|NCT00511810|79446642|FG001|Overall Study|Lost to Follow-up|2|||
44437852|NCT00511810|79446641|FG000|Overall Study|Lack of Efficacy|0|||
44437853|NCT00511810|79446642|FG001|Overall Study|Lack of Efficacy|2|||
44437854|NCT00511810|79446641|FG000|Overall Study|Refused second scn|0|||
44437855|NCT00511810|79446642|FG001|Overall Study|Refused second scn|1|||
44437856|NCT00291499|79446650|FG000|Overall Study|Adverse Event|3|||
44437857|NCT00291499|79446651|FG001|Overall Study|Adverse Event|8|||
44437858|NCT00291499|79446650|FG000|Overall Study|Change to other therapy|2|||
44437859|NCT00291499|79446651|FG001|Overall Study|Change to other therapy|1|||
44437860|NCT00291499|79446650|FG000|Overall Study|Intercurrent illness|1|||
44437861|NCT00291499|79446651|FG001|Overall Study|Intercurrent illness|0|||
44437862|NCT00291499|79446650|FG000|Overall Study|Protocol Violation|2|||
44437863|NCT00291499|79446651|FG001|Overall Study|Protocol Violation|2|||
44437864|NCT00291499|79446650|FG000|Overall Study|Other reasons|1|||
44437865|NCT00291499|79446651|FG001|Overall Study|Other reasons|4|||
44437866|NCT00553605|79446659|FG000|Overall Study|Did not meet entrance criteria|1|||
44437867|NCT00553605|79446660|FG001|Overall Study|Did not meet entrance criteria|3|||
44437868|NCT00553605|79446659|FG000|Overall Study|Did not receive full dose|1|||
44437869|NCT00553605|79446660|FG001|Overall Study|Did not receive full dose|0|||
44437870|NCT00553605|79446659|FG000|Overall Study|Randomized but not treated|2|||
44437871|NCT00553605|79446660|FG001|Overall Study|Randomized but not treated|0|||
44437872|NCT00621582|79446666|FG000|Overall Study|Adverse Event|7|||
44437873|NCT00621582|79446666|FG000|Overall Study|Protocol Violation|57|||
44437874|NCT00621582|79446666|FG000|Overall Study|Lost to Follow-up|24|||
44437875|NCT00621582|79446666|FG000|Overall Study|issues not identified by investigators|18|||
44437876|NCT00744497|79446672|FG000|Overall Study|Withdrawal by Subject|21|||
44437877|NCT00744497|79446673|FG001|Overall Study|Withdrawal by Subject|18|||
44437878|NCT00744497|79446672|FG000|Overall Study|Death|11|||
44437879|NCT00744497|79446673|FG001|Overall Study|Death|9|||
44437880|NCT00744497|79446672|FG000|Overall Study|Lost to Follow-up|4|||
44437881|NCT00744497|79446673|FG001|Overall Study|Lost to Follow-up|2|||
44437882|NCT00744497|79446672|FG000|Overall Study|Poor compliance/noncompliance|9|||
44437883|NCT00744497|79446673|FG001|Overall Study|Poor compliance/noncompliance|5|||
44437884|NCT00744497|79446672|FG000|Overall Study|No longer meets study criteria|7|||
44437885|NCT00744497|79446673|FG001|Overall Study|No longer meets study criteria|3|||
44437886|NCT00744497|79446672|FG000|Overall Study|Administrative Reason By Sponsor|25|||
44437887|NCT00744497|79446673|FG001|Overall Study|Administrative Reason By Sponsor|8|||
44437888|NCT00744497|79446672|FG000|Overall Study|Disease progression|312|||
44437889|NCT00744497|79446673|FG001|Overall Study|Disease progression|219|||
44437890|NCT00744497|79446672|FG000|Overall Study|Study drug toxicity|68|||
44437891|NCT00744497|79446673|FG001|Overall Study|Study drug toxicity|141|||
44437892|NCT00744497|79446672|FG000|Overall Study|Adverse event unrelated to study drug|78|||
44437893|NCT00744497|79446673|FG001|Overall Study|Adverse event unrelated to study drug|122|||
44437894|NCT00744497|79446672|FG000|Overall Study|Patient requested to stop study drug|65|||
44437895|NCT00744497|79446673|FG001|Overall Study|Patient requested to stop study drug|80|||
44437896|NCT00744497|79446672|FG000|Overall Study|Maximum clinical benefit|141|||
44437897|NCT00744497|79446673|FG001|Overall Study|Maximum clinical benefit|142|||
44437898|NCT00744497|79446672|FG000|Overall Study|Not defined|19|||
44437899|NCT00744497|79446673|FG001|Overall Study|Not defined|13|||
44437900|NCT00747227|79446681|FG000|Overall Study|Death|3|||
44437901|NCT00747227|79446682|FG001|Overall Study|Death|1|||
44437902|NCT00747227|79446681|FG000|Overall Study|Withdrawal by Subject|1|||
44437903|NCT00747227|79446682|FG001|Overall Study|Withdrawal by Subject|0|||
44437904|NCT00747227|79446681|FG000|Overall Study|Lost to Follow-up|1|||
44437905|NCT00747227|79446682|FG001|Overall Study|Lost to Follow-up|2|||
44437906|NCT00747227|79446681|FG000|Overall Study|Illness|1|||
44437907|NCT00747227|79446682|FG001|Overall Study|Illness|1|||
44437908|NCT00747149|79446690|FG000|Overall Study|Adverse Event|0|||
44437909|NCT00747149|79446691|FG001|Overall Study|Adverse Event|15|||
44437910|NCT00747149|79446690|FG000|Overall Study|Lost to Follow-up|0|||
44437911|NCT00747149|79446691|FG001|Overall Study|Lost to Follow-up|10|||
44437912|NCT00747149|79446690|FG000|Overall Study|Withdrawal by Subject|0|||
44437913|NCT00747149|79446691|FG001|Overall Study|Withdrawal by Subject|6|||
44437914|NCT00747149|79446690|FG000|Overall Study|Did not receive treatment|0|||
44437915|NCT00747149|79446691|FG001|Overall Study|Did not receive treatment|1|||
44437916|NCT00747149|79446690|FG000|Overall Study|Incorrect enrollment|0|||
44437917|NCT00747149|79446691|FG001|Overall Study|Incorrect enrollment|6|||
44437918|NCT00747149|79446690|FG000|Overall Study|Severe non-compliance to protocol|0|||
44437919|NCT00747149|79446691|FG001|Overall Study|Severe non-compliance to protocol|1|||
44437920|NCT00747149|79446690|FG000|Overall Study|Not reported|1|||
44437921|NCT00747149|79446691|FG001|Overall Study|Not reported|4|||
44437922|NCT00271609|79446705|FG000|Overall Study|Adverse Event|11|||
44338393|NCT01072630|79342859|FG000|Overall Study|Noncompliance with study procedures|1|||
44437923|NCT00271609|79446706|FG001|Overall Study|Adverse Event|3|||
44437924|NCT00271609|79446705|FG000|Overall Study|Withdrawal by Subject|2|||
44437925|NCT00271609|79446706|FG001|Overall Study|Withdrawal by Subject|0|||
44437926|NCT00548847|79446712|FG000|Overall Study|Disease progression|7|||
44437927|NCT00290407|79446716|FG000|Overall Study|Physician Decision|2|||
44437928|NCT00749411|79446722|FG000|Overall Study|Adverse Event|0|||
44437929|NCT00749411|79446723|FG001|Overall Study|Adverse Event|2|||
44437930|NCT00749411|79446722|FG000|Overall Study|Lack of Efficacy|0|||
44437931|NCT00749411|79446723|FG001|Overall Study|Lack of Efficacy|1|||
44437932|NCT00749411|79446722|FG000|Overall Study|Protocol Violation|1|||
44437933|NCT00749411|79446723|FG001|Overall Study|Protocol Violation|1|||
44437934|NCT00749411|79446722|FG000|Overall Study|Protocol-defined stopping criteria|0|||
44437935|NCT00749411|79446723|FG001|Overall Study|Protocol-defined stopping criteria|1|||
44437936|NCT03958149|79446731|FG000|Overall Study|Withdrawal by Subject|0|||
44437937|NCT03958149|79446732|FG001|Overall Study|Withdrawal by Subject|1|||
44437938|NCT00549549|79446746|FG000|Overall Study|Adverse Event|5|||
44437939|NCT00549549|79446747|FG001|Overall Study|Adverse Event|3|||
44437940|NCT00549549|79446748|FG002|Overall Study|Adverse Event|1|||
44437941|NCT00549549|79446749|FG003|Overall Study|Adverse Event|9|||
44437942|NCT00549549|79446746|FG000|Overall Study|Lack of Efficacy|9|||
44437943|NCT00549549|79446747|FG001|Overall Study|Lack of Efficacy|6|||
44338394|NCT01072630|79342860|FG001|Overall Study|Noncompliance with study procedures|2|||
44338395|NCT01072630|79342861|FG002|Overall Study|Noncompliance with study procedures|1|||
44338396|NCT01072630|79342859|FG000|Overall Study|Other|3|||
44338397|NCT01072630|79342860|FG001|Overall Study|Other|2|||
44338398|NCT01072630|79342861|FG002|Overall Study|Other|1|||
44338399|NCT01281306|79342877|FG000|Overall Study|Lack of Efficacy|0|||
44338400|NCT01281306|79342878|FG001|Overall Study|Lack of Efficacy|1|||
44338401|NCT01281306|79342879|FG002|Overall Study|Lack of Efficacy|3|||
44338402|NCT01281306|79342880|FG003|Overall Study|Lack of Efficacy|0|||
44338403|NCT01281306|79342881|FG004|Overall Study|Lack of Efficacy|2|||
44437944|NCT00549549|79446748|FG002|Overall Study|Lack of Efficacy|4|||
44338404|NCT01281306|79342882|FG005|Overall Study|Lack of Efficacy|0|||
44437945|NCT00549549|79446749|FG003|Overall Study|Lack of Efficacy|2|||
44437946|NCT00549549|79446746|FG000|Overall Study|Lost to Follow-up|1|||
44437947|NCT00549549|79446747|FG001|Overall Study|Lost to Follow-up|0|||
44437948|NCT00549549|79446748|FG002|Overall Study|Lost to Follow-up|1|||
44437949|NCT00549549|79446749|FG003|Overall Study|Lost to Follow-up|2|||
44437950|NCT00549549|79446746|FG000|Overall Study|Withdrawal by Subject|0|||
44437951|NCT00549549|79446747|FG001|Overall Study|Withdrawal by Subject|4|||
44437952|NCT00549549|79446748|FG002|Overall Study|Withdrawal by Subject|1|||
44437953|NCT00549549|79446749|FG003|Overall Study|Withdrawal by Subject|0|||
44437954|NCT00549549|79446746|FG000|Overall Study|Other|9|||
44437955|NCT00549549|79446747|FG001|Overall Study|Other|9|||
44338405|NCT01281306|79342883|FG006|Overall Study|Lack of Efficacy|1|||
44338406|NCT01281306|79342877|FG000|Overall Study|Withdrawal by Subject|1|||
44338407|NCT01281306|79342878|FG001|Overall Study|Withdrawal by Subject|0|||
44338408|NCT01281306|79342879|FG002|Overall Study|Withdrawal by Subject|2|||
44338409|NCT01281306|79342880|FG003|Overall Study|Withdrawal by Subject|4|||
44338410|NCT01281306|79342881|FG004|Overall Study|Withdrawal by Subject|1|||
44338411|NCT01281306|79342882|FG005|Overall Study|Withdrawal by Subject|3|||
44338412|NCT01281306|79342883|FG006|Overall Study|Withdrawal by Subject|1|||
44338413|NCT01281306|79342877|FG000|Overall Study|Protocol deviation|0|||
44437956|NCT00549549|79446748|FG002|Overall Study|Other|9|||
44437957|NCT00549549|79446749|FG003|Overall Study|Other|11|||
44437958|NCT00549549|79446746|FG000|Overall Study|Randomized but not treated|0|||
44437959|NCT00549549|79446747|FG001|Overall Study|Randomized but not treated|0|||
44437960|NCT00549549|79446748|FG002|Overall Study|Randomized but not treated|1|||
44437961|NCT00549549|79446749|FG003|Overall Study|Randomized but not treated|1|||
44437962|NCT00270205|79446763|FG000|Overall Study|Lost to Follow-up|1|||
44437963|NCT00270205|79446764|FG001|Overall Study|Lost to Follow-up|0|||
44437964|NCT00270205|79446765|FG002|Overall Study|Lost to Follow-up|0|||
44437965|NCT00270205|79446766|FG003|Overall Study|Lost to Follow-up|1|||
44437966|NCT00622284|79446778|FG000|Overall Study|Lack of Efficacy|45|||
44437967|NCT00622284|79446779|FG001|Overall Study|Lack of Efficacy|15|||
44437968|NCT00622284|79446778|FG000|Overall Study|Adverse Event|61|||
44437969|NCT00622284|79446779|FG001|Overall Study|Adverse Event|90|||
44437970|NCT00622284|79446778|FG000|Overall Study|Protocol Violation|12|||
44437971|NCT00622284|79446779|FG001|Overall Study|Protocol Violation|5|||
44437972|NCT00622284|79446778|FG000|Overall Study|Lost to Follow-up|11|||
44437973|NCT00622284|79446779|FG001|Overall Study|Lost to Follow-up|13|||
44437974|NCT00622284|79446778|FG000|Overall Study|Withdrawal by Subject|27|||
44437975|NCT00622284|79446779|FG001|Overall Study|Withdrawal by Subject|24|||
44437976|NCT00622284|79446778|FG000|Overall Study|Other reason (not specified)|33|||
44437977|NCT00622284|79446779|FG001|Overall Study|Other reason (not specified)|24|||
44437978|NCT00269113|79446787|FG000|Overall Study|Adverse Event|14|||
44437979|NCT00269113|79446788|FG001|Overall Study|Adverse Event|7|||
44437980|NCT00269113|79446787|FG000|Overall Study|Lack of Efficacy|35|||
44437981|NCT00269113|79446788|FG001|Overall Study|Lack of Efficacy|18|||
44437982|NCT00269113|79446787|FG000|Overall Study|Early Improvement|2|||
44437983|NCT00269113|79446788|FG001|Overall Study|Early Improvement|0|||
44437984|NCT00269113|79446787|FG000|Overall Study|Withdrawal by Subject|0|||
44437985|NCT00269113|79446788|FG001|Overall Study|Withdrawal by Subject|2|||
44437986|NCT00269113|79446787|FG000|Overall Study|Death|6|||
44437987|NCT00269113|79446788|FG001|Overall Study|Death|2|||
44338414|NCT01281306|79342878|FG001|Overall Study|Protocol deviation|1|||
44437988|NCT00269113|79446787|FG000|Overall Study|Lost to Follow-up|2|||
44437989|NCT00269113|79446788|FG001|Overall Study|Lost to Follow-up|1|||
44437990|NCT00269113|79446787|FG000|Overall Study|Protocol Violation|15|||
44338415|NCT01281306|79342879|FG002|Overall Study|Protocol deviation|1|||
44437991|NCT00269113|79446788|FG001|Overall Study|Protocol Violation|5|||
44437992|NCT00269113|79446787|FG000|Overall Study|Other|0|||
44437993|NCT00269113|79446788|FG001|Overall Study|Other|2|||
44437994|NCT00291187|79446798|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
44437995|NCT00291187|79446799|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
44437996|NCT00291187|79446800|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
44437997|NCT00291187|79446801|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
44437998|NCT00546819|79446817|FG000|Overall Study|Adverse Event|2|||
44437999|NCT00546819|79446818|FG001|Overall Study|Adverse Event|3|||
44438000|NCT00546819|79446817|FG000|Overall Study|Lost to Follow-up|2|||
44438001|NCT00546819|79446818|FG001|Overall Study|Lost to Follow-up|1|||
44438002|NCT00546819|79446817|FG000|Overall Study|Withdrawal by Subject|4|||
44438003|NCT00546819|79446818|FG001|Overall Study|Withdrawal by Subject|2|||
44438004|NCT00621504|79446826|FG000|Overall Study|Adverse Event|1|||
44438005|NCT00621504|79446827|FG001|Overall Study|Adverse Event|3|||
44438006|NCT00621504|79446826|FG000|Overall Study|At the request of sponsor/investigator|1|||
44438007|NCT00621504|79446827|FG001|Overall Study|At the request of sponsor/investigator|0|||
44438008|NCT00621504|79446826|FG000|Overall Study|Withdrew consent|9|||
44438009|NCT00621504|79446827|FG001|Overall Study|Withdrew consent|6|||
44438010|NCT00621504|79446826|FG000|Overall Study|Lost to Follow-up|8|||
44438011|NCT00621504|79446827|FG001|Overall Study|Lost to Follow-up|10|||
44438012|NCT00621504|79446826|FG000|Overall Study|Other|1|||
44438013|NCT00621504|79446827|FG001|Overall Study|Other|0|||
44438014|NCT00621504|79446826|FG000|Overall Study|Death|6|||
44438015|NCT00621504|79446827|FG001|Overall Study|Death|6|||
44438016|NCT00548145|79446835|FG000|Overall Study|Death|0|||
44438017|NCT00548145|79446836|FG001|Overall Study|Death|1|||
44438018|NCT00548145|79446835|FG000|Overall Study|Withdrawal by Subject|0|||
44438019|NCT00548145|79446836|FG001|Overall Study|Withdrawal by Subject|2|||
44438020|NCT00548145|79446835|FG000|Overall Study|Physician Decision|1|||
44338416|NCT01281306|79342880|FG003|Overall Study|Protocol deviation|1|||
44338417|NCT01281306|79342881|FG004|Overall Study|Protocol deviation|1|||
44338418|NCT01281306|79342882|FG005|Overall Study|Protocol deviation|0|||
44338419|NCT01281306|79342883|FG006|Overall Study|Protocol deviation|0|||
44338420|NCT01281306|79342877|FG000|Overall Study|Condition no longer requires study drug|1|||
44338421|NCT01281306|79342878|FG001|Overall Study|Condition no longer requires study drug|0|||
44338422|NCT01281306|79342879|FG002|Overall Study|Condition no longer requires study drug|0|||
44338423|NCT01281306|79342880|FG003|Overall Study|Condition no longer requires study drug|0|||
44338424|NCT01281306|79342881|FG004|Overall Study|Condition no longer requires study drug|0|||
44438021|NCT00548145|79446836|FG001|Overall Study|Physician Decision|1|||
44438022|NCT00547911|79446846|FG000|Overall Study|Adverse Event|0|||
44438023|NCT00547911|79446847|FG001|Overall Study|Adverse Event|0|||
44438024|NCT00547911|79446848|FG002|Overall Study|Adverse Event|0|||
44438025|NCT00547911|79446849|FG003|Overall Study|Adverse Event|1|||
44438026|NCT00547911|79446850|FG004|Overall Study|Adverse Event|0|||
44157587|NCT00712881|78949411|FG001|Overall Study|Withdrawal by Subject|1|||
44338425|NCT01281306|79342882|FG005|Overall Study|Condition no longer requires study drug|1|||
44338426|NCT01281306|79342883|FG006|Overall Study|Condition no longer requires study drug|1|||
44338427|NCT01281306|79342877|FG000|Overall Study|Lost to Follow-up|1|||
44338428|NCT01281306|79342878|FG001|Overall Study|Lost to Follow-up|0|||
44338429|NCT01281306|79342879|FG002|Overall Study|Lost to Follow-up|0|||
44338430|NCT01281306|79342880|FG003|Overall Study|Lost to Follow-up|2|||
44338431|NCT01281306|79342881|FG004|Overall Study|Lost to Follow-up|0|||
44338432|NCT01281306|79342882|FG005|Overall Study|Lost to Follow-up|0|||
44338433|NCT01281306|79342883|FG006|Overall Study|Lost to Follow-up|1|||
44338434|NCT01281306|79342877|FG000|Overall Study|Death|1|||
44338435|NCT01281306|79342878|FG001|Overall Study|Death|0|||
44338436|NCT01281306|79342879|FG002|Overall Study|Death|0|||
44338437|NCT01281306|79342880|FG003|Overall Study|Death|0|||
44338438|NCT01281306|79342881|FG004|Overall Study|Death|0|||
44338439|NCT01281306|79342882|FG005|Overall Study|Death|0|||
44338440|NCT01281306|79342883|FG006|Overall Study|Death|0|||
44157588|NCT00712881|78949410|FG000|Overall Study|Disease Progression|2|||
44338441|NCT01281306|79342877|FG000|Overall Study|Adverse Event|3|||
44338442|NCT01281306|79342878|FG001|Overall Study|Adverse Event|2|||
44338443|NCT01281306|79342879|FG002|Overall Study|Adverse Event|2|||
44338444|NCT01281306|79342880|FG003|Overall Study|Adverse Event|3|||
44438027|NCT00547911|79446851|FG005|Overall Study|Adverse Event|0|||
44438028|NCT00289783|79446866|FG000|Primary Phase|Adverse Event|10|||
44438029|NCT00289783|79446867|FG001|Primary Phase|Adverse Event|1|||
44338445|NCT01281306|79342881|FG004|Overall Study|Adverse Event|5|||
44338446|NCT01281306|79342882|FG005|Overall Study|Adverse Event|3|||
44438030|NCT00289783|79446866|FG000|Primary Phase|Protocol Violation|27|||
44438031|NCT00289783|79446867|FG001|Primary Phase|Protocol Violation|6|||
44438032|NCT00289783|79446866|FG000|Primary Phase|Withdrawal by Subject|93|||
44338447|NCT01281306|79342883|FG006|Overall Study|Adverse Event|3|||
44338448|NCT01281306|79342877|FG000|Overall Study|Randomized in error|1|||
44338449|NCT01281306|79342878|FG001|Overall Study|Randomized in error|0|||
44338450|NCT01281306|79342879|FG002|Overall Study|Randomized in error|0|||
44338451|NCT01281306|79342880|FG003|Overall Study|Randomized in error|1|||
44338452|NCT01281306|79342881|FG004|Overall Study|Randomized in error|0|||
44338453|NCT01281306|79342882|FG005|Overall Study|Randomized in error|0|||
44338454|NCT01281306|79342883|FG006|Overall Study|Randomized in error|0|||
44338455|NCT01250145|79342901|FG000|Overall Study|Adverse Event|2|||
44438033|NCT00289783|79446867|FG001|Primary Phase|Withdrawal by Subject|40|||
44438034|NCT00289783|79446866|FG000|Primary Phase|Lost to Follow-up|60|||
44438035|NCT00289783|79446867|FG001|Primary Phase|Lost to Follow-up|14|||
44438036|NCT00289783|79446866|FG000|Primary Phase|Migration from the study area|26|||
44438037|NCT00289783|79446867|FG001|Primary Phase|Migration from the study area|10|||
44438038|NCT00289783|79446866|FG000|Primary Phase|Other|32|||
44438039|NCT00289783|79446867|FG001|Primary Phase|Other|12|||
44438040|NCT00289783|79446866|FG000|Fourth Dose Phase|Adverse Event|1|||
44438041|NCT00289783|79446867|FG001|Fourth Dose Phase|Adverse Event|0|||
44438042|NCT00289783|79446866|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
44438043|NCT00289783|79446867|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
44438044|NCT00289783|79446866|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
44438045|NCT00289783|79446867|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
44438046|NCT00289783|79446866|FG000|Fourth Dose Phase|Migration from the study area|1|||
44438047|NCT00289783|79446867|FG001|Fourth Dose Phase|Migration from the study area|1|||
44438048|NCT00289783|79446866|FG000|Fourth Dose Phase|Other|22|||
44438049|NCT00289783|79446867|FG001|Fourth Dose Phase|Other|10|||
44438050|NCT00574080|79446883|FG000|Overall Study|Death|10|||
44438051|NCT00574080|79446884|FG001|Overall Study|Death|10|||
44438052|NCT00267865|79446890|FG000|Induction Treatment|Died before completing.|2|||
44438053|NCT00267865|79446890|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
44438054|NCT00546117|79446896|FG000|Overall Study|Withdrawal by Subject|3|||
44438055|NCT00546117|79446897|FG001|Overall Study|Withdrawal by Subject|0|||
44438056|NCT00546117|79446896|FG000|Overall Study|Inability to schedule follow-up visit|1|||
44438057|NCT00546117|79446897|FG001|Overall Study|Inability to schedule follow-up visit|0|||
44438058|NCT00251719|79446908|FG000|Overall Study|Adverse Event|14|||
44438059|NCT00251719|79446909|FG001|Overall Study|Adverse Event|8|||
44438060|NCT00251719|79446910|FG002|Overall Study|Adverse Event|7|||
44438061|NCT00251719|79446908|FG000|Overall Study|Protocol Violation|1|||
44438062|NCT00251719|79446909|FG001|Overall Study|Protocol Violation|1|||
44438063|NCT00251719|79446910|FG002|Overall Study|Protocol Violation|1|||
44438064|NCT00251719|79446908|FG000|Overall Study|Lost to Follow-up|5|||
44438065|NCT00251719|79446909|FG001|Overall Study|Lost to Follow-up|11|||
44438066|NCT00251719|79446910|FG002|Overall Study|Lost to Follow-up|8|||
44438067|NCT00251719|79446908|FG000|Overall Study|Withdrawal by Subject|14|||
44438068|NCT00251719|79446909|FG001|Overall Study|Withdrawal by Subject|12|||
44438069|NCT00251719|79446910|FG002|Overall Study|Withdrawal by Subject|11|||
44438070|NCT00251719|79446908|FG000|Overall Study|Lack of Efficacy|2|||
44438071|NCT00251719|79446909|FG001|Overall Study|Lack of Efficacy|1|||
44438072|NCT00251719|79446910|FG002|Overall Study|Lack of Efficacy|0|||
44338456|NCT01250145|79342902|FG001|Overall Study|Adverse Event|1|||
44438073|NCT00251719|79446908|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
44438074|NCT00251719|79446909|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
44438075|NCT00251719|79446910|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
44438076|NCT00251719|79446908|FG000|Overall Study|Investigator decision|1|||
44438077|NCT00251719|79446909|FG001|Overall Study|Investigator decision|1|||
44438078|NCT00251719|79446910|FG002|Overall Study|Investigator decision|0|||
44438079|NCT00251719|79446908|FG000|Overall Study|Noncompliance|2|||
44438080|NCT00251719|79446909|FG001|Overall Study|Noncompliance|3|||
44438081|NCT00251719|79446910|FG002|Overall Study|Noncompliance|1|||
44338457|NCT01250145|79342901|FG000|Overall Study|Withdrawal by Subject|0|||
44338458|NCT01250145|79342902|FG001|Overall Study|Withdrawal by Subject|4|||
44338459|NCT01067326|79342924|FG000|Overall Study|Adverse Event|0|||
44338460|NCT01067326|79342925|FG001|Overall Study|Adverse Event|2|||
44438082|NCT00251719|79446908|FG000|Overall Study|Barrett's esophagus|2|||
44438083|NCT00251719|79446909|FG001|Overall Study|Barrett's esophagus|2|||
44438084|NCT00251719|79446910|FG002|Overall Study|Barrett's esophagus|0|||
44438085|NCT03952143|79446920|FG000|Lead-In Period|Adverse Event|2|||
44438086|NCT03952143|79446921|FG001|Lead-In Period|Adverse Event|0|||
44338461|NCT01067326|79342924|FG000|Overall Study|Withdrawal by Subject|1|||
44338462|NCT01067326|79342925|FG001|Overall Study|Withdrawal by Subject|0|||
44338463|NCT01067326|79342924|FG000|Overall Study|Early Study Termination|1|||
44338464|NCT01067326|79342925|FG001|Overall Study|Early Study Termination|1|||
44438087|NCT03952143|79446922|FG002|Lead-In Period|Adverse Event|0|||
44438088|NCT03952143|79446920|FG000|Lead-In Period|Lack of Efficacy|2|||
44438089|NCT03952143|79446921|FG001|Lead-In Period|Lack of Efficacy|0|||
44438090|NCT03952143|79446922|FG002|Lead-In Period|Lack of Efficacy|0|||
44438091|NCT03952143|79446920|FG000|Lead-In Period|Physician Decision|5|||
44438092|NCT03952143|79446921|FG001|Lead-In Period|Physician Decision|0|||
44438093|NCT03952143|79446922|FG002|Lead-In Period|Physician Decision|0|||
44438094|NCT03952143|79446920|FG000|Lead-In Period|Protocol Violation|5|||
44338465|NCT01279200|79342933|FG000|Overall Study|Withdrawal by Subject|1|||
44438095|NCT03952143|79446921|FG001|Lead-In Period|Protocol Violation|0|||
44438096|NCT03952143|79446922|FG002|Lead-In Period|Protocol Violation|0|||
44438097|NCT03952143|79446920|FG000|Lead-In Period|Withdrawal by Subject|19|||
44438098|NCT03952143|79446921|FG001|Lead-In Period|Withdrawal by Subject|0|||
44438099|NCT03952143|79446922|FG002|Lead-In Period|Withdrawal by Subject|0|||
44438100|NCT03952143|79446920|FG000|Treatment Period|Adverse Event|0|||
44438101|NCT03952143|79446921|FG001|Treatment Period|Adverse Event|0|||
44438102|NCT03952143|79446922|FG002|Treatment Period|Adverse Event|1|||
44438103|NCT03952143|79446920|FG000|Treatment Period|Lost to Follow-up|0|||
44438104|NCT03952143|79446921|FG001|Treatment Period|Lost to Follow-up|2|||
44438105|NCT03952143|79446922|FG002|Treatment Period|Lost to Follow-up|0|||
44438106|NCT03952143|79446920|FG000|Treatment Period|Physician Decision|0|||
44438107|NCT03952143|79446921|FG001|Treatment Period|Physician Decision|0|||
44438108|NCT03952143|79446922|FG002|Treatment Period|Physician Decision|2|||
44438109|NCT03952143|79446920|FG000|Treatment Period|Protocol Violation|0|||
44438110|NCT03952143|79446921|FG001|Treatment Period|Protocol Violation|0|||
44438111|NCT03952143|79446922|FG002|Treatment Period|Protocol Violation|1|||
44438112|NCT03952143|79446920|FG000|Treatment Period|Withdrawal by Subject|0|||
44438113|NCT03952143|79446921|FG001|Treatment Period|Withdrawal by Subject|5|||
44438114|NCT03952143|79446922|FG002|Treatment Period|Withdrawal by Subject|26|||
44438115|NCT03952143|79446920|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
44438116|NCT03952143|79446921|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
44438117|NCT03952143|79446922|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
44438118|NCT03952143|79446920|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
44438119|NCT03952143|79446921|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
44438120|NCT03952143|79446922|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
44438121|NCT00267007|79446931|FG000|Overall Study|Withdrawal by Subject|6|||
44438122|NCT00267007|79446932|FG001|Overall Study|Withdrawal by Subject|0|||
44438123|NCT00267007|79446931|FG000|Overall Study|Lost to Follow-up|1|||
44438124|NCT00267007|79446932|FG001|Overall Study|Lost to Follow-up|0|||
44438125|NCT00267007|79446931|FG000|Overall Study|Non-compliance|0|||
44438126|NCT00267007|79446932|FG001|Overall Study|Non-compliance|1|||
44438127|NCT00267007|79446931|FG000|Overall Study|Adverse Event|1|||
44438128|NCT00267007|79446932|FG001|Overall Study|Adverse Event|0|||
44438129|NCT03943095|79446940|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
44438130|NCT03943095|79446941|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
44438131|NCT03943095|79446940|FG000|Overall Study|Withdrawal by Subject|1|||
44438132|NCT03943095|79446941|FG001|Overall Study|Withdrawal by Subject|0|||
44438133|NCT00251641|79446950|FG000|Overall Study|Adverse Event|80|||
44438134|NCT00251641|79446951|FG001|Overall Study|Adverse Event|8|||
44438135|NCT00251641|79446950|FG000|Overall Study|Lack of Efficacy|2|||
44438136|NCT00251641|79446951|FG001|Overall Study|Lack of Efficacy|1|||
44438137|NCT00251641|79446950|FG000|Overall Study|Progression of Disease|0|||
44438138|NCT00251641|79446951|FG001|Overall Study|Progression of Disease|2|||
44438139|NCT00251641|79446950|FG000|Overall Study|Lost to Follow-up|3|||
44438140|NCT00251641|79446951|FG001|Overall Study|Lost to Follow-up|3|||
44338466|NCT01279200|79342934|FG001|Overall Study|Withdrawal by Subject|3|||
44338467|NCT01279200|79342933|FG000|Overall Study|Patient withdrawal due to high cost|0|||
44338468|NCT01279200|79342934|FG001|Overall Study|Patient withdrawal due to high cost|1|||
44338469|NCT01279200|79342933|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
44338470|NCT01279200|79342934|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
44338471|NCT01279200|79342933|FG000|Overall Study|ultrasound screening failure|0|||
44338472|NCT01279200|79342934|FG001|Overall Study|ultrasound screening failure|1|||
44338473|NCT01279200|79342933|FG000|Overall Study|Lost to Follow-up|0|||
44438141|NCT00251641|79446950|FG000|Overall Study|Withdrawal by Subject|6|||
44338474|NCT01279200|79342934|FG001|Overall Study|Lost to Follow-up|1|||
44438142|NCT00251641|79446951|FG001|Overall Study|Withdrawal by Subject|8|||
44438143|NCT00251641|79446950|FG000|Overall Study|Protocol Violation|10|||
44438144|NCT00251641|79446951|FG001|Overall Study|Protocol Violation|2|||
44438145|NCT00251641|79446950|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
44438146|NCT00251641|79446951|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
44438147|NCT00251641|79446950|FG000|Overall Study|Switched Treatment|9|||
44438148|NCT00251641|79446951|FG001|Overall Study|Switched Treatment|63|||
44438149|NCT00250705|79446959|FG000|Overall Study|Lack of Efficacy|2|||
44438150|NCT00266695|79446965|FG000|Overall Study|Adverse Event|1|||
44438151|NCT00266695|79446965|FG000|Overall Study|Death|9|||
44438152|NCT00266695|79446965|FG000|Overall Study|Physician Decision|1|||
44438153|NCT00266695|79446965|FG000|Overall Study|Lost to Follow-up|3|||
44438154|NCT00266695|79446965|FG000|Overall Study|Withdrawal by Subject|15|||
44438155|NCT00620022|79446969|FG000|Treatment Period 1|Adverse Event|4|||
44438156|NCT00620022|79446970|FG001|Treatment Period 1|Adverse Event|6|||
44438157|NCT00620022|79446969|FG000|Treatment Period 1|Subject withdrew consent|1|||
44438158|NCT00620022|79446970|FG001|Treatment Period 1|Subject withdrew consent|0|||
44438159|NCT00620022|79446969|FG000|Treatment Period 2|Adverse Event|2|||
44438160|NCT00620022|79446970|FG001|Treatment Period 2|Adverse Event|2|||
44438161|NCT00547521|79446978|FG000|Short Term Study (4 Months)|Adverse Event|1|||
44438162|NCT00547521|79446979|FG001|Short Term Study (4 Months)|Adverse Event|0|||
44438163|NCT00547521|79446978|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
44438164|NCT00547521|79446979|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
44438165|NCT00547521|79446978|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
44438166|NCT00547521|79446979|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
44438167|NCT00547521|79446978|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
44438168|NCT00547521|79446979|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
44438169|NCT00547521|79446978|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
44438170|NCT00547521|79446979|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
44438171|NCT00547521|79446978|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
44438172|NCT00547521|79446979|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
44438173|NCT00547521|79446978|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
44438174|NCT00547521|79446979|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
44438175|NCT00547521|79446978|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
44438176|NCT00547521|79446979|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
44438177|NCT00547521|79446978|FG000|Long Term Extension (LTE) Study|Other|0|||
44438178|NCT00547521|79446979|FG001|Long Term Extension (LTE) Study|Other|2|||
44438179|NCT00547521|79446978|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
44438180|NCT00547521|79446979|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
44438181|NCT00266227|79446994|FG000|Initial Treatment|Adverse Event|0|||
44438182|NCT00266227|79446995|FG001|Initial Treatment|Adverse Event|0|||
44438183|NCT00266227|79446996|FG002|Initial Treatment|Adverse Event|13|||
44438184|NCT00266227|79446994|FG000|Initial Treatment|Lost to Follow-up|0|||
44438185|NCT00266227|79446995|FG001|Initial Treatment|Lost to Follow-up|0|||
44438186|NCT00266227|79446996|FG002|Initial Treatment|Lost to Follow-up|6|||
44438187|NCT00266227|79446994|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
44438188|NCT00266227|79446995|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
44438189|NCT00266227|79446996|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
44438190|NCT00266227|79446994|FG000|Initial Treatment|Physician decision to withdraw|0|||
44438191|NCT00266227|79446995|FG001|Initial Treatment|Physician decision to withdraw|0|||
44438192|NCT00266227|79446996|FG002|Initial Treatment|Physician decision to withdraw|12|||
44438193|NCT00266227|79446994|FG000|Initial Treatment|Pregnancy|0|||
44438194|NCT00266227|79446995|FG001|Initial Treatment|Pregnancy|0|||
44438195|NCT00266227|79446996|FG002|Initial Treatment|Pregnancy|1|||
44438196|NCT00266227|79446994|FG000|Retreatment: Up to Week 48|Death|1|||
44438197|NCT00266227|79446995|FG001|Retreatment: Up to Week 48|Death|0|||
44438198|NCT00266227|79446996|FG002|Retreatment: Up to Week 48|Death|0|||
44438199|NCT00266227|79446994|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
44438200|NCT00266227|79446995|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
44438201|NCT00266227|79446996|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
44438202|NCT00266227|79446994|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
44438203|NCT00266227|79446995|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
44338475|NCT01279200|79342933|FG000|Overall Study|Adverse Event|1|||
44338476|NCT01279200|79342934|FG001|Overall Study|Adverse Event|0|||
44338477|NCT01273818|79342943|FG000|Overall Study|Physician Decision|13|||
44338478|NCT01273818|79342944|FG001|Overall Study|Physician Decision|2|||
44338479|NCT01273818|79342945|FG002|Overall Study|Physician Decision|9|||
44338480|NCT01245387|79342953|FG000|Overall Study|Lost to Follow-up|106|||
44338481|NCT01245387|79342953|FG000|Overall Study|Lack of Efficacy|195|||
44338482|NCT01245387|79342953|FG000|Overall Study|Adverse Event|9|||
44338483|NCT01245387|79342953|FG000|Overall Study|Death|3|||
44438204|NCT00266227|79446996|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
44438205|NCT00266227|79446994|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
44438206|NCT00266227|79446995|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
44338484|NCT01245387|79342953|FG000|Overall Study|Other|131|||
44438207|NCT00266227|79446996|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
44438208|NCT00266227|79446994|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
44438209|NCT00266227|79446995|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
44438210|NCT00266227|79446996|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
44438211|NCT00266227|79446994|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
44438212|NCT00266227|79446995|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
44438213|NCT00266227|79446996|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
44438214|NCT00266227|79446994|FG000|Retreatment: Week 48 to Week 72|Death|1|||
44438215|NCT00266227|79446995|FG001|Retreatment: Week 48 to Week 72|Death|1|||
44438216|NCT00266227|79446996|FG002|Retreatment: Week 48 to Week 72|Death|0|||
44438217|NCT00266227|79446994|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
44438218|NCT00266227|79446995|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
44259389|NCT00088166|79119257|FG000|Overall Study|Patient deterioration|29|||
44259390|NCT00088166|79119258|FG001|Overall Study|Patient deterioration|39|||
44438219|NCT00266227|79446996|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
44438220|NCT00266227|79446994|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
44438221|NCT00266227|79446995|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
44438222|NCT00266227|79446996|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
44438223|NCT00266227|79446994|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
44438224|NCT00266227|79446995|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
44438225|NCT00266227|79446996|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
44438226|NCT00266227|79446994|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
44438227|NCT00266227|79446995|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
44438228|NCT00266227|79446996|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
44438229|NCT00287365|79447005|FG000|Overall Study|sample not acquired|13|||
44438230|NCT00573768|79447013|FG000|Overall Study|Adverse Event|1|||
44438231|NCT00573768|79447014|FG001|Overall Study|Adverse Event|1|||
44438232|NCT00573768|79447015|FG002|Overall Study|Adverse Event|2|||
44438233|NCT00573768|79447013|FG000|Overall Study|Protocol Violation|1|||
44438234|NCT00573768|79447014|FG001|Overall Study|Protocol Violation|0|||
44438235|NCT00573768|79447015|FG002|Overall Study|Protocol Violation|1|||
44438236|NCT00573768|79447013|FG000|Overall Study|Withdrawal by Subject|0|||
44438237|NCT00573768|79447014|FG001|Overall Study|Withdrawal by Subject|1|||
44438238|NCT00573768|79447015|FG002|Overall Study|Withdrawal by Subject|0|||
44438239|NCT00573768|79447013|FG000|Overall Study|Lost to Follow-up|0|||
44438240|NCT00573768|79447014|FG001|Overall Study|Lost to Follow-up|0|||
44438241|NCT00573768|79447015|FG002|Overall Study|Lost to Follow-up|1|||
44438242|NCT00547365|79447023|FG000|Overall Study|Physician Decision|1|||
44438243|NCT00547365|79447023|FG000|Overall Study|Lost to Follow-up|1|||
44438244|NCT00547365|79447023|FG000|Overall Study|Protocol Violation|2|||
44438245|NCT00547365|79447023|FG000|Overall Study|death (not related to study)|4|||
44438246|NCT00619866|79447031|FG000|Weeks 1 - 12|Adverse Event|0|||
44438247|NCT00619866|79447032|FG001|Weeks 1 - 12|Adverse Event|1|||
44438248|NCT00619866|79447033|FG002|Weeks 1 - 12|Adverse Event|2|||
44438249|NCT00619866|79447034|FG003|Weeks 1 - 12|Adverse Event|0|||
44438250|NCT00619866|79447035|FG004|Weeks 1 - 12|Adverse Event|0|||
44438251|NCT00619866|79447031|FG000|Weeks 1 - 12|Non-compliance|0|||
44438252|NCT00619866|79447032|FG001|Weeks 1 - 12|Non-compliance|0|||
44438253|NCT00619866|79447033|FG002|Weeks 1 - 12|Non-compliance|1|||
44438254|NCT00619866|79447034|FG003|Weeks 1 - 12|Non-compliance|0|||
44438255|NCT00619866|79447035|FG004|Weeks 1 - 12|Non-compliance|0|||
44438256|NCT00619866|79447031|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
44438257|NCT00619866|79447032|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
44438258|NCT00619866|79447033|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
44438259|NCT00619866|79447034|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
44438260|NCT00619866|79447035|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
44438261|NCT00619866|79447031|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
44438262|NCT00619866|79447032|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
44438263|NCT00619866|79447033|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
44438264|NCT00619866|79447034|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
44438265|NCT00619866|79447035|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
44438266|NCT00619866|79447031|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
44438267|NCT00619866|79447032|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
44438268|NCT00619866|79447033|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
44438269|NCT00619866|79447034|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
44438270|NCT00619866|79447035|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
44438271|NCT00619866|79447031|FG000|Weeks 1 - 12|Sponsor Decision|0|||
44438272|NCT00619866|79447032|FG001|Weeks 1 - 12|Sponsor Decision|1|||
44438273|NCT00619866|79447033|FG002|Weeks 1 - 12|Sponsor Decision|0|||
44438274|NCT00619866|79447034|FG003|Weeks 1 - 12|Sponsor Decision|0|||
44438275|NCT00619866|79447035|FG004|Weeks 1 - 12|Sponsor Decision|0|||
44438276|NCT00619866|79447031|FG000|Weeks 13 - 24|Adverse Event|0|||
44438277|NCT00619866|79447032|FG001|Weeks 13 - 24|Adverse Event|0|||
44438278|NCT00619866|79447033|FG002|Weeks 13 - 24|Adverse Event|2|||
44438279|NCT00619866|79447034|FG003|Weeks 13 - 24|Adverse Event|1|||
44438280|NCT00619866|79447035|FG004|Weeks 13 - 24|Adverse Event|0|||
44438281|NCT00619866|79447031|FG000|Weeks 13 - 24|Protocol Deviation|0|||
44259391|NCT00088166|79119257|FG000|Overall Study|Withdrawal by Subject|5|||
44438282|NCT00619866|79447032|FG001|Weeks 13 - 24|Protocol Deviation|0|||
44438283|NCT00619866|79447033|FG002|Weeks 13 - 24|Protocol Deviation|0|||
44438284|NCT00619866|79447034|FG003|Weeks 13 - 24|Protocol Deviation|1|||
44438285|NCT00619866|79447035|FG004|Weeks 13 - 24|Protocol Deviation|0|||
44438286|NCT00619866|79447031|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
44438287|NCT00619866|79447032|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
44438288|NCT00619866|79447033|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
44438289|NCT00619866|79447034|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
44438290|NCT00619866|79447035|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
44438291|NCT00619866|79447031|FG000|Weeks 13 - 24|Non-compliance|0|||
44438292|NCT00619866|79447032|FG001|Weeks 13 - 24|Non-compliance|1|||
44438293|NCT00619866|79447033|FG002|Weeks 13 - 24|Non-compliance|1|||
44438294|NCT00619866|79447034|FG003|Weeks 13 - 24|Non-compliance|0|||
44438295|NCT00619866|79447035|FG004|Weeks 13 - 24|Non-compliance|0|||
44438296|NCT00619866|79447031|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
44438297|NCT00619866|79447032|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
44438298|NCT00619866|79447033|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
44438299|NCT00619866|79447034|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
44438300|NCT00619866|79447035|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
44438301|NCT03937479|79447063|FG000|Overall Study|Adverse Event|2|||
44438302|NCT03937479|79447064|FG001|Overall Study|Adverse Event|3|||
44438303|NCT03937479|79447065|FG002|Overall Study|Adverse Event|0|||
44438304|NCT03937479|79447066|FG003|Overall Study|Adverse Event|0|||
44438305|NCT03937479|79447067|FG004|Overall Study|Adverse Event|1|||
44438306|NCT03937479|79447063|FG000|Overall Study|Withdrawal by Subject|3|||
44438307|NCT03937479|79447064|FG001|Overall Study|Withdrawal by Subject|5|||
44438308|NCT03937479|79447065|FG002|Overall Study|Withdrawal by Subject|2|||
44438309|NCT03937479|79447066|FG003|Overall Study|Withdrawal by Subject|2|||
44438310|NCT03937479|79447067|FG004|Overall Study|Withdrawal by Subject|1|||
44438311|NCT03937479|79447063|FG000|Overall Study|Protocol Violation|5|||
44438312|NCT03937479|79447064|FG001|Overall Study|Protocol Violation|6|||
44438313|NCT03937479|79447065|FG002|Overall Study|Protocol Violation|4|||
44438314|NCT03937479|79447066|FG003|Overall Study|Protocol Violation|3|||
44438315|NCT03937479|79447067|FG004|Overall Study|Protocol Violation|2|||
44438316|NCT03937479|79447063|FG000|Overall Study|Lost to Follow-up|0|||
44438317|NCT03937479|79447064|FG001|Overall Study|Lost to Follow-up|1|||
44438318|NCT03937479|79447065|FG002|Overall Study|Lost to Follow-up|0|||
44438319|NCT03937479|79447066|FG003|Overall Study|Lost to Follow-up|1|||
44438320|NCT03937479|79447067|FG004|Overall Study|Lost to Follow-up|0|||
44338485|NCT01245387|79342953|FG000|Overall Study|Missing discontinuation status|369|||
44338486|NCT01037218|79342961|FG000|Overall Study|Adverse Event|4|||
44338487|NCT01037218|79342962|FG001|Overall Study|Adverse Event|2|||
44338488|NCT01037218|79342963|FG002|Overall Study|Adverse Event|2|||
44338489|NCT01037218|79342964|FG003|Overall Study|Adverse Event|1|||
44338490|NCT01037218|79342961|FG000|Overall Study|Lack of Efficacy|0|||
44338491|NCT01037218|79342962|FG001|Overall Study|Lack of Efficacy|2|||
44338492|NCT01037218|79342963|FG002|Overall Study|Lack of Efficacy|1|||
44338493|NCT01037218|79342964|FG003|Overall Study|Lack of Efficacy|5|||
44338494|NCT01037218|79342961|FG000|Overall Study|Lost to Follow-up|3|||
44338495|NCT01037218|79342962|FG001|Overall Study|Lost to Follow-up|5|||
44338496|NCT01037218|79342963|FG002|Overall Study|Lost to Follow-up|4|||
44338497|NCT01037218|79342964|FG003|Overall Study|Lost to Follow-up|2|||
44338498|NCT01037218|79342961|FG000|Overall Study|Withdrawal by Subject|6|||
44338499|NCT01037218|79342962|FG001|Overall Study|Withdrawal by Subject|7|||
44338500|NCT01037218|79342963|FG002|Overall Study|Withdrawal by Subject|7|||
44338501|NCT01037218|79342964|FG003|Overall Study|Withdrawal by Subject|4|||
44338502|NCT01037218|79342961|FG000|Overall Study|Partner Withdrew Consent|0|||
44338503|NCT01037218|79342962|FG001|Overall Study|Partner Withdrew Consent|3|||
44338504|NCT01037218|79342963|FG002|Overall Study|Partner Withdrew Consent|2|||
44338505|NCT01037218|79342964|FG003|Overall Study|Partner Withdrew Consent|1|||
44338506|NCT01037218|79342961|FG000|Overall Study|Protocol Violation|0|||
44338507|NCT01037218|79342962|FG001|Overall Study|Protocol Violation|0|||
44338508|NCT01037218|79342963|FG002|Overall Study|Protocol Violation|2|||
44338509|NCT01037218|79342964|FG003|Overall Study|Protocol Violation|2|||
44338510|NCT01037218|79342961|FG000|Overall Study|Various|3|||
44338511|NCT01037218|79342962|FG001|Overall Study|Various|2|||
44338512|NCT01037218|79342963|FG002|Overall Study|Various|3|||
44338513|NCT01037218|79342964|FG003|Overall Study|Various|1|||
44338514|NCT01038856|79342974|FG000|Overall Study|Adverse Event|2|||
44338515|NCT01066546|79342980|FG000|Overall Study|Study terminated by sponsor|5|||
44438321|NCT03937479|79447063|FG000|Overall Study|Physician Decision|0|||
44438322|NCT03937479|79447064|FG001|Overall Study|Physician Decision|0|||
44438323|NCT03937479|79447065|FG002|Overall Study|Physician Decision|1|||
44438324|NCT03937479|79447066|FG003|Overall Study|Physician Decision|0|||
44438325|NCT03937479|79447067|FG004|Overall Study|Physician Decision|1|||
44438326|NCT00619476|79447083|FG000|Overall Study|Adverse Event|12|||
44157589|NCT00712881|78949411|FG001|Overall Study|Disease Progression|1|||
44438327|NCT00619476|79447084|FG001|Overall Study|Adverse Event|6|||
44338516|NCT01272804|79342990|FG000|Overall Study|Adverse Event|1|||
44338517|NCT01272804|79342991|FG001|Overall Study|Adverse Event|0|||
44338518|NCT01272804|79342992|FG002|Overall Study|Adverse Event|0|||
44338519|NCT01272804|79342993|FG003|Overall Study|Adverse Event|0|||
44438328|NCT00619476|79447085|FG002|Overall Study|Adverse Event|12|||
44338520|NCT01272804|79342994|FG004|Overall Study|Adverse Event|2|||
44338521|NCT01272804|79342995|FG005|Overall Study|Adverse Event|1|||
44338522|NCT01269918|79343011|FG000|Overall Study|Did not receive study drug|0|||
44157590|NCT00712881|78949410|FG000|Overall Study|Lost to Follow-up|1|||
44438329|NCT00619476|79447086|FG003|Overall Study|Adverse Event|16|||
44438330|NCT00619476|79447083|FG000|Overall Study|Lack of Efficacy|6|||
44438331|NCT00619476|79447084|FG001|Overall Study|Lack of Efficacy|1|||
44438332|NCT00619476|79447085|FG002|Overall Study|Lack of Efficacy|1|||
44438333|NCT00619476|79447086|FG003|Overall Study|Lack of Efficacy|4|||
44438334|NCT00619476|79447083|FG000|Overall Study|Protocol Violation|5|||
44438335|NCT00619476|79447084|FG001|Overall Study|Protocol Violation|4|||
44438336|NCT00619476|79447085|FG002|Overall Study|Protocol Violation|4|||
44438337|NCT00619476|79447086|FG003|Overall Study|Protocol Violation|9|||
44438338|NCT00619476|79447083|FG000|Overall Study|Lost to Follow-up|1|||
44438339|NCT00619476|79447084|FG001|Overall Study|Lost to Follow-up|2|||
44438340|NCT00619476|79447085|FG002|Overall Study|Lost to Follow-up|0|||
44438341|NCT00619476|79447086|FG003|Overall Study|Lost to Follow-up|1|||
44259392|NCT00088166|79119258|FG001|Overall Study|Withdrawal by Subject|5|||
44338523|NCT01269918|79343012|FG001|Overall Study|Did not receive study drug|3|||
44338524|NCT01036594|79343018|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
44438342|NCT00619476|79447083|FG000|Overall Study|Investigator Discretion|2|||
44438343|NCT00619476|79447084|FG001|Overall Study|Investigator Discretion|2|||
44438344|NCT00619476|79447085|FG002|Overall Study|Investigator Discretion|2|||
44438345|NCT00619476|79447086|FG003|Overall Study|Investigator Discretion|0|||
44438346|NCT00619476|79447083|FG000|Overall Study|Withdrawal by Subject|5|||
44438347|NCT00619476|79447084|FG001|Overall Study|Withdrawal by Subject|7|||
44438348|NCT00619476|79447085|FG002|Overall Study|Withdrawal by Subject|5|||
44438349|NCT00619476|79447086|FG003|Overall Study|Withdrawal by Subject|4|||
44438350|NCT00618072|79447099|FG000|Overall Study|Lost to Follow-up|2|||
44438351|NCT00618072|79447100|FG001|Overall Study|Lost to Follow-up|0|||
44259393|NCT00087698|79119302|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
44259394|NCT00087698|79119302|FG000|Overall Study|Death from Other Causes|3|||
44259395|NCT00087698|79119302|FG000|Overall Study|Adverse Event|4|||
44259396|NCT00087698|79119302|FG000|Overall Study|Withdrawal by Subject|4|||
44259397|NCT00087698|79119302|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
44259398|NCT00087698|79119302|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
44259399|NCT00087698|79119302|FG000|Overall Study|Clinical Relapse|1|||
44259400|NCT00087698|79119302|FG000|Overall Study|Death from Study Disease|2|||
44259401|NCT00087698|79119302|FG000|Overall Study|Death from Study Drug Toxicity|2|||
44259402|NCT00087698|79119302|FG000|Overall Study|Protocol Violation|1|||
44259403|NCT00087152|79119320|FG000|Overall Study|Ineligible|6|||
44259404|NCT00086996|79119372|FG000|Overall Study|Adverse Event|29|||
44259405|NCT00086996|79119372|FG000|Overall Study|Death|4|||
44259406|NCT00086996|79119372|FG000|Overall Study|progression/relapse|7|||
44438352|NCT00618072|79447101|FG002|Overall Study|Lost to Follow-up|3|||
44438353|NCT00618072|79447099|FG000|Overall Study|Physician Decision|0|||
44438354|NCT00618072|79447100|FG001|Overall Study|Physician Decision|1|||
44438355|NCT00618072|79447101|FG002|Overall Study|Physician Decision|1|||
44438356|NCT00666926|79447109|FG000|Overall Study|Adverse Event|0|||
44438357|NCT00666926|79447110|FG001|Overall Study|Adverse Event|0|||
44438358|NCT00666926|79447111|FG002|Overall Study|Adverse Event|0|||
44438359|NCT00666926|79447112|FG003|Overall Study|Adverse Event|0|||
44438360|NCT00666926|79447113|FG004|Overall Study|Adverse Event|0|||
44438361|NCT00666926|79447114|FG005|Overall Study|Adverse Event|0|||
44438362|NCT00666926|79447115|FG006|Overall Study|Adverse Event|0|||
44438363|NCT00666926|79447116|FG007|Overall Study|Adverse Event|0|||
44438364|NCT00666926|79447117|FG008|Overall Study|Adverse Event|0|||
44438365|NCT00666926|79447118|FG009|Overall Study|Adverse Event|2|||
44438366|NCT00666926|79447119|FG010|Overall Study|Adverse Event|2|||
44438367|NCT00666926|79447120|FG011|Overall Study|Adverse Event|2|||
44438368|NCT00666926|79447121|FG012|Overall Study|Adverse Event|0|||
44438369|NCT00666926|79447122|FG013|Overall Study|Adverse Event|1|||
44438370|NCT00666926|79447123|FG014|Overall Study|Adverse Event|0|||
44438371|NCT00666926|79447124|FG015|Overall Study|Adverse Event|0|||
44438372|NCT00666926|79447109|FG000|Overall Study|Laboratory abnormality|0|||
44438373|NCT00666926|79447110|FG001|Overall Study|Laboratory abnormality|0|||
44438374|NCT00666926|79447111|FG002|Overall Study|Laboratory abnormality|0|||
44438375|NCT00666926|79447112|FG003|Overall Study|Laboratory abnormality|0|||
44438376|NCT00666926|79447113|FG004|Overall Study|Laboratory abnormality|0|||
44438377|NCT00666926|79447114|FG005|Overall Study|Laboratory abnormality|0|||
44438378|NCT00666926|79447115|FG006|Overall Study|Laboratory abnormality|0|||
44438379|NCT00666926|79447116|FG007|Overall Study|Laboratory abnormality|0|||
44438380|NCT00666926|79447117|FG008|Overall Study|Laboratory abnormality|0|||
44438381|NCT00666926|79447118|FG009|Overall Study|Laboratory abnormality|0|||
44438382|NCT00666926|79447119|FG010|Overall Study|Laboratory abnormality|1|||
44438383|NCT00666926|79447120|FG011|Overall Study|Laboratory abnormality|0|||
44438384|NCT00666926|79447121|FG012|Overall Study|Laboratory abnormality|0|||
44438385|NCT00666926|79447122|FG013|Overall Study|Laboratory abnormality|0|||
44438386|NCT00666926|79447123|FG014|Overall Study|Laboratory abnormality|0|||
44438387|NCT00666926|79447124|FG015|Overall Study|Laboratory abnormality|1|||
44338525|NCT01036594|79343019|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
44438388|NCT00666926|79447109|FG000|Overall Study|Lack of Efficacy|0|||
44438389|NCT00666926|79447110|FG001|Overall Study|Lack of Efficacy|0|||
44438390|NCT00666926|79447111|FG002|Overall Study|Lack of Efficacy|0|||
44438391|NCT00666926|79447112|FG003|Overall Study|Lack of Efficacy|0|||
44438392|NCT00666926|79447113|FG004|Overall Study|Lack of Efficacy|0|||
44438393|NCT00666926|79447114|FG005|Overall Study|Lack of Efficacy|1|||
44438394|NCT00666926|79447115|FG006|Overall Study|Lack of Efficacy|0|||
44438395|NCT00666926|79447116|FG007|Overall Study|Lack of Efficacy|0|||
44438396|NCT00666926|79447117|FG008|Overall Study|Lack of Efficacy|0|||
44438397|NCT00666926|79447118|FG009|Overall Study|Lack of Efficacy|0|||
44438398|NCT00666926|79447119|FG010|Overall Study|Lack of Efficacy|0|||
44438399|NCT00666926|79447120|FG011|Overall Study|Lack of Efficacy|1|||
44259407|NCT00086996|79119372|FG000|Overall Study|Withdrawal by Subject|13|||
44259408|NCT00086996|79119372|FG000|Overall Study|Other|6|||
44259409|NCT00086996|79119372|FG000|Overall Study|not eligible|5|||
44259410|NCT00086684|79119674|FG000|Overall Study|Adverse Event|12|||
44259411|NCT00086684|79119675|FG001|Overall Study|Adverse Event|17|||
44259412|NCT00086684|79119676|FG002|Overall Study|Adverse Event|14|||
44259413|NCT00086684|79119674|FG000|Overall Study|Lack of Efficacy|6|||
44259414|NCT00086684|79119675|FG001|Overall Study|Lack of Efficacy|6|||
44338526|NCT01036594|79343018|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
44338527|NCT01036594|79343019|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
44338528|NCT01036594|79343018|FG000|Week 12 Evaluation|Adverse Event|5|||
44338529|NCT01036594|79343019|FG001|Week 12 Evaluation|Adverse Event|0|||
44338530|NCT01036594|79343018|FG000|Week 12 Evaluation|Physician Decision|1|||
44338531|NCT01036594|79343019|FG001|Week 12 Evaluation|Physician Decision|0|||
44338532|NCT01036594|79343018|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
44338533|NCT01036594|79343019|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
44338534|NCT01036594|79343018|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
44338535|NCT01036594|79343019|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
44338536|NCT01036594|79343018|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
44438400|NCT00666926|79447121|FG012|Overall Study|Lack of Efficacy|0|||
44438401|NCT00666926|79447122|FG013|Overall Study|Lack of Efficacy|0|||
44438402|NCT00666926|79447123|FG014|Overall Study|Lack of Efficacy|0|||
44157591|NCT00712881|78949411|FG001|Overall Study|Lost to Follow-up|1|||
44157592|NCT00712881|78949410|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
44157593|NCT00712881|78949411|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
44438403|NCT00666926|79447124|FG015|Overall Study|Lack of Efficacy|0|||
44438404|NCT00666926|79447109|FG000|Overall Study|Lost to Follow-up|0|||
44438405|NCT00666926|79447110|FG001|Overall Study|Lost to Follow-up|0|||
44438406|NCT00666926|79447111|FG002|Overall Study|Lost to Follow-up|0|||
44438407|NCT00666926|79447112|FG003|Overall Study|Lost to Follow-up|1|||
44438408|NCT00666926|79447113|FG004|Overall Study|Lost to Follow-up|0|||
44438409|NCT00666926|79447114|FG005|Overall Study|Lost to Follow-up|0|||
44438410|NCT00666926|79447115|FG006|Overall Study|Lost to Follow-up|0|||
44438411|NCT00666926|79447116|FG007|Overall Study|Lost to Follow-up|0|||
44438412|NCT00666926|79447117|FG008|Overall Study|Lost to Follow-up|0|||
44438413|NCT00666926|79447118|FG009|Overall Study|Lost to Follow-up|0|||
44438414|NCT00666926|79447119|FG010|Overall Study|Lost to Follow-up|0|||
44438415|NCT00666926|79447120|FG011|Overall Study|Lost to Follow-up|0|||
44438416|NCT00666926|79447121|FG012|Overall Study|Lost to Follow-up|0|||
44438417|NCT00666926|79447122|FG013|Overall Study|Lost to Follow-up|0|||
44338537|NCT01036594|79343019|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
44338538|NCT01036594|79343018|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
44438418|NCT00666926|79447123|FG014|Overall Study|Lost to Follow-up|0|||
44438419|NCT00666926|79447124|FG015|Overall Study|Lost to Follow-up|0|||
44438420|NCT00666926|79447109|FG000|Overall Study|Other|2|||
44438421|NCT00666926|79447110|FG001|Overall Study|Other|4|||
44438422|NCT00666926|79447111|FG002|Overall Study|Other|3|||
44438423|NCT00666926|79447112|FG003|Overall Study|Other|3|||
44438424|NCT00666926|79447113|FG004|Overall Study|Other|3|||
44438425|NCT00666926|79447114|FG005|Overall Study|Other|3|||
44438426|NCT00666926|79447115|FG006|Overall Study|Other|4|||
44438427|NCT00666926|79447116|FG007|Overall Study|Other|0|||
44438428|NCT00666926|79447117|FG008|Overall Study|Other|3|||
44438429|NCT00666926|79447118|FG009|Overall Study|Other|5|||
44438430|NCT00666926|79447119|FG010|Overall Study|Other|3|||
44438431|NCT00666926|79447120|FG011|Overall Study|Other|26|||
44438432|NCT00666926|79447121|FG012|Overall Study|Other|3|||
44438433|NCT00666926|79447122|FG013|Overall Study|Other|2|||
44438434|NCT00666926|79447123|FG014|Overall Study|Other|4|||
44438435|NCT00666926|79447124|FG015|Overall Study|Other|4|||
44338539|NCT01036594|79343019|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
44338540|NCT01036594|79343018|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
44338541|NCT01036594|79343019|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
44338542|NCT01036438|79343027|FG000|Overall Study|Adverse Event|7|||
44338543|NCT01036438|79343028|FG001|Overall Study|Adverse Event|8|||
44438436|NCT00666926|79447109|FG000|Overall Study|Withdrawal by Subject|0|||
44438437|NCT00666926|79447110|FG001|Overall Study|Withdrawal by Subject|0|||
44438438|NCT00666926|79447111|FG002|Overall Study|Withdrawal by Subject|0|||
44438439|NCT00666926|79447112|FG003|Overall Study|Withdrawal by Subject|0|||
44338544|NCT01036438|79343027|FG000|Overall Study|Death|0|||
44438440|NCT00666926|79447113|FG004|Overall Study|Withdrawal by Subject|0|||
44438441|NCT00666926|79447114|FG005|Overall Study|Withdrawal by Subject|0|||
44438442|NCT00666926|79447115|FG006|Overall Study|Withdrawal by Subject|0|||
44157594|NCT00712881|78949410|FG000|Overall Study|Protocol Violation|1|||
44157595|NCT00712881|78949411|FG001|Overall Study|Protocol Violation|1|||
44157596|NCT00712881|78949410|FG000|Overall Study|Randomized but not treated|1|||
44157597|NCT00712881|78949411|FG001|Overall Study|Randomized but not treated|0|||
44167847|NCT02528357|78961058|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167848|NCT02528357|78961059|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167849|NCT02528357|78961060|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167850|NCT02528357|78961061|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167851|NCT02528357|78961043|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44338545|NCT01036438|79343028|FG001|Overall Study|Death|1|||
44167852|NCT02528357|78961044|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167853|NCT02528357|78961045|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167854|NCT02528357|78961046|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44338546|NCT01036438|79343027|FG000|Overall Study|No effect of study treatment|3|||
44157598|NCT03573817|78949419|FG000|Overall Study|Adverse Event|0|||
44157599|NCT03573817|78949420|FG001|Overall Study|Adverse Event|2|||
44338547|NCT01036438|79343028|FG001|Overall Study|No effect of study treatment|1|||
44338548|NCT01268046|79343038|FG000|Overall Study|Withdrawal by Subject|1|||
44338549|NCT01268046|79343039|FG001|Overall Study|Withdrawal by Subject|0|||
44338550|NCT01268046|79343040|FG002|Overall Study|Withdrawal by Subject|0|||
44438443|NCT00666926|79447116|FG007|Overall Study|Withdrawal by Subject|1|||
44438444|NCT00666926|79447117|FG008|Overall Study|Withdrawal by Subject|0|||
44338551|NCT01268046|79343041|FG003|Overall Study|Withdrawal by Subject|1|||
44338552|NCT01268046|79343038|FG000|Overall Study|Lost to Follow-up|0|||
44338553|NCT01268046|79343039|FG001|Overall Study|Lost to Follow-up|0|||
44338554|NCT01268046|79343040|FG002|Overall Study|Lost to Follow-up|1|||
44338555|NCT01268046|79343041|FG003|Overall Study|Lost to Follow-up|0|||
44338556|NCT01267266|79343051|FG000|Enrollment Phase|Withdrawal by Subject|2|||
44338557|NCT01267266|79343052|FG001|Enrollment Phase|Withdrawal by Subject|0|||
44338558|NCT01267266|79343051|FG000|Lead-in Phase|Lack of Efficacy|20|||
44338559|NCT01267266|79343052|FG001|Lead-in Phase|Lack of Efficacy|0|||
44338560|NCT01267266|79343051|FG000|Lead-in Phase|Adverse Event|2|||
44338561|NCT01267266|79343052|FG001|Lead-in Phase|Adverse Event|0|||
44338562|NCT01267266|79343051|FG000|Lead-in Phase|Withdrawal by Subject|1|||
44338563|NCT01267266|79343052|FG001|Lead-in Phase|Withdrawal by Subject|0|||
44338564|NCT01034176|79343063|FG000|Overall Study|Physician Decision|2|||
44338565|NCT01034176|79343064|FG001|Overall Study|Physician Decision|0|||
44338566|NCT01034176|79343063|FG000|Overall Study|Withdrawal by Subject|0|||
44338567|NCT01034176|79343064|FG001|Overall Study|Withdrawal by Subject|1|||
44338568|NCT01034176|79343063|FG000|Overall Study|Lost to Follow-up|0|||
44338569|NCT01034176|79343064|FG001|Overall Study|Lost to Follow-up|1|||
44338570|NCT01033942|79343073|FG000|Overall Study|Withdrawal by Subject|1|||
44338571|NCT01033942|79343074|FG001|Overall Study|Withdrawal by Subject|1|||
44338572|NCT01033942|79343075|FG002|Overall Study|Withdrawal by Subject|1|||
44338573|NCT01033942|79343073|FG000|Overall Study|Lost to Follow-up|1|||
44338574|NCT01033942|79343074|FG001|Overall Study|Lost to Follow-up|0|||
44338575|NCT01033942|79343075|FG002|Overall Study|Lost to Follow-up|0|||
44338576|NCT01033942|79343073|FG000|Overall Study|Enrolled in Extension Study|0|||
44338577|NCT01033942|79343074|FG001|Overall Study|Enrolled in Extension Study|3|||
44338578|NCT01033942|79343075|FG002|Overall Study|Enrolled in Extension Study|0|||
44338579|NCT01062256|79343088|FG000|Overall Study|Adverse Event|1|||
44338580|NCT01062256|79343089|FG001|Overall Study|Adverse Event|0|||
44338581|NCT01062256|79343090|FG002|Overall Study|Adverse Event|0|||
44338582|NCT01062256|79343088|FG000|Overall Study|Withdrawal by Subject|1|||
44438445|NCT00666926|79447118|FG009|Overall Study|Withdrawal by Subject|3|||
44438446|NCT00666926|79447119|FG010|Overall Study|Withdrawal by Subject|0|||
44438447|NCT00666926|79447120|FG011|Overall Study|Withdrawal by Subject|3|||
44438448|NCT00666926|79447121|FG012|Overall Study|Withdrawal by Subject|0|||
44438449|NCT00666926|79447122|FG013|Overall Study|Withdrawal by Subject|1|||
44438450|NCT00666926|79447123|FG014|Overall Study|Withdrawal by Subject|3|||
44438451|NCT00666926|79447124|FG015|Overall Study|Withdrawal by Subject|3|||
44157600|NCT03573817|78949419|FG000|Overall Study|Protocol Violation|0|||
44157601|NCT03573817|78949420|FG001|Overall Study|Protocol Violation|1|||
44338583|NCT01062256|79343089|FG001|Overall Study|Withdrawal by Subject|1|||
44338584|NCT01062256|79343090|FG002|Overall Study|Withdrawal by Subject|1|||
44338585|NCT01062256|79343088|FG000|Overall Study|Ineligible|1|||
44157602|NCT03573817|78949419|FG000|Overall Study|Withdrawal by Subject|1|||
44338586|NCT01062256|79343089|FG001|Overall Study|Ineligible|4|||
44338587|NCT01062256|79343090|FG002|Overall Study|Ineligible|3|||
44338588|NCT01062256|79343088|FG000|Overall Study|Administrative|0|||
44338589|NCT01062256|79343089|FG001|Overall Study|Administrative|2|||
44157603|NCT03573817|78949420|FG001|Overall Study|Withdrawal by Subject|1|||
44438452|NCT00666926|79447109|FG000|Overall Study|Death|0|||
44438453|NCT00666926|79447110|FG001|Overall Study|Death|0|||
44438454|NCT00666926|79447111|FG002|Overall Study|Death|0|||
44438455|NCT00666926|79447112|FG003|Overall Study|Death|0|||
44438456|NCT00666926|79447113|FG004|Overall Study|Death|0|||
44438457|NCT00666926|79447114|FG005|Overall Study|Death|0|||
44438458|NCT00666926|79447115|FG006|Overall Study|Death|0|||
44438459|NCT00666926|79447116|FG007|Overall Study|Death|0|||
44338590|NCT01062256|79343090|FG002|Overall Study|Administrative|0|||
44338591|NCT01029886|79343100|FG000|Overall Study|Adverse Event|12|||
44338592|NCT01029886|79343101|FG001|Overall Study|Adverse Event|25|||
44338593|NCT01029886|79343100|FG000|Overall Study|Lost to Follow-up|1|||
44338594|NCT01029886|79343101|FG001|Overall Study|Lost to Follow-up|0|||
44338595|NCT01029886|79343100|FG000|Overall Study|Physician Decision|2|||
44338596|NCT01029886|79343101|FG001|Overall Study|Physician Decision|6|||
44338597|NCT01029886|79343100|FG000|Overall Study|Protocol Violation|17|||
44338598|NCT01029886|79343101|FG001|Overall Study|Protocol Violation|5|||
44438460|NCT00666926|79447117|FG008|Overall Study|Death|0|||
44438461|NCT00666926|79447118|FG009|Overall Study|Death|0|||
44338599|NCT01029886|79343100|FG000|Overall Study|Withdrawal by Subject|8|||
44438462|NCT00666926|79447119|FG010|Overall Study|Death|0|||
44438463|NCT00666926|79447120|FG011|Overall Study|Death|1|||
44438464|NCT00666926|79447121|FG012|Overall Study|Death|0|||
44438465|NCT00666926|79447122|FG013|Overall Study|Death|0|||
44438466|NCT00666926|79447123|FG014|Overall Study|Death|0|||
44438467|NCT00666926|79447124|FG015|Overall Study|Death|0|||
44338600|NCT01029886|79343101|FG001|Overall Study|Withdrawal by Subject|18|||
44338601|NCT01029886|79343100|FG000|Overall Study|Entry Criteria Not Met|13|||
44338602|NCT01029886|79343101|FG001|Overall Study|Entry Criteria Not Met|5|||
44338603|NCT01029886|79343100|FG000|Overall Study|Sponsor Decision|1|||
44338604|NCT01029886|79343101|FG001|Overall Study|Sponsor Decision|0|||
44338605|NCT01029886|79343100|FG000|Overall Study|Loss Glucose Control|7|||
44338606|NCT01029886|79343101|FG001|Overall Study|Loss Glucose Control|1|||
44338607|NCT01244763|79343117|FG000|Overall Study|Adverse Event|1|||
44338608|NCT01244763|79343118|FG001|Overall Study|Adverse Event|0|||
44338609|NCT01244763|79343119|FG002|Overall Study|Adverse Event|0|||
44338610|NCT01244763|79343120|FG003|Overall Study|Adverse Event|0|||
44338611|NCT01244763|79343121|FG004|Overall Study|Adverse Event|0|||
44338612|NCT01244763|79343122|FG005|Overall Study|Adverse Event|1|||
44438468|NCT03861052|79447179|FG000|Overall Study|Adverse Event|1|||
44438469|NCT03861052|79447180|FG001|Overall Study|Adverse Event|1|||
44338613|NCT01244763|79343117|FG000|Overall Study|Death|1|||
44438470|NCT03861052|79447181|FG002|Overall Study|Adverse Event|2|||
44438471|NCT03861052|79447182|FG003|Overall Study|Adverse Event|4|||
44438472|NCT03861052|79447179|FG000|Overall Study|Lost to Follow-up|0|||
44438473|NCT03861052|79447180|FG001|Overall Study|Lost to Follow-up|0|||
44438474|NCT03861052|79447181|FG002|Overall Study|Lost to Follow-up|0|||
44438475|NCT03861052|79447182|FG003|Overall Study|Lost to Follow-up|1|||
44438476|NCT03861052|79447179|FG000|Overall Study|Physician Decision|0|||
44438477|NCT03861052|79447180|FG001|Overall Study|Physician Decision|1|||
44438478|NCT03861052|79447181|FG002|Overall Study|Physician Decision|0|||
44438479|NCT03861052|79447182|FG003|Overall Study|Physician Decision|0|||
44438480|NCT03861052|79447179|FG000|Overall Study|Withdrawal by Subject|2|||
44438481|NCT03861052|79447180|FG001|Overall Study|Withdrawal by Subject|5|||
44338614|NCT01244763|79343118|FG001|Overall Study|Death|0|||
44338615|NCT01244763|79343119|FG002|Overall Study|Death|1|||
44338616|NCT01244763|79343120|FG003|Overall Study|Death|0|||
44338617|NCT01244763|79343121|FG004|Overall Study|Death|2|||
44338618|NCT01244763|79343122|FG005|Overall Study|Death|0|||
44338619|NCT01244763|79343117|FG000|Overall Study|Physician Decision|0|||
44338620|NCT01244763|79343118|FG001|Overall Study|Physician Decision|0|||
44338621|NCT01244763|79343119|FG002|Overall Study|Physician Decision|1|||
44338622|NCT01244763|79343120|FG003|Overall Study|Physician Decision|0|||
44338623|NCT01244763|79343121|FG004|Overall Study|Physician Decision|0|||
44338624|NCT01244763|79343122|FG005|Overall Study|Physician Decision|0|||
44338625|NCT01244763|79343117|FG000|Overall Study|Withdrawal by Subject|1|||
44338626|NCT01244763|79343118|FG001|Overall Study|Withdrawal by Subject|2|||
44338627|NCT01244763|79343119|FG002|Overall Study|Withdrawal by Subject|0|||
44438482|NCT03861052|79447181|FG002|Overall Study|Withdrawal by Subject|3|||
44438483|NCT03861052|79447182|FG003|Overall Study|Withdrawal by Subject|0|||
44438484|NCT03861052|79447179|FG000|Overall Study|Relocation to other city|1|||
44438485|NCT03861052|79447180|FG001|Overall Study|Relocation to other city|0|||
44438486|NCT03861052|79447181|FG002|Overall Study|Relocation to other city|0|||
44438487|NCT03861052|79447182|FG003|Overall Study|Relocation to other city|0|||
44338628|NCT01244763|79343120|FG003|Overall Study|Withdrawal by Subject|1|||
44338629|NCT01244763|79343121|FG004|Overall Study|Withdrawal by Subject|1|||
44338630|NCT01244763|79343122|FG005|Overall Study|Withdrawal by Subject|2|||
44338631|NCT01244763|79343117|FG000|Overall Study|Lost to Follow-up|0|||
44338632|NCT01244763|79343118|FG001|Overall Study|Lost to Follow-up|1|||
44338633|NCT01244763|79343119|FG002|Overall Study|Lost to Follow-up|0|||
44338634|NCT01244763|79343120|FG003|Overall Study|Lost to Follow-up|0|||
44338635|NCT01244763|79343121|FG004|Overall Study|Lost to Follow-up|0|||
44338636|NCT01244763|79343122|FG005|Overall Study|Lost to Follow-up|0|||
44338637|NCT01244763|79343117|FG000|Overall Study|Enrolled into the Extension Study|0|||
44338638|NCT01244763|79343118|FG001|Overall Study|Enrolled into the Extension Study|0|||
44338639|NCT01244763|79343119|FG002|Overall Study|Enrolled into the Extension Study|0|||
44438488|NCT00664742|79447197|FG000|Overall Study|Withdrawn due to adverse events|3|||
44438489|NCT00664742|79447197|FG000|Overall Study|Withdrawal by Subject|31|||
44438490|NCT00664742|79447197|FG000|Overall Study|Lost to Follow-up|92|||
44438491|NCT00511342|79447203|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
44438492|NCT00511342|79447204|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
44438493|NCT00511342|79447203|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
44438494|NCT00511342|79447204|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
44438495|NCT00511342|79447203|FG000|Overall Study|Pregnancy|0|||
44438496|NCT00511342|79447204|FG001|Overall Study|Pregnancy|1|||
44438497|NCT00511342|79447203|FG000|Overall Study|Pregnancy wish|0|||
44438498|NCT00511342|79447204|FG001|Overall Study|Pregnancy wish|1|||
44438499|NCT00511342|79447203|FG000|Overall Study|Lost to Follow-up|1|||
44438500|NCT00511342|79447204|FG001|Overall Study|Lost to Follow-up|5|||
44438501|NCT00511342|79447203|FG000|Overall Study|Other Reason|2|||
44438502|NCT00511342|79447204|FG001|Overall Study|Other Reason|2|||
44438503|NCT03931785|79447214|FG000|Overall Study|Lost to Follow-up|4|||
44438504|NCT03931785|79447215|FG001|Overall Study|Lost to Follow-up|1|||
44438505|NCT03931785|79447216|FG002|Overall Study|Lost to Follow-up|4|||
44438506|NCT03931785|79447217|FG003|Overall Study|Lost to Follow-up|3|||
44438507|NCT03931785|79447214|FG000|Overall Study|Adverse Event|1|||
44438508|NCT03931785|79447215|FG001|Overall Study|Adverse Event|0|||
44438509|NCT03931785|79447216|FG002|Overall Study|Adverse Event|3|||
44438510|NCT03931785|79447217|FG003|Overall Study|Adverse Event|4|||
44438511|NCT03931785|79447214|FG000|Overall Study|Protocol Violation|0|||
44438512|NCT03931785|79447215|FG001|Overall Study|Protocol Violation|1|||
44438513|NCT03931785|79447216|FG002|Overall Study|Protocol Violation|0|||
44438514|NCT03931785|79447217|FG003|Overall Study|Protocol Violation|0|||
44438515|NCT03931785|79447214|FG000|Overall Study|Noncompliance With Study drug|0|||
44438516|NCT03931785|79447215|FG001|Overall Study|Noncompliance With Study drug|1|||
44438517|NCT03931785|79447216|FG002|Overall Study|Noncompliance With Study drug|0|||
44157604|NCT02638103|78949435|FG000|Overall Study|Adverse Event|13|||
44157605|NCT02638103|78949436|FG001|Overall Study|Adverse Event|12|||
44157606|NCT02638103|78949437|FG002|Overall Study|Adverse Event|19|||
44157607|NCT02638103|78949438|FG003|Overall Study|Adverse Event|12|||
44157608|NCT02638103|78949435|FG000|Overall Study|Withdrawal by Subject|43|||
44157609|NCT02638103|78949436|FG001|Overall Study|Withdrawal by Subject|53|||
44157610|NCT02638103|78949437|FG002|Overall Study|Withdrawal by Subject|30|||
44157611|NCT02638103|78949438|FG003|Overall Study|Withdrawal by Subject|61|||
44157612|NCT02638103|78949435|FG000|Overall Study|Protocol Violation|1|||
44157613|NCT02638103|78949436|FG001|Overall Study|Protocol Violation|2|||
44157614|NCT02638103|78949437|FG002|Overall Study|Protocol Violation|1|||
44157615|NCT02638103|78949438|FG003|Overall Study|Protocol Violation|4|||
44157616|NCT02638103|78949435|FG000|Overall Study|Pregnancy|2|||
44157617|NCT02638103|78949436|FG001|Overall Study|Pregnancy|3|||
44157618|NCT02638103|78949437|FG002|Overall Study|Pregnancy|0|||
44157619|NCT02638103|78949438|FG003|Overall Study|Pregnancy|1|||
44157620|NCT02638103|78949435|FG000|Overall Study|Non-compliance to Study Procedures|2|||
44157621|NCT02638103|78949436|FG001|Overall Study|Non-compliance to Study Procedures|1|||
44157622|NCT02638103|78949437|FG002|Overall Study|Non-compliance to Study Procedures|1|||
44157623|NCT02638103|78949438|FG003|Overall Study|Non-compliance to Study Procedures|1|||
44157624|NCT02638103|78949435|FG000|Overall Study|Lost to Follow-up|26|||
44157625|NCT02638103|78949436|FG001|Overall Study|Lost to Follow-up|33|||
44157626|NCT02638103|78949437|FG002|Overall Study|Lost to Follow-up|20|||
44157627|NCT02638103|78949438|FG003|Overall Study|Lost to Follow-up|37|||
44438518|NCT03931785|79447217|FG003|Overall Study|Noncompliance With Study drug|0|||
44438519|NCT03931785|79447214|FG000|Overall Study|Other Not specified|0|||
44438520|NCT03931785|79447215|FG001|Overall Study|Other Not specified|2|||
44157628|NCT02638103|78949435|FG000|Overall Study|Lack of Efficacy|14|||
44157629|NCT02638103|78949436|FG001|Overall Study|Lack of Efficacy|10|||
44338640|NCT01244763|79343120|FG003|Overall Study|Enrolled into the Extension Study|0|||
44438521|NCT03931785|79447216|FG002|Overall Study|Other Not specified|2|||
44438522|NCT03931785|79447217|FG003|Overall Study|Other Not specified|2|||
44157630|NCT02638103|78949437|FG002|Overall Study|Lack of Efficacy|12|||
44438523|NCT03931785|79447214|FG000|Overall Study|Withdrawal by Subject|0|||
44157631|NCT02638103|78949438|FG003|Overall Study|Lack of Efficacy|22|||
44338641|NCT01244763|79343121|FG004|Overall Study|Enrolled into the Extension Study|0|||
44338642|NCT01244763|79343122|FG005|Overall Study|Enrolled into the Extension Study|1|||
44338643|NCT01244061|79343138|FG000|Overall Study|Death|1|||
44338644|NCT01244061|79343139|FG001|Overall Study|Death|0|||
44338645|NCT01244061|79343138|FG000|Overall Study|Did not meet entrance criteria|1|||
44338646|NCT01244061|79343139|FG001|Overall Study|Did not meet entrance criteria|0|||
44338647|NCT01244061|79343138|FG000|Overall Study|Lack of Efficacy|1|||
44338648|NCT01244061|79343139|FG001|Overall Study|Lack of Efficacy|3|||
44338649|NCT01244061|79343138|FG000|Overall Study|Lost to Follow-up|34|||
44338650|NCT01244061|79343139|FG001|Overall Study|Lost to Follow-up|30|||
44338651|NCT01244061|79343138|FG000|Overall Study|Withdrawal by Subject|29|||
44338652|NCT01244061|79343139|FG001|Overall Study|Withdrawal by Subject|46|||
44338653|NCT01244061|79343138|FG000|Overall Study|Other|8|||
44338654|NCT01244061|79343139|FG001|Overall Study|Other|19|||
44338655|NCT01244061|79343138|FG000|Overall Study|Protocol Violation|1|||
44338656|NCT01244061|79343139|FG001|Overall Study|Protocol Violation|1|||
44338657|NCT01244061|79343138|FG000|Overall Study|Adverse Event|5|||
44338658|NCT01244061|79343139|FG001|Overall Study|Adverse Event|2|||
44338659|NCT01244061|79343138|FG000|Overall Study|Randomized but not treated|2|||
44338660|NCT01244061|79343139|FG001|Overall Study|Randomized but not treated|2|||
44338661|NCT01243671|79343145|FG000|Overall Study|Adverse Event|3|||
44338662|NCT01243671|79343145|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
44338663|NCT01243671|79343145|FG000|Overall Study|Other|1|||
44438524|NCT03931785|79447215|FG001|Overall Study|Withdrawal by Subject|2|||
44438525|NCT03931785|79447216|FG002|Overall Study|Withdrawal by Subject|4|||
44438526|NCT03931785|79447217|FG003|Overall Study|Withdrawal by Subject|1|||
44438527|NCT03931785|79447214|FG000|Overall Study|Pregnancy|0|||
44438528|NCT03931785|79447215|FG001|Overall Study|Pregnancy|0|||
44438529|NCT03931785|79447216|FG002|Overall Study|Pregnancy|0|||
44438530|NCT03931785|79447217|FG003|Overall Study|Pregnancy|1|||
44438531|NCT00666536|79447229|FG000|Overall Study|Adverse Event|9|||
44438532|NCT00666536|79447230|FG001|Overall Study|Adverse Event|19|||
44438533|NCT00666536|79447229|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44438534|NCT00666536|79447230|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44438535|NCT00666536|79447229|FG000|Overall Study|Protocol deviation(s)|8|||
44438536|NCT00666536|79447230|FG001|Overall Study|Protocol deviation(s)|6|||
44338664|NCT01240785|79343151|FG000|Overall Study|Lost to Follow-up|1|||
44338665|NCT01240785|79343152|FG001|Overall Study|Lost to Follow-up|0|||
44338666|NCT01240785|79343151|FG000|Overall Study|Protocol Violation|0|||
44338667|NCT01240785|79343152|FG001|Overall Study|Protocol Violation|3|||
44338668|NCT01240551|79343160|FG000|Overall Study|Refused further treatment|3|||
44338669|NCT01240551|79343161|FG001|Overall Study|Refused further treatment|2|||
44438537|NCT00666536|79447229|FG000|Overall Study|Withdrawal by Subject|10|||
44438538|NCT00666536|79447230|FG001|Overall Study|Withdrawal by Subject|9|||
44338670|NCT01240551|79343160|FG000|Overall Study|Lost to Follow-up|1|||
44338671|NCT01240551|79343161|FG001|Overall Study|Lost to Follow-up|1|||
44338672|NCT01239381|79343167|FG000|Overall Study|Protocol Violation|1|||
44438539|NCT00666536|79447229|FG000|Overall Study|Lost to Follow-up|4|||
44438540|NCT00666536|79447230|FG001|Overall Study|Lost to Follow-up|3|||
44438541|NCT00519532|79447236|FG000|Overall Study|Adverse Event|11|||
44438542|NCT00519532|79447236|FG000|Overall Study|Withdrawal by Subject|5|||
44438543|NCT00519532|79447236|FG000|Overall Study|Lost to Follow-up|2|||
44438544|NCT00666458|79447242|FG000|Overall Study|Adverse Event|8|||
44438545|NCT00666458|79447243|FG001|Overall Study|Adverse Event|7|||
44438546|NCT00666458|79447242|FG000|Overall Study|Withdrawal by Subject|5|||
44438547|NCT00666458|79447243|FG001|Overall Study|Withdrawal by Subject|4|||
44438548|NCT00666458|79447242|FG000|Overall Study|Lost to Follow-up|0|||
44438549|NCT00666458|79447243|FG001|Overall Study|Lost to Follow-up|3|||
44438550|NCT00666458|79447242|FG000|Overall Study|Administrative reason by sponsor|1|||
44438551|NCT00666458|79447243|FG001|Overall Study|Administrative reason by sponsor|1|||
44438552|NCT00666458|79447242|FG000|Overall Study|Incorrect enrollment|7|||
44438553|NCT00666458|79447243|FG001|Overall Study|Incorrect enrollment|1|||
44438554|NCT00666458|79447242|FG000|Overall Study|Study specific discontinuation criteria|14|||
44438555|NCT00666458|79447243|FG001|Overall Study|Study specific discontinuation criteria|7|||
44438556|NCT00666458|79447242|FG000|Overall Study|Severe non-compliance to the protocol|1|||
44438557|NCT00666458|79447243|FG001|Overall Study|Severe non-compliance to the protocol|1|||
44438558|NCT00666458|79447242|FG000|Overall Study|Safety reasons|1|||
44438559|NCT00666458|79447243|FG001|Overall Study|Safety reasons|0|||
44438560|NCT00666458|79447242|FG000|Overall Study|Medical history of anemia|1|||
44438561|NCT00666458|79447243|FG001|Overall Study|Medical history of anemia|0|||
44338673|NCT01239381|79343167|FG000|Overall Study|Withdrawal by Subject|1|||
44338674|NCT01266876|79343177|FG000|Overall Study|Adverse Event|0|||
44338675|NCT01266876|79343178|FG001|Overall Study|Adverse Event|0|||
44438562|NCT00511108|79447253|FG000|Overall Study|Adverse Event|2|||
44438563|NCT00511108|79447254|FG001|Overall Study|Adverse Event|0|||
44438564|NCT00511108|79447255|FG002|Overall Study|Adverse Event|1|||
44438565|NCT00511108|79447256|FG003|Overall Study|Adverse Event|2|||
44438566|NCT00511108|79447253|FG000|Overall Study|Lost to Follow-up|0|||
44438567|NCT00511108|79447254|FG001|Overall Study|Lost to Follow-up|2|||
44438568|NCT00511108|79447255|FG002|Overall Study|Lost to Follow-up|1|||
44438569|NCT00511108|79447256|FG003|Overall Study|Lost to Follow-up|0|||
44438570|NCT00511108|79447253|FG000|Overall Study|Physician Decision|0|||
44438571|NCT00511108|79447254|FG001|Overall Study|Physician Decision|0|||
44157632|NCT02638103|78949435|FG000|Overall Study|Other than specified|5|||
44259415|NCT00086684|79119676|FG002|Overall Study|Lack of Efficacy|5|||
44259416|NCT00086684|79119674|FG000|Overall Study|Lost to Follow-up|15|||
44259417|NCT00086684|79119675|FG001|Overall Study|Lost to Follow-up|8|||
44259418|NCT00086684|79119676|FG002|Overall Study|Lost to Follow-up|10|||
44259419|NCT00086684|79119674|FG000|Overall Study|Protocol Violation|8|||
44259420|NCT00086684|79119675|FG001|Overall Study|Protocol Violation|3|||
44259421|NCT00086684|79119676|FG002|Overall Study|Protocol Violation|0|||
44259422|NCT00086684|79119674|FG000|Overall Study|Withdrawal by Subject|0|||
44259423|NCT00086684|79119675|FG001|Overall Study|Withdrawal by Subject|4|||
44259424|NCT00086684|79119676|FG002|Overall Study|Withdrawal by Subject|10|||
44259425|NCT00086684|79119674|FG000|Overall Study|NONCOMPLIANCE|5|||
44259426|NCT00086684|79119675|FG001|Overall Study|NONCOMPLIANCE|7|||
44438572|NCT00511108|79447255|FG002|Overall Study|Physician Decision|0|||
44438573|NCT00511108|79447256|FG003|Overall Study|Physician Decision|1|||
44438574|NCT00511108|79447253|FG000|Overall Study|Withdrawal by Subject|4|||
44438575|NCT00511108|79447254|FG001|Overall Study|Withdrawal by Subject|0|||
44438576|NCT00511108|79447255|FG002|Overall Study|Withdrawal by Subject|3|||
44438577|NCT00511108|79447256|FG003|Overall Study|Withdrawal by Subject|2|||
44438578|NCT00510952|79447268|FG000|Overall Study|Adverse Event|1|||
44438579|NCT00510952|79447269|FG001|Overall Study|Adverse Event|0|||
44438580|NCT00510952|79447268|FG000|Overall Study|Entry Criteria Not Met|3|||
44438581|NCT00510952|79447269|FG001|Overall Study|Entry Criteria Not Met|1|||
44438582|NCT00510952|79447268|FG000|Overall Study|Lost to Follow-up|5|||
44438583|NCT00510952|79447269|FG001|Overall Study|Lost to Follow-up|3|||
44438584|NCT00510952|79447268|FG000|Overall Study|Physician Decision|1|||
44438585|NCT00510952|79447269|FG001|Overall Study|Physician Decision|1|||
44438586|NCT00510952|79447268|FG000|Overall Study|Protocol Violation|7|||
44438587|NCT00510952|79447269|FG001|Overall Study|Protocol Violation|4|||
44438588|NCT00510952|79447268|FG000|Overall Study|Sponsor Decision|1|||
44438589|NCT00510952|79447269|FG001|Overall Study|Sponsor Decision|0|||
44157633|NCT02638103|78949436|FG001|Overall Study|Other than specified|4|||
44157634|NCT02638103|78949437|FG002|Overall Study|Other than specified|2|||
44157635|NCT02638103|78949438|FG003|Overall Study|Other than specified|4|||
44157636|NCT03551743|78949460|FG000|Overall Study|Adverse Event|1|||
44157637|NCT03551743|78949461|FG001|Overall Study|Adverse Event|0|||
44157638|NCT03551743|78949462|FG002|Overall Study|Adverse Event|0|||
44157639|NCT03551743|78949463|FG003|Overall Study|Adverse Event|0|||
44157640|NCT03551743|78949460|FG000|Overall Study|Withdrawal by Subject|1|||
44157641|NCT03551743|78949461|FG001|Overall Study|Withdrawal by Subject|0|||
44157642|NCT03551743|78949462|FG002|Overall Study|Withdrawal by Subject|0|||
44157643|NCT03551743|78949463|FG003|Overall Study|Withdrawal by Subject|0|||
44157644|NCT02636699|78949475|FG000|Overall Study|Adverse Event|4|||
44157645|NCT02636699|78949476|FG001|Overall Study|Adverse Event|0|||
44157646|NCT02636699|78949475|FG000|Overall Study|Lost to Follow-up|3|||
44157647|NCT02636699|78949476|FG001|Overall Study|Lost to Follow-up|3|||
44157648|NCT02636699|78949475|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
44157649|NCT02636699|78949476|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
44157650|NCT02636699|78949475|FG000|Overall Study|Physician Decision|0|||
44157651|NCT02636699|78949476|FG001|Overall Study|Physician Decision|1|||
44157652|NCT02636699|78949475|FG000|Overall Study|Withdrawal by Subject|13|||
44157653|NCT02636699|78949476|FG001|Overall Study|Withdrawal by Subject|6|||
44157654|NCT02636699|78949475|FG000|Overall Study|Other|3|||
44157655|NCT02636699|78949476|FG001|Overall Study|Other|1|||
44157656|NCT02634983|78949482|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
44157657|NCT02634983|78949483|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
44157658|NCT02633501|78949495|FG000|Overall Study|Adverse Event|0|||
44157659|NCT02633501|78949496|FG001|Overall Study|Adverse Event|0|||
44157660|NCT02633501|78949497|FG002|Overall Study|Adverse Event|1|||
44438590|NCT00510952|79447268|FG000|Overall Study|Withdrawal by Subject|6|||
44157661|NCT02633501|78949498|FG003|Overall Study|Adverse Event|0|||
44157662|NCT02633501|78949499|FG004|Overall Study|Adverse Event|1|||
44157663|NCT02633501|78949500|FG005|Overall Study|Adverse Event|1|||
44157664|NCT02633501|78949495|FG000|Overall Study|Withdrawal by Subject|2|||
44157665|NCT02633501|78949496|FG001|Overall Study|Withdrawal by Subject|1|||
44157666|NCT02633501|78949497|FG002|Overall Study|Withdrawal by Subject|2|||
44157667|NCT02633501|78949498|FG003|Overall Study|Withdrawal by Subject|2|||
44157668|NCT02633501|78949499|FG004|Overall Study|Withdrawal by Subject|1|||
44157669|NCT02633501|78949500|FG005|Overall Study|Withdrawal by Subject|3|||
44157670|NCT02633501|78949495|FG000|Overall Study|Various other reasons|0|||
44157671|NCT02633501|78949496|FG001|Overall Study|Various other reasons|2|||
44157672|NCT02633501|78949497|FG002|Overall Study|Various other reasons|4|||
44157673|NCT02633501|78949498|FG003|Overall Study|Various other reasons|1|||
44157674|NCT02633501|78949499|FG004|Overall Study|Various other reasons|7|||
44157675|NCT02633501|78949500|FG005|Overall Study|Various other reasons|11|||
44157676|NCT02633501|78949495|FG000|Overall Study|Lost to Follow-up|0|||
44157677|NCT02633501|78949496|FG001|Overall Study|Lost to Follow-up|0|||
44338676|NCT01266876|79343179|FG002|Overall Study|Adverse Event|0|||
44338677|NCT01266876|79343180|FG003|Overall Study|Adverse Event|1|||
44338678|NCT01266876|79343181|FG004|Overall Study|Adverse Event|0|||
44338679|NCT01033240|79343196|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
44338680|NCT01033240|79343197|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
44338681|NCT01033240|79343198|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
44338682|NCT01033240|79343196|FG000|Overall Study|Death|2|||
44338683|NCT01033240|79343197|FG001|Overall Study|Death|0|||
44338684|NCT01033240|79343198|FG002|Overall Study|Death|0|||
44338685|NCT01033240|79343196|FG000|Overall Study|Withdrew Consent|2|||
44157678|NCT02633501|78949497|FG002|Overall Study|Lost to Follow-up|0|||
44157679|NCT02633501|78949498|FG003|Overall Study|Lost to Follow-up|1|||
44338686|NCT01033240|79343197|FG001|Overall Study|Withdrew Consent|9|||
44338687|NCT01033240|79343198|FG002|Overall Study|Withdrew Consent|2|||
44338688|NCT01033240|79343196|FG000|Overall Study|Disease Progression|35|||
44438591|NCT00510952|79447269|FG001|Overall Study|Withdrawal by Subject|7|||
44438592|NCT00510952|79447268|FG000|Overall Study|Did Not Receive Study Drug|2|||
44438593|NCT00510952|79447269|FG001|Overall Study|Did Not Receive Study Drug|0|||
44438594|NCT00617604|79447277|FG000|Overall Study|Death|2|||
44438595|NCT00617604|79447278|FG001|Overall Study|Death|1|||
44438596|NCT00617604|79447277|FG000|Overall Study|Lost to Follow-up|1|||
44438597|NCT00617604|79447278|FG001|Overall Study|Lost to Follow-up|0|||
44438598|NCT00617604|79447277|FG000|Overall Study|Miscellaneous Reasons|8|||
44438599|NCT00617604|79447278|FG001|Overall Study|Miscellaneous Reasons|10|||
44438600|NCT00617604|79447277|FG000|Overall Study|Withdrawal by Subject|4|||
44438601|NCT00617604|79447278|FG001|Overall Study|Withdrawal by Subject|6|||
44438602|NCT00617604|79447277|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
44438603|NCT00617604|79447278|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
44438604|NCT00661622|79447286|FG000|Overall Study|Protocol Violation|1|||
44438605|NCT00661622|79447287|FG001|Overall Study|Protocol Violation|0|||
44438606|NCT04093752|79447298|FG000|Overall Study|Adverse Event|7|||
44438607|NCT04093752|79447299|FG001|Overall Study|Adverse Event|19|||
44438608|NCT04093752|79447300|FG002|Overall Study|Adverse Event|18|||
44438609|NCT04093752|79447301|FG003|Overall Study|Adverse Event|4|||
44438610|NCT04093752|79447298|FG000|Overall Study|Withdrawal by Subject|6|||
44438611|NCT04093752|79447299|FG001|Overall Study|Withdrawal by Subject|6|||
44438612|NCT04093752|79447300|FG002|Overall Study|Withdrawal by Subject|8|||
44438613|NCT04093752|79447301|FG003|Overall Study|Withdrawal by Subject|20|||
44338689|NCT01033240|79343197|FG001|Overall Study|Disease Progression|32|||
44338690|NCT01033240|79343198|FG002|Overall Study|Disease Progression|41|||
44338691|NCT01033240|79343196|FG000|Overall Study|Investigator Discretion|0|||
44338692|NCT01033240|79343197|FG001|Overall Study|Investigator Discretion|0|||
44338693|NCT01033240|79343198|FG002|Overall Study|Investigator Discretion|2|||
44338694|NCT01033240|79343196|FG000|Overall Study|Other|0|||
44438614|NCT04093752|79447298|FG000|Overall Study|Lost to Follow-up|2|||
44438615|NCT04093752|79447299|FG001|Overall Study|Lost to Follow-up|1|||
44438616|NCT04093752|79447300|FG002|Overall Study|Lost to Follow-up|1|||
44438617|NCT04093752|79447301|FG003|Overall Study|Lost to Follow-up|1|||
44438618|NCT04093752|79447298|FG000|Overall Study|Death|0|||
44438619|NCT04093752|79447299|FG001|Overall Study|Death|0|||
44438620|NCT04093752|79447300|FG002|Overall Study|Death|1|||
44438621|NCT04093752|79447301|FG003|Overall Study|Death|2|||
44438622|NCT04093752|79447298|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
44438623|NCT04093752|79447299|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
44438624|NCT04093752|79447300|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
44438625|NCT04093752|79447301|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
44438626|NCT04093752|79447298|FG000|Overall Study|Covid 19|0|||
44438627|NCT04093752|79447299|FG001|Overall Study|Covid 19|0|||
44438628|NCT04093752|79447300|FG002|Overall Study|Covid 19|0|||
44438629|NCT04093752|79447301|FG003|Overall Study|Covid 19|1|||
44438630|NCT04093752|79447298|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
44338695|NCT01033240|79343197|FG001|Overall Study|Other|1|||
44438631|NCT04093752|79447299|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
44438632|NCT04093752|79447300|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
44438633|NCT04093752|79447301|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
44438634|NCT04093752|79447298|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
44438635|NCT04093752|79447299|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
44157680|NCT02633501|78949499|FG004|Overall Study|Lost to Follow-up|2|||
44338696|NCT01033240|79343198|FG002|Overall Study|Other|2|||
44438636|NCT04093752|79447300|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
44157681|NCT02633501|78949500|FG005|Overall Study|Lost to Follow-up|0|||
44438637|NCT04093752|79447301|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
44438638|NCT04093752|79447298|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
44438639|NCT04093752|79447299|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
44438640|NCT04093752|79447300|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
44438641|NCT04093752|79447301|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
44438642|NCT03928821|79447319|FG000|Overall Study|Death|0|||
44438643|NCT03928821|79447320|FG001|Overall Study|Death|1|||
44438644|NCT03928821|79447321|FG002|Overall Study|Death|0|||
44438645|NCT03928821|79447322|FG003|Overall Study|Death|0|||
44438646|NCT03928821|79447319|FG000|Overall Study|Lost to Follow-up|0|||
44157682|NCT03591107|78949521|FG000|Overall Study|Same patient in both arms|1|||
44157683|NCT03591107|78949522|FG001|Overall Study|Same patient in both arms|1|||
44338697|NCT01266018|79343206|FG000|Overall Study|Physician Decision|1|||
44338698|NCT01266018|79343207|FG001|Overall Study|Physician Decision|0|||
44338699|NCT01266018|79343206|FG000|Overall Study|Progressive disease|0|||
44338700|NCT01266018|79343207|FG001|Overall Study|Progressive disease|1|||
44338701|NCT01032382|79343215|FG000|Overall Study|Disease dissemination|1|||
44338702|NCT01032382|79343216|FG001|Overall Study|Disease dissemination|1|||
44338703|NCT01032382|79343215|FG000|Overall Study|Treatment failure|3|||
44338704|NCT01032382|79343216|FG001|Overall Study|Treatment failure|1|||
44157684|NCT03591107|78949521|FG000|Overall Study|Sought care at other clinics|0|||
44338705|NCT01032382|79343215|FG000|Overall Study|Index lesion relapse|1|||
44338706|NCT01032382|79343216|FG001|Overall Study|Index lesion relapse|3|||
44157685|NCT03591107|78949522|FG001|Overall Study|Sought care at other clinics|2|||
44157686|NCT03591107|78949521|FG000|Overall Study|Discharged from clinic|0|||
44259427|NCT00086684|79119676|FG002|Overall Study|NONCOMPLIANCE|6|||
44157687|NCT03591107|78949522|FG001|Overall Study|Discharged from clinic|1|||
44157688|NCT03591107|78949521|FG000|Overall Study|Withdrawal by Subject|0|||
44157689|NCT03591107|78949522|FG001|Overall Study|Withdrawal by Subject|1|||
44157690|NCT02922023|78949535|FG000|Overall Study|Lost to Follow-up|2|||
44438647|NCT03928821|79447320|FG001|Overall Study|Lost to Follow-up|2|||
44157691|NCT02922023|78949536|FG001|Overall Study|Lost to Follow-up|0|||
44438648|NCT03928821|79447321|FG002|Overall Study|Lost to Follow-up|3|||
44438649|NCT03928821|79447322|FG003|Overall Study|Lost to Follow-up|0|||
44438650|NCT03928821|79447319|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
44438651|NCT03928821|79447320|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
44438652|NCT03928821|79447321|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
44438653|NCT03928821|79447322|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
44438654|NCT00666224|79447334|FG000|Double-Blind|Adverse Event|15|||
44438655|NCT00666224|79447335|FG001|Double-Blind|Adverse Event|5|||
44438656|NCT00666224|79447334|FG000|Double-Blind|Lost to Follow-up|2|||
44438657|NCT00666224|79447335|FG001|Double-Blind|Lost to Follow-up|2|||
44438658|NCT00666224|79447334|FG000|Double-Blind|Withdrawal by Subject|18|||
44438659|NCT00666224|79447335|FG001|Double-Blind|Withdrawal by Subject|14|||
44438660|NCT00666224|79447334|FG000|Double-Blind|Physician Decision|0|||
44438661|NCT00666224|79447335|FG001|Double-Blind|Physician Decision|3|||
44438662|NCT00666224|79447334|FG000|Double-Blind|Sponsor decision|1|||
44438663|NCT00666224|79447335|FG001|Double-Blind|Sponsor decision|0|||
44438664|NCT00666224|79447334|FG000|Double-Blind|Pregnancy|3|||
44438665|NCT00666224|79447335|FG001|Double-Blind|Pregnancy|2|||
44438666|NCT00666224|79447334|FG000|Double-Blind|Noncompliance|1|||
44438667|NCT00666224|79447335|FG001|Double-Blind|Noncompliance|0|||
44438668|NCT00666224|79447334|FG000|Double-Blind|Death|1|||
44438669|NCT00666224|79447335|FG001|Double-Blind|Death|0|||
44438670|NCT00666224|79447334|FG000|Double-Blind|Undefined/Unknown|4|||
44438671|NCT00666224|79447335|FG001|Double-Blind|Undefined/Unknown|1|||
44438672|NCT00666224|79447334|FG000|Open-Label|Adverse Event|8|||
44438673|NCT00666224|79447335|FG001|Open-Label|Adverse Event|43|||
44438674|NCT00666224|79447334|FG000|Open-Label|Lost to Follow-up|4|||
44438675|NCT00666224|79447335|FG001|Open-Label|Lost to Follow-up|5|||
44438676|NCT00666224|79447334|FG000|Open-Label|Withdrawal by Subject|12|||
44438677|NCT00666224|79447335|FG001|Open-Label|Withdrawal by Subject|25|||
44438678|NCT00666224|79447334|FG000|Open-Label|Physician Decision|7|||
44438679|NCT00666224|79447335|FG001|Open-Label|Physician Decision|5|||
44438680|NCT00666224|79447334|FG000|Open-Label|Pregnancy|1|||
44438681|NCT00666224|79447335|FG001|Open-Label|Pregnancy|5|||
44438682|NCT00666224|79447334|FG000|Open-Label|Noncompliance|2|||
44438683|NCT00666224|79447335|FG001|Open-Label|Noncompliance|1|||
44438684|NCT00666224|79447334|FG000|Open-Label|Undefined/Unknown|1|||
44438685|NCT00666224|79447335|FG001|Open-Label|Undefined/Unknown|1|||
44438686|NCT00663962|79447344|FG000|Overall Study|somnolence|1|||
44438687|NCT00663962|79447345|FG001|Overall Study|somnolence|0|||
44438688|NCT00265759|79447357|FG000|Overall Study|Withdrawal by Subject|0|||
44438689|NCT00265759|79447358|FG001|Overall Study|Withdrawal by Subject|1|||
44438690|NCT00265759|79447359|FG002|Overall Study|Withdrawal by Subject|2|||
44438691|NCT00265759|79447360|FG003|Overall Study|Withdrawal by Subject|2|||
44438692|NCT00265759|79447357|FG000|Overall Study|Cancel|0|||
44438693|NCT00265759|79447358|FG001|Overall Study|Cancel|0|||
44438694|NCT00265759|79447359|FG002|Overall Study|Cancel|0|||
44438695|NCT00265759|79447360|FG003|Overall Study|Cancel|3|||
44438696|NCT00265759|79447357|FG000|Overall Study|Ineligible|0|||
44438697|NCT00265759|79447358|FG001|Overall Study|Ineligible|0|||
44438698|NCT00265759|79447359|FG002|Overall Study|Ineligible|0|||
44438699|NCT00265759|79447360|FG003|Overall Study|Ineligible|1|||
44438700|NCT00265759|79447357|FG000|Overall Study|Bilateral disease|0|||
44438701|NCT00265759|79447358|FG001|Overall Study|Bilateral disease|0|||
44438702|NCT00265759|79447359|FG002|Overall Study|Bilateral disease|0|||
44438703|NCT00265759|79447360|FG003|Overall Study|Bilateral disease|2|||
44438704|NCT00265759|79447357|FG000|Overall Study|Discontinued due to intolerability|0|||
44438705|NCT00265759|79447358|FG001|Overall Study|Discontinued due to intolerability|0|||
44438706|NCT00265759|79447359|FG002|Overall Study|Discontinued due to intolerability|0|||
44438707|NCT00265759|79447360|FG003|Overall Study|Discontinued due to intolerability|1|||
44438708|NCT00744263|79447373|FG000|Overall Study|Death|3006|||
44438709|NCT00744263|79447374|FG001|Overall Study|Death|3005|||
44438710|NCT00744263|79447373|FG000|Overall Study|Lost to Follow-up|2038|||
44438711|NCT00744263|79447374|FG001|Overall Study|Lost to Follow-up|2135|||
44438712|NCT00744263|79447373|FG000|Overall Study|Withdrawal by Subject|166|||
44438713|NCT00744263|79447374|FG001|Overall Study|Withdrawal by Subject|150|||
44438714|NCT00744263|79447373|FG000|Overall Study|Physician Decision|20|||
44438715|NCT00744263|79447374|FG001|Overall Study|Physician Decision|23|||
44438716|NCT00744263|79447373|FG000|Overall Study|Protocol Violation|3|||
44438717|NCT00744263|79447374|FG001|Overall Study|Protocol Violation|5|||
44438718|NCT00744263|79447373|FG000|Overall Study|Adverse Event|1|||
44438719|NCT00744263|79447374|FG001|Overall Study|Adverse Event|0|||
44438720|NCT00744263|79447373|FG000|Overall Study|Other|2|||
44438721|NCT00744263|79447374|FG001|Overall Study|Other|2|||
44438722|NCT00618774|79447384|FG000|Overall Study|Adverse Event|5|||
44438723|NCT00618774|79447385|FG001|Overall Study|Adverse Event|3|||
44157692|NCT01672853|78949545|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
44157693|NCT01672853|78949546|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
44157694|NCT01672853|78949547|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
44157695|NCT01672853|78949545|FG000|Overall Study|Pregnancy|0|||
44259428|NCT00086684|79119674|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44338707|NCT01029652|79343224|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
44338708|NCT01029652|79343225|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
44338709|NCT01029652|79343224|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
44338710|NCT01029652|79343225|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
44338711|NCT01029652|79343224|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
44338712|NCT01029652|79343225|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
44338713|NCT01029652|79343224|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
44338714|NCT01029652|79343225|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
44338715|NCT01029652|79343224|FG000|Core Study (0-12 Weeks)|Death|0|||
44338716|NCT01029652|79343225|FG001|Core Study (0-12 Weeks)|Death|1|||
44338717|NCT01029652|79343224|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
44438724|NCT00618774|79447384|FG000|Overall Study|Withdrawal by Subject|1|||
44438725|NCT00618774|79447385|FG001|Overall Study|Withdrawal by Subject|0|||
44438726|NCT00545571|79447391|FG000|Overall Study|Administrative Reasons|1|||
44157696|NCT01672853|78949546|FG001|Overall Study|Pregnancy|1|||
44157697|NCT01672853|78949547|FG002|Overall Study|Pregnancy|0|||
44338718|NCT01029652|79343225|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
44338719|NCT01029652|79343224|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
44338720|NCT01029652|79343225|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
44338721|NCT01029652|79343224|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
44338722|NCT01029652|79343225|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
44338723|NCT01029652|79343224|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
44338724|NCT01029652|79343225|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
44338725|NCT01029652|79343224|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
44338726|NCT01029652|79343225|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
44338727|NCT01029652|79343224|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
44338728|NCT01029652|79343225|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
44338729|NCT01029652|79343224|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
44338730|NCT01029652|79343225|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
44338731|NCT01029340|79343254|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
44338732|NCT01029340|79343255|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
44338733|NCT01029340|79343256|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
44338734|NCT01029340|79343257|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
44338735|NCT01029340|79343258|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
44338736|NCT01029340|79343259|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
44338737|NCT01029340|79343254|FG000|Part B Treatment Period|Protocol Violation|0|||
44338738|NCT01029340|79343255|FG001|Part B Treatment Period|Protocol Violation|0|||
44338739|NCT01029340|79343256|FG002|Part B Treatment Period|Protocol Violation|1|||
44338740|NCT01029340|79343257|FG003|Part B Treatment Period|Protocol Violation|0|||
44338741|NCT01029340|79343258|FG004|Part B Treatment Period|Protocol Violation|0|||
44438727|NCT00545571|79447391|FG000|Overall Study|Adverse Event|2|||
44438728|NCT00545571|79447391|FG000|Overall Study|Death|5|||
44438729|NCT00545571|79447391|FG000|Overall Study|Lack of Efficacy|1|||
44438730|NCT00545571|79447391|FG000|Overall Study|Protocol Violation|2|||
44338742|NCT01029340|79343259|FG005|Part B Treatment Period|Protocol Violation|0|||
44338743|NCT01029340|79343254|FG000|Extension Period|Adverse Event|0|||
44338744|NCT01029340|79343255|FG001|Extension Period|Adverse Event|0|||
44338745|NCT01029340|79343256|FG002|Extension Period|Adverse Event|0|||
44338746|NCT01029340|79343257|FG003|Extension Period|Adverse Event|0|||
44338747|NCT01029340|79343258|FG004|Extension Period|Adverse Event|0|||
44338748|NCT01029340|79343259|FG005|Extension Period|Adverse Event|1|||
44338749|NCT01029340|79343254|FG000|Extension Period|starting another study|0|||
44338750|NCT01029340|79343255|FG001|Extension Period|starting another study|0|||
44338751|NCT01029340|79343256|FG002|Extension Period|starting another study|0|||
44338752|NCT01029340|79343257|FG003|Extension Period|starting another study|0|||
44438731|NCT00545571|79447391|FG000|Overall Study|Refused Treatment|1|||
44438732|NCT00545571|79447391|FG000|Overall Study|Screen Failure|16|||
44438733|NCT00545571|79447391|FG000|Overall Study|Transfusion|12|||
44157698|NCT01672853|78949545|FG000|Overall Study|Investigator's Discretion|1|||
44157699|NCT01672853|78949546|FG001|Overall Study|Investigator's Discretion|0|||
44157700|NCT01672853|78949547|FG002|Overall Study|Investigator's Discretion|0|||
44157701|NCT01672853|78949545|FG000|Overall Study|Withdrew Consent|5|||
44157702|NCT01672853|78949546|FG001|Overall Study|Withdrew Consent|5|||
44157703|NCT01672853|78949547|FG002|Overall Study|Withdrew Consent|5|||
44338753|NCT01029340|79343258|FG004|Extension Period|starting another study|0|||
44338754|NCT01029340|79343259|FG005|Extension Period|starting another study|8|||
44338755|NCT01029340|79343254|FG000|Extension Period|non-compliance|0|||
44338756|NCT01029340|79343255|FG001|Extension Period|non-compliance|0|||
44338757|NCT01029340|79343256|FG002|Extension Period|non-compliance|0|||
44338758|NCT01029340|79343257|FG003|Extension Period|non-compliance|0|||
44438734|NCT00545571|79447391|FG000|Overall Study|Early Termination of Study|24|||
44438735|NCT00545571|79447391|FG000|Overall Study|Kidney Transplantation|3|||
44438736|NCT00748709|79447395|FG000|Overall Study|Progressive disease|15|||
44438737|NCT00748709|79447395|FG000|Overall Study|Drug reducing Toxity|2|||
44438738|NCT00748709|79447395|FG000|Overall Study|Other Adverse Event|1|||
44438739|NCT00748709|79447395|FG000|Overall Study|Withdrawal by Subject|1|||
44438740|NCT00748709|79447395|FG000|Overall Study|Other Reasons|1|||
44438741|NCT00263887|79447401|FG000|Overall Study|Withdrawal by Subject|1|||
44438742|NCT00263887|79447402|FG001|Overall Study|Withdrawal by Subject|1|||
44438743|NCT00263887|79447401|FG000|Overall Study|Lung transplantation|1|||
44438744|NCT00263887|79447402|FG001|Overall Study|Lung transplantation|2|||
44438745|NCT00263887|79447401|FG000|Overall Study|Too ill to attend visit|1|||
44438746|NCT00263887|79447402|FG001|Overall Study|Too ill to attend visit|0|||
44438747|NCT00263887|79447401|FG000|Overall Study|Adverse Event|0|||
44438748|NCT00263887|79447402|FG001|Overall Study|Adverse Event|2|||
44338759|NCT01029340|79343258|FG004|Extension Period|non-compliance|0|||
44338760|NCT01029340|79343259|FG005|Extension Period|non-compliance|1|||
44338761|NCT01029340|79343254|FG000|Extension Period|Withdrawal by Subject|0|||
44338762|NCT01029340|79343255|FG001|Extension Period|Withdrawal by Subject|0|||
44338763|NCT01029340|79343256|FG002|Extension Period|Withdrawal by Subject|0|||
44338764|NCT01029340|79343257|FG003|Extension Period|Withdrawal by Subject|0|||
44338765|NCT01029340|79343258|FG004|Extension Period|Withdrawal by Subject|0|||
44338766|NCT01029340|79343259|FG005|Extension Period|Withdrawal by Subject|1|||
44338767|NCT01029340|79343254|FG000|Extension Period|Physician Decision|0|||
44338768|NCT01029340|79343255|FG001|Extension Period|Physician Decision|0|||
44338769|NCT01029340|79343256|FG002|Extension Period|Physician Decision|0|||
44438749|NCT00263887|79447401|FG000|Overall Study|Disease progression|0|||
44338770|NCT01029340|79343257|FG003|Extension Period|Physician Decision|0|||
44338771|NCT01029340|79343258|FG004|Extension Period|Physician Decision|0|||
44438750|NCT00263887|79447402|FG001|Overall Study|Disease progression|1|||
44438751|NCT00263887|79447401|FG000|Overall Study|Lack of Efficacy|0|||
44438752|NCT00263887|79447402|FG001|Overall Study|Lack of Efficacy|1|||
44157704|NCT01672853|78949545|FG000|Overall Study|Adverse Event|4|||
44157705|NCT01672853|78949546|FG001|Overall Study|Adverse Event|6|||
44438753|NCT00748553|79447410|FG000|Overall Study|Adverse Event|0|||
44438754|NCT00748553|79447411|FG001|Overall Study|Adverse Event|1|||
44438755|NCT00748553|79447410|FG000|Overall Study|disease progression|2|||
44438756|NCT00748553|79447411|FG001|Overall Study|disease progression|0|||
44157706|NCT01672853|78949547|FG002|Overall Study|Adverse Event|8|||
44157707|NCT01672853|78949545|FG000|Overall Study|Lost to Follow-up|0|||
44157708|NCT01672853|78949546|FG001|Overall Study|Lost to Follow-up|1|||
44157709|NCT01672853|78949547|FG002|Overall Study|Lost to Follow-up|0|||
44157710|NCT01672853|78949545|FG000|Overall Study|Randomized but Never Treated|0|||
44157711|NCT01672853|78949546|FG001|Overall Study|Randomized but Never Treated|0|||
44157712|NCT01672853|78949547|FG002|Overall Study|Randomized but Never Treated|1|||
44157713|NCT01603459|78949555|FG000|Overall Study|Adverse Event|5|||
44157714|NCT01603459|78949555|FG000|Overall Study|Withdrawal by Subject|5|||
44157715|NCT01603459|78949555|FG000|Overall Study|Lost to Follow-up|3|||
44157716|NCT01603459|78949555|FG000|Overall Study|Predefined discontinuation criteria|3|||
44157717|NCT01603459|78949555|FG000|Overall Study|Non-compliance|1|||
44157718|NCT01603459|78949555|FG000|Overall Study|Administrative reason|1|||
44157719|NCT01678807|78949594|FG000|Overall Study|Adverse Event|4|||
44157720|NCT01678807|78949595|FG001|Overall Study|Adverse Event|4|||
44157721|NCT01678807|78949596|FG002|Overall Study|Adverse Event|0|||
44157722|NCT01678807|78949594|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
44438757|NCT00748553|79447410|FG000|Overall Study|noncompliance|1|||
44438758|NCT00748553|79447411|FG001|Overall Study|noncompliance|0|||
44438759|NCT00661388|79447416|FG000|Overall Study|Adverse Event|14|||
44438760|NCT00661388|79447416|FG000|Overall Study|Protocol Violation|7|||
44438761|NCT00661388|79447416|FG000|Overall Study|Renal transplantation|1|||
44438762|NCT00661388|79447416|FG000|Overall Study|Dialysis initiation|1|||
44438763|NCT00661388|79447416|FG000|Overall Study|Administrative reasons|1|||
44438764|NCT00743483|79447420|FG000|Baseline Period|Physician Decision|1|||
44438765|NCT00743483|79447420|FG000|Treatment Period|Adverse Event|1|||
44438766|NCT00263575|79447424|FG000|Titration Period|Adverse Event|14|||
44438767|NCT00263575|79447424|FG000|Titration Period|Withdrawal by Subject|10|||
44438768|NCT00263575|79447424|FG000|Titration Period|Protocol Violation|9|||
44438769|NCT00263575|79447424|FG000|Titration Period|Sponsor Decision|2|||
44438770|NCT00263575|79447424|FG000|Titration Period|Other|2|||
44438771|NCT00263575|79447424|FG000|Titration Period|Lack of Efficacy|6|||
44438772|NCT00263575|79447424|FG000|Maintence Period|Adverse Event|23|||
44438773|NCT00263575|79447424|FG000|Maintence Period|Withdrawal by Subject|8|||
44438774|NCT00263575|79447424|FG000|Maintence Period|Protocol Violation|4|||
44438775|NCT00263575|79447424|FG000|Maintence Period|Lack of Efficacy|4|||
44438776|NCT00263575|79447424|FG000|Maintence Period|Physician Decision|6|||
44157723|NCT01678807|78949595|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
44157724|NCT01678807|78949596|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
44157725|NCT03073525|78949607|FG000|Overall Study|Withdrawal by Subject|0|||
44157726|NCT03073525|78949608|FG001|Overall Study|Withdrawal by Subject|0|||
44157727|NCT03073525|78949609|FG002|Overall Study|Withdrawal by Subject|3|||
44157728|NCT02631551|78949630|FG000|Overall Study|Adverse Event|1|||
44438777|NCT00263575|79447424|FG000|Maintence Period|Lost to Follow-up|1|||
44438778|NCT00263575|79447424|FG000|Maintence Period|Sponsor Decision|24|||
44438779|NCT00263575|79447424|FG000|Maintence Period|Other|7|||
44157729|NCT02631551|78949631|FG001|Overall Study|Adverse Event|2|||
44157730|NCT02631551|78949632|FG002|Overall Study|Adverse Event|4|||
44157731|NCT02631551|78949633|FG003|Overall Study|Adverse Event|0|||
44438780|NCT00748241|79447430|FG000|Overall Study|Implant failure|1|||
44438781|NCT00748241|79447430|FG000|Overall Study|Lost to Follow-up|5|||
44157732|NCT02631551|78949630|FG000|Overall Study|Lack of Efficacy|0|||
44157733|NCT02631551|78949631|FG001|Overall Study|Lack of Efficacy|0|||
44157734|NCT02631551|78949632|FG002|Overall Study|Lack of Efficacy|1|||
44157735|NCT02631551|78949633|FG003|Overall Study|Lack of Efficacy|0|||
44157736|NCT02631551|78949630|FG000|Overall Study|Lost to Follow-up|1|||
44157737|NCT02631551|78949631|FG001|Overall Study|Lost to Follow-up|2|||
44157738|NCT02631551|78949632|FG002|Overall Study|Lost to Follow-up|0|||
44438782|NCT00748241|79447430|FG000|Overall Study|Death|2|||
44438783|NCT00570128|79447436|FG000|Overall Study|Adverse Event|1|||
44157739|NCT02631551|78949633|FG003|Overall Study|Lost to Follow-up|3|||
44438784|NCT00570128|79447437|FG001|Overall Study|Adverse Event|0|||
44438785|NCT00570128|79447436|FG000|Overall Study|Lost to Follow-up|1|||
44438786|NCT00570128|79447437|FG001|Overall Study|Lost to Follow-up|0|||
44438787|NCT00570128|79447436|FG000|Overall Study|Withdrawal by Subject|2|||
44438788|NCT00570128|79447437|FG001|Overall Study|Withdrawal by Subject|0|||
44438789|NCT00743249|79447445|FG000|Overall Study|Adverse Event|0|||
44438790|NCT00743249|79447446|FG001|Overall Study|Adverse Event|4|||
44438791|NCT00743249|79447445|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
44438792|NCT00743249|79447446|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
44438793|NCT00743249|79447445|FG000|Overall Study|Unsuccessful insertion of stent|2|||
44438794|NCT00743249|79447446|FG001|Overall Study|Unsuccessful insertion of stent|1|||
44438795|NCT00262951|79447452|FG000|Overall Study|Progressive disease/relapse|3|||
44438796|NCT00262951|79447452|FG000|Overall Study|Adverse Event|7|||
44438797|NCT00262951|79447452|FG000|Overall Study|Death|1|||
44438798|NCT00262951|79447452|FG000|Overall Study|Withdrawal by Subject|1|||
44438799|NCT00262951|79447452|FG000|Overall Study|Alternative treatment|3|||
44157740|NCT02631551|78949630|FG000|Overall Study|Withdrawal by Subject|2|||
44338772|NCT01029340|79343259|FG005|Extension Period|Physician Decision|1|||
44338773|NCT01265550|79343276|FG000|Pre Randomization|Withdrawal by Subject|0|||
44338774|NCT01265550|79343277|FG001|Pre Randomization|Withdrawal by Subject|0|||
44338775|NCT01265550|79343278|FG002|Pre Randomization|Withdrawal by Subject|0|||
44338776|NCT01265550|79343279|FG003|Pre Randomization|Withdrawal by Subject|70|||
44338777|NCT01265550|79343276|FG000|Pre Randomization|Technical Exclusions|0|||
44338778|NCT01265550|79343277|FG001|Pre Randomization|Technical Exclusions|0|||
44438800|NCT00262951|79447452|FG000|Overall Study|Off treatment for other disease|1|||
44438801|NCT00262873|79447456|FG000|Overall Study|Adverse Event|3|||
44438802|NCT00262873|79447456|FG000|Overall Study|Withdrawal by Subject|5|||
44157741|NCT02631551|78949631|FG001|Overall Study|Withdrawal by Subject|2|||
44157742|NCT02631551|78949632|FG002|Overall Study|Withdrawal by Subject|0|||
44157743|NCT02631551|78949633|FG003|Overall Study|Withdrawal by Subject|5|||
44338779|NCT01265550|79343278|FG002|Pre Randomization|Technical Exclusions|0|||
44338780|NCT01265550|79343279|FG003|Pre Randomization|Technical Exclusions|54|||
44438803|NCT00573534|79447460|FG000|Overall Study|oppositional behavior|3|||
44438804|NCT00260533|79447467|FG000|Overall Study|Other|3|||
44438805|NCT00260533|79447468|FG001|Overall Study|Other|3|||
44438806|NCT03945981|79447474|FG000|Overall Study|Lost to Follow-up|12|||
44157744|NCT02631551|78949630|FG000|Overall Study|Protocol deviation|3|||
44157745|NCT02631551|78949631|FG001|Overall Study|Protocol deviation|6|||
44157746|NCT02631551|78949632|FG002|Overall Study|Protocol deviation|3|||
44157747|NCT02631551|78949633|FG003|Overall Study|Protocol deviation|0|||
44338781|NCT01265550|79343276|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
44338782|NCT01265550|79343277|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
44338783|NCT01265550|79343278|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
44338784|NCT01265550|79343279|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
44338785|NCT01265550|79343276|FG000|Pre Randomization|Non-GERD organic disorders|0|||
44338786|NCT01265550|79343277|FG001|Pre Randomization|Non-GERD organic disorders|0|||
44157748|NCT02631551|78949630|FG000|Overall Study|Non-compliance with study procedures|0|||
44157749|NCT02631551|78949631|FG001|Overall Study|Non-compliance with study procedures|0|||
44338787|NCT01265550|79343278|FG002|Pre Randomization|Non-GERD organic disorders|0|||
44438807|NCT03945981|79447474|FG000|Overall Study|Physician Decision|4|||
44338788|NCT01265550|79343279|FG003|Pre Randomization|Non-GERD organic disorders|23|||
44338789|NCT01265550|79343276|FG000|Pre Randomization|Functional heartburn|0|||
44338790|NCT01265550|79343277|FG001|Pre Randomization|Functional heartburn|0|||
44338791|NCT01265550|79343278|FG002|Pre Randomization|Functional heartburn|0|||
44338792|NCT01265550|79343279|FG003|Pre Randomization|Functional heartburn|99|||
44338793|NCT01265394|79343293|FG000|Overall Study|Subjects withdrawn|37|||
44338794|NCT01029262|79343300|FG000|Overall Study|Adverse Event|9|||
44338795|NCT01029262|79343301|FG001|Overall Study|Adverse Event|52|||
44338796|NCT01029262|79343300|FG000|Overall Study|Lack of therapeutic effect|57|||
44338797|NCT01029262|79343301|FG001|Overall Study|Lack of therapeutic effect|76|||
44438808|NCT03945981|79447474|FG000|Overall Study|Withdrawal by Subject|6|||
44438809|NCT03945981|79447474|FG000|Overall Study|Protocol Violation|1|||
44438810|NCT00745901|79447501|FG000|Overall Study|Adverse Event|3|||
44438811|NCT00745901|79447502|FG001|Overall Study|Adverse Event|4|||
44438812|NCT00745901|79447501|FG000|Overall Study|Protocol Violation|0|||
44438813|NCT00745901|79447502|FG001|Overall Study|Protocol Violation|1|||
44438814|NCT00745901|79447501|FG000|Overall Study|Withdrawal by Subject|1|||
44438815|NCT00745901|79447502|FG001|Overall Study|Withdrawal by Subject|0|||
44338798|NCT01029262|79343300|FG000|Overall Study|Withdrawal by Subject|10|||
44338799|NCT01029262|79343301|FG001|Overall Study|Withdrawal by Subject|17|||
44338800|NCT01029262|79343300|FG000|Overall Study|Protocol Violation|2|||
44338801|NCT01029262|79343301|FG001|Overall Study|Protocol Violation|3|||
44338802|NCT01029262|79343300|FG000|Overall Study|Miscellaneous|1|||
44338803|NCT01029262|79343301|FG001|Overall Study|Miscellaneous|9|||
44338804|NCT01029262|79343300|FG000|Overall Study|Death|0|||
44338805|NCT01029262|79343301|FG001|Overall Study|Death|3|||
44338806|NCT01028560|79343314|FG000|Overall Study|Lack of Efficacy|3|||
44338807|NCT01028560|79343315|FG001|Overall Study|Lack of Efficacy|6|||
44338808|NCT01028560|79343314|FG000|Overall Study|Withdrawal by Subject|7|||
44338809|NCT01028560|79343315|FG001|Overall Study|Withdrawal by Subject|12|||
44338810|NCT01061710|79343322|FG000|Overall Study|Protocol Violation|14|||
44338811|NCT01028014|79343332|FG000|Overall Study|Lost to Follow-up|1|||
44338812|NCT01028014|79343333|FG001|Overall Study|Lost to Follow-up|2|||
44338813|NCT01028014|79343334|FG002|Overall Study|Lost to Follow-up|0|||
44338814|NCT01028014|79343335|FG003|Overall Study|Lost to Follow-up|1|||
44338815|NCT01028014|79343336|FG004|Overall Study|Lost to Follow-up|1|||
44338816|NCT01028014|79343337|FG005|Overall Study|Lost to Follow-up|2|||
44338817|NCT01264770|79343357|FG000|Overall Study|Not reported|0|||
44338818|NCT01264770|79343358|FG001|Overall Study|Not reported|0|||
44338819|NCT01264770|79343359|FG002|Overall Study|Not reported|1|||
44338820|NCT01264770|79343360|FG003|Overall Study|Not reported|0|||
44338821|NCT01264770|79343361|FG004|Overall Study|Not reported|0|||
44338822|NCT01264770|79343362|FG005|Overall Study|Not reported|0|||
44338823|NCT01264770|79343357|FG000|Overall Study|e.g., change in circumstances|8|||
44338824|NCT01264770|79343358|FG001|Overall Study|e.g., change in circumstances|3|||
44338825|NCT01264770|79343359|FG002|Overall Study|e.g., change in circumstances|3|||
44338826|NCT01264770|79343360|FG003|Overall Study|e.g., change in circumstances|3|||
44338827|NCT01264770|79343361|FG004|Overall Study|e.g., change in circumstances|4|||
44338828|NCT01264770|79343362|FG005|Overall Study|e.g., change in circumstances|4|||
44338829|NCT01264770|79343357|FG000|Overall Study|Severe non-compliance to protocol|0|||
44438816|NCT00745901|79447501|FG000|Overall Study|Lost to Follow-up|7|||
44438817|NCT00745901|79447502|FG001|Overall Study|Lost to Follow-up|4|||
44438818|NCT00745901|79447501|FG000|Overall Study|Pregnancy|2|||
44438819|NCT00745901|79447502|FG001|Overall Study|Pregnancy|4|||
44438820|NCT00745901|79447501|FG000|Overall Study|Lack of compliance|2|||
44438821|NCT00745901|79447502|FG001|Overall Study|Lack of compliance|2|||
44438822|NCT00745901|79447501|FG000|Overall Study|Patient's next menses did not start with|1|||
44438823|NCT00745901|79447502|FG001|Overall Study|Patient's next menses did not start with|0|||
44338830|NCT01264770|79343358|FG001|Overall Study|Severe non-compliance to protocol|0|||
44338831|NCT01264770|79343359|FG002|Overall Study|Severe non-compliance to protocol|1|||
44338832|NCT01264770|79343360|FG003|Overall Study|Severe non-compliance to protocol|1|||
44338833|NCT01264770|79343361|FG004|Overall Study|Severe non-compliance to protocol|0|||
44338834|NCT01264770|79343362|FG005|Overall Study|Severe non-compliance to protocol|0|||
44338835|NCT01264770|79343357|FG000|Overall Study|Lack of therapeutic response|1|||
44338836|NCT01264770|79343358|FG001|Overall Study|Lack of therapeutic response|0|||
44338837|NCT01264770|79343359|FG002|Overall Study|Lack of therapeutic response|2|||
44338838|NCT01264770|79343360|FG003|Overall Study|Lack of therapeutic response|1|||
44338839|NCT01264770|79343361|FG004|Overall Study|Lack of therapeutic response|1|||
44338840|NCT01264770|79343362|FG005|Overall Study|Lack of therapeutic response|0|||
44338841|NCT01264770|79343357|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
44338842|NCT01264770|79343358|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
44338843|NCT01264770|79343359|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
44338844|NCT01264770|79343360|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
44338845|NCT01264770|79343361|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
44338846|NCT01264770|79343362|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
44157750|NCT02631551|78949632|FG002|Overall Study|Non-compliance with study procedures|1|||
44338847|NCT01264770|79343357|FG000|Overall Study|Lost to Follow-up|0|||
44338848|NCT01264770|79343358|FG001|Overall Study|Lost to Follow-up|0|||
44338849|NCT01264770|79343359|FG002|Overall Study|Lost to Follow-up|1|||
44338850|NCT01264770|79343360|FG003|Overall Study|Lost to Follow-up|1|||
44338851|NCT01264770|79343361|FG004|Overall Study|Lost to Follow-up|0|||
44338852|NCT01264770|79343362|FG005|Overall Study|Lost to Follow-up|0|||
44338853|NCT01264770|79343357|FG000|Overall Study|Adverse Event|7|||
44338854|NCT01264770|79343358|FG001|Overall Study|Adverse Event|7|||
44338855|NCT01264770|79343359|FG002|Overall Study|Adverse Event|8|||
44338856|NCT01264770|79343360|FG003|Overall Study|Adverse Event|0|||
44338857|NCT01264770|79343361|FG004|Overall Study|Adverse Event|2|||
44338858|NCT01264770|79343362|FG005|Overall Study|Adverse Event|1|||
44338859|NCT01027702|79343382|FG000|Overall Study|Received subsequent therapy|1|||
44438824|NCT00745901|79447501|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
44438825|NCT00745901|79447502|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
44438826|NCT00745901|79447501|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
44438827|NCT00745901|79447502|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
44438828|NCT00745901|79447501|FG000|Overall Study|Patient didn't take any study medication|7|||
44438829|NCT00745901|79447502|FG001|Overall Study|Patient didn't take any study medication|3|||
44438830|NCT00286429|79447511|FG000|Overall Study|Adverse Event|4|||
44438831|NCT00286429|79447512|FG001|Overall Study|Adverse Event|1|||
44438832|NCT00286429|79447513|FG002|Overall Study|Adverse Event|6|||
44438833|NCT00286429|79447511|FG000|Overall Study|Lack of Efficacy|52|||
44438834|NCT00286429|79447512|FG001|Overall Study|Lack of Efficacy|27|||
44438835|NCT00286429|79447513|FG002|Overall Study|Lack of Efficacy|25|||
44438836|NCT00286429|79447511|FG000|Overall Study|Lost to Follow-up|2|||
44438837|NCT00286429|79447512|FG001|Overall Study|Lost to Follow-up|4|||
44438838|NCT00286429|79447513|FG002|Overall Study|Lost to Follow-up|3|||
44438839|NCT00286429|79447511|FG000|Overall Study|Physician Decision|10|||
44438840|NCT00286429|79447512|FG001|Overall Study|Physician Decision|7|||
44438841|NCT00286429|79447513|FG002|Overall Study|Physician Decision|7|||
44438842|NCT00286429|79447511|FG000|Overall Study|Protocol Violation|3|||
44438843|NCT00286429|79447512|FG001|Overall Study|Protocol Violation|5|||
44438844|NCT00286429|79447513|FG002|Overall Study|Protocol Violation|4|||
44438845|NCT00286429|79447511|FG000|Overall Study|Withdrawal by Subject|3|||
44438846|NCT00286429|79447512|FG001|Overall Study|Withdrawal by Subject|2|||
44438847|NCT00286429|79447513|FG002|Overall Study|Withdrawal by Subject|6|||
44438848|NCT00286429|79447511|FG000|Overall Study|Administrative Error|1|||
44438849|NCT00286429|79447512|FG001|Overall Study|Administrative Error|1|||
44438850|NCT00286429|79447513|FG002|Overall Study|Administrative Error|1|||
44438851|NCT00286429|79447511|FG000|Overall Study|Administrative Decision|0|||
44438852|NCT00286429|79447512|FG001|Overall Study|Administrative Decision|1|||
44438853|NCT00286429|79447513|FG002|Overall Study|Administrative Decision|0|||
44438854|NCT00665444|79447521|FG000|Overall Study|Physician Decision|1|||
44438855|NCT00665444|79447521|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
44438856|NCT03926169|79447528|FG000|Period A|Adverse Event|2|||
44438857|NCT03926169|79447529|FG001|Period A|Adverse Event|2|||
44438858|NCT03926169|79447530|FG002|Period A|Adverse Event|1|||
44438859|NCT03926169|79447528|FG000|Period A|Withdrawal by Subject|2|||
44438860|NCT03926169|79447529|FG001|Period A|Withdrawal by Subject|2|||
44438861|NCT03926169|79447530|FG002|Period A|Withdrawal by Subject|2|||
44438862|NCT03926169|79447528|FG000|Period A|Lost to Follow-up|3|||
44438863|NCT03926169|79447529|FG001|Period A|Lost to Follow-up|1|||
44438864|NCT03926169|79447530|FG002|Period A|Lost to Follow-up|0|||
44438865|NCT03926169|79447528|FG000|Period A|Lack of Efficacy|0|||
44438866|NCT03926169|79447529|FG001|Period A|Lack of Efficacy|2|||
44438867|NCT03926169|79447530|FG002|Period A|Lack of Efficacy|2|||
44438868|NCT03926169|79447528|FG000|Period A|COVID-19 Infection|0|||
44438869|NCT03926169|79447529|FG001|Period A|COVID-19 Infection|1|||
44438870|NCT03926169|79447530|FG002|Period A|COVID-19 Infection|0|||
44438871|NCT03926169|79447528|FG000|Period A|COVID-19 Logistical Restrictions|0|||
44438872|NCT03926169|79447529|FG001|Period A|COVID-19 Logistical Restrictions|2|||
44438873|NCT03926169|79447530|FG002|Period A|COVID-19 Logistical Restrictions|1|||
44438874|NCT03926169|79447528|FG000|Period A|Other, Not Specified|1|||
44438875|NCT03926169|79447529|FG001|Period A|Other, Not Specified|0|||
44338860|NCT01027702|79343383|FG001|Overall Study|Received subsequent therapy|2|||
44438876|NCT03926169|79447530|FG002|Period A|Other, Not Specified|0|||
44438877|NCT03926169|79447528|FG000|Period B|Adverse Event|3|||
44438878|NCT03926169|79447529|FG001|Period B|Adverse Event|1|||
44438879|NCT03926169|79447530|FG002|Period B|Adverse Event|1|||
44438880|NCT03926169|79447528|FG000|Period B|Withdrawal by Subject|1|||
44438881|NCT03926169|79447529|FG001|Period B|Withdrawal by Subject|3|||
44438882|NCT03926169|79447530|FG002|Period B|Withdrawal by Subject|0|||
44438883|NCT03926169|79447528|FG000|Period B|Lack of Efficacy|3|||
44438884|NCT03926169|79447529|FG001|Period B|Lack of Efficacy|1|||
44157751|NCT02631551|78949633|FG003|Overall Study|Non-compliance with study procedures|1|||
44438885|NCT03926169|79447530|FG002|Period B|Lack of Efficacy|1|||
44438886|NCT03926169|79447528|FG000|Period B|Lost to Follow-up|1|||
44438887|NCT03926169|79447529|FG001|Period B|Lost to Follow-up|1|||
44438888|NCT03926169|79447530|FG002|Period B|Lost to Follow-up|4|||
44438889|NCT03926169|79447528|FG000|Period B|Other, Not Specified|62|||
44438890|NCT03926169|79447529|FG001|Period B|Other, Not Specified|57|||
44438891|NCT03926169|79447530|FG002|Period B|Other, Not Specified|65|||
44438892|NCT00285649|79447544|FG000|Overall Study|Lost to Follow-up|6|||
44438893|NCT00285649|79447545|FG001|Overall Study|Lost to Follow-up|4|||
44438894|NCT00285649|79447546|FG002|Overall Study|Lost to Follow-up|4|||
44438895|NCT00285649|79447544|FG000|Overall Study|Withdrawal by Subject|3|||
44438896|NCT00285649|79447545|FG001|Overall Study|Withdrawal by Subject|2|||
44438897|NCT00285649|79447546|FG002|Overall Study|Withdrawal by Subject|2|||
44438898|NCT00745823|79447556|FG000|Overall Study|Adverse Event|5|||
44438899|NCT00745823|79447557|FG001|Overall Study|Adverse Event|3|||
44438900|NCT00745823|79447556|FG000|Overall Study|Lack of Efficacy|20|||
44438901|NCT00745823|79447557|FG001|Overall Study|Lack of Efficacy|6|||
44438902|NCT00745823|79447556|FG000|Overall Study|Lost to Follow-up|10|||
44438903|NCT00745823|79447557|FG001|Overall Study|Lost to Follow-up|11|||
44438904|NCT00745823|79447556|FG000|Overall Study|Physician Decision|10|||
44438905|NCT00745823|79447557|FG001|Overall Study|Physician Decision|5|||
44438906|NCT00745823|79447556|FG000|Overall Study|Pregnancy|0|||
44438907|NCT00745823|79447557|FG001|Overall Study|Pregnancy|4|||
44438908|NCT00745823|79447556|FG000|Overall Study|Withdrawal by Subject|14|||
44438909|NCT00745823|79447557|FG001|Overall Study|Withdrawal by Subject|8|||
44438910|NCT00745823|79447556|FG000|Overall Study|Study Terminated by Sponsor|326|||
44438911|NCT00745823|79447557|FG001|Overall Study|Study Terminated by Sponsor|349|||
44438912|NCT00663260|79447568|FG000|Overall Study|Lack of Efficacy|2|||
44438913|NCT00663260|79447569|FG001|Overall Study|Lack of Efficacy|0|||
44438914|NCT00663260|79447570|FG002|Overall Study|Lack of Efficacy|0|||
44438915|NCT00663260|79447568|FG000|Overall Study|Adverse Event|12|||
44438916|NCT00663260|79447569|FG001|Overall Study|Adverse Event|7|||
44438917|NCT00663260|79447570|FG002|Overall Study|Adverse Event|6|||
44438918|NCT00663260|79447568|FG000|Overall Study|Withdrawal by Subject|3|||
44438919|NCT00663260|79447569|FG001|Overall Study|Withdrawal by Subject|1|||
44438920|NCT00663260|79447570|FG002|Overall Study|Withdrawal by Subject|6|||
44438921|NCT00663260|79447568|FG000|Overall Study|Death|1|||
44438922|NCT00663260|79447569|FG001|Overall Study|Death|0|||
44438923|NCT00663260|79447570|FG002|Overall Study|Death|1|||
44438924|NCT00663260|79447568|FG000|Overall Study|Lost to Follow-up|0|||
44438925|NCT00663260|79447569|FG001|Overall Study|Lost to Follow-up|1|||
44438926|NCT00663260|79447570|FG002|Overall Study|Lost to Follow-up|0|||
44438927|NCT00663260|79447568|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
44438928|NCT00663260|79447569|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
44438929|NCT00663260|79447570|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
44438930|NCT00740597|79447578|FG000|Overall Study|insurance would not cover treatment|1|||
44438931|NCT00284089|79447586|FG000|Multiple Dose Phase|Adverse Event|1|||
44438932|NCT00284089|79447587|FG001|Multiple Dose Phase|Adverse Event|0|||
44438933|NCT00284089|79447588|FG002|Multiple Dose Phase|Adverse Event|1|||
44438934|NCT00284089|79447589|FG003|Multiple Dose Phase|Adverse Event|1|||
44438935|NCT00284089|79447586|FG000|Multiple Dose Phase|Protocol Violation|0|||
44438936|NCT00284089|79447587|FG001|Multiple Dose Phase|Protocol Violation|0|||
44438937|NCT00284089|79447588|FG002|Multiple Dose Phase|Protocol Violation|1|||
44438938|NCT00284089|79447589|FG003|Multiple Dose Phase|Protocol Violation|0|||
44438939|NCT00284089|79447586|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
44438940|NCT00284089|79447587|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
44438941|NCT00284089|79447588|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
44438942|NCT00284089|79447589|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
44438943|NCT00284089|79447586|FG000|Multiple Dose Phase|Death|0|||
44438944|NCT00284089|79447587|FG001|Multiple Dose Phase|Death|0|||
44438945|NCT00284089|79447588|FG002|Multiple Dose Phase|Death|1|||
44438946|NCT00284089|79447589|FG003|Multiple Dose Phase|Death|1|||
44438947|NCT00284089|79447586|FG000|Extension Phase|Adverse Event|0|||
44438948|NCT00284089|79447587|FG001|Extension Phase|Adverse Event|0|||
44438949|NCT00284089|79447588|FG002|Extension Phase|Adverse Event|2|||
44438950|NCT00284089|79447589|FG003|Extension Phase|Adverse Event|2|||
44438951|NCT00284089|79447586|FG000|Extension Phase|condition no longer requires study drug|2|||
44438952|NCT00284089|79447587|FG001|Extension Phase|condition no longer requires study drug|0|||
44438953|NCT00284089|79447588|FG002|Extension Phase|condition no longer requires study drug|2|||
44438954|NCT00284089|79447589|FG003|Extension Phase|condition no longer requires study drug|7|||
44438955|NCT00284089|79447586|FG000|Extension Phase|Protocol Violation|0|||
44438956|NCT00284089|79447587|FG001|Extension Phase|Protocol Violation|0|||
44438957|NCT00284089|79447588|FG002|Extension Phase|Protocol Violation|1|||
44438958|NCT00284089|79447589|FG003|Extension Phase|Protocol Violation|0|||
44438959|NCT00284089|79447586|FG000|Extension Phase|Withdrawal by Subject|0|||
44438960|NCT00284089|79447587|FG001|Extension Phase|Withdrawal by Subject|0|||
44438961|NCT00284089|79447588|FG002|Extension Phase|Withdrawal by Subject|1|||
44438962|NCT00284089|79447589|FG003|Extension Phase|Withdrawal by Subject|3|||
44438963|NCT00659984|79447599|FG000|Overall Study|Adverse Event|1|||
44438964|NCT00283387|79447613|FG000|First Intervention|Subject non-compliant|1|||
44438965|NCT00283387|79447614|FG001|First Intervention|Subject non-compliant|1|||
44438966|NCT00283387|79447613|FG000|First Intervention|Withdrawal by Subject|0|||
44438967|NCT00283387|79447614|FG001|First Intervention|Withdrawal by Subject|1|||
44438968|NCT00282919|79447620|FG000|Overall Study|Lack of Efficacy|4|||
44438969|NCT00282919|79447620|FG000|Overall Study|Withdrawal by Subject|1|||
44438970|NCT00282919|79447620|FG000|Overall Study|Asymptomatic Parasitemia|2|||
44438971|NCT00282295|79447627|FG000|Overall Study|Adverse Event|0|||
44438972|NCT00282295|79447628|FG001|Overall Study|Adverse Event|1|||
44438973|NCT00282295|79447629|FG002|Overall Study|Adverse Event|0|||
44438974|NCT00282295|79447627|FG000|Overall Study|Serious Adverse Events|0|||
44438975|NCT00282295|79447628|FG001|Overall Study|Serious Adverse Events|0|||
44438976|NCT00282295|79447629|FG002|Overall Study|Serious Adverse Events|1|||
44438977|NCT00282295|79447627|FG000|Overall Study|Protocol Violation|0|||
44438978|NCT00282295|79447628|FG001|Overall Study|Protocol Violation|2|||
44438979|NCT00282295|79447629|FG002|Overall Study|Protocol Violation|1|||
44438980|NCT00282295|79447627|FG000|Overall Study|Withdrawal by Subject|2|||
44438981|NCT00282295|79447628|FG001|Overall Study|Withdrawal by Subject|6|||
44438982|NCT00282295|79447629|FG002|Overall Study|Withdrawal by Subject|4|||
44438983|NCT00282295|79447627|FG000|Overall Study|Lost to Follow-up|1|||
44438984|NCT00282295|79447628|FG001|Overall Study|Lost to Follow-up|7|||
44438985|NCT00282295|79447629|FG002|Overall Study|Lost to Follow-up|2|||
44438986|NCT00282295|79447627|FG000|Overall Study|Other|0|||
44438987|NCT00282295|79447628|FG001|Overall Study|Other|1|||
44438988|NCT00282295|79447629|FG002|Overall Study|Other|0|||
44438989|NCT00742781|79447642|FG000|Overall Study|Withdrawal by Subject|3|||
44438990|NCT00663026|79447650|FG000|Overall Study|Lost to Follow-up|1|||
44438991|NCT00663026|79447651|FG001|Overall Study|Lost to Follow-up|0|||
44438992|NCT00663026|79447652|FG002|Overall Study|Lost to Follow-up|0|||
44438993|NCT00663026|79447650|FG000|Overall Study|Other|1|||
44438994|NCT00663026|79447651|FG001|Overall Study|Other|2|||
44438995|NCT00663026|79447652|FG002|Overall Study|Other|0|||
44438996|NCT00663026|79447650|FG000|Overall Study|Adverse Event|0|||
44438997|NCT00663026|79447651|FG001|Overall Study|Adverse Event|2|||
44438998|NCT00663026|79447652|FG002|Overall Study|Adverse Event|3|||
44438999|NCT00663026|79447650|FG000|Overall Study|Caregiver Request|0|||
44439000|NCT00663026|79447651|FG001|Overall Study|Caregiver Request|2|||
44439001|NCT00663026|79447652|FG002|Overall Study|Caregiver Request|0|||
44439002|NCT00663026|79447650|FG000|Overall Study|Withdrawal by Subject|0|||
44439003|NCT00663026|79447651|FG001|Overall Study|Withdrawal by Subject|0|||
44439004|NCT00663026|79447652|FG002|Overall Study|Withdrawal by Subject|1|||
44439005|NCT00280735|79447662|FG000|Overall Study|Adverse Event|5|||
44439006|NCT00280735|79447662|FG000|Overall Study|Lack of Efficacy|3|||
44439007|NCT00280735|79447662|FG000|Overall Study|Withdrawal by Subject|8|||
44439008|NCT00280735|79447662|FG000|Overall Study|Intercurrent Illness|2|||
44157752|NCT02631551|78949630|FG000|Overall Study|Non-compliance with study drug|1|||
44439009|NCT00260065|79447670|FG000|Overall Study|Progressive Disease|22|||
44439010|NCT00260065|79447670|FG000|Overall Study|Adverse Event|17|||
44439011|NCT00260065|79447670|FG000|Overall Study|Death|13|||
44439012|NCT00260065|79447670|FG000|Overall Study|Withdrawal by Subject|13|||
44157753|NCT02631551|78949631|FG001|Overall Study|Non-compliance with study drug|0|||
44439013|NCT00260065|79447670|FG000|Overall Study|Physician Decision|19|||
44439014|NCT00260065|79447670|FG000|Overall Study|Not otherwise specified|8|||
44439015|NCT00260065|79447670|FG000|Overall Study|Medication Noncompliance|1|||
44439016|NCT00506350|79447683|FG000|Overall Study|Serious Adverse Event|1|||
44439017|NCT00506350|79447684|FG001|Overall Study|Serious Adverse Event|0|||
44157754|NCT02631551|78949632|FG002|Overall Study|Non-compliance with study drug|0|||
44157755|NCT02631551|78949633|FG003|Overall Study|Non-compliance with study drug|0|||
44157756|NCT02631551|78949630|FG000|Overall Study|Other, specific reasons not collected|5|||
44439018|NCT00506350|79447685|FG002|Overall Study|Serious Adverse Event|0|||
44157757|NCT02631551|78949631|FG001|Overall Study|Other, specific reasons not collected|7|||
44439019|NCT00506350|79447686|FG003|Overall Study|Serious Adverse Event|0|||
44439020|NCT00506350|79447687|FG004|Overall Study|Serious Adverse Event|0|||
44439021|NCT00506350|79447688|FG005|Overall Study|Serious Adverse Event|0|||
44439022|NCT00506350|79447689|FG006|Overall Study|Serious Adverse Event|0|||
44439023|NCT00506350|79447690|FG007|Overall Study|Serious Adverse Event|0|||
44439024|NCT00506350|79447691|FG008|Overall Study|Serious Adverse Event|0|||
44439025|NCT00506350|79447683|FG000|Overall Study|Adverse Event|0|||
44439026|NCT00506350|79447684|FG001|Overall Study|Adverse Event|0|||
44439027|NCT00506350|79447685|FG002|Overall Study|Adverse Event|0|||
44439028|NCT00506350|79447686|FG003|Overall Study|Adverse Event|0|||
44439029|NCT00506350|79447687|FG004|Overall Study|Adverse Event|0|||
44439030|NCT00506350|79447688|FG005|Overall Study|Adverse Event|0|||
44439031|NCT00506350|79447689|FG006|Overall Study|Adverse Event|0|||
44439032|NCT00506350|79447690|FG007|Overall Study|Adverse Event|1|||
44439033|NCT00506350|79447691|FG008|Overall Study|Adverse Event|1|||
44439034|NCT00506350|79447683|FG000|Overall Study|Protocol Violation|0|||
44439035|NCT00506350|79447684|FG001|Overall Study|Protocol Violation|0|||
44439036|NCT00506350|79447685|FG002|Overall Study|Protocol Violation|1|||
44439037|NCT00506350|79447686|FG003|Overall Study|Protocol Violation|0|||
44439038|NCT00506350|79447687|FG004|Overall Study|Protocol Violation|0|||
44439039|NCT00506350|79447688|FG005|Overall Study|Protocol Violation|0|||
44439040|NCT00506350|79447689|FG006|Overall Study|Protocol Violation|1|||
44439041|NCT00506350|79447690|FG007|Overall Study|Protocol Violation|0|||
44439042|NCT00506350|79447691|FG008|Overall Study|Protocol Violation|0|||
44439043|NCT00506350|79447683|FG000|Overall Study|Withdrawal by Subject|0|||
44439044|NCT00506350|79447684|FG001|Overall Study|Withdrawal by Subject|1|||
44439045|NCT00506350|79447685|FG002|Overall Study|Withdrawal by Subject|1|||
44439046|NCT00506350|79447686|FG003|Overall Study|Withdrawal by Subject|1|||
44439047|NCT00506350|79447687|FG004|Overall Study|Withdrawal by Subject|4|||
44439048|NCT00506350|79447688|FG005|Overall Study|Withdrawal by Subject|1|||
44439049|NCT00506350|79447689|FG006|Overall Study|Withdrawal by Subject|1|||
44439050|NCT00506350|79447690|FG007|Overall Study|Withdrawal by Subject|2|||
44439051|NCT00506350|79447691|FG008|Overall Study|Withdrawal by Subject|0|||
44439052|NCT00506350|79447683|FG000|Overall Study|Lost to Follow-up|1|||
44439053|NCT00506350|79447684|FG001|Overall Study|Lost to Follow-up|1|||
44439054|NCT00506350|79447685|FG002|Overall Study|Lost to Follow-up|1|||
44439055|NCT00506350|79447686|FG003|Overall Study|Lost to Follow-up|1|||
44157758|NCT02631551|78949632|FG002|Overall Study|Other, specific reasons not collected|2|||
44157759|NCT02631551|78949633|FG003|Overall Study|Other, specific reasons not collected|2|||
44338861|NCT01027702|79343384|FG002|Overall Study|Received subsequent therapy|0|||
44338862|NCT01027702|79343385|FG003|Overall Study|Received subsequent therapy|4|||
44338863|NCT01027702|79343386|FG004|Overall Study|Received subsequent therapy|1|||
44338864|NCT01027702|79343387|FG005|Overall Study|Received subsequent therapy|0|||
44338865|NCT01027702|79343388|FG006|Overall Study|Received subsequent therapy|1|||
44338866|NCT01027702|79343382|FG000|Overall Study|Death|0|||
44338867|NCT01027702|79343383|FG001|Overall Study|Death|0|||
44439056|NCT00506350|79447687|FG004|Overall Study|Lost to Follow-up|2|||
44439057|NCT00506350|79447688|FG005|Overall Study|Lost to Follow-up|1|||
44439058|NCT00506350|79447689|FG006|Overall Study|Lost to Follow-up|0|||
44439059|NCT00506350|79447690|FG007|Overall Study|Lost to Follow-up|0|||
44439060|NCT00506350|79447691|FG008|Overall Study|Lost to Follow-up|2|||
44439061|NCT00506350|79447683|FG000|Overall Study|Medical Reason|0|||
44439062|NCT00506350|79447684|FG001|Overall Study|Medical Reason|0|||
44439063|NCT00506350|79447685|FG002|Overall Study|Medical Reason|0|||
44439064|NCT00506350|79447686|FG003|Overall Study|Medical Reason|0|||
44439065|NCT00506350|79447687|FG004|Overall Study|Medical Reason|1|||
44439066|NCT00506350|79447688|FG005|Overall Study|Medical Reason|0|||
44439067|NCT00506350|79447689|FG006|Overall Study|Medical Reason|0|||
44439068|NCT00506350|79447690|FG007|Overall Study|Medical Reason|0|||
44439069|NCT00506350|79447691|FG008|Overall Study|Medical Reason|0|||
44439070|NCT00506350|79447683|FG000|Overall Study|Other|1|||
44439071|NCT00506350|79447684|FG001|Overall Study|Other|1|||
44439072|NCT00506350|79447685|FG002|Overall Study|Other|3|||
44439073|NCT00506350|79447686|FG003|Overall Study|Other|0|||
44439074|NCT00506350|79447687|FG004|Overall Study|Other|3|||
44439075|NCT00506350|79447688|FG005|Overall Study|Other|0|||
44439076|NCT00506350|79447689|FG006|Overall Study|Other|0|||
44338868|NCT01027702|79343384|FG002|Overall Study|Death|1|||
44338869|NCT01027702|79343385|FG003|Overall Study|Death|0|||
44338870|NCT01027702|79343386|FG004|Overall Study|Death|0|||
44338871|NCT01027702|79343387|FG005|Overall Study|Death|0|||
44338872|NCT01027702|79343388|FG006|Overall Study|Death|0|||
44338873|NCT01302080|79343402|FG000|Overall Study|Withdrew Consent|92|||
44338874|NCT01302080|79343403|FG001|Overall Study|Withdrew Consent|39|||
44338875|NCT01302080|79343402|FG000|Overall Study|Patient/Family Moved|28|||
44338876|NCT01302080|79343403|FG001|Overall Study|Patient/Family Moved|3|||
44338877|NCT01302080|79343402|FG000|Overall Study|Lost to Follow-up|192|||
44338878|NCT01302080|79343403|FG001|Overall Study|Lost to Follow-up|93|||
44338879|NCT01302080|79343402|FG000|Overall Study|Death|1|||
44338880|NCT01302080|79343403|FG001|Overall Study|Death|0|||
44338881|NCT01302080|79343402|FG000|Overall Study|Other|52|||
44338882|NCT01302080|79343403|FG001|Overall Study|Other|8|||
44338883|NCT01302080|79343402|FG000|Overall Study|Reason Missing For Discontinuation|1|||
44439077|NCT00506350|79447690|FG007|Overall Study|Other|2|||
44439078|NCT00506350|79447691|FG008|Overall Study|Other|2|||
44338884|NCT01302080|79343403|FG001|Overall Study|Reason Missing For Discontinuation|0|||
44338885|NCT01238991|79343443|FG000|Overall Study|Adverse Event|1|||
44338886|NCT01238991|79343444|FG001|Overall Study|Adverse Event|0|||
44439079|NCT00258895|79447720|FG000|Overall Study|Lost to Follow-up|3|||
44439080|NCT00258895|79447721|FG001|Overall Study|Lost to Follow-up|1|||
44439081|NCT00258895|79447720|FG000|Overall Study|Protocol Violation|6|||
44439082|NCT00258895|79447721|FG001|Overall Study|Protocol Violation|2|||
44439083|NCT00258895|79447720|FG000|Overall Study|Withdrawal by Subject|1|||
44439084|NCT00258895|79447721|FG001|Overall Study|Withdrawal by Subject|0|||
44157760|NCT01680991|78949646|FG000|Overall Study|Adverse Event|1|||
44157761|NCT01680991|78949647|FG001|Overall Study|Adverse Event|0|||
44338887|NCT01238991|79343445|FG002|Overall Study|Adverse Event|3|||
44338888|NCT01238991|79343446|FG003|Overall Study|Adverse Event|1|||
44338889|NCT01238991|79343447|FG004|Overall Study|Adverse Event|1|||
44338890|NCT01238991|79343448|FG005|Overall Study|Adverse Event|0|||
44439085|NCT00742625|79447727|FG000|Remission Induction|Progression|6|||
44338891|NCT01238991|79343449|FG006|Overall Study|Adverse Event|1|||
44338892|NCT01238991|79343450|FG007|Overall Study|Adverse Event|1|||
44338893|NCT01238991|79343451|FG008|Overall Study|Adverse Event|0|||
44338894|NCT01238991|79343452|FG009|Overall Study|Adverse Event|0|||
44338895|NCT01238991|79343443|FG000|Overall Study|Death|0|||
44338896|NCT01238991|79343444|FG001|Overall Study|Death|0|||
44338897|NCT01238991|79343445|FG002|Overall Study|Death|0|||
44338898|NCT01238991|79343446|FG003|Overall Study|Death|1|||
44338899|NCT01238991|79343447|FG004|Overall Study|Death|0|||
44439086|NCT00742625|79447727|FG000|Remission Induction|Failed induction|8|||
44439087|NCT00742625|79447727|FG000|Remission Induction|Adverse Event|3|||
44439088|NCT00742625|79447727|FG000|Remission Induction|Death|10|||
44439089|NCT00742625|79447727|FG000|Remission Induction|Refusal|5|||
44439090|NCT00742625|79447727|FG000|Remission Induction|Non protocol treatment|17|||
44439091|NCT00742625|79447727|FG000|Remission Induction|Other, not specified|5|||
44439092|NCT00742625|79447727|FG000|Consolidation|Progression|5|||
44439093|NCT00742625|79447727|FG000|Consolidation|Adverse Event|1|||
44439094|NCT00742625|79447727|FG000|Consolidation|Death|1|||
44338900|NCT01238991|79343448|FG005|Overall Study|Death|0|||
44338901|NCT01238991|79343449|FG006|Overall Study|Death|0|||
44338902|NCT01238991|79343450|FG007|Overall Study|Death|0|||
44338903|NCT01238991|79343451|FG008|Overall Study|Death|0|||
44439095|NCT00742625|79447727|FG000|Consolidation|Refused|1|||
44439096|NCT00742625|79447727|FG000|Consolidation|Non protocol therapy|13|||
44338904|NCT01238991|79343452|FG009|Overall Study|Death|0|||
44338905|NCT01238991|79343443|FG000|Overall Study|Lack of Efficacy|0|||
44338906|NCT01238991|79343444|FG001|Overall Study|Lack of Efficacy|0|||
44338907|NCT01238991|79343445|FG002|Overall Study|Lack of Efficacy|1|||
44338908|NCT01238991|79343446|FG003|Overall Study|Lack of Efficacy|0|||
44338909|NCT01238991|79343447|FG004|Overall Study|Lack of Efficacy|0|||
44338910|NCT01238991|79343448|FG005|Overall Study|Lack of Efficacy|0|||
44338911|NCT01238991|79343449|FG006|Overall Study|Lack of Efficacy|0|||
44338912|NCT01238991|79343450|FG007|Overall Study|Lack of Efficacy|0|||
44338913|NCT01238991|79343451|FG008|Overall Study|Lack of Efficacy|1|||
44338914|NCT01238991|79343452|FG009|Overall Study|Lack of Efficacy|0|||
44338915|NCT01238991|79343443|FG000|Overall Study|Withdrawal by Subject|0|||
44439097|NCT00618618|79447738|FG000|Overall Study|Patient Request|0|||
44439098|NCT00618618|79447739|FG001|Overall Study|Patient Request|0|||
44439099|NCT00618618|79447740|FG002|Overall Study|Patient Request|2|||
44439100|NCT00618618|79447741|FG003|Overall Study|Patient Request|0|||
44439101|NCT00618618|79447738|FG000|Overall Study|Inability to Complete Study Procedures|0|||
44439102|NCT00618618|79447739|FG001|Overall Study|Inability to Complete Study Procedures|1|||
44439103|NCT00618618|79447740|FG002|Overall Study|Inability to Complete Study Procedures|0|||
44439104|NCT00618618|79447741|FG003|Overall Study|Inability to Complete Study Procedures|0|||
44439105|NCT00618618|79447738|FG000|Overall Study|Lost to Follow-up|3|||
44338916|NCT01238991|79343444|FG001|Overall Study|Withdrawal by Subject|0|||
44338917|NCT01238991|79343445|FG002|Overall Study|Withdrawal by Subject|1|||
44338918|NCT01238991|79343446|FG003|Overall Study|Withdrawal by Subject|0|||
44338919|NCT01238991|79343447|FG004|Overall Study|Withdrawal by Subject|0|||
44338920|NCT01238991|79343448|FG005|Overall Study|Withdrawal by Subject|0|||
44338921|NCT01238991|79343449|FG006|Overall Study|Withdrawal by Subject|0|||
44338922|NCT01238991|79343450|FG007|Overall Study|Withdrawal by Subject|0|||
44338923|NCT01238991|79343451|FG008|Overall Study|Withdrawal by Subject|0|||
44439106|NCT00618618|79447739|FG001|Overall Study|Lost to Follow-up|0|||
44439107|NCT00618618|79447740|FG002|Overall Study|Lost to Follow-up|0|||
44439108|NCT00618618|79447741|FG003|Overall Study|Lost to Follow-up|1|||
44439109|NCT00618618|79447738|FG000|Overall Study|Non-compliance|1|||
44439110|NCT00618618|79447739|FG001|Overall Study|Non-compliance|1|||
44439111|NCT00618618|79447740|FG002|Overall Study|Non-compliance|0|||
44439112|NCT00618618|79447741|FG003|Overall Study|Non-compliance|0|||
44439113|NCT00618618|79447738|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
44439114|NCT00618618|79447739|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
44439115|NCT00618618|79447740|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
44338924|NCT01238991|79343452|FG009|Overall Study|Withdrawal by Subject|0|||
44338925|NCT01238991|79343443|FG000|Overall Study|Study Terminated by Sponsor|0|||
44338926|NCT01238991|79343444|FG001|Overall Study|Study Terminated by Sponsor|0|||
44439116|NCT00618618|79447741|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
44439117|NCT00618618|79447738|FG000|Overall Study|Death|0|||
44338927|NCT01238991|79343445|FG002|Overall Study|Study Terminated by Sponsor|0|||
44338928|NCT01238991|79343446|FG003|Overall Study|Study Terminated by Sponsor|0|||
44338929|NCT01238991|79343447|FG004|Overall Study|Study Terminated by Sponsor|1|||
44338930|NCT01238991|79343448|FG005|Overall Study|Study Terminated by Sponsor|0|||
44338931|NCT01238991|79343449|FG006|Overall Study|Study Terminated by Sponsor|7|||
44338932|NCT01238991|79343450|FG007|Overall Study|Study Terminated by Sponsor|4|||
44338933|NCT01238991|79343451|FG008|Overall Study|Study Terminated by Sponsor|2|||
44338934|NCT01238991|79343452|FG009|Overall Study|Study Terminated by Sponsor|2|||
44338935|NCT01238991|79343443|FG000|Overall Study|Caregiver's request|0|||
44338936|NCT01238991|79343444|FG001|Overall Study|Caregiver's request|0|||
44338937|NCT01238991|79343445|FG002|Overall Study|Caregiver's request|0|||
44338938|NCT01238991|79343446|FG003|Overall Study|Caregiver's request|0|||
44338939|NCT01238991|79343447|FG004|Overall Study|Caregiver's request|0|||
44338940|NCT01238991|79343448|FG005|Overall Study|Caregiver's request|0|||
44338941|NCT01238991|79343449|FG006|Overall Study|Caregiver's request|0|||
44338942|NCT01238991|79343450|FG007|Overall Study|Caregiver's request|0|||
44338943|NCT01238991|79343451|FG008|Overall Study|Caregiver's request|1|||
44338944|NCT01238991|79343452|FG009|Overall Study|Caregiver's request|0|||
44338945|NCT01238991|79343443|FG000|Overall Study|Admission to a nursing home|1|||
44338946|NCT01238991|79343444|FG001|Overall Study|Admission to a nursing home|0|||
44338947|NCT01238991|79343445|FG002|Overall Study|Admission to a nursing home|1|||
44338948|NCT01238991|79343446|FG003|Overall Study|Admission to a nursing home|0|||
44338949|NCT01238991|79343447|FG004|Overall Study|Admission to a nursing home|0|||
44338950|NCT01238991|79343448|FG005|Overall Study|Admission to a nursing home|0|||
44338951|NCT01238991|79343449|FG006|Overall Study|Admission to a nursing home|0|||
44338952|NCT01238991|79343450|FG007|Overall Study|Admission to a nursing home|0|||
44338953|NCT01238991|79343451|FG008|Overall Study|Admission to a nursing home|0|||
44338954|NCT01238991|79343452|FG009|Overall Study|Admission to a nursing home|0|||
44338955|NCT01238835|79343477|FG000|Overall Study|Death|124|||
44338956|NCT01238835|79343477|FG000|Overall Study|Withdrawal by Subject|9|||
44338957|NCT01238835|79343477|FG000|Overall Study|Lost to Follow-up|1|||
44338958|NCT01238835|79343477|FG000|Overall Study|Site early discontinuation|2|||
44338959|NCT01032070|79343483|FG000|Overall Study|Disease progression|13|||
44439118|NCT00618618|79447739|FG001|Overall Study|Death|1|||
44439119|NCT00618618|79447740|FG002|Overall Study|Death|0|||
44439120|NCT00618618|79447741|FG003|Overall Study|Death|0|||
44439121|NCT00246805|79447754|FG000|Phase 1|Lost to Follow-up|1|||
44439122|NCT00246805|79447755|FG001|Phase 1|Lost to Follow-up|0|||
44439123|NCT00519376|79447761|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439124|NCT00519376|79447762|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439125|NCT00519376|79447763|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439126|NCT00519376|79447764|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439127|NCT00519376|79447765|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439128|NCT00519376|79447766|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439129|NCT00519376|79447767|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439130|NCT00519376|79447768|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439131|NCT00519376|79447769|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439132|NCT00519376|79447770|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439133|NCT00519376|79447771|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44338960|NCT01032070|79343484|FG001|Overall Study|Disease progression|8|||
44338961|NCT01032070|79343483|FG000|Overall Study|Medical or ethical reasons|0|||
44338962|NCT01032070|79343484|FG001|Overall Study|Medical or ethical reasons|2|||
44338963|NCT01032070|79343483|FG000|Overall Study|Withdrawal by Subject|0|||
44338964|NCT01032070|79343484|FG001|Overall Study|Withdrawal by Subject|2|||
44338965|NCT01237899|79343501|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
44338966|NCT01237899|79343502|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
44338967|NCT01237899|79343503|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
44338968|NCT01237899|79343504|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
44439134|NCT00519376|79447772|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439135|NCT00519376|79447773|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
44439136|NCT00519376|79447774|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44338969|NCT01237899|79343505|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
44338970|NCT01237899|79343506|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
44439137|NCT00519376|79447775|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439138|NCT00519376|79447776|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
44439139|NCT00519376|79447761|FG000|Treatment Period 4|Lost to Follow-up|0|||
44439140|NCT00519376|79447762|FG001|Treatment Period 4|Lost to Follow-up|0|||
44439141|NCT00519376|79447763|FG002|Treatment Period 4|Lost to Follow-up|1|||
44439142|NCT00519376|79447764|FG003|Treatment Period 4|Lost to Follow-up|0|||
44439143|NCT00519376|79447765|FG004|Treatment Period 4|Lost to Follow-up|0|||
44439144|NCT00519376|79447766|FG005|Treatment Period 4|Lost to Follow-up|0|||
44439145|NCT00519376|79447767|FG006|Treatment Period 4|Lost to Follow-up|0|||
44439146|NCT00519376|79447768|FG007|Treatment Period 4|Lost to Follow-up|0|||
44439147|NCT00519376|79447769|FG008|Treatment Period 4|Lost to Follow-up|0|||
44439148|NCT00519376|79447770|FG009|Treatment Period 4|Lost to Follow-up|0|||
44439149|NCT00519376|79447771|FG010|Treatment Period 4|Lost to Follow-up|0|||
44439150|NCT00519376|79447772|FG011|Treatment Period 4|Lost to Follow-up|0|||
44439151|NCT00519376|79447773|FG012|Treatment Period 4|Lost to Follow-up|0|||
44439152|NCT00519376|79447774|FG013|Treatment Period 4|Lost to Follow-up|0|||
44439153|NCT00519376|79447775|FG014|Treatment Period 4|Lost to Follow-up|0|||
44439154|NCT00519376|79447776|FG015|Treatment Period 4|Lost to Follow-up|0|||
44338971|NCT01237899|79343507|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
44338972|NCT01237899|79343508|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
44338973|NCT01237899|79343509|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
44338974|NCT01237899|79343510|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
44338975|NCT01237899|79343511|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
44338976|NCT01264380|79343529|FG000|Period C|Disease Progression|0|||
44338977|NCT01264380|79343530|FG001|Period C|Disease Progression|0|||
44338978|NCT01264380|79343531|FG002|Period C|Disease Progression|4|||
44338979|NCT01264380|79343529|FG000|Period C|Death|0|||
44338980|NCT01264380|79343530|FG001|Period C|Death|0|||
44338981|NCT01264380|79343531|FG002|Period C|Death|2|||
44338982|NCT01264380|79343529|FG000|Period C|Follow-up for survival status|0|||
44338983|NCT01264380|79343530|FG001|Period C|Follow-up for survival status|0|||
44338984|NCT01264380|79343531|FG002|Period C|Follow-up for survival status|6|||
44338985|NCT01264380|79343529|FG000|Period C|Withdrawal by Subject|0|||
44338986|NCT01264380|79343530|FG001|Period C|Withdrawal by Subject|0|||
44338987|NCT01264380|79343531|FG002|Period C|Withdrawal by Subject|1|||
44338988|NCT01264380|79343529|FG000|Period C|Adverse Event|0|||
44338989|NCT01264380|79343530|FG001|Period C|Adverse Event|0|||
44338990|NCT01264380|79343531|FG002|Period C|Adverse Event|1|||
44338991|NCT01263444|79343539|FG000|Overall Study|Adverse Event|8|||
44338992|NCT01263444|79343539|FG000|Overall Study|Withdrawal by Subject|1|||
44338993|NCT01263444|79343539|FG000|Overall Study|Protocol Violation|1|||
44338994|NCT01263054|79343545|FG000|Overall Study|Death|1|||
44338995|NCT01263054|79343546|FG001|Overall Study|Death|0|||
44338996|NCT01263054|79343545|FG000|Overall Study|Lost to Follow-up|2|||
44338997|NCT01263054|79343546|FG001|Overall Study|Lost to Follow-up|2|||
44338998|NCT01263054|79343545|FG000|Overall Study|Withdrawal by Subject|1|||
44338999|NCT01263054|79343546|FG001|Overall Study|Withdrawal by Subject|3|||
44339000|NCT01263054|79343545|FG000|Overall Study|Qualification Violation|1|||
44339001|NCT01263054|79343546|FG001|Overall Study|Qualification Violation|0|||
44339002|NCT01263054|79343545|FG000|Overall Study|Other|0|||
44339003|NCT01263054|79343546|FG001|Overall Study|Other|1|||
44339004|NCT01031836|79343558|FG000|Stage I|Adverse Event|1|||
44339005|NCT01031836|79343559|FG001|Stage I|Adverse Event|1|||
44339006|NCT01031836|79343560|FG002|Stage I|Adverse Event|0|||
44339007|NCT01031836|79343561|FG003|Stage I|Adverse Event|0|||
44439155|NCT00745121|79447790|FG000|Overall Study|Death|3|||
44439156|NCT00745121|79447791|FG001|Overall Study|Death|0|||
44439157|NCT00745121|79447790|FG000|Overall Study|Adverse Event|1|||
44439158|NCT00745121|79447791|FG001|Overall Study|Adverse Event|0|||
44439159|NCT00745121|79447790|FG000|Overall Study|Lost to Follow-up|1|||
44439160|NCT00745121|79447791|FG001|Overall Study|Lost to Follow-up|0|||
44259429|NCT00086684|79119675|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
44259430|NCT00086684|79119676|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
44259431|NCT00086684|79119674|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
44439161|NCT00745121|79447790|FG000|Overall Study|Withdrawal by Subject|4|||
44439162|NCT00745121|79447791|FG001|Overall Study|Withdrawal by Subject|2|||
44439163|NCT00740051|79447799|FG000|Overall Study|Lack of Efficacy|2|||
44439164|NCT00740051|79447800|FG001|Overall Study|Lack of Efficacy|5|||
44439165|NCT00740051|79447799|FG000|Overall Study|Adverse Event|1|||
44439166|NCT00740051|79447800|FG001|Overall Study|Adverse Event|4|||
44439167|NCT00740051|79447799|FG000|Overall Study|Protocol Violation|2|||
44439168|NCT00740051|79447800|FG001|Overall Study|Protocol Violation|6|||
44439169|NCT00740051|79447799|FG000|Overall Study|Lost to Follow-up|3|||
44439170|NCT00740051|79447800|FG001|Overall Study|Lost to Follow-up|8|||
44439171|NCT00740051|79447799|FG000|Overall Study|Withdrawal by Subject|6|||
44439172|NCT00740051|79447800|FG001|Overall Study|Withdrawal by Subject|8|||
44439173|NCT00740051|79447799|FG000|Overall Study|Other reason (not specified)|4|||
44439174|NCT00740051|79447800|FG001|Overall Study|Other reason (not specified)|1|||
44439175|NCT00518986|79447809|FG000|Overall Study|Adverse Event|12|||
44439176|NCT00518986|79447810|FG001|Overall Study|Adverse Event|7|||
44439177|NCT00518986|79447809|FG000|Overall Study|Lack of Efficacy|0|||
44439178|NCT00518986|79447810|FG001|Overall Study|Lack of Efficacy|2|||
44439179|NCT00518986|79447809|FG000|Overall Study|Lost to Follow-up|3|||
44439180|NCT00518986|79447810|FG001|Overall Study|Lost to Follow-up|2|||
44157762|NCT01680991|78949648|FG002|Overall Study|Adverse Event|0|||
44157763|NCT01680991|78949646|FG000|Overall Study|Death|1|||
44439181|NCT00518986|79447809|FG000|Overall Study|Physician Decision|0|||
44439182|NCT00518986|79447810|FG001|Overall Study|Physician Decision|3|||
44157764|NCT01680991|78949647|FG001|Overall Study|Death|0|||
44339008|NCT01031836|79343562|FG004|Stage I|Adverse Event|0|||
44339009|NCT01031836|79343563|FG005|Stage I|Adverse Event|0|||
44439183|NCT00518986|79447809|FG000|Overall Study|Protocol Violation|5|||
44439184|NCT00518986|79447810|FG001|Overall Study|Protocol Violation|7|||
44439185|NCT00518986|79447809|FG000|Overall Study|Withdrawal by Subject|4|||
44439186|NCT00518986|79447810|FG001|Overall Study|Withdrawal by Subject|4|||
44439187|NCT00518986|79447809|FG000|Overall Study|Non-Specific|2|||
44439188|NCT00518986|79447810|FG001|Overall Study|Non-Specific|1|||
44439189|NCT00742391|79447818|FG000|Overall Study|Adverse Event|2|||
44439190|NCT00742391|79447819|FG001|Overall Study|Adverse Event|1|||
44259432|NCT00086684|79119675|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
44259433|NCT00086684|79119676|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
44439191|NCT00742391|79447818|FG000|Overall Study|Lost to Follow-up|1|||
44157765|NCT01680991|78949648|FG002|Overall Study|Death|1|||
44339010|NCT01031836|79343558|FG000|Stage I|Other|0|||
44339011|NCT01031836|79343559|FG001|Stage I|Other|1|||
44339012|NCT01031836|79343560|FG002|Stage I|Other|0|||
44339013|NCT01031836|79343561|FG003|Stage I|Other|0|||
44339014|NCT01031836|79343562|FG004|Stage I|Other|0|||
44339015|NCT01031836|79343563|FG005|Stage I|Other|1|||
44339016|NCT01031836|79343558|FG000|Stage II|Adverse Event|0|||
44339017|NCT01031836|79343559|FG001|Stage II|Adverse Event|0|||
44339018|NCT01031836|79343560|FG002|Stage II|Adverse Event|2|||
44339019|NCT01031836|79343561|FG003|Stage II|Adverse Event|2|||
44339020|NCT01031836|79343562|FG004|Stage II|Adverse Event|1|||
44339021|NCT01031836|79343563|FG005|Stage II|Adverse Event|1|||
44339022|NCT01031836|79343558|FG000|Stage II|Other|2|||
44339023|NCT01031836|79343559|FG001|Stage II|Other|0|||
44339024|NCT01031836|79343560|FG002|Stage II|Other|0|||
44339025|NCT01031836|79343561|FG003|Stage II|Other|1|||
44339026|NCT01031836|79343562|FG004|Stage II|Other|1|||
44339027|NCT01031836|79343563|FG005|Stage II|Other|0|||
44339028|NCT01237587|79343579|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
44339029|NCT01237587|79343580|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
44339030|NCT01237587|79343579|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
44339031|NCT01237587|79343580|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
44339032|NCT01237587|79343579|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
44339033|NCT01237587|79343580|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
44339034|NCT01237587|79343579|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
44157766|NCT01680991|78949646|FG000|Overall Study|Protocol Violation|0|||
44157767|NCT01680991|78949647|FG001|Overall Study|Protocol Violation|1|||
44157768|NCT01680991|78949648|FG002|Overall Study|Protocol Violation|0|||
44157769|NCT01680991|78949646|FG000|Overall Study|Withdrawal by Subject|5|||
44339035|NCT01237587|79343580|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
44339036|NCT01237587|79343579|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
44339037|NCT01237587|79343580|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
44339038|NCT01237587|79343579|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
44339039|NCT01237587|79343580|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
44339040|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
44339041|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
44339042|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
44339043|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
44339044|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
44339045|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
44339046|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
44339047|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
44339048|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
44339049|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
44339050|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
44339051|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
44339052|NCT01237587|79343579|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
44339053|NCT01237587|79343580|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
44439192|NCT00742391|79447819|FG001|Overall Study|Lost to Follow-up|0|||
44439193|NCT00742391|79447818|FG000|Overall Study|Protocol Violation|1|||
44439194|NCT00742391|79447819|FG001|Overall Study|Protocol Violation|0|||
44439195|NCT00742235|79447827|FG000|Overall Study|Lost to Follow-up|0|||
44439196|NCT00742235|79447828|FG001|Overall Study|Lost to Follow-up|31|||
44439197|NCT00742079|79447836|FG000|Overall Study|Lost to Follow-up|0|||
44439198|NCT00742079|79447837|FG001|Overall Study|Lost to Follow-up|1|||
44439199|NCT00662792|79447843|FG000|Period 1|Personal Reasons|0|||
44439200|NCT00662792|79447844|FG001|Period 1|Personal Reasons|0|||
44439201|NCT00662792|79447845|FG002|Period 1|Personal Reasons|1|||
44439202|NCT00662792|79447846|FG003|Period 1|Personal Reasons|0|||
44439203|NCT00662792|79447843|FG000|Period 1|Refused continuing medication|0|||
44439204|NCT00662792|79447844|FG001|Period 1|Refused continuing medication|1|||
44439205|NCT00662792|79447845|FG002|Period 1|Refused continuing medication|1|||
44439206|NCT00662792|79447846|FG003|Period 1|Refused continuing medication|0|||
44439207|NCT00662792|79447843|FG000|Period 1|Lost to Follow-up|1|||
44439208|NCT00662792|79447844|FG001|Period 1|Lost to Follow-up|0|||
44439209|NCT00662792|79447845|FG002|Period 1|Lost to Follow-up|0|||
44259434|NCT00086684|79119674|FG000|Overall Study|Other|4|||
44259435|NCT00086684|79119675|FG001|Overall Study|Other|2|||
44259436|NCT00086684|79119676|FG002|Overall Study|Other|3|||
44259437|NCT00082628|79119740|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
44439210|NCT00662792|79447846|FG003|Period 1|Lost to Follow-up|0|||
44339054|NCT01237587|79343579|FG000|Taper Phase|Adverse Event|0|||
44439211|NCT00662792|79447843|FG000|Period 1|Other adverse event (AE)|0|||
44439212|NCT00662792|79447844|FG001|Period 1|Other adverse event (AE)|2|||
44439213|NCT00662792|79447845|FG002|Period 1|Other adverse event (AE)|0|||
44439214|NCT00662792|79447846|FG003|Period 1|Other adverse event (AE)|0|||
44439215|NCT00662792|79447843|FG000|Period 1|Worsening of disease under study (AE)|1|||
44439216|NCT00662792|79447844|FG001|Period 1|Worsening of disease under study (AE)|3|||
44439217|NCT00662792|79447845|FG002|Period 1|Worsening of disease under study (AE)|2|||
44439218|NCT00662792|79447846|FG003|Period 1|Worsening of disease under study (AE)|0|||
44439219|NCT00662792|79447843|FG000|Period 1|Not treated|0|||
44157770|NCT01680991|78949647|FG001|Overall Study|Withdrawal by Subject|1|||
44157771|NCT01680991|78949648|FG002|Overall Study|Withdrawal by Subject|0|||
44439220|NCT00662792|79447844|FG001|Period 1|Not treated|1|||
44439221|NCT00662792|79447845|FG002|Period 1|Not treated|0|||
44439222|NCT00662792|79447846|FG003|Period 1|Not treated|0|||
44439223|NCT00662792|79447843|FG000|Period 2|Worsening of disease under study|1|||
44439224|NCT00662792|79447844|FG001|Period 2|Worsening of disease under study|0|||
44439225|NCT00662792|79447845|FG002|Period 2|Worsening of disease under study|0|||
44157772|NCT01680991|78949646|FG000|Overall Study|Progressive disease (PD)|0|||
44339055|NCT01237587|79343580|FG001|Taper Phase|Adverse Event|2|||
44339056|NCT01237587|79343579|FG000|Taper Phase|Protocol Violation|2|||
44339057|NCT01237587|79343580|FG001|Taper Phase|Protocol Violation|0|||
44339058|NCT01237587|79343579|FG000|Taper Phase|Lack of Efficacy|2|||
44157773|NCT01680991|78949647|FG001|Overall Study|Progressive disease (PD)|10|||
44439226|NCT00662792|79447846|FG003|Period 2|Worsening of disease under study|3|||
44439227|NCT00662792|79447843|FG000|Period 3|Refused continuing medication|1|||
44439228|NCT00662792|79447844|FG001|Period 3|Refused continuing medication|0|||
44439229|NCT00662792|79447845|FG002|Period 3|Refused continuing medication|1|||
44439230|NCT00662792|79447846|FG003|Period 3|Refused continuing medication|0|||
44439231|NCT00662792|79447843|FG000|Period 3|Other adverse event (AE)|0|||
44439232|NCT00662792|79447844|FG001|Period 3|Other adverse event (AE)|0|||
44439233|NCT00662792|79447845|FG002|Period 3|Other adverse event (AE)|1|||
44439234|NCT00662792|79447846|FG003|Period 3|Other adverse event (AE)|1|||
44439235|NCT00662792|79447843|FG000|Period 4|Refused continuing medication|0|||
44439236|NCT00662792|79447844|FG001|Period 4|Refused continuing medication|1|||
44339059|NCT01237587|79343580|FG001|Taper Phase|Lack of Efficacy|5|||
44339060|NCT01237587|79343579|FG000|Taper Phase|Parent/Guardian Decision|0|||
44339061|NCT01237587|79343580|FG001|Taper Phase|Parent/Guardian Decision|2|||
44339062|NCT01237587|79343579|FG000|Taper Phase|Sponsor Decision|1|||
44339063|NCT01237587|79343580|FG001|Taper Phase|Sponsor Decision|0|||
44339064|NCT01237587|79343579|FG000|Taper Phase|Withdrawal by Subject|0|||
44339065|NCT01237587|79343580|FG001|Taper Phase|Withdrawal by Subject|1|||
44339066|NCT01031680|79343595|FG000|Overall Study|Adverse Event|8|||
44339067|NCT01031680|79343596|FG001|Overall Study|Adverse Event|3|||
44339068|NCT01031680|79343595|FG000|Overall Study|Lost to Follow-up|2|||
44439237|NCT00662792|79447845|FG002|Period 4|Refused continuing medication|0|||
44259438|NCT00082628|79119741|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
44259439|NCT00082628|79119742|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
44259440|NCT00082628|79119743|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
44259441|NCT00082628|79119744|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
44259442|NCT00082628|79119740|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
44259443|NCT00082628|79119741|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
44439238|NCT00662792|79447846|FG003|Period 4|Refused continuing medication|0|||
44439239|NCT00662792|79447843|FG000|Period 4|Other adverse event (AE)|1|||
44339069|NCT01031680|79343596|FG001|Overall Study|Lost to Follow-up|10|||
44339070|NCT01031680|79343595|FG000|Overall Study|Withdrawal by Subject|12|||
44339071|NCT01031680|79343596|FG001|Overall Study|Withdrawal by Subject|16|||
44339072|NCT01031680|79343595|FG000|Overall Study|Death|2|||
44339073|NCT01031680|79343596|FG001|Overall Study|Death|1|||
44339074|NCT01031680|79343595|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
44339075|NCT01031680|79343596|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
44339076|NCT01031680|79343595|FG000|Overall Study|Poor/Non-compliance|5|||
44339077|NCT01031680|79343596|FG001|Overall Study|Poor/Non-compliance|6|||
44339078|NCT01031680|79343595|FG000|Overall Study|Safety|1|||
44339079|NCT01031680|79343596|FG001|Overall Study|Safety|0|||
44339080|NCT01031680|79343595|FG000|Overall Study|Incorrect Enrolment|1|||
44339081|NCT01031680|79343596|FG001|Overall Study|Incorrect Enrolment|2|||
44339082|NCT01031680|79343595|FG000|Overall Study|Administrative Reason by Sponsor|0|||
44339083|NCT01031680|79343596|FG001|Overall Study|Administrative Reason by Sponsor|1|||
44157774|NCT01680991|78949648|FG002|Overall Study|Progressive disease (PD)|0|||
44157775|NCT01680991|78949646|FG000|Overall Study|Physician Decision|0|||
44157776|NCT01680991|78949647|FG001|Overall Study|Physician Decision|7|||
44157777|NCT01680991|78949648|FG002|Overall Study|Physician Decision|2|||
44157778|NCT01680991|78949646|FG000|Overall Study|Bad physical condition|0|||
44339084|NCT01031680|79343595|FG000|Overall Study|Various|0|||
44339085|NCT01031680|79343596|FG001|Overall Study|Various|2|||
44339086|NCT01031446|79343602|FG000|Overall Study|Disease Progression|38|||
44339087|NCT01031446|79343602|FG000|Overall Study|Adverse Event|9|||
44339088|NCT01031446|79343602|FG000|Overall Study|Physician Decision|4|||
44339089|NCT01031446|79343602|FG000|Overall Study|Withdrawal by Subject|3|||
44339090|NCT01031446|79343602|FG000|Overall Study|Still on treatment|1|||
44339091|NCT01030900|79343608|FG000|Overall Study|Not treated due to congestive heart failure|1|||
44339092|NCT01030900|79343608|FG000|Overall Study|Not treated due to rapid disease|1|||
44339093|NCT01030822|79343615|FG000|Overall Study|Moved/migrated from study area|6|||
44339094|NCT01030822|79343616|FG001|Overall Study|Moved/migrated from study area|7|||
44339095|NCT01030822|79343617|FG002|Overall Study|Moved/migrated from study area|3|||
44339096|NCT01030822|79343615|FG000|Overall Study|Withdrawal by Subject|16|||
44339097|NCT01030822|79343616|FG001|Overall Study|Withdrawal by Subject|13|||
44339098|NCT01030822|79343617|FG002|Overall Study|Withdrawal by Subject|16|||
44339099|NCT01030822|79343615|FG000|Overall Study|Lost to Follow-up|9|||
44339100|NCT01030822|79343616|FG001|Overall Study|Lost to Follow-up|4|||
44339101|NCT01030822|79343617|FG002|Overall Study|Lost to Follow-up|7|||
44339102|NCT01026454|79343628|FG000|Second Intervention|Pregnancy|1|||
44339103|NCT01026454|79343629|FG001|Second Intervention|Pregnancy|1|||
44339104|NCT01026220|79343635|FG000|Induction|Death|1|||
44339105|NCT01026220|79343636|FG001|Induction|Death|0|||
44157779|NCT01680991|78949647|FG001|Overall Study|Bad physical condition|0|||
44339106|NCT01026220|79343637|FG002|Induction|Death|0|||
44339107|NCT01026220|79343635|FG000|Induction|Lack of Efficacy|2|||
44259444|NCT00082628|79119742|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
44259445|NCT00082628|79119743|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
44259446|NCT00082628|79119744|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
44259447|NCT00082628|79119740|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
44259448|NCT00082628|79119741|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
44259449|NCT00082628|79119742|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
44259450|NCT00082628|79119743|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
44259451|NCT00082628|79119744|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
44259452|NCT00082628|79119740|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
44259453|NCT00082628|79119741|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
44259454|NCT00082628|79119742|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
44259455|NCT00082628|79119743|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
44259456|NCT00082628|79119744|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
44259457|NCT00082628|79119740|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
44259458|NCT00082628|79119741|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
44259459|NCT00082628|79119742|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
44259460|NCT00082628|79119743|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
44259461|NCT00082628|79119744|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
44259462|NCT00082628|79119740|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
44259463|NCT00082628|79119741|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
44259464|NCT00082628|79119742|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
44259465|NCT00082628|79119743|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
44259466|NCT00082628|79119744|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
44339108|NCT01026220|79343636|FG001|Induction|Lack of Efficacy|0|||
44339109|NCT01026220|79343637|FG002|Induction|Lack of Efficacy|0|||
44439240|NCT00662792|79447844|FG001|Period 4|Other adverse event (AE)|0|||
44439241|NCT00662792|79447845|FG002|Period 4|Other adverse event (AE)|0|||
44439242|NCT00662792|79447846|FG003|Period 4|Other adverse event (AE)|0|||
44439243|NCT00662792|79447843|FG000|Period 4|Worsening of disease under study (AE)|0|||
44439244|NCT00662792|79447844|FG001|Period 4|Worsening of disease under study (AE)|0|||
44439245|NCT00662792|79447845|FG002|Period 4|Worsening of disease under study (AE)|0|||
44439246|NCT00662792|79447846|FG003|Period 4|Worsening of disease under study (AE)|1|||
44439247|NCT00742001|79447861|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
44439248|NCT00742001|79447862|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
44439249|NCT00742001|79447863|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
44439250|NCT00616902|79447876|FG000|Overall Study|Termination of study|6|||
44439251|NCT00616902|79447877|FG001|Overall Study|Termination of study|6|||
44439252|NCT00741611|79447886|FG000|Overall Study|Death|0|||
44439253|NCT00741611|79447887|FG001|Overall Study|Death|0|||
44439254|NCT00741611|79447888|FG002|Overall Study|Death|1|||
44439255|NCT00741611|79447886|FG000|Overall Study|Withdrawal by Subject|0|||
44439256|NCT00741611|79447887|FG001|Overall Study|Withdrawal by Subject|2|||
44439257|NCT00741611|79447888|FG002|Overall Study|Withdrawal by Subject|2|||
44439258|NCT00662558|79447899|FG000|Overall Study|Adverse Event|21|||
44439259|NCT00662558|79447900|FG001|Overall Study|Adverse Event|59|||
44439260|NCT00662558|79447899|FG000|Overall Study|Lack of Efficacy|4|||
44439261|NCT00662558|79447900|FG001|Overall Study|Lack of Efficacy|7|||
44439262|NCT00662558|79447899|FG000|Overall Study|Lost to Follow-up|13|||
44439263|NCT00662558|79447900|FG001|Overall Study|Lost to Follow-up|10|||
44439264|NCT00662558|79447899|FG000|Overall Study|Other|9|||
44339110|NCT01026220|79343635|FG000|Induction|Physician Decision|12|||
44439265|NCT00662558|79447900|FG001|Overall Study|Other|14|||
44339111|NCT01026220|79343636|FG001|Induction|Physician Decision|0|||
44439266|NCT00662558|79447899|FG000|Overall Study|Withdrawal by Subject|7|||
44439267|NCT00662558|79447900|FG001|Overall Study|Withdrawal by Subject|12|||
44439268|NCT00662558|79447899|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
44157780|NCT01680991|78949648|FG002|Overall Study|Bad physical condition|1|||
44339112|NCT01026220|79343637|FG002|Induction|Physician Decision|0|||
44339113|NCT01026220|79343635|FG000|Induction|Withdrawal by Subject|9|||
44259467|NCT00082628|79119740|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
44259468|NCT00082628|79119741|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
44259469|NCT00082628|79119742|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
44259470|NCT00082628|79119743|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
44259471|NCT00082628|79119744|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
44259472|NCT02993263|79120086|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
44259473|NCT01274533|79120114|FG000|Overall Study|Withdrawal by Subject|1|||
44259474|NCT01274533|79120114|FG000|Overall Study|Non-compliance|1|||
44259475|NCT01274533|79120114|FG000|Overall Study|Disease progression|2|||
44259476|NCT01273597|79120118|FG000|Overall Study|Adverse Event|5|||
44259477|NCT01273597|79120118|FG000|Overall Study|Underwent Kidney Transplantation|2|||
44439269|NCT00662558|79447900|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
44439270|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
44439271|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44439272|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44439273|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44439274|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44157781|NCT01680991|78949646|FG000|Overall Study|PD confirmed in other hospital|1|||
44157782|NCT01680991|78949647|FG001|Overall Study|PD confirmed in other hospital|0|||
44157783|NCT01680991|78949648|FG002|Overall Study|PD confirmed in other hospital|0|||
44157784|NCT02819479|78949658|FG000|Overall Study|Adverse Event|2|||
44339114|NCT01026220|79343636|FG001|Induction|Withdrawal by Subject|0|||
44439275|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44439276|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44259478|NCT01273597|79120118|FG000|Overall Study|Reason Not Reported|1|||
44259479|NCT01273519|79120125|FG000|Overall Study|Adverse Event|3|||
44259480|NCT01273519|79120126|FG001|Overall Study|Adverse Event|0|||
44259481|NCT01273519|79120127|FG002|Overall Study|Adverse Event|0|||
44259482|NCT01273519|79120125|FG000|Overall Study|Lost to Follow-up|2|||
44259483|NCT01273519|79120126|FG001|Overall Study|Lost to Follow-up|1|||
44259484|NCT01273519|79120127|FG002|Overall Study|Lost to Follow-up|3|||
44259485|NCT01273519|79120125|FG000|Overall Study|Lack of Efficacy|8|||
44259486|NCT01273519|79120126|FG001|Overall Study|Lack of Efficacy|3|||
44259487|NCT01273519|79120127|FG002|Overall Study|Lack of Efficacy|4|||
44259488|NCT01273519|79120125|FG000|Overall Study|Other|6|||
44259489|NCT01273519|79120126|FG001|Overall Study|Other|1|||
44259490|NCT01273519|79120127|FG002|Overall Study|Other|1|||
44259491|NCT01272661|79120184|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
44259492|NCT01272661|79120185|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
44439277|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44439278|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
44157785|NCT04064411|78949665|FG000|Overall Study|Adverse Event|29|||
44157786|NCT04064411|78949666|FG001|Overall Study|Adverse Event|19|||
44157787|NCT04064411|78949665|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
44439279|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
44439280|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44439281|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44339115|NCT01026220|79343637|FG002|Induction|Withdrawal by Subject|0|||
44339116|NCT01026220|79343635|FG000|Induction|Ineligible|1|||
44339117|NCT01026220|79343636|FG001|Induction|Ineligible|0|||
44339118|NCT01026220|79343637|FG002|Induction|Ineligible|0|||
44339119|NCT01026220|79343635|FG000|Consolidation Maintenance|Death|0|||
44339120|NCT01026220|79343636|FG001|Consolidation Maintenance|Death|1|||
44439282|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44439283|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44439284|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44439285|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44157788|NCT04064411|78949666|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
44157789|NCT04064411|78949665|FG000|Overall Study|Protocol Deviation|0|||
44259493|NCT01272661|79120186|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
44259494|NCT04276051|79120352|FG000|Overall Study|Lost to Follow-up|0|||
44259495|NCT04276051|79120353|FG001|Overall Study|Lost to Follow-up|1|||
44259496|NCT04276051|79120352|FG000|Overall Study|Physician Decision|0|||
44259497|NCT04276051|79120353|FG001|Overall Study|Physician Decision|1|||
44259498|NCT04276051|79120352|FG000|Overall Study|Withdrawal by Subject|1|||
44259499|NCT04276051|79120353|FG001|Overall Study|Withdrawal by Subject|1|||
44259500|NCT00081770|79120613|FG000|Overall Study|Adverse Event|130|||
44259501|NCT00081770|79120614|FG001|Overall Study|Adverse Event|98|||
44259502|NCT00081770|79120615|FG002|Overall Study|Adverse Event|136|||
44259503|NCT00081770|79120613|FG000|Overall Study|Lack of Efficacy|262|||
44259504|NCT00081770|79120614|FG001|Overall Study|Lack of Efficacy|357|||
44259505|NCT00081770|79120615|FG002|Overall Study|Lack of Efficacy|211|||
44259506|NCT00081770|79120613|FG000|Overall Study|Lost to Follow-up|45|||
44259507|NCT00081770|79120614|FG001|Overall Study|Lost to Follow-up|34|||
44259508|NCT00081770|79120615|FG002|Overall Study|Lost to Follow-up|45|||
44259509|NCT00081770|79120613|FG000|Overall Study|Protocol Violation|15|||
44339121|NCT01026220|79343637|FG002|Consolidation Maintenance|Death|0|||
44339122|NCT01026220|79343635|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
44259510|NCT00081770|79120614|FG001|Overall Study|Protocol Violation|10|||
44259511|NCT00081770|79120615|FG002|Overall Study|Protocol Violation|10|||
44259512|NCT00081770|79120613|FG000|Overall Study|Withdrawal by Subject|45|||
44339123|NCT01026220|79343636|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
44339124|NCT01026220|79343637|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
44339125|NCT01026220|79343635|FG000|Consolidation Maintenance|Physician Decision|0|||
44339126|NCT01026220|79343636|FG001|Consolidation Maintenance|Physician Decision|2|||
44339127|NCT01026220|79343637|FG002|Consolidation Maintenance|Physician Decision|7|||
44339128|NCT01026220|79343635|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
44339129|NCT01026220|79343636|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
44259513|NCT00081770|79120614|FG001|Overall Study|Withdrawal by Subject|40|||
44259514|NCT00081770|79120615|FG002|Overall Study|Withdrawal by Subject|42|||
44259515|NCT00081770|79120613|FG000|Overall Study|Did not meet protocol eligibility|2|||
44259516|NCT00081770|79120614|FG001|Overall Study|Did not meet protocol eligibility|0|||
44259517|NCT00081770|79120615|FG002|Overall Study|Did not meet protocol eligibility|3|||
44259518|NCT00081770|79120613|FG000|Overall Study|Administrative|1|||
44259519|NCT00081770|79120614|FG001|Overall Study|Administrative|0|||
44259520|NCT00081770|79120615|FG002|Overall Study|Administrative|1|||
44259521|NCT00081770|79120613|FG000|Overall Study|Other|2|||
44259522|NCT00081770|79120614|FG001|Overall Study|Other|7|||
44439286|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44439287|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
44439288|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
44540801|NCT03289143|79552950|FG000|Overall Study|Withdrawal by Subject|14|||
44540802|NCT03289143|79552951|FG001|Overall Study|Withdrawal by Subject|6|||
44540803|NCT03289143|79552952|FG002|Overall Study|Withdrawal by Subject|14|||
44540804|NCT03289143|79552953|FG003|Overall Study|Withdrawal by Subject|12|||
44540805|NCT03289143|79552950|FG000|Overall Study|Adverse Event|10|||
44540806|NCT03289143|79552951|FG001|Overall Study|Adverse Event|7|||
44540807|NCT03289143|79552952|FG002|Overall Study|Adverse Event|6|||
44540808|NCT03289143|79552953|FG003|Overall Study|Adverse Event|5|||
44540809|NCT03289143|79552950|FG000|Overall Study|Death|2|||
44540810|NCT03289143|79552951|FG001|Overall Study|Death|0|||
44540811|NCT03289143|79552952|FG002|Overall Study|Death|2|||
44540812|NCT03289143|79552953|FG003|Overall Study|Death|1|||
44540813|NCT03289143|79552950|FG000|Overall Study|Lost to Follow-up|2|||
44540814|NCT03289143|79552951|FG001|Overall Study|Lost to Follow-up|1|||
44540815|NCT03289143|79552952|FG002|Overall Study|Lost to Follow-up|1|||
44439289|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439290|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439291|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439292|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439293|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439294|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439295|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439296|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
44439297|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
44439298|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44439299|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44439300|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44439301|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44439302|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44439303|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44339130|NCT01026220|79343637|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
44339131|NCT01026142|79343654|FG000|Overall Study|Death|136|||
44339132|NCT01026142|79343655|FG001|Overall Study|Death|134|||
44339133|NCT01026142|79343654|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
44339134|NCT01026142|79343655|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
44339135|NCT04615403|79343670|FG000|Overall Study|Death|1|||
44339136|NCT04368429|79343680|FG000|Overall Study|Adverse Event|1|||
44339137|NCT04368429|79343681|FG001|Overall Study|Adverse Event|0|||
44339138|NCT04091438|79343698|FG000|Treatment Period 1 (1 Day)|Other|1|||
44439304|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44439305|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
44540816|NCT03289143|79552953|FG003|Overall Study|Lost to Follow-up|0|||
44339139|NCT04091438|79343699|FG001|Treatment Period 1 (1 Day)|Other|0|||
44339140|NCT04091438|79343698|FG000|Washout Period (1 Day)|Protocol deviation|0|||
44339141|NCT04091438|79343699|FG001|Washout Period (1 Day)|Protocol deviation|1|||
44339142|NCT04091438|79343698|FG000|Washout Period (1 Day)|Other|0|||
44439306|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
44439307|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44339143|NCT04091438|79343699|FG001|Washout Period (1 Day)|Other|1|||
44339144|NCT04084769|79343711|FG000|Overall Study|Protocol Violation|1|||
44339145|NCT04084769|79343712|FG001|Overall Study|Protocol Violation|3|||
44339146|NCT04084769|79343713|FG002|Overall Study|Protocol Violation|0|||
44439308|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439309|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439310|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439311|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439312|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439313|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439314|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
44439315|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
44439316|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439317|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439318|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439319|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439320|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439321|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439322|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44439323|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
44339147|NCT04084769|79343714|FG003|Overall Study|Protocol Violation|1|||
44339148|NCT04084769|79343711|FG000|Overall Study|Withdrawal by Subject|0|||
44339149|NCT04084769|79343712|FG001|Overall Study|Withdrawal by Subject|1|||
44339150|NCT04084769|79343713|FG002|Overall Study|Withdrawal by Subject|0|||
44339151|NCT04084769|79343714|FG003|Overall Study|Withdrawal by Subject|0|||
44339152|NCT04084769|79343711|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44339153|NCT04084769|79343712|FG001|Overall Study|Withdrawal by parent/guardian|0|||
44339154|NCT04084769|79343713|FG002|Overall Study|Withdrawal by parent/guardian|0|||
44339155|NCT04084769|79343714|FG003|Overall Study|Withdrawal by parent/guardian|1|||
44339156|NCT04084769|79343711|FG000|Overall Study|Lost to Follow-up|2|||
44339157|NCT04084769|79343712|FG001|Overall Study|Lost to Follow-up|0|||
44339158|NCT04084769|79343713|FG002|Overall Study|Lost to Follow-up|0|||
44339159|NCT04084769|79343714|FG003|Overall Study|Lost to Follow-up|0|||
44339160|NCT03890367|79343732|FG000|Overall Study|Withdrawal by parent/guardian|1|||
44339161|NCT03890367|79343733|FG001|Overall Study|Withdrawal by parent/guardian|3|||
44339162|NCT03890367|79343734|FG002|Overall Study|Withdrawal by parent/guardian|0|||
44339163|NCT03890367|79343732|FG000|Overall Study|Protocol deviation|2|||
44339164|NCT03890367|79343733|FG001|Overall Study|Protocol deviation|2|||
44339165|NCT03890367|79343734|FG002|Overall Study|Protocol deviation|1|||
44339166|NCT03890367|79343732|FG000|Overall Study|Lost to Follow-up|1|||
44339167|NCT03890367|79343733|FG001|Overall Study|Lost to Follow-up|1|||
44339168|NCT03890367|79343734|FG002|Overall Study|Lost to Follow-up|0|||
44339169|NCT03868124|79343745|FG000|Overall Study|Withdrawal by Subject|4|||
44339170|NCT03868124|79343746|FG001|Overall Study|Withdrawal by Subject|0|||
44339171|NCT03868124|79343747|FG002|Overall Study|Withdrawal by Subject|1|||
44339172|NCT03868124|79343745|FG000|Overall Study|Physician Decision|1|||
44339173|NCT03868124|79343746|FG001|Overall Study|Physician Decision|0|||
44339174|NCT03868124|79343747|FG002|Overall Study|Physician Decision|1|||
44339175|NCT03868124|79343745|FG000|Overall Study|Lost to Follow-up|1|||
44339176|NCT03868124|79343746|FG001|Overall Study|Lost to Follow-up|1|||
44339177|NCT03868124|79343747|FG002|Overall Study|Lost to Follow-up|2|||
44339178|NCT03868124|79343745|FG000|Overall Study|Death|1|||
44339179|NCT03868124|79343746|FG001|Overall Study|Death|1|||
44339180|NCT03868124|79343747|FG002|Overall Study|Death|2|||
44439324|NCT00739973|79447915|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
44439325|NCT00739973|79447916|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439326|NCT00739973|79447917|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439327|NCT00739973|79447918|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44339181|NCT03868124|79343745|FG000|Overall Study|Adverse Event|0|||
44339182|NCT03868124|79343746|FG001|Overall Study|Adverse Event|0|||
44339183|NCT03868124|79343747|FG002|Overall Study|Adverse Event|3|||
44339184|NCT03868124|79343745|FG000|Overall Study|Explanted|2|||
44339185|NCT03868124|79343746|FG001|Overall Study|Explanted|1|||
44339186|NCT03868124|79343747|FG002|Overall Study|Explanted|0|||
44339187|NCT03868124|79343745|FG000|Overall Study|Ongoing in study|176|||
44339188|NCT03868124|79343746|FG001|Overall Study|Ongoing in study|180|||
44339189|NCT03868124|79343747|FG002|Overall Study|Ongoing in study|183|||
44339190|NCT03733249|79343755|FG000|Overall Study|Death|7|||
44339191|NCT03733249|79343755|FG000|Overall Study|Disease relapse|16|||
44339192|NCT03733249|79343755|FG000|Overall Study|Lost to Follow-up|4|||
44339193|NCT03733249|79343755|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
44439328|NCT00739973|79447919|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439329|NCT00739973|79447920|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439330|NCT00739973|79447921|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439331|NCT00739973|79447922|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439332|NCT00739973|79447923|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
44439333|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
44439334|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
44439335|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
44439336|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
44439337|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
44439338|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
44339194|NCT03733249|79343755|FG000|Overall Study|Withdrawal by Subject|1|||
44339195|NCT03469271|79343767|FG000|Overall Study|Withdrawal by Subject|2|||
44157790|NCT04064411|78949666|FG001|Overall Study|Protocol Deviation|2|||
44157791|NCT04064411|78949665|FG000|Overall Study|Withdrawal by Subject|25|||
44157792|NCT04064411|78949666|FG001|Overall Study|Withdrawal by Subject|29|||
44157793|NCT04064411|78949665|FG000|Overall Study|Lost to Follow-up|5|||
44157794|NCT04064411|78949666|FG001|Overall Study|Lost to Follow-up|2|||
44339196|NCT03469271|79343768|FG001|Overall Study|Withdrawal by Subject|0|||
44339197|NCT03469271|79343769|FG002|Overall Study|Withdrawal by Subject|0|||
44339198|NCT03469271|79343770|FG003|Overall Study|Withdrawal by Subject|1|||
44339199|NCT03302234|79343786|FG000|Overall Study|Death|191|||
44339200|NCT03302234|79343787|FG001|Overall Study|Death|192|||
44339201|NCT03302234|79343786|FG000|Overall Study|Withdrawal by Subject|2|||
44339202|NCT03302234|79343787|FG001|Overall Study|Withdrawal by Subject|2|||
44339203|NCT03302234|79343786|FG000|Overall Study|Sponsor Decision|90|||
44339204|NCT03302234|79343787|FG001|Overall Study|Sponsor Decision|89|||
44339205|NCT03302234|79343786|FG000|Overall Study|Laryngeal carcinoma|0|||
44339206|NCT03302234|79343787|FG001|Overall Study|Laryngeal carcinoma|1|||
44439339|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
44439340|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
44439341|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
44439342|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439343|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439344|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439345|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439346|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
44540817|NCT03289143|79552950|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
44157795|NCT04064411|78949665|FG000|Overall Study|Other than Specified|4|||
44157796|NCT04064411|78949666|FG001|Overall Study|Other than Specified|1|||
44339207|NCT03302234|79343786|FG000|Overall Study|Not Reported|1|||
44157797|NCT04064411|78949665|FG000|Overall Study|Death|1|||
44157798|NCT04064411|78949666|FG001|Overall Study|Death|0|||
44157799|NCT02629133|78949674|FG000|Overall Study|Lost to Follow-up|3|||
44439347|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439348|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439349|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
44439350|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
44439351|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
44439352|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
44439353|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439354|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439355|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439356|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439357|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439358|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439359|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
44439360|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
44439361|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
44439362|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
44439363|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
44439364|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
44439365|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
44439366|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
44439367|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
44439368|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
44439369|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439370|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439371|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
44439372|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439373|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439374|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44157800|NCT02629133|78949675|FG001|Overall Study|Lost to Follow-up|1|||
44339208|NCT03302234|79343787|FG001|Overall Study|Not Reported|0|||
44339209|NCT02754596|79343797|FG000|Overall Study|Withdrawal by Subject|3|||
44339210|NCT02754596|79343798|FG001|Overall Study|Withdrawal by Subject|4|||
44339211|NCT02754596|79343799|FG002|Overall Study|Withdrawal by Subject|0|||
44339212|NCT02754596|79343797|FG000|Overall Study|Physician Decision|1|||
44339213|NCT02754596|79343798|FG001|Overall Study|Physician Decision|1|||
44339214|NCT02754596|79343799|FG002|Overall Study|Physician Decision|1|||
44339215|NCT02754596|79343797|FG000|Overall Study|Lost to Follow-up|1|||
44339216|NCT02754596|79343798|FG001|Overall Study|Lost to Follow-up|1|||
44339217|NCT02754596|79343799|FG002|Overall Study|Lost to Follow-up|2|||
44339218|NCT02754596|79343797|FG000|Overall Study|Death|0|||
44339219|NCT02754596|79343798|FG001|Overall Study|Death|2|||
44339220|NCT02754596|79343799|FG002|Overall Study|Death|0|||
44339221|NCT02754596|79343797|FG000|Overall Study|Adverse Event|1|||
44339222|NCT02754596|79343798|FG001|Overall Study|Adverse Event|0|||
44339223|NCT02754596|79343799|FG002|Overall Study|Adverse Event|1|||
44339224|NCT02754596|79343797|FG000|Overall Study|Other|1|||
44339225|NCT02754596|79343798|FG001|Overall Study|Other|0|||
44339226|NCT02754596|79343799|FG002|Overall Study|Other|0|||
44339227|NCT02744898|79343807|FG000|Overall Study|Progressive Disease|2|||
44339228|NCT02744898|79343807|FG000|Overall Study|Physician Decision|1|||
44339229|NCT02744898|79343807|FG000|Overall Study|Toxicity|1|||
44339230|NCT02095132|79343820|FG000|Overall Study|Adverse Event|0|||
44339231|NCT02095132|79343821|FG001|Overall Study|Adverse Event|0|||
44339232|NCT02095132|79343822|FG002|Overall Study|Adverse Event|0|||
44339233|NCT02095132|79343823|FG003|Overall Study|Adverse Event|0|||
44339234|NCT02095132|79343824|FG004|Overall Study|Adverse Event|1|||
44339235|NCT02095132|79343825|FG005|Overall Study|Adverse Event|0|||
44339236|NCT02095132|79343826|FG006|Overall Study|Adverse Event|1|||
44339237|NCT02095132|79343827|FG007|Overall Study|Adverse Event|0|||
44339238|NCT02095132|79343828|FG008|Overall Study|Adverse Event|0|||
44339239|NCT02095132|79343820|FG000|Overall Study|Death|0|||
44339240|NCT02095132|79343821|FG001|Overall Study|Death|0|||
44339241|NCT02095132|79343822|FG002|Overall Study|Death|0|||
44339242|NCT02095132|79343823|FG003|Overall Study|Death|0|||
44439375|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439376|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439377|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
44439378|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
44439379|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
44439380|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
44439381|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
44439382|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
44339243|NCT02095132|79343824|FG004|Overall Study|Death|0|||
44339244|NCT02095132|79343825|FG005|Overall Study|Death|0|||
44339245|NCT02095132|79343826|FG006|Overall Study|Death|1|||
44339246|NCT02095132|79343827|FG007|Overall Study|Death|0|||
44339247|NCT02095132|79343828|FG008|Overall Study|Death|0|||
44339248|NCT02095132|79343820|FG000|Overall Study|Lack of Efficacy|3|||
44339249|NCT02095132|79343821|FG001|Overall Study|Lack of Efficacy|5|||
44339250|NCT02095132|79343822|FG002|Overall Study|Lack of Efficacy|2|||
44339251|NCT02095132|79343823|FG003|Overall Study|Lack of Efficacy|8|||
44339252|NCT02095132|79343824|FG004|Overall Study|Lack of Efficacy|3|||
44339253|NCT02095132|79343825|FG005|Overall Study|Lack of Efficacy|6|||
44339254|NCT02095132|79343826|FG006|Overall Study|Lack of Efficacy|10|||
44339255|NCT02095132|79343827|FG007|Overall Study|Lack of Efficacy|9|||
44339256|NCT02095132|79343828|FG008|Overall Study|Lack of Efficacy|8|||
44339257|NCT02095132|79343820|FG000|Overall Study|Physician Decision|1|||
44339258|NCT02095132|79343821|FG001|Overall Study|Physician Decision|0|||
44339259|NCT02095132|79343822|FG002|Overall Study|Physician Decision|0|||
44339260|NCT02095132|79343823|FG003|Overall Study|Physician Decision|0|||
44339261|NCT02095132|79343824|FG004|Overall Study|Physician Decision|0|||
44339262|NCT02095132|79343825|FG005|Overall Study|Physician Decision|0|||
44339263|NCT02095132|79343826|FG006|Overall Study|Physician Decision|1|||
44339264|NCT02095132|79343827|FG007|Overall Study|Physician Decision|0|||
44339265|NCT02095132|79343828|FG008|Overall Study|Physician Decision|2|||
44339266|NCT02095132|79343820|FG000|Overall Study|Withdrawal by Subject|0|||
44339267|NCT02095132|79343821|FG001|Overall Study|Withdrawal by Subject|0|||
44339268|NCT02095132|79343822|FG002|Overall Study|Withdrawal by Subject|2|||
44339269|NCT02095132|79343823|FG003|Overall Study|Withdrawal by Subject|2|||
44339270|NCT02095132|79343824|FG004|Overall Study|Withdrawal by Subject|3|||
44339271|NCT02095132|79343825|FG005|Overall Study|Withdrawal by Subject|0|||
44339272|NCT02095132|79343826|FG006|Overall Study|Withdrawal by Subject|5|||
44339273|NCT02095132|79343827|FG007|Overall Study|Withdrawal by Subject|0|||
44339274|NCT02095132|79343828|FG008|Overall Study|Withdrawal by Subject|0|||
44339275|NCT01867333|79343853|FG000|Overall Study|Withdrawal by Subject|1|||
44339276|NCT01867333|79343854|FG001|Overall Study|Withdrawal by Subject|0|||
44339277|NCT01867333|79343853|FG000|Overall Study|Adverse Event|1|||
44339278|NCT01867333|79343854|FG001|Overall Study|Adverse Event|0|||
44339279|NCT01867333|79343853|FG000|Overall Study|Participant choice|1|||
44339280|NCT01867333|79343854|FG001|Overall Study|Participant choice|2|||
44339281|NCT01867333|79343853|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
44339282|NCT01867333|79343854|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
44339283|NCT01867333|79343853|FG000|Overall Study|Death|0|||
44339284|NCT01867333|79343854|FG001|Overall Study|Death|1|||
44339285|NCT01867333|79343853|FG000|Overall Study|Physician Decision|3|||
44339286|NCT01867333|79343854|FG001|Overall Study|Physician Decision|2|||
44339287|NCT01867333|79343853|FG000|Overall Study|Switched to alternative treatment|1|||
44339288|NCT01867333|79343854|FG001|Overall Study|Switched to alternative treatment|0|||
44339289|NCT01534494|79343860|FG000|Overall Study|Withdrawal by Subject|1|||
44339290|NCT00788671|79343873|FG000|Overall Study|Death|2|||
44339291|NCT00788671|79343873|FG000|Overall Study|Unable to biopsy|1|||
44339292|NCT00788671|79343873|FG000|Overall Study|Withdrawal by Subject|4|||
44339293|NCT00788671|79343873|FG000|Overall Study|IUD expulsed|1|||
44339294|NCT00788671|79343873|FG000|Overall Study|Lost to follow up|2|||
44339295|NCT00602797|79343877|FG000|Overall Study|Adverse Event|1|||
44339296|NCT00550615|79343884|FG000|Overall Study|Withdrawal by Subject|0|||
44339297|NCT00550615|79343885|FG001|Overall Study|Withdrawal by Subject|0|||
44339298|NCT00550615|79343886|FG002|Overall Study|Withdrawal by Subject|2|||
44339299|NCT00550615|79343887|FG003|Overall Study|Withdrawal by Subject|3|||
44339300|NCT00550615|79343884|FG000|Overall Study|Not evaluable|0|||
44339301|NCT00550615|79343885|FG001|Overall Study|Not evaluable|0|||
44339302|NCT00550615|79343886|FG002|Overall Study|Not evaluable|2|||
44339303|NCT00550615|79343887|FG003|Overall Study|Not evaluable|7|||
44339304|NCT00006721|79343900|FG000|Overall Study|Adverse Event|0|||
44339305|NCT00006721|79343901|FG001|Overall Study|Adverse Event|4|||
44339306|NCT00006721|79343902|FG002|Overall Study|Adverse Event|4|||
44339307|NCT00006721|79343900|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
44339308|NCT00006721|79343901|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
44339309|NCT00006721|79343902|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
44339310|NCT00006721|79343900|FG000|Overall Study|Progression/Relapse|0|||
44339311|NCT00006721|79343901|FG001|Overall Study|Progression/Relapse|1|||
44339312|NCT00006721|79343902|FG002|Overall Study|Progression/Relapse|2|||
44339313|NCT00006721|79343900|FG000|Overall Study|Death|0|||
44339314|NCT00006721|79343901|FG001|Overall Study|Death|1|||
44339315|NCT00006721|79343902|FG002|Overall Study|Death|2|||
44339316|NCT00006721|79343900|FG000|Overall Study|Other - Not Protocol Specified|0|||
44339317|NCT00006721|79343901|FG001|Overall Study|Other - Not Protocol Specified|7|||
44339318|NCT00006721|79343902|FG002|Overall Study|Other - Not Protocol Specified|7|||
44339319|NCT00006721|79343900|FG000|Overall Study|Ineligible|2|||
44339320|NCT00006721|79343901|FG001|Overall Study|Ineligible|12|||
44339321|NCT00006721|79343902|FG002|Overall Study|Ineligible|10|||
44339322|NCT00006721|79343900|FG000|Overall Study|Eligible but no Treatment Received|1|||
44339323|NCT00006721|79343901|FG001|Overall Study|Eligible but no Treatment Received|0|||
44339324|NCT00006721|79343902|FG002|Overall Study|Eligible but no Treatment Received|0|||
44339325|NCT01030666|79343914|FG000|Overall Study|Lost to Follow-up|3|||
44339326|NCT01030666|79343915|FG001|Overall Study|Lost to Follow-up|2|||
44339327|NCT01025752|79343924|FG000|Overall Study|Lost to Follow-up|7|||
44339328|NCT01025752|79343925|FG001|Overall Study|Lost to Follow-up|10|||
44339329|NCT01025752|79343924|FG000|Overall Study|Physician Decision|1|||
44339330|NCT01025752|79343925|FG001|Overall Study|Physician Decision|3|||
44339331|NCT01030198|79343933|FG000|Overall Study|Could not measure efficacy accurately|0|||
44339332|NCT01030198|79343934|FG001|Overall Study|Could not measure efficacy accurately|7|||
44339333|NCT01301456|79343952|FG000|Stage 1|Withdrawal by Subject|0|||
44339334|NCT01301456|79343953|FG001|Stage 1|Withdrawal by Subject|0|||
44339335|NCT01301456|79343954|FG002|Stage 1|Withdrawal by Subject|1|||
44339336|NCT01301456|79343955|FG003|Stage 1|Withdrawal by Subject|0|||
44339337|NCT01301456|79343956|FG004|Stage 1|Withdrawal by Subject|1|||
44339338|NCT01301456|79343957|FG005|Stage 1|Withdrawal by Subject|0|||
44339339|NCT01301456|79343958|FG006|Stage 1|Withdrawal by Subject|0|||
44339340|NCT01301456|79343959|FG007|Stage 1|Withdrawal by Subject|0|||
44339341|NCT01301456|79343960|FG008|Stage 1|Withdrawal by Subject|0|||
44339342|NCT01301456|79343961|FG009|Stage 1|Withdrawal by Subject|0|||
44339343|NCT01301456|79343962|FG010|Stage 1|Withdrawal by Subject|0|||
44339344|NCT01301456|79343963|FG011|Stage 1|Withdrawal by Subject|0|||
44339345|NCT01301456|79343952|FG000|Stage 1|Randomized but not treated|0|||
44339346|NCT01301456|79343953|FG001|Stage 1|Randomized but not treated|0|||
44339347|NCT01301456|79343954|FG002|Stage 1|Randomized but not treated|0|||
44339348|NCT01301456|79343955|FG003|Stage 1|Randomized but not treated|0|||
44339349|NCT01301456|79343956|FG004|Stage 1|Randomized but not treated|0|||
44339350|NCT01301456|79343957|FG005|Stage 1|Randomized but not treated|0|||
44339351|NCT01301456|79343958|FG006|Stage 1|Randomized but not treated|1|||
44339352|NCT01301456|79343959|FG007|Stage 1|Randomized but not treated|0|||
44339353|NCT01301456|79343960|FG008|Stage 1|Randomized but not treated|0|||
44339354|NCT01301456|79343961|FG009|Stage 1|Randomized but not treated|0|||
44339355|NCT01301456|79343962|FG010|Stage 1|Randomized but not treated|0|||
44339356|NCT01301456|79343963|FG011|Stage 1|Randomized but not treated|0|||
44339357|NCT01301456|79343952|FG000|Stage 2|Adverse Event|0|||
44339358|NCT01301456|79343953|FG001|Stage 2|Adverse Event|0|||
44339359|NCT01301456|79343954|FG002|Stage 2|Adverse Event|0|||
44339360|NCT01301456|79343955|FG003|Stage 2|Adverse Event|0|||
44339361|NCT01301456|79343956|FG004|Stage 2|Adverse Event|0|||
44339362|NCT01301456|79343957|FG005|Stage 2|Adverse Event|0|||
44339363|NCT01301456|79343958|FG006|Stage 2|Adverse Event|0|||
44339364|NCT01301456|79343959|FG007|Stage 2|Adverse Event|0|||
44339365|NCT01301456|79343960|FG008|Stage 2|Adverse Event|0|||
44339366|NCT01301456|79343961|FG009|Stage 2|Adverse Event|0|||
44339367|NCT01301456|79343962|FG010|Stage 2|Adverse Event|1|||
44339368|NCT01301456|79343963|FG011|Stage 2|Adverse Event|0|||
44339369|NCT01023256|79344011|FG000|Overall Study|Protocol Violation|2|||
44339370|NCT01023256|79344012|FG001|Overall Study|Protocol Violation|3|||
44339371|NCT01023256|79344013|FG002|Overall Study|Protocol Violation|0|||
44339372|NCT01023256|79344014|FG003|Overall Study|Protocol Violation|0|||
44339373|NCT01023256|79344011|FG000|Overall Study|Randomized but not treated|1|||
44339374|NCT01023256|79344012|FG001|Overall Study|Randomized but not treated|0|||
44339375|NCT01023256|79344013|FG002|Overall Study|Randomized but not treated|1|||
44339376|NCT01023256|79344014|FG003|Overall Study|Randomized but not treated|0|||
44339377|NCT01023256|79344011|FG000|Overall Study|Other|1|||
44339378|NCT01023256|79344012|FG001|Overall Study|Other|0|||
44339379|NCT01023256|79344013|FG002|Overall Study|Other|0|||
44339380|NCT01023256|79344014|FG003|Overall Study|Other|2|||
44339381|NCT01023256|79344011|FG000|Overall Study|Adverse Event|0|||
44339382|NCT01023256|79344012|FG001|Overall Study|Adverse Event|0|||
44339383|NCT01023256|79344013|FG002|Overall Study|Adverse Event|0|||
44339384|NCT01023256|79344014|FG003|Overall Study|Adverse Event|1|||
44339385|NCT01023256|79344011|FG000|Overall Study|Withdrawal by Subject|0|||
44339386|NCT01023256|79344012|FG001|Overall Study|Withdrawal by Subject|0|||
44439383|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
44439384|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
44439385|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
44439386|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
44439387|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
44439388|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
44439389|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
44439390|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
44439391|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
44439392|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
44439393|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
44439394|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
44339387|NCT01023256|79344013|FG002|Overall Study|Withdrawal by Subject|0|||
44339388|NCT01023256|79344014|FG003|Overall Study|Withdrawal by Subject|2|||
44339389|NCT01023022|79344027|FG000|Overall Study|Death|5|||
44339390|NCT01023022|79344027|FG000|Overall Study|Lost to Follow-up|7|||
44339391|NCT01023022|79344027|FG000|Overall Study|due to technical issues|2|||
44339392|NCT01058668|79344034|FG000|Double-blind Treatment Phase|Adverse Event|8|||
44339393|NCT01058668|79344035|FG001|Double-blind Treatment Phase|Adverse Event|15|||
44339394|NCT01058668|79344036|FG002|Double-blind Treatment Phase|Adverse Event|25|||
44339395|NCT01058668|79344034|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
44339396|NCT01058668|79344035|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
44339397|NCT01058668|79344036|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
44339398|NCT01058668|79344034|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
44339399|NCT01058668|79344035|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
44339400|NCT01058668|79344036|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
44339401|NCT01058668|79344034|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
44339402|NCT01058668|79344035|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
44339403|NCT01058668|79344036|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
44339404|NCT01058668|79344034|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
44339405|NCT01058668|79344035|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
44439395|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
44439396|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439397|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44339406|NCT01058668|79344036|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
44339407|NCT01058668|79344034|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
44339408|NCT01058668|79344035|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
44339409|NCT01058668|79344036|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
44339410|NCT01301066|79344046|FG000|Overall Study|Lost to Follow-up|5|||
44339411|NCT01301066|79344047|FG001|Overall Study|Lost to Follow-up|11|||
44339412|NCT01301066|79344046|FG000|Overall Study|Protocol Violation|8|||
44439398|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439399|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439400|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439401|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439402|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
44439403|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439404|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
44439405|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
44439406|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
44439407|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
44439408|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
44439409|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
44439410|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
44439411|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
44439412|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
44439413|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
44439414|NCT00739973|79447915|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439415|NCT00739973|79447916|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
44439416|NCT00739973|79447917|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439417|NCT00739973|79447918|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439418|NCT00739973|79447919|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439419|NCT00739973|79447920|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439420|NCT00739973|79447921|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
44439421|NCT00739973|79447922|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439422|NCT00739973|79447923|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
44439423|NCT00510874|79447958|FG000|Overall Study|Withdrawal by Subject|1|||
44439424|NCT00510874|79447959|FG001|Overall Study|Withdrawal by Subject|1|||
44439425|NCT00510874|79447960|FG002|Overall Study|Withdrawal by Subject|0|||
44439426|NCT00510874|79447961|FG003|Overall Study|Withdrawal by Subject|0|||
44439427|NCT00510874|79447962|FG004|Overall Study|Withdrawal by Subject|3|||
44439428|NCT00510874|79447963|FG005|Overall Study|Withdrawal by Subject|0|||
44439429|NCT00510874|79447964|FG006|Overall Study|Withdrawal by Subject|0|||
44439430|NCT00510874|79447958|FG000|Overall Study|Lost to Follow-up|2|||
44439431|NCT00510874|79447959|FG001|Overall Study|Lost to Follow-up|3|||
44439432|NCT00510874|79447960|FG002|Overall Study|Lost to Follow-up|1|||
44439433|NCT00510874|79447961|FG003|Overall Study|Lost to Follow-up|3|||
44439434|NCT00510874|79447962|FG004|Overall Study|Lost to Follow-up|4|||
44439435|NCT00510874|79447963|FG005|Overall Study|Lost to Follow-up|0|||
44439436|NCT00510874|79447964|FG006|Overall Study|Lost to Follow-up|1|||
44439437|NCT00739661|79447983|FG000|Overall Study|Adverse Event|2|||
44439438|NCT00739661|79447984|FG001|Overall Study|Adverse Event|0|||
44439439|NCT00739661|79447983|FG000|Overall Study|Physician decision to withdraw patient|1|||
44439440|NCT00739661|79447984|FG001|Overall Study|Physician decision to withdraw patient|0|||
44439441|NCT00739661|79447983|FG000|Overall Study|Patient decision to withdraw|9|||
44439442|NCT00739661|79447984|FG001|Overall Study|Patient decision to withdraw|4|||
44339413|NCT01301066|79344047|FG001|Overall Study|Protocol Violation|7|||
44259523|NCT00081770|79120615|FG002|Overall Study|Other|8|||
44259524|NCT00081458|79120715|FG000|Overall Study|Adverse Event|1|||
44259525|NCT00081458|79120716|FG001|Overall Study|Adverse Event|5|||
44259526|NCT00081458|79120717|FG002|Overall Study|Adverse Event|2|||
44259527|NCT00081458|79120715|FG000|Overall Study|Withdrawal by Subject|0|||
44259528|NCT00081458|79120716|FG001|Overall Study|Withdrawal by Subject|3|||
44259529|NCT00081458|79120717|FG002|Overall Study|Withdrawal by Subject|1|||
44259530|NCT00081458|79120715|FG000|Overall Study|Randomized but not dosed|0|||
44259531|NCT00081458|79120716|FG001|Overall Study|Randomized but not dosed|0|||
44259532|NCT00081458|79120717|FG002|Overall Study|Randomized but not dosed|1|||
44259533|NCT01271803|79120794|FG000|Overall Study|Progressive disease|0|||
44259534|NCT01271803|79120795|FG001|Overall Study|Progressive disease|0|||
44259535|NCT01271803|79120796|FG002|Overall Study|Progressive disease|2|||
44259536|NCT01271803|79120794|FG000|Overall Study|Death|53|||
44259537|NCT01271803|79120795|FG001|Overall Study|Death|34|||
44259538|NCT01271803|79120796|FG002|Overall Study|Death|0|||
44259539|NCT01271803|79120794|FG000|Overall Study|Withdrawal by Subject|1|||
44259540|NCT01271803|79120795|FG001|Overall Study|Withdrawal by Subject|5|||
44259541|NCT01271803|79120796|FG002|Overall Study|Withdrawal by Subject|0|||
44259542|NCT01271803|79120794|FG000|Overall Study|Lost to Follow-up|1|||
44259543|NCT01271803|79120795|FG001|Overall Study|Lost to Follow-up|0|||
44259544|NCT01271803|79120796|FG002|Overall Study|Lost to Follow-up|0|||
44259545|NCT00080288|79120847|FG000|Overall Study|Adverse Event|7|||
44259546|NCT00080288|79120848|FG001|Overall Study|Adverse Event|4|||
44439443|NCT00739661|79447983|FG000|Overall Study|Disease progression, radiographic|33|||
44439444|NCT00739661|79447984|FG001|Overall Study|Disease progression, radiographic|37|||
44439445|NCT00739661|79447983|FG000|Overall Study|Reason for discontinuation not available|1|||
44439446|NCT00739661|79447984|FG001|Overall Study|Reason for discontinuation not available|1|||
44439447|NCT00615030|79447990|FG000|Period I|Administrative problem|0|||
44439448|NCT00615030|79447991|FG001|Period I|Administrative problem|0|||
44439449|NCT00615030|79447992|FG002|Period I|Administrative problem|0|||
44439450|NCT00615030|79447993|FG003|Period I|Administrative problem|0|||
44439451|NCT00615030|79447994|FG004|Period I|Administrative problem|1|||
44439452|NCT00615030|79447995|FG005|Period I|Administrative problem|0|||
44439453|NCT00615030|79447996|FG006|Period I|Administrative problem|0|||
44157801|NCT02629133|78949674|FG000|Overall Study|Withdrawal by Subject|1|||
44439454|NCT00615030|79447997|FG007|Period I|Administrative problem|0|||
44157802|NCT02629133|78949675|FG001|Overall Study|Withdrawal by Subject|1|||
44157803|NCT02660359|78949684|FG000|Overall Study|Protocol Deviation|0|||
44439455|NCT00615030|79447998|FG008|Period I|Administrative problem|0|||
44157804|NCT02660359|78949685|FG001|Overall Study|Protocol Deviation|0|||
44339414|NCT01301066|79344046|FG000|Overall Study|Withdrawal by Subject|4|||
44339415|NCT01301066|79344047|FG001|Overall Study|Withdrawal by Subject|9|||
44339416|NCT01301066|79344046|FG000|Overall Study|Adverse Event|6|||
44339417|NCT01301066|79344047|FG001|Overall Study|Adverse Event|6|||
44339418|NCT01301066|79344046|FG000|Overall Study|Sponsor Decision|2|||
44339419|NCT01301066|79344047|FG001|Overall Study|Sponsor Decision|1|||
44339420|NCT01301066|79344046|FG000|Overall Study|Physician Decision|0|||
44339421|NCT01301066|79344047|FG001|Overall Study|Physician Decision|1|||
44339422|NCT01301066|79344046|FG000|Overall Study|Other|2|||
44339423|NCT01301066|79344047|FG001|Overall Study|Other|0|||
44339424|NCT01022398|79344055|FG000|Overall Study|Study terminated|2|||
44339425|NCT01022398|79344056|FG001|Overall Study|Study terminated|2|||
44339426|NCT01262976|79344067|FG000|Up to Month 2|Serious Adverse Event|0|||
44339427|NCT01262976|79344068|FG001|Up to Month 2|Serious Adverse Event|0|||
44339428|NCT01262976|79344069|FG002|Up to Month 2|Serious Adverse Event|1|||
44439456|NCT00615030|79447999|FG009|Period I|Administrative problem|0|||
44157805|NCT02660359|78949686|FG002|Overall Study|Protocol Deviation|1|||
44157806|NCT02660359|78949684|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
44157807|NCT02660359|78949685|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
44157808|NCT02660359|78949686|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
44157809|NCT02660359|78949684|FG000|Overall Study|Lack of Efficacy|1|||
44157810|NCT02660359|78949685|FG001|Overall Study|Lack of Efficacy|1|||
44157811|NCT02660359|78949686|FG002|Overall Study|Lack of Efficacy|1|||
44157812|NCT02660359|78949684|FG000|Overall Study|Adverse Event|0|||
44157813|NCT02660359|78949685|FG001|Overall Study|Adverse Event|1|||
44157814|NCT02660359|78949686|FG002|Overall Study|Adverse Event|0|||
44157815|NCT02660359|78949684|FG000|Overall Study|Other|2|||
44157816|NCT02660359|78949685|FG001|Overall Study|Other|1|||
44157817|NCT02660359|78949686|FG002|Overall Study|Other|3|||
44157818|NCT02660359|78949684|FG000|Overall Study|Withdrawal by Subject|7|||
44157819|NCT02660359|78949685|FG001|Overall Study|Withdrawal by Subject|5|||
44157820|NCT02660359|78949686|FG002|Overall Study|Withdrawal by Subject|8|||
44157821|NCT02660359|78949684|FG000|Overall Study|Lost to Follow-up|3|||
44157822|NCT02660359|78949685|FG001|Overall Study|Lost to Follow-up|3|||
44157823|NCT02660359|78949686|FG002|Overall Study|Lost to Follow-up|0|||
44157824|NCT02628743|78949694|FG000|Overall Study|Other|3|||
44157825|NCT02628743|78949694|FG000|Overall Study|Withdrawal by Subject|50|||
44157826|NCT02628743|78949694|FG000|Overall Study|Study Terminated by Sponsor|76|||
44157827|NCT02628743|78949694|FG000|Overall Study|Physician Decision|2|||
44439457|NCT00615030|79448000|FG010|Period I|Administrative problem|0|||
44439458|NCT00615030|79448001|FG011|Period I|Administrative problem|0|||
44439459|NCT00615030|79447990|FG000|Period I|Protocol deviation|1|||
44439460|NCT00615030|79447991|FG001|Period I|Protocol deviation|0|||
44439461|NCT00615030|79447992|FG002|Period I|Protocol deviation|0|||
44439462|NCT00615030|79447993|FG003|Period I|Protocol deviation|0|||
44439463|NCT00615030|79447994|FG004|Period I|Protocol deviation|0|||
44439464|NCT00615030|79447995|FG005|Period I|Protocol deviation|0|||
44439465|NCT00615030|79447996|FG006|Period I|Protocol deviation|0|||
44439466|NCT00615030|79447997|FG007|Period I|Protocol deviation|0|||
44439467|NCT00615030|79447998|FG008|Period I|Protocol deviation|0|||
44439468|NCT00615030|79447999|FG009|Period I|Protocol deviation|0|||
44439469|NCT00615030|79448000|FG010|Period I|Protocol deviation|0|||
44439470|NCT00615030|79448001|FG011|Period I|Protocol deviation|0|||
44439471|NCT00615030|79447990|FG000|Period I|Subject withdrew consent|0|||
44439472|NCT00615030|79447991|FG001|Period I|Subject withdrew consent|0|||
44439473|NCT00615030|79447992|FG002|Period I|Subject withdrew consent|0|||
44439474|NCT00615030|79447993|FG003|Period I|Subject withdrew consent|0|||
44439475|NCT00615030|79447994|FG004|Period I|Subject withdrew consent|0|||
44157828|NCT05059301|78949701|FG000|Overall Study|Adverse Event|0|||
44157829|NCT05059301|78949702|FG001|Overall Study|Adverse Event|2|||
44157830|NCT05059301|78949703|FG002|Overall Study|Adverse Event|2|||
44439476|NCT00615030|79447995|FG005|Period I|Subject withdrew consent|0|||
44157831|NCT05059301|78949701|FG000|Overall Study|Lost to Follow-up|2|||
44157832|NCT05059301|78949702|FG001|Overall Study|Lost to Follow-up|3|||
44157833|NCT05059301|78949703|FG002|Overall Study|Lost to Follow-up|3|||
44157834|NCT01938430|78949729|FG000|Overall Study|Randomized but Not Treated|0|||
44157835|NCT01938430|78949730|FG001|Overall Study|Randomized but Not Treated|0|||
44157836|NCT01938430|78949731|FG002|Overall Study|Randomized but Not Treated|0|||
44439477|NCT00615030|79447996|FG006|Period I|Subject withdrew consent|0|||
44439478|NCT00615030|79447997|FG007|Period I|Subject withdrew consent|0|||
44439479|NCT00615030|79447998|FG008|Period I|Subject withdrew consent|1|||
44439480|NCT00615030|79447999|FG009|Period I|Subject withdrew consent|0|||
44439481|NCT00615030|79448000|FG010|Period I|Subject withdrew consent|1|||
44157837|NCT01938430|78949732|FG003|Overall Study|Randomized but Not Treated|0|||
44157838|NCT01938430|78949733|FG004|Overall Study|Randomized but Not Treated|0|||
44157839|NCT01938430|78949734|FG005|Overall Study|Randomized but Not Treated|0|||
44157840|NCT01938430|78949735|FG006|Overall Study|Randomized but Not Treated|0|||
44157841|NCT01938430|78949736|FG007|Overall Study|Randomized but Not Treated|0|||
44157842|NCT01938430|78949737|FG008|Overall Study|Randomized but Not Treated|0|||
44157843|NCT01938430|78949738|FG009|Overall Study|Randomized but Not Treated|0|||
44157844|NCT01938430|78949739|FG010|Overall Study|Randomized but Not Treated|1|||
44157845|NCT01938430|78949740|FG011|Overall Study|Randomized but Not Treated|0|||
44157846|NCT01938430|78949741|FG012|Overall Study|Randomized but Not Treated|0|||
44157847|NCT01938430|78949742|FG013|Overall Study|Randomized but Not Treated|1|||
44157848|NCT01938430|78949729|FG000|Overall Study|Adverse Event|0|||
44157849|NCT01938430|78949730|FG001|Overall Study|Adverse Event|0|||
44157850|NCT01938430|78949731|FG002|Overall Study|Adverse Event|0|||
44157851|NCT01938430|78949732|FG003|Overall Study|Adverse Event|0|||
44157852|NCT01938430|78949733|FG004|Overall Study|Adverse Event|0|||
44157853|NCT01938430|78949734|FG005|Overall Study|Adverse Event|0|||
44157854|NCT01938430|78949735|FG006|Overall Study|Adverse Event|1|||
44157855|NCT01938430|78949736|FG007|Overall Study|Adverse Event|0|||
44157856|NCT01938430|78949737|FG008|Overall Study|Adverse Event|0|||
44157857|NCT01938430|78949738|FG009|Overall Study|Adverse Event|0|||
44157858|NCT01938430|78949739|FG010|Overall Study|Adverse Event|0|||
44157859|NCT01938430|78949740|FG011|Overall Study|Adverse Event|0|||
44157860|NCT01938430|78949741|FG012|Overall Study|Adverse Event|0|||
44157861|NCT01938430|78949742|FG013|Overall Study|Adverse Event|0|||
44157862|NCT01938430|78949729|FG000|Overall Study|Death|1|||
44157863|NCT01938430|78949730|FG001|Overall Study|Death|2|||
44157864|NCT01938430|78949731|FG002|Overall Study|Death|2|||
44157865|NCT01938430|78949732|FG003|Overall Study|Death|1|||
44157866|NCT01938430|78949733|FG004|Overall Study|Death|0|||
44157867|NCT01938430|78949734|FG005|Overall Study|Death|0|||
44157868|NCT01938430|78949735|FG006|Overall Study|Death|1|||
44157869|NCT01938430|78949736|FG007|Overall Study|Death|1|||
44157870|NCT01938430|78949737|FG008|Overall Study|Death|2|||
44157871|NCT01938430|78949738|FG009|Overall Study|Death|3|||
44157872|NCT01938430|78949739|FG010|Overall Study|Death|0|||
44157873|NCT01938430|78949740|FG011|Overall Study|Death|0|||
44157874|NCT01938430|78949741|FG012|Overall Study|Death|0|||
44157875|NCT01938430|78949742|FG013|Overall Study|Death|0|||
44439482|NCT00615030|79448001|FG011|Period I|Subject withdrew consent|1|||
44439483|NCT00615030|79447990|FG000|Period I|Abnormal laboratory value(s)|0|||
44439484|NCT00615030|79447991|FG001|Period I|Abnormal laboratory value(s)|0|||
44439485|NCT00615030|79447992|FG002|Period I|Abnormal laboratory value(s)|0|||
44439486|NCT00615030|79447993|FG003|Period I|Abnormal laboratory value(s)|0|||
44439487|NCT00615030|79447994|FG004|Period I|Abnormal laboratory value(s)|0|||
44439488|NCT00615030|79447995|FG005|Period I|Abnormal laboratory value(s)|1|||
44439489|NCT00615030|79447996|FG006|Period I|Abnormal laboratory value(s)|0|||
44439490|NCT00615030|79447997|FG007|Period I|Abnormal laboratory value(s)|0|||
44439491|NCT00615030|79447998|FG008|Period I|Abnormal laboratory value(s)|0|||
44439492|NCT00615030|79447999|FG009|Period I|Abnormal laboratory value(s)|0|||
44439493|NCT00615030|79448000|FG010|Period I|Abnormal laboratory value(s)|0|||
44157876|NCT01938430|78949729|FG000|Overall Study|Investigator's Discretion|0|||
44157877|NCT01938430|78949730|FG001|Overall Study|Investigator's Discretion|0|||
44157878|NCT01938430|78949731|FG002|Overall Study|Investigator's Discretion|1|||
44157879|NCT01938430|78949732|FG003|Overall Study|Investigator's Discretion|0|||
44157880|NCT01938430|78949733|FG004|Overall Study|Investigator's Discretion|0|||
44157881|NCT01938430|78949734|FG005|Overall Study|Investigator's Discretion|0|||
44157882|NCT01938430|78949735|FG006|Overall Study|Investigator's Discretion|0|||
44339429|NCT01262976|79344070|FG003|Up to Month 2|Serious Adverse Event|0|||
44157883|NCT01938430|78949736|FG007|Overall Study|Investigator's Discretion|0|||
44157884|NCT01938430|78949737|FG008|Overall Study|Investigator's Discretion|0|||
44339430|NCT01262976|79344071|FG004|Up to Month 2|Serious Adverse Event|0|||
44157885|NCT01938430|78949738|FG009|Overall Study|Investigator's Discretion|0|||
44157886|NCT01938430|78949739|FG010|Overall Study|Investigator's Discretion|0|||
44157887|NCT01938430|78949740|FG011|Overall Study|Investigator's Discretion|0|||
44157888|NCT01938430|78949741|FG012|Overall Study|Investigator's Discretion|0|||
44157889|NCT01938430|78949742|FG013|Overall Study|Investigator's Discretion|0|||
44157890|NCT01938430|78949729|FG000|Overall Study|Lack of Efficacy|3|||
44439494|NCT00615030|79448001|FG011|Period I|Abnormal laboratory value(s)|0|||
44439495|NCT00615030|79447990|FG000|Period II|Adverse Event|0|||
44439496|NCT00615030|79447991|FG001|Period II|Adverse Event|0|||
44439497|NCT00615030|79447992|FG002|Period II|Adverse Event|1|||
44439498|NCT00615030|79447993|FG003|Period II|Adverse Event|0|||
44439499|NCT00615030|79447994|FG004|Period II|Adverse Event|0|||
44439500|NCT00615030|79447995|FG005|Period II|Adverse Event|0|||
44439501|NCT00615030|79447996|FG006|Period II|Adverse Event|0|||
44439502|NCT00615030|79447997|FG007|Period II|Adverse Event|0|||
44439503|NCT00615030|79447998|FG008|Period II|Adverse Event|1|||
44439504|NCT00615030|79447999|FG009|Period II|Adverse Event|0|||
44439505|NCT00615030|79448000|FG010|Period II|Adverse Event|0|||
44439506|NCT00615030|79448001|FG011|Period II|Adverse Event|0|||
44439507|NCT00615030|79447990|FG000|Period II|Subject withdrew consent|0|||
44439508|NCT00615030|79447991|FG001|Period II|Subject withdrew consent|0|||
44439509|NCT00615030|79447992|FG002|Period II|Subject withdrew consent|0|||
44439510|NCT00615030|79447993|FG003|Period II|Subject withdrew consent|1|||
44439511|NCT00615030|79447994|FG004|Period II|Subject withdrew consent|0|||
44439512|NCT00615030|79447995|FG005|Period II|Subject withdrew consent|0|||
44439513|NCT00615030|79447996|FG006|Period II|Subject withdrew consent|1|||
44439514|NCT00615030|79447997|FG007|Period II|Subject withdrew consent|0|||
44439515|NCT00615030|79447998|FG008|Period II|Subject withdrew consent|0|||
44439516|NCT00615030|79447999|FG009|Period II|Subject withdrew consent|0|||
44439517|NCT00615030|79448000|FG010|Period II|Subject withdrew consent|0|||
44439518|NCT00615030|79448001|FG011|Period II|Subject withdrew consent|0|||
44439519|NCT00615030|79447990|FG000|Period III|Administrative problems|1|||
44439520|NCT00615030|79447991|FG001|Period III|Administrative problems|0|||
44439521|NCT00615030|79447992|FG002|Period III|Administrative problems|0|||
44439522|NCT00615030|79447993|FG003|Period III|Administrative problems|1|||
44439523|NCT00615030|79447994|FG004|Period III|Administrative problems|0|||
44439524|NCT00615030|79447995|FG005|Period III|Administrative problems|0|||
44439525|NCT00615030|79447996|FG006|Period III|Administrative problems|0|||
44439526|NCT00615030|79447997|FG007|Period III|Administrative problems|0|||
44439527|NCT00615030|79447998|FG008|Period III|Administrative problems|0|||
44439528|NCT00615030|79447999|FG009|Period III|Administrative problems|0|||
44439529|NCT00615030|79448000|FG010|Period III|Administrative problems|0|||
44439530|NCT00615030|79448001|FG011|Period III|Administrative problems|0|||
44439531|NCT00518284|79448019|FG000|Overall Study|Adverse Event|0|||
44439532|NCT00518284|79448020|FG001|Overall Study|Adverse Event|1|||
44439533|NCT00518284|79448021|FG002|Overall Study|Adverse Event|0|||
44439534|NCT00518284|79448022|FG003|Overall Study|Adverse Event|0|||
44439535|NCT00518284|79448019|FG000|Overall Study|Study Termination|0|||
44439536|NCT00518284|79448020|FG001|Overall Study|Study Termination|2|||
44439537|NCT00518284|79448021|FG002|Overall Study|Study Termination|1|||
44439538|NCT00518284|79448022|FG003|Overall Study|Study Termination|2|||
44439539|NCT00614874|79448032|FG000|Overall Study|Protocol Violation|1|||
44439540|NCT00614874|79448032|FG000|Overall Study|Withdrawal by Subject|1|||
44439541|NCT00727415|79448036|FG000|Phase I|Dose Limiting Toxicity|2|||
44439542|NCT00544557|79448040|FG000|Overall Study|Adverse Event|140|||
44439543|NCT00544557|79448040|FG000|Overall Study|Lack of Efficacy|196|||
44439544|NCT00544557|79448040|FG000|Overall Study|Other|98|||
44157891|NCT01938430|78949730|FG001|Overall Study|Lack of Efficacy|1|||
44259547|NCT00080288|79120847|FG000|Overall Study|Lost to Follow-up|3|||
44339431|NCT01262976|79344072|FG005|Up to Month 2|Serious Adverse Event|0|||
44339432|NCT01262976|79344067|FG000|Up to Month 2|Withdrawal by Subject|1|||
44339433|NCT01262976|79344068|FG001|Up to Month 2|Withdrawal by Subject|0|||
44339434|NCT01262976|79344069|FG002|Up to Month 2|Withdrawal by Subject|0|||
44339435|NCT01262976|79344070|FG003|Up to Month 2|Withdrawal by Subject|0|||
44339436|NCT01262976|79344071|FG004|Up to Month 2|Withdrawal by Subject|0|||
44339437|NCT01262976|79344072|FG005|Up to Month 2|Withdrawal by Subject|0|||
44339438|NCT01262976|79344067|FG000|Up to Month 2|Migrated/moved from study area|0|||
44339439|NCT01262976|79344068|FG001|Up to Month 2|Migrated/moved from study area|1|||
44339440|NCT01262976|79344069|FG002|Up to Month 2|Migrated/moved from study area|0|||
44339441|NCT01262976|79344070|FG003|Up to Month 2|Migrated/moved from study area|0|||
44339442|NCT01262976|79344071|FG004|Up to Month 2|Migrated/moved from study area|1|||
44339443|NCT01262976|79344072|FG005|Up to Month 2|Migrated/moved from study area|1|||
44339444|NCT01262976|79344067|FG000|Up to Month 2|Lost to Follow-up|1|||
44339445|NCT01262976|79344068|FG001|Up to Month 2|Lost to Follow-up|0|||
44339446|NCT01262976|79344069|FG002|Up to Month 2|Lost to Follow-up|0|||
44339447|NCT01262976|79344070|FG003|Up to Month 2|Lost to Follow-up|1|||
44339448|NCT01262976|79344071|FG004|Up to Month 2|Lost to Follow-up|1|||
44339449|NCT01262976|79344072|FG005|Up to Month 2|Lost to Follow-up|1|||
44339450|NCT01262976|79344067|FG000|Up to Month 2|Other|1|||
44339451|NCT01262976|79344068|FG001|Up to Month 2|Other|0|||
44339452|NCT01262976|79344069|FG002|Up to Month 2|Other|0|||
44439545|NCT00727259|79448044|FG000|Overall Study|Not all questionnaires completed|1055|||
44439546|NCT00735371|79448053|FG000|Overall Study|Adverse Event|3|||
44439547|NCT00735371|79448054|FG001|Overall Study|Adverse Event|3|||
44259548|NCT00080288|79120848|FG001|Overall Study|Lost to Follow-up|5|||
44259549|NCT00080288|79120847|FG000|Overall Study|Physician Decision|6|||
44259550|NCT00080288|79120848|FG001|Overall Study|Physician Decision|2|||
44259551|NCT00080288|79120847|FG000|Overall Study|Withdrawal by Subject|3|||
44259552|NCT00080288|79120848|FG001|Overall Study|Withdrawal by Subject|16|||
44259553|NCT00080288|79120847|FG000|Overall Study|Miscellaneous|11|||
44259554|NCT00080288|79120848|FG001|Overall Study|Miscellaneous|11|||
44339453|NCT01262976|79344070|FG003|Up to Month 2|Other|1|||
44339454|NCT01262976|79344071|FG004|Up to Month 2|Other|0|||
44339455|NCT01262976|79344072|FG005|Up to Month 2|Other|2|||
44339456|NCT01262976|79344067|FG000|Up to Month 7|Serious Adverse Event|0|||
44339457|NCT01262976|79344068|FG001|Up to Month 7|Serious Adverse Event|0|||
44339458|NCT01262976|79344069|FG002|Up to Month 7|Serious Adverse Event|2|||
44439548|NCT00735371|79448055|FG002|Overall Study|Adverse Event|4|||
44439549|NCT00735371|79448056|FG003|Overall Study|Adverse Event|1|||
44339459|NCT01262976|79344070|FG003|Up to Month 7|Serious Adverse Event|0|||
44339460|NCT01262976|79344071|FG004|Up to Month 7|Serious Adverse Event|0|||
44339461|NCT01262976|79344072|FG005|Up to Month 7|Serious Adverse Event|0|||
44339462|NCT01262976|79344067|FG000|Up to Month 7|Withdrawal by Subject|1|||
44339463|NCT01262976|79344068|FG001|Up to Month 7|Withdrawal by Subject|0|||
44339464|NCT01262976|79344069|FG002|Up to Month 7|Withdrawal by Subject|0|||
44339465|NCT01262976|79344070|FG003|Up to Month 7|Withdrawal by Subject|0|||
44339466|NCT01262976|79344071|FG004|Up to Month 7|Withdrawal by Subject|0|||
44339467|NCT01262976|79344072|FG005|Up to Month 7|Withdrawal by Subject|0|||
44339468|NCT01262976|79344067|FG000|Up to Month 7|Migrated/moved from study area|0|||
44339469|NCT01262976|79344068|FG001|Up to Month 7|Migrated/moved from study area|0|||
44339470|NCT01262976|79344069|FG002|Up to Month 7|Migrated/moved from study area|1|||
44339471|NCT01262976|79344070|FG003|Up to Month 7|Migrated/moved from study area|3|||
44339472|NCT01262976|79344071|FG004|Up to Month 7|Migrated/moved from study area|1|||
44339473|NCT01262976|79344072|FG005|Up to Month 7|Migrated/moved from study area|1|||
44339474|NCT01262976|79344067|FG000|Up to Month 7|Lost to Follow-up|1|||
44339475|NCT01262976|79344068|FG001|Up to Month 7|Lost to Follow-up|0|||
44339476|NCT01262976|79344069|FG002|Up to Month 7|Lost to Follow-up|1|||
44339477|NCT01262976|79344070|FG003|Up to Month 7|Lost to Follow-up|3|||
44339478|NCT01262976|79344071|FG004|Up to Month 7|Lost to Follow-up|1|||
44339479|NCT01262976|79344072|FG005|Up to Month 7|Lost to Follow-up|3|||
44339480|NCT01262976|79344067|FG000|Up to Month 7|Other|3|||
44339481|NCT01262976|79344068|FG001|Up to Month 7|Other|0|||
44339482|NCT01262976|79344069|FG002|Up to Month 7|Other|2|||
44339483|NCT01262976|79344070|FG003|Up to Month 7|Other|0|||
44339484|NCT01262976|79344071|FG004|Up to Month 7|Other|0|||
44339485|NCT01262976|79344072|FG005|Up to Month 7|Other|0|||
44339486|NCT01262976|79344067|FG000|Up to Year 1|Serious Adverse Event|0|||
44339487|NCT01262976|79344068|FG001|Up to Year 1|Serious Adverse Event|0|||
44339488|NCT01262976|79344069|FG002|Up to Year 1|Serious Adverse Event|2|||
44339489|NCT01262976|79344070|FG003|Up to Year 1|Serious Adverse Event|0|||
44339490|NCT01262976|79344071|FG004|Up to Year 1|Serious Adverse Event|0|||
44339491|NCT01262976|79344072|FG005|Up to Year 1|Serious Adverse Event|0|||
44439550|NCT00735371|79448053|FG000|Overall Study|Protocol Violation|2|||
44339492|NCT01262976|79344067|FG000|Up to Year 1|Withdrawal by Subject|1|||
44339493|NCT01262976|79344068|FG001|Up to Year 1|Withdrawal by Subject|0|||
44339494|NCT01262976|79344069|FG002|Up to Year 1|Withdrawal by Subject|0|||
44339495|NCT01262976|79344070|FG003|Up to Year 1|Withdrawal by Subject|0|||
44339496|NCT01262976|79344071|FG004|Up to Year 1|Withdrawal by Subject|0|||
44339497|NCT01262976|79344072|FG005|Up to Year 1|Withdrawal by Subject|0|||
44339498|NCT01262976|79344067|FG000|Up to Year 1|Migrated/moved from study area|1|||
44339499|NCT01262976|79344068|FG001|Up to Year 1|Migrated/moved from study area|0|||
44339500|NCT01262976|79344069|FG002|Up to Year 1|Migrated/moved from study area|0|||
44339501|NCT01262976|79344070|FG003|Up to Year 1|Migrated/moved from study area|3|||
44339502|NCT01262976|79344071|FG004|Up to Year 1|Migrated/moved from study area|3|||
44339503|NCT01262976|79344072|FG005|Up to Year 1|Migrated/moved from study area|2|||
44339504|NCT01262976|79344067|FG000|Up to Year 1|Lost to Follow-up|4|||
44339505|NCT01262976|79344068|FG001|Up to Year 1|Lost to Follow-up|0|||
44339506|NCT01262976|79344069|FG002|Up to Year 1|Lost to Follow-up|0|||
44339507|NCT01262976|79344070|FG003|Up to Year 1|Lost to Follow-up|1|||
44339508|NCT01262976|79344071|FG004|Up to Year 1|Lost to Follow-up|6|||
44339509|NCT01262976|79344072|FG005|Up to Year 1|Lost to Follow-up|5|||
44339510|NCT01262976|79344067|FG000|Up to Year 1|Other|3|||
44339511|NCT01262976|79344068|FG001|Up to Year 1|Other|1|||
44339512|NCT01262976|79344069|FG002|Up to Year 1|Other|0|||
44339513|NCT01262976|79344070|FG003|Up to Year 1|Other|0|||
44339514|NCT01262976|79344071|FG004|Up to Year 1|Other|2|||
44339515|NCT01262976|79344072|FG005|Up to Year 1|Other|1|||
44259555|NCT01271725|79120914|FG000|Part A|Progressive disease according to RECIST|8|||
44259556|NCT01271725|79120915|FG001|Part A|Progressive disease according to RECIST|0|||
44259557|NCT01271725|79120914|FG000|Part A|Clinical signs/symptoms of progression|2|||
44259558|NCT01271725|79120915|FG001|Part A|Clinical signs/symptoms of progression|0|||
44259559|NCT01271725|79120914|FG000|Part A|Other Adverse Event|8|||
44259560|NCT01271725|79120915|FG001|Part A|Other Adverse Event|0|||
44259561|NCT01271725|79120914|FG000|Part A|Lost to Follow-up|1|||
44259562|NCT01271725|79120915|FG001|Part A|Lost to Follow-up|0|||
44339516|NCT01262976|79344067|FG000|Up to Year 1|Subjects with unknown completion status|0|||
44439551|NCT00735371|79448054|FG001|Overall Study|Protocol Violation|2|||
44259563|NCT01271725|79120914|FG000|Part A|Withdrawal by Subject|12|||
44439552|NCT00735371|79448055|FG002|Overall Study|Protocol Violation|0|||
44439553|NCT00735371|79448056|FG003|Overall Study|Protocol Violation|3|||
44439554|NCT00735371|79448053|FG000|Overall Study|Withdrawal by Subject|0|||
44439555|NCT00735371|79448054|FG001|Overall Study|Withdrawal by Subject|2|||
44439556|NCT00735371|79448055|FG002|Overall Study|Withdrawal by Subject|2|||
44439557|NCT00735371|79448056|FG003|Overall Study|Withdrawal by Subject|0|||
44439558|NCT00735371|79448053|FG000|Overall Study|Lost to Follow-up|1|||
44439559|NCT00735371|79448054|FG001|Overall Study|Lost to Follow-up|1|||
44439560|NCT00735371|79448055|FG002|Overall Study|Lost to Follow-up|3|||
44439561|NCT00735371|79448056|FG003|Overall Study|Lost to Follow-up|1|||
44439562|NCT00735371|79448053|FG000|Overall Study|Lack of Efficacy|4|||
44339517|NCT01262976|79344068|FG001|Up to Year 1|Subjects with unknown completion status|0|||
44339518|NCT01262976|79344069|FG002|Up to Year 1|Subjects with unknown completion status|1|||
44339519|NCT01262976|79344070|FG003|Up to Year 1|Subjects with unknown completion status|0|||
44339520|NCT01262976|79344071|FG004|Up to Year 1|Subjects with unknown completion status|0|||
44339521|NCT01262976|79344072|FG005|Up to Year 1|Subjects with unknown completion status|1|||
44339522|NCT01262976|79344067|FG000|Up to Year 2|Serious Adverse Event|0|||
44339523|NCT01262976|79344068|FG001|Up to Year 2|Serious Adverse Event|0|||
44339524|NCT01262976|79344069|FG002|Up to Year 2|Serious Adverse Event|2|||
44439563|NCT00735371|79448054|FG001|Overall Study|Lack of Efficacy|2|||
44439564|NCT00735371|79448055|FG002|Overall Study|Lack of Efficacy|0|||
44339525|NCT01262976|79344070|FG003|Up to Year 2|Serious Adverse Event|0|||
44439565|NCT00735371|79448056|FG003|Overall Study|Lack of Efficacy|4|||
44439566|NCT00735371|79448053|FG000|Overall Study|Sponsor Decision|3|||
44439567|NCT00735371|79448054|FG001|Overall Study|Sponsor Decision|1|||
44439568|NCT00735371|79448055|FG002|Overall Study|Sponsor Decision|0|||
44439569|NCT00735371|79448056|FG003|Overall Study|Sponsor Decision|1|||
44439570|NCT00735371|79448053|FG000|Overall Study|Protocol Violation|0|||
44439571|NCT00735371|79448054|FG001|Overall Study|Protocol Violation|1|||
44439572|NCT00735371|79448055|FG002|Overall Study|Protocol Violation|2|||
44439573|NCT00735371|79448056|FG003|Overall Study|Protocol Violation|0|||
44439574|NCT00735371|79448053|FG000|Overall Study|Prior Vyvanse Exposure|1|||
44439575|NCT00735371|79448054|FG001|Overall Study|Prior Vyvanse Exposure|1|||
44439576|NCT00735371|79448055|FG002|Overall Study|Prior Vyvanse Exposure|0|||
44439577|NCT00735371|79448056|FG003|Overall Study|Prior Vyvanse Exposure|0|||
44439578|NCT00735371|79448053|FG000|Overall Study|Exclusion criteria|1|||
44439579|NCT00735371|79448054|FG001|Overall Study|Exclusion criteria|0|||
44439580|NCT00735371|79448055|FG002|Overall Study|Exclusion criteria|0|||
44439581|NCT00735371|79448056|FG003|Overall Study|Exclusion criteria|0|||
44439582|NCT00518206|79448068|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
44439583|NCT00518206|79448069|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
44339526|NCT01262976|79344071|FG004|Up to Year 2|Serious Adverse Event|0|||
44339527|NCT01262976|79344072|FG005|Up to Year 2|Serious Adverse Event|0|||
44439584|NCT00518206|79448068|FG000|Overall Study|Withdrawal by Subject|2|||
44439585|NCT00518206|79448069|FG001|Overall Study|Withdrawal by Subject|0|||
44439586|NCT00518206|79448068|FG000|Overall Study|Drug Supply Issue|1|||
44439587|NCT00518206|79448069|FG001|Overall Study|Drug Supply Issue|0|||
44439588|NCT00518206|79448068|FG000|Overall Study|Reason Unknown|1|||
44439589|NCT00518206|79448069|FG001|Overall Study|Reason Unknown|0|||
44439590|NCT00518206|79448068|FG000|Overall Study|Completion Status Unknown|1|||
44439591|NCT00518206|79448069|FG001|Overall Study|Completion Status Unknown|0|||
44439592|NCT00586313|79448075|FG000|Overall Study|Lack of Efficacy|2|||
44439593|NCT00734747|79448079|FG000|SRS Procedure|No staples placed|3|||
44439594|NCT00734747|79448079|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
44439595|NCT00726557|79448083|FG000|Overall Study|Screening failure|4|||
44439596|NCT00726557|79448083|FG000|Overall Study|No end of treatment documentation|37|||
44439597|NCT00726557|79448083|FG000|Overall Study|No follow-up documentation available|55|||
44439598|NCT00726557|79448083|FG000|Overall Study|Treatment less than 3 months|17|||
44439599|NCT00726557|79448083|FG000|Overall Study|Inclusion criteria not met|15|||
44439600|NCT00738881|79448090|FG000|Overall Study|Withdrawal by Subject|0|||
44439601|NCT00738881|79448091|FG001|Overall Study|Withdrawal by Subject|2|||
44439602|NCT00657020|79448097|FG000|PERIOD 1|Adverse Event|0|||
44439603|NCT00657020|79448098|FG001|PERIOD 1|Adverse Event|1|||
44439604|NCT03921723|79448110|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
44439605|NCT03921723|79448110|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
44439606|NCT00544167|79448118|FG000|Overall Study|Adverse Event|21|||
44439607|NCT00544167|79448118|FG000|Overall Study|Physician Decision|8|||
44439608|NCT00659438|79448124|FG000|Overall Study|Withdrawal by Subject|2|||
44439609|NCT00659438|79448125|FG001|Overall Study|Withdrawal by Subject|2|||
44439610|NCT00659438|79448124|FG000|Overall Study|Death|11|||
44439611|NCT00659438|79448125|FG001|Overall Study|Death|6|||
44439612|NCT00659438|79448124|FG000|Overall Study|Lost to Follow-up|1|||
44439613|NCT00659438|79448125|FG001|Overall Study|Lost to Follow-up|0|||
44439614|NCT00543855|79448135|FG000|Overall Study|Adverse Event|3|||
44439615|NCT00543855|79448136|FG001|Overall Study|Adverse Event|1|||
44439616|NCT00543855|79448137|FG002|Overall Study|Adverse Event|3|||
44439617|NCT00543855|79448138|FG003|Overall Study|Adverse Event|4|||
44439618|NCT00543855|79448135|FG000|Overall Study|Lost to Follow-up|0|||
44439619|NCT00543855|79448136|FG001|Overall Study|Lost to Follow-up|0|||
44439620|NCT00543855|79448137|FG002|Overall Study|Lost to Follow-up|1|||
44439621|NCT00543855|79448138|FG003|Overall Study|Lost to Follow-up|0|||
44439622|NCT00543855|79448135|FG000|Overall Study|Withdrawal by Subject|0|||
44439623|NCT00543855|79448136|FG001|Overall Study|Withdrawal by Subject|1|||
44439624|NCT00543855|79448137|FG002|Overall Study|Withdrawal by Subject|2|||
44439625|NCT00543855|79448138|FG003|Overall Study|Withdrawal by Subject|0|||
44439626|NCT00543855|79448135|FG000|Overall Study|Protocol Violation|1|||
44439627|NCT00543855|79448136|FG001|Overall Study|Protocol Violation|0|||
44439628|NCT00543855|79448137|FG002|Overall Study|Protocol Violation|0|||
44439629|NCT00543855|79448138|FG003|Overall Study|Protocol Violation|0|||
44439630|NCT00656474|79448148|FG000|Overall Study|Other Reason|1|||
44439631|NCT00656084|79448153|FG000|Overall Study|Adverse Event|4|||
44439632|NCT00656084|79448153|FG000|Overall Study|Withdrawal by Subject|1|||
44439633|NCT00656084|79448153|FG000|Overall Study|Patient Request|1|||
44439634|NCT00656084|79448153|FG000|Overall Study|Investigator Request|1|||
44439635|NCT00613938|79448161|FG000|Overall Study|Withdrawal by Subject|2|||
44439636|NCT00613938|79448162|FG001|Overall Study|Withdrawal by Subject|4|||
44439637|NCT00613938|79448163|FG002|Overall Study|Withdrawal by Subject|9|||
44259564|NCT01271725|79120915|FG001|Part A|Withdrawal by Subject|0|||
44439638|NCT00613938|79448164|FG003|Overall Study|Withdrawal by Subject|9|||
44439639|NCT00613938|79448161|FG000|Overall Study|Adverse Event|1|||
44439640|NCT00613938|79448162|FG001|Overall Study|Adverse Event|4|||
44439641|NCT00613938|79448163|FG002|Overall Study|Adverse Event|8|||
44439642|NCT00613938|79448164|FG003|Overall Study|Adverse Event|5|||
44439643|NCT00613938|79448161|FG000|Overall Study|Lack of Efficacy|16|||
44439644|NCT00613938|79448162|FG001|Overall Study|Lack of Efficacy|18|||
44439645|NCT00613938|79448163|FG002|Overall Study|Lack of Efficacy|5|||
44439646|NCT00613938|79448164|FG003|Overall Study|Lack of Efficacy|9|||
44439647|NCT00613938|79448161|FG000|Overall Study|Other|1|||
44439648|NCT00613938|79448162|FG001|Overall Study|Other|2|||
44439649|NCT00613938|79448163|FG002|Overall Study|Other|1|||
44439650|NCT00613938|79448164|FG003|Overall Study|Other|3|||
44439651|NCT00655928|79448176|FG000|Overall Study|Withdrawal by Subject|2|||
44439652|NCT00655928|79448177|FG001|Overall Study|Withdrawal by Subject|1|||
44439653|NCT00655928|79448176|FG000|Overall Study|Physician Decision|1|||
44439654|NCT00655928|79448177|FG001|Overall Study|Physician Decision|1|||
44439655|NCT00655850|79448183|FG000|Overall Study|Death|2|||
44439656|NCT00655850|79448183|FG000|Overall Study|Withdrawal by Subject|1|||
44439657|NCT00726323|79448191|FG000|Overall Study|Withdrawal by Subject|3|||
44439658|NCT00726323|79448192|FG001|Overall Study|Withdrawal by Subject|1|||
44439659|NCT00726323|79448191|FG000|Overall Study|Physician Decision|1|||
44439660|NCT00726323|79448192|FG001|Overall Study|Physician Decision|0|||
44439661|NCT00726323|79448191|FG000|Overall Study|Progressive disease|23|||
44439662|NCT00726323|79448192|FG001|Overall Study|Progressive disease|16|||
44439663|NCT00726323|79448191|FG000|Overall Study|Clinical progression|0|||
44439664|NCT00726323|79448192|FG001|Overall Study|Clinical progression|3|||
44439665|NCT00726323|79448191|FG000|Overall Study|Adverse Event|9|||
44439666|NCT00726323|79448192|FG001|Overall Study|Adverse Event|9|||
44439667|NCT00726323|79448191|FG000|Overall Study|Death|1|||
44439668|NCT00726323|79448192|FG001|Overall Study|Death|0|||
44439669|NCT00726323|79448191|FG000|Overall Study|Participant wished to discontinue|0|||
44439670|NCT00726323|79448192|FG001|Overall Study|Participant wished to discontinue|1|||
44439671|NCT00726323|79448191|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
44439672|NCT00726323|79448192|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
44439673|NCT00246571|79448200|FG000|Overall Study|Adverse Event|7|||
44439674|NCT00246571|79448201|FG001|Overall Study|Adverse Event|0|||
44439675|NCT00246571|79448200|FG000|Overall Study|Protocol Violation|0|||
44439676|NCT00246571|79448201|FG001|Overall Study|Protocol Violation|1|||
44439677|NCT00246571|79448200|FG000|Overall Study|Withdrawal by Subject|2|||
44157892|NCT01938430|78949731|FG002|Overall Study|Lack of Efficacy|1|||
44439678|NCT00246571|79448201|FG001|Overall Study|Withdrawal by Subject|3|||
44439679|NCT00246571|79448200|FG000|Overall Study|Lack of Efficacy|84|||
44439680|NCT00246571|79448201|FG001|Overall Study|Lack of Efficacy|21|||
44439681|NCT00246571|79448200|FG000|Overall Study|Death|17|||
44439682|NCT00246571|79448201|FG001|Overall Study|Death|3|||
44439683|NCT00246571|79448200|FG000|Overall Study|Sponsor|0|||
44439684|NCT00246571|79448201|FG001|Overall Study|Sponsor|1|||
44439685|NCT00246571|79448200|FG000|Overall Study|Did not meet entrance criteria|2|||
44439686|NCT00246571|79448201|FG001|Overall Study|Did not meet entrance criteria|1|||
44439687|NCT00246571|79448200|FG000|Overall Study|Laboratory abnormalities|1|||
44439688|NCT00246571|79448201|FG001|Overall Study|Laboratory abnormalities|0|||
44439689|NCT00246571|79448200|FG000|Overall Study|Crossover participants|0|||
44439690|NCT00246571|79448201|FG001|Overall Study|Crossover participants|74|||
44439691|NCT00734591|79448209|FG000|Screening for Prospective Period|Site did not participate|1604|||
44439692|NCT00734591|79448210|FG001|Screening for Prospective Period|Site did not participate|1488|||
44439693|NCT00734591|79448209|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
44439694|NCT00734591|79448210|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
44439695|NCT00734591|79448209|FG000|Prospective Period|Withdrawal by Subject|11|||
44439696|NCT00734591|79448210|FG001|Prospective Period|Withdrawal by Subject|9|||
44439697|NCT00734591|79448209|FG000|Prospective Period|Lost to Follow-up|37|||
44439698|NCT00734591|79448210|FG001|Prospective Period|Lost to Follow-up|33|||
44439699|NCT00734591|79448209|FG000|Prospective Period|Study Terminated|1|||
44439700|NCT00734591|79448210|FG001|Prospective Period|Study Terminated|0|||
44439701|NCT00734591|79448209|FG000|Prospective Period|Other|2|||
44439702|NCT00734591|79448210|FG001|Prospective Period|Other|2|||
44439703|NCT00569270|79448216|FG000|Period: First Intervention|Protocol Violation|0|||
44439704|NCT00569270|79448217|FG001|Period: First Intervention|Protocol Violation|1|||
44439705|NCT00545103|79448236|FG000|Overall Study|Lack of Efficacy|48|||
44439706|NCT00545103|79448237|FG001|Overall Study|Lack of Efficacy|45|||
44439707|NCT00545103|79448238|FG002|Overall Study|Lack of Efficacy|31|||
44439708|NCT00545103|79448239|FG003|Overall Study|Lack of Efficacy|27|||
44439709|NCT00545103|79448236|FG000|Overall Study|Withdrawal by Subject|6|||
44439710|NCT00545103|79448237|FG001|Overall Study|Withdrawal by Subject|10|||
44439711|NCT00545103|79448238|FG002|Overall Study|Withdrawal by Subject|18|||
44439712|NCT00545103|79448239|FG003|Overall Study|Withdrawal by Subject|22|||
44439713|NCT00545103|79448236|FG000|Overall Study|Adverse Event|11|||
44439714|NCT00545103|79448237|FG001|Overall Study|Adverse Event|12|||
44439715|NCT00545103|79448238|FG002|Overall Study|Adverse Event|17|||
44439716|NCT00545103|79448239|FG003|Overall Study|Adverse Event|10|||
44439717|NCT00545103|79448236|FG000|Overall Study|Lost to Follow-up|4|||
44439718|NCT00545103|79448237|FG001|Overall Study|Lost to Follow-up|6|||
44439719|NCT00545103|79448238|FG002|Overall Study|Lost to Follow-up|3|||
44439720|NCT00545103|79448239|FG003|Overall Study|Lost to Follow-up|4|||
44439721|NCT00545103|79448236|FG000|Overall Study|Protocol Violation|1|||
44439722|NCT00545103|79448237|FG001|Overall Study|Protocol Violation|2|||
44439723|NCT00545103|79448238|FG002|Overall Study|Protocol Violation|3|||
44439724|NCT00545103|79448239|FG003|Overall Study|Protocol Violation|0|||
44439725|NCT00545103|79448236|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
44439726|NCT00545103|79448237|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
44439727|NCT00545103|79448238|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
44439728|NCT00545103|79448239|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
44439729|NCT00545103|79448236|FG000|Overall Study|Difficult to open package|0|||
44439730|NCT00545103|79448237|FG001|Overall Study|Difficult to open package|0|||
44439731|NCT00545103|79448238|FG002|Overall Study|Difficult to open package|0|||
44439732|NCT00545103|79448239|FG003|Overall Study|Difficult to open package|1|||
44439733|NCT00545103|79448236|FG000|Overall Study|Investigational product not taken|1|||
44439734|NCT00545103|79448237|FG001|Overall Study|Investigational product not taken|0|||
44439735|NCT00545103|79448238|FG002|Overall Study|Investigational product not taken|0|||
44439736|NCT00545103|79448239|FG003|Overall Study|Investigational product not taken|1|||
44439737|NCT00545103|79448236|FG000|Overall Study|Wish to start a family|0|||
44439738|NCT00545103|79448237|FG001|Overall Study|Wish to start a family|0|||
44439739|NCT00545103|79448238|FG002|Overall Study|Wish to start a family|0|||
44439740|NCT00545103|79448239|FG003|Overall Study|Wish to start a family|1|||
44439741|NCT00545103|79448236|FG000|Overall Study|Diverticulitis crisis|0|||
44439742|NCT00545103|79448237|FG001|Overall Study|Diverticulitis crisis|0|||
44439743|NCT00545103|79448238|FG002|Overall Study|Diverticulitis crisis|0|||
44439744|NCT00545103|79448239|FG003|Overall Study|Diverticulitis crisis|1|||
44439745|NCT00545103|79448236|FG000|Overall Study|Personal reasons|1|||
44439746|NCT00545103|79448237|FG001|Overall Study|Personal reasons|0|||
44439747|NCT00545103|79448238|FG002|Overall Study|Personal reasons|0|||
44439748|NCT00545103|79448239|FG003|Overall Study|Personal reasons|0|||
44439749|NCT00545103|79448236|FG000|Overall Study|Subject's decision|1|||
44439750|NCT00545103|79448237|FG001|Overall Study|Subject's decision|0|||
44439751|NCT00545103|79448238|FG002|Overall Study|Subject's decision|0|||
44439752|NCT00545103|79448239|FG003|Overall Study|Subject's decision|0|||
44439753|NCT00545103|79448236|FG000|Overall Study|Noncompliance|0|||
44439754|NCT00545103|79448237|FG001|Overall Study|Noncompliance|1|||
44439755|NCT00545103|79448238|FG002|Overall Study|Noncompliance|0|||
44439756|NCT00545103|79448239|FG003|Overall Study|Noncompliance|0|||
44439757|NCT00545103|79448236|FG000|Overall Study|Investigator decision|0|||
44439758|NCT00545103|79448237|FG001|Overall Study|Investigator decision|0|||
44439759|NCT00545103|79448238|FG002|Overall Study|Investigator decision|1|||
44439760|NCT00545103|79448239|FG003|Overall Study|Investigator decision|0|||
44439761|NCT00545103|79448236|FG000|Overall Study|Subject moved|0|||
44439762|NCT00545103|79448237|FG001|Overall Study|Subject moved|1|||
44439763|NCT00545103|79448238|FG002|Overall Study|Subject moved|0|||
44439764|NCT00545103|79448239|FG003|Overall Study|Subject moved|0|||
44439765|NCT00545103|79448236|FG000|Overall Study|Use of prohibited medication|0|||
44439766|NCT00545103|79448237|FG001|Overall Study|Use of prohibited medication|0|||
44439767|NCT00545103|79448238|FG002|Overall Study|Use of prohibited medication|1|||
44439768|NCT00545103|79448239|FG003|Overall Study|Use of prohibited medication|0|||
44439769|NCT00545103|79448236|FG000|Overall Study|Does not want to take study drug anymore|1|||
44439770|NCT00545103|79448237|FG001|Overall Study|Does not want to take study drug anymore|0|||
44439771|NCT00545103|79448238|FG002|Overall Study|Does not want to take study drug anymore|1|||
44439772|NCT00545103|79448239|FG003|Overall Study|Does not want to take study drug anymore|0|||
44339528|NCT01262976|79344067|FG000|Up to Year 2|Withdrawal by Subject|1|||
44339529|NCT01262976|79344068|FG001|Up to Year 2|Withdrawal by Subject|0|||
44339530|NCT01262976|79344069|FG002|Up to Year 2|Withdrawal by Subject|0|||
44339531|NCT01262976|79344070|FG003|Up to Year 2|Withdrawal by Subject|0|||
44339532|NCT01262976|79344071|FG004|Up to Year 2|Withdrawal by Subject|0|||
44339533|NCT01262976|79344072|FG005|Up to Year 2|Withdrawal by Subject|0|||
44339534|NCT01262976|79344067|FG000|Up to Year 2|Migrated/moved from study area|0|||
44339535|NCT01262976|79344068|FG001|Up to Year 2|Migrated/moved from study area|0|||
44439773|NCT00545103|79448236|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
44439774|NCT00545103|79448237|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
44439775|NCT00545103|79448238|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
44439776|NCT00545103|79448239|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
44439777|NCT00545103|79448236|FG000|Overall Study|Death|0|||
44439778|NCT00545103|79448237|FG001|Overall Study|Death|1|||
44339536|NCT01262976|79344069|FG002|Up to Year 2|Migrated/moved from study area|0|||
44439779|NCT00545103|79448238|FG002|Overall Study|Death|0|||
44439780|NCT00545103|79448239|FG003|Overall Study|Death|0|||
44439781|NCT00586157|79448249|FG000|First Intervention|Worsening behavior|1|||
44439782|NCT00586157|79448250|FG001|First Intervention|Worsening behavior|0|||
44439783|NCT00586157|79448249|FG000|Second Intervention|Withdrawal by Subject|1|||
44439784|NCT00586157|79448250|FG001|Second Intervention|Withdrawal by Subject|0|||
44157893|NCT01938430|78949732|FG003|Overall Study|Lack of Efficacy|1|||
44339537|NCT01262976|79344070|FG003|Up to Year 2|Migrated/moved from study area|2|||
44339538|NCT01262976|79344071|FG004|Up to Year 2|Migrated/moved from study area|1|||
44339539|NCT01262976|79344072|FG005|Up to Year 2|Migrated/moved from study area|2|||
44339540|NCT01262976|79344067|FG000|Up to Year 2|Lost to Follow-up|1|||
44339541|NCT01262976|79344068|FG001|Up to Year 2|Lost to Follow-up|1|||
44339542|NCT01262976|79344069|FG002|Up to Year 2|Lost to Follow-up|2|||
44339543|NCT01262976|79344070|FG003|Up to Year 2|Lost to Follow-up|2|||
44339544|NCT01262976|79344071|FG004|Up to Year 2|Lost to Follow-up|3|||
44339545|NCT01262976|79344072|FG005|Up to Year 2|Lost to Follow-up|3|||
44339546|NCT01262976|79344067|FG000|Up to Year 2|Subjects with unknown completion status|0|||
44339547|NCT01262976|79344068|FG001|Up to Year 2|Subjects with unknown completion status|0|||
44339548|NCT01262976|79344069|FG002|Up to Year 2|Subjects with unknown completion status|1|||
44339549|NCT01262976|79344070|FG003|Up to Year 2|Subjects with unknown completion status|0|||
44339550|NCT01262976|79344071|FG004|Up to Year 2|Subjects with unknown completion status|0|||
44339551|NCT01262976|79344072|FG005|Up to Year 2|Subjects with unknown completion status|0|||
44339552|NCT01262976|79344067|FG000|Up to Year 2|Other|3|||
44339553|NCT01262976|79344068|FG001|Up to Year 2|Other|0|||
44339554|NCT01262976|79344069|FG002|Up to Year 2|Other|0|||
44339555|NCT01262976|79344070|FG003|Up to Year 2|Other|0|||
44339556|NCT01262976|79344071|FG004|Up to Year 2|Other|0|||
44339557|NCT01262976|79344072|FG005|Up to Year 2|Other|0|||
44339558|NCT01262976|79344067|FG000|Up to Year 3|Serious Adverse Event|0|||
44339559|NCT01262976|79344068|FG001|Up to Year 3|Serious Adverse Event|0|||
44339560|NCT01262976|79344069|FG002|Up to Year 3|Serious Adverse Event|2|||
44339561|NCT01262976|79344070|FG003|Up to Year 3|Serious Adverse Event|0|||
44339562|NCT01262976|79344071|FG004|Up to Year 3|Serious Adverse Event|0|||
44339563|NCT01262976|79344072|FG005|Up to Year 3|Serious Adverse Event|0|||
44439785|NCT00586157|79448249|FG000|Second Intervention|Worsening behavior|1|||
44439786|NCT00586157|79448250|FG001|Second Intervention|Worsening behavior|0|||
44439787|NCT00586157|79448249|FG000|Second Intervention|Adverse Event|0|||
44439788|NCT00586157|79448250|FG001|Second Intervention|Adverse Event|1|||
44439789|NCT00246337|79448265|FG000|Overall Study|Lost to Follow-up|3|||
44439790|NCT00246337|79448266|FG001|Overall Study|Lost to Follow-up|0|||
44439791|NCT00246337|79448267|FG002|Overall Study|Lost to Follow-up|0|||
44439792|NCT00246337|79448268|FG003|Overall Study|Lost to Follow-up|0|||
44439793|NCT00246337|79448269|FG004|Overall Study|Lost to Follow-up|2|||
44157894|NCT01938430|78949733|FG004|Overall Study|Lack of Efficacy|0|||
44157895|NCT01938430|78949734|FG005|Overall Study|Lack of Efficacy|0|||
44157896|NCT01938430|78949735|FG006|Overall Study|Lack of Efficacy|0|||
44439794|NCT00246337|79448270|FG005|Overall Study|Lost to Follow-up|2|||
44439795|NCT00246337|79448271|FG006|Overall Study|Lost to Follow-up|1|||
44157897|NCT01938430|78949736|FG007|Overall Study|Lack of Efficacy|0|||
44339564|NCT01262976|79344067|FG000|Up to Year 3|Withdrawal by Subject|1|||
44339565|NCT01262976|79344068|FG001|Up to Year 3|Withdrawal by Subject|0|||
44339566|NCT01262976|79344069|FG002|Up to Year 3|Withdrawal by Subject|0|||
44439796|NCT00246337|79448272|FG007|Overall Study|Lost to Follow-up|2|||
44439797|NCT00246337|79448273|FG008|Overall Study|Lost to Follow-up|0|||
44157898|NCT01938430|78949737|FG008|Overall Study|Lack of Efficacy|1|||
44339567|NCT01262976|79344070|FG003|Up to Year 3|Withdrawal by Subject|0|||
44157899|NCT01938430|78949738|FG009|Overall Study|Lack of Efficacy|0|||
44439798|NCT00246337|79448265|FG000|Overall Study|Protocol Violation|1|||
44439799|NCT00246337|79448266|FG001|Overall Study|Protocol Violation|0|||
44439800|NCT00246337|79448267|FG002|Overall Study|Protocol Violation|0|||
44439801|NCT00246337|79448268|FG003|Overall Study|Protocol Violation|0|||
44439802|NCT00246337|79448269|FG004|Overall Study|Protocol Violation|1|||
44439803|NCT00246337|79448270|FG005|Overall Study|Protocol Violation|0|||
44439804|NCT00246337|79448271|FG006|Overall Study|Protocol Violation|1|||
44439805|NCT00246337|79448272|FG007|Overall Study|Protocol Violation|1|||
44439806|NCT00246337|79448273|FG008|Overall Study|Protocol Violation|0|||
44439807|NCT00246337|79448265|FG000|Overall Study|Withdrawal by Subject|2|||
44439808|NCT00246337|79448266|FG001|Overall Study|Withdrawal by Subject|0|||
44439809|NCT00246337|79448267|FG002|Overall Study|Withdrawal by Subject|0|||
44439810|NCT00246337|79448268|FG003|Overall Study|Withdrawal by Subject|0|||
44439811|NCT00246337|79448269|FG004|Overall Study|Withdrawal by Subject|0|||
44439812|NCT00246337|79448270|FG005|Overall Study|Withdrawal by Subject|0|||
44439813|NCT00246337|79448271|FG006|Overall Study|Withdrawal by Subject|1|||
44439814|NCT00246337|79448272|FG007|Overall Study|Withdrawal by Subject|1|||
44439815|NCT00246337|79448273|FG008|Overall Study|Withdrawal by Subject|0|||
44439816|NCT00246337|79448265|FG000|Overall Study|Lack of Qualifying Event|8|||
44439817|NCT00246337|79448266|FG001|Overall Study|Lack of Qualifying Event|2|||
44439818|NCT00246337|79448267|FG002|Overall Study|Lack of Qualifying Event|1|||
44439819|NCT00246337|79448268|FG003|Overall Study|Lack of Qualifying Event|1|||
44439820|NCT00246337|79448269|FG004|Overall Study|Lack of Qualifying Event|1|||
44439821|NCT00246337|79448270|FG005|Overall Study|Lack of Qualifying Event|3|||
44439822|NCT00246337|79448271|FG006|Overall Study|Lack of Qualifying Event|3|||
44439823|NCT00246337|79448272|FG007|Overall Study|Lack of Qualifying Event|2|||
44439824|NCT00246337|79448273|FG008|Overall Study|Lack of Qualifying Event|5|||
44439825|NCT00246337|79448265|FG000|Overall Study|Site Terminated|10|||
44439826|NCT00246337|79448266|FG001|Overall Study|Site Terminated|0|||
44439827|NCT00246337|79448267|FG002|Overall Study|Site Terminated|0|||
44439828|NCT00246337|79448268|FG003|Overall Study|Site Terminated|0|||
44439829|NCT00246337|79448269|FG004|Overall Study|Site Terminated|0|||
44439830|NCT00246337|79448270|FG005|Overall Study|Site Terminated|7|||
44439831|NCT00246337|79448271|FG006|Overall Study|Site Terminated|1|||
44439832|NCT00246337|79448272|FG007|Overall Study|Site Terminated|6|||
44439833|NCT00246337|79448273|FG008|Overall Study|Site Terminated|2|||
44339568|NCT01262976|79344071|FG004|Up to Year 3|Withdrawal by Subject|0|||
44339569|NCT01262976|79344072|FG005|Up to Year 3|Withdrawal by Subject|0|||
44339570|NCT01262976|79344067|FG000|Up to Year 3|Migrated/moved from study area|0|||
44339571|NCT01262976|79344068|FG001|Up to Year 3|Migrated/moved from study area|0|||
44339572|NCT01262976|79344069|FG002|Up to Year 3|Migrated/moved from study area|0|||
44339573|NCT01262976|79344070|FG003|Up to Year 3|Migrated/moved from study area|2|||
44339574|NCT01262976|79344071|FG004|Up to Year 3|Migrated/moved from study area|1|||
44339575|NCT01262976|79344072|FG005|Up to Year 3|Migrated/moved from study area|1|||
44339576|NCT01262976|79344067|FG000|Up to Year 3|Lost to Follow-up|2|||
44339577|NCT01262976|79344068|FG001|Up to Year 3|Lost to Follow-up|2|||
44339578|NCT01262976|79344069|FG002|Up to Year 3|Lost to Follow-up|4|||
44339579|NCT01262976|79344070|FG003|Up to Year 3|Lost to Follow-up|3|||
44339580|NCT01262976|79344071|FG004|Up to Year 3|Lost to Follow-up|1|||
44157900|NCT01938430|78949739|FG010|Overall Study|Lack of Efficacy|2|||
44439834|NCT00246337|79448265|FG000|Overall Study|Abnormal baseline lab values|7|||
44439835|NCT00246337|79448266|FG001|Overall Study|Abnormal baseline lab values|0|||
44439836|NCT00246337|79448267|FG002|Overall Study|Abnormal baseline lab values|2|||
44439837|NCT00246337|79448268|FG003|Overall Study|Abnormal baseline lab values|0|||
44439838|NCT00246337|79448269|FG004|Overall Study|Abnormal baseline lab values|0|||
44439839|NCT00246337|79448270|FG005|Overall Study|Abnormal baseline lab values|2|||
44439840|NCT00246337|79448271|FG006|Overall Study|Abnormal baseline lab values|2|||
44439841|NCT00246337|79448272|FG007|Overall Study|Abnormal baseline lab values|0|||
44439842|NCT00246337|79448273|FG008|Overall Study|Abnormal baseline lab values|4|||
44439843|NCT00246337|79448265|FG000|Overall Study|Overwhelmed|0|||
44439844|NCT00246337|79448266|FG001|Overall Study|Overwhelmed|0|||
44439845|NCT00246337|79448267|FG002|Overall Study|Overwhelmed|0|||
44439846|NCT00246337|79448268|FG003|Overall Study|Overwhelmed|0|||
44439847|NCT00246337|79448269|FG004|Overall Study|Overwhelmed|0|||
44439848|NCT00246337|79448270|FG005|Overall Study|Overwhelmed|1|||
44439849|NCT00246337|79448271|FG006|Overall Study|Overwhelmed|0|||
44339581|NCT01262976|79344072|FG005|Up to Year 3|Lost to Follow-up|3|||
44339582|NCT01262976|79344067|FG000|Up to Year 3|Subjects with unknown completion status|0|||
44339583|NCT01262976|79344068|FG001|Up to Year 3|Subjects with unknown completion status|0|||
44339584|NCT01262976|79344069|FG002|Up to Year 3|Subjects with unknown completion status|1|||
44339585|NCT01262976|79344070|FG003|Up to Year 3|Subjects with unknown completion status|0|||
44339586|NCT01262976|79344071|FG004|Up to Year 3|Subjects with unknown completion status|0|||
44339587|NCT01262976|79344072|FG005|Up to Year 3|Subjects with unknown completion status|0|||
44339588|NCT01262976|79344067|FG000|Up to Year 3|Other|3|||
44439850|NCT00246337|79448272|FG007|Overall Study|Overwhelmed|0|||
44439851|NCT00246337|79448273|FG008|Overall Study|Overwhelmed|0|||
44439852|NCT00246337|79448265|FG000|Overall Study|Protocol Violator|1|||
44439853|NCT00246337|79448266|FG001|Overall Study|Protocol Violator|0|||
44439854|NCT00246337|79448267|FG002|Overall Study|Protocol Violator|0|||
44439855|NCT00246337|79448268|FG003|Overall Study|Protocol Violator|0|||
44439856|NCT00246337|79448269|FG004|Overall Study|Protocol Violator|0|||
44439857|NCT00246337|79448270|FG005|Overall Study|Protocol Violator|0|||
44339589|NCT01262976|79344068|FG001|Up to Year 3|Other|0|||
44339590|NCT01262976|79344069|FG002|Up to Year 3|Other|0|||
44339591|NCT01262976|79344070|FG003|Up to Year 3|Other|0|||
44339592|NCT01262976|79344071|FG004|Up to Year 3|Other|0|||
44339593|NCT01262976|79344072|FG005|Up to Year 3|Other|0|||
44339594|NCT01300286|79344087|FG000|Overall Study|did not get dosed|1|||
44339595|NCT01300052|79344094|FG000|Overall Study|Adverse Event|3|||
44339596|NCT01300052|79344095|FG001|Overall Study|Adverse Event|0|||
44339597|NCT01300052|79344094|FG000|Overall Study|Withdrawal by Subject|2|||
44339598|NCT01300052|79344095|FG001|Overall Study|Withdrawal by Subject|2|||
44339599|NCT01300052|79344094|FG000|Overall Study|Protocol Violation|1|||
44339600|NCT01300052|79344095|FG001|Overall Study|Protocol Violation|1|||
44339601|NCT01299896|79344103|FG000|Overall Study|Withdrawal by Subject|1|||
44339602|NCT01299896|79344104|FG001|Overall Study|Withdrawal by Subject|7|||
44439858|NCT00246337|79448271|FG006|Overall Study|Protocol Violator|0|||
44439859|NCT00246337|79448272|FG007|Overall Study|Protocol Violator|0|||
44339603|NCT01299896|79344103|FG000|Overall Study|Lost to Follow-up|0|||
44339604|NCT01299896|79344104|FG001|Overall Study|Lost to Follow-up|11|||
44439860|NCT00246337|79448273|FG008|Overall Study|Protocol Violator|0|||
44339605|NCT01299584|79344110|FG000|Overall Study|Protocol Violation|9|||
44339606|NCT01236573|79344125|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339607|NCT01236573|79344126|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339608|NCT01236573|79344127|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44439861|NCT00246337|79448265|FG000|Overall Study|Reported as completing trial in error|0|||
44439862|NCT00246337|79448266|FG001|Overall Study|Reported as completing trial in error|0|||
44439863|NCT00246337|79448267|FG002|Overall Study|Reported as completing trial in error|0|||
44439864|NCT00246337|79448268|FG003|Overall Study|Reported as completing trial in error|0|||
44439865|NCT00246337|79448269|FG004|Overall Study|Reported as completing trial in error|0|||
44439866|NCT00246337|79448270|FG005|Overall Study|Reported as completing trial in error|0|||
44439867|NCT00246337|79448271|FG006|Overall Study|Reported as completing trial in error|0|||
44439868|NCT00246337|79448272|FG007|Overall Study|Reported as completing trial in error|1|||
44439869|NCT00246337|79448273|FG008|Overall Study|Reported as completing trial in error|0|||
44439870|NCT00243919|79448296|FG000|Overall Study|Death|3|||
44339609|NCT01236573|79344128|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339610|NCT01236573|79344129|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339611|NCT01236573|79344130|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339612|NCT01236573|79344131|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
44339613|NCT01236573|79344132|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339614|NCT01236573|79344133|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
44339615|NCT01236573|79344134|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
44339616|NCT01236573|79344135|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
44339617|NCT01236573|79344125|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339618|NCT01236573|79344126|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339619|NCT01236573|79344127|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339620|NCT01236573|79344128|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339621|NCT01236573|79344129|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339622|NCT01236573|79344130|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44439871|NCT00243919|79448297|FG001|Overall Study|Death|4|||
44439872|NCT00243919|79448298|FG002|Overall Study|Death|6|||
44439873|NCT00243919|79448296|FG000|Overall Study|Withdrawal by Subject|6|||
44439874|NCT00243919|79448297|FG001|Overall Study|Withdrawal by Subject|6|||
44439875|NCT00243919|79448298|FG002|Overall Study|Withdrawal by Subject|2|||
44439876|NCT00243919|79448296|FG000|Overall Study|Lost to Follow-up|6|||
44439877|NCT00243919|79448297|FG001|Overall Study|Lost to Follow-up|7|||
44157901|NCT01938430|78949740|FG011|Overall Study|Lack of Efficacy|1|||
44157902|NCT01938430|78949741|FG012|Overall Study|Lack of Efficacy|0|||
44157903|NCT01938430|78949742|FG013|Overall Study|Lack of Efficacy|0|||
44157904|NCT01938430|78949729|FG000|Overall Study|Lost to Follow-up|0|||
44157905|NCT01938430|78949730|FG001|Overall Study|Lost to Follow-up|0|||
44157906|NCT01938430|78949731|FG002|Overall Study|Lost to Follow-up|1|||
44157907|NCT01938430|78949732|FG003|Overall Study|Lost to Follow-up|0|||
44157908|NCT01938430|78949733|FG004|Overall Study|Lost to Follow-up|0|||
44157909|NCT01938430|78949734|FG005|Overall Study|Lost to Follow-up|1|||
44157910|NCT01938430|78949735|FG006|Overall Study|Lost to Follow-up|0|||
44157911|NCT01938430|78949736|FG007|Overall Study|Lost to Follow-up|0|||
44157912|NCT01938430|78949737|FG008|Overall Study|Lost to Follow-up|0|||
44157913|NCT01938430|78949738|FG009|Overall Study|Lost to Follow-up|0|||
44157914|NCT01938430|78949739|FG010|Overall Study|Lost to Follow-up|0|||
44157915|NCT01938430|78949740|FG011|Overall Study|Lost to Follow-up|0|||
44157916|NCT01938430|78949741|FG012|Overall Study|Lost to Follow-up|0|||
44157917|NCT01938430|78949742|FG013|Overall Study|Lost to Follow-up|0|||
44157918|NCT01938430|78949729|FG000|Overall Study|Withdrew Consent|0|||
44157919|NCT01938430|78949730|FG001|Overall Study|Withdrew Consent|0|||
44157920|NCT01938430|78949731|FG002|Overall Study|Withdrew Consent|0|||
44157921|NCT01938430|78949732|FG003|Overall Study|Withdrew Consent|0|||
44339623|NCT01236573|79344131|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339624|NCT01236573|79344132|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339625|NCT01236573|79344133|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
44339626|NCT01236573|79344134|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339627|NCT01236573|79344135|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
44339628|NCT01236573|79344125|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339629|NCT01236573|79344126|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44439878|NCT00243919|79448298|FG002|Overall Study|Lost to Follow-up|3|||
44439879|NCT00243919|79448296|FG000|Overall Study|Administrative Error|1|||
44439880|NCT00243919|79448297|FG001|Overall Study|Administrative Error|0|||
44439881|NCT00243919|79448298|FG002|Overall Study|Administrative Error|0|||
44439882|NCT00243919|79448296|FG000|Overall Study|Physician Decision|1|||
44439883|NCT00243919|79448297|FG001|Overall Study|Physician Decision|1|||
44439884|NCT00243919|79448298|FG002|Overall Study|Physician Decision|0|||
44439885|NCT00725621|79448306|FG000|Overall Study|Adverse Event|25|||
44439886|NCT00725621|79448306|FG000|Overall Study|Lack of Efficacy|46|||
44439887|NCT00725621|79448306|FG000|Overall Study|Withdrawal by Subject|57|||
44439888|NCT00725621|79448306|FG000|Overall Study|Physician Decision|19|||
44439889|NCT00725621|79448306|FG000|Overall Study|Lost to Follow-up|52|||
44439890|NCT00725621|79448306|FG000|Overall Study|Non-compliance|8|||
44439891|NCT00725621|79448306|FG000|Overall Study|Continued treatment by other physician|6|||
44439892|NCT00725621|79448306|FG000|Overall Study|Switched to other study|1|||
44439893|NCT00725621|79448306|FG000|Overall Study|Switched to other drug|1|||
44439894|NCT00725621|79448306|FG000|Overall Study|Prepared for elective surgery|1|||
44439895|NCT00725621|79448306|FG000|Overall Study|Reason not specified|55|||
44439896|NCT00613626|79448317|FG000|Overall Study|Ineligible|0|||
44439897|NCT00613626|79448318|FG001|Overall Study|Ineligible|1|||
44439898|NCT00613626|79448319|FG002|Overall Study|Ineligible|0|||
44439899|NCT00725543|79448326|FG000|Overall Study|Adverse Event|10|||
44439900|NCT00725543|79448326|FG000|Overall Study|Lack of Efficacy|3|||
44439901|NCT00725543|79448326|FG000|Overall Study|Withdrawal by Subject|10|||
44439902|NCT00725543|79448326|FG000|Overall Study|Physician Decision|5|||
44439903|NCT00725543|79448326|FG000|Overall Study|Lost to Follow-up|4|||
44439904|NCT00725543|79448326|FG000|Overall Study|Non-compliance|2|||
44439905|NCT00725543|79448326|FG000|Overall Study|Other|119|||
44439906|NCT00239005|79448332|FG000|Overall Study|Adverse Event|6|||
44439907|NCT00239005|79448333|FG001|Overall Study|Adverse Event|6|||
44339630|NCT01236573|79344127|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339631|NCT01236573|79344128|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339632|NCT01236573|79344129|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339633|NCT01236573|79344130|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339634|NCT01236573|79344131|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339635|NCT01236573|79344132|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339636|NCT01236573|79344133|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339637|NCT01236573|79344134|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
44339638|NCT01236573|79344135|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
44339639|NCT01236339|79344162|FG000|Overall Study|Termination of study by sponsor|11|||
44339640|NCT01236339|79344163|FG001|Overall Study|Termination of study by sponsor|13|||
44339641|NCT01262898|79344174|FG000|Overall Study|Protocol Violation|1|||
44339642|NCT01262898|79344175|FG001|Overall Study|Protocol Violation|1|||
44339643|NCT01262898|79344176|FG002|Overall Study|Protocol Violation|0|||
44339644|NCT01262898|79344177|FG003|Overall Study|Protocol Violation|0|||
44339645|NCT01262898|79344174|FG000|Overall Study|Lost to Follow-up|1|||
44339646|NCT01262898|79344175|FG001|Overall Study|Lost to Follow-up|0|||
44339647|NCT01262898|79344176|FG002|Overall Study|Lost to Follow-up|0|||
44339648|NCT01262898|79344177|FG003|Overall Study|Lost to Follow-up|0|||
44339649|NCT01262898|79344174|FG000|Overall Study|Withdrawal by Subject|1|||
44339650|NCT01262898|79344175|FG001|Overall Study|Withdrawal by Subject|1|||
44339651|NCT01262898|79344176|FG002|Overall Study|Withdrawal by Subject|0|||
44339652|NCT01262898|79344177|FG003|Overall Study|Withdrawal by Subject|0|||
44339653|NCT01262820|79344190|FG000|Overall Study|Adverse Event|5|||
44339654|NCT01262820|79344190|FG000|Overall Study|Lack of Efficacy|9|||
44339655|NCT01262820|79344190|FG000|Overall Study|Drug held for 21+ days|1|||
44339656|NCT01057810|79344196|FG000|Overall Study|Disease progression|156|||
44339657|NCT01057810|79344197|FG001|Overall Study|Disease progression|197|||
44339658|NCT01057810|79344196|FG000|Overall Study|Study drug toxicity|5|||
44339659|NCT01057810|79344197|FG001|Overall Study|Study drug toxicity|114|||
44339660|NCT01057810|79344196|FG000|Overall Study|Adverse event unrelated to study drug|13|||
44339661|NCT01057810|79344197|FG001|Overall Study|Adverse event unrelated to study drug|29|||
44339662|NCT01057810|79344196|FG000|Overall Study|Withdrawal by Subject|10|||
44339663|NCT01057810|79344197|FG001|Overall Study|Withdrawal by Subject|25|||
44157922|NCT01938430|78949733|FG004|Overall Study|Withdrew Consent|0|||
44339664|NCT01057810|79344196|FG000|Overall Study|Death|2|||
44339665|NCT01057810|79344197|FG001|Overall Study|Death|12|||
44339666|NCT01057810|79344196|FG000|Overall Study|Maximum clinical benefit|5|||
44339667|NCT01057810|79344197|FG001|Overall Study|Maximum clinical benefit|5|||
44339668|NCT01057810|79344196|FG000|Overall Study|Poor/non-compliance|0|||
44339669|NCT01057810|79344197|FG001|Overall Study|Poor/non-compliance|1|||
44439908|NCT00239005|79448332|FG000|Overall Study|Withdrawal by Subject|3|||
44439909|NCT00239005|79448333|FG001|Overall Study|Withdrawal by Subject|4|||
44439910|NCT00239005|79448332|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
44439911|NCT00239005|79448333|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
44439912|NCT00239005|79448332|FG000|Overall Study|Protocol Violation|1|||
44439913|NCT00239005|79448333|FG001|Overall Study|Protocol Violation|0|||
44439914|NCT00239005|79448332|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
44339670|NCT01057810|79344196|FG000|Overall Study|No longer met study criteria|0|||
44339671|NCT01057810|79344197|FG001|Overall Study|No longer met study criteria|1|||
44339672|NCT01057810|79344196|FG000|Overall Study|Other|7|||
44439915|NCT00239005|79448333|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
44439916|NCT00239005|79448332|FG000|Overall Study|Lost to Follow-up|0|||
44439917|NCT00239005|79448333|FG001|Overall Study|Lost to Follow-up|1|||
44439918|NCT00616434|79448341|FG000|Overall Study|Adverse Event|5|||
44439919|NCT00616434|79448342|FG001|Overall Study|Adverse Event|2|||
44157923|NCT01938430|78949734|FG005|Overall Study|Withdrew Consent|0|||
44439920|NCT00616434|79448341|FG000|Overall Study|Physician Decision|0|||
44157924|NCT01938430|78949735|FG006|Overall Study|Withdrew Consent|0|||
44157925|NCT01938430|78949736|FG007|Overall Study|Withdrew Consent|0|||
44157926|NCT01938430|78949737|FG008|Overall Study|Withdrew Consent|1|||
44157927|NCT01938430|78949738|FG009|Overall Study|Withdrew Consent|0|||
44157928|NCT01938430|78949739|FG010|Overall Study|Withdrew Consent|0|||
44157929|NCT01938430|78949740|FG011|Overall Study|Withdrew Consent|0|||
44157930|NCT01938430|78949741|FG012|Overall Study|Withdrew Consent|0|||
44157931|NCT01938430|78949742|FG013|Overall Study|Withdrew Consent|0|||
44157932|NCT01937884|78949799|FG000|Overall Study|Withdrawal by Subject|1|||
44157933|NCT01937884|78949800|FG001|Overall Study|Withdrawal by Subject|0|||
44157934|NCT01916824|78949810|FG000|Overall Study|Lost to Follow-up|3|||
44157935|NCT01916824|78949811|FG001|Overall Study|Lost to Follow-up|6|||
44157936|NCT01916824|78949810|FG000|Overall Study|Physician Decision|2|||
44157937|NCT01916824|78949811|FG001|Overall Study|Physician Decision|0|||
44157938|NCT01916824|78949810|FG000|Overall Study|Withdrawal by Subject|2|||
44157939|NCT01916824|78949811|FG001|Overall Study|Withdrawal by Subject|3|||
44157940|NCT01915732|78949819|FG000|Overall Study|Withdrawal by Subject|18|||
44157941|NCT01915732|78949820|FG001|Overall Study|Withdrawal by Subject|18|||
44157942|NCT01915732|78949819|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
44157943|NCT01915732|78949820|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
44157944|NCT01915732|78949819|FG000|Overall Study|Adverse Event|12|||
44157945|NCT01915732|78949820|FG001|Overall Study|Adverse Event|4|||
44157946|NCT01915732|78949819|FG000|Overall Study|Protocol Violation|5|||
44157947|NCT01915732|78949820|FG001|Overall Study|Protocol Violation|5|||
44157948|NCT01915732|78949819|FG000|Overall Study|Lack of Efficacy|6|||
44157949|NCT01915732|78949820|FG001|Overall Study|Lack of Efficacy|11|||
44157950|NCT01915732|78949819|FG000|Overall Study|Lost to Follow-up|22|||
44157951|NCT01915732|78949820|FG001|Overall Study|Lost to Follow-up|26|||
44157952|NCT01915732|78949819|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
44157953|NCT01915732|78949820|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
44157954|NCT01915732|78949819|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
44157955|NCT01915732|78949820|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
44157956|NCT01915732|78949819|FG000|Overall Study|Drug Release Error|1|||
44157957|NCT01915732|78949820|FG001|Overall Study|Drug Release Error|0|||
44157958|NCT01915732|78949819|FG000|Overall Study|Recovered|1|||
44157959|NCT01915732|78949820|FG001|Overall Study|Recovered|0|||
44157960|NCT01915732|78949819|FG000|Overall Study|Pregnancy|1|||
44157961|NCT01915732|78949820|FG001|Overall Study|Pregnancy|0|||
44157962|NCT01915732|78949819|FG000|Overall Study|Poor Perceived Efficacy|1|||
44157963|NCT01915732|78949820|FG001|Overall Study|Poor Perceived Efficacy|0|||
44157964|NCT01915732|78949819|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
44157965|NCT01915732|78949820|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
44157966|NCT01915732|78949819|FG000|Overall Study|Got Well|0|||
44157967|NCT01915732|78949820|FG001|Overall Study|Got Well|1|||
44157968|NCT01915732|78949819|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
44439921|NCT00616434|79448342|FG001|Overall Study|Physician Decision|4|||
44157969|NCT01915732|78949820|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
44157970|NCT01915732|78949819|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
44157971|NCT01915732|78949820|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
44157972|NCT01915732|78949819|FG000|Overall Study|Job Transfer|0|||
44157973|NCT01915732|78949820|FG001|Overall Study|Job Transfer|1|||
44157974|NCT01915732|78949819|FG000|Overall Study|Improper Facial Procedure|0|||
44157975|NCT01915732|78949820|FG001|Overall Study|Improper Facial Procedure|1|||
44157976|NCT01915732|78949819|FG000|Overall Study|Poor Conscious Effect|0|||
44157977|NCT01915732|78949820|FG001|Overall Study|Poor Conscious Effect|1|||
44157978|NCT01936948|78949830|FG000|Overall Study|no 30-day follow-up data|0|||
44157979|NCT01936948|78949831|FG001|Overall Study|no 30-day follow-up data|3|||
44157980|NCT01936948|78949832|FG002|Overall Study|no 30-day follow-up data|3|||
44157981|NCT01936948|78949833|FG003|Overall Study|no 30-day follow-up data|3|||
44157982|NCT01936870|78949841|FG000|Overall Study|No Visit After Treatment|176|||
44157983|NCT01936870|78949841|FG000|Overall Study|Protocol Violation|12|||
44157984|NCT01936870|78949841|FG000|Overall Study|No Drug Administration|1|||
44157985|NCT01618864|78949845|FG000|Overall Study|Withdrawal by Subject|2|||
44157986|NCT01618864|78949845|FG000|Overall Study|Lost to Follow-up|2|||
44157987|NCT01618708|78949856|FG000|Overall Study|Adverse Event|10|||
44157988|NCT01618708|78949857|FG001|Overall Study|Adverse Event|10|||
44157989|NCT01618708|78949856|FG000|Overall Study|Lost to Follow-up|3|||
44157990|NCT01618708|78949857|FG001|Overall Study|Lost to Follow-up|3|||
44157991|NCT01618708|78949856|FG000|Overall Study|Withdrawal by Subject|17|||
44439922|NCT00616434|79448341|FG000|Overall Study|Withdrawal by Subject|1|||
44157992|NCT01618708|78949857|FG001|Overall Study|Withdrawal by Subject|22|||
44157993|NCT01618708|78949856|FG000|Overall Study|Lack of Efficacy|8|||
44157994|NCT01618708|78949857|FG001|Overall Study|Lack of Efficacy|8|||
44157995|NCT01618708|78949856|FG000|Overall Study|Technical problems|2|||
44157996|NCT01618708|78949857|FG001|Overall Study|Technical problems|0|||
44157997|NCT01618708|78949856|FG000|Overall Study|Other than specified above|1|||
44157998|NCT01618708|78949857|FG001|Overall Study|Other than specified above|1|||
44157999|NCT01618708|78949856|FG000|Overall Study|Randomized but not treated|3|||
44439923|NCT00616434|79448342|FG001|Overall Study|Withdrawal by Subject|1|||
44439924|NCT00616434|79448341|FG000|Overall Study|Protocol deviation|0|||
44439925|NCT00616434|79448342|FG001|Overall Study|Protocol deviation|1|||
44439926|NCT00652340|79448350|FG000|Overall Study|Had not progressed.|4|||
44439927|NCT00652340|79448351|FG001|Overall Study|Had not progressed.|3|||
44439928|NCT00613314|79448357|FG000|Overall Study|Adverse Event|5|||
44158000|NCT01618708|78949857|FG001|Overall Study|Randomized but not treated|2|||
44339673|NCT01057810|79344197|FG001|Overall Study|Other|14|||
44439929|NCT00613314|79448357|FG000|Overall Study|Protocol Violation|14|||
44439930|NCT00613314|79448357|FG000|Overall Study|Lost to Follow-up|46|||
44259565|NCT01271725|79120914|FG000|Part A|Other than specified|3|||
44259566|NCT01271725|79120915|FG001|Part A|Other than specified|0|||
44259567|NCT01271725|79120914|FG000|Part A|Protocol Violation|1|||
44259568|NCT01271725|79120915|FG001|Part A|Protocol Violation|0|||
44259569|NCT01271725|79120914|FG000|Part B|Other than specified|0|||
44259570|NCT01271725|79120915|FG001|Part B|Other than specified|2|||
44259571|NCT01271725|79120914|FG000|Part B|Clinical signs/symptoms of progression|0|||
44259572|NCT01271725|79120915|FG001|Part B|Clinical signs/symptoms of progression|2|||
44259573|NCT01271725|79120914|FG000|Part B|Other Adverse Event|0|||
44259574|NCT01271725|79120915|FG001|Part B|Other Adverse Event|1|||
44439931|NCT00613314|79448357|FG000|Overall Study|Other reason not defined above|90|||
44439932|NCT00257725|79448361|FG000|Overall Study|Adverse Event|3|||
44439933|NCT00544869|79448369|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
44158001|NCT00790933|78949873|FG000|Overall Study|Adverse Event|94|||
44339674|NCT01262352|79344205|FG000|Period 1|Illness after randomization|1|||
44339675|NCT01262352|79344206|FG001|Period 1|Illness after randomization|0|||
44339676|NCT01262352|79344205|FG000|Washout|Adverse Event|1|||
44339677|NCT01262352|79344206|FG001|Washout|Adverse Event|1|||
44339678|NCT01262352|79344205|FG000|Washout|Extended Washout|0|||
44339679|NCT01262352|79344206|FG001|Washout|Extended Washout|1|||
44339680|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
44339681|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
44339682|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
44339683|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
44339684|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
44339685|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
44339686|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
44339687|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
44339688|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
44339689|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
44339690|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
44339691|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
44339692|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
44339693|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
44339694|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
44339695|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
44339696|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
44339697|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
44339698|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
44339699|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
44339700|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
44339701|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
44339702|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
44339703|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
44339704|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
44339705|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
44339706|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
44439934|NCT00544869|79448370|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
44439935|NCT00544869|79448371|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
44439936|NCT00544869|79448369|FG000|Overall Study|Adverse Event|6|||
44439937|NCT00544869|79448370|FG001|Overall Study|Adverse Event|1|||
44439938|NCT00544869|79448371|FG002|Overall Study|Adverse Event|0|||
44339707|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
44339708|NCT01299272|79344212|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
44439939|NCT00544869|79448369|FG000|Overall Study|Lack of Efficacy|1|||
44439940|NCT00544869|79448370|FG001|Overall Study|Lack of Efficacy|1|||
44439941|NCT00544869|79448371|FG002|Overall Study|Lack of Efficacy|0|||
44339709|NCT01299272|79344213|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
44339710|NCT01299272|79344214|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
44339711|NCT01299272|79344215|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
44339712|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
44339713|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
44339714|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
44339715|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
44339716|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
44339717|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
44339718|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
44339719|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
44339720|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
44339721|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
44339722|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
44339723|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
44339724|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
44339725|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
44339726|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
44339727|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
44339728|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
44339729|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
44339730|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
44339731|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
44339732|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
44339733|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
44339734|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
44339735|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
44339736|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
44339737|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
44339738|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
44339739|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
44339740|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
44339741|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
44339742|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
44339743|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
44339744|NCT01299272|79344212|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
44158002|NCT00790933|78949874|FG001|Overall Study|Adverse Event|119|||
44158003|NCT00790933|78949875|FG002|Overall Study|Adverse Event|65|||
44158004|NCT00790933|78949876|FG003|Overall Study|Adverse Event|5|||
44339745|NCT01299272|79344213|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
44339746|NCT01299272|79344214|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
44339747|NCT01299272|79344215|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
44339748|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
44339749|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
44339750|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
44339751|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
44339752|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
44339753|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
44339754|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
44339755|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
44339756|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
44339757|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
44339758|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
44339759|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
44339760|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
44339761|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
44158005|NCT00790933|78949877|FG004|Overall Study|Adverse Event|69|||
44158006|NCT00790933|78949873|FG000|Overall Study|Protocol Violation(s)|8|||
44439942|NCT00544869|79448369|FG000|Overall Study|Physician Decision|2|||
44439943|NCT00544869|79448370|FG001|Overall Study|Physician Decision|0|||
44439944|NCT00544869|79448371|FG002|Overall Study|Physician Decision|0|||
44439945|NCT00725075|79448382|FG000|Overall Study|Use of Excluded Medication|0|||
44439946|NCT00725075|79448383|FG001|Overall Study|Use of Excluded Medication|1|||
44439947|NCT00725075|79448384|FG002|Overall Study|Use of Excluded Medication|0|||
44439948|NCT00725075|79448382|FG000|Overall Study|Protocol Violation|0|||
44439949|NCT00725075|79448383|FG001|Overall Study|Protocol Violation|0|||
44439950|NCT00725075|79448384|FG002|Overall Study|Protocol Violation|1|||
44439951|NCT00725075|79448382|FG000|Overall Study|Lost to Follow-up|1|||
44439952|NCT00725075|79448383|FG001|Overall Study|Lost to Follow-up|0|||
44439953|NCT00725075|79448384|FG002|Overall Study|Lost to Follow-up|0|||
44439954|NCT00725075|79448382|FG000|Overall Study|Withdrawal by Subject|4|||
44439955|NCT00725075|79448383|FG001|Overall Study|Withdrawal by Subject|5|||
44439956|NCT00725075|79448384|FG002|Overall Study|Withdrawal by Subject|4|||
44439957|NCT00725075|79448382|FG000|Overall Study|Adverse Event|2|||
44439958|NCT00725075|79448383|FG001|Overall Study|Adverse Event|1|||
44439959|NCT00725075|79448384|FG002|Overall Study|Adverse Event|1|||
44439960|NCT00725075|79448382|FG000|Overall Study|Worsening of Disease|2|||
44439961|NCT00725075|79448383|FG001|Overall Study|Worsening of Disease|1|||
44439962|NCT00725075|79448384|FG002|Overall Study|Worsening of Disease|2|||
44439963|NCT00725075|79448382|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
44439964|NCT00725075|79448383|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
44439965|NCT00725075|79448384|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
44158007|NCT00790933|78949874|FG001|Overall Study|Protocol Violation(s)|18|||
44158008|NCT00790933|78949875|FG002|Overall Study|Protocol Violation(s)|7|||
44158009|NCT00790933|78949876|FG003|Overall Study|Protocol Violation(s)|0|||
44158010|NCT00790933|78949877|FG004|Overall Study|Protocol Violation(s)|12|||
44158011|NCT00790933|78949873|FG000|Overall Study|Lack of Efficacy|192|||
44158012|NCT00790933|78949874|FG001|Overall Study|Lack of Efficacy|176|||
44158013|NCT00790933|78949875|FG002|Overall Study|Lack of Efficacy|130|||
44158014|NCT00790933|78949876|FG003|Overall Study|Lack of Efficacy|1|||
44158015|NCT00790933|78949877|FG004|Overall Study|Lack of Efficacy|121|||
44158016|NCT00790933|78949873|FG000|Overall Study|Study Terminated by Sponsor|0|||
44158017|NCT00790933|78949874|FG001|Overall Study|Study Terminated by Sponsor|0|||
44158018|NCT00790933|78949875|FG002|Overall Study|Study Terminated by Sponsor|1|||
44158019|NCT00790933|78949876|FG003|Overall Study|Study Terminated by Sponsor|0|||
44158020|NCT00790933|78949877|FG004|Overall Study|Study Terminated by Sponsor|0|||
44158021|NCT00790933|78949873|FG000|Overall Study|Withdrawal by Subject|123|||
44339762|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
44259575|NCT01271725|79120914|FG000|Part B|Protocol Violation|0|||
44158022|NCT00790933|78949874|FG001|Overall Study|Withdrawal by Subject|120|||
44158023|NCT00790933|78949875|FG002|Overall Study|Withdrawal by Subject|52|||
44259576|NCT01271725|79120915|FG001|Part B|Protocol Violation|1|||
44259577|NCT01271725|79120914|FG000|Part B|Withdrawal by Subject|0|||
44158024|NCT00790933|78949876|FG003|Overall Study|Withdrawal by Subject|6|||
44158025|NCT00790933|78949877|FG004|Overall Study|Withdrawal by Subject|50|||
44158026|NCT00790933|78949873|FG000|Overall Study|Lost to Follow-up|13|||
44158027|NCT00790933|78949874|FG001|Overall Study|Lost to Follow-up|31|||
44339763|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
44158028|NCT00790933|78949875|FG002|Overall Study|Lost to Follow-up|10|||
44339764|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
44339765|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
44339766|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
44339767|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
44339768|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
44339769|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
44339770|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
44339771|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
44339772|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
44339773|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
44339774|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
44339775|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
44339776|NCT01299272|79344212|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
44339777|NCT01299272|79344213|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
44339778|NCT01299272|79344214|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
44339779|NCT01299272|79344215|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
44339780|NCT01299116|79344232|FG000|Overall Study|Lost to Follow-up|65|||
44339781|NCT01299116|79344233|FG001|Overall Study|Lost to Follow-up|9|||
44339782|NCT01299116|79344234|FG002|Overall Study|Lost to Follow-up|11|||
44339783|NCT01299038|79344247|FG000|Overall Study|Withdrawal by Subject|1|||
44339784|NCT01299038|79344248|FG001|Overall Study|Withdrawal by Subject|0|||
44339785|NCT01298648|79344254|FG000|Overall Study|Withdrawal by Subject|2|||
44339786|NCT01298648|79344254|FG000|Overall Study|Lost to Follow-up|21|||
44339787|NCT01261338|79344260|FG000|Overall Study|Withdrawal by Subject|3|||
44339788|NCT01261338|79344261|FG001|Overall Study|Withdrawal by Subject|2|||
44339789|NCT01260948|79344269|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
44339790|NCT01260948|79344270|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
44339791|NCT01260948|79344269|FG000|Second Intervention|Emesis|0|||
44339792|NCT01260948|79344270|FG001|Second Intervention|Emesis|1|||
44339793|NCT01025284|79344279|FG000|Overall Study|Investigator Decision|0|||
44339794|NCT01025284|79344280|FG001|Overall Study|Investigator Decision|1|||
44339795|NCT01025284|79344281|FG002|Overall Study|Investigator Decision|0|||
44339796|NCT01025284|79344279|FG000|Overall Study|Withdrawal by Subject|0|||
44339797|NCT01025284|79344280|FG001|Overall Study|Withdrawal by Subject|1|||
44158029|NCT00790933|78949876|FG003|Overall Study|Lost to Follow-up|1|||
44439966|NCT00725075|79448382|FG000|Overall Study|Other|1|||
44439967|NCT00725075|79448383|FG001|Overall Study|Other|0|||
44439968|NCT00725075|79448384|FG002|Overall Study|Other|0|||
44439969|NCT00733499|79448394|FG000|Pre-operative|Protocol Violation|0|||
44439970|NCT00733499|79448395|FG001|Pre-operative|Protocol Violation|1|||
44439971|NCT00733499|79448394|FG000|3 Months Follow-up|Death|1|||
44439972|NCT00733499|79448395|FG001|3 Months Follow-up|Death|2|||
44439973|NCT00733499|79448394|FG000|6 Months Follow-up|Death|0|||
44439974|NCT00733499|79448395|FG001|6 Months Follow-up|Death|2|||
44439975|NCT00733499|79448394|FG000|6 Months Follow-up|Adverse Event|0|||
44439976|NCT00733499|79448395|FG001|6 Months Follow-up|Adverse Event|1|||
44439977|NCT00733499|79448394|FG000|12 Months Follow-up|Death|2|||
44439978|NCT00733499|79448395|FG001|12 Months Follow-up|Death|1|||
44439979|NCT00733499|79448394|FG000|24 Months Follow-up|Death|0|||
44339798|NCT01025284|79344281|FG002|Overall Study|Withdrawal by Subject|0|||
44439980|NCT00733499|79448395|FG001|24 Months Follow-up|Death|1|||
44439981|NCT00733499|79448394|FG000|5 Year Followup|Adverse Event|2|||
44439982|NCT00733499|79448395|FG001|5 Year Followup|Adverse Event|2|||
44439983|NCT00733499|79448394|FG000|5 Year Followup|Non device related AE|0|||
44439984|NCT00733499|79448395|FG001|5 Year Followup|Non device related AE|1|||
44439985|NCT00733499|79448394|FG000|5 Year Followup|Revision of Study Implant|0|||
44158030|NCT00790933|78949877|FG004|Overall Study|Lost to Follow-up|15|||
44439986|NCT00733499|79448395|FG001|5 Year Followup|Revision of Study Implant|1|||
44439987|NCT00733499|79448394|FG000|5 Year Followup|Lost to Follow-up|2|||
44439988|NCT00733499|79448395|FG001|5 Year Followup|Lost to Follow-up|0|||
44439989|NCT00733499|79448394|FG000|5 Year Followup|Death|13|||
44439990|NCT00733499|79448395|FG001|5 Year Followup|Death|19|||
44158031|NCT00790933|78949873|FG000|Overall Study|Reason Not Specified|8|||
44158032|NCT00790933|78949874|FG001|Overall Study|Reason Not Specified|16|||
44158033|NCT00790933|78949875|FG002|Overall Study|Reason Not Specified|4|||
44158034|NCT00790933|78949876|FG003|Overall Study|Reason Not Specified|1|||
44158035|NCT00790933|78949877|FG004|Overall Study|Reason Not Specified|9|||
44158036|NCT02161211|78949896|FG000|Overall Study|Lost to Follow-up|21|||
44158037|NCT02161211|78949897|FG001|Overall Study|Lost to Follow-up|27|||
44158038|NCT02161211|78949898|FG002|Overall Study|Lost to Follow-up|21|||
44158039|NCT02161211|78949896|FG000|Overall Study|Dropped|12|||
44158040|NCT02161211|78949897|FG001|Overall Study|Dropped|5|||
44158041|NCT02161211|78949898|FG002|Overall Study|Dropped|9|||
44158042|NCT01676701|78949908|FG000|Overall Study|Protocol Violation|1|||
44158043|NCT01676701|78949909|FG001|Overall Study|Protocol Violation|0|||
44158044|NCT01676701|78949908|FG000|Overall Study|Sponsor Decision|3|||
44158045|NCT01676701|78949909|FG001|Overall Study|Sponsor Decision|4|||
44158046|NCT01670279|78949920|FG000|Overall Study|Adverse Event|0|||
44158047|NCT01670279|78949921|FG001|Overall Study|Adverse Event|1|||
44158048|NCT01670279|78949922|FG002|Overall Study|Adverse Event|0|||
44158049|NCT01670279|78949923|FG003|Overall Study|Adverse Event|0|||
44158050|NCT01670279|78949920|FG000|Overall Study|Physician Decision|0|||
44158051|NCT01670279|78949921|FG001|Overall Study|Physician Decision|1|||
44158052|NCT01670279|78949922|FG002|Overall Study|Physician Decision|0|||
44158053|NCT01670279|78949923|FG003|Overall Study|Physician Decision|0|||
44158054|NCT01670279|78949920|FG000|Overall Study|Participant met withdrawal criteria|0|||
44158055|NCT01670279|78949921|FG001|Overall Study|Participant met withdrawal criteria|0|||
44158056|NCT01670279|78949922|FG002|Overall Study|Participant met withdrawal criteria|0|||
44158057|NCT01670279|78949923|FG003|Overall Study|Participant met withdrawal criteria|1|||
44158058|NCT02627495|78949931|FG000|Overall Study|Withdrawal by Subject|4|||
44158059|NCT01670045|78949935|FG000|Overall Study|Withdrawal by Subject|3|||
44158060|NCT01670045|78949935|FG000|Overall Study|Adverse Event|1|||
44158061|NCT01670045|78949935|FG000|Overall Study|Death|1|||
44158062|NCT01670045|78949935|FG000|Overall Study|Lost to Follow-up|11|||
44158063|NCT01669421|78949939|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
44158064|NCT01669421|78949939|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
44158065|NCT01671059|78949953|FG000|Overall Study|Adverse Event|4|||
44158066|NCT01671059|78949953|FG000|Overall Study|Lack of Efficacy|1|||
44158067|NCT01669811|78949969|FG000|Overall Study|Investigator decision|0|||
44158068|NCT01669811|78949970|FG001|Overall Study|Investigator decision|1|||
44158069|NCT01669811|78949969|FG000|Overall Study|Withdrawal by Subject|1|||
44158070|NCT01669811|78949970|FG001|Overall Study|Withdrawal by Subject|2|||
44158071|NCT01669811|78949969|FG000|Overall Study|Adverse Event|2|||
44158072|NCT01669811|78949970|FG001|Overall Study|Adverse Event|6|||
44158073|NCT01669811|78949969|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
44158074|NCT01669811|78949970|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
44158075|NCT01669577|78949976|FG000|Overall Study|Death|22|||
44158076|NCT01669577|78949976|FG000|Overall Study|Lost to Follow-up|78|||
44439991|NCT00733499|79448394|FG000|5 Year Followup|missing, unable to locate|0|||
44439992|NCT00733499|79448395|FG001|5 Year Followup|missing, unable to locate|1|||
44439993|NCT00733499|79448394|FG000|5 Year Followup|Withdrawal by Subject|4|||
44439994|NCT00733499|79448395|FG001|5 Year Followup|Withdrawal by Subject|1|||
44439995|NCT00733499|79448394|FG000|10 Year Followup|Death|9|||
44439996|NCT00733499|79448395|FG001|10 Year Followup|Death|7|||
44439997|NCT00733499|79448394|FG000|10 Year Followup|Adverse Event|3|||
44439998|NCT00733499|79448395|FG001|10 Year Followup|Adverse Event|3|||
44439999|NCT00733499|79448394|FG000|10 Year Followup|Lost to Follow-up|3|||
44440000|NCT00733499|79448395|FG001|10 Year Followup|Lost to Follow-up|2|||
44440001|NCT00733499|79448394|FG000|10 Year Followup|Withdrawal by Subject|5|||
44440002|NCT00733499|79448395|FG001|10 Year Followup|Withdrawal by Subject|5|||
44440003|NCT00733499|79448394|FG000|10 Year Followup|missing, unable to locate|0|||
44440004|NCT00733499|79448395|FG001|10 Year Followup|missing, unable to locate|2|||
44440005|NCT00652028|79448405|FG000|Overall Study|Adverse Event|1|||
44440006|NCT00652028|79448406|FG001|Overall Study|Adverse Event|0|||
44440007|NCT00652028|79448407|FG002|Overall Study|Adverse Event|0|||
44440008|NCT00652028|79448408|FG003|Overall Study|Adverse Event|0|||
44440009|NCT00652028|79448405|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
44440010|NCT00652028|79448406|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
44440011|NCT00652028|79448407|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
44440012|NCT00652028|79448408|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
44440013|NCT00652028|79448405|FG000|Overall Study|Physician Decision|0|||
44440014|NCT00652028|79448406|FG001|Overall Study|Physician Decision|0|||
44440015|NCT00652028|79448407|FG002|Overall Study|Physician Decision|1|||
44440016|NCT00652028|79448408|FG003|Overall Study|Physician Decision|0|||
44440017|NCT00738101|79448418|FG000|Overall Study|Physician Decision|5|||
44440018|NCT00738101|79448418|FG000|Overall Study|Death|1|||
44440019|NCT00738101|79448418|FG000|Overall Study|Repeat enrollment|1|||
44440020|NCT00733421|79448424|FG000|Overall Study|Withdrawal by Subject|1|||
44339799|NCT01021852|79344299|FG000|Treatment Period 1|Adverse Event|3|||
44339800|NCT01021852|79344300|FG001|Treatment Period 1|Adverse Event|1|||
44339801|NCT01021852|79344301|FG002|Treatment Period 1|Adverse Event|1|||
44339802|NCT01021852|79344302|FG003|Treatment Period 1|Adverse Event|0|||
44339803|NCT01021852|79344303|FG004|Treatment Period 1|Adverse Event|2|||
44339804|NCT01021852|79344304|FG005|Treatment Period 1|Adverse Event|2|||
44339805|NCT01021852|79344305|FG006|Treatment Period 1|Adverse Event|0|||
44339806|NCT01021852|79344306|FG007|Treatment Period 1|Adverse Event|0|||
44339807|NCT01021852|79344299|FG000|Treatment Period 1|Pregnancy|0|||
44339808|NCT01021852|79344300|FG001|Treatment Period 1|Pregnancy|0|||
44339809|NCT01021852|79344301|FG002|Treatment Period 1|Pregnancy|1|||
44339810|NCT01021852|79344302|FG003|Treatment Period 1|Pregnancy|0|||
44339811|NCT01021852|79344303|FG004|Treatment Period 1|Pregnancy|0|||
44339812|NCT01021852|79344304|FG005|Treatment Period 1|Pregnancy|0|||
44339813|NCT01021852|79344305|FG006|Treatment Period 1|Pregnancy|0|||
44339814|NCT01021852|79344306|FG007|Treatment Period 1|Pregnancy|0|||
44339815|NCT01021852|79344299|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44339816|NCT01021852|79344300|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44339817|NCT01021852|79344301|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44339818|NCT01021852|79344302|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44339819|NCT01021852|79344303|FG004|Treatment Period 1|Withdrawal by Subject|1|||
44339820|NCT01021852|79344304|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44339821|NCT01021852|79344305|FG006|Treatment Period 1|Withdrawal by Subject|0|||
44339822|NCT01021852|79344306|FG007|Treatment Period 1|Withdrawal by Subject|1|||
44339823|NCT01021852|79344299|FG000|Treatment Period 1|Not Treated|0|||
44339824|NCT01021852|79344300|FG001|Treatment Period 1|Not Treated|0|||
44339825|NCT01021852|79344301|FG002|Treatment Period 1|Not Treated|0|||
44339826|NCT01021852|79344302|FG003|Treatment Period 1|Not Treated|2|||
44339827|NCT01021852|79344303|FG004|Treatment Period 1|Not Treated|0|||
44339828|NCT01021852|79344304|FG005|Treatment Period 1|Not Treated|0|||
44339829|NCT01021852|79344305|FG006|Treatment Period 1|Not Treated|0|||
44339830|NCT01021852|79344306|FG007|Treatment Period 1|Not Treated|0|||
44339831|NCT01021852|79344299|FG000|Washout Period-Placebo|Adverse Event|0|||
44339832|NCT01021852|79344300|FG001|Washout Period-Placebo|Adverse Event|0|||
44339833|NCT01021852|79344301|FG002|Washout Period-Placebo|Adverse Event|0|||
44339834|NCT01021852|79344302|FG003|Washout Period-Placebo|Adverse Event|1|||
44339835|NCT01021852|79344303|FG004|Washout Period-Placebo|Adverse Event|0|||
44339836|NCT01021852|79344304|FG005|Washout Period-Placebo|Adverse Event|1|||
44339837|NCT01021852|79344305|FG006|Washout Period-Placebo|Adverse Event|0|||
44339838|NCT01021852|79344306|FG007|Washout Period-Placebo|Adverse Event|0|||
44339839|NCT01021852|79344299|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
44339840|NCT01021852|79344300|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
44339841|NCT01021852|79344301|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
44339842|NCT01021852|79344302|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
44339843|NCT01021852|79344303|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
44339844|NCT01021852|79344304|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
44339845|NCT01021852|79344305|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
44339846|NCT01021852|79344306|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
44339847|NCT01021852|79344299|FG000|Washout Period-Placebo|Protocol Violation|0|||
44440021|NCT00733421|79448425|FG001|Overall Study|Withdrawal by Subject|1|||
44339848|NCT01021852|79344300|FG001|Washout Period-Placebo|Protocol Violation|0|||
44339849|NCT01021852|79344301|FG002|Washout Period-Placebo|Protocol Violation|0|||
44339850|NCT01021852|79344302|FG003|Washout Period-Placebo|Protocol Violation|0|||
44339851|NCT01021852|79344303|FG004|Washout Period-Placebo|Protocol Violation|0|||
44339852|NCT01021852|79344304|FG005|Washout Period-Placebo|Protocol Violation|0|||
44440022|NCT00613080|79448431|FG000|Overall Study|Ineligible / no protocol treatment|11|||
44440023|NCT00732875|79448435|FG000|Overall Study|Adverse Event|16|||
44339853|NCT01021852|79344305|FG006|Washout Period-Placebo|Protocol Violation|1|||
44339854|NCT01021852|79344306|FG007|Washout Period-Placebo|Protocol Violation|0|||
44339855|NCT01021852|79344299|FG000|Washout Period-No Drug|Adverse Event|1|||
44339856|NCT01021852|79344300|FG001|Washout Period-No Drug|Adverse Event|0|||
44440024|NCT00732875|79448435|FG000|Overall Study|Withdrawal by Subject|6|||
44339857|NCT01021852|79344301|FG002|Washout Period-No Drug|Adverse Event|0|||
44339858|NCT01021852|79344302|FG003|Washout Period-No Drug|Adverse Event|0|||
44339859|NCT01021852|79344303|FG004|Washout Period-No Drug|Adverse Event|0|||
44339860|NCT01021852|79344304|FG005|Washout Period-No Drug|Adverse Event|1|||
44339861|NCT01021852|79344305|FG006|Washout Period-No Drug|Adverse Event|0|||
44158077|NCT01669577|78949976|FG000|Overall Study|Physician Decision|34|||
44440025|NCT00732875|79448435|FG000|Overall Study|Lack of Efficacy|13|||
44440026|NCT00615264|79448445|FG000|Overall Study|Withdrawal by Subject|17|||
44440027|NCT00615264|79448446|FG001|Overall Study|Withdrawal by Subject|19|||
44440028|NCT00615264|79448445|FG000|Overall Study|Lost to Follow-up|6|||
44440029|NCT00615264|79448446|FG001|Overall Study|Lost to Follow-up|13|||
44158078|NCT02658175|78949983|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
44259578|NCT01271725|79120915|FG001|Part B|Withdrawal by Subject|6|||
44440030|NCT00615264|79448445|FG000|Overall Study|Adverse Event|8|||
44440031|NCT00615264|79448446|FG001|Overall Study|Adverse Event|5|||
44440032|NCT00615264|79448445|FG000|Overall Study|Death|1|||
44440033|NCT00615264|79448446|FG001|Overall Study|Death|1|||
44339862|NCT01021852|79344306|FG007|Washout Period-No Drug|Adverse Event|0|||
44339863|NCT01021852|79344299|FG000|Treatment Period 2|Adverse Event|0|||
44339864|NCT01021852|79344300|FG001|Treatment Period 2|Adverse Event|1|||
44339865|NCT01021852|79344301|FG002|Treatment Period 2|Adverse Event|0|||
44339866|NCT01021852|79344302|FG003|Treatment Period 2|Adverse Event|0|||
44339867|NCT01021852|79344303|FG004|Treatment Period 2|Adverse Event|1|||
44339868|NCT01021852|79344304|FG005|Treatment Period 2|Adverse Event|0|||
44339869|NCT01021852|79344305|FG006|Treatment Period 2|Adverse Event|1|||
44339870|NCT01021852|79344306|FG007|Treatment Period 2|Adverse Event|0|||
44339871|NCT01021852|79344299|FG000|Treatment Period 2|Lack of Efficacy|0|||
44339872|NCT01021852|79344300|FG001|Treatment Period 2|Lack of Efficacy|0|||
44158079|NCT02658175|78949984|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
44158080|NCT02658175|78949985|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
44158081|NCT02658175|78949983|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
44158082|NCT02658175|78949984|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
44158083|NCT02658175|78949985|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
44440034|NCT00615264|79448445|FG000|Overall Study|Protocol Violation|11|||
44440035|NCT00615264|79448446|FG001|Overall Study|Protocol Violation|7|||
44339873|NCT01021852|79344301|FG002|Treatment Period 2|Lack of Efficacy|0|||
44440036|NCT00615264|79448445|FG000|Overall Study|Not defined|7|||
44440037|NCT00615264|79448446|FG001|Overall Study|Not defined|4|||
44440038|NCT00615264|79448445|FG000|Overall Study|Dermal Hypersensitivity|0|||
44440039|NCT00615264|79448446|FG001|Overall Study|Dermal Hypersensitivity|3|||
44440040|NCT00732641|79448454|FG000|Overall Study|Relapse or Progressive Disease|65|||
44440041|NCT00732641|79448455|FG001|Overall Study|Relapse or Progressive Disease|101|||
44339874|NCT01021852|79344302|FG003|Treatment Period 2|Lack of Efficacy|0|||
44339875|NCT01021852|79344303|FG004|Treatment Period 2|Lack of Efficacy|0|||
44339876|NCT01021852|79344304|FG005|Treatment Period 2|Lack of Efficacy|1|||
44339877|NCT01021852|79344305|FG006|Treatment Period 2|Lack of Efficacy|0|||
44339878|NCT01021852|79344306|FG007|Treatment Period 2|Lack of Efficacy|0|||
44339879|NCT01021852|79344299|FG000|Treatment Period 2|Physician Decision|0|||
44339880|NCT01021852|79344300|FG001|Treatment Period 2|Physician Decision|0|||
44339881|NCT01021852|79344301|FG002|Treatment Period 2|Physician Decision|1|||
44339882|NCT01021852|79344302|FG003|Treatment Period 2|Physician Decision|0|||
44339883|NCT01021852|79344303|FG004|Treatment Period 2|Physician Decision|0|||
44339884|NCT01021852|79344304|FG005|Treatment Period 2|Physician Decision|0|||
44339885|NCT01021852|79344305|FG006|Treatment Period 2|Physician Decision|0|||
44339886|NCT01021852|79344306|FG007|Treatment Period 2|Physician Decision|0|||
44339887|NCT01021852|79344299|FG000|Treatment Period 2|Protocol Violation|0|||
44339888|NCT01021852|79344300|FG001|Treatment Period 2|Protocol Violation|0|||
44339889|NCT01021852|79344301|FG002|Treatment Period 2|Protocol Violation|0|||
44339890|NCT01021852|79344302|FG003|Treatment Period 2|Protocol Violation|0|||
44339891|NCT01021852|79344303|FG004|Treatment Period 2|Protocol Violation|1|||
44339892|NCT01021852|79344304|FG005|Treatment Period 2|Protocol Violation|0|||
44339893|NCT01021852|79344305|FG006|Treatment Period 2|Protocol Violation|1|||
44339894|NCT01021852|79344306|FG007|Treatment Period 2|Protocol Violation|0|||
44339895|NCT01021852|79344299|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44339896|NCT01021852|79344300|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44339897|NCT01021852|79344301|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44339898|NCT01021852|79344302|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44339899|NCT01021852|79344303|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44339900|NCT01021852|79344304|FG005|Treatment Period 2|Withdrawal by Subject|0|||
44339901|NCT01021852|79344305|FG006|Treatment Period 2|Withdrawal by Subject|1|||
44339902|NCT01021852|79344306|FG007|Treatment Period 2|Withdrawal by Subject|2|||
44339903|NCT01056718|79344320|FG000|Overall Study|Withdrawal by Subject|2|||
44339904|NCT01056718|79344320|FG000|Overall Study|Ischemia on baseline stress test|1|||
44339905|NCT01298570|79344327|FG000|Overall Study|Disease progression, relapse during acti|64|||
44339906|NCT01298570|79344328|FG001|Overall Study|Disease progression, relapse during acti|40|||
44339907|NCT01298570|79344327|FG000|Overall Study|Adverse Event|20|||
44339908|NCT01298570|79344328|FG001|Overall Study|Adverse Event|2|||
44339909|NCT01298570|79344327|FG000|Overall Study|Withdrawal by Subject|21|||
44339910|NCT01298570|79344328|FG001|Overall Study|Withdrawal by Subject|6|||
44339911|NCT01298570|79344327|FG000|Overall Study|Treatment delay > 4 weeks|4|||
44339912|NCT01298570|79344328|FG001|Overall Study|Treatment delay > 4 weeks|5|||
44339913|NCT01298570|79344327|FG000|Overall Study|Physician Decision|4|||
44339914|NCT01298570|79344328|FG001|Overall Study|Physician Decision|2|||
44339915|NCT01298570|79344327|FG000|Overall Study|Other complicating disease|2|||
44339916|NCT01298570|79344328|FG001|Overall Study|Other complicating disease|1|||
44339917|NCT01298570|79344327|FG000|Overall Study|Surgery|2|||
44339918|NCT01298570|79344328|FG001|Overall Study|Surgery|1|||
44339919|NCT01298570|79344327|FG000|Overall Study|Symptomatic progression/deterioration|3|||
44339920|NCT01298570|79344328|FG001|Overall Study|Symptomatic progression/deterioration|2|||
44339921|NCT01298570|79344327|FG000|Overall Study|Death|0|||
44339922|NCT01298570|79344328|FG001|Overall Study|Death|1|||
44339923|NCT01298570|79344327|FG000|Overall Study|Ineligibility|0|||
44339924|NCT01298570|79344328|FG001|Overall Study|Ineligibility|1|||
44339925|NCT01259856|79344336|FG000|Overall Study|Adverse Event|12|||
44339926|NCT01259856|79344337|FG001|Overall Study|Adverse Event|9|||
44339927|NCT01259856|79344336|FG000|Overall Study|Death|0|||
44339928|NCT01259856|79344337|FG001|Overall Study|Death|1|||
44339929|NCT01259856|79344336|FG000|Overall Study|Lack of Efficacy|3|||
44339930|NCT01259856|79344337|FG001|Overall Study|Lack of Efficacy|1|||
44339931|NCT01259856|79344336|FG000|Overall Study|Lost to Follow-up|1|||
44339932|NCT01259856|79344337|FG001|Overall Study|Lost to Follow-up|1|||
44339933|NCT01259856|79344336|FG000|Overall Study|Physician Decision|2|||
44339934|NCT01259856|79344337|FG001|Overall Study|Physician Decision|1|||
44339935|NCT01259856|79344336|FG000|Overall Study|Withdrawal by Subject|9|||
44339936|NCT01259856|79344337|FG001|Overall Study|Withdrawal by Subject|10|||
44339937|NCT01259856|79344336|FG000|Overall Study|Treatment never started|0|||
44339938|NCT01259856|79344337|FG001|Overall Study|Treatment never started|6|||
44339939|NCT01259856|79344336|FG000|Overall Study|Study closure by sponsor|40|||
44339940|NCT01259856|79344337|FG001|Overall Study|Study closure by sponsor|41|||
44339941|NCT01259856|79344336|FG000|Overall Study|Patient developed other disease|0|||
44339942|NCT01259856|79344337|FG001|Overall Study|Patient developed other disease|1|||
44339943|NCT01259856|79344336|FG000|Overall Study|Transfer to another study|0|||
44339944|NCT01259856|79344337|FG001|Overall Study|Transfer to another study|1|||
44339945|NCT01259856|79344336|FG000|Overall Study|Unknown/missing|2|||
44339946|NCT01259856|79344337|FG001|Overall Study|Unknown/missing|2|||
44339947|NCT01020838|79344343|FG000|Overall Study|Death|90|||
44339948|NCT01020838|79344343|FG000|Overall Study|Adverse Event|1|||
44339949|NCT01020838|79344343|FG000|Overall Study|Withdrawal by Subject|9|||
44339950|NCT01020838|79344343|FG000|Overall Study|Lost to Follow-up|6|||
44158084|NCT02658175|78949983|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
44158085|NCT02658175|78949984|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
44158086|NCT02658175|78949985|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
44158087|NCT02658175|78949983|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
44158088|NCT02658175|78949984|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
44158089|NCT02658175|78949985|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
44158090|NCT02658175|78949983|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
44158091|NCT02658175|78949984|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
44158092|NCT02658175|78949985|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
44259579|NCT01270321|79120940|FG000|Overall Study|Death|3|||
44259580|NCT01270321|79120941|FG001|Overall Study|Death|1|||
44259581|NCT01270321|79120942|FG002|Overall Study|Death|4|||
44259582|NCT01270321|79120940|FG000|Overall Study|Adverse Event|7|||
44158093|NCT02658175|78949983|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
44158094|NCT02658175|78949984|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
44158095|NCT02658175|78949985|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
44158096|NCT02658175|78949983|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
44158097|NCT02658175|78949984|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
44158098|NCT02658175|78949985|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
44158099|NCT02658175|78949983|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
44158100|NCT02658175|78949984|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
44158101|NCT02658175|78949985|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
44158102|NCT02658175|78949983|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
44158103|NCT02658175|78949984|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
44158104|NCT02658175|78949985|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
44158105|NCT02658175|78949983|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
44158106|NCT02658175|78949984|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
44158107|NCT02658175|78949985|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
44158108|NCT02625623|78949995|FG000|Overall Study|Participants randomized but not treated|9|||
44158109|NCT02625623|78949996|FG001|Overall Study|Participants randomized but not treated|1|||
44158110|NCT02658019|78950004|FG000|Overall Study|Adverse Event|1|||
44158111|NCT02624687|78950010|FG000|Overall Study|Withdrawal by Subject|1|||
44158112|NCT02624687|78950011|FG001|Overall Study|Withdrawal by Subject|1|||
44158113|NCT02624687|78950010|FG000|Overall Study|medical leave from work|0|||
44158114|NCT02624687|78950011|FG001|Overall Study|medical leave from work|1|||
44158115|NCT01675765|78950019|FG000|Overall Study|Progressive disease|4|||
44158116|NCT01675765|78950020|FG001|Overall Study|Progressive disease|4|||
44158117|NCT01675765|78950019|FG000|Overall Study|Adverse Event|1|||
44158118|NCT01675765|78950020|FG001|Overall Study|Adverse Event|2|||
44158119|NCT01675765|78950019|FG000|Overall Study|Withdrawal by Subject|2|||
44158120|NCT01675765|78950020|FG001|Overall Study|Withdrawal by Subject|0|||
44158121|NCT01675765|78950019|FG000|Overall Study|Death|1|||
44158122|NCT01675765|78950020|FG001|Overall Study|Death|0|||
44158123|NCT01675765|78950019|FG000|Overall Study|Clinical progression|3|||
44158124|NCT01675765|78950020|FG001|Overall Study|Clinical progression|2|||
44158125|NCT02625233|78950028|FG000|Overall Study|Adverse Event|2|||
44158126|NCT02625233|78950029|FG001|Overall Study|Adverse Event|0|||
44158127|NCT02656693|78950038|FG000|Overall Study|Pregnancy|1|||
44158128|NCT02656693|78950039|FG001|Overall Study|Pregnancy|1|||
44259583|NCT01270321|79120941|FG001|Overall Study|Adverse Event|9|||
44259584|NCT01270321|79120942|FG002|Overall Study|Adverse Event|5|||
44259585|NCT00249769|79121036|FG000|Overall Study|Withdrawal by Subject|1|||
44259586|NCT00249769|79121037|FG001|Overall Study|Withdrawal by Subject|10|||
44259587|NCT00249769|79121038|FG002|Overall Study|Withdrawal by Subject|6|||
44339951|NCT01020838|79344343|FG000|Overall Study|Most common: Study ended by sponsor|77|||
44158129|NCT02656693|78950040|FG002|Overall Study|Pregnancy|1|||
44158130|NCT02656693|78950038|FG000|Overall Study|Bariatric surgery|0|||
44158131|NCT02656693|78950039|FG001|Overall Study|Bariatric surgery|1|||
44158132|NCT02656693|78950040|FG002|Overall Study|Bariatric surgery|2|||
44158133|NCT02633293|78950048|FG000|Overall Study|Death|56|||
44158134|NCT02633293|78950048|FG000|Overall Study|Progressive Disease|12|||
44158135|NCT02633293|78950048|FG000|Overall Study|Adverse Event|29|||
44158136|NCT02633293|78950048|FG000|Overall Study|Withdrawal by Subject|41|||
44158137|NCT02633293|78950048|FG000|Overall Study|Protocol Violation|1|||
44158138|NCT02633293|78950048|FG000|Overall Study|Lost to Follow-up|1|||
44158139|NCT02633293|78950048|FG000|Overall Study|Study Terminated by Sponsor|24|||
44158140|NCT02633293|78950048|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
44158141|NCT02633293|78950048|FG000|Overall Study|Lung Transplant|5|||
44158142|NCT02633293|78950048|FG000|Overall Study|Lack of Efficacy|2|||
44158143|NCT02633293|78950048|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
44158144|NCT02623829|78950054|FG000|Overall Study|Lost to Follow-up|1|||
44158145|NCT02623829|78950055|FG001|Overall Study|Lost to Follow-up|1|||
44158146|NCT02655679|78950066|FG000|Overall Study|Adverse Event|0|||
44158147|NCT02655679|78950067|FG001|Overall Study|Adverse Event|1|||
44158148|NCT02655679|78950068|FG002|Overall Study|Adverse Event|0|||
44158149|NCT02655679|78950069|FG003|Overall Study|Adverse Event|0|||
44158150|NCT02655679|78950070|FG004|Overall Study|Adverse Event|0|||
44158151|NCT02655679|78950066|FG000|Overall Study|Withdrawal by Subject|1|||
44158152|NCT02655679|78950067|FG001|Overall Study|Withdrawal by Subject|1|||
44158153|NCT02655679|78950068|FG002|Overall Study|Withdrawal by Subject|0|||
44158154|NCT02655679|78950069|FG003|Overall Study|Withdrawal by Subject|3|||
44158155|NCT02655679|78950070|FG004|Overall Study|Withdrawal by Subject|1|||
44158156|NCT02655679|78950066|FG000|Overall Study|Inability to Comply with the Protocol|1|||
44158157|NCT02655679|78950067|FG001|Overall Study|Inability to Comply with the Protocol|0|||
44339952|NCT01259466|79344358|FG000|Overall Study|Withdrawal by Subject|1|||
44339953|NCT01259466|79344359|FG001|Overall Study|Withdrawal by Subject|9|||
44339954|NCT01259388|79344367|FG000|Overall Study|Adverse Event|3|||
44339955|NCT01259388|79344368|FG001|Overall Study|Adverse Event|0|||
44339956|NCT01259388|79344367|FG000|Overall Study|Withdrawal by Subject|1|||
44339957|NCT01259388|79344368|FG001|Overall Study|Withdrawal by Subject|1|||
44339958|NCT01259388|79344367|FG000|Overall Study|Physician Decision|1|||
44339959|NCT01259388|79344368|FG001|Overall Study|Physician Decision|0|||
44339960|NCT01298492|79344374|FG000|Overall Study|Death|2|||
44339961|NCT01298492|79344374|FG000|Overall Study|Insufficient Clinical Response|22|||
44339962|NCT01298492|79344374|FG000|Overall Study|Lost to Follow-up|12|||
44339963|NCT01298492|79344374|FG000|Overall Study|Withdrawal by Subject|47|||
44339964|NCT01298492|79344374|FG000|Overall Study|Other (Unspecified)|7|||
44339965|NCT01298492|79344374|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
44339966|NCT01298492|79344374|FG000|Overall Study|Protocol Violation|2|||
44339967|NCT01298492|79344374|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
44339968|NCT01298492|79344374|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
44339969|NCT01297322|79344380|FG000|Overall Study|Lost to Follow-up|1|||
44339970|NCT01297322|79344381|FG001|Overall Study|Lost to Follow-up|0|||
44339971|NCT01297322|79344380|FG000|Overall Study|Withdrawal by Subject|0|||
44339972|NCT01297322|79344381|FG001|Overall Study|Withdrawal by Subject|1|||
44339973|NCT01297322|79344380|FG000|Overall Study|Protocol Violation|0|||
44339974|NCT01297322|79344381|FG001|Overall Study|Protocol Violation|3|||
44339975|NCT01297244|79344390|FG000|Overall Study|Progressive disease|22|||
44339976|NCT01297244|79344391|FG001|Overall Study|Progressive disease|3|||
44339977|NCT01297244|79344390|FG000|Overall Study|Adverse Event|9|||
44339978|NCT01297244|79344391|FG001|Overall Study|Adverse Event|1|||
44339979|NCT01297244|79344390|FG000|Overall Study|Death|1|||
44339980|NCT01297244|79344391|FG001|Overall Study|Death|1|||
44339981|NCT01297244|79344390|FG000|Overall Study|Clinical progression|1|||
44158158|NCT02655679|78950068|FG002|Overall Study|Inability to Comply with the Protocol|0|||
44158159|NCT02655679|78950069|FG003|Overall Study|Inability to Comply with the Protocol|0|||
44158160|NCT02655679|78950070|FG004|Overall Study|Inability to Comply with the Protocol|0|||
44158161|NCT02655679|78950066|FG000|Overall Study|Lost to Follow-up|0|||
44339982|NCT01297244|79344391|FG001|Overall Study|Clinical progression|1|||
44339983|NCT01297244|79344390|FG000|Overall Study|Withdrawal by Subject|2|||
44339984|NCT01297244|79344391|FG001|Overall Study|Withdrawal by Subject|0|||
44339985|NCT03456726|79344404|FG000|Overall Study|Disease Progression|6|||
44339986|NCT03456726|79344405|FG001|Overall Study|Disease Progression|1|||
44339987|NCT03456726|79344404|FG000|Overall Study|Adverse Event|4|||
44158162|NCT02655679|78950067|FG001|Overall Study|Lost to Follow-up|1|||
44339988|NCT03456726|79344405|FG001|Overall Study|Adverse Event|2|||
44339989|NCT03456726|79344404|FG000|Overall Study|Withdrawal by Subject|1|||
44339990|NCT03456726|79344405|FG001|Overall Study|Withdrawal by Subject|0|||
44339991|NCT03456726|79344404|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
44354764|NCT01186770|79359156|FG003|Overall Study|Other than specified|2|||
44158163|NCT02655679|78950068|FG002|Overall Study|Lost to Follow-up|1|||
44158164|NCT02655679|78950069|FG003|Overall Study|Lost to Follow-up|1|||
44158165|NCT02655679|78950070|FG004|Overall Study|Lost to Follow-up|0|||
44339992|NCT03456726|79344405|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
44339993|NCT03181932|79344413|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
44339994|NCT03181932|79344414|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
44339995|NCT03181932|79344413|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
44339996|NCT03181932|79344414|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
44339997|NCT03181932|79344413|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
44339998|NCT03181932|79344414|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
44339999|NCT03181932|79344413|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
44340000|NCT03181932|79344414|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
44340001|NCT03181932|79344413|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
44340002|NCT03181932|79344414|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
44340003|NCT03181932|79344413|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
44340004|NCT03181932|79344414|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
44340005|NCT03181932|79344413|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
44340006|NCT03181932|79344414|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
44340007|NCT03181932|79344413|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
44340008|NCT03181932|79344414|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
44340009|NCT03181932|79344413|FG000|Period 2 (Open-label Period)|Reason missing|2|||
44340010|NCT03181932|79344414|FG001|Period 2 (Open-label Period)|Reason missing|0|||
44340011|NCT02864862|79344424|FG000|Overall Study|Lost to Follow-up|1|||
44340012|NCT02864862|79344425|FG001|Overall Study|Lost to Follow-up|0|||
44340013|NCT02864862|79344426|FG002|Overall Study|Lost to Follow-up|1|||
44340014|NCT02864862|79344424|FG000|Overall Study|Protocol Violation|0|||
44340015|NCT02864862|79344425|FG001|Overall Study|Protocol Violation|0|||
44340016|NCT02864862|79344426|FG002|Overall Study|Protocol Violation|1|||
44340017|NCT01598298|79344438|FG000|Overall Study|Not eligible|5|||
44340018|NCT01598298|79344439|FG001|Overall Study|Not eligible|5|||
44340019|NCT01598298|79344438|FG000|Overall Study|Adverse Event|21|||
44340020|NCT01598298|79344439|FG001|Overall Study|Adverse Event|19|||
44340021|NCT01598298|79344438|FG000|Overall Study|Progression/relapse|0|||
44340022|NCT01598298|79344439|FG001|Overall Study|Progression/relapse|2|||
44340023|NCT01598298|79344438|FG000|Overall Study|Withdrawal by Subject|10|||
44158166|NCT02655679|78950066|FG000|Overall Study|Other Miscellaneous Reasons|1|||
44340024|NCT01598298|79344439|FG001|Overall Study|Withdrawal by Subject|15|||
44158167|NCT02655679|78950067|FG001|Overall Study|Other Miscellaneous Reasons|0|||
44340025|NCT01598298|79344438|FG000|Overall Study|Other reason (not protocol specified)|4|||
44340026|NCT01598298|79344439|FG001|Overall Study|Other reason (not protocol specified)|0|||
44158168|NCT02655679|78950068|FG002|Overall Study|Other Miscellaneous Reasons|0|||
44158169|NCT02655679|78950069|FG003|Overall Study|Other Miscellaneous Reasons|0|||
44340027|NCT01235949|79344463|FG000|Primary Phase|Migrated/moved from study area|1|||
44340028|NCT01235949|79344464|FG001|Primary Phase|Migrated/moved from study area|1|||
44340029|NCT01235949|79344465|FG002|Primary Phase|Migrated/moved from study area|0|||
44340030|NCT01235949|79344466|FG003|Primary Phase|Migrated/moved from study area|0|||
44340031|NCT01235949|79344467|FG004|Primary Phase|Migrated/moved from study area|1|||
44340032|NCT01235949|79344468|FG005|Primary Phase|Migrated/moved from study area|2|||
44340033|NCT01235949|79344469|FG006|Primary Phase|Migrated/moved from study area|0|||
44259588|NCT00249769|79121036|FG000|Overall Study|Migration from Study Area|1|||
44259589|NCT00249769|79121037|FG001|Overall Study|Migration from Study Area|3|||
44340034|NCT01235949|79344470|FG007|Primary Phase|Migrated/moved from study area|0|||
44259590|NCT00249769|79121038|FG002|Overall Study|Migration from Study Area|14|||
44259591|NCT00249769|79121036|FG000|Overall Study|Miscellaneous|0|||
44259592|NCT00249769|79121037|FG001|Overall Study|Miscellaneous|2|||
44259593|NCT00249769|79121038|FG002|Overall Study|Miscellaneous|2|||
44259594|NCT00249769|79121036|FG000|Overall Study|Adverse Event|0|||
44259595|NCT00249769|79121037|FG001|Overall Study|Adverse Event|0|||
44259596|NCT00249769|79121038|FG002|Overall Study|Adverse Event|1|||
44259597|NCT00249769|79121036|FG000|Overall Study|Physician Decision|0|||
44259598|NCT00249769|79121037|FG001|Overall Study|Physician Decision|0|||
44259599|NCT00249769|79121038|FG002|Overall Study|Physician Decision|2|||
44259600|NCT00249769|79121036|FG000|Overall Study|Lost to Follow-up|0|||
44259601|NCT00249769|79121037|FG001|Overall Study|Lost to Follow-up|0|||
44259602|NCT00249769|79121038|FG002|Overall Study|Lost to Follow-up|3|||
44259603|NCT00249613|79121048|FG000|12 Month Follow-up|Death|1|||
44259604|NCT00249613|79121049|FG001|12 Month Follow-up|Death|1|||
44259605|NCT00249613|79121048|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
44259606|NCT00249613|79121049|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
44259607|NCT00249613|79121048|FG000|12 Month Follow-up|Lost to Follow-up|10|||
44259608|NCT00249613|79121049|FG001|12 Month Follow-up|Lost to Follow-up|8|||
44259609|NCT00248833|79121085|FG000|Overall Study|Adverse Event|2|||
44259610|NCT00248833|79121086|FG001|Overall Study|Adverse Event|0|||
44259611|NCT00248833|79121087|FG002|Overall Study|Adverse Event|0|||
44259612|NCT00248833|79121085|FG000|Overall Study|Withdrawal by Subject|0|||
44340035|NCT01235949|79344471|FG008|Primary Phase|Migrated/moved from study area|0|||
44440042|NCT00732641|79448454|FG000|Overall Study|Serious Adverse Events|12|||
44440043|NCT00732641|79448455|FG001|Overall Study|Serious Adverse Events|3|||
44440044|NCT00732641|79448454|FG000|Overall Study|Physician Decision|6|||
44440045|NCT00732641|79448455|FG001|Overall Study|Physician Decision|0|||
44440046|NCT00732641|79448454|FG000|Overall Study|Withdrawal by Subject|4|||
44440047|NCT00732641|79448455|FG001|Overall Study|Withdrawal by Subject|2|||
44340036|NCT01235949|79344472|FG009|Primary Phase|Migrated/moved from study area|0|||
44340037|NCT01235949|79344473|FG010|Primary Phase|Migrated/moved from study area|0|||
44340038|NCT01235949|79344474|FG011|Primary Phase|Migrated/moved from study area|0|||
44340039|NCT01235949|79344475|FG012|Primary Phase|Migrated/moved from study area|0|||
44440048|NCT00732641|79448454|FG000|Overall Study|Unable to Complete|1|||
44440049|NCT00732641|79448455|FG001|Overall Study|Unable to Complete|1|||
44440050|NCT00732641|79448454|FG000|Overall Study|Other|18|||
44440051|NCT00732641|79448455|FG001|Overall Study|Other|5|||
44259613|NCT00248833|79121086|FG001|Overall Study|Withdrawal by Subject|1|||
44259614|NCT00248833|79121087|FG002|Overall Study|Withdrawal by Subject|1|||
44259615|NCT00248833|79121085|FG000|Overall Study|Lost to Follow-up|1|||
44440052|NCT00737711|79448461|FG000|Overall Study|Adverse Event|2|||
44259616|NCT00248833|79121086|FG001|Overall Study|Lost to Follow-up|1|||
44259617|NCT00248833|79121087|FG002|Overall Study|Lost to Follow-up|1|||
44340040|NCT01235949|79344476|FG013|Primary Phase|Migrated/moved from study area|0|||
44340041|NCT01235949|79344477|FG014|Primary Phase|Migrated/moved from study area|0|||
44340042|NCT01235949|79344478|FG015|Primary Phase|Migrated/moved from study area|0|||
44340043|NCT01235949|79344479|FG016|Primary Phase|Migrated/moved from study area|0|||
44340044|NCT01235949|79344480|FG017|Primary Phase|Migrated/moved from study area|0|||
44340045|NCT01235949|79344463|FG000|Primary Phase|Adverse Event|0|||
44340046|NCT01235949|79344464|FG001|Primary Phase|Adverse Event|0|||
44340047|NCT01235949|79344465|FG002|Primary Phase|Adverse Event|0|||
44340048|NCT01235949|79344466|FG003|Primary Phase|Adverse Event|1|||
44340049|NCT01235949|79344467|FG004|Primary Phase|Adverse Event|0|||
44340050|NCT01235949|79344468|FG005|Primary Phase|Adverse Event|0|||
44340051|NCT01235949|79344469|FG006|Primary Phase|Adverse Event|0|||
44340052|NCT01235949|79344470|FG007|Primary Phase|Adverse Event|0|||
44340053|NCT01235949|79344471|FG008|Primary Phase|Adverse Event|0|||
44340054|NCT01235949|79344472|FG009|Primary Phase|Adverse Event|0|||
44340055|NCT01235949|79344473|FG010|Primary Phase|Adverse Event|0|||
44340056|NCT01235949|79344474|FG011|Primary Phase|Adverse Event|0|||
44340057|NCT01235949|79344475|FG012|Primary Phase|Adverse Event|0|||
44340058|NCT01235949|79344476|FG013|Primary Phase|Adverse Event|0|||
44340059|NCT01235949|79344477|FG014|Primary Phase|Adverse Event|0|||
44340060|NCT01235949|79344478|FG015|Primary Phase|Adverse Event|0|||
44340061|NCT01235949|79344479|FG016|Primary Phase|Adverse Event|0|||
44340062|NCT01235949|79344480|FG017|Primary Phase|Adverse Event|0|||
44340063|NCT01235949|79344463|FG000|Primary Phase|Withdrawal by Subject|3|||
44340064|NCT01235949|79344464|FG001|Primary Phase|Withdrawal by Subject|2|||
44340065|NCT01235949|79344465|FG002|Primary Phase|Withdrawal by Subject|2|||
44340066|NCT01235949|79344466|FG003|Primary Phase|Withdrawal by Subject|0|||
44340067|NCT01235949|79344467|FG004|Primary Phase|Withdrawal by Subject|0|||
44340068|NCT01235949|79344468|FG005|Primary Phase|Withdrawal by Subject|3|||
44340069|NCT01235949|79344469|FG006|Primary Phase|Withdrawal by Subject|0|||
44340070|NCT01235949|79344470|FG007|Primary Phase|Withdrawal by Subject|0|||
44340071|NCT01235949|79344471|FG008|Primary Phase|Withdrawal by Subject|0|||
44340072|NCT01235949|79344472|FG009|Primary Phase|Withdrawal by Subject|0|||
44340073|NCT01235949|79344473|FG010|Primary Phase|Withdrawal by Subject|0|||
44340074|NCT01235949|79344474|FG011|Primary Phase|Withdrawal by Subject|0|||
44340075|NCT01235949|79344475|FG012|Primary Phase|Withdrawal by Subject|0|||
44340076|NCT01235949|79344476|FG013|Primary Phase|Withdrawal by Subject|0|||
44340077|NCT01235949|79344477|FG014|Primary Phase|Withdrawal by Subject|0|||
44340078|NCT01235949|79344478|FG015|Primary Phase|Withdrawal by Subject|0|||
44340079|NCT01235949|79344479|FG016|Primary Phase|Withdrawal by Subject|0|||
44340080|NCT01235949|79344480|FG017|Primary Phase|Withdrawal by Subject|0|||
44340081|NCT01235949|79344463|FG000|Primary Phase|Lost to Follow-up|0|||
44340082|NCT01235949|79344464|FG001|Primary Phase|Lost to Follow-up|0|||
44340083|NCT01235949|79344465|FG002|Primary Phase|Lost to Follow-up|1|||
44340084|NCT01235949|79344466|FG003|Primary Phase|Lost to Follow-up|1|||
44340085|NCT01235949|79344467|FG004|Primary Phase|Lost to Follow-up|0|||
44340086|NCT01235949|79344468|FG005|Primary Phase|Lost to Follow-up|2|||
44340087|NCT01235949|79344469|FG006|Primary Phase|Lost to Follow-up|0|||
44340088|NCT01235949|79344470|FG007|Primary Phase|Lost to Follow-up|0|||
44340089|NCT01235949|79344471|FG008|Primary Phase|Lost to Follow-up|0|||
44340090|NCT01235949|79344472|FG009|Primary Phase|Lost to Follow-up|0|||
44340091|NCT01235949|79344473|FG010|Primary Phase|Lost to Follow-up|0|||
44340092|NCT01235949|79344474|FG011|Primary Phase|Lost to Follow-up|0|||
44340093|NCT01235949|79344475|FG012|Primary Phase|Lost to Follow-up|0|||
44340094|NCT01235949|79344476|FG013|Primary Phase|Lost to Follow-up|0|||
44340095|NCT01235949|79344477|FG014|Primary Phase|Lost to Follow-up|0|||
44340096|NCT01235949|79344478|FG015|Primary Phase|Lost to Follow-up|0|||
44340097|NCT01235949|79344479|FG016|Primary Phase|Lost to Follow-up|0|||
44340098|NCT01235949|79344480|FG017|Primary Phase|Lost to Follow-up|0|||
44340099|NCT01235949|79344463|FG000|Booster Phase|Migrated/moved from study area|0|||
44340100|NCT01235949|79344464|FG001|Booster Phase|Migrated/moved from study area|0|||
44340101|NCT01235949|79344465|FG002|Booster Phase|Migrated/moved from study area|0|||
44340102|NCT01235949|79344466|FG003|Booster Phase|Migrated/moved from study area|0|||
44340103|NCT01235949|79344467|FG004|Booster Phase|Migrated/moved from study area|0|||
44158170|NCT02655679|78950070|FG004|Overall Study|Other Miscellaneous Reasons|0|||
44158171|NCT02623361|78950085|FG000|Overall Study|Protocol Violation|0|||
44158172|NCT02623361|78950086|FG001|Overall Study|Protocol Violation|1|||
44158173|NCT02623361|78950085|FG000|Overall Study|Withdrawal by Subject|0|||
44340104|NCT01235949|79344468|FG005|Booster Phase|Migrated/moved from study area|0|||
44440053|NCT00737711|79448461|FG000|Overall Study|Death|8|||
44259618|NCT00248833|79121085|FG000|Overall Study|Other|0|||
44259619|NCT00248833|79121086|FG001|Overall Study|Other|1|||
44259620|NCT00248833|79121087|FG002|Overall Study|Other|0|||
44259621|NCT00247273|79121249|FG000|Overall Study|Adverse Event|85|||
44259622|NCT00247273|79121250|FG001|Overall Study|Adverse Event|80|||
44259623|NCT00247273|79121249|FG000|Overall Study|Physician Decision|6|||
44259624|NCT00247273|79121250|FG001|Overall Study|Physician Decision|3|||
44259625|NCT00247273|79121249|FG000|Overall Study|Lost to Follow-up|7|||
44259626|NCT00247273|79121250|FG001|Overall Study|Lost to Follow-up|7|||
44259627|NCT00247273|79121249|FG000|Overall Study|Withdrawal by Subject|46|||
44259628|NCT00247273|79121250|FG001|Overall Study|Withdrawal by Subject|47|||
44259629|NCT00247273|79121249|FG000|Overall Study|Did not take any study drug|2|||
44259630|NCT00247273|79121250|FG001|Overall Study|Did not take any study drug|0|||
44259631|NCT00246259|79121338|FG000|Overall Study|Other|3|||
44259632|NCT00246259|79121339|FG001|Overall Study|Other|3|||
44259633|NCT00246259|79121338|FG000|Overall Study|Not stable by Week 18|2|||
44340105|NCT01235949|79344469|FG006|Booster Phase|Migrated/moved from study area|0|||
44340106|NCT01235949|79344470|FG007|Booster Phase|Migrated/moved from study area|0|||
44340107|NCT01235949|79344471|FG008|Booster Phase|Migrated/moved from study area|0|||
44340108|NCT01235949|79344472|FG009|Booster Phase|Migrated/moved from study area|0|||
44340109|NCT01235949|79344473|FG010|Booster Phase|Migrated/moved from study area|0|||
44340110|NCT01235949|79344474|FG011|Booster Phase|Migrated/moved from study area|1|||
44340111|NCT01235949|79344475|FG012|Booster Phase|Migrated/moved from study area|1|||
44340112|NCT01235949|79344476|FG013|Booster Phase|Migrated/moved from study area|0|||
44340113|NCT01235949|79344477|FG014|Booster Phase|Migrated/moved from study area|0|||
44340114|NCT01235949|79344478|FG015|Booster Phase|Migrated/moved from study area|0|||
44340115|NCT01235949|79344479|FG016|Booster Phase|Migrated/moved from study area|0|||
44340116|NCT01235949|79344480|FG017|Booster Phase|Migrated/moved from study area|1|||
44340117|NCT01235949|79344463|FG000|Booster Phase|Adverse Event|0|||
44340118|NCT01235949|79344464|FG001|Booster Phase|Adverse Event|0|||
44340119|NCT01235949|79344465|FG002|Booster Phase|Adverse Event|0|||
44340120|NCT01235949|79344466|FG003|Booster Phase|Adverse Event|0|||
44340121|NCT01235949|79344467|FG004|Booster Phase|Adverse Event|0|||
44340122|NCT01235949|79344468|FG005|Booster Phase|Adverse Event|0|||
44340123|NCT01235949|79344469|FG006|Booster Phase|Adverse Event|0|||
44340124|NCT01235949|79344470|FG007|Booster Phase|Adverse Event|0|||
44340125|NCT01235949|79344471|FG008|Booster Phase|Adverse Event|0|||
44340126|NCT01235949|79344472|FG009|Booster Phase|Adverse Event|0|||
44340127|NCT01235949|79344473|FG010|Booster Phase|Adverse Event|0|||
44340128|NCT01235949|79344474|FG011|Booster Phase|Adverse Event|0|||
44340129|NCT01235949|79344475|FG012|Booster Phase|Adverse Event|0|||
44340130|NCT01235949|79344476|FG013|Booster Phase|Adverse Event|0|||
44340131|NCT01235949|79344477|FG014|Booster Phase|Adverse Event|0|||
44340132|NCT01235949|79344478|FG015|Booster Phase|Adverse Event|1|||
44340133|NCT01235949|79344479|FG016|Booster Phase|Adverse Event|0|||
44340134|NCT01235949|79344480|FG017|Booster Phase|Adverse Event|0|||
44340135|NCT01235949|79344463|FG000|Booster Phase|Withdrawal by Subject|0|||
44340136|NCT01235949|79344464|FG001|Booster Phase|Withdrawal by Subject|0|||
44340137|NCT01235949|79344465|FG002|Booster Phase|Withdrawal by Subject|0|||
44340138|NCT01235949|79344466|FG003|Booster Phase|Withdrawal by Subject|0|||
44340139|NCT01235949|79344467|FG004|Booster Phase|Withdrawal by Subject|0|||
44340140|NCT01235949|79344468|FG005|Booster Phase|Withdrawal by Subject|0|||
44340141|NCT01235949|79344469|FG006|Booster Phase|Withdrawal by Subject|0|||
44340142|NCT01235949|79344470|FG007|Booster Phase|Withdrawal by Subject|1|||
44340143|NCT01235949|79344471|FG008|Booster Phase|Withdrawal by Subject|1|||
44340144|NCT01235949|79344472|FG009|Booster Phase|Withdrawal by Subject|0|||
44340145|NCT01235949|79344473|FG010|Booster Phase|Withdrawal by Subject|1|||
44340146|NCT01235949|79344474|FG011|Booster Phase|Withdrawal by Subject|1|||
44340147|NCT01235949|79344475|FG012|Booster Phase|Withdrawal by Subject|2|||
44340148|NCT01235949|79344476|FG013|Booster Phase|Withdrawal by Subject|0|||
44340149|NCT01235949|79344477|FG014|Booster Phase|Withdrawal by Subject|2|||
44340150|NCT01235949|79344478|FG015|Booster Phase|Withdrawal by Subject|0|||
44340151|NCT01235949|79344479|FG016|Booster Phase|Withdrawal by Subject|0|||
44340152|NCT01235949|79344480|FG017|Booster Phase|Withdrawal by Subject|0|||
44340153|NCT01235949|79344463|FG000|Booster Phase|Lost to Follow-up|0|||
44340154|NCT01235949|79344464|FG001|Booster Phase|Lost to Follow-up|0|||
44340155|NCT01235949|79344465|FG002|Booster Phase|Lost to Follow-up|0|||
44340156|NCT01235949|79344466|FG003|Booster Phase|Lost to Follow-up|0|||
44340157|NCT01235949|79344467|FG004|Booster Phase|Lost to Follow-up|0|||
44158174|NCT02623361|78950086|FG001|Overall Study|Withdrawal by Subject|1|||
44340158|NCT01235949|79344468|FG005|Booster Phase|Lost to Follow-up|0|||
44340159|NCT01235949|79344469|FG006|Booster Phase|Lost to Follow-up|0|||
44340160|NCT01235949|79344470|FG007|Booster Phase|Lost to Follow-up|0|||
44340161|NCT01235949|79344471|FG008|Booster Phase|Lost to Follow-up|1|||
44340162|NCT01235949|79344472|FG009|Booster Phase|Lost to Follow-up|1|||
44340163|NCT01235949|79344473|FG010|Booster Phase|Lost to Follow-up|1|||
44340164|NCT01235949|79344474|FG011|Booster Phase|Lost to Follow-up|1|||
44158175|NCT01675531|78950133|FG000|Overall Study|Adverse Event|9|||
44158176|NCT01675531|78950133|FG000|Overall Study|Withdrawal by Subject|7|||
44158177|NCT01675531|78950133|FG000|Overall Study|Lack of Efficacy|1|||
44158178|NCT01675531|78950133|FG000|Overall Study|Protocol Violation|8|||
44158179|NCT02532543|78950142|FG000|Overall Study|Lost to Follow-up|0|||
44158180|NCT02532543|78950143|FG001|Overall Study|Lost to Follow-up|0|||
44158181|NCT02532543|78950144|FG002|Overall Study|Lost to Follow-up|1|||
44158182|NCT02532543|78950145|FG003|Overall Study|Lost to Follow-up|0|||
44158183|NCT02532465|78950157|FG000|Overall Study|Protocol Violation|1|||
44158184|NCT02532465|78950158|FG001|Overall Study|Protocol Violation|0|||
44158185|NCT02532465|78950157|FG000|Overall Study|Lack of Efficacy|0|||
44158186|NCT02532465|78950158|FG001|Overall Study|Lack of Efficacy|1|||
44158187|NCT02528331|78950164|FG000|Overall Study|Withdrawal by Subject|2|||
44158188|NCT02654977|78950168|FG000|Overall Study|Death|1|||
44158189|NCT02654977|78950168|FG000|Overall Study|Lost to Follow-up|1|||
44158190|NCT02654977|78950168|FG000|Overall Study|Adverse Event|1|||
44158191|NCT02654977|78950168|FG000|Overall Study|Withdrawal by Subject|1|||
44158192|NCT02654977|78950168|FG000|Overall Study|Lack of Efficacy|3|||
44158193|NCT01362517|78950172|FG000|Overall Study|Protocol Violation|1|||
44158194|NCT01362517|78950172|FG000|Overall Study|Lost to Follow-up|1|||
44158195|NCT01362439|78950179|FG000|Overall Study|Adverse Event|1|||
44158196|NCT01362439|78950179|FG000|Overall Study|Lack of Efficacy|3|||
44158197|NCT01362439|78950179|FG000|Overall Study|Lost to Follow-up|2|||
44158198|NCT01362439|78950179|FG000|Overall Study|Study medication non-compliant|1|||
44158199|NCT01362439|78950179|FG000|Overall Study|Participant who withdrew consent|8|||
44158200|NCT02653495|78950186|FG000|Overall Study|Lost to Follow-up|2|||
44158201|NCT02653495|78950187|FG001|Overall Study|Lost to Follow-up|0|||
44158202|NCT02653495|78950186|FG000|Overall Study|Screening Failure|10|||
44158203|NCT02653495|78950187|FG001|Overall Study|Screening Failure|0|||
44158204|NCT01675141|78950193|FG000|Overall Study|Lenalidomide outside NIH|3|||
44158205|NCT01675141|78950193|FG000|Overall Study|Withdrawal by Subject|3|||
44158206|NCT01675141|78950193|FG000|Overall Study|Physician Decision|4|||
44158207|NCT01675141|78950193|FG000|Overall Study|No treatment, per protocol|1|||
44259634|NCT00246259|79121339|FG001|Overall Study|Not stable by Week 18|1|||
44158208|NCT03367819|78950228|FG000|Overall Study|Adverse Event|4|||
44158209|NCT03367819|78950229|FG001|Overall Study|Adverse Event|4|||
44158210|NCT03367819|78950228|FG000|Overall Study|Progressive Disease|15|||
44158211|NCT03367819|78950229|FG001|Overall Study|Progressive Disease|13|||
44158212|NCT03367819|78950228|FG000|Overall Study|Withdrawal by Subject|1|||
44259635|NCT00246259|79121338|FG000|Overall Study|Participant non-compliant|4|||
44340165|NCT01235949|79344475|FG012|Booster Phase|Lost to Follow-up|0|||
44158213|NCT03367819|78950229|FG001|Overall Study|Withdrawal by Subject|0|||
44158214|NCT03367819|78950228|FG000|Overall Study|Other|4|||
44158215|NCT03367819|78950229|FG001|Overall Study|Other|2|||
44158216|NCT01597193|78950272|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
44158217|NCT01597193|78950273|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
44158218|NCT01597193|78950274|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
44158219|NCT01597193|78950275|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
44158220|NCT01597193|78950276|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
44158221|NCT01597193|78950277|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
44340166|NCT01235949|79344476|FG013|Booster Phase|Lost to Follow-up|0|||
44340167|NCT01235949|79344477|FG014|Booster Phase|Lost to Follow-up|0|||
44340168|NCT01235949|79344478|FG015|Booster Phase|Lost to Follow-up|0|||
44158222|NCT01597193|78950278|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
44340169|NCT01235949|79344479|FG016|Booster Phase|Lost to Follow-up|0|||
44158223|NCT01597193|78950272|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
44158224|NCT01597193|78950273|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
44340170|NCT01235949|79344480|FG017|Booster Phase|Lost to Follow-up|1|||
44340171|NCT01235793|79344518|FG000|Overall Study|Death|6|||
44340172|NCT01258998|79344523|FG000|Overall Study|Ineligible|1|||
44340173|NCT01235715|79344529|FG000|Overall Study|Physician Decision|0|||
44340174|NCT01235715|79344530|FG001|Overall Study|Physician Decision|2|||
44340175|NCT01235403|79344537|FG000|Overall Study|Adverse Event|14|||
44340176|NCT01235403|79344537|FG000|Overall Study|Lost to Follow-up|2|||
44340177|NCT01235403|79344537|FG000|Overall Study|Withdrawal by Subject|4|||
44158225|NCT01597193|78950274|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
44158226|NCT01597193|78950275|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
44158227|NCT01597193|78950276|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
44158228|NCT01597193|78950277|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
44158229|NCT01597193|78950278|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
44158230|NCT01597193|78950272|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
44158231|NCT01597193|78950273|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
44158232|NCT01597193|78950274|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
44158233|NCT01597193|78950275|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
44158234|NCT01597193|78950276|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
44158235|NCT01597193|78950277|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
44158236|NCT01597193|78950278|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
44158237|NCT01597193|78950272|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
44158238|NCT01597193|78950273|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
44158239|NCT01597193|78950274|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
44158240|NCT01597193|78950275|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
44158241|NCT01597193|78950276|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
44158242|NCT01597193|78950277|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
44158243|NCT01597193|78950278|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
44340178|NCT01235403|79344537|FG000|Overall Study|Lack of Efficacy|2|||
44340179|NCT01235403|79344537|FG000|Overall Study|Other reasons for premature termination|4|||
44340180|NCT01024036|79344543|FG000|Blinded Treatment|Adverse Event|1|||
44340181|NCT01024036|79344544|FG001|Blinded Treatment|Adverse Event|1|||
44440054|NCT00737711|79448461|FG000|Overall Study|Failure to return|4|||
44440055|NCT00737711|79448461|FG000|Overall Study|Protocol Violation|1|||
44440056|NCT00737711|79448461|FG000|Overall Study|Withdrawal by Subject|5|||
44440057|NCT00737711|79448461|FG000|Overall Study|Blood transfusion|6|||
44440058|NCT00737711|79448461|FG000|Overall Study|Other|5|||
44440059|NCT00615108|79448465|FG000|Overall Study|Adverse Event|122|||
44440060|NCT00615108|79448465|FG000|Overall Study|Other|370|||
44340182|NCT01024036|79344543|FG000|Blinded Treatment|Lack of Efficacy|16|||
44340183|NCT01024036|79344544|FG001|Blinded Treatment|Lack of Efficacy|14|||
44340184|NCT01024036|79344543|FG000|Blinded Treatment|Physician Decision|1|||
44340185|NCT01024036|79344544|FG001|Blinded Treatment|Physician Decision|0|||
44340186|NCT01024036|79344543|FG000|Blinded Treatment|Death|0|||
44340187|NCT01024036|79344544|FG001|Blinded Treatment|Death|2|||
44340188|NCT01024036|79344543|FG000|Blinded Treatment|Withdrawal by Subject|4|||
44340189|NCT01024036|79344544|FG001|Blinded Treatment|Withdrawal by Subject|3|||
44340190|NCT01024036|79344543|FG000|Unblinded Treatment|Adverse Event|0|||
44340191|NCT01024036|79344544|FG001|Unblinded Treatment|Adverse Event|1|||
44340192|NCT01024036|79344543|FG000|Unblinded Treatment|Lack of Efficacy|0|||
44340193|NCT01024036|79344544|FG001|Unblinded Treatment|Lack of Efficacy|2|||
44340194|NCT01024036|79344543|FG000|Follow-Up Period|Lost to Follow-up|1|||
44340195|NCT01024036|79344544|FG001|Follow-Up Period|Lost to Follow-up|1|||
44340196|NCT01024036|79344543|FG000|Follow-Up Period|Withdrawal by Subject|0|||
44340197|NCT01024036|79344544|FG001|Follow-Up Period|Withdrawal by Subject|1|||
44340198|NCT01024036|79344543|FG000|Follow-Up Period|Adverse Event|4|||
44340199|NCT01024036|79344544|FG001|Follow-Up Period|Adverse Event|1|||
44340200|NCT01234467|79344553|FG000|Overall Study|Adverse Event|3|||
44340201|NCT01234467|79344553|FG000|Overall Study|Death|2|||
44340202|NCT01234467|79344553|FG000|Overall Study|Withdrawal by Subject|2|||
44340203|NCT01234467|79344553|FG000|Overall Study|Disease Progression|2|||
44340204|NCT01234467|79344553|FG000|Overall Study|Clinical deterioration|1|||
44158244|NCT01597193|78950272|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
44158245|NCT01597193|78950273|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
44158246|NCT01597193|78950274|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
44158247|NCT01597193|78950275|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
44158248|NCT01597193|78950276|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
44158249|NCT01597193|78950277|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
44158250|NCT01597193|78950278|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
44158251|NCT02649439|78950301|FG000|Overall Study|Switched to alternative treatment|6|||
44158252|NCT02649439|78950302|FG001|Overall Study|Switched to alternative treatment|4|||
44158253|NCT02649439|78950301|FG000|Overall Study|Patient decision|1|||
44158254|NCT02649439|78950302|FG001|Overall Study|Patient decision|0|||
44158255|NCT02649439|78950301|FG000|Overall Study|Patient going out of country|1|||
44158256|NCT02649439|78950302|FG001|Overall Study|Patient going out of country|0|||
44158257|NCT02649439|78950301|FG000|Overall Study|To start finasteride|1|||
44158258|NCT02649439|78950302|FG001|Overall Study|To start finasteride|0|||
44158259|NCT02649439|78950301|FG000|Overall Study|Physician Decision|1|||
44158260|NCT02649439|78950302|FG001|Overall Study|Physician Decision|0|||
44158261|NCT02649439|78950301|FG000|Overall Study|Disease progression on study|12|||
44158262|NCT02649439|78950302|FG001|Overall Study|Disease progression on study|13|||
44158263|NCT02649439|78950301|FG000|Overall Study|Refused further treatment|1|||
44158264|NCT02649439|78950302|FG001|Overall Study|Refused further treatment|0|||
44158265|NCT02649439|78950301|FG000|Overall Study|Refused further follow up|2|||
44158266|NCT02649439|78950302|FG001|Overall Study|Refused further follow up|7|||
44158267|NCT02649439|78950301|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
44158268|NCT02649439|78950302|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
44158269|NCT02649439|78950301|FG000|Overall Study|No treatment, per protocol|1|||
44158270|NCT02649439|78950302|FG001|Overall Study|No treatment, per protocol|0|||
44158271|NCT02649439|78950301|FG000|Overall Study|PSA DT makes ineligible|0|||
44158272|NCT02649439|78950302|FG001|Overall Study|PSA DT makes ineligible|1|||
44158273|NCT02649439|78950301|FG000|Overall Study|Rising PSA No Mets|0|||
44158274|NCT02649439|78950302|FG001|Overall Study|Rising PSA No Mets|1|||
44158275|NCT02649439|78950301|FG000|Overall Study|Rising PSA|0|||
44340205|NCT01234467|79344553|FG000|Overall Study|Physician Decision|1|||
44340206|NCT01234467|79344553|FG000|Overall Study|Other complicating disease (stroke)|1|||
44340207|NCT01233999|79344557|FG000|Overall Study|Withdrawal by Subject|1|||
44340208|NCT01233999|79344557|FG000|Overall Study|Lost to Follow-up|1|||
44340209|NCT01233687|79344561|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
44340210|NCT01233687|79344561|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
44340211|NCT01233687|79344561|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
44340212|NCT01023958|79344565|FG000|Overall Study|Progressive disease|48|||
44340213|NCT01023958|79344565|FG000|Overall Study|Other adverse event|1|||
44340214|NCT01023958|79344565|FG000|Overall Study|Refused to continue medication|1|||
44340215|NCT01233609|79344571|FG000|Overall Study|Death|1|||
44340216|NCT01233609|79344572|FG001|Overall Study|Death|0|||
44340217|NCT01233609|79344571|FG000|Overall Study|Lost to Follow-up|3|||
44340218|NCT01233609|79344572|FG001|Overall Study|Lost to Follow-up|1|||
44340219|NCT01233609|79344571|FG000|Overall Study|Adverse Event|2|||
44158276|NCT02649439|78950302|FG001|Overall Study|Rising PSA|1|||
44158277|NCT02649439|78950301|FG000|Overall Study|Signed follow up protocol|0|||
44158278|NCT02649439|78950302|FG001|Overall Study|Signed follow up protocol|1|||
44340220|NCT01233609|79344572|FG001|Overall Study|Adverse Event|1|||
44340221|NCT01233609|79344571|FG000|Overall Study|Withdrawal by Subject|3|||
44340222|NCT01233609|79344572|FG001|Overall Study|Withdrawal by Subject|0|||
44340223|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
44340224|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
44340225|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340226|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340227|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340228|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340229|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340230|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340231|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340232|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
44340233|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
44340234|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
44340235|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44340236|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44340237|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44340238|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44354765|NCT01186692|79359166|FG000|Overall Study|Not Catheterized|11|||
44158279|NCT02622113|78950317|FG000|Overall Study|Adverse Event|4|||
44158280|NCT02622113|78950318|FG001|Overall Study|Adverse Event|4|||
44158281|NCT02622113|78950317|FG000|Overall Study|Physician Decision|0|||
44158282|NCT02622113|78950318|FG001|Overall Study|Physician Decision|1|||
44158283|NCT02622113|78950317|FG000|Overall Study|Withdrawal by Subject|0|||
44158284|NCT02622113|78950318|FG001|Overall Study|Withdrawal by Subject|2|||
44158285|NCT02622113|78950317|FG000|Overall Study|Stopping Criteria|1|||
44158286|NCT02622113|78950318|FG001|Overall Study|Stopping Criteria|3|||
44158287|NCT02651467|78950327|FG000|Overall Study|Withdrawal by Subject|0|||
44158288|NCT02651467|78950328|FG001|Overall Study|Withdrawal by Subject|0|||
44158289|NCT02651467|78950329|FG002|Overall Study|Withdrawal by Subject|2|||
44158290|NCT02651467|78950327|FG000|Overall Study|Other (Not specified)|1|||
44158291|NCT02651467|78950328|FG001|Overall Study|Other (Not specified)|0|||
44158292|NCT02651467|78950329|FG002|Overall Study|Other (Not specified)|2|||
44158293|NCT02620787|78950358|FG000|Overall Study|Adverse Event|1|||
44158294|NCT02620787|78950359|FG001|Overall Study|Adverse Event|0|||
44158295|NCT02620787|78950358|FG000|Overall Study|Eligibility Criteria Not Met|1|||
44158296|NCT02620787|78950359|FG001|Overall Study|Eligibility Criteria Not Met|0|||
44158297|NCT02651155|78950367|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
44158298|NCT02651155|78950368|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
44158299|NCT02651155|78950367|FG000|Overall Study|Voluntary Withdrawal|5|||
44158300|NCT02651155|78950368|FG001|Overall Study|Voluntary Withdrawal|0|||
44158301|NCT02619617|78950374|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
44158302|NCT02619617|78950375|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
44158303|NCT02619617|78950374|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
44158304|NCT02619617|78950375|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
44158305|NCT02650921|78950396|FG000|Overall Study|Withdrawal by Subject|4|||
44158306|NCT02650921|78950396|FG000|Overall Study|Lost to Follow-up|2|||
44158307|NCT02650921|78950396|FG000|Overall Study|Adverse Event|1|||
44158308|NCT02650921|78950396|FG000|Overall Study|Due to Medical Condition|1|||
44158309|NCT01596335|78950404|FG000|Overall Study|exacerbation of primary disease|5|||
44158310|NCT01596335|78950405|FG001|Overall Study|exacerbation of primary disease|9|||
44158311|NCT02618759|78950413|FG000|Overall Study|Lost to Follow-up|0|||
44158312|NCT02618759|78950414|FG001|Overall Study|Lost to Follow-up|1|||
44158313|NCT02618759|78950413|FG000|Overall Study|Withdrawal by Subject|1|||
44158314|NCT02618759|78950414|FG001|Overall Study|Withdrawal by Subject|0|||
44158315|NCT02618759|78950413|FG000|Overall Study|Other Reasons|1|||
44158316|NCT02618759|78950414|FG001|Overall Study|Other Reasons|4|||
44158317|NCT02614079|78950429|FG000|Overall Study|Withdrawal by Subject|1|||
44158318|NCT02616029|78950435|FG000|Overall Study|Adverse Event|1|||
44158319|NCT02616029|78950436|FG001|Overall Study|Adverse Event|0|||
44158320|NCT02616029|78950435|FG000|Overall Study|Death|0|||
44158321|NCT02616029|78950436|FG001|Overall Study|Death|1|||
44158322|NCT02616029|78950435|FG000|Overall Study|Protocol Violation|1|||
44158323|NCT02616029|78950436|FG001|Overall Study|Protocol Violation|0|||
44340239|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44340240|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44340241|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44340242|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
44440061|NCT00615108|79448465|FG000|Overall Study|Lost to Follow-up|15|||
44158324|NCT02616029|78950435|FG000|Overall Study|Withdrew Consent|1|||
44158325|NCT02616029|78950436|FG001|Overall Study|Withdrew Consent|0|||
44158326|NCT02616029|78950435|FG000|Overall Study|Enrolled and Never Treated|1|||
44158327|NCT02616029|78950436|FG001|Overall Study|Enrolled and Never Treated|1|||
44158328|NCT02614859|78950444|FG000|Overall Study|Physician Decision|0|||
44158329|NCT02614859|78950445|FG001|Overall Study|Physician Decision|1|||
44158330|NCT02615249|78950453|FG000|Overall Study|Withdrawal by Subject|1|||
44158331|NCT02615171|78950460|FG000|Overall Study|Lost to Follow-up|2|||
44158332|NCT02615171|78950461|FG001|Overall Study|Lost to Follow-up|1|||
44158333|NCT02648347|78950469|FG000|Overall Study|Death|174|||
44158334|NCT02648347|78950470|FG001|Overall Study|Death|167|||
44158335|NCT02648347|78950469|FG000|Overall Study|Withdrawal by Subject|16|||
44158336|NCT02648347|78950470|FG001|Overall Study|Withdrawal by Subject|9|||
44158337|NCT02648347|78950469|FG000|Overall Study|Lost to Follow-up|18|||
44158338|NCT02648347|78950470|FG001|Overall Study|Lost to Follow-up|21|||
44158339|NCT02648347|78950469|FG000|Overall Study|Missing|1|||
44158340|NCT02648347|78950470|FG001|Overall Study|Missing|0|||
44158341|NCT02614703|78950478|FG000|Overall Study|Withdrawal by Subject|7|||
44158342|NCT02614703|78950479|FG001|Overall Study|Withdrawal by Subject|1|||
44158343|NCT01669343|78950485|FG000|Part A: All Patients|Withdrawal by Subject|7|||
44158344|NCT01669343|78950485|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
44158345|NCT01669343|78950485|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
44158346|NCT01669343|78950485|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
44158347|NCT01669343|78950485|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
44158348|NCT01594931|78950495|FG000|Overall Study|Adverse Event|3|||
44158349|NCT01594931|78950496|FG001|Overall Study|Adverse Event|1|||
44158350|NCT01594931|78950497|FG002|Overall Study|Adverse Event|1|||
44158351|NCT01594931|78950495|FG000|Overall Study|Withdrawal by Subject|2|||
44158352|NCT01594931|78950496|FG001|Overall Study|Withdrawal by Subject|1|||
44158353|NCT01594931|78950497|FG002|Overall Study|Withdrawal by Subject|1|||
44158354|NCT01594931|78950495|FG000|Overall Study|Lack of Efficacy|7|||
44158355|NCT01594931|78950496|FG001|Overall Study|Lack of Efficacy|2|||
44158356|NCT01594931|78950497|FG002|Overall Study|Lack of Efficacy|2|||
44158357|NCT01594931|78950495|FG000|Overall Study|Lost to Follow-up|4|||
44158358|NCT01594931|78950496|FG001|Overall Study|Lost to Follow-up|3|||
44158359|NCT01594931|78950497|FG002|Overall Study|Lost to Follow-up|3|||
44158360|NCT01594931|78950495|FG000|Overall Study|Protocol Violation|2|||
44158361|NCT01594931|78950496|FG001|Overall Study|Protocol Violation|1|||
44158362|NCT01594931|78950497|FG002|Overall Study|Protocol Violation|0|||
44158363|NCT01594931|78950495|FG000|Overall Study|No defiined|11|||
44158364|NCT01594931|78950496|FG001|Overall Study|No defiined|4|||
44158365|NCT01594931|78950497|FG002|Overall Study|No defiined|7|||
44158366|NCT01594853|78950507|FG000|Overall Study|Withdrawal by Subject|1|||
44158367|NCT01594853|78950508|FG001|Overall Study|Withdrawal by Subject|1|||
44158368|NCT01594853|78950507|FG000|Overall Study|Lost to Follow-up|1|||
44158369|NCT01594853|78950508|FG001|Overall Study|Lost to Follow-up|1|||
44158370|NCT01594853|78950507|FG000|Overall Study|noncompliance with exercise|0|||
44158371|NCT01594853|78950508|FG001|Overall Study|noncompliance with exercise|1|||
44158372|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
44158373|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
44158374|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
44158375|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
44158376|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
44158377|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
44158378|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
44158379|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
44158380|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
44158381|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
44158382|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
44158383|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
44158384|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
44158385|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
44158386|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
44158387|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
44158388|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
44158389|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
44158390|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
44158391|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
44158392|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
44158393|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
44158394|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
44158395|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
44158396|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
44158397|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
44158398|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
44158399|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
44158400|NCT01668797|78950525|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
44158401|NCT01668797|78950526|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
44158402|NCT01668797|78950527|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
44158403|NCT01668797|78950528|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
44158404|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
44158405|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
44158406|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
44158407|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
44158408|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
44158409|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
44158410|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
44158411|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
44158412|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
44158413|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
44158414|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
44158415|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
44158416|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
44158417|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
44158418|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
44158419|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
44158420|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
44158421|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
44158422|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
44158423|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
44158424|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
44158425|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
44158426|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
44158427|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
44158428|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
44158429|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
44158430|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
44158431|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
44158432|NCT01668797|78950525|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
44158433|NCT01668797|78950526|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
44158434|NCT01668797|78950527|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
44158435|NCT01668797|78950528|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
44158436|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
44158437|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
44158438|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
44158439|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
44158440|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
44158441|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
44158442|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
44158443|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
44158444|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
44340243|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
44340244|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44158445|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
44158446|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
44158447|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
44158448|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
44158449|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
44158450|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
44158451|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
44158452|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
44158453|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
44158454|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
44158455|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
44158456|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
44158457|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
44158458|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
44158459|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
44158460|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
44158461|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
44158462|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
44158463|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
44158464|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
44158465|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
44158466|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
44158467|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
44158468|NCT01668797|78950525|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
44158469|NCT01668797|78950526|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
44158470|NCT01668797|78950527|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
44158471|NCT01668797|78950528|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
44158472|NCT02613221|78950535|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
44158473|NCT02613221|78950535|FG000|Overall Study|Adverse Event|2|||
44158474|NCT02613221|78950535|FG000|Overall Study|Voluntary Discontinuation|1|||
44158475|NCT02613221|78950535|FG000|Overall Study|Delayed Treatment|1|||
44158476|NCT02613221|78950535|FG000|Overall Study|Enrolled but Not Treated|1|||
44158477|NCT01362049|78950543|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
44158478|NCT01362049|78950544|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
44158479|NCT01362049|78950545|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
44158480|NCT01362049|78950546|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
44158481|NCT01362049|78950543|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
44158482|NCT01362049|78950544|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
44158483|NCT01362049|78950545|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
44158484|NCT01362049|78950546|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
44158485|NCT02612909|78950578|FG000|Phase 2|Withdrawal by Subject|2|||
44158486|NCT02612909|78950579|FG001|Phase 2|Withdrawal by Subject|5|||
44158487|NCT02612909|78950580|FG002|Phase 2|Withdrawal by Subject|0|||
44158488|NCT02612909|78950581|FG003|Phase 2|Withdrawal by Subject|0|||
44158489|NCT02612909|78950582|FG004|Phase 2|Withdrawal by Subject|0|||
44158490|NCT02612909|78950578|FG000|Phase 2|Pregnancy|0|||
44158491|NCT02612909|78950579|FG001|Phase 2|Pregnancy|0|||
44158492|NCT02612909|78950580|FG002|Phase 2|Pregnancy|1|||
44158493|NCT02612909|78950581|FG003|Phase 2|Pregnancy|0|||
44158494|NCT02612909|78950582|FG004|Phase 2|Pregnancy|0|||
44158495|NCT02612909|78950578|FG000|Phase 3|Withdrawal by Subject|0|||
44158496|NCT02612909|78950579|FG001|Phase 3|Withdrawal by Subject|0|||
44158497|NCT02612909|78950580|FG002|Phase 3|Withdrawal by Subject|0|||
44158498|NCT02612909|78950581|FG003|Phase 3|Withdrawal by Subject|1|||
44158499|NCT02612909|78950582|FG004|Phase 3|Withdrawal by Subject|0|||
44158500|NCT02612285|78950596|FG000|Overall Study|Withdrawal by Subject|1|||
44158501|NCT02609633|78950602|FG000|Overall Study|Consent Withdrawn|0|||
44158502|NCT02609633|78950603|FG001|Overall Study|Consent Withdrawn|1|||
44158503|NCT02609633|78950602|FG000|Overall Study|Protocol Deviation|1|||
44158504|NCT02609633|78950603|FG001|Overall Study|Protocol Deviation|0|||
44158505|NCT02609633|78950602|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
44158506|NCT02609633|78950603|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
44158507|NCT02609633|78950602|FG000|Overall Study|Reason not Specified|2|||
44158508|NCT02609633|78950603|FG001|Overall Study|Reason not Specified|1|||
44158509|NCT01597375|78950625|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
44158510|NCT01597375|78950626|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
44158511|NCT01597375|78950625|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
44158512|NCT01597375|78950626|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
44158513|NCT01597375|78950625|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
44158514|NCT01597375|78950626|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
44158515|NCT01597375|78950625|FG000|Washout (2 Weeks)|Adverse Event|1|||
44158516|NCT01597375|78950626|FG001|Washout (2 Weeks)|Adverse Event|0|||
44158517|NCT01597375|78950625|FG000|Second Intervention|Failed to react at both Aspirin|1|||
44158518|NCT01597375|78950626|FG001|Second Intervention|Failed to react at both Aspirin|1|||
44158519|NCT02527161|78950633|FG000|Overall Study|Failed MRI|52|||
44158520|NCT02527161|78950633|FG000|Overall Study|Withdrawal by Subject|19|||
44158521|NCT02527161|78950633|FG000|Overall Study|Delay in or unfit for surgery|16|||
44158522|NCT02527161|78950633|FG000|Overall Study|MRI contraindication|6|||
44158523|NCT02527161|78950633|FG000|Overall Study|Consent violation|4|||
44158524|NCT02527161|78950633|FG000|Overall Study|Only Recruited to Part A|27|||
44158525|NCT02527161|78950633|FG000|Overall Study|Physician Decision|1|||
44158526|NCT02527161|78950633|FG000|Overall Study|Adverse Event|1|||
44158527|NCT02527161|78950633|FG000|Overall Study|Lost to Follow-up|6|||
44158528|NCT02609399|78950640|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
44158529|NCT02609399|78950641|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
44158530|NCT02609399|78950640|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
44158531|NCT02609399|78950641|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
44158532|NCT02609399|78950640|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
44158533|NCT02609399|78950641|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
44158534|NCT02720185|78950649|FG000|Overall Study|Lost to Follow-up|1|||
44158535|NCT02526693|78950672|FG000|Overall Study|Physician Decision|3|||
44158536|NCT02526693|78950673|FG001|Overall Study|Physician Decision|1|||
44158537|NCT02710669|78950691|FG000|Overall Study|Physician Decision|2|||
44158538|NCT02710669|78950692|FG001|Overall Study|Physician Decision|1|||
44158539|NCT02710669|78950693|FG002|Overall Study|Physician Decision|0|||
44158540|NCT02710669|78950691|FG000|Overall Study|Institutional delays (including COVID)|2|||
44158541|NCT02710669|78950692|FG001|Overall Study|Institutional delays (including COVID)|2|||
44158542|NCT02710669|78950693|FG002|Overall Study|Institutional delays (including COVID)|0|||
44158543|NCT02710669|78950691|FG000|Overall Study|arrived in afib/aflutter|10|||
44158544|NCT02710669|78950692|FG001|Overall Study|arrived in afib/aflutter|8|||
44158545|NCT02710669|78950693|FG002|Overall Study|arrived in afib/aflutter|2|||
44158546|NCT02610725|78950701|FG000|Overall Study|Lost to Follow-up|197|||
44158547|NCT02610725|78950701|FG000|Overall Study|self-reported contraindication|9|||
44158548|NCT02684461|78950708|FG000|Overall Study|Adverse Event|1|||
44158549|NCT02684461|78950709|FG001|Overall Study|Adverse Event|0|||
44158550|NCT02684461|78950710|FG002|Overall Study|Adverse Event|0|||
44158551|NCT02684461|78950708|FG000|Overall Study|Lack of Efficacy|1|||
44158552|NCT02684461|78950709|FG001|Overall Study|Lack of Efficacy|2|||
44158553|NCT02684461|78950710|FG002|Overall Study|Lack of Efficacy|0|||
44158554|NCT02647645|78950735|FG000|Overall Study|Lost to Follow-up|2|||
44158555|NCT02647645|78950736|FG001|Overall Study|Lost to Follow-up|1|||
44158556|NCT02531373|78950751|FG000|Overall Study|Lack of Efficacy|0|||
44158557|NCT02531373|78950752|FG001|Overall Study|Lack of Efficacy|0|||
44158558|NCT02531373|78950753|FG002|Overall Study|Lack of Efficacy|0|||
44158559|NCT02531373|78950754|FG003|Overall Study|Lack of Efficacy|0|||
44158560|NCT02531373|78950755|FG004|Overall Study|Lack of Efficacy|3|||
44158561|NCT02531373|78950756|FG005|Overall Study|Lack of Efficacy|2|||
44158562|NCT02531373|78950757|FG006|Overall Study|Lack of Efficacy|4|||
44158563|NCT02531373|78950758|FG007|Overall Study|Lack of Efficacy|8|||
44158564|NCT02531373|78950759|FG008|Overall Study|Lack of Efficacy|5|||
44158565|NCT02531373|78950751|FG000|Overall Study|Lost to Follow-up|0|||
44158566|NCT02531373|78950752|FG001|Overall Study|Lost to Follow-up|0|||
44158567|NCT02531373|78950753|FG002|Overall Study|Lost to Follow-up|0|||
44158568|NCT02531373|78950754|FG003|Overall Study|Lost to Follow-up|0|||
44158569|NCT02531373|78950755|FG004|Overall Study|Lost to Follow-up|0|||
44158570|NCT02531373|78950756|FG005|Overall Study|Lost to Follow-up|2|||
44158571|NCT02531373|78950757|FG006|Overall Study|Lost to Follow-up|2|||
44158572|NCT02531373|78950758|FG007|Overall Study|Lost to Follow-up|0|||
44158573|NCT02531373|78950759|FG008|Overall Study|Lost to Follow-up|0|||
44158574|NCT02531373|78950751|FG000|Overall Study|Physician Decision|0|||
44158575|NCT02531373|78950752|FG001|Overall Study|Physician Decision|0|||
44158576|NCT02531373|78950753|FG002|Overall Study|Physician Decision|0|||
44158577|NCT02531373|78950754|FG003|Overall Study|Physician Decision|0|||
44158578|NCT02531373|78950755|FG004|Overall Study|Physician Decision|2|||
44158579|NCT02531373|78950756|FG005|Overall Study|Physician Decision|1|||
44158580|NCT02531373|78950757|FG006|Overall Study|Physician Decision|0|||
44158581|NCT02531373|78950758|FG007|Overall Study|Physician Decision|0|||
44158582|NCT02531373|78950759|FG008|Overall Study|Physician Decision|0|||
44158583|NCT02531373|78950751|FG000|Overall Study|Protocol Violation|0|||
44158584|NCT02531373|78950752|FG001|Overall Study|Protocol Violation|0|||
44158585|NCT02531373|78950753|FG002|Overall Study|Protocol Violation|0|||
44158586|NCT02531373|78950754|FG003|Overall Study|Protocol Violation|0|||
44158587|NCT02531373|78950755|FG004|Overall Study|Protocol Violation|0|||
44158588|NCT02531373|78950756|FG005|Overall Study|Protocol Violation|1|||
44158589|NCT02531373|78950757|FG006|Overall Study|Protocol Violation|1|||
44158590|NCT02531373|78950758|FG007|Overall Study|Protocol Violation|0|||
44158591|NCT02531373|78950759|FG008|Overall Study|Protocol Violation|1|||
44158592|NCT02531373|78950751|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44158593|NCT02531373|78950752|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
44158594|NCT02531373|78950753|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
44158595|NCT02531373|78950754|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
44158596|NCT02531373|78950755|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
44158597|NCT02531373|78950756|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
44158598|NCT02531373|78950757|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
44158599|NCT02531373|78950758|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
44158600|NCT02531373|78950759|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
44158601|NCT02531373|78950751|FG000|Overall Study|Withdrawal by Subject|0|||
44158602|NCT02531373|78950752|FG001|Overall Study|Withdrawal by Subject|0|||
44158603|NCT02531373|78950753|FG002|Overall Study|Withdrawal by Subject|0|||
44158604|NCT02531373|78950754|FG003|Overall Study|Withdrawal by Subject|0|||
44158605|NCT02531373|78950755|FG004|Overall Study|Withdrawal by Subject|3|||
44158606|NCT02531373|78950756|FG005|Overall Study|Withdrawal by Subject|0|||
44158607|NCT02531373|78950757|FG006|Overall Study|Withdrawal by Subject|0|||
44158608|NCT02531373|78950758|FG007|Overall Study|Withdrawal by Subject|0|||
44158609|NCT02531373|78950759|FG008|Overall Study|Withdrawal by Subject|0|||
44158610|NCT02606279|78950782|FG000|Overall Study|Lost to Follow-up|0|||
44158611|NCT02606279|78950783|FG001|Overall Study|Lost to Follow-up|1|||
44158612|NCT02643355|78950797|FG000|Overall Study|Withdrawal by Subject|1|||
44158613|NCT02643355|78950798|FG001|Overall Study|Withdrawal by Subject|3|||
44158614|NCT02643355|78950797|FG000|Overall Study|Protocol Violation|0|||
44158615|NCT02643355|78950798|FG001|Overall Study|Protocol Violation|2|||
44158616|NCT02604017|78950806|FG000|Overall Study|Withdrew Consent|0|||
44158617|NCT02604017|78950807|FG001|Overall Study|Withdrew Consent|2|||
44158618|NCT02604017|78950806|FG000|Overall Study|Lost to Follow-up|5|||
44158619|NCT02604017|78950807|FG001|Overall Study|Lost to Follow-up|6|||
44158620|NCT02604017|78950806|FG000|Overall Study|Other|1|||
44158621|NCT02604017|78950807|FG001|Overall Study|Other|0|||
44158622|NCT02640547|78950813|FG000|Overall Study|Failure to Return|1|||
44158623|NCT02640547|78950813|FG000|Overall Study|Withdrawal by Subject|1|||
44158624|NCT02640547|78950813|FG000|Overall Study|Death|6|||
44158625|NCT02640547|78950813|FG000|Overall Study|Miscellaneous|3|||
44158626|NCT02530905|78950827|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
44158627|NCT02530905|78950828|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
44158628|NCT02530905|78950829|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
44158629|NCT02530671|78950853|FG000|Overall Study|Lost to Follow-up|2|||
44158630|NCT02530671|78950854|FG001|Overall Study|Lost to Follow-up|0|||
44158631|NCT02530671|78950853|FG000|Overall Study|Withdrawal by Subject|1|||
44158632|NCT02530671|78950854|FG001|Overall Study|Withdrawal by Subject|0|||
44158633|NCT02603393|78950862|FG000|Overall Study|Patient/guardian decision|32|||
44158634|NCT02603393|78950863|FG001|Overall Study|Patient/guardian decision|18|||
44158635|NCT02603393|78950862|FG000|Overall Study|Adverse Event|17|||
44158636|NCT02603393|78950863|FG001|Overall Study|Adverse Event|15|||
44158637|NCT02603393|78950862|FG000|Overall Study|Technical problems|4|||
44158638|NCT02603393|78950863|FG001|Overall Study|Technical problems|7|||
44158639|NCT02603393|78950862|FG000|Overall Study|Lack of Efficacy|7|||
44158640|NCT02603393|78950863|FG001|Overall Study|Lack of Efficacy|2|||
44158641|NCT02603393|78950862|FG000|Overall Study|Death|3|||
44158642|NCT02603393|78950863|FG001|Overall Study|Death|4|||
44158643|NCT02603393|78950862|FG000|Overall Study|Physician Decision|3|||
44158644|NCT02603393|78950863|FG001|Overall Study|Physician Decision|3|||
44158645|NCT02603393|78950862|FG000|Overall Study|Protocol deviation|2|||
44158646|NCT02603393|78950863|FG001|Overall Study|Protocol deviation|3|||
44158647|NCT02603393|78950862|FG000|Overall Study|Lost to Follow-up|1|||
44158648|NCT02603393|78950863|FG001|Overall Study|Lost to Follow-up|2|||
44158649|NCT02603393|78950862|FG000|Overall Study|Non-compliance with study treatment|1|||
44158650|NCT02603393|78950863|FG001|Overall Study|Non-compliance with study treatment|0|||
44158651|NCT02603393|78950862|FG000|Overall Study|Sponsor decision|1|||
44158652|NCT02603393|78950863|FG001|Overall Study|Sponsor decision|0|||
44158653|NCT02642653|78950871|FG000|Overall Study|Adverse Event|2|||
44158654|NCT02642653|78950872|FG001|Overall Study|Adverse Event|0|||
44158655|NCT01659567|78950878|FG000|Overall Study|Lack of Efficacy|22|||
44158656|NCT01659567|78950878|FG000|Overall Study|Switched to Pegferon|6|||
44158657|NCT01659567|78950878|FG000|Overall Study|Adverse Event|12|||
44158658|NCT01659567|78950878|FG000|Overall Study|Good result at early stage of treatment|5|||
44158659|NCT01659567|78950878|FG000|Overall Study|Withdrawal by Subject|64|||
44158660|NCT01659567|78950878|FG000|Overall Study|Progression of the main disease|1|||
44158661|NCT01659567|78950878|FG000|Overall Study|Other|13|||
44158662|NCT02605967|78950894|FG000|Overall Study|subject / guardian decision|1|||
44158663|NCT02605967|78950895|FG001|Overall Study|subject / guardian decision|2|||
44158664|NCT02605967|78950894|FG000|Overall Study|Physician Decision|10|||
44158665|NCT02605967|78950895|FG001|Overall Study|Physician Decision|1|||
44158666|NCT02605967|78950894|FG000|Overall Study|Death|4|||
44158667|NCT02605967|78950895|FG001|Overall Study|Death|2|||
44158668|NCT02605967|78950894|FG000|Overall Study|Adverse Event|1|||
44158669|NCT02605967|78950895|FG001|Overall Study|Adverse Event|0|||
44158670|NCT02605967|78950894|FG000|Overall Study|progressive disease|66|||
44158671|NCT02605967|78950895|FG001|Overall Study|progressive disease|35|||
44158672|NCT01668173|78950905|FG000|Overall Study|Adverse Event|3|||
44158673|NCT01668173|78950905|FG000|Overall Study|Trial suspension|4|||
44158674|NCT02600351|78950922|FG000|Overall Study|Lack of Efficacy|3|||
44158675|NCT02600351|78950923|FG001|Overall Study|Lack of Efficacy|0|||
44158676|NCT02600351|78950924|FG002|Overall Study|Lack of Efficacy|5|||
44158677|NCT02600351|78950925|FG003|Overall Study|Lack of Efficacy|2|||
44158678|NCT02600351|78950922|FG000|Overall Study|Lost to Follow-up|1|||
44158679|NCT02600351|78950923|FG001|Overall Study|Lost to Follow-up|0|||
44158680|NCT02600351|78950924|FG002|Overall Study|Lost to Follow-up|0|||
44158681|NCT02600351|78950925|FG003|Overall Study|Lost to Follow-up|0|||
44158682|NCT02600351|78950922|FG000|Overall Study|Randomized but Not Treated|1|||
44158683|NCT02600351|78950923|FG001|Overall Study|Randomized but Not Treated|0|||
44158684|NCT02600351|78950924|FG002|Overall Study|Randomized but Not Treated|1|||
44158685|NCT02600351|78950925|FG003|Overall Study|Randomized but Not Treated|3|||
44158686|NCT02640235|78950939|FG000|Overall Study|Withdrawal by Subject|7|||
44158687|NCT02640235|78950940|FG001|Overall Study|Withdrawal by Subject|6|||
44158688|NCT02640235|78950939|FG000|Overall Study|Lost to Follow-up|4|||
44158689|NCT02640235|78950940|FG001|Overall Study|Lost to Follow-up|3|||
44158690|NCT02640235|78950939|FG000|Overall Study|Death|2|||
44158691|NCT02640235|78950940|FG001|Overall Study|Death|3|||
44158692|NCT02640235|78950939|FG000|Overall Study|Other|1|||
44158693|NCT02640235|78950940|FG001|Overall Study|Other|2|||
44158694|NCT02599961|78950946|FG000|Overall Study|Withdrawal by Subject|1|||
44158695|NCT02599961|78950946|FG000|Overall Study|Subject Non-Compliance|2|||
44158696|NCT02599961|78950946|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
44158697|NCT02599961|78950946|FG000|Overall Study|Other, Not Specified|3|||
44158698|NCT02640157|78950971|FG000|Overall Study|Adverse Event|2|||
44158699|NCT02640157|78950972|FG001|Overall Study|Adverse Event|2|||
44158700|NCT02640157|78950973|FG002|Overall Study|Adverse Event|1|||
44158701|NCT02640157|78950971|FG000|Overall Study|Withdrew consent|2|||
44158702|NCT02640157|78950972|FG001|Overall Study|Withdrew consent|0|||
44158703|NCT02640157|78950973|FG002|Overall Study|Withdrew consent|2|||
44158704|NCT02640157|78950971|FG000|Overall Study|Lost to Follow-up|9|||
44158705|NCT02640157|78950972|FG001|Overall Study|Lost to Follow-up|2|||
44158706|NCT02640157|78950973|FG002|Overall Study|Lost to Follow-up|7|||
44158707|NCT02640157|78950971|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
44158708|NCT02640157|78950972|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
44158709|NCT02640157|78950973|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
44158710|NCT01673347|78950982|FG000|Overall Study|failure of allograft|7|||
44158711|NCT02528253|78950991|FG000|Overall Study|Adverse Event|3|||
44158712|NCT02528253|78950992|FG001|Overall Study|Adverse Event|4|||
44158713|NCT02528253|78950993|FG002|Overall Study|Adverse Event|4|||
44158714|NCT02528253|78950994|FG003|Overall Study|Adverse Event|8|||
44158715|NCT02528253|78950995|FG004|Overall Study|Adverse Event|18|||
44158716|NCT02528253|78950991|FG000|Overall Study|Death|2|||
44158717|NCT02528253|78950992|FG001|Overall Study|Death|2|||
44158718|NCT02528253|78950993|FG002|Overall Study|Death|1|||
44158719|NCT02528253|78950994|FG003|Overall Study|Death|0|||
44158720|NCT02528253|78950995|FG004|Overall Study|Death|1|||
44158721|NCT02528253|78950991|FG000|Overall Study|Insufficient clinical response|7|||
44158722|NCT02528253|78950992|FG001|Overall Study|Insufficient clinical response|10|||
44158723|NCT02528253|78950993|FG002|Overall Study|Insufficient clinical response|13|||
44158724|NCT02528253|78950994|FG003|Overall Study|Insufficient clinical response|12|||
44158725|NCT02528253|78950995|FG004|Overall Study|Insufficient clinical response|16|||
44158726|NCT02528253|78950991|FG000|Overall Study|Lost to Follow-up|16|||
44158727|NCT02528253|78950992|FG001|Overall Study|Lost to Follow-up|9|||
44158728|NCT02528253|78950993|FG002|Overall Study|Lost to Follow-up|31|||
44158729|NCT02528253|78950994|FG003|Overall Study|Lost to Follow-up|16|||
44158730|NCT02528253|78950995|FG004|Overall Study|Lost to Follow-up|34|||
44158731|NCT02528253|78950991|FG000|Overall Study|Other|21|||
44158732|NCT02528253|78950992|FG001|Overall Study|Other|22|||
44158733|NCT02528253|78950993|FG002|Overall Study|Other|58|||
44158734|NCT02528253|78950994|FG003|Overall Study|Other|52|||
44158735|NCT02528253|78950995|FG004|Overall Study|Other|76|||
44158736|NCT02528253|78950991|FG000|Overall Study|Withdrawal by Subject|25|||
44158737|NCT02528253|78950992|FG001|Overall Study|Withdrawal by Subject|20|||
44158738|NCT02528253|78950993|FG002|Overall Study|Withdrawal by Subject|29|||
44158739|NCT02528253|78950994|FG003|Overall Study|Withdrawal by Subject|48|||
44158740|NCT02528253|78950995|FG004|Overall Study|Withdrawal by Subject|73|||
44158741|NCT02528253|78950991|FG000|Overall Study|Protocol Violation|1|||
44158742|NCT02528253|78950992|FG001|Overall Study|Protocol Violation|2|||
44158743|NCT02528253|78950993|FG002|Overall Study|Protocol Violation|4|||
44158744|NCT02528253|78950994|FG003|Overall Study|Protocol Violation|0|||
44340245|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340246|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340247|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340248|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340249|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340250|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340251|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340252|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
44340253|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
44340254|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
44340255|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340256|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340257|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340258|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340259|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340260|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340261|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340262|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
44340263|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
44158745|NCT02528253|78950995|FG004|Overall Study|Protocol Violation|4|||
44158746|NCT02528253|78950991|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
44158747|NCT02528253|78950992|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
44158748|NCT02528253|78950993|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
44158749|NCT02528253|78950994|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
44158750|NCT02528253|78950995|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
44158751|NCT01672957|78951026|FG000|Overall Study|Protocol Violation|48|||
44158752|NCT01672957|78951026|FG000|Overall Study|Death|2|||
44158753|NCT01672957|78951026|FG000|Overall Study|ICF Signed After Transplantation|5|||
44158754|NCT02525133|78951032|FG000|Overall Study|Adverse Event|0|||
44158755|NCT02525133|78951033|FG001|Overall Study|Adverse Event|1|||
44158756|NCT02525133|78951032|FG000|Overall Study|Death|0|||
44158757|NCT02525133|78951033|FG001|Overall Study|Death|1|||
44158758|NCT02525133|78951032|FG000|Overall Study|did not meet randomization criteria|1|||
44158759|NCT02525133|78951033|FG001|Overall Study|did not meet randomization criteria|0|||
44158760|NCT02525133|78951032|FG000|Overall Study|Lost to Follow-up|5|||
44158761|NCT02525133|78951033|FG001|Overall Study|Lost to Follow-up|1|||
44158762|NCT02525133|78951032|FG000|Overall Study|randomized not enrolled|3|||
44158763|NCT02525133|78951033|FG001|Overall Study|randomized not enrolled|0|||
44158764|NCT02525133|78951032|FG000|Overall Study|Withdrawal by Subject|1|||
44158765|NCT02525133|78951033|FG001|Overall Study|Withdrawal by Subject|0|||
44158766|NCT01659255|78951060|FG000|Overall Study|Adverse Event|0|||
44158767|NCT01659255|78951061|FG001|Overall Study|Adverse Event|0|||
44158768|NCT01659255|78951062|FG002|Overall Study|Adverse Event|0|||
44158769|NCT01659255|78951063|FG003|Overall Study|Adverse Event|0|||
44158770|NCT01659255|78951064|FG004|Overall Study|Adverse Event|0|||
44158771|NCT01659255|78951065|FG005|Overall Study|Adverse Event|1|||
44158772|NCT01659255|78951066|FG006|Overall Study|Adverse Event|1|||
44158773|NCT01659255|78951067|FG007|Overall Study|Adverse Event|0|||
44158774|NCT01659255|78951068|FG008|Overall Study|Adverse Event|0|||
44158775|NCT01659255|78951069|FG009|Overall Study|Adverse Event|1|||
44158776|NCT01659255|78951070|FG010|Overall Study|Adverse Event|0|||
44158777|NCT01659255|78951071|FG011|Overall Study|Adverse Event|1|||
44158778|NCT01659255|78951072|FG012|Overall Study|Adverse Event|0|||
44158779|NCT01659255|78951073|FG013|Overall Study|Adverse Event|2|||
44158780|NCT01659255|78951074|FG014|Overall Study|Adverse Event|0|||
44158781|NCT01659255|78951075|FG015|Overall Study|Adverse Event|1|||
44158782|NCT01659255|78951076|FG016|Overall Study|Adverse Event|0|||
44158783|NCT01659255|78951060|FG000|Overall Study|Death|0|||
44158784|NCT01659255|78951061|FG001|Overall Study|Death|1|||
44158785|NCT01659255|78951062|FG002|Overall Study|Death|0|||
44158786|NCT01659255|78951063|FG003|Overall Study|Death|0|||
44158787|NCT01659255|78951064|FG004|Overall Study|Death|0|||
44158788|NCT01659255|78951065|FG005|Overall Study|Death|0|||
44158789|NCT01659255|78951066|FG006|Overall Study|Death|0|||
44158790|NCT01659255|78951067|FG007|Overall Study|Death|1|||
44158791|NCT01659255|78951068|FG008|Overall Study|Death|1|||
44158792|NCT01659255|78951069|FG009|Overall Study|Death|0|||
44158793|NCT01659255|78951070|FG010|Overall Study|Death|0|||
44158794|NCT01659255|78951071|FG011|Overall Study|Death|0|||
44158795|NCT01659255|78951072|FG012|Overall Study|Death|1|||
44158796|NCT01659255|78951073|FG013|Overall Study|Death|1|||
44158797|NCT01659255|78951074|FG014|Overall Study|Death|2|||
44158798|NCT01659255|78951075|FG015|Overall Study|Death|1|||
44158799|NCT01659255|78951076|FG016|Overall Study|Death|0|||
44158800|NCT01659255|78951060|FG000|Overall Study|Progressive Disease|2|||
44158801|NCT01659255|78951061|FG001|Overall Study|Progressive Disease|0|||
44158802|NCT01659255|78951062|FG002|Overall Study|Progressive Disease|0|||
44158803|NCT01659255|78951063|FG003|Overall Study|Progressive Disease|0|||
44158804|NCT01659255|78951064|FG004|Overall Study|Progressive Disease|0|||
44158805|NCT01659255|78951065|FG005|Overall Study|Progressive Disease|0|||
44158806|NCT01659255|78951066|FG006|Overall Study|Progressive Disease|0|||
44340264|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
44340265|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44340266|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44158807|NCT01659255|78951067|FG007|Overall Study|Progressive Disease|1|||
44340267|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44340268|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44158808|NCT01659255|78951068|FG008|Overall Study|Progressive Disease|0|||
44158809|NCT01659255|78951069|FG009|Overall Study|Progressive Disease|2|||
44158810|NCT01659255|78951070|FG010|Overall Study|Progressive Disease|2|||
44158811|NCT01659255|78951071|FG011|Overall Study|Progressive Disease|3|||
44158812|NCT01659255|78951072|FG012|Overall Study|Progressive Disease|5|||
44158813|NCT01659255|78951073|FG013|Overall Study|Progressive Disease|13|||
44158814|NCT01659255|78951074|FG014|Overall Study|Progressive Disease|6|||
44158815|NCT01659255|78951075|FG015|Overall Study|Progressive Disease|2|||
44158816|NCT01659255|78951076|FG016|Overall Study|Progressive Disease|3|||
44158817|NCT01659255|78951060|FG000|Overall Study|Withdrew Consent|0|||
44158818|NCT01659255|78951061|FG001|Overall Study|Withdrew Consent|0|||
44158819|NCT01659255|78951062|FG002|Overall Study|Withdrew Consent|0|||
44158820|NCT01659255|78951063|FG003|Overall Study|Withdrew Consent|0|||
44158821|NCT01659255|78951064|FG004|Overall Study|Withdrew Consent|0|||
44158822|NCT01659255|78951065|FG005|Overall Study|Withdrew Consent|0|||
44158823|NCT01659255|78951066|FG006|Overall Study|Withdrew Consent|0|||
44158824|NCT01659255|78951067|FG007|Overall Study|Withdrew Consent|0|||
44158825|NCT01659255|78951068|FG008|Overall Study|Withdrew Consent|0|||
44158826|NCT01659255|78951069|FG009|Overall Study|Withdrew Consent|0|||
44158827|NCT01659255|78951070|FG010|Overall Study|Withdrew Consent|1|||
44158828|NCT01659255|78951071|FG011|Overall Study|Withdrew Consent|0|||
44158829|NCT01659255|78951072|FG012|Overall Study|Withdrew Consent|0|||
44158830|NCT01659255|78951073|FG013|Overall Study|Withdrew Consent|1|||
44158831|NCT01659255|78951074|FG014|Overall Study|Withdrew Consent|0|||
44158832|NCT01659255|78951075|FG015|Overall Study|Withdrew Consent|0|||
44158833|NCT01659255|78951076|FG016|Overall Study|Withdrew Consent|0|||
44158834|NCT01659255|78951060|FG000|Overall Study|Investigator Decision|0|||
44158835|NCT01659255|78951061|FG001|Overall Study|Investigator Decision|0|||
44158836|NCT01659255|78951062|FG002|Overall Study|Investigator Decision|0|||
44158837|NCT01659255|78951063|FG003|Overall Study|Investigator Decision|0|||
44158838|NCT01659255|78951064|FG004|Overall Study|Investigator Decision|0|||
44158839|NCT01659255|78951065|FG005|Overall Study|Investigator Decision|0|||
44158840|NCT01659255|78951066|FG006|Overall Study|Investigator Decision|0|||
44158841|NCT01659255|78951067|FG007|Overall Study|Investigator Decision|0|||
44158842|NCT01659255|78951068|FG008|Overall Study|Investigator Decision|0|||
44158843|NCT01659255|78951069|FG009|Overall Study|Investigator Decision|0|||
44158844|NCT01659255|78951070|FG010|Overall Study|Investigator Decision|0|||
44158845|NCT01659255|78951071|FG011|Overall Study|Investigator Decision|0|||
44158846|NCT01659255|78951072|FG012|Overall Study|Investigator Decision|1|||
44158847|NCT01659255|78951073|FG013|Overall Study|Investigator Decision|1|||
44158848|NCT01659255|78951074|FG014|Overall Study|Investigator Decision|0|||
44158849|NCT01659255|78951075|FG015|Overall Study|Investigator Decision|0|||
44158850|NCT01659255|78951076|FG016|Overall Study|Investigator Decision|0|||
44158851|NCT01659255|78951060|FG000|Overall Study|Sponsor's Decision|0|||
44158852|NCT01659255|78951061|FG001|Overall Study|Sponsor's Decision|0|||
44158853|NCT01659255|78951062|FG002|Overall Study|Sponsor's Decision|0|||
44158854|NCT01659255|78951063|FG003|Overall Study|Sponsor's Decision|0|||
44158855|NCT01659255|78951064|FG004|Overall Study|Sponsor's Decision|0|||
44158856|NCT01659255|78951065|FG005|Overall Study|Sponsor's Decision|0|||
44158857|NCT01659255|78951066|FG006|Overall Study|Sponsor's Decision|1|||
44158858|NCT01659255|78951067|FG007|Overall Study|Sponsor's Decision|0|||
44158859|NCT01659255|78951068|FG008|Overall Study|Sponsor's Decision|0|||
44158860|NCT01659255|78951069|FG009|Overall Study|Sponsor's Decision|0|||
44158861|NCT01659255|78951070|FG010|Overall Study|Sponsor's Decision|0|||
44158862|NCT01659255|78951071|FG011|Overall Study|Sponsor's Decision|0|||
44158863|NCT01659255|78951072|FG012|Overall Study|Sponsor's Decision|0|||
44158864|NCT01659255|78951073|FG013|Overall Study|Sponsor's Decision|0|||
44158865|NCT01659255|78951074|FG014|Overall Study|Sponsor's Decision|0|||
44158866|NCT01659255|78951075|FG015|Overall Study|Sponsor's Decision|0|||
44158867|NCT01659255|78951076|FG016|Overall Study|Sponsor's Decision|0|||
44158868|NCT01659255|78951060|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158869|NCT01659255|78951061|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158870|NCT01659255|78951062|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158871|NCT01659255|78951063|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158872|NCT01659255|78951064|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158873|NCT01659255|78951065|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158874|NCT01659255|78951066|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158875|NCT01659255|78951067|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158876|NCT01659255|78951068|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158877|NCT01659255|78951069|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158878|NCT01659255|78951070|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158879|NCT01659255|78951071|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158880|NCT01659255|78951072|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158881|NCT01659255|78951073|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158882|NCT01659255|78951074|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158883|NCT01659255|78951075|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
44158884|NCT01659255|78951076|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
44158885|NCT01659255|78951060|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
44158886|NCT01659255|78951061|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
44158887|NCT01659255|78951062|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
44158888|NCT01659255|78951063|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
44158889|NCT01659255|78951064|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
44158890|NCT01659255|78951065|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
44158891|NCT01659255|78951066|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
44158892|NCT01659255|78951067|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
44158893|NCT01659255|78951068|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
44158894|NCT01659255|78951069|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
44158895|NCT01659255|78951070|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
44158896|NCT01659255|78951071|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
44158897|NCT01659255|78951072|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
44158898|NCT01659255|78951073|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
44158899|NCT01659255|78951074|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
44158900|NCT01659255|78951075|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
44158901|NCT01659255|78951076|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
44158902|NCT02637037|78951116|FG000|Overall Study|Positive drug screen at admission|1|||
44158903|NCT02637037|78951117|FG001|Overall Study|Positive drug screen at admission|0|||
44158904|NCT02637037|78951116|FG000|Overall Study|Withdrawal by Subject|2|||
44158905|NCT02637037|78951117|FG001|Overall Study|Withdrawal by Subject|1|||
44158906|NCT02637037|78951116|FG000|Overall Study|Adverse Event|1|||
44158907|NCT02637037|78951117|FG001|Overall Study|Adverse Event|0|||
44158908|NCT02637895|78951137|FG000|Overall Study|Lost to Follow-up|4|||
44158909|NCT02637895|78951138|FG001|Overall Study|Lost to Follow-up|0|||
44158910|NCT02637895|78951137|FG000|Overall Study|Protocol Violation|0|||
44158911|NCT02637895|78951138|FG001|Overall Study|Protocol Violation|1|||
44158912|NCT02637895|78951137|FG000|Overall Study|Lack of Efficacy|1|||
44158913|NCT02637895|78951138|FG001|Overall Study|Lack of Efficacy|0|||
44158914|NCT02637895|78951137|FG000|Overall Study|Withdrawal by Subject|1|||
44158915|NCT02637895|78951138|FG001|Overall Study|Withdrawal by Subject|1|||
44158916|NCT02637895|78951137|FG000|Overall Study|Abnormal baseline lab|0|||
44158917|NCT02637895|78951138|FG001|Overall Study|Abnormal baseline lab|1|||
44158918|NCT02522481|78951145|FG000|Overall Study|discontinued|1|||
44158919|NCT02522481|78951145|FG000|Overall Study|Not dosed|2|||
44158920|NCT02522403|78951158|FG000|Overall Study|Lost to Follow-up|2|||
44158921|NCT02522403|78951159|FG001|Overall Study|Lost to Follow-up|2|||
44158922|NCT02522403|78951158|FG000|Overall Study|Withdrawal by Subject|2|||
44158923|NCT02522403|78951159|FG001|Overall Study|Withdrawal by Subject|4|||
44158924|NCT02522325|78951165|FG000|Overall Study|Adverse Event|0|||
44158925|NCT02522325|78951166|FG001|Overall Study|Adverse Event|1|||
44158926|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
44158927|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
44158928|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
44158929|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
44158930|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
44158931|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
44158932|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
44158933|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
44158934|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
44158935|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
44158936|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
44158937|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
44158938|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
44158939|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
44158940|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
44158941|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
44158942|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
44158943|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
44158944|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
44158945|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
44158946|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
44158947|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
44158948|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
44158949|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
44158950|NCT01672879|78951175|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
44158951|NCT01672879|78951176|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
44158952|NCT01672879|78951177|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
44158953|NCT01672879|78951175|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
44158954|NCT01672879|78951176|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
44158955|NCT01672879|78951177|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
44158956|NCT01672879|78951175|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
44158957|NCT01672879|78951176|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
44158958|NCT01672879|78951177|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
44158959|NCT01672879|78951175|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
44158960|NCT01672879|78951176|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
44158961|NCT01672879|78951177|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
44158962|NCT01672879|78951175|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
44158963|NCT01672879|78951176|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
44158964|NCT01672879|78951177|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
44158965|NCT02601209|78951193|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
44158966|NCT02601209|78951194|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
44158967|NCT02601209|78951195|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
44158968|NCT02601209|78951196|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
44158969|NCT02601209|78951197|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
44158970|NCT02601209|78951198|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
44158971|NCT02601209|78951199|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
44158972|NCT02601209|78951200|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
44158973|NCT02601209|78951201|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
44158974|NCT02601209|78951193|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
44158975|NCT02601209|78951194|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
44158976|NCT02601209|78951195|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
44158977|NCT02601209|78951196|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
44158978|NCT02601209|78951197|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
44158979|NCT02601209|78951198|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
44158980|NCT02601209|78951199|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
44158981|NCT02601209|78951200|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
44158982|NCT02601209|78951201|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
44158983|NCT01659021|78951217|FG000|Main Study|Adverse Event|2|||
44158984|NCT01659021|78951218|FG001|Main Study|Adverse Event|3|||
44158985|NCT01659021|78951217|FG000|Main Study|Lost to Follow-up|1|||
44158986|NCT01659021|78951218|FG001|Main Study|Lost to Follow-up|0|||
44158987|NCT01659021|78951217|FG000|Main Study|Unknown Reasons|2|||
44158988|NCT01659021|78951218|FG001|Main Study|Unknown Reasons|1|||
44158989|NCT01659021|78951217|FG000|Main Study|Physician Decision|34|||
44158990|NCT01659021|78951218|FG001|Main Study|Physician Decision|16|||
44158991|NCT01659021|78951217|FG000|Main Study|Withdrawal by Subject|19|||
44158992|NCT01659021|78951218|FG001|Main Study|Withdrawal by Subject|16|||
44158993|NCT01659021|78951217|FG000|Main Study|Study Terminated by Sponsor|16|||
44158994|NCT01659021|78951218|FG001|Main Study|Study Terminated by Sponsor|1|||
44158995|NCT01659021|78951217|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
44158996|NCT01659021|78951218|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
44158997|NCT01659021|78951217|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
44158998|NCT01659021|78951218|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
44158999|NCT04654468|78951258|FG000|Overall Study|Death|1|||
44159000|NCT04654468|78951258|FG000|Overall Study|Ongoing in the Study|50|||
44159001|NCT04478266|78951264|FG000|Overall Study|Adverse Event|20|||
44159002|NCT04478266|78951265|FG001|Overall Study|Adverse Event|21|||
44159003|NCT04478266|78951264|FG000|Overall Study|Progressive disease|146|||
44159004|NCT04478266|78951265|FG001|Overall Study|Progressive disease|168|||
44159005|NCT04478266|78951264|FG000|Overall Study|Poor compliance to protocol|1|||
44159006|NCT04478266|78951265|FG001|Overall Study|Poor compliance to protocol|0|||
44159007|NCT04478266|78951264|FG000|Overall Study|Withdrawal by Subject|19|||
44159008|NCT04478266|78951265|FG001|Overall Study|Withdrawal by Subject|16|||
44159009|NCT04478266|78951264|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
44159010|NCT04478266|78951265|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
44159011|NCT04478266|78951264|FG000|Overall Study|Study terminated by sponsor|33|||
44159012|NCT04478266|78951265|FG001|Overall Study|Study terminated by sponsor|35|||
44159013|NCT04478266|78951264|FG000|Overall Study|Other: unspecified|5|||
44159014|NCT04478266|78951265|FG001|Overall Study|Other: unspecified|7|||
44159015|NCT04478266|78951264|FG000|Overall Study|Randomized but not treated|1|||
44159016|NCT04478266|78951265|FG001|Overall Study|Randomized but not treated|1|||
44340269|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44159017|NCT04233216|78951277|FG000|Overall Study|Lost to Follow-up|0|||
44159018|NCT04233216|78951278|FG001|Overall Study|Lost to Follow-up|0|||
44259636|NCT00246259|79121339|FG001|Overall Study|Participant non-compliant|9|||
44259637|NCT00246259|79121338|FG000|Overall Study|Lack of Efficacy|2|||
44259638|NCT00246259|79121339|FG001|Overall Study|Lack of Efficacy|2|||
44159019|NCT04233216|78951279|FG002|Overall Study|Lost to Follow-up|2|||
44159020|NCT04233216|78951280|FG003|Overall Study|Lost to Follow-up|0|||
44159021|NCT04233216|78951277|FG000|Overall Study|Physician Decision|0|||
44159022|NCT04233216|78951278|FG001|Overall Study|Physician Decision|1|||
44159023|NCT04233216|78951279|FG002|Overall Study|Physician Decision|0|||
44159024|NCT04233216|78951280|FG003|Overall Study|Physician Decision|0|||
44159025|NCT04233216|78951277|FG000|Overall Study|Withdrawal by Subject|0|||
44159026|NCT04233216|78951278|FG001|Overall Study|Withdrawal by Subject|1|||
44159027|NCT04233216|78951279|FG002|Overall Study|Withdrawal by Subject|1|||
44159028|NCT04233216|78951280|FG003|Overall Study|Withdrawal by Subject|0|||
44159029|NCT04233216|78951277|FG000|Overall Study|Ongoing participation in study|7|||
44159030|NCT04233216|78951278|FG001|Overall Study|Ongoing participation in study|12|||
44159031|NCT04233216|78951279|FG002|Overall Study|Ongoing participation in study|4|||
44159032|NCT04233216|78951280|FG003|Overall Study|Ongoing participation in study|7|||
44159033|NCT04173507|78951291|FG000|Overall Study|On Treatment|3|||
44159034|NCT04173507|78951291|FG000|Overall Study|Adverse Event|3|||
44259639|NCT00246259|79121338|FG000|Overall Study|Investigator withdrew participant|2|||
44259640|NCT00246259|79121339|FG001|Overall Study|Investigator withdrew participant|0|||
44259641|NCT00246259|79121338|FG000|Overall Study|Adverse Event|5|||
44259642|NCT00246259|79121339|FG001|Overall Study|Adverse Event|0|||
44259643|NCT00246259|79121338|FG000|Overall Study|Lost to Follow-up|3|||
44259644|NCT00246259|79121339|FG001|Overall Study|Lost to Follow-up|4|||
44259645|NCT00246259|79121338|FG000|Overall Study|Withdrawal by Subject|5|||
44259646|NCT00246259|79121339|FG001|Overall Study|Withdrawal by Subject|1|||
44259647|NCT00246259|79121338|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
44259648|NCT00246259|79121339|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
44259649|NCT00246025|79121391|FG000|Overall Study|Adverse Event|7|||
44259650|NCT00246025|79121392|FG001|Overall Study|Adverse Event|9|||
44259651|NCT00246025|79121393|FG002|Overall Study|Adverse Event|9|||
44340270|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44340271|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44340272|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
44340273|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
44340274|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
44340275|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340276|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340277|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340278|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340279|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340280|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340281|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340282|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
44340283|NCT01232283|79344588|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
44340284|NCT01232283|79344589|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
44340285|NCT01232283|79344590|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340286|NCT01232283|79344591|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340287|NCT01232283|79344592|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44259652|NCT00246025|79121394|FG003|Overall Study|Adverse Event|10|||
44259653|NCT00246025|79121391|FG000|Overall Study|Withdrawal by Subject|3|||
44340288|NCT01232283|79344593|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340289|NCT01232283|79344594|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340290|NCT01232283|79344595|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340291|NCT01232283|79344596|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340292|NCT01232283|79344597|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
44340293|NCT01232283|79344588|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340294|NCT01232283|79344589|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340295|NCT01232283|79344590|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
44340296|NCT01232283|79344591|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
44340297|NCT01232283|79344592|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340298|NCT01232283|79344593|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340299|NCT01232283|79344594|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340300|NCT01232283|79344595|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340301|NCT01232283|79344596|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340302|NCT01232283|79344597|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
44340303|NCT01232283|79344588|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340304|NCT01232283|79344589|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340305|NCT01232283|79344590|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
44340306|NCT01232283|79344591|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
44340307|NCT01232283|79344592|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340308|NCT01232283|79344593|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340309|NCT01232283|79344594|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340310|NCT01232283|79344595|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340311|NCT01232283|79344596|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340312|NCT01232283|79344597|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
44340313|NCT01232283|79344588|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340314|NCT01232283|79344589|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340315|NCT01232283|79344590|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
44340316|NCT01232283|79344591|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340317|NCT01232283|79344592|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340318|NCT01232283|79344593|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340319|NCT01232283|79344594|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340320|NCT01232283|79344595|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340321|NCT01232283|79344596|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340322|NCT01232283|79344597|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
44340323|NCT01232283|79344588|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340324|NCT01232283|79344589|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340325|NCT01232283|79344590|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
44340326|NCT01232283|79344591|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
44340327|NCT01232283|79344592|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340328|NCT01232283|79344593|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340329|NCT01232283|79344594|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340330|NCT01232283|79344595|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340331|NCT01232283|79344596|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340332|NCT01232283|79344597|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
44340333|NCT01232283|79344588|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340334|NCT01232283|79344589|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340335|NCT01232283|79344590|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
44340336|NCT01232283|79344591|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
44340337|NCT01232283|79344592|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340338|NCT01232283|79344593|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340339|NCT01232283|79344594|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340340|NCT01232283|79344595|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340341|NCT01232283|79344596|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340342|NCT01232283|79344597|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
44340343|NCT01232283|79344588|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
44340344|NCT01232283|79344589|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
44340345|NCT01232283|79344590|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
44340346|NCT01232283|79344591|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
44340347|NCT01232283|79344592|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
44340348|NCT01232283|79344593|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
44340349|NCT01232283|79344594|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
44340350|NCT01232283|79344595|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
44340351|NCT01232283|79344596|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
44340352|NCT01232283|79344597|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
44340353|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44159035|NCT04173507|78951291|FG000|Overall Study|Progression/Relapse|34|||
44440062|NCT00238303|79448474|FG000|Overall Study|Withdrawal by Subject|11|||
44259654|NCT00246025|79121392|FG001|Overall Study|Withdrawal by Subject|0|||
44259655|NCT00246025|79121393|FG002|Overall Study|Withdrawal by Subject|1|||
44259656|NCT00246025|79121394|FG003|Overall Study|Withdrawal by Subject|2|||
44259657|NCT00246025|79121391|FG000|Overall Study|unsuitable medical history was found|0|||
44259658|NCT00246025|79121392|FG001|Overall Study|unsuitable medical history was found|0|||
44440063|NCT00238303|79448475|FG001|Overall Study|Withdrawal by Subject|1|||
44440064|NCT00238303|79448476|FG002|Overall Study|Withdrawal by Subject|2|||
44340354|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44340355|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44340356|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44340357|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
44340358|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
44340359|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44340360|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
44340361|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44340362|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
44340363|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340364|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340365|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340366|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340367|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
44340368|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340369|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
44340370|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
44340371|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340372|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
44340373|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
44340374|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
44340375|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
44340376|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
44340377|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
44340378|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
44340379|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
44340380|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
44340381|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
44340382|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
44340383|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340384|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340385|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340386|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340387|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
44340388|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340389|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340390|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44440065|NCT00238303|79448474|FG000|Overall Study|Death|1|||
44440066|NCT00238303|79448475|FG001|Overall Study|Death|0|||
44440067|NCT00238303|79448476|FG002|Overall Study|Death|1|||
44440068|NCT00238303|79448474|FG000|Overall Study|Other Medical Problems|2|||
44440069|NCT00238303|79448475|FG001|Overall Study|Other Medical Problems|0|||
44440070|NCT00238303|79448476|FG002|Overall Study|Other Medical Problems|2|||
44440071|NCT00238303|79448474|FG000|Overall Study|Poor tolerance of study treatment|1|||
44440072|NCT00238303|79448475|FG001|Overall Study|Poor tolerance of study treatment|0|||
44440073|NCT00238303|79448476|FG002|Overall Study|Poor tolerance of study treatment|1|||
44440074|NCT00238303|79448474|FG000|Overall Study|Adverse Event|0|||
44440075|NCT00238303|79448475|FG001|Overall Study|Adverse Event|1|||
44440076|NCT00238303|79448476|FG002|Overall Study|Adverse Event|3|||
44440077|NCT00737633|79448487|FG000|Overall Study|Study terminated by sponsor|44|||
44440078|NCT00737633|79448488|FG001|Overall Study|Study terminated by sponsor|55|||
44440079|NCT00737633|79448487|FG000|Overall Study|Lost to Follow-up|0|||
44440080|NCT00737633|79448488|FG001|Overall Study|Lost to Follow-up|1|||
44440081|NCT00737633|79448487|FG000|Overall Study|protocol non-compliance|0|||
44440082|NCT00737633|79448488|FG001|Overall Study|protocol non-compliance|1|||
44259659|NCT00246025|79121393|FG002|Overall Study|unsuitable medical history was found|0|||
44259660|NCT00246025|79121394|FG003|Overall Study|unsuitable medical history was found|1|||
44259661|NCT00245011|79121524|FG000|Overall Study|Lack of Efficacy|1|||
44259662|NCT00244855|79121543|FG000|Overall Study|Withdrawal by Subject|0|||
44259663|NCT00244855|79121544|FG001|Overall Study|Withdrawal by Subject|1|||
44259664|NCT00244621|79121574|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44259665|NCT00244621|79121575|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
44259666|NCT00244621|79121576|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
44259667|NCT00244621|79121574|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
44259668|NCT00244621|79121575|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
44259669|NCT00244621|79121576|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44440083|NCT00732251|79448494|FG000|Overall Study|Lost to Follow-up|3|||
44259670|NCT00244621|79121574|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
44340391|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340392|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
44340393|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340394|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340395|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340396|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340397|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
44340398|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340399|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
44340400|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
44340401|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340402|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
44340403|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340404|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340405|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340406|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340407|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340408|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340409|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340410|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
44340411|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340412|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
44340413|NCT01232283|79344588|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340414|NCT01232283|79344589|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340415|NCT01232283|79344590|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340416|NCT01232283|79344591|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340417|NCT01232283|79344592|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340418|NCT01232283|79344593|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
44340419|NCT01232283|79344594|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340420|NCT01232283|79344595|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340421|NCT01232283|79344596|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340422|NCT01232283|79344597|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
44340423|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340424|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340425|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340426|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340427|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340428|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340429|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340430|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
44340431|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
44340432|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
44340433|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44340434|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44340435|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44340436|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44340437|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44440084|NCT00732251|79448494|FG000|Overall Study|Withdrawal by Subject|3|||
44259671|NCT00244621|79121575|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
44259672|NCT00244621|79121576|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
44259673|NCT00244621|79121574|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
44259674|NCT00244621|79121575|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
44259675|NCT00244621|79121576|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
44259676|NCT00244621|79121574|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
44259677|NCT00244621|79121575|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
44259678|NCT00244621|79121576|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
44259679|NCT00244621|79121574|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
44259680|NCT00244621|79121575|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
44259681|NCT00244621|79121576|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
44259682|NCT00244621|79121574|FG000|Open-label Treatment Period|Adverse Event|0|||
44259683|NCT00244621|79121575|FG001|Open-label Treatment Period|Adverse Event|0|||
44259684|NCT00244621|79121576|FG002|Open-label Treatment Period|Adverse Event|1|||
44259685|NCT00244621|79121574|FG000|Open-label Treatment Period|Moved abroad|0|||
44340438|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44440085|NCT00732251|79448494|FG000|Overall Study|Early Term due to Site Closure|1|||
44440086|NCT00737477|79448498|FG000|Overall Study|Adverse Event|9|||
44259686|NCT00244621|79121575|FG001|Open-label Treatment Period|Moved abroad|0|||
44340439|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44340440|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
44340441|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
44340442|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
44340443|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340444|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340445|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340446|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340447|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340448|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340449|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340450|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
44340451|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
44340452|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
44340453|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340454|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340455|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340456|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340457|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340458|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340459|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340460|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
44340461|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
44340462|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
44340463|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340464|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340465|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340466|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340467|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340468|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340469|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340470|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
44340471|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
44340472|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
44340473|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340474|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340475|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340476|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340477|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340478|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340479|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340480|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340481|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
44340482|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
44340483|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340484|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340485|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340486|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340487|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340488|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44440087|NCT00737477|79448498|FG000|Overall Study|Death|9|||
44440088|NCT00737477|79448498|FG000|Overall Study|Treatment Refusal|1|||
44440089|NCT00737477|79448498|FG000|Overall Study|Withdrawal by Subject|1|||
44440090|NCT00737477|79448498|FG000|Overall Study|Renal Transplantation|10|||
44440091|NCT00737477|79448498|FG000|Overall Study|Other|4|||
44440092|NCT00256867|79448510|FG000|Overall Study|Adverse Event|0|||
44440093|NCT00256867|79448511|FG001|Overall Study|Adverse Event|1|||
44440094|NCT00256867|79448512|FG002|Overall Study|Adverse Event|1|||
44440095|NCT00256867|79448513|FG003|Overall Study|Adverse Event|1|||
44440096|NCT00256867|79448514|FG004|Overall Study|Adverse Event|2|||
44440097|NCT00256867|79448515|FG005|Overall Study|Adverse Event|2|||
44440098|NCT00256867|79448516|FG006|Overall Study|Adverse Event|1|||
44340489|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340490|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340491|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
44340492|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
44340493|NCT01232283|79344588|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340494|NCT01232283|79344589|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340495|NCT01232283|79344590|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340496|NCT01232283|79344591|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340497|NCT01232283|79344592|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340498|NCT01232283|79344593|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340499|NCT01232283|79344594|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340500|NCT01232283|79344595|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
44340501|NCT01232283|79344596|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
44340502|NCT01232283|79344597|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
44340503|NCT01232127|79344619|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
44440099|NCT00256867|79448517|FG007|Overall Study|Adverse Event|4|||
44440100|NCT00256867|79448510|FG000|Overall Study|Lost to Follow-up|2|||
44340504|NCT01232127|79344620|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
44340505|NCT01232127|79344621|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
44340506|NCT01258608|79344635|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
44340507|NCT01258608|79344636|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
44340508|NCT01258608|79344635|FG000|Overall Study|Clinical progression|1|||
44340509|NCT01258608|79344636|FG001|Overall Study|Clinical progression|0|||
44340510|NCT01258608|79344635|FG000|Overall Study|Sponsor decision|0|||
44340511|NCT01258608|79344636|FG001|Overall Study|Sponsor decision|1|||
44340512|NCT01258608|79344635|FG000|Overall Study|Physician Decision|6|||
44340513|NCT01258608|79344636|FG001|Overall Study|Physician Decision|1|||
44340514|NCT01258608|79344635|FG000|Overall Study|Lost to Follow-up|0|||
44340515|NCT01258608|79344636|FG001|Overall Study|Lost to Follow-up|1|||
44340516|NCT01258608|79344635|FG000|Overall Study|Lack of compliance|1|||
44440101|NCT00256867|79448511|FG001|Overall Study|Lost to Follow-up|2|||
44340517|NCT01258608|79344636|FG001|Overall Study|Lack of compliance|0|||
44340518|NCT01258608|79344635|FG000|Overall Study|Lack of Efficacy|0|||
44340519|NCT01258608|79344636|FG001|Overall Study|Lack of Efficacy|1|||
44340520|NCT01258608|79344635|FG000|Overall Study|Adverse Event|6|||
44340521|NCT01258608|79344636|FG001|Overall Study|Adverse Event|10|||
44340522|NCT01258608|79344635|FG000|Overall Study|Withdrawal by Subject|6|||
44340523|NCT01258608|79344636|FG001|Overall Study|Withdrawal by Subject|5|||
44340524|NCT01015612|79344643|FG000|Overall Study|Death|113|||
44340525|NCT01015612|79344643|FG000|Overall Study|Withdrawal by Subject|40|||
44340526|NCT01231659|79344647|FG000|Overall Study|Adverse Event|9|||
44340527|NCT01231659|79344647|FG000|Overall Study|Disease Progression|48|||
44340528|NCT01231659|79344647|FG000|Overall Study|Death|2|||
44340529|NCT01231659|79344647|FG000|Overall Study|Patient refused to complete study visit|1|||
44340530|NCT01231659|79344647|FG000|Overall Study|Other protocol defined criteria|12|||
44340531|NCT01054222|79344651|FG000|Overall Study|Lack of Efficacy|1|||
44340532|NCT01054222|79344651|FG000|Overall Study|Lost to Follow-up|4|||
44340533|NCT01054222|79344651|FG000|Overall Study|Withdrawal by Subject|6|||
44340534|NCT01052428|79344657|FG000|Overall Study|Death|1|||
44340535|NCT01052428|79344658|FG001|Overall Study|Death|0|||
44340536|NCT01052428|79344657|FG000|Overall Study|Withdrawal by Subject|0|||
44340537|NCT01052428|79344658|FG001|Overall Study|Withdrawal by Subject|1|||
44340538|NCT01052272|79344668|FG000|Overall Study|Death|0|||
44340539|NCT01052272|79344669|FG001|Overall Study|Death|0|||
44340540|NCT01052272|79344670|FG002|Overall Study|Death|1|||
44340541|NCT01052272|79344671|FG003|Overall Study|Death|1|||
44340542|NCT01052272|79344668|FG000|Overall Study|Physician Decision|0|||
44340543|NCT01052272|79344669|FG001|Overall Study|Physician Decision|1|||
44340544|NCT01052272|79344670|FG002|Overall Study|Physician Decision|0|||
44340545|NCT01052272|79344671|FG003|Overall Study|Physician Decision|0|||
44340546|NCT01052272|79344668|FG000|Overall Study|patient refuses follow-up|5|||
44340547|NCT01052272|79344669|FG001|Overall Study|patient refuses follow-up|4|||
44340548|NCT01052272|79344670|FG002|Overall Study|patient refuses follow-up|2|||
44340549|NCT01052272|79344671|FG003|Overall Study|patient refuses follow-up|4|||
44340550|NCT01052272|79344668|FG000|Overall Study|Withdrawal by Subject|0|||
44340551|NCT01052272|79344669|FG001|Overall Study|Withdrawal by Subject|2|||
44340552|NCT01052272|79344670|FG002|Overall Study|Withdrawal by Subject|3|||
44340553|NCT01052272|79344671|FG003|Overall Study|Withdrawal by Subject|2|||
44340554|NCT01052272|79344668|FG000|Overall Study|placed in long-term care|0|||
44340555|NCT01052272|79344669|FG001|Overall Study|placed in long-term care|0|||
44340556|NCT01052272|79344670|FG002|Overall Study|placed in long-term care|1|||
44340557|NCT01052272|79344671|FG003|Overall Study|placed in long-term care|0|||
44340558|NCT01052272|79344668|FG000|Overall Study|decline in health|0|||
44340559|NCT01052272|79344669|FG001|Overall Study|decline in health|0|||
44340560|NCT01052272|79344670|FG002|Overall Study|decline in health|1|||
44340561|NCT01052272|79344671|FG003|Overall Study|decline in health|0|||
44340562|NCT01257204|79344684|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
44340563|NCT01257204|79344685|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
44340564|NCT01257204|79344686|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
44340565|NCT01257204|79344684|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
44340566|NCT01257204|79344685|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
44340567|NCT01257204|79344686|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
44340568|NCT01257204|79344684|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
44340569|NCT01257204|79344685|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
44340570|NCT01257204|79344686|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
44340571|NCT01257204|79344684|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
44340572|NCT01257204|79344685|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
44340573|NCT01257204|79344686|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
44340574|NCT01257204|79344684|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
44340575|NCT01257204|79344685|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
44340576|NCT01257204|79344686|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
44340577|NCT01257204|79344684|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
44340578|NCT01257204|79344685|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
44340579|NCT01257204|79344686|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
44340580|NCT01257204|79344684|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
44340581|NCT01257204|79344685|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
44340582|NCT01257204|79344686|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
44440102|NCT00256867|79448512|FG002|Overall Study|Lost to Follow-up|2|||
44440103|NCT00256867|79448513|FG003|Overall Study|Lost to Follow-up|3|||
44440104|NCT00256867|79448514|FG004|Overall Study|Lost to Follow-up|2|||
44440105|NCT00256867|79448515|FG005|Overall Study|Lost to Follow-up|0|||
44440106|NCT00256867|79448516|FG006|Overall Study|Lost to Follow-up|1|||
44340583|NCT01257204|79344684|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
44440107|NCT00256867|79448517|FG007|Overall Study|Lost to Follow-up|2|||
44440108|NCT00256867|79448510|FG000|Overall Study|Protocol Violation|0|||
44340584|NCT01257204|79344685|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
44340585|NCT01257204|79344686|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
44340586|NCT01257204|79344684|FG000|Follow-up Period (up to Week 48)|Other|0|||
44340587|NCT01257204|79344685|FG001|Follow-up Period (up to Week 48)|Other|0|||
44340588|NCT01257204|79344686|FG002|Follow-up Period (up to Week 48)|Other|5|||
44340589|NCT01231581|79344708|FG000|Overall Study|Lost to Follow-up|2|||
44340590|NCT01231581|79344709|FG001|Overall Study|Lost to Follow-up|2|||
44340591|NCT01231581|79344708|FG000|Overall Study|Withdrawal by Subject|6|||
44340592|NCT01231581|79344709|FG001|Overall Study|Withdrawal by Subject|9|||
44340593|NCT01231581|79344708|FG000|Overall Study|Study Closed/Terminated|6|||
44340594|NCT01231581|79344709|FG001|Overall Study|Study Closed/Terminated|5|||
44340595|NCT01231581|79344708|FG000|Overall Study|Death|65|||
44340596|NCT01231581|79344709|FG001|Overall Study|Death|64|||
44340597|NCT01231581|79344708|FG000|Overall Study|Ongoing|1|||
44340598|NCT01231581|79344709|FG001|Overall Study|Ongoing|0|||
44340599|NCT01050634|79344715|FG000|Overall Study|Enrolled, but Not Treated|56|||
44340600|NCT01050634|79344715|FG000|Overall Study|Death|2|||
44340601|NCT01050634|79344715|FG000|Overall Study|Adverse Event|42|||
44340602|NCT01050634|79344715|FG000|Overall Study|Lost to Follow-up|2|||
44340603|NCT01050634|79344715|FG000|Overall Study|Other|21|||
44340604|NCT01050634|79344715|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
44340605|NCT01020526|79344719|FG000|Overall Study|Withdrawal by Subject|5|||
44340606|NCT01020526|79344719|FG000|Overall Study|Other reasons|3|||
44340607|NCT01020526|79344719|FG000|Overall Study|Insufficient clinical response|3|||
44340608|NCT01020526|79344719|FG000|Overall Study|Lost to Follow-up|1|||
44340609|NCT01020526|79344719|FG000|Overall Study|Adverse Event|2|||
44340610|NCT01020448|79344723|FG000|Pre-assignment|Adverse Event|6|||
44340611|NCT01020448|79344723|FG000|Pre-assignment|Withdrawal by Subject|5|||
44340612|NCT01020448|79344723|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
44340613|NCT01020448|79344723|FG000|Treatment|Adverse Event|11|||
44340614|NCT01020448|79344723|FG000|Treatment|Consent Withdrawn|3|||
44340615|NCT01020448|79344723|FG000|Treatment|Disease Progression|2|||
44340616|NCT01020448|79344723|FG000|Treatment|Lack of Efficacy|8|||
44340617|NCT01020448|79344723|FG000|Treatment|Lost to Follow-up|2|||
44340618|NCT01256658|79344730|FG000|Period 1|Lost to Follow-up|837|||
44340619|NCT01256658|79344731|FG001|Period 1|Lost to Follow-up|661|||
44340620|NCT01256658|79344730|FG000|Period 1|Withdrawal by Subject|35|||
44340621|NCT01256658|79344731|FG001|Period 1|Withdrawal by Subject|43|||
44340622|NCT01256658|79344730|FG000|Period 1|Death|48|||
44340623|NCT01256658|79344731|FG001|Period 1|Death|44|||
44340624|NCT01256502|79344740|FG000|Overall Study|Had scaffold removed|4|||
44340625|NCT01256502|79344740|FG000|Overall Study|Personal reasons|5|||
44340626|NCT01256502|79344740|FG000|Overall Study|Protocol deviation|1|||
44340627|NCT01256190|79344751|FG000|Overall Study|Lost to Follow-up|2|||
44340628|NCT01256190|79344752|FG001|Overall Study|Lost to Follow-up|0|||
44340629|NCT01255722|79344761|FG000|Overall Study|Adverse Event|0|||
44340630|NCT01255722|79344762|FG001|Overall Study|Adverse Event|1|||
44340631|NCT01255722|79344763|FG002|Overall Study|Adverse Event|1|||
44440109|NCT00256867|79448511|FG001|Overall Study|Protocol Violation|0|||
44440110|NCT00256867|79448512|FG002|Overall Study|Protocol Violation|0|||
44440111|NCT00256867|79448513|FG003|Overall Study|Protocol Violation|1|||
44440112|NCT00256867|79448514|FG004|Overall Study|Protocol Violation|0|||
44440113|NCT00256867|79448515|FG005|Overall Study|Protocol Violation|1|||
44440114|NCT00256867|79448516|FG006|Overall Study|Protocol Violation|0|||
44440115|NCT00256867|79448517|FG007|Overall Study|Protocol Violation|1|||
44440116|NCT00256867|79448510|FG000|Overall Study|Withdrawal by Subject|0|||
44440117|NCT00256867|79448511|FG001|Overall Study|Withdrawal by Subject|0|||
44440118|NCT00256867|79448512|FG002|Overall Study|Withdrawal by Subject|1|||
44440119|NCT00256867|79448513|FG003|Overall Study|Withdrawal by Subject|1|||
44440120|NCT00256867|79448514|FG004|Overall Study|Withdrawal by Subject|2|||
44440121|NCT00256867|79448515|FG005|Overall Study|Withdrawal by Subject|2|||
44440122|NCT00256867|79448516|FG006|Overall Study|Withdrawal by Subject|3|||
44440123|NCT00256867|79448517|FG007|Overall Study|Withdrawal by Subject|2|||
44340632|NCT01255722|79344761|FG000|Overall Study|asymptomatic patient|1|||
44340633|NCT01255722|79344762|FG001|Overall Study|asymptomatic patient|0|||
44340634|NCT01255722|79344763|FG002|Overall Study|asymptomatic patient|0|||
44340635|NCT01255722|79344761|FG000|Overall Study|beta-blocker contraindicated|2|||
44340636|NCT01255722|79344762|FG001|Overall Study|beta-blocker contraindicated|0|||
44340637|NCT01255722|79344763|FG002|Overall Study|beta-blocker contraindicated|0|||
44340638|NCT01231503|79344780|FG000|Overall Study|Adverse Event|0|||
44340639|NCT01231503|79344781|FG001|Overall Study|Adverse Event|0|||
44340640|NCT01231503|79344782|FG002|Overall Study|Adverse Event|0|||
44440124|NCT00256867|79448510|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44440125|NCT00256867|79448511|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
44340641|NCT01231503|79344783|FG003|Overall Study|Adverse Event|0|||
44340642|NCT01231503|79344784|FG004|Overall Study|Adverse Event|0|||
44340643|NCT01231503|79344785|FG005|Overall Study|Adverse Event|1|||
44340644|NCT01231503|79344786|FG006|Overall Study|Adverse Event|0|||
44340645|NCT01231503|79344787|FG007|Overall Study|Adverse Event|0|||
44340646|NCT01231503|79344780|FG000|Overall Study|Adverse event, serious fatal|0|||
44340647|NCT01231503|79344781|FG001|Overall Study|Adverse event, serious fatal|0|||
44340648|NCT01231503|79344782|FG002|Overall Study|Adverse event, serious fatal|1|||
44340649|NCT01231503|79344783|FG003|Overall Study|Adverse event, serious fatal|1|||
44340650|NCT01231503|79344784|FG004|Overall Study|Adverse event, serious fatal|0|||
44340651|NCT01231503|79344785|FG005|Overall Study|Adverse event, serious fatal|1|||
44340652|NCT01231503|79344786|FG006|Overall Study|Adverse event, serious fatal|0|||
44340653|NCT01231503|79344787|FG007|Overall Study|Adverse event, serious fatal|0|||
44340654|NCT01231503|79344780|FG000|Overall Study|Withdrawal by Subject|6|||
44340655|NCT01231503|79344781|FG001|Overall Study|Withdrawal by Subject|3|||
44340656|NCT01231503|79344782|FG002|Overall Study|Withdrawal by Subject|3|||
44340657|NCT01231503|79344783|FG003|Overall Study|Withdrawal by Subject|1|||
44340658|NCT01231503|79344784|FG004|Overall Study|Withdrawal by Subject|3|||
44340659|NCT01231503|79344785|FG005|Overall Study|Withdrawal by Subject|5|||
44340660|NCT01231503|79344786|FG006|Overall Study|Withdrawal by Subject|1|||
44340661|NCT01231503|79344787|FG007|Overall Study|Withdrawal by Subject|2|||
44340662|NCT01231503|79344780|FG000|Overall Study|Lost to Follow-up|8|||
44340663|NCT01231503|79344781|FG001|Overall Study|Lost to Follow-up|10|||
44340664|NCT01231503|79344782|FG002|Overall Study|Lost to Follow-up|8|||
44340665|NCT01231503|79344783|FG003|Overall Study|Lost to Follow-up|5|||
44340666|NCT01231503|79344784|FG004|Overall Study|Lost to Follow-up|7|||
44340667|NCT01231503|79344785|FG005|Overall Study|Lost to Follow-up|9|||
44340668|NCT01231503|79344786|FG006|Overall Study|Lost to Follow-up|6|||
44340669|NCT01231503|79344787|FG007|Overall Study|Lost to Follow-up|6|||
44340670|NCT01231503|79344780|FG000|Overall Study|Protocol Violation|0|||
44340671|NCT01231503|79344781|FG001|Overall Study|Protocol Violation|0|||
44340672|NCT01231503|79344782|FG002|Overall Study|Protocol Violation|0|||
44340673|NCT01231503|79344783|FG003|Overall Study|Protocol Violation|1|||
44340674|NCT01231503|79344784|FG004|Overall Study|Protocol Violation|0|||
44340675|NCT01231503|79344785|FG005|Overall Study|Protocol Violation|0|||
44340676|NCT01231503|79344786|FG006|Overall Study|Protocol Violation|0|||
44340677|NCT01231503|79344787|FG007|Overall Study|Protocol Violation|0|||
44340678|NCT01230489|79344815|FG000|Overall Study|Death|2|||
44340679|NCT01230489|79344815|FG000|Overall Study|Adverse Event|2|||
44340680|NCT01230489|79344815|FG000|Overall Study|Treatment modality changed|1|||
44340681|NCT01229397|79344821|FG000|Overall Study|Withdrawal by Subject|3|||
44340682|NCT01229397|79344822|FG001|Overall Study|Withdrawal by Subject|3|||
44340683|NCT01229397|79344821|FG000|Overall Study|Lost to Follow-up|7|||
44340684|NCT01229397|79344822|FG001|Overall Study|Lost to Follow-up|6|||
44340685|NCT01229397|79344821|FG000|Overall Study|Migrated/moved from study area|1|||
44340686|NCT01229397|79344822|FG001|Overall Study|Migrated/moved from study area|0|||
44340687|NCT01228071|79344832|FG000|Overall Study|Protocol Violation|1|||
44340688|NCT01228071|79344832|FG000|Overall Study|Withdrawal by Subject|1|||
44340689|NCT01008475|79344843|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
44340690|NCT01008475|79344844|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
44340691|NCT01008475|79344845|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
44340692|NCT01008475|79344846|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
44340693|NCT01008475|79344847|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
44340694|NCT01008475|79344848|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
44259687|NCT00244621|79121576|FG002|Open-label Treatment Period|Moved abroad|1|||
44259688|NCT00243841|79121659|FG000|Overall Study|Physician Decision|0|||
44259689|NCT00243841|79121660|FG001|Overall Study|Physician Decision|0|||
44259690|NCT00243841|79121661|FG002|Overall Study|Physician Decision|1|||
44259691|NCT00243841|79121662|FG003|Overall Study|Physician Decision|0|||
44259692|NCT00243841|79121663|FG004|Overall Study|Physician Decision|0|||
44259693|NCT00243841|79121664|FG005|Overall Study|Physician Decision|2|||
44259694|NCT02980731|79121857|FG000|Overall Study|Death|63|||
44259695|NCT02980731|79121857|FG000|Overall Study|Withdrawal by Subject|6|||
44259696|NCT02980731|79121857|FG000|Overall Study|Lost to Follow-up|5|||
44259697|NCT02980731|79121857|FG000|Overall Study|Study terminated by Sponsor|4|||
44340695|NCT01008475|79344849|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
44340696|NCT01226745|79344871|FG000|Overall Study|Did not complete schedule of assessments|8|||
44340697|NCT01226745|79344872|FG001|Overall Study|Did not complete schedule of assessments|3|||
44340698|NCT01226745|79344873|FG002|Overall Study|Did not complete schedule of assessments|6|||
44259698|NCT02980731|79121857|FG000|Overall Study|Completed survival follow-up period|65|||
44259699|NCT02980731|79121857|FG000|Overall Study|COVID-19 infection|1|||
44259700|NCT02980731|79121857|FG000|Overall Study|Other, not specified|66|||
44340699|NCT01226745|79344874|FG003|Overall Study|Did not complete schedule of assessments|0|||
44340700|NCT01226745|79344875|FG004|Overall Study|Did not complete schedule of assessments|0|||
44340701|NCT01226745|79344876|FG005|Overall Study|Did not complete schedule of assessments|1|||
44340702|NCT01226745|79344871|FG000|Overall Study|Lost to Follow-up|2|||
44340703|NCT01226745|79344872|FG001|Overall Study|Lost to Follow-up|6|||
44340704|NCT01226745|79344873|FG002|Overall Study|Lost to Follow-up|6|||
44340705|NCT01226745|79344874|FG003|Overall Study|Lost to Follow-up|1|||
44340706|NCT01226745|79344875|FG004|Overall Study|Lost to Follow-up|1|||
44340707|NCT01226745|79344876|FG005|Overall Study|Lost to Follow-up|2|||
44340708|NCT01226745|79344871|FG000|Overall Study|Death|1|||
44340709|NCT01226745|79344872|FG001|Overall Study|Death|0|||
44340710|NCT01226745|79344873|FG002|Overall Study|Death|0|||
44340711|NCT01226745|79344874|FG003|Overall Study|Death|0|||
44340712|NCT01226745|79344875|FG004|Overall Study|Death|0|||
44340713|NCT01226745|79344876|FG005|Overall Study|Death|1|||
44340714|NCT01226745|79344871|FG000|Overall Study|Other|6|||
44340715|NCT01226745|79344872|FG001|Overall Study|Other|7|||
44340716|NCT01226745|79344873|FG002|Overall Study|Other|8|||
44340717|NCT01226745|79344874|FG003|Overall Study|Other|4|||
44340718|NCT01226745|79344875|FG004|Overall Study|Other|3|||
44340719|NCT01226745|79344876|FG005|Overall Study|Other|1|||
44340720|NCT01226511|79344893|FG000|Acute Treatment Period|Adverse Event|7|||
44340721|NCT01226511|79344894|FG001|Acute Treatment Period|Adverse Event|6|||
44340722|NCT01226511|79344893|FG000|Acute Treatment Period|Lack of Efficacy|2|||
44340723|NCT01226511|79344894|FG001|Acute Treatment Period|Lack of Efficacy|1|||
44340724|NCT01226511|79344893|FG000|Acute Treatment Period|Lost to Follow-up|3|||
44340725|NCT01226511|79344894|FG001|Acute Treatment Period|Lost to Follow-up|6|||
44340726|NCT01226511|79344893|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
44340727|NCT01226511|79344894|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
44340728|NCT01226511|79344893|FG000|Acute Treatment Period|Protocol Violation|5|||
44340729|NCT01226511|79344894|FG001|Acute Treatment Period|Protocol Violation|5|||
44340730|NCT01226511|79344893|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
44340731|NCT01226511|79344894|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
44340732|NCT01226511|79344893|FG000|Extension Treatment Period|Adverse Event|8|||
44340733|NCT01226511|79344894|FG001|Extension Treatment Period|Adverse Event|8|||
44340734|NCT01226511|79344893|FG000|Extension Treatment Period|Lack of Efficacy|3|||
44340735|NCT01226511|79344894|FG001|Extension Treatment Period|Lack of Efficacy|2|||
44340736|NCT01226511|79344893|FG000|Extension Treatment Period|Lost to Follow-up|4|||
44340737|NCT01226511|79344894|FG001|Extension Treatment Period|Lost to Follow-up|3|||
44340738|NCT01226511|79344893|FG000|Extension Treatment Period|Protocol Violation|2|||
44340739|NCT01226511|79344894|FG001|Extension Treatment Period|Protocol Violation|2|||
44340740|NCT01226511|79344893|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
44340741|NCT01226511|79344894|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
44340742|NCT01226511|79344893|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
44340743|NCT01226511|79344894|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
44340744|NCT01226511|79344893|FG000|Extension Treatment Period|Sponsor Decision|1|||
44340745|NCT01226511|79344894|FG001|Extension Treatment Period|Sponsor Decision|1|||
44340746|NCT01226511|79344893|FG000|Taper Period|Adverse Event|1|||
44340747|NCT01226511|79344894|FG001|Taper Period|Adverse Event|0|||
44340748|NCT01226511|79344893|FG000|Taper Period|Lost to Follow-up|2|||
44340749|NCT01226511|79344894|FG001|Taper Period|Lost to Follow-up|2|||
44340750|NCT01226511|79344893|FG000|Taper Period|Protocol Violation|1|||
44340751|NCT01226511|79344894|FG001|Taper Period|Protocol Violation|0|||
44340752|NCT01226511|79344893|FG000|Taper Period|Parent/Caregiver Decision|1|||
44340753|NCT01226511|79344894|FG001|Taper Period|Parent/Caregiver Decision|1|||
44340754|NCT01226121|79344909|FG000|Overall Study|Lost to Follow-up|2|||
44340755|NCT01226121|79344910|FG001|Overall Study|Lost to Follow-up|0|||
44340756|NCT01226121|79344911|FG002|Overall Study|Lost to Follow-up|1|||
44340757|NCT01226043|79344921|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
44340758|NCT01226043|79344922|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
44340759|NCT01226043|79344923|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
44340760|NCT01226043|79344924|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
44340761|NCT01226043|79344921|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
44340762|NCT01226043|79344922|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
44340763|NCT01226043|79344923|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
44340764|NCT01226043|79344924|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
44159036|NCT04173507|78951291|FG000|Overall Study|Death|2|||
44340765|NCT01226043|79344921|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
44340766|NCT01226043|79344922|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
44340767|NCT01226043|79344923|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
44340768|NCT01226043|79344924|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
44340769|NCT01226043|79344921|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
44340770|NCT01226043|79344922|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
44340771|NCT01226043|79344923|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
44340772|NCT01226043|79344924|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
44340773|NCT01226043|79344921|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
44340774|NCT01226043|79344922|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
44340775|NCT01226043|79344923|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
44340776|NCT01226043|79344924|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
44340777|NCT01226043|79344921|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
44340778|NCT01226043|79344922|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
44340779|NCT01226043|79344923|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
44340780|NCT01226043|79344924|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
44340781|NCT01226043|79344921|FG000|6-week Re-randomization Phase|Adverse Event|0|||
44340782|NCT01226043|79344922|FG001|6-week Re-randomization Phase|Adverse Event|0|||
44340783|NCT01226043|79344923|FG002|6-week Re-randomization Phase|Adverse Event|1|||
44340784|NCT01226043|79344924|FG003|6-week Re-randomization Phase|Adverse Event|1|||
44340785|NCT01226043|79344921|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
44340786|NCT01226043|79344922|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
44340787|NCT01226043|79344923|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
44340788|NCT01226043|79344924|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
44340789|NCT01226043|79344921|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
44340790|NCT01226043|79344922|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
44340791|NCT01226043|79344923|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
44340792|NCT01226043|79344924|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
44340793|NCT01226043|79344921|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
44340794|NCT01226043|79344922|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
44340795|NCT01226043|79344923|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
44340796|NCT01226043|79344924|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
44340797|NCT01226043|79344921|FG000|6-week Re-randomization Phase|Physician Decision|0|||
44340798|NCT01226043|79344922|FG001|6-week Re-randomization Phase|Physician Decision|0|||
44340799|NCT01226043|79344923|FG002|6-week Re-randomization Phase|Physician Decision|3|||
44340800|NCT01226043|79344924|FG003|6-week Re-randomization Phase|Physician Decision|2|||
44340801|NCT01226043|79344921|FG000|6-week Re-randomization Phase|completed in error|0|||
44340802|NCT01226043|79344922|FG001|6-week Re-randomization Phase|completed in error|0|||
44340803|NCT01226043|79344923|FG002|6-week Re-randomization Phase|completed in error|0|||
44340804|NCT01226043|79344924|FG003|6-week Re-randomization Phase|completed in error|1|||
44340805|NCT01226043|79344921|FG000|30-week Observational Phase|Adverse Event|0|||
44340806|NCT01226043|79344922|FG001|30-week Observational Phase|Adverse Event|0|||
44340807|NCT01226043|79344923|FG002|30-week Observational Phase|Adverse Event|1|||
44340808|NCT01226043|79344924|FG003|30-week Observational Phase|Adverse Event|1|||
44340809|NCT01226043|79344921|FG000|30-week Observational Phase|Protocol Violation|0|||
44340810|NCT01226043|79344922|FG001|30-week Observational Phase|Protocol Violation|0|||
44340811|NCT01226043|79344923|FG002|30-week Observational Phase|Protocol Violation|0|||
44340812|NCT01226043|79344924|FG003|30-week Observational Phase|Protocol Violation|1|||
44340813|NCT01226043|79344921|FG000|30-week Observational Phase|Lost to Follow-up|0|||
44340814|NCT01226043|79344922|FG001|30-week Observational Phase|Lost to Follow-up|0|||
44340815|NCT01226043|79344923|FG002|30-week Observational Phase|Lost to Follow-up|2|||
44340816|NCT01226043|79344924|FG003|30-week Observational Phase|Lost to Follow-up|2|||
44340817|NCT01226043|79344921|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
44340818|NCT01226043|79344922|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
44340819|NCT01226043|79344923|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
44340820|NCT01226043|79344924|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
44340821|NCT01226043|79344921|FG000|30-week Observational Phase|Physician Decision|0|||
44340822|NCT01226043|79344922|FG001|30-week Observational Phase|Physician Decision|0|||
44340823|NCT01226043|79344923|FG002|30-week Observational Phase|Physician Decision|2|||
44340824|NCT01226043|79344924|FG003|30-week Observational Phase|Physician Decision|2|||
44340825|NCT01001377|79344956|FG000|Overall Study|Ineligibility determined|2|||
44340826|NCT01001377|79344957|FG001|Overall Study|Ineligibility determined|0|||
44340827|NCT01001377|79344956|FG000|Overall Study|Withdrawal by Subject|19|||
44340828|NCT01001377|79344957|FG001|Overall Study|Withdrawal by Subject|20|||
44340829|NCT01001377|79344956|FG000|Overall Study|Lost to Follow-up|14|||
44340830|NCT01001377|79344957|FG001|Overall Study|Lost to Follow-up|17|||
44340831|NCT01001377|79344956|FG000|Overall Study|Death|391|||
44340832|NCT01001377|79344957|FG001|Overall Study|Death|384|||
44340833|NCT01225887|79344963|FG000|Overall Study|Ineligible:required test not done|2|||
44340834|NCT01225887|79344963|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
44340835|NCT01225887|79344963|FG000|Overall Study|Ineligible:inadequate pathology|2|||
44340836|NCT01001299|79344967|FG000|Overall Study|Insufficient Therapeutic Response|20|||
44340837|NCT01001299|79344967|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
44340838|NCT01001299|79344967|FG000|Overall Study|Death|1|||
44340839|NCT01001299|79344967|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
44340840|NCT01001299|79344967|FG000|Overall Study|Withdrew Consent|1|||
44340841|NCT01296932|79344980|FG000|Overall Study|Dose limiting toxicity|0|||
44340842|NCT01296932|79344981|FG001|Overall Study|Dose limiting toxicity|0|||
44340843|NCT01296932|79344982|FG002|Overall Study|Dose limiting toxicity|0|||
44340844|NCT01296932|79344983|FG003|Overall Study|Dose limiting toxicity|0|||
44340845|NCT01296932|79344984|FG004|Overall Study|Dose limiting toxicity|0|||
44340846|NCT01296932|79344985|FG005|Overall Study|Dose limiting toxicity|0|||
44340847|NCT01296932|79344986|FG006|Overall Study|Dose limiting toxicity|1|||
44340848|NCT01296932|79344987|FG007|Overall Study|Dose limiting toxicity|0|||
44340849|NCT01296932|79344988|FG008|Overall Study|Dose limiting toxicity|1|||
44340850|NCT01296932|79344980|FG000|Overall Study|Progressive disease|2|||
44340851|NCT01296932|79344981|FG001|Overall Study|Progressive disease|0|||
44340852|NCT01296932|79344982|FG002|Overall Study|Progressive disease|1|||
44340853|NCT01296932|79344983|FG003|Overall Study|Progressive disease|1|||
44340854|NCT01296932|79344984|FG004|Overall Study|Progressive disease|2|||
44340855|NCT01296932|79344985|FG005|Overall Study|Progressive disease|3|||
44340856|NCT01296932|79344986|FG006|Overall Study|Progressive disease|1|||
44340857|NCT01296932|79344987|FG007|Overall Study|Progressive disease|0|||
44340858|NCT01296932|79344988|FG008|Overall Study|Progressive disease|0|||
44340859|NCT01296932|79344980|FG000|Overall Study|Withdrawal by Subject|0|||
44340860|NCT01296932|79344981|FG001|Overall Study|Withdrawal by Subject|0|||
44340861|NCT01296932|79344982|FG002|Overall Study|Withdrawal by Subject|1|||
44340862|NCT01296932|79344983|FG003|Overall Study|Withdrawal by Subject|1|||
44340863|NCT01296932|79344984|FG004|Overall Study|Withdrawal by Subject|0|||
44340864|NCT01296932|79344985|FG005|Overall Study|Withdrawal by Subject|0|||
44340865|NCT01296932|79344986|FG006|Overall Study|Withdrawal by Subject|3|||
44340866|NCT01296932|79344987|FG007|Overall Study|Withdrawal by Subject|0|||
44340867|NCT01296932|79344988|FG008|Overall Study|Withdrawal by Subject|0|||
44340868|NCT01296932|79344980|FG000|Overall Study|Adverse Event|1|||
44340869|NCT01296932|79344981|FG001|Overall Study|Adverse Event|1|||
44340870|NCT01296932|79344982|FG002|Overall Study|Adverse Event|1|||
44340871|NCT01296932|79344983|FG003|Overall Study|Adverse Event|2|||
44340872|NCT01296932|79344984|FG004|Overall Study|Adverse Event|1|||
44340873|NCT01296932|79344985|FG005|Overall Study|Adverse Event|0|||
44340874|NCT01296932|79344986|FG006|Overall Study|Adverse Event|0|||
44340875|NCT01296932|79344987|FG007|Overall Study|Adverse Event|0|||
44340876|NCT01296932|79344988|FG008|Overall Study|Adverse Event|1|||
44340877|NCT01296932|79344980|FG000|Overall Study|Investigator decision|0|||
44340878|NCT01296932|79344981|FG001|Overall Study|Investigator decision|1|||
44340879|NCT01296932|79344982|FG002|Overall Study|Investigator decision|0|||
44340880|NCT01296932|79344983|FG003|Overall Study|Investigator decision|1|||
44340881|NCT01296932|79344984|FG004|Overall Study|Investigator decision|0|||
44340882|NCT01296932|79344985|FG005|Overall Study|Investigator decision|0|||
44340883|NCT01296932|79344986|FG006|Overall Study|Investigator decision|1|||
44340884|NCT01296932|79344987|FG007|Overall Study|Investigator decision|0|||
44340885|NCT01296932|79344988|FG008|Overall Study|Investigator decision|1|||
44340886|NCT01296932|79344980|FG000|Overall Study|No clinical benefit anymore|0|||
44340887|NCT01296932|79344981|FG001|Overall Study|No clinical benefit anymore|1|||
44340888|NCT01296932|79344982|FG002|Overall Study|No clinical benefit anymore|0|||
44340889|NCT01296932|79344983|FG003|Overall Study|No clinical benefit anymore|0|||
44340890|NCT01296932|79344984|FG004|Overall Study|No clinical benefit anymore|0|||
44340891|NCT01296932|79344985|FG005|Overall Study|No clinical benefit anymore|0|||
44340892|NCT01296932|79344986|FG006|Overall Study|No clinical benefit anymore|0|||
44340893|NCT01296932|79344987|FG007|Overall Study|No clinical benefit anymore|0|||
44340894|NCT01296932|79344988|FG008|Overall Study|No clinical benefit anymore|0|||
44340895|NCT01296932|79344980|FG000|Overall Study|Physician Decision|0|||
44340896|NCT01296932|79344981|FG001|Overall Study|Physician Decision|0|||
44440126|NCT00256867|79448512|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44440127|NCT00256867|79448513|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44340897|NCT01296932|79344982|FG002|Overall Study|Physician Decision|1|||
44340898|NCT01296932|79344983|FG003|Overall Study|Physician Decision|0|||
44340899|NCT01296932|79344984|FG004|Overall Study|Physician Decision|0|||
44340900|NCT01296932|79344985|FG005|Overall Study|Physician Decision|0|||
44340901|NCT01296932|79344986|FG006|Overall Study|Physician Decision|0|||
44340902|NCT01296932|79344987|FG007|Overall Study|Physician Decision|0|||
44340903|NCT01296932|79344988|FG008|Overall Study|Physician Decision|0|||
44440128|NCT00256867|79448514|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44440129|NCT00256867|79448515|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44340904|NCT01296932|79344980|FG000|Overall Study|IV problems, administration not possible|0|||
44340905|NCT01296932|79344981|FG001|Overall Study|IV problems, administration not possible|0|||
44340906|NCT01296932|79344982|FG002|Overall Study|IV problems, administration not possible|1|||
44440130|NCT00256867|79448516|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44340907|NCT01296932|79344983|FG003|Overall Study|IV problems, administration not possible|0|||
44340908|NCT01296932|79344984|FG004|Overall Study|IV problems, administration not possible|0|||
44340909|NCT01296932|79344985|FG005|Overall Study|IV problems, administration not possible|0|||
44340910|NCT01296932|79344986|FG006|Overall Study|IV problems, administration not possible|0|||
44340911|NCT01296932|79344987|FG007|Overall Study|IV problems, administration not possible|0|||
44340912|NCT01296932|79344988|FG008|Overall Study|IV problems, administration not possible|0|||
44340913|NCT01296932|79344980|FG000|Overall Study|per protocol|0|||
44340914|NCT01296932|79344981|FG001|Overall Study|per protocol|0|||
44340915|NCT01296932|79344982|FG002|Overall Study|per protocol|1|||
44340916|NCT01296932|79344983|FG003|Overall Study|per protocol|1|||
44340917|NCT01296932|79344984|FG004|Overall Study|per protocol|0|||
44340918|NCT01296932|79344985|FG005|Overall Study|per protocol|0|||
44340919|NCT01296932|79344986|FG006|Overall Study|per protocol|0|||
44340920|NCT01296932|79344987|FG007|Overall Study|per protocol|0|||
44340921|NCT01296932|79344988|FG008|Overall Study|per protocol|0|||
44340922|NCT01296932|79344980|FG000|Overall Study|Low benefit and too many side effects|0|||
44340923|NCT01296932|79344981|FG001|Overall Study|Low benefit and too many side effects|0|||
44340924|NCT01296932|79344982|FG002|Overall Study|Low benefit and too many side effects|0|||
44340925|NCT01296932|79344983|FG003|Overall Study|Low benefit and too many side effects|0|||
44340926|NCT01296932|79344984|FG004|Overall Study|Low benefit and too many side effects|0|||
44340927|NCT01296932|79344985|FG005|Overall Study|Low benefit and too many side effects|0|||
44340928|NCT01296932|79344986|FG006|Overall Study|Low benefit and too many side effects|0|||
44340929|NCT01296932|79344987|FG007|Overall Study|Low benefit and too many side effects|1|||
44340930|NCT01296932|79344988|FG008|Overall Study|Low benefit and too many side effects|0|||
44340931|NCT01296932|79344980|FG000|Overall Study|No adequate treatment response|0|||
44340932|NCT01296932|79344981|FG001|Overall Study|No adequate treatment response|0|||
44340933|NCT01296932|79344982|FG002|Overall Study|No adequate treatment response|0|||
44340934|NCT01296932|79344983|FG003|Overall Study|No adequate treatment response|0|||
44340935|NCT01296932|79344984|FG004|Overall Study|No adequate treatment response|0|||
44340936|NCT01296932|79344985|FG005|Overall Study|No adequate treatment response|0|||
44340937|NCT01296932|79344986|FG006|Overall Study|No adequate treatment response|0|||
44340938|NCT01296932|79344987|FG007|Overall Study|No adequate treatment response|1|||
44340939|NCT01296932|79344988|FG008|Overall Study|No adequate treatment response|0|||
44340940|NCT01296932|79344980|FG000|Overall Study|Dosage already reduced, AE still present|0|||
44340941|NCT01296932|79344981|FG001|Overall Study|Dosage already reduced, AE still present|0|||
44340942|NCT01296932|79344982|FG002|Overall Study|Dosage already reduced, AE still present|0|||
44340943|NCT01296932|79344983|FG003|Overall Study|Dosage already reduced, AE still present|0|||
44340944|NCT01296932|79344984|FG004|Overall Study|Dosage already reduced, AE still present|0|||
44340945|NCT01296932|79344985|FG005|Overall Study|Dosage already reduced, AE still present|0|||
44340946|NCT01296932|79344986|FG006|Overall Study|Dosage already reduced, AE still present|0|||
44340947|NCT01296932|79344987|FG007|Overall Study|Dosage already reduced, AE still present|0|||
44340948|NCT01296932|79344988|FG008|Overall Study|Dosage already reduced, AE still present|1|||
44340949|NCT01296698|79345011|FG000|Overall Study|Adverse Event|1|||
44340950|NCT01296698|79345012|FG001|Overall Study|Adverse Event|0|||
44340951|NCT01296698|79345011|FG000|Overall Study|Death|1|||
44340952|NCT01296698|79345012|FG001|Overall Study|Death|0|||
44340953|NCT01296698|79345011|FG000|Overall Study|Lost to Follow-up|19|||
44340954|NCT01296698|79345012|FG001|Overall Study|Lost to Follow-up|1|||
44340955|NCT01296698|79345011|FG000|Overall Study|Withdrawal by Subject|12|||
44340956|NCT01296698|79345012|FG001|Overall Study|Withdrawal by Subject|0|||
44340957|NCT01296698|79345011|FG000|Overall Study|Difficulty Contacting Subject|2|||
44340958|NCT01296698|79345012|FG001|Overall Study|Difficulty Contacting Subject|0|||
44340959|NCT01296698|79345011|FG000|Overall Study|Study Terminated by Sponsor|209|||
44340960|NCT01296698|79345012|FG001|Overall Study|Study Terminated by Sponsor|12|||
44340961|NCT01001221|79345022|FG000|Overall Study|Adverse Event|1|||
44340962|NCT01001221|79345023|FG001|Overall Study|Adverse Event|2|||
44340963|NCT01001221|79345024|FG002|Overall Study|Adverse Event|0|||
44340964|NCT01001221|79345025|FG003|Overall Study|Adverse Event|2|||
44440131|NCT00256867|79448517|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
44440132|NCT00256867|79448510|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44440133|NCT00256867|79448511|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44440134|NCT00256867|79448512|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44159037|NCT03971474|78951297|FG000|Overall Study|Adverse Event|11|||
44159038|NCT03971474|78951298|FG001|Overall Study|Adverse Event|7|||
44159039|NCT03971474|78951297|FG000|Overall Study|Refusal unrelated to adverse event|5|||
44340965|NCT01001221|79345026|FG004|Overall Study|Adverse Event|0|||
44340966|NCT01001221|79345022|FG000|Overall Study|Disease progression|3|||
44340967|NCT01001221|79345023|FG001|Overall Study|Disease progression|2|||
44340968|NCT01001221|79345024|FG002|Overall Study|Disease progression|2|||
44340969|NCT01001221|79345025|FG003|Overall Study|Disease progression|4|||
44340970|NCT01001221|79345026|FG004|Overall Study|Disease progression|0|||
44340971|NCT01001221|79345022|FG000|Overall Study|Other|1|||
44340972|NCT01001221|79345023|FG001|Overall Study|Other|1|||
44340973|NCT01001221|79345024|FG002|Overall Study|Other|0|||
44340974|NCT01001221|79345025|FG003|Overall Study|Other|0|||
44340975|NCT01001221|79345026|FG004|Overall Study|Other|0|||
44340976|NCT01001221|79345022|FG000|Overall Study|Not treated; protocol exclusion|0|||
44340977|NCT01001221|79345023|FG001|Overall Study|Not treated; protocol exclusion|0|||
44340978|NCT01001221|79345024|FG002|Overall Study|Not treated; protocol exclusion|1|||
44340979|NCT01001221|79345025|FG003|Overall Study|Not treated; protocol exclusion|0|||
44340980|NCT01001221|79345026|FG004|Overall Study|Not treated; protocol exclusion|0|||
44340981|NCT01296152|79345037|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
44340982|NCT01002547|79345044|FG000|Overall Study|Withdrawal by Subject|4|||
44340983|NCT01002547|79345045|FG001|Overall Study|Withdrawal by Subject|0|||
44340984|NCT01002547|79345046|FG002|Overall Study|Withdrawal by Subject|5|||
44340985|NCT01002547|79345044|FG000|Overall Study|Lost to Follow-up|2|||
44340986|NCT01002547|79345045|FG001|Overall Study|Lost to Follow-up|1|||
44340987|NCT01002547|79345046|FG002|Overall Study|Lost to Follow-up|1|||
44340988|NCT01002547|79345044|FG000|Overall Study|Physician Decision|1|||
44340989|NCT01002547|79345045|FG001|Overall Study|Physician Decision|0|||
44340990|NCT01002547|79345046|FG002|Overall Study|Physician Decision|0|||
44340991|NCT01002547|79345044|FG000|Overall Study|Death|0|||
44340992|NCT01002547|79345045|FG001|Overall Study|Death|2|||
44340993|NCT01002547|79345046|FG002|Overall Study|Death|2|||
44340994|NCT01002547|79345044|FG000|Overall Study|Adverse Event|1|||
44340995|NCT01002547|79345045|FG001|Overall Study|Adverse Event|0|||
44159040|NCT03971474|78951298|FG001|Overall Study|Refusal unrelated to adverse event|1|||
44340996|NCT01002547|79345046|FG002|Overall Study|Adverse Event|0|||
44340997|NCT01225731|79345059|FG000|Part 1|Did not meet eligibility criteria|1|||
44340998|NCT01225731|79345060|FG001|Part 1|Did not meet eligibility criteria|0|||
44340999|NCT01225731|79345061|FG002|Part 1|Did not meet eligibility criteria|0|||
44341000|NCT01225731|79345062|FG003|Part 1|Did not meet eligibility criteria|0|||
44341001|NCT01225731|79345063|FG004|Part 1|Did not meet eligibility criteria|1|||
44341002|NCT01225731|79345064|FG005|Part 1|Did not meet eligibility criteria|0|||
44341003|NCT01225731|79345065|FG006|Part 1|Did not meet eligibility criteria|0|||
44341004|NCT01225731|79345066|FG007|Part 1|Did not meet eligibility criteria|0|||
44341005|NCT01225731|79345067|FG008|Part 1|Did not meet eligibility criteria|0|||
44341006|NCT01225731|79345068|FG009|Part 1|Did not meet eligibility criteria|0|||
44341007|NCT01225731|79345069|FG010|Part 1|Did not meet eligibility criteria|0|||
44341008|NCT01225731|79345070|FG011|Part 1|Did not meet eligibility criteria|0|||
44341009|NCT01225731|79345071|FG012|Part 1|Did not meet eligibility criteria|0|||
44341010|NCT01225731|79345059|FG000|Part 1|Adverse Event|1|||
44341011|NCT01225731|79345060|FG001|Part 1|Adverse Event|2|||
44341012|NCT01225731|79345061|FG002|Part 1|Adverse Event|1|||
44341013|NCT01225731|79345062|FG003|Part 1|Adverse Event|1|||
44341014|NCT01225731|79345063|FG004|Part 1|Adverse Event|1|||
44341015|NCT01225731|79345064|FG005|Part 1|Adverse Event|0|||
44341016|NCT01225731|79345065|FG006|Part 1|Adverse Event|0|||
44341017|NCT01225731|79345066|FG007|Part 1|Adverse Event|0|||
44341018|NCT01225731|79345067|FG008|Part 1|Adverse Event|0|||
44341019|NCT01225731|79345068|FG009|Part 1|Adverse Event|0|||
44341020|NCT01225731|79345069|FG010|Part 1|Adverse Event|0|||
44341021|NCT01225731|79345070|FG011|Part 1|Adverse Event|0|||
44341022|NCT01225731|79345071|FG012|Part 1|Adverse Event|0|||
44341023|NCT01225731|79345059|FG000|Part 1|Withdrawal by Subject|0|||
44341024|NCT01225731|79345060|FG001|Part 1|Withdrawal by Subject|3|||
44341025|NCT01225731|79345061|FG002|Part 1|Withdrawal by Subject|0|||
44341026|NCT01225731|79345062|FG003|Part 1|Withdrawal by Subject|0|||
44341027|NCT01225731|79345063|FG004|Part 1|Withdrawal by Subject|4|||
44341028|NCT01225731|79345064|FG005|Part 1|Withdrawal by Subject|0|||
44341029|NCT01225731|79345065|FG006|Part 1|Withdrawal by Subject|0|||
44341030|NCT01225731|79345066|FG007|Part 1|Withdrawal by Subject|0|||
44341031|NCT01225731|79345067|FG008|Part 1|Withdrawal by Subject|0|||
44341032|NCT01225731|79345068|FG009|Part 1|Withdrawal by Subject|0|||
44341033|NCT01225731|79345069|FG010|Part 1|Withdrawal by Subject|0|||
44341034|NCT01225731|79345070|FG011|Part 1|Withdrawal by Subject|0|||
44341035|NCT01225731|79345071|FG012|Part 1|Withdrawal by Subject|0|||
44341036|NCT01225731|79345059|FG000|Part 1|Protocol Violation|0|||
44341037|NCT01225731|79345060|FG001|Part 1|Protocol Violation|0|||
44341038|NCT01225731|79345061|FG002|Part 1|Protocol Violation|0|||
44341039|NCT01225731|79345062|FG003|Part 1|Protocol Violation|1|||
44341040|NCT01225731|79345063|FG004|Part 1|Protocol Violation|0|||
44341041|NCT01225731|79345064|FG005|Part 1|Protocol Violation|0|||
44341042|NCT01225731|79345065|FG006|Part 1|Protocol Violation|0|||
44341043|NCT01225731|79345066|FG007|Part 1|Protocol Violation|0|||
44341044|NCT01225731|79345067|FG008|Part 1|Protocol Violation|0|||
44341045|NCT01225731|79345068|FG009|Part 1|Protocol Violation|0|||
44341046|NCT01225731|79345069|FG010|Part 1|Protocol Violation|0|||
44341047|NCT01225731|79345070|FG011|Part 1|Protocol Violation|0|||
44341048|NCT01225731|79345071|FG012|Part 1|Protocol Violation|0|||
44341049|NCT01225731|79345059|FG000|Part 2|Protocol Violation|0|||
44341050|NCT01225731|79345060|FG001|Part 2|Protocol Violation|0|||
44341051|NCT01225731|79345061|FG002|Part 2|Protocol Violation|0|||
44341052|NCT01225731|79345062|FG003|Part 2|Protocol Violation|0|||
44341053|NCT01225731|79345063|FG004|Part 2|Protocol Violation|0|||
44341054|NCT01225731|79345064|FG005|Part 2|Protocol Violation|1|||
44341055|NCT01225731|79345065|FG006|Part 2|Protocol Violation|0|||
44341056|NCT01225731|79345066|FG007|Part 2|Protocol Violation|0|||
44341057|NCT01225731|79345067|FG008|Part 2|Protocol Violation|1|||
44341058|NCT01225731|79345068|FG009|Part 2|Protocol Violation|0|||
44341059|NCT01225731|79345069|FG010|Part 2|Protocol Violation|0|||
44341060|NCT01225731|79345070|FG011|Part 2|Protocol Violation|0|||
44341061|NCT01225731|79345071|FG012|Part 2|Protocol Violation|0|||
44341062|NCT01225731|79345059|FG000|Part 2|Adverse Event|0|||
44341063|NCT01225731|79345060|FG001|Part 2|Adverse Event|0|||
44341064|NCT01225731|79345061|FG002|Part 2|Adverse Event|0|||
44341065|NCT01225731|79345062|FG003|Part 2|Adverse Event|0|||
44341066|NCT01225731|79345063|FG004|Part 2|Adverse Event|0|||
44341067|NCT01225731|79345064|FG005|Part 2|Adverse Event|0|||
44341068|NCT01225731|79345065|FG006|Part 2|Adverse Event|4|||
44440135|NCT00256867|79448513|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44440136|NCT00256867|79448514|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44440137|NCT00256867|79448515|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44440138|NCT00256867|79448516|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
44341069|NCT01225731|79345066|FG007|Part 2|Adverse Event|4|||
44341070|NCT01225731|79345067|FG008|Part 2|Adverse Event|2|||
44341071|NCT01225731|79345068|FG009|Part 2|Adverse Event|0|||
44341072|NCT01225731|79345069|FG010|Part 2|Adverse Event|0|||
44341073|NCT01225731|79345070|FG011|Part 2|Adverse Event|0|||
44341074|NCT01225731|79345071|FG012|Part 2|Adverse Event|0|||
44341075|NCT01225731|79345059|FG000|Part 2|Lack of Efficacy|0|||
44341076|NCT01225731|79345060|FG001|Part 2|Lack of Efficacy|0|||
44341077|NCT01225731|79345061|FG002|Part 2|Lack of Efficacy|0|||
44341078|NCT01225731|79345062|FG003|Part 2|Lack of Efficacy|0|||
44341079|NCT01225731|79345063|FG004|Part 2|Lack of Efficacy|0|||
44341080|NCT01225731|79345064|FG005|Part 2|Lack of Efficacy|1|||
44341081|NCT01225731|79345065|FG006|Part 2|Lack of Efficacy|0|||
44341082|NCT01225731|79345066|FG007|Part 2|Lack of Efficacy|12|||
44341083|NCT01225731|79345067|FG008|Part 2|Lack of Efficacy|3|||
44341084|NCT01225731|79345068|FG009|Part 2|Lack of Efficacy|0|||
44341085|NCT01225731|79345069|FG010|Part 2|Lack of Efficacy|0|||
44341086|NCT01225731|79345070|FG011|Part 2|Lack of Efficacy|0|||
44341087|NCT01225731|79345071|FG012|Part 2|Lack of Efficacy|0|||
44341088|NCT01225731|79345059|FG000|Part 2|Pregnancy|0|||
44341089|NCT01225731|79345060|FG001|Part 2|Pregnancy|0|||
44341090|NCT01225731|79345061|FG002|Part 2|Pregnancy|0|||
44341091|NCT01225731|79345062|FG003|Part 2|Pregnancy|0|||
44341092|NCT01225731|79345063|FG004|Part 2|Pregnancy|0|||
44341093|NCT01225731|79345064|FG005|Part 2|Pregnancy|0|||
44341094|NCT01225731|79345065|FG006|Part 2|Pregnancy|1|||
44341095|NCT01225731|79345066|FG007|Part 2|Pregnancy|0|||
44341096|NCT01225731|79345067|FG008|Part 2|Pregnancy|1|||
44341097|NCT01225731|79345068|FG009|Part 2|Pregnancy|0|||
44341098|NCT01225731|79345069|FG010|Part 2|Pregnancy|0|||
44341099|NCT01225731|79345070|FG011|Part 2|Pregnancy|0|||
44341100|NCT01225731|79345071|FG012|Part 2|Pregnancy|0|||
44341101|NCT01225731|79345059|FG000|Part 2|Lost to Follow-up|0|||
44341102|NCT01225731|79345060|FG001|Part 2|Lost to Follow-up|0|||
44440139|NCT00256867|79448517|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
44341103|NCT01225731|79345061|FG002|Part 2|Lost to Follow-up|0|||
44341104|NCT01225731|79345062|FG003|Part 2|Lost to Follow-up|0|||
44440140|NCT00256867|79448510|FG000|Overall Study|Investigator's Decision|0|||
44440141|NCT00256867|79448511|FG001|Overall Study|Investigator's Decision|0|||
44440142|NCT00256867|79448512|FG002|Overall Study|Investigator's Decision|0|||
44440143|NCT00256867|79448513|FG003|Overall Study|Investigator's Decision|0|||
44440144|NCT00256867|79448514|FG004|Overall Study|Investigator's Decision|1|||
44440145|NCT00256867|79448515|FG005|Overall Study|Investigator's Decision|0|||
44440146|NCT00256867|79448516|FG006|Overall Study|Investigator's Decision|0|||
44440147|NCT00256867|79448517|FG007|Overall Study|Investigator's Decision|0|||
44440148|NCT00256867|79448510|FG000|Overall Study|Non-compliance with study medication|0|||
44440149|NCT00256867|79448511|FG001|Overall Study|Non-compliance with study medication|0|||
44440150|NCT00256867|79448512|FG002|Overall Study|Non-compliance with study medication|0|||
44440151|NCT00256867|79448513|FG003|Overall Study|Non-compliance with study medication|0|||
44440152|NCT00256867|79448514|FG004|Overall Study|Non-compliance with study medication|0|||
44440153|NCT00256867|79448515|FG005|Overall Study|Non-compliance with study medication|0|||
44440154|NCT00256867|79448516|FG006|Overall Study|Non-compliance with study medication|0|||
44440155|NCT00256867|79448517|FG007|Overall Study|Non-compliance with study medication|1|||
44440156|NCT00256867|79448510|FG000|Overall Study|Participant travelled Overseas|0|||
44440157|NCT00256867|79448511|FG001|Overall Study|Participant travelled Overseas|1|||
44440158|NCT00256867|79448512|FG002|Overall Study|Participant travelled Overseas|0|||
44440159|NCT00256867|79448513|FG003|Overall Study|Participant travelled Overseas|0|||
44440160|NCT00256867|79448514|FG004|Overall Study|Participant travelled Overseas|0|||
44440161|NCT00256867|79448515|FG005|Overall Study|Participant travelled Overseas|0|||
44440162|NCT00256867|79448516|FG006|Overall Study|Participant travelled Overseas|0|||
44440163|NCT00256867|79448517|FG007|Overall Study|Participant travelled Overseas|0|||
44440164|NCT00256867|79448510|FG000|Overall Study|Participant out of assessment window|0|||
44440165|NCT00256867|79448511|FG001|Overall Study|Participant out of assessment window|0|||
44440166|NCT00256867|79448512|FG002|Overall Study|Participant out of assessment window|1|||
44440167|NCT00256867|79448513|FG003|Overall Study|Participant out of assessment window|0|||
44440168|NCT00256867|79448514|FG004|Overall Study|Participant out of assessment window|0|||
44440169|NCT00256867|79448515|FG005|Overall Study|Participant out of assessment window|0|||
44440170|NCT00256867|79448516|FG006|Overall Study|Participant out of assessment window|0|||
44341105|NCT01225731|79345063|FG004|Part 2|Lost to Follow-up|0|||
44341106|NCT01225731|79345064|FG005|Part 2|Lost to Follow-up|0|||
44341107|NCT01225731|79345065|FG006|Part 2|Lost to Follow-up|0|||
44341108|NCT01225731|79345066|FG007|Part 2|Lost to Follow-up|3|||
44341109|NCT01225731|79345067|FG008|Part 2|Lost to Follow-up|1|||
44440171|NCT00256867|79448517|FG007|Overall Study|Participant out of assessment window|0|||
44341110|NCT01225731|79345068|FG009|Part 2|Lost to Follow-up|0|||
44159041|NCT03971474|78951297|FG000|Overall Study|Progression/relapse|40|||
44341111|NCT01225731|79345069|FG010|Part 2|Lost to Follow-up|0|||
44341112|NCT01225731|79345070|FG011|Part 2|Lost to Follow-up|0|||
44440172|NCT00256867|79448510|FG000|Overall Study|Withdrawal by participant|0|||
44440173|NCT00256867|79448511|FG001|Overall Study|Withdrawal by participant|0|||
44440174|NCT00256867|79448512|FG002|Overall Study|Withdrawal by participant|0|||
44440175|NCT00256867|79448513|FG003|Overall Study|Withdrawal by participant|0|||
44440176|NCT00256867|79448514|FG004|Overall Study|Withdrawal by participant|0|||
44440177|NCT00256867|79448515|FG005|Overall Study|Withdrawal by participant|1|||
44440178|NCT00256867|79448516|FG006|Overall Study|Withdrawal by participant|0|||
44440179|NCT00256867|79448517|FG007|Overall Study|Withdrawal by participant|0|||
44440180|NCT00731939|79448540|FG000|Overall Study|Adverse Event|6|||
44440181|NCT00731939|79448540|FG000|Overall Study|Lost to Follow-up|15|||
44440182|NCT00731939|79448540|FG000|Overall Study|Not implanted with study device|9|||
44440183|NCT00731939|79448540|FG000|Overall Study|Withdrawal by Subject|2|||
44440184|NCT00731939|79448540|FG000|Overall Study|Did not meet enrollment criteria|2|||
44440185|NCT00731783|79448546|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
44440186|NCT00731783|79448547|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
44440187|NCT00731783|79448546|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
44440188|NCT00731783|79448547|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
44440189|NCT00731783|79448546|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
44440190|NCT00731783|79448547|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
44440191|NCT00731783|79448546|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
44440192|NCT00731783|79448547|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
44440193|NCT00724451|79448553|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
44159042|NCT03971474|78951298|FG001|Overall Study|Progression/relapse|47|||
44159043|NCT03971474|78951297|FG000|Overall Study|Death|6|||
44159044|NCT03971474|78951298|FG001|Overall Study|Death|3|||
44159045|NCT03971474|78951297|FG000|Overall Study|Other - not protocol specified|5|||
44159046|NCT03971474|78951298|FG001|Overall Study|Other - not protocol specified|4|||
44159047|NCT03971474|78951297|FG000|Overall Study|On treatment|0|||
44159048|NCT03971474|78951298|FG001|Overall Study|On treatment|7|||
44159049|NCT03901079|78951305|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
44159050|NCT03845296|78951311|FG000|Overall Study|On Treatment|2|||
44159051|NCT03845296|78951312|FG001|Overall Study|On Treatment|1|||
44159052|NCT03845296|78951311|FG000|Overall Study|Adverse Event|4|||
44159053|NCT03845296|78951312|FG001|Overall Study|Adverse Event|11|||
44159054|NCT03845296|78951311|FG000|Overall Study|Refusal unrelated to adverse event|0|||
44159055|NCT03845296|78951312|FG001|Overall Study|Refusal unrelated to adverse event|1|||
44159056|NCT03845296|78951311|FG000|Overall Study|Progression/relapse|14|||
44159057|NCT03845296|78951312|FG001|Overall Study|Progression/relapse|18|||
44159058|NCT03845296|78951311|FG000|Overall Study|Death|4|||
44159059|NCT03845296|78951312|FG001|Overall Study|Death|0|||
44159060|NCT03845296|78951311|FG000|Overall Study|Other - not protocol specified|1|||
44159061|NCT03845296|78951312|FG001|Overall Study|Other - not protocol specified|3|||
44159062|NCT03841448|78951320|FG000|Double Blind Treatment Period|Death|1|||
44159063|NCT03841448|78951321|FG001|Double Blind Treatment Period|Death|1|||
44159064|NCT03841448|78951322|FG002|Double Blind Treatment Period|Death|0|||
44159065|NCT03841448|78951323|FG003|Double Blind Treatment Period|Death|0|||
44159066|NCT03841448|78951320|FG000|Open-Label Extension Period|Participants Stopped Participation in the Study|0|||
44159067|NCT03841448|78951321|FG001|Open-Label Extension Period|Participants Stopped Participation in the Study|0|||
44159068|NCT03841448|78951322|FG002|Open-Label Extension Period|Participants Stopped Participation in the Study|1|||
44159069|NCT03841448|78951323|FG003|Open-Label Extension Period|Participants Stopped Participation in the Study|1|||
44159070|NCT03841448|78951320|FG000|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|0|||
44159071|NCT03841448|78951321|FG001|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|0|||
44159072|NCT03841448|78951322|FG002|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|7|||
44159073|NCT03841448|78951323|FG003|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|19|||
44159074|NCT03382782|78951334|FG000|Cohort 1|Withdrawal by Subject|11|||
44159075|NCT03382782|78951335|FG001|Cohort 1|Withdrawal by Subject|5|||
44159076|NCT03382782|78951336|FG002|Cohort 1|Withdrawal by Subject|0|||
44159077|NCT03382782|78951334|FG000|Cohort 2|Withdrawal by Subject|1|||
44159078|NCT03382782|78951335|FG001|Cohort 2|Withdrawal by Subject|1|||
44159079|NCT03382782|78951336|FG002|Cohort 2|Withdrawal by Subject|0|||
44440194|NCT00724451|79448553|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
44440195|NCT00724451|79448553|FG000|Overall Study|Not Eligible for Treatment|431|||
44440196|NCT00724451|79448553|FG000|Overall Study|Participant Refused Treatment|89|||
44440197|NCT00724451|79448553|FG000|Overall Study|Never Started Treatment|89|||
44440198|NCT00724451|79448553|FG000|Overall Study|Unknown; No Data Sources Available|9|||
44440199|NCT00724451|79448553|FG000|Overall Study|Physician Decision|116|||
44440200|NCT00724451|79448553|FG000|Overall Study|Withdrawal by Subject|45|||
44440201|NCT00724451|79448553|FG000|Overall Study|Investigator + Participant Decision|13|||
44440202|NCT00724373|79448557|FG000|Overall Study|Adverse Event|41|||
44440203|NCT00724373|79448557|FG000|Overall Study|Lack of Efficacy|82|||
44440204|NCT00724373|79448557|FG000|Overall Study|Lost to Follow-up|7|||
44440205|NCT00724373|79448557|FG000|Overall Study|Non-compliance|2|||
44440206|NCT00724373|79448557|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
44440207|NCT00724373|79448557|FG000|Overall Study|Participant moved away|1|||
44440208|NCT00724373|79448557|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
44440209|NCT00724373|79448557|FG000|Overall Study|Only to have 24 week regimen|1|||
44259701|NCT02641587|79121897|FG000|Confinement Period|Adverse Event|1|||
44341113|NCT01225731|79345071|FG012|Part 2|Lost to Follow-up|0|||
44341114|NCT01225731|79345059|FG000|Part 2|Physician Decision|0|||
44341115|NCT01225731|79345060|FG001|Part 2|Physician Decision|0|||
44341116|NCT01225731|79345061|FG002|Part 2|Physician Decision|0|||
44341117|NCT01225731|79345062|FG003|Part 2|Physician Decision|0|||
44341118|NCT01225731|79345063|FG004|Part 2|Physician Decision|0|||
44341119|NCT01225731|79345064|FG005|Part 2|Physician Decision|0|||
44341120|NCT01225731|79345065|FG006|Part 2|Physician Decision|0|||
44341121|NCT01225731|79345066|FG007|Part 2|Physician Decision|2|||
44341122|NCT01225731|79345067|FG008|Part 2|Physician Decision|2|||
44341123|NCT01225731|79345068|FG009|Part 2|Physician Decision|0|||
44341124|NCT01225731|79345069|FG010|Part 2|Physician Decision|0|||
44341125|NCT01225731|79345070|FG011|Part 2|Physician Decision|0|||
44341126|NCT01225731|79345071|FG012|Part 2|Physician Decision|0|||
44341127|NCT01225731|79345059|FG000|Part 2|Withdrawal by Subject|0|||
44341128|NCT01225731|79345060|FG001|Part 2|Withdrawal by Subject|0|||
44341129|NCT01225731|79345061|FG002|Part 2|Withdrawal by Subject|0|||
44341130|NCT01225731|79345062|FG003|Part 2|Withdrawal by Subject|0|||
44341131|NCT01225731|79345063|FG004|Part 2|Withdrawal by Subject|0|||
44341132|NCT01225731|79345064|FG005|Part 2|Withdrawal by Subject|1|||
44341133|NCT01225731|79345065|FG006|Part 2|Withdrawal by Subject|3|||
44341134|NCT01225731|79345066|FG007|Part 2|Withdrawal by Subject|4|||
44341135|NCT01225731|79345067|FG008|Part 2|Withdrawal by Subject|1|||
44341136|NCT01225731|79345068|FG009|Part 2|Withdrawal by Subject|0|||
44341137|NCT01225731|79345069|FG010|Part 2|Withdrawal by Subject|0|||
44341138|NCT01225731|79345070|FG011|Part 2|Withdrawal by Subject|0|||
44341139|NCT01225731|79345071|FG012|Part 2|Withdrawal by Subject|0|||
44341140|NCT01225731|79345059|FG000|Part 3|Adverse Event|0|||
44341141|NCT01225731|79345060|FG001|Part 3|Adverse Event|0|||
44341142|NCT01225731|79345061|FG002|Part 3|Adverse Event|0|||
44341143|NCT01225731|79345062|FG003|Part 3|Adverse Event|0|||
44341144|NCT01225731|79345063|FG004|Part 3|Adverse Event|0|||
44341145|NCT01225731|79345064|FG005|Part 3|Adverse Event|0|||
44341146|NCT01225731|79345065|FG006|Part 3|Adverse Event|0|||
44341147|NCT01225731|79345066|FG007|Part 3|Adverse Event|0|||
44341148|NCT01225731|79345067|FG008|Part 3|Adverse Event|0|||
44341149|NCT01225731|79345068|FG009|Part 3|Adverse Event|0|||
44341150|NCT01225731|79345069|FG010|Part 3|Adverse Event|1|||
44341151|NCT01225731|79345070|FG011|Part 3|Adverse Event|1|||
44341152|NCT01225731|79345071|FG012|Part 3|Adverse Event|0|||
44341153|NCT01225731|79345059|FG000|Part 3|Lost to Follow-up|0|||
44440210|NCT00724373|79448557|FG000|Overall Study|Viral Relapse|1|||
44440211|NCT00724373|79448557|FG000|Overall Study|Acute HCV infection|1|||
44259702|NCT02641587|79121898|FG001|Confinement Period|Adverse Event|0|||
44259703|NCT02641587|79121897|FG000|Confinement Period|Withdrawal by Subject|2|||
44259704|NCT02641587|79121898|FG001|Confinement Period|Withdrawal by Subject|1|||
44259705|NCT02641587|79121897|FG000|Ambulatory Period|Withdrawal by Subject|1|||
44259706|NCT02641587|79121898|FG001|Ambulatory Period|Withdrawal by Subject|0|||
44259707|NCT04672083|79122005|FG000|Overall Study|Lost to Follow-up|1|||
44259708|NCT04672083|79122006|FG001|Overall Study|Lost to Follow-up|0|||
44259709|NCT04672083|79122007|FG002|Overall Study|Lost to Follow-up|0|||
44259710|NCT04672083|79122008|FG003|Overall Study|Lost to Follow-up|0|||
44259711|NCT04672083|79122009|FG004|Overall Study|Lost to Follow-up|0|||
44259712|NCT01781637|79122112|FG000|Overall Study|Adverse Event|1|||
44259713|NCT01781637|79122113|FG001|Overall Study|Adverse Event|0|||
44259714|NCT01781637|79122112|FG000|Overall Study|Lack of Efficacy|2|||
44259715|NCT01781637|79122113|FG001|Overall Study|Lack of Efficacy|6|||
44259716|NCT01781637|79122112|FG000|Overall Study|Withdrawal by Subject|1|||
44259717|NCT01781637|79122113|FG001|Overall Study|Withdrawal by Subject|0|||
44259718|NCT04575584|79122502|FG000|Overall Study|Death|6|||
44259719|NCT04575584|79122503|FG001|Overall Study|Death|4|||
44259720|NCT04575584|79122504|FG002|Overall Study|Death|6|||
44259721|NCT04575584|79122505|FG003|Overall Study|Death|2|||
44259722|NCT04575584|79122506|FG004|Overall Study|Death|0|||
44341154|NCT01225731|79345060|FG001|Part 3|Lost to Follow-up|0|||
44341155|NCT01225731|79345061|FG002|Part 3|Lost to Follow-up|0|||
44341156|NCT01225731|79345062|FG003|Part 3|Lost to Follow-up|0|||
44341157|NCT01225731|79345063|FG004|Part 3|Lost to Follow-up|0|||
44341158|NCT01225731|79345064|FG005|Part 3|Lost to Follow-up|0|||
44440212|NCT00724373|79448557|FG000|Overall Study|Drug Relapse|1|||
44440213|NCT00724373|79448557|FG000|Overall Study|Tolerability|23|||
44440214|NCT00724061|79448561|FG000|Dose Escalation Phase|Adverse Event|2|||
44440215|NCT00724061|79448561|FG000|Dose Escalation Phase|Disease Progression|3|||
44440216|NCT00731549|79448565|FG000|Overall Study|Lost to Follow-up|19|||
44440217|NCT00731549|79448565|FG000|Overall Study|Met withdrawal criteria|24|||
44440218|NCT00731549|79448565|FG000|Overall Study|Physician Decision|16|||
44440219|NCT00731549|79448565|FG000|Overall Study|Withdrawal by Subject|89|||
44440220|NCT00731549|79448565|FG000|Overall Study|Protocol deviation|1|||
44440221|NCT00731549|79448565|FG000|Overall Study|Adverse Event|31|||
44440222|NCT00731549|79448565|FG000|Overall Study|Lack of efficacy with AE|37|||
44440223|NCT00731549|79448565|FG000|Overall Study|Lack of efficacy without AE|6|||
44440224|NCT00730925|79448610|FG000|Overall Study|Progressive Disease|21|||
44440225|NCT00730925|79448610|FG000|Overall Study|Dose reducing Event|2|||
44440226|NCT00730925|79448610|FG000|Overall Study|Other Averse Event|7|||
44440227|NCT00730925|79448610|FG000|Overall Study|Protocol Violation|1|||
44440228|NCT00730925|79448610|FG000|Overall Study|Withdrawal by Subject|1|||
44440229|NCT00730925|79448610|FG000|Overall Study|Switch to combination therapy|8|||
44440230|NCT00730925|79448610|FG000|Overall Study|Other|1|||
44440231|NCT00236899|79448618|FG000|Overall Study|Adverse Event (Study Related)|1|||
44440232|NCT00236899|79448619|FG001|Overall Study|Adverse Event (Study Related)|1|||
44440233|NCT00236899|79448620|FG002|Overall Study|Adverse Event (Study Related)|2|||
44440234|NCT00236899|79448621|FG003|Overall Study|Adverse Event (Study Related)|1|||
44440235|NCT00236899|79448618|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
44440236|NCT00236899|79448619|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
44440237|NCT00236899|79448620|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
44440238|NCT00236899|79448621|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
44440239|NCT00236899|79448618|FG000|Overall Study|Death (Study Disease)|1|||
44440240|NCT00236899|79448619|FG001|Overall Study|Death (Study Disease)|4|||
44440241|NCT00236899|79448620|FG002|Overall Study|Death (Study Disease)|0|||
44440242|NCT00236899|79448621|FG003|Overall Study|Death (Study Disease)|0|||
44440243|NCT00236899|79448618|FG000|Overall Study|Death (Not Study Related)|2|||
44440244|NCT00236899|79448619|FG001|Overall Study|Death (Not Study Related)|0|||
44440245|NCT00236899|79448620|FG002|Overall Study|Death (Not Study Related)|0|||
44440246|NCT00236899|79448621|FG003|Overall Study|Death (Not Study Related)|0|||
44440247|NCT00236899|79448618|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
44440248|NCT00236899|79448619|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
44440249|NCT00236899|79448620|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
44440250|NCT00236899|79448621|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
44341159|NCT01225731|79345065|FG006|Part 3|Lost to Follow-up|0|||
44341160|NCT01225731|79345066|FG007|Part 3|Lost to Follow-up|0|||
44341161|NCT01225731|79345067|FG008|Part 3|Lost to Follow-up|0|||
44341162|NCT01225731|79345068|FG009|Part 3|Lost to Follow-up|0|||
44341163|NCT01225731|79345069|FG010|Part 3|Lost to Follow-up|1|||
44341164|NCT01225731|79345070|FG011|Part 3|Lost to Follow-up|2|||
44341165|NCT01225731|79345071|FG012|Part 3|Lost to Follow-up|1|||
44341166|NCT01225731|79345059|FG000|Part 3|Physician Decision|0|||
44341167|NCT01225731|79345060|FG001|Part 3|Physician Decision|0|||
44341168|NCT01225731|79345061|FG002|Part 3|Physician Decision|0|||
44440251|NCT00236899|79448618|FG000|Overall Study|Lost to Follow-up|0|||
44440252|NCT00236899|79448619|FG001|Overall Study|Lost to Follow-up|1|||
44440253|NCT00236899|79448620|FG002|Overall Study|Lost to Follow-up|0|||
44440254|NCT00236899|79448621|FG003|Overall Study|Lost to Follow-up|0|||
44440255|NCT00236899|79448618|FG000|Overall Study|Entry Criteria Exclusion|0|||
44440256|NCT00236899|79448619|FG001|Overall Study|Entry Criteria Exclusion|1|||
44440257|NCT00236899|79448620|FG002|Overall Study|Entry Criteria Exclusion|1|||
44440258|NCT00236899|79448621|FG003|Overall Study|Entry Criteria Exclusion|0|||
44440259|NCT00236899|79448618|FG000|Overall Study|Protocol Violation|1|||
44440260|NCT00236899|79448619|FG001|Overall Study|Protocol Violation|0|||
44440261|NCT00236899|79448620|FG002|Overall Study|Protocol Violation|0|||
44440262|NCT00236899|79448621|FG003|Overall Study|Protocol Violation|0|||
44440263|NCT00236899|79448618|FG000|Overall Study|Withdrawal by Subject|6|||
44440264|NCT00236899|79448619|FG001|Overall Study|Withdrawal by Subject|4|||
44440265|NCT00236899|79448620|FG002|Overall Study|Withdrawal by Subject|5|||
44440266|NCT00236899|79448621|FG003|Overall Study|Withdrawal by Subject|2|||
44440267|NCT00236899|79448618|FG000|Overall Study|Physician Decision|7|||
44440268|NCT00236899|79448619|FG001|Overall Study|Physician Decision|8|||
44341169|NCT01225731|79345062|FG003|Part 3|Physician Decision|0|||
44341170|NCT01225731|79345063|FG004|Part 3|Physician Decision|0|||
44440269|NCT00236899|79448620|FG002|Overall Study|Physician Decision|7|||
44440270|NCT00236899|79448621|FG003|Overall Study|Physician Decision|6|||
44440271|NCT00236899|79448618|FG000|Overall Study|Satisfactory Response|2|||
44440272|NCT00236899|79448619|FG001|Overall Study|Satisfactory Response|0|||
44341171|NCT01225731|79345064|FG005|Part 3|Physician Decision|0|||
44341172|NCT01225731|79345065|FG006|Part 3|Physician Decision|0|||
44440273|NCT00236899|79448620|FG002|Overall Study|Satisfactory Response|0|||
44440274|NCT00236899|79448621|FG003|Overall Study|Satisfactory Response|1|||
44440275|NCT00236899|79448618|FG000|Overall Study|Lack of Efficacy|18|||
44440276|NCT00236899|79448619|FG001|Overall Study|Lack of Efficacy|18|||
44440277|NCT00236899|79448620|FG002|Overall Study|Lack of Efficacy|25|||
44440278|NCT00236899|79448621|FG003|Overall Study|Lack of Efficacy|23|||
44440279|NCT00611130|79448640|FG000|Overall Study|Lost to Follow-up|25|||
44440280|NCT00611130|79448641|FG001|Overall Study|Lost to Follow-up|29|||
44440281|NCT00611130|79448640|FG000|Overall Study|Protocol noncompliance|7|||
44440282|NCT00611130|79448641|FG001|Overall Study|Protocol noncompliance|6|||
44440283|NCT00611130|79448640|FG000|Overall Study|Withdrawal by Subject|6|||
44440284|NCT00611130|79448641|FG001|Overall Study|Withdrawal by Subject|5|||
44440285|NCT00611130|79448640|FG000|Overall Study|Other|5|||
44440286|NCT00611130|79448641|FG001|Overall Study|Other|4|||
44440287|NCT00611130|79448640|FG000|Overall Study|Incarceration|3|||
44440288|NCT00611130|79448641|FG001|Overall Study|Incarceration|2|||
44440289|NCT00611130|79448640|FG000|Overall Study|Administrative|1|||
44440290|NCT00611130|79448641|FG001|Overall Study|Administrative|1|||
44440291|NCT00611130|79448640|FG000|Overall Study|Adverse Event|1|||
44440292|NCT00611130|79448641|FG001|Overall Study|Adverse Event|0|||
44440293|NCT00611130|79448640|FG000|Overall Study|Death|1|||
44440294|NCT00611130|79448641|FG001|Overall Study|Death|0|||
44440295|NCT00256243|79448648|FG000|Overall Study|Lost to Follow-up|2|||
44440296|NCT00256243|79448648|FG000|Overall Study|Death|7|||
44440297|NCT00256243|79448648|FG000|Overall Study|Not treated|1|||
44440298|NCT00236197|79448655|FG000|Overall Study|Withdrawal by Subject|3|||
44440299|NCT00236197|79448656|FG001|Overall Study|Withdrawal by Subject|2|||
44440300|NCT00236197|79448655|FG000|Overall Study|Lost to Follow-up|1|||
44440301|NCT00236197|79448656|FG001|Overall Study|Lost to Follow-up|5|||
44440302|NCT00236197|79448655|FG000|Overall Study|Protocol Violation|0|||
44440303|NCT00236197|79448656|FG001|Overall Study|Protocol Violation|3|||
44440304|NCT00236197|79448655|FG000|Overall Study|Medication non-compliance|1|||
44440305|NCT00236197|79448656|FG001|Overall Study|Medication non-compliance|2|||
44440306|NCT00236197|79448655|FG000|Overall Study|Other|0|||
44440307|NCT00236197|79448656|FG001|Overall Study|Other|2|||
44440308|NCT00278629|79448662|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
44440309|NCT00612690|79448669|FG000|Overall Study|Lost to Follow-up|72|||
44440310|NCT00612690|79448670|FG001|Overall Study|Lost to Follow-up|98|||
44440311|NCT00612690|79448669|FG000|Overall Study|Withdrawal by Subject|32|||
44440312|NCT00612690|79448670|FG001|Overall Study|Withdrawal by Subject|20|||
44440313|NCT00612690|79448669|FG000|Overall Study|Withdrawal by Site|11|||
44440314|NCT00612690|79448670|FG001|Overall Study|Withdrawal by Site|0|||
44440315|NCT00278473|79448680|FG000|Overall Study|drop out|4|||
44440316|NCT00278473|79448681|FG001|Overall Study|drop out|3|||
44440317|NCT00278395|79448687|FG000|Overall Study|Adverse Event|2|||
44440318|NCT00278395|79448687|FG000|Overall Study|Nonevaluable|1|||
44440319|NCT00612534|79448698|FG000|Overall Study|Adverse Event|0|||
44440320|NCT00612534|79448699|FG001|Overall Study|Adverse Event|4|||
44440321|NCT00612534|79448700|FG002|Overall Study|Adverse Event|2|||
44440322|NCT00612534|79448701|FG003|Overall Study|Adverse Event|1|||
44440323|NCT00612534|79448698|FG000|Overall Study|Lack of Efficacy|13|||
44440324|NCT00612534|79448699|FG001|Overall Study|Lack of Efficacy|12|||
44440325|NCT00612534|79448700|FG002|Overall Study|Lack of Efficacy|5|||
44440326|NCT00612534|79448701|FG003|Overall Study|Lack of Efficacy|16|||
44159080|NCT03382782|78951334|FG000|Cohort 3|Withdrawal by Subject|1|||
44159081|NCT03382782|78951335|FG001|Cohort 3|Withdrawal by Subject|2|||
44159082|NCT03382782|78951336|FG002|Cohort 3|Withdrawal by Subject|0|||
44341173|NCT01225731|79345066|FG007|Part 3|Physician Decision|0|||
44341174|NCT01225731|79345067|FG008|Part 3|Physician Decision|0|||
44341175|NCT01225731|79345068|FG009|Part 3|Physician Decision|0|||
44341176|NCT01225731|79345069|FG010|Part 3|Physician Decision|0|||
44341177|NCT01225731|79345070|FG011|Part 3|Physician Decision|1|||
44341178|NCT01225731|79345071|FG012|Part 3|Physician Decision|2|||
44341179|NCT01225731|79345059|FG000|Part 3|Withdrawal by Subject|0|||
44341180|NCT01225731|79345060|FG001|Part 3|Withdrawal by Subject|0|||
44341181|NCT01225731|79345061|FG002|Part 3|Withdrawal by Subject|0|||
44341182|NCT01225731|79345062|FG003|Part 3|Withdrawal by Subject|0|||
44341183|NCT01225731|79345063|FG004|Part 3|Withdrawal by Subject|0|||
44341184|NCT01225731|79345064|FG005|Part 3|Withdrawal by Subject|0|||
44341185|NCT01225731|79345065|FG006|Part 3|Withdrawal by Subject|0|||
44440327|NCT00612534|79448698|FG000|Overall Study|Other Reason|0|||
44440328|NCT00612534|79448699|FG001|Overall Study|Other Reason|1|||
44440329|NCT00612534|79448700|FG002|Overall Study|Other Reason|0|||
44440330|NCT00612534|79448701|FG003|Overall Study|Other Reason|0|||
44440331|NCT00736853|79448711|FG000|Open-Label Period|Physician Decision|2|||
44440332|NCT00736853|79448712|FG001|Open-Label Period|Physician Decision|0|||
44440333|NCT00736853|79448713|FG002|Open-Label Period|Physician Decision|0|||
44440334|NCT00736853|79448711|FG000|Open-Label Period|Adverse Event|31|||
44341186|NCT01225731|79345066|FG007|Part 3|Withdrawal by Subject|0|||
44440335|NCT00736853|79448712|FG001|Open-Label Period|Adverse Event|0|||
44440336|NCT00736853|79448713|FG002|Open-Label Period|Adverse Event|0|||
44440337|NCT00736853|79448711|FG000|Open-Label Period|Withdrawal by Subject|16|||
44440338|NCT00736853|79448712|FG001|Open-Label Period|Withdrawal by Subject|0|||
44440339|NCT00736853|79448713|FG002|Open-Label Period|Withdrawal by Subject|0|||
44440340|NCT00736853|79448711|FG000|Open-Label Period|Started but not treated|42|||
44440341|NCT00736853|79448712|FG001|Open-Label Period|Started but not treated|0|||
44440342|NCT00736853|79448713|FG002|Open-Label Period|Started but not treated|0|||
44440343|NCT00736853|79448711|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
44440344|NCT00736853|79448712|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
44440345|NCT00736853|79448713|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
44440346|NCT00736853|79448711|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
44440347|NCT00736853|79448712|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
44440348|NCT00736853|79448713|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
44440349|NCT00736853|79448711|FG000|Double-Blind Period|Lack of Efficacy|0|||
44440350|NCT00736853|79448712|FG001|Double-Blind Period|Lack of Efficacy|19|||
44440351|NCT00736853|79448713|FG002|Double-Blind Period|Lack of Efficacy|42|||
44440352|NCT00736853|79448711|FG000|Double-Blind Period|Adverse Event|0|||
44440353|NCT00736853|79448712|FG001|Double-Blind Period|Adverse Event|3|||
44440354|NCT00736853|79448713|FG002|Double-Blind Period|Adverse Event|2|||
44440355|NCT00736853|79448711|FG000|Double-Blind Period|Withdrawal by Subject|0|||
44440356|NCT00736853|79448712|FG001|Double-Blind Period|Withdrawal by Subject|1|||
44440357|NCT00736853|79448713|FG002|Double-Blind Period|Withdrawal by Subject|4|||
44440358|NCT00736853|79448711|FG000|Double-Blind Period|Ineligible to participate the study|0|||
44440359|NCT00736853|79448712|FG001|Double-Blind Period|Ineligible to participate the study|1|||
44440360|NCT00736853|79448713|FG002|Double-Blind Period|Ineligible to participate the study|0|||
44440361|NCT00730847|79448722|FG000|Overall Study|Adverse Event|1|||
44440362|NCT00730847|79448722|FG000|Overall Study|Protocol Violation|2|||
44440363|NCT00730847|79448722|FG000|Overall Study|Withdrawal by Subject|16|||
44440364|NCT00730847|79448722|FG000|Overall Study|Lost to Follow-up|67|||
44440365|NCT00730847|79448722|FG000|Overall Study|Unknown completion status|21|||
44159083|NCT02876328|78951383|FG000|Overall Study|Death|2|||
44440366|NCT00730847|79448722|FG000|Overall Study|Other|24|||
44440367|NCT00573066|79448726|FG000|Overall Study|Exclusion criteria|18|||
44159084|NCT02876328|78951384|FG001|Overall Study|Death|1|||
44440368|NCT00573066|79448726|FG000|Overall Study|IV malfunction|1|||
44440369|NCT00573066|79448726|FG000|Overall Study|Postoperative bleeding|1|||
44440370|NCT00612456|79448733|FG000|Overall Study|Adverse Event|1|||
44440371|NCT00612456|79448734|FG001|Overall Study|Adverse Event|0|||
44440372|NCT00612456|79448735|FG002|Overall Study|Adverse Event|0|||
44440373|NCT00612456|79448733|FG000|Overall Study|Lack of Efficacy|1|||
44440374|NCT00612456|79448734|FG001|Overall Study|Lack of Efficacy|1|||
44440375|NCT00612456|79448735|FG002|Overall Study|Lack of Efficacy|0|||
44440376|NCT00612456|79448733|FG000|Overall Study|Withdrawal by Subject|0|||
44440377|NCT00612456|79448734|FG001|Overall Study|Withdrawal by Subject|1|||
44440378|NCT00612456|79448735|FG002|Overall Study|Withdrawal by Subject|0|||
44440379|NCT00730691|79448750|FG000|Overall Study|Adverse Event|4|||
44440380|NCT00730691|79448751|FG001|Overall Study|Adverse Event|8|||
44440381|NCT00730691|79448752|FG002|Overall Study|Adverse Event|11|||
44440382|NCT00730691|79448753|FG003|Overall Study|Adverse Event|11|||
44440383|NCT00730691|79448754|FG004|Overall Study|Adverse Event|23|||
44440384|NCT00730691|79448750|FG000|Overall Study|Lack of Efficacy|4|||
44440385|NCT00730691|79448751|FG001|Overall Study|Lack of Efficacy|4|||
44440386|NCT00730691|79448752|FG002|Overall Study|Lack of Efficacy|2|||
44440387|NCT00730691|79448753|FG003|Overall Study|Lack of Efficacy|1|||
44440388|NCT00730691|79448754|FG004|Overall Study|Lack of Efficacy|1|||
44440389|NCT00730691|79448750|FG000|Overall Study|Non-compliance with Study Drug|6|||
44440390|NCT00730691|79448751|FG001|Overall Study|Non-compliance with Study Drug|1|||
44440391|NCT00730691|79448752|FG002|Overall Study|Non-compliance with Study Drug|6|||
44440392|NCT00730691|79448753|FG003|Overall Study|Non-compliance with Study Drug|3|||
44440393|NCT00730691|79448754|FG004|Overall Study|Non-compliance with Study Drug|3|||
44440394|NCT00730691|79448750|FG000|Overall Study|Protocol Deviations|3|||
44440395|NCT00730691|79448751|FG001|Overall Study|Protocol Deviations|5|||
44440396|NCT00730691|79448752|FG002|Overall Study|Protocol Deviations|3|||
44440397|NCT00730691|79448753|FG003|Overall Study|Protocol Deviations|7|||
44440398|NCT00730691|79448754|FG004|Overall Study|Protocol Deviations|5|||
44440399|NCT00730691|79448750|FG000|Overall Study|Withdrawal of Consent|7|||
44440400|NCT00730691|79448751|FG001|Overall Study|Withdrawal of Consent|9|||
44440401|NCT00730691|79448752|FG002|Overall Study|Withdrawal of Consent|3|||
44440402|NCT00730691|79448753|FG003|Overall Study|Withdrawal of Consent|6|||
44440403|NCT00730691|79448754|FG004|Overall Study|Withdrawal of Consent|3|||
44440404|NCT00730691|79448750|FG000|Overall Study|Lost to Follow-up|11|||
44440405|NCT00730691|79448751|FG001|Overall Study|Lost to Follow-up|8|||
44440406|NCT00730691|79448752|FG002|Overall Study|Lost to Follow-up|13|||
44440407|NCT00730691|79448753|FG003|Overall Study|Lost to Follow-up|15|||
44440408|NCT00730691|79448754|FG004|Overall Study|Lost to Follow-up|13|||
44440409|NCT00730691|79448750|FG000|Overall Study|Other|1|||
44440410|NCT00730691|79448751|FG001|Overall Study|Other|1|||
44440411|NCT00730691|79448752|FG002|Overall Study|Other|1|||
44440412|NCT00730691|79448753|FG003|Overall Study|Other|2|||
44440413|NCT00730691|79448754|FG004|Overall Study|Other|2|||
44440414|NCT00235495|79448768|FG000|Overall Study|Death|52|||
44440415|NCT00235495|79448769|FG001|Overall Study|Death|42|||
44440416|NCT00235495|79448768|FG000|Overall Study|Withdrawal by Subject|5|||
44440417|NCT00235495|79448769|FG001|Overall Study|Withdrawal by Subject|3|||
44440418|NCT00235495|79448768|FG000|Overall Study|Lost to Follow-up|11|||
44440419|NCT00235495|79448769|FG001|Overall Study|Lost to Follow-up|13|||
44440420|NCT00235495|79448768|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
44440421|NCT00235495|79448769|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
44440422|NCT00278161|79448775|FG000|Overall Study|Death|11|||
44440423|NCT00255151|79448782|FG000|Overall Study|Adverse Event|10|||
44440424|NCT00255151|79448783|FG001|Overall Study|Adverse Event|6|||
44440425|NCT00255151|79448784|FG002|Overall Study|Adverse Event|9|||
44440426|NCT00255151|79448782|FG000|Overall Study|Lost to Follow-up|4|||
44440427|NCT00255151|79448783|FG001|Overall Study|Lost to Follow-up|3|||
44440428|NCT00255151|79448784|FG002|Overall Study|Lost to Follow-up|4|||
44440429|NCT00255151|79448782|FG000|Overall Study|Withdrawal by Subject|18|||
44440430|NCT00255151|79448783|FG001|Overall Study|Withdrawal by Subject|17|||
44440431|NCT00255151|79448784|FG002|Overall Study|Withdrawal by Subject|8|||
44440432|NCT00255151|79448782|FG000|Overall Study|Noncompliance|0|||
44440433|NCT00255151|79448783|FG001|Overall Study|Noncompliance|1|||
44440434|NCT00255151|79448784|FG002|Overall Study|Noncompliance|2|||
44440435|NCT00255151|79448782|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
44440436|NCT00255151|79448783|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
44440437|NCT00255151|79448784|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
44440438|NCT00255151|79448782|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
44440439|NCT00255151|79448783|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
44440440|NCT00255151|79448784|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
44440441|NCT00255151|79448782|FG000|Overall Study|Possible Barrett's Esophagus|1|||
44440442|NCT00255151|79448783|FG001|Overall Study|Possible Barrett's Esophagus|3|||
44440443|NCT00255151|79448784|FG002|Overall Study|Possible Barrett's Esophagus|8|||
44440444|NCT00255151|79448782|FG000|Overall Study|Esophageal Stricture|0|||
44440445|NCT00255151|79448783|FG001|Overall Study|Esophageal Stricture|0|||
44440446|NCT00255151|79448784|FG002|Overall Study|Esophageal Stricture|1|||
44440447|NCT00255151|79448782|FG000|Overall Study|Therapeutic Failure|11|||
44440448|NCT00255151|79448783|FG001|Overall Study|Therapeutic Failure|2|||
44440449|NCT00255151|79448784|FG002|Overall Study|Therapeutic Failure|3|||
44440450|NCT00658658|79448797|FG000|Overall Study|Withdrawal by Subject|0|||
44440451|NCT00658658|79448798|FG001|Overall Study|Withdrawal by Subject|1|||
44440452|NCT00658658|79448799|FG002|Overall Study|Withdrawal by Subject|0|||
44440453|NCT00658658|79448800|FG003|Overall Study|Withdrawal by Subject|0|||
44440454|NCT00658658|79448801|FG004|Overall Study|Withdrawal by Subject|0|||
44440455|NCT00658658|79448797|FG000|Overall Study|Death|4|||
44440456|NCT00658658|79448798|FG001|Overall Study|Death|0|||
44159085|NCT02876328|78951385|FG002|Overall Study|Death|3|||
44440457|NCT00658658|79448799|FG002|Overall Study|Death|0|||
44440458|NCT00658658|79448800|FG003|Overall Study|Death|1|||
44159086|NCT02876328|78951386|FG003|Overall Study|Death|0|||
44440459|NCT00658658|79448801|FG004|Overall Study|Death|1|||
44440460|NCT00658658|79448797|FG000|Overall Study|Disease Progression|0|||
44440461|NCT00658658|79448798|FG001|Overall Study|Disease Progression|1|||
44440462|NCT00658658|79448799|FG002|Overall Study|Disease Progression|0|||
44440463|NCT00658658|79448800|FG003|Overall Study|Disease Progression|1|||
44440464|NCT00658658|79448801|FG004|Overall Study|Disease Progression|3|||
44440465|NCT00658658|79448797|FG000|Overall Study|Protocol-specified Criteria|1|||
44440466|NCT00658658|79448798|FG001|Overall Study|Protocol-specified Criteria|0|||
44440467|NCT00658658|79448799|FG002|Overall Study|Protocol-specified Criteria|0|||
44440468|NCT00658658|79448800|FG003|Overall Study|Protocol-specified Criteria|0|||
44440469|NCT00658658|79448801|FG004|Overall Study|Protocol-specified Criteria|0|||
44440470|NCT00658658|79448797|FG000|Overall Study|Other|0|||
44440471|NCT00658658|79448798|FG001|Overall Study|Other|0|||
44440472|NCT00658658|79448799|FG002|Overall Study|Other|0|||
44440473|NCT00658658|79448800|FG003|Overall Study|Other|0|||
44440474|NCT00658658|79448801|FG004|Overall Study|Other|1|||
44440475|NCT00723203|79448813|FG000|Overall Study|Withdrawal by Subject|3|||
44440476|NCT00233389|79448819|FG000|Overall Study|Adverse Event|5|||
44440477|NCT00233389|79448820|FG001|Overall Study|Adverse Event|5|||
44440478|NCT00233389|79448819|FG000|Overall Study|Lack of Efficacy|11|||
44259723|NCT04575584|79122507|FG005|Overall Study|Death|0|||
44259724|NCT04575584|79122502|FG000|Overall Study|Lost to Follow-up|1|||
44259725|NCT04575584|79122503|FG001|Overall Study|Lost to Follow-up|1|||
44341187|NCT01225731|79345067|FG008|Part 3|Withdrawal by Subject|0|||
44341188|NCT01225731|79345068|FG009|Part 3|Withdrawal by Subject|0|||
44341189|NCT01225731|79345069|FG010|Part 3|Withdrawal by Subject|4|||
44341190|NCT01225731|79345070|FG011|Part 3|Withdrawal by Subject|6|||
44341191|NCT01225731|79345071|FG012|Part 3|Withdrawal by Subject|4|||
44341192|NCT01007149|79345102|FG000|Overall Study|Administrative problems|0|||
44341193|NCT01007149|79345103|FG001|Overall Study|Administrative problems|1|||
44341194|NCT00998335|79345111|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
44341195|NCT00998335|79345112|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
44341196|NCT01294670|79345129|FG000|Overall Study|Not treated|1|||
44341197|NCT01294670|79345130|FG001|Overall Study|Not treated|0|||
44341198|NCT01294670|79345131|FG002|Overall Study|Not treated|0|||
44341199|NCT01294670|79345132|FG003|Overall Study|Not treated|0|||
44341200|NCT01294670|79345133|FG004|Overall Study|Not treated|0|||
44341201|NCT01006603|79345147|FG000|Overall Study|Withdrawal by Subject|17|||
44341202|NCT01006603|79345148|FG001|Overall Study|Withdrawal by Subject|19|||
44341203|NCT01006603|79345147|FG000|Overall Study|Lost to Follow-up|0|||
44341204|NCT01006603|79345148|FG001|Overall Study|Lost to Follow-up|1|||
44341205|NCT01006603|79345147|FG000|Overall Study|Safety reason|1|||
44341206|NCT01006603|79345148|FG001|Overall Study|Safety reason|1|||
44341207|NCT01006603|79345147|FG000|Overall Study|Protocol Violation|1|||
44341208|NCT01006603|79345148|FG001|Overall Study|Protocol Violation|3|||
44341209|NCT01006603|79345147|FG000|Overall Study|Incorrect enrolment|0|||
44341210|NCT01006603|79345148|FG001|Overall Study|Incorrect enrolment|2|||
44341211|NCT01006603|79345147|FG000|Overall Study|Adverse Event|15|||
44341212|NCT01006603|79345148|FG001|Overall Study|Adverse Event|7|||
44341213|NCT01006603|79345147|FG000|Overall Study|Death|1|||
44341214|NCT01006603|79345148|FG001|Overall Study|Death|1|||
44341215|NCT01006603|79345147|FG000|Overall Study|Study specific discontinuation criteria|33|||
44341216|NCT01006603|79345148|FG001|Overall Study|Study specific discontinuation criteria|34|||
44341217|NCT01006603|79345147|FG000|Overall Study|Other|3|||
44341218|NCT01006603|79345148|FG001|Overall Study|Other|7|||
44341219|NCT00997321|79345156|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
44341220|NCT00997321|79345157|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
44341221|NCT01294592|79345171|FG000|Overall Study|Adverse Event|28|||
44341222|NCT01294592|79345172|FG001|Overall Study|Adverse Event|13|||
44341223|NCT01294592|79345171|FG000|Overall Study|Lack of Efficacy|7|||
44259726|NCT04575584|79122504|FG002|Overall Study|Lost to Follow-up|1|||
44259727|NCT04575584|79122505|FG003|Overall Study|Lost to Follow-up|1|||
44259728|NCT04575584|79122506|FG004|Overall Study|Lost to Follow-up|0|||
44259729|NCT04575584|79122507|FG005|Overall Study|Lost to Follow-up|0|||
44259730|NCT04575584|79122502|FG000|Overall Study|Physician Decision|0|||
44341224|NCT01294592|79345172|FG001|Overall Study|Lack of Efficacy|5|||
44341225|NCT01294592|79345171|FG000|Overall Study|Protocol Violation|1|||
44341226|NCT01294592|79345172|FG001|Overall Study|Protocol Violation|7|||
44341227|NCT01294592|79345171|FG000|Overall Study|Lost to Follow-up|7|||
44341228|NCT01294592|79345172|FG001|Overall Study|Lost to Follow-up|9|||
44341229|NCT01294592|79345171|FG000|Overall Study|Physician Decision|6|||
44341230|NCT01294592|79345172|FG001|Overall Study|Physician Decision|11|||
44341231|NCT01294592|79345171|FG000|Overall Study|Withdrawal by Subject|28|||
44341232|NCT01294592|79345172|FG001|Overall Study|Withdrawal by Subject|28|||
44440479|NCT00233389|79448820|FG001|Overall Study|Lack of Efficacy|8|||
44440480|NCT00233389|79448819|FG000|Overall Study|Lost to Follow-up|1|||
44259731|NCT04575584|79122503|FG001|Overall Study|Physician Decision|1|||
44259732|NCT04575584|79122504|FG002|Overall Study|Physician Decision|1|||
44341233|NCT00997243|79345181|FG000|Overall Study|Early termination of study by sponsor|7|||
44341234|NCT01294514|79345185|FG000|Overall Study|Excluded due to Arrhythmia|1|||
44341235|NCT00999661|79345193|FG000|Overall Study|Lost to Follow-up|59|||
44440481|NCT00233389|79448820|FG001|Overall Study|Lost to Follow-up|1|||
44341236|NCT00999661|79345193|FG000|Overall Study|Adverse Event|1|||
44341237|NCT00999661|79345193|FG000|Overall Study|Withdrawal by Subject|1|||
44341238|NCT00999661|79345193|FG000|Overall Study|Not meeting eligibility criteria|9|||
44341239|NCT01294436|79345199|FG000|Overall Study|Adverse Event|10|||
44341240|NCT01294436|79345200|FG001|Overall Study|Adverse Event|17|||
44341241|NCT01294436|79345199|FG000|Overall Study|Withdrawal by Subject|11|||
44341242|NCT01294436|79345200|FG001|Overall Study|Withdrawal by Subject|28|||
44341243|NCT01294436|79345199|FG000|Overall Study|subject no longer meets study criteria|5|||
44341244|NCT01294436|79345200|FG001|Overall Study|subject no longer meets study criteria|20|||
44341245|NCT01294436|79345199|FG000|Overall Study|poor/non-compliance|2|||
44341246|NCT01294436|79345200|FG001|Overall Study|poor/non-compliance|5|||
44341247|NCT00995371|79345208|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
44341248|NCT00995371|79345209|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
44341249|NCT01294358|79345217|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
44341250|NCT01294358|79345218|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
44341251|NCT01294358|79345219|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
44341252|NCT01294358|79345220|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
44341253|NCT01294358|79345221|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
44341254|NCT01294358|79345217|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
44341255|NCT01294358|79345218|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
44341256|NCT01294358|79345219|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
44341257|NCT01294358|79345220|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
44341258|NCT01294358|79345221|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
44341259|NCT01294358|79345217|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
44341260|NCT01294358|79345218|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
44341261|NCT01294358|79345219|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
44341262|NCT01294358|79345220|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
44341263|NCT01294358|79345221|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
44341264|NCT01294358|79345217|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
44341265|NCT01294358|79345218|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
44341266|NCT01294358|79345219|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
44341267|NCT01294358|79345220|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
44341268|NCT01294358|79345221|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
44341269|NCT00994279|79345240|FG000|Overall Study|Withdrawal by Subject|2|||
44440482|NCT00233389|79448819|FG000|Overall Study|Physician Decision|1|||
44440483|NCT00233389|79448820|FG001|Overall Study|Physician Decision|0|||
44440484|NCT00233389|79448819|FG000|Overall Study|Protocol Violation|0|||
44440485|NCT00233389|79448820|FG001|Overall Study|Protocol Violation|1|||
44440486|NCT00233389|79448819|FG000|Overall Study|Withdrawal by Subject|0|||
44440487|NCT00233389|79448820|FG001|Overall Study|Withdrawal by Subject|1|||
44440488|NCT00649220|79448826|FG000|Overall Study|Adverse Event|2|||
44440489|NCT00649220|79448826|FG000|Overall Study|Withdrawal by Subject|1|||
44341270|NCT00994279|79345241|FG001|Overall Study|Withdrawal by Subject|2|||
44341271|NCT00994279|79345240|FG000|Overall Study|Toxicity|1|||
44341272|NCT00994279|79345241|FG001|Overall Study|Toxicity|0|||
44341273|NCT00994279|79345240|FG000|Overall Study|Multiple reasons|1|||
44341274|NCT00994279|79345241|FG001|Overall Study|Multiple reasons|3|||
44341275|NCT01294046|79345247|FG000|Overall Study|Infection and surgical explant|1|||
44341276|NCT01294046|79345247|FG000|Overall Study|Eligibility criteria expanded|1|||
44341277|NCT01294046|79345247|FG000|Overall Study|Stimulation response inadqequate|1|||
44341278|NCT01224639|79345262|FG000|Overall Study|Withdrawal by Subject|0|||
44341279|NCT01224639|79345263|FG001|Overall Study|Withdrawal by Subject|0|||
44341280|NCT01224639|79345264|FG002|Overall Study|Withdrawal by Subject|0|||
44341281|NCT01224639|79345265|FG003|Overall Study|Withdrawal by Subject|0|||
44341282|NCT01224639|79345266|FG004|Overall Study|Withdrawal by Subject|2|||
44341283|NCT01224639|79345267|FG005|Overall Study|Withdrawal by Subject|0|||
44341284|NCT01224639|79345268|FG006|Overall Study|Withdrawal by Subject|1|||
44341285|NCT01224639|79345269|FG007|Overall Study|Withdrawal by Subject|1|||
44440490|NCT00654368|79448833|FG000|Overall Study|Ineligibility determined|6|||
44440491|NCT00654368|79448834|FG001|Overall Study|Ineligibility determined|0|||
44440492|NCT00654368|79448835|FG002|Overall Study|Ineligibility determined|0|||
44440493|NCT00654368|79448833|FG000|Overall Study|Protocol deviation|3|||
44440494|NCT00654368|79448834|FG001|Overall Study|Protocol deviation|2|||
44440495|NCT00654368|79448835|FG002|Overall Study|Protocol deviation|1|||
44440496|NCT00654368|79448833|FG000|Overall Study|Non-compliance|2|||
44440497|NCT00654368|79448834|FG001|Overall Study|Non-compliance|1|||
44440498|NCT00654368|79448835|FG002|Overall Study|Non-compliance|2|||
44440499|NCT00654368|79448833|FG000|Overall Study|Withdrawal by Subject|5|||
44440500|NCT00654368|79448834|FG001|Overall Study|Withdrawal by Subject|2|||
44440501|NCT00654368|79448835|FG002|Overall Study|Withdrawal by Subject|2|||
44440502|NCT00654368|79448833|FG000|Overall Study|Disease progression|21|||
44440503|NCT00654368|79448834|FG001|Overall Study|Disease progression|31|||
44440504|NCT00654368|79448835|FG002|Overall Study|Disease progression|13|||
44159087|NCT02876328|78951387|FG004|Overall Study|Death|0|||
44341286|NCT01224639|79345262|FG000|Overall Study|Adverse Event|0|||
44341287|NCT01224639|79345263|FG001|Overall Study|Adverse Event|0|||
44341288|NCT01224639|79345264|FG002|Overall Study|Adverse Event|0|||
44341289|NCT01224639|79345265|FG003|Overall Study|Adverse Event|0|||
44341290|NCT01224639|79345266|FG004|Overall Study|Adverse Event|0|||
44341291|NCT01224639|79345267|FG005|Overall Study|Adverse Event|0|||
44341292|NCT01224639|79345268|FG006|Overall Study|Adverse Event|0|||
44341293|NCT01224639|79345269|FG007|Overall Study|Adverse Event|1|||
44341294|NCT01293968|79345289|FG000|Overall Study|non-cooperation|3|||
44341295|NCT01293968|79345290|FG001|Overall Study|non-cooperation|3|||
44341296|NCT01293032|79345300|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
44341297|NCT01293032|79345301|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
44341298|NCT01293032|79345302|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
44341299|NCT01293032|79345303|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
44341300|NCT01293032|79345300|FG000|Treatment|Adverse Event|0|||
44341301|NCT01293032|79345301|FG001|Treatment|Adverse Event|0|||
44341302|NCT01293032|79345302|FG002|Treatment|Adverse Event|1|||
44341303|NCT01293032|79345303|FG003|Treatment|Adverse Event|1|||
44341304|NCT01293032|79345300|FG000|Treatment|Withdrawal by Subject|2|||
44341305|NCT01293032|79345301|FG001|Treatment|Withdrawal by Subject|4|||
44341306|NCT01293032|79345302|FG002|Treatment|Withdrawal by Subject|0|||
44341307|NCT01293032|79345303|FG003|Treatment|Withdrawal by Subject|0|||
44341308|NCT01293032|79345300|FG000|Treatment|Disease Progression, relapse|0|||
44341309|NCT01293032|79345301|FG001|Treatment|Disease Progression, relapse|1|||
44341310|NCT01293032|79345302|FG002|Treatment|Disease Progression, relapse|0|||
44341311|NCT01293032|79345303|FG003|Treatment|Disease Progression, relapse|0|||
44341312|NCT01292876|79345310|FG000|Overall Study|Physician Decision|4|||
44341313|NCT01224171|79345318|FG000|Overall Study|Adverse Event|8|||
44341314|NCT01224171|79345319|FG001|Overall Study|Adverse Event|4|||
44341315|NCT01224171|79345318|FG000|Overall Study|Protocol Violation|0|||
44341316|NCT01224171|79345319|FG001|Overall Study|Protocol Violation|1|||
44341317|NCT01224171|79345318|FG000|Overall Study|Lack of Efficacy|5|||
44341318|NCT01224171|79345319|FG001|Overall Study|Lack of Efficacy|1|||
44341319|NCT01224171|79345318|FG000|Overall Study|Withdrawal of Consent|2|||
44341320|NCT01224171|79345319|FG001|Overall Study|Withdrawal of Consent|4|||
44341321|NCT01224171|79345318|FG000|Overall Study|Lost to Follow-up|0|||
44341322|NCT01224171|79345319|FG001|Overall Study|Lost to Follow-up|3|||
44341323|NCT01292486|79345325|FG000|Overall Study|Protocol Violation|2|||
44341324|NCT01292486|79345325|FG000|Overall Study|Did not meet screening criteria|2|||
44341325|NCT01292486|79345325|FG000|Overall Study|Adverse Event|1|||
44341326|NCT01292486|79345325|FG000|Overall Study|Physician Decision|1|||
44341327|NCT01223937|79345332|FG000|Overall Study|Withdrawal by Subject|3|||
44341328|NCT01223937|79345333|FG001|Overall Study|Withdrawal by Subject|2|||
44341329|NCT01223937|79345332|FG000|Overall Study|Lost to Follow-up|1|||
44341330|NCT01223937|79345333|FG001|Overall Study|Lost to Follow-up|4|||
44341331|NCT01223937|79345332|FG000|Overall Study|Adverse Event|1|||
44341332|NCT01223937|79345333|FG001|Overall Study|Adverse Event|4|||
44341333|NCT01223937|79345332|FG000|Overall Study|Protocol Violation|8|||
44341334|NCT01223937|79345333|FG001|Overall Study|Protocol Violation|7|||
44341335|NCT01223937|79345332|FG000|Overall Study|Other|4|||
44341336|NCT01223937|79345333|FG001|Overall Study|Other|1|||
44341337|NCT01290224|79345339|FG000|Overall Study|Adverse Event|1|||
44341338|NCT01290224|79345339|FG000|Overall Study|Refused Further Treatment|4|||
44341339|NCT01223235|79345345|FG000|Overall Study|Withdrawal by Subject|1|||
44341340|NCT01290068|79345351|FG000|Overall Study|Adverse Event|1|||
44341341|NCT01290068|79345352|FG001|Overall Study|Adverse Event|3|||
44341342|NCT01290068|79345351|FG000|Overall Study|Lost to Follow-up|3|||
44341343|NCT01290068|79345352|FG001|Overall Study|Lost to Follow-up|0|||
44341344|NCT01290068|79345351|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
44341345|NCT01290068|79345352|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
44159088|NCT02876328|78951388|FG005|Overall Study|Death|0|||
44159089|NCT02876328|78951389|FG006|Overall Study|Death|1|||
44159090|NCT02876328|78951390|FG007|Overall Study|Death|3|||
44159091|NCT02876328|78951391|FG008|Overall Study|Death|0|||
44341346|NCT01290068|79345351|FG000|Overall Study|Other|3|||
44159092|NCT02876328|78951392|FG009|Overall Study|Death|1|||
44159093|NCT02876328|78951393|FG010|Overall Study|Death|1|||
44341347|NCT01290068|79345352|FG001|Overall Study|Other|1|||
44341348|NCT00998881|79345360|FG000|Overall Study|Adverse Event|2|||
44341349|NCT00998881|79345361|FG001|Overall Study|Adverse Event|2|||
44341350|NCT00998881|79345360|FG000|Overall Study|Lack of Efficacy|1|||
44341351|NCT00998881|79345361|FG001|Overall Study|Lack of Efficacy|0|||
44341352|NCT00998881|79345360|FG000|Overall Study|Physician Decision|3|||
44341353|NCT00998881|79345361|FG001|Overall Study|Physician Decision|0|||
44341354|NCT00998881|79345360|FG000|Overall Study|Withdrawal by Subject|1|||
44341355|NCT00998881|79345361|FG001|Overall Study|Withdrawal by Subject|0|||
44341356|NCT00998881|79345360|FG000|Overall Study|Personal matter|1|||
44341357|NCT00998881|79345361|FG001|Overall Study|Personal matter|0|||
44341358|NCT01222767|79345367|FG000|Overall Study|Progressive disease|13|||
44440505|NCT00654368|79448833|FG000|Overall Study|Requirement for alternative therapy|1|||
44440506|NCT00654368|79448834|FG001|Overall Study|Requirement for alternative therapy|1|||
44440507|NCT00654368|79448835|FG002|Overall Study|Requirement for alternative therapy|1|||
44440508|NCT00654368|79448833|FG000|Overall Study|Physician Decision|0|||
44440509|NCT00654368|79448834|FG001|Overall Study|Physician Decision|0|||
44440510|NCT00654368|79448835|FG002|Overall Study|Physician Decision|2|||
44440511|NCT00654368|79448833|FG000|Overall Study|Death|1|||
44440512|NCT00654368|79448834|FG001|Overall Study|Death|0|||
44440513|NCT00654368|79448835|FG002|Overall Study|Death|0|||
44440514|NCT00654368|79448833|FG000|Overall Study|Pregnancy|0|||
44440515|NCT00654368|79448834|FG001|Overall Study|Pregnancy|0|||
44440516|NCT00654368|79448835|FG002|Overall Study|Pregnancy|2|||
44440517|NCT00654368|79448833|FG000|Overall Study|Other|0|||
44440518|NCT00654368|79448834|FG001|Overall Study|Other|2|||
44440519|NCT00654368|79448835|FG002|Overall Study|Other|3|||
44440520|NCT00654368|79448833|FG000|Overall Study|Adverse Event|14|||
44440521|NCT00654368|79448834|FG001|Overall Study|Adverse Event|9|||
44440522|NCT00654368|79448835|FG002|Overall Study|Adverse Event|6|||
44440523|NCT00647426|79448842|FG000|Overall Study|Withdrawal by Subject|2|||
44440524|NCT00647348|79448849|FG000|Overall Study|Lost to Follow-up|3|||
44440525|NCT00647348|79448850|FG001|Overall Study|Lost to Follow-up|6|||
44440526|NCT00647270|79448859|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
44440527|NCT00647270|79448860|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
44440528|NCT00647270|79448861|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
44440529|NCT00647270|79448859|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
44440530|NCT00647270|79448860|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
44440531|NCT00647270|79448861|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
44440532|NCT00647270|79448859|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
44440533|NCT00647270|79448860|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
44440534|NCT00647270|79448861|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
44440535|NCT00647270|79448859|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
44440536|NCT00647270|79448860|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
44440537|NCT00647270|79448861|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
44440538|NCT00647270|79448859|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
44440539|NCT00647270|79448860|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
44440540|NCT00647270|79448861|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
44440541|NCT00647270|79448859|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
44440542|NCT00647270|79448860|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
44440543|NCT00647270|79448861|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
44440544|NCT00647270|79448859|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
44440545|NCT00647270|79448860|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
44440546|NCT00647270|79448861|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
44440547|NCT00645944|79448874|FG000|Randomized|Withdrawal by Subject|1|||
44440548|NCT00645944|79448875|FG001|Randomized|Withdrawal by Subject|2|||
44440549|NCT00645944|79448874|FG000|Received Medication|Adverse Event|2|||
44440550|NCT00645944|79448875|FG001|Received Medication|Adverse Event|1|||
44440551|NCT00645944|79448874|FG000|Received Medication|Withdrawal by Subject|1|||
44440552|NCT00645944|79448875|FG001|Received Medication|Withdrawal by Subject|1|||
44440553|NCT00645944|79448874|FG000|Received Medication|Lost to Follow-up|1|||
44440554|NCT00645944|79448875|FG001|Received Medication|Lost to Follow-up|0|||
44440555|NCT00645944|79448874|FG000|Received Medication|Protocol Violation|2|||
44440556|NCT00645944|79448875|FG001|Received Medication|Protocol Violation|1|||
44440557|NCT00646958|79448884|FG000|Overall Study|Lack of Efficacy|1|||
44440558|NCT00646958|79448885|FG001|Overall Study|Lack of Efficacy|0|||
44440559|NCT00646958|79448886|FG002|Overall Study|Lack of Efficacy|0|||
44440560|NCT00646958|79448884|FG000|Overall Study|Adverse Event|4|||
44440561|NCT00646958|79448885|FG001|Overall Study|Adverse Event|0|||
44440562|NCT00646958|79448886|FG002|Overall Study|Adverse Event|0|||
44440563|NCT00646958|79448884|FG000|Overall Study|Lost to Follow-up|1|||
44440564|NCT00646958|79448885|FG001|Overall Study|Lost to Follow-up|5|||
44159094|NCT02876328|78951394|FG011|Overall Study|Death|0|||
44440565|NCT00646958|79448886|FG002|Overall Study|Lost to Follow-up|7|||
44440566|NCT00646958|79448884|FG000|Overall Study|Protocol Violation|1|||
44440567|NCT00646958|79448885|FG001|Overall Study|Protocol Violation|1|||
44440568|NCT00646958|79448886|FG002|Overall Study|Protocol Violation|0|||
44440569|NCT00646958|79448884|FG000|Overall Study|Abnormal screening lab tests|1|||
44440570|NCT00646958|79448885|FG001|Overall Study|Abnormal screening lab tests|1|||
44159095|NCT02876328|78951395|FG012|Overall Study|Death|0|||
44440571|NCT00646958|79448886|FG002|Overall Study|Abnormal screening lab tests|0|||
44440572|NCT00646958|79448884|FG000|Overall Study|Withdrawal by Subject|1|||
44440573|NCT00646958|79448885|FG001|Overall Study|Withdrawal by Subject|2|||
44440574|NCT00646958|79448886|FG002|Overall Study|Withdrawal by Subject|0|||
44159096|NCT02876328|78951396|FG013|Overall Study|Death|0|||
44440575|NCT00646958|79448884|FG000|Overall Study|Did not receive study drug|2|||
44440576|NCT00646958|79448885|FG001|Overall Study|Did not receive study drug|0|||
44440577|NCT00646958|79448886|FG002|Overall Study|Did not receive study drug|2|||
44440578|NCT00642746|79448896|FG000|Overall Study|Patient unevaluable|1|||
44440579|NCT00642746|79448897|FG001|Overall Study|Patient unevaluable|0|||
44440580|NCT00642668|79448903|FG000|Overall Study|Lost to Follow-up|1|||
44440581|NCT00642668|79448903|FG000|Overall Study|Adverse Event|2|||
44440582|NCT00642668|79448903|FG000|Overall Study|Death|2|||
44440583|NCT00642668|79448903|FG000|Overall Study|Insufficient Therapeutic Response|1|||
44440584|NCT00642668|79448903|FG000|Overall Study|Failure to Return|1|||
44440585|NCT00642668|79448903|FG000|Overall Study|Dialysis Initiation|5|||
44440586|NCT00642668|79448903|FG000|Overall Study|Blood Transfusion|2|||
44440587|NCT00729833|79448907|FG000|Overall Study|Death|5|||
44440588|NCT00729833|79448908|FG001|Overall Study|Death|1|||
44440589|NCT00729833|79448909|FG002|Overall Study|Death|3|||
44440590|NCT00729833|79448910|FG003|Overall Study|Death|5|||
44440591|NCT00729833|79448907|FG000|Overall Study|Study Terminated by Sponsor|0|||
44440592|NCT00729833|79448908|FG001|Overall Study|Study Terminated by Sponsor|0|||
44440593|NCT00729833|79448909|FG002|Overall Study|Study Terminated by Sponsor|1|||
44440594|NCT00729833|79448910|FG003|Overall Study|Study Terminated by Sponsor|0|||
44440595|NCT00729833|79448907|FG000|Overall Study|Lost to Follow-up|1|||
44440596|NCT00729833|79448908|FG001|Overall Study|Lost to Follow-up|0|||
44440597|NCT00729833|79448909|FG002|Overall Study|Lost to Follow-up|0|||
44440598|NCT00729833|79448910|FG003|Overall Study|Lost to Follow-up|0|||
44440599|NCT00729833|79448907|FG000|Overall Study|Withdrawal by Subject|3|||
44440600|NCT00729833|79448908|FG001|Overall Study|Withdrawal by Subject|1|||
44440601|NCT00729833|79448909|FG002|Overall Study|Withdrawal by Subject|3|||
44440602|NCT00729833|79448910|FG003|Overall Study|Withdrawal by Subject|0|||
44440603|NCT00729833|79448907|FG000|Overall Study|Unspecified Reasons|11|||
44440604|NCT00729833|79448908|FG001|Overall Study|Unspecified Reasons|5|||
44440605|NCT00729833|79448909|FG002|Overall Study|Unspecified Reasons|5|||
44440606|NCT00729833|79448910|FG003|Overall Study|Unspecified Reasons|1|||
44440607|NCT00645788|79448925|FG000|Overall Study|Did not receive study drug|1|||
44440608|NCT00645788|79448926|FG001|Overall Study|Did not receive study drug|1|||
44440609|NCT00645788|79448927|FG002|Overall Study|Did not receive study drug|0|||
44440610|NCT00645788|79448928|FG003|Overall Study|Did not receive study drug|0|||
44440611|NCT00645788|79448925|FG000|Overall Study|Adverse Event|4|||
44440612|NCT00645788|79448926|FG001|Overall Study|Adverse Event|9|||
44440613|NCT00645788|79448927|FG002|Overall Study|Adverse Event|5|||
44440614|NCT00645788|79448928|FG003|Overall Study|Adverse Event|3|||
44440615|NCT00645788|79448925|FG000|Overall Study|Lost to Follow-up|1|||
44440616|NCT00645788|79448926|FG001|Overall Study|Lost to Follow-up|0|||
44440617|NCT00645788|79448927|FG002|Overall Study|Lost to Follow-up|0|||
44440618|NCT00645788|79448928|FG003|Overall Study|Lost to Follow-up|0|||
44440619|NCT00645788|79448925|FG000|Overall Study|Protocol Violation|1|||
44440620|NCT00645788|79448926|FG001|Overall Study|Protocol Violation|0|||
44440621|NCT00645788|79448927|FG002|Overall Study|Protocol Violation|2|||
44341359|NCT01222767|79345367|FG000|Overall Study|Adverse Event|2|||
44341360|NCT01222767|79345367|FG000|Overall Study|Surgical resection|1|||
44341361|NCT01222767|79345367|FG000|Overall Study|Never treated|1|||
44341362|NCT00993967|79345371|FG000|Overall Study|Adverse Event|8|||
44341363|NCT00993967|79345371|FG000|Overall Study|Death|1|||
44341364|NCT00993967|79345371|FG000|Overall Study|Lost to Follow-up|14|||
44341365|NCT00993967|79345371|FG000|Overall Study|Withdrawal by Subject|36|||
44341366|NCT00993967|79345371|FG000|Overall Study|Protocol Violation|2|||
44341367|NCT01222533|79345375|FG000|Overall Study|Adverse Event|5|||
44341368|NCT01222533|79345375|FG000|Overall Study|Withdrawal by Subject|5|||
44341369|NCT01222533|79345375|FG000|Overall Study|Other|4|||
44341370|NCT01221753|79345387|FG000|Overall Study|Adverse Event|1|||
44341371|NCT01221597|79345393|FG000|Overall Study|Adverse Event|4|||
44341372|NCT01221597|79345394|FG001|Overall Study|Adverse Event|1|||
44341373|NCT01221597|79345393|FG000|Overall Study|Withdrawal by Subject|20|||
44341374|NCT01221597|79345394|FG001|Overall Study|Withdrawal by Subject|6|||
44341375|NCT01221597|79345393|FG000|Overall Study|Lost to Follow-up|6|||
44341376|NCT01221597|79345394|FG001|Overall Study|Lost to Follow-up|5|||
44341377|NCT01221597|79345393|FG000|Overall Study|Protocol Violation|1|||
44341378|NCT01221597|79345394|FG001|Overall Study|Protocol Violation|0|||
44341379|NCT01221597|79345393|FG000|Overall Study|Other|3|||
44341380|NCT01221597|79345394|FG001|Overall Study|Other|4|||
44341381|NCT01221597|79345393|FG000|Overall Study|Death|2|||
44341382|NCT01221597|79345394|FG001|Overall Study|Death|0|||
44341383|NCT01221363|79345403|FG000|Overall Study|Pregnancy|1|||
44341384|NCT01221363|79345404|FG001|Overall Study|Pregnancy|0|||
44440622|NCT00645788|79448928|FG003|Overall Study|Protocol Violation|0|||
44440623|NCT00645788|79448925|FG000|Overall Study|Withdrawal by Subject|0|||
44440624|NCT00645788|79448926|FG001|Overall Study|Withdrawal by Subject|1|||
44440625|NCT00645788|79448927|FG002|Overall Study|Withdrawal by Subject|0|||
44440626|NCT00645788|79448928|FG003|Overall Study|Withdrawal by Subject|2|||
44440627|NCT00645788|79448925|FG000|Overall Study|Pulmonary exacerbation|13|||
44440628|NCT00645788|79448926|FG001|Overall Study|Pulmonary exacerbation|16|||
44440629|NCT00645788|79448927|FG002|Overall Study|Pulmonary exacerbation|11|||
44440630|NCT00645788|79448928|FG003|Overall Study|Pulmonary exacerbation|9|||
44440631|NCT00642356|79448940|FG000|Overall Study|Adverse Event|1|||
44440632|NCT00642356|79448941|FG001|Overall Study|Adverse Event|0|||
44440633|NCT00642356|79448940|FG000|Overall Study|Protocol Violation|0|||
44440634|NCT00642356|79448941|FG001|Overall Study|Protocol Violation|3|||
44440635|NCT00642356|79448940|FG000|Overall Study|Lack of Efficacy|1|||
44440636|NCT00642356|79448941|FG001|Overall Study|Lack of Efficacy|0|||
44440637|NCT00642278|79448954|FG000|Overall Study|Adverse Event|2|||
44440638|NCT00642278|79448955|FG001|Overall Study|Adverse Event|1|||
44440639|NCT00642278|79448956|FG002|Overall Study|Adverse Event|3|||
44440640|NCT00642278|79448957|FG003|Overall Study|Adverse Event|1|||
44440641|NCT00642278|79448958|FG004|Overall Study|Adverse Event|2|||
44440642|NCT00642278|79448959|FG005|Overall Study|Adverse Event|2|||
44440643|NCT00642278|79448960|FG006|Overall Study|Adverse Event|0|||
44440644|NCT00642278|79448954|FG000|Overall Study|Lack of Efficacy|0|||
44440645|NCT00642278|79448955|FG001|Overall Study|Lack of Efficacy|1|||
44440646|NCT00642278|79448956|FG002|Overall Study|Lack of Efficacy|0|||
44440647|NCT00642278|79448957|FG003|Overall Study|Lack of Efficacy|0|||
44440648|NCT00642278|79448958|FG004|Overall Study|Lack of Efficacy|0|||
44440649|NCT00642278|79448959|FG005|Overall Study|Lack of Efficacy|0|||
44440650|NCT00642278|79448960|FG006|Overall Study|Lack of Efficacy|0|||
44440651|NCT00642278|79448954|FG000|Overall Study|Lost to Follow-up|5|||
44440652|NCT00642278|79448955|FG001|Overall Study|Lost to Follow-up|1|||
44440653|NCT00642278|79448956|FG002|Overall Study|Lost to Follow-up|0|||
44440654|NCT00642278|79448957|FG003|Overall Study|Lost to Follow-up|1|||
44440655|NCT00642278|79448958|FG004|Overall Study|Lost to Follow-up|0|||
44440656|NCT00642278|79448959|FG005|Overall Study|Lost to Follow-up|1|||
44440657|NCT00642278|79448960|FG006|Overall Study|Lost to Follow-up|1|||
44440658|NCT00642278|79448954|FG000|Overall Study|Physician Decision|0|||
44440659|NCT00642278|79448955|FG001|Overall Study|Physician Decision|0|||
44440660|NCT00642278|79448956|FG002|Overall Study|Physician Decision|0|||
44440661|NCT00642278|79448957|FG003|Overall Study|Physician Decision|1|||
44440662|NCT00642278|79448958|FG004|Overall Study|Physician Decision|0|||
44440663|NCT00642278|79448959|FG005|Overall Study|Physician Decision|0|||
44440664|NCT00642278|79448960|FG006|Overall Study|Physician Decision|0|||
44440665|NCT00642278|79448954|FG000|Overall Study|Protocol Violation|0|||
44440666|NCT00642278|79448955|FG001|Overall Study|Protocol Violation|0|||
44440667|NCT00642278|79448956|FG002|Overall Study|Protocol Violation|1|||
44440668|NCT00642278|79448957|FG003|Overall Study|Protocol Violation|1|||
44440669|NCT00642278|79448958|FG004|Overall Study|Protocol Violation|0|||
44440670|NCT00642278|79448959|FG005|Overall Study|Protocol Violation|1|||
44440671|NCT00642278|79448960|FG006|Overall Study|Protocol Violation|2|||
44440672|NCT00642278|79448954|FG000|Overall Study|Withdrawal by Subject|1|||
44440673|NCT00642278|79448955|FG001|Overall Study|Withdrawal by Subject|1|||
44440674|NCT00642278|79448956|FG002|Overall Study|Withdrawal by Subject|1|||
44440675|NCT00642278|79448957|FG003|Overall Study|Withdrawal by Subject|3|||
44440676|NCT00642278|79448958|FG004|Overall Study|Withdrawal by Subject|6|||
44341385|NCT01221363|79345403|FG000|Overall Study|Withdrawal by Subject|11|||
44341386|NCT01221363|79345404|FG001|Overall Study|Withdrawal by Subject|5|||
44341387|NCT01221285|79345410|FG000|Overall Study|Withdrawal by Subject|1|||
44341388|NCT01014988|79345420|FG000|Overall Study|Adverse Event|20|||
44341389|NCT01014988|79345421|FG001|Overall Study|Adverse Event|0|||
44341390|NCT01014988|79345422|FG002|Overall Study|Adverse Event|1|||
44341391|NCT01014988|79345423|FG003|Overall Study|Adverse Event|0|||
44341392|NCT01014988|79345424|FG004|Overall Study|Adverse Event|1|||
44341393|NCT01014988|79345425|FG005|Overall Study|Adverse Event|3|||
44341394|NCT01014988|79345420|FG000|Overall Study|Lost to Follow-up|1|||
44440677|NCT00642278|79448959|FG005|Overall Study|Withdrawal by Subject|2|||
44440678|NCT00642278|79448960|FG006|Overall Study|Withdrawal by Subject|2|||
44440679|NCT00642278|79448954|FG000|Overall Study|Noncompliance with study drug regimen|0|||
44440680|NCT00642278|79448955|FG001|Overall Study|Noncompliance with study drug regimen|0|||
44440681|NCT00642278|79448956|FG002|Overall Study|Noncompliance with study drug regimen|0|||
44440682|NCT00642278|79448957|FG003|Overall Study|Noncompliance with study drug regimen|1|||
44440683|NCT00642278|79448958|FG004|Overall Study|Noncompliance with study drug regimen|0|||
44440684|NCT00642278|79448959|FG005|Overall Study|Noncompliance with study drug regimen|0|||
44440685|NCT00642278|79448960|FG006|Overall Study|Noncompliance with study drug regimen|0|||
44341395|NCT01014988|79345421|FG001|Overall Study|Lost to Follow-up|0|||
44341396|NCT01014988|79345422|FG002|Overall Study|Lost to Follow-up|1|||
44440686|NCT00642278|79448954|FG000|Overall Study|Other|2|||
44440687|NCT00642278|79448955|FG001|Overall Study|Other|1|||
44341397|NCT01014988|79345423|FG003|Overall Study|Lost to Follow-up|0|||
44341398|NCT01014988|79345424|FG004|Overall Study|Lost to Follow-up|0|||
44440688|NCT00642278|79448956|FG002|Overall Study|Other|0|||
44440689|NCT00642278|79448957|FG003|Overall Study|Other|1|||
44440690|NCT00642278|79448958|FG004|Overall Study|Other|0|||
44440691|NCT00642278|79448959|FG005|Overall Study|Other|1|||
44440692|NCT00642278|79448960|FG006|Overall Study|Other|0|||
44440693|NCT00543543|79448980|FG000|Base Study|Adverse Event|1|||
44440694|NCT00543543|79448981|FG001|Base Study|Adverse Event|11|||
44440695|NCT00543543|79448982|FG002|Base Study|Adverse Event|0|||
44440696|NCT00543543|79448983|FG003|Base Study|Adverse Event|5|||
44440697|NCT00543543|79448980|FG000|Base Study|Lost to Follow-up|12|||
44440698|NCT00543543|79448981|FG001|Base Study|Lost to Follow-up|749|||
44440699|NCT00543543|79448982|FG002|Base Study|Lost to Follow-up|9|||
44440700|NCT00543543|79448983|FG003|Base Study|Lost to Follow-up|701|||
44440701|NCT00543543|79448980|FG000|Base Study|Physician Decision|0|||
44440702|NCT00543543|79448981|FG001|Base Study|Physician Decision|4|||
44440703|NCT00543543|79448982|FG002|Base Study|Physician Decision|0|||
44440704|NCT00543543|79448983|FG003|Base Study|Physician Decision|7|||
44440705|NCT00543543|79448980|FG000|Base Study|Protocol Violation|0|||
44440706|NCT00543543|79448981|FG001|Base Study|Protocol Violation|6|||
44440707|NCT00543543|79448982|FG002|Base Study|Protocol Violation|0|||
44440708|NCT00543543|79448983|FG003|Base Study|Protocol Violation|6|||
44440709|NCT00543543|79448980|FG000|Base Study|Withdrawal by Subject|7|||
44440710|NCT00543543|79448981|FG001|Base Study|Withdrawal by Subject|482|||
44440711|NCT00543543|79448982|FG002|Base Study|Withdrawal by Subject|5|||
44440712|NCT00543543|79448983|FG003|Base Study|Withdrawal by Subject|503|||
44440713|NCT00543543|79448980|FG000|Extension Study|Adverse Event|0|||
44440714|NCT00543543|79448981|FG001|Extension Study|Adverse Event|0|||
44440715|NCT00543543|79448982|FG002|Extension Study|Adverse Event|0|||
44440716|NCT00543543|79448983|FG003|Extension Study|Adverse Event|5|||
44440717|NCT00543543|79448980|FG000|Extension Study|Lost to Follow-up|0|||
44440718|NCT00543543|79448981|FG001|Extension Study|Lost to Follow-up|0|||
44440719|NCT00543543|79448982|FG002|Extension Study|Lost to Follow-up|0|||
44440720|NCT00543543|79448983|FG003|Extension Study|Lost to Follow-up|77|||
44440721|NCT00543543|79448980|FG000|Extension Study|Physician Decision|0|||
44440722|NCT00543543|79448981|FG001|Extension Study|Physician Decision|0|||
44440723|NCT00543543|79448982|FG002|Extension Study|Physician Decision|0|||
44440724|NCT00543543|79448983|FG003|Extension Study|Physician Decision|7|||
44440725|NCT00543543|79448980|FG000|Extension Study|Pregnancy|0|||
44440726|NCT00543543|79448981|FG001|Extension Study|Pregnancy|0|||
44440727|NCT00543543|79448982|FG002|Extension Study|Pregnancy|0|||
44440728|NCT00543543|79448983|FG003|Extension Study|Pregnancy|6|||
44440729|NCT00543543|79448980|FG000|Extension Study|Protocol Violation|0|||
44440730|NCT00543543|79448981|FG001|Extension Study|Protocol Violation|0|||
44440731|NCT00543543|79448982|FG002|Extension Study|Protocol Violation|0|||
44440732|NCT00543543|79448983|FG003|Extension Study|Protocol Violation|11|||
44440733|NCT00543543|79448980|FG000|Extension Study|Withdrawal by Subject|0|||
44440734|NCT00543543|79448981|FG001|Extension Study|Withdrawal by Subject|0|||
44440735|NCT00543543|79448982|FG002|Extension Study|Withdrawal by Subject|0|||
44440736|NCT00543543|79448983|FG003|Extension Study|Withdrawal by Subject|120|||
44440737|NCT00645164|79448998|FG000|Overall Study|Lost to Follow-up|2|||
44440738|NCT00645164|79448998|FG000|Overall Study|Withdrawal by Subject|4|||
44440739|NCT00645164|79448998|FG000|Overall Study|Protocol Violation|1|||
44440740|NCT00723125|79449004|FG000|Overall Study|Met Dx|1|||
44440741|NCT00723125|79449005|FG001|Overall Study|Met Dx|0|||
44440742|NCT00723125|79449004|FG000|Overall Study|Withdrawal by Subject|15|||
44440743|NCT00723125|79449005|FG001|Overall Study|Withdrawal by Subject|6|||
44440744|NCT00723125|79449004|FG000|Overall Study|Adverse Event|2|||
44440745|NCT00723125|79449005|FG001|Overall Study|Adverse Event|0|||
44440746|NCT00722423|79449019|FG000|Overall Study|Protocol Violation|0|||
44440747|NCT00722423|79449020|FG001|Overall Study|Protocol Violation|1|||
44440748|NCT00640562|79449030|FG000|Overall Study|Adverse Event|8|||
44440749|NCT00640562|79449031|FG001|Overall Study|Adverse Event|5|||
44440750|NCT00640562|79449030|FG000|Overall Study|Lack of Efficacy|1|||
44440751|NCT00640562|79449031|FG001|Overall Study|Lack of Efficacy|4|||
44440752|NCT00640562|79449030|FG000|Overall Study|Protocol Violation|2|||
44440753|NCT00640562|79449031|FG001|Overall Study|Protocol Violation|4|||
44440754|NCT00640562|79449030|FG000|Overall Study|Withdrawal by Subject|6|||
44440755|NCT00640562|79449031|FG001|Overall Study|Withdrawal by Subject|10|||
44440756|NCT00640562|79449030|FG000|Overall Study|Known risperidone intolerance|0|||
44440757|NCT00640562|79449031|FG001|Overall Study|Known risperidone intolerance|1|||
44440758|NCT00640562|79449030|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
44440759|NCT00640562|79449031|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
44440760|NCT00640562|79449030|FG000|Overall Study|Low study drug dose|0|||
44440761|NCT00640562|79449031|FG001|Overall Study|Low study drug dose|1|||
44440762|NCT00640562|79449030|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
44440763|NCT00640562|79449031|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
44440764|NCT00585923|79449039|FG000|Overall Study|Physician decided not to continue|31|||
44440765|NCT00585923|79449040|FG001|Overall Study|Physician decided not to continue|33|||
44440766|NCT00721955|79449049|FG000|Overall Study|Adverse Event|0|||
44440767|NCT00721955|79449050|FG001|Overall Study|Adverse Event|0|||
44440768|NCT00721955|79449051|FG002|Overall Study|Adverse Event|2|||
44440769|NCT00585689|79449059|FG000|Overall Study|Received different ABI-007 schedule|3|||
44440770|NCT00585689|79449059|FG000|Overall Study|Adverse Event|1|||
44440771|NCT00585689|79449059|FG000|Overall Study|Patient Declined Surgery|1|||
44440772|NCT00585689|79449059|FG000|Overall Study|Patient had unresectable disease|1|||
44440773|NCT00585689|79449059|FG000|Overall Study|Death|1|||
44440774|NCT00721799|79449063|FG000|Overall Study|Withdrawal by Subject|7|||
44440775|NCT00721799|79449063|FG000|Overall Study|withdraw by subject after scan 1|1|||
44440776|NCT00729365|79449070|FG000|Overall Study|Physician Decision|33|||
44440777|NCT00729365|79449071|FG001|Overall Study|Physician Decision|6|||
44440778|NCT00729365|79449072|FG002|Overall Study|Physician Decision|7|||
44440779|NCT00254293|79449088|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
44440780|NCT00254293|79449089|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
44440781|NCT00254293|79449090|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
44440782|NCT00254293|79449091|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
44440783|NCT00254293|79449092|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
44440784|NCT00254293|79449093|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
44440785|NCT00254293|79449094|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
44440786|NCT00254293|79449088|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
44440787|NCT00254293|79449089|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
44440788|NCT00254293|79449090|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
44440789|NCT00254293|79449091|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
44440790|NCT00254293|79449092|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
44440791|NCT00254293|79449093|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
44440792|NCT00254293|79449094|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
44440793|NCT00254293|79449088|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
44440794|NCT00254293|79449089|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
44440795|NCT00254293|79449090|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
44440796|NCT00254293|79449091|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
44440797|NCT00254293|79449092|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
44440798|NCT00254293|79449093|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
44440799|NCT00254293|79449094|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
44440800|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Death|0|||
44440801|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Death|0|||
44440802|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Death|1|||
44440803|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Death|0|||
44440804|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Death|0|||
44440805|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Death|0|||
44440806|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Death|0|||
44440807|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
44440808|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
44440809|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
44440810|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
44440811|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
44440812|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
44440813|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
44440814|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
44440815|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
44440816|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
44440817|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
44440818|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
44440819|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
44440820|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
44440821|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
44440822|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
44440823|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
44440824|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
44440825|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
44440826|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
44440827|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
44440828|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
44440829|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
44440830|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
44440831|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
44440832|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
44440833|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
44440834|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
44440835|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
44440836|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
44440837|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
44440838|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
44440839|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
44440840|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
44440841|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
44440842|NCT00254293|79449088|FG000|LTE Open Label Variable SC Dosing|Other|0|||
44440843|NCT00254293|79449089|FG001|LTE Open Label Variable SC Dosing|Other|0|||
44440844|NCT00254293|79449090|FG002|LTE Open Label Variable SC Dosing|Other|2|||
44440845|NCT00254293|79449091|FG003|LTE Open Label Variable SC Dosing|Other|0|||
44440846|NCT00254293|79449092|FG004|LTE Open Label Variable SC Dosing|Other|0|||
44440847|NCT00254293|79449093|FG005|LTE Open Label Variable SC Dosing|Other|0|||
44440848|NCT00254293|79449094|FG006|LTE Open Label Variable SC Dosing|Other|0|||
44440849|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Death|0|||
44440850|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Death|0|||
44440851|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Death|0|||
44440852|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Death|0|||
44440853|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Death|0|||
44440854|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Death|0|||
44440855|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Death|3|||
44440856|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
44440857|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
44440858|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
44440859|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
44440860|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
44440861|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
44440862|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
44440863|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
44440864|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
44440865|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
44440866|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
44440867|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
44440868|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
44440869|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
44440870|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
44440871|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
44159097|NCT02876328|78951397|FG014|Overall Study|Death|0|||
44440872|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
44440873|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
44440874|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
44440875|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
44440876|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
44440877|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
44440878|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
44440879|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
44440880|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
44440881|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
44440882|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
44440883|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
44440884|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
44440885|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
44440886|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
44440887|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
44440888|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
44440889|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
44440890|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
44440891|NCT00254293|79449088|FG000|LTE Open Label Fixed Dosing|Other|0|||
44440892|NCT00254293|79449089|FG001|LTE Open Label Fixed Dosing|Other|0|||
44440893|NCT00254293|79449090|FG002|LTE Open Label Fixed Dosing|Other|0|||
44440894|NCT00254293|79449091|FG003|LTE Open Label Fixed Dosing|Other|0|||
44440895|NCT00254293|79449092|FG004|LTE Open Label Fixed Dosing|Other|0|||
44440896|NCT00254293|79449093|FG005|LTE Open Label Fixed Dosing|Other|0|||
44440897|NCT00254293|79449094|FG006|LTE Open Label Fixed Dosing|Other|1|||
44440898|NCT00585221|79449137|FG000|Overall Study|Protocol Violation|8|||
44440899|NCT00253747|79449143|FG000|Overall Study|Lost to Follow-up|13|||
44440900|NCT00253747|79449144|FG001|Overall Study|Lost to Follow-up|14|||
44440901|NCT00253747|79449143|FG000|Overall Study|Withdrawal by Subject|10|||
44440902|NCT00253747|79449144|FG001|Overall Study|Withdrawal by Subject|11|||
44440903|NCT00253747|79449143|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
44440904|NCT00253747|79449144|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
44440905|NCT00252733|79449162|FG000|Overall Study|Withdrawal by Subject|73|||
44440906|NCT00252733|79449163|FG001|Overall Study|Withdrawal by Subject|67|||
44440907|NCT00252733|79449162|FG000|Overall Study|Death|7|||
44440908|NCT00252733|79449163|FG001|Overall Study|Death|5|||
44341399|NCT01014988|79345425|FG005|Overall Study|Lost to Follow-up|0|||
44341400|NCT01014988|79345420|FG000|Overall Study|Physician Decision|1|||
44341401|NCT01014988|79345421|FG001|Overall Study|Physician Decision|0|||
44341402|NCT01014988|79345422|FG002|Overall Study|Physician Decision|0|||
44341403|NCT01014988|79345423|FG003|Overall Study|Physician Decision|0|||
44341404|NCT01014988|79345424|FG004|Overall Study|Physician Decision|0|||
44341405|NCT01014988|79345425|FG005|Overall Study|Physician Decision|0|||
44341406|NCT01014988|79345420|FG000|Overall Study|Withdrawal by Subject|1|||
44341407|NCT01014988|79345421|FG001|Overall Study|Withdrawal by Subject|0|||
44341408|NCT01014988|79345422|FG002|Overall Study|Withdrawal by Subject|0|||
44341409|NCT01014988|79345423|FG003|Overall Study|Withdrawal by Subject|0|||
44440909|NCT00252733|79449162|FG000|Overall Study|Lost to Follow-up|12|||
44440910|NCT00252733|79449163|FG001|Overall Study|Lost to Follow-up|6|||
44440911|NCT00252733|79449162|FG000|Overall Study|Multiple Reasons|14|||
44440912|NCT00252733|79449163|FG001|Overall Study|Multiple Reasons|14|||
44440913|NCT00275821|79449172|FG000|Overall Study|Adverse Event|4|||
44440914|NCT00275821|79449173|FG001|Overall Study|Adverse Event|12|||
44440915|NCT00275821|79449174|FG002|Overall Study|Adverse Event|5|||
44440916|NCT00275821|79449172|FG000|Overall Study|Administrative problems|3|||
44440917|NCT00275821|79449173|FG001|Overall Study|Administrative problems|4|||
44440918|NCT00275821|79449174|FG002|Overall Study|Administrative problems|4|||
44440919|NCT00275821|79449172|FG000|Overall Study|Withdrawal by Subject|0|||
44440920|NCT00275821|79449173|FG001|Overall Study|Withdrawal by Subject|2|||
44440921|NCT00275821|79449174|FG002|Overall Study|Withdrawal by Subject|1|||
44440922|NCT00275821|79449172|FG000|Overall Study|Lost to Follow-up|0|||
44440923|NCT00275821|79449173|FG001|Overall Study|Lost to Follow-up|1|||
44159098|NCT02876328|78951398|FG015|Overall Study|Death|0|||
44440924|NCT00275821|79449174|FG002|Overall Study|Lost to Follow-up|1|||
44440925|NCT00275821|79449172|FG000|Overall Study|Death|0|||
44440926|NCT00275821|79449173|FG001|Overall Study|Death|2|||
44341410|NCT01014988|79345424|FG004|Overall Study|Withdrawal by Subject|0|||
44341411|NCT01014988|79345425|FG005|Overall Study|Withdrawal by Subject|0|||
44341412|NCT01014910|79345449|FG000|Overall Study|Withdrawal by Subject|0|||
44341413|NCT01014910|79345450|FG001|Overall Study|Withdrawal by Subject|2|||
44440927|NCT00275821|79449174|FG002|Overall Study|Death|1|||
44440928|NCT00275821|79449172|FG000|Overall Study|Lack of Efficacy|2|||
44440929|NCT00275821|79449173|FG001|Overall Study|Lack of Efficacy|1|||
44440930|NCT00275821|79449174|FG002|Overall Study|Lack of Efficacy|0|||
44440931|NCT00275821|79449172|FG000|Overall Study|Protocol Violation|5|||
44440932|NCT00275821|79449173|FG001|Overall Study|Protocol Violation|1|||
44440933|NCT00275821|79449174|FG002|Overall Study|Protocol Violation|0|||
44440934|NCT00275509|79449184|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
44440935|NCT00275509|79449185|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
44440936|NCT00252577|79449191|FG000|Overall Study|Lost to Follow-up|20|||
44440937|NCT00252499|79449198|FG000|Overall Study|Lost to Follow-up|1|||
44440938|NCT00252499|79449199|FG001|Overall Study|Lost to Follow-up|0|||
44440939|NCT00252499|79449200|FG002|Overall Study|Lost to Follow-up|0|||
44440940|NCT00252187|79449210|FG000|Overall Study|Adverse Event|3|||
44440941|NCT00252187|79449211|FG001|Overall Study|Adverse Event|1|||
44440942|NCT00252187|79449210|FG000|Overall Study|Withdrawal by Subject|1|||
44440943|NCT00252187|79449211|FG001|Overall Study|Withdrawal by Subject|0|||
44440944|NCT00572910|79449223|FG000|Overall Study|Adverse Event|1|||
44440945|NCT00572910|79449224|FG001|Overall Study|Adverse Event|2|||
44440946|NCT00572910|79449225|FG002|Overall Study|Adverse Event|0|||
44440947|NCT00572910|79449226|FG003|Overall Study|Adverse Event|2|||
44440948|NCT00572910|79449227|FG004|Overall Study|Adverse Event|0|||
44440949|NCT00572910|79449228|FG005|Overall Study|Adverse Event|0|||
44440950|NCT00572910|79449229|FG006|Overall Study|Adverse Event|4|||
44440951|NCT00572910|79449230|FG007|Overall Study|Adverse Event|2|||
44440952|NCT00572910|79449231|FG008|Overall Study|Adverse Event|1|||
44440953|NCT00572910|79449232|FG009|Overall Study|Adverse Event|3|||
44440954|NCT00572910|79449233|FG010|Overall Study|Adverse Event|2|||
44440955|NCT00572910|79449223|FG000|Overall Study|Lost to Follow-up|0|||
44440956|NCT00572910|79449224|FG001|Overall Study|Lost to Follow-up|1|||
44440957|NCT00572910|79449225|FG002|Overall Study|Lost to Follow-up|1|||
44440958|NCT00572910|79449226|FG003|Overall Study|Lost to Follow-up|2|||
44440959|NCT00572910|79449227|FG004|Overall Study|Lost to Follow-up|1|||
44440960|NCT00572910|79449228|FG005|Overall Study|Lost to Follow-up|0|||
44440961|NCT00572910|79449229|FG006|Overall Study|Lost to Follow-up|0|||
44440962|NCT00572910|79449230|FG007|Overall Study|Lost to Follow-up|0|||
44440963|NCT00572910|79449231|FG008|Overall Study|Lost to Follow-up|0|||
44440964|NCT00572910|79449232|FG009|Overall Study|Lost to Follow-up|1|||
44440965|NCT00572910|79449233|FG010|Overall Study|Lost to Follow-up|0|||
44440966|NCT00572910|79449223|FG000|Overall Study|Withdrawal by Subject|3|||
44440967|NCT00572910|79449224|FG001|Overall Study|Withdrawal by Subject|0|||
44440968|NCT00572910|79449225|FG002|Overall Study|Withdrawal by Subject|1|||
44440969|NCT00572910|79449226|FG003|Overall Study|Withdrawal by Subject|0|||
44440970|NCT00572910|79449227|FG004|Overall Study|Withdrawal by Subject|1|||
44440971|NCT00572910|79449228|FG005|Overall Study|Withdrawal by Subject|3|||
44440972|NCT00572910|79449229|FG006|Overall Study|Withdrawal by Subject|0|||
44440973|NCT00572910|79449230|FG007|Overall Study|Withdrawal by Subject|2|||
44440974|NCT00572910|79449231|FG008|Overall Study|Withdrawal by Subject|2|||
44440975|NCT00572910|79449232|FG009|Overall Study|Withdrawal by Subject|2|||
44440976|NCT00572910|79449233|FG010|Overall Study|Withdrawal by Subject|1|||
44440977|NCT00163657|79449271|FG000|Overall Study|Death|12|||
44440978|NCT00163657|79449272|FG001|Overall Study|Death|14|||
44259733|NCT04575584|79122505|FG003|Overall Study|Physician Decision|1|||
44259734|NCT04575584|79122506|FG004|Overall Study|Physician Decision|0|||
44259735|NCT04575584|79122507|FG005|Overall Study|Physician Decision|0|||
44259736|NCT04575584|79122502|FG000|Overall Study|Withdrawal by Subject|7|||
44259737|NCT04575584|79122503|FG001|Overall Study|Withdrawal by Subject|9|||
44259738|NCT04575584|79122504|FG002|Overall Study|Withdrawal by Subject|5|||
44259739|NCT04575584|79122505|FG003|Overall Study|Withdrawal by Subject|3|||
44259740|NCT04575584|79122506|FG004|Overall Study|Withdrawal by Subject|0|||
44341414|NCT01019980|79345458|FG000|Overall Study|Drug not available.|2|||
44341415|NCT01019980|79345459|FG001|Overall Study|Drug not available.|0|||
44341416|NCT00993499|79345471|FG000|Run-in Period (8 Days)|Adverse Event|0|||
44341417|NCT00993499|79345472|FG001|Run-in Period (8 Days)|Adverse Event|1|||
44341418|NCT00993499|79345473|FG002|Run-in Period (8 Days)|Adverse Event|0|||
44341419|NCT00993499|79345474|FG003|Run-in Period (8 Days)|Adverse Event|0|||
44341420|NCT00993499|79345475|FG004|Run-in Period (8 Days)|Adverse Event|0|||
44341421|NCT00993499|79345476|FG005|Run-in Period (8 Days)|Adverse Event|0|||
44341422|NCT00993499|79345471|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
44341423|NCT00993499|79345472|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
44341424|NCT00993499|79345473|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
44341425|NCT00993499|79345474|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
44341426|NCT00993499|79345475|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
44440979|NCT00163657|79449273|FG002|Overall Study|Death|19|||
44159099|NCT02876328|78951399|FG016|Overall Study|Death|1|||
44159100|NCT02876328|78951400|FG017|Overall Study|Death|1|||
44259741|NCT04575584|79122507|FG005|Overall Study|Withdrawal by Subject|0|||
44259742|NCT04575584|79122502|FG000|Overall Study|Not recorded|0|||
44259743|NCT04575584|79122503|FG001|Overall Study|Not recorded|0|||
44259744|NCT04575584|79122504|FG002|Overall Study|Not recorded|0|||
44341427|NCT00993499|79345476|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
44440980|NCT00163657|79449271|FG000|Overall Study|graft loss|4|||
44259745|NCT04575584|79122505|FG003|Overall Study|Not recorded|1|||
44259746|NCT04575584|79122506|FG004|Overall Study|Not recorded|0|||
44259747|NCT04575584|79122507|FG005|Overall Study|Not recorded|0|||
44440981|NCT00163657|79449272|FG001|Overall Study|graft loss|1|||
44440982|NCT00163657|79449273|FG002|Overall Study|graft loss|2|||
44440983|NCT00163657|79449271|FG000|Overall Study|Withdrawal by Subject|2|||
44440984|NCT00163657|79449272|FG001|Overall Study|Withdrawal by Subject|3|||
44440985|NCT00163657|79449273|FG002|Overall Study|Withdrawal by Subject|2|||
44440986|NCT00163657|79449271|FG000|Overall Study|Physician Decision|0|||
44440987|NCT00163657|79449272|FG001|Overall Study|Physician Decision|1|||
44440988|NCT00163657|79449273|FG002|Overall Study|Physician Decision|1|||
44440989|NCT00163657|79449271|FG000|Overall Study|Non Compliance|1|||
44440990|NCT00163657|79449272|FG001|Overall Study|Non Compliance|0|||
44440991|NCT00163657|79449273|FG002|Overall Study|Non Compliance|0|||
44440992|NCT00163657|79449271|FG000|Overall Study|Lost to Follow-up|1|||
44440993|NCT00163657|79449272|FG001|Overall Study|Lost to Follow-up|3|||
44440994|NCT00163657|79449273|FG002|Overall Study|Lost to Follow-up|10|||
44440995|NCT00163657|79449271|FG000|Overall Study|Other reason|0|||
44440996|NCT00163657|79449272|FG001|Overall Study|Other reason|1|||
44440997|NCT00163657|79449273|FG002|Overall Study|Other reason|3|||
44440998|NCT00609492|79449284|FG000|Overall Study|Withdrawal by Subject|0|||
44440999|NCT00609492|79449285|FG001|Overall Study|Withdrawal by Subject|2|||
44441000|NCT00609492|79449286|FG002|Overall Study|Withdrawal by Subject|3|||
44441001|NCT00609492|79449284|FG000|Overall Study|Lost to Follow-up|1|||
44441002|NCT00609492|79449285|FG001|Overall Study|Lost to Follow-up|1|||
44441003|NCT00609492|79449286|FG002|Overall Study|Lost to Follow-up|4|||
44441004|NCT00230971|79449298|FG000|Randomization|No study drug administered|3|||
44441005|NCT00230971|79449299|FG001|Randomization|No study drug administered|3|||
44441006|NCT00230971|79449298|FG000|Baseline Participants|Lost to Follow-up|5|||
44441007|NCT00230971|79449299|FG001|Baseline Participants|Lost to Follow-up|12|||
44441008|NCT00230971|79449298|FG000|Baseline Participants|Death|6|||
44441009|NCT00230971|79449299|FG001|Baseline Participants|Death|5|||
44441010|NCT00230971|79449298|FG000|Baseline Participants|Withdrawal by Subject|7|||
44441011|NCT00230971|79449299|FG001|Baseline Participants|Withdrawal by Subject|1|||
44441012|NCT00230971|79449298|FG000|Baseline Participants|Adverse Event|1|||
44441013|NCT00230971|79449299|FG001|Baseline Participants|Adverse Event|0|||
44441014|NCT00230971|79449298|FG000|Baseline Participants|No bacteria observed|1|||
44441015|NCT00230971|79449299|FG001|Baseline Participants|No bacteria observed|0|||
44441016|NCT00230971|79449298|FG000|Baseline Participants|Failure to return|1|||
44441017|NCT00230971|79449299|FG001|Baseline Participants|Failure to return|1|||
44441018|NCT00230971|79449298|FG000|Baseline Participants|Reintervention|1|||
44441019|NCT00230971|79449299|FG001|Baseline Participants|Reintervention|0|||
44441020|NCT00211081|79449305|FG000|Overall Study|Withdrawal by Subject|2|||
44441021|NCT00609336|79449309|FG000|Overall Study|Protocol Violation|3|||
44441022|NCT00609336|79449309|FG000|Overall Study|Death|1|||
44441023|NCT00609336|79449309|FG000|Overall Study|LA or Met at Surgery|9|||
44441024|NCT00612066|79449314|FG000|Overall Study|Adverse Event|1|||
44441025|NCT00573144|79449320|FG000|Overall Study|Withdrawal by Subject|2|||
44441026|NCT00573144|79449321|FG001|Overall Study|Withdrawal by Subject|3|||
44159101|NCT02876328|78951401|FG018|Overall Study|Death|0|||
44159102|NCT02876328|78951402|FG019|Overall Study|Death|0|||
44159103|NCT02876328|78951403|FG020|Overall Study|Death|0|||
44159104|NCT02876328|78951404|FG021|Overall Study|Death|1|||
44441027|NCT00640328|79449333|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
44441028|NCT00640328|79449334|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
44441029|NCT00640328|79449335|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
44441030|NCT00640328|79449336|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
44441031|NCT00640328|79449337|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
44441032|NCT00640328|79449338|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
44441033|NCT00640328|79449333|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
44441034|NCT00640328|79449334|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
44159105|NCT02876328|78951405|FG022|Overall Study|Death|0|||
44441035|NCT00640328|79449335|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
44441036|NCT00640328|79449336|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
44441037|NCT00640328|79449337|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
44441038|NCT00640328|79449338|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
44159106|NCT02876328|78951406|FG023|Overall Study|Death|0|||
44441039|NCT00640328|79449333|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
44441040|NCT00640328|79449334|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
44441041|NCT00640328|79449335|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
44441042|NCT00640328|79449336|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
44441043|NCT00640328|79449337|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
44441044|NCT00640328|79449338|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
44441045|NCT00640328|79449333|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
44441046|NCT00640328|79449334|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
44441047|NCT00640328|79449335|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
44441048|NCT00640328|79449336|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
44441049|NCT00640328|79449337|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
44441050|NCT00640328|79449338|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
44441051|NCT00163189|79449359|FG000|Overall Study|Other|6|||
44441052|NCT00163189|79449359|FG000|Overall Study|Lost to Follow-up|1|||
44441053|NCT00163189|79449359|FG000|Overall Study|Protocol Violation|2|||
44441054|NCT00163189|79449359|FG000|Overall Study|Death|3|||
44441055|NCT00163189|79449359|FG000|Overall Study|Adverse Event|6|||
44441056|NCT00163189|79449359|FG000|Overall Study|Lack of Efficacy|7|||
44441057|NCT00163189|79449359|FG000|Overall Study|Study terminated by sponsor|11|||
44441058|NCT00163189|79449359|FG000|Overall Study|Withdrawal by Subject|11|||
44441059|NCT00163189|79449359|FG000|Overall Study|Did not meet continuation criterion|16|||
44441060|NCT00162097|79449367|FG000|Overall Study|Participant no longer met study criteria|0|||
44441061|NCT00162097|79449368|FG001|Overall Study|Participant no longer met study criteria|0|||
44441062|NCT00162097|79449369|FG002|Overall Study|Participant no longer met study criteria|0|||
44441063|NCT00162097|79449370|FG003|Overall Study|Participant no longer met study criteria|1|||
44441064|NCT00640016|79449390|FG000|Overall Study|Withdrawal by Subject|0|||
44441065|NCT00640016|79449391|FG001|Overall Study|Withdrawal by Subject|1|||
44441066|NCT00640016|79449392|FG002|Overall Study|Withdrawal by Subject|0|||
44441067|NCT00640016|79449393|FG003|Overall Study|Withdrawal by Subject|0|||
44441068|NCT00640016|79449390|FG000|Overall Study|Study termination|2|||
44441069|NCT00640016|79449391|FG001|Overall Study|Study termination|1|||
44441070|NCT00640016|79449392|FG002|Overall Study|Study termination|3|||
44441071|NCT00640016|79449393|FG003|Overall Study|Study termination|2|||
44441072|NCT00640016|79449390|FG000|Overall Study|Adverse Event|0|||
44441073|NCT00640016|79449391|FG001|Overall Study|Adverse Event|0|||
44441074|NCT00640016|79449392|FG002|Overall Study|Adverse Event|0|||
44441075|NCT00640016|79449393|FG003|Overall Study|Adverse Event|1|||
44441076|NCT00608868|79449410|FG000|Overall Study|Withdrawal by Subject|7|||
44441077|NCT00608868|79449410|FG000|Overall Study|Protocol Violation|3|||
44441078|NCT00608868|79449410|FG000|Overall Study|Lost to Follow-up|2|||
44441079|NCT00608868|79449410|FG000|Overall Study|Adverse Event|1|||
44441080|NCT00608868|79449410|FG000|Overall Study|Physician Decision|2|||
44441081|NCT00608322|79449416|FG000|Overall Study|Death|2|||
44441082|NCT00608322|79449417|FG001|Overall Study|Death|1|||
44441083|NCT00608244|79449423|FG000|Overall Study|Adverse Event|1|||
44441084|NCT00608244|79449423|FG000|Overall Study|Low trough levels|1|||
44441085|NCT00605280|79449433|FG000|Year 1|Protocol Violation|0|||
44441086|NCT00605280|79449434|FG001|Year 1|Protocol Violation|0|||
44441087|NCT00605280|79449435|FG002|Year 1|Protocol Violation|0|||
44441088|NCT00605280|79449436|FG003|Year 1|Protocol Violation|1|||
44441089|NCT00605280|79449433|FG000|Year 1|Adverse Event|3|||
44441090|NCT00605280|79449434|FG001|Year 1|Adverse Event|1|||
44441091|NCT00605280|79449435|FG002|Year 1|Adverse Event|1|||
44441092|NCT00605280|79449436|FG003|Year 1|Adverse Event|5|||
44441093|NCT00605280|79449433|FG000|Year 1|Physician Decision|7|||
44441094|NCT00605280|79449434|FG001|Year 1|Physician Decision|4|||
44441095|NCT00605280|79449435|FG002|Year 1|Physician Decision|0|||
44441096|NCT00605280|79449436|FG003|Year 1|Physician Decision|6|||
44441097|NCT00605280|79449433|FG000|Year 1|Withdrawal by Subject|2|||
44441098|NCT00605280|79449434|FG001|Year 1|Withdrawal by Subject|4|||
44441099|NCT00605280|79449435|FG002|Year 1|Withdrawal by Subject|0|||
44441100|NCT00605280|79449436|FG003|Year 1|Withdrawal by Subject|4|||
44441101|NCT00605280|79449433|FG000|Year 1|Other|2|||
44441102|NCT00605280|79449434|FG001|Year 1|Other|1|||
44441103|NCT00605280|79449435|FG002|Year 1|Other|0|||
44441104|NCT00605280|79449436|FG003|Year 1|Other|1|||
44441105|NCT00605280|79449433|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
44441106|NCT00605280|79449434|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
44441107|NCT00605280|79449435|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
44441108|NCT00605280|79449436|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
44441109|NCT00605280|79449433|FG000|Year 2|Adverse Event|4|||
44441110|NCT00605280|79449434|FG001|Year 2|Adverse Event|0|||
44441111|NCT00605280|79449435|FG002|Year 2|Adverse Event|2|||
44441112|NCT00605280|79449436|FG003|Year 2|Adverse Event|4|||
44441113|NCT00605280|79449433|FG000|Year 2|Physician Decision|11|||
44441114|NCT00605280|79449434|FG001|Year 2|Physician Decision|6|||
44441115|NCT00605280|79449435|FG002|Year 2|Physician Decision|4|||
44441116|NCT00605280|79449436|FG003|Year 2|Physician Decision|11|||
44441117|NCT00605280|79449433|FG000|Year 2|Withdrawal by Subject|4|||
44441118|NCT00605280|79449434|FG001|Year 2|Withdrawal by Subject|0|||
44441119|NCT00605280|79449435|FG002|Year 2|Withdrawal by Subject|0|||
44441120|NCT00605280|79449436|FG003|Year 2|Withdrawal by Subject|4|||
44441121|NCT00605280|79449433|FG000|Year 2|Other|1|||
44441122|NCT00605280|79449434|FG001|Year 2|Other|0|||
44441123|NCT00605280|79449435|FG002|Year 2|Other|0|||
44441124|NCT00605280|79449436|FG003|Year 2|Other|1|||
44441125|NCT00605280|79449433|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
44441126|NCT00605280|79449434|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
44441127|NCT00605280|79449435|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
44441128|NCT00605280|79449436|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
44441129|NCT00605280|79449433|FG000|Year 3 Extension|Adverse Event|2|||
44441130|NCT00605280|79449434|FG001|Year 3 Extension|Adverse Event|0|||
44441131|NCT00605280|79449435|FG002|Year 3 Extension|Adverse Event|0|||
44441132|NCT00605280|79449436|FG003|Year 3 Extension|Adverse Event|2|||
44441133|NCT00605280|79449433|FG000|Year 3 Extension|Physician Decision|0|||
44441134|NCT00605280|79449434|FG001|Year 3 Extension|Physician Decision|0|||
44441135|NCT00605280|79449435|FG002|Year 3 Extension|Physician Decision|0|||
44441136|NCT00605280|79449436|FG003|Year 3 Extension|Physician Decision|2|||
44441137|NCT00605280|79449433|FG000|Year 3 Extension|Withdrawal by Subject|2|||
44441138|NCT00605280|79449434|FG001|Year 3 Extension|Withdrawal by Subject|0|||
44441139|NCT00605280|79449435|FG002|Year 3 Extension|Withdrawal by Subject|0|||
44441140|NCT00605280|79449436|FG003|Year 3 Extension|Withdrawal by Subject|5|||
44441141|NCT00605280|79449433|FG000|Year 3 Extension|Other|2|||
44441142|NCT00605280|79449434|FG001|Year 3 Extension|Other|0|||
44441143|NCT00605280|79449435|FG002|Year 3 Extension|Other|0|||
44441144|NCT00605280|79449436|FG003|Year 3 Extension|Other|0|||
44441145|NCT00605280|79449433|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
44441146|NCT00605280|79449434|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
44441147|NCT00605280|79449435|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
44159107|NCT02876328|78951383|FG000|Overall Study|Withdrawal by Subject|0|||
44341428|NCT00993499|79345471|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
44341429|NCT00993499|79345472|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
44441148|NCT00605280|79449436|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
44441149|NCT00607386|79449446|FG000|Overall Study|Physician Decision|1|||
44441150|NCT00638690|79449452|FG000|Overall Study|Death|655|||
44441151|NCT00638690|79449453|FG001|Overall Study|Death|335|||
44441152|NCT00638690|79449452|FG000|Overall Study|Withdrawal by Subject|22|||
44441153|NCT00638690|79449453|FG001|Overall Study|Withdrawal by Subject|5|||
44441154|NCT00638690|79449452|FG000|Overall Study|Lost to Follow-up|4|||
44441155|NCT00638690|79449453|FG001|Overall Study|Lost to Follow-up|2|||
44441156|NCT00543387|79449469|FG000|Panel 1 + Panel 2|Adverse Event|0|||
44441157|NCT00543387|79449470|FG001|Panel 1 + Panel 2|Adverse Event|1|||
44441158|NCT00543387|79449471|FG002|Panel 1 + Panel 2|Adverse Event|0|||
44441159|NCT00543387|79449472|FG003|Panel 1 + Panel 2|Adverse Event|0|||
44441160|NCT00543387|79449473|FG004|Panel 1 + Panel 2|Adverse Event|0|||
44441161|NCT00543387|79449474|FG005|Panel 1 + Panel 2|Adverse Event|0|||
44441162|NCT00543387|79449475|FG006|Panel 1 + Panel 2|Adverse Event|0|||
44441163|NCT00543387|79449476|FG007|Panel 1 + Panel 2|Adverse Event|1|||
44441164|NCT00543387|79449477|FG008|Panel 1 + Panel 2|Adverse Event|1|||
44441165|NCT00543387|79449478|FG009|Panel 1 + Panel 2|Adverse Event|0|||
44441166|NCT00543387|79449479|FG010|Panel 1 + Panel 2|Adverse Event|0|||
44441167|NCT00543387|79449469|FG000|Panel 1 + Panel 2|Physician Decision|0|||
44441168|NCT00543387|79449470|FG001|Panel 1 + Panel 2|Physician Decision|0|||
44441169|NCT00543387|79449471|FG002|Panel 1 + Panel 2|Physician Decision|1|||
44441170|NCT00543387|79449472|FG003|Panel 1 + Panel 2|Physician Decision|0|||
44441171|NCT00543387|79449473|FG004|Panel 1 + Panel 2|Physician Decision|0|||
44441172|NCT00543387|79449474|FG005|Panel 1 + Panel 2|Physician Decision|0|||
44441173|NCT00543387|79449475|FG006|Panel 1 + Panel 2|Physician Decision|0|||
44441174|NCT00543387|79449476|FG007|Panel 1 + Panel 2|Physician Decision|1|||
44441175|NCT00543387|79449477|FG008|Panel 1 + Panel 2|Physician Decision|0|||
44441176|NCT00543387|79449478|FG009|Panel 1 + Panel 2|Physician Decision|0|||
44441177|NCT00543387|79449479|FG010|Panel 1 + Panel 2|Physician Decision|0|||
44441178|NCT00543387|79449469|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
44441179|NCT00543387|79449470|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
44441180|NCT00543387|79449471|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
44441181|NCT00543387|79449472|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
44441182|NCT00543387|79449473|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
44441183|NCT00543387|79449474|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
44441184|NCT00543387|79449475|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
44441185|NCT00543387|79449476|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
44441186|NCT00543387|79449477|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
44441187|NCT00543387|79449478|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
44441188|NCT00543387|79449479|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
44441189|NCT00543387|79449469|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441190|NCT00543387|79449470|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441191|NCT00543387|79449471|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441192|NCT00543387|79449472|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441193|NCT00543387|79449473|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441194|NCT00543387|79449474|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441195|NCT00543387|79449475|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
44441196|NCT00543387|79449476|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441197|NCT00543387|79449477|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441198|NCT00543387|79449478|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441199|NCT00543387|79449479|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
44441200|NCT00543387|79449469|FG000|Crossover Participants|Progressive Disease|0|||
44441201|NCT00543387|79449470|FG001|Crossover Participants|Progressive Disease|0|||
44441202|NCT00543387|79449471|FG002|Crossover Participants|Progressive Disease|0|||
44441203|NCT00543387|79449472|FG003|Crossover Participants|Progressive Disease|0|||
44441204|NCT00543387|79449473|FG004|Crossover Participants|Progressive Disease|0|||
44441205|NCT00543387|79449474|FG005|Crossover Participants|Progressive Disease|0|||
44441206|NCT00543387|79449475|FG006|Crossover Participants|Progressive Disease|0|||
44441207|NCT00543387|79449476|FG007|Crossover Participants|Progressive Disease|0|||
44441208|NCT00543387|79449477|FG008|Crossover Participants|Progressive Disease|0|||
44441209|NCT00543387|79449478|FG009|Crossover Participants|Progressive Disease|1|||
44441210|NCT00543387|79449479|FG010|Crossover Participants|Progressive Disease|2|||
44441211|NCT00543387|79449469|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
44441212|NCT00543387|79449470|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
44441213|NCT00543387|79449471|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
44441214|NCT00543387|79449472|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
44441215|NCT00543387|79449473|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
44441216|NCT00543387|79449474|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
44441217|NCT00543387|79449475|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
44441218|NCT00543387|79449476|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
44441219|NCT00543387|79449477|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
44441220|NCT00543387|79449478|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
44441221|NCT00543387|79449479|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
44441222|NCT00635570|79449509|FG000|Overall Study|Lost to Follow-up|8|||
44441223|NCT00635570|79449510|FG001|Overall Study|Lost to Follow-up|8|||
44441224|NCT00635570|79449509|FG000|Overall Study|Withdrawal by Subject|1|||
44441225|NCT00635570|79449510|FG001|Overall Study|Withdrawal by Subject|1|||
44441226|NCT00635570|79449509|FG000|Overall Study|Adverse Event|2|||
44441227|NCT00635570|79449510|FG001|Overall Study|Adverse Event|0|||
44441228|NCT00635570|79449509|FG000|Overall Study|Physician Decision|1|||
44441229|NCT00635570|79449510|FG001|Overall Study|Physician Decision|0|||
44441230|NCT00635570|79449509|FG000|Overall Study|Did not complete survey|2|||
44441231|NCT00635570|79449510|FG001|Overall Study|Did not complete survey|1|||
44441232|NCT00635570|79449509|FG000|Overall Study|Early termination(No sexual activity)|1|||
44441233|NCT00635570|79449510|FG001|Overall Study|Early termination(No sexual activity)|1|||
44441234|NCT00635492|79449518|FG000|Overall Study|Death|12|||
44441235|NCT00635492|79449519|FG001|Overall Study|Death|40|||
44441236|NCT00635492|79449518|FG000|Overall Study|Lost to Follow-up|151|||
44441237|NCT00635492|79449519|FG001|Overall Study|Lost to Follow-up|172|||
44441238|NCT00635492|79449518|FG000|Overall Study|Physician Decision|32|||
44441239|NCT00635492|79449519|FG001|Overall Study|Physician Decision|22|||
44441240|NCT00635492|79449518|FG000|Overall Study|Sponsor decision|2|||
44441241|NCT00635492|79449519|FG001|Overall Study|Sponsor decision|3|||
44159108|NCT02876328|78951384|FG001|Overall Study|Withdrawal by Subject|2|||
44341430|NCT00993499|79345473|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
44341431|NCT00993499|79345474|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
44341432|NCT00993499|79345475|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
44341433|NCT00993499|79345476|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
44341434|NCT00993499|79345471|FG000|Run-in Period (8 Days)|Progressive disease|0|||
44341435|NCT00993499|79345472|FG001|Run-in Period (8 Days)|Progressive disease|1|||
44341436|NCT00993499|79345473|FG002|Run-in Period (8 Days)|Progressive disease|1|||
44341437|NCT00993499|79345474|FG003|Run-in Period (8 Days)|Progressive disease|0|||
44341438|NCT00993499|79345475|FG004|Run-in Period (8 Days)|Progressive disease|0|||
44341439|NCT00993499|79345476|FG005|Run-in Period (8 Days)|Progressive disease|0|||
44341440|NCT00993499|79345471|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
44341441|NCT00993499|79345472|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
44341442|NCT00993499|79345473|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
44341443|NCT00993499|79345474|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
44341444|NCT00993499|79345475|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
44341445|NCT00993499|79345476|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
44341446|NCT00993499|79345471|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
44341447|NCT00993499|79345472|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
44341448|NCT00993499|79345473|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
44341449|NCT00993499|79345474|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
44341450|NCT00993499|79345475|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
44341451|NCT00993499|79345476|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
44341452|NCT00993499|79345471|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
44341453|NCT00993499|79345472|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
44341454|NCT00993499|79345473|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
44341455|NCT00993499|79345474|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
44341456|NCT00993499|79345475|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
44341457|NCT00993499|79345476|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
44341458|NCT00993499|79345471|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
44341459|NCT00993499|79345472|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
44341460|NCT00993499|79345473|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
44441242|NCT00635492|79449518|FG000|Overall Study|Withdrawal by Subject|82|||
44441243|NCT00635492|79449519|FG001|Overall Study|Withdrawal by Subject|45|||
44441244|NCT00543309|79449532|FG000|Overall Study|Physician Decision|0|||
44441245|NCT00543309|79449533|FG001|Overall Study|Physician Decision|1|||
44441246|NCT00543309|79449534|FG002|Overall Study|Physician Decision|0|||
44441247|NCT00569582|79449543|FG000|Overall Study|Withdrawal by Subject|5|||
44441248|NCT00569582|79449543|FG000|Overall Study|Death|2|||
44441249|NCT00569582|79449543|FG000|Overall Study|Adverse Event|7|||
44441250|NCT00569582|79449543|FG000|Overall Study|Subject was too ill to travel.|1|||
44441251|NCT00569582|79449543|FG000|Overall Study|Subject was non-compliant.|1|||
44441252|NCT00721409|79449550|FG000|Overall Study|Global deterioration of health status|2|||
44441253|NCT00721409|79449551|FG001|Overall Study|Global deterioration of health status|6|||
44441254|NCT00721409|79449552|FG002|Overall Study|Global deterioration of health status|3|||
44441255|NCT00721409|79449550|FG000|Overall Study|Death|0|||
44441256|NCT00721409|79449551|FG001|Overall Study|Death|1|||
44441257|NCT00721409|79449552|FG002|Overall Study|Death|0|||
44441258|NCT00721409|79449550|FG000|Overall Study|Randomized not Treated|0|||
44441259|NCT00721409|79449551|FG001|Overall Study|Randomized not Treated|1|||
44441260|NCT00721409|79449552|FG002|Overall Study|Randomized not Treated|4|||
44441261|NCT00721409|79449550|FG000|Overall Study|Reason not specified|1|||
44441262|NCT00721409|79449551|FG001|Overall Study|Reason not specified|0|||
44441263|NCT00721409|79449552|FG002|Overall Study|Reason not specified|2|||
44441264|NCT00721409|79449550|FG000|Overall Study|Adverse Event|0|||
44441265|NCT00721409|79449551|FG001|Overall Study|Adverse Event|13|||
44441266|NCT00721409|79449552|FG002|Overall Study|Adverse Event|2|||
44441267|NCT00721409|79449550|FG000|Overall Study|Lost to Follow-up|0|||
44441268|NCT00721409|79449551|FG001|Overall Study|Lost to Follow-up|0|||
44441269|NCT00721409|79449552|FG002|Overall Study|Lost to Follow-up|1|||
44441270|NCT00721409|79449550|FG000|Overall Study|Withdrawal by Subject|1|||
44441271|NCT00721409|79449551|FG001|Overall Study|Withdrawal by Subject|6|||
44441272|NCT00721409|79449552|FG002|Overall Study|Withdrawal by Subject|5|||
44441273|NCT00721409|79449550|FG000|Overall Study|Objective progression or relapse|8|||
44441274|NCT00721409|79449551|FG001|Overall Study|Objective progression or relapse|55|||
44441275|NCT00721409|79449552|FG002|Overall Study|Objective progression or relapse|62|||
44441276|NCT00542997|79449576|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
44441277|NCT00542997|79449576|FG000|Wash in / Wash Out Period|Adverse Event|3|||
44441278|NCT00542997|79449576|FG000|Efficacy Period|Adverse Event|3|||
44441279|NCT00572832|79449585|FG000|Overall Study|Lost to Follow-up|0|||
44441280|NCT00572832|79449586|FG001|Overall Study|Lost to Follow-up|11|||
44441281|NCT00572832|79449585|FG000|Overall Study|Pregnancy|0|||
44441282|NCT00572832|79449586|FG001|Overall Study|Pregnancy|1|||
44441283|NCT03917823|79449594|FG000|Overall Study|Lost to Follow-up|1|||
44441284|NCT03917823|79449595|FG001|Overall Study|Lost to Follow-up|1|||
44441285|NCT03917823|79449594|FG000|Overall Study|Withdrawal by Subject|0|||
44441286|NCT03917823|79449595|FG001|Overall Study|Withdrawal by Subject|1|||
44441287|NCT00229723|79449608|FG000|Concomitant Phase|Adverse Event|4|||
44441288|NCT00229723|79449609|FG001|Concomitant Phase|Adverse Event|2|||
44441289|NCT00229723|79449610|FG002|Concomitant Phase|Adverse Event|5|||
44441290|NCT00229723|79449611|FG003|Concomitant Phase|Adverse Event|2|||
44441291|NCT00229723|79449612|FG004|Concomitant Phase|Adverse Event|0|||
44441292|NCT00229723|79449613|FG005|Concomitant Phase|Adverse Event|1|||
44441293|NCT00229723|79449614|FG006|Concomitant Phase|Adverse Event|2|||
44441294|NCT00229723|79449608|FG000|Concomitant Phase|Objective disease progression|0|||
44441295|NCT00229723|79449609|FG001|Concomitant Phase|Objective disease progression|0|||
44441296|NCT00229723|79449610|FG002|Concomitant Phase|Objective disease progression|0|||
44441297|NCT00229723|79449611|FG003|Concomitant Phase|Objective disease progression|0|||
44441298|NCT00229723|79449612|FG004|Concomitant Phase|Objective disease progression|0|||
44441299|NCT00229723|79449613|FG005|Concomitant Phase|Objective disease progression|0|||
44441300|NCT00229723|79449614|FG006|Concomitant Phase|Objective disease progression|0|||
44441301|NCT00229723|79449608|FG000|Concomitant Phase|Clinical progression|0|||
44441302|NCT00229723|79449609|FG001|Concomitant Phase|Clinical progression|0|||
44441303|NCT00229723|79449610|FG002|Concomitant Phase|Clinical progression|0|||
44441304|NCT00229723|79449611|FG003|Concomitant Phase|Clinical progression|0|||
44441305|NCT00229723|79449612|FG004|Concomitant Phase|Clinical progression|0|||
44441306|NCT00229723|79449613|FG005|Concomitant Phase|Clinical progression|0|||
44159109|NCT02876328|78951385|FG002|Overall Study|Withdrawal by Subject|3|||
44159110|NCT02876328|78951386|FG003|Overall Study|Withdrawal by Subject|3|||
44159111|NCT02876328|78951387|FG004|Overall Study|Withdrawal by Subject|0|||
44159112|NCT02876328|78951388|FG005|Overall Study|Withdrawal by Subject|1|||
44159113|NCT02876328|78951389|FG006|Overall Study|Withdrawal by Subject|0|||
44159114|NCT02876328|78951390|FG007|Overall Study|Withdrawal by Subject|1|||
44259748|NCT03721965|79122546|FG000|Overall Study|Death|1|||
44441307|NCT00229723|79449614|FG006|Concomitant Phase|Clinical progression|1|||
44441308|NCT00229723|79449608|FG000|Concomitant Phase|Lost to Follow-up|0|||
44441309|NCT00229723|79449609|FG001|Concomitant Phase|Lost to Follow-up|0|||
44441310|NCT00229723|79449610|FG002|Concomitant Phase|Lost to Follow-up|0|||
44441311|NCT00229723|79449611|FG003|Concomitant Phase|Lost to Follow-up|0|||
44441312|NCT00229723|79449612|FG004|Concomitant Phase|Lost to Follow-up|1|||
44441313|NCT00229723|79449613|FG005|Concomitant Phase|Lost to Follow-up|0|||
44441314|NCT00229723|79449614|FG006|Concomitant Phase|Lost to Follow-up|0|||
44441315|NCT00229723|79449608|FG000|Concomitant Phase|Informed consent withdrawn|3|||
44441316|NCT00229723|79449609|FG001|Concomitant Phase|Informed consent withdrawn|2|||
44441317|NCT00229723|79449610|FG002|Concomitant Phase|Informed consent withdrawn|0|||
44441318|NCT00229723|79449611|FG003|Concomitant Phase|Informed consent withdrawn|2|||
44441319|NCT00229723|79449612|FG004|Concomitant Phase|Informed consent withdrawn|0|||
44441320|NCT00229723|79449613|FG005|Concomitant Phase|Informed consent withdrawn|0|||
44441321|NCT00229723|79449614|FG006|Concomitant Phase|Informed consent withdrawn|0|||
44441322|NCT00229723|79449608|FG000|Concomitant Phase|Severe non-compliance|0|||
44341461|NCT00993499|79345474|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
44341462|NCT00993499|79345475|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
44341463|NCT00993499|79345476|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
44341464|NCT00993499|79345471|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
44341465|NCT00993499|79345472|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
44341466|NCT00993499|79345473|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
44341467|NCT00993499|79345474|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
44341468|NCT00993499|79345475|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
44341469|NCT00993499|79345476|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
44341470|NCT00993499|79345471|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
44341471|NCT00993499|79345472|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
44341472|NCT00993499|79345473|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
44341473|NCT00993499|79345474|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
44341474|NCT00993499|79345475|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
44341475|NCT00993499|79345476|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
44341476|NCT00993499|79345471|FG000|Discontinued After Starting Course 3|DLT|1|||
44341477|NCT00993499|79345472|FG001|Discontinued After Starting Course 3|DLT|0|||
44341478|NCT00993499|79345473|FG002|Discontinued After Starting Course 3|DLT|2|||
44341479|NCT00993499|79345474|FG003|Discontinued After Starting Course 3|DLT|1|||
44341480|NCT00993499|79345475|FG004|Discontinued After Starting Course 3|DLT|0|||
44341481|NCT00993499|79345476|FG005|Discontinued After Starting Course 3|DLT|0|||
44341482|NCT00993499|79345471|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
44341483|NCT00993499|79345472|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
44341484|NCT00993499|79345473|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
44341485|NCT00993499|79345474|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
44341486|NCT00993499|79345475|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
44341487|NCT00993499|79345476|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
44341488|NCT01014442|79345492|FG000|Overall Study|Adverse Event|0|||
44341489|NCT01014442|79345493|FG001|Overall Study|Adverse Event|8|||
44341490|NCT01014442|79345492|FG000|Overall Study|Withdrawal by Subject|4|||
44341491|NCT01014442|79345493|FG001|Overall Study|Withdrawal by Subject|4|||
44341492|NCT01014442|79345492|FG000|Overall Study|Protocol Violation|2|||
44341493|NCT01014442|79345493|FG001|Overall Study|Protocol Violation|5|||
44341494|NCT01014442|79345492|FG000|Overall Study|Lack of Compliance|0|||
44341495|NCT01014442|79345493|FG001|Overall Study|Lack of Compliance|1|||
44341496|NCT01014442|79345492|FG000|Overall Study|Unspecified Reason|1|||
44341497|NCT01014442|79345493|FG001|Overall Study|Unspecified Reason|1|||
44341498|NCT00996307|79345507|FG000|Overall Study|Adverse Event|0|||
44341499|NCT00996307|79345508|FG001|Overall Study|Adverse Event|1|||
44341500|NCT00996307|79345509|FG002|Overall Study|Adverse Event|0|||
44341501|NCT00996307|79345510|FG003|Overall Study|Adverse Event|0|||
44341502|NCT00996307|79345507|FG000|Overall Study|Withdrawal by Subject|3|||
44341503|NCT00996307|79345508|FG001|Overall Study|Withdrawal by Subject|2|||
44341504|NCT00996307|79345509|FG002|Overall Study|Withdrawal by Subject|5|||
44341505|NCT00996307|79345510|FG003|Overall Study|Withdrawal by Subject|5|||
44341506|NCT00996307|79345507|FG000|Overall Study|Lost to Follow-up|13|||
44341507|NCT00996307|79345508|FG001|Overall Study|Lost to Follow-up|13|||
44341508|NCT00996307|79345509|FG002|Overall Study|Lost to Follow-up|7|||
44341509|NCT00996307|79345510|FG003|Overall Study|Lost to Follow-up|15|||
44341510|NCT00996307|79345507|FG000|Overall Study|Administrative reason|0|||
44341511|NCT00996307|79345508|FG001|Overall Study|Administrative reason|1|||
44341512|NCT00996307|79345509|FG002|Overall Study|Administrative reason|0|||
44341513|NCT00996307|79345510|FG003|Overall Study|Administrative reason|0|||
44341514|NCT00996307|79345507|FG000|Overall Study|Unable to classify|4|||
44341515|NCT00996307|79345508|FG001|Overall Study|Unable to classify|0|||
44341516|NCT00996307|79345509|FG002|Overall Study|Unable to classify|2|||
44441323|NCT00229723|79449609|FG001|Concomitant Phase|Severe non-compliance|1|||
44341517|NCT00996307|79345510|FG003|Overall Study|Unable to classify|1|||
44341518|NCT01219959|79345540|FG000|Overall Study|Adverse Event|6|||
44341519|NCT01219959|79345541|FG001|Overall Study|Adverse Event|14|||
44341520|NCT01219959|79345540|FG000|Overall Study|Physician Decision|0|||
44341521|NCT01219959|79345541|FG001|Overall Study|Physician Decision|4|||
44441324|NCT00229723|79449610|FG002|Concomitant Phase|Severe non-compliance|0|||
44441325|NCT00229723|79449611|FG003|Concomitant Phase|Severe non-compliance|0|||
44441326|NCT00229723|79449612|FG004|Concomitant Phase|Severe non-compliance|1|||
44441327|NCT00229723|79449613|FG005|Concomitant Phase|Severe non-compliance|0|||
44441328|NCT00229723|79449614|FG006|Concomitant Phase|Severe non-compliance|0|||
44441329|NCT00229723|79449608|FG000|Concomitant Phase|Other|3|||
44441330|NCT00229723|79449609|FG001|Concomitant Phase|Other|0|||
44441331|NCT00229723|79449610|FG002|Concomitant Phase|Other|1|||
44441332|NCT00229723|79449611|FG003|Concomitant Phase|Other|1|||
44441333|NCT00229723|79449612|FG004|Concomitant Phase|Other|0|||
44441334|NCT00229723|79449613|FG005|Concomitant Phase|Other|2|||
44441335|NCT00229723|79449614|FG006|Concomitant Phase|Other|0|||
44441336|NCT00229723|79449608|FG000|Maintenance Phase|Adverse Event|7|||
44441337|NCT00229723|79449609|FG001|Maintenance Phase|Adverse Event|2|||
44441338|NCT00229723|79449610|FG002|Maintenance Phase|Adverse Event|1|||
44441339|NCT00229723|79449611|FG003|Maintenance Phase|Adverse Event|4|||
44441340|NCT00229723|79449612|FG004|Maintenance Phase|Adverse Event|7|||
44441341|NCT00229723|79449613|FG005|Maintenance Phase|Adverse Event|5|||
44441342|NCT00229723|79449614|FG006|Maintenance Phase|Adverse Event|2|||
44441343|NCT00229723|79449608|FG000|Maintenance Phase|Objective disease progression|5|||
44441344|NCT00229723|79449609|FG001|Maintenance Phase|Objective disease progression|5|||
44441345|NCT00229723|79449610|FG002|Maintenance Phase|Objective disease progression|3|||
44441346|NCT00229723|79449611|FG003|Maintenance Phase|Objective disease progression|6|||
44441347|NCT00229723|79449612|FG004|Maintenance Phase|Objective disease progression|2|||
44441348|NCT00229723|79449613|FG005|Maintenance Phase|Objective disease progression|9|||
44441349|NCT00229723|79449614|FG006|Maintenance Phase|Objective disease progression|5|||
44441350|NCT00229723|79449608|FG000|Maintenance Phase|Clinical progression|4|||
44441351|NCT00229723|79449609|FG001|Maintenance Phase|Clinical progression|1|||
44441352|NCT00229723|79449610|FG002|Maintenance Phase|Clinical progression|2|||
44441353|NCT00229723|79449611|FG003|Maintenance Phase|Clinical progression|2|||
44441354|NCT00229723|79449612|FG004|Maintenance Phase|Clinical progression|1|||
44441355|NCT00229723|79449613|FG005|Maintenance Phase|Clinical progression|1|||
44441356|NCT00229723|79449614|FG006|Maintenance Phase|Clinical progression|1|||
44441357|NCT00229723|79449608|FG000|Maintenance Phase|Lost to Follow-up|0|||
44441358|NCT00229723|79449609|FG001|Maintenance Phase|Lost to Follow-up|1|||
44441359|NCT00229723|79449610|FG002|Maintenance Phase|Lost to Follow-up|2|||
44441360|NCT00229723|79449611|FG003|Maintenance Phase|Lost to Follow-up|2|||
44441361|NCT00229723|79449612|FG004|Maintenance Phase|Lost to Follow-up|0|||
44159115|NCT02876328|78951391|FG008|Overall Study|Withdrawal by Subject|1|||
44159116|NCT02876328|78951392|FG009|Overall Study|Withdrawal by Subject|2|||
44159117|NCT02876328|78951393|FG010|Overall Study|Withdrawal by Subject|0|||
44441362|NCT00229723|79449613|FG005|Maintenance Phase|Lost to Follow-up|0|||
44441363|NCT00229723|79449614|FG006|Maintenance Phase|Lost to Follow-up|1|||
44441364|NCT00229723|79449608|FG000|Maintenance Phase|Informed consent withdrawn|1|||
44159118|NCT02876328|78951394|FG011|Overall Study|Withdrawal by Subject|0|||
44441365|NCT00229723|79449609|FG001|Maintenance Phase|Informed consent withdrawn|0|||
44441366|NCT00229723|79449610|FG002|Maintenance Phase|Informed consent withdrawn|0|||
44441367|NCT00229723|79449611|FG003|Maintenance Phase|Informed consent withdrawn|1|||
44441368|NCT00229723|79449612|FG004|Maintenance Phase|Informed consent withdrawn|1|||
44441369|NCT00229723|79449613|FG005|Maintenance Phase|Informed consent withdrawn|1|||
44441370|NCT00229723|79449614|FG006|Maintenance Phase|Informed consent withdrawn|0|||
44441371|NCT00229723|79449608|FG000|Maintenance Phase|Severe non-compliance|3|||
44441372|NCT00229723|79449609|FG001|Maintenance Phase|Severe non-compliance|1|||
44441373|NCT00229723|79449610|FG002|Maintenance Phase|Severe non-compliance|0|||
44441374|NCT00229723|79449611|FG003|Maintenance Phase|Severe non-compliance|0|||
44441375|NCT00229723|79449612|FG004|Maintenance Phase|Severe non-compliance|1|||
44441376|NCT00229723|79449613|FG005|Maintenance Phase|Severe non-compliance|0|||
44441377|NCT00229723|79449614|FG006|Maintenance Phase|Severe non-compliance|0|||
44441378|NCT00229723|79449608|FG000|Maintenance Phase|Other|5|||
44441379|NCT00229723|79449609|FG001|Maintenance Phase|Other|4|||
44441380|NCT00229723|79449610|FG002|Maintenance Phase|Other|1|||
44441381|NCT00229723|79449611|FG003|Maintenance Phase|Other|2|||
44441382|NCT00229723|79449612|FG004|Maintenance Phase|Other|3|||
44441383|NCT00229723|79449613|FG005|Maintenance Phase|Other|3|||
44441384|NCT00229723|79449614|FG006|Maintenance Phase|Other|1|||
44441385|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
44441386|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
44441387|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
44441388|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
44441389|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
44441390|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
44441391|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
44441392|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
44441393|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
44441394|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
44441395|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
44441396|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
44441397|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
44441398|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
44441399|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
44441400|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
44441401|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
44441402|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
44341522|NCT01219959|79345540|FG000|Overall Study|Withdrawal by Subject|0|||
44341523|NCT01219959|79345541|FG001|Overall Study|Withdrawal by Subject|2|||
44341524|NCT01219959|79345540|FG000|Overall Study|Renal Transplantation|0|||
44341525|NCT01219959|79345541|FG001|Overall Study|Renal Transplantation|3|||
44341526|NCT01219959|79345540|FG000|Overall Study|Other|1|||
44341527|NCT01219959|79345541|FG001|Overall Study|Other|0|||
44341528|NCT00993421|79345554|FG000|Overall Study|Adverse Event|2|||
44341529|NCT00993421|79345555|FG001|Overall Study|Adverse Event|7|||
44341530|NCT00993421|79345556|FG002|Overall Study|Adverse Event|6|||
44341531|NCT00993421|79345557|FG003|Overall Study|Adverse Event|9|||
44341532|NCT00993421|79345558|FG004|Overall Study|Adverse Event|5|||
44341533|NCT00993421|79345559|FG005|Overall Study|Adverse Event|7|||
44341534|NCT00993421|79345560|FG006|Overall Study|Adverse Event|1|||
44341535|NCT00993421|79345554|FG000|Overall Study|Sponsor Decision|36|||
44341536|NCT00993421|79345555|FG001|Overall Study|Sponsor Decision|31|||
44341537|NCT00993421|79345556|FG002|Overall Study|Sponsor Decision|28|||
44341538|NCT00993421|79345557|FG003|Overall Study|Sponsor Decision|30|||
44341539|NCT00993421|79345558|FG004|Overall Study|Sponsor Decision|38|||
44341540|NCT00993421|79345559|FG005|Overall Study|Sponsor Decision|30|||
44341541|NCT00993421|79345560|FG006|Overall Study|Sponsor Decision|29|||
44341542|NCT00993421|79345554|FG000|Overall Study|Lost to Follow-up|3|||
44441403|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
44441404|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
44441405|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
44441406|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
44341543|NCT00993421|79345555|FG001|Overall Study|Lost to Follow-up|5|||
44341544|NCT00993421|79345556|FG002|Overall Study|Lost to Follow-up|5|||
44341545|NCT00993421|79345557|FG003|Overall Study|Lost to Follow-up|0|||
44341546|NCT00993421|79345558|FG004|Overall Study|Lost to Follow-up|0|||
44341547|NCT00993421|79345559|FG005|Overall Study|Lost to Follow-up|0|||
44441407|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
44441408|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
44441409|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
44441410|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
44441411|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
44441412|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
44441413|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
44441414|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
44441415|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
44441416|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
44441417|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
44441418|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
44441419|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
44441420|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
44441421|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
44341548|NCT00993421|79345560|FG006|Overall Study|Lost to Follow-up|6|||
44341549|NCT00993421|79345554|FG000|Overall Study|Withdrawal by Subject|3|||
44341550|NCT00993421|79345555|FG001|Overall Study|Withdrawal by Subject|2|||
44341551|NCT00993421|79345556|FG002|Overall Study|Withdrawal by Subject|3|||
44341552|NCT00993421|79345557|FG003|Overall Study|Withdrawal by Subject|3|||
44341553|NCT00993421|79345558|FG004|Overall Study|Withdrawal by Subject|3|||
44341554|NCT00993421|79345559|FG005|Overall Study|Withdrawal by Subject|5|||
44341555|NCT00993421|79345560|FG006|Overall Study|Withdrawal by Subject|3|||
44341556|NCT00993421|79345554|FG000|Overall Study|Death|0|||
44341557|NCT00993421|79345555|FG001|Overall Study|Death|0|||
44341558|NCT00993421|79345556|FG002|Overall Study|Death|0|||
44341559|NCT00993421|79345557|FG003|Overall Study|Death|0|||
44341560|NCT00993421|79345558|FG004|Overall Study|Death|0|||
44341561|NCT00993421|79345559|FG005|Overall Study|Death|0|||
44341562|NCT00993421|79345560|FG006|Overall Study|Death|1|||
44341563|NCT00993421|79345554|FG000|Overall Study|Entry Criteria Exclusion|0|||
44341564|NCT00993421|79345555|FG001|Overall Study|Entry Criteria Exclusion|0|||
44341565|NCT00993421|79345556|FG002|Overall Study|Entry Criteria Exclusion|1|||
44341566|NCT00993421|79345557|FG003|Overall Study|Entry Criteria Exclusion|3|||
44341567|NCT00993421|79345558|FG004|Overall Study|Entry Criteria Exclusion|0|||
44341568|NCT00993421|79345559|FG005|Overall Study|Entry Criteria Exclusion|1|||
44341569|NCT00993421|79345560|FG006|Overall Study|Entry Criteria Exclusion|0|||
44341570|NCT00993421|79345554|FG000|Overall Study|Physician Decision|0|||
44341571|NCT00993421|79345555|FG001|Overall Study|Physician Decision|0|||
44341572|NCT00993421|79345556|FG002|Overall Study|Physician Decision|0|||
44341573|NCT00993421|79345557|FG003|Overall Study|Physician Decision|0|||
44341574|NCT00993421|79345558|FG004|Overall Study|Physician Decision|0|||
44341575|NCT00993421|79345559|FG005|Overall Study|Physician Decision|1|||
44341576|NCT00993421|79345560|FG006|Overall Study|Physician Decision|1|||
44341577|NCT00993421|79345554|FG000|Overall Study|Protocol Violation|0|||
44341578|NCT00993421|79345555|FG001|Overall Study|Protocol Violation|0|||
44341579|NCT00993421|79345556|FG002|Overall Study|Protocol Violation|0|||
44341580|NCT00993421|79345557|FG003|Overall Study|Protocol Violation|0|||
44341581|NCT00993421|79345558|FG004|Overall Study|Protocol Violation|0|||
44341582|NCT00993421|79345559|FG005|Overall Study|Protocol Violation|2|||
44341583|NCT00993421|79345560|FG006|Overall Study|Protocol Violation|1|||
44341584|NCT01014208|79345578|FG000|Overall Study|Lost to Follow-up|2|||
44341585|NCT01014208|79345579|FG001|Overall Study|Lost to Follow-up|5|||
44341586|NCT01014208|79345578|FG000|Overall Study|Participant Withdrew Consent|12|||
44341587|NCT01014208|79345579|FG001|Overall Study|Participant Withdrew Consent|12|||
44341588|NCT01014208|79345578|FG000|Overall Study|Did Not Receive Study Drug|2|||
44341589|NCT01014208|79345579|FG001|Overall Study|Did Not Receive Study Drug|0|||
44341590|NCT01014208|79345578|FG000|Overall Study|Study Closed/terminated|78|||
44341591|NCT01014208|79345579|FG001|Overall Study|Study Closed/terminated|83|||
44341592|NCT00991939|79345587|FG000|Overall Study|Lost to Follow-up|0|||
44341593|NCT00991939|79345588|FG001|Overall Study|Lost to Follow-up|1|||
44341594|NCT00991939|79345587|FG000|Overall Study|Withdrawal by Subject|1|||
44341595|NCT00991939|79345588|FG001|Overall Study|Withdrawal by Subject|0|||
44341596|NCT00991939|79345587|FG000|Overall Study|Entire study terminated|4|||
44341597|NCT00991939|79345588|FG001|Overall Study|Entire study terminated|1|||
44341598|NCT00993265|79345598|FG000|Overall Study|Adverse Event|1|||
44441422|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
44441423|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
44341599|NCT00993265|79345599|FG001|Overall Study|Adverse Event|0|||
44341600|NCT00993265|79345598|FG000|Overall Study|Changed dose of concomitant drug|2|||
44341601|NCT00993265|79345599|FG001|Overall Study|Changed dose of concomitant drug|0|||
44341602|NCT00993265|79345598|FG000|Overall Study|Non-compliant with study medication|1|||
44341603|NCT00993265|79345599|FG001|Overall Study|Non-compliant with study medication|0|||
44341604|NCT04211389|79345607|FG000|Overall Study|Adverse Event|1|||
44341605|NCT04211389|79345608|FG001|Overall Study|Adverse Event|2|||
44441424|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
44441425|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
44441426|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
44441427|NCT00606684|79449636|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
44441428|NCT00606684|79449637|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
44441429|NCT00606684|79449638|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
44441430|NCT00606684|79449639|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
44441431|NCT00606684|79449640|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
44441432|NCT00606684|79449641|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
44441433|NCT00606684|79449642|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
44441434|NCT00606684|79449636|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44441435|NCT00606684|79449637|FG001|Double-Blind Treatment Period|Adverse Event|3|||
44441436|NCT00606684|79449638|FG002|Double-Blind Treatment Period|Adverse Event|2|||
44441437|NCT00606684|79449639|FG003|Double-Blind Treatment Period|Adverse Event|4|||
44441438|NCT00606684|79449640|FG004|Double-Blind Treatment Period|Adverse Event|2|||
44441439|NCT00606684|79449641|FG005|Double-Blind Treatment Period|Adverse Event|0|||
44441440|NCT00606684|79449642|FG006|Double-Blind Treatment Period|Adverse Event|1|||
44441441|NCT00606684|79449636|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
44441442|NCT00606684|79449637|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
44441443|NCT00606684|79449638|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
44441444|NCT00606684|79449639|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
44441445|NCT00606684|79449640|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
44441446|NCT00606684|79449641|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
44441447|NCT00606684|79449642|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
44441448|NCT00606684|79449636|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
44441449|NCT00606684|79449637|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
44441450|NCT00606684|79449638|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
44441451|NCT00606684|79449639|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
44441452|NCT00606684|79449640|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
44441453|NCT00606684|79449641|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
44441454|NCT00606684|79449642|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
44441455|NCT00606684|79449636|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
44441456|NCT00606684|79449637|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
44441457|NCT00606684|79449638|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
44441458|NCT00606684|79449639|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
44441459|NCT00606684|79449640|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
44441460|NCT00606684|79449641|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
44441461|NCT00606684|79449642|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
44441462|NCT00606684|79449636|FG000|Double-Blind Treatment Period|Physician Decision|0|||
44441463|NCT00606684|79449637|FG001|Double-Blind Treatment Period|Physician Decision|5|||
44441464|NCT00606684|79449638|FG002|Double-Blind Treatment Period|Physician Decision|1|||
44441465|NCT00606684|79449639|FG003|Double-Blind Treatment Period|Physician Decision|0|||
44441466|NCT00606684|79449640|FG004|Double-Blind Treatment Period|Physician Decision|3|||
44441467|NCT00606684|79449641|FG005|Double-Blind Treatment Period|Physician Decision|1|||
44441468|NCT00606684|79449642|FG006|Double-Blind Treatment Period|Physician Decision|2|||
44441469|NCT00606684|79449636|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44441470|NCT00606684|79449637|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44441471|NCT00606684|79449638|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44441472|NCT00606684|79449639|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44441473|NCT00606684|79449640|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
44259749|NCT03721965|79122546|FG000|Overall Study|Study Terminated by Sponsor|1|||
44341606|NCT04211389|79345607|FG000|Overall Study|Lost to Follow-up|15|||
44341607|NCT04211389|79345608|FG001|Overall Study|Lost to Follow-up|7|||
44441474|NCT00606684|79449641|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
44441475|NCT00606684|79449642|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
44441476|NCT00627926|79449659|FG000|Overall Study|Adverse Event|26|||
44441477|NCT00627926|79449660|FG001|Overall Study|Adverse Event|37|||
44441478|NCT00627926|79449661|FG002|Overall Study|Adverse Event|36|||
44441479|NCT00627926|79449659|FG000|Overall Study|Death|1|||
44441480|NCT00627926|79449660|FG001|Overall Study|Death|0|||
44441481|NCT00627926|79449661|FG002|Overall Study|Death|0|||
44441482|NCT00627926|79449659|FG000|Overall Study|Lost to Follow-up|4|||
44441483|NCT00627926|79449660|FG001|Overall Study|Lost to Follow-up|3|||
44441484|NCT00627926|79449661|FG002|Overall Study|Lost to Follow-up|4|||
44441485|NCT00627926|79449659|FG000|Overall Study|Withdrawal by Subject|2|||
44441486|NCT00627926|79449660|FG001|Overall Study|Withdrawal by Subject|1|||
44441487|NCT00627926|79449661|FG002|Overall Study|Withdrawal by Subject|0|||
44441488|NCT00627926|79449659|FG000|Overall Study|Lack of Efficacy|118|||
44441489|NCT00627926|79449660|FG001|Overall Study|Lack of Efficacy|40|||
44441490|NCT00627926|79449661|FG002|Overall Study|Lack of Efficacy|38|||
44441491|NCT00627926|79449659|FG000|Overall Study|Noncompliance/unspecified|8|||
44441492|NCT00627926|79449660|FG001|Overall Study|Noncompliance/unspecified|23|||
44441493|NCT00627926|79449661|FG002|Overall Study|Noncompliance/unspecified|17|||
44441494|NCT00228553|79449669|FG000|Overall Study|Adverse Event|112|||
44441495|NCT00228553|79449669|FG000|Overall Study|Lack of Efficacy|34|||
44441496|NCT00228553|79449669|FG000|Overall Study|Lost to Follow-up|67|||
44441497|NCT00228553|79449669|FG000|Overall Study|Physician Decision|48|||
44441498|NCT00228553|79449669|FG000|Overall Study|Protocol Violation|6|||
44441499|NCT00228553|79449669|FG000|Overall Study|Withdrawal by Subject|115|||
44441500|NCT00228553|79449669|FG000|Overall Study|Pregnancy|2|||
44441501|NCT00228553|79449669|FG000|Overall Study|Miscellaneous|46|||
44441502|NCT00643916|79449679|FG000|Overall Study|Protocol Violation|0|||
44441503|NCT00643916|79449680|FG001|Overall Study|Protocol Violation|1|||
44441504|NCT00643916|79449681|FG002|Overall Study|Protocol Violation|1|||
44441505|NCT00643916|79449682|FG003|Overall Study|Protocol Violation|1|||
44441506|NCT00643916|79449683|FG004|Overall Study|Protocol Violation|0|||
44441507|NCT00643916|79449684|FG005|Overall Study|Protocol Violation|0|||
44441508|NCT00643916|79449679|FG000|Overall Study|Lost to Follow-up|0|||
44441509|NCT00643916|79449680|FG001|Overall Study|Lost to Follow-up|1|||
44441510|NCT00643916|79449681|FG002|Overall Study|Lost to Follow-up|0|||
44441511|NCT00643916|79449682|FG003|Overall Study|Lost to Follow-up|0|||
44441512|NCT00643916|79449683|FG004|Overall Study|Lost to Follow-up|0|||
44441513|NCT00643916|79449684|FG005|Overall Study|Lost to Follow-up|0|||
44441514|NCT00643916|79449679|FG000|Overall Study|Withdrawal by Subject|2|||
44441515|NCT00643916|79449680|FG001|Overall Study|Withdrawal by Subject|2|||
44441516|NCT00643916|79449681|FG002|Overall Study|Withdrawal by Subject|2|||
44441517|NCT00643916|79449682|FG003|Overall Study|Withdrawal by Subject|1|||
44441518|NCT00643916|79449683|FG004|Overall Study|Withdrawal by Subject|0|||
44441519|NCT00643916|79449684|FG005|Overall Study|Withdrawal by Subject|1|||
44441520|NCT00643916|79449679|FG000|Overall Study|Not Vaccinated|2|||
44441521|NCT00643916|79449680|FG001|Overall Study|Not Vaccinated|2|||
44441522|NCT00643916|79449681|FG002|Overall Study|Not Vaccinated|3|||
44441523|NCT00643916|79449682|FG003|Overall Study|Not Vaccinated|0|||
44441524|NCT00643916|79449683|FG004|Overall Study|Not Vaccinated|2|||
44441525|NCT00643916|79449684|FG005|Overall Study|Not Vaccinated|0|||
44441526|NCT00160693|79449698|FG000|Overall Study|Adverse Event|97|||
44441527|NCT00160693|79449698|FG000|Overall Study|Lack of Efficacy|30|||
44441528|NCT00160693|79449698|FG000|Overall Study|Protocol Violation|24|||
44441529|NCT00160693|79449698|FG000|Overall Study|Lost to Follow-up|15|||
44441530|NCT00160693|79449698|FG000|Overall Study|Withdrawal by Subject|54|||
44441531|NCT00160693|79449698|FG000|Overall Study|Study terminated by sponsor|15|||
44441532|NCT00643760|79449707|FG000|Overall Study|Adverse Event|11|||
44441533|NCT00643760|79449708|FG001|Overall Study|Adverse Event|5|||
44441534|NCT00643760|79449709|FG002|Overall Study|Adverse Event|12|||
44341608|NCT04211389|79345607|FG000|Overall Study|Protocol Violation|0|||
44341609|NCT04211389|79345608|FG001|Overall Study|Protocol Violation|1|||
44341610|NCT04211389|79345607|FG000|Overall Study|Withdrawal by Subject|10|||
44341611|NCT04211389|79345608|FG001|Overall Study|Withdrawal by Subject|11|||
44341612|NCT00993031|79345616|FG000|Overall Study|Death|0|||
44341613|NCT00993031|79345617|FG001|Overall Study|Death|1|||
44441535|NCT00643760|79449710|FG003|Overall Study|Adverse Event|21|||
44441536|NCT00643760|79449711|FG004|Overall Study|Adverse Event|6|||
44441537|NCT00643760|79449707|FG000|Overall Study|Lack of Efficacy|3|||
44441538|NCT00643760|79449708|FG001|Overall Study|Lack of Efficacy|1|||
44441539|NCT00643760|79449709|FG002|Overall Study|Lack of Efficacy|0|||
44441540|NCT00643760|79449710|FG003|Overall Study|Lack of Efficacy|4|||
44441541|NCT00643760|79449711|FG004|Overall Study|Lack of Efficacy|3|||
44441542|NCT00643760|79449707|FG000|Overall Study|Protocol Violation|7|||
44441543|NCT00643760|79449708|FG001|Overall Study|Protocol Violation|6|||
44441544|NCT00643760|79449709|FG002|Overall Study|Protocol Violation|4|||
44441545|NCT00643760|79449710|FG003|Overall Study|Protocol Violation|4|||
44441546|NCT00643760|79449711|FG004|Overall Study|Protocol Violation|6|||
44441547|NCT00643760|79449707|FG000|Overall Study|Lost to Follow-up|6|||
44441548|NCT00643760|79449708|FG001|Overall Study|Lost to Follow-up|2|||
44441549|NCT00643760|79449709|FG002|Overall Study|Lost to Follow-up|1|||
44441550|NCT00643760|79449710|FG003|Overall Study|Lost to Follow-up|3|||
44441551|NCT00643760|79449711|FG004|Overall Study|Lost to Follow-up|3|||
44441552|NCT00643760|79449707|FG000|Overall Study|Investigator Discretion|0|||
44341614|NCT00993031|79345616|FG000|Overall Study|Physician Decision|0|||
44441553|NCT00643760|79449708|FG001|Overall Study|Investigator Discretion|0|||
44441554|NCT00643760|79449709|FG002|Overall Study|Investigator Discretion|0|||
44441555|NCT00643760|79449710|FG003|Overall Study|Investigator Discretion|2|||
44441556|NCT00643760|79449711|FG004|Overall Study|Investigator Discretion|0|||
44441557|NCT00643760|79449707|FG000|Overall Study|Withdrawal by Subject|3|||
44441558|NCT00643760|79449708|FG001|Overall Study|Withdrawal by Subject|1|||
44441559|NCT00643760|79449709|FG002|Overall Study|Withdrawal by Subject|2|||
44441560|NCT00643760|79449710|FG003|Overall Study|Withdrawal by Subject|4|||
44441561|NCT00643760|79449711|FG004|Overall Study|Withdrawal by Subject|1|||
44441562|NCT00643682|79449725|FG000|Overall Study|did not keep appointment|522|||
44441563|NCT00643682|79449726|FG001|Overall Study|did not keep appointment|509|||
44341615|NCT00993031|79345617|FG001|Overall Study|Physician Decision|2|||
44341616|NCT00993031|79345616|FG000|Overall Study|Withdrawal by Subject|3|||
44341617|NCT00993031|79345617|FG001|Overall Study|Withdrawal by Subject|3|||
44341618|NCT00993031|79345616|FG000|Overall Study|Lost to Follow-up|19|||
44341619|NCT00993031|79345617|FG001|Overall Study|Lost to Follow-up|13|||
44341620|NCT01010776|79345627|FG000|Main Phase|Withdrawal by Subject|14|||
44341621|NCT01010776|79345627|FG000|Main Phase|Lack of Efficacy|8|||
44341622|NCT01010776|79345627|FG000|Main Phase|Adverse Event|7|||
44341623|NCT01010776|79345627|FG000|Main Phase|Lost to Follow-up|6|||
44341624|NCT01010776|79345627|FG000|Main Phase|Non-compliance to study medication|5|||
44341625|NCT01010776|79345627|FG000|Main Phase|Selection failure|2|||
44341626|NCT01010776|79345627|FG000|Main Phase|Inform consent withdrawal|1|||
44341627|NCT01010776|79345627|FG000|Main Phase|Other|1|||
44341628|NCT01010776|79345627|FG000|Main Phase|Did not received study medication|5|||
44341629|NCT01010776|79345627|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
44341630|NCT01010776|79345627|FG000|Extension Phase|Other|3|||
44341631|NCT01018810|79345647|FG000|Overall Study|Withdrawal by Subject|0|||
44341632|NCT01018810|79345648|FG001|Overall Study|Withdrawal by Subject|1|||
44341633|NCT01018810|79345649|FG002|Overall Study|Withdrawal by Subject|0|||
44341634|NCT01018810|79345650|FG003|Overall Study|Withdrawal by Subject|0|||
44341635|NCT01018810|79345651|FG004|Overall Study|Withdrawal by Subject|0|||
44341636|NCT01018810|79345647|FG000|Overall Study|Sponsor Decision|2|||
44341637|NCT01018810|79345648|FG001|Overall Study|Sponsor Decision|0|||
44341638|NCT01018810|79345649|FG002|Overall Study|Sponsor Decision|1|||
44341639|NCT01018810|79345650|FG003|Overall Study|Sponsor Decision|1|||
44341640|NCT01018810|79345651|FG004|Overall Study|Sponsor Decision|1|||
44341641|NCT01018732|79345666|FG000|Overall Study|Lost to Follow-up|0|||
44441564|NCT00603798|79449735|FG000|Overall Study|Adverse Event|4|||
44341642|NCT01018732|79345667|FG001|Overall Study|Lost to Follow-up|0|||
44441565|NCT00603798|79449736|FG001|Overall Study|Adverse Event|2|||
44441566|NCT00603798|79449737|FG002|Overall Study|Adverse Event|1|||
44441567|NCT00603798|79449735|FG000|Overall Study|Withdrawal by Subject|4|||
44341643|NCT01018732|79345668|FG002|Overall Study|Lost to Follow-up|3|||
44341644|NCT01018732|79345666|FG000|Overall Study|Protocol Violation|1|||
44159119|NCT02876328|78951395|FG012|Overall Study|Withdrawal by Subject|0|||
44159120|NCT02876328|78951396|FG013|Overall Study|Withdrawal by Subject|0|||
44441568|NCT00603798|79449736|FG001|Overall Study|Withdrawal by Subject|3|||
44441569|NCT00603798|79449737|FG002|Overall Study|Withdrawal by Subject|4|||
44441570|NCT00603798|79449735|FG000|Overall Study|Lost to Follow-up|1|||
44441571|NCT00603798|79449736|FG001|Overall Study|Lost to Follow-up|0|||
44441572|NCT00603798|79449737|FG002|Overall Study|Lost to Follow-up|1|||
44441573|NCT00603798|79449735|FG000|Overall Study|Non-compliance with study procedures|0|||
44441574|NCT00603798|79449736|FG001|Overall Study|Non-compliance with study procedures|1|||
44441575|NCT00603798|79449737|FG002|Overall Study|Non-compliance with study procedures|0|||
44441576|NCT00603798|79449735|FG000|Overall Study|Not due to AE|1|||
44441577|NCT00603798|79449736|FG001|Overall Study|Not due to AE|1|||
44441578|NCT00603798|79449737|FG002|Overall Study|Not due to AE|4|||
44441579|NCT00630812|79449747|FG000|Randomisation to First Dose|Adverse Event|1|||
44441580|NCT00630812|79449748|FG001|Randomisation to First Dose|Adverse Event|1|||
44441581|NCT00630812|79449747|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
44441582|NCT00630812|79449748|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
44441583|NCT00630812|79449747|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
44441584|NCT00630812|79449748|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
44441585|NCT00630812|79449747|FG000|Randomisation to First Dose|Protocol Violation|4|||
44441586|NCT00630812|79449748|FG001|Randomisation to First Dose|Protocol Violation|1|||
44441587|NCT00630812|79449747|FG000|Double Blind Treatment Period|Adverse Event|13|||
44441588|NCT00630812|79449748|FG001|Double Blind Treatment Period|Adverse Event|5|||
44441589|NCT00630812|79449747|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
44441590|NCT00630812|79449748|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
44441591|NCT00630812|79449747|FG000|Double Blind Treatment Period|Physician Decision|2|||
44441592|NCT00630812|79449748|FG001|Double Blind Treatment Period|Physician Decision|1|||
44441593|NCT00630812|79449747|FG000|Double Blind Treatment Period|Protocol Violation|1|||
44441594|NCT00630812|79449748|FG001|Double Blind Treatment Period|Protocol Violation|0|||
44441595|NCT00630812|79449747|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
44441596|NCT00630812|79449748|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
44441597|NCT00630812|79449747|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
44441598|NCT00630812|79449748|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
44441599|NCT00630812|79449747|FG000|Double Blind Treatment Period|Non-compliance|0|||
44441600|NCT00630812|79449748|FG001|Double Blind Treatment Period|Non-compliance|1|||
44441601|NCT00629798|79449754|FG000|Overall Study|Not Treated|4|||
44540818|NCT03289143|79552951|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
44540819|NCT03289143|79552952|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
44540820|NCT03289143|79552953|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
44540821|NCT03289143|79552950|FG000|Overall Study|Withdrawal by Caregiver|0|||
44540822|NCT03289143|79552951|FG001|Overall Study|Withdrawal by Caregiver|1|||
44540823|NCT03289143|79552952|FG002|Overall Study|Withdrawal by Caregiver|0|||
44540824|NCT03289143|79552953|FG003|Overall Study|Withdrawal by Caregiver|0|||
44540825|NCT03289143|79552950|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
44540826|NCT03289143|79552951|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
44540827|NCT03289143|79552952|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
44540828|NCT03289143|79552953|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
44540829|NCT03289143|79552950|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
44540830|NCT03289143|79552951|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
44540831|NCT03289143|79552952|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
44540832|NCT03289143|79552953|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
44540833|NCT03311724|79552972|FG000|Overall Study|Physician Decision|0|||
44540834|NCT03311724|79552973|FG001|Overall Study|Physician Decision|0|||
44540835|NCT03311724|79552974|FG002|Overall Study|Physician Decision|0|||
44540836|NCT03311724|79552975|FG003|Overall Study|Physician Decision|1|||
44540837|NCT03311724|79552972|FG000|Overall Study|Protocol Violation|1|||
44540838|NCT03311724|79552973|FG001|Overall Study|Protocol Violation|0|||
44159121|NCT02876328|78951397|FG014|Overall Study|Withdrawal by Subject|0|||
44341645|NCT01018732|79345667|FG001|Overall Study|Protocol Violation|1|||
44341646|NCT01018732|79345668|FG002|Overall Study|Protocol Violation|0|||
44341647|NCT01018732|79345666|FG000|Overall Study|Inappropriate Enrollment|0|||
44341648|NCT01018732|79345667|FG001|Overall Study|Inappropriate Enrollment|1|||
44341649|NCT01018732|79345668|FG002|Overall Study|Inappropriate Enrollment|0|||
44341650|NCT01018732|79345666|FG000|Overall Study|Unable to Classify|0|||
44540839|NCT03311724|79552974|FG002|Overall Study|Protocol Violation|1|||
44540840|NCT03311724|79552975|FG003|Overall Study|Protocol Violation|0|||
44540841|NCT03311724|79552972|FG000|Overall Study|Withdrawal by Subject|1|||
44540842|NCT03311724|79552973|FG001|Overall Study|Withdrawal by Subject|1|||
44540843|NCT03311724|79552974|FG002|Overall Study|Withdrawal by Subject|0|||
44540844|NCT03311724|79552975|FG003|Overall Study|Withdrawal by Subject|0|||
44159122|NCT02876328|78951398|FG015|Overall Study|Withdrawal by Subject|0|||
44540845|NCT03311724|79552972|FG000|Overall Study|Lost to Follow-up|1|||
44540846|NCT03311724|79552973|FG001|Overall Study|Lost to Follow-up|0|||
44341651|NCT01018732|79345667|FG001|Overall Study|Unable to Classify|0|||
44441602|NCT00160615|79449760|FG000|Overall Study|Adverse Event|5|||
44441603|NCT00160615|79449761|FG001|Overall Study|Adverse Event|12|||
44441604|NCT00160615|79449760|FG000|Overall Study|Withdrawal by Subject|0|||
44441605|NCT00160615|79449761|FG001|Overall Study|Withdrawal by Subject|2|||
44441606|NCT00160615|79449760|FG000|Overall Study|Lack of Efficacy|11|||
44441607|NCT00160615|79449761|FG001|Overall Study|Lack of Efficacy|23|||
44441608|NCT00160615|79449760|FG000|Overall Study|Patient decision|1|||
44441609|NCT00160615|79449761|FG001|Overall Study|Patient decision|2|||
44441610|NCT00160615|79449760|FG000|Overall Study|Investigator decision|1|||
44441611|NCT00160615|79449761|FG001|Overall Study|Investigator decision|1|||
44441612|NCT00160615|79449760|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
44441613|NCT00160615|79449761|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
44441614|NCT00160615|79449760|FG000|Overall Study|Switch to surgical treatment|0|||
44441615|NCT00160615|79449761|FG001|Overall Study|Switch to surgical treatment|2|||
44441616|NCT00160615|79449760|FG000|Overall Study|Non-compliance was suspected|0|||
44441617|NCT00160615|79449761|FG001|Overall Study|Non-compliance was suspected|1|||
44441618|NCT00160615|79449760|FG000|Overall Study|Poor compliance|0|||
44441619|NCT00160615|79449761|FG001|Overall Study|Poor compliance|1|||
44441620|NCT00643448|79449772|FG000|Overall Study|Lack of Efficacy|2|||
44441621|NCT00643448|79449773|FG001|Overall Study|Lack of Efficacy|0|||
44441622|NCT00643448|79449774|FG002|Overall Study|Lack of Efficacy|4|||
44441623|NCT00643448|79449772|FG000|Overall Study|Adverse Event|2|||
44441624|NCT00643448|79449773|FG001|Overall Study|Adverse Event|2|||
44441625|NCT00643448|79449774|FG002|Overall Study|Adverse Event|2|||
44441626|NCT00643448|79449772|FG000|Overall Study|QTcF>550 ms|0|||
44441627|NCT00643448|79449773|FG001|Overall Study|QTcF>550 ms|3|||
44441628|NCT00643448|79449774|FG002|Overall Study|QTcF>550 ms|0|||
44441629|NCT00604500|79449784|FG000|Overall Study|Adverse Event|2|||
44441630|NCT00604500|79449784|FG000|Overall Study|Protocol Violation|2|||
44441631|NCT00604500|79449784|FG000|Overall Study|Treatment Failure|1|||
44441632|NCT00604500|79449784|FG000|Overall Study|Withdrawal by Subject|4|||
44441633|NCT00604500|79449784|FG000|Overall Study|Administrative|1|||
44441634|NCT00604500|79449784|FG000|Overall Study|Did not meet protocol eligibility|1|||
44441635|NCT00627458|79449791|FG000|Overall Study|Migrated from study area|1|||
44441636|NCT00627458|79449792|FG001|Overall Study|Migrated from study area|0|||
44441637|NCT00627458|79449793|FG002|Overall Study|Migrated from study area|1|||
44441638|NCT00627458|79449791|FG000|Overall Study|Withdrawal by Subject|2|||
44441639|NCT00627458|79449792|FG001|Overall Study|Withdrawal by Subject|6|||
44441640|NCT00627458|79449793|FG002|Overall Study|Withdrawal by Subject|5|||
44441641|NCT00627458|79449791|FG000|Overall Study|Lost to Follow-up|1|||
44441642|NCT00627458|79449792|FG001|Overall Study|Lost to Follow-up|1|||
44441643|NCT00627458|79449793|FG002|Overall Study|Lost to Follow-up|0|||
44441644|NCT00542919|79449805|FG000|Overall Study|Adverse Event|1|||
44441645|NCT00542919|79449806|FG001|Overall Study|Adverse Event|5|||
44441646|NCT00542919|79449807|FG002|Overall Study|Adverse Event|1|||
44441647|NCT00542919|79449805|FG000|Overall Study|Withdrawal by Subject|1|||
44441648|NCT00542919|79449806|FG001|Overall Study|Withdrawal by Subject|0|||
44441649|NCT00542919|79449807|FG002|Overall Study|Withdrawal by Subject|3|||
44441650|NCT00542919|79449805|FG000|Overall Study|Physician Decision|2|||
44441651|NCT00542919|79449806|FG001|Overall Study|Physician Decision|2|||
44441652|NCT00542919|79449807|FG002|Overall Study|Physician Decision|1|||
44441653|NCT00542919|79449805|FG000|Overall Study|Sponsor Decision|1|||
44441654|NCT00542919|79449806|FG001|Overall Study|Sponsor Decision|0|||
44441655|NCT00542919|79449807|FG002|Overall Study|Sponsor Decision|0|||
44441656|NCT00542919|79449805|FG000|Overall Study|Lost to Follow-up|2|||
44441657|NCT00542919|79449806|FG001|Overall Study|Lost to Follow-up|0|||
44441658|NCT00542919|79449807|FG002|Overall Study|Lost to Follow-up|1|||
44441659|NCT00159913|79449834|FG000|Overall Study|Adverse Event|1|||
44441660|NCT00159913|79449835|FG001|Overall Study|Adverse Event|0|||
44441661|NCT00159913|79449836|FG002|Overall Study|Adverse Event|1|||
44441662|NCT00159913|79449837|FG003|Overall Study|Adverse Event|0|||
44441663|NCT00159913|79449834|FG000|Overall Study|Withdrawal by Subject|0|||
44441664|NCT00159913|79449835|FG001|Overall Study|Withdrawal by Subject|0|||
44441665|NCT00159913|79449836|FG002|Overall Study|Withdrawal by Subject|0|||
44441666|NCT00159913|79449837|FG003|Overall Study|Withdrawal by Subject|1|||
44441667|NCT00159913|79449834|FG000|Overall Study|Lost to Follow-up|0|||
44441668|NCT00159913|79449835|FG001|Overall Study|Lost to Follow-up|0|||
44441669|NCT00159913|79449836|FG002|Overall Study|Lost to Follow-up|0|||
44441670|NCT00159913|79449837|FG003|Overall Study|Lost to Follow-up|1|||
44441671|NCT00159913|79449834|FG000|Overall Study|Protocol Violation|1|||
44441672|NCT00159913|79449835|FG001|Overall Study|Protocol Violation|0|||
44441673|NCT00159913|79449836|FG002|Overall Study|Protocol Violation|1|||
44441674|NCT00159913|79449837|FG003|Overall Study|Protocol Violation|0|||
44441675|NCT00604188|79449851|FG000|Overall Study|Adverse Event|1|||
44441676|NCT00604188|79449852|FG001|Overall Study|Adverse Event|4|||
44441677|NCT00604188|79449851|FG000|Overall Study|Lost to Follow-up|17|||
44441678|NCT00604188|79449852|FG001|Overall Study|Lost to Follow-up|15|||
44441679|NCT00604188|79449851|FG000|Overall Study|Withdrawal by Subject|5|||
44441680|NCT00604188|79449852|FG001|Overall Study|Withdrawal by Subject|1|||
44441681|NCT00604188|79449851|FG000|Overall Study|Non-compliance with protocol|4|||
44441682|NCT00604188|79449852|FG001|Overall Study|Non-compliance with protocol|4|||
44441683|NCT00604188|79449851|FG000|Overall Study|Did not receive study drug|0|||
44441684|NCT00604188|79449852|FG001|Overall Study|Did not receive study drug|1|||
44441685|NCT03913377|79449860|FG000|Period 1|Test Article no longer available|0|||
44441686|NCT03913377|79449861|FG001|Period 1|Test Article no longer available|1|||
44441687|NCT03913377|79449862|FG002|Period 1|Test Article no longer available|0|||
44441688|NCT03913377|79449860|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
44441689|NCT03913377|79449861|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
44441690|NCT03913377|79449862|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
44441691|NCT00227539|79449869|FG000|Overall Study|Protocol Violation|1|||
44441692|NCT00227305|79449873|FG000|Overall Study|Adverse Event|40|||
44441693|NCT00227305|79449873|FG000|Overall Study|Withdrawal by Subject|42|||
44441694|NCT00227305|79449873|FG000|Overall Study|Lost to Follow-up|33|||
44441695|NCT00227305|79449873|FG000|Overall Study|Study specific discontinuation|13|||
44441696|NCT00227305|79449873|FG000|Overall Study|MOVED OUT OF AREA|3|||
44441697|NCT00227305|79449873|FG000|Overall Study|Lack of Efficacy|7|||
44441698|NCT00227305|79449873|FG000|Overall Study|Physician Decision|3|||
44341652|NCT01018732|79345668|FG002|Overall Study|Unable to Classify|1|||
44341653|NCT01218867|79345687|FG000|Overall Study|Death during treatment|0|||
44341654|NCT01218867|79345688|FG001|Overall Study|Death during treatment|0|||
44441699|NCT00227305|79449873|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
44441700|NCT00227305|79449873|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
44441701|NCT00227305|79449873|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
44441702|NCT00720941|79449879|FG000|Overall Study|Death|334|||
44341655|NCT01218867|79345689|FG002|Overall Study|Death during treatment|0|||
44341656|NCT01218867|79345690|FG003|Overall Study|Death during treatment|0|||
44341657|NCT01218867|79345691|FG004|Overall Study|Death during treatment|0|||
44259750|NCT03873116|79122602|FG000|Overall Study|Study drug discontinuation due to rash|0|||
44259751|NCT03873116|79122603|FG001|Overall Study|Study drug discontinuation due to rash|0|||
44259752|NCT03873116|79122604|FG002|Overall Study|Study drug discontinuation due to rash|1|||
44341658|NCT01218867|79345692|FG005|Overall Study|Death during treatment|0|||
44341659|NCT01218867|79345693|FG006|Overall Study|Death during treatment|1|||
44341660|NCT01218867|79345694|FG007|Overall Study|Death during treatment|0|||
44341661|NCT01218867|79345695|FG008|Overall Study|Death during treatment|0|||
44341662|NCT01218867|79345696|FG009|Overall Study|Death during treatment|0|||
44341663|NCT01218867|79345697|FG010|Overall Study|Death during treatment|0|||
44341664|NCT01018264|79345734|FG000|Overall Study|Withdrawal by Subject|1|||
44259753|NCT03686384|79123052|FG000|Overall Study|Lack of Efficacy|4|||
44259754|NCT03686384|79123053|FG001|Overall Study|Lack of Efficacy|13|||
44259755|NCT03686384|79123052|FG000|Overall Study|Lost to Follow-up|3|||
44259756|NCT03686384|79123053|FG001|Overall Study|Lost to Follow-up|0|||
44259757|NCT03686384|79123052|FG000|Overall Study|Physician Decision|0|||
44341665|NCT01018264|79345735|FG001|Overall Study|Withdrawal by Subject|0|||
44259758|NCT03686384|79123053|FG001|Overall Study|Physician Decision|1|||
44259759|NCT03686384|79123052|FG000|Overall Study|Took prohibited medication|0|||
44341666|NCT01018264|79345734|FG000|Overall Study|Lost to Follow-up|0|||
44441703|NCT00720941|79449880|FG001|Overall Study|Death|335|||
44441704|NCT00720941|79449879|FG000|Overall Study|Protocol Violation|0|||
44441705|NCT00720941|79449880|FG001|Overall Study|Protocol Violation|2|||
44441706|NCT00720941|79449879|FG000|Overall Study|Lost to Follow-up|17|||
44441707|NCT00720941|79449880|FG001|Overall Study|Lost to Follow-up|15|||
44441708|NCT00720941|79449879|FG000|Overall Study|Physician Decision|1|||
44441709|NCT00720941|79449880|FG001|Overall Study|Physician Decision|5|||
44441710|NCT00720941|79449879|FG000|Overall Study|Withdrawal by Subject|27|||
44441711|NCT00720941|79449880|FG001|Overall Study|Withdrawal by Subject|35|||
44441712|NCT00720941|79449879|FG000|Overall Study|Ongoing|34|||
44441713|NCT00720941|79449880|FG001|Overall Study|Ongoing|23|||
44441714|NCT00585533|79449886|FG000|Overall Study|objective or symptomatic progression|9|||
44441715|NCT00628862|79449893|FG000|Overall Study|Adverse Event|6|||
44159123|NCT02876328|78951399|FG016|Overall Study|Withdrawal by Subject|1|||
44159124|NCT02876328|78951400|FG017|Overall Study|Withdrawal by Subject|3|||
44159125|NCT02876328|78951401|FG018|Overall Study|Withdrawal by Subject|0|||
44441716|NCT00628862|79449894|FG001|Overall Study|Adverse Event|8|||
44159126|NCT02876328|78951402|FG019|Overall Study|Withdrawal by Subject|0|||
44159127|NCT02876328|78951403|FG020|Overall Study|Withdrawal by Subject|1|||
44259760|NCT03686384|79123053|FG001|Overall Study|Took prohibited medication|1|||
44441717|NCT00628862|79449895|FG002|Overall Study|Adverse Event|10|||
44441718|NCT00628862|79449893|FG000|Overall Study|Withdrawal by Subject|4|||
44441719|NCT00628862|79449894|FG001|Overall Study|Withdrawal by Subject|6|||
44441720|NCT00628862|79449895|FG002|Overall Study|Withdrawal by Subject|11|||
44441721|NCT00628862|79449893|FG000|Overall Study|Lost to Follow-up|0|||
44441722|NCT00628862|79449894|FG001|Overall Study|Lost to Follow-up|2|||
44441723|NCT00628862|79449895|FG002|Overall Study|Lost to Follow-up|1|||
44441724|NCT00628862|79449893|FG000|Overall Study|Protocol Violation|1|||
44441725|NCT00628862|79449894|FG001|Overall Study|Protocol Violation|0|||
44441726|NCT00628862|79449895|FG002|Overall Study|Protocol Violation|0|||
44341667|NCT01018264|79345735|FG001|Overall Study|Lost to Follow-up|1|||
44341668|NCT01018186|79345744|FG000|2-week Run-in Period|Protocol Violation|1|||
44341669|NCT01018186|79345745|FG001|2-week Run-in Period|Protocol Violation|0|||
44341670|NCT01018186|79345746|FG002|2-week Run-in Period|Protocol Violation|0|||
44341671|NCT01018186|79345747|FG003|2-week Run-in Period|Protocol Violation|0|||
44341672|NCT01018186|79345744|FG000|2-week Run-in Period|Lost to Follow-up|2|||
44341673|NCT01018186|79345745|FG001|2-week Run-in Period|Lost to Follow-up|0|||
44341674|NCT01018186|79345746|FG002|2-week Run-in Period|Lost to Follow-up|0|||
44341675|NCT01018186|79345747|FG003|2-week Run-in Period|Lost to Follow-up|0|||
44341676|NCT01018186|79345744|FG000|2-week Run-in Period|Physician Decision|3|||
44341677|NCT01018186|79345745|FG001|2-week Run-in Period|Physician Decision|0|||
44341678|NCT01018186|79345746|FG002|2-week Run-in Period|Physician Decision|0|||
44341679|NCT01018186|79345747|FG003|2-week Run-in Period|Physician Decision|0|||
44341680|NCT01018186|79345744|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
44341681|NCT01018186|79345745|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
44341682|NCT01018186|79345746|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
44341683|NCT01018186|79345747|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
44159128|NCT02876328|78951404|FG021|Overall Study|Withdrawal by Subject|0|||
44159129|NCT02876328|78951405|FG022|Overall Study|Withdrawal by Subject|0|||
44341684|NCT01018186|79345744|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
44341685|NCT01018186|79345745|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
44441727|NCT00628862|79449893|FG000|Overall Study|COPD Exacerbation|0|||
44441728|NCT00628862|79449894|FG001|Overall Study|COPD Exacerbation|1|||
44341686|NCT01018186|79345746|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
44341687|NCT01018186|79345747|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
44341688|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
44341689|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
44341690|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
44341691|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
44341692|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
44341693|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
44341694|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
44341695|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
44341696|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
44341697|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
44341698|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
44341699|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
44341700|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
44341701|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
44341702|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
44341703|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
44341704|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
44341705|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
44341706|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
44341707|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
44341708|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
44341709|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
44341710|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
44341711|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
44341712|NCT01018186|79345744|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
44341713|NCT01018186|79345745|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
44341714|NCT01018186|79345746|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
44341715|NCT01018186|79345747|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
44341716|NCT00987337|79345762|FG000|Overall Study|Adverse Event|10|||
44341717|NCT00987337|79345763|FG001|Overall Study|Adverse Event|9|||
44341718|NCT00987337|79345764|FG002|Overall Study|Adverse Event|8|||
44341719|NCT00987337|79345762|FG000|Overall Study|Insufficient Virologic Response|10|||
44341720|NCT00987337|79345763|FG001|Overall Study|Insufficient Virologic Response|7|||
44341721|NCT00987337|79345764|FG002|Overall Study|Insufficient Virologic Response|12|||
44341722|NCT00987337|79345762|FG000|Overall Study|Virologic Breakthrough|2|||
44341723|NCT00987337|79345763|FG001|Overall Study|Virologic Breakthrough|2|||
44341724|NCT00987337|79345764|FG002|Overall Study|Virologic Breakthrough|8|||
44341725|NCT00987337|79345762|FG000|Overall Study|Lost to Follow-up|10|||
44341726|NCT00987337|79345763|FG001|Overall Study|Lost to Follow-up|6|||
44341727|NCT00987337|79345764|FG002|Overall Study|Lost to Follow-up|2|||
44341728|NCT00987337|79345762|FG000|Overall Study|Withdrawal by Subject|6|||
44341729|NCT00987337|79345763|FG001|Overall Study|Withdrawal by Subject|9|||
44341730|NCT00987337|79345764|FG002|Overall Study|Withdrawal by Subject|9|||
44341731|NCT00987337|79345762|FG000|Overall Study|Other|0|||
44341732|NCT00987337|79345763|FG001|Overall Study|Other|2|||
44341733|NCT00987337|79345764|FG002|Overall Study|Other|5|||
44341734|NCT00987337|79345762|FG000|Overall Study|Protocol Violation|1|||
44341735|NCT00987337|79345763|FG001|Overall Study|Protocol Violation|0|||
44341736|NCT00987337|79345764|FG002|Overall Study|Protocol Violation|2|||
44341737|NCT00987337|79345762|FG000|Overall Study|Participant Relapsed|18|||
44441729|NCT00628862|79449895|FG002|Overall Study|COPD Exacerbation|0|||
44441730|NCT00584987|79449907|FG000|Overall Study|Protocol Violation|1|||
44441731|NCT00584987|79449908|FG001|Overall Study|Protocol Violation|1|||
44441732|NCT00584987|79449909|FG002|Overall Study|Protocol Violation|1|||
44441733|NCT00584987|79449910|FG003|Overall Study|Protocol Violation|0|||
44441734|NCT00584987|79449907|FG000|Overall Study|Adverse Event|0|||
44441735|NCT00584987|79449908|FG001|Overall Study|Adverse Event|0|||
44441736|NCT00584987|79449909|FG002|Overall Study|Adverse Event|0|||
44441737|NCT00584987|79449910|FG003|Overall Study|Adverse Event|1|||
44441738|NCT00727961|79449920|FG000|Overall Study|Lost to Follow-up|1|||
44441739|NCT00727961|79449920|FG000|Overall Study|Adverse Event|4|||
44441740|NCT00727961|79449920|FG000|Overall Study|Patient's refusal|2|||
44441741|NCT00727961|79449920|FG000|Overall Study|Progression|30|||
44441742|NCT00568958|79449926|FG000|Allocation|Withdrawal by Subject|7|||
44441743|NCT00568958|79449927|FG001|Allocation|Withdrawal by Subject|3|||
44441744|NCT00568958|79449926|FG000|Allocation|Physician Decision|2|||
44441745|NCT00568958|79449927|FG001|Allocation|Physician Decision|0|||
44441746|NCT00568958|79449926|FG000|Follow-Up|Withdrawal by Subject|6|||
44441747|NCT00568958|79449927|FG001|Follow-Up|Withdrawal by Subject|6|||
44441748|NCT00568958|79449926|FG000|Follow-Up|Physician Decision|1|||
44441749|NCT00568958|79449927|FG001|Follow-Up|Physician Decision|1|||
44441750|NCT00568958|79449926|FG000|Follow-Up|Family Emergency|1|||
44441751|NCT00568958|79449927|FG001|Follow-Up|Family Emergency|0|||
44441752|NCT00568958|79449926|FG000|Follow-Up|Adverse Event|1|||
44441753|NCT00568958|79449927|FG001|Follow-Up|Adverse Event|0|||
44441754|NCT00727649|79449935|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
44441755|NCT00727649|79449936|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
44441756|NCT00727649|79449935|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
44441757|NCT00727649|79449936|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
44441758|NCT00727649|79449935|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
44441759|NCT00727649|79449936|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
44441760|NCT00727649|79449935|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
44441761|NCT00727649|79449936|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
44441762|NCT00727649|79449935|FG000|Second Intervention (4-weeks)|Death|1|||
44441763|NCT00727649|79449936|FG001|Second Intervention (4-weeks)|Death|0|||
44441764|NCT00727649|79449935|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
44441765|NCT00727649|79449936|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
44441766|NCT00727649|79449935|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
44441767|NCT00727649|79449936|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
44441768|NCT00568334|79449946|FG000|Overall Study|Withdrawal by Subject|0|||
44441769|NCT00568334|79449947|FG001|Overall Study|Withdrawal by Subject|1|||
44441770|NCT00568334|79449946|FG000|Overall Study|Lost to Follow-up|1|||
44441771|NCT00568334|79449947|FG001|Overall Study|Lost to Follow-up|0|||
44441772|NCT00727571|79449957|FG000|Overall Study|Ineligibility determined|1|||
44441773|NCT00727571|79449958|FG001|Overall Study|Ineligibility determined|1|||
44441774|NCT00727571|79449959|FG002|Overall Study|Ineligibility determined|1|||
44441775|NCT00727571|79449960|FG003|Overall Study|Ineligibility determined|0|||
44441776|NCT00727571|79449957|FG000|Overall Study|Death|0|||
44441777|NCT00727571|79449958|FG001|Overall Study|Death|19|||
44441778|NCT00727571|79449959|FG002|Overall Study|Death|5|||
44441779|NCT00727571|79449960|FG003|Overall Study|Death|1|||
44441780|NCT00727571|79449957|FG000|Overall Study|Physician Decision|0|||
44441781|NCT00727571|79449958|FG001|Overall Study|Physician Decision|5|||
44441782|NCT00727571|79449959|FG002|Overall Study|Physician Decision|0|||
44441783|NCT00727571|79449960|FG003|Overall Study|Physician Decision|0|||
44441784|NCT00727571|79449957|FG000|Overall Study|Withdrawal by Subject|0|||
44441785|NCT00727571|79449958|FG001|Overall Study|Withdrawal by Subject|10|||
44441786|NCT00727571|79449959|FG002|Overall Study|Withdrawal by Subject|11|||
44441787|NCT00727571|79449960|FG003|Overall Study|Withdrawal by Subject|0|||
44441788|NCT00727571|79449957|FG000|Overall Study|Subject Non Compliance|0|||
44441789|NCT00727571|79449958|FG001|Overall Study|Subject Non Compliance|6|||
44441790|NCT00727571|79449959|FG002|Overall Study|Subject Non Compliance|0|||
44441791|NCT00727571|79449960|FG003|Overall Study|Subject Non Compliance|4|||
44441792|NCT00727571|79449957|FG000|Overall Study|Dismissed from nursing home|0|||
44441793|NCT00727571|79449958|FG001|Overall Study|Dismissed from nursing home|9|||
44441794|NCT00727571|79449959|FG002|Overall Study|Dismissed from nursing home|5|||
44441795|NCT00727571|79449960|FG003|Overall Study|Dismissed from nursing home|0|||
44441796|NCT00727571|79449957|FG000|Overall Study|Hospitalization|0|||
44441797|NCT00727571|79449958|FG001|Overall Study|Hospitalization|1|||
44441798|NCT00727571|79449959|FG002|Overall Study|Hospitalization|0|||
44441799|NCT00727571|79449960|FG003|Overall Study|Hospitalization|1|||
44441800|NCT00727571|79449957|FG000|Overall Study|AE not leading to hospitalization|0|||
44441801|NCT00727571|79449958|FG001|Overall Study|AE not leading to hospitalization|0|||
44441802|NCT00727571|79449959|FG002|Overall Study|AE not leading to hospitalization|2|||
44441803|NCT00727571|79449960|FG003|Overall Study|AE not leading to hospitalization|0|||
44441804|NCT00727571|79449957|FG000|Overall Study|Other|0|||
44441805|NCT00727571|79449958|FG001|Overall Study|Other|4|||
44441806|NCT00727571|79449959|FG002|Overall Study|Other|6|||
44441807|NCT00727571|79449960|FG003|Overall Study|Other|0|||
44441808|NCT00225277|79449972|FG000|Overall Study|Adverse Event|30|||
44441809|NCT00225277|79449973|FG001|Overall Study|Adverse Event|34|||
44441810|NCT00225277|79449972|FG000|Overall Study|Lack of Efficacy|4|||
44441811|NCT00225277|79449973|FG001|Overall Study|Lack of Efficacy|1|||
44441812|NCT00225277|79449972|FG000|Overall Study|Lost to Follow-up|4|||
44441813|NCT00225277|79449973|FG001|Overall Study|Lost to Follow-up|6|||
44441814|NCT00225277|79449972|FG000|Overall Study|Physician Decision|6|||
44441815|NCT00225277|79449973|FG001|Overall Study|Physician Decision|8|||
44441816|NCT00225277|79449972|FG000|Overall Study|Protocol Violation|6|||
44441817|NCT00225277|79449973|FG001|Overall Study|Protocol Violation|3|||
44441818|NCT00225277|79449972|FG000|Overall Study|Withdrawal by Subject|40|||
44441819|NCT00225277|79449973|FG001|Overall Study|Withdrawal by Subject|34|||
44441820|NCT00225277|79449972|FG000|Overall Study|Other|7|||
44441821|NCT00225277|79449973|FG001|Overall Study|Other|9|||
44159130|NCT02876328|78951406|FG023|Overall Study|Withdrawal by Subject|0|||
44341738|NCT00987337|79345763|FG001|Overall Study|Participant Relapsed|20|||
44341739|NCT00987337|79345764|FG002|Overall Study|Participant Relapsed|5|||
44341740|NCT00992407|79345776|FG000|Overall Study|Protocol Violation|2|||
44441822|NCT00567996|79449982|FG000|Overall Study|Adverse Event|18|||
44441823|NCT00567996|79449983|FG001|Overall Study|Adverse Event|16|||
44441824|NCT00567996|79449984|FG002|Overall Study|Adverse Event|13|||
44259761|NCT00240331|79123125|FG000|Overall Study|Withdrawal by Subject|125|||
44259762|NCT00240331|79123126|FG001|Overall Study|Withdrawal by Subject|132|||
44259763|NCT00240331|79123125|FG000|Overall Study|Option selected by investigator|1|||
44259764|NCT00240331|79123126|FG001|Overall Study|Option selected by investigator|2|||
44259765|NCT00240097|79123132|FG000|Part I|Adverse Event|1|||
44259766|NCT00240097|79123132|FG000|Part I|Death|1|||
44259767|NCT00240097|79123132|FG000|Part I|histology|1|||
44259768|NCT00240097|79123132|FG000|Part I|unevaluable|1|||
44259769|NCT00240097|79123132|FG000|Part II|did not continue from Part I|23|||
44259770|NCT03620162|79123223|FG000|Overall Study|Physician Decision|4|||
44259771|NCT03620162|79123224|FG001|Overall Study|Physician Decision|0|||
44259772|NCT03620162|79123225|FG002|Overall Study|Physician Decision|1|||
44259773|NCT03620162|79123226|FG003|Overall Study|Physician Decision|0|||
44259774|NCT03620162|79123227|FG004|Overall Study|Physician Decision|2|||
44259775|NCT03620162|79123223|FG000|Overall Study|Lost to Follow-up|2|||
44259776|NCT03620162|79123224|FG001|Overall Study|Lost to Follow-up|6|||
44259777|NCT03620162|79123225|FG002|Overall Study|Lost to Follow-up|7|||
44259778|NCT03620162|79123226|FG003|Overall Study|Lost to Follow-up|3|||
44259779|NCT03620162|79123227|FG004|Overall Study|Lost to Follow-up|2|||
44259780|NCT03620162|79123223|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
44259781|NCT03620162|79123224|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
44259782|NCT03620162|79123225|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
44259783|NCT03620162|79123226|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
44259784|NCT03620162|79123227|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
44259785|NCT03084302|79123368|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
44259786|NCT03084302|79123368|FG000|Overall Study|No valid objective monitor data|6|||
44259787|NCT01279681|79123510|FG000|Overall Study|Disease Progression|9|||
44259788|NCT01279681|79123511|FG001|Overall Study|Disease Progression|6|||
44441825|NCT00567996|79449982|FG000|Overall Study|Protocol Deviation|9|||
44441826|NCT00567996|79449983|FG001|Overall Study|Protocol Deviation|11|||
44441827|NCT00567996|79449984|FG002|Overall Study|Protocol Deviation|13|||
44159131|NCT02876328|78951383|FG000|Overall Study|Missed 12 Month Visit|15|||
44259789|NCT01279681|79123510|FG000|Overall Study|Withdrawal by Subject|3|||
44259790|NCT01279681|79123511|FG001|Overall Study|Withdrawal by Subject|4|||
44259791|NCT01279681|79123510|FG000|Overall Study|Adverse Event|2|||
44259792|NCT01279681|79123511|FG001|Overall Study|Adverse Event|3|||
44259793|NCT01279681|79123510|FG000|Overall Study|Death|0|||
44441828|NCT00567996|79449982|FG000|Overall Study|Withdrawal by Subject|8|||
44441829|NCT00567996|79449983|FG001|Overall Study|Withdrawal by Subject|12|||
44441830|NCT00567996|79449984|FG002|Overall Study|Withdrawal by Subject|22|||
44441831|NCT00567996|79449982|FG000|Overall Study|Abnormal Lab value(s)|2|||
44441832|NCT00567996|79449983|FG001|Overall Study|Abnormal Lab value(s)|1|||
44441833|NCT00567996|79449984|FG002|Overall Study|Abnormal Lab value(s)|2|||
44441834|NCT00567996|79449982|FG000|Overall Study|Abnormal test procedure result(s)|2|||
44441835|NCT00567996|79449983|FG001|Overall Study|Abnormal test procedure result(s)|1|||
44441836|NCT00567996|79449984|FG002|Overall Study|Abnormal test procedure result(s)|1|||
44441837|NCT00567996|79449982|FG000|Overall Study|Lost to Follow-up|2|||
44441838|NCT00567996|79449983|FG001|Overall Study|Lost to Follow-up|5|||
44441839|NCT00567996|79449984|FG002|Overall Study|Lost to Follow-up|2|||
44441840|NCT00567996|79449982|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
44441841|NCT00567996|79449983|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44441842|NCT00567996|79449984|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
44441843|NCT00567996|79449982|FG000|Overall Study|Administrative problems|1|||
44441844|NCT00567996|79449983|FG001|Overall Study|Administrative problems|1|||
44441845|NCT00567996|79449984|FG002|Overall Study|Administrative problems|0|||
44441846|NCT00567996|79449982|FG000|Overall Study|Death|1|||
44441847|NCT00567996|79449983|FG001|Overall Study|Death|0|||
44441848|NCT00567996|79449984|FG002|Overall Study|Death|2|||
44441849|NCT00567996|79449982|FG000|Overall Study|Patient's inability to use the device|0|||
44441850|NCT00567996|79449983|FG001|Overall Study|Patient's inability to use the device|1|||
44441851|NCT00567996|79449984|FG002|Overall Study|Patient's inability to use the device|0|||
44441852|NCT00224887|79449998|FG000|Overall Study|Pregnancy|6|||
44441853|NCT00224887|79449999|FG001|Overall Study|Pregnancy|6|||
44441854|NCT00148759|79450007|FG000|Overall Study|Withdrawal by Subject|1|||
44441855|NCT00148759|79450008|FG001|Overall Study|Withdrawal by Subject|1|||
44441856|NCT00148759|79450007|FG000|Overall Study|Lost to Follow-up|1|||
44441857|NCT00148759|79450008|FG001|Overall Study|Lost to Follow-up|0|||
44441858|NCT00717275|79450014|FG000|Overall Study|Premature study termination.|3|||
44441859|NCT00584909|79450018|FG000|Overall Study|Adverse Event|4|||
44441860|NCT00147823|79450024|FG000|Overall Study|Lost to Follow-up|6|||
44441861|NCT00147823|79450025|FG001|Overall Study|Lost to Follow-up|12|||
44441862|NCT00147823|79450024|FG000|Overall Study|Physician Decision|1|||
44441863|NCT00147823|79450025|FG001|Overall Study|Physician Decision|0|||
44441864|NCT00147823|79450024|FG000|Overall Study|Withdrawal by Subject|0|||
44441865|NCT00147823|79450025|FG001|Overall Study|Withdrawal by Subject|1|||
44441866|NCT00147823|79450024|FG000|Overall Study|Did not receive vitoss due to infection|6|||
44441867|NCT00147823|79450025|FG001|Overall Study|Did not receive vitoss due to infection|2|||
44441868|NCT00717197|79450031|FG000|Overall Study|Unable to purchase study drug|5|||
44441869|NCT00717197|79450031|FG000|Overall Study|Tumor Progression|1|||
44441870|NCT00717197|79450031|FG000|Overall Study|Physician Decision|1|||
44441871|NCT00147745|79450038|FG000|Overall Study|Withdrawal by Subject|1|||
44441872|NCT00147745|79450039|FG001|Overall Study|Withdrawal by Subject|0|||
44441873|NCT00147745|79450040|FG002|Overall Study|Withdrawal by Subject|0|||
44441874|NCT00642902|79450052|FG000|Overall Study|Adverse Event|0|||
44441875|NCT00642902|79450053|FG001|Overall Study|Adverse Event|1|||
44441876|NCT00642902|79450054|FG002|Overall Study|Adverse Event|3|||
44441877|NCT00642902|79450055|FG003|Overall Study|Adverse Event|1|||
44441878|NCT00642902|79450052|FG000|Overall Study|Lost to Follow-up|1|||
44441879|NCT00642902|79450053|FG001|Overall Study|Lost to Follow-up|1|||
44441880|NCT00642902|79450054|FG002|Overall Study|Lost to Follow-up|0|||
44441881|NCT00642902|79450055|FG003|Overall Study|Lost to Follow-up|0|||
44441882|NCT00642902|79450052|FG000|Overall Study|Lack of Efficacy|0|||
44441883|NCT00642902|79450053|FG001|Overall Study|Lack of Efficacy|3|||
44441884|NCT00642902|79450054|FG002|Overall Study|Lack of Efficacy|3|||
44441885|NCT00642902|79450055|FG003|Overall Study|Lack of Efficacy|0|||
44441886|NCT00642902|79450052|FG000|Overall Study|Death|1|||
44441887|NCT00642902|79450053|FG001|Overall Study|Death|0|||
44441888|NCT00642902|79450054|FG002|Overall Study|Death|0|||
44441889|NCT00642902|79450055|FG003|Overall Study|Death|0|||
44441890|NCT00642902|79450052|FG000|Overall Study|Premature termination of clinical trial|37|||
44441891|NCT00642902|79450053|FG001|Overall Study|Premature termination of clinical trial|32|||
44441892|NCT00642902|79450054|FG002|Overall Study|Premature termination of clinical trial|35|||
44441893|NCT00642902|79450055|FG003|Overall Study|Premature termination of clinical trial|35|||
44441894|NCT00642902|79450052|FG000|Overall Study|Randomized, but not treated|0|||
44441895|NCT00642902|79450053|FG001|Overall Study|Randomized, but not treated|0|||
44441896|NCT00642902|79450054|FG002|Overall Study|Randomized, but not treated|1|||
44441897|NCT00642902|79450055|FG003|Overall Study|Randomized, but not treated|0|||
44441898|NCT00642902|79450052|FG000|Overall Study|Other|1|||
44441899|NCT00642902|79450053|FG001|Overall Study|Other|5|||
44441900|NCT00642902|79450054|FG002|Overall Study|Other|1|||
44441901|NCT00642902|79450055|FG003|Overall Study|Other|4|||
44441902|NCT00224107|79450067|FG000|Overall Study|Adverse Event|20|||
44441903|NCT00224107|79450068|FG001|Overall Study|Adverse Event|6|||
44441904|NCT00224107|79450067|FG000|Overall Study|Protocol Violation|2|||
44441905|NCT00224107|79450068|FG001|Overall Study|Protocol Violation|3|||
44441906|NCT00224107|79450067|FG000|Overall Study|Withdrawal by Subject|1|||
44441907|NCT00224107|79450068|FG001|Overall Study|Withdrawal by Subject|4|||
44441908|NCT00224107|79450067|FG000|Overall Study|Lack of Efficacy|2|||
44441909|NCT00224107|79450068|FG001|Overall Study|Lack of Efficacy|0|||
44441910|NCT00224107|79450067|FG000|Overall Study|Lost to Follow-up|4|||
44441911|NCT00224107|79450068|FG001|Overall Study|Lost to Follow-up|0|||
44441912|NCT00224107|79450067|FG000|Overall Study|Physician Decision|1|||
44441913|NCT00224107|79450068|FG001|Overall Study|Physician Decision|0|||
44441914|NCT00224107|79450067|FG000|Overall Study|Other|1|||
44441915|NCT00224107|79450068|FG001|Overall Study|Other|1|||
44441916|NCT00720083|79450076|FG000|Overall Study|Ineligible|1|||
44441917|NCT00720083|79450077|FG001|Overall Study|Ineligible|2|||
44441918|NCT00209131|79450085|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
44441919|NCT00209131|79450086|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
44441920|NCT00224029|79450092|FG000|Overall Study|Lost to Follow-up|1|||
44441921|NCT00224029|79450092|FG000|Overall Study|Withdrawal by Subject|4|||
44441922|NCT00224029|79450092|FG000|Overall Study|Other|1|||
44441923|NCT00223795|79450096|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
44441924|NCT00223795|79450097|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
44441925|NCT00223795|79450096|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
44441926|NCT00223795|79450097|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
44441927|NCT00719849|79450106|FG000|Overall Study|Death|0|||
44441928|NCT00719849|79450107|FG001|Overall Study|Death|1|||
44441929|NCT03907683|79450113|FG000|Overall Study|Pregnancy|1|||
44441930|NCT03907683|79450113|FG000|Overall Study|Withdrawal by Subject|1|||
44441931|NCT00626522|79450123|FG000|Overall Study|Protocol Violation|0|||
44441932|NCT00626522|79450124|FG001|Overall Study|Protocol Violation|0|||
44441933|NCT00626522|79450125|FG002|Overall Study|Protocol Violation|0|||
44441934|NCT00626522|79450126|FG003|Overall Study|Protocol Violation|0|||
44441935|NCT00626522|79450127|FG004|Overall Study|Protocol Violation|1|||
44441936|NCT00626522|79450128|FG005|Overall Study|Protocol Violation|0|||
44441937|NCT00626522|79450123|FG000|Overall Study|Adverse Event|2|||
44441938|NCT00626522|79450124|FG001|Overall Study|Adverse Event|1|||
44441939|NCT00626522|79450125|FG002|Overall Study|Adverse Event|2|||
44441940|NCT00626522|79450126|FG003|Overall Study|Adverse Event|0|||
44441941|NCT00626522|79450127|FG004|Overall Study|Adverse Event|1|||
44441942|NCT00626522|79450128|FG005|Overall Study|Adverse Event|1|||
44441943|NCT00626522|79450123|FG000|Overall Study|Withdrawal by Subject|2|||
44441944|NCT00626522|79450124|FG001|Overall Study|Withdrawal by Subject|5|||
44441945|NCT00626522|79450125|FG002|Overall Study|Withdrawal by Subject|5|||
44441946|NCT00626522|79450126|FG003|Overall Study|Withdrawal by Subject|0|||
44441947|NCT00626522|79450127|FG004|Overall Study|Withdrawal by Subject|4|||
44441948|NCT00626522|79450128|FG005|Overall Study|Withdrawal by Subject|1|||
44441949|NCT00626522|79450123|FG000|Overall Study|COPD exacerbation|0|||
44441950|NCT00626522|79450124|FG001|Overall Study|COPD exacerbation|0|||
44441951|NCT00626522|79450125|FG002|Overall Study|COPD exacerbation|0|||
44441952|NCT00626522|79450126|FG003|Overall Study|COPD exacerbation|1|||
44441953|NCT00626522|79450127|FG004|Overall Study|COPD exacerbation|1|||
44441954|NCT00626522|79450128|FG005|Overall Study|COPD exacerbation|0|||
44441955|NCT00626522|79450123|FG000|Overall Study|Lost to Follow-up|0|||
44441956|NCT00626522|79450124|FG001|Overall Study|Lost to Follow-up|1|||
44341741|NCT00992407|79345777|FG001|Overall Study|Protocol Violation|1|||
44341742|NCT00992407|79345776|FG000|Overall Study|Lost to Follow-up|3|||
44341743|NCT00992407|79345777|FG001|Overall Study|Lost to Follow-up|3|||
44341744|NCT00992407|79345776|FG000|Overall Study|Adverse Event|3|||
44341745|NCT00992407|79345777|FG001|Overall Study|Adverse Event|2|||
44341746|NCT00992407|79345776|FG000|Overall Study|protocol Violation & Adverse events|2|||
44341747|NCT00992407|79345777|FG001|Overall Study|protocol Violation & Adverse events|4|||
44341748|NCT00992407|79345776|FG000|Overall Study|Other|2|||
44341749|NCT00992407|79345777|FG001|Overall Study|Other|0|||
44441957|NCT00626522|79450125|FG002|Overall Study|Lost to Follow-up|0|||
44441958|NCT00626522|79450126|FG003|Overall Study|Lost to Follow-up|0|||
44441959|NCT00626522|79450127|FG004|Overall Study|Lost to Follow-up|0|||
44441960|NCT00626522|79450128|FG005|Overall Study|Lost to Follow-up|0|||
44441961|NCT00626522|79450123|FG000|Overall Study|Inconsistent reason reported|1|||
44441962|NCT00626522|79450124|FG001|Overall Study|Inconsistent reason reported|0|||
44341750|NCT00992407|79345776|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
44441963|NCT00626522|79450125|FG002|Overall Study|Inconsistent reason reported|0|||
44441964|NCT00626522|79450126|FG003|Overall Study|Inconsistent reason reported|0|||
44441965|NCT00626522|79450127|FG004|Overall Study|Inconsistent reason reported|0|||
44441966|NCT00626522|79450128|FG005|Overall Study|Inconsistent reason reported|0|||
44441967|NCT00626522|79450123|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
44441968|NCT00626522|79450124|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
44441969|NCT00626522|79450125|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
44441970|NCT00626522|79450126|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
44441971|NCT00626522|79450127|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
44441972|NCT00626522|79450128|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
44441973|NCT00540423|79450153|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44441974|NCT00540423|79450154|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44441975|NCT00540423|79450155|FG002|Double-Blind Treatment Period|Adverse Event|0|||
44441976|NCT00540423|79450153|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
44441977|NCT00540423|79450154|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
44441978|NCT00540423|79450155|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
44441979|NCT00566982|79450175|FG000|Overall Study|Adverse Event|6|||
44441980|NCT00566982|79450176|FG001|Overall Study|Adverse Event|48|||
44441981|NCT00566982|79450175|FG000|Overall Study|Withdrawal by Subject|1|||
44441982|NCT00566982|79450176|FG001|Overall Study|Withdrawal by Subject|14|||
44441983|NCT00566982|79450175|FG000|Overall Study|Protocol Violation|1|||
44441984|NCT00566982|79450176|FG001|Overall Study|Protocol Violation|4|||
44441985|NCT00566982|79450175|FG000|Overall Study|Lost to Follow-up|0|||
44441986|NCT00566982|79450176|FG001|Overall Study|Lost to Follow-up|1|||
44441987|NCT00566982|79450175|FG000|Overall Study|Other-family problems & doctor's request|0|||
44441988|NCT00566982|79450176|FG001|Overall Study|Other-family problems & doctor's request|2|||
44441989|NCT00624338|79450188|FG000|Overall Study|Adverse Event|14|||
44441990|NCT00624338|79450189|FG001|Overall Study|Adverse Event|14|||
44441991|NCT00624338|79450190|FG002|Overall Study|Adverse Event|18|||
44441992|NCT00624338|79450188|FG000|Overall Study|Lost to Follow-up|1|||
44441993|NCT00624338|79450189|FG001|Overall Study|Lost to Follow-up|0|||
44441994|NCT00624338|79450190|FG002|Overall Study|Lost to Follow-up|0|||
44441995|NCT00624338|79450188|FG000|Overall Study|Lack of Efficacy|11|||
44441996|NCT00624338|79450189|FG001|Overall Study|Lack of Efficacy|3|||
44441997|NCT00624338|79450190|FG002|Overall Study|Lack of Efficacy|14|||
44441998|NCT00624338|79450188|FG000|Overall Study|Protocol Violation|3|||
44441999|NCT00624338|79450189|FG001|Overall Study|Protocol Violation|3|||
44442000|NCT00624338|79450190|FG002|Overall Study|Protocol Violation|2|||
44442001|NCT00624338|79450188|FG000|Overall Study|Death|0|||
44442002|NCT00624338|79450189|FG001|Overall Study|Death|2|||
44442003|NCT00624338|79450190|FG002|Overall Study|Death|0|||
44442004|NCT00624338|79450188|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
44442005|NCT00624338|79450189|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
44442006|NCT00624338|79450190|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
44442007|NCT00624338|79450188|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
44442008|NCT00624338|79450189|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
44442009|NCT00624338|79450190|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
44442010|NCT00624338|79450188|FG000|Overall Study|Other|15|||
44442011|NCT00624338|79450189|FG001|Overall Study|Other|5|||
44442012|NCT00624338|79450190|FG002|Overall Study|Other|9|||
44442013|NCT00624338|79450188|FG000|Overall Study|Randomized but not treated|2|||
44442014|NCT00624338|79450189|FG001|Overall Study|Randomized but not treated|1|||
44442015|NCT00624338|79450190|FG002|Overall Study|Randomized but not treated|3|||
44442016|NCT03977454|79450200|FG000|Overall Study|immediate postoperative revision|2|||
44442017|NCT03977454|79450201|FG001|Overall Study|immediate postoperative revision|2|||
44442018|NCT00538785|79450209|FG000|Overall Study|Death|9|||
44442019|NCT00538785|79450210|FG001|Overall Study|Death|10|||
44442020|NCT00538785|79450209|FG000|Overall Study|Withdrawal of consent|9|||
44442021|NCT00538785|79450210|FG001|Overall Study|Withdrawal of consent|7|||
44442022|NCT00538785|79450209|FG000|Overall Study|Lost to Follow-up|1|||
44442023|NCT00538785|79450210|FG001|Overall Study|Lost to Follow-up|0|||
44442024|NCT00538629|79450216|FG000|Overall Study|At subject's request|1|||
44442025|NCT00538629|79450216|FG000|Overall Study|Adverse Event|2|||
44442026|NCT00538629|79450216|FG000|Overall Study|Lack of Efficacy|12|||
44442027|NCT00538629|79450216|FG000|Overall Study|Lost to Follow-up|6|||
44442028|NCT00538629|79450216|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
44442029|NCT00622700|79450223|FG000|Core Treatment Period|Randomized but Not Treated|0|||
44259794|NCT01279681|79123511|FG001|Overall Study|Death|1|||
44341751|NCT00992407|79345777|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
44442030|NCT00622700|79450224|FG001|Core Treatment Period|Randomized but Not Treated|2|||
44442031|NCT00622700|79450225|FG002|Core Treatment Period|Randomized but Not Treated|2|||
44442032|NCT00622700|79450226|FG003|Core Treatment Period|Randomized but Not Treated|0|||
44442033|NCT00622700|79450227|FG004|Core Treatment Period|Randomized but Not Treated|0|||
44442034|NCT00622700|79450228|FG005|Core Treatment Period|Randomized but Not Treated|0|||
44442035|NCT00622700|79450229|FG006|Core Treatment Period|Randomized but Not Treated|0|||
44442036|NCT00622700|79450223|FG000|Core Treatment Period|Adverse Event|18|||
44442037|NCT00622700|79450224|FG001|Core Treatment Period|Adverse Event|25|||
44442038|NCT00622700|79450225|FG002|Core Treatment Period|Adverse Event|18|||
44442039|NCT00622700|79450226|FG003|Core Treatment Period|Adverse Event|0|||
44259795|NCT01279681|79123510|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
44442040|NCT00622700|79450227|FG004|Core Treatment Period|Adverse Event|0|||
44442041|NCT00622700|79450228|FG005|Core Treatment Period|Adverse Event|0|||
44442042|NCT00622700|79450229|FG006|Core Treatment Period|Adverse Event|0|||
44442043|NCT00622700|79450223|FG000|Core Treatment Period|Lack of Efficacy|19|||
44442044|NCT00622700|79450224|FG001|Core Treatment Period|Lack of Efficacy|6|||
44442045|NCT00622700|79450225|FG002|Core Treatment Period|Lack of Efficacy|12|||
44442046|NCT00622700|79450226|FG003|Core Treatment Period|Lack of Efficacy|0|||
44442047|NCT00622700|79450227|FG004|Core Treatment Period|Lack of Efficacy|0|||
44442048|NCT00622700|79450228|FG005|Core Treatment Period|Lack of Efficacy|0|||
44442049|NCT00622700|79450229|FG006|Core Treatment Period|Lack of Efficacy|0|||
44442050|NCT00622700|79450223|FG000|Core Treatment Period|Lost to Follow-up|1|||
44442051|NCT00622700|79450224|FG001|Core Treatment Period|Lost to Follow-up|1|||
44442052|NCT00622700|79450225|FG002|Core Treatment Period|Lost to Follow-up|1|||
44442053|NCT00622700|79450226|FG003|Core Treatment Period|Lost to Follow-up|0|||
44442054|NCT00622700|79450227|FG004|Core Treatment Period|Lost to Follow-up|0|||
44442055|NCT00622700|79450228|FG005|Core Treatment Period|Lost to Follow-up|0|||
44442056|NCT00622700|79450229|FG006|Core Treatment Period|Lost to Follow-up|0|||
44442057|NCT00622700|79450223|FG000|Core Treatment Period|Death|1|||
44442058|NCT00622700|79450224|FG001|Core Treatment Period|Death|0|||
44442059|NCT00622700|79450225|FG002|Core Treatment Period|Death|0|||
44442060|NCT00622700|79450226|FG003|Core Treatment Period|Death|0|||
44442061|NCT00622700|79450227|FG004|Core Treatment Period|Death|0|||
44442062|NCT00622700|79450228|FG005|Core Treatment Period|Death|0|||
44442063|NCT00622700|79450229|FG006|Core Treatment Period|Death|0|||
44442064|NCT00622700|79450223|FG000|Core Treatment Period|Progressive Disease|3|||
44442065|NCT00622700|79450224|FG001|Core Treatment Period|Progressive Disease|1|||
44442066|NCT00622700|79450225|FG002|Core Treatment Period|Progressive Disease|0|||
44442067|NCT00622700|79450226|FG003|Core Treatment Period|Progressive Disease|0|||
44442068|NCT00622700|79450227|FG004|Core Treatment Period|Progressive Disease|0|||
44442069|NCT00622700|79450228|FG005|Core Treatment Period|Progressive Disease|0|||
44442070|NCT00622700|79450229|FG006|Core Treatment Period|Progressive Disease|0|||
44442071|NCT00622700|79450223|FG000|Core Treatment Period|Withdrawal by Subject|12|||
44442072|NCT00622700|79450224|FG001|Core Treatment Period|Withdrawal by Subject|18|||
44442073|NCT00622700|79450225|FG002|Core Treatment Period|Withdrawal by Subject|15|||
44442074|NCT00622700|79450226|FG003|Core Treatment Period|Withdrawal by Subject|0|||
44442075|NCT00622700|79450227|FG004|Core Treatment Period|Withdrawal by Subject|0|||
44442076|NCT00622700|79450228|FG005|Core Treatment Period|Withdrawal by Subject|0|||
44442077|NCT00622700|79450229|FG006|Core Treatment Period|Withdrawal by Subject|0|||
44341752|NCT00992407|79345776|FG000|Overall Study|Study medication not administered|17|||
44341753|NCT00992407|79345777|FG001|Overall Study|Study medication not administered|13|||
44341754|NCT00986479|79345788|FG000|Period 1|Improved mood|1|||
44341755|NCT00986479|79345789|FG001|Period 1|Improved mood|0|||
44341756|NCT00986479|79345788|FG000|Period 1|Administrative reasons|1|||
44341757|NCT00986479|79345789|FG001|Period 1|Administrative reasons|0|||
44341758|NCT00986245|79345795|FG000|First Intervention|Poor compliance|8|||
44341759|NCT00986245|79345796|FG001|First Intervention|Poor compliance|4|||
44341760|NCT00986245|79345795|FG000|First Intervention|Lack of Efficacy|1|||
44341761|NCT00986245|79345796|FG001|First Intervention|Lack of Efficacy|2|||
44341762|NCT00986245|79345795|FG000|First Intervention|Withdrawal by Subject|0|||
44341763|NCT00986245|79345796|FG001|First Intervention|Withdrawal by Subject|1|||
44341764|NCT00986245|79345795|FG000|First Intervention|Protocol Violation|0|||
44341765|NCT00986245|79345796|FG001|First Intervention|Protocol Violation|1|||
44341766|NCT00986245|79345795|FG000|First Intervention|Out of indication|1|||
44341767|NCT00986245|79345796|FG001|First Intervention|Out of indication|0|||
44341768|NCT00986245|79345795|FG000|Second Intervention|Poor compliance|1|||
44341769|NCT00986245|79345796|FG001|Second Intervention|Poor compliance|0|||
44341770|NCT00986245|79345795|FG000|Second Intervention|Lost to Follow-up|1|||
44341771|NCT00986245|79345796|FG001|Second Intervention|Lost to Follow-up|0|||
44341772|NCT00986245|79345795|FG000|Second Intervention|Protocol Violation|0|||
44341773|NCT00986245|79345796|FG001|Second Intervention|Protocol Violation|1|||
44442078|NCT00622700|79450223|FG000|Core Treatment Period|Other than specified above|2|||
44442079|NCT00622700|79450224|FG001|Core Treatment Period|Other than specified above|2|||
44442080|NCT00622700|79450225|FG002|Core Treatment Period|Other than specified above|5|||
44442081|NCT00622700|79450226|FG003|Core Treatment Period|Other than specified above|0|||
44442082|NCT00622700|79450227|FG004|Core Treatment Period|Other than specified above|0|||
44442083|NCT00622700|79450228|FG005|Core Treatment Period|Other than specified above|0|||
44442084|NCT00622700|79450229|FG006|Core Treatment Period|Other than specified above|0|||
44442085|NCT00622700|79450223|FG000|Extension Treatment Period|Adverse Event|0|||
44442086|NCT00622700|79450224|FG001|Extension Treatment Period|Adverse Event|0|||
44442087|NCT00622700|79450225|FG002|Extension Treatment Period|Adverse Event|0|||
44442088|NCT00622700|79450226|FG003|Extension Treatment Period|Adverse Event|5|||
44341774|NCT00989833|79345810|FG000|Overall Study|Lost to Follow-up|0|||
44341775|NCT00989833|79345811|FG001|Overall Study|Lost to Follow-up|1|||
44442089|NCT00622700|79450227|FG004|Extension Treatment Period|Adverse Event|9|||
44442090|NCT00622700|79450228|FG005|Extension Treatment Period|Adverse Event|6|||
44442091|NCT00622700|79450229|FG006|Extension Treatment Period|Adverse Event|8|||
44442092|NCT00622700|79450223|FG000|Extension Treatment Period|Lack of Efficacy|0|||
44442093|NCT00622700|79450224|FG001|Extension Treatment Period|Lack of Efficacy|0|||
44442094|NCT00622700|79450225|FG002|Extension Treatment Period|Lack of Efficacy|0|||
44442095|NCT00622700|79450226|FG003|Extension Treatment Period|Lack of Efficacy|2|||
44442096|NCT00622700|79450227|FG004|Extension Treatment Period|Lack of Efficacy|8|||
44442097|NCT00622700|79450228|FG005|Extension Treatment Period|Lack of Efficacy|1|||
44442098|NCT00622700|79450229|FG006|Extension Treatment Period|Lack of Efficacy|9|||
44341776|NCT00989833|79345812|FG002|Overall Study|Lost to Follow-up|0|||
44442099|NCT00622700|79450223|FG000|Extension Treatment Period|Protocol Violation|0|||
44442100|NCT00622700|79450224|FG001|Extension Treatment Period|Protocol Violation|0|||
44442101|NCT00622700|79450225|FG002|Extension Treatment Period|Protocol Violation|0|||
44442102|NCT00622700|79450226|FG003|Extension Treatment Period|Protocol Violation|0|||
44442103|NCT00622700|79450227|FG004|Extension Treatment Period|Protocol Violation|0|||
44442104|NCT00622700|79450228|FG005|Extension Treatment Period|Protocol Violation|2|||
44442105|NCT00622700|79450229|FG006|Extension Treatment Period|Protocol Violation|0|||
44442106|NCT00622700|79450223|FG000|Extension Treatment Period|Lost to Follow-up|0|||
44442107|NCT00622700|79450224|FG001|Extension Treatment Period|Lost to Follow-up|0|||
44442108|NCT00622700|79450225|FG002|Extension Treatment Period|Lost to Follow-up|0|||
44442109|NCT00622700|79450226|FG003|Extension Treatment Period|Lost to Follow-up|0|||
44442110|NCT00622700|79450227|FG004|Extension Treatment Period|Lost to Follow-up|1|||
44442111|NCT00622700|79450228|FG005|Extension Treatment Period|Lost to Follow-up|0|||
44442112|NCT00622700|79450229|FG006|Extension Treatment Period|Lost to Follow-up|0|||
44442113|NCT00622700|79450223|FG000|Extension Treatment Period|Progressive Disease|0|||
44442114|NCT00622700|79450224|FG001|Extension Treatment Period|Progressive Disease|0|||
44442115|NCT00622700|79450225|FG002|Extension Treatment Period|Progressive Disease|0|||
44442116|NCT00622700|79450226|FG003|Extension Treatment Period|Progressive Disease|1|||
44442117|NCT00622700|79450227|FG004|Extension Treatment Period|Progressive Disease|2|||
44442118|NCT00622700|79450228|FG005|Extension Treatment Period|Progressive Disease|0|||
44442119|NCT00622700|79450229|FG006|Extension Treatment Period|Progressive Disease|2|||
44442120|NCT00622700|79450223|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
44442121|NCT00622700|79450224|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
44442122|NCT00622700|79450225|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
44442123|NCT00622700|79450226|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
44442124|NCT00622700|79450227|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
44442125|NCT00622700|79450228|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
44442126|NCT00622700|79450229|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
44442127|NCT00622700|79450223|FG000|Extension Treatment Period|Missing|0|||
44442128|NCT00622700|79450224|FG001|Extension Treatment Period|Missing|0|||
44442129|NCT00622700|79450225|FG002|Extension Treatment Period|Missing|0|||
44442130|NCT00622700|79450226|FG003|Extension Treatment Period|Missing|2|||
44442131|NCT00622700|79450227|FG004|Extension Treatment Period|Missing|3|||
44442132|NCT00622700|79450228|FG005|Extension Treatment Period|Missing|1|||
44442133|NCT00622700|79450229|FG006|Extension Treatment Period|Missing|0|||
44442134|NCT00622700|79450223|FG000|Extension Treatment Period|Other than specified above|0|||
44442135|NCT00622700|79450224|FG001|Extension Treatment Period|Other than specified above|0|||
44442136|NCT00622700|79450225|FG002|Extension Treatment Period|Other than specified above|0|||
44442137|NCT00622700|79450226|FG003|Extension Treatment Period|Other than specified above|0|||
44442138|NCT00622700|79450227|FG004|Extension Treatment Period|Other than specified above|0|||
44442139|NCT00622700|79450228|FG005|Extension Treatment Period|Other than specified above|1|||
44442140|NCT00622700|79450229|FG006|Extension Treatment Period|Other than specified above|1|||
44442141|NCT00538473|79450248|FG000|Overall Study|Adverse Event|1|||
44442142|NCT00538473|79450249|FG001|Overall Study|Adverse Event|0|||
44442143|NCT00622466|79450255|FG000|Overall Study|Death|1|||
44442144|NCT00622466|79450255|FG000|Overall Study|Adverse Event|1|||
44442145|NCT00622466|79450255|FG000|Overall Study|Withdrawal by Subject|2|||
44442146|NCT00537771|79450261|FG000|Overall Study|Withdrawal by Subject|6|||
44442147|NCT00537771|79450262|FG001|Overall Study|Withdrawal by Subject|23|||
44442148|NCT00537771|79450261|FG000|Overall Study|Adverse Event|8|||
44442149|NCT00537771|79450262|FG001|Overall Study|Adverse Event|15|||
44442150|NCT00537771|79450261|FG000|Overall Study|Lost to Follow-up|9|||
44442151|NCT00537771|79450262|FG001|Overall Study|Lost to Follow-up|15|||
44442152|NCT00537771|79450261|FG000|Overall Study|Protocol Violation|2|||
44442153|NCT00537771|79450262|FG001|Overall Study|Protocol Violation|6|||
44442154|NCT00537771|79450261|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
44442155|NCT00537771|79450262|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
44442156|NCT00623480|79450270|FG000|Overall Study|Lost to Follow-up|0|||
44442157|NCT00623480|79450271|FG001|Overall Study|Lost to Follow-up|1|||
44442158|NCT00623480|79450270|FG000|Overall Study|Withdrawal by Subject|2|||
44442159|NCT00623480|79450271|FG001|Overall Study|Withdrawal by Subject|4|||
44442160|NCT00623480|79450270|FG000|Overall Study|Lack of Efficacy|1|||
44442161|NCT00623480|79450271|FG001|Overall Study|Lack of Efficacy|0|||
44442162|NCT00623480|79450270|FG000|Overall Study|Non-compliant with study medication|4|||
44442163|NCT00623480|79450271|FG001|Overall Study|Non-compliant with study medication|0|||
44442164|NCT00623480|79450270|FG000|Overall Study|Protocol Violation|0|||
44442165|NCT00623480|79450271|FG001|Overall Study|Protocol Violation|1|||
44442166|NCT00623480|79450270|FG000|Overall Study|Site closed by sponsor|0|||
44442167|NCT00623480|79450271|FG001|Overall Study|Site closed by sponsor|1|||
44442168|NCT02513667|79450279|FG000|Overall Study|Withdrawal by Subject|0|||
44442169|NCT02513667|79450280|FG001|Overall Study|Withdrawal by Subject|1|||
44341777|NCT00989833|79345810|FG000|Overall Study|Protocol Violation|1|||
44341778|NCT00989833|79345811|FG001|Overall Study|Protocol Violation|2|||
44341779|NCT00989833|79345812|FG002|Overall Study|Protocol Violation|1|||
44341780|NCT00989833|79345810|FG000|Overall Study|Withdrawal by Subject|0|||
44341781|NCT00989833|79345811|FG001|Overall Study|Withdrawal by Subject|0|||
44341782|NCT00989833|79345812|FG002|Overall Study|Withdrawal by Subject|1|||
44341783|NCT00989833|79345810|FG000|Overall Study|Incorrectly randomized|1|||
44341784|NCT00989833|79345811|FG001|Overall Study|Incorrectly randomized|0|||
44341785|NCT00989833|79345812|FG002|Overall Study|Incorrectly randomized|0|||
44341786|NCT01218477|79345824|FG000|Overall Study|Disease progression|2|||
44442170|NCT03823911|79450289|FG000|Overall Study|Lost to Follow-up|1|||
44159132|NCT02876328|78951384|FG001|Overall Study|Missed 12 Month Visit|10|||
44159133|NCT02876328|78951385|FG002|Overall Study|Missed 12 Month Visit|11|||
44159134|NCT02876328|78951386|FG003|Overall Study|Missed 12 Month Visit|6|||
44159135|NCT02876328|78951387|FG004|Overall Study|Missed 12 Month Visit|10|||
44159136|NCT02876328|78951388|FG005|Overall Study|Missed 12 Month Visit|14|||
44159137|NCT02876328|78951389|FG006|Overall Study|Missed 12 Month Visit|3|||
44159138|NCT02876328|78951390|FG007|Overall Study|Missed 12 Month Visit|8|||
44159139|NCT02876328|78951391|FG008|Overall Study|Missed 12 Month Visit|9|||
44159140|NCT02876328|78951392|FG009|Overall Study|Missed 12 Month Visit|5|||
44159141|NCT02876328|78951393|FG010|Overall Study|Missed 12 Month Visit|4|||
44159142|NCT02876328|78951394|FG011|Overall Study|Missed 12 Month Visit|1|||
44159143|NCT02876328|78951395|FG012|Overall Study|Missed 12 Month Visit|5|||
44159144|NCT02876328|78951396|FG013|Overall Study|Missed 12 Month Visit|4|||
44159145|NCT02876328|78951397|FG014|Overall Study|Missed 12 Month Visit|4|||
44159146|NCT02876328|78951398|FG015|Overall Study|Missed 12 Month Visit|4|||
44159147|NCT02876328|78951399|FG016|Overall Study|Missed 12 Month Visit|3|||
44159148|NCT02876328|78951400|FG017|Overall Study|Missed 12 Month Visit|6|||
44159149|NCT02876328|78951401|FG018|Overall Study|Missed 12 Month Visit|2|||
44159150|NCT02876328|78951402|FG019|Overall Study|Missed 12 Month Visit|2|||
44159151|NCT02876328|78951403|FG020|Overall Study|Missed 12 Month Visit|11|||
44159152|NCT02876328|78951404|FG021|Overall Study|Missed 12 Month Visit|7|||
44159153|NCT02876328|78951405|FG022|Overall Study|Missed 12 Month Visit|1|||
44159154|NCT02876328|78951406|FG023|Overall Study|Missed 12 Month Visit|0|||
44159155|NCT02577354|78951452|FG000|Overall Study|Lack of Efficacy|4|||
44341787|NCT01218477|79345825|FG001|Overall Study|Disease progression|3|||
44442171|NCT03823911|79450290|FG001|Overall Study|Lost to Follow-up|5|||
44442172|NCT03823911|79450291|FG002|Overall Study|Lost to Follow-up|2|||
44442173|NCT03823911|79450289|FG000|Overall Study|Did not meet eligibility criteria|13|||
44442174|NCT03823911|79450290|FG001|Overall Study|Did not meet eligibility criteria|7|||
44442175|NCT03823911|79450291|FG002|Overall Study|Did not meet eligibility criteria|4|||
44442176|NCT03823911|79450289|FG000|Overall Study|Death|0|||
44442177|NCT03823911|79450290|FG001|Overall Study|Death|1|||
44442178|NCT03823911|79450291|FG002|Overall Study|Death|0|||
44442179|NCT00621764|79450302|FG000|Overall Study|Protocol Violation|0|||
44442180|NCT00621764|79450303|FG001|Overall Study|Protocol Violation|0|||
44442181|NCT00621764|79450304|FG002|Overall Study|Protocol Violation|0|||
44442182|NCT00621764|79450305|FG003|Overall Study|Protocol Violation|1|||
44442183|NCT00510718|79450323|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
44442184|NCT00510718|79450324|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
44442185|NCT00510718|79450323|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
44442186|NCT00510718|79450324|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
44442187|NCT00510718|79450323|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
44442188|NCT00510718|79450324|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
44442189|NCT00510718|79450323|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
44442190|NCT00510718|79450324|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
44442191|NCT00510718|79450323|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
44442192|NCT00510718|79450324|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
44442193|NCT00510718|79450323|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
44442194|NCT00510718|79450324|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
44442195|NCT00537381|79450345|FG000|Overall Study|Adverse Event|13|||
44442196|NCT00537381|79450346|FG001|Overall Study|Adverse Event|9|||
44442197|NCT00537381|79450345|FG000|Overall Study|Death|3|||
44442198|NCT00537381|79450346|FG001|Overall Study|Death|3|||
44442199|NCT00537381|79450345|FG000|Overall Study|Withdrawal by Subject|5|||
44442200|NCT00537381|79450346|FG001|Overall Study|Withdrawal by Subject|14|||
44442201|NCT00537381|79450345|FG000|Overall Study|Physician Decision|7|||
44442202|NCT00537381|79450346|FG001|Overall Study|Physician Decision|6|||
44442203|NCT00537381|79450345|FG000|Overall Study|Disease Progression|9|||
44442204|NCT00537381|79450346|FG001|Overall Study|Disease Progression|18|||
44442205|NCT00537381|79450345|FG000|Overall Study|Sponsor decision|14|||
44442206|NCT00537381|79450346|FG001|Overall Study|Sponsor decision|9|||
44442207|NCT00537381|79450345|FG000|Overall Study|Other|5|||
44442208|NCT00537381|79450346|FG001|Overall Study|Other|3|||
44442209|NCT03791398|79450357|FG000|Overall Study|Progression of Disease Under Study|2|||
44442210|NCT03791398|79450358|FG001|Overall Study|Progression of Disease Under Study|0|||
44442211|NCT03791398|79450359|FG002|Overall Study|Progression of Disease Under Study|0|||
44442212|NCT00517192|79450365|FG000|Overall Study|Adverse Event|1|||
44442213|NCT00517192|79450366|FG001|Overall Study|Adverse Event|1|||
44442214|NCT00517192|79450365|FG000|Overall Study|Lost to Follow-up|1|||
44442215|NCT00517192|79450366|FG001|Overall Study|Lost to Follow-up|1|||
44442216|NCT00517192|79450365|FG000|Overall Study|Withdrawal by Subject|1|||
44442217|NCT00517192|79450366|FG001|Overall Study|Withdrawal by Subject|0|||
44442218|NCT00517192|79450365|FG000|Overall Study|Early termination of the trial|16|||
44442219|NCT00517192|79450366|FG001|Overall Study|Early termination of the trial|18|||
44442220|NCT00625820|79450372|FG000|Overall Study|Withdrawal by Subject|1|||
44442221|NCT00145327|79450380|FG000|Overall Study|Withdrawal by Subject|77|||
44442222|NCT00145327|79450381|FG001|Overall Study|Withdrawal by Subject|72|||
44442223|NCT00145327|79450382|FG002|Overall Study|Withdrawal by Subject|164|||
44442224|NCT00145327|79450380|FG000|Overall Study|Death|26|||
44442225|NCT00145327|79450381|FG001|Overall Study|Death|18|||
44442226|NCT00145327|79450382|FG002|Overall Study|Death|30|||
44442227|NCT00145327|79450380|FG000|Overall Study|Adverse Event|14|||
44442228|NCT00145327|79450381|FG001|Overall Study|Adverse Event|11|||
44442229|NCT00145327|79450382|FG002|Overall Study|Adverse Event|22|||
44442230|NCT00145327|79450380|FG000|Overall Study|Lost to Follow-up|9|||
44442231|NCT00145327|79450381|FG001|Overall Study|Lost to Follow-up|14|||
44442232|NCT00145327|79450382|FG002|Overall Study|Lost to Follow-up|14|||
44442233|NCT00145327|79450380|FG000|Overall Study|Administrative problems|12|||
44442234|NCT00145327|79450381|FG001|Overall Study|Administrative problems|9|||
44442235|NCT00145327|79450382|FG002|Overall Study|Administrative problems|13|||
44442236|NCT00145327|79450380|FG000|Overall Study|Protocol Violation|2|||
44442237|NCT00145327|79450381|FG001|Overall Study|Protocol Violation|0|||
44442238|NCT00145327|79450382|FG002|Overall Study|Protocol Violation|2|||
44442239|NCT00145327|79450380|FG000|Overall Study|Abnormal laboratory value(s)|1|||
44442240|NCT00145327|79450381|FG001|Overall Study|Abnormal laboratory value(s)|0|||
44442241|NCT00145327|79450382|FG002|Overall Study|Abnormal laboratory value(s)|2|||
44442242|NCT00145327|79450380|FG000|Overall Study|Missing - not stated|1|||
44442243|NCT00145327|79450381|FG001|Overall Study|Missing - not stated|0|||
44442244|NCT00145327|79450382|FG002|Overall Study|Missing - not stated|1|||
44442245|NCT00510484|79450392|FG000|Wash-out Period|Adverse Event|0|||
44442246|NCT00510484|79450393|FG001|Wash-out Period|Adverse Event|1|||
44159156|NCT02577354|78951453|FG001|Overall Study|Lack of Efficacy|4|||
44159157|NCT02577354|78951452|FG000|Overall Study|Lost to Follow-up|3|||
44442247|NCT00622388|79450399|FG000|Overall Study|Disease Progression|47|||
44442248|NCT00622388|79450399|FG000|Overall Study|Adverse Event|6|||
44442249|NCT00622388|79450399|FG000|Overall Study|Protocol Violation|3|||
44442250|NCT00622388|79450399|FG000|Overall Study|Participant Refusal|1|||
44442251|NCT00622388|79450399|FG000|Overall Study|Death|3|||
44442252|NCT00622388|79450399|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
44442253|NCT00622388|79450399|FG000|Overall Study|Took Prohibited Medication|2|||
44442254|NCT00622388|79450399|FG000|Overall Study|Withdrew Consent|1|||
44442255|NCT00622388|79450399|FG000|Overall Study|Insurance Expired|1|||
44442256|NCT01156389|79450406|FG000|Overall Study|Elevated liver enzymes|4|||
44442257|NCT01156389|79450407|FG001|Overall Study|Elevated liver enzymes|0|||
44442258|NCT01156389|79450406|FG000|Overall Study|Vomiting|0|||
44442259|NCT01156389|79450407|FG001|Overall Study|Vomiting|1|||
44442260|NCT01105767|79450416|FG000|Overall Study|Lost to Follow-up|1160|||
44442261|NCT01105767|79450417|FG001|Overall Study|Lost to Follow-up|1614|||
44442262|NCT01105767|79450418|FG002|Overall Study|Lost to Follow-up|1184|||
44442263|NCT03693430|79450428|FG000|Overall Study|Lost to Follow-up|3|||
44442264|NCT03693430|79450429|FG001|Overall Study|Lost to Follow-up|14|||
44442265|NCT03693430|79450428|FG000|Overall Study|Death|1|||
44442266|NCT03693430|79450429|FG001|Overall Study|Death|0|||
44442267|NCT03693430|79450428|FG000|Overall Study|Withdrawal by Subject|0|||
44442268|NCT03693430|79450429|FG001|Overall Study|Withdrawal by Subject|4|||
44442269|NCT00625742|79450435|FG000|Overall Study|Disease Progression|2|||
44442270|NCT00625742|79450435|FG000|Overall Study|Withdrawal by Subject|1|||
44442271|NCT00625742|79450435|FG000|Overall Study|Adverse Event|4|||
44442272|NCT00625742|79450435|FG000|Overall Study|Lost to Follow-up|4|||
44442273|NCT00625742|79450435|FG000|Overall Study|Ineligible|1|||
44442274|NCT00621296|79450448|FG000|Overall Study|Adverse Event|2|||
44442275|NCT00621296|79450448|FG000|Overall Study|Lack of Efficacy|1|||
44442276|NCT00621296|79450448|FG000|Overall Study|Physician Decision|7|||
44442277|NCT00621296|79450448|FG000|Overall Study|Unmatch Criteria|1|||
44442278|NCT00621296|79450448|FG000|Overall Study|Stopping Criteria|3|||
44442279|NCT00537303|79450454|FG000|Overall Study|Adverse Event|1|||
44442280|NCT00537303|79450455|FG001|Overall Study|Adverse Event|4|||
44442281|NCT00537303|79450454|FG000|Overall Study|Lack of Efficacy|6|||
44442282|NCT00537303|79450455|FG001|Overall Study|Lack of Efficacy|7|||
44442283|NCT00537303|79450454|FG000|Overall Study|Protocol Violation|8|||
44442284|NCT00537303|79450455|FG001|Overall Study|Protocol Violation|4|||
44442285|NCT00537303|79450454|FG000|Overall Study|Withdrawal criteria|3|||
44442286|NCT00537303|79450455|FG001|Overall Study|Withdrawal criteria|3|||
44442287|NCT00537303|79450454|FG000|Overall Study|Unclassified|8|||
44442288|NCT00537303|79450455|FG001|Overall Study|Unclassified|7|||
44442289|NCT00505414|79450463|FG000|Titration Phase|Adverse Event|0|||
44442290|NCT00505414|79450464|FG001|Titration Phase|Adverse Event|0|||
44442291|NCT00505414|79450465|FG002|Titration Phase|Adverse Event|0|||
44442292|NCT00505414|79450466|FG003|Titration Phase|Adverse Event|8|||
44442293|NCT00505414|79450467|FG004|Titration Phase|Adverse Event|3|||
44442294|NCT00505414|79450463|FG000|Titration Phase|Death|0|||
44442295|NCT00505414|79450464|FG001|Titration Phase|Death|0|||
44442296|NCT00505414|79450465|FG002|Titration Phase|Death|0|||
44442297|NCT00505414|79450466|FG003|Titration Phase|Death|2|||
44341788|NCT01218477|79345826|FG002|Overall Study|Disease progression|6|||
44341789|NCT01218477|79345827|FG003|Overall Study|Disease progression|2|||
44341790|NCT01218477|79345824|FG000|Overall Study|Study drug toxicity|0|||
44341791|NCT01218477|79345825|FG001|Overall Study|Study drug toxicity|2|||
44341792|NCT01218477|79345826|FG002|Overall Study|Study drug toxicity|5|||
44341793|NCT01218477|79345827|FG003|Overall Study|Study drug toxicity|0|||
44341794|NCT01218477|79345824|FG000|Overall Study|No longer meets study criteria|1|||
44341795|NCT01218477|79345825|FG001|Overall Study|No longer meets study criteria|0|||
44341796|NCT01218477|79345826|FG002|Overall Study|No longer meets study criteria|0|||
44341797|NCT01218477|79345827|FG003|Overall Study|No longer meets study criteria|0|||
44341798|NCT01218477|79345824|FG000|Overall Study|Withdrawal by Subject|0|||
44341799|NCT01218477|79345825|FG001|Overall Study|Withdrawal by Subject|0|||
44442298|NCT00505414|79450467|FG004|Titration Phase|Death|0|||
44442299|NCT00505414|79450463|FG000|Titration Phase|Lack of Efficacy|0|||
44442300|NCT00505414|79450464|FG001|Titration Phase|Lack of Efficacy|0|||
44442301|NCT00505414|79450465|FG002|Titration Phase|Lack of Efficacy|0|||
44341800|NCT01218477|79345826|FG002|Overall Study|Withdrawal by Subject|1|||
44341801|NCT01218477|79345827|FG003|Overall Study|Withdrawal by Subject|0|||
44442302|NCT00505414|79450466|FG003|Titration Phase|Lack of Efficacy|10|||
44442303|NCT00505414|79450467|FG004|Titration Phase|Lack of Efficacy|1|||
44442304|NCT00505414|79450463|FG000|Titration Phase|Protocol Violation|0|||
44442305|NCT00505414|79450464|FG001|Titration Phase|Protocol Violation|0|||
44442306|NCT00505414|79450465|FG002|Titration Phase|Protocol Violation|0|||
44442307|NCT00505414|79450466|FG003|Titration Phase|Protocol Violation|0|||
44442308|NCT00505414|79450467|FG004|Titration Phase|Protocol Violation|1|||
44442309|NCT00505414|79450463|FG000|Titration Phase|Withdrawal by Subject|0|||
44442310|NCT00505414|79450464|FG001|Titration Phase|Withdrawal by Subject|0|||
44442311|NCT00505414|79450465|FG002|Titration Phase|Withdrawal by Subject|0|||
44442312|NCT00505414|79450466|FG003|Titration Phase|Withdrawal by Subject|3|||
44442313|NCT00505414|79450467|FG004|Titration Phase|Withdrawal by Subject|4|||
44442314|NCT00505414|79450463|FG000|Titration Phase|Underlying disease and therapy required|0|||
44442315|NCT00505414|79450464|FG001|Titration Phase|Underlying disease and therapy required|0|||
44442316|NCT00505414|79450465|FG002|Titration Phase|Underlying disease and therapy required|0|||
44442317|NCT00505414|79450466|FG003|Titration Phase|Underlying disease and therapy required|7|||
44442318|NCT00505414|79450467|FG004|Titration Phase|Underlying disease and therapy required|3|||
44442319|NCT00505414|79450463|FG000|Maintenance Phase|Adverse Event|2|||
44442320|NCT00505414|79450464|FG001|Maintenance Phase|Adverse Event|2|||
44442321|NCT00505414|79450465|FG002|Maintenance Phase|Adverse Event|3|||
44442322|NCT00505414|79450466|FG003|Maintenance Phase|Adverse Event|0|||
44442323|NCT00505414|79450467|FG004|Maintenance Phase|Adverse Event|0|||
44442324|NCT00505414|79450463|FG000|Maintenance Phase|Death|2|||
44442325|NCT00505414|79450464|FG001|Maintenance Phase|Death|0|||
44442326|NCT00505414|79450465|FG002|Maintenance Phase|Death|1|||
44442327|NCT00505414|79450466|FG003|Maintenance Phase|Death|0|||
44442328|NCT00505414|79450467|FG004|Maintenance Phase|Death|0|||
44442329|NCT00505414|79450463|FG000|Maintenance Phase|Lack of Efficacy|2|||
44442330|NCT00505414|79450464|FG001|Maintenance Phase|Lack of Efficacy|1|||
44442331|NCT00505414|79450465|FG002|Maintenance Phase|Lack of Efficacy|1|||
44442332|NCT00505414|79450466|FG003|Maintenance Phase|Lack of Efficacy|0|||
44442333|NCT00505414|79450467|FG004|Maintenance Phase|Lack of Efficacy|0|||
44442334|NCT00505414|79450463|FG000|Maintenance Phase|Withdrawal by Subject|0|||
44442335|NCT00505414|79450464|FG001|Maintenance Phase|Withdrawal by Subject|0|||
44442336|NCT00505414|79450465|FG002|Maintenance Phase|Withdrawal by Subject|1|||
44442337|NCT00505414|79450466|FG003|Maintenance Phase|Withdrawal by Subject|0|||
44442338|NCT00505414|79450467|FG004|Maintenance Phase|Withdrawal by Subject|0|||
44442339|NCT00505414|79450463|FG000|Maintenance Phase|underlying disease and therapy required|0|||
44442340|NCT00505414|79450464|FG001|Maintenance Phase|underlying disease and therapy required|2|||
44442341|NCT00505414|79450465|FG002|Maintenance Phase|underlying disease and therapy required|2|||
44442342|NCT00505414|79450466|FG003|Maintenance Phase|underlying disease and therapy required|0|||
44442343|NCT00505414|79450467|FG004|Maintenance Phase|underlying disease and therapy required|0|||
44442344|NCT00144781|79450501|FG000|Overall Study|Adverse Event|0|||
44442345|NCT00144781|79450502|FG001|Overall Study|Adverse Event|1|||
44442346|NCT00144781|79450503|FG002|Overall Study|Adverse Event|0|||
44442347|NCT00144781|79450504|FG003|Overall Study|Adverse Event|0|||
44442348|NCT00144781|79450501|FG000|Overall Study|Non-compliant|0|||
44442349|NCT00144781|79450502|FG001|Overall Study|Non-compliant|1|||
44442350|NCT00144781|79450503|FG002|Overall Study|Non-compliant|0|||
44442351|NCT00144781|79450504|FG003|Overall Study|Non-compliant|0|||
44442352|NCT00621140|79450520|FG000|Overall Study|Adverse Event|4|||
44442353|NCT00621140|79450521|FG001|Overall Study|Adverse Event|5|||
44442354|NCT00621140|79450520|FG000|Overall Study|Lost to Follow-up|1|||
44442355|NCT00621140|79450521|FG001|Overall Study|Lost to Follow-up|2|||
44442356|NCT00621140|79450520|FG000|Overall Study|Withdrawal by Subject|4|||
44442357|NCT00621140|79450521|FG001|Overall Study|Withdrawal by Subject|6|||
44442358|NCT00621140|79450520|FG000|Overall Study|Other incl. lack of efficacy|6|||
44442359|NCT00621140|79450521|FG001|Overall Study|Other incl. lack of efficacy|5|||
44442360|NCT00207727|79450532|FG000|Overall Study|Withdrawal by Subject|0|||
44442361|NCT00207727|79450533|FG001|Overall Study|Withdrawal by Subject|0|||
44442362|NCT00207727|79450534|FG002|Overall Study|Withdrawal by Subject|0|||
44442363|NCT00207727|79450535|FG003|Overall Study|Withdrawal by Subject|0|||
44442364|NCT00207727|79450536|FG004|Overall Study|Withdrawal by Subject|1|||
44442365|NCT00207727|79450532|FG000|Overall Study|Lost to Follow-up|0|||
44442366|NCT00207727|79450533|FG001|Overall Study|Lost to Follow-up|1|||
44442367|NCT00207727|79450534|FG002|Overall Study|Lost to Follow-up|0|||
44442368|NCT00207727|79450535|FG003|Overall Study|Lost to Follow-up|0|||
44442369|NCT00207727|79450536|FG004|Overall Study|Lost to Follow-up|0|||
44442370|NCT00207727|79450532|FG000|Overall Study|Other|38|||
44442371|NCT00207727|79450533|FG001|Overall Study|Other|41|||
44442372|NCT00207727|79450534|FG002|Overall Study|Other|41|||
44442373|NCT00207727|79450535|FG003|Overall Study|Other|37|||
44442374|NCT00207727|79450536|FG004|Overall Study|Other|33|||
44442375|NCT00504556|79450553|FG000|Overall Study|Adverse Event|11|||
44442376|NCT00504556|79450554|FG001|Overall Study|Adverse Event|11|||
44442377|NCT00504556|79450555|FG002|Overall Study|Adverse Event|14|||
44442378|NCT00504556|79450556|FG003|Overall Study|Adverse Event|13|||
44442379|NCT00504556|79450557|FG004|Overall Study|Adverse Event|5|||
44442380|NCT00504556|79450553|FG000|Overall Study|Death|3|||
44442381|NCT00504556|79450554|FG001|Overall Study|Death|3|||
44442382|NCT00504556|79450555|FG002|Overall Study|Death|1|||
44442383|NCT00504556|79450556|FG003|Overall Study|Death|0|||
44442384|NCT00504556|79450557|FG004|Overall Study|Death|2|||
44442385|NCT00504556|79450553|FG000|Overall Study|Protocol Violation|1|||
44442386|NCT00504556|79450554|FG001|Overall Study|Protocol Violation|3|||
44442387|NCT00504556|79450555|FG002|Overall Study|Protocol Violation|2|||
44442388|NCT00504556|79450556|FG003|Overall Study|Protocol Violation|1|||
44442389|NCT00504556|79450557|FG004|Overall Study|Protocol Violation|2|||
44442390|NCT00504556|79450553|FG000|Overall Study|Lost to Follow-up|0|||
44442391|NCT00504556|79450554|FG001|Overall Study|Lost to Follow-up|0|||
44442392|NCT00504556|79450555|FG002|Overall Study|Lost to Follow-up|1|||
44442393|NCT00504556|79450556|FG003|Overall Study|Lost to Follow-up|1|||
44442394|NCT00504556|79450557|FG004|Overall Study|Lost to Follow-up|1|||
44442395|NCT00504556|79450553|FG000|Overall Study|Withdrawal by Subject|16|||
44442396|NCT00504556|79450554|FG001|Overall Study|Withdrawal by Subject|16|||
44442397|NCT00504556|79450555|FG002|Overall Study|Withdrawal by Subject|7|||
44442398|NCT00504556|79450556|FG003|Overall Study|Withdrawal by Subject|8|||
44442399|NCT00504556|79450557|FG004|Overall Study|Withdrawal by Subject|12|||
44442400|NCT00504556|79450553|FG000|Overall Study|administrative reasons|0|||
44442401|NCT00504556|79450554|FG001|Overall Study|administrative reasons|2|||
44159158|NCT02577354|78951453|FG001|Overall Study|Lost to Follow-up|1|||
44341802|NCT01218477|79345824|FG000|Overall Study|Prepared for cell transplantation|0|||
44341803|NCT01218477|79345825|FG001|Overall Study|Prepared for cell transplantation|1|||
44341804|NCT01218477|79345826|FG002|Overall Study|Prepared for cell transplantation|1|||
44341805|NCT01218477|79345827|FG003|Overall Study|Prepared for cell transplantation|0|||
44341806|NCT01218477|79345824|FG000|Overall Study|Administrative reason by sponsor|0|||
44341807|NCT01218477|79345825|FG001|Overall Study|Administrative reason by sponsor|0|||
44341808|NCT01218477|79345826|FG002|Overall Study|Administrative reason by sponsor|1|||
44341809|NCT01218477|79345827|FG003|Overall Study|Administrative reason by sponsor|0|||
44341810|NCT01218477|79345824|FG000|Overall Study|Maximum clinical benefit|0|||
44341811|NCT01218477|79345825|FG001|Overall Study|Maximum clinical benefit|2|||
44341812|NCT01218477|79345826|FG002|Overall Study|Maximum clinical benefit|0|||
44341813|NCT01218477|79345827|FG003|Overall Study|Maximum clinical benefit|0|||
44341814|NCT01218243|79345843|FG000|Overall Study|Lack of Efficacy|1|||
44341815|NCT01218243|79345844|FG001|Overall Study|Lack of Efficacy|1|||
44341816|NCT01218243|79345843|FG000|Overall Study|Lost to Follow-up|3|||
44341817|NCT01218243|79345844|FG001|Overall Study|Lost to Follow-up|3|||
44341818|NCT01218243|79345843|FG000|Overall Study|Protocol Violation|5|||
44341819|NCT01218243|79345844|FG001|Overall Study|Protocol Violation|10|||
44341820|NCT00989287|79345852|FG000|Overall Study|Adverse Event|1|||
44341821|NCT00989287|79345853|FG001|Overall Study|Adverse Event|0|||
44341822|NCT00989287|79345852|FG000|Overall Study|Lost to Follow-up|0|||
44341823|NCT00989287|79345853|FG001|Overall Study|Lost to Follow-up|1|||
44341824|NCT01218087|79345874|FG000|Overall Study|Death|2|||
44341825|NCT01218087|79345875|FG001|Overall Study|Death|1|||
44341826|NCT01218087|79345874|FG000|Overall Study|Withdrawal by Subject|5|||
44341827|NCT01218087|79345875|FG001|Overall Study|Withdrawal by Subject|0|||
44442402|NCT00504556|79450555|FG002|Overall Study|administrative reasons|2|||
44442403|NCT00504556|79450556|FG003|Overall Study|administrative reasons|1|||
44442404|NCT00504556|79450557|FG004|Overall Study|administrative reasons|2|||
44442405|NCT00504556|79450553|FG000|Overall Study|did not meet entry criteria|2|||
44442406|NCT00504556|79450554|FG001|Overall Study|did not meet entry criteria|0|||
44442407|NCT00504556|79450555|FG002|Overall Study|did not meet entry criteria|1|||
44442408|NCT00504556|79450556|FG003|Overall Study|did not meet entry criteria|1|||
44442409|NCT00504556|79450557|FG004|Overall Study|did not meet entry criteria|0|||
44442410|NCT00504556|79450553|FG000|Overall Study|data monitor committee decision|0|||
44442411|NCT00504556|79450554|FG001|Overall Study|data monitor committee decision|0|||
44442412|NCT00504556|79450555|FG002|Overall Study|data monitor committee decision|0|||
44442413|NCT00504556|79450556|FG003|Overall Study|data monitor committee decision|100|||
44442414|NCT00504556|79450557|FG004|Overall Study|data monitor committee decision|0|||
44442415|NCT00504556|79450553|FG000|Overall Study|Other|2|||
44341828|NCT01218087|79345874|FG000|Overall Study|Transferred|8|||
44341829|NCT01218087|79345875|FG001|Overall Study|Transferred|5|||
44341830|NCT01218009|79345883|FG000|Overall Study|Protocol Violation|2|||
44341831|NCT01218009|79345884|FG001|Overall Study|Protocol Violation|1|||
44341832|NCT01218009|79345883|FG000|Overall Study|Withdrawal by Subject|3|||
44341833|NCT01218009|79345884|FG001|Overall Study|Withdrawal by Subject|1|||
44341834|NCT01218009|79345883|FG000|Overall Study|Sponsor terminated study|161|||
44341835|NCT01218009|79345884|FG001|Overall Study|Sponsor terminated study|163|||
44341836|NCT00992017|79345890|FG000|Overall Study|Lost to Follow-up|2|||
44341837|NCT00992017|79345890|FG000|Overall Study|Withdrawal by Subject|2|||
44341838|NCT00992017|79345890|FG000|Overall Study|Unable to get to clinic|5|||
44341839|NCT00992017|79345890|FG000|Overall Study|Not adhere to study requirements|1|||
44341840|NCT01217463|79345901|FG000|Overall Study|Adverse Event|8|||
44341841|NCT01217463|79345902|FG001|Overall Study|Adverse Event|5|||
44341842|NCT01217463|79345901|FG000|Overall Study|Physician Decision|0|||
44341843|NCT01217463|79345902|FG001|Overall Study|Physician Decision|1|||
44341844|NCT01217463|79345901|FG000|Overall Study|Withdrawal by Subject|3|||
44341845|NCT01217463|79345902|FG001|Overall Study|Withdrawal by Subject|0|||
44341846|NCT01217463|79345901|FG000|Overall Study|Surgery on the Target Limb|0|||
44341847|NCT01217463|79345902|FG001|Overall Study|Surgery on the Target Limb|1|||
44341848|NCT01217463|79345901|FG000|Overall Study|Patient Non-compliant|1|||
44341849|NCT01217463|79345902|FG001|Overall Study|Patient Non-compliant|0|||
44341850|NCT01217463|79345901|FG000|Overall Study|Other|1|||
44341851|NCT01217463|79345902|FG001|Overall Study|Other|1|||
44341852|NCT01217307|79345912|FG000|Overall Study|Withdrawal by Subject|0|||
44341853|NCT01217307|79345913|FG001|Overall Study|Withdrawal by Subject|1|||
44341854|NCT01217229|79345919|FG000|Overall Study|Adverse Event|1|||
44341855|NCT01217229|79345919|FG000|Overall Study|Disease progression, deterioration|2|||
44341856|NCT01217229|79345919|FG000|Overall Study|Disease progression, Cheson criteria|14|||
44341857|NCT01217229|79345919|FG000|Overall Study|Protocol Violation|1|||
44341858|NCT01217229|79345919|FG000|Overall Study|Disease progression not confirmed|2|||
44341859|NCT01013740|79345925|FG000|Overall Study|Lost to Follow-up|3|||
44341860|NCT01013740|79345926|FG001|Overall Study|Lost to Follow-up|5|||
44341861|NCT01013740|79345925|FG000|Overall Study|Physician Decision|2|||
44341862|NCT01013740|79345926|FG001|Overall Study|Physician Decision|0|||
44341863|NCT01013740|79345925|FG000|Overall Study|Withdrawal by Subject|2|||
44341864|NCT01013740|79345926|FG001|Overall Study|Withdrawal by Subject|10|||
44341865|NCT01013740|79345925|FG000|Overall Study|study close / terminated : done in error|2|||
44341866|NCT01013740|79345926|FG001|Overall Study|study close / terminated : done in error|1|||
44341867|NCT01013740|79345925|FG000|Overall Study|Missing|2|||
44341868|NCT01013740|79345926|FG001|Overall Study|Missing|1|||
44442416|NCT00504556|79450554|FG001|Overall Study|Other|2|||
44442417|NCT00504556|79450555|FG002|Overall Study|Other|2|||
44341869|NCT01013740|79345925|FG000|Overall Study|Ongoing: Study records not completed|0|||
44341870|NCT01013740|79345926|FG001|Overall Study|Ongoing: Study records not completed|2|||
44341871|NCT01013350|79345936|FG000|Overall Study|Lost to Follow-up|15|||
44341872|NCT01013350|79345937|FG001|Overall Study|Lost to Follow-up|95|||
44341873|NCT01013350|79345936|FG000|Overall Study|Adverse Event|0|||
44442418|NCT00504556|79450556|FG003|Overall Study|Other|3|||
44442419|NCT00504556|79450557|FG004|Overall Study|Other|0|||
44442420|NCT00504556|79450553|FG000|Overall Study|not in safety analysis set|0|||
44442421|NCT00504556|79450554|FG001|Overall Study|not in safety analysis set|1|||
44442422|NCT00504556|79450555|FG002|Overall Study|not in safety analysis set|1|||
44442423|NCT00504556|79450556|FG003|Overall Study|not in safety analysis set|0|||
44442424|NCT00504556|79450557|FG004|Overall Study|not in safety analysis set|1|||
44442425|NCT00206323|79450571|FG000|Overall Study|Lack of Efficacy|4|||
44442426|NCT00206323|79450572|FG001|Overall Study|Lack of Efficacy|1|||
44442427|NCT00206323|79450571|FG000|Overall Study|Adverse Event|1|||
44442428|NCT00206323|79450572|FG001|Overall Study|Adverse Event|1|||
44341874|NCT01013350|79345937|FG001|Overall Study|Adverse Event|1|||
44442429|NCT00206323|79450571|FG000|Overall Study|Lost to Follow-up|1|||
44442430|NCT00206323|79450572|FG001|Overall Study|Lost to Follow-up|1|||
44442431|NCT03903159|79450578|FG000|Overall Study|Discharged with Staff Approval|2|||
44442432|NCT03903159|79450578|FG000|Overall Study|Discharged at Staff Request|2|||
44442433|NCT03903159|79450578|FG000|Overall Study|Discharged Against Staff Advice|1|||
44442434|NCT00205855|79450582|FG000|Overall Study|Only received temporary implants|16|||
44442435|NCT00205855|79450582|FG000|Overall Study|Withdrawal by Subject|5|||
44442436|NCT00536991|79450586|FG000|Overall Study|Withdrawal by Subject|10|||
44442437|NCT00536991|79450586|FG000|Overall Study|Physician Decision|1|||
44442438|NCT00536991|79450586|FG000|Overall Study|patient ineligible|2|||
44442439|NCT00504166|79450593|FG000|Overall Study|Adverse Event|1|||
44442440|NCT00504166|79450594|FG001|Overall Study|Adverse Event|4|||
44442441|NCT00504166|79450593|FG000|Overall Study|Withdrawal by Subject|3|||
44442442|NCT00504166|79450594|FG001|Overall Study|Withdrawal by Subject|6|||
44442443|NCT00504166|79450593|FG000|Overall Study|Physician Decision|1|||
44442444|NCT00504166|79450594|FG001|Overall Study|Physician Decision|1|||
44442445|NCT00504166|79450593|FG000|Overall Study|Lost to Follow-up|1|||
44442446|NCT00504166|79450594|FG001|Overall Study|Lost to Follow-up|3|||
44442447|NCT00509236|79450602|FG000|Overall Study|Adverse Event|7|||
44442448|NCT00509236|79450603|FG001|Overall Study|Adverse Event|9|||
44442449|NCT00509236|79450602|FG000|Overall Study|Withdrawal by Subject|5|||
44442450|NCT00509236|79450603|FG001|Overall Study|Withdrawal by Subject|10|||
44442451|NCT00509236|79450602|FG000|Overall Study|Protocol Violation|3|||
44442452|NCT00509236|79450603|FG001|Overall Study|Protocol Violation|0|||
44442453|NCT00509236|79450602|FG000|Overall Study|Excluded Medication|1|||
44442454|NCT00509236|79450603|FG001|Overall Study|Excluded Medication|1|||
44442455|NCT00509236|79450602|FG000|Overall Study|Scheduled Kidney Transplant|1|||
44442456|NCT00509236|79450603|FG001|Overall Study|Scheduled Kidney Transplant|0|||
44442457|NCT00508924|79450613|FG000|Overall Study|Protocol Violation|0|||
44442458|NCT00508924|79450614|FG001|Overall Study|Protocol Violation|0|||
44442459|NCT00508924|79450615|FG002|Overall Study|Protocol Violation|1|||
44442460|NCT00508924|79450616|FG003|Overall Study|Protocol Violation|1|||
44442461|NCT00620750|79450626|FG000|Overall Study|Lost to Follow-up|25|||
44442462|NCT00508144|79450630|FG000|Overall Study|Not eligible|6|||
44442463|NCT00508144|79450630|FG000|Overall Study|Death|5|||
44442464|NCT00621842|79450634|FG000|Overall Study|Adverse Event|6|||
44442465|NCT00621842|79450634|FG000|Overall Study|Withdrawal by Subject|7|||
44442466|NCT00621842|79450634|FG000|Overall Study|Protocol Violation|4|||
44442467|NCT00621842|79450634|FG000|Overall Study|Lack of Efficacy|2|||
44442468|NCT00503776|79450642|FG000|Overall Study|Withdrawal by Subject|1|||
44442469|NCT00503776|79450643|FG001|Overall Study|Withdrawal by Subject|0|||
44442470|NCT00503776|79450644|FG002|Overall Study|Withdrawal by Subject|1|||
44442471|NCT00503776|79450645|FG003|Overall Study|Withdrawal by Subject|1|||
44442472|NCT00503776|79450642|FG000|Overall Study|Physician Decision|0|||
44442473|NCT00503776|79450643|FG001|Overall Study|Physician Decision|0|||
44442474|NCT00503776|79450644|FG002|Overall Study|Physician Decision|1|||
44442475|NCT00503776|79450645|FG003|Overall Study|Physician Decision|1|||
44442476|NCT00619112|79450662|FG000|Overall Study|Adverse Event|1|||
44442477|NCT00619112|79450663|FG001|Overall Study|Adverse Event|2|||
44442478|NCT00619502|79450674|FG000|Overall Study|Lost to Follow-up|8|||
44442479|NCT00619502|79450675|FG001|Overall Study|Lost to Follow-up|10|||
44442480|NCT00618956|79450685|FG000|Overall Study|Adverse Event|10|||
44442481|NCT00618956|79450686|FG001|Overall Study|Adverse Event|34|||
44442482|NCT00618956|79450685|FG000|Overall Study|Lack of Efficacy|2|||
44442483|NCT00618956|79450686|FG001|Overall Study|Lack of Efficacy|1|||
44442484|NCT00618956|79450685|FG000|Overall Study|Withdrawal by Subject|5|||
44442485|NCT00618956|79450686|FG001|Overall Study|Withdrawal by Subject|7|||
44442486|NCT00618956|79450685|FG000|Overall Study|Lost to Follow-up|4|||
44442487|NCT00618956|79450686|FG001|Overall Study|Lost to Follow-up|5|||
44442488|NCT00618956|79450685|FG000|Overall Study|Protocol Violation|2|||
44442489|NCT00618956|79450686|FG001|Overall Study|Protocol Violation|2|||
44442490|NCT00618956|79450685|FG000|Overall Study|did not meet criteria, non-compliance|2|||
44442491|NCT00618956|79450686|FG001|Overall Study|did not meet criteria, non-compliance|1|||
44442492|NCT00716417|79450708|FG000|Overall Study|Adverse Event|0|||
44442493|NCT00716417|79450709|FG001|Overall Study|Adverse Event|0|||
44442494|NCT00716417|79450710|FG002|Overall Study|Adverse Event|2|||
44442495|NCT00716417|79450711|FG003|Overall Study|Adverse Event|1|||
44442496|NCT00716417|79450712|FG004|Overall Study|Adverse Event|0|||
44442497|NCT00716417|79450713|FG005|Overall Study|Adverse Event|0|||
44442498|NCT00716417|79450714|FG006|Overall Study|Adverse Event|3|||
44442499|NCT00716417|79450715|FG007|Overall Study|Adverse Event|1|||
44442500|NCT00716417|79450716|FG008|Overall Study|Adverse Event|0|||
44442501|NCT00716417|79450717|FG009|Overall Study|Adverse Event|3|||
44442502|NCT00716417|79450708|FG000|Overall Study|Withdrawal by Subject|0|||
44442503|NCT00716417|79450709|FG001|Overall Study|Withdrawal by Subject|1|||
44442504|NCT00716417|79450710|FG002|Overall Study|Withdrawal by Subject|0|||
44159159|NCT02577354|78951452|FG000|Overall Study|Missed Visit|4|||
44159160|NCT02577354|78951453|FG001|Overall Study|Missed Visit|3|||
44341875|NCT01013350|79345936|FG000|Overall Study|Physician Decision|4|||
44341876|NCT01013350|79345937|FG001|Overall Study|Physician Decision|20|||
44341877|NCT01013350|79345936|FG000|Overall Study|Withdrawal by Subject|15|||
44341878|NCT01013350|79345937|FG001|Overall Study|Withdrawal by Subject|38|||
44341879|NCT01013350|79345936|FG000|Overall Study|Death|3|||
44341880|NCT01013350|79345937|FG001|Overall Study|Death|5|||
44341881|NCT01013350|79345936|FG000|Overall Study|Participant entered interventional study|0|||
44341882|NCT01013350|79345937|FG001|Overall Study|Participant entered interventional study|8|||
44341883|NCT01013350|79345936|FG000|Overall Study|Other|1|||
44442505|NCT00716417|79450711|FG003|Overall Study|Withdrawal by Subject|2|||
44442506|NCT00716417|79450712|FG004|Overall Study|Withdrawal by Subject|0|||
44442507|NCT00716417|79450713|FG005|Overall Study|Withdrawal by Subject|0|||
44341884|NCT01013350|79345937|FG001|Overall Study|Other|25|||
44341885|NCT01018030|79345947|FG000|Overall Study|Adverse Event|10|||
44442508|NCT00716417|79450714|FG006|Overall Study|Withdrawal by Subject|1|||
44442509|NCT00716417|79450715|FG007|Overall Study|Withdrawal by Subject|0|||
44442510|NCT00716417|79450716|FG008|Overall Study|Withdrawal by Subject|0|||
44442511|NCT00716417|79450717|FG009|Overall Study|Withdrawal by Subject|0|||
44341886|NCT01018030|79345948|FG001|Overall Study|Adverse Event|5|||
44442512|NCT00716417|79450708|FG000|Overall Study|Progressive disease|3|||
44442513|NCT00716417|79450709|FG001|Overall Study|Progressive disease|5|||
44442514|NCT00716417|79450710|FG002|Overall Study|Progressive disease|3|||
44442515|NCT00716417|79450711|FG003|Overall Study|Progressive disease|8|||
44442516|NCT00716417|79450712|FG004|Overall Study|Progressive disease|0|||
44442517|NCT00716417|79450713|FG005|Overall Study|Progressive disease|3|||
44442518|NCT00716417|79450714|FG006|Overall Study|Progressive disease|3|||
44442519|NCT00716417|79450715|FG007|Overall Study|Progressive disease|1|||
44442520|NCT00716417|79450716|FG008|Overall Study|Progressive disease|5|||
44442521|NCT00716417|79450717|FG009|Overall Study|Progressive disease|0|||
44442522|NCT00716417|79450708|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
44442523|NCT00716417|79450709|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
44442524|NCT00716417|79450710|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
44442525|NCT00716417|79450711|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
44442526|NCT00716417|79450712|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
44442527|NCT00716417|79450713|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
44442528|NCT00716417|79450714|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
44442529|NCT00716417|79450715|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
44442530|NCT00716417|79450716|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
44442531|NCT00716417|79450717|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
44442532|NCT00716417|79450708|FG000|Overall Study|On patient request due to toxicities|0|||
44442533|NCT00716417|79450709|FG001|Overall Study|On patient request due to toxicities|0|||
44442534|NCT00716417|79450710|FG002|Overall Study|On patient request due to toxicities|0|||
44442535|NCT00716417|79450711|FG003|Overall Study|On patient request due to toxicities|0|||
44442536|NCT00716417|79450712|FG004|Overall Study|On patient request due to toxicities|0|||
44442537|NCT00716417|79450713|FG005|Overall Study|On patient request due to toxicities|0|||
44442538|NCT00716417|79450714|FG006|Overall Study|On patient request due to toxicities|0|||
44442539|NCT00716417|79450715|FG007|Overall Study|On patient request due to toxicities|1|||
44442540|NCT00716417|79450716|FG008|Overall Study|On patient request due to toxicities|0|||
44442541|NCT00716417|79450717|FG009|Overall Study|On patient request due to toxicities|0|||
44442542|NCT00719537|79450743|FG000|Overall Study|Withdrawal by Subject|1|||
44442543|NCT00719537|79450744|FG001|Overall Study|Withdrawal by Subject|0|||
44442544|NCT00719537|79450743|FG000|Overall Study|Lost to Follow-up|0|||
44442545|NCT00719537|79450744|FG001|Overall Study|Lost to Follow-up|1|||
44442546|NCT00715949|79450750|FG000|Overall Study|could not finish first test|4|||
44442547|NCT00503698|79450756|FG000|Overall Study|Protocol Violation|5|||
44442548|NCT00503698|79450757|FG001|Overall Study|Protocol Violation|6|||
44442549|NCT00503698|79450756|FG000|Overall Study|Adverse Event|52|||
44442550|NCT00503698|79450757|FG001|Overall Study|Adverse Event|41|||
44259796|NCT01279681|79123511|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
44259797|NCT01279681|79123510|FG000|Overall Study|Physician Decision|1|||
44442551|NCT00503698|79450756|FG000|Overall Study|Death|1|||
44442552|NCT00503698|79450757|FG001|Overall Study|Death|0|||
44442553|NCT00503698|79450756|FG000|Overall Study|Lack of Efficacy|3|||
44442554|NCT00503698|79450757|FG001|Overall Study|Lack of Efficacy|4|||
44259798|NCT01279681|79123511|FG001|Overall Study|Physician Decision|0|||
44259799|NCT01279681|79123510|FG000|Overall Study|Other Reason|0|||
44259800|NCT01279681|79123511|FG001|Overall Study|Other Reason|2|||
44259801|NCT01279057|79123529|FG000|Overall Study|Adverse Event|1|||
44259802|NCT01279057|79123530|FG001|Overall Study|Adverse Event|0|||
44259803|NCT01279057|79123531|FG002|Overall Study|Adverse Event|1|||
44259804|NCT01279057|79123529|FG000|Overall Study|Insufficient therapeutic response|0|||
44259805|NCT01279057|79123530|FG001|Overall Study|Insufficient therapeutic response|0|||
44259806|NCT01279057|79123531|FG002|Overall Study|Insufficient therapeutic response|1|||
44259807|NCT01279057|79123529|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
44259808|NCT01279057|79123530|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
44442555|NCT00503698|79450756|FG000|Overall Study|Trial terminated|216|||
44442556|NCT00503698|79450757|FG001|Overall Study|Trial terminated|253|||
44442557|NCT00503698|79450756|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
44442558|NCT00503698|79450757|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
44259809|NCT01279057|79123531|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
44442559|NCT00503698|79450756|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
44442560|NCT00503698|79450757|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
44442561|NCT00503698|79450756|FG000|Overall Study|Any condition in exclusion criteria|4|||
44442562|NCT00503698|79450757|FG001|Overall Study|Any condition in exclusion criteria|6|||
44442563|NCT00503698|79450756|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
44442564|NCT00503698|79450757|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
44442565|NCT00503698|79450756|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
44442566|NCT00503698|79450757|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
44442567|NCT00503698|79450756|FG000|Overall Study|Critically ill|2|||
44442568|NCT00503698|79450757|FG001|Overall Study|Critically ill|0|||
44442569|NCT00503698|79450756|FG000|Overall Study|Unclassified|48|||
44442570|NCT00503698|79450757|FG001|Overall Study|Unclassified|32|||
44442571|NCT00503698|79450756|FG000|Overall Study|Not exposed to trial drug|11|||
44442572|NCT00503698|79450757|FG001|Overall Study|Not exposed to trial drug|6|||
44442573|NCT00573794|79450772|FG000|Overall Study|Adverse Event|81|||
44442574|NCT00573794|79450772|FG000|Overall Study|Withdrew Consent|90|||
44442575|NCT00573794|79450772|FG000|Overall Study|Lost to Follow-up|13|||
44442576|NCT00573794|79450772|FG000|Overall Study|Protocol Violation|6|||
44442577|NCT00573794|79450772|FG000|Overall Study|Lack of Efficacy|94|||
44442578|NCT00573794|79450772|FG000|Overall Study|Other|46|||
44442579|NCT00715793|79450776|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
44442580|NCT00715793|79450777|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
44442581|NCT00715793|79450776|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
44442582|NCT00715793|79450777|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
44442583|NCT00718523|79450786|FG000|Overall Study|Withdrawal by Subject|5|||
44442584|NCT00718523|79450787|FG001|Overall Study|Withdrawal by Subject|7|||
44442585|NCT00718523|79450786|FG000|Overall Study|Death|13|||
44442586|NCT00718523|79450787|FG001|Overall Study|Death|17|||
44442587|NCT00715559|79450793|FG000|Overall Study|medication not tolerated - nausea|1|||
44442588|NCT00620282|79450800|FG000|Overall Study|Adverse Event|0|||
44442589|NCT00620282|79450801|FG001|Overall Study|Adverse Event|1|||
44442590|NCT00620282|79450802|FG002|Overall Study|Adverse Event|0|||
44442591|NCT00620282|79450800|FG000|Overall Study|Arterial line unable to be placed|0|||
44442592|NCT00620282|79450801|FG001|Overall Study|Arterial line unable to be placed|0|||
44442593|NCT00620282|79450802|FG002|Overall Study|Arterial line unable to be placed|1|||
44442594|NCT00620282|79450800|FG000|Overall Study|Withdrawal by Subject|0|||
44442595|NCT00620282|79450801|FG001|Overall Study|Withdrawal by Subject|1|||
44442596|NCT00620282|79450802|FG002|Overall Study|Withdrawal by Subject|0|||
44442597|NCT00515086|79450814|FG000|Overall Study|Adverse Event|1|||
44442598|NCT00515086|79450815|FG001|Overall Study|Adverse Event|1|||
44442599|NCT00515086|79450816|FG002|Overall Study|Adverse Event|2|||
44442600|NCT00515086|79450817|FG003|Overall Study|Adverse Event|3|||
44442601|NCT00515086|79450814|FG000|Overall Study|Administrative|1|||
44442602|NCT00515086|79450815|FG001|Overall Study|Administrative|1|||
44442603|NCT00515086|79450816|FG002|Overall Study|Administrative|0|||
44442604|NCT00515086|79450817|FG003|Overall Study|Administrative|0|||
44442605|NCT00515086|79450814|FG000|Overall Study|Withdrawal by Subject|1|||
44442606|NCT00515086|79450815|FG001|Overall Study|Withdrawal by Subject|0|||
44442607|NCT00515086|79450816|FG002|Overall Study|Withdrawal by Subject|0|||
44442608|NCT00515086|79450817|FG003|Overall Study|Withdrawal by Subject|1|||
44442609|NCT00515086|79450814|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
44442610|NCT00515086|79450815|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44442611|NCT00515086|79450816|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
44442612|NCT00515086|79450817|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
44442613|NCT00515086|79450814|FG000|Overall Study|Lost to Follow-up|1|||
44442614|NCT00515086|79450815|FG001|Overall Study|Lost to Follow-up|0|||
44442615|NCT00515086|79450816|FG002|Overall Study|Lost to Follow-up|0|||
44442616|NCT00515086|79450817|FG003|Overall Study|Lost to Follow-up|0|||
44341887|NCT01018030|79345949|FG002|Overall Study|Adverse Event|5|||
44341888|NCT01018030|79345947|FG000|Overall Study|Withdrawal by Subject|2|||
44442617|NCT00515086|79450814|FG000|Overall Study|Study drug no longer required|0|||
44442618|NCT00515086|79450815|FG001|Overall Study|Study drug no longer required|1|||
44442619|NCT00515086|79450816|FG002|Overall Study|Study drug no longer required|0|||
44442620|NCT00515086|79450817|FG003|Overall Study|Study drug no longer required|0|||
44442621|NCT00515086|79450814|FG000|Overall Study|Death|2|||
44442622|NCT00515086|79450815|FG001|Overall Study|Death|0|||
44442623|NCT00515086|79450816|FG002|Overall Study|Death|0|||
44442624|NCT00515086|79450817|FG003|Overall Study|Death|0|||
44159161|NCT02577354|78951452|FG000|Overall Study|Adverse Event|4|||
44159162|NCT02577354|78951453|FG001|Overall Study|Adverse Event|5|||
44159163|NCT02468232|78951473|FG000|Core Part of Study|Adverse Event|0|||
44159164|NCT02468232|78951474|FG001|Core Part of Study|Adverse Event|1|||
44159165|NCT02468232|78951475|FG002|Core Part of Study|Adverse Event|0|||
44159166|NCT02468232|78951476|FG003|Core Part of Study|Adverse Event|0|||
44159167|NCT02468232|78951473|FG000|Core Part of Study|Death|20|||
44159168|NCT02468232|78951474|FG001|Core Part of Study|Death|17|||
44159169|NCT02468232|78951475|FG002|Core Part of Study|Death|0|||
44159170|NCT02468232|78951476|FG003|Core Part of Study|Death|0|||
44341889|NCT01018030|79345948|FG001|Overall Study|Withdrawal by Subject|2|||
44341890|NCT01018030|79345949|FG002|Overall Study|Withdrawal by Subject|4|||
44341891|NCT01018030|79345947|FG000|Overall Study|Lost to Follow-up|2|||
44341892|NCT01018030|79345948|FG001|Overall Study|Lost to Follow-up|0|||
44341893|NCT01018030|79345949|FG002|Overall Study|Lost to Follow-up|3|||
44341894|NCT01018030|79345947|FG000|Overall Study|Protocol Violation|2|||
44341895|NCT01018030|79345948|FG001|Overall Study|Protocol Violation|1|||
44341896|NCT01018030|79345949|FG002|Overall Study|Protocol Violation|0|||
44341897|NCT01018030|79345947|FG000|Overall Study|Physician Decision|1|||
44341898|NCT01018030|79345948|FG001|Overall Study|Physician Decision|0|||
44341899|NCT01018030|79345949|FG002|Overall Study|Physician Decision|1|||
44341900|NCT01018030|79345947|FG000|Overall Study|Lack of Efficacy|1|||
44341901|NCT01018030|79345948|FG001|Overall Study|Lack of Efficacy|0|||
44341902|NCT01018030|79345949|FG002|Overall Study|Lack of Efficacy|0|||
44341903|NCT01018030|79345947|FG000|Overall Study|Did Not Receive Study Drug|1|||
44341904|NCT01018030|79345948|FG001|Overall Study|Did Not Receive Study Drug|3|||
44341905|NCT01018030|79345949|FG002|Overall Study|Did Not Receive Study Drug|0|||
44341906|NCT01217073|79345965|FG000|Base Period|Adverse Event|1|||
44341907|NCT01217073|79345966|FG001|Base Period|Adverse Event|0|||
44341908|NCT01217073|79345967|FG002|Base Period|Adverse Event|1|||
44341909|NCT01217073|79345968|FG003|Base Period|Adverse Event|0|||
44341910|NCT01217073|79345969|FG004|Base Period|Adverse Event|4|||
44341911|NCT01217073|79345970|FG005|Base Period|Adverse Event|1|||
44442625|NCT00618410|79450833|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
44442626|NCT00618410|79450834|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
44442627|NCT00618722|79450844|FG000|Overall Study|Refusal of Treatment|0|||
44442628|NCT00618722|79450845|FG001|Overall Study|Refusal of Treatment|0|||
44442629|NCT00618722|79450846|FG002|Overall Study|Refusal of Treatment|1|||
44442630|NCT00618722|79450847|FG003|Overall Study|Refusal of Treatment|0|||
44442631|NCT00618722|79450844|FG000|Overall Study|Patient Request|1|||
44442632|NCT00618722|79450845|FG001|Overall Study|Patient Request|1|||
44442633|NCT00618722|79450846|FG002|Overall Study|Patient Request|1|||
44442634|NCT00618722|79450847|FG003|Overall Study|Patient Request|1|||
44442635|NCT00618722|79450844|FG000|Overall Study|Inability to Complete Study Procedure|0|||
44442636|NCT00618722|79450845|FG001|Overall Study|Inability to Complete Study Procedure|1|||
44442637|NCT00618722|79450846|FG002|Overall Study|Inability to Complete Study Procedure|0|||
44442638|NCT00618722|79450847|FG003|Overall Study|Inability to Complete Study Procedure|0|||
44442639|NCT00618722|79450844|FG000|Overall Study|Lost to Follow-up|2|||
44442640|NCT00618722|79450845|FG001|Overall Study|Lost to Follow-up|0|||
44159171|NCT02468232|78951473|FG000|Core Part of Study|Technical Problems|1|||
44159172|NCT02468232|78951474|FG001|Core Part of Study|Technical Problems|1|||
44159173|NCT02468232|78951475|FG002|Core Part of Study|Technical Problems|0|||
44341912|NCT01217073|79345971|FG006|Base Period|Adverse Event|0|||
44341913|NCT01217073|79345972|FG007|Base Period|Adverse Event|0|||
44341914|NCT01217073|79345965|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
44341915|NCT01217073|79345966|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44341916|NCT01217073|79345967|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44442641|NCT00618722|79450846|FG002|Overall Study|Lost to Follow-up|0|||
44442642|NCT00618722|79450847|FG003|Overall Study|Lost to Follow-up|2|||
44442643|NCT00618722|79450844|FG000|Overall Study|Miscellaneous Reasons|0|||
44442644|NCT00618722|79450845|FG001|Overall Study|Miscellaneous Reasons|0|||
44442645|NCT00618722|79450846|FG002|Overall Study|Miscellaneous Reasons|1|||
44442646|NCT00618722|79450847|FG003|Overall Study|Miscellaneous Reasons|1|||
44442647|NCT00507442|79450861|FG000|Overall Study|Adverse Event|8|||
44442648|NCT00507442|79450862|FG001|Overall Study|Adverse Event|11|||
44442649|NCT00507442|79450863|FG002|Overall Study|Adverse Event|4|||
44442650|NCT00507442|79450864|FG003|Overall Study|Adverse Event|1|||
44442651|NCT00507442|79450861|FG000|Overall Study|Protocol Violation|0|||
44442652|NCT00507442|79450862|FG001|Overall Study|Protocol Violation|1|||
44442653|NCT00507442|79450863|FG002|Overall Study|Protocol Violation|0|||
44442654|NCT00507442|79450864|FG003|Overall Study|Protocol Violation|0|||
44442655|NCT00507442|79450861|FG000|Overall Study|Lost to Follow-up|0|||
44442656|NCT00507442|79450862|FG001|Overall Study|Lost to Follow-up|0|||
44442657|NCT00507442|79450863|FG002|Overall Study|Lost to Follow-up|1|||
44442658|NCT00507442|79450864|FG003|Overall Study|Lost to Follow-up|0|||
44341917|NCT01217073|79345968|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44341918|NCT01217073|79345969|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44341919|NCT01217073|79345970|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44341920|NCT01217073|79345971|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44341921|NCT01217073|79345972|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
44341922|NCT01217073|79345965|FG000|Base Period|Excluded medication|0|||
44341923|NCT01217073|79345966|FG001|Base Period|Excluded medication|0|||
44341924|NCT01217073|79345967|FG002|Base Period|Excluded medication|0|||
44341925|NCT01217073|79345968|FG003|Base Period|Excluded medication|0|||
44341926|NCT01217073|79345969|FG004|Base Period|Excluded medication|1|||
44341927|NCT01217073|79345970|FG005|Base Period|Excluded medication|0|||
44341928|NCT01217073|79345971|FG006|Base Period|Excluded medication|0|||
44341929|NCT01217073|79345972|FG007|Base Period|Excluded medication|0|||
44341930|NCT01217073|79345965|FG000|Base Period|Lack of Efficacy|0|||
44341931|NCT01217073|79345966|FG001|Base Period|Lack of Efficacy|0|||
44341932|NCT01217073|79345967|FG002|Base Period|Lack of Efficacy|0|||
44341933|NCT01217073|79345968|FG003|Base Period|Lack of Efficacy|0|||
44341934|NCT01217073|79345969|FG004|Base Period|Lack of Efficacy|0|||
44341935|NCT01217073|79345970|FG005|Base Period|Lack of Efficacy|1|||
44341936|NCT01217073|79345971|FG006|Base Period|Lack of Efficacy|0|||
44341937|NCT01217073|79345972|FG007|Base Period|Lack of Efficacy|0|||
44341938|NCT01217073|79345965|FG000|Base Period|Lost to Follow-up|0|||
44341939|NCT01217073|79345966|FG001|Base Period|Lost to Follow-up|0|||
44341940|NCT01217073|79345967|FG002|Base Period|Lost to Follow-up|1|||
44341941|NCT01217073|79345968|FG003|Base Period|Lost to Follow-up|1|||
44341942|NCT01217073|79345969|FG004|Base Period|Lost to Follow-up|3|||
44341943|NCT01217073|79345970|FG005|Base Period|Lost to Follow-up|0|||
44341944|NCT01217073|79345971|FG006|Base Period|Lost to Follow-up|0|||
44341945|NCT01217073|79345972|FG007|Base Period|Lost to Follow-up|0|||
44341946|NCT01217073|79345965|FG000|Base Period|Physician Decision|0|||
44341947|NCT01217073|79345966|FG001|Base Period|Physician Decision|0|||
44341948|NCT01217073|79345967|FG002|Base Period|Physician Decision|0|||
44341949|NCT01217073|79345968|FG003|Base Period|Physician Decision|0|||
44341950|NCT01217073|79345969|FG004|Base Period|Physician Decision|1|||
44341951|NCT01217073|79345970|FG005|Base Period|Physician Decision|0|||
44341952|NCT01217073|79345971|FG006|Base Period|Physician Decision|0|||
44341953|NCT01217073|79345972|FG007|Base Period|Physician Decision|0|||
44341954|NCT01217073|79345965|FG000|Base Period|Protocol Violation|1|||
44341955|NCT01217073|79345966|FG001|Base Period|Protocol Violation|0|||
44341956|NCT01217073|79345967|FG002|Base Period|Protocol Violation|0|||
44341957|NCT01217073|79345968|FG003|Base Period|Protocol Violation|0|||
44341958|NCT01217073|79345969|FG004|Base Period|Protocol Violation|1|||
44341959|NCT01217073|79345970|FG005|Base Period|Protocol Violation|2|||
44341960|NCT01217073|79345971|FG006|Base Period|Protocol Violation|0|||
44341961|NCT01217073|79345972|FG007|Base Period|Protocol Violation|0|||
44341962|NCT01217073|79345965|FG000|Base Period|Withdrawal by Subject|4|||
44341963|NCT01217073|79345966|FG001|Base Period|Withdrawal by Subject|5|||
44341964|NCT01217073|79345967|FG002|Base Period|Withdrawal by Subject|5|||
44341965|NCT01217073|79345968|FG003|Base Period|Withdrawal by Subject|1|||
44341966|NCT01217073|79345969|FG004|Base Period|Withdrawal by Subject|5|||
44341967|NCT01217073|79345970|FG005|Base Period|Withdrawal by Subject|5|||
44442659|NCT00507442|79450861|FG000|Overall Study|Physician Decision|0|||
44442660|NCT00507442|79450862|FG001|Overall Study|Physician Decision|2|||
44442661|NCT00507442|79450863|FG002|Overall Study|Physician Decision|4|||
44341968|NCT01217073|79345971|FG006|Base Period|Withdrawal by Subject|0|||
44341969|NCT01217073|79345972|FG007|Base Period|Withdrawal by Subject|0|||
44341970|NCT01217073|79345965|FG000|Extension Period|Adverse Event|0|||
44341971|NCT01217073|79345966|FG001|Extension Period|Adverse Event|0|||
44341972|NCT01217073|79345967|FG002|Extension Period|Adverse Event|0|||
44442662|NCT00507442|79450864|FG003|Overall Study|Physician Decision|1|||
44442663|NCT00507442|79450861|FG000|Overall Study|Progressive Disease|2|||
44341973|NCT01217073|79345968|FG003|Extension Period|Adverse Event|0|||
44341974|NCT01217073|79345969|FG004|Extension Period|Adverse Event|0|||
44341975|NCT01217073|79345970|FG005|Extension Period|Adverse Event|0|||
44442664|NCT00507442|79450862|FG001|Overall Study|Progressive Disease|4|||
44442665|NCT00507442|79450863|FG002|Overall Study|Progressive Disease|2|||
44442666|NCT00507442|79450864|FG003|Overall Study|Progressive Disease|0|||
44442667|NCT00507442|79450861|FG000|Overall Study|Withdrawal by Subject|4|||
44442668|NCT00507442|79450862|FG001|Overall Study|Withdrawal by Subject|4|||
44442669|NCT00507442|79450863|FG002|Overall Study|Withdrawal by Subject|2|||
44442670|NCT00507442|79450864|FG003|Overall Study|Withdrawal by Subject|1|||
44442671|NCT00507442|79450861|FG000|Overall Study|Other|2|||
44442672|NCT00507442|79450862|FG001|Overall Study|Other|5|||
44442673|NCT00507442|79450863|FG002|Overall Study|Other|2|||
44442674|NCT00507442|79450864|FG003|Overall Study|Other|2|||
44442675|NCT00619892|79450880|FG000|Overall Study|Adverse Event|3|||
44442676|NCT00619892|79450881|FG001|Overall Study|Adverse Event|0|||
44442677|NCT00619892|79450880|FG000|Overall Study|Lost to Follow-up|0|||
44442678|NCT00619892|79450881|FG001|Overall Study|Lost to Follow-up|1|||
44442679|NCT00619892|79450880|FG000|Overall Study|Intercurrent illness|0|||
44442680|NCT00619892|79450881|FG001|Overall Study|Intercurrent illness|1|||
44442681|NCT00507130|79450893|FG000|Overall Study|Lost to Follow-up|0|||
44442682|NCT00507130|79450894|FG001|Overall Study|Lost to Follow-up|0|||
44442683|NCT00507130|79450895|FG002|Overall Study|Lost to Follow-up|1|||
44442684|NCT00507130|79450896|FG003|Overall Study|Lost to Follow-up|1|||
44442685|NCT00507130|79450893|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
44442686|NCT00507130|79450894|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
44442687|NCT00507130|79450895|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
44442688|NCT00507130|79450896|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
44442689|NCT00503308|79450908|FG000|Overall Study|Protocol Violation|2|||
44442690|NCT00503308|79450909|FG001|Overall Study|Protocol Violation|1|||
44442691|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
44442692|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
44442693|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
44442694|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
44442695|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
44442696|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
44442697|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
44442698|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
44442699|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
44442700|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442701|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
44442702|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442703|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442704|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442705|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442706|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442707|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442708|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
44442709|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442710|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
44442711|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442712|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
44442713|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442714|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442715|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442716|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442717|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44341976|NCT01217073|79345971|FG006|Extension Period|Adverse Event|19|||
44341977|NCT01217073|79345972|FG007|Extension Period|Adverse Event|5|||
44341978|NCT01217073|79345965|FG000|Extension Period|ALT/AST|0|||
44341979|NCT01217073|79345966|FG001|Extension Period|ALT/AST|0|||
44341980|NCT01217073|79345967|FG002|Extension Period|ALT/AST|0|||
44341981|NCT01217073|79345968|FG003|Extension Period|ALT/AST|0|||
44341982|NCT01217073|79345969|FG004|Extension Period|ALT/AST|0|||
44341983|NCT01217073|79345970|FG005|Extension Period|ALT/AST|0|||
44341984|NCT01217073|79345971|FG006|Extension Period|ALT/AST|2|||
44341985|NCT01217073|79345972|FG007|Extension Period|ALT/AST|0|||
44341986|NCT01217073|79345965|FG000|Extension Period|Contraindication to study medication|0|||
44442718|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442719|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
44341987|NCT01217073|79345966|FG001|Extension Period|Contraindication to study medication|0|||
44341988|NCT01217073|79345967|FG002|Extension Period|Contraindication to study medication|0|||
44341989|NCT01217073|79345968|FG003|Extension Period|Contraindication to study medication|0|||
44341990|NCT01217073|79345969|FG004|Extension Period|Contraindication to study medication|0|||
44442720|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442721|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
44442722|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442723|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442724|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442725|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442726|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
44442727|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
44442728|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
44442729|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
44442730|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442731|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
44442732|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442733|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442734|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442735|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442736|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44540847|NCT03311724|79552974|FG002|Overall Study|Lost to Follow-up|0|||
44540848|NCT03311724|79552975|FG003|Overall Study|Lost to Follow-up|0|||
44540849|NCT03311724|79552972|FG000|Overall Study|Sponsor Decision|0|||
44540850|NCT03311724|79552973|FG001|Overall Study|Sponsor Decision|0|||
44540851|NCT03311724|79552974|FG002|Overall Study|Sponsor Decision|1|||
44540852|NCT03311724|79552975|FG003|Overall Study|Sponsor Decision|0|||
44540853|NCT03311646|79552997|FG000|Overall Study|Physician Decision|1|||
44540854|NCT03311646|79552997|FG000|Overall Study|Withdrawal by Subject|5|||
44540855|NCT03311646|79552997|FG000|Overall Study|Lost to Follow-up|5|||
44442737|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
44442738|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442739|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442740|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442741|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442742|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442743|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442744|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
44442745|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442746|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442747|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442748|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
44442749|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442750|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442751|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442752|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442753|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442754|NCT03893565|79450920|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
44442755|NCT03893565|79450921|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
44442756|NCT03893565|79450922|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
44442757|NCT03893565|79450923|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
44442758|NCT03893565|79450924|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
44442759|NCT03893565|79450925|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
44442760|NCT03893565|79450926|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
44442761|NCT03893565|79450927|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
44442762|NCT03893565|79450928|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
44442763|NCT03893565|79450920|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
44442764|NCT03893565|79450921|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
44442765|NCT03893565|79450922|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
44442766|NCT03893565|79450923|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
44442767|NCT03893565|79450924|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
44442768|NCT03893565|79450925|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
44442769|NCT03893565|79450926|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
44442770|NCT03893565|79450927|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
44442771|NCT03893565|79450928|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
44442772|NCT03893565|79450920|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442773|NCT03893565|79450921|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442774|NCT03893565|79450922|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442775|NCT03893565|79450923|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442776|NCT03893565|79450924|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442777|NCT03893565|79450925|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442778|NCT03893565|79450926|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
44442779|NCT03893565|79450927|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442780|NCT03893565|79450928|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
44442781|NCT03893565|79450920|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442782|NCT03893565|79450921|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442783|NCT03893565|79450922|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442784|NCT03893565|79450923|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442785|NCT03893565|79450924|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442786|NCT03893565|79450925|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
44442787|NCT03893565|79450926|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
44442788|NCT03893565|79450927|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442789|NCT03893565|79450928|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
44442790|NCT03893565|79450920|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
44442791|NCT03893565|79450921|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
44442792|NCT03893565|79450922|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
44442793|NCT03893565|79450923|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
44442794|NCT03893565|79450924|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
44442795|NCT03893565|79450925|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
44442796|NCT03893565|79450926|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
44442797|NCT03893565|79450927|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
44442798|NCT03893565|79450928|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
44442799|NCT03893565|79450920|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442800|NCT03893565|79450921|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442801|NCT03893565|79450922|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442802|NCT03893565|79450923|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442803|NCT03893565|79450924|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442804|NCT03893565|79450925|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442805|NCT03893565|79450926|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442806|NCT03893565|79450927|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
44442807|NCT03893565|79450928|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
44442808|NCT03893565|79450920|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442809|NCT03893565|79450921|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44159174|NCT02468232|78951476|FG003|Core Part of Study|Technical Problems|0|||
44159175|NCT02468232|78951473|FG000|OLE Part of Study|Adverse Event|0|||
44159176|NCT02468232|78951474|FG001|OLE Part of Study|Adverse Event|0|||
44442810|NCT03893565|79450922|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442811|NCT03893565|79450923|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442812|NCT03893565|79450924|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442813|NCT03893565|79450925|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442814|NCT03893565|79450926|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442815|NCT03893565|79450927|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
44442816|NCT03893565|79450928|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
44442817|NCT03893565|79450920|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44159177|NCT02468232|78951475|FG002|OLE Part of Study|Adverse Event|4|||
44159178|NCT02468232|78951476|FG003|OLE Part of Study|Adverse Event|5|||
44159179|NCT02468232|78951473|FG000|OLE Part of Study|Death|0|||
44442818|NCT03893565|79450921|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442819|NCT03893565|79450922|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442820|NCT03893565|79450923|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442821|NCT03893565|79450924|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442822|NCT03893565|79450925|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442823|NCT03893565|79450926|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442824|NCT03893565|79450927|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
44442825|NCT03893565|79450928|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
44442826|NCT03893565|79450920|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442827|NCT03893565|79450921|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442828|NCT03893565|79450922|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442829|NCT03893565|79450923|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442830|NCT03893565|79450924|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442831|NCT03893565|79450925|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442832|NCT03893565|79450926|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442833|NCT03893565|79450927|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
44442834|NCT03893565|79450928|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
44442835|NCT00502996|79450947|FG000|Overall Study|Lost to Follow-up|9|||
44442836|NCT00502996|79450947|FG000|Overall Study|Protocol Violation|2|||
44442837|NCT00502996|79450947|FG000|Overall Study|Treatment failure|25|||
44442838|NCT00502996|79450947|FG000|Overall Study|Withdrawal Informed Consent|6|||
44442839|NCT00502996|79450947|FG000|Overall Study|Adverse Event|2|||
44442840|NCT00715403|79450958|FG000|Overall Study|Progressive disease|0|||
44442841|NCT00715403|79450959|FG001|Overall Study|Progressive disease|1|||
44442842|NCT00715403|79450960|FG002|Overall Study|Progressive disease|3|||
44442843|NCT00715403|79450961|FG003|Overall Study|Progressive disease|9|||
44442844|NCT00715403|79450962|FG004|Overall Study|Progressive disease|5|||
44442845|NCT00715403|79450963|FG005|Overall Study|Progressive disease|14|||
44442846|NCT00715403|79450964|FG006|Overall Study|Progressive disease|1|||
44442847|NCT00715403|79450958|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
44442848|NCT00715403|79450959|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
44442849|NCT00715403|79450960|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
44442850|NCT00715403|79450961|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
44442851|NCT00715403|79450962|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
44442852|NCT00715403|79450963|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
44442853|NCT00715403|79450964|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
44442854|NCT00715403|79450958|FG000|Overall Study|Other Adverse Event than DLT|1|||
44442855|NCT00715403|79450959|FG001|Overall Study|Other Adverse Event than DLT|0|||
44442856|NCT00715403|79450960|FG002|Overall Study|Other Adverse Event than DLT|0|||
44442857|NCT00715403|79450961|FG003|Overall Study|Other Adverse Event than DLT|0|||
44442858|NCT00715403|79450962|FG004|Overall Study|Other Adverse Event than DLT|0|||
44442859|NCT00715403|79450963|FG005|Overall Study|Other Adverse Event than DLT|2|||
44442860|NCT00715403|79450964|FG006|Overall Study|Other Adverse Event than DLT|0|||
44442861|NCT00715403|79450958|FG000|Overall Study|Protocol Violation|0|||
44442862|NCT00715403|79450959|FG001|Overall Study|Protocol Violation|0|||
44442863|NCT00715403|79450960|FG002|Overall Study|Protocol Violation|0|||
44442864|NCT00715403|79450961|FG003|Overall Study|Protocol Violation|0|||
44442865|NCT00715403|79450962|FG004|Overall Study|Protocol Violation|0|||
44442866|NCT00715403|79450963|FG005|Overall Study|Protocol Violation|1|||
44442867|NCT00715403|79450964|FG006|Overall Study|Protocol Violation|0|||
44442868|NCT00715403|79450958|FG000|Overall Study|Other reason not defined above|0|||
44442869|NCT00715403|79450959|FG001|Overall Study|Other reason not defined above|0|||
44442870|NCT00715403|79450960|FG002|Overall Study|Other reason not defined above|1|||
44159180|NCT02468232|78951474|FG001|OLE Part of Study|Death|0|||
44159181|NCT02468232|78951475|FG002|OLE Part of Study|Death|4|||
44442871|NCT00715403|79450961|FG003|Overall Study|Other reason not defined above|0|||
44442872|NCT00715403|79450962|FG004|Overall Study|Other reason not defined above|1|||
44442873|NCT00715403|79450963|FG005|Overall Study|Other reason not defined above|1|||
44442874|NCT00715403|79450964|FG006|Overall Study|Other reason not defined above|0|||
44442875|NCT00502840|79450980|FG000|Overall Study|Adverse Event|5|||
44442876|NCT00502840|79450980|FG000|Overall Study|Additional or changed therapy|48|||
44442877|NCT00502840|79450980|FG000|Overall Study|Lack of Efficacy|11|||
44442878|NCT00502840|79450980|FG000|Overall Study|Protocol Violation|4|||
44442879|NCT00502840|79450980|FG000|Overall Study|Withdrawal by Subject|5|||
44442880|NCT00502840|79450980|FG000|Overall Study|Lost to Follow-up|6|||
44442881|NCT00502840|79450980|FG000|Overall Study|Administrative problems|1|||
44442882|NCT00502840|79450980|FG000|Overall Study|Other|20|||
44442883|NCT00515008|79450987|FG000|Overall Study|Lost to Follow-up|1|||
44442884|NCT00515008|79450988|FG001|Overall Study|Lost to Follow-up|0|||
44442885|NCT00515008|79450987|FG000|Overall Study|Declined|0|||
44442886|NCT00515008|79450988|FG001|Overall Study|Declined|3|||
44442887|NCT00515008|79450987|FG000|Overall Study|Left the Boston Area|1|||
44442888|NCT00515008|79450988|FG001|Overall Study|Left the Boston Area|1|||
44442889|NCT00515008|79450987|FG000|Overall Study|Scheduling conflict|1|||
44442890|NCT00515008|79450988|FG001|Overall Study|Scheduling conflict|0|||
44442891|NCT00514540|79450997|FG000|First-Line Chemo|Withdrawal by Subject|1|||
44442892|NCT00514540|79450997|FG000|First-Line Chemo|Protocol Violation|7|||
44442893|NCT00514540|79450997|FG000|Second-Line|Physician/Patient Decision|31|||
44442894|NCT00713609|79451015|FG000|Overall Study|Adverse Event|2|||
44442895|NCT00713609|79451016|FG001|Overall Study|Adverse Event|0|||
44442896|NCT00713609|79451017|FG002|Overall Study|Adverse Event|2|||
44442897|NCT00713609|79451018|FG003|Overall Study|Adverse Event|2|||
44442898|NCT00713609|79451019|FG004|Overall Study|Adverse Event|3|||
44442899|NCT00713609|79451020|FG005|Overall Study|Adverse Event|1|||
44442900|NCT00713609|79451015|FG000|Overall Study|Lost to Follow-up|5|||
44442901|NCT00713609|79451016|FG001|Overall Study|Lost to Follow-up|7|||
44442902|NCT00713609|79451017|FG002|Overall Study|Lost to Follow-up|5|||
44442903|NCT00713609|79451018|FG003|Overall Study|Lost to Follow-up|5|||
44442904|NCT00713609|79451019|FG004|Overall Study|Lost to Follow-up|7|||
44442905|NCT00713609|79451020|FG005|Overall Study|Lost to Follow-up|0|||
44442906|NCT00713609|79451015|FG000|Overall Study|Lack of Efficacy|1|||
44442907|NCT00713609|79451016|FG001|Overall Study|Lack of Efficacy|3|||
44442908|NCT00713609|79451017|FG002|Overall Study|Lack of Efficacy|0|||
44442909|NCT00713609|79451018|FG003|Overall Study|Lack of Efficacy|0|||
44442910|NCT00713609|79451019|FG004|Overall Study|Lack of Efficacy|1|||
44442911|NCT00713609|79451020|FG005|Overall Study|Lack of Efficacy|0|||
44442912|NCT00713609|79451015|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
44442913|NCT00713609|79451016|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
44442914|NCT00713609|79451017|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
44442915|NCT00713609|79451018|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
44442916|NCT00713609|79451019|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
44442917|NCT00713609|79451020|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
44442918|NCT00713609|79451015|FG000|Overall Study|Withdrawal by Subject|6|||
44442919|NCT00713609|79451016|FG001|Overall Study|Withdrawal by Subject|1|||
44442920|NCT00713609|79451017|FG002|Overall Study|Withdrawal by Subject|5|||
44442921|NCT00713609|79451018|FG003|Overall Study|Withdrawal by Subject|1|||
44341991|NCT01217073|79345970|FG005|Extension Period|Contraindication to study medication|0|||
44341992|NCT01217073|79345971|FG006|Extension Period|Contraindication to study medication|1|||
44341993|NCT01217073|79345972|FG007|Extension Period|Contraindication to study medication|0|||
44341994|NCT01217073|79345965|FG000|Extension Period|Creatinine/eGFR|0|||
44341995|NCT01217073|79345966|FG001|Extension Period|Creatinine/eGFR|0|||
44341996|NCT01217073|79345967|FG002|Extension Period|Creatinine/eGFR|0|||
44442922|NCT00713609|79451019|FG004|Overall Study|Withdrawal by Subject|5|||
44442923|NCT00713609|79451020|FG005|Overall Study|Withdrawal by Subject|7|||
44442924|NCT00713609|79451015|FG000|Overall Study|Protocol Violation|6|||
44442925|NCT00713609|79451016|FG001|Overall Study|Protocol Violation|3|||
44442926|NCT00713609|79451017|FG002|Overall Study|Protocol Violation|1|||
44442927|NCT00713609|79451018|FG003|Overall Study|Protocol Violation|1|||
44442928|NCT00713609|79451019|FG004|Overall Study|Protocol Violation|2|||
44442929|NCT00713609|79451020|FG005|Overall Study|Protocol Violation|0|||
44442930|NCT00513682|79451034|FG000|Washout Phase|Adverse Event|2|||
44442931|NCT00493012|79451043|FG000|Overall Study|Lost to Follow-up|18|||
44442932|NCT00493012|79451044|FG001|Overall Study|Lost to Follow-up|17|||
44442933|NCT05144477|79451052|FG000|Overall Study|Withdrawal by Subject|1|||
44442934|NCT05144477|79451053|FG001|Overall Study|Withdrawal by Subject|1|||
44442935|NCT00617708|79451069|FG000|Overall Study|Adverse Event|0|||
44442936|NCT00617708|79451070|FG001|Overall Study|Adverse Event|6|||
44442937|NCT00617708|79451071|FG002|Overall Study|Adverse Event|9|||
44442938|NCT00617708|79451069|FG000|Overall Study|Withdrawal by Subject|1|||
44442939|NCT00617708|79451070|FG001|Overall Study|Withdrawal by Subject|1|||
44442940|NCT00617708|79451071|FG002|Overall Study|Withdrawal by Subject|7|||
44442941|NCT00617708|79451069|FG000|Overall Study|Death|0|||
44442942|NCT00617708|79451070|FG001|Overall Study|Death|6|||
44442943|NCT00617708|79451071|FG002|Overall Study|Death|5|||
44442944|NCT00617708|79451069|FG000|Overall Study|Progression/Relapse|7|||
44442945|NCT00617708|79451070|FG001|Overall Study|Progression/Relapse|40|||
44442946|NCT00617708|79451071|FG002|Overall Study|Progression/Relapse|36|||
44442947|NCT00617708|79451069|FG000|Overall Study|Not protocol specified|1|||
44442948|NCT00617708|79451070|FG001|Overall Study|Not protocol specified|4|||
44442949|NCT00617708|79451071|FG002|Overall Study|Not protocol specified|2|||
44442950|NCT00617708|79451069|FG000|Overall Study|Not eligible|1|||
44442951|NCT00617708|79451070|FG001|Overall Study|Not eligible|3|||
44442952|NCT00617708|79451071|FG002|Overall Study|Not eligible|5|||
44442953|NCT03894969|79451086|FG000|Overall Study|Adverse Event|0|||
44442954|NCT03894969|79451087|FG001|Overall Study|Adverse Event|2|||
44442955|NCT03894969|79451088|FG002|Overall Study|Adverse Event|0|||
44442956|NCT03894969|79451089|FG003|Overall Study|Adverse Event|1|||
44442957|NCT03894969|79451090|FG004|Overall Study|Adverse Event|2|||
44442958|NCT03894969|79451086|FG000|Overall Study|Lost to Follow-up|3|||
44442959|NCT03894969|79451087|FG001|Overall Study|Lost to Follow-up|1|||
44442960|NCT03894969|79451088|FG002|Overall Study|Lost to Follow-up|1|||
44442961|NCT03894969|79451089|FG003|Overall Study|Lost to Follow-up|0|||
44442962|NCT03894969|79451090|FG004|Overall Study|Lost to Follow-up|0|||
44442963|NCT03894969|79451086|FG000|Overall Study|Withdrawal by Subject|2|||
44442964|NCT03894969|79451087|FG001|Overall Study|Withdrawal by Subject|1|||
44442965|NCT03894969|79451088|FG002|Overall Study|Withdrawal by Subject|3|||
44442966|NCT03894969|79451089|FG003|Overall Study|Withdrawal by Subject|4|||
44442967|NCT03894969|79451090|FG004|Overall Study|Withdrawal by Subject|8|||
44442968|NCT03894969|79451086|FG000|Overall Study|Other|0|||
44442969|NCT03894969|79451087|FG001|Overall Study|Other|0|||
44442970|NCT03894969|79451088|FG002|Overall Study|Other|0|||
44442971|NCT03894969|79451089|FG003|Overall Study|Other|0|||
44442972|NCT03894969|79451090|FG004|Overall Study|Other|3|||
44442973|NCT03894969|79451086|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
44442974|NCT03894969|79451087|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
44442975|NCT03894969|79451088|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
44442976|NCT03894969|79451089|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
44442977|NCT03894969|79451090|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
44442978|NCT03894969|79451086|FG000|Overall Study|Solicited Adverse Event|0|||
44442979|NCT03894969|79451087|FG001|Overall Study|Solicited Adverse Event|1|||
44442980|NCT03894969|79451088|FG002|Overall Study|Solicited Adverse Event|0|||
44442981|NCT03894969|79451089|FG003|Overall Study|Solicited Adverse Event|0|||
44442982|NCT03894969|79451090|FG004|Overall Study|Solicited Adverse Event|0|||
44442983|NCT03894813|79451106|FG000|Overall Study|Adverse Event|1|||
44442984|NCT03894813|79451107|FG001|Overall Study|Adverse Event|1|||
44442985|NCT03894813|79451106|FG000|Overall Study|Lack of Efficacy|3|||
44442986|NCT03894813|79451107|FG001|Overall Study|Lack of Efficacy|3|||
44442987|NCT03894813|79451106|FG000|Overall Study|Lost to Follow-up|1|||
44442988|NCT03894813|79451107|FG001|Overall Study|Lost to Follow-up|0|||
44442989|NCT03894813|79451106|FG000|Overall Study|Pregnancy|2|||
44442990|NCT03894813|79451107|FG001|Overall Study|Pregnancy|1|||
44341997|NCT01217073|79345968|FG003|Extension Period|Creatinine/eGFR|0|||
44341998|NCT01217073|79345969|FG004|Extension Period|Creatinine/eGFR|0|||
44341999|NCT01217073|79345970|FG005|Extension Period|Creatinine/eGFR|0|||
44342000|NCT01217073|79345971|FG006|Extension Period|Creatinine/eGFR|11|||
44342001|NCT01217073|79345972|FG007|Extension Period|Creatinine/eGFR|1|||
44342002|NCT01217073|79345965|FG000|Extension Period|Death|0|||
44442991|NCT03894813|79451106|FG000|Overall Study|Protocol Violation|3|||
44442992|NCT03894813|79451107|FG001|Overall Study|Protocol Violation|7|||
44442993|NCT03894813|79451106|FG000|Overall Study|Withdrawal by Subject|1|||
44442994|NCT03894813|79451107|FG001|Overall Study|Withdrawal by Subject|3|||
44442995|NCT03894813|79451106|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
44442996|NCT03894813|79451107|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
44442997|NCT00615992|79451113|FG000|Overall Study|Protocol Violation|67|||
44159182|NCT02468232|78951476|FG003|OLE Part of Study|Death|2|||
44342003|NCT01217073|79345966|FG001|Extension Period|Death|0|||
44442998|NCT03892707|79451119|FG000|Overall Study|Screen failure|6|||
44342004|NCT01217073|79345967|FG002|Extension Period|Death|0|||
44342005|NCT01217073|79345968|FG003|Extension Period|Death|0|||
44342006|NCT01217073|79345969|FG004|Extension Period|Death|0|||
44342007|NCT01217073|79345970|FG005|Extension Period|Death|0|||
44342008|NCT01217073|79345971|FG006|Extension Period|Death|1|||
44342009|NCT01217073|79345972|FG007|Extension Period|Death|0|||
44342010|NCT01217073|79345965|FG000|Extension Period|Excluded medication|0|||
44342011|NCT01217073|79345966|FG001|Extension Period|Excluded medication|0|||
44342012|NCT01217073|79345967|FG002|Extension Period|Excluded medication|0|||
44159183|NCT02468232|78951473|FG000|OLE Part of Study|Physician Decision|0|||
44159184|NCT02468232|78951474|FG001|OLE Part of Study|Physician Decision|0|||
44159185|NCT02468232|78951475|FG002|OLE Part of Study|Physician Decision|4|||
44159186|NCT02468232|78951476|FG003|OLE Part of Study|Physician Decision|0|||
44159187|NCT02468232|78951473|FG000|OLE Part of Study|Subject/Guardian decision|0|||
44159188|NCT02468232|78951474|FG001|OLE Part of Study|Subject/Guardian decision|0|||
44159189|NCT02468232|78951475|FG002|OLE Part of Study|Subject/Guardian decision|2|||
44442999|NCT03892707|79451120|FG001|Overall Study|Screen failure|0|||
44443000|NCT03892707|79451119|FG000|Overall Study|Pain resolution|0|||
44443001|NCT03892707|79451120|FG001|Overall Study|Pain resolution|4|||
44443002|NCT03892707|79451119|FG000|Overall Study|Withdrawal by Subject|0|||
44443003|NCT03892707|79451120|FG001|Overall Study|Withdrawal by Subject|1|||
44443004|NCT03892707|79451119|FG000|Overall Study|Other (long business trip)|0|||
44443005|NCT03892707|79451120|FG001|Overall Study|Other (long business trip)|1|||
44443006|NCT00615914|79451127|FG000|Overall Study|Adverse Event|274|||
44443007|NCT00615914|79451127|FG000|Overall Study|Death|20|||
44443008|NCT00615914|79451127|FG000|Overall Study|Lack of Efficacy|59|||
44443009|NCT00615914|79451127|FG000|Overall Study|Lost to Follow-up|187|||
44443010|NCT00615914|79451127|FG000|Overall Study|Withdrawal by Subject|16|||
44443011|NCT00615914|79451127|FG000|Overall Study|Physician Decision|4|||
44443012|NCT00615914|79451127|FG000|Overall Study|No data was collected.|65|||
44443013|NCT00615914|79451127|FG000|Overall Study|No treatment|2|||
44443014|NCT00615914|79451127|FG000|Overall Study|Irregularly enrolled patients|10|||
44443015|NCT00513604|79451137|FG000|Overall Study|Not treated|2|||
44443016|NCT00513604|79451138|FG001|Overall Study|Not treated|0|||
44443017|NCT00513604|79451139|FG002|Overall Study|Not treated|1|||
44443018|NCT00513604|79451140|FG003|Overall Study|Not treated|0|||
44159190|NCT02468232|78951476|FG003|OLE Part of Study|Subject/Guardian decision|5|||
44159191|NCT01804816|78951486|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
44159192|NCT01804816|78951486|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
44159193|NCT01803555|78951495|FG000|Overall Study|Adverse Event|3|||
44159194|NCT01803555|78951496|FG001|Overall Study|Adverse Event|2|||
44159195|NCT01803555|78951495|FG000|Overall Study|Withdrawal by Subject|3|||
44159196|NCT01803555|78951496|FG001|Overall Study|Withdrawal by Subject|3|||
44159197|NCT01803555|78951495|FG000|Overall Study|Non-compliance|1|||
44159198|NCT01803555|78951496|FG001|Overall Study|Non-compliance|1|||
44342013|NCT01217073|79345968|FG003|Extension Period|Excluded medication|0|||
44342014|NCT01217073|79345969|FG004|Extension Period|Excluded medication|0|||
44159199|NCT01803555|78951495|FG000|Overall Study|Protocol Violation|3|||
44159200|NCT01803555|78951496|FG001|Overall Study|Protocol Violation|5|||
44159201|NCT01803555|78951495|FG000|Overall Study|Lost to Follow-up|0|||
44159202|NCT01803555|78951496|FG001|Overall Study|Lost to Follow-up|2|||
44159203|NCT01803555|78951495|FG000|Overall Study|Other than specified|3|||
44159204|NCT01803555|78951496|FG001|Overall Study|Other than specified|5|||
44159205|NCT01112306|78951502|FG000|Overall Study|Death|175|||
44342015|NCT01217073|79345970|FG005|Extension Period|Excluded medication|0|||
44443019|NCT00513604|79451141|FG004|Overall Study|Not treated|0|||
44443020|NCT00513604|79451137|FG000|Overall Study|Death during treatment|0|||
44443021|NCT00513604|79451138|FG001|Overall Study|Death during treatment|3|||
44443022|NCT00513604|79451139|FG002|Overall Study|Death during treatment|2|||
44159206|NCT01112306|78951502|FG000|Overall Study|Lost to Follow-up|9|||
44159207|NCT01112306|78951502|FG000|Overall Study|Withdrawal by Subject|31|||
44159208|NCT01112306|78951502|FG000|Overall Study|Other|70|||
44159209|NCT02524665|78951506|FG000|Overall Study|Lost to Follow-up|1|||
44159210|NCT02638129|78951513|FG000|Overall Study|Study terminated|28|||
44159211|NCT02638129|78951514|FG001|Overall Study|Study terminated|30|||
44159212|NCT01658943|78951522|FG000|Overall Study|Adverse Event|6|||
44159213|NCT01658943|78951523|FG001|Overall Study|Adverse Event|13|||
44159214|NCT01658943|78951522|FG000|Overall Study|Withdrawal by Subject|9|||
44159215|NCT01658943|78951523|FG001|Overall Study|Withdrawal by Subject|2|||
44159216|NCT01658943|78951522|FG000|Overall Study|Progression/Relapse|39|||
44159217|NCT01658943|78951523|FG001|Overall Study|Progression/Relapse|40|||
44159218|NCT01658943|78951522|FG000|Overall Study|Death|4|||
44159219|NCT01658943|78951523|FG001|Overall Study|Death|2|||
44159220|NCT01658943|78951522|FG000|Overall Study|not protocol specified|4|||
44159221|NCT01658943|78951523|FG001|Overall Study|not protocol specified|1|||
44159222|NCT01658943|78951522|FG000|Overall Study|Not eligible|7|||
44159223|NCT01658943|78951523|FG001|Overall Study|Not eligible|9|||
44159224|NCT01658943|78951522|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
44159225|NCT01658943|78951523|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
44159226|NCT02600819|78951529|FG000|GEN Phase|Adverse Event|2|||
44159227|NCT02600819|78951530|FG001|GEN Phase|Adverse Event|0|||
44159228|NCT02600819|78951529|FG000|GEN Phase|Death|2|||
44159229|NCT02600819|78951530|FG001|GEN Phase|Death|0|||
44159230|NCT02600819|78951529|FG000|GEN Phase|Investigator's Discretion|4|||
44159231|NCT02600819|78951530|FG001|GEN Phase|Investigator's Discretion|0|||
44159232|NCT02600819|78951529|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
44159233|NCT02600819|78951530|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
44159234|NCT02600819|78951529|FG000|GEN Phase|Withdrew Consent|5|||
44159235|NCT02600819|78951530|FG001|GEN Phase|Withdrew Consent|0|||
44159236|NCT02600819|78951529|FG000|GEN Phase|Lost to Follow-up|2|||
44159237|NCT02600819|78951530|FG001|GEN Phase|Lost to Follow-up|0|||
44159238|NCT02597933|78951538|FG000|Overall Study|Withdrawal by Subject|7|||
44159239|NCT02597933|78951539|FG001|Overall Study|Withdrawal by Subject|5|||
44159240|NCT02597933|78951538|FG000|Overall Study|Protocol Violation|2|||
44159241|NCT02597933|78951539|FG001|Overall Study|Protocol Violation|2|||
44159242|NCT02597933|78951538|FG000|Overall Study|Adverse Event|20|||
44159243|NCT02597933|78951539|FG001|Overall Study|Adverse Event|28|||
44159244|NCT02597933|78951538|FG000|Overall Study|Not treated|2|||
44159245|NCT02597933|78951539|FG001|Overall Study|Not treated|2|||
44159246|NCT02597933|78951538|FG000|Overall Study|Other than stated above|7|||
44159247|NCT02597933|78951539|FG001|Overall Study|Other than stated above|14|||
44159248|NCT02597855|78951547|FG000|Overall Study|Lost to Follow-up|2|||
44159249|NCT02597855|78951548|FG001|Overall Study|Lost to Follow-up|1|||
44159250|NCT02604407|78951557|FG000|Overall Study|Adverse Event|0|||
44159251|NCT02604407|78951558|FG001|Overall Study|Adverse Event|7|||
44159252|NCT02604407|78951559|FG002|Overall Study|Adverse Event|5|||
44159253|NCT02604407|78951557|FG000|Overall Study|Protocol Violation|2|||
44159254|NCT02604407|78951558|FG001|Overall Study|Protocol Violation|0|||
44159255|NCT02604407|78951559|FG002|Overall Study|Protocol Violation|0|||
44159256|NCT02604407|78951557|FG000|Overall Study|Withdrawal by Subject|3|||
44159257|NCT02604407|78951558|FG001|Overall Study|Withdrawal by Subject|3|||
44159258|NCT02604407|78951559|FG002|Overall Study|Withdrawal by Subject|5|||
44159259|NCT02604407|78951557|FG000|Overall Study|Lost to Follow-up|2|||
44159260|NCT02604407|78951558|FG001|Overall Study|Lost to Follow-up|1|||
44159261|NCT02604407|78951559|FG002|Overall Study|Lost to Follow-up|2|||
44159262|NCT02604407|78951557|FG000|Overall Study|Lack of Efficacy|1|||
44159263|NCT02604407|78951558|FG001|Overall Study|Lack of Efficacy|0|||
44159264|NCT02604407|78951559|FG002|Overall Study|Lack of Efficacy|0|||
44159265|NCT02604407|78951557|FG000|Overall Study|Other|3|||
44159266|NCT02604407|78951558|FG001|Overall Study|Other|1|||
44159267|NCT02604407|78951559|FG002|Overall Study|Other|4|||
44159268|NCT02593097|78951569|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
44159269|NCT02593097|78951570|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
44159270|NCT02593097|78951569|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
44159271|NCT02593097|78951570|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
44159272|NCT02593097|78951569|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
44159273|NCT02593097|78951570|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
44159274|NCT02593097|78951569|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
44159275|NCT02593097|78951570|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
44159276|NCT02593097|78951569|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
44159277|NCT02593097|78951570|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
44159278|NCT01657461|78951578|FG000|Overall Study|Death|9|||
44159279|NCT01657461|78951579|FG001|Overall Study|Death|12|||
44159280|NCT01657461|78951578|FG000|Overall Study|Lost to Follow-up|0|||
44159281|NCT01657461|78951579|FG001|Overall Study|Lost to Follow-up|3|||
44159282|NCT01657461|78951578|FG000|Overall Study|Physician Decision|0|||
44159283|NCT01657461|78951579|FG001|Overall Study|Physician Decision|2|||
44443023|NCT00513604|79451140|FG003|Overall Study|Death during treatment|0|||
44443024|NCT00513604|79451141|FG004|Overall Study|Death during treatment|0|||
44443025|NCT00534105|79451155|FG000|Overall Study|Lost to Follow-up|23|||
44443026|NCT00534105|79451156|FG001|Overall Study|Lost to Follow-up|39|||
44443027|NCT00573248|79451171|FG000|Overall Study|scheduling conflicts|15|||
44443028|NCT00573248|79451172|FG001|Overall Study|scheduling conflicts|11|||
44443029|NCT00532935|79451180|FG000|Overall Study|Adverse Event|11|||
44443030|NCT00532935|79451181|FG001|Overall Study|Adverse Event|12|||
44443031|NCT00532935|79451180|FG000|Overall Study|Lack of Efficacy|0|||
44443032|NCT00532935|79451181|FG001|Overall Study|Lack of Efficacy|3|||
44443033|NCT00532935|79451180|FG000|Overall Study|Lost to Follow-up|10|||
44443034|NCT00532935|79451181|FG001|Overall Study|Lost to Follow-up|6|||
44443035|NCT00532935|79451180|FG000|Overall Study|Physician Decision|4|||
44443036|NCT00532935|79451181|FG001|Overall Study|Physician Decision|5|||
44443037|NCT00532935|79451180|FG000|Overall Study|Pregnancy|1|||
44443038|NCT00532935|79451181|FG001|Overall Study|Pregnancy|0|||
44159284|NCT01657461|78951578|FG000|Overall Study|Withdrawal by Subject|1|||
44159285|NCT01657461|78951579|FG001|Overall Study|Withdrawal by Subject|3|||
44159286|NCT02592551|78951588|FG000|Overall Study|Not evaluable|1|||
44159287|NCT02592551|78951589|FG001|Overall Study|Not evaluable|3|||
44159288|NCT02592551|78951590|FG002|Overall Study|Not evaluable|0|||
44159289|NCT02595749|78951601|FG000|Overall Study|Withdrawal by Subject|12|||
44159290|NCT02595749|78951602|FG001|Overall Study|Withdrawal by Subject|7|||
44159291|NCT01657305|78951608|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
44159292|NCT01657305|78951608|FG000|Overall Study|Withdrawal by Subject|4|||
44159293|NCT01657305|78951608|FG000|Overall Study|Adverse Event|1|||
44159294|NCT01657305|78951608|FG000|Overall Study|Lost to Follow-up|1|||
44159295|NCT01657305|78951608|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
44159296|NCT02634307|78951651|FG000|Overall Study|Adverse Event|50|||
44159297|NCT02634307|78951652|FG001|Overall Study|Adverse Event|24|||
44159298|NCT02634307|78951653|FG002|Overall Study|Adverse Event|14|||
44159299|NCT02634307|78951651|FG000|Overall Study|Lost to Follow-up|21|||
44159300|NCT02634307|78951652|FG001|Overall Study|Lost to Follow-up|5|||
44159301|NCT02634307|78951653|FG002|Overall Study|Lost to Follow-up|6|||
44159302|NCT02634307|78951651|FG000|Overall Study|Pregnancy|5|||
44159303|NCT02634307|78951652|FG001|Overall Study|Pregnancy|1|||
44159304|NCT02634307|78951653|FG002|Overall Study|Pregnancy|3|||
44159305|NCT02634307|78951651|FG000|Overall Study|Withdrawal by Subject|38|||
44159306|NCT02634307|78951652|FG001|Overall Study|Withdrawal by Subject|24|||
44159307|NCT02634307|78951653|FG002|Overall Study|Withdrawal by Subject|18|||
44159308|NCT02634307|78951651|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44159309|NCT02634307|78951652|FG001|Overall Study|Non-Compliance with Study Drug|2|||
44159310|NCT02634307|78951653|FG002|Overall Study|Non-Compliance with Study Drug|2|||
44159311|NCT02634307|78951651|FG000|Overall Study|Lack of Efficacy|1|||
44159312|NCT02634307|78951652|FG001|Overall Study|Lack of Efficacy|5|||
44159313|NCT02634307|78951653|FG002|Overall Study|Lack of Efficacy|3|||
44159314|NCT02634307|78951651|FG000|Overall Study|Physician Decision|7|||
44159315|NCT02634307|78951652|FG001|Overall Study|Physician Decision|5|||
44159316|NCT02634307|78951653|FG002|Overall Study|Physician Decision|5|||
44159317|NCT02634307|78951651|FG000|Overall Study|Reason not Specified|3|||
44159318|NCT02634307|78951652|FG001|Overall Study|Reason not Specified|5|||
44159319|NCT02634307|78951653|FG002|Overall Study|Reason not Specified|10|||
44159320|NCT01365273|78951663|FG000|Overall Study|Lost to Follow-up|1|||
44159321|NCT01365273|78951664|FG001|Overall Study|Lost to Follow-up|0|||
44159322|NCT01365273|78951663|FG000|Overall Study|Protocol Violation|0|||
44159323|NCT01365273|78951664|FG001|Overall Study|Protocol Violation|1|||
44159324|NCT01365273|78951663|FG000|Overall Study|Physician Decision|1|||
44159325|NCT01365273|78951664|FG001|Overall Study|Physician Decision|0|||
44159326|NCT02595437|78951670|FG000|Triferic Via IV|Withdrawal by Subject|1|||
44159327|NCT02594735|78951691|FG000|Overall Study|Adverse Event|1|||
44159328|NCT02634151|78951699|FG000|Overall Study|Withdrawal by Subject|1|||
44159329|NCT02634151|78951700|FG001|Overall Study|Withdrawal by Subject|0|||
44159330|NCT02634151|78951699|FG000|Overall Study|Non-Compliance|0|||
44159331|NCT02634151|78951700|FG001|Overall Study|Non-Compliance|1|||
44159332|NCT02634151|78951699|FG000|Overall Study|Other|0|||
44159333|NCT02634151|78951700|FG001|Overall Study|Other|1|||
44159334|NCT01655823|78951711|FG000|Overall Study|Lost to Follow-up|0|||
44159335|NCT01655823|78951712|FG001|Overall Study|Lost to Follow-up|1|||
44443039|NCT00532935|79451180|FG000|Overall Study|Protocol Violation|4|||
44443040|NCT00532935|79451181|FG001|Overall Study|Protocol Violation|2|||
44159336|NCT01655823|78951713|FG002|Overall Study|Lost to Follow-up|0|||
44159337|NCT01655823|78951714|FG003|Overall Study|Lost to Follow-up|0|||
44159338|NCT01655823|78951715|FG004|Overall Study|Lost to Follow-up|1|||
44159339|NCT01655823|78951711|FG000|Overall Study|Withdrawal by Subject|0|||
44159340|NCT01655823|78951712|FG001|Overall Study|Withdrawal by Subject|1|||
44159341|NCT01655823|78951713|FG002|Overall Study|Withdrawal by Subject|0|||
44159342|NCT01655823|78951714|FG003|Overall Study|Withdrawal by Subject|1|||
44159343|NCT01655823|78951715|FG004|Overall Study|Withdrawal by Subject|0|||
44159344|NCT01360645|78951729|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
44159345|NCT01360645|78951730|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
44159346|NCT01360645|78951731|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
44159347|NCT01360645|78951732|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
44159348|NCT01360645|78951729|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
44159349|NCT01360645|78951730|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
44443041|NCT00532935|79451180|FG000|Overall Study|Withdrawal by Subject|10|||
44443042|NCT00532935|79451181|FG001|Overall Study|Withdrawal by Subject|9|||
44443043|NCT00532935|79451180|FG000|Overall Study|Protocol Specific Criteria|11|||
44443044|NCT00532935|79451181|FG001|Overall Study|Protocol Specific Criteria|15|||
44443045|NCT03016312|79451189|FG000|Overall Study|Death|194|||
44443046|NCT03016312|79451190|FG001|Overall Study|Death|164|||
44443047|NCT03016312|79451189|FG000|Overall Study|Lost to Follow-up|11|||
44443048|NCT03016312|79451190|FG001|Overall Study|Lost to Follow-up|12|||
44443049|NCT03016312|79451189|FG000|Overall Study|Started new therapy, loss of contact|2|||
44443050|NCT03016312|79451190|FG001|Overall Study|Started new therapy, loss of contact|1|||
44443051|NCT03016312|79451189|FG000|Overall Study|Physician Decision|0|||
44443052|NCT03016312|79451190|FG001|Overall Study|Physician Decision|2|||
44443053|NCT03016312|79451189|FG000|Overall Study|Withdrawal by Subject|34|||
44159350|NCT01360645|78951731|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
44443054|NCT03016312|79451190|FG001|Overall Study|Withdrawal by Subject|39|||
44443055|NCT00512902|79451196|FG000|Overall Study|Adverse Event|7|||
44443056|NCT00512902|79451196|FG000|Overall Study|Lost to Follow-up|1|||
44443057|NCT00492232|79451202|FG000|Placebo Run-in|Adverse Event|0|||
44443058|NCT00492232|79451203|FG001|Placebo Run-in|Adverse Event|2|||
44443059|NCT00492232|79451202|FG000|Placebo Run-in|Protocol Violation|0|||
44443060|NCT00492232|79451203|FG001|Placebo Run-in|Protocol Violation|3|||
44443061|NCT00492232|79451202|FG000|Placebo Run-in|Lost to Follow-up|0|||
44443062|NCT00492232|79451203|FG001|Placebo Run-in|Lost to Follow-up|3|||
44443063|NCT00492232|79451202|FG000|Placebo Run-in|Withdrawal by Subject|0|||
44443064|NCT00492232|79451203|FG001|Placebo Run-in|Withdrawal by Subject|8|||
44443065|NCT00492232|79451202|FG000|Placebo Run-in|Pregnancy|0|||
44443066|NCT00492232|79451203|FG001|Placebo Run-in|Pregnancy|1|||
44443067|NCT00492232|79451202|FG000|Placebo Run-in|Entrance criteria not met|0|||
44443068|NCT00492232|79451203|FG001|Placebo Run-in|Entrance criteria not met|45|||
44443069|NCT00492232|79451202|FG000|Placebo Run-in|Other|0|||
44443070|NCT00492232|79451203|FG001|Placebo Run-in|Other|6|||
44443071|NCT00492232|79451202|FG000|Placebo Run-in|Missing|0|||
44443072|NCT00492232|79451203|FG001|Placebo Run-in|Missing|2|||
44443073|NCT00492232|79451202|FG000|Double-Blind Treatment|Adverse Event|1|||
44443074|NCT00492232|79451203|FG001|Double-Blind Treatment|Adverse Event|2|||
44443075|NCT00492232|79451202|FG000|Double-Blind Treatment|Protocol Violation|3|||
44443076|NCT00492232|79451203|FG001|Double-Blind Treatment|Protocol Violation|7|||
44443077|NCT00492232|79451202|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
44443078|NCT00492232|79451203|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
44443079|NCT00492232|79451202|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
44443080|NCT00492232|79451203|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
44259810|NCT01279057|79123529|FG000|Overall Study|Withdrew consent|2|||
44259811|NCT01279057|79123530|FG001|Overall Study|Withdrew consent|0|||
44259812|NCT01279057|79123531|FG002|Overall Study|Withdrew consent|1|||
44259813|NCT01279057|79123529|FG000|Overall Study|Pregnancy|0|||
44159351|NCT01360645|78951732|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
44159352|NCT01360645|78951729|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
44159353|NCT01360645|78951730|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
44159354|NCT01360645|78951731|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
44342016|NCT01217073|79345971|FG006|Extension Period|Excluded medication|2|||
44342017|NCT01217073|79345972|FG007|Extension Period|Excluded medication|0|||
44443081|NCT00492232|79451202|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
44443082|NCT00492232|79451203|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
44443083|NCT00492232|79451202|FG000|Double-Blind Treatment|Other|6|||
44443084|NCT00492232|79451203|FG001|Double-Blind Treatment|Other|5|||
44443085|NCT00492232|79451202|FG000|Double-Blind Treatment|Randomized not treated|1|||
44443086|NCT00492232|79451203|FG001|Double-Blind Treatment|Randomized not treated|0|||
44443087|NCT00492232|79451202|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
44443088|NCT00492232|79451203|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
44443089|NCT00491764|79451215|FG000|Overall Study|Adverse Event|1|||
44443090|NCT00491764|79451216|FG001|Overall Study|Adverse Event|2|||
44443091|NCT00491764|79451217|FG002|Overall Study|Adverse Event|4|||
44443092|NCT00491764|79451218|FG003|Overall Study|Adverse Event|4|||
44443093|NCT00491764|79451219|FG004|Overall Study|Adverse Event|0|||
44159355|NCT01360645|78951732|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
44159356|NCT01360645|78951729|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
44159357|NCT01360645|78951730|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
44159358|NCT01360645|78951731|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
44159359|NCT01360645|78951732|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
44159360|NCT01360645|78951729|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
44159361|NCT01360645|78951730|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
44159362|NCT01360645|78951731|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
44443094|NCT00491764|79451220|FG005|Overall Study|Adverse Event|1|||
44443095|NCT00491764|79451215|FG000|Overall Study|Lost to Follow-up|0|||
44443096|NCT00491764|79451216|FG001|Overall Study|Lost to Follow-up|1|||
44443097|NCT00491764|79451217|FG002|Overall Study|Lost to Follow-up|0|||
44443098|NCT00491764|79451218|FG003|Overall Study|Lost to Follow-up|1|||
44443099|NCT00491764|79451219|FG004|Overall Study|Lost to Follow-up|0|||
44443100|NCT00491764|79451220|FG005|Overall Study|Lost to Follow-up|3|||
44443101|NCT00491764|79451215|FG000|Overall Study|Withdrawal by Subject|2|||
44443102|NCT00491764|79451216|FG001|Overall Study|Withdrawal by Subject|3|||
44443103|NCT00491764|79451217|FG002|Overall Study|Withdrawal by Subject|1|||
44443104|NCT00491764|79451218|FG003|Overall Study|Withdrawal by Subject|2|||
44443105|NCT00491764|79451219|FG004|Overall Study|Withdrawal by Subject|2|||
44443106|NCT00491764|79451220|FG005|Overall Study|Withdrawal by Subject|4|||
44443107|NCT00491764|79451215|FG000|Overall Study|Non Compliance with the Protocol|1|||
44443108|NCT00491764|79451216|FG001|Overall Study|Non Compliance with the Protocol|0|||
44443109|NCT00491764|79451217|FG002|Overall Study|Non Compliance with the Protocol|0|||
44443110|NCT00491764|79451218|FG003|Overall Study|Non Compliance with the Protocol|0|||
44443111|NCT00491764|79451219|FG004|Overall Study|Non Compliance with the Protocol|0|||
44443112|NCT00491764|79451220|FG005|Overall Study|Non Compliance with the Protocol|0|||
44443113|NCT00491764|79451215|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
44443114|NCT00491764|79451216|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
44443115|NCT00491764|79451217|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
44443116|NCT00491764|79451218|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
44443117|NCT00491764|79451219|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
44443118|NCT00491764|79451220|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
44443119|NCT00491764|79451215|FG000|Overall Study|Administrative|1|||
44443120|NCT00491764|79451216|FG001|Overall Study|Administrative|0|||
44443121|NCT00491764|79451217|FG002|Overall Study|Administrative|2|||
44443122|NCT00491764|79451218|FG003|Overall Study|Administrative|1|||
44443123|NCT00491764|79451219|FG004|Overall Study|Administrative|0|||
44443124|NCT00491764|79451220|FG005|Overall Study|Administrative|0|||
44443125|NCT00491608|79451234|FG000|Overall Study|Death|2|||
44443126|NCT00491608|79451234|FG000|Overall Study|Withdrawal by Subject|1|||
44443127|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
44443128|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
44443129|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
44443130|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
44443131|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
44443132|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
44443133|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
44443134|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
44443135|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
44443136|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
44443137|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
44443138|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
44443139|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
44443140|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
44443141|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
44443142|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
44443143|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
44443144|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
44443145|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
44443146|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
44443147|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
44443148|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
44443149|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
44443150|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
44443151|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
44443152|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
44443153|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
44443154|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
44443155|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
44443156|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
44443157|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Other|10|||
44443158|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Other|7|||
44443159|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Other|8|||
44443160|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Other|8|||
44443161|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Other|0|||
44443162|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
44443163|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
44443164|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
44443165|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
44443166|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
44443167|NCT00615836|79451242|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
44443168|NCT00615836|79451243|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
44443169|NCT00615836|79451244|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
44443170|NCT00615836|79451245|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
44443171|NCT00615836|79451246|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
44443172|NCT00491530|79451265|FG000|Overall Study|Adverse Event|6|||
44443173|NCT00491530|79451266|FG001|Overall Study|Adverse Event|1|||
44443174|NCT00491530|79451267|FG002|Overall Study|Adverse Event|2|||
44443175|NCT00491530|79451265|FG000|Overall Study|Withdrawal by Subject|3|||
44443176|NCT00491530|79451266|FG001|Overall Study|Withdrawal by Subject|0|||
44443177|NCT00491530|79451267|FG002|Overall Study|Withdrawal by Subject|0|||
44443178|NCT00491530|79451265|FG000|Overall Study|Lost to Follow-up|3|||
44443179|NCT00491530|79451266|FG001|Overall Study|Lost to Follow-up|2|||
44443180|NCT00491530|79451267|FG002|Overall Study|Lost to Follow-up|2|||
44443181|NCT00491530|79451265|FG000|Overall Study|Lack of Efficacy|0|||
44443182|NCT00491530|79451266|FG001|Overall Study|Lack of Efficacy|1|||
44443183|NCT00491530|79451267|FG002|Overall Study|Lack of Efficacy|0|||
44443184|NCT00491530|79451265|FG000|Overall Study|Investigator Discretion|0|||
44443185|NCT00491530|79451266|FG001|Overall Study|Investigator Discretion|1|||
44443186|NCT00491530|79451267|FG002|Overall Study|Investigator Discretion|0|||
44443187|NCT00491530|79451265|FG000|Overall Study|Patient Request|0|||
44342018|NCT01217073|79345965|FG000|Extension Period|Lack of Efficacy|0|||
44342019|NCT01217073|79345966|FG001|Extension Period|Lack of Efficacy|0|||
44342020|NCT01217073|79345967|FG002|Extension Period|Lack of Efficacy|0|||
44342021|NCT01217073|79345968|FG003|Extension Period|Lack of Efficacy|0|||
44342022|NCT01217073|79345969|FG004|Extension Period|Lack of Efficacy|0|||
44342023|NCT01217073|79345970|FG005|Extension Period|Lack of Efficacy|0|||
44342024|NCT01217073|79345971|FG006|Extension Period|Lack of Efficacy|3|||
44342025|NCT01217073|79345972|FG007|Extension Period|Lack of Efficacy|0|||
44342026|NCT01217073|79345965|FG000|Extension Period|Lost to Follow-up|0|||
44342027|NCT01217073|79345966|FG001|Extension Period|Lost to Follow-up|0|||
44342028|NCT01217073|79345967|FG002|Extension Period|Lost to Follow-up|0|||
44342029|NCT01217073|79345968|FG003|Extension Period|Lost to Follow-up|0|||
44342030|NCT01217073|79345969|FG004|Extension Period|Lost to Follow-up|0|||
44342031|NCT01217073|79345970|FG005|Extension Period|Lost to Follow-up|0|||
44342032|NCT01217073|79345971|FG006|Extension Period|Lost to Follow-up|9|||
44342033|NCT01217073|79345972|FG007|Extension Period|Lost to Follow-up|1|||
44342034|NCT01217073|79345965|FG000|Extension Period|Non-compliance with study drug|0|||
44342035|NCT01217073|79345966|FG001|Extension Period|Non-compliance with study drug|0|||
44342036|NCT01217073|79345967|FG002|Extension Period|Non-compliance with study drug|0|||
44342037|NCT01217073|79345968|FG003|Extension Period|Non-compliance with study drug|0|||
44342038|NCT01217073|79345969|FG004|Extension Period|Non-compliance with study drug|0|||
44443188|NCT00491530|79451266|FG001|Overall Study|Patient Request|1|||
44159363|NCT01360645|78951732|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
44159364|NCT01360645|78951729|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
44159365|NCT01360645|78951730|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
44342039|NCT01217073|79345970|FG005|Extension Period|Non-compliance with study drug|0|||
44342040|NCT01217073|79345971|FG006|Extension Period|Non-compliance with study drug|0|||
44342041|NCT01217073|79345972|FG007|Extension Period|Non-compliance with study drug|1|||
44342042|NCT01217073|79345965|FG000|Extension Period|Physician Decision|0|||
44342043|NCT01217073|79345966|FG001|Extension Period|Physician Decision|0|||
44342044|NCT01217073|79345967|FG002|Extension Period|Physician Decision|0|||
44443189|NCT00491530|79451267|FG002|Overall Study|Patient Request|0|||
44443190|NCT00491530|79451265|FG000|Overall Study|Use of Prohibited Medication|0|||
44443191|NCT00491530|79451266|FG001|Overall Study|Use of Prohibited Medication|0|||
44443192|NCT00491530|79451267|FG002|Overall Study|Use of Prohibited Medication|1|||
44443193|NCT00617240|79451277|FG000|Overall Study|Lack of Efficacy|1|||
44443194|NCT00617240|79451278|FG001|Overall Study|Lack of Efficacy|0|||
44443195|NCT00615290|79451284|FG000|Overall Study|Adverse Event|2|||
44342045|NCT01217073|79345968|FG003|Extension Period|Physician Decision|0|||
44443196|NCT00615290|79451284|FG000|Overall Study|Lost to Follow-up|3|||
44443197|NCT00615290|79451284|FG000|Overall Study|Withdrawal by Subject|1|||
44443198|NCT00615290|79451284|FG000|Overall Study|Other|2|||
44443199|NCT00501046|79451290|FG000|Overall Study|Adverse Event|21|||
44443200|NCT00501046|79451291|FG001|Overall Study|Adverse Event|25|||
44443201|NCT00501046|79451290|FG000|Overall Study|Death|23|||
44443202|NCT00501046|79451291|FG001|Overall Study|Death|30|||
44443203|NCT00501046|79451290|FG000|Overall Study|Lost to Follow-up|14|||
44443204|NCT00501046|79451291|FG001|Overall Study|Lost to Follow-up|13|||
44443205|NCT00501046|79451290|FG000|Overall Study|Physician Decision|7|||
44443206|NCT00501046|79451291|FG001|Overall Study|Physician Decision|2|||
44443207|NCT00501046|79451290|FG000|Overall Study|Pregnancy|0|||
44443208|NCT00501046|79451291|FG001|Overall Study|Pregnancy|3|||
44443209|NCT00501046|79451290|FG000|Overall Study|Protocol Violation|2|||
44443210|NCT00501046|79451291|FG001|Overall Study|Protocol Violation|1|||
44443211|NCT00501046|79451290|FG000|Overall Study|Withdrawal by Subject|84|||
44443212|NCT00501046|79451291|FG001|Overall Study|Withdrawal by Subject|83|||
44443213|NCT00501046|79451290|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
44443214|NCT00501046|79451291|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
44443215|NCT00533949|79451301|FG000|Overall Study|Protocol Violation|12|||
44443216|NCT00533949|79451302|FG001|Overall Study|Protocol Violation|12|||
44443217|NCT00533949|79451303|FG002|Overall Study|Protocol Violation|9|||
44443218|NCT00533949|79451304|FG003|Overall Study|Protocol Violation|9|||
44443219|NCT00533949|79451301|FG000|Overall Study|Withdrawal by Subject|3|||
44443220|NCT00533949|79451302|FG001|Overall Study|Withdrawal by Subject|2|||
44443221|NCT00533949|79451303|FG002|Overall Study|Withdrawal by Subject|1|||
44443222|NCT00533949|79451304|FG003|Overall Study|Withdrawal by Subject|1|||
44443223|NCT00485134|79451330|FG000|Overall Study|Lost to Follow-up|1|||
44443224|NCT00485134|79451331|FG001|Overall Study|Lost to Follow-up|0|||
44443225|NCT00485134|79451332|FG002|Overall Study|Lost to Follow-up|0|||
44443226|NCT00485134|79451333|FG003|Overall Study|Lost to Follow-up|0|||
44443227|NCT00485134|79451334|FG004|Overall Study|Lost to Follow-up|0|||
44443228|NCT00485134|79451335|FG005|Overall Study|Lost to Follow-up|0|||
44443229|NCT00485134|79451336|FG006|Overall Study|Lost to Follow-up|0|||
44443230|NCT00485134|79451337|FG007|Overall Study|Lost to Follow-up|0|||
44443231|NCT00485134|79451330|FG000|Overall Study|Withdrawal by Subject|0|||
44443232|NCT00485134|79451331|FG001|Overall Study|Withdrawal by Subject|1|||
44443233|NCT00485134|79451332|FG002|Overall Study|Withdrawal by Subject|0|||
44443234|NCT00485134|79451333|FG003|Overall Study|Withdrawal by Subject|0|||
44443235|NCT00485134|79451334|FG004|Overall Study|Withdrawal by Subject|0|||
44443236|NCT00485134|79451335|FG005|Overall Study|Withdrawal by Subject|0|||
44443237|NCT00485134|79451336|FG006|Overall Study|Withdrawal by Subject|0|||
44443238|NCT00485134|79451337|FG007|Overall Study|Withdrawal by Subject|0|||
44443239|NCT00485134|79451330|FG000|Overall Study|Change in health status|0|||
44443240|NCT00485134|79451331|FG001|Overall Study|Change in health status|1|||
44443241|NCT00485134|79451332|FG002|Overall Study|Change in health status|2|||
44443242|NCT00485134|79451333|FG003|Overall Study|Change in health status|1|||
44443243|NCT00485134|79451334|FG004|Overall Study|Change in health status|0|||
44443244|NCT00485134|79451335|FG005|Overall Study|Change in health status|1|||
44443245|NCT00485134|79451336|FG006|Overall Study|Change in health status|0|||
44443246|NCT00485134|79451337|FG007|Overall Study|Change in health status|0|||
44443247|NCT00485134|79451330|FG000|Overall Study|Withdrew for adverse event|0|||
44443248|NCT00485134|79451331|FG001|Overall Study|Withdrew for adverse event|0|||
44443249|NCT00485134|79451332|FG002|Overall Study|Withdrew for adverse event|1|||
44443250|NCT00485134|79451333|FG003|Overall Study|Withdrew for adverse event|0|||
44443251|NCT00485134|79451334|FG004|Overall Study|Withdrew for adverse event|0|||
44443252|NCT00485134|79451335|FG005|Overall Study|Withdrew for adverse event|0|||
44443253|NCT00485134|79451336|FG006|Overall Study|Withdrew for adverse event|0|||
44443254|NCT00485134|79451337|FG007|Overall Study|Withdrew for adverse event|0|||
44443255|NCT00485134|79451330|FG000|Overall Study|Positive drug test|0|||
44443256|NCT00485134|79451331|FG001|Overall Study|Positive drug test|0|||
44443257|NCT00485134|79451332|FG002|Overall Study|Positive drug test|0|||
44443258|NCT00485134|79451333|FG003|Overall Study|Positive drug test|0|||
44443259|NCT00485134|79451334|FG004|Overall Study|Positive drug test|2|||
44443260|NCT00485134|79451335|FG005|Overall Study|Positive drug test|1|||
44443261|NCT00485134|79451336|FG006|Overall Study|Positive drug test|0|||
44443262|NCT00485134|79451337|FG007|Overall Study|Positive drug test|0|||
44159366|NCT01360645|78951731|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
44159367|NCT01360645|78951732|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
44159368|NCT01360645|78951729|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
44443263|NCT00485134|79451330|FG000|Overall Study|Non-compliance|0|||
44443264|NCT00485134|79451331|FG001|Overall Study|Non-compliance|0|||
44443265|NCT00485134|79451332|FG002|Overall Study|Non-compliance|0|||
44443266|NCT00485134|79451333|FG003|Overall Study|Non-compliance|0|||
44443267|NCT00485134|79451334|FG004|Overall Study|Non-compliance|1|||
44443268|NCT00485134|79451335|FG005|Overall Study|Non-compliance|2|||
44443269|NCT00485134|79451336|FG006|Overall Study|Non-compliance|2|||
44443270|NCT00485134|79451337|FG007|Overall Study|Non-compliance|0|||
44443271|NCT00485134|79451330|FG000|Overall Study|Unable to comply with study schedule|0|||
44159369|NCT01360645|78951730|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
44159370|NCT01360645|78951731|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
44159371|NCT01360645|78951732|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
44159372|NCT01360645|78951729|FG000|Phase B (6 Weeks)|Adverse Event|0|||
44443272|NCT00485134|79451331|FG001|Overall Study|Unable to comply with study schedule|0|||
44443273|NCT00485134|79451332|FG002|Overall Study|Unable to comply with study schedule|0|||
44443274|NCT00485134|79451333|FG003|Overall Study|Unable to comply with study schedule|0|||
44443275|NCT00485134|79451334|FG004|Overall Study|Unable to comply with study schedule|0|||
44443276|NCT00485134|79451335|FG005|Overall Study|Unable to comply with study schedule|0|||
44443277|NCT00485134|79451336|FG006|Overall Study|Unable to comply with study schedule|0|||
44443278|NCT00485134|79451337|FG007|Overall Study|Unable to comply with study schedule|1|||
44443279|NCT00485134|79451330|FG000|Overall Study|Pregnancy|0|||
44443280|NCT00485134|79451331|FG001|Overall Study|Pregnancy|0|||
44443281|NCT00485134|79451332|FG002|Overall Study|Pregnancy|0|||
44443282|NCT00485134|79451333|FG003|Overall Study|Pregnancy|0|||
44443283|NCT00485134|79451334|FG004|Overall Study|Pregnancy|0|||
44443284|NCT00485134|79451335|FG005|Overall Study|Pregnancy|0|||
44443285|NCT00485134|79451336|FG006|Overall Study|Pregnancy|1|||
44443286|NCT00485134|79451337|FG007|Overall Study|Pregnancy|0|||
44443287|NCT00583115|79451349|FG000|Overall Study|Death|1|||
44443288|NCT00532779|79451356|FG000|Overall Study|Adverse Event|122|||
44443289|NCT00532779|79451357|FG001|Overall Study|Adverse Event|112|||
44443290|NCT00532779|79451358|FG002|Overall Study|Adverse Event|56|||
44443291|NCT00532779|79451356|FG000|Overall Study|Lost to Follow-up|76|||
44443292|NCT00532779|79451357|FG001|Overall Study|Lost to Follow-up|65|||
44443293|NCT00532779|79451358|FG002|Overall Study|Lost to Follow-up|66|||
44443294|NCT00532779|79451356|FG000|Overall Study|Withdrawal by Subject|63|||
44443295|NCT00532779|79451357|FG001|Overall Study|Withdrawal by Subject|60|||
44443296|NCT00532779|79451358|FG002|Overall Study|Withdrawal by Subject|90|||
44443297|NCT00532779|79451356|FG000|Overall Study|Lack of Efficacy|12|||
44443298|NCT00532779|79451357|FG001|Overall Study|Lack of Efficacy|12|||
44443299|NCT00532779|79451358|FG002|Overall Study|Lack of Efficacy|40|||
44443300|NCT00532779|79451356|FG000|Overall Study|Protocol Violation|5|||
44443301|NCT00532779|79451357|FG001|Overall Study|Protocol Violation|9|||
44443302|NCT00532779|79451358|FG002|Overall Study|Protocol Violation|7|||
44443303|NCT00532779|79451356|FG000|Overall Study|Pregnancy|2|||
44443304|NCT00532779|79451357|FG001|Overall Study|Pregnancy|5|||
44443305|NCT00532779|79451358|FG002|Overall Study|Pregnancy|3|||
44443306|NCT00532779|79451356|FG000|Overall Study|Death|0|||
44443307|NCT00532779|79451357|FG001|Overall Study|Death|1|||
44443308|NCT00532779|79451358|FG002|Overall Study|Death|0|||
44443309|NCT00532779|79451356|FG000|Overall Study|Drug noncompliance, moved, other|14|||
44443310|NCT00532779|79451357|FG001|Overall Study|Drug noncompliance, moved, other|23|||
44443311|NCT00532779|79451358|FG002|Overall Study|Drug noncompliance, moved, other|29|||
44159373|NCT01360645|78951730|FG001|Phase B (6 Weeks)|Adverse Event|6|||
44159374|NCT01360645|78951731|FG002|Phase B (6 Weeks)|Adverse Event|0|||
44443312|NCT00500266|79451366|FG000|Overall Study|Death|3|||
44443313|NCT00500266|79451366|FG000|Overall Study|Lost to Follow-up|3|||
44443314|NCT00500266|79451366|FG000|Overall Study|Withdrawal by Subject|3|||
44443315|NCT00500266|79451366|FG000|Overall Study|Assigned, not treated|4|||
44443316|NCT00500110|79451371|FG000|Overall Study|Withdrawal by Subject|3|||
44443317|NCT00534495|79451377|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
44443318|NCT00534495|79451378|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
44443319|NCT00534495|79451379|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
44443320|NCT00534495|79451377|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
44443321|NCT00534495|79451378|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
44159375|NCT01360645|78951732|FG003|Phase B (6 Weeks)|Adverse Event|0|||
44443322|NCT00534495|79451379|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
44342046|NCT01217073|79345969|FG004|Extension Period|Physician Decision|0|||
44342047|NCT01217073|79345970|FG005|Extension Period|Physician Decision|0|||
44342048|NCT01217073|79345971|FG006|Extension Period|Physician Decision|4|||
44342049|NCT01217073|79345972|FG007|Extension Period|Physician Decision|1|||
44342050|NCT01217073|79345965|FG000|Extension Period|Protocol Violation|0|||
44342051|NCT01217073|79345966|FG001|Extension Period|Protocol Violation|0|||
44443323|NCT00534495|79451377|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
44443324|NCT00534495|79451378|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
44443325|NCT00534495|79451379|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
44443326|NCT00534495|79451377|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
44443327|NCT00534495|79451378|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
44443328|NCT00534495|79451379|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
44443329|NCT00534495|79451377|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
44443330|NCT00534495|79451378|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
44443331|NCT00534495|79451379|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
44443332|NCT00534495|79451377|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
44443333|NCT00534495|79451378|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
44443334|NCT00534495|79451379|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
44443335|NCT00534495|79451377|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
44443336|NCT00534495|79451378|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
44443337|NCT00534495|79451379|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
44443338|NCT00534495|79451377|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
44443339|NCT00534495|79451378|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
44443340|NCT00534495|79451379|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
44443341|NCT00534495|79451377|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
44443342|NCT00534495|79451378|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
44443343|NCT00534495|79451379|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
44443344|NCT00484198|79451403|FG000|Overall Study|Participant Withdrew Consent|12|||
44443345|NCT00484198|79451404|FG001|Overall Study|Participant Withdrew Consent|21|||
44443346|NCT00484198|79451405|FG002|Overall Study|Participant Withdrew Consent|47|||
44443347|NCT00484198|79451406|FG003|Overall Study|Participant Withdrew Consent|59|||
44443348|NCT00484198|79451403|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
44443349|NCT00484198|79451404|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
44443350|NCT00484198|79451405|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
44443351|NCT00484198|79451406|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
44443352|NCT00484198|79451403|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
44443353|NCT00484198|79451404|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
44443354|NCT00484198|79451405|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
44443355|NCT00484198|79451406|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
44342052|NCT01217073|79345967|FG002|Extension Period|Protocol Violation|0|||
44342053|NCT01217073|79345968|FG003|Extension Period|Protocol Violation|0|||
44342054|NCT01217073|79345969|FG004|Extension Period|Protocol Violation|0|||
44342055|NCT01217073|79345970|FG005|Extension Period|Protocol Violation|0|||
44342056|NCT01217073|79345971|FG006|Extension Period|Protocol Violation|2|||
44342057|NCT01217073|79345972|FG007|Extension Period|Protocol Violation|1|||
44443356|NCT00484198|79451403|FG000|Overall Study|Adverse Event|3|||
44443357|NCT00484198|79451404|FG001|Overall Study|Adverse Event|11|||
44443358|NCT00484198|79451405|FG002|Overall Study|Adverse Event|32|||
44443359|NCT00484198|79451406|FG003|Overall Study|Adverse Event|31|||
44443360|NCT00484198|79451403|FG000|Overall Study|Protocol Violation|0|||
44443361|NCT00484198|79451404|FG001|Overall Study|Protocol Violation|5|||
44443362|NCT00484198|79451405|FG002|Overall Study|Protocol Violation|6|||
44443363|NCT00484198|79451406|FG003|Overall Study|Protocol Violation|8|||
44443364|NCT00484198|79451403|FG000|Overall Study|Other|7|||
44443365|NCT00484198|79451404|FG001|Overall Study|Other|10|||
44443366|NCT00484198|79451405|FG002|Overall Study|Other|31|||
44443367|NCT00484198|79451406|FG003|Overall Study|Other|28|||
44443368|NCT00499486|79451421|FG000|Overall Study|Withdrawal by Subject|16|||
44443369|NCT00499252|79451425|FG000|Overall Study|Adverse Event|3|||
44443370|NCT00499252|79451425|FG000|Overall Study|Refused further treatment|2|||
44443371|NCT00499252|79451425|FG000|Overall Study|Ineligible|4|||
44443372|NCT00499252|79451425|FG000|Overall Study|<no further label>|3|||
44443373|NCT00499174|79451435|FG000|Overall Study|Physician Decision|78|||
44443374|NCT00499174|79451436|FG001|Overall Study|Physician Decision|9|||
44443375|NCT03775421|79451444|FG000|Overall Study|Lost to Follow-up|2|||
44443376|NCT03775421|79451444|FG000|Overall Study|Withdrawal by Subject|10|||
44443377|NCT03775421|79451444|FG000|Overall Study|Physician Decision|3|||
44342058|NCT01217073|79345965|FG000|Extension Period|Site discontinued study participation|0|||
44342059|NCT01217073|79345966|FG001|Extension Period|Site discontinued study participation|0|||
44342060|NCT01217073|79345967|FG002|Extension Period|Site discontinued study participation|0|||
44342061|NCT01217073|79345968|FG003|Extension Period|Site discontinued study participation|0|||
44342062|NCT01217073|79345969|FG004|Extension Period|Site discontinued study participation|0|||
44342063|NCT01217073|79345970|FG005|Extension Period|Site discontinued study participation|0|||
44342064|NCT01217073|79345971|FG006|Extension Period|Site discontinued study participation|7|||
44342065|NCT01217073|79345972|FG007|Extension Period|Site discontinued study participation|2|||
44342066|NCT01217073|79345965|FG000|Extension Period|Withdrawal by Subject|0|||
44342067|NCT01217073|79345966|FG001|Extension Period|Withdrawal by Subject|0|||
44342068|NCT01217073|79345967|FG002|Extension Period|Withdrawal by Subject|0|||
44342069|NCT01217073|79345968|FG003|Extension Period|Withdrawal by Subject|0|||
44342070|NCT01217073|79345969|FG004|Extension Period|Withdrawal by Subject|0|||
44342071|NCT01217073|79345970|FG005|Extension Period|Withdrawal by Subject|0|||
44342072|NCT01217073|79345971|FG006|Extension Period|Withdrawal by Subject|30|||
44342073|NCT01217073|79345972|FG007|Extension Period|Withdrawal by Subject|8|||
44342074|NCT00985621|79346000|FG000|Overall Study|Adverse Event|2|||
44342075|NCT00985621|79346001|FG001|Overall Study|Adverse Event|3|||
44342076|NCT00985621|79346002|FG002|Overall Study|Adverse Event|4|||
44342077|NCT00985621|79346003|FG003|Overall Study|Adverse Event|16|||
44342078|NCT00985621|79346000|FG000|Overall Study|Lack of Efficacy|10|||
44342079|NCT00985621|79346001|FG001|Overall Study|Lack of Efficacy|6|||
44342080|NCT00985621|79346002|FG002|Overall Study|Lack of Efficacy|5|||
44342081|NCT00985621|79346003|FG003|Overall Study|Lack of Efficacy|12|||
44443378|NCT03775421|79451444|FG000|Overall Study|Death|1|||
44443379|NCT03775421|79451444|FG000|Overall Study|Study Terminated by Sponsor|94|||
44443380|NCT00532155|79451450|FG000|Overall Study|Adverse Event|66|||
44443381|NCT00532155|79451451|FG001|Overall Study|Adverse Event|123|||
44443382|NCT00532155|79451450|FG000|Overall Study|Lack of Efficacy|332|||
44443383|NCT00532155|79451451|FG001|Overall Study|Lack of Efficacy|255|||
44443384|NCT00532155|79451450|FG000|Overall Study|Protocol Violation|1|||
44443385|NCT00532155|79451451|FG001|Overall Study|Protocol Violation|3|||
44443386|NCT00532155|79451450|FG000|Overall Study|Lost to Follow-up|2|||
44443387|NCT00532155|79451451|FG001|Overall Study|Lost to Follow-up|0|||
44443388|NCT00532155|79451450|FG000|Overall Study|Physician Decision|16|||
44443389|NCT00532155|79451451|FG001|Overall Study|Physician Decision|15|||
44443390|NCT00532155|79451450|FG000|Overall Study|Withdrawal by Subject|23|||
44443391|NCT00532155|79451451|FG001|Overall Study|Withdrawal by Subject|44|||
44443392|NCT00532155|79451450|FG000|Overall Study|Consent withdrawn|5|||
44443393|NCT00532155|79451451|FG001|Overall Study|Consent withdrawn|7|||
44443394|NCT00532155|79451450|FG000|Overall Study|Moved|1|||
44443395|NCT00532155|79451451|FG001|Overall Study|Moved|0|||
44443396|NCT00532155|79451450|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
44443397|NCT00532155|79451451|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
44443398|NCT00532155|79451450|FG000|Overall Study|Occurence of a second cancer|0|||
44443399|NCT00532155|79451451|FG001|Overall Study|Occurence of a second cancer|1|||
44443400|NCT00532155|79451450|FG000|Overall Study|Occurence of a secondary cancer|0|||
44443401|NCT00532155|79451451|FG001|Overall Study|Occurence of a secondary cancer|1|||
44443402|NCT00532155|79451450|FG000|Overall Study|Promotor ended study|1|||
44443403|NCT00532155|79451451|FG001|Overall Study|Promotor ended study|0|||
44443404|NCT00532155|79451450|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
44443405|NCT00532155|79451451|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
44443406|NCT00532155|79451450|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
44443407|NCT00532155|79451451|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
44443408|NCT00532155|79451450|FG000|Overall Study|Study stopped|1|||
44443409|NCT00532155|79451451|FG001|Overall Study|Study stopped|0|||
44443410|NCT00532155|79451450|FG000|Overall Study|Study terminated by sponsor|1|||
44443411|NCT00532155|79451451|FG001|Overall Study|Study terminated by sponsor|0|||
44443412|NCT00532155|79451450|FG000|Overall Study|Study termination stop further treatment|4|||
44443413|NCT00532155|79451451|FG001|Overall Study|Study termination stop further treatment|0|||
44443414|NCT00532155|79451450|FG000|Overall Study|Did not receive study medication|2|||
44443415|NCT00532155|79451451|FG001|Overall Study|Did not receive study medication|6|||
44443416|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
44443417|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
44443418|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
44443419|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
44443420|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
44443421|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
44443422|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Death|9|||
44443423|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Death|7|||
44443424|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Death|14|||
44443425|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Death|7|||
44443426|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Death|0|||
44443427|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Death|0|||
44443428|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
44443429|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
44443430|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
44443431|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
44443432|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
44443433|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
44443434|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Other Event|49|||
44443435|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Other Event|52|||
44443436|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Other Event|41|||
44443437|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Other Event|58|||
44443438|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Other Event|0|||
44443439|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Other Event|0|||
44443440|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
44443441|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
44443442|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
44443443|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
44443444|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
44443445|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
44443446|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
44443447|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
44443448|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
44443449|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
44443450|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
44443451|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
44443452|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
44443453|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
44443454|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
44443455|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
44443456|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
44443457|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
44443458|NCT00205777|79451461|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
44443459|NCT00205777|79451462|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
44443460|NCT00205777|79451463|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
44443461|NCT00205777|79451464|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
44443462|NCT00205777|79451465|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
44443463|NCT00205777|79451466|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
44443464|NCT00205777|79451461|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
44443465|NCT00205777|79451462|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
44443466|NCT00205777|79451463|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
44443467|NCT00205777|79451464|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
44443468|NCT00205777|79451465|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
44443469|NCT00205777|79451466|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
44443470|NCT00205777|79451461|FG000|Completed Core Study, Entered SE I|Other Event|52|||
44443471|NCT00205777|79451462|FG001|Completed Core Study, Entered SE I|Other Event|46|||
44443472|NCT00205777|79451463|FG002|Completed Core Study, Entered SE I|Other Event|47|||
44443473|NCT00205777|79451464|FG003|Completed Core Study, Entered SE I|Other Event|50|||
44443474|NCT00205777|79451465|FG004|Completed Core Study, Entered SE I|Other Event|0|||
44443475|NCT00205777|79451466|FG005|Completed Core Study, Entered SE I|Other Event|0|||
44443476|NCT00205777|79451461|FG000|Study Extension I|Adverse Event|57|||
44443477|NCT00205777|79451462|FG001|Study Extension I|Adverse Event|0|||
44443478|NCT00205777|79451463|FG002|Study Extension I|Adverse Event|0|||
44443479|NCT00205777|79451464|FG003|Study Extension I|Adverse Event|61|||
44443480|NCT00205777|79451465|FG004|Study Extension I|Adverse Event|58|||
44443481|NCT00205777|79451466|FG005|Study Extension I|Adverse Event|0|||
44159376|NCT01360645|78951729|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
44259814|NCT01279057|79123530|FG001|Overall Study|Pregnancy|1|||
44342082|NCT00985621|79346000|FG000|Overall Study|Lost to Follow-up|2|||
44342083|NCT00985621|79346001|FG001|Overall Study|Lost to Follow-up|3|||
44342084|NCT00985621|79346002|FG002|Overall Study|Lost to Follow-up|4|||
44342085|NCT00985621|79346003|FG003|Overall Study|Lost to Follow-up|4|||
44342086|NCT00985621|79346000|FG000|Overall Study|Study Terminated by Sponsor|89|||
44342087|NCT00985621|79346001|FG001|Overall Study|Study Terminated by Sponsor|108|||
44342088|NCT00985621|79346002|FG002|Overall Study|Study Terminated by Sponsor|99|||
44443482|NCT00205777|79451461|FG000|Study Extension I|Death|5|||
44443483|NCT00205777|79451462|FG001|Study Extension I|Death|0|||
44443484|NCT00205777|79451463|FG002|Study Extension I|Death|0|||
44443485|NCT00205777|79451464|FG003|Study Extension I|Death|1|||
44443486|NCT00205777|79451465|FG004|Study Extension I|Death|2|||
44443487|NCT00205777|79451466|FG005|Study Extension I|Death|0|||
44342089|NCT00985621|79346003|FG003|Overall Study|Study Terminated by Sponsor|92|||
44443488|NCT00205777|79451461|FG000|Study Extension I|Withdrawal by Subject|99|||
44443489|NCT00205777|79451462|FG001|Study Extension I|Withdrawal by Subject|0|||
44443490|NCT00205777|79451463|FG002|Study Extension I|Withdrawal by Subject|0|||
44443491|NCT00205777|79451464|FG003|Study Extension I|Withdrawal by Subject|106|||
44443492|NCT00205777|79451465|FG004|Study Extension I|Withdrawal by Subject|89|||
44443493|NCT00205777|79451466|FG005|Study Extension I|Withdrawal by Subject|0|||
44443494|NCT00205777|79451461|FG000|Study Extension I|Protocol Violation|4|||
44443495|NCT00205777|79451462|FG001|Study Extension I|Protocol Violation|0|||
44443496|NCT00205777|79451463|FG002|Study Extension I|Protocol Violation|0|||
44443497|NCT00205777|79451464|FG003|Study Extension I|Protocol Violation|8|||
44443498|NCT00205777|79451465|FG004|Study Extension I|Protocol Violation|8|||
44443499|NCT00205777|79451466|FG005|Study Extension I|Protocol Violation|0|||
44443500|NCT00205777|79451461|FG000|Study Extension I|Lack of Efficacy|0|||
44443501|NCT00205777|79451462|FG001|Study Extension I|Lack of Efficacy|0|||
44443502|NCT00205777|79451463|FG002|Study Extension I|Lack of Efficacy|0|||
44443503|NCT00205777|79451464|FG003|Study Extension I|Lack of Efficacy|1|||
44443504|NCT00205777|79451465|FG004|Study Extension I|Lack of Efficacy|2|||
44443505|NCT00205777|79451466|FG005|Study Extension I|Lack of Efficacy|0|||
44443506|NCT00205777|79451461|FG000|Study Extension I|Failed to return|15|||
44443507|NCT00205777|79451462|FG001|Study Extension I|Failed to return|0|||
44342090|NCT00985621|79346000|FG000|Overall Study|Protocol Violation|1|||
44342091|NCT00985621|79346001|FG001|Overall Study|Protocol Violation|1|||
44342092|NCT00985621|79346002|FG002|Overall Study|Protocol Violation|1|||
44342093|NCT00985621|79346003|FG003|Overall Study|Protocol Violation|0|||
44342094|NCT00985621|79346000|FG000|Overall Study|Withdrawal by Subject|8|||
44342095|NCT00985621|79346001|FG001|Overall Study|Withdrawal by Subject|10|||
44342096|NCT00985621|79346002|FG002|Overall Study|Withdrawal by Subject|8|||
44342097|NCT00985621|79346003|FG003|Overall Study|Withdrawal by Subject|12|||
44443508|NCT00205777|79451463|FG002|Study Extension I|Failed to return|0|||
44342098|NCT00985621|79346000|FG000|Overall Study|Other|1|||
44443509|NCT00205777|79451464|FG003|Study Extension I|Failed to return|17|||
44443510|NCT00205777|79451465|FG004|Study Extension I|Failed to return|13|||
44443511|NCT00205777|79451466|FG005|Study Extension I|Failed to return|0|||
44443512|NCT00205777|79451461|FG000|Study Extension I|Other Event|34|||
44342099|NCT00985621|79346001|FG001|Overall Study|Other|0|||
44443513|NCT00205777|79451462|FG001|Study Extension I|Other Event|0|||
44159377|NCT01360645|78951730|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
44443514|NCT00205777|79451463|FG002|Study Extension I|Other Event|0|||
44443515|NCT00205777|79451464|FG003|Study Extension I|Other Event|34|||
44443516|NCT00205777|79451465|FG004|Study Extension I|Other Event|29|||
44443517|NCT00205777|79451466|FG005|Study Extension I|Other Event|0|||
44443518|NCT00205777|79451461|FG000|Study Extension I|Withdrawn as per protocol|0|||
44443519|NCT00205777|79451462|FG001|Study Extension I|Withdrawn as per protocol|0|||
44443520|NCT00205777|79451463|FG002|Study Extension I|Withdrawn as per protocol|1070|||
44443521|NCT00205777|79451464|FG003|Study Extension I|Withdrawn as per protocol|0|||
44443522|NCT00205777|79451465|FG004|Study Extension I|Withdrawn as per protocol|0|||
44443523|NCT00205777|79451466|FG005|Study Extension I|Withdrawn as per protocol|0|||
44443524|NCT00205777|79451461|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
44443525|NCT00205777|79451462|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
44443526|NCT00205777|79451463|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
44443527|NCT00205777|79451464|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
44443528|NCT00205777|79451465|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
44443529|NCT00205777|79451466|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
44443530|NCT00205777|79451461|FG000|Study Extension II|Adverse Event|0|||
44159378|NCT01360645|78951731|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
44443531|NCT00205777|79451462|FG001|Study Extension II|Adverse Event|0|||
44443532|NCT00205777|79451463|FG002|Study Extension II|Adverse Event|0|||
44443533|NCT00205777|79451464|FG003|Study Extension II|Adverse Event|14|||
44443534|NCT00205777|79451465|FG004|Study Extension II|Adverse Event|0|||
44443535|NCT00205777|79451466|FG005|Study Extension II|Adverse Event|30|||
44443536|NCT00205777|79451461|FG000|Study Extension II|Death|0|||
44443537|NCT00205777|79451462|FG001|Study Extension II|Death|0|||
44443538|NCT00205777|79451463|FG002|Study Extension II|Death|0|||
44443539|NCT00205777|79451464|FG003|Study Extension II|Death|2|||
44443540|NCT00205777|79451465|FG004|Study Extension II|Death|0|||
44443541|NCT00205777|79451466|FG005|Study Extension II|Death|5|||
44443542|NCT00205777|79451461|FG000|Study Extension II|Withdrawal by Subject|0|||
44443543|NCT00205777|79451462|FG001|Study Extension II|Withdrawal by Subject|0|||
44443544|NCT00205777|79451463|FG002|Study Extension II|Withdrawal by Subject|0|||
44443545|NCT00205777|79451464|FG003|Study Extension II|Withdrawal by Subject|35|||
44443546|NCT00205777|79451465|FG004|Study Extension II|Withdrawal by Subject|0|||
44443547|NCT00205777|79451466|FG005|Study Extension II|Withdrawal by Subject|59|||
44443548|NCT00205777|79451461|FG000|Study Extension II|Protocol Violation|0|||
44443549|NCT00205777|79451462|FG001|Study Extension II|Protocol Violation|0|||
44443550|NCT00205777|79451463|FG002|Study Extension II|Protocol Violation|0|||
44443551|NCT00205777|79451464|FG003|Study Extension II|Protocol Violation|1|||
44443552|NCT00205777|79451465|FG004|Study Extension II|Protocol Violation|0|||
44443553|NCT00205777|79451466|FG005|Study Extension II|Protocol Violation|10|||
44443554|NCT00205777|79451461|FG000|Study Extension II|Lack of Efficacy|0|||
44443555|NCT00205777|79451462|FG001|Study Extension II|Lack of Efficacy|0|||
44443556|NCT00205777|79451463|FG002|Study Extension II|Lack of Efficacy|0|||
44443557|NCT00205777|79451464|FG003|Study Extension II|Lack of Efficacy|0|||
44443558|NCT00205777|79451465|FG004|Study Extension II|Lack of Efficacy|0|||
44443559|NCT00205777|79451466|FG005|Study Extension II|Lack of Efficacy|1|||
44443560|NCT00205777|79451461|FG000|Study Extension II|Failed to return|0|||
44443561|NCT00205777|79451462|FG001|Study Extension II|Failed to return|0|||
44443562|NCT00205777|79451463|FG002|Study Extension II|Failed to return|0|||
44443563|NCT00205777|79451464|FG003|Study Extension II|Failed to return|14|||
44443564|NCT00205777|79451465|FG004|Study Extension II|Failed to return|0|||
44443565|NCT00205777|79451466|FG005|Study Extension II|Failed to return|26|||
44443566|NCT00205777|79451461|FG000|Study Extension II|Other Event|0|||
44443567|NCT00205777|79451462|FG001|Study Extension II|Other Event|0|||
44443568|NCT00205777|79451463|FG002|Study Extension II|Other Event|0|||
44443569|NCT00205777|79451464|FG003|Study Extension II|Other Event|12|||
44443570|NCT00205777|79451465|FG004|Study Extension II|Other Event|0|||
44443571|NCT00205777|79451466|FG005|Study Extension II|Other Event|20|||
44443572|NCT00205777|79451461|FG000|Study Extension II|Enrolled but not treated|0|||
44443573|NCT00205777|79451462|FG001|Study Extension II|Enrolled but not treated|0|||
44443574|NCT00205777|79451463|FG002|Study Extension II|Enrolled but not treated|0|||
44443575|NCT00205777|79451464|FG003|Study Extension II|Enrolled but not treated|71|||
44443576|NCT00205777|79451465|FG004|Study Extension II|Enrolled but not treated|0|||
44443577|NCT00205777|79451466|FG005|Study Extension II|Enrolled but not treated|131|||
44443578|NCT00483652|79451483|FG000|Double-blind Treatment Period|Protocol Violation|2|||
44443579|NCT00483652|79451484|FG001|Double-blind Treatment Period|Protocol Violation|1|||
44443580|NCT00483652|79451483|FG000|Double-blind Treatment Period|Adverse Event|3|||
44443581|NCT00483652|79451484|FG001|Double-blind Treatment Period|Adverse Event|4|||
44443582|NCT00483652|79451483|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
44443583|NCT00483652|79451484|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
44443584|NCT00483652|79451483|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
44443585|NCT00483652|79451484|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
44443586|NCT00483574|79451492|FG000|Overall Study|Adverse Event|6|||
44443587|NCT00483574|79451493|FG001|Overall Study|Adverse Event|0|||
44443588|NCT00483574|79451492|FG000|Overall Study|Protocol Violation|28|||
44443589|NCT00483574|79451493|FG001|Overall Study|Protocol Violation|9|||
44443590|NCT00483574|79451492|FG000|Overall Study|Lost to Follow-up|16|||
44443591|NCT00483574|79451493|FG001|Overall Study|Lost to Follow-up|4|||
44443592|NCT00483574|79451492|FG000|Overall Study|Withdrawal by Subject|52|||
44443593|NCT00483574|79451493|FG001|Overall Study|Withdrawal by Subject|0|||
44443594|NCT00483184|79451504|FG000|Overall Study|Withdrawal by Subject|2|||
44443595|NCT00483184|79451505|FG001|Overall Study|Withdrawal by Subject|2|||
44443596|NCT00483184|79451506|FG002|Overall Study|Withdrawal by Subject|0|||
44443597|NCT00483184|79451504|FG000|Overall Study|Lost to Follow-up|1|||
44443598|NCT00483184|79451505|FG001|Overall Study|Lost to Follow-up|0|||
44443599|NCT00483184|79451506|FG002|Overall Study|Lost to Follow-up|0|||
44443600|NCT00483184|79451504|FG000|Overall Study|Adverse Event|1|||
44443601|NCT00483184|79451505|FG001|Overall Study|Adverse Event|2|||
44443602|NCT00483184|79451506|FG002|Overall Study|Adverse Event|2|||
44443603|NCT00483184|79451504|FG000|Overall Study|Protocol Violation|1|||
44443604|NCT00483184|79451505|FG001|Overall Study|Protocol Violation|0|||
44443605|NCT00483184|79451506|FG002|Overall Study|Protocol Violation|1|||
44443606|NCT00482170|79451516|FG000|Overall Study|Adverse Event|5|||
44443607|NCT00482170|79451517|FG001|Overall Study|Adverse Event|14|||
44342100|NCT00985621|79346002|FG002|Overall Study|Other|0|||
44342101|NCT00985621|79346003|FG003|Overall Study|Other|0|||
44342102|NCT00985621|79346000|FG000|Overall Study|Randomized but not Treated|1|||
44342103|NCT00985621|79346001|FG001|Overall Study|Randomized but not Treated|0|||
44342104|NCT00985621|79346002|FG002|Overall Study|Randomized but not Treated|2|||
44342105|NCT00985621|79346003|FG003|Overall Study|Randomized but not Treated|1|||
44342106|NCT01215981|79346017|FG000|Overall Study|Physician Decision|0|||
44342107|NCT01215981|79346018|FG001|Overall Study|Physician Decision|1|||
44443608|NCT00482170|79451516|FG000|Overall Study|Withdrawal by Subject|6|||
44443609|NCT00482170|79451517|FG001|Overall Study|Withdrawal by Subject|1|||
44443610|NCT00482170|79451516|FG000|Overall Study|Protocol Violation|2|||
44443611|NCT00482170|79451517|FG001|Overall Study|Protocol Violation|3|||
44443612|NCT00482170|79451516|FG000|Overall Study|Lost to Follow-up|2|||
44443613|NCT00482170|79451517|FG001|Overall Study|Lost to Follow-up|0|||
44443614|NCT00482170|79451516|FG000|Overall Study|Unspecified reason|0|||
44443615|NCT00482170|79451517|FG001|Overall Study|Unspecified reason|2|||
44443616|NCT03883113|79451525|FG000|Overall Study|Physician Decision|4|||
44342108|NCT01215981|79346017|FG000|Overall Study|Protocol Violation|1|||
44443617|NCT03883113|79451526|FG001|Overall Study|Physician Decision|2|||
44443618|NCT03883113|79451525|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
44443619|NCT03883113|79451526|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
44443620|NCT03883113|79451525|FG000|Overall Study|Pregnancy|1|||
44443621|NCT03883113|79451526|FG001|Overall Study|Pregnancy|0|||
44443622|NCT03883113|79451525|FG000|Overall Study|Adverse Event|0|||
44443623|NCT03883113|79451526|FG001|Overall Study|Adverse Event|1|||
44443624|NCT03883113|79451525|FG000|Overall Study|Withdrawal by Subject|1|||
44259815|NCT01279057|79123531|FG002|Overall Study|Pregnancy|0|||
44259816|NCT01279057|79123529|FG000|Overall Study|Other|3|||
44259817|NCT01279057|79123530|FG001|Overall Study|Other|3|||
44259818|NCT01279057|79123531|FG002|Overall Study|Other|0|||
44259819|NCT02999633|79123539|FG000|Overall Study|Adverse Event|2|||
44259820|NCT02999633|79123539|FG000|Overall Study|Progressive disease|12|||
44259821|NCT01278745|79123641|FG000|Overall Study|Death|2|||
44259822|NCT01278745|79123642|FG001|Overall Study|Death|5|||
44259823|NCT01278745|79123643|FG002|Overall Study|Death|7|||
44259824|NCT01278745|79123644|FG003|Overall Study|Death|0|||
44259825|NCT01278745|79123641|FG000|Overall Study|Physician Decision|1|||
44259826|NCT01278745|79123642|FG001|Overall Study|Physician Decision|0|||
44259827|NCT01278745|79123643|FG002|Overall Study|Physician Decision|0|||
44259828|NCT01278745|79123644|FG003|Overall Study|Physician Decision|9|||
44259829|NCT01278745|79123641|FG000|Overall Study|Withdrawal by Subject|1|||
44259830|NCT01278745|79123642|FG001|Overall Study|Withdrawal by Subject|1|||
44259831|NCT01278745|79123643|FG002|Overall Study|Withdrawal by Subject|5|||
44259832|NCT01278745|79123644|FG003|Overall Study|Withdrawal by Subject|1|||
44259833|NCT01278745|79123641|FG000|Overall Study|Sponsor Decision|1|||
44259834|NCT01278745|79123642|FG001|Overall Study|Sponsor Decision|0|||
44259835|NCT01278745|79123643|FG002|Overall Study|Sponsor Decision|62|||
44259836|NCT01278745|79123644|FG003|Overall Study|Sponsor Decision|6|||
44259837|NCT01278745|79123641|FG000|Overall Study|Ineligible|0|||
44259838|NCT01278745|79123642|FG001|Overall Study|Ineligible|0|||
44259839|NCT01278745|79123643|FG002|Overall Study|Ineligible|42|||
44259840|NCT01278745|79123644|FG003|Overall Study|Ineligible|61|||
44259841|NCT01278745|79123641|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
44259842|NCT01278745|79123642|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
44259843|NCT01278745|79123643|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
44259844|NCT01278745|79123644|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
44259845|NCT01277887|79123706|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
44342109|NCT01215981|79346018|FG001|Overall Study|Protocol Violation|0|||
44342110|NCT01215981|79346017|FG000|Overall Study|Withdrawal by Subject|1|||
44342111|NCT01215981|79346018|FG001|Overall Study|Withdrawal by Subject|0|||
44342112|NCT01215513|79346024|FG000|Overall Study|Not completed CS42|9|||
44342113|NCT01215513|79346024|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
44342114|NCT01215513|79346024|FG000|Overall Study|Adverse event (CS42A)|2|||
44342115|NCT01215513|79346024|FG000|Overall Study|Physician decision (CS42A)|6|||
44342116|NCT01215513|79346024|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
44342117|NCT01215513|79346024|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
44342118|NCT01215435|79346031|FG000|Overall Study|Adverse Event|1|||
44342119|NCT01215435|79346032|FG001|Overall Study|Adverse Event|0|||
44342120|NCT01215435|79346031|FG000|Overall Study|Protocol Violation|2|||
44342121|NCT01215435|79346032|FG001|Overall Study|Protocol Violation|0|||
44342122|NCT01215435|79346031|FG000|Overall Study|Withdrawal Criteria|8|||
44259846|NCT01277887|79123707|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
44342123|NCT01215435|79346032|FG001|Overall Study|Withdrawal Criteria|11|||
44342124|NCT01215435|79346031|FG000|Overall Study|Lost to Follow-up|3|||
44342125|NCT01215435|79346032|FG001|Overall Study|Lost to Follow-up|0|||
44259847|NCT01277887|79123706|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
44259848|NCT01277887|79123707|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
44259849|NCT01277887|79123706|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
44259850|NCT01277887|79123707|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
44259851|NCT01276327|79123721|FG000|Overall Study|Adverse Event|1|||
44259852|NCT01276327|79123722|FG001|Overall Study|Adverse Event|3|||
44443625|NCT03883113|79451526|FG001|Overall Study|Withdrawal by Subject|2|||
44443626|NCT03883113|79451525|FG000|Overall Study|Lost to Follow-up|1|||
44259853|NCT01276327|79123721|FG000|Overall Study|Withdrawal by Subject|1|||
44259854|NCT01276327|79123722|FG001|Overall Study|Withdrawal by Subject|0|||
44259855|NCT00639002|79123835|FG000|Overall Study|Death|1|||
44259856|NCT00639002|79123835|FG000|Overall Study|Adverse Event|1|||
44259857|NCT00639002|79123835|FG000|Overall Study|Protocol Violation|1|||
44259858|NCT00639002|79123835|FG000|Overall Study|Disease progression|3|||
44259859|NCT00639002|79123835|FG000|Overall Study|Physician Decision|6|||
44259860|NCT00639002|79123835|FG000|Overall Study|Lack of Efficacy|1|||
44259861|NCT00638846|79123871|FG000|Overall Study|Adverse Event|0|||
44259862|NCT00638846|79123872|FG001|Overall Study|Adverse Event|1|||
44259863|NCT00638846|79123871|FG000|Overall Study|Lost to Follow-up|3|||
44259864|NCT00638846|79123872|FG001|Overall Study|Lost to Follow-up|2|||
44259865|NCT00638846|79123871|FG000|Overall Study|lens issue|1|||
44259866|NCT00638846|79123872|FG001|Overall Study|lens issue|3|||
44259867|NCT00638456|79123880|FG000|Overall Study|Withdrawal by Subject|6|||
44259868|NCT00638456|79123881|FG001|Overall Study|Withdrawal by Subject|2|||
44259869|NCT00638378|79123910|FG000|Overall Study|Death|2|||
44259870|NCT00638378|79123910|FG000|Overall Study|Adverse Event|1|||
44259871|NCT00638378|79123910|FG000|Overall Study|Disease progression|15|||
44259872|NCT00638378|79123910|FG000|Overall Study|Physician Decision|4|||
44259873|NCT03807349|79124087|FG000|Overall Study|Early Study Termination|9|||
44259874|NCT03802825|79124097|FG000|Overall Study|Lost to follow-up for intervention|12|||
44259875|NCT03802825|79124098|FG001|Overall Study|Lost to follow-up for intervention|3|||
44259876|NCT03802825|79124097|FG000|Overall Study|Received only 1 component of intervention|0|||
44259877|NCT03802825|79124098|FG001|Overall Study|Received only 1 component of intervention|13|||
44259878|NCT03808909|79124117|FG000|Overall Study|Lost to Follow-up|3|||
44259879|NCT03808909|79124118|FG001|Overall Study|Lost to Follow-up|0|||
44259880|NCT03802513|79124139|FG000|Overall Study|Lost to Follow-up|1|||
44259881|NCT01276223|79124330|FG000|Overall Study|Adverse Event|7|||
44259882|NCT01276223|79124331|FG001|Overall Study|Adverse Event|4|||
44259883|NCT01276223|79124332|FG002|Overall Study|Adverse Event|1|||
44259884|NCT01276223|79124330|FG000|Overall Study|Lost to Follow-up|0|||
44259885|NCT01276223|79124331|FG001|Overall Study|Lost to Follow-up|0|||
44259886|NCT01276223|79124332|FG002|Overall Study|Lost to Follow-up|1|||
44259887|NCT01276223|79124330|FG000|Overall Study|Other|0|||
44259888|NCT01276223|79124331|FG001|Overall Study|Other|0|||
44259889|NCT01276223|79124332|FG002|Overall Study|Other|1|||
44259890|NCT01276223|79124330|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
44259891|NCT01276223|79124331|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
44259892|NCT01276223|79124332|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
44259893|NCT01276223|79124330|FG000|Overall Study|Protocol Violation|1|||
44259894|NCT01276223|79124331|FG001|Overall Study|Protocol Violation|0|||
44259895|NCT01276223|79124332|FG002|Overall Study|Protocol Violation|0|||
44259896|NCT01275833|79124341|FG000|Overall Study|Study terminated|1|||
44259897|NCT01275833|79124342|FG001|Overall Study|Study terminated|1|||
44259898|NCT01275755|79124350|FG000|Double-blind Treatment Period|Adverse Event|0|||
44259899|NCT01275755|79124351|FG001|Double-blind Treatment Period|Adverse Event|2|||
44259900|NCT01275755|79124350|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
44259901|NCT01275755|79124351|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
44259902|NCT01275755|79124350|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
44259903|NCT01275755|79124351|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
44259904|NCT01275755|79124350|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
44259905|NCT01275755|79124351|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
44443627|NCT03883113|79451526|FG001|Overall Study|Lost to Follow-up|0|||
44443628|NCT04218695|79451548|FG000|Overall Study|Adverse Event|1|||
44443629|NCT04218695|79451549|FG001|Overall Study|Adverse Event|0|||
44443630|NCT00490282|79451555|FG000|Overall Study|Withdrawal by Subject|3|||
44443631|NCT00615056|79451564|FG000|Overall Study|Death|31|||
44443632|NCT00615056|79451565|FG001|Overall Study|Death|31|||
44443633|NCT00615056|79451566|FG002|Overall Study|Death|21|||
44443634|NCT00615056|79451567|FG003|Overall Study|Death|23|||
44443635|NCT00615056|79451564|FG000|Overall Study|Lost to Follow-up|1|||
44443636|NCT00615056|79451565|FG001|Overall Study|Lost to Follow-up|2|||
44443637|NCT00615056|79451566|FG002|Overall Study|Lost to Follow-up|4|||
44443638|NCT00615056|79451567|FG003|Overall Study|Lost to Follow-up|5|||
44443639|NCT00615056|79451564|FG000|Overall Study|Other|13|||
44259906|NCT01275131|79124382|FG000|Period 1|Withdrawal by Subject|1|||
44259907|NCT01275131|79124383|FG001|Period 1|Withdrawal by Subject|0|||
44259908|NCT01275131|79124384|FG002|Period 1|Withdrawal by Subject|3|||
44259909|NCT01275131|79124385|FG003|Period 1|Withdrawal by Subject|2|||
44259910|NCT01275131|79124382|FG000|Period 1|Physician Decision|1|||
44259911|NCT01275131|79124383|FG001|Period 1|Physician Decision|0|||
44259912|NCT01275131|79124384|FG002|Period 1|Physician Decision|0|||
44259913|NCT01275131|79124385|FG003|Period 1|Physician Decision|0|||
44259914|NCT01275131|79124382|FG000|Period 2 (Crossover)|Adverse Event|0|||
44259915|NCT01275131|79124383|FG001|Period 2 (Crossover)|Adverse Event|1|||
44259916|NCT01275131|79124384|FG002|Period 2 (Crossover)|Adverse Event|0|||
44443640|NCT00615056|79451565|FG001|Overall Study|Other|15|||
44443641|NCT00615056|79451566|FG002|Overall Study|Other|10|||
44443642|NCT00615056|79451567|FG003|Overall Study|Other|7|||
44443643|NCT00615056|79451564|FG000|Overall Study|Objective progression or relapse|0|||
44443644|NCT00615056|79451565|FG001|Overall Study|Objective progression or relapse|2|||
44443645|NCT00615056|79451566|FG002|Overall Study|Objective progression or relapse|0|||
44443646|NCT00615056|79451567|FG003|Overall Study|Objective progression or relapse|0|||
44443647|NCT00615056|79451564|FG000|Overall Study|Withdrawal by Subject|0|||
44443648|NCT00615056|79451565|FG001|Overall Study|Withdrawal by Subject|1|||
44443649|NCT00615056|79451566|FG002|Overall Study|Withdrawal by Subject|1|||
44443650|NCT00615056|79451567|FG003|Overall Study|Withdrawal by Subject|0|||
44443651|NCT00615056|79451564|FG000|Overall Study|Discontinued by Sponsor|1|||
44443652|NCT00615056|79451565|FG001|Overall Study|Discontinued by Sponsor|0|||
44342126|NCT01215435|79346031|FG000|Overall Study|Unclassified|5|||
44443653|NCT00615056|79451566|FG002|Overall Study|Discontinued by Sponsor|0|||
44443654|NCT00615056|79451567|FG003|Overall Study|Discontinued by Sponsor|0|||
44443655|NCT00615056|79451564|FG000|Overall Study|Randomized but not treated|3|||
44443656|NCT00615056|79451565|FG001|Overall Study|Randomized but not treated|0|||
44443657|NCT00615056|79451566|FG002|Overall Study|Randomized but not treated|0|||
44159379|NCT01360645|78951732|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
44443658|NCT00615056|79451567|FG003|Overall Study|Randomized but not treated|0|||
44443659|NCT00482014|79451581|FG000|Overall Study|Withdrawal by Subject|1|||
44443660|NCT00482014|79451582|FG001|Overall Study|Withdrawal by Subject|2|||
44443661|NCT00482014|79451583|FG002|Overall Study|Withdrawal by Subject|3|||
44443662|NCT00482014|79451584|FG003|Overall Study|Withdrawal by Subject|4|||
44443663|NCT00482014|79451581|FG000|Overall Study|Adverse Event|3|||
44443664|NCT00482014|79451582|FG001|Overall Study|Adverse Event|0|||
44443665|NCT00482014|79451583|FG002|Overall Study|Adverse Event|2|||
44443666|NCT00482014|79451584|FG003|Overall Study|Adverse Event|8|||
44443667|NCT00482014|79451581|FG000|Overall Study|Death|1|||
44159380|NCT01360645|78951729|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
44443668|NCT00482014|79451582|FG001|Overall Study|Death|2|||
44443669|NCT00482014|79451583|FG002|Overall Study|Death|1|||
44443670|NCT00482014|79451584|FG003|Overall Study|Death|4|||
44443671|NCT00482014|79451581|FG000|Overall Study|Lack of Efficacy|1|||
44443672|NCT00482014|79451582|FG001|Overall Study|Lack of Efficacy|0|||
44443673|NCT00482014|79451583|FG002|Overall Study|Lack of Efficacy|4|||
44443674|NCT00482014|79451584|FG003|Overall Study|Lack of Efficacy|6|||
44443675|NCT00482014|79451581|FG000|Overall Study|Sponsor Decision|1|||
44159381|NCT01360645|78951730|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
44159382|NCT01360645|78951731|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
44159383|NCT01360645|78951732|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
44159384|NCT01360645|78951729|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
44159385|NCT01360645|78951730|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
44159386|NCT01360645|78951731|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
44159387|NCT01360645|78951732|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
44159388|NCT01360645|78951729|FG000|Phase A+|Lost to Follow-up|0|||
44159389|NCT01360645|78951730|FG001|Phase A+|Lost to Follow-up|0|||
44159390|NCT01360645|78951731|FG002|Phase A+|Lost to Follow-up|0|||
44159391|NCT01360645|78951732|FG003|Phase A+|Lost to Follow-up|7|||
44159392|NCT01360645|78951729|FG000|Phase A+|Adverse Event|0|||
44159393|NCT01360645|78951730|FG001|Phase A+|Adverse Event|0|||
44159394|NCT01360645|78951731|FG002|Phase A+|Adverse Event|0|||
44159395|NCT01360645|78951732|FG003|Phase A+|Adverse Event|2|||
44159396|NCT01360645|78951729|FG000|Phase A+|Met Withdrawal Criteria|0|||
44159397|NCT01360645|78951730|FG001|Phase A+|Met Withdrawal Criteria|0|||
44159398|NCT01360645|78951731|FG002|Phase A+|Met Withdrawal Criteria|0|||
44159399|NCT01360645|78951732|FG003|Phase A+|Met Withdrawal Criteria|4|||
44159400|NCT01360645|78951729|FG000|Phase A+|Physician Decision|0|||
44159401|NCT01360645|78951730|FG001|Phase A+|Physician Decision|0|||
44159402|NCT01360645|78951731|FG002|Phase A+|Physician Decision|0|||
44159403|NCT01360645|78951732|FG003|Phase A+|Physician Decision|2|||
44159404|NCT01360645|78951729|FG000|Phase A+|Withdrawal by Subject|0|||
44159405|NCT01360645|78951730|FG001|Phase A+|Withdrawal by Subject|0|||
44259917|NCT01275131|79124385|FG003|Period 2 (Crossover)|Adverse Event|0|||
44259918|NCT01275131|79124382|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
44259919|NCT01275131|79124383|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
44342127|NCT01215435|79346032|FG001|Overall Study|Unclassified|5|||
44159406|NCT01360645|78951731|FG002|Phase A+|Withdrawal by Subject|0|||
44159407|NCT01360645|78951732|FG003|Phase A+|Withdrawal by Subject|5|||
44159408|NCT01360645|78951729|FG000|Phase A+|Protocol Deviation|0|||
44159409|NCT01360645|78951730|FG001|Phase A+|Protocol Deviation|0|||
44159410|NCT01360645|78951731|FG002|Phase A+|Protocol Deviation|0|||
44159411|NCT01360645|78951732|FG003|Phase A+|Protocol Deviation|4|||
44159412|NCT04336163|78951744|FG000|Overall Study|Lost to Follow-up|55|||
44159413|NCT04336163|78951745|FG001|Overall Study|Lost to Follow-up|0|||
44159414|NCT02633527|78951756|FG000|Overall Study|Failed to meet eligibility|0|||
44159415|NCT02633527|78951757|FG001|Overall Study|Failed to meet eligibility|1|||
44159416|NCT02633527|78951758|FG002|Overall Study|Failed to meet eligibility|1|||
44159417|NCT02633527|78951759|FG003|Overall Study|Failed to meet eligibility|0|||
44159418|NCT02633527|78951760|FG004|Overall Study|Failed to meet eligibility|1|||
44159419|NCT02633527|78951756|FG000|Overall Study|Adverse Event|0|||
44159420|NCT02633527|78951757|FG001|Overall Study|Adverse Event|4|||
44159421|NCT02633527|78951758|FG002|Overall Study|Adverse Event|3|||
44159422|NCT02633527|78951759|FG003|Overall Study|Adverse Event|1|||
44159423|NCT02633527|78951760|FG004|Overall Study|Adverse Event|5|||
44159424|NCT02633527|78951756|FG000|Overall Study|Lost to Follow-up|1|||
44159425|NCT02633527|78951757|FG001|Overall Study|Lost to Follow-up|2|||
44159426|NCT02633527|78951758|FG002|Overall Study|Lost to Follow-up|5|||
44159427|NCT02633527|78951759|FG003|Overall Study|Lost to Follow-up|5|||
44159428|NCT02633527|78951760|FG004|Overall Study|Lost to Follow-up|4|||
44159429|NCT02633527|78951756|FG000|Overall Study|Withdrawal by Subject|0|||
44159430|NCT02633527|78951757|FG001|Overall Study|Withdrawal by Subject|3|||
44159431|NCT02633527|78951758|FG002|Overall Study|Withdrawal by Subject|5|||
44159432|NCT02633527|78951759|FG003|Overall Study|Withdrawal by Subject|4|||
44159433|NCT02633527|78951760|FG004|Overall Study|Withdrawal by Subject|4|||
44159434|NCT02633527|78951756|FG000|Overall Study|Protocol Violation|0|||
44159435|NCT02633527|78951757|FG001|Overall Study|Protocol Violation|1|||
44159436|NCT02633527|78951758|FG002|Overall Study|Protocol Violation|1|||
44159437|NCT02633527|78951759|FG003|Overall Study|Protocol Violation|1|||
44159438|NCT02633527|78951760|FG004|Overall Study|Protocol Violation|1|||
44159439|NCT02633527|78951756|FG000|Overall Study|Physician Decision|0|||
44159440|NCT02633527|78951757|FG001|Overall Study|Physician Decision|0|||
44159441|NCT02633527|78951758|FG002|Overall Study|Physician Decision|0|||
44159442|NCT02633527|78951759|FG003|Overall Study|Physician Decision|0|||
44159443|NCT02633527|78951760|FG004|Overall Study|Physician Decision|1|||
44159444|NCT02633527|78951756|FG000|Overall Study|Administrative reason|1|||
44159445|NCT02633527|78951757|FG001|Overall Study|Administrative reason|0|||
44159446|NCT02633527|78951758|FG002|Overall Study|Administrative reason|0|||
44159447|NCT02633527|78951759|FG003|Overall Study|Administrative reason|1|||
44159448|NCT02633527|78951760|FG004|Overall Study|Administrative reason|0|||
44159449|NCT02633527|78951756|FG000|Overall Study|Multiple reasons|1|||
44159450|NCT02633527|78951757|FG001|Overall Study|Multiple reasons|0|||
44159451|NCT02633527|78951758|FG002|Overall Study|Multiple reasons|2|||
44159452|NCT02633527|78951759|FG003|Overall Study|Multiple reasons|2|||
44159453|NCT02633527|78951760|FG004|Overall Study|Multiple reasons|1|||
44159454|NCT01667549|78951777|FG000|Overall Study|Withdrawal by Subject|3|||
44159455|NCT01667549|78951778|FG001|Overall Study|Withdrawal by Subject|5|||
44159456|NCT01667549|78951779|FG002|Overall Study|Withdrawal by Subject|7|||
44159457|NCT01667549|78951780|FG003|Overall Study|Withdrawal by Subject|6|||
44159458|NCT01667549|78951781|FG004|Overall Study|Withdrawal by Subject|1|||
44159459|NCT01672801|78951820|FG000|Overall Study|Screen Failure|0|||
44159460|NCT01672801|78951821|FG001|Overall Study|Screen Failure|1|||
44159461|NCT01655901|78951827|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
44159462|NCT01655901|78951828|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
44159463|NCT01655901|78951829|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
44159464|NCT01655901|78951830|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
44159465|NCT01655901|78951831|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
44159466|NCT01655901|78951832|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
44159467|NCT01656759|78951843|FG000|Overall Study|Protocol Violation|2|||
44159468|NCT01656759|78951844|FG001|Overall Study|Protocol Violation|3|||
44159469|NCT02631577|78951852|FG000|Overall Study|Death|1|||
44159470|NCT02631577|78951853|FG001|Overall Study|Death|7|||
44159471|NCT02631577|78951852|FG000|Overall Study|Withdrawal by Subject|0|||
44159472|NCT02631577|78951853|FG001|Overall Study|Withdrawal by Subject|3|||
44159473|NCT01667081|78951861|FG000|Overall Study|Death|43|||
44159474|NCT01667081|78951862|FG001|Overall Study|Death|3|||
44159475|NCT01667081|78951861|FG000|Overall Study|Lost to Follow-up|99|||
44159476|NCT01667081|78951862|FG001|Overall Study|Lost to Follow-up|48|||
44159477|NCT01667081|78951861|FG000|Overall Study|Physician Decision|16|||
44159478|NCT01667081|78951862|FG001|Overall Study|Physician Decision|2|||
44159479|NCT01667081|78951861|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
44159480|NCT01667081|78951862|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
44159481|NCT01667081|78951861|FG000|Overall Study|Withdrawal by Subject|90|||
44159482|NCT01667081|78951862|FG001|Overall Study|Withdrawal by Subject|35|||
44443676|NCT00482014|79451582|FG001|Overall Study|Sponsor Decision|2|||
44443677|NCT00482014|79451583|FG002|Overall Study|Sponsor Decision|1|||
44443678|NCT00482014|79451584|FG003|Overall Study|Sponsor Decision|1|||
44443679|NCT03595553|79451598|FG000|Overall Study|Withdrawal by Subject|20|||
44443680|NCT03595553|79451599|FG001|Overall Study|Withdrawal by Subject|8|||
44443681|NCT03595553|79451598|FG000|Overall Study|Physician Decision|3|||
44443682|NCT03595553|79451599|FG001|Overall Study|Physician Decision|2|||
44443683|NCT03595553|79451598|FG000|Overall Study|Adverse Event|2|||
44443684|NCT03595553|79451599|FG001|Overall Study|Adverse Event|5|||
44443685|NCT03595553|79451598|FG000|Overall Study|Death|24|||
44443686|NCT03595553|79451599|FG001|Overall Study|Death|22|||
44443687|NCT03595553|79451598|FG000|Overall Study|Lost to Follow-up|6|||
44443688|NCT03595553|79451599|FG001|Overall Study|Lost to Follow-up|7|||
44443689|NCT03595553|79451598|FG000|Overall Study|Other as indicated in CSR|3|||
44443690|NCT03595553|79451599|FG001|Overall Study|Other as indicated in CSR|3|||
44443691|NCT03595553|79451598|FG000|Overall Study|Sponsor Decision|0|||
44443692|NCT03595553|79451599|FG001|Overall Study|Sponsor Decision|1|||
44159483|NCT04545619|78951879|FG000|Overall Study|due to equipment challenges|1|||
44159484|NCT02518971|78951885|FG000|Overall Study|Lost to Follow-up|0|||
44159485|NCT02518971|78951886|FG001|Overall Study|Lost to Follow-up|1|||
44443693|NCT00614822|79451605|FG000|Overall Study|Adverse Event|3|||
44342128|NCT01215357|79346038|FG000|Overall Study|Withdrawal by Subject|3|||
44342129|NCT01215357|79346038|FG000|Overall Study|Protocol Violation|9|||
44342130|NCT00984295|79346045|FG000|Overall Study|Lost to Follow-up|31|||
44342131|NCT00984295|79346046|FG001|Overall Study|Lost to Follow-up|12|||
44342132|NCT00984295|79346047|FG002|Overall Study|Lost to Follow-up|13|||
44342133|NCT00984295|79346045|FG000|Overall Study|Protocol Violation|2|||
44342134|NCT00984295|79346046|FG001|Overall Study|Protocol Violation|1|||
44342135|NCT00984295|79346047|FG002|Overall Study|Protocol Violation|4|||
44342136|NCT00984295|79346045|FG000|Overall Study|Withdrawal by Subject|18|||
44342137|NCT00984295|79346046|FG001|Overall Study|Withdrawal by Subject|9|||
44342138|NCT00984295|79346047|FG002|Overall Study|Withdrawal by Subject|12|||
44342139|NCT00984295|79346045|FG000|Overall Study|CAE - discontinued test vaccine|0|||
44342140|NCT00984295|79346046|FG001|Overall Study|CAE - discontinued test vaccine|1|||
44342141|NCT00984295|79346047|FG002|Overall Study|CAE - discontinued test vaccine|3|||
44342142|NCT00984295|79346045|FG000|Overall Study|Missed one or more blood samplings|3|||
44342143|NCT00984295|79346046|FG001|Overall Study|Missed one or more blood samplings|7|||
44342144|NCT00984295|79346047|FG002|Overall Study|Missed one or more blood samplings|2|||
44342145|NCT00984295|79346045|FG000|Overall Study|Incomplete safety follow-up|11|||
44342146|NCT00984295|79346046|FG001|Overall Study|Incomplete safety follow-up|2|||
44342147|NCT00984295|79346047|FG002|Overall Study|Incomplete safety follow-up|3|||
44342148|NCT01017952|79346059|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
44443694|NCT00529659|79451612|FG000|Overall Study|Adverse Event|8|||
44443695|NCT00529659|79451613|FG001|Overall Study|Adverse Event|7|||
44443696|NCT00529659|79451612|FG000|Overall Study|Lost to Follow-up|0|||
44443697|NCT00529659|79451613|FG001|Overall Study|Lost to Follow-up|2|||
44443698|NCT00529659|79451612|FG000|Overall Study|Physician Decision|0|||
44443699|NCT00529659|79451613|FG001|Overall Study|Physician Decision|2|||
44342149|NCT01017952|79346060|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44342150|NCT01017952|79346061|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44443700|NCT00529659|79451612|FG000|Overall Study|Protocol Violation|2|||
44443701|NCT00529659|79451613|FG001|Overall Study|Protocol Violation|6|||
44159486|NCT02518971|78951885|FG000|Overall Study|Physician Decision|6|||
44159487|NCT02518971|78951886|FG001|Overall Study|Physician Decision|6|||
44443702|NCT00529659|79451612|FG000|Overall Study|Withdrawal by Subject|1|||
44443703|NCT00529659|79451613|FG001|Overall Study|Withdrawal by Subject|6|||
44443704|NCT00143455|79451623|FG000|Cohort 1|Adverse Event|8|||
44443705|NCT00143455|79451624|FG001|Cohort 1|Adverse Event|4|||
44159488|NCT02518971|78951885|FG000|Overall Study|Protocol Violation|6|||
44443706|NCT00143455|79451625|FG002|Cohort 1|Adverse Event|0|||
44443707|NCT00143455|79451626|FG003|Cohort 1|Adverse Event|0|||
44342151|NCT01017952|79346062|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44342152|NCT01017952|79346063|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
44342153|NCT01017952|79346059|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
44342154|NCT01017952|79346060|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
44342155|NCT01017952|79346061|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
44443708|NCT00143455|79451623|FG000|Cohort 1|Death|5|||
44443709|NCT00143455|79451624|FG001|Cohort 1|Death|2|||
44443710|NCT00143455|79451625|FG002|Cohort 1|Death|0|||
44342156|NCT01017952|79346062|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
44342157|NCT01017952|79346063|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
44443711|NCT00143455|79451626|FG003|Cohort 1|Death|0|||
44443712|NCT00143455|79451623|FG000|Cohort 1|Progressive Disease|0|||
44443713|NCT00143455|79451624|FG001|Cohort 1|Progressive Disease|6|||
44342158|NCT01017952|79346059|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
44342159|NCT01017952|79346060|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
44342160|NCT01017952|79346061|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
44342161|NCT01017952|79346062|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
44159489|NCT02518971|78951886|FG001|Overall Study|Protocol Violation|4|||
44259920|NCT01275131|79124384|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
44259921|NCT01275131|79124385|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
44259922|NCT01274429|79124414|FG000|Overall Study|Study closed do to lack of funding|5|||
44443714|NCT00143455|79451625|FG002|Cohort 1|Progressive Disease|0|||
44259923|NCT01273883|79124418|FG000|First Intervention|Adverse Event|2|||
44259924|NCT01273883|79124419|FG001|First Intervention|Adverse Event|1|||
44259925|NCT01273883|79124418|FG000|Second Intervention|Lost to Follow-up|1|||
44259926|NCT01273883|79124419|FG001|Second Intervention|Lost to Follow-up|1|||
44259927|NCT01273883|79124418|FG000|Second Intervention|Lack of Efficacy|1|||
44259928|NCT01273883|79124419|FG001|Second Intervention|Lack of Efficacy|0|||
44259929|NCT01273805|79124427|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
44259930|NCT01273805|79124428|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
44259931|NCT01273181|79124438|FG000|Phase I, Dose 1|Study termination|1|||
44259932|NCT01273181|79124439|FG001|Phase I, Dose 1|Study termination|0|||
44259933|NCT01273181|79124440|FG002|Phase I, Dose 1|Study termination|0|||
44259934|NCT01273181|79124441|FG003|Phase I, Dose 1|Study termination|0|||
44259935|NCT01273181|79124438|FG000|Phase I, Dose 2|Death during treatment|0|||
44259936|NCT01273181|79124439|FG001|Phase I, Dose 2|Death during treatment|1|||
44259937|NCT01273181|79124440|FG002|Phase I, Dose 2|Death during treatment|0|||
44259938|NCT01273181|79124441|FG003|Phase I, Dose 2|Death during treatment|0|||
44259939|NCT01273181|79124438|FG000|Phase 2, Dose 1|Study termination|0|||
44259940|NCT01273181|79124439|FG001|Phase 2, Dose 1|Study termination|0|||
44259941|NCT01273181|79124440|FG002|Phase 2, Dose 1|Study termination|1|||
44259942|NCT01273181|79124441|FG003|Phase 2, Dose 1|Study termination|0|||
44259943|NCT01273181|79124438|FG000|Phase 2, Dose 2|Death during treatment|0|||
44259944|NCT01273181|79124439|FG001|Phase 2, Dose 2|Death during treatment|0|||
44259945|NCT01273181|79124440|FG002|Phase 2, Dose 2|Death during treatment|0|||
44259946|NCT01273181|79124441|FG003|Phase 2, Dose 2|Death during treatment|1|||
44259947|NCT01272947|79124457|FG000|Overall Study|Abnormal Laboratory Value|2|||
44259948|NCT01272947|79124458|FG001|Overall Study|Abnormal Laboratory Value|2|||
44259949|NCT01279343|79124466|FG000|Overall Study|Did not receive treatment|2|||
44259950|NCT01279343|79124467|FG001|Overall Study|Did not receive treatment|6|||
44259951|NCT01278797|79124473|FG000|Period 1|Adverse Event|0|||
44259952|NCT01278797|79124474|FG001|Period 1|Adverse Event|1|||
44259953|NCT01278797|79124473|FG000|Period 1|Protocol Violation|1|||
44342162|NCT01017952|79346063|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
44342163|NCT01017952|79346059|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
44443715|NCT00143455|79451626|FG003|Cohort 1|Progressive Disease|0|||
44443716|NCT00143455|79451623|FG000|Cohort 1|Withdrawal by Subject|1|||
44443717|NCT00143455|79451624|FG001|Cohort 1|Withdrawal by Subject|4|||
44443718|NCT00143455|79451625|FG002|Cohort 1|Withdrawal by Subject|0|||
44443719|NCT00143455|79451626|FG003|Cohort 1|Withdrawal by Subject|0|||
44443720|NCT00143455|79451623|FG000|Cohort 1|Randomized But Not Treated|0|||
44443721|NCT00143455|79451624|FG001|Cohort 1|Randomized But Not Treated|1|||
44443722|NCT00143455|79451625|FG002|Cohort 1|Randomized But Not Treated|0|||
44443723|NCT00143455|79451626|FG003|Cohort 1|Randomized But Not Treated|0|||
44443724|NCT00143455|79451623|FG000|Cohort 2|Adverse Event|0|||
44443725|NCT00143455|79451624|FG001|Cohort 2|Adverse Event|0|||
44443726|NCT00143455|79451625|FG002|Cohort 2|Adverse Event|42|||
44443727|NCT00143455|79451626|FG003|Cohort 2|Adverse Event|30|||
44159490|NCT02518971|78951885|FG000|Overall Study|Withdrawal by Subject|4|||
44159491|NCT02518971|78951886|FG001|Overall Study|Withdrawal by Subject|5|||
44159492|NCT02518971|78951885|FG000|Overall Study|Side effects|1|||
44159493|NCT02518971|78951886|FG001|Overall Study|Side effects|0|||
44159494|NCT02518971|78951885|FG000|Overall Study|medication lost in mail|0|||
44159495|NCT02518971|78951886|FG001|Overall Study|medication lost in mail|1|||
44159496|NCT02518971|78951885|FG000|Overall Study|eligibility criteria no longer met|6|||
44159497|NCT02518971|78951886|FG001|Overall Study|eligibility criteria no longer met|3|||
44159498|NCT01365039|78951895|FG000|Overall Study|Study related symptoms and complaints|1|||
44159499|NCT01365039|78951896|FG001|Overall Study|Study related symptoms and complaints|0|||
44159500|NCT01364727|78951903|FG000|Overall Study|Not Eligible|2|||
44159501|NCT02633215|78951911|FG000|Overall Study|Lost to Follow-up|2|||
44159502|NCT02633215|78951912|FG001|Overall Study|Lost to Follow-up|3|||
44159503|NCT01364649|78951920|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
44159504|NCT01364649|78951921|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
44159505|NCT01364649|78951920|FG000|Overall Study|Lack of Efficacy|6|||
44159506|NCT01364649|78951921|FG001|Overall Study|Lack of Efficacy|0|||
44159507|NCT01364649|78951920|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
44159508|NCT01364649|78951921|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
44159509|NCT01364649|78951920|FG000|Overall Study|Protocol Deviations|4|||
44159510|NCT01364649|78951921|FG001|Overall Study|Protocol Deviations|8|||
44159511|NCT01364649|78951920|FG000|Overall Study|Withdrawal of Consent|9|||
44159512|NCT01364649|78951921|FG001|Overall Study|Withdrawal of Consent|7|||
44159513|NCT01364649|78951920|FG000|Overall Study|Lost to Follow-up|12|||
44159514|NCT01364649|78951921|FG001|Overall Study|Lost to Follow-up|13|||
44159515|NCT01364649|78951920|FG000|Overall Study|Other|4|||
44342164|NCT01017952|79346060|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44342165|NCT01017952|79346061|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44159516|NCT01364649|78951921|FG001|Overall Study|Other|1|||
44159517|NCT02588261|78951929|FG000|Overall Study|Study Terminated by Sponsor|157|||
44159518|NCT02588261|78951930|FG001|Overall Study|Study Terminated by Sponsor|142|||
44159519|NCT02588261|78951929|FG000|Overall Study|Protocol Deviation|1|||
44159520|NCT02588261|78951930|FG001|Overall Study|Protocol Deviation|0|||
44159521|NCT02588261|78951929|FG000|Overall Study|Death|1|||
44159522|NCT02588261|78951930|FG001|Overall Study|Death|2|||
44159523|NCT02588261|78951929|FG000|Overall Study|Withdrawal by Subject|12|||
44159524|NCT02588261|78951930|FG001|Overall Study|Withdrawal by Subject|8|||
44159525|NCT02588261|78951929|FG000|Overall Study|Noncompliance with Study Drug|0|||
44159526|NCT02588261|78951930|FG001|Overall Study|Noncompliance with Study Drug|1|||
44159527|NCT02588261|78951929|FG000|Overall Study|Miscellaneous|5|||
44443728|NCT00143455|79451623|FG000|Cohort 2|No Longer Required Study Treatment|0|||
44443729|NCT00143455|79451624|FG001|Cohort 2|No Longer Required Study Treatment|0|||
44443730|NCT00143455|79451625|FG002|Cohort 2|No Longer Required Study Treatment|1|||
44159528|NCT02588261|78951930|FG001|Overall Study|Miscellaneous|4|||
44159529|NCT02588261|78951929|FG000|Overall Study|Progressive Disease|61|||
44159530|NCT02588261|78951930|FG001|Overall Study|Progressive Disease|82|||
44159531|NCT02588261|78951929|FG000|Overall Study|Adverse Event|29|||
44159532|NCT02588261|78951930|FG001|Overall Study|Adverse Event|24|||
44342166|NCT01017952|79346062|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44443731|NCT00143455|79451626|FG003|Cohort 2|No Longer Required Study Treatment|0|||
44443732|NCT00143455|79451623|FG000|Cohort 2|Protocol Violation|0|||
44443733|NCT00143455|79451624|FG001|Cohort 2|Protocol Violation|0|||
44443734|NCT00143455|79451625|FG002|Cohort 2|Protocol Violation|1|||
44443735|NCT00143455|79451626|FG003|Cohort 2|Protocol Violation|1|||
44443736|NCT00143455|79451623|FG000|Cohort 2|Lost to Follow-up|0|||
44443737|NCT00143455|79451624|FG001|Cohort 2|Lost to Follow-up|0|||
44443738|NCT00143455|79451625|FG002|Cohort 2|Lost to Follow-up|1|||
44443739|NCT00143455|79451626|FG003|Cohort 2|Lost to Follow-up|4|||
44443740|NCT00143455|79451623|FG000|Cohort 2|Death|0|||
44443741|NCT00143455|79451624|FG001|Cohort 2|Death|0|||
44443742|NCT00143455|79451625|FG002|Cohort 2|Death|20|||
44443743|NCT00143455|79451626|FG003|Cohort 2|Death|12|||
44443744|NCT00143455|79451623|FG000|Cohort 2|Progressive Disease|0|||
44443745|NCT00143455|79451624|FG001|Cohort 2|Progressive Disease|0|||
44443746|NCT00143455|79451625|FG002|Cohort 2|Progressive Disease|20|||
44159533|NCT02588261|78951929|FG000|Overall Study|Lost to Follow-up|1|||
44159534|NCT02588261|78951930|FG001|Overall Study|Lost to Follow-up|0|||
44342167|NCT01017952|79346063|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
44342168|NCT01017952|79346059|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
44342169|NCT01017952|79346060|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
44342170|NCT01017952|79346061|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
44159535|NCT01359449|78951938|FG000|Overall Study|Lost to Follow-up|1|||
44159536|NCT01359449|78951939|FG001|Overall Study|Lost to Follow-up|0|||
44159537|NCT01359449|78951938|FG000|Overall Study|Protocol Violation|0|||
44443747|NCT00143455|79451626|FG003|Cohort 2|Progressive Disease|27|||
44443748|NCT00143455|79451623|FG000|Cohort 2|Withdrawal by Subject|0|||
44443749|NCT00143455|79451624|FG001|Cohort 2|Withdrawal by Subject|0|||
44342171|NCT01017952|79346062|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
44159538|NCT01359449|78951939|FG001|Overall Study|Protocol Violation|2|||
44159539|NCT01359449|78951938|FG000|Overall Study|Withdrawal by Subject|3|||
44159540|NCT01359449|78951939|FG001|Overall Study|Withdrawal by Subject|2|||
44159541|NCT01672723|78951945|FG000|First Intervention|Adverse Event|3|||
44159542|NCT01672723|78951946|FG001|First Intervention|Adverse Event|0|||
44159543|NCT02632747|78951954|FG000|Wash-out Period|Adverse Event|1|||
44159544|NCT02632747|78951955|FG001|Wash-out Period|Adverse Event|0|||
44159545|NCT01671319|78951972|FG000|Overall Study|Withdrawal by Subject|1|||
44159546|NCT01670539|78951976|FG000|Overall Study|Death|3|||
44159547|NCT01670539|78951977|FG001|Overall Study|Death|5|||
44159548|NCT01670539|78951976|FG000|Overall Study|Withdrawal by Subject|3|||
44159549|NCT01670539|78951977|FG001|Overall Study|Withdrawal by Subject|0|||
44159550|NCT02516163|78951984|FG000|Overall Study|Withdrawal by Subject|1|||
44159551|NCT02516163|78951984|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
44159552|NCT02516163|78951984|FG000|Overall Study|Unfit/delay in surgery|3|||
44159553|NCT02516163|78951984|FG000|Overall Study|Use of incorrect measurement technique|5|||
44159554|NCT02516163|78951984|FG000|Overall Study|Data not recorded|2|||
44159555|NCT02516163|78951984|FG000|Overall Study|MRI contraindication exclusion|6|||
44159556|NCT02589665|78951992|FG000|Induction Period|Did not receive drug|0|||
44159557|NCT02589665|78951993|FG001|Induction Period|Did not receive drug|0|||
44159558|NCT02589665|78951994|FG002|Induction Period|Did not receive drug|0|||
44159559|NCT02589665|78951995|FG003|Induction Period|Did not receive drug|1|||
44159560|NCT02589665|78951996|FG004|Induction Period|Did not receive drug|0|||
44159561|NCT02589665|78951997|FG005|Induction Period|Did not receive drug|0|||
44159562|NCT02589665|78951998|FG006|Induction Period|Did not receive drug|0|||
44159563|NCT02589665|78951999|FG007|Induction Period|Did not receive drug|0|||
44159564|NCT02589665|78952000|FG008|Induction Period|Did not receive drug|0|||
44159565|NCT02589665|78952001|FG009|Induction Period|Did not receive drug|0|||
44159566|NCT02589665|78951992|FG000|Induction Period|Adverse Event|3|||
44342172|NCT01017952|79346063|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
44342173|NCT01017952|79346059|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
44159567|NCT02589665|78951993|FG001|Induction Period|Adverse Event|0|||
44159568|NCT02589665|78951994|FG002|Induction Period|Adverse Event|2|||
44342174|NCT01017952|79346060|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44342175|NCT01017952|79346061|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44342176|NCT01017952|79346062|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44342177|NCT01017952|79346063|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
44342178|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
44342179|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
44342180|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
44342181|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
44342182|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
44342183|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
44342184|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
44342185|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
44342186|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
44342187|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
44342188|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
44342189|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
44342190|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
44342191|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
44342192|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
44342193|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
44342194|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
44342195|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
44443750|NCT00143455|79451625|FG002|Cohort 2|Withdrawal by Subject|13|||
44159569|NCT02589665|78951995|FG003|Induction Period|Adverse Event|2|||
44342196|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
44342197|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
44342198|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
44342199|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
44342200|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
44342201|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
44342202|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
44342203|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
44159570|NCT02589665|78951996|FG004|Induction Period|Adverse Event|0|||
44159571|NCT02589665|78951997|FG005|Induction Period|Adverse Event|0|||
44159572|NCT02589665|78951998|FG006|Induction Period|Adverse Event|0|||
44443751|NCT00143455|79451626|FG003|Cohort 2|Withdrawal by Subject|12|||
44443752|NCT00143455|79451623|FG000|Cohort 2|Other|0|||
44443753|NCT00143455|79451624|FG001|Cohort 2|Other|0|||
44443754|NCT00143455|79451625|FG002|Cohort 2|Other|7|||
44159573|NCT02589665|78951999|FG007|Induction Period|Adverse Event|0|||
44443755|NCT00143455|79451626|FG003|Cohort 2|Other|6|||
44443756|NCT00143455|79451623|FG000|Cohort 2|Randomized But Not Treated|0|||
44443757|NCT00143455|79451624|FG001|Cohort 2|Randomized But Not Treated|0|||
44443758|NCT00143455|79451625|FG002|Cohort 2|Randomized But Not Treated|1|||
44443759|NCT00143455|79451626|FG003|Cohort 2|Randomized But Not Treated|1|||
44443760|NCT03529955|79451638|FG000|Overall Study|Adverse Event|1|||
44443761|NCT03529955|79451638|FG000|Overall Study|Lack of Efficacy|1|||
44259954|NCT01278797|79124474|FG001|Period 1|Protocol Violation|0|||
44259955|NCT01272869|79124482|FG000|Period 2 (14 Days)|Adverse Event|1|||
44259956|NCT01272869|79124483|FG001|Period 2 (14 Days)|Adverse Event|0|||
44259957|NCT01272635|79124491|FG000|Overall Study|Lost to Follow-up|31|||
44259958|NCT01272635|79124492|FG001|Overall Study|Lost to Follow-up|20|||
44259959|NCT01272635|79124493|FG002|Overall Study|Lost to Follow-up|31|||
44259960|NCT01272635|79124494|FG003|Overall Study|Lost to Follow-up|23|||
44259961|NCT01272011|79124505|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
44259962|NCT01272011|79124506|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
44259963|NCT01272011|79124507|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
44259964|NCT01270841|79124528|FG000|Overall Study|Adverse Event|0|||
44259965|NCT01270841|79124529|FG001|Overall Study|Adverse Event|1|||
44259966|NCT01270841|79124530|FG002|Overall Study|Adverse Event|0|||
44259967|NCT01270841|79124531|FG003|Overall Study|Adverse Event|3|||
44259968|NCT01270841|79124528|FG000|Overall Study|Withdrawal by Subject|3|||
44259969|NCT01270841|79124529|FG001|Overall Study|Withdrawal by Subject|2|||
44259970|NCT01270841|79124530|FG002|Overall Study|Withdrawal by Subject|3|||
44259971|NCT01270841|79124531|FG003|Overall Study|Withdrawal by Subject|3|||
44259972|NCT01270841|79124528|FG000|Overall Study|Lost to Follow-up|3|||
44342204|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
44342205|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
44342206|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
44342207|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
44342208|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
44342209|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
44342210|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
44342211|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
44159574|NCT02589665|78952000|FG008|Induction Period|Adverse Event|0|||
44159575|NCT02589665|78952001|FG009|Induction Period|Adverse Event|0|||
44342212|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
44342213|NCT01017952|79346059|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
44342214|NCT01017952|79346060|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
44159576|NCT02589665|78951992|FG000|Induction Period|Withdrawal by Subject|0|||
44443762|NCT00142909|79451654|FG000|Randomization|Various Reasons|7|||
44259973|NCT01270841|79124529|FG001|Overall Study|Lost to Follow-up|1|||
44159577|NCT02589665|78951993|FG001|Induction Period|Withdrawal by Subject|1|||
44159578|NCT02589665|78951994|FG002|Induction Period|Withdrawal by Subject|0|||
44159579|NCT02589665|78951995|FG003|Induction Period|Withdrawal by Subject|1|||
44159580|NCT02589665|78951996|FG004|Induction Period|Withdrawal by Subject|0|||
44159581|NCT02589665|78951997|FG005|Induction Period|Withdrawal by Subject|0|||
44159582|NCT02589665|78951998|FG006|Induction Period|Withdrawal by Subject|0|||
44159583|NCT02589665|78951999|FG007|Induction Period|Withdrawal by Subject|0|||
44159584|NCT02589665|78952000|FG008|Induction Period|Withdrawal by Subject|0|||
44159585|NCT02589665|78952001|FG009|Induction Period|Withdrawal by Subject|0|||
44159586|NCT02589665|78951992|FG000|Induction Period|Protocol Violation|0|||
44159587|NCT02589665|78951993|FG001|Induction Period|Protocol Violation|1|||
44159588|NCT02589665|78951994|FG002|Induction Period|Protocol Violation|0|||
44159589|NCT02589665|78951995|FG003|Induction Period|Protocol Violation|0|||
44159590|NCT02589665|78951996|FG004|Induction Period|Protocol Violation|0|||
44159591|NCT02589665|78951997|FG005|Induction Period|Protocol Violation|0|||
44159592|NCT02589665|78951998|FG006|Induction Period|Protocol Violation|0|||
44159593|NCT02589665|78951999|FG007|Induction Period|Protocol Violation|0|||
44159594|NCT02589665|78952000|FG008|Induction Period|Protocol Violation|0|||
44159595|NCT02589665|78952001|FG009|Induction Period|Protocol Violation|0|||
44159596|NCT02589665|78951992|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159597|NCT02589665|78951993|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159598|NCT02589665|78951994|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159599|NCT02589665|78951995|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159600|NCT02589665|78951996|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
44159601|NCT02589665|78951997|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
44159602|NCT02589665|78951998|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
44159603|NCT02589665|78951999|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159604|NCT02589665|78952000|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44259974|NCT01270841|79124530|FG002|Overall Study|Lost to Follow-up|4|||
44342215|NCT01017952|79346061|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
44159605|NCT02589665|78952001|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159606|NCT02589665|78951992|FG000|Maintenance Period|Withdrawal by Subject|0|||
44159607|NCT02589665|78951993|FG001|Maintenance Period|Withdrawal by Subject|0|||
44159608|NCT02589665|78951994|FG002|Maintenance Period|Withdrawal by Subject|0|||
44259975|NCT01270841|79124531|FG003|Overall Study|Lost to Follow-up|2|||
44342216|NCT01017952|79346062|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
44159609|NCT02589665|78951995|FG003|Maintenance Period|Withdrawal by Subject|0|||
44259976|NCT01270841|79124528|FG000|Overall Study|Physician Decision|0|||
44159610|NCT02589665|78951996|FG004|Maintenance Period|Withdrawal by Subject|4|||
44342217|NCT01017952|79346063|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
44342218|NCT01214655|79346076|FG000|Part A|Progressive Disease|7|||
44342219|NCT01214655|79346077|FG001|Part A|Progressive Disease|0|||
44342220|NCT01214655|79346078|FG002|Part A|Progressive Disease|0|||
44342221|NCT01214655|79346076|FG000|Part A|Physician Decision|1|||
44342222|NCT01214655|79346077|FG001|Part A|Physician Decision|0|||
44342223|NCT01214655|79346078|FG002|Part A|Physician Decision|0|||
44342224|NCT01214655|79346076|FG000|Part B|Progressive disease|0|||
44342225|NCT01214655|79346077|FG001|Part B|Progressive disease|10|||
44342226|NCT01214655|79346078|FG002|Part B|Progressive disease|0|||
44342227|NCT01214655|79346076|FG000|Part B|Death|0|||
44342228|NCT01214655|79346077|FG001|Part B|Death|1|||
44342229|NCT01214655|79346078|FG002|Part B|Death|0|||
44342230|NCT01214655|79346076|FG000|Part B|Withdrawal by Subject|0|||
44159611|NCT02589665|78951997|FG005|Maintenance Period|Withdrawal by Subject|2|||
44342231|NCT01214655|79346077|FG001|Part B|Withdrawal by Subject|2|||
44342232|NCT01214655|79346078|FG002|Part B|Withdrawal by Subject|0|||
44443763|NCT00142909|79451655|FG001|Randomization|Various Reasons|10|||
44443764|NCT00142909|79451654|FG000|Medications Begin|Protocol Violation|2|||
44443765|NCT00142909|79451655|FG001|Medications Begin|Protocol Violation|0|||
44443766|NCT00142909|79451654|FG000|Medications Begin|Withdrawal by Subject|5|||
44443767|NCT00142909|79451655|FG001|Medications Begin|Withdrawal by Subject|3|||
44159612|NCT02589665|78951998|FG006|Maintenance Period|Withdrawal by Subject|4|||
44159613|NCT02589665|78951999|FG007|Maintenance Period|Withdrawal by Subject|0|||
44159614|NCT02589665|78952000|FG008|Maintenance Period|Withdrawal by Subject|0|||
44259977|NCT01270841|79124529|FG001|Overall Study|Physician Decision|1|||
44342233|NCT01214655|79346076|FG000|Part C|Progressive Disease|0|||
44342234|NCT01214655|79346077|FG001|Part C|Progressive Disease|0|||
44342235|NCT01214655|79346078|FG002|Part C|Progressive Disease|5|||
44159615|NCT02589665|78952001|FG009|Maintenance Period|Withdrawal by Subject|0|||
44159616|NCT02589665|78951992|FG000|Maintenance Period|Lack of Efficacy|0|||
44159617|NCT02589665|78951993|FG001|Maintenance Period|Lack of Efficacy|0|||
44159618|NCT02589665|78951994|FG002|Maintenance Period|Lack of Efficacy|0|||
44159619|NCT02589665|78951995|FG003|Maintenance Period|Lack of Efficacy|0|||
44159620|NCT02589665|78951996|FG004|Maintenance Period|Lack of Efficacy|2|||
44259978|NCT01270841|79124530|FG002|Overall Study|Physician Decision|0|||
44259979|NCT01270841|79124531|FG003|Overall Study|Physician Decision|0|||
44259980|NCT01270841|79124528|FG000|Overall Study|Did not qualify|6|||
44259981|NCT01270841|79124529|FG001|Overall Study|Did not qualify|3|||
44259982|NCT01270841|79124530|FG002|Overall Study|Did not qualify|4|||
44159621|NCT02589665|78951997|FG005|Maintenance Period|Lack of Efficacy|1|||
44159622|NCT02589665|78951998|FG006|Maintenance Period|Lack of Efficacy|0|||
44159623|NCT02589665|78951999|FG007|Maintenance Period|Lack of Efficacy|0|||
44159624|NCT02589665|78952000|FG008|Maintenance Period|Lack of Efficacy|0|||
44159625|NCT02589665|78952001|FG009|Maintenance Period|Lack of Efficacy|0|||
44159626|NCT02589665|78951992|FG000|Maintenance Period|Adverse Event|0|||
44159627|NCT02589665|78951993|FG001|Maintenance Period|Adverse Event|0|||
44159628|NCT02589665|78951994|FG002|Maintenance Period|Adverse Event|0|||
44159629|NCT02589665|78951995|FG003|Maintenance Period|Adverse Event|0|||
44159630|NCT02589665|78951996|FG004|Maintenance Period|Adverse Event|0|||
44159631|NCT02589665|78951997|FG005|Maintenance Period|Adverse Event|0|||
44342236|NCT01214655|79346076|FG000|Part C|Death|0|||
44443768|NCT00142909|79451654|FG000|Medications Begin|Withdrawal by Subject|2|||
44159632|NCT02589665|78951998|FG006|Maintenance Period|Adverse Event|2|||
44443769|NCT00142909|79451655|FG001|Medications Begin|Withdrawal by Subject|0|||
44342237|NCT01214655|79346077|FG001|Part C|Death|0|||
44342238|NCT01214655|79346078|FG002|Part C|Death|1|||
44159633|NCT02589665|78951999|FG007|Maintenance Period|Adverse Event|0|||
44159634|NCT02589665|78952000|FG008|Maintenance Period|Adverse Event|0|||
44159635|NCT02589665|78952001|FG009|Maintenance Period|Adverse Event|0|||
44159636|NCT02589665|78951992|FG000|Maintenance Period|Lost to Follow-up|0|||
44159637|NCT02589665|78951993|FG001|Maintenance Period|Lost to Follow-up|0|||
44159638|NCT02589665|78951994|FG002|Maintenance Period|Lost to Follow-up|0|||
44159639|NCT02589665|78951995|FG003|Maintenance Period|Lost to Follow-up|0|||
44159640|NCT02589665|78951996|FG004|Maintenance Period|Lost to Follow-up|0|||
44159641|NCT02589665|78951997|FG005|Maintenance Period|Lost to Follow-up|1|||
44159642|NCT02589665|78951998|FG006|Maintenance Period|Lost to Follow-up|0|||
44159643|NCT02589665|78951999|FG007|Maintenance Period|Lost to Follow-up|0|||
44159644|NCT02589665|78952000|FG008|Maintenance Period|Lost to Follow-up|0|||
44159645|NCT02589665|78952001|FG009|Maintenance Period|Lost to Follow-up|0|||
44159646|NCT02589665|78951992|FG000|Maintenance Period|Physician Decision|0|||
44159647|NCT02589665|78951993|FG001|Maintenance Period|Physician Decision|0|||
44159648|NCT02589665|78951994|FG002|Maintenance Period|Physician Decision|0|||
44159649|NCT02589665|78951995|FG003|Maintenance Period|Physician Decision|0|||
44159650|NCT02589665|78951996|FG004|Maintenance Period|Physician Decision|0|||
44159651|NCT02589665|78951997|FG005|Maintenance Period|Physician Decision|1|||
44159652|NCT02589665|78951998|FG006|Maintenance Period|Physician Decision|0|||
44159653|NCT02589665|78951999|FG007|Maintenance Period|Physician Decision|0|||
44159654|NCT02589665|78952000|FG008|Maintenance Period|Physician Decision|0|||
44159655|NCT02589665|78952001|FG009|Maintenance Period|Physician Decision|0|||
44159656|NCT02589665|78951992|FG000|Maintenance Period|Reason Not Collected|0|||
44159657|NCT02589665|78951993|FG001|Maintenance Period|Reason Not Collected|0|||
44159658|NCT02589665|78951994|FG002|Maintenance Period|Reason Not Collected|0|||
44159659|NCT02589665|78951995|FG003|Maintenance Period|Reason Not Collected|0|||
44159660|NCT02589665|78951996|FG004|Maintenance Period|Reason Not Collected|0|||
44159661|NCT02589665|78951997|FG005|Maintenance Period|Reason Not Collected|1|||
44159662|NCT02589665|78951998|FG006|Maintenance Period|Reason Not Collected|1|||
44159663|NCT02589665|78951999|FG007|Maintenance Period|Reason Not Collected|0|||
44159664|NCT02589665|78952000|FG008|Maintenance Period|Reason Not Collected|0|||
44159665|NCT02589665|78952001|FG009|Maintenance Period|Reason Not Collected|0|||
44159666|NCT02589665|78951992|FG000|Induction Extension Period|Adverse Event|0|||
44159667|NCT02589665|78951993|FG001|Induction Extension Period|Adverse Event|0|||
44159668|NCT02589665|78951994|FG002|Induction Extension Period|Adverse Event|0|||
44159669|NCT02589665|78951995|FG003|Induction Extension Period|Adverse Event|0|||
44159670|NCT02589665|78951996|FG004|Induction Extension Period|Adverse Event|0|||
44159671|NCT02589665|78951997|FG005|Induction Extension Period|Adverse Event|0|||
44259983|NCT01270841|79124531|FG003|Overall Study|Did not qualify|5|||
44159672|NCT02589665|78951998|FG006|Induction Extension Period|Adverse Event|0|||
44159673|NCT02589665|78951999|FG007|Induction Extension Period|Adverse Event|0|||
44443770|NCT00205699|79451664|FG000|Overall Study|Lost to Follow-up|1|||
44443771|NCT00205699|79451665|FG001|Overall Study|Lost to Follow-up|3|||
44443772|NCT00205699|79451666|FG002|Overall Study|Lost to Follow-up|5|||
44443773|NCT00205699|79451664|FG000|Overall Study|Adverse Event|1|||
44443774|NCT00205699|79451665|FG001|Overall Study|Adverse Event|0|||
44259984|NCT01270841|79124528|FG000|Overall Study|Protocol Violation|1|||
44443775|NCT00205699|79451666|FG002|Overall Study|Adverse Event|0|||
44443776|NCT00205699|79451664|FG000|Overall Study|Withdrawal by Subject|1|||
44159674|NCT02589665|78952000|FG008|Induction Extension Period|Adverse Event|4|||
44159675|NCT02589665|78952001|FG009|Induction Extension Period|Adverse Event|0|||
44159676|NCT02589665|78951992|FG000|Induction Extension Period|Lack of Efficacy|0|||
44259985|NCT01270841|79124529|FG001|Overall Study|Protocol Violation|5|||
44443777|NCT00205699|79451665|FG001|Overall Study|Withdrawal by Subject|2|||
44443778|NCT00205699|79451666|FG002|Overall Study|Withdrawal by Subject|1|||
44443779|NCT00205699|79451664|FG000|Overall Study|Lack of Efficacy|0|||
44443780|NCT00205699|79451665|FG001|Overall Study|Lack of Efficacy|1|||
44342239|NCT01214655|79346076|FG000|Part C|Physician Decision|0|||
44342240|NCT01214655|79346077|FG001|Part C|Physician Decision|0|||
44342241|NCT01214655|79346078|FG002|Part C|Physician Decision|1|||
44443781|NCT00205699|79451666|FG002|Overall Study|Lack of Efficacy|0|||
44443782|NCT03882801|79451679|FG000|Period 1|Adverse Event|0|||
44443783|NCT03882801|79451680|FG001|Period 1|Adverse Event|1|||
44342242|NCT01017874|79346126|FG000|Overall Study|Withdrawal by Subject|23|||
44342243|NCT01017874|79346127|FG001|Overall Study|Withdrawal by Subject|20|||
44342244|NCT01017874|79346126|FG000|Overall Study|Sponsor decision|3|||
44342245|NCT01017874|79346127|FG001|Overall Study|Sponsor decision|1|||
44342246|NCT01017874|79346126|FG000|Overall Study|Lost to Follow-up|3|||
44342247|NCT01017874|79346127|FG001|Overall Study|Lost to Follow-up|2|||
44342248|NCT01017874|79346126|FG000|Overall Study|Physician Decision|1|||
44342249|NCT01017874|79346127|FG001|Overall Study|Physician Decision|3|||
44342250|NCT01015768|79346133|FG000|Overall Study|Some subject data unuseable|4|||
44342251|NCT01015768|79346134|FG001|Overall Study|Some subject data unuseable|4|||
44342252|NCT04426630|79346142|FG000|Overall Study|Death|4|||
44342253|NCT04426630|79346142|FG000|Overall Study|Lost to Follow-up|2|||
44342254|NCT01010230|79346148|FG000|Overall Study|Withdrawal by Subject|6|||
44342255|NCT01010230|79346149|FG001|Overall Study|Withdrawal by Subject|5|||
44342256|NCT01010230|79346148|FG000|Overall Study|Lost to Follow-up|4|||
44342257|NCT01010230|79346149|FG001|Overall Study|Lost to Follow-up|2|||
44342258|NCT01009840|79346155|FG000|Overall Study|Lost to Follow-up|1|||
44159677|NCT02589665|78951993|FG001|Induction Extension Period|Lack of Efficacy|0|||
44159678|NCT02589665|78951994|FG002|Induction Extension Period|Lack of Efficacy|0|||
44259986|NCT01270841|79124530|FG002|Overall Study|Protocol Violation|0|||
44342259|NCT01009840|79346155|FG000|Overall Study|Adverse Event|4|||
44259987|NCT01270841|79124531|FG003|Overall Study|Protocol Violation|0|||
44342260|NCT01009840|79346155|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
44342261|NCT01009840|79346155|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
44159679|NCT02589665|78951995|FG003|Induction Extension Period|Lack of Efficacy|0|||
44159680|NCT02589665|78951996|FG004|Induction Extension Period|Lack of Efficacy|0|||
44159681|NCT02589665|78951997|FG005|Induction Extension Period|Lack of Efficacy|0|||
44159682|NCT02589665|78951998|FG006|Induction Extension Period|Lack of Efficacy|0|||
44159683|NCT02589665|78951999|FG007|Induction Extension Period|Lack of Efficacy|0|||
44159684|NCT02589665|78952000|FG008|Induction Extension Period|Lack of Efficacy|3|||
44159685|NCT02589665|78952001|FG009|Induction Extension Period|Lack of Efficacy|0|||
44259988|NCT01270841|79124528|FG000|Overall Study|Enrolled in error|0|||
44259989|NCT01270841|79124529|FG001|Overall Study|Enrolled in error|1|||
44342262|NCT01009840|79346155|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
44342263|NCT00982657|79346163|FG000|Overall Study|Death|1|||
44342264|NCT00982657|79346164|FG001|Overall Study|Death|0|||
44159686|NCT02589665|78951992|FG000|Induction Extension Period|Withdrawal by Subject|0|||
44159687|NCT02589665|78951993|FG001|Induction Extension Period|Withdrawal by Subject|0|||
44159688|NCT02589665|78951994|FG002|Induction Extension Period|Withdrawal by Subject|0|||
44159689|NCT02589665|78951995|FG003|Induction Extension Period|Withdrawal by Subject|0|||
44159690|NCT02589665|78951996|FG004|Induction Extension Period|Withdrawal by Subject|0|||
44159691|NCT02589665|78951997|FG005|Induction Extension Period|Withdrawal by Subject|0|||
44159692|NCT02589665|78951998|FG006|Induction Extension Period|Withdrawal by Subject|0|||
44159693|NCT02589665|78951999|FG007|Induction Extension Period|Withdrawal by Subject|2|||
44159694|NCT02589665|78952000|FG008|Induction Extension Period|Withdrawal by Subject|3|||
44159695|NCT02589665|78952001|FG009|Induction Extension Period|Withdrawal by Subject|0|||
44159696|NCT02589665|78951992|FG000|Induction Extension Period|Physician Decision|0|||
44159697|NCT02589665|78951993|FG001|Induction Extension Period|Physician Decision|0|||
44159698|NCT02589665|78951994|FG002|Induction Extension Period|Physician Decision|0|||
44159699|NCT02589665|78951995|FG003|Induction Extension Period|Physician Decision|0|||
44159700|NCT02589665|78951996|FG004|Induction Extension Period|Physician Decision|0|||
44159701|NCT02589665|78951997|FG005|Induction Extension Period|Physician Decision|0|||
44159702|NCT02589665|78951998|FG006|Induction Extension Period|Physician Decision|0|||
44159703|NCT02589665|78951999|FG007|Induction Extension Period|Physician Decision|0|||
44159704|NCT02589665|78952000|FG008|Induction Extension Period|Physician Decision|1|||
44159705|NCT02589665|78952001|FG009|Induction Extension Period|Physician Decision|0|||
44159706|NCT02589665|78951992|FG000|Induction Extension Period|Reason Not Collected|0|||
44159707|NCT02589665|78951993|FG001|Induction Extension Period|Reason Not Collected|0|||
44159708|NCT02589665|78951994|FG002|Induction Extension Period|Reason Not Collected|0|||
44342265|NCT00982657|79346165|FG002|Overall Study|Death|1|||
44159709|NCT02589665|78951995|FG003|Induction Extension Period|Reason Not Collected|0|||
44159710|NCT02589665|78951996|FG004|Induction Extension Period|Reason Not Collected|0|||
44342266|NCT00982657|79346166|FG003|Overall Study|Death|1|||
44342267|NCT00982657|79346163|FG000|Overall Study|Withdrawal by Subject|0|||
44342268|NCT00982657|79346164|FG001|Overall Study|Withdrawal by Subject|0|||
44342269|NCT00982657|79346165|FG002|Overall Study|Withdrawal by Subject|1|||
44342270|NCT00982657|79346166|FG003|Overall Study|Withdrawal by Subject|3|||
44342271|NCT00982657|79346163|FG000|Overall Study|Other|0|||
44342272|NCT00982657|79346164|FG001|Overall Study|Other|0|||
44342273|NCT00982657|79346165|FG002|Overall Study|Other|0|||
44342274|NCT00982657|79346166|FG003|Overall Study|Other|4|||
44342275|NCT00982657|79346163|FG000|Overall Study|On going at date of cut-off|0|||
44342276|NCT00982657|79346164|FG001|Overall Study|On going at date of cut-off|0|||
44342277|NCT00982657|79346165|FG002|Overall Study|On going at date of cut-off|0|||
44342278|NCT00982657|79346166|FG003|Overall Study|On going at date of cut-off|1|||
44342279|NCT01005316|79346189|FG000|Overall Study|Adverse Event|0|||
44342280|NCT01005316|79346190|FG001|Overall Study|Adverse Event|0|||
44342281|NCT01005316|79346191|FG002|Overall Study|Adverse Event|0|||
44342282|NCT01005316|79346192|FG003|Overall Study|Adverse Event|1|||
44342283|NCT01005316|79346189|FG000|Overall Study|Death|20|||
44342284|NCT01005316|79346190|FG001|Overall Study|Death|5|||
44342285|NCT01005316|79346191|FG002|Overall Study|Death|1|||
44342286|NCT01005316|79346192|FG003|Overall Study|Death|15|||
44342287|NCT01005316|79346189|FG000|Overall Study|Study Termination|5|||
44342288|NCT01005316|79346190|FG001|Overall Study|Study Termination|63|||
44342289|NCT01005316|79346191|FG002|Overall Study|Study Termination|9|||
44342290|NCT01005316|79346192|FG003|Overall Study|Study Termination|85|||
44342291|NCT01005316|79346189|FG000|Overall Study|Lost to Follow-up|1|||
44342292|NCT01005316|79346190|FG001|Overall Study|Lost to Follow-up|3|||
44342293|NCT01005316|79346191|FG002|Overall Study|Lost to Follow-up|0|||
44342294|NCT01005316|79346192|FG003|Overall Study|Lost to Follow-up|2|||
44342295|NCT01005316|79346189|FG000|Overall Study|Physician Decision|6|||
44342296|NCT01005316|79346190|FG001|Overall Study|Physician Decision|0|||
44342297|NCT01005316|79346191|FG002|Overall Study|Physician Decision|0|||
44342298|NCT01005316|79346192|FG003|Overall Study|Physician Decision|0|||
44342299|NCT01005316|79346189|FG000|Overall Study|Sponsor Decision|6|||
44342300|NCT01005316|79346190|FG001|Overall Study|Sponsor Decision|3|||
44342301|NCT01005316|79346191|FG002|Overall Study|Sponsor Decision|0|||
44342302|NCT01005316|79346192|FG003|Overall Study|Sponsor Decision|0|||
44159711|NCT02589665|78951997|FG005|Induction Extension Period|Reason Not Collected|0|||
44259990|NCT01270841|79124530|FG002|Overall Study|Enrolled in error|0|||
44342303|NCT01005316|79346189|FG000|Overall Study|Withdrawal by Subject|1|||
44342304|NCT01005316|79346190|FG001|Overall Study|Withdrawal by Subject|1|||
44342305|NCT01005316|79346191|FG002|Overall Study|Withdrawal by Subject|0|||
44443784|NCT03882801|79451679|FG000|Period 1|Non-compliance with study drug|1|||
44342306|NCT01005316|79346192|FG003|Overall Study|Withdrawal by Subject|2|||
44342307|NCT01005316|79346189|FG000|Overall Study|Consented to Another Study|2|||
44342308|NCT01005316|79346190|FG001|Overall Study|Consented to Another Study|0|||
44342309|NCT01005316|79346191|FG002|Overall Study|Consented to Another Study|0|||
44443785|NCT03882801|79451680|FG001|Period 1|Non-compliance with study drug|1|||
44443786|NCT03882801|79451679|FG000|Period 1|Never treated with study drug|1|||
44443787|NCT03882801|79451680|FG001|Period 1|Never treated with study drug|0|||
44443788|NCT03882801|79451679|FG000|Washout Period|Physician Decision|0|||
44443789|NCT03882801|79451680|FG001|Washout Period|Physician Decision|1|||
44443790|NCT03882801|79451679|FG000|Period 2|Non-compliance with study drug|0|||
44443791|NCT03882801|79451680|FG001|Period 2|Non-compliance with study drug|1|||
44443792|NCT03880227|79451690|FG000|First Visit|Withdrawal by Subject|1|||
44259991|NCT01270841|79124531|FG003|Overall Study|Enrolled in error|0|||
44159712|NCT02589665|78951998|FG006|Induction Extension Period|Reason Not Collected|0|||
44159713|NCT02589665|78951999|FG007|Induction Extension Period|Reason Not Collected|0|||
44443793|NCT03880227|79451691|FG001|First Visit|Withdrawal by Subject|0|||
44443794|NCT03880227|79451692|FG002|First Visit|Withdrawal by Subject|0|||
44443795|NCT03880227|79451693|FG003|First Visit|Withdrawal by Subject|0|||
44342310|NCT01005316|79346192|FG003|Overall Study|Consented to Another Study|0|||
44342311|NCT01005316|79346189|FG000|Overall Study|Delisted|8|||
44159714|NCT02589665|78952000|FG008|Induction Extension Period|Reason Not Collected|1|||
44159715|NCT02589665|78952001|FG009|Induction Extension Period|Reason Not Collected|0|||
44159716|NCT02589665|78951992|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159717|NCT02589665|78951993|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159718|NCT02589665|78951994|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44342312|NCT01005316|79346190|FG001|Overall Study|Delisted|0|||
44259992|NCT01270139|79124544|FG000|Overall Study|Adverse Event|8|||
44259993|NCT01270139|79124545|FG001|Overall Study|Adverse Event|17|||
44159719|NCT02589665|78951995|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44342313|NCT01005316|79346191|FG002|Overall Study|Delisted|0|||
44342314|NCT01005316|79346192|FG003|Overall Study|Delisted|0|||
44342315|NCT01005316|79346189|FG000|Overall Study|Transferred Care|1|||
44342316|NCT01005316|79346190|FG001|Overall Study|Transferred Care|0|||
44342317|NCT01005316|79346191|FG002|Overall Study|Transferred Care|1|||
44342318|NCT01005316|79346192|FG003|Overall Study|Transferred Care|3|||
44342319|NCT01005316|79346189|FG000|Overall Study|Retransplanted|0|||
44342320|NCT01005316|79346190|FG001|Overall Study|Retransplanted|1|||
44342321|NCT01005316|79346191|FG002|Overall Study|Retransplanted|0|||
44342322|NCT01005316|79346192|FG003|Overall Study|Retransplanted|0|||
44342323|NCT01004848|79346205|FG000|Overall Study|Lost to Follow-up|55|||
44342324|NCT01004848|79346206|FG001|Overall Study|Lost to Follow-up|45|||
44342325|NCT01009294|79346214|FG000|Overall Study|Study discontinued by Sponsor|6|||
44342326|NCT01009060|79346220|FG000|Overall Study|Adverse Event|1|||
44342327|NCT01009060|79346221|FG001|Overall Study|Adverse Event|2|||
44159720|NCT02589665|78951996|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159721|NCT02589665|78951997|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159722|NCT02589665|78951998|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159723|NCT02589665|78951999|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159724|NCT02589665|78952000|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
44159725|NCT02589665|78952001|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
44159726|NCT02589665|78951992|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
44159727|NCT02589665|78951993|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
44159728|NCT02589665|78951994|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
44259994|NCT01270139|79124546|FG002|Overall Study|Adverse Event|18|||
44342328|NCT01009060|79346220|FG000|Overall Study|Protocol Violation|0|||
44342329|NCT01009060|79346221|FG001|Overall Study|Protocol Violation|1|||
44342330|NCT01009060|79346220|FG000|Overall Study|Lost to Follow-up|1|||
44259995|NCT01270139|79124544|FG000|Overall Study|Lost to Follow-up|10|||
44342331|NCT01009060|79346221|FG001|Overall Study|Lost to Follow-up|0|||
44342332|NCT01009060|79346220|FG000|Overall Study|Physician Decision|1|||
44342333|NCT01009060|79346221|FG001|Overall Study|Physician Decision|1|||
44443796|NCT03880227|79451690|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
44443797|NCT03880227|79451691|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
44443798|NCT03880227|79451692|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
44443799|NCT03880227|79451693|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
44159729|NCT02589665|78951995|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
44159730|NCT02589665|78951996|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
44159731|NCT02589665|78951997|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
44159732|NCT02589665|78951998|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
44159733|NCT02589665|78951999|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
44159734|NCT02589665|78952000|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
44159735|NCT02589665|78952001|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
44443800|NCT03880227|79451690|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
44443801|NCT03880227|79451691|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
44443802|NCT03880227|79451692|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
44443803|NCT03880227|79451693|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
44342334|NCT01009060|79346220|FG000|Overall Study|Withdrawal by Subject|1|||
44342335|NCT01009060|79346221|FG001|Overall Study|Withdrawal by Subject|1|||
44342336|NCT00988429|79346234|FG000|Overall Study|Adverse Event|9|||
44342337|NCT00988429|79346235|FG001|Overall Study|Adverse Event|21|||
44342338|NCT00988429|79346236|FG002|Overall Study|Adverse Event|45|||
44342339|NCT00988429|79346234|FG000|Overall Study|Lack of Efficacy|0|||
44342340|NCT00988429|79346235|FG001|Overall Study|Lack of Efficacy|0|||
44342341|NCT00988429|79346236|FG002|Overall Study|Lack of Efficacy|1|||
44342342|NCT00988429|79346234|FG000|Overall Study|Non-Compliance with Study Drug|5|||
44342343|NCT00988429|79346235|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44342344|NCT00988429|79346236|FG002|Overall Study|Non-Compliance with Study Drug|3|||
44342345|NCT00988429|79346234|FG000|Overall Study|Physician Decision|1|||
44342346|NCT00988429|79346235|FG001|Overall Study|Physician Decision|0|||
44342347|NCT00988429|79346236|FG002|Overall Study|Physician Decision|3|||
44342348|NCT00988429|79346234|FG000|Overall Study|Pregnancy|2|||
44342349|NCT00988429|79346235|FG001|Overall Study|Pregnancy|1|||
44342350|NCT00988429|79346236|FG002|Overall Study|Pregnancy|0|||
44342351|NCT00988429|79346234|FG000|Overall Study|Protocol Violation|4|||
44443804|NCT03880227|79451690|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
44342352|NCT00988429|79346235|FG001|Overall Study|Protocol Violation|3|||
44342353|NCT00988429|79346236|FG002|Overall Study|Protocol Violation|3|||
44342354|NCT00988429|79346234|FG000|Overall Study|Withdrawal by Subject|7|||
44342355|NCT00988429|79346235|FG001|Overall Study|Withdrawal by Subject|7|||
44342356|NCT00988429|79346236|FG002|Overall Study|Withdrawal by Subject|12|||
44443805|NCT03880227|79451691|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
44342357|NCT00988429|79346234|FG000|Overall Study|Administrative Reasons|1|||
44342358|NCT00988429|79346235|FG001|Overall Study|Administrative Reasons|2|||
44342359|NCT00988429|79346236|FG002|Overall Study|Administrative Reasons|1|||
44342360|NCT00988429|79346234|FG000|Overall Study|other reasons|8|||
44342361|NCT00988429|79346235|FG001|Overall Study|other reasons|8|||
44342362|NCT00988429|79346236|FG002|Overall Study|other reasons|1|||
44259996|NCT01270139|79124545|FG001|Overall Study|Lost to Follow-up|9|||
44259997|NCT01270139|79124546|FG002|Overall Study|Lost to Follow-up|2|||
44259998|NCT01278407|79124564|FG000|Confirmatory Phase|Adverse Event|5|||
44259999|NCT01278407|79124565|FG001|Confirmatory Phase|Adverse Event|10|||
44260000|NCT01278407|79124566|FG002|Confirmatory Phase|Adverse Event|1|||
44260001|NCT01278407|79124567|FG003|Confirmatory Phase|Adverse Event|0|||
44260002|NCT01278407|79124568|FG004|Confirmatory Phase|Adverse Event|0|||
44260003|NCT01278407|79124564|FG000|Confirmatory Phase|Participant's Choice|3|||
44260004|NCT01278407|79124565|FG001|Confirmatory Phase|Participant's Choice|5|||
44260005|NCT01278407|79124566|FG002|Confirmatory Phase|Participant's Choice|3|||
44260006|NCT01278407|79124567|FG003|Confirmatory Phase|Participant's Choice|0|||
44443806|NCT03880227|79451692|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
44443807|NCT03880227|79451693|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
44443808|NCT00530439|79451717|FG000|Overall Study|GDM|9|||
44443809|NCT00530439|79451718|FG001|Overall Study|GDM|3|||
44443810|NCT00530439|79451717|FG000|Overall Study|Withdraw|18|||
44342363|NCT01008904|79346245|FG000|Overall Study|Lost to Follow-up|1|||
44342364|NCT01008904|79346245|FG000|Overall Study|Adverse Event|2|||
44342365|NCT01008904|79346245|FG000|Overall Study|unexpected unrelated surgery|1|||
44342366|NCT01004614|79346253|FG000|Washout|Withdrawal by Subject|0|||
44342367|NCT01004614|79346254|FG001|Washout|Withdrawal by Subject|1|||
44342368|NCT01004614|79346255|FG002|Washout|Withdrawal by Subject|0|||
44342369|NCT01004614|79346256|FG003|Washout|Withdrawal by Subject|0|||
44342370|NCT00981409|79346268|FG000|Overall Study|Adverse Event|4|||
44342371|NCT00981409|79346269|FG001|Overall Study|Adverse Event|0|||
44342372|NCT00981409|79346268|FG000|Overall Study|Protocol Violation|0|||
44342373|NCT00981409|79346269|FG001|Overall Study|Protocol Violation|1|||
44342374|NCT00981409|79346268|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
44342375|NCT00981409|79346269|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
44342376|NCT01008748|79346275|FG000|Overall Study|Lost to Follow-up|80|||
44342377|NCT01008748|79346275|FG000|Overall Study|Other|1|||
44443811|NCT00530439|79451718|FG001|Overall Study|Withdraw|14|||
44443812|NCT00530439|79451717|FG000|Overall Study|Missed abortion|1|||
44342378|NCT01004146|79346281|FG000|Overall Study|Withdrawal by Subject|4|||
44342379|NCT01004146|79346282|FG001|Overall Study|Withdrawal by Subject|5|||
44342380|NCT01012414|79346288|FG000|Overall Study|Withdrawal by Subject|2|||
44342381|NCT01012414|79346288|FG000|Overall Study|Lost to Follow-up|1|||
44159736|NCT02589665|78951992|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
44159737|NCT02589665|78951993|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
44159738|NCT02589665|78951994|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
44159739|NCT02589665|78951995|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
44159740|NCT02589665|78951996|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
44159741|NCT02589665|78951997|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
44159742|NCT02589665|78951998|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
44159743|NCT02589665|78951999|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
44159744|NCT02589665|78952000|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
44159745|NCT02589665|78952001|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
44159746|NCT02589665|78951992|FG000|Maintenance Extension Period|Adverse Event|0|||
44159747|NCT02589665|78951993|FG001|Maintenance Extension Period|Adverse Event|0|||
44159748|NCT02589665|78951994|FG002|Maintenance Extension Period|Adverse Event|0|||
44159749|NCT02589665|78951995|FG003|Maintenance Extension Period|Adverse Event|0|||
44159750|NCT02589665|78951996|FG004|Maintenance Extension Period|Adverse Event|0|||
44159751|NCT02589665|78951997|FG005|Maintenance Extension Period|Adverse Event|0|||
44159752|NCT02589665|78951998|FG006|Maintenance Extension Period|Adverse Event|0|||
44159753|NCT02589665|78951999|FG007|Maintenance Extension Period|Adverse Event|0|||
44159754|NCT02589665|78952000|FG008|Maintenance Extension Period|Adverse Event|0|||
44159755|NCT02589665|78952001|FG009|Maintenance Extension Period|Adverse Event|2|||
44159756|NCT02589665|78951992|FG000|Maintenance Extension Period|Non-responder|0|||
44159757|NCT02589665|78951993|FG001|Maintenance Extension Period|Non-responder|0|||
44443813|NCT00530439|79451718|FG001|Overall Study|Missed abortion|4|||
44443814|NCT00530439|79451717|FG000|Overall Study|Misclassification|2|||
44443815|NCT00530439|79451718|FG001|Overall Study|Misclassification|0|||
44443816|NCT00530439|79451717|FG000|Overall Study|Twin pregnancy|0|||
44443817|NCT00530439|79451718|FG001|Overall Study|Twin pregnancy|2|||
44159758|NCT02589665|78951994|FG002|Maintenance Extension Period|Non-responder|0|||
44159759|NCT02589665|78951995|FG003|Maintenance Extension Period|Non-responder|0|||
44159760|NCT02589665|78951996|FG004|Maintenance Extension Period|Non-responder|0|||
44159761|NCT02589665|78951997|FG005|Maintenance Extension Period|Non-responder|0|||
44159762|NCT02589665|78951998|FG006|Maintenance Extension Period|Non-responder|0|||
44159763|NCT02589665|78951999|FG007|Maintenance Extension Period|Non-responder|0|||
44159764|NCT02589665|78952000|FG008|Maintenance Extension Period|Non-responder|0|||
44159765|NCT02589665|78952001|FG009|Maintenance Extension Period|Non-responder|1|||
44159766|NCT01905397|78952027|FG000|Overall Study|Death|0|||
44159767|NCT01905397|78952028|FG001|Overall Study|Death|1|||
44159768|NCT01905397|78952027|FG000|Overall Study|Withdrawal by Subject|2|||
44159769|NCT01905397|78952028|FG001|Overall Study|Withdrawal by Subject|0|||
44159770|NCT01905397|78952027|FG000|Overall Study|Surgery canceled/aborted|9|||
44159771|NCT01905397|78952028|FG001|Overall Study|Surgery canceled/aborted|5|||
44159772|NCT01905397|78952027|FG000|Overall Study|Incision < 7 cm|2|||
44159773|NCT01905397|78952028|FG001|Overall Study|Incision < 7 cm|0|||
44159774|NCT01905397|78952027|FG000|Overall Study|Wrong treatment|1|||
44159775|NCT01905397|78952028|FG001|Overall Study|Wrong treatment|1|||
44159776|NCT01905397|78952027|FG000|Overall Study|Device not applied|3|||
44159777|NCT01905397|78952028|FG001|Overall Study|Device not applied|0|||
44159778|NCT01905397|78952027|FG000|Overall Study|Dressing not applied in operating room|1|||
44159779|NCT01905397|78952028|FG001|Overall Study|Dressing not applied in operating room|0|||
44159780|NCT01905397|78952027|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
44260007|NCT01278407|79124568|FG004|Confirmatory Phase|Participant's Choice|0|||
44443818|NCT00530439|79451717|FG000|Overall Study|Severe malformation/abortion|0|||
44443819|NCT00530439|79451718|FG001|Overall Study|Severe malformation/abortion|3|||
44159781|NCT01905397|78952028|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
44159782|NCT01362595|78952034|FG000|Overall Study|Screen failure|10|||
44159783|NCT01362595|78952034|FG000|Overall Study|Withdrawal by Subject|2|||
44159784|NCT02519595|78952041|FG000|Overall Study|Protocol Violation|8|||
44342382|NCT01012414|79346288|FG000|Overall Study|Trial was stopped before completed|7|||
44342383|NCT00975715|79346296|FG000|Titration Period|Adverse Event|6|||
44443820|NCT00497146|79451726|FG000|Treatment Period|Adverse Event|6|||
44342384|NCT00975715|79346297|FG001|Titration Period|Adverse Event|0|||
44342385|NCT00975715|79346296|FG000|Titration Period|Protocol Violation|1|||
44342386|NCT00975715|79346297|FG001|Titration Period|Protocol Violation|0|||
44159785|NCT02519595|78952042|FG001|Overall Study|Protocol Violation|22|||
44159786|NCT02519595|78952043|FG002|Overall Study|Protocol Violation|16|||
44159787|NCT00660673|78952055|FG000|Overall Study|Adverse Event|84|||
44159788|NCT00660673|78952055|FG000|Overall Study|Lack of Efficacy|7|||
44260008|NCT01278407|79124564|FG000|Confirmatory Phase|Other|1|||
44260009|NCT01278407|79124565|FG001|Confirmatory Phase|Other|1|||
44159789|NCT00660673|78952055|FG000|Overall Study|Withdrawal by Subject|22|||
44260010|NCT01278407|79124566|FG002|Confirmatory Phase|Other|2|||
44260011|NCT01278407|79124567|FG003|Confirmatory Phase|Other|0|||
44260012|NCT01278407|79124568|FG004|Confirmatory Phase|Other|0|||
44159790|NCT00660673|78952055|FG000|Overall Study|Administrative|2|||
44159791|NCT00660673|78952055|FG000|Overall Study|Protocol Violation|2|||
44159792|NCT02630563|78952070|FG000|Overall Study|Administrative|1|||
44159793|NCT02588339|78952084|FG000|Overall Study|Withdrawal by Subject|1|||
44159794|NCT02588339|78952084|FG000|Overall Study|GVHD Progression prior to treatment|2|||
44260013|NCT01278407|79124564|FG000|Extension Phase|Adverse Event|0|||
44159795|NCT02629159|78952091|FG000|Overall Study|Adverse Event|17|||
44342387|NCT00975715|79346296|FG000|Maintenance Period|Adverse Event|2|||
44159796|NCT02629159|78952092|FG001|Overall Study|Adverse Event|20|||
44159797|NCT02629159|78952093|FG002|Overall Study|Adverse Event|22|||
44159798|NCT02629159|78952091|FG000|Overall Study|Withdrawal by Subject|22|||
44159799|NCT02629159|78952092|FG001|Overall Study|Withdrawal by Subject|11|||
44159800|NCT02629159|78952093|FG002|Overall Study|Withdrawal by Subject|15|||
44159801|NCT02629159|78952091|FG000|Overall Study|Lost to Follow-up|7|||
44159802|NCT02629159|78952092|FG001|Overall Study|Lost to Follow-up|4|||
44159803|NCT02629159|78952093|FG002|Overall Study|Lost to Follow-up|5|||
44159804|NCT02629159|78952091|FG000|Overall Study|Lack of Efficacy|4|||
44159805|NCT02629159|78952092|FG001|Overall Study|Lack of Efficacy|0|||
44159806|NCT02629159|78952093|FG002|Overall Study|Lack of Efficacy|1|||
44159807|NCT02629159|78952091|FG000|Overall Study|Other|6|||
44159808|NCT02629159|78952092|FG001|Overall Study|Other|4|||
44159809|NCT02629159|78952093|FG002|Overall Study|Other|8|||
44159810|NCT02628769|78952104|FG000|First Intervention|Adverse Event|1|||
44159811|NCT02628769|78952105|FG001|First Intervention|Adverse Event|0|||
44159812|NCT02628769|78952104|FG000|First Intervention|Withdrawal by Subject|0|||
44159813|NCT02628769|78952105|FG001|First Intervention|Withdrawal by Subject|1|||
44159814|NCT02628769|78952104|FG000|Second Intervention|Adverse Event|2|||
44159815|NCT02628769|78952105|FG001|Second Intervention|Adverse Event|0|||
44159816|NCT02628769|78952104|FG000|Second Intervention|Physician Decision|0|||
44159817|NCT02628769|78952105|FG001|Second Intervention|Physician Decision|1|||
44159818|NCT02626819|78952113|FG000|Overall Study|Lost to Follow-up|3|||
44159819|NCT02626819|78952114|FG001|Overall Study|Lost to Follow-up|2|||
44159820|NCT02626819|78952113|FG000|Overall Study|Withdrawal by Subject|1|||
44159821|NCT02626819|78952114|FG001|Overall Study|Withdrawal by Subject|0|||
44159822|NCT02626819|78952113|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
44159823|NCT02626819|78952114|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
44159824|NCT02630251|78952124|FG000|Overall Study|Physician Decision|0|||
44159825|NCT02630251|78952125|FG001|Overall Study|Physician Decision|0|||
44159826|NCT02630251|78952126|FG002|Overall Study|Physician Decision|1|||
44159827|NCT02630251|78952127|FG003|Overall Study|Physician Decision|0|||
44159828|NCT02518113|78952141|FG000|Overall Study|Adverse Event|1|||
44159829|NCT02518113|78952142|FG001|Overall Study|Adverse Event|0|||
44159830|NCT02518113|78952143|FG002|Overall Study|Adverse Event|1|||
44159831|NCT02518113|78952144|FG003|Overall Study|Adverse Event|0|||
44159832|NCT02518113|78952141|FG000|Overall Study|Death|1|||
44159833|NCT02518113|78952142|FG001|Overall Study|Death|2|||
44159834|NCT02518113|78952143|FG002|Overall Study|Death|0|||
44159835|NCT02518113|78952144|FG003|Overall Study|Death|0|||
44159836|NCT02518113|78952141|FG000|Overall Study|Physician Decision|0|||
44159837|NCT02518113|78952142|FG001|Overall Study|Physician Decision|1|||
44159838|NCT02518113|78952143|FG002|Overall Study|Physician Decision|0|||
44159839|NCT02518113|78952144|FG003|Overall Study|Physician Decision|0|||
44159840|NCT02518113|78952141|FG000|Overall Study|Progressive Disease|1|||
44159841|NCT02518113|78952142|FG001|Overall Study|Progressive Disease|2|||
44159842|NCT02518113|78952143|FG002|Overall Study|Progressive Disease|3|||
44159843|NCT02518113|78952144|FG003|Overall Study|Progressive Disease|0|||
44159844|NCT02629861|78952160|FG000|Overall Study|Adverse Event|7|||
44159845|NCT02629861|78952161|FG001|Overall Study|Adverse Event|5|||
44260014|NCT01278407|79124565|FG001|Extension Phase|Adverse Event|0|||
44159846|NCT02629861|78952162|FG002|Overall Study|Adverse Event|4|||
44159847|NCT02629861|78952160|FG000|Overall Study|Withdrawal by Subject|5|||
44159848|NCT02629861|78952161|FG001|Overall Study|Withdrawal by Subject|8|||
44159849|NCT02629861|78952162|FG002|Overall Study|Withdrawal by Subject|13|||
44159850|NCT02629861|78952160|FG000|Overall Study|Protocol Violation|2|||
44159851|NCT02629861|78952161|FG001|Overall Study|Protocol Violation|3|||
44159852|NCT02629861|78952162|FG002|Overall Study|Protocol Violation|7|||
44159853|NCT02629861|78952160|FG000|Overall Study|Lost to Follow-up|12|||
44159854|NCT02629861|78952161|FG001|Overall Study|Lost to Follow-up|9|||
44159855|NCT02629861|78952162|FG002|Overall Study|Lost to Follow-up|4|||
44159856|NCT02629861|78952160|FG000|Overall Study|Other|1|||
44159857|NCT02629861|78952161|FG001|Overall Study|Other|1|||
44159858|NCT02629861|78952162|FG002|Overall Study|Other|0|||
44159859|NCT02629861|78952160|FG000|Overall Study|Pregnancy|2|||
44159860|NCT02629861|78952161|FG001|Overall Study|Pregnancy|1|||
44159861|NCT02629861|78952162|FG002|Overall Study|Pregnancy|0|||
44159862|NCT02482935|78952170|FG000|Period 1|Withdrawal by Subject|1|||
44159863|NCT02482935|78952171|FG001|Period 1|Withdrawal by Subject|0|||
44159864|NCT02513823|78952177|FG000|Overall Study|Lost to Follow-up|4|||
44159865|NCT02513823|78952177|FG000|Overall Study|Physician Decision|1|||
44159866|NCT02513745|78952183|FG000|Overall Study|Criteria at time of surgery not met.|3|||
44159867|NCT02513745|78952184|FG001|Overall Study|Criteria at time of surgery not met.|3|||
44159868|NCT02477553|78952192|FG000|Overall Study|Screening up-to-date|12|||
44159869|NCT02477553|78952193|FG001|Overall Study|Screening up-to-date|13|||
44159870|NCT02477553|78952192|FG000|Overall Study|No MD visit|1|||
44159871|NCT02477553|78952193|FG001|Overall Study|No MD visit|1|||
44159872|NCT02477553|78952192|FG000|Overall Study|Workup consistent w/CRC|1|||
44159873|NCT02477553|78952193|FG001|Overall Study|Workup consistent w/CRC|1|||
44159874|NCT02477553|78952192|FG000|Overall Study|Technical issues with intervention|2|||
44159875|NCT02477553|78952193|FG001|Overall Study|Technical issues with intervention|0|||
44159876|NCT02477553|78952192|FG000|Overall Study|Elevated risk for CRC|2|||
44159877|NCT02477553|78952193|FG001|Overall Study|Elevated risk for CRC|2|||
44159878|NCT02477553|78952192|FG000|Overall Study|MD advised against screening|1|||
44159879|NCT02477553|78952193|FG001|Overall Study|MD advised against screening|3|||
44159880|NCT02477553|78952192|FG000|Overall Study|patient deceased|1|||
44159881|NCT02477553|78952193|FG001|Overall Study|patient deceased|0|||
44159882|NCT01665911|78952199|FG000|Overall Study|Protocol Violation|4|||
44159883|NCT01665911|78952199|FG000|Overall Study|Withdrawal by Subject|1|||
44159884|NCT01665911|78952199|FG000|Overall Study|Adverse Event|1|||
44159885|NCT02452359|78952204|FG000|Overall Study|Adverse Event|1|||
44159886|NCT02452359|78952204|FG000|Overall Study|Lost to Follow-up|15|||
44159887|NCT02452359|78952204|FG000|Overall Study|Pregnancy|1|||
44159888|NCT02452359|78952204|FG000|Overall Study|Withdrawal by Subject|4|||
44159889|NCT02476617|78952208|FG000|Overall Study|Adverse Event|1|||
44159890|NCT02476617|78952208|FG000|Overall Study|Lost to Follow-up|1|||
44159891|NCT01665599|78952225|FG000|Overall Study|Adverse Event|1|||
44159892|NCT01665599|78952225|FG000|Overall Study|Consent Withdrawn|1|||
44159893|NCT01665599|78952225|FG000|Overall Study|Investigator/Sponsor decision|1|||
44159894|NCT01665599|78952225|FG000|Overall Study|Death|1|||
44159895|NCT01665599|78952225|FG000|Overall Study|Lost to Follow-up|2|||
44159896|NCT01665599|78952225|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
44159897|NCT01665599|78952225|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
44159898|NCT01671085|78952231|FG000|Overall Study|Withdrawal by Subject|1|||
44159899|NCT01671085|78952232|FG001|Overall Study|Withdrawal by Subject|0|||
44159900|NCT02510001|78952247|FG000|Overall Study|Early disease progression|0|||
44342388|NCT00975715|79346297|FG001|Maintenance Period|Adverse Event|1|||
44342389|NCT03962491|79346305|FG000|Overall Study|Lost to Follow-up|4|||
44159901|NCT02510001|78952248|FG001|Overall Study|Early disease progression|0|||
44159902|NCT02510001|78952249|FG002|Overall Study|Early disease progression|0|||
44159903|NCT02510001|78952250|FG003|Overall Study|Early disease progression|1|||
44159904|NCT02510001|78952251|FG004|Overall Study|Early disease progression|1|||
44159905|NCT02510001|78952252|FG005|Overall Study|Early disease progression|1|||
44159906|NCT02510001|78952253|FG006|Overall Study|Early disease progression|0|||
44159907|NCT02510001|78952254|FG007|Overall Study|Early disease progression|0|||
44159908|NCT02510001|78952247|FG000|Overall Study|Adverse Event|0|||
44159909|NCT02510001|78952248|FG001|Overall Study|Adverse Event|0|||
44159910|NCT02510001|78952249|FG002|Overall Study|Adverse Event|0|||
44159911|NCT02510001|78952250|FG003|Overall Study|Adverse Event|1|||
44342390|NCT03962491|79346306|FG001|Overall Study|Lost to Follow-up|5|||
44159912|NCT02510001|78952251|FG004|Overall Study|Adverse Event|2|||
44159913|NCT02510001|78952252|FG005|Overall Study|Adverse Event|1|||
44159914|NCT02510001|78952253|FG006|Overall Study|Adverse Event|2|||
44159915|NCT02510001|78952254|FG007|Overall Study|Adverse Event|5|||
44159916|NCT02510001|78952247|FG000|Overall Study|Physician Decision|0|||
44159917|NCT02510001|78952248|FG001|Overall Study|Physician Decision|0|||
44159918|NCT02510001|78952249|FG002|Overall Study|Physician Decision|0|||
44159919|NCT02510001|78952250|FG003|Overall Study|Physician Decision|0|||
44159920|NCT02510001|78952251|FG004|Overall Study|Physician Decision|1|||
44159921|NCT02510001|78952252|FG005|Overall Study|Physician Decision|0|||
44159922|NCT02510001|78952253|FG006|Overall Study|Physician Decision|0|||
44159923|NCT02510001|78952254|FG007|Overall Study|Physician Decision|0|||
44159924|NCT02510001|78952247|FG000|Overall Study|Withdrawal by Subject|0|||
44159925|NCT02510001|78952248|FG001|Overall Study|Withdrawal by Subject|0|||
44159926|NCT02510001|78952249|FG002|Overall Study|Withdrawal by Subject|0|||
44159927|NCT02510001|78952250|FG003|Overall Study|Withdrawal by Subject|0|||
44159928|NCT02510001|78952251|FG004|Overall Study|Withdrawal by Subject|0|||
44159929|NCT02510001|78952252|FG005|Overall Study|Withdrawal by Subject|0|||
44159930|NCT02510001|78952253|FG006|Overall Study|Withdrawal by Subject|0|||
44159931|NCT02510001|78952254|FG007|Overall Study|Withdrawal by Subject|2|||
44159932|NCT02452047|78952293|FG000|Overall Study|Adverse Event|0|||
44159933|NCT02452047|78952294|FG001|Overall Study|Adverse Event|1|||
44159934|NCT02452047|78952295|FG002|Overall Study|Adverse Event|1|||
44159935|NCT02452047|78952293|FG000|Overall Study|Death|1|||
44159936|NCT02452047|78952294|FG001|Overall Study|Death|3|||
44159937|NCT02452047|78952295|FG002|Overall Study|Death|1|||
44159938|NCT02452047|78952293|FG000|Overall Study|Physician Decision|1|||
44159939|NCT02452047|78952294|FG001|Overall Study|Physician Decision|0|||
44342391|NCT00978757|79346314|FG000|Overall Study|Physician Decision|1|||
44443821|NCT00497146|79451727|FG001|Treatment Period|Adverse Event|2|||
44443822|NCT00497146|79451726|FG000|Treatment Period|Withdrawal by Subject|5|||
44443823|NCT00497146|79451727|FG001|Treatment Period|Withdrawal by Subject|9|||
44443824|NCT00497146|79451726|FG000|Treatment Period|Lost to Follow-up|1|||
44443825|NCT00497146|79451727|FG001|Treatment Period|Lost to Follow-up|3|||
44159940|NCT02452047|78952295|FG002|Overall Study|Physician Decision|0|||
44159941|NCT02452047|78952293|FG000|Overall Study|Lost to Follow-up|1|||
44159942|NCT02452047|78952294|FG001|Overall Study|Lost to Follow-up|1|||
44159943|NCT02452047|78952295|FG002|Overall Study|Lost to Follow-up|0|||
44159944|NCT02452047|78952293|FG000|Overall Study|Withdrawal by Subject|1|||
44159945|NCT02452047|78952294|FG001|Overall Study|Withdrawal by Subject|0|||
44159946|NCT02452047|78952295|FG002|Overall Study|Withdrawal by Subject|0|||
44159947|NCT02475369|78952303|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
44159948|NCT02475369|78952304|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
44159949|NCT02474589|78952317|FG000|Overall Study|Adverse Event|6|||
44159950|NCT02474589|78952318|FG001|Overall Study|Adverse Event|2|||
44159951|NCT02474589|78952317|FG000|Overall Study|Lost to Follow-up|6|||
44159952|NCT02474589|78952318|FG001|Overall Study|Lost to Follow-up|1|||
44159953|NCT02474589|78952317|FG000|Overall Study|Protocol Violation|4|||
44159954|NCT02474589|78952318|FG001|Overall Study|Protocol Violation|1|||
44159955|NCT02474589|78952317|FG000|Overall Study|Withdrawal by Subject|4|||
44159956|NCT02474589|78952318|FG001|Overall Study|Withdrawal by Subject|0|||
44159957|NCT02474589|78952317|FG000|Overall Study|Inability to complete study procedures|5|||
44159958|NCT02474589|78952318|FG001|Overall Study|Inability to complete study procedures|1|||
44159959|NCT02586233|78952331|FG000|Overall Study|Randomized but did not receive treatment|0|||
44159960|NCT02586233|78952332|FG001|Overall Study|Randomized but did not receive treatment|1|||
44159961|NCT02586233|78952333|FG002|Overall Study|Randomized but did not receive treatment|0|||
44159962|NCT02586233|78952334|FG003|Overall Study|Randomized but did not receive treatment|0|||
44159963|NCT02586233|78952335|FG004|Overall Study|Randomized but did not receive treatment|0|||
44159964|NCT02586233|78952336|FG005|Overall Study|Randomized but did not receive treatment|2|||
44159965|NCT02586233|78952337|FG006|Overall Study|Randomized but did not receive treatment|2|||
44159966|NCT02586233|78952331|FG000|Overall Study|Death|0|||
44159967|NCT02586233|78952332|FG001|Overall Study|Death|1|||
44159968|NCT02586233|78952333|FG002|Overall Study|Death|0|||
44159969|NCT02586233|78952334|FG003|Overall Study|Death|0|||
44159970|NCT02586233|78952335|FG004|Overall Study|Death|2|||
44159971|NCT02586233|78952336|FG005|Overall Study|Death|0|||
44159972|NCT02586233|78952337|FG006|Overall Study|Death|0|||
44159973|NCT02474355|78952357|FG000|Overall Study|Other|43|||
44159974|NCT02474355|78952357|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
44159975|NCT02474355|78952357|FG000|Overall Study|Lost to Follow-up|98|||
44159976|NCT02474355|78952357|FG000|Overall Study|Withdrawal by Subject|124|||
44159977|NCT02474355|78952357|FG000|Overall Study|Death|1361|||
44159978|NCT02474199|78952363|FG000|Overall Study|Lost to Follow-up|1|||
44159979|NCT02474199|78952364|FG001|Overall Study|Lost to Follow-up|0|||
44159980|NCT02474199|78952365|FG002|Overall Study|Lost to Follow-up|0|||
44159981|NCT02474199|78952366|FG003|Overall Study|Lost to Follow-up|0|||
44159982|NCT02474199|78952363|FG000|Overall Study|Withdrawal by Subject|1|||
44159983|NCT02474199|78952364|FG001|Overall Study|Withdrawal by Subject|2|||
44159984|NCT02474199|78952365|FG002|Overall Study|Withdrawal by Subject|0|||
44159985|NCT02474199|78952366|FG003|Overall Study|Withdrawal by Subject|1|||
44159986|NCT02474199|78952363|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
44159987|NCT02474199|78952364|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
44159988|NCT02474199|78952365|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
44159989|NCT02474199|78952366|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
44159990|NCT02474199|78952363|FG000|Overall Study|Did not meet eligibility criteria|0|||
44159991|NCT02474199|78952364|FG001|Overall Study|Did not meet eligibility criteria|0|||
44159992|NCT02474199|78952365|FG002|Overall Study|Did not meet eligibility criteria|2|||
44159993|NCT02474199|78952366|FG003|Overall Study|Did not meet eligibility criteria|2|||
44159994|NCT02450487|78952373|FG000|Overall Study|Lost to Follow-up|3|||
44159995|NCT02473965|78952380|FG000|Overall Study|Adverse Event|6|||
44159996|NCT02473965|78952381|FG001|Overall Study|Adverse Event|4|||
44159997|NCT02473965|78952380|FG000|Overall Study|MG worsening|4|||
44159998|NCT02473965|78952381|FG001|Overall Study|MG worsening|1|||
44159999|NCT02473965|78952380|FG000|Overall Study|Withdrawal by Subject|2|||
44160000|NCT02473965|78952381|FG001|Overall Study|Withdrawal by Subject|3|||
44160001|NCT02473965|78952380|FG000|Overall Study|Physician Decision|0|||
44160002|NCT02473965|78952381|FG001|Overall Study|Physician Decision|2|||
44160003|NCT02472795|78952392|FG000|Overall Study|Adverse Event|0|||
44160004|NCT02472795|78952393|FG001|Overall Study|Adverse Event|1|||
44160005|NCT02472795|78952394|FG002|Overall Study|Adverse Event|0|||
44160006|NCT02472795|78952395|FG003|Overall Study|Adverse Event|0|||
44160007|NCT02472795|78952396|FG004|Overall Study|Adverse Event|2|||
44160008|NCT02472795|78952392|FG000|Overall Study|Withdrawal by Subject|0|||
44160009|NCT02472795|78952393|FG001|Overall Study|Withdrawal by Subject|0|||
44160010|NCT02472795|78952394|FG002|Overall Study|Withdrawal by Subject|0|||
44160011|NCT02472795|78952395|FG003|Overall Study|Withdrawal by Subject|0|||
44160012|NCT02472795|78952396|FG004|Overall Study|Withdrawal by Subject|1|||
44160013|NCT02507349|78952410|FG000|Overall Study|Death|12|||
44160014|NCT02507349|78952411|FG001|Overall Study|Death|16|||
44160015|NCT02507349|78952410|FG000|Overall Study|Withdrawal by Subject|1|||
44160016|NCT02507349|78952411|FG001|Overall Study|Withdrawal by Subject|1|||
44160017|NCT02507349|78952410|FG000|Overall Study|Lost to Follow-up|174|||
44160018|NCT02507349|78952411|FG001|Overall Study|Lost to Follow-up|144|||
44160019|NCT02506881|78952421|FG000|First Intervention (Day 1)|Protocol Violation|0|||
44160020|NCT02506881|78952422|FG001|First Intervention (Day 1)|Protocol Violation|0|||
44160021|NCT02506881|78952423|FG002|First Intervention (Day 1)|Protocol Violation|1|||
44160022|NCT02506881|78952424|FG003|First Intervention (Day 1)|Protocol Violation|0|||
44160023|NCT02506881|78952421|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
44160024|NCT02506881|78952422|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160025|NCT02506881|78952423|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160026|NCT02506881|78952424|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160027|NCT02506881|78952421|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
44160028|NCT02506881|78952422|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
44160029|NCT02506881|78952423|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
44160030|NCT02506881|78952424|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
44160031|NCT02506257|78952448|FG000|Overall Study|Adverse Event|0|||
44160032|NCT02506257|78952449|FG001|Overall Study|Adverse Event|2|||
44160033|NCT02506257|78952450|FG002|Overall Study|Adverse Event|3|||
44160034|NCT02506257|78952451|FG003|Overall Study|Adverse Event|0|||
44160035|NCT02506257|78952448|FG000|Overall Study|Protocol Violation|0|||
44160036|NCT02506257|78952449|FG001|Overall Study|Protocol Violation|0|||
44160037|NCT02506257|78952450|FG002|Overall Study|Protocol Violation|1|||
44160038|NCT02506257|78952451|FG003|Overall Study|Protocol Violation|0|||
44160039|NCT02506101|78952463|FG000|Overall Study|Transportation issues|1|||
44160040|NCT02506101|78952464|FG001|Overall Study|Transportation issues|0|||
44160041|NCT02506101|78952463|FG000|Overall Study|No enrollment and staff unavailability|1|||
44160042|NCT02506101|78952464|FG001|Overall Study|No enrollment and staff unavailability|0|||
44160043|NCT01671007|78952479|FG000|Overall Study|Other reasons than listed|166|||
44160044|NCT01671007|78952480|FG001|Overall Study|Other reasons than listed|373|||
44160045|NCT01671007|78952481|FG002|Overall Study|Other reasons than listed|197|||
44160046|NCT01671007|78952482|FG003|Overall Study|Other reasons than listed|228|||
44160047|NCT01671007|78952483|FG004|Overall Study|Other reasons than listed|14|||
44160048|NCT01671007|78952484|FG005|Overall Study|Other reasons than listed|71|||
44160049|NCT01671007|78952485|FG006|Overall Study|Other reasons than listed|17|||
44160050|NCT01671007|78952486|FG007|Overall Study|Other reasons than listed|66|||
44160051|NCT01671007|78952487|FG008|Overall Study|Other reasons than listed|0|||
44160052|NCT01671007|78952479|FG000|Overall Study|Withdrawal by Subject|36|||
44160053|NCT01671007|78952480|FG001|Overall Study|Withdrawal by Subject|59|||
44160054|NCT01671007|78952481|FG002|Overall Study|Withdrawal by Subject|53|||
44160055|NCT01671007|78952482|FG003|Overall Study|Withdrawal by Subject|58|||
44160056|NCT01671007|78952483|FG004|Overall Study|Withdrawal by Subject|4|||
44160057|NCT01671007|78952484|FG005|Overall Study|Withdrawal by Subject|15|||
44160058|NCT01671007|78952485|FG006|Overall Study|Withdrawal by Subject|1|||
44160059|NCT01671007|78952486|FG007|Overall Study|Withdrawal by Subject|19|||
44160060|NCT01671007|78952487|FG008|Overall Study|Withdrawal by Subject|0|||
44160061|NCT01671007|78952479|FG000|Overall Study|Lost to Follow-up|93|||
44160062|NCT01671007|78952480|FG001|Overall Study|Lost to Follow-up|142|||
44160063|NCT01671007|78952481|FG002|Overall Study|Lost to Follow-up|91|||
44160064|NCT01671007|78952482|FG003|Overall Study|Lost to Follow-up|63|||
44160065|NCT01671007|78952483|FG004|Overall Study|Lost to Follow-up|7|||
44160066|NCT01671007|78952484|FG005|Overall Study|Lost to Follow-up|20|||
44160067|NCT01671007|78952485|FG006|Overall Study|Lost to Follow-up|2|||
44160068|NCT01671007|78952486|FG007|Overall Study|Lost to Follow-up|28|||
44160069|NCT01671007|78952487|FG008|Overall Study|Lost to Follow-up|0|||
44160070|NCT01671007|78952479|FG000|Overall Study|No end of study case report form|3|||
44160071|NCT01671007|78952480|FG001|Overall Study|No end of study case report form|1|||
44160072|NCT01671007|78952481|FG002|Overall Study|No end of study case report form|0|||
44160073|NCT01671007|78952482|FG003|Overall Study|No end of study case report form|2|||
44160074|NCT01671007|78952483|FG004|Overall Study|No end of study case report form|0|||
44160075|NCT01671007|78952484|FG005|Overall Study|No end of study case report form|0|||
44160076|NCT01671007|78952485|FG006|Overall Study|No end of study case report form|0|||
44160077|NCT01671007|78952486|FG007|Overall Study|No end of study case report form|0|||
44160078|NCT01671007|78952487|FG008|Overall Study|No end of study case report form|0|||
44342392|NCT00978757|79346315|FG001|Overall Study|Physician Decision|3|||
44342393|NCT01214421|79346325|FG000|Overall Study|Lost to Follow-up|7|||
44342394|NCT01214421|79346326|FG001|Overall Study|Lost to Follow-up|3|||
44342395|NCT01214421|79346327|FG002|Overall Study|Lost to Follow-up|7|||
44342396|NCT01214421|79346328|FG003|Overall Study|Lost to Follow-up|3|||
44342397|NCT01214421|79346325|FG000|Overall Study|Adverse Event|16|||
44342398|NCT01214421|79346326|FG001|Overall Study|Adverse Event|35|||
44342399|NCT01214421|79346327|FG002|Overall Study|Adverse Event|14|||
44342400|NCT01214421|79346328|FG003|Overall Study|Adverse Event|3|||
44260015|NCT01278407|79124566|FG002|Extension Phase|Adverse Event|0|||
44260016|NCT01278407|79124567|FG003|Extension Phase|Adverse Event|7|||
44260017|NCT01278407|79124568|FG004|Extension Phase|Adverse Event|16|||
44260018|NCT01278407|79124564|FG000|Extension Phase|Participant's Choice|0|||
44260019|NCT01278407|79124565|FG001|Extension Phase|Participant's Choice|0|||
44260020|NCT01278407|79124566|FG002|Extension Phase|Participant's Choice|0|||
44260021|NCT01278407|79124567|FG003|Extension Phase|Participant's Choice|4|||
44260022|NCT01278407|79124568|FG004|Extension Phase|Participant's Choice|11|||
44260023|NCT01278407|79124564|FG000|Extension Phase|Other|0|||
44260024|NCT01278407|79124565|FG001|Extension Phase|Other|0|||
44260025|NCT01278407|79124566|FG002|Extension Phase|Other|0|||
44260026|NCT01278407|79124567|FG003|Extension Phase|Other|1|||
44260027|NCT01278407|79124568|FG004|Extension Phase|Other|3|||
44260028|NCT01278173|79124578|FG000|Overall Study|Lack of Efficacy|13|||
44260029|NCT01278173|79124578|FG000|Overall Study|Adverse Event|8|||
44260030|NCT01278173|79124578|FG000|Overall Study|Administrative or other reason|4|||
44342401|NCT01214421|79346325|FG000|Overall Study|Sponsor Discontinued Site|1|||
44342402|NCT01214421|79346326|FG001|Overall Study|Sponsor Discontinued Site|2|||
44342403|NCT01214421|79346327|FG002|Overall Study|Sponsor Discontinued Site|0|||
44342404|NCT01214421|79346328|FG003|Overall Study|Sponsor Discontinued Site|0|||
44342405|NCT01214421|79346325|FG000|Overall Study|Withdrawal Criteria Met|3|||
44342406|NCT01214421|79346326|FG001|Overall Study|Withdrawal Criteria Met|0|||
44342407|NCT01214421|79346327|FG002|Overall Study|Withdrawal Criteria Met|2|||
44342408|NCT01214421|79346328|FG003|Overall Study|Withdrawal Criteria Met|1|||
44342409|NCT01214421|79346325|FG000|Overall Study|Physician Decision|2|||
44342410|NCT01214421|79346326|FG001|Overall Study|Physician Decision|0|||
44342411|NCT01214421|79346327|FG002|Overall Study|Physician Decision|4|||
44342412|NCT01214421|79346328|FG003|Overall Study|Physician Decision|0|||
44342413|NCT01214421|79346325|FG000|Overall Study|Withdrawal by Subject|21|||
44342414|NCT01214421|79346326|FG001|Overall Study|Withdrawal by Subject|18|||
44342415|NCT01214421|79346327|FG002|Overall Study|Withdrawal by Subject|11|||
44342416|NCT01214421|79346328|FG003|Overall Study|Withdrawal by Subject|2|||
44342417|NCT04102111|79346340|FG000|Overall Study|Withdrawal by Subject|2|||
44342418|NCT04102111|79346341|FG001|Overall Study|Withdrawal by Subject|3|||
44342419|NCT04102111|79346340|FG000|Overall Study|Adverse Event|1|||
44342420|NCT04102111|79346341|FG001|Overall Study|Adverse Event|1|||
44342421|NCT04102111|79346340|FG000|Overall Study|Study terminated by sponsor|1|||
44342422|NCT04102111|79346341|FG001|Overall Study|Study terminated by sponsor|3|||
44342423|NCT01214187|79346349|FG000|Overall Study|Adverse Event|6|||
44342424|NCT01214187|79346350|FG001|Overall Study|Adverse Event|2|||
44342425|NCT01214187|79346349|FG000|Overall Study|Death|1|||
44342426|NCT01214187|79346350|FG001|Overall Study|Death|1|||
44342427|NCT01214187|79346349|FG000|Overall Study|Withdrawal by Subject|0|||
44342428|NCT01214187|79346350|FG001|Overall Study|Withdrawal by Subject|3|||
44342429|NCT01003990|79346359|FG000|Overall Study|Adverse Event|8|||
44342430|NCT01003990|79346360|FG001|Overall Study|Adverse Event|5|||
44342431|NCT01003990|79346361|FG002|Overall Study|Adverse Event|11|||
44342432|NCT01003990|79346359|FG000|Overall Study|Death|0|||
44342433|NCT01003990|79346360|FG001|Overall Study|Death|8|||
44342434|NCT01003990|79346361|FG002|Overall Study|Death|1|||
44342435|NCT01003990|79346359|FG000|Overall Study|Lack of Efficacy|10|||
44342436|NCT01003990|79346360|FG001|Overall Study|Lack of Efficacy|2|||
44342437|NCT01003990|79346361|FG002|Overall Study|Lack of Efficacy|3|||
44342438|NCT01003990|79346359|FG000|Overall Study|Lost to Follow-up|30|||
44342439|NCT01003990|79346360|FG001|Overall Study|Lost to Follow-up|12|||
44342440|NCT01003990|79346361|FG002|Overall Study|Lost to Follow-up|7|||
44342441|NCT01003990|79346359|FG000|Overall Study|Reasons Not Identified|14|||
44342442|NCT01003990|79346360|FG001|Overall Study|Reasons Not Identified|13|||
44342443|NCT01003990|79346361|FG002|Overall Study|Reasons Not Identified|8|||
44342444|NCT01003990|79346359|FG000|Overall Study|Poor/Non-compliance|4|||
44342445|NCT01003990|79346360|FG001|Overall Study|Poor/Non-compliance|3|||
44342446|NCT01003990|79346361|FG002|Overall Study|Poor/Non-compliance|2|||
44342447|NCT01003990|79346359|FG000|Overall Study|Pregnancy|10|||
44342448|NCT01003990|79346360|FG001|Overall Study|Pregnancy|2|||
44342449|NCT01003990|79346361|FG002|Overall Study|Pregnancy|4|||
44342450|NCT01003990|79346359|FG000|Overall Study|No Longer Met Study Criteria|4|||
44342451|NCT01003990|79346360|FG001|Overall Study|No Longer Met Study Criteria|1|||
44342452|NCT01003990|79346361|FG002|Overall Study|No Longer Met Study Criteria|0|||
44342453|NCT01003990|79346359|FG000|Overall Study|Subject Withdrew Consent|12|||
44342454|NCT01003990|79346360|FG001|Overall Study|Subject Withdrew Consent|5|||
44342455|NCT01003990|79346361|FG002|Overall Study|Subject Withdrew Consent|7|||
44342456|NCT01003210|79346371|FG000|Overall Study|Lost to Follow-up|1|||
44342457|NCT01003210|79346372|FG001|Overall Study|Lost to Follow-up|3|||
44342458|NCT01002820|79346378|FG000|Overall Study|Adverse Event|1|||
44342459|NCT01002820|79346378|FG000|Overall Study|Withdrawal by Subject|2|||
44342460|NCT01002820|79346378|FG000|Overall Study|Lack of Efficacy|1|||
44342461|NCT01012258|79346382|FG000|Overall Study|Death|14|||
44342462|NCT01012258|79346382|FG000|Overall Study|Lost to Follow-up|1|||
44342463|NCT01012258|79346382|FG000|Overall Study|Adverse Event|1|||
44342464|NCT01012258|79346382|FG000|Overall Study|Progressive Disease (PD)|18|||
44342465|NCT01012258|79346382|FG000|Overall Study|Symptomatic Deterioration|1|||
44342466|NCT01012258|79346382|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
44342467|NCT01012258|79346382|FG000|Overall Study|Another Tumor Discovered|1|||
44342468|NCT01012258|79346382|FG000|Overall Study|Ongoing|29|||
44342469|NCT01011946|79346387|FG000|Overall Study|Transferred to another hospital|2|||
44342470|NCT01011946|79346387|FG000|Overall Study|No pathological lab value|1|||
44342471|NCT00975481|79346391|FG000|Second Intervention Period|Adverse Event|2|||
44342472|NCT00975481|79346392|FG001|Second Intervention Period|Adverse Event|1|||
44342473|NCT00975481|79346393|FG002|Second Intervention Period|Adverse Event|0|||
44342474|NCT00975481|79346394|FG003|Second Intervention Period|Adverse Event|0|||
44342475|NCT00975481|79346395|FG004|Second Intervention Period|Adverse Event|0|||
44342476|NCT00975481|79346396|FG005|Second Intervention Period|Adverse Event|0|||
44342477|NCT00975481|79346391|FG000|Second Intervention Period|Withdrawal by Subject|0|||
44342478|NCT00975481|79346392|FG001|Second Intervention Period|Withdrawal by Subject|0|||
44342479|NCT00975481|79346393|FG002|Second Intervention Period|Withdrawal by Subject|1|||
44342480|NCT00975481|79346394|FG003|Second Intervention Period|Withdrawal by Subject|0|||
44342481|NCT00975481|79346395|FG004|Second Intervention Period|Withdrawal by Subject|0|||
44342482|NCT00975481|79346396|FG005|Second Intervention Period|Withdrawal by Subject|0|||
44342483|NCT00975481|79346391|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
44342484|NCT00975481|79346392|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
44342485|NCT00975481|79346393|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
44342486|NCT00975481|79346394|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
44342487|NCT00975481|79346395|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
44342488|NCT00975481|79346396|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
44342489|NCT00975481|79346391|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
44342490|NCT00975481|79346392|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
44342491|NCT00975481|79346393|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
44342492|NCT00975481|79346394|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
44342493|NCT00975481|79346395|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
44342494|NCT00975481|79346396|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
44342495|NCT01011868|79346417|FG000|After Week 18 Follow-up|Adverse Event|8|||
44342496|NCT01011868|79346418|FG001|After Week 18 Follow-up|Adverse Event|6|||
44342497|NCT01011868|79346419|FG002|After Week 18 Follow-up|Adverse Event|13|||
44342498|NCT01011868|79346417|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
44342499|NCT01011868|79346418|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
44342500|NCT01011868|79346419|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
44342501|NCT01011868|79346417|FG000|After Week 18 Follow-up|Protocol Violation|1|||
44342502|NCT01011868|79346418|FG001|After Week 18 Follow-up|Protocol Violation|1|||
44342503|NCT01011868|79346419|FG002|After Week 18 Follow-up|Protocol Violation|1|||
44342504|NCT01011868|79346417|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
44342505|NCT01011868|79346418|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
44342506|NCT01011868|79346419|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
44342507|NCT01011868|79346417|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
44342508|NCT01011868|79346418|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
44342509|NCT01011868|79346419|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
44342510|NCT01011868|79346417|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
44342511|NCT01011868|79346418|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
44342512|NCT01011868|79346419|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
44342513|NCT01011868|79346417|FG000|After Week 78 Follow-up|Adverse Event|14|||
44342514|NCT01011868|79346418|FG001|After Week 78 Follow-up|Adverse Event|18|||
44342515|NCT01011868|79346419|FG002|After Week 78 Follow-up|Adverse Event|21|||
44342516|NCT01011868|79346417|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
44342517|NCT01011868|79346418|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
44342518|NCT01011868|79346419|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
44342519|NCT01011868|79346417|FG000|After Week 78 Follow-up|Protocol Violation|9|||
44342520|NCT01011868|79346418|FG001|After Week 78 Follow-up|Protocol Violation|1|||
44342521|NCT01011868|79346419|FG002|After Week 78 Follow-up|Protocol Violation|2|||
44342522|NCT01011868|79346417|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
44342523|NCT01011868|79346418|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
44342524|NCT01011868|79346419|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
44342525|NCT01011868|79346417|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
44342526|NCT01011868|79346418|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
44342527|NCT01011868|79346419|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
44342528|NCT01011868|79346417|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
44342529|NCT01011868|79346418|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
44342530|NCT01011868|79346419|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
44342531|NCT01213251|79346430|FG000|Overall Study|Death|2|||
44342532|NCT01213251|79346431|FG001|Overall Study|Death|1|||
44342533|NCT01213251|79346432|FG002|Overall Study|Death|2|||
44342534|NCT01213251|79346430|FG000|Overall Study|Exit|3|||
44342535|NCT01213251|79346431|FG001|Overall Study|Exit|2|||
44342536|NCT01213251|79346432|FG002|Overall Study|Exit|8|||
44342537|NCT01213251|79346430|FG000|Overall Study|Protocol Violation|1|||
44342538|NCT01213251|79346431|FG001|Overall Study|Protocol Violation|1|||
44342539|NCT01213251|79346432|FG002|Overall Study|Protocol Violation|0|||
44342540|NCT01213251|79346430|FG000|Overall Study|Missed 18-Month Follow-up|0|||
44342541|NCT01213251|79346431|FG001|Overall Study|Missed 18-Month Follow-up|0|||
44342542|NCT01213251|79346432|FG002|Overall Study|Missed 18-Month Follow-up|1|||
44342543|NCT01213173|79346447|FG000|Overall Study|Protocol Violation|2|||
44342544|NCT01213173|79346448|FG001|Overall Study|Protocol Violation|0|||
44342545|NCT01213173|79346447|FG000|Overall Study|Adverse Event|4|||
44342546|NCT01213173|79346448|FG001|Overall Study|Adverse Event|8|||
44342547|NCT01213173|79346447|FG000|Overall Study|Withdrawal by Subject|5|||
44342548|NCT01213173|79346448|FG001|Overall Study|Withdrawal by Subject|5|||
44342549|NCT01213173|79346447|FG000|Overall Study|Incorrect Enrollment|1|||
44342550|NCT01213173|79346448|FG001|Overall Study|Incorrect Enrollment|3|||
44342551|NCT01212159|79346456|FG000|Overall Study|Withdrawal by Subject|12|||
44342552|NCT01212159|79346457|FG001|Overall Study|Withdrawal by Subject|12|||
44342553|NCT00973765|79346465|FG000|Overall Study|Lost to Follow-up|8|||
44342554|NCT00973765|79346466|FG001|Overall Study|Lost to Follow-up|14|||
44342555|NCT01211769|79346476|FG000|Overall Study|Lost to Follow-up|7|||
44342556|NCT01211769|79346477|FG001|Overall Study|Lost to Follow-up|9|||
44342557|NCT01211769|79346478|FG002|Overall Study|Lost to Follow-up|5|||
44342558|NCT01211769|79346479|FG003|Overall Study|Lost to Follow-up|9|||
44342559|NCT01211769|79346476|FG000|Overall Study|Physician Decision|2|||
44342560|NCT01211769|79346477|FG001|Overall Study|Physician Decision|0|||
44443826|NCT00497146|79451726|FG000|Treatment Period|Required dialysis|4|||
44443827|NCT00497146|79451727|FG001|Treatment Period|Required dialysis|1|||
44443828|NCT00497146|79451726|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
44443829|NCT00497146|79451727|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
44443830|NCT00497146|79451726|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
44443831|NCT00497146|79451727|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
44443832|NCT00497146|79451726|FG000|Treatment Period|Other Reason|2|||
44443833|NCT00497146|79451727|FG001|Treatment Period|Other Reason|3|||
44443834|NCT00497146|79451726|FG000|Long-term Follow-up Period|Adverse Event|2|||
44443835|NCT00497146|79451727|FG001|Long-term Follow-up Period|Adverse Event|2|||
44443836|NCT00497146|79451726|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
44443837|NCT00497146|79451727|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
44443838|NCT00497146|79451726|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
44443839|NCT00497146|79451727|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
44443840|NCT00497146|79451726|FG000|Long-term Follow-up Period|Other|0|||
44443841|NCT00497146|79451727|FG001|Long-term Follow-up Period|Other|1|||
44443842|NCT00489970|79451738|FG000|Persistence Year 9|Lost to Follow-up|2|||
44443843|NCT00489970|79451739|FG001|Persistence Year 9|Lost to Follow-up|2|||
44443844|NCT00489970|79451740|FG002|Persistence Year 9|Lost to Follow-up|3|||
44443845|NCT00489970|79451738|FG000|Persistence Year 9|Other|1|||
44443846|NCT00489970|79451739|FG001|Persistence Year 9|Other|0|||
44443847|NCT00489970|79451740|FG002|Persistence Year 9|Other|2|||
44443848|NCT02798471|79451753|FG000|Overall Study|Adverse Event|7|||
44443849|NCT02798471|79451754|FG001|Overall Study|Adverse Event|2|||
44443850|NCT02798471|79451753|FG000|Overall Study|Physician Decision|3|||
44443851|NCT02798471|79451754|FG001|Overall Study|Physician Decision|7|||
44443852|NCT02798471|79451753|FG000|Overall Study|Death|2|||
44443853|NCT02798471|79451754|FG001|Overall Study|Death|3|||
44443854|NCT02798471|79451753|FG000|Overall Study|Lost to Follow-up|0|||
44443855|NCT02798471|79451754|FG001|Overall Study|Lost to Follow-up|1|||
44443856|NCT02798471|79451753|FG000|Overall Study|Other|5|||
44443857|NCT02798471|79451754|FG001|Overall Study|Other|3|||
44443858|NCT02798471|79451753|FG000|Overall Study|Subject withdrew consent|0|||
44443859|NCT02798471|79451754|FG001|Overall Study|Subject withdrew consent|6|||
44443860|NCT02798471|79451753|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
44443861|NCT02798471|79451754|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
44443862|NCT02798471|79451753|FG000|Overall Study|Randomized, but not treated|0|||
44443863|NCT02798471|79451754|FG001|Overall Study|Randomized, but not treated|2|||
44443864|NCT00489736|79451762|FG000|Overall Study|Lack of Efficacy|53|||
44443865|NCT00489736|79451763|FG001|Overall Study|Lack of Efficacy|14|||
44443866|NCT00489736|79451762|FG000|Overall Study|Adverse Event|32|||
44443867|NCT00489736|79451763|FG001|Overall Study|Adverse Event|45|||
44443868|NCT00489736|79451762|FG000|Overall Study|Poor compliance|6|||
44443869|NCT00489736|79451763|FG001|Overall Study|Poor compliance|2|||
44443870|NCT00489736|79451762|FG000|Overall Study|Not coded/ Not pre-specified|5|||
44443871|NCT00489736|79451763|FG001|Overall Study|Not coded/ Not pre-specified|8|||
44443872|NCT00617084|79451771|FG000|Overall Study|Withdrawal by Subject|5|||
44443873|NCT00617084|79451772|FG001|Overall Study|Withdrawal by Subject|7|||
44443874|NCT00617084|79451771|FG000|Overall Study|Missed 12 Months visit|16|||
44443875|NCT00617084|79451772|FG001|Overall Study|Missed 12 Months visit|19|||
44443876|NCT00489424|79451781|FG000|Overall Study|Adverse Event|3|||
44443877|NCT00489424|79451782|FG001|Overall Study|Adverse Event|3|||
44443878|NCT00489424|79451783|FG002|Overall Study|Adverse Event|4|||
44443879|NCT00489424|79451781|FG000|Overall Study|Lack of Efficacy|1|||
44443880|NCT00489424|79451782|FG001|Overall Study|Lack of Efficacy|0|||
44443881|NCT00489424|79451783|FG002|Overall Study|Lack of Efficacy|0|||
44443882|NCT00489424|79451781|FG000|Overall Study|Administrative problems|0|||
44443883|NCT00489424|79451782|FG001|Overall Study|Administrative problems|2|||
44443884|NCT00489424|79451783|FG002|Overall Study|Administrative problems|1|||
44443885|NCT00614744|79451793|FG000|Overall Study|Lost to Follow-up|5|||
44443886|NCT00614744|79451794|FG001|Overall Study|Lost to Follow-up|4|||
44443887|NCT00614744|79451793|FG000|Overall Study|Incomplete for Behavior Issues|0|||
44443888|NCT00614744|79451794|FG001|Overall Study|Incomplete for Behavior Issues|2|||
44443889|NCT00565812|79451803|FG000|Overall Study|Death|2|||
44443890|NCT00565812|79451804|FG001|Overall Study|Death|1|||
44443891|NCT00565812|79451805|FG002|Overall Study|Death|3|||
44443892|NCT00565812|79451803|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
44443893|NCT00565812|79451804|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
44443894|NCT00565812|79451805|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
44160079|NCT01671007|78952479|FG000|Overall Study|Not eligible|23|||
44342561|NCT01211769|79346478|FG002|Overall Study|Physician Decision|2|||
44342562|NCT01211769|79346479|FG003|Overall Study|Physician Decision|1|||
44342563|NCT01211769|79346476|FG000|Overall Study|Adverse Event|0|||
44342564|NCT01211769|79346477|FG001|Overall Study|Adverse Event|1|||
44342565|NCT01211769|79346478|FG002|Overall Study|Adverse Event|1|||
44342566|NCT01211769|79346479|FG003|Overall Study|Adverse Event|1|||
44342567|NCT01211613|79346492|FG000|Overall Study|Lost to Follow-up|2|||
44342568|NCT01211613|79346493|FG001|Overall Study|Lost to Follow-up|2|||
44342569|NCT01211613|79346494|FG002|Overall Study|Lost to Follow-up|2|||
44342570|NCT01211613|79346492|FG000|Overall Study|Withdrawal by Subject|1|||
44342571|NCT01211613|79346493|FG001|Overall Study|Withdrawal by Subject|0|||
44342572|NCT01211613|79346494|FG002|Overall Study|Withdrawal by Subject|0|||
44342573|NCT01211535|79346504|FG000|Overall Study|Adverse Event|0|||
44342574|NCT01211535|79346505|FG001|Overall Study|Adverse Event|1|||
44342575|NCT01011556|79346515|FG000|Overall Study|Adverse Event|1|||
44342576|NCT01011556|79346516|FG001|Overall Study|Adverse Event|3|||
44342577|NCT01011556|79346517|FG002|Overall Study|Adverse Event|2|||
44342578|NCT01011556|79346518|FG003|Overall Study|Adverse Event|1|||
44342579|NCT01011556|79346515|FG000|Overall Study|Lost to Follow-up|1|||
44342580|NCT01011556|79346516|FG001|Overall Study|Lost to Follow-up|0|||
44342581|NCT01011556|79346517|FG002|Overall Study|Lost to Follow-up|0|||
44342582|NCT01011556|79346518|FG003|Overall Study|Lost to Follow-up|0|||
44342583|NCT01011556|79346515|FG000|Overall Study|Physician Decision|1|||
44342584|NCT01011556|79346516|FG001|Overall Study|Physician Decision|0|||
44342585|NCT01011556|79346517|FG002|Overall Study|Physician Decision|0|||
44342586|NCT01011556|79346518|FG003|Overall Study|Physician Decision|1|||
44342587|NCT01011556|79346515|FG000|Overall Study|Protocol Violation|0|||
44342588|NCT01011556|79346516|FG001|Overall Study|Protocol Violation|1|||
44342589|NCT01011556|79346517|FG002|Overall Study|Protocol Violation|0|||
44342590|NCT01011556|79346518|FG003|Overall Study|Protocol Violation|0|||
44342591|NCT01011556|79346515|FG000|Overall Study|Withdrawal by Subject|1|||
44342592|NCT01011556|79346516|FG001|Overall Study|Withdrawal by Subject|2|||
44342593|NCT01011556|79346517|FG002|Overall Study|Withdrawal by Subject|4|||
44342594|NCT01011556|79346518|FG003|Overall Study|Withdrawal by Subject|4|||
44342595|NCT01011556|79346515|FG000|Overall Study|Sponsor decision|0|||
44342596|NCT01011556|79346516|FG001|Overall Study|Sponsor decision|1|||
44342597|NCT01011556|79346517|FG002|Overall Study|Sponsor decision|1|||
44342598|NCT01011556|79346518|FG003|Overall Study|Sponsor decision|2|||
44342599|NCT01011556|79346515|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
44342600|NCT01011556|79346516|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
44342601|NCT01011556|79346517|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
44342602|NCT01011556|79346518|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
44342603|NCT01211145|79346535|FG000|Overall Study|Reason not specified|3|||
44342604|NCT01211145|79346536|FG001|Overall Study|Reason not specified|2|||
44342605|NCT01211145|79346537|FG002|Overall Study|Reason not specified|2|||
44342606|NCT01211145|79346538|FG003|Overall Study|Reason not specified|1|||
44342607|NCT01211145|79346535|FG000|Overall Study|Lost to Follow-up|3|||
44342608|NCT01211145|79346536|FG001|Overall Study|Lost to Follow-up|2|||
44342609|NCT01211145|79346537|FG002|Overall Study|Lost to Follow-up|1|||
44342610|NCT01211145|79346538|FG003|Overall Study|Lost to Follow-up|2|||
44342611|NCT01211145|79346535|FG000|Overall Study|Study-specific withdrawal criteria|1|||
44342612|NCT01211145|79346536|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44342613|NCT01211145|79346537|FG002|Overall Study|Study-specific withdrawal criteria|0|||
44342614|NCT01211145|79346538|FG003|Overall Study|Study-specific withdrawal criteria|0|||
44342615|NCT01211145|79346535|FG000|Overall Study|Severe noncompliance to protocol|1|||
44342616|NCT01211145|79346536|FG001|Overall Study|Severe noncompliance to protocol|0|||
44342617|NCT01211145|79346537|FG002|Overall Study|Severe noncompliance to protocol|0|||
44342618|NCT01211145|79346538|FG003|Overall Study|Severe noncompliance to protocol|0|||
44342619|NCT01211145|79346535|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
44342620|NCT01211145|79346536|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
44342621|NCT01211145|79346537|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
44342622|NCT01211145|79346538|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
44342623|NCT01211145|79346535|FG000|Overall Study|Patient decision|2|||
44342624|NCT01211145|79346536|FG001|Overall Study|Patient decision|1|||
44342625|NCT01211145|79346537|FG002|Overall Study|Patient decision|0|||
44342626|NCT01211145|79346538|FG003|Overall Study|Patient decision|2|||
44342627|NCT00977665|79346550|FG000|Overall Study|Withdrawal by Subject|1|||
44342628|NCT00977665|79346551|FG001|Overall Study|Withdrawal by Subject|3|||
44342629|NCT00977665|79346550|FG000|Overall Study|Physician Decision|2|||
44443895|NCT00565812|79451803|FG000|Overall Study|Lost to Follow-up|10|||
44160080|NCT01671007|78952480|FG001|Overall Study|Not eligible|76|||
44342630|NCT00977665|79346551|FG001|Overall Study|Physician Decision|1|||
44342631|NCT00977665|79346550|FG000|Overall Study|Sponsor requested withdrawal|0|||
44342632|NCT00977665|79346551|FG001|Overall Study|Sponsor requested withdrawal|1|||
44342633|NCT00977665|79346550|FG000|Overall Study|Lost to Follow-up|1|||
44342634|NCT00977665|79346551|FG001|Overall Study|Lost to Follow-up|0|||
44342635|NCT00977665|79346550|FG000|Overall Study|Death|3|||
44342636|NCT00977665|79346551|FG001|Overall Study|Death|2|||
44342637|NCT00977665|79346550|FG000|Overall Study|Adverse Event|14|||
44342638|NCT00977665|79346551|FG001|Overall Study|Adverse Event|7|||
44342639|NCT00977665|79346550|FG000|Overall Study|Treatment failure|0|||
44342640|NCT00977665|79346551|FG001|Overall Study|Treatment failure|1|||
44342641|NCT01210443|79346557|FG000|Overall Study|Study terminated by sponsor|2|||
44342642|NCT01007812|79346561|FG000|Period 1, One Week|Lost to Follow-up|0|||
44342643|NCT01007812|79346562|FG001|Period 1, One Week|Lost to Follow-up|1|||
44342644|NCT01007812|79346561|FG000|Period 1, One Week|Discomfort|1|||
44342645|NCT01007812|79346562|FG001|Period 1, One Week|Discomfort|0|||
44342646|NCT01208961|79346568|FG000|High-Fat Period III|Protocol Violation|1|||
44342647|NCT01208961|79346569|FG001|High-Fat Period III|Protocol Violation|0|||
44342648|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
44342649|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
44342650|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
44342651|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
44342652|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
44342653|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
44342654|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
44342655|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
44342656|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
44342657|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
44342658|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
44342659|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
44342660|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
44342661|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
44342662|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
44342663|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
44342664|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
44342665|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
44342666|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
44342667|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
44443896|NCT00565812|79451804|FG001|Overall Study|Lost to Follow-up|8|||
44443897|NCT00565812|79451805|FG002|Overall Study|Lost to Follow-up|8|||
44443898|NCT00565812|79451803|FG000|Overall Study|Withdrawal by Subject|58|||
44443899|NCT00565812|79451804|FG001|Overall Study|Withdrawal by Subject|47|||
44443900|NCT00565812|79451805|FG002|Overall Study|Withdrawal by Subject|48|||
44443901|NCT00565812|79451803|FG000|Overall Study|Work Schedule|5|||
44443902|NCT00565812|79451804|FG001|Overall Study|Work Schedule|3|||
44443903|NCT00565812|79451805|FG002|Overall Study|Work Schedule|1|||
44443904|NCT00565812|79451803|FG000|Overall Study|Protocol Violation|2|||
44443905|NCT00565812|79451804|FG001|Overall Study|Protocol Violation|6|||
44443906|NCT00565812|79451805|FG002|Overall Study|Protocol Violation|4|||
44443907|NCT00565812|79451803|FG000|Overall Study|Adverse Event|41|||
44443908|NCT00565812|79451804|FG001|Overall Study|Adverse Event|54|||
44443909|NCT00565812|79451805|FG002|Overall Study|Adverse Event|40|||
44443910|NCT00565812|79451803|FG000|Overall Study|Jury Duty|1|||
44443911|NCT00565812|79451804|FG001|Overall Study|Jury Duty|0|||
44443912|NCT00565812|79451805|FG002|Overall Study|Jury Duty|0|||
44160081|NCT01671007|78952481|FG002|Overall Study|Not eligible|25|||
44160082|NCT01671007|78952482|FG003|Overall Study|Not eligible|17|||
44160083|NCT01671007|78952483|FG004|Overall Study|Not eligible|0|||
44160084|NCT01671007|78952484|FG005|Overall Study|Not eligible|6|||
44160085|NCT01671007|78952485|FG006|Overall Study|Not eligible|1|||
44160086|NCT01671007|78952486|FG007|Overall Study|Not eligible|19|||
44160087|NCT01671007|78952487|FG008|Overall Study|Not eligible|0|||
44160088|NCT02505945|78952500|FG000|Overall Study|Withdrawal by Subject|13|||
44160089|NCT02505945|78952501|FG001|Overall Study|Withdrawal by Subject|2|||
44160090|NCT02505945|78952500|FG000|Overall Study|Adverse Event|1|||
44160091|NCT02505945|78952501|FG001|Overall Study|Adverse Event|0|||
44160092|NCT02505945|78952500|FG000|Overall Study|Physician Decision|2|||
44160093|NCT02505945|78952501|FG001|Overall Study|Physician Decision|1|||
44160094|NCT02505945|78952500|FG000|Overall Study|Lost to Follow-up|6|||
44160095|NCT02505945|78952501|FG001|Overall Study|Lost to Follow-up|1|||
44160096|NCT02505867|78952509|FG000|Overall Study|Lack of Efficacy|6|||
44443913|NCT00565812|79451803|FG000|Overall Study|Relocated Out of Area|5|||
44160097|NCT02505867|78952510|FG001|Overall Study|Lack of Efficacy|6|||
44160098|NCT02472639|78952518|FG000|Overall Study|Physician Decision|4|||
44160099|NCT02472639|78952519|FG001|Overall Study|Physician Decision|3|||
44160100|NCT02472405|78952525|FG000|Overall Study|Lost to Follow-up|9|||
44443914|NCT00565812|79451804|FG001|Overall Study|Relocated Out of Area|8|||
44443915|NCT00565812|79451805|FG002|Overall Study|Relocated Out of Area|9|||
44443916|NCT00565812|79451803|FG000|Overall Study|Sponsor Decision|1|||
44160101|NCT02472405|78952525|FG000|Overall Study|Adverse Event|1|||
44160102|NCT02448771|78952531|FG000|Overall Study|Disease Progression|30|||
44160103|NCT02448771|78952531|FG000|Overall Study|Unacceptable Toxicity|1|||
44160104|NCT02448771|78952531|FG000|Overall Study|Physician Decision|3|||
44160105|NCT02448771|78952531|FG000|Overall Study|Started new therapy|2|||
44160106|NCT02504541|78952536|FG000|Overall Study|Adverse Event|4|||
44160107|NCT02504541|78952536|FG000|Overall Study|Withdrawal by Subject|4|||
44160108|NCT02504541|78952536|FG000|Overall Study|Lost to Follow-up|1|||
44160109|NCT02504541|78952536|FG000|Overall Study|Met Stopping Criteria|1|||
44160110|NCT02504541|78952536|FG000|Overall Study|Protocol Violation|2|||
44160111|NCT02504541|78952536|FG000|Overall Study|Termination by Sponsor|1|||
44160112|NCT02504541|78952536|FG000|Overall Study|Other|2|||
44160113|NCT02504541|78952536|FG000|Overall Study|Multiple|5|||
44160114|NCT02448537|78952543|FG000|Overall Study|Withdrawal by Subject|1|||
44160115|NCT02448537|78952544|FG001|Overall Study|Withdrawal by Subject|1|||
44160116|NCT02448537|78952545|FG002|Overall Study|Withdrawal by Subject|1|||
44160117|NCT02504151|78952555|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
44160118|NCT02504151|78952556|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
44160119|NCT02504151|78952555|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
44160120|NCT02504151|78952556|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
44160121|NCT02504151|78952555|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
44160122|NCT02504151|78952556|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
44160123|NCT02504151|78952555|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
44160124|NCT02504151|78952556|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
44167855|NCT02528357|78961047|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167856|NCT02528357|78961048|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167857|NCT02528357|78961049|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167858|NCT02528357|78961050|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167859|NCT02528357|78961051|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
44167860|NCT02528357|78961052|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
44167861|NCT02528357|78961053|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167862|NCT02528357|78961054|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
44167863|NCT02528357|78961055|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
44167864|NCT02528357|78961056|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
44167865|NCT02528357|78961057|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
44167866|NCT02528357|78961058|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167867|NCT02528357|78961059|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167868|NCT02528357|78961060|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167869|NCT02528357|78961061|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167870|NCT02528357|78961043|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167871|NCT02528357|78961044|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167872|NCT02528357|78961045|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167873|NCT02528357|78961046|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167874|NCT02528357|78961047|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167875|NCT02528357|78961048|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167876|NCT02528357|78961049|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167877|NCT02528357|78961050|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167878|NCT02528357|78961051|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167879|NCT02528357|78961052|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167880|NCT02528357|78961053|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167881|NCT02528357|78961054|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167882|NCT02528357|78961055|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167883|NCT02528357|78961056|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167884|NCT02528357|78961057|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167885|NCT02528357|78961058|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44443917|NCT00565812|79451804|FG001|Overall Study|Sponsor Decision|5|||
44443918|NCT00565812|79451805|FG002|Overall Study|Sponsor Decision|1|||
44443919|NCT00565812|79451803|FG000|Overall Study|Domestic Reasons|7|||
44443920|NCT00565812|79451804|FG001|Overall Study|Domestic Reasons|1|||
44443921|NCT00565812|79451805|FG002|Overall Study|Domestic Reasons|3|||
44443922|NCT00565812|79451803|FG000|Overall Study|Research Site Closure|6|||
44160125|NCT02448381|78952564|FG000|Overall Study|Adverse Event|2|||
44160126|NCT02448381|78952565|FG001|Overall Study|Adverse Event|0|||
44160127|NCT02448381|78952564|FG000|Overall Study|Lost to Follow-up|16|||
44160128|NCT02448381|78952565|FG001|Overall Study|Lost to Follow-up|9|||
44160129|NCT02448381|78952564|FG000|Overall Study|Physician Decision|1|||
44160130|NCT02448381|78952565|FG001|Overall Study|Physician Decision|1|||
44160131|NCT02448381|78952564|FG000|Overall Study|Pregnancy|1|||
44160132|NCT02448381|78952565|FG001|Overall Study|Pregnancy|0|||
44160133|NCT02448381|78952564|FG000|Overall Study|Withdrawal by Subject|13|||
44160134|NCT02448381|78952565|FG001|Overall Study|Withdrawal by Subject|9|||
44160135|NCT02448381|78952564|FG000|Overall Study|Noncompliance with Study Procedures|2|||
44160136|NCT02448381|78952565|FG001|Overall Study|Noncompliance with Study Procedures|0|||
44160137|NCT02448225|78952577|FG000|Overall Study|Withdrawal by Subject|1|||
44160138|NCT02448225|78952577|FG000|Overall Study|Did not get FSPG scan|18|||
44160139|NCT02448225|78952577|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
44160140|NCT02503215|78952584|FG000|Overall Study|Unable to wear compression stockings|1|||
44160141|NCT02503215|78952584|FG000|Overall Study|Unable to use positive airway pressure|2|||
44160142|NCT02447991|78952590|FG000|Overall Study|Withdrawn by subject - no data|0|||
44160143|NCT02447991|78952591|FG001|Overall Study|Withdrawn by subject - no data|2|||
44160144|NCT02447991|78952590|FG000|Overall Study|Withdrawn by Subject - with data|4|||
44160145|NCT02447991|78952591|FG001|Overall Study|Withdrawn by Subject - with data|4|||
44160146|NCT02447991|78952590|FG000|Overall Study|Lost to Follow-up - no data|3|||
44160147|NCT02447991|78952591|FG001|Overall Study|Lost to Follow-up - no data|6|||
44160148|NCT02447991|78952590|FG000|Overall Study|Lost to follow-up - with data|0|||
44160149|NCT02447991|78952591|FG001|Overall Study|Lost to follow-up - with data|3|||
44160150|NCT02447991|78952590|FG000|Overall Study|End of study - no treatment results|3|||
44160151|NCT02447991|78952591|FG001|Overall Study|End of study - no treatment results|6|||
44160152|NCT02447991|78952590|FG000|Overall Study|End of study - partial treatment results|0|||
44160153|NCT02447991|78952591|FG001|Overall Study|End of study - partial treatment results|9|||
44160154|NCT02586155|78952603|FG000|Overall Study|Adverse Event|2|||
44160155|NCT02586155|78952604|FG001|Overall Study|Adverse Event|3|||
44160156|NCT02586155|78952603|FG000|Overall Study|Withdrawal by Subject|31|||
44160157|NCT02586155|78952604|FG001|Overall Study|Withdrawal by Subject|24|||
44160158|NCT02586155|78952603|FG000|Overall Study|Lost to Follow-up|7|||
44160159|NCT02586155|78952604|FG001|Overall Study|Lost to Follow-up|13|||
44160160|NCT02586155|78952603|FG000|Overall Study|Death|61|||
44160161|NCT02586155|78952604|FG001|Overall Study|Death|72|||
44160162|NCT02586155|78952603|FG000|Overall Study|Other reasons|26|||
44160163|NCT02586155|78952604|FG001|Overall Study|Other reasons|15|||
44160164|NCT02446743|78952612|FG000|Overall Study|Withdrawal by Subject|1|||
44160165|NCT02446743|78952613|FG001|Overall Study|Withdrawal by Subject|1|||
44160166|NCT02446743|78952612|FG000|Overall Study|Lost to Follow-up|1|||
44160167|NCT02446743|78952613|FG001|Overall Study|Lost to Follow-up|0|||
44160168|NCT02446743|78952612|FG000|Overall Study|Adverse Event|1|||
44160169|NCT02446743|78952613|FG001|Overall Study|Adverse Event|1|||
44160170|NCT02446743|78952612|FG000|Overall Study|Other|2|||
44160171|NCT02446743|78952613|FG001|Overall Study|Other|3|||
44160172|NCT02586077|78952628|FG000|Overall Study|Withdrawal by Subject|1|||
44160173|NCT02586077|78952628|FG000|Overall Study|Physician Decision|4|||
44160174|NCT02586077|78952628|FG000|Overall Study|Lost to Follow-up|3|||
44160175|NCT02583425|78952633|FG000|Screening|Did not meet entry criteria|12|||
44160176|NCT02583425|78952633|FG000|Baseline|Did not meet continued criteria|5|||
44160177|NCT02583425|78952633|FG000|Treatment Period|Adverse Event|1|||
44160178|NCT02581163|78952638|FG000|Overall Study|Failure to return|15|||
44160179|NCT02581163|78952638|FG000|Overall Study|Insufficient virological response|3|||
44160180|NCT02581163|78952638|FG000|Overall Study|Withdrew consent|1|||
44160181|NCT02581163|78952638|FG000|Overall Study|Death|1|||
44160182|NCT02581163|78952638|FG000|Overall Study|Other, not specified|9|||
44160183|NCT02627677|78952648|FG000|Overall Study|Adverse event (not progressive disease)|1|||
44160184|NCT02627677|78952649|FG001|Overall Study|Adverse event (not progressive disease)|4|||
44160185|NCT02627677|78952650|FG002|Overall Study|Adverse event (not progressive disease)|1|||
44160186|NCT02627677|78952648|FG000|Overall Study|Progressive disease|1|||
44160187|NCT02627677|78952649|FG001|Overall Study|Progressive disease|3|||
44160188|NCT02627677|78952650|FG002|Overall Study|Progressive disease|0|||
44160189|NCT02627677|78952648|FG000|Overall Study|Lack of Efficacy|1|||
44160190|NCT02627677|78952649|FG001|Overall Study|Lack of Efficacy|2|||
44160191|NCT02627677|78952650|FG002|Overall Study|Lack of Efficacy|0|||
44160192|NCT02627677|78952648|FG000|Overall Study|Lost to Follow-up|0|||
44160193|NCT02627677|78952649|FG001|Overall Study|Lost to Follow-up|0|||
44160194|NCT02627677|78952650|FG002|Overall Study|Lost to Follow-up|1|||
44160195|NCT02627677|78952648|FG000|Overall Study|Pregnancy|0|||
44160196|NCT02627677|78952649|FG001|Overall Study|Pregnancy|1|||
44160197|NCT02627677|78952650|FG002|Overall Study|Pregnancy|0|||
44160198|NCT02627677|78952648|FG000|Overall Study|Study Terminated by Sponsor|5|||
44160199|NCT02627677|78952649|FG001|Overall Study|Study Terminated by Sponsor|10|||
44160200|NCT02627677|78952650|FG002|Overall Study|Study Terminated by Sponsor|6|||
44160201|NCT02627677|78952648|FG000|Overall Study|Physician Decision|0|||
44160202|NCT02627677|78952649|FG001|Overall Study|Physician Decision|0|||
44160203|NCT02627677|78952650|FG002|Overall Study|Physician Decision|2|||
44160204|NCT02627677|78952648|FG000|Overall Study|Withdrawal by Subject|2|||
44160205|NCT02627677|78952649|FG001|Overall Study|Withdrawal by Subject|1|||
44160206|NCT02627677|78952650|FG002|Overall Study|Withdrawal by Subject|1|||
44160207|NCT02627677|78952648|FG000|Overall Study|Reason not Specified|0|||
44160208|NCT02627677|78952649|FG001|Overall Study|Reason not Specified|0|||
44160209|NCT02627677|78952650|FG002|Overall Study|Reason not Specified|1|||
44160210|NCT02627677|78952648|FG000|Overall Study|Randomized but not Treated|1|||
44160211|NCT02627677|78952649|FG001|Overall Study|Randomized but not Treated|0|||
44160212|NCT02627677|78952650|FG002|Overall Study|Randomized but not Treated|0|||
44160213|NCT02501811|78952663|FG000|Overall Study|Death|1|||
44160214|NCT02501811|78952664|FG001|Overall Study|Death|3|||
44160215|NCT02501811|78952665|FG002|Overall Study|Death|2|||
44160216|NCT02501811|78952666|FG003|Overall Study|Death|3|||
44160217|NCT02501811|78952663|FG000|Overall Study|Withdrawal by Subject|3|||
44160218|NCT02501811|78952664|FG001|Overall Study|Withdrawal by Subject|3|||
44160219|NCT02501811|78952665|FG002|Overall Study|Withdrawal by Subject|2|||
44160220|NCT02501811|78952666|FG003|Overall Study|Withdrawal by Subject|3|||
44160221|NCT02501811|78952663|FG000|Overall Study|Lost to Follow-up|0|||
44342668|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
44342669|NCT01001572|79346576|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
44342670|NCT01001572|79346577|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
44342671|NCT01001572|79346578|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
44342672|NCT01001572|79346576|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
44342673|NCT01001572|79346577|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
44342674|NCT01001572|79346578|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
44342675|NCT01001572|79346576|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44342676|NCT01001572|79346577|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
44342677|NCT01001572|79346578|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
44342678|NCT01001572|79346576|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
44160222|NCT02501811|78952664|FG001|Overall Study|Lost to Follow-up|0|||
44160223|NCT02501811|78952665|FG002|Overall Study|Lost to Follow-up|2|||
44160224|NCT02501811|78952666|FG003|Overall Study|Lost to Follow-up|1|||
44342679|NCT01001572|79346577|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
44342680|NCT01001572|79346578|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
44342681|NCT01001572|79346576|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
44342682|NCT01001572|79346577|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
44443923|NCT00565812|79451804|FG001|Overall Study|Research Site Closure|1|||
44160225|NCT02585999|78952676|FG000|Overall Study|Lost to Follow-up|1|||
44160226|NCT02585999|78952676|FG000|Overall Study|Protocol Violation|1|||
44160227|NCT02582255|78952683|FG000|Overall Study|Protocol Violation|0|||
44160228|NCT02582255|78952684|FG001|Overall Study|Protocol Violation|3|||
44160229|NCT02500719|78952693|FG000|Overall Study|Lost to Follow-up|2|||
44160230|NCT02500719|78952694|FG001|Overall Study|Lost to Follow-up|3|||
44160231|NCT02500719|78952693|FG000|Overall Study|Trauma history|1|||
44160232|NCT02500719|78952694|FG001|Overall Study|Trauma history|0|||
44160233|NCT02500719|78952693|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
44160234|NCT02500719|78952694|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
44160235|NCT02500719|78952693|FG000|Overall Study|Did not meet criteria for PTSD|0|||
44443924|NCT00565812|79451805|FG002|Overall Study|Research Site Closure|8|||
44160236|NCT02500719|78952694|FG001|Overall Study|Did not meet criteria for PTSD|1|||
44160237|NCT02500719|78952693|FG000|Overall Study|Claustrophobia|0|||
44160238|NCT02500719|78952694|FG001|Overall Study|Claustrophobia|1|||
44160239|NCT02500719|78952693|FG000|Overall Study|History of head trauma|0|||
44160240|NCT02500719|78952694|FG001|Overall Study|History of head trauma|1|||
44160241|NCT02500641|78952702|FG000|Overall Study|Adverse Event|0|||
44160242|NCT02500641|78952703|FG001|Overall Study|Adverse Event|2|||
44160243|NCT02500641|78952702|FG000|Overall Study|Withdrawal by Subject|4|||
44160244|NCT02500641|78952703|FG001|Overall Study|Withdrawal by Subject|5|||
44160245|NCT02500641|78952702|FG000|Overall Study|Unable to follow study procedures|3|||
44160246|NCT02500641|78952703|FG001|Overall Study|Unable to follow study procedures|2|||
44160247|NCT02500641|78952702|FG000|Overall Study|Protocol Violation|1|||
44160248|NCT02500641|78952703|FG001|Overall Study|Protocol Violation|2|||
44160249|NCT02500641|78952702|FG000|Overall Study|Lost to Follow-up|1|||
44160250|NCT02500641|78952703|FG001|Overall Study|Lost to Follow-up|0|||
44160251|NCT02500641|78952702|FG000|Overall Study|Sponsor decision|1|||
44160252|NCT02500641|78952703|FG001|Overall Study|Sponsor decision|0|||
44160253|NCT02500641|78952702|FG000|Overall Study|Non compliance to study drug|0|||
44160254|NCT02500641|78952703|FG001|Overall Study|Non compliance to study drug|1|||
44160255|NCT02499783|78952711|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
44160256|NCT02499783|78952712|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
44160257|NCT02499783|78952713|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
44160258|NCT02499783|78952711|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
44160259|NCT02499783|78952712|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
44160260|NCT02499783|78952713|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
44160261|NCT02499783|78952711|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
44160262|NCT02499783|78952712|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
44160263|NCT02499783|78952713|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
44160264|NCT02499783|78952711|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
44160265|NCT02499783|78952712|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
44160266|NCT02499783|78952713|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
44160267|NCT02499783|78952711|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
44160268|NCT02499783|78952712|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
44160269|NCT02499783|78952713|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
44160270|NCT02499783|78952711|FG000|DB Period: Weeks 0-8|Other|1|||
44160271|NCT02499783|78952712|FG001|DB Period: Weeks 0-8|Other|1|||
44160272|NCT02499783|78952713|FG002|DB Period: Weeks 0-8|Other|0|||
44160273|NCT02499783|78952711|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
44160274|NCT02499783|78952712|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
44160275|NCT02499783|78952713|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
44160276|NCT02499783|78952711|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
44160277|NCT02499783|78952712|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
44160278|NCT02499783|78952713|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
44160279|NCT02499783|78952711|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
44160280|NCT02499783|78952712|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
44160281|NCT02499783|78952713|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
44160282|NCT02499783|78952711|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
44160283|NCT02499783|78952712|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
44160284|NCT02499783|78952713|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
44160285|NCT02468193|78952723|FG000|Overall Study|Adverse Event|4|||
44160286|NCT02468193|78952723|FG000|Overall Study|Subject/ Guardian decision|2|||
44160287|NCT02466555|78952743|FG000|Overall Study|Lost to Follow-up|2|||
44160288|NCT02466399|78952750|FG000|Overall Study|Adverse Event|1|||
44160289|NCT02466399|78952751|FG001|Overall Study|Adverse Event|0|||
44342683|NCT01001572|79346578|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
44342684|NCT01001572|79346576|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
44342685|NCT01001572|79346577|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
44342686|NCT01001572|79346578|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
44342687|NCT01001572|79346576|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44342688|NCT01001572|79346577|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44342689|NCT01001572|79346578|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
44342690|NCT01208415|79346584|FG000|Overall Study|Death|1|||
44342691|NCT01208415|79346584|FG000|Overall Study|Lost to Follow-up|2|||
44342692|NCT01208415|79346584|FG000|Overall Study|Withdrawal by Subject|3|||
44342693|NCT01208415|79346584|FG000|Overall Study|Device not placed|1|||
44342694|NCT01208415|79346584|FG000|Overall Study|Still be eligible for follow-up|33|||
44160290|NCT02466399|78952750|FG000|Overall Study|Early exit due to family emergency|1|||
44160291|NCT02466399|78952751|FG001|Overall Study|Early exit due to family emergency|0|||
44160292|NCT02465931|78952759|FG000|Overall Study|Lost to Follow-up|9|||
44160293|NCT02465931|78952760|FG001|Overall Study|Lost to Follow-up|11|||
44342695|NCT01208337|79346588|FG000|Overall Study|Death|3|||
44342696|NCT01208181|79346604|FG000|Part 1|Withdrawal by Subject|11|||
44342697|NCT01208181|79346605|FG001|Part 1|Withdrawal by Subject|10|||
44342698|NCT01208181|79346606|FG002|Part 1|Withdrawal by Subject|0|||
44342699|NCT01208181|79346607|FG003|Part 1|Withdrawal by Subject|0|||
44342700|NCT01208181|79346608|FG004|Part 1|Withdrawal by Subject|0|||
44342701|NCT01208181|79346604|FG000|Part 1|Technical problem|5|||
44342702|NCT01208181|79346605|FG001|Part 1|Technical problem|0|||
44443925|NCT00565812|79451803|FG000|Overall Study|Surgical Intervention|0|||
44443926|NCT00565812|79451804|FG001|Overall Study|Surgical Intervention|1|||
44160294|NCT02465931|78952759|FG000|Overall Study|Protocol Violation|1|||
44342703|NCT01208181|79346606|FG002|Part 1|Technical problem|0|||
44342704|NCT01208181|79346607|FG003|Part 1|Technical problem|0|||
44342705|NCT01208181|79346608|FG004|Part 1|Technical problem|0|||
44342706|NCT01208181|79346604|FG000|Part 1|Protocol Violation|10|||
44342707|NCT01208181|79346605|FG001|Part 1|Protocol Violation|5|||
44342708|NCT01208181|79346606|FG002|Part 1|Protocol Violation|0|||
44342709|NCT01208181|79346607|FG003|Part 1|Protocol Violation|0|||
44342710|NCT01208181|79346608|FG004|Part 1|Protocol Violation|0|||
44342711|NCT01208181|79346604|FG000|Part 1|Physician Decision|4|||
44342712|NCT01208181|79346605|FG001|Part 1|Physician Decision|0|||
44342713|NCT01208181|79346606|FG002|Part 1|Physician Decision|0|||
44342714|NCT01208181|79346607|FG003|Part 1|Physician Decision|0|||
44342715|NCT01208181|79346608|FG004|Part 1|Physician Decision|0|||
44342716|NCT01208181|79346604|FG000|Part 1|Non-compliance with study drug|1|||
44342717|NCT01208181|79346605|FG001|Part 1|Non-compliance with study drug|1|||
44342718|NCT01208181|79346606|FG002|Part 1|Non-compliance with study drug|0|||
44342719|NCT01208181|79346607|FG003|Part 1|Non-compliance with study drug|0|||
44342720|NCT01208181|79346608|FG004|Part 1|Non-compliance with study drug|0|||
44342721|NCT01208181|79346604|FG000|Part 1|Lost to Follow-up|5|||
44342722|NCT01208181|79346605|FG001|Part 1|Lost to Follow-up|3|||
44342723|NCT01208181|79346606|FG002|Part 1|Lost to Follow-up|0|||
44342724|NCT01208181|79346607|FG003|Part 1|Lost to Follow-up|0|||
44342725|NCT01208181|79346608|FG004|Part 1|Lost to Follow-up|1|||
44342726|NCT01208181|79346604|FG000|Part 1|Lack of Efficacy|37|||
44342727|NCT01208181|79346605|FG001|Part 1|Lack of Efficacy|12|||
44342728|NCT01208181|79346606|FG002|Part 1|Lack of Efficacy|0|||
44342729|NCT01208181|79346607|FG003|Part 1|Lack of Efficacy|0|||
44342730|NCT01208181|79346608|FG004|Part 1|Lack of Efficacy|17|||
44342731|NCT01208181|79346604|FG000|Part 1|Adverse Event|26|||
44342732|NCT01208181|79346605|FG001|Part 1|Adverse Event|24|||
44342733|NCT01208181|79346606|FG002|Part 1|Adverse Event|0|||
44342734|NCT01208181|79346607|FG003|Part 1|Adverse Event|0|||
44342735|NCT01208181|79346608|FG004|Part 1|Adverse Event|4|||
44342736|NCT01208181|79346604|FG000|Part 2|Adverse Event|0|||
44342737|NCT01208181|79346605|FG001|Part 2|Adverse Event|0|||
44342738|NCT01208181|79346606|FG002|Part 2|Adverse Event|6|||
44342739|NCT01208181|79346607|FG003|Part 2|Adverse Event|7|||
44342740|NCT01208181|79346608|FG004|Part 2|Adverse Event|0|||
44342741|NCT01208181|79346604|FG000|Part 2|Withdrawal by Subject|0|||
44342742|NCT01208181|79346605|FG001|Part 2|Withdrawal by Subject|0|||
44342743|NCT01208181|79346606|FG002|Part 2|Withdrawal by Subject|1|||
44342744|NCT01208181|79346607|FG003|Part 2|Withdrawal by Subject|1|||
44342745|NCT01208181|79346608|FG004|Part 2|Withdrawal by Subject|0|||
44342746|NCT01208181|79346604|FG000|Part 2|Protocol Violation|0|||
44342747|NCT01208181|79346605|FG001|Part 2|Protocol Violation|0|||
44342748|NCT01208181|79346606|FG002|Part 2|Protocol Violation|1|||
44342749|NCT01208181|79346607|FG003|Part 2|Protocol Violation|0|||
44342750|NCT01208181|79346608|FG004|Part 2|Protocol Violation|0|||
44342751|NCT01208181|79346604|FG000|Part 2|Physician Decision|0|||
44342752|NCT01208181|79346605|FG001|Part 2|Physician Decision|0|||
44342753|NCT01208181|79346606|FG002|Part 2|Physician Decision|1|||
44342754|NCT01208181|79346607|FG003|Part 2|Physician Decision|2|||
44342755|NCT01208181|79346608|FG004|Part 2|Physician Decision|0|||
44342756|NCT01208181|79346604|FG000|Part 2|Non-compliance with study drug|0|||
44342757|NCT01208181|79346605|FG001|Part 2|Non-compliance with study drug|0|||
44342758|NCT01208181|79346606|FG002|Part 2|Non-compliance with study drug|1|||
44342759|NCT01208181|79346607|FG003|Part 2|Non-compliance with study drug|1|||
44342760|NCT01208181|79346608|FG004|Part 2|Non-compliance with study drug|0|||
44342761|NCT01208181|79346604|FG000|Part 2|Lost to Follow-up|0|||
44342762|NCT01208181|79346605|FG001|Part 2|Lost to Follow-up|0|||
44342763|NCT01208181|79346606|FG002|Part 2|Lost to Follow-up|1|||
44342764|NCT01208181|79346607|FG003|Part 2|Lost to Follow-up|2|||
44160295|NCT02465931|78952760|FG001|Overall Study|Protocol Violation|0|||
44260031|NCT01278173|79124578|FG000|Overall Study|Protocol Violation|1|||
44260032|NCT01278173|79124578|FG000|Overall Study|Withdrawal by Subject|1|||
44260033|NCT01277861|79124611|FG000|Overall Study|Physician Decision|2|||
44260034|NCT01277861|79124612|FG001|Overall Study|Physician Decision|2|||
44260035|NCT01277549|79124639|FG000|Overall Study|Failed to meet eligibility criteria|13|||
44260036|NCT01277549|79124640|FG001|Overall Study|Failed to meet eligibility criteria|9|||
44260037|NCT01277549|79124639|FG000|Overall Study|Withdrawal by Subject|1|||
44342765|NCT01208181|79346608|FG004|Part 2|Lost to Follow-up|0|||
44342766|NCT01208181|79346604|FG000|Part 2|Lack of Efficacy|0|||
44342767|NCT01208181|79346605|FG001|Part 2|Lack of Efficacy|0|||
44342768|NCT01208181|79346606|FG002|Part 2|Lack of Efficacy|5|||
44342769|NCT01208181|79346607|FG003|Part 2|Lack of Efficacy|7|||
44342770|NCT01208181|79346608|FG004|Part 2|Lack of Efficacy|0|||
44260038|NCT01277549|79124640|FG001|Overall Study|Withdrawal by Subject|3|||
44260039|NCT01277549|79124639|FG000|Overall Study|Protocol Violation|10|||
44260040|NCT01277549|79124640|FG001|Overall Study|Protocol Violation|1|||
44260041|NCT01277549|79124639|FG000|Overall Study|Physician Decision|2|||
44260042|NCT01277549|79124640|FG001|Overall Study|Physician Decision|1|||
44260043|NCT01276847|79124652|FG000|Overall Study|Withdrawal by Subject|1|||
44342771|NCT01208103|79346625|FG000|Overall Study|Adverse Event|1|||
44342772|NCT01208103|79346625|FG000|Overall Study|Withdrawal by Subject|1|||
44342773|NCT01206777|79346630|FG000|Overall Study|Death|1|||
44342774|NCT01206777|79346630|FG000|Overall Study|Adverse Event|1|||
44342775|NCT01001494|79346637|FG000|Overall Study|Adverse Event|8|||
44342776|NCT01001494|79346638|FG001|Overall Study|Adverse Event|4|||
44342777|NCT01001494|79346639|FG002|Overall Study|Adverse Event|6|||
44160296|NCT02465931|78952759|FG000|Overall Study|Withdrawal by Subject|1|||
44160297|NCT02465931|78952760|FG001|Overall Study|Withdrawal by Subject|0|||
44160298|NCT02465463|78952768|FG000|Overall Study|Lost to Follow-up|2|||
44160299|NCT02465463|78952769|FG001|Overall Study|Lost to Follow-up|1|||
44160300|NCT02465463|78952768|FG000|Overall Study|Death|1|||
44160301|NCT02465463|78952769|FG001|Overall Study|Death|0|||
44160302|NCT02465463|78952768|FG000|Overall Study|Protocol Violation|1|||
44160303|NCT02465463|78952769|FG001|Overall Study|Protocol Violation|0|||
44160304|NCT02464059|78952776|FG000|Overall Study|Lost to Follow-up|6|||
44160305|NCT02463357|78952785|FG000|Overall Study|Withdrawal by Subject|1|||
44342778|NCT01001494|79346637|FG000|Overall Study|Protocol Violation|0|||
44342779|NCT01001494|79346638|FG001|Overall Study|Protocol Violation|1|||
44342780|NCT01001494|79346639|FG002|Overall Study|Protocol Violation|1|||
44342781|NCT01001494|79346637|FG000|Overall Study|Lost to Follow-up|2|||
44342782|NCT01001494|79346638|FG001|Overall Study|Lost to Follow-up|0|||
44342783|NCT01001494|79346639|FG002|Overall Study|Lost to Follow-up|1|||
44342784|NCT01001494|79346637|FG000|Overall Study|Withdrawal by Subject|9|||
44342785|NCT01001494|79346638|FG001|Overall Study|Withdrawal by Subject|7|||
44342786|NCT01001494|79346639|FG002|Overall Study|Withdrawal by Subject|17|||
44342787|NCT01001494|79346637|FG000|Overall Study|COPD exacerbation|3|||
44342788|NCT01001494|79346638|FG001|Overall Study|COPD exacerbation|4|||
44342789|NCT01001494|79346639|FG002|Overall Study|COPD exacerbation|5|||
44342790|NCT01001494|79346637|FG000|Overall Study|Lack of Efficacy|2|||
44342791|NCT01001494|79346638|FG001|Overall Study|Lack of Efficacy|0|||
44342792|NCT01001494|79346639|FG002|Overall Study|Lack of Efficacy|8|||
44342793|NCT01001494|79346637|FG000|Overall Study|Other|0|||
44342794|NCT01001494|79346638|FG001|Overall Study|Other|1|||
44342795|NCT01001494|79346639|FG002|Overall Study|Other|3|||
44342796|NCT01205685|79346647|FG000|Overall Study|Disease Progression|10|||
44342797|NCT01205685|79346647|FG000|Overall Study|Withdrawal by Subject|1|||
44342798|NCT01205529|79346651|FG000|Overall Study|Procedure Cancelled|4|||
44342799|NCT01205529|79346651|FG000|Overall Study|Withdrawal by Subject|2|||
44342800|NCT01205529|79346651|FG000|Overall Study|Physician Decision|4|||
44342801|NCT01205529|79346651|FG000|Overall Study|Unstable post op|15|||
44342802|NCT01205529|79346651|FG000|Overall Study|No longer met criteria|30|||
44342803|NCT01205451|79346657|FG000|Overall Study|Lost to Follow-up|1|||
44342804|NCT01205451|79346658|FG001|Overall Study|Lost to Follow-up|1|||
44342805|NCT01205451|79346657|FG000|Overall Study|Withdrawal by Subject|5|||
44342806|NCT01205451|79346658|FG001|Overall Study|Withdrawal by Subject|9|||
44342807|NCT01001104|79346668|FG000|Overall Study|Adverse Event|2|||
44342808|NCT01001104|79346669|FG001|Overall Study|Adverse Event|1|||
44342809|NCT01001104|79346670|FG002|Overall Study|Adverse Event|0|||
44342810|NCT01001104|79346671|FG003|Overall Study|Adverse Event|0|||
44342811|NCT01001104|79346668|FG000|Overall Study|Lost to Follow-up|0|||
44342812|NCT01001104|79346669|FG001|Overall Study|Lost to Follow-up|0|||
44342813|NCT01001104|79346670|FG002|Overall Study|Lost to Follow-up|1|||
44342814|NCT01001104|79346671|FG003|Overall Study|Lost to Follow-up|0|||
44342815|NCT01001104|79346668|FG000|Overall Study|Entry Criteria Not Met|0|||
44342816|NCT01001104|79346669|FG001|Overall Study|Entry Criteria Not Met|0|||
44342817|NCT01001104|79346670|FG002|Overall Study|Entry Criteria Not Met|0|||
44342818|NCT01001104|79346671|FG003|Overall Study|Entry Criteria Not Met|1|||
44342819|NCT01001104|79346668|FG000|Overall Study|Withdrawal by Subject|0|||
44342820|NCT01001104|79346669|FG001|Overall Study|Withdrawal by Subject|0|||
44342821|NCT01001104|79346670|FG002|Overall Study|Withdrawal by Subject|0|||
44342822|NCT01001104|79346671|FG003|Overall Study|Withdrawal by Subject|2|||
44342823|NCT00998764|79346686|FG000|Overall Study|Lack of Efficacy|3|||
44342824|NCT00998764|79346687|FG001|Overall Study|Lack of Efficacy|6|||
44342825|NCT00998764|79346686|FG000|Overall Study|Adverse Event|17|||
44342826|NCT00998764|79346687|FG001|Overall Study|Adverse Event|12|||
44342827|NCT00998764|79346686|FG000|Overall Study|Withdrawal by Subject|19|||
44342828|NCT00998764|79346687|FG001|Overall Study|Withdrawal by Subject|25|||
44342829|NCT00998764|79346686|FG000|Overall Study|Physician Decision|3|||
44342830|NCT00998764|79346687|FG001|Overall Study|Physician Decision|3|||
44342831|NCT00998764|79346686|FG000|Overall Study|Death|3|||
44342832|NCT00998764|79346687|FG001|Overall Study|Death|1|||
44342833|NCT00998764|79346686|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
44342834|NCT00998764|79346687|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
44342835|NCT00998764|79346686|FG000|Overall Study|Protocol Violation|0|||
44342836|NCT00998764|79346687|FG001|Overall Study|Protocol Violation|1|||
44160306|NCT02463357|78952786|FG001|Overall Study|Withdrawal by Subject|0|||
44160307|NCT02463357|78952787|FG002|Overall Study|Withdrawal by Subject|0|||
44160308|NCT02463357|78952788|FG003|Overall Study|Withdrawal by Subject|0|||
44342837|NCT00998764|79346686|FG000|Overall Study|Failed to Return|1|||
44342838|NCT00998764|79346687|FG001|Overall Study|Failed to Return|1|||
44342839|NCT00998764|79346686|FG000|Overall Study|Lost to Follow-up|1|||
44342840|NCT00998764|79346687|FG001|Overall Study|Lost to Follow-up|1|||
44342841|NCT00998764|79346686|FG000|Overall Study|Loss of Caregiver|0|||
44342842|NCT00998764|79346687|FG001|Overall Study|Loss of Caregiver|3|||
44342843|NCT00998764|79346686|FG000|Overall Study|Other|4|||
44342844|NCT00998764|79346687|FG001|Overall Study|Other|4|||
44342845|NCT00998764|79346686|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
44342846|NCT00998764|79346687|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
44342847|NCT01204671|79346700|FG000|Overall Study|Adverse Event|4|||
44342848|NCT01204671|79346701|FG001|Overall Study|Adverse Event|3|||
44342849|NCT01204671|79346702|FG002|Overall Study|Adverse Event|3|||
44342850|NCT01204671|79346703|FG003|Overall Study|Adverse Event|3|||
44342851|NCT01204671|79346704|FG004|Overall Study|Adverse Event|1|||
44342852|NCT01204671|79346700|FG000|Overall Study|Withdrawal by Subject|2|||
44342853|NCT01204671|79346701|FG001|Overall Study|Withdrawal by Subject|3|||
44342854|NCT01204671|79346702|FG002|Overall Study|Withdrawal by Subject|4|||
44342855|NCT01204671|79346703|FG003|Overall Study|Withdrawal by Subject|5|||
44342856|NCT01204671|79346704|FG004|Overall Study|Withdrawal by Subject|3|||
44342857|NCT01204671|79346700|FG000|Overall Study|Lost to Follow-up|7|||
44342858|NCT01204671|79346701|FG001|Overall Study|Lost to Follow-up|8|||
44342859|NCT01204671|79346702|FG002|Overall Study|Lost to Follow-up|6|||
44342860|NCT01204671|79346703|FG003|Overall Study|Lost to Follow-up|4|||
44342861|NCT01204671|79346704|FG004|Overall Study|Lost to Follow-up|0|||
44342862|NCT01204671|79346700|FG000|Overall Study|Unknown Completion Status|1|||
44342863|NCT01204671|79346701|FG001|Overall Study|Unknown Completion Status|1|||
44342864|NCT01204671|79346702|FG002|Overall Study|Unknown Completion Status|0|||
44342865|NCT01204671|79346703|FG003|Overall Study|Unknown Completion Status|0|||
44342866|NCT01204671|79346704|FG004|Overall Study|Unknown Completion Status|0|||
44342867|NCT01204671|79346700|FG000|Overall Study|Physician Decision|0|||
44342868|NCT01204671|79346701|FG001|Overall Study|Physician Decision|0|||
44342869|NCT01204671|79346702|FG002|Overall Study|Physician Decision|0|||
44342870|NCT01204671|79346703|FG003|Overall Study|Physician Decision|1|||
44342871|NCT01204671|79346704|FG004|Overall Study|Physician Decision|0|||
44443927|NCT00565812|79451805|FG002|Overall Study|Surgical Intervention|2|||
44443928|NCT00565812|79451803|FG000|Overall Study|Low Compliance|1|||
44443929|NCT00565812|79451804|FG001|Overall Study|Low Compliance|0|||
44443930|NCT00565812|79451805|FG002|Overall Study|Low Compliance|1|||
44443931|NCT00565812|79451803|FG000|Overall Study|Follow-up Visit Not Completed|2|||
44443932|NCT00565812|79451804|FG001|Overall Study|Follow-up Visit Not Completed|0|||
44443933|NCT00565812|79451805|FG002|Overall Study|Follow-up Visit Not Completed|1|||
44443934|NCT00565812|79451803|FG000|Overall Study|Physician Decision|2|||
44443935|NCT00565812|79451804|FG001|Overall Study|Physician Decision|0|||
44443936|NCT00565812|79451805|FG002|Overall Study|Physician Decision|0|||
44443937|NCT03974334|79451813|FG000|Overall Study|Lost to Follow-up|1|||
44443938|NCT03970824|79451820|FG000|Overall Study|Withdrawal by Subject|1|||
44160309|NCT02463357|78952789|FG004|Overall Study|Withdrawal by Subject|0|||
44160310|NCT02463357|78952785|FG000|Overall Study|Withdrawal by Subject|0|||
44160311|NCT02463357|78952786|FG001|Overall Study|Withdrawal by Subject|0|||
44443939|NCT03970824|79451821|FG001|Overall Study|Withdrawal by Subject|1|||
44443940|NCT03970824|79451822|FG002|Overall Study|Withdrawal by Subject|3|||
44443941|NCT03970824|79451820|FG000|Overall Study|Lost to Follow-up|0|||
44443942|NCT03970824|79451821|FG001|Overall Study|Lost to Follow-up|2|||
44443943|NCT03970824|79451822|FG002|Overall Study|Lost to Follow-up|1|||
44443944|NCT03970824|79451820|FG000|Overall Study|Adverse Event|1|||
44443945|NCT03970824|79451821|FG001|Overall Study|Adverse Event|0|||
44443946|NCT03970824|79451822|FG002|Overall Study|Adverse Event|0|||
44443947|NCT00564486|79451833|FG000|Overall Study|Adverse Event|0|||
44443948|NCT00564486|79451834|FG001|Overall Study|Adverse Event|1|||
44443949|NCT00564486|79451835|FG002|Overall Study|Adverse Event|0|||
44443950|NCT00564486|79451836|FG003|Overall Study|Adverse Event|0|||
44342872|NCT01202955|79346722|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
44342873|NCT01202955|79346723|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
44342874|NCT01202877|79346732|FG000|Overall Study|Disease Progression|0|||
44342875|NCT01202877|79346733|FG001|Overall Study|Disease Progression|1|||
44342876|NCT01202877|79346734|FG002|Overall Study|Disease Progression|2|||
44342877|NCT01202877|79346732|FG000|Overall Study|Adverse Event|0|||
44443951|NCT00564486|79451833|FG000|Overall Study|Withdrawal by Subject|4|||
44443952|NCT00564486|79451834|FG001|Overall Study|Withdrawal by Subject|0|||
44443953|NCT00564486|79451835|FG002|Overall Study|Withdrawal by Subject|0|||
44443954|NCT00564486|79451836|FG003|Overall Study|Withdrawal by Subject|5|||
44443955|NCT00564486|79451833|FG000|Overall Study|Subject refused to have blood drawn|0|||
44342878|NCT01202877|79346733|FG001|Overall Study|Adverse Event|0|||
44342879|NCT01202877|79346734|FG002|Overall Study|Adverse Event|2|||
44342880|NCT01202877|79346732|FG000|Overall Study|Withdrawal by Subject|0|||
44342881|NCT01202877|79346733|FG001|Overall Study|Withdrawal by Subject|0|||
44342882|NCT01202877|79346734|FG002|Overall Study|Withdrawal by Subject|1|||
44342883|NCT01202877|79346732|FG000|Overall Study|Death|0|||
44342884|NCT01202877|79346733|FG001|Overall Study|Death|0|||
44342885|NCT01202877|79346734|FG002|Overall Study|Death|1|||
44342886|NCT01202409|79346742|FG000|Overall Study|Adverse Event|1|||
44342887|NCT01202409|79346742|FG000|Overall Study|Ineligible - KRAS mutants|7|||
44342888|NCT01202175|79346748|FG000|Overall Study|Lost to Follow-up|2|||
44342889|NCT01202175|79346748|FG000|Overall Study|Withdrawal by Subject|1|||
44342890|NCT01202175|79346748|FG000|Overall Study|Adverse Event|2|||
44342891|NCT01201785|79346753|FG000|Overall Study|Lost to Follow-up|16|||
44342892|NCT01201317|79346760|FG000|Overall Study|Withdrawal by Subject|5|||
44342893|NCT01201317|79346761|FG001|Overall Study|Withdrawal by Subject|0|||
44342894|NCT01201317|79346762|FG002|Overall Study|Withdrawal by Subject|3|||
44342895|NCT01201317|79346760|FG000|Overall Study|Adverse Event|2|||
44342896|NCT01201317|79346761|FG001|Overall Study|Adverse Event|2|||
44342897|NCT01201317|79346762|FG002|Overall Study|Adverse Event|2|||
44342898|NCT01201317|79346760|FG000|Overall Study|Screen failure|1|||
44342899|NCT01201317|79346761|FG001|Overall Study|Screen failure|1|||
44342900|NCT01201317|79346762|FG002|Overall Study|Screen failure|0|||
44342901|NCT01201317|79346760|FG000|Overall Study|Protocol Violation|0|||
44342902|NCT01201317|79346761|FG001|Overall Study|Protocol Violation|1|||
44342903|NCT01201317|79346762|FG002|Overall Study|Protocol Violation|1|||
44342904|NCT01201317|79346760|FG000|Overall Study|Death|0|||
44342905|NCT01201317|79346761|FG001|Overall Study|Death|1|||
44342906|NCT01201317|79346762|FG002|Overall Study|Death|0|||
44342907|NCT01201317|79346760|FG000|Overall Study|Study-specific withdrawal criteria|0|||
44342908|NCT01201317|79346761|FG001|Overall Study|Study-specific withdrawal criteria|0|||
44342909|NCT01201317|79346762|FG002|Overall Study|Study-specific withdrawal criteria|1|||
44342910|NCT01201317|79346760|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
44342911|NCT01201317|79346761|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
44342912|NCT01201317|79346762|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
44342913|NCT01201317|79346760|FG000|Overall Study|Decrease in renal function|0|||
44342914|NCT01201317|79346761|FG001|Overall Study|Decrease in renal function|1|||
44342915|NCT01201317|79346762|FG002|Overall Study|Decrease in renal function|0|||
44342916|NCT01201317|79346760|FG000|Overall Study|Lack of Efficacy|1|||
44342917|NCT01201317|79346761|FG001|Overall Study|Lack of Efficacy|0|||
44342918|NCT01201317|79346762|FG002|Overall Study|Lack of Efficacy|0|||
44342919|NCT01201317|79346760|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
44342920|NCT01201317|79346761|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
44342921|NCT01201317|79346762|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
44342922|NCT01200069|79346772|FG000|Overall Study|Withdrawal by Subject|0|||
44342923|NCT01200069|79346773|FG001|Overall Study|Withdrawal by Subject|1|||
44342924|NCT01199601|79346824|FG000|Overall Study|Lost to Follow-up|47|||
44342925|NCT01199601|79346825|FG001|Overall Study|Lost to Follow-up|66|||
44342926|NCT01199601|79346824|FG000|Overall Study|Withdrawal by Subject|15|||
44342927|NCT01199601|79346825|FG001|Overall Study|Withdrawal by Subject|3|||
44342928|NCT01199601|79346824|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
44342929|NCT01199601|79346825|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
44342930|NCT01199289|79346835|FG000|Overall Study|Ineligibility determined|2|||
44342931|NCT01199289|79346836|FG001|Overall Study|Ineligibility determined|1|||
44342932|NCT01199289|79346837|FG002|Overall Study|Ineligibility determined|0|||
44342933|NCT01199289|79346838|FG003|Overall Study|Ineligibility determined|0|||
44342934|NCT01199289|79346835|FG000|Overall Study|Protocol Violation|1|||
44342935|NCT01199289|79346836|FG001|Overall Study|Protocol Violation|0|||
44342936|NCT01199289|79346837|FG002|Overall Study|Protocol Violation|0|||
44342937|NCT01199289|79346838|FG003|Overall Study|Protocol Violation|1|||
44342938|NCT01199289|79346835|FG000|Overall Study|Noncompliance|1|||
44342939|NCT01199289|79346836|FG001|Overall Study|Noncompliance|0|||
44342940|NCT01199289|79346837|FG002|Overall Study|Noncompliance|2|||
44342941|NCT01199289|79346838|FG003|Overall Study|Noncompliance|0|||
44342942|NCT01199289|79346835|FG000|Overall Study|Adverse Event|0|||
44342943|NCT01199289|79346836|FG001|Overall Study|Adverse Event|3|||
44342944|NCT01199289|79346837|FG002|Overall Study|Adverse Event|1|||
44342945|NCT01199289|79346838|FG003|Overall Study|Adverse Event|4|||
44342946|NCT01199289|79346835|FG000|Overall Study|Full consent withdrawn|2|||
44342947|NCT01199289|79346836|FG001|Overall Study|Full consent withdrawn|2|||
44342948|NCT01199289|79346837|FG002|Overall Study|Full consent withdrawn|2|||
44342949|NCT01199289|79346838|FG003|Overall Study|Full consent withdrawn|3|||
44443956|NCT00564486|79451834|FG001|Overall Study|Subject refused to have blood drawn|0|||
44443957|NCT00564486|79451835|FG002|Overall Study|Subject refused to have blood drawn|1|||
44342950|NCT01199289|79346835|FG000|Overall Study|Administrative decision|0|||
44342951|NCT01199289|79346836|FG001|Overall Study|Administrative decision|0|||
44342952|NCT01199289|79346837|FG002|Overall Study|Administrative decision|0|||
44342953|NCT01199289|79346838|FG003|Overall Study|Administrative decision|1|||
44342954|NCT01199289|79346835|FG000|Overall Study|Lost to Follow-up|0|||
44342955|NCT01199289|79346836|FG001|Overall Study|Lost to Follow-up|0|||
44342956|NCT01199289|79346837|FG002|Overall Study|Lost to Follow-up|0|||
44342957|NCT01199289|79346838|FG003|Overall Study|Lost to Follow-up|1|||
44342958|NCT01199289|79346835|FG000|Overall Study|Protocol-specified criteria|3|||
44342959|NCT01199289|79346836|FG001|Overall Study|Protocol-specified criteria|0|||
44342960|NCT01199289|79346837|FG002|Overall Study|Protocol-specified criteria|0|||
44342961|NCT01199289|79346838|FG003|Overall Study|Protocol-specified criteria|1|||
44342962|NCT01199289|79346835|FG000|Overall Study|Pregnancy|0|||
44342963|NCT01199289|79346836|FG001|Overall Study|Pregnancy|1|||
44342964|NCT01199289|79346837|FG002|Overall Study|Pregnancy|0|||
44342965|NCT01199289|79346838|FG003|Overall Study|Pregnancy|1|||
44342966|NCT01199055|79346854|FG000|Overall Study|Death|0|||
44342967|NCT01199055|79346855|FG001|Overall Study|Death|1|||
44342968|NCT01199055|79346856|FG002|Overall Study|Death|0|||
44342969|NCT01199055|79346854|FG000|Overall Study|Physician Decision|0|||
44342970|NCT01199055|79346855|FG001|Overall Study|Physician Decision|1|||
44342971|NCT01199055|79346856|FG002|Overall Study|Physician Decision|1|||
44342972|NCT01199055|79346854|FG000|Overall Study|Progressive disease|2|||
44342973|NCT01199055|79346855|FG001|Overall Study|Progressive disease|1|||
44342974|NCT01199055|79346856|FG002|Overall Study|Progressive disease|2|||
44342975|NCT01199055|79346854|FG000|Overall Study|Withdrawal by Subject|0|||
44342976|NCT01199055|79346855|FG001|Overall Study|Withdrawal by Subject|0|||
44342977|NCT01199055|79346856|FG002|Overall Study|Withdrawal by Subject|1|||
44342978|NCT01198977|79346868|FG000|Overall Study|Lost to Follow-up|1|||
44342979|NCT01198977|79346869|FG001|Overall Study|Lost to Follow-up|0|||
44342980|NCT01198587|79346881|FG000|Overall Study|Lost to Follow-up|8|||
44342981|NCT01198587|79346882|FG001|Overall Study|Lost to Follow-up|0|||
44342982|NCT01198587|79346883|FG002|Overall Study|Lost to Follow-up|9|||
44342983|NCT01198587|79346884|FG003|Overall Study|Lost to Follow-up|0|||
44342984|NCT01198509|79346905|FG000|Overall Study|Withdrawal by Subject|1|||
44342985|NCT01198509|79346906|FG001|Overall Study|Withdrawal by Subject|0|||
44342986|NCT01198509|79346907|FG002|Overall Study|Withdrawal by Subject|0|||
44342987|NCT01198509|79346908|FG003|Overall Study|Withdrawal by Subject|0|||
44342988|NCT01198509|79346909|FG004|Overall Study|Withdrawal by Subject|0|||
44342989|NCT01198509|79346910|FG005|Overall Study|Withdrawal by Subject|0|||
44342990|NCT01198275|79346924|FG000|Overall Study|Adverse Event|2|||
44342991|NCT01198275|79346925|FG001|Overall Study|Adverse Event|3|||
44342992|NCT01198275|79346924|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
44342993|NCT01198275|79346925|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
44342994|NCT01197417|79346933|FG000|Overall Study|Physician Decision|3|||
44342995|NCT01197417|79346934|FG001|Overall Study|Physician Decision|2|||
44342996|NCT01197417|79346933|FG000|Overall Study|Withdrawal by Subject|2|||
44342997|NCT01197417|79346934|FG001|Overall Study|Withdrawal by Subject|4|||
44342998|NCT01197417|79346933|FG000|Overall Study|Site miscommunication|0|||
44342999|NCT01197417|79346934|FG001|Overall Study|Site miscommunication|1|||
44343000|NCT01197417|79346933|FG000|Overall Study|Subject transferred to intensive care|0|||
44343001|NCT01197417|79346934|FG001|Overall Study|Subject transferred to intensive care|1|||
44343002|NCT01197417|79346933|FG000|Overall Study|Not consented in time to receive drug|0|||
44343003|NCT01197417|79346934|FG001|Overall Study|Not consented in time to receive drug|1|||
44343004|NCT01197417|79346933|FG000|Overall Study|Hypotension|1|||
44343005|NCT01197417|79346934|FG001|Overall Study|Hypotension|2|||
44343006|NCT01197417|79346933|FG000|Overall Study|Found to be ineligible|2|||
44343007|NCT01197417|79346934|FG001|Overall Study|Found to be ineligible|5|||
44343008|NCT01197417|79346933|FG000|Overall Study|No 25-hour magnesium level|0|||
44343009|NCT01197417|79346934|FG001|Overall Study|No 25-hour magnesium level|2|||
44343010|NCT00977431|79346945|FG000|Overall Study|Other than listed|1|||
44343011|NCT00977431|79346946|FG001|Overall Study|Other than listed|0|||
44343012|NCT00977431|79346947|FG002|Overall Study|Other than listed|0|||
44343013|NCT00977431|79346948|FG003|Overall Study|Other than listed|0|||
44343014|NCT00977431|79346949|FG004|Overall Study|Other than listed|2|||
44343015|NCT00977431|79346945|FG000|Overall Study|Protocol Violation|0|||
44343016|NCT00977431|79346946|FG001|Overall Study|Protocol Violation|0|||
44343017|NCT00977431|79346947|FG002|Overall Study|Protocol Violation|1|||
44443958|NCT00564486|79451836|FG003|Overall Study|Subject refused to have blood drawn|0|||
44443959|NCT00564486|79451833|FG000|Overall Study|Lost to Follow-up|3|||
44343018|NCT00977431|79346948|FG003|Overall Study|Protocol Violation|0|||
44343019|NCT00977431|79346949|FG004|Overall Study|Protocol Violation|0|||
44343020|NCT00977431|79346945|FG000|Overall Study|Adverse Event|3|||
44343021|NCT00977431|79346946|FG001|Overall Study|Adverse Event|0|||
44343022|NCT00977431|79346947|FG002|Overall Study|Adverse Event|4|||
44343023|NCT00977431|79346948|FG003|Overall Study|Adverse Event|0|||
44343024|NCT00977431|79346949|FG004|Overall Study|Adverse Event|6|||
44343025|NCT00977431|79346945|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
44343026|NCT00977431|79346946|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
44343027|NCT00977431|79346947|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
44343028|NCT00977431|79346948|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
44343029|NCT00977431|79346949|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
44343030|NCT00977431|79346945|FG000|Overall Study|Progressive disease|2|||
44343031|NCT00977431|79346946|FG001|Overall Study|Progressive disease|6|||
44343032|NCT00977431|79346947|FG002|Overall Study|Progressive disease|1|||
44343033|NCT00977431|79346948|FG003|Overall Study|Progressive disease|3|||
44343034|NCT00977431|79346949|FG004|Overall Study|Progressive disease|5|||
44343035|NCT00977197|79346967|FG000|Overall Study|Withdrawal by Subject|3|||
44343036|NCT00977197|79346968|FG001|Overall Study|Withdrawal by Subject|4|||
44343037|NCT00977197|79346967|FG000|Overall Study|Adverse Event|3|||
44343038|NCT00977197|79346968|FG001|Overall Study|Adverse Event|1|||
44343039|NCT00977197|79346967|FG000|Overall Study|Lack of Efficacy|1|||
44343040|NCT00977197|79346968|FG001|Overall Study|Lack of Efficacy|0|||
44343041|NCT00977197|79346967|FG000|Overall Study|Lost to Follow-up|1|||
44343042|NCT00977197|79346968|FG001|Overall Study|Lost to Follow-up|3|||
44343043|NCT00977197|79346967|FG000|Overall Study|Nonadherence|1|||
44343044|NCT00977197|79346968|FG001|Overall Study|Nonadherence|1|||
44343045|NCT00974311|79346976|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
44343046|NCT00974311|79346977|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
44343047|NCT00974311|79346976|FG000|DB Phase (up to 24 Months)|Death|561|||
44343048|NCT00974311|79346977|FG001|DB Phase (up to 24 Months)|Death|298|||
44343049|NCT00974311|79346976|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
44343050|NCT00974311|79346977|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
44343051|NCT00974311|79346976|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
44343052|NCT00974311|79346977|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
44343053|NCT00974311|79346976|FG000|DB Phase (up to 24 Months)|Other|1|||
44343054|NCT00974311|79346977|FG001|DB Phase (up to 24 Months)|Other|0|||
44343055|NCT00974311|79346976|FG000|OLE Phase (up to 77 Months)|Death|14|||
44343056|NCT00974311|79346977|FG001|OLE Phase (up to 77 Months)|Death|21|||
44343057|NCT00974311|79346976|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
44343058|NCT00974311|79346977|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
44343059|NCT00974311|79346976|FG000|OLE Phase (up to 77 Months)|Other|15|||
44343060|NCT00974311|79346977|FG001|OLE Phase (up to 77 Months)|Other|2|||
44343061|NCT00974311|79346976|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
44343062|NCT00974311|79346977|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
44343063|NCT00974233|79346986|FG000|Induction Chemoimmunotherapy|Death|2|||
44343064|NCT00974233|79346986|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
44343065|NCT00974233|79346986|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
44343066|NCT00974233|79346986|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
44343067|NCT00974233|79346986|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
44343068|NCT00974233|79346986|FG000|Maintenance Lenalidomide|Adverse Event|8|||
44343069|NCT00973921|79346998|FG000|Overall Study|IVUS results were not available|9|||
44343070|NCT00972595|79347002|FG000|Period 1|Adverse Event|1|||
44343071|NCT00972595|79347003|FG001|Period 1|Adverse Event|0|||
44343072|NCT01196091|79347012|FG000|Overall Study|Adverse Event|22|||
44343073|NCT01196091|79347013|FG001|Overall Study|Adverse Event|27|||
44343074|NCT01196091|79347014|FG002|Overall Study|Adverse Event|26|||
44343075|NCT01196091|79347012|FG000|Overall Study|Death|3|||
44343076|NCT01196091|79347013|FG001|Overall Study|Death|2|||
44343077|NCT01196091|79347014|FG002|Overall Study|Death|2|||
44343078|NCT01196091|79347012|FG000|Overall Study|Entry Criteria Not Met|11|||
44343079|NCT01196091|79347013|FG001|Overall Study|Entry Criteria Not Met|11|||
44343080|NCT01196091|79347014|FG002|Overall Study|Entry Criteria Not Met|10|||
44343081|NCT01196091|79347012|FG000|Overall Study|Lack of Efficacy|15|||
44343082|NCT01196091|79347013|FG001|Overall Study|Lack of Efficacy|12|||
44343083|NCT01196091|79347014|FG002|Overall Study|Lack of Efficacy|17|||
44343084|NCT01196091|79347012|FG000|Overall Study|Lost to Follow-up|5|||
44343085|NCT01196091|79347013|FG001|Overall Study|Lost to Follow-up|5|||
44343086|NCT01196091|79347014|FG002|Overall Study|Lost to Follow-up|6|||
44343087|NCT01196091|79347012|FG000|Overall Study|Parent/Caregiver Decision|0|||
44343088|NCT01196091|79347013|FG001|Overall Study|Parent/Caregiver Decision|0|||
44343089|NCT01196091|79347014|FG002|Overall Study|Parent/Caregiver Decision|1|||
44343090|NCT01196091|79347012|FG000|Overall Study|Withdrawal by Subject|16|||
44343091|NCT01196091|79347013|FG001|Overall Study|Withdrawal by Subject|19|||
44343092|NCT01196091|79347014|FG002|Overall Study|Withdrawal by Subject|22|||
44343093|NCT01196091|79347012|FG000|Overall Study|Physician Decision|3|||
44343094|NCT01196091|79347013|FG001|Overall Study|Physician Decision|3|||
44343095|NCT01196091|79347014|FG002|Overall Study|Physician Decision|4|||
44343096|NCT01196091|79347012|FG000|Overall Study|Protocol Violation|1|||
44343097|NCT01196091|79347013|FG001|Overall Study|Protocol Violation|3|||
44343098|NCT01196091|79347014|FG002|Overall Study|Protocol Violation|3|||
44343099|NCT01196091|79347012|FG000|Overall Study|Sponsor Decision|6|||
44343100|NCT01196091|79347013|FG001|Overall Study|Sponsor Decision|5|||
44343101|NCT01196091|79347014|FG002|Overall Study|Sponsor Decision|4|||
44343102|NCT01196091|79347012|FG000|Overall Study|Excluded Site|5|||
44343103|NCT01196091|79347013|FG001|Overall Study|Excluded Site|11|||
44343104|NCT01196091|79347014|FG002|Overall Study|Excluded Site|8|||
44343105|NCT01196091|79347012|FG000|Overall Study|Randomized, No Study Drug Received|1|||
44343106|NCT01196091|79347013|FG001|Overall Study|Randomized, No Study Drug Received|0|||
44343107|NCT01196091|79347014|FG002|Overall Study|Randomized, No Study Drug Received|1|||
44343108|NCT01195623|79347029|FG000|Overall Study|Lost to Follow-up|35|||
44343109|NCT01195623|79347030|FG001|Overall Study|Lost to Follow-up|37|||
44343110|NCT01195545|79347036|FG000|Overall Study|Protocol Violation|4|||
44343111|NCT01194999|79347040|FG000|Overall Study|Lost to Follow-up|17|||
44343112|NCT01194531|79347046|FG000|Overall Study|Withdrawal by Subject|1|||
44343113|NCT01194531|79347047|FG001|Overall Study|Withdrawal by Subject|0|||
44343114|NCT01194531|79347046|FG000|Overall Study|Protocol Violation|4|||
44343115|NCT01194531|79347047|FG001|Overall Study|Protocol Violation|1|||
44343116|NCT01194531|79347046|FG000|Overall Study|Physician Decision|0|||
44343117|NCT01194531|79347047|FG001|Overall Study|Physician Decision|2|||
44343118|NCT00972517|79347053|FG000|Overall Study|Adverse Event|0|||
44343119|NCT00972517|79347054|FG001|Overall Study|Adverse Event|0|||
44343120|NCT00972517|79347055|FG002|Overall Study|Adverse Event|0|||
44343121|NCT00972517|79347056|FG003|Overall Study|Adverse Event|1|||
44343122|NCT00972517|79347057|FG004|Overall Study|Adverse Event|0|||
44343123|NCT00972517|79347058|FG005|Overall Study|Adverse Event|0|||
44343124|NCT00972517|79347053|FG000|Overall Study|Withdrawal by Subject|0|||
44343125|NCT00972517|79347054|FG001|Overall Study|Withdrawal by Subject|1|||
44343126|NCT00972517|79347055|FG002|Overall Study|Withdrawal by Subject|0|||
44343127|NCT00972517|79347056|FG003|Overall Study|Withdrawal by Subject|2|||
44343128|NCT00972517|79347057|FG004|Overall Study|Withdrawal by Subject|1|||
44343129|NCT00972517|79347058|FG005|Overall Study|Withdrawal by Subject|0|||
44343130|NCT00972283|79347080|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
44343131|NCT00972283|79347081|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
44343132|NCT00972283|79347080|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
44343133|NCT00972283|79347081|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
44343134|NCT00972283|79347080|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
44343135|NCT00972283|79347081|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
44343136|NCT00972283|79347080|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
44343137|NCT00972283|79347081|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
44343138|NCT00972283|79347080|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
44343139|NCT00972283|79347081|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
44343140|NCT00972283|79347080|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
44343141|NCT00972283|79347081|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
44343142|NCT00972283|79347080|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
44343143|NCT00972283|79347081|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
44343144|NCT00972283|79347080|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
44343145|NCT00972283|79347081|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
44343146|NCT00972283|79347080|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
44343147|NCT00972283|79347081|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
44343148|NCT00972283|79347080|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
44343149|NCT00972283|79347081|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
44343150|NCT00969709|79347091|FG000|Overall Study|Adverse Event|3|||
44343151|NCT00969709|79347092|FG001|Overall Study|Adverse Event|13|||
44343152|NCT00969709|79347093|FG002|Overall Study|Adverse Event|26|||
44343153|NCT00969709|79347094|FG003|Overall Study|Adverse Event|12|||
44343154|NCT00969709|79347091|FG000|Overall Study|Lack of Efficacy|7|||
44343155|NCT00969709|79347092|FG001|Overall Study|Lack of Efficacy|4|||
44343156|NCT00969709|79347093|FG002|Overall Study|Lack of Efficacy|1|||
44343157|NCT00969709|79347094|FG003|Overall Study|Lack of Efficacy|3|||
44343158|NCT00969709|79347091|FG000|Overall Study|Protocol Violation|9|||
44343159|NCT00969709|79347092|FG001|Overall Study|Protocol Violation|5|||
44343160|NCT00969709|79347093|FG002|Overall Study|Protocol Violation|9|||
44343161|NCT00969709|79347094|FG003|Overall Study|Protocol Violation|10|||
44343162|NCT00969709|79347091|FG000|Overall Study|Withdrawal by Subject|9|||
44343163|NCT00969709|79347092|FG001|Overall Study|Withdrawal by Subject|12|||
44343164|NCT00969709|79347093|FG002|Overall Study|Withdrawal by Subject|11|||
44343165|NCT00969709|79347094|FG003|Overall Study|Withdrawal by Subject|23|||
44343166|NCT00969709|79347091|FG000|Overall Study|Lost to Follow-up|10|||
44343167|NCT00969709|79347092|FG001|Overall Study|Lost to Follow-up|14|||
44343168|NCT00969709|79347093|FG002|Overall Study|Lost to Follow-up|8|||
44343169|NCT00969709|79347094|FG003|Overall Study|Lost to Follow-up|15|||
44343170|NCT00969709|79347091|FG000|Overall Study|Other reasons|0|||
44343171|NCT00969709|79347092|FG001|Overall Study|Other reasons|0|||
44343172|NCT00969709|79347093|FG002|Overall Study|Other reasons|3|||
44343173|NCT00969709|79347094|FG003|Overall Study|Other reasons|0|||
44160312|NCT02463357|78952787|FG002|Overall Study|Withdrawal by Subject|0|||
44343174|NCT01193517|79347111|FG000|Overall Study|Early Progression|1|||
44343175|NCT01193517|79347112|FG001|Overall Study|Early Progression|0|||
44343176|NCT01193517|79347113|FG002|Overall Study|Early Progression|0|||
44343177|NCT01193283|79347122|FG000|Overall Study|Death|1|||
44343178|NCT00971425|79347128|FG000|Overall Study|Adverse Event|1|||
44343179|NCT00971425|79347129|FG001|Overall Study|Adverse Event|1|||
44160313|NCT02463357|78952788|FG003|Overall Study|Withdrawal by Subject|0|||
44343180|NCT00971425|79347128|FG000|Overall Study|Withdrawal by Subject|0|||
44343181|NCT00971425|79347129|FG001|Overall Study|Withdrawal by Subject|1|||
44343182|NCT01193127|79347139|FG000|Randomized|Surgery Cancelled|0|||
44343183|NCT01193127|79347140|FG001|Randomized|Surgery Cancelled|0|||
44343184|NCT01193127|79347141|FG002|Randomized|Surgery Cancelled|0|||
44343185|NCT01193127|79347142|FG003|Randomized|Surgery Cancelled|1|||
44343186|NCT01193127|79347139|FG000|Treated|Withdrawal by Subject|0|||
44343187|NCT01193127|79347140|FG001|Treated|Withdrawal by Subject|0|||
44343188|NCT01193127|79347141|FG002|Treated|Withdrawal by Subject|0|||
44343189|NCT01193127|79347142|FG003|Treated|Withdrawal by Subject|1|||
44343190|NCT01192815|79347154|FG000|Overall Study|Withdrawal by Subject|1|||
44343191|NCT01192815|79347154|FG000|Overall Study|Lack of Efficacy|1|||
44343192|NCT01192347|79347158|FG000|Overall Study|Death|3|||
44343193|NCT01192347|79347158|FG000|Overall Study|Lost to Follow-up|3|||
44343194|NCT01192347|79347158|FG000|Overall Study|Withdrawal by Subject|1|||
44343195|NCT01192347|79347158|FG000|Overall Study|Adverse Event|1|||
44343196|NCT01192347|79347158|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
44343197|NCT01192347|79347158|FG000|Overall Study|Patient seen in different hospital|1|||
44343198|NCT01192347|79347158|FG000|Overall Study|Patient not visiting hospital regularly|1|||
44343199|NCT01192347|79347158|FG000|Overall Study|Patient did not show up for visits|1|||
44343200|NCT01192191|79347164|FG000|Overall Study|Adverse Event|7|||
44343201|NCT01192191|79347165|FG001|Overall Study|Adverse Event|12|||
44343202|NCT01192191|79347164|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
44343203|NCT01192191|79347165|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
44343204|NCT01192191|79347164|FG000|Overall Study|Lost to Follow-up|0|||
44343205|NCT01192191|79347165|FG001|Overall Study|Lost to Follow-up|1|||
44343206|NCT01192191|79347164|FG000|Overall Study|Withdrawal by Subject|1|||
44343207|NCT01192191|79347165|FG001|Overall Study|Withdrawal by Subject|6|||
44343208|NCT01307267|79347194|FG000|Overall Study|Death|4|||
44343209|NCT01307267|79347195|FG001|Overall Study|Death|3|||
44343210|NCT01307267|79347196|FG002|Overall Study|Death|5|||
44343211|NCT01307267|79347197|FG003|Overall Study|Death|3|||
44343212|NCT01307267|79347198|FG004|Overall Study|Death|1|||
44343213|NCT01307267|79347199|FG005|Overall Study|Death|26|||
44343214|NCT01307267|79347200|FG006|Overall Study|Death|2|||
44343215|NCT01307267|79347201|FG007|Overall Study|Death|2|||
44343216|NCT01307267|79347202|FG008|Overall Study|Death|21|||
44343217|NCT01307267|79347203|FG009|Overall Study|Death|2|||
44343218|NCT01307267|79347204|FG010|Overall Study|Death|3|||
44343219|NCT01307267|79347205|FG011|Overall Study|Death|9|||
44343220|NCT01307267|79347206|FG012|Overall Study|Death|0|||
44343221|NCT01307267|79347207|FG013|Overall Study|Death|0|||
44343222|NCT01307267|79347208|FG014|Overall Study|Death|0|||
44343223|NCT01307267|79347209|FG015|Overall Study|Death|0|||
44343224|NCT01307267|79347210|FG016|Overall Study|Death|1|||
44343225|NCT01307267|79347211|FG017|Overall Study|Death|1|||
44343226|NCT01307267|79347212|FG018|Overall Study|Death|2|||
44343227|NCT01307267|79347213|FG019|Overall Study|Death|8|||
44343228|NCT01307267|79347214|FG020|Overall Study|Death|1|||
44343229|NCT01307267|79347215|FG021|Overall Study|Death|2|||
44343230|NCT01307267|79347216|FG022|Overall Study|Death|2|||
44343231|NCT01307267|79347194|FG000|Overall Study|Lost to Follow-up|0|||
44343232|NCT01307267|79347195|FG001|Overall Study|Lost to Follow-up|0|||
44343233|NCT01307267|79347196|FG002|Overall Study|Lost to Follow-up|0|||
44343234|NCT01307267|79347197|FG003|Overall Study|Lost to Follow-up|0|||
44343235|NCT01307267|79347198|FG004|Overall Study|Lost to Follow-up|0|||
44343236|NCT01307267|79347199|FG005|Overall Study|Lost to Follow-up|7|||
44343237|NCT01307267|79347200|FG006|Overall Study|Lost to Follow-up|0|||
44343238|NCT01307267|79347201|FG007|Overall Study|Lost to Follow-up|0|||
44343239|NCT01307267|79347202|FG008|Overall Study|Lost to Follow-up|1|||
44343240|NCT01307267|79347203|FG009|Overall Study|Lost to Follow-up|2|||
44343241|NCT01307267|79347204|FG010|Overall Study|Lost to Follow-up|1|||
44343242|NCT01307267|79347205|FG011|Overall Study|Lost to Follow-up|0|||
44343243|NCT01307267|79347206|FG012|Overall Study|Lost to Follow-up|0|||
44343244|NCT01307267|79347207|FG013|Overall Study|Lost to Follow-up|0|||
44343245|NCT01307267|79347208|FG014|Overall Study|Lost to Follow-up|0|||
44343246|NCT01307267|79347209|FG015|Overall Study|Lost to Follow-up|0|||
44343247|NCT01307267|79347210|FG016|Overall Study|Lost to Follow-up|0|||
44343248|NCT01307267|79347211|FG017|Overall Study|Lost to Follow-up|0|||
44343249|NCT01307267|79347212|FG018|Overall Study|Lost to Follow-up|0|||
44343250|NCT01307267|79347213|FG019|Overall Study|Lost to Follow-up|2|||
44343251|NCT01307267|79347214|FG020|Overall Study|Lost to Follow-up|0|||
44343252|NCT01307267|79347215|FG021|Overall Study|Lost to Follow-up|0|||
44343253|NCT01307267|79347216|FG022|Overall Study|Lost to Follow-up|0|||
44343254|NCT01307267|79347194|FG000|Overall Study|Withdrawal by Subject|0|||
44343255|NCT01307267|79347195|FG001|Overall Study|Withdrawal by Subject|0|||
44343256|NCT01307267|79347196|FG002|Overall Study|Withdrawal by Subject|0|||
44343257|NCT01307267|79347197|FG003|Overall Study|Withdrawal by Subject|0|||
44343258|NCT01307267|79347198|FG004|Overall Study|Withdrawal by Subject|0|||
44343259|NCT01307267|79347199|FG005|Overall Study|Withdrawal by Subject|1|||
44343260|NCT01307267|79347200|FG006|Overall Study|Withdrawal by Subject|0|||
44343261|NCT01307267|79347201|FG007|Overall Study|Withdrawal by Subject|1|||
44343262|NCT01307267|79347202|FG008|Overall Study|Withdrawal by Subject|5|||
44343263|NCT01307267|79347203|FG009|Overall Study|Withdrawal by Subject|1|||
44343264|NCT01307267|79347204|FG010|Overall Study|Withdrawal by Subject|1|||
44343265|NCT01307267|79347205|FG011|Overall Study|Withdrawal by Subject|1|||
44343266|NCT01307267|79347206|FG012|Overall Study|Withdrawal by Subject|0|||
44343267|NCT01307267|79347207|FG013|Overall Study|Withdrawal by Subject|0|||
44343268|NCT01307267|79347208|FG014|Overall Study|Withdrawal by Subject|0|||
44343269|NCT01307267|79347209|FG015|Overall Study|Withdrawal by Subject|0|||
44343270|NCT01307267|79347210|FG016|Overall Study|Withdrawal by Subject|0|||
44343271|NCT01307267|79347211|FG017|Overall Study|Withdrawal by Subject|0|||
44343272|NCT01307267|79347212|FG018|Overall Study|Withdrawal by Subject|0|||
44343273|NCT01307267|79347213|FG019|Overall Study|Withdrawal by Subject|3|||
44343274|NCT01307267|79347214|FG020|Overall Study|Withdrawal by Subject|0|||
44343275|NCT01307267|79347215|FG021|Overall Study|Withdrawal by Subject|0|||
44343276|NCT01307267|79347216|FG022|Overall Study|Withdrawal by Subject|0|||
44343277|NCT01307267|79347194|FG000|Overall Study|Other|0|||
44343278|NCT01307267|79347195|FG001|Overall Study|Other|0|||
44343279|NCT01307267|79347196|FG002|Overall Study|Other|0|||
44343280|NCT01307267|79347197|FG003|Overall Study|Other|0|||
44343281|NCT01307267|79347198|FG004|Overall Study|Other|0|||
44343282|NCT01307267|79347199|FG005|Overall Study|Other|7|||
44343283|NCT01307267|79347200|FG006|Overall Study|Other|0|||
44343284|NCT01307267|79347201|FG007|Overall Study|Other|1|||
44343285|NCT01307267|79347202|FG008|Overall Study|Other|3|||
44343286|NCT01307267|79347203|FG009|Overall Study|Other|0|||
44343287|NCT01307267|79347204|FG010|Overall Study|Other|1|||
44343288|NCT01307267|79347205|FG011|Overall Study|Other|1|||
44343289|NCT01307267|79347206|FG012|Overall Study|Other|1|||
44343290|NCT01307267|79347207|FG013|Overall Study|Other|0|||
44343291|NCT01307267|79347208|FG014|Overall Study|Other|2|||
44343292|NCT01307267|79347209|FG015|Overall Study|Other|1|||
44343293|NCT01307267|79347210|FG016|Overall Study|Other|0|||
44343294|NCT01307267|79347211|FG017|Overall Study|Other|0|||
44343295|NCT01307267|79347212|FG018|Overall Study|Other|0|||
44343296|NCT01307267|79347213|FG019|Overall Study|Other|19|||
44443960|NCT00564486|79451834|FG001|Overall Study|Lost to Follow-up|0|||
44443961|NCT00564486|79451835|FG002|Overall Study|Lost to Follow-up|2|||
44443962|NCT00564486|79451836|FG003|Overall Study|Lost to Follow-up|2|||
44443963|NCT00481078|79451852|FG000|Overall Study|Progression of disease|11|||
44443964|NCT00481078|79451853|FG001|Overall Study|Progression of disease|11|||
44443965|NCT00481078|79451852|FG000|Overall Study|Adverse Event|15|||
44443966|NCT00481078|79451853|FG001|Overall Study|Adverse Event|3|||
44443967|NCT00481078|79451852|FG000|Overall Study|Death|5|||
44443968|NCT00481078|79451853|FG001|Overall Study|Death|3|||
44443969|NCT00481078|79451852|FG000|Overall Study|Intercurrent illness|1|||
44443970|NCT00481078|79451853|FG001|Overall Study|Intercurrent illness|0|||
44443971|NCT00481078|79451852|FG000|Overall Study|Withdrawal by Subject|7|||
44443972|NCT00481078|79451853|FG001|Overall Study|Withdrawal by Subject|1|||
44443973|NCT00481078|79451852|FG000|Overall Study|Information not available|1|||
44443974|NCT00481078|79451853|FG001|Overall Study|Information not available|0|||
44443975|NCT00481078|79451852|FG000|Overall Study|Received other treatment|2|||
44443976|NCT00481078|79451853|FG001|Overall Study|Received other treatment|1|||
44443977|NCT00481078|79451852|FG000|Overall Study|Brain metastasis|0|||
44443978|NCT00481078|79451853|FG001|Overall Study|Brain metastasis|1|||
44443979|NCT00480532|79451863|FG000|Overall Study|Withdrawal by Subject|2|||
44443980|NCT00480532|79451864|FG001|Overall Study|Withdrawal by Subject|4|||
44443981|NCT00480532|79451865|FG002|Overall Study|Withdrawal by Subject|3|||
44443982|NCT00480532|79451866|FG003|Overall Study|Withdrawal by Subject|1|||
44443983|NCT00480532|79451863|FG000|Overall Study|Protocol Violation|0|||
44443984|NCT00480532|79451864|FG001|Overall Study|Protocol Violation|0|||
44343297|NCT01307267|79347214|FG020|Overall Study|Other|2|||
44343298|NCT01307267|79347215|FG021|Overall Study|Other|3|||
44343299|NCT01307267|79347216|FG022|Overall Study|Other|2|||
44343300|NCT01307111|79347278|FG000|IUD Insertion|Lost to Follow-up|2|||
44443985|NCT00480532|79451865|FG002|Overall Study|Protocol Violation|1|||
44443986|NCT00480532|79451866|FG003|Overall Study|Protocol Violation|0|||
44443987|NCT00496366|79451876|FG000|Overall Study|Death|1|||
44443988|NCT00488644|79451880|FG000|Overall Study|Not Eligible|1|||
44160314|NCT02463357|78952789|FG004|Overall Study|Withdrawal by Subject|1|||
44343301|NCT01307111|79347279|FG001|IUD Insertion|Lost to Follow-up|0|||
44343302|NCT01307111|79347278|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
44343303|NCT01307111|79347279|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
44343304|NCT01306877|79347287|FG000|Overall Study|Lost to Follow-up|3|||
44343305|NCT01306877|79347288|FG001|Overall Study|Lost to Follow-up|3|||
44343306|NCT01306877|79347287|FG000|Overall Study|Physician Decision|0|||
44343307|NCT01306877|79347288|FG001|Overall Study|Physician Decision|1|||
44443989|NCT00488644|79451880|FG000|Overall Study|Not Evaluable|1|||
44343308|NCT01191801|79347296|FG000|Overall Study|Death|36|||
44443990|NCT00564018|79451887|FG000|Overall Study|Withdrawal by Subject|2|||
44343309|NCT01191801|79347297|FG001|Overall Study|Death|12|||
44343310|NCT01191801|79347296|FG000|Overall Study|Lack of Efficacy|176|||
44343311|NCT01191801|79347297|FG001|Overall Study|Lack of Efficacy|258|||
44343312|NCT01191801|79347296|FG000|Overall Study|Adverse Event|9|||
44343313|NCT01191801|79347297|FG001|Overall Study|Adverse Event|8|||
44343314|NCT01191801|79347296|FG000|Overall Study|Protocol Violation|2|||
44343315|NCT01191801|79347297|FG001|Overall Study|Protocol Violation|4|||
44343316|NCT01191801|79347296|FG000|Overall Study|Physician Decision|47|||
44343317|NCT01191801|79347297|FG001|Overall Study|Physician Decision|24|||
44343318|NCT01191801|79347296|FG000|Overall Study|Withdrawal by Subject|1|||
44343319|NCT01191801|79347297|FG001|Overall Study|Withdrawal by Subject|4|||
44343320|NCT01191801|79347296|FG000|Overall Study|Not Provided|45|||
44343321|NCT01191801|79347297|FG001|Overall Study|Not Provided|27|||
44343322|NCT01306643|79347303|FG000|Overall Study|Adverse Event|5|||
44343323|NCT01306643|79347303|FG000|Overall Study|Disease Progression|7|||
44343324|NCT01306643|79347303|FG000|Overall Study|Other: Change in Eligibility Status|1|||
44343325|NCT01306331|79347309|FG000|Overall Study|Adverse Event|28|||
44343326|NCT01306331|79347310|FG001|Overall Study|Adverse Event|25|||
44443991|NCT00564018|79451888|FG001|Overall Study|Withdrawal by Subject|3|||
44443992|NCT00564018|79451889|FG002|Overall Study|Withdrawal by Subject|1|||
44443993|NCT03381287|79451901|FG000|Overall Study|Withdrawal by Subject|0|||
44443994|NCT03381287|79451902|FG001|Overall Study|Withdrawal by Subject|1|||
44443995|NCT03381287|79451903|FG002|Overall Study|Withdrawal by Subject|0|||
44443996|NCT03381287|79451904|FG003|Overall Study|Withdrawal by Subject|0|||
44443997|NCT03381287|79451901|FG000|Overall Study|Adverse Event|0|||
44443998|NCT03381287|79451902|FG001|Overall Study|Adverse Event|0|||
44443999|NCT03381287|79451903|FG002|Overall Study|Adverse Event|0|||
44444000|NCT03381287|79451904|FG003|Overall Study|Adverse Event|1|||
44444001|NCT03381287|79451901|FG000|Overall Study|Physician Decision|0|||
44444002|NCT03381287|79451902|FG001|Overall Study|Physician Decision|0|||
44444003|NCT03381287|79451903|FG002|Overall Study|Physician Decision|0|||
44444004|NCT03381287|79451904|FG003|Overall Study|Physician Decision|1|||
44444005|NCT00616928|79451928|FG000|Overall Study|Adverse Event|6|||
44444006|NCT00616928|79451929|FG001|Overall Study|Adverse Event|3|||
44444007|NCT00616928|79451930|FG002|Overall Study|Adverse Event|2|||
44444008|NCT00616928|79451931|FG003|Overall Study|Adverse Event|2|||
44444009|NCT00616928|79451928|FG000|Overall Study|Other|51|||
44444010|NCT00616928|79451929|FG001|Overall Study|Other|8|||
44444011|NCT00616928|79451930|FG002|Overall Study|Other|15|||
44444012|NCT00616928|79451931|FG003|Overall Study|Other|5|||
44444013|NCT00616928|79451928|FG000|Overall Study|Lost to Follow-up|5|||
44444014|NCT00616928|79451929|FG001|Overall Study|Lost to Follow-up|7|||
44444015|NCT00616928|79451930|FG002|Overall Study|Lost to Follow-up|0|||
44444016|NCT00616928|79451931|FG003|Overall Study|Lost to Follow-up|0|||
44444017|NCT00563784|79451953|FG000|Overall Study|Withdrawal by Subject|2|||
44444018|NCT00563784|79451953|FG000|Overall Study|Screen Failures|20|||
44444019|NCT00203047|79451968|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
44444020|NCT00203047|79451969|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
44444021|NCT00203047|79451968|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
44444022|NCT00203047|79451969|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
44444023|NCT00203047|79451968|FG000|Overall Study|Withdrawal by Subject|13|||
44444024|NCT00203047|79451969|FG001|Overall Study|Withdrawal by Subject|47|||
44444025|NCT00203047|79451968|FG000|Overall Study|Teva requested participant withdrawal|1|||
44444026|NCT00203047|79451969|FG001|Overall Study|Teva requested participant withdrawal|1|||
44444027|NCT00203047|79451968|FG000|Overall Study|Physician Decision|8|||
44444028|NCT00203047|79451969|FG001|Overall Study|Physician Decision|7|||
44444029|NCT00203047|79451968|FG000|Overall Study|Non-compliance|4|||
44444030|NCT00203047|79451969|FG001|Overall Study|Non-compliance|8|||
44444031|NCT00203047|79451968|FG000|Overall Study|Protocol Violation|1|||
44444032|NCT00203047|79451969|FG001|Overall Study|Protocol Violation|0|||
44444033|NCT00203047|79451968|FG000|Overall Study|Lost to Follow-up|11|||
44444034|NCT00203047|79451969|FG001|Overall Study|Lost to Follow-up|5|||
44444035|NCT00203047|79451968|FG000|Overall Study|Adverse Event|8|||
44160315|NCT02579759|78952804|FG000|Overall Study|Protocol Violation|2|||
44444036|NCT00203047|79451969|FG001|Overall Study|Adverse Event|18|||
44444037|NCT00203047|79451968|FG000|Overall Study|Death|1|||
44444038|NCT00203047|79451969|FG001|Overall Study|Death|2|||
44343327|NCT01306331|79347309|FG000|Overall Study|Lost to Follow-up|321|||
44444039|NCT00203047|79451968|FG000|Overall Study|Pregnancy|3|||
44343328|NCT01306331|79347310|FG001|Overall Study|Lost to Follow-up|323|||
44343329|NCT01306331|79347309|FG000|Overall Study|Physician Decision|26|||
44343330|NCT01306331|79347310|FG001|Overall Study|Physician Decision|22|||
44343331|NCT01306331|79347309|FG000|Overall Study|Pregnancy|136|||
44343332|NCT01306331|79347310|FG001|Overall Study|Pregnancy|151|||
44444040|NCT00203047|79451969|FG001|Overall Study|Pregnancy|0|||
44444041|NCT00203047|79451968|FG000|Overall Study|Other|5|||
44444042|NCT00203047|79451969|FG001|Overall Study|Other|5|||
44444043|NCT00142519|79451977|FG000|Overall Study|Not Treated|7|||
44444044|NCT00142519|79451978|FG001|Overall Study|Not Treated|9|||
44444045|NCT00142519|79451977|FG000|Overall Study|Protocol Violation|1|||
44343333|NCT01306331|79347309|FG000|Overall Study|Protocol Violation|154|||
44343334|NCT01306331|79347310|FG001|Overall Study|Protocol Violation|124|||
44343335|NCT01306331|79347309|FG000|Overall Study|Withdrawal by Subject|163|||
44343336|NCT01306331|79347310|FG001|Overall Study|Withdrawal by Subject|152|||
44343337|NCT01306331|79347309|FG000|Overall Study|Not sexually active|29|||
44343338|NCT01306331|79347310|FG001|Overall Study|Not sexually active|28|||
44343339|NCT01306331|79347309|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
44343340|NCT01306331|79347310|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
44343341|NCT01306331|79347309|FG000|Overall Study|Other|34|||
44343342|NCT01306331|79347310|FG001|Overall Study|Other|32|||
44343343|NCT01306253|79347318|FG000|Overall Study|Lost to Follow-up|1|||
44343344|NCT01306253|79347319|FG001|Overall Study|Lost to Follow-up|1|||
44343345|NCT01305941|79347325|FG000|Overall Study|Adverse Event|6|||
44343346|NCT01305941|79347325|FG000|Overall Study|Clinical decline|2|||
44343347|NCT01305941|79347325|FG000|Overall Study|Withdrawal by Subject|1|||
44343348|NCT01305941|79347325|FG000|Overall Study|Death|1|||
44343349|NCT01305239|79347329|FG000|Overall Study|Adverse Event|22|||
44343350|NCT01305239|79347329|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
44343351|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
44343352|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
44343353|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343354|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343355|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343356|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343357|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343358|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343359|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343360|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
44343361|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
44343362|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
44343363|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343364|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343365|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343366|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343367|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343368|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343369|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343370|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
44343371|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
44343372|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343373|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343374|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343375|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343376|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343377|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343378|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343379|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343380|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
44343381|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
44343382|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
44343383|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343384|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343385|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343386|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343387|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343388|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343389|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343390|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
44343391|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343392|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
44343393|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343394|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343395|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343396|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343397|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343398|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343399|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44343400|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
44444046|NCT00142519|79451978|FG001|Overall Study|Protocol Violation|0|||
44444047|NCT00142519|79451977|FG000|Overall Study|Withdrawal by Subject|10|||
44343401|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
44343402|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
44343403|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343404|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343405|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343406|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343407|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343408|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343409|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343410|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
44343411|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
44343412|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
44343413|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343414|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343415|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343416|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343417|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343418|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343419|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343420|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
44343421|NCT01194219|79347335|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
44343422|NCT01194219|79347336|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
44343423|NCT01194219|79347337|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343424|NCT01194219|79347338|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343425|NCT01194219|79347339|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343426|NCT01194219|79347340|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343427|NCT01194219|79347341|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343428|NCT01194219|79347342|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343429|NCT01194219|79347343|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343430|NCT01194219|79347344|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
44343431|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343432|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343433|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
44343434|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
44343435|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343436|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343437|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343438|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343439|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343440|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
44343441|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343442|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343443|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
44343444|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
44343445|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343446|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343447|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343448|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343449|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343450|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
44343451|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343452|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343453|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
44343454|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
44343455|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343456|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343457|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343458|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343459|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343460|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
44343461|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343462|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343463|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
44343464|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
44343465|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343466|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343467|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343468|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343469|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343470|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
44343471|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343472|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343473|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
44343474|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343475|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343476|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343477|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343478|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343479|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343480|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
44343481|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343482|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343483|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343484|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
44343485|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343486|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343487|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343488|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343489|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343490|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
44343491|NCT01194219|79347335|FG000|Maintenance Phase Weeks16-32|Other|0|||
44343492|NCT01194219|79347336|FG001|Maintenance Phase Weeks16-32|Other|0|||
44343493|NCT01194219|79347337|FG002|Maintenance Phase Weeks16-32|Other|2|||
44343494|NCT01194219|79347338|FG003|Maintenance Phase Weeks16-32|Other|1|||
44343495|NCT01194219|79347339|FG004|Maintenance Phase Weeks16-32|Other|0|||
44343496|NCT01194219|79347340|FG005|Maintenance Phase Weeks16-32|Other|0|||
44343497|NCT01194219|79347341|FG006|Maintenance Phase Weeks16-32|Other|0|||
44343498|NCT01194219|79347342|FG007|Maintenance Phase Weeks16-32|Other|0|||
44343499|NCT01194219|79347343|FG008|Maintenance Phase Weeks16-32|Other|0|||
44343500|NCT01194219|79347344|FG009|Maintenance Phase Weeks16-32|Other|0|||
44343501|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343502|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343503|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343504|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343505|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343506|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
44343507|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
44343508|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
44343509|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343510|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
44343511|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
44343512|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
44343513|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
44343514|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
44343515|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
44343516|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
44343517|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
44343518|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
44343519|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
44343520|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
44343521|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343522|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343523|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343524|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343525|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
44160316|NCT02579759|78952805|FG001|Overall Study|Protocol Violation|0|||
44343526|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343527|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
44343528|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343529|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343530|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
44343531|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343532|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343533|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343534|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343535|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
44343536|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343537|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
44343538|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
44343539|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343540|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
44343541|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343542|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343543|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343544|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343545|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
44343546|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
44343547|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
44343548|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343549|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343550|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
44343551|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343552|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343553|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343554|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343555|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343556|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343557|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343558|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
44343559|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343560|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
44343561|NCT01194219|79347335|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343562|NCT01194219|79347336|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343563|NCT01194219|79347337|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343564|NCT01194219|79347338|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343565|NCT01194219|79347339|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343566|NCT01194219|79347340|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343567|NCT01194219|79347341|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
44343568|NCT01194219|79347342|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343569|NCT01194219|79347343|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343570|NCT01194219|79347344|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
44343571|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343572|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343573|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343574|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343575|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343576|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343577|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343578|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
44343579|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
44343580|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
44343581|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343582|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343583|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343584|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343585|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44444048|NCT00142519|79451978|FG001|Overall Study|Withdrawal by Subject|7|||
44444049|NCT00141817|79451997|FG000|Overall Study|Protocol Violation|0|||
44444050|NCT00141817|79451998|FG001|Overall Study|Protocol Violation|0|||
44444051|NCT00141817|79451999|FG002|Overall Study|Protocol Violation|1|||
44444052|NCT00141817|79452000|FG003|Overall Study|Protocol Violation|0|||
44444053|NCT00141817|79451997|FG000|Overall Study|Parent request|1|||
44343586|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343587|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343588|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
44343589|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
44343590|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
44343591|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343592|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343593|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343594|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343595|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343596|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343597|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343598|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
44343599|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
44343600|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
44343601|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343602|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343603|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343604|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343605|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343606|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343607|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343608|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
44343609|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
44343610|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
44343611|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
44343612|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
44343613|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
44343614|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
44343615|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
44343616|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
44343617|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
44343618|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
44343619|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
44343620|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
44343621|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343622|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343623|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343624|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343625|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343626|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343627|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343628|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
44343629|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
44343630|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
44343631|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343632|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343633|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343634|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343635|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343636|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343637|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343638|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343639|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
44343640|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
44343641|NCT01194219|79347335|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343642|NCT01194219|79347336|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343643|NCT01194219|79347337|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343644|NCT01194219|79347338|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343645|NCT01194219|79347339|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343646|NCT01194219|79347340|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343647|NCT01194219|79347341|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343648|NCT01194219|79347342|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
44343649|NCT01194219|79347343|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
44343650|NCT01194219|79347344|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
44343651|NCT01304693|79347372|FG000|Overall Study|Adverse Event|0|||
44343652|NCT01304693|79347373|FG001|Overall Study|Adverse Event|0|||
44343653|NCT01304693|79347374|FG002|Overall Study|Adverse Event|0|||
44343654|NCT01304693|79347375|FG003|Overall Study|Adverse Event|0|||
44343655|NCT01304693|79347376|FG004|Overall Study|Adverse Event|1|||
44343656|NCT01304693|79347372|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
44343657|NCT01304693|79347373|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
44343658|NCT01304693|79347374|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
44343659|NCT01304693|79347375|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
44343660|NCT01304693|79347376|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
44343661|NCT01304147|79347388|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
44343662|NCT01304147|79347389|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
44343663|NCT01303445|79347395|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
44343664|NCT01303445|79347396|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
44343665|NCT01303445|79347395|FG000|Second Intervention (7 Days)|Adverse Event|0|||
44343666|NCT01303445|79347396|FG001|Second Intervention (7 Days)|Adverse Event|2|||
44343667|NCT01303445|79347395|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
44343668|NCT01303445|79347396|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
44343669|NCT01303445|79347395|FG000|Washout (14 Days)|Protocol Violation|1|||
44343670|NCT01303445|79347396|FG001|Washout (14 Days)|Protocol Violation|0|||
44343671|NCT01303445|79347395|FG000|Washout (14 Days)|Lost to Follow-up|0|||
44343672|NCT01303445|79347396|FG001|Washout (14 Days)|Lost to Follow-up|2|||
44343673|NCT01303445|79347395|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
44343674|NCT01303445|79347396|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
44343675|NCT01303445|79347395|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
44343676|NCT01303445|79347396|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
44343677|NCT01188681|79347410|FG000|Overall Study|bladder cancer|0|||
44343678|NCT01188681|79347411|FG001|Overall Study|bladder cancer|0|||
44343679|NCT01188681|79347412|FG002|Overall Study|bladder cancer|1|||
44343680|NCT01188681|79347413|FG003|Overall Study|bladder cancer|0|||
44343681|NCT01188681|79347410|FG000|Overall Study|Withdrawal by Subject|0|||
44343682|NCT01188681|79347411|FG001|Overall Study|Withdrawal by Subject|0|||
44343683|NCT01188681|79347412|FG002|Overall Study|Withdrawal by Subject|0|||
44343684|NCT01188681|79347413|FG003|Overall Study|Withdrawal by Subject|1|||
44343685|NCT01302899|79347429|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
44343686|NCT01302899|79347430|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
44343687|NCT01302899|79347429|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
44343688|NCT01302899|79347430|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
44343689|NCT01187901|79347442|FG000|Overall Study|Protocol Violation|1|||
44343690|NCT01187901|79347443|FG001|Overall Study|Protocol Violation|0|||
44343691|NCT01187901|79347442|FG000|Overall Study|Lost to Follow-up|1|||
44343692|NCT01187901|79347443|FG001|Overall Study|Lost to Follow-up|2|||
44343693|NCT01187901|79347442|FG000|Overall Study|Unrelated Health Reasons|1|||
44343694|NCT01187901|79347443|FG001|Overall Study|Unrelated Health Reasons|2|||
44343695|NCT01187901|79347442|FG000|Overall Study|Suspected Allergic Reaction|1|||
44343696|NCT01187901|79347443|FG001|Overall Study|Suspected Allergic Reaction|1|||
44343697|NCT01187901|79347442|FG000|Overall Study|Adverse Event|3|||
44343698|NCT01187901|79347443|FG001|Overall Study|Adverse Event|0|||
44343699|NCT01187901|79347442|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
44343700|NCT01187901|79347443|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
44343701|NCT01187901|79347442|FG000|Overall Study|Pregnancy|0|||
44343702|NCT01187901|79347443|FG001|Overall Study|Pregnancy|2|||
44343703|NCT01302119|79347451|FG000|Overall Study|Withdrawal by Subject|30|||
44343704|NCT01302119|79347452|FG001|Overall Study|Withdrawal by Subject|20|||
44343705|NCT01302119|79347451|FG000|Overall Study|Lost to Follow-up|10|||
44343706|NCT01302119|79347452|FG001|Overall Study|Lost to Follow-up|4|||
44343707|NCT01302119|79347451|FG000|Overall Study|Adverse Event|2|||
44343708|NCT01302119|79347452|FG001|Overall Study|Adverse Event|1|||
44343709|NCT01302119|79347451|FG000|Overall Study|Non-compliance|4|||
44343710|NCT01302119|79347452|FG001|Overall Study|Non-compliance|2|||
44343711|NCT01302119|79347451|FG000|Overall Study|Non-specific|4|||
44343712|NCT01302119|79347452|FG001|Overall Study|Non-specific|1|||
44343713|NCT05038982|79347460|FG000|Overall Study|Withdrawal by Subject|0|||
44343714|NCT05038982|79347461|FG001|Overall Study|Withdrawal by Subject|2|||
44343715|NCT04867785|79347480|FG000|Overall Study|Adverse Event|1|||
44343716|NCT04867785|79347481|FG001|Overall Study|Adverse Event|0|||
44343717|NCT04867785|79347482|FG002|Overall Study|Adverse Event|1|||
44343718|NCT04867785|79347483|FG003|Overall Study|Adverse Event|0|||
44343719|NCT04867785|79347484|FG004|Overall Study|Adverse Event|0|||
44343720|NCT04867785|79347485|FG005|Overall Study|Adverse Event|0|||
44343721|NCT04867785|79347486|FG006|Overall Study|Adverse Event|0|||
44343722|NCT04867785|79347487|FG007|Overall Study|Adverse Event|2|||
44343723|NCT04867785|79347480|FG000|Overall Study|Lost to Follow-up|4|||
44343724|NCT04867785|79347481|FG001|Overall Study|Lost to Follow-up|4|||
44343725|NCT04867785|79347482|FG002|Overall Study|Lost to Follow-up|3|||
44343726|NCT04867785|79347483|FG003|Overall Study|Lost to Follow-up|2|||
44343727|NCT04867785|79347484|FG004|Overall Study|Lost to Follow-up|0|||
44343728|NCT04867785|79347485|FG005|Overall Study|Lost to Follow-up|1|||
44343729|NCT04867785|79347486|FG006|Overall Study|Lost to Follow-up|0|||
44343730|NCT04867785|79347487|FG007|Overall Study|Lost to Follow-up|1|||
44343731|NCT04867785|79347480|FG000|Overall Study|Withdrawal by Subject|6|||
44343732|NCT04867785|79347481|FG001|Overall Study|Withdrawal by Subject|2|||
44343733|NCT04867785|79347482|FG002|Overall Study|Withdrawal by Subject|2|||
44343734|NCT04867785|79347483|FG003|Overall Study|Withdrawal by Subject|1|||
44343735|NCT04867785|79347484|FG004|Overall Study|Withdrawal by Subject|2|||
44343736|NCT04867785|79347485|FG005|Overall Study|Withdrawal by Subject|0|||
44343737|NCT04867785|79347486|FG006|Overall Study|Withdrawal by Subject|2|||
44343738|NCT04867785|79347487|FG007|Overall Study|Withdrawal by Subject|5|||
44343739|NCT04867785|79347480|FG000|Overall Study|Physician Decision|0|||
44343740|NCT04867785|79347481|FG001|Overall Study|Physician Decision|0|||
44343741|NCT04867785|79347482|FG002|Overall Study|Physician Decision|0|||
44343742|NCT04867785|79347483|FG003|Overall Study|Physician Decision|0|||
44343743|NCT04867785|79347484|FG004|Overall Study|Physician Decision|0|||
44343744|NCT04867785|79347485|FG005|Overall Study|Physician Decision|0|||
44343745|NCT04867785|79347486|FG006|Overall Study|Physician Decision|0|||
44343746|NCT04867785|79347487|FG007|Overall Study|Physician Decision|1|||
44343747|NCT04867785|79347480|FG000|Overall Study|Inadvertent Enrollment|0|||
44343748|NCT04867785|79347481|FG001|Overall Study|Inadvertent Enrollment|0|||
44343749|NCT04867785|79347482|FG002|Overall Study|Inadvertent Enrollment|0|||
44343750|NCT04867785|79347483|FG003|Overall Study|Inadvertent Enrollment|1|||
44343751|NCT04867785|79347484|FG004|Overall Study|Inadvertent Enrollment|1|||
44343752|NCT04867785|79347485|FG005|Overall Study|Inadvertent Enrollment|0|||
44343753|NCT04867785|79347486|FG006|Overall Study|Inadvertent Enrollment|0|||
44343754|NCT04867785|79347487|FG007|Overall Study|Inadvertent Enrollment|1|||
44343755|NCT04867785|79347480|FG000|Overall Study|Eligibility Criteria Not Met|0|||
44343756|NCT04867785|79347481|FG001|Overall Study|Eligibility Criteria Not Met|0|||
44343757|NCT04867785|79347482|FG002|Overall Study|Eligibility Criteria Not Met|0|||
44343758|NCT04867785|79347483|FG003|Overall Study|Eligibility Criteria Not Met|0|||
44343759|NCT04867785|79347484|FG004|Overall Study|Eligibility Criteria Not Met|0|||
44343760|NCT04867785|79347485|FG005|Overall Study|Eligibility Criteria Not Met|0|||
44343761|NCT04867785|79347486|FG006|Overall Study|Eligibility Criteria Not Met|0|||
44343762|NCT04867785|79347487|FG007|Overall Study|Eligibility Criteria Not Met|1|||
44343763|NCT04541004|79347514|FG000|Overall Study|Adverse Event|2|||
44343764|NCT04091646|79347521|FG000|Overall Study|Adverse Event|2|||
44343765|NCT04091646|79347522|FG001|Overall Study|Adverse Event|1|||
44343766|NCT04091646|79347521|FG000|Overall Study|Lost to Follow-up|6|||
44343767|NCT04091646|79347522|FG001|Overall Study|Lost to Follow-up|2|||
44343768|NCT04091646|79347521|FG000|Overall Study|Protocol Violation|0|||
44343769|NCT04091646|79347522|FG001|Overall Study|Protocol Violation|1|||
44343770|NCT04091646|79347521|FG000|Overall Study|Withdrawal by Subject|4|||
44343771|NCT04091646|79347522|FG001|Overall Study|Withdrawal by Subject|1|||
44343772|NCT04091646|79347521|FG000|Overall Study|Participant Incarcerated|1|||
44343773|NCT04091646|79347522|FG001|Overall Study|Participant Incarcerated|0|||
44343774|NCT04040933|79347534|FG000|Overall Study|Protocol Violation|1|||
44343775|NCT04040933|79347534|FG000|Overall Study|Withdrawal by Subject|2|||
44343776|NCT03995355|79347547|FG000|Overall Study|Adverse Event|1|||
44343777|NCT03995355|79347548|FG001|Overall Study|Adverse Event|0|||
44343778|NCT03995355|79347547|FG000|Overall Study|Withdrawal by Subject|1|||
44343779|NCT03995355|79347548|FG001|Overall Study|Withdrawal by Subject|0|||
44343780|NCT03995355|79347547|FG000|Overall Study|Scheduling Issues|0|||
44343781|NCT03995355|79347548|FG001|Overall Study|Scheduling Issues|1|||
44343782|NCT03933397|79347556|FG000|Overall Study|No emergency department visit|65|||
44343783|NCT03933397|79347557|FG001|Overall Study|No emergency department visit|71|||
44343784|NCT03933397|79347556|FG000|Overall Study|Missed emergency department visit|25|||
44343785|NCT03933397|79347557|FG001|Overall Study|Missed emergency department visit|30|||
44343786|NCT03933397|79347556|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
44343787|NCT03933397|79347557|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
44343788|NCT03933397|79347556|FG000|Overall Study|Withdrawal by Subject|1|||
44343789|NCT03933397|79347557|FG001|Overall Study|Withdrawal by Subject|0|||
44343790|NCT03933397|79347556|FG000|Overall Study|Physician Decision|1|||
44343791|NCT03933397|79347557|FG001|Overall Study|Physician Decision|1|||
44343792|NCT03933397|79347556|FG000|Overall Study|missing pain score|1|||
44343793|NCT03933397|79347557|FG001|Overall Study|missing pain score|1|||
44343794|NCT03933397|79347556|FG000|Overall Study|Confirmed COVID-19|1|||
44343795|NCT03933397|79347557|FG001|Overall Study|Confirmed COVID-19|2|||
44343796|NCT03624881|79347598|FG000|Overall Study|Screen Failure|14|||
44343797|NCT03624881|79347599|FG001|Overall Study|Screen Failure|0|||
44343798|NCT03624881|79347598|FG000|Overall Study|No Catheter Inserted|6|||
44343799|NCT03624881|79347599|FG001|Overall Study|No Catheter Inserted|1|||
44343800|NCT03624881|79347598|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
44343801|NCT03624881|79347599|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
44343802|NCT03624881|79347598|FG000|Overall Study|Death|2|||
44343803|NCT03624881|79347599|FG001|Overall Study|Death|0|||
44343804|NCT03624881|79347598|FG000|Overall Study|Lost to Follow-up|10|||
44343805|NCT03624881|79347599|FG001|Overall Study|Lost to Follow-up|4|||
44343806|NCT03624881|79347598|FG000|Overall Study|Withdrawal by Subject|12|||
44343807|NCT03624881|79347599|FG001|Overall Study|Withdrawal by Subject|1|||
44343808|NCT03428997|79347622|FG000|Overall Study|Sponsor decision.|1|||
44343809|NCT03428997|79347622|FG000|Overall Study|Withdrawal by Subject|3|||
44343810|NCT03428997|79347622|FG000|Overall Study|Lost to Follow-up|4|||
44343811|NCT03118674|79347655|FG000|Overall Study|Lost to Follow-up|2|||
44343812|NCT03118674|79347655|FG000|Overall Study|Screen Faliure|8|||
44343813|NCT03118674|79347655|FG000|Overall Study|Withdrawal by Subject|5|||
44343814|NCT03069352|79347661|FG000|Overall Study|Ongoing|12|||
44343815|NCT03069352|79347662|FG001|Overall Study|Ongoing|40|||
44343816|NCT02993523|79347673|FG000|Overall Study|Withdrew Consent|0|||
44343817|NCT02993523|79347674|FG001|Overall Study|Withdrew Consent|0|||
44343818|NCT02993523|79347675|FG002|Overall Study|Withdrew Consent|2|||
44343819|NCT02993523|79347676|FG003|Overall Study|Withdrew Consent|9|||
44343820|NCT02993523|79347677|FG004|Overall Study|Withdrew Consent|0|||
44343821|NCT02993523|79347673|FG000|Overall Study|Lost to Follow-up|0|||
44343822|NCT02993523|79347674|FG001|Overall Study|Lost to Follow-up|0|||
44343823|NCT02993523|79347675|FG002|Overall Study|Lost to Follow-up|3|||
44343824|NCT02993523|79347676|FG003|Overall Study|Lost to Follow-up|6|||
44343825|NCT02993523|79347677|FG004|Overall Study|Lost to Follow-up|0|||
44343826|NCT02993523|79347673|FG000|Overall Study|Death|1|||
44343827|NCT02993523|79347674|FG001|Overall Study|Death|1|||
44343828|NCT02993523|79347675|FG002|Overall Study|Death|138|||
44343829|NCT02993523|79347676|FG003|Overall Study|Death|222|||
44343830|NCT02993523|79347677|FG004|Overall Study|Death|6|||
44343831|NCT02993523|79347673|FG000|Overall Study|Reason not Specified|0|||
44343832|NCT02993523|79347674|FG001|Overall Study|Reason not Specified|0|||
44343833|NCT02993523|79347675|FG002|Overall Study|Reason not Specified|1|||
44343834|NCT02993523|79347676|FG003|Overall Study|Reason not Specified|1|||
44343835|NCT02993523|79347677|FG004|Overall Study|Reason not Specified|0|||
44343836|NCT02795429|79347690|FG000|Overall Study|Adverse Event|1|||
44343837|NCT02795429|79347691|FG001|Overall Study|Adverse Event|2|||
44343838|NCT02795429|79347692|FG002|Overall Study|Adverse Event|1|||
44343839|NCT02795429|79347693|FG003|Overall Study|Adverse Event|2|||
44343840|NCT02795429|79347694|FG004|Overall Study|Adverse Event|1|||
44343841|NCT02795429|79347690|FG000|Overall Study|Death|1|||
44343842|NCT02795429|79347691|FG001|Overall Study|Death|0|||
44343843|NCT02795429|79347692|FG002|Overall Study|Death|1|||
44343844|NCT02795429|79347693|FG003|Overall Study|Death|2|||
44343845|NCT02795429|79347694|FG004|Overall Study|Death|1|||
44343846|NCT02795429|79347690|FG000|Overall Study|Physician Decision|0|||
44343847|NCT02795429|79347691|FG001|Overall Study|Physician Decision|0|||
44343848|NCT02795429|79347692|FG002|Overall Study|Physician Decision|2|||
44343849|NCT02795429|79347693|FG003|Overall Study|Physician Decision|1|||
44343850|NCT02795429|79347694|FG004|Overall Study|Physician Decision|5|||
44343851|NCT02795429|79347690|FG000|Overall Study|Progressive disease|3|||
44343852|NCT02795429|79347691|FG001|Overall Study|Progressive disease|7|||
44343853|NCT02795429|79347692|FG002|Overall Study|Progressive disease|6|||
44343854|NCT02795429|79347693|FG003|Overall Study|Progressive disease|26|||
44343855|NCT02795429|79347694|FG004|Overall Study|Progressive disease|20|||
44343856|NCT02795429|79347690|FG000|Overall Study|Subject/guardian decision|1|||
44343857|NCT02795429|79347691|FG001|Overall Study|Subject/guardian decision|1|||
44343858|NCT02795429|79347692|FG002|Overall Study|Subject/guardian decision|1|||
44444054|NCT00141817|79451998|FG001|Overall Study|Parent request|0|||
44444055|NCT00141817|79451999|FG002|Overall Study|Parent request|0|||
44444056|NCT00141817|79452000|FG003|Overall Study|Parent request|0|||
44444057|NCT00573170|79452010|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
44343859|NCT02795429|79347693|FG003|Overall Study|Subject/guardian decision|1|||
44444058|NCT00573170|79452011|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
44343860|NCT02795429|79347694|FG004|Overall Study|Subject/guardian decision|3|||
44160317|NCT02579759|78952806|FG002|Overall Study|Protocol Violation|0|||
44343876|NCT02632344|79347728|FG000|Overall Study|Adverse Event|3|||
44343877|NCT02632344|79347728|FG000|Overall Study|Lack of Efficacy|3|||
44343878|NCT02632344|79347728|FG000|Overall Study|Withdrawal by Subject|2|||
44343894|NCT02213328|79347768|FG000|Overall Study|Withdrawal by Subject|10|||
44343895|NCT02213328|79347768|FG000|Overall Study|Physician Decision|2|||
44343896|NCT02213328|79347768|FG000|Overall Study|Lost to Follow-up|16|||
44343897|NCT02085408|79347797|FG000|Step 1: Induction|Disease Progression|19|||
44343898|NCT02085408|79347798|FG001|Step 1: Induction|Disease Progression|19|||
44343899|NCT02085408|79347797|FG000|Step 1: Induction|Adverse Event|18|||
44343900|NCT02085408|79347798|FG001|Step 1: Induction|Adverse Event|17|||
44343901|NCT02085408|79347797|FG000|Step 1: Induction|Death|33|||
44343902|NCT02085408|79347798|FG001|Step 1: Induction|Death|30|||
44343903|NCT02085408|79347797|FG000|Step 1: Induction|Withdrawal by Subject|16|||
44343904|NCT02085408|79347798|FG001|Step 1: Induction|Withdrawal by Subject|8|||
44343905|NCT02085408|79347797|FG000|Step 1: Induction|Alternative Therapy|15|||
44343906|NCT02085408|79347798|FG001|Step 1: Induction|Alternative Therapy|19|||
44343907|NCT02085408|79347797|FG000|Step 1: Induction|Complicating Disease|2|||
44343908|NCT02085408|79347798|FG001|Step 1: Induction|Complicating Disease|3|||
44343909|NCT02085408|79347797|FG000|Step 1: Induction|Other|27|||
44343910|NCT02085408|79347798|FG001|Step 1: Induction|Other|39|||
44343911|NCT02085408|79347797|FG000|Step 1: Induction|Never started treatment|6|||
44343912|NCT02085408|79347798|FG001|Step 1: Induction|Never started treatment|4|||
44343913|NCT02085408|79347797|FG000|Step 2: Consolidation|Disease Progression|5|||
44343914|NCT02085408|79347798|FG001|Step 2: Consolidation|Disease Progression|20|||
44343915|NCT02085408|79347797|FG000|Step 2: Consolidation|Adverse Event|9|||
44343916|NCT02085408|79347798|FG001|Step 2: Consolidation|Adverse Event|8|||
44343917|NCT02085408|79347797|FG000|Step 2: Consolidation|Death|4|||
44343918|NCT02085408|79347798|FG001|Step 2: Consolidation|Death|3|||
44343919|NCT02085408|79347797|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
44343920|NCT02085408|79347798|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
44343921|NCT02085408|79347797|FG000|Step 2: Consolidation|Alternative Therapy|9|||
44343922|NCT02085408|79347798|FG001|Step 2: Consolidation|Alternative Therapy|3|||
44343923|NCT02085408|79347797|FG000|Step 2: Consolidation|Complicating Disease|0|||
44343924|NCT02085408|79347798|FG001|Step 2: Consolidation|Complicating Disease|2|||
44343925|NCT02085408|79347797|FG000|Step 2: Consolidation|Other|6|||
44343926|NCT02085408|79347798|FG001|Step 2: Consolidation|Other|6|||
44343927|NCT02085408|79347797|FG000|Step 2: Consolidation|Never started treatment|4|||
44343928|NCT02085408|79347798|FG001|Step 2: Consolidation|Never started treatment|3|||
44444059|NCT00573170|79452012|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
44444060|NCT00573170|79452013|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
44444061|NCT00573170|79452014|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
44444062|NCT00573170|79452015|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
44444063|NCT00573170|79452010|FG000|First Washout Period|Adverse Event|1|||
44444064|NCT00573170|79452011|FG001|First Washout Period|Adverse Event|1|||
44444065|NCT00573170|79452012|FG002|First Washout Period|Adverse Event|0|||
44444066|NCT00573170|79452013|FG003|First Washout Period|Adverse Event|0|||
44343929|NCT02085408|79347797|FG000|Step 3: Maintenance|Disease Progression|13|||
44343930|NCT02085408|79347798|FG001|Step 3: Maintenance|Disease Progression|11|||
44343931|NCT02085408|79347797|FG000|Step 3: Maintenance|Adverse Event|2|||
44343932|NCT02085408|79347798|FG001|Step 3: Maintenance|Adverse Event|4|||
44343933|NCT02085408|79347797|FG000|Step 3: Maintenance|Death|1|||
44343934|NCT02085408|79347798|FG001|Step 3: Maintenance|Death|2|||
44343935|NCT02085408|79347797|FG000|Step 3: Maintenance|Alternative Therapy|1|||
44343936|NCT02085408|79347798|FG001|Step 3: Maintenance|Alternative Therapy|1|||
44343937|NCT02085408|79347797|FG000|Step 3: Maintenance|Complicating Disease|0|||
44343938|NCT02085408|79347798|FG001|Step 3: Maintenance|Complicating Disease|1|||
44343939|NCT02085408|79347797|FG000|Step 3: Maintenance|Other|3|||
44343940|NCT02085408|79347798|FG001|Step 3: Maintenance|Other|2|||
44343941|NCT02085408|79347797|FG000|Step 3: Maintenance|Never started treatment|5|||
44343942|NCT02085408|79347798|FG001|Step 3: Maintenance|Never started treatment|1|||
44343943|NCT01475786|79347816|FG000|Overall Study|Adverse Event|0|||
44343944|NCT01475786|79347817|FG001|Overall Study|Adverse Event|1|||
44343945|NCT01475786|79347818|FG002|Overall Study|Adverse Event|0|||
44343946|NCT01475786|79347816|FG000|Overall Study|Lost to Follow-up|1|||
44343947|NCT01475786|79347817|FG001|Overall Study|Lost to Follow-up|2|||
44343948|NCT01475786|79347818|FG002|Overall Study|Lost to Follow-up|1|||
44343949|NCT01475786|79347816|FG000|Overall Study|Withdrawal by Subject|0|||
44343950|NCT01475786|79347817|FG001|Overall Study|Withdrawal by Subject|1|||
44343951|NCT01475786|79347818|FG002|Overall Study|Withdrawal by Subject|1|||
44343952|NCT01475786|79347816|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
44343953|NCT01475786|79347817|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
44343954|NCT01475786|79347818|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
44343955|NCT01290692|79347826|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
44343956|NCT00700882|79347862|FG000|Overall Study|Never received treatment|6|||
44343957|NCT00700882|79347862|FG000|Overall Study|Ineligible|2|||
44343958|NCT00700882|79347862|FG000|Overall Study|No KIT mutation|51|||
44343959|NCT00666835|79347900|FG000|Overall Study|Withdrawal by Subject|5|||
44343960|NCT00666835|79347901|FG001|Overall Study|Withdrawal by Subject|2|||
44343961|NCT00666835|79347900|FG000|Overall Study|Lack of Efficacy|0|||
44343962|NCT00666835|79347901|FG001|Overall Study|Lack of Efficacy|1|||
44343963|NCT00666835|79347900|FG000|Overall Study|Incl./excl. not fulfilled|7|||
44343964|NCT00666835|79347901|FG001|Overall Study|Incl./excl. not fulfilled|2|||
44343965|NCT00666835|79347900|FG000|Overall Study|Adverse Event|7|||
44343966|NCT00666835|79347901|FG001|Overall Study|Adverse Event|6|||
44343967|NCT00666835|79347900|FG000|Overall Study|Protocol Violation|2|||
44343968|NCT00666835|79347901|FG001|Overall Study|Protocol Violation|0|||
44343969|NCT00666835|79347900|FG000|Overall Study|Death|15|||
44343970|NCT00666835|79347901|FG001|Overall Study|Death|4|||
44343971|NCT00666835|79347900|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
44343972|NCT00666835|79347901|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
44343973|NCT00666835|79347900|FG000|Overall Study|Hemoglobulin concentration|4|||
44343974|NCT00666835|79347901|FG001|Overall Study|Hemoglobulin concentration|3|||
44343975|NCT00666835|79347900|FG000|Overall Study|Planned operation|2|||
44343976|NCT00666835|79347901|FG001|Overall Study|Planned operation|0|||
44343977|NCT00666835|79347900|FG000|Overall Study|Physician Decision|1|||
44343978|NCT00666835|79347901|FG001|Overall Study|Physician Decision|2|||
44343979|NCT00551759|79347908|FG000|Overall Study|Adverse Event|7|||
44343980|NCT00551759|79347908|FG000|Overall Study|Death|5|||
44343981|NCT00551759|79347908|FG000|Overall Study|Ineligible|1|||
44343982|NCT00335140|79347912|FG000|Overall Study|Ineligible|1|||
44343983|NCT00304239|79347918|FG000|Overall Study|Protocol Deviations/Violations|15|||
44343984|NCT00304239|79347919|FG001|Overall Study|Protocol Deviations/Violations|0|||
44343985|NCT00304239|79347918|FG000|Overall Study|Adverse Event|2|||
44343986|NCT00304239|79347919|FG001|Overall Study|Adverse Event|0|||
44343987|NCT00101283|79347927|FG000|Overall Study|Withdrawal by Subject|0|||
44343988|NCT00101283|79347928|FG001|Overall Study|Withdrawal by Subject|1|||
44343989|NCT00101283|79347927|FG000|Overall Study|Insurance Refusal|0|||
44343990|NCT00101283|79347928|FG001|Overall Study|Insurance Refusal|1|||
44343991|NCT00101283|79347927|FG000|Overall Study|Prostate Cancer Recurrence|0|||
44343992|NCT00101283|79347928|FG001|Overall Study|Prostate Cancer Recurrence|1|||
44343993|NCT01302041|79347934|FG000|Overall Study|Death|5|||
44343994|NCT01302041|79347934|FG000|Overall Study|Withdrawal by Subject|4|||
44343995|NCT01302041|79347934|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
44160318|NCT02579759|78952804|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
44343996|NCT01302041|79347934|FG000|Overall Study|Other-Miscellaneous Reason|2|||
44343997|NCT01301729|79347939|FG000|Overall Study|Withdrawal by Subject|2|||
44343998|NCT01301729|79347939|FG000|Overall Study|Participant did not Return for Treatment|1|||
44343999|NCT01301729|79347939|FG000|Overall Study|Violated Selection Criteria|1|||
44344000|NCT01187043|79347949|FG000|Overall Study|Adverse Event|0|||
44344001|NCT01187043|79347950|FG001|Overall Study|Adverse Event|0|||
44344002|NCT01187043|79347951|FG002|Overall Study|Adverse Event|0|||
44344003|NCT01187043|79347952|FG003|Overall Study|Adverse Event|0|||
44344004|NCT01187043|79347953|FG004|Overall Study|Adverse Event|1|||
44344005|NCT01187043|79347949|FG000|Overall Study|Unable to make scheduled visits|1|||
44344006|NCT01187043|79347950|FG001|Overall Study|Unable to make scheduled visits|0|||
44344007|NCT01187043|79347951|FG002|Overall Study|Unable to make scheduled visits|4|||
44344008|NCT01187043|79347952|FG003|Overall Study|Unable to make scheduled visits|0|||
44344009|NCT01187043|79347953|FG004|Overall Study|Unable to make scheduled visits|1|||
44344010|NCT01186809|79347965|FG000|Overall Study|Death|30|||
44344011|NCT01186419|79347971|FG000|Overall Study|Withdrawal by Subject|5|||
44344012|NCT01186419|79347972|FG001|Overall Study|Withdrawal by Subject|3|||
44344013|NCT01186419|79347971|FG000|Overall Study|Adverse Event|1|||
44344014|NCT01186419|79347972|FG001|Overall Study|Adverse Event|2|||
44344015|NCT01186419|79347971|FG000|Overall Study|Physician Decision|0|||
44344016|NCT01186419|79347972|FG001|Overall Study|Physician Decision|3|||
44344017|NCT01186419|79347971|FG000|Overall Study|Other|1|||
44344018|NCT01186419|79347972|FG001|Overall Study|Other|1|||
44344019|NCT01301027|79347979|FG000|Overall Study|Physician Decision|2|||
44344020|NCT01301027|79347980|FG001|Overall Study|Physician Decision|0|||
44344021|NCT01301027|79347979|FG000|Overall Study|Withdrawal by Subject|2|||
44344022|NCT01301027|79347980|FG001|Overall Study|Withdrawal by Subject|3|||
44344023|NCT01301027|79347979|FG000|Overall Study|Adverse Event|0|||
44344024|NCT01301027|79347980|FG001|Overall Study|Adverse Event|2|||
44344025|NCT01301027|79347979|FG000|Overall Study|Fracture|1|||
44344026|NCT01301027|79347980|FG001|Overall Study|Fracture|3|||
44344027|NCT01301027|79347979|FG000|Overall Study|Transplant|0|||
44344028|NCT01301027|79347980|FG001|Overall Study|Transplant|2|||
44344029|NCT01301027|79347979|FG000|Overall Study|Volume Overload|3|||
44344030|NCT01301027|79347980|FG001|Overall Study|Volume Overload|0|||
44344031|NCT01185639|79347986|FG000|Overall Study|Progressed and didn't receive therapy|2|||
44344032|NCT01185561|79347992|FG000|Overall Study|Lost to Follow-up|0|||
44344033|NCT01185561|79347993|FG001|Overall Study|Lost to Follow-up|4|||
44344034|NCT01185561|79347992|FG000|Overall Study|Withdrawal by Subject|2|||
44344035|NCT01185561|79347993|FG001|Overall Study|Withdrawal by Subject|8|||
44344036|NCT01185249|79347999|FG000|Overall Study|Patients discharged or change in status|42|||
44344037|NCT01184859|79348009|FG000|Period 1: Single Dose|Insufficient urine production|0|||
44344038|NCT01184859|79348010|FG001|Period 1: Single Dose|Insufficient urine production|1|||
44344039|NCT01184859|79348011|FG002|Period 1: Single Dose|Insufficient urine production|0|||
44344040|NCT01184859|79348012|FG003|Period 1: Single Dose|Insufficient urine production|0|||
44344041|NCT01184859|79348013|FG004|Period 1: Single Dose|Insufficient urine production|0|||
44344042|NCT01184859|79348009|FG000|Period 1: Single Dose|Protocol Violation|0|||
44344043|NCT01184859|79348010|FG001|Period 1: Single Dose|Protocol Violation|1|||
44344044|NCT01184859|79348011|FG002|Period 1: Single Dose|Protocol Violation|0|||
44344045|NCT01184859|79348012|FG003|Period 1: Single Dose|Protocol Violation|0|||
44344046|NCT01184859|79348013|FG004|Period 1: Single Dose|Protocol Violation|0|||
44344047|NCT01184859|79348009|FG000|Period 1: Single Dose|Adverse Event|0|||
44344048|NCT01184859|79348010|FG001|Period 1: Single Dose|Adverse Event|0|||
44344049|NCT01184859|79348011|FG002|Period 1: Single Dose|Adverse Event|0|||
44344050|NCT01184859|79348012|FG003|Period 1: Single Dose|Adverse Event|0|||
44344051|NCT01184859|79348013|FG004|Period 1: Single Dose|Adverse Event|1|||
44344052|NCT01184859|79348009|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
44344053|NCT01184859|79348010|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
44344054|NCT01184859|79348011|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
44344055|NCT01184859|79348012|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
44344056|NCT01184859|79348013|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
44344057|NCT01184859|79348009|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
44344058|NCT01184859|79348010|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
44344059|NCT01184859|79348011|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
44344060|NCT01184859|79348012|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
44344061|NCT01184859|79348013|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
44344062|NCT01184079|79348032|FG000|Overall Study|Lost to Follow-up|14|||
44344063|NCT01184079|79348033|FG001|Overall Study|Lost to Follow-up|2|||
44344064|NCT01190865|79348041|FG000|Overall Study|Withdrawal by Subject|1|||
44344065|NCT01190865|79348041|FG000|Overall Study|Non-compliance|2|||
44344066|NCT01190475|79348048|FG000|Overall Study|Withdrawal by Subject|0|||
44344067|NCT01190475|79348049|FG001|Overall Study|Withdrawal by Subject|0|||
44344068|NCT01190475|79348050|FG002|Overall Study|Withdrawal by Subject|1|||
44344069|NCT01289990|79348073|FG000|Overall Study|Death|0|||
44344070|NCT01289990|79348074|FG001|Overall Study|Death|0|||
44344071|NCT01289990|79348075|FG002|Overall Study|Death|0|||
44344072|NCT01289990|79348076|FG003|Overall Study|Death|1|||
44344073|NCT01289990|79348077|FG004|Overall Study|Death|2|||
44344074|NCT01289990|79348078|FG005|Overall Study|Death|1|||
44344075|NCT01289990|79348079|FG006|Overall Study|Death|0|||
44344076|NCT01289990|79348080|FG007|Overall Study|Death|0|||
44344077|NCT01289990|79348081|FG008|Overall Study|Death|0|||
44344078|NCT01289990|79348082|FG009|Overall Study|Death|0|||
44344079|NCT01289990|79348083|FG010|Overall Study|Death|0|||
44344080|NCT01289990|79348084|FG011|Overall Study|Death|1|||
44344081|NCT01289990|79348085|FG012|Overall Study|Death|0|||
44344082|NCT01289990|79348073|FG000|Overall Study|Lost to Follow-up|3|||
44344083|NCT01289990|79348074|FG001|Overall Study|Lost to Follow-up|2|||
44344084|NCT01289990|79348075|FG002|Overall Study|Lost to Follow-up|5|||
44344085|NCT01289990|79348076|FG003|Overall Study|Lost to Follow-up|5|||
44344086|NCT01289990|79348077|FG004|Overall Study|Lost to Follow-up|3|||
44344087|NCT01289990|79348078|FG005|Overall Study|Lost to Follow-up|4|||
44344088|NCT01289990|79348079|FG006|Overall Study|Lost to Follow-up|2|||
44344089|NCT01289990|79348080|FG007|Overall Study|Lost to Follow-up|2|||
44344090|NCT01289990|79348081|FG008|Overall Study|Lost to Follow-up|1|||
44344091|NCT01289990|79348082|FG009|Overall Study|Lost to Follow-up|4|||
44344092|NCT01289990|79348083|FG010|Overall Study|Lost to Follow-up|2|||
44344093|NCT01289990|79348084|FG011|Overall Study|Lost to Follow-up|1|||
44344094|NCT01289990|79348085|FG012|Overall Study|Lost to Follow-up|2|||
44344095|NCT01289990|79348073|FG000|Overall Study|Withdrawal by Subject|15|||
44344096|NCT01289990|79348074|FG001|Overall Study|Withdrawal by Subject|14|||
44344097|NCT01289990|79348075|FG002|Overall Study|Withdrawal by Subject|12|||
44344098|NCT01289990|79348076|FG003|Overall Study|Withdrawal by Subject|13|||
44344099|NCT01289990|79348077|FG004|Overall Study|Withdrawal by Subject|8|||
44344100|NCT01289990|79348078|FG005|Overall Study|Withdrawal by Subject|7|||
44344101|NCT01289990|79348079|FG006|Overall Study|Withdrawal by Subject|13|||
44344102|NCT01289990|79348080|FG007|Overall Study|Withdrawal by Subject|9|||
44344103|NCT01289990|79348081|FG008|Overall Study|Withdrawal by Subject|12|||
44344104|NCT01289990|79348082|FG009|Overall Study|Withdrawal by Subject|13|||
44344105|NCT01289990|79348083|FG010|Overall Study|Withdrawal by Subject|11|||
44344106|NCT01289990|79348084|FG011|Overall Study|Withdrawal by Subject|13|||
44344107|NCT01289990|79348085|FG012|Overall Study|Withdrawal by Subject|16|||
44344108|NCT01289990|79348073|FG000|Overall Study|discontinued in preceding trial|18|||
44344109|NCT01289990|79348074|FG001|Overall Study|discontinued in preceding trial|20|||
44344110|NCT01289990|79348075|FG002|Overall Study|discontinued in preceding trial|41|||
44344111|NCT01289990|79348076|FG003|Overall Study|discontinued in preceding trial|17|||
44344112|NCT01289990|79348077|FG004|Overall Study|discontinued in preceding trial|11|||
44344113|NCT01289990|79348078|FG005|Overall Study|discontinued in preceding trial|12|||
44344114|NCT01289990|79348079|FG006|Overall Study|discontinued in preceding trial|18|||
44344115|NCT01289990|79348080|FG007|Overall Study|discontinued in preceding trial|8|||
44344116|NCT01289990|79348081|FG008|Overall Study|discontinued in preceding trial|17|||
44344117|NCT01289990|79348082|FG009|Overall Study|discontinued in preceding trial|21|||
44344118|NCT01289990|79348083|FG010|Overall Study|discontinued in preceding trial|17|||
44344119|NCT01289990|79348084|FG011|Overall Study|discontinued in preceding trial|17|||
44344120|NCT01289990|79348085|FG012|Overall Study|discontinued in preceding trial|24|||
44344121|NCT01289990|79348073|FG000|Overall Study|did not continue in extension|41|||
44344122|NCT01289990|79348074|FG001|Overall Study|did not continue in extension|45|||
44344123|NCT01289990|79348075|FG002|Overall Study|did not continue in extension|51|||
44344124|NCT01289990|79348076|FG003|Overall Study|did not continue in extension|51|||
44344125|NCT01289990|79348077|FG004|Overall Study|did not continue in extension|48|||
44344126|NCT01289990|79348078|FG005|Overall Study|did not continue in extension|50|||
44344127|NCT01289990|79348079|FG006|Overall Study|did not continue in extension|54|||
44344128|NCT01289990|79348080|FG007|Overall Study|did not continue in extension|36|||
44344129|NCT01289990|79348081|FG008|Overall Study|did not continue in extension|44|||
44344130|NCT01289990|79348082|FG009|Overall Study|did not continue in extension|48|||
44344131|NCT01289990|79348083|FG010|Overall Study|did not continue in extension|45|||
44344132|NCT01289990|79348084|FG011|Overall Study|did not continue in extension|34|||
44344133|NCT01289990|79348085|FG012|Overall Study|did not continue in extension|56|||
44344134|NCT01289990|79348073|FG000|Overall Study|Not treated|0|||
44344135|NCT01289990|79348074|FG001|Overall Study|Not treated|0|||
44344136|NCT01289990|79348075|FG002|Overall Study|Not treated|0|||
44344137|NCT01289990|79348076|FG003|Overall Study|Not treated|0|||
44344138|NCT01289990|79348077|FG004|Overall Study|Not treated|0|||
44344139|NCT01289990|79348078|FG005|Overall Study|Not treated|0|||
44344140|NCT01289990|79348079|FG006|Overall Study|Not treated|1|||
44344141|NCT01289990|79348080|FG007|Overall Study|Not treated|0|||
44344142|NCT01289990|79348081|FG008|Overall Study|Not treated|1|||
44344143|NCT01289990|79348082|FG009|Overall Study|Not treated|0|||
44344144|NCT01289990|79348083|FG010|Overall Study|Not treated|1|||
44344145|NCT01289990|79348084|FG011|Overall Study|Not treated|2|||
44344146|NCT01289990|79348085|FG012|Overall Study|Not treated|0|||
44344147|NCT01190007|79348113|FG000|Overall Study|Withdrawal by Subject|4|||
44344148|NCT01190007|79348113|FG000|Overall Study|Adverse Event|8|||
44344149|NCT01190007|79348113|FG000|Overall Study|Difficulty of visit for complications|1|||
44344150|NCT01190007|79348113|FG000|Overall Study|Participant was arrested|1|||
44344151|NCT01189461|79348117|FG000|Overall Study|Lack of Efficacy|13|||
44344152|NCT01189461|79348117|FG000|Overall Study|Lost to Follow-up|1|||
44344153|NCT01189461|79348117|FG000|Overall Study|Withdrawal by Subject|6|||
44344154|NCT01189461|79348117|FG000|Overall Study|Protocol Violation|1|||
44344155|NCT01189461|79348117|FG000|Overall Study|Adverse Event|2|||
44344156|NCT01189461|79348117|FG000|Overall Study|Did not meet entrance criteria|3|||
44344157|NCT01189461|79348117|FG000|Overall Study|Other|8|||
44344158|NCT01189227|79348123|FG000|Overall Study|Study terminated due to low accrual|6|||
44344159|NCT01189227|79348124|FG001|Overall Study|Study terminated due to low accrual|3|||
44344160|NCT01300247|79348132|FG000|Overall Study|Death|1|||
44344161|NCT01300247|79348133|FG001|Overall Study|Death|1|||
44344162|NCT01300247|79348132|FG000|Overall Study|Lost to Follow-up|2|||
44344163|NCT01300247|79348133|FG001|Overall Study|Lost to Follow-up|0|||
44344164|NCT01300247|79348132|FG000|Overall Study|Withdrawal by Subject|1|||
44344165|NCT01300247|79348133|FG001|Overall Study|Withdrawal by Subject|0|||
44344166|NCT01300247|79348132|FG000|Overall Study|Non-Compliance|0|||
44344167|NCT01300247|79348133|FG001|Overall Study|Non-Compliance|1|||
44344168|NCT01289678|79348139|FG000|Overall Study|Physician Decision|6|||
44344169|NCT01289210|79348143|FG000|Overall Study|Adverse Event|1|||
44344170|NCT01183221|79348149|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
44344171|NCT01183221|79348150|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
44344172|NCT01183143|79348156|FG000|Overall Study|Protocol Violation|115|||
44344173|NCT01183143|79348156|FG000|Overall Study|Withdrawal by Subject|19|||
44344174|NCT01183143|79348156|FG000|Overall Study|Subject Questionnaires not returned|5|||
44344175|NCT01183143|79348156|FG000|Overall Study|Subjects enrolled, but not treated|11|||
44344176|NCT01183065|79348160|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
44344177|NCT01182441|79348166|FG000|Overall Study|Patient Still in Follow-up|152|||
44344178|NCT01182441|79348167|FG001|Overall Study|Patient Still in Follow-up|72|||
44344179|NCT01182441|79348166|FG000|Overall Study|Death|37|||
44344180|NCT01182441|79348167|FG001|Overall Study|Death|25|||
44344181|NCT01182441|79348166|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
44344182|NCT01182441|79348167|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
44344183|NCT01182441|79348166|FG000|Overall Study|Lost to Follow-up|5|||
44344184|NCT01182441|79348167|FG001|Overall Study|Lost to Follow-up|8|||
44344185|NCT01182441|79348166|FG000|Overall Study|Withdrawal by Subject|6|||
44344186|NCT01182441|79348167|FG001|Overall Study|Withdrawal by Subject|13|||
44344187|NCT01182441|79348166|FG000|Overall Study|Implant Not Attempted|4|||
44344188|NCT01182441|79348167|FG001|Overall Study|Implant Not Attempted|0|||
44344189|NCT01182441|79348166|FG000|Overall Study|Adverse Event|2|||
44344190|NCT01182441|79348167|FG001|Overall Study|Adverse Event|0|||
44344191|NCT01182441|79348166|FG000|Overall Study|Physician Decision|1|||
44444067|NCT00573170|79452014|FG004|First Washout Period|Adverse Event|0|||
44444068|NCT00573170|79452015|FG005|First Washout Period|Adverse Event|1|||
44444069|NCT00573170|79452010|FG000|First Washout Period|Lack of Efficacy|0|||
44444070|NCT00573170|79452011|FG001|First Washout Period|Lack of Efficacy|0|||
44444071|NCT00573170|79452012|FG002|First Washout Period|Lack of Efficacy|0|||
44444072|NCT00573170|79452013|FG003|First Washout Period|Lack of Efficacy|0|||
44444073|NCT00573170|79452014|FG004|First Washout Period|Lack of Efficacy|0|||
44444074|NCT00573170|79452015|FG005|First Washout Period|Lack of Efficacy|1|||
44444075|NCT00573170|79452010|FG000|First Washout Period|Lost to Follow-up|1|||
44444076|NCT00573170|79452011|FG001|First Washout Period|Lost to Follow-up|1|||
44444077|NCT00573170|79452012|FG002|First Washout Period|Lost to Follow-up|0|||
44444078|NCT00573170|79452013|FG003|First Washout Period|Lost to Follow-up|2|||
44444079|NCT00573170|79452014|FG004|First Washout Period|Lost to Follow-up|0|||
44444080|NCT00573170|79452015|FG005|First Washout Period|Lost to Follow-up|2|||
44444081|NCT00573170|79452010|FG000|First Washout Period|Withdrawal by Subject|2|||
44444082|NCT00573170|79452011|FG001|First Washout Period|Withdrawal by Subject|0|||
44444083|NCT00573170|79452012|FG002|First Washout Period|Withdrawal by Subject|0|||
44444084|NCT00573170|79452013|FG003|First Washout Period|Withdrawal by Subject|2|||
44444085|NCT00573170|79452014|FG004|First Washout Period|Withdrawal by Subject|3|||
44444086|NCT00573170|79452015|FG005|First Washout Period|Withdrawal by Subject|3|||
44444087|NCT00573170|79452010|FG000|First Washout Period|Other|4|||
44444088|NCT00573170|79452011|FG001|First Washout Period|Other|0|||
44444089|NCT00573170|79452012|FG002|First Washout Period|Other|1|||
44444090|NCT00573170|79452013|FG003|First Washout Period|Other|1|||
44444091|NCT00573170|79452014|FG004|First Washout Period|Other|0|||
44444092|NCT00573170|79452015|FG005|First Washout Period|Other|0|||
44444093|NCT00573170|79452010|FG000|Second Washout Period|Adverse Event|1|||
44444094|NCT00573170|79452011|FG001|Second Washout Period|Adverse Event|0|||
44444095|NCT00573170|79452012|FG002|Second Washout Period|Adverse Event|0|||
44444096|NCT00573170|79452013|FG003|Second Washout Period|Adverse Event|0|||
44444097|NCT00573170|79452014|FG004|Second Washout Period|Adverse Event|1|||
44444098|NCT00573170|79452015|FG005|Second Washout Period|Adverse Event|0|||
44444099|NCT00573170|79452010|FG000|Second Washout Period|Protocol Violation|2|||
44344192|NCT01182441|79348167|FG001|Overall Study|Physician Decision|1|||
44344193|NCT01182285|79348173|FG000|First Intervention Week 1-10|Disease progression|1|||
44344194|NCT01182285|79348174|FG001|First Intervention Week 1-10|Disease progression|0|||
44344195|NCT01182285|79348175|FG002|First Intervention Week 1-10|Disease progression|0|||
44444100|NCT00573170|79452011|FG001|Second Washout Period|Protocol Violation|1|||
44444101|NCT00573170|79452012|FG002|Second Washout Period|Protocol Violation|1|||
44444102|NCT00573170|79452013|FG003|Second Washout Period|Protocol Violation|0|||
44444103|NCT00573170|79452014|FG004|Second Washout Period|Protocol Violation|0|||
44444104|NCT00573170|79452015|FG005|Second Washout Period|Protocol Violation|0|||
44444105|NCT00573170|79452010|FG000|Second Washout Period|Withdrawal by Subject|1|||
44344196|NCT01182285|79348173|FG000|First Intervention Week 1-10|Adverse Event|1|||
44444106|NCT00573170|79452011|FG001|Second Washout Period|Withdrawal by Subject|1|||
44444107|NCT00573170|79452012|FG002|Second Washout Period|Withdrawal by Subject|2|||
44444108|NCT00573170|79452013|FG003|Second Washout Period|Withdrawal by Subject|0|||
44444109|NCT00573170|79452014|FG004|Second Washout Period|Withdrawal by Subject|1|||
44444110|NCT00573170|79452015|FG005|Second Washout Period|Withdrawal by Subject|0|||
44444111|NCT00573170|79452010|FG000|Second Washout Period|Lost to Follow-up|0|||
44444112|NCT00573170|79452011|FG001|Second Washout Period|Lost to Follow-up|0|||
44444113|NCT00573170|79452012|FG002|Second Washout Period|Lost to Follow-up|0|||
44444114|NCT00573170|79452013|FG003|Second Washout Period|Lost to Follow-up|1|||
44444115|NCT00573170|79452014|FG004|Second Washout Period|Lost to Follow-up|0|||
44444116|NCT00573170|79452015|FG005|Second Washout Period|Lost to Follow-up|0|||
44444117|NCT00573170|79452010|FG000|Second Washout Period|Other|1|||
44444118|NCT00573170|79452011|FG001|Second Washout Period|Other|2|||
44444119|NCT00573170|79452012|FG002|Second Washout Period|Other|1|||
44444120|NCT00573170|79452013|FG003|Second Washout Period|Other|4|||
44444121|NCT00573170|79452014|FG004|Second Washout Period|Other|6|||
44444122|NCT00573170|79452015|FG005|Second Washout Period|Other|2|||
44444123|NCT00573170|79452010|FG000|Third Treatment Period|Withdrawal by Subject|1|||
44444124|NCT00573170|79452011|FG001|Third Treatment Period|Withdrawal by Subject|0|||
44444125|NCT00573170|79452012|FG002|Third Treatment Period|Withdrawal by Subject|0|||
44444126|NCT00573170|79452013|FG003|Third Treatment Period|Withdrawal by Subject|0|||
44444127|NCT00573170|79452014|FG004|Third Treatment Period|Withdrawal by Subject|0|||
44444128|NCT00573170|79452015|FG005|Third Treatment Period|Withdrawal by Subject|0|||
44444129|NCT00573170|79452010|FG000|Third Treatment Period|Lost to Follow-up|0|||
44444130|NCT00573170|79452011|FG001|Third Treatment Period|Lost to Follow-up|0|||
44444131|NCT00573170|79452012|FG002|Third Treatment Period|Lost to Follow-up|0|||
44444132|NCT00573170|79452013|FG003|Third Treatment Period|Lost to Follow-up|0|||
44444133|NCT00573170|79452014|FG004|Third Treatment Period|Lost to Follow-up|0|||
44444134|NCT00573170|79452015|FG005|Third Treatment Period|Lost to Follow-up|2|||
44444135|NCT00201643|79452034|FG000|Overall Study|Withdrawal by Subject|5|||
44444136|NCT00201643|79452035|FG001|Overall Study|Withdrawal by Subject|4|||
44444137|NCT00130039|79452043|FG000|Overall Study|Withdrawal by Subject|15|||
44444138|NCT00130039|79452044|FG001|Overall Study|Withdrawal by Subject|11|||
44444139|NCT00130039|79452043|FG000|Overall Study|Lost to Follow-up|3|||
44444140|NCT00130039|79452044|FG001|Overall Study|Lost to Follow-up|1|||
44444141|NCT00130039|79452043|FG000|Overall Study|Adverse Event|4|||
44444142|NCT00130039|79452044|FG001|Overall Study|Adverse Event|2|||
44444143|NCT00130039|79452043|FG000|Overall Study|Physician Decision|3|||
44444144|NCT00130039|79452044|FG001|Overall Study|Physician Decision|0|||
44444145|NCT00130039|79452043|FG000|Overall Study|clinical events without follow up MRI|5|||
44444146|NCT00130039|79452044|FG001|Overall Study|clinical events without follow up MRI|4|||
44444147|NCT00475852|79452052|FG000|Overall Study|Death|444|||
44444148|NCT00475852|79452053|FG001|Overall Study|Death|456|||
44444149|NCT00475852|79452052|FG000|Overall Study|Withdrawal by Subject|19|||
44444150|NCT00475852|79452053|FG001|Overall Study|Withdrawal by Subject|24|||
44444151|NCT00475852|79452052|FG000|Overall Study|Lost to Follow-up|54|||
44444152|NCT00475852|79452053|FG001|Overall Study|Lost to Follow-up|68|||
44444153|NCT00141271|79452062|FG000|Overall Study|Adverse Event|31|||
44444154|NCT00141271|79452063|FG001|Overall Study|Adverse Event|19|||
44444155|NCT00141271|79452064|FG002|Overall Study|Adverse Event|17|||
44344197|NCT01182285|79348174|FG001|First Intervention Week 1-10|Adverse Event|0|||
44344198|NCT01182285|79348175|FG002|First Intervention Week 1-10|Adverse Event|0|||
44344199|NCT01182285|79348173|FG000|First Intervention Week 1-10|Non-compliance|1|||
44344200|NCT01182285|79348174|FG001|First Intervention Week 1-10|Non-compliance|0|||
44344201|NCT01182285|79348175|FG002|First Intervention Week 1-10|Non-compliance|0|||
44344202|NCT01182285|79348173|FG000|Third Intervention Week 11-52|Disease Progression|0|||
44344203|NCT01182285|79348174|FG001|Third Intervention Week 11-52|Disease Progression|0|||
44344204|NCT01182285|79348175|FG002|Third Intervention Week 11-52|Disease Progression|6|||
44344205|NCT01182285|79348173|FG000|Third Intervention Week 11-52|Other|0|||
44344206|NCT01182285|79348174|FG001|Third Intervention Week 11-52|Other|0|||
44344207|NCT01182285|79348175|FG002|Third Intervention Week 11-52|Other|2|||
44344208|NCT01182207|79348184|FG000|First Intervention|Positive Hepatitis Results|0|||
44444156|NCT00141271|79452062|FG000|Overall Study|Laboratory Abnormality|2|||
44444157|NCT00141271|79452063|FG001|Overall Study|Laboratory Abnormality|1|||
44444158|NCT00141271|79452064|FG002|Overall Study|Laboratory Abnormality|1|||
44444159|NCT00141271|79452062|FG000|Overall Study|Lack of Efficacy|7|||
44444160|NCT00141271|79452063|FG001|Overall Study|Lack of Efficacy|7|||
44344209|NCT01182207|79348185|FG001|First Intervention|Positive Hepatitis Results|1|||
44344210|NCT01182207|79348184|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
44344211|NCT01182207|79348185|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
44444161|NCT00141271|79452064|FG002|Overall Study|Lack of Efficacy|3|||
44444162|NCT00141271|79452062|FG000|Overall Study|Lost to Follow-up|15|||
44444163|NCT00141271|79452063|FG001|Overall Study|Lost to Follow-up|15|||
44444164|NCT00141271|79452064|FG002|Overall Study|Lost to Follow-up|21|||
44444165|NCT00141271|79452062|FG000|Overall Study|Withdrawal by Subject|14|||
44444166|NCT00141271|79452063|FG001|Overall Study|Withdrawal by Subject|9|||
44444167|NCT00141271|79452064|FG002|Overall Study|Withdrawal by Subject|10|||
44444168|NCT00141271|79452062|FG000|Overall Study|Other|11|||
44444169|NCT00141271|79452063|FG001|Overall Study|Other|12|||
44444170|NCT00141271|79452064|FG002|Overall Study|Other|5|||
44444171|NCT00614120|79452076|FG000|Overall Study|Adverse Event|9|||
44444172|NCT00614120|79452077|FG001|Overall Study|Adverse Event|22|||
44444173|NCT00614120|79452078|FG002|Overall Study|Adverse Event|30|||
44444174|NCT00614120|79452079|FG003|Overall Study|Adverse Event|3|||
44444175|NCT00614120|79452076|FG000|Overall Study|Lack of Efficacy|3|||
44444176|NCT00614120|79452077|FG001|Overall Study|Lack of Efficacy|3|||
44444177|NCT00614120|79452078|FG002|Overall Study|Lack of Efficacy|2|||
44444178|NCT00614120|79452079|FG003|Overall Study|Lack of Efficacy|2|||
44444179|NCT00614120|79452076|FG000|Overall Study|Protocol Violation|2|||
44444180|NCT00614120|79452077|FG001|Overall Study|Protocol Violation|5|||
44444181|NCT00614120|79452078|FG002|Overall Study|Protocol Violation|3|||
44444182|NCT00614120|79452079|FG003|Overall Study|Protocol Violation|1|||
44444183|NCT00614120|79452076|FG000|Overall Study|Withdrawal criteria|1|||
44344212|NCT01181895|79348194|FG000|Overall Study|Adverse Event|3|||
44344213|NCT01181895|79348195|FG001|Overall Study|Adverse Event|1|||
44344214|NCT01181895|79348196|FG002|Overall Study|Adverse Event|1|||
44344215|NCT01181895|79348194|FG000|Overall Study|Lack of Efficacy|8|||
44444184|NCT00614120|79452077|FG001|Overall Study|Withdrawal criteria|0|||
44444185|NCT00614120|79452078|FG002|Overall Study|Withdrawal criteria|0|||
44444186|NCT00614120|79452079|FG003|Overall Study|Withdrawal criteria|0|||
44444187|NCT00614120|79452076|FG000|Overall Study|Withdrawal by Subject|9|||
44444188|NCT00614120|79452077|FG001|Overall Study|Withdrawal by Subject|10|||
44444189|NCT00614120|79452078|FG002|Overall Study|Withdrawal by Subject|16|||
44444190|NCT00614120|79452079|FG003|Overall Study|Withdrawal by Subject|3|||
44444191|NCT00614120|79452076|FG000|Overall Study|Did not meet trial criteria|0|||
44444192|NCT00614120|79452077|FG001|Overall Study|Did not meet trial criteria|1|||
44444193|NCT00614120|79452078|FG002|Overall Study|Did not meet trial criteria|1|||
44444194|NCT00614120|79452079|FG003|Overall Study|Did not meet trial criteria|1|||
44444195|NCT00614120|79452076|FG000|Overall Study|hCG positive (not pregnant)|0|||
44444196|NCT00614120|79452077|FG001|Overall Study|hCG positive (not pregnant)|0|||
44444197|NCT00614120|79452078|FG002|Overall Study|hCG positive (not pregnant)|1|||
44444198|NCT00614120|79452079|FG003|Overall Study|hCG positive (not pregnant)|0|||
44444199|NCT00614120|79452076|FG000|Overall Study|Hypoglycaemia|0|||
44444200|NCT00614120|79452077|FG001|Overall Study|Hypoglycaemia|0|||
44160319|NCT02579759|78952805|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
44160320|NCT02579759|78952806|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
44344216|NCT01181895|79348195|FG001|Overall Study|Lack of Efficacy|9|||
44344217|NCT01181895|79348196|FG002|Overall Study|Lack of Efficacy|9|||
44344218|NCT01181895|79348194|FG000|Overall Study|Protocol Violation|2|||
44344219|NCT01181895|79348195|FG001|Overall Study|Protocol Violation|1|||
44344220|NCT01181895|79348196|FG002|Overall Study|Protocol Violation|0|||
44344221|NCT01181895|79348194|FG000|Overall Study|Lost to Follow-up|0|||
44344222|NCT01181895|79348195|FG001|Overall Study|Lost to Follow-up|1|||
44344223|NCT01181895|79348196|FG002|Overall Study|Lost to Follow-up|2|||
44344224|NCT01181895|79348194|FG000|Overall Study|Investigator Discretion|1|||
44344225|NCT01181895|79348195|FG001|Overall Study|Investigator Discretion|2|||
44344226|NCT01181895|79348196|FG002|Overall Study|Investigator Discretion|1|||
44344227|NCT01181895|79348194|FG000|Overall Study|Withdrawal by Subject|3|||
44344228|NCT01181895|79348195|FG001|Overall Study|Withdrawal by Subject|0|||
44344229|NCT01181895|79348196|FG002|Overall Study|Withdrawal by Subject|5|||
44344230|NCT01181271|79348204|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
44344231|NCT01181271|79348204|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
44344232|NCT01181271|79348204|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
44444201|NCT00614120|79452078|FG002|Overall Study|Hypoglycaemia|0|||
44444202|NCT00614120|79452079|FG003|Overall Study|Hypoglycaemia|1|||
44444203|NCT00614120|79452076|FG000|Overall Study|Lack of trial product|3|||
44444204|NCT00614120|79452077|FG001|Overall Study|Lack of trial product|3|||
44444205|NCT00614120|79452078|FG002|Overall Study|Lack of trial product|2|||
44444206|NCT00614120|79452079|FG003|Overall Study|Lack of trial product|0|||
44160321|NCT02579759|78952804|FG000|Overall Study|BfArM hold|13|||
44444207|NCT00614120|79452076|FG000|Overall Study|Late syphilis, latent|1|||
44444208|NCT00614120|79452077|FG001|Overall Study|Late syphilis, latent|0|||
44444209|NCT00614120|79452078|FG002|Overall Study|Late syphilis, latent|0|||
44344233|NCT01181271|79348204|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
44344234|NCT01180647|79348210|FG000|Overall Study|Lost to Follow-up|5|||
44344235|NCT01180647|79348211|FG001|Overall Study|Lost to Follow-up|6|||
44344236|NCT00969553|79348226|FG000|Overall Study|Progressive disease (PD)|2|||
44444210|NCT00614120|79452079|FG003|Overall Study|Late syphilis, latent|0|||
44444211|NCT00614120|79452076|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
44444212|NCT00614120|79452077|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
44444213|NCT00614120|79452078|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
44444214|NCT00614120|79452079|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
44444215|NCT00614120|79452076|FG000|Overall Study|Lost to Follow-up|1|||
44444216|NCT00614120|79452077|FG001|Overall Study|Lost to Follow-up|2|||
44444217|NCT00614120|79452078|FG002|Overall Study|Lost to Follow-up|3|||
44444218|NCT00614120|79452079|FG003|Overall Study|Lost to Follow-up|4|||
44444219|NCT00496054|79452089|FG000|Overall Study|Adverse Event|1|||
44444220|NCT00496054|79452089|FG000|Overall Study|Lost to Follow-up|7|||
44444221|NCT00495820|79452095|FG000|Overall Study|Adverse Event|1|||
44444222|NCT00495820|79452096|FG001|Overall Study|Adverse Event|1|||
44444223|NCT00495586|79452104|FG000|Overall Study|Withdrawal by Subject|4|||
44444224|NCT00495586|79452105|FG001|Overall Study|Withdrawal by Subject|4|||
44444225|NCT00613730|79452113|FG000|Overall Study|Disease progression|2|||
44444226|NCT00613730|79452113|FG000|Overall Study|Administrative decision|1|||
44444227|NCT00613574|79452117|FG000|Overall Study|Adverse Event|3|||
44444228|NCT00613574|79452117|FG000|Overall Study|Lost to Follow-up|2|||
44444229|NCT00613574|79452117|FG000|Overall Study|Other|1|||
44444230|NCT00613106|79452123|FG000|Overall Study|Adverse Event|3|||
44444231|NCT00613106|79452124|FG001|Overall Study|Adverse Event|1|||
44444232|NCT00613106|79452123|FG000|Overall Study|Withdrawal by Subject|6|||
44444233|NCT00613106|79452124|FG001|Overall Study|Withdrawal by Subject|3|||
44444234|NCT00613106|79452123|FG000|Overall Study|Lost to Follow-up|7|||
44444235|NCT00613106|79452124|FG001|Overall Study|Lost to Follow-up|2|||
44444236|NCT00613106|79452123|FG000|Overall Study|misc|4|||
44444237|NCT00613106|79452124|FG001|Overall Study|misc|3|||
44444238|NCT00141037|79452132|FG000|Overall Study|Physician Decision|1|||
44444239|NCT00141037|79452133|FG001|Overall Study|Physician Decision|2|||
44444240|NCT00141037|79452132|FG000|Overall Study|Lost to Follow-up|3|||
44444241|NCT00141037|79452133|FG001|Overall Study|Lost to Follow-up|1|||
44444242|NCT00141037|79452132|FG000|Overall Study|Protocol Violation|0|||
44444243|NCT00141037|79452133|FG001|Overall Study|Protocol Violation|2|||
44444244|NCT00141037|79452132|FG000|Overall Study|Withdrawal by Subject|2|||
44444245|NCT00141037|79452133|FG001|Overall Study|Withdrawal by Subject|1|||
44444246|NCT00141037|79452132|FG000|Overall Study|Other|0|||
44444247|NCT00141037|79452133|FG001|Overall Study|Other|1|||
44444248|NCT00141037|79452132|FG000|Overall Study|Moved from area|1|||
44444249|NCT00141037|79452133|FG001|Overall Study|Moved from area|7|||
44444250|NCT00141037|79452132|FG000|Overall Study|Graft Failure|3|||
44444251|NCT00141037|79452133|FG001|Overall Study|Graft Failure|4|||
44444252|NCT00140413|79452142|FG000|Overall Study|Lost to Follow-up|1|||
44444253|NCT00140413|79452143|FG001|Overall Study|Lost to Follow-up|0|||
44444254|NCT00140413|79452142|FG000|Overall Study|Withdrawal by Subject|2|||
44444255|NCT00140413|79452143|FG001|Overall Study|Withdrawal by Subject|0|||
44444256|NCT00563706|79452159|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
44444257|NCT00563706|79452160|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
44444258|NCT00563706|79452161|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
44444259|NCT00563706|79452162|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
44444260|NCT00563706|79452163|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
44444261|NCT00563706|79452164|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
44444262|NCT00563706|79452165|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
44444263|NCT00563706|79452166|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
44444264|NCT00563706|79452167|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
44444265|NCT00563706|79452159|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
44444266|NCT00563706|79452160|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
44444267|NCT00563706|79452161|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
44444268|NCT00563706|79452162|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
44444269|NCT00563706|79452163|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
44444270|NCT00563706|79452164|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
44444271|NCT00563706|79452165|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
44444272|NCT00563706|79452166|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
44444273|NCT00563706|79452167|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
44444274|NCT00563706|79452159|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
44444275|NCT00563706|79452160|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
44444276|NCT00563706|79452161|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
44444277|NCT00563706|79452162|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
44444278|NCT00563706|79452163|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
44444279|NCT00563706|79452164|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
44444280|NCT00563706|79452165|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
44444281|NCT00563706|79452166|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
44444282|NCT00563706|79452167|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
44444283|NCT00563706|79452159|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
44444284|NCT00563706|79452160|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444285|NCT00563706|79452161|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444286|NCT00563706|79452162|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444287|NCT00563706|79452163|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444288|NCT00563706|79452164|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444289|NCT00563706|79452165|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444290|NCT00563706|79452166|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
44444291|NCT00563706|79452167|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
44444292|NCT00563706|79452159|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444293|NCT00563706|79452160|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444294|NCT00563706|79452161|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444295|NCT00563706|79452162|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444296|NCT00563706|79452163|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444297|NCT00563706|79452164|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444298|NCT00563706|79452165|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
44444299|NCT00563706|79452166|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
44444300|NCT00563706|79452167|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
44444301|NCT00129961|79452189|FG000|Overall Study|Adverse Event|1|||
44444302|NCT00129961|79452190|FG001|Overall Study|Adverse Event|0|||
44444303|NCT00129961|79452189|FG000|Overall Study|Death|1|||
44444304|NCT00129961|79452190|FG001|Overall Study|Death|1|||
44444305|NCT00129961|79452189|FG000|Overall Study|Withdrawal by Sponsor|14|||
44444306|NCT00129961|79452190|FG001|Overall Study|Withdrawal by Sponsor|20|||
44444307|NCT00129961|79452189|FG000|Overall Study|Physician Decision|1|||
44444308|NCT00129961|79452190|FG001|Overall Study|Physician Decision|0|||
44444309|NCT00129961|79452189|FG000|Overall Study|Withdrawal by Subject|2|||
44444310|NCT00129961|79452190|FG001|Overall Study|Withdrawal by Subject|1|||
44444311|NCT00129961|79452189|FG000|Overall Study|Missing Record|0|||
44444312|NCT00129961|79452190|FG001|Overall Study|Missing Record|1|||
44444313|NCT00528567|79452198|FG000|Overall Study|Death|4|||
44444314|NCT00528567|79452199|FG001|Overall Study|Death|5|||
44444315|NCT00528567|79452198|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
44444316|NCT00528567|79452199|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
44444317|NCT00528567|79452198|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
44444318|NCT00528567|79452199|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
44444319|NCT00528567|79452198|FG000|Overall Study|Violation Criteria at Entry|3|||
44444320|NCT00528567|79452199|FG001|Overall Study|Violation Criteria at Entry|17|||
44444321|NCT00528567|79452198|FG000|Overall Study|Withdrew Consent|59|||
44444322|NCT00528567|79452199|FG001|Overall Study|Withdrew Consent|55|||
44444323|NCT00528567|79452198|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
44444324|NCT00528567|79452199|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
44444325|NCT00528567|79452198|FG000|Overall Study|Failure to Return|1|||
44444326|NCT00528567|79452199|FG001|Overall Study|Failure to Return|4|||
44444327|NCT00528567|79452198|FG000|Overall Study|Other Protocol Violation|5|||
44444328|NCT00528567|79452199|FG001|Overall Study|Other Protocol Violation|21|||
44444329|NCT00528567|79452198|FG000|Overall Study|Administrative/Other|22|||
44444330|NCT00528567|79452199|FG001|Overall Study|Administrative/Other|75|||
44444331|NCT00138151|79452212|FG000|Overall Study|Withdrawal by Subject|3|||
44444332|NCT00138151|79452212|FG000|Overall Study|Physician Decision|1|||
44444333|NCT00138073|79452216|FG000|Overall Study|lack of resources|55|||
44444334|NCT02581631|79452225|FG000|Overall Study|Disease progression|29|||
44444335|NCT02581631|79452226|FG001|Overall Study|Disease progression|19|||
44444336|NCT02581631|79452227|FG002|Overall Study|Disease progression|13|||
44444337|NCT02581631|79452228|FG003|Overall Study|Disease progression|5|||
44444338|NCT02581631|79452229|FG004|Overall Study|Disease progression|8|||
44444339|NCT02581631|79452225|FG000|Overall Study|Study drug toxicity|4|||
44444340|NCT02581631|79452226|FG001|Overall Study|Study drug toxicity|6|||
44444341|NCT02581631|79452227|FG002|Overall Study|Study drug toxicity|7|||
44444342|NCT02581631|79452228|FG003|Overall Study|Study drug toxicity|0|||
44444343|NCT02581631|79452229|FG004|Overall Study|Study drug toxicity|3|||
44444344|NCT02581631|79452225|FG000|Overall Study|AE unrelated to study drug|3|||
44444345|NCT02581631|79452226|FG001|Overall Study|AE unrelated to study drug|1|||
44444346|NCT02581631|79452227|FG002|Overall Study|AE unrelated to study drug|1|||
44444347|NCT02581631|79452228|FG003|Overall Study|AE unrelated to study drug|0|||
44444348|NCT02581631|79452229|FG004|Overall Study|AE unrelated to study drug|2|||
44444349|NCT02581631|79452225|FG000|Overall Study|Request to discontinue|1|||
44444350|NCT02581631|79452226|FG001|Overall Study|Request to discontinue|0|||
44344237|NCT00969553|79348227|FG001|Overall Study|Progressive disease (PD)|2|||
44344238|NCT00969553|79348228|FG002|Overall Study|Progressive disease (PD)|6|||
44344239|NCT00969553|79348229|FG003|Overall Study|Progressive disease (PD)|9|||
44344240|NCT00969553|79348230|FG004|Overall Study|Progressive disease (PD)|2|||
44344241|NCT00969553|79348231|FG005|Overall Study|Progressive disease (PD)|4|||
44344242|NCT00969553|79348232|FG006|Overall Study|Progressive disease (PD)|2|||
44344243|NCT00969553|79348233|FG007|Overall Study|Progressive disease (PD)|12|||
44344244|NCT00969553|79348234|FG008|Overall Study|Progressive disease (PD)|3|||
44344245|NCT00969553|79348226|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344246|NCT00969553|79348227|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344247|NCT00969553|79348228|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344248|NCT00969553|79348229|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344249|NCT00969553|79348230|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
44444351|NCT02581631|79452227|FG002|Overall Study|Request to discontinue|3|||
44444352|NCT02581631|79452228|FG003|Overall Study|Request to discontinue|0|||
44444353|NCT02581631|79452229|FG004|Overall Study|Request to discontinue|1|||
44444354|NCT02581631|79452225|FG000|Overall Study|participant withdrew consent|3|||
44444355|NCT02581631|79452226|FG001|Overall Study|participant withdrew consent|0|||
44444356|NCT02581631|79452227|FG002|Overall Study|participant withdrew consent|1|||
44444357|NCT02581631|79452228|FG003|Overall Study|participant withdrew consent|0|||
44444358|NCT02581631|79452229|FG004|Overall Study|participant withdrew consent|0|||
44444359|NCT02581631|79452225|FG000|Overall Study|Maximum clinical benefit|1|||
44444360|NCT02581631|79452226|FG001|Overall Study|Maximum clinical benefit|7|||
44444361|NCT02581631|79452227|FG002|Overall Study|Maximum clinical benefit|1|||
44444362|NCT02581631|79452228|FG003|Overall Study|Maximum clinical benefit|3|||
44444363|NCT02581631|79452229|FG004|Overall Study|Maximum clinical benefit|13|||
44444364|NCT02581631|79452225|FG000|Overall Study|Other Reasons|1|||
44444365|NCT02581631|79452226|FG001|Overall Study|Other Reasons|0|||
44444366|NCT02581631|79452227|FG002|Overall Study|Other Reasons|2|||
44444367|NCT02581631|79452228|FG003|Overall Study|Other Reasons|2|||
44444368|NCT02581631|79452229|FG004|Overall Study|Other Reasons|3|||
44444369|NCT02581631|79452225|FG000|Overall Study|Poor/Non-Compliance|0|||
44444370|NCT02581631|79452226|FG001|Overall Study|Poor/Non-Compliance|0|||
44444371|NCT02581631|79452227|FG002|Overall Study|Poor/Non-Compliance|1|||
44444372|NCT02581631|79452228|FG003|Overall Study|Poor/Non-Compliance|0|||
44444373|NCT02581631|79452229|FG004|Overall Study|Poor/Non-Compliance|0|||
44444374|NCT00529035|79452241|FG000|Overall Study|Withdrawal by Subject|1|||
44444375|NCT00609674|79452254|FG000|Overall Study|Adverse Event|1|||
44444376|NCT00609674|79452255|FG001|Overall Study|Adverse Event|1|||
44444377|NCT00609674|79452254|FG000|Overall Study|Protocol Violation|3|||
44444378|NCT00609674|79452255|FG001|Overall Study|Protocol Violation|5|||
44444379|NCT00609674|79452254|FG000|Overall Study|Lost to Follow-up|1|||
44444380|NCT00609674|79452255|FG001|Overall Study|Lost to Follow-up|0|||
44444381|NCT00609674|79452254|FG000|Overall Study|Withdrew consent|2|||
44444382|NCT00609674|79452255|FG001|Overall Study|Withdrew consent|1|||
44444383|NCT00137839|79452261|FG000|Overall Study|Adverse Event|7|||
44444384|NCT00137839|79452261|FG000|Overall Study|Physician Decision|7|||
44444385|NCT00137839|79452261|FG000|Overall Study|Death|8|||
44444386|NCT00137839|79452261|FG000|Overall Study|Disease Progression|60|||
44444387|NCT00137839|79452261|FG000|Overall Study|Not Start Treatment|1|||
44444388|NCT00137839|79452261|FG000|Overall Study|Prolonged Treatment Delay|1|||
44444389|NCT00563316|79452268|FG000|Overall Study|Adverse Event|2|||
44444390|NCT00563316|79452268|FG000|Overall Study|Physician Decision|1|||
44444391|NCT00563316|79452268|FG000|Overall Study|Lost to Follow-up|2|||
44444392|NCT00563316|79452268|FG000|Overall Study|Death|1|||
44444393|NCT00563316|79452268|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
44344250|NCT00969553|79348231|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344251|NCT00969553|79348232|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344252|NCT00969553|79348233|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344253|NCT00969553|79348234|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
44344254|NCT00969553|79348226|FG000|Overall Study|Other Adverse Event|0|||
44344255|NCT00969553|79348227|FG001|Overall Study|Other Adverse Event|0|||
44344256|NCT00969553|79348228|FG002|Overall Study|Other Adverse Event|0|||
44344257|NCT00969553|79348229|FG003|Overall Study|Other Adverse Event|1|||
44344258|NCT00969553|79348230|FG004|Overall Study|Other Adverse Event|0|||
44344259|NCT00969553|79348231|FG005|Overall Study|Other Adverse Event|0|||
44344260|NCT00969553|79348232|FG006|Overall Study|Other Adverse Event|1|||
44344261|NCT00969553|79348233|FG007|Overall Study|Other Adverse Event|0|||
44344262|NCT00969553|79348234|FG008|Overall Study|Other Adverse Event|0|||
44344263|NCT00969553|79348226|FG000|Overall Study|Refused cont. medication|1|||
44344264|NCT00969553|79348227|FG001|Overall Study|Refused cont. medication|1|||
44344265|NCT00969553|79348228|FG002|Overall Study|Refused cont. medication|0|||
44344266|NCT00969553|79348229|FG003|Overall Study|Refused cont. medication|2|||
44344267|NCT00969553|79348230|FG004|Overall Study|Refused cont. medication|0|||
44344268|NCT00969553|79348231|FG005|Overall Study|Refused cont. medication|0|||
44344269|NCT00969553|79348232|FG006|Overall Study|Refused cont. medication|0|||
44344270|NCT00969553|79348233|FG007|Overall Study|Refused cont. medication|1|||
44344271|NCT00969553|79348234|FG008|Overall Study|Refused cont. medication|0|||
44344272|NCT00969553|79348226|FG000|Overall Study|Not specified above|0|||
44344273|NCT00969553|79348227|FG001|Overall Study|Not specified above|0|||
44344274|NCT00969553|79348228|FG002|Overall Study|Not specified above|0|||
44344275|NCT00969553|79348229|FG003|Overall Study|Not specified above|4|||
44344276|NCT00969553|79348230|FG004|Overall Study|Not specified above|0|||
44344277|NCT00969553|79348231|FG005|Overall Study|Not specified above|0|||
44344278|NCT00969553|79348232|FG006|Overall Study|Not specified above|1|||
44444394|NCT00563316|79452268|FG000|Overall Study|Other|1|||
44444395|NCT03178487|79452278|FG000|Period 1|Adverse Event|1|||
44444396|NCT03178487|79452279|FG001|Period 1|Adverse Event|2|||
44444397|NCT03178487|79452278|FG000|Period 1|Withdrawal by Subject|2|||
44344279|NCT00969553|79348233|FG007|Overall Study|Not specified above|1|||
44344280|NCT00969553|79348234|FG008|Overall Study|Not specified above|0|||
44344281|NCT01179477|79348262|FG000|Overall Study|Death|542|||
44344282|NCT01179477|79348262|FG000|Overall Study|Unsuccessful implant|80|||
44444398|NCT03178487|79452279|FG001|Period 1|Withdrawal by Subject|1|||
44444399|NCT03178487|79452278|FG000|Period 1|Lost to Follow-up|1|||
44444400|NCT03178487|79452279|FG001|Period 1|Lost to Follow-up|0|||
44344283|NCT01179477|79348262|FG000|Overall Study|Non-death withdrawal|438|||
44444401|NCT03178487|79452278|FG000|Period 1|Other|0|||
44444402|NCT03178487|79452279|FG001|Period 1|Other|1|||
44444403|NCT03178487|79452278|FG000|Period 2|Adverse Event|4|||
44344284|NCT01179477|79348262|FG000|Overall Study|Did not complete final visit|27|||
44344285|NCT01179399|79348266|FG000|Overall Study|Adverse Event|1|||
44344286|NCT01179399|79348266|FG000|Overall Study|Lack of Efficacy|30|||
44344287|NCT01179399|79348266|FG000|Overall Study|Withdrawal by Subject|1|||
44344288|NCT01178853|79348272|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
44344289|NCT01178853|79348273|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
44344290|NCT01178853|79348272|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
44344291|NCT01178853|79348273|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
44344292|NCT01178853|79348272|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
44344293|NCT01178853|79348273|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
44344294|NCT01178853|79348272|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
44344295|NCT01178853|79348273|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
44344296|NCT01178853|79348272|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
44344297|NCT01178853|79348273|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
44344298|NCT01178385|79348281|FG000|Overall Study|Withdrawal by Subject|2|||
44344299|NCT01178385|79348282|FG001|Overall Study|Withdrawal by Subject|0|||
44344300|NCT01288976|79348291|FG000|Overall Study|Withdrawal by Subject|58|||
44344301|NCT01288976|79348292|FG001|Overall Study|Withdrawal by Subject|12|||
44344302|NCT01288976|79348293|FG002|Overall Study|Withdrawal by Subject|9|||
44344303|NCT01288976|79348291|FG000|Overall Study|Death|98|||
44344304|NCT01288976|79348292|FG001|Overall Study|Death|6|||
44344305|NCT01288976|79348293|FG002|Overall Study|Death|4|||
44344306|NCT01288976|79348291|FG000|Overall Study|Data unavailable|22|||
44344307|NCT01288976|79348292|FG001|Overall Study|Data unavailable|9|||
44344308|NCT01288976|79348293|FG002|Overall Study|Data unavailable|7|||
44344309|NCT00970489|79348301|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
44344310|NCT00970489|79348302|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
44344311|NCT00968617|79348308|FG000|Overall Study|Study terminated by sponsor|6|||
44344312|NCT00968539|79348314|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
44344313|NCT00968539|79348315|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
44344314|NCT00976573|79348324|FG000|Overall Study|Ineligible|0|||
44344315|NCT00976573|79348325|FG001|Overall Study|Ineligible|1|||
44344316|NCT00976573|79348324|FG000|Overall Study|Cancel prior to receiving treatment|4|||
44344317|NCT00976573|79348325|FG001|Overall Study|Cancel prior to receiving treatment|2|||
44344318|NCT00976495|79348334|FG000|Overall Study|Withdrawal by Subject|0|||
44344319|NCT00976495|79348335|FG001|Overall Study|Withdrawal by Subject|1|||
44344320|NCT00976495|79348336|FG002|Overall Study|Withdrawal by Subject|0|||
44344321|NCT01288430|79348354|FG000|Part 1|Progressive disease|2|||
44344322|NCT01288430|79348355|FG001|Part 1|Progressive disease|1|||
44344323|NCT01288430|79348356|FG002|Part 1|Progressive disease|1|||
44344324|NCT01288430|79348357|FG003|Part 1|Progressive disease|6|||
44344325|NCT01288430|79348358|FG004|Part 1|Progressive disease|2|||
44344326|NCT01288430|79348359|FG005|Part 1|Progressive disease|4|||
44344327|NCT01288430|79348360|FG006|Part 1|Progressive disease|2|||
44344328|NCT01288430|79348361|FG007|Part 1|Progressive disease|0|||
44344329|NCT01288430|79348362|FG008|Part 1|Progressive disease|0|||
44344330|NCT01288430|79348363|FG009|Part 1|Progressive disease|0|||
44344331|NCT01288430|79348354|FG000|Part 1|Clinical disease progression|0|||
44444404|NCT03178487|79452279|FG001|Period 2|Adverse Event|4|||
44444405|NCT03178487|79452278|FG000|Period 2|Withdrawal by Subject|6|||
44444406|NCT03178487|79452279|FG001|Period 2|Withdrawal by Subject|6|||
44444407|NCT03178487|79452278|FG000|Period 2|Lost to Follow-up|2|||
44444408|NCT03178487|79452279|FG001|Period 2|Lost to Follow-up|2|||
44444409|NCT03178487|79452278|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
44444410|NCT03178487|79452279|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
44444411|NCT03178487|79452278|FG000|Period 2|Other|8|||
44444412|NCT03178487|79452279|FG001|Period 2|Other|7|||
44444413|NCT00528957|79452288|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
44444414|NCT00528957|79452289|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
44344332|NCT01288430|79348355|FG001|Part 1|Clinical disease progression|0|||
44344333|NCT01288430|79348356|FG002|Part 1|Clinical disease progression|1|||
44344334|NCT01288430|79348357|FG003|Part 1|Clinical disease progression|0|||
44344335|NCT01288430|79348358|FG004|Part 1|Clinical disease progression|0|||
44344336|NCT01288430|79348359|FG005|Part 1|Clinical disease progression|2|||
44444415|NCT00528957|79452288|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
44344337|NCT01288430|79348360|FG006|Part 1|Clinical disease progression|2|||
44444416|NCT00528957|79452289|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
44344338|NCT01288430|79348361|FG007|Part 1|Clinical disease progression|0|||
44344339|NCT01288430|79348362|FG008|Part 1|Clinical disease progression|0|||
44344340|NCT01288430|79348363|FG009|Part 1|Clinical disease progression|0|||
44344341|NCT01288430|79348354|FG000|Part 1|Death due to disease progression|0|||
44344342|NCT01288430|79348355|FG001|Part 1|Death due to disease progression|0|||
44444417|NCT00528957|79452288|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
44444418|NCT00528957|79452289|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
44444419|NCT00528957|79452288|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
44444420|NCT00528957|79452289|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
44444421|NCT00528957|79452288|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
44444422|NCT00528957|79452289|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
44444423|NCT00528957|79452288|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
44444424|NCT00528957|79452289|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
44444425|NCT00528957|79452288|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
44444426|NCT00528957|79452289|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
44444427|NCT00528957|79452288|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
44444428|NCT00528957|79452289|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
44444429|NCT00528957|79452288|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
44444430|NCT00528957|79452289|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
44444431|NCT00528957|79452288|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
44444432|NCT00528957|79452289|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
44444433|NCT00528957|79452288|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
44444434|NCT00528957|79452289|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
44444435|NCT00528957|79452288|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
44444436|NCT00528957|79452289|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
44444437|NCT00528957|79452288|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
44444438|NCT00528957|79452289|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
44444439|NCT00528957|79452288|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
44444440|NCT00528957|79452289|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
44444441|NCT00528957|79452288|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
44444442|NCT00528957|79452289|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
44444443|NCT00528957|79452288|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
44444444|NCT00528957|79452289|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
44444445|NCT00560508|79452307|FG000|12 Week Double-blind Period|Adverse Event|3|||
44444446|NCT00560508|79452308|FG001|12 Week Double-blind Period|Adverse Event|2|||
44444447|NCT00560508|79452307|FG000|12 Week Double-blind Period|Protocol Violation|1|||
44444448|NCT00560508|79452308|FG001|12 Week Double-blind Period|Protocol Violation|0|||
44444449|NCT00560508|79452307|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
44444450|NCT00560508|79452308|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
44444451|NCT00560508|79452307|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
44444452|NCT00560508|79452308|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
44444453|NCT00560508|79452307|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
44444454|NCT00560508|79452308|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
44444455|NCT00560508|79452307|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
44444456|NCT00560508|79452308|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
44444457|NCT00560508|79452307|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
44444458|NCT00560508|79452308|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
44444459|NCT03962790|79452319|FG000|Period 1|Adverse Event|0|||
44444460|NCT03962790|79452320|FG001|Period 1|Adverse Event|1|||
44444461|NCT03962790|79452319|FG000|Period 1|Failed to meet all eligibility criteria|1|||
44444462|NCT03962790|79452320|FG001|Period 1|Failed to meet all eligibility criteria|1|||
44444463|NCT03962790|79452319|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
44444464|NCT03962790|79452320|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
44444465|NCT03962790|79452319|FG000|Period 1|Withdrawal by Subject|1|||
44444466|NCT03962790|79452320|FG001|Period 1|Withdrawal by Subject|0|||
44444467|NCT00609518|79452328|FG000|Overall Study|Death from Study Disease|32|||
44444468|NCT00609518|79452329|FG001|Overall Study|Death from Study Disease|32|||
44444469|NCT00609518|79452328|FG000|Overall Study|Withdrawal by Subject|5|||
44444470|NCT00609518|79452329|FG001|Overall Study|Withdrawal by Subject|3|||
44444471|NCT00609518|79452328|FG000|Overall Study|Lost to Follow-up|3|||
44444472|NCT00609518|79452329|FG001|Overall Study|Lost to Follow-up|0|||
44444473|NCT00609518|79452328|FG000|Overall Study|Physician Decision|1|||
44444474|NCT00609518|79452329|FG001|Overall Study|Physician Decision|3|||
44444475|NCT00609518|79452328|FG000|Overall Study|Death from Adverse Event|2|||
44444476|NCT00609518|79452329|FG001|Overall Study|Death from Adverse Event|2|||
44444477|NCT00609362|79452337|FG000|Overall Study|Withdrawal by Subject|2|||
44444478|NCT00609362|79452338|FG001|Overall Study|Withdrawal by Subject|1|||
44444479|NCT00609362|79452337|FG000|Overall Study|Adverse Event|1|||
44444480|NCT00609362|79452338|FG001|Overall Study|Adverse Event|0|||
44444481|NCT00611858|79452344|FG000|Overall Study|Adverse Event|2|||
44444482|NCT00611858|79452344|FG000|Overall Study|Withdrawal by Subject|2|||
44444483|NCT00137449|79452352|FG000|Overall Study|Disease Progression|8|||
44444484|NCT00137449|79452353|FG001|Overall Study|Disease Progression|13|||
44444485|NCT00137449|79452352|FG000|Overall Study|Death|4|||
44160322|NCT02579759|78952805|FG001|Overall Study|BfArM hold|12|||
44444486|NCT00137449|79452353|FG001|Overall Study|Death|3|||
44444487|NCT00137449|79452352|FG000|Overall Study|Adverse Event|3|||
44444488|NCT00137449|79452353|FG001|Overall Study|Adverse Event|1|||
44444489|NCT00137449|79452352|FG000|Overall Study|Withdrawal by Subject|1|||
44444490|NCT00137449|79452353|FG001|Overall Study|Withdrawal by Subject|1|||
44444491|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
44444492|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
44444493|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
44444494|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
44444495|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
44444496|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
44444497|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
44444498|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
44444499|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
44444500|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
44444501|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
44444502|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
44444503|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
44444504|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
44444505|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
44444506|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
44444507|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
44444508|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
44444509|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
44444510|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
44160323|NCT02579759|78952806|FG002|Overall Study|BfArM hold|12|||
44444511|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
44444512|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
44444513|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
44444514|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
44444515|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
44444516|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
44444517|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
44444518|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
44444519|NCT00528879|79452364|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
44444520|NCT00528879|79452365|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
44444521|NCT00528879|79452366|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
44444522|NCT00528879|79452367|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
44444523|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
44444524|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
44444525|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
44444526|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
44444527|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
44444528|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
44444529|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
44444530|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
44444531|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
44444532|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
44444533|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
44444534|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
44444535|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
44444536|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
44444537|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
44444538|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
44444539|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
44444540|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
44444541|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
44444542|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
44444543|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
44444544|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
44444545|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
44444546|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
44444547|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
44444548|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
44444549|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
44444550|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
44444551|NCT00528879|79452364|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
44444552|NCT00528879|79452365|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
44444553|NCT00528879|79452366|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
44444554|NCT00528879|79452367|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
44444555|NCT00608894|79452379|FG000|Overall Study|Withdrawal by Subject|0|||
44444556|NCT00608894|79452380|FG001|Overall Study|Withdrawal by Subject|2|||
44444557|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
44444558|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
44344343|NCT01288430|79348356|FG002|Part 1|Death due to disease progression|0|||
44344344|NCT01288430|79348357|FG003|Part 1|Death due to disease progression|0|||
44344345|NCT01288430|79348358|FG004|Part 1|Death due to disease progression|1|||
44344346|NCT01288430|79348359|FG005|Part 1|Death due to disease progression|0|||
44344347|NCT01288430|79348360|FG006|Part 1|Death due to disease progression|0|||
44344348|NCT01288430|79348361|FG007|Part 1|Death due to disease progression|0|||
44344349|NCT01288430|79348362|FG008|Part 1|Death due to disease progression|0|||
44344350|NCT01288430|79348363|FG009|Part 1|Death due to disease progression|0|||
44344351|NCT01288430|79348354|FG000|Part 1|Adverse Event|0|||
44344352|NCT01288430|79348355|FG001|Part 1|Adverse Event|0|||
44344353|NCT01288430|79348356|FG002|Part 1|Adverse Event|3|||
44344354|NCT01288430|79348357|FG003|Part 1|Adverse Event|1|||
44344355|NCT01288430|79348358|FG004|Part 1|Adverse Event|0|||
44344356|NCT01288430|79348359|FG005|Part 1|Adverse Event|0|||
44344357|NCT01288430|79348360|FG006|Part 1|Adverse Event|2|||
44344358|NCT01288430|79348361|FG007|Part 1|Adverse Event|0|||
44344359|NCT01288430|79348362|FG008|Part 1|Adverse Event|0|||
44344360|NCT01288430|79348363|FG009|Part 1|Adverse Event|0|||
44344361|NCT01288430|79348354|FG000|Part 1|Other|0|||
44344362|NCT01288430|79348355|FG001|Part 1|Other|2|||
44344363|NCT01288430|79348356|FG002|Part 1|Other|0|||
44344364|NCT01288430|79348357|FG003|Part 1|Other|0|||
44344365|NCT01288430|79348358|FG004|Part 1|Other|0|||
44344366|NCT01288430|79348359|FG005|Part 1|Other|0|||
44344367|NCT01288430|79348360|FG006|Part 1|Other|1|||
44344368|NCT01288430|79348361|FG007|Part 1|Other|0|||
44344369|NCT01288430|79348362|FG008|Part 1|Other|0|||
44344370|NCT01288430|79348363|FG009|Part 1|Other|0|||
44344371|NCT01288430|79348354|FG000|Part 2|Progressive disease|0|||
44344372|NCT01288430|79348355|FG001|Part 2|Progressive disease|0|||
44344373|NCT01288430|79348356|FG002|Part 2|Progressive disease|0|||
44344374|NCT01288430|79348357|FG003|Part 2|Progressive disease|0|||
44344375|NCT01288430|79348358|FG004|Part 2|Progressive disease|0|||
44344376|NCT01288430|79348359|FG005|Part 2|Progressive disease|0|||
44344377|NCT01288430|79348360|FG006|Part 2|Progressive disease|0|||
44344378|NCT01288430|79348361|FG007|Part 2|Progressive disease|8|||
44344379|NCT01288430|79348362|FG008|Part 2|Progressive disease|7|||
44344380|NCT01288430|79348363|FG009|Part 2|Progressive disease|2|||
44344381|NCT01288430|79348354|FG000|Part 2|Clinical disease progression|0|||
44344382|NCT01288430|79348355|FG001|Part 2|Clinical disease progression|0|||
44344383|NCT01288430|79348356|FG002|Part 2|Clinical disease progression|0|||
44344384|NCT01288430|79348357|FG003|Part 2|Clinical disease progression|0|||
44344385|NCT01288430|79348358|FG004|Part 2|Clinical disease progression|0|||
44344386|NCT01288430|79348359|FG005|Part 2|Clinical disease progression|0|||
44344387|NCT01288430|79348360|FG006|Part 2|Clinical disease progression|0|||
44344388|NCT01288430|79348361|FG007|Part 2|Clinical disease progression|2|||
44344389|NCT01288430|79348362|FG008|Part 2|Clinical disease progression|0|||
44344390|NCT01288430|79348363|FG009|Part 2|Clinical disease progression|0|||
44344391|NCT01288430|79348354|FG000|Part 2|Withdrawal by Subject|0|||
44344392|NCT01288430|79348355|FG001|Part 2|Withdrawal by Subject|0|||
44444559|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
44444560|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
44444561|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
44444562|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
44444563|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
44444564|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
44444565|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
44444566|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
44444567|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444568|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
44444569|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444570|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444571|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444572|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444573|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444574|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
44444575|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
44444576|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
44444577|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
44444578|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
44444579|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
44444580|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
44444581|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
44444582|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
44444583|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
44444584|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|Other|0|||
44444585|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|Other|0|||
44444586|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|Other|1|||
44444587|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|Other|1|||
44444588|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|Other|0|||
44444589|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|Other|0|||
44444590|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|Other|0|||
44444591|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|Other|1|||
44444592|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|Other|0|||
44444593|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|Death|0|||
44444594|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|Death|0|||
44444595|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|Death|0|||
44344393|NCT01288430|79348356|FG002|Part 2|Withdrawal by Subject|0|||
44344394|NCT01288430|79348357|FG003|Part 2|Withdrawal by Subject|0|||
44344395|NCT01288430|79348358|FG004|Part 2|Withdrawal by Subject|0|||
44344396|NCT01288430|79348359|FG005|Part 2|Withdrawal by Subject|0|||
44444596|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|Death|0|||
44344397|NCT01288430|79348360|FG006|Part 2|Withdrawal by Subject|0|||
44344398|NCT01288430|79348361|FG007|Part 2|Withdrawal by Subject|1|||
44344399|NCT01288430|79348362|FG008|Part 2|Withdrawal by Subject|4|||
44444597|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|Death|0|||
44444598|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|Death|1|||
44444599|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|Death|0|||
44444600|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|Death|0|||
44444601|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|Death|0|||
44444602|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444603|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444604|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444605|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444606|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444607|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
44444608|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
44444609|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444610|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
44444611|NCT00557856|79452388|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
44444612|NCT00557856|79452389|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444613|NCT00557856|79452390|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444614|NCT00557856|79452391|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444615|NCT00557856|79452392|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444616|NCT00557856|79452393|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444617|NCT00557856|79452394|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444618|NCT00557856|79452395|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444619|NCT00557856|79452396|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
44444620|NCT00557856|79452388|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444621|NCT00557856|79452389|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444622|NCT00557856|79452390|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444623|NCT00557856|79452391|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444624|NCT00557856|79452392|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444625|NCT00557856|79452393|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444626|NCT00557856|79452394|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444627|NCT00557856|79452395|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
44444628|NCT00557856|79452396|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
44444629|NCT00557856|79452388|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444630|NCT00557856|79452389|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444631|NCT00557856|79452390|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444632|NCT00557856|79452391|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444633|NCT00557856|79452392|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444634|NCT00557856|79452393|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444635|NCT00557856|79452394|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444636|NCT00557856|79452395|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
44444637|NCT00557856|79452396|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
44444638|NCT00557856|79452388|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
44444639|NCT00557856|79452389|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
44444640|NCT00557856|79452390|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
44444641|NCT00557856|79452391|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
44444642|NCT00557856|79452392|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
44444643|NCT00557856|79452393|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
44444644|NCT00557856|79452394|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
44444645|NCT00557856|79452395|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
44444646|NCT00557856|79452396|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
44444647|NCT00557856|79452388|FG000|Part 2: Exploratory Phase|Other|0|||
44444648|NCT00557856|79452389|FG001|Part 2: Exploratory Phase|Other|0|||
44444649|NCT00557856|79452390|FG002|Part 2: Exploratory Phase|Other|0|||
44444650|NCT00557856|79452391|FG003|Part 2: Exploratory Phase|Other|0|||
44444651|NCT00557856|79452392|FG004|Part 2: Exploratory Phase|Other|0|||
44444652|NCT00557856|79452393|FG005|Part 2: Exploratory Phase|Other|0|||
44444653|NCT00557856|79452394|FG006|Part 2: Exploratory Phase|Other|0|||
44444654|NCT00557856|79452395|FG007|Part 2: Exploratory Phase|Other|0|||
44444655|NCT00557856|79452396|FG008|Part 2: Exploratory Phase|Other|1|||
44444656|NCT00557856|79452388|FG000|Part 2: Exploratory Phase|Death|0|||
44444657|NCT00557856|79452389|FG001|Part 2: Exploratory Phase|Death|0|||
44444658|NCT00557856|79452390|FG002|Part 2: Exploratory Phase|Death|0|||
44444659|NCT00557856|79452391|FG003|Part 2: Exploratory Phase|Death|0|||
44444660|NCT00557856|79452392|FG004|Part 2: Exploratory Phase|Death|0|||
44444661|NCT00557856|79452393|FG005|Part 2: Exploratory Phase|Death|0|||
44444662|NCT00557856|79452394|FG006|Part 2: Exploratory Phase|Death|0|||
44444663|NCT00557856|79452395|FG007|Part 2: Exploratory Phase|Death|0|||
44444664|NCT00557856|79452396|FG008|Part 2: Exploratory Phase|Death|2|||
44444665|NCT00557856|79452388|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444666|NCT00557856|79452389|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444667|NCT00557856|79452390|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444668|NCT00557856|79452391|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444669|NCT00557856|79452392|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444670|NCT00557856|79452393|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444671|NCT00557856|79452394|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444672|NCT00557856|79452395|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
44444673|NCT00557856|79452396|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
44444674|NCT00191113|79452413|FG000|Core Study|Withdrawal by Subject|25|||
44444675|NCT00191113|79452414|FG001|Core Study|Withdrawal by Subject|9|||
44444676|NCT00191113|79452413|FG000|Core Study|Protocol Violation|6|||
44444677|NCT00191113|79452414|FG001|Core Study|Protocol Violation|2|||
44444678|NCT00191113|79452413|FG000|Core Study|Lost to Follow-up|3|||
44444679|NCT00191113|79452414|FG001|Core Study|Lost to Follow-up|0|||
44444680|NCT00191113|79452413|FG000|Core Study|Adverse Event|0|||
44444681|NCT00191113|79452414|FG001|Core Study|Adverse Event|2|||
44444682|NCT00191113|79452413|FG000|Core Study|Lack of Efficacy|0|||
44444683|NCT00191113|79452414|FG001|Core Study|Lack of Efficacy|2|||
44444684|NCT00191113|79452413|FG000|Core Study|Death|1|||
44444685|NCT00191113|79452414|FG001|Core Study|Death|0|||
44444686|NCT00608582|79452428|FG000|Overall Study|Lost to Follow-up|2|||
44444687|NCT00608582|79452429|FG001|Overall Study|Lost to Follow-up|0|||
44444688|NCT00608582|79452428|FG000|Overall Study|No Best Response in Phase 1 located|1|||
44444689|NCT00608582|79452429|FG001|Overall Study|No Best Response in Phase 1 located|1|||
44444690|NCT00608582|79452428|FG000|Overall Study|Illicit Drug Use|1|||
44444691|NCT00608582|79452429|FG001|Overall Study|Illicit Drug Use|0|||
44444692|NCT00608582|79452428|FG000|Overall Study|Early stage Design Change|0|||
44444693|NCT00608582|79452429|FG001|Overall Study|Early stage Design Change|3|||
44444694|NCT03965052|79452439|FG000|Overall Study|Protocol Violation|1|||
44444695|NCT03965052|79452440|FG001|Overall Study|Protocol Violation|0|||
44444696|NCT03964974|79452448|FG000|Overall Study|Lost to Follow-up|3|||
44444697|NCT03964974|79452449|FG001|Overall Study|Lost to Follow-up|2|||
44444698|NCT03964974|79452448|FG000|Overall Study|Withdrawal by Subject|0|||
44160324|NCT02579759|78952804|FG000|Overall Study|Sponsor stopped Dose 2|0|||
44344400|NCT01288430|79348363|FG009|Part 2|Withdrawal by Subject|0|||
44444699|NCT03964974|79452449|FG001|Overall Study|Withdrawal by Subject|3|||
44444700|NCT00606320|79452455|FG000|Overall Study|Adverse Event|3|||
44444701|NCT00606320|79452455|FG000|Overall Study|Lack of Efficacy|5|||
44444702|NCT00606320|79452455|FG000|Overall Study|Physician Decision|7|||
44444703|NCT00606320|79452455|FG000|Overall Study|Protocol Violation|8|||
44444704|NCT00606320|79452455|FG000|Overall Study|Withdrawal by Subject|10|||
44444705|NCT00606320|79452455|FG000|Overall Study|Progression to depressive phase|4|||
44444706|NCT00528411|79452462|FG000|Overall Study|Adverse Event|4|||
44444707|NCT00528411|79452463|FG001|Overall Study|Adverse Event|0|||
44444708|NCT00528411|79452464|FG002|Overall Study|Adverse Event|1|||
44344401|NCT01288430|79348354|FG000|Part 2|Adverse Event|0|||
44444709|NCT00528411|79452462|FG000|Overall Study|Incorrect Enrolment|1|||
44344402|NCT01288430|79348355|FG001|Part 2|Adverse Event|0|||
44344403|NCT01288430|79348356|FG002|Part 2|Adverse Event|0|||
44160325|NCT02579759|78952805|FG001|Overall Study|Sponsor stopped Dose 2|41|||
44160326|NCT02579759|78952806|FG002|Overall Study|Sponsor stopped Dose 2|0|||
44160327|NCT02579759|78952804|FG000|Overall Study|Non compliance|0|||
44160328|NCT02579759|78952805|FG001|Overall Study|Non compliance|1|||
44160329|NCT02579759|78952806|FG002|Overall Study|Non compliance|0|||
44160330|NCT02579759|78952804|FG000|Overall Study|Pregnancy|0|||
44160331|NCT02579759|78952805|FG001|Overall Study|Pregnancy|1|||
44160332|NCT02579759|78952806|FG002|Overall Study|Pregnancy|0|||
44160333|NCT02579759|78952804|FG000|Overall Study|Inclusion/exclusion criteria|0|||
44160334|NCT02579759|78952805|FG001|Overall Study|Inclusion/exclusion criteria|0|||
44160335|NCT02579759|78952806|FG002|Overall Study|Inclusion/exclusion criteria|1|||
44160336|NCT02579759|78952804|FG000|Overall Study|Adverse Event|4|||
44160337|NCT02579759|78952805|FG001|Overall Study|Adverse Event|3|||
44160338|NCT02579759|78952806|FG002|Overall Study|Adverse Event|1|||
44160339|NCT02579759|78952804|FG000|Overall Study|Withdrawal by Subject|3|||
44160340|NCT02579759|78952805|FG001|Overall Study|Withdrawal by Subject|3|||
44160341|NCT02579759|78952806|FG002|Overall Study|Withdrawal by Subject|5|||
44160342|NCT02579759|78952804|FG000|Overall Study|Lost to Follow-up|2|||
44160343|NCT02579759|78952805|FG001|Overall Study|Lost to Follow-up|2|||
44160344|NCT02579759|78952806|FG002|Overall Study|Lost to Follow-up|2|||
44160345|NCT02445963|78952820|FG000|Overall Study|Lost to Follow-up|1|||
44160346|NCT02445963|78952821|FG001|Overall Study|Lost to Follow-up|0|||
44160347|NCT02445963|78952822|FG002|Overall Study|Lost to Follow-up|0|||
44444710|NCT00528411|79452463|FG001|Overall Study|Incorrect Enrolment|1|||
44444711|NCT00528411|79452464|FG002|Overall Study|Incorrect Enrolment|0|||
44444712|NCT00528411|79452462|FG000|Overall Study|Severe non-compliance to protocol|0|||
44160348|NCT02445963|78952823|FG003|Overall Study|Lost to Follow-up|0|||
44160349|NCT02445963|78952820|FG000|Overall Study|Change in employment|1|||
44160350|NCT02445963|78952821|FG001|Overall Study|Change in employment|0|||
44160351|NCT02445963|78952822|FG002|Overall Study|Change in employment|0|||
44160352|NCT02445963|78952823|FG003|Overall Study|Change in employment|0|||
44160353|NCT02445963|78952820|FG000|Overall Study|Symptoms post-vaccination|0|||
44160354|NCT02445963|78952821|FG001|Overall Study|Symptoms post-vaccination|0|||
44160355|NCT02445963|78952822|FG002|Overall Study|Symptoms post-vaccination|1|||
44160356|NCT02445963|78952823|FG003|Overall Study|Symptoms post-vaccination|0|||
44160357|NCT02499159|78952837|FG000|Randomization|Protocol Violation|1|||
44160358|NCT02499159|78952838|FG001|Randomization|Protocol Violation|1|||
44160359|NCT02499159|78952837|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
44160360|NCT02499159|78952838|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
44160361|NCT02499159|78952837|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
44160362|NCT02499159|78952838|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
44160363|NCT02499159|78952837|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
44160364|NCT02499159|78952838|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
44160365|NCT02499159|78952837|FG000|30-Day Follow-Up Phone Call|Other|1|||
44160366|NCT02499159|78952838|FG001|30-Day Follow-Up Phone Call|Other|0|||
44160367|NCT01664039|78952846|FG000|Overall Study|Adverse Event|3|||
44444713|NCT00528411|79452463|FG001|Overall Study|Severe non-compliance to protocol|1|||
44444714|NCT00528411|79452464|FG002|Overall Study|Severe non-compliance to protocol|0|||
44160368|NCT01664039|78952847|FG001|Overall Study|Adverse Event|4|||
44160369|NCT01664039|78952846|FG000|Overall Study|Lost to Follow-up|1|||
44160370|NCT01664039|78952847|FG001|Overall Study|Lost to Follow-up|1|||
44160371|NCT01664039|78952846|FG000|Overall Study|Withdrawal by Subject|1|||
44160372|NCT01664039|78952847|FG001|Overall Study|Withdrawal by Subject|3|||
44160373|NCT01664039|78952846|FG000|Overall Study|Noncompliance|1|||
44160374|NCT01664039|78952847|FG001|Overall Study|Noncompliance|1|||
44160375|NCT02445573|78952855|FG000|Overall Study|Withdrawal by Subject|1|||
44160376|NCT02445573|78952856|FG001|Overall Study|Withdrawal by Subject|1|||
44160377|NCT02445573|78952855|FG000|Overall Study|Lost to Follow-up|0|||
44160378|NCT02445573|78952856|FG001|Overall Study|Lost to Follow-up|1|||
44344404|NCT01288430|79348357|FG003|Part 2|Adverse Event|0|||
44344405|NCT01288430|79348358|FG004|Part 2|Adverse Event|0|||
44344406|NCT01288430|79348359|FG005|Part 2|Adverse Event|0|||
44344407|NCT01288430|79348360|FG006|Part 2|Adverse Event|0|||
44344408|NCT01288430|79348361|FG007|Part 2|Adverse Event|1|||
44344409|NCT01288430|79348362|FG008|Part 2|Adverse Event|1|||
44344410|NCT01288430|79348363|FG009|Part 2|Adverse Event|0|||
44344411|NCT01288430|79348354|FG000|Part 2|Other|0|||
44344412|NCT01288430|79348355|FG001|Part 2|Other|0|||
44344413|NCT01288430|79348356|FG002|Part 2|Other|0|||
44344414|NCT01288430|79348357|FG003|Part 2|Other|0|||
44344415|NCT01288430|79348358|FG004|Part 2|Other|0|||
44344416|NCT01288430|79348359|FG005|Part 2|Other|0|||
44344417|NCT01288430|79348360|FG006|Part 2|Other|0|||
44344418|NCT01288430|79348361|FG007|Part 2|Other|0|||
44344419|NCT01288430|79348362|FG008|Part 2|Other|0|||
44344420|NCT01288430|79348363|FG009|Part 2|Other|1|||
44344421|NCT01287416|79348392|FG000|Pre-post Training|Withdrawal by Subject|17|||
44344422|NCT01287416|79348393|FG001|Pre-post Training|Withdrawal by Subject|24|||
44344423|NCT01287416|79348392|FG000|Pre-post Training|Lost to Follow-up|5|||
44344424|NCT01287416|79348393|FG001|Pre-post Training|Lost to Follow-up|1|||
44344425|NCT01287416|79348392|FG000|6 Month Follow-up|Lost to Follow-up|3|||
44344426|NCT01287416|79348393|FG001|6 Month Follow-up|Lost to Follow-up|2|||
44344427|NCT00998296|79348410|FG000|Overall Study|Progressive disease|0|||
44344428|NCT00998296|79348411|FG001|Overall Study|Progressive disease|1|||
44344429|NCT00998296|79348412|FG002|Overall Study|Progressive disease|0|||
44344430|NCT00998296|79348413|FG003|Overall Study|Progressive disease|0|||
44344431|NCT00998296|79348414|FG004|Overall Study|Progressive disease|0|||
44344432|NCT00998296|79348415|FG005|Overall Study|Progressive disease|0|||
44344433|NCT00998296|79348416|FG006|Overall Study|Progressive disease|1|||
44344434|NCT00998296|79348417|FG007|Overall Study|Progressive disease|0|||
44344435|NCT00998296|79348418|FG008|Overall Study|Progressive disease|0|||
44344436|NCT00998296|79348419|FG009|Overall Study|Progressive disease|14|||
44344437|NCT00998296|79348420|FG010|Overall Study|Progressive disease|5|||
44344438|NCT00998296|79348410|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344439|NCT00998296|79348411|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344440|NCT00998296|79348412|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344441|NCT00998296|79348413|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344442|NCT00998296|79348414|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
44344443|NCT00998296|79348415|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344444|NCT00998296|79348416|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344445|NCT00998296|79348417|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
44344446|NCT00998296|79348418|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
44344447|NCT00998296|79348419|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344448|NCT00998296|79348420|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
44344449|NCT00998296|79348410|FG000|Overall Study|Other adverse event|0|||
44344450|NCT00998296|79348411|FG001|Overall Study|Other adverse event|0|||
44344451|NCT00998296|79348412|FG002|Overall Study|Other adverse event|0|||
44344452|NCT00998296|79348413|FG003|Overall Study|Other adverse event|0|||
44344453|NCT00998296|79348414|FG004|Overall Study|Other adverse event|1|||
44344454|NCT00998296|79348415|FG005|Overall Study|Other adverse event|0|||
44344455|NCT00998296|79348416|FG006|Overall Study|Other adverse event|0|||
44344456|NCT00998296|79348417|FG007|Overall Study|Other adverse event|0|||
44344457|NCT00998296|79348418|FG008|Overall Study|Other adverse event|0|||
44344458|NCT00998296|79348419|FG009|Overall Study|Other adverse event|1|||
44344459|NCT00998296|79348420|FG010|Overall Study|Other adverse event|2|||
44344460|NCT00998296|79348410|FG000|Overall Study|Refused to continue taking trial med.|0|||
44160379|NCT02445339|78952864|FG000|Overall Study|Physician Decision|1|||
44344461|NCT00998296|79348411|FG001|Overall Study|Refused to continue taking trial med.|0|||
44344462|NCT00998296|79348412|FG002|Overall Study|Refused to continue taking trial med.|0|||
44344463|NCT00998296|79348413|FG003|Overall Study|Refused to continue taking trial med.|0|||
44344464|NCT00998296|79348414|FG004|Overall Study|Refused to continue taking trial med.|0|||
44344465|NCT00998296|79348415|FG005|Overall Study|Refused to continue taking trial med.|0|||
44344466|NCT00998296|79348416|FG006|Overall Study|Refused to continue taking trial med.|0|||
44344467|NCT00998296|79348417|FG007|Overall Study|Refused to continue taking trial med.|0|||
44344468|NCT00998296|79348418|FG008|Overall Study|Refused to continue taking trial med.|0|||
44160380|NCT02445339|78952865|FG001|Overall Study|Physician Decision|0|||
44344469|NCT00998296|79348419|FG009|Overall Study|Refused to continue taking trial med.|2|||
44344470|NCT00998296|79348420|FG010|Overall Study|Refused to continue taking trial med.|0|||
44344471|NCT00998296|79348410|FG000|Overall Study|Reason other than those specified above|0|||
44344472|NCT00998296|79348411|FG001|Overall Study|Reason other than those specified above|0|||
44344473|NCT00998296|79348412|FG002|Overall Study|Reason other than those specified above|0|||
44160381|NCT02445339|78952864|FG000|Overall Study|Lost to Follow-up|11|||
44160382|NCT02445339|78952865|FG001|Overall Study|Lost to Follow-up|15|||
44160383|NCT02579603|78952873|FG000|Overall Study|Not treated|1|||
44160384|NCT02579603|78952874|FG001|Overall Study|Not treated|0|||
44160385|NCT02579603|78952873|FG000|Overall Study|Adverse Event|2|||
44160386|NCT02579603|78952874|FG001|Overall Study|Adverse Event|2|||
44160387|NCT02579603|78952873|FG000|Overall Study|Other than stated|1|||
44160388|NCT02579603|78952874|FG001|Overall Study|Other than stated|0|||
44160389|NCT02625259|78952886|FG000|First Intervention (Day 1)|Other|0|||
44160390|NCT02625259|78952887|FG001|First Intervention (Day 1)|Other|0|||
44160391|NCT02625259|78952888|FG002|First Intervention (Day 1)|Other|1|||
44160392|NCT02625259|78952889|FG003|First Intervention (Day 1)|Other|0|||
44160393|NCT02625259|78952890|FG004|First Intervention (Day 1)|Other|0|||
44160394|NCT02625259|78952886|FG000|First Intervention (Day 1)|Adverse Event|2|||
44160395|NCT02625259|78952887|FG001|First Intervention (Day 1)|Adverse Event|1|||
44160396|NCT02625259|78952888|FG002|First Intervention (Day 1)|Adverse Event|0|||
44160397|NCT02625259|78952889|FG003|First Intervention (Day 1)|Adverse Event|0|||
44160398|NCT02625259|78952890|FG004|First Intervention (Day 1)|Adverse Event|0|||
44160399|NCT02625259|78952886|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160400|NCT02625259|78952887|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160401|NCT02625259|78952888|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160402|NCT02625259|78952889|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
44160403|NCT02625259|78952890|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
44160404|NCT02577107|78952907|FG000|Overall Study|Protocol deviation|0|||
44160405|NCT02577107|78952908|FG001|Overall Study|Protocol deviation|1|||
44160406|NCT02444793|78952918|FG000|Overall Study|Lost to Follow-up|2|||
44160407|NCT02444793|78952919|FG001|Overall Study|Lost to Follow-up|2|||
44160408|NCT02444793|78952920|FG002|Overall Study|Lost to Follow-up|0|||
44160409|NCT02444793|78952921|FG003|Overall Study|Lost to Follow-up|0|||
44160410|NCT02444793|78952918|FG000|Overall Study|Death|0|||
44160411|NCT02444793|78952919|FG001|Overall Study|Death|3|||
44160412|NCT02444793|78952920|FG002|Overall Study|Death|0|||
44160413|NCT02444793|78952921|FG003|Overall Study|Death|0|||
44160414|NCT02444793|78952918|FG000|Overall Study|Other|0|||
44160415|NCT02444793|78952919|FG001|Overall Study|Other|0|||
44160416|NCT02444793|78952920|FG002|Overall Study|Other|2|||
44160417|NCT02444793|78952921|FG003|Overall Study|Other|0|||
44160418|NCT02444793|78952918|FG000|Overall Study|Objective progression or relapse|9|||
44160419|NCT02444793|78952919|FG001|Overall Study|Objective progression or relapse|1|||
44160420|NCT02444793|78952920|FG002|Overall Study|Objective progression or relapse|2|||
44160421|NCT02444793|78952921|FG003|Overall Study|Objective progression or relapse|3|||
44160422|NCT02624713|78952934|FG000|Overall Study|Lost to Follow-up|14|||
44160423|NCT02624713|78952935|FG001|Overall Study|Lost to Follow-up|0|||
44160424|NCT02624791|78952942|FG000|Overall Study|Withdrawal by Subject|2|||
44160425|NCT02624791|78952943|FG001|Overall Study|Withdrawal by Subject|0|||
44160426|NCT02624791|78952944|FG002|Overall Study|Withdrawal by Subject|0|||
44160427|NCT02624791|78952945|FG003|Overall Study|Withdrawal by Subject|0|||
44160428|NCT02624791|78952946|FG004|Overall Study|Withdrawal by Subject|0|||
44160429|NCT02624791|78952947|FG005|Overall Study|Withdrawal by Subject|0|||
44160430|NCT02577029|78952959|FG000|Overall Study|Adverse Event|1|||
44160431|NCT02577029|78952960|FG001|Overall Study|Adverse Event|0|||
44160432|NCT02577029|78952961|FG002|Overall Study|Adverse Event|2|||
44160433|NCT02577029|78952962|FG003|Overall Study|Adverse Event|0|||
44160434|NCT02577029|78952963|FG004|Overall Study|Adverse Event|1|||
44160435|NCT02577029|78952964|FG005|Overall Study|Adverse Event|0|||
44160436|NCT02577029|78952965|FG006|Overall Study|Adverse Event|0|||
44160437|NCT02577029|78952966|FG007|Overall Study|Adverse Event|0|||
44160438|NCT02577029|78952959|FG000|Overall Study|Withdrawal by Subject|0|||
44160439|NCT02577029|78952960|FG001|Overall Study|Withdrawal by Subject|0|||
44160440|NCT02577029|78952961|FG002|Overall Study|Withdrawal by Subject|0|||
44160441|NCT02577029|78952962|FG003|Overall Study|Withdrawal by Subject|0|||
44160442|NCT02577029|78952963|FG004|Overall Study|Withdrawal by Subject|0|||
44160443|NCT02577029|78952964|FG005|Overall Study|Withdrawal by Subject|1|||
44160444|NCT02577029|78952965|FG006|Overall Study|Withdrawal by Subject|0|||
44160445|NCT02577029|78952966|FG007|Overall Study|Withdrawal by Subject|0|||
44160446|NCT02577029|78952959|FG000|Overall Study|Sponsor Termination of the Study|9|||
44160447|NCT02577029|78952960|FG001|Overall Study|Sponsor Termination of the Study|2|||
44160448|NCT02577029|78952961|FG002|Overall Study|Sponsor Termination of the Study|5|||
44160449|NCT02577029|78952962|FG003|Overall Study|Sponsor Termination of the Study|12|||
44160450|NCT02577029|78952963|FG004|Overall Study|Sponsor Termination of the Study|10|||
44160451|NCT02577029|78952964|FG005|Overall Study|Sponsor Termination of the Study|12|||
44160452|NCT02577029|78952965|FG006|Overall Study|Sponsor Termination of the Study|12|||
44160453|NCT02577029|78952966|FG007|Overall Study|Sponsor Termination of the Study|12|||
44160454|NCT02577887|78952984|FG000|Overall Study|Death|93|||
44160455|NCT02577887|78952984|FG000|Overall Study|Protocol Violation|125|||
44160456|NCT02577887|78952984|FG000|Overall Study|Withdrawal by Subject|80|||
44160457|NCT03597347|78952991|FG000|Overall Study|Withdrawal by Subject|1|||
44160458|NCT03597347|78952992|FG001|Overall Study|Withdrawal by Subject|1|||
44160459|NCT03597347|78952993|FG002|Overall Study|Withdrawal by Subject|0|||
44160460|NCT03597347|78952991|FG000|Overall Study|Withdrawal due to Covid-19|3|||
44160461|NCT03597347|78952992|FG001|Overall Study|Withdrawal due to Covid-19|0|||
44160462|NCT03597347|78952993|FG002|Overall Study|Withdrawal due to Covid-19|0|||
44160463|NCT03597347|78952991|FG000|Overall Study|Sponsor decision to terminate study|3|||
44160464|NCT03597347|78952992|FG001|Overall Study|Sponsor decision to terminate study|2|||
44160465|NCT03597347|78952993|FG002|Overall Study|Sponsor decision to terminate study|4|||
44160466|NCT02576951|78953005|FG000|Overall Study|Lost to Follow-up|0|||
44160467|NCT02576951|78953006|FG001|Overall Study|Lost to Follow-up|0|||
44344474|NCT00998296|79348413|FG003|Overall Study|Reason other than those specified above|0|||
44344475|NCT00998296|79348414|FG004|Overall Study|Reason other than those specified above|0|||
44344476|NCT00998296|79348415|FG005|Overall Study|Reason other than those specified above|0|||
44344477|NCT00998296|79348416|FG006|Overall Study|Reason other than those specified above|0|||
44344478|NCT00998296|79348417|FG007|Overall Study|Reason other than those specified above|0|||
44344479|NCT00998296|79348418|FG008|Overall Study|Reason other than those specified above|0|||
44344480|NCT00998296|79348419|FG009|Overall Study|Reason other than those specified above|1|||
44344481|NCT00998296|79348420|FG010|Overall Study|Reason other than those specified above|0|||
44344482|NCT01178073|79348452|FG000|Overall Study|Adverse Event|34|||
44344483|NCT01178073|79348453|FG001|Overall Study|Adverse Event|27|||
44344484|NCT01178073|79348454|FG002|Overall Study|Adverse Event|24|||
44344485|NCT01178073|79348452|FG000|Overall Study|Protocol Violation|1|||
44344486|NCT01178073|79348453|FG001|Overall Study|Protocol Violation|1|||
44344487|NCT01178073|79348454|FG002|Overall Study|Protocol Violation|1|||
44344488|NCT01178073|79348452|FG000|Overall Study|Lost to Follow-up|2|||
44344489|NCT01178073|79348453|FG001|Overall Study|Lost to Follow-up|0|||
44344490|NCT01178073|79348454|FG002|Overall Study|Lost to Follow-up|3|||
44344491|NCT01178073|79348452|FG000|Overall Study|Physician Decision|14|||
44344492|NCT01178073|79348453|FG001|Overall Study|Physician Decision|10|||
44344493|NCT01178073|79348454|FG002|Overall Study|Physician Decision|10|||
44344494|NCT01178073|79348452|FG000|Overall Study|Withdrawal by Subject|10|||
44344495|NCT01178073|79348453|FG001|Overall Study|Withdrawal by Subject|6|||
44344496|NCT01178073|79348454|FG002|Overall Study|Withdrawal by Subject|8|||
44344497|NCT01178073|79348452|FG000|Overall Study|Missing Completion Status|1|||
44344498|NCT01178073|79348453|FG001|Overall Study|Missing Completion Status|0|||
44344499|NCT01178073|79348454|FG002|Overall Study|Missing Completion Status|0|||
44344500|NCT00997984|79348466|FG000|Overall Study|Adverse Event|1|||
44344501|NCT00997984|79348467|FG001|Overall Study|Adverse Event|8|||
44344502|NCT00997984|79348468|FG002|Overall Study|Adverse Event|8|||
44344503|NCT00997984|79348466|FG000|Overall Study|Protocol Violation|1|||
44344504|NCT00997984|79348467|FG001|Overall Study|Protocol Violation|3|||
44344505|NCT00997984|79348468|FG002|Overall Study|Protocol Violation|0|||
44344506|NCT00997984|79348466|FG000|Overall Study|Withdrawal by Subject|6|||
44344507|NCT00997984|79348467|FG001|Overall Study|Withdrawal by Subject|9|||
44344508|NCT00997984|79348468|FG002|Overall Study|Withdrawal by Subject|5|||
44344509|NCT00997984|79348466|FG000|Overall Study|Lost to Follow-up|8|||
44344510|NCT00997984|79348467|FG001|Overall Study|Lost to Follow-up|5|||
44344511|NCT00997984|79348468|FG002|Overall Study|Lost to Follow-up|4|||
44344512|NCT00997984|79348466|FG000|Overall Study|Lack of Efficacy|20|||
44344513|NCT00997984|79348467|FG001|Overall Study|Lack of Efficacy|6|||
44344514|NCT00997984|79348468|FG002|Overall Study|Lack of Efficacy|3|||
44344515|NCT00997984|79348466|FG000|Overall Study|Met exclusion criteria|1|||
44344516|NCT00997984|79348467|FG001|Overall Study|Met exclusion criteria|0|||
44344517|NCT00997984|79348468|FG002|Overall Study|Met exclusion criteria|0|||
44444715|NCT00528411|79452462|FG000|Overall Study|Prior commitment medication|0|||
44444716|NCT00528411|79452463|FG001|Overall Study|Prior commitment medication|1|||
44444717|NCT00528411|79452464|FG002|Overall Study|Prior commitment medication|0|||
44444718|NCT00136357|79452474|FG000|Overall Study|Withdrawal by Subject|3|||
44160468|NCT02576951|78953007|FG002|Overall Study|Lost to Follow-up|2|||
44160469|NCT02576951|78953008|FG003|Overall Study|Lost to Follow-up|2|||
44160470|NCT02576951|78953005|FG000|Overall Study|Withdrawal by Subject|1|||
44160471|NCT02576951|78953006|FG001|Overall Study|Withdrawal by Subject|0|||
44160472|NCT02576951|78953007|FG002|Overall Study|Withdrawal by Subject|0|||
44344518|NCT00997984|79348466|FG000|Overall Study|non-compliance|0|||
44344519|NCT00997984|79348467|FG001|Overall Study|non-compliance|2|||
44344520|NCT00997984|79348468|FG002|Overall Study|non-compliance|3|||
44344521|NCT00997984|79348466|FG000|Overall Study|Wrong medication dispensed|0|||
44344522|NCT00997984|79348467|FG001|Overall Study|Wrong medication dispensed|1|||
44344523|NCT00997984|79348468|FG002|Overall Study|Wrong medication dispensed|0|||
44344524|NCT00997984|79348466|FG000|Overall Study|Suicidal ideation|0|||
44344525|NCT00997984|79348467|FG001|Overall Study|Suicidal ideation|0|||
44344526|NCT00997984|79348468|FG002|Overall Study|Suicidal ideation|1|||
44344527|NCT00997984|79348466|FG000|Overall Study|Work schedule|0|||
44344528|NCT00997984|79348467|FG001|Overall Study|Work schedule|0|||
44344529|NCT00997984|79348468|FG002|Overall Study|Work schedule|2|||
44160473|NCT02576951|78953008|FG003|Overall Study|Withdrawal by Subject|2|||
44160474|NCT02576951|78953005|FG000|Overall Study|Protocol Violation|0|||
44160475|NCT02576951|78953006|FG001|Overall Study|Protocol Violation|0|||
44160476|NCT02576951|78953007|FG002|Overall Study|Protocol Violation|0|||
44160477|NCT02576951|78953008|FG003|Overall Study|Protocol Violation|1|||
44160478|NCT04929613|78953020|FG000|Overall Study|Withdrawal by Subject|12|||
44160479|NCT02621047|78953027|FG000|Overall Study|Adverse Event|0|||
44160480|NCT02621047|78953028|FG001|Overall Study|Adverse Event|0|||
44160481|NCT02621047|78953029|FG002|Overall Study|Adverse Event|1|||
44160482|NCT02443155|78953042|FG000|Overall Study|Adverse Event|3|||
44160483|NCT02443155|78953043|FG001|Overall Study|Adverse Event|4|||
44160484|NCT02443155|78953044|FG002|Overall Study|Adverse Event|1|||
44160485|NCT02443155|78953045|FG003|Overall Study|Adverse Event|2|||
44160486|NCT02443155|78953042|FG000|Overall Study|Unclassified|0|||
44160487|NCT02443155|78953043|FG001|Overall Study|Unclassified|0|||
44160488|NCT02443155|78953044|FG002|Overall Study|Unclassified|2|||
44160489|NCT02443155|78953045|FG003|Overall Study|Unclassified|1|||
44160490|NCT02443155|78953042|FG000|Overall Study|Withdrawal by Subject|4|||
44160491|NCT02443155|78953043|FG001|Overall Study|Withdrawal by Subject|7|||
44160492|NCT02443155|78953044|FG002|Overall Study|Withdrawal by Subject|3|||
44160493|NCT02443155|78953045|FG003|Overall Study|Withdrawal by Subject|9|||
44160494|NCT02443155|78953042|FG000|Overall Study|Pregnancy|3|||
44160495|NCT02443155|78953043|FG001|Overall Study|Pregnancy|1|||
44160496|NCT02443155|78953044|FG002|Overall Study|Pregnancy|1|||
44160497|NCT02443155|78953045|FG003|Overall Study|Pregnancy|2|||
44160498|NCT02443155|78953042|FG000|Overall Study|Lost to Follow-up|1|||
44160499|NCT02443155|78953043|FG001|Overall Study|Lost to Follow-up|2|||
44160500|NCT02443155|78953044|FG002|Overall Study|Lost to Follow-up|0|||
44160501|NCT02443155|78953045|FG003|Overall Study|Lost to Follow-up|1|||
44160502|NCT02443155|78953042|FG000|Overall Study|Protocol Violation|1|||
44160503|NCT02443155|78953043|FG001|Overall Study|Protocol Violation|0|||
44160504|NCT02443155|78953044|FG002|Overall Study|Protocol Violation|1|||
44160505|NCT02443155|78953045|FG003|Overall Study|Protocol Violation|1|||
44160506|NCT02443155|78953042|FG000|Overall Study|Death|0|||
44160507|NCT02443155|78953043|FG001|Overall Study|Death|0|||
44160508|NCT02443155|78953044|FG002|Overall Study|Death|1|||
44160509|NCT02443155|78953045|FG003|Overall Study|Death|0|||
44160510|NCT02460159|78953058|FG000|Overall Study|Adverse Event|4|||
44160511|NCT02460159|78953059|FG001|Overall Study|Adverse Event|1|||
44160512|NCT02460159|78953058|FG000|Overall Study|Withdrawal by Subject|2|||
44160513|NCT02460159|78953059|FG001|Overall Study|Withdrawal by Subject|0|||
44160514|NCT02498067|78953065|FG000|Overall Study|Lost to Follow-up|22|||
44160515|NCT02498067|78953065|FG000|Overall Study|Did not meet inclusion criteria|11|||
44160516|NCT02497755|78953073|FG000|Overall Study|Protocol Violation|1|||
44160517|NCT02497755|78953074|FG001|Overall Study|Protocol Violation|0|||
44160518|NCT02619175|78953083|FG000|Overall Study|Withdrawal by Subject|1|||
44160519|NCT02619175|78953084|FG001|Overall Study|Withdrawal by Subject|0|||
44160520|NCT02619175|78953083|FG000|Overall Study|foot pain|1|||
44160521|NCT02619175|78953084|FG001|Overall Study|foot pain|0|||
44160522|NCT01360021|78953101|FG000|Overall Study|Eligibility criteria + other|2|||
44160523|NCT01360021|78953102|FG001|Overall Study|Eligibility criteria + other|1|||
44160524|NCT01360021|78953103|FG002|Overall Study|Eligibility criteria + other|1|||
44160525|NCT01360021|78953101|FG000|Overall Study|Protocol Violation|0|||
44160526|NCT01360021|78953102|FG001|Overall Study|Protocol Violation|0|||
44160527|NCT01360021|78953103|FG002|Overall Study|Protocol Violation|1|||
44160528|NCT01360021|78953101|FG000|Overall Study|Withdrawal by Subject|4|||
44160529|NCT01360021|78953102|FG001|Overall Study|Withdrawal by Subject|0|||
44160530|NCT01360021|78953103|FG002|Overall Study|Withdrawal by Subject|2|||
44160531|NCT01360021|78953101|FG000|Overall Study|Adverse Event|2|||
44160532|NCT01360021|78953102|FG001|Overall Study|Adverse Event|3|||
44160533|NCT01360021|78953103|FG002|Overall Study|Adverse Event|3|||
44160534|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
44160535|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
44160536|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
44160537|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
44160538|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Other|13|||
44160539|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
44160540|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
44160541|NCT02497287|78953120|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
44160542|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
44160543|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
44160544|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
44160545|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
44160546|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
44160547|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
44160548|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
44160549|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
44160550|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
44160551|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
44160552|NCT02497287|78953120|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
44160553|NCT02497287|78953120|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
44160554|NCT02497287|78953120|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
44160555|NCT02497287|78953120|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
44160556|NCT02497287|78953120|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
44160557|NCT02497287|78953120|FG000|Follow-up Phase (4 Week)|Other|1|||
44160558|NCT02458287|78953130|FG000|Overall Study|Adverse Event|0|||
44160559|NCT02458287|78953131|FG001|Overall Study|Adverse Event|0|||
44160560|NCT02458287|78953132|FG002|Overall Study|Adverse Event|0|||
44160561|NCT02458287|78953133|FG003|Overall Study|Adverse Event|1|||
44160562|NCT02458287|78953130|FG000|Overall Study|Lost to Follow-up|0|||
44160563|NCT02458287|78953131|FG001|Overall Study|Lost to Follow-up|1|||
44160564|NCT02458287|78953132|FG002|Overall Study|Lost to Follow-up|1|||
44160565|NCT02458287|78953133|FG003|Overall Study|Lost to Follow-up|0|||
44160566|NCT02458287|78953130|FG000|Overall Study|Protocol Violation|0|||
44160567|NCT02458287|78953131|FG001|Overall Study|Protocol Violation|1|||
44160568|NCT02458287|78953132|FG002|Overall Study|Protocol Violation|0|||
44160569|NCT02458287|78953133|FG003|Overall Study|Protocol Violation|0|||
44160570|NCT02458287|78953130|FG000|Overall Study|Withdrawal by Subject|0|||
44160571|NCT02458287|78953131|FG001|Overall Study|Withdrawal by Subject|2|||
44160572|NCT02458287|78953132|FG002|Overall Study|Withdrawal by Subject|2|||
44160573|NCT02458287|78953133|FG003|Overall Study|Withdrawal by Subject|1|||
44160574|NCT02458287|78953130|FG000|Overall Study|Relocated Out of State|0|||
44160575|NCT02458287|78953131|FG001|Overall Study|Relocated Out of State|0|||
44160576|NCT02458287|78953132|FG002|Overall Study|Relocated Out of State|0|||
44160577|NCT02458287|78953133|FG003|Overall Study|Relocated Out of State|1|||
44160578|NCT02441517|78953149|FG000|Overall Study|Lost to Follow-up|1|||
44160579|NCT02441517|78953149|FG000|Overall Study|Withdrawal by Subject|2|||
44160580|NCT02441517|78953149|FG000|Overall Study|Study Terminated by Sponsor|1|||
44160581|NCT02457819|78953153|FG000|Overall Study|reason not given|8|||
44160582|NCT02457819|78953153|FG000|Overall Study|Withdrawal by Subject|24|||
44160583|NCT02457819|78953153|FG000|Overall Study|Protocol Violation|1|||
44160584|NCT02457819|78953153|FG000|Overall Study|non compliance with study drug|4|||
44160585|NCT02457819|78953153|FG000|Overall Study|Lost to Follow-up|10|||
44160586|NCT02457819|78953153|FG000|Overall Study|Lack of Efficacy|19|||
44160587|NCT02457819|78953153|FG000|Overall Study|Adverse Event|33|||
44160588|NCT02496039|78953157|FG000|Overall Study|Adverse Event|3|||
44160589|NCT02496039|78953157|FG000|Overall Study|Protocol Violation|1|||
44160590|NCT02441283|78953161|FG000|Overall Study|Withdrew consent|15|||
44160591|NCT02441283|78953161|FG000|Overall Study|Lost to Follow-up|42|||
44160592|NCT02441283|78953161|FG000|Overall Study|Death|1|||
44160593|NCT02441283|78953161|FG000|Overall Study|Other, not specified|32|||
44160594|NCT02495883|78953167|FG000|Overall Study|Excessive head motion|1|||
44160595|NCT02495883|78953168|FG001|Overall Study|Excessive head motion|0|||
44160596|NCT02495025|78953175|FG000|Overall Study|Lost to Follow-up|21|||
44160597|NCT02495025|78953176|FG001|Overall Study|Lost to Follow-up|14|||
44160598|NCT02495025|78953175|FG000|Overall Study|Withdrawal by Subject|5|||
44160599|NCT02495025|78953176|FG001|Overall Study|Withdrawal by Subject|0|||
44160600|NCT02439957|78953184|FG000|Overall Study|Study Terminated|3|||
44160601|NCT02439957|78953185|FG001|Overall Study|Study Terminated|3|||
44160602|NCT02494401|78953193|FG000|Overall Study|Lost to Follow-up|22|||
44160603|NCT02494401|78953194|FG001|Overall Study|Lost to Follow-up|25|||
44160604|NCT02494401|78953193|FG000|Overall Study|Withdrawal by Subject|3|||
44160605|NCT02494401|78953194|FG001|Overall Study|Withdrawal by Subject|2|||
44160606|NCT02457195|78953200|FG000|Overall Study|Adverse Event|3|||
44160607|NCT02457195|78953200|FG000|Overall Study|Protocol Violation|2|||
44160608|NCT02457195|78953200|FG000|Overall Study|Withdrawal by Subject|4|||
44444719|NCT00136357|79452475|FG001|Overall Study|Withdrawal by Subject|2|||
44444720|NCT00129649|79452483|FG000|Overall Study|Withdrawal by Subject|76|||
44444721|NCT00129649|79452484|FG001|Overall Study|Withdrawal by Subject|65|||
44444722|NCT00187135|79452496|FG000|Visit One|Withdrawal by Subject|1|||
44444723|NCT00187135|79452497|FG001|Visit One|Withdrawal by Subject|0|||
44160609|NCT02456727|78953206|FG000|Overall Study|Lost to Follow-up|63|||
44160610|NCT02456727|78953207|FG001|Overall Study|Lost to Follow-up|65|||
44160611|NCT02456727|78953206|FG000|Overall Study|Death|2|||
44160612|NCT02456727|78953207|FG001|Overall Study|Death|1|||
44160613|NCT02456727|78953206|FG000|Overall Study|Withdrawal by Subject|1|||
44160614|NCT02456727|78953207|FG001|Overall Study|Withdrawal by Subject|10|||
44160615|NCT02456727|78953206|FG000|Overall Study|Never Initiated Treatment|43|||
44160616|NCT02456727|78953207|FG001|Overall Study|Never Initiated Treatment|30|||
44160617|NCT02456103|78953229|FG000|Overall Study|Study Closure|207|||
44160618|NCT02456103|78953229|FG000|Overall Study|Physician Decision|1|||
44444724|NCT00187135|79452498|FG002|Visit One|Withdrawal by Subject|0|||
44444725|NCT00187135|79452499|FG003|Visit One|Withdrawal by Subject|0|||
44160619|NCT02456103|78953229|FG000|Overall Study|Required prohibited medications|5|||
44444726|NCT00187135|79452500|FG004|Visit One|Withdrawal by Subject|0|||
44160620|NCT02456103|78953229|FG000|Overall Study|Protocol Violation|1|||
44160621|NCT02456103|78953229|FG000|Overall Study|Adverse Event|5|||
44160622|NCT02456103|78953229|FG000|Overall Study|Abnormal Laboratory Value|2|||
44160623|NCT02456103|78953229|FG000|Overall Study|Lost to Follow-up|1|||
44160624|NCT02456103|78953229|FG000|Overall Study|Withdrawal by Subject|24|||
44160625|NCT01653327|78953233|FG000|Overall Study|Withdrawal by Subject|1|||
44160626|NCT02493855|78953242|FG000|Overall Study|Non-compliance|1|||
44160627|NCT02493855|78953243|FG001|Overall Study|Non-compliance|0|||
44160628|NCT02493855|78953244|FG002|Overall Study|Non-compliance|0|||
44160629|NCT02493855|78953242|FG000|Overall Study|Adverse Event|0|||
44160630|NCT02493855|78953243|FG001|Overall Study|Adverse Event|1|||
44160631|NCT02493855|78953244|FG002|Overall Study|Adverse Event|0|||
44160632|NCT02493855|78953242|FG000|Overall Study|Withdrawal by Subject|1|||
44160633|NCT02493855|78953243|FG001|Overall Study|Withdrawal by Subject|0|||
44160634|NCT02493855|78953244|FG002|Overall Study|Withdrawal by Subject|0|||
44160635|NCT02438787|78953255|FG000|Overall Study|Adverse Event|1|||
44160636|NCT02438787|78953256|FG001|Overall Study|Adverse Event|0|||
44160637|NCT02438787|78953257|FG002|Overall Study|Adverse Event|2|||
44160638|NCT02438787|78953255|FG000|Overall Study|Lack of Efficacy|1|||
44160639|NCT02438787|78953256|FG001|Overall Study|Lack of Efficacy|2|||
44160640|NCT02438787|78953257|FG002|Overall Study|Lack of Efficacy|0|||
44160641|NCT02438787|78953255|FG000|Overall Study|Lost to Follow-up|0|||
44160642|NCT02438787|78953256|FG001|Overall Study|Lost to Follow-up|1|||
44160643|NCT02438787|78953257|FG002|Overall Study|Lost to Follow-up|0|||
44160644|NCT02438787|78953255|FG000|Overall Study|Protocol Violation|0|||
44160645|NCT02438787|78953256|FG001|Overall Study|Protocol Violation|0|||
44160646|NCT02438787|78953257|FG002|Overall Study|Protocol Violation|1|||
44160647|NCT02438787|78953255|FG000|Overall Study|Withdrawal by Subject|15|||
44160648|NCT02438787|78953256|FG001|Overall Study|Withdrawal by Subject|7|||
44160649|NCT02438787|78953257|FG002|Overall Study|Withdrawal by Subject|10|||
44160650|NCT02438787|78953255|FG000|Overall Study|Study discontinued by sponsor|64|||
44160651|NCT02438787|78953256|FG001|Overall Study|Study discontinued by sponsor|72|||
44160652|NCT02438787|78953257|FG002|Overall Study|Study discontinued by sponsor|69|||
44160653|NCT02438787|78953255|FG000|Overall Study|Other|0|||
44160654|NCT02438787|78953256|FG001|Overall Study|Other|1|||
44160655|NCT02438787|78953257|FG002|Overall Study|Other|0|||
44160656|NCT02438787|78953255|FG000|Overall Study|Site terminated by sponsor|0|||
44160657|NCT02438787|78953256|FG001|Overall Study|Site terminated by sponsor|0|||
44160658|NCT02438787|78953257|FG002|Overall Study|Site terminated by sponsor|1|||
44160659|NCT02493777|78953272|FG000|Overall Study|Lost to Follow-up|0|||
44160660|NCT02493777|78953273|FG001|Overall Study|Lost to Follow-up|1|||
44160661|NCT02616601|78953282|FG000|Overall Study|Withdrawal by Subject|4|||
44160662|NCT02616601|78953283|FG001|Overall Study|Withdrawal by Subject|4|||
44160663|NCT02616601|78953284|FG002|Overall Study|Withdrawal by Subject|3|||
44160664|NCT02616601|78953282|FG000|Overall Study|Adverse Event|2|||
44160665|NCT02616601|78953283|FG001|Overall Study|Adverse Event|0|||
44160666|NCT02616601|78953284|FG002|Overall Study|Adverse Event|2|||
44160667|NCT02616601|78953282|FG000|Overall Study|Death|1|||
44160668|NCT02616601|78953283|FG001|Overall Study|Death|0|||
44344530|NCT01177293|79348478|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
44444727|NCT00187135|79452501|FG005|Visit One|Withdrawal by Subject|1|||
44444728|NCT00187135|79452496|FG000|Visit One|Physician Decision|3|||
44444729|NCT00187135|79452497|FG001|Visit One|Physician Decision|1|||
44160669|NCT02616601|78953284|FG002|Overall Study|Death|0|||
44160670|NCT02616601|78953282|FG000|Overall Study|Lost to Follow-up|1|||
44160671|NCT02616601|78953283|FG001|Overall Study|Lost to Follow-up|0|||
44160672|NCT02616601|78953284|FG002|Overall Study|Lost to Follow-up|1|||
44160673|NCT02616601|78953282|FG000|Overall Study|Non-Compliance with Test Article|1|||
44160674|NCT02616601|78953283|FG001|Overall Study|Non-Compliance with Test Article|0|||
44160675|NCT02616601|78953284|FG002|Overall Study|Non-Compliance with Test Article|1|||
44160676|NCT02492997|78953294|FG000|Overall Study|Withdrawal by Subject|1|||
44160677|NCT02492997|78953295|FG001|Overall Study|Withdrawal by Subject|0|||
44160678|NCT02492997|78953294|FG000|Overall Study|Gained Weight|1|||
44160679|NCT02492997|78953295|FG001|Overall Study|Gained Weight|0|||
44160680|NCT02492997|78953294|FG000|Overall Study|Lost to Follow-up|0|||
44160681|NCT02492997|78953295|FG001|Overall Study|Lost to Follow-up|1|||
44160682|NCT02437305|78953303|FG000|Overall Study|Lost to Follow-up|18|||
44444730|NCT00187135|79452498|FG002|Visit One|Physician Decision|0|||
44160683|NCT02437305|78953304|FG001|Overall Study|Lost to Follow-up|12|||
44160684|NCT02492841|78953313|FG000|Overall Study|Lost to Follow-up|34|||
44160685|NCT02492841|78953314|FG001|Overall Study|Lost to Follow-up|31|||
44160686|NCT02492841|78953315|FG002|Overall Study|Lost to Follow-up|35|||
44160687|NCT02436915|78953328|FG000|Overall Study|Withdrawal by Subject|0|||
44160688|NCT02436915|78953329|FG001|Overall Study|Withdrawal by Subject|1|||
44160689|NCT02492763|78953341|FG000|Overall Study|Withdrawal by Subject|0|||
44160690|NCT02492763|78953342|FG001|Overall Study|Withdrawal by Subject|2|||
44160691|NCT02492763|78953343|FG002|Overall Study|Withdrawal by Subject|1|||
44160692|NCT02492763|78953344|FG003|Overall Study|Withdrawal by Subject|0|||
44160693|NCT02492763|78953341|FG000|Overall Study|Adverse Event|3|||
44160694|NCT02492763|78953342|FG001|Overall Study|Adverse Event|1|||
44160695|NCT02492763|78953343|FG002|Overall Study|Adverse Event|1|||
44160696|NCT02492763|78953344|FG003|Overall Study|Adverse Event|2|||
44160697|NCT02492763|78953341|FG000|Overall Study|Death|0|||
44160698|NCT02492763|78953342|FG001|Overall Study|Death|0|||
44160699|NCT02492763|78953343|FG002|Overall Study|Death|1|||
44160700|NCT02492763|78953344|FG003|Overall Study|Death|0|||
44160701|NCT02492763|78953341|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
44160702|NCT02492763|78953342|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
44160703|NCT02492763|78953343|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
44160704|NCT02492763|78953344|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
44160705|NCT02492763|78953341|FG000|Overall Study|Lost to Follow-up|0|||
44160706|NCT02492763|78953342|FG001|Overall Study|Lost to Follow-up|0|||
44160707|NCT02492763|78953343|FG002|Overall Study|Lost to Follow-up|1|||
44160708|NCT02492763|78953344|FG003|Overall Study|Lost to Follow-up|0|||
44160709|NCT02492763|78953341|FG000|Overall Study|Non-Compliance With Study Drug|0|||
44160710|NCT02492763|78953342|FG001|Overall Study|Non-Compliance With Study Drug|1|||
44160711|NCT02492763|78953343|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44160712|NCT02492763|78953344|FG003|Overall Study|Non-Compliance With Study Drug|0|||
44160713|NCT02492763|78953341|FG000|Overall Study|Screen Failure|0|||
44160714|NCT02492763|78953342|FG001|Overall Study|Screen Failure|0|||
44160715|NCT02492763|78953343|FG002|Overall Study|Screen Failure|0|||
44160716|NCT02492763|78953344|FG003|Overall Study|Screen Failure|1|||
44160717|NCT02492763|78953341|FG000|Overall Study|Study Terminated by Sponsor|13|||
44160718|NCT02492763|78953342|FG001|Overall Study|Study Terminated by Sponsor|10|||
44160719|NCT02492763|78953343|FG002|Overall Study|Study Terminated by Sponsor|6|||
44160720|NCT02492763|78953344|FG003|Overall Study|Study Terminated by Sponsor|10|||
44160721|NCT02491671|78953356|FG000|Overall Study|Adverse Event|6|||
44160722|NCT02491671|78953357|FG001|Overall Study|Adverse Event|8|||
44160723|NCT02491671|78953356|FG000|Overall Study|Death|0|||
44160724|NCT02491671|78953357|FG001|Overall Study|Death|2|||
44160725|NCT02491671|78953356|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
44160726|NCT02491671|78953357|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
44160727|NCT02453841|78953363|FG000|Overall Study|Protocol Violation|1|||
44160728|NCT02453841|78953363|FG000|Overall Study|Unable to obtain blood samples|2|||
44160729|NCT02453685|78953369|FG000|Overall Study|Adverse Event|0|||
44160730|NCT02453685|78953370|FG001|Overall Study|Adverse Event|1|||
44160731|NCT02453685|78953369|FG000|Overall Study|Protocol Violation|7|||
44160732|NCT02453685|78953370|FG001|Overall Study|Protocol Violation|4|||
44160733|NCT02453685|78953369|FG000|Overall Study|Lost to Follow-up|0|||
44160734|NCT02453685|78953370|FG001|Overall Study|Lost to Follow-up|1|||
44160735|NCT02453685|78953369|FG000|Overall Study|Withdrawal by Subject|8|||
44160736|NCT02453685|78953370|FG001|Overall Study|Withdrawal by Subject|4|||
44160737|NCT02453685|78953369|FG000|Overall Study|Unclassified|4|||
44160738|NCT02453685|78953370|FG001|Overall Study|Unclassified|2|||
44160739|NCT02436759|78953378|FG000|Overall Study|Adverse Event|3|||
44160740|NCT02436759|78953379|FG001|Overall Study|Adverse Event|0|||
44160741|NCT02436759|78953378|FG000|Overall Study|Protocol Violation|1|||
44160742|NCT02436759|78953379|FG001|Overall Study|Protocol Violation|0|||
44160743|NCT02436759|78953378|FG000|Overall Study|Withdrawal by Subject|0|||
44160744|NCT02436759|78953379|FG001|Overall Study|Withdrawal by Subject|1|||
44160745|NCT02436681|78953385|FG000|Overall Study|Lost to Follow-up|10|||
44160746|NCT02436681|78953385|FG000|Overall Study|Withdrawal by Subject|2|||
44160747|NCT02436681|78953385|FG000|Overall Study|Death|2|||
44160748|NCT02436135|78953391|FG000|Overall Study|Progressive Disease|3|||
44160749|NCT02436135|78953392|FG001|Overall Study|Progressive Disease|1|||
44160750|NCT02436135|78953391|FG000|Overall Study|Investigator Discretion|1|||
44160751|NCT02436135|78953392|FG001|Overall Study|Investigator Discretion|2|||
44160752|NCT02436135|78953391|FG000|Overall Study|Adverse Event|1|||
44160753|NCT02436135|78953392|FG001|Overall Study|Adverse Event|0|||
44160754|NCT02436135|78953391|FG000|Overall Study|Withdrawal by Participant|1|||
44160755|NCT02436135|78953392|FG001|Overall Study|Withdrawal by Participant|0|||
44160756|NCT02436135|78953391|FG000|Overall Study|Study Terminated By Sponsor|0|||
44160757|NCT02436135|78953392|FG001|Overall Study|Study Terminated By Sponsor|1|||
44160758|NCT02489799|78953400|FG000|Overall Study|Lost to Follow-up|4|||
44160759|NCT02489799|78953401|FG001|Overall Study|Lost to Follow-up|1|||
44160760|NCT02489799|78953400|FG000|Overall Study|Failure to Maintain Eligibility|4|||
44160761|NCT02489799|78953401|FG001|Overall Study|Failure to Maintain Eligibility|6|||
44160762|NCT02489799|78953400|FG000|Overall Study|Withdrawal by Subject|1|||
44160763|NCT02489799|78953401|FG001|Overall Study|Withdrawal by Subject|1|||
44344531|NCT01177293|79348479|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
44344532|NCT01177137|79348488|FG000|Overall Study|Withdrawal by Subject|10|||
44344533|NCT01177137|79348489|FG001|Overall Study|Withdrawal by Subject|10|||
44344534|NCT01177137|79348490|FG002|Overall Study|Withdrawal by Subject|2|||
44344535|NCT01177059|79348501|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
44160764|NCT02489799|78953400|FG000|Overall Study|Death|0|||
44160765|NCT02489799|78953401|FG001|Overall Study|Death|1|||
44260044|NCT01276847|79124653|FG001|Overall Study|Withdrawal by Subject|0|||
44260045|NCT01276847|79124654|FG002|Overall Study|Withdrawal by Subject|0|||
44260046|NCT01276457|79124686|FG000|Core Study|Adverse Event|6|||
44260047|NCT01276457|79124687|FG001|Core Study|Adverse Event|3|||
44160766|NCT02435277|78953411|FG000|Overall Study|Adverse Event|1|||
44160767|NCT02435277|78953412|FG001|Overall Study|Adverse Event|1|||
44160768|NCT02435277|78953413|FG002|Overall Study|Adverse Event|0|||
44160769|NCT02435277|78953414|FG003|Overall Study|Adverse Event|0|||
44160770|NCT02435277|78953411|FG000|Overall Study|Withdrawal by Subject|1|||
44160771|NCT02435277|78953412|FG001|Overall Study|Withdrawal by Subject|0|||
44160772|NCT02435277|78953413|FG002|Overall Study|Withdrawal by Subject|0|||
44160773|NCT02435277|78953414|FG003|Overall Study|Withdrawal by Subject|0|||
44160774|NCT02420223|78953426|FG000|Overall Study|Adverse Event|1|||
44160775|NCT02420223|78953427|FG001|Overall Study|Adverse Event|0|||
44160776|NCT02420223|78953426|FG000|Overall Study|Physician Decision|0|||
44160777|NCT02420223|78953427|FG001|Overall Study|Physician Decision|2|||
44160778|NCT02433483|78953433|FG000|Overall Study|Unacceptable toxicity|1|||
44160779|NCT02433483|78953433|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
44160780|NCT02419755|78953439|FG000|Overall Study|Death|1|||
44160781|NCT02419755|78953440|FG001|Overall Study|Death|3|||
44160782|NCT02419755|78953439|FG000|Overall Study|Relapse|0|||
44160783|NCT02419755|78953440|FG001|Overall Study|Relapse|1|||
44160784|NCT02419755|78953439|FG000|Overall Study|Ineligible|1|||
44160785|NCT02419755|78953440|FG001|Overall Study|Ineligible|0|||
44160786|NCT02419755|78953439|FG000|Overall Study|Withdrawal by Subject|1|||
44160787|NCT02419755|78953440|FG001|Overall Study|Withdrawal by Subject|0|||
44160788|NCT02488551|78953450|FG000|Overall Study|Lost to Follow-up|4|||
44160789|NCT02488551|78953451|FG001|Overall Study|Lost to Follow-up|7|||
44160790|NCT02488551|78953452|FG002|Overall Study|Lost to Follow-up|0|||
44160791|NCT02488551|78953453|FG003|Overall Study|Lost to Follow-up|0|||
44160792|NCT02488551|78953450|FG000|Overall Study|Military Deployment|1|||
44160793|NCT02488551|78953451|FG001|Overall Study|Military Deployment|1|||
44160794|NCT02488551|78953452|FG002|Overall Study|Military Deployment|0|||
44160795|NCT02488551|78953453|FG003|Overall Study|Military Deployment|0|||
44160796|NCT02488239|78953463|FG000|Overall Study|Death|3|||
44160797|NCT02488239|78953463|FG000|Overall Study|Withdrawal by Subject|3|||
44160798|NCT02488239|78953463|FG000|Overall Study|Physician Decision|2|||
44160799|NCT02488239|78953463|FG000|Overall Study|Consent ineligible|1|||
44160800|NCT02488239|78953463|FG000|Overall Study|Did not undergo implant procedure|1|||
44160801|NCT02488005|78953468|FG000|Overall Study|Lost to Follow-up|2|||
44160802|NCT02487771|78953474|FG000|Overall Study|Lost to Follow-up|2|||
44160803|NCT02487771|78953475|FG001|Overall Study|Lost to Follow-up|3|||
44160804|NCT02487771|78953474|FG000|Overall Study|Moved out of area|5|||
44160805|NCT02487771|78953475|FG001|Overall Study|Moved out of area|6|||
44160806|NCT02487771|78953474|FG000|Overall Study|Withdrawal by Subject|3|||
44160807|NCT02487771|78953475|FG001|Overall Study|Withdrawal by Subject|5|||
44160808|NCT01359943|78953484|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
44160809|NCT01359943|78953485|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
44160810|NCT01359943|78953486|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
44160811|NCT01359943|78953484|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
44160812|NCT01359943|78953485|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
44160813|NCT01359943|78953486|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
44160814|NCT01359943|78953484|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
44160815|NCT01359943|78953485|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
44160816|NCT01359943|78953486|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
44160817|NCT01359943|78953484|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
44160818|NCT01359943|78953485|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
44160819|NCT01359943|78953486|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
44160820|NCT01359943|78953484|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
44160821|NCT01359943|78953485|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
44160822|NCT01359943|78953486|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
44160823|NCT01359943|78953484|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
44160824|NCT01359943|78953485|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
44160825|NCT01359943|78953486|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
44160826|NCT01359943|78953484|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
44260048|NCT01276457|79124686|FG000|Core Study|Lost to Follow-up|1|||
44260049|NCT01276457|79124687|FG001|Core Study|Lost to Follow-up|2|||
44260050|NCT01276457|79124686|FG000|Core Study|Administrative problems|1|||
44160827|NCT01359943|78953485|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
44160828|NCT01359943|78953486|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
44160829|NCT01359943|78953484|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
44160830|NCT01359943|78953485|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
44160831|NCT01359943|78953486|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
44160832|NCT01359943|78953484|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
44160833|NCT01359943|78953485|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
44160834|NCT01359943|78953486|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
44160835|NCT01359943|78953484|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
44160836|NCT01359943|78953485|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
44160837|NCT01359943|78953486|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
44160838|NCT01359943|78953484|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
44260051|NCT01276457|79124687|FG001|Core Study|Administrative problems|1|||
44260052|NCT01276457|79124686|FG000|Core Study|Death|2|||
44260053|NCT01276457|79124687|FG001|Core Study|Death|2|||
44260054|NCT01276457|79124686|FG000|Core Study|Lack of Efficacy|3|||
44260055|NCT01276457|79124687|FG001|Core Study|Lack of Efficacy|12|||
44260056|NCT01276457|79124686|FG000|Extension Study|Lost to Follow-up|3|||
44260057|NCT01276457|79124687|FG001|Extension Study|Lost to Follow-up|0|||
44160839|NCT01359943|78953485|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
44160840|NCT01359943|78953486|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
44160841|NCT01359943|78953484|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
44160842|NCT01359943|78953485|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
44160843|NCT01359943|78953486|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
44160844|NCT01359943|78953484|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
44160845|NCT01359943|78953485|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
44160846|NCT01359943|78953486|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
44160847|NCT01359943|78953484|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
44160848|NCT01359943|78953485|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
44160849|NCT01359943|78953486|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
44160850|NCT01359943|78953484|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
44160851|NCT01359943|78953485|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
44160852|NCT01359943|78953486|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
44160853|NCT02432703|78953498|FG000|Overall Study|Adverse Event|1|||
44160854|NCT02432703|78953499|FG001|Overall Study|Adverse Event|4|||
44160855|NCT02432703|78953498|FG000|Overall Study|Lack of Efficacy|1|||
44160856|NCT02432703|78953499|FG001|Overall Study|Lack of Efficacy|0|||
44160857|NCT02432703|78953498|FG000|Overall Study|Lost to Follow-up|5|||
44160858|NCT02432703|78953499|FG001|Overall Study|Lost to Follow-up|3|||
44344536|NCT01177059|79348501|FG000|Overall Study|Withdrew consent|2|||
44344537|NCT01177059|79348501|FG000|Overall Study|Lost to Follow-up|18|||
44344538|NCT01176513|79348505|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
44344539|NCT01299389|79348511|FG000|Double-blind|Adverse Event|45|||
44344540|NCT01299389|79348512|FG001|Double-blind|Adverse Event|27|||
44344541|NCT01299389|79348513|FG002|Double-blind|Adverse Event|0|||
44344542|NCT01299389|79348514|FG003|Double-blind|Adverse Event|0|||
44344543|NCT01299389|79348511|FG000|Double-blind|Lack of Efficacy|45|||
44344544|NCT01299389|79348512|FG001|Double-blind|Lack of Efficacy|21|||
44344545|NCT01299389|79348513|FG002|Double-blind|Lack of Efficacy|0|||
44344546|NCT01299389|79348514|FG003|Double-blind|Lack of Efficacy|0|||
44344547|NCT01299389|79348511|FG000|Double-blind|Lost to Follow-up|2|||
44344548|NCT01299389|79348512|FG001|Double-blind|Lost to Follow-up|1|||
44344549|NCT01299389|79348513|FG002|Double-blind|Lost to Follow-up|0|||
44344550|NCT01299389|79348514|FG003|Double-blind|Lost to Follow-up|0|||
44344551|NCT01299389|79348511|FG000|Double-blind|Withdrawal by Subject|16|||
44344552|NCT01299389|79348512|FG001|Double-blind|Withdrawal by Subject|13|||
44344553|NCT01299389|79348513|FG002|Double-blind|Withdrawal by Subject|0|||
44344554|NCT01299389|79348514|FG003|Double-blind|Withdrawal by Subject|0|||
44344555|NCT01299389|79348511|FG000|Double-blind|Other|1|||
44260058|NCT01276457|79124686|FG000|Extension Study|Death|0|||
44160859|NCT02432703|78953498|FG000|Overall Study|Withdrawal by Subject|9|||
44160860|NCT02432703|78953499|FG001|Overall Study|Withdrawal by Subject|6|||
44160861|NCT02432703|78953498|FG000|Overall Study|Other|6|||
44160862|NCT02432703|78953499|FG001|Overall Study|Other|5|||
44160863|NCT02486757|78953505|FG000|Overall Study|Lost to Follow-up|1|||
44260059|NCT01276457|79124687|FG001|Extension Study|Death|1|||
44260060|NCT01276457|79124686|FG000|Extension Study|Lack of Efficacy|3|||
44260061|NCT01276457|79124687|FG001|Extension Study|Lack of Efficacy|1|||
44344556|NCT01299389|79348512|FG001|Double-blind|Other|1|||
44344557|NCT01299389|79348513|FG002|Double-blind|Other|0|||
44344558|NCT01299389|79348514|FG003|Double-blind|Other|0|||
44344559|NCT01299389|79348511|FG000|Double-blind|"fail to meet study population criteria"|0|||
44260062|NCT01276379|79124777|FG000|Overall Study|Screening failure|40|||
44344560|NCT01299389|79348512|FG001|Double-blind|"fail to meet study population criteria"|1|||
44344561|NCT01299389|79348513|FG002|Double-blind|"fail to meet study population criteria"|0|||
44344562|NCT01299389|79348514|FG003|Double-blind|"fail to meet study population criteria"|0|||
44344563|NCT01299389|79348511|FG000|Post-observational|Other|0|||
44344564|NCT01299389|79348512|FG001|Post-observational|Other|0|||
44344565|NCT01299389|79348513|FG002|Post-observational|Other|12|||
44344566|NCT01299389|79348514|FG003|Post-observational|Other|6|||
44344567|NCT01298999|79348525|FG000|Overall Study|Physician Decision|0|||
44344568|NCT01298999|79348526|FG001|Overall Study|Physician Decision|1|||
44344569|NCT01298999|79348525|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
44344570|NCT01298999|79348526|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
44344571|NCT01007032|79348536|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
44344572|NCT01007032|79348537|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
44344573|NCT01007032|79348538|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
44344574|NCT01007032|79348539|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
44344575|NCT01007032|79348536|FG000|Overall Study|Withdrawal by Subject|0|||
44344576|NCT01007032|79348537|FG001|Overall Study|Withdrawal by Subject|0|||
44344577|NCT01007032|79348538|FG002|Overall Study|Withdrawal by Subject|0|||
44344578|NCT01007032|79348539|FG003|Overall Study|Withdrawal by Subject|1|||
44344579|NCT00976027|79348556|FG000|Overall Study|Serious Adverse Event|36|||
44344580|NCT00976027|79348557|FG001|Overall Study|Serious Adverse Event|17|||
44344581|NCT00976027|79348556|FG000|Overall Study|Adverse Event|0|||
44344582|NCT00976027|79348557|FG001|Overall Study|Adverse Event|2|||
44344583|NCT00976027|79348556|FG000|Overall Study|Protocol Violation|60|||
44344584|NCT00976027|79348557|FG001|Overall Study|Protocol Violation|27|||
44344585|NCT00976027|79348556|FG000|Overall Study|Lost to Follow-up|208|||
44344586|NCT00976027|79348557|FG001|Overall Study|Lost to Follow-up|103|||
44344587|NCT00976027|79348556|FG000|Overall Study|Withdrawal by Subject|107|||
44344588|NCT00976027|79348557|FG001|Overall Study|Withdrawal by Subject|66|||
44344589|NCT01298765|79348563|FG000|Titration Period|Adverse Event|26|||
44344590|NCT01298765|79348563|FG000|Titration Period|Death|1|||
44344591|NCT01298765|79348563|FG000|Titration Period|Lack of Efficacy|21|||
44344592|NCT01298765|79348563|FG000|Titration Period|Lost to Follow-up|9|||
44344593|NCT01298765|79348563|FG000|Titration Period|Physician Decision|1|||
44344594|NCT01298765|79348563|FG000|Titration Period|Withdrawal by Subject|10|||
44344595|NCT01298765|79348563|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
44344596|NCT01298765|79348563|FG000|Long-Term Treatment Period|Adverse Event|19|||
44344597|NCT01298765|79348563|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
44344598|NCT01298765|79348563|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
44344599|NCT01298765|79348563|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
44344600|NCT01298765|79348563|FG000|Long-Term Treatment Period|Physician Decision|1|||
44344601|NCT01298765|79348563|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
44344602|NCT00997438|79348570|FG000|Overall Study|Blood draw difficulty|2|||
44344603|NCT00997438|79348571|FG001|Overall Study|Blood draw difficulty|0|||
44344604|NCT00997438|79348572|FG002|Overall Study|Blood draw difficulty|1|||
44344605|NCT00997438|79348570|FG000|Overall Study|Withdrawal by Subject|1|||
44344606|NCT00997438|79348571|FG001|Overall Study|Withdrawal by Subject|1|||
44344607|NCT00997438|79348572|FG002|Overall Study|Withdrawal by Subject|0|||
44344608|NCT00997438|79348570|FG000|Overall Study|Exclusion criteria at visit 1|2|||
44160864|NCT02418819|78953513|FG000|Overall Study|Adverse Event|0|||
44160865|NCT02418819|78953514|FG001|Overall Study|Adverse Event|0|||
44260063|NCT03809663|79125073|FG000|Overall Study|Decision by sponsor|24|||
44260064|NCT03809663|79125074|FG001|Overall Study|Decision by sponsor|18|||
44260065|NCT03809663|79125075|FG002|Overall Study|Decision by sponsor|20|||
44260066|NCT03809663|79125076|FG003|Overall Study|Decision by sponsor|20|||
44260067|NCT03809663|79125077|FG004|Overall Study|Decision by sponsor|0|||
44260068|NCT03809663|79125078|FG005|Overall Study|Decision by sponsor|0|||
44260069|NCT03809663|79125073|FG000|Overall Study|Withdrawal by Subject|26|||
44260070|NCT03809663|79125074|FG001|Overall Study|Withdrawal by Subject|22|||
44260071|NCT03809663|79125075|FG002|Overall Study|Withdrawal by Subject|27|||
44260072|NCT03809663|79125076|FG003|Overall Study|Withdrawal by Subject|26|||
44260073|NCT03809663|79125077|FG004|Overall Study|Withdrawal by Subject|0|||
44260074|NCT03809663|79125078|FG005|Overall Study|Withdrawal by Subject|0|||
44260075|NCT03809663|79125073|FG000|Overall Study|Lost to Follow-up|1|||
44260076|NCT03809663|79125074|FG001|Overall Study|Lost to Follow-up|4|||
44260077|NCT03809663|79125075|FG002|Overall Study|Lost to Follow-up|1|||
44260078|NCT03809663|79125076|FG003|Overall Study|Lost to Follow-up|1|||
44260079|NCT03809663|79125077|FG004|Overall Study|Lost to Follow-up|0|||
44260080|NCT03809663|79125078|FG005|Overall Study|Lost to Follow-up|0|||
44260081|NCT00249821|79125140|FG000|Overall Study|Technical problem|0|||
44260082|NCT00249821|79125141|FG001|Overall Study|Technical problem|1|||
44344609|NCT00997438|79348571|FG001|Overall Study|Exclusion criteria at visit 1|2|||
44344610|NCT00997438|79348572|FG002|Overall Study|Exclusion criteria at visit 1|3|||
44344611|NCT00997126|79348583|FG000|Overall Study|Physician Decision|7|||
44344612|NCT00997126|79348584|FG001|Overall Study|Physician Decision|11|||
44344613|NCT01000636|79348590|FG000|Overall Study|Withdrawal by Subject|1|||
44344614|NCT01000636|79348590|FG000|Overall Study|Adverse Event|1|||
44260083|NCT00248651|79125216|FG000|Overall Study|Withdrawal by Subject|28|||
44344615|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Adverse Event|33|||
44344616|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
44344617|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
44344618|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
44344619|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Physician Decision|6|||
44344620|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
44344621|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
44344622|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
44344623|NCT00965419|79348594|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
44344624|NCT00965419|79348594|FG000|Follow-up Phase|Adverse Event|9|||
44344625|NCT00965419|79348594|FG000|Follow-up Phase|Protocol Violation|4|||
44344626|NCT00965419|79348594|FG000|Follow-up Phase|Withdrawal by Subject|8|||
44344627|NCT00965419|79348594|FG000|Follow-up Phase|Physician Decision|4|||
44344628|NCT00965419|79348594|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
44344629|NCT00965419|79348594|FG000|Follow-up Phase|Lack of Efficacy|28|||
44344630|NCT01000480|79348599|FG000|Induction Phase|Adverse Event|2|||
44344631|NCT01000480|79348599|FG000|Induction Phase|Lost to Follow-up|1|||
44344632|NCT01000480|79348599|FG000|Induction Phase|Physician Decision|1|||
44344633|NCT01000480|79348599|FG000|Induction Phase|Entry Criteria Not Met|3|||
44344634|NCT01000480|79348599|FG000|Concurrent Therapy Phase|Adverse Event|4|||
44344635|NCT01000480|79348599|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
44344636|NCT01000480|79348599|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
44344637|NCT01000480|79348599|FG000|Concurrent Therapy Phase|Physician Decision|1|||
44344638|NCT00965341|79348605|FG000|Overall Study|Withdrew consent|1|||
44344639|NCT00965341|79348606|FG001|Overall Study|Withdrew consent|5|||
44344640|NCT00965341|79348605|FG000|Overall Study|Lost to Follow-up|1|||
44344641|NCT00965341|79348606|FG001|Overall Study|Lost to Follow-up|0|||
44344642|NCT00965341|79348605|FG000|Overall Study|Transportation issues|4|||
44344643|NCT00965341|79348606|FG001|Overall Study|Transportation issues|3|||
44344644|NCT01175811|79348614|FG000|Overall Study|Adverse Event|1|||
44344645|NCT01175811|79348615|FG001|Overall Study|Adverse Event|1|||
44344646|NCT01175811|79348614|FG000|Overall Study|Entry criteria not met|3|||
44344647|NCT01175811|79348615|FG001|Overall Study|Entry criteria not met|1|||
44344648|NCT01175811|79348614|FG000|Overall Study|Lack of Efficacy|1|||
44344649|NCT01175811|79348615|FG001|Overall Study|Lack of Efficacy|0|||
44344650|NCT01175811|79348614|FG000|Overall Study|Lost to Follow-up|3|||
44344651|NCT01175811|79348615|FG001|Overall Study|Lost to Follow-up|2|||
44344652|NCT01175811|79348614|FG000|Overall Study|Physician Decision|1|||
44344653|NCT01175811|79348615|FG001|Overall Study|Physician Decision|1|||
44344654|NCT01175811|79348614|FG000|Overall Study|Protocol Violation|1|||
44344655|NCT01175811|79348615|FG001|Overall Study|Protocol Violation|2|||
44344656|NCT01175811|79348614|FG000|Overall Study|Withdrawal by Subject|6|||
44344657|NCT01175811|79348615|FG001|Overall Study|Withdrawal by Subject|7|||
44344658|NCT00965263|79348623|FG000|Overall Study|Physician Decision|2|||
44344659|NCT00965263|79348624|FG001|Overall Study|Physician Decision|0|||
44344660|NCT00965263|79348623|FG000|Overall Study|Family emergency|0|||
44344661|NCT00965263|79348624|FG001|Overall Study|Family emergency|1|||
44344662|NCT00965263|79348623|FG000|Overall Study|Protocol Violation|0|||
44344663|NCT00965263|79348624|FG001|Overall Study|Protocol Violation|2|||
44344664|NCT00965185|79348650|FG000|Overall Study|Lost to Follow-up|2|||
44344665|NCT00965185|79348651|FG001|Overall Study|Lost to Follow-up|0|||
44344666|NCT00965185|79348650|FG000|Overall Study|Withdrawal by Subject|0|||
44344667|NCT00965185|79348651|FG001|Overall Study|Withdrawal by Subject|1|||
44344668|NCT01174563|79348659|FG000|Overall Study|Progressive Disease|45|||
44344669|NCT01174563|79348659|FG000|Overall Study|Death|5|||
44344670|NCT01174563|79348659|FG000|Overall Study|Investigator's Discretion|5|||
44344671|NCT01174563|79348659|FG000|Overall Study|Participant Withdrew Consent|3|||
44344672|NCT01174563|79348659|FG000|Overall Study|Rash Adverse Event|1|||
44344673|NCT01174563|79348659|FG000|Overall Study|Sponsor's decision|1|||
44344674|NCT01298531|79348665|FG000|Overall Study|Lack of Efficacy|0|||
44344675|NCT01298531|79348666|FG001|Overall Study|Lack of Efficacy|1|||
44344676|NCT01298531|79348665|FG000|Overall Study|Lost to Follow-up|2|||
44344677|NCT01298531|79348666|FG001|Overall Study|Lost to Follow-up|0|||
44344678|NCT01298531|79348665|FG000|Overall Study|Protocol Violation|1|||
44344679|NCT01298531|79348666|FG001|Overall Study|Protocol Violation|1|||
44344680|NCT01298531|79348665|FG000|Overall Study|Adverse Event|4|||
44344681|NCT01298531|79348666|FG001|Overall Study|Adverse Event|3|||
44344682|NCT01298531|79348665|FG000|Overall Study|Does not meet entrance criteria|0|||
44344683|NCT01298531|79348666|FG001|Overall Study|Does not meet entrance criteria|1|||
44344684|NCT01298531|79348665|FG000|Overall Study|Other|2|||
44344685|NCT01298531|79348666|FG001|Overall Study|Other|1|||
44344686|NCT01174173|79348673|FG000|Overall Study|drug-drug interaction|1|||
44344687|NCT00964795|79348678|FG000|Overall Study|Withdrawal by Subject|79|||
44344688|NCT00964795|79348678|FG000|Overall Study|Adverse Event|12|||
44344689|NCT00964795|79348678|FG000|Overall Study|Death|14|||
44344690|NCT00964795|79348678|FG000|Overall Study|Lost to Follow-up|7|||
44344691|NCT00964795|79348678|FG000|Overall Study|Termination of Study by Sponsor|169|||
44344692|NCT00964795|79348678|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
44344693|NCT00964795|79348678|FG000|Overall Study|Other|23|||
44344694|NCT01173471|79348687|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44344695|NCT01173471|79348688|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
44344696|NCT01173471|79348689|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
44344697|NCT01173471|79348690|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
44344698|NCT01173471|79348687|FG000|Overall Study|Condition under investigation worsened|2|||
44344699|NCT01173471|79348688|FG001|Overall Study|Condition under investigation worsened|0|||
44344700|NCT01173471|79348689|FG002|Overall Study|Condition under investigation worsened|0|||
44344701|NCT01173471|79348690|FG003|Overall Study|Condition under investigation worsened|0|||
44344702|NCT01173471|79348687|FG000|Overall Study|Lost to Follow-up|0|||
44344703|NCT01173471|79348688|FG001|Overall Study|Lost to Follow-up|0|||
44344704|NCT01173471|79348689|FG002|Overall Study|Lost to Follow-up|1|||
44344705|NCT01173471|79348690|FG003|Overall Study|Lost to Follow-up|0|||
44344706|NCT01173471|79348687|FG000|Overall Study|Reason given as Other|0|||
44344707|NCT01173471|79348688|FG001|Overall Study|Reason given as Other|0|||
44344708|NCT01173471|79348689|FG002|Overall Study|Reason given as Other|1|||
44344709|NCT01173471|79348690|FG003|Overall Study|Reason given as Other|0|||
44344710|NCT01172847|79348700|FG000|Overall Study|Withdrawal by Subject|3|||
44344711|NCT00966355|79348713|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
44344712|NCT00966355|79348714|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
44344713|NCT00966355|79348715|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
44344714|NCT00966355|79348713|FG000|Overall Study|newly diagnosed advanced HCC|11|||
44344715|NCT00966355|79348714|FG001|Overall Study|newly diagnosed advanced HCC|12|||
44344716|NCT00966355|79348715|FG002|Overall Study|newly diagnosed advanced HCC|10|||
44344717|NCT00966355|79348713|FG000|Overall Study|Lost to Follow-up|5|||
44344718|NCT00966355|79348714|FG001|Overall Study|Lost to Follow-up|4|||
44344719|NCT00966355|79348715|FG002|Overall Study|Lost to Follow-up|3|||
44344720|NCT01172535|79348723|FG000|Overall Study|Death|3|||
44344721|NCT01172535|79348723|FG000|Overall Study|Withdrawal by Subject|2|||
44344722|NCT01172535|79348723|FG000|Overall Study|Lost to Follow-up|1|||
44344723|NCT01172535|79348723|FG000|Overall Study|Ineligible at study entry|1|||
44344724|NCT01172535|79348723|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
44344725|NCT00966277|79348732|FG000|Overall Study|Withdrawal by Subject|3|||
44344726|NCT00966277|79348733|FG001|Overall Study|Withdrawal by Subject|0|||
44344727|NCT00966277|79348732|FG000|Overall Study|Ineligible|1|||
44344728|NCT00966277|79348733|FG001|Overall Study|Ineligible|3|||
44344729|NCT00966277|79348732|FG000|Overall Study|Treatment Plan Changed|0|||
44344730|NCT00966277|79348733|FG001|Overall Study|Treatment Plan Changed|1|||
44344731|NCT01298141|79348739|FG000|Overall Study|Adverse Event|3|||
44344732|NCT01298141|79348739|FG000|Overall Study|Refusal of Required Study Procedures|1|||
44344733|NCT01298141|79348739|FG000|Overall Study|Withdrawal by Subject|6|||
44344734|NCT01298141|79348739|FG000|Overall Study|Termination of Study by the Investigator|5|||
44344735|NCT01298141|79348739|FG000|Overall Study|Other|5|||
44344736|NCT01298141|79348739|FG000|Overall Study|Lost to Follow-up|1|||
44344737|NCT01298141|79348739|FG000|Overall Study|Death|6|||
44344738|NCT01298141|79348739|FG000|Overall Study|Not treated|4|||
44344739|NCT01171989|79348746|FG000|Overall Study|Lost to Follow-up|0|||
44344740|NCT01171989|79348747|FG001|Overall Study|Lost to Follow-up|0|||
44344741|NCT01171989|79348748|FG002|Overall Study|Lost to Follow-up|1|||
44344742|NCT01297517|79348759|FG000|Overall Study|Adverse Event|21|||
44344743|NCT01297517|79348760|FG001|Overall Study|Adverse Event|7|||
44344744|NCT01297517|79348761|FG002|Overall Study|Adverse Event|16|||
44344745|NCT01297517|79348759|FG000|Overall Study|Lost to Follow-up|1|||
44344746|NCT01297517|79348760|FG001|Overall Study|Lost to Follow-up|0|||
44344747|NCT01297517|79348761|FG002|Overall Study|Lost to Follow-up|1|||
44344748|NCT01297517|79348759|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
44344749|NCT01297517|79348760|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
44344750|NCT01297517|79348761|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
44344751|NCT01297517|79348759|FG000|Overall Study|Noncompliance|1|||
44344752|NCT01297517|79348760|FG001|Overall Study|Noncompliance|0|||
44344753|NCT01297517|79348761|FG002|Overall Study|Noncompliance|0|||
44344754|NCT01297517|79348759|FG000|Overall Study|Protocol Violation|1|||
44344755|NCT01297517|79348760|FG001|Overall Study|Protocol Violation|1|||
44344756|NCT01297517|79348761|FG002|Overall Study|Protocol Violation|1|||
44344757|NCT01297517|79348759|FG000|Overall Study|Inadequate Control of IOP|1|||
44344758|NCT01297517|79348760|FG001|Overall Study|Inadequate Control of IOP|1|||
44344759|NCT01297517|79348761|FG002|Overall Study|Inadequate Control of IOP|2|||
44344760|NCT01171677|79348771|FG000|Overall Study|Withdrawal by Subject|0|||
44444731|NCT00187135|79452499|FG003|Visit One|Physician Decision|0|||
44344761|NCT01171677|79348772|FG001|Overall Study|Withdrawal by Subject|3|||
44344762|NCT01171677|79348771|FG000|Overall Study|Adverse Event|1|||
44344763|NCT01171677|79348772|FG001|Overall Study|Adverse Event|0|||
44344764|NCT01171677|79348771|FG000|Overall Study|completed <70% IntenSati classes|5|||
44344765|NCT01171677|79348772|FG001|Overall Study|completed <70% IntenSati classes|0|||
44344766|NCT01171521|79348778|FG000|Overall Study|Lost to Follow-up|5|||
44344767|NCT01171521|79348778|FG000|Overall Study|screen failure|1|||
44344768|NCT01296347|79348784|FG000|Allocation|Withdrawal by Subject|1|||
44344769|NCT01296347|79348785|FG001|Allocation|Withdrawal by Subject|2|||
44344770|NCT01296347|79348784|FG000|Allocation|Lack of Efficacy|1|||
44344771|NCT01296347|79348785|FG001|Allocation|Lack of Efficacy|2|||
44344772|NCT01296347|79348784|FG000|Allocation|not received infusion|1|||
44344773|NCT01296347|79348785|FG001|Allocation|not received infusion|0|||
44344774|NCT01296347|79348784|FG000|6 Week Follow up|Death|0|||
44344775|NCT01296347|79348785|FG001|6 Week Follow up|Death|1|||
44344776|NCT01296347|79348784|FG000|3 Month Follow up|Death|1|||
44344777|NCT01296347|79348785|FG001|3 Month Follow up|Death|0|||
44344778|NCT01296347|79348784|FG000|3 Month Follow up|Lost to Follow-up|0|||
44344779|NCT01296347|79348785|FG001|3 Month Follow up|Lost to Follow-up|1|||
44344780|NCT01296347|79348784|FG000|6 Month Follow up|Death|2|||
44344781|NCT01296347|79348785|FG001|6 Month Follow up|Death|1|||
44344782|NCT01296347|79348784|FG000|6 Month Follow up|Lost to Follow-up|0|||
44344783|NCT01296347|79348785|FG001|6 Month Follow up|Lost to Follow-up|1|||
44344784|NCT01296347|79348784|FG000|12 Month Follow up|Lost to Follow-up|3|||
44344785|NCT01296347|79348785|FG001|12 Month Follow up|Lost to Follow-up|1|||
44344786|NCT01296347|79348784|FG000|12 Month Follow up|Death|1|||
44344787|NCT01296347|79348785|FG001|12 Month Follow up|Death|1|||
44344788|NCT01296347|79348784|FG000|12 Month Follow up|Withdrawal by Subject|0|||
44344789|NCT01296347|79348785|FG001|12 Month Follow up|Withdrawal by Subject|1|||
44344790|NCT01296035|79348794|FG000|Overall Study|Withdrawal by Subject|1|||
44344791|NCT01294787|79348798|FG000|Period 1|Adverse Event|0|||
44344792|NCT01294787|79348799|FG001|Period 1|Adverse Event|0|||
44344793|NCT01294787|79348800|FG002|Period 1|Adverse Event|0|||
44344794|NCT01294787|79348801|FG003|Period 1|Adverse Event|0|||
44344795|NCT01294787|79348802|FG004|Period 1|Adverse Event|1|||
44344796|NCT01294787|79348803|FG005|Period 1|Adverse Event|0|||
44344797|NCT01294787|79348798|FG000|Period 1|Withdrawal by Subject|0|||
44344798|NCT01294787|79348799|FG001|Period 1|Withdrawal by Subject|0|||
44344799|NCT01294787|79348800|FG002|Period 1|Withdrawal by Subject|0|||
44344800|NCT01294787|79348801|FG003|Period 1|Withdrawal by Subject|1|||
44344801|NCT01294787|79348802|FG004|Period 1|Withdrawal by Subject|1|||
44344802|NCT01294787|79348803|FG005|Period 1|Withdrawal by Subject|1|||
44344803|NCT01294787|79348798|FG000|Period 1|Administrative problem|0|||
44344804|NCT01294787|79348799|FG001|Period 1|Administrative problem|0|||
44344805|NCT01294787|79348800|FG002|Period 1|Administrative problem|1|||
44344806|NCT01294787|79348801|FG003|Period 1|Administrative problem|0|||
44344807|NCT01294787|79348802|FG004|Period 1|Administrative problem|0|||
44344808|NCT01294787|79348803|FG005|Period 1|Administrative problem|1|||
44260084|NCT00248651|79125217|FG001|Overall Study|Withdrawal by Subject|40|||
44260085|NCT00248651|79125218|FG002|Overall Study|Withdrawal by Subject|32|||
44260086|NCT00248495|79125255|FG000|Overall Study|Withdrawal by Subject|1|||
44260087|NCT03802565|79125352|FG000|Overall Study|Adverse Event|0|||
44260088|NCT03802565|79125353|FG001|Overall Study|Adverse Event|1|||
44260089|NCT03802565|79125354|FG002|Overall Study|Adverse Event|2|||
44344809|NCT01294787|79348798|FG000|Period 2|Adverse Event|0|||
44344810|NCT01294787|79348799|FG001|Period 2|Adverse Event|3|||
44344811|NCT01294787|79348800|FG002|Period 2|Adverse Event|0|||
44344812|NCT01294787|79348801|FG003|Period 2|Adverse Event|1|||
44344813|NCT01294787|79348802|FG004|Period 2|Adverse Event|0|||
44344814|NCT01294787|79348803|FG005|Period 2|Adverse Event|0|||
44344815|NCT01294787|79348798|FG000|Period 2|No longer needs study drug|0|||
44344816|NCT01294787|79348799|FG001|Period 2|No longer needs study drug|0|||
44344817|NCT01294787|79348800|FG002|Period 2|No longer needs study drug|0|||
44344818|NCT01294787|79348801|FG003|Period 2|No longer needs study drug|1|||
44344819|NCT01294787|79348802|FG004|Period 2|No longer needs study drug|0|||
44344820|NCT01294787|79348803|FG005|Period 2|No longer needs study drug|0|||
44344821|NCT01294787|79348798|FG000|Period 3|Adverse Event|0|||
44444732|NCT00187135|79452500|FG004|Visit One|Physician Decision|0|||
44444733|NCT00187135|79452501|FG005|Visit One|Physician Decision|1|||
44160866|NCT02418819|78953515|FG002|Overall Study|Adverse Event|1|||
44260090|NCT03802565|79125355|FG003|Overall Study|Adverse Event|1|||
44260091|NCT03802565|79125356|FG004|Overall Study|Adverse Event|1|||
44260092|NCT03802565|79125352|FG000|Overall Study|Withdrawal by Subject|2|||
44260093|NCT03802565|79125353|FG001|Overall Study|Withdrawal by Subject|2|||
44344822|NCT01294787|79348799|FG001|Period 3|Adverse Event|0|||
44344823|NCT01294787|79348800|FG002|Period 3|Adverse Event|0|||
44344824|NCT01294787|79348801|FG003|Period 3|Adverse Event|0|||
44344825|NCT01294787|79348802|FG004|Period 3|Adverse Event|1|||
44344826|NCT01294787|79348803|FG005|Period 3|Adverse Event|0|||
44344827|NCT01294553|79348814|FG000|Overall Study|Duplicated Participants|1|||
44344828|NCT01294553|79348814|FG000|Overall Study|Protocol Violation|268|||
44344829|NCT01294397|79348819|FG000|Overall Study|Withdrawal by Subject|1|||
44344830|NCT01294397|79348819|FG000|Overall Study|Administrative Decision|1|||
44344831|NCT01293695|79348827|FG000|Overall Study|Withdrawal by Subject|7|||
44344832|NCT01293695|79348828|FG001|Overall Study|Withdrawal by Subject|1|||
44344833|NCT01293695|79348827|FG000|Overall Study|Lost to Follow-up|8|||
44344834|NCT01293695|79348828|FG001|Overall Study|Lost to Follow-up|6|||
44344835|NCT01293539|79348837|FG000|Overall Study|Physician Decision|1|||
44344836|NCT01292837|79348841|FG000|Overall Study|Adverse Event|1|||
44344837|NCT01292837|79348841|FG000|Overall Study|Further treatment determined|1|||
44344838|NCT00965731|79348847|FG000|Overall Study|Death|0|||
44344839|NCT00965731|79348848|FG001|Overall Study|Death|4|||
44344840|NCT00965731|79348847|FG000|Overall Study|Withdrawal by Subject|0|||
44344841|NCT00965731|79348848|FG001|Overall Study|Withdrawal by Subject|1|||
44344842|NCT00965731|79348847|FG000|Overall Study|Other|7|||
44344843|NCT00965731|79348848|FG001|Overall Study|Other|15|||
44344844|NCT00965575|79348861|FG000|Overall Study|subject unwillingness to swallow study c|1|||
44344845|NCT00965575|79348862|FG001|Overall Study|subject unwillingness to swallow study c|0|||
44344846|NCT00965497|79348870|FG000|Overall Study|Physician Decision|1|||
44344847|NCT00963937|79348877|FG000|Overall Study|Protocol Violation|1|||
44344848|NCT00963937|79348878|FG001|Overall Study|Protocol Violation|1|||
44344849|NCT00963937|79348879|FG002|Overall Study|Protocol Violation|0|||
44344850|NCT00963937|79348877|FG000|Overall Study|Physician Decision|18|||
44344851|NCT00963937|79348878|FG001|Overall Study|Physician Decision|10|||
44344852|NCT00963937|79348879|FG002|Overall Study|Physician Decision|4|||
44344853|NCT01170663|79348892|FG000|Overall Study|Lost to Follow-up|3|||
44344854|NCT01170663|79348893|FG001|Overall Study|Lost to Follow-up|9|||
44344855|NCT01170663|79348892|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
44344856|NCT01170663|79348893|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
44344857|NCT01170273|79348901|FG000|Overall Study|Lost to Follow-up|6|||
44344858|NCT01170273|79348902|FG001|Overall Study|Lost to Follow-up|8|||
44344859|NCT01170273|79348901|FG000|Overall Study|Protocol Violation|1|||
44344860|NCT01170273|79348902|FG001|Overall Study|Protocol Violation|0|||
44344861|NCT01170273|79348901|FG000|Overall Study|Death|1|||
44344862|NCT01170273|79348902|FG001|Overall Study|Death|0|||
44344863|NCT01170273|79348901|FG000|Overall Study|Adverse Event|0|||
44344864|NCT01170273|79348902|FG001|Overall Study|Adverse Event|1|||
44344865|NCT01170039|79348910|FG000|Overall Study|Withdrawal by Subject|5|||
44344866|NCT01170039|79348911|FG001|Overall Study|Withdrawal by Subject|3|||
44344867|NCT01170039|79348910|FG000|Overall Study|Lack of funding, drug not available|3|||
44344868|NCT01170039|79348911|FG001|Overall Study|Lack of funding, drug not available|3|||
44344869|NCT01169649|79348917|FG000|Overall Study|Patient Not Treated|3|||
44344870|NCT01169493|79348927|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
44344871|NCT01169493|79348928|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
44344872|NCT01169493|79348929|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
44344873|NCT01169493|79348930|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
44344874|NCT01169493|79348931|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
44344875|NCT01169493|79348932|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
44344876|NCT01169493|79348927|FG000|Period 3 (6 Months)|Adverse Event|0|||
44344877|NCT01169493|79348928|FG001|Period 3 (6 Months)|Adverse Event|1|||
44344878|NCT01169493|79348929|FG002|Period 3 (6 Months)|Adverse Event|0|||
44344879|NCT01169493|79348930|FG003|Period 3 (6 Months)|Adverse Event|0|||
44344880|NCT01169493|79348931|FG004|Period 3 (6 Months)|Adverse Event|0|||
44344881|NCT01169493|79348932|FG005|Period 3 (6 Months)|Adverse Event|0|||
44344882|NCT01169493|79348927|FG000|Period 3 (6 Months)|Physician Decision|0|||
44344883|NCT01169493|79348928|FG001|Period 3 (6 Months)|Physician Decision|1|||
44344884|NCT01169493|79348929|FG002|Period 3 (6 Months)|Physician Decision|1|||
44344885|NCT01169493|79348930|FG003|Period 3 (6 Months)|Physician Decision|0|||
44344886|NCT01169493|79348931|FG004|Period 3 (6 Months)|Physician Decision|0|||
44344887|NCT01169493|79348932|FG005|Period 3 (6 Months)|Physician Decision|0|||
44344888|NCT01287104|79348944|FG000|Overall Study|Patient developed progressive disease|1|||
44344889|NCT01287104|79348945|FG001|Overall Study|Patient developed progressive disease|1|||
44344890|NCT01287104|79348946|FG002|Overall Study|Patient developed progressive disease|3|||
44344891|NCT01287104|79348947|FG003|Overall Study|Patient developed progressive disease|2|||
44344892|NCT01287104|79348944|FG000|Overall Study|Donor anaphylaxis|0|||
44344893|NCT01287104|79348945|FG001|Overall Study|Donor anaphylaxis|1|||
44344894|NCT01287104|79348946|FG002|Overall Study|Donor anaphylaxis|0|||
44344895|NCT01287104|79348947|FG003|Overall Study|Donor anaphylaxis|1|||
44344896|NCT01287104|79348944|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
44344897|NCT01287104|79348945|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
44444734|NCT00187135|79452496|FG000|Visit Two|Death|0|||
44344898|NCT01287104|79348946|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
44344899|NCT01287104|79348947|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
44344900|NCT01287104|79348944|FG000|Overall Study|Low donor chimerism|0|||
44344901|NCT01287104|79348945|FG001|Overall Study|Low donor chimerism|1|||
44344902|NCT01287104|79348946|FG002|Overall Study|Low donor chimerism|0|||
44344903|NCT01287104|79348947|FG003|Overall Study|Low donor chimerism|0|||
44344904|NCT01287104|79348944|FG000|Overall Study|NK cells did not meet release criteria|0|||
44344905|NCT01287104|79348945|FG001|Overall Study|NK cells did not meet release criteria|1|||
44344906|NCT01287104|79348946|FG002|Overall Study|NK cells did not meet release criteria|0|||
44344907|NCT01287104|79348947|FG003|Overall Study|NK cells did not meet release criteria|0|||
44344908|NCT01286558|79348966|FG000|Overall Study|Adverse Event|1|||
44344909|NCT01286558|79348967|FG001|Overall Study|Adverse Event|1|||
44344910|NCT01286558|79348966|FG000|Overall Study|Withdrawal by Subject|0|||
44344911|NCT01286558|79348967|FG001|Overall Study|Withdrawal by Subject|1|||
44344912|NCT01169103|79348975|FG000|Overall Study|Lost to Follow-up|3|||
44344913|NCT01169103|79348976|FG001|Overall Study|Lost to Follow-up|3|||
44344914|NCT01169103|79348975|FG000|Overall Study|Withdrawal by Subject|3|||
44344915|NCT01169103|79348976|FG001|Overall Study|Withdrawal by Subject|1|||
44344916|NCT01286480|79348984|FG000|Overall Study|Withdrawal by Subject|5|||
44344917|NCT01286480|79348985|FG001|Overall Study|Withdrawal by Subject|3|||
44344918|NCT01286168|79348991|FG000|Overall Study|Withdrawal by Subject|1|||
44344919|NCT01286168|79348991|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
44344920|NCT01286012|79348998|FG000|Overall Study|Adverse Event|3|||
44344921|NCT01286012|79348999|FG001|Overall Study|Adverse Event|3|||
44344922|NCT01286012|79348998|FG000|Overall Study|Death|2|||
44344923|NCT01286012|79348999|FG001|Overall Study|Death|3|||
44344924|NCT01286012|79348998|FG000|Overall Study|Protocol Violation|1|||
44344925|NCT01286012|79348999|FG001|Overall Study|Protocol Violation|1|||
44344926|NCT01286012|79348998|FG000|Overall Study|Withdrawal by Subject|4|||
44344927|NCT01286012|79348999|FG001|Overall Study|Withdrawal by Subject|4|||
44344928|NCT01286012|79348998|FG000|Overall Study|Physician Decision|2|||
44344929|NCT01286012|79348999|FG001|Overall Study|Physician Decision|0|||
44344930|NCT01286012|79348998|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
44344931|NCT01286012|79348999|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
44344932|NCT00963547|79349010|FG000|Overall Study|Adverse Event|0|||
44344933|NCT00963547|79349011|FG001|Overall Study|Adverse Event|1|||
44344934|NCT00963547|79349012|FG002|Overall Study|Adverse Event|0|||
44344935|NCT00963547|79349013|FG003|Overall Study|Adverse Event|1|||
44344936|NCT00963547|79349014|FG004|Overall Study|Adverse Event|0|||
44344937|NCT00963547|79349015|FG005|Overall Study|Adverse Event|0|||
44344938|NCT00963547|79349016|FG006|Overall Study|Adverse Event|0|||
44344939|NCT00963547|79349010|FG000|Overall Study|Physician Decision|1|||
44344940|NCT00963547|79349011|FG001|Overall Study|Physician Decision|1|||
44344941|NCT00963547|79349012|FG002|Overall Study|Physician Decision|0|||
44344942|NCT00963547|79349013|FG003|Overall Study|Physician Decision|0|||
44344943|NCT00963547|79349014|FG004|Overall Study|Physician Decision|0|||
44344944|NCT00963547|79349015|FG005|Overall Study|Physician Decision|0|||
44344945|NCT00963547|79349016|FG006|Overall Study|Physician Decision|0|||
44344946|NCT00963547|79349010|FG000|Overall Study|Progressive Disease|3|||
44344947|NCT00963547|79349011|FG001|Overall Study|Progressive Disease|8|||
44344948|NCT00963547|79349012|FG002|Overall Study|Progressive Disease|9|||
44344949|NCT00963547|79349013|FG003|Overall Study|Progressive Disease|5|||
44344950|NCT00963547|79349014|FG004|Overall Study|Progressive Disease|0|||
44344951|NCT00963547|79349015|FG005|Overall Study|Progressive Disease|0|||
44444735|NCT00187135|79452497|FG001|Visit Two|Death|0|||
44444736|NCT00187135|79452498|FG002|Visit Two|Death|0|||
44444737|NCT00187135|79452499|FG003|Visit Two|Death|1|||
44444738|NCT00187135|79452500|FG004|Visit Two|Death|0|||
44444739|NCT00187135|79452501|FG005|Visit Two|Death|1|||
44444740|NCT00187135|79452496|FG000|Visit Two|Physician Decision|1|||
44444741|NCT00187135|79452497|FG001|Visit Two|Physician Decision|0|||
44444742|NCT00187135|79452498|FG002|Visit Two|Physician Decision|0|||
44444743|NCT00187135|79452499|FG003|Visit Two|Physician Decision|0|||
44444744|NCT00187135|79452500|FG004|Visit Two|Physician Decision|0|||
44444745|NCT00187135|79452501|FG005|Visit Two|Physician Decision|0|||
44444746|NCT00187135|79452496|FG000|Visit Two|Withdrawal by Subject|1|||
44444747|NCT00187135|79452497|FG001|Visit Two|Withdrawal by Subject|1|||
44444748|NCT00187135|79452498|FG002|Visit Two|Withdrawal by Subject|1|||
44444749|NCT00187135|79452499|FG003|Visit Two|Withdrawal by Subject|0|||
44444750|NCT00187135|79452500|FG004|Visit Two|Withdrawal by Subject|1|||
44444751|NCT00187135|79452501|FG005|Visit Two|Withdrawal by Subject|1|||
44444752|NCT00187135|79452496|FG000|Visit Two|Study Discontinued|3|||
44444753|NCT00187135|79452497|FG001|Visit Two|Study Discontinued|2|||
44444754|NCT00187135|79452498|FG002|Visit Two|Study Discontinued|1|||
44444755|NCT00187135|79452499|FG003|Visit Two|Study Discontinued|7|||
44444756|NCT00187135|79452500|FG004|Visit Two|Study Discontinued|5|||
44444757|NCT00187135|79452501|FG005|Visit Two|Study Discontinued|6|||
44444758|NCT00187135|79452496|FG000|Visit Three|Death|0|||
44444759|NCT00187135|79452497|FG001|Visit Three|Death|0|||
44444760|NCT00187135|79452498|FG002|Visit Three|Death|1|||
44444761|NCT00187135|79452499|FG003|Visit Three|Death|0|||
44444762|NCT00187135|79452500|FG004|Visit Three|Death|1|||
44444763|NCT00187135|79452501|FG005|Visit Three|Death|0|||
44444764|NCT00187135|79452496|FG000|Visit Three|Withdrawal by Subject|0|||
44444765|NCT00187135|79452497|FG001|Visit Three|Withdrawal by Subject|1|||
44444766|NCT00187135|79452498|FG002|Visit Three|Withdrawal by Subject|1|||
44444767|NCT00187135|79452499|FG003|Visit Three|Withdrawal by Subject|2|||
44444768|NCT00187135|79452500|FG004|Visit Three|Withdrawal by Subject|0|||
44444769|NCT00187135|79452501|FG005|Visit Three|Withdrawal by Subject|0|||
44444770|NCT00187135|79452496|FG000|Visit Three|Study Discontinued|7|||
44444771|NCT00187135|79452497|FG001|Visit Three|Study Discontinued|6|||
44444772|NCT00187135|79452498|FG002|Visit Three|Study Discontinued|7|||
44444773|NCT00187135|79452499|FG003|Visit Three|Study Discontinued|7|||
44444774|NCT00187135|79452500|FG004|Visit Three|Study Discontinued|7|||
44344952|NCT00963547|79349016|FG006|Overall Study|Progressive Disease|0|||
44344953|NCT00963547|79349010|FG000|Overall Study|Withdrawal by Subject|0|||
44344954|NCT00963547|79349011|FG001|Overall Study|Withdrawal by Subject|0|||
44344955|NCT00963547|79349012|FG002|Overall Study|Withdrawal by Subject|3|||
44344956|NCT00963547|79349013|FG003|Overall Study|Withdrawal by Subject|0|||
44344957|NCT00963547|79349014|FG004|Overall Study|Withdrawal by Subject|0|||
44344958|NCT00963547|79349015|FG005|Overall Study|Withdrawal by Subject|0|||
44344959|NCT00963547|79349016|FG006|Overall Study|Withdrawal by Subject|0|||
44344960|NCT00963547|79349010|FG000|Overall Study|Reason Unknown|0|||
44344961|NCT00963547|79349011|FG001|Overall Study|Reason Unknown|1|||
44344962|NCT00963547|79349012|FG002|Overall Study|Reason Unknown|0|||
44344963|NCT00963547|79349013|FG003|Overall Study|Reason Unknown|0|||
44344964|NCT00963547|79349014|FG004|Overall Study|Reason Unknown|0|||
44344965|NCT00963547|79349015|FG005|Overall Study|Reason Unknown|0|||
44344966|NCT00963547|79349016|FG006|Overall Study|Reason Unknown|0|||
44344967|NCT01285310|79349032|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
44344968|NCT01285310|79349033|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
44344969|NCT01285310|79349034|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
44344970|NCT01285310|79349035|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
44344971|NCT01285310|79349036|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
44344972|NCT01285310|79349032|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
44344973|NCT01285310|79349033|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
44344974|NCT01285310|79349034|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
44344975|NCT01285310|79349035|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
44344976|NCT01285310|79349036|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
44344977|NCT01285310|79349032|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
44344978|NCT01285310|79349033|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
44344979|NCT01285310|79349034|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
44344980|NCT01285310|79349035|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
44344981|NCT01285310|79349036|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
44344982|NCT01285310|79349032|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
44344983|NCT01285310|79349033|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
44344984|NCT01285310|79349034|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
44344985|NCT01285310|79349035|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
44344986|NCT01285310|79349036|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
44344987|NCT01285310|79349032|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
44344988|NCT01285310|79349033|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
44344989|NCT01285310|79349034|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
44344990|NCT01285310|79349035|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
44344991|NCT01285310|79349036|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
44344992|NCT01285310|79349032|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
44344993|NCT01285310|79349033|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
44344994|NCT01285310|79349034|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
44344995|NCT01285310|79349035|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
44344996|NCT01285310|79349036|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
44344997|NCT01285310|79349032|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
44344998|NCT01285310|79349033|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
44344999|NCT01285310|79349034|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
44345000|NCT01285310|79349035|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
44345001|NCT01285310|79349036|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
44345002|NCT01285310|79349032|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
44345003|NCT01285310|79349033|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
44345004|NCT01285310|79349034|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
44345005|NCT01285310|79349035|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
44345006|NCT01285310|79349036|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
44345007|NCT01285310|79349032|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
44345008|NCT01285310|79349033|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
44345009|NCT01285310|79349034|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
44345010|NCT01285310|79349035|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
44345011|NCT01285310|79349036|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
44345012|NCT01285310|79349032|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
44345013|NCT01285310|79349033|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
44345014|NCT01285310|79349034|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
44345015|NCT01285310|79349035|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
44345016|NCT01285310|79349036|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
44345017|NCT01285310|79349032|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
44444775|NCT00187135|79452501|FG005|Visit Three|Study Discontinued|6|||
44444776|NCT00528021|79452517|FG000|Overall Study|Lack of Efficacy|17|||
44444777|NCT00528021|79452518|FG001|Overall Study|Lack of Efficacy|13|||
44345018|NCT01285310|79349033|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
44345019|NCT01285310|79349034|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
44345020|NCT01285310|79349035|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
44444778|NCT00528021|79452519|FG002|Overall Study|Lack of Efficacy|7|||
44444779|NCT00528021|79452520|FG003|Overall Study|Lack of Efficacy|9|||
44444780|NCT00560352|79452533|FG000|Overall Study|Adverse event unrelated to study drug|2|||
44444781|NCT00560352|79452534|FG001|Overall Study|Adverse event unrelated to study drug|1|||
44444782|NCT00560352|79452535|FG002|Overall Study|Adverse event unrelated to study drug|1|||
44444783|NCT00560352|79452533|FG000|Overall Study|Study drug toxicity|3|||
44444784|NCT00560352|79452534|FG001|Overall Study|Study drug toxicity|0|||
44345021|NCT01285310|79349036|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
44345022|NCT01285310|79349032|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
44345023|NCT01285310|79349033|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
44444785|NCT00560352|79452535|FG002|Overall Study|Study drug toxicity|1|||
44444786|NCT00560352|79452533|FG000|Overall Study|Disease progression|0|||
44444787|NCT00560352|79452534|FG001|Overall Study|Disease progression|1|||
44444788|NCT00560352|79452535|FG002|Overall Study|Disease progression|1|||
44444789|NCT00560352|79452533|FG000|Overall Study|Withdrawal by Subject|1|||
44444790|NCT00560352|79452534|FG001|Overall Study|Withdrawal by Subject|1|||
44444791|NCT00560352|79452535|FG002|Overall Study|Withdrawal by Subject|1|||
44444792|NCT00560352|79452533|FG000|Overall Study|Maximum clinical benefit|1|||
44444793|NCT00560352|79452534|FG001|Overall Study|Maximum clinical benefit|0|||
44444794|NCT00560352|79452535|FG002|Overall Study|Maximum clinical benefit|0|||
44444795|NCT00527787|79452549|FG000|Overall Study|Adverse Event|14|||
44345024|NCT01285310|79349034|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
44345025|NCT01285310|79349035|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
44345026|NCT01285310|79349036|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
44345027|NCT01254630|79349078|FG000|Overall Study|Adverse Event|36|||
44345028|NCT01254630|79349079|FG001|Overall Study|Adverse Event|15|||
44345029|NCT01254630|79349080|FG002|Overall Study|Adverse Event|40|||
44345030|NCT01254630|79349081|FG003|Overall Study|Adverse Event|8|||
44345031|NCT01254630|79349078|FG000|Overall Study|Death|461|||
44345032|NCT01254630|79349079|FG001|Overall Study|Death|151|||
44345033|NCT01254630|79349080|FG002|Overall Study|Death|478|||
44345034|NCT01254630|79349081|FG003|Overall Study|Death|139|||
44345035|NCT01254630|79349078|FG000|Overall Study|Lost to Follow-up|80|||
44345036|NCT01254630|79349079|FG001|Overall Study|Lost to Follow-up|26|||
44345037|NCT01254630|79349080|FG002|Overall Study|Lost to Follow-up|89|||
44345038|NCT01254630|79349081|FG003|Overall Study|Lost to Follow-up|32|||
44345039|NCT01254630|79349078|FG000|Overall Study|Physician Decision|24|||
44345040|NCT01254630|79349079|FG001|Overall Study|Physician Decision|8|||
44345041|NCT01254630|79349080|FG002|Overall Study|Physician Decision|16|||
44345042|NCT01254630|79349081|FG003|Overall Study|Physician Decision|7|||
44345043|NCT01254630|79349078|FG000|Overall Study|Withdrawal by Subject|201|||
44345044|NCT01254630|79349079|FG001|Overall Study|Withdrawal by Subject|94|||
44345045|NCT01254630|79349080|FG002|Overall Study|Withdrawal by Subject|188|||
44345046|NCT01254630|79349081|FG003|Overall Study|Withdrawal by Subject|89|||
44345047|NCT01254630|79349078|FG000|Overall Study|Study terminated by sponsor|0|||
44345048|NCT01254630|79349079|FG001|Overall Study|Study terminated by sponsor|994|||
44345049|NCT01254630|79349080|FG002|Overall Study|Study terminated by sponsor|0|||
44345050|NCT01254630|79349081|FG003|Overall Study|Study terminated by sponsor|1010|||
44345051|NCT01254630|79349078|FG000|Overall Study|Status not recorded|0|||
44345052|NCT01254630|79349079|FG001|Overall Study|Status not recorded|0|||
44345053|NCT01254630|79349080|FG002|Overall Study|Status not recorded|1|||
44345054|NCT01254630|79349081|FG003|Overall Study|Status not recorded|0|||
44444796|NCT00527787|79452550|FG001|Overall Study|Adverse Event|24|||
44444797|NCT00527787|79452549|FG000|Overall Study|Withdrawal by Subject|13|||
44444798|NCT00527787|79452550|FG001|Overall Study|Withdrawal by Subject|25|||
44444799|NCT00527787|79452549|FG000|Overall Study|Lost to Follow-up|5|||
44444800|NCT00527787|79452550|FG001|Overall Study|Lost to Follow-up|2|||
44444801|NCT00527787|79452549|FG000|Overall Study|Duodenal Ulcer|1|||
44444802|NCT00527787|79452550|FG001|Overall Study|Duodenal Ulcer|10|||
44444803|NCT00527787|79452549|FG000|Overall Study|misc|5|||
44444804|NCT00527787|79452550|FG001|Overall Study|misc|2|||
44444805|NCT00608426|79452558|FG000|Overall Study|Death|32|||
44444806|NCT00608426|79452559|FG001|Overall Study|Death|36|||
44444807|NCT00608426|79452558|FG000|Overall Study|Lost to Follow-up|485|||
44444808|NCT00608426|79452559|FG001|Overall Study|Lost to Follow-up|521|||
44444809|NCT00608426|79452558|FG000|Overall Study|refused, health issues, wrong address|319|||
44444810|NCT00608426|79452559|FG001|Overall Study|refused, health issues, wrong address|348|||
44444811|NCT00557076|79452567|FG000|Overall Study|Unblinding|0|||
44444812|NCT00557076|79452568|FG001|Overall Study|Unblinding|1|||
44444813|NCT00129259|79452576|FG000|Overall Study|Lost to Follow-up|1|||
44444814|NCT00129259|79452577|FG001|Overall Study|Lost to Follow-up|1|||
44444815|NCT00129259|79452576|FG000|Overall Study|Withdrawal by Subject|2|||
44260094|NCT03802565|79125354|FG002|Overall Study|Withdrawal by Subject|2|||
44260095|NCT03802565|79125355|FG003|Overall Study|Withdrawal by Subject|0|||
44260096|NCT03802565|79125356|FG004|Overall Study|Withdrawal by Subject|1|||
44260097|NCT03802565|79125352|FG000|Overall Study|Protocol Violation|2|||
44260098|NCT03802565|79125353|FG001|Overall Study|Protocol Violation|1|||
44260099|NCT03802565|79125354|FG002|Overall Study|Protocol Violation|4|||
44260100|NCT03802565|79125355|FG003|Overall Study|Protocol Violation|5|||
44260101|NCT03802565|79125356|FG004|Overall Study|Protocol Violation|1|||
44260102|NCT03802565|79125352|FG000|Overall Study|Lost to Follow-up|0|||
44260103|NCT03802565|79125353|FG001|Overall Study|Lost to Follow-up|0|||
44260104|NCT03802565|79125354|FG002|Overall Study|Lost to Follow-up|1|||
44260105|NCT03802565|79125355|FG003|Overall Study|Lost to Follow-up|0|||
44260106|NCT03802565|79125356|FG004|Overall Study|Lost to Follow-up|0|||
44260107|NCT03802565|79125352|FG000|Overall Study|Subjects Related to Each Other|1|||
44260108|NCT03802565|79125353|FG001|Overall Study|Subjects Related to Each Other|0|||
44260109|NCT03802565|79125354|FG002|Overall Study|Subjects Related to Each Other|0|||
44260110|NCT03802565|79125355|FG003|Overall Study|Subjects Related to Each Other|2|||
44260111|NCT03802565|79125356|FG004|Overall Study|Subjects Related to Each Other|1|||
44260112|NCT03802565|79125352|FG000|Overall Study|Elevated Enzymes|0|||
44260113|NCT03802565|79125353|FG001|Overall Study|Elevated Enzymes|0|||
44260114|NCT03802565|79125354|FG002|Overall Study|Elevated Enzymes|0|||
44260115|NCT03802565|79125355|FG003|Overall Study|Elevated Enzymes|0|||
44260116|NCT03802565|79125356|FG004|Overall Study|Elevated Enzymes|2|||
44260117|NCT00245765|79125400|FG000|Overall Study|Adverse Event|1|||
44260118|NCT00245765|79125401|FG001|Overall Study|Adverse Event|1|||
44260119|NCT00245765|79125402|FG002|Overall Study|Adverse Event|0|||
44260120|NCT00245765|79125400|FG000|Overall Study|Lack of Efficacy|14|||
44260121|NCT00245765|79125401|FG001|Overall Study|Lack of Efficacy|7|||
44260122|NCT00245765|79125402|FG002|Overall Study|Lack of Efficacy|0|||
44260123|NCT00245765|79125400|FG000|Overall Study|Lost to Follow-up|1|||
44260124|NCT00245765|79125401|FG001|Overall Study|Lost to Follow-up|2|||
44260125|NCT00245765|79125402|FG002|Overall Study|Lost to Follow-up|0|||
44260126|NCT00245765|79125400|FG000|Overall Study|Withdrawal by Subject|1|||
44260127|NCT00245765|79125401|FG001|Overall Study|Withdrawal by Subject|0|||
44260128|NCT00245765|79125402|FG002|Overall Study|Withdrawal by Subject|3|||
44260129|NCT00245765|79125400|FG000|Overall Study|Other reason|2|||
44260130|NCT00245765|79125401|FG001|Overall Study|Other reason|0|||
44260131|NCT00245765|79125402|FG002|Overall Study|Other reason|1|||
44260132|NCT00245765|79125400|FG000|Overall Study|Other|13|||
44260133|NCT00245765|79125401|FG001|Overall Study|Other|4|||
44260134|NCT00245765|79125402|FG002|Overall Study|Other|4|||
44260135|NCT00245063|79125474|FG000|Overall Study|Adverse Event|6|||
44260136|NCT00245063|79125475|FG001|Overall Study|Adverse Event|5|||
44260137|NCT00245063|79125474|FG000|Overall Study|Death|1|||
44260138|NCT00245063|79125475|FG001|Overall Study|Death|0|||
44260139|NCT04329091|79125540|FG000|Overall Study|Physician Decision|5|||
44260140|NCT00244751|79125547|FG000|Overall Study|Adverse Event|7|||
44260141|NCT00244751|79125548|FG001|Overall Study|Adverse Event|7|||
44260142|NCT00244751|79125549|FG002|Overall Study|Adverse Event|5|||
44260143|NCT00244751|79125547|FG000|Overall Study|Lost to Follow-up|0|||
44260144|NCT00244751|79125548|FG001|Overall Study|Lost to Follow-up|1|||
44444816|NCT00129259|79452577|FG001|Overall Study|Withdrawal by Subject|1|||
44444817|NCT00129259|79452576|FG000|Overall Study|Only available minimal phone assessments|0|||
44444818|NCT00129259|79452577|FG001|Overall Study|Only available minimal phone assessments|1|||
44160867|NCT02418819|78953516|FG003|Overall Study|Adverse Event|0|||
44260145|NCT00244751|79125549|FG002|Overall Study|Lost to Follow-up|0|||
44260146|NCT00244751|79125547|FG000|Overall Study|Protocol Violation|1|||
44260147|NCT00244751|79125548|FG001|Overall Study|Protocol Violation|0|||
44260148|NCT00244751|79125549|FG002|Overall Study|Protocol Violation|1|||
44444819|NCT00186901|79452586|FG000|Overall Study|Pregnancy|6|||
44444820|NCT00186901|79452587|FG001|Overall Study|Pregnancy|3|||
44444821|NCT00186901|79452588|FG002|Overall Study|Pregnancy|0|||
44444822|NCT00186901|79452586|FG000|Overall Study|Lost to Follow-up|6|||
44444823|NCT00186901|79452587|FG001|Overall Study|Lost to Follow-up|3|||
44444824|NCT00186901|79452588|FG002|Overall Study|Lost to Follow-up|0|||
44444825|NCT00186901|79452586|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
44444826|NCT00186901|79452587|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
44444827|NCT00186901|79452588|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
44444828|NCT00186901|79452586|FG000|Overall Study|ALL relapse or second malignancy|1|||
44444829|NCT00186901|79452587|FG001|Overall Study|ALL relapse or second malignancy|2|||
44444830|NCT00186901|79452588|FG002|Overall Study|ALL relapse or second malignancy|0|||
44444831|NCT00186901|79452586|FG000|Overall Study|Withdrawal by Subject|4|||
44444832|NCT00186901|79452587|FG001|Overall Study|Withdrawal by Subject|5|||
44444833|NCT00186901|79452588|FG002|Overall Study|Withdrawal by Subject|0|||
44444834|NCT00186901|79452586|FG000|Overall Study|Open label|3|||
44444835|NCT00186901|79452587|FG001|Overall Study|Open label|2|||
44444836|NCT00186901|79452588|FG002|Overall Study|Open label|0|||
44444837|NCT00186901|79452586|FG000|Overall Study|Limited adherence to study requirements|20|||
44444838|NCT00186901|79452587|FG001|Overall Study|Limited adherence to study requirements|23|||
44444839|NCT00186901|79452588|FG002|Overall Study|Limited adherence to study requirements|0|||
44444840|NCT00186901|79452586|FG000|Overall Study|Bone Mineral Density > 0|0|||
44444841|NCT00186901|79452587|FG001|Overall Study|Bone Mineral Density > 0|0|||
44444842|NCT00186901|79452588|FG002|Overall Study|Bone Mineral Density > 0|149|||
44444843|NCT00186121|79452625|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
44444844|NCT00186121|79452625|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
44444845|NCT00186121|79452625|FG000|Overall Study|Not eligible (no treatment)|1|||
44444846|NCT00186043|79452631|FG000|Overall Study|Lack of Efficacy|1|||
44444847|NCT00186043|79452632|FG001|Overall Study|Lack of Efficacy|3|||
44444848|NCT00186043|79452631|FG000|Overall Study|Lost to Follow-up|4|||
44444849|NCT00186043|79452632|FG001|Overall Study|Lost to Follow-up|6|||
44444850|NCT00186043|79452631|FG000|Overall Study|Withdrawal by Subject|1|||
44444851|NCT00186043|79452632|FG001|Overall Study|Withdrawal by Subject|0|||
44444852|NCT00186043|79452631|FG000|Overall Study|Adverse Event|7|||
44444853|NCT00186043|79452632|FG001|Overall Study|Adverse Event|3|||
44444854|NCT00186043|79452631|FG000|Overall Study|Protocol Violation|2|||
44444855|NCT00186043|79452632|FG001|Overall Study|Protocol Violation|1|||
44444856|NCT00185965|79452640|FG000|Overall Study|Adverse Event|0|||
44444857|NCT00185965|79452641|FG001|Overall Study|Adverse Event|1|||
44444858|NCT00607880|79452649|FG000|Overall Study|Unable to place port due to occlusion|1|||
44444859|NCT00607880|79452650|FG001|Overall Study|Unable to place port due to occlusion|0|||
44444860|NCT00127933|79452658|FG000|Overall Study|Randomized but not dosed|1|||
44444861|NCT00127933|79452659|FG001|Overall Study|Randomized but not dosed|0|||
44444862|NCT03875313|79452670|FG000|Overall Study|Withdrawal by Subject|1|||
44444863|NCT03875313|79452671|FG001|Overall Study|Withdrawal by Subject|3|||
44444864|NCT03875313|79452672|FG002|Overall Study|Withdrawal by Subject|0|||
44444865|NCT03875313|79452673|FG003|Overall Study|Withdrawal by Subject|0|||
44444866|NCT03875313|79452674|FG004|Overall Study|Withdrawal by Subject|0|||
44444867|NCT03875313|79452670|FG000|Overall Study|Death|0|||
44444868|NCT03875313|79452671|FG001|Overall Study|Death|0|||
44444869|NCT03875313|79452672|FG002|Overall Study|Death|0|||
44444870|NCT03875313|79452673|FG003|Overall Study|Death|0|||
44444871|NCT03875313|79452674|FG004|Overall Study|Death|1|||
44444872|NCT03875313|79452670|FG000|Overall Study|Lost to Follow-up|0|||
44444873|NCT03875313|79452671|FG001|Overall Study|Lost to Follow-up|0|||
44444874|NCT03875313|79452672|FG002|Overall Study|Lost to Follow-up|0|||
44444875|NCT03875313|79452673|FG003|Overall Study|Lost to Follow-up|0|||
44444876|NCT03875313|79452674|FG004|Overall Study|Lost to Follow-up|1|||
44444877|NCT03875313|79452670|FG000|Overall Study|Study Termination by Sponsor|0|||
44444878|NCT03875313|79452671|FG001|Overall Study|Study Termination by Sponsor|1|||
44444879|NCT03875313|79452672|FG002|Overall Study|Study Termination by Sponsor|1|||
44444880|NCT03875313|79452673|FG003|Overall Study|Study Termination by Sponsor|0|||
44444881|NCT03875313|79452674|FG004|Overall Study|Study Termination by Sponsor|1|||
44444882|NCT03875313|79452670|FG000|Overall Study|New Anticancer Treatment|0|||
44260149|NCT00244751|79125547|FG000|Overall Study|Withdrawal by Subject|7|||
44444883|NCT03875313|79452671|FG001|Overall Study|New Anticancer Treatment|1|||
44444884|NCT03875313|79452672|FG002|Overall Study|New Anticancer Treatment|2|||
44444885|NCT03875313|79452673|FG003|Overall Study|New Anticancer Treatment|1|||
44444886|NCT03875313|79452674|FG004|Overall Study|New Anticancer Treatment|0|||
44444887|NCT03875313|79452670|FG000|Overall Study|Other, Not Specified|2|||
44444888|NCT03875313|79452671|FG001|Overall Study|Other, Not Specified|11|||
44444889|NCT03875313|79452672|FG002|Overall Study|Other, Not Specified|3|||
44260150|NCT00244751|79125548|FG001|Overall Study|Withdrawal by Subject|5|||
44444890|NCT03875313|79452673|FG003|Overall Study|Other, Not Specified|3|||
44444891|NCT03875313|79452674|FG004|Overall Study|Other, Not Specified|1|||
44444892|NCT04796415|79452717|FG000|Overall Study|not interested|12|||
44444893|NCT04796415|79452717|FG000|Overall Study|health issue|8|||
44444894|NCT04796415|79452717|FG000|Overall Study|Other|4|||
44444895|NCT04796415|79452717|FG000|Overall Study|discharged from home health service|3|||
44444896|NCT04796415|79452717|FG000|Overall Study|re-hospitalization|2|||
44444897|NCT04796415|79452717|FG000|Overall Study|moving to nursing home|1|||
44444898|NCT04796415|79452717|FG000|Overall Study|lost contact|1|||
44444899|NCT04678557|79452724|FG000|Overall Study|Withdrawal by Subject|1|||
44444900|NCT04678557|79452725|FG001|Overall Study|Withdrawal by Subject|0|||
44444901|NCT04678557|79452724|FG000|Overall Study|Lack of Efficacy|0|||
44160868|NCT02418819|78953513|FG000|Overall Study|Lost to Follow-up|1|||
44345055|NCT01284140|79349091|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
44345056|NCT01284140|79349092|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
44345057|NCT01284140|79349091|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
44345058|NCT01284140|79349092|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
44345059|NCT01254318|79349098|FG000|Overall Study|Lost to Follow-up|5|||
44345060|NCT01254318|79349098|FG000|Overall Study|Death|47|||
44345061|NCT01284062|79349106|FG000|Overall Study|Adverse Event|4|||
44345062|NCT01284062|79349107|FG001|Overall Study|Adverse Event|5|||
44345063|NCT01284062|79349108|FG002|Overall Study|Adverse Event|0|||
44345064|NCT01284062|79349109|FG003|Overall Study|Adverse Event|5|||
44345065|NCT01284062|79349106|FG000|Overall Study|Lack of Efficacy|3|||
44345066|NCT01284062|79349107|FG001|Overall Study|Lack of Efficacy|2|||
44345067|NCT01284062|79349108|FG002|Overall Study|Lack of Efficacy|2|||
44345068|NCT01284062|79349109|FG003|Overall Study|Lack of Efficacy|1|||
44345069|NCT01284062|79349106|FG000|Overall Study|Medication error without adverse event|0|||
44345070|NCT01284062|79349107|FG001|Overall Study|Medication error without adverse event|0|||
44345071|NCT01284062|79349108|FG002|Overall Study|Medication error without adverse event|1|||
44345072|NCT01284062|79349109|FG003|Overall Study|Medication error without adverse event|0|||
44345073|NCT01284062|79349106|FG000|Overall Study|Protocol Violation|1|||
44160869|NCT02418819|78953514|FG001|Overall Study|Lost to Follow-up|0|||
44160870|NCT02418819|78953515|FG002|Overall Study|Lost to Follow-up|0|||
44160871|NCT02418819|78953516|FG003|Overall Study|Lost to Follow-up|0|||
44160872|NCT02418819|78953513|FG000|Overall Study|No longer meets eligibility criteria|0|||
44160873|NCT02418819|78953514|FG001|Overall Study|No longer meets eligibility criteria|0|||
44160874|NCT02418819|78953515|FG002|Overall Study|No longer meets eligibility criteria|1|||
44160875|NCT02418819|78953516|FG003|Overall Study|No longer meets eligibility criteria|0|||
44160876|NCT02418819|78953513|FG000|Overall Study|No longer willing to participate|0|||
44160877|NCT02418819|78953514|FG001|Overall Study|No longer willing to participate|0|||
44160878|NCT02418819|78953515|FG002|Overall Study|No longer willing to participate|2|||
44160879|NCT02418819|78953516|FG003|Overall Study|No longer willing to participate|1|||
44160880|NCT02576639|78953531|FG000|Overall Study|Withdrawal by Subject|1|||
44160881|NCT02576639|78953532|FG001|Overall Study|Withdrawal by Subject|2|||
44160882|NCT02576639|78953533|FG002|Overall Study|Withdrawal by Subject|1|||
44160883|NCT02576639|78953534|FG003|Overall Study|Withdrawal by Subject|0|||
44160884|NCT02576639|78953535|FG004|Overall Study|Withdrawal by Subject|1|||
44160885|NCT02576639|78953531|FG000|Overall Study|Adverse Event|1|||
44160886|NCT02576639|78953532|FG001|Overall Study|Adverse Event|0|||
44160887|NCT02576639|78953533|FG002|Overall Study|Adverse Event|1|||
44160888|NCT02576639|78953534|FG003|Overall Study|Adverse Event|1|||
44160889|NCT02576639|78953535|FG004|Overall Study|Adverse Event|2|||
44160890|NCT02576639|78953531|FG000|Overall Study|Physician Decision|0|||
44160891|NCT02576639|78953532|FG001|Overall Study|Physician Decision|0|||
44160892|NCT02576639|78953533|FG002|Overall Study|Physician Decision|0|||
44160893|NCT02576639|78953534|FG003|Overall Study|Physician Decision|0|||
44160894|NCT02576639|78953535|FG004|Overall Study|Physician Decision|1|||
44160895|NCT02418585|78953553|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
44160896|NCT02418585|78953554|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
44160897|NCT02418585|78953553|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
44160898|NCT02418585|78953554|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
44160899|NCT02418585|78953553|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
44160900|NCT02418585|78953554|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
44160901|NCT02418585|78953553|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
44160902|NCT02418585|78953554|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
44160903|NCT02418585|78953553|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
44160904|NCT02418585|78953554|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
44160905|NCT02418585|78953553|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
44160906|NCT02418585|78953554|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
44345074|NCT01284062|79349107|FG001|Overall Study|Protocol Violation|0|||
44345075|NCT01284062|79349108|FG002|Overall Study|Protocol Violation|0|||
44345076|NCT01284062|79349109|FG003|Overall Study|Protocol Violation|2|||
44444902|NCT04678557|79452725|FG001|Overall Study|Lack of Efficacy|13|||
44160907|NCT02418585|78953553|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
44160908|NCT02418585|78953554|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
44160909|NCT02418585|78953553|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
44260151|NCT00244751|79125549|FG002|Overall Study|Withdrawal by Subject|3|||
44260152|NCT00244751|79125547|FG000|Overall Study|Elevated liver enzymes|1|||
44260153|NCT00244751|79125548|FG001|Overall Study|Elevated liver enzymes|0|||
44260154|NCT00244751|79125549|FG002|Overall Study|Elevated liver enzymes|0|||
44260155|NCT00244751|79125547|FG000|Overall Study|Lack of compliance with protocol|0|||
44260156|NCT00244751|79125548|FG001|Overall Study|Lack of compliance with protocol|1|||
44260157|NCT00244751|79125549|FG002|Overall Study|Lack of compliance with protocol|0|||
44260158|NCT00244751|79125547|FG000|Overall Study|Safety reasons|0|||
44260159|NCT00244751|79125548|FG001|Overall Study|Safety reasons|1|||
44260160|NCT00244751|79125549|FG002|Overall Study|Safety reasons|0|||
44260161|NCT00244751|79125547|FG000|Overall Study|Participant randomized by mistake|0|||
44260162|NCT00244751|79125548|FG001|Overall Study|Participant randomized by mistake|0|||
44260163|NCT00244751|79125549|FG002|Overall Study|Participant randomized by mistake|1|||
44260164|NCT00243659|79125591|FG000|Overall Study|Withdrawal by Subject|1|||
44260165|NCT00243659|79125592|FG001|Overall Study|Withdrawal by Subject|1|||
44260166|NCT00243659|79125591|FG000|Overall Study|Protocol Violation|1|||
44260167|NCT00243659|79125592|FG001|Overall Study|Protocol Violation|2|||
44260168|NCT00243347|79125607|FG000|Overall Study|Lack of Efficacy|4|||
44260169|NCT00243347|79125607|FG000|Overall Study|Adverse Event|2|||
44260170|NCT00243347|79125607|FG000|Overall Study|Death|1|||
44160910|NCT02418585|78953554|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
44160911|NCT02418585|78953553|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
44160912|NCT02418585|78953554|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
44160913|NCT02418585|78953553|FG000|Follow-up Phase (24 Weeks)|Other|3|||
44160914|NCT02418585|78953554|FG001|Follow-up Phase (24 Weeks)|Other|2|||
44160915|NCT02417961|78953562|FG000|Overall Study|Adverse Event|1|||
44160916|NCT02417961|78953562|FG000|Overall Study|Lost to Follow-up|1|||
44160917|NCT02417961|78953562|FG000|Overall Study|Withdrawal by Subject|2|||
44160918|NCT01596127|78953566|FG000|Overall Study|Patient Ineligible|1|||
44160919|NCT01595581|78953572|FG000|Overall Study|Withdrawal by Subject|1|||
44160920|NCT01595581|78953573|FG001|Overall Study|Withdrawal by Subject|0|||
44160921|NCT01610687|78953581|FG000|Overall Study|Lack of Efficacy|26|||
44160922|NCT01610687|78953581|FG000|Overall Study|Adverse Event|18|||
44160923|NCT01610687|78953581|FG000|Overall Study|Moved out of area|6|||
44160924|NCT01610687|78953581|FG000|Overall Study|Withdrawal by Subject|7|||
44160925|NCT01610687|78953581|FG000|Overall Study|Lost to Follow-up|4|||
44160926|NCT01610687|78953581|FG000|Overall Study|Symptom control without study medication|2|||
44160927|NCT01610687|78953581|FG000|Overall Study|Unable to make journey|1|||
44160928|NCT01610687|78953581|FG000|Overall Study|Death|1|||
44160929|NCT01610687|78953581|FG000|Overall Study|Cannabis affecting job|1|||
44160930|NCT01610687|78953581|FG000|Overall Study|Felt more alter without study medication|1|||
44160931|NCT02615509|78953585|FG000|Overall Study|Lost to Follow-up|134|||
44160932|NCT02615509|78953585|FG000|Overall Study|Death|4|||
44160933|NCT02615509|78953585|FG000|Overall Study|Withdrawal by Subject|8|||
44160934|NCT02575079|78953591|FG000|Overall Study|Death|3|||
44160935|NCT02575079|78953592|FG001|Overall Study|Death|0|||
44160936|NCT02575079|78953591|FG000|Overall Study|Withdrawal by Subject|3|||
44160937|NCT02575079|78953592|FG001|Overall Study|Withdrawal by Subject|0|||
44160938|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Adverse Event|10|||
44160939|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Adverse Event|9|||
44160940|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Adverse Event|7|||
44160941|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
44160942|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
44160943|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
44160944|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
44160945|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
44160946|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
44160947|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Physician Decision|7|||
44160948|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Physician Decision|3|||
44160949|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Physician Decision|2|||
44160950|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Pregnancy|2|||
44160951|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Pregnancy|1|||
44160952|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Pregnancy|3|||
44160953|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
44160954|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
44160955|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
44160956|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
44160957|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
44160958|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
44160959|NCT02614183|78953600|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
44160960|NCT02614183|78953601|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
44160961|NCT02614183|78953602|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
44160962|NCT02614183|78953600|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
44160963|NCT02614183|78953601|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
44160964|NCT02614183|78953602|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
44160965|NCT02614183|78953600|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
44160966|NCT02614183|78953601|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
44160967|NCT02614183|78953602|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
44160968|NCT02614183|78953600|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
44160969|NCT02614183|78953601|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
44160970|NCT02614183|78953602|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
44160971|NCT02614183|78953600|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
44160972|NCT02614183|78953601|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
44160973|NCT02614183|78953602|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
44160974|NCT02612155|78953627|FG000|Overall Study|Death|1|||
44160975|NCT02612155|78953628|FG001|Overall Study|Death|1|||
44160976|NCT02612155|78953627|FG000|Overall Study|Lost to Follow-up|2|||
44160977|NCT02612155|78953628|FG001|Overall Study|Lost to Follow-up|2|||
44160978|NCT02614729|78953636|FG000|Overall Study|Withdrawal by Subject|1|||
44160979|NCT02614729|78953637|FG001|Overall Study|Withdrawal by Subject|0|||
44160980|NCT02613871|78953645|FG000|Overall Study|Death|2|||
44160981|NCT02613871|78953645|FG000|Overall Study|Withdrew Consent|1|||
44160982|NCT05021081|78953651|FG000|Phase 2|Subject enrolled in error|1|||
44160983|NCT05021081|78953652|FG001|Phase 2|Subject enrolled in error|1|||
44160984|NCT05021081|78953653|FG002|Phase 2|Subject enrolled in error|0|||
44160985|NCT02612077|78953669|FG000|Overall Study|Adverse Event|3|||
44160986|NCT02612077|78953669|FG000|Overall Study|Withdrawal by Subject|9|||
44160987|NCT02612077|78953669|FG000|Overall Study|Protocol Violation|28|||
44160988|NCT02612077|78953669|FG000|Overall Study|Lost to Follow-up|20|||
44160989|NCT02612077|78953669|FG000|Overall Study|Death|377|||
44444903|NCT04678557|79452724|FG000|Overall Study|Safety Evaluation|0|||
44444904|NCT04678557|79452725|FG001|Overall Study|Safety Evaluation|1|||
44160990|NCT02612077|78953669|FG000|Overall Study|Moved or Changed Medical Team|23|||
44160991|NCT02612077|78953669|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
44444905|NCT04230980|79452746|FG000|Overall Study|Lost to Follow-up|1|||
44160992|NCT02612077|78953669|FG000|Overall Study|Disease Progression|3|||
44160993|NCT02612077|78953669|FG000|Overall Study|Unknown reason|2|||
44160994|NCT02613481|78953676|FG000|Overall Study|Lost to Follow-up|7|||
44160995|NCT02613481|78953676|FG000|Overall Study|Withdrawal by Subject|2|||
44160996|NCT02613403|78953684|FG000|Overall Study|Lost to Follow-up|0|||
44160997|NCT02613403|78953685|FG001|Overall Study|Lost to Follow-up|1|||
44160998|NCT02613403|78953686|FG002|Overall Study|Lost to Follow-up|0|||
44160999|NCT02613403|78953687|FG003|Overall Study|Lost to Follow-up|0|||
44161000|NCT02613403|78953688|FG004|Overall Study|Lost to Follow-up|0|||
44161001|NCT02613403|78953684|FG000|Overall Study|Withdrawal by Subject|2|||
44161002|NCT02613403|78953685|FG001|Overall Study|Withdrawal by Subject|0|||
44161003|NCT02613403|78953686|FG002|Overall Study|Withdrawal by Subject|0|||
44161004|NCT02613403|78953687|FG003|Overall Study|Withdrawal by Subject|0|||
44161005|NCT02613403|78953688|FG004|Overall Study|Withdrawal by Subject|0|||
44161006|NCT02572817|78953700|FG000|Overall Study|Death|6|||
44161007|NCT02572817|78953701|FG001|Overall Study|Death|3|||
44161008|NCT02572817|78953700|FG000|Overall Study|Lost to Follow-up|3|||
44161009|NCT02572817|78953701|FG001|Overall Study|Lost to Follow-up|3|||
44161010|NCT02566109|78953707|FG000|Overall Study|Withdrawal by Subject|1|||
44161011|NCT02566031|78953713|FG000|Overall Study|Patient/guardian decision|14|||
44161012|NCT02566031|78953714|FG001|Overall Study|Patient/guardian decision|7|||
44161013|NCT02566031|78953713|FG000|Overall Study|Protocol deviation|2|||
44161014|NCT02566031|78953714|FG001|Overall Study|Protocol deviation|3|||
44161015|NCT02566031|78953713|FG000|Overall Study|Adverse Event|3|||
44161016|NCT02566031|78953714|FG001|Overall Study|Adverse Event|1|||
44161017|NCT02566031|78953713|FG000|Overall Study|Lost to Follow-up|1|||
44161018|NCT02566031|78953714|FG001|Overall Study|Lost to Follow-up|1|||
44161019|NCT02569853|78953723|FG000|Overall Study|Adverse Event|2|||
44161020|NCT02569853|78953724|FG001|Overall Study|Adverse Event|0|||
44161021|NCT02569853|78953723|FG000|Overall Study|Withdrawal by Subject|3|||
44161022|NCT02569853|78953724|FG001|Overall Study|Withdrawal by Subject|2|||
44161023|NCT02569853|78953723|FG000|Overall Study|Lost to Follow-up|3|||
44161024|NCT02569853|78953724|FG001|Overall Study|Lost to Follow-up|3|||
44161025|NCT02569853|78953723|FG000|Overall Study|Protocol Violation|1|||
44161026|NCT02569853|78953724|FG001|Overall Study|Protocol Violation|1|||
44161027|NCT02569853|78953723|FG000|Overall Study|Did not experience migraine attack|10|||
44161028|NCT02569853|78953724|FG001|Overall Study|Did not experience migraine attack|7|||
44161029|NCT02569853|78953723|FG000|Overall Study|Physician Decision|1|||
44161030|NCT02569853|78953724|FG001|Overall Study|Physician Decision|1|||
44161031|NCT02570711|78953734|FG000|Overall Study|Death|1|||
44161032|NCT02570711|78953735|FG001|Overall Study|Death|0|||
44161033|NCT02570711|78953734|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
44161034|NCT02570711|78953735|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
44161035|NCT02570165|78953748|FG000|Overall Study|Adverse Event|1|||
44161036|NCT02570165|78953749|FG001|Overall Study|Adverse Event|0|||
44161037|NCT02570165|78953750|FG002|Overall Study|Adverse Event|2|||
44161038|NCT02570165|78953751|FG003|Overall Study|Adverse Event|0|||
44161039|NCT02570165|78953752|FG004|Overall Study|Adverse Event|0|||
44161040|NCT02570165|78953753|FG005|Overall Study|Adverse Event|0|||
44161041|NCT02570165|78953754|FG006|Overall Study|Adverse Event|0|||
44161042|NCT02570165|78953748|FG000|Overall Study|Lack of Efficacy|0|||
44161043|NCT02570165|78953749|FG001|Overall Study|Lack of Efficacy|1|||
44161044|NCT02570165|78953750|FG002|Overall Study|Lack of Efficacy|0|||
44161045|NCT02570165|78953751|FG003|Overall Study|Lack of Efficacy|0|||
44161046|NCT02570165|78953752|FG004|Overall Study|Lack of Efficacy|4|||
44161047|NCT02570165|78953753|FG005|Overall Study|Lack of Efficacy|0|||
44161048|NCT02570165|78953754|FG006|Overall Study|Lack of Efficacy|0|||
44161049|NCT02570165|78953748|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
44161050|NCT02570165|78953749|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
44161051|NCT02570165|78953750|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
44161052|NCT02570165|78953751|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
44161053|NCT02570165|78953752|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
44161054|NCT02570165|78953753|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
44161055|NCT02570165|78953754|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
44161056|NCT02570165|78953748|FG000|Overall Study|Lost to Follow-up|0|||
44161057|NCT02570165|78953749|FG001|Overall Study|Lost to Follow-up|0|||
44161058|NCT02570165|78953750|FG002|Overall Study|Lost to Follow-up|1|||
44161059|NCT02570165|78953751|FG003|Overall Study|Lost to Follow-up|1|||
44161060|NCT02570165|78953752|FG004|Overall Study|Lost to Follow-up|0|||
44161061|NCT02570165|78953753|FG005|Overall Study|Lost to Follow-up|0|||
44161062|NCT02570165|78953754|FG006|Overall Study|Lost to Follow-up|0|||
44161063|NCT02570165|78953748|FG000|Overall Study|Physician Decision|0|||
44161064|NCT02570165|78953749|FG001|Overall Study|Physician Decision|1|||
44161065|NCT02570165|78953750|FG002|Overall Study|Physician Decision|0|||
44161066|NCT02570165|78953751|FG003|Overall Study|Physician Decision|0|||
44161067|NCT02570165|78953752|FG004|Overall Study|Physician Decision|0|||
44161068|NCT02570165|78953753|FG005|Overall Study|Physician Decision|0|||
44161069|NCT02570165|78953754|FG006|Overall Study|Physician Decision|0|||
44161070|NCT02570165|78953748|FG000|Overall Study|Withdrawal by Subject|0|||
44161071|NCT02570165|78953749|FG001|Overall Study|Withdrawal by Subject|0|||
44161072|NCT02570165|78953750|FG002|Overall Study|Withdrawal by Subject|0|||
44161073|NCT02570165|78953751|FG003|Overall Study|Withdrawal by Subject|2|||
44161074|NCT02570165|78953752|FG004|Overall Study|Withdrawal by Subject|1|||
44161075|NCT02570165|78953753|FG005|Overall Study|Withdrawal by Subject|0|||
44161076|NCT02570165|78953754|FG006|Overall Study|Withdrawal by Subject|0|||
44161077|NCT02570165|78953748|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
44161078|NCT02570165|78953749|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
44161079|NCT02570165|78953750|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
44161080|NCT02570165|78953751|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
44161081|NCT02570165|78953752|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
44161082|NCT02570165|78953753|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
44161083|NCT02570165|78953754|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
44161084|NCT02570165|78953748|FG000|Overall Study|Withdrawal Request by GSK|0|||
44161085|NCT02570165|78953749|FG001|Overall Study|Withdrawal Request by GSK|0|||
44161086|NCT02570165|78953750|FG002|Overall Study|Withdrawal Request by GSK|2|||
44161087|NCT02570165|78953751|FG003|Overall Study|Withdrawal Request by GSK|0|||
44161088|NCT02570165|78953752|FG004|Overall Study|Withdrawal Request by GSK|0|||
44161089|NCT02570165|78953753|FG005|Overall Study|Withdrawal Request by GSK|0|||
44161090|NCT02570165|78953754|FG006|Overall Study|Withdrawal Request by GSK|0|||
44161091|NCT02564471|78953774|FG000|Overall Study|Adverse Event|1|||
44161092|NCT02564471|78953775|FG001|Overall Study|Adverse Event|0|||
44161093|NCT02564471|78953776|FG002|Overall Study|Adverse Event|0|||
44161094|NCT02564471|78953777|FG003|Overall Study|Adverse Event|0|||
44161095|NCT02564471|78953774|FG000|Overall Study|Withdrawal by Subject|2|||
44161096|NCT02564471|78953775|FG001|Overall Study|Withdrawal by Subject|1|||
44161097|NCT02564471|78953776|FG002|Overall Study|Withdrawal by Subject|3|||
44161098|NCT02564471|78953777|FG003|Overall Study|Withdrawal by Subject|0|||
44161099|NCT02564471|78953774|FG000|Overall Study|Lost to Follow-up|0|||
44161100|NCT02564471|78953775|FG001|Overall Study|Lost to Follow-up|2|||
44161101|NCT02564471|78953776|FG002|Overall Study|Lost to Follow-up|0|||
44161102|NCT02564471|78953777|FG003|Overall Study|Lost to Follow-up|0|||
44161103|NCT02563067|78953790|FG000|Overall Study|Subject/guardian decision|14|||
44260171|NCT00243347|79125607|FG000|Overall Study|Withdrawal by Subject|5|||
44260172|NCT00243347|79125607|FG000|Overall Study|Condition worsened|7|||
44260173|NCT00243269|79125615|FG000|Overall Study|Protocol Violation|2|||
44260174|NCT00243269|79125616|FG001|Overall Study|Protocol Violation|1|||
44260175|NCT00243269|79125617|FG002|Overall Study|Protocol Violation|0|||
44260176|NCT00243269|79125618|FG003|Overall Study|Protocol Violation|1|||
44260177|NCT00243269|79125615|FG000|Overall Study|Lost to Follow-up|1|||
44260178|NCT00243269|79125616|FG001|Overall Study|Lost to Follow-up|0|||
44161104|NCT02563067|78953791|FG001|Overall Study|Subject/guardian decision|20|||
44260179|NCT00243269|79125617|FG002|Overall Study|Lost to Follow-up|1|||
44260180|NCT00243269|79125618|FG003|Overall Study|Lost to Follow-up|3|||
44260181|NCT00242567|79126833|FG000|Overall Study|Adverse Event|70|||
44260182|NCT00242567|79126834|FG001|Overall Study|Adverse Event|43|||
44161105|NCT02563067|78953792|FG002|Overall Study|Subject/guardian decision|16|||
44161106|NCT02563067|78953790|FG000|Overall Study|Physician Decision|0|||
44161107|NCT02563067|78953791|FG001|Overall Study|Physician Decision|1|||
44161108|NCT02563067|78953792|FG002|Overall Study|Physician Decision|3|||
44161109|NCT02563067|78953790|FG000|Overall Study|Lost to Follow-up|1|||
44161110|NCT02563067|78953791|FG001|Overall Study|Lost to Follow-up|2|||
44161111|NCT02563067|78953792|FG002|Overall Study|Lost to Follow-up|0|||
44161112|NCT02563067|78953790|FG000|Overall Study|Technical problems|0|||
44161113|NCT02563067|78953791|FG001|Overall Study|Technical problems|1|||
44161114|NCT02563067|78953792|FG002|Overall Study|Technical problems|0|||
44161115|NCT02563067|78953790|FG000|Overall Study|Lack of Efficacy|1|||
44161116|NCT02563067|78953791|FG001|Overall Study|Lack of Efficacy|0|||
44161117|NCT02563067|78953792|FG002|Overall Study|Lack of Efficacy|0|||
44161118|NCT02563067|78953790|FG000|Overall Study|Death|0|||
44161119|NCT02563067|78953791|FG001|Overall Study|Death|1|||
44161120|NCT02563067|78953792|FG002|Overall Study|Death|1|||
44161121|NCT02563067|78953790|FG000|Overall Study|Adverse Event|2|||
44161122|NCT02563067|78953791|FG001|Overall Study|Adverse Event|1|||
44161123|NCT02563067|78953792|FG002|Overall Study|Adverse Event|0|||
44161124|NCT02563067|78953790|FG000|Overall Study|Death post Treatment/safety period|1|||
44161125|NCT02563067|78953791|FG001|Overall Study|Death post Treatment/safety period|0|||
44161126|NCT02563067|78953792|FG002|Overall Study|Death post Treatment/safety period|0|||
44161127|NCT02568683|78953802|FG000|Overall Study|Death|0|||
44161128|NCT02568683|78953803|FG001|Overall Study|Death|2|||
44161129|NCT02568683|78953802|FG000|Overall Study|Withdrew Consent|1|||
44161130|NCT02568683|78953803|FG001|Overall Study|Withdrew Consent|0|||
44161131|NCT02568683|78953802|FG000|Overall Study|Study Terminated By Sponsor|5|||
44161132|NCT02568683|78953803|FG001|Overall Study|Study Terminated By Sponsor|2|||
44161133|NCT02563925|78953809|FG000|Overall Study|Withdrawal by Subject|2|||
44161134|NCT01663727|78953816|FG000|Overall Study|Death|161|||
44161135|NCT01663727|78953817|FG001|Overall Study|Death|155|||
44161136|NCT01663727|78953816|FG000|Overall Study|Lost to Follow-up|10|||
44161137|NCT01663727|78953817|FG001|Overall Study|Lost to Follow-up|8|||
44161138|NCT01663727|78953816|FG000|Overall Study|Withdrawal by Subject|18|||
44161139|NCT01663727|78953817|FG001|Overall Study|Withdrawal by Subject|25|||
44161140|NCT01663727|78953816|FG000|Overall Study|Study Terminated|51|||
44161141|NCT01663727|78953817|FG001|Overall Study|Study Terminated|50|||
44161142|NCT01663727|78953816|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
44161143|NCT01663727|78953817|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
44161144|NCT01663727|78953816|FG000|Overall Study|Withdrawal prior to dosing.|1|||
44161145|NCT01663727|78953817|FG001|Overall Study|Withdrawal prior to dosing.|0|||
44161146|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
44161147|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
44161148|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
44161149|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
44161150|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
44161151|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44161152|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44161153|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
44161154|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
44161155|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
44161156|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
44161157|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
44161158|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
44161159|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
44161160|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
44161161|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
44161162|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
44161163|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
44161164|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
44161165|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
44161166|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
44161167|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
44161168|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
44161169|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
44161170|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Screen failure|0|||
44161171|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Screen failure|1|||
44161172|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Screen failure|2|||
44161173|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Screen failure|0|||
44161174|NCT02614261|78953826|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
44161175|NCT02614261|78953827|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
44161176|NCT02614261|78953828|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
44161177|NCT02614261|78953829|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
44161178|NCT02614261|78953826|FG000|Open-Label Extension Phase|Adverse Event|23|||
44161179|NCT02614261|78953827|FG001|Open-Label Extension Phase|Adverse Event|12|||
44161180|NCT02614261|78953828|FG002|Open-Label Extension Phase|Adverse Event|11|||
44161181|NCT02614261|78953829|FG003|Open-Label Extension Phase|Adverse Event|0|||
44161182|NCT02614261|78953826|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
44161183|NCT02614261|78953827|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
44161184|NCT02614261|78953828|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
44161185|NCT02614261|78953829|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
44161186|NCT02614261|78953826|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
44161187|NCT02614261|78953827|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
44161188|NCT02614261|78953828|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
44161189|NCT02614261|78953829|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
44161190|NCT02614261|78953826|FG000|Open-Label Extension Phase|Physician Decision|2|||
44161191|NCT02614261|78953827|FG001|Open-Label Extension Phase|Physician Decision|0|||
44161192|NCT02614261|78953828|FG002|Open-Label Extension Phase|Physician Decision|0|||
44161193|NCT02614261|78953829|FG003|Open-Label Extension Phase|Physician Decision|0|||
44161194|NCT02614261|78953826|FG000|Open-Label Extension Phase|Pregnancy|1|||
44161195|NCT02614261|78953827|FG001|Open-Label Extension Phase|Pregnancy|2|||
44161196|NCT02614261|78953828|FG002|Open-Label Extension Phase|Pregnancy|1|||
44161197|NCT02614261|78953829|FG003|Open-Label Extension Phase|Pregnancy|0|||
44161198|NCT02614261|78953826|FG000|Open-Label Extension Phase|Protocol Violation|3|||
44161199|NCT02614261|78953827|FG001|Open-Label Extension Phase|Protocol Violation|4|||
44161200|NCT02614261|78953828|FG002|Open-Label Extension Phase|Protocol Violation|1|||
44161201|NCT02614261|78953829|FG003|Open-Label Extension Phase|Protocol Violation|0|||
44161202|NCT02614261|78953826|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
44161203|NCT02614261|78953827|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
44161204|NCT02614261|78953828|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
44161205|NCT02614261|78953829|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
44161206|NCT02614261|78953826|FG000|Follow-up Phase|Adverse Event|2|||
44161207|NCT02614261|78953827|FG001|Follow-up Phase|Adverse Event|0|||
44161208|NCT02614261|78953828|FG002|Follow-up Phase|Adverse Event|1|||
44161209|NCT02614261|78953829|FG003|Follow-up Phase|Adverse Event|0|||
44161210|NCT02614261|78953826|FG000|Follow-up Phase|Lost to Follow-up|12|||
44161211|NCT02614261|78953827|FG001|Follow-up Phase|Lost to Follow-up|5|||
44161212|NCT02614261|78953828|FG002|Follow-up Phase|Lost to Follow-up|2|||
44161213|NCT02614261|78953829|FG003|Follow-up Phase|Lost to Follow-up|0|||
44161214|NCT02614261|78953826|FG000|Follow-up Phase|Physician Decision|5|||
44161215|NCT02614261|78953827|FG001|Follow-up Phase|Physician Decision|1|||
44161216|NCT02614261|78953828|FG002|Follow-up Phase|Physician Decision|0|||
44161217|NCT02614261|78953829|FG003|Follow-up Phase|Physician Decision|0|||
44161218|NCT02614261|78953826|FG000|Follow-up Phase|Pregnancy|0|||
44161219|NCT02614261|78953827|FG001|Follow-up Phase|Pregnancy|1|||
44161220|NCT02614261|78953828|FG002|Follow-up Phase|Pregnancy|0|||
44161221|NCT02614261|78953829|FG003|Follow-up Phase|Pregnancy|0|||
44161222|NCT02614261|78953826|FG000|Follow-up Phase|Protocol Violation|1|||
44161223|NCT02614261|78953827|FG001|Follow-up Phase|Protocol Violation|0|||
44161224|NCT02614261|78953828|FG002|Follow-up Phase|Protocol Violation|0|||
44161225|NCT02614261|78953829|FG003|Follow-up Phase|Protocol Violation|0|||
44161226|NCT02614261|78953826|FG000|Follow-up Phase|Withdrawal by Subject|12|||
44161227|NCT02614261|78953827|FG001|Follow-up Phase|Withdrawal by Subject|4|||
44161228|NCT02614261|78953828|FG002|Follow-up Phase|Withdrawal by Subject|11|||
44161229|NCT02614261|78953829|FG003|Follow-up Phase|Withdrawal by Subject|0|||
44161230|NCT02614261|78953826|FG000|Israel Addendum|Withdrawal by Subject|0|||
44161231|NCT02614261|78953827|FG001|Israel Addendum|Withdrawal by Subject|0|||
44161232|NCT02614261|78953828|FG002|Israel Addendum|Withdrawal by Subject|0|||
44161233|NCT02614261|78953829|FG003|Israel Addendum|Withdrawal by Subject|4|||
44161234|NCT01594411|78953855|FG000|Overall Study|Lost to Follow-up|2|||
44161235|NCT01594333|78953864|FG000|Overall Study|Death|96|||
44161236|NCT01594333|78953865|FG001|Overall Study|Death|83|||
44161237|NCT01594333|78953864|FG000|Overall Study|Lost to Follow-up|5|||
44161238|NCT01594333|78953865|FG001|Overall Study|Lost to Follow-up|5|||
44161239|NCT01594333|78953864|FG000|Overall Study|Withdrawal by Subject|60|||
44161240|NCT01594333|78953865|FG001|Overall Study|Withdrawal by Subject|63|||
44161241|NCT02609659|78953871|FG000|Overall Study|Adverse Event|1|||
44161242|NCT02609659|78953871|FG000|Overall Study|Lost to Follow-up|6|||
44161243|NCT02609659|78953871|FG000|Overall Study|Other|1|||
44161244|NCT02612779|78953877|FG000|Overall Study|Administrative reason by sponsor|4|||
44161245|NCT02612779|78953878|FG001|Overall Study|Administrative reason by sponsor|1|||
44161246|NCT02612779|78953877|FG000|Overall Study|No longer meet study criteria|0|||
44161247|NCT02612779|78953878|FG001|Overall Study|No longer meet study criteria|1|||
44161248|NCT02612779|78953877|FG000|Overall Study|Disease progression|29|||
44161249|NCT02612779|78953878|FG001|Overall Study|Disease progression|2|||
44161250|NCT02612779|78953877|FG000|Overall Study|Study drug toxicity|10|||
44161251|NCT02612779|78953878|FG001|Overall Study|Study drug toxicity|1|||
44161252|NCT02612779|78953877|FG000|Overall Study|Death|1|||
44161253|NCT02612779|78953878|FG001|Overall Study|Death|0|||
44161254|NCT02612779|78953877|FG000|Overall Study|Adverse event unrelated to study drug|5|||
44161255|NCT02612779|78953878|FG001|Overall Study|Adverse event unrelated to study drug|0|||
44161256|NCT02612779|78953877|FG000|Overall Study|Participant withdrew consent|4|||
44161257|NCT02612779|78953878|FG001|Overall Study|Participant withdrew consent|0|||
44161258|NCT02612779|78953877|FG000|Overall Study|Lost to Follow-up|1|||
44161259|NCT02612779|78953878|FG001|Overall Study|Lost to Follow-up|0|||
44161260|NCT02612779|78953877|FG000|Overall Study|Maximum clinical benefit|10|||
44161261|NCT02612779|78953878|FG001|Overall Study|Maximum clinical benefit|1|||
44161262|NCT02612779|78953877|FG000|Overall Study|Other reasons|4|||
44345077|NCT01284062|79349106|FG000|Overall Study|Withdrawal by Subject|3|||
44345078|NCT01284062|79349107|FG001|Overall Study|Withdrawal by Subject|1|||
44345079|NCT01284062|79349108|FG002|Overall Study|Withdrawal by Subject|2|||
44345080|NCT01284062|79349109|FG003|Overall Study|Withdrawal by Subject|5|||
44345081|NCT01284062|79349106|FG000|Overall Study|Other|0|||
44444906|NCT04230980|79452747|FG001|Overall Study|Lost to Follow-up|2|||
44161263|NCT02612779|78953878|FG001|Overall Study|Other reasons|0|||
44161264|NCT02612623|78953889|FG000|Overall Study|Withdrawal by Subject|0|||
44345082|NCT01284062|79349107|FG001|Overall Study|Other|0|||
44345083|NCT01284062|79349108|FG002|Overall Study|Other|0|||
44161265|NCT02612623|78953890|FG001|Overall Study|Withdrawal by Subject|1|||
44161266|NCT02612623|78953891|FG002|Overall Study|Withdrawal by Subject|0|||
44260183|NCT00242567|79126833|FG000|Overall Study|Disease Progression|17|||
44161267|NCT02612623|78953892|FG003|Overall Study|Withdrawal by Subject|0|||
44260184|NCT00242567|79126834|FG001|Overall Study|Disease Progression|22|||
44161268|NCT02612623|78953889|FG000|Overall Study|Adverse Event|1|||
44161269|NCT02612623|78953890|FG001|Overall Study|Adverse Event|0|||
44161270|NCT02612623|78953891|FG002|Overall Study|Adverse Event|1|||
44161271|NCT02612623|78953892|FG003|Overall Study|Adverse Event|0|||
44345084|NCT01284062|79349109|FG003|Overall Study|Other|1|||
44345085|NCT01284062|79349106|FG000|Overall Study|Site Closed|0|||
44345086|NCT01284062|79349107|FG001|Overall Study|Site Closed|0|||
44345087|NCT01284062|79349108|FG002|Overall Study|Site Closed|1|||
44345088|NCT01284062|79349109|FG003|Overall Study|Site Closed|0|||
44345089|NCT01253304|79349126|FG000|Overall Study|Adverse Event|0|||
44345090|NCT01253304|79349127|FG001|Overall Study|Adverse Event|0|||
44345091|NCT01253304|79349128|FG002|Overall Study|Adverse Event|0|||
44345092|NCT01253304|79349129|FG003|Overall Study|Adverse Event|1|||
44345093|NCT01253226|79349144|FG000|Overall Study|Adverse Event|0|||
44345094|NCT01253226|79349145|FG001|Overall Study|Adverse Event|0|||
44345095|NCT01253226|79349146|FG002|Overall Study|Adverse Event|1|||
44345096|NCT01253226|79349147|FG003|Overall Study|Adverse Event|0|||
44345097|NCT01253226|79349148|FG004|Overall Study|Adverse Event|0|||
44345098|NCT01253226|79349144|FG000|Overall Study|Death|0|||
44345099|NCT01253226|79349145|FG001|Overall Study|Death|1|||
44345100|NCT01253226|79349146|FG002|Overall Study|Death|0|||
44345101|NCT01253226|79349147|FG003|Overall Study|Death|0|||
44345102|NCT01253226|79349148|FG004|Overall Study|Death|0|||
44161272|NCT02607865|78953906|FG000|Overall Study|Lost to Follow-up|9|||
44161273|NCT02607865|78953907|FG001|Overall Study|Lost to Follow-up|7|||
44345103|NCT01253226|79349144|FG000|Overall Study|Physician Decision|0|||
44345104|NCT01253226|79349145|FG001|Overall Study|Physician Decision|0|||
44161274|NCT02607865|78953908|FG002|Overall Study|Lost to Follow-up|7|||
44161275|NCT02607865|78953909|FG003|Overall Study|Lost to Follow-up|5|||
44161276|NCT02607865|78953906|FG000|Overall Study|Withdrawal by Subject|18|||
44161277|NCT02607865|78953907|FG001|Overall Study|Withdrawal by Subject|18|||
44161278|NCT02607865|78953908|FG002|Overall Study|Withdrawal by Subject|17|||
44161279|NCT02607865|78953909|FG003|Overall Study|Withdrawal by Subject|8|||
44161280|NCT02607865|78953906|FG000|Overall Study|Death|5|||
44161281|NCT02607865|78953907|FG001|Overall Study|Death|4|||
44161282|NCT02607865|78953908|FG002|Overall Study|Death|1|||
44161283|NCT02607865|78953909|FG003|Overall Study|Death|3|||
44161284|NCT02607865|78953906|FG000|Overall Study|Unclassified|1|||
44161285|NCT02607865|78953907|FG001|Overall Study|Unclassified|1|||
44161286|NCT02607865|78953908|FG002|Overall Study|Unclassified|2|||
44161287|NCT02607865|78953909|FG003|Overall Study|Unclassified|0|||
44161288|NCT01668667|78953923|FG000|Overall Study|Adverse Event|3|||
44161289|NCT01668667|78953924|FG001|Overall Study|Adverse Event|6|||
44161290|NCT01668667|78953925|FG002|Overall Study|Adverse Event|4|||
44161291|NCT01668667|78953926|FG003|Overall Study|Adverse Event|4|||
44161292|NCT01668667|78953923|FG000|Overall Study|Lack of Efficacy|3|||
44161293|NCT01668667|78953924|FG001|Overall Study|Lack of Efficacy|2|||
44161294|NCT01668667|78953925|FG002|Overall Study|Lack of Efficacy|2|||
44161295|NCT01668667|78953926|FG003|Overall Study|Lack of Efficacy|3|||
44161296|NCT01668667|78953923|FG000|Overall Study|Protocol Violation|6|||
44161297|NCT01668667|78953924|FG001|Overall Study|Protocol Violation|10|||
44161298|NCT01668667|78953925|FG002|Overall Study|Protocol Violation|12|||
44161299|NCT01668667|78953926|FG003|Overall Study|Protocol Violation|5|||
44161300|NCT01668667|78953923|FG000|Overall Study|Lost to Follow-up|9|||
44161301|NCT01668667|78953924|FG001|Overall Study|Lost to Follow-up|4|||
44161302|NCT01668667|78953925|FG002|Overall Study|Lost to Follow-up|7|||
44161303|NCT01668667|78953926|FG003|Overall Study|Lost to Follow-up|6|||
44161304|NCT01668667|78953923|FG000|Overall Study|Physician Decision|3|||
44161305|NCT01668667|78953924|FG001|Overall Study|Physician Decision|0|||
44161306|NCT01668667|78953925|FG002|Overall Study|Physician Decision|1|||
44161307|NCT01668667|78953926|FG003|Overall Study|Physician Decision|0|||
44161308|NCT01668667|78953923|FG000|Overall Study|Withdrawal by Subject|7|||
44161309|NCT01668667|78953924|FG001|Overall Study|Withdrawal by Subject|4|||
44161310|NCT01668667|78953925|FG002|Overall Study|Withdrawal by Subject|5|||
44161311|NCT01668667|78953926|FG003|Overall Study|Withdrawal by Subject|5|||
44161312|NCT02608879|78953939|FG000|Overall Study|Lost to Follow-up|1|||
44161313|NCT02608879|78953940|FG001|Overall Study|Lost to Follow-up|0|||
44161314|NCT02608879|78953941|FG002|Overall Study|Lost to Follow-up|0|||
44161315|NCT02608879|78953939|FG000|Overall Study|Did not meet continuation criteria|0|||
44444907|NCT04230980|79452746|FG000|Overall Study|Adverse Event|0|||
44161316|NCT02608879|78953940|FG001|Overall Study|Did not meet continuation criteria|0|||
44161317|NCT02608879|78953941|FG002|Overall Study|Did not meet continuation criteria|3|||
44161318|NCT02608099|78953951|FG000|Overall Study|Ablation procedure not initiated|3|||
44161319|NCT02608099|78953952|FG001|Overall Study|Ablation procedure not initiated|2|||
44161320|NCT01668589|78953962|FG000|Overall Study|Lost to Follow-up|29|||
44161321|NCT01668589|78953963|FG001|Overall Study|Lost to Follow-up|37|||
44161322|NCT01668589|78953964|FG002|Overall Study|Lost to Follow-up|15|||
44161323|NCT01668589|78953965|FG003|Overall Study|Lost to Follow-up|5|||
44161324|NCT01668589|78953962|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
44161325|NCT01668589|78953963|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
44161326|NCT01668589|78953964|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
44161327|NCT01668589|78953965|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
44345105|NCT01253226|79349146|FG002|Overall Study|Physician Decision|0|||
44345106|NCT01253226|79349147|FG003|Overall Study|Physician Decision|0|||
44161328|NCT01668589|78953962|FG000|Overall Study|Death|12|||
44161329|NCT01668589|78953963|FG001|Overall Study|Death|3|||
44161330|NCT01668589|78953964|FG002|Overall Study|Death|2|||
44161331|NCT01668589|78953965|FG003|Overall Study|Death|11|||
44161332|NCT01668589|78953962|FG000|Overall Study|Other|44|||
44161333|NCT01668589|78953963|FG001|Overall Study|Other|10|||
44161334|NCT01668589|78953964|FG002|Overall Study|Other|7|||
44161335|NCT01668589|78953965|FG003|Overall Study|Other|15|||
44161336|NCT02432235|78953987|FG000|Overall Study|Death|1|||
44161337|NCT02432235|78953988|FG001|Overall Study|Death|1|||
44161338|NCT02432235|78953989|FG002|Overall Study|Death|2|||
44161339|NCT02432235|78953990|FG003|Overall Study|Death|2|||
44161340|NCT02432235|78953991|FG004|Overall Study|Death|1|||
44161341|NCT02432235|78953992|FG005|Overall Study|Death|3|||
44161342|NCT02432235|78953993|FG006|Overall Study|Death|11|||
44161343|NCT02432235|78953994|FG007|Overall Study|Death|15|||
44161344|NCT02432235|78953995|FG008|Overall Study|Death|15|||
44161345|NCT02432235|78953996|FG009|Overall Study|Death|3|||
44161346|NCT02432235|78953997|FG010|Overall Study|Death|1|||
44161347|NCT02432235|78953998|FG011|Overall Study|Death|0|||
44161348|NCT02432235|78953987|FG000|Overall Study|Withdrawal by Subject|0|||
44161349|NCT02432235|78953988|FG001|Overall Study|Withdrawal by Subject|1|||
44161350|NCT02432235|78953989|FG002|Overall Study|Withdrawal by Subject|0|||
44161351|NCT02432235|78953990|FG003|Overall Study|Withdrawal by Subject|0|||
44161352|NCT02432235|78953991|FG004|Overall Study|Withdrawal by Subject|0|||
44161353|NCT02432235|78953992|FG005|Overall Study|Withdrawal by Subject|2|||
44161354|NCT02432235|78953993|FG006|Overall Study|Withdrawal by Subject|5|||
44161355|NCT02432235|78953994|FG007|Overall Study|Withdrawal by Subject|3|||
44161356|NCT02432235|78953995|FG008|Overall Study|Withdrawal by Subject|1|||
44161357|NCT02432235|78953996|FG009|Overall Study|Withdrawal by Subject|0|||
44161358|NCT02432235|78953997|FG010|Overall Study|Withdrawal by Subject|0|||
44161359|NCT02432235|78953998|FG011|Overall Study|Withdrawal by Subject|0|||
44161360|NCT02432235|78953987|FG000|Overall Study|Lost to Follow-up|0|||
44161361|NCT02432235|78953988|FG001|Overall Study|Lost to Follow-up|0|||
44161362|NCT02432235|78953989|FG002|Overall Study|Lost to Follow-up|0|||
44161363|NCT02432235|78953990|FG003|Overall Study|Lost to Follow-up|0|||
44161364|NCT02432235|78953991|FG004|Overall Study|Lost to Follow-up|0|||
44161365|NCT02432235|78953992|FG005|Overall Study|Lost to Follow-up|1|||
44161366|NCT02432235|78953993|FG006|Overall Study|Lost to Follow-up|0|||
44161367|NCT02432235|78953994|FG007|Overall Study|Lost to Follow-up|0|||
44161368|NCT02432235|78953995|FG008|Overall Study|Lost to Follow-up|1|||
44161369|NCT02432235|78953996|FG009|Overall Study|Lost to Follow-up|0|||
44161370|NCT02432235|78953997|FG010|Overall Study|Lost to Follow-up|0|||
44161371|NCT02432235|78953998|FG011|Overall Study|Lost to Follow-up|0|||
44161372|NCT02432235|78953987|FG000|Overall Study|Miscellaneous|0|||
44161373|NCT02432235|78953988|FG001|Overall Study|Miscellaneous|0|||
44161374|NCT02432235|78953989|FG002|Overall Study|Miscellaneous|0|||
44161375|NCT02432235|78953990|FG003|Overall Study|Miscellaneous|0|||
44161376|NCT02432235|78953991|FG004|Overall Study|Miscellaneous|1|||
44161377|NCT02432235|78953992|FG005|Overall Study|Miscellaneous|6|||
44161378|NCT02432235|78953993|FG006|Overall Study|Miscellaneous|2|||
44345107|NCT01253226|79349148|FG004|Overall Study|Physician Decision|2|||
44161379|NCT02432235|78953994|FG007|Overall Study|Miscellaneous|2|||
44444908|NCT04230980|79452747|FG001|Overall Study|Adverse Event|1|||
44444909|NCT03697720|79452797|FG000|Overall Study|Lost to Follow-up|7|||
44345108|NCT01253226|79349144|FG000|Overall Study|Withdrawal by Subject|0|||
44345109|NCT01253226|79349145|FG001|Overall Study|Withdrawal by Subject|0|||
44444910|NCT03635983|79452803|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
44161380|NCT02432235|78953995|FG008|Overall Study|Miscellaneous|4|||
44161381|NCT02432235|78953996|FG009|Overall Study|Miscellaneous|0|||
44161382|NCT02432235|78953997|FG010|Overall Study|Miscellaneous|0|||
44161383|NCT02432235|78953998|FG011|Overall Study|Miscellaneous|1|||
44161384|NCT02431533|78954028|FG000|Overall Study|Withdrawal by Subject|1|||
44161385|NCT02431533|78954029|FG001|Overall Study|Withdrawal by Subject|3|||
44161386|NCT02431533|78954028|FG000|Overall Study|Developed Exclusionary criteria|1|||
44161387|NCT02431533|78954029|FG001|Overall Study|Developed Exclusionary criteria|0|||
44161388|NCT02416791|78954038|FG000|6 Months|Lost to Follow-up|0|||
44161389|NCT02416791|78954039|FG001|6 Months|Lost to Follow-up|0|||
44161390|NCT02416791|78954040|FG002|6 Months|Lost to Follow-up|1|||
44161391|NCT02414841|78954050|FG000|Overall Study|Withdrawal by Subject|7|||
44161392|NCT02414841|78954051|FG001|Overall Study|Withdrawal by Subject|5|||
44161393|NCT02414841|78954050|FG000|Overall Study|Lost to Follow-up|13|||
44161394|NCT02414841|78954051|FG001|Overall Study|Lost to Follow-up|6|||
44161395|NCT02414841|78954050|FG000|Overall Study|Death|17|||
44161396|NCT02414841|78954051|FG001|Overall Study|Death|14|||
44161397|NCT02414841|78954050|FG000|Overall Study|Received a Kidney Transplant|13|||
44345110|NCT01253226|79349146|FG002|Overall Study|Withdrawal by Subject|0|||
44345111|NCT01253226|79349147|FG003|Overall Study|Withdrawal by Subject|1|||
44345112|NCT01253226|79349148|FG004|Overall Study|Withdrawal by Subject|0|||
44161398|NCT02414841|78954051|FG001|Overall Study|Received a Kidney Transplant|4|||
44161399|NCT02414841|78954050|FG000|Overall Study|Randomized But Not Treated|6|||
44161400|NCT02414841|78954051|FG001|Overall Study|Randomized But Not Treated|4|||
44161401|NCT02413593|78954059|FG000|Overall Study|Lost to Follow-up|3|||
44161402|NCT02413593|78954059|FG000|Overall Study|Adverse Event|1|||
44161403|NCT01652703|78954069|FG000|Overall Study|Withdrawal by Subject|0|||
44161404|NCT01652703|78954070|FG001|Overall Study|Withdrawal by Subject|1|||
44161405|NCT01652703|78954071|FG002|Overall Study|Withdrawal by Subject|3|||
44161406|NCT01652703|78954072|FG003|Overall Study|Withdrawal by Subject|1|||
44161407|NCT01652703|78954073|FG004|Overall Study|Withdrawal by Subject|0|||
44161408|NCT01652703|78954074|FG005|Overall Study|Withdrawal by Subject|1|||
44161409|NCT01652703|78954069|FG000|Overall Study|Other|0|||
44161410|NCT01652703|78954070|FG001|Overall Study|Other|0|||
44161411|NCT01652703|78954071|FG002|Overall Study|Other|0|||
44161412|NCT01652703|78954072|FG003|Overall Study|Other|1|||
44161413|NCT01652703|78954073|FG004|Overall Study|Other|1|||
44161414|NCT01652703|78954074|FG005|Overall Study|Other|1|||
44161415|NCT01652469|78954090|FG000|Overall Study|Withdrawal by Subject|1|||
44161416|NCT01652469|78954091|FG001|Overall Study|Withdrawal by Subject|4|||
44161417|NCT01652469|78954090|FG000|Overall Study|Lost to Follow-up|0|||
44161418|NCT01652469|78954091|FG001|Overall Study|Lost to Follow-up|2|||
44161419|NCT02429427|78954099|FG000|Overall Study|Adverse Event|220|||
44161420|NCT02429427|78954100|FG001|Overall Study|Adverse Event|92|||
44161421|NCT02429427|78954099|FG000|Overall Study|Protocol Violation|10|||
44161422|NCT02429427|78954100|FG001|Overall Study|Protocol Violation|6|||
44161423|NCT02429427|78954099|FG000|Overall Study|Lost to Follow-up|15|||
44161424|NCT02429427|78954100|FG001|Overall Study|Lost to Follow-up|6|||
44161425|NCT02429427|78954099|FG000|Overall Study|Withdrawal by Subject|64|||
44161426|NCT02429427|78954100|FG001|Overall Study|Withdrawal by Subject|34|||
44161427|NCT02429427|78954099|FG000|Overall Study|Other|62|||
44161428|NCT02429427|78954100|FG001|Overall Study|Other|41|||
44161429|NCT02412735|78954109|FG000|Overall Study|Adverse Event|0|||
44161430|NCT02412735|78954110|FG001|Overall Study|Adverse Event|1|||
44161431|NCT02412735|78954111|FG002|Overall Study|Adverse Event|2|||
44161432|NCT02412735|78954109|FG000|Overall Study|Withdrawal by Subject|23|||
44161433|NCT02412735|78954110|FG001|Overall Study|Withdrawal by Subject|27|||
44161434|NCT02412735|78954111|FG002|Overall Study|Withdrawal by Subject|22|||
44161435|NCT02412735|78954109|FG000|Overall Study|Investigator Decision|3|||
44161436|NCT02412735|78954110|FG001|Overall Study|Investigator Decision|3|||
44161437|NCT02412735|78954111|FG002|Overall Study|Investigator Decision|2|||
44161438|NCT02412735|78954109|FG000|Overall Study|Lost to Follow-up|17|||
44161439|NCT02412735|78954110|FG001|Overall Study|Lost to Follow-up|11|||
44161440|NCT02412735|78954111|FG002|Overall Study|Lost to Follow-up|18|||
44161441|NCT02412735|78954109|FG000|Overall Study|Reason not Specified|3|||
44161442|NCT02412735|78954110|FG001|Overall Study|Reason not Specified|2|||
44161443|NCT02412735|78954111|FG002|Overall Study|Reason not Specified|2|||
44161444|NCT02412657|78954122|FG000|Overall Study|Lost to Follow-up|1|||
44161445|NCT02412657|78954123|FG001|Overall Study|Lost to Follow-up|0|||
44161446|NCT02412657|78954124|FG002|Overall Study|Lost to Follow-up|0|||
44161447|NCT02412657|78954122|FG000|Overall Study|Protocol Violation|0|||
44161448|NCT02412657|78954123|FG001|Overall Study|Protocol Violation|2|||
44161449|NCT02412657|78954124|FG002|Overall Study|Protocol Violation|3|||
44161450|NCT02428413|78954134|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
44161451|NCT02428413|78954135|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
44161452|NCT02428413|78954134|FG000|Overall Study|Protocol Violation|1|||
44161453|NCT02428413|78954135|FG001|Overall Study|Protocol Violation|2|||
44161454|NCT02428413|78954134|FG000|Overall Study|Case Cancelled|2|||
44161455|NCT02428413|78954135|FG001|Overall Study|Case Cancelled|0|||
44161456|NCT02428413|78954134|FG000|Overall Study|Missed Cases|1|||
44161457|NCT02428413|78954135|FG001|Overall Study|Missed Cases|2|||
44161458|NCT02428413|78954134|FG000|Overall Study|Nurse Refusal|1|||
44161459|NCT02428413|78954135|FG001|Overall Study|Nurse Refusal|0|||
44161460|NCT02412111|78954143|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
44161461|NCT02412111|78954144|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
44161462|NCT02412111|78954145|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
44161463|NCT02412111|78954143|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
44161464|NCT02412111|78954144|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
44444911|NCT03635983|79452804|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
44444912|NCT03635983|79452803|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
44161465|NCT02412111|78954145|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
44161466|NCT02412111|78954143|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
44161467|NCT02412111|78954144|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
44161468|NCT02412111|78954145|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
44161469|NCT02412111|78954143|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
44161470|NCT02412111|78954144|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
44161471|NCT02412111|78954145|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
44161472|NCT02412111|78954143|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
44161473|NCT02412111|78954144|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
44161474|NCT02412111|78954145|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
44161475|NCT02412111|78954143|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
44161476|NCT02412111|78954144|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
44161477|NCT02412111|78954145|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
44161478|NCT02412111|78954143|FG000|Active Comparator Period (8 Weeks)|Other|0|||
44161479|NCT02412111|78954144|FG001|Active Comparator Period (8 Weeks)|Other|0|||
44161480|NCT02412111|78954145|FG002|Active Comparator Period (8 Weeks)|Other|2|||
44161481|NCT02427477|78954157|FG000|Period 1|Adverse Event|1|||
44161482|NCT02427477|78954158|FG001|Period 1|Adverse Event|0|||
44161483|NCT02427399|78954169|FG000|Overall Study|Protocol Violation|14|||
44161484|NCT02427399|78954170|FG001|Overall Study|Protocol Violation|16|||
44161485|NCT02427399|78954171|FG002|Overall Study|Protocol Violation|12|||
44161486|NCT02427399|78954172|FG003|Overall Study|Protocol Violation|18|||
44161487|NCT02427399|78954173|FG004|Overall Study|Protocol Violation|15|||
44161488|NCT02426541|78954187|FG000|Overall Study|Protocol Violation|1|||
44161489|NCT02426541|78954188|FG001|Overall Study|Protocol Violation|0|||
44161490|NCT02484651|78954196|FG000|Overall Study|Patients' data files were corrupted.|1|||
44161491|NCT02484651|78954197|FG001|Overall Study|Patients' data files were corrupted.|1|||
44161492|NCT02484651|78954196|FG000|Overall Study|BIS monitoring failed.|1|||
44161493|NCT02484651|78954197|FG001|Overall Study|BIS monitoring failed.|1|||
44161494|NCT02484651|78954196|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
44161495|NCT02484651|78954197|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
44161496|NCT02410551|78954204|FG000|Overall Study|Adverse Event|1|||
44161497|NCT02410551|78954204|FG000|Overall Study|Withdrawal by Subject|1|||
44161498|NCT02410551|78954204|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
44161499|NCT02424591|78954211|FG000|Overall Study|Protocol Violation|2|||
44161500|NCT02424591|78954212|FG001|Overall Study|Protocol Violation|3|||
44161501|NCT02408523|78954220|FG000|Overall Study|Adverse Event|4|||
44161502|NCT02408523|78954221|FG001|Overall Study|Adverse Event|10|||
44161503|NCT02408523|78954220|FG000|Overall Study|Lack of Efficacy|0|||
44161504|NCT02408523|78954221|FG001|Overall Study|Lack of Efficacy|1|||
44161505|NCT02408523|78954220|FG000|Overall Study|Protocol Violation|1|||
44161506|NCT02408523|78954221|FG001|Overall Study|Protocol Violation|2|||
44161507|NCT02408523|78954220|FG000|Overall Study|Lost to Follow-up|2|||
44161508|NCT02408523|78954221|FG001|Overall Study|Lost to Follow-up|3|||
44161509|NCT02408523|78954220|FG000|Overall Study|Withdrawal by Subject|3|||
44161510|NCT02408523|78954221|FG001|Overall Study|Withdrawal by Subject|1|||
44161511|NCT02408523|78954220|FG000|Overall Study|Sponsor request|1|||
44161512|NCT02408523|78954221|FG001|Overall Study|Sponsor request|0|||
44161513|NCT02408523|78954220|FG000|Overall Study|Did not satisfy extension conditions|0|||
44161514|NCT02408523|78954221|FG001|Overall Study|Did not satisfy extension conditions|1|||
44161515|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
44161516|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
44161517|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
44161518|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
44161519|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
44161520|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
44161521|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
44161522|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
44161523|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
44161524|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
44161525|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
44161526|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
44161527|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
44444913|NCT03635983|79452804|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
44444914|NCT03635983|79452803|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44444915|NCT03635983|79452804|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44161528|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
44161529|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
44161530|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
44161531|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
44161532|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
44161533|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
44161534|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
44161535|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
44161536|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
44161537|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
44161538|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
44161539|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
44161540|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
44161541|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
44161542|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
44161543|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
44161544|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
44161545|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
44161546|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
44161547|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
44161548|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
44161549|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
44161550|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
44161551|NCT02603419|78954241|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
44161552|NCT02603419|78954242|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
44161553|NCT02603419|78954243|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
44161554|NCT02603419|78954244|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
44444916|NCT03635983|79452803|FG000|Pre-Treatment Period|Other reasons|1|||
44161555|NCT02603419|78954245|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
44161556|NCT02603419|78954246|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
44161557|NCT02603419|78954241|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
44444917|NCT03635983|79452804|FG001|Pre-Treatment Period|Other reasons|2|||
44444918|NCT03635983|79452803|FG000|Pre-Treatment Period|Disease Progression|0|||
44444919|NCT03635983|79452804|FG001|Pre-Treatment Period|Disease Progression|1|||
44444920|NCT03635983|79452803|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
44444921|NCT03635983|79452804|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
44444922|NCT03635983|79452803|FG000|Treatment Period|Completed treatment period|13|||
44444923|NCT03635983|79452804|FG001|Treatment Period|Completed treatment period|20|||
44444924|NCT03635983|79452803|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
44444925|NCT03635983|79452804|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
44444926|NCT03635983|79452803|FG000|Treatment Period|Withdrawal by Subject|2|||
44444927|NCT03635983|79452804|FG001|Treatment Period|Withdrawal by Subject|4|||
44444928|NCT03635983|79452803|FG000|Treatment Period|Death|3|||
44444929|NCT03635983|79452804|FG001|Treatment Period|Death|4|||
44444930|NCT03635983|79452803|FG000|Treatment Period|Poor/Non-compliance|1|||
44161558|NCT02603419|78954242|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
44161559|NCT02603419|78954243|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
44161560|NCT02603419|78954244|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
44161561|NCT02603419|78954245|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
44161562|NCT02603419|78954246|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
44161563|NCT02603419|78954241|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
44161564|NCT02603419|78954242|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
44161565|NCT02603419|78954243|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
44161566|NCT02603419|78954244|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
44161567|NCT02603419|78954245|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
44161568|NCT02603419|78954246|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
44161569|NCT02603419|78954241|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
44161570|NCT02603419|78954242|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
44161571|NCT02603419|78954243|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
44161572|NCT02603419|78954244|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
44161573|NCT02603419|78954245|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
44161574|NCT02603419|78954246|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
44161575|NCT01668355|78954263|FG000|Overall Study|Death|3|||
44161576|NCT01668355|78954264|FG001|Overall Study|Death|1|||
44161577|NCT01668355|78954263|FG000|Overall Study|Withdrawal by Subject|6|||
44161578|NCT01668355|78954264|FG001|Overall Study|Withdrawal by Subject|1|||
44161579|NCT01667731|78954276|FG000|Overall Study|Enrolled but not treated|0|||
44161580|NCT01667731|78954277|FG001|Overall Study|Enrolled but not treated|0|||
44161581|NCT01667731|78954278|FG002|Overall Study|Enrolled but not treated|0|||
44161582|NCT01667731|78954279|FG003|Overall Study|Enrolled but not treated|0|||
44161583|NCT01667731|78954280|FG004|Overall Study|Enrolled but not treated|1|||
44161584|NCT01667731|78954276|FG000|Overall Study|Efficacy Failure|1|||
44161585|NCT01667731|78954277|FG001|Overall Study|Efficacy Failure|12|||
44161586|NCT01667731|78954278|FG002|Overall Study|Efficacy Failure|0|||
44161587|NCT01667731|78954279|FG003|Overall Study|Efficacy Failure|1|||
44161588|NCT01667731|78954280|FG004|Overall Study|Efficacy Failure|24|||
44161589|NCT01667731|78954276|FG000|Overall Study|Lost to Follow-up|2|||
44161590|NCT01667731|78954277|FG001|Overall Study|Lost to Follow-up|3|||
44161591|NCT01667731|78954278|FG002|Overall Study|Lost to Follow-up|1|||
44161592|NCT01667731|78954279|FG003|Overall Study|Lost to Follow-up|1|||
44161593|NCT01667731|78954280|FG004|Overall Study|Lost to Follow-up|2|||
44161594|NCT01667731|78954276|FG000|Overall Study|Subject Withdrew Consent|2|||
44161595|NCT01667731|78954277|FG001|Overall Study|Subject Withdrew Consent|0|||
44161596|NCT01667731|78954278|FG002|Overall Study|Subject Withdrew Consent|1|||
44161597|NCT01667731|78954279|FG003|Overall Study|Subject Withdrew Consent|0|||
44161598|NCT01667731|78954280|FG004|Overall Study|Subject Withdrew Consent|1|||
44161599|NCT01667731|78954276|FG000|Overall Study|Death|0|||
44161600|NCT01667731|78954277|FG001|Overall Study|Death|1|||
44161601|NCT01667731|78954278|FG002|Overall Study|Death|0|||
44161602|NCT01667731|78954279|FG003|Overall Study|Death|0|||
44161603|NCT01667731|78954280|FG004|Overall Study|Death|0|||
44161604|NCT02605837|78954295|FG000|Overall Study|Adverse Event|3|||
44161605|NCT02605837|78954296|FG001|Overall Study|Adverse Event|1|||
44161606|NCT02605837|78954295|FG000|Overall Study|Non-Compliance with Study Drug|0|||
44161607|NCT02605837|78954296|FG001|Overall Study|Non-Compliance with Study Drug|1|||
44161608|NCT02605837|78954295|FG000|Overall Study|Withdrawal by Subject|8|||
44161609|NCT02605837|78954296|FG001|Overall Study|Withdrawal by Subject|8|||
44161610|NCT02605837|78954295|FG000|Overall Study|Physician Decision|0|||
44161611|NCT02605837|78954296|FG001|Overall Study|Physician Decision|1|||
44444931|NCT03635983|79452804|FG001|Treatment Period|Poor/Non-compliance|0|||
44161612|NCT02423343|78954309|FG000|Overall Study|Withdrawal by Subject|0|||
44161613|NCT02423343|78954310|FG001|Overall Study|Withdrawal by Subject|1|||
44161614|NCT02423343|78954311|FG002|Overall Study|Withdrawal by Subject|0|||
44161615|NCT02423343|78954312|FG003|Overall Study|Withdrawal by Subject|0|||
44161616|NCT02423343|78954313|FG004|Overall Study|Withdrawal by Subject|0|||
44161617|NCT02423343|78954314|FG005|Overall Study|Withdrawal by Subject|0|||
44161618|NCT02423343|78954309|FG000|Overall Study|Progressive Disease|0|||
44444932|NCT03635983|79452803|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
44161619|NCT02423343|78954310|FG001|Overall Study|Progressive Disease|0|||
44161620|NCT02423343|78954311|FG002|Overall Study|Progressive Disease|0|||
44161621|NCT02423343|78954312|FG003|Overall Study|Progressive Disease|0|||
44161622|NCT02423343|78954313|FG004|Overall Study|Progressive Disease|2|||
44161623|NCT02423343|78954314|FG005|Overall Study|Progressive Disease|0|||
44161624|NCT02423343|78954309|FG000|Overall Study|Adverse Event|0|||
44161625|NCT02423343|78954310|FG001|Overall Study|Adverse Event|0|||
44161626|NCT02423343|78954311|FG002|Overall Study|Adverse Event|0|||
44161627|NCT02423343|78954312|FG003|Overall Study|Adverse Event|0|||
44161628|NCT02423343|78954313|FG004|Overall Study|Adverse Event|2|||
44161629|NCT02423343|78954314|FG005|Overall Study|Adverse Event|0|||
44161630|NCT02423343|78954309|FG000|Overall Study|Death|0|||
44161631|NCT02423343|78954310|FG001|Overall Study|Death|0|||
44161632|NCT02423343|78954311|FG002|Overall Study|Death|0|||
44161633|NCT02423343|78954312|FG003|Overall Study|Death|0|||
44161634|NCT02423343|78954313|FG004|Overall Study|Death|1|||
44161635|NCT02423343|78954314|FG005|Overall Study|Death|0|||
44161636|NCT02605447|78954342|FG000|Overall Study|Death|66|||
44161637|NCT02605447|78954342|FG000|Overall Study|Physician Decision|1|||
44161638|NCT02605447|78954342|FG000|Overall Study|Lost to Follow-up|24|||
44161639|NCT02605447|78954342|FG000|Overall Study|Withdrawal by Subject|10|||
44161640|NCT02605447|78954342|FG000|Overall Study|Not disclosed|1|||
44161641|NCT02485899|78954349|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
44161642|NCT02485899|78954350|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
44161643|NCT02485899|78954349|FG000|Overall Study|Withdrawal by Subject|1|||
44161644|NCT02485899|78954350|FG001|Overall Study|Withdrawal by Subject|0|||
44161645|NCT02485899|78954349|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
44161646|NCT02485899|78954350|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
44161647|NCT02423109|78954356|FG000|Lens 1|Adverse Event|1|||
44161648|NCT02423109|78954357|FG001|Lens 1|Adverse Event|0|||
44161649|NCT02420691|78954365|FG000|Overall Study|Adverse Event|3|||
44161650|NCT02420691|78954365|FG000|Overall Study|Withdrawal by Subject|3|||
44161651|NCT02406651|78954369|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
44161652|NCT02406261|78954376|FG000|Period 1|Lost to Follow-up|2|||
44161653|NCT02406261|78954377|FG001|Period 1|Lost to Follow-up|0|||
44161654|NCT02406261|78954376|FG000|Period 1|Adverse Event|1|||
44161655|NCT02406261|78954377|FG001|Period 1|Adverse Event|0|||
44161656|NCT02406261|78954376|FG000|Period 2|Physician Decision|0|||
44161657|NCT02406261|78954377|FG001|Period 2|Physician Decision|1|||
44161658|NCT02406261|78954376|FG000|Period 2|Protocol Violation|0|||
44161659|NCT02406261|78954377|FG001|Period 2|Protocol Violation|1|||
44161660|NCT02406261|78954376|FG000|Period 2|Withdrawal by Subject|0|||
44161661|NCT02406261|78954377|FG001|Period 2|Withdrawal by Subject|1|||
44161662|NCT02405091|78954387|FG000|Overall Study|Adverse Event|16|||
44161663|NCT02405091|78954388|FG001|Overall Study|Adverse Event|10|||
44161664|NCT02405091|78954389|FG002|Overall Study|Adverse Event|0|||
44161665|NCT02405091|78954387|FG000|Overall Study|Protocol Violation|1|||
44161666|NCT02405091|78954388|FG001|Overall Study|Protocol Violation|0|||
44161667|NCT02405091|78954389|FG002|Overall Study|Protocol Violation|0|||
44161668|NCT02405091|78954387|FG000|Overall Study|Noncompliance|1|||
44161669|NCT02405091|78954388|FG001|Overall Study|Noncompliance|6|||
44161670|NCT02405091|78954389|FG002|Overall Study|Noncompliance|2|||
44161671|NCT02405091|78954387|FG000|Overall Study|Withdrawal by Subject|4|||
44161672|NCT02405091|78954388|FG001|Overall Study|Withdrawal by Subject|8|||
44161673|NCT02405091|78954389|FG002|Overall Study|Withdrawal by Subject|0|||
44161674|NCT02405091|78954387|FG000|Overall Study|Death|0|||
44161675|NCT02405091|78954388|FG001|Overall Study|Death|1|||
44161676|NCT02405091|78954389|FG002|Overall Study|Death|0|||
44161677|NCT02405091|78954387|FG000|Overall Study|Lost to Follow-up|5|||
44161678|NCT02405091|78954388|FG001|Overall Study|Lost to Follow-up|6|||
44161679|NCT02405091|78954389|FG002|Overall Study|Lost to Follow-up|0|||
44161680|NCT02405091|78954387|FG000|Overall Study|Physician Decision|2|||
44161681|NCT02405091|78954388|FG001|Overall Study|Physician Decision|2|||
44161682|NCT02405091|78954389|FG002|Overall Study|Physician Decision|0|||
44161683|NCT02485353|78954400|FG000|Overall Study|Death|1|||
44161684|NCT02485353|78954400|FG000|Overall Study|Disease Progression|1|||
44161685|NCT02603107|78954406|FG000|Randomized Phase|Withdrew consent|8|||
44161686|NCT02603107|78954407|FG001|Randomized Phase|Withdrew consent|15|||
44161687|NCT02603107|78954406|FG000|Randomized Phase|Lost to Follow-up|1|||
44161688|NCT02603107|78954407|FG001|Randomized Phase|Lost to Follow-up|3|||
44161689|NCT02603107|78954406|FG000|Randomized Phase|Adverse Event|2|||
44161690|NCT02603107|78954407|FG001|Randomized Phase|Adverse Event|0|||
44161691|NCT02603107|78954406|FG000|Randomized Phase|Death|1|||
44161692|NCT02603107|78954407|FG001|Randomized Phase|Death|1|||
44161693|NCT02603107|78954406|FG000|Randomized Phase|Non-compliance with study drug|1|||
44161694|NCT02603107|78954407|FG001|Randomized Phase|Non-compliance with study drug|1|||
44161695|NCT02603107|78954406|FG000|Randomized Phase|Investigator's discretion|0|||
44161696|NCT02603107|78954407|FG001|Randomized Phase|Investigator's discretion|1|||
44161697|NCT02603107|78954406|FG000|Randomized Phase|Lack of Efficacy|1|||
44161698|NCT02603107|78954407|FG001|Randomized Phase|Lack of Efficacy|0|||
44161699|NCT02603107|78954406|FG000|Randomized Phase|Protocol Violation|1|||
44161700|NCT02603107|78954407|FG001|Randomized Phase|Protocol Violation|0|||
44161701|NCT02603107|78954406|FG000|Optional Extension Phase|Lost to Follow-up|3|||
44161702|NCT02603107|78954407|FG001|Optional Extension Phase|Lost to Follow-up|3|||
44161703|NCT02603107|78954406|FG000|Optional Extension Phase|Withdrew consent|3|||
44161704|NCT02603107|78954407|FG001|Optional Extension Phase|Withdrew consent|2|||
44161705|NCT02603107|78954406|FG000|Optional Extension Phase|Investigator's discretion|2|||
44161706|NCT02603107|78954407|FG001|Optional Extension Phase|Investigator's discretion|2|||
44161707|NCT02603107|78954406|FG000|Optional Extension Phase|Pregnancy|0|||
44161708|NCT02603107|78954407|FG001|Optional Extension Phase|Pregnancy|3|||
44161709|NCT02603107|78954406|FG000|Optional Extension Phase|Adverse Event|0|||
44161710|NCT02603107|78954407|FG001|Optional Extension Phase|Adverse Event|2|||
44161711|NCT02603107|78954406|FG000|Optional Extension Phase|Not treated in extension phase|0|||
44161712|NCT02603107|78954407|FG001|Optional Extension Phase|Not treated in extension phase|1|||
44161713|NCT02603107|78954406|FG000|Optional Extension Phase|Protocol Violation|1|||
44161714|NCT02603107|78954407|FG001|Optional Extension Phase|Protocol Violation|0|||
44161715|NCT02484729|78954425|FG000|Overall Study|Failure of IntelliCap Error|0|||
44161716|NCT02484729|78954426|FG001|Overall Study|Failure of IntelliCap Error|0|||
44161717|NCT02484729|78954427|FG002|Overall Study|Failure of IntelliCap Error|0|||
44161718|NCT02484729|78954428|FG003|Overall Study|Failure of IntelliCap Error|0|||
44161719|NCT02484729|78954429|FG004|Overall Study|Failure of IntelliCap Error|0|||
44161720|NCT02484729|78954430|FG005|Overall Study|Failure of IntelliCap Error|0|||
44161721|NCT02484729|78954431|FG006|Overall Study|Failure of IntelliCap Error|0|||
44161722|NCT02484729|78954432|FG007|Overall Study|Failure of IntelliCap Error|0|||
44161723|NCT02484729|78954433|FG008|Overall Study|Failure of IntelliCap Error|0|||
44161724|NCT02484729|78954434|FG009|Overall Study|Failure of IntelliCap Error|1|||
44161725|NCT02601625|78954472|FG000|Overall Study|Lost to Follow-up|0|||
44161726|NCT02601625|78954473|FG001|Overall Study|Lost to Follow-up|0|||
44161727|NCT02601625|78954474|FG002|Overall Study|Lost to Follow-up|1|||
44161728|NCT02601625|78954475|FG003|Overall Study|Lost to Follow-up|1|||
44161729|NCT02601469|78954501|FG000|Overall Study|Enrolled in Error|1|||
44161730|NCT02601469|78954502|FG001|Overall Study|Enrolled in Error|0|||
44161731|NCT02604589|78954511|FG000|Overall Study|catheter dislodgement|0|||
44161732|NCT02604589|78954512|FG001|Overall Study|catheter dislodgement|0|||
44161733|NCT02604589|78954513|FG002|Overall Study|catheter dislodgement|1|||
44161734|NCT02601001|78954524|FG000|Dosing Period 2|Adverse Event|0|||
44161735|NCT02601001|78954525|FG001|Dosing Period 2|Adverse Event|0|||
44161736|NCT02601001|78954526|FG002|Dosing Period 2|Adverse Event|0|||
44161737|NCT02601001|78954527|FG003|Dosing Period 2|Adverse Event|0|||
44161738|NCT02601001|78954528|FG004|Dosing Period 2|Adverse Event|0|||
44161739|NCT02601001|78954529|FG005|Dosing Period 2|Adverse Event|0|||
44161740|NCT02601001|78954530|FG006|Dosing Period 2|Adverse Event|1|||
44161741|NCT02604199|78954555|FG000|Overall Study|Pregnancy|0|||
44161742|NCT02604199|78954556|FG001|Overall Study|Pregnancy|0|||
44161743|NCT02604199|78954557|FG002|Overall Study|Pregnancy|0|||
44161744|NCT02604199|78954558|FG003|Overall Study|Pregnancy|1|||
44161745|NCT02604199|78954555|FG000|Overall Study|Study terminated by sponsor|0|||
44161746|NCT02604199|78954556|FG001|Overall Study|Study terminated by sponsor|2|||
44161747|NCT02604199|78954557|FG002|Overall Study|Study terminated by sponsor|0|||
44161748|NCT02604199|78954558|FG003|Overall Study|Study terminated by sponsor|2|||
44161749|NCT02604199|78954555|FG000|Overall Study|Withdrawal by Subject|0|||
44161750|NCT02604199|78954556|FG001|Overall Study|Withdrawal by Subject|1|||
44161751|NCT02604199|78954557|FG002|Overall Study|Withdrawal by Subject|0|||
44161752|NCT02604199|78954558|FG003|Overall Study|Withdrawal by Subject|0|||
44161753|NCT02600845|78954571|FG000|Overall Study|Reason Not Specified|3|||
44161754|NCT02600845|78954571|FG000|Overall Study|Non-compliance with Study Procedures|10|||
44161755|NCT02600845|78954571|FG000|Overall Study|Consent Withdrawal|5|||
44161756|NCT02599129|78954577|FG000|Overall Study|Lack of Efficacy|2|||
44161757|NCT02599129|78954578|FG001|Overall Study|Lack of Efficacy|2|||
44161758|NCT02599129|78954577|FG000|Overall Study|Lost to Follow-up|1|||
44161759|NCT02599129|78954578|FG001|Overall Study|Lost to Follow-up|0|||
44161760|NCT02599129|78954577|FG000|Overall Study|Withdrawal by Subject|2|||
44161761|NCT02599129|78954578|FG001|Overall Study|Withdrawal by Subject|1|||
44161762|NCT02596711|78954587|FG000|Overall Study|Lost to Follow-up|1|||
44444933|NCT03635983|79452804|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
44161763|NCT02596711|78954588|FG001|Overall Study|Lost to Follow-up|2|||
44161764|NCT02596711|78954589|FG002|Overall Study|Lost to Follow-up|3|||
44161765|NCT02596009|78954597|FG000|Overall Study|Administrative problems|0|||
44161766|NCT02596009|78954598|FG001|Overall Study|Administrative problems|1|||
44161767|NCT02596009|78954599|FG002|Overall Study|Administrative problems|0|||
44161768|NCT02596009|78954600|FG003|Overall Study|Administrative problems|0|||
44161769|NCT02596009|78954601|FG004|Overall Study|Administrative problems|0|||
44161770|NCT02596009|78954602|FG005|Overall Study|Administrative problems|0|||
44161771|NCT02590939|78954610|FG000|Overall Study|Withdrawal by Subject|3|||
44444934|NCT03635983|79452803|FG000|Treatment Period|Other reasons|5|||
44444935|NCT03635983|79452804|FG001|Treatment Period|Other reasons|2|||
44161772|NCT02590939|78954611|FG001|Overall Study|Withdrawal by Subject|1|||
44161773|NCT02590939|78954610|FG000|Overall Study|Failed the nociceptive test|2|||
44161774|NCT02590939|78954611|FG001|Overall Study|Failed the nociceptive test|1|||
44161775|NCT04351087|78954619|FG000|Overall Study|Lost to Follow-up|7|||
44161776|NCT04351087|78954620|FG001|Overall Study|Lost to Follow-up|3|||
44161777|NCT04351087|78954619|FG000|Overall Study|Withdrawal by Subject|3|||
44161778|NCT04351087|78954620|FG001|Overall Study|Withdrawal by Subject|4|||
44161779|NCT04351087|78954619|FG000|Overall Study|Lack of Efficacy|3|||
44161780|NCT04351087|78954620|FG001|Overall Study|Lack of Efficacy|2|||
44161781|NCT02598193|78954626|FG000|Overall Study|Adverse Event|13|||
44161782|NCT02598193|78954626|FG000|Overall Study|Withdrawal by Subject|1|||
44161783|NCT02598193|78954626|FG000|Overall Study|Listed in active lung transplant list|1|||
44161784|NCT02598193|78954626|FG000|Overall Study|Does not want to take Nintedanib|1|||
44161785|NCT02595073|78954632|FG000|Overall Study|Progressive Disease|0|||
44161786|NCT02595073|78954633|FG001|Overall Study|Progressive Disease|1|||
44161787|NCT02595073|78954632|FG000|Overall Study|Protocol Violation|2|||
44161788|NCT02595073|78954633|FG001|Overall Study|Protocol Violation|0|||
44161789|NCT02593825|78954641|FG000|Intervention|Lost to Follow-up|10|||
44161790|NCT02593825|78954642|FG001|Intervention|Lost to Follow-up|12|||
44161791|NCT02388165|78954652|FG000|Overall Study|Study terminated by sponsor|5|||
44161792|NCT02388165|78954653|FG001|Overall Study|Study terminated by sponsor|5|||
44161793|NCT02388165|78954652|FG000|Overall Study|Other|11|||
44161794|NCT02388165|78954653|FG001|Overall Study|Other|13|||
44161795|NCT02388165|78954652|FG000|Overall Study|No longer meet eligibility criteria|40|||
44161796|NCT02388165|78954653|FG001|Overall Study|No longer meet eligibility criteria|43|||
44161797|NCT02388165|78954652|FG000|Overall Study|Withdrawal of consent|31|||
44161798|NCT02388165|78954653|FG001|Overall Study|Withdrawal of consent|32|||
44161799|NCT02388165|78954652|FG000|Overall Study|Lost to Follow-up|19|||
44161800|NCT02388165|78954653|FG001|Overall Study|Lost to Follow-up|20|||
44161801|NCT02388165|78954652|FG000|Overall Study|Death|13|||
44161802|NCT02388165|78954653|FG001|Overall Study|Death|10|||
44161803|NCT02388165|78954652|FG000|Overall Study|Adverse Event|3|||
44161804|NCT02388165|78954653|FG001|Overall Study|Adverse Event|5|||
44161805|NCT02388165|78954652|FG000|Overall Study|Did not meet entrance criteria|5|||
44161806|NCT02388165|78954653|FG001|Overall Study|Did not meet entrance criteria|2|||
44161807|NCT02404545|78954661|FG000|Overall Study|Sponsor Termination|6|||
44161808|NCT02404545|78954662|FG001|Overall Study|Sponsor Termination|6|||
44161809|NCT02420379|78954671|FG000|Overall Study|Withdrawal by Subject|0|||
44161810|NCT02420379|78954672|FG001|Overall Study|Withdrawal by Subject|3|||
44161811|NCT02420379|78954671|FG000|Overall Study|Unable to complete due to schooling|0|||
44161812|NCT02420379|78954672|FG001|Overall Study|Unable to complete due to schooling|1|||
44161813|NCT02420379|78954671|FG000|Overall Study|Transitioned to commercial drug|1|||
44161814|NCT02420379|78954672|FG001|Overall Study|Transitioned to commercial drug|0|||
44161815|NCT02347761|78954681|FG000|All Collected|Death|1|||
44161816|NCT02347761|78954682|FG001|All Collected|Death|0|||
44161817|NCT02347761|78954683|FG002|All Collected|Death|0|||
44161818|NCT02347761|78954681|FG000|All Collected|Lost to Follow-up|3|||
44161819|NCT02347761|78954682|FG001|All Collected|Lost to Follow-up|2|||
44161820|NCT02347761|78954683|FG002|All Collected|Lost to Follow-up|3|||
44161821|NCT02347761|78954681|FG000|All Collected|Withdrawal by Subject|11|||
44161822|NCT02347761|78954682|FG001|All Collected|Withdrawal by Subject|11|||
44161823|NCT02347761|78954683|FG002|All Collected|Withdrawal by Subject|22|||
44161824|NCT02347761|78954681|FG000|All Collected|invetigator disretion|2|||
44161825|NCT02347761|78954682|FG001|All Collected|invetigator disretion|0|||
44161826|NCT02347761|78954683|FG002|All Collected|invetigator disretion|0|||
44161827|NCT02347761|78954681|FG000|All Collected|instillation site pain|0|||
44161828|NCT02347761|78954682|FG001|All Collected|instillation site pain|0|||
44161829|NCT02347761|78954683|FG002|All Collected|instillation site pain|1|||
44161830|NCT02347761|78954681|FG000|All Collected|exacerbation of COPD|0|||
44161831|NCT02347761|78954682|FG001|All Collected|exacerbation of COPD|0|||
44161832|NCT02347761|78954683|FG002|All Collected|exacerbation of COPD|1|||
44161833|NCT02347761|78954681|FG000|All Collected|moved/travel|0|||
44161834|NCT02347761|78954682|FG001|All Collected|moved/travel|1|||
44161835|NCT02347761|78954683|FG002|All Collected|moved/travel|0|||
44161836|NCT02347761|78954681|FG000|On Study Treatment|Lack of Efficacy|2|||
44161837|NCT02347761|78954682|FG001|On Study Treatment|Lack of Efficacy|3|||
44161838|NCT02347761|78954683|FG002|On Study Treatment|Lack of Efficacy|4|||
44161839|NCT02347761|78954681|FG000|On Study Treatment|non-compliance with study medication|0|||
44161840|NCT02347761|78954682|FG001|On Study Treatment|non-compliance with study medication|0|||
44161841|NCT02347761|78954683|FG002|On Study Treatment|non-compliance with study medication|2|||
44444936|NCT03635983|79452803|FG000|Treatment Period|Disease progression|184|||
44161842|NCT02347761|78954681|FG000|On Study Treatment|Withdrawal by Subject|7|||
44161843|NCT02347761|78954682|FG001|On Study Treatment|Withdrawal by Subject|3|||
44161844|NCT02347761|78954683|FG002|On Study Treatment|Withdrawal by Subject|5|||
44161845|NCT02347761|78954681|FG000|On Study Treatment|move/travel|2|||
44161846|NCT02347761|78954682|FG001|On Study Treatment|move/travel|6|||
44161847|NCT02347761|78954683|FG002|On Study Treatment|move/travel|5|||
44161848|NCT02347761|78954681|FG000|On Study Treatment|dissastisfaction with device|2|||
44161849|NCT02347761|78954682|FG001|On Study Treatment|dissastisfaction with device|1|||
44161850|NCT02347761|78954683|FG002|On Study Treatment|dissastisfaction with device|4|||
44161851|NCT02347761|78954681|FG000|On Study Treatment|Lost to Follow-up|2|||
44161852|NCT02347761|78954682|FG001|On Study Treatment|Lost to Follow-up|1|||
44161853|NCT02347761|78954683|FG002|On Study Treatment|Lost to Follow-up|1|||
44161854|NCT02347761|78954681|FG000|On Study Treatment|investigator discretion|2|||
44161855|NCT02347761|78954682|FG001|On Study Treatment|investigator discretion|0|||
44161856|NCT02347761|78954683|FG002|On Study Treatment|investigator discretion|0|||
44161857|NCT02347761|78954681|FG000|On Study Treatment|durg not working|0|||
44161858|NCT02347761|78954682|FG001|On Study Treatment|durg not working|1|||
44161859|NCT02347761|78954683|FG002|On Study Treatment|durg not working|1|||
44161860|NCT02347761|78954681|FG000|On Study Treatment|Adverse Event|10|||
44161861|NCT02347761|78954682|FG001|On Study Treatment|Adverse Event|8|||
44161862|NCT02347761|78954683|FG002|On Study Treatment|Adverse Event|20|||
44161863|NCT02596945|78954691|FG000|Overall Study|No documentation of study drug dosing|3|||
44161864|NCT02596945|78954691|FG000|Overall Study|Other|32|||
44161865|NCT02596945|78954691|FG000|Overall Study|Change to hemodialysis|15|||
44161866|NCT02596945|78954691|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
44161867|NCT02596945|78954691|FG000|Overall Study|Withdrawal by Subject|1|||
44161868|NCT02596945|78954691|FG000|Overall Study|Missing|1|||
44161869|NCT02404389|78954709|FG000|Overall Study|Adverse Event|1|||
44161870|NCT02404389|78954710|FG001|Overall Study|Adverse Event|0|||
44161871|NCT02404389|78954711|FG002|Overall Study|Adverse Event|1|||
44161872|NCT02404389|78954712|FG003|Overall Study|Adverse Event|0|||
44161873|NCT02404389|78954713|FG004|Overall Study|Adverse Event|2|||
44161874|NCT02404389|78954709|FG000|Overall Study|Subject/guardian decision|1|||
44161875|NCT02404389|78954710|FG001|Overall Study|Subject/guardian decision|0|||
44161876|NCT02404389|78954711|FG002|Overall Study|Subject/guardian decision|0|||
44161877|NCT02404389|78954712|FG003|Overall Study|Subject/guardian decision|1|||
44161878|NCT02404389|78954713|FG004|Overall Study|Subject/guardian decision|1|||
44161879|NCT01667419|78954731|FG000|Overall Study|Reason Not Specified|1|||
44161880|NCT01667419|78954732|FG001|Overall Study|Reason Not Specified|0|||
44161881|NCT01667419|78954733|FG002|Overall Study|Reason Not Specified|0|||
44161882|NCT01667419|78954734|FG003|Overall Study|Reason Not Specified|0|||
44161883|NCT01667419|78954731|FG000|Overall Study|Withdrawal by Subject|16|||
44161884|NCT01667419|78954732|FG001|Overall Study|Withdrawal by Subject|8|||
44161885|NCT01667419|78954733|FG002|Overall Study|Withdrawal by Subject|9|||
44161886|NCT01667419|78954734|FG003|Overall Study|Withdrawal by Subject|8|||
44161887|NCT01667419|78954731|FG000|Overall Study|Non-compliance|0|||
44161888|NCT01667419|78954732|FG001|Overall Study|Non-compliance|0|||
44161889|NCT01667419|78954733|FG002|Overall Study|Non-compliance|0|||
44161890|NCT01667419|78954734|FG003|Overall Study|Non-compliance|1|||
44161891|NCT01667419|78954731|FG000|Overall Study|Protocol Violation|1|||
44161892|NCT01667419|78954732|FG001|Overall Study|Protocol Violation|0|||
44161893|NCT01667419|78954733|FG002|Overall Study|Protocol Violation|0|||
44161894|NCT01667419|78954734|FG003|Overall Study|Protocol Violation|0|||
44161895|NCT01667419|78954731|FG000|Overall Study|Lost to Follow-up|7|||
44161896|NCT01667419|78954732|FG001|Overall Study|Lost to Follow-up|6|||
44161897|NCT01667419|78954733|FG002|Overall Study|Lost to Follow-up|2|||
44161898|NCT01667419|78954734|FG003|Overall Study|Lost to Follow-up|4|||
44161899|NCT01667419|78954731|FG000|Overall Study|Death|18|||
44161900|NCT01667419|78954732|FG001|Overall Study|Death|33|||
44161901|NCT01667419|78954733|FG002|Overall Study|Death|25|||
44161902|NCT01667419|78954734|FG003|Overall Study|Death|26|||
44161903|NCT02588833|78954751|FG000|Part 1|Withdrawal by Subject|1|||
44161904|NCT02588833|78954752|FG001|Part 1|Withdrawal by Subject|0|||
44161905|NCT02588833|78954751|FG000|Part 2A|Physician Decision|0|||
44161906|NCT02588833|78954752|FG001|Part 2A|Physician Decision|1|||
44161907|NCT02588833|78954751|FG000|Part 2A|Withdrawal by Subject|0|||
44161908|NCT02588833|78954752|FG001|Part 2A|Withdrawal by Subject|1|||
44161909|NCT02588833|78954751|FG000|Part 2B|Adverse Event|0|||
44161910|NCT02588833|78954752|FG001|Part 2B|Adverse Event|1|||
44161911|NCT02588833|78954751|FG000|Part 2C|Adverse Event|0|||
44161912|NCT02588833|78954752|FG001|Part 2C|Adverse Event|1|||
44345113|NCT01252290|79349160|FG000|Overall Study|Withdrawal by Subject|1|||
44161913|NCT02588833|78954751|FG000|Part 2C|Withdrawal by Subject|0|||
44161914|NCT02588833|78954752|FG001|Part 2C|Withdrawal by Subject|1|||
44161915|NCT02588833|78954751|FG000|Part 3 (Safety Follow-up)|Other|0|||
44161916|NCT02588833|78954752|FG001|Part 3 (Safety Follow-up)|Other|2|||
44161917|NCT01667107|78954761|FG000|Overall Study|Adverse Event|4|||
44161918|NCT01667107|78954762|FG001|Overall Study|Adverse Event|3|||
44161919|NCT01667107|78954761|FG000|Overall Study|Tolerability issues|0|||
44161920|NCT01667107|78954762|FG001|Overall Study|Tolerability issues|2|||
44161921|NCT01667107|78954761|FG000|Overall Study|Protocol Violation|0|||
44161922|NCT01667107|78954762|FG001|Overall Study|Protocol Violation|1|||
44161923|NCT01667107|78954761|FG000|Overall Study|Lack of Efficacy|0|||
44161924|NCT01667107|78954762|FG001|Overall Study|Lack of Efficacy|1|||
44161925|NCT02590003|78954786|FG000|Overall Study|Death|1|||
44161926|NCT02590003|78954787|FG001|Overall Study|Death|2|||
44161927|NCT02404311|78954816|FG000|Part A: Month 0-18|Death|2|||
44161928|NCT02404311|78954817|FG001|Part A: Month 0-18|Death|0|||
44161929|NCT02404311|78954818|FG002|Part A: Month 0-18|Death|0|||
44161930|NCT02404311|78954819|FG003|Part A: Month 0-18|Death|0|||
44161931|NCT02404311|78954820|FG004|Part A: Month 0-18|Death|0|||
44161932|NCT02404311|78954816|FG000|Part A: Month 0-18|Physician Decision|1|||
44161933|NCT02404311|78954817|FG001|Part A: Month 0-18|Physician Decision|0|||
44161934|NCT02404311|78954818|FG002|Part A: Month 0-18|Physician Decision|0|||
44161935|NCT02404311|78954819|FG003|Part A: Month 0-18|Physician Decision|0|||
44161936|NCT02404311|78954820|FG004|Part A: Month 0-18|Physician Decision|0|||
44161937|NCT02404311|78954816|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
44161938|NCT02404311|78954817|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
44161939|NCT02404311|78954818|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
44161940|NCT02404311|78954819|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
44161941|NCT02404311|78954820|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
44161942|NCT02404311|78954816|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
44161943|NCT02404311|78954817|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
44161944|NCT02404311|78954818|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
44161945|NCT02404311|78954819|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
44161946|NCT02404311|78954820|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
44161947|NCT02404311|78954816|FG000|Part A: Month 0-18|HIV Infection|6|||
44161948|NCT02404311|78954817|FG001|Part A: Month 0-18|HIV Infection|2|||
44161949|NCT02404311|78954818|FG002|Part A: Month 0-18|HIV Infection|0|||
44161950|NCT02404311|78954819|FG003|Part A: Month 0-18|HIV Infection|0|||
44161951|NCT02404311|78954820|FG004|Part A: Month 0-18|HIV Infection|0|||
44161952|NCT02404311|78954816|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
44161953|NCT02404311|78954817|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
44161954|NCT02404311|78954818|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
44161955|NCT02404311|78954819|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
44161956|NCT02404311|78954820|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
44161957|NCT01650519|78954834|FG000|Overall Study|Withdrawal by Subject|1|||
44161958|NCT01650519|78954835|FG001|Overall Study|Withdrawal by Subject|0|||
44161959|NCT01650285|78954841|FG000|Overall Study|Adverse Event|1|||
44161960|NCT02347527|78954849|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
44161961|NCT02347527|78954850|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
44161962|NCT02347527|78954851|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
44161963|NCT02347527|78954852|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
44161964|NCT02347527|78954849|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
44161965|NCT02347527|78954850|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
44161966|NCT02347527|78954851|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
44161967|NCT02347527|78954852|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
44161968|NCT02347527|78954849|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
44161969|NCT02347527|78954850|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
44161970|NCT02347527|78954851|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
44161971|NCT02347527|78954852|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
44161972|NCT02347527|78954849|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
44161973|NCT02347527|78954850|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
44161974|NCT02347527|78954851|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
44161975|NCT02347527|78954852|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
44161976|NCT02347527|78954849|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
44161977|NCT02347527|78954850|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
44161978|NCT02347527|78954851|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
44161979|NCT02347527|78954852|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
44161980|NCT02386839|78954866|FG000|Overall Study|Death|1|||
44161981|NCT02386839|78954867|FG001|Overall Study|Death|0|||
44161982|NCT02386839|78954866|FG000|Overall Study|Withdrawal by Subject|9|||
44161983|NCT02386839|78954867|FG001|Overall Study|Withdrawal by Subject|10|||
44161984|NCT02386839|78954866|FG000|Overall Study|Lost to Follow-up|4|||
44161985|NCT02386839|78954867|FG001|Overall Study|Lost to Follow-up|4|||
44161986|NCT02386839|78954866|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
44161987|NCT02386839|78954867|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
44161988|NCT02386839|78954866|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
44161989|NCT02386839|78954867|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
44161990|NCT02386839|78954866|FG000|Overall Study|Other (unspecified)|1|||
44161991|NCT02386839|78954867|FG001|Overall Study|Other (unspecified)|0|||
44161992|NCT01649271|78954879|FG000|Overall Study|Progressive disease|4|||
44161993|NCT01649271|78954880|FG001|Overall Study|Progressive disease|5|||
44161994|NCT01649271|78954879|FG000|Overall Study|Other Adverse Event|0|||
44161995|NCT01649271|78954880|FG001|Overall Study|Other Adverse Event|2|||
44161996|NCT01649271|78954879|FG000|Overall Study|Withdrawal by Subject|1|||
44161997|NCT01649271|78954880|FG001|Overall Study|Withdrawal by Subject|0|||
44161998|NCT01649271|78954879|FG000|Overall Study|Other than stated above|1|||
44161999|NCT01649271|78954880|FG001|Overall Study|Other than stated above|0|||
44162000|NCT02385669|78954887|FG000|Overall Study|Adverse Event|2|||
44162001|NCT02402907|78954893|FG000|Overall Study|Delivered vaginally|9|||
44162002|NCT02402907|78954894|FG001|Overall Study|Delivered vaginally|3|||
44162003|NCT02402907|78954893|FG000|Overall Study|Delivered outside of Sinai|1|||
44162004|NCT02402907|78954894|FG001|Overall Study|Delivered outside of Sinai|1|||
44162005|NCT02402907|78954893|FG000|Overall Study|Lost to follow up after C-Section|10|||
44162006|NCT02402907|78954894|FG001|Overall Study|Lost to follow up after C-Section|23|||
44162007|NCT02345889|78954904|FG000|Overall Study|Inadequate Bowel Prep|17|||
44162008|NCT02345889|78954905|FG001|Overall Study|Inadequate Bowel Prep|16|||
44162009|NCT02345889|78954906|FG002|Overall Study|Inadequate Bowel Prep|18|||
44162010|NCT02345889|78954907|FG003|Overall Study|Inadequate Bowel Prep|14|||
44162011|NCT02345889|78954904|FG000|Overall Study|Polyposis identified during procedure|1|||
44162012|NCT02345889|78954905|FG001|Overall Study|Polyposis identified during procedure|1|||
44162013|NCT02345889|78954906|FG002|Overall Study|Polyposis identified during procedure|0|||
44162014|NCT02345889|78954907|FG003|Overall Study|Polyposis identified during procedure|1|||
44162015|NCT02345889|78954904|FG000|Overall Study|Recognized ineligible post-randomization|1|||
44162016|NCT02345889|78954905|FG001|Overall Study|Recognized ineligible post-randomization|0|||
44162017|NCT02345889|78954906|FG002|Overall Study|Recognized ineligible post-randomization|2|||
44162018|NCT02345889|78954907|FG003|Overall Study|Recognized ineligible post-randomization|1|||
44162019|NCT02345889|78954904|FG000|Overall Study|Ulcerative Colitis identified|1|||
44162020|NCT02345889|78954905|FG001|Overall Study|Ulcerative Colitis identified|0|||
44162021|NCT02345889|78954906|FG002|Overall Study|Ulcerative Colitis identified|0|||
44162022|NCT02345889|78954907|FG003|Overall Study|Ulcerative Colitis identified|0|||
44162023|NCT02345889|78954904|FG000|Overall Study|Cecum not intubated|1|||
44162024|NCT02345889|78954905|FG001|Overall Study|Cecum not intubated|0|||
44162025|NCT02345889|78954906|FG002|Overall Study|Cecum not intubated|0|||
44162026|NCT02345889|78954907|FG003|Overall Study|Cecum not intubated|0|||
44162027|NCT02345811|78954917|FG000|First Intervention|Withdrawal by Subject|1|||
44162028|NCT02345811|78954918|FG001|First Intervention|Withdrawal by Subject|1|||
44162029|NCT02344173|78954926|FG000|Procedure|Ablation Procedure Not Performed|7|||
44162030|NCT02344173|78954926|FG000|12-month Visit|Death|8|||
44162031|NCT02344173|78954926|FG000|12-month Visit|Withdrawal by Subject|30|||
44162032|NCT02344173|78954926|FG000|12-month Visit|Lost to Follow-up|58|||
44162033|NCT02586493|78954932|FG000|Overall Study|Adverse Event|4|||
44162034|NCT02586493|78954932|FG000|Overall Study|Protocol Violation|6|||
44162035|NCT02586493|78954932|FG000|Overall Study|Lost to Follow-up|1|||
44162036|NCT02586493|78954932|FG000|Overall Study|Withdrawal by Subject|1|||
44162037|NCT02400333|78954940|FG000|Overall Study|Withdrawal by Subject|0|||
44162038|NCT02400333|78954941|FG001|Overall Study|Withdrawal by Subject|1|||
44162039|NCT02400333|78954942|FG002|Overall Study|Withdrawal by Subject|0|||
44162040|NCT02400333|78954943|FG003|Overall Study|Withdrawal by Subject|1|||
44162041|NCT02400333|78954940|FG000|Overall Study|Protocol Violation|1|||
44162042|NCT02400333|78954941|FG001|Overall Study|Protocol Violation|0|||
44162043|NCT02400333|78954942|FG002|Overall Study|Protocol Violation|2|||
44162044|NCT02400333|78954943|FG003|Overall Study|Protocol Violation|1|||
44162045|NCT02399475|78954956|FG000|Overall Study|Physician Decision|1|||
44162046|NCT02399475|78954957|FG001|Overall Study|Physician Decision|0|||
44162047|NCT02399163|78954963|FG000|Overall Study|Adverse Event|2|||
44162048|NCT02399163|78954963|FG000|Overall Study|Protocol Deviation|2|||
44162049|NCT02399163|78954963|FG000|Overall Study|Withdrawal by Participant|5|||
44162050|NCT02398227|78954977|FG000|Overall Study|Lost to Follow-up|21|||
44162051|NCT02398227|78954978|FG001|Overall Study|Lost to Follow-up|12|||
44162052|NCT02398227|78954977|FG000|Overall Study|Withdrawal by Subject|5|||
44162053|NCT02398227|78954978|FG001|Overall Study|Withdrawal by Subject|6|||
44162054|NCT02398227|78954977|FG000|Overall Study|Removed from treatment and dropped out|1|||
44162055|NCT02398227|78954978|FG001|Overall Study|Removed from treatment and dropped out|0|||
44162056|NCT02397915|78954984|FG000|Period 1|Protocol Violation|0|||
44162057|NCT02397915|78954985|FG001|Period 1|Protocol Violation|1|||
44162058|NCT02397915|78954986|FG002|Period 1|Protocol Violation|0|||
44162059|NCT02397915|78954987|FG003|Period 1|Protocol Violation|0|||
44162060|NCT02397915|78954984|FG000|Period 1|Physician Decision|1|||
44162061|NCT02397915|78954985|FG001|Period 1|Physician Decision|0|||
44162062|NCT02397915|78954986|FG002|Period 1|Physician Decision|0|||
44162063|NCT02397915|78954987|FG003|Period 1|Physician Decision|0|||
44162064|NCT02397837|78954997|FG000|Overall Study|Withdrawal by Subject|6|||
44162065|NCT02397837|78954998|FG001|Overall Study|Withdrawal by Subject|5|||
44162066|NCT02397837|78954997|FG000|Overall Study|Physician Decision|1|||
44162067|NCT02397837|78954998|FG001|Overall Study|Physician Decision|1|||
44162068|NCT02586415|78955006|FG000|Overall Study|Death|13|||
44162069|NCT02586415|78955007|FG001|Overall Study|Death|23|||
44162070|NCT02586415|78955006|FG000|Overall Study|Lost to Follow-up|1|||
44162071|NCT02586415|78955007|FG001|Overall Study|Lost to Follow-up|2|||
44162072|NCT02383017|78955016|FG000|Overall Study|Injury Sustained Outside Study|1|||
44162073|NCT02383017|78955017|FG001|Overall Study|Injury Sustained Outside Study|0|||
44162074|NCT02383017|78955016|FG000|Overall Study|Compliance|3|||
44162075|NCT02383017|78955017|FG001|Overall Study|Compliance|2|||
44162076|NCT02383017|78955016|FG000|Overall Study|Found to be Hypogonadal|1|||
44162077|NCT02383017|78955017|FG001|Overall Study|Found to be Hypogonadal|0|||
44162078|NCT02382939|78955025|FG000|Overall Study|Adverse Event|1|||
44162079|NCT02382939|78955026|FG001|Overall Study|Adverse Event|1|||
44162080|NCT02382939|78955025|FG000|Overall Study|Withdrawal by Subject|2|||
44162081|NCT02382939|78955026|FG001|Overall Study|Withdrawal by Subject|2|||
44162082|NCT02587819|78955033|FG000|Overall Study|Adverse Event|1|||
44162083|NCT02587819|78955033|FG000|Overall Study|Lost to Follow-up|1|||
44162084|NCT01666951|78955040|FG000|Overall Study|Not dosed|1|||
44162085|NCT01666951|78955041|FG001|Overall Study|Not dosed|1|||
44162086|NCT02586805|78955051|FG000|Overall Study|Withdrawal by Subject|3|||
44162087|NCT02586805|78955052|FG001|Overall Study|Withdrawal by Subject|1|||
44162088|NCT02586805|78955053|FG002|Overall Study|Withdrawal by Subject|1|||
44162089|NCT02586805|78955054|FG003|Overall Study|Withdrawal by Subject|2|||
44162090|NCT02586805|78955051|FG000|Overall Study|Adverse Event|2|||
44162091|NCT02586805|78955052|FG001|Overall Study|Adverse Event|0|||
44162092|NCT02586805|78955053|FG002|Overall Study|Adverse Event|1|||
44162093|NCT02586805|78955054|FG003|Overall Study|Adverse Event|0|||
44162094|NCT02586805|78955051|FG000|Overall Study|Lost to Follow-up|0|||
44162095|NCT02586805|78955052|FG001|Overall Study|Lost to Follow-up|0|||
44162096|NCT02586805|78955053|FG002|Overall Study|Lost to Follow-up|1|||
44162097|NCT02586805|78955054|FG003|Overall Study|Lost to Follow-up|0|||
44162098|NCT02586805|78955051|FG000|Overall Study|Physician Decision|1|||
44162099|NCT02586805|78955052|FG001|Overall Study|Physician Decision|0|||
44162100|NCT02586805|78955053|FG002|Overall Study|Physician Decision|0|||
44162101|NCT02586805|78955054|FG003|Overall Study|Physician Decision|0|||
44162102|NCT02580877|78955066|FG000|Overall Study|Withdrawal by Subject|1|||
44162103|NCT02580877|78955067|FG001|Overall Study|Withdrawal by Subject|3|||
44162104|NCT02580877|78955066|FG000|Overall Study|Adverse Event|0|||
44162105|NCT02580877|78955067|FG001|Overall Study|Adverse Event|1|||
44162106|NCT02582983|78955083|FG000|Overall Study|Death|3|||
44162107|NCT02582983|78955083|FG000|Overall Study|Withdrawal by Subject|2|||
44162108|NCT02582983|78955083|FG000|Overall Study|Adverse Event|1|||
44162109|NCT02582749|78955089|FG000|Overall Study|Study terminated by funder|5|||
44162110|NCT02582749|78955090|FG001|Overall Study|Study terminated by funder|10|||
44162111|NCT02582749|78955089|FG000|Overall Study|Withdrawal by Subject|0|||
44162112|NCT02582749|78955090|FG001|Overall Study|Withdrawal by Subject|1|||
44162113|NCT02582671|78955096|FG000|Overall Study|Failure to return|1|||
44162114|NCT02582671|78955096|FG000|Overall Study|Other, not specified|1|||
44162115|NCT02585713|78955103|FG000|Overall Study|Withdrew prior to treatment|2|||
44162116|NCT02585713|78955104|FG001|Overall Study|Withdrew prior to treatment|7|||
44162117|NCT02585713|78955103|FG000|Overall Study|Other|3|||
44162118|NCT02585713|78955104|FG001|Overall Study|Other|1|||
44162119|NCT02579863|78955112|FG000|Overall Study|Final Disposition Unknown|2|||
44162120|NCT02579863|78955113|FG001|Overall Study|Final Disposition Unknown|1|||
44162121|NCT02579863|78955112|FG000|Overall Study|Adverse Event|18|||
44162122|NCT02579863|78955113|FG001|Overall Study|Adverse Event|11|||
44162123|NCT02579863|78955112|FG000|Overall Study|Death|31|||
44162124|NCT02579863|78955113|FG001|Overall Study|Death|29|||
44162125|NCT02579863|78955112|FG000|Overall Study|Lost to Follow-up|2|||
44162126|NCT02579863|78955113|FG001|Overall Study|Lost to Follow-up|1|||
44162127|NCT02579863|78955112|FG000|Overall Study|Physician Decision|1|||
44162128|NCT02579863|78955113|FG001|Overall Study|Physician Decision|2|||
44162129|NCT02579863|78955112|FG000|Overall Study|Screen Failure|0|||
44162130|NCT02579863|78955113|FG001|Overall Study|Screen Failure|2|||
44162131|NCT02579863|78955112|FG000|Overall Study|Study Terminated at Selected Sites|82|||
44162132|NCT02579863|78955113|FG001|Overall Study|Study Terminated at Selected Sites|88|||
44162133|NCT02579863|78955112|FG000|Overall Study|Withdrawal by Subject|20|||
44162134|NCT02579863|78955113|FG001|Overall Study|Withdrawal by Subject|20|||
44162135|NCT02582515|78955121|FG000|Overall Study|Withdrawal by Subject|0|||
44162136|NCT02582515|78955122|FG001|Overall Study|Withdrawal by Subject|1|||
44162137|NCT02579629|78955131|FG000|Overall Study|Withdrawal by Subject|0|||
44162138|NCT02579629|78955132|FG001|Overall Study|Withdrawal by Subject|1|||
44162139|NCT02579629|78955133|FG002|Overall Study|Withdrawal by Subject|0|||
44162140|NCT02579629|78955131|FG000|Overall Study|Screen Failure|2|||
44162141|NCT02579629|78955132|FG001|Overall Study|Screen Failure|0|||
44162142|NCT02579629|78955133|FG002|Overall Study|Screen Failure|2|||
44162143|NCT02343939|78955150|FG000|Overall Study|Death|0|||
44162144|NCT02343939|78955151|FG001|Overall Study|Death|15|||
44162145|NCT02343939|78955152|FG002|Overall Study|Death|4|||
44162146|NCT02343939|78955153|FG003|Overall Study|Death|2|||
44162147|NCT02343939|78955154|FG004|Overall Study|Death|5|||
44162148|NCT02343939|78955155|FG005|Overall Study|Death|11|||
44162149|NCT02343939|78955156|FG006|Overall Study|Death|8|||
44162150|NCT02343939|78955157|FG007|Overall Study|Death|22|||
44162151|NCT02343939|78955158|FG008|Overall Study|Death|1|||
44162152|NCT02343939|78955150|FG000|Overall Study|Study terminated by sponsor|0|||
44162153|NCT02343939|78955151|FG001|Overall Study|Study terminated by sponsor|27|||
44162154|NCT02343939|78955152|FG002|Overall Study|Study terminated by sponsor|0|||
44162155|NCT02343939|78955153|FG003|Overall Study|Study terminated by sponsor|1|||
44162156|NCT02343939|78955154|FG004|Overall Study|Study terminated by sponsor|1|||
44162157|NCT02343939|78955155|FG005|Overall Study|Study terminated by sponsor|5|||
44162158|NCT02343939|78955156|FG006|Overall Study|Study terminated by sponsor|3|||
44162159|NCT02343939|78955157|FG007|Overall Study|Study terminated by sponsor|4|||
44162160|NCT02343939|78955158|FG008|Overall Study|Study terminated by sponsor|0|||
44162161|NCT02343939|78955150|FG000|Overall Study|Withdrew consent|3|||
44162162|NCT02343939|78955151|FG001|Overall Study|Withdrew consent|6|||
44162163|NCT02343939|78955152|FG002|Overall Study|Withdrew consent|1|||
44162164|NCT02343939|78955153|FG003|Overall Study|Withdrew consent|2|||
44162165|NCT02343939|78955154|FG004|Overall Study|Withdrew consent|2|||
44162166|NCT02343939|78955155|FG005|Overall Study|Withdrew consent|0|||
44162167|NCT02343939|78955156|FG006|Overall Study|Withdrew consent|0|||
44162168|NCT02343939|78955157|FG007|Overall Study|Withdrew consent|8|||
44162169|NCT02343939|78955158|FG008|Overall Study|Withdrew consent|6|||
44162170|NCT02343939|78955150|FG000|Overall Study|Treatment failure|0|||
44162171|NCT02343939|78955151|FG001|Overall Study|Treatment failure|0|||
44162172|NCT02343939|78955152|FG002|Overall Study|Treatment failure|0|||
44162173|NCT02343939|78955153|FG003|Overall Study|Treatment failure|0|||
44162174|NCT02343939|78955154|FG004|Overall Study|Treatment failure|0|||
44162175|NCT02343939|78955155|FG005|Overall Study|Treatment failure|0|||
44162176|NCT02343939|78955156|FG006|Overall Study|Treatment failure|2|||
44162177|NCT02343939|78955157|FG007|Overall Study|Treatment failure|1|||
44162178|NCT02343939|78955158|FG008|Overall Study|Treatment failure|0|||
44162179|NCT02343939|78955150|FG000|Overall Study|Investigator's discretion|0|||
44162180|NCT02343939|78955151|FG001|Overall Study|Investigator's discretion|0|||
44162181|NCT02343939|78955152|FG002|Overall Study|Investigator's discretion|0|||
44162182|NCT02343939|78955153|FG003|Overall Study|Investigator's discretion|1|||
44162183|NCT02343939|78955154|FG004|Overall Study|Investigator's discretion|0|||
44162184|NCT02343939|78955155|FG005|Overall Study|Investigator's discretion|0|||
44162185|NCT02343939|78955156|FG006|Overall Study|Investigator's discretion|1|||
44162186|NCT02343939|78955157|FG007|Overall Study|Investigator's discretion|0|||
44162187|NCT02343939|78955158|FG008|Overall Study|Investigator's discretion|0|||
44162188|NCT02343939|78955150|FG000|Overall Study|Adverse Event|0|||
44162189|NCT02343939|78955151|FG001|Overall Study|Adverse Event|0|||
44162190|NCT02343939|78955152|FG002|Overall Study|Adverse Event|0|||
44162191|NCT02343939|78955153|FG003|Overall Study|Adverse Event|0|||
44162192|NCT02343939|78955154|FG004|Overall Study|Adverse Event|0|||
44162193|NCT02343939|78955155|FG005|Overall Study|Adverse Event|1|||
44162194|NCT02343939|78955156|FG006|Overall Study|Adverse Event|0|||
44162195|NCT02343939|78955157|FG007|Overall Study|Adverse Event|0|||
44162196|NCT02343939|78955158|FG008|Overall Study|Adverse Event|0|||
44162197|NCT02343939|78955150|FG000|Overall Study|Never Treated With ENTO|0|||
44162198|NCT02343939|78955151|FG001|Overall Study|Never Treated With ENTO|0|||
44162199|NCT02343939|78955152|FG002|Overall Study|Never Treated With ENTO|0|||
44162200|NCT02343939|78955153|FG003|Overall Study|Never Treated With ENTO|0|||
44162201|NCT02343939|78955154|FG004|Overall Study|Never Treated With ENTO|0|||
44162202|NCT02343939|78955155|FG005|Overall Study|Never Treated With ENTO|0|||
44162203|NCT02343939|78955156|FG006|Overall Study|Never Treated With ENTO|1|||
44162204|NCT02343939|78955157|FG007|Overall Study|Never Treated With ENTO|2|||
44162205|NCT02343939|78955158|FG008|Overall Study|Never Treated With ENTO|0|||
44162206|NCT02397447|78955194|FG000|Overall Study|Lost to Follow-up|2|||
44162207|NCT02397447|78955195|FG001|Overall Study|Lost to Follow-up|2|||
44162208|NCT02397057|78955203|FG000|Overall Study|Withdrawal by Subject|6|||
44162209|NCT02397057|78955204|FG001|Overall Study|Withdrawal by Subject|7|||
44162210|NCT02397057|78955203|FG000|Overall Study|Lost to Follow-up|4|||
44162211|NCT02397057|78955204|FG001|Overall Study|Lost to Follow-up|3|||
44162212|NCT02397057|78955203|FG000|Overall Study|Death|1|||
44162213|NCT02397057|78955204|FG001|Overall Study|Death|0|||
44162214|NCT02397057|78955203|FG000|Overall Study|Adverse Event|0|||
44162215|NCT02397057|78955204|FG001|Overall Study|Adverse Event|1|||
44162216|NCT02397057|78955203|FG000|Overall Study|Physician Decision|0|||
44162217|NCT02397057|78955204|FG001|Overall Study|Physician Decision|1|||
44162218|NCT02397057|78955203|FG000|Overall Study|Subject did not receive study drug|0|||
44162219|NCT02397057|78955204|FG001|Overall Study|Subject did not receive study drug|1|||
44162220|NCT02343549|78955210|FG000|Overall Study|Death|11|||
44162221|NCT02343549|78955210|FG000|Overall Study|Withdrawal by Subject|2|||
44162222|NCT02343159|78955217|FG000|Overall Study|Early Study Termination|16|||
44162223|NCT02343159|78955218|FG001|Overall Study|Early Study Termination|19|||
44162224|NCT02343159|78955219|FG002|Overall Study|Early Study Termination|23|||
44162225|NCT02343159|78955217|FG000|Overall Study|Physician Decision|2|||
44162226|NCT02343159|78955218|FG001|Overall Study|Physician Decision|0|||
44162227|NCT02343159|78955219|FG002|Overall Study|Physician Decision|1|||
44162228|NCT02343159|78955217|FG000|Overall Study|Withdrawal by Subject|3|||
44162229|NCT02343159|78955218|FG001|Overall Study|Withdrawal by Subject|0|||
44162230|NCT02343159|78955219|FG002|Overall Study|Withdrawal by Subject|2|||
44162231|NCT02343159|78955217|FG000|Overall Study|Lost to Follow-up|0|||
44162232|NCT02343159|78955218|FG001|Overall Study|Lost to Follow-up|2|||
44162233|NCT02343159|78955219|FG002|Overall Study|Lost to Follow-up|2|||
44162234|NCT02343159|78955217|FG000|Overall Study|Adverse Event|4|||
44162235|NCT02343159|78955218|FG001|Overall Study|Adverse Event|4|||
44162236|NCT02343159|78955219|FG002|Overall Study|Adverse Event|2|||
44162237|NCT02343159|78955217|FG000|Overall Study|Sponsor Decision|0|||
44162238|NCT02343159|78955218|FG001|Overall Study|Sponsor Decision|1|||
44162239|NCT02343159|78955219|FG002|Overall Study|Sponsor Decision|0|||
44162240|NCT02343159|78955217|FG000|Overall Study|Enrollment Error|1|||
44162241|NCT02343159|78955218|FG001|Overall Study|Enrollment Error|0|||
44162242|NCT02343159|78955219|FG002|Overall Study|Enrollment Error|0|||
44162243|NCT02395653|78955228|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
44162244|NCT02395653|78955228|FG000|Overall Study|Consent Withdrawn at Screening|1|||
44162245|NCT02395653|78955228|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
44162246|NCT02395653|78955228|FG000|Overall Study|Investigator Decision at Screening|1|||
44162247|NCT02395653|78955228|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
44162248|NCT02395653|78955228|FG000|Overall Study|Withdrawal by Subject|1|||
44162249|NCT02395653|78955228|FG000|Overall Study|Lost to Follow-up|1|||
44162250|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
44162251|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
44162252|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
44162253|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
44162254|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
44162255|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
44162256|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
44162257|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
44162258|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
44162259|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
44162260|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
44162261|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
44162262|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
44162263|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
44162264|NCT01664923|78955234|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
44162265|NCT01664923|78955235|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
44162266|NCT01664923|78955234|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
44162267|NCT01664923|78955235|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
44162268|NCT01664923|78955234|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
44162269|NCT01664923|78955235|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
44162270|NCT01664923|78955234|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
44162271|NCT01664923|78955235|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
44162272|NCT01664923|78955234|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
44162273|NCT01664923|78955235|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
44162274|NCT01664923|78955234|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
44162275|NCT01664923|78955235|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
44162276|NCT01664923|78955234|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
44162277|NCT01664923|78955235|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
44162278|NCT01664533|78955245|FG000|Overall Study|Death|42|||
44162279|NCT01664533|78955245|FG000|Overall Study|Lost to Follow-up|3|||
44162280|NCT01664533|78955245|FG000|Overall Study|Study termination|9|||
44162281|NCT01664533|78955245|FG000|Overall Study|Protocol Violation|3|||
44162282|NCT02584855|78955250|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
44162283|NCT02584855|78955251|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
44162284|NCT02584855|78955252|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
44162285|NCT02584855|78955253|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
44162286|NCT02584855|78955254|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
44162287|NCT02584855|78955255|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
44162288|NCT02584855|78955250|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
44162289|NCT02584855|78955251|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
44162290|NCT02584855|78955252|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
44162291|NCT02584855|78955253|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
44162292|NCT02584855|78955254|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
44162293|NCT02584855|78955255|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
44162294|NCT02584855|78955250|FG000|Open-Label Treatment Period|Adverse Event|14|||
44162295|NCT02584855|78955251|FG001|Open-Label Treatment Period|Adverse Event|0|||
44162296|NCT02584855|78955252|FG002|Open-Label Treatment Period|Adverse Event|0|||
44162297|NCT02584855|78955253|FG003|Open-Label Treatment Period|Adverse Event|0|||
44162298|NCT02584855|78955254|FG004|Open-Label Treatment Period|Adverse Event|0|||
44162299|NCT02584855|78955255|FG005|Open-Label Treatment Period|Adverse Event|0|||
44162300|NCT02584855|78955250|FG000|Open-Label Treatment Period|Death|2|||
44162301|NCT02584855|78955251|FG001|Open-Label Treatment Period|Death|0|||
44162302|NCT02584855|78955252|FG002|Open-Label Treatment Period|Death|0|||
44162303|NCT02584855|78955253|FG003|Open-Label Treatment Period|Death|0|||
44162304|NCT02584855|78955254|FG004|Open-Label Treatment Period|Death|0|||
44162305|NCT02584855|78955255|FG005|Open-Label Treatment Period|Death|0|||
44162306|NCT02584855|78955250|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
44162307|NCT02584855|78955251|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
44162308|NCT02584855|78955252|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
44162309|NCT02584855|78955253|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
44162310|NCT02584855|78955254|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
44162311|NCT02584855|78955255|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
44162312|NCT02584855|78955250|FG000|Open-Label Treatment Period|Protocol Violation|1|||
44162313|NCT02584855|78955251|FG001|Open-Label Treatment Period|Protocol Violation|0|||
44162314|NCT02584855|78955252|FG002|Open-Label Treatment Period|Protocol Violation|0|||
44162315|NCT02584855|78955253|FG003|Open-Label Treatment Period|Protocol Violation|0|||
44162316|NCT02584855|78955254|FG004|Open-Label Treatment Period|Protocol Violation|0|||
44162317|NCT02584855|78955255|FG005|Open-Label Treatment Period|Protocol Violation|0|||
44162318|NCT02584855|78955250|FG000|Open-Label Treatment Period|No PI Available|2|||
44162319|NCT02584855|78955251|FG001|Open-Label Treatment Period|No PI Available|0|||
44162320|NCT02584855|78955252|FG002|Open-Label Treatment Period|No PI Available|0|||
44162321|NCT02584855|78955253|FG003|Open-Label Treatment Period|No PI Available|0|||
44162322|NCT02584855|78955254|FG004|Open-Label Treatment Period|No PI Available|0|||
44162323|NCT02584855|78955255|FG005|Open-Label Treatment Period|No PI Available|0|||
44162324|NCT02584855|78955250|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
44162325|NCT02584855|78955251|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
44162326|NCT02584855|78955252|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
44162327|NCT02584855|78955253|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
44162328|NCT02584855|78955254|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
44162329|NCT02584855|78955255|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
44162330|NCT02584855|78955250|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
44162331|NCT02584855|78955251|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
44162332|NCT02584855|78955252|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
44162333|NCT02584855|78955253|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
44162334|NCT02584855|78955254|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
44162335|NCT02584855|78955255|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
44162336|NCT02584855|78955250|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
44162337|NCT02584855|78955251|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
44162338|NCT02584855|78955252|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
44162339|NCT02584855|78955253|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
44162340|NCT02584855|78955254|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
44162341|NCT02584855|78955255|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
44162342|NCT02584855|78955250|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
44345114|NCT01252134|79349164|FG000|Period 1, 8 Hours|Personal Reasons|0|||
44162343|NCT02584855|78955251|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
44162344|NCT02584855|78955252|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
44162345|NCT02584855|78955253|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
44162346|NCT02584855|78955254|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
44162347|NCT02584855|78955255|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
44162348|NCT02584855|78955250|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
44162349|NCT02584855|78955251|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
44162350|NCT02584855|78955252|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
44162351|NCT02584855|78955253|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
44162352|NCT02584855|78955254|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
44162353|NCT02584855|78955255|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
44162354|NCT02584855|78955250|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44162355|NCT02584855|78955251|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44162356|NCT02584855|78955252|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44162357|NCT02584855|78955253|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44162358|NCT02584855|78955254|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
44162359|NCT02584855|78955255|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
44162360|NCT02584855|78955250|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
44162361|NCT02584855|78955251|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
44162362|NCT02584855|78955252|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
44162363|NCT02584855|78955253|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
44162364|NCT02584855|78955254|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
44162365|NCT02584855|78955255|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
44162366|NCT02581345|78955270|FG000|Part 1: up to Week 16|Adverse Event|3|||
44162367|NCT02581345|78955271|FG001|Part 1: up to Week 16|Adverse Event|8|||
44162368|NCT02581345|78955272|FG002|Part 1: up to Week 16|Adverse Event|0|||
44162369|NCT02581345|78955273|FG003|Part 1: up to Week 16|Adverse Event|0|||
44162370|NCT02581345|78955270|FG000|Part 1: up to Week 16|Physician Decision|2|||
44162371|NCT02581345|78955271|FG001|Part 1: up to Week 16|Physician Decision|4|||
44162372|NCT02581345|78955272|FG002|Part 1: up to Week 16|Physician Decision|0|||
44162373|NCT02581345|78955273|FG003|Part 1: up to Week 16|Physician Decision|0|||
44162374|NCT02581345|78955270|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
44162375|NCT02581345|78955271|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
44162376|NCT02581345|78955272|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
44162377|NCT02581345|78955273|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
44162378|NCT02581345|78955270|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
44162379|NCT02581345|78955271|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
44162380|NCT02581345|78955272|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
44162381|NCT02581345|78955273|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
44162382|NCT02581345|78955270|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
44162383|NCT02581345|78955271|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
44162384|NCT02581345|78955272|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
44162385|NCT02581345|78955273|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
44162386|NCT02581345|78955270|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
44162387|NCT02581345|78955271|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
44162388|NCT02581345|78955272|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
44162389|NCT02581345|78955273|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
44162390|NCT02581345|78955270|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
44162391|NCT02581345|78955271|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
44162392|NCT02581345|78955272|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
44162393|NCT02581345|78955273|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
44162394|NCT02581345|78955270|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
44162395|NCT02581345|78955271|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
44162396|NCT02581345|78955272|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
44162397|NCT02581345|78955273|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
44162398|NCT02581345|78955270|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
44345115|NCT01252134|79349165|FG001|Period 1, 8 Hours|Personal Reasons|1|||
44345116|NCT01252134|79349166|FG002|Period 1, 8 Hours|Personal Reasons|1|||
44345117|NCT01252134|79349167|FG003|Period 1, 8 Hours|Personal Reasons|0|||
44345118|NCT01252134|79349168|FG004|Period 1, 8 Hours|Personal Reasons|0|||
44345119|NCT01252134|79349169|FG005|Period 1, 8 Hours|Personal Reasons|0|||
44345120|NCT01251744|79349179|FG000|Overall Study|Lost to Follow-up|1|||
44345121|NCT01251744|79349180|FG001|Overall Study|Lost to Follow-up|0|||
44162399|NCT02581345|78955271|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
44162400|NCT02581345|78955272|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
44162401|NCT02581345|78955273|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
44162402|NCT02581345|78955270|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
44345122|NCT01251354|79349193|FG000|Overall Study|Adverse Event|1|||
44345123|NCT01251354|79349193|FG000|Overall Study|Investigator's Decision|1|||
44345124|NCT01251354|79349193|FG000|Overall Study|Disease Progression|4|||
44162403|NCT02581345|78955271|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
44162404|NCT02581345|78955272|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
44162405|NCT02581345|78955273|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
44162406|NCT02581345|78955270|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
44162407|NCT02581345|78955271|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
44162408|NCT02581345|78955272|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
44162409|NCT02581345|78955273|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
44162410|NCT02581345|78955270|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
44162411|NCT02581345|78955271|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
44162412|NCT02581345|78955272|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
44162413|NCT02581345|78955273|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
44162414|NCT02581189|78955291|FG000|Overall Study|Failure to return|36|||
44162415|NCT02581189|78955291|FG000|Overall Study|Withdrew consent|5|||
44162416|NCT02581189|78955291|FG000|Overall Study|Death|3|||
44162417|NCT02581189|78955291|FG000|Overall Study|Insufficient virological response|2|||
44162418|NCT02581189|78955291|FG000|Overall Study|Other, not specified|7|||
44162419|NCT02576977|78955300|FG000|Overall Study|Adverse Event|13|||
44162420|NCT02576977|78955301|FG001|Overall Study|Adverse Event|2|||
44162421|NCT02576977|78955300|FG000|Overall Study|Death|73|||
44162422|NCT02576977|78955301|FG001|Overall Study|Death|60|||
44162423|NCT02576977|78955300|FG000|Overall Study|Screen failure|1|||
44162424|NCT02576977|78955301|FG001|Overall Study|Screen failure|0|||
44162425|NCT02576977|78955300|FG000|Overall Study|Study Terminated at Selected Sites|27|||
44162426|NCT02576977|78955301|FG001|Overall Study|Study Terminated at Selected Sites|50|||
44162427|NCT02576977|78955300|FG000|Overall Study|Withdrawal by Subject|11|||
44162428|NCT02576977|78955301|FG001|Overall Study|Withdrawal by Subject|11|||
44162429|NCT02576977|78955300|FG000|Overall Study|Final Disposition Unknown|0|||
44162430|NCT02576977|78955301|FG001|Overall Study|Final Disposition Unknown|1|||
44162431|NCT02576977|78955300|FG000|Overall Study|Lost to Follow-up|1|||
44162432|NCT02576977|78955301|FG001|Overall Study|Lost to Follow-up|0|||
44162433|NCT02576977|78955300|FG000|Overall Study|Progressive Disease|0|||
44162434|NCT02576977|78955301|FG001|Overall Study|Progressive Disease|1|||
44162435|NCT05150964|78955307|FG000|Overall Study|Lost to Follow-up|2|||
44162436|NCT04952402|78955315|FG000|Overall Study|Lost to Follow-up|1|||
44162437|NCT04952402|78955316|FG001|Overall Study|Lost to Follow-up|3|||
44162438|NCT04952402|78955315|FG000|Overall Study|Lack Of Venous Access|0|||
44162439|NCT04952402|78955316|FG001|Overall Study|Lack Of Venous Access|1|||
44162440|NCT04378010|78955355|FG000|Overall Study|Adverse Event|8|||
44162441|NCT04378010|78955356|FG001|Overall Study|Adverse Event|14|||
44162442|NCT04378010|78955357|FG002|Overall Study|Adverse Event|4|||
44162443|NCT04378010|78955355|FG000|Overall Study|Withdrawal by Subject|0|||
44162444|NCT04378010|78955356|FG001|Overall Study|Withdrawal by Subject|2|||
44162445|NCT04378010|78955357|FG002|Overall Study|Withdrawal by Subject|1|||
44162446|NCT04378010|78955355|FG000|Overall Study|Protocol Violation|2|||
44162447|NCT04378010|78955356|FG001|Overall Study|Protocol Violation|1|||
44162448|NCT04378010|78955357|FG002|Overall Study|Protocol Violation|4|||
44162449|NCT04378010|78955355|FG000|Overall Study|Study terminated by Sponsor|22|||
44162450|NCT04378010|78955356|FG001|Overall Study|Study terminated by Sponsor|16|||
44162451|NCT04378010|78955357|FG002|Overall Study|Study terminated by Sponsor|22|||
44162452|NCT04378010|78955355|FG000|Overall Study|Subject inability to complete study visit|0|||
44162453|NCT04378010|78955356|FG001|Overall Study|Subject inability to complete study visit|0|||
44162454|NCT04378010|78955357|FG002|Overall Study|Subject inability to complete study visit|1|||
44162455|NCT04378010|78955355|FG000|Overall Study|Subject never dosed|0|||
44162456|NCT04378010|78955356|FG001|Overall Study|Subject never dosed|1|||
44162457|NCT04378010|78955357|FG002|Overall Study|Subject never dosed|0|||
44162458|NCT04349072|78955368|FG000|Randomization Period|Found ineligible post enrollment|0|||
44162459|NCT04349072|78955369|FG001|Randomization Period|Found ineligible post enrollment|1|||
44162460|NCT04349072|78955368|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
44162461|NCT04349072|78955369|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
44162462|NCT04349072|78955368|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
44162463|NCT04349072|78955369|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
44162464|NCT04349072|78955368|FG000|Treatment Period|Physician Decision|0|||
44162465|NCT04349072|78955369|FG001|Treatment Period|Physician Decision|1|||
44162466|NCT04349072|78955368|FG000|Treatment Period|Protocol Violation|0|||
44162467|NCT04349072|78955369|FG001|Treatment Period|Protocol Violation|1|||
44162468|NCT04349072|78955368|FG000|Treatment Period|Withdrawal by Subject|1|||
44162469|NCT04349072|78955369|FG001|Treatment Period|Withdrawal by Subject|1|||
44162470|NCT04240886|78955375|FG000|Treatment Phase|Death|4|||
44162471|NCT04240886|78955375|FG000|Treatment Phase|Discontinuation by Subject|1|||
44162472|NCT04240886|78955375|FG000|Treatment Phase|Adverse Event|5|||
44162473|NCT04240886|78955375|FG000|Follow-up Phase|Withdrawal by Subject|1|||
44162474|NCT04240886|78955375|FG000|Follow-up Phase|Discontinuation by Subject|1|||
44162475|NCT04240886|78955375|FG000|Follow-up Phase|Death|2|||
44162476|NCT04074161|78955391|FG000|Overall Study|Withdrawal by Subject|2|||
44162477|NCT04074161|78955392|FG001|Overall Study|Withdrawal by Subject|4|||
44162478|NCT04074161|78955393|FG002|Overall Study|Withdrawal by Subject|1|||
44162479|NCT04074161|78955391|FG000|Overall Study|Lost to Follow-up|4|||
44162480|NCT04074161|78955392|FG001|Overall Study|Lost to Follow-up|5|||
44162481|NCT04074161|78955393|FG002|Overall Study|Lost to Follow-up|3|||
44162482|NCT03966157|78955403|FG000|Overall Study|Physician Decision|1|||
44162483|NCT03966157|78955404|FG001|Overall Study|Physician Decision|0|||
44162484|NCT03733210|78955412|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
44162485|NCT03733210|78955413|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
44162486|NCT03627468|78955421|FG000|Overall Study|Adverse Event|5|||
44162487|NCT03627468|78955422|FG001|Overall Study|Adverse Event|33|||
44162488|NCT03627468|78955421|FG000|Overall Study|Withdrawal by Subject|13|||
44162489|NCT03627468|78955422|FG001|Overall Study|Withdrawal by Subject|23|||
44162490|NCT03627468|78955421|FG000|Overall Study|Physician Decision|1|||
44162491|NCT03627468|78955422|FG001|Overall Study|Physician Decision|0|||
44162492|NCT03627468|78955421|FG000|Overall Study|Protocol Violation|0|||
44162493|NCT03627468|78955422|FG001|Overall Study|Protocol Violation|2|||
44162494|NCT03627468|78955421|FG000|Overall Study|Lost to Follow-up|10|||
44162495|NCT03627468|78955422|FG001|Overall Study|Lost to Follow-up|16|||
44162496|NCT03627468|78955421|FG000|Overall Study|Death|1|||
44162497|NCT03627468|78955422|FG001|Overall Study|Death|0|||
44162498|NCT03627468|78955421|FG000|Overall Study|Pregnancy|1|||
44162499|NCT03627468|78955422|FG001|Overall Study|Pregnancy|1|||
44162500|NCT03627468|78955421|FG000|Overall Study|Lack of Efficacy|0|||
44162501|NCT03627468|78955422|FG001|Overall Study|Lack of Efficacy|2|||
44162502|NCT03627468|78955421|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
44162503|NCT03627468|78955422|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
44162504|NCT03595176|78955430|FG000|Overall Study|Death|0|||
44162505|NCT03595176|78955431|FG001|Overall Study|Death|2|||
44162506|NCT03595176|78955430|FG000|Overall Study|Lost to Follow-up|0|||
44162507|NCT03595176|78955431|FG001|Overall Study|Lost to Follow-up|1|||
44162508|NCT03052816|78955440|FG000|Overall Study|Withdrawal by Subject|1|||
44162509|NCT03052816|78955441|FG001|Overall Study|Withdrawal by Subject|0|||
44162510|NCT03052816|78955440|FG000|Overall Study|Desired opioids|2|||
44162511|NCT03052816|78955441|FG001|Overall Study|Desired opioids|0|||
44162512|NCT02682238|78955460|FG000|Overall Study|Lost to Follow-up|0|||
44162513|NCT02682238|78955461|FG001|Overall Study|Lost to Follow-up|2|||
44162514|NCT02682238|78955460|FG000|Overall Study|Withdrawal by Subject|1|||
44162515|NCT02682238|78955461|FG001|Overall Study|Withdrawal by Subject|0|||
44162516|NCT02682238|78955460|FG000|Overall Study|Adverse Event|1|||
44162517|NCT02682238|78955461|FG001|Overall Study|Adverse Event|0|||
44162518|NCT02682238|78955460|FG000|Overall Study|Non-compliance with Study Drug|1|||
44162519|NCT02682238|78955461|FG001|Overall Study|Non-compliance with Study Drug|0|||
44162520|NCT02682238|78955460|FG000|Overall Study|Non-compliance with Protocol|0|||
44162521|NCT02682238|78955461|FG001|Overall Study|Non-compliance with Protocol|2|||
44162522|NCT01719562|78955503|FG000|Overall Study|Lost to Follow-up|1|||
44162523|NCT01719562|78955504|FG001|Overall Study|Lost to Follow-up|0|||
44162524|NCT01719562|78955503|FG000|Overall Study|Death|1|||
44162525|NCT01719562|78955504|FG001|Overall Study|Death|0|||
44162526|NCT01719562|78955503|FG000|Overall Study|New cancer diagnosis|1|||
44162527|NCT01719562|78955504|FG001|Overall Study|New cancer diagnosis|0|||
44162528|NCT01700439|78955510|FG000|Overall Study|Lost to Follow-up|47|||
44162529|NCT01700439|78955510|FG000|Overall Study|Withdrawal by Subject|183|||
44162530|NCT01700439|78955510|FG000|Overall Study|Death|186|||
44162531|NCT01433289|78955532|FG000|Overall Study|Pregnancy|0|||
44162532|NCT01433289|78955533|FG001|Overall Study|Pregnancy|1|||
44162533|NCT01433289|78955534|FG002|Overall Study|Pregnancy|0|||
44162534|NCT01433289|78955535|FG003|Overall Study|Pregnancy|0|||
44162535|NCT02576587|78955579|FG000|Baseline|Equipment failure|0|||
44162536|NCT02576587|78955580|FG001|Baseline|Equipment failure|1|||
44162537|NCT02576587|78955579|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
44162538|NCT02576587|78955580|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
44162539|NCT02576587|78955579|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
44162540|NCT02576587|78955580|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
44162541|NCT02576587|78955579|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
44162542|NCT02576587|78955580|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
44162543|NCT05340751|78955645|FG000|Overall Study|Physician Decision|3|||
44162544|NCT02575807|78955654|FG000|Overall Study|Death|8|||
44162545|NCT02575807|78955655|FG001|Overall Study|Death|3|||
44162546|NCT02575807|78955656|FG002|Overall Study|Death|7|||
44162547|NCT02575807|78955657|FG003|Overall Study|Death|0|||
44162548|NCT02575807|78955658|FG004|Overall Study|Death|1|||
44162549|NCT02575807|78955654|FG000|Overall Study|Study terminated by Sponsor|0|||
44162550|NCT02575807|78955655|FG001|Overall Study|Study terminated by Sponsor|1|||
44162551|NCT02575807|78955656|FG002|Overall Study|Study terminated by Sponsor|7|||
44162552|NCT02575807|78955657|FG003|Overall Study|Study terminated by Sponsor|0|||
44162553|NCT02575807|78955658|FG004|Overall Study|Study terminated by Sponsor|1|||
44162554|NCT02575807|78955654|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
44162555|NCT02575807|78955655|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
44162556|NCT02575807|78955656|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
44162557|NCT02575807|78955657|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
44162558|NCT02575807|78955658|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
44162559|NCT02575807|78955654|FG000|Overall Study|Terminated due to physician decision|0|||
44162560|NCT02575807|78955655|FG001|Overall Study|Terminated due to physician decision|0|||
44162561|NCT02575807|78955656|FG002|Overall Study|Terminated due to physician decision|1|||
44162562|NCT02575807|78955657|FG003|Overall Study|Terminated due to physician decision|0|||
44162563|NCT02575807|78955658|FG004|Overall Study|Terminated due to physician decision|0|||
44162564|NCT02575807|78955654|FG000|Overall Study|Subject ineligible - medical implant|0|||
44162565|NCT02575807|78955655|FG001|Overall Study|Subject ineligible - medical implant|0|||
44162566|NCT02575807|78955656|FG002|Overall Study|Subject ineligible - medical implant|0|||
44162567|NCT02575807|78955657|FG003|Overall Study|Subject ineligible - medical implant|1|||
44162568|NCT02575807|78955658|FG004|Overall Study|Subject ineligible - medical implant|0|||
44162569|NCT02575807|78955654|FG000|Overall Study|Withdrawal by Subject|0|||
44162570|NCT02575807|78955655|FG001|Overall Study|Withdrawal by Subject|0|||
44162571|NCT02575807|78955656|FG002|Overall Study|Withdrawal by Subject|1|||
44162572|NCT02575807|78955657|FG003|Overall Study|Withdrawal by Subject|1|||
44162573|NCT02575807|78955658|FG004|Overall Study|Withdrawal by Subject|2|||
44162574|NCT02575339|78955684|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
44162575|NCT02575339|78955685|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
44162576|NCT02575339|78955686|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
44162577|NCT02575339|78955684|FG000|Study Treatment|Disease Progression|5|||
44345125|NCT01251276|79349199|FG000|Overall Study|Protocol Violation|1|||
44345126|NCT01251276|79349200|FG001|Overall Study|Protocol Violation|0|||
44162578|NCT02575339|78955685|FG001|Study Treatment|Disease Progression|2|||
44162579|NCT02575339|78955686|FG002|Study Treatment|Disease Progression|0|||
44162580|NCT02575339|78955684|FG000|Study Treatment|Adverse Event|1|||
44162581|NCT02575339|78955685|FG001|Study Treatment|Adverse Event|2|||
44162582|NCT02575339|78955686|FG002|Study Treatment|Adverse Event|0|||
44162583|NCT02575339|78955684|FG000|Follow up|Death|6|||
44345127|NCT01251276|79349199|FG000|Overall Study|Lost to Follow-up|0|||
44162584|NCT02575339|78955685|FG001|Follow up|Death|2|||
44162585|NCT02575339|78955686|FG002|Follow up|Death|0|||
44162586|NCT02575339|78955684|FG000|Follow up|Study Terminated|0|||
44162587|NCT02575339|78955685|FG001|Follow up|Study Terminated|2|||
44162588|NCT02575339|78955686|FG002|Follow up|Study Terminated|0|||
44162589|NCT02575339|78955684|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
44162590|NCT02575339|78955685|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
44162591|NCT02575339|78955686|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
44162592|NCT01712659|78955699|FG000|Dose Escalation|Physician Decision|0|||
44162593|NCT01712659|78955700|FG001|Dose Escalation|Physician Decision|1|||
44162594|NCT01712659|78955701|FG002|Dose Escalation|Physician Decision|0|||
44162595|NCT01712659|78955702|FG003|Dose Escalation|Physician Decision|0|||
44162596|NCT01712659|78955703|FG004|Dose Escalation|Physician Decision|0|||
44162597|NCT01712659|78955699|FG000|Dose Escalation|Unable to take study drug|0|||
44162598|NCT01712659|78955700|FG001|Dose Escalation|Unable to take study drug|1|||
44162599|NCT01712659|78955701|FG002|Dose Escalation|Unable to take study drug|0|||
44162600|NCT01712659|78955702|FG003|Dose Escalation|Unable to take study drug|0|||
44162601|NCT01712659|78955703|FG004|Dose Escalation|Unable to take study drug|0|||
44162602|NCT01712659|78955699|FG000|Dose Expansion|Early disease progression|1|||
44162603|NCT01712659|78955700|FG001|Dose Expansion|Early disease progression|0|||
44162604|NCT01712659|78955701|FG002|Dose Expansion|Early disease progression|0|||
44162605|NCT01712659|78955702|FG003|Dose Expansion|Early disease progression|0|||
44162606|NCT01712659|78955703|FG004|Dose Expansion|Early disease progression|0|||
44162607|NCT01712659|78955699|FG000|Dose Expansion|Physician Decision|1|||
44162608|NCT01712659|78955700|FG001|Dose Expansion|Physician Decision|0|||
44162609|NCT01712659|78955701|FG002|Dose Expansion|Physician Decision|0|||
44162610|NCT01712659|78955702|FG003|Dose Expansion|Physician Decision|0|||
44345128|NCT01251276|79349200|FG001|Overall Study|Lost to Follow-up|1|||
44345129|NCT01251120|79349208|FG000|Overall Study|Lack of Efficacy|0|||
44345130|NCT01251120|79349209|FG001|Overall Study|Lack of Efficacy|1|||
44345131|NCT01250418|79349217|FG000|Overall Study|monitor data failure|1|||
44345132|NCT01250418|79349218|FG001|Overall Study|monitor data failure|1|||
44345133|NCT01292603|79349229|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
44345134|NCT01292603|79349230|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
44345135|NCT01292603|79349231|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
44345136|NCT01292603|79349232|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
44345137|NCT01292603|79349233|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
44345138|NCT01292603|79349234|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
44345139|NCT01292603|79349229|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
44345140|NCT01292603|79349230|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
44345141|NCT01292603|79349231|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
44345142|NCT01292603|79349232|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
44345143|NCT01292603|79349233|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
44345144|NCT01292603|79349234|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
44345145|NCT01292603|79349229|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
44345146|NCT01292603|79349230|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
44345147|NCT01292603|79349231|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
44345148|NCT01292603|79349232|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
44345149|NCT01292603|79349233|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
44345150|NCT01292603|79349234|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
44345151|NCT01292603|79349229|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
44345152|NCT01292603|79349230|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
44345153|NCT01292603|79349231|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
44345154|NCT01292603|79349232|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
44345155|NCT01292603|79349233|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
44345156|NCT01292603|79349234|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
44345157|NCT01292603|79349229|FG000|Part 1: Regular Follow-Up Period|Death|3|||
44345158|NCT01292603|79349230|FG001|Part 1: Regular Follow-Up Period|Death|1|||
44345159|NCT01292603|79349231|FG002|Part 1: Regular Follow-Up Period|Death|3|||
44345160|NCT01292603|79349232|FG003|Part 1: Regular Follow-Up Period|Death|1|||
44345161|NCT01292603|79349233|FG004|Part 1: Regular Follow-Up Period|Death|0|||
44345162|NCT01292603|79349234|FG005|Part 1: Regular Follow-Up Period|Death|0|||
44345163|NCT01292603|79349229|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
44345164|NCT01292603|79349230|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
44345165|NCT01292603|79349231|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
44345166|NCT01292603|79349232|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
44345167|NCT01292603|79349233|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
44345168|NCT01292603|79349234|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
44345169|NCT01292603|79349229|FG000|Part 2: Dose Confirmation Period|Death|0|||
44345170|NCT01292603|79349230|FG001|Part 2: Dose Confirmation Period|Death|0|||
44345171|NCT01292603|79349231|FG002|Part 2: Dose Confirmation Period|Death|0|||
44162611|NCT01712659|78955703|FG004|Dose Expansion|Physician Decision|0|||
44345172|NCT01292603|79349232|FG003|Part 2: Dose Confirmation Period|Death|0|||
44345173|NCT01292603|79349233|FG004|Part 2: Dose Confirmation Period|Death|1|||
44345174|NCT01292603|79349234|FG005|Part 2: Dose Confirmation Period|Death|0|||
44162612|NCT01610713|78955729|FG000|Overall Study|Adverse Event|3|||
44162613|NCT01610713|78955730|FG001|Overall Study|Adverse Event|0|||
44162614|NCT01610713|78955729|FG000|Overall Study|Lack of Efficacy|1|||
44162615|NCT01610713|78955730|FG001|Overall Study|Lack of Efficacy|0|||
44162616|NCT01610713|78955729|FG000|Overall Study|low mood and poor motivation|1|||
44162617|NCT01610713|78955730|FG001|Overall Study|low mood and poor motivation|0|||
44162618|NCT01610713|78955729|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
44162619|NCT01610713|78955730|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
44162620|NCT01610713|78955729|FG000|Overall Study|Lost to Follow-up|0|||
44162621|NCT01610713|78955730|FG001|Overall Study|Lost to Follow-up|1|||
44162622|NCT01606189|78955736|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
44162623|NCT01606189|78955737|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
44162624|NCT01606189|78955738|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
44162625|NCT01606189|78955739|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
44162626|NCT01606189|78955740|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
44162627|NCT01606189|78955741|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
44162628|NCT01606189|78955736|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
44162629|NCT01606189|78955737|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
44162630|NCT01606189|78955738|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
44162631|NCT01606189|78955739|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
44162632|NCT01606189|78955740|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
44162633|NCT01606189|78955741|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
44162634|NCT01663987|78955751|FG000|Overall Study|Adverse Event|7|||
44162635|NCT01663987|78955752|FG001|Overall Study|Adverse Event|2|||
44162636|NCT01663987|78955751|FG000|Overall Study|Lost to Follow-up|1|||
44162637|NCT01663987|78955752|FG001|Overall Study|Lost to Follow-up|1|||
44162638|NCT01663987|78955751|FG000|Overall Study|Withdrawal by Subject|2|||
44162639|NCT01663987|78955752|FG001|Overall Study|Withdrawal by Subject|3|||
44162640|NCT01663987|78955751|FG000|Overall Study|Other reason not defined above|3|||
44162641|NCT01663987|78955752|FG001|Overall Study|Other reason not defined above|0|||
44162642|NCT02380677|78955770|FG000|Overall Study|Adverse Event|0|||
44162643|NCT02380677|78955771|FG001|Overall Study|Adverse Event|0|||
44162644|NCT02380677|78955772|FG002|Overall Study|Adverse Event|0|||
44162645|NCT02380677|78955773|FG003|Overall Study|Adverse Event|1|||
44162646|NCT02380677|78955774|FG004|Overall Study|Adverse Event|1|||
44162647|NCT02380677|78955775|FG005|Overall Study|Adverse Event|4|||
44162648|NCT02380677|78955776|FG006|Overall Study|Adverse Event|2|||
44162649|NCT02380677|78955777|FG007|Overall Study|Adverse Event|2|||
44162650|NCT02380677|78955778|FG008|Overall Study|Adverse Event|2|||
44162651|NCT02380677|78955779|FG009|Overall Study|Adverse Event|1|||
44162652|NCT02380677|78955780|FG010|Overall Study|Adverse Event|2|||
44162653|NCT02380677|78955781|FG011|Overall Study|Adverse Event|1|||
44162654|NCT02380677|78955770|FG000|Overall Study|Physician Decision|1|||
44162655|NCT02380677|78955771|FG001|Overall Study|Physician Decision|0|||
44162656|NCT02380677|78955772|FG002|Overall Study|Physician Decision|1|||
44162657|NCT02380677|78955773|FG003|Overall Study|Physician Decision|1|||
44162658|NCT02380677|78955774|FG004|Overall Study|Physician Decision|0|||
44162659|NCT02380677|78955775|FG005|Overall Study|Physician Decision|0|||
44162660|NCT02380677|78955776|FG006|Overall Study|Physician Decision|0|||
44162661|NCT02380677|78955777|FG007|Overall Study|Physician Decision|0|||
44162662|NCT02380677|78955778|FG008|Overall Study|Physician Decision|0|||
44162663|NCT02380677|78955779|FG009|Overall Study|Physician Decision|0|||
44162664|NCT02380677|78955780|FG010|Overall Study|Physician Decision|0|||
44162665|NCT02380677|78955781|FG011|Overall Study|Physician Decision|0|||
44162666|NCT02380677|78955770|FG000|Overall Study|Lack of Efficacy|0|||
44162667|NCT02380677|78955771|FG001|Overall Study|Lack of Efficacy|1|||
44162668|NCT02380677|78955772|FG002|Overall Study|Lack of Efficacy|2|||
44162669|NCT02380677|78955773|FG003|Overall Study|Lack of Efficacy|0|||
44162670|NCT02380677|78955774|FG004|Overall Study|Lack of Efficacy|4|||
44162671|NCT02380677|78955775|FG005|Overall Study|Lack of Efficacy|1|||
44162672|NCT02380677|78955776|FG006|Overall Study|Lack of Efficacy|1|||
44162673|NCT02380677|78955777|FG007|Overall Study|Lack of Efficacy|2|||
44162674|NCT02380677|78955778|FG008|Overall Study|Lack of Efficacy|2|||
44162675|NCT02380677|78955779|FG009|Overall Study|Lack of Efficacy|0|||
44162676|NCT02380677|78955780|FG010|Overall Study|Lack of Efficacy|2|||
44162677|NCT02380677|78955781|FG011|Overall Study|Lack of Efficacy|1|||
44162678|NCT02380677|78955770|FG000|Overall Study|Withdrawal by Subject|0|||
44162679|NCT02380677|78955771|FG001|Overall Study|Withdrawal by Subject|0|||
44162680|NCT02380677|78955772|FG002|Overall Study|Withdrawal by Subject|0|||
44162681|NCT02380677|78955773|FG003|Overall Study|Withdrawal by Subject|0|||
44162682|NCT02380677|78955774|FG004|Overall Study|Withdrawal by Subject|0|||
44162683|NCT02380677|78955775|FG005|Overall Study|Withdrawal by Subject|0|||
44162684|NCT02380677|78955776|FG006|Overall Study|Withdrawal by Subject|0|||
44162685|NCT02380677|78955777|FG007|Overall Study|Withdrawal by Subject|0|||
44162686|NCT02380677|78955778|FG008|Overall Study|Withdrawal by Subject|0|||
44162687|NCT02380677|78955779|FG009|Overall Study|Withdrawal by Subject|1|||
44162688|NCT02380677|78955780|FG010|Overall Study|Withdrawal by Subject|0|||
44162689|NCT02380677|78955781|FG011|Overall Study|Withdrawal by Subject|3|||
44162690|NCT02380677|78955770|FG000|Overall Study|Other|0|||
44162691|NCT02380677|78955771|FG001|Overall Study|Other|0|||
44162692|NCT02380677|78955772|FG002|Overall Study|Other|0|||
44162693|NCT02380677|78955773|FG003|Overall Study|Other|1|||
44162694|NCT02380677|78955774|FG004|Overall Study|Other|1|||
44162695|NCT02380677|78955775|FG005|Overall Study|Other|1|||
44162696|NCT02380677|78955776|FG006|Overall Study|Other|0|||
44162697|NCT02380677|78955777|FG007|Overall Study|Other|0|||
44162698|NCT02380677|78955778|FG008|Overall Study|Other|0|||
44162699|NCT02380677|78955779|FG009|Overall Study|Other|0|||
44162700|NCT02380677|78955780|FG010|Overall Study|Other|0|||
44162701|NCT02380677|78955781|FG011|Overall Study|Other|0|||
44162702|NCT02380287|78955817|FG000|Overall Study|Adverse Event|0|||
44162703|NCT02380287|78955818|FG001|Overall Study|Adverse Event|0|||
44162704|NCT02380287|78955819|FG002|Overall Study|Adverse Event|1|||
44162705|NCT02380287|78955820|FG003|Overall Study|Adverse Event|0|||
44162706|NCT02380287|78955821|FG004|Overall Study|Adverse Event|0|||
44162707|NCT02380287|78955822|FG005|Overall Study|Adverse Event|0|||
44162708|NCT02380287|78955823|FG006|Overall Study|Adverse Event|0|||
44162709|NCT02380287|78955824|FG007|Overall Study|Adverse Event|0|||
44162710|NCT02343003|78955851|FG000|Overall Study|Withdrawal by Subject|9|||
44162711|NCT02343003|78955852|FG001|Overall Study|Withdrawal by Subject|4|||
44162712|NCT02343003|78955851|FG000|Overall Study|Lost to Follow-up|5|||
44162713|NCT02343003|78955852|FG001|Overall Study|Lost to Follow-up|1|||
44162714|NCT02343003|78955851|FG000|Overall Study|Protocol Violation|1|||
44162715|NCT02343003|78955852|FG001|Overall Study|Protocol Violation|0|||
44162716|NCT02343003|78955851|FG000|Overall Study|Death|0|||
44162717|NCT02343003|78955852|FG001|Overall Study|Death|1|||
44162718|NCT02343003|78955851|FG000|Overall Study|exclusion criteria met|1|||
44162719|NCT02343003|78955852|FG001|Overall Study|exclusion criteria met|1|||
44162720|NCT02343003|78955851|FG000|Overall Study|terminated by sponsor|2|||
44162721|NCT02343003|78955852|FG001|Overall Study|terminated by sponsor|0|||
44162722|NCT02394561|78955860|FG000|CORE Phase|Adverse Event|7|||
44162723|NCT02394561|78955861|FG001|CORE Phase|Adverse Event|9|||
44162724|NCT02394561|78955860|FG000|CORE Phase|Death|0|||
44162725|NCT02394561|78955861|FG001|CORE Phase|Death|1|||
44162726|NCT02394561|78955860|FG000|CORE Phase|Pregnancy|1|||
44162727|NCT02394561|78955861|FG001|CORE Phase|Pregnancy|0|||
44162728|NCT02394561|78955860|FG000|CORE Phase|Lost to Follow-up|1|||
44162729|NCT02394561|78955861|FG001|CORE Phase|Lost to Follow-up|0|||
44162730|NCT02394561|78955860|FG000|CORE Phase|Physician Decision|1|||
44162731|NCT02394561|78955861|FG001|CORE Phase|Physician Decision|1|||
44162732|NCT02394561|78955860|FG000|CORE Phase|Withdrawal by Subject|2|||
44162733|NCT02394561|78955861|FG001|CORE Phase|Withdrawal by Subject|2|||
44162734|NCT02394561|78955860|FG000|CORE Phase|Lack of Efficacy|1|||
44162735|NCT02394561|78955861|FG001|CORE Phase|Lack of Efficacy|6|||
44162736|NCT02394561|78955860|FG000|Extension Phase|Adverse Event|6|||
44162737|NCT02394561|78955861|FG001|Extension Phase|Adverse Event|1|||
44162738|NCT02394561|78955860|FG000|Extension Phase|Death|0|||
44162739|NCT02394561|78955861|FG001|Extension Phase|Death|1|||
44162740|NCT02394561|78955860|FG000|Extension Phase|Protocol Violation|1|||
44162741|NCT02394561|78955861|FG001|Extension Phase|Protocol Violation|0|||
44162742|NCT02394561|78955860|FG000|Extension Phase|Lost to Follow-up|1|||
44162743|NCT02394561|78955861|FG001|Extension Phase|Lost to Follow-up|0|||
44162744|NCT02394561|78955860|FG000|Extension Phase|Physician Decision|0|||
44162745|NCT02394561|78955861|FG001|Extension Phase|Physician Decision|2|||
44162746|NCT02394561|78955860|FG000|Extension Phase|Withdrawal by Subject|0|||
44162747|NCT02394561|78955861|FG001|Extension Phase|Withdrawal by Subject|5|||
44162748|NCT02394561|78955860|FG000|Extension Phase|Lack of Efficacy|3|||
44162749|NCT02394561|78955861|FG001|Extension Phase|Lack of Efficacy|3|||
44162750|NCT02342223|78955870|FG000|Overall Study|Lost to Follow-up|1|||
44162751|NCT02393547|78955874|FG000|Overall Study|Adverse Event|2|||
44345175|NCT01292603|79349229|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
44162752|NCT02393547|78955874|FG000|Overall Study|Withdrawal by Subject|3|||
44345176|NCT01292603|79349230|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
44345177|NCT01292603|79349231|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
44345178|NCT01292603|79349232|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
44345179|NCT01292603|79349233|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
44345180|NCT01292603|79349234|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
44162753|NCT02393547|78955874|FG000|Overall Study|Lost to Follow-up|1|||
44162754|NCT02574637|78955883|FG000|Double-blind Period|Adverse Event|1|||
44162755|NCT02574637|78955884|FG001|Double-blind Period|Adverse Event|0|||
44162756|NCT02574637|78955885|FG002|Double-blind Period|Adverse Event|0|||
44162757|NCT02574637|78955886|FG003|Double-blind Period|Adverse Event|0|||
44162758|NCT02574637|78955887|FG004|Double-blind Period|Adverse Event|0|||
44162759|NCT02574637|78955888|FG005|Double-blind Period|Adverse Event|0|||
44162760|NCT02574637|78955889|FG006|Double-blind Period|Adverse Event|0|||
44162761|NCT02574637|78955890|FG007|Double-blind Period|Adverse Event|0|||
44162762|NCT02574637|78955891|FG008|Double-blind Period|Adverse Event|0|||
44162763|NCT02574637|78955892|FG009|Double-blind Period|Adverse Event|0|||
44162764|NCT02574637|78955883|FG000|Double-blind Period|Lack of Efficacy|0|||
44162765|NCT02574637|78955884|FG001|Double-blind Period|Lack of Efficacy|0|||
44162766|NCT02574637|78955885|FG002|Double-blind Period|Lack of Efficacy|2|||
44162767|NCT02574637|78955886|FG003|Double-blind Period|Lack of Efficacy|0|||
44162768|NCT02574637|78955887|FG004|Double-blind Period|Lack of Efficacy|0|||
44162769|NCT02574637|78955888|FG005|Double-blind Period|Lack of Efficacy|0|||
44162770|NCT02574637|78955889|FG006|Double-blind Period|Lack of Efficacy|0|||
44162771|NCT02574637|78955890|FG007|Double-blind Period|Lack of Efficacy|0|||
44162772|NCT02574637|78955891|FG008|Double-blind Period|Lack of Efficacy|0|||
44162773|NCT02574637|78955892|FG009|Double-blind Period|Lack of Efficacy|0|||
44162774|NCT02574637|78955883|FG000|Double-blind Period|Protocol Deviation|1|||
44162775|NCT02574637|78955884|FG001|Double-blind Period|Protocol Deviation|0|||
44162776|NCT02574637|78955885|FG002|Double-blind Period|Protocol Deviation|0|||
44162777|NCT02574637|78955886|FG003|Double-blind Period|Protocol Deviation|0|||
44162778|NCT02574637|78955887|FG004|Double-blind Period|Protocol Deviation|0|||
44162779|NCT02574637|78955888|FG005|Double-blind Period|Protocol Deviation|0|||
44162780|NCT02574637|78955889|FG006|Double-blind Period|Protocol Deviation|0|||
44162781|NCT02574637|78955890|FG007|Double-blind Period|Protocol Deviation|0|||
44162782|NCT02574637|78955891|FG008|Double-blind Period|Protocol Deviation|0|||
44162783|NCT02574637|78955892|FG009|Double-blind Period|Protocol Deviation|0|||
44162784|NCT02574637|78955883|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
44162785|NCT02574637|78955884|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
44162786|NCT02574637|78955885|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
44162787|NCT02574637|78955886|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
44162788|NCT02574637|78955887|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
44162789|NCT02574637|78955888|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
44162790|NCT02574637|78955889|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
44162791|NCT02574637|78955890|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
44162792|NCT02574637|78955891|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
44162793|NCT02574637|78955892|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
44162794|NCT02574637|78955883|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
44162795|NCT02574637|78955884|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
44162796|NCT02574637|78955885|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
44162797|NCT02574637|78955886|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
44162798|NCT02574637|78955887|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
44162799|NCT02574637|78955888|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
44162800|NCT02574637|78955889|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
44162801|NCT02574637|78955890|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
44162802|NCT02574637|78955891|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
44162803|NCT02574637|78955892|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
44162804|NCT02574637|78955883|FG000|Double-blind Period|Reason Not Specified|0|||
44162805|NCT02574637|78955884|FG001|Double-blind Period|Reason Not Specified|0|||
44162806|NCT02574637|78955885|FG002|Double-blind Period|Reason Not Specified|0|||
44162807|NCT02574637|78955886|FG003|Double-blind Period|Reason Not Specified|1|||
44162808|NCT02574637|78955887|FG004|Double-blind Period|Reason Not Specified|0|||
44162809|NCT02574637|78955888|FG005|Double-blind Period|Reason Not Specified|0|||
44162810|NCT02574637|78955889|FG006|Double-blind Period|Reason Not Specified|0|||
44162811|NCT02574637|78955890|FG007|Double-blind Period|Reason Not Specified|0|||
44162812|NCT02574637|78955891|FG008|Double-blind Period|Reason Not Specified|0|||
44162813|NCT02574637|78955892|FG009|Double-blind Period|Reason Not Specified|0|||
44162814|NCT02574637|78955883|FG000|Open-label (OL) Period|Adverse Event|0|||
44162815|NCT02574637|78955884|FG001|Open-label (OL) Period|Adverse Event|0|||
44162816|NCT02574637|78955885|FG002|Open-label (OL) Period|Adverse Event|0|||
44162817|NCT02574637|78955886|FG003|Open-label (OL) Period|Adverse Event|0|||
44162818|NCT02574637|78955887|FG004|Open-label (OL) Period|Adverse Event|0|||
44162819|NCT02574637|78955888|FG005|Open-label (OL) Period|Adverse Event|0|||
44162820|NCT02574637|78955889|FG006|Open-label (OL) Period|Adverse Event|0|||
44162821|NCT02574637|78955890|FG007|Open-label (OL) Period|Adverse Event|0|||
44162822|NCT02574637|78955891|FG008|Open-label (OL) Period|Adverse Event|1|||
44162823|NCT02574637|78955892|FG009|Open-label (OL) Period|Adverse Event|0|||
44162824|NCT02574637|78955883|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
44162825|NCT02574637|78955884|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
44162826|NCT02574637|78955885|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
44162827|NCT02574637|78955886|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
44162828|NCT02574637|78955887|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
44162829|NCT02574637|78955888|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
44162830|NCT02574637|78955889|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
44162831|NCT02574637|78955890|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
44162832|NCT02574637|78955891|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
44162833|NCT02574637|78955892|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
44162834|NCT02574637|78955883|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
44162835|NCT02574637|78955884|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
44162836|NCT02574637|78955885|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
44162837|NCT02574637|78955886|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
44162838|NCT02574637|78955887|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
44162839|NCT02574637|78955888|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
44162840|NCT02574637|78955889|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
44162841|NCT02574637|78955890|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
44162842|NCT02574637|78955891|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
44162843|NCT02574637|78955892|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
44162844|NCT02392611|78955922|FG000|Overall Study|Adverse Event|0|||
44162845|NCT02392611|78955923|FG001|Overall Study|Adverse Event|0|||
44162846|NCT02392611|78955924|FG002|Overall Study|Adverse Event|0|||
44162847|NCT02392611|78955925|FG003|Overall Study|Adverse Event|1|||
44162848|NCT02392611|78955926|FG004|Overall Study|Adverse Event|0|||
44162849|NCT02392611|78955927|FG005|Overall Study|Adverse Event|0|||
44162850|NCT02392611|78955928|FG006|Overall Study|Adverse Event|0|||
44162851|NCT02392611|78955929|FG007|Overall Study|Adverse Event|0|||
44162852|NCT02392611|78955930|FG008|Overall Study|Adverse Event|0|||
44162853|NCT02392611|78955922|FG000|Overall Study|Progressive disease|0|||
44162854|NCT02392611|78955923|FG001|Overall Study|Progressive disease|0|||
44162855|NCT02392611|78955924|FG002|Overall Study|Progressive disease|0|||
44162856|NCT02392611|78955925|FG003|Overall Study|Progressive disease|2|||
44162857|NCT02392611|78955926|FG004|Overall Study|Progressive disease|1|||
44162858|NCT02392611|78955927|FG005|Overall Study|Progressive disease|0|||
44345181|NCT01292603|79349229|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
44444937|NCT03635983|79452804|FG001|Treatment Period|Disease progression|168|||
44444938|NCT03635983|79452803|FG000|Treatment Period|Study drug toxicity|26|||
44444939|NCT03635983|79452804|FG001|Treatment Period|Study drug toxicity|29|||
44444940|NCT03635983|79452803|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
44162859|NCT02392611|78955928|FG006|Overall Study|Progressive disease|0|||
44162860|NCT02392611|78955929|FG007|Overall Study|Progressive disease|0|||
44162861|NCT02392611|78955930|FG008|Overall Study|Progressive disease|0|||
44345182|NCT01292603|79349230|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
44345183|NCT01292603|79349231|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
44345184|NCT01292603|79349232|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
44345185|NCT01292603|79349233|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
44345186|NCT01292603|79349234|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
44345187|NCT01292603|79349229|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
44345188|NCT01292603|79349230|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
44345189|NCT01292603|79349231|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
44345190|NCT01292603|79349232|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
44345191|NCT01292603|79349233|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
44345192|NCT01292603|79349234|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
44345193|NCT01292603|79349229|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
44444941|NCT03635983|79452804|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
44162862|NCT02392611|78955922|FG000|Overall Study|Death|1|||
44162863|NCT02392611|78955923|FG001|Overall Study|Death|0|||
44162864|NCT02392611|78955924|FG002|Overall Study|Death|0|||
44162865|NCT02392611|78955925|FG003|Overall Study|Death|0|||
44162866|NCT02392611|78955926|FG004|Overall Study|Death|0|||
44444942|NCT03635983|79452803|FG000|Treatment Period|Maximum clinical benefit|3|||
44444943|NCT03635983|79452804|FG001|Treatment Period|Maximum clinical benefit|2|||
44162867|NCT02392611|78955927|FG005|Overall Study|Death|1|||
44162868|NCT02392611|78955928|FG006|Overall Study|Death|0|||
44162869|NCT02392611|78955929|FG007|Overall Study|Death|0|||
44162870|NCT02392611|78955930|FG008|Overall Study|Death|0|||
44162871|NCT02392611|78955922|FG000|Overall Study|Withdrawal by Subject|0|||
44162872|NCT02392611|78955923|FG001|Overall Study|Withdrawal by Subject|0|||
44162873|NCT02392611|78955924|FG002|Overall Study|Withdrawal by Subject|0|||
44162874|NCT02392611|78955925|FG003|Overall Study|Withdrawal by Subject|1|||
44162875|NCT02392611|78955926|FG004|Overall Study|Withdrawal by Subject|0|||
44162876|NCT02392611|78955927|FG005|Overall Study|Withdrawal by Subject|0|||
44162877|NCT02392611|78955928|FG006|Overall Study|Withdrawal by Subject|0|||
44162878|NCT02392611|78955929|FG007|Overall Study|Withdrawal by Subject|0|||
44162879|NCT02392611|78955930|FG008|Overall Study|Withdrawal by Subject|0|||
44162880|NCT02392611|78955922|FG000|Overall Study|Lost to Follow-up|0|||
44162881|NCT02392611|78955923|FG001|Overall Study|Lost to Follow-up|0|||
44162882|NCT02392611|78955924|FG002|Overall Study|Lost to Follow-up|0|||
44162883|NCT02392611|78955925|FG003|Overall Study|Lost to Follow-up|0|||
44162884|NCT02392611|78955926|FG004|Overall Study|Lost to Follow-up|0|||
44162885|NCT02392611|78955927|FG005|Overall Study|Lost to Follow-up|0|||
44162886|NCT02392611|78955928|FG006|Overall Study|Lost to Follow-up|1|||
44162887|NCT02392611|78955929|FG007|Overall Study|Lost to Follow-up|0|||
44162888|NCT02392611|78955930|FG008|Overall Study|Lost to Follow-up|0|||
44162889|NCT02392611|78955922|FG000|Overall Study|Enrolled, not treated|0|||
44162890|NCT02392611|78955923|FG001|Overall Study|Enrolled, not treated|0|||
44162891|NCT02392611|78955924|FG002|Overall Study|Enrolled, not treated|0|||
44162892|NCT02392611|78955925|FG003|Overall Study|Enrolled, not treated|2|||
44162893|NCT02392611|78955926|FG004|Overall Study|Enrolled, not treated|0|||
44162894|NCT02392611|78955927|FG005|Overall Study|Enrolled, not treated|0|||
44162895|NCT02392611|78955928|FG006|Overall Study|Enrolled, not treated|0|||
44162896|NCT02392611|78955929|FG007|Overall Study|Enrolled, not treated|0|||
44162897|NCT02392611|78955930|FG008|Overall Study|Enrolled, not treated|0|||
44162898|NCT02378961|78955954|FG000|Overall Study|Lack of Efficacy|4|||
44162899|NCT02378961|78955955|FG001|Overall Study|Lack of Efficacy|2|||
44162900|NCT02378961|78955956|FG002|Overall Study|Lack of Efficacy|0|||
44162901|NCT02378961|78955957|FG003|Overall Study|Lack of Efficacy|1|||
44162902|NCT02378961|78955954|FG000|Overall Study|Death|0|||
44162903|NCT02378961|78955955|FG001|Overall Study|Death|0|||
44162904|NCT02378961|78955956|FG002|Overall Study|Death|1|||
44162905|NCT02378961|78955957|FG003|Overall Study|Death|0|||
44162906|NCT02378883|78955967|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
44162907|NCT02378883|78955967|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
44162908|NCT02378883|78955967|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
44162909|NCT02378883|78955967|FG000|30 Day Follow-Up|Physician Decision|2|||
44162910|NCT02378883|78955967|FG000|30 Day Follow-Up|Missed Visit|2|||
44162911|NCT02378883|78955967|FG000|30 Day Follow-Up|Death|1|||
44162912|NCT02378883|78955967|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
44162913|NCT02378883|78955967|FG000|12 Months Follow-Up|Death|2|||
44162914|NCT02340975|78955978|FG000|Overall Study|Death|6|||
44162915|NCT02340975|78955979|FG001|Overall Study|Death|23|||
44162916|NCT02340975|78955980|FG002|Overall Study|Death|21|||
44162917|NCT02340975|78955981|FG003|Overall Study|Death|7|||
44162918|NCT02340975|78955982|FG004|Overall Study|Death|21|||
44162919|NCT02340975|78955983|FG005|Overall Study|Death|13|||
44162920|NCT02340975|78955978|FG000|Overall Study|Lost to Follow-up|0|||
44162921|NCT02340975|78955979|FG001|Overall Study|Lost to Follow-up|0|||
44162922|NCT02340975|78955980|FG002|Overall Study|Lost to Follow-up|0|||
44162923|NCT02340975|78955981|FG003|Overall Study|Lost to Follow-up|0|||
44162924|NCT02340975|78955982|FG004|Overall Study|Lost to Follow-up|2|||
44162925|NCT02340975|78955983|FG005|Overall Study|Lost to Follow-up|0|||
44162926|NCT02340975|78955978|FG000|Overall Study|Withdrawal by Subject|0|||
44162927|NCT02340975|78955979|FG001|Overall Study|Withdrawal by Subject|0|||
44162928|NCT02340975|78955980|FG002|Overall Study|Withdrawal by Subject|3|||
44162929|NCT02340975|78955981|FG003|Overall Study|Withdrawal by Subject|3|||
44162930|NCT02340975|78955982|FG004|Overall Study|Withdrawal by Subject|2|||
44162931|NCT02340975|78955983|FG005|Overall Study|Withdrawal by Subject|0|||
44162932|NCT02340975|78955978|FG000|Overall Study|Other|0|||
44162933|NCT02340975|78955979|FG001|Overall Study|Other|4|||
44162934|NCT02340975|78955980|FG002|Overall Study|Other|0|||
44162935|NCT02340975|78955981|FG003|Overall Study|Other|2|||
44162936|NCT02340975|78955982|FG004|Overall Study|Other|0|||
44162937|NCT02340975|78955983|FG005|Overall Study|Other|6|||
44162938|NCT02392377|78956000|FG000|Overall Study|Withdrawal by Subject|0|||
44162939|NCT02392377|78956001|FG001|Overall Study|Withdrawal by Subject|1|||
44162940|NCT02340819|78956009|FG000|Overall Study|Adverse Event|1|||
44162941|NCT02340819|78956009|FG000|Overall Study|Withdrawal by Subject|2|||
44162942|NCT02340819|78956009|FG000|Overall Study|Discontinued with other reason|1|||
44162943|NCT02340663|78956015|FG000|Overall Study|Lost to Follow-up|1|||
44162944|NCT02340663|78956016|FG001|Overall Study|Lost to Follow-up|0|||
44162945|NCT02340663|78956015|FG000|Overall Study|Protocol Violation|1|||
44162946|NCT02340663|78956016|FG001|Overall Study|Protocol Violation|0|||
44162947|NCT02340663|78956015|FG000|Overall Study|Withdrawal by Subject|3|||
44162948|NCT02340663|78956016|FG001|Overall Study|Withdrawal by Subject|1|||
44162949|NCT02573467|78956026|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
44162950|NCT02573467|78956027|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
44162951|NCT02573467|78956028|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
44162952|NCT02573467|78956029|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
44162953|NCT02573467|78956026|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
44162954|NCT02573467|78956027|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
44162955|NCT02573467|78956028|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
44162956|NCT02573467|78956029|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
44162957|NCT02573467|78956026|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
44162958|NCT02573467|78956027|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
44162959|NCT02573467|78956028|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
44162960|NCT02573467|78956029|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
44162961|NCT02573467|78956026|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
44162962|NCT02573467|78956027|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
44162963|NCT02573467|78956028|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
44162964|NCT02573467|78956029|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
44162965|NCT02573467|78956026|FG000|Post-treatment Follow up Epoch|Death|1|||
44162966|NCT02573467|78956027|FG001|Post-treatment Follow up Epoch|Death|1|||
44162967|NCT02573467|78956028|FG002|Post-treatment Follow up Epoch|Death|0|||
44162968|NCT02573467|78956029|FG003|Post-treatment Follow up Epoch|Death|1|||
44162969|NCT02573467|78956026|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
44162970|NCT02573467|78956027|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
44162971|NCT02573467|78956028|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
44162972|NCT02573467|78956029|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
44162973|NCT02573467|78956026|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
44162974|NCT02573467|78956027|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
44162975|NCT02573467|78956028|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
44162976|NCT02573467|78956029|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
44162977|NCT02337387|78956044|FG000|Overall Study|Adverse Event|0|||
44162978|NCT02337387|78956045|FG001|Overall Study|Adverse Event|1|||
44162979|NCT02337387|78956046|FG002|Overall Study|Adverse Event|0|||
44162980|NCT02337387|78956047|FG003|Overall Study|Adverse Event|0|||
44162981|NCT02337387|78956044|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
44162982|NCT02337387|78956045|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
44162983|NCT02337387|78956046|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
44162984|NCT02337387|78956047|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
44162985|NCT02574247|78956060|FG000|Overall Study|Withdrawal by Subject|1|||
44162986|NCT02574247|78956061|FG001|Overall Study|Withdrawal by Subject|0|||
44162987|NCT02574247|78956062|FG002|Overall Study|Withdrawal by Subject|0|||
44162988|NCT02574247|78956060|FG000|Overall Study|Did not meet inclusion criteria|4|||
44162989|NCT02574247|78956061|FG001|Overall Study|Did not meet inclusion criteria|3|||
44162990|NCT02574247|78956062|FG002|Overall Study|Did not meet inclusion criteria|5|||
44162991|NCT02391363|78956074|FG000|Overall Study|Lost to Follow-up|5|||
44162992|NCT02391363|78956075|FG001|Overall Study|Lost to Follow-up|5|||
44162993|NCT02391363|78956074|FG000|Overall Study|Withdrawal by Subject|6|||
44162994|NCT02391363|78956075|FG001|Overall Study|Withdrawal by Subject|3|||
44162995|NCT02569957|78956083|FG000|Overall Study|Withdrawal by Subject|0|||
44162996|NCT02569957|78956084|FG001|Overall Study|Withdrawal by Subject|1|||
44162997|NCT01649427|78956092|FG000|Overall Study|Adverse Event|1|||
44162998|NCT01649427|78956093|FG001|Overall Study|Adverse Event|1|||
44162999|NCT01649427|78956092|FG000|Overall Study|Withdrawal by Subject|8|||
44163000|NCT01649427|78956093|FG001|Overall Study|Withdrawal by Subject|7|||
44163001|NCT01649427|78956092|FG000|Overall Study|Lost to Follow-up|0|||
44163002|NCT01649427|78956093|FG001|Overall Study|Lost to Follow-up|1|||
44163003|NCT01649427|78956092|FG000|Overall Study|Graft loss|0|||
44163004|NCT01649427|78956093|FG001|Overall Study|Graft loss|1|||
44163005|NCT01649427|78956092|FG000|Overall Study|Surgical problems during nephrectomy|2|||
44163006|NCT01649427|78956093|FG001|Overall Study|Surgical problems during nephrectomy|2|||
44163007|NCT02375373|78956099|FG000|Overall Study|Withdrawal by Subject|11|||
44163008|NCT02336607|78956107|FG000|Overall Study|Physician Decision|1|||
44163009|NCT02336607|78956108|FG001|Overall Study|Physician Decision|4|||
44163010|NCT02336607|78956109|FG002|Overall Study|Physician Decision|3|||
44163011|NCT02336607|78956110|FG003|Overall Study|Physician Decision|15|||
44163012|NCT02336607|78956107|FG000|Overall Study|Lack of Efficacy|1|||
44163013|NCT02336607|78956108|FG001|Overall Study|Lack of Efficacy|0|||
44163014|NCT02336607|78956109|FG002|Overall Study|Lack of Efficacy|0|||
44163015|NCT02336607|78956110|FG003|Overall Study|Lack of Efficacy|2|||
44163016|NCT02336607|78956107|FG000|Overall Study|Lost to Follow-up|2|||
44163017|NCT02336607|78956108|FG001|Overall Study|Lost to Follow-up|1|||
44163018|NCT02336607|78956109|FG002|Overall Study|Lost to Follow-up|0|||
44163019|NCT02336607|78956110|FG003|Overall Study|Lost to Follow-up|21|||
44163020|NCT02336607|78956107|FG000|Overall Study|Protocol Violation|0|||
44163021|NCT02336607|78956108|FG001|Overall Study|Protocol Violation|1|||
44163022|NCT02336607|78956109|FG002|Overall Study|Protocol Violation|1|||
44163023|NCT02336607|78956110|FG003|Overall Study|Protocol Violation|3|||
44163024|NCT02336607|78956107|FG000|Overall Study|Adverse Event|0|||
44163025|NCT02336607|78956108|FG001|Overall Study|Adverse Event|2|||
44163026|NCT02336607|78956109|FG002|Overall Study|Adverse Event|2|||
44163027|NCT02336607|78956110|FG003|Overall Study|Adverse Event|26|||
44163028|NCT02336607|78956107|FG000|Overall Study|Withdrawal by Subject|0|||
44163029|NCT02336607|78956108|FG001|Overall Study|Withdrawal by Subject|2|||
44163030|NCT02336607|78956109|FG002|Overall Study|Withdrawal by Subject|0|||
44163031|NCT02336607|78956110|FG003|Overall Study|Withdrawal by Subject|20|||
44163032|NCT02374671|78956123|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
44163033|NCT02374671|78956124|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
44163034|NCT02374671|78956125|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
44163035|NCT02374671|78956123|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
44163036|NCT02374671|78956124|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
44163037|NCT02374671|78956125|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
44163038|NCT02374671|78956123|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
44163039|NCT02374671|78956124|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
44163040|NCT02374671|78956125|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
44163041|NCT02374671|78956123|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
44163042|NCT02374671|78956124|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
44163043|NCT02374671|78956125|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
44163044|NCT02374671|78956123|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
44163045|NCT02374671|78956124|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
44163046|NCT02374671|78956125|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
44163047|NCT02569801|78956133|FG000|Overall Study|Withdrawal by Subject|9|||
44163048|NCT02569801|78956134|FG001|Overall Study|Withdrawal by Subject|9|||
44163049|NCT02569801|78956133|FG000|Overall Study|Sponsor Decision|13|||
44163050|NCT02569801|78956134|FG001|Overall Study|Sponsor Decision|14|||
44163051|NCT02569801|78956133|FG000|Overall Study|Progressive Disease|2|||
44163052|NCT02569801|78956134|FG001|Overall Study|Progressive Disease|7|||
44163053|NCT02569801|78956133|FG000|Overall Study|Lost to Follow-up|0|||
44163054|NCT02569801|78956134|FG001|Overall Study|Lost to Follow-up|1|||
44163055|NCT02569801|78956133|FG000|Overall Study|Death|12|||
44163056|NCT02569801|78956134|FG001|Overall Study|Death|4|||
44163057|NCT02573311|78956142|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
44163058|NCT02573311|78956143|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
44163059|NCT02573311|78956142|FG000|Disposition for Part 2|Physician Decision|25|||
44163060|NCT02573311|78956143|FG001|Disposition for Part 2|Physician Decision|7|||
44345194|NCT01292603|79349230|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
44345195|NCT01292603|79349231|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
44345196|NCT01292603|79349232|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
44345197|NCT01292603|79349233|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
44345198|NCT01292603|79349234|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
44345199|NCT01292603|79349229|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
44345200|NCT01292603|79349230|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
44345201|NCT01292603|79349231|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
44345202|NCT01292603|79349232|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
44345203|NCT01292603|79349233|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
44345204|NCT01292603|79349234|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
44345205|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Death|0|||
44345206|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Death|0|||
44345207|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Death|0|||
44345208|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Death|0|||
44345209|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Death|6|||
44345210|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Death|3|||
44345211|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
44345212|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
44345213|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
44345214|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
44345215|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
44345216|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
44345217|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
44345218|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
44163061|NCT02573311|78956142|FG000|Disposition for Part 2|Adverse Event|36|||
44163062|NCT02573311|78956143|FG001|Disposition for Part 2|Adverse Event|5|||
44163063|NCT02573311|78956142|FG000|Disposition for Part 2|Lost to Follow-up|76|||
44163064|NCT02573311|78956143|FG001|Disposition for Part 2|Lost to Follow-up|7|||
44163065|NCT02573311|78956142|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
44163066|NCT02573311|78956143|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
44163067|NCT02573311|78956142|FG000|Disposition for Part 2|Investigator decision|0|||
44163068|NCT02573311|78956143|FG001|Disposition for Part 2|Investigator decision|1|||
44163069|NCT02573311|78956142|FG000|Disposition for Part 2|Other than specified above|13|||
44163070|NCT02573311|78956143|FG001|Disposition for Part 2|Other than specified above|3|||
44163071|NCT02571049|78956149|FG000|Screening|Did not meet entry criteria|2|||
44163072|NCT02571049|78956150|FG001|Screening|Did not meet entry criteria|2|||
44345219|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
44345220|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
44345221|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
44345222|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
44345223|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
44345224|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
44345225|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
44345226|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
44345227|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
44345228|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
44345229|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
44345230|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
44345231|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
44345232|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
44345233|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
44345234|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
44345235|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
44345236|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
44345237|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
44345238|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
44345239|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
44345240|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
44345241|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
44345242|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
44345243|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
44345244|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
44345245|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
44345246|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
44345247|NCT01292603|79349229|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
44345248|NCT01292603|79349230|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
44345249|NCT01292603|79349231|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
44345250|NCT01292603|79349232|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
44345251|NCT01292603|79349233|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
44345252|NCT01292603|79349234|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
44345253|NCT01292603|79349229|FG000|Overall Survival Status|Death|3|||
44345254|NCT01292603|79349230|FG001|Overall Survival Status|Death|1|||
44345255|NCT01292603|79349231|FG002|Overall Survival Status|Death|3|||
44345256|NCT01292603|79349232|FG003|Overall Survival Status|Death|1|||
44345257|NCT01292603|79349233|FG004|Overall Survival Status|Death|16|||
44345258|NCT01292603|79349234|FG005|Overall Survival Status|Death|10|||
44345259|NCT01292057|79349257|FG000|Overall Study|Protocol Violation|1|||
44345260|NCT01292057|79349258|FG001|Overall Study|Protocol Violation|1|||
44345261|NCT01292057|79349257|FG000|Overall Study|Lost to Follow-up|1|||
44345262|NCT01292057|79349258|FG001|Overall Study|Lost to Follow-up|1|||
44345263|NCT01291277|79349266|FG000|Overall Study|Death|2|||
44345264|NCT01291277|79349267|FG001|Overall Study|Death|2|||
44345265|NCT01291277|79349266|FG000|Overall Study|Lost to Follow-up|3|||
44345266|NCT01291277|79349267|FG001|Overall Study|Lost to Follow-up|1|||
44345267|NCT01290887|79349275|FG000|Overall Study|Adverse Event|6|||
44444944|NCT03517449|79452812|FG000|Overall Study|Death|184|||
44345268|NCT01290887|79349276|FG001|Overall Study|Adverse Event|11|||
44345269|NCT01290887|79349275|FG000|Overall Study|Lack of Efficacy|4|||
44345270|NCT01290887|79349276|FG001|Overall Study|Lack of Efficacy|5|||
44345271|NCT01290887|79349275|FG000|Overall Study|Withdrawal by Subject|26|||
44345272|NCT01290887|79349276|FG001|Overall Study|Withdrawal by Subject|32|||
44345273|NCT01290887|79349275|FG000|Overall Study|Protocol Violation|2|||
44345274|NCT01290887|79349276|FG001|Overall Study|Protocol Violation|1|||
44345275|NCT01290887|79349275|FG000|Overall Study|Lost to Follow-up|4|||
44345276|NCT01290887|79349276|FG001|Overall Study|Lost to Follow-up|4|||
44444945|NCT03517449|79452813|FG001|Overall Study|Death|236|||
44163073|NCT02571049|78956149|FG000|Randomization|No migraine attack|0|||
44163074|NCT02571049|78956150|FG001|Randomization|No migraine attack|1|||
44345277|NCT01290887|79349275|FG000|Overall Study|Non-compliance to study procedures|0|||
44163075|NCT02571049|78956149|FG000|Randomization|Adverse Event|0|||
44345278|NCT01290887|79349276|FG001|Overall Study|Non-compliance to study procedures|1|||
44345279|NCT01290887|79349275|FG000|Overall Study|Non-compliance to study medications|1|||
44345280|NCT01290887|79349276|FG001|Overall Study|Non-compliance to study medications|0|||
44345281|NCT01290887|79349275|FG000|Overall Study|Sponsor closure of study|420|||
44163076|NCT02571049|78956150|FG001|Randomization|Adverse Event|1|||
44163077|NCT02573155|78956158|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
44163078|NCT02573155|78956159|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
44163079|NCT02573155|78956158|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
44163080|NCT02573155|78956159|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
44163081|NCT02573155|78956158|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
44163082|NCT02573155|78956159|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
44163083|NCT02573155|78956158|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
44163084|NCT02573155|78956159|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
44163085|NCT02573155|78956158|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
44163086|NCT02573155|78956159|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
44163087|NCT02573155|78956158|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
44163088|NCT02573155|78956159|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
44163089|NCT02573155|78956158|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
44163090|NCT02573155|78956159|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
44163091|NCT02573155|78956158|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
44163092|NCT02573155|78956159|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
44163093|NCT02568475|78956187|FG000|Overall Study|Lost to Follow-up|40|||
44163094|NCT02568475|78956188|FG001|Overall Study|Lost to Follow-up|39|||
44163095|NCT02568475|78956187|FG000|Overall Study|Withdrawal by Subject|2|||
44163096|NCT02568475|78956188|FG001|Overall Study|Withdrawal by Subject|0|||
44163097|NCT02568475|78956187|FG000|Overall Study|Discharged home|4|||
44163098|NCT02568475|78956188|FG001|Overall Study|Discharged home|4|||
44163099|NCT02568475|78956187|FG000|Overall Study|Short-term: Discharge location unknown|4|||
44163100|NCT02568475|78956188|FG001|Overall Study|Short-term: Discharge location unknown|0|||
44163101|NCT02568475|78956187|FG000|Overall Study|Transferred to another facility|1|||
44163102|NCT02568475|78956188|FG001|Overall Study|Transferred to another facility|0|||
44163103|NCT02568397|78956194|FG000|Period 2|Withdrawal by Subject|0|||
44163104|NCT02568397|78956195|FG001|Period 2|Withdrawal by Subject|1|||
44163105|NCT02568397|78956194|FG000|Period 2|Physician Decision|0|||
44163106|NCT02568397|78956195|FG001|Period 2|Physician Decision|1|||
44163107|NCT02566525|78956212|FG000|Overall Study|Protocol Violation|3|||
44163108|NCT02566525|78956213|FG001|Overall Study|Protocol Violation|5|||
44163123|NCT02336451|78956235|FG000|Overall Study|Adverse Event|1|||
44163124|NCT02336451|78956236|FG001|Overall Study|Adverse Event|2|||
44163125|NCT02336451|78956237|FG002|Overall Study|Adverse Event|0|||
44163126|NCT02336451|78956238|FG003|Overall Study|Adverse Event|6|||
44163127|NCT02336451|78956239|FG004|Overall Study|Adverse Event|4|||
44163128|NCT02336451|78956235|FG000|Overall Study|Death|6|||
44163129|NCT02336451|78956236|FG001|Overall Study|Death|2|||
44163130|NCT02336451|78956237|FG002|Overall Study|Death|3|||
44163131|NCT02336451|78956238|FG003|Overall Study|Death|6|||
44163132|NCT02336451|78956239|FG004|Overall Study|Death|6|||
44163133|NCT02336451|78956235|FG000|Overall Study|Physician Decision|9|||
44163134|NCT02336451|78956236|FG001|Overall Study|Physician Decision|6|||
44163135|NCT02336451|78956237|FG002|Overall Study|Physician Decision|7|||
44163136|NCT02336451|78956238|FG003|Overall Study|Physician Decision|16|||
44163137|NCT02336451|78956239|FG004|Overall Study|Physician Decision|3|||
44163138|NCT02336451|78956235|FG000|Overall Study|Progressive disease|23|||
44163139|NCT02336451|78956236|FG001|Overall Study|Progressive disease|26|||
44163140|NCT02336451|78956237|FG002|Overall Study|Progressive disease|2|||
44163141|NCT02336451|78956238|FG003|Overall Study|Progressive disease|14|||
44163142|NCT02336451|78956239|FG004|Overall Study|Progressive disease|4|||
44163143|NCT02336451|78956235|FG000|Overall Study|Protocol Violation|1|||
44163144|NCT02336451|78956236|FG001|Overall Study|Protocol Violation|0|||
44163145|NCT02336451|78956237|FG002|Overall Study|Protocol Violation|0|||
44163146|NCT02336451|78956238|FG003|Overall Study|Protocol Violation|0|||
44163147|NCT02336451|78956239|FG004|Overall Study|Protocol Violation|0|||
44163148|NCT02336451|78956235|FG000|Overall Study|Patient/guardian decision|2|||
44163149|NCT02336451|78956236|FG001|Overall Study|Patient/guardian decision|4|||
44163150|NCT02336451|78956237|FG002|Overall Study|Patient/guardian decision|0|||
44163151|NCT02336451|78956238|FG003|Overall Study|Patient/guardian decision|2|||
44163152|NCT02336451|78956239|FG004|Overall Study|Patient/guardian decision|1|||
44163153|NCT02374593|78956255|FG000|Overall Study|non-compliant|2|||
44163154|NCT02374593|78956256|FG001|Overall Study|non-compliant|0|||
44163155|NCT01648101|78956269|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
44163156|NCT01648101|78956270|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
44163157|NCT01648101|78956271|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
44163158|NCT01648101|78956269|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
44163159|NCT01648101|78956270|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
44163160|NCT01648101|78956271|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
44163161|NCT01648101|78956269|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
44163162|NCT01648101|78956270|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
44163163|NCT01648101|78956271|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
44163164|NCT01648101|78956269|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
44163165|NCT01648101|78956270|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
44163166|NCT01648101|78956271|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
44163167|NCT01648101|78956269|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
44163168|NCT01648101|78956270|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
44163169|NCT01648101|78956271|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
44163170|NCT01648101|78956269|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
44163171|NCT01648101|78956270|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
44163172|NCT01648101|78956271|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
44163173|NCT01648101|78956269|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
44163174|NCT01648101|78956270|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
44163175|NCT01648101|78956271|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
44163176|NCT01648101|78956269|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
44163177|NCT01648101|78956270|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
44163178|NCT01648101|78956271|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
44163179|NCT01648101|78956269|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
44163180|NCT01648101|78956270|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
44163181|NCT01648101|78956271|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
44163182|NCT01648101|78956269|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
44163183|NCT01648101|78956270|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
44163184|NCT01648101|78956271|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
44163185|NCT01648101|78956269|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
44163186|NCT01648101|78956270|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
44163187|NCT01648101|78956271|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
44163188|NCT02336373|78956283|FG000|Overall Study|Protocol closed early|4|||
44163189|NCT02336373|78956283|FG000|Overall Study|Physician Decision|14|||
44163190|NCT02372799|78956292|FG000|Treatment Period|Adverse Event|3|||
44163191|NCT02372799|78956293|FG001|Treatment Period|Adverse Event|10|||
44163192|NCT02372799|78956294|FG002|Treatment Period|Adverse Event|6|||
44163193|NCT02372799|78956292|FG000|Treatment Period|Insufficient therapeutic response|2|||
44163194|NCT02372799|78956293|FG001|Treatment Period|Insufficient therapeutic response|2|||
44163195|NCT02372799|78956294|FG002|Treatment Period|Insufficient therapeutic response|0|||
44163196|NCT02372799|78956292|FG000|Treatment Period|Withdrawal by Subject|10|||
44163197|NCT02372799|78956293|FG001|Treatment Period|Withdrawal by Subject|10|||
44163198|NCT02372799|78956294|FG002|Treatment Period|Withdrawal by Subject|2|||
44163199|NCT02372799|78956292|FG000|Treatment Period|Lost to Follow-up|11|||
44163200|NCT02372799|78956293|FG001|Treatment Period|Lost to Follow-up|5|||
44163201|NCT02372799|78956294|FG002|Treatment Period|Lost to Follow-up|3|||
44163202|NCT02372799|78956292|FG000|Treatment Period|Protocol Violation|3|||
44163203|NCT02372799|78956293|FG001|Treatment Period|Protocol Violation|0|||
44163204|NCT02372799|78956294|FG002|Treatment Period|Protocol Violation|0|||
44163205|NCT02372799|78956292|FG000|Treatment Period|Non-compliance with study drug|4|||
44163206|NCT02372799|78956293|FG001|Treatment Period|Non-compliance with study drug|4|||
44163207|NCT02372799|78956294|FG002|Treatment Period|Non-compliance with study drug|4|||
44163208|NCT02372799|78956292|FG000|Treatment Period|Miscellaneous Reasons|1|||
44163209|NCT02372799|78956293|FG001|Treatment Period|Miscellaneous Reasons|1|||
44163210|NCT02372799|78956294|FG002|Treatment Period|Miscellaneous Reasons|0|||
44345282|NCT01290887|79349276|FG001|Overall Study|Sponsor closure of study|476|||
44345283|NCT01290887|79349275|FG000|Overall Study|Other|3|||
44163211|NCT02372799|78956292|FG000|Down-taper Period|Lost to Follow-up|1|||
44163212|NCT02372799|78956293|FG001|Down-taper Period|Lost to Follow-up|2|||
44163213|NCT02372799|78956294|FG002|Down-taper Period|Lost to Follow-up|2|||
44163214|NCT02566993|78956304|FG000|Overall Study|Randomized but not treated|5|||
44163215|NCT02566993|78956305|FG001|Overall Study|Randomized but not treated|16|||
44163216|NCT02566993|78956304|FG000|Overall Study|Progressive disease|213|||
44163217|NCT02566993|78956305|FG001|Overall Study|Progressive disease|152|||
44163218|NCT02566993|78956304|FG000|Overall Study|Withdrawal by Subject|12|||
44163219|NCT02566993|78956305|FG001|Overall Study|Withdrawal by Subject|28|||
44163220|NCT02566993|78956304|FG000|Overall Study|Death|17|||
44163221|NCT02566993|78956305|FG001|Overall Study|Death|23|||
44163222|NCT02566993|78956304|FG000|Overall Study|Physician Decision|10|||
44163223|NCT02566993|78956305|FG001|Overall Study|Physician Decision|17|||
44163224|NCT02566993|78956304|FG000|Overall Study|Study drug-related adverse event|20|||
44163225|NCT02566993|78956305|FG001|Overall Study|Study drug-related adverse event|41|||
44163226|NCT02566993|78956304|FG000|Overall Study|Non study drug-related adverse event|9|||
44163227|NCT02566993|78956305|FG001|Overall Study|Non study drug-related adverse event|9|||
44163228|NCT02566993|78956304|FG000|Overall Study|Symptomatic deterioration|9|||
44163229|NCT02566993|78956305|FG001|Overall Study|Symptomatic deterioration|16|||
44163230|NCT02566993|78956304|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
44163231|NCT02566993|78956305|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
44163232|NCT02566993|78956304|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
44163233|NCT02566993|78956305|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
44163234|NCT02566993|78956304|FG000|Overall Study|Screening failure|2|||
44163235|NCT02566993|78956305|FG001|Overall Study|Screening failure|0|||
44163236|NCT02566993|78956304|FG000|Overall Study|Lost to Follow-up|0|||
44163237|NCT02566993|78956305|FG001|Overall Study|Lost to Follow-up|1|||
44163238|NCT02566993|78956304|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
44163239|NCT02566993|78956305|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
44163240|NCT02311881|78956316|FG000|Overall Study|Did not meet the study criteria|2|||
44163241|NCT02311881|78956317|FG001|Overall Study|Did not meet the study criteria|2|||
44163242|NCT02311881|78956318|FG002|Overall Study|Did not meet the study criteria|0|||
44163243|NCT02311881|78956316|FG000|Overall Study|Adverse Event|7|||
44163244|NCT02311881|78956317|FG001|Overall Study|Adverse Event|15|||
44163245|NCT02311881|78956318|FG002|Overall Study|Adverse Event|8|||
44163246|NCT02311881|78956316|FG000|Overall Study|Lost to Follow-up|3|||
44163247|NCT02311881|78956317|FG001|Overall Study|Lost to Follow-up|3|||
44163248|NCT02311881|78956318|FG002|Overall Study|Lost to Follow-up|2|||
44163249|NCT02311881|78956316|FG000|Overall Study|Protocol Violation|1|||
44163250|NCT02311881|78956317|FG001|Overall Study|Protocol Violation|2|||
44163251|NCT02311881|78956318|FG002|Overall Study|Protocol Violation|3|||
44163252|NCT02311881|78956316|FG000|Overall Study|Withdrawal of consent|14|||
44163253|NCT02311881|78956317|FG001|Overall Study|Withdrawal of consent|16|||
44163254|NCT02311881|78956318|FG002|Overall Study|Withdrawal of consent|17|||
44163255|NCT02311881|78956316|FG000|Overall Study|Other|0|||
44163256|NCT02311881|78956317|FG001|Overall Study|Other|0|||
44163257|NCT02311881|78956318|FG002|Overall Study|Other|1|||
44163258|NCT02311881|78956316|FG000|Overall Study|Lack of Efficacy|1|||
44163259|NCT02311881|78956317|FG001|Overall Study|Lack of Efficacy|2|||
44163260|NCT02311881|78956318|FG002|Overall Study|Lack of Efficacy|0|||
44163261|NCT02311881|78956316|FG000|Overall Study|Subject has border line pregnancy test|1|||
44163262|NCT02311881|78956317|FG001|Overall Study|Subject has border line pregnancy test|0|||
44163263|NCT02311881|78956318|FG002|Overall Study|Subject has border line pregnancy test|0|||
44163264|NCT02311881|78956316|FG000|Overall Study|Withdrawal by Subject|3|||
44163265|NCT02311881|78956317|FG001|Overall Study|Withdrawal by Subject|1|||
44163266|NCT02311881|78956318|FG002|Overall Study|Withdrawal by Subject|4|||
44163267|NCT02311881|78956316|FG000|Overall Study|Sponsor Decision|1|||
44163268|NCT02311881|78956317|FG001|Overall Study|Sponsor Decision|1|||
44163269|NCT02311881|78956318|FG002|Overall Study|Sponsor Decision|1|||
44163270|NCT02311881|78956316|FG000|Overall Study|Protocol Deviation|1|||
44163271|NCT02311881|78956317|FG001|Overall Study|Protocol Deviation|0|||
44163272|NCT02311881|78956318|FG002|Overall Study|Protocol Deviation|0|||
44163273|NCT02311881|78956316|FG000|Overall Study|Non-Compliance|1|||
44163274|NCT02311881|78956317|FG001|Overall Study|Non-Compliance|0|||
44163275|NCT02311881|78956318|FG002|Overall Study|Non-Compliance|2|||
44163276|NCT02311881|78956316|FG000|Overall Study|Physician Decision|0|||
44163277|NCT02311881|78956317|FG001|Overall Study|Physician Decision|0|||
44163278|NCT02311881|78956318|FG002|Overall Study|Physician Decision|1|||
44163279|NCT02311881|78956316|FG000|Overall Study|Medical Monitor Discretion|0|||
44163280|NCT02311881|78956317|FG001|Overall Study|Medical Monitor Discretion|0|||
44163281|NCT02311881|78956318|FG002|Overall Study|Medical Monitor Discretion|1|||
44163282|NCT02311881|78956316|FG000|Overall Study|Participant taking another medication|0|||
44444946|NCT03517449|79452812|FG000|Overall Study|Lost to Follow-up|0|||
44163283|NCT02311881|78956317|FG001|Overall Study|Participant taking another medication|0|||
44163284|NCT02311881|78956318|FG002|Overall Study|Participant taking another medication|1|||
44163285|NCT02311881|78956316|FG000|Overall Study|Serious Adverse Event|0|||
44163286|NCT02311881|78956317|FG001|Overall Study|Serious Adverse Event|1|||
44163287|NCT02311881|78956318|FG002|Overall Study|Serious Adverse Event|0|||
44163288|NCT02565511|78956333|FG000|Overall Study|Study terminated by Sponsor|35|||
44163289|NCT02565511|78956334|FG001|Overall Study|Study terminated by Sponsor|22|||
44163290|NCT02565511|78956335|FG002|Overall Study|Study terminated by Sponsor|235|||
44163291|NCT02565511|78956336|FG003|Overall Study|Study terminated by Sponsor|156|||
44163292|NCT02565511|78956333|FG000|Overall Study|Withdrawal by Subject|3|||
44163293|NCT02565511|78956334|FG001|Overall Study|Withdrawal by Subject|0|||
44163294|NCT02565511|78956335|FG002|Overall Study|Withdrawal by Subject|12|||
44163295|NCT02565511|78956336|FG003|Overall Study|Withdrawal by Subject|5|||
44163296|NCT02565511|78956333|FG000|Overall Study|Adverse Event|0|||
44163297|NCT02565511|78956334|FG001|Overall Study|Adverse Event|0|||
44163298|NCT02565511|78956335|FG002|Overall Study|Adverse Event|1|||
44163299|NCT02565511|78956336|FG003|Overall Study|Adverse Event|1|||
44163300|NCT02565511|78956333|FG000|Overall Study|Lost to Follow-up|4|||
44163301|NCT02565511|78956334|FG001|Overall Study|Lost to Follow-up|1|||
44163302|NCT02565511|78956335|FG002|Overall Study|Lost to Follow-up|0|||
44163303|NCT02565511|78956336|FG003|Overall Study|Lost to Follow-up|1|||
44163304|NCT02565511|78956333|FG000|Overall Study|Physician Decision|0|||
44163305|NCT02565511|78956334|FG001|Overall Study|Physician Decision|0|||
44163306|NCT02565511|78956335|FG002|Overall Study|Physician Decision|0|||
44163307|NCT02565511|78956336|FG003|Overall Study|Physician Decision|1|||
44163308|NCT02565511|78956333|FG000|Overall Study|Protocol deviation|0|||
44163309|NCT02565511|78956334|FG001|Overall Study|Protocol deviation|0|||
44163310|NCT02565511|78956335|FG002|Overall Study|Protocol deviation|3|||
44163311|NCT02565511|78956336|FG003|Overall Study|Protocol deviation|0|||
44163312|NCT02561455|78956350|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
44163313|NCT02561455|78956351|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
44163314|NCT02561455|78956352|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
44163315|NCT02561455|78956353|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
44163316|NCT02561455|78956350|FG000|Overall Study|Withdrawal by Subject|1|||
44163317|NCT02561455|78956351|FG001|Overall Study|Withdrawal by Subject|0|||
44163318|NCT02561455|78956352|FG002|Overall Study|Withdrawal by Subject|1|||
44163319|NCT02561455|78956353|FG003|Overall Study|Withdrawal by Subject|0|||
44163320|NCT02561455|78956350|FG000|Overall Study|Disease Progression|0|||
44163321|NCT02561455|78956351|FG001|Overall Study|Disease Progression|1|||
44163322|NCT02561455|78956352|FG002|Overall Study|Disease Progression|0|||
44163323|NCT02561455|78956353|FG003|Overall Study|Disease Progression|0|||
44163324|NCT02561299|78956365|FG000|Overall Study|Death|2|||
44163325|NCT02561299|78956366|FG001|Overall Study|Death|4|||
44163326|NCT02561299|78956365|FG000|Overall Study|Lost to Follow-up|1|||
44163327|NCT02561299|78956366|FG001|Overall Study|Lost to Follow-up|0|||
44163328|NCT02561299|78956365|FG000|Overall Study|Withdrawal by Subject|2|||
44163329|NCT02561299|78956366|FG001|Overall Study|Withdrawal by Subject|2|||
44163330|NCT02566759|78956389|FG000|All Parts|Withdrawal by Subject|0|||
44163331|NCT02566759|78956390|FG001|All Parts|Withdrawal by Subject|1|||
44163332|NCT02566759|78956391|FG002|All Parts|Withdrawal by Subject|0|||
44163333|NCT02566759|78956392|FG003|All Parts|Withdrawal by Subject|0|||
44163334|NCT02566759|78956393|FG004|All Parts|Withdrawal by Subject|0|||
44163335|NCT02566759|78956394|FG005|All Parts|Withdrawal by Subject|0|||
44163336|NCT02566759|78956395|FG006|All Parts|Withdrawal by Subject|0|||
44163337|NCT02566759|78956396|FG007|All Parts|Withdrawal by Subject|0|||
44163338|NCT02566759|78956397|FG008|All Parts|Withdrawal by Subject|0|||
44163339|NCT02566759|78956398|FG009|All Parts|Withdrawal by Subject|0|||
44163340|NCT02566759|78956399|FG010|All Parts|Withdrawal by Subject|0|||
44163341|NCT02566759|78956400|FG011|All Parts|Withdrawal by Subject|0|||
44163342|NCT02566759|78956401|FG012|All Parts|Withdrawal by Subject|0|||
44163343|NCT02566759|78956402|FG013|All Parts|Withdrawal by Subject|0|||
44163344|NCT02566759|78956403|FG014|All Parts|Withdrawal by Subject|0|||
44163345|NCT02566759|78956404|FG015|All Parts|Withdrawal by Subject|0|||
44163346|NCT02566759|78956405|FG016|All Parts|Withdrawal by Subject|0|||
44163347|NCT02566759|78956389|FG000|All Parts|Adverse Event|0|||
44163348|NCT02566759|78956390|FG001|All Parts|Adverse Event|0|||
44163349|NCT02566759|78956391|FG002|All Parts|Adverse Event|0|||
44163350|NCT02566759|78956392|FG003|All Parts|Adverse Event|0|||
44163351|NCT02566759|78956393|FG004|All Parts|Adverse Event|0|||
44163352|NCT02566759|78956394|FG005|All Parts|Adverse Event|0|||
44163353|NCT02566759|78956395|FG006|All Parts|Adverse Event|0|||
44163354|NCT02566759|78956396|FG007|All Parts|Adverse Event|0|||
44163355|NCT02566759|78956397|FG008|All Parts|Adverse Event|0|||
44163356|NCT02566759|78956398|FG009|All Parts|Adverse Event|0|||
44163357|NCT02566759|78956399|FG010|All Parts|Adverse Event|0|||
44163358|NCT02566759|78956400|FG011|All Parts|Adverse Event|0|||
44163359|NCT02566759|78956401|FG012|All Parts|Adverse Event|1|||
44163360|NCT02566759|78956402|FG013|All Parts|Adverse Event|3|||
44163361|NCT02566759|78956403|FG014|All Parts|Adverse Event|0|||
44163362|NCT02566759|78956404|FG015|All Parts|Adverse Event|0|||
44163363|NCT02566759|78956405|FG016|All Parts|Adverse Event|0|||
44163364|NCT02566759|78956389|FG000|All Parts|Other|0|||
44163365|NCT02566759|78956390|FG001|All Parts|Other|0|||
44163366|NCT02566759|78956391|FG002|All Parts|Other|0|||
44163367|NCT02566759|78956392|FG003|All Parts|Other|0|||
44163368|NCT02566759|78956393|FG004|All Parts|Other|0|||
44163369|NCT02566759|78956394|FG005|All Parts|Other|0|||
44163370|NCT02566759|78956395|FG006|All Parts|Other|0|||
44163371|NCT02566759|78956396|FG007|All Parts|Other|0|||
44163372|NCT02566759|78956397|FG008|All Parts|Other|0|||
44163373|NCT02566759|78956398|FG009|All Parts|Other|0|||
44163374|NCT02566759|78956399|FG010|All Parts|Other|0|||
44163375|NCT02566759|78956400|FG011|All Parts|Other|0|||
44163376|NCT02566759|78956401|FG012|All Parts|Other|0|||
44163377|NCT02566759|78956402|FG013|All Parts|Other|2|||
44163378|NCT02566759|78956403|FG014|All Parts|Other|0|||
44163379|NCT02566759|78956404|FG015|All Parts|Other|0|||
44163380|NCT02566759|78956405|FG016|All Parts|Other|0|||
44163381|NCT02566759|78956389|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163382|NCT02566759|78956390|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163383|NCT02566759|78956391|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163384|NCT02566759|78956392|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163385|NCT02566759|78956393|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163386|NCT02566759|78956394|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44345284|NCT01290887|79349276|FG001|Overall Study|Other|6|||
44345285|NCT01290731|79349282|FG000|Overall Study|Withdrawal by Subject|1|||
44345286|NCT01290341|79349288|FG000|Overall Study|Protocol Violation|7|||
44345287|NCT01290341|79349289|FG001|Overall Study|Protocol Violation|3|||
44345288|NCT01290341|79349288|FG000|Overall Study|Adverse Event|1|||
44345289|NCT01290341|79349289|FG001|Overall Study|Adverse Event|0|||
44345290|NCT01290341|79349288|FG000|Overall Study|Lost to Follow-up|21|||
44345291|NCT01290341|79349289|FG001|Overall Study|Lost to Follow-up|10|||
44345292|NCT01290341|79349288|FG000|Overall Study|Withdrawal by Subject|19|||
44345293|NCT01290341|79349289|FG001|Overall Study|Withdrawal by Subject|5|||
44345294|NCT01290341|79349288|FG000|Overall Study|Negative baseline culture and others|44|||
44345295|NCT01290341|79349289|FG001|Overall Study|Negative baseline culture and others|11|||
44345296|NCT01290263|79349297|FG000|Overall Study|Adverse Event|0|||
44345297|NCT01290263|79349298|FG001|Overall Study|Adverse Event|0|||
44345298|NCT01290263|79349299|FG002|Overall Study|Adverse Event|0|||
44345299|NCT01290263|79349300|FG003|Overall Study|Adverse Event|1|||
44345300|NCT01290263|79349301|FG004|Overall Study|Adverse Event|1|||
44345301|NCT01290263|79349297|FG000|Overall Study|Lack of Efficacy|8|||
44345302|NCT01290263|79349298|FG001|Overall Study|Lack of Efficacy|2|||
44345303|NCT01290263|79349299|FG002|Overall Study|Lack of Efficacy|7|||
44345304|NCT01290263|79349300|FG003|Overall Study|Lack of Efficacy|24|||
44345305|NCT01290263|79349301|FG004|Overall Study|Lack of Efficacy|33|||
44345306|NCT01290263|79349297|FG000|Overall Study|Withdrawal by Subject|3|||
44345307|NCT01290263|79349298|FG001|Overall Study|Withdrawal by Subject|1|||
44345308|NCT01290263|79349299|FG002|Overall Study|Withdrawal by Subject|0|||
44345309|NCT01290263|79349300|FG003|Overall Study|Withdrawal by Subject|1|||
44345310|NCT01290263|79349301|FG004|Overall Study|Withdrawal by Subject|2|||
44345311|NCT01290263|79349297|FG000|Overall Study|Participant Non-Compliance|0|||
44345312|NCT01290263|79349298|FG001|Overall Study|Participant Non-Compliance|0|||
44345313|NCT01290263|79349299|FG002|Overall Study|Participant Non-Compliance|0|||
44345314|NCT01290263|79349300|FG003|Overall Study|Participant Non-Compliance|1|||
44345315|NCT01290263|79349301|FG004|Overall Study|Participant Non-Compliance|1|||
44345316|NCT01290029|79349309|FG000|Overall Study|Other|2|||
44345317|NCT01289639|79349316|FG000|Overall Study|Lost to Follow-up|1|||
44345318|NCT01289639|79349317|FG001|Overall Study|Lost to Follow-up|0|||
44345319|NCT01289639|79349318|FG002|Overall Study|Lost to Follow-up|0|||
44345320|NCT01289015|79349328|FG000|Overall Study|Protocol Violation|12|||
44345321|NCT01289015|79349329|FG001|Overall Study|Protocol Violation|9|||
44345322|NCT01289015|79349328|FG000|Overall Study|Adverse Event|3|||
44345323|NCT01289015|79349329|FG001|Overall Study|Adverse Event|0|||
44345324|NCT01289015|79349328|FG000|Overall Study|Lost to Follow-up|33|||
44345325|NCT01289015|79349329|FG001|Overall Study|Lost to Follow-up|17|||
44345326|NCT01289015|79349328|FG000|Overall Study|Withdrawal by Subject|17|||
44345327|NCT01289015|79349329|FG001|Overall Study|Withdrawal by Subject|8|||
44345328|NCT01289015|79349328|FG000|Overall Study|Disease progression|1|||
44345329|NCT01289015|79349329|FG001|Overall Study|Disease progression|0|||
44345330|NCT01289015|79349328|FG000|Overall Study|Negative baseline culture and others|33|||
44345331|NCT01289015|79349329|FG001|Overall Study|Negative baseline culture and others|20|||
44345332|NCT01288937|79349337|FG000|Overall Study|Adverse Event|1|||
44345333|NCT01288937|79349338|FG001|Overall Study|Adverse Event|0|||
44345334|NCT01288469|79349347|FG000|Overall Study|Adverse Event|4|||
44345335|NCT01288469|79349348|FG001|Overall Study|Adverse Event|1|||
44345336|NCT01288469|79349349|FG002|Overall Study|Adverse Event|1|||
44345337|NCT01288469|79349347|FG000|Overall Study|Poor compliance to protocol|0|||
44345338|NCT01288469|79349348|FG001|Overall Study|Poor compliance to protocol|1|||
44345339|NCT01288469|79349349|FG002|Overall Study|Poor compliance to protocol|0|||
44345340|NCT01288469|79349347|FG000|Overall Study|Participant Moved|1|||
44345341|NCT01288469|79349348|FG001|Overall Study|Participant Moved|0|||
44345342|NCT01288469|79349349|FG002|Overall Study|Participant Moved|0|||
44345343|NCT01288469|79349347|FG000|Overall Study|Consent withdrawn by subject|1|||
44163387|NCT02566759|78956395|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163388|NCT02566759|78956396|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44345344|NCT01288469|79349348|FG001|Overall Study|Consent withdrawn by subject|1|||
44345345|NCT01288469|79349349|FG002|Overall Study|Consent withdrawn by subject|1|||
44345346|NCT01288469|79349347|FG000|Overall Study|Exclusion criteria finally met|1|||
44345347|NCT01288469|79349348|FG001|Overall Study|Exclusion criteria finally met|0|||
44345348|NCT01288469|79349349|FG002|Overall Study|Exclusion criteria finally met|0|||
44345349|NCT01288079|79349361|FG000|Overall Study|Withdrawal by Subject|2|||
44345350|NCT01288079|79349362|FG001|Overall Study|Withdrawal by Subject|4|||
44345351|NCT01288079|79349363|FG002|Overall Study|Withdrawal by Subject|1|||
44345352|NCT01288079|79349364|FG003|Overall Study|Withdrawal by Subject|0|||
44345353|NCT01288079|79349361|FG000|Overall Study|Adverse Event|2|||
44345354|NCT01288079|79349362|FG001|Overall Study|Adverse Event|1|||
44345355|NCT01288079|79349363|FG002|Overall Study|Adverse Event|2|||
44345356|NCT01288079|79349364|FG003|Overall Study|Adverse Event|3|||
44345357|NCT01288079|79349361|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
44345358|NCT01288079|79349362|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
44345359|NCT01288079|79349363|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
44345360|NCT01288079|79349364|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
44345361|NCT01288079|79349361|FG000|Overall Study|Condition under Investigation Worsened|0|||
44345362|NCT01288079|79349362|FG001|Overall Study|Condition under Investigation Worsened|0|||
44345363|NCT01288079|79349363|FG002|Overall Study|Condition under Investigation Worsened|0|||
44345364|NCT01288079|79349364|FG003|Overall Study|Condition under Investigation Worsened|1|||
44345365|NCT01288079|79349361|FG000|Overall Study|Lack of Efficacy|2|||
44345366|NCT01288079|79349362|FG001|Overall Study|Lack of Efficacy|2|||
44345367|NCT01288079|79349363|FG002|Overall Study|Lack of Efficacy|0|||
44345368|NCT01288079|79349364|FG003|Overall Study|Lack of Efficacy|2|||
44345369|NCT01288079|79349361|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
44345370|NCT01288079|79349362|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
44345371|NCT01288079|79349363|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
44345372|NCT01288079|79349364|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
44345373|NCT01288079|79349361|FG000|Overall Study|Lost to Follow-up|1|||
44345374|NCT01288079|79349362|FG001|Overall Study|Lost to Follow-up|1|||
44345375|NCT01288079|79349363|FG002|Overall Study|Lost to Follow-up|1|||
44345376|NCT01288079|79349364|FG003|Overall Study|Lost to Follow-up|0|||
44345377|NCT01288079|79349361|FG000|Overall Study|Other or Study Termination|11|||
44345378|NCT01288079|79349362|FG001|Overall Study|Other or Study Termination|15|||
44345379|NCT01288079|79349363|FG002|Overall Study|Other or Study Termination|14|||
44345380|NCT01288079|79349364|FG003|Overall Study|Other or Study Termination|8|||
44345381|NCT01287221|79349376|FG000|Overall Study|Lack of Perceived Benefit|1|||
44345382|NCT01287221|79349377|FG001|Overall Study|Lack of Perceived Benefit|1|||
44345383|NCT01287221|79349376|FG000|Overall Study|Adverse Event|3|||
44345384|NCT01287221|79349377|FG001|Overall Study|Adverse Event|3|||
44345385|NCT01287221|79349376|FG000|Overall Study|Withdrawal by Subject|0|||
44345386|NCT01287221|79349377|FG001|Overall Study|Withdrawal by Subject|1|||
44345387|NCT01168401|79349394|FG000|Overall Study|Lost to Follow-up|1|||
44345388|NCT01168401|79349395|FG001|Overall Study|Lost to Follow-up|1|||
44345389|NCT01168401|79349396|FG002|Overall Study|Lost to Follow-up|2|||
44345390|NCT01168401|79349397|FG003|Overall Study|Lost to Follow-up|1|||
44345391|NCT01168401|79349398|FG004|Overall Study|Lost to Follow-up|0|||
44345392|NCT01168401|79349399|FG005|Overall Study|Lost to Follow-up|0|||
44345393|NCT01168401|79349400|FG006|Overall Study|Lost to Follow-up|0|||
44345394|NCT01168401|79349401|FG007|Overall Study|Lost to Follow-up|0|||
44345395|NCT01168401|79349402|FG008|Overall Study|Lost to Follow-up|0|||
44345396|NCT01168401|79349403|FG009|Overall Study|Lost to Follow-up|0|||
44345397|NCT01168401|79349404|FG010|Overall Study|Lost to Follow-up|0|||
44345398|NCT01168401|79349394|FG000|Overall Study|Withdrawal by Subject|0|||
44345399|NCT01168401|79349395|FG001|Overall Study|Withdrawal by Subject|0|||
44345400|NCT01168401|79349396|FG002|Overall Study|Withdrawal by Subject|0|||
44345401|NCT01168401|79349397|FG003|Overall Study|Withdrawal by Subject|1|||
44345402|NCT01168401|79349398|FG004|Overall Study|Withdrawal by Subject|0|||
44345403|NCT01168401|79349399|FG005|Overall Study|Withdrawal by Subject|0|||
44345404|NCT01168401|79349400|FG006|Overall Study|Withdrawal by Subject|0|||
44345405|NCT01168401|79349401|FG007|Overall Study|Withdrawal by Subject|0|||
44345406|NCT01168401|79349402|FG008|Overall Study|Withdrawal by Subject|0|||
44345407|NCT01168401|79349403|FG009|Overall Study|Withdrawal by Subject|0|||
44345408|NCT01168401|79349404|FG010|Overall Study|Withdrawal by Subject|0|||
44345409|NCT01287065|79349428|FG000|Treatment Period 1|Adverse Event|0|||
44345410|NCT01287065|79349429|FG001|Treatment Period 1|Adverse Event|0|||
44345411|NCT01287065|79349430|FG002|Treatment Period 1|Adverse Event|0|||
44345412|NCT01287065|79349431|FG003|Treatment Period 1|Adverse Event|0|||
44345413|NCT01287065|79349432|FG004|Treatment Period 1|Adverse Event|1|||
44345414|NCT01287065|79349433|FG005|Treatment Period 1|Adverse Event|0|||
44345415|NCT01287065|79349428|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44345416|NCT01287065|79349429|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44345417|NCT01287065|79349430|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44345418|NCT01287065|79349431|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44345419|NCT01287065|79349432|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44345420|NCT01287065|79349433|FG005|Treatment Period 1|Withdrawal by Subject|1|||
44345421|NCT01167153|79349443|FG000|Overall Study|Non-effective therapy|1|||
44345422|NCT01167153|79349444|FG001|Overall Study|Non-effective therapy|4|||
44345423|NCT01167153|79349443|FG000|Overall Study|AE including clinical laboratory AE|2|||
44345424|NCT01167153|79349444|FG001|Overall Study|AE including clinical laboratory AE|8|||
44345425|NCT01167153|79349443|FG000|Overall Study|Hypotension|1|||
44345426|NCT01167153|79349444|FG001|Overall Study|Hypotension|0|||
44345427|NCT01167153|79349443|FG000|Overall Study|Lost to Follow-up|7|||
44345428|NCT01167153|79349444|FG001|Overall Study|Lost to Follow-up|9|||
44345429|NCT01167153|79349443|FG000|Overall Study|Non-compliance to concomitant medication|0|||
44345430|NCT01167153|79349444|FG001|Overall Study|Non-compliance to concomitant medication|2|||
44345431|NCT01167153|79349443|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
44345432|NCT01167153|79349444|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
44345433|NCT01167153|79349443|FG000|Overall Study|Withdrawal consent|1|||
44345434|NCT01167153|79349444|FG001|Overall Study|Withdrawal consent|1|||
44345435|NCT01167153|79349443|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
44345436|NCT01167153|79349444|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
44345437|NCT01166763|79349450|FG000|Overall Study|Withdrawal by Subject|3|||
44345438|NCT01166373|79349458|FG000|Overall Study|Lost to Follow-up|3|||
44345439|NCT01166373|79349459|FG001|Overall Study|Lost to Follow-up|2|||
44345440|NCT01166373|79349460|FG002|Overall Study|Lost to Follow-up|2|||
44345441|NCT01166373|79349461|FG003|Overall Study|Lost to Follow-up|2|||
44345442|NCT01166373|79349458|FG000|Overall Study|Withdrawal by Subject|1|||
44345443|NCT01166373|79349459|FG001|Overall Study|Withdrawal by Subject|2|||
44345444|NCT01166373|79349460|FG002|Overall Study|Withdrawal by Subject|2|||
44345445|NCT01166373|79349461|FG003|Overall Study|Withdrawal by Subject|3|||
44345446|NCT01166373|79349458|FG000|Overall Study|Physician Decision|1|||
44345447|NCT01166373|79349459|FG001|Overall Study|Physician Decision|0|||
44345448|NCT01166373|79349460|FG002|Overall Study|Physician Decision|0|||
44345449|NCT01166373|79349461|FG003|Overall Study|Physician Decision|0|||
44345450|NCT00963235|79349473|FG000|Overall Study|Withdrawal by Subject|22|||
44345451|NCT00963235|79349473|FG000|Overall Study|Lost to Follow-up|14|||
44345452|NCT00963235|79349473|FG000|Overall Study|Failed to return|9|||
44345453|NCT00963235|79349473|FG000|Overall Study|Protocol Violation|7|||
44345454|NCT00963235|79349473|FG000|Overall Study|Adverse Event|5|||
44345455|NCT00963235|79349473|FG000|Overall Study|Physician Decision|2|||
44345456|NCT00963235|79349473|FG000|Overall Study|Other|1|||
44345457|NCT01165281|79349482|FG000|Overall Study|Adverse Event|12|||
44345458|NCT01165281|79349483|FG001|Overall Study|Adverse Event|14|||
44345459|NCT01165281|79349482|FG000|Overall Study|Death|3|||
44345460|NCT01165281|79349483|FG001|Overall Study|Death|4|||
44345461|NCT01165281|79349482|FG000|Overall Study|Lack of Efficacy|4|||
44345462|NCT01165281|79349483|FG001|Overall Study|Lack of Efficacy|1|||
44345463|NCT01165281|79349482|FG000|Overall Study|Lost to Follow-up|0|||
44345464|NCT01165281|79349483|FG001|Overall Study|Lost to Follow-up|1|||
44345465|NCT01165281|79349482|FG000|Overall Study|Physician Decision|8|||
44345466|NCT01165281|79349483|FG001|Overall Study|Physician Decision|1|||
44345467|NCT01165281|79349482|FG000|Overall Study|Protocol Violation|6|||
44345468|NCT01165281|79349483|FG001|Overall Study|Protocol Violation|5|||
44345469|NCT01165281|79349482|FG000|Overall Study|Withdrawal by Subject|8|||
44345470|NCT01165281|79349483|FG001|Overall Study|Withdrawal by Subject|7|||
44345471|NCT01165281|79349482|FG000|Overall Study|Noncompliance with Study Drug|1|||
44345472|NCT01165281|79349483|FG001|Overall Study|Noncompliance with Study Drug|4|||
44345473|NCT01165281|79349482|FG000|Overall Study|Progressive Disease|10|||
44345474|NCT01165281|79349483|FG001|Overall Study|Progressive Disease|14|||
44345475|NCT01165281|79349482|FG000|Overall Study|Other|6|||
44345476|NCT01165281|79349483|FG001|Overall Study|Other|0|||
44345477|NCT01165203|79349491|FG000|Active Phase|Serious Adverse Event|1|||
44345478|NCT01165203|79349492|FG001|Active Phase|Serious Adverse Event|0|||
44345479|NCT01165203|79349491|FG000|Active Phase|Withdrawal by Subject|2|||
44345480|NCT01165203|79349492|FG001|Active Phase|Withdrawal by Subject|1|||
44345481|NCT01165203|79349491|FG000|Active Phase|Migrated/moved from study area|0|||
44345482|NCT01165203|79349492|FG001|Active Phase|Migrated/moved from study area|1|||
44345483|NCT01165203|79349491|FG000|Active Phase|Lost to Follow-up|2|||
44345484|NCT01165203|79349492|FG001|Active Phase|Lost to Follow-up|0|||
44345485|NCT01165203|79349491|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
44345486|NCT01165203|79349492|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
44345487|NCT01165203|79349491|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
44345488|NCT01165203|79349492|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
44345489|NCT01165203|79349491|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
44345490|NCT01165203|79349492|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
44345491|NCT01165203|79349491|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
44345492|NCT01165203|79349492|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
44345493|NCT01165203|79349491|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
44345494|NCT01165203|79349492|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
44345495|NCT00960661|79349507|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
44345496|NCT00960661|79349508|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
44345497|NCT00960661|79349509|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
44345498|NCT00960661|79349507|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
44345499|NCT00960661|79349508|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
44345500|NCT00960661|79349509|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
44345501|NCT00960661|79349507|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
44345502|NCT00960661|79349508|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
44345503|NCT00960661|79349509|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
44345504|NCT00960661|79349507|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
44345505|NCT00960661|79349508|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
44345506|NCT00960661|79349509|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
44345507|NCT00960661|79349507|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
44345508|NCT00960661|79349508|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
44345509|NCT00960661|79349509|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
44345510|NCT00960661|79349507|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
44345511|NCT00960661|79349508|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
44345512|NCT00960661|79349509|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
44345513|NCT00960661|79349507|FG000|Interventional Phase|Adverse Event|0|||
44345514|NCT00960661|79349508|FG001|Interventional Phase|Adverse Event|17|||
44345515|NCT00960661|79349509|FG002|Interventional Phase|Adverse Event|8|||
44345516|NCT00960661|79349507|FG000|Interventional Phase|Death|0|||
44345517|NCT00960661|79349508|FG001|Interventional Phase|Death|1|||
44345518|NCT00960661|79349509|FG002|Interventional Phase|Death|0|||
44345519|NCT00960661|79349507|FG000|Interventional Phase|Lost to Follow-up|0|||
44345520|NCT00960661|79349508|FG001|Interventional Phase|Lost to Follow-up|0|||
44345521|NCT00960661|79349509|FG002|Interventional Phase|Lost to Follow-up|2|||
44345522|NCT00960661|79349507|FG000|Interventional Phase|entry criteria not met|0|||
44345523|NCT00960661|79349508|FG001|Interventional Phase|entry criteria not met|3|||
44345524|NCT00960661|79349509|FG002|Interventional Phase|entry criteria not met|0|||
44345525|NCT00960661|79349507|FG000|Interventional Phase|Protocol Violation|0|||
44345526|NCT00960661|79349508|FG001|Interventional Phase|Protocol Violation|7|||
44345527|NCT00960661|79349509|FG002|Interventional Phase|Protocol Violation|2|||
44345528|NCT00960661|79349507|FG000|Interventional Phase|Withdrawal by Subject|0|||
44345529|NCT00960661|79349508|FG001|Interventional Phase|Withdrawal by Subject|18|||
44345530|NCT00960661|79349509|FG002|Interventional Phase|Withdrawal by Subject|29|||
44345531|NCT00960661|79349507|FG000|Interventional Phase|Physician Decision|0|||
44345532|NCT00960661|79349508|FG001|Interventional Phase|Physician Decision|3|||
44345533|NCT00960661|79349509|FG002|Interventional Phase|Physician Decision|5|||
44345534|NCT00960661|79349507|FG000|Interventional Phase|sponsor decision|0|||
44345535|NCT00960661|79349508|FG001|Interventional Phase|sponsor decision|1|||
44345536|NCT00960661|79349509|FG002|Interventional Phase|sponsor decision|0|||
44345537|NCT00960661|79349507|FG000|Interventional Phase|Lack of Efficacy|0|||
44345538|NCT00960661|79349508|FG001|Interventional Phase|Lack of Efficacy|2|||
44345539|NCT00960661|79349509|FG002|Interventional Phase|Lack of Efficacy|0|||
44345540|NCT00960193|79349515|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
44345541|NCT00960115|79349524|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
44345542|NCT00960115|79349525|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
44345543|NCT00959647|79349531|FG000|Overall Study|Adverse Event|2|||
44345544|NCT00959647|79349531|FG000|Overall Study|Progressive disease|6|||
44345545|NCT00959647|79349531|FG000|Overall Study|Study terminated by sponsor|4|||
44345546|NCT00959647|79349531|FG000|Overall Study|Withdrawal by Subject|7|||
44345547|NCT00957931|79349535|FG000|Overall Study|Death|4|||
44345548|NCT00957853|79349542|FG000|Overall Study|Withdrawal by Subject|1|||
44345549|NCT00957853|79349543|FG001|Overall Study|Withdrawal by Subject|0|||
44345550|NCT00957853|79349544|FG002|Overall Study|Withdrawal by Subject|0|||
44345551|NCT00957229|79349554|FG000|Study Start|Adverse Event|0|||
44345552|NCT00957229|79349555|FG001|Study Start|Adverse Event|3|||
44345553|NCT00957229|79349554|FG000|Study Start|Disease Progression|1|||
44345554|NCT00957229|79349555|FG001|Study Start|Disease Progression|0|||
44345555|NCT00957229|79349554|FG000|Reallocated to or Continued Vismodegib|Death|1|||
44345556|NCT00957229|79349555|FG001|Reallocated to or Continued Vismodegib|Death|1|||
44345557|NCT00957229|79349554|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
44345558|NCT00957229|79349555|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
44345559|NCT02604511|79349561|FG000|Overall Study|Adverse Event|3|||
44345560|NCT02604511|79349561|FG000|Overall Study|Disease Progression|4|||
44345561|NCT02604511|79349561|FG000|Overall Study|Withdrawal by Subject|3|||
44345562|NCT02604511|79349561|FG000|Overall Study|Participant ineligible|1|||
44345563|NCT02604511|79349561|FG000|Overall Study|Intercurrent illness|1|||
44345564|NCT00956839|79349569|FG000|Overall Study|Lost to Follow-up|3|||
44345565|NCT00956839|79349570|FG001|Overall Study|Lost to Follow-up|0|||
44345566|NCT00956839|79349571|FG002|Overall Study|Lost to Follow-up|3|||
44345567|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
44345568|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
44345569|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
44345570|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Death|0|||
44345571|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Death|0|||
44345572|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Death|1|||
44345573|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
44345574|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
44345575|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
44345576|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
44345577|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
44345578|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
44345579|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
44345580|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
44345581|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
44345582|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Graft loss|0|||
44345583|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Graft loss|0|||
44345584|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Graft loss|7|||
44345585|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
44345586|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
44345587|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
44345588|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
44345589|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
44345590|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
44345591|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
44345592|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
44345593|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
44345594|NCT00956293|79349581|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
44345595|NCT00956293|79349582|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
44345596|NCT00956293|79349583|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
44345597|NCT00956293|79349581|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
44345598|NCT00956293|79349582|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
44345599|NCT00956293|79349583|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
44345600|NCT00956293|79349581|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
44345601|NCT00956293|79349582|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
44345602|NCT00956293|79349583|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
44345603|NCT00956293|79349581|FG000|Main Period (Randomization)|Adverse Event|0|||
44345604|NCT00956293|79349582|FG001|Main Period (Randomization)|Adverse Event|15|||
44345605|NCT00956293|79349583|FG002|Main Period (Randomization)|Adverse Event|0|||
44345606|NCT00956293|79349581|FG000|Follow-up Period|Follow-up period was terminated.|20|||
44345607|NCT00956293|79349582|FG001|Follow-up Period|Follow-up period was terminated.|32|||
44345608|NCT00956293|79349583|FG002|Follow-up Period|Follow-up period was terminated.|0|||
44345609|NCT00955825|79349591|FG000|Overall Study|Adverse Event|15|||
44345610|NCT00955825|79349592|FG001|Overall Study|Adverse Event|2|||
44345611|NCT00955825|79349591|FG000|Overall Study|Withdrawal by Subject|4|||
44345612|NCT00955825|79349592|FG001|Overall Study|Withdrawal by Subject|6|||
44345613|NCT00955825|79349591|FG000|Overall Study|Any other reason not above-mentioned|7|||
44345614|NCT00955825|79349592|FG001|Overall Study|Any other reason not above-mentioned|9|||
44345615|NCT01164579|79349601|FG000|Overall Study|Lack of Efficacy|0|||
44345616|NCT01164579|79349602|FG001|Overall Study|Lack of Efficacy|0|||
44345617|NCT01164579|79349603|FG002|Overall Study|Lack of Efficacy|6|||
44345618|NCT01164579|79349601|FG000|Overall Study|Lost to Follow-up|1|||
44345619|NCT01164579|79349602|FG001|Overall Study|Lost to Follow-up|1|||
44345620|NCT01164579|79349603|FG002|Overall Study|Lost to Follow-up|0|||
44345621|NCT01164579|79349601|FG000|Overall Study|Withdrawal by Subject|2|||
44345622|NCT01164579|79349602|FG001|Overall Study|Withdrawal by Subject|5|||
44345623|NCT01164579|79349603|FG002|Overall Study|Withdrawal by Subject|3|||
44345624|NCT01164579|79349601|FG000|Overall Study|Protocol Violation|0|||
44345625|NCT01164579|79349602|FG001|Overall Study|Protocol Violation|1|||
44345626|NCT01164579|79349603|FG002|Overall Study|Protocol Violation|2|||
44345627|NCT01164579|79349601|FG000|Overall Study|Adverse Event|4|||
44345628|NCT01164579|79349602|FG001|Overall Study|Adverse Event|2|||
44345629|NCT01164579|79349603|FG002|Overall Study|Adverse Event|5|||
44345630|NCT01164579|79349601|FG000|Overall Study|Reason not specified|1|||
44345631|NCT01164579|79349602|FG001|Overall Study|Reason not specified|0|||
44345632|NCT01164579|79349603|FG002|Overall Study|Reason not specified|0|||
44345633|NCT00958789|79349612|FG000|Overall Study|Death|5|||
44345634|NCT00958789|79349612|FG000|Overall Study|Lost to Follow-up|14|||
44345635|NCT00958789|79349612|FG000|Overall Study|Withdrawal by Subject|17|||
44345636|NCT00958789|79349612|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
44345637|NCT00958789|79349612|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
44345638|NCT00958789|79349612|FG000|Overall Study|Subject terminated|2|||
44345639|NCT00958789|79349612|FG000|Overall Study|Revision|7|||
44345640|NCT02445391|79349623|FG000|Overall Study|No active protocol treatment|3|||
44345641|NCT02445391|79349624|FG001|Overall Study|No active protocol treatment|0|||
44345642|NCT02445391|79349625|FG002|Overall Study|No active protocol treatment|0|||
44345643|NCT02445391|79349623|FG000|Overall Study|Adverse Event|0|||
44345644|NCT02445391|79349624|FG001|Overall Study|Adverse Event|21|||
44345645|NCT02445391|79349625|FG002|Overall Study|Adverse Event|12|||
44345646|NCT02445391|79349623|FG000|Overall Study|Alternative therapy|0|||
44345647|NCT02445391|79349624|FG001|Overall Study|Alternative therapy|0|||
44345648|NCT02445391|79349625|FG002|Overall Study|Alternative therapy|1|||
44345649|NCT02445391|79349623|FG000|Overall Study|Disease progression|0|||
44345650|NCT02445391|79349624|FG001|Overall Study|Disease progression|7|||
44345651|NCT02445391|79349625|FG002|Overall Study|Disease progression|22|||
44345652|NCT02445391|79349623|FG000|Overall Study|Complicating disease|0|||
44345653|NCT02445391|79349624|FG001|Overall Study|Complicating disease|2|||
44345654|NCT02445391|79349625|FG002|Overall Study|Complicating disease|1|||
44345655|NCT02445391|79349623|FG000|Overall Study|Withdrawal by Subject|0|||
44345656|NCT02445391|79349624|FG001|Overall Study|Withdrawal by Subject|4|||
44345657|NCT02445391|79349625|FG002|Overall Study|Withdrawal by Subject|9|||
44345658|NCT02445391|79349623|FG000|Overall Study|Financial issue|0|||
44345659|NCT02445391|79349624|FG001|Overall Study|Financial issue|0|||
44345660|NCT02445391|79349625|FG002|Overall Study|Financial issue|2|||
44345661|NCT02445391|79349623|FG000|Overall Study|Still on treatment|0|||
44345662|NCT02445391|79349624|FG001|Overall Study|Still on treatment|7|||
44345663|NCT02445391|79349625|FG002|Overall Study|Still on treatment|16|||
44345664|NCT02445391|79349623|FG000|Overall Study|Not start protocol therapy|0|||
44345665|NCT02445391|79349624|FG001|Overall Study|Not start protocol therapy|12|||
44345666|NCT02445391|79349625|FG002|Overall Study|Not start protocol therapy|9|||
44345667|NCT01246986|79349641|FG000|Overall Study|Lost to Follow-up|0|||
44345668|NCT01246986|79349642|FG001|Overall Study|Lost to Follow-up|1|||
44345669|NCT01246986|79349643|FG002|Overall Study|Lost to Follow-up|3|||
44345670|NCT01246986|79349644|FG003|Overall Study|Lost to Follow-up|0|||
44345671|NCT01246986|79349645|FG004|Overall Study|Lost to Follow-up|0|||
44345672|NCT01246986|79349646|FG005|Overall Study|Lost to Follow-up|1|||
44345673|NCT01246986|79349647|FG006|Overall Study|Lost to Follow-up|0|||
44345674|NCT01246986|79349641|FG000|Overall Study|Withdrawal by Subject|3|||
44345675|NCT01246986|79349642|FG001|Overall Study|Withdrawal by Subject|4|||
44345676|NCT01246986|79349643|FG002|Overall Study|Withdrawal by Subject|3|||
44345677|NCT01246986|79349644|FG003|Overall Study|Withdrawal by Subject|0|||
44345678|NCT01246986|79349645|FG004|Overall Study|Withdrawal by Subject|4|||
44345679|NCT01246986|79349646|FG005|Overall Study|Withdrawal by Subject|0|||
44345680|NCT01246986|79349647|FG006|Overall Study|Withdrawal by Subject|0|||
44345681|NCT01164501|79349681|FG000|Overall Study|Not treated|2|||
44345682|NCT01164501|79349682|FG001|Overall Study|Not treated|0|||
44345683|NCT01164501|79349683|FG002|Overall Study|Not treated|1|||
44345684|NCT01164501|79349681|FG000|Overall Study|Adverse Event|18|||
44345685|NCT01164501|79349682|FG001|Overall Study|Adverse Event|4|||
44345686|NCT01164501|79349683|FG002|Overall Study|Adverse Event|21|||
44345687|NCT01164501|79349681|FG000|Overall Study|Lack of Efficacy|0|||
44345688|NCT01164501|79349682|FG001|Overall Study|Lack of Efficacy|0|||
44345689|NCT01164501|79349683|FG002|Overall Study|Lack of Efficacy|1|||
44345690|NCT01164501|79349681|FG000|Overall Study|Non compliant with protocol|1|||
44345691|NCT01164501|79349682|FG001|Overall Study|Non compliant with protocol|1|||
44345692|NCT01164501|79349683|FG002|Overall Study|Non compliant with protocol|4|||
44345693|NCT01164501|79349681|FG000|Overall Study|Lost to Follow-up|3|||
44345694|NCT01164501|79349682|FG001|Overall Study|Lost to Follow-up|0|||
44345695|NCT01164501|79349683|FG002|Overall Study|Lost to Follow-up|3|||
44345696|NCT01164501|79349681|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
44345697|NCT01164501|79349682|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
44345698|NCT01164501|79349683|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
44345699|NCT01164501|79349681|FG000|Overall Study|Other reason not defined above|9|||
44345700|NCT01164501|79349682|FG001|Overall Study|Other reason not defined above|1|||
44345701|NCT01164501|79349683|FG002|Overall Study|Other reason not defined above|4|||
44345702|NCT00958711|79349695|FG000|Overall Study|Withdrawal by Subject|0|||
44345703|NCT00958711|79349696|FG001|Overall Study|Withdrawal by Subject|4|||
44345704|NCT00958711|79349695|FG000|Overall Study|Physician Decision|5|||
44345705|NCT00958711|79349696|FG001|Overall Study|Physician Decision|7|||
44345706|NCT00958711|79349695|FG000|Overall Study|Lost to Follow-up|4|||
44345707|NCT00958711|79349696|FG001|Overall Study|Lost to Follow-up|1|||
44345708|NCT00958711|79349695|FG000|Overall Study|Other|2|||
44345709|NCT00958711|79349696|FG001|Overall Study|Other|5|||
44345710|NCT00958711|79349695|FG000|Overall Study|Death|1|||
44345711|NCT00958711|79349696|FG001|Overall Study|Death|2|||
44345712|NCT00958711|79349695|FG000|Overall Study|Adverse Event|1|||
44345713|NCT00958711|79349696|FG001|Overall Study|Adverse Event|2|||
44345714|NCT01163721|79349704|FG000|Overall Study|Adverse Event|5|||
44345715|NCT01163721|79349705|FG001|Overall Study|Adverse Event|6|||
44345716|NCT01163721|79349704|FG000|Overall Study|Withdrawal by Subject|3|||
44345717|NCT01163721|79349705|FG001|Overall Study|Withdrawal by Subject|4|||
44345718|NCT01163721|79349704|FG000|Overall Study|Lost to Follow-up|0|||
44345719|NCT01163721|79349705|FG001|Overall Study|Lost to Follow-up|1|||
44345720|NCT01163721|79349704|FG000|Overall Study|Physician Decision|0|||
44345721|NCT01163721|79349705|FG001|Overall Study|Physician Decision|1|||
44345722|NCT00958243|79349717|FG000|Overall Study|Withdrawal by Subject|0|||
44345723|NCT00958243|79349718|FG001|Overall Study|Withdrawal by Subject|1|||
44345724|NCT00958243|79349719|FG002|Overall Study|Withdrawal by Subject|3|||
44345725|NCT00958243|79349720|FG003|Overall Study|Withdrawal by Subject|1|||
44345726|NCT00958243|79349721|FG004|Overall Study|Withdrawal by Subject|1|||
44345727|NCT00958243|79349722|FG005|Overall Study|Withdrawal by Subject|5|||
44345728|NCT00958243|79349717|FG000|Overall Study|Lost to Follow-up|2|||
44345729|NCT00958243|79349718|FG001|Overall Study|Lost to Follow-up|5|||
44345730|NCT00958243|79349719|FG002|Overall Study|Lost to Follow-up|11|||
44345731|NCT00958243|79349720|FG003|Overall Study|Lost to Follow-up|2|||
44345732|NCT00958243|79349721|FG004|Overall Study|Lost to Follow-up|8|||
44345733|NCT00958243|79349722|FG005|Overall Study|Lost to Follow-up|5|||
44345734|NCT01241760|79349744|FG000|Overall Study|Adverse Event|1|||
44345735|NCT01241760|79349745|FG001|Overall Study|Adverse Event|0|||
44345736|NCT01241760|79349744|FG000|Overall Study|Lost to Follow-up|18|||
44345737|NCT01241760|79349745|FG001|Overall Study|Lost to Follow-up|22|||
44345738|NCT01241760|79349744|FG000|Overall Study|Withdrawal by Subject|13|||
44345739|NCT01241760|79349745|FG001|Overall Study|Withdrawal by Subject|13|||
44345740|NCT01241760|79349744|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
44345741|NCT01241760|79349745|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
44345742|NCT01241760|79349744|FG000|Overall Study|Other|1|||
44345743|NCT01241760|79349745|FG001|Overall Study|Other|1|||
44345744|NCT00958165|79349752|FG000|Overall Study|Lost to Follow-up|5|||
44345745|NCT00958165|79349752|FG000|Overall Study|Not eligible|9|||
44345746|NCT00958009|79349756|FG000|Overall Study|Adverse Event|1|||
44345747|NCT00958009|79349756|FG000|Overall Study|Subject found device difficult to use|1|||
44345748|NCT00953407|79349765|FG000|Overall Study|Failed inclusion criteria|1|||
44345749|NCT00953407|79349766|FG001|Overall Study|Failed inclusion criteria|1|||
44345750|NCT00953407|79349767|FG002|Overall Study|Failed inclusion criteria|1|||
44345751|NCT00953407|79349768|FG003|Overall Study|Failed inclusion criteria|1|||
44345752|NCT00953407|79349769|FG004|Overall Study|Failed inclusion criteria|1|||
44345753|NCT00953407|79349765|FG000|Overall Study|Lost to Follow-up|0|||
44345754|NCT00953407|79349766|FG001|Overall Study|Lost to Follow-up|0|||
44345755|NCT00953407|79349767|FG002|Overall Study|Lost to Follow-up|0|||
44345756|NCT00953407|79349768|FG003|Overall Study|Lost to Follow-up|1|||
44345757|NCT00953407|79349769|FG004|Overall Study|Lost to Follow-up|0|||
44345758|NCT00953329|79349781|FG000|Overall Study|Lack of Efficacy|1|||
44345759|NCT00953017|79349789|FG000|Overall Study|DId not show up for colonoscopy|4|||
44345760|NCT00953017|79349790|FG001|Overall Study|DId not show up for colonoscopy|4|||
44345761|NCT00953017|79349791|FG002|Overall Study|DId not show up for colonoscopy|5|||
44345762|NCT00953017|79349792|FG003|Overall Study|DId not show up for colonoscopy|4|||
44345763|NCT00953017|79349789|FG000|Overall Study|Incomplete data|1|||
44345764|NCT00953017|79349790|FG001|Overall Study|Incomplete data|1|||
44345765|NCT00953017|79349791|FG002|Overall Study|Incomplete data|0|||
44345766|NCT00953017|79349792|FG003|Overall Study|Incomplete data|0|||
44345767|NCT00953017|79349789|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
44345768|NCT00953017|79349790|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
44345769|NCT00953017|79349791|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
44345770|NCT00953017|79349792|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
44345771|NCT00953017|79349789|FG000|Overall Study|Brown stool prior to procedure|0|||
44345772|NCT00953017|79349790|FG001|Overall Study|Brown stool prior to procedure|0|||
44345773|NCT00953017|79349791|FG002|Overall Study|Brown stool prior to procedure|1|||
44345774|NCT00953017|79349792|FG003|Overall Study|Brown stool prior to procedure|0|||
44345775|NCT00952705|79349805|FG000|Overall Study|Lost to Follow-up|24|||
44345776|NCT00952705|79349806|FG001|Overall Study|Lost to Follow-up|8|||
44345777|NCT00952705|79349807|FG002|Overall Study|Lost to Follow-up|9|||
44345778|NCT00952705|79349805|FG000|Overall Study|Withdrawal by Subject|2|||
44345779|NCT00952705|79349806|FG001|Overall Study|Withdrawal by Subject|1|||
44345780|NCT00952705|79349807|FG002|Overall Study|Withdrawal by Subject|1|||
44345781|NCT00952705|79349805|FG000|Overall Study|Death|2|||
44345782|NCT00952705|79349806|FG001|Overall Study|Death|0|||
44345783|NCT00952705|79349807|FG002|Overall Study|Death|0|||
44345784|NCT00952705|79349805|FG000|Overall Study|Incarcerated post dose|5|||
44345785|NCT00952705|79349806|FG001|Overall Study|Incarcerated post dose|0|||
44163389|NCT02566759|78956397|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44345786|NCT00952705|79349807|FG002|Overall Study|Incarcerated post dose|0|||
44345787|NCT00952705|79349805|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
44345788|NCT00952705|79349806|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
44345789|NCT00952705|79349807|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
44345790|NCT00955357|79349821|FG000|Titration Phase|Adverse Event|9|||
44345791|NCT00955357|79349822|FG001|Titration Phase|Adverse Event|46|||
44345792|NCT00955357|79349821|FG000|Titration Phase|Lack of Efficacy|0|||
44345793|NCT00955357|79349822|FG001|Titration Phase|Lack of Efficacy|2|||
44345794|NCT00955357|79349821|FG000|Titration Phase|Protocol Violation|3|||
44345795|NCT00955357|79349822|FG001|Titration Phase|Protocol Violation|7|||
44345796|NCT00955357|79349821|FG000|Titration Phase|Lost to Follow-up|1|||
44345797|NCT00955357|79349822|FG001|Titration Phase|Lost to Follow-up|3|||
44345798|NCT00955357|79349821|FG000|Titration Phase|Withdrawal by Subject|3|||
44345799|NCT00955357|79349822|FG001|Titration Phase|Withdrawal by Subject|5|||
44345800|NCT00955357|79349821|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
44345801|NCT00955357|79349822|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
44345802|NCT00955357|79349821|FG000|Titration Phase|Study medication not tolerated|0|||
44345803|NCT00955357|79349822|FG001|Titration Phase|Study medication not tolerated|1|||
44345804|NCT00955357|79349821|FG000|Titration Phase|Non compliance to study procedures|0|||
44345805|NCT00955357|79349822|FG001|Titration Phase|Non compliance to study procedures|1|||
44345806|NCT00955357|79349821|FG000|Maintenance Phase|Adverse Event|3|||
44345807|NCT00955357|79349822|FG001|Maintenance Phase|Adverse Event|23|||
44345808|NCT00955357|79349821|FG000|Maintenance Phase|Lack of Efficacy|0|||
44345809|NCT00955357|79349822|FG001|Maintenance Phase|Lack of Efficacy|4|||
44345810|NCT00955357|79349821|FG000|Maintenance Phase|Protocol Violation|2|||
44345811|NCT00955357|79349822|FG001|Maintenance Phase|Protocol Violation|6|||
44345812|NCT00955357|79349821|FG000|Maintenance Phase|Lost to Follow-up|2|||
44345813|NCT00955357|79349822|FG001|Maintenance Phase|Lost to Follow-up|7|||
44345814|NCT00955357|79349821|FG000|Maintenance Phase|Withdrawal by Subject|4|||
44345815|NCT00955357|79349822|FG001|Maintenance Phase|Withdrawal by Subject|4|||
44345816|NCT00955357|79349821|FG000|Maintenance Phase|Patient moving out of area|0|||
44345817|NCT00955357|79349822|FG001|Maintenance Phase|Patient moving out of area|1|||
44345818|NCT00955357|79349821|FG000|Maintenance Phase|Non compliance to study procedures|1|||
44345819|NCT00955357|79349822|FG001|Maintenance Phase|Non compliance to study procedures|0|||
44345820|NCT00955279|79349831|FG000|Overall Study|Other|0|||
44345821|NCT00955279|79349832|FG001|Overall Study|Other|0|||
44345822|NCT00955279|79349833|FG002|Overall Study|Other|3|||
44345823|NCT00955279|79349831|FG000|Overall Study|Death|1|||
44345824|NCT00955279|79349832|FG001|Overall Study|Death|1|||
44345825|NCT00955279|79349833|FG002|Overall Study|Death|1|||
44345826|NCT00955279|79349831|FG000|Overall Study|Lost to Follow-up|0|||
44345827|NCT00955279|79349832|FG001|Overall Study|Lost to Follow-up|3|||
44345828|NCT00955279|79349833|FG002|Overall Study|Lost to Follow-up|1|||
44345829|NCT00955279|79349831|FG000|Overall Study|Withdrawal by Subject|2|||
44345830|NCT00955279|79349832|FG001|Overall Study|Withdrawal by Subject|0|||
44345831|NCT00955279|79349833|FG002|Overall Study|Withdrawal by Subject|3|||
44345832|NCT00954733|79349841|FG000|Overall Study|blood gas machine did not work|1|||
44345833|NCT00954421|79349845|FG000|Screening|screen failures|3|||
44345834|NCT00954421|79349845|FG000|6 Months of DBS|Withdrawal by Subject|1|||
44345835|NCT00954421|79349845|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
44345836|NCT01241448|79349855|FG000|Overall Study|Adverse Event|1|||
44345837|NCT01241448|79349856|FG001|Overall Study|Adverse Event|0|||
44345838|NCT01241448|79349857|FG002|Overall Study|Adverse Event|2|||
44345839|NCT01241448|79349858|FG003|Overall Study|Adverse Event|2|||
44345840|NCT01241448|79349855|FG000|Overall Study|Lost to Follow-up|2|||
44345841|NCT01241448|79349856|FG001|Overall Study|Lost to Follow-up|1|||
44345842|NCT01241448|79349857|FG002|Overall Study|Lost to Follow-up|1|||
44345843|NCT01241448|79349858|FG003|Overall Study|Lost to Follow-up|1|||
44345844|NCT01241448|79349855|FG000|Overall Study|Physician Decision|0|||
44345845|NCT01241448|79349856|FG001|Overall Study|Physician Decision|2|||
44345846|NCT01241448|79349857|FG002|Overall Study|Physician Decision|0|||
44345847|NCT01241448|79349858|FG003|Overall Study|Physician Decision|0|||
44345848|NCT01241448|79349855|FG000|Overall Study|Protocol Violation|10|||
44345849|NCT01241448|79349856|FG001|Overall Study|Protocol Violation|5|||
44345850|NCT01241448|79349857|FG002|Overall Study|Protocol Violation|3|||
44345851|NCT01241448|79349858|FG003|Overall Study|Protocol Violation|6|||
44345852|NCT01241448|79349855|FG000|Overall Study|Sponsor Decision|17|||
44345853|NCT01241448|79349856|FG001|Overall Study|Sponsor Decision|14|||
44345854|NCT01241448|79349857|FG002|Overall Study|Sponsor Decision|12|||
44345855|NCT01241448|79349858|FG003|Overall Study|Sponsor Decision|6|||
44345856|NCT01241448|79349855|FG000|Overall Study|Withdrawal by Subject|4|||
44345857|NCT01241448|79349856|FG001|Overall Study|Withdrawal by Subject|5|||
44345858|NCT01241448|79349857|FG002|Overall Study|Withdrawal by Subject|3|||
44345859|NCT01241448|79349858|FG003|Overall Study|Withdrawal by Subject|6|||
44345860|NCT01241448|79349855|FG000|Overall Study|Excluded due to data integrity issues|3|||
44345861|NCT01241448|79349856|FG001|Overall Study|Excluded due to data integrity issues|2|||
44345862|NCT01241448|79349857|FG002|Overall Study|Excluded due to data integrity issues|2|||
44345863|NCT01241448|79349858|FG003|Overall Study|Excluded due to data integrity issues|2|||
44345864|NCT01240356|79349871|FG000|Overall Study|Withdrawal by Subject|2|||
44345865|NCT01240356|79349872|FG001|Overall Study|Withdrawal by Subject|0|||
44345866|NCT01240356|79349871|FG000|Overall Study|MRI contraindication|1|||
44345867|NCT01240356|79349872|FG001|Overall Study|MRI contraindication|0|||
44345868|NCT01239732|79349881|FG000|Overall Study|Termination of study per protocol|667|||
44345869|NCT01239732|79349881|FG000|Overall Study|Death|226|||
44345870|NCT01239732|79349881|FG000|Overall Study|Withdrawal by Subject|87|||
44345871|NCT01239732|79349881|FG000|Overall Study|Adverse Event|6|||
44345872|NCT01239732|79349881|FG000|Overall Study|Protocol Violation|3|||
44345873|NCT01239732|79349881|FG000|Overall Study|Participant non compliance|5|||
44345874|NCT01239732|79349881|FG000|Overall Study|Study termination by sponsor|2|||
44345875|NCT01239732|79349881|FG000|Overall Study|Investigator's decision|4|||
44345876|NCT01239732|79349881|FG000|Overall Study|Treatment failure|2|||
44345877|NCT01239732|79349881|FG000|Overall Study|Other|19|||
44345878|NCT02227147|79349887|FG000|Controlled Treatment Period|Adverse Event|4|||
44345879|NCT02227147|79349888|FG001|Controlled Treatment Period|Adverse Event|3|||
44345880|NCT02227147|79349887|FG000|Controlled Treatment Period|Other|2|||
44345881|NCT02227147|79349888|FG001|Controlled Treatment Period|Other|0|||
44345882|NCT02227147|79349887|FG000|Follow-up Period|Other|3|||
44345883|NCT02227147|79349888|FG001|Follow-up Period|Other|5|||
44345884|NCT00948025|79349900|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
44345885|NCT00948025|79349901|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
44345886|NCT00948025|79349900|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
44345887|NCT00948025|79349901|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
44345888|NCT00948025|79349900|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
44345889|NCT00948025|79349901|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
44345890|NCT00947011|79349908|FG000|Overall Study|Study was terminated,PI left institution|12|||
44345891|NCT01239342|79349916|FG000|Overall Study|Adverse Event|1|||
44345892|NCT01239342|79349917|FG001|Overall Study|Adverse Event|0|||
44345893|NCT01239342|79349916|FG000|Overall Study|Withdrawal by Subject|1|||
44345894|NCT01239342|79349917|FG001|Overall Study|Withdrawal by Subject|5|||
44345895|NCT01239342|79349916|FG000|Overall Study|Reason Unknown|1|||
44345896|NCT01239342|79349917|FG001|Overall Study|Reason Unknown|1|||
44345897|NCT00946309|79349925|FG000|Overall Study|Protocol Violation|1|||
44345898|NCT00946309|79349926|FG001|Overall Study|Protocol Violation|0|||
44345899|NCT00946309|79349925|FG000|Overall Study|Lost to Follow-up|0|||
44345900|NCT00946309|79349926|FG001|Overall Study|Lost to Follow-up|1|||
44345901|NCT00946309|79349925|FG000|Overall Study|Procedure cancelled/discontinued|0|||
44345902|NCT00946309|79349926|FG001|Overall Study|Procedure cancelled/discontinued|3|||
44345903|NCT01236534|79349935|FG000|Overall Study|Adverse Event|3|||
44345904|NCT01236534|79349936|FG001|Overall Study|Adverse Event|0|||
44345905|NCT01235598|79349944|FG000|Overall Study|Adverse Event|0|||
44345906|NCT01235598|79349945|FG001|Overall Study|Adverse Event|3|||
44345907|NCT01235598|79349944|FG000|Overall Study|Lack of Efficacy|0|||
44345908|NCT01235598|79349945|FG001|Overall Study|Lack of Efficacy|1|||
44345909|NCT01235598|79349944|FG000|Overall Study|Withdrawal by Subject|1|||
44345910|NCT01235598|79349945|FG001|Overall Study|Withdrawal by Subject|0|||
44345911|NCT01235442|79349954|FG000|Overall Study|Lost to Follow-up|12|||
44345912|NCT01235442|79349955|FG001|Overall Study|Lost to Follow-up|10|||
44345913|NCT01235442|79349954|FG000|Overall Study|Death|0|||
44345914|NCT01235442|79349955|FG001|Overall Study|Death|2|||
44345915|NCT01235442|79349954|FG000|Overall Study|Pregnancy|1|||
44345916|NCT01235442|79349955|FG001|Overall Study|Pregnancy|1|||
44345917|NCT01235442|79349954|FG000|Overall Study|Ineligibility determined|5|||
44163390|NCT02566759|78956398|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163391|NCT02566759|78956399|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163392|NCT02566759|78956400|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163393|NCT02566759|78956401|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163394|NCT02566759|78956402|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163395|NCT02566759|78956403|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163396|NCT02566759|78956404|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
44163397|NCT02566759|78956405|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
44163398|NCT02335983|78956470|FG000|Overall Study|Sponsor Decision|0|||
44163399|NCT02335983|78956471|FG001|Overall Study|Sponsor Decision|0|||
44163400|NCT02335983|78956472|FG002|Overall Study|Sponsor Decision|1|||
44163401|NCT02335983|78956473|FG003|Overall Study|Sponsor Decision|1|||
44163402|NCT02335983|78956474|FG004|Overall Study|Sponsor Decision|0|||
44163403|NCT02335983|78956475|FG005|Overall Study|Sponsor Decision|1|||
44163404|NCT02335983|78956470|FG000|Overall Study|Withdrawal by Subject|3|||
44163405|NCT02335983|78956471|FG001|Overall Study|Withdrawal by Subject|2|||
44163406|NCT02335983|78956472|FG002|Overall Study|Withdrawal by Subject|2|||
44163407|NCT02335983|78956473|FG003|Overall Study|Withdrawal by Subject|1|||
44163408|NCT02335983|78956474|FG004|Overall Study|Withdrawal by Subject|3|||
44163409|NCT02335983|78956475|FG005|Overall Study|Withdrawal by Subject|9|||
44345918|NCT01235442|79349955|FG001|Overall Study|Ineligibility determined|4|||
44345919|NCT01235442|79349954|FG000|Overall Study|Protocol Violation|3|||
44345920|NCT01235442|79349955|FG001|Overall Study|Protocol Violation|3|||
44345921|NCT01235442|79349954|FG000|Overall Study|Adverse Event|4|||
44345922|NCT01235442|79349955|FG001|Overall Study|Adverse Event|6|||
44345923|NCT01235442|79349954|FG000|Overall Study|Withdrawal by Subject|15|||
44345924|NCT01235442|79349955|FG001|Overall Study|Withdrawal by Subject|9|||
44345925|NCT01235442|79349954|FG000|Overall Study|Lack of Efficacy|1|||
44345926|NCT01235442|79349955|FG001|Overall Study|Lack of Efficacy|3|||
44163410|NCT02335983|78956470|FG000|Overall Study|Death|0|||
44163411|NCT02335983|78956471|FG001|Overall Study|Death|0|||
44163412|NCT02335983|78956472|FG002|Overall Study|Death|2|||
44163413|NCT02335983|78956473|FG003|Overall Study|Death|0|||
44163414|NCT02335983|78956474|FG004|Overall Study|Death|0|||
44163415|NCT02335983|78956475|FG005|Overall Study|Death|0|||
44163416|NCT02335983|78956470|FG000|Overall Study|Lost to Follow-up|0|||
44163417|NCT02335983|78956471|FG001|Overall Study|Lost to Follow-up|0|||
44163418|NCT02335983|78956472|FG002|Overall Study|Lost to Follow-up|0|||
44163419|NCT02335983|78956473|FG003|Overall Study|Lost to Follow-up|0|||
44163420|NCT02335983|78956474|FG004|Overall Study|Lost to Follow-up|0|||
44163421|NCT02335983|78956475|FG005|Overall Study|Lost to Follow-up|1|||
44163422|NCT02335983|78956470|FG000|Overall Study|Protocol Specified Criteria|5|||
44163423|NCT02335983|78956471|FG001|Overall Study|Protocol Specified Criteria|7|||
44163424|NCT02335983|78956472|FG002|Overall Study|Protocol Specified Criteria|27|||
44163425|NCT02335983|78956473|FG003|Overall Study|Protocol Specified Criteria|7|||
44163426|NCT02335983|78956474|FG004|Overall Study|Protocol Specified Criteria|5|||
44163427|NCT02335983|78956475|FG005|Overall Study|Protocol Specified Criteria|21|||
44163428|NCT04640311|78956511|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
44163429|NCT04640311|78956512|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163430|NCT04640311|78956513|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163431|NCT04640311|78956514|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163432|NCT04640311|78956515|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163433|NCT04640311|78956516|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163434|NCT04640311|78956517|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163435|NCT04640311|78956518|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163436|NCT04640311|78956519|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163437|NCT04640311|78956520|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163438|NCT04640311|78956521|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163439|NCT04640311|78956522|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163440|NCT04640311|78956523|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163441|NCT04640311|78956511|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163442|NCT04640311|78956512|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
44163443|NCT04640311|78956513|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163444|NCT04640311|78956514|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163445|NCT04640311|78956515|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163446|NCT04640311|78956516|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163447|NCT04640311|78956517|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163448|NCT04640311|78956518|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163449|NCT04640311|78956519|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163450|NCT04640311|78956520|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163451|NCT04640311|78956521|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163452|NCT04640311|78956522|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163453|NCT04640311|78956523|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
44163454|NCT04640311|78956511|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163455|NCT04640311|78956512|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
44163456|NCT04640311|78956513|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163457|NCT04640311|78956514|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163458|NCT04640311|78956515|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163459|NCT04640311|78956516|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44345927|NCT01235442|79349954|FG000|Overall Study|Noncompliance|1|||
44345928|NCT01235442|79349955|FG001|Overall Study|Noncompliance|2|||
44345929|NCT01235442|79349954|FG000|Overall Study|Administrative decision|1|||
44345930|NCT01235442|79349955|FG001|Overall Study|Administrative decision|2|||
44345931|NCT01235442|79349954|FG000|Overall Study|Other unspecified|1|||
44345932|NCT01235442|79349955|FG001|Overall Study|Other unspecified|2|||
44345933|NCT01163253|79349963|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
44345934|NCT01163253|79349964|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
44345935|NCT01163253|79349963|FG000|Overall Study|Study Terminated by Sponsor|978|||
44345936|NCT01163253|79349964|FG001|Overall Study|Study Terminated by Sponsor|349|||
44345937|NCT01163253|79349963|FG000|Overall Study|Protocol Violation|43|||
44345938|NCT01163253|79349964|FG001|Overall Study|Protocol Violation|12|||
44345939|NCT01163253|79349963|FG000|Overall Study|Withdrawal by Subject|199|||
44345940|NCT01163253|79349964|FG001|Overall Study|Withdrawal by Subject|50|||
44345941|NCT01163253|79349963|FG000|Overall Study|Medication Error|1|||
44345942|NCT01163253|79349964|FG001|Overall Study|Medication Error|0|||
44345943|NCT01163253|79349963|FG000|Overall Study|Lost to Follow-up|125|||
44345944|NCT01163253|79349964|FG001|Overall Study|Lost to Follow-up|23|||
44345945|NCT01163253|79349963|FG000|Overall Study|Insufficient Clinical Response|423|||
44345946|NCT01163253|79349964|FG001|Overall Study|Insufficient Clinical Response|29|||
44345947|NCT01163253|79349963|FG000|Overall Study|Adverse Event|300|||
44345948|NCT01163253|79349964|FG001|Overall Study|Adverse Event|78|||
44345949|NCT01163253|79349963|FG000|Overall Study|Death|17|||
44345950|NCT01163253|79349964|FG001|Overall Study|Death|5|||
44345951|NCT01163253|79349963|FG000|Overall Study|Ongoing|13|||
44345952|NCT01163253|79349964|FG001|Overall Study|Ongoing|4|||
44345953|NCT01163253|79349963|FG000|Overall Study|Other Unspecified|170|||
44345954|NCT01163253|79349964|FG001|Overall Study|Other Unspecified|34|||
44345955|NCT01162863|79349973|FG000|Overall Study|Lack of Efficacy|1|||
44345956|NCT01162863|79349974|FG001|Overall Study|Lack of Efficacy|0|||
44345957|NCT01162863|79349975|FG002|Overall Study|Lack of Efficacy|0|||
44345958|NCT01162863|79349973|FG000|Overall Study|Adverse Event|0|||
44345959|NCT01162863|79349974|FG001|Overall Study|Adverse Event|1|||
44345960|NCT01162863|79349975|FG002|Overall Study|Adverse Event|0|||
44345961|NCT01162473|79349985|FG000|Overall Study|Adverse Event|2|||
44345962|NCT01162473|79349986|FG001|Overall Study|Adverse Event|1|||
44345963|NCT01162473|79349985|FG000|Overall Study|Withdrawal by Subject|0|||
44345964|NCT01162473|79349986|FG001|Overall Study|Withdrawal by Subject|4|||
44345965|NCT01162239|79349996|FG000|Treatment Phase|Withdrawal by Subject|1|||
44345966|NCT01162239|79349997|FG001|Treatment Phase|Withdrawal by Subject|3|||
44345967|NCT01162239|79349998|FG002|Treatment Phase|Withdrawal by Subject|2|||
44345968|NCT01162239|79349999|FG003|Treatment Phase|Withdrawal by Subject|3|||
44345969|NCT01162239|79349996|FG000|Treatment Phase|Death|0|||
44345970|NCT01162239|79349997|FG001|Treatment Phase|Death|0|||
44345971|NCT01162239|79349998|FG002|Treatment Phase|Death|0|||
44345972|NCT01162239|79349999|FG003|Treatment Phase|Death|1|||
44345973|NCT01162239|79349996|FG000|Treatment Phase|Lost to Follow-up|5|||
44345974|NCT01162239|79349997|FG001|Treatment Phase|Lost to Follow-up|4|||
44345975|NCT01162239|79349998|FG002|Treatment Phase|Lost to Follow-up|2|||
44345976|NCT01162239|79349999|FG003|Treatment Phase|Lost to Follow-up|1|||
44345977|NCT01162239|79349996|FG000|Extended Follow-up|Lost to Follow-up|8|||
44345978|NCT01162239|79349997|FG001|Extended Follow-up|Lost to Follow-up|13|||
44345979|NCT01162239|79349998|FG002|Extended Follow-up|Lost to Follow-up|8|||
44345980|NCT01162239|79349999|FG003|Extended Follow-up|Lost to Follow-up|6|||
44345981|NCT01161537|79350010|FG000|Part B|Withdrawal by Subject|2|||
44345982|NCT01234350|79350021|FG000|Overall Study|Adverse Event|277|||
44345983|NCT01234350|79350022|FG001|Overall Study|Adverse Event|92|||
44345984|NCT01234350|79350021|FG000|Overall Study|Withdrawal by Subject|61|||
44345985|NCT01234350|79350022|FG001|Overall Study|Withdrawal by Subject|36|||
44345986|NCT01234350|79350021|FG000|Overall Study|Lost to Follow-up|115|||
44345987|NCT01234350|79350022|FG001|Overall Study|Lost to Follow-up|47|||
44345988|NCT01234350|79350021|FG000|Overall Study|Covers a diverse set of reasons|234|||
44345989|NCT01234350|79350022|FG001|Overall Study|Covers a diverse set of reasons|92|||
44345990|NCT01233258|79350033|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
44345991|NCT01233258|79350034|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
44345992|NCT01233258|79350035|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
44345993|NCT01233258|79350036|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
44345994|NCT01233258|79350037|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
44345995|NCT01233258|79350038|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
44345996|NCT01233258|79350033|FG000|First Intervention (6 Months)|Protocol Violation|0|||
44345997|NCT01233258|79350034|FG001|First Intervention (6 Months)|Protocol Violation|0|||
44345998|NCT01233258|79350035|FG002|First Intervention (6 Months)|Protocol Violation|1|||
44345999|NCT01233258|79350036|FG003|First Intervention (6 Months)|Protocol Violation|0|||
44346000|NCT01233258|79350037|FG004|First Intervention (6 Months)|Protocol Violation|0|||
44346001|NCT01233258|79350038|FG005|First Intervention (6 Months)|Protocol Violation|0|||
44346002|NCT01233258|79350033|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
44346003|NCT01233258|79350034|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
44346004|NCT01233258|79350035|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
44346005|NCT01233258|79350036|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
44346006|NCT01233258|79350037|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
44346007|NCT01233258|79350038|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
44346008|NCT01232868|79350055|FG000|Overall Study|Lost to Follow-up|2|||
44346009|NCT01232868|79350056|FG001|Overall Study|Lost to Follow-up|4|||
44444947|NCT03517449|79452813|FG001|Overall Study|Lost to Follow-up|2|||
44167886|NCT02528357|78961059|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
44346010|NCT01232790|79350062|FG000|Randomization|Withdrawal by Subject|2|||
44346011|NCT01232790|79350063|FG001|Randomization|Withdrawal by Subject|0|||
44346012|NCT01232790|79350062|FG000|Randomization|Protocol Violation|0|||
44346013|NCT01232790|79350063|FG001|Randomization|Protocol Violation|1|||
44346014|NCT01232790|79350062|FG000|Randomization|Physician Decision|0|||
44444948|NCT03517449|79452812|FG000|Overall Study|Withdrawal by Subject|7|||
44346015|NCT01232790|79350063|FG001|Randomization|Physician Decision|1|||
44346016|NCT01232790|79350062|FG000|Initial Assessment|Withdrawal by Subject|0|||
44346017|NCT01232790|79350063|FG001|Initial Assessment|Withdrawal by Subject|1|||
44346018|NCT01232790|79350062|FG000|First Crossover|Withdrawal by Subject|1|||
44346019|NCT01232790|79350063|FG001|First Crossover|Withdrawal by Subject|0|||
44346020|NCT01232790|79350062|FG000|Second Crossover|Withdrawal by Subject|1|||
44346021|NCT01232790|79350063|FG001|Second Crossover|Withdrawal by Subject|2|||
44346022|NCT01232556|79350081|FG000|Overall Study|Withdrawal by Subject|21|||
44346023|NCT01232556|79350082|FG001|Overall Study|Withdrawal by Subject|17|||
44346024|NCT01232556|79350081|FG000|Overall Study|Death|97|||
44346025|NCT01232556|79350082|FG001|Overall Study|Death|97|||
44346026|NCT01232556|79350081|FG000|Overall Study|Lost to Follow-up|0|||
44346027|NCT01232556|79350082|FG001|Overall Study|Lost to Follow-up|2|||
44346028|NCT01232556|79350081|FG000|Overall Study|Terminated by Sponsor|35|||
44346029|NCT01232556|79350082|FG001|Overall Study|Terminated by Sponsor|51|||
44346030|NCT01232556|79350081|FG000|Overall Study|Other|6|||
44346031|NCT01232556|79350082|FG001|Overall Study|Other|4|||
44346032|NCT00946153|79350093|FG000|Phase 2|Adverse Event|0|||
44346033|NCT00946153|79350094|FG001|Phase 2|Adverse Event|0|||
44346034|NCT00946153|79350095|FG002|Phase 2|Adverse Event|0|||
44346035|NCT00946153|79350096|FG003|Phase 2|Adverse Event|0|||
44346036|NCT00946153|79350097|FG004|Phase 2|Adverse Event|6|||
44346037|NCT00946153|79350093|FG000|Phase 2|Need more reduction of dose|0|||
44346038|NCT00946153|79350094|FG001|Phase 2|Need more reduction of dose|0|||
44346039|NCT00946153|79350095|FG002|Phase 2|Need more reduction of dose|0|||
44346040|NCT00946153|79350096|FG003|Phase 2|Need more reduction of dose|0|||
44346041|NCT00946153|79350097|FG004|Phase 2|Need more reduction of dose|2|||
44346042|NCT00946153|79350093|FG000|Phase 2|Physician Decision|0|||
44346043|NCT00946153|79350094|FG001|Phase 2|Physician Decision|0|||
44346044|NCT00946153|79350095|FG002|Phase 2|Physician Decision|0|||
44346045|NCT00946153|79350096|FG003|Phase 2|Physician Decision|0|||
44346046|NCT00946153|79350097|FG004|Phase 2|Physician Decision|1|||
44346047|NCT00946153|79350093|FG000|Phase 2|14 days washout for recovery due to AE|0|||
44346048|NCT00946153|79350094|FG001|Phase 2|14 days washout for recovery due to AE|0|||
44346049|NCT00946153|79350095|FG002|Phase 2|14 days washout for recovery due to AE|0|||
44346050|NCT00946153|79350096|FG003|Phase 2|14 days washout for recovery due to AE|0|||
44346051|NCT00946153|79350097|FG004|Phase 2|14 days washout for recovery due to AE|4|||
44346052|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
44346053|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
44346054|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
44346055|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
44346056|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
44346057|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
44346058|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
44346059|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
44346060|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
44346061|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
44346062|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
44346063|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
44346064|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
44346065|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
44346066|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
44346067|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
44346068|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
44346069|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
44346070|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
44346071|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
44346072|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
44163460|NCT04640311|78956517|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44346073|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
44346074|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
44346075|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
44346076|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
44346077|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
44346078|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
44346079|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
44346080|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
44346081|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
44346082|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
44346083|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
44346084|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
44163461|NCT04640311|78956518|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163462|NCT04640311|78956519|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163463|NCT04640311|78956520|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163464|NCT04640311|78956521|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163465|NCT04640311|78956522|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163466|NCT04640311|78956523|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163467|NCT04640311|78956511|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
44163468|NCT04640311|78956512|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
44163469|NCT04640311|78956513|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
44346085|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
44346086|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
44346087|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
44346088|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
44346089|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
44346090|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
44346091|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
44346092|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
44346093|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
44346094|NCT01160289|79350119|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
44346095|NCT01160289|79350120|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
44346096|NCT01160289|79350121|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
44346097|NCT01160289|79350122|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
44346098|NCT01160289|79350123|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
44346099|NCT01160289|79350124|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
44346100|NCT01160289|79350119|FG000|Post-Randomization Period|Adverse Event|0|||
44346101|NCT01160289|79350120|FG001|Post-Randomization Period|Adverse Event|4|||
44346102|NCT01160289|79350121|FG002|Post-Randomization Period|Adverse Event|4|||
44346103|NCT01160289|79350122|FG003|Post-Randomization Period|Adverse Event|2|||
44346104|NCT01160289|79350123|FG004|Post-Randomization Period|Adverse Event|0|||
44346105|NCT01160289|79350124|FG005|Post-Randomization Period|Adverse Event|0|||
44346106|NCT01160289|79350119|FG000|Post-Randomization Period|Death|0|||
44346107|NCT01160289|79350120|FG001|Post-Randomization Period|Death|0|||
44346108|NCT01160289|79350121|FG002|Post-Randomization Period|Death|0|||
44346109|NCT01160289|79350122|FG003|Post-Randomization Period|Death|1|||
44346110|NCT01160289|79350123|FG004|Post-Randomization Period|Death|0|||
44346111|NCT01160289|79350124|FG005|Post-Randomization Period|Death|0|||
44346112|NCT01160289|79350119|FG000|Post-Randomization Period|Lack of Efficacy|0|||
44346113|NCT01160289|79350120|FG001|Post-Randomization Period|Lack of Efficacy|1|||
44346114|NCT01160289|79350121|FG002|Post-Randomization Period|Lack of Efficacy|0|||
44346115|NCT01160289|79350122|FG003|Post-Randomization Period|Lack of Efficacy|3|||
44346116|NCT01160289|79350123|FG004|Post-Randomization Period|Lack of Efficacy|0|||
44346117|NCT01160289|79350124|FG005|Post-Randomization Period|Lack of Efficacy|0|||
44346118|NCT01160289|79350119|FG000|Post-Randomization Period|Lost to Follow-up|0|||
44346119|NCT01160289|79350120|FG001|Post-Randomization Period|Lost to Follow-up|3|||
44346120|NCT01160289|79350121|FG002|Post-Randomization Period|Lost to Follow-up|2|||
44346121|NCT01160289|79350122|FG003|Post-Randomization Period|Lost to Follow-up|5|||
44346122|NCT01160289|79350123|FG004|Post-Randomization Period|Lost to Follow-up|3|||
44346123|NCT01160289|79350124|FG005|Post-Randomization Period|Lost to Follow-up|4|||
44346124|NCT01160289|79350119|FG000|Post-Randomization Period|Physician Decision|0|||
44346125|NCT01160289|79350120|FG001|Post-Randomization Period|Physician Decision|0|||
44346126|NCT01160289|79350121|FG002|Post-Randomization Period|Physician Decision|1|||
44346127|NCT01160289|79350122|FG003|Post-Randomization Period|Physician Decision|0|||
44346128|NCT01160289|79350123|FG004|Post-Randomization Period|Physician Decision|0|||
44346129|NCT01160289|79350124|FG005|Post-Randomization Period|Physician Decision|0|||
44346130|NCT01160289|79350119|FG000|Post-Randomization Period|Protocol Violation|0|||
44346131|NCT01160289|79350120|FG001|Post-Randomization Period|Protocol Violation|4|||
44346132|NCT01160289|79350121|FG002|Post-Randomization Period|Protocol Violation|2|||
44346133|NCT01160289|79350122|FG003|Post-Randomization Period|Protocol Violation|0|||
44346134|NCT01160289|79350123|FG004|Post-Randomization Period|Protocol Violation|1|||
44346135|NCT01160289|79350124|FG005|Post-Randomization Period|Protocol Violation|3|||
44346136|NCT01160289|79350119|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
44346137|NCT01160289|79350120|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
44346138|NCT01160289|79350121|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
44346139|NCT01160289|79350122|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
44346140|NCT01160289|79350123|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
44346141|NCT01160289|79350124|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
44346142|NCT01160289|79350119|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
44346143|NCT01160289|79350120|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
44346144|NCT01160289|79350121|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
44346145|NCT01160289|79350122|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
44346146|NCT01160289|79350123|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
44346147|NCT01160289|79350124|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
44346148|NCT01160289|79350119|FG000|Post-Randomization Period|Sponsor Decision|0|||
44346149|NCT01160289|79350120|FG001|Post-Randomization Period|Sponsor Decision|1|||
44346150|NCT01160289|79350121|FG002|Post-Randomization Period|Sponsor Decision|0|||
44346151|NCT01160289|79350122|FG003|Post-Randomization Period|Sponsor Decision|0|||
44346152|NCT01160289|79350123|FG004|Post-Randomization Period|Sponsor Decision|0|||
44346153|NCT01160289|79350124|FG005|Post-Randomization Period|Sponsor Decision|0|||
44346154|NCT01159665|79350143|FG000|Overall Study|Withdrawal by Subject|0|||
44346155|NCT01159665|79350144|FG001|Overall Study|Withdrawal by Subject|1|||
44346156|NCT01159665|79350145|FG002|Overall Study|Withdrawal by Subject|0|||
44346157|NCT01159665|79350146|FG003|Overall Study|Withdrawal by Subject|0|||
44346158|NCT01159665|79350147|FG004|Overall Study|Withdrawal by Subject|0|||
44346159|NCT01159665|79350148|FG005|Overall Study|Withdrawal by Subject|0|||
44346160|NCT01159431|79350164|FG000|Overall Study|Adverse Event|1|||
44346161|NCT01159431|79350165|FG001|Overall Study|Adverse Event|2|||
44346162|NCT01159431|79350164|FG000|Overall Study|non-compliance|1|||
44346163|NCT01159431|79350165|FG001|Overall Study|non-compliance|1|||
44346164|NCT01159431|79350164|FG000|Overall Study|Lack of Efficacy|0|||
44346165|NCT01159431|79350165|FG001|Overall Study|Lack of Efficacy|3|||
44346166|NCT01158261|79350178|FG000|Overall Study|Lost to Follow-up|9|||
44346167|NCT01158261|79350178|FG000|Overall Study|Death|7|||
44346168|NCT01158261|79350178|FG000|Overall Study|Withdrawal by Subject|1|||
44346169|NCT01157169|79350184|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
44346170|NCT01157169|79350185|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
44346171|NCT01157169|79350184|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
44346172|NCT01157169|79350185|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
44346173|NCT01231620|79350194|FG000|Overall Study|Physician Decision|3|||
44346174|NCT01231620|79350195|FG001|Overall Study|Physician Decision|5|||
44346175|NCT01231620|79350196|FG002|Overall Study|Physician Decision|10|||
44346176|NCT01231620|79350194|FG000|Overall Study|Death|12|||
44346177|NCT01231620|79350195|FG001|Overall Study|Death|14|||
44346178|NCT01231620|79350196|FG002|Overall Study|Death|11|||
44346179|NCT01231620|79350194|FG000|Overall Study|Adverse Event|2|||
44346180|NCT01231620|79350195|FG001|Overall Study|Adverse Event|2|||
44346181|NCT01231620|79350196|FG002|Overall Study|Adverse Event|1|||
44346182|NCT01231620|79350194|FG000|Overall Study|Withdrawal by Subject|6|||
44346183|NCT01231620|79350195|FG001|Overall Study|Withdrawal by Subject|6|||
44346184|NCT01231620|79350196|FG002|Overall Study|Withdrawal by Subject|8|||
44346185|NCT01231620|79350194|FG000|Overall Study|Lost to Follow-up|3|||
44444949|NCT03517449|79452813|FG001|Overall Study|Withdrawal by Subject|26|||
44444950|NCT03517449|79452812|FG000|Overall Study|Participants Ongoing|220|||
44444951|NCT03517449|79452813|FG001|Overall Study|Participants Ongoing|152|||
44444952|NCT03257631|79452831|FG000|Overall Study|Death|8|||
44444953|NCT03257631|79452832|FG001|Overall Study|Death|5|||
44444954|NCT03257631|79452833|FG002|Overall Study|Death|13|||
44444955|NCT03257631|79452834|FG003|Overall Study|Death|5|||
44444956|NCT03257631|79452831|FG000|Overall Study|Progressive Disease|0|||
44444957|NCT03257631|79452832|FG001|Overall Study|Progressive Disease|0|||
44444958|NCT03257631|79452833|FG002|Overall Study|Progressive Disease|1|||
44444959|NCT03257631|79452834|FG003|Overall Study|Progressive Disease|0|||
44444960|NCT03257631|79452831|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
44444961|NCT03257631|79452832|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
44444962|NCT03257631|79452833|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
44444963|NCT03257631|79452834|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
44444964|NCT03257631|79452831|FG000|Overall Study|Lost to Follow-up|0|||
44444965|NCT03257631|79452832|FG001|Overall Study|Lost to Follow-up|0|||
44444966|NCT03257631|79452833|FG002|Overall Study|Lost to Follow-up|1|||
44444967|NCT03257631|79452834|FG003|Overall Study|Lost to Follow-up|0|||
44444968|NCT03257631|79452831|FG000|Overall Study|Still on Study|3|||
44444969|NCT03257631|79452832|FG001|Overall Study|Still on Study|2|||
44444970|NCT03257631|79452833|FG002|Overall Study|Still on Study|4|||
44444971|NCT03257631|79452834|FG003|Overall Study|Still on Study|4|||
44444972|NCT03055767|79452846|FG000|Open-Label Period|Lost to Follow-up|0|||
44444973|NCT03055767|79452847|FG001|Open-Label Period|Lost to Follow-up|0|||
44444974|NCT03055767|79452848|FG002|Open-Label Period|Lost to Follow-up|2|||
44444975|NCT03055767|79452849|FG003|Open-Label Period|Lost to Follow-up|0|||
44444976|NCT03055767|79452846|FG000|Open-Label Period|Withdrawal by Subject|0|||
44444977|NCT03055767|79452847|FG001|Open-Label Period|Withdrawal by Subject|0|||
44444978|NCT03055767|79452848|FG002|Open-Label Period|Withdrawal by Subject|0|||
44444979|NCT03055767|79452849|FG003|Open-Label Period|Withdrawal by Subject|1|||
44444980|NCT02702414|79452866|FG000|Overall Study|Death|77|||
44444981|NCT02702414|79452867|FG001|Overall Study|Death|34|||
44444982|NCT02702414|79452866|FG000|Overall Study|Lost to Follow-up|0|||
44444983|NCT02702414|79452867|FG001|Overall Study|Lost to Follow-up|1|||
44444984|NCT02702414|79452866|FG000|Overall Study|Withdrawal by Subject|0|||
44444985|NCT02702414|79452867|FG001|Overall Study|Withdrawal by Subject|1|||
44444986|NCT02702414|79452866|FG000|Overall Study|Participants Ongoing in Study|27|||
44444987|NCT02702414|79452867|FG001|Overall Study|Participants Ongoing in Study|15|||
44444988|NCT02702414|79452866|FG000|Overall Study|Not Treated|1|||
44444989|NCT02702414|79452867|FG001|Overall Study|Not Treated|0|||
44444990|NCT01064479|79452897|FG000|Overall Study|Death|10|||
44444991|NCT01064479|79452898|FG001|Overall Study|Death|11|||
44444992|NCT01064479|79452897|FG000|Overall Study|Withdrawal by Subject|2|||
44444993|NCT01064479|79452898|FG001|Overall Study|Withdrawal by Subject|2|||
44444994|NCT01064479|79452897|FG000|Overall Study|Disease progression|1|||
44444995|NCT01064479|79452898|FG001|Overall Study|Disease progression|1|||
44346186|NCT01231620|79350195|FG001|Overall Study|Lost to Follow-up|4|||
44346187|NCT01231620|79350196|FG002|Overall Study|Lost to Follow-up|9|||
44346188|NCT01231464|79350206|FG000|Overall Study|Adverse Event|0|||
44346189|NCT01231464|79350207|FG001|Overall Study|Adverse Event|1|||
44346190|NCT01231464|79350206|FG000|Overall Study|Protocol Violation|1|||
44346191|NCT01231464|79350207|FG001|Overall Study|Protocol Violation|2|||
44346192|NCT01231464|79350206|FG000|Overall Study|Lost to Follow-up|1|||
44346193|NCT01231464|79350207|FG001|Overall Study|Lost to Follow-up|2|||
44346194|NCT01231464|79350206|FG000|Overall Study|Withdrawal by Subject|3|||
44444996|NCT01064479|79452897|FG000|Overall Study|Toxicity|1|||
44444997|NCT01064479|79452898|FG001|Overall Study|Toxicity|1|||
44444998|NCT01064479|79452897|FG000|Overall Study|Other|1|||
44444999|NCT01064479|79452898|FG001|Overall Study|Other|2|||
44445000|NCT00556998|79452912|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
44445001|NCT00556998|79452912|FG000|Voriconazole Intravenous (IV)|Other|4|||
44445002|NCT00556998|79452912|FG000|Voriconazole Oral|Adverse Event|1|||
44445003|NCT00556998|79452912|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
44445004|NCT00528801|79452922|FG000|Overall Study|Withdrawal by Subject|1|||
44445005|NCT00528801|79452923|FG001|Overall Study|Withdrawal by Subject|1|||
44445006|NCT00528801|79452922|FG000|Overall Study|Protocol Violation|11|||
44445007|NCT00528801|79452923|FG001|Overall Study|Protocol Violation|5|||
44445008|NCT00528801|79452922|FG000|Overall Study|Lost to Follow-up|15|||
44445009|NCT00528801|79452923|FG001|Overall Study|Lost to Follow-up|4|||
44445010|NCT00528801|79452922|FG000|Overall Study|Administrative Reasons|0|||
44445011|NCT00528801|79452923|FG001|Overall Study|Administrative Reasons|1|||
44445012|NCT00527397|79452929|FG000|Overall Study|Adverse Event|3|||
44445013|NCT00527397|79452929|FG000|Overall Study|Lack of Efficacy|1|||
44445014|NCT00527397|79452929|FG000|Overall Study|Protocol Violation|1|||
44445015|NCT00527397|79452929|FG000|Overall Study|Withdrawal by Subject|6|||
44445016|NCT00527397|79452929|FG000|Overall Study|Study terminated by sponsor|13|||
44445017|NCT00527319|79452939|FG000|Overall Study|Withdrawal by Subject|5|||
44445018|NCT00527319|79452940|FG001|Overall Study|Withdrawal by Subject|0|||
44445019|NCT00527319|79452941|FG002|Overall Study|Withdrawal by Subject|1|||
44445020|NCT00527319|79452939|FG000|Overall Study|Lost to Follow-up|1|||
44445021|NCT00527319|79452940|FG001|Overall Study|Lost to Follow-up|0|||
44445022|NCT00527319|79452941|FG002|Overall Study|Lost to Follow-up|0|||
44445023|NCT00527319|79452939|FG000|Overall Study|Death|0|||
44445024|NCT00527319|79452940|FG001|Overall Study|Death|3|||
44445025|NCT00527319|79452941|FG002|Overall Study|Death|1|||
44445026|NCT00527319|79452939|FG000|Overall Study|Intercurrent Medical Illness|0|||
44445027|NCT00527319|79452940|FG001|Overall Study|Intercurrent Medical Illness|1|||
44346195|NCT01231464|79350207|FG001|Overall Study|Withdrawal by Subject|2|||
44346196|NCT01156311|79350217|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
44346197|NCT01156311|79350218|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
44346198|NCT01156311|79350219|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
44346199|NCT01156311|79350220|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
44346200|NCT01156311|79350217|FG000|2-Month Monotherapy Period|Physician Decision|0|||
44346201|NCT01156311|79350218|FG001|2-Month Monotherapy Period|Physician Decision|1|||
44445028|NCT00527319|79452941|FG002|Overall Study|Intercurrent Medical Illness|3|||
44445029|NCT00527319|79452939|FG000|Overall Study|Adverse Event|0|||
44445030|NCT00527319|79452940|FG001|Overall Study|Adverse Event|0|||
44445031|NCT00527319|79452941|FG002|Overall Study|Adverse Event|1|||
44445032|NCT00562302|79452951|FG000|Overall Study|Lost to Follow-up|3|||
44445033|NCT00562302|79452952|FG001|Overall Study|Lost to Follow-up|3|||
44445034|NCT00562302|79452951|FG000|Overall Study|Adverse Event|0|||
44445035|NCT00562302|79452952|FG001|Overall Study|Adverse Event|6|||
44445036|NCT00562302|79452951|FG000|Overall Study|Non-compliance|1|||
44445037|NCT00562302|79452952|FG001|Overall Study|Non-compliance|2|||
44445038|NCT00562302|79452951|FG000|Overall Study|Withdrawal by Subject|7|||
44445039|NCT00562302|79452952|FG001|Overall Study|Withdrawal by Subject|8|||
44445040|NCT00562302|79452951|FG000|Overall Study|Death|1|||
44445041|NCT00562302|79452952|FG001|Overall Study|Death|2|||
44445042|NCT00562302|79452951|FG000|Overall Study|Lung resection prior to study completion|7|||
44445043|NCT00562302|79452952|FG001|Overall Study|Lung resection prior to study completion|7|||
44445044|NCT00562302|79452951|FG000|Overall Study|Not stated|1|||
44445045|NCT00562302|79452952|FG001|Overall Study|Not stated|4|||
44445046|NCT00134719|79452961|FG000|Primary Vaccination Phase|Adverse Event|4|||
44445047|NCT00134719|79452962|FG001|Primary Vaccination Phase|Adverse Event|0|||
44445048|NCT00134719|79452963|FG002|Primary Vaccination Phase|Adverse Event|0|||
44445049|NCT00134719|79452961|FG000|Primary Vaccination Phase|Protocol Violation|1|||
44445050|NCT00134719|79452962|FG001|Primary Vaccination Phase|Protocol Violation|0|||
44445051|NCT00134719|79452963|FG002|Primary Vaccination Phase|Protocol Violation|0|||
44445052|NCT00134719|79452961|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
44445053|NCT00134719|79452962|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
44445054|NCT00134719|79452963|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
44445055|NCT00134719|79452961|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
44346202|NCT01156311|79350219|FG002|2-Month Monotherapy Period|Physician Decision|0|||
44445056|NCT00134719|79452962|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
44445057|NCT00134719|79452963|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
44445058|NCT00134719|79452961|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
44445059|NCT00134719|79452962|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
44445060|NCT00134719|79452963|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
44346203|NCT01156311|79350220|FG003|2-Month Monotherapy Period|Physician Decision|0|||
44445061|NCT00134719|79452961|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
44445062|NCT00134719|79452962|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
44445063|NCT00134719|79452963|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
44445064|NCT00526071|79452971|FG000|Overall Study|Adverse Event|1|||
44445065|NCT00526071|79452971|FG000|Overall Study|Withdrawal by Subject|1|||
44445066|NCT00526071|79452971|FG000|Overall Study|Lack of Response to Study Drug|4|||
44445067|NCT00525915|79452981|FG000|Overall Study|Non-Compliance|0|||
44445068|NCT00525915|79452982|FG001|Overall Study|Non-Compliance|1|||
44445069|NCT00525915|79452981|FG000|Overall Study|Disease Progression|5|||
44445070|NCT00525915|79452982|FG001|Overall Study|Disease Progression|6|||
44445071|NCT00525915|79452981|FG000|Overall Study|Withdrawal by Subject|1|||
44445072|NCT00525915|79452982|FG001|Overall Study|Withdrawal by Subject|0|||
44445073|NCT00525915|79452981|FG000|Overall Study|Refused Surgery|1|||
44445074|NCT00525915|79452982|FG001|Overall Study|Refused Surgery|2|||
44445075|NCT00525915|79452981|FG000|Overall Study|Unrelated illness|1|||
44445076|NCT00525915|79452982|FG001|Overall Study|Unrelated illness|0|||
44445077|NCT00521079|79452990|FG000|Overall Study|Adverse Event|7|||
44445078|NCT00521079|79452991|FG001|Overall Study|Adverse Event|1|||
44445079|NCT00521079|79452990|FG000|Overall Study|Lost to Follow-up|2|||
44445080|NCT00521079|79452991|FG001|Overall Study|Lost to Follow-up|1|||
44445081|NCT00521079|79452990|FG000|Overall Study|Withdrawal by Subject|5|||
44445082|NCT00521079|79452991|FG001|Overall Study|Withdrawal by Subject|3|||
44445083|NCT00521001|79452997|FG000|Overall Study|Ineligible|1|||
44445084|NCT00134563|79453004|FG000|Overall Study|Not treated due to protocol violation|0|||
44445085|NCT00134563|79453005|FG001|Overall Study|Not treated due to protocol violation|1|||
44445086|NCT00134563|79453006|FG002|Overall Study|Not treated due to protocol violation|1|||
44445087|NCT00134563|79453004|FG000|Overall Study|Adverse Event|29|||
44445088|NCT00134563|79453005|FG001|Overall Study|Adverse Event|37|||
44445089|NCT00134563|79453006|FG002|Overall Study|Adverse Event|38|||
44445090|NCT00134563|79453004|FG000|Overall Study|Lack of Efficacy|24|||
44445091|NCT00134563|79453005|FG001|Overall Study|Lack of Efficacy|14|||
44445092|NCT00134563|79453006|FG002|Overall Study|Lack of Efficacy|17|||
44445093|NCT00134563|79453004|FG000|Overall Study|Protocol Violation|3|||
44445094|NCT00134563|79453005|FG001|Overall Study|Protocol Violation|2|||
44445095|NCT00134563|79453006|FG002|Overall Study|Protocol Violation|5|||
44445096|NCT00134563|79453004|FG000|Overall Study|Lost to Follow-up|4|||
44445097|NCT00134563|79453005|FG001|Overall Study|Lost to Follow-up|0|||
44445098|NCT00134563|79453006|FG002|Overall Study|Lost to Follow-up|2|||
44445099|NCT00134563|79453004|FG000|Overall Study|progressive disease|11|||
44445100|NCT00134563|79453005|FG001|Overall Study|progressive disease|4|||
44445101|NCT00134563|79453006|FG002|Overall Study|progressive disease|2|||
44445102|NCT00134563|79453004|FG000|Overall Study|did not wish to continue|33|||
44445103|NCT00134563|79453005|FG001|Overall Study|did not wish to continue|32|||
44445104|NCT00134563|79453006|FG002|Overall Study|did not wish to continue|26|||
44445105|NCT00134563|79453004|FG000|Overall Study|Reason other than above|0|||
44445106|NCT00134563|79453005|FG001|Overall Study|Reason other than above|2|||
44445107|NCT00134563|79453006|FG002|Overall Study|Reason other than above|5|||
44445108|NCT00520845|79453014|FG000|Overall Study|Death|3|||
44445109|NCT00520845|79453014|FG000|Overall Study|Adverse Event|4|||
44445110|NCT00520845|79453014|FG000|Overall Study|Disease Progression, relapse|13|||
44445111|NCT00520845|79453014|FG000|Overall Study|Withdrawal by Subject|1|||
44445112|NCT00520845|79453014|FG000|Overall Study|Alternative Therapy|1|||
44445113|NCT00185731|79453018|FG000|Overall Study|Withdrawal by Subject|1|||
44445114|NCT00185731|79453018|FG000|Overall Study|Not Eligible|1|||
44445115|NCT00582491|79453026|FG000|Overall Study|Withdrawal by Subject|1|||
44445116|NCT00582491|79453027|FG001|Overall Study|Withdrawal by Subject|0|||
44445117|NCT00520767|79453033|FG000|Overall Study|Death|2|||
44445118|NCT04679051|79453039|FG000|Overall Study|felt tired after restricted time in bed|3|||
44445119|NCT04679051|79453040|FG001|Overall Study|felt tired after restricted time in bed|0|||
44445120|NCT04679051|79453039|FG000|Overall Study|discomfort with blood pressure cuff|2|||
44445121|NCT04679051|79453040|FG001|Overall Study|discomfort with blood pressure cuff|0|||
44445122|NCT04679051|79453039|FG000|Overall Study|scheduling conflict|1|||
44445123|NCT04679051|79453040|FG001|Overall Study|scheduling conflict|1|||
44445124|NCT04679051|79453039|FG000|Overall Study|Protocol Violation|0|||
44445125|NCT04679051|79453040|FG001|Overall Study|Protocol Violation|4|||
44445126|NCT03873987|79453051|FG000|Overall Study|Adverse Event|1|||
44445127|NCT03873987|79453052|FG001|Overall Study|Adverse Event|0|||
44445128|NCT03873987|79453051|FG000|Overall Study|staff was unable to start a new IV line|1|||
44445129|NCT03873987|79453052|FG001|Overall Study|staff was unable to start a new IV line|0|||
44445130|NCT03873987|79453051|FG000|Overall Study|Lost to Follow-up|0|||
44445131|NCT03873987|79453052|FG001|Overall Study|Lost to Follow-up|1|||
44445132|NCT00474760|79453070|FG000|Overall Study|Death|0|||
44163470|NCT04640311|78956514|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163471|NCT04640311|78956515|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44346204|NCT01156311|79350217|FG000|2-Month Monotherapy Period|Other|1|||
44445133|NCT00474760|79453071|FG001|Overall Study|Death|0|||
44445134|NCT00474760|79453072|FG002|Overall Study|Death|0|||
44445135|NCT00474760|79453073|FG003|Overall Study|Death|0|||
44445136|NCT00474760|79453074|FG004|Overall Study|Death|2|||
44260185|NCT00242567|79126833|FG000|Overall Study|Symptomatic deterioration|9|||
44260186|NCT00242567|79126834|FG001|Overall Study|Symptomatic deterioration|3|||
44260187|NCT00242567|79126833|FG000|Overall Study|Lack of Efficacy|2|||
44260188|NCT00242567|79126834|FG001|Overall Study|Lack of Efficacy|2|||
44260189|NCT00242567|79126833|FG000|Overall Study|Lost to Follow-up|9|||
44260190|NCT00242567|79126834|FG001|Overall Study|Lost to Follow-up|19|||
44260191|NCT00242567|79126833|FG000|Overall Study|Withdrawal by Subject|33|||
44260192|NCT00242567|79126834|FG001|Overall Study|Withdrawal by Subject|28|||
44260193|NCT00242567|79126833|FG000|Overall Study|Protocol Violation|12|||
44260194|NCT00242567|79126834|FG001|Overall Study|Protocol Violation|12|||
44260195|NCT00242567|79126833|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
44445137|NCT00474760|79453075|FG005|Overall Study|Death|0|||
44445138|NCT00474760|79453076|FG006|Overall Study|Death|0|||
44445139|NCT00474760|79453070|FG000|Overall Study|Adverse Event|0|||
44445140|NCT00474760|79453071|FG001|Overall Study|Adverse Event|0|||
44445141|NCT00474760|79453072|FG002|Overall Study|Adverse Event|0|||
44445142|NCT00474760|79453073|FG003|Overall Study|Adverse Event|0|||
44445143|NCT00474760|79453074|FG004|Overall Study|Adverse Event|1|||
44445144|NCT00474760|79453075|FG005|Overall Study|Adverse Event|7|||
44445145|NCT00474760|79453076|FG006|Overall Study|Adverse Event|0|||
44445146|NCT00474760|79453070|FG000|Overall Study|Laboratory abnormality|0|||
44445147|NCT00474760|79453071|FG001|Overall Study|Laboratory abnormality|0|||
44445148|NCT00474760|79453072|FG002|Overall Study|Laboratory abnormality|0|||
44445149|NCT00474760|79453073|FG003|Overall Study|Laboratory abnormality|0|||
44445150|NCT00474760|79453074|FG004|Overall Study|Laboratory abnormality|0|||
44445151|NCT00474760|79453075|FG005|Overall Study|Laboratory abnormality|1|||
44445152|NCT00474760|79453076|FG006|Overall Study|Laboratory abnormality|0|||
44445153|NCT00474760|79453070|FG000|Overall Study|Withdrawal by Subject|0|||
44445154|NCT00474760|79453071|FG001|Overall Study|Withdrawal by Subject|0|||
44445155|NCT00474760|79453072|FG002|Overall Study|Withdrawal by Subject|0|||
44445156|NCT00474760|79453073|FG003|Overall Study|Withdrawal by Subject|1|||
44445157|NCT00474760|79453074|FG004|Overall Study|Withdrawal by Subject|0|||
44445158|NCT00474760|79453075|FG005|Overall Study|Withdrawal by Subject|1|||
44445159|NCT00474760|79453076|FG006|Overall Study|Withdrawal by Subject|1|||
44445160|NCT00474760|79453070|FG000|Overall Study|Other|0|||
44445161|NCT00474760|79453071|FG001|Overall Study|Other|1|||
44445162|NCT00474760|79453072|FG002|Overall Study|Other|0|||
44445163|NCT00474760|79453073|FG003|Overall Study|Other|0|||
44445164|NCT00474760|79453074|FG004|Overall Study|Other|1|||
44445165|NCT00474760|79453075|FG005|Overall Study|Other|0|||
44445166|NCT00474760|79453076|FG006|Overall Study|Other|0|||
44445167|NCT00474760|79453070|FG000|Overall Study|Progressive disease|3|||
44445168|NCT00474760|79453071|FG001|Overall Study|Progressive disease|2|||
44445169|NCT00474760|79453072|FG002|Overall Study|Progressive disease|3|||
44445170|NCT00474760|79453073|FG003|Overall Study|Progressive disease|2|||
44445171|NCT00474760|79453074|FG004|Overall Study|Progressive disease|8|||
44445172|NCT00474760|79453075|FG005|Overall Study|Progressive disease|20|||
44445173|NCT00474760|79453076|FG006|Overall Study|Progressive disease|7|||
44445174|NCT00474760|79453070|FG000|Overall Study|Terminated by sponsor|0|||
44445175|NCT00474760|79453071|FG001|Overall Study|Terminated by sponsor|0|||
44445176|NCT00474760|79453072|FG002|Overall Study|Terminated by sponsor|0|||
44445177|NCT00474760|79453073|FG003|Overall Study|Terminated by sponsor|0|||
44445178|NCT00474760|79453074|FG004|Overall Study|Terminated by sponsor|0|||
44445179|NCT00474760|79453075|FG005|Overall Study|Terminated by sponsor|0|||
44445180|NCT00474760|79453076|FG006|Overall Study|Terminated by sponsor|2|||
44445181|NCT00528645|79453099|FG000|Overall Study|Adverse Event|3|||
44445182|NCT00524745|79453108|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
44445183|NCT00524745|79453109|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
44445184|NCT00524745|79453110|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
44445185|NCT00524745|79453111|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
44445186|NCT00495040|79453121|FG000|Overall Study|Withdrawal by Subject|3|||
44445187|NCT00494026|79453129|FG000|Overall Study|Sponsor Decision|4|||
44445188|NCT00524589|79453133|FG000|Overall Study|Withdrawal by Subject|2|||
44445189|NCT00524589|79453133|FG000|Overall Study|Disease Progression|16|||
44445190|NCT00472030|79453139|FG000|Overall Study|Physician Decision|1|||
44445191|NCT00472030|79453140|FG001|Overall Study|Physician Decision|0|||
44445192|NCT00127855|79453155|FG000|Primary Vaccination Course|Adverse Event|0|||
44445193|NCT00127855|79453156|FG001|Primary Vaccination Course|Adverse Event|0|||
44445194|NCT00127855|79453157|FG002|Primary Vaccination Course|Adverse Event|1|||
44445195|NCT00127855|79453158|FG003|Primary Vaccination Course|Adverse Event|0|||
44445196|NCT00127855|79453159|FG004|Primary Vaccination Course|Adverse Event|0|||
44445197|NCT00127855|79453155|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
44445198|NCT00127855|79453156|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
44260196|NCT00242567|79126834|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
44445199|NCT00127855|79453157|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
44445200|NCT00127855|79453158|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
44445201|NCT00127855|79453159|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
44445202|NCT00127855|79453155|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
44445203|NCT00127855|79453156|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
44445204|NCT00127855|79453157|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
44445205|NCT00127855|79453158|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
44445206|NCT00127855|79453159|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
44445207|NCT00127855|79453155|FG000|Primary Vaccination Course|Other|0|||
44445208|NCT00127855|79453156|FG001|Primary Vaccination Course|Other|0|||
44445209|NCT00127855|79453157|FG002|Primary Vaccination Course|Other|0|||
44445210|NCT00127855|79453158|FG003|Primary Vaccination Course|Other|0|||
44445211|NCT00127855|79453159|FG004|Primary Vaccination Course|Other|1|||
44445212|NCT00493636|79453173|FG000|Overall Study|Withdrawal by Subject|1|||
44445213|NCT00493636|79453174|FG001|Overall Study|Withdrawal by Subject|0|||
44445214|NCT00493636|79453173|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
44445215|NCT00493636|79453174|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
44445216|NCT00493636|79453173|FG000|Overall Study|Mis-randomization|1|||
44445217|NCT00493636|79453174|FG001|Overall Study|Mis-randomization|1|||
44445218|NCT00524121|79453180|FG000|Overall Study|Disease progression|6|||
44445219|NCT00524121|79453180|FG000|Overall Study|Adverse Event|4|||
44445220|NCT00524121|79453180|FG000|Overall Study|Patient refused|2|||
44445221|NCT00524121|79453180|FG000|Overall Study|Other|1|||
44445222|NCT00524121|79453180|FG000|Overall Study|Death|1|||
44445223|NCT00524121|79453180|FG000|Overall Study|Not treated (became ineligible)|4|||
44445224|NCT00524121|79453180|FG000|Overall Study|Not treated (changed mind)|1|||
44445225|NCT00470626|79453195|FG000|Overall Study|Lost to Follow-up|10|||
44445226|NCT00470626|79453195|FG000|Overall Study|Withdrawal by Subject|7|||
44445227|NCT00132769|79453201|FG000|Overall Study|Withdrawal by Subject|1|||
44445228|NCT00132769|79453202|FG001|Overall Study|Withdrawal by Subject|3|||
44445229|NCT00132769|79453201|FG000|Overall Study|Lack of Efficacy|7|||
44445230|NCT00132769|79453202|FG001|Overall Study|Lack of Efficacy|6|||
44445231|NCT00132769|79453201|FG000|Overall Study|Adverse Event|2|||
44445232|NCT00132769|79453202|FG001|Overall Study|Adverse Event|1|||
44445233|NCT00132769|79453201|FG000|Overall Study|Protocol Violation|1|||
44445234|NCT00132769|79453202|FG001|Overall Study|Protocol Violation|1|||
44445235|NCT00520299|79453211|FG000|Overall Study|Withdrawal by Subject|0|||
44445236|NCT00520299|79453212|FG001|Overall Study|Withdrawal by Subject|0|||
44445237|NCT00520299|79453213|FG002|Overall Study|Withdrawal by Subject|2|||
44445238|NCT00520299|79453211|FG000|Overall Study|Progressive disease|0|||
44445239|NCT00520299|79453212|FG001|Overall Study|Progressive disease|3|||
44445240|NCT00520299|79453213|FG002|Overall Study|Progressive disease|4|||
44445241|NCT02478255|79453223|FG000|Overall Study|Physician Decision|6|||
44445242|NCT02478255|79453224|FG001|Overall Study|Physician Decision|0|||
44445243|NCT02478255|79453223|FG000|Overall Study|Withdrawal by Subject|2|||
44445244|NCT02478255|79453224|FG001|Overall Study|Withdrawal by Subject|0|||
44445245|NCT00132691|79453232|FG000|Overall Study|Lost to Follow-up|5|||
44445246|NCT00132691|79453233|FG001|Overall Study|Lost to Follow-up|8|||
44445247|NCT00132691|79453232|FG000|Overall Study|Missed 2-year visit|4|||
44445248|NCT00132691|79453233|FG001|Overall Study|Missed 2-year visit|4|||
44445249|NCT00132691|79453232|FG000|Overall Study|Death|2|||
44445250|NCT00132691|79453233|FG001|Overall Study|Death|0|||
44445251|NCT00125359|79453244|FG000|Overall Study|Death|4|||
44445252|NCT00125359|79453244|FG000|Overall Study|Adverse Event|5|||
44445253|NCT00125359|79453244|FG000|Overall Study|Physician Decision|14|||
44445254|NCT00524043|79453251|FG000|Overall Study|Lack of Efficacy|15|||
44445255|NCT00524043|79453252|FG001|Overall Study|Lack of Efficacy|13|||
44163472|NCT04640311|78956516|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44346205|NCT01156311|79350218|FG001|2-Month Monotherapy Period|Other|0|||
44346206|NCT01156311|79350219|FG002|2-Month Monotherapy Period|Other|0|||
44346207|NCT01156311|79350220|FG003|2-Month Monotherapy Period|Other|0|||
44346208|NCT01156311|79350217|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
44346209|NCT01156311|79350218|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
44346210|NCT01156311|79350219|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
44346211|NCT01156311|79350220|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
44346212|NCT01156311|79350217|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
44346213|NCT01156311|79350218|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
44346214|NCT01156311|79350219|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
44346215|NCT01156311|79350220|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
44346216|NCT01156311|79350217|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
44346217|NCT01156311|79350218|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
44346218|NCT01156311|79350219|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
44445256|NCT00524043|79453253|FG002|Overall Study|Lack of Efficacy|14|||
44445257|NCT00524043|79453251|FG000|Overall Study|Withdrawal by Subject|5|||
44445258|NCT00524043|79453252|FG001|Overall Study|Withdrawal by Subject|7|||
44445259|NCT00524043|79453253|FG002|Overall Study|Withdrawal by Subject|7|||
44445260|NCT00524043|79453251|FG000|Overall Study|Adverse Event|5|||
44445261|NCT00524043|79453252|FG001|Overall Study|Adverse Event|2|||
44445262|NCT00524043|79453253|FG002|Overall Study|Adverse Event|7|||
44260197|NCT00242567|79126833|FG000|Overall Study|Other|14|||
44260198|NCT00242567|79126834|FG001|Overall Study|Other|9|||
44260199|NCT00241631|79126844|FG000|Run in (2 Weeks)|Physician Decision|3|||
44260200|NCT00241631|79126845|FG001|Run in (2 Weeks)|Physician Decision|3|||
44260201|NCT00241631|79126844|FG000|Phase 1 (4 Weeks)|sore throat|1|||
44260202|NCT00241631|79126845|FG001|Phase 1 (4 Weeks)|sore throat|0|||
44260203|NCT00241631|79126844|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
44260204|NCT00241631|79126845|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
44260205|NCT00241631|79126844|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
44260206|NCT00241631|79126845|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
44260207|NCT00241631|79126844|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
44346219|NCT01156311|79350220|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
44445263|NCT00524043|79453251|FG000|Overall Study|Lost to Follow-up|3|||
44445264|NCT00524043|79453252|FG001|Overall Study|Lost to Follow-up|5|||
44445265|NCT00524043|79453253|FG002|Overall Study|Lost to Follow-up|3|||
44445266|NCT00524043|79453251|FG000|Overall Study|Various (eg, incarceration)|2|||
44445267|NCT00524043|79453252|FG001|Overall Study|Various (eg, incarceration)|1|||
44445268|NCT00524043|79453253|FG002|Overall Study|Various (eg, incarceration)|0|||
44445269|NCT00523419|79453261|FG000|Overall Study|Adverse Event|1|||
44445270|NCT00523419|79453261|FG000|Overall Study|Withdrawal by Subject|1|||
44445271|NCT00523419|79453261|FG000|Overall Study|Physician Decision|2|||
44445272|NCT00523419|79453261|FG000|Overall Study|Progressive Disease|22|||
44445273|NCT00523419|79453261|FG000|Overall Study|Death due to Study Disease|4|||
44445274|NCT00523419|79453261|FG000|Overall Study|Death due to Adverse Event|2|||
44445275|NCT03868059|79453265|FG000|Overall Study|Adverse Event|3|||
44445276|NCT03868059|79453265|FG000|Overall Study|Lost to Follow-up|3|||
44445277|NCT03868059|79453265|FG000|Overall Study|Withdrawal by Subject|6|||
44445278|NCT00522951|79453269|FG000|Period 1|body motion|0|||
44445279|NCT00522951|79453270|FG001|Period 1|body motion|1|||
44346220|NCT01156311|79350217|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
44346221|NCT01156311|79350218|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
44346222|NCT01156311|79350219|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
44346223|NCT01156311|79350220|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
44346224|NCT01156311|79350217|FG000|6-month Add-on Therapy Period|Other|0|||
44346225|NCT01156311|79350218|FG001|6-month Add-on Therapy Period|Other|0|||
44346226|NCT01156311|79350219|FG002|6-month Add-on Therapy Period|Other|1|||
44346227|NCT01156311|79350220|FG003|6-month Add-on Therapy Period|Other|2|||
44346228|NCT01230060|79350231|FG000|Overall Study|Withdrawal by Subject|1|||
44346229|NCT01155531|79350239|FG000|Overall Study|Adverse Event|0|||
44346230|NCT01155531|79350240|FG001|Overall Study|Adverse Event|0|||
44346231|NCT01155531|79350241|FG002|Overall Study|Adverse Event|1|||
44346232|NCT01155531|79350242|FG003|Overall Study|Adverse Event|0|||
44346233|NCT01155531|79350239|FG000|Overall Study|Lost to Follow-up|0|||
44346234|NCT01155531|79350240|FG001|Overall Study|Lost to Follow-up|0|||
44346235|NCT01155531|79350241|FG002|Overall Study|Lost to Follow-up|0|||
44346236|NCT01155531|79350242|FG003|Overall Study|Lost to Follow-up|1|||
44346237|NCT01155531|79350239|FG000|Overall Study|Withdrawal by Subject|1|||
44346238|NCT01155531|79350240|FG001|Overall Study|Withdrawal by Subject|0|||
44346239|NCT01155531|79350241|FG002|Overall Study|Withdrawal by Subject|1|||
44346240|NCT01155531|79350242|FG003|Overall Study|Withdrawal by Subject|0|||
44346241|NCT01155219|79350254|FG000|Overall Study|Adverse Event|3|||
44346242|NCT01155219|79350255|FG001|Overall Study|Adverse Event|1|||
44346243|NCT01155219|79350254|FG000|Overall Study|non-medical reason|1|||
44346244|NCT01155219|79350255|FG001|Overall Study|non-medical reason|2|||
44346245|NCT01229436|79350261|FG000|Overall Study|Withdrawal by Subject|2|||
44346246|NCT01229436|79350261|FG000|Overall Study|Lost to Follow-up|3|||
44346247|NCT01155141|79350265|FG000|Overall Study|Withdrawal by Subject|1|||
44346248|NCT01155141|79350265|FG000|Overall Study|Screen Failure|1|||
44346249|NCT01155063|79350269|FG000|Overall Study|Adverse Event|1|||
44346250|NCT01155063|79350269|FG000|Overall Study|Withdrawal by Subject|1|||
44346251|NCT01155063|79350269|FG000|Overall Study|Study terminated by sponsor|87|||
44346252|NCT01154673|79350275|FG000|Overall Study|Lost to Follow-up|1|||
44346253|NCT01154673|79350276|FG001|Overall Study|Lost to Follow-up|0|||
44445280|NCT00522951|79453269|FG000|Washout Period|Adverse Event|0|||
44163473|NCT04640311|78956517|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44260208|NCT00241631|79126845|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
44346254|NCT01154673|79350275|FG000|Overall Study|moved out of province|1|||
44346255|NCT01154673|79350276|FG001|Overall Study|moved out of province|0|||
44346256|NCT01154283|79350284|FG000|0-6 Weeks|Withdrawal by Subject|7|||
44346257|NCT01154283|79350285|FG001|0-6 Weeks|Withdrawal by Subject|2|||
44346258|NCT01154283|79350284|FG000|0-6 Weeks|Death|0|||
44346259|NCT01154283|79350285|FG001|0-6 Weeks|Death|1|||
44346260|NCT01154283|79350284|FG000|7-12 Weeks|Death|1|||
44346261|NCT01154283|79350285|FG001|7-12 Weeks|Death|0|||
44346262|NCT01154283|79350284|FG000|7-12 Weeks|Withdrawal by Subject|0|||
44445281|NCT00522951|79453270|FG001|Washout Period|Adverse Event|1|||
44445282|NCT00522951|79453269|FG000|Washout Period|Death|0|||
44445283|NCT00522951|79453270|FG001|Washout Period|Death|1|||
44445284|NCT00522951|79453269|FG000|Period 2|Withdrawal by Subject|1|||
44445285|NCT00522951|79453270|FG001|Period 2|Withdrawal by Subject|0|||
44445286|NCT00522951|79453269|FG000|Period 2|residual contrast medium|1|||
44445287|NCT00522951|79453270|FG001|Period 2|residual contrast medium|1|||
44445288|NCT03865953|79453282|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
44445289|NCT03865953|79453283|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
44445290|NCT03865953|79453282|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
44445291|NCT03865953|79453283|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
44445292|NCT03865953|79453282|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
44445293|NCT03865953|79453283|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
44445294|NCT05439941|79453292|FG000|Overall Study|Lack of Efficacy|8|||
44445295|NCT05439941|79453293|FG001|Overall Study|Lack of Efficacy|5|||
44445296|NCT05439941|79453294|FG002|Overall Study|Lack of Efficacy|3|||
44445297|NCT05439941|79453292|FG000|Overall Study|Treatment Failure|0|||
44445298|NCT05439941|79453293|FG001|Overall Study|Treatment Failure|1|||
44445299|NCT05439941|79453294|FG002|Overall Study|Treatment Failure|0|||
44445300|NCT05439941|79453292|FG000|Overall Study|Adverse Event|1|||
44445301|NCT05439941|79453293|FG001|Overall Study|Adverse Event|3|||
44445302|NCT05439941|79453294|FG002|Overall Study|Adverse Event|0|||
44445303|NCT05439941|79453292|FG000|Overall Study|Adverse Event - Parent Study|1|||
44445304|NCT05439941|79453293|FG001|Overall Study|Adverse Event - Parent Study|0|||
44445305|NCT05439941|79453294|FG002|Overall Study|Adverse Event - Parent Study|0|||
44445306|NCT05439941|79453292|FG000|Overall Study|Pregnancy|1|||
44445307|NCT05439941|79453293|FG001|Overall Study|Pregnancy|0|||
44445308|NCT05439941|79453294|FG002|Overall Study|Pregnancy|0|||
44445309|NCT05439941|79453292|FG000|Overall Study|Withdrawal by Subject|9|||
44445310|NCT05439941|79453293|FG001|Overall Study|Withdrawal by Subject|6|||
44445311|NCT05439941|79453294|FG002|Overall Study|Withdrawal by Subject|10|||
44445312|NCT05439941|79453292|FG000|Overall Study|Non-Compliance|1|||
44445313|NCT05439941|79453293|FG001|Overall Study|Non-Compliance|1|||
44445314|NCT05439941|79453294|FG002|Overall Study|Non-Compliance|1|||
44445315|NCT05439941|79453292|FG000|Overall Study|Lost to Follow-up|2|||
44445316|NCT05439941|79453293|FG001|Overall Study|Lost to Follow-up|2|||
44445317|NCT05439941|79453294|FG002|Overall Study|Lost to Follow-up|0|||
44445318|NCT05439941|79453292|FG000|Overall Study|Physician Decision|1|||
44445319|NCT05439941|79453293|FG001|Overall Study|Physician Decision|0|||
44445320|NCT05439941|79453294|FG002|Overall Study|Physician Decision|0|||
44445321|NCT05439941|79453292|FG000|Overall Study|Trial Termination by Sponsor|78|||
44445322|NCT05439941|79453293|FG001|Overall Study|Trial Termination by Sponsor|83|||
44445323|NCT05439941|79453294|FG002|Overall Study|Trial Termination by Sponsor|65|||
44445324|NCT05439941|79453292|FG000|Overall Study|Other than Reasons Listed|2|||
44445325|NCT05439941|79453293|FG001|Overall Study|Other than Reasons Listed|1|||
44445326|NCT05439941|79453294|FG002|Overall Study|Other than Reasons Listed|0|||
44445327|NCT05091918|79453302|FG000|Overall Study|Adverse Event|1|||
44445328|NCT05091918|79453302|FG000|Overall Study|Withdrawal by Subject|81|||
44445329|NCT04912895|79453309|FG000|Overall Study|Unable to provide specimen|2|||
44445330|NCT04912895|79453310|FG001|Overall Study|Unable to provide specimen|0|||
44445331|NCT04912895|79453311|FG002|Overall Study|Unable to provide specimen|0|||
44445332|NCT04776720|79453319|FG000|Overall Study|COVID Related|4|||
44445333|NCT04776720|79453320|FG001|Overall Study|COVID Related|2|||
44445334|NCT04776720|79453319|FG000|Overall Study|Adverse Event|2|||
44445335|NCT04776720|79453320|FG001|Overall Study|Adverse Event|0|||
44445336|NCT04776720|79453319|FG000|Overall Study|Serious Adverse Event|0|||
44445337|NCT04776720|79453320|FG001|Overall Study|Serious Adverse Event|1|||
44445338|NCT04776720|79453319|FG000|Overall Study|Too Busy|3|||
44445339|NCT04776720|79453320|FG001|Overall Study|Too Busy|1|||
44445340|NCT04776720|79453319|FG000|Overall Study|Lost to Follow-up|1|||
44445341|NCT04776720|79453320|FG001|Overall Study|Lost to Follow-up|2|||
44445342|NCT04776720|79453319|FG000|Overall Study|Family|2|||
44445343|NCT04776720|79453320|FG001|Overall Study|Family|2|||
44445344|NCT04776720|79453319|FG000|Overall Study|No remote technology access|0|||
44445345|NCT04776720|79453320|FG001|Overall Study|No remote technology access|1|||
44445346|NCT04776720|79453319|FG000|Overall Study|Withdrawal by Subject|1|||
44445347|NCT04776720|79453320|FG001|Overall Study|Withdrawal by Subject|0|||
44445348|NCT04776720|79453319|FG000|Overall Study|Cannot tolerate intervention|1|||
44445349|NCT04776720|79453320|FG001|Overall Study|Cannot tolerate intervention|0|||
44445350|NCT04776720|79453319|FG000|Overall Study|Incomplete outcome data|6|||
44445351|NCT04776720|79453320|FG001|Overall Study|Incomplete outcome data|1|||
44445352|NCT04675151|79453339|FG000|Overall Study|Protocol Violation|1|||
44445353|NCT04675151|79453340|FG001|Overall Study|Protocol Violation|0|||
44445354|NCT04675151|79453341|FG002|Overall Study|Protocol Violation|0|||
44445355|NCT04675151|79453342|FG003|Overall Study|Protocol Violation|1|||
44445356|NCT04599907|79453355|FG000|Overall Study|Withdrawal by Subject|1|||
44445357|NCT04599907|79453356|FG001|Overall Study|Withdrawal by Subject|7|||
44445358|NCT04599907|79453357|FG002|Overall Study|Withdrawal by Subject|6|||
44445359|NCT04599907|79453355|FG000|Overall Study|Lost to Follow-up|0|||
44445360|NCT04599907|79453356|FG001|Overall Study|Lost to Follow-up|1|||
44445361|NCT04599907|79453357|FG002|Overall Study|Lost to Follow-up|0|||
44445362|NCT04503096|79453380|FG000|Overall Study|Withdrawal by Subject|3|||
44445363|NCT04270760|79453389|FG000|Overall Study|Withdrawal by Subject|0|||
44445364|NCT04270760|79453390|FG001|Overall Study|Withdrawal by Subject|1|||
44445365|NCT04270760|79453391|FG002|Overall Study|Withdrawal by Subject|3|||
44445366|NCT04270760|79453392|FG003|Overall Study|Withdrawal by Subject|0|||
44445367|NCT04270760|79453393|FG004|Overall Study|Withdrawal by Subject|0|||
44346263|NCT01154283|79350285|FG001|7-12 Weeks|Withdrawal by Subject|1|||
44346264|NCT00944125|79350291|FG000|3 to 6 Months|Withdrawal by Subject|0|||
44346265|NCT00944125|79350292|FG001|3 to 6 Months|Withdrawal by Subject|2|||
44346266|NCT00944125|79350291|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
44346267|NCT00944125|79350292|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
44346268|NCT00912223|79350298|FG000|Overall Study|Withdrawal by Subject|1|||
44346269|NCT00912223|79350298|FG000|Overall Study|Not transplanted|1|||
44346270|NCT00912223|79350298|FG000|Overall Study|Transformed disease|1|||
44346271|NCT01154127|79350304|FG000|Period 1 (21 Days)|Adverse Event|3|||
44346272|NCT01154127|79350305|FG001|Period 1 (21 Days)|Adverse Event|4|||
44346273|NCT01154127|79350304|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
44346274|NCT01154127|79350305|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
44346275|NCT01154127|79350304|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
44346276|NCT01154127|79350305|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
44346277|NCT01154127|79350304|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
44346278|NCT01154127|79350305|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
44346279|NCT01154127|79350304|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
44346280|NCT01154127|79350305|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
44346281|NCT01228734|79350313|FG000|Overall Study|Randomized, but not treated|0|||
44346282|NCT01228734|79350314|FG001|Overall Study|Randomized, but not treated|4|||
44346283|NCT01227954|79350320|FG000|Overall Study|Protocol Violation|6|||
44346284|NCT01227954|79350320|FG000|Overall Study|No protocol treatment|7|||
44346285|NCT01153971|79350324|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
44346286|NCT01153971|79350324|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
44346287|NCT01153971|79350324|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
44346288|NCT01153971|79350324|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
44346289|NCT01153971|79350324|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
44346290|NCT01153971|79350324|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
44346291|NCT01153971|79350324|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
44346292|NCT01153893|79350330|FG000|Overall Study|Adverse Event|1|||
44346293|NCT01153893|79350331|FG001|Overall Study|Adverse Event|0|||
44346294|NCT00951379|79350339|FG000|Overall Study|Adverse Event|4|||
44346295|NCT00951379|79350340|FG001|Overall Study|Adverse Event|1|||
44346296|NCT00951379|79350339|FG000|Overall Study|Withdrawal by Subject|1|||
44346297|NCT00951379|79350340|FG001|Overall Study|Withdrawal by Subject|0|||
44346298|NCT00951379|79350339|FG000|Overall Study|Noncompliance|1|||
44346299|NCT00951379|79350340|FG001|Overall Study|Noncompliance|0|||
44346300|NCT00951379|79350339|FG000|Overall Study|Disease Progression|0|||
44346301|NCT00951379|79350340|FG001|Overall Study|Disease Progression|1|||
44346302|NCT01153815|79350356|FG000|Overall Study|Adverse Event|3|||
44346303|NCT01153815|79350357|FG001|Overall Study|Adverse Event|1|||
44346304|NCT01153815|79350356|FG000|Overall Study|Withdrawal by Subject|6|||
44346305|NCT01153815|79350357|FG001|Overall Study|Withdrawal by Subject|4|||
44346306|NCT01153425|79350365|FG000|Overall Study|Withdrawal by Subject|3|||
44346307|NCT01153425|79350366|FG001|Overall Study|Withdrawal by Subject|3|||
44346308|NCT01153347|79350377|FG000|Overall Study|Withdrawal by Subject|7|||
44346309|NCT01153347|79350378|FG001|Overall Study|Withdrawal by Subject|7|||
44346310|NCT01153347|79350379|FG002|Overall Study|Withdrawal by Subject|7|||
44346311|NCT01153347|79350380|FG003|Overall Study|Withdrawal by Subject|7|||
44346312|NCT01153347|79350377|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
44346313|NCT01153347|79350378|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
44346314|NCT01153347|79350379|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
44346315|NCT01153347|79350380|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
44346316|NCT01153347|79350377|FG000|Overall Study|Adverse Event|3|||
44346317|NCT01153347|79350378|FG001|Overall Study|Adverse Event|9|||
44346318|NCT01153347|79350379|FG002|Overall Study|Adverse Event|21|||
44346319|NCT01153347|79350380|FG003|Overall Study|Adverse Event|7|||
44445368|NCT04270760|79453389|FG000|Overall Study|Lost to Follow-up|1|||
44445369|NCT04270760|79453390|FG001|Overall Study|Lost to Follow-up|2|||
44346320|NCT01153347|79350377|FG000|Overall Study|Severe non-compliance to protocol|6|||
44346321|NCT01153347|79350378|FG001|Overall Study|Severe non-compliance to protocol|7|||
44346322|NCT01153347|79350379|FG002|Overall Study|Severe non-compliance to protocol|4|||
44346323|NCT01153347|79350380|FG003|Overall Study|Severe non-compliance to protocol|3|||
44346324|NCT01153347|79350377|FG000|Overall Study|Condition under investigation worsened|1|||
44346325|NCT01153347|79350378|FG001|Overall Study|Condition under investigation worsened|1|||
44445370|NCT04270760|79453391|FG002|Overall Study|Lost to Follow-up|1|||
44445371|NCT04270760|79453392|FG003|Overall Study|Lost to Follow-up|0|||
44445372|NCT04270760|79453393|FG004|Overall Study|Lost to Follow-up|0|||
44346326|NCT01153347|79350379|FG002|Overall Study|Condition under investigation worsened|0|||
44346327|NCT01153347|79350380|FG003|Overall Study|Condition under investigation worsened|0|||
44346328|NCT01153347|79350377|FG000|Overall Study|Lack of Efficacy|2|||
44346329|NCT01153347|79350378|FG001|Overall Study|Lack of Efficacy|2|||
44346330|NCT01153347|79350379|FG002|Overall Study|Lack of Efficacy|0|||
44346331|NCT01153347|79350380|FG003|Overall Study|Lack of Efficacy|4|||
44346332|NCT01153347|79350377|FG000|Overall Study|Study-specific withdrawal criteria|4|||
44346333|NCT01153347|79350378|FG001|Overall Study|Study-specific withdrawal criteria|3|||
44346334|NCT01153347|79350379|FG002|Overall Study|Study-specific withdrawal criteria|1|||
44346335|NCT01153347|79350380|FG003|Overall Study|Study-specific withdrawal criteria|2|||
44346336|NCT01153347|79350377|FG000|Overall Study|Lost to Follow-up|4|||
44346337|NCT01153347|79350378|FG001|Overall Study|Lost to Follow-up|9|||
44346338|NCT01153347|79350379|FG002|Overall Study|Lost to Follow-up|11|||
44346339|NCT01153347|79350380|FG003|Overall Study|Lost to Follow-up|8|||
44346340|NCT01153347|79350377|FG000|Overall Study|Other|5|||
44346341|NCT01153347|79350378|FG001|Overall Study|Other|5|||
44346342|NCT01153347|79350379|FG002|Overall Study|Other|4|||
44346343|NCT01153347|79350380|FG003|Overall Study|Other|0|||
44346344|NCT01153347|79350377|FG000|Overall Study|Death|1|||
44346345|NCT01153347|79350378|FG001|Overall Study|Death|0|||
44346346|NCT01153347|79350379|FG002|Overall Study|Death|0|||
44346347|NCT01153347|79350380|FG003|Overall Study|Death|0|||
44346348|NCT01153269|79350390|FG000|Overall Study|Withdrawal by Subject|1|||
44346349|NCT01153269|79350390|FG000|Overall Study|Antiretroviral therapy break|1|||
44346350|NCT01152021|79350399|FG000|Overall Study|Adverse Event|4|||
44346351|NCT01152021|79350400|FG001|Overall Study|Adverse Event|4|||
44346352|NCT01152021|79350399|FG000|Overall Study|Study drug had expired|1|||
44346353|NCT01152021|79350400|FG001|Overall Study|Study drug had expired|0|||
44346354|NCT01152021|79350399|FG000|Overall Study|Physician Decision|1|||
44346355|NCT01152021|79350400|FG001|Overall Study|Physician Decision|1|||
44346356|NCT01152021|79350399|FG000|Overall Study|No access to study drug in Pharmacy|0|||
44346357|NCT01152021|79350400|FG001|Overall Study|No access to study drug in Pharmacy|1|||
44346358|NCT01151085|79350408|FG000|Overall Study|Lost to Follow-up|31|||
44346359|NCT01151085|79350408|FG000|Overall Study|Protocol Violation|25|||
44346360|NCT01149681|79350419|FG000|Overall Study|Withdrawal by Subject|7|||
44346361|NCT01149681|79350419|FG000|Overall Study|Progressive disease|1|||
44346362|NCT01149681|79350419|FG000|Overall Study|Physician Decision|2|||
44346363|NCT01149681|79350419|FG000|Overall Study|adverse events nonrelated study drug|2|||
44346364|NCT01149369|79350426|FG000|Overall Study|Adverse Event|6|||
44346365|NCT01149369|79350427|FG001|Overall Study|Adverse Event|3|||
44346366|NCT01149057|79350433|FG000|Overall Study|Lack of Efficacy|16|||
44346367|NCT01149057|79350433|FG000|Overall Study|Adverse Event|13|||
44346368|NCT01149057|79350433|FG000|Overall Study|Withdrawal by Subject|9|||
44346369|NCT01149057|79350433|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
44346370|NCT01149057|79350433|FG000|Overall Study|B Cell Depletion|4|||
44346371|NCT01149057|79350433|FG000|Overall Study|Participant Non-Compliance|2|||
44346372|NCT01149057|79350433|FG000|Overall Study|Lost to Follow-up|1|||
44346373|NCT01149057|79350433|FG000|Overall Study|High Parathyroid Hormone Value|1|||
44346374|NCT01149057|79350433|FG000|Overall Study|Other|6|||
44346375|NCT01227564|79350440|FG000|Overall Study|No Longer Willing to Participate|4|||
44346376|NCT01227564|79350441|FG001|Overall Study|No Longer Willing to Participate|2|||
44346377|NCT01227564|79350442|FG002|Overall Study|No Longer Willing to Participate|5|||
44346378|NCT01227564|79350440|FG000|Overall Study|Participant moved to another town|0|||
44346379|NCT01227564|79350441|FG001|Overall Study|Participant moved to another town|0|||
44346380|NCT01227564|79350442|FG002|Overall Study|Participant moved to another town|1|||
44346381|NCT01148979|79350458|FG000|Overall Study|Lost to Follow-up|0|||
44346382|NCT01148979|79350459|FG001|Overall Study|Lost to Follow-up|1|||
44346383|NCT01148511|79350467|FG000|Exposed to Study Drug|Protocol Violation|2|||
44346384|NCT01148511|79350468|FG001|Exposed to Study Drug|Protocol Violation|0|||
44346385|NCT01148511|79350469|FG002|Exposed to Study Drug|Protocol Violation|0|||
44346386|NCT01148511|79350467|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
44346387|NCT01148511|79350468|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
44346388|NCT01148511|79350469|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
44346389|NCT01148511|79350467|FG000|Randomized|Adverse Event|0|||
44346390|NCT01148511|79350468|FG001|Randomized|Adverse Event|1|||
44346391|NCT01148511|79350469|FG002|Randomized|Adverse Event|0|||
44346392|NCT01148511|79350467|FG000|Randomized|Protocol Violation|0|||
44346393|NCT01148511|79350468|FG001|Randomized|Protocol Violation|2|||
44346394|NCT01148511|79350469|FG002|Randomized|Protocol Violation|1|||
44346395|NCT01148511|79350467|FG000|Randomized|Lost to Follow-up|0|||
44346396|NCT01148511|79350468|FG001|Randomized|Lost to Follow-up|1|||
44346397|NCT01148511|79350469|FG002|Randomized|Lost to Follow-up|1|||
44346398|NCT01148511|79350467|FG000|Randomized|Consent withdrawal|0|||
44346399|NCT01148511|79350468|FG001|Randomized|Consent withdrawal|5|||
44346400|NCT01148511|79350469|FG002|Randomized|Consent withdrawal|3|||
44346401|NCT01148511|79350467|FG000|Randomized|Other|0|||
44346402|NCT01148511|79350468|FG001|Randomized|Other|1|||
44346403|NCT01148511|79350469|FG002|Randomized|Other|1|||
44346404|NCT00547339|79350480|FG000|Overall Study|Physician Decision|0|||
44346405|NCT00547339|79350481|FG001|Overall Study|Physician Decision|0|||
44346406|NCT00547339|79350482|FG002|Overall Study|Physician Decision|1|||
44346407|NCT00547339|79350483|FG003|Overall Study|Physician Decision|0|||
44346408|NCT01227252|79350506|FG000|Overall Study|Sponsor Decision|0|||
44346409|NCT01227252|79350507|FG001|Overall Study|Sponsor Decision|1|||
44346410|NCT01227252|79350508|FG002|Overall Study|Sponsor Decision|0|||
44346411|NCT01227252|79350509|FG003|Overall Study|Sponsor Decision|0|||
44346412|NCT01227252|79350506|FG000|Overall Study|Lost to Follow-up|0|||
44346413|NCT01227252|79350507|FG001|Overall Study|Lost to Follow-up|1|||
44346414|NCT01227252|79350508|FG002|Overall Study|Lost to Follow-up|0|||
44346415|NCT01227252|79350509|FG003|Overall Study|Lost to Follow-up|0|||
44346416|NCT01227252|79350506|FG000|Overall Study|Withdrawal by Subject|0|||
44346417|NCT01227252|79350507|FG001|Overall Study|Withdrawal by Subject|1|||
44346418|NCT01227252|79350508|FG002|Overall Study|Withdrawal by Subject|0|||
44346419|NCT01227252|79350509|FG003|Overall Study|Withdrawal by Subject|0|||
44346420|NCT01227018|79350522|FG000|Overall Study|Disease progression|9|||
44346421|NCT01227018|79350522|FG000|Overall Study|Toxicity|2|||
44346422|NCT01227018|79350522|FG000|Overall Study|Withdrew after beginning treatment|4|||
44346423|NCT01226472|79350536|FG000|Overall Study|Progressive Disease|1|||
44346424|NCT01225146|79350542|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
44346425|NCT01225146|79350543|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
44346426|NCT01223196|79350553|FG000|Overall Study|Lost to Follow-up|2|||
44346427|NCT01223196|79350554|FG001|Overall Study|Lost to Follow-up|0|||
44346428|NCT01223196|79350553|FG000|Overall Study|Physician Decision|1|||
44346429|NCT01223196|79350554|FG001|Overall Study|Physician Decision|0|||
44346430|NCT01223196|79350553|FG000|Overall Study|Withdrawal by Subject|1|||
44346431|NCT01223196|79350554|FG001|Overall Study|Withdrawal by Subject|0|||
44346432|NCT01222416|79350564|FG000|Overall Study|ineligible;metastasis|3|||
44346433|NCT01222416|79350565|FG001|Overall Study|ineligible;metastasis|0|||
44346434|NCT01222416|79350564|FG000|Overall Study|Adverse Event|4|||
44346435|NCT01222416|79350565|FG001|Overall Study|Adverse Event|0|||
44346436|NCT01222416|79350564|FG000|Overall Study|Withdrawal by Subject|5|||
44346437|NCT01222416|79350565|FG001|Overall Study|Withdrawal by Subject|0|||
44346438|NCT01222416|79350564|FG000|Overall Study|scheduling|6|||
44346439|NCT01222416|79350565|FG001|Overall Study|scheduling|0|||
44346440|NCT01222416|79350564|FG000|Overall Study|missed view/scan|1|||
44346441|NCT01222416|79350565|FG001|Overall Study|missed view/scan|0|||
44346442|NCT01222416|79350564|FG000|Overall Study|Death|1|||
44346443|NCT01222416|79350565|FG001|Overall Study|Death|0|||
44346444|NCT01222104|79350571|FG000|Overall Study|Lost to Follow-up|37|||
44346445|NCT01222104|79350571|FG000|Overall Study|Death|10|||
44346446|NCT01221948|79350581|FG000|Overall Study|Physician Decision|5|||
44346447|NCT01221948|79350581|FG000|Overall Study|Withdrawal by Subject|2|||
44346448|NCT01221948|79350581|FG000|Overall Study|not disclosed|2|||
44346449|NCT01221948|79350581|FG000|Overall Study|Death|1|||
44346450|NCT01221948|79350581|FG000|Overall Study|Protocol Violation|4|||
44346451|NCT01221090|79350589|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
44346452|NCT01221090|79350590|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
44346453|NCT01221090|79350591|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
44346454|NCT01221090|79350592|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
44346455|NCT01221090|79350589|FG000|Overall Study|Withdrawal by Subject|0|||
44346456|NCT01221090|79350590|FG001|Overall Study|Withdrawal by Subject|22|||
44346457|NCT01221090|79350591|FG002|Overall Study|Withdrawal by Subject|27|||
44346458|NCT01221090|79350592|FG003|Overall Study|Withdrawal by Subject|2|||
44346459|NCT00950911|79350604|FG000|Overall Study|Adverse Event|0|||
44346460|NCT00950911|79350605|FG001|Overall Study|Adverse Event|2|||
44346461|NCT00950911|79350604|FG000|Overall Study|Death|4|||
44346462|NCT00950911|79350605|FG001|Overall Study|Death|6|||
44346463|NCT00950911|79350604|FG000|Overall Study|Disease progression|2|||
44346464|NCT00950911|79350605|FG001|Overall Study|Disease progression|2|||
44346465|NCT00950911|79350604|FG000|Overall Study|Consent withdrawn|1|||
44346466|NCT00950911|79350605|FG001|Overall Study|Consent withdrawn|3|||
44346467|NCT00950911|79350604|FG000|Overall Study|Administrative decision|3|||
44445373|NCT04270760|79453389|FG000|Overall Study|Death|0|||
44445374|NCT04270760|79453390|FG001|Overall Study|Death|0|||
44445375|NCT04270760|79453391|FG002|Overall Study|Death|0|||
44346468|NCT00950911|79350605|FG001|Overall Study|Administrative decision|1|||
44346469|NCT00950911|79350604|FG000|Overall Study|Ineligibility determined|1|||
44346470|NCT00950911|79350605|FG001|Overall Study|Ineligibility determined|0|||
44346471|NCT00950911|79350604|FG000|Overall Study|Noncompliance|1|||
44445376|NCT04270760|79453392|FG003|Overall Study|Death|0|||
44445377|NCT04270760|79453393|FG004|Overall Study|Death|1|||
44346472|NCT00950911|79350605|FG001|Overall Study|Noncompliance|0|||
44346473|NCT00950911|79350604|FG000|Overall Study|Poor performance status|0|||
44346474|NCT00950911|79350605|FG001|Overall Study|Poor performance status|1|||
44445378|NCT04198363|79453412|FG000|Overall Study|Adverse Event|1|||
44445379|NCT04198363|79453413|FG001|Overall Study|Adverse Event|1|||
44346475|NCT01220856|79350613|FG000|Overall Study|graft loss|3|||
44346476|NCT01220856|79350614|FG001|Overall Study|graft loss|3|||
44346477|NCT01220856|79350613|FG000|Overall Study|Lost to Follow-up|1|||
44346478|NCT01220856|79350614|FG001|Overall Study|Lost to Follow-up|0|||
44346479|NCT01218594|79350623|FG000|Overall Study|Death|1|||
44346480|NCT01218594|79350623|FG000|Overall Study|Withdrawal by Subject|3|||
44346481|NCT01218594|79350623|FG000|Overall Study|Adverse Event|2|||
44346482|NCT01218594|79350623|FG000|Overall Study|Physician Decision|6|||
44346483|NCT01610557|79350631|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
44346484|NCT01610557|79350632|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
44346485|NCT01610557|79350633|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
44346486|NCT01610557|79350634|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
44346487|NCT01610557|79350635|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
44346488|NCT01610557|79350631|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
44346489|NCT01610557|79350632|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
44346490|NCT01610557|79350633|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
44346491|NCT01610557|79350634|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
44346492|NCT01610557|79350635|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
44346493|NCT00943735|79350646|FG000|Overall Study|Adverse Event|12|||
44346494|NCT00943735|79350646|FG000|Overall Study|Withdrawal by Subject|8|||
44346495|NCT00943735|79350646|FG000|Overall Study|Death|1|||
44346496|NCT00943735|79350646|FG000|Overall Study|Other|8|||
44346497|NCT00943735|79350646|FG000|Overall Study|Other|3|||
44346498|NCT00943579|79350652|FG000|Overall Study|Adverse Event|4|||
44346499|NCT00943579|79350653|FG001|Overall Study|Adverse Event|3|||
44346500|NCT00943579|79350652|FG000|Overall Study|Lack of Efficacy|2|||
44346501|NCT00943579|79350653|FG001|Overall Study|Lack of Efficacy|2|||
44346502|NCT01147809|79350668|FG000|Phase I (168 Days)|Adverse Event|0|||
44346503|NCT01147809|79350669|FG001|Phase I (168 Days)|Adverse Event|0|||
44346504|NCT01147809|79350670|FG002|Phase I (168 Days)|Adverse Event|0|||
44346505|NCT01147809|79350671|FG003|Phase I (168 Days)|Adverse Event|1|||
44346506|NCT01147809|79350672|FG004|Phase I (168 Days)|Adverse Event|0|||
44346507|NCT01147809|79350673|FG005|Phase I (168 Days)|Adverse Event|0|||
44346508|NCT01147809|79350668|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
44346509|NCT01147809|79350669|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
44346510|NCT01147809|79350670|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
44346511|NCT01147809|79350671|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
44346512|NCT01147809|79350672|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
44346513|NCT01147809|79350673|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
44346514|NCT01147809|79350668|FG000|Phase I (168 Days)|Physician Decision|0|||
44346515|NCT01147809|79350669|FG001|Phase I (168 Days)|Physician Decision|1|||
44346516|NCT01147809|79350670|FG002|Phase I (168 Days)|Physician Decision|2|||
44346517|NCT01147809|79350671|FG003|Phase I (168 Days)|Physician Decision|0|||
44346518|NCT01147809|79350672|FG004|Phase I (168 Days)|Physician Decision|0|||
44346519|NCT01147809|79350673|FG005|Phase I (168 Days)|Physician Decision|0|||
44346520|NCT01147809|79350668|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
44346521|NCT01147809|79350669|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
44346522|NCT01147809|79350670|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
44346523|NCT01147809|79350671|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
44346524|NCT01147809|79350672|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
44346525|NCT01147809|79350673|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
44346526|NCT01147809|79350668|FG000|Phase II (168 Days)|Adverse Event|0|||
44346527|NCT01147809|79350669|FG001|Phase II (168 Days)|Adverse Event|0|||
44346528|NCT01147809|79350670|FG002|Phase II (168 Days)|Adverse Event|0|||
44346529|NCT01147809|79350671|FG003|Phase II (168 Days)|Adverse Event|0|||
44346530|NCT01147809|79350672|FG004|Phase II (168 Days)|Adverse Event|3|||
44346531|NCT01147809|79350673|FG005|Phase II (168 Days)|Adverse Event|6|||
44346532|NCT01147809|79350668|FG000|Phase II (168 Days)|Protocol Violation|0|||
44346533|NCT01147809|79350669|FG001|Phase II (168 Days)|Protocol Violation|0|||
44346534|NCT01147809|79350670|FG002|Phase II (168 Days)|Protocol Violation|0|||
44346535|NCT01147809|79350671|FG003|Phase II (168 Days)|Protocol Violation|0|||
44346536|NCT01147809|79350672|FG004|Phase II (168 Days)|Protocol Violation|0|||
44346537|NCT01147809|79350673|FG005|Phase II (168 Days)|Protocol Violation|1|||
44346538|NCT01147809|79350668|FG000|Phase II (168 Days)|Physician Decision|0|||
44346539|NCT01147809|79350669|FG001|Phase II (168 Days)|Physician Decision|0|||
44346540|NCT01147809|79350670|FG002|Phase II (168 Days)|Physician Decision|0|||
44346541|NCT01147809|79350671|FG003|Phase II (168 Days)|Physician Decision|0|||
44346542|NCT01147809|79350672|FG004|Phase II (168 Days)|Physician Decision|5|||
44346543|NCT01147809|79350673|FG005|Phase II (168 Days)|Physician Decision|11|||
44346544|NCT01147809|79350668|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
44346545|NCT01147809|79350669|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
44346546|NCT01147809|79350670|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
44346547|NCT01147809|79350671|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
44346548|NCT01147809|79350672|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
44346549|NCT01147809|79350673|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
44346550|NCT01147809|79350668|FG000|Phase II (168 Days)|Ongoing|0|||
44346551|NCT01147809|79350669|FG001|Phase II (168 Days)|Ongoing|0|||
44445380|NCT04198363|79453412|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
44346552|NCT01147809|79350670|FG002|Phase II (168 Days)|Ongoing|0|||
44346553|NCT01147809|79350671|FG003|Phase II (168 Days)|Ongoing|0|||
44346554|NCT01147809|79350672|FG004|Phase II (168 Days)|Ongoing|1|||
44346555|NCT01147809|79350673|FG005|Phase II (168 Days)|Ongoing|0|||
44346556|NCT00943111|79350690|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
44346557|NCT00943111|79350691|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
44346558|NCT00943111|79350692|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
44346559|NCT00943111|79350690|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
44346560|NCT00943111|79350691|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
44346561|NCT00943111|79350692|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
44346562|NCT00943111|79350690|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
44346563|NCT00943111|79350691|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
44346564|NCT00943111|79350692|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
44346565|NCT00943111|79350690|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
44346566|NCT00943111|79350691|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
44346567|NCT00943111|79350692|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
44346568|NCT00943111|79350690|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
44346569|NCT00943111|79350691|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
44346570|NCT00943111|79350692|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
44346571|NCT00943111|79350690|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
44346572|NCT00943111|79350691|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
44346573|NCT00943111|79350692|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
44346574|NCT00943111|79350690|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
44346575|NCT00943111|79350691|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
44346576|NCT00943111|79350692|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
44346577|NCT00943111|79350690|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
44346578|NCT00943111|79350691|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
44346579|NCT00943111|79350692|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
44346580|NCT01147497|79350701|FG000|Overall Study|failed insertion|2|||
44346581|NCT01147497|79350702|FG001|Overall Study|failed insertion|0|||
44346582|NCT01147341|79350710|FG000|Double Blind Period|Lack of Efficacy|1|||
44346583|NCT01147341|79350711|FG001|Double Blind Period|Lack of Efficacy|1|||
44346584|NCT01147341|79350710|FG000|Double Blind Period|Withdrawal by Subject|0|||
44346585|NCT01147341|79350711|FG001|Double Blind Period|Withdrawal by Subject|1|||
44346586|NCT01147341|79350710|FG000|Open Label Period|Lack of Efficacy|3|||
44346587|NCT01147341|79350711|FG001|Open Label Period|Lack of Efficacy|0|||
44346588|NCT01147341|79350710|FG000|Open Label Period|Subject moved|1|||
44346589|NCT01147341|79350711|FG001|Open Label Period|Subject moved|0|||
44346590|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
44346591|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
44346592|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
44346593|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
44346594|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
44346595|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
44346596|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
44346597|NCT00950755|79350717|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
44346598|NCT00950755|79350717|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
44346599|NCT00950755|79350717|FG000|Long-Term Follow-Up|Death|8|||
44346600|NCT01147107|79350723|FG000|Overall Study|Lack of Efficacy|5|||
44346601|NCT01147107|79350724|FG001|Overall Study|Lack of Efficacy|0|||
44346602|NCT01147107|79350723|FG000|Overall Study|Withdrawal by Subject|1|||
44346603|NCT01147107|79350724|FG001|Overall Study|Withdrawal by Subject|1|||
44346604|NCT00942409|79350730|FG000|Overall Study|Lack of Efficacy|1|||
44346605|NCT00942409|79350730|FG000|Overall Study|study drug unavailable|2|||
44346606|NCT01146951|79350736|FG000|Overall Study|Adverse Event|4|||
44346607|NCT01146951|79350737|FG001|Overall Study|Adverse Event|1|||
44346608|NCT01146873|79350745|FG000|Overall Study|Transfer out|0|||
44346609|NCT01146873|79350746|FG001|Overall Study|Transfer out|6|||
44346610|NCT01146795|79350752|FG000|Overall Study|Withdrawal by Subject|4|||
44346611|NCT01146795|79350752|FG000|Overall Study|Adverse Event|6|||
44346612|NCT01146795|79350752|FG000|Overall Study|Still in treatment at study closure|10|||
44346613|NCT01146561|79350756|FG000|Overall Study|Withdrawal by Subject|1|||
44346614|NCT01146561|79350756|FG000|Overall Study|Lost to Follow-up|1|||
44346615|NCT00942175|79350764|FG000|Overall Study|Adverse Event|2|||
44346616|NCT00942175|79350765|FG001|Overall Study|Adverse Event|1|||
44346617|NCT00942175|79350766|FG002|Overall Study|Adverse Event|0|||
44346618|NCT00942175|79350767|FG003|Overall Study|Adverse Event|0|||
44346619|NCT00942175|79350764|FG000|Overall Study|Protocol Violation|0|||
44346620|NCT00942175|79350765|FG001|Overall Study|Protocol Violation|1|||
44346621|NCT00942175|79350766|FG002|Overall Study|Protocol Violation|2|||
44346622|NCT00942175|79350767|FG003|Overall Study|Protocol Violation|0|||
44346623|NCT00942175|79350764|FG000|Overall Study|Pregnancy|0|||
44346624|NCT00942175|79350765|FG001|Overall Study|Pregnancy|0|||
44346625|NCT00942175|79350766|FG002|Overall Study|Pregnancy|0|||
44346626|NCT00942175|79350767|FG003|Overall Study|Pregnancy|1|||
44346627|NCT00942175|79350764|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
44346628|NCT00942175|79350765|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
44346629|NCT00942175|79350766|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
44346630|NCT00942175|79350767|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
44346631|NCT00942175|79350764|FG000|Overall Study|Low Platelet Count|0|||
44346632|NCT00942175|79350765|FG001|Overall Study|Low Platelet Count|2|||
44346633|NCT00942175|79350766|FG002|Overall Study|Low Platelet Count|0|||
44346634|NCT00942175|79350767|FG003|Overall Study|Low Platelet Count|0|||
44346635|NCT01145625|79350787|FG000|Overall Study|Lost to Follow-up|8|||
44346636|NCT01145625|79350788|FG001|Overall Study|Lost to Follow-up|9|||
44346637|NCT01145625|79350787|FG000|Overall Study|Adverse Event|6|||
44346638|NCT01145625|79350788|FG001|Overall Study|Adverse Event|4|||
44346639|NCT01145625|79350787|FG000|Overall Study|Protocol Violation|3|||
44346640|NCT01145625|79350788|FG001|Overall Study|Protocol Violation|1|||
44346641|NCT01145625|79350787|FG000|Overall Study|Withdrawal by Subject|7|||
44346642|NCT01145625|79350788|FG001|Overall Study|Withdrawal by Subject|16|||
44346643|NCT01145625|79350787|FG000|Overall Study|Pregnancy|0|||
44346644|NCT01145625|79350788|FG001|Overall Study|Pregnancy|1|||
44346645|NCT01144377|79350799|FG000|52 Week Treatment Period|Adverse Event|0|||
44346646|NCT01144377|79350800|FG001|52 Week Treatment Period|Adverse Event|0|||
44346647|NCT01144377|79350801|FG002|52 Week Treatment Period|Adverse Event|3|||
44346648|NCT01144377|79350802|FG003|52 Week Treatment Period|Adverse Event|2|||
44346649|NCT01144377|79350803|FG004|52 Week Treatment Period|Adverse Event|1|||
44346650|NCT01144377|79350799|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
44346651|NCT01144377|79350800|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
44346652|NCT01144377|79350801|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
44346653|NCT01144377|79350802|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
44346654|NCT01144377|79350803|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
44346655|NCT01144377|79350799|FG000|52 Week Treatment Period|Protocol Violation|0|||
44346656|NCT01144377|79350800|FG001|52 Week Treatment Period|Protocol Violation|0|||
44346657|NCT01144377|79350801|FG002|52 Week Treatment Period|Protocol Violation|0|||
44346658|NCT01144377|79350802|FG003|52 Week Treatment Period|Protocol Violation|0|||
44346659|NCT01144377|79350803|FG004|52 Week Treatment Period|Protocol Violation|1|||
44346660|NCT01144377|79350799|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
44346661|NCT01144377|79350800|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
44346662|NCT01144377|79350801|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
44346663|NCT01144377|79350802|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
44346664|NCT01144377|79350803|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
44346665|NCT01144377|79350799|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
44346666|NCT01144377|79350800|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
44346667|NCT01144377|79350801|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
44346668|NCT01144377|79350802|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
44346669|NCT01144377|79350803|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
44346670|NCT01144377|79350799|FG000|52 Week Treatment Period|Sponsor Decision|0|||
44346671|NCT01144377|79350800|FG001|52 Week Treatment Period|Sponsor Decision|0|||
44346672|NCT01144377|79350801|FG002|52 Week Treatment Period|Sponsor Decision|0|||
44346673|NCT01144377|79350802|FG003|52 Week Treatment Period|Sponsor Decision|0|||
44346674|NCT01144377|79350803|FG004|52 Week Treatment Period|Sponsor Decision|1|||
44346675|NCT01144377|79350799|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
44346676|NCT01144377|79350800|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
44346677|NCT01144377|79350801|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
44346678|NCT01144377|79350802|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
44346679|NCT01144377|79350803|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
44346680|NCT01144377|79350799|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
44346681|NCT01144377|79350800|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
44346682|NCT01144377|79350801|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
44346683|NCT01144377|79350802|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
44346684|NCT01144377|79350803|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
44346685|NCT01144377|79350799|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
44346686|NCT01144377|79350800|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
44346687|NCT01144377|79350801|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
44346688|NCT01144377|79350802|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
44346689|NCT01144377|79350803|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
44346690|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346691|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346692|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346693|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
44346694|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346695|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346696|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346697|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346698|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346699|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
44346700|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Adverse Event|0|||
44346701|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Adverse Event|1|||
44346702|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Adverse Event|1|||
44346703|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Adverse Event|1|||
44346704|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Adverse Event|1|||
44346705|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Adverse Event|1|||
44346706|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Adverse Event|0|||
44346707|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Adverse Event|0|||
44346708|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Adverse Event|0|||
44346709|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Adverse Event|0|||
44346710|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
44346711|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
44346712|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
44346713|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
44346714|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
44346715|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
44346716|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
44346717|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
44346718|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
44346719|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
44346720|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
44346721|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
44346722|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
44346723|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
44346724|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
44346725|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
44346726|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
44346727|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
44346728|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
44346729|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
44346730|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
44346731|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
44346732|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346733|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346734|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346735|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346736|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346737|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
44445381|NCT04198363|79453413|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
44445382|NCT04198363|79453412|FG000|Overall Study|Reason not Specified|1|||
44445383|NCT04198363|79453413|FG001|Overall Study|Reason not Specified|0|||
44445384|NCT04173247|79453421|FG000|Overall Study|Withdrawal by Subject|0|||
44445385|NCT04173247|79453422|FG001|Overall Study|Withdrawal by Subject|2|||
44445386|NCT04173247|79453421|FG000|Overall Study|Death|1|||
44346738|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346739|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
44346740|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346741|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346742|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346743|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346744|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
44346745|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
44346746|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346747|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346748|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346749|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
44346750|NCT00950599|79350825|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
44346751|NCT00950599|79350826|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
44346752|NCT00950599|79350827|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
44445387|NCT04173247|79453422|FG001|Overall Study|Death|0|||
44445388|NCT04173247|79453421|FG000|Overall Study|Physician Decision|1|||
44445389|NCT04173247|79453422|FG001|Overall Study|Physician Decision|0|||
44167887|NCT02528357|78961060|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44445390|NCT03943446|79453435|FG000|Overall Study|Lost to Follow-up|0|||
44445391|NCT03943446|79453436|FG001|Overall Study|Lost to Follow-up|0|||
44445392|NCT03943446|79453437|FG002|Overall Study|Lost to Follow-up|1|||
44445393|NCT03943446|79453435|FG000|Overall Study|Withdrawal by Subject|1|||
44445394|NCT03943446|79453436|FG001|Overall Study|Withdrawal by Subject|1|||
44445395|NCT03943446|79453437|FG002|Overall Study|Withdrawal by Subject|2|||
44445396|NCT03943446|79453435|FG000|Overall Study|Study Terminated by Sponsor|1|||
44445397|NCT03943446|79453436|FG001|Overall Study|Study Terminated by Sponsor|2|||
44445398|NCT03943446|79453437|FG002|Overall Study|Study Terminated by Sponsor|1|||
44445399|NCT03943446|79453435|FG000|Overall Study|Reason not Specified|5|||
44445400|NCT03943446|79453436|FG001|Overall Study|Reason not Specified|1|||
44445401|NCT03943446|79453437|FG002|Overall Study|Reason not Specified|3|||
44445402|NCT03632993|79453514|FG000|Overall Study|Withdrawal by Subject|1|||
44445403|NCT03632993|79453515|FG001|Overall Study|Withdrawal by Subject|0|||
44445404|NCT03632993|79453516|FG002|Overall Study|Withdrawal by Subject|0|||
44445405|NCT03632993|79453517|FG003|Overall Study|Withdrawal by Subject|0|||
44445406|NCT03632993|79453518|FG004|Overall Study|Withdrawal by Subject|0|||
44445407|NCT03632993|79453519|FG005|Overall Study|Withdrawal by Subject|0|||
44445408|NCT03632993|79453520|FG006|Overall Study|Withdrawal by Subject|0|||
44445409|NCT03632993|79453521|FG007|Overall Study|Withdrawal by Subject|0|||
44445410|NCT03632993|79453522|FG008|Overall Study|Withdrawal by Subject|0|||
44445411|NCT03632993|79453523|FG009|Overall Study|Withdrawal by Subject|1|||
44445412|NCT03632993|79453514|FG000|Overall Study|Protocol Non-compliance|0|||
44445413|NCT03632993|79453515|FG001|Overall Study|Protocol Non-compliance|1|||
44445414|NCT03632993|79453516|FG002|Overall Study|Protocol Non-compliance|0|||
44445415|NCT03632993|79453517|FG003|Overall Study|Protocol Non-compliance|0|||
44445416|NCT03632993|79453518|FG004|Overall Study|Protocol Non-compliance|0|||
44445417|NCT03632993|79453519|FG005|Overall Study|Protocol Non-compliance|0|||
44445418|NCT03632993|79453520|FG006|Overall Study|Protocol Non-compliance|0|||
44445419|NCT03632993|79453521|FG007|Overall Study|Protocol Non-compliance|0|||
44445420|NCT03632993|79453522|FG008|Overall Study|Protocol Non-compliance|0|||
44445421|NCT03632993|79453523|FG009|Overall Study|Protocol Non-compliance|0|||
44445422|NCT03632993|79453514|FG000|Overall Study|Lost to Follow-up|0|||
44445423|NCT03632993|79453515|FG001|Overall Study|Lost to Follow-up|0|||
44445424|NCT03632993|79453516|FG002|Overall Study|Lost to Follow-up|0|||
44445425|NCT03632993|79453517|FG003|Overall Study|Lost to Follow-up|0|||
44445426|NCT03632993|79453518|FG004|Overall Study|Lost to Follow-up|0|||
44445427|NCT03632993|79453519|FG005|Overall Study|Lost to Follow-up|1|||
44445428|NCT03632993|79453520|FG006|Overall Study|Lost to Follow-up|0|||
44445429|NCT03632993|79453521|FG007|Overall Study|Lost to Follow-up|1|||
44445430|NCT03632993|79453522|FG008|Overall Study|Lost to Follow-up|0|||
44445431|NCT03632993|79453523|FG009|Overall Study|Lost to Follow-up|0|||
44445432|NCT03632993|79453514|FG000|Overall Study|Adverse Event|0|||
44445433|NCT03632993|79453515|FG001|Overall Study|Adverse Event|0|||
44445434|NCT03632993|79453516|FG002|Overall Study|Adverse Event|0|||
44346753|NCT00950599|79350828|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
44346754|NCT00950599|79350829|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
44346755|NCT00950599|79350830|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
44346756|NCT00950599|79350831|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
44346757|NCT00950599|79350832|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
44346758|NCT00950599|79350833|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
44346759|NCT00950599|79350834|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
44346760|NCT00950599|79350825|FG000|Follow-Up Period|Adverse Event|0|||
44346761|NCT00950599|79350826|FG001|Follow-Up Period|Adverse Event|0|||
44346762|NCT00950599|79350827|FG002|Follow-Up Period|Adverse Event|0|||
44346763|NCT00950599|79350828|FG003|Follow-Up Period|Adverse Event|0|||
44346764|NCT00950599|79350829|FG004|Follow-Up Period|Adverse Event|0|||
44346765|NCT00950599|79350830|FG005|Follow-Up Period|Adverse Event|0|||
44346766|NCT00950599|79350831|FG006|Follow-Up Period|Adverse Event|0|||
44346767|NCT00950599|79350832|FG007|Follow-Up Period|Adverse Event|0|||
44346768|NCT00950599|79350833|FG008|Follow-Up Period|Adverse Event|1|||
44346769|NCT00950599|79350834|FG009|Follow-Up Period|Adverse Event|0|||
44346770|NCT00950599|79350825|FG000|Follow-Up Period|Lack of Efficacy|0|||
44445435|NCT03632993|79453517|FG003|Overall Study|Adverse Event|0|||
44445436|NCT03632993|79453518|FG004|Overall Study|Adverse Event|0|||
44445437|NCT03632993|79453519|FG005|Overall Study|Adverse Event|1|||
44445438|NCT03632993|79453520|FG006|Overall Study|Adverse Event|0|||
44445439|NCT03632993|79453521|FG007|Overall Study|Adverse Event|1|||
44445440|NCT03632993|79453522|FG008|Overall Study|Adverse Event|0|||
44346771|NCT00950599|79350826|FG001|Follow-Up Period|Lack of Efficacy|0|||
44346772|NCT00950599|79350827|FG002|Follow-Up Period|Lack of Efficacy|0|||
44346773|NCT00950599|79350828|FG003|Follow-Up Period|Lack of Efficacy|0|||
44346774|NCT00950599|79350829|FG004|Follow-Up Period|Lack of Efficacy|0|||
44445441|NCT03632993|79453523|FG009|Overall Study|Adverse Event|0|||
44445442|NCT03493282|79453548|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
44445443|NCT03493282|79453549|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
44445444|NCT03493282|79453550|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
44445445|NCT03493282|79453548|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
44445446|NCT03493282|79453549|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
44445447|NCT03493282|79453550|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
44445448|NCT02998203|79453603|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
44445449|NCT02998203|79453604|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
44445450|NCT02998203|79453603|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
44445451|NCT02998203|79453604|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
44445452|NCT02873338|79453630|FG000|Overall Study|Adverse Event|0|||
44445453|NCT02873338|79453631|FG001|Overall Study|Adverse Event|2|||
44445454|NCT02873338|79453632|FG002|Overall Study|Adverse Event|1|||
44445455|NCT02873338|79453630|FG000|Overall Study|Death|2|||
44445456|NCT02873338|79453631|FG001|Overall Study|Death|1|||
44445457|NCT02873338|79453632|FG002|Overall Study|Death|1|||
44445458|NCT02873338|79453630|FG000|Overall Study|Withdrawal by Subject|2|||
44445459|NCT02873338|79453631|FG001|Overall Study|Withdrawal by Subject|1|||
44445460|NCT02873338|79453632|FG002|Overall Study|Withdrawal by Subject|3|||
44445461|NCT02873338|79453630|FG000|Overall Study|Lack of Efficacy|0|||
44445462|NCT02873338|79453631|FG001|Overall Study|Lack of Efficacy|2|||
44445463|NCT02873338|79453632|FG002|Overall Study|Lack of Efficacy|0|||
44445464|NCT02873338|79453630|FG000|Overall Study|Other or Missing|14|||
44445465|NCT02873338|79453631|FG001|Overall Study|Other or Missing|15|||
44445466|NCT02873338|79453632|FG002|Overall Study|Other or Missing|13|||
44445467|NCT02725567|79453647|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
44445468|NCT02725567|79453648|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
44445469|NCT02725567|79453647|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
44445470|NCT02725567|79453648|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
44445471|NCT02725567|79453647|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
44445472|NCT02725567|79453648|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
44445473|NCT02108964|79453680|FG000|Overall Study|Progressive disease|12|||
44445474|NCT02108964|79453681|FG001|Overall Study|Progressive disease|25|||
44445475|NCT02108964|79453682|FG002|Overall Study|Progressive disease|50|||
44445476|NCT02108964|79453683|FG003|Overall Study|Progressive disease|6|||
44445477|NCT02108964|79453684|FG004|Overall Study|Progressive disease|18|||
44445478|NCT02108964|79453685|FG005|Overall Study|Progressive disease|5|||
44445479|NCT02108964|79453686|FG006|Overall Study|Progressive disease|7|||
44445480|NCT02108964|79453687|FG007|Overall Study|Progressive disease|9|||
44445481|NCT02108964|79453680|FG000|Overall Study|Physician Decision|1|||
44445482|NCT02108964|79453681|FG001|Overall Study|Physician Decision|5|||
44445483|NCT02108964|79453682|FG002|Overall Study|Physician Decision|6|||
44445484|NCT02108964|79453683|FG003|Overall Study|Physician Decision|0|||
44445485|NCT02108964|79453684|FG004|Overall Study|Physician Decision|1|||
44445486|NCT02108964|79453685|FG005|Overall Study|Physician Decision|0|||
44445487|NCT02108964|79453686|FG006|Overall Study|Physician Decision|0|||
44445488|NCT02108964|79453687|FG007|Overall Study|Physician Decision|0|||
44445489|NCT02108964|79453680|FG000|Overall Study|Adverse Event|0|||
44445490|NCT02108964|79453681|FG001|Overall Study|Adverse Event|0|||
44445491|NCT02108964|79453682|FG002|Overall Study|Adverse Event|4|||
44445492|NCT02108964|79453683|FG003|Overall Study|Adverse Event|0|||
44445493|NCT02108964|79453684|FG004|Overall Study|Adverse Event|1|||
44445494|NCT02108964|79453685|FG005|Overall Study|Adverse Event|0|||
44445495|NCT02108964|79453686|FG006|Overall Study|Adverse Event|3|||
44445496|NCT02108964|79453687|FG007|Overall Study|Adverse Event|1|||
44445497|NCT02108964|79453680|FG000|Overall Study|Death|1|||
44445498|NCT02108964|79453681|FG001|Overall Study|Death|1|||
44445499|NCT02108964|79453682|FG002|Overall Study|Death|2|||
44445500|NCT02108964|79453683|FG003|Overall Study|Death|0|||
44445501|NCT02108964|79453684|FG004|Overall Study|Death|3|||
44445502|NCT02108964|79453685|FG005|Overall Study|Death|0|||
44445503|NCT02108964|79453686|FG006|Overall Study|Death|0|||
44445504|NCT02108964|79453687|FG007|Overall Study|Death|1|||
44445505|NCT02108964|79453680|FG000|Overall Study|Subject/Guardian decision|0|||
44445506|NCT02108964|79453681|FG001|Overall Study|Subject/Guardian decision|1|||
44445507|NCT02108964|79453682|FG002|Overall Study|Subject/Guardian decision|3|||
44445508|NCT02108964|79453683|FG003|Overall Study|Subject/Guardian decision|0|||
44445509|NCT02108964|79453684|FG004|Overall Study|Subject/Guardian decision|2|||
44445510|NCT02108964|79453685|FG005|Overall Study|Subject/Guardian decision|0|||
44445511|NCT02108964|79453686|FG006|Overall Study|Subject/Guardian decision|1|||
44445512|NCT02108964|79453687|FG007|Overall Study|Subject/Guardian decision|1|||
44445513|NCT01909453|79453711|FG000|Overall Study|Ongoing|118|||
44445514|NCT01909453|79453712|FG001|Overall Study|Ongoing|103|||
44445515|NCT01909453|79453713|FG002|Overall Study|Ongoing|83|||
44445516|NCT01909453|79453714|FG003|Overall Study|Ongoing|164|||
44445517|NCT01909453|79453715|FG004|Overall Study|Ongoing|50|||
44445518|NCT01909453|79453711|FG000|Overall Study|Death|69|||
44445519|NCT01909453|79453712|FG001|Overall Study|Death|74|||
44445520|NCT01909453|79453713|FG002|Overall Study|Death|88|||
44445521|NCT01909453|79453714|FG003|Overall Study|Death|86|||
44445522|NCT01909453|79453715|FG004|Overall Study|Death|29|||
44445523|NCT01909453|79453711|FG000|Overall Study|Lost to Follow-up|3|||
44445524|NCT01909453|79453712|FG001|Overall Study|Lost to Follow-up|4|||
44445525|NCT01909453|79453713|FG002|Overall Study|Lost to Follow-up|4|||
44445526|NCT01909453|79453714|FG003|Overall Study|Lost to Follow-up|3|||
44445527|NCT01909453|79453715|FG004|Overall Study|Lost to Follow-up|3|||
44445528|NCT01909453|79453711|FG000|Overall Study|Withdrawal by Subject|2|||
44445529|NCT01909453|79453712|FG001|Overall Study|Withdrawal by Subject|13|||
44445530|NCT01909453|79453713|FG002|Overall Study|Withdrawal by Subject|16|||
44445531|NCT01909453|79453714|FG003|Overall Study|Withdrawal by Subject|5|||
44445532|NCT01909453|79453715|FG004|Overall Study|Withdrawal by Subject|4|||
44445533|NCT01882803|79453733|FG000|Overall Study|Disease Progression|1|||
44445534|NCT01882803|79453733|FG000|Overall Study|Withdrawal by Subject|9|||
44445535|NCT01882803|79453733|FG000|Overall Study|Death|68|||
44445536|NCT01882803|79453733|FG000|Overall Study|Physician Decision|3|||
44445537|NCT01882803|79453733|FG000|Overall Study|Lost to Follow-up|3|||
44445538|NCT01882803|79453733|FG000|Overall Study|Follow-up Completed|39|||
44445539|NCT01882803|79453733|FG000|Overall Study|Study Terminated by the Sponsor|6|||
44445540|NCT01196390|79453744|FG000|Overall Study|Protocol Violation|4|||
44445541|NCT01196390|79453745|FG001|Overall Study|Protocol Violation|5|||
44445542|NCT00659126|79453768|FG000|Overall Study|Adverse Event|2|||
44445543|NCT00659126|79453769|FG001|Overall Study|Adverse Event|2|||
44445544|NCT00659126|79453768|FG000|Overall Study|Screen failure|1|||
44445545|NCT00659126|79453769|FG001|Overall Study|Screen failure|1|||
44445546|NCT00659126|79453768|FG000|Overall Study|Technical problems with MRI|0|||
44445547|NCT00659126|79453769|FG001|Overall Study|Technical problems with MRI|1|||
44445548|NCT00152503|79453800|FG000|Overall Study|Adverse Event|4|||
44445549|NCT03865407|79453806|FG000|Overall Study|Adverse Event|1|||
44445550|NCT03865407|79453807|FG001|Overall Study|Adverse Event|0|||
44445551|NCT03865407|79453806|FG000|Overall Study|Withdrawal by Subject|1|||
44445552|NCT03865407|79453807|FG001|Overall Study|Withdrawal by Subject|0|||
44445553|NCT03865407|79453806|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
44445554|NCT03865407|79453807|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
44445555|NCT00487942|79453817|FG000|Overall Study|Adverse Event|1|||
44445556|NCT00487942|79453818|FG001|Overall Study|Adverse Event|1|||
44445557|NCT00487942|79453819|FG002|Overall Study|Adverse Event|1|||
44445558|NCT00487942|79453820|FG003|Overall Study|Adverse Event|1|||
44445559|NCT00487942|79453817|FG000|Overall Study|Lost to Follow-up|1|||
44445560|NCT00487942|79453818|FG001|Overall Study|Lost to Follow-up|0|||
44445561|NCT00487942|79453819|FG002|Overall Study|Lost to Follow-up|0|||
44445562|NCT00487942|79453820|FG003|Overall Study|Lost to Follow-up|1|||
44445563|NCT00487942|79453817|FG000|Overall Study|Protocol Violation|1|||
44445564|NCT00487942|79453818|FG001|Overall Study|Protocol Violation|1|||
44445565|NCT00487942|79453819|FG002|Overall Study|Protocol Violation|0|||
44445566|NCT00487942|79453820|FG003|Overall Study|Protocol Violation|0|||
44445567|NCT00487942|79453817|FG000|Overall Study|Withdrawal by Subject|0|||
44163474|NCT04640311|78956518|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163475|NCT04640311|78956519|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163476|NCT04640311|78956520|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163477|NCT04640311|78956521|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44163478|NCT04640311|78956522|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44346775|NCT00950599|79350830|FG005|Follow-Up Period|Lack of Efficacy|0|||
44346776|NCT00950599|79350831|FG006|Follow-Up Period|Lack of Efficacy|0|||
44346777|NCT00950599|79350832|FG007|Follow-Up Period|Lack of Efficacy|0|||
44346778|NCT00950599|79350833|FG008|Follow-Up Period|Lack of Efficacy|3|||
44346779|NCT00950599|79350834|FG009|Follow-Up Period|Lack of Efficacy|0|||
44346780|NCT00950599|79350825|FG000|Follow-Up Period|Lost to Follow-up|0|||
44346781|NCT00950599|79350826|FG001|Follow-Up Period|Lost to Follow-up|0|||
44346782|NCT00950599|79350827|FG002|Follow-Up Period|Lost to Follow-up|0|||
44346783|NCT00950599|79350828|FG003|Follow-Up Period|Lost to Follow-up|0|||
44346784|NCT00950599|79350829|FG004|Follow-Up Period|Lost to Follow-up|0|||
44346785|NCT00950599|79350830|FG005|Follow-Up Period|Lost to Follow-up|0|||
44346786|NCT00950599|79350831|FG006|Follow-Up Period|Lost to Follow-up|0|||
44346787|NCT00950599|79350832|FG007|Follow-Up Period|Lost to Follow-up|0|||
44445568|NCT00487942|79453818|FG001|Overall Study|Withdrawal by Subject|1|||
44445569|NCT00487942|79453819|FG002|Overall Study|Withdrawal by Subject|2|||
44445570|NCT00487942|79453820|FG003|Overall Study|Withdrawal by Subject|0|||
44445571|NCT00132301|79453832|FG000|Overall Study|Death|7|||
44445572|NCT00132301|79453833|FG001|Overall Study|Death|6|||
44445573|NCT00132301|79453832|FG000|Overall Study|Withdrawal by Subject|5|||
44445574|NCT00132301|79453833|FG001|Overall Study|Withdrawal by Subject|2|||
44445575|NCT00132301|79453832|FG000|Overall Study|Physician Decision|1|||
44445576|NCT00132301|79453833|FG001|Overall Study|Physician Decision|1|||
44445577|NCT00132301|79453832|FG000|Overall Study|Lost to Follow-up|5|||
44445578|NCT00132301|79453833|FG001|Overall Study|Lost to Follow-up|3|||
44445579|NCT00132301|79453832|FG000|Overall Study|Other|1|||
44445580|NCT00132301|79453833|FG001|Overall Study|Other|1|||
44445581|NCT00132301|79453832|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
44445582|NCT00132301|79453833|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
44445583|NCT00522873|79453841|FG000|Overall Study|Adverse Event|41|||
44445584|NCT00522873|79453842|FG001|Overall Study|Adverse Event|26|||
44445585|NCT00522873|79453841|FG000|Overall Study|Withdrawal by Subject|20|||
44445586|NCT00522873|79453842|FG001|Overall Study|Withdrawal by Subject|9|||
44445587|NCT00522873|79453841|FG000|Overall Study|Protocol Violation|14|||
44445588|NCT00522873|79453842|FG001|Overall Study|Protocol Violation|4|||
44445589|NCT00522873|79453841|FG000|Overall Study|Lost to Follow-up|11|||
44445590|NCT00522873|79453842|FG001|Overall Study|Lost to Follow-up|3|||
44445591|NCT00522873|79453841|FG000|Overall Study|Personal Reasons|8|||
44445592|NCT00522873|79453842|FG001|Overall Study|Personal Reasons|1|||
44445593|NCT00522873|79453841|FG000|Overall Study|Medication Errors|1|||
44445594|NCT00522873|79453842|FG001|Overall Study|Medication Errors|1|||
44445595|NCT00522873|79453841|FG000|Overall Study|Never Received Medication|1|||
44445596|NCT00522873|79453842|FG001|Overall Study|Never Received Medication|0|||
44445597|NCT03684057|79453850|FG000|Overall Study|Withdrawal by Subject|4|||
44445598|NCT03684057|79453851|FG001|Overall Study|Withdrawal by Subject|5|||
44445599|NCT03864627|79453860|FG000|Overall Study|Adverse Event|0|||
44445600|NCT03864627|79453861|FG001|Overall Study|Adverse Event|1|||
44445601|NCT03864627|79453860|FG000|Overall Study|Lack of Efficacy|0|||
44445602|NCT03864627|79453861|FG001|Overall Study|Lack of Efficacy|1|||
44445603|NCT03864627|79453860|FG000|Overall Study|Lost to Follow-up|0|||
44445604|NCT03864627|79453861|FG001|Overall Study|Lost to Follow-up|1|||
44445605|NCT03864627|79453860|FG000|Overall Study|Withdrawal by Subject|4|||
44445606|NCT03864627|79453861|FG001|Overall Study|Withdrawal by Subject|8|||
44445607|NCT03864627|79453860|FG000|Overall Study|Study terminated by sponsor|0|||
44445608|NCT03864627|79453861|FG001|Overall Study|Study terminated by sponsor|1|||
44445609|NCT00519831|79453868|FG000|Overall Study|Adverse Event|3|||
44445610|NCT00131911|79453878|FG000|Overall Study|Withdrawal by Subject|1|||
44445611|NCT00131911|79453879|FG001|Overall Study|Withdrawal by Subject|0|||
44445612|NCT00184093|79453884|FG000|Overall Study|Adverse Event|3|||
44445613|NCT00184093|79453884|FG000|Overall Study|Lost to Follow-up|3|||
44445614|NCT00184093|79453884|FG000|Overall Study|Physician Decision|1|||
44445615|NCT00184093|79453884|FG000|Overall Study|Withdrawal by Subject|2|||
44445616|NCT00183625|79453890|FG000|Overall Study|Withdrawal by Subject|18|||
44445617|NCT00183625|79453891|FG001|Overall Study|Withdrawal by Subject|18|||
44445618|NCT00183625|79453892|FG002|Overall Study|Withdrawal by Subject|19|||
44445619|NCT00183625|79453893|FG003|Overall Study|Withdrawal by Subject|14|||
44445620|NCT00511875|79453903|FG000|Overall Study|Lost to Follow-up|4|||
44445621|NCT00511875|79453904|FG001|Overall Study|Lost to Follow-up|0|||
44445622|NCT00511875|79453903|FG000|Overall Study|Missing variables|1|||
44445623|NCT00511875|79453904|FG001|Overall Study|Missing variables|0|||
44445624|NCT00183391|79453912|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
44445625|NCT00183391|79453913|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
44445626|NCT00183391|79453912|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
44445627|NCT00183391|79453913|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
44445628|NCT00493246|79453929|FG000|Overall Study|Withdrawal by Subject|0|||
44445629|NCT00493246|79453930|FG001|Overall Study|Withdrawal by Subject|0|||
44445630|NCT00493246|79453931|FG002|Overall Study|Withdrawal by Subject|0|||
44445631|NCT00493246|79453932|FG003|Overall Study|Withdrawal by Subject|0|||
44445632|NCT00493246|79453933|FG004|Overall Study|Withdrawal by Subject|1|||
44445633|NCT00493246|79453934|FG005|Overall Study|Withdrawal by Subject|0|||
44445634|NCT00493246|79453935|FG006|Overall Study|Withdrawal by Subject|0|||
44445635|NCT00493246|79453936|FG007|Overall Study|Withdrawal by Subject|0|||
44445636|NCT00493246|79453929|FG000|Overall Study|No access to draw blood|0|||
44445637|NCT00493246|79453930|FG001|Overall Study|No access to draw blood|0|||
44445638|NCT00493246|79453931|FG002|Overall Study|No access to draw blood|0|||
44445639|NCT00493246|79453932|FG003|Overall Study|No access to draw blood|0|||
44445640|NCT00493246|79453933|FG004|Overall Study|No access to draw blood|0|||
44445641|NCT00493246|79453934|FG005|Overall Study|No access to draw blood|1|||
44445642|NCT00493246|79453935|FG006|Overall Study|No access to draw blood|0|||
44445643|NCT00493246|79453936|FG007|Overall Study|No access to draw blood|0|||
44445644|NCT00493246|79453929|FG000|Overall Study|Lost to Follow-up|0|||
44445645|NCT00493246|79453930|FG001|Overall Study|Lost to Follow-up|0|||
44445646|NCT00493246|79453931|FG002|Overall Study|Lost to Follow-up|0|||
44445647|NCT00493246|79453932|FG003|Overall Study|Lost to Follow-up|0|||
44445648|NCT00493246|79453933|FG004|Overall Study|Lost to Follow-up|0|||
44445649|NCT00493246|79453934|FG005|Overall Study|Lost to Follow-up|0|||
44445650|NCT00493246|79453935|FG006|Overall Study|Lost to Follow-up|1|||
44445651|NCT00493246|79453936|FG007|Overall Study|Lost to Follow-up|0|||
44445652|NCT02281955|79453954|FG000|Overall Study|Death|1|||
44445653|NCT00511797|79453962|FG000|Overall Study|Adverse Event|1|||
44445654|NCT00511797|79453963|FG001|Overall Study|Adverse Event|2|||
44445655|NCT00511797|79453964|FG002|Overall Study|Adverse Event|2|||
44445656|NCT00511797|79453965|FG003|Overall Study|Adverse Event|2|||
44445657|NCT00511797|79453962|FG000|Overall Study|Lost to Follow-up|1|||
44445658|NCT00511797|79453963|FG001|Overall Study|Lost to Follow-up|0|||
44445659|NCT00511797|79453964|FG002|Overall Study|Lost to Follow-up|0|||
44445660|NCT00511797|79453965|FG003|Overall Study|Lost to Follow-up|1|||
44445661|NCT00511797|79453962|FG000|Overall Study|Pregnancy|0|||
44445662|NCT00511797|79453963|FG001|Overall Study|Pregnancy|0|||
44445663|NCT00511797|79453964|FG002|Overall Study|Pregnancy|0|||
44445664|NCT00511797|79453965|FG003|Overall Study|Pregnancy|1|||
44445665|NCT00511797|79453962|FG000|Overall Study|Protocol Violation|0|||
44445666|NCT00511797|79453963|FG001|Overall Study|Protocol Violation|2|||
44445667|NCT00511797|79453964|FG002|Overall Study|Protocol Violation|2|||
44445668|NCT00511797|79453965|FG003|Overall Study|Protocol Violation|3|||
44445669|NCT00511797|79453962|FG000|Overall Study|Withdrawal by Subject|3|||
44445670|NCT00511797|79453963|FG001|Overall Study|Withdrawal by Subject|3|||
44445671|NCT00511797|79453964|FG002|Overall Study|Withdrawal by Subject|4|||
44346788|NCT00950599|79350833|FG008|Follow-Up Period|Lost to Follow-up|5|||
44346789|NCT00950599|79350834|FG009|Follow-Up Period|Lost to Follow-up|1|||
44346790|NCT00950599|79350825|FG000|Follow-Up Period|Physician Decision|0|||
44346791|NCT00950599|79350826|FG001|Follow-Up Period|Physician Decision|0|||
44346792|NCT00950599|79350827|FG002|Follow-Up Period|Physician Decision|0|||
44346793|NCT00950599|79350828|FG003|Follow-Up Period|Physician Decision|0|||
44346794|NCT00950599|79350829|FG004|Follow-Up Period|Physician Decision|0|||
44346795|NCT00950599|79350830|FG005|Follow-Up Period|Physician Decision|0|||
44346796|NCT00950599|79350831|FG006|Follow-Up Period|Physician Decision|0|||
44346797|NCT00950599|79350832|FG007|Follow-Up Period|Physician Decision|0|||
44346798|NCT00950599|79350833|FG008|Follow-Up Period|Physician Decision|1|||
44346799|NCT00950599|79350834|FG009|Follow-Up Period|Physician Decision|0|||
44346800|NCT00950599|79350825|FG000|Follow-Up Period|Poor/Noncompliance|0|||
44346801|NCT00950599|79350826|FG001|Follow-Up Period|Poor/Noncompliance|0|||
44346802|NCT00950599|79350827|FG002|Follow-Up Period|Poor/Noncompliance|0|||
44346803|NCT00950599|79350828|FG003|Follow-Up Period|Poor/Noncompliance|0|||
44346804|NCT00950599|79350829|FG004|Follow-Up Period|Poor/Noncompliance|0|||
44346805|NCT00950599|79350830|FG005|Follow-Up Period|Poor/Noncompliance|0|||
44346806|NCT00950599|79350831|FG006|Follow-Up Period|Poor/Noncompliance|0|||
44346807|NCT00950599|79350832|FG007|Follow-Up Period|Poor/Noncompliance|0|||
44346808|NCT00950599|79350833|FG008|Follow-Up Period|Poor/Noncompliance|1|||
44346809|NCT00950599|79350834|FG009|Follow-Up Period|Poor/Noncompliance|0|||
44346810|NCT00950599|79350825|FG000|Follow-Up Period|Subject withdrew Consent|0|||
44346811|NCT00950599|79350826|FG001|Follow-Up Period|Subject withdrew Consent|0|||
44346812|NCT00950599|79350827|FG002|Follow-Up Period|Subject withdrew Consent|0|||
44346813|NCT00950599|79350828|FG003|Follow-Up Period|Subject withdrew Consent|0|||
44346814|NCT00950599|79350829|FG004|Follow-Up Period|Subject withdrew Consent|0|||
44346815|NCT00950599|79350830|FG005|Follow-Up Period|Subject withdrew Consent|0|||
44346816|NCT00950599|79350831|FG006|Follow-Up Period|Subject withdrew Consent|0|||
44346817|NCT00950599|79350832|FG007|Follow-Up Period|Subject withdrew Consent|0|||
44346818|NCT00950599|79350833|FG008|Follow-Up Period|Subject withdrew Consent|2|||
44346819|NCT00950599|79350834|FG009|Follow-Up Period|Subject withdrew Consent|1|||
44346820|NCT01144299|79350859|FG000|Overall Study|Lost to Follow-up|1|||
44346821|NCT01144299|79350860|FG001|Overall Study|Lost to Follow-up|0|||
44346822|NCT01144299|79350859|FG000|Overall Study|Withdrawal by Subject|1|||
44346823|NCT01144299|79350860|FG001|Overall Study|Withdrawal by Subject|0|||
44346824|NCT01143207|79350866|FG000|Overall Study|Lost to Follow-up|2|||
44346825|NCT01143051|79350876|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
44346826|NCT01143051|79350877|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
44346827|NCT01143051|79350878|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
44346828|NCT01143051|79350879|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
44346829|NCT01143051|79350880|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
44346830|NCT01143051|79350881|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
44346831|NCT01143051|79350876|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
44346832|NCT01143051|79350877|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
44346833|NCT01143051|79350878|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
44346834|NCT01143051|79350879|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
44346835|NCT01143051|79350880|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
44346836|NCT01143051|79350881|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
44445672|NCT00511797|79453965|FG003|Overall Study|Withdrawal by Subject|2|||
44445673|NCT00511797|79453962|FG000|Overall Study|Never dispensed|1|||
44346837|NCT01142661|79350891|FG000|Overall Study|Adverse Event|2|||
44346838|NCT01142661|79350891|FG000|Overall Study|Withdrawal by Subject|1|||
44346839|NCT01142661|79350891|FG000|Overall Study|Physician Decision|1|||
44346840|NCT01142193|79350897|FG000|Overall Study|Adverse Event|12|||
44346841|NCT01142193|79350898|FG001|Overall Study|Adverse Event|4|||
44445674|NCT00511797|79453963|FG001|Overall Study|Never dispensed|0|||
44445675|NCT00511797|79453964|FG002|Overall Study|Never dispensed|1|||
44445676|NCT00511797|79453965|FG003|Overall Study|Never dispensed|3|||
44445677|NCT00511797|79453962|FG000|Overall Study|Study drug not taken|0|||
44445678|NCT00511797|79453963|FG001|Overall Study|Study drug not taken|1|||
44445679|NCT00511797|79453964|FG002|Overall Study|Study drug not taken|0|||
44346842|NCT01142193|79350897|FG000|Overall Study|Lack of Efficacy|2|||
44346843|NCT01142193|79350898|FG001|Overall Study|Lack of Efficacy|1|||
44346844|NCT01142193|79350897|FG000|Overall Study|Physician Decision|1|||
44346845|NCT01142193|79350898|FG001|Overall Study|Physician Decision|1|||
44163479|NCT04640311|78956523|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
44346846|NCT01142193|79350897|FG000|Overall Study|Withdrawal by Subject|4|||
44346847|NCT01142193|79350898|FG001|Overall Study|Withdrawal by Subject|3|||
44346848|NCT01142193|79350897|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
44346849|NCT01142193|79350898|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
44346850|NCT01142193|79350897|FG000|Overall Study|Other|1|||
44346851|NCT01142193|79350898|FG001|Overall Study|Other|2|||
44445680|NCT00511797|79453965|FG003|Overall Study|Study drug not taken|1|||
44346852|NCT01142115|79350904|FG000|First Intervention|Lack of Efficacy|1|||
44163480|NCT04640311|78956511|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163481|NCT04640311|78956512|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163482|NCT04640311|78956513|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
44163483|NCT04640311|78956514|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163484|NCT04640311|78956515|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163485|NCT04640311|78956516|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163486|NCT04640311|78956517|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163487|NCT04640311|78956518|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163488|NCT04640311|78956519|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163489|NCT04640311|78956520|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163490|NCT04640311|78956521|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163491|NCT04640311|78956522|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163492|NCT04640311|78956523|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
44163493|NCT04640311|78956511|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163494|NCT04640311|78956512|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163495|NCT04640311|78956513|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163496|NCT04640311|78956514|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
44346853|NCT01142115|79350905|FG001|First Intervention|Lack of Efficacy|1|||
44346854|NCT01142115|79350904|FG000|First Intervention|Adverse Event|1|||
44346855|NCT01142115|79350905|FG001|First Intervention|Adverse Event|0|||
44346856|NCT01140477|79350912|FG000|Overall Study|Lost to Follow-up|4|||
44346857|NCT01140477|79350913|FG001|Overall Study|Lost to Follow-up|0|||
44346858|NCT01140477|79350912|FG000|Overall Study|Withdrawal by Subject|1|||
44346859|NCT01140477|79350913|FG001|Overall Study|Withdrawal by Subject|4|||
44346860|NCT01140477|79350912|FG000|Overall Study|Surgical complication preventing implant|2|||
44346861|NCT01140477|79350913|FG001|Overall Study|Surgical complication preventing implant|0|||
44346862|NCT01140477|79350912|FG000|Overall Study|Death|1|||
44346863|NCT01140477|79350913|FG001|Overall Study|Death|1|||
44346864|NCT01140477|79350912|FG000|Overall Study|Subject explanted|0|||
44346865|NCT01140477|79350913|FG001|Overall Study|Subject explanted|1|||
44346866|NCT01139775|79350922|FG000|Overall Study|Adverse Event|0|||
44346867|NCT01139775|79350923|FG001|Overall Study|Adverse Event|6|||
44346868|NCT01139775|79350924|FG002|Overall Study|Adverse Event|2|||
44346869|NCT01139775|79350922|FG000|Overall Study|Protocol Violation|0|||
44346870|NCT01139775|79350923|FG001|Overall Study|Protocol Violation|5|||
44346871|NCT01139775|79350924|FG002|Overall Study|Protocol Violation|0|||
44346872|NCT01139775|79350922|FG000|Overall Study|Withdrawal by Subject|1|||
44346873|NCT01139775|79350923|FG001|Overall Study|Withdrawal by Subject|0|||
44346874|NCT01139775|79350924|FG002|Overall Study|Withdrawal by Subject|2|||
44346875|NCT01139775|79350922|FG000|Overall Study|Physician Decision|0|||
44346876|NCT01139775|79350923|FG001|Overall Study|Physician Decision|2|||
44346877|NCT01139775|79350924|FG002|Overall Study|Physician Decision|2|||
44346878|NCT01283516|79350943|FG000|Overall Study|Adverse Event|0|||
44346879|NCT01283516|79350944|FG001|Overall Study|Adverse Event|0|||
44346880|NCT01283516|79350945|FG002|Overall Study|Adverse Event|0|||
44346881|NCT01283516|79350946|FG003|Overall Study|Adverse Event|0|||
44445681|NCT00511797|79453962|FG000|Overall Study|Partially missing diary|0|||
44445682|NCT00511797|79453963|FG001|Overall Study|Partially missing diary|0|||
44445683|NCT00511797|79453964|FG002|Overall Study|Partially missing diary|1|||
44346882|NCT01283516|79350947|FG004|Overall Study|Adverse Event|0|||
44346883|NCT01283516|79350948|FG005|Overall Study|Adverse Event|0|||
44346884|NCT01283516|79350949|FG006|Overall Study|Adverse Event|2|||
44346885|NCT01283516|79350950|FG007|Overall Study|Adverse Event|0|||
44346886|NCT01283516|79350951|FG008|Overall Study|Adverse Event|28|||
44346887|NCT01283516|79350943|FG000|Overall Study|Death|0|||
44346888|NCT01283516|79350944|FG001|Overall Study|Death|0|||
44163497|NCT04640311|78956515|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163498|NCT04640311|78956516|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163499|NCT04640311|78956517|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
44163500|NCT04640311|78956518|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44445684|NCT00511797|79453965|FG003|Overall Study|Partially missing diary|0|||
44346889|NCT01283516|79350945|FG002|Overall Study|Death|0|||
44163501|NCT04640311|78956519|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44346890|NCT01283516|79350946|FG003|Overall Study|Death|0|||
44163502|NCT04640311|78956520|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163503|NCT04640311|78956521|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163504|NCT04640311|78956522|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163505|NCT04640311|78956523|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
44163506|NCT04640311|78956511|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163507|NCT04640311|78956512|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163508|NCT04640311|78956513|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163509|NCT04640311|78956514|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163510|NCT04640311|78956515|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163511|NCT04640311|78956516|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
44163512|NCT04640311|78956517|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163513|NCT04640311|78956518|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163514|NCT04640311|78956519|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
44163515|NCT04640311|78956520|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163516|NCT04640311|78956521|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163517|NCT04640311|78956522|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163518|NCT04640311|78956523|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
44163519|NCT04640311|78956511|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163520|NCT04640311|78956512|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163521|NCT04640311|78956513|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163522|NCT04640311|78956514|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163523|NCT04640311|78956515|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163524|NCT04640311|78956516|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163525|NCT04640311|78956517|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
44163526|NCT04640311|78956518|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163527|NCT04640311|78956519|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163528|NCT04640311|78956520|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163529|NCT04640311|78956521|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
44163530|NCT04640311|78956522|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163531|NCT04640311|78956523|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
44163532|NCT04640311|78956511|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163533|NCT04640311|78956512|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163534|NCT04640311|78956513|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163535|NCT04640311|78956514|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163536|NCT04640311|78956515|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163537|NCT04640311|78956516|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163538|NCT04640311|78956517|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163539|NCT04640311|78956518|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163540|NCT04640311|78956519|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44346891|NCT01283516|79350947|FG004|Overall Study|Death|0|||
44445685|NCT00511797|79453962|FG000|Overall Study|Other (moving etc)|1|||
44163541|NCT04640311|78956520|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163542|NCT04640311|78956521|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163543|NCT04640311|78956522|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
44163544|NCT04640311|78956523|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
44163545|NCT02334423|78956554|FG000|Overall Study|Protocol Violation|10|||
44163546|NCT02334423|78956555|FG001|Overall Study|Protocol Violation|3|||
44163547|NCT02310789|78956561|FG000|Overall Study|Adverse Event|1|||
44163548|NCT02372253|78956567|FG000|Overall Study|Non Compliance|2|||
44163549|NCT02372253|78956568|FG001|Overall Study|Non Compliance|0|||
44163550|NCT02559895|78956580|FG000|Overall Study|Adverse Event|3|||
44163551|NCT02559895|78956581|FG001|Overall Study|Adverse Event|3|||
44163552|NCT02559895|78956582|FG002|Overall Study|Adverse Event|2|||
44163553|NCT02559895|78956583|FG003|Overall Study|Adverse Event|1|||
44163554|NCT02559895|78956580|FG000|Overall Study|Lack of Efficacy|2|||
44163555|NCT02559895|78956581|FG001|Overall Study|Lack of Efficacy|3|||
44163556|NCT02559895|78956582|FG002|Overall Study|Lack of Efficacy|2|||
44163557|NCT02559895|78956583|FG003|Overall Study|Lack of Efficacy|8|||
44163558|NCT02559895|78956580|FG000|Overall Study|Lost to Follow-up|22|||
44163559|NCT02559895|78956581|FG001|Overall Study|Lost to Follow-up|16|||
44163560|NCT02559895|78956582|FG002|Overall Study|Lost to Follow-up|12|||
44163561|NCT02559895|78956583|FG003|Overall Study|Lost to Follow-up|17|||
44163562|NCT02559895|78956580|FG000|Overall Study|Physician Decision|1|||
44163563|NCT02559895|78956581|FG001|Overall Study|Physician Decision|1|||
44163564|NCT02559895|78956582|FG002|Overall Study|Physician Decision|3|||
44163565|NCT02559895|78956583|FG003|Overall Study|Physician Decision|0|||
44163566|NCT02559895|78956580|FG000|Overall Study|Withdrawal by Subject|16|||
44163567|NCT02559895|78956581|FG001|Overall Study|Withdrawal by Subject|9|||
44163568|NCT02559895|78956582|FG002|Overall Study|Withdrawal by Subject|20|||
44163569|NCT02559895|78956583|FG003|Overall Study|Withdrawal by Subject|9|||
44163570|NCT02559895|78956580|FG000|Overall Study|Study Burden|10|||
44163571|NCT02559895|78956581|FG001|Overall Study|Study Burden|16|||
44163572|NCT02559895|78956582|FG002|Overall Study|Study Burden|12|||
44163573|NCT02559895|78956583|FG003|Overall Study|Study Burden|22|||
44163574|NCT02559895|78956580|FG000|Overall Study|Other|1|||
44163575|NCT02559895|78956581|FG001|Overall Study|Other|5|||
44163576|NCT02559895|78956582|FG002|Overall Study|Other|3|||
44163577|NCT02559895|78956583|FG003|Overall Study|Other|3|||
44163578|NCT02371629|78956595|FG000|Overall Study|Patient decision|14|||
44163579|NCT02371629|78956596|FG001|Overall Study|Patient decision|10|||
44163580|NCT02371629|78956595|FG000|Overall Study|Adverse Event|8|||
44163581|NCT02371629|78956596|FG001|Overall Study|Adverse Event|8|||
44163582|NCT02371629|78956595|FG000|Overall Study|Physician Decision|2|||
44163583|NCT02371629|78956596|FG001|Overall Study|Physician Decision|3|||
44163584|NCT02371629|78956595|FG000|Overall Study|Death|1|||
44163585|NCT02371629|78956596|FG001|Overall Study|Death|1|||
44163586|NCT02371629|78956595|FG000|Overall Study|Noncompliance with study treatment|1|||
44163587|NCT02371629|78956596|FG001|Overall Study|Noncompliance with study treatment|0|||
44163588|NCT02371629|78956595|FG000|Overall Study|Lack of Efficacy|0|||
44163589|NCT02371629|78956596|FG001|Overall Study|Lack of Efficacy|2|||
44163590|NCT02371629|78956595|FG000|Overall Study|Protocol deviation|0|||
44163591|NCT02371629|78956596|FG001|Overall Study|Protocol deviation|1|||
44163592|NCT02559817|78956607|FG000|Treatment Period|Adverse Event|1|||
44163593|NCT02559817|78956608|FG001|Treatment Period|Adverse Event|0|||
44163594|NCT02559817|78956609|FG002|Treatment Period|Adverse Event|1|||
44163595|NCT02559817|78956610|FG003|Treatment Period|Adverse Event|0|||
44163596|NCT02559817|78956611|FG004|Treatment Period|Adverse Event|0|||
44163597|NCT02559817|78956607|FG000|Treatment Period|Lack of Efficacy|0|||
44163598|NCT02559817|78956608|FG001|Treatment Period|Lack of Efficacy|1|||
44163599|NCT02559817|78956609|FG002|Treatment Period|Lack of Efficacy|0|||
44163600|NCT02559817|78956610|FG003|Treatment Period|Lack of Efficacy|0|||
44163601|NCT02559817|78956611|FG004|Treatment Period|Lack of Efficacy|0|||
44163602|NCT02559817|78956607|FG000|Treatment Period|Lost to Follow-up|0|||
44163603|NCT02559817|78956608|FG001|Treatment Period|Lost to Follow-up|1|||
44163604|NCT02559817|78956609|FG002|Treatment Period|Lost to Follow-up|0|||
44163605|NCT02559817|78956610|FG003|Treatment Period|Lost to Follow-up|1|||
44163606|NCT02559817|78956611|FG004|Treatment Period|Lost to Follow-up|0|||
44163607|NCT02559817|78956607|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
44163608|NCT02559817|78956608|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
44163609|NCT02559817|78956609|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
44163610|NCT02559817|78956610|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
44163611|NCT02559817|78956611|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
44163612|NCT02559817|78956607|FG000|Treatment Period|Protocol Violation|0|||
44163613|NCT02559817|78956608|FG001|Treatment Period|Protocol Violation|0|||
44163614|NCT02559817|78956609|FG002|Treatment Period|Protocol Violation|0|||
44163615|NCT02559817|78956610|FG003|Treatment Period|Protocol Violation|1|||
44163616|NCT02559817|78956611|FG004|Treatment Period|Protocol Violation|0|||
44163617|NCT02564887|78956625|FG000|Overall Study|Lost to Follow-up|6|||
44163618|NCT02564887|78956626|FG001|Overall Study|Lost to Follow-up|0|||
44163619|NCT02333487|78956637|FG000|Overall Study|Adverse Event|0|||
44163620|NCT02333487|78956638|FG001|Overall Study|Adverse Event|2|||
44163621|NCT02333487|78956639|FG002|Overall Study|Adverse Event|0|||
44163622|NCT02333331|78956652|FG000|Overall Study|Adverse Event|1|||
44163623|NCT02333331|78956653|FG001|Overall Study|Adverse Event|0|||
44163624|NCT02333331|78956654|FG002|Overall Study|Adverse Event|4|||
44163625|NCT02333331|78956655|FG003|Overall Study|Adverse Event|1|||
44163626|NCT02333331|78956652|FG000|Overall Study|Death|0|||
44163627|NCT02333331|78956653|FG001|Overall Study|Death|0|||
44163628|NCT02333331|78956654|FG002|Overall Study|Death|2|||
44163629|NCT02333331|78956655|FG003|Overall Study|Death|0|||
44163630|NCT02333331|78956652|FG000|Overall Study|Lost to Follow-up|0|||
44163631|NCT02333331|78956653|FG001|Overall Study|Lost to Follow-up|0|||
44163632|NCT02333331|78956654|FG002|Overall Study|Lost to Follow-up|1|||
44163633|NCT02333331|78956655|FG003|Overall Study|Lost to Follow-up|0|||
44163634|NCT02333331|78956652|FG000|Overall Study|Physician Decision|0|||
44163635|NCT02333331|78956653|FG001|Overall Study|Physician Decision|1|||
44163636|NCT02333331|78956654|FG002|Overall Study|Physician Decision|0|||
44163637|NCT02333331|78956655|FG003|Overall Study|Physician Decision|0|||
44163638|NCT02333331|78956652|FG000|Overall Study|Protocol Deviation|0|||
44163639|NCT02333331|78956653|FG001|Overall Study|Protocol Deviation|3|||
44163640|NCT02333331|78956654|FG002|Overall Study|Protocol Deviation|2|||
44163641|NCT02333331|78956655|FG003|Overall Study|Protocol Deviation|1|||
44163642|NCT02333331|78956652|FG000|Overall Study|Patient/Guardian Decision|1|||
44163643|NCT02333331|78956653|FG001|Overall Study|Patient/Guardian Decision|2|||
44163644|NCT02333331|78956654|FG002|Overall Study|Patient/Guardian Decision|9|||
44163645|NCT02333331|78956655|FG003|Overall Study|Patient/Guardian Decision|1|||
44163646|NCT02563561|78956668|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
44346892|NCT01283516|79350948|FG005|Overall Study|Death|1|||
44346893|NCT01283516|79350949|FG006|Overall Study|Death|0|||
44346894|NCT01283516|79350950|FG007|Overall Study|Death|1|||
44346895|NCT01283516|79350951|FG008|Overall Study|Death|12|||
44346896|NCT01283516|79350943|FG000|Overall Study|Disease Progression|2|||
44346897|NCT01283516|79350944|FG001|Overall Study|Disease Progression|2|||
44346898|NCT01283516|79350945|FG002|Overall Study|Disease Progression|3|||
44346899|NCT01283516|79350946|FG003|Overall Study|Disease Progression|3|||
44346900|NCT01283516|79350947|FG004|Overall Study|Disease Progression|13|||
44346901|NCT01283516|79350948|FG005|Overall Study|Disease Progression|8|||
44346902|NCT01283516|79350949|FG006|Overall Study|Disease Progression|6|||
44346903|NCT01283516|79350950|FG007|Overall Study|Disease Progression|3|||
44346904|NCT01283516|79350951|FG008|Overall Study|Disease Progression|139|||
44346905|NCT01283516|79350943|FG000|Overall Study|Withdrawal by Subject|0|||
44346906|NCT01283516|79350944|FG001|Overall Study|Withdrawal by Subject|0|||
44346907|NCT01283516|79350945|FG002|Overall Study|Withdrawal by Subject|0|||
44346908|NCT01283516|79350946|FG003|Overall Study|Withdrawal by Subject|0|||
44346909|NCT01283516|79350947|FG004|Overall Study|Withdrawal by Subject|1|||
44346910|NCT01283516|79350948|FG005|Overall Study|Withdrawal by Subject|0|||
44346911|NCT01283516|79350949|FG006|Overall Study|Withdrawal by Subject|1|||
44346912|NCT01283516|79350950|FG007|Overall Study|Withdrawal by Subject|0|||
44346913|NCT01283516|79350951|FG008|Overall Study|Withdrawal by Subject|36|||
44346914|NCT01283516|79350943|FG000|Overall Study|Administrative problems|0|||
44346915|NCT01283516|79350944|FG001|Overall Study|Administrative problems|0|||
44346916|NCT01283516|79350945|FG002|Overall Study|Administrative problems|0|||
44346917|NCT01283516|79350946|FG003|Overall Study|Administrative problems|0|||
44346918|NCT01283516|79350947|FG004|Overall Study|Administrative problems|0|||
44346919|NCT01283516|79350948|FG005|Overall Study|Administrative problems|1|||
44163647|NCT02563561|78956669|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
44163648|NCT02563561|78956670|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
44163649|NCT02563561|78956668|FG000|Overall Study|Withdrew of Consent|1|||
44163650|NCT02563561|78956669|FG001|Overall Study|Withdrew of Consent|1|||
44163651|NCT02563561|78956670|FG002|Overall Study|Withdrew of Consent|2|||
44163652|NCT02563561|78956668|FG000|Overall Study|Lost to Follow-up|1|||
44163653|NCT02563561|78956669|FG001|Overall Study|Lost to Follow-up|1|||
44346920|NCT01283516|79350949|FG006|Overall Study|Administrative problems|1|||
44346921|NCT01283516|79350950|FG007|Overall Study|Administrative problems|1|||
44346922|NCT01283516|79350951|FG008|Overall Study|Administrative problems|39|||
44346923|NCT01283516|79350943|FG000|Overall Study|Lost to Follow-up|0|||
44346924|NCT01283516|79350944|FG001|Overall Study|Lost to Follow-up|0|||
44346925|NCT01283516|79350945|FG002|Overall Study|Lost to Follow-up|0|||
44346926|NCT01283516|79350946|FG003|Overall Study|Lost to Follow-up|0|||
44346927|NCT01283516|79350947|FG004|Overall Study|Lost to Follow-up|0|||
44346928|NCT01283516|79350948|FG005|Overall Study|Lost to Follow-up|0|||
44346929|NCT01283516|79350949|FG006|Overall Study|Lost to Follow-up|0|||
44346930|NCT01283516|79350950|FG007|Overall Study|Lost to Follow-up|0|||
44346931|NCT01283516|79350951|FG008|Overall Study|Lost to Follow-up|1|||
44346932|NCT01137435|79350979|FG000|Overall Study|Lost to Follow-up|24|||
44346933|NCT01137435|79350979|FG000|Overall Study|Off label usage|4|||
44346934|NCT01283282|79350983|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
44346935|NCT01283282|79350984|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
44346936|NCT01283282|79350983|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
44346937|NCT01283282|79350984|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
44346938|NCT01283282|79350983|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
44346939|NCT01283282|79350984|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
44346940|NCT01282814|79350993|FG000|First Intervention|Emesis During Dosing Interval|0|||
44346941|NCT01282814|79350994|FG001|First Intervention|Emesis During Dosing Interval|3|||
44346942|NCT01282814|79350993|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
44346943|NCT01282814|79350994|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
44346944|NCT00941863|79351005|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
44346945|NCT00941863|79351006|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
44346946|NCT00941863|79351007|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
44346947|NCT00941863|79351008|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
44346948|NCT00941863|79351009|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
44346949|NCT00941863|79351005|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
44346950|NCT00941863|79351006|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
44346951|NCT00941863|79351007|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
44346952|NCT00941863|79351008|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
44346953|NCT00941863|79351009|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
44346954|NCT00941863|79351005|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
44346955|NCT00941863|79351006|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
44346956|NCT00941863|79351007|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
44346957|NCT00941863|79351008|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
44346958|NCT00941863|79351009|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
44346959|NCT00941863|79351005|FG000|Until Primary Completion Date (PCD)|Death|0|||
44346960|NCT00941863|79351006|FG001|Until Primary Completion Date (PCD)|Death|0|||
44346961|NCT00941863|79351007|FG002|Until Primary Completion Date (PCD)|Death|1|||
44346962|NCT00941863|79351008|FG003|Until Primary Completion Date (PCD)|Death|2|||
44346963|NCT00941863|79351009|FG004|Until Primary Completion Date (PCD)|Death|7|||
44346964|NCT00941863|79351005|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
44346965|NCT00941863|79351006|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
44346966|NCT00941863|79351007|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
44346967|NCT00941863|79351008|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
44346968|NCT00941863|79351009|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
44346969|NCT00941863|79351005|FG000|Continued After PCD|Withdrawal by Subject|0|||
44346970|NCT00941863|79351006|FG001|Continued After PCD|Withdrawal by Subject|0|||
44346971|NCT00941863|79351007|FG002|Continued After PCD|Withdrawal by Subject|0|||
44346972|NCT00941863|79351008|FG003|Continued After PCD|Withdrawal by Subject|0|||
44346973|NCT00941863|79351009|FG004|Continued After PCD|Withdrawal by Subject|1|||
44346974|NCT00941863|79351005|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
44346975|NCT00941863|79351006|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
44346976|NCT00941863|79351007|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
44346977|NCT00941863|79351008|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
44346978|NCT00941863|79351009|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
44346979|NCT01282424|79351025|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
44346980|NCT01282424|79351025|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
44346981|NCT01282424|79351025|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
44346982|NCT01282424|79351025|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
44346983|NCT01282424|79351025|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
44346984|NCT01282424|79351025|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
44346985|NCT01282424|79351025|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
44346986|NCT01282424|79351025|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
44346987|NCT01281956|79351029|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
44346988|NCT01281956|79351030|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
44346989|NCT00949975|79351043|FG000|Overall Study|Voluntary discontinuation|6|||
44346990|NCT00949975|79351044|FG001|Overall Study|Voluntary discontinuation|5|||
44346991|NCT00949975|79351045|FG002|Overall Study|Voluntary discontinuation|3|||
44445686|NCT00511797|79453963|FG001|Overall Study|Other (moving etc)|0|||
44346992|NCT00949975|79351046|FG003|Overall Study|Voluntary discontinuation|6|||
44346993|NCT00949975|79351043|FG000|Overall Study|Adverse Event|11|||
44346994|NCT00949975|79351044|FG001|Overall Study|Adverse Event|11|||
44346995|NCT00949975|79351045|FG002|Overall Study|Adverse Event|10|||
44346996|NCT00949975|79351046|FG003|Overall Study|Adverse Event|10|||
44346997|NCT00949975|79351043|FG000|Overall Study|Safety reason|0|||
44346998|NCT00949975|79351044|FG001|Overall Study|Safety reason|1|||
44346999|NCT00949975|79351045|FG002|Overall Study|Safety reason|0|||
44347000|NCT00949975|79351046|FG003|Overall Study|Safety reason|0|||
44347001|NCT00949975|79351043|FG000|Overall Study|Study-specific criteria|0|||
44347002|NCT00949975|79351044|FG001|Overall Study|Study-specific criteria|1|||
44347003|NCT00949975|79351045|FG002|Overall Study|Study-specific criteria|1|||
44347004|NCT00949975|79351046|FG003|Overall Study|Study-specific criteria|0|||
44347005|NCT00949975|79351043|FG000|Overall Study|Incorrect enrolment|5|||
44347006|NCT00949975|79351044|FG001|Overall Study|Incorrect enrolment|10|||
44347007|NCT00949975|79351045|FG002|Overall Study|Incorrect enrolment|4|||
44347008|NCT00949975|79351046|FG003|Overall Study|Incorrect enrolment|7|||
44347009|NCT00949975|79351043|FG000|Overall Study|Severe non-compliance|3|||
44347010|NCT00949975|79351044|FG001|Overall Study|Severe non-compliance|1|||
44347011|NCT00949975|79351045|FG002|Overall Study|Severe non-compliance|0|||
44347012|NCT00949975|79351046|FG003|Overall Study|Severe non-compliance|2|||
44347013|NCT00949975|79351043|FG000|Overall Study|Lost to Follow-up|1|||
44347014|NCT00949975|79351044|FG001|Overall Study|Lost to Follow-up|0|||
44347015|NCT00949975|79351045|FG002|Overall Study|Lost to Follow-up|1|||
44347016|NCT00949975|79351046|FG003|Overall Study|Lost to Follow-up|3|||
44347017|NCT00949975|79351043|FG000|Overall Study|Other|1|||
44347018|NCT00949975|79351044|FG001|Overall Study|Other|0|||
44347019|NCT00949975|79351045|FG002|Overall Study|Other|0|||
44347020|NCT00949975|79351046|FG003|Overall Study|Other|0|||
44347021|NCT00939055|79351058|FG000|Overall Study|Discontinuation prior to procedure|4|||
44347022|NCT00939055|79351059|FG001|Overall Study|Discontinuation prior to procedure|0|||
44347023|NCT01136967|79351068|FG000|Overall Study|Adverse Event|9|||
44347024|NCT01136967|79351069|FG001|Overall Study|Adverse Event|12|||
44347025|NCT01136967|79351068|FG000|Overall Study|Participant Choice|8|||
44347026|NCT01136967|79351069|FG001|Overall Study|Participant Choice|3|||
44347027|NCT01136967|79351068|FG000|Overall Study|Lost to Follow-up|0|||
44347028|NCT01136967|79351069|FG001|Overall Study|Lost to Follow-up|1|||
44347029|NCT01136967|79351068|FG000|Overall Study|Withdrawal by Subject|1|||
44347030|NCT01136967|79351069|FG001|Overall Study|Withdrawal by Subject|2|||
44347031|NCT01136967|79351068|FG000|Overall Study|Clinical Progression|3|||
44347032|NCT01136967|79351069|FG001|Overall Study|Clinical Progression|5|||
44347033|NCT01136967|79351068|FG000|Overall Study|Radiation|1|||
44347034|NCT01136967|79351069|FG001|Overall Study|Radiation|0|||
44347035|NCT01136967|79351068|FG000|Overall Study|Non-compliance|1|||
44347036|NCT01136967|79351069|FG001|Overall Study|Non-compliance|0|||
44347037|NCT01136967|79351068|FG000|Overall Study|Investigator's Choice|1|||
44347038|NCT01136967|79351069|FG001|Overall Study|Investigator's Choice|1|||
44347039|NCT01136967|79351068|FG000|Overall Study|Increase in Lesion Size|0|||
44347040|NCT01136967|79351069|FG001|Overall Study|Increase in Lesion Size|2|||
44347041|NCT01136967|79351068|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
44347042|NCT01136967|79351069|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
44347043|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
44347044|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
44347045|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
44347046|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
44347047|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
44347048|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
44347049|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
44347050|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
44347051|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
44347052|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
44347053|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
44347054|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
44347055|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
44347056|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
44347057|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
44347058|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
44347059|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
44347060|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
44347061|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
44347062|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
44347063|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
44347064|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
44347065|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
44347066|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
44347067|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
44347068|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
44347069|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
44347070|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
44347071|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
44347072|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
44347073|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
44347074|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
44347075|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
44347076|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
44347077|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
44347078|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
44347079|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
44347080|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
44347081|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
44347082|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
44347083|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
44347084|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
44347085|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
44347086|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
44347087|NCT01218516|79351077|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
44347088|NCT01218516|79351078|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
44347089|NCT01218516|79351079|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
44347090|NCT01218516|79351080|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
44347091|NCT00938431|79351093|FG000|Overall Study|Adverse Event|5|||
44347092|NCT00938431|79351094|FG001|Overall Study|Adverse Event|8|||
44347093|NCT00938431|79351095|FG002|Overall Study|Adverse Event|6|||
44347094|NCT00938431|79351093|FG000|Overall Study|Lack of Efficacy|0|||
44347095|NCT00938431|79351094|FG001|Overall Study|Lack of Efficacy|1|||
44347096|NCT00938431|79351095|FG002|Overall Study|Lack of Efficacy|0|||
44347097|NCT00938431|79351093|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
44347098|NCT00938431|79351094|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
44347099|NCT00938431|79351095|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
44347100|NCT00938431|79351093|FG000|Overall Study|Dosing compliance issue|0|||
44347101|NCT00938431|79351094|FG001|Overall Study|Dosing compliance issue|0|||
44347102|NCT00938431|79351095|FG002|Overall Study|Dosing compliance issue|1|||
44347103|NCT00938431|79351093|FG000|Overall Study|Reached maximum dose early|0|||
44347104|NCT00938431|79351094|FG001|Overall Study|Reached maximum dose early|0|||
44347105|NCT00938431|79351095|FG002|Overall Study|Reached maximum dose early|1|||
44347106|NCT01136811|79351107|FG000|Overall Study|Physician Decision|11|||
44347107|NCT00949117|79351113|FG000|Overall Study|Lack of Efficacy|2|||
44347108|NCT00949117|79351114|FG001|Overall Study|Lack of Efficacy|3|||
44347109|NCT00949117|79351113|FG000|Overall Study|Protocol Violation|1|||
44347110|NCT00949117|79351114|FG001|Overall Study|Protocol Violation|1|||
44347111|NCT00949117|79351113|FG000|Overall Study|Adverse Event|0|||
44347112|NCT00949117|79351114|FG001|Overall Study|Adverse Event|1|||
44347113|NCT00938041|79351122|FG000|Overall Study|Lost to Follow-up|6|||
44347114|NCT00938041|79351122|FG000|Overall Study|Received Alternative Therapy|1|||
44347115|NCT00938041|79351122|FG000|Overall Study|Progressive Disease|5|||
44347116|NCT00938041|79351122|FG000|Overall Study|Death|12|||
44347117|NCT00938041|79351122|FG000|Overall Study|Adrenal Insufficiency|3|||
44347118|NCT01218438|79351126|FG000|Epoch 1|Physician Decision|2|||
44347119|NCT01218438|79351126|FG000|Epoch 1|Adverse Event|1|||
44347120|NCT01218438|79351126|FG000|Epoch 3|Withdrawal by Subject|3|||
44347121|NCT01218438|79351126|FG000|Epoch 3|Adverse Event|1|||
44347122|NCT01218438|79351126|FG000|Epoch 4|Physician Decision|1|||
44347123|NCT01218438|79351126|FG000|Epoch 4|Withdrawal by Subject|2|||
44347124|NCT00935701|79351200|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
44347125|NCT01277510|79351207|FG000|Double-blind Phase|Non-compliance|0|||
44347126|NCT01277510|79351208|FG001|Double-blind Phase|Non-compliance|1|||
44347127|NCT01277510|79351207|FG000|Double-blind Phase|Adverse Event|1|||
44347128|NCT01277510|79351208|FG001|Double-blind Phase|Adverse Event|0|||
44347129|NCT01277510|79351207|FG000|Double-blind Phase|Withdrawal by Subject|2|||
44347130|NCT01277510|79351208|FG001|Double-blind Phase|Withdrawal by Subject|0|||
44347131|NCT01277510|79351207|FG000|Double-blind Phase|Administrative decision|7|||
44347132|NCT01277510|79351208|FG001|Double-blind Phase|Administrative decision|9|||
44347133|NCT01277510|79351207|FG000|Double-blind Phase|Death|0|||
44347134|NCT01277510|79351208|FG001|Double-blind Phase|Death|1|||
44347135|NCT01277510|79351207|FG000|Double-blind Phase|Protocol-specified criteria|2|||
44347136|NCT01277510|79351208|FG001|Double-blind Phase|Protocol-specified criteria|6|||
44347137|NCT01277510|79351207|FG000|Double-blind Phase|Other|1|||
44347138|NCT01277510|79351208|FG001|Double-blind Phase|Other|1|||
44347139|NCT01277510|79351207|FG000|Open-label Phase|Administrative decision|4|||
44347140|NCT01277510|79351208|FG001|Open-label Phase|Administrative decision|3|||
44347141|NCT01277510|79351207|FG000|Open-label Phase|Protocol-specified criteria|1|||
44347142|NCT01277510|79351208|FG001|Open-label Phase|Protocol-specified criteria|0|||
44347143|NCT01277510|79351207|FG000|Open-label Phase|Never received investigational product|2|||
44347144|NCT01277510|79351208|FG001|Open-label Phase|Never received investigational product|0|||
44347145|NCT00937495|79351216|FG000|Overall Study|Protocol Violation|2|||
44347146|NCT01268306|79351220|FG000|Overall Study|Lost to Follow-up|1|||
44347147|NCT00936715|79351224|FG000|Overall Study|Investigators Discretion|1|||
44347148|NCT00936715|79351224|FG000|Overall Study|Protocol Violation|1|||
44347149|NCT00936715|79351224|FG000|Overall Study|Safety or Tolerability Reasons|4|||
44347150|NCT01267994|79351228|FG000|Overall Study|Adverse Event|2|||
44347151|NCT00934843|79351235|FG000|Overall Study|Protocol Violation|0|||
44347152|NCT00934843|79351236|FG001|Overall Study|Protocol Violation|1|||
44347153|NCT01266902|79351244|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
44347154|NCT01266902|79351245|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
44347155|NCT01266902|79351246|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
44347156|NCT01266902|79351244|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
44347157|NCT01266902|79351245|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
44347158|NCT01266902|79351246|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
44347159|NCT01266902|79351244|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
44347160|NCT01266902|79351245|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
44347161|NCT01266902|79351246|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
44347162|NCT01266902|79351244|FG000|Period 1 (Main Study)|Adverse Event|3|||
44347163|NCT01266902|79351245|FG001|Period 1 (Main Study)|Adverse Event|11|||
44347164|NCT01266902|79351246|FG002|Period 1 (Main Study)|Adverse Event|0|||
44347165|NCT01266902|79351244|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
44347166|NCT01266902|79351245|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
44347167|NCT01266902|79351246|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
44347168|NCT01266902|79351244|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
44347169|NCT01266902|79351245|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
44347170|NCT01266902|79351246|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
44445687|NCT00511797|79453964|FG002|Overall Study|Other (moving etc)|1|||
44445688|NCT00511797|79453965|FG003|Overall Study|Other (moving etc)|2|||
44445689|NCT00487552|79453975|FG000|Overall Study|Unsuccessful magnet placements|3|||
44445690|NCT00487552|79453975|FG000|Overall Study|Death due to progressive malignancy|2|||
44445691|NCT00487552|79453975|FG000|Overall Study|Stent not placed|1|||
44445692|NCT00182689|79453982|FG000|Overall Study|Adverse Event|8|||
44445693|NCT00182689|79453983|FG001|Overall Study|Adverse Event|11|||
44445694|NCT00182689|79453982|FG000|Overall Study|Withdrawal by Subject|2|||
44445695|NCT00182689|79453983|FG001|Overall Study|Withdrawal by Subject|2|||
44445696|NCT00182689|79453982|FG000|Overall Study|Progression|27|||
44445697|NCT00182689|79453983|FG001|Overall Study|Progression|29|||
44445698|NCT00182689|79453982|FG000|Overall Study|Death|1|||
44445699|NCT00182689|79453983|FG001|Overall Study|Death|0|||
44445700|NCT00182689|79453982|FG000|Overall Study|not protocol specified|0|||
44445701|NCT00182689|79453983|FG001|Overall Study|not protocol specified|3|||
44445702|NCT00182689|79453982|FG000|Overall Study|Ineligible|1|||
44445703|NCT00182689|79453983|FG001|Overall Study|Ineligible|4|||
44445704|NCT00182689|79453982|FG000|Overall Study|Never received treatment|1|||
44445705|NCT00182689|79453983|FG001|Overall Study|Never received treatment|0|||
44445706|NCT03860259|79453995|FG000|Overall Study|Lost to Follow-up|5|||
44445707|NCT03860259|79453996|FG001|Overall Study|Lost to Follow-up|5|||
44445708|NCT03860259|79453995|FG000|Overall Study|Protocol Violation|1|||
44445709|NCT03860259|79453996|FG001|Overall Study|Protocol Violation|0|||
44445710|NCT00131365|79454002|FG000|Overall Study|Withdrawal by Subject|1|||
44445711|NCT00131365|79454002|FG000|Overall Study|Alternative treatment|3|||
44445712|NCT00487240|79454009|FG000|Overall Study|Withdrawal by Subject|12|||
44445713|NCT00487240|79454010|FG001|Overall Study|Withdrawal by Subject|6|||
44445714|NCT00487240|79454009|FG000|Overall Study|Lost to Follow-up|7|||
44445715|NCT00487240|79454010|FG001|Overall Study|Lost to Follow-up|6|||
44445716|NCT00487240|79454009|FG000|Overall Study|Adverse Event|0|||
44445717|NCT00487240|79454010|FG001|Overall Study|Adverse Event|4|||
44445718|NCT00487240|79454009|FG000|Overall Study|Protocol Violation|5|||
44445719|NCT00487240|79454010|FG001|Overall Study|Protocol Violation|5|||
44445720|NCT00487240|79454009|FG000|Overall Study|Entry Criteria Not Met|3|||
44445721|NCT00487240|79454010|FG001|Overall Study|Entry Criteria Not Met|4|||
44445722|NCT00487240|79454009|FG000|Overall Study|Sponsor Decision|2|||
44445723|NCT00487240|79454010|FG001|Overall Study|Sponsor Decision|1|||
44347171|NCT01266902|79351244|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
44347172|NCT01266902|79351245|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
44445724|NCT00487240|79454009|FG000|Overall Study|Physician Decision|2|||
44347173|NCT01266902|79351246|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
44347174|NCT01266902|79351244|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
44347175|NCT01266902|79351245|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
44347176|NCT01266902|79351246|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
44347177|NCT01266902|79351244|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
44347178|NCT01266902|79351245|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
44347179|NCT01266902|79351246|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
44347180|NCT01266902|79351244|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
44347181|NCT01266902|79351245|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
44347182|NCT01266902|79351246|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
44260209|NCT00240071|79126860|FG000|Overall Study|Withdrawal by Subject|3|||
44260210|NCT03761277|79127834|FG000|Enrollment to Implant|Screen Failure|17|||
44347183|NCT01266824|79351256|FG000|Overall Study|Study terminated prior to completion|2|||
44347184|NCT01266824|79351257|FG001|Overall Study|Study terminated prior to completion|3|||
44347185|NCT01266590|79351263|FG000|Overall Study|Adverse Event|3|||
44347186|NCT01266590|79351263|FG000|Overall Study|Lost to Follow-up|1|||
44347187|NCT01266590|79351263|FG000|Overall Study|Withdrawal by Subject|1|||
44163654|NCT02563561|78956670|FG002|Overall Study|Lost to Follow-up|0|||
44347188|NCT01266590|79351263|FG000|Overall Study|Physician Decision|1|||
44347189|NCT01266122|79351272|FG000|Overall Study|Lost to Follow-up|6|||
44347190|NCT01266122|79351273|FG001|Overall Study|Lost to Follow-up|6|||
44347191|NCT01265498|79351281|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
44347192|NCT01265498|79351282|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
44347193|NCT01265420|79351288|FG000|Overall Study|Lost to Follow-up|1|||
44347194|NCT01264718|79351294|FG000|Overall Study|Lost to Follow-up|3|||
44347195|NCT01264718|79351295|FG001|Overall Study|Lost to Follow-up|2|||
44347196|NCT01264718|79351294|FG000|Overall Study|Withdrawal by Subject|9|||
44347197|NCT01264718|79351295|FG001|Overall Study|Withdrawal by Subject|15|||
44347198|NCT01264718|79351294|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
44347199|NCT01264718|79351295|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
44347200|NCT01264016|79351301|FG000|Overall Study|Withdrawal by Subject|1|||
44347201|NCT01264016|79351301|FG000|Overall Study|Felt faint at sight of blood|1|||
44347202|NCT01263782|79351310|FG000|Overall Study|Death|0|||
44347203|NCT01263782|79351311|FG001|Overall Study|Death|0|||
44347204|NCT01263782|79351312|FG002|Overall Study|Death|1|||
44347205|NCT01263782|79351313|FG003|Overall Study|Death|0|||
44347206|NCT01263782|79351310|FG000|Overall Study|Progressive disease|0|||
44347207|NCT01263782|79351311|FG001|Overall Study|Progressive disease|0|||
44347208|NCT01263782|79351312|FG002|Overall Study|Progressive disease|0|||
44347209|NCT01263782|79351313|FG003|Overall Study|Progressive disease|1|||
44347210|NCT01263782|79351310|FG000|Overall Study|Too early|0|||
44347211|NCT01263782|79351311|FG001|Overall Study|Too early|0|||
44347212|NCT01263782|79351312|FG002|Overall Study|Too early|1|||
44347213|NCT01263782|79351313|FG003|Overall Study|Too early|0|||
44347214|NCT01263782|79351310|FG000|Overall Study|Inevaluable|0|||
44347215|NCT01263782|79351311|FG001|Overall Study|Inevaluable|0|||
44347216|NCT01263782|79351312|FG002|Overall Study|Inevaluable|1|||
44347217|NCT01263782|79351313|FG003|Overall Study|Inevaluable|0|||
44347218|NCT01263704|79351323|FG000|Overall Study|Progressive disease|18|||
44347219|NCT01263704|79351323|FG000|Overall Study|Adverse Event|3|||
44347220|NCT01263704|79351323|FG000|Overall Study|Death|2|||
44347221|NCT01263704|79351323|FG000|Overall Study|Patient withdrew consent|2|||
44260211|NCT03761277|79127834|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
44260212|NCT03761277|79127834|FG000|Enrollment to Implant|Physician Decision|2|||
44260213|NCT03761277|79127834|FG000|Enrollment to Implant|Site Closure|3|||
44260214|NCT03761277|79127834|FG000|Enrollment to Implant|Sponsor Request|2|||
44260215|NCT03761277|79127834|FG000|Post-Implant to 6 Months|Adverse Event|2|||
44260216|NCT03761277|79127834|FG000|Post-Implant to 6 Months|Death|1|||
44260217|NCT03761277|79127834|FG000|Post-Implant to 6 Months|Site Closure|2|||
44260218|NCT03761277|79127834|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
44260219|NCT03761277|79127834|FG000|6 Months to 12 Months|Physician Decision|2|||
44260220|NCT03761277|79127834|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
44347222|NCT01263704|79351323|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
44347223|NCT01263704|79351323|FG000|Overall Study|Lost to Follow-up|1|||
44347224|NCT01263704|79351323|FG000|Overall Study|Colon metastases|1|||
44347225|NCT01263704|79351323|FG000|Overall Study|Principal Investigator (PI) decision|1|||
44347226|NCT01263470|79351333|FG000|Overall Study|Adverse Event|2|||
44347227|NCT01263470|79351334|FG001|Overall Study|Adverse Event|2|||
44260221|NCT04099641|79127885|FG000|Overall Study|Death|46|||
44347228|NCT01263470|79351335|FG002|Overall Study|Adverse Event|1|||
44347229|NCT01263470|79351336|FG003|Overall Study|Adverse Event|1|||
44347230|NCT01263470|79351337|FG004|Overall Study|Adverse Event|2|||
44347231|NCT01263470|79351338|FG005|Overall Study|Adverse Event|2|||
44347232|NCT01263470|79351333|FG000|Overall Study|Protocol Violation|0|||
44347233|NCT01263470|79351334|FG001|Overall Study|Protocol Violation|1|||
44347234|NCT01263470|79351335|FG002|Overall Study|Protocol Violation|0|||
44347235|NCT01263470|79351336|FG003|Overall Study|Protocol Violation|0|||
44347236|NCT01263470|79351337|FG004|Overall Study|Protocol Violation|0|||
44347237|NCT01263470|79351338|FG005|Overall Study|Protocol Violation|1|||
44347238|NCT01263470|79351333|FG000|Overall Study|Withdrawal by Subject|0|||
44347239|NCT01263470|79351334|FG001|Overall Study|Withdrawal by Subject|1|||
44347240|NCT01263470|79351335|FG002|Overall Study|Withdrawal by Subject|1|||
44347241|NCT01263470|79351336|FG003|Overall Study|Withdrawal by Subject|2|||
44347242|NCT01263470|79351337|FG004|Overall Study|Withdrawal by Subject|0|||
44347243|NCT01263470|79351338|FG005|Overall Study|Withdrawal by Subject|2|||
44347244|NCT01263470|79351333|FG000|Overall Study|Lack of Efficacy|0|||
44347245|NCT01263470|79351334|FG001|Overall Study|Lack of Efficacy|0|||
44163655|NCT02563561|78956668|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
44347246|NCT01263470|79351335|FG002|Overall Study|Lack of Efficacy|2|||
44347247|NCT01263470|79351336|FG003|Overall Study|Lack of Efficacy|0|||
44347248|NCT01263470|79351337|FG004|Overall Study|Lack of Efficacy|0|||
44347249|NCT01263470|79351338|FG005|Overall Study|Lack of Efficacy|0|||
44347250|NCT01263470|79351333|FG000|Overall Study|Participant Unavailability|0|||
44347251|NCT01263470|79351334|FG001|Overall Study|Participant Unavailability|1|||
44347252|NCT01263470|79351335|FG002|Overall Study|Participant Unavailability|0|||
44347253|NCT01263470|79351336|FG003|Overall Study|Participant Unavailability|0|||
44347254|NCT01263470|79351337|FG004|Overall Study|Participant Unavailability|0|||
44347255|NCT01263470|79351338|FG005|Overall Study|Participant Unavailability|0|||
44347256|NCT01263470|79351333|FG000|Overall Study|Study Drug Non-compliance|0|||
44347257|NCT01263470|79351334|FG001|Overall Study|Study Drug Non-compliance|0|||
44347258|NCT01263470|79351335|FG002|Overall Study|Study Drug Non-compliance|0|||
44347259|NCT01263470|79351336|FG003|Overall Study|Study Drug Non-compliance|0|||
44347260|NCT01263470|79351337|FG004|Overall Study|Study Drug Non-compliance|1|||
44347261|NCT01263470|79351338|FG005|Overall Study|Study Drug Non-compliance|0|||
44347262|NCT01262456|79351355|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
44347263|NCT01262456|79351356|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
44347264|NCT01262456|79351357|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
44347265|NCT01262456|79351355|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
44347266|NCT01262456|79351356|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
44347267|NCT01262456|79351357|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
44347268|NCT01262456|79351355|FG000|3-Month Double-Blind Period|Adverse Event|6|||
44347269|NCT01262456|79351356|FG001|3-Month Double-Blind Period|Adverse Event|4|||
44347270|NCT01262456|79351357|FG002|3-Month Double-Blind Period|Adverse Event|8|||
44347271|NCT01262456|79351355|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
44347272|NCT01262456|79351356|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
44347273|NCT01262456|79351357|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
44347274|NCT01262456|79351355|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
44347275|NCT01262456|79351356|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
44347276|NCT01262456|79351357|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
44347277|NCT01262456|79351355|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
44347278|NCT01262456|79351356|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
44347279|NCT01262456|79351357|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
44347280|NCT01262456|79351355|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
44347281|NCT01262456|79351356|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
44347282|NCT01262456|79351357|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
44347283|NCT01262456|79351355|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
44445725|NCT00487240|79454010|FG001|Overall Study|Physician Decision|0|||
44347284|NCT01262456|79351356|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
44445726|NCT02224391|79454018|FG000|Overall Study|Lost to Follow-up|26|||
44445727|NCT02224391|79454019|FG001|Overall Study|Lost to Follow-up|19|||
44163656|NCT02563561|78956669|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
44347285|NCT01262456|79351357|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
44347286|NCT01262456|79351355|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
44347287|NCT01262456|79351356|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
44347288|NCT01262456|79351357|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
44347289|NCT00932893|79351375|FG000|Overall Study|Death|115|||
44347290|NCT00932893|79351376|FG001|Overall Study|Death|24|||
44347291|NCT00932893|79351375|FG000|Overall Study|Lost to Follow-up|8|||
44347292|NCT00932893|79351376|FG001|Overall Study|Lost to Follow-up|0|||
44347293|NCT00932893|79351375|FG000|Overall Study|Withdrawal by Subject|5|||
44347294|NCT00932893|79351376|FG001|Overall Study|Withdrawal by Subject|2|||
44347295|NCT00932893|79351375|FG000|Overall Study|Other|5|||
44347296|NCT00932893|79351376|FG001|Overall Study|Other|144|||
44347297|NCT01260896|79351385|FG000|First Intervention|Withdrawn Due to Emesis|2|||
44347298|NCT01260896|79351386|FG001|First Intervention|Withdrawn Due to Emesis|0|||
44347299|NCT00932737|79351394|FG000|Overall Study|Not treated in second episode|1|||
44347300|NCT00932737|79351395|FG001|Overall Study|Not treated in second episode|0|||
44347301|NCT00932737|79351394|FG000|Overall Study|Adverse Event|0|||
44347302|NCT00932737|79351395|FG001|Overall Study|Adverse Event|1|||
44347303|NCT00939523|79351401|FG000|Overall Study|Lack of Efficacy|1|||
44347304|NCT00939523|79351401|FG000|Overall Study|Physician Decision|2|||
44347305|NCT01260584|79351409|FG000|Period 1|Protocol Violation|0|||
44347306|NCT01260584|79351410|FG001|Period 1|Protocol Violation|0|||
44347307|NCT01260584|79351411|FG002|Period 1|Protocol Violation|1|||
44347308|NCT01260584|79351412|FG003|Period 1|Protocol Violation|1|||
44347309|NCT01260584|79351409|FG000|Period 1|Adverse Event|0|||
44347310|NCT01260584|79351410|FG001|Period 1|Adverse Event|0|||
44347311|NCT01260584|79351411|FG002|Period 1|Adverse Event|1|||
44347312|NCT01260584|79351412|FG003|Period 1|Adverse Event|0|||
44347313|NCT01260584|79351409|FG000|Period 2|Protocol Violation|0|||
44347314|NCT01260584|79351410|FG001|Period 2|Protocol Violation|2|||
44347315|NCT01260584|79351411|FG002|Period 2|Protocol Violation|3|||
44347316|NCT01260584|79351412|FG003|Period 2|Protocol Violation|1|||
44347317|NCT01260584|79351409|FG000|Period 2|Adverse Event|1|||
44347318|NCT01260584|79351410|FG001|Period 2|Adverse Event|0|||
44347319|NCT01260584|79351411|FG002|Period 2|Adverse Event|2|||
44347320|NCT01260584|79351412|FG003|Period 2|Adverse Event|0|||
44347321|NCT01260584|79351409|FG000|Period 2|Withdrawal by Subject|0|||
44347322|NCT01260584|79351410|FG001|Period 2|Withdrawal by Subject|1|||
44347323|NCT01260584|79351411|FG002|Period 2|Withdrawal by Subject|0|||
44347324|NCT01260584|79351412|FG003|Period 2|Withdrawal by Subject|0|||
44347325|NCT00927589|79351422|FG000|Overall Study|Death|1|||
44347326|NCT00927589|79351422|FG000|Overall Study|Physician Decision|1|||
44347327|NCT00927589|79351422|FG000|Overall Study|Withdrawal by Subject|3|||
44347328|NCT00927589|79351422|FG000|Overall Study|Adverse Event|2|||
44347329|NCT00927589|79351422|FG000|Overall Study|Disease Progression|8|||
44347330|NCT00927589|79351422|FG000|Overall Study|Non-compliance|1|||
44347331|NCT00932425|79351428|FG000|Overall Study|Lost to Follow-up|0|||
44347332|NCT00932425|79351429|FG001|Overall Study|Lost to Follow-up|1|||
44347333|NCT00932425|79351428|FG000|Overall Study|Withdrawal by Subject|0|||
44347334|NCT00932425|79351429|FG001|Overall Study|Withdrawal by Subject|1|||
44347335|NCT05867342|79351435|FG000|Overall Study|Investigator Decision|3|||
44347336|NCT05867342|79351436|FG001|Overall Study|Investigator Decision|3|||
44347337|NCT04340362|79351471|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
44347338|NCT03980808|79351493|FG000|Overall Study|Lost to Follow-up|2|||
44347339|NCT03980808|79351494|FG001|Overall Study|Lost to Follow-up|2|||
44347340|NCT03943953|79351511|FG000|Trial of ITG 1|Lost to Follow-up|19|||
44347341|NCT03943953|79351512|FG001|Trial of ITG 1|Lost to Follow-up|1|||
44347342|NCT03943953|79351511|FG000|Trial of ITG 2|Lost to Follow-up|8|||
44347343|NCT03943953|79351512|FG001|Trial of ITG 2|Lost to Follow-up|0|||
44347344|NCT03943953|79351511|FG000|Trial of ITG 3|Lost to Follow-up|2|||
44347345|NCT03943953|79351512|FG001|Trial of ITG 3|Lost to Follow-up|0|||
44347346|NCT03943953|79351511|FG000|Trial of ITG 4|Lost to Follow-up|2|||
44347347|NCT03943953|79351512|FG001|Trial of ITG 4|Lost to Follow-up|0|||
44347348|NCT03670628|79351522|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
44347349|NCT03670628|79351523|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
44347350|NCT03670628|79351522|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
44347351|NCT03670628|79351523|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
44347352|NCT03637764|79351533|FG000|Overall Study|Adverse Event|2|||
44347353|NCT03637764|79351534|FG001|Overall Study|Adverse Event|0|||
44347354|NCT03637764|79351535|FG002|Overall Study|Adverse Event|0|||
44347355|NCT03637764|79351536|FG003|Overall Study|Adverse Event|1|||
44347356|NCT03637764|79351533|FG000|Overall Study|Progressive Disease|23|||
44347357|NCT03637764|79351534|FG001|Overall Study|Progressive Disease|23|||
44347358|NCT03637764|79351535|FG002|Overall Study|Progressive Disease|18|||
44347359|NCT03637764|79351536|FG003|Overall Study|Progressive Disease|31|||
44347360|NCT03637764|79351533|FG000|Overall Study|Withdrawal by Subject|1|||
44347361|NCT03637764|79351534|FG001|Overall Study|Withdrawal by Subject|3|||
44347362|NCT03637764|79351535|FG002|Overall Study|Withdrawal by Subject|0|||
44347363|NCT03637764|79351536|FG003|Overall Study|Withdrawal by Subject|1|||
44347364|NCT05060003|79351585|FG000|Overall Study|ctDNA negative|7|||
44347365|NCT04906616|79351609|FG000|Overall Study|Divorce|3|||
44347366|NCT04906616|79351610|FG001|Overall Study|Divorce|2|||
44347367|NCT04880733|79351620|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
44347368|NCT04880733|79351621|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
44347369|NCT04880733|79351622|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
44347370|NCT04880733|79351620|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
44347371|NCT04880733|79351621|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
44347372|NCT04880733|79351622|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
44347373|NCT04880733|79351620|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
44347374|NCT04880733|79351621|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
44347375|NCT04880733|79351622|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
44347376|NCT04880733|79351620|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
44347377|NCT04880733|79351621|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
44347378|NCT04880733|79351622|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
44347379|NCT04880733|79351620|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
44347380|NCT04880733|79351621|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
44347381|NCT04880733|79351622|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
44347382|NCT04862143|79351657|FG000|Overall Study|Adverse Event|1|||
44347383|NCT04862143|79351657|FG000|Overall Study|Study terminated by sponsor|1|||
44347384|NCT04342390|79351705|FG000|Overall Study|Lost to Follow-up|3|||
44347385|NCT04342390|79351706|FG001|Overall Study|Lost to Follow-up|0|||
44347386|NCT04271280|79351712|FG000|Overall Study|Lost to Follow-up|300|||
44347387|NCT04271280|79351712|FG000|Overall Study|Death|153|||
44347388|NCT04271280|79351712|FG000|Overall Study|Withdrawal of consent by patient|59|||
44347389|NCT04271280|79351712|FG000|Overall Study|Other|51|||
44347390|NCT04271280|79351712|FG000|Overall Study|No end of study information|42|||
44347391|NCT04195906|79351736|FG000|Part 1|Adverse Event|3|||
44347392|NCT04195906|79351737|FG001|Part 1|Adverse Event|7|||
44347393|NCT04195906|79351736|FG000|Part 1|Withdrawal by Subject|0|||
44347394|NCT04195906|79351737|FG001|Part 1|Withdrawal by Subject|1|||
44347395|NCT04195906|79351736|FG000|Part 2|Adverse Event|1|||
44347396|NCT04195906|79351737|FG001|Part 2|Adverse Event|1|||
44347397|NCT04195906|79351736|FG000|Part 2|Withdrawal by Subject|0|||
44347398|NCT04195906|79351737|FG001|Part 2|Withdrawal by Subject|3|||
44347399|NCT04195906|79351736|FG000|Part 2|Other|1|||
44347400|NCT04195906|79351737|FG001|Part 2|Other|3|||
44347401|NCT03345784|79351791|FG000|Overall Study|Withdrawal by Subject|2|||
44347402|NCT03345784|79351792|FG001|Overall Study|Withdrawal by Subject|1|||
44347403|NCT03313180|79351798|FG000|Overall Study|Adverse Event|120|||
44347404|NCT03313180|79351798|FG000|Overall Study|Lost to Follow-up|3|||
44347405|NCT03313180|79351798|FG000|Overall Study|Withdrawal by Subject|39|||
44347406|NCT03313180|79351798|FG000|Overall Study|Other than listed above|15|||
44347407|NCT03313180|79351798|FG000|Overall Study|Covid-19 related|2|||
44347408|NCT03275285|79351804|FG000|Overall Study|Ongoing|45|||
44347409|NCT03275285|79351805|FG001|Overall Study|Ongoing|69|||
44347410|NCT03256344|79351819|FG000|Overall Study|Death|6|||
44347411|NCT03256344|79351820|FG001|Overall Study|Death|22|||
44347412|NCT03256344|79351819|FG000|Overall Study|Withdrawal by Subject|3|||
44347413|NCT03256344|79351820|FG001|Overall Study|Withdrawal by Subject|3|||
44347414|NCT03256344|79351819|FG000|Overall Study|Sponsor Decision|1|||
44347415|NCT03256344|79351820|FG001|Overall Study|Sponsor Decision|0|||
44347416|NCT03052608|79351828|FG000|Treatment Phase|Adverse Event|10|||
44347417|NCT03052608|79351829|FG001|Treatment Phase|Adverse Event|12|||
44347418|NCT03052608|79351828|FG000|Treatment Phase|Death|6|||
44347419|NCT03052608|79351829|FG001|Treatment Phase|Death|4|||
44347420|NCT03052608|79351828|FG000|Treatment Phase|Withdrawal by Subject|4|||
44347421|NCT03052608|79351829|FG001|Treatment Phase|Withdrawal by Subject|12|||
44347422|NCT03052608|79351828|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
44347423|NCT03052608|79351829|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
44347424|NCT03052608|79351828|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
44347425|NCT03052608|79351829|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
44347426|NCT03052608|79351828|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
44347427|NCT03052608|79351829|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
44347428|NCT03052608|79351828|FG000|Treatment Phase|Ongoing|103|||
44347429|NCT03052608|79351829|FG001|Treatment Phase|Ongoing|31|||
44347430|NCT03052608|79351828|FG000|Long-Term Follow-up Phase|Death|23|||
44347431|NCT03052608|79351829|FG001|Long-Term Follow-up Phase|Death|28|||
44347432|NCT03052608|79351828|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
44347433|NCT03052608|79351829|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
44347434|NCT03052608|79351828|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
44347435|NCT03052608|79351829|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
44347436|NCT03052608|79351828|FG000|Long-Term Follow-up Phase|Ongoing|122|||
44347437|NCT03052608|79351829|FG001|Long-Term Follow-up Phase|Ongoing|99|||
44347438|NCT03004183|79351840|FG000|Overall Study|Adverse Event|7|||
44347439|NCT03004183|79351840|FG000|Overall Study|Lost to Follow-up|1|||
44347440|NCT03004183|79351840|FG000|Overall Study|Physician Decision|40|||
44347441|NCT03004183|79351840|FG000|Overall Study|Withdrawal by Subject|1|||
44347442|NCT03004183|79351840|FG000|Overall Study|COVID-19|1|||
44347443|NCT02949128|79351844|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
44347444|NCT02949128|79351844|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
44347445|NCT02949128|79351844|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
44347446|NCT02949128|79351844|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
44347447|NCT02949128|79351844|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
44347448|NCT02949128|79351844|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
44347449|NCT02949128|79351844|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
44347450|NCT02949128|79351844|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
44347451|NCT02949128|79351844|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
44347452|NCT02949128|79351844|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
44347453|NCT02756845|79351854|FG000|Overall Study|Death|12|||
44347454|NCT02756845|79351855|FG001|Overall Study|Death|2|||
44347455|NCT02756845|79351854|FG000|Overall Study|Withdrawal by Subject|1|||
44347456|NCT02756845|79351855|FG001|Overall Study|Withdrawal by Subject|0|||
44347457|NCT02452697|79351880|FG000|Overall Study|Physician Decision|4|||
44347458|NCT02452697|79351881|FG001|Overall Study|Physician Decision|4|||
44347459|NCT02452697|79351882|FG002|Overall Study|Physician Decision|3|||
44347460|NCT02452697|79351883|FG003|Overall Study|Physician Decision|2|||
44347461|NCT02452697|79351880|FG000|Overall Study|Withdrawal by Subject|1|||
44163657|NCT02563561|78956670|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
44163658|NCT02563561|78956668|FG000|Overall Study|Investigator Decision|3|||
44347462|NCT02452697|79351881|FG001|Overall Study|Withdrawal by Subject|0|||
44347463|NCT02452697|79351882|FG002|Overall Study|Withdrawal by Subject|0|||
44347464|NCT02452697|79351883|FG003|Overall Study|Withdrawal by Subject|0|||
44347465|NCT02452697|79351880|FG000|Overall Study|still in follow-up|2|||
44347466|NCT02452697|79351881|FG001|Overall Study|still in follow-up|2|||
44347467|NCT02452697|79351882|FG002|Overall Study|still in follow-up|1|||
44347468|NCT02452697|79351883|FG003|Overall Study|still in follow-up|3|||
44347469|NCT02325557|79351897|FG000|Overall Study|Progressive disease|1|||
44347470|NCT02325557|79351898|FG001|Overall Study|Progressive disease|0|||
44347471|NCT02325557|79351899|FG002|Overall Study|Progressive disease|0|||
44347472|NCT02325557|79351900|FG003|Overall Study|Progressive disease|0|||
44347473|NCT02325557|79351897|FG000|Overall Study|Withdrawal by Subject|4|||
44347474|NCT02325557|79351898|FG001|Overall Study|Withdrawal by Subject|0|||
44347475|NCT02325557|79351899|FG002|Overall Study|Withdrawal by Subject|0|||
44347476|NCT02325557|79351900|FG003|Overall Study|Withdrawal by Subject|15|||
44347477|NCT02325557|79351897|FG000|Overall Study|Death|5|||
44347478|NCT02325557|79351898|FG001|Overall Study|Death|1|||
44347479|NCT02325557|79351899|FG002|Overall Study|Death|1|||
44347480|NCT02325557|79351900|FG003|Overall Study|Death|16|||
44347481|NCT02325557|79351897|FG000|Overall Study|Lost to Follow-up|0|||
44347482|NCT02325557|79351898|FG001|Overall Study|Lost to Follow-up|0|||
44163659|NCT02563561|78956669|FG001|Overall Study|Investigator Decision|4|||
44347483|NCT02325557|79351899|FG002|Overall Study|Lost to Follow-up|1|||
44347484|NCT02325557|79351900|FG003|Overall Study|Lost to Follow-up|1|||
44347485|NCT02325557|79351897|FG000|Overall Study|Other|0|||
44347486|NCT02325557|79351898|FG001|Overall Study|Other|0|||
44347487|NCT02325557|79351899|FG002|Overall Study|Other|0|||
44347488|NCT02325557|79351900|FG003|Overall Study|Other|5|||
44347489|NCT02213458|79351921|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
44347490|NCT02213458|79351922|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
44347491|NCT02213458|79351921|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
44347492|NCT02213458|79351922|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
44347493|NCT02213458|79351921|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
44347494|NCT02213458|79351922|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
44347495|NCT02213458|79351921|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
44347496|NCT02213458|79351922|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
44347497|NCT02213458|79351921|FG000|Overall Study|Refused re-consent|6|||
44347498|NCT02213458|79351922|FG001|Overall Study|Refused re-consent|0|||
44163660|NCT02563561|78956670|FG002|Overall Study|Investigator Decision|2|||
44163661|NCT02563561|78956668|FG000|Overall Study|Sponsor Decision|5|||
44347499|NCT02213458|79351921|FG000|Overall Study|Lost to Follow-up|2|||
44347500|NCT02213458|79351922|FG001|Overall Study|Lost to Follow-up|2|||
44163662|NCT02563561|78956669|FG001|Overall Study|Sponsor Decision|2|||
44347501|NCT02213458|79351921|FG000|Overall Study|Withdrawal by Subject|26|||
44347502|NCT02213458|79351922|FG001|Overall Study|Withdrawal by Subject|8|||
44347503|NCT02152995|79351930|FG000|Overall Study|Withdrawal by Subject|1|||
44163663|NCT02563561|78956670|FG002|Overall Study|Sponsor Decision|4|||
44163664|NCT02563561|78956668|FG000|Overall Study|Other|1|||
44163665|NCT02563561|78956669|FG001|Overall Study|Other|5|||
44163666|NCT02563561|78956670|FG002|Overall Study|Other|2|||
44163667|NCT02559505|78956686|FG000|Overall Study|Lost to Follow-up|23|||
44163668|NCT02559505|78956687|FG001|Overall Study|Lost to Follow-up|20|||
44163669|NCT02559505|78956686|FG000|Overall Study|Withdrawal by Subject|4|||
44163670|NCT02559505|78956687|FG001|Overall Study|Withdrawal by Subject|2|||
44163671|NCT04191967|78956709|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
44163672|NCT04191967|78956709|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
44163673|NCT02556307|78956715|FG000|Overall Study|Premature treatment interruption|11|||
44163674|NCT02556307|78956715|FG000|Overall Study|Lost to Follow-up|36|||
44163675|NCT02556307|78956715|FG000|Overall Study|Change to triple therapy|4|||
44163676|NCT02556307|78956715|FG000|Overall Study|Enrolled but not treated|2|||
44163677|NCT04364737|78956721|FG000|Overall Study|Withdrawal by Subject|4|||
44163678|NCT04364737|78956722|FG001|Overall Study|Withdrawal by Subject|9|||
44163679|NCT04364737|78956721|FG000|Overall Study|Lost to Follow-up|1|||
44163680|NCT04364737|78956722|FG001|Overall Study|Lost to Follow-up|1|||
44163681|NCT02559115|78956728|FG000|Overall Study|Withdrawal by Subject|3|||
44163682|NCT01662895|78956746|FG000|Overall Study|Lost to Follow-up|0|||
44163683|NCT01662895|78956747|FG001|Overall Study|Lost to Follow-up|1|||
44163684|NCT02557399|78956755|FG000|Overall Study|Adverse Event|6|||
44163685|NCT02557399|78956756|FG001|Overall Study|Adverse Event|5|||
44163686|NCT02557399|78956755|FG000|Overall Study|Protocol Violation|0|||
44163687|NCT02557399|78956756|FG001|Overall Study|Protocol Violation|1|||
44163688|NCT02557399|78956755|FG000|Overall Study|Protocol-defined stopping criteria|0|||
44163689|NCT02557399|78956756|FG001|Overall Study|Protocol-defined stopping criteria|1|||
44163690|NCT02557399|78956755|FG000|Overall Study|Withdrawal by Subject|1|||
44163691|NCT02557399|78956756|FG001|Overall Study|Withdrawal by Subject|1|||
44163692|NCT02555371|78956765|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
44163693|NCT02555371|78956766|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
44163694|NCT02555371|78956767|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
44163695|NCT02555371|78956768|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
44163696|NCT02555371|78956769|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
44163697|NCT02555371|78956765|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
44163698|NCT02555371|78956766|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
44163699|NCT02555371|78956767|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
44163700|NCT02555371|78956768|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
44163701|NCT02555371|78956769|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
44163702|NCT02555371|78956765|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
44163703|NCT02555371|78956766|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
44163704|NCT02555371|78956767|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
44163705|NCT02555371|78956768|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
44163706|NCT02555371|78956769|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
44163707|NCT02555371|78956765|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
44163708|NCT02555371|78956766|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
44163709|NCT02555371|78956767|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
44163710|NCT02555371|78956768|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
44163711|NCT02555371|78956769|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
44163712|NCT02555371|78956765|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
44163713|NCT02555371|78956766|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
44163714|NCT02555371|78956767|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
44163715|NCT02555371|78956768|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
44163716|NCT02555371|78956769|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
44163717|NCT02555371|78956765|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
44163718|NCT02555371|78956766|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
44163719|NCT02555371|78956767|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
44163720|NCT02555371|78956768|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
44163721|NCT02555371|78956769|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
44163722|NCT02555371|78956765|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
44163723|NCT02555371|78956766|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
44163724|NCT02555371|78956767|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
44163725|NCT02555371|78956768|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
44163726|NCT02555371|78956769|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
44163727|NCT02555371|78956765|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
44163728|NCT02555371|78956766|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
44163729|NCT02555371|78956767|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
44163730|NCT02555371|78956768|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
44163731|NCT02555371|78956769|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
44163732|NCT02555371|78956765|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
44163733|NCT02555371|78956766|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
44163734|NCT02555371|78956767|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
44163735|NCT02555371|78956768|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
44163736|NCT02555371|78956769|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
44163737|NCT02555371|78956765|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
44163738|NCT02555371|78956766|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
44163739|NCT02555371|78956767|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
44163740|NCT02555371|78956768|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
44163741|NCT02555371|78956769|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
44163742|NCT02555371|78956765|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
44260222|NCT04099641|79127886|FG001|Overall Study|Death|12|||
44260223|NCT04099641|79127885|FG000|Overall Study|Lost to Follow-up|1|||
44260224|NCT04099641|79127886|FG001|Overall Study|Lost to Follow-up|0|||
44260225|NCT04099641|79127885|FG000|Overall Study|Withdrawal by Subject|2|||
44260226|NCT04099641|79127886|FG001|Overall Study|Withdrawal by Subject|0|||
44260227|NCT03123393|79128012|FG000|Overall Study|Study Terminated by Sponsor|6|||
44260228|NCT03123393|79128013|FG001|Overall Study|Study Terminated by Sponsor|9|||
44260229|NCT03123393|79128012|FG000|Overall Study|Withdrawal by Subject|2|||
44260230|NCT03123393|79128013|FG001|Overall Study|Withdrawal by Subject|1|||
44347504|NCT02152995|79351931|FG001|Overall Study|Withdrawal by Subject|0|||
44347505|NCT02003924|79351940|FG000|Double-blind Phase|Lost to Follow-up|2|||
44347506|NCT02003924|79351941|FG001|Double-blind Phase|Lost to Follow-up|1|||
44347507|NCT02003924|79351942|FG002|Double-blind Phase|Lost to Follow-up|0|||
44347508|NCT02003924|79351940|FG000|Double-blind Phase|Protocol Violation|1|||
44347509|NCT02003924|79351941|FG001|Double-blind Phase|Protocol Violation|2|||
44347510|NCT02003924|79351942|FG002|Double-blind Phase|Protocol Violation|0|||
44347511|NCT02003924|79351940|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
44347512|NCT02003924|79351941|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
44347513|NCT02003924|79351942|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
44347514|NCT02003924|79351940|FG000|Double-blind Phase|Disease Progression|229|||
44347515|NCT02003924|79351941|FG001|Double-blind Phase|Disease Progression|247|||
44347516|NCT02003924|79351942|FG002|Double-blind Phase|Disease Progression|0|||
44347517|NCT02003924|79351940|FG000|Double-blind Phase|Adverse Event|120|||
44347518|NCT02003924|79351941|FG001|Double-blind Phase|Adverse Event|31|||
44347519|NCT02003924|79351942|FG002|Double-blind Phase|Adverse Event|0|||
44347520|NCT02003924|79351940|FG000|Double-blind Phase|Randomized But not Treated|3|||
44347521|NCT02003924|79351941|FG001|Double-blind Phase|Randomized But not Treated|3|||
44347522|NCT02003924|79351942|FG002|Double-blind Phase|Randomized But not Treated|0|||
44347523|NCT02003924|79351940|FG000|Double-blind Phase|Other|29|||
44347524|NCT02003924|79351941|FG001|Double-blind Phase|Other|50|||
44347525|NCT02003924|79351942|FG002|Double-blind Phase|Other|0|||
44347526|NCT02003924|79351940|FG000|Open-label Phase|Lost to Follow-up|0|||
44347527|NCT02003924|79351941|FG001|Open-label Phase|Lost to Follow-up|0|||
44347528|NCT02003924|79351942|FG002|Open-label Phase|Lost to Follow-up|1|||
44347529|NCT02003924|79351940|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
44347530|NCT02003924|79351941|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
44260231|NCT03123393|79128012|FG000|Overall Study|Reason not Specified|13|||
44260232|NCT03123393|79128013|FG001|Overall Study|Reason not Specified|13|||
44260233|NCT02834247|79128635|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
44260234|NCT02834247|79128636|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
44163743|NCT02555371|78956766|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
44163744|NCT02555371|78956767|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
44163745|NCT02555371|78956768|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
44163746|NCT02555371|78956769|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
44163747|NCT02555371|78956765|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
44163748|NCT02555371|78956766|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
44163749|NCT02555371|78956767|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
44163750|NCT02555371|78956768|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
44163751|NCT02555371|78956769|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
44163752|NCT02555371|78956765|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
44163753|NCT02555371|78956766|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
44163754|NCT02555371|78956767|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
44163755|NCT02555371|78956768|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
44163756|NCT02555371|78956769|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
44260235|NCT02834247|79128637|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
44260236|NCT02834247|79128638|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
44260237|NCT02834247|79128635|FG000|Dose Escalation Phase|Death|5|||
44163757|NCT02555371|78956765|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
44260238|NCT02834247|79128636|FG001|Dose Escalation Phase|Death|6|||
44260239|NCT02834247|79128637|FG002|Dose Escalation Phase|Death|5|||
44260240|NCT02834247|79128638|FG003|Dose Escalation Phase|Death|0|||
44260241|NCT02834247|79128635|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
44260242|NCT02834247|79128636|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
44260243|NCT02834247|79128637|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
44260244|NCT02834247|79128638|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
44347531|NCT02003924|79351942|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
44347532|NCT02003924|79351940|FG000|Open-label Phase|Disease Progression|59|||
44347533|NCT02003924|79351941|FG001|Open-label Phase|Disease Progression|0|||
44347534|NCT02003924|79351942|FG002|Open-label Phase|Disease Progression|5|||
44347535|NCT02003924|79351940|FG000|Open-label Phase|Adverse Event|25|||
44347536|NCT02003924|79351941|FG001|Open-label Phase|Adverse Event|0|||
44347537|NCT02003924|79351942|FG002|Open-label Phase|Adverse Event|10|||
44347538|NCT02003924|79351940|FG000|Open-label Phase|Other|7|||
44347539|NCT02003924|79351941|FG001|Open-label Phase|Other|0|||
44347540|NCT02003924|79351942|FG002|Open-label Phase|Other|0|||
44347541|NCT02003924|79351940|FG000|Long-term Follow-up Phase|Death|288|||
44347542|NCT02003924|79351941|FG001|Long-term Follow-up Phase|Death|174|||
44347543|NCT02003924|79351942|FG002|Long-term Follow-up Phase|Death|4|||
44347544|NCT02003924|79351940|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
44445728|NCT02224391|79454018|FG000|Overall Study|Withdrawal by Subject|6|||
44163758|NCT02555371|78956766|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
44163759|NCT02555371|78956767|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
44163760|NCT02555371|78956768|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
44163761|NCT02555371|78956769|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
44163762|NCT02555215|78956778|FG000|Overall Study|Other|1|||
44163763|NCT02555215|78956778|FG000|Overall Study|Investigator Decision|2|||
44163764|NCT02555683|78956785|FG000|Overall Study|Physician Decision|1|||
44163765|NCT02555683|78956786|FG001|Overall Study|Physician Decision|0|||
44163766|NCT02555683|78956787|FG002|Overall Study|Physician Decision|2|||
44163767|NCT02555683|78956785|FG000|Overall Study|Lost to Follow-up|2|||
44163768|NCT02555683|78956786|FG001|Overall Study|Lost to Follow-up|1|||
44163769|NCT02555683|78956787|FG002|Overall Study|Lost to Follow-up|2|||
44163770|NCT02555683|78956785|FG000|Overall Study|Technical Problems|1|||
44163771|NCT02555683|78956786|FG001|Overall Study|Technical Problems|1|||
44163772|NCT02555683|78956787|FG002|Overall Study|Technical Problems|0|||
44163773|NCT02555683|78956785|FG000|Overall Study|Protocol deviation|0|||
44163774|NCT02555683|78956786|FG001|Overall Study|Protocol deviation|1|||
44163775|NCT02555683|78956787|FG002|Overall Study|Protocol deviation|0|||
44163776|NCT02555683|78956785|FG000|Overall Study|Lack of Efficacy|2|||
44163777|NCT02555683|78956786|FG001|Overall Study|Lack of Efficacy|0|||
44163778|NCT02555683|78956787|FG002|Overall Study|Lack of Efficacy|0|||
44163779|NCT02555683|78956785|FG000|Overall Study|Death|0|||
44163780|NCT02555683|78956786|FG001|Overall Study|Death|1|||
44163781|NCT02555683|78956787|FG002|Overall Study|Death|2|||
44163782|NCT02555683|78956785|FG000|Overall Study|Adverse Event|1|||
44163783|NCT02555683|78956786|FG001|Overall Study|Adverse Event|0|||
44163784|NCT02555683|78956787|FG002|Overall Study|Adverse Event|1|||
44163785|NCT02555683|78956785|FG000|Overall Study|Subject/guardian decision|12|||
44163786|NCT02555683|78956786|FG001|Overall Study|Subject/guardian decision|12|||
44163787|NCT02555683|78956787|FG002|Overall Study|Subject/guardian decision|22|||
44163788|NCT02555683|78956785|FG000|Overall Study|Death post Treatment/safety period|0|||
44163789|NCT02555683|78956786|FG001|Overall Study|Death post Treatment/safety period|1|||
44163790|NCT02555683|78956787|FG002|Overall Study|Death post Treatment/safety period|0|||
44163791|NCT02554981|78956795|FG000|Overall Study|Adverse Event|1|||
44163792|NCT02554981|78956795|FG000|Overall Study|Administrative Reasons|1|||
44163793|NCT02554981|78956795|FG000|Overall Study|Other Miscellaneous Reasons|3|||
44163794|NCT02556775|78956803|FG000|Overall Study|Withdrawal by Subject|1|||
44163795|NCT02556775|78956804|FG001|Overall Study|Withdrawal by Subject|0|||
44163796|NCT02556775|78956805|FG002|Overall Study|Withdrawal by Subject|1|||
44163797|NCT02556775|78956806|FG003|Overall Study|Withdrawal by Subject|0|||
44163798|NCT02556775|78956803|FG000|Overall Study|Lost to Follow-up|1|||
44163799|NCT02556775|78956804|FG001|Overall Study|Lost to Follow-up|0|||
44163800|NCT02556775|78956805|FG002|Overall Study|Lost to Follow-up|0|||
44163801|NCT02556775|78956806|FG003|Overall Study|Lost to Follow-up|0|||
44163802|NCT01662505|78956821|FG000|Overall Study|Progressive disease|6|||
44163803|NCT01662505|78956822|FG001|Overall Study|Progressive disease|1|||
44163804|NCT01662505|78956823|FG002|Overall Study|Progressive disease|5|||
44163805|NCT01662505|78956821|FG000|Overall Study|Refused cont. medication|0|||
44163806|NCT01662505|78956822|FG001|Overall Study|Refused cont. medication|0|||
44163807|NCT01662505|78956823|FG002|Overall Study|Refused cont. medication|1|||
44163808|NCT01662505|78956821|FG000|Overall Study|Not specified above|1|||
44163809|NCT01662505|78956822|FG001|Overall Study|Not specified above|3|||
44163810|NCT01662505|78956823|FG002|Overall Study|Not specified above|2|||
44163811|NCT03796195|78956832|FG000|Overall Study|Study closed early|1|||
44163812|NCT02554513|78956836|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
44163813|NCT02554513|78956837|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
44347545|NCT02003924|79351941|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
44347546|NCT02003924|79351942|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
44347547|NCT02003924|79351940|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
44347548|NCT02003924|79351941|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
44347549|NCT02003924|79351942|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
44347550|NCT02003924|79351940|FG000|Long-term Follow-up Phase|Other|5|||
44347551|NCT02003924|79351941|FG001|Long-term Follow-up Phase|Other|2|||
44347552|NCT02003924|79351942|FG002|Long-term Follow-up Phase|Other|1|||
44347553|NCT01973452|79351951|FG000|Overall Study|Lack of Efficacy|0|||
44347554|NCT01973452|79351952|FG001|Overall Study|Lack of Efficacy|1|||
44347555|NCT01973452|79351951|FG000|Overall Study|Lost to Follow-up|1|||
44347556|NCT01973452|79351952|FG001|Overall Study|Lost to Follow-up|0|||
44347557|NCT01973452|79351951|FG000|Overall Study|Withdrawal by Subject|10|||
44347558|NCT01973452|79351952|FG001|Overall Study|Withdrawal by Subject|9|||
44347559|NCT01973452|79351951|FG000|Overall Study|Ineligible|1|||
44347560|NCT01973452|79351952|FG001|Overall Study|Ineligible|1|||
44347561|NCT01973452|79351951|FG000|Overall Study|Surgery canceled by participant|5|||
44347562|NCT01973452|79351952|FG001|Overall Study|Surgery canceled by participant|3|||
44347563|NCT01937117|79351958|FG000|Overall Study|Disease Progression|7|||
44347564|NCT01937117|79351958|FG000|Overall Study|Physician Decision|4|||
44347565|NCT01937117|79351958|FG000|Overall Study|Adverse Event|2|||
44347566|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
44347567|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
44347568|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
44347569|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
44347570|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
44347571|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
44347572|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
44347573|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
44347574|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
44347575|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
44347576|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
44347577|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
44347578|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
44347579|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
44347580|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
44347581|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
44347582|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
44354766|NCT01186692|79359166|FG000|Overall Study|Futher testing contraindicated implant|19|||
44354767|NCT01186692|79359166|FG000|Overall Study|Adverse Event|2|||
44445729|NCT02224391|79454019|FG001|Overall Study|Withdrawal by Subject|5|||
44445730|NCT00487162|79454027|FG000|Overall Study|Adverse Event|0|||
44445731|NCT00487162|79454028|FG001|Overall Study|Adverse Event|1|||
44445732|NCT00487162|79454027|FG000|Overall Study|Physician Decision|0|||
44445733|NCT00487162|79454028|FG001|Overall Study|Physician Decision|1|||
44445734|NCT00487162|79454027|FG000|Overall Study|Withdrawal by Subject|2|||
44445735|NCT00487162|79454028|FG001|Overall Study|Withdrawal by Subject|3|||
44445736|NCT00487084|79454037|FG000|Overall Study|Did not receive intervention|4|||
44445737|NCT00487084|79454038|FG001|Overall Study|Did not receive intervention|3|||
44445738|NCT00487084|79454039|FG002|Overall Study|Did not receive intervention|5|||
44445739|NCT00466726|79454047|FG000|Overall Study|Not evaluable for response|14|||
44445740|NCT01721291|79454053|FG000|Overall Study|Withdrawal by Subject|1|||
44445741|NCT01721291|79454054|FG001|Overall Study|Withdrawal by Subject|0|||
44445742|NCT01721291|79454053|FG000|Overall Study|did not like the treatment|1|||
44445743|NCT01721291|79454054|FG001|Overall Study|did not like the treatment|0|||
44163814|NCT02554903|78956851|FG000|Overall Study|Death|1|||
44260245|NCT02834247|79128635|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
44260246|NCT02834247|79128636|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
44260247|NCT02834247|79128637|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
44260248|NCT02834247|79128638|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44260249|NCT02834247|79128635|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
44260250|NCT02834247|79128636|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
44260251|NCT02834247|79128637|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
44260252|NCT02834247|79128638|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
44260253|NCT02834247|79128635|FG000|Dose Expansion Phase|Death|0|||
44354768|NCT01186458|79359174|FG000|Overall Study|Adverse Event|1|||
44354769|NCT01185834|79359178|FG000|Overall Study|Lost to Follow-up|2|||
44354770|NCT01185834|79359178|FG000|Overall Study|Discomfort|4|||
44354771|NCT01185834|79359178|FG000|Overall Study|Biomicroscopy|4|||
44354772|NCT01185834|79359178|FG000|Overall Study|Time/Job Conflict|2|||
44354773|NCT01185834|79359178|FG000|Overall Study|Early exit - Site error|2|||
44354774|NCT01185600|79359184|FG000|Overall Study|Adverse Event|1|||
44354775|NCT01185600|79359185|FG001|Overall Study|Adverse Event|1|||
44445744|NCT00486226|79454080|FG000|Overall Study|Death|3|||
44445745|NCT00486226|79454080|FG000|Overall Study|Adverse Event|1|||
44445746|NCT00486226|79454080|FG000|Overall Study|Withdrawal by Subject|1|||
44445747|NCT00486226|79454080|FG000|Overall Study|Lost to Follow-up|8|||
44347583|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
44347584|NCT01910402|79351964|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
44347585|NCT01910402|79351965|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
44347586|NCT01910402|79351966|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
44445748|NCT00485758|79454089|FG000|Overall Study|Adverse Event|102|||
44445749|NCT00485758|79454090|FG001|Overall Study|Adverse Event|31|||
44445750|NCT00485758|79454089|FG000|Overall Study|Death|0|||
44445751|NCT00485758|79454090|FG001|Overall Study|Death|1|||
44445752|NCT00485758|79454089|FG000|Overall Study|Lost to Follow-up|5|||
44445753|NCT00485758|79454090|FG001|Overall Study|Lost to Follow-up|1|||
44445754|NCT00485758|79454089|FG000|Overall Study|Physician Decision|3|||
44445755|NCT00485758|79454090|FG001|Overall Study|Physician Decision|3|||
44163815|NCT02554903|78956852|FG001|Overall Study|Death|1|||
44163816|NCT02554903|78956851|FG000|Overall Study|Physician Decision|2|||
44163817|NCT02554903|78956852|FG001|Overall Study|Physician Decision|2|||
44163818|NCT02554903|78956851|FG000|Overall Study|Heart Transplant|1|||
44163819|NCT02554903|78956852|FG001|Overall Study|Heart Transplant|2|||
44163820|NCT02332707|78956877|FG000|Overall Study|Adverse Event|0|||
44163821|NCT02332707|78956878|FG001|Overall Study|Adverse Event|0|||
44163822|NCT02332707|78956879|FG002|Overall Study|Adverse Event|0|||
44163823|NCT02332707|78956880|FG003|Overall Study|Adverse Event|0|||
44163824|NCT02332707|78956881|FG004|Overall Study|Adverse Event|0|||
44163825|NCT02332707|78956882|FG005|Overall Study|Adverse Event|0|||
44163826|NCT02332707|78956883|FG006|Overall Study|Adverse Event|0|||
44163827|NCT02332707|78956884|FG007|Overall Study|Adverse Event|0|||
44163828|NCT02332707|78956885|FG008|Overall Study|Adverse Event|0|||
44163829|NCT02332707|78956886|FG009|Overall Study|Adverse Event|0|||
44163830|NCT02332707|78956887|FG010|Overall Study|Adverse Event|0|||
44163831|NCT02332707|78956888|FG011|Overall Study|Adverse Event|0|||
44163832|NCT02332707|78956889|FG012|Overall Study|Adverse Event|1|||
44163833|NCT02332707|78956890|FG013|Overall Study|Adverse Event|0|||
44163834|NCT02332707|78956891|FG014|Overall Study|Adverse Event|0|||
44163835|NCT02332707|78956892|FG015|Overall Study|Adverse Event|0|||
44163836|NCT02332707|78956893|FG016|Overall Study|Adverse Event|0|||
44163837|NCT02332707|78956894|FG017|Overall Study|Adverse Event|0|||
44163838|NCT02332707|78956877|FG000|Overall Study|Lost to Follow-up|0|||
44163839|NCT02332707|78956878|FG001|Overall Study|Lost to Follow-up|0|||
44163840|NCT02332707|78956879|FG002|Overall Study|Lost to Follow-up|0|||
44163841|NCT02332707|78956880|FG003|Overall Study|Lost to Follow-up|0|||
44163842|NCT02332707|78956881|FG004|Overall Study|Lost to Follow-up|0|||
44163843|NCT02332707|78956882|FG005|Overall Study|Lost to Follow-up|1|||
44163844|NCT02332707|78956883|FG006|Overall Study|Lost to Follow-up|0|||
44163845|NCT02332707|78956884|FG007|Overall Study|Lost to Follow-up|0|||
44163846|NCT02332707|78956885|FG008|Overall Study|Lost to Follow-up|0|||
44163847|NCT02332707|78956886|FG009|Overall Study|Lost to Follow-up|0|||
44163848|NCT02332707|78956887|FG010|Overall Study|Lost to Follow-up|2|||
44163849|NCT02332707|78956888|FG011|Overall Study|Lost to Follow-up|0|||
44163850|NCT02332707|78956889|FG012|Overall Study|Lost to Follow-up|3|||
44163851|NCT02332707|78956890|FG013|Overall Study|Lost to Follow-up|0|||
44163852|NCT02332707|78956891|FG014|Overall Study|Lost to Follow-up|0|||
44163853|NCT02332707|78956892|FG015|Overall Study|Lost to Follow-up|0|||
44163854|NCT02332707|78956893|FG016|Overall Study|Lost to Follow-up|0|||
44163855|NCT02332707|78956894|FG017|Overall Study|Lost to Follow-up|0|||
44163856|NCT02332707|78956877|FG000|Overall Study|Physician Decision|0|||
44163857|NCT02332707|78956878|FG001|Overall Study|Physician Decision|0|||
44260254|NCT02834247|79128636|FG001|Dose Expansion Phase|Death|0|||
44260255|NCT02834247|79128637|FG002|Dose Expansion Phase|Death|0|||
44260256|NCT02834247|79128638|FG003|Dose Expansion Phase|Death|8|||
44260257|NCT02834247|79128635|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
44260258|NCT02834247|79128636|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
44260259|NCT02834247|79128637|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
44260260|NCT02834247|79128638|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
44260261|NCT02834247|79128635|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
44260262|NCT02834247|79128636|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
44260263|NCT02834247|79128637|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
44163858|NCT02332707|78956879|FG002|Overall Study|Physician Decision|0|||
44163859|NCT02332707|78956880|FG003|Overall Study|Physician Decision|1|||
44163860|NCT02332707|78956881|FG004|Overall Study|Physician Decision|0|||
44163861|NCT02332707|78956882|FG005|Overall Study|Physician Decision|0|||
44163862|NCT02332707|78956883|FG006|Overall Study|Physician Decision|0|||
44260264|NCT02834247|79128638|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
44260265|NCT01839331|79129903|FG000|Overall Study|Early Termination|3|||
44445756|NCT00485758|79454089|FG000|Overall Study|Protocol Violation|11|||
44445757|NCT00485758|79454090|FG001|Overall Study|Protocol Violation|2|||
44445758|NCT00485758|79454089|FG000|Overall Study|Withdrawal by Subject|32|||
44163863|NCT02332707|78956884|FG007|Overall Study|Physician Decision|0|||
44163864|NCT02332707|78956885|FG008|Overall Study|Physician Decision|0|||
44163865|NCT02332707|78956886|FG009|Overall Study|Physician Decision|0|||
44163866|NCT02332707|78956887|FG010|Overall Study|Physician Decision|0|||
44163867|NCT02332707|78956888|FG011|Overall Study|Physician Decision|0|||
44163868|NCT02332707|78956889|FG012|Overall Study|Physician Decision|1|||
44163869|NCT02332707|78956890|FG013|Overall Study|Physician Decision|0|||
44163870|NCT02332707|78956891|FG014|Overall Study|Physician Decision|0|||
44163871|NCT02332707|78956892|FG015|Overall Study|Physician Decision|0|||
44163872|NCT02332707|78956893|FG016|Overall Study|Physician Decision|0|||
44163873|NCT02332707|78956894|FG017|Overall Study|Physician Decision|0|||
44163874|NCT02332707|78956877|FG000|Overall Study|Withdrawal by Subject|0|||
44163875|NCT02332707|78956878|FG001|Overall Study|Withdrawal by Subject|0|||
44163876|NCT02332707|78956879|FG002|Overall Study|Withdrawal by Subject|1|||
44163877|NCT02332707|78956880|FG003|Overall Study|Withdrawal by Subject|0|||
44163878|NCT02332707|78956881|FG004|Overall Study|Withdrawal by Subject|0|||
44163879|NCT02332707|78956882|FG005|Overall Study|Withdrawal by Subject|0|||
44163880|NCT02332707|78956883|FG006|Overall Study|Withdrawal by Subject|0|||
44163881|NCT02332707|78956884|FG007|Overall Study|Withdrawal by Subject|0|||
44163882|NCT02332707|78956885|FG008|Overall Study|Withdrawal by Subject|0|||
44163883|NCT02332707|78956886|FG009|Overall Study|Withdrawal by Subject|3|||
44163884|NCT02332707|78956887|FG010|Overall Study|Withdrawal by Subject|0|||
44163885|NCT02332707|78956888|FG011|Overall Study|Withdrawal by Subject|0|||
44163886|NCT02332707|78956889|FG012|Overall Study|Withdrawal by Subject|0|||
44163887|NCT02332707|78956890|FG013|Overall Study|Withdrawal by Subject|0|||
44163888|NCT02332707|78956891|FG014|Overall Study|Withdrawal by Subject|0|||
44163889|NCT02332707|78956892|FG015|Overall Study|Withdrawal by Subject|0|||
44163890|NCT02332707|78956893|FG016|Overall Study|Withdrawal by Subject|0|||
44163891|NCT02332707|78956894|FG017|Overall Study|Withdrawal by Subject|0|||
44163892|NCT02370615|78956934|FG000|Overall Study|Adverse Event|1|||
44163893|NCT02370615|78956935|FG001|Overall Study|Adverse Event|0|||
44163894|NCT02307513|78956950|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
44163895|NCT02307513|78956951|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
44163896|NCT02307513|78956950|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
44163897|NCT02307513|78956951|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
44163898|NCT02307513|78956950|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
44163899|NCT02307513|78956951|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
44163900|NCT02307513|78956950|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
44163901|NCT02307513|78956951|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
44163902|NCT02307513|78956950|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
44163903|NCT02307513|78956951|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
44163904|NCT02307513|78956950|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
44163905|NCT02307513|78956951|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
44163906|NCT02307513|78956950|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
44163907|NCT02307513|78956951|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
44163908|NCT02307513|78956950|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
44163909|NCT02307513|78956951|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
44163910|NCT02307513|78956950|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
44163911|NCT02307513|78956951|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
44163912|NCT02307513|78956950|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
44163913|NCT02307513|78956951|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
44163914|NCT02307513|78956950|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
44163915|NCT02307513|78956951|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
44163916|NCT02307513|78956950|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
44163917|NCT02307513|78956951|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
44163918|NCT02307513|78956950|FG000|Long-term Extension|Physician Decision|1|||
44163919|NCT02307513|78956951|FG001|Long-term Extension|Physician Decision|0|||
44163920|NCT02332239|78956963|FG000|Overall Study|Lost to Follow-up|4|||
44163921|NCT02332239|78956964|FG001|Overall Study|Lost to Follow-up|6|||
44163922|NCT02370537|78956975|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
44163923|NCT02370537|78956976|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
44163924|NCT02370537|78956977|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
44163925|NCT02370537|78956975|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
44163926|NCT02370537|78956976|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
44163927|NCT02370537|78956977|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
44163928|NCT02370537|78956975|FG000|Part B|Not randomised to receive treatment|1|||
44163929|NCT02370537|78956976|FG001|Part B|Not randomised to receive treatment|2|||
44163930|NCT02370537|78956977|FG002|Part B|Not randomised to receive treatment|259|||
44163931|NCT02370537|78956975|FG000|Part B|Withdrawal by Subject|0|||
44163932|NCT02370537|78956976|FG001|Part B|Withdrawal by Subject|1|||
44163933|NCT02370537|78956977|FG002|Part B|Withdrawal by Subject|0|||
44163934|NCT02330055|78956996|FG000|Overall Study|technical issues|2|||
44163935|NCT02330055|78956997|FG001|Overall Study|technical issues|0|||
44163936|NCT02330055|78956996|FG000|Overall Study|participant forgot to wear device|5|||
44163937|NCT02330055|78956997|FG001|Overall Study|participant forgot to wear device|5|||
44163938|NCT02330055|78956996|FG000|Overall Study|data for less than 60 minutes|3|||
44163939|NCT02330055|78956997|FG001|Overall Study|data for less than 60 minutes|3|||
44163940|NCT02330055|78956996|FG000|Overall Study|participant did not sleep|0|||
44163941|NCT02330055|78956997|FG001|Overall Study|participant did not sleep|1|||
44163942|NCT02306265|78957003|FG000|Overall Study|Withdrawal by Subject|1|||
44163943|NCT02329743|78957011|FG000|Overall Study|Adverse Event|1|||
44163944|NCT02329743|78957012|FG001|Overall Study|Adverse Event|1|||
44163945|NCT02329743|78957013|FG002|Overall Study|Adverse Event|3|||
44163946|NCT02329743|78957011|FG000|Overall Study|Lost to Follow-up|1|||
44163947|NCT02329743|78957012|FG001|Overall Study|Lost to Follow-up|0|||
44163948|NCT02329743|78957013|FG002|Overall Study|Lost to Follow-up|1|||
44163949|NCT02329743|78957011|FG000|Overall Study|Withdrawal by Subject|4|||
44163950|NCT02329743|78957012|FG001|Overall Study|Withdrawal by Subject|4|||
44163951|NCT02329743|78957013|FG002|Overall Study|Withdrawal by Subject|1|||
44163952|NCT02329743|78957011|FG000|Overall Study|Other|0|||
44163953|NCT02329743|78957012|FG001|Overall Study|Other|2|||
44163954|NCT02329743|78957013|FG002|Overall Study|Other|3|||
44163955|NCT02329431|78957023|FG000|Overall Study|Lost to Follow-up|20|||
44163956|NCT02329431|78957024|FG001|Overall Study|Lost to Follow-up|13|||
44163957|NCT02328105|78957030|FG000|Overall Study|Death|6|||
44163958|NCT02328105|78957030|FG000|Overall Study|Withdrawal by Subject|1|||
44163959|NCT02328105|78957030|FG000|Overall Study|Still On Study in Follow-Up|4|||
44163960|NCT02305797|78957036|FG000|Overall Study|Adverse Event|11|||
44163961|NCT02305797|78957037|FG001|Overall Study|Adverse Event|2|||
44163962|NCT02305797|78957036|FG000|Overall Study|Withdrawal by Subject|9|||
44163963|NCT02305797|78957037|FG001|Overall Study|Withdrawal by Subject|10|||
44163964|NCT02305797|78957036|FG000|Overall Study|Lack of Efficacy|6|||
44163965|NCT02305797|78957037|FG001|Overall Study|Lack of Efficacy|0|||
44163966|NCT02305797|78957036|FG000|Overall Study|Lost to Follow-up|5|||
44163967|NCT02305797|78957037|FG001|Overall Study|Lost to Follow-up|11|||
44163968|NCT02305797|78957036|FG000|Overall Study|Pregnancy|0|||
44163969|NCT02305797|78957037|FG001|Overall Study|Pregnancy|2|||
44163970|NCT02305797|78957036|FG000|Overall Study|Noncompliance|14|||
44163971|NCT02305797|78957037|FG001|Overall Study|Noncompliance|12|||
44163972|NCT02305797|78957036|FG000|Overall Study|Reason not collected|0|||
44163973|NCT02305797|78957037|FG001|Overall Study|Reason not collected|1|||
44163974|NCT01646073|78957045|FG000|Period A (12 Weeks)|Adverse Event|0|||
44163975|NCT01646073|78957046|FG001|Period A (12 Weeks)|Adverse Event|2|||
44163976|NCT01646073|78957045|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
44163977|NCT01646073|78957046|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
44163978|NCT01646073|78957045|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
44163979|NCT01646073|78957046|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
44163980|NCT01646073|78957045|FG000|Period A (12 Weeks)|Protocol Violation|0|||
44163981|NCT01646073|78957046|FG001|Period A (12 Weeks)|Protocol Violation|1|||
44163982|NCT01646073|78957045|FG000|Period A (12 Weeks)|Other|0|||
44163983|NCT01646073|78957046|FG001|Period A (12 Weeks)|Other|1|||
44163984|NCT01646073|78957045|FG000|Period B (12 Weeks)|Adverse Event|0|||
44163985|NCT01646073|78957046|FG001|Period B (12 Weeks)|Adverse Event|7|||
44163986|NCT01646073|78957045|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
44163987|NCT01646073|78957046|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
44163988|NCT01646073|78957045|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
44163989|NCT01646073|78957046|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
44163990|NCT02328027|78957057|FG000|Overall Study|Withdrawal by Subject|0|||
44163991|NCT02328027|78957058|FG001|Overall Study|Withdrawal by Subject|1|||
44163992|NCT02551159|78957068|FG000|Overall Study|Death|352|||
44163993|NCT02551159|78957069|FG001|Overall Study|Death|174|||
44163994|NCT02551159|78957070|FG002|Overall Study|Death|161|||
44163995|NCT02551159|78957068|FG000|Overall Study|Withdrawal by Subject|8|||
44163996|NCT02551159|78957069|FG001|Overall Study|Withdrawal by Subject|5|||
44163997|NCT02551159|78957070|FG002|Overall Study|Withdrawal by Subject|16|||
44354776|NCT01185600|79359184|FG000|Overall Study|Death|0|||
44163998|NCT02551159|78957068|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
44163999|NCT02551159|78957069|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
44164000|NCT02551159|78957070|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
44164001|NCT02305563|78957083|FG000|Treatment Period|Disease progression|0|||
44164002|NCT02305563|78957084|FG001|Treatment Period|Disease progression|0|||
44164003|NCT02305563|78957085|FG002|Treatment Period|Disease progression|15|||
44164004|NCT02305563|78957086|FG003|Treatment Period|Disease progression|6|||
44164005|NCT02305563|78957087|FG004|Treatment Period|Disease progression|6|||
44164006|NCT02305563|78957083|FG000|Treatment Period|Study drug toxicity|0|||
44164007|NCT02305563|78957084|FG001|Treatment Period|Study drug toxicity|0|||
44164008|NCT02305563|78957085|FG002|Treatment Period|Study drug toxicity|0|||
44164009|NCT02305563|78957086|FG003|Treatment Period|Study drug toxicity|1|||
44164010|NCT02305563|78957087|FG004|Treatment Period|Study drug toxicity|2|||
44164011|NCT02305563|78957083|FG000|Treatment Period|Death|0|||
44164012|NCT02305563|78957084|FG001|Treatment Period|Death|0|||
44164013|NCT02305563|78957085|FG002|Treatment Period|Death|1|||
44164014|NCT02305563|78957086|FG003|Treatment Period|Death|2|||
44164015|NCT02305563|78957087|FG004|Treatment Period|Death|1|||
44164016|NCT02305563|78957083|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
44164017|NCT02305563|78957084|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
44164018|NCT02305563|78957085|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
44164019|NCT02305563|78957086|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
44164020|NCT02305563|78957087|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
44164021|NCT02305563|78957083|FG000|Treatment Period|Participant request to stop therapy|0|||
44164022|NCT02305563|78957084|FG001|Treatment Period|Participant request to stop therapy|2|||
44164023|NCT02305563|78957085|FG002|Treatment Period|Participant request to stop therapy|0|||
44164024|NCT02305563|78957086|FG003|Treatment Period|Participant request to stop therapy|1|||
44164025|NCT02305563|78957087|FG004|Treatment Period|Participant request to stop therapy|0|||
44164026|NCT02305563|78957083|FG000|Treatment Period|Participant withdrew consent|0|||
44164027|NCT02305563|78957084|FG001|Treatment Period|Participant withdrew consent|0|||
44164028|NCT02305563|78957085|FG002|Treatment Period|Participant withdrew consent|1|||
44164029|NCT02305563|78957086|FG003|Treatment Period|Participant withdrew consent|1|||
44164030|NCT02305563|78957087|FG004|Treatment Period|Participant withdrew consent|1|||
44164031|NCT02305563|78957083|FG000|Treatment Period|Maximum clinical benefit|0|||
44164032|NCT02305563|78957084|FG001|Treatment Period|Maximum clinical benefit|0|||
44164033|NCT02305563|78957085|FG002|Treatment Period|Maximum clinical benefit|0|||
44164034|NCT02305563|78957086|FG003|Treatment Period|Maximum clinical benefit|0|||
44164035|NCT02305563|78957087|FG004|Treatment Period|Maximum clinical benefit|1|||
44164036|NCT02305563|78957083|FG000|Treatment Period|Poor/non-compliance|0|||
44164037|NCT02305563|78957084|FG001|Treatment Period|Poor/non-compliance|0|||
44164038|NCT02305563|78957085|FG002|Treatment Period|Poor/non-compliance|0|||
44164039|NCT02305563|78957086|FG003|Treatment Period|Poor/non-compliance|0|||
44164040|NCT02305563|78957087|FG004|Treatment Period|Poor/non-compliance|1|||
44164041|NCT02305563|78957083|FG000|Treatment Period|Administrative reason by Sponsor|0|||
44164042|NCT02305563|78957084|FG001|Treatment Period|Administrative reason by Sponsor|0|||
44164043|NCT02305563|78957085|FG002|Treatment Period|Administrative reason by Sponsor|0|||
44164044|NCT02305563|78957086|FG003|Treatment Period|Administrative reason by Sponsor|0|||
44164045|NCT02305563|78957087|FG004|Treatment Period|Administrative reason by Sponsor|1|||
44164046|NCT02305563|78957083|FG000|Treatment Period|other reason|2|||
44164047|NCT02305563|78957084|FG001|Treatment Period|other reason|0|||
44164048|NCT02305563|78957085|FG002|Treatment Period|other reason|2|||
44164049|NCT02305563|78957086|FG003|Treatment Period|other reason|2|||
44164050|NCT02305563|78957087|FG004|Treatment Period|other reason|1|||
44164051|NCT02305563|78957083|FG000|Treatment Period|Randomized but not treated|0|||
44164052|NCT02305563|78957084|FG001|Treatment Period|Randomized but not treated|0|||
44164053|NCT02305563|78957085|FG002|Treatment Period|Randomized but not treated|0|||
44164054|NCT02305563|78957086|FG003|Treatment Period|Randomized but not treated|0|||
44164055|NCT02305563|78957087|FG004|Treatment Period|Randomized but not treated|2|||
44164056|NCT02305563|78957083|FG000|Treatment Period|added ULO, then disease progression|0|||
44164057|NCT02305563|78957084|FG001|Treatment Period|added ULO, then disease progression|0|||
44164058|NCT02305563|78957085|FG002|Treatment Period|added ULO, then disease progression|0|||
44164059|NCT02305563|78957086|FG003|Treatment Period|added ULO, then disease progression|0|||
44164060|NCT02305563|78957087|FG004|Treatment Period|added ULO, then disease progression|4|||
44164061|NCT02305563|78957083|FG000|Treatment Period|added ULO; then other reason|0|||
44164062|NCT02305563|78957084|FG001|Treatment Period|added ULO; then other reason|0|||
44164063|NCT02305563|78957085|FG002|Treatment Period|added ULO; then other reason|0|||
44164064|NCT02305563|78957086|FG003|Treatment Period|added ULO; then other reason|0|||
44164065|NCT02305563|78957087|FG004|Treatment Period|added ULO; then other reason|1|||
44164066|NCT02305563|78957083|FG000|Treatment Period|added ULO, then request to stop|0|||
44164067|NCT02305563|78957084|FG001|Treatment Period|added ULO, then request to stop|0|||
44164068|NCT02305563|78957085|FG002|Treatment Period|added ULO, then request to stop|0|||
44164069|NCT02305563|78957086|FG003|Treatment Period|added ULO, then request to stop|0|||
44164070|NCT02305563|78957087|FG004|Treatment Period|added ULO, then request to stop|1|||
44164071|NCT02305563|78957083|FG000|Follow-up Period|Death|0|||
44164072|NCT02305563|78957084|FG001|Follow-up Period|Death|0|||
44164073|NCT02305563|78957085|FG002|Follow-up Period|Death|5|||
44164074|NCT02305563|78957086|FG003|Follow-up Period|Death|4|||
44164075|NCT02305563|78957087|FG004|Follow-up Period|Death|7|||
44164076|NCT02305563|78957083|FG000|Follow-up Period|Participant withdrew consent|0|||
44164077|NCT02305563|78957084|FG001|Follow-up Period|Participant withdrew consent|0|||
44164078|NCT02305563|78957085|FG002|Follow-up Period|Participant withdrew consent|2|||
44164079|NCT02305563|78957086|FG003|Follow-up Period|Participant withdrew consent|1|||
44164080|NCT02305563|78957087|FG004|Follow-up Period|Participant withdrew consent|0|||
44164081|NCT02305563|78957083|FG000|Follow-up Period|other reason|0|||
44164082|NCT02305563|78957084|FG001|Follow-up Period|other reason|0|||
44164083|NCT02305563|78957085|FG002|Follow-up Period|other reason|0|||
44164084|NCT02305563|78957086|FG003|Follow-up Period|other reason|0|||
44164085|NCT02305563|78957087|FG004|Follow-up Period|other reason|1|||
44164086|NCT02305563|78957083|FG000|Follow-up Period|Followup no longer required per protocol|3|||
44164087|NCT02305563|78957084|FG001|Follow-up Period|Followup no longer required per protocol|3|||
44164088|NCT02305563|78957085|FG002|Follow-up Period|Followup no longer required per protocol|4|||
44164089|NCT02305563|78957086|FG003|Follow-up Period|Followup no longer required per protocol|1|||
44164090|NCT02305563|78957087|FG004|Follow-up Period|Followup no longer required per protocol|4|||
44164091|NCT02327325|78957106|FG000|Overall Study|Withdrawal by Subject|1|||
44164092|NCT02327325|78957107|FG001|Overall Study|Withdrawal by Subject|4|||
44164093|NCT02327325|78957108|FG002|Overall Study|Withdrawal by Subject|4|||
44164094|NCT02327325|78957106|FG000|Overall Study|Excluded by Study Team|0|||
44164095|NCT02327325|78957107|FG001|Overall Study|Excluded by Study Team|0|||
44164096|NCT02327325|78957108|FG002|Overall Study|Excluded by Study Team|1|||
44164097|NCT02304705|78957118|FG000|Overall Study|Withdrawal by Subject|2|||
44164098|NCT02304705|78957119|FG001|Overall Study|Withdrawal by Subject|0|||
44164099|NCT02304705|78957118|FG000|Overall Study|Physician Decision|2|||
44164100|NCT02304705|78957119|FG001|Overall Study|Physician Decision|4|||
44164101|NCT02304705|78957118|FG000|Overall Study|Death|0|||
44164102|NCT02304705|78957119|FG001|Overall Study|Death|1|||
44164103|NCT02304705|78957118|FG000|Overall Study|Lost to Follow-up|0|||
44164104|NCT02304705|78957119|FG001|Overall Study|Lost to Follow-up|2|||
44164105|NCT02553499|78957139|FG000|Overall Study|Adverse Event|0|||
44164106|NCT02553499|78957140|FG001|Overall Study|Adverse Event|0|||
44164107|NCT02553499|78957141|FG002|Overall Study|Adverse Event|0|||
44164108|NCT02553499|78957142|FG003|Overall Study|Adverse Event|0|||
44445759|NCT00485758|79454090|FG001|Overall Study|Withdrawal by Subject|27|||
44445760|NCT00485758|79454089|FG000|Overall Study|Study Terminated by Sponsor|3|||
44445761|NCT00485758|79454090|FG001|Overall Study|Study Terminated by Sponsor|0|||
44445762|NCT00469612|79454098|FG000|Overall Study|Study terminated before data collected|2|||
44445763|NCT00469612|79454099|FG001|Overall Study|Study terminated before data collected|0|||
44445764|NCT00469456|79454107|FG000|Overall Study|Adverse Event|4|||
44445765|NCT00469456|79454108|FG001|Overall Study|Adverse Event|3|||
44445766|NCT00469456|79454107|FG000|Overall Study|Protocol Violation|1|||
44445767|NCT00469456|79454108|FG001|Overall Study|Protocol Violation|0|||
44445768|NCT00469456|79454107|FG000|Overall Study|Withdrawal by Subject|4|||
44445769|NCT00469456|79454108|FG001|Overall Study|Withdrawal by Subject|1|||
44445770|NCT00581555|79454116|FG000|Overall Study|Adverse Event|4|||
44445771|NCT00581555|79454117|FG001|Overall Study|Adverse Event|3|||
44445772|NCT00581555|79454116|FG000|Overall Study|Physician Decision|3|||
44445773|NCT00581555|79454117|FG001|Overall Study|Physician Decision|2|||
44445774|NCT00581555|79454116|FG000|Overall Study|Withdrawal by Subject|18|||
44445775|NCT00581555|79454117|FG001|Overall Study|Withdrawal by Subject|9|||
44445776|NCT00581555|79454116|FG000|Overall Study|Lost to Follow-up|2|||
44445777|NCT00581555|79454117|FG001|Overall Study|Lost to Follow-up|2|||
44445778|NCT00581555|79454116|FG000|Overall Study|Other reasons|16|||
44445779|NCT00581555|79454117|FG001|Overall Study|Other reasons|4|||
44445780|NCT00469144|79454125|FG000|Overall Study|Death|0|||
44445781|NCT00469144|79454126|FG001|Overall Study|Death|1|||
44445782|NCT00469144|79454125|FG000|Overall Study|No Response|5|||
44445783|NCT00469144|79454126|FG001|Overall Study|No Response|5|||
44445784|NCT00469144|79454125|FG000|Overall Study|Progressive Disease|1|||
44445785|NCT00469144|79454126|FG001|Overall Study|Progressive Disease|0|||
44445786|NCT00468910|79454138|FG000|Overall Study|Lost to Follow-up|2|||
44445787|NCT00468910|79454139|FG001|Overall Study|Lost to Follow-up|1|||
44445788|NCT00468910|79454138|FG000|Overall Study|Withdrawal by Subject|2|||
44445789|NCT00468910|79454139|FG001|Overall Study|Withdrawal by Subject|1|||
44445790|NCT00468910|79454138|FG000|Overall Study|Medical Contraindication|0|||
44445791|NCT00468910|79454139|FG001|Overall Study|Medical Contraindication|1|||
44445792|NCT01412333|79454148|FG000|Overall Study|Death|1|||
44445793|NCT01412333|79454149|FG001|Overall Study|Death|1|||
44445794|NCT01412333|79454148|FG000|Overall Study|Physician Decision|0|||
44445795|NCT01412333|79454149|FG001|Overall Study|Physician Decision|1|||
44445796|NCT01412333|79454148|FG000|Overall Study|Reason not specified|16|||
44445797|NCT01412333|79454149|FG001|Overall Study|Reason not specified|10|||
44445798|NCT01412333|79454148|FG000|Overall Study|Non-compliance with study drug|1|||
44164109|NCT02553499|78957143|FG004|Overall Study|Adverse Event|0|||
44164110|NCT02553499|78957144|FG005|Overall Study|Adverse Event|0|||
44164111|NCT02553499|78957145|FG006|Overall Study|Adverse Event|1|||
44164112|NCT02553499|78957146|FG007|Overall Study|Adverse Event|1|||
44445799|NCT01412333|79454149|FG001|Overall Study|Non-compliance with study drug|1|||
44445800|NCT01412333|79454148|FG000|Overall Study|Protocol Violation|1|||
44445801|NCT01412333|79454149|FG001|Overall Study|Protocol Violation|1|||
44445802|NCT01412333|79454148|FG000|Overall Study|Non-compliance|1|||
44445803|NCT01412333|79454149|FG001|Overall Study|Non-compliance|3|||
44445804|NCT01412333|79454148|FG000|Overall Study|Lack of Efficacy|15|||
44445805|NCT01412333|79454149|FG001|Overall Study|Lack of Efficacy|6|||
44445806|NCT01412333|79454148|FG000|Overall Study|Pregnancy|3|||
44445807|NCT01412333|79454149|FG001|Overall Study|Pregnancy|0|||
44445808|NCT01412333|79454148|FG000|Overall Study|Consent withdrawn by participant|25|||
44445809|NCT01412333|79454149|FG001|Overall Study|Consent withdrawn by participant|12|||
44445810|NCT01412333|79454148|FG000|Overall Study|Adverse Event|25|||
44445811|NCT01412333|79454149|FG001|Overall Study|Adverse Event|16|||
44445812|NCT01412333|79454148|FG000|Overall Study|Lost to Follow-up|10|||
44445813|NCT01412333|79454149|FG001|Overall Study|Lost to Follow-up|6|||
44445814|NCT00519285|79454158|FG000|Overall Study|Adverse Event|127|||
44445815|NCT00519285|79454159|FG001|Overall Study|Adverse Event|266|||
44445816|NCT00519285|79454158|FG000|Overall Study|Disease progression|334|||
44445817|NCT00519285|79454159|FG001|Overall Study|Disease progression|186|||
44445818|NCT00519285|79454158|FG000|Overall Study|Physician Decision|75|||
44445819|NCT00519285|79454159|FG001|Overall Study|Physician Decision|47|||
44445820|NCT00519285|79454158|FG000|Overall Study|Participant's request|53|||
44445821|NCT00519285|79454159|FG001|Overall Study|Participant's request|84|||
44445822|NCT00519285|79454158|FG000|Overall Study|Consent withdrawn|4|||
44445823|NCT00519285|79454159|FG001|Overall Study|Consent withdrawn|5|||
44445824|NCT00519285|79454158|FG000|Overall Study|Poor compliance to protocol|5|||
44445825|NCT00519285|79454159|FG001|Overall Study|Poor compliance to protocol|7|||
44445826|NCT00519285|79454158|FG000|Overall Study|Reason unspecified|5|||
44445827|NCT00519285|79454159|FG001|Overall Study|Reason unspecified|8|||
44445828|NCT00519285|79454158|FG000|Overall Study|Not treated|8|||
44445829|NCT00519285|79454159|FG001|Overall Study|Not treated|7|||
44445830|NCT00519285|79454158|FG000|Overall Study|Treatment ongoing|1|||
44445831|NCT00519285|79454159|FG001|Overall Study|Treatment ongoing|2|||
44445832|NCT00464620|79454165|FG000|Overall Study|Physician Decision|1|||
44445833|NCT00464620|79454166|FG001|Overall Study|Physician Decision|0|||
44445834|NCT00464620|79454167|FG002|Overall Study|Physician Decision|0|||
44445835|NCT00464620|79454165|FG000|Overall Study|Withdrawal by Subject|1|||
44445836|NCT00464620|79454166|FG001|Overall Study|Withdrawal by Subject|0|||
44445837|NCT00464620|79454167|FG002|Overall Study|Withdrawal by Subject|3|||
44445838|NCT00464620|79454165|FG000|Overall Study|Ineligible sarcoma subtype|0|||
44445839|NCT00464620|79454166|FG001|Overall Study|Ineligible sarcoma subtype|2|||
44445840|NCT00464620|79454167|FG002|Overall Study|Ineligible sarcoma subtype|2|||
44445841|NCT00464620|79454165|FG000|Overall Study|Use of prohibited concomitant medication|0|||
44445842|NCT00464620|79454166|FG001|Overall Study|Use of prohibited concomitant medication|0|||
44445843|NCT00464620|79454167|FG002|Overall Study|Use of prohibited concomitant medication|2|||
44445844|NCT00464542|79454180|FG000|Pre-treatment|Withdrawal by Subject|2|||
44445845|NCT00468676|79454186|FG000|Overall Study|Lost to Follow-up|14|||
44445846|NCT00468676|79454187|FG001|Overall Study|Lost to Follow-up|11|||
44445847|NCT00468676|79454186|FG000|Overall Study|Death|2|||
44445848|NCT00468676|79454187|FG001|Overall Study|Death|1|||
44445849|NCT00464308|79454198|FG000|Overall Study|Adverse Event|22|||
44445850|NCT00464308|79454199|FG001|Overall Study|Adverse Event|27|||
44445851|NCT00464308|79454200|FG002|Overall Study|Adverse Event|16|||
44445852|NCT00464308|79454198|FG000|Overall Study|Lost to Follow-up|29|||
44445853|NCT00464308|79454199|FG001|Overall Study|Lost to Follow-up|19|||
44445854|NCT00464308|79454200|FG002|Overall Study|Lost to Follow-up|20|||
44445855|NCT00464308|79454198|FG000|Overall Study|Patient discontinued and other reasons|17|||
44445856|NCT00464308|79454199|FG001|Overall Study|Patient discontinued and other reasons|17|||
44445857|NCT00464308|79454200|FG002|Overall Study|Patient discontinued and other reasons|23|||
44445858|NCT00464308|79454198|FG000|Overall Study|Physician Decision|1|||
44445859|NCT00464308|79454199|FG001|Overall Study|Physician Decision|0|||
44445860|NCT00464308|79454200|FG002|Overall Study|Physician Decision|0|||
44445861|NCT00468286|79454210|FG000|Overall Study|Adverse Event|1|||
44445862|NCT00468286|79454211|FG001|Overall Study|Adverse Event|6|||
44445863|NCT00468286|79454210|FG000|Overall Study|Protocol Violation|2|||
44445864|NCT00468286|79454211|FG001|Overall Study|Protocol Violation|2|||
44445865|NCT00468286|79454210|FG000|Overall Study|Withdrawal by Subject|4|||
44445866|NCT00468286|79454211|FG001|Overall Study|Withdrawal by Subject|3|||
44445867|NCT00468286|79454210|FG000|Overall Study|Physician Decision|0|||
44445868|NCT00468286|79454211|FG001|Overall Study|Physician Decision|1|||
44445869|NCT00463840|79454217|FG000|Overall Study|Disease progression|7|||
44445870|NCT00463840|79454217|FG000|Overall Study|Withdrawal by Subject|2|||
44164113|NCT02553499|78957147|FG008|Overall Study|Adverse Event|0|||
44164114|NCT02553499|78957148|FG009|Overall Study|Adverse Event|0|||
44445871|NCT00463840|79454217|FG000|Overall Study|Adverse Event|3|||
44445872|NCT00129389|79454223|FG000|Overall Study|Adverse Event|19|||
44445873|NCT00129389|79454224|FG001|Overall Study|Adverse Event|87|||
44445874|NCT00129389|79454223|FG000|Overall Study|Death|0|||
44445875|NCT00129389|79454224|FG001|Overall Study|Death|1|||
44445876|NCT00129389|79454223|FG000|Overall Study|Lost to Follow-up|2|||
44445877|NCT00129389|79454224|FG001|Overall Study|Lost to Follow-up|1|||
44445878|NCT00129389|79454223|FG000|Overall Study|Physician Decision|0|||
44445879|NCT00129389|79454224|FG001|Overall Study|Physician Decision|4|||
44445880|NCT00129389|79454223|FG000|Overall Study|Protocol Violation|0|||
44445881|NCT00129389|79454224|FG001|Overall Study|Protocol Violation|6|||
44445882|NCT00129389|79454223|FG000|Overall Study|Withdrawal by Subject|9|||
44445883|NCT00129389|79454224|FG001|Overall Study|Withdrawal by Subject|23|||
44445884|NCT00129389|79454223|FG000|Overall Study|Relapse|1|||
44445885|NCT00129389|79454224|FG001|Overall Study|Relapse|0|||
44445886|NCT00129389|79454223|FG000|Overall Study|Not eligible|1|||
44445887|NCT00129389|79454224|FG001|Overall Study|Not eligible|2|||
44445888|NCT00129389|79454223|FG000|Overall Study|Crossed to the other arm|1|||
44445889|NCT00129389|79454224|FG001|Overall Study|Crossed to the other arm|16|||
44445890|NCT00468052|79454232|FG000|Overall Study|Protocol Violation|7|||
44445891|NCT00468052|79454233|FG001|Overall Study|Protocol Violation|8|||
44445892|NCT00453310|79454241|FG000|Overall Study|Progression of Disease|10|||
44445893|NCT00124657|79454248|FG000|Overall Study|Toxicity|0|||
44445894|NCT00124657|79454249|FG001|Overall Study|Toxicity|0|||
44445895|NCT00124657|79454250|FG002|Overall Study|Toxicity|1|||
44445896|NCT00124657|79454248|FG000|Overall Study|Non-compliance|1|||
44445897|NCT00124657|79454249|FG001|Overall Study|Non-compliance|0|||
44445898|NCT00124657|79454250|FG002|Overall Study|Non-compliance|4|||
44445899|NCT00124657|79454248|FG000|Overall Study|Progressive disease|14|||
44445900|NCT00124657|79454249|FG001|Overall Study|Progressive disease|5|||
44445901|NCT00124657|79454250|FG002|Overall Study|Progressive disease|27|||
44445902|NCT00124657|79454248|FG000|Overall Study|Intercurrent illness|1|||
44445903|NCT00124657|79454249|FG001|Overall Study|Intercurrent illness|0|||
44445904|NCT00124657|79454250|FG002|Overall Study|Intercurrent illness|0|||
44445905|NCT00581945|79454273|FG000|Overall Study|Adverse Event|4|||
44445906|NCT00581945|79454274|FG001|Overall Study|Adverse Event|4|||
44445907|NCT00581945|79454273|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
44445908|NCT00581945|79454274|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
44445909|NCT00581945|79454273|FG000|Overall Study|Withdrawal by Subject|2|||
44445910|NCT00581945|79454274|FG001|Overall Study|Withdrawal by Subject|6|||
44445911|NCT00581945|79454273|FG000|Overall Study|Death|1|||
44445912|NCT00581945|79454274|FG001|Overall Study|Death|0|||
44445913|NCT00555906|79454283|FG000|Phase 1|Objective Progression or Relapse|3|||
44445914|NCT00555906|79454284|FG001|Phase 1|Objective Progression or Relapse|5|||
44445915|NCT00555906|79454285|FG002|Phase 1|Objective Progression or Relapse|3|||
44445916|NCT00555906|79454286|FG003|Phase 1|Objective Progression or Relapse|1|||
44445917|NCT00555906|79454287|FG004|Phase 1|Objective Progression or Relapse|0|||
44445918|NCT00555906|79454283|FG000|Phase 1|Global Deterioration of Health Status|0|||
44445919|NCT00555906|79454284|FG001|Phase 1|Global Deterioration of Health Status|1|||
44445920|NCT00555906|79454285|FG002|Phase 1|Global Deterioration of Health Status|1|||
44445921|NCT00555906|79454286|FG003|Phase 1|Global Deterioration of Health Status|1|||
44445922|NCT00555906|79454287|FG004|Phase 1|Global Deterioration of Health Status|0|||
44445923|NCT00555906|79454283|FG000|Phase 1|Adverse Event|0|||
44445924|NCT00555906|79454284|FG001|Phase 1|Adverse Event|0|||
44445925|NCT00555906|79454285|FG002|Phase 1|Adverse Event|3|||
44445926|NCT00555906|79454286|FG003|Phase 1|Adverse Event|2|||
44445927|NCT00555906|79454287|FG004|Phase 1|Adverse Event|0|||
44445928|NCT00555906|79454283|FG000|Phase 1|Withdrawal by Subject|0|||
44164115|NCT02553499|78957149|FG010|Overall Study|Adverse Event|0|||
44164116|NCT02553499|78957150|FG011|Overall Study|Adverse Event|0|||
44347587|NCT01910402|79351964|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
44347588|NCT01910402|79351965|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
44347589|NCT01910402|79351966|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
44347590|NCT01910402|79351964|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
44347591|NCT01910402|79351965|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
44347592|NCT01910402|79351966|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
44347593|NCT01910402|79351964|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
44347594|NCT01910402|79351965|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
44347595|NCT01910402|79351966|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
44347596|NCT01910402|79351964|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
44347597|NCT01910402|79351965|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
44347598|NCT01910402|79351966|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
44347599|NCT01910402|79351964|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
44347600|NCT01910402|79351965|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
44347601|NCT01910402|79351966|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
44347602|NCT01910402|79351964|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
44347603|NCT01910402|79351965|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
44347604|NCT01910402|79351966|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
44445929|NCT00555906|79454284|FG001|Phase 1|Withdrawal by Subject|0|||
44445930|NCT00555906|79454285|FG002|Phase 1|Withdrawal by Subject|0|||
44445931|NCT00555906|79454286|FG003|Phase 1|Withdrawal by Subject|1|||
44445932|NCT00555906|79454287|FG004|Phase 1|Withdrawal by Subject|0|||
44164117|NCT02553499|78957151|FG012|Overall Study|Adverse Event|0|||
44445933|NCT00555906|79454283|FG000|Phase 2|Adverse Event|0|||
44445934|NCT00555906|79454284|FG001|Phase 2|Adverse Event|0|||
44445935|NCT00555906|79454285|FG002|Phase 2|Adverse Event|0|||
44445936|NCT00555906|79454286|FG003|Phase 2|Adverse Event|0|||
44164118|NCT02553499|78957152|FG013|Overall Study|Adverse Event|1|||
44445937|NCT00555906|79454287|FG004|Phase 2|Adverse Event|4|||
44445938|NCT00555906|79454283|FG000|Phase 2|Global Deterioration of Health Status|0|||
44164119|NCT02553499|78957139|FG000|Overall Study|Death|0|||
44164120|NCT02553499|78957140|FG001|Overall Study|Death|1|||
44164121|NCT02553499|78957141|FG002|Overall Study|Death|1|||
44164122|NCT02553499|78957142|FG003|Overall Study|Death|0|||
44164123|NCT02553499|78957143|FG004|Overall Study|Death|1|||
44164124|NCT02553499|78957144|FG005|Overall Study|Death|2|||
44164125|NCT02553499|78957145|FG006|Overall Study|Death|0|||
44164126|NCT02553499|78957146|FG007|Overall Study|Death|0|||
44164127|NCT02553499|78957147|FG008|Overall Study|Death|0|||
44164128|NCT02553499|78957148|FG009|Overall Study|Death|0|||
44164129|NCT02553499|78957149|FG010|Overall Study|Death|1|||
44164130|NCT02553499|78957150|FG011|Overall Study|Death|0|||
44164131|NCT02553499|78957151|FG012|Overall Study|Death|0|||
44164132|NCT02553499|78957152|FG013|Overall Study|Death|0|||
44445939|NCT00555906|79454284|FG001|Phase 2|Global Deterioration of Health Status|0|||
44445940|NCT00555906|79454285|FG002|Phase 2|Global Deterioration of Health Status|0|||
44445941|NCT00555906|79454286|FG003|Phase 2|Global Deterioration of Health Status|0|||
44445942|NCT00555906|79454287|FG004|Phase 2|Global Deterioration of Health Status|2|||
44445943|NCT00555906|79454283|FG000|Phase 2|Objective Progression or Relapse|0|||
44445944|NCT00555906|79454284|FG001|Phase 2|Objective Progression or Relapse|0|||
44445945|NCT00555906|79454285|FG002|Phase 2|Objective Progression or Relapse|0|||
44445946|NCT00555906|79454286|FG003|Phase 2|Objective Progression or Relapse|0|||
44445947|NCT00555906|79454287|FG004|Phase 2|Objective Progression or Relapse|16|||
44445948|NCT00555906|79454283|FG000|Phase 2|Withdrawal by Subject|0|||
44445949|NCT00555906|79454284|FG001|Phase 2|Withdrawal by Subject|0|||
44445950|NCT00555906|79454285|FG002|Phase 2|Withdrawal by Subject|0|||
44445951|NCT00555906|79454286|FG003|Phase 2|Withdrawal by Subject|0|||
44445952|NCT00555906|79454287|FG004|Phase 2|Withdrawal by Subject|2|||
44445953|NCT00555906|79454283|FG000|Phase 2|Other|0|||
44445954|NCT00555906|79454284|FG001|Phase 2|Other|0|||
44445955|NCT00555906|79454285|FG002|Phase 2|Other|0|||
44445956|NCT00555906|79454286|FG003|Phase 2|Other|0|||
44445957|NCT00555906|79454287|FG004|Phase 2|Other|6|||
44445958|NCT00555906|79454283|FG000|Phase 2|Randomized but not Treated|0|||
44445959|NCT00555906|79454284|FG001|Phase 2|Randomized but not Treated|0|||
44445960|NCT00555906|79454285|FG002|Phase 2|Randomized but not Treated|0|||
44445961|NCT00555906|79454286|FG003|Phase 2|Randomized but not Treated|0|||
44445962|NCT00555906|79454287|FG004|Phase 2|Randomized but not Treated|2|||
44445963|NCT03817879|79454304|FG000|Overall Study|Drop out|5|||
44445964|NCT03817879|79454305|FG001|Overall Study|Drop out|12|||
44445965|NCT03817879|79454304|FG000|Overall Study|Withdrawal by Subject|0|||
44445966|NCT03817879|79454305|FG001|Overall Study|Withdrawal by Subject|1|||
44445967|NCT00555672|79454313|FG000|Overall Study|Death|0|||
44445968|NCT00555672|79454314|FG001|Overall Study|Death|2|||
44445969|NCT00555672|79454313|FG000|Overall Study|Adverse Event|8|||
44445970|NCT00555672|79454314|FG001|Overall Study|Adverse Event|2|||
44445971|NCT00555672|79454313|FG000|Overall Study|Objective progression or relapse|11|||
44445972|NCT00555672|79454314|FG001|Overall Study|Objective progression or relapse|5|||
44445973|NCT00555672|79454313|FG000|Overall Study|Other|3|||
44445974|NCT00555672|79454314|FG001|Overall Study|Other|1|||
44445975|NCT00555672|79454313|FG000|Overall Study|Participant refused|2|||
44445976|NCT00555672|79454314|FG001|Overall Study|Participant refused|0|||
44445977|NCT03958656|79454324|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
44445978|NCT03958656|79454325|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
44445979|NCT03958656|79454326|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
44445980|NCT03958656|79454327|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
44445981|NCT03958656|79454324|FG000|Overall Study|No longer meets eligibility criteria|0|||
44445982|NCT03958656|79454325|FG001|Overall Study|No longer meets eligibility criteria|0|||
44445983|NCT03958656|79454326|FG002|Overall Study|No longer meets eligibility criteria|1|||
44164133|NCT02553499|78957139|FG000|Overall Study|Lost to Follow-up|0|||
44164134|NCT02553499|78957140|FG001|Overall Study|Lost to Follow-up|0|||
44164135|NCT02553499|78957141|FG002|Overall Study|Lost to Follow-up|0|||
44164136|NCT02553499|78957142|FG003|Overall Study|Lost to Follow-up|0|||
44445984|NCT03958656|79454327|FG003|Overall Study|No longer meets eligibility criteria|0|||
44445985|NCT03958656|79454324|FG000|Overall Study|Started anti-cancer treatment|0|||
44445986|NCT03958656|79454325|FG001|Overall Study|Started anti-cancer treatment|0|||
44445987|NCT03958656|79454326|FG002|Overall Study|Started anti-cancer treatment|1|||
44445988|NCT03958656|79454327|FG003|Overall Study|Started anti-cancer treatment|0|||
44445989|NCT00561912|79454337|FG000|Overall Study|ineligible|1|||
44445990|NCT00561678|79454343|FG000|Overall Study|Withdrawal by Subject|4|||
44445991|NCT00561678|79454344|FG001|Overall Study|Withdrawal by Subject|3|||
44445992|NCT00561678|79454343|FG000|Overall Study|surgery cancelled|1|||
44445993|NCT00561678|79454344|FG001|Overall Study|surgery cancelled|1|||
44445994|NCT00561678|79454343|FG000|Overall Study|surgery rescheduled to different site|2|||
44445995|NCT00561678|79454344|FG001|Overall Study|surgery rescheduled to different site|2|||
44445996|NCT00561678|79454343|FG000|Overall Study|anesthesia provider refusal|1|||
44164137|NCT02553499|78957143|FG004|Overall Study|Lost to Follow-up|0|||
44164138|NCT02553499|78957144|FG005|Overall Study|Lost to Follow-up|0|||
44445997|NCT00561678|79454344|FG001|Overall Study|anesthesia provider refusal|0|||
44445998|NCT00463684|79454350|FG000|Overall Study|Withdrawal by Subject|1|||
44445999|NCT00463684|79454350|FG000|Overall Study|Lost to Follow-up|3|||
44446000|NCT00463606|79454357|FG000|Overall Study|Adverse Event|21|||
44446001|NCT00463606|79454358|FG001|Overall Study|Adverse Event|18|||
44446002|NCT00463606|79454359|FG002|Overall Study|Adverse Event|11|||
44446003|NCT00463606|79454357|FG000|Overall Study|Withdrawal by Subject|11|||
44446004|NCT00463606|79454358|FG001|Overall Study|Withdrawal by Subject|11|||
44446005|NCT00463606|79454359|FG002|Overall Study|Withdrawal by Subject|5|||
44446006|NCT00463606|79454357|FG000|Overall Study|Lost to Follow-up|2|||
44446007|NCT00463606|79454358|FG001|Overall Study|Lost to Follow-up|2|||
44446008|NCT00463606|79454359|FG002|Overall Study|Lost to Follow-up|3|||
44446009|NCT00463606|79454357|FG000|Overall Study|Subject noncompliance|1|||
44446010|NCT00463606|79454358|FG001|Overall Study|Subject noncompliance|1|||
44446011|NCT00463606|79454359|FG002|Overall Study|Subject noncompliance|0|||
44446012|NCT00463606|79454357|FG000|Overall Study|Subject moved out of town|1|||
44446013|NCT00463606|79454358|FG001|Overall Study|Subject moved out of town|0|||
44446014|NCT00463606|79454359|FG002|Overall Study|Subject moved out of town|0|||
44446015|NCT00463606|79454357|FG000|Overall Study|Physician Decision|0|||
44446016|NCT00463606|79454358|FG001|Overall Study|Physician Decision|1|||
44446017|NCT00463606|79454359|FG002|Overall Study|Physician Decision|0|||
44446018|NCT00463606|79454357|FG000|Overall Study|Sponsor request|0|||
44446019|NCT00463606|79454358|FG001|Overall Study|Sponsor request|1|||
44446020|NCT00463606|79454359|FG002|Overall Study|Sponsor request|0|||
44446021|NCT00463606|79454357|FG000|Overall Study|Exclusion criteria violation|2|||
44446022|NCT00463606|79454358|FG001|Overall Study|Exclusion criteria violation|0|||
44446023|NCT00463606|79454359|FG002|Overall Study|Exclusion criteria violation|0|||
44446024|NCT00463606|79454357|FG000|Overall Study|Coordinator error|1|||
44446025|NCT00463606|79454358|FG001|Overall Study|Coordinator error|0|||
44446026|NCT00463606|79454359|FG002|Overall Study|Coordinator error|0|||
44446027|NCT00463606|79454357|FG000|Overall Study|Patient randomized in error|1|||
44446028|NCT00463606|79454358|FG001|Overall Study|Patient randomized in error|0|||
44446029|NCT00463606|79454359|FG002|Overall Study|Patient randomized in error|0|||
44446030|NCT00463606|79454357|FG000|Overall Study|Participation in another ABT-335 trial|1|||
44446031|NCT00463606|79454358|FG001|Overall Study|Participation in another ABT-335 trial|0|||
44446032|NCT00463606|79454359|FG002|Overall Study|Participation in another ABT-335 trial|0|||
44446033|NCT00463606|79454357|FG000|Overall Study|Protocol Violation|0|||
44446034|NCT00463606|79454358|FG001|Overall Study|Protocol Violation|0|||
44446035|NCT00463606|79454359|FG002|Overall Study|Protocol Violation|1|||
44446036|NCT03961308|79454369|FG000|Overall Study|Withdrawal by Subject|1|||
44446037|NCT03961308|79454370|FG001|Overall Study|Withdrawal by Subject|0|||
44446038|NCT03961308|79454369|FG000|Overall Study|Other|1|||
44446039|NCT03961308|79454370|FG001|Overall Study|Other|0|||
44446040|NCT03961308|79454369|FG000|Overall Study|Lost to Follow-up|0|||
44446041|NCT03961308|79454370|FG001|Overall Study|Lost to Follow-up|1|||
44446042|NCT03961308|79454369|FG000|Overall Study|Adverse Event|0|||
44446043|NCT03961308|79454370|FG001|Overall Study|Adverse Event|1|||
44446044|NCT00174187|79454378|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
44446045|NCT00174187|79454379|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
44347605|NCT01754402|79351980|FG000|Overall Study|Death|0|||
44347606|NCT01754402|79351981|FG001|Overall Study|Death|0|||
44347607|NCT01754402|79351982|FG002|Overall Study|Death|1|||
44347608|NCT01754402|79351980|FG000|Overall Study|Adverse Event|2|||
44347609|NCT01754402|79351981|FG001|Overall Study|Adverse Event|2|||
44347610|NCT01754402|79351982|FG002|Overall Study|Adverse Event|1|||
44347611|NCT01754402|79351980|FG000|Overall Study|Withdrawal by Subject|0|||
44347612|NCT01754402|79351981|FG001|Overall Study|Withdrawal by Subject|0|||
44347613|NCT01754402|79351982|FG002|Overall Study|Withdrawal by Subject|1|||
44347614|NCT01754402|79351980|FG000|Overall Study|Lack of Efficacy|0|||
44347615|NCT01754402|79351981|FG001|Overall Study|Lack of Efficacy|0|||
44347616|NCT01754402|79351982|FG002|Overall Study|Lack of Efficacy|1|||
44347617|NCT01740297|79351994|FG000|Overall Study|Withdrawal by Subject|4|||
44347618|NCT01740297|79351995|FG001|Overall Study|Withdrawal by Subject|16|||
44347619|NCT01740297|79351996|FG002|Overall Study|Withdrawal by Subject|17|||
44347620|NCT01740297|79351994|FG000|Overall Study|Death|8|||
44347621|NCT01740297|79351995|FG001|Overall Study|Death|46|||
44446046|NCT00174187|79454380|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
44446047|NCT00174187|79454378|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
44446048|NCT00174187|79454379|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
44446049|NCT00174187|79454380|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
44446050|NCT00174187|79454378|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
44446051|NCT00174187|79454379|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
44446052|NCT00174187|79454380|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
44164139|NCT02553499|78957145|FG006|Overall Study|Lost to Follow-up|1|||
44347622|NCT01740297|79351996|FG002|Overall Study|Death|40|||
44347623|NCT01740297|79351994|FG000|Overall Study|Lost to Follow-up|1|||
44446053|NCT00174187|79454378|FG000|Period 1 (up to 3 Years)|Other|0|||
44446054|NCT00174187|79454379|FG001|Period 1 (up to 3 Years)|Other|1|||
44164140|NCT02553499|78957146|FG007|Overall Study|Lost to Follow-up|0|||
44164141|NCT02553499|78957147|FG008|Overall Study|Lost to Follow-up|0|||
44164142|NCT02553499|78957148|FG009|Overall Study|Lost to Follow-up|0|||
44164143|NCT02553499|78957149|FG010|Overall Study|Lost to Follow-up|0|||
44164144|NCT02553499|78957150|FG011|Overall Study|Lost to Follow-up|0|||
44164145|NCT02553499|78957151|FG012|Overall Study|Lost to Follow-up|0|||
44164146|NCT02553499|78957152|FG013|Overall Study|Lost to Follow-up|0|||
44164147|NCT02553499|78957139|FG000|Overall Study|Physician Decision|0|||
44164148|NCT02553499|78957140|FG001|Overall Study|Physician Decision|1|||
44164149|NCT02553499|78957141|FG002|Overall Study|Physician Decision|1|||
44164150|NCT02553499|78957142|FG003|Overall Study|Physician Decision|0|||
44164151|NCT02553499|78957143|FG004|Overall Study|Physician Decision|1|||
44164152|NCT02553499|78957144|FG005|Overall Study|Physician Decision|0|||
44164153|NCT02553499|78957145|FG006|Overall Study|Physician Decision|0|||
44164154|NCT02553499|78957146|FG007|Overall Study|Physician Decision|1|||
44164155|NCT02553499|78957147|FG008|Overall Study|Physician Decision|1|||
44164156|NCT02553499|78957148|FG009|Overall Study|Physician Decision|2|||
44164157|NCT02553499|78957149|FG010|Overall Study|Physician Decision|1|||
44164158|NCT02553499|78957150|FG011|Overall Study|Physician Decision|3|||
44164159|NCT02553499|78957151|FG012|Overall Study|Physician Decision|1|||
44164160|NCT02553499|78957152|FG013|Overall Study|Physician Decision|0|||
44164161|NCT02553499|78957139|FG000|Overall Study|Progressive Disease|0|||
44164162|NCT02553499|78957140|FG001|Overall Study|Progressive Disease|0|||
44164163|NCT02553499|78957141|FG002|Overall Study|Progressive Disease|0|||
44164164|NCT02553499|78957142|FG003|Overall Study|Progressive Disease|2|||
44164165|NCT02553499|78957143|FG004|Overall Study|Progressive Disease|1|||
44164166|NCT02553499|78957144|FG005|Overall Study|Progressive Disease|1|||
44164167|NCT02553499|78957145|FG006|Overall Study|Progressive Disease|1|||
44164168|NCT02553499|78957146|FG007|Overall Study|Progressive Disease|0|||
44164169|NCT02553499|78957147|FG008|Overall Study|Progressive Disease|0|||
44164170|NCT02553499|78957148|FG009|Overall Study|Progressive Disease|1|||
44164171|NCT02553499|78957149|FG010|Overall Study|Progressive Disease|0|||
44164172|NCT02553499|78957150|FG011|Overall Study|Progressive Disease|0|||
44164173|NCT02553499|78957151|FG012|Overall Study|Progressive Disease|2|||
44164174|NCT02553499|78957152|FG013|Overall Study|Progressive Disease|1|||
44164175|NCT02553499|78957139|FG000|Overall Study|Study Terminated by Sponsor|0|||
44164176|NCT02553499|78957140|FG001|Overall Study|Study Terminated by Sponsor|0|||
44164177|NCT02553499|78957141|FG002|Overall Study|Study Terminated by Sponsor|0|||
44164178|NCT02553499|78957142|FG003|Overall Study|Study Terminated by Sponsor|0|||
44164179|NCT02553499|78957143|FG004|Overall Study|Study Terminated by Sponsor|0|||
44164180|NCT02553499|78957144|FG005|Overall Study|Study Terminated by Sponsor|0|||
44164181|NCT02553499|78957145|FG006|Overall Study|Study Terminated by Sponsor|0|||
44164182|NCT02553499|78957146|FG007|Overall Study|Study Terminated by Sponsor|0|||
44164183|NCT02553499|78957147|FG008|Overall Study|Study Terminated by Sponsor|1|||
44164184|NCT02553499|78957148|FG009|Overall Study|Study Terminated by Sponsor|0|||
44164185|NCT02553499|78957149|FG010|Overall Study|Study Terminated by Sponsor|0|||
44164186|NCT02553499|78957150|FG011|Overall Study|Study Terminated by Sponsor|0|||
44164187|NCT02553499|78957151|FG012|Overall Study|Study Terminated by Sponsor|0|||
44164188|NCT02553499|78957152|FG013|Overall Study|Study Terminated by Sponsor|0|||
44164189|NCT02553499|78957139|FG000|Overall Study|Withdrawal by Subject|2|||
44164190|NCT02553499|78957140|FG001|Overall Study|Withdrawal by Subject|0|||
44164191|NCT02553499|78957141|FG002|Overall Study|Withdrawal by Subject|0|||
44164192|NCT02553499|78957142|FG003|Overall Study|Withdrawal by Subject|0|||
44164193|NCT02553499|78957143|FG004|Overall Study|Withdrawal by Subject|0|||
44260266|NCT01839331|79129904|FG001|Overall Study|Early Termination|0|||
44260267|NCT01839331|79129905|FG002|Overall Study|Early Termination|1|||
44260268|NCT01839331|79129906|FG003|Overall Study|Early Termination|2|||
44260269|NCT01839331|79129903|FG000|Overall Study|Protocol Violation|1|||
44260270|NCT01839331|79129904|FG001|Overall Study|Protocol Violation|6|||
44260271|NCT01839331|79129905|FG002|Overall Study|Protocol Violation|4|||
44260272|NCT01839331|79129906|FG003|Overall Study|Protocol Violation|3|||
44260273|NCT01606176|79130244|FG000|Overall Study|Adverse Event|2|||
44260274|NCT01606176|79130245|FG001|Overall Study|Adverse Event|3|||
44260275|NCT01606176|79130244|FG000|Overall Study|Disease progression|1|||
44260276|NCT01606176|79130245|FG001|Overall Study|Disease progression|0|||
44260277|NCT01606176|79130244|FG000|Overall Study|Withdrawal by Subject|1|||
44260278|NCT01606176|79130245|FG001|Overall Study|Withdrawal by Subject|0|||
44260279|NCT01663896|79130311|FG000|Overall Study|Various reasons|43|||
44260280|NCT02576652|79130364|FG000|Overall Study|Withdrawal by Subject|2|||
44260281|NCT02575950|79130448|FG000|Overall Study|Withdrawal by Subject|0|||
44260282|NCT02575950|79130449|FG001|Overall Study|Withdrawal by Subject|0|||
44260283|NCT02575950|79130450|FG002|Overall Study|Withdrawal by Subject|0|||
44260284|NCT02575950|79130451|FG003|Overall Study|Withdrawal by Subject|2|||
44260285|NCT02575950|79130448|FG000|Overall Study|Lost to Follow-up|0|||
44446055|NCT00174187|79454380|FG002|Period 1 (up to 3 Years)|Other|0|||
44164194|NCT02553499|78957144|FG005|Overall Study|Withdrawal by Subject|0|||
44164195|NCT02553499|78957145|FG006|Overall Study|Withdrawal by Subject|0|||
44164196|NCT02553499|78957146|FG007|Overall Study|Withdrawal by Subject|1|||
44260286|NCT02575950|79130449|FG001|Overall Study|Lost to Follow-up|1|||
44164197|NCT02553499|78957147|FG008|Overall Study|Withdrawal by Subject|1|||
44164198|NCT02553499|78957148|FG009|Overall Study|Withdrawal by Subject|0|||
44164199|NCT02553499|78957149|FG010|Overall Study|Withdrawal by Subject|1|||
44164200|NCT02553499|78957150|FG011|Overall Study|Withdrawal by Subject|0|||
44164201|NCT02553499|78957151|FG012|Overall Study|Withdrawal by Subject|0|||
44164202|NCT02553499|78957152|FG013|Overall Study|Withdrawal by Subject|0|||
44164203|NCT02553421|78957185|FG000|Overall Study|Lost to Follow-up|21|||
44164204|NCT02553421|78957186|FG001|Overall Study|Lost to Follow-up|1|||
44164205|NCT02553421|78957185|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
44164206|NCT02553421|78957186|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
44164207|NCT02553421|78957185|FG000|Overall Study|Improper Device Placement|3|||
44164208|NCT02553421|78957186|FG001|Overall Study|Improper Device Placement|0|||
44164209|NCT02549287|78957195|FG000|Overall Study|Lost to Follow-up|65|||
44164210|NCT02549287|78957196|FG001|Overall Study|Lost to Follow-up|26|||
44164211|NCT02549287|78957195|FG000|Overall Study|Withdrawal by Subject|15|||
44164212|NCT02549287|78957196|FG001|Overall Study|Withdrawal by Subject|6|||
44164213|NCT02553265|78957202|FG000|Enrollment|Death|0|||
44164214|NCT02553265|78957203|FG001|Enrollment|Death|0|||
44164215|NCT02553265|78957204|FG002|Enrollment|Death|1|||
44164216|NCT02553265|78957202|FG000|First Intervention (28 Days)|Adverse Event|1|||
44164217|NCT02553265|78957203|FG001|First Intervention (28 Days)|Adverse Event|0|||
44164218|NCT02553265|78957204|FG002|First Intervention (28 Days)|Adverse Event|0|||
44164219|NCT02553265|78957202|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
44164220|NCT02553265|78957203|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
44164221|NCT02553265|78957204|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
44164222|NCT02553265|78957202|FG000|Second Intervention (28 Days)|Adverse Event|1|||
44164223|NCT02553265|78957203|FG001|Second Intervention (28 Days)|Adverse Event|0|||
44164224|NCT02553265|78957204|FG002|Second Intervention (28 Days)|Adverse Event|0|||
44164225|NCT02553265|78957202|FG000|Third Intervention (28 Days)|Adverse Event|1|||
44164226|NCT02553265|78957203|FG001|Third Intervention (28 Days)|Adverse Event|0|||
44164227|NCT02553265|78957204|FG002|Third Intervention (28 Days)|Adverse Event|0|||
44164228|NCT02553265|78957202|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
44164229|NCT02553265|78957203|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
44164230|NCT02553265|78957204|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
44164231|NCT02561195|78957221|FG000|Vaccination 1 to 3|Adverse Event|4|||
44164232|NCT02561195|78957222|FG001|Vaccination 1 to 3|Adverse Event|5|||
44164233|NCT02561195|78957223|FG002|Vaccination 1 to 3|Adverse Event|0|||
44164234|NCT02561195|78957224|FG003|Vaccination 1 to 3|Adverse Event|3|||
44164235|NCT02561195|78957225|FG004|Vaccination 1 to 3|Adverse Event|4|||
44164236|NCT02561195|78957226|FG005|Vaccination 1 to 3|Adverse Event|0|||
44164237|NCT02561195|78957227|FG006|Vaccination 1 to 3|Adverse Event|0|||
44164238|NCT02561195|78957228|FG007|Vaccination 1 to 3|Adverse Event|0|||
44164239|NCT02561195|78957229|FG008|Vaccination 1 to 3|Adverse Event|0|||
44164240|NCT02561195|78957230|FG009|Vaccination 1 to 3|Adverse Event|0|||
44164241|NCT02561195|78957231|FG010|Vaccination 1 to 3|Adverse Event|0|||
44164242|NCT02561195|78957232|FG011|Vaccination 1 to 3|Adverse Event|0|||
44164243|NCT02561195|78957233|FG012|Vaccination 1 to 3|Adverse Event|0|||
44164244|NCT02561195|78957234|FG013|Vaccination 1 to 3|Adverse Event|0|||
44164245|NCT02561195|78957221|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
44164246|NCT02561195|78957222|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
44164247|NCT02561195|78957223|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
44164248|NCT02561195|78957224|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
44164249|NCT02561195|78957225|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
44164250|NCT02561195|78957226|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
44164251|NCT02561195|78957227|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
44164252|NCT02561195|78957228|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
44164253|NCT02561195|78957229|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
44164254|NCT02561195|78957230|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
44164255|NCT02561195|78957231|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
44164256|NCT02561195|78957232|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
44347624|NCT01740297|79351995|FG001|Overall Study|Lost to Follow-up|2|||
44347625|NCT01740297|79351996|FG002|Overall Study|Lost to Follow-up|4|||
44347626|NCT01539720|79352008|FG000|Overall Study|Screen Fail|15|||
44347627|NCT01539720|79352009|FG001|Overall Study|Screen Fail|3|||
44347628|NCT01539720|79352008|FG000|Overall Study|Lost to Follow-up|14|||
44164257|NCT02561195|78957233|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
44164258|NCT02561195|78957234|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
44164259|NCT02561195|78957221|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44164260|NCT02561195|78957222|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
44164261|NCT02561195|78957223|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44164262|NCT02561195|78957224|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
44347629|NCT01539720|79352009|FG001|Overall Study|Lost to Follow-up|7|||
44354777|NCT01185600|79359185|FG001|Overall Study|Death|1|||
44354778|NCT01185600|79359184|FG000|Overall Study|Lost to Follow-up|0|||
44347630|NCT01236560|79352021|FG000|Overall Study|Adverse Event|0|||
44347631|NCT01236560|79352022|FG001|Overall Study|Adverse Event|2|||
44347632|NCT01236560|79352023|FG002|Overall Study|Adverse Event|1|||
44347633|NCT01236560|79352024|FG003|Overall Study|Adverse Event|3|||
44347634|NCT01236560|79352025|FG004|Overall Study|Adverse Event|0|||
44347635|NCT01236560|79352026|FG005|Overall Study|Adverse Event|0|||
44347636|NCT01236560|79352021|FG000|Overall Study|Death|0|||
44347637|NCT01236560|79352022|FG001|Overall Study|Death|1|||
44347638|NCT01236560|79352023|FG002|Overall Study|Death|0|||
44347639|NCT01236560|79352024|FG003|Overall Study|Death|1|||
44347640|NCT01236560|79352025|FG004|Overall Study|Death|0|||
44347641|NCT01236560|79352026|FG005|Overall Study|Death|0|||
44347642|NCT01236560|79352021|FG000|Overall Study|Lost to Follow-up|0|||
44347643|NCT01236560|79352022|FG001|Overall Study|Lost to Follow-up|1|||
44347644|NCT01236560|79352023|FG002|Overall Study|Lost to Follow-up|1|||
44347645|NCT01236560|79352024|FG003|Overall Study|Lost to Follow-up|0|||
44347646|NCT01236560|79352025|FG004|Overall Study|Lost to Follow-up|0|||
44347647|NCT01236560|79352026|FG005|Overall Study|Lost to Follow-up|0|||
44347648|NCT01236560|79352021|FG000|Overall Study|Physician Decision|0|||
44347649|NCT01236560|79352022|FG001|Overall Study|Physician Decision|1|||
44347650|NCT01236560|79352023|FG002|Overall Study|Physician Decision|8|||
44347651|NCT01236560|79352024|FG003|Overall Study|Physician Decision|0|||
44347652|NCT01236560|79352025|FG004|Overall Study|Physician Decision|0|||
44347653|NCT01236560|79352026|FG005|Overall Study|Physician Decision|0|||
44347654|NCT01236560|79352021|FG000|Overall Study|Withdrawal by Subject|0|||
44347655|NCT01236560|79352022|FG001|Overall Study|Withdrawal by Subject|0|||
44347656|NCT01236560|79352023|FG002|Overall Study|Withdrawal by Subject|1|||
44347657|NCT01236560|79352024|FG003|Overall Study|Withdrawal by Subject|2|||
44347658|NCT01236560|79352025|FG004|Overall Study|Withdrawal by Subject|0|||
44347659|NCT01236560|79352026|FG005|Overall Study|Withdrawal by Subject|0|||
44347660|NCT01236560|79352021|FG000|Overall Study|Progressive disease|5|||
44347661|NCT01236560|79352022|FG001|Overall Study|Progressive disease|19|||
44347662|NCT01236560|79352023|FG002|Overall Study|Progressive disease|9|||
44347663|NCT01236560|79352024|FG003|Overall Study|Progressive disease|16|||
44347664|NCT01236560|79352025|FG004|Overall Study|Progressive disease|0|||
44347665|NCT01236560|79352026|FG005|Overall Study|Progressive disease|0|||
44347666|NCT00333801|79352047|FG000|Overall Study|Moved to another state|5|||
44347667|NCT00333801|79352048|FG001|Overall Study|Moved to another state|3|||
44347668|NCT00333801|79352047|FG000|Overall Study|Lost to Follow-up|2|||
44347669|NCT00333801|79352048|FG001|Overall Study|Lost to Follow-up|0|||
44347670|NCT00333801|79352047|FG000|Overall Study|Incarcerated|1|||
44347671|NCT00333801|79352048|FG001|Overall Study|Incarcerated|2|||
44347672|NCT00333801|79352047|FG000|Overall Study|Withdrawal by Subject|0|||
44347673|NCT00333801|79352048|FG001|Overall Study|Withdrawal by Subject|1|||
44347674|NCT03483116|79352058|FG000|Overall Study|Adverse Event|0|||
44347675|NCT03483116|79352059|FG001|Overall Study|Adverse Event|1|||
44347676|NCT03483116|79352060|FG002|Overall Study|Adverse Event|0|||
44347677|NCT03483116|79352061|FG003|Overall Study|Adverse Event|1|||
44347678|NCT03483116|79352058|FG000|Overall Study|Protocol Violation|1|||
44347679|NCT03483116|79352059|FG001|Overall Study|Protocol Violation|0|||
44347680|NCT03483116|79352060|FG002|Overall Study|Protocol Violation|0|||
44347681|NCT03483116|79352061|FG003|Overall Study|Protocol Violation|7|||
44347682|NCT03483116|79352058|FG000|Overall Study|Lost to Follow-up|9|||
44347683|NCT03483116|79352059|FG001|Overall Study|Lost to Follow-up|4|||
44347684|NCT03483116|79352060|FG002|Overall Study|Lost to Follow-up|9|||
44347685|NCT03483116|79352061|FG003|Overall Study|Lost to Follow-up|5|||
44260287|NCT02575950|79130450|FG002|Overall Study|Lost to Follow-up|0|||
44260288|NCT02575950|79130451|FG003|Overall Study|Lost to Follow-up|3|||
44260289|NCT01049581|79130533|FG000|Overall Study|Lost to Follow-up|2|||
44260290|NCT01049581|79130534|FG001|Overall Study|Lost to Follow-up|1|||
44260291|NCT02571972|79130552|FG000|Overall Study|Protocol Violation|2|||
44260292|NCT02571972|79130552|FG000|Overall Study|Withdrawal by Subject|2|||
44260293|NCT02166905|79130650|FG000|Overall Study|Withdrawal by Subject|1|||
44260294|NCT02166905|79130651|FG001|Overall Study|Withdrawal by Subject|0|||
44164263|NCT02561195|78957225|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
44347686|NCT03483116|79352058|FG000|Overall Study|Death|1|||
44347687|NCT03483116|79352059|FG001|Overall Study|Death|0|||
44347688|NCT03483116|79352060|FG002|Overall Study|Death|2|||
44347689|NCT03483116|79352061|FG003|Overall Study|Death|1|||
44347690|NCT03483116|79352058|FG000|Overall Study|Withdrawal by Subject|14|||
44347691|NCT03483116|79352059|FG001|Overall Study|Withdrawal by Subject|16|||
44347692|NCT03483116|79352060|FG002|Overall Study|Withdrawal by Subject|14|||
44347693|NCT03483116|79352061|FG003|Overall Study|Withdrawal by Subject|16|||
44347694|NCT03483116|79352058|FG000|Overall Study|Unknown other reason|3|||
44347695|NCT03483116|79352059|FG001|Overall Study|Unknown other reason|2|||
44347696|NCT03483116|79352060|FG002|Overall Study|Unknown other reason|1|||
44347697|NCT03483116|79352061|FG003|Overall Study|Unknown other reason|1|||
44347698|NCT02811861|79352092|FG000|Overall Study|Radiological Disease Progression|123|||
44347699|NCT02811861|79352093|FG001|Overall Study|Radiological Disease Progression|97|||
44347700|NCT02811861|79352094|FG002|Overall Study|Radiological Disease Progression|174|||
44347701|NCT02811861|79352092|FG000|Overall Study|Clinical Disease Progression|20|||
44347702|NCT02811861|79352093|FG001|Overall Study|Clinical Disease Progression|19|||
44347703|NCT02811861|79352094|FG002|Overall Study|Clinical Disease Progression|22|||
44347704|NCT02811861|79352092|FG000|Overall Study|Adverse Event|63|||
44347705|NCT02811861|79352093|FG001|Overall Study|Adverse Event|60|||
44347706|NCT02811861|79352094|FG002|Overall Study|Adverse Event|41|||
44347707|NCT02811861|79352092|FG000|Overall Study|Lost to Follow-up|0|||
44347708|NCT02811861|79352093|FG001|Overall Study|Lost to Follow-up|0|||
44347709|NCT02811861|79352094|FG002|Overall Study|Lost to Follow-up|1|||
44347710|NCT02811861|79352092|FG000|Overall Study|Subject Choice|29|||
44347711|NCT02811861|79352093|FG001|Overall Study|Subject Choice|17|||
44347712|NCT02811861|79352094|FG002|Overall Study|Subject Choice|23|||
44347713|NCT02811861|79352092|FG000|Overall Study|Withdrawal by Subject|4|||
44347714|NCT02811861|79352093|FG001|Overall Study|Withdrawal by Subject|4|||
44347715|NCT02811861|79352094|FG002|Overall Study|Withdrawal by Subject|9|||
44347716|NCT02811861|79352092|FG000|Overall Study|Other|4|||
44347717|NCT02811861|79352093|FG001|Overall Study|Other|13|||
44347718|NCT02811861|79352094|FG002|Overall Study|Other|3|||
44347719|NCT02811861|79352092|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
44347720|NCT02811861|79352093|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
44347721|NCT02811861|79352094|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
44347722|NCT02811861|79352092|FG000|Overall Study|Randomized but not treated|2|||
44347723|NCT02811861|79352093|FG001|Overall Study|Randomized but not treated|3|||
44347724|NCT02811861|79352094|FG002|Overall Study|Randomized but not treated|17|||
44347725|NCT02700451|79352105|FG000|Overall Study|Protocol Violation|2|||
44347726|NCT02700451|79352106|FG001|Overall Study|Protocol Violation|2|||
44347727|NCT02700451|79352107|FG002|Overall Study|Protocol Violation|3|||
44347728|NCT02700451|79352105|FG000|Overall Study|Discontinued intervention|14|||
44347729|NCT02700451|79352106|FG001|Overall Study|Discontinued intervention|15|||
44347730|NCT02700451|79352107|FG002|Overall Study|Discontinued intervention|14|||
44347731|NCT02623426|79352118|FG000|Overall Study|Lost to Follow-up|0|||
44347732|NCT02623426|79352119|FG001|Overall Study|Lost to Follow-up|0|||
44347733|NCT02623426|79352120|FG002|Overall Study|Lost to Follow-up|1|||
44347734|NCT02623426|79352118|FG000|Overall Study|Withdrawal by Subject|1|||
44347735|NCT02623426|79352119|FG001|Overall Study|Withdrawal by Subject|2|||
44347736|NCT02623426|79352120|FG002|Overall Study|Withdrawal by Subject|2|||
44347737|NCT02580058|79352131|FG000|Overall Study|Adverse Event|16|||
44347738|NCT02580058|79352132|FG001|Overall Study|Adverse Event|30|||
44347739|NCT02580058|79352133|FG002|Overall Study|Adverse Event|20|||
44347740|NCT02580058|79352131|FG000|Overall Study|Death|4|||
44347741|NCT02580058|79352132|FG001|Overall Study|Death|4|||
44347742|NCT02580058|79352133|FG002|Overall Study|Death|5|||
44347743|NCT02580058|79352131|FG000|Overall Study|Physician Decision|1|||
44347744|NCT02580058|79352132|FG001|Overall Study|Physician Decision|3|||
44347745|NCT02580058|79352133|FG002|Overall Study|Physician Decision|11|||
44347746|NCT02580058|79352131|FG000|Overall Study|Other|5|||
44347747|NCT02580058|79352132|FG001|Overall Study|Other|1|||
44347748|NCT02580058|79352133|FG002|Overall Study|Other|3|||
44347749|NCT02580058|79352131|FG000|Overall Study|Withdrawal by Subject|4|||
44347750|NCT02580058|79352132|FG001|Overall Study|Withdrawal by Subject|7|||
44347751|NCT02580058|79352133|FG002|Overall Study|Withdrawal by Subject|31|||
44347752|NCT02580058|79352131|FG000|Overall Study|Global Deterioration of Health Status|19|||
44347753|NCT02580058|79352132|FG001|Overall Study|Global Deterioration of Health Status|18|||
44347754|NCT02580058|79352133|FG002|Overall Study|Global Deterioration of Health Status|24|||
44347755|NCT02580058|79352131|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
44347756|NCT02580058|79352132|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
44347757|NCT02580058|79352133|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
44347758|NCT02580058|79352131|FG000|Overall Study|Progressive Disease|137|||
44347759|NCT02580058|79352132|FG001|Overall Study|Progressive Disease|125|||
44347760|NCT02580058|79352133|FG002|Overall Study|Progressive Disease|94|||
44347761|NCT02580058|79352131|FG000|Overall Study|Non-Compliance With Study Drug|1|||
44347762|NCT02580058|79352132|FG001|Overall Study|Non-Compliance With Study Drug|0|||
44347763|NCT02580058|79352133|FG002|Overall Study|Non-Compliance With Study Drug|0|||
44347764|NCT02539394|79352145|FG000|Overall Study|Protocol Violation|1|||
44347765|NCT02539394|79352146|FG001|Overall Study|Protocol Violation|3|||
44347766|NCT02539394|79352145|FG000|Overall Study|Lost to Follow-up|1|||
44347767|NCT02539394|79352146|FG001|Overall Study|Lost to Follow-up|2|||
44347768|NCT02539394|79352145|FG000|Overall Study|Incomplete dataset|6|||
44347769|NCT02539394|79352146|FG001|Overall Study|Incomplete dataset|6|||
44347770|NCT02412670|79352160|FG000|Overall Study|Adverse Event|4|||
44347771|NCT02412670|79352161|FG001|Overall Study|Adverse Event|1|||
44347772|NCT02412670|79352160|FG000|Overall Study|Physician Decision|1|||
44347773|NCT02412670|79352161|FG001|Overall Study|Physician Decision|0|||
44347774|NCT02412670|79352160|FG000|Overall Study|Withdrawal by Subject|1|||
44347775|NCT02412670|79352161|FG001|Overall Study|Withdrawal by Subject|0|||
44347776|NCT02412670|79352160|FG000|Overall Study|Ineligible|1|||
44347777|NCT02412670|79352161|FG001|Overall Study|Ineligible|0|||
44347778|NCT05111145|79352181|FG000|Overall Study|Commercial drug is available for participant|76|||
44347779|NCT05111145|79352181|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
44446056|NCT00174187|79454378|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
44446057|NCT00174187|79454379|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
44446058|NCT00174187|79454380|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
44446059|NCT00174187|79454378|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
44446060|NCT00174187|79454379|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
44446061|NCT00174187|79454380|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
44446062|NCT00174187|79454378|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
44446063|NCT00174187|79454379|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
44446064|NCT00174187|79454380|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
44446065|NCT00174187|79454378|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
44164264|NCT02561195|78957226|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
44164265|NCT02561195|78957227|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44164266|NCT02561195|78957228|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44164267|NCT02561195|78957229|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44260295|NCT02166905|79130652|FG002|Overall Study|Withdrawal by Subject|0|||
44260296|NCT02166905|79130653|FG003|Overall Study|Withdrawal by Subject|0|||
44260297|NCT01501955|79130700|FG000|Overall Study|Withdrawal by Subject|1|||
44260298|NCT01501955|79130701|FG001|Overall Study|Withdrawal by Subject|0|||
44260299|NCT01501955|79130700|FG000|Overall Study|Adverse Event|1|||
44260300|NCT01501955|79130701|FG001|Overall Study|Adverse Event|3|||
44260301|NCT02574312|79130829|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
44260302|NCT02574312|79130830|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
44260303|NCT01049035|79130852|FG000|Overall Study|Serious adverse event|0|||
44260304|NCT01049035|79130853|FG001|Overall Study|Serious adverse event|1|||
44260305|NCT01049035|79130854|FG002|Overall Study|Serious adverse event|1|||
44260306|NCT01049035|79130855|FG003|Overall Study|Serious adverse event|2|||
44260307|NCT01049035|79130856|FG004|Overall Study|Serious adverse event|0|||
44260308|NCT01049035|79130857|FG005|Overall Study|Serious adverse event|0|||
44260309|NCT01049035|79130858|FG006|Overall Study|Serious adverse event|0|||
44260310|NCT01049035|79130852|FG000|Overall Study|Other adverse event (AE)|0|||
44260311|NCT01049035|79130853|FG001|Overall Study|Other adverse event (AE)|0|||
44260312|NCT01049035|79130854|FG002|Overall Study|Other adverse event (AE)|0|||
44260313|NCT01049035|79130855|FG003|Overall Study|Other adverse event (AE)|1|||
44347780|NCT04823130|79352200|FG000|Overall Study|Withdrawal by Subject|2|||
44347781|NCT04823130|79352201|FG001|Overall Study|Withdrawal by Subject|3|||
44347782|NCT04823130|79352200|FG000|Overall Study|Failure to meet inclusion criteria|6|||
44164268|NCT02561195|78957230|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44260314|NCT01049035|79130856|FG004|Overall Study|Other adverse event (AE)|0|||
44260315|NCT01049035|79130857|FG005|Overall Study|Other adverse event (AE)|0|||
44347783|NCT04823130|79352201|FG001|Overall Study|Failure to meet inclusion criteria|4|||
44347784|NCT04823130|79352200|FG000|Overall Study|Other-unspecified|1|||
44446066|NCT00174187|79454379|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
44446067|NCT00174187|79454380|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
44446068|NCT00174187|79454378|FG000|Period 2 (After 3 Years)|Other|0|||
44446069|NCT00174187|79454379|FG001|Period 2 (After 3 Years)|Other|0|||
44164269|NCT02561195|78957231|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44446070|NCT00174187|79454380|FG002|Period 2 (After 3 Years)|Other|5|||
44446071|NCT01011335|79454392|FG000|Overall Study|Lost to Follow-up|0|||
44446072|NCT01011335|79454393|FG001|Overall Study|Lost to Follow-up|0|||
44446073|NCT01011335|79454394|FG002|Overall Study|Lost to Follow-up|1|||
44446074|NCT01011335|79454395|FG003|Overall Study|Lost to Follow-up|1|||
44446075|NCT01011335|79454396|FG004|Overall Study|Lost to Follow-up|1|||
44446076|NCT01011335|79454397|FG005|Overall Study|Lost to Follow-up|1|||
44446077|NCT01011335|79454398|FG006|Overall Study|Lost to Follow-up|2|||
44446078|NCT01011335|79454399|FG007|Overall Study|Lost to Follow-up|2|||
44446079|NCT01011335|79454400|FG008|Overall Study|Lost to Follow-up|1|||
44446080|NCT01011335|79454401|FG009|Overall Study|Lost to Follow-up|0|||
44446081|NCT01011335|79454402|FG010|Overall Study|Lost to Follow-up|0|||
44446082|NCT01011335|79454403|FG011|Overall Study|Lost to Follow-up|1|||
44446083|NCT01011335|79454404|FG012|Overall Study|Lost to Follow-up|2|||
44446084|NCT01011335|79454392|FG000|Overall Study|Protocol Violation|0|||
44446085|NCT01011335|79454393|FG001|Overall Study|Protocol Violation|1|||
44446086|NCT01011335|79454394|FG002|Overall Study|Protocol Violation|0|||
44446087|NCT01011335|79454395|FG003|Overall Study|Protocol Violation|0|||
44446088|NCT01011335|79454396|FG004|Overall Study|Protocol Violation|0|||
44446089|NCT01011335|79454397|FG005|Overall Study|Protocol Violation|0|||
44446090|NCT01011335|79454398|FG006|Overall Study|Protocol Violation|0|||
44446091|NCT01011335|79454399|FG007|Overall Study|Protocol Violation|0|||
44446092|NCT01011335|79454400|FG008|Overall Study|Protocol Violation|0|||
44446093|NCT01011335|79454401|FG009|Overall Study|Protocol Violation|0|||
44446094|NCT01011335|79454402|FG010|Overall Study|Protocol Violation|0|||
44446095|NCT01011335|79454403|FG011|Overall Study|Protocol Violation|0|||
44446096|NCT01011335|79454404|FG012|Overall Study|Protocol Violation|0|||
44446097|NCT01011335|79454392|FG000|Overall Study|Moved/deployed or no booster|1|||
44446098|NCT01011335|79454393|FG001|Overall Study|Moved/deployed or no booster|0|||
44446099|NCT01011335|79454394|FG002|Overall Study|Moved/deployed or no booster|0|||
44446100|NCT01011335|79454395|FG003|Overall Study|Moved/deployed or no booster|1|||
44446101|NCT01011335|79454396|FG004|Overall Study|Moved/deployed or no booster|0|||
44446102|NCT01011335|79454397|FG005|Overall Study|Moved/deployed or no booster|0|||
44446103|NCT01011335|79454398|FG006|Overall Study|Moved/deployed or no booster|1|||
44446104|NCT01011335|79454399|FG007|Overall Study|Moved/deployed or no booster|0|||
44446105|NCT01011335|79454400|FG008|Overall Study|Moved/deployed or no booster|1|||
44446106|NCT01011335|79454401|FG009|Overall Study|Moved/deployed or no booster|0|||
44446107|NCT01011335|79454402|FG010|Overall Study|Moved/deployed or no booster|2|||
44446108|NCT01011335|79454403|FG011|Overall Study|Moved/deployed or no booster|0|||
44446109|NCT01011335|79454404|FG012|Overall Study|Moved/deployed or no booster|0|||
44446110|NCT01011335|79454392|FG000|Overall Study|Adverse Event|0|||
44446111|NCT01011335|79454393|FG001|Overall Study|Adverse Event|0|||
44446112|NCT01011335|79454394|FG002|Overall Study|Adverse Event|0|||
44446113|NCT01011335|79454395|FG003|Overall Study|Adverse Event|0|||
44446114|NCT01011335|79454396|FG004|Overall Study|Adverse Event|0|||
44446115|NCT01011335|79454397|FG005|Overall Study|Adverse Event|0|||
44446116|NCT01011335|79454398|FG006|Overall Study|Adverse Event|0|||
44446117|NCT01011335|79454399|FG007|Overall Study|Adverse Event|0|||
44446118|NCT01011335|79454400|FG008|Overall Study|Adverse Event|0|||
44446119|NCT01011335|79454401|FG009|Overall Study|Adverse Event|0|||
44446120|NCT01011335|79454402|FG010|Overall Study|Adverse Event|4|||
44446121|NCT01011335|79454403|FG011|Overall Study|Adverse Event|0|||
44446122|NCT01011335|79454404|FG012|Overall Study|Adverse Event|1|||
44446123|NCT00467896|79454441|FG000|Overall Study|Consent Withdrawal|18|||
44446124|NCT00467896|79454441|FG000|Overall Study|Adverse Event|7|||
44446125|NCT00467896|79454441|FG000|Overall Study|Serious Adverse Event|13|||
44446126|NCT00467896|79454441|FG000|Overall Study|Non-compliance|3|||
44446127|NCT00467896|79454441|FG000|Overall Study|Changed therapy|2|||
44446128|NCT00467896|79454441|FG000|Overall Study|Patient received transplant|2|||
44446129|NCT00467896|79454441|FG000|Overall Study|Patient had atrial septostomy|1|||
44446130|NCT00467896|79454441|FG000|Overall Study|Patient weaned off iloprost|1|||
44446131|NCT00467896|79454441|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
44446132|NCT00467896|79454441|FG000|Overall Study|Started intravenous prostacyclin|1|||
44446133|NCT00467896|79454441|FG000|Overall Study|Started inhaled Remodulin|1|||
44446134|NCT00467896|79454441|FG000|Overall Study|Patient had no improvement|1|||
44446135|NCT00579059|79454449|FG000|Overall Study|Study Canceled at 1 Year|21|||
44446136|NCT00579059|79454450|FG001|Overall Study|Study Canceled at 1 Year|10|||
44446137|NCT00467818|79454458|FG000|Overall Study|Adverse Event|1|||
44446138|NCT00467818|79454459|FG001|Overall Study|Adverse Event|0|||
44446139|NCT00467818|79454458|FG000|Overall Study|Lost to Follow-up|2|||
44446140|NCT00467818|79454459|FG001|Overall Study|Lost to Follow-up|2|||
44446141|NCT00467740|79454472|FG000|Overall Study|Adverse Event|0|||
44446142|NCT00467740|79454473|FG001|Overall Study|Adverse Event|0|||
44446143|NCT00467740|79454474|FG002|Overall Study|Adverse Event|1|||
44446144|NCT00467740|79454475|FG003|Overall Study|Adverse Event|0|||
44446145|NCT00467740|79454476|FG004|Overall Study|Adverse Event|0|||
44446146|NCT00467740|79454472|FG000|Overall Study|Protocol Violation|0|||
44446147|NCT00467740|79454473|FG001|Overall Study|Protocol Violation|0|||
44446148|NCT00467740|79454474|FG002|Overall Study|Protocol Violation|1|||
44446149|NCT00467740|79454475|FG003|Overall Study|Protocol Violation|0|||
44446150|NCT00467740|79454476|FG004|Overall Study|Protocol Violation|0|||
44446151|NCT00467740|79454472|FG000|Overall Study|Lost to Follow-up|0|||
44446152|NCT00467740|79454473|FG001|Overall Study|Lost to Follow-up|1|||
44446153|NCT00467740|79454474|FG002|Overall Study|Lost to Follow-up|0|||
44446154|NCT00467740|79454475|FG003|Overall Study|Lost to Follow-up|0|||
44446155|NCT00467740|79454476|FG004|Overall Study|Lost to Follow-up|0|||
44446156|NCT00467740|79454472|FG000|Overall Study|Withdrawal by Subject|1|||
44446157|NCT00467740|79454473|FG001|Overall Study|Withdrawal by Subject|1|||
44446158|NCT00467740|79454474|FG002|Overall Study|Withdrawal by Subject|0|||
44446159|NCT00467740|79454475|FG003|Overall Study|Withdrawal by Subject|1|||
44446160|NCT00467740|79454476|FG004|Overall Study|Withdrawal by Subject|0|||
44446161|NCT00467740|79454472|FG000|Overall Study|Lack of Efficacy|0|||
44446162|NCT00467740|79454473|FG001|Overall Study|Lack of Efficacy|1|||
44446163|NCT00467740|79454474|FG002|Overall Study|Lack of Efficacy|0|||
44446164|NCT00467740|79454475|FG003|Overall Study|Lack of Efficacy|0|||
44446165|NCT00467740|79454476|FG004|Overall Study|Lack of Efficacy|0|||
44446166|NCT00553254|79454490|FG000|Overall Study|Death|3|||
44446167|NCT00553254|79454491|FG001|Overall Study|Death|6|||
44446168|NCT00553254|79454492|FG002|Overall Study|Death|25|||
44446169|NCT00553254|79454490|FG000|Overall Study|Lost to Follow-up|0|||
44446170|NCT00553254|79454491|FG001|Overall Study|Lost to Follow-up|0|||
44446171|NCT00553254|79454492|FG002|Overall Study|Lost to Follow-up|2|||
44446172|NCT00553254|79454490|FG000|Overall Study|Withdrawal by Subject|2|||
44446173|NCT00553254|79454491|FG001|Overall Study|Withdrawal by Subject|0|||
44446174|NCT00553254|79454492|FG002|Overall Study|Withdrawal by Subject|2|||
44164270|NCT02561195|78957232|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44260316|NCT01049035|79130858|FG006|Overall Study|Other adverse event (AE)|0|||
44260317|NCT01049035|79130852|FG000|Overall Study|Non-compliance with the protocol|12|||
44260318|NCT01049035|79130853|FG001|Overall Study|Non-compliance with the protocol|6|||
44260319|NCT01049035|79130854|FG002|Overall Study|Non-compliance with the protocol|14|||
44260320|NCT01049035|79130855|FG003|Overall Study|Non-compliance with the protocol|5|||
44260321|NCT01049035|79130856|FG004|Overall Study|Non-compliance with the protocol|3|||
44260322|NCT01049035|79130857|FG005|Overall Study|Non-compliance with the protocol|4|||
44260323|NCT01049035|79130858|FG006|Overall Study|Non-compliance with the protocol|10|||
44260324|NCT01049035|79130852|FG000|Overall Study|Lost to Follow-up|5|||
44260325|NCT01049035|79130853|FG001|Overall Study|Lost to Follow-up|4|||
44260326|NCT01049035|79130854|FG002|Overall Study|Lost to Follow-up|4|||
44260327|NCT01049035|79130855|FG003|Overall Study|Lost to Follow-up|1|||
44260328|NCT01049035|79130856|FG004|Overall Study|Lost to Follow-up|0|||
44347785|NCT04823130|79352201|FG001|Overall Study|Other-unspecified|0|||
44164271|NCT02561195|78957233|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44260329|NCT01049035|79130857|FG005|Overall Study|Lost to Follow-up|3|||
44347786|NCT04402385|79352260|FG000|Overall Study|Withdrawal by Subject|4|||
44347787|NCT04402385|79352261|FG001|Overall Study|Withdrawal by Subject|4|||
44347788|NCT04402385|79352260|FG000|Overall Study|Lost to Follow-up|1|||
44347789|NCT04402385|79352261|FG001|Overall Study|Lost to Follow-up|1|||
44260330|NCT01049035|79130858|FG006|Overall Study|Lost to Follow-up|3|||
44260331|NCT01049035|79130852|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
44260332|NCT01049035|79130853|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
44260333|NCT01049035|79130854|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
44260334|NCT01049035|79130855|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
44260335|NCT01049035|79130856|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
44347790|NCT04402385|79352260|FG000|Overall Study|Physician Decision|0|||
44347791|NCT04402385|79352261|FG001|Overall Study|Physician Decision|1|||
44347792|NCT03785210|79352271|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
44446175|NCT00553254|79454490|FG000|Overall Study|Study terminated by Sponsor|0|||
44446176|NCT00553254|79454491|FG001|Overall Study|Study terminated by Sponsor|0|||
44446177|NCT00553254|79454492|FG002|Overall Study|Study terminated by Sponsor|1|||
44446178|NCT00553254|79454490|FG000|Overall Study|Other|1|||
44446179|NCT00553254|79454491|FG001|Overall Study|Other|0|||
44446180|NCT00553254|79454492|FG002|Overall Study|Other|13|||
44446181|NCT00168805|79454507|FG000|Overall Study|Adverse Event|7|||
44446182|NCT00168805|79454508|FG001|Overall Study|Adverse Event|11|||
44446183|NCT00168805|79454509|FG002|Overall Study|Adverse Event|16|||
44446184|NCT00168805|79454507|FG000|Overall Study|Protocol Violation|12|||
44446185|NCT00168805|79454508|FG001|Overall Study|Protocol Violation|11|||
44446186|NCT00168805|79454509|FG002|Overall Study|Protocol Violation|8|||
44446187|NCT00168805|79454507|FG000|Overall Study|Lost to Follow-up|12|||
44446188|NCT00168805|79454508|FG001|Overall Study|Lost to Follow-up|17|||
44446189|NCT00168805|79454509|FG002|Overall Study|Lost to Follow-up|11|||
44446190|NCT00168805|79454507|FG000|Overall Study|Withdrawal by Subject|16|||
44446191|NCT00168805|79454508|FG001|Overall Study|Withdrawal by Subject|18|||
44446192|NCT00168805|79454509|FG002|Overall Study|Withdrawal by Subject|21|||
44446193|NCT00168805|79454507|FG000|Overall Study|Other|24|||
44446194|NCT00168805|79454508|FG001|Overall Study|Other|21|||
44446195|NCT00168805|79454509|FG002|Overall Study|Other|22|||
44446196|NCT00168805|79454507|FG000|Treatment|Adverse Event|25|||
44446197|NCT00168805|79454508|FG001|Treatment|Adverse Event|26|||
44446198|NCT00168805|79454509|FG002|Treatment|Adverse Event|32|||
44446199|NCT00168805|79454507|FG000|Treatment|Protocol Violation|3|||
44446200|NCT00168805|79454508|FG001|Treatment|Protocol Violation|5|||
44446201|NCT00168805|79454509|FG002|Treatment|Protocol Violation|5|||
44446202|NCT00168805|79454507|FG000|Treatment|Withdrawal by Subject|3|||
44446203|NCT00168805|79454508|FG001|Treatment|Withdrawal by Subject|7|||
44446204|NCT00168805|79454509|FG002|Treatment|Withdrawal by Subject|8|||
44446205|NCT00168805|79454507|FG000|Treatment|Other|18|||
44446206|NCT00168805|79454508|FG001|Treatment|Other|18|||
44446207|NCT00168805|79454509|FG002|Treatment|Other|17|||
44446208|NCT00467584|79454520|FG000|Overall Study|Withdrawal by Subject|4|||
44446209|NCT00467584|79454521|FG001|Overall Study|Withdrawal by Subject|5|||
44446210|NCT00467584|79454522|FG002|Overall Study|Withdrawal by Subject|1|||
44446211|NCT03839212|79454530|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
44446212|NCT00168103|79454537|FG000|Overall Study|Withdrawal by Subject|1|||
44446213|NCT00168103|79454538|FG001|Overall Study|Withdrawal by Subject|2|||
44446214|NCT00168103|79454539|FG002|Overall Study|Withdrawal by Subject|1|||
44446215|NCT00168103|79454540|FG003|Overall Study|Withdrawal by Subject|0|||
44446216|NCT00168103|79454537|FG000|Overall Study|Lost to Follow-up|1|||
44446217|NCT00168103|79454538|FG001|Overall Study|Lost to Follow-up|3|||
44446218|NCT00168103|79454539|FG002|Overall Study|Lost to Follow-up|0|||
44446219|NCT00168103|79454540|FG003|Overall Study|Lost to Follow-up|0|||
44446220|NCT00463060|79454550|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
44446221|NCT00463060|79454550|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
44446222|NCT00462982|79454559|FG000|Overall Study|Adverse Event|1|||
44446223|NCT00462982|79454559|FG000|Overall Study|Patient Not Treated|2|||
44446224|NCT00462904|79454580|FG000|Overall Study|Lost to Follow-up|1|||
44446225|NCT00467272|79454584|FG000|Overall Study|Pneumonia|2|||
44446226|NCT00467272|79454584|FG000|Overall Study|Thrombophlebitis|1|||
44446227|NCT00462826|79454588|FG000|Overall Study|Ineligible - second primary|1|||
44446228|NCT00462826|79454588|FG000|Overall Study|Ineligible - wrong cell type|1|||
44446229|NCT00462826|79454588|FG000|Overall Study|Ineligible - wrong primary|2|||
44446230|NCT00462826|79454588|FG000|Overall Study|Never treated|1|||
44164272|NCT02561195|78957234|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
44347793|NCT03785210|79352272|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
44347794|NCT03750968|79352280|FG000|Overall Study|Adverse Event|2|||
44347795|NCT03750968|79352281|FG001|Overall Study|Adverse Event|0|||
44347796|NCT03750968|79352280|FG000|Overall Study|Lost to Follow-up|1|||
44347797|NCT03750968|79352281|FG001|Overall Study|Lost to Follow-up|3|||
44347798|NCT03690388|79352293|FG000|Overall Study|Adverse Event|8|||
44347799|NCT03690388|79352294|FG001|Overall Study|Adverse Event|1|||
44347800|NCT03690388|79352293|FG000|Overall Study|Radiographic Progression|14|||
44347801|NCT03690388|79352294|FG001|Overall Study|Radiographic Progression|29|||
44347802|NCT03690388|79352293|FG000|Overall Study|Clinical deterioration|10|||
44347803|NCT03690388|79352294|FG001|Overall Study|Clinical deterioration|6|||
44347804|NCT03690388|79352293|FG000|Overall Study|Withdrawal by Subject|2|||
44347805|NCT03690388|79352294|FG001|Overall Study|Withdrawal by Subject|0|||
44347806|NCT03690388|79352293|FG000|Overall Study|Lack of Efficacy|1|||
44347807|NCT03690388|79352294|FG001|Overall Study|Lack of Efficacy|0|||
44446231|NCT00551616|79454600|FG000|Overall Study|Lost to Follow-up|48|||
44446232|NCT00551616|79454601|FG001|Overall Study|Lost to Follow-up|40|||
44446233|NCT00452530|79454609|FG000|Overall Study|Death|1|||
44446234|NCT00452530|79454610|FG001|Overall Study|Death|0|||
44446235|NCT00452530|79454609|FG000|Overall Study|Adverse Event|40|||
44446236|NCT00452530|79454610|FG001|Overall Study|Adverse Event|44|||
44446237|NCT00452530|79454609|FG000|Overall Study|Withdrawal by Subject|68|||
44446238|NCT00452530|79454610|FG001|Overall Study|Withdrawal by Subject|57|||
44446239|NCT00452530|79454609|FG000|Overall Study|Lost to Follow-up|1|||
44446240|NCT00452530|79454610|FG001|Overall Study|Lost to Follow-up|0|||
44446241|NCT00452530|79454609|FG000|Overall Study|Poor compliance/noncompliance|1|||
44446242|NCT00452530|79454610|FG001|Overall Study|Poor compliance/noncompliance|2|||
44446243|NCT00452530|79454609|FG000|Overall Study|No longer met study criteria|18|||
44446244|NCT00452530|79454610|FG001|Overall Study|No longer met study criteria|22|||
44446245|NCT00452530|79454609|FG000|Overall Study|Other|7|||
44446246|NCT00452530|79454610|FG001|Overall Study|Other|11|||
44446247|NCT00549198|79454622|FG000|Overall Study|Adverse Event|28|||
44446248|NCT00549198|79454623|FG001|Overall Study|Adverse Event|26|||
44446249|NCT00549198|79454622|FG000|Overall Study|Insufficient Viral Load Response|4|||
44446250|NCT00549198|79454623|FG001|Overall Study|Insufficient Viral Load Response|2|||
44446251|NCT00549198|79454622|FG000|Overall Study|Protocol-defined Virological Failure|7|||
44446252|NCT00549198|79454623|FG001|Overall Study|Protocol-defined Virological Failure|0|||
44446253|NCT00549198|79454622|FG000|Overall Study|Non-compliance|2|||
44446254|NCT00549198|79454623|FG001|Overall Study|Non-compliance|4|||
44446255|NCT00549198|79454622|FG000|Overall Study|Lost to Follow-up|7|||
44446256|NCT00549198|79454623|FG001|Overall Study|Lost to Follow-up|8|||
44446257|NCT00549198|79454622|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
44446258|NCT00549198|79454623|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446259|NCT00549198|79454622|FG000|Overall Study|Protocol Violation|7|||
44446260|NCT00549198|79454623|FG001|Overall Study|Protocol Violation|2|||
44446261|NCT00549198|79454622|FG000|Overall Study|Investigator Decision|4|||
44446262|NCT00549198|79454623|FG001|Overall Study|Investigator Decision|3|||
44446263|NCT00549198|79454622|FG000|Overall Study|Withdrawal by Subject|7|||
44446264|NCT00549198|79454623|FG001|Overall Study|Withdrawal by Subject|7|||
44446265|NCT00549198|79454622|FG000|Overall Study|Disease Progression|1|||
44446266|NCT00549198|79454623|FG001|Overall Study|Disease Progression|0|||
44446267|NCT00549198|79454622|FG000|Overall Study|Participant Moved|2|||
44446268|NCT00549198|79454623|FG001|Overall Study|Participant Moved|0|||
44446269|NCT00549198|79454622|FG000|Overall Study|Participant not able to perform Week 96|1|||
44446270|NCT00549198|79454623|FG001|Overall Study|Participant not able to perform Week 96|0|||
44446271|NCT00549198|79454622|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
44446272|NCT00549198|79454623|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
44446273|NCT00549198|79454622|FG000|Overall Study|Prohibited Medication|1|||
44446274|NCT00549198|79454623|FG001|Overall Study|Prohibited Medication|2|||
44446275|NCT00549198|79454622|FG000|Overall Study|Participant planning pregnancy|1|||
44446276|NCT00549198|79454623|FG001|Overall Study|Participant planning pregnancy|0|||
44446277|NCT00549198|79454622|FG000|Overall Study|Participant overweight, no scan possible|1|||
44446278|NCT00549198|79454623|FG001|Overall Study|Participant overweight, no scan possible|0|||
44446279|NCT00549198|79454622|FG000|Overall Study|No scan facilities|0|||
44446280|NCT00549198|79454623|FG001|Overall Study|No scan facilities|2|||
44446281|NCT00549198|79454622|FG000|Overall Study|Pregnancy|0|||
44446282|NCT00549198|79454623|FG001|Overall Study|Pregnancy|3|||
44446283|NCT00549198|79454622|FG000|Overall Study|Not Exposed to Study Drug|3|||
44446284|NCT00549198|79454623|FG001|Overall Study|Not Exposed to Study Drug|4|||
44446285|NCT00607724|79454636|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
44446286|NCT00607724|79454637|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
44446287|NCT00607724|79454638|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
44446288|NCT00607724|79454639|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
44446289|NCT00607724|79454640|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
44446290|NCT00607724|79454641|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
44446291|NCT00607724|79454642|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
44446292|NCT00607724|79454636|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
44446293|NCT00607724|79454637|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
44446294|NCT00607724|79454638|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
44446295|NCT00607724|79454639|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
44446296|NCT00607724|79454640|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
44446297|NCT00607724|79454641|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
44446298|NCT00607724|79454642|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
44446299|NCT00607724|79454636|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
44446300|NCT00607724|79454637|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
44446301|NCT00607724|79454638|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
44446302|NCT00607724|79454639|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
44446303|NCT00607724|79454640|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
44446304|NCT00607724|79454641|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
44446305|NCT00607724|79454642|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
44446306|NCT00607724|79454636|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
44446307|NCT00607724|79454637|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
44446308|NCT00607724|79454638|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
44446309|NCT00607724|79454639|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
44446310|NCT00607724|79454640|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
44446311|NCT00607724|79454641|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
44446312|NCT00607724|79454642|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
44446313|NCT00607724|79454636|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
44446314|NCT00607724|79454637|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
44164273|NCT02561195|78957221|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
44446315|NCT00607724|79454638|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
44446316|NCT00607724|79454639|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
44164274|NCT02561195|78957222|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
44164275|NCT02561195|78957223|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
44164276|NCT02561195|78957224|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
44164277|NCT02561195|78957225|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
44164278|NCT02561195|78957226|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
44164279|NCT02561195|78957227|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
44164280|NCT02561195|78957228|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
44164281|NCT02561195|78957229|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
44164282|NCT02561195|78957230|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
44164283|NCT02561195|78957231|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
44164284|NCT02561195|78957232|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
44164285|NCT02561195|78957233|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
44164286|NCT02561195|78957234|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
44164287|NCT02561195|78957221|FG000|Vaccination 1 to 3|Other|7|||
44164288|NCT02561195|78957222|FG001|Vaccination 1 to 3|Other|3|||
44164289|NCT02561195|78957223|FG002|Vaccination 1 to 3|Other|1|||
44164290|NCT02561195|78957224|FG003|Vaccination 1 to 3|Other|7|||
44164291|NCT02561195|78957225|FG004|Vaccination 1 to 3|Other|5|||
44164292|NCT02561195|78957226|FG005|Vaccination 1 to 3|Other|1|||
44164293|NCT02561195|78957227|FG006|Vaccination 1 to 3|Other|0|||
44164294|NCT02561195|78957228|FG007|Vaccination 1 to 3|Other|0|||
44164295|NCT02561195|78957229|FG008|Vaccination 1 to 3|Other|0|||
44164296|NCT02561195|78957230|FG009|Vaccination 1 to 3|Other|0|||
44164297|NCT02561195|78957231|FG010|Vaccination 1 to 3|Other|0|||
44164298|NCT02561195|78957232|FG011|Vaccination 1 to 3|Other|0|||
44164299|NCT02561195|78957233|FG012|Vaccination 1 to 3|Other|0|||
44164300|NCT02561195|78957234|FG013|Vaccination 1 to 3|Other|0|||
44164301|NCT02561195|78957221|FG000|Vaccination 1 to 3|Protocol Violation|1|||
44164302|NCT02561195|78957222|FG001|Vaccination 1 to 3|Protocol Violation|0|||
44164303|NCT02561195|78957223|FG002|Vaccination 1 to 3|Protocol Violation|1|||
44164304|NCT02561195|78957224|FG003|Vaccination 1 to 3|Protocol Violation|2|||
44164305|NCT02561195|78957225|FG004|Vaccination 1 to 3|Protocol Violation|5|||
44164306|NCT02561195|78957226|FG005|Vaccination 1 to 3|Protocol Violation|2|||
44164307|NCT02561195|78957227|FG006|Vaccination 1 to 3|Protocol Violation|0|||
44164308|NCT02561195|78957228|FG007|Vaccination 1 to 3|Protocol Violation|0|||
44164309|NCT02561195|78957229|FG008|Vaccination 1 to 3|Protocol Violation|0|||
44164310|NCT02561195|78957230|FG009|Vaccination 1 to 3|Protocol Violation|0|||
44164311|NCT02561195|78957231|FG010|Vaccination 1 to 3|Protocol Violation|0|||
44164312|NCT02561195|78957232|FG011|Vaccination 1 to 3|Protocol Violation|0|||
44164313|NCT02561195|78957233|FG012|Vaccination 1 to 3|Protocol Violation|0|||
44164314|NCT02561195|78957234|FG013|Vaccination 1 to 3|Protocol Violation|0|||
44164315|NCT02561195|78957221|FG000|Vaccination 1 to 3|Death|2|||
44164316|NCT02561195|78957222|FG001|Vaccination 1 to 3|Death|1|||
44164317|NCT02561195|78957223|FG002|Vaccination 1 to 3|Death|0|||
44164318|NCT02561195|78957224|FG003|Vaccination 1 to 3|Death|2|||
44164319|NCT02561195|78957225|FG004|Vaccination 1 to 3|Death|0|||
44164320|NCT02561195|78957226|FG005|Vaccination 1 to 3|Death|0|||
44164321|NCT02561195|78957227|FG006|Vaccination 1 to 3|Death|0|||
44164322|NCT02561195|78957228|FG007|Vaccination 1 to 3|Death|0|||
44164323|NCT02561195|78957229|FG008|Vaccination 1 to 3|Death|0|||
44164324|NCT02561195|78957230|FG009|Vaccination 1 to 3|Death|0|||
44164325|NCT02561195|78957231|FG010|Vaccination 1 to 3|Death|0|||
44164326|NCT02561195|78957232|FG011|Vaccination 1 to 3|Death|0|||
44164327|NCT02561195|78957233|FG012|Vaccination 1 to 3|Death|0|||
44164328|NCT02561195|78957234|FG013|Vaccination 1 to 3|Death|0|||
44164329|NCT02561195|78957221|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
44164330|NCT02561195|78957222|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
44164331|NCT02561195|78957223|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
44164332|NCT02561195|78957224|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
44164333|NCT02561195|78957225|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
44164334|NCT02561195|78957226|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164335|NCT02561195|78957227|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164336|NCT02561195|78957228|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164337|NCT02561195|78957229|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164338|NCT02561195|78957230|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164339|NCT02561195|78957231|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164340|NCT02561195|78957232|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164341|NCT02561195|78957233|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164342|NCT02561195|78957234|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
44164343|NCT02561195|78957221|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
44164344|NCT02561195|78957222|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
44164345|NCT02561195|78957223|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
44164346|NCT02561195|78957224|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
44164347|NCT02561195|78957225|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
44164348|NCT02561195|78957226|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
44164349|NCT02561195|78957227|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
44164350|NCT02561195|78957228|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
44164351|NCT02561195|78957229|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
44164352|NCT02561195|78957230|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
44164353|NCT02561195|78957231|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
44164354|NCT02561195|78957232|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
44164355|NCT02561195|78957233|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
44164356|NCT02561195|78957234|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
44164357|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164358|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164359|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164360|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164361|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164362|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164363|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164364|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164365|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
44164366|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
44164367|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
44164368|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
44164369|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
44164370|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
44164371|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164372|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164373|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
44260336|NCT01049035|79130857|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
44164374|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164375|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164376|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164377|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164378|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164379|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164380|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164381|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164382|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164383|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
44164384|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
44164385|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|Death|0|||
44164386|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|Death|0|||
44164387|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|Death|0|||
44164388|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|Death|0|||
44164389|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|Death|0|||
44164390|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|Death|0|||
44164391|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|Death|0|||
44164392|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|Death|0|||
44164393|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|Death|0|||
44164394|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|Death|1|||
44164395|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|Death|0|||
44164396|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|Death|0|||
44164397|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|Death|0|||
44164398|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|Death|0|||
44164399|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44260337|NCT01049035|79130858|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
44446317|NCT00607724|79454640|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
44446318|NCT00607724|79454641|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
44446319|NCT00607724|79454642|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
44446320|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
44446321|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
44446322|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
44446323|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
44446324|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
44446325|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
44446326|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
44446327|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
44446328|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
44446329|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
44446330|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
44446331|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
44446332|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
44347808|NCT03690388|79352293|FG000|Overall Study|Lost to Follow-up|1|||
44347809|NCT03690388|79352294|FG001|Overall Study|Lost to Follow-up|0|||
44347810|NCT03619213|79352306|FG000|Overall Study|Lost to Follow-up|2|||
44347811|NCT03619213|79352307|FG001|Overall Study|Lost to Follow-up|1|||
44347812|NCT03619213|79352306|FG000|Overall Study|Withdrawal by Subject|8|||
44347813|NCT03619213|79352307|FG001|Overall Study|Withdrawal by Subject|10|||
44347814|NCT03342690|79352313|FG000|Overall Study|Missing Information|9|||
44347815|NCT03342690|79352313|FG000|Overall Study|Protocol Violation|16|||
44347816|NCT03257267|79352332|FG000|Overall Study|Adverse Event|9|||
44347817|NCT03257267|79352333|FG001|Overall Study|Adverse Event|7|||
44347818|NCT03257267|79352332|FG000|Overall Study|Death|92|||
44347819|NCT03257267|79352333|FG001|Overall Study|Death|95|||
44347820|NCT03257267|79352332|FG000|Overall Study|Lost to Follow-up|2|||
44347821|NCT03257267|79352333|FG001|Overall Study|Lost to Follow-up|2|||
44347822|NCT03257267|79352332|FG000|Overall Study|Non-compliance with Study Drug|0|||
44347823|NCT03257267|79352333|FG001|Overall Study|Non-compliance with Study Drug|1|||
44347824|NCT03257267|79352332|FG000|Overall Study|Participant Decision|34|||
44347825|NCT03257267|79352333|FG001|Overall Study|Participant Decision|42|||
44347826|NCT03257267|79352332|FG000|Overall Study|Physician Decision|1|||
44347827|NCT03257267|79352333|FG001|Overall Study|Physician Decision|3|||
44347828|NCT03257267|79352332|FG000|Overall Study|Disease Progression|98|||
44347829|NCT03257267|79352333|FG001|Overall Study|Disease Progression|117|||
44347830|NCT03257267|79352332|FG000|Overall Study|Withdrawal of Consent|8|||
44446333|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
44446334|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
44260338|NCT01048333|79130884|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
44260339|NCT01048333|79130885|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
44260340|NCT01048333|79130886|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
44260341|NCT01048333|79130887|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
44260342|NCT01048333|79130888|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
44260343|NCT01048333|79130889|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
44260344|NCT02323113|79130904|FG000|Overall Study|Adverse Event|3|||
44347831|NCT03257267|79352333|FG001|Overall Study|Withdrawal of Consent|26|||
44347832|NCT03257267|79352332|FG000|Overall Study|Study Ongoing|53|||
44446335|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
44446336|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
44446337|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
44446338|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
44446339|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
44446340|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
44446341|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
44446342|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
44446343|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
44446344|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
44446345|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
44446346|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
44446347|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
44446348|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
44446349|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
44446350|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
44446351|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
44164400|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164401|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164402|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164403|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164404|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164405|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
44164406|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
44164407|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164408|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
44164409|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
44164410|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
44164411|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
44164412|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
44164413|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164414|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164415|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164416|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164417|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164418|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164419|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164420|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164421|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164422|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44260345|NCT02323113|79130905|FG001|Overall Study|Adverse Event|3|||
44260346|NCT02323113|79130906|FG002|Overall Study|Adverse Event|2|||
44260347|NCT02323113|79130907|FG003|Overall Study|Adverse Event|5|||
44260348|NCT02323113|79130908|FG004|Overall Study|Adverse Event|8|||
44260349|NCT02323113|79130909|FG005|Overall Study|Adverse Event|3|||
44260350|NCT02323113|79130910|FG006|Overall Study|Adverse Event|6|||
44260351|NCT02323113|79130911|FG007|Overall Study|Adverse Event|0|||
44260352|NCT02323113|79130904|FG000|Overall Study|Progressive Disease|0|||
44260353|NCT02323113|79130905|FG001|Overall Study|Progressive Disease|1|||
44260354|NCT02323113|79130906|FG002|Overall Study|Progressive Disease|1|||
44260355|NCT02323113|79130907|FG003|Overall Study|Progressive Disease|0|||
44260356|NCT02323113|79130908|FG004|Overall Study|Progressive Disease|0|||
44260357|NCT02323113|79130909|FG005|Overall Study|Progressive Disease|3|||
44260358|NCT02323113|79130910|FG006|Overall Study|Progressive Disease|0|||
44260359|NCT02323113|79130911|FG007|Overall Study|Progressive Disease|0|||
44260360|NCT02323113|79130904|FG000|Overall Study|Symptomatic Deterioration|0|||
44164423|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
44164424|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
44347833|NCT03257267|79352333|FG001|Overall Study|Study Ongoing|11|||
44347834|NCT02991456|79352350|FG000|Overall Study|Adverse Event|2|||
44347835|NCT02991456|79352351|FG001|Overall Study|Adverse Event|0|||
44347836|NCT02991456|79352350|FG000|Overall Study|Lost to Follow-up|0|||
44347837|NCT02991456|79352351|FG001|Overall Study|Lost to Follow-up|2|||
44347838|NCT02991456|79352350|FG000|Overall Study|Withdrawal by Subject|1|||
44164425|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
44164426|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
44164427|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|Other|0|||
44164428|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|Other|0|||
44164429|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|Other|0|||
44164430|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|Other|0|||
44164431|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|Other|0|||
44164432|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|Other|0|||
44164433|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|Other|0|||
44164434|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|Other|0|||
44164435|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|Other|0|||
44164436|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|Other|0|||
44164437|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|Other|2|||
44164438|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|Other|2|||
44164439|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|Other|1|||
44164440|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|Other|0|||
44164441|NCT02561195|78957221|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164442|NCT02561195|78957222|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164443|NCT02561195|78957223|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164444|NCT02561195|78957224|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164445|NCT02561195|78957225|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164446|NCT02561195|78957226|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164447|NCT02561195|78957227|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
44164448|NCT02561195|78957228|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164449|NCT02561195|78957229|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164450|NCT02561195|78957230|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164451|NCT02561195|78957231|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
44164452|NCT02561195|78957232|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
44164453|NCT02561195|78957233|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
44164454|NCT02561195|78957234|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
44164455|NCT01663103|78957268|FG000|Overall Study|Withdrawal by Subject|1|||
44164456|NCT01663103|78957269|FG001|Overall Study|Withdrawal by Subject|2|||
44164457|NCT01663103|78957268|FG000|Overall Study|Adverse Event|1|||
44164458|NCT01663103|78957269|FG001|Overall Study|Adverse Event|0|||
44164459|NCT01663103|78957268|FG000|Overall Study|dog bite|1|||
44164460|NCT01663103|78957269|FG001|Overall Study|dog bite|0|||
44164461|NCT02560025|78957288|FG000|Overall Study|Ineligible after consent/ registration|3|||
44164462|NCT02566889|78957303|FG000|Overall Study|Withdrawal by Subject|3|||
44164463|NCT02566889|78957304|FG001|Overall Study|Withdrawal by Subject|1|||
44164464|NCT02566889|78957303|FG000|Overall Study|Adverse Event|4|||
44164465|NCT02566889|78957304|FG001|Overall Study|Adverse Event|2|||
44164466|NCT02566889|78957303|FG000|Overall Study|Other|6|||
44164467|NCT02566889|78957304|FG001|Overall Study|Other|2|||
44164468|NCT02566577|78957311|FG000|Overall Study|Withdrawal by Subject|1|||
44164469|NCT02566577|78957312|FG001|Overall Study|Withdrawal by Subject|1|||
44164470|NCT02566577|78957311|FG000|Overall Study|Equipment failure|1|||
44164471|NCT02566577|78957312|FG001|Overall Study|Equipment failure|1|||
44164472|NCT02566577|78957311|FG000|Overall Study|Physical limitation|1|||
44354779|NCT01185600|79359185|FG001|Overall Study|Lost to Follow-up|5|||
44164473|NCT02566577|78957312|FG001|Overall Study|Physical limitation|0|||
44164474|NCT02559713|78957324|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
44164475|NCT01358981|78957335|FG000|Period 1|Withdrawal by Subject|0|||
44164476|NCT01358981|78957336|FG001|Period 1|Withdrawal by Subject|0|||
44164477|NCT01358981|78957337|FG002|Period 1|Withdrawal by Subject|0|||
44164478|NCT01358981|78957338|FG003|Period 1|Withdrawal by Subject|1|||
44164479|NCT01358981|78957339|FG004|Period 1|Withdrawal by Subject|0|||
44164480|NCT01358981|78957340|FG005|Period 1|Withdrawal by Subject|0|||
44164481|NCT01358981|78957341|FG006|Period 1|Withdrawal by Subject|0|||
44164482|NCT02548585|78957373|FG000|Overall Study|Withdrawal by Subject|0|||
44164483|NCT02548585|78957374|FG001|Overall Study|Withdrawal by Subject|0|||
44164484|NCT02548585|78957375|FG002|Overall Study|Withdrawal by Subject|0|||
44164485|NCT02548585|78957376|FG003|Overall Study|Withdrawal by Subject|0|||
44164486|NCT02548585|78957377|FG004|Overall Study|Withdrawal by Subject|0|||
44164487|NCT02548585|78957378|FG005|Overall Study|Withdrawal by Subject|1|||
44164488|NCT02548585|78957379|FG006|Overall Study|Withdrawal by Subject|0|||
44164489|NCT02548585|78957373|FG000|Overall Study|Lost to Follow-up|1|||
44164490|NCT02548585|78957374|FG001|Overall Study|Lost to Follow-up|0|||
44164491|NCT02548585|78957375|FG002|Overall Study|Lost to Follow-up|0|||
44164492|NCT02548585|78957376|FG003|Overall Study|Lost to Follow-up|0|||
44164493|NCT02548585|78957377|FG004|Overall Study|Lost to Follow-up|0|||
44164494|NCT02548585|78957378|FG005|Overall Study|Lost to Follow-up|0|||
44164495|NCT02548585|78957379|FG006|Overall Study|Lost to Follow-up|0|||
44164496|NCT02548585|78957373|FG000|Overall Study|Other|1|||
44164497|NCT02548585|78957374|FG001|Overall Study|Other|0|||
44164498|NCT02548585|78957375|FG002|Overall Study|Other|0|||
44164499|NCT02548585|78957376|FG003|Overall Study|Other|2|||
44164500|NCT02548585|78957377|FG004|Overall Study|Other|3|||
44164501|NCT02548585|78957378|FG005|Overall Study|Other|0|||
44164502|NCT02548585|78957379|FG006|Overall Study|Other|1|||
44164503|NCT02548585|78957373|FG000|Overall Study|Randomized but not treated|0|||
44164504|NCT02548585|78957374|FG001|Overall Study|Randomized but not treated|0|||
44164505|NCT02548585|78957375|FG002|Overall Study|Randomized but not treated|0|||
44164506|NCT02548585|78957376|FG003|Overall Study|Randomized but not treated|0|||
44164507|NCT02548585|78957377|FG004|Overall Study|Randomized but not treated|0|||
44164508|NCT02548585|78957378|FG005|Overall Study|Randomized but not treated|1|||
44164509|NCT02548585|78957379|FG006|Overall Study|Randomized but not treated|0|||
44164510|NCT02547649|78957423|FG000|Overall Study|Lost to Follow-up|3|||
44164511|NCT02547649|78957424|FG001|Overall Study|Lost to Follow-up|1|||
44164512|NCT02547649|78957425|FG002|Overall Study|Lost to Follow-up|1|||
44164513|NCT02547649|78957423|FG000|Overall Study|Not vaccinated|0|||
44164514|NCT02547649|78957424|FG001|Overall Study|Not vaccinated|0|||
44164515|NCT02547649|78957425|FG002|Overall Study|Not vaccinated|1|||
44164516|NCT02547649|78957423|FG000|Overall Study|Withdrawal by Subject|0|||
44164517|NCT02547649|78957424|FG001|Overall Study|Withdrawal by Subject|4|||
44164518|NCT02547649|78957425|FG002|Overall Study|Withdrawal by Subject|2|||
44164519|NCT02535715|78957445|FG000|Overall Study|Withdrawal by Subject|0|||
44164520|NCT02535715|78957446|FG001|Overall Study|Withdrawal by Subject|0|||
44164521|NCT02535715|78957447|FG002|Overall Study|Withdrawal by Subject|1|||
44164522|NCT02336815|78957460|FG000|Overall Study|Disease Progression|45|||
44164523|NCT02336815|78957461|FG001|Overall Study|Disease Progression|70|||
44164524|NCT02336815|78957460|FG000|Overall Study|Adverse Event|18|||
44164525|NCT02336815|78957461|FG001|Overall Study|Adverse Event|39|||
44164526|NCT02336815|78957460|FG000|Overall Study|Physician Decision|11|||
44164527|NCT02336815|78957461|FG001|Overall Study|Physician Decision|4|||
44164528|NCT02336815|78957460|FG000|Overall Study|Withdrawal by Subject|3|||
44164529|NCT02336815|78957461|FG001|Overall Study|Withdrawal by Subject|2|||
44164530|NCT02336815|78957460|FG000|Overall Study|Lost to Follow-up|1|||
44164531|NCT02336815|78957461|FG001|Overall Study|Lost to Follow-up|3|||
44164532|NCT02336815|78957460|FG000|Overall Study|Other|1|||
44164533|NCT02336815|78957461|FG001|Overall Study|Other|5|||
44164534|NCT02543203|78957471|FG000|Overall Study|Unpalatable Fragrance|2|||
44164535|NCT02543203|78957472|FG001|Overall Study|Unpalatable Fragrance|2|||
44164536|NCT02543203|78957471|FG000|Overall Study|Lost to Follow-up|1|||
44164537|NCT02543203|78957472|FG001|Overall Study|Lost to Follow-up|0|||
44164538|NCT02543203|78957471|FG000|Overall Study|Increased Irritability|1|||
44164539|NCT02543203|78957472|FG001|Overall Study|Increased Irritability|0|||
44164540|NCT02543203|78957471|FG000|Overall Study|Family|1|||
44164541|NCT02543203|78957472|FG001|Overall Study|Family|2|||
44164542|NCT02543203|78957471|FG000|Overall Study|Negative Behavior|1|||
44164543|NCT02543203|78957472|FG001|Overall Study|Negative Behavior|0|||
44164544|NCT02543203|78957471|FG000|Overall Study|Withdrawal by Subject|0|||
44164545|NCT02543203|78957472|FG001|Overall Study|Withdrawal by Subject|1|||
44164546|NCT02546323|78957488|FG000|Overall Study|Withdrawal by Subject|36|||
44164547|NCT02546323|78957489|FG001|Overall Study|Withdrawal by Subject|33|||
44164548|NCT02546323|78957488|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
44164549|NCT02546323|78957489|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
44164550|NCT02546323|78957488|FG000|Overall Study|Adverse Event|17|||
44164551|NCT02546323|78957489|FG001|Overall Study|Adverse Event|11|||
44164552|NCT02546323|78957488|FG000|Overall Study|Patient Specific Reasons|1|||
44164553|NCT02546323|78957489|FG001|Overall Study|Patient Specific Reasons|2|||
44164554|NCT02546323|78957488|FG000|Overall Study|Lost to Follow-up|2|||
44164555|NCT02546323|78957489|FG001|Overall Study|Lost to Follow-up|3|||
44164556|NCT02546323|78957488|FG000|Overall Study|Non-compliance with Study Drug|2|||
44446352|NCT00506415|79454666|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
44446353|NCT00506415|79454667|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
44446354|NCT00506415|79454668|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
44446355|NCT00506415|79454669|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
44446356|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
44446357|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
44446358|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
44446359|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
44446360|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
44446361|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
44446362|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
44446363|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
44446364|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
44446365|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
44446366|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
44446367|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
44446368|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
44164557|NCT02546323|78957489|FG001|Overall Study|Non-compliance with Study Drug|2|||
44164558|NCT02546323|78957488|FG000|Overall Study|Met Withdrawal Criteria|2|||
44164559|NCT02546323|78957489|FG001|Overall Study|Met Withdrawal Criteria|14|||
44164560|NCT02545933|78957498|FG000|Overall Study|Adverse Event|3|||
44164561|NCT02545933|78957499|FG001|Overall Study|Adverse Event|0|||
44164562|NCT02545933|78957500|FG002|Overall Study|Adverse Event|0|||
44164563|NCT02545933|78957498|FG000|Overall Study|Withdrawal by Subject|2|||
44164564|NCT02545933|78957499|FG001|Overall Study|Withdrawal by Subject|3|||
44164565|NCT02545933|78957500|FG002|Overall Study|Withdrawal by Subject|3|||
44164566|NCT02545933|78957498|FG000|Overall Study|Protocol Violation|1|||
44164567|NCT02545933|78957499|FG001|Overall Study|Protocol Violation|0|||
44164568|NCT02545933|78957500|FG002|Overall Study|Protocol Violation|1|||
44164569|NCT01661179|78957508|FG000|Overall Study|Death|1|||
44164570|NCT01661179|78957508|FG000|Overall Study|Withdrawal by Subject|1|||
44164571|NCT01661179|78957508|FG000|Overall Study|Other Eligibility criteria|4|||
44164572|NCT02545543|78957514|FG000|Overall Study|Lost to Follow-up|67|||
44164573|NCT02545543|78957515|FG001|Overall Study|Lost to Follow-up|25|||
44164574|NCT02545543|78957514|FG000|Overall Study|Physician Decision|3|||
44164575|NCT02545543|78957515|FG001|Overall Study|Physician Decision|0|||
44164576|NCT02545543|78957514|FG000|Overall Study|Withdrawal by Subject|9|||
44164577|NCT02545543|78957515|FG001|Overall Study|Withdrawal by Subject|8|||
44164578|NCT02545543|78957514|FG000|Overall Study|Noncomplaince|1|||
44164579|NCT02545543|78957515|FG001|Overall Study|Noncomplaince|0|||
44164580|NCT02545543|78957514|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
44164581|NCT02545543|78957515|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
44164582|NCT02545075|78957525|FG000|Randomization|Lost to Follow-up|0|||
44164583|NCT02545075|78957526|FG001|Randomization|Lost to Follow-up|1|||
44164584|NCT02545075|78957525|FG000|Randomization|Withdrawal by Subject|0|||
44164585|NCT02545075|78957526|FG001|Randomization|Withdrawal by Subject|6|||
44164586|NCT02545075|78957525|FG000|Treatment|Disease progression|71|||
44164587|NCT02545075|78957526|FG001|Treatment|Disease progression|32|||
44164588|NCT02545075|78957525|FG000|Treatment|Participant dicontinued study treatment|7|||
44164589|NCT02545075|78957526|FG001|Treatment|Participant dicontinued study treatment|9|||
44164590|NCT02545075|78957525|FG000|Treatment|Withdrawal by Subject|1|||
44164591|NCT02545075|78957526|FG001|Treatment|Withdrawal by Subject|0|||
44164592|NCT02545075|78957525|FG000|Treatment|Adverse event not related to study drug|1|||
44164593|NCT02545075|78957526|FG001|Treatment|Adverse event not related to study drug|0|||
44164594|NCT02545075|78957525|FG000|Treatment|Death|1|||
44164595|NCT02545075|78957526|FG001|Treatment|Death|0|||
44164596|NCT02545075|78957525|FG000|Treatment|Participant drug toxicity|1|||
44164597|NCT02545075|78957526|FG001|Treatment|Participant drug toxicity|0|||
44164598|NCT02545075|78957525|FG000|Treatment|Completed treatment|40|||
44164599|NCT02545075|78957526|FG001|Treatment|Completed treatment|12|||
44164600|NCT02544763|78957544|FG000|Overall Study|Adverse Event|8|||
44164601|NCT02544763|78957545|FG001|Overall Study|Adverse Event|8|||
44164602|NCT02544763|78957546|FG002|Overall Study|Adverse Event|0|||
44164603|NCT02544763|78957544|FG000|Overall Study|Withdrawn by parent/guardian|1|||
44164604|NCT02544763|78957545|FG001|Overall Study|Withdrawn by parent/guardian|1|||
44164605|NCT02544763|78957546|FG002|Overall Study|Withdrawn by parent/guardian|1|||
44164606|NCT02544763|78957544|FG000|Overall Study|Met withdrawal criteria|0|||
44164607|NCT02544763|78957545|FG001|Overall Study|Met withdrawal criteria|2|||
44164608|NCT02544763|78957546|FG002|Overall Study|Met withdrawal criteria|0|||
44164609|NCT02544763|78957544|FG000|Overall Study|Physician Decision|0|||
44164610|NCT02544763|78957545|FG001|Overall Study|Physician Decision|1|||
44164611|NCT02544763|78957546|FG002|Overall Study|Physician Decision|0|||
44164612|NCT02544763|78957544|FG000|Overall Study|Difficulties taking IMP|1|||
44164613|NCT02544763|78957545|FG001|Overall Study|Difficulties taking IMP|0|||
44164614|NCT02544763|78957546|FG002|Overall Study|Difficulties taking IMP|0|||
44164615|NCT02556203|78957556|FG000|Overall Study|Withdrawal by Subject|21|||
44347839|NCT02991456|79352351|FG001|Overall Study|Withdrawal by Subject|0|||
44347840|NCT02842827|79352368|FG000|Overall Study|Adverse Event|0|||
44347841|NCT02842827|79352369|FG001|Overall Study|Adverse Event|1|||
44347842|NCT02842827|79352370|FG002|Overall Study|Adverse Event|0|||
44347843|NCT02842827|79352371|FG003|Overall Study|Adverse Event|1|||
44347844|NCT02842827|79352372|FG004|Overall Study|Adverse Event|0|||
44347845|NCT02842827|79352373|FG005|Overall Study|Adverse Event|1|||
44347846|NCT02842827|79352374|FG006|Overall Study|Adverse Event|0|||
44347847|NCT02842827|79352375|FG007|Overall Study|Adverse Event|0|||
44347848|NCT02842827|79352368|FG000|Overall Study|Death|1|||
44347849|NCT02842827|79352369|FG001|Overall Study|Death|0|||
44347850|NCT02842827|79352370|FG002|Overall Study|Death|2|||
44164616|NCT02556203|78957557|FG001|Overall Study|Withdrawal by Subject|21|||
44164617|NCT02556203|78957556|FG000|Overall Study|Lost to Follow-up|5|||
44164618|NCT02556203|78957557|FG001|Overall Study|Lost to Follow-up|5|||
44347851|NCT02842827|79352371|FG003|Overall Study|Death|3|||
44347852|NCT02842827|79352372|FG004|Overall Study|Death|2|||
44347853|NCT02842827|79352373|FG005|Overall Study|Death|1|||
44164619|NCT02556203|78957556|FG000|Overall Study|Adverse Event|1|||
44164620|NCT02556203|78957557|FG001|Overall Study|Adverse Event|0|||
44164621|NCT02558231|78957574|FG000|Overall Study|Death|4|||
44164622|NCT02558231|78957575|FG001|Overall Study|Death|12|||
44164623|NCT02558231|78957574|FG000|Overall Study|Lost to Follow-up|7|||
44164624|NCT02558231|78957575|FG001|Overall Study|Lost to Follow-up|4|||
44164625|NCT02558231|78957574|FG000|Overall Study|Withdrawal by Subject|7|||
44164626|NCT02558231|78957575|FG001|Overall Study|Withdrawal by Subject|4|||
44164627|NCT02558231|78957574|FG000|Overall Study|Physician Decision|7|||
44347854|NCT02842827|79352374|FG006|Overall Study|Death|0|||
44347855|NCT02842827|79352375|FG007|Overall Study|Death|4|||
44347856|NCT02842827|79352368|FG000|Overall Study|Physician Decision|1|||
44347857|NCT02842827|79352369|FG001|Overall Study|Physician Decision|3|||
44347858|NCT02842827|79352370|FG002|Overall Study|Physician Decision|0|||
44347859|NCT02842827|79352371|FG003|Overall Study|Physician Decision|0|||
44347860|NCT02842827|79352372|FG004|Overall Study|Physician Decision|1|||
44164628|NCT02558231|78957575|FG001|Overall Study|Physician Decision|5|||
44164629|NCT02558231|78957574|FG000|Overall Study|Sponsor Decision|0|||
44164630|NCT02558231|78957575|FG001|Overall Study|Sponsor Decision|1|||
44164631|NCT02554877|78957585|FG000|Overall Study|Adverse Event|2|||
44164632|NCT02554877|78957586|FG001|Overall Study|Adverse Event|0|||
44164633|NCT02554877|78957587|FG002|Overall Study|Adverse Event|0|||
44347861|NCT02842827|79352373|FG005|Overall Study|Physician Decision|4|||
44164634|NCT02554877|78957588|FG003|Overall Study|Adverse Event|1|||
44164635|NCT02554877|78957585|FG000|Overall Study|Lost to Follow-up|1|||
44164636|NCT02554877|78957586|FG001|Overall Study|Lost to Follow-up|1|||
44164637|NCT02554877|78957587|FG002|Overall Study|Lost to Follow-up|1|||
44164638|NCT02554877|78957588|FG003|Overall Study|Lost to Follow-up|2|||
44164639|NCT02554877|78957585|FG000|Overall Study|Did not meet entrance criteria|0|||
44164640|NCT02554877|78957586|FG001|Overall Study|Did not meet entrance criteria|0|||
44164641|NCT02554877|78957587|FG002|Overall Study|Did not meet entrance criteria|1|||
44164642|NCT02554877|78957588|FG003|Overall Study|Did not meet entrance criteria|0|||
44164643|NCT02554877|78957585|FG000|Overall Study|No longer met eligibility criteria|1|||
44164644|NCT02554877|78957586|FG001|Overall Study|No longer met eligibility criteria|0|||
44164645|NCT02554877|78957587|FG002|Overall Study|No longer met eligibility criteria|1|||
44164646|NCT02554877|78957588|FG003|Overall Study|No longer met eligibility criteria|1|||
44164647|NCT02554877|78957585|FG000|Overall Study|Protocol Violation|3|||
44164648|NCT02554877|78957586|FG001|Overall Study|Protocol Violation|1|||
44164649|NCT02554877|78957587|FG002|Overall Study|Protocol Violation|1|||
44164650|NCT02554877|78957588|FG003|Overall Study|Protocol Violation|0|||
44164651|NCT02554877|78957585|FG000|Overall Study|Other|1|||
44164652|NCT02554877|78957586|FG001|Overall Study|Other|3|||
44164653|NCT02554877|78957587|FG002|Overall Study|Other|0|||
44164654|NCT02554877|78957588|FG003|Overall Study|Other|3|||
44164655|NCT02554877|78957585|FG000|Overall Study|Insufficient clinical response|4|||
44164656|NCT02554877|78957586|FG001|Overall Study|Insufficient clinical response|0|||
44164657|NCT02554877|78957587|FG002|Overall Study|Insufficient clinical response|0|||
44164658|NCT02554877|78957588|FG003|Overall Study|Insufficient clinical response|0|||
44164659|NCT02554877|78957585|FG000|Overall Study|No longer willing to participate|0|||
44164660|NCT02554877|78957586|FG001|Overall Study|No longer willing to participate|2|||
44164661|NCT02554877|78957587|FG002|Overall Study|No longer willing to participate|2|||
44164662|NCT02554877|78957588|FG003|Overall Study|No longer willing to participate|0|||
44164663|NCT02554721|78957603|FG000|Overall Study|Adverse Event|1|||
44164664|NCT02554721|78957604|FG001|Overall Study|Adverse Event|0|||
44164665|NCT02554721|78957605|FG002|Overall Study|Adverse Event|0|||
44446369|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
44164666|NCT02554721|78957606|FG003|Overall Study|Adverse Event|0|||
44446370|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
44164667|NCT02554721|78957607|FG004|Overall Study|Adverse Event|1|||
44164668|NCT02554721|78957603|FG000|Overall Study|Noncompliance|0|||
44164669|NCT02554721|78957604|FG001|Overall Study|Noncompliance|0|||
44164670|NCT02554721|78957605|FG002|Overall Study|Noncompliance|0|||
44164671|NCT02554721|78957606|FG003|Overall Study|Noncompliance|0|||
44164672|NCT02554721|78957607|FG004|Overall Study|Noncompliance|1|||
44164673|NCT02552225|78957618|FG000|Overall Study|Withdrawal by Subject|1|||
44164674|NCT02552225|78957619|FG001|Overall Study|Withdrawal by Subject|0|||
44164675|NCT02552147|78957625|FG000|First Intervention (7 Days)|Protocol Violation|1|||
44164676|NCT02552147|78957626|FG001|First Intervention (7 Days)|Protocol Violation|0|||
44164677|NCT02552147|78957625|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
44164678|NCT02552147|78957626|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
44164679|NCT01662635|78957632|FG000|Overall Study|scarce samples for evaluation|30|||
44164680|NCT02534935|78957641|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
44164681|NCT02534935|78957642|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
44164682|NCT02534935|78957643|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
44164683|NCT02534935|78957641|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
44164684|NCT02534935|78957642|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
44164685|NCT02534935|78957643|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
44164686|NCT02534935|78957641|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
44164687|NCT02534935|78957642|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
44164688|NCT02534935|78957643|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
44164689|NCT02534935|78957641|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
44164690|NCT02534935|78957642|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
44164691|NCT02534935|78957643|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
44164692|NCT02534935|78957641|FG000|Stage 1: 24 Months|Adverse Event|0|||
44164693|NCT02534935|78957642|FG001|Stage 1: 24 Months|Adverse Event|2|||
44164694|NCT02534935|78957643|FG002|Stage 1: 24 Months|Adverse Event|0|||
44164695|NCT02534935|78957641|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
44164696|NCT02534935|78957642|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
44164697|NCT02534935|78957643|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
44164698|NCT02534935|78957641|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
44164699|NCT02534935|78957642|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
44164700|NCT02534935|78957643|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
44164701|NCT02544451|78957672|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
44164702|NCT02544451|78957673|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
44164703|NCT02544451|78957674|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
44164704|NCT02544451|78957675|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
44164705|NCT02544451|78957672|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
44164706|NCT02544451|78957673|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
44164707|NCT02544451|78957674|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
44164708|NCT02544451|78957675|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
44164709|NCT02544451|78957672|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
44164710|NCT02544451|78957673|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
44164711|NCT02544451|78957674|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
44164712|NCT02544451|78957675|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
44164713|NCT02544451|78957672|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
44164714|NCT02544451|78957673|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
44164715|NCT02544451|78957674|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
44164716|NCT02544451|78957675|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
44164717|NCT02544451|78957672|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
44164718|NCT02544451|78957673|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
44164719|NCT02544451|78957674|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
44164720|NCT02544451|78957675|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
44164721|NCT02544451|78957672|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
44164722|NCT02544451|78957673|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
44164723|NCT02544451|78957674|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
44164724|NCT02544451|78957675|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
44164725|NCT02544373|78957695|FG000|Overall Study|Lost to Follow-up|5|||
44164726|NCT02544373|78957696|FG001|Overall Study|Lost to Follow-up|3|||
44164727|NCT02544373|78957695|FG000|Overall Study|Withdrawal by Subject|8|||
44164728|NCT02544373|78957696|FG001|Overall Study|Withdrawal by Subject|2|||
44164729|NCT02551991|78957708|FG000|Overall Study|Death|5|||
44164730|NCT02551991|78957709|FG001|Overall Study|Death|7|||
44164731|NCT02551991|78957710|FG002|Overall Study|Death|8|||
44164732|NCT02551991|78957711|FG003|Overall Study|Death|7|||
44164733|NCT02551991|78957712|FG004|Overall Study|Death|17|||
44164734|NCT02551991|78957708|FG000|Overall Study|Withdrawal by Subject|1|||
44164735|NCT02551991|78957709|FG001|Overall Study|Withdrawal by Subject|0|||
44164736|NCT02551991|78957710|FG002|Overall Study|Withdrawal by Subject|0|||
44164737|NCT02551991|78957711|FG003|Overall Study|Withdrawal by Subject|0|||
44164738|NCT02551991|78957712|FG004|Overall Study|Withdrawal by Subject|2|||
44260361|NCT02323113|79130905|FG001|Overall Study|Symptomatic Deterioration|0|||
44164739|NCT02551991|78957708|FG000|Overall Study|Lost to Follow-up|0|||
44164740|NCT02551991|78957709|FG001|Overall Study|Lost to Follow-up|0|||
44164741|NCT02551991|78957710|FG002|Overall Study|Lost to Follow-up|1|||
44164742|NCT02551991|78957711|FG003|Overall Study|Lost to Follow-up|0|||
44164743|NCT02551991|78957712|FG004|Overall Study|Lost to Follow-up|0|||
44164744|NCT02551991|78957708|FG000|Overall Study|Sponsor Decision|1|||
44164745|NCT02551991|78957709|FG001|Overall Study|Sponsor Decision|0|||
44164746|NCT02551991|78957710|FG002|Overall Study|Sponsor Decision|1|||
44164747|NCT02551991|78957711|FG003|Overall Study|Sponsor Decision|0|||
44164748|NCT02551991|78957712|FG004|Overall Study|Sponsor Decision|5|||
44164749|NCT02551991|78957708|FG000|Overall Study|Other|0|||
44164750|NCT02551991|78957709|FG001|Overall Study|Other|0|||
44164751|NCT02551991|78957710|FG002|Overall Study|Other|0|||
44164752|NCT02551991|78957711|FG003|Overall Study|Other|0|||
44164753|NCT02551991|78957712|FG004|Overall Study|Other|1|||
44164754|NCT01661933|78957725|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
44164755|NCT01661933|78957725|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
44164756|NCT02544217|78957737|FG000|Overall Study|Withdrawal by Subject|1|||
44164757|NCT02544217|78957738|FG001|Overall Study|Withdrawal by Subject|1|||
44164758|NCT02544217|78957739|FG002|Overall Study|Withdrawal by Subject|0|||
44164759|NCT02544217|78957740|FG003|Overall Study|Withdrawal by Subject|0|||
44164760|NCT02544217|78957741|FG004|Overall Study|Withdrawal by Subject|0|||
44164761|NCT02544217|78957742|FG005|Overall Study|Withdrawal by Subject|0|||
44164762|NCT02533999|78957811|FG000|Overall Study|Lost to Follow-up|3|||
44164763|NCT02533999|78957812|FG001|Overall Study|Lost to Follow-up|5|||
44164764|NCT02533999|78957811|FG000|Overall Study|Protocol Violation|3|||
44164765|NCT02533999|78957812|FG001|Overall Study|Protocol Violation|0|||
44164766|NCT02533999|78957811|FG000|Overall Study|Adverse Event|0|||
44164767|NCT02533999|78957812|FG001|Overall Study|Adverse Event|1|||
44164768|NCT02533999|78957811|FG000|Overall Study|Randomized but intervention not received|0|||
44164769|NCT02533999|78957812|FG001|Overall Study|Randomized but intervention not received|1|||
44164770|NCT02533531|78957818|FG000|Overall Study|Device did not turn on|1|||
44164771|NCT02533453|78957822|FG000|Overall Study|Adverse Event|6|||
44164772|NCT02533453|78957822|FG000|Overall Study|Protocol Violation|1|||
44164773|NCT02533453|78957822|FG000|Overall Study|Withdrawal by Subject|2|||
44164774|NCT02533375|78957826|FG000|Overall Study|Lack of Efficacy|3|||
44164775|NCT02533375|78957826|FG000|Overall Study|Adverse Event|2|||
44164776|NCT02551055|78957837|FG000|Overall Study|Death|2|||
44164777|NCT02551055|78957838|FG001|Overall Study|Death|4|||
44164778|NCT02551055|78957839|FG002|Overall Study|Death|2|||
44164779|NCT02551055|78957840|FG003|Overall Study|Death|2|||
44164780|NCT02551055|78957841|FG004|Overall Study|Death|2|||
44164781|NCT02551055|78957842|FG005|Overall Study|Death|1|||
44164782|NCT02551055|78957843|FG006|Overall Study|Death|2|||
44164783|NCT02551055|78957844|FG007|Overall Study|Death|0|||
44164784|NCT02551055|78957837|FG000|Overall Study|Study Terminated by Sponsor|1|||
44164785|NCT02551055|78957838|FG001|Overall Study|Study Terminated by Sponsor|1|||
44164786|NCT02551055|78957839|FG002|Overall Study|Study Terminated by Sponsor|0|||
44164787|NCT02551055|78957840|FG003|Overall Study|Study Terminated by Sponsor|2|||
44164788|NCT02551055|78957841|FG004|Overall Study|Study Terminated by Sponsor|2|||
44164789|NCT02551055|78957842|FG005|Overall Study|Study Terminated by Sponsor|0|||
44164790|NCT02551055|78957843|FG006|Overall Study|Study Terminated by Sponsor|0|||
44164791|NCT02551055|78957844|FG007|Overall Study|Study Terminated by Sponsor|0|||
44164792|NCT02551055|78957837|FG000|Overall Study|Withdrawal by Subject|1|||
44164793|NCT02551055|78957838|FG001|Overall Study|Withdrawal by Subject|1|||
44164794|NCT02551055|78957839|FG002|Overall Study|Withdrawal by Subject|0|||
44164795|NCT02551055|78957840|FG003|Overall Study|Withdrawal by Subject|1|||
44164796|NCT02551055|78957841|FG004|Overall Study|Withdrawal by Subject|2|||
44164797|NCT02551055|78957842|FG005|Overall Study|Withdrawal by Subject|0|||
44164798|NCT02551055|78957843|FG006|Overall Study|Withdrawal by Subject|0|||
44164799|NCT02551055|78957844|FG007|Overall Study|Withdrawal by Subject|0|||
44164800|NCT02551055|78957837|FG000|Overall Study|Reason not specified|0|||
44164801|NCT02551055|78957838|FG001|Overall Study|Reason not specified|0|||
44164802|NCT02551055|78957839|FG002|Overall Study|Reason not specified|0|||
44164803|NCT02551055|78957840|FG003|Overall Study|Reason not specified|0|||
44164804|NCT02551055|78957841|FG004|Overall Study|Reason not specified|1|||
44164805|NCT02551055|78957842|FG005|Overall Study|Reason not specified|0|||
44164806|NCT02551055|78957843|FG006|Overall Study|Reason not specified|1|||
44164807|NCT02551055|78957844|FG007|Overall Study|Reason not specified|0|||
44164808|NCT02542943|78957865|FG000|Overall Study|Lost to Follow-up|1|||
44164809|NCT02542943|78957866|FG001|Overall Study|Lost to Follow-up|0|||
44164810|NCT02542943|78957867|FG002|Overall Study|Lost to Follow-up|0|||
44164811|NCT02542943|78957865|FG000|Overall Study|Withdrawal by Subject|0|||
44164812|NCT02542943|78957866|FG001|Overall Study|Withdrawal by Subject|1|||
44164813|NCT02542943|78957867|FG002|Overall Study|Withdrawal by Subject|0|||
44164814|NCT02542865|78957878|FG000|Overall Study|Identified as screen failure|1|||
44164815|NCT02542865|78957879|FG001|Overall Study|Identified as screen failure|0|||
44164816|NCT02542865|78957878|FG000|Overall Study|Withdrawal by Subject|16|||
44164817|NCT02542865|78957879|FG001|Overall Study|Withdrawal by Subject|0|||
44164818|NCT03644927|78957885|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
44164819|NCT03644927|78957886|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
44164820|NCT02542631|78957893|FG000|Overall Study|Adverse Event|1|||
44164821|NCT02542631|78957894|FG001|Overall Study|Adverse Event|1|||
44164822|NCT02542631|78957893|FG000|Overall Study|Sponsor Termination|1|||
44164823|NCT02542631|78957894|FG001|Overall Study|Sponsor Termination|0|||
44164824|NCT02542631|78957893|FG000|Overall Study|Withdrawal by Subject|11|||
44164825|NCT02542631|78957894|FG001|Overall Study|Withdrawal by Subject|16|||
44164826|NCT02542631|78957893|FG000|Overall Study|Protocol Violation|1|||
44164827|NCT02542631|78957894|FG001|Overall Study|Protocol Violation|1|||
44164828|NCT02542631|78957893|FG000|Overall Study|Physician Decision|6|||
44164829|NCT02542631|78957894|FG001|Overall Study|Physician Decision|4|||
44164830|NCT02542631|78957893|FG000|Overall Study|Lost to Follow-up|6|||
44164831|NCT02542631|78957894|FG001|Overall Study|Lost to Follow-up|5|||
44164832|NCT02542631|78957893|FG000|Overall Study|Death|1|||
44164833|NCT02542631|78957894|FG001|Overall Study|Death|2|||
44164834|NCT02542631|78957893|FG000|Overall Study|Other|2|||
44164835|NCT02542631|78957894|FG001|Overall Study|Other|1|||
44164836|NCT02542631|78957893|FG000|Overall Study|Used Prohibited Medication|2|||
44164837|NCT02542631|78957894|FG001|Overall Study|Used Prohibited Medication|1|||
44164838|NCT02542397|78957900|FG000|Overall Study|Death|2|||
44164839|NCT02542397|78957900|FG000|Overall Study|Physician Decision|6|||
44164840|NCT02542397|78957900|FG000|Overall Study|Withdrawal by Subject|6|||
44164841|NCT02542397|78957900|FG000|Overall Study|Lost to Follow-up|2|||
44164842|NCT02549339|78957907|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
44164843|NCT02549339|78957908|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
44164844|NCT02549339|78957907|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
44164845|NCT02549339|78957908|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
44164846|NCT02549339|78957907|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
44164847|NCT02549339|78957908|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
44164848|NCT02549339|78957907|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
44164849|NCT02549339|78957908|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
44164850|NCT02549339|78957907|FG000|12-month Follow-up|Lack of Efficacy|0|||
44164851|NCT02549339|78957908|FG001|12-month Follow-up|Lack of Efficacy|2|||
44164852|NCT02549339|78957907|FG000|12-month Follow-up|Withdrawal by Subject|8|||
44164853|NCT02549339|78957908|FG001|12-month Follow-up|Withdrawal by Subject|3|||
44164854|NCT02549339|78957907|FG000|12-month Follow-up|Lost to Follow-up|1|||
44164855|NCT02549339|78957908|FG001|12-month Follow-up|Lost to Follow-up|3|||
44164856|NCT02549339|78957907|FG000|12-month Follow-up|Other|0|||
44164857|NCT02549339|78957908|FG001|12-month Follow-up|Other|3|||
44164858|NCT02549027|78957916|FG000|Washout After Period 4|Withdrawal by Subject|0|||
44164859|NCT02549027|78957917|FG001|Washout After Period 4|Withdrawal by Subject|1|||
44164860|NCT02549027|78957918|FG002|Washout After Period 4|Withdrawal by Subject|1|||
44164861|NCT02549027|78957919|FG003|Washout After Period 4|Withdrawal by Subject|1|||
44164862|NCT02549027|78957920|FG004|Washout After Period 4|Withdrawal by Subject|0|||
44164863|NCT02549027|78957921|FG005|Washout After Period 4|Withdrawal by Subject|0|||
44164864|NCT02549027|78957916|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
44164865|NCT02549027|78957917|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
44164866|NCT02549027|78957918|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
44164867|NCT02549027|78957919|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
44164868|NCT02549027|78957920|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
44164869|NCT02549027|78957921|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
44164870|NCT02529553|78957949|FG000|Overall Study|Progressive Disease|1|||
44164871|NCT02529553|78957950|FG001|Overall Study|Progressive Disease|0|||
44164872|NCT02529553|78957951|FG002|Overall Study|Progressive Disease|1|||
44164873|NCT02529553|78957952|FG003|Overall Study|Progressive Disease|3|||
44164874|NCT02529553|78957953|FG004|Overall Study|Progressive Disease|2|||
44164875|NCT02529553|78957954|FG005|Overall Study|Progressive Disease|3|||
44164876|NCT02529553|78957955|FG006|Overall Study|Progressive Disease|3|||
44164877|NCT02529553|78957956|FG007|Overall Study|Progressive Disease|5|||
44164878|NCT02529553|78957957|FG008|Overall Study|Progressive Disease|3|||
44164879|NCT02529553|78957949|FG000|Overall Study|Physician Decision|0|||
44164880|NCT02529553|78957950|FG001|Overall Study|Physician Decision|1|||
44164881|NCT02529553|78957951|FG002|Overall Study|Physician Decision|0|||
44164882|NCT02529553|78957952|FG003|Overall Study|Physician Decision|0|||
44164883|NCT02529553|78957953|FG004|Overall Study|Physician Decision|1|||
44164884|NCT02529553|78957954|FG005|Overall Study|Physician Decision|0|||
44164885|NCT02529553|78957955|FG006|Overall Study|Physician Decision|0|||
44164886|NCT02529553|78957956|FG007|Overall Study|Physician Decision|0|||
44164887|NCT02529553|78957957|FG008|Overall Study|Physician Decision|0|||
44164888|NCT02529553|78957949|FG000|Overall Study|Withdrawal by Subject|0|||
44164889|NCT02529553|78957950|FG001|Overall Study|Withdrawal by Subject|0|||
44164890|NCT02529553|78957951|FG002|Overall Study|Withdrawal by Subject|0|||
44164891|NCT02529553|78957952|FG003|Overall Study|Withdrawal by Subject|0|||
44164892|NCT02529553|78957953|FG004|Overall Study|Withdrawal by Subject|0|||
44164893|NCT02529553|78957954|FG005|Overall Study|Withdrawal by Subject|1|||
44164894|NCT02529553|78957955|FG006|Overall Study|Withdrawal by Subject|0|||
44164895|NCT02529553|78957956|FG007|Overall Study|Withdrawal by Subject|1|||
44164896|NCT02529553|78957957|FG008|Overall Study|Withdrawal by Subject|0|||
44164897|NCT02547935|78957981|FG000|Overall Study|Other|0|||
44164898|NCT02547935|78957982|FG001|Overall Study|Other|1|||
44164899|NCT02547935|78957983|FG002|Overall Study|Other|0|||
44164900|NCT02547935|78957981|FG000|Overall Study|Withdrawal by Subject|2|||
44164901|NCT02547935|78957982|FG001|Overall Study|Withdrawal by Subject|3|||
44164902|NCT02547935|78957983|FG002|Overall Study|Withdrawal by Subject|4|||
44164903|NCT02547935|78957981|FG000|Overall Study|Screen Failure|2|||
44164904|NCT02547935|78957982|FG001|Overall Study|Screen Failure|0|||
44164905|NCT02547935|78957983|FG002|Overall Study|Screen Failure|0|||
44164906|NCT02547935|78957981|FG000|Overall Study|Physician Decision|0|||
44164907|NCT02547935|78957982|FG001|Overall Study|Physician Decision|1|||
44164908|NCT02547935|78957983|FG002|Overall Study|Physician Decision|0|||
44164909|NCT02547935|78957981|FG000|Overall Study|Lost to Follow-up|0|||
44164910|NCT02547935|78957982|FG001|Overall Study|Lost to Follow-up|2|||
44164911|NCT02547935|78957983|FG002|Overall Study|Lost to Follow-up|1|||
44164912|NCT02547935|78957981|FG000|Overall Study|Death|1|||
44164913|NCT02547935|78957982|FG001|Overall Study|Death|1|||
44164914|NCT02547935|78957983|FG002|Overall Study|Death|0|||
44164915|NCT02554019|78957996|FG000|Overall Study|Withdrawal by Subject|1|||
44164916|NCT02554019|78957997|FG001|Overall Study|Withdrawal by Subject|0|||
44164917|NCT02554019|78957998|FG002|Overall Study|Withdrawal by Subject|2|||
44164918|NCT02554019|78957996|FG000|Overall Study|Adverse Event|1|||
44164919|NCT02554019|78957997|FG001|Overall Study|Adverse Event|0|||
44164920|NCT02554019|78957998|FG002|Overall Study|Adverse Event|0|||
44164921|NCT02327169|78958021|FG000|Overall Study|Progressive Disease|1|||
44164922|NCT02327169|78958022|FG001|Overall Study|Progressive Disease|3|||
44164923|NCT02327169|78958023|FG002|Overall Study|Progressive Disease|4|||
44164924|NCT02327169|78958024|FG003|Overall Study|Progressive Disease|3|||
44164925|NCT02327169|78958025|FG004|Overall Study|Progressive Disease|4|||
44164926|NCT02327169|78958026|FG005|Overall Study|Progressive Disease|3|||
44164927|NCT02327169|78958027|FG006|Overall Study|Progressive Disease|3|||
44164928|NCT02327169|78958028|FG007|Overall Study|Progressive Disease|3|||
44164929|NCT02327169|78958029|FG008|Overall Study|Progressive Disease|4|||
44164930|NCT02327169|78958030|FG009|Overall Study|Progressive Disease|4|||
44164931|NCT02327169|78958031|FG010|Overall Study|Progressive Disease|4|||
44164932|NCT02327169|78958032|FG011|Overall Study|Progressive Disease|3|||
44164933|NCT02327169|78958033|FG012|Overall Study|Progressive Disease|1|||
44164934|NCT02327169|78958034|FG013|Overall Study|Progressive Disease|3|||
44164935|NCT02327169|78958035|FG014|Overall Study|Progressive Disease|3|||
44164936|NCT02327169|78958021|FG000|Overall Study|Adverse Event|2|||
44164937|NCT02327169|78958022|FG001|Overall Study|Adverse Event|0|||
44164938|NCT02327169|78958023|FG002|Overall Study|Adverse Event|1|||
44164939|NCT02327169|78958024|FG003|Overall Study|Adverse Event|0|||
44164940|NCT02327169|78958025|FG004|Overall Study|Adverse Event|1|||
44164941|NCT02327169|78958026|FG005|Overall Study|Adverse Event|0|||
44164942|NCT02327169|78958027|FG006|Overall Study|Adverse Event|0|||
44164943|NCT02327169|78958028|FG007|Overall Study|Adverse Event|0|||
44164944|NCT02327169|78958029|FG008|Overall Study|Adverse Event|0|||
44164945|NCT02327169|78958030|FG009|Overall Study|Adverse Event|2|||
44164946|NCT02327169|78958031|FG010|Overall Study|Adverse Event|0|||
44164947|NCT02327169|78958032|FG011|Overall Study|Adverse Event|3|||
44164948|NCT02327169|78958033|FG012|Overall Study|Adverse Event|0|||
44164949|NCT02327169|78958034|FG013|Overall Study|Adverse Event|2|||
44164950|NCT02327169|78958035|FG014|Overall Study|Adverse Event|1|||
44164951|NCT02327169|78958021|FG000|Overall Study|Symptomatic Deterioration|0|||
44164952|NCT02327169|78958022|FG001|Overall Study|Symptomatic Deterioration|0|||
44164953|NCT02327169|78958023|FG002|Overall Study|Symptomatic Deterioration|1|||
44164954|NCT02327169|78958024|FG003|Overall Study|Symptomatic Deterioration|0|||
44164955|NCT02327169|78958025|FG004|Overall Study|Symptomatic Deterioration|1|||
44164956|NCT02327169|78958026|FG005|Overall Study|Symptomatic Deterioration|1|||
44164957|NCT02327169|78958027|FG006|Overall Study|Symptomatic Deterioration|0|||
44164958|NCT02327169|78958028|FG007|Overall Study|Symptomatic Deterioration|0|||
44164959|NCT02327169|78958029|FG008|Overall Study|Symptomatic Deterioration|2|||
44164960|NCT02327169|78958030|FG009|Overall Study|Symptomatic Deterioration|1|||
44164961|NCT02327169|78958031|FG010|Overall Study|Symptomatic Deterioration|0|||
44164962|NCT02327169|78958032|FG011|Overall Study|Symptomatic Deterioration|0|||
44164963|NCT02327169|78958033|FG012|Overall Study|Symptomatic Deterioration|0|||
44164964|NCT02327169|78958034|FG013|Overall Study|Symptomatic Deterioration|2|||
44164965|NCT02327169|78958035|FG014|Overall Study|Symptomatic Deterioration|1|||
44164966|NCT02327169|78958021|FG000|Overall Study|Reason Not Specified|0|||
44164967|NCT02327169|78958022|FG001|Overall Study|Reason Not Specified|0|||
44164968|NCT02327169|78958023|FG002|Overall Study|Reason Not Specified|1|||
44164969|NCT02327169|78958024|FG003|Overall Study|Reason Not Specified|0|||
44164970|NCT02327169|78958025|FG004|Overall Study|Reason Not Specified|0|||
44164971|NCT02327169|78958026|FG005|Overall Study|Reason Not Specified|0|||
44164972|NCT02327169|78958027|FG006|Overall Study|Reason Not Specified|0|||
44164973|NCT02327169|78958028|FG007|Overall Study|Reason Not Specified|0|||
44164974|NCT02327169|78958029|FG008|Overall Study|Reason Not Specified|0|||
44164975|NCT02327169|78958030|FG009|Overall Study|Reason Not Specified|1|||
44164976|NCT02327169|78958031|FG010|Overall Study|Reason Not Specified|2|||
44164977|NCT02327169|78958032|FG011|Overall Study|Reason Not Specified|1|||
44164978|NCT02327169|78958033|FG012|Overall Study|Reason Not Specified|0|||
44164979|NCT02327169|78958034|FG013|Overall Study|Reason Not Specified|0|||
44164980|NCT02327169|78958035|FG014|Overall Study|Reason Not Specified|2|||
44164981|NCT02327169|78958021|FG000|Overall Study|Withdrawal by Subject|1|||
44164982|NCT02327169|78958022|FG001|Overall Study|Withdrawal by Subject|0|||
44164983|NCT02327169|78958023|FG002|Overall Study|Withdrawal by Subject|0|||
44164984|NCT02327169|78958024|FG003|Overall Study|Withdrawal by Subject|0|||
44164985|NCT02327169|78958025|FG004|Overall Study|Withdrawal by Subject|1|||
44164986|NCT02327169|78958026|FG005|Overall Study|Withdrawal by Subject|0|||
44164987|NCT02327169|78958027|FG006|Overall Study|Withdrawal by Subject|0|||
44164988|NCT02327169|78958028|FG007|Overall Study|Withdrawal by Subject|1|||
44164989|NCT02327169|78958029|FG008|Overall Study|Withdrawal by Subject|0|||
44164990|NCT02327169|78958030|FG009|Overall Study|Withdrawal by Subject|0|||
44164991|NCT02327169|78958031|FG010|Overall Study|Withdrawal by Subject|0|||
44164992|NCT02327169|78958032|FG011|Overall Study|Withdrawal by Subject|0|||
44164993|NCT02327169|78958033|FG012|Overall Study|Withdrawal by Subject|0|||
44164994|NCT02327169|78958034|FG013|Overall Study|Withdrawal by Subject|0|||
44164995|NCT02327169|78958035|FG014|Overall Study|Withdrawal by Subject|3|||
44164996|NCT02327169|78958021|FG000|Overall Study|Lost to Follow-up|0|||
44164997|NCT02327169|78958022|FG001|Overall Study|Lost to Follow-up|0|||
44164998|NCT02327169|78958023|FG002|Overall Study|Lost to Follow-up|0|||
44164999|NCT02327169|78958024|FG003|Overall Study|Lost to Follow-up|0|||
44165000|NCT02327169|78958025|FG004|Overall Study|Lost to Follow-up|1|||
44165001|NCT02327169|78958026|FG005|Overall Study|Lost to Follow-up|0|||
44165002|NCT02327169|78958027|FG006|Overall Study|Lost to Follow-up|0|||
44165003|NCT02327169|78958028|FG007|Overall Study|Lost to Follow-up|0|||
44165004|NCT02327169|78958029|FG008|Overall Study|Lost to Follow-up|0|||
44165005|NCT02327169|78958030|FG009|Overall Study|Lost to Follow-up|0|||
44165006|NCT02327169|78958031|FG010|Overall Study|Lost to Follow-up|0|||
44165007|NCT02327169|78958032|FG011|Overall Study|Lost to Follow-up|0|||
44165008|NCT02327169|78958033|FG012|Overall Study|Lost to Follow-up|0|||
44165009|NCT02327169|78958034|FG013|Overall Study|Lost to Follow-up|0|||
44165010|NCT02327169|78958035|FG014|Overall Study|Lost to Follow-up|0|||
44165011|NCT02327013|78958080|FG000|Overall Study|Adverse Event|4|||
44165012|NCT02327013|78958081|FG001|Overall Study|Adverse Event|4|||
44165013|NCT02327013|78958082|FG002|Overall Study|Adverse Event|3|||
44165014|NCT02327013|78958083|FG003|Overall Study|Adverse Event|0|||
44165015|NCT02327013|78958084|FG004|Overall Study|Adverse Event|1|||
44165016|NCT02327013|78958080|FG000|Overall Study|Lack of Efficacy|2|||
44165017|NCT02327013|78958081|FG001|Overall Study|Lack of Efficacy|0|||
44165018|NCT02327013|78958082|FG002|Overall Study|Lack of Efficacy|5|||
44165019|NCT02327013|78958083|FG003|Overall Study|Lack of Efficacy|0|||
44165020|NCT02327013|78958084|FG004|Overall Study|Lack of Efficacy|1|||
44165021|NCT02327013|78958080|FG000|Overall Study|Non-compliance with IMP|1|||
44165022|NCT02327013|78958081|FG001|Overall Study|Non-compliance with IMP|2|||
44165023|NCT02327013|78958082|FG002|Overall Study|Non-compliance with IMP|7|||
44165024|NCT02327013|78958083|FG003|Overall Study|Non-compliance with IMP|0|||
44165025|NCT02327013|78958084|FG004|Overall Study|Non-compliance with IMP|0|||
44165026|NCT02327013|78958080|FG000|Overall Study|Withdrawal of Consent|1|||
44165027|NCT02327013|78958081|FG001|Overall Study|Withdrawal of Consent|0|||
44165028|NCT02327013|78958082|FG002|Overall Study|Withdrawal of Consent|3|||
44165029|NCT02327013|78958083|FG003|Overall Study|Withdrawal of Consent|0|||
44165030|NCT02327013|78958084|FG004|Overall Study|Withdrawal of Consent|0|||
44165031|NCT02327013|78958080|FG000|Overall Study|Lost to Follow-up|2|||
44165032|NCT02327013|78958081|FG001|Overall Study|Lost to Follow-up|4|||
44165033|NCT02327013|78958082|FG002|Overall Study|Lost to Follow-up|5|||
44165034|NCT02327013|78958083|FG003|Overall Study|Lost to Follow-up|0|||
44446371|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
44165035|NCT02327013|78958084|FG004|Overall Study|Lost to Follow-up|0|||
44165036|NCT02327013|78958080|FG000|Overall Study|Administrative or other reason(s)|1|||
44165037|NCT02327013|78958081|FG001|Overall Study|Administrative or other reason(s)|5|||
44165038|NCT02327013|78958082|FG002|Overall Study|Administrative or other reason(s)|11|||
44165039|NCT02327013|78958083|FG003|Overall Study|Administrative or other reason(s)|1|||
44165040|NCT02327013|78958084|FG004|Overall Study|Administrative or other reason(s)|1|||
44165041|NCT02327013|78958080|FG000|Overall Study|Protocol Violation|0|||
44165042|NCT02327013|78958081|FG001|Overall Study|Protocol Violation|0|||
44165043|NCT02327013|78958082|FG002|Overall Study|Protocol Violation|3|||
44165044|NCT02327013|78958083|FG003|Overall Study|Protocol Violation|0|||
44165045|NCT02327013|78958084|FG004|Overall Study|Protocol Violation|1|||
44165046|NCT02327013|78958080|FG000|Overall Study|Withdrawal before treatment|2|||
44165047|NCT02327013|78958081|FG001|Overall Study|Withdrawal before treatment|1|||
44165048|NCT02327013|78958082|FG002|Overall Study|Withdrawal before treatment|5|||
44165049|NCT02327013|78958083|FG003|Overall Study|Withdrawal before treatment|0|||
44165050|NCT02327013|78958084|FG004|Overall Study|Withdrawal before treatment|0|||
44165051|NCT02301975|78958107|FG000|Overall Study|Adverse Event|8|||
44165052|NCT02301975|78958108|FG001|Overall Study|Adverse Event|3|||
44165053|NCT02301975|78958109|FG002|Overall Study|Adverse Event|2|||
44165054|NCT02301975|78958107|FG000|Overall Study|Lack of Efficacy|1|||
44165055|NCT02301975|78958108|FG001|Overall Study|Lack of Efficacy|1|||
44165056|NCT02301975|78958109|FG002|Overall Study|Lack of Efficacy|1|||
44165057|NCT02301975|78958107|FG000|Overall Study|Protocol Violation|3|||
44165058|NCT02301975|78958108|FG001|Overall Study|Protocol Violation|5|||
44165059|NCT02301975|78958109|FG002|Overall Study|Protocol Violation|3|||
44165060|NCT02301975|78958107|FG000|Overall Study|Lost to Follow-up|0|||
44165061|NCT02301975|78958108|FG001|Overall Study|Lost to Follow-up|2|||
44165062|NCT02301975|78958109|FG002|Overall Study|Lost to Follow-up|2|||
44165063|NCT02301975|78958107|FG000|Overall Study|Physician Decision|4|||
44165064|NCT02301975|78958108|FG001|Overall Study|Physician Decision|2|||
44165065|NCT02301975|78958109|FG002|Overall Study|Physician Decision|3|||
44165066|NCT02301975|78958107|FG000|Overall Study|Withdrawal by Subject|15|||
44165067|NCT02301975|78958108|FG001|Overall Study|Withdrawal by Subject|12|||
44165068|NCT02301975|78958109|FG002|Overall Study|Withdrawal by Subject|11|||
44165069|NCT02301897|78958120|FG000|Treatment Course 1|Non-Compliance|0|||
44165070|NCT02301897|78958121|FG001|Treatment Course 1|Non-Compliance|0|||
44165071|NCT02301897|78958122|FG002|Treatment Course 1|Non-Compliance|1|||
44165072|NCT02301897|78958120|FG000|Treatment Course 1|Adverse Event|1|||
44165073|NCT02301897|78958121|FG001|Treatment Course 1|Adverse Event|1|||
44165074|NCT02301897|78958122|FG002|Treatment Course 1|Adverse Event|0|||
44165075|NCT02301897|78958120|FG000|Treatment Course 1|Lost to Follow-up|1|||
44165076|NCT02301897|78958121|FG001|Treatment Course 1|Lost to Follow-up|2|||
44165077|NCT02301897|78958122|FG002|Treatment Course 1|Lost to Follow-up|1|||
44165078|NCT02301897|78958120|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
44165079|NCT02301897|78958121|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
44165080|NCT02301897|78958122|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
44165081|NCT02301897|78958120|FG000|Treatment Course 1|Withdrawal by Subject|0|||
44165082|NCT02301897|78958121|FG001|Treatment Course 1|Withdrawal by Subject|0|||
44165083|NCT02301897|78958122|FG002|Treatment Course 1|Withdrawal by Subject|2|||
44165084|NCT02301897|78958120|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
44165085|NCT02301897|78958121|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
44165086|NCT02301897|78958122|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
44165087|NCT02301897|78958120|FG000|Treatment Course 2|Lost to Follow-up|0|||
44165088|NCT02301897|78958121|FG001|Treatment Course 2|Lost to Follow-up|2|||
44165089|NCT02301897|78958122|FG002|Treatment Course 2|Lost to Follow-up|0|||
44165090|NCT02301897|78958120|FG000|Treatment Course 2|Pregnancy|0|||
44165091|NCT02301897|78958121|FG001|Treatment Course 2|Pregnancy|1|||
44165092|NCT02301897|78958122|FG002|Treatment Course 2|Pregnancy|1|||
44165093|NCT02301897|78958120|FG000|Treatment Course 2|Withdrawal by Subject|0|||
44165094|NCT02301897|78958121|FG001|Treatment Course 2|Withdrawal by Subject|2|||
44165095|NCT02301897|78958122|FG002|Treatment Course 2|Withdrawal by Subject|0|||
44165096|NCT02301897|78958120|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
44165097|NCT02301897|78958121|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
44165098|NCT02301897|78958122|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
44165099|NCT02301429|78958130|FG000|Overall Study|not acceptable vascular anatomy|3|||
44165100|NCT02300259|78958137|FG000|Period 1|Adverse Event|0|||
44165101|NCT02300259|78958138|FG001|Period 1|Adverse Event|0|||
44165102|NCT02300259|78958139|FG002|Period 1|Adverse Event|1|||
44165103|NCT02300259|78958137|FG000|Period 1|Withdrawal by Subject|0|||
44165104|NCT02300259|78958138|FG001|Period 1|Withdrawal by Subject|0|||
44165105|NCT02300259|78958139|FG002|Period 1|Withdrawal by Subject|1|||
44165106|NCT02300259|78958137|FG000|Period 2|Adverse Event|1|||
44165107|NCT02300259|78958138|FG001|Period 2|Adverse Event|0|||
44165108|NCT02300259|78958139|FG002|Period 2|Adverse Event|0|||
44165109|NCT02300259|78958137|FG000|Period 2|Withdrawal by Subject|0|||
44347862|NCT02842827|79352374|FG006|Overall Study|Physician Decision|2|||
44347863|NCT02842827|79352375|FG007|Overall Study|Physician Decision|1|||
44347864|NCT02842827|79352368|FG000|Overall Study|Protocol Defined Disease Progression|0|||
44165110|NCT02300259|78958138|FG001|Period 2|Withdrawal by Subject|0|||
44165111|NCT02300259|78958139|FG002|Period 2|Withdrawal by Subject|1|||
44165112|NCT02367885|78958161|FG000|Overall Study|Lost to Follow-up|1|||
44165113|NCT02367885|78958162|FG001|Overall Study|Lost to Follow-up|0|||
44165114|NCT02367885|78958163|FG002|Overall Study|Lost to Follow-up|0|||
44165115|NCT02367885|78958161|FG000|Overall Study|Withdrawal by Subject|1|||
44165116|NCT02367885|78958162|FG001|Overall Study|Withdrawal by Subject|0|||
44165117|NCT02367885|78958163|FG002|Overall Study|Withdrawal by Subject|0|||
44165118|NCT02367729|78958176|FG000|Overall Study|Organic disorder diagnosed|2|||
44165119|NCT02367729|78958177|FG001|Overall Study|Organic disorder diagnosed|1|||
44165120|NCT02367729|78958176|FG000|Overall Study|Adverse Event|1|||
44347865|NCT02842827|79352369|FG001|Overall Study|Protocol Defined Disease Progression|0|||
44165121|NCT02367729|78958177|FG001|Overall Study|Adverse Event|2|||
44165122|NCT02367729|78958176|FG000|Overall Study|Withdrawal by Subject|0|||
44165123|NCT02367729|78958177|FG001|Overall Study|Withdrawal by Subject|5|||
44165124|NCT02366637|78958184|FG000|First Intervention Period|Adverse Event|0|||
44165125|NCT02366637|78958185|FG001|First Intervention Period|Adverse Event|1|||
44165126|NCT02366637|78958184|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
44165127|NCT02366637|78958185|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
44165128|NCT02366637|78958184|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
44165129|NCT02366637|78958185|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
44165130|NCT02300103|78958191|FG000|Overall Study|Lack of Efficacy|3|||
44165131|NCT02300103|78958191|FG000|Overall Study|Protocol Violation|1|||
44165132|NCT02300103|78958191|FG000|Overall Study|Withdrew Consent|2|||
44165133|NCT02326467|78958195|FG000|Overall Study|Withdrawal by Subject|1|||
44165134|NCT02299635|78958200|FG000|Overall Study|Adverse Event|2|||
44165135|NCT02299635|78958200|FG000|Overall Study|Death|1|||
44165136|NCT02299635|78958200|FG000|Overall Study|Global deterioration of health status|1|||
44165137|NCT02299635|78958200|FG000|Overall Study|Objective progression or relapse|10|||
44165138|NCT02299635|78958200|FG000|Overall Study|Withdrawal by Subject|2|||
44165139|NCT02299635|78958200|FG000|Overall Study|Other|3|||
44165140|NCT02366091|78958208|FG000|Overall Study|Withdrawal by Subject|3|||
44165141|NCT02366091|78958209|FG001|Overall Study|Withdrawal by Subject|7|||
44165142|NCT02366091|78958210|FG002|Overall Study|Withdrawal by Subject|3|||
44165143|NCT02366091|78958211|FG003|Overall Study|Withdrawal by Subject|1|||
44165144|NCT02326155|78958223|FG000|Overall Study|Adverse Event|21|||
44165145|NCT02326155|78958224|FG001|Overall Study|Adverse Event|5|||
44165146|NCT02326155|78958223|FG000|Overall Study|Death|3|||
44165147|NCT02326155|78958224|FG001|Overall Study|Death|0|||
44165148|NCT02326155|78958223|FG000|Overall Study|Lack of Efficacy|49|||
44165149|NCT02326155|78958224|FG001|Overall Study|Lack of Efficacy|5|||
44165150|NCT02326155|78958223|FG000|Overall Study|Lost to Follow-up|14|||
44165151|NCT02326155|78958224|FG001|Overall Study|Lost to Follow-up|3|||
44165152|NCT02326155|78958223|FG000|Overall Study|Protocol Violation|2|||
44165153|NCT02326155|78958224|FG001|Overall Study|Protocol Violation|0|||
44165154|NCT02326155|78958223|FG000|Overall Study|Withdrawal by Subject|34|||
44165155|NCT02326155|78958224|FG001|Overall Study|Withdrawal by Subject|11|||
44165156|NCT02326155|78958223|FG000|Overall Study|Disease progression|37|||
44165157|NCT02326155|78958224|FG001|Overall Study|Disease progression|4|||
44165158|NCT02326155|78958223|FG000|Overall Study|Study close|188|||
44165159|NCT02326155|78958224|FG001|Overall Study|Study close|21|||
44165160|NCT02326155|78958223|FG000|Overall Study|except for study close|46|||
44165161|NCT02326155|78958224|FG001|Overall Study|except for study close|13|||
44165162|NCT02299167|78958230|FG000|Overall Study|patients were excluded from the study|11|||
44165163|NCT01647711|78958239|FG000|Overall Study|Progressive disease|6|||
44165164|NCT01647711|78958240|FG001|Overall Study|Progressive disease|2|||
44165165|NCT01647711|78958241|FG002|Overall Study|Progressive disease|6|||
44165166|NCT01647711|78958242|FG003|Overall Study|Progressive disease|8|||
44165167|NCT01647711|78958243|FG004|Overall Study|Progressive disease|2|||
44165168|NCT01647711|78958239|FG000|Overall Study|Other adverse event|0|||
44165169|NCT01647711|78958240|FG001|Overall Study|Other adverse event|0|||
44165170|NCT01647711|78958241|FG002|Overall Study|Other adverse event|2|||
44165171|NCT01647711|78958242|FG003|Overall Study|Other adverse event|0|||
44165172|NCT01647711|78958243|FG004|Overall Study|Other adverse event|2|||
44165173|NCT01647711|78958239|FG000|Overall Study|Protocol Violation|0|||
44165174|NCT01647711|78958240|FG001|Overall Study|Protocol Violation|0|||
44165175|NCT01647711|78958241|FG002|Overall Study|Protocol Violation|0|||
44165176|NCT01647711|78958242|FG003|Overall Study|Protocol Violation|0|||
44165177|NCT01647711|78958243|FG004|Overall Study|Protocol Violation|1|||
44165178|NCT01647711|78958239|FG000|Overall Study|Refused to continue taking medication|0|||
44165179|NCT01647711|78958240|FG001|Overall Study|Refused to continue taking medication|0|||
44165180|NCT01647711|78958241|FG002|Overall Study|Refused to continue taking medication|0|||
44165181|NCT01647711|78958242|FG003|Overall Study|Refused to continue taking medication|2|||
44165182|NCT01647711|78958243|FG004|Overall Study|Refused to continue taking medication|1|||
44165183|NCT01647711|78958239|FG000|Overall Study|Other reason not defined|0|||
44165184|NCT01647711|78958240|FG001|Overall Study|Other reason not defined|1|||
44165185|NCT01647711|78958241|FG002|Overall Study|Other reason not defined|1|||
44165186|NCT01647711|78958242|FG003|Overall Study|Other reason not defined|1|||
44165187|NCT01647711|78958243|FG004|Overall Study|Other reason not defined|0|||
44165188|NCT02547233|78958259|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
44165189|NCT02547233|78958260|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
44165190|NCT02547233|78958259|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
44165191|NCT02547233|78958260|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
44165192|NCT02547233|78958259|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
44165193|NCT02547233|78958260|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
44165194|NCT02547233|78958259|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
44165195|NCT02547233|78958260|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
44165196|NCT02547233|78958259|FG000|12-month Follow-up|Withdrawal by Subject|10|||
44165197|NCT02547233|78958260|FG001|12-month Follow-up|Withdrawal by Subject|10|||
44165198|NCT02547233|78958259|FG000|12-month Follow-up|Lost to Follow-up|3|||
44165199|NCT02547233|78958260|FG001|12-month Follow-up|Lost to Follow-up|3|||
44165200|NCT02547233|78958259|FG000|12-month Follow-up|Lack of Efficacy|1|||
44165201|NCT02547233|78958260|FG001|12-month Follow-up|Lack of Efficacy|2|||
44165202|NCT02547233|78958259|FG000|12-month Follow-up|Protocol Violation|0|||
44165203|NCT02547233|78958260|FG001|12-month Follow-up|Protocol Violation|1|||
44165204|NCT02547233|78958259|FG000|12-month Follow-up|Other|0|||
44165205|NCT02547233|78958260|FG001|12-month Follow-up|Other|1|||
44165206|NCT05476679|78958273|FG000|Overall Study|Withdrawal by Subject|0|||
44165207|NCT05476679|78958274|FG001|Overall Study|Withdrawal by Subject|0|||
44165208|NCT05476679|78958275|FG002|Overall Study|Withdrawal by Subject|0|||
44165209|NCT05476679|78958276|FG003|Overall Study|Withdrawal by Subject|1|||
44165210|NCT05476679|78958277|FG004|Overall Study|Withdrawal by Subject|0|||
44165211|NCT05476679|78958273|FG000|Overall Study|Lost to Follow-up|0|||
44165212|NCT05476679|78958274|FG001|Overall Study|Lost to Follow-up|0|||
44165213|NCT05476679|78958275|FG002|Overall Study|Lost to Follow-up|0|||
44165214|NCT05476679|78958276|FG003|Overall Study|Lost to Follow-up|1|||
44165215|NCT05476679|78958277|FG004|Overall Study|Lost to Follow-up|0|||
44165216|NCT02546765|78958295|FG000|Overall Study|Withdrawal by Subject|0|||
44165217|NCT02546765|78958296|FG001|Overall Study|Withdrawal by Subject|1|||
44165218|NCT02546765|78958297|FG002|Overall Study|Withdrawal by Subject|0|||
44165219|NCT02546765|78958298|FG003|Overall Study|Withdrawal by Subject|0|||
44165220|NCT02553629|78958321|FG000|Overall Study|Logistic reasons|3|||
44165221|NCT02553629|78958322|FG001|Overall Study|Logistic reasons|6|||
44165222|NCT02546609|78958331|FG000|Overall Study|Withdrawal by Subject|0|||
44165223|NCT02546609|78958332|FG001|Overall Study|Withdrawal by Subject|1|||
44165224|NCT02546609|78958333|FG002|Overall Study|Withdrawal by Subject|2|||
44165225|NCT02546609|78958331|FG000|Overall Study|Adverse Event|0|||
44165226|NCT02546609|78958332|FG001|Overall Study|Adverse Event|6|||
44165227|NCT02546609|78958333|FG002|Overall Study|Adverse Event|1|||
44165228|NCT02546609|78958331|FG000|Overall Study|Protocol Violation|0|||
44165229|NCT02546609|78958332|FG001|Overall Study|Protocol Violation|1|||
44165230|NCT02546609|78958333|FG002|Overall Study|Protocol Violation|1|||
44165231|NCT02546609|78958331|FG000|Overall Study|Lost to Follow-up|2|||
44165232|NCT02546609|78958332|FG001|Overall Study|Lost to Follow-up|3|||
44165233|NCT02546609|78958333|FG002|Overall Study|Lost to Follow-up|1|||
44165234|NCT02546609|78958331|FG000|Overall Study|travel or work schedule restriction|0|||
44165235|NCT02546609|78958332|FG001|Overall Study|travel or work schedule restriction|0|||
44165236|NCT02546609|78958333|FG002|Overall Study|travel or work schedule restriction|2|||
44165237|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
44165238|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
44165239|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
44165240|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
44165241|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
44165242|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
44165243|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Death|1|||
44165244|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Death|3|||
44165245|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
44165246|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
44165247|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
44165248|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
44165249|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
44165250|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
44165251|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
44165252|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
44165253|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
44165254|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
44165255|NCT02553317|78958343|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
44165256|NCT02553317|78958344|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
44165257|NCT02325219|78958354|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
44165258|NCT02325219|78958355|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
44347866|NCT02842827|79352370|FG002|Overall Study|Protocol Defined Disease Progression|0|||
44165259|NCT02325219|78958356|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
44165260|NCT02325219|78958357|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
44165261|NCT02325219|78958358|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
44165262|NCT02325219|78958354|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
44446372|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
44165263|NCT02325219|78958355|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
44165264|NCT02325219|78958356|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44165265|NCT02325219|78958357|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44165266|NCT02325219|78958358|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
44165267|NCT02325219|78958354|FG000|Controlled Period (Week 0 - 16)|Other|0|||
44165268|NCT02325219|78958355|FG001|Controlled Period (Week 0 - 16)|Other|0|||
44165269|NCT02325219|78958356|FG002|Controlled Period (Week 0 - 16)|Other|1|||
44165270|NCT02325219|78958357|FG003|Controlled Period (Week 0 - 16)|Other|0|||
44165271|NCT02325219|78958358|FG004|Controlled Period (Week 0 - 16)|Other|0|||
44165272|NCT02325219|78958354|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
44165273|NCT02325219|78958355|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
44165274|NCT02325219|78958356|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
44165275|NCT02325219|78958357|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
44165276|NCT02325219|78958358|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
44165277|NCT02325219|78958354|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
44165278|NCT02325219|78958355|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
44165279|NCT02325219|78958356|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
44165280|NCT02325219|78958357|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
44165281|NCT02325219|78958358|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
44165282|NCT02325219|78958354|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44165283|NCT02325219|78958355|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
44165284|NCT02325219|78958356|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44165285|NCT02325219|78958357|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44165286|NCT02325219|78958358|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
44165287|NCT02297841|78958374|FG000|Overall Study|Withdrawal by Subject|1|||
44165288|NCT02297841|78958374|FG000|Overall Study|Protocol Violation|7|||
44165289|NCT02324361|78958380|FG000|Overall Study|Lost to Follow-up|5|||
44165290|NCT02324361|78958381|FG001|Overall Study|Lost to Follow-up|2|||
44165291|NCT02365233|78958390|FG000|Overall Study|IRB withheld the data|1|||
44165292|NCT02365233|78958391|FG001|Overall Study|IRB withheld the data|2|||
44165293|NCT02365233|78958392|FG002|Overall Study|IRB withheld the data|2|||
44165294|NCT02324205|78958400|FG000|Overall Study|Withdrawal by Subject|37|||
44165295|NCT02324049|78958404|FG000|Part C|Study terminated|11|||
44165296|NCT02364999|78958410|FG000|Overall Study|Death|136|||
44165297|NCT02364999|78958411|FG001|Overall Study|Death|138|||
44165298|NCT02364999|78958410|FG000|Overall Study|Lost to Follow-up|10|||
44165299|NCT02364999|78958411|FG001|Overall Study|Lost to Follow-up|15|||
44165300|NCT02364999|78958410|FG000|Overall Study|Protocol Violation|3|||
44165301|NCT02364999|78958411|FG001|Overall Study|Protocol Violation|2|||
44165302|NCT02364999|78958410|FG000|Overall Study|Withdrawal by Subject|14|||
44165303|NCT02364999|78958411|FG001|Overall Study|Withdrawal by Subject|14|||
44165304|NCT02364999|78958410|FG000|Overall Study|Other|0|||
44165305|NCT02364999|78958411|FG001|Overall Study|Other|1|||
44165306|NCT02364999|78958410|FG000|Overall Study|Randomized but did not receive treatment|2|||
44165307|NCT02364999|78958411|FG001|Overall Study|Randomized but did not receive treatment|3|||
44165308|NCT02322879|78958420|FG000|First Intervention|Physician Decision|1|||
44165309|NCT02322879|78958421|FG001|First Intervention|Physician Decision|0|||
44165310|NCT02322411|78958429|FG000|Overall Study|Lost to Follow-up|4|||
44165311|NCT02322411|78958430|FG001|Overall Study|Lost to Follow-up|7|||
44165312|NCT02322411|78958429|FG000|Overall Study|Withdrawal by Subject|1|||
44165313|NCT02322411|78958430|FG001|Overall Study|Withdrawal by Subject|0|||
44165314|NCT02322021|78958440|FG000|Core Phase|Adverse Event|1|||
44165315|NCT02322021|78958441|FG001|Core Phase|Adverse Event|3|||
44165316|NCT02322021|78958442|FG002|Core Phase|Adverse Event|4|||
44165317|NCT02322021|78958443|FG003|Core Phase|Adverse Event|2|||
44165318|NCT02322021|78958444|FG004|Core Phase|Adverse Event|0|||
44165319|NCT02322021|78958440|FG000|Core Phase|Participant Choice|4|||
44165320|NCT02322021|78958441|FG001|Core Phase|Participant Choice|5|||
44165321|NCT02322021|78958442|FG002|Core Phase|Participant Choice|4|||
44165322|NCT02322021|78958443|FG003|Core Phase|Participant Choice|2|||
44165323|NCT02322021|78958444|FG004|Core Phase|Participant Choice|0|||
44165324|NCT02322021|78958440|FG000|Core Phase|Lost to Follow-up|0|||
44165325|NCT02322021|78958441|FG001|Core Phase|Lost to Follow-up|0|||
44165326|NCT02322021|78958442|FG002|Core Phase|Lost to Follow-up|0|||
44165327|NCT02322021|78958443|FG003|Core Phase|Lost to Follow-up|1|||
44165328|NCT02322021|78958444|FG004|Core Phase|Lost to Follow-up|0|||
44165329|NCT02322021|78958440|FG000|Core Phase|Other|0|||
44165330|NCT02322021|78958441|FG001|Core Phase|Other|0|||
44165331|NCT02322021|78958442|FG002|Core Phase|Other|1|||
44165332|NCT02322021|78958443|FG003|Core Phase|Other|0|||
44165333|NCT02322021|78958444|FG004|Core Phase|Other|0|||
44165334|NCT02322021|78958440|FG000|Extension Phase|Adverse Event|0|||
44165335|NCT02322021|78958441|FG001|Extension Phase|Adverse Event|0|||
44165336|NCT02322021|78958442|FG002|Extension Phase|Adverse Event|0|||
44165337|NCT02322021|78958443|FG003|Extension Phase|Adverse Event|0|||
44165338|NCT02322021|78958444|FG004|Extension Phase|Adverse Event|3|||
44165339|NCT02322021|78958440|FG000|Extension Phase|Participant Choice|0|||
44165340|NCT02322021|78958441|FG001|Extension Phase|Participant Choice|0|||
44165341|NCT02322021|78958442|FG002|Extension Phase|Participant Choice|0|||
44165342|NCT02322021|78958443|FG003|Extension Phase|Participant Choice|0|||
44165343|NCT02322021|78958444|FG004|Extension Phase|Participant Choice|6|||
44165344|NCT02322021|78958440|FG000|Extension Phase|Other|0|||
44165345|NCT02322021|78958441|FG001|Extension Phase|Other|0|||
44165346|NCT02322021|78958442|FG002|Extension Phase|Other|0|||
44165347|NCT02322021|78958443|FG003|Extension Phase|Other|0|||
44165348|NCT02322021|78958444|FG004|Extension Phase|Other|3|||
44165349|NCT02322021|78958440|FG000|Extension Phase|Lost to Follow-up|0|||
44165350|NCT02322021|78958441|FG001|Extension Phase|Lost to Follow-up|0|||
44165351|NCT02322021|78958442|FG002|Extension Phase|Lost to Follow-up|0|||
44165352|NCT02322021|78958443|FG003|Extension Phase|Lost to Follow-up|0|||
44165353|NCT02322021|78958444|FG004|Extension Phase|Lost to Follow-up|1|||
44165354|NCT02322021|78958440|FG000|Extension Phase|Study terminated by sponsor|0|||
44165355|NCT02322021|78958441|FG001|Extension Phase|Study terminated by sponsor|0|||
44165356|NCT02322021|78958442|FG002|Extension Phase|Study terminated by sponsor|0|||
44165357|NCT02322021|78958443|FG003|Extension Phase|Study terminated by sponsor|0|||
44165358|NCT02322021|78958444|FG004|Extension Phase|Study terminated by sponsor|28|||
44165359|NCT02363439|78958459|FG000|Overall Study|Lack of Efficacy|4|||
44165360|NCT02363283|78958463|FG000|Overall Study|Withdrawal by Subject|1|||
44165361|NCT02363283|78958463|FG000|Overall Study|Not eligible due to transaminitis|1|||
44165362|NCT02321319|78958467|FG000|Overall Study|Product discontinued|5|||
44165363|NCT02294175|78958473|FG000|Overall Study|Withdrawal by Subject|1|||
44165364|NCT02294175|78958474|FG001|Overall Study|Withdrawal by Subject|2|||
44165365|NCT02294175|78958473|FG000|Overall Study|pt taking excluded medication|3|||
44165366|NCT02294175|78958474|FG001|Overall Study|pt taking excluded medication|1|||
44165367|NCT02294175|78958473|FG000|Overall Study|Protocol Violation|1|||
44165368|NCT02294175|78958474|FG001|Overall Study|Protocol Violation|0|||
44165369|NCT02294175|78958473|FG000|Overall Study|Lost to Follow-up|0|||
44165370|NCT02294175|78958474|FG001|Overall Study|Lost to Follow-up|1|||
44165371|NCT02294175|78958473|FG000|Overall Study|wound healed|0|||
44165372|NCT02294175|78958474|FG001|Overall Study|wound healed|2|||
44165373|NCT02088541|78958485|FG000|Overall Study|Adverse Event|3|||
44165374|NCT02088541|78958486|FG001|Overall Study|Adverse Event|0|||
44165375|NCT02088541|78958487|FG002|Overall Study|Adverse Event|3|||
44165376|NCT02088541|78958488|FG003|Overall Study|Adverse Event|3|||
44165377|NCT02088541|78958489|FG004|Overall Study|Adverse Event|0|||
44165378|NCT02088541|78958485|FG000|Overall Study|Death|51|||
44165379|NCT02088541|78958486|FG001|Overall Study|Death|21|||
44165380|NCT02088541|78958487|FG002|Overall Study|Death|85|||
44165381|NCT02088541|78958488|FG003|Overall Study|Death|28|||
44165382|NCT02088541|78958489|FG004|Overall Study|Death|38|||
44165383|NCT02088541|78958485|FG000|Overall Study|Lost to Follow-up|2|||
44165384|NCT02088541|78958486|FG001|Overall Study|Lost to Follow-up|0|||
44165385|NCT02088541|78958487|FG002|Overall Study|Lost to Follow-up|1|||
44165386|NCT02088541|78958488|FG003|Overall Study|Lost to Follow-up|0|||
44165387|NCT02088541|78958489|FG004|Overall Study|Lost to Follow-up|0|||
44165388|NCT02088541|78958485|FG000|Overall Study|Physician Decision|2|||
44165389|NCT02088541|78958486|FG001|Overall Study|Physician Decision|1|||
44165390|NCT02088541|78958487|FG002|Overall Study|Physician Decision|2|||
44165391|NCT02088541|78958488|FG003|Overall Study|Physician Decision|0|||
44165392|NCT02088541|78958489|FG004|Overall Study|Physician Decision|2|||
44165393|NCT02088541|78958485|FG000|Overall Study|Disease progression|7|||
44165394|NCT02088541|78958486|FG001|Overall Study|Disease progression|1|||
44165395|NCT02088541|78958487|FG002|Overall Study|Disease progression|2|||
44165396|NCT02088541|78958488|FG003|Overall Study|Disease progression|3|||
44165397|NCT02088541|78958489|FG004|Overall Study|Disease progression|1|||
44165398|NCT02088541|78958485|FG000|Overall Study|Study terminated by sponsor|1|||
44165399|NCT02088541|78958486|FG001|Overall Study|Study terminated by sponsor|1|||
44165400|NCT02088541|78958487|FG002|Overall Study|Study terminated by sponsor|12|||
44165401|NCT02088541|78958488|FG003|Overall Study|Study terminated by sponsor|2|||
44165402|NCT02088541|78958489|FG004|Overall Study|Study terminated by sponsor|6|||
44165403|NCT02088541|78958485|FG000|Overall Study|Withdrawal by Subject|3|||
44165404|NCT02088541|78958486|FG001|Overall Study|Withdrawal by Subject|2|||
44347867|NCT02842827|79352371|FG003|Overall Study|Protocol Defined Disease Progression|0|||
44347868|NCT02842827|79352372|FG004|Overall Study|Protocol Defined Disease Progression|0|||
44165405|NCT02088541|78958487|FG002|Overall Study|Withdrawal by Subject|9|||
44165406|NCT02088541|78958488|FG003|Overall Study|Withdrawal by Subject|7|||
44165407|NCT02088541|78958489|FG004|Overall Study|Withdrawal by Subject|10|||
44165408|NCT02088541|78958485|FG000|Overall Study|Other|2|||
44165409|NCT02088541|78958486|FG001|Overall Study|Other|1|||
44165410|NCT02088541|78958487|FG002|Overall Study|Other|3|||
44165411|NCT02088541|78958488|FG003|Overall Study|Other|1|||
44165412|NCT02088541|78958489|FG004|Overall Study|Other|1|||
44165413|NCT02294019|78958499|FG000|Overall Study|Adverse Event|2|||
44165414|NCT02294019|78958499|FG000|Overall Study|Protocol Violation|68|||
44165415|NCT02294019|78958499|FG000|Overall Study|Lost to Follow-up|31|||
44165416|NCT02294019|78958499|FG000|Overall Study|Other|1|||
44165417|NCT02294019|78958499|FG000|Overall Study|Withdrawal by Subject|1|||
44165418|NCT02320149|78958505|FG000|Overall Study|Adverse Event|3|||
44165419|NCT02320149|78958506|FG001|Overall Study|Adverse Event|7|||
44165420|NCT02320149|78958505|FG000|Overall Study|Withdrawal of Consent|28|||
44165421|NCT02320149|78958506|FG001|Overall Study|Withdrawal of Consent|32|||
44165422|NCT02320149|78958505|FG000|Overall Study|Lost to Follow-up|21|||
44165423|NCT02320149|78958506|FG001|Overall Study|Lost to Follow-up|34|||
44165424|NCT02320149|78958505|FG000|Overall Study|Protocol Violation|2|||
44165425|NCT02320149|78958506|FG001|Overall Study|Protocol Violation|1|||
44165426|NCT02320149|78958505|FG000|Overall Study|Noncompliance with Study Treatment|7|||
44165427|NCT02320149|78958506|FG001|Overall Study|Noncompliance with Study Treatment|2|||
44165428|NCT02320149|78958505|FG000|Overall Study|Lack of Efficacy|0|||
44165429|NCT02320149|78958506|FG001|Overall Study|Lack of Efficacy|1|||
44165430|NCT02320149|78958505|FG000|Overall Study|Other Miscellaneous Reasons|2|||
44165431|NCT02320149|78958506|FG001|Overall Study|Other Miscellaneous Reasons|3|||
44165432|NCT02540083|78958512|FG000|Overall Study|Withdrawal by Subject|16|||
44165433|NCT02293863|78958519|FG000|Overall Study|Death|4|||
44165434|NCT02293863|78958520|FG001|Overall Study|Death|6|||
44165435|NCT02293863|78958521|FG002|Overall Study|Death|4|||
44165436|NCT02293863|78958519|FG000|Overall Study|Lost to Follow-up|2|||
44165437|NCT02293863|78958520|FG001|Overall Study|Lost to Follow-up|2|||
44165438|NCT02293863|78958521|FG002|Overall Study|Lost to Follow-up|2|||
44165439|NCT02293863|78958519|FG000|Overall Study|Withdrawal by Subject|3|||
44165440|NCT02293863|78958520|FG001|Overall Study|Withdrawal by Subject|3|||
44165441|NCT02293863|78958521|FG002|Overall Study|Withdrawal by Subject|1|||
44165442|NCT02293863|78958519|FG000|Overall Study|Reason Not Specified|0|||
44165443|NCT02293863|78958520|FG001|Overall Study|Reason Not Specified|2|||
44165444|NCT02293863|78958521|FG002|Overall Study|Reason Not Specified|2|||
44165445|NCT02293395|78958533|FG000|Overall Study|Lost to Follow-up|1|||
44165446|NCT02293395|78958534|FG001|Overall Study|Lost to Follow-up|0|||
44165447|NCT02293395|78958533|FG000|Overall Study|Withdrawal by Subject|8|||
44165448|NCT02293395|78958534|FG001|Overall Study|Withdrawal by Subject|7|||
44165449|NCT02025985|78958545|FG000|Overall Study|Consent withdrawn|0|||
44165450|NCT02025985|78958546|FG001|Overall Study|Consent withdrawn|0|||
44165451|NCT02025985|78958547|FG002|Overall Study|Consent withdrawn|1|||
44165452|NCT02025985|78958548|FG003|Overall Study|Consent withdrawn|0|||
44165453|NCT02025985|78958549|FG004|Overall Study|Consent withdrawn|0|||
44165454|NCT02025985|78958545|FG000|Overall Study|Termination of study by Sponsor|4|||
44165455|NCT02025985|78958546|FG001|Overall Study|Termination of study by Sponsor|3|||
44165456|NCT02025985|78958547|FG002|Overall Study|Termination of study by Sponsor|1|||
44165457|NCT02025985|78958548|FG003|Overall Study|Termination of study by Sponsor|1|||
44165458|NCT02025985|78958549|FG004|Overall Study|Termination of study by Sponsor|3|||
44165459|NCT02025985|78958545|FG000|Overall Study|Death|21|||
44165460|NCT02025985|78958546|FG001|Overall Study|Death|20|||
44165461|NCT02025985|78958547|FG002|Overall Study|Death|23|||
44165462|NCT02025985|78958548|FG003|Overall Study|Death|20|||
44165463|NCT02025985|78958549|FG004|Overall Study|Death|17|||
44165464|NCT02528305|78958563|FG000|Overall Study|Withdrawal by Subject|1|||
44165465|NCT02528305|78958563|FG000|Overall Study|Adverse Event|1|||
44165466|NCT02528305|78958563|FG000|Overall Study|Physician Decision|1|||
44165467|NCT02532517|78958569|FG000|Overall Study|Did not complete 24-Month visit|4|||
44165468|NCT02532517|78958569|FG000|Overall Study|Failed Angiographic eligibility|1|||
44165469|NCT02532517|78958569|FG000|Overall Study|Lost to Follow-up|4|||
44165470|NCT02532517|78958569|FG000|Overall Study|Withdrawal by Subject|4|||
44165471|NCT02532517|78958569|FG000|Overall Study|Death|4|||
44165472|NCT02545049|78958575|FG000|Overall Study|Withdrawal by Subject|1|||
44165473|NCT02545049|78958576|FG001|Overall Study|Withdrawal by Subject|7|||
44165474|NCT02545049|78958575|FG000|Overall Study|Lost to Follow-up|4|||
44165475|NCT02545049|78958576|FG001|Overall Study|Lost to Follow-up|6|||
44165476|NCT02545049|78958575|FG000|Overall Study|GCP violations|37|||
44165477|NCT02545049|78958576|FG001|Overall Study|GCP violations|48|||
44165478|NCT02532283|78958584|FG000|Overall Study|Adverse Event|0|||
44165479|NCT02532283|78958585|FG001|Overall Study|Adverse Event|1|||
44165480|NCT02532283|78958584|FG000|Overall Study|Death|1|||
44165481|NCT02532283|78958585|FG001|Overall Study|Death|0|||
44165482|NCT02532283|78958584|FG000|Overall Study|Lost to Follow-up|0|||
44165483|NCT02532283|78958585|FG001|Overall Study|Lost to Follow-up|1|||
44165484|NCT02532283|78958584|FG000|Overall Study|Withdrawal by Subject|8|||
44165485|NCT02532283|78958585|FG001|Overall Study|Withdrawal by Subject|3|||
44165486|NCT01295125|78958606|FG000|Overall Study|Study stopped prematurely|9|||
44165487|NCT02540291|78958614|FG000|Overall Study|Death|7|||
44165488|NCT02540291|78958615|FG001|Overall Study|Death|7|||
44165489|NCT02540291|78958616|FG002|Overall Study|Death|5|||
44165490|NCT02540291|78958617|FG003|Overall Study|Death|7|||
44165491|NCT02540291|78958614|FG000|Overall Study|Lost to Follow-up|0|||
44165492|NCT02540291|78958615|FG001|Overall Study|Lost to Follow-up|0|||
44165493|NCT02540291|78958616|FG002|Overall Study|Lost to Follow-up|1|||
44165494|NCT02540291|78958617|FG003|Overall Study|Lost to Follow-up|0|||
44165495|NCT02540291|78958614|FG000|Overall Study|Withdrawal Of Consent|0|||
44165496|NCT02540291|78958615|FG001|Overall Study|Withdrawal Of Consent|1|||
44165497|NCT02540291|78958616|FG002|Overall Study|Withdrawal Of Consent|0|||
44165498|NCT02540291|78958617|FG003|Overall Study|Withdrawal Of Consent|0|||
44165499|NCT02540291|78958614|FG000|Overall Study|Study Terminated By Sponsor|1|||
44165500|NCT02540291|78958615|FG001|Overall Study|Study Terminated By Sponsor|0|||
44165501|NCT02540291|78958616|FG002|Overall Study|Study Terminated By Sponsor|0|||
44165502|NCT02540291|78958617|FG003|Overall Study|Study Terminated By Sponsor|0|||
44165503|NCT02540291|78958614|FG000|Overall Study|Other|0|||
44165504|NCT02540291|78958615|FG001|Overall Study|Other|0|||
44165505|NCT02540291|78958616|FG002|Overall Study|Other|1|||
44165506|NCT02540291|78958617|FG003|Overall Study|Other|0|||
44165507|NCT02540213|78958629|FG000|Overall Study|Death/adverse event|18|||
44165508|NCT02540213|78958629|FG000|Overall Study|Administrative reasons|3|||
44165509|NCT02540213|78958629|FG000|Overall Study|Kidney transplant|3|||
44165510|NCT02540213|78958629|FG000|Overall Study|Lack of Efficacy|6|||
44165511|NCT02540213|78958629|FG000|Overall Study|Consent withdrawn|7|||
44165512|NCT02540213|78958629|FG000|Overall Study|Enrolled but not treated|2|||
44165513|NCT02552303|78958637|FG000|Allocation|Withdrawal by Subject|2|||
44165514|NCT02552303|78958638|FG001|Allocation|Withdrawal by Subject|1|||
44165515|NCT02552303|78958639|FG002|Allocation|Withdrawal by Subject|1|||
44165516|NCT02552303|78958640|FG003|Allocation|Withdrawal by Subject|1|||
44165517|NCT02552303|78958637|FG000|Allocation|ineligible|1|||
44165518|NCT02552303|78958638|FG001|Allocation|ineligible|1|||
44165519|NCT02552303|78958639|FG002|Allocation|ineligible|0|||
44165520|NCT02552303|78958640|FG003|Allocation|ineligible|0|||
44165521|NCT02552303|78958637|FG000|Follow-Up|Lost to Follow-up|0|||
44165522|NCT02552303|78958638|FG001|Follow-Up|Lost to Follow-up|0|||
44165523|NCT02552303|78958639|FG002|Follow-Up|Lost to Follow-up|1|||
44165524|NCT02552303|78958640|FG003|Follow-Up|Lost to Follow-up|0|||
44165525|NCT02552303|78958637|FG000|Follow-Up|ineligible|0|||
44165526|NCT02552303|78958638|FG001|Follow-Up|ineligible|2|||
44165527|NCT02552303|78958639|FG002|Follow-Up|ineligible|0|||
44165528|NCT02552303|78958640|FG003|Follow-Up|ineligible|0|||
44165529|NCT01660711|78958650|FG000|Overall Study|Adverse Event|7|||
44165530|NCT01660711|78958650|FG000|Overall Study|Withdrawal by Subject|1|||
44165531|NCT02544113|78958656|FG000|Overall Study|Death|3|||
44165532|NCT02544113|78958657|FG001|Overall Study|Death|4|||
44165533|NCT02538965|78958663|FG000|Treatment Period|Other = Death due to disease progression|1|||
44165534|NCT02538965|78958663|FG000|Treatment Period|Adverse Event|2|||
44165535|NCT02538965|78958663|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
44165536|NCT02538965|78958663|FG000|Treatment Period|Treatment Failure|9|||
44165537|NCT02538965|78958663|FG000|Treatment Period|Disease Progression|1|||
44347869|NCT02842827|79352373|FG005|Overall Study|Protocol Defined Disease Progression|1|||
44347870|NCT02842827|79352374|FG006|Overall Study|Protocol Defined Disease Progression|0|||
44347871|NCT02842827|79352375|FG007|Overall Study|Protocol Defined Disease Progression|0|||
44347872|NCT02842827|79352368|FG000|Overall Study|Participant Withdrawal of Consent|1|||
44347873|NCT02842827|79352369|FG001|Overall Study|Participant Withdrawal of Consent|2|||
44347874|NCT02842827|79352370|FG002|Overall Study|Participant Withdrawal of Consent|2|||
44347875|NCT02842827|79352371|FG003|Overall Study|Participant Withdrawal of Consent|2|||
44347876|NCT02842827|79352372|FG004|Overall Study|Participant Withdrawal of Consent|2|||
44347877|NCT02842827|79352373|FG005|Overall Study|Participant Withdrawal of Consent|1|||
44347878|NCT02842827|79352374|FG006|Overall Study|Participant Withdrawal of Consent|2|||
44347879|NCT02842827|79352375|FG007|Overall Study|Participant Withdrawal of Consent|1|||
44347880|NCT02432274|79352401|FG000|Overall Study|Death|2|||
44347881|NCT02432274|79352402|FG001|Overall Study|Death|6|||
44446373|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
44446374|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
44446375|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
44165538|NCT02538965|78958663|FG000|Treatment Period|Physician Decision|2|||
44165539|NCT02538965|78958663|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
44165540|NCT02538965|78958663|FG000|Follow-Up Period|Withdrawal by Parent|4|||
44165541|NCT02543801|78958671|FG000|Overall Study|Protocol Violation|1|||
44165542|NCT02543801|78958672|FG001|Overall Study|Protocol Violation|2|||
44347882|NCT02432274|79352403|FG002|Overall Study|Death|7|||
44165543|NCT02543801|78958673|FG002|Overall Study|Protocol Violation|0|||
44165544|NCT02543801|78958674|FG003|Overall Study|Protocol Violation|0|||
44165545|NCT02535065|78958684|FG000|Overall Study|Death|13|||
44165546|NCT02535065|78958684|FG000|Overall Study|Lost to Follow-up|1|||
44165547|NCT02535065|78958684|FG000|Overall Study|Withdrawal by Subject|6|||
44165548|NCT02530619|78958688|FG000|Registered for Study|Withdrawal by Subject|2|||
44165549|NCT02530619|78958688|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
44165550|NCT02530619|78958688|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
44165551|NCT02530619|78958688|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
44165552|NCT02530619|78958688|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
44165553|NCT02530619|78958688|FG000|Follow-up Period (6 Months)|Death|4|||
44165554|NCT02530619|78958688|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
44165555|NCT02530619|78958688|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
44165556|NCT02530385|78958694|FG000|Overall Study|Withdrawal by Subject|0|||
44165557|NCT02530385|78958695|FG001|Overall Study|Withdrawal by Subject|1|||
44165558|NCT02362425|78958705|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
44165559|NCT02362425|78958706|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
44165560|NCT02362425|78958707|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
44165561|NCT02362425|78958708|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
44165562|NCT02362425|78958705|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
44165563|NCT02362425|78958706|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
44165564|NCT02362425|78958707|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
44165565|NCT02362425|78958708|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
44165566|NCT02362425|78958705|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
44165567|NCT02362425|78958706|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
44165568|NCT02362425|78958707|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
44165569|NCT02362425|78958708|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
44165570|NCT02362425|78958705|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
44165571|NCT02362425|78958706|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
44165572|NCT02362425|78958707|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
44165573|NCT02362425|78958708|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
44165574|NCT02362425|78958705|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
44165575|NCT02362425|78958706|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
44165576|NCT02362425|78958707|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
44165577|NCT02362425|78958708|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
44165578|NCT02362425|78958705|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
44165579|NCT02362425|78958706|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
44165580|NCT02362425|78958707|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
44165581|NCT02362425|78958708|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
44165582|NCT02362425|78958705|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
44165583|NCT02362425|78958706|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
44165584|NCT02362425|78958707|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
44165585|NCT02362425|78958708|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
44165586|NCT02362425|78958705|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
44165587|NCT02362425|78958706|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
44165588|NCT02362425|78958707|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
44165589|NCT02362425|78958708|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
44165590|NCT02362269|78958721|FG000|Overall Study|Moved|1|||
44165591|NCT02362269|78958722|FG001|Overall Study|Moved|0|||
44165592|NCT02362269|78958721|FG000|Overall Study|Lost to Follow-up|0|||
44165593|NCT02362269|78958722|FG001|Overall Study|Lost to Follow-up|6|||
44165594|NCT02529995|78958730|FG000|Part A|Ongoing Study at Data Cut-off|14|||
44165595|NCT02529995|78958731|FG001|Part A|Ongoing Study at Data Cut-off|16|||
44165596|NCT02529995|78958730|FG000|Part A|Discontinued Study|1|||
44165597|NCT02529995|78958731|FG001|Part A|Discontinued Study|0|||
44165598|NCT02529995|78958730|FG000|Part B|Ongoing Study at Data Cut-off|0|||
44165599|NCT02529995|78958731|FG001|Part B|Ongoing Study at Data Cut-off|7|||
44165600|NCT02529995|78958730|FG000|Part B|Discontinued Study|6|||
44165601|NCT02529995|78958731|FG001|Part B|Discontinued Study|5|||
44165602|NCT02529137|78958737|FG000|Overall Study|Discontinuation for different reasons|8|||
44165603|NCT02319759|78958744|FG000|Week 0 - 16|Lack of Efficacy|1|||
44165604|NCT02319759|78958745|FG001|Week 0 - 16|Lack of Efficacy|0|||
44165605|NCT02319759|78958746|FG002|Week 0 - 16|Lack of Efficacy|0|||
44165606|NCT02319759|78958747|FG003|Week 0 - 16|Lack of Efficacy|0|||
44165607|NCT02319759|78958748|FG004|Week 0 - 16|Lack of Efficacy|0|||
44165608|NCT02319759|78958744|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
44165609|NCT02319759|78958745|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
44165610|NCT02319759|78958746|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
44165611|NCT02319759|78958747|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
44165612|NCT02319759|78958748|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
44347883|NCT02432274|79352404|FG003|Overall Study|Death|0|||
44446376|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
44446377|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
44165613|NCT02319759|78958744|FG000|Week 16 - 24|Lack of Efficacy|1|||
44165614|NCT02319759|78958745|FG001|Week 16 - 24|Lack of Efficacy|0|||
44165615|NCT02319759|78958746|FG002|Week 16 - 24|Lack of Efficacy|1|||
44165616|NCT02319759|78958747|FG003|Week 16 - 24|Lack of Efficacy|0|||
44165617|NCT02319759|78958748|FG004|Week 16 - 24|Lack of Efficacy|0|||
44165618|NCT02319759|78958744|FG000|Week 16 - 24|Lost to Follow-up|1|||
44165619|NCT02319759|78958745|FG001|Week 16 - 24|Lost to Follow-up|0|||
44165620|NCT02319759|78958746|FG002|Week 16 - 24|Lost to Follow-up|0|||
44165621|NCT02319759|78958747|FG003|Week 16 - 24|Lost to Follow-up|0|||
44165622|NCT02319759|78958748|FG004|Week 16 - 24|Lost to Follow-up|0|||
44165623|NCT02319759|78958744|FG000|Week 16 - 24|Withdrawal by Subject|0|||
44165624|NCT02319759|78958745|FG001|Week 16 - 24|Withdrawal by Subject|0|||
44165625|NCT02319759|78958746|FG002|Week 16 - 24|Withdrawal by Subject|2|||
44165626|NCT02319759|78958747|FG003|Week 16 - 24|Withdrawal by Subject|0|||
44165627|NCT02319759|78958748|FG004|Week 16 - 24|Withdrawal by Subject|0|||
44165628|NCT02319759|78958744|FG000|Week 24 - 56|Adverse Event|0|||
44165629|NCT02319759|78958745|FG001|Week 24 - 56|Adverse Event|0|||
44165630|NCT02319759|78958746|FG002|Week 24 - 56|Adverse Event|2|||
44165631|NCT02319759|78958747|FG003|Week 24 - 56|Adverse Event|0|||
44165632|NCT02319759|78958748|FG004|Week 24 - 56|Adverse Event|0|||
44165633|NCT02319759|78958744|FG000|Week 24 - 56|Lack of Efficacy|0|||
44165634|NCT02319759|78958745|FG001|Week 24 - 56|Lack of Efficacy|0|||
44165635|NCT02319759|78958746|FG002|Week 24 - 56|Lack of Efficacy|0|||
44165636|NCT02319759|78958747|FG003|Week 24 - 56|Lack of Efficacy|2|||
44165637|NCT02319759|78958748|FG004|Week 24 - 56|Lack of Efficacy|1|||
44165638|NCT02319759|78958744|FG000|Week 24 - 56|Withdrawal by Subject|0|||
44165639|NCT02319759|78958745|FG001|Week 24 - 56|Withdrawal by Subject|1|||
44165640|NCT02319759|78958746|FG002|Week 24 - 56|Withdrawal by Subject|0|||
44165641|NCT02319759|78958747|FG003|Week 24 - 56|Withdrawal by Subject|0|||
44165642|NCT02319759|78958748|FG004|Week 24 - 56|Withdrawal by Subject|0|||
44165643|NCT02319759|78958744|FG000|Week 24 - 56|Lost to Follow-up|0|||
44165644|NCT02319759|78958745|FG001|Week 24 - 56|Lost to Follow-up|0|||
44165645|NCT02319759|78958746|FG002|Week 24 - 56|Lost to Follow-up|0|||
44165646|NCT02319759|78958747|FG003|Week 24 - 56|Lost to Follow-up|0|||
44165647|NCT02319759|78958748|FG004|Week 24 - 56|Lost to Follow-up|1|||
44165648|NCT02293005|78958761|FG000|Overall Study|Adverse Event|2|||
44165649|NCT02293005|78958761|FG000|Overall Study|Death|4|||
44165650|NCT02293005|78958761|FG000|Overall Study|Lost to Follow-up|1|||
44165651|NCT02293005|78958761|FG000|Overall Study|Withdrawal by Subject|2|||
44165652|NCT02293005|78958761|FG000|Overall Study|Progression|17|||
44165653|NCT02319525|78958767|FG000|Overall Study|Withdrawal by Subject|2|||
44165654|NCT02319525|78958768|FG001|Overall Study|Withdrawal by Subject|1|||
44165655|NCT02292927|78958776|FG000|Overall Study|Protocol Violation|13|||
44165656|NCT02292927|78958777|FG001|Overall Study|Protocol Violation|7|||
44165657|NCT02292849|78958789|FG000|Overall Study|Lost to Follow-up|0|||
44165658|NCT02292849|78958790|FG001|Overall Study|Lost to Follow-up|2|||
44165659|NCT02292849|78958791|FG002|Overall Study|Lost to Follow-up|2|||
44165660|NCT02292849|78958789|FG000|Overall Study|Physician Decision|4|||
44165661|NCT02292849|78958790|FG001|Overall Study|Physician Decision|0|||
44165662|NCT02292849|78958791|FG002|Overall Study|Physician Decision|0|||
44165663|NCT02318667|78958799|FG000|Overall Study|Adverse Event|1|||
44165664|NCT02318667|78958799|FG000|Overall Study|Lack of Efficacy|6|||
44165665|NCT02318667|78958799|FG000|Overall Study|Protocol Violation|2|||
44165666|NCT02292771|78958809|FG000|Overall Study|Withdrawal by Subject|2|||
44165667|NCT02292771|78958810|FG001|Overall Study|Withdrawal by Subject|1|||
44165668|NCT02292771|78958809|FG000|Overall Study|Lost to Follow-up|2|||
44165669|NCT02292771|78958810|FG001|Overall Study|Lost to Follow-up|1|||
44165670|NCT02291913|78958820|FG000|Overall Study|Progressive Disease|32|||
44165671|NCT02291913|78958820|FG000|Overall Study|Adverse Event|11|||
44165672|NCT02291913|78958820|FG000|Overall Study|Death|2|||
44165673|NCT02291913|78958820|FG000|Overall Study|Physician Decision|1|||
44165674|NCT02291913|78958820|FG000|Overall Study|Withdrawal by Subject|1|||
44165675|NCT02291913|78958820|FG000|Overall Study|Protocol Violation|1|||
44165676|NCT02291679|78958827|FG000|Overall Study|Adverse Event|2|||
44165677|NCT02291679|78958828|FG001|Overall Study|Adverse Event|12|||
44165678|NCT02291679|78958829|FG002|Overall Study|Adverse Event|19|||
44165679|NCT02291679|78958827|FG000|Overall Study|Protocol Violation|5|||
44165680|NCT02291679|78958828|FG001|Overall Study|Protocol Violation|1|||
44165681|NCT02291679|78958829|FG002|Overall Study|Protocol Violation|7|||
44165682|NCT02291679|78958827|FG000|Overall Study|Withdrew Consent|18|||
44165683|NCT02291679|78958828|FG001|Overall Study|Withdrew Consent|10|||
44165684|NCT02291679|78958829|FG002|Overall Study|Withdrew Consent|15|||
44165685|NCT02291679|78958827|FG000|Overall Study|Lost to Follow-up|12|||
44165686|NCT02291679|78958828|FG001|Overall Study|Lost to Follow-up|10|||
44165687|NCT02291679|78958829|FG002|Overall Study|Lost to Follow-up|9|||
44165688|NCT02291679|78958827|FG000|Overall Study|Insufficient Therapeutic Response|5|||
44165689|NCT02291679|78958828|FG001|Overall Study|Insufficient Therapeutic Response|5|||
44165690|NCT02291679|78958829|FG002|Overall Study|Insufficient Therapeutic Response|7|||
44165691|NCT02291679|78958827|FG000|Overall Study|Other|2|||
44165692|NCT02291679|78958828|FG001|Overall Study|Other|4|||
44165693|NCT02291679|78958829|FG002|Overall Study|Other|2|||
44165694|NCT02291601|78958836|FG000|Abdomen|Did not qualify|333|||
44165695|NCT02291601|78958837|FG001|Abdomen|Did not qualify|54|||
44165696|NCT02291601|78958838|FG002|Abdomen|Did not qualify|339|||
44165697|NCT02291601|78958836|FG000|Groin|Did not qualify|183|||
44165698|NCT02291601|78958837|FG001|Groin|Did not qualify|30|||
44165699|NCT02291601|78958838|FG002|Groin|Did not qualify|177|||
44165700|NCT02360475|78958853|FG000|Overall Study|Lost to Follow-up|4|||
44165701|NCT02360475|78958854|FG001|Overall Study|Lost to Follow-up|12|||
44165702|NCT02360475|78958855|FG002|Overall Study|Lost to Follow-up|6|||
44165703|NCT02360475|78958856|FG003|Overall Study|Lost to Follow-up|4|||
44165704|NCT02360475|78958853|FG000|Overall Study|Withdrawal by Subject|0|||
44165705|NCT02360475|78958854|FG001|Overall Study|Withdrawal by Subject|1|||
44165706|NCT02360475|78958855|FG002|Overall Study|Withdrawal by Subject|2|||
44165707|NCT02360475|78958856|FG003|Overall Study|Withdrawal by Subject|0|||
44165708|NCT02360475|78958853|FG000|Overall Study|Migrated/moved from study area|0|||
44165709|NCT02360475|78958854|FG001|Overall Study|Migrated/moved from study area|0|||
44165710|NCT02360475|78958855|FG002|Overall Study|Migrated/moved from study area|0|||
44165711|NCT02360475|78958856|FG003|Overall Study|Migrated/moved from study area|1|||
44165712|NCT02360397|78958866|FG000|Overall Study|Incomplete screening|3|||
44165713|NCT02360397|78958866|FG000|Overall Study|Adverse Event|1|||
44165714|NCT02317809|78958871|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
44165715|NCT02317809|78958872|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
44165716|NCT02317809|78958871|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
44165717|NCT02317809|78958872|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
44165718|NCT02359851|78958881|FG000|Overall Study|Death|1|||
44165719|NCT02359851|78958881|FG000|Overall Study|Disease progression|1|||
44165720|NCT01607905|78958892|FG000|Overall Study|Withdrawal by participant|7|||
44165721|NCT01607905|78958893|FG001|Overall Study|Withdrawal by participant|2|||
44165722|NCT01607905|78958894|FG002|Overall Study|Withdrawal by participant|4|||
44165723|NCT01607905|78958895|FG003|Overall Study|Withdrawal by participant|6|||
44165724|NCT01607905|78958896|FG004|Overall Study|Withdrawal by participant|0|||
44165725|NCT01607905|78958897|FG005|Overall Study|Withdrawal by participant|4|||
44165726|NCT01607905|78958898|FG006|Overall Study|Withdrawal by participant|12|||
44165727|NCT01607905|78958892|FG000|Overall Study|Incidence or severity of AEs|5|||
44165728|NCT01607905|78958893|FG001|Overall Study|Incidence or severity of AEs|1|||
44165729|NCT01607905|78958894|FG002|Overall Study|Incidence or severity of AEs|1|||
44165730|NCT01607905|78958895|FG003|Overall Study|Incidence or severity of AEs|3|||
44165731|NCT01607905|78958896|FG004|Overall Study|Incidence or severity of AEs|0|||
44165732|NCT01607905|78958897|FG005|Overall Study|Incidence or severity of AEs|2|||
44165733|NCT01607905|78958898|FG006|Overall Study|Incidence or severity of AEs|8|||
44165734|NCT01607905|78958892|FG000|Overall Study|Disease progression|44|||
44165735|NCT01607905|78958893|FG001|Overall Study|Disease progression|16|||
44165736|NCT01607905|78958894|FG002|Overall Study|Disease progression|15|||
44165737|NCT01607905|78958895|FG003|Overall Study|Disease progression|11|||
44165738|NCT01607905|78958896|FG004|Overall Study|Disease progression|6|||
44165739|NCT01607905|78958897|FG005|Overall Study|Disease progression|7|||
44165740|NCT01607905|78958898|FG006|Overall Study|Disease progression|21|||
44165741|NCT01607905|78958892|FG000|Overall Study|Non-compliance with study procedures|0|||
44165742|NCT01607905|78958893|FG001|Overall Study|Non-compliance with study procedures|0|||
44165743|NCT01607905|78958894|FG002|Overall Study|Non-compliance with study procedures|0|||
44165744|NCT01607905|78958895|FG003|Overall Study|Non-compliance with study procedures|0|||
44165745|NCT01607905|78958896|FG004|Overall Study|Non-compliance with study procedures|0|||
44165746|NCT01607905|78958897|FG005|Overall Study|Non-compliance with study procedures|0|||
44165747|NCT01607905|78958898|FG006|Overall Study|Non-compliance with study procedures|1|||
44165748|NCT01607905|78958892|FG000|Overall Study|Death|1|||
44165749|NCT01607905|78958893|FG001|Overall Study|Death|1|||
44165750|NCT01607905|78958894|FG002|Overall Study|Death|1|||
44165751|NCT01607905|78958895|FG003|Overall Study|Death|1|||
44165752|NCT01607905|78958896|FG004|Overall Study|Death|0|||
44165753|NCT01607905|78958897|FG005|Overall Study|Death|0|||
44165754|NCT01607905|78958898|FG006|Overall Study|Death|3|||
44165755|NCT01607905|78958892|FG000|Overall Study|Other treatments become available|1|||
44165756|NCT01607905|78958893|FG001|Overall Study|Other treatments become available|0|||
44165757|NCT01607905|78958894|FG002|Overall Study|Other treatments become available|0|||
44165758|NCT01607905|78958895|FG003|Overall Study|Other treatments become available|0|||
44165759|NCT01607905|78958896|FG004|Overall Study|Other treatments become available|0|||
44165760|NCT01607905|78958897|FG005|Overall Study|Other treatments become available|0|||
44165761|NCT01607905|78958898|FG006|Overall Study|Other treatments become available|1|||
44165762|NCT01607905|78958892|FG000|Overall Study|Investigator discretion|0|||
44165763|NCT01607905|78958893|FG001|Overall Study|Investigator discretion|0|||
44165764|NCT01607905|78958894|FG002|Overall Study|Investigator discretion|0|||
44165765|NCT01607905|78958895|FG003|Overall Study|Investigator discretion|0|||
44165766|NCT01607905|78958896|FG004|Overall Study|Investigator discretion|0|||
44165767|NCT01607905|78958897|FG005|Overall Study|Investigator discretion|1|||
44165768|NCT01607905|78958898|FG006|Overall Study|Investigator discretion|0|||
44165769|NCT01607905|78958892|FG000|Overall Study|Other|1|||
44165770|NCT01607905|78958893|FG001|Overall Study|Other|0|||
44165771|NCT01607905|78958894|FG002|Overall Study|Other|0|||
44165772|NCT01607905|78958895|FG003|Overall Study|Other|0|||
44165773|NCT01607905|78958896|FG004|Overall Study|Other|0|||
44165774|NCT01607905|78958897|FG005|Overall Study|Other|0|||
44165775|NCT01607905|78958898|FG006|Overall Study|Other|1|||
44165776|NCT01607905|78958892|FG000|Overall Study|Randomized but not treated|1|||
44165777|NCT01607905|78958893|FG001|Overall Study|Randomized but not treated|0|||
44165778|NCT01607905|78958894|FG002|Overall Study|Randomized but not treated|0|||
44165779|NCT01607905|78958895|FG003|Overall Study|Randomized but not treated|0|||
44165780|NCT01607905|78958896|FG004|Overall Study|Randomized but not treated|1|||
44165781|NCT01607905|78958897|FG005|Overall Study|Randomized but not treated|1|||
44165782|NCT01607905|78958898|FG006|Overall Study|Randomized but not treated|0|||
44165783|NCT02536963|78958956|FG000|Overall Study|Withdrawal by Subject|18|||
44165784|NCT02531035|78958962|FG000|Overall Study|Death|0|||
44165785|NCT02531035|78958963|FG001|Overall Study|Death|1|||
44165786|NCT02531035|78958962|FG000|Overall Study|Protocol Violation|1|||
44165787|NCT02531035|78958963|FG001|Overall Study|Protocol Violation|1|||
44165788|NCT02531035|78958962|FG000|Overall Study|Noncompliance with study drug|8|||
44165789|NCT02531035|78958963|FG001|Overall Study|Noncompliance with study drug|3|||
44165790|NCT02531035|78958962|FG000|Overall Study|Physician Decision|1|||
44165791|NCT02531035|78958963|FG001|Overall Study|Physician Decision|0|||
44165792|NCT02531035|78958962|FG000|Overall Study|Adverse Event|16|||
44165793|NCT02531035|78958963|FG001|Overall Study|Adverse Event|45|||
44165794|NCT02531035|78958962|FG000|Overall Study|Other|3|||
44165795|NCT02531035|78958963|FG001|Overall Study|Other|2|||
44165796|NCT02531035|78958962|FG000|Overall Study|Withdrawal by Subject|42|||
44165797|NCT02531035|78958963|FG001|Overall Study|Withdrawal by Subject|32|||
44165798|NCT02531035|78958962|FG000|Overall Study|Lost to Follow-up|8|||
44165799|NCT02531035|78958963|FG001|Overall Study|Lost to Follow-up|10|||
44165800|NCT02531035|78958962|FG000|Overall Study|Randomized, not treated|2|||
44165801|NCT02531035|78958963|FG001|Overall Study|Randomized, not treated|1|||
44165802|NCT01659853|78958979|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
44165803|NCT01659853|78958980|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
44165804|NCT01659853|78958979|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
44165805|NCT01659853|78958980|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
44165806|NCT01660243|78958992|FG000|Overall Study|Adverse Event|1|||
44165807|NCT01660243|78958993|FG001|Overall Study|Adverse Event|0|||
44165808|NCT01660243|78958994|FG002|Overall Study|Adverse Event|1|||
44165809|NCT01660243|78958995|FG003|Overall Study|Adverse Event|0|||
44165810|NCT01660243|78958992|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
44165811|NCT01660243|78958993|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
44165812|NCT01660243|78958994|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
44165813|NCT01660243|78958995|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
44165814|NCT01660243|78958992|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
44165815|NCT01660243|78958993|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
44165816|NCT01660243|78958994|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
44165817|NCT01660243|78958995|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
44165818|NCT01660243|78958992|FG000|Overall Study|Randomization error|0|||
44165819|NCT01660243|78958993|FG001|Overall Study|Randomization error|0|||
44165820|NCT01660243|78958994|FG002|Overall Study|Randomization error|0|||
44165821|NCT01660243|78958995|FG003|Overall Study|Randomization error|1|||
44165822|NCT02531113|78959005|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
44165823|NCT02531113|78959005|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
44165824|NCT02531113|78959005|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
44165825|NCT02531113|78959005|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
44165826|NCT02531113|78959005|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
44165827|NCT02531113|78959005|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
44165828|NCT02531113|78959005|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
44165829|NCT02531113|78959005|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
44165830|NCT02522767|78959015|FG000|Double-blind|Withdrawal by Subject|8|||
44165831|NCT02522767|78959016|FG001|Double-blind|Withdrawal by Subject|11|||
44165832|NCT02522767|78959015|FG000|Double-blind|Lost to Follow-up|1|||
44165833|NCT02522767|78959016|FG001|Double-blind|Lost to Follow-up|0|||
44165834|NCT02522767|78959015|FG000|Double-blind|Adverse Event|1|||
44165835|NCT02522767|78959016|FG001|Double-blind|Adverse Event|10|||
44165836|NCT02522767|78959015|FG000|Double-blind|Protocol Violation|0|||
44165837|NCT02522767|78959016|FG001|Double-blind|Protocol Violation|1|||
44165838|NCT02522767|78959015|FG000|Double-blind|Lack of Efficacy|0|||
44165839|NCT02522767|78959016|FG001|Double-blind|Lack of Efficacy|2|||
44165840|NCT02522767|78959015|FG000|Double-blind|Protocol Deviation|1|||
44165841|NCT02522767|78959016|FG001|Double-blind|Protocol Deviation|0|||
44165842|NCT02522767|78959015|FG000|Open-label|Withdrawal by Subject|2|||
44165843|NCT02522767|78959016|FG001|Open-label|Withdrawal by Subject|3|||
44165844|NCT02522767|78959015|FG000|Open-label|Lost to Follow-up|0|||
44165845|NCT02522767|78959016|FG001|Open-label|Lost to Follow-up|1|||
44165846|NCT02522767|78959015|FG000|Open-label|Adverse Event|2|||
44165847|NCT02522767|78959016|FG001|Open-label|Adverse Event|1|||
44165848|NCT02522767|78959015|FG000|Open-label|Lack of Efficacy|1|||
44165849|NCT02522767|78959016|FG001|Open-label|Lack of Efficacy|1|||
44165850|NCT02522767|78959015|FG000|Open-label|Protocol Violation|0|||
44165851|NCT02522767|78959016|FG001|Open-label|Protocol Violation|1|||
44165852|NCT02522377|78959026|FG000|Overall Study|Withdrawal by Subject|1|||
44165853|NCT02522377|78959027|FG001|Overall Study|Withdrawal by Subject|0|||
44165854|NCT02522377|78959026|FG000|Overall Study|Remission Achieved|3|||
44165855|NCT02522377|78959027|FG001|Overall Study|Remission Achieved|0|||
44165856|NCT01657903|78959033|FG000|Overall Study|Lost to Follow-up|1|||
44165857|NCT01657903|78959033|FG000|Overall Study|Withdrawal by Subject|1|||
44165858|NCT01656733|78959046|FG000|Overall Study|No permission to collect birth outcomes|0|||
44165859|NCT01656733|78959047|FG001|Overall Study|No permission to collect birth outcomes|1|||
44165860|NCT01656733|78959046|FG000|Overall Study|Delivery at another hospital|0|||
44165861|NCT01656733|78959047|FG001|Overall Study|Delivery at another hospital|2|||
44165862|NCT01656733|78959046|FG000|Overall Study|Spontaneous abortion|0|||
44165863|NCT01656733|78959047|FG001|Overall Study|Spontaneous abortion|1|||
44165864|NCT01656967|78959055|FG000|Overall Study|faulty monitor|1|||
44165865|NCT01656967|78959056|FG001|Overall Study|faulty monitor|0|||
44165866|NCT01656967|78959055|FG000|Overall Study|unsuccessful ETT insertion|3|||
44165867|NCT01656967|78959056|FG001|Overall Study|unsuccessful ETT insertion|2|||
44165868|NCT01656889|78959068|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
44165869|NCT01656889|78959069|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
44165870|NCT01656889|78959068|FG000|Treatment Period, 12 Weeks|Death|0|||
44165871|NCT01656889|78959069|FG001|Treatment Period, 12 Weeks|Death|1|||
44165872|NCT01656889|78959068|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
44165873|NCT01656889|78959069|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
44165874|NCT01656889|78959068|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
44165875|NCT01656889|78959069|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
44165876|NCT01656889|78959068|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
44165877|NCT01656889|78959069|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
44165878|NCT01656889|78959068|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
44165879|NCT01656889|78959069|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
44165880|NCT01656889|78959068|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
44165881|NCT01656889|78959069|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
44165882|NCT01656889|78959068|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
44165883|NCT01656889|78959069|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
44165884|NCT01656889|78959068|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
44165885|NCT01656889|78959069|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
44165886|NCT01656889|78959068|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
44165887|NCT01656889|78959069|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
44165888|NCT02522299|78959077|FG000|Overall Study|Adverse Event|2|||
44165889|NCT02522299|78959078|FG001|Overall Study|Adverse Event|0|||
44165890|NCT02522299|78959077|FG000|Overall Study|Physician Decision|0|||
44165891|NCT02522299|78959078|FG001|Overall Study|Physician Decision|1|||
44165892|NCT02522299|78959077|FG000|Overall Study|Withdrawal by Subject|2|||
44165893|NCT02522299|78959078|FG001|Overall Study|Withdrawal by Subject|0|||
44165894|NCT01365091|78959102|FG000|Period 1|Adverse Event|1|||
44165895|NCT01365091|78959103|FG001|Period 1|Adverse Event|0|||
44165896|NCT01365091|78959104|FG002|Period 1|Adverse Event|2|||
44165897|NCT01365091|78959105|FG003|Period 1|Adverse Event|3|||
44165898|NCT01365091|78959102|FG000|Period 1|Positive test result for drugs of abuse|1|||
44165899|NCT01365091|78959103|FG001|Period 1|Positive test result for drugs of abuse|0|||
44165900|NCT01365091|78959104|FG002|Period 1|Positive test result for drugs of abuse|0|||
44165901|NCT01365091|78959105|FG003|Period 1|Positive test result for drugs of abuse|0|||
44165902|NCT01365091|78959102|FG000|Period 1|No longer met study criteria|0|||
44165903|NCT01365091|78959103|FG001|Period 1|No longer met study criteria|1|||
44165904|NCT01365091|78959104|FG002|Period 1|No longer met study criteria|0|||
44165905|NCT01365091|78959105|FG003|Period 1|No longer met study criteria|0|||
44165906|NCT01365091|78959102|FG000|Period 1|Withdrawal by Subject|0|||
44165907|NCT01365091|78959103|FG001|Period 1|Withdrawal by Subject|1|||
44165908|NCT01365091|78959104|FG002|Period 1|Withdrawal by Subject|0|||
44165909|NCT01365091|78959105|FG003|Period 1|Withdrawal by Subject|0|||
44165910|NCT01365091|78959102|FG000|Period 1|Personal reasons|0|||
44165911|NCT01365091|78959103|FG001|Period 1|Personal reasons|0|||
44165912|NCT01365091|78959104|FG002|Period 1|Personal reasons|1|||
44165913|NCT01365091|78959105|FG003|Period 1|Personal reasons|0|||
44165914|NCT01365091|78959102|FG000|Period 2|Withdrawal by Subject|1|||
44165915|NCT01365091|78959103|FG001|Period 2|Withdrawal by Subject|0|||
44165916|NCT01365091|78959104|FG002|Period 2|Withdrawal by Subject|0|||
44165917|NCT01365091|78959105|FG003|Period 2|Withdrawal by Subject|0|||
44165918|NCT01365091|78959102|FG000|Period 2|Adverse Event|0|||
44165919|NCT01365091|78959103|FG001|Period 2|Adverse Event|0|||
44165920|NCT01365091|78959104|FG002|Period 2|Adverse Event|1|||
44165921|NCT01365091|78959105|FG003|Period 2|Adverse Event|0|||
44165922|NCT01364467|78959131|FG000|Overall Study|Lost to Follow-up|1|||
44165923|NCT01364467|78959132|FG001|Overall Study|Lost to Follow-up|2|||
44165924|NCT02520661|78959140|FG000|Overall Study|Lost to Follow-up|7|||
44165925|NCT02520661|78959141|FG001|Overall Study|Lost to Follow-up|3|||
44165926|NCT02520661|78959140|FG000|Overall Study|Admitted from ED|49|||
44165927|NCT02520661|78959141|FG001|Overall Study|Admitted from ED|48|||
44165928|NCT02520661|78959140|FG000|Overall Study|ED greater than 24 hours|29|||
44165929|NCT02520661|78959141|FG001|Overall Study|ED greater than 24 hours|38|||
44165930|NCT02520661|78959140|FG000|Overall Study|other ineligibility|14|||
44165931|NCT02520661|78959141|FG001|Overall Study|other ineligibility|22|||
44165932|NCT02520661|78959140|FG000|Overall Study|Withdrawal by Subject|7|||
44165933|NCT02520661|78959141|FG001|Overall Study|Withdrawal by Subject|16|||
44165934|NCT01364389|78959154|FG000|Overall Study|Withdrawal by Subject|0|||
44165935|NCT01364389|78959155|FG001|Overall Study|Withdrawal by Subject|1|||
44165936|NCT01364389|78959156|FG002|Overall Study|Withdrawal by Subject|0|||
44165937|NCT01364389|78959154|FG000|Overall Study|Protocol deviation|0|||
44165938|NCT01364389|78959155|FG001|Overall Study|Protocol deviation|0|||
44165939|NCT01364389|78959156|FG002|Overall Study|Protocol deviation|1|||
44165940|NCT01364389|78959154|FG000|Overall Study|Administrative problems|1|||
44165941|NCT01364389|78959155|FG001|Overall Study|Administrative problems|0|||
44165942|NCT01364389|78959156|FG002|Overall Study|Administrative problems|0|||
44165943|NCT01364389|78959154|FG000|Overall Study|Adverse Event|1|||
44165944|NCT01364389|78959155|FG001|Overall Study|Adverse Event|0|||
44165945|NCT01364389|78959156|FG002|Overall Study|Adverse Event|0|||
44165946|NCT01364233|78959164|FG000|Overall Study|Lost to Follow-up|1|||
44165947|NCT02291289|78959172|FG000|Induction Treatment|Not Dosed|2|||
44165948|NCT02291289|78959173|FG001|Induction Treatment|Not Dosed|0|||
44165949|NCT02291289|78959174|FG002|Induction Treatment|Not Dosed|0|||
44165950|NCT02291289|78959175|FG003|Induction Treatment|Not Dosed|9|||
44165951|NCT02291289|78959176|FG004|Induction Treatment|Not Dosed|0|||
44165952|NCT02291289|78959177|FG005|Induction Treatment|Not Dosed|0|||
44165953|NCT02291289|78959178|FG006|Induction Treatment|Not Dosed|0|||
44165954|NCT02291289|78959179|FG007|Induction Treatment|Not Dosed|0|||
44165955|NCT02291289|78959180|FG008|Induction Treatment|Not Dosed|0|||
44165956|NCT02291289|78959181|FG009|Induction Treatment|Not Dosed|1|||
44165957|NCT02291289|78959182|FG010|Induction Treatment|Not Dosed|0|||
44165958|NCT02291289|78959183|FG011|Induction Treatment|Not Dosed|0|||
44165959|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165960|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165961|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165962|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165963|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
44165964|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
44165965|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165966|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165967|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165968|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
44165969|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
44165970|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
44165971|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
44165972|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
44165973|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
44165974|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
44165975|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
44165976|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
44165977|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
44165978|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
44165979|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
44165980|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
44165981|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
44165982|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
44165983|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Death|0|||
44165984|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Death|23|||
44165985|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Death|13|||
44165986|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Death|0|||
44165987|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Death|185|||
44165988|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Death|100|||
44165989|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Death|0|||
44165990|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Death|1|||
44165991|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Death|1|||
44165992|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Death|0|||
44165993|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Death|26|||
44165994|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Death|11|||
44165995|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Adverse Event|0|||
44165996|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Adverse Event|0|||
44165997|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Adverse Event|0|||
44165998|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Adverse Event|0|||
44165999|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Adverse Event|1|||
44166000|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Adverse Event|0|||
44166001|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Adverse Event|0|||
44166002|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Adverse Event|0|||
44166003|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Adverse Event|0|||
44166004|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Adverse Event|0|||
44166005|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Adverse Event|0|||
44166006|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Adverse Event|0|||
44166007|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166008|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166009|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166010|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166011|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
44166012|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
44166013|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166014|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
44166015|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166016|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
44166017|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
44166018|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
44166019|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Other|0|||
44166020|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Other|0|||
44166021|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Other|1|||
44166022|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Other|0|||
44166023|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Other|29|||
44166024|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Other|8|||
44166025|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Other|0|||
44166026|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Other|0|||
44166027|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Other|1|||
44166028|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Other|0|||
44166029|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Other|0|||
44166030|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Other|0|||
44166031|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Physician Decision|0|||
44166032|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Physician Decision|0|||
44166033|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Physician Decision|0|||
44166034|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Physician Decision|0|||
44166035|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Physician Decision|2|||
44166036|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Physician Decision|0|||
44166037|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Physician Decision|0|||
44166038|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Physician Decision|0|||
44166039|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Physician Decision|0|||
44166040|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Physician Decision|0|||
44166041|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Physician Decision|0|||
44166042|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Physician Decision|1|||
44166043|NCT02291289|78959172|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
44166044|NCT02291289|78959173|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
44166045|NCT02291289|78959174|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
44166046|NCT02291289|78959175|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
44166047|NCT02291289|78959176|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
44166048|NCT02291289|78959177|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
44166049|NCT02291289|78959178|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
44166050|NCT02291289|78959179|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
44166051|NCT02291289|78959180|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
44166052|NCT02291289|78959181|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
44166053|NCT02291289|78959182|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
44166054|NCT02291289|78959183|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
44166055|NCT02291289|78959172|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
44166056|NCT02291289|78959173|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
44166057|NCT02291289|78959174|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
44166058|NCT02291289|78959175|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
44166059|NCT02291289|78959176|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
44166060|NCT02291289|78959177|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
44166061|NCT02291289|78959178|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
44166062|NCT02291289|78959179|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
44166063|NCT02291289|78959180|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
44166064|NCT02291289|78959181|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
44166065|NCT02291289|78959182|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
44166066|NCT02291289|78959183|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
44166067|NCT02317575|78959208|FG000|Period 1|Difficulty with venous cannulation|0|||
44166068|NCT02317575|78959209|FG001|Period 1|Difficulty with venous cannulation|1|||
44166069|NCT02317575|78959210|FG002|Period 1|Difficulty with venous cannulation|0|||
44166070|NCT02317575|78959211|FG003|Period 1|Difficulty with venous cannulation|0|||
44166071|NCT02317575|78959212|FG004|Period 1|Difficulty with venous cannulation|0|||
44166072|NCT02317575|78959208|FG000|Period 1|Withdrawal by Subject|1|||
44166073|NCT02317575|78959209|FG001|Period 1|Withdrawal by Subject|0|||
44166074|NCT02317575|78959210|FG002|Period 1|Withdrawal by Subject|0|||
44166075|NCT02317575|78959211|FG003|Period 1|Withdrawal by Subject|0|||
44166076|NCT02317575|78959212|FG004|Period 1|Withdrawal by Subject|0|||
44166077|NCT02316717|78959233|FG000|Overall Study|Adverse Event|2|||
44166078|NCT02316717|78959234|FG001|Overall Study|Adverse Event|2|||
44166079|NCT02316717|78959235|FG002|Overall Study|Adverse Event|0|||
44166080|NCT02316717|78959233|FG000|Overall Study|Lost to Follow-up|1|||
44166081|NCT02316717|78959234|FG001|Overall Study|Lost to Follow-up|2|||
44166082|NCT02316717|78959235|FG002|Overall Study|Lost to Follow-up|1|||
44166083|NCT02316717|78959233|FG000|Overall Study|Non compliance|3|||
44166084|NCT02316717|78959234|FG001|Overall Study|Non compliance|1|||
44166085|NCT02316717|78959235|FG002|Overall Study|Non compliance|0|||
44166086|NCT02316717|78959233|FG000|Overall Study|Protocol Violation|2|||
44166087|NCT02316717|78959234|FG001|Overall Study|Protocol Violation|0|||
44166088|NCT02316717|78959235|FG002|Overall Study|Protocol Violation|0|||
44166089|NCT02316717|78959233|FG000|Overall Study|Withdrawal by Subject|2|||
44166090|NCT02316717|78959234|FG001|Overall Study|Withdrawal by Subject|1|||
44166091|NCT02316717|78959235|FG002|Overall Study|Withdrawal by Subject|1|||
44166092|NCT02316717|78959233|FG000|Overall Study|Death|0|||
44166093|NCT02316717|78959234|FG001|Overall Study|Death|0|||
44166094|NCT02316717|78959235|FG002|Overall Study|Death|1|||
44166095|NCT02316717|78959233|FG000|Overall Study|Physician Decision|0|||
44166096|NCT02316717|78959234|FG001|Overall Study|Physician Decision|1|||
44166097|NCT02316717|78959235|FG002|Overall Study|Physician Decision|0|||
44166098|NCT02316717|78959233|FG000|Overall Study|TBC|1|||
44166099|NCT02316717|78959234|FG001|Overall Study|TBC|0|||
44166100|NCT02316717|78959235|FG002|Overall Study|TBC|0|||
44166101|NCT02290821|78959248|FG000|Overall Study|Withdrawal by Subject|1|||
44166102|NCT02290821|78959249|FG001|Overall Study|Withdrawal by Subject|1|||
44166103|NCT02290821|78959248|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
44166104|NCT02290821|78959249|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
44166105|NCT02290821|78959248|FG000|Overall Study|Lost to Follow-up|3|||
44166106|NCT02290821|78959249|FG001|Overall Study|Lost to Follow-up|2|||
44166107|NCT02289963|78959257|FG000|Overall Study|Adverse Event|1|||
44166108|NCT02289963|78959258|FG001|Overall Study|Adverse Event|2|||
44166109|NCT02289963|78959257|FG000|Overall Study|Poor compliance to protocol|1|||
44166110|NCT02289963|78959258|FG001|Overall Study|Poor compliance to protocol|0|||
44166111|NCT02289963|78959257|FG000|Overall Study|Withdrawal by Subject|1|||
44166112|NCT02289963|78959258|FG001|Overall Study|Withdrawal by Subject|0|||
44166113|NCT02289963|78959257|FG000|Overall Study|Last injection missed|2|||
44166114|NCT02289963|78959258|FG001|Overall Study|Last injection missed|2|||
44166115|NCT02289963|78959257|FG000|Overall Study|End treatment visit outside visit window|0|||
44166116|NCT02289963|78959258|FG001|Overall Study|End treatment visit outside visit window|4|||
44166117|NCT02289963|78959257|FG000|Overall Study|Other than specified above|0|||
44166118|NCT02289963|78959258|FG001|Overall Study|Other than specified above|2|||
44166119|NCT02358369|78959267|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
44166120|NCT02358369|78959268|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
44166121|NCT02358369|78959269|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
44166122|NCT02358369|78959270|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
44166123|NCT02358369|78959271|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
44166124|NCT02358369|78959267|FG000|Treatment Period A/B|Adverse Event|0|||
44166125|NCT02358369|78959268|FG001|Treatment Period A/B|Adverse Event|0|||
44166126|NCT02358369|78959269|FG002|Treatment Period A/B|Adverse Event|1|||
44166127|NCT02358369|78959270|FG003|Treatment Period A/B|Adverse Event|2|||
44166128|NCT02358369|78959271|FG004|Treatment Period A/B|Adverse Event|0|||
44166129|NCT02358369|78959267|FG000|Treatment Period A/B|Death|0|||
44166130|NCT02358369|78959268|FG001|Treatment Period A/B|Death|0|||
44166131|NCT02358369|78959269|FG002|Treatment Period A/B|Death|1|||
44166132|NCT02358369|78959270|FG003|Treatment Period A/B|Death|0|||
44166133|NCT02358369|78959271|FG004|Treatment Period A/B|Death|0|||
44166134|NCT02358369|78959267|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
44166135|NCT02358369|78959268|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
44166136|NCT02358369|78959269|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
44166137|NCT02358369|78959270|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
44166138|NCT02358369|78959271|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
44166139|NCT02358369|78959267|FG000|Treatment Period C|Adverse Event|0|||
44166140|NCT02358369|78959268|FG001|Treatment Period C|Adverse Event|0|||
44166141|NCT02358369|78959269|FG002|Treatment Period C|Adverse Event|0|||
44166142|NCT02358369|78959270|FG003|Treatment Period C|Adverse Event|0|||
44166143|NCT02358369|78959271|FG004|Treatment Period C|Adverse Event|7|||
44166144|NCT02316171|78959283|FG000|Overall Study|difficulties with urinary catheter|1|||
44166145|NCT02316171|78959284|FG001|Overall Study|difficulties with urinary catheter|0|||
44166146|NCT02316171|78959285|FG002|Overall Study|difficulties with urinary catheter|0|||
44166147|NCT02316171|78959286|FG003|Overall Study|difficulties with urinary catheter|0|||
44166148|NCT02289729|78959292|FG000|Overall Study|Lack of Efficacy|3|||
44166149|NCT02289729|78959292|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
44166150|NCT02289729|78959292|FG000|Overall Study|Withdrawal by Subject|1|||
44166151|NCT02289729|78959292|FG000|Overall Study|Death|1|||
44166152|NCT02315625|78959298|FG000|First Intervention|Disease Progression|1|||
44166153|NCT02315625|78959299|FG001|First Intervention|Disease Progression|0|||
44166154|NCT02315625|78959298|FG000|Second Intervention|Physician Decision|2|||
44166155|NCT02315625|78959299|FG001|Second Intervention|Physician Decision|1|||
44166156|NCT02315625|78959298|FG000|Second Intervention|Study closure|1|||
44166157|NCT02315625|78959299|FG001|Second Intervention|Study closure|0|||
44166158|NCT02315625|78959298|FG000|Second Intervention|Disease Progression|1|||
44166159|NCT02315625|78959299|FG001|Second Intervention|Disease Progression|0|||
44166160|NCT02357979|78959309|FG000|Overall Study|Lost to Follow-up|5|||
44166161|NCT02357979|78959310|FG001|Overall Study|Lost to Follow-up|5|||
44166162|NCT02357901|78959319|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
44166163|NCT02357901|78959320|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
44166164|NCT02357901|78959321|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
44166165|NCT02357901|78959322|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
44166166|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
44166167|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
44166168|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
44166169|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
44166170|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
44347884|NCT02432274|79352405|FG004|Overall Study|Death|27|||
44166171|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
44166172|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
44166173|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
44166174|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
44166175|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
44166176|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
44166177|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
44166178|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
44166179|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
44166180|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
44166181|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
44166182|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
44166183|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
44166184|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
44166185|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
44166186|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
44166187|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
44166188|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
44166189|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
44166190|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
44166191|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
44166192|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
44166193|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
44166194|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
44166195|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
44166196|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
44166197|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
44166198|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
44166199|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
44166200|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
44166201|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
44166202|NCT02357901|78959319|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
44166203|NCT02357901|78959320|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
44166204|NCT02357901|78959321|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
44166205|NCT02357901|78959322|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
44166206|NCT01601847|78959332|FG000|Overall Study|Death|1|||
44166207|NCT01601847|78959333|FG001|Overall Study|Death|0|||
44166208|NCT01601847|78959332|FG000|Overall Study|Withdrawal by Subject|11|||
44166209|NCT01601847|78959333|FG001|Overall Study|Withdrawal by Subject|7|||
44166210|NCT01601847|78959332|FG000|Overall Study|Lost to Follow-up|1|||
44166211|NCT01601847|78959333|FG001|Overall Study|Lost to Follow-up|3|||
44166212|NCT02515669|78959343|FG000|228 Week Open-Label Phase|Other|0|||
44166213|NCT02515669|78959344|FG001|228 Week Open-Label Phase|Other|0|||
44166214|NCT02515669|78959345|FG002|228 Week Open-Label Phase|Other|1|||
44166215|NCT02515669|78959346|FG003|228 Week Open-Label Phase|Other|4|||
44166216|NCT02515669|78959343|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
44166217|NCT02515669|78959344|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
44166218|NCT02515669|78959345|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
44166219|NCT02515669|78959346|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
44166220|NCT02515669|78959343|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
44166221|NCT02515669|78959344|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
44166222|NCT02515669|78959345|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
44166223|NCT02515669|78959346|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
44166224|NCT02515669|78959343|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
44166225|NCT02515669|78959344|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
44166226|NCT02515669|78959345|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
44166227|NCT02515669|78959346|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
44166228|NCT02515669|78959343|FG000|228 Week Open-Label Phase|Missing|0|||
44166229|NCT02515669|78959344|FG001|228 Week Open-Label Phase|Missing|2|||
44166230|NCT02515669|78959345|FG002|228 Week Open-Label Phase|Missing|2|||
44166231|NCT02515669|78959346|FG003|228 Week Open-Label Phase|Missing|2|||
44166232|NCT02515279|78959376|FG000|Overall Study|Adverse Event|7|||
44166233|NCT02515279|78959376|FG000|Overall Study|Lack of Efficacy|31|||
44166234|NCT02515279|78959376|FG000|Overall Study|Lost to Follow-up|9|||
44166235|NCT02515279|78959376|FG000|Overall Study|Withdrawal by Subject|18|||
44166236|NCT02515279|78959376|FG000|Overall Study|End-of-treatment visit not attended|17|||
44166237|NCT02515279|78959376|FG000|Overall Study|Other|22|||
44166238|NCT02515045|78959382|FG000|Overall Study|Adverse Event|0|||
44166239|NCT02515045|78959383|FG001|Overall Study|Adverse Event|3|||
44166240|NCT02515045|78959384|FG002|Overall Study|Adverse Event|3|||
44166241|NCT02515045|78959382|FG000|Overall Study|Lost to Follow-up|0|||
44166242|NCT02515045|78959383|FG001|Overall Study|Lost to Follow-up|1|||
44166243|NCT02515045|78959384|FG002|Overall Study|Lost to Follow-up|1|||
44166244|NCT02514577|78959394|FG000|Overall Study|Lost to Follow-up|6|||
44166245|NCT02514577|78959395|FG001|Overall Study|Lost to Follow-up|6|||
44166246|NCT02514577|78959394|FG000|Overall Study|Protocol Violation|1|||
44166247|NCT02514577|78959395|FG001|Overall Study|Protocol Violation|0|||
44166248|NCT02514577|78959394|FG000|Overall Study|Withdrawal by Subject|6|||
44166249|NCT02514577|78959395|FG001|Overall Study|Withdrawal by Subject|6|||
44166250|NCT02514577|78959394|FG000|Overall Study|Adverse Event|1|||
44166251|NCT02514577|78959395|FG001|Overall Study|Adverse Event|1|||
44166252|NCT02513485|78959403|FG000|Overall Study|Adverse Event|1|||
44166253|NCT02513485|78959404|FG001|Overall Study|Adverse Event|0|||
44166254|NCT02289417|78959413|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
44166255|NCT02289417|78959414|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166256|NCT02289417|78959415|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
44166257|NCT02289417|78959416|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166258|NCT02289417|78959417|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166259|NCT02289417|78959418|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166260|NCT02289417|78959419|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166261|NCT02289417|78959420|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166262|NCT02289417|78959421|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
44166263|NCT02289417|78959413|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
44166264|NCT02289417|78959414|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
44166265|NCT02289417|78959415|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
44166266|NCT02289417|78959416|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
44166267|NCT02289417|78959417|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
44166268|NCT02289417|78959418|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
44166269|NCT02289417|78959419|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
44166270|NCT02289417|78959420|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
44166271|NCT02289417|78959421|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
44166272|NCT02289417|78959413|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166273|NCT02289417|78959414|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
44166274|NCT02289417|78959415|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166275|NCT02289417|78959416|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166276|NCT02289417|78959417|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166277|NCT02289417|78959418|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166278|NCT02289417|78959419|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166279|NCT02289417|78959420|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166280|NCT02289417|78959421|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
44166281|NCT02289417|78959413|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
44166282|NCT02289417|78959414|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166283|NCT02289417|78959415|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166284|NCT02289417|78959416|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166285|NCT02289417|78959417|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166286|NCT02289417|78959418|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166287|NCT02289417|78959419|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166288|NCT02289417|78959420|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166289|NCT02289417|78959421|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
44166290|NCT02289417|78959413|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
44166291|NCT02289417|78959414|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
44166292|NCT02289417|78959415|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
44166293|NCT02289417|78959416|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
44166294|NCT02289417|78959417|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
44166295|NCT02289417|78959418|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
44166296|NCT02289417|78959419|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
44166297|NCT02289417|78959420|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
44166298|NCT02289417|78959421|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
44166299|NCT02289417|78959413|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166300|NCT02289417|78959414|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166301|NCT02289417|78959415|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
44166302|NCT02289417|78959416|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166303|NCT02289417|78959417|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166304|NCT02289417|78959418|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166305|NCT02289417|78959419|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166306|NCT02289417|78959420|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166307|NCT02289417|78959421|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
44166308|NCT02289417|78959413|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
44166309|NCT02289417|78959414|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
44166310|NCT02289417|78959415|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
44166311|NCT02289417|78959416|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
44166312|NCT02289417|78959417|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
44166313|NCT02289417|78959418|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
44166314|NCT02289417|78959419|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
44166315|NCT02289417|78959420|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
44166316|NCT02289417|78959421|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
44166317|NCT02289417|78959413|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
44166318|NCT02289417|78959414|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
44166319|NCT02289417|78959415|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
44166320|NCT02289417|78959416|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
44166321|NCT02289417|78959417|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
44166322|NCT02289417|78959418|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
44166323|NCT02289417|78959419|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
44166324|NCT02289417|78959420|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
44166325|NCT02289417|78959421|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
44166326|NCT02289417|78959413|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166327|NCT02289417|78959414|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166328|NCT02289417|78959415|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166329|NCT02289417|78959416|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166330|NCT02289417|78959417|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166331|NCT02289417|78959418|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166332|NCT02289417|78959419|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
44166333|NCT02289417|78959420|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166334|NCT02289417|78959421|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
44166335|NCT02289417|78959413|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166336|NCT02289417|78959414|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166337|NCT02289417|78959415|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166338|NCT02289417|78959416|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
44166339|NCT02289417|78959417|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166340|NCT02289417|78959418|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166341|NCT02289417|78959419|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
44166342|NCT02289417|78959420|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166343|NCT02289417|78959421|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
44166344|NCT02289417|78959413|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
44166345|NCT02289417|78959414|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
44166346|NCT02289417|78959415|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
44166347|NCT02289417|78959416|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
44166348|NCT02289417|78959417|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
44166349|NCT02289417|78959418|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
44166350|NCT02289417|78959419|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
44166351|NCT02289417|78959420|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
44166352|NCT02289417|78959421|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
44166353|NCT02289417|78959413|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166354|NCT02289417|78959414|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166355|NCT02289417|78959415|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166356|NCT02289417|78959416|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166357|NCT02289417|78959417|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166358|NCT02289417|78959418|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166359|NCT02289417|78959419|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
44166360|NCT02289417|78959420|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
44166361|NCT02289417|78959421|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
44166362|NCT02289417|78959413|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166363|NCT02289417|78959414|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166364|NCT02289417|78959415|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166365|NCT02289417|78959416|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166366|NCT02289417|78959417|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166367|NCT02289417|78959418|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166368|NCT02289417|78959419|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
44166369|NCT02289417|78959420|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
44166370|NCT02289417|78959421|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
44347885|NCT02432274|79352406|FG005|Overall Study|Death|7|||
44347886|NCT02432274|79352407|FG006|Overall Study|Death|9|||
44347887|NCT02432274|79352408|FG007|Overall Study|Death|14|||
44347888|NCT02432274|79352401|FG000|Overall Study|Withdrawal of Consent|0|||
44347889|NCT02432274|79352402|FG001|Overall Study|Withdrawal of Consent|0|||
44347890|NCT02432274|79352403|FG002|Overall Study|Withdrawal of Consent|0|||
44347891|NCT02432274|79352404|FG003|Overall Study|Withdrawal of Consent|0|||
44347892|NCT02432274|79352405|FG004|Overall Study|Withdrawal of Consent|2|||
44347893|NCT02432274|79352406|FG005|Overall Study|Withdrawal of Consent|0|||
44347894|NCT02432274|79352407|FG006|Overall Study|Withdrawal of Consent|1|||
44347895|NCT02432274|79352408|FG007|Overall Study|Withdrawal of Consent|2|||
44347896|NCT02096588|79352444|FG000|Overall Study|Lack of Efficacy|2|||
44347897|NCT02096588|79352445|FG001|Overall Study|Lack of Efficacy|0|||
44347898|NCT02096588|79352444|FG000|Overall Study|Withdrawal by Subject|0|||
44347899|NCT02096588|79352445|FG001|Overall Study|Withdrawal by Subject|1|||
44347900|NCT01359592|79352451|FG000|Initial Registration|Adverse Event|1|||
44347901|NCT01359592|79352452|FG001|Initial Registration|Adverse Event|0|||
44347902|NCT01359592|79352453|FG002|Initial Registration|Adverse Event|0|||
44347903|NCT01359592|79352454|FG003|Initial Registration|Adverse Event|0|||
44347904|NCT01359592|79352451|FG000|Initial Registration|Death|1|||
44347905|NCT01359592|79352452|FG001|Initial Registration|Death|0|||
44347906|NCT01359592|79352453|FG002|Initial Registration|Death|0|||
44347907|NCT01359592|79352454|FG003|Initial Registration|Death|0|||
44347908|NCT01359592|79352451|FG000|Initial Registration|Other reason not protocol specified|1|||
44347909|NCT01359592|79352452|FG001|Initial Registration|Other reason not protocol specified|0|||
44347910|NCT01359592|79352453|FG002|Initial Registration|Other reason not protocol specified|0|||
44347911|NCT01359592|79352454|FG003|Initial Registration|Other reason not protocol specified|0|||
44347912|NCT01359592|79352451|FG000|Initial Registration|Ineligible|26|||
44347913|NCT01359592|79352452|FG001|Initial Registration|Ineligible|0|||
44347914|NCT01359592|79352453|FG002|Initial Registration|Ineligible|0|||
44347915|NCT01359592|79352454|FG003|Initial Registration|Ineligible|0|||
44347916|NCT01359592|79352451|FG000|PET-Directed Therapy|Adverse Event|0|||
44347917|NCT01359592|79352452|FG001|PET-Directed Therapy|Adverse Event|0|||
44347918|NCT01359592|79352453|FG002|PET-Directed Therapy|Adverse Event|1|||
44347919|NCT01359592|79352454|FG003|PET-Directed Therapy|Adverse Event|0|||
44347920|NCT01359592|79352451|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
44347921|NCT01359592|79352452|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
44347922|NCT01359592|79352453|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
44347923|NCT01359592|79352454|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
44347924|NCT01359592|79352451|FG000|PET-Directed Therapy|Ineligible|0|||
44347925|NCT01359592|79352452|FG001|PET-Directed Therapy|Ineligible|0|||
44347926|NCT01359592|79352453|FG002|PET-Directed Therapy|Ineligible|24|||
44347927|NCT01359592|79352454|FG003|PET-Directed Therapy|Ineligible|0|||
44347928|NCT00699816|79352471|FG000|Overall Study|Protocol Violation|1|||
44347929|NCT00699816|79352472|FG001|Overall Study|Protocol Violation|3|||
44347930|NCT00697073|79352478|FG000|Overall Study|Withdrawal by Subject|2|||
44347931|NCT00697073|79352478|FG000|Overall Study|Pregnancy|1|||
44347932|NCT00697073|79352478|FG000|Overall Study|non compliance and other|6|||
44347933|NCT00653432|79352484|FG000|Overall Study|Adverse Event|4|||
44347934|NCT00653432|79352485|FG001|Overall Study|Adverse Event|1|||
44347935|NCT00653432|79352484|FG000|Overall Study|Withdrawal by Subject|4|||
44347936|NCT00653432|79352485|FG001|Overall Study|Withdrawal by Subject|5|||
44347937|NCT00653432|79352484|FG000|Overall Study|Lost to Follow-up|7|||
44347938|NCT00653432|79352485|FG001|Overall Study|Lost to Follow-up|6|||
44446378|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
44347939|NCT00653432|79352484|FG000|Overall Study|Use/Need of Con Therapy|2|||
44347940|NCT00653432|79352485|FG001|Overall Study|Use/Need of Con Therapy|1|||
44347941|NCT00653432|79352484|FG000|Overall Study|Other - Reason Not Provided|5|||
44347942|NCT00653432|79352485|FG001|Overall Study|Other - Reason Not Provided|3|||
44347943|NCT00446043|79352504|FG000|Overall Study|Adverse Event|9|||
44347944|NCT00446043|79352504|FG000|Overall Study|Withdrawal by Subject|70|||
44347945|NCT00446043|79352504|FG000|Overall Study|Protocol Violation|2|||
44347946|NCT00446043|79352504|FG000|Overall Study|Lost to Follow-up|42|||
44347947|NCT00446043|79352504|FG000|Overall Study|Pregnancy|2|||
44347948|NCT00400725|79352511|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
44347949|NCT00400725|79352512|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
44446379|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
44166371|NCT02289417|78959413|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
44347950|NCT00400725|79352513|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
44347951|NCT00400725|79352511|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
44347952|NCT00400725|79352512|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
44347953|NCT00400725|79352513|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
44347954|NCT00400725|79352511|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
44347955|NCT00400725|79352512|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
44347956|NCT00400725|79352513|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
44347957|NCT00400725|79352511|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
44347958|NCT00400725|79352512|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
44347959|NCT00400725|79352513|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
44347960|NCT00400725|79352511|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
44347961|NCT00400725|79352512|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
44347962|NCT00400725|79352513|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
44347963|NCT00400725|79352511|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
44347964|NCT00400725|79352512|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
44347965|NCT00400725|79352513|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
44347966|NCT00400725|79352511|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
44347967|NCT00400725|79352512|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
44347968|NCT00400725|79352513|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
44347969|NCT00400725|79352511|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
44347970|NCT00400725|79352512|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
44347971|NCT00400725|79352513|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
44347972|NCT00400725|79352511|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
44347973|NCT00400725|79352512|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
44347974|NCT00400725|79352513|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
44347975|NCT00932113|79352529|FG000|Overall Study|Lost to Follow-up|1|||
44347976|NCT00932113|79352530|FG001|Overall Study|Lost to Follow-up|0|||
44347977|NCT00931801|79352539|FG000|Overall Study|Adverse Event|0|||
44347978|NCT00931801|79352540|FG001|Overall Study|Adverse Event|0|||
44347979|NCT00931801|79352541|FG002|Overall Study|Adverse Event|1|||
44347980|NCT00931801|79352539|FG000|Overall Study|Lost to Follow-up|0|||
44347981|NCT00931801|79352540|FG001|Overall Study|Lost to Follow-up|1|||
44347982|NCT00931801|79352541|FG002|Overall Study|Lost to Follow-up|0|||
44347983|NCT00931801|79352539|FG000|Overall Study|Withdrawal by Subject|1|||
44347984|NCT00931801|79352540|FG001|Overall Study|Withdrawal by Subject|0|||
44347985|NCT00931801|79352541|FG002|Overall Study|Withdrawal by Subject|0|||
44347986|NCT00931801|79352539|FG000|Overall Study|Confirmed Virologic Failure|0|||
44347987|NCT00931801|79352540|FG001|Overall Study|Confirmed Virologic Failure|0|||
44347988|NCT00931801|79352541|FG002|Overall Study|Confirmed Virologic Failure|3|||
44347989|NCT00931723|79352555|FG000|Overall Study|Withdrawal by Subject|11|||
44347990|NCT00931723|79352556|FG001|Overall Study|Withdrawal by Subject|13|||
44347991|NCT00931723|79352555|FG000|Overall Study|Adverse Event|6|||
44347992|NCT00931723|79352556|FG001|Overall Study|Adverse Event|13|||
44347993|NCT00931723|79352555|FG000|Overall Study|Lithium found in blood|0|||
44347994|NCT00931723|79352556|FG001|Overall Study|Lithium found in blood|1|||
44347995|NCT00931723|79352555|FG000|Overall Study|Condition under investigation worsened|1|||
44347996|NCT00931723|79352556|FG001|Overall Study|Condition under investigation worsened|2|||
44347997|NCT00931723|79352555|FG000|Overall Study|Lost to Follow-up|1|||
44347998|NCT00931723|79352556|FG001|Overall Study|Lost to Follow-up|2|||
44347999|NCT00931723|79352555|FG000|Overall Study|Study-specific discontinuation criteria|1|||
44348000|NCT00931723|79352556|FG001|Overall Study|Study-specific discontinuation criteria|1|||
44348001|NCT00931723|79352555|FG000|Overall Study|Severe non-compliance to protocol|2|||
44348002|NCT00931723|79352556|FG001|Overall Study|Severe non-compliance to protocol|0|||
44348003|NCT00931723|79352555|FG000|Overall Study|Safety reasons|0|||
44348004|NCT00931723|79352556|FG001|Overall Study|Safety reasons|1|||
44348005|NCT00931723|79352555|FG000|Overall Study|Took prohibited concomitant medication|0|||
44348006|NCT00931723|79352556|FG001|Overall Study|Took prohibited concomitant medication|1|||
44348007|NCT00931723|79352555|FG000|Overall Study|Lack or insufficient theraputic response|2|||
44348008|NCT00931723|79352556|FG001|Overall Study|Lack or insufficient theraputic response|5|||
44348009|NCT00931723|79352555|FG000|Overall Study|Sponsor decision|1|||
44348010|NCT00931723|79352556|FG001|Overall Study|Sponsor decision|0|||
44348011|NCT00931723|79352555|FG000|Overall Study|Late hospital discharge|1|||
44348012|NCT00931723|79352556|FG001|Overall Study|Late hospital discharge|0|||
44348013|NCT00931411|79352564|FG000|First Intervention - 42 Days|Adverse Event|2|||
44166372|NCT02289417|78959414|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
44348014|NCT00931411|79352565|FG001|First Intervention - 42 Days|Adverse Event|3|||
44348015|NCT00931411|79352564|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
44348016|NCT00931411|79352565|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
44348017|NCT00931411|79352564|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
44348018|NCT00931411|79352565|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
44348019|NCT00931255|79352577|FG000|Overall Study|Follow up biopsy not done|2|||
44166373|NCT02289417|78959415|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
44348020|NCT00931255|79352578|FG001|Overall Study|Follow up biopsy not done|3|||
44348021|NCT00930553|79352584|FG000|Overall Study|Adverse Event|1|||
44348022|NCT00930553|79352584|FG000|Overall Study|Lack of Efficacy|7|||
44348023|NCT00930553|79352584|FG000|Overall Study|Physician Decision|39|||
44348024|NCT00930553|79352584|FG000|Overall Study|Protocol Violation|1|||
44348025|NCT00930553|79352584|FG000|Overall Study|Pregnancy|1|||
44348026|NCT00930553|79352584|FG000|Overall Study|Withdrawal by Subject|88|||
44348027|NCT00930553|79352584|FG000|Overall Study|Lost to Follow-up|25|||
44348028|NCT00930553|79352584|FG000|Overall Study|Death|9|||
44348029|NCT00930553|79352584|FG000|Overall Study|Study terminated by sponsor|24|||
44348030|NCT00930553|79352584|FG000|Overall Study|Other than specified above|28|||
44348031|NCT00929695|79352608|FG000|Overall Study|Death|2|||
44348032|NCT00929695|79352609|FG001|Overall Study|Death|1|||
44348033|NCT00929695|79352608|FG000|Overall Study|Withdrawal by Subject|0|||
44348034|NCT00929695|79352609|FG001|Overall Study|Withdrawal by Subject|2|||
44348035|NCT00929695|79352608|FG000|Overall Study|discharge home|4|||
44348036|NCT00929695|79352609|FG001|Overall Study|discharge home|3|||
44348037|NCT00929695|79352608|FG000|Overall Study|incorrect stratification|2|||
44348038|NCT00929695|79352609|FG001|Overall Study|incorrect stratification|0|||
44348039|NCT00927355|79352622|FG000|Overall Study|Adverse Event|1|||
44348040|NCT00927355|79352623|FG001|Overall Study|Adverse Event|1|||
44348041|NCT00923845|79352643|FG000|Induction Therapy|Poor performance status|0|||
44348042|NCT00923845|79352644|FG001|Induction Therapy|Poor performance status|2|||
44348043|NCT00922987|79352651|FG000|Overall Study|Insufficient clinical response|1|||
44348044|NCT00922987|79352651|FG000|Overall Study|Protocol Violation|2|||
44348045|NCT00922987|79352651|FG000|Overall Study|Adverse Event|1|||
44348046|NCT00928135|79352657|FG000|Overall Study|Withdrawal by Subject|1|||
44348047|NCT00928135|79352658|FG001|Overall Study|Withdrawal by Subject|0|||
44348048|NCT00928057|79352666|FG000|Overall Study|Adverse Event|1|||
44348049|NCT00928057|79352667|FG001|Overall Study|Adverse Event|2|||
44348050|NCT00928057|79352666|FG000|Overall Study|Withdrawal by Subject|1|||
44348051|NCT00928057|79352667|FG001|Overall Study|Withdrawal by Subject|0|||
44348052|NCT00928057|79352666|FG000|Overall Study|Lost to Follow-up|0|||
44348053|NCT00928057|79352667|FG001|Overall Study|Lost to Follow-up|1|||
44348054|NCT00928057|79352666|FG000|Overall Study|Protocol Violation|0|||
44348055|NCT00928057|79352667|FG001|Overall Study|Protocol Violation|1|||
44348056|NCT00927901|79352683|FG000|Treatment Period 1|Subject withdrew consent|0|||
44446380|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
44446381|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
44446382|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
44446383|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
44446384|NCT00506415|79454666|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
44446385|NCT00506415|79454667|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
44446386|NCT00506415|79454668|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
44446387|NCT00506415|79454669|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
44446388|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
44446389|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
44446390|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
44446391|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
44446392|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
44446393|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
44446394|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
44446395|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
44446396|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
44446397|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
44446398|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
44446399|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
44446400|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
44446401|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
44446402|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
44446403|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
44446404|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
44446405|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
44446406|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
44348057|NCT00927901|79352684|FG001|Treatment Period 1|Subject withdrew consent|0|||
44348058|NCT00927901|79352685|FG002|Treatment Period 1|Subject withdrew consent|1|||
44348059|NCT00927901|79352686|FG003|Treatment Period 1|Subject withdrew consent|0|||
44348060|NCT00927901|79352683|FG000|Treatment Period 4|Adverse Event|0|||
44348061|NCT00927901|79352684|FG001|Treatment Period 4|Adverse Event|0|||
44348062|NCT00927901|79352685|FG002|Treatment Period 4|Adverse Event|0|||
44348063|NCT00927901|79352686|FG003|Treatment Period 4|Adverse Event|1|||
44348064|NCT00927901|79352683|FG000|Treatment Period 4|Subject withdrew consent|0|||
44348065|NCT00927901|79352684|FG001|Treatment Period 4|Subject withdrew consent|0|||
44348066|NCT00927901|79352685|FG002|Treatment Period 4|Subject withdrew consent|1|||
44348067|NCT00927901|79352686|FG003|Treatment Period 4|Subject withdrew consent|0|||
44348068|NCT01218204|79352701|FG000|Part B Washout|Adverse Event|0|||
44348069|NCT01218204|79352702|FG001|Part B Washout|Adverse Event|1|||
44348070|NCT01218204|79352703|FG002|Part B Washout|Adverse Event|0|||
44348071|NCT01218204|79352704|FG003|Part B Washout|Adverse Event|0|||
44348072|NCT01218204|79352701|FG000|Part B Washout|Lost to Follow-up|0|||
44348073|NCT01218204|79352702|FG001|Part B Washout|Lost to Follow-up|2|||
44348074|NCT01218204|79352703|FG002|Part B Washout|Lost to Follow-up|0|||
44348075|NCT01218204|79352704|FG003|Part B Washout|Lost to Follow-up|0|||
44348076|NCT01218204|79352701|FG000|Part B Washout|Physician Decision|0|||
44348077|NCT01218204|79352702|FG001|Part B Washout|Physician Decision|14|||
44348078|NCT01218204|79352703|FG002|Part B Washout|Physician Decision|0|||
44348079|NCT01218204|79352704|FG003|Part B Washout|Physician Decision|0|||
44348080|NCT01218204|79352701|FG000|Part B Washout|Withdrawal by Subject|0|||
44348081|NCT01218204|79352702|FG001|Part B Washout|Withdrawal by Subject|14|||
44348082|NCT01218204|79352703|FG002|Part B Washout|Withdrawal by Subject|0|||
44348083|NCT01218204|79352704|FG003|Part B Washout|Withdrawal by Subject|0|||
44348084|NCT01218204|79352701|FG000|Part B Washout|Reached defined stopping criteria|0|||
44348085|NCT01218204|79352702|FG001|Part B Washout|Reached defined stopping criteria|2|||
44348086|NCT01218204|79352703|FG002|Part B Washout|Reached defined stopping criteria|0|||
44348087|NCT01218204|79352704|FG003|Part B Washout|Reached defined stopping criteria|0|||
44348088|NCT01218204|79352701|FG000|Part B Washout|Did not meet continuation criteria|0|||
44348089|NCT01218204|79352702|FG001|Part B Washout|Did not meet continuation criteria|112|||
44348090|NCT01218204|79352703|FG002|Part B Washout|Did not meet continuation criteria|0|||
44348091|NCT01218204|79352704|FG003|Part B Washout|Did not meet continuation criteria|0|||
44348092|NCT01218204|79352701|FG000|Part B Run-in|Adverse Event|0|||
44348093|NCT01218204|79352702|FG001|Part B Run-in|Adverse Event|0|||
44348094|NCT01218204|79352703|FG002|Part B Run-in|Adverse Event|1|||
44348095|NCT01218204|79352704|FG003|Part B Run-in|Adverse Event|0|||
44348096|NCT01218204|79352701|FG000|Part B Run-in|Protocol Violation|0|||
44348097|NCT01218204|79352702|FG001|Part B Run-in|Protocol Violation|0|||
44348098|NCT01218204|79352703|FG002|Part B Run-in|Protocol Violation|2|||
44348099|NCT01218204|79352704|FG003|Part B Run-in|Protocol Violation|0|||
44348100|NCT01218204|79352701|FG000|Part B Run-in|Withdrawal by Subject|0|||
44348101|NCT01218204|79352702|FG001|Part B Run-in|Withdrawal by Subject|0|||
44348102|NCT01218204|79352703|FG002|Part B Run-in|Withdrawal by Subject|3|||
44348103|NCT01218204|79352704|FG003|Part B Run-in|Withdrawal by Subject|0|||
44348104|NCT01218204|79352701|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
44348105|NCT01218204|79352702|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
44348106|NCT01218204|79352703|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
44348107|NCT01218204|79352704|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
44348108|NCT01218204|79352701|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
44348109|NCT01218204|79352702|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
44348110|NCT01218204|79352703|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
44348111|NCT01218204|79352704|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
44348112|NCT00926575|79352753|FG000|Overall Study|Adverse Event|1|||
44348113|NCT00926575|79352754|FG001|Overall Study|Adverse Event|1|||
44348114|NCT00926575|79352753|FG000|Overall Study|Death|4|||
44348115|NCT00926575|79352754|FG001|Overall Study|Death|4|||
44348116|NCT00926575|79352753|FG000|Overall Study|Lost to Follow-up|1|||
44348117|NCT00926575|79352754|FG001|Overall Study|Lost to Follow-up|1|||
44348118|NCT00926575|79352753|FG000|Overall Study|Physician Decision|1|||
44348119|NCT00926575|79352754|FG001|Overall Study|Physician Decision|2|||
44348120|NCT00926575|79352753|FG000|Overall Study|Protocol Violation|1|||
44348121|NCT00926575|79352754|FG001|Overall Study|Protocol Violation|0|||
44348122|NCT00926575|79352753|FG000|Overall Study|Withdrawal by Subject|8|||
44348123|NCT00926575|79352754|FG001|Overall Study|Withdrawal by Subject|9|||
44348124|NCT01218126|79352764|FG000|Overall Study|Adverse Event|8|||
44348125|NCT01218126|79352765|FG001|Overall Study|Adverse Event|10|||
44348126|NCT01218126|79352766|FG002|Overall Study|Adverse Event|12|||
44348127|NCT01218126|79352767|FG003|Overall Study|Adverse Event|16|||
44348128|NCT01218126|79352764|FG000|Overall Study|Lack of Efficacy|7|||
44348129|NCT01218126|79352765|FG001|Overall Study|Lack of Efficacy|2|||
44348130|NCT01218126|79352766|FG002|Overall Study|Lack of Efficacy|2|||
44446407|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
44348131|NCT01218126|79352767|FG003|Overall Study|Lack of Efficacy|6|||
44348132|NCT01218126|79352764|FG000|Overall Study|Protocol Violation|5|||
44348133|NCT01218126|79352765|FG001|Overall Study|Protocol Violation|2|||
44348134|NCT01218126|79352766|FG002|Overall Study|Protocol Violation|2|||
44348135|NCT01218126|79352767|FG003|Overall Study|Protocol Violation|3|||
44348136|NCT01218126|79352764|FG000|Overall Study|Protocol-defined stopping criteria|1|||
44348137|NCT01218126|79352765|FG001|Overall Study|Protocol-defined stopping criteria|1|||
44348138|NCT01218126|79352766|FG002|Overall Study|Protocol-defined stopping criteria|0|||
44348139|NCT01218126|79352767|FG003|Overall Study|Protocol-defined stopping criteria|0|||
44348140|NCT01218126|79352764|FG000|Overall Study|Lost to Follow-up|0|||
44348141|NCT01218126|79352765|FG001|Overall Study|Lost to Follow-up|0|||
44348142|NCT01218126|79352766|FG002|Overall Study|Lost to Follow-up|0|||
44348143|NCT01218126|79352767|FG003|Overall Study|Lost to Follow-up|2|||
44348144|NCT01218126|79352764|FG000|Overall Study|Physician Decision|1|||
44348145|NCT01218126|79352765|FG001|Overall Study|Physician Decision|2|||
44348146|NCT01218126|79352766|FG002|Overall Study|Physician Decision|4|||
44348147|NCT01218126|79352767|FG003|Overall Study|Physician Decision|2|||
44348148|NCT01218126|79352764|FG000|Overall Study|Withdrawal by Subject|2|||
44348149|NCT01218126|79352765|FG001|Overall Study|Withdrawal by Subject|5|||
44348150|NCT01218126|79352766|FG002|Overall Study|Withdrawal by Subject|4|||
44348151|NCT01218126|79352767|FG003|Overall Study|Withdrawal by Subject|6|||
44348152|NCT01217892|79352781|FG000|Overall Study|Adverse Event|1|||
44348153|NCT01217892|79352782|FG001|Overall Study|Adverse Event|1|||
44348154|NCT01217892|79352783|FG002|Overall Study|Adverse Event|1|||
44348155|NCT01217892|79352784|FG003|Overall Study|Adverse Event|0|||
44348156|NCT01217892|79352781|FG000|Overall Study|Withdrawal by Subject|0|||
44348157|NCT01217892|79352782|FG001|Overall Study|Withdrawal by Subject|2|||
44348158|NCT01217892|79352783|FG002|Overall Study|Withdrawal by Subject|1|||
44348159|NCT01217892|79352784|FG003|Overall Study|Withdrawal by Subject|0|||
44348160|NCT01217892|79352781|FG000|Overall Study|Lab value|1|||
44348161|NCT01217892|79352782|FG001|Overall Study|Lab value|0|||
44348162|NCT01217892|79352783|FG002|Overall Study|Lab value|1|||
44348163|NCT01217892|79352784|FG003|Overall Study|Lab value|0|||
44348164|NCT01217892|79352781|FG000|Overall Study|Subject no longer meets study criteria|5|||
44348165|NCT01217892|79352782|FG001|Overall Study|Subject no longer meets study criteria|2|||
44348166|NCT01217892|79352783|FG002|Overall Study|Subject no longer meets study criteria|4|||
44348167|NCT01217892|79352784|FG003|Overall Study|Subject no longer meets study criteria|8|||
44348168|NCT01217892|79352781|FG000|Overall Study|Incorrect enrollment|0|||
44348169|NCT01217892|79352782|FG001|Overall Study|Incorrect enrollment|1|||
44348170|NCT01217892|79352783|FG002|Overall Study|Incorrect enrollment|1|||
44348171|NCT01217892|79352784|FG003|Overall Study|Incorrect enrollment|0|||
44348172|NCT01217892|79352781|FG000|Overall Study|Poor/Non-Compliance|0|||
44348173|NCT01217892|79352782|FG001|Overall Study|Poor/Non-Compliance|0|||
44348174|NCT01217892|79352783|FG002|Overall Study|Poor/Non-Compliance|1|||
44348175|NCT01217892|79352784|FG003|Overall Study|Poor/Non-Compliance|0|||
44348176|NCT01217814|79352797|FG000|Overall Study|Adverse Event|1|||
44348177|NCT01217814|79352798|FG001|Overall Study|Adverse Event|1|||
44348178|NCT01217814|79352799|FG002|Overall Study|Adverse Event|0|||
44348179|NCT01217814|79352797|FG000|Overall Study|Lack of Efficacy|0|||
44348180|NCT01217814|79352798|FG001|Overall Study|Lack of Efficacy|0|||
44348181|NCT01217814|79352799|FG002|Overall Study|Lack of Efficacy|1|||
44348182|NCT01217190|79352810|FG000|Second Dosing|Withdrawal by Subject|0|||
44348183|NCT01217190|79352811|FG001|Second Dosing|Withdrawal by Subject|2|||
44348184|NCT01136733|79352827|FG000|Phase 1b|Adverse Event|0|||
44348185|NCT01136733|79352828|FG001|Phase 1b|Adverse Event|3|||
44348186|NCT01136733|79352829|FG002|Phase 1b|Adverse Event|1|||
44348187|NCT01136733|79352830|FG003|Phase 1b|Adverse Event|0|||
44348188|NCT01136733|79352831|FG004|Phase 1b|Adverse Event|0|||
44348189|NCT01136733|79352832|FG005|Phase 1b|Adverse Event|0|||
44348190|NCT01136733|79352833|FG006|Phase 1b|Adverse Event|0|||
44348191|NCT01136733|79352827|FG000|Phase 1b|Participant Choice|0|||
44348192|NCT01136733|79352828|FG001|Phase 1b|Participant Choice|0|||
44348193|NCT01136733|79352829|FG002|Phase 1b|Participant Choice|1|||
44348194|NCT01136733|79352830|FG003|Phase 1b|Participant Choice|0|||
44348195|NCT01136733|79352831|FG004|Phase 1b|Participant Choice|0|||
44348196|NCT01136733|79352832|FG005|Phase 1b|Participant Choice|0|||
44348197|NCT01136733|79352833|FG006|Phase 1b|Participant Choice|0|||
44348198|NCT01136733|79352827|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
44348199|NCT01136733|79352828|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
44348200|NCT01136733|79352829|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
44348201|NCT01136733|79352830|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
44348202|NCT01136733|79352831|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
44348203|NCT01136733|79352832|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
44348204|NCT01136733|79352833|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
44348205|NCT01136733|79352827|FG000|Phase 1b|Clinical Progression|1|||
44348206|NCT01136733|79352828|FG001|Phase 1b|Clinical Progression|1|||
44348207|NCT01136733|79352829|FG002|Phase 1b|Clinical Progression|0|||
44348208|NCT01136733|79352830|FG003|Phase 1b|Clinical Progression|0|||
44348209|NCT01136733|79352831|FG004|Phase 1b|Clinical Progression|0|||
44348210|NCT01136733|79352832|FG005|Phase 1b|Clinical Progression|0|||
44348211|NCT01136733|79352833|FG006|Phase 1b|Clinical Progression|0|||
44348212|NCT01136733|79352827|FG000|Phase 2|Disease Progression|0|||
44348213|NCT01136733|79352828|FG001|Phase 2|Disease Progression|0|||
44348214|NCT01136733|79352829|FG002|Phase 2|Disease Progression|0|||
44348215|NCT01136733|79352830|FG003|Phase 2|Disease Progression|0|||
44348216|NCT01136733|79352831|FG004|Phase 2|Disease Progression|30|||
44348217|NCT01136733|79352832|FG005|Phase 2|Disease Progression|32|||
44348218|NCT01136733|79352833|FG006|Phase 2|Disease Progression|38|||
44348219|NCT01136733|79352827|FG000|Phase 2|Adverse Event|0|||
44348220|NCT01136733|79352828|FG001|Phase 2|Adverse Event|0|||
44348221|NCT01136733|79352829|FG002|Phase 2|Adverse Event|0|||
44348222|NCT01136733|79352830|FG003|Phase 2|Adverse Event|0|||
44348223|NCT01136733|79352831|FG004|Phase 2|Adverse Event|11|||
44348224|NCT01136733|79352832|FG005|Phase 2|Adverse Event|13|||
44348225|NCT01136733|79352833|FG006|Phase 2|Adverse Event|5|||
44348226|NCT01136733|79352827|FG000|Phase 2|Participant Choice|0|||
44348227|NCT01136733|79352828|FG001|Phase 2|Participant Choice|0|||
44348228|NCT01136733|79352829|FG002|Phase 2|Participant Choice|0|||
44348229|NCT01136733|79352830|FG003|Phase 2|Participant Choice|0|||
44348230|NCT01136733|79352831|FG004|Phase 2|Participant Choice|3|||
44348231|NCT01136733|79352832|FG005|Phase 2|Participant Choice|0|||
44348232|NCT01136733|79352833|FG006|Phase 2|Participant Choice|1|||
44348233|NCT01136733|79352827|FG000|Phase 2|Administrative-Withdrew Consent|0|||
44348234|NCT01136733|79352828|FG001|Phase 2|Administrative-Withdrew Consent|0|||
44348235|NCT01136733|79352829|FG002|Phase 2|Administrative-Withdrew Consent|0|||
44348236|NCT01136733|79352830|FG003|Phase 2|Administrative-Withdrew Consent|0|||
44348237|NCT01136733|79352831|FG004|Phase 2|Administrative-Withdrew Consent|1|||
44348238|NCT01136733|79352832|FG005|Phase 2|Administrative-Withdrew Consent|0|||
44348239|NCT01136733|79352833|FG006|Phase 2|Administrative-Withdrew Consent|0|||
44348240|NCT01136733|79352827|FG000|Phase 2|Other|0|||
44348241|NCT01136733|79352828|FG001|Phase 2|Other|0|||
44348242|NCT01136733|79352829|FG002|Phase 2|Other|0|||
44348243|NCT01136733|79352830|FG003|Phase 2|Other|0|||
44348244|NCT01136733|79352831|FG004|Phase 2|Other|6|||
44348245|NCT01136733|79352832|FG005|Phase 2|Other|7|||
44348246|NCT01136733|79352833|FG006|Phase 2|Other|6|||
44348247|NCT01136655|79352863|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
44348248|NCT01136655|79352863|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
44348249|NCT01136655|79352863|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
44348250|NCT01136655|79352863|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
44348251|NCT01135017|79352878|FG000|Overall Study|Adverse Event|3|||
44348252|NCT01135017|79352879|FG001|Overall Study|Adverse Event|8|||
44348253|NCT01135017|79352878|FG000|Overall Study|Other than above|3|||
44348254|NCT01135017|79352879|FG001|Overall Study|Other than above|4|||
44348255|NCT01134939|79352893|FG000|Overall Study|Adverse Event|9|||
44348256|NCT01134939|79352894|FG001|Overall Study|Adverse Event|3|||
44348257|NCT01134939|79352895|FG002|Overall Study|Adverse Event|4|||
44348258|NCT01134939|79352896|FG003|Overall Study|Adverse Event|5|||
44348259|NCT01134939|79352897|FG004|Overall Study|Adverse Event|5|||
44348260|NCT01134939|79352898|FG005|Overall Study|Adverse Event|5|||
44348261|NCT01134939|79352899|FG006|Overall Study|Adverse Event|1|||
44348262|NCT01134939|79352900|FG007|Overall Study|Adverse Event|0|||
44348263|NCT01134939|79352893|FG000|Overall Study|Lack of Efficacy|2|||
44348264|NCT01134939|79352894|FG001|Overall Study|Lack of Efficacy|5|||
44348265|NCT01134939|79352895|FG002|Overall Study|Lack of Efficacy|1|||
44348266|NCT01134939|79352896|FG003|Overall Study|Lack of Efficacy|0|||
44348267|NCT01134939|79352897|FG004|Overall Study|Lack of Efficacy|3|||
44348268|NCT01134939|79352898|FG005|Overall Study|Lack of Efficacy|0|||
44348269|NCT01134939|79352899|FG006|Overall Study|Lack of Efficacy|1|||
44348270|NCT01134939|79352900|FG007|Overall Study|Lack of Efficacy|0|||
44348271|NCT01134939|79352893|FG000|Overall Study|Lost to Follow-up|2|||
44348272|NCT01134939|79352894|FG001|Overall Study|Lost to Follow-up|3|||
44348273|NCT01134939|79352895|FG002|Overall Study|Lost to Follow-up|0|||
44348274|NCT01134939|79352896|FG003|Overall Study|Lost to Follow-up|1|||
44348275|NCT01134939|79352897|FG004|Overall Study|Lost to Follow-up|2|||
44348276|NCT01134939|79352898|FG005|Overall Study|Lost to Follow-up|1|||
44348277|NCT01134939|79352899|FG006|Overall Study|Lost to Follow-up|0|||
44348278|NCT01134939|79352900|FG007|Overall Study|Lost to Follow-up|0|||
44348279|NCT01134939|79352893|FG000|Overall Study|Death|0|||
44348280|NCT01134939|79352894|FG001|Overall Study|Death|1|||
44348281|NCT01134939|79352895|FG002|Overall Study|Death|0|||
44348282|NCT01134939|79352896|FG003|Overall Study|Death|0|||
44348283|NCT01134939|79352897|FG004|Overall Study|Death|0|||
44348284|NCT01134939|79352898|FG005|Overall Study|Death|0|||
44348285|NCT01134939|79352899|FG006|Overall Study|Death|0|||
44348286|NCT01134939|79352900|FG007|Overall Study|Death|0|||
44348287|NCT01134939|79352893|FG000|Overall Study|Termination page not available|4|||
44348288|NCT01134939|79352894|FG001|Overall Study|Termination page not available|6|||
44348289|NCT01134939|79352895|FG002|Overall Study|Termination page not available|5|||
44348290|NCT01134939|79352896|FG003|Overall Study|Termination page not available|8|||
44348291|NCT01134939|79352897|FG004|Overall Study|Termination page not available|0|||
44348292|NCT01134939|79352898|FG005|Overall Study|Termination page not available|3|||
44446408|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
44446409|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
44348293|NCT01134939|79352899|FG006|Overall Study|Termination page not available|7|||
44348294|NCT01134939|79352900|FG007|Overall Study|Termination page not available|0|||
44348295|NCT01134783|79352916|FG000|Overall Study|Pregnancy|16|||
44348296|NCT01134783|79352917|FG001|Overall Study|Pregnancy|8|||
44348297|NCT01134783|79352916|FG000|Overall Study|Withdrawal by Subject|15|||
44348298|NCT01134783|79352917|FG001|Overall Study|Withdrawal by Subject|9|||
44348299|NCT01134783|79352916|FG000|Overall Study|Lost to Follow-up|5|||
44348300|NCT01134783|79352917|FG001|Overall Study|Lost to Follow-up|20|||
44348301|NCT01134705|79352929|FG000|Overall Study|Adverse Event|1|||
44348302|NCT01134705|79352930|FG001|Overall Study|Adverse Event|7|||
44348303|NCT01134705|79352929|FG000|Overall Study|Withdrawal by Subject|6|||
44348304|NCT01134705|79352930|FG001|Overall Study|Withdrawal by Subject|6|||
44348305|NCT01134705|79352929|FG000|Overall Study|Pregnancy|1|||
44348306|NCT01134705|79352930|FG001|Overall Study|Pregnancy|0|||
44348307|NCT01134705|79352929|FG000|Overall Study|Lost to Follow-up|5|||
44348308|NCT01134705|79352930|FG001|Overall Study|Lost to Follow-up|2|||
44348309|NCT01134705|79352929|FG000|Overall Study|Protocol Violation|1|||
44348310|NCT01134705|79352930|FG001|Overall Study|Protocol Violation|1|||
44348311|NCT01134705|79352929|FG000|Overall Study|Other|1|||
44348312|NCT01134705|79352930|FG001|Overall Study|Other|6|||
44348313|NCT00927823|79352936|FG000|Continuous Dosing Period|Death|0|||
44348314|NCT00927823|79352937|FG001|Continuous Dosing Period|Death|0|||
44348315|NCT00927823|79352938|FG002|Continuous Dosing Period|Death|6|||
44348316|NCT00927823|79352939|FG003|Continuous Dosing Period|Death|0|||
44348317|NCT00927823|79352936|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
44348318|NCT00927823|79352937|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
44348319|NCT00927823|79352938|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
44348320|NCT00927823|79352939|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
44348321|NCT00927823|79352936|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
44348322|NCT00927823|79352937|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
44348323|NCT00927823|79352938|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
44348324|NCT00927823|79352939|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
44348325|NCT00927823|79352936|FG000|Continuous Dosing Period|Other|1|||
44348326|NCT00927823|79352937|FG001|Continuous Dosing Period|Other|2|||
44348327|NCT00927823|79352938|FG002|Continuous Dosing Period|Other|9|||
44348328|NCT00927823|79352939|FG003|Continuous Dosing Period|Other|3|||
44348329|NCT01134627|79352958|FG000|Overall Study|Adverse Event|47|||
44348330|NCT01134627|79352959|FG001|Overall Study|Adverse Event|31|||
44348331|NCT01134627|79352958|FG000|Overall Study|Lost to Follow-up|1|||
44348332|NCT01134627|79352959|FG001|Overall Study|Lost to Follow-up|2|||
44348333|NCT01134627|79352958|FG000|Overall Study|Protocol Violation|3|||
44348334|NCT01134627|79352959|FG001|Overall Study|Protocol Violation|5|||
44348335|NCT01134627|79352958|FG000|Overall Study|Lack of Efficacy|2|||
44348336|NCT01134627|79352959|FG001|Overall Study|Lack of Efficacy|12|||
44348337|NCT01134627|79352958|FG000|Overall Study|Withdrawal by Subject|4|||
44348338|NCT01134627|79352959|FG001|Overall Study|Withdrawal by Subject|3|||
44348339|NCT01134627|79352958|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
44348340|NCT01134627|79352959|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
44348341|NCT01134627|79352958|FG000|Overall Study|Other|11|||
44348342|NCT01134627|79352959|FG001|Overall Study|Other|14|||
44348343|NCT01134393|79352965|FG000|Overall Study|Adverse Event|18|||
44348344|NCT01134393|79352965|FG000|Overall Study|Lack of Efficacy|2|||
44348345|NCT01134393|79352965|FG000|Overall Study|Protocol Violation|12|||
44348346|NCT01134393|79352965|FG000|Overall Study|Lost to Follow-up|3|||
44348347|NCT01134393|79352965|FG000|Overall Study|Withdrawal by Subject|11|||
44348348|NCT01134393|79352965|FG000|Overall Study|Other|6|||
44348349|NCT00922441|79352973|FG000|Overall Study|Protocol Violation|0|||
44348350|NCT00922441|79352974|FG001|Overall Study|Protocol Violation|0|||
44348351|NCT00922441|79352975|FG002|Overall Study|Protocol Violation|2|||
44348352|NCT00922441|79352973|FG000|Overall Study|Withdrawal by Subject|0|||
44348353|NCT00922441|79352974|FG001|Overall Study|Withdrawal by Subject|0|||
44348354|NCT00922441|79352975|FG002|Overall Study|Withdrawal by Subject|1|||
44348355|NCT01217112|79352988|FG000|Overall Study|Adverse Event|0|||
44348356|NCT01217112|79352989|FG001|Overall Study|Adverse Event|2|||
44348357|NCT01217112|79352990|FG002|Overall Study|Adverse Event|0|||
44348358|NCT01217112|79352991|FG003|Overall Study|Adverse Event|2|||
44348359|NCT01217112|79352992|FG004|Overall Study|Adverse Event|0|||
44446410|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
44446411|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
44446412|NCT00506415|79454666|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
44348360|NCT01217112|79352988|FG000|Overall Study|Withdrawal by Subject|0|||
44348361|NCT01217112|79352989|FG001|Overall Study|Withdrawal by Subject|0|||
44348362|NCT01217112|79352990|FG002|Overall Study|Withdrawal by Subject|1|||
44348363|NCT01217112|79352991|FG003|Overall Study|Withdrawal by Subject|0|||
44348364|NCT01217112|79352992|FG004|Overall Study|Withdrawal by Subject|0|||
44348365|NCT01217112|79352988|FG000|Overall Study|Physician Decision|0|||
44348366|NCT01217112|79352989|FG001|Overall Study|Physician Decision|0|||
44348367|NCT01217112|79352990|FG002|Overall Study|Physician Decision|0|||
44348368|NCT01217112|79352991|FG003|Overall Study|Physician Decision|0|||
44348369|NCT01217112|79352992|FG004|Overall Study|Physician Decision|1|||
44348370|NCT01216332|79353006|FG000|Overall Study|Withdrawal by Subject|4|||
44348371|NCT01216332|79353007|FG001|Overall Study|Withdrawal by Subject|0|||
44348372|NCT00922207|79353016|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
44348373|NCT00922207|79353017|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
44348374|NCT00922207|79353018|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
44348375|NCT00922207|79353016|FG000|Overall Study|Insufficient Therapeutic Response|0|||
44348376|NCT00922207|79353017|FG001|Overall Study|Insufficient Therapeutic Response|0|||
44348377|NCT00922207|79353018|FG002|Overall Study|Insufficient Therapeutic Response|1|||
44348378|NCT00922207|79353016|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
44348379|NCT00922207|79353017|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
44348380|NCT00922207|79353018|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
44348381|NCT00922207|79353016|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
44348382|NCT00922207|79353017|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
44348383|NCT00922207|79353018|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
44348384|NCT00922207|79353016|FG000|Overall Study|Withdrew Consent|2|||
44348385|NCT00922207|79353017|FG001|Overall Study|Withdrew Consent|5|||
44348386|NCT00922207|79353018|FG002|Overall Study|Withdrew Consent|2|||
44348387|NCT00922207|79353016|FG000|Overall Study|Abnormality of Laboratory Test|0|||
44348388|NCT00922207|79353017|FG001|Overall Study|Abnormality of Laboratory Test|1|||
44348389|NCT00922207|79353018|FG002|Overall Study|Abnormality of Laboratory Test|1|||
44348390|NCT01134315|79353028|FG000|Overall Study|Adverse Event|1|||
44348391|NCT01134315|79353029|FG001|Overall Study|Adverse Event|2|||
44348392|NCT01134315|79353028|FG000|Overall Study|Other Reason|8|||
44348393|NCT01134315|79353029|FG001|Overall Study|Other Reason|17|||
44348394|NCT01216176|79353038|FG000|Overall Study|Adverse Event|0|||
44348395|NCT01216176|79353039|FG001|Overall Study|Adverse Event|8|||
44348396|NCT01216176|79353040|FG002|Overall Study|Adverse Event|0|||
44348397|NCT01216176|79353038|FG000|Overall Study|Physician Decision|0|||
44348398|NCT01216176|79353039|FG001|Overall Study|Physician Decision|0|||
44348399|NCT01216176|79353040|FG002|Overall Study|Physician Decision|1|||
44348400|NCT01133847|79353052|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
44348401|NCT01133847|79353053|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
44348402|NCT01133847|79353054|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
44348403|NCT01133847|79353052|FG000|Follow-Up Phase|Lost to Follow-up|1|||
44348404|NCT01133847|79353053|FG001|Follow-Up Phase|Lost to Follow-up|3|||
44348405|NCT01133847|79353054|FG002|Follow-Up Phase|Lost to Follow-up|7|||
44348406|NCT01133379|79353066|FG000|Overall Study|Withdrawal by Subject|0|||
44348407|NCT01133379|79353067|FG001|Overall Study|Withdrawal by Subject|1|||
44348408|NCT01133379|79353068|FG002|Overall Study|Withdrawal by Subject|1|||
44348409|NCT01133379|79353066|FG000|Overall Study|Lost to Follow-up|1|||
44348410|NCT01133379|79353067|FG001|Overall Study|Lost to Follow-up|1|||
44348411|NCT01133379|79353068|FG002|Overall Study|Lost to Follow-up|1|||
44348412|NCT01133067|79353076|FG000|Overall Study|Death|136|||
44348413|NCT01133067|79353076|FG000|Overall Study|Lost to Follow-up|3|||
44348414|NCT01132755|79353080|FG000|Overall Study|Procedure not done due to medical reason|23|||
44348415|NCT01132755|79353080|FG000|Overall Study|Protocol Violation|15|||
44348416|NCT01132755|79353080|FG000|Overall Study|Withdrawal by Subject|4|||
44348417|NCT00919711|79353086|FG000|Overall Study|Withdrawal by Subject|15|||
44348418|NCT00919711|79353087|FG001|Overall Study|Withdrawal by Subject|7|||
44348419|NCT00919711|79353086|FG000|Overall Study|Adverse Event|13|||
44348420|NCT00919711|79353087|FG001|Overall Study|Adverse Event|3|||
44348421|NCT00919711|79353086|FG000|Overall Study|Other|1|||
44348422|NCT00919711|79353087|FG001|Overall Study|Other|2|||
44348423|NCT00919711|79353086|FG000|Overall Study|Administrative Decision|0|||
44348424|NCT00919711|79353087|FG001|Overall Study|Administrative Decision|1|||
44348425|NCT00919711|79353086|FG000|Overall Study|Lost to Follow-up|2|||
44348426|NCT00919711|79353087|FG001|Overall Study|Lost to Follow-up|0|||
44348427|NCT00919711|79353086|FG000|Overall Study|Death|1|||
44348428|NCT00919711|79353087|FG001|Overall Study|Death|0|||
44348429|NCT00919711|79353086|FG000|Overall Study|Noncompliance|1|||
44348430|NCT00919711|79353087|FG001|Overall Study|Noncompliance|0|||
44348431|NCT01131585|79353095|FG000|Overall Study|Adverse Event|0|||
44348432|NCT01131585|79353096|FG001|Overall Study|Adverse Event|2|||
44348433|NCT01131585|79353095|FG000|Overall Study|Abnormal laboratory value|1|||
44446413|NCT00506415|79454667|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
44348434|NCT01131585|79353096|FG001|Overall Study|Abnormal laboratory value|0|||
44348435|NCT01131585|79353095|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
44348436|NCT01131585|79353096|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
44348437|NCT01131585|79353095|FG000|Overall Study|Protocol Violation|2|||
44348438|NCT01131585|79353096|FG001|Overall Study|Protocol Violation|1|||
44348439|NCT01131585|79353095|FG000|Overall Study|Withdrawal by Subject|3|||
44348440|NCT01131585|79353096|FG001|Overall Study|Withdrawal by Subject|3|||
44446414|NCT00506415|79454668|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
44348441|NCT01131585|79353095|FG000|Overall Study|Lost to Follow-up|0|||
44348442|NCT01131585|79353096|FG001|Overall Study|Lost to Follow-up|1|||
44348443|NCT01131585|79353095|FG000|Overall Study|Administrative problems|1|||
44348444|NCT01131585|79353096|FG001|Overall Study|Administrative problems|1|||
44348445|NCT01131585|79353095|FG000|Overall Study|Study termination|78|||
44348446|NCT01131585|79353096|FG001|Overall Study|Study termination|32|||
44348447|NCT01131507|79353102|FG000|Overall Study|Adverse Event|1|||
44348448|NCT01131507|79353102|FG000|Overall Study|Lost to Follow-up|1|||
44348449|NCT01131507|79353102|FG000|Overall Study|Withdrawal by Subject|1|||
44348450|NCT01131351|79353108|FG000|Overall Study|Adverse Event|0|||
44348451|NCT01131351|79353109|FG001|Overall Study|Adverse Event|2|||
44348452|NCT01131351|79353108|FG000|Overall Study|Protocol Deviation|0|||
44348453|NCT01131351|79353109|FG001|Overall Study|Protocol Deviation|1|||
44348454|NCT00919633|79353119|FG000|Overall Study|Adverse Event|1|||
44348455|NCT00919633|79353120|FG001|Overall Study|Adverse Event|9|||
44348456|NCT00919633|79353121|FG002|Overall Study|Adverse Event|12|||
44348457|NCT00919633|79353122|FG003|Overall Study|Adverse Event|10|||
44348458|NCT00919633|79353119|FG000|Overall Study|Death|0|||
44348459|NCT00919633|79353120|FG001|Overall Study|Death|0|||
44348460|NCT00919633|79353121|FG002|Overall Study|Death|2|||
44348461|NCT00919633|79353122|FG003|Overall Study|Death|0|||
44348462|NCT00919633|79353119|FG000|Overall Study|Lack of Efficacy|17|||
44348463|NCT00919633|79353120|FG001|Overall Study|Lack of Efficacy|3|||
44348464|NCT00919633|79353121|FG002|Overall Study|Lack of Efficacy|2|||
44348465|NCT00919633|79353122|FG003|Overall Study|Lack of Efficacy|3|||
44348466|NCT00919633|79353119|FG000|Overall Study|Withdrawal by Subject|1|||
44348467|NCT00919633|79353120|FG001|Overall Study|Withdrawal by Subject|2|||
44348468|NCT00919633|79353121|FG002|Overall Study|Withdrawal by Subject|4|||
44348469|NCT00919633|79353122|FG003|Overall Study|Withdrawal by Subject|3|||
44348470|NCT00919633|79353119|FG000|Overall Study|Lost to Follow-up|3|||
44348471|NCT00919633|79353120|FG001|Overall Study|Lost to Follow-up|1|||
44348472|NCT00919633|79353121|FG002|Overall Study|Lost to Follow-up|0|||
44348473|NCT00919633|79353122|FG003|Overall Study|Lost to Follow-up|2|||
44348474|NCT00919633|79353119|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
44348475|NCT00919633|79353120|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
44348476|NCT00919633|79353121|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
44348477|NCT00919633|79353122|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
44348478|NCT00919633|79353119|FG000|Overall Study|Protocol Violation|0|||
44348479|NCT00919633|79353120|FG001|Overall Study|Protocol Violation|0|||
44348480|NCT00919633|79353121|FG002|Overall Study|Protocol Violation|0|||
44348481|NCT00919633|79353122|FG003|Overall Study|Protocol Violation|1|||
44348482|NCT00919633|79353119|FG000|Overall Study|Physician Decision|0|||
44348483|NCT00919633|79353120|FG001|Overall Study|Physician Decision|0|||
44348484|NCT00919633|79353121|FG002|Overall Study|Physician Decision|0|||
44348485|NCT00919633|79353122|FG003|Overall Study|Physician Decision|1|||
44348486|NCT00919633|79353119|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
44348487|NCT00919633|79353120|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
44348488|NCT00919633|79353121|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
44348489|NCT00919633|79353122|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
44348490|NCT00919633|79353119|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
44348491|NCT00919633|79353120|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
44348492|NCT00919633|79353121|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
44348493|NCT00919633|79353122|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
44348494|NCT01130883|79353132|FG000|Overall Study|Patient Noncompliance|6|||
44348495|NCT01130883|79353132|FG000|Overall Study|Reason Unknown|1|||
44348496|NCT01130883|79353132|FG000|Overall Study|Adverse Event|3|||
44348497|NCT00926029|79353139|FG000|Overall Study|Lost to Follow-up|2|||
44348498|NCT00926029|79353140|FG001|Overall Study|Lost to Follow-up|1|||
44348499|NCT00926029|79353141|FG002|Overall Study|Lost to Follow-up|1|||
44348500|NCT01130493|79353151|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
44348501|NCT01130493|79353152|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
44348502|NCT01130493|79353153|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
44348503|NCT01130493|79353151|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
44348504|NCT01130493|79353152|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
44348505|NCT01130493|79353153|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
44348506|NCT01130493|79353151|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
44348507|NCT01130493|79353152|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
44348508|NCT01130493|79353153|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
44348509|NCT01130493|79353151|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
44348510|NCT01130493|79353152|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
44348511|NCT01130493|79353153|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
44348512|NCT01130493|79353151|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
44348513|NCT01130493|79353152|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
44348514|NCT01130493|79353153|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
44348515|NCT01130493|79353151|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
44446415|NCT00506415|79454669|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
44446416|NCT00452452|79454685|FG000|Overall Study|Protocol Violation|0|||
44446417|NCT00452452|79454686|FG001|Overall Study|Protocol Violation|0|||
44446418|NCT00452452|79454687|FG002|Overall Study|Protocol Violation|1|||
44348516|NCT01130493|79353152|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
44348517|NCT01130493|79353153|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
44348518|NCT01130493|79353151|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
44348519|NCT01130493|79353152|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
44348520|NCT01130493|79353153|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
44348521|NCT01130493|79353151|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
44348522|NCT01130493|79353152|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
44348523|NCT01130493|79353153|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
44348524|NCT01130493|79353151|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
44348525|NCT01130493|79353152|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
44348526|NCT01130493|79353153|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
44348527|NCT01130493|79353151|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
44348528|NCT01130493|79353152|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
44348529|NCT01130493|79353153|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
44348530|NCT01130493|79353151|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
44348531|NCT01130493|79353152|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
44348532|NCT01130493|79353153|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
44348533|NCT01130493|79353151|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
44348534|NCT01130493|79353152|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
44348535|NCT01130493|79353153|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
44348536|NCT01130493|79353151|FG000|Part 2: OLE|Adverse Event|0|||
44348537|NCT01130493|79353152|FG001|Part 2: OLE|Adverse Event|2|||
44348538|NCT01130493|79353153|FG002|Part 2: OLE|Adverse Event|1|||
44348539|NCT01130493|79353151|FG000|Part 2: OLE|Withdrawal by Subject|0|||
44348540|NCT01130493|79353152|FG001|Part 2: OLE|Withdrawal by Subject|1|||
44348541|NCT01130493|79353153|FG002|Part 2: OLE|Withdrawal by Subject|4|||
44348542|NCT01130337|79353164|FG000|Overall Study|Withdrawal by Subject|3|||
44348543|NCT01130337|79353164|FG000|Overall Study|Principal investigator decision|1|||
44348544|NCT01130337|79353164|FG000|Overall Study|Death|1|||
44348545|NCT01130337|79353164|FG000|Overall Study|Disease progression|1|||
44348546|NCT01130337|79353164|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
44348547|NCT01130337|79353164|FG000|Overall Study|Surgical resection (R2)|1|||
44348548|NCT01130103|79353170|FG000|Randomized Treatment|Adverse Event|1|||
44348549|NCT01130103|79353171|FG001|Randomized Treatment|Adverse Event|1|||
44348550|NCT01130103|79353170|FG000|Randomized Treatment|Lost to Follow-up|1|||
44348551|NCT01130103|79353171|FG001|Randomized Treatment|Lost to Follow-up|0|||
44348552|NCT01130103|79353170|FG000|Randomized Treatment|Protocol Violation|3|||
44348553|NCT01130103|79353171|FG001|Randomized Treatment|Protocol Violation|2|||
44348554|NCT01130103|79353170|FG000|Randomized Treatment|Withdrawal by Subject|1|||
44348555|NCT01130103|79353171|FG001|Randomized Treatment|Withdrawal by Subject|2|||
44348556|NCT01130103|79353170|FG000|Maintenance Treatment|Lack of Efficacy|0|||
44348557|NCT01130103|79353171|FG001|Maintenance Treatment|Lack of Efficacy|1|||
44348558|NCT01130103|79353170|FG000|Maintenance Treatment|Lost to Follow-up|1|||
44348559|NCT01130103|79353171|FG001|Maintenance Treatment|Lost to Follow-up|1|||
44348560|NCT01130103|79353170|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
44348561|NCT01130103|79353171|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
44348562|NCT01129557|79353180|FG000|Overall Study|Adverse Event|1|||
44348563|NCT01129557|79353181|FG001|Overall Study|Adverse Event|2|||
44348564|NCT01129557|79353182|FG002|Overall Study|Adverse Event|2|||
44348565|NCT01129557|79353180|FG000|Overall Study|Novartis terminated study early|3|||
44348566|NCT01129557|79353181|FG001|Overall Study|Novartis terminated study early|3|||
44348567|NCT01129557|79353182|FG002|Overall Study|Novartis terminated study early|2|||
44348568|NCT01129011|79353203|FG000|Overall Study|Adverse Event|20|||
44348569|NCT01129011|79353204|FG001|Overall Study|Adverse Event|30|||
44348570|NCT01129011|79353203|FG000|Overall Study|Withdrawal by Subject|24|||
44348571|NCT01129011|79353204|FG001|Overall Study|Withdrawal by Subject|8|||
44348572|NCT01129011|79353203|FG000|Overall Study|Lost to Follow-up|6|||
44348573|NCT01129011|79353204|FG001|Overall Study|Lost to Follow-up|7|||
44348574|NCT01129011|79353203|FG000|Overall Study|Duodenal Ulcer|2|||
44348575|NCT01129011|79353204|FG001|Overall Study|Duodenal Ulcer|8|||
44348576|NCT01129011|79353203|FG000|Overall Study|misc|7|||
44348577|NCT01129011|79353204|FG001|Overall Study|misc|4|||
44348578|NCT00919867|79353216|FG000|First Intervention|Withdrawal by Subject|0|||
44348579|NCT00919867|79353217|FG001|First Intervention|Withdrawal by Subject|0|||
44348580|NCT00919867|79353218|FG002|First Intervention|Withdrawal by Subject|1|||
44348581|NCT00919867|79353219|FG003|First Intervention|Withdrawal by Subject|0|||
44348582|NCT00919867|79353220|FG004|First Intervention|Withdrawal by Subject|0|||
44348583|NCT00919867|79353221|FG005|First Intervention|Withdrawal by Subject|0|||
44166374|NCT02289417|78959416|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
44166375|NCT02289417|78959417|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
44348584|NCT00919867|79353216|FG000|First Intervention|Physician Decision|0|||
44348585|NCT00919867|79353217|FG001|First Intervention|Physician Decision|0|||
44348586|NCT00919867|79353218|FG002|First Intervention|Physician Decision|0|||
44348587|NCT00919867|79353219|FG003|First Intervention|Physician Decision|0|||
44348588|NCT00919867|79353220|FG004|First Intervention|Physician Decision|0|||
44348589|NCT00919867|79353221|FG005|First Intervention|Physician Decision|1|||
44348590|NCT01215942|79353231|FG000|Treatment Period|Adverse Event|15|||
44348591|NCT01215942|79353232|FG001|Treatment Period|Adverse Event|26|||
44348592|NCT01215942|79353231|FG000|Treatment Period|Death|2|||
44348593|NCT01215942|79353232|FG001|Treatment Period|Death|4|||
44348594|NCT01215942|79353231|FG000|Treatment Period|Lack of Efficacy|23|||
44348595|NCT01215942|79353232|FG001|Treatment Period|Lack of Efficacy|62|||
44348596|NCT01215942|79353231|FG000|Treatment Period|Lost to Follow-up|3|||
44348597|NCT01215942|79353232|FG001|Treatment Period|Lost to Follow-up|4|||
44348598|NCT01215942|79353231|FG000|Treatment Period|Withdrawal by Subject|17|||
44348599|NCT01215942|79353232|FG001|Treatment Period|Withdrawal by Subject|40|||
44348600|NCT01215942|79353231|FG000|Treatment Period|Physician Decision|5|||
44348601|NCT01215942|79353232|FG001|Treatment Period|Physician Decision|5|||
44348602|NCT01215942|79353231|FG000|Treatment Period|Protocol Violation|0|||
44348603|NCT01215942|79353232|FG001|Treatment Period|Protocol Violation|1|||
44348604|NCT01215942|79353231|FG000|Treatment Period|Sponsor Decision|349|||
44348605|NCT01215942|79353232|FG001|Treatment Period|Sponsor Decision|530|||
44348606|NCT01215942|79353231|FG000|Post-Treatment Follow-Up Period|Death|0|||
44348607|NCT01215942|79353232|FG001|Post-Treatment Follow-Up Period|Death|1|||
44348608|NCT01215942|79353231|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
44348609|NCT01215942|79353232|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
44348610|NCT01215942|79353231|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
44348611|NCT01215942|79353232|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
44348612|NCT01215942|79353231|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
44348613|NCT01215942|79353232|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
44348614|NCT01215942|79353231|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
44348615|NCT01215942|79353232|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
44348616|NCT01128621|79353251|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
44348617|NCT01128621|79353252|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
44348618|NCT00918463|79353274|FG000|Overall Study|Death|1|||
44348619|NCT00918463|79353274|FG000|Overall Study|Lack of Efficacy|1|||
44348620|NCT01128543|79353278|FG000|Overall Study|Withdrawal by Subject|3|||
44348621|NCT01128543|79353278|FG000|Overall Study|Protocol Violation|1|||
44348622|NCT01128387|79353284|FG000|Overall Study|Physician Decision|0|||
44348623|NCT01128387|79353285|FG001|Overall Study|Physician Decision|1|||
44348624|NCT01214850|79353294|FG000|Overall Study|Withdrawal by Subject|38|||
44348625|NCT01214850|79353295|FG001|Overall Study|Withdrawal by Subject|31|||
44348626|NCT01214850|79353296|FG002|Overall Study|Withdrawal by Subject|28|||
44348627|NCT01214850|79353294|FG000|Overall Study|Lost to Follow-up|124|||
44348628|NCT01214850|79353295|FG001|Overall Study|Lost to Follow-up|98|||
44348629|NCT01214850|79353296|FG002|Overall Study|Lost to Follow-up|123|||
44348630|NCT01214850|79353294|FG000|Overall Study|Protocol Violation|5|||
44348631|NCT01214850|79353295|FG001|Overall Study|Protocol Violation|5|||
44348632|NCT01214850|79353296|FG002|Overall Study|Protocol Violation|6|||
44348633|NCT01214850|79353294|FG000|Overall Study|Adverse event or death|11|||
44348634|NCT01214850|79353295|FG001|Overall Study|Adverse event or death|8|||
44348635|NCT01214850|79353296|FG002|Overall Study|Adverse event or death|3|||
44348636|NCT01214850|79353294|FG000|Overall Study|Inappropriate enrollment|2|||
44348637|NCT01214850|79353295|FG001|Overall Study|Inappropriate enrollment|1|||
44348638|NCT01214850|79353296|FG002|Overall Study|Inappropriate enrollment|0|||
44348639|NCT01214850|79353294|FG000|Overall Study|Administrative reason|1|||
44348640|NCT01214850|79353295|FG001|Overall Study|Administrative reason|0|||
44348641|NCT01214850|79353296|FG002|Overall Study|Administrative reason|0|||
44348642|NCT01214850|79353294|FG000|Overall Study|Unable to classify|2|||
44348643|NCT01214850|79353295|FG001|Overall Study|Unable to classify|1|||
44348644|NCT01214850|79353296|FG002|Overall Study|Unable to classify|1|||
44348645|NCT01128153|79353309|FG000|Overall Study|Adverse Event|1|||
44348646|NCT01128153|79353310|FG001|Overall Study|Adverse Event|3|||
44348647|NCT01128153|79353309|FG000|Overall Study|Condition under investigation worsened|8|||
44348648|NCT01128153|79353310|FG001|Overall Study|Condition under investigation worsened|7|||
44348649|NCT01128153|79353309|FG000|Overall Study|Withdrawal by Subject|2|||
44348650|NCT01128153|79353310|FG001|Overall Study|Withdrawal by Subject|3|||
44348651|NCT01128153|79353309|FG000|Overall Study|Incorrect enrolment to study|2|||
44348652|NCT01128153|79353310|FG001|Overall Study|Incorrect enrolment to study|1|||
44348653|NCT01128153|79353309|FG000|Overall Study|Protocol Violation|2|||
44348654|NCT01128153|79353310|FG001|Overall Study|Protocol Violation|0|||
44348655|NCT01128153|79353309|FG000|Overall Study|Developed discontinuation criteria|1|||
44348656|NCT01128153|79353310|FG001|Overall Study|Developed discontinuation criteria|1|||
44348657|NCT00925015|79353319|FG000|Overall Study|Adverse Event|1|||
44348658|NCT00925015|79353320|FG001|Overall Study|Adverse Event|2|||
44348659|NCT00925015|79353321|FG002|Overall Study|Adverse Event|1|||
44348660|NCT00925015|79353319|FG000|Overall Study|Physician Decision|0|||
44348661|NCT00925015|79353320|FG001|Overall Study|Physician Decision|1|||
44348662|NCT00925015|79353321|FG002|Overall Study|Physician Decision|0|||
44348663|NCT00925015|79353319|FG000|Overall Study|Progressive Disease|7|||
44348664|NCT00925015|79353320|FG001|Overall Study|Progressive Disease|3|||
44348665|NCT00925015|79353321|FG002|Overall Study|Progressive Disease|4|||
44348666|NCT00925015|79353319|FG000|Overall Study|Withdrawal by Subject|0|||
44348667|NCT00925015|79353320|FG001|Overall Study|Withdrawal by Subject|0|||
44348668|NCT00925015|79353321|FG002|Overall Study|Withdrawal by Subject|1|||
44446419|NCT00452452|79454685|FG000|Overall Study|Withdrawal by Subject|1|||
44446420|NCT00452452|79454686|FG001|Overall Study|Withdrawal by Subject|0|||
44446421|NCT00452452|79454687|FG002|Overall Study|Withdrawal by Subject|0|||
44446422|NCT00452452|79454685|FG000|Overall Study|Lost to Follow-up|1|||
44446423|NCT00452452|79454686|FG001|Overall Study|Lost to Follow-up|0|||
44446424|NCT00452452|79454687|FG002|Overall Study|Lost to Follow-up|0|||
44446425|NCT00510783|79454703|FG000|Overall Study|Lost to Follow-up|29|||
44446426|NCT00510783|79454704|FG001|Overall Study|Lost to Follow-up|25|||
44446427|NCT00510783|79454703|FG000|Overall Study|Withdrawal by Subject|2|||
44446428|NCT00510783|79454704|FG001|Overall Study|Withdrawal by Subject|3|||
44446429|NCT00510783|79454703|FG000|Overall Study|Protocol Violation|0|||
44446430|NCT00510783|79454704|FG001|Overall Study|Protocol Violation|1|||
44446431|NCT00518973|79454712|FG000|Overall Study|Withdrawal by Subject|3|||
44446432|NCT00518973|79454713|FG001|Overall Study|Withdrawal by Subject|2|||
44446433|NCT00462670|79454721|FG000|Overall Study|Adverse Event|3|||
44446434|NCT00462670|79454722|FG001|Overall Study|Adverse Event|5|||
44446435|NCT00462670|79454721|FG000|Overall Study|Lack of Efficacy|1|||
44446436|NCT00462670|79454722|FG001|Overall Study|Lack of Efficacy|0|||
44446437|NCT00462670|79454721|FG000|Overall Study|Protocol Violation|1|||
44446438|NCT00462670|79454722|FG001|Overall Study|Protocol Violation|0|||
44446439|NCT00462670|79454721|FG000|Overall Study|Resolution of signs and symptoms|0|||
44446440|NCT00462670|79454722|FG001|Overall Study|Resolution of signs and symptoms|2|||
44446441|NCT00606086|79454730|FG000|Overall Study|Adverse Event|1|||
44446442|NCT00606086|79454731|FG001|Overall Study|Adverse Event|1|||
44446443|NCT00606086|79454730|FG000|Overall Study|Lost to Follow-up|4|||
44446444|NCT00606086|79454731|FG001|Overall Study|Lost to Follow-up|8|||
44446445|NCT00606086|79454730|FG000|Overall Study|Protocol Violation|1|||
44446446|NCT00606086|79454731|FG001|Overall Study|Protocol Violation|0|||
44446447|NCT00606086|79454730|FG000|Overall Study|Withdrawal by Subject|5|||
44446448|NCT00606086|79454731|FG001|Overall Study|Withdrawal by Subject|3|||
44446449|NCT00606086|79454730|FG000|Overall Study|Non-compliance|0|||
44446450|NCT00606086|79454731|FG001|Overall Study|Non-compliance|1|||
44446451|NCT00606086|79454730|FG000|Overall Study|Randomized, not treated|1|||
44446452|NCT00606086|79454731|FG001|Overall Study|Randomized, not treated|2|||
44446453|NCT00609986|79454739|FG000|Overall Study|Did not receive transplant or treatment|8|||
44446454|NCT00609986|79454740|FG001|Overall Study|Did not receive transplant or treatment|3|||
44446455|NCT00451906|79454746|FG000|Overall Study|Adverse Event|515|||
44446456|NCT00451906|79454746|FG000|Overall Study|Lost to Follow-up|31|||
44446457|NCT00451906|79454746|FG000|Overall Study|Withdrawal by Subject|111|||
44348669|NCT01127763|79353333|FG000|Overall Study|Adverse Event|2|||
44348670|NCT01127763|79353333|FG000|Overall Study|Withdrawal by Subject|1|||
44348671|NCT01127763|79353333|FG000|Overall Study|Physician Decision|2|||
44348672|NCT01127607|79353343|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
44348673|NCT01127607|79353344|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
44348674|NCT01127607|79353343|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
44446458|NCT00451906|79454746|FG000|Overall Study|Protocol Violation|21|||
44446459|NCT00451906|79454746|FG000|Overall Study|Progressive disease|1328|||
44446460|NCT00451906|79454746|FG000|Overall Study|Termination of the study|108|||
44446461|NCT00451906|79454746|FG000|Overall Study|Other Reasons|121|||
44446462|NCT00451906|79454746|FG000|Overall Study|Did not complete final visit|4|||
44446463|NCT00451282|79454752|FG000|Overall Study|Lost to Follow-up|6|||
44446464|NCT00451282|79454753|FG001|Overall Study|Lost to Follow-up|5|||
44446465|NCT03838198|79454761|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
44446466|NCT03838198|79454762|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
44446467|NCT03838198|79454763|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
44446468|NCT03838198|79454764|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
44446469|NCT03838198|79454761|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
44446470|NCT03838198|79454762|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
44446471|NCT03838198|79454763|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
44446472|NCT03838198|79454764|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
44446473|NCT00115765|79454779|FG000|Overall Study|Withdrawal by Subject|22|||
44446474|NCT00115765|79454780|FG001|Overall Study|Withdrawal by Subject|53|||
44446475|NCT00115765|79454781|FG002|Overall Study|Withdrawal by Subject|76|||
44446476|NCT00115765|79454782|FG003|Overall Study|Withdrawal by Subject|15|||
44446477|NCT00115765|79454779|FG000|Overall Study|Physician Decision|4|||
44446478|NCT00115765|79454780|FG001|Overall Study|Physician Decision|15|||
44446479|NCT00115765|79454781|FG002|Overall Study|Physician Decision|18|||
44446480|NCT00115765|79454782|FG003|Overall Study|Physician Decision|13|||
44446481|NCT00115765|79454779|FG000|Overall Study|Lost to Follow-up|3|||
44446482|NCT00115765|79454780|FG001|Overall Study|Lost to Follow-up|20|||
44446483|NCT00115765|79454781|FG002|Overall Study|Lost to Follow-up|18|||
44446484|NCT00115765|79454782|FG003|Overall Study|Lost to Follow-up|1|||
44446485|NCT00115765|79454779|FG000|Overall Study|Other|6|||
44446486|NCT00115765|79454780|FG001|Overall Study|Other|12|||
44446487|NCT00115765|79454781|FG002|Overall Study|Other|9|||
44446488|NCT00115765|79454782|FG003|Overall Study|Other|2|||
44446489|NCT00606008|79454790|FG000|Overall Study|Adverse Event|1|||
44446490|NCT00606008|79454790|FG000|Overall Study|Withdrawal by Subject|4|||
44446491|NCT00461812|79454802|FG000|Overall Study|study terminated|10|||
44446492|NCT00123955|79454809|FG000|Overall Study|Adverse Event|1|||
44446493|NCT00123955|79454810|FG001|Overall Study|Adverse Event|0|||
44446494|NCT00123955|79454809|FG000|Overall Study|Withdrawal by Subject|4|||
44446495|NCT00123955|79454810|FG001|Overall Study|Withdrawal by Subject|3|||
44446496|NCT00123955|79454809|FG000|Overall Study|Death|0|||
44446497|NCT00123955|79454810|FG001|Overall Study|Death|1|||
44446498|NCT03837028|79454820|FG000|Overall Study|Lost to Follow-up|4|||
44446499|NCT03837028|79454821|FG001|Overall Study|Lost to Follow-up|0|||
44446500|NCT03837028|79454822|FG002|Overall Study|Lost to Follow-up|2|||
44446501|NCT03837028|79454823|FG003|Overall Study|Lost to Follow-up|0|||
44446502|NCT03837028|79454820|FG000|Overall Study|Withdrawal by Subject|12|||
44446503|NCT03837028|79454821|FG001|Overall Study|Withdrawal by Subject|11|||
44446504|NCT03837028|79454822|FG002|Overall Study|Withdrawal by Subject|11|||
44446505|NCT03837028|79454823|FG003|Overall Study|Withdrawal by Subject|7|||
44446506|NCT00115063|79454835|FG000|Overall Study|Lost to Follow-up|98|||
44446507|NCT00115063|79454836|FG001|Overall Study|Lost to Follow-up|104|||
44446508|NCT00115063|79454835|FG000|Overall Study|Death|1|||
44446509|NCT00115063|79454836|FG001|Overall Study|Death|0|||
44446510|NCT00461500|79454844|FG000|Overall Study|Adverse Event|1|||
44446511|NCT00461500|79454845|FG001|Overall Study|Adverse Event|0|||
44446512|NCT00461500|79454844|FG000|Overall Study|Lack of Efficacy|0|||
44446513|NCT00461500|79454845|FG001|Overall Study|Lack of Efficacy|1|||
44446514|NCT00461500|79454844|FG000|Overall Study|Expired Drug Treatment|1|||
44446515|NCT00461500|79454845|FG001|Overall Study|Expired Drug Treatment|1|||
44446516|NCT00461500|79454844|FG000|Overall Study|Study Stopped|1|||
44446517|NCT00461500|79454845|FG001|Overall Study|Study Stopped|2|||
44446518|NCT00461500|79454844|FG000|Overall Study|Drug Treatment Misuse|1|||
44446519|NCT00461500|79454845|FG001|Overall Study|Drug Treatment Misuse|0|||
44446520|NCT00461500|79454844|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
44446521|NCT00461500|79454845|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
44446522|NCT00461500|79454844|FG000|Overall Study|Lost to Follow-up|2|||
44446523|NCT00461500|79454845|FG001|Overall Study|Lost to Follow-up|2|||
44446524|NCT00167245|79454853|FG000|Overall Study|Lost to Follow-up|20|||
44446525|NCT00167245|79454854|FG001|Overall Study|Lost to Follow-up|31|||
44446526|NCT00167245|79454853|FG000|Overall Study|Withdrawal by Subject|5|||
44446527|NCT00167245|79454854|FG001|Overall Study|Withdrawal by Subject|8|||
44446528|NCT00167245|79454853|FG000|Overall Study|Incarcerated|3|||
44446529|NCT00167245|79454854|FG001|Overall Study|Incarcerated|2|||
44446530|NCT00167245|79454853|FG000|Overall Study|Drowsy|1|||
44446531|NCT00167245|79454854|FG001|Overall Study|Drowsy|0|||
44260362|NCT02323113|79130906|FG002|Overall Study|Symptomatic Deterioration|1|||
44260363|NCT02323113|79130907|FG003|Overall Study|Symptomatic Deterioration|0|||
44446532|NCT00443560|79454865|FG000|Overall Study|No intrathecal dose|58|||
44446533|NCT00443560|79454866|FG001|Overall Study|No intrathecal dose|26|||
44446534|NCT00443560|79454865|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
44446535|NCT00443560|79454866|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
44446536|NCT00451204|79454874|FG000|Overall Study|Adverse Event|4|||
44446537|NCT00451204|79454875|FG001|Overall Study|Adverse Event|6|||
44446538|NCT00451204|79454874|FG000|Overall Study|Lack of Efficacy|4|||
44446539|NCT00451204|79454875|FG001|Overall Study|Lack of Efficacy|4|||
44446540|NCT00451204|79454874|FG000|Overall Study|Lost to Follow-up|4|||
44446541|NCT00451204|79454875|FG001|Overall Study|Lost to Follow-up|4|||
44446542|NCT00451204|79454874|FG000|Overall Study|Protocol Violation|1|||
44446543|NCT00451204|79454875|FG001|Overall Study|Protocol Violation|0|||
44446544|NCT00451204|79454874|FG000|Overall Study|Patient refusal|8|||
44446545|NCT00451204|79454875|FG001|Overall Study|Patient refusal|4|||
44446546|NCT00451204|79454874|FG000|Overall Study|Other|1|||
44446547|NCT00451204|79454875|FG001|Overall Study|Other|2|||
44446548|NCT00605540|79454884|FG000|Overall Study|Death|15|||
44446549|NCT00605540|79454884|FG000|Overall Study|Lost to Follow-up|23|||
44446550|NCT00605306|79454890|FG000|Overall Study|Adverse Event|0|||
44446551|NCT00605306|79454891|FG001|Overall Study|Adverse Event|1|||
44446552|NCT00607022|79454900|FG000|Overall Study|Withdrawal by Subject|1|||
44446553|NCT00607022|79454901|FG001|Overall Study|Withdrawal by Subject|0|||
44446554|NCT00607022|79454902|FG002|Overall Study|Withdrawal by Subject|0|||
44446555|NCT00606632|79454910|FG000|Overall Study|Withdrawal by Subject|13|||
44446556|NCT00606632|79454910|FG000|Overall Study|Miscellaneous reasons|9|||
44446557|NCT00450814|79454929|FG000|Overall Study|Failed to complete the initial therapy|0|||
44446558|NCT00450814|79454930|FG001|Overall Study|Failed to complete the initial therapy|0|||
44446559|NCT00450814|79454931|FG002|Overall Study|Failed to complete the initial therapy|0|||
44446560|NCT00450814|79454932|FG003|Overall Study|Failed to complete the initial therapy|1|||
44446561|NCT00450814|79454933|FG004|Overall Study|Failed to complete the initial therapy|1|||
44446562|NCT00450814|79454934|FG005|Overall Study|Failed to complete the initial therapy|1|||
44446563|NCT00450814|79454935|FG006|Overall Study|Failed to complete the initial therapy|0|||
44446564|NCT00450814|79454936|FG007|Overall Study|Failed to complete the initial therapy|0|||
44446565|NCT00450814|79454937|FG008|Overall Study|Failed to complete the initial therapy|0|||
44446566|NCT00450814|79454938|FG009|Overall Study|Failed to complete the initial therapy|0|||
44446567|NCT00450814|79454939|FG010|Overall Study|Failed to complete the initial therapy|0|||
44446568|NCT00450814|79454929|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
44446569|NCT00450814|79454930|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
44446570|NCT00450814|79454931|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
44446571|NCT00450814|79454932|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
44446572|NCT00450814|79454933|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
44446573|NCT00450814|79454934|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
44446574|NCT00450814|79454935|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
44446575|NCT00450814|79454936|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
44446576|NCT00450814|79454937|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
44446577|NCT00450814|79454938|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
44446578|NCT00450814|79454939|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
44446579|NCT00518115|79454974|FG000|Overall Study|Adverse Event|6|||
44446580|NCT00518115|79454975|FG001|Overall Study|Adverse Event|1|||
44446581|NCT00518115|79454976|FG002|Overall Study|Adverse Event|5|||
44446582|NCT00518115|79454977|FG003|Overall Study|Adverse Event|6|||
44446583|NCT00518115|79454978|FG004|Overall Study|Adverse Event|5|||
44446584|NCT00518115|79454979|FG005|Overall Study|Adverse Event|5|||
44446585|NCT00518115|79454980|FG006|Overall Study|Adverse Event|5|||
44446586|NCT00518115|79454981|FG007|Overall Study|Adverse Event|10|||
44446587|NCT00518115|79454982|FG008|Overall Study|Adverse Event|2|||
44446588|NCT00518115|79454983|FG009|Overall Study|Adverse Event|9|||
44446589|NCT00518115|79454974|FG000|Overall Study|Lost to Follow-up|0|||
44446590|NCT00518115|79454975|FG001|Overall Study|Lost to Follow-up|0|||
44446591|NCT00518115|79454976|FG002|Overall Study|Lost to Follow-up|2|||
44446592|NCT00518115|79454977|FG003|Overall Study|Lost to Follow-up|3|||
44446593|NCT00518115|79454978|FG004|Overall Study|Lost to Follow-up|1|||
44446594|NCT00518115|79454979|FG005|Overall Study|Lost to Follow-up|3|||
44446595|NCT00518115|79454980|FG006|Overall Study|Lost to Follow-up|0|||
44446596|NCT00518115|79454981|FG007|Overall Study|Lost to Follow-up|1|||
44446597|NCT00518115|79454982|FG008|Overall Study|Lost to Follow-up|1|||
44446598|NCT00518115|79454983|FG009|Overall Study|Lost to Follow-up|1|||
44446599|NCT00518115|79454974|FG000|Overall Study|Protocol Violation|1|||
44446600|NCT00518115|79454975|FG001|Overall Study|Protocol Violation|3|||
44446601|NCT00518115|79454976|FG002|Overall Study|Protocol Violation|1|||
44446602|NCT00518115|79454977|FG003|Overall Study|Protocol Violation|0|||
44446603|NCT00518115|79454978|FG004|Overall Study|Protocol Violation|0|||
44446604|NCT00518115|79454979|FG005|Overall Study|Protocol Violation|0|||
44446605|NCT00518115|79454980|FG006|Overall Study|Protocol Violation|0|||
44446606|NCT00518115|79454981|FG007|Overall Study|Protocol Violation|0|||
44446607|NCT00518115|79454982|FG008|Overall Study|Protocol Violation|0|||
44446608|NCT00518115|79454983|FG009|Overall Study|Protocol Violation|0|||
44446609|NCT00518115|79454974|FG000|Overall Study|Withdrawal by Subject|1|||
44446610|NCT00518115|79454975|FG001|Overall Study|Withdrawal by Subject|1|||
44446611|NCT00518115|79454976|FG002|Overall Study|Withdrawal by Subject|5|||
44446612|NCT00518115|79454977|FG003|Overall Study|Withdrawal by Subject|0|||
44446613|NCT00518115|79454978|FG004|Overall Study|Withdrawal by Subject|2|||
44446614|NCT00518115|79454979|FG005|Overall Study|Withdrawal by Subject|1|||
44446615|NCT00518115|79454980|FG006|Overall Study|Withdrawal by Subject|0|||
44446616|NCT00518115|79454981|FG007|Overall Study|Withdrawal by Subject|2|||
44446617|NCT00518115|79454982|FG008|Overall Study|Withdrawal by Subject|1|||
44446618|NCT00518115|79454983|FG009|Overall Study|Withdrawal by Subject|3|||
44446619|NCT00518115|79454974|FG000|Overall Study|Lack of Efficacy|1|||
44446620|NCT00518115|79454975|FG001|Overall Study|Lack of Efficacy|0|||
44446621|NCT00518115|79454976|FG002|Overall Study|Lack of Efficacy|1|||
44446622|NCT00518115|79454977|FG003|Overall Study|Lack of Efficacy|1|||
44446623|NCT00518115|79454978|FG004|Overall Study|Lack of Efficacy|0|||
44446624|NCT00518115|79454979|FG005|Overall Study|Lack of Efficacy|0|||
44446625|NCT00518115|79454980|FG006|Overall Study|Lack of Efficacy|0|||
44446626|NCT00518115|79454981|FG007|Overall Study|Lack of Efficacy|1|||
44446627|NCT00518115|79454982|FG008|Overall Study|Lack of Efficacy|0|||
44446628|NCT00518115|79454983|FG009|Overall Study|Lack of Efficacy|0|||
44446629|NCT00518115|79454974|FG000|Overall Study|Non-Compliance|1|||
44446630|NCT00518115|79454975|FG001|Overall Study|Non-Compliance|0|||
44446631|NCT00518115|79454976|FG002|Overall Study|Non-Compliance|1|||
44446632|NCT00518115|79454977|FG003|Overall Study|Non-Compliance|0|||
44446633|NCT00518115|79454978|FG004|Overall Study|Non-Compliance|1|||
44446634|NCT00518115|79454979|FG005|Overall Study|Non-Compliance|1|||
44446635|NCT00518115|79454980|FG006|Overall Study|Non-Compliance|1|||
44446636|NCT00518115|79454981|FG007|Overall Study|Non-Compliance|1|||
44446637|NCT00518115|79454982|FG008|Overall Study|Non-Compliance|0|||
44446638|NCT00518115|79454983|FG009|Overall Study|Non-Compliance|1|||
44446639|NCT00518115|79454974|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
44446640|NCT00518115|79454975|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
44446641|NCT00518115|79454976|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446642|NCT00518115|79454977|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446643|NCT00518115|79454978|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446644|NCT00518115|79454979|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
44446645|NCT00518115|79454980|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446646|NCT00518115|79454981|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446647|NCT00518115|79454982|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446648|NCT00518115|79454983|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
44446649|NCT00518115|79454974|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
44446650|NCT00518115|79454975|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44348675|NCT01127607|79353344|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
44348676|NCT00924781|79353371|FG000|Overall Study|Study terminated by sponsor|12|||
44348677|NCT00924781|79353372|FG001|Overall Study|Study terminated by sponsor|10|||
44348678|NCT01127451|79353390|FG000|Overall Study|Other|2|||
44348679|NCT01127451|79353391|FG001|Overall Study|Other|1|||
44348680|NCT01127451|79353390|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
44348681|NCT01127451|79353391|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
44348682|NCT01127451|79353390|FG000|Overall Study|Death|22|||
44348683|NCT01127451|79353391|FG001|Overall Study|Death|17|||
44348684|NCT01127451|79353390|FG000|Overall Study|Lost to Follow-up|3|||
44348685|NCT01127451|79353391|FG001|Overall Study|Lost to Follow-up|0|||
44348686|NCT01127451|79353390|FG000|Overall Study|Administrative Reason by Sponsor|2|||
44348687|NCT01127451|79353391|FG001|Overall Study|Administrative Reason by Sponsor|2|||
44348688|NCT01127373|79353397|FG000|Overall Study|Not Treated|3|||
44348689|NCT01127373|79353397|FG000|Overall Study|Lost to Follow-up|7|||
44348690|NCT01127373|79353397|FG000|Overall Study|Withdrawal by Subject|1|||
44446651|NCT00518115|79454976|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44348691|NCT01127373|79353397|FG000|Overall Study|Disease progression|1|||
44348692|NCT01127139|79353401|FG000|Overall Study|Adverse Event|40|||
44446652|NCT00518115|79454977|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446653|NCT00518115|79454978|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446654|NCT00518115|79454979|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446655|NCT00518115|79454980|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446656|NCT00518115|79454981|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446657|NCT00518115|79454982|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446658|NCT00518115|79454983|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
44446659|NCT00518115|79454974|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446660|NCT00518115|79454975|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446661|NCT00518115|79454976|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
44446662|NCT00518115|79454977|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446663|NCT00518115|79454978|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446664|NCT00518115|79454979|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446665|NCT00518115|79454980|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446666|NCT00518115|79454981|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446667|NCT00518115|79454982|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
44446668|NCT00518115|79454983|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
44446669|NCT00518115|79454974|FG000|Overall Study|Wrong Monotherapy Administered|0|||
44446670|NCT00518115|79454975|FG001|Overall Study|Wrong Monotherapy Administered|0|||
44446671|NCT00518115|79454976|FG002|Overall Study|Wrong Monotherapy Administered|1|||
44446672|NCT00518115|79454977|FG003|Overall Study|Wrong Monotherapy Administered|0|||
44446673|NCT00518115|79454978|FG004|Overall Study|Wrong Monotherapy Administered|0|||
44446674|NCT00518115|79454979|FG005|Overall Study|Wrong Monotherapy Administered|0|||
44446675|NCT00518115|79454980|FG006|Overall Study|Wrong Monotherapy Administered|1|||
44446676|NCT00518115|79454981|FG007|Overall Study|Wrong Monotherapy Administered|0|||
44446677|NCT00518115|79454982|FG008|Overall Study|Wrong Monotherapy Administered|0|||
44446678|NCT00518115|79454983|FG009|Overall Study|Wrong Monotherapy Administered|0|||
44446679|NCT00518115|79454974|FG000|Overall Study|Violation of Exclusion Criteria|0|||
44446680|NCT00518115|79454975|FG001|Overall Study|Violation of Exclusion Criteria|0|||
44446681|NCT00518115|79454976|FG002|Overall Study|Violation of Exclusion Criteria|0|||
44446682|NCT00518115|79454977|FG003|Overall Study|Violation of Exclusion Criteria|1|||
44446683|NCT00518115|79454978|FG004|Overall Study|Violation of Exclusion Criteria|0|||
44446684|NCT00518115|79454979|FG005|Overall Study|Violation of Exclusion Criteria|0|||
44446685|NCT00518115|79454980|FG006|Overall Study|Violation of Exclusion Criteria|1|||
44446686|NCT00518115|79454981|FG007|Overall Study|Violation of Exclusion Criteria|0|||
44446687|NCT00518115|79454982|FG008|Overall Study|Violation of Exclusion Criteria|0|||
44446688|NCT00518115|79454983|FG009|Overall Study|Violation of Exclusion Criteria|0|||
44446689|NCT00518115|79454974|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
44446690|NCT00518115|79454975|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
44446691|NCT00518115|79454976|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
44446692|NCT00518115|79454977|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
44446693|NCT00518115|79454978|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
44446694|NCT00518115|79454979|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
44446695|NCT00518115|79454980|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
44446696|NCT00518115|79454981|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
44446697|NCT00518115|79454982|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
44446698|NCT00518115|79454983|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
44446699|NCT00518115|79454974|FG000|Overall Study|Withdrew Consent|0|||
44446700|NCT00518115|79454975|FG001|Overall Study|Withdrew Consent|0|||
44446701|NCT00518115|79454976|FG002|Overall Study|Withdrew Consent|0|||
44446702|NCT00518115|79454977|FG003|Overall Study|Withdrew Consent|0|||
44446703|NCT00518115|79454978|FG004|Overall Study|Withdrew Consent|0|||
44446704|NCT00518115|79454979|FG005|Overall Study|Withdrew Consent|1|||
44446705|NCT00518115|79454980|FG006|Overall Study|Withdrew Consent|0|||
44446706|NCT00518115|79454981|FG007|Overall Study|Withdrew Consent|0|||
44446707|NCT00518115|79454982|FG008|Overall Study|Withdrew Consent|0|||
44446708|NCT00518115|79454983|FG009|Overall Study|Withdrew Consent|0|||
44446709|NCT00518115|79454974|FG000|Overall Study|Moved Out of State|0|||
44446710|NCT00518115|79454975|FG001|Overall Study|Moved Out of State|0|||
44446711|NCT00518115|79454976|FG002|Overall Study|Moved Out of State|0|||
44446712|NCT00518115|79454977|FG003|Overall Study|Moved Out of State|0|||
44446713|NCT00518115|79454978|FG004|Overall Study|Moved Out of State|0|||
44446714|NCT00518115|79454979|FG005|Overall Study|Moved Out of State|0|||
44446715|NCT00518115|79454980|FG006|Overall Study|Moved Out of State|0|||
44446716|NCT00518115|79454981|FG007|Overall Study|Moved Out of State|0|||
44446717|NCT00518115|79454982|FG008|Overall Study|Moved Out of State|0|||
44446718|NCT00518115|79454983|FG009|Overall Study|Moved Out of State|1|||
44446719|NCT00450658|79455008|FG000|Overall Study|Adverse Event|24|||
44446720|NCT00450658|79455009|FG001|Overall Study|Adverse Event|15|||
44446721|NCT00450658|79455008|FG000|Overall Study|Withdrawal by Subject|43|||
44446722|NCT00450658|79455009|FG001|Overall Study|Withdrawal by Subject|26|||
44446723|NCT00450658|79455008|FG000|Overall Study|Lost to Follow-up|22|||
44446724|NCT00450658|79455009|FG001|Overall Study|Lost to Follow-up|5|||
44446725|NCT00450658|79455008|FG000|Overall Study|UGI ulcer|33|||
44446726|NCT00450658|79455009|FG001|Overall Study|UGI ulcer|34|||
44446727|NCT00450658|79455008|FG000|Overall Study|misc|21|||
44446728|NCT00450658|79455009|FG001|Overall Study|misc|10|||
44446729|NCT00517881|79455015|FG000|Overall Study|Protocol Violation|2|||
44446730|NCT00517881|79455015|FG000|Overall Study|Adverse Event|1|||
44446731|NCT00517881|79455015|FG000|Overall Study|Renal transplantation|2|||
44446732|NCT00517413|79455036|FG000|Overall Study|Adverse Event|7|||
44446733|NCT00517413|79455036|FG000|Overall Study|Death|13|||
44446734|NCT00517413|79455036|FG000|Overall Study|Protocol Violation|15|||
44446735|NCT00517413|79455036|FG000|Overall Study|Withdrawal by Subject|2|||
44446736|NCT00517413|79455036|FG000|Overall Study|Failure to return|1|||
44446737|NCT00517413|79455036|FG000|Overall Study|Other-Reasons|23|||
44446738|NCT00604214|79455050|FG000|Baseline to Day 28|Death|223|||
44446739|NCT00604214|79455051|FG001|Baseline to Day 28|Death|202|||
44446740|NCT00604214|79455050|FG000|Baseline to Day 28|Lost to Follow-up|2|||
44446741|NCT00604214|79455051|FG001|Baseline to Day 28|Lost to Follow-up|4|||
44446742|NCT00604214|79455050|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
44446743|NCT00604214|79455051|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
44446744|NCT00604214|79455050|FG000|Day 29 to Day 90|Death|64|||
44446745|NCT00604214|79455051|FG001|Day 29 to Day 90|Death|67|||
44446746|NCT00604214|79455050|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
44446747|NCT00604214|79455051|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
44446748|NCT00604214|79455050|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
44446749|NCT00604214|79455051|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
44446750|NCT00604214|79455050|FG000|Day 91 to Day 180|Death|19|||
44446751|NCT00604214|79455051|FG001|Day 91 to Day 180|Death|23|||
44446752|NCT00604214|79455050|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
44446753|NCT00604214|79455051|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
44446754|NCT00604214|79455050|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
44446755|NCT00604214|79455051|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
44446756|NCT00450580|79455059|FG000|Overall Study|Adverse Event|5|||
44446757|NCT00450580|79455060|FG001|Overall Study|Adverse Event|7|||
44446758|NCT00450580|79455059|FG000|Overall Study|Lost to Follow-up|4|||
44446759|NCT00450580|79455060|FG001|Overall Study|Lost to Follow-up|5|||
44446760|NCT00450580|79455059|FG000|Overall Study|Withdrawal by Subject|2|||
44446761|NCT00450580|79455060|FG001|Overall Study|Withdrawal by Subject|2|||
44446762|NCT00450580|79455059|FG000|Overall Study|Protocol Violation|1|||
44446763|NCT00450580|79455060|FG001|Overall Study|Protocol Violation|1|||
44446764|NCT00450580|79455059|FG000|Overall Study|Protocol-defined virologic failure|1|||
44446765|NCT00450580|79455060|FG001|Overall Study|Protocol-defined virologic failure|0|||
44446766|NCT00450580|79455059|FG000|Overall Study|Could not comply with scheduled visits|1|||
44446767|NCT00450580|79455060|FG001|Overall Study|Could not comply with scheduled visits|0|||
44446768|NCT00450580|79455059|FG000|Overall Study|Patient went to Brazil|1|||
44446769|NCT00450580|79455060|FG001|Overall Study|Patient went to Brazil|0|||
44446770|NCT00450580|79455059|FG000|Overall Study|Patient could not swallow Norvir|1|||
44446771|NCT00450580|79455060|FG001|Overall Study|Patient could not swallow Norvir|0|||
44446772|NCT00450580|79455059|FG000|Overall Study|Withdrawal due to pregnancy|0|||
44446773|NCT00450580|79455060|FG001|Overall Study|Withdrawal due to pregnancy|1|||
44446774|NCT00123487|79455068|FG000|Randomized|Death prior to starting treatment|0|||
44446775|NCT00123487|79455069|FG001|Randomized|Death prior to starting treatment|1|||
44446776|NCT00123487|79455068|FG000|Randomized|SAE prior to starting treatment|1|||
44446777|NCT00123487|79455069|FG001|Randomized|SAE prior to starting treatment|0|||
44446778|NCT00123487|79455068|FG000|Treated With Study Drug|Adverse Event|23|||
44446779|NCT00123487|79455069|FG001|Treated With Study Drug|Adverse Event|22|||
44348693|NCT01127139|79353401|FG000|Overall Study|Incompliance|12|||
44348694|NCT01127139|79353401|FG000|Overall Study|Lack of Efficacy|4|||
44348695|NCT01127139|79353401|FG000|Overall Study|Reason not specified|1|||
44348696|NCT01214616|79353412|FG000|Overall Study|Progressive disease|2|||
44348697|NCT01214616|79353413|FG001|Overall Study|Progressive disease|2|||
44348698|NCT01214616|79353414|FG002|Overall Study|Progressive disease|2|||
44348699|NCT01214616|79353415|FG003|Overall Study|Progressive disease|4|||
44348700|NCT01214616|79353412|FG000|Overall Study|Dose limiting toxicity|0|||
44348701|NCT01214616|79353413|FG001|Overall Study|Dose limiting toxicity|2|||
44446780|NCT00123487|79455068|FG000|Treated With Study Drug|Disease Progression|141|||
44446781|NCT00123487|79455069|FG001|Treated With Study Drug|Disease Progression|122|||
44446782|NCT00123487|79455068|FG000|Treated With Study Drug|Physician Decision|8|||
44446783|NCT00123487|79455069|FG001|Treated With Study Drug|Physician Decision|9|||
44446784|NCT00123487|79455068|FG000|Treated With Study Drug|Other|59|||
44260364|NCT02323113|79130908|FG004|Overall Study|Symptomatic Deterioration|1|||
44446785|NCT00123487|79455069|FG001|Treated With Study Drug|Other|58|||
44446786|NCT00123487|79455068|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
44446787|NCT00123487|79455069|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
44446788|NCT00123487|79455068|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
44446789|NCT00123487|79455069|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
44446790|NCT00123487|79455068|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
44446791|NCT00123487|79455069|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
44446792|NCT00509925|79455076|FG000|Overall Study|Personal reasons|0|||
44446793|NCT00509925|79455077|FG001|Overall Study|Personal reasons|1|||
44446794|NCT00504777|79455085|FG000|Overall Study|Adverse Event|1|||
44446795|NCT00509769|79455089|FG000|Overall Study|Progressive disease|77|||
44446796|NCT00509769|79455089|FG000|Overall Study|Adverse Event|4|||
44446797|NCT00509769|79455089|FG000|Overall Study|Patient's decision|1|||
44446798|NCT00509769|79455089|FG000|Overall Study|Physician Decision|8|||
44446799|NCT00509769|79455089|FG000|Overall Study|Use of prohibited therapies during study|1|||
44446800|NCT00114127|79455095|FG000|Overall Study|Adverse Event|2|||
44446801|NCT00114127|79455096|FG001|Overall Study|Adverse Event|1|||
44446802|NCT00114127|79455095|FG000|Overall Study|Lost to Follow-up|1|||
44446803|NCT00114127|79455096|FG001|Overall Study|Lost to Follow-up|0|||
44446804|NCT00114127|79455095|FG000|Overall Study|Withdrawal by Subject|1|||
44446805|NCT00114127|79455096|FG001|Overall Study|Withdrawal by Subject|3|||
44446806|NCT00572624|79455108|FG000|Overall Study|Lost to Follow-up|10|||
44446807|NCT00572624|79455109|FG001|Overall Study|Lost to Follow-up|4|||
44446808|NCT00572624|79455108|FG000|Overall Study|Wanted to do a different diet program|1|||
44446809|NCT00572624|79455109|FG001|Overall Study|Wanted to do a different diet program|0|||
44446810|NCT00572624|79455108|FG000|Overall Study|Medication change|1|||
44446811|NCT00572624|79455109|FG001|Overall Study|Medication change|0|||
44446812|NCT00572624|79455108|FG000|Overall Study|Started a new job-- no time for study|1|||
44446813|NCT00572624|79455109|FG001|Overall Study|Started a new job-- no time for study|0|||
44446814|NCT00572624|79455108|FG000|Overall Study|Admitted to being a smoker|1|||
44446815|NCT00572624|79455109|FG001|Overall Study|Admitted to being a smoker|0|||
44446816|NCT00572624|79455108|FG000|Overall Study|Refused to do the stress test|1|||
44446817|NCT00572624|79455109|FG001|Overall Study|Refused to do the stress test|0|||
44446818|NCT00572624|79455108|FG000|Overall Study|Problem with vascular access|1|||
44446819|NCT00572624|79455109|FG001|Overall Study|Problem with vascular access|0|||
44446820|NCT00572624|79455108|FG000|Overall Study|Health issues unrelated to the study|1|||
44446821|NCT00572624|79455109|FG001|Overall Study|Health issues unrelated to the study|0|||
44446822|NCT00122317|79455115|FG000|Overall Study|Death|3|||
44260365|NCT02323113|79130909|FG005|Overall Study|Symptomatic Deterioration|0|||
44260366|NCT02323113|79130910|FG006|Overall Study|Symptomatic Deterioration|0|||
44260367|NCT02323113|79130911|FG007|Overall Study|Symptomatic Deterioration|0|||
44260368|NCT02323113|79130904|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
44260369|NCT02323113|79130905|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
44260370|NCT02323113|79130906|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
44260371|NCT02323113|79130907|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
44260372|NCT02323113|79130908|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
44260373|NCT02323113|79130909|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
44260374|NCT02323113|79130910|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
44260375|NCT02323113|79130911|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
44260376|NCT02323113|79130904|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44446823|NCT00122317|79455115|FG000|Overall Study|Adverse Event|4|||
44446824|NCT00122317|79455115|FG000|Overall Study|Physician Decision|2|||
44446825|NCT00122317|79455115|FG000|Overall Study|patient non-compliance|1|||
44446826|NCT00122317|79455115|FG000|Overall Study|Withdrawal by Subject|1|||
44446827|NCT03870555|79455122|FG000|Period 3 (2 Days)|Adverse Event|1|||
44446828|NCT03870555|79455123|FG001|Period 3 (2 Days)|Adverse Event|0|||
44446829|NCT03870555|79455124|FG002|Period 3 (2 Days)|Adverse Event|0|||
44446830|NCT03870477|79455135|FG000|Overall Study|Early Study Termination|1|||
44446831|NCT00165841|79455141|FG000|Overall Study|Adverse Event|2|||
44446832|NCT00165841|79455142|FG001|Overall Study|Adverse Event|3|||
44446833|NCT00165841|79455141|FG000|Overall Study|Lack of Efficacy|6|||
44446834|NCT00165841|79455142|FG001|Overall Study|Lack of Efficacy|33|||
44446835|NCT00165841|79455141|FG000|Overall Study|Lost to Follow-up|4|||
44446836|NCT00165841|79455142|FG001|Overall Study|Lost to Follow-up|4|||
44446837|NCT00165841|79455141|FG000|Overall Study|Withdrawal by Subject|7|||
44446838|NCT00165841|79455142|FG001|Overall Study|Withdrawal by Subject|8|||
44446839|NCT00165841|79455141|FG000|Overall Study|Physician Decision|1|||
44446840|NCT00165841|79455142|FG001|Overall Study|Physician Decision|0|||
44446841|NCT00165841|79455141|FG000|Overall Study|Protocol Violation|6|||
44446842|NCT00165841|79455142|FG001|Overall Study|Protocol Violation|8|||
44446843|NCT00165841|79455141|FG000|Overall Study|Other|3|||
44446844|NCT00165841|79455142|FG001|Overall Study|Other|5|||
44446845|NCT00165841|79455141|FG000|Overall Study|Medication Noncompliance|1|||
44446846|NCT00165841|79455142|FG001|Overall Study|Medication Noncompliance|1|||
44446847|NCT00509223|79455150|FG000|Overall Study|Lost to Follow-up|1|||
44446848|NCT00509223|79455151|FG001|Overall Study|Lost to Follow-up|1|||
44446849|NCT00509223|79455150|FG000|Overall Study|Adverse Event|1|||
44446850|NCT00509223|79455151|FG001|Overall Study|Adverse Event|1|||
44446851|NCT00509223|79455150|FG000|Overall Study|Withdrawal by Subject|25|||
44446852|NCT00509223|79455151|FG001|Overall Study|Withdrawal by Subject|6|||
44446853|NCT00509223|79455150|FG000|Overall Study|Including: subject change of address|5|||
44446854|NCT00509223|79455151|FG001|Overall Study|Including: subject change of address|2|||
44446855|NCT00509223|79455150|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
44446856|NCT00509223|79455151|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
44446857|NCT00460798|79455157|FG000|Overall Study|Death|59|||
44446858|NCT00460798|79455157|FG000|Overall Study|Adverse Event|27|||
44446859|NCT00460798|79455157|FG000|Overall Study|Lost to Follow-up|19|||
44446860|NCT00460798|79455157|FG000|Overall Study|Progressive Disease|99|||
44446861|NCT00460798|79455157|FG000|Overall Study|Other|27|||
44446862|NCT00460798|79455157|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
44446863|NCT00460798|79455157|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
44446864|NCT00603980|79455161|FG000|Study Qualification|Protocol Violation|3|||
44446865|NCT00603980|79455161|FG000|Study Qualification|Inconsistent data reporting|13|||
44446866|NCT00603980|79455161|FG000|Main Study|14th subject completed trial|1|||
44446867|NCT00450190|79455181|FG000|Overall Study|Withdrawal by Subject|2|||
44446868|NCT00450112|79455187|FG000|Overall Study|Other Treatment Required|5|||
44446869|NCT00450112|79455188|FG001|Overall Study|Other Treatment Required|1|||
44446870|NCT00450112|79455187|FG000|Overall Study|Withdrawal by Subject|4|||
44446871|NCT00450112|79455188|FG001|Overall Study|Withdrawal by Subject|1|||
44446872|NCT00450112|79455187|FG000|Overall Study|Lost to Follow-up|2|||
44446873|NCT00450112|79455188|FG001|Overall Study|Lost to Follow-up|1|||
44446874|NCT00450112|79455187|FG000|Overall Study|Others|2|||
44446875|NCT00450112|79455188|FG001|Overall Study|Others|3|||
44446876|NCT00449956|79455197|FG000|Overall Study|Adverse Event|7|||
44446877|NCT00449956|79455198|FG001|Overall Study|Adverse Event|1|||
44446878|NCT00449956|79455199|FG002|Overall Study|Adverse Event|6|||
44446879|NCT00449956|79455197|FG000|Overall Study|Lack of Efficacy|0|||
44446880|NCT00449956|79455198|FG001|Overall Study|Lack of Efficacy|0|||
44446881|NCT00449956|79455199|FG002|Overall Study|Lack of Efficacy|1|||
44446882|NCT00449956|79455197|FG000|Overall Study|Protocol Violation|1|||
44446883|NCT00449956|79455198|FG001|Overall Study|Protocol Violation|1|||
44446884|NCT00449956|79455199|FG002|Overall Study|Protocol Violation|1|||
44446885|NCT00449956|79455197|FG000|Overall Study|Withdrawal by Subject|0|||
44446886|NCT00449956|79455198|FG001|Overall Study|Withdrawal by Subject|1|||
44446887|NCT00449956|79455199|FG002|Overall Study|Withdrawal by Subject|0|||
44446888|NCT00449956|79455197|FG000|Overall Study|Physician Decision|2|||
44446889|NCT00449956|79455198|FG001|Overall Study|Physician Decision|1|||
44446890|NCT00449956|79455199|FG002|Overall Study|Physician Decision|1|||
44446891|NCT00509145|79455209|FG000|Overall Study|Death|0|||
44446892|NCT00509145|79455210|FG001|Overall Study|Death|2|||
44446893|NCT00509145|79455209|FG000|Overall Study|Adverse Event|42|||
44446894|NCT00509145|79455210|FG001|Overall Study|Adverse Event|28|||
44446895|NCT00509145|79455209|FG000|Overall Study|Withdrawal by Subject|32|||
44446896|NCT00509145|79455210|FG001|Overall Study|Withdrawal by Subject|38|||
44446897|NCT00509145|79455209|FG000|Overall Study|Physician Decision|11|||
44446898|NCT00509145|79455210|FG001|Overall Study|Physician Decision|14|||
44446899|NCT00509145|79455209|FG000|Overall Study|Protocol Violation|1|||
44446900|NCT00509145|79455210|FG001|Overall Study|Protocol Violation|6|||
44446901|NCT00509145|79455209|FG000|Overall Study|Pregnancy|3|||
44446902|NCT00509145|79455210|FG001|Overall Study|Pregnancy|8|||
44446903|NCT00509145|79455209|FG000|Overall Study|Lost to Follow-up|6|||
44446904|NCT00509145|79455210|FG001|Overall Study|Lost to Follow-up|5|||
44446905|NCT00509145|79455209|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
44446906|NCT00509145|79455210|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
44446907|NCT00509145|79455209|FG000|Overall Study|Other|6|||
44446908|NCT00509145|79455210|FG001|Overall Study|Other|6|||
44446909|NCT00509067|79455218|FG000|Overall Study|Lost to Follow-up|1|||
44446910|NCT00509067|79455219|FG001|Overall Study|Lost to Follow-up|1|||
44446911|NCT00509067|79455218|FG000|Overall Study|Adverse Event|3|||
44446912|NCT00509067|79455219|FG001|Overall Study|Adverse Event|1|||
44446913|NCT00509067|79455218|FG000|Overall Study|Protocol Violation|0|||
44446914|NCT00509067|79455219|FG001|Overall Study|Protocol Violation|3|||
44446915|NCT00504309|79455235|FG000|Overall Study|Death|0|||
44446916|NCT00504309|79455236|FG001|Overall Study|Death|0|||
44446917|NCT00504309|79455237|FG002|Overall Study|Death|0|||
44446918|NCT00504309|79455238|FG003|Overall Study|Death|0|||
44446919|NCT00504309|79455239|FG004|Overall Study|Death|1|||
44446920|NCT00504309|79455240|FG005|Overall Study|Death|0|||
44446921|NCT00504309|79455235|FG000|Overall Study|Withdrawal by Subject|0|||
44446922|NCT00504309|79455236|FG001|Overall Study|Withdrawal by Subject|0|||
44446923|NCT00504309|79455237|FG002|Overall Study|Withdrawal by Subject|1|||
44446924|NCT00504309|79455238|FG003|Overall Study|Withdrawal by Subject|0|||
44446925|NCT00504309|79455239|FG004|Overall Study|Withdrawal by Subject|0|||
44446926|NCT00504309|79455240|FG005|Overall Study|Withdrawal by Subject|0|||
44446927|NCT00508755|79455252|FG000|Overall Study|Withdrawal by Subject|1|||
44446928|NCT00504231|79455262|FG000|Overall Study|Discrepant chart documentation re route|0|||
44446929|NCT00504231|79455263|FG001|Overall Study|Discrepant chart documentation re route|0|||
44446930|NCT00504231|79455264|FG002|Overall Study|Discrepant chart documentation re route|1|||
44446931|NCT00504231|79455265|FG003|Overall Study|Discrepant chart documentation re route|0|||
44446932|NCT00568178|79455309|FG000|Double Blind Base Study|Adverse Event|0|||
44446933|NCT00568178|79455310|FG001|Double Blind Base Study|Adverse Event|2|||
44446934|NCT00568178|79455311|FG002|Double Blind Base Study|Adverse Event|1|||
44446935|NCT00568178|79455312|FG003|Double Blind Base Study|Adverse Event|2|||
44446936|NCT00568178|79455313|FG004|Double Blind Base Study|Adverse Event|0|||
44446937|NCT00568178|79455314|FG005|Double Blind Base Study|Adverse Event|0|||
44446938|NCT00568178|79455309|FG000|Double Blind Base Study|Lost to Follow-up|1|||
44446939|NCT00568178|79455310|FG001|Double Blind Base Study|Lost to Follow-up|0|||
44446940|NCT00568178|79455311|FG002|Double Blind Base Study|Lost to Follow-up|0|||
44446941|NCT00568178|79455312|FG003|Double Blind Base Study|Lost to Follow-up|1|||
44446942|NCT00568178|79455313|FG004|Double Blind Base Study|Lost to Follow-up|0|||
44446943|NCT00568178|79455314|FG005|Double Blind Base Study|Lost to Follow-up|0|||
44446944|NCT00568178|79455309|FG000|Double Blind Base Study|Physician Decision|1|||
44446945|NCT00568178|79455310|FG001|Double Blind Base Study|Physician Decision|1|||
44446946|NCT00568178|79455311|FG002|Double Blind Base Study|Physician Decision|0|||
44446947|NCT00568178|79455312|FG003|Double Blind Base Study|Physician Decision|1|||
44446948|NCT00568178|79455313|FG004|Double Blind Base Study|Physician Decision|0|||
44446949|NCT00568178|79455314|FG005|Double Blind Base Study|Physician Decision|0|||
44446950|NCT00568178|79455309|FG000|Double Blind Base Study|Protocol Violation|3|||
44446951|NCT00568178|79455310|FG001|Double Blind Base Study|Protocol Violation|2|||
44446952|NCT00568178|79455311|FG002|Double Blind Base Study|Protocol Violation|0|||
44446953|NCT00568178|79455312|FG003|Double Blind Base Study|Protocol Violation|0|||
44446954|NCT00568178|79455313|FG004|Double Blind Base Study|Protocol Violation|0|||
44446955|NCT00568178|79455314|FG005|Double Blind Base Study|Protocol Violation|0|||
44446956|NCT00568178|79455309|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
44446957|NCT00568178|79455310|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
44446958|NCT00568178|79455311|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
44446959|NCT00568178|79455312|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
44348702|NCT01214616|79353414|FG002|Overall Study|Dose limiting toxicity|0|||
44348703|NCT01214616|79353415|FG003|Overall Study|Dose limiting toxicity|0|||
44348704|NCT01214616|79353412|FG000|Overall Study|Other adverse events|0|||
44348705|NCT01214616|79353413|FG001|Overall Study|Other adverse events|1|||
44348706|NCT01214616|79353414|FG002|Overall Study|Other adverse events|1|||
44348707|NCT01214616|79353415|FG003|Overall Study|Other adverse events|1|||
44348708|NCT01214616|79353412|FG000|Overall Study|Withdrawal by Subject|1|||
44348709|NCT01214616|79353413|FG001|Overall Study|Withdrawal by Subject|0|||
44348710|NCT01214616|79353414|FG002|Overall Study|Withdrawal by Subject|0|||
44348711|NCT01214616|79353415|FG003|Overall Study|Withdrawal by Subject|1|||
44348712|NCT01213836|79353435|FG000|Period 1, First Intervention|Adverse Event|2|||
44348713|NCT01213836|79353436|FG001|Period 1, First Intervention|Adverse Event|1|||
44348714|NCT01213836|79353435|FG000|Period 1, First Intervention|Protocol Violation|0|||
44348715|NCT01213836|79353436|FG001|Period 1, First Intervention|Protocol Violation|1|||
44348716|NCT01213836|79353435|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
44348717|NCT01213836|79353436|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
44348718|NCT01127061|79353447|FG000|Overall Study|Lost to Follow-up|7|||
44348719|NCT01127061|79353448|FG001|Overall Study|Lost to Follow-up|10|||
44348720|NCT01127061|79353447|FG000|Overall Study|Physician Decision|3|||
44348721|NCT01127061|79353448|FG001|Overall Study|Physician Decision|3|||
44354780|NCT01185600|79359184|FG000|Overall Study|Physician Decision|29|||
44354781|NCT01185600|79359185|FG001|Overall Study|Physician Decision|35|||
44354782|NCT01185600|79359184|FG000|Overall Study|Withdrawal by Subject|1|||
44354783|NCT01185600|79359185|FG001|Overall Study|Withdrawal by Subject|1|||
44354784|NCT01185600|79359184|FG000|Overall Study|Hold by DSMB|1|||
44354785|NCT01185600|79359185|FG001|Overall Study|Hold by DSMB|2|||
44354786|NCT01185522|79359194|FG000|Overall Study|Lack of Efficacy|28|||
44354787|NCT01185522|79359194|FG000|Overall Study|Lost to Follow-up|19|||
44354788|NCT01185522|79359194|FG000|Overall Study|Withdrawal by Subject|10|||
44166376|NCT02289417|78959418|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
44166377|NCT02289417|78959419|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
44348722|NCT00924703|79353454|FG000|Overall Study|Withdrawal by Subject|11|||
44348723|NCT00924703|79353454|FG000|Overall Study|Physician Decision|5|||
44348724|NCT00924703|79353454|FG000|Overall Study|Lost to Follow-up|3|||
44348725|NCT00924703|79353454|FG000|Overall Study|Adverse Event|2|||
44348726|NCT00924703|79353454|FG000|Overall Study|Withdrawal by Sponsor|1|||
44348727|NCT01213524|79353460|FG000|Baseline|Withdrawal by Subject|5|||
44354789|NCT01185522|79359194|FG000|Overall Study|Poor tolerance|39|||
44354790|NCT01185522|79359194|FG000|Overall Study|Other reasons|12|||
44348728|NCT01213524|79353460|FG000|Baseline|high breath alcohol levels|1|||
44348729|NCT01213524|79353460|FG000|Baseline|Physician Decision|1|||
44348730|NCT01213524|79353460|FG000|Session 2|Withdrawal by Subject|5|||
44348731|NCT01213524|79353460|FG000|Session 3|Withdrawal by Subject|4|||
44348732|NCT01213524|79353460|FG000|Session 4|Physician Decision|1|||
44348733|NCT01213524|79353460|FG000|Session 4|Withdrawal by Subject|2|||
44348734|NCT01212744|79353471|FG000|Overall Study|Withdrawal by Subject|1|||
44348735|NCT01212588|79353479|FG000|Overall Study|Physician Decision|0|||
44348736|NCT01212588|79353480|FG001|Overall Study|Physician Decision|1|||
44348737|NCT01212588|79353479|FG000|Overall Study|Protocol Violation|1|||
44348738|NCT01212588|79353480|FG001|Overall Study|Protocol Violation|1|||
44348739|NCT00918385|79353488|FG000|Monotherapy|Adverse Event|1|||
44348740|NCT00918385|79353489|FG001|Monotherapy|Adverse Event|6|||
44348741|NCT00918385|79353488|FG000|Monotherapy|Complicating illness|1|||
44166378|NCT02289417|78959420|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
44348742|NCT00918385|79353489|FG001|Monotherapy|Complicating illness|0|||
44348743|NCT00918385|79353488|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
44348744|NCT00918385|79353489|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
44348745|NCT00918385|79353488|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
44348746|NCT00918385|79353489|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
44446960|NCT00568178|79455313|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
44446961|NCT00568178|79455314|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
44446962|NCT00568178|79455309|FG000|Double Blind Base Study|Progressive Disease|0|||
44446963|NCT00568178|79455310|FG001|Double Blind Base Study|Progressive Disease|0|||
44446964|NCT00568178|79455311|FG002|Double Blind Base Study|Progressive Disease|0|||
44446965|NCT00568178|79455312|FG003|Double Blind Base Study|Progressive Disease|1|||
44446966|NCT00568178|79455313|FG004|Double Blind Base Study|Progressive Disease|0|||
44446967|NCT00568178|79455314|FG005|Double Blind Base Study|Progressive Disease|0|||
44446968|NCT00568178|79455309|FG000|Open Label Extension|Adverse Event|0|||
44446969|NCT00568178|79455310|FG001|Open Label Extension|Adverse Event|0|||
44446970|NCT00568178|79455311|FG002|Open Label Extension|Adverse Event|0|||
44446971|NCT00568178|79455312|FG003|Open Label Extension|Adverse Event|0|||
44446972|NCT00568178|79455313|FG004|Open Label Extension|Adverse Event|11|||
44446973|NCT00568178|79455314|FG005|Open Label Extension|Adverse Event|8|||
44446974|NCT00568178|79455309|FG000|Open Label Extension|Protocol Violation|0|||
44446975|NCT00568178|79455310|FG001|Open Label Extension|Protocol Violation|0|||
44446976|NCT00568178|79455311|FG002|Open Label Extension|Protocol Violation|0|||
44446977|NCT00568178|79455312|FG003|Open Label Extension|Protocol Violation|0|||
44446978|NCT00568178|79455313|FG004|Open Label Extension|Protocol Violation|1|||
44446979|NCT00568178|79455314|FG005|Open Label Extension|Protocol Violation|0|||
44446980|NCT00568178|79455309|FG000|Open Label Extension|Lost to Follow-up|0|||
44446981|NCT00568178|79455310|FG001|Open Label Extension|Lost to Follow-up|0|||
44446982|NCT00568178|79455311|FG002|Open Label Extension|Lost to Follow-up|0|||
44446983|NCT00568178|79455312|FG003|Open Label Extension|Lost to Follow-up|0|||
44446984|NCT00568178|79455313|FG004|Open Label Extension|Lost to Follow-up|6|||
44446985|NCT00568178|79455314|FG005|Open Label Extension|Lost to Follow-up|11|||
44446986|NCT00568178|79455309|FG000|Open Label Extension|Physician Decision|0|||
44446987|NCT00568178|79455310|FG001|Open Label Extension|Physician Decision|0|||
44446988|NCT00568178|79455311|FG002|Open Label Extension|Physician Decision|0|||
44446989|NCT00568178|79455312|FG003|Open Label Extension|Physician Decision|0|||
44446990|NCT00568178|79455313|FG004|Open Label Extension|Physician Decision|9|||
44446991|NCT00568178|79455314|FG005|Open Label Extension|Physician Decision|8|||
44446992|NCT00568178|79455309|FG000|Open Label Extension|Pregnancy|0|||
44446993|NCT00568178|79455310|FG001|Open Label Extension|Pregnancy|0|||
44446994|NCT00568178|79455311|FG002|Open Label Extension|Pregnancy|0|||
44446995|NCT00568178|79455312|FG003|Open Label Extension|Pregnancy|0|||
44446996|NCT00568178|79455313|FG004|Open Label Extension|Pregnancy|0|||
44446997|NCT00568178|79455314|FG005|Open Label Extension|Pregnancy|1|||
44446998|NCT00568178|79455309|FG000|Open Label Extension|Progressive Disease|0|||
44446999|NCT00568178|79455310|FG001|Open Label Extension|Progressive Disease|0|||
44447000|NCT00568178|79455311|FG002|Open Label Extension|Progressive Disease|0|||
44447001|NCT00568178|79455312|FG003|Open Label Extension|Progressive Disease|0|||
44166379|NCT02289417|78959421|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
44166380|NCT02512861|78959439|FG000|Overall Study|Protocol Violation|3|||
44348747|NCT00918385|79353488|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
44166381|NCT02512861|78959440|FG001|Overall Study|Protocol Violation|7|||
44166382|NCT02512861|78959439|FG000|Overall Study|Physician Decision|3|||
44166383|NCT02512861|78959440|FG001|Overall Study|Physician Decision|1|||
44166384|NCT02512861|78959439|FG000|Overall Study|Withdrawal by Subject|0|||
44166385|NCT02512861|78959440|FG001|Overall Study|Withdrawal by Subject|1|||
44166386|NCT02288559|78959450|FG000|Overall Study|Adverse Event|1|||
44166387|NCT02288559|78959451|FG001|Overall Study|Adverse Event|1|||
44166388|NCT02288559|78959452|FG002|Overall Study|Adverse Event|5|||
44166389|NCT02288559|78959453|FG003|Overall Study|Adverse Event|0|||
44166390|NCT02288559|78959450|FG000|Overall Study|Death|0|||
44260377|NCT02323113|79130905|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
44166391|NCT02288559|78959451|FG001|Overall Study|Death|0|||
44166392|NCT02288559|78959452|FG002|Overall Study|Death|1|||
44166393|NCT02288559|78959453|FG003|Overall Study|Death|0|||
44166394|NCT02288559|78959450|FG000|Overall Study|Lost to Follow-up|0|||
44166395|NCT02288559|78959451|FG001|Overall Study|Lost to Follow-up|0|||
44166396|NCT02288559|78959452|FG002|Overall Study|Lost to Follow-up|0|||
44166397|NCT02288559|78959453|FG003|Overall Study|Lost to Follow-up|1|||
44166398|NCT02288559|78959450|FG000|Overall Study|Withdrawal by Subject|0|||
44166399|NCT02288559|78959451|FG001|Overall Study|Withdrawal by Subject|0|||
44166400|NCT02288559|78959452|FG002|Overall Study|Withdrawal by Subject|2|||
44166401|NCT02288559|78959453|FG003|Overall Study|Withdrawal by Subject|1|||
44166402|NCT02288559|78959450|FG000|Overall Study|Reason Not Specified|0|||
44166403|NCT02288559|78959451|FG001|Overall Study|Reason Not Specified|0|||
44166404|NCT02288559|78959452|FG002|Overall Study|Reason Not Specified|3|||
44166405|NCT02288559|78959453|FG003|Overall Study|Reason Not Specified|0|||
44166406|NCT02288325|78959465|FG000|Run-in Period|Adverse Event|48|||
44166407|NCT02288325|78959466|FG001|Run-in Period|Adverse Event|0|||
44166408|NCT02288325|78959467|FG002|Run-in Period|Adverse Event|0|||
44166409|NCT02288325|78959465|FG000|Run-in Period|Lack of Efficacy|16|||
44166410|NCT02288325|78959466|FG001|Run-in Period|Lack of Efficacy|0|||
44166411|NCT02288325|78959467|FG002|Run-in Period|Lack of Efficacy|0|||
44166412|NCT02288325|78959465|FG000|Run-in Period|Withdrawal of Consent|28|||
44166413|NCT02288325|78959466|FG001|Run-in Period|Withdrawal of Consent|0|||
44166414|NCT02288325|78959467|FG002|Run-in Period|Withdrawal of Consent|0|||
44166415|NCT02288325|78959465|FG000|Run-in Period|Lost to Follow-up|25|||
44166416|NCT02288325|78959466|FG001|Run-in Period|Lost to Follow-up|0|||
44166417|NCT02288325|78959467|FG002|Run-in Period|Lost to Follow-up|0|||
44166418|NCT02288325|78959465|FG000|Run-in Period|Protocol Violation|17|||
44166419|NCT02288325|78959466|FG001|Run-in Period|Protocol Violation|0|||
44166420|NCT02288325|78959467|FG002|Run-in Period|Protocol Violation|0|||
44166421|NCT02288325|78959465|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
44166422|NCT02288325|78959466|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
44166423|NCT02288325|78959467|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
44166424|NCT02288325|78959465|FG000|Run-in Period|Reason not Specified|8|||
44166425|NCT02288325|78959466|FG001|Run-in Period|Reason not Specified|0|||
44166426|NCT02288325|78959467|FG002|Run-in Period|Reason not Specified|0|||
44166427|NCT02288325|78959465|FG000|Stabilization Period|Adverse Event|13|||
44166428|NCT02288325|78959466|FG001|Stabilization Period|Adverse Event|0|||
44166429|NCT02288325|78959467|FG002|Stabilization Period|Adverse Event|0|||
44166430|NCT02288325|78959465|FG000|Stabilization Period|Lack of Efficacy|22|||
44166431|NCT02288325|78959466|FG001|Stabilization Period|Lack of Efficacy|0|||
44166432|NCT02288325|78959467|FG002|Stabilization Period|Lack of Efficacy|0|||
44166433|NCT02288325|78959465|FG000|Stabilization Period|Withdrawal of Consent|23|||
44166434|NCT02288325|78959466|FG001|Stabilization Period|Withdrawal of Consent|0|||
44166435|NCT02288325|78959467|FG002|Stabilization Period|Withdrawal of Consent|0|||
44166436|NCT02288325|78959465|FG000|Stabilization Period|Lost to Follow-up|12|||
44166437|NCT02288325|78959466|FG001|Stabilization Period|Lost to Follow-up|0|||
44166438|NCT02288325|78959467|FG002|Stabilization Period|Lost to Follow-up|0|||
44166439|NCT02288325|78959465|FG000|Stabilization Period|Protocol Violation|8|||
44166440|NCT02288325|78959466|FG001|Stabilization Period|Protocol Violation|0|||
44166441|NCT02288325|78959467|FG002|Stabilization Period|Protocol Violation|0|||
44166442|NCT02288325|78959465|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
44166443|NCT02288325|78959466|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
44166444|NCT02288325|78959467|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
44166445|NCT02288325|78959465|FG000|Stabilization Period|Reason not Specified|15|||
44166446|NCT02288325|78959466|FG001|Stabilization Period|Reason not Specified|0|||
44166447|NCT02288325|78959467|FG002|Stabilization Period|Reason not Specified|0|||
44166448|NCT02288325|78959465|FG000|Double-blind Treatment Period|Adverse Event|0|||
44166449|NCT02288325|78959466|FG001|Double-blind Treatment Period|Adverse Event|2|||
44166450|NCT02288325|78959467|FG002|Double-blind Treatment Period|Adverse Event|5|||
44260378|NCT02323113|79130906|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44447002|NCT00568178|79455313|FG004|Open Label Extension|Progressive Disease|3|||
44166451|NCT02288325|78959465|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
44166452|NCT02288325|78959466|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
44166453|NCT02288325|78959467|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
44166454|NCT02288325|78959465|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
44166455|NCT02288325|78959466|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
44166456|NCT02288325|78959467|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
44260379|NCT02323113|79130907|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44260380|NCT02323113|79130908|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44260381|NCT02323113|79130909|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44260382|NCT02323113|79130910|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44260383|NCT02323113|79130911|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
44260384|NCT02281383|79130958|FG000|Overall Study|Progressive Disease|1|||
44260385|NCT02281383|79130958|FG000|Overall Study|Withdrawal by Subject|6|||
44260386|NCT02281383|79130958|FG000|Overall Study|Protocol Violation|2|||
44260387|NCT02281383|79130958|FG000|Overall Study|Death|1|||
44260388|NCT02281383|79130958|FG000|Overall Study|Adverse Event|2|||
44260389|NCT01047553|79130964|FG000|Overall Study|Adverse Event|10|||
44260390|NCT01047553|79130965|FG001|Overall Study|Adverse Event|5|||
44260391|NCT01047553|79130964|FG000|Overall Study|Withdrawal by Subject|4|||
44260392|NCT01047553|79130965|FG001|Overall Study|Withdrawal by Subject|2|||
44260393|NCT01047553|79130964|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
44260394|NCT01047553|79130965|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
44260395|NCT01047553|79130964|FG000|Overall Study|Lost to Follow-up|1|||
44260396|NCT01047553|79130965|FG001|Overall Study|Lost to Follow-up|0|||
44260397|NCT01047553|79130964|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
44260398|NCT01047553|79130965|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
44260399|NCT01047553|79130964|FG000|Overall Study|PI's decision|0|||
44260400|NCT01047553|79130965|FG001|Overall Study|PI's decision|1|||
44260401|NCT01046695|79130997|FG000|Overall Study|Subject had a pacemaker|0|||
44260402|NCT01046695|79130998|FG001|Overall Study|Subject had a pacemaker|1|||
44260403|NCT01046695|79130997|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
44260404|NCT01046695|79130998|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
44260405|NCT03304379|79131013|FG000|Overall Study|Protocol Violation|8|||
44260406|NCT03304379|79131014|FG001|Overall Study|Protocol Violation|10|||
44260407|NCT03304379|79131015|FG002|Overall Study|Protocol Violation|5|||
44260408|NCT03304379|79131016|FG003|Overall Study|Protocol Violation|0|||
44260409|NCT03304379|79131017|FG004|Overall Study|Protocol Violation|2|||
44260410|NCT03304379|79131013|FG000|Overall Study|Adverse Event|4|||
44260411|NCT03304379|79131014|FG001|Overall Study|Adverse Event|20|||
44260412|NCT03304379|79131015|FG002|Overall Study|Adverse Event|17|||
44260413|NCT03304379|79131016|FG003|Overall Study|Adverse Event|1|||
44260414|NCT03304379|79131017|FG004|Overall Study|Adverse Event|0|||
44260415|NCT03304379|79131013|FG000|Overall Study|Lack of Efficacy|17|||
44260416|NCT03304379|79131014|FG001|Overall Study|Lack of Efficacy|16|||
44260417|NCT03304379|79131015|FG002|Overall Study|Lack of Efficacy|20|||
44260418|NCT03304379|79131016|FG003|Overall Study|Lack of Efficacy|0|||
44260419|NCT03304379|79131017|FG004|Overall Study|Lack of Efficacy|0|||
44260420|NCT03304379|79131013|FG000|Overall Study|Physician Decision|6|||
44260421|NCT03304379|79131014|FG001|Overall Study|Physician Decision|10|||
44260422|NCT03304379|79131015|FG002|Overall Study|Physician Decision|6|||
44260423|NCT03304379|79131016|FG003|Overall Study|Physician Decision|9|||
44260424|NCT03304379|79131017|FG004|Overall Study|Physician Decision|10|||
44260425|NCT03304379|79131013|FG000|Overall Study|Withdrawal by Subject|26|||
44260426|NCT03304379|79131014|FG001|Overall Study|Withdrawal by Subject|58|||
44260427|NCT03304379|79131015|FG002|Overall Study|Withdrawal by Subject|66|||
44260428|NCT03304379|79131016|FG003|Overall Study|Withdrawal by Subject|3|||
44260429|NCT03304379|79131017|FG004|Overall Study|Withdrawal by Subject|5|||
44260430|NCT03304379|79131013|FG000|Overall Study|Lost to Follow-up|8|||
44260431|NCT03304379|79131014|FG001|Overall Study|Lost to Follow-up|24|||
44260432|NCT03304379|79131015|FG002|Overall Study|Lost to Follow-up|35|||
44260433|NCT03304379|79131016|FG003|Overall Study|Lost to Follow-up|4|||
44260434|NCT03304379|79131017|FG004|Overall Study|Lost to Follow-up|0|||
44260435|NCT03304379|79131013|FG000|Overall Study|Death|1|||
44260436|NCT03304379|79131014|FG001|Overall Study|Death|2|||
44260437|NCT03304379|79131015|FG002|Overall Study|Death|0|||
44260438|NCT03304379|79131016|FG003|Overall Study|Death|0|||
44260439|NCT03304379|79131017|FG004|Overall Study|Death|0|||
44260440|NCT03304379|79131013|FG000|Overall Study|Other|0|||
44260441|NCT03304379|79131014|FG001|Overall Study|Other|1|||
44260442|NCT03304379|79131015|FG002|Overall Study|Other|0|||
44260443|NCT03304379|79131016|FG003|Overall Study|Other|0|||
44260444|NCT03304379|79131017|FG004|Overall Study|Other|0|||
44260445|NCT01044433|79131090|FG000|Overall Study|Lost to Follow-up|3|||
44260446|NCT01044433|79131090|FG000|Overall Study|Withdrawal by Subject|3|||
44260447|NCT01043185|79131099|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
44260448|NCT01043185|79131100|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
44260449|NCT01043185|79131101|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
44260450|NCT01043185|79131102|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
44260451|NCT01043185|79131103|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
44260452|NCT01043185|79131104|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
44260453|NCT01043185|79131105|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
44260454|NCT01043185|79131106|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
44260455|NCT01043185|79131107|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
44260456|NCT01043185|79131108|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
44260457|NCT01042093|79131133|FG000|Overall Study|Protocol Violation|2|||
44260458|NCT01042093|79131134|FG001|Overall Study|Protocol Violation|2|||
44260459|NCT01042093|79131135|FG002|Overall Study|Protocol Violation|2|||
44260460|NCT01042093|79131136|FG003|Overall Study|Protocol Violation|3|||
44260461|NCT01042093|79131133|FG000|Overall Study|Withdrawal by Subject|0|||
44260462|NCT01042093|79131134|FG001|Overall Study|Withdrawal by Subject|0|||
44260463|NCT01042093|79131135|FG002|Overall Study|Withdrawal by Subject|0|||
44260464|NCT01042093|79131136|FG003|Overall Study|Withdrawal by Subject|1|||
44260465|NCT01041859|79131166|FG000|Open-Label Titration|Adverse Event|69|||
44260466|NCT01041859|79131167|FG001|Open-Label Titration|Adverse Event|0|||
44260467|NCT01041859|79131168|FG002|Open-Label Titration|Adverse Event|0|||
44260468|NCT01041859|79131166|FG000|Open-Label Titration|Lack of Efficacy|3|||
44260469|NCT01041859|79131167|FG001|Open-Label Titration|Lack of Efficacy|0|||
44260470|NCT01041859|79131168|FG002|Open-Label Titration|Lack of Efficacy|0|||
44260471|NCT01041859|79131166|FG000|Open-Label Titration|Lost to Follow-up|1|||
44260472|NCT01041859|79131167|FG001|Open-Label Titration|Lost to Follow-up|0|||
44260473|NCT01041859|79131168|FG002|Open-Label Titration|Lost to Follow-up|0|||
44260474|NCT01041859|79131166|FG000|Open-Label Titration|Physician Decision|1|||
44260475|NCT01041859|79131167|FG001|Open-Label Titration|Physician Decision|0|||
44260476|NCT01041859|79131168|FG002|Open-Label Titration|Physician Decision|0|||
44260477|NCT01041859|79131166|FG000|Open-Label Titration|Protocol Violation|1|||
44260478|NCT01041859|79131167|FG001|Open-Label Titration|Protocol Violation|0|||
44260479|NCT01041859|79131168|FG002|Open-Label Titration|Protocol Violation|0|||
44260480|NCT01041859|79131166|FG000|Open-Label Titration|Other|7|||
44260481|NCT01041859|79131167|FG001|Open-Label Titration|Other|0|||
44260482|NCT01041859|79131168|FG002|Open-Label Titration|Other|0|||
44260483|NCT01041859|79131166|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
44260484|NCT01041859|79131167|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
44260485|NCT01041859|79131168|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
44260486|NCT01041859|79131166|FG000|Open-Label Titration|Withdrawal by Subject|11|||
44260487|NCT01041859|79131167|FG001|Open-Label Titration|Withdrawal by Subject|0|||
44260488|NCT01041859|79131168|FG002|Open-Label Titration|Withdrawal by Subject|0|||
44260489|NCT01041859|79131166|FG000|Double-Blind Maintenance|Adverse Event|0|||
44260490|NCT01041859|79131167|FG001|Double-Blind Maintenance|Adverse Event|23|||
44260491|NCT01041859|79131168|FG002|Double-Blind Maintenance|Adverse Event|13|||
44260492|NCT01041859|79131166|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
44260493|NCT01041859|79131167|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
44260494|NCT01041859|79131168|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
44260495|NCT01041859|79131166|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
44260496|NCT01041859|79131167|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
44260497|NCT01041859|79131168|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
44260498|NCT01041859|79131166|FG000|Double-Blind Maintenance|Physician Decision|0|||
44260499|NCT01041859|79131167|FG001|Double-Blind Maintenance|Physician Decision|2|||
44260500|NCT01041859|79131168|FG002|Double-Blind Maintenance|Physician Decision|1|||
44260501|NCT01041859|79131166|FG000|Double-Blind Maintenance|Protocol Violation|0|||
44260502|NCT01041859|79131167|FG001|Double-Blind Maintenance|Protocol Violation|1|||
44260503|NCT01041859|79131168|FG002|Double-Blind Maintenance|Protocol Violation|3|||
44260504|NCT01041859|79131166|FG000|Double-Blind Maintenance|Other|0|||
44260505|NCT01041859|79131167|FG001|Double-Blind Maintenance|Other|6|||
44260506|NCT01041859|79131168|FG002|Double-Blind Maintenance|Other|2|||
44260507|NCT01041859|79131166|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
44260508|NCT01041859|79131167|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
44260509|NCT01041859|79131168|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
44260510|NCT01041859|79131166|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
44260511|NCT01041859|79131167|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
44260512|NCT01041859|79131168|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
44260513|NCT01040845|79131177|FG000|Overall Study|Withdrawal by Subject|1|||
44260514|NCT01040845|79131178|FG001|Overall Study|Withdrawal by Subject|1|||
44260515|NCT01040845|79131177|FG000|Overall Study|Physician Decision|1|||
44260516|NCT01040845|79131178|FG001|Overall Study|Physician Decision|0|||
44260517|NCT01040689|79131186|FG000|Overall Study|Adverse Event|0|||
44260518|NCT01040689|79131187|FG001|Overall Study|Adverse Event|0|||
44260519|NCT01040689|79131188|FG002|Overall Study|Adverse Event|2|||
44260520|NCT01040689|79131189|FG003|Overall Study|Adverse Event|4|||
44260521|NCT01040689|79131186|FG000|Overall Study|Lack of Efficacy|0|||
44260522|NCT01040689|79131187|FG001|Overall Study|Lack of Efficacy|0|||
44260523|NCT01040689|79131188|FG002|Overall Study|Lack of Efficacy|1|||
44260524|NCT01040689|79131189|FG003|Overall Study|Lack of Efficacy|0|||
44260525|NCT01040689|79131186|FG000|Overall Study|Lost to Follow-up|1|||
44260526|NCT01040689|79131187|FG001|Overall Study|Lost to Follow-up|0|||
44260527|NCT01040689|79131188|FG002|Overall Study|Lost to Follow-up|0|||
44260528|NCT01040689|79131189|FG003|Overall Study|Lost to Follow-up|0|||
44260529|NCT01040689|79131186|FG000|Overall Study|Withdrawal by Subject|2|||
44260530|NCT01040689|79131187|FG001|Overall Study|Withdrawal by Subject|1|||
44260531|NCT01040689|79131188|FG002|Overall Study|Withdrawal by Subject|1|||
44260532|NCT01040689|79131189|FG003|Overall Study|Withdrawal by Subject|0|||
44260533|NCT01040689|79131186|FG000|Overall Study|Other reasons not listed above|0|||
44260534|NCT01040689|79131187|FG001|Overall Study|Other reasons not listed above|1|||
44260535|NCT01040689|79131188|FG002|Overall Study|Other reasons not listed above|0|||
44260536|NCT01040689|79131189|FG003|Overall Study|Other reasons not listed above|0|||
44260537|NCT01047319|79131238|FG000|Overall Study|Teva requested participant withdrawal|3|||
44260538|NCT01047319|79131239|FG001|Overall Study|Teva requested participant withdrawal|0|||
44260539|NCT01047319|79131240|FG002|Overall Study|Teva requested participant withdrawal|1|||
44260540|NCT01047319|79131238|FG000|Overall Study|Protocol Violation|3|||
44260541|NCT01047319|79131239|FG001|Overall Study|Protocol Violation|2|||
44260542|NCT01047319|79131240|FG002|Overall Study|Protocol Violation|4|||
44260543|NCT01047319|79131238|FG000|Overall Study|Lack of Efficacy|4|||
44260544|NCT01047319|79131239|FG001|Overall Study|Lack of Efficacy|3|||
44260545|NCT01047319|79131240|FG002|Overall Study|Lack of Efficacy|3|||
44260546|NCT01047319|79131238|FG000|Overall Study|Death|5|||
44260547|NCT01047319|79131239|FG001|Overall Study|Death|1|||
44260548|NCT01047319|79131240|FG002|Overall Study|Death|5|||
44260549|NCT01047319|79131238|FG000|Overall Study|Pregnancy|13|||
44260550|NCT01047319|79131239|FG001|Overall Study|Pregnancy|8|||
44260551|NCT01047319|79131240|FG002|Overall Study|Pregnancy|8|||
44260552|NCT01047319|79131238|FG000|Overall Study|Physician Decision|12|||
44260553|NCT01047319|79131239|FG001|Overall Study|Physician Decision|9|||
44260554|NCT01047319|79131240|FG002|Overall Study|Physician Decision|10|||
44260555|NCT01047319|79131238|FG000|Overall Study|Lost to Follow-up|14|||
44260556|NCT01047319|79131239|FG001|Overall Study|Lost to Follow-up|10|||
44260557|NCT01047319|79131240|FG002|Overall Study|Lost to Follow-up|10|||
44260558|NCT01047319|79131238|FG000|Overall Study|Adverse Event|16|||
44260559|NCT01047319|79131239|FG001|Overall Study|Adverse Event|27|||
44260560|NCT01047319|79131240|FG002|Overall Study|Adverse Event|21|||
44260561|NCT01047319|79131238|FG000|Overall Study|Withdrawal by Subject|77|||
44260562|NCT01047319|79131239|FG001|Overall Study|Withdrawal by Subject|75|||
44260563|NCT01047319|79131240|FG002|Overall Study|Withdrawal by Subject|87|||
44260564|NCT01047319|79131238|FG000|Overall Study|Study terminated by Sponsor|198|||
44260565|NCT01047319|79131239|FG001|Overall Study|Study terminated by Sponsor|215|||
44260566|NCT01047319|79131240|FG002|Overall Study|Study terminated by Sponsor|203|||
44260567|NCT00014911|79131557|FG000|Overall Study|Adverse Event|1|||
44260568|NCT00014911|79131557|FG000|Overall Study|Lost to Follow-up|1|||
44260569|NCT00014911|79131557|FG000|Overall Study|Withdrawal by Subject|6|||
44260570|NCT00014911|79131557|FG000|Overall Study|Unknown Reasons|2|||
44260571|NCT00014911|79131557|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
44260572|NCT01049009|79132104|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
44260573|NCT01049009|79132105|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
44260574|NCT01049009|79132104|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
44260575|NCT01049009|79132105|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
44260576|NCT01049009|79132104|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
44260577|NCT01049009|79132105|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
44260578|NCT01049009|79132104|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
44260579|NCT01049009|79132105|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
44260580|NCT01047683|79132127|FG000|Overall Study|Adverse Event|3|||
44260581|NCT01047683|79132128|FG001|Overall Study|Adverse Event|1|||
44260582|NCT01047683|79132129|FG002|Overall Study|Adverse Event|0|||
44260583|NCT01047683|79132127|FG000|Overall Study|Withdrew Consent|1|||
44260584|NCT01047683|79132128|FG001|Overall Study|Withdrew Consent|4|||
44260585|NCT01047683|79132129|FG002|Overall Study|Withdrew Consent|2|||
44260586|NCT01047683|79132127|FG000|Overall Study|Lost to Follow-up|0|||
44260587|NCT01047683|79132128|FG001|Overall Study|Lost to Follow-up|1|||
44260588|NCT01047683|79132129|FG002|Overall Study|Lost to Follow-up|0|||
44260589|NCT01047683|79132127|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
44260590|NCT01047683|79132128|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
44260591|NCT01047683|79132129|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
44260592|NCT01047293|79132217|FG000|Overall Study|DLT criteria not fulfilled|1|||
44260593|NCT01047293|79132218|FG001|Overall Study|DLT criteria not fulfilled|1|||
44260594|NCT01047293|79132219|FG002|Overall Study|DLT criteria not fulfilled|0|||
44260595|NCT01047293|79132220|FG003|Overall Study|DLT criteria not fulfilled|0|||
44260596|NCT01045967|79132229|FG000|Second Intervention|Protocol Violation|0|||
44260597|NCT01045967|79132230|FG001|Second Intervention|Protocol Violation|1|||
44260598|NCT01045421|79132816|FG000|Phase 1|Progressive Disease|0|||
44260599|NCT01045421|79132817|FG001|Phase 1|Progressive Disease|0|||
44260600|NCT01045421|79132818|FG002|Phase 1|Progressive Disease|0|||
44260601|NCT01045421|79132819|FG003|Phase 1|Progressive Disease|0|||
44260602|NCT01045421|79132820|FG004|Phase 1|Progressive Disease|1|||
44260603|NCT01045421|79132821|FG005|Phase 1|Progressive Disease|0|||
44260604|NCT01045421|79132822|FG006|Phase 1|Progressive Disease|0|||
44260605|NCT01045421|79132823|FG007|Phase 1|Progressive Disease|0|||
44260606|NCT01045421|79132824|FG008|Phase 1|Progressive Disease|0|||
44260607|NCT01045421|79132825|FG009|Phase 1|Progressive Disease|0|||
44260608|NCT01045421|79132826|FG010|Phase 1|Progressive Disease|0|||
44260609|NCT01045421|79132816|FG000|Phase 1|Withdrawal by Subject|0|||
44260610|NCT01045421|79132817|FG001|Phase 1|Withdrawal by Subject|0|||
44260611|NCT01045421|79132818|FG002|Phase 1|Withdrawal by Subject|0|||
44348748|NCT00918385|79353489|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
44447003|NCT00568178|79455314|FG005|Open Label Extension|Progressive Disease|1|||
44447004|NCT00568178|79455309|FG000|Open Label Extension|Termination of Trial|0|||
44447005|NCT00568178|79455310|FG001|Open Label Extension|Termination of Trial|0|||
44447006|NCT00568178|79455311|FG002|Open Label Extension|Termination of Trial|0|||
44348749|NCT00918385|79353488|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
44348750|NCT00918385|79353489|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
44348751|NCT01211262|79353499|FG000|Overall Study|Progressive Disease|18|||
44348752|NCT01211262|79353500|FG001|Overall Study|Progressive Disease|9|||
44348753|NCT01211262|79353499|FG000|Overall Study|Adverse Event|4|||
44348754|NCT01211262|79353500|FG001|Overall Study|Adverse Event|0|||
44348755|NCT01211262|79353499|FG000|Overall Study|Withdrawal of Consent|1|||
44348756|NCT01211262|79353500|FG001|Overall Study|Withdrawal of Consent|0|||
44348757|NCT01211262|79353499|FG000|Overall Study|Other|0|||
44348758|NCT01211262|79353500|FG001|Overall Study|Other|1|||
44348759|NCT01211184|79353512|FG000|Overall Study|Withdrawal by Subject|0|||
44348760|NCT01211184|79353513|FG001|Overall Study|Withdrawal by Subject|2|||
44348761|NCT01211184|79353514|FG002|Overall Study|Withdrawal by Subject|1|||
44348762|NCT00924469|79353527|FG000|Overall Study|Adverse Event|2|||
44348763|NCT00924469|79353528|FG001|Overall Study|Adverse Event|0|||
44348764|NCT00924469|79353527|FG000|Overall Study|Withdrawal by Subject|0|||
44348765|NCT00924469|79353528|FG001|Overall Study|Withdrawal by Subject|1|||
44348766|NCT00924469|79353527|FG000|Overall Study|Lost to Follow-up|0|||
44447007|NCT00568178|79455312|FG003|Open Label Extension|Termination of Trial|0|||
44447008|NCT00568178|79455313|FG004|Open Label Extension|Termination of Trial|45|||
44447009|NCT00568178|79455314|FG005|Open Label Extension|Termination of Trial|47|||
44447010|NCT00568178|79455309|FG000|Open Label Extension|Withdrawal by Subject|0|||
44447011|NCT00568178|79455310|FG001|Open Label Extension|Withdrawal by Subject|0|||
44447012|NCT00568178|79455311|FG002|Open Label Extension|Withdrawal by Subject|0|||
44447013|NCT00568178|79455312|FG003|Open Label Extension|Withdrawal by Subject|0|||
44447014|NCT00568178|79455313|FG004|Open Label Extension|Withdrawal by Subject|4|||
44447015|NCT00568178|79455314|FG005|Open Label Extension|Withdrawal by Subject|4|||
44447016|NCT00577889|79455331|FG000|Overall Study|Withdrawal by Subject|1|||
44447017|NCT00577889|79455332|FG001|Overall Study|Withdrawal by Subject|0|||
44447018|NCT00577889|79455333|FG002|Overall Study|Withdrawal by Subject|0|||
44447019|NCT00460564|79455345|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
44447020|NCT00460564|79455346|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
44447021|NCT00460564|79455347|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44447022|NCT00460564|79455348|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44447023|NCT00460564|79455349|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44447024|NCT00460564|79455350|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44447025|NCT00460564|79455351|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44447026|NCT00460564|79455352|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
44447027|NCT00460564|79455345|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
44447028|NCT00460564|79455346|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447029|NCT00460564|79455347|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447030|NCT00460564|79455348|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447031|NCT00460564|79455349|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447032|NCT00460564|79455350|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447033|NCT00460564|79455351|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447034|NCT00460564|79455352|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
44447035|NCT00460564|79455345|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44447036|NCT00460564|79455346|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44447037|NCT00460564|79455347|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44447038|NCT00460564|79455348|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44447039|NCT00460564|79455349|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
44447040|NCT00460564|79455350|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
44447041|NCT00460564|79455351|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
44447042|NCT00460564|79455352|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
44447043|NCT00460564|79455345|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44447044|NCT00460564|79455346|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44447045|NCT00460564|79455347|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44447046|NCT00460564|79455348|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44348767|NCT00924469|79353528|FG001|Overall Study|Lost to Follow-up|1|||
44260612|NCT01045421|79132819|FG003|Phase 1|Withdrawal by Subject|1|||
44447047|NCT00460564|79455349|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
44447048|NCT00460564|79455350|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
44447049|NCT00460564|79455351|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44447050|NCT00460564|79455352|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
44447051|NCT00460564|79455345|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447052|NCT00460564|79455346|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447053|NCT00460564|79455347|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447054|NCT00460564|79455348|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447055|NCT00460564|79455349|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
44447056|NCT00460564|79455350|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447057|NCT00460564|79455351|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447058|NCT00460564|79455352|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
44447059|NCT00567476|79455374|FG000|Overall Study|Adverse Event|2|||
44447060|NCT00567476|79455375|FG001|Overall Study|Adverse Event|0|||
44447061|NCT00567476|79455374|FG000|Overall Study|Pregnancy|1|||
44447062|NCT00567476|79455375|FG001|Overall Study|Pregnancy|0|||
44447063|NCT00567476|79455374|FG000|Overall Study|Protocol Violation|4|||
44447064|NCT00567476|79455375|FG001|Overall Study|Protocol Violation|1|||
44447065|NCT00567476|79455374|FG000|Overall Study|Lost to Follow-up|0|||
44447066|NCT00567476|79455375|FG001|Overall Study|Lost to Follow-up|1|||
44447067|NCT00567476|79455374|FG000|Overall Study|Administrative issues|1|||
44447068|NCT00567476|79455375|FG001|Overall Study|Administrative issues|0|||
44447069|NCT00567476|79455374|FG000|Overall Study|Medical Decision|0|||
44447070|NCT00567476|79455375|FG001|Overall Study|Medical Decision|1|||
44447071|NCT00567476|79455374|FG000|Overall Study|Non-adherence to protocol|0|||
44447072|NCT00567476|79455375|FG001|Overall Study|Non-adherence to protocol|1|||
44447073|NCT00516321|79455383|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
44447074|NCT00516321|79455384|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
44447075|NCT00516321|79455385|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
44447076|NCT00516321|79455383|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
44447077|NCT00516321|79455384|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
44447078|NCT00516321|79455385|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
44166457|NCT02288325|78959465|FG000|Double-blind Treatment Period|Protocol Violation|0|||
44166458|NCT02288325|78959466|FG001|Double-blind Treatment Period|Protocol Violation|1|||
44166459|NCT02288325|78959467|FG002|Double-blind Treatment Period|Protocol Violation|2|||
44166460|NCT02288325|78959465|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
44166461|NCT02288325|78959466|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
44166462|NCT02288325|78959467|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
44166463|NCT02288325|78959465|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
44166464|NCT02288325|78959466|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
44166465|NCT02288325|78959467|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
44166466|NCT02509117|78959484|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166467|NCT02509117|78959485|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
44166468|NCT02509117|78959486|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166469|NCT02509117|78959487|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166470|NCT02509117|78959488|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166471|NCT02509117|78959489|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166472|NCT02509117|78959490|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166473|NCT02509117|78959491|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166474|NCT02509117|78959492|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166475|NCT02509117|78959493|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
44166476|NCT02509117|78959484|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166477|NCT02509117|78959485|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166478|NCT02509117|78959486|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166479|NCT02509117|78959487|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166480|NCT02509117|78959488|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166481|NCT02509117|78959489|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166482|NCT02509117|78959490|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166483|NCT02509117|78959491|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166484|NCT02509117|78959492|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
44166485|NCT02509117|78959493|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
44166486|NCT02509117|78959484|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166487|NCT02509117|78959485|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166488|NCT02509117|78959486|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166489|NCT02509117|78959487|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166490|NCT02509117|78959488|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166491|NCT02509117|78959489|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166492|NCT02509117|78959490|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166493|NCT02509117|78959491|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166494|NCT02509117|78959492|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
44166495|NCT02509117|78959493|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
44166496|NCT01654549|78959533|FG000|Overall Study|H.pylori eradication not successful|0|||
44166497|NCT01654549|78959534|FG001|Overall Study|H.pylori eradication not successful|1|||
44166498|NCT02508649|78959548|FG000|Overall Study|Withdrawal by Subject|4|||
44166499|NCT02508649|78959549|FG001|Overall Study|Withdrawal by Subject|6|||
44166500|NCT02508649|78959550|FG002|Overall Study|Withdrawal by Subject|5|||
44166501|NCT02508649|78959551|FG003|Overall Study|Withdrawal by Subject|6|||
44166502|NCT02508649|78959548|FG000|Overall Study|Investigator withdrew the subject|1|||
44166503|NCT02508649|78959549|FG001|Overall Study|Investigator withdrew the subject|2|||
44166504|NCT02508649|78959550|FG002|Overall Study|Investigator withdrew the subject|1|||
44166505|NCT02508649|78959551|FG003|Overall Study|Investigator withdrew the subject|0|||
44166506|NCT02508649|78959548|FG000|Overall Study|Post randomization screening failure|12|||
44166507|NCT02508649|78959549|FG001|Overall Study|Post randomization screening failure|4|||
44166508|NCT02508649|78959550|FG002|Overall Study|Post randomization screening failure|9|||
44166509|NCT02508649|78959551|FG003|Overall Study|Post randomization screening failure|3|||
44166510|NCT02508649|78959548|FG000|Overall Study|Lost to Follow-up|1|||
44166511|NCT02508649|78959549|FG001|Overall Study|Lost to Follow-up|1|||
44166512|NCT02508649|78959550|FG002|Overall Study|Lost to Follow-up|0|||
44166513|NCT02508649|78959551|FG003|Overall Study|Lost to Follow-up|1|||
44166514|NCT02505217|78959566|FG000|Overall Study|Withdrawal by Subject|1|||
44166515|NCT02505217|78959567|FG001|Overall Study|Withdrawal by Subject|2|||
44260613|NCT01045421|79132820|FG004|Phase 1|Withdrawal by Subject|0|||
44447079|NCT00516321|79455383|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
44260614|NCT01045421|79132821|FG005|Phase 1|Withdrawal by Subject|0|||
44166516|NCT02504827|78959573|FG000|Overall Study|Could not produce sputum|1|||
44260615|NCT01045421|79132822|FG006|Phase 1|Withdrawal by Subject|0|||
44260616|NCT01045421|79132823|FG007|Phase 1|Withdrawal by Subject|0|||
44260617|NCT01045421|79132824|FG008|Phase 1|Withdrawal by Subject|0|||
44260618|NCT01045421|79132825|FG009|Phase 1|Withdrawal by Subject|0|||
44260619|NCT01045421|79132826|FG010|Phase 1|Withdrawal by Subject|0|||
44260620|NCT01045421|79132816|FG000|Phase 2|Progressive Disease|0|||
44260621|NCT01045421|79132817|FG001|Phase 2|Progressive Disease|0|||
44260622|NCT01045421|79132818|FG002|Phase 2|Progressive Disease|0|||
44260623|NCT01045421|79132819|FG003|Phase 2|Progressive Disease|0|||
44260624|NCT01045421|79132820|FG004|Phase 2|Progressive Disease|0|||
44260625|NCT01045421|79132821|FG005|Phase 2|Progressive Disease|0|||
44260626|NCT01045421|79132822|FG006|Phase 2|Progressive Disease|0|||
44260627|NCT01045421|79132823|FG007|Phase 2|Progressive Disease|1|||
44260628|NCT01045421|79132824|FG008|Phase 2|Progressive Disease|1|||
44260629|NCT01045421|79132825|FG009|Phase 2|Progressive Disease|1|||
44260630|NCT01045421|79132826|FG010|Phase 2|Progressive Disease|1|||
44260631|NCT01045421|79132816|FG000|Phase 2|Death|0|||
44260632|NCT01045421|79132817|FG001|Phase 2|Death|0|||
44260633|NCT01045421|79132818|FG002|Phase 2|Death|0|||
44260634|NCT01045421|79132819|FG003|Phase 2|Death|0|||
44260635|NCT01045421|79132820|FG004|Phase 2|Death|0|||
44260636|NCT01045421|79132821|FG005|Phase 2|Death|0|||
44260637|NCT01045421|79132822|FG006|Phase 2|Death|0|||
44260638|NCT01045421|79132823|FG007|Phase 2|Death|1|||
44260639|NCT01045421|79132824|FG008|Phase 2|Death|1|||
44260640|NCT01045421|79132825|FG009|Phase 2|Death|2|||
44260641|NCT01045421|79132826|FG010|Phase 2|Death|0|||
44260642|NCT01045421|79132816|FG000|Phase 2|Other|0|||
44260643|NCT01045421|79132817|FG001|Phase 2|Other|0|||
44260644|NCT01045421|79132818|FG002|Phase 2|Other|0|||
44260645|NCT01045421|79132819|FG003|Phase 2|Other|0|||
44260646|NCT01045421|79132820|FG004|Phase 2|Other|0|||
44260647|NCT01045421|79132821|FG005|Phase 2|Other|0|||
44260648|NCT01045421|79132822|FG006|Phase 2|Other|0|||
44260649|NCT01045421|79132823|FG007|Phase 2|Other|3|||
44260650|NCT01045421|79132824|FG008|Phase 2|Other|0|||
44260651|NCT01045421|79132825|FG009|Phase 2|Other|0|||
44260652|NCT01045421|79132826|FG010|Phase 2|Other|1|||
44260653|NCT01042535|79132874|FG000|Overall Study|disease progression prior to treatment|3|||
44260654|NCT01042535|79132874|FG000|Overall Study|disease progression during treatment|3|||
44260655|NCT01042535|79132874|FG000|Overall Study|complications from other disease|2|||
44260656|NCT01041287|79132880|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
44260657|NCT01041287|79132881|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
44260658|NCT01041287|79132880|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
44260659|NCT01041287|79132881|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
44260660|NCT01040351|79132902|FG000|Overall Study|poor ovarian response|1|||
44260661|NCT01040351|79132903|FG001|Overall Study|poor ovarian response|2|||
44260662|NCT02049957|79132923|FG000|Overall Study|Progressive Disease|5|||
44260663|NCT02049957|79132924|FG001|Overall Study|Progressive Disease|4|||
44260664|NCT02049957|79132925|FG002|Overall Study|Progressive Disease|2|||
44260665|NCT02049957|79132926|FG003|Overall Study|Progressive Disease|2|||
44260666|NCT02049957|79132927|FG004|Overall Study|Progressive Disease|6|||
44260667|NCT02049957|79132928|FG005|Overall Study|Progressive Disease|35|||
44260668|NCT02049957|79132929|FG006|Overall Study|Progressive Disease|7|||
44260669|NCT02049957|79132930|FG007|Overall Study|Progressive Disease|26|||
44260670|NCT02049957|79132931|FG008|Overall Study|Progressive Disease|6|||
44260671|NCT02049957|79132923|FG000|Overall Study|Adverse Event|1|||
44260672|NCT02049957|79132924|FG001|Overall Study|Adverse Event|1|||
44260673|NCT02049957|79132925|FG002|Overall Study|Adverse Event|1|||
44260674|NCT02049957|79132926|FG003|Overall Study|Adverse Event|0|||
44260675|NCT02049957|79132927|FG004|Overall Study|Adverse Event|0|||
44260676|NCT02049957|79132928|FG005|Overall Study|Adverse Event|5|||
44260677|NCT02049957|79132929|FG006|Overall Study|Adverse Event|0|||
44260678|NCT02049957|79132930|FG007|Overall Study|Adverse Event|6|||
44260679|NCT02049957|79132931|FG008|Overall Study|Adverse Event|1|||
44260680|NCT02049957|79132923|FG000|Overall Study|Study Terminated by Sponsor|0|||
44260681|NCT02049957|79132924|FG001|Overall Study|Study Terminated by Sponsor|1|||
44260682|NCT02049957|79132925|FG002|Overall Study|Study Terminated by Sponsor|0|||
44348768|NCT00924313|79353534|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
44260683|NCT02049957|79132926|FG003|Overall Study|Study Terminated by Sponsor|0|||
44260684|NCT02049957|79132927|FG004|Overall Study|Study Terminated by Sponsor|0|||
44260685|NCT02049957|79132928|FG005|Overall Study|Study Terminated by Sponsor|0|||
44260686|NCT02049957|79132929|FG006|Overall Study|Study Terminated by Sponsor|1|||
44260687|NCT02049957|79132930|FG007|Overall Study|Study Terminated by Sponsor|0|||
44260688|NCT02049957|79132931|FG008|Overall Study|Study Terminated by Sponsor|0|||
44260689|NCT02049957|79132923|FG000|Overall Study|Withdrawal by Subject|0|||
44260690|NCT02049957|79132924|FG001|Overall Study|Withdrawal by Subject|0|||
44260691|NCT02049957|79132925|FG002|Overall Study|Withdrawal by Subject|0|||
44260692|NCT02049957|79132926|FG003|Overall Study|Withdrawal by Subject|1|||
44260693|NCT02049957|79132927|FG004|Overall Study|Withdrawal by Subject|0|||
44260694|NCT02049957|79132928|FG005|Overall Study|Withdrawal by Subject|2|||
44260695|NCT02049957|79132929|FG006|Overall Study|Withdrawal by Subject|0|||
44260696|NCT02049957|79132930|FG007|Overall Study|Withdrawal by Subject|3|||
44260697|NCT02049957|79132931|FG008|Overall Study|Withdrawal by Subject|1|||
44447080|NCT00516321|79455384|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
44447081|NCT00516321|79455385|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
44447082|NCT00516321|79455383|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
44447083|NCT00516321|79455384|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
44260698|NCT02049957|79132923|FG000|Overall Study|Physician Decision|0|||
44348769|NCT01209780|79353542|FG000|Overall Study|Adverse Event|0|||
44260699|NCT02049957|79132924|FG001|Overall Study|Physician Decision|0|||
44260700|NCT02049957|79132925|FG002|Overall Study|Physician Decision|0|||
44260701|NCT02049957|79132926|FG003|Overall Study|Physician Decision|0|||
44260702|NCT02049957|79132927|FG004|Overall Study|Physician Decision|0|||
44260703|NCT02049957|79132928|FG005|Overall Study|Physician Decision|1|||
44260704|NCT02049957|79132929|FG006|Overall Study|Physician Decision|0|||
44260705|NCT02049957|79132930|FG007|Overall Study|Physician Decision|0|||
44260706|NCT02049957|79132931|FG008|Overall Study|Physician Decision|0|||
44260707|NCT00014495|79133194|FG000|Overall Study|Death|0|||
44260708|NCT00014495|79133195|FG001|Overall Study|Death|0|||
44260709|NCT00014495|79133196|FG002|Overall Study|Death|1|||
44260710|NCT00014495|79133197|FG003|Overall Study|Death|0|||
44260711|NCT00014495|79133194|FG000|Overall Study|Clinical deterioration|0|||
44260712|NCT00014495|79133195|FG001|Overall Study|Clinical deterioration|0|||
44260713|NCT00014495|79133196|FG002|Overall Study|Clinical deterioration|0|||
44260714|NCT00014495|79133197|FG003|Overall Study|Clinical deterioration|1|||
44260715|NCT01351623|79135209|FG000|Overall Study|Protocol Violation|2|||
44260716|NCT01351623|79135209|FG000|Overall Study|Adverse Event|4|||
44260717|NCT01351623|79135209|FG000|Overall Study|Withdrawal by Subject|1|||
44260718|NCT01351623|79135209|FG000|Overall Study|Death|2|||
44260719|NCT03670953|79135350|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
44260720|NCT03670953|79135351|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
44260721|NCT03670953|79135352|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
44260722|NCT03670953|79135353|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
44260723|NCT03670953|79135350|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
44260724|NCT03670953|79135351|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
44260725|NCT03670953|79135352|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
44260726|NCT03670953|79135353|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
44260727|NCT03670953|79135350|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
44260728|NCT03670953|79135351|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
44260729|NCT03670953|79135352|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
44260730|NCT03670953|79135353|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
44260731|NCT03670953|79135350|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
44260732|NCT03670953|79135351|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
44260733|NCT03670953|79135352|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
44260734|NCT03670953|79135353|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
44260735|NCT03670953|79135350|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
44260736|NCT03670953|79135351|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
44260737|NCT03670953|79135352|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
44260738|NCT03670953|79135353|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
44260739|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
44260740|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
44260741|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
44260742|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
44260743|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
44260744|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
44260745|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
44260746|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
44260747|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
44260748|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
44260749|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
44260750|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
44260751|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
44260752|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
44260753|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
44260754|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
44260755|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
44260756|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
44260757|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
44260758|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
44260759|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
44260760|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
44260761|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
44260762|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
44260763|NCT03670953|79135350|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
44260764|NCT03670953|79135351|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
44260765|NCT03670953|79135352|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
44260766|NCT03670953|79135353|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
44260767|NCT03670953|79135350|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
44260768|NCT03670953|79135351|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
44260769|NCT03670953|79135352|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
44260770|NCT03670953|79135353|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
44260771|NCT03670953|79135350|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
44260772|NCT03670953|79135351|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
44260773|NCT03670953|79135352|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
44260774|NCT03670953|79135353|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
44260775|NCT03670953|79135350|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
44260776|NCT03670953|79135351|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
44260777|NCT03670953|79135352|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
44260778|NCT03670953|79135353|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
44260779|NCT03670953|79135350|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
44260780|NCT03670953|79135351|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
44260781|NCT03670953|79135352|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
44260782|NCT03670953|79135353|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
44260783|NCT03670953|79135350|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
44260784|NCT03670953|79135351|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
44260785|NCT03670953|79135352|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
44260786|NCT03670953|79135353|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
44260787|NCT03670953|79135350|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
44260788|NCT03670953|79135351|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
44260789|NCT03670953|79135352|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
44260790|NCT03670953|79135353|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
44260791|NCT00636818|79135379|FG000|Overall Study|Adverse Event|1|||
44260792|NCT00636818|79135379|FG000|Overall Study|Lost to Follow-up|2|||
44260793|NCT00636818|79135379|FG000|Overall Study|Entry Criteria Exclusion|3|||
44260794|NCT00636818|79135379|FG000|Overall Study|Protocol Violation|1|||
44260795|NCT00636818|79135379|FG000|Overall Study|Withdrawal by Subject|4|||
44260796|NCT03127137|79135385|FG000|Overall Study|Requested sedation after consent|1|||
44260797|NCT03127137|79135386|FG001|Overall Study|Requested sedation after consent|0|||
44260798|NCT03127137|79135385|FG000|Overall Study|Malfunction in electronic data collection|1|||
44260799|NCT03127137|79135386|FG001|Overall Study|Malfunction in electronic data collection|0|||
44260800|NCT03127137|79135385|FG000|Overall Study|Post procedure testing could not be obtained|0|||
44260801|NCT03127137|79135386|FG001|Overall Study|Post procedure testing could not be obtained|1|||
44260802|NCT00636506|79135394|FG000|Overall Study|Lost to Follow-up|8|||
44260803|NCT00636506|79135394|FG000|Overall Study|Explanted|1|||
44260804|NCT00636506|79135394|FG000|Overall Study|Withdrawal by Subject|6|||
44260805|NCT00636506|79135394|FG000|Overall Study|Procedure aborted|1|||
44260806|NCT00636194|79135418|FG000|Overall Study|Study related symptoms and complaints|1|||
44260807|NCT00636194|79135419|FG001|Overall Study|Study related symptoms and complaints|0|||
44260808|NCT00636194|79135418|FG000|Overall Study|Protocol Violation|2|||
44260809|NCT00636194|79135419|FG001|Overall Study|Protocol Violation|0|||
44260810|NCT00635804|79135481|FG000|Overall Study|Adverse Event|0|||
44260811|NCT00635804|79135482|FG001|Overall Study|Adverse Event|0|||
44260812|NCT00635804|79135483|FG002|Overall Study|Adverse Event|0|||
44260813|NCT00635804|79135484|FG003|Overall Study|Adverse Event|0|||
44260814|NCT00635804|79135485|FG004|Overall Study|Adverse Event|0|||
44260815|NCT00635804|79135486|FG005|Overall Study|Adverse Event|1|||
44260816|NCT00635804|79135487|FG006|Overall Study|Adverse Event|0|||
44260817|NCT00635804|79135488|FG007|Overall Study|Adverse Event|0|||
44260818|NCT00635804|79135481|FG000|Overall Study|Withdrawal by Subject|1|||
44260819|NCT00635804|79135482|FG001|Overall Study|Withdrawal by Subject|0|||
44260820|NCT00635804|79135483|FG002|Overall Study|Withdrawal by Subject|0|||
44260821|NCT00635804|79135484|FG003|Overall Study|Withdrawal by Subject|0|||
44260822|NCT00635804|79135485|FG004|Overall Study|Withdrawal by Subject|0|||
44260823|NCT00635804|79135486|FG005|Overall Study|Withdrawal by Subject|0|||
44260824|NCT00635804|79135487|FG006|Overall Study|Withdrawal by Subject|0|||
44260825|NCT00635804|79135488|FG007|Overall Study|Withdrawal by Subject|0|||
44260826|NCT00635648|79135518|FG000|Overall Study|Adverse Event|12|||
44260827|NCT00635648|79135518|FG000|Overall Study|Withdrawal by Subject|9|||
44260828|NCT00635648|79135518|FG000|Overall Study|Physician Decision|4|||
44260829|NCT00635648|79135518|FG000|Overall Study|Rapid progression of baseline disease|4|||
44260830|NCT00635648|79135518|FG000|Overall Study|Use of other antifungal agent needed|1|||
44260831|NCT00635648|79135518|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
44260832|NCT00635648|79135518|FG000|Overall Study|Noncompliance with protocol|1|||
44260833|NCT00635648|79135518|FG000|Overall Study|Other reason|2|||
44260834|NCT00635102|79135543|FG000|Overall Study|Withdrawal by Subject|7|||
44260835|NCT00635102|79135544|FG001|Overall Study|Withdrawal by Subject|8|||
44260836|NCT00635024|79135559|FG000|Overall Study|Adverse Event|1|||
44260837|NCT00634244|79135617|FG000|Overall Study|Never started treatment|0|||
44260838|NCT00634244|79135618|FG001|Overall Study|Never started treatment|1|||
44260839|NCT00634244|79135619|FG002|Overall Study|Never started treatment|0|||
44260840|NCT00634244|79135617|FG000|Overall Study|Death|1|||
44260841|NCT00634244|79135618|FG001|Overall Study|Death|6|||
44260842|NCT00634244|79135619|FG002|Overall Study|Death|0|||
44260843|NCT00634244|79135617|FG000|Overall Study|Adverse Event|0|||
44260844|NCT00634244|79135618|FG001|Overall Study|Adverse Event|2|||
44260845|NCT00634244|79135619|FG002|Overall Study|Adverse Event|0|||
44260846|NCT00634244|79135617|FG000|Overall Study|Withdrawal by Subject|0|||
44260847|NCT00634244|79135618|FG001|Overall Study|Withdrawal by Subject|1|||
44260848|NCT00634244|79135619|FG002|Overall Study|Withdrawal by Subject|0|||
44260849|NCT00634244|79135617|FG000|Overall Study|Physician Decision|0|||
44260850|NCT00634244|79135618|FG001|Overall Study|Physician Decision|1|||
44260851|NCT00634244|79135619|FG002|Overall Study|Physician Decision|0|||
44260852|NCT00634244|79135617|FG000|Overall Study|Disease progression/relapse|0|||
44260853|NCT00634244|79135618|FG001|Overall Study|Disease progression/relapse|1|||
44260854|NCT00634244|79135619|FG002|Overall Study|Disease progression/relapse|0|||
44348770|NCT01209780|79353543|FG001|Overall Study|Adverse Event|1|||
44348771|NCT01209780|79353544|FG002|Overall Study|Adverse Event|0|||
44348772|NCT01209780|79353545|FG003|Overall Study|Adverse Event|0|||
44348773|NCT01209780|79353546|FG004|Overall Study|Adverse Event|0|||
44348774|NCT01209780|79353542|FG000|Overall Study|Withdrawal by Subject|9|||
44348775|NCT01209780|79353543|FG001|Overall Study|Withdrawal by Subject|2|||
44348776|NCT01209780|79353544|FG002|Overall Study|Withdrawal by Subject|1|||
44260855|NCT00634244|79135617|FG000|Overall Study|Other complicating disease|0|||
44348777|NCT01209780|79353545|FG003|Overall Study|Withdrawal by Subject|1|||
44348778|NCT01209780|79353546|FG004|Overall Study|Withdrawal by Subject|0|||
44348779|NCT01209780|79353542|FG000|Overall Study|Lost to Follow-up|17|||
44348780|NCT01209780|79353543|FG001|Overall Study|Lost to Follow-up|12|||
44348781|NCT01209780|79353544|FG002|Overall Study|Lost to Follow-up|3|||
44348782|NCT01209780|79353545|FG003|Overall Study|Lost to Follow-up|9|||
44348783|NCT01209780|79353546|FG004|Overall Study|Lost to Follow-up|4|||
44348784|NCT01209780|79353542|FG000|Overall Study|Protocol Violation|0|||
44348785|NCT01209780|79353543|FG001|Overall Study|Protocol Violation|1|||
44348786|NCT01209780|79353544|FG002|Overall Study|Protocol Violation|0|||
44348787|NCT01209780|79353545|FG003|Overall Study|Protocol Violation|0|||
44348788|NCT01209780|79353546|FG004|Overall Study|Protocol Violation|0|||
44348789|NCT01209780|79353542|FG000|Overall Study|Inappropriate enrollment|0|||
44348790|NCT01209780|79353543|FG001|Overall Study|Inappropriate enrollment|2|||
44348791|NCT01209780|79353544|FG002|Overall Study|Inappropriate enrollment|0|||
44348792|NCT01209780|79353545|FG003|Overall Study|Inappropriate enrollment|0|||
44348793|NCT01209780|79353546|FG004|Overall Study|Inappropriate enrollment|1|||
44348794|NCT00916357|79353559|FG000|Period 1|Withdrawal by Subject|1|||
44348795|NCT00916357|79353560|FG001|Period 1|Withdrawal by Subject|0|||
44348796|NCT00916357|79353561|FG002|Period 1|Withdrawal by Subject|0|||
44348797|NCT00916357|79353562|FG003|Period 1|Withdrawal by Subject|0|||
44348798|NCT00916357|79353563|FG004|Period 1|Withdrawal by Subject|0|||
44348799|NCT00916357|79353564|FG005|Period 1|Withdrawal by Subject|0|||
44348800|NCT00916357|79353559|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
44348801|NCT00916357|79353560|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
44348802|NCT00916357|79353561|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
44348803|NCT00916357|79353562|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
44348804|NCT00916357|79353563|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
44447084|NCT00516321|79455385|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
44348805|NCT00916357|79353564|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
44348806|NCT01209624|79353573|FG000|Overall Study|Death|2|||
44348807|NCT01209624|79353573|FG000|Overall Study|Adverse Event|13|||
44348808|NCT01209624|79353573|FG000|Overall Study|Lack of Efficacy|17|||
44348809|NCT01209624|79353573|FG000|Overall Study|Lost to Follow-up|290|||
44348810|NCT01209624|79353573|FG000|Overall Study|Other|4|||
44348811|NCT00916279|79353577|FG000|Overall Study|Death|2|||
44348812|NCT00916279|79353577|FG000|Overall Study|Lost to Follow-up|2|||
44348813|NCT01209078|79353586|FG000|Overall Study|Adverse Event|5|||
44348814|NCT01209078|79353587|FG001|Overall Study|Adverse Event|0|||
44447085|NCT00516321|79455383|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
44348815|NCT01209078|79353586|FG000|Overall Study|Lost to Follow-up|4|||
44348816|NCT01209078|79353587|FG001|Overall Study|Lost to Follow-up|0|||
44348817|NCT01209078|79353586|FG000|Overall Study|Physician Decision|5|||
44348818|NCT01209078|79353587|FG001|Overall Study|Physician Decision|2|||
44348819|NCT01209078|79353586|FG000|Overall Study|Withdrawal by Subject|2|||
44348820|NCT01209078|79353587|FG001|Overall Study|Withdrawal by Subject|1|||
44348821|NCT01207596|79353595|FG000|Overall Study|Physician Decision|4|||
44348822|NCT01207596|79353595|FG000|Overall Study|Lack of Efficacy|1|||
44348823|NCT01207596|79353595|FG000|Overall Study|Adverse Event|3|||
44348824|NCT01207596|79353595|FG000|Overall Study|Withdrawal by Subject|1|||
44348825|NCT00915343|79353599|FG000|Part B - Open Label Period|Treatment switch|0|||
44348826|NCT00915343|79353600|FG001|Part B - Open Label Period|Treatment switch|0|||
44348827|NCT00915343|79353601|FG002|Part B - Open Label Period|Treatment switch|1|||
44348828|NCT00915343|79353599|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
44348829|NCT00915343|79353600|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
44348830|NCT00915343|79353601|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
44348831|NCT00911989|79353613|FG000|Overall Study|Adverse Event|1|||
44348832|NCT00910273|79353619|FG000|Overall Study|Lack of Efficacy|6|||
44348833|NCT00910273|79353620|FG001|Overall Study|Lack of Efficacy|9|||
44348834|NCT00910273|79353619|FG000|Overall Study|Adverse Event|1|||
44348835|NCT00910273|79353620|FG001|Overall Study|Adverse Event|1|||
44348836|NCT00910273|79353619|FG000|Overall Study|Withdrawal by Subject|1|||
44348837|NCT00910273|79353620|FG001|Overall Study|Withdrawal by Subject|0|||
44348838|NCT00910273|79353619|FG000|Overall Study|Discontinuation of study by sponsor|8|||
44348839|NCT00910273|79353620|FG001|Overall Study|Discontinuation of study by sponsor|2|||
44348840|NCT00910273|79353619|FG000|Overall Study|Protocol Violation|1|||
44348841|NCT00910273|79353620|FG001|Overall Study|Protocol Violation|0|||
44348842|NCT00910273|79353619|FG000|Overall Study|Lost to Follow-up|1|||
44348843|NCT00910273|79353620|FG001|Overall Study|Lost to Follow-up|1|||
44348844|NCT00910039|79353626|FG000|Overall Study|Physician Decision|1|||
44348845|NCT00909181|79353634|FG000|Overall Study|Lost to Follow-up|39|||
44348846|NCT00909181|79353635|FG001|Overall Study|Lost to Follow-up|18|||
44348847|NCT00909181|79353636|FG002|Overall Study|Lost to Follow-up|33|||
44348848|NCT01286987|79353659|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
44348849|NCT01286987|79353660|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
44348850|NCT01286987|79353661|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
44348851|NCT01286987|79353662|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
44348852|NCT01286987|79353663|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
44348853|NCT01286987|79353664|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
44348854|NCT01286987|79353665|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
44348855|NCT01286987|79353666|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
44348856|NCT01286987|79353667|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
44348857|NCT01286987|79353668|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
44348858|NCT01286987|79353669|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
44348859|NCT01286987|79353670|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
44348860|NCT01286987|79353671|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
44348861|NCT01286987|79353672|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
44348862|NCT01286987|79353673|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
44348863|NCT01286987|79353659|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
44348864|NCT01286987|79353660|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
44348865|NCT01286987|79353661|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
44348866|NCT01286987|79353662|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
44348867|NCT01286987|79353663|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
44348868|NCT01286987|79353664|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
44348869|NCT01286987|79353665|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
44348870|NCT01286987|79353666|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
44348871|NCT01286987|79353667|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
44348872|NCT01286987|79353668|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
44348873|NCT01286987|79353669|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
44348874|NCT01286987|79353670|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
44348875|NCT01286987|79353671|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
44348876|NCT01286987|79353672|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
44348877|NCT01286987|79353673|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
44348878|NCT01286987|79353659|FG000|Part 1: Dose Escalation|Physician Decision|0|||
44348879|NCT01286987|79353660|FG001|Part 1: Dose Escalation|Physician Decision|0|||
44348880|NCT01286987|79353661|FG002|Part 1: Dose Escalation|Physician Decision|0|||
44348881|NCT01286987|79353662|FG003|Part 1: Dose Escalation|Physician Decision|0|||
44348882|NCT01286987|79353663|FG004|Part 1: Dose Escalation|Physician Decision|1|||
44348883|NCT01286987|79353664|FG005|Part 1: Dose Escalation|Physician Decision|0|||
44348884|NCT01286987|79353665|FG006|Part 1: Dose Escalation|Physician Decision|0|||
44348885|NCT01286987|79353666|FG007|Part 1: Dose Escalation|Physician Decision|0|||
44348886|NCT01286987|79353667|FG008|Part 1: Dose Escalation|Physician Decision|0|||
44348887|NCT01286987|79353668|FG009|Part 1: Dose Escalation|Physician Decision|0|||
44348888|NCT01286987|79353669|FG010|Part 1: Dose Escalation|Physician Decision|0|||
44348889|NCT01286987|79353670|FG011|Part 1: Dose Escalation|Physician Decision|0|||
44348890|NCT01286987|79353671|FG012|Part 1: Dose Escalation|Physician Decision|0|||
44348891|NCT01286987|79353672|FG013|Part 1: Dose Escalation|Physician Decision|0|||
44348892|NCT01286987|79353673|FG014|Part 1: Dose Escalation|Physician Decision|0|||
44348893|NCT01286987|79353659|FG000|Part 2: Dose Expansion|Death|0|||
44348894|NCT01286987|79353660|FG001|Part 2: Dose Expansion|Death|0|||
44348895|NCT01286987|79353661|FG002|Part 2: Dose Expansion|Death|0|||
44348896|NCT01286987|79353662|FG003|Part 2: Dose Expansion|Death|0|||
44447086|NCT00516321|79455384|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
44260856|NCT00634244|79135618|FG001|Overall Study|Other complicating disease|1|||
44348897|NCT01286987|79353663|FG004|Part 2: Dose Expansion|Death|0|||
44348898|NCT01286987|79353664|FG005|Part 2: Dose Expansion|Death|0|||
44348899|NCT01286987|79353665|FG006|Part 2: Dose Expansion|Death|0|||
44348900|NCT01286987|79353666|FG007|Part 2: Dose Expansion|Death|0|||
44348901|NCT01286987|79353667|FG008|Part 2: Dose Expansion|Death|0|||
44348902|NCT01286987|79353668|FG009|Part 2: Dose Expansion|Death|0|||
44348903|NCT01286987|79353669|FG010|Part 2: Dose Expansion|Death|0|||
44348904|NCT01286987|79353670|FG011|Part 2: Dose Expansion|Death|0|||
44348905|NCT01286987|79353671|FG012|Part 2: Dose Expansion|Death|1|||
44348906|NCT01286987|79353672|FG013|Part 2: Dose Expansion|Death|1|||
44348907|NCT01286987|79353673|FG014|Part 2: Dose Expansion|Death|0|||
44447087|NCT00516321|79455385|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
44348908|NCT01286987|79353659|FG000|Part 2: Dose Expansion|Physician Decision|0|||
44348909|NCT01286987|79353660|FG001|Part 2: Dose Expansion|Physician Decision|0|||
44348910|NCT01286987|79353661|FG002|Part 2: Dose Expansion|Physician Decision|0|||
44348911|NCT01286987|79353662|FG003|Part 2: Dose Expansion|Physician Decision|0|||
44348912|NCT01286987|79353663|FG004|Part 2: Dose Expansion|Physician Decision|0|||
44348913|NCT01286987|79353664|FG005|Part 2: Dose Expansion|Physician Decision|0|||
44348914|NCT01286987|79353665|FG006|Part 2: Dose Expansion|Physician Decision|0|||
44348915|NCT01286987|79353666|FG007|Part 2: Dose Expansion|Physician Decision|0|||
44348916|NCT01286987|79353667|FG008|Part 2: Dose Expansion|Physician Decision|0|||
44348917|NCT01286987|79353668|FG009|Part 2: Dose Expansion|Physician Decision|0|||
44348918|NCT01286987|79353669|FG010|Part 2: Dose Expansion|Physician Decision|1|||
44348919|NCT01286987|79353670|FG011|Part 2: Dose Expansion|Physician Decision|1|||
44348920|NCT01286987|79353671|FG012|Part 2: Dose Expansion|Physician Decision|0|||
44348921|NCT01286987|79353672|FG013|Part 2: Dose Expansion|Physician Decision|1|||
44348922|NCT01286987|79353673|FG014|Part 2: Dose Expansion|Physician Decision|0|||
44348923|NCT01286987|79353659|FG000|Part 2: Dose Expansion|Other|0|||
44348924|NCT01286987|79353660|FG001|Part 2: Dose Expansion|Other|0|||
44348925|NCT01286987|79353661|FG002|Part 2: Dose Expansion|Other|0|||
44166517|NCT02504671|78959583|FG000|Overall Study|Withdrawal by Subject|1|||
44348926|NCT01286987|79353662|FG003|Part 2: Dose Expansion|Other|0|||
44348927|NCT01286987|79353663|FG004|Part 2: Dose Expansion|Other|0|||
44348928|NCT01286987|79353664|FG005|Part 2: Dose Expansion|Other|0|||
44348929|NCT01286987|79353665|FG006|Part 2: Dose Expansion|Other|0|||
44348930|NCT01286987|79353666|FG007|Part 2: Dose Expansion|Other|0|||
44348931|NCT01286987|79353667|FG008|Part 2: Dose Expansion|Other|0|||
44348932|NCT01286987|79353668|FG009|Part 2: Dose Expansion|Other|0|||
44348933|NCT01286987|79353669|FG010|Part 2: Dose Expansion|Other|0|||
44348934|NCT01286987|79353670|FG011|Part 2: Dose Expansion|Other|0|||
44348935|NCT01286987|79353671|FG012|Part 2: Dose Expansion|Other|0|||
44348936|NCT01286987|79353672|FG013|Part 2: Dose Expansion|Other|1|||
44348937|NCT01286987|79353673|FG014|Part 2: Dose Expansion|Other|0|||
44348938|NCT01286987|79353659|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
44348939|NCT01286987|79353660|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
44348940|NCT01286987|79353661|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
44348941|NCT01286987|79353662|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
44348942|NCT01286987|79353663|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
44348943|NCT01286987|79353664|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
44348944|NCT01286987|79353665|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
44348945|NCT01286987|79353666|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
44348946|NCT01286987|79353667|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
44348947|NCT01286987|79353668|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
44348948|NCT01286987|79353669|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
44348949|NCT01286987|79353670|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
44348950|NCT01286987|79353671|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
44348951|NCT01286987|79353672|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
44348952|NCT01286987|79353673|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
44348953|NCT01286987|79353659|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
44348954|NCT01286987|79353660|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
44348955|NCT01286987|79353661|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
44348956|NCT01286987|79353662|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
44348957|NCT01286987|79353663|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
44348958|NCT01286987|79353664|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
44348959|NCT01286987|79353665|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
44348960|NCT01286987|79353666|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
44348961|NCT01286987|79353667|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
44348962|NCT01286987|79353668|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
44348963|NCT01286987|79353669|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
44348964|NCT01286987|79353670|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
44348965|NCT01286987|79353671|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
44348966|NCT01286987|79353672|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
44348967|NCT01286987|79353673|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
44348968|NCT01286987|79353659|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348969|NCT01286987|79353660|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348970|NCT01286987|79353661|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348971|NCT01286987|79353662|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348972|NCT01286987|79353663|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348973|NCT01286987|79353664|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348974|NCT01286987|79353665|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348975|NCT01286987|79353666|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348976|NCT01286987|79353667|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348977|NCT01286987|79353668|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348978|NCT01286987|79353669|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
44348979|NCT01286987|79353670|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348980|NCT01286987|79353671|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348981|NCT01286987|79353672|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348982|NCT01286987|79353673|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
44348983|NCT01286753|79353716|FG000|Overall Study|Adverse Event|7|||
44348984|NCT01286753|79353717|FG001|Overall Study|Adverse Event|6|||
44348985|NCT01286753|79353716|FG000|Overall Study|Progression|11|||
44348986|NCT01286753|79353717|FG001|Overall Study|Progression|13|||
44348987|NCT01286753|79353716|FG000|Overall Study|Refused Treatment|1|||
44348988|NCT01286753|79353717|FG001|Overall Study|Refused Treatment|0|||
44348989|NCT01286753|79353716|FG000|Overall Study|Withdrawal of Consent|0|||
44348990|NCT01286753|79353717|FG001|Overall Study|Withdrawal of Consent|2|||
44348991|NCT01286753|79353716|FG000|Overall Study|Discontinued to Join Extension Study|6|||
44348992|NCT01286753|79353717|FG001|Overall Study|Discontinued to Join Extension Study|4|||
44348993|NCT01286753|79353716|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
44348994|NCT01286753|79353717|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
44348995|NCT01286129|79353726|FG000|Overall Study|Withdrawal by Subject|4|||
44348996|NCT01286129|79353727|FG001|Overall Study|Withdrawal by Subject|1|||
44348997|NCT01286129|79353726|FG000|Overall Study|Could not comply with study requirements|4|||
44348998|NCT01286129|79353727|FG001|Overall Study|Could not comply with study requirements|4|||
44348999|NCT01285349|79353738|FG000|Overall Study|Lost to Follow-up|27|||
44349000|NCT01285349|79353739|FG001|Overall Study|Lost to Follow-up|20|||
44349001|NCT01285349|79353740|FG002|Overall Study|Lost to Follow-up|27|||
44349002|NCT01284959|79353752|FG000|Overall Study|Withdrawal by Subject|1|||
44349003|NCT01284959|79353753|FG001|Overall Study|Withdrawal by Subject|0|||
44349004|NCT01284959|79353754|FG002|Overall Study|Withdrawal by Subject|0|||
44349005|NCT01284959|79353752|FG000|Overall Study|Adverse Event|0|||
44349006|NCT01284959|79353753|FG001|Overall Study|Adverse Event|0|||
44349007|NCT01284959|79353754|FG002|Overall Study|Adverse Event|1|||
44349008|NCT01284491|79353762|FG000|Overall Study|Study termination|13|||
44349009|NCT01283009|79353770|FG000|Overall Study|Death|83|||
44349010|NCT01283009|79353771|FG001|Overall Study|Death|78|||
44349011|NCT01283009|79353770|FG000|Overall Study|Study ended early|23|||
44349012|NCT01283009|79353771|FG001|Overall Study|Study ended early|26|||
44349013|NCT01283009|79353770|FG000|Overall Study|Withdrawal by Subject|10|||
44349014|NCT01283009|79353771|FG001|Overall Study|Withdrawal by Subject|8|||
44349015|NCT01283009|79353770|FG000|Overall Study|Physician Decision|1|||
44349016|NCT01283009|79353771|FG001|Overall Study|Physician Decision|1|||
44349017|NCT01283009|79353770|FG000|Overall Study|Lost to Follow-up|1|||
44349018|NCT01283009|79353771|FG001|Overall Study|Lost to Follow-up|0|||
44349019|NCT01283009|79353770|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
44349020|NCT01283009|79353771|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
44349021|NCT01282463|79353780|FG000|Overall Study|Lost to Follow-up|1|||
44349022|NCT01282463|79353781|FG001|Overall Study|Lost to Follow-up|0|||
44349023|NCT01282463|79353782|FG002|Overall Study|Lost to Follow-up|0|||
44349024|NCT01282463|79353780|FG000|Overall Study|Withdrawal by Subject|6|||
44349025|NCT01282463|79353781|FG001|Overall Study|Withdrawal by Subject|2|||
44349026|NCT01282463|79353782|FG002|Overall Study|Withdrawal by Subject|3|||
44349027|NCT01282463|79353780|FG000|Overall Study|"Never Treated Death"|0|||
44349028|NCT01282463|79353781|FG001|Overall Study|"Never Treated Death"|1|||
44349029|NCT01282463|79353782|FG002|Overall Study|"Never Treated Death"|0|||
44349030|NCT01282463|79353780|FG000|Overall Study|"Never Treated PD"|0|||
44349031|NCT01282463|79353781|FG001|Overall Study|"Never Treated PD"|1|||
44349032|NCT01282463|79353782|FG002|Overall Study|"Never Treated PD"|0|||
44349033|NCT01282463|79353780|FG000|Overall Study|Protocol Violation|0|||
44349034|NCT01282463|79353781|FG001|Overall Study|Protocol Violation|0|||
44349035|NCT01282463|79353782|FG002|Overall Study|Protocol Violation|1|||
44349036|NCT01282463|79353780|FG000|Overall Study|Physician Decision|1|||
44349037|NCT01282463|79353781|FG001|Overall Study|Physician Decision|0|||
44349038|NCT01282463|79353782|FG002|Overall Study|Physician Decision|0|||
44349039|NCT01282229|79353798|FG000|Overall Study|Protocol Violation|2|||
44349040|NCT01281917|79353816|FG000|Overall Study|Withdrawal by Subject|1|||
44349041|NCT01281839|79353822|FG000|Overall Study|Lost to Follow-up|6|||
44349042|NCT01281839|79353823|FG001|Overall Study|Lost to Follow-up|3|||
44349043|NCT01281839|79353822|FG000|Overall Study|Withdrawal by Subject|4|||
44349044|NCT01281839|79353823|FG001|Overall Study|Withdrawal by Subject|10|||
44349045|NCT01281839|79353822|FG000|Overall Study|Reason not specified|0|||
44349046|NCT01281839|79353823|FG001|Overall Study|Reason not specified|1|||
44349047|NCT01281137|79353831|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
44349048|NCT01281137|79353832|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
44349049|NCT01281137|79353831|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
44349050|NCT01281137|79353832|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
44349051|NCT01281137|79353831|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
44349052|NCT01281137|79353832|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
44349053|NCT01281137|79353831|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
44349054|NCT01281137|79353832|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
44349055|NCT01281137|79353831|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
44349056|NCT01281137|79353832|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
44349057|NCT01280981|79353856|FG000|Overall Study|Withdrawal by Subject|11|||
44349058|NCT01280981|79353856|FG000|Overall Study|Protocol Violation|2|||
44349059|NCT01280981|79353856|FG000|Overall Study|Lack of Efficacy|13|||
44349060|NCT01280981|79353856|FG000|Overall Study|Lost to Follow-up|3|||
44349061|NCT01280981|79353856|FG000|Overall Study|Adverse Event|6|||
44166518|NCT02504671|78959584|FG001|Overall Study|Withdrawal by Subject|5|||
44166519|NCT02504671|78959585|FG002|Overall Study|Withdrawal by Subject|4|||
44166520|NCT02504671|78959586|FG003|Overall Study|Withdrawal by Subject|4|||
44166521|NCT02504671|78959587|FG004|Overall Study|Withdrawal by Subject|5|||
44349062|NCT01280981|79353856|FG000|Overall Study|Irregular or discontinued menses|3|||
44349063|NCT01280981|79353856|FG000|Overall Study|Failed to return|45|||
44349064|NCT01280981|79353856|FG000|Overall Study|Non-compliance with protocol|3|||
44166522|NCT02504671|78959588|FG005|Overall Study|Withdrawal by Subject|3|||
44166523|NCT02504671|78959583|FG000|Overall Study|Lack of Efficacy|1|||
44166524|NCT02504671|78959584|FG001|Overall Study|Lack of Efficacy|3|||
44349065|NCT01280981|79353856|FG000|Overall Study|Withdrawal of consent|3|||
44349066|NCT01280981|79353856|FG000|Overall Study|Elective surgery|2|||
44349067|NCT01280981|79353856|FG000|Overall Study|Study site closure|1|||
44349068|NCT01280903|79353862|FG000|Overall Study|Lost to Follow-up|23|||
44349069|NCT01280903|79353863|FG001|Overall Study|Lost to Follow-up|16|||
44349070|NCT01280591|79353873|FG000|Overall Study|Withdrawal by Subject|0|||
44349071|NCT01280591|79353874|FG001|Overall Study|Withdrawal by Subject|0|||
44349072|NCT01280591|79353875|FG002|Overall Study|Withdrawal by Subject|0|||
44349073|NCT01280591|79353876|FG003|Overall Study|Withdrawal by Subject|2|||
44349074|NCT01280591|79353873|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
44349075|NCT01280591|79353874|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
44349076|NCT01280591|79353875|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
44349077|NCT01280591|79353876|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
44349078|NCT01280357|79353886|FG000|Overall Study|Excluded no internal monitoring|14|||
44349079|NCT01280357|79353886|FG000|Overall Study|IInsufficient data/No data supplied|12|||
44349080|NCT01274351|79353893|FG000|Overall Study|Lost to Follow-up|1|||
44349081|NCT01274351|79353893|FG000|Overall Study|patient not compliant with the protocol|1|||
44349082|NCT01274351|79353893|FG000|Overall Study|Pregnancy|1|||
44349083|NCT01274351|79353893|FG000|Overall Study|Death|2|||
44349084|NCT01274351|79353893|FG000|Overall Study|Withdrawal by Subject|3|||
44349085|NCT01274351|79353893|FG000|Overall Study|Adverse Event|8|||
44349086|NCT01274351|79353893|FG000|Overall Study|progression of disease|3|||
44349087|NCT01274351|79353893|FG000|Overall Study|hospitalization|1|||
44349088|NCT01271933|79353897|FG000|Single-Blind Phase|Lack of Efficacy|37|||
44349089|NCT01271933|79353898|FG001|Single-Blind Phase|Lack of Efficacy|0|||
44349090|NCT01271933|79353899|FG002|Single-Blind Phase|Lack of Efficacy|0|||
44349091|NCT01271933|79353897|FG000|Single-Blind Phase|Lost to Follow-up|10|||
44349092|NCT01271933|79353898|FG001|Single-Blind Phase|Lost to Follow-up|0|||
44349093|NCT01271933|79353899|FG002|Single-Blind Phase|Lost to Follow-up|0|||
44349094|NCT01271933|79353897|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
44349095|NCT01271933|79353898|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
44349096|NCT01271933|79353899|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
44349097|NCT01271933|79353897|FG000|Single-Blind Phase|Protocol Violation|3|||
44349098|NCT01271933|79353898|FG001|Single-Blind Phase|Protocol Violation|0|||
44349099|NCT01271933|79353899|FG002|Single-Blind Phase|Protocol Violation|0|||
44349100|NCT01271933|79353897|FG000|Single-Blind Phase|Adverse Event|52|||
44349101|NCT01271933|79353898|FG001|Single-Blind Phase|Adverse Event|0|||
44349102|NCT01271933|79353899|FG002|Single-Blind Phase|Adverse Event|0|||
44349103|NCT01271933|79353897|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
44349104|NCT01271933|79353898|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
44349105|NCT01271933|79353899|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
44349106|NCT01271933|79353897|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
44349107|NCT01271933|79353898|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
44349108|NCT01271933|79353899|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
44349109|NCT01271933|79353897|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
44349110|NCT01271933|79353898|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
44349111|NCT01271933|79353899|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
44349112|NCT01271933|79353897|FG000|Double-Blind Phase|Randomized but not treated|0|||
44166525|NCT02504671|78959585|FG002|Overall Study|Lack of Efficacy|1|||
44166526|NCT02504671|78959586|FG003|Overall Study|Lack of Efficacy|0|||
44166527|NCT02504671|78959587|FG004|Overall Study|Lack of Efficacy|4|||
44166528|NCT02504671|78959588|FG005|Overall Study|Lack of Efficacy|4|||
44166529|NCT02504671|78959583|FG000|Overall Study|Adverse Event|1|||
44166530|NCT02504671|78959584|FG001|Overall Study|Adverse Event|1|||
44166531|NCT02504671|78959585|FG002|Overall Study|Adverse Event|0|||
44166532|NCT02504671|78959586|FG003|Overall Study|Adverse Event|1|||
44166533|NCT02504671|78959587|FG004|Overall Study|Adverse Event|0|||
44166534|NCT02504671|78959588|FG005|Overall Study|Adverse Event|2|||
44166535|NCT02504671|78959583|FG000|Overall Study|Protocol Violation|2|||
44166536|NCT02504671|78959584|FG001|Overall Study|Protocol Violation|1|||
44166537|NCT02504671|78959585|FG002|Overall Study|Protocol Violation|0|||
44166538|NCT02504671|78959586|FG003|Overall Study|Protocol Violation|0|||
44166539|NCT02504671|78959587|FG004|Overall Study|Protocol Violation|0|||
44166540|NCT02504671|78959588|FG005|Overall Study|Protocol Violation|1|||
44349113|NCT01271933|79353898|FG001|Double-Blind Phase|Randomized but not treated|0|||
44349114|NCT01271933|79353899|FG002|Double-Blind Phase|Randomized but not treated|1|||
44349115|NCT01271933|79353897|FG000|Double-Blind Phase|Lack of Efficacy|0|||
44349116|NCT01271933|79353898|FG001|Double-Blind Phase|Lack of Efficacy|6|||
44349117|NCT01271933|79353899|FG002|Double-Blind Phase|Lack of Efficacy|9|||
44349118|NCT01271933|79353897|FG000|Double-Blind Phase|Lost to Follow-up|0|||
44349119|NCT01271933|79353898|FG001|Double-Blind Phase|Lost to Follow-up|1|||
44166541|NCT02504671|78959583|FG000|Overall Study|Lost to Follow-up|0|||
44349120|NCT01271933|79353899|FG002|Double-Blind Phase|Lost to Follow-up|1|||
44349121|NCT01271933|79353897|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
44349122|NCT01271933|79353898|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
44349123|NCT01271933|79353899|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
44349124|NCT01271933|79353897|FG000|Double-Blind Phase|Adverse Event|0|||
44349125|NCT01271933|79353898|FG001|Double-Blind Phase|Adverse Event|3|||
44349126|NCT01271933|79353899|FG002|Double-Blind Phase|Adverse Event|0|||
44349127|NCT01271933|79353897|FG000|Double-Blind Phase|Participant request-personal reason|0|||
44349128|NCT01271933|79353898|FG001|Double-Blind Phase|Participant request-personal reason|1|||
44349129|NCT01271933|79353899|FG002|Double-Blind Phase|Participant request-personal reason|0|||
44349130|NCT01269125|79353912|FG000|Overall Study|Adverse Event|3|||
44349131|NCT01269125|79353913|FG001|Overall Study|Adverse Event|5|||
44349132|NCT01269125|79353914|FG002|Overall Study|Adverse Event|0|||
44349133|NCT01269125|79353912|FG000|Overall Study|Lost to Follow-up|4|||
44349134|NCT01269125|79353913|FG001|Overall Study|Lost to Follow-up|0|||
44349135|NCT01269125|79353914|FG002|Overall Study|Lost to Follow-up|0|||
44349136|NCT01268891|79353924|FG000|Overall Study|Adverse Event|3|||
44349137|NCT01268891|79353925|FG001|Overall Study|Adverse Event|7|||
44349138|NCT01268891|79353924|FG000|Overall Study|Lack of Efficacy|1|||
44349139|NCT01268891|79353925|FG001|Overall Study|Lack of Efficacy|0|||
44349140|NCT01268891|79353924|FG000|Overall Study|Withdrawal of Consent|3|||
44349141|NCT01268891|79353925|FG001|Overall Study|Withdrawal of Consent|1|||
44349142|NCT01268891|79353924|FG000|Overall Study|Administrative or other reason(s)|1|||
44349143|NCT01268891|79353925|FG001|Overall Study|Administrative or other reason(s)|0|||
44349144|NCT01268501|79353931|FG000|Overall Study|Lost to Follow-up|1|||
44349145|NCT01268501|79353931|FG000|Overall Study|Withdrawal by Subject|3|||
44349146|NCT01268501|79353931|FG000|Overall Study|Unacceptable Subjective Vision|3|||
44447088|NCT00516321|79455383|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
44447089|NCT00516321|79455384|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
44447090|NCT00516321|79455385|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
44447091|NCT00516321|79455383|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
44447092|NCT00516321|79455384|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
44447093|NCT00516321|79455385|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
44447094|NCT00516321|79455383|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
44447095|NCT00516321|79455384|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
44447096|NCT00516321|79455385|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
44447097|NCT00516321|79455383|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
44447098|NCT00516321|79455384|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
44447099|NCT00516321|79455385|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
44447100|NCT00516321|79455383|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
44447101|NCT00516321|79455384|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
44447102|NCT00516321|79455385|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
44447103|NCT00516321|79455383|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
44447104|NCT00516321|79455384|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
44447105|NCT00516321|79455385|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
44447106|NCT00460408|79455397|FG000|Overall Study|Adverse Event|1|||
44447107|NCT00460408|79455398|FG001|Overall Study|Adverse Event|0|||
44447108|NCT00460408|79455399|FG002|Overall Study|Adverse Event|0|||
44447109|NCT00460408|79455400|FG003|Overall Study|Adverse Event|0|||
44447110|NCT00460408|79455397|FG000|Overall Study|Death|7|||
44447111|NCT00460408|79455398|FG001|Overall Study|Death|0|||
44447112|NCT00460408|79455399|FG002|Overall Study|Death|0|||
44447113|NCT00460408|79455400|FG003|Overall Study|Death|0|||
44447114|NCT00460408|79455397|FG000|Overall Study|Lost to Follow-up|11|||
44447115|NCT00460408|79455398|FG001|Overall Study|Lost to Follow-up|0|||
44447116|NCT00460408|79455399|FG002|Overall Study|Lost to Follow-up|1|||
44447117|NCT00460408|79455400|FG003|Overall Study|Lost to Follow-up|0|||
44447118|NCT00460408|79455397|FG000|Overall Study|Withdrawal by Subject|31|||
44447119|NCT00460408|79455398|FG001|Overall Study|Withdrawal by Subject|0|||
44447120|NCT00460408|79455399|FG002|Overall Study|Withdrawal by Subject|0|||
44447121|NCT00460408|79455400|FG003|Overall Study|Withdrawal by Subject|0|||
44447122|NCT00460408|79455397|FG000|Overall Study|Insufficient clinical response|5|||
44447123|NCT00460408|79455398|FG001|Overall Study|Insufficient clinical response|1|||
44349147|NCT01268501|79353931|FG000|Overall Study|Handling Difficulties|2|||
44349148|NCT01268267|79353935|FG000|Overall Study|Protocol Violation|1|||
44349149|NCT01267253|79353940|FG000|Overall Study|Ineligible - required test not done|1|||
44349150|NCT01267253|79353940|FG000|Overall Study|Inevaluable-never received study treatme|2|||
44349151|NCT01266317|79353944|FG000|Overall Study|Withdrawal by Subject|2|||
44349152|NCT01266161|79353950|FG000|Overall Study|Ineligible|1|||
44349153|NCT01266161|79353951|FG001|Overall Study|Ineligible|0|||
44447124|NCT00460408|79455399|FG002|Overall Study|Insufficient clinical response|5|||
44349154|NCT01266161|79353950|FG000|Overall Study|Lack of Efficacy|0|||
44349155|NCT01266161|79353951|FG001|Overall Study|Lack of Efficacy|1|||
44349156|NCT01266161|79353950|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
44349157|NCT01266161|79353951|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
44349158|NCT01265849|79353960|FG000|Overall Study|Randomized//Treatment not initiated|1|||
44349159|NCT01265849|79353961|FG001|Overall Study|Randomized//Treatment not initiated|4|||
44349160|NCT01265849|79353962|FG002|Overall Study|Randomized//Treatment not initiated|0|||
44349161|NCT01265849|79353960|FG000|Overall Study|Physician Decision|1|||
44349162|NCT01265849|79353961|FG001|Overall Study|Physician Decision|2|||
44349163|NCT01265849|79353962|FG002|Overall Study|Physician Decision|0|||
44349164|NCT01265849|79353960|FG000|Overall Study|Lost to Follow-up|18|||
44349165|NCT01265849|79353961|FG001|Overall Study|Lost to Follow-up|15|||
44349166|NCT01265849|79353962|FG002|Overall Study|Lost to Follow-up|5|||
44349167|NCT01265849|79353960|FG000|Overall Study|Not otherwise specified|1|||
44349168|NCT01265849|79353961|FG001|Overall Study|Not otherwise specified|6|||
44349169|NCT01265849|79353962|FG002|Overall Study|Not otherwise specified|1|||
44349170|NCT01265849|79353960|FG000|Overall Study|Withdrawal by Subject|25|||
44349171|NCT01265849|79353961|FG001|Overall Study|Withdrawal by Subject|34|||
44349172|NCT01265849|79353962|FG002|Overall Study|Withdrawal by Subject|13|||
44349173|NCT01265615|79353978|FG000|Overall Study|Protocol Violation|2|||
44349174|NCT01265615|79353979|FG001|Overall Study|Protocol Violation|2|||
44349175|NCT01265615|79353980|FG002|Overall Study|Protocol Violation|4|||
44349176|NCT01265615|79353981|FG003|Overall Study|Protocol Violation|3|||
44349177|NCT01264835|79353991|FG000|Overall Study|Lost to Follow-up|1|||
44349178|NCT01264679|79353995|FG000|Overall Study|Participation in Another Clinical Trial|1|||
44349179|NCT01264679|79353995|FG000|Overall Study|Physician Decision|1|||
44349180|NCT01264679|79353995|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
44349181|NCT01264679|79353995|FG000|Overall Study|Withdrawal by Subject|1|||
44349182|NCT01263665|79354000|FG000|Overall Study|Withdrew Consent|1|||
44349183|NCT01263665|79354000|FG000|Overall Study|Lost to Follow-up|3|||
44349184|NCT01263665|79354000|FG000|Overall Study|Death|2|||
44349185|NCT01263665|79354000|FG000|Overall Study|Amputation above the ankle|1|||
44349186|NCT01263665|79354000|FG000|Overall Study|Surgical Bypass|2|||
44349187|NCT01263509|79354006|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
44349188|NCT01263509|79354007|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
44349189|NCT01263509|79354008|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
44349190|NCT01263509|79354009|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
44349191|NCT01263509|79354006|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
44349192|NCT01263509|79354007|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
44349193|NCT01263509|79354008|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
44349194|NCT01263509|79354009|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
44349195|NCT01263509|79354006|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
44349196|NCT01263509|79354007|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
44349197|NCT01263509|79354008|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44349198|NCT01263509|79354009|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
44349199|NCT01263509|79354006|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
44349200|NCT01263509|79354007|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
44349201|NCT01263509|79354008|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44349202|NCT01263509|79354009|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
44349203|NCT01263509|79354006|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
44349204|NCT01263509|79354007|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
44349205|NCT01263509|79354008|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
44349206|NCT01263509|79354009|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
44349207|NCT01263197|79354017|FG000|First Intervention (Period 1)|Adverse Event|0|||
44349208|NCT01263197|79354018|FG001|First Intervention (Period 1)|Adverse Event|0|||
44349209|NCT01263197|79354019|FG002|First Intervention (Period 1)|Adverse Event|0|||
44349210|NCT01263197|79354020|FG003|First Intervention (Period 1)|Adverse Event|0|||
44349211|NCT01263197|79354021|FG004|First Intervention (Period 1)|Adverse Event|0|||
44349212|NCT01263197|79354022|FG005|First Intervention (Period 1)|Adverse Event|1|||
44349213|NCT01263197|79354017|FG000|Washout Period 1|Protocol Violation|0|||
44349214|NCT01263197|79354018|FG001|Washout Period 1|Protocol Violation|0|||
44349215|NCT01263197|79354019|FG002|Washout Period 1|Protocol Violation|0|||
44349216|NCT01263197|79354020|FG003|Washout Period 1|Protocol Violation|0|||
44349217|NCT01263197|79354021|FG004|Washout Period 1|Protocol Violation|1|||
44349218|NCT01263197|79354022|FG005|Washout Period 1|Protocol Violation|0|||
44349219|NCT01263197|79354017|FG000|Washout Period 2|Physician Decision|0|||
44349220|NCT01263197|79354018|FG001|Washout Period 2|Physician Decision|0|||
44349221|NCT01263197|79354019|FG002|Washout Period 2|Physician Decision|0|||
44349222|NCT01263197|79354020|FG003|Washout Period 2|Physician Decision|0|||
44349223|NCT01263197|79354021|FG004|Washout Period 2|Physician Decision|0|||
44349224|NCT01263197|79354022|FG005|Washout Period 2|Physician Decision|1|||
44349225|NCT01263197|79354017|FG000|Washout Period 2|Protocol Violation|0|||
44349226|NCT01263197|79354018|FG001|Washout Period 2|Protocol Violation|0|||
44349227|NCT01263197|79354019|FG002|Washout Period 2|Protocol Violation|0|||
44349228|NCT01263197|79354020|FG003|Washout Period 2|Protocol Violation|1|||
44349229|NCT01263197|79354021|FG004|Washout Period 2|Protocol Violation|0|||
44349230|NCT01263197|79354022|FG005|Washout Period 2|Protocol Violation|0|||
44349231|NCT01263197|79354017|FG000|Third Intervention (Period 3)|Adverse Event|0|||
44349232|NCT01263197|79354018|FG001|Third Intervention (Period 3)|Adverse Event|1|||
44349233|NCT01263197|79354019|FG002|Third Intervention (Period 3)|Adverse Event|0|||
44349234|NCT01263197|79354020|FG003|Third Intervention (Period 3)|Adverse Event|0|||
44349235|NCT01263197|79354021|FG004|Third Intervention (Period 3)|Adverse Event|0|||
44349236|NCT01263197|79354022|FG005|Third Intervention (Period 3)|Adverse Event|0|||
44349237|NCT01263119|79354036|FG000|Period 1|Protocol Violation|2|||
44349238|NCT01263119|79354036|FG000|Period 2|Adverse Event|2|||
44349239|NCT01262651|79354046|FG000|Overall Study|Adverse Event|40|||
44349240|NCT01262651|79354047|FG001|Overall Study|Adverse Event|35|||
44349241|NCT01262651|79354046|FG000|Overall Study|Withdrawal by Subject|15|||
44349242|NCT01262651|79354047|FG001|Overall Study|Withdrawal by Subject|11|||
44349243|NCT01262651|79354046|FG000|Overall Study|Withdrawal by Investigator|2|||
44349244|NCT01262651|79354047|FG001|Overall Study|Withdrawal by Investigator|2|||
44349245|NCT01262651|79354046|FG000|Overall Study|Met Withdrawal Criteria|1|||
44349246|NCT01262651|79354047|FG001|Overall Study|Met Withdrawal Criteria|0|||
44349247|NCT01262573|79354055|FG000|Overall Study|Withdrawal by Subject|0|||
44349248|NCT01262573|79354056|FG001|Overall Study|Withdrawal by Subject|1|||
44349249|NCT01262027|79354062|FG000|Overall Study|Adverse Event|1|||
44349250|NCT01262027|79354062|FG000|Overall Study|Withdrawal by Subject|3|||
44349251|NCT01262027|79354062|FG000|Overall Study|Protocol Violation|1|||
44349252|NCT01261793|79354069|FG000|Overall Study|Lack of Efficacy|44|||
44349253|NCT01261793|79354070|FG001|Overall Study|Lack of Efficacy|37|||
44349254|NCT01261793|79354071|FG002|Overall Study|Lack of Efficacy|32|||
44349255|NCT01261793|79354069|FG000|Overall Study|Protocol Violation|3|||
44349256|NCT01261793|79354070|FG001|Overall Study|Protocol Violation|5|||
44349257|NCT01261793|79354071|FG002|Overall Study|Protocol Violation|6|||
44349258|NCT01261793|79354069|FG000|Overall Study|Lost to Follow-up|10|||
44349259|NCT01261793|79354070|FG001|Overall Study|Lost to Follow-up|3|||
44349260|NCT01261793|79354071|FG002|Overall Study|Lost to Follow-up|7|||
44349261|NCT01261793|79354069|FG000|Overall Study|Withdrawal by Subject|12|||
44349262|NCT01261793|79354070|FG001|Overall Study|Withdrawal by Subject|14|||
44349263|NCT01261793|79354071|FG002|Overall Study|Withdrawal by Subject|14|||
44349264|NCT01261793|79354069|FG000|Overall Study|Death|3|||
44349265|NCT01261793|79354070|FG001|Overall Study|Death|1|||
44349266|NCT01261793|79354071|FG002|Overall Study|Death|0|||
44349267|NCT01261793|79354069|FG000|Overall Study|Adverse Event|9|||
44349268|NCT01261793|79354070|FG001|Overall Study|Adverse Event|24|||
44349269|NCT01261793|79354071|FG002|Overall Study|Adverse Event|19|||
44349270|NCT01261793|79354069|FG000|Overall Study|Patient non-availability|1|||
44349271|NCT01261793|79354070|FG001|Overall Study|Patient non-availability|1|||
44447125|NCT00460408|79455400|FG003|Overall Study|Insufficient clinical response|0|||
44447126|NCT00460408|79455397|FG000|Overall Study|Other|12|||
44447127|NCT00460408|79455398|FG001|Overall Study|Other|2|||
44447128|NCT00460408|79455399|FG002|Overall Study|Other|0|||
44447129|NCT00460408|79455400|FG003|Overall Study|Other|0|||
44447130|NCT00507819|79455410|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
44166542|NCT02504671|78959584|FG001|Overall Study|Lost to Follow-up|0|||
44166543|NCT02504671|78959585|FG002|Overall Study|Lost to Follow-up|2|||
44166544|NCT02504671|78959586|FG003|Overall Study|Lost to Follow-up|0|||
44166545|NCT02504671|78959587|FG004|Overall Study|Lost to Follow-up|0|||
44166546|NCT02504671|78959588|FG005|Overall Study|Lost to Follow-up|1|||
44349272|NCT01261793|79354071|FG002|Overall Study|Patient non-availability|1|||
44349273|NCT01261793|79354069|FG000|Overall Study|Suspected pregnancy|1|||
44349274|NCT01261793|79354070|FG001|Overall Study|Suspected pregnancy|1|||
44349275|NCT01261793|79354071|FG002|Overall Study|Suspected pregnancy|0|||
44349276|NCT01261793|79354069|FG000|Overall Study|Patient non-compliance|1|||
44349277|NCT01261793|79354070|FG001|Overall Study|Patient non-compliance|0|||
44349278|NCT01261793|79354071|FG002|Overall Study|Patient non-compliance|1|||
44349279|NCT01261793|79354069|FG000|Overall Study|Patient pregnant|1|||
44349280|NCT01261793|79354070|FG001|Overall Study|Patient pregnant|0|||
44349281|NCT01261793|79354071|FG002|Overall Study|Patient pregnant|0|||
44349282|NCT01261793|79354069|FG000|Overall Study|Outside the study area|0|||
44349283|NCT01261793|79354070|FG001|Overall Study|Outside the study area|2|||
44349284|NCT01261793|79354071|FG002|Overall Study|Outside the study area|1|||
44349285|NCT01261793|79354069|FG000|Overall Study|Lack of efficacy & patient not available|0|||
44349286|NCT01261793|79354070|FG001|Overall Study|Lack of efficacy & patient not available|1|||
44349287|NCT01261793|79354071|FG002|Overall Study|Lack of efficacy & patient not available|0|||
44349288|NCT01261793|79354069|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
44349289|NCT01261793|79354070|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
44349290|NCT01261793|79354071|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
44166547|NCT02504671|78959583|FG000|Overall Study|Protocol defined stopping criteria|7|||
44166548|NCT02504671|78959584|FG001|Overall Study|Protocol defined stopping criteria|4|||
44166549|NCT02504671|78959585|FG002|Overall Study|Protocol defined stopping criteria|3|||
44447131|NCT00507819|79455411|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
44447132|NCT00442936|79455441|FG000|Overall Study|Protocol Violation|1|||
44447133|NCT00442936|79455442|FG001|Overall Study|Protocol Violation|0|||
44447134|NCT00442936|79455443|FG002|Overall Study|Protocol Violation|1|||
44447135|NCT00442936|79455444|FG003|Overall Study|Protocol Violation|1|||
44447136|NCT00577655|79455456|FG000|Overall Study|Patient Request|0|||
44447137|NCT00577655|79455457|FG001|Overall Study|Patient Request|2|||
44447138|NCT00577655|79455456|FG000|Overall Study|Protocol Violation|0|||
44447139|NCT00577655|79455457|FG001|Overall Study|Protocol Violation|1|||
44447140|NCT00577655|79455456|FG000|Overall Study|Lost to Follow-up|1|||
44447141|NCT00577655|79455457|FG001|Overall Study|Lost to Follow-up|1|||
44447142|NCT00113269|79455468|FG000|Overall Study|Not transplanted, donor issues|4|||
44447143|NCT00113269|79455469|FG001|Overall Study|Not transplanted, donor issues|0|||
44447144|NCT00113269|79455470|FG002|Overall Study|Not transplanted, donor issues|2|||
44447145|NCT00113269|79455471|FG003|Overall Study|Not transplanted, donor issues|2|||
44447146|NCT00113269|79455468|FG000|Overall Study|Not transplanted, recipient issues|2|||
44447147|NCT00113269|79455469|FG001|Overall Study|Not transplanted, recipient issues|1|||
44447148|NCT00113269|79455470|FG002|Overall Study|Not transplanted, recipient issues|7|||
44447149|NCT00113269|79455471|FG003|Overall Study|Not transplanted, recipient issues|4|||
44447150|NCT00113269|79455468|FG000|Overall Study|Early graft loss, technical|0|||
44447151|NCT00113269|79455469|FG001|Overall Study|Early graft loss, technical|0|||
44447152|NCT00113269|79455470|FG002|Overall Study|Early graft loss, technical|2|||
44447153|NCT00113269|79455471|FG003|Overall Study|Early graft loss, technical|0|||
44447154|NCT00113269|79455468|FG000|Overall Study|Death in operating room|0|||
44447155|NCT00113269|79455469|FG001|Overall Study|Death in operating room|0|||
44447156|NCT00113269|79455470|FG002|Overall Study|Death in operating room|0|||
44447157|NCT00113269|79455471|FG003|Overall Study|Death in operating room|1|||
44447158|NCT00113269|79455468|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
44447159|NCT00113269|79455469|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
44447160|NCT00113269|79455470|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
44447161|NCT00113269|79455471|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
44447162|NCT00113269|79455468|FG000|Overall Study|Adverse Event|2|||
44447163|NCT00113269|79455469|FG001|Overall Study|Adverse Event|7|||
44447164|NCT00113269|79455470|FG002|Overall Study|Adverse Event|11|||
44447165|NCT00113269|79455471|FG003|Overall Study|Adverse Event|7|||
44447166|NCT00113269|79455468|FG000|Overall Study|Withdrawal by Subject|4|||
44447167|NCT00113269|79455469|FG001|Overall Study|Withdrawal by Subject|3|||
44447168|NCT00113269|79455470|FG002|Overall Study|Withdrawal by Subject|4|||
44447169|NCT00113269|79455471|FG003|Overall Study|Withdrawal by Subject|2|||
44447170|NCT00113269|79455468|FG000|Overall Study|Graft loss|6|||
44447171|NCT00113269|79455469|FG001|Overall Study|Graft loss|6|||
44447172|NCT00113269|79455470|FG002|Overall Study|Graft loss|4|||
44447173|NCT00113269|79455471|FG003|Overall Study|Graft loss|9|||
44447174|NCT00113269|79455468|FG000|Overall Study|Protocol Violation|1|||
44447175|NCT00113269|79455469|FG001|Overall Study|Protocol Violation|0|||
44447176|NCT00113269|79455470|FG002|Overall Study|Protocol Violation|4|||
44447177|NCT00113269|79455471|FG003|Overall Study|Protocol Violation|2|||
44447178|NCT00113269|79455468|FG000|Overall Study|Lost to Follow-up|2|||
44447179|NCT00113269|79455469|FG001|Overall Study|Lost to Follow-up|3|||
44447180|NCT00113269|79455470|FG002|Overall Study|Lost to Follow-up|6|||
44447181|NCT00113269|79455471|FG003|Overall Study|Lost to Follow-up|3|||
44447182|NCT00113269|79455468|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
44447183|NCT00113269|79455469|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
44447184|NCT00113269|79455470|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
44447185|NCT00113269|79455471|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
44447186|NCT00113269|79455468|FG000|Overall Study|Discontinued due to rejection|0|||
44447187|NCT00113269|79455469|FG001|Overall Study|Discontinued due to rejection|0|||
44447188|NCT00113269|79455470|FG002|Overall Study|Discontinued due to rejection|1|||
44447189|NCT00113269|79455471|FG003|Overall Study|Discontinued due to rejection|0|||
44447190|NCT00113269|79455468|FG000|Overall Study|Moved|0|||
44447191|NCT00113269|79455469|FG001|Overall Study|Moved|1|||
44447192|NCT00113269|79455470|FG002|Overall Study|Moved|0|||
44447193|NCT00113269|79455471|FG003|Overall Study|Moved|3|||
44447194|NCT00113269|79455468|FG000|Overall Study|Received pancreas transplant|0|||
44447195|NCT00113269|79455469|FG001|Overall Study|Received pancreas transplant|0|||
44447196|NCT00113269|79455470|FG002|Overall Study|Received pancreas transplant|0|||
44447197|NCT00113269|79455471|FG003|Overall Study|Received pancreas transplant|2|||
44447198|NCT00113269|79455468|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
44447199|NCT00113269|79455469|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
44447200|NCT00113269|79455470|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
44447201|NCT00113269|79455471|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
44447202|NCT00113269|79455468|FG000|Overall Study|Did not meet eligibility criteria|1|||
44447203|NCT00113269|79455469|FG001|Overall Study|Did not meet eligibility criteria|0|||
44447204|NCT00113269|79455470|FG002|Overall Study|Did not meet eligibility criteria|0|||
44447205|NCT00113269|79455471|FG003|Overall Study|Did not meet eligibility criteria|1|||
44447206|NCT00113269|79455468|FG000|Overall Study|Unable to return for follow up|2|||
44447207|NCT00113269|79455469|FG001|Overall Study|Unable to return for follow up|1|||
44447208|NCT00113269|79455470|FG002|Overall Study|Unable to return for follow up|0|||
44447209|NCT00113269|79455471|FG003|Overall Study|Unable to return for follow up|0|||
44447210|NCT00515619|79455481|FG000|Overall Study|Adverse Event|34|||
44447211|NCT00515619|79455481|FG000|Overall Study|Lack of Efficacy|92|||
44447212|NCT00515619|79455481|FG000|Overall Study|Withdrawal by Subject|66|||
44447213|NCT00515619|79455481|FG000|Overall Study|Protocol Violation|3|||
44447214|NCT00515619|79455481|FG000|Overall Study|Lost to Follow-up|4|||
44447215|NCT00515619|79455481|FG000|Overall Study|Unsatisfactory compliance|6|||
44447216|NCT00515619|79455481|FG000|Overall Study|Other: Site discontinuing trials|2|||
44447217|NCT00515619|79455481|FG000|Overall Study|Other: Subject cannot attend visits|2|||
44447218|NCT00515619|79455481|FG000|Overall Study|Other: Subject required surgery|1|||
44447219|NCT00515619|79455481|FG000|Overall Study|Other: Subject moved to another country|1|||
44447220|NCT00515619|79455481|FG000|Overall Study|Other: Investigator decision|1|||
44447221|NCT00515619|79455481|FG000|Overall Study|Other: Subject became pregnant|1|||
44447222|NCT00515619|79455481|FG000|Overall Study|Other: Request from sponsor|1|||
44447223|NCT00515619|79455481|FG000|Overall Study|Other: Drug available on license|1|||
44447224|NCT00515619|79455481|FG000|Overall Study|Other: Subject interested in other AED|1|||
44447225|NCT00449644|79455489|FG000|Overall Study|Adverse Event|0|||
44447226|NCT00449644|79455490|FG001|Overall Study|Adverse Event|0|||
44447227|NCT00449644|79455491|FG002|Overall Study|Adverse Event|3|||
44447228|NCT00449644|79455492|FG003|Overall Study|Adverse Event|5|||
44447229|NCT00449644|79455489|FG000|Overall Study|Death|1|||
44447230|NCT00449644|79455490|FG001|Overall Study|Death|0|||
44447231|NCT00449644|79455491|FG002|Overall Study|Death|6|||
44447232|NCT00449644|79455492|FG003|Overall Study|Death|1|||
44447233|NCT00449644|79455489|FG000|Overall Study|Lost to Follow-up|1|||
44447234|NCT00449644|79455490|FG001|Overall Study|Lost to Follow-up|1|||
44447235|NCT00449644|79455491|FG002|Overall Study|Lost to Follow-up|5|||
44447236|NCT00449644|79455492|FG003|Overall Study|Lost to Follow-up|3|||
44447237|NCT00449644|79455489|FG000|Overall Study|Pregnancy|0|||
44447238|NCT00449644|79455490|FG001|Overall Study|Pregnancy|0|||
44447239|NCT00449644|79455491|FG002|Overall Study|Pregnancy|3|||
44447240|NCT00449644|79455492|FG003|Overall Study|Pregnancy|2|||
44447241|NCT00449644|79455489|FG000|Overall Study|Protocol Violation|4|||
44447242|NCT00449644|79455490|FG001|Overall Study|Protocol Violation|4|||
44447243|NCT00449644|79455491|FG002|Overall Study|Protocol Violation|3|||
44447244|NCT00449644|79455492|FG003|Overall Study|Protocol Violation|7|||
44447245|NCT00449644|79455489|FG000|Overall Study|Withdrawal by Subject|3|||
44447246|NCT00449644|79455490|FG001|Overall Study|Withdrawal by Subject|4|||
44447247|NCT00449644|79455491|FG002|Overall Study|Withdrawal by Subject|6|||
44447248|NCT00449644|79455492|FG003|Overall Study|Withdrawal by Subject|7|||
44447249|NCT00449644|79455489|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
44447250|NCT00449644|79455490|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
44447251|NCT00449644|79455491|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
44447252|NCT00449644|79455492|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
44447253|NCT00449644|79455489|FG000|Overall Study|Other|1|||
44349291|NCT01261793|79354069|FG000|Overall Study|Randomization error|0|||
44349292|NCT01261793|79354070|FG001|Overall Study|Randomization error|1|||
44349293|NCT01261793|79354071|FG002|Overall Study|Randomization error|0|||
44349294|NCT01261793|79354069|FG000|Overall Study|Patient unable to start IV line|0|||
44447254|NCT00449644|79455490|FG001|Overall Study|Other|4|||
44447255|NCT00449644|79455491|FG002|Overall Study|Other|1|||
44447256|NCT00449644|79455492|FG003|Overall Study|Other|0|||
44447257|NCT00449644|79455489|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
44447258|NCT00449644|79455490|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
44447259|NCT00449644|79455491|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
44349295|NCT01261793|79354070|FG001|Overall Study|Patient unable to start IV line|0|||
44349296|NCT01261793|79354071|FG002|Overall Study|Patient unable to start IV line|1|||
44349297|NCT01261325|79354082|FG000|Overall Study|Lack of Efficacy|1|||
44349298|NCT01261325|79354083|FG001|Overall Study|Lack of Efficacy|1|||
44349299|NCT01261325|79354084|FG002|Overall Study|Lack of Efficacy|0|||
44349300|NCT01261325|79354082|FG000|Overall Study|Withdrawal by Subject|2|||
44349301|NCT01261325|79354083|FG001|Overall Study|Withdrawal by Subject|2|||
44349302|NCT01261325|79354084|FG002|Overall Study|Withdrawal by Subject|4|||
44349303|NCT01261325|79354082|FG000|Overall Study|SAE, non-fatal|1|||
44349304|NCT01261325|79354083|FG001|Overall Study|SAE, non-fatal|5|||
44349305|NCT01261325|79354084|FG002|Overall Study|SAE, non-fatal|1|||
44349306|NCT01261325|79354082|FG000|Overall Study|AE, non-serious non-fatal|9|||
44349307|NCT01261325|79354083|FG001|Overall Study|AE, non-serious non-fatal|15|||
44349308|NCT01261325|79354084|FG002|Overall Study|AE, non-serious non-fatal|13|||
44447260|NCT00449644|79455492|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
44447261|NCT00515541|79455509|FG000|Overall Study|Physician Decision|0|||
44447262|NCT00515541|79455510|FG001|Overall Study|Physician Decision|2|||
44447263|NCT00515541|79455511|FG002|Overall Study|Physician Decision|0|||
44447264|NCT00515541|79455512|FG003|Overall Study|Physician Decision|1|||
44447265|NCT00515541|79455509|FG000|Overall Study|No show for appointments|0|||
44447266|NCT00515541|79455510|FG001|Overall Study|No show for appointments|1|||
44447267|NCT00515541|79455511|FG002|Overall Study|No show for appointments|0|||
44447268|NCT00515541|79455512|FG003|Overall Study|No show for appointments|2|||
44349309|NCT01261325|79354082|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
44349310|NCT01261325|79354083|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44349311|NCT01261325|79354084|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44349312|NCT01261325|79354082|FG000|Overall Study|Non Compliance|2|||
44349313|NCT01261325|79354083|FG001|Overall Study|Non Compliance|0|||
44349314|NCT01261325|79354084|FG002|Overall Study|Non Compliance|0|||
44349315|NCT01261325|79354082|FG000|Overall Study|Patient Randomized by Mistake|0|||
44349316|NCT01261325|79354083|FG001|Overall Study|Patient Randomized by Mistake|1|||
44349317|NCT01261325|79354084|FG002|Overall Study|Patient Randomized by Mistake|0|||
44349318|NCT01261325|79354082|FG000|Overall Study|Erroneously Randomized|1|||
44349319|NCT01261325|79354083|FG001|Overall Study|Erroneously Randomized|0|||
44349320|NCT01261325|79354084|FG002|Overall Study|Erroneously Randomized|0|||
44349321|NCT01261325|79354082|FG000|Overall Study|Screen Failure|1|||
44349322|NCT01261325|79354083|FG001|Overall Study|Screen Failure|0|||
44349323|NCT01261325|79354084|FG002|Overall Study|Screen Failure|0|||
44349324|NCT01261325|79354082|FG000|Overall Study|Randomized in Error|0|||
44349325|NCT01261325|79354083|FG001|Overall Study|Randomized in Error|0|||
44349326|NCT01261325|79354084|FG002|Overall Study|Randomized in Error|1|||
44349327|NCT01261325|79354082|FG000|Overall Study|Protocol Violation|0|||
44349328|NCT01261325|79354083|FG001|Overall Study|Protocol Violation|3|||
44349329|NCT01261325|79354084|FG002|Overall Study|Protocol Violation|1|||
44349330|NCT01261325|79354082|FG000|Overall Study|Lost to Follow-up|0|||
44349331|NCT01261325|79354083|FG001|Overall Study|Lost to Follow-up|1|||
44349332|NCT01261325|79354084|FG002|Overall Study|Lost to Follow-up|3|||
44349333|NCT01261325|79354082|FG000|Overall Study|AE, serious fatal|0|||
44349334|NCT01261325|79354083|FG001|Overall Study|AE, serious fatal|0|||
44349335|NCT01261325|79354084|FG002|Overall Study|AE, serious fatal|2|||
44349336|NCT01260701|79354095|FG000|Overall Study|Adverse Event|9|||
44349337|NCT01260701|79354095|FG000|Overall Study|Withdrawal by Subject|2|||
44349338|NCT01260701|79354095|FG000|Overall Study|Progression|53|||
44349339|NCT01260701|79354095|FG000|Overall Study|Death|2|||
44349340|NCT01260701|79354095|FG000|Overall Study|Not protocol specified|3|||
44349341|NCT01260701|79354095|FG000|Overall Study|Under review|1|||
44349342|NCT01260701|79354095|FG000|Overall Study|Ineligible|4|||
44349343|NCT01260701|79354095|FG000|Overall Study|Did not begin protocol therapy|1|||
44349344|NCT01260467|79354099|FG000|Overall Study|Withdrawal by Subject|2|||
44349345|NCT01260311|79354105|FG000|Overall Study|Adverse Event|11|||
44349346|NCT01260311|79354105|FG000|Overall Study|Lack of Efficacy|4|||
44349347|NCT01260311|79354105|FG000|Overall Study|Lost to Follow-up|25|||
44349348|NCT01260311|79354105|FG000|Overall Study|Withdrawal by Subject|6|||
44349349|NCT01260311|79354105|FG000|Overall Study|Financial Constraints|77|||
44349350|NCT01260311|79354105|FG000|Overall Study|Gone to Province|2|||
44349351|NCT01260311|79354105|FG000|Overall Study|Medication Stopped|1|||
44349352|NCT01260311|79354105|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
44349353|NCT01259375|79354109|FG000|Overall Study|Adverse Event|1|||
44349354|NCT01259297|79354132|FG000|Double Blind Randomized Period|Death|1|||
44349355|NCT01259297|79354133|FG001|Double Blind Randomized Period|Death|1|||
44349356|NCT01259297|79354134|FG002|Double Blind Randomized Period|Death|1|||
44349357|NCT01259297|79354135|FG003|Double Blind Randomized Period|Death|2|||
44349358|NCT01259297|79354136|FG004|Double Blind Randomized Period|Death|1|||
44349359|NCT01259297|79354137|FG005|Double Blind Randomized Period|Death|5|||
44349360|NCT01259297|79354138|FG006|Double Blind Randomized Period|Death|2|||
44349361|NCT01259297|79354139|FG007|Double Blind Randomized Period|Death|1|||
44349362|NCT01259297|79354132|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
44349363|NCT01259297|79354133|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
44349364|NCT01259297|79354134|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
44349365|NCT01259297|79354135|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
44349366|NCT01259297|79354136|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
44349367|NCT01259297|79354137|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
44349368|NCT01259297|79354138|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
44349369|NCT01259297|79354139|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
44349370|NCT01259297|79354132|FG000|Double Blind Randomized Period|Other reasons|0|||
44349371|NCT01259297|79354133|FG001|Double Blind Randomized Period|Other reasons|1|||
44349372|NCT01259297|79354134|FG002|Double Blind Randomized Period|Other reasons|0|||
44349373|NCT01259297|79354135|FG003|Double Blind Randomized Period|Other reasons|0|||
44349374|NCT01259297|79354136|FG004|Double Blind Randomized Period|Other reasons|1|||
44349375|NCT01259297|79354137|FG005|Double Blind Randomized Period|Other reasons|2|||
44349376|NCT01259297|79354138|FG006|Double Blind Randomized Period|Other reasons|3|||
44349377|NCT01259297|79354139|FG007|Double Blind Randomized Period|Other reasons|1|||
44349378|NCT01126437|79354159|FG000|Overall Study|Not treated|11|||
44349379|NCT01126437|79354160|FG001|Overall Study|Not treated|18|||
44349380|NCT01126437|79354161|FG002|Overall Study|Not treated|19|||
44349381|NCT01126437|79354159|FG000|Overall Study|Sites with data irregularities/fraud|6|||
44349382|NCT01126437|79354160|FG001|Overall Study|Sites with data irregularities/fraud|6|||
44349383|NCT01126437|79354161|FG002|Overall Study|Sites with data irregularities/fraud|7|||
44349384|NCT01126437|79354159|FG000|Overall Study|Adverse Event|602|||
44349385|NCT01126437|79354160|FG001|Overall Study|Adverse Event|606|||
44349386|NCT01126437|79354161|FG002|Overall Study|Adverse Event|635|||
44349387|NCT01126437|79354159|FG000|Overall Study|Lack of Efficacy|65|||
44349388|NCT01126437|79354160|FG001|Overall Study|Lack of Efficacy|60|||
44349389|NCT01126437|79354161|FG002|Overall Study|Lack of Efficacy|59|||
44349390|NCT01126437|79354159|FG000|Overall Study|Protocol Violation|64|||
44349391|NCT01126437|79354160|FG001|Overall Study|Protocol Violation|66|||
44349392|NCT01126437|79354161|FG002|Overall Study|Protocol Violation|41|||
44349393|NCT01126437|79354159|FG000|Overall Study|Lost to Follow-up|52|||
44349394|NCT01126437|79354160|FG001|Overall Study|Lost to Follow-up|63|||
44349395|NCT01126437|79354161|FG002|Overall Study|Lost to Follow-up|55|||
44349396|NCT01126437|79354159|FG000|Overall Study|Withdrawal by Subject|331|||
44349397|NCT01126437|79354160|FG001|Overall Study|Withdrawal by Subject|335|||
44349398|NCT01126437|79354161|FG002|Overall Study|Withdrawal by Subject|319|||
44349399|NCT01126437|79354159|FG000|Overall Study|Other reason not specified|210|||
44349400|NCT01126437|79354160|FG001|Overall Study|Other reason not specified|176|||
44349401|NCT01126437|79354161|FG002|Overall Study|Other reason not specified|178|||
44349402|NCT01258595|79354171|FG000|Overall Study|Lost to Follow-up|1|||
44349403|NCT01258595|79354172|FG001|Overall Study|Lost to Follow-up|0|||
44349404|NCT01258595|79354171|FG000|Overall Study|Withdrawal by Subject|0|||
44349405|NCT01258595|79354172|FG001|Overall Study|Withdrawal by Subject|1|||
44349406|NCT01257737|79354180|FG000|Overall Study|Lost to Follow-up|1|||
44349407|NCT01257737|79354181|FG001|Overall Study|Lost to Follow-up|2|||
44349408|NCT01257737|79354180|FG000|Overall Study|Liver transplant|1|||
44349409|NCT01257737|79354181|FG001|Overall Study|Liver transplant|0|||
44349410|NCT01257737|79354180|FG000|Overall Study|Relocation out of the country|0|||
44349411|NCT01257737|79354181|FG001|Overall Study|Relocation out of the country|1|||
44349412|NCT01257737|79354180|FG000|Overall Study|Withdrew from study|0|||
44349413|NCT01257737|79354181|FG001|Overall Study|Withdrew from study|1|||
44349414|NCT01126359|79354188|FG000|First Intervention (20-minutes)|Physician Decision|0|||
44349415|NCT01126359|79354189|FG001|First Intervention (20-minutes)|Physician Decision|1|||
44349416|NCT01125813|79354199|FG000|Overall Study|Death|1|||
44349417|NCT01125813|79354199|FG000|Overall Study|Withdrawal by Subject|1|||
44349418|NCT01125813|79354199|FG000|Overall Study|Screen Failures|4|||
44349419|NCT00996892|79354203|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
44349420|NCT00996892|79354204|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
44349421|NCT00996892|79354205|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
44349422|NCT00996892|79354206|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
44349423|NCT00996892|79354207|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
44349424|NCT00996892|79354208|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
44349425|NCT00996892|79354209|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
44349426|NCT00996892|79354210|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
44349427|NCT00996892|79354211|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
44349428|NCT00996892|79354212|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
44349429|NCT00996892|79354213|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
44349430|NCT00996892|79354214|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
44349431|NCT00996892|79354215|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
44349432|NCT00996892|79354216|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
44349433|NCT00996892|79354217|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
44349434|NCT00996892|79354218|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
44349435|NCT00996892|79354219|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
44349436|NCT00996892|79354220|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
44349437|NCT00996892|79354221|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
44349438|NCT00996892|79354222|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
44349439|NCT00996892|79354203|FG000|Dose-Escalation Stage 1|Death|1|||
44166550|NCT02504671|78959586|FG003|Overall Study|Protocol defined stopping criteria|5|||
44166551|NCT02504671|78959587|FG004|Overall Study|Protocol defined stopping criteria|3|||
44166552|NCT02504671|78959588|FG005|Overall Study|Protocol defined stopping criteria|3|||
44166553|NCT02314143|78959605|FG000|Overall Study|Adverse Event|0|||
44166554|NCT02314143|78959606|FG001|Overall Study|Adverse Event|6|||
44166555|NCT02314143|78959607|FG002|Overall Study|Adverse Event|4|||
44166556|NCT02314143|78959605|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
44166557|NCT02314143|78959606|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
44166558|NCT02314143|78959607|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
44166559|NCT02314143|78959605|FG000|Overall Study|Physician Decision|2|||
44166560|NCT02314143|78959606|FG001|Overall Study|Physician Decision|1|||
44166561|NCT02314143|78959607|FG002|Overall Study|Physician Decision|0|||
44166562|NCT02314143|78959605|FG000|Overall Study|Withdrawal by Subject|1|||
44166563|NCT02314143|78959606|FG001|Overall Study|Withdrawal by Subject|0|||
44166564|NCT02314143|78959607|FG002|Overall Study|Withdrawal by Subject|1|||
44166565|NCT02288091|78959616|FG000|Overall Study|Lost to Follow-up|1|||
44166566|NCT02288091|78959616|FG000|Overall Study|Screen fail|7|||
44166567|NCT02503501|78959622|FG000|Overall Study|Physician Decision|1|||
44349440|NCT00996892|79354204|FG001|Dose-Escalation Stage 1|Death|0|||
44349441|NCT00996892|79354205|FG002|Dose-Escalation Stage 1|Death|0|||
44349442|NCT00996892|79354206|FG003|Dose-Escalation Stage 1|Death|0|||
44349443|NCT00996892|79354207|FG004|Dose-Escalation Stage 1|Death|0|||
44166568|NCT02503501|78959623|FG001|Overall Study|Physician Decision|0|||
44166569|NCT02503501|78959622|FG000|Overall Study|Protocol Violation|0|||
44166570|NCT02503501|78959623|FG001|Overall Study|Protocol Violation|1|||
44166571|NCT02503501|78959622|FG000|Overall Study|Withdrawal by Subject|0|||
44166572|NCT02503501|78959623|FG001|Overall Study|Withdrawal by Subject|2|||
44166573|NCT02502097|78959633|FG000|Period 1|Adverse Event|0|||
44166574|NCT02502097|78959634|FG001|Period 1|Adverse Event|0|||
44166575|NCT02502097|78959635|FG002|Period 1|Adverse Event|1|||
44166576|NCT02502097|78959636|FG003|Period 1|Adverse Event|0|||
44166577|NCT02502097|78959633|FG000|Wash Out Period|Adverse Event|0|||
44166578|NCT02502097|78959634|FG001|Wash Out Period|Adverse Event|1|||
44166579|NCT02502097|78959635|FG002|Wash Out Period|Adverse Event|1|||
44166580|NCT02502097|78959636|FG003|Wash Out Period|Adverse Event|1|||
44166581|NCT02502097|78959633|FG000|Period 2|Adverse Event|0|||
44166582|NCT02502097|78959634|FG001|Period 2|Adverse Event|0|||
44166583|NCT02502097|78959635|FG002|Period 2|Adverse Event|1|||
44166584|NCT02502097|78959636|FG003|Period 2|Adverse Event|0|||
44166585|NCT02501629|78959645|FG000|Overall Study|Death|0|||
44166586|NCT02501629|78959646|FG001|Overall Study|Death|1|||
44166587|NCT02501629|78959645|FG000|Overall Study|Withdrawn from study by sponsor|1|||
44166588|NCT02501629|78959646|FG001|Overall Study|Withdrawn from study by sponsor|0|||
44166589|NCT02501629|78959645|FG000|Overall Study|Early termination by sponsor|1|||
44166590|NCT02501629|78959646|FG001|Overall Study|Early termination by sponsor|0|||
44166591|NCT02501629|78959645|FG000|Overall Study|Withdrawal by Subject|3|||
44166592|NCT02501629|78959646|FG001|Overall Study|Withdrawal by Subject|5|||
44166593|NCT02501629|78959645|FG000|Overall Study|Subject did not return to site|0|||
44349444|NCT00996892|79354208|FG005|Dose-Escalation Stage 1|Death|1|||
44349445|NCT00996892|79354209|FG006|Dose-Escalation Stage 1|Death|0|||
44349446|NCT00996892|79354210|FG007|Dose-Escalation Stage 1|Death|0|||
44349447|NCT00996892|79354211|FG008|Dose-Escalation Stage 1|Death|0|||
44349448|NCT00996892|79354212|FG009|Dose-Escalation Stage 1|Death|0|||
44349449|NCT00996892|79354213|FG010|Dose-Escalation Stage 1|Death|0|||
44349450|NCT00996892|79354214|FG011|Dose-Escalation Stage 1|Death|0|||
44349451|NCT00996892|79354215|FG012|Dose-Escalation Stage 1|Death|0|||
44349452|NCT00996892|79354216|FG013|Dose-Escalation Stage 1|Death|0|||
44349453|NCT00996892|79354217|FG014|Dose-Escalation Stage 1|Death|0|||
44349454|NCT00996892|79354218|FG015|Dose-Escalation Stage 1|Death|0|||
44349455|NCT00996892|79354219|FG016|Dose-Escalation Stage 1|Death|0|||
44349456|NCT00996892|79354220|FG017|Dose-Escalation Stage 1|Death|0|||
44349457|NCT00996892|79354221|FG018|Dose-Escalation Stage 1|Death|0|||
44349458|NCT00996892|79354222|FG019|Dose-Escalation Stage 1|Death|0|||
44349459|NCT00996892|79354203|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
44349460|NCT00996892|79354204|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
44349461|NCT00996892|79354205|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
44349462|NCT00996892|79354206|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
44349463|NCT00996892|79354207|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
44349464|NCT00996892|79354208|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
44349465|NCT00996892|79354209|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
44349466|NCT00996892|79354210|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
44349467|NCT00996892|79354211|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
44349468|NCT00996892|79354212|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
44349469|NCT00996892|79354213|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
44349470|NCT00996892|79354214|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
44349471|NCT00996892|79354215|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
44349472|NCT00996892|79354216|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
44349473|NCT00996892|79354217|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
44349474|NCT00996892|79354218|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
44349475|NCT00996892|79354219|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
44349476|NCT00996892|79354220|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
44349477|NCT00996892|79354221|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
44349478|NCT00996892|79354222|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
44349479|NCT00996892|79354203|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349480|NCT00996892|79354204|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
44349481|NCT00996892|79354205|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349482|NCT00996892|79354206|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
44349483|NCT00996892|79354207|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
44166594|NCT02501629|78959646|FG001|Overall Study|Subject did not return to site|1|||
44166595|NCT02501473|78959659|FG000|Overall Study|Study Terminated|2|||
44349484|NCT00996892|79354208|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
44349485|NCT00996892|79354209|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
44447269|NCT00515541|79455509|FG000|Overall Study|Withdrawal by Subject|0|||
44447270|NCT00515541|79455510|FG001|Overall Study|Withdrawal by Subject|2|||
44447271|NCT00515541|79455511|FG002|Overall Study|Withdrawal by Subject|0|||
44166596|NCT02501473|78959660|FG001|Overall Study|Study Terminated|3|||
44166597|NCT02501473|78959661|FG002|Overall Study|Study Terminated|7|||
44166598|NCT02501473|78959662|FG003|Overall Study|Study Terminated|9|||
44166599|NCT02501473|78959663|FG004|Overall Study|Study Terminated|2|||
44166600|NCT02501473|78959664|FG005|Overall Study|Study Terminated|10|||
44166601|NCT02501473|78959665|FG006|Overall Study|Study Terminated|1|||
44166602|NCT02501473|78959666|FG007|Overall Study|Study Terminated|0|||
44166603|NCT02501473|78959659|FG000|Overall Study|Withdrawal by Subject|0|||
44166604|NCT02501473|78959660|FG001|Overall Study|Withdrawal by Subject|0|||
44166605|NCT02501473|78959661|FG002|Overall Study|Withdrawal by Subject|3|||
44166606|NCT02501473|78959662|FG003|Overall Study|Withdrawal by Subject|3|||
44166607|NCT02501473|78959663|FG004|Overall Study|Withdrawal by Subject|2|||
44166608|NCT02501473|78959664|FG005|Overall Study|Withdrawal by Subject|2|||
44166609|NCT02501473|78959665|FG006|Overall Study|Withdrawal by Subject|0|||
44166610|NCT02501473|78959666|FG007|Overall Study|Withdrawal by Subject|0|||
44166611|NCT02501473|78959659|FG000|Overall Study|Death|0|||
44166612|NCT02501473|78959660|FG001|Overall Study|Death|0|||
44166613|NCT02501473|78959661|FG002|Overall Study|Death|1|||
44166614|NCT02501473|78959662|FG003|Overall Study|Death|1|||
44166615|NCT02501473|78959663|FG004|Overall Study|Death|0|||
44166616|NCT02501473|78959664|FG005|Overall Study|Death|1|||
44166617|NCT02501473|78959665|FG006|Overall Study|Death|0|||
44166618|NCT02501473|78959666|FG007|Overall Study|Death|0|||
44166619|NCT02501473|78959659|FG000|Overall Study|Lost to Follow-up|1|||
44166620|NCT02501473|78959660|FG001|Overall Study|Lost to Follow-up|0|||
44349486|NCT00996892|79354210|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44447272|NCT00515541|79455512|FG003|Overall Study|Withdrawal by Subject|2|||
44166621|NCT02501473|78959661|FG002|Overall Study|Lost to Follow-up|1|||
44166622|NCT02501473|78959662|FG003|Overall Study|Lost to Follow-up|0|||
44166623|NCT02501473|78959663|FG004|Overall Study|Lost to Follow-up|0|||
44166624|NCT02501473|78959664|FG005|Overall Study|Lost to Follow-up|1|||
44166625|NCT02501473|78959665|FG006|Overall Study|Lost to Follow-up|0|||
44166626|NCT02501473|78959666|FG007|Overall Study|Lost to Follow-up|0|||
44166627|NCT02501473|78959659|FG000|Overall Study|Reason not specified|0|||
44166628|NCT02501473|78959660|FG001|Overall Study|Reason not specified|0|||
44166629|NCT02501473|78959661|FG002|Overall Study|Reason not specified|1|||
44166630|NCT02501473|78959662|FG003|Overall Study|Reason not specified|1|||
44166631|NCT02501473|78959663|FG004|Overall Study|Reason not specified|0|||
44166632|NCT02501473|78959664|FG005|Overall Study|Reason not specified|0|||
44166633|NCT02501473|78959665|FG006|Overall Study|Reason not specified|0|||
44166634|NCT02501473|78959666|FG007|Overall Study|Reason not specified|0|||
44166635|NCT02501161|78959684|FG000|Overall Study|Adverse Event|2|||
44166636|NCT02501161|78959685|FG001|Overall Study|Adverse Event|6|||
44166637|NCT02501161|78959684|FG000|Overall Study|Lost to Follow-up|7|||
44166638|NCT02501161|78959685|FG001|Overall Study|Lost to Follow-up|4|||
44166639|NCT02501161|78959684|FG000|Overall Study|Withdrawal by Subject|10|||
44166640|NCT02501161|78959685|FG001|Overall Study|Withdrawal by Subject|15|||
44166641|NCT02501161|78959684|FG000|Overall Study|Other|3|||
44166642|NCT02501161|78959685|FG001|Overall Study|Other|0|||
44166643|NCT02500537|78959693|FG000|Overall Study|Death|2|||
44166644|NCT02500537|78959694|FG001|Overall Study|Death|0|||
44166645|NCT02500537|78959693|FG000|Overall Study|Lost to Follow-up|0|||
44166646|NCT02500537|78959694|FG001|Overall Study|Lost to Follow-up|1|||
44166647|NCT02500537|78959693|FG000|Overall Study|Withdrawal by Subject|1|||
44166648|NCT02500537|78959694|FG001|Overall Study|Withdrawal by Subject|0|||
44166649|NCT02498821|78959703|FG000|Overall Study|Screen failure|3|||
44166650|NCT02498821|78959704|FG001|Overall Study|Screen failure|5|||
44166651|NCT02313909|78959712|FG000|Overall Study|Consent withdrawn by participant|33|||
44166652|NCT02313909|78959713|FG001|Overall Study|Consent withdrawn by participant|33|||
44166653|NCT02313909|78959712|FG000|Overall Study|Lost to Follow-up|24|||
44166654|NCT02313909|78959713|FG001|Overall Study|Lost to Follow-up|17|||
44166655|NCT02287467|78959721|FG000|Overall Study|Protocol Violation|12|||
44166656|NCT02287467|78959722|FG001|Overall Study|Protocol Violation|9|||
44166657|NCT02287233|78959734|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
44166658|NCT02287233|78959735|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
44166659|NCT02287233|78959736|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
44166660|NCT02287233|78959734|FG000|Overall Study|Adverse Event Related to Progression|0|||
44166661|NCT02287233|78959735|FG001|Overall Study|Adverse Event Related to Progression|2|||
44166662|NCT02287233|78959736|FG002|Overall Study|Adverse Event Related to Progression|8|||
44166663|NCT02287233|78959734|FG000|Overall Study|Physician Decision|1|||
44166664|NCT02287233|78959735|FG001|Overall Study|Physician Decision|2|||
44166665|NCT02287233|78959736|FG002|Overall Study|Physician Decision|4|||
44166666|NCT02287233|78959734|FG000|Overall Study|Progressive Disease with Death|0|||
44166667|NCT02287233|78959735|FG001|Overall Study|Progressive Disease with Death|0|||
44166668|NCT02287233|78959736|FG002|Overall Study|Progressive Disease with Death|10|||
44166669|NCT02287233|78959734|FG000|Overall Study|Progressive Disease Without Death|2|||
44166670|NCT02287233|78959735|FG001|Overall Study|Progressive Disease Without Death|3|||
44166671|NCT02287233|78959736|FG002|Overall Study|Progressive Disease Without Death|20|||
44166672|NCT02287233|78959734|FG000|Overall Study|Withdrawal by Subject|1|||
44166673|NCT02287233|78959735|FG001|Overall Study|Withdrawal by Subject|1|||
44166674|NCT02287233|78959736|FG002|Overall Study|Withdrawal by Subject|7|||
44166675|NCT02287233|78959734|FG000|Overall Study|Other|3|||
44166676|NCT02287233|78959735|FG001|Overall Study|Other|0|||
44166677|NCT02287233|78959736|FG002|Overall Study|Other|15|||
44349487|NCT00996892|79354211|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349488|NCT00996892|79354212|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349489|NCT00996892|79354213|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349490|NCT00996892|79354214|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349491|NCT00996892|79354215|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349492|NCT00996892|79354216|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349493|NCT00996892|79354217|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349494|NCT00996892|79354218|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349495|NCT00996892|79354219|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349496|NCT00996892|79354220|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349497|NCT00996892|79354221|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349498|NCT00996892|79354222|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
44349499|NCT00996892|79354203|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
44349500|NCT00996892|79354204|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
44349501|NCT00996892|79354205|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
44349502|NCT00996892|79354206|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
44349503|NCT00996892|79354207|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
44349504|NCT00996892|79354208|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
44349505|NCT00996892|79354209|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
44349506|NCT00996892|79354210|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
44349507|NCT00996892|79354211|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
44349508|NCT00996892|79354212|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
44349509|NCT00996892|79354213|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
44349510|NCT00996892|79354214|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
44349511|NCT00996892|79354215|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
44349512|NCT00996892|79354216|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
44349513|NCT00996892|79354217|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
44349514|NCT00996892|79354218|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
44349515|NCT00996892|79354219|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
44349516|NCT00996892|79354220|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
44349517|NCT00996892|79354221|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
44349518|NCT00996892|79354222|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
44349519|NCT00996892|79354203|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
44349520|NCT00996892|79354204|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
44349521|NCT00996892|79354205|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
44349522|NCT00996892|79354206|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
44349523|NCT00996892|79354207|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
44349524|NCT00996892|79354208|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
44349525|NCT00996892|79354209|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
44349526|NCT00996892|79354210|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
44349527|NCT00996892|79354211|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
44349528|NCT00996892|79354212|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
44349529|NCT00996892|79354213|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
44349530|NCT00996892|79354214|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
44349531|NCT00996892|79354215|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
44349532|NCT00996892|79354216|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
44349533|NCT00996892|79354217|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
44349534|NCT00996892|79354218|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
44349535|NCT00996892|79354219|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
44349536|NCT00996892|79354220|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
44349537|NCT00996892|79354221|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
44349538|NCT00996892|79354222|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
44349539|NCT00996892|79354203|FG000|Dose-Escalation Stage 1A|Death|0|||
44349540|NCT00996892|79354204|FG001|Dose-Escalation Stage 1A|Death|0|||
44349541|NCT00996892|79354205|FG002|Dose-Escalation Stage 1A|Death|0|||
44349542|NCT00996892|79354206|FG003|Dose-Escalation Stage 1A|Death|0|||
44349543|NCT00996892|79354207|FG004|Dose-Escalation Stage 1A|Death|0|||
44349544|NCT00996892|79354208|FG005|Dose-Escalation Stage 1A|Death|0|||
44349545|NCT00996892|79354209|FG006|Dose-Escalation Stage 1A|Death|0|||
44349546|NCT00996892|79354210|FG007|Dose-Escalation Stage 1A|Death|0|||
44349547|NCT00996892|79354211|FG008|Dose-Escalation Stage 1A|Death|0|||
44349548|NCT00996892|79354212|FG009|Dose-Escalation Stage 1A|Death|2|||
44349549|NCT00996892|79354213|FG010|Dose-Escalation Stage 1A|Death|0|||
44349550|NCT00996892|79354214|FG011|Dose-Escalation Stage 1A|Death|1|||
44349551|NCT00996892|79354215|FG012|Dose-Escalation Stage 1A|Death|1|||
44349552|NCT00996892|79354216|FG013|Dose-Escalation Stage 1A|Death|0|||
44349553|NCT00996892|79354217|FG014|Dose-Escalation Stage 1A|Death|0|||
44349554|NCT00996892|79354218|FG015|Dose-Escalation Stage 1A|Death|0|||
44349555|NCT00996892|79354219|FG016|Dose-Escalation Stage 1A|Death|0|||
44349556|NCT00996892|79354220|FG017|Dose-Escalation Stage 1A|Death|0|||
44349557|NCT00996892|79354221|FG018|Dose-Escalation Stage 1A|Death|0|||
44447273|NCT00112489|79455522|FG000|Overall Study|Refused further treatment|8|||
44447274|NCT00112489|79455522|FG000|Overall Study|Adverse Event|12|||
44349558|NCT00996892|79354222|FG019|Dose-Escalation Stage 1A|Death|0|||
44349559|NCT00996892|79354203|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
44349560|NCT00996892|79354204|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
44349561|NCT00996892|79354205|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
44349562|NCT00996892|79354206|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
44349563|NCT00996892|79354207|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
44349564|NCT00996892|79354208|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
44349565|NCT00996892|79354209|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
44349566|NCT00996892|79354210|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
44349567|NCT00996892|79354211|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
44349568|NCT00996892|79354212|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
44349569|NCT00996892|79354213|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
44349570|NCT00996892|79354214|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
44349571|NCT00996892|79354215|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
44349572|NCT00996892|79354216|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
44349573|NCT00996892|79354217|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
44349574|NCT00996892|79354218|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
44349575|NCT00996892|79354219|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
44349576|NCT00996892|79354220|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
44349577|NCT00996892|79354221|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
44349578|NCT00996892|79354222|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
44349579|NCT00996892|79354203|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349580|NCT00996892|79354204|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349581|NCT00996892|79354205|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349582|NCT00996892|79354206|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349583|NCT00996892|79354207|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349584|NCT00996892|79354208|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349585|NCT00996892|79354209|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349586|NCT00996892|79354210|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349587|NCT00996892|79354211|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349588|NCT00996892|79354212|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
44349589|NCT00996892|79354213|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
44349590|NCT00996892|79354214|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
44349591|NCT00996892|79354215|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
44349592|NCT00996892|79354216|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349593|NCT00996892|79354217|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349594|NCT00996892|79354218|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349595|NCT00996892|79354219|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349596|NCT00996892|79354220|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349597|NCT00996892|79354221|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349598|NCT00996892|79354222|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
44349599|NCT00996892|79354203|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
44349600|NCT00996892|79354204|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
44349601|NCT00996892|79354205|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
44349602|NCT00996892|79354206|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
44349603|NCT00996892|79354207|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
44349604|NCT00996892|79354208|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
44349605|NCT00996892|79354209|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
44349606|NCT00996892|79354210|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
44349607|NCT00996892|79354211|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
44349608|NCT00996892|79354212|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
44349609|NCT00996892|79354213|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
44349610|NCT00996892|79354214|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
44349611|NCT00996892|79354215|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
44349612|NCT00996892|79354216|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
44349613|NCT00996892|79354217|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
44349614|NCT00996892|79354218|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
44349615|NCT00996892|79354219|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
44349616|NCT00996892|79354220|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
44349617|NCT00996892|79354221|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
44349618|NCT00996892|79354222|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
44349619|NCT00996892|79354203|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
44349620|NCT00996892|79354204|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
44349621|NCT00996892|79354205|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
44349622|NCT00996892|79354206|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
44349623|NCT00996892|79354207|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
44349624|NCT00996892|79354208|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
44349625|NCT00996892|79354209|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
44349626|NCT00996892|79354210|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
44349627|NCT00996892|79354211|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
44349628|NCT00996892|79354212|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
44349629|NCT00996892|79354213|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
44349630|NCT00996892|79354214|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
44349631|NCT00996892|79354215|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
44349632|NCT00996892|79354216|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
44349633|NCT00996892|79354217|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
44349634|NCT00996892|79354218|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
44349635|NCT00996892|79354219|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
44349636|NCT00996892|79354220|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
44349637|NCT00996892|79354221|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
44349638|NCT00996892|79354222|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
44349639|NCT00996892|79354203|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
44349640|NCT00996892|79354204|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
44349641|NCT00996892|79354205|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
44349642|NCT00996892|79354206|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
44349643|NCT00996892|79354207|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
44349644|NCT00996892|79354208|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
44349645|NCT00996892|79354209|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
44349646|NCT00996892|79354210|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
44349647|NCT00996892|79354211|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
44349648|NCT00996892|79354212|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
44349649|NCT00996892|79354213|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
44349650|NCT00996892|79354214|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
44349651|NCT00996892|79354215|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
44349652|NCT00996892|79354216|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
44349653|NCT00996892|79354217|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
44349654|NCT00996892|79354218|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
44349655|NCT00996892|79354219|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
44349656|NCT00996892|79354220|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
44349657|NCT00996892|79354221|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
44349658|NCT00996892|79354222|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
44349659|NCT00996892|79354203|FG000|Expansion Stage 2|Adverse Event|0|||
44349660|NCT00996892|79354204|FG001|Expansion Stage 2|Adverse Event|0|||
44349661|NCT00996892|79354205|FG002|Expansion Stage 2|Adverse Event|0|||
44349662|NCT00996892|79354206|FG003|Expansion Stage 2|Adverse Event|0|||
44349663|NCT00996892|79354207|FG004|Expansion Stage 2|Adverse Event|0|||
44349664|NCT00996892|79354208|FG005|Expansion Stage 2|Adverse Event|0|||
44349665|NCT00996892|79354209|FG006|Expansion Stage 2|Adverse Event|0|||
44349666|NCT00996892|79354210|FG007|Expansion Stage 2|Adverse Event|0|||
44349667|NCT00996892|79354211|FG008|Expansion Stage 2|Adverse Event|0|||
44349668|NCT00996892|79354212|FG009|Expansion Stage 2|Adverse Event|0|||
44349669|NCT00996892|79354213|FG010|Expansion Stage 2|Adverse Event|0|||
44349670|NCT00996892|79354214|FG011|Expansion Stage 2|Adverse Event|0|||
44349671|NCT00996892|79354215|FG012|Expansion Stage 2|Adverse Event|0|||
44349672|NCT00996892|79354216|FG013|Expansion Stage 2|Adverse Event|0|||
44349673|NCT00996892|79354217|FG014|Expansion Stage 2|Adverse Event|0|||
44349674|NCT00996892|79354218|FG015|Expansion Stage 2|Adverse Event|0|||
44349675|NCT00996892|79354219|FG016|Expansion Stage 2|Adverse Event|0|||
44349676|NCT00996892|79354220|FG017|Expansion Stage 2|Adverse Event|0|||
44349677|NCT00996892|79354221|FG018|Expansion Stage 2|Adverse Event|3|||
44349678|NCT00996892|79354222|FG019|Expansion Stage 2|Adverse Event|0|||
44349679|NCT00996892|79354203|FG000|Expansion Stage 2|Death|0|||
44349680|NCT00996892|79354204|FG001|Expansion Stage 2|Death|0|||
44447275|NCT00112489|79455522|FG000|Overall Study|Death|2|||
44447276|NCT00112489|79455522|FG000|Overall Study|Other, Not Specified|9|||
44447277|NCT00112489|79455522|FG000|Overall Study|Patient never treated|2|||
44447278|NCT00112489|79455522|FG000|Overall Study|Ineligible|7|||
44447279|NCT00711971|79455535|FG000|Overall Study|Lost to Follow-up|3|||
44447280|NCT00711971|79455536|FG001|Overall Study|Lost to Follow-up|4|||
44447281|NCT00711971|79455537|FG002|Overall Study|Lost to Follow-up|1|||
44447282|NCT00515463|79455551|FG000|Overall Study|Physician Decision|4|||
44447283|NCT00515463|79455552|FG001|Overall Study|Physician Decision|2|||
44447284|NCT00515463|79455551|FG000|Overall Study|Adverse Event|1|||
44447285|NCT00515463|79455552|FG001|Overall Study|Adverse Event|2|||
44447286|NCT00515463|79455551|FG000|Overall Study|Withdrawal by Subject|3|||
44447287|NCT00515463|79455552|FG001|Overall Study|Withdrawal by Subject|4|||
44447288|NCT00515463|79455551|FG000|Overall Study|Lost to Follow-up|6|||
44447289|NCT00515463|79455552|FG001|Overall Study|Lost to Follow-up|5|||
44447290|NCT00515463|79455551|FG000|Overall Study|Other|0|||
44447291|NCT00515463|79455552|FG001|Overall Study|Other|1|||
44447292|NCT00507507|79455561|FG000|Treatment Period|Lost to Follow-up|0|||
44447293|NCT00507507|79455562|FG001|Treatment Period|Lost to Follow-up|2|||
44447294|NCT00507507|79455561|FG000|Treatment Period|Physician Decision|4|||
44447295|NCT00507507|79455562|FG001|Treatment Period|Physician Decision|1|||
44447296|NCT00507507|79455561|FG000|Treatment Period|Protocol Violation|1|||
44447297|NCT00507507|79455562|FG001|Treatment Period|Protocol Violation|2|||
44447298|NCT00507507|79455561|FG000|Treatment Period|Adverse Event|1|||
44447299|NCT00507507|79455562|FG001|Treatment Period|Adverse Event|1|||
44447300|NCT00507507|79455561|FG000|Treatment Period|Withdrawal by Subject|46|||
44349681|NCT00996892|79354205|FG002|Expansion Stage 2|Death|0|||
44349682|NCT00996892|79354206|FG003|Expansion Stage 2|Death|0|||
44349683|NCT00996892|79354207|FG004|Expansion Stage 2|Death|0|||
44447301|NCT00507507|79455562|FG001|Treatment Period|Withdrawal by Subject|47|||
44447302|NCT00507507|79455561|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
44447303|NCT00507507|79455562|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
44447304|NCT00507507|79455561|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
44447305|NCT00507507|79455562|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
44447306|NCT00507507|79455561|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
44447307|NCT00507507|79455562|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
44447308|NCT00459706|79455572|FG000|Overall Study|Adverse Event|19|||
44447309|NCT00459706|79455573|FG001|Overall Study|Adverse Event|13|||
44447310|NCT00459706|79455572|FG000|Overall Study|Withdrawal by Subject|1|||
44447311|NCT00459706|79455573|FG001|Overall Study|Withdrawal by Subject|6|||
44447312|NCT00459706|79455572|FG000|Overall Study|Physician Decision|2|||
44447313|NCT00459706|79455573|FG001|Overall Study|Physician Decision|0|||
44447314|NCT00459706|79455572|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
44447315|NCT00459706|79455573|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
44447316|NCT00459706|79455572|FG000|Overall Study|Protocol Violation|2|||
44447317|NCT00459706|79455573|FG001|Overall Study|Protocol Violation|1|||
44447318|NCT00459706|79455572|FG000|Overall Study|Failed to Return|1|||
44447319|NCT00459706|79455573|FG001|Overall Study|Failed to Return|0|||
44447320|NCT00459706|79455572|FG000|Overall Study|Other|0|||
44447321|NCT00459706|79455573|FG001|Overall Study|Other|1|||
44447322|NCT00507429|79455581|FG000|Treatment Phase|Disease Progression|12|||
44447323|NCT00507429|79455582|FG001|Treatment Phase|Disease Progression|5|||
44447324|NCT00507429|79455581|FG000|Treatment Phase|Adverse Event|12|||
44447325|NCT00507429|79455582|FG001|Treatment Phase|Adverse Event|5|||
44447326|NCT00507429|79455581|FG000|Treatment Phase|Withdrawal by Subject|3|||
44447327|NCT00507429|79455582|FG001|Treatment Phase|Withdrawal by Subject|3|||
44447328|NCT00507429|79455581|FG000|Treatment Phase|Physician Decision|4|||
44447329|NCT00507429|79455582|FG001|Treatment Phase|Physician Decision|2|||
44447330|NCT00507429|79455581|FG000|Treatment Phase|Other|6|||
44447331|NCT00507429|79455582|FG001|Treatment Phase|Other|3|||
44447332|NCT00507429|79455581|FG000|Maintenance Phase|Progressive Disease|14|||
44447333|NCT00507429|79455582|FG001|Maintenance Phase|Progressive Disease|0|||
44447334|NCT00449176|79455593|FG000|Overall Study|Withdrawal by Subject|39|||
44447335|NCT00449176|79455594|FG001|Overall Study|Withdrawal by Subject|43|||
44447336|NCT00449176|79455595|FG002|Overall Study|Withdrawal by Subject|59|||
44447337|NCT00449176|79455593|FG000|Overall Study|Lost to Follow-up|13|||
44447338|NCT00449176|79455594|FG001|Overall Study|Lost to Follow-up|8|||
44447339|NCT00449176|79455595|FG002|Overall Study|Lost to Follow-up|12|||
44447340|NCT00449176|79455593|FG000|Overall Study|Adverse Event|51|||
44447341|NCT00449176|79455594|FG001|Overall Study|Adverse Event|107|||
44166678|NCT02287233|78959734|FG000|Overall Study|Did Not Receive Treatment|0|||
44447342|NCT00449176|79455595|FG002|Overall Study|Adverse Event|15|||
44447343|NCT00449176|79455593|FG000|Overall Study|Lack of Efficacy|13|||
44447344|NCT00449176|79455594|FG001|Overall Study|Lack of Efficacy|7|||
44447345|NCT00449176|79455595|FG002|Overall Study|Lack of Efficacy|50|||
44447346|NCT00449176|79455593|FG000|Overall Study|Study drug non-compliant|14|||
44447347|NCT00449176|79455594|FG001|Overall Study|Study drug non-compliant|11|||
44447348|NCT00449176|79455595|FG002|Overall Study|Study drug non-compliant|11|||
44447349|NCT00449176|79455593|FG000|Overall Study|all other|22|||
44447350|NCT00449176|79455594|FG001|Overall Study|all other|19|||
44447351|NCT00449176|79455595|FG002|Overall Study|all other|20|||
44447352|NCT00515073|79455603|FG000|Overall Study|Withdrawal by Subject|1|||
44447353|NCT00515073|79455603|FG000|Overall Study|Physician Decision|1|||
44447354|NCT00710021|79455610|FG000|Overall Study|Lost to Follow-up|1|||
44447355|NCT00710021|79455611|FG001|Overall Study|Lost to Follow-up|0|||
44447356|NCT00710021|79455612|FG002|Overall Study|Lost to Follow-up|0|||
44447357|NCT00710021|79455610|FG000|Overall Study|Subject's Decision|0|||
44447358|NCT00710021|79455611|FG001|Overall Study|Subject's Decision|1|||
44447359|NCT00710021|79455612|FG002|Overall Study|Subject's Decision|0|||
44447360|NCT00710021|79455610|FG000|Overall Study|Subject misrandomized|0|||
44447361|NCT00710021|79455611|FG001|Overall Study|Subject misrandomized|1|||
44447362|NCT00710021|79455612|FG002|Overall Study|Subject misrandomized|1|||
44447363|NCT00710021|79455610|FG000|Overall Study|Physician Decision|0|||
44447364|NCT00710021|79455611|FG001|Overall Study|Physician Decision|1|||
44447365|NCT00710021|79455612|FG002|Overall Study|Physician Decision|0|||
44447366|NCT00504153|79455621|FG000|Overall Study|Withdrawal by Subject|1|||
44447367|NCT00504153|79455621|FG000|Overall Study|Adverse Event|4|||
44447368|NCT00504153|79455621|FG000|Overall Study|Death|1|||
44447369|NCT00442702|79455627|FG000|Titration Period|Adverse Event|2|||
44447370|NCT00442702|79455628|FG001|Titration Period|Adverse Event|0|||
44447371|NCT00442702|79455627|FG000|Titration Period|Death|3|||
44447372|NCT00442702|79455628|FG001|Titration Period|Death|2|||
44447373|NCT00442702|79455627|FG000|Titration Period|Insufficient Therapeutic Response|1|||
44447374|NCT00442702|79455628|FG001|Titration Period|Insufficient Therapeutic Response|0|||
44447375|NCT00442702|79455627|FG000|Titration Period|Refused Treatment|4|||
44447376|NCT00442702|79455628|FG001|Titration Period|Refused Treatment|1|||
44447377|NCT00442702|79455627|FG000|Titration Period|Failure to return|1|||
44447378|NCT00442702|79455628|FG001|Titration Period|Failure to return|0|||
44447379|NCT00442702|79455627|FG000|Titration Period|Hospitalized in another hospital|1|||
44447380|NCT00442702|79455628|FG001|Titration Period|Hospitalized in another hospital|0|||
44447381|NCT00442702|79455627|FG000|Evaluation Period|Adverse Event|1|||
44447382|NCT00442702|79455628|FG001|Evaluation Period|Adverse Event|0|||
44447383|NCT00442702|79455627|FG000|Evaluation Period|Death|1|||
44447384|NCT00442702|79455628|FG001|Evaluation Period|Death|1|||
44447385|NCT00442702|79455627|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
44447386|NCT00442702|79455628|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
44447387|NCT00442702|79455627|FG000|Evaluation Period|Refused treatment|1|||
44447388|NCT00442702|79455628|FG001|Evaluation Period|Refused treatment|1|||
44447389|NCT00442702|79455627|FG000|Evaluation Period|Renal transplant|0|||
44447390|NCT00442702|79455628|FG001|Evaluation Period|Renal transplant|1|||
44447391|NCT00442702|79455627|FG000|Evaluation Period|Failure to return|1|||
44447392|NCT00442702|79455628|FG001|Evaluation Period|Failure to return|0|||
44447393|NCT00442702|79455627|FG000|Evaluation Period|Site closure|0|||
44447394|NCT00442702|79455628|FG001|Evaluation Period|Site closure|1|||
44447395|NCT00514917|79455636|FG000|Overall Study|Death|4|||
44447396|NCT00514917|79455637|FG001|Overall Study|Death|10|||
44447397|NCT00514917|79455636|FG000|Overall Study|Protocol Violation|1|||
44447398|NCT00514917|79455637|FG001|Overall Study|Protocol Violation|0|||
44447399|NCT00514917|79455636|FG000|Overall Study|Lost to Follow-up|4|||
44447400|NCT00514917|79455637|FG001|Overall Study|Lost to Follow-up|3|||
44447401|NCT00514917|79455636|FG000|Overall Study|Withdrawal by Subject|18|||
44447402|NCT00514917|79455637|FG001|Overall Study|Withdrawal by Subject|16|||
44447403|NCT00514917|79455636|FG000|Overall Study|Discontinued due to study closure|88|||
44447404|NCT00514917|79455637|FG001|Overall Study|Discontinued due to study closure|81|||
44447405|NCT00514917|79455636|FG000|Overall Study|Undefined|11|||
44447406|NCT00514917|79455637|FG001|Overall Study|Undefined|5|||
44447407|NCT00711425|79455645|FG000|Overall Study|Protocol Violation|1|||
44447408|NCT00711425|79455645|FG000|Overall Study|Death|2|||
44447409|NCT00711425|79455645|FG000|Overall Study|Lost to Follow-up|1|||
44447410|NCT00504075|79455649|FG000|Overall Study|Adverse Event|1|||
44447411|NCT00504075|79455649|FG000|Overall Study|Lost to Follow-up|5|||
44447412|NCT00504075|79455649|FG000|Overall Study|Withdrawal by Subject|1|||
44447413|NCT00504075|79455649|FG000|Overall Study|Required other therapeutic intervention|1|||
44447414|NCT00503997|79455654|FG000|Overall Study|disease progression|1|||
44447415|NCT00503997|79455654|FG000|Overall Study|Adverse Event|5|||
44447416|NCT00503997|79455654|FG000|Overall Study|Death|1|||
44447417|NCT00503997|79455654|FG000|Overall Study|Withdrawal by Subject|1|||
44447418|NCT00096265|79455661|FG000|Overall Study|Ineligible|1|||
44447419|NCT00096265|79455662|FG001|Overall Study|Ineligible|0|||
44447420|NCT00096265|79455663|FG002|Overall Study|Ineligible|0|||
44447421|NCT00711191|79455675|FG000|Overall Study|Adverse Event|1|||
44166679|NCT02287233|78959735|FG001|Overall Study|Did Not Receive Treatment|0|||
44260857|NCT00634244|79135619|FG002|Overall Study|Other complicating disease|0|||
44447422|NCT00711191|79455676|FG001|Overall Study|Adverse Event|1|||
44447423|NCT00711191|79455677|FG002|Overall Study|Adverse Event|2|||
44447424|NCT00711191|79455675|FG000|Overall Study|Objective progression or relapse|2|||
44447425|NCT00711191|79455676|FG001|Overall Study|Objective progression or relapse|3|||
44447426|NCT00711191|79455677|FG002|Overall Study|Objective progression or relapse|7|||
44447427|NCT00711191|79455675|FG000|Overall Study|Withdrawal by Subject|0|||
44447428|NCT00711191|79455676|FG001|Overall Study|Withdrawal by Subject|1|||
44447429|NCT00711191|79455677|FG002|Overall Study|Withdrawal by Subject|3|||
44447430|NCT00706511|79455692|FG000|Overall Study|Withdrawal by Subject|1|||
44447431|NCT00706511|79455693|FG001|Overall Study|Withdrawal by Subject|0|||
44447432|NCT00706511|79455694|FG002|Overall Study|Withdrawal by Subject|0|||
44447433|NCT00706511|79455695|FG003|Overall Study|Withdrawal by Subject|0|||
44447434|NCT00448864|79455706|FG000|Overall Study|Death|1|||
44447435|NCT00448864|79455707|FG001|Overall Study|Death|0|||
44447436|NCT00448864|79455708|FG002|Overall Study|Death|0|||
44447437|NCT00448864|79455706|FG000|Overall Study|Lost to Follow-up|3|||
44447438|NCT00448864|79455707|FG001|Overall Study|Lost to Follow-up|1|||
44447439|NCT00448864|79455708|FG002|Overall Study|Lost to Follow-up|0|||
44447440|NCT00448864|79455706|FG000|Overall Study|Physician Decision|1|||
44447441|NCT00448864|79455707|FG001|Overall Study|Physician Decision|0|||
44447442|NCT00448864|79455708|FG002|Overall Study|Physician Decision|1|||
44447443|NCT00448864|79455706|FG000|Overall Study|Withdrawal by Subject|0|||
44447444|NCT00448864|79455707|FG001|Overall Study|Withdrawal by Subject|2|||
44447445|NCT00448864|79455708|FG002|Overall Study|Withdrawal by Subject|0|||
44447446|NCT00448864|79455706|FG000|Overall Study|Protocol Violation|0|||
44447447|NCT00448864|79455707|FG001|Overall Study|Protocol Violation|2|||
44447448|NCT00448864|79455708|FG002|Overall Study|Protocol Violation|0|||
44447449|NCT00567398|79455720|FG000|Overall Study|Adverse Event|6|||
44447450|NCT00567398|79455721|FG001|Overall Study|Adverse Event|14|||
44447451|NCT00567398|79455720|FG000|Overall Study|Physician Decision|0|||
44447452|NCT00567398|79455721|FG001|Overall Study|Physician Decision|4|||
44447453|NCT00567398|79455720|FG000|Overall Study|Withdrawal by Subject|0|||
44447454|NCT00567398|79455721|FG001|Overall Study|Withdrawal by Subject|2|||
44447455|NCT00567398|79455720|FG000|Overall Study|Renal Transplantation|0|||
44447456|NCT00567398|79455721|FG001|Overall Study|Renal Transplantation|3|||
44447457|NCT00567398|79455720|FG000|Overall Study|Other|1|||
44447458|NCT00567398|79455721|FG001|Overall Study|Other|0|||
44447459|NCT00448708|79455729|FG000|Overall Study|Death|21|||
44447460|NCT00448708|79455730|FG001|Overall Study|Death|17|||
44447461|NCT00448708|79455729|FG000|Overall Study|Withdrawal by Subject|8|||
44447462|NCT00448708|79455730|FG001|Overall Study|Withdrawal by Subject|4|||
44447463|NCT00448708|79455729|FG000|Overall Study|Lost to Follow-up|6|||
44447464|NCT00448708|79455730|FG001|Overall Study|Lost to Follow-up|8|||
44447465|NCT00448708|79455729|FG000|Overall Study|not listed|0|||
44447466|NCT00448708|79455730|FG001|Overall Study|not listed|2|||
44447467|NCT00706355|79455740|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
44447468|NCT00706355|79455741|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
44447469|NCT00706355|79455742|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
44447470|NCT00706355|79455743|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
44447471|NCT00706355|79455740|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
44447472|NCT00706355|79455741|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
44447473|NCT00706355|79455742|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
44447474|NCT00706355|79455743|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
44447475|NCT00706355|79455740|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
44447476|NCT00706355|79455741|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
44447477|NCT00706355|79455742|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
44447478|NCT00706355|79455743|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
44447479|NCT00706355|79455740|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
44447480|NCT00706355|79455741|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
44447481|NCT00706355|79455742|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
44447482|NCT00706355|79455743|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
44447483|NCT00706355|79455740|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
44447484|NCT00706355|79455741|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
44447485|NCT00706355|79455742|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
44447486|NCT00706355|79455743|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
44447487|NCT00706355|79455740|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
44447488|NCT00706355|79455741|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
44447489|NCT00706355|79455742|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
44447490|NCT00706355|79455743|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
44447491|NCT00706355|79455740|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
44447492|NCT00706355|79455741|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
44447493|NCT00706355|79455742|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
44447494|NCT00706355|79455743|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
44447495|NCT00706355|79455740|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
44447496|NCT00706355|79455741|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
44447497|NCT00706355|79455742|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
44447498|NCT00706355|79455743|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
44447499|NCT00706355|79455740|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
44447500|NCT00706355|79455741|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
44447501|NCT00706355|79455742|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
44447502|NCT00706355|79455743|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
44447503|NCT00711113|79455755|FG000|Overall Study|Lost to Follow-up|9|||
44447504|NCT00711113|79455755|FG000|Overall Study|Implant lost|2|||
44447505|NCT00710879|79455765|FG000|Overall Study|Lost to Follow-up|2|||
44447506|NCT00710879|79455766|FG001|Overall Study|Lost to Follow-up|1|||
44447507|NCT00710879|79455765|FG000|Overall Study|Protocol Violation|0|||
44447508|NCT00710879|79455766|FG001|Overall Study|Protocol Violation|3|||
44447509|NCT03979274|79455772|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44447510|NCT03979274|79455773|FG001|Treatment Period 2|Withdrawal by Subject|1|||
44447511|NCT00459316|79455783|FG000|Steps 1 & 2|Other eligibility failure|1|||
44447512|NCT00459316|79455784|FG001|Steps 1 & 2|Other eligibility failure|1|||
44447513|NCT00459316|79455785|FG002|Steps 1 & 2|Other eligibility failure|0|||
44447514|NCT00459316|79455783|FG000|Steps 1 & 2|Death|1|||
44447515|NCT00459316|79455784|FG001|Steps 1 & 2|Death|1|||
44447516|NCT00459316|79455785|FG002|Steps 1 & 2|Death|0|||
44447517|NCT00459316|79455783|FG000|Steps 1 & 2|Not able to get to clinic|7|||
44447518|NCT00459316|79455784|FG001|Steps 1 & 2|Not able to get to clinic|4|||
44447519|NCT00459316|79455785|FG002|Steps 1 & 2|Not able to get to clinic|0|||
44447520|NCT00459316|79455783|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
44447521|NCT00459316|79455784|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
44447522|NCT00459316|79455785|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
44447523|NCT00459316|79455783|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
44447524|NCT00459316|79455784|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
44447525|NCT00459316|79455785|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
44447526|NCT00459316|79455783|FG000|Steps 1 & 2|Lost to Follow-up|5|||
44447527|NCT00459316|79455784|FG001|Steps 1 & 2|Lost to Follow-up|0|||
44447528|NCT00459316|79455785|FG002|Steps 1 & 2|Lost to Follow-up|2|||
44447529|NCT00459316|79455783|FG000|Step 3|Withdrawal by Subject|3|||
44447530|NCT00459316|79455784|FG001|Step 3|Withdrawal by Subject|0|||
44447531|NCT00459316|79455785|FG002|Step 3|Withdrawal by Subject|1|||
44447532|NCT05445557|79455808|FG000|Double Blind Part|Lost to Follow-up|1|||
44447533|NCT05074498|79455842|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
44447534|NCT05074498|79455843|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
44447535|NCT05074498|79455844|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
44447536|NCT05074498|79455845|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
44447537|NCT05074498|79455846|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
44447538|NCT05074498|79455847|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
44447539|NCT05074498|79455842|FG000|Part 1 (Upto Day 104)|Other|1|||
44447540|NCT05074498|79455843|FG001|Part 1 (Upto Day 104)|Other|0|||
44447541|NCT05074498|79455844|FG002|Part 1 (Upto Day 104)|Other|0|||
44447542|NCT05074498|79455845|FG003|Part 1 (Upto Day 104)|Other|0|||
44447543|NCT05074498|79455846|FG004|Part 1 (Upto Day 104)|Other|0|||
44447544|NCT05074498|79455847|FG005|Part 1 (Upto Day 104)|Other|0|||
44447545|NCT05074498|79455842|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
44447546|NCT05074498|79455843|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
44447547|NCT05074498|79455844|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
44447548|NCT05074498|79455845|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
44447549|NCT05074498|79455846|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
44447550|NCT05074498|79455847|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
44447551|NCT05074498|79455842|FG000|Part 2 (Upto Day 104)|Death|0|||
44447552|NCT05074498|79455843|FG001|Part 2 (Upto Day 104)|Death|0|||
44447553|NCT05074498|79455844|FG002|Part 2 (Upto Day 104)|Death|0|||
44447554|NCT05074498|79455845|FG003|Part 2 (Upto Day 104)|Death|0|||
44447555|NCT05074498|79455846|FG004|Part 2 (Upto Day 104)|Death|1|||
44447556|NCT05074498|79455847|FG005|Part 2 (Upto Day 104)|Death|0|||
44447557|NCT05074498|79455842|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
44447558|NCT05074498|79455843|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
44447559|NCT05074498|79455844|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
44447560|NCT05074498|79455845|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
44447561|NCT05074498|79455846|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
44447562|NCT05074498|79455847|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
44447563|NCT05074498|79455842|FG000|Part 2 (Upto Day 104)|Other|0|||
44447564|NCT05074498|79455843|FG001|Part 2 (Upto Day 104)|Other|0|||
44447565|NCT05074498|79455844|FG002|Part 2 (Upto Day 104)|Other|0|||
44447566|NCT05074498|79455845|FG003|Part 2 (Upto Day 104)|Other|0|||
44447567|NCT05074498|79455846|FG004|Part 2 (Upto Day 104)|Other|1|||
44447568|NCT05074498|79455847|FG005|Part 2 (Upto Day 104)|Other|0|||
44447569|NCT04871113|79455884|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
44447570|NCT04871113|79455885|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
44447571|NCT04871113|79455886|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
44447572|NCT04871113|79455887|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
44447573|NCT04871113|79455888|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
44447574|NCT04871113|79455889|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|7|||
44447575|NCT04871113|79455890|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|5|||
44447576|NCT04871113|79455891|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
44447577|NCT04871113|79455892|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
44447578|NCT04871113|79455893|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
44447579|NCT04871113|79455884|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447580|NCT04871113|79455885|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447581|NCT04871113|79455886|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447582|NCT04871113|79455887|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447583|NCT04871113|79455888|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447584|NCT04871113|79455889|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447585|NCT04871113|79455890|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|1|||
44447586|NCT04871113|79455891|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447587|NCT04871113|79455892|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447588|NCT04871113|79455893|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
44447589|NCT04715230|79455917|FG000|Overall Study|Withdrawal by Subject|1|||
44447590|NCT04715230|79455918|FG001|Overall Study|Withdrawal by Subject|0|||
44447591|NCT04715230|79455919|FG002|Overall Study|Withdrawal by Subject|0|||
44447592|NCT04715230|79455917|FG000|Overall Study|Lost to Follow-up|0|||
44447593|NCT04715230|79455918|FG001|Overall Study|Lost to Follow-up|5|||
44447594|NCT04715230|79455919|FG002|Overall Study|Lost to Follow-up|1|||
44447595|NCT04710368|79455927|FG000|Overall Study|Withdrawal by Subject|9|||
44447596|NCT04710368|79455927|FG000|Overall Study|Lost to Follow-up|4|||
44447597|NCT04710368|79455927|FG000|Overall Study|Death|2|||
44447598|NCT04710368|79455927|FG000|Overall Study|Patient preference|11|||
44447599|NCT04710368|79455927|FG000|Overall Study|Treatment discontinuation|1|||
44447600|NCT04590963|79455959|FG000|Overall Study|Death|118|||
44447601|NCT04590963|79455960|FG001|Overall Study|Death|59|||
44447602|NCT04590963|79455959|FG000|Overall Study|Lost to Follow-up|1|||
44447603|NCT04590963|79455960|FG001|Overall Study|Lost to Follow-up|1|||
44447604|NCT04590963|79455959|FG000|Overall Study|Progressive disease|0|||
44447605|NCT04590963|79455960|FG001|Overall Study|Progressive disease|1|||
44447606|NCT04590963|79455959|FG000|Overall Study|Study terminated by sponsor|103|||
44447607|NCT04590963|79455960|FG001|Overall Study|Study terminated by sponsor|50|||
44447608|NCT04590963|79455959|FG000|Overall Study|Withdrawal by Subject|15|||
44447609|NCT04590963|79455960|FG001|Overall Study|Withdrawal by Subject|8|||
44447610|NCT04590963|79455959|FG000|Overall Study|Ongoing at data cut-off|9|||
44447611|NCT04590963|79455960|FG001|Overall Study|Ongoing at data cut-off|4|||
44349684|NCT00996892|79354208|FG005|Expansion Stage 2|Death|0|||
44349685|NCT00996892|79354209|FG006|Expansion Stage 2|Death|0|||
44349686|NCT00996892|79354210|FG007|Expansion Stage 2|Death|0|||
44349687|NCT00996892|79354211|FG008|Expansion Stage 2|Death|0|||
44349688|NCT00996892|79354212|FG009|Expansion Stage 2|Death|0|||
44349689|NCT00996892|79354213|FG010|Expansion Stage 2|Death|0|||
44349690|NCT00996892|79354214|FG011|Expansion Stage 2|Death|0|||
44349691|NCT00996892|79354215|FG012|Expansion Stage 2|Death|0|||
44349692|NCT00996892|79354216|FG013|Expansion Stage 2|Death|0|||
44447612|NCT04590963|79455959|FG000|Overall Study|Screen failure|1|||
44447613|NCT04590963|79455960|FG001|Overall Study|Screen failure|0|||
44349693|NCT00996892|79354217|FG014|Expansion Stage 2|Death|0|||
44349694|NCT00996892|79354218|FG015|Expansion Stage 2|Death|0|||
44349695|NCT00996892|79354219|FG016|Expansion Stage 2|Death|0|||
44349696|NCT00996892|79354220|FG017|Expansion Stage 2|Death|0|||
44349697|NCT00996892|79354221|FG018|Expansion Stage 2|Death|2|||
44349698|NCT00996892|79354222|FG019|Expansion Stage 2|Death|0|||
44349699|NCT00996892|79354203|FG000|Expansion Stage 2|Physician Decision|0|||
44349700|NCT00996892|79354204|FG001|Expansion Stage 2|Physician Decision|0|||
44349701|NCT00996892|79354205|FG002|Expansion Stage 2|Physician Decision|0|||
44349702|NCT00996892|79354206|FG003|Expansion Stage 2|Physician Decision|0|||
44349703|NCT00996892|79354207|FG004|Expansion Stage 2|Physician Decision|0|||
44349704|NCT00996892|79354208|FG005|Expansion Stage 2|Physician Decision|0|||
44349705|NCT00996892|79354209|FG006|Expansion Stage 2|Physician Decision|0|||
44349706|NCT00996892|79354210|FG007|Expansion Stage 2|Physician Decision|0|||
44349707|NCT00996892|79354211|FG008|Expansion Stage 2|Physician Decision|0|||
44349708|NCT00996892|79354212|FG009|Expansion Stage 2|Physician Decision|0|||
44349709|NCT00996892|79354213|FG010|Expansion Stage 2|Physician Decision|0|||
44349710|NCT00996892|79354214|FG011|Expansion Stage 2|Physician Decision|0|||
44349711|NCT00996892|79354215|FG012|Expansion Stage 2|Physician Decision|0|||
44447614|NCT04493216|79455970|FG000|Overall Study|Adverse Event|1|||
44349712|NCT00996892|79354216|FG013|Expansion Stage 2|Physician Decision|0|||
44349713|NCT00996892|79354217|FG014|Expansion Stage 2|Physician Decision|0|||
44349714|NCT00996892|79354218|FG015|Expansion Stage 2|Physician Decision|0|||
44349715|NCT00996892|79354219|FG016|Expansion Stage 2|Physician Decision|0|||
44349716|NCT00996892|79354220|FG017|Expansion Stage 2|Physician Decision|0|||
44349717|NCT00996892|79354221|FG018|Expansion Stage 2|Physician Decision|1|||
44349718|NCT00996892|79354222|FG019|Expansion Stage 2|Physician Decision|0|||
44349719|NCT00996892|79354203|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
44349720|NCT00996892|79354204|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
44349721|NCT00996892|79354205|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
44349722|NCT00996892|79354206|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
44349723|NCT00996892|79354207|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
44349724|NCT00996892|79354208|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
44349725|NCT00996892|79354209|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
44349726|NCT00996892|79354210|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
44349727|NCT00996892|79354211|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
44349728|NCT00996892|79354212|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
44349729|NCT00996892|79354213|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
44349730|NCT00996892|79354214|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
44349731|NCT00996892|79354215|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
44349732|NCT00996892|79354216|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
44349733|NCT00996892|79354217|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
44349734|NCT00996892|79354218|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
44349735|NCT00996892|79354219|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
44349736|NCT00996892|79354220|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
44349737|NCT00996892|79354221|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
44349738|NCT00996892|79354222|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
44349739|NCT00996892|79354203|FG000|Expansion Stage 2|Disease Progression|0|||
44349740|NCT00996892|79354204|FG001|Expansion Stage 2|Disease Progression|0|||
44349741|NCT00996892|79354205|FG002|Expansion Stage 2|Disease Progression|0|||
44349742|NCT00996892|79354206|FG003|Expansion Stage 2|Disease Progression|0|||
44349743|NCT00996892|79354207|FG004|Expansion Stage 2|Disease Progression|0|||
44349744|NCT00996892|79354208|FG005|Expansion Stage 2|Disease Progression|0|||
44349745|NCT00996892|79354209|FG006|Expansion Stage 2|Disease Progression|0|||
44349746|NCT00996892|79354210|FG007|Expansion Stage 2|Disease Progression|0|||
44349747|NCT00996892|79354211|FG008|Expansion Stage 2|Disease Progression|0|||
44349748|NCT00996892|79354212|FG009|Expansion Stage 2|Disease Progression|0|||
44349749|NCT00996892|79354213|FG010|Expansion Stage 2|Disease Progression|0|||
44349750|NCT00996892|79354214|FG011|Expansion Stage 2|Disease Progression|0|||
44349751|NCT00996892|79354215|FG012|Expansion Stage 2|Disease Progression|0|||
44349752|NCT00996892|79354216|FG013|Expansion Stage 2|Disease Progression|0|||
44349753|NCT00996892|79354217|FG014|Expansion Stage 2|Disease Progression|0|||
44349754|NCT00996892|79354218|FG015|Expansion Stage 2|Disease Progression|0|||
44349755|NCT00996892|79354219|FG016|Expansion Stage 2|Disease Progression|0|||
44349756|NCT00996892|79354220|FG017|Expansion Stage 2|Disease Progression|0|||
44349757|NCT00996892|79354221|FG018|Expansion Stage 2|Disease Progression|28|||
44349758|NCT00996892|79354222|FG019|Expansion Stage 2|Disease Progression|0|||
44349759|NCT00996892|79354203|FG000|Expansion Stage 2A|Adverse Event|0|||
44349760|NCT00996892|79354204|FG001|Expansion Stage 2A|Adverse Event|0|||
44349761|NCT00996892|79354205|FG002|Expansion Stage 2A|Adverse Event|0|||
44349762|NCT00996892|79354206|FG003|Expansion Stage 2A|Adverse Event|0|||
44349763|NCT00996892|79354207|FG004|Expansion Stage 2A|Adverse Event|0|||
44349764|NCT00996892|79354208|FG005|Expansion Stage 2A|Adverse Event|0|||
44349765|NCT00996892|79354209|FG006|Expansion Stage 2A|Adverse Event|0|||
44349766|NCT00996892|79354210|FG007|Expansion Stage 2A|Adverse Event|0|||
44349767|NCT00996892|79354211|FG008|Expansion Stage 2A|Adverse Event|0|||
44349768|NCT00996892|79354212|FG009|Expansion Stage 2A|Adverse Event|0|||
44349769|NCT00996892|79354213|FG010|Expansion Stage 2A|Adverse Event|0|||
44349770|NCT00996892|79354214|FG011|Expansion Stage 2A|Adverse Event|0|||
44349771|NCT00996892|79354215|FG012|Expansion Stage 2A|Adverse Event|0|||
44260858|NCT00634088|79135803|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
44260859|NCT00634088|79135804|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
44260860|NCT00634088|79135805|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
44260861|NCT00634088|79135806|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
44260862|NCT00634088|79135803|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
44260863|NCT00634088|79135804|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
44260864|NCT00634088|79135805|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
44260865|NCT00634088|79135806|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
44260866|NCT00634088|79135803|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
44260867|NCT00634088|79135804|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
44260868|NCT00634088|79135805|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
44260869|NCT00634088|79135806|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
44260870|NCT00634088|79135803|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
44260871|NCT00634088|79135804|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
44260872|NCT00634088|79135805|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
44260873|NCT00634088|79135806|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
44260874|NCT00634088|79135803|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
44260875|NCT00634088|79135804|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
44260876|NCT00634088|79135805|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
44260877|NCT00634088|79135806|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
44260878|NCT00634088|79135803|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
44260879|NCT00634088|79135804|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
44260880|NCT00634088|79135805|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
44260881|NCT00634088|79135806|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
44260882|NCT00634010|79135906|FG000|Overall Study|Adverse Event|2|||
44260883|NCT00634010|79135907|FG001|Overall Study|Adverse Event|5|||
44260884|NCT00634010|79135906|FG000|Overall Study|Withdrawal by Subject|5|||
44260885|NCT00634010|79135907|FG001|Overall Study|Withdrawal by Subject|6|||
44349772|NCT00996892|79354216|FG013|Expansion Stage 2A|Adverse Event|0|||
44349773|NCT00996892|79354217|FG014|Expansion Stage 2A|Adverse Event|0|||
44349774|NCT00996892|79354218|FG015|Expansion Stage 2A|Adverse Event|0|||
44349775|NCT00996892|79354219|FG016|Expansion Stage 2A|Adverse Event|0|||
44349776|NCT00996892|79354220|FG017|Expansion Stage 2A|Adverse Event|0|||
44349777|NCT00996892|79354221|FG018|Expansion Stage 2A|Adverse Event|0|||
44349778|NCT00996892|79354222|FG019|Expansion Stage 2A|Adverse Event|8|||
44349779|NCT00996892|79354203|FG000|Expansion Stage 2A|Physician Decision|0|||
44349780|NCT00996892|79354204|FG001|Expansion Stage 2A|Physician Decision|0|||
44349781|NCT00996892|79354205|FG002|Expansion Stage 2A|Physician Decision|0|||
44349782|NCT00996892|79354206|FG003|Expansion Stage 2A|Physician Decision|0|||
44349783|NCT00996892|79354207|FG004|Expansion Stage 2A|Physician Decision|0|||
44349784|NCT00996892|79354208|FG005|Expansion Stage 2A|Physician Decision|0|||
44349785|NCT00996892|79354209|FG006|Expansion Stage 2A|Physician Decision|0|||
44349786|NCT00996892|79354210|FG007|Expansion Stage 2A|Physician Decision|0|||
44349787|NCT00996892|79354211|FG008|Expansion Stage 2A|Physician Decision|0|||
44349788|NCT00996892|79354212|FG009|Expansion Stage 2A|Physician Decision|0|||
44349789|NCT00996892|79354213|FG010|Expansion Stage 2A|Physician Decision|0|||
44349790|NCT00996892|79354214|FG011|Expansion Stage 2A|Physician Decision|0|||
44349791|NCT00996892|79354215|FG012|Expansion Stage 2A|Physician Decision|0|||
44349792|NCT00996892|79354216|FG013|Expansion Stage 2A|Physician Decision|0|||
44349793|NCT00996892|79354217|FG014|Expansion Stage 2A|Physician Decision|0|||
44349794|NCT00996892|79354218|FG015|Expansion Stage 2A|Physician Decision|0|||
44349795|NCT00996892|79354219|FG016|Expansion Stage 2A|Physician Decision|0|||
44349796|NCT00996892|79354220|FG017|Expansion Stage 2A|Physician Decision|0|||
44349797|NCT00996892|79354221|FG018|Expansion Stage 2A|Physician Decision|0|||
44349798|NCT00996892|79354222|FG019|Expansion Stage 2A|Physician Decision|2|||
44349799|NCT00996892|79354203|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
44349800|NCT00996892|79354204|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
44349801|NCT00996892|79354205|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
44349802|NCT00996892|79354206|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
44349803|NCT00996892|79354207|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
44349804|NCT00996892|79354208|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
44349805|NCT00996892|79354209|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
44349806|NCT00996892|79354210|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
44349807|NCT00996892|79354211|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
44349808|NCT00996892|79354212|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
44349809|NCT00996892|79354213|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
44349810|NCT00996892|79354214|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
44349811|NCT00996892|79354215|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
44349812|NCT00996892|79354216|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
44349813|NCT00996892|79354217|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
44349814|NCT00996892|79354218|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
44349815|NCT00996892|79354219|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
44349816|NCT00996892|79354220|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
44349817|NCT00996892|79354221|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
44349818|NCT00996892|79354222|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
44349819|NCT00996892|79354203|FG000|Expansion Stage 2A|Disease Progression|0|||
44349820|NCT00996892|79354204|FG001|Expansion Stage 2A|Disease Progression|0|||
44349821|NCT00996892|79354205|FG002|Expansion Stage 2A|Disease Progression|0|||
44349822|NCT00996892|79354206|FG003|Expansion Stage 2A|Disease Progression|0|||
44349823|NCT00996892|79354207|FG004|Expansion Stage 2A|Disease Progression|0|||
44349824|NCT00996892|79354208|FG005|Expansion Stage 2A|Disease Progression|0|||
44349825|NCT00996892|79354209|FG006|Expansion Stage 2A|Disease Progression|0|||
44349826|NCT00996892|79354210|FG007|Expansion Stage 2A|Disease Progression|0|||
44349827|NCT00996892|79354211|FG008|Expansion Stage 2A|Disease Progression|0|||
44349828|NCT00996892|79354212|FG009|Expansion Stage 2A|Disease Progression|0|||
44349829|NCT00996892|79354213|FG010|Expansion Stage 2A|Disease Progression|0|||
44349830|NCT00996892|79354214|FG011|Expansion Stage 2A|Disease Progression|0|||
44349831|NCT00996892|79354215|FG012|Expansion Stage 2A|Disease Progression|0|||
44349832|NCT00996892|79354216|FG013|Expansion Stage 2A|Disease Progression|0|||
44349833|NCT00996892|79354217|FG014|Expansion Stage 2A|Disease Progression|0|||
44349834|NCT00996892|79354218|FG015|Expansion Stage 2A|Disease Progression|0|||
44349835|NCT00996892|79354219|FG016|Expansion Stage 2A|Disease Progression|0|||
44349836|NCT00996892|79354220|FG017|Expansion Stage 2A|Disease Progression|0|||
44349837|NCT00996892|79354221|FG018|Expansion Stage 2A|Disease Progression|0|||
44349838|NCT00996892|79354222|FG019|Expansion Stage 2A|Disease Progression|31|||
44349839|NCT01257581|79354286|FG000|Overall Study|Early Termination|3|||
44349840|NCT01257581|79354287|FG001|Overall Study|Early Termination|1|||
44349841|NCT01257581|79354288|FG002|Overall Study|Early Termination|2|||
44349842|NCT01257581|79354286|FG000|Overall Study|Death|2|||
44349843|NCT01257581|79354287|FG001|Overall Study|Death|2|||
44349844|NCT01257581|79354288|FG002|Overall Study|Death|4|||
44349845|NCT01257503|79354298|FG000|Overall Study|Lost to Follow-up|7|||
44349846|NCT01257503|79354299|FG001|Overall Study|Lost to Follow-up|10|||
44349847|NCT01257503|79354298|FG000|Overall Study|Over 5 years old at enrollment|0|||
44349848|NCT01257503|79354299|FG001|Overall Study|Over 5 years old at enrollment|1|||
44349849|NCT01257503|79354298|FG000|Overall Study|strep culture positive at enrollment|1|||
44349850|NCT01257503|79354299|FG001|Overall Study|strep culture positive at enrollment|0|||
44349851|NCT00995566|79354305|FG000|Overall Study|Adverse Event|2|||
44349852|NCT00995566|79354305|FG000|Overall Study|Early study termination|52|||
44349853|NCT01257425|79354311|FG000|Overall Study|Lack of Efficacy|3|||
44349854|NCT01257425|79354312|FG001|Overall Study|Lack of Efficacy|3|||
44349855|NCT01257425|79354311|FG000|Overall Study|Adverse Event|1|||
44349856|NCT01257425|79354312|FG001|Overall Study|Adverse Event|1|||
44349857|NCT01257425|79354311|FG000|Overall Study|Protocol Violation|1|||
44349858|NCT01257425|79354312|FG001|Overall Study|Protocol Violation|1|||
44349859|NCT01257425|79354311|FG000|Overall Study|Withdrawal by Subject|0|||
44349860|NCT01257425|79354312|FG001|Overall Study|Withdrawal by Subject|1|||
44349861|NCT01257425|79354311|FG000|Overall Study|Death|1|||
44349862|NCT01257425|79354312|FG001|Overall Study|Death|0|||
44349863|NCT00995488|79354318|FG000|Overall Study|Withdrawal by Subject|1|||
44349864|NCT01256879|79354322|FG000|Overall Study|Withdrawal by Subject|1|||
44349865|NCT01125189|79354335|FG000|Treatment Period|Lack of Efficacy|15|||
44349866|NCT01125189|79354336|FG001|Treatment Period|Lack of Efficacy|18|||
44349867|NCT01125189|79354337|FG002|Treatment Period|Lack of Efficacy|25|||
44349868|NCT01125189|79354335|FG000|Treatment Period|Adverse Event|7|||
44349869|NCT01125189|79354336|FG001|Treatment Period|Adverse Event|8|||
44349870|NCT01125189|79354337|FG002|Treatment Period|Adverse Event|8|||
44349871|NCT01125189|79354335|FG000|Treatment Period|Withdrawal by Subject|3|||
44349872|NCT01125189|79354336|FG001|Treatment Period|Withdrawal by Subject|1|||
44349873|NCT01125189|79354337|FG002|Treatment Period|Withdrawal by Subject|1|||
44349874|NCT01125189|79354335|FG000|Treatment Period|Death|1|||
44349875|NCT01125189|79354336|FG001|Treatment Period|Death|0|||
44349876|NCT01125189|79354337|FG002|Treatment Period|Death|0|||
44349877|NCT01125189|79354335|FG000|Treatment Period|Lost to Follow-up|1|||
44349878|NCT01125189|79354336|FG001|Treatment Period|Lost to Follow-up|2|||
44349879|NCT01125189|79354337|FG002|Treatment Period|Lost to Follow-up|1|||
44349880|NCT01125189|79354335|FG000|Treatment Period|Poor compliance/noncompliance|0|||
44349881|NCT01125189|79354336|FG001|Treatment Period|Poor compliance/noncompliance|1|||
44349882|NCT01125189|79354337|FG002|Treatment Period|Poor compliance/noncompliance|0|||
44349883|NCT01125189|79354335|FG000|Treatment Period|Participants requested to discontinue|1|||
44349884|NCT01125189|79354336|FG001|Treatment Period|Participants requested to discontinue|3|||
44349885|NCT01125189|79354337|FG002|Treatment Period|Participants requested to discontinue|4|||
44349886|NCT01125189|79354335|FG000|Treatment Period|Other reasons|1|||
44349887|NCT01125189|79354336|FG001|Treatment Period|Other reasons|1|||
44349888|NCT01125189|79354337|FG002|Treatment Period|Other reasons|0|||
44349889|NCT01125189|79354335|FG000|Treatment Period|Completed 24 week treatment period only|2|||
44349890|NCT01125189|79354336|FG001|Treatment Period|Completed 24 week treatment period only|1|||
44349891|NCT01125189|79354337|FG002|Treatment Period|Completed 24 week treatment period only|2|||
44349892|NCT01125189|79354335|FG000|Follow up Period|Withdrawal by Subject|3|||
44349893|NCT01125189|79354336|FG001|Follow up Period|Withdrawal by Subject|2|||
44349894|NCT01125189|79354337|FG002|Follow up Period|Withdrawal by Subject|5|||
44349895|NCT01125189|79354335|FG000|Follow up Period|Death|1|||
44349896|NCT01125189|79354336|FG001|Follow up Period|Death|0|||
44349897|NCT01125189|79354337|FG002|Follow up Period|Death|0|||
44349898|NCT01125189|79354335|FG000|Follow up Period|Lost to Follow-up|12|||
44349899|NCT01125189|79354336|FG001|Follow up Period|Lost to Follow-up|9|||
44349900|NCT01125189|79354337|FG002|Follow up Period|Lost to Follow-up|6|||
44349901|NCT01125189|79354335|FG000|Follow up Period|Other reasons|4|||
44349902|NCT01125189|79354336|FG001|Follow up Period|Other reasons|4|||
44349903|NCT01125189|79354337|FG002|Follow up Period|Other reasons|5|||
44349904|NCT01256567|79354348|FG000|Overall Study|Withdrawal by Subject|1|||
44349905|NCT00996736|79354355|FG000|Overall Study|Death|1|||
44349906|NCT00996736|79354356|FG001|Overall Study|Death|1|||
44349907|NCT00996736|79354355|FG000|Overall Study|Lost to Follow-up|15|||
44349908|NCT00996736|79354356|FG001|Overall Study|Lost to Follow-up|14|||
44349909|NCT00996736|79354355|FG000|Overall Study|Visit not within 3-month window|5|||
44349910|NCT00996736|79354356|FG001|Overall Study|Visit not within 3-month window|3|||
44349911|NCT00996658|79354364|FG000|Overall Study|Adverse Event|2|||
44349912|NCT00996658|79354365|FG001|Overall Study|Adverse Event|5|||
44349913|NCT00996658|79354364|FG000|Overall Study|Protocol Violation|0|||
44349914|NCT00996658|79354365|FG001|Overall Study|Protocol Violation|1|||
44349915|NCT00996658|79354364|FG000|Overall Study|Lost to Follow-up|2|||
44349916|NCT00996658|79354365|FG001|Overall Study|Lost to Follow-up|5|||
44349917|NCT00996658|79354364|FG000|Overall Study|Non-compliance issues|3|||
44349918|NCT00996658|79354365|FG001|Overall Study|Non-compliance issues|3|||
44349919|NCT00996658|79354364|FG000|Overall Study|Other|9|||
44349920|NCT00996658|79354365|FG001|Overall Study|Other|7|||
44349921|NCT01124643|79354371|FG000|Overall Study|Death|1|||
44349922|NCT01256411|79354379|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
44349923|NCT01256411|79354380|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
44349924|NCT01256411|79354381|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
44349925|NCT01256411|79354382|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
44349926|NCT01256411|79354383|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
44349927|NCT01256411|79354384|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
44349928|NCT01256411|79354379|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
44349929|NCT01256411|79354380|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
44349930|NCT01256411|79354381|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
44349931|NCT01256411|79354382|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
44349932|NCT01256411|79354383|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
44349933|NCT01256411|79354384|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
44349934|NCT01256411|79354379|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
44349935|NCT01256411|79354380|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
44349936|NCT01256411|79354381|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
44349937|NCT01256411|79354382|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
44349938|NCT01256411|79354383|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
44349939|NCT01256411|79354384|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
44349940|NCT01256411|79354379|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
44349941|NCT01256411|79354380|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
44349942|NCT01256411|79354381|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
44349943|NCT01256411|79354382|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
44349944|NCT01256411|79354383|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
44349945|NCT01256411|79354384|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
44349946|NCT01256411|79354379|FG000|Extension by Maximum Treatment|Adverse Event|4|||
44349947|NCT01256411|79354380|FG001|Extension by Maximum Treatment|Adverse Event|2|||
44349948|NCT01256411|79354381|FG002|Extension by Maximum Treatment|Adverse Event|1|||
44349949|NCT01256411|79354382|FG003|Extension by Maximum Treatment|Adverse Event|0|||
44349950|NCT01256411|79354383|FG004|Extension by Maximum Treatment|Adverse Event|0|||
44349951|NCT01256411|79354384|FG005|Extension by Maximum Treatment|Adverse Event|0|||
44349952|NCT01256411|79354379|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
44349953|NCT01256411|79354380|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
44349954|NCT01256411|79354381|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
44349955|NCT01256411|79354382|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
44349956|NCT01256411|79354383|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
44349957|NCT01256411|79354384|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
44349958|NCT01256411|79354379|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
44349959|NCT01256411|79354380|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
44349960|NCT01256411|79354381|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
44349961|NCT01256411|79354382|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
44349962|NCT01256411|79354383|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
44349963|NCT01256411|79354384|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
44349964|NCT01256411|79354379|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
44349965|NCT01256411|79354380|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
44349966|NCT01256411|79354381|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
44349967|NCT01256411|79354382|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
44349968|NCT01256411|79354383|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
44349969|NCT01256411|79354384|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
44349970|NCT01256411|79354379|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
44349971|NCT01256411|79354380|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
44349972|NCT01256411|79354381|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
44349973|NCT01256411|79354382|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
44349974|NCT01256411|79354383|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
44349975|NCT01256411|79354384|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
44349976|NCT01256411|79354379|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
44349977|NCT01256411|79354380|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
44349978|NCT01256411|79354381|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
44349979|NCT01256411|79354382|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
44349980|NCT01256411|79354383|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
44349981|NCT01256411|79354384|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
44349982|NCT00996580|79354398|FG000|Overall Study|Adverse Event|466|||
44349983|NCT00996580|79354398|FG000|Overall Study|Lost to Follow-up|480|||
44349984|NCT00996580|79354398|FG000|Overall Study|Noncompliance with the protocol|137|||
44349985|NCT00996580|79354398|FG000|Overall Study|Physician Decision|5|||
44349986|NCT00996580|79354398|FG000|Overall Study|Pregnancy|68|||
44349987|NCT00996580|79354398|FG000|Overall Study|Protocol Violation|16|||
44349988|NCT00996580|79354398|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
44349989|NCT00996580|79354398|FG000|Overall Study|Withdrawal by Subject|217|||
44349990|NCT00996580|79354398|FG000|Overall Study|Other|29|||
44349991|NCT01124175|79354407|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
44349992|NCT01124175|79354408|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
44349993|NCT01256177|79354416|FG000|Overall Study|Withdrawal by Subject|23|||
44349994|NCT01256177|79354417|FG001|Overall Study|Withdrawal by Subject|22|||
44349995|NCT01256177|79354416|FG000|Overall Study|Lost to Follow-up|2|||
44349996|NCT01256177|79354417|FG001|Overall Study|Lost to Follow-up|2|||
44349997|NCT01256177|79354416|FG000|Overall Study|Adverse Event|8|||
44349998|NCT01256177|79354417|FG001|Overall Study|Adverse Event|9|||
44349999|NCT01256177|79354416|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
44350000|NCT01256177|79354417|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
44350001|NCT01256177|79354416|FG000|Overall Study|Condition under Investigation Worsened|1|||
44350002|NCT01256177|79354417|FG001|Overall Study|Condition under Investigation Worsened|0|||
44350003|NCT01256177|79354416|FG000|Overall Study|Lack of Efficacy|11|||
44350004|NCT01256177|79354417|FG001|Overall Study|Lack of Efficacy|2|||
44350005|NCT01256177|79354416|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
44350006|NCT01256177|79354417|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
44350007|NCT00999544|79354423|FG000|Overall Study|Withdrawal by Subject|1|||
44350008|NCT01124097|79354460|FG000|Overall Study|Withdrawal by Subject|4|||
44350009|NCT01124097|79354461|FG001|Overall Study|Withdrawal by Subject|3|||
44350010|NCT01124097|79354462|FG002|Overall Study|Withdrawal by Subject|2|||
44350011|NCT01124097|79354463|FG003|Overall Study|Withdrawal by Subject|3|||
44350012|NCT01124097|79354460|FG000|Overall Study|Lack of Efficacy|2|||
44350013|NCT01124097|79354461|FG001|Overall Study|Lack of Efficacy|3|||
44350014|NCT01124097|79354462|FG002|Overall Study|Lack of Efficacy|1|||
44350015|NCT01124097|79354463|FG003|Overall Study|Lack of Efficacy|3|||
44350016|NCT01124097|79354460|FG000|Overall Study|Adverse Event|24|||
44350017|NCT01124097|79354461|FG001|Overall Study|Adverse Event|15|||
44350018|NCT01124097|79354462|FG002|Overall Study|Adverse Event|15|||
44350019|NCT01124097|79354463|FG003|Overall Study|Adverse Event|7|||
44350020|NCT01124097|79354460|FG000|Overall Study|Protocol Violation|2|||
44350021|NCT01124097|79354461|FG001|Overall Study|Protocol Violation|0|||
44350022|NCT01124097|79354462|FG002|Overall Study|Protocol Violation|2|||
44350023|NCT01124097|79354463|FG003|Overall Study|Protocol Violation|1|||
44350024|NCT01124097|79354460|FG000|Overall Study|Physician Decision|2|||
44350025|NCT01124097|79354461|FG001|Overall Study|Physician Decision|1|||
44350026|NCT01124097|79354462|FG002|Overall Study|Physician Decision|0|||
44350027|NCT01124097|79354463|FG003|Overall Study|Physician Decision|0|||
44350028|NCT01123941|79354475|FG000|Overall Study|Lost to Follow-up|2|||
44350029|NCT01123941|79354476|FG001|Overall Study|Lost to Follow-up|1|||
44350030|NCT01123395|79354482|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
44350031|NCT01123395|79354483|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
44350032|NCT01255787|79354493|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
44350033|NCT01255787|79354494|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
44350034|NCT01255787|79354495|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
44350035|NCT01255787|79354496|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
44350036|NCT01255787|79354493|FG000|Overall Study|Major Protocol Deviation|1|||
44350037|NCT01255787|79354494|FG001|Overall Study|Major Protocol Deviation|1|||
44350038|NCT01255787|79354495|FG002|Overall Study|Major Protocol Deviation|0|||
44350039|NCT01255787|79354496|FG003|Overall Study|Major Protocol Deviation|4|||
44350040|NCT01255787|79354493|FG000|Overall Study|Lost to Follow-up|1|||
44350041|NCT01255787|79354494|FG001|Overall Study|Lost to Follow-up|2|||
44350042|NCT01255787|79354495|FG002|Overall Study|Lost to Follow-up|4|||
44350043|NCT01255787|79354496|FG003|Overall Study|Lost to Follow-up|2|||
44350044|NCT01255787|79354493|FG000|Overall Study|Withdrawal of Consent|3|||
44350045|NCT01255787|79354494|FG001|Overall Study|Withdrawal of Consent|9|||
44350046|NCT01255787|79354495|FG002|Overall Study|Withdrawal of Consent|3|||
44350047|NCT01255787|79354496|FG003|Overall Study|Withdrawal of Consent|4|||
44350048|NCT01255787|79354493|FG000|Overall Study|Pregnancy|0|||
44350049|NCT01255787|79354494|FG001|Overall Study|Pregnancy|0|||
44350050|NCT01255787|79354495|FG002|Overall Study|Pregnancy|0|||
44350051|NCT01255787|79354496|FG003|Overall Study|Pregnancy|1|||
44350052|NCT01255787|79354493|FG000|Overall Study|Lack of Efficacy|2|||
44350053|NCT01255787|79354494|FG001|Overall Study|Lack of Efficacy|2|||
44350054|NCT01255787|79354495|FG002|Overall Study|Lack of Efficacy|2|||
44350055|NCT01255787|79354496|FG003|Overall Study|Lack of Efficacy|2|||
44350056|NCT01255787|79354493|FG000|Overall Study|Noncompliance with Study Drug|3|||
44350057|NCT01255787|79354494|FG001|Overall Study|Noncompliance with Study Drug|1|||
44350058|NCT01255787|79354495|FG002|Overall Study|Noncompliance with Study Drug|0|||
44350059|NCT01255787|79354496|FG003|Overall Study|Noncompliance with Study Drug|0|||
44350060|NCT01123161|79354508|FG000|Overall Study|Lost to Follow-up|1|||
44350061|NCT01123161|79354509|FG001|Overall Study|Lost to Follow-up|0|||
44350062|NCT01123161|79354508|FG000|Overall Study|Withdrawal by Subject|1|||
44350063|NCT01123161|79354509|FG001|Overall Study|Withdrawal by Subject|0|||
44350064|NCT01255631|79354520|FG000|Overall Study|poor enrollment, no data analyzed|9|||
44350065|NCT01255631|79354521|FG001|Overall Study|poor enrollment, no data analyzed|6|||
44350066|NCT00999466|79354530|FG000|Main Part|Withdrawal by Subject|0|||
44350067|NCT00999466|79354531|FG001|Main Part|Withdrawal by Subject|0|||
44350068|NCT00999466|79354532|FG002|Main Part|Withdrawal by Subject|2|||
44350069|NCT00999466|79354530|FG000|Main Part|Adverse Event|0|||
44350070|NCT00999466|79354531|FG001|Main Part|Adverse Event|4|||
44350071|NCT00999466|79354532|FG002|Main Part|Adverse Event|2|||
44350072|NCT01255163|79354542|FG000|Overall Study|Withdrawal by Subject|1|||
44350073|NCT01255163|79354543|FG001|Overall Study|Withdrawal by Subject|0|||
44350074|NCT01255163|79354542|FG000|Overall Study|Lost to Follow-up|2|||
44350075|NCT01255163|79354543|FG001|Overall Study|Lost to Follow-up|0|||
44350076|NCT01255163|79354542|FG000|Overall Study|Adverse Event|0|||
44350077|NCT01255163|79354543|FG001|Overall Study|Adverse Event|2|||
44350078|NCT01255163|79354542|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
44350079|NCT01255163|79354543|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
44350080|NCT01123083|79354553|FG000|Overall Study|Investigator recommendation|1|||
44350081|NCT01123083|79354554|FG001|Overall Study|Investigator recommendation|1|||
44350082|NCT01123083|79354553|FG000|Overall Study|Administrative reasons|0|||
44350083|NCT01123083|79354554|FG001|Overall Study|Administrative reasons|4|||
44350084|NCT01123083|79354553|FG000|Overall Study|Lost to Follow-up|2|||
44350085|NCT01123083|79354554|FG001|Overall Study|Lost to Follow-up|6|||
44350086|NCT01123083|79354553|FG000|Overall Study|Adverse Event|1|||
44350087|NCT01123083|79354554|FG001|Overall Study|Adverse Event|0|||
44350088|NCT01123083|79354553|FG000|Overall Study|Withdrew for another reason not covered|0|||
44350089|NCT01123083|79354554|FG001|Overall Study|Withdrew for another reason not covered|1|||
44350090|NCT01123083|79354553|FG000|Overall Study|Participant/legal representative request|7|||
44350091|NCT01123083|79354554|FG001|Overall Study|Participant/legal representative request|3|||
44350092|NCT01254305|79354563|FG000|Overall Study|Adverse Event|6|||
44350093|NCT01254305|79354564|FG001|Overall Study|Adverse Event|3|||
44350094|NCT01254305|79354565|FG002|Overall Study|Adverse Event|2|||
44350095|NCT01254305|79354563|FG000|Overall Study|Lack of Efficacy|1|||
44447615|NCT04493216|79455971|FG001|Overall Study|Adverse Event|4|||
44260886|NCT00634010|79135906|FG000|Overall Study|Physician Decision|1|||
44447616|NCT04493216|79455972|FG002|Overall Study|Adverse Event|5|||
44447617|NCT04493216|79455973|FG003|Overall Study|Adverse Event|2|||
44447618|NCT04493216|79455970|FG000|Overall Study|Lost to Follow-up|1|||
44447619|NCT04493216|79455971|FG001|Overall Study|Lost to Follow-up|1|||
44447620|NCT04493216|79455972|FG002|Overall Study|Lost to Follow-up|0|||
44447621|NCT04493216|79455973|FG003|Overall Study|Lost to Follow-up|1|||
44447622|NCT04493216|79455970|FG000|Overall Study|Physician Decision|0|||
44447623|NCT04493216|79455971|FG001|Overall Study|Physician Decision|0|||
44447624|NCT04493216|79455972|FG002|Overall Study|Physician Decision|1|||
44447625|NCT04493216|79455973|FG003|Overall Study|Physician Decision|0|||
44447626|NCT04493216|79455970|FG000|Overall Study|Withdrawal by Subject|1|||
44447627|NCT04493216|79455971|FG001|Overall Study|Withdrawal by Subject|1|||
44447628|NCT04493216|79455972|FG002|Overall Study|Withdrawal by Subject|1|||
44447629|NCT04493216|79455973|FG003|Overall Study|Withdrawal by Subject|2|||
44447630|NCT04493216|79455970|FG000|Overall Study|Ongoing|18|||
44447631|NCT04493216|79455971|FG001|Overall Study|Ongoing|18|||
44447632|NCT04493216|79455972|FG002|Overall Study|Ongoing|16|||
44447633|NCT04493216|79455973|FG003|Overall Study|Ongoing|16|||
44447634|NCT04493216|79455970|FG000|Overall Study|Site closed|14|||
44447635|NCT04493216|79455971|FG001|Overall Study|Site closed|15|||
44350096|NCT01254305|79354564|FG001|Overall Study|Lack of Efficacy|0|||
44350097|NCT01254305|79354565|FG002|Overall Study|Lack of Efficacy|1|||
44447636|NCT04493216|79455972|FG002|Overall Study|Site closed|11|||
44447637|NCT04493216|79455973|FG003|Overall Study|Site closed|11|||
44447638|NCT04493216|79455970|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|4|||
44447639|NCT04493216|79455971|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
44447640|NCT04493216|79455972|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|8|||
44447641|NCT04493216|79455973|FG003|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
44447642|NCT04493216|79455970|FG000|Overall Study|Protocol Deviation|1|||
44447643|NCT04493216|79455971|FG001|Overall Study|Protocol Deviation|2|||
44447644|NCT04493216|79455972|FG002|Overall Study|Protocol Deviation|0|||
44447645|NCT04493216|79455973|FG003|Overall Study|Protocol Deviation|2|||
44447646|NCT04329949|79456004|FG000|Overall Study|Death|36|||
44447647|NCT04329949|79456004|FG000|Overall Study|Withdrawal by Subject|4|||
44447648|NCT04329949|79456004|FG000|Overall Study|Termination of study by sponsor|3|||
44447649|NCT04290624|79456010|FG000|Overall Study|Adverse Event|1|||
44350098|NCT01254305|79354563|FG000|Overall Study|Protocol Violation|1|||
44447650|NCT04290624|79456011|FG001|Overall Study|Adverse Event|0|||
44260887|NCT00634010|79135907|FG001|Overall Study|Physician Decision|1|||
44447651|NCT04288115|79456019|FG000|Overall Study|Withdrawal by Subject|0|||
44447652|NCT04288115|79456020|FG001|Overall Study|Withdrawal by Subject|1|||
44260888|NCT00634010|79135906|FG000|Overall Study|Disease Progression|1|||
44350099|NCT01254305|79354564|FG001|Overall Study|Protocol Violation|7|||
44350100|NCT01254305|79354565|FG002|Overall Study|Protocol Violation|3|||
44350101|NCT01254305|79354563|FG000|Overall Study|Withdrawal by Subject|4|||
44350102|NCT01254305|79354564|FG001|Overall Study|Withdrawal by Subject|2|||
44350103|NCT01254305|79354565|FG002|Overall Study|Withdrawal by Subject|4|||
44350104|NCT01254305|79354563|FG000|Overall Study|Lost to Follow-up|10|||
44350105|NCT01254305|79354564|FG001|Overall Study|Lost to Follow-up|6|||
44350106|NCT01254305|79354565|FG002|Overall Study|Lost to Follow-up|5|||
44350107|NCT01254305|79354563|FG000|Overall Study|Other Reasons|0|||
44350108|NCT01254305|79354564|FG001|Overall Study|Other Reasons|0|||
44350109|NCT01254305|79354565|FG002|Overall Study|Other Reasons|2|||
44350110|NCT01122927|79354576|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
44350111|NCT01122927|79354577|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
44350112|NCT01122927|79354576|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
44350113|NCT01122927|79354577|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
44350114|NCT01122927|79354576|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
44350115|NCT01122927|79354577|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
44350116|NCT01122927|79354576|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
44350117|NCT01122927|79354577|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
44350118|NCT01122927|79354576|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
44350119|NCT01122927|79354577|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
44350120|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
44350121|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
44350122|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
44350123|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
44350124|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
44350125|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
44350126|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
44350127|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
44350128|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
44350129|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
44350130|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
44350131|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
44350132|NCT01122927|79354576|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
44350133|NCT01122927|79354577|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
44350134|NCT01254227|79354587|FG000|Overall Study|Withdrawal by Subject|6|||
44350135|NCT01254227|79354587|FG000|Overall Study|Lost to Follow-up|6|||
44350136|NCT01254227|79354587|FG000|Overall Study|Adverse Event|5|||
44350137|NCT01254227|79354587|FG000|Overall Study|Abnormal test procedure result|5|||
44350138|NCT01254227|79354587|FG000|Overall Study|Administrative problems|2|||
44350139|NCT01254227|79354587|FG000|Overall Study|Death|1|||
44350140|NCT01254227|79354587|FG000|Overall Study|Protocol deviation|1|||
44350141|NCT00995410|79354591|FG000|Overall Study|Adverse Event|51|||
44350142|NCT00995410|79354591|FG000|Overall Study|Withdrawal by Subject|7|||
44350143|NCT00995410|79354591|FG000|Overall Study|Lost to Follow-up|2|||
44350144|NCT00995410|79354591|FG000|Overall Study|Misc|28|||
44350145|NCT00995020|79354597|FG000|Overall Study|margin analysis not performed|2|||
44350146|NCT00995020|79354598|FG001|Overall Study|margin analysis not performed|5|||
44350147|NCT00995020|79354597|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
44350148|NCT00995020|79354598|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
44350149|NCT01122381|79354608|FG000|Overall Study|study terminated early|0|||
44350150|NCT01122381|79354609|FG001|Overall Study|study terminated early|1|||
44350151|NCT00996034|79354615|FG000|Overall Study|Lost to Follow-up|2|||
44350152|NCT00996034|79354615|FG000|Overall Study|withdrawn by PI|1|||
44350153|NCT01253447|79354619|FG000|Overall Study|Adverse Event|2|||
44350154|NCT01121991|79354624|FG000|Overall Study|Lack of Ovarian Response|2|||
44350155|NCT01121991|79354624|FG000|Overall Study|No Oocytes Retrieved|3|||
44350156|NCT01121991|79354624|FG000|Overall Study|No Fertilization|1|||
44350157|NCT00994240|79354630|FG000|Overall Study|Lost to Follow-up|3|||
44350158|NCT00994240|79354631|FG001|Overall Study|Lost to Follow-up|2|||
44350159|NCT00994240|79354630|FG000|Overall Study|Withdrawal by Subject|1|||
44350160|NCT00994240|79354631|FG001|Overall Study|Withdrawal by Subject|0|||
44350161|NCT00994240|79354630|FG000|Overall Study|study termination|2|||
44350162|NCT00994240|79354631|FG001|Overall Study|study termination|3|||
44350163|NCT01253369|79354637|FG000|Overall Study|Adverse Event|4|||
44350164|NCT01253369|79354637|FG000|Overall Study|Withdrawal by Subject|2|||
44350165|NCT01253369|79354637|FG000|Overall Study|Death|1|||
44350166|NCT01253369|79354637|FG000|Overall Study|Progressive disease|23|||
44350167|NCT01253369|79354637|FG000|Overall Study|Not Evaluable|3|||
44350168|NCT01121913|79354641|FG000|First Intervention Period|Adverse Event|0|||
44350169|NCT01121913|79354642|FG001|First Intervention Period|Adverse Event|0|||
44350170|NCT01121913|79354643|FG002|First Intervention Period|Adverse Event|1|||
44350171|NCT01121913|79354644|FG003|First Intervention Period|Adverse Event|0|||
44350172|NCT01121913|79354641|FG000|First Washout Period|Withdrawal by Subject|1|||
44350173|NCT01121913|79354642|FG001|First Washout Period|Withdrawal by Subject|0|||
44350174|NCT01121913|79354643|FG002|First Washout Period|Withdrawal by Subject|0|||
44350175|NCT01121913|79354644|FG003|First Washout Period|Withdrawal by Subject|0|||
44350176|NCT01121913|79354641|FG000|Second Intervention Period|Adverse Event|0|||
44350177|NCT01121913|79354642|FG001|Second Intervention Period|Adverse Event|0|||
44350178|NCT01121913|79354643|FG002|Second Intervention Period|Adverse Event|1|||
44350179|NCT01121913|79354644|FG003|Second Intervention Period|Adverse Event|0|||
44350180|NCT01121913|79354641|FG000|Second Washout Period|Withdrawal by Subject|0|||
44350181|NCT01121913|79354642|FG001|Second Washout Period|Withdrawal by Subject|0|||
44350182|NCT01121913|79354643|FG002|Second Washout Period|Withdrawal by Subject|1|||
44350183|NCT01121913|79354644|FG003|Second Washout Period|Withdrawal by Subject|0|||
44350184|NCT01121913|79354641|FG000|Third Washout Period|Adverse Event|1|||
44350185|NCT01121913|79354642|FG001|Third Washout Period|Adverse Event|0|||
44350186|NCT01121913|79354643|FG002|Third Washout Period|Adverse Event|0|||
44350187|NCT01121913|79354644|FG003|Third Washout Period|Adverse Event|0|||
44350188|NCT00994162|79354656|FG000|Overall Study|Withdrawal by Subject|1|||
44350189|NCT00994162|79354656|FG000|Overall Study|Lost to Follow-up|2|||
44350190|NCT00994162|79354656|FG000|Overall Study|Product Complaint|1|||
44350191|NCT00994162|79354656|FG000|Overall Study|Poor Compliance|5|||
44350192|NCT00994162|79354656|FG000|Overall Study|Lack of Response|3|||
44350193|NCT00994162|79354656|FG000|Overall Study|Discharged from Hospital|4|||
44350194|NCT00994162|79354656|FG000|Overall Study|Death|2|||
44350195|NCT00994162|79354656|FG000|Overall Study|Care Transferred to Another Physician|2|||
44350196|NCT00994162|79354656|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
44350197|NCT00994162|79354656|FG000|Overall Study|Physician Decision|2|||
44350198|NCT00994162|79354656|FG000|Overall Study|Surrounding Wound Erythematous|1|||
44350199|NCT00994162|79354656|FG000|Overall Study|Machine Losing Vaccum|1|||
44350200|NCT00994162|79354656|FG000|Overall Study|Patient Lived Too Far Away|1|||
44350201|NCT00994162|79354656|FG000|Overall Study|Above Knee Amputation|1|||
44350202|NCT00994162|79354656|FG000|Overall Study|Reason Not Reported By Site|1|||
44350203|NCT00993928|79354663|FG000|Overall Study|Withdrawal by Subject|4|||
44350204|NCT00993928|79354664|FG001|Overall Study|Withdrawal by Subject|7|||
44350205|NCT00993928|79354663|FG000|Overall Study|ineligible|1|||
44350206|NCT00993928|79354664|FG001|Overall Study|ineligible|0|||
44350207|NCT01253291|79354679|FG000|Overall Study|Withdrawal by Subject|1|||
44350208|NCT01253291|79354680|FG001|Overall Study|Withdrawal by Subject|1|||
44350209|NCT01253291|79354681|FG002|Overall Study|Withdrawal by Subject|0|||
44350210|NCT01253291|79354682|FG003|Overall Study|Withdrawal by Subject|0|||
44350211|NCT01253291|79354683|FG004|Overall Study|Withdrawal by Subject|0|||
44350212|NCT01253291|79354679|FG000|Overall Study|Adverse Event|0|||
44350213|NCT01253291|79354680|FG001|Overall Study|Adverse Event|1|||
44350214|NCT01253291|79354681|FG002|Overall Study|Adverse Event|0|||
44350215|NCT01253291|79354682|FG003|Overall Study|Adverse Event|0|||
44350216|NCT01253291|79354683|FG004|Overall Study|Adverse Event|0|||
44350217|NCT01253291|79354679|FG000|Overall Study|Lack of Efficacy|1|||
44350218|NCT01253291|79354680|FG001|Overall Study|Lack of Efficacy|0|||
44350219|NCT01253291|79354681|FG002|Overall Study|Lack of Efficacy|0|||
44350220|NCT01253291|79354682|FG003|Overall Study|Lack of Efficacy|0|||
44350221|NCT01253291|79354683|FG004|Overall Study|Lack of Efficacy|0|||
44350222|NCT01253291|79354679|FG000|Overall Study|Physician Decision|2|||
44350223|NCT01253291|79354680|FG001|Overall Study|Physician Decision|0|||
44350224|NCT01253291|79354681|FG002|Overall Study|Physician Decision|0|||
44350225|NCT01253291|79354682|FG003|Overall Study|Physician Decision|0|||
44350226|NCT01253291|79354683|FG004|Overall Study|Physician Decision|2|||
44350227|NCT01121757|79354698|FG000|First Drug|Death|1|||
44350228|NCT01121757|79354699|FG001|First Drug|Death|0|||
44350229|NCT01121757|79354698|FG000|First Drug|Disease Progression|0|||
44350230|NCT01121757|79354699|FG001|First Drug|Disease Progression|2|||
44350231|NCT01121757|79354698|FG000|Combination|Physician Decision|0|||
44350232|NCT01121757|79354699|FG001|Combination|Physician Decision|1|||
44350233|NCT01121757|79354698|FG000|Combination|Disease Progression|2|||
44350234|NCT01121757|79354699|FG001|Combination|Disease Progression|0|||
44350235|NCT01253135|79354707|FG000|Original Protocol|Protocol Amendment|15|||
44350236|NCT01253135|79354707|FG000|Amended Protocol|Non-compliance|1|||
44350237|NCT00993616|79354715|FG000|Overall Study|No tumor at entry|1|||
44350238|NCT00993616|79354715|FG000|Overall Study|Never treated|1|||
44350239|NCT01120899|79354725|FG000|Overall Study|Withdrawal by Subject|3|||
44350240|NCT01120275|79354729|FG000|Overall Study|Adverse Event|3|||
44350241|NCT01120275|79354729|FG000|Overall Study|Progression|27|||
44350242|NCT01120275|79354729|FG000|Overall Study|Ineligible|3|||
44350243|NCT01120275|79354729|FG000|Overall Study|Withdrawal by Subject|1|||
44350244|NCT01120275|79354729|FG000|Overall Study|Refusal|1|||
44350245|NCT01120275|79354729|FG000|Overall Study|Not specific|1|||
44350246|NCT00991510|79354736|FG000|Period I (Days 1-14)|Adverse Event|1|||
44350247|NCT00991510|79354737|FG001|Period I (Days 1-14)|Adverse Event|0|||
44350248|NCT00991510|79354736|FG000|Period III (Days 29-112)|Adverse Event|1|||
44350249|NCT00991510|79354737|FG001|Period III (Days 29-112)|Adverse Event|1|||
44350250|NCT01119963|79354749|FG000|Overall Study|Lost to Follow-up|1|||
44350251|NCT01119963|79354750|FG001|Overall Study|Lost to Follow-up|1|||
44350252|NCT01252667|79354764|FG000|Overall Study|Transplant aborted post-conditioning|0|||
44350253|NCT01252667|79354765|FG001|Overall Study|Transplant aborted post-conditioning|0|||
44350254|NCT01252667|79354766|FG002|Overall Study|Transplant aborted post-conditioning|0|||
44350255|NCT01252667|79354767|FG003|Overall Study|Transplant aborted post-conditioning|0|||
44350256|NCT01252667|79354768|FG004|Overall Study|Transplant aborted post-conditioning|0|||
44350257|NCT01252667|79354769|FG005|Overall Study|Transplant aborted post-conditioning|1|||
44350258|NCT01119105|79354786|FG000|Overall Study|Withdrawal by Subject|1|||
44350259|NCT01119105|79354787|FG001|Overall Study|Withdrawal by Subject|1|||
44350260|NCT01119105|79354788|FG002|Overall Study|Withdrawal by Subject|1|||
44350261|NCT01119105|79354786|FG000|Overall Study|Lost to Follow-up|0|||
44350262|NCT01119105|79354787|FG001|Overall Study|Lost to Follow-up|2|||
44350263|NCT01119105|79354788|FG002|Overall Study|Lost to Follow-up|5|||
44350264|NCT01119105|79354786|FG000|Overall Study|Adverse Event|1|||
44350265|NCT01119105|79354787|FG001|Overall Study|Adverse Event|0|||
44350266|NCT01119105|79354788|FG002|Overall Study|Adverse Event|1|||
44350267|NCT01119105|79354786|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
44350268|NCT01119105|79354787|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
44350269|NCT01119105|79354788|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
44350270|NCT01119105|79354786|FG000|Overall Study|Other|1|||
44350271|NCT01119105|79354787|FG001|Overall Study|Other|1|||
44350272|NCT01119105|79354788|FG002|Overall Study|Other|0|||
44350273|NCT01118949|79354796|FG000|Overall Study|Adverse Event|5|||
44350274|NCT01118949|79354796|FG000|Overall Study|Withdrawal by Subject|4|||
44350275|NCT01252355|79354803|FG000|Overall Study|Adverse Event|9|||
44350276|NCT01252355|79354804|FG001|Overall Study|Adverse Event|17|||
44350277|NCT01252355|79354805|FG002|Overall Study|Adverse Event|22|||
44350278|NCT01252355|79354803|FG000|Overall Study|Lack of Efficacy|6|||
44350279|NCT01252355|79354804|FG001|Overall Study|Lack of Efficacy|4|||
44350280|NCT01252355|79354805|FG002|Overall Study|Lack of Efficacy|2|||
44350281|NCT01252355|79354803|FG000|Overall Study|Lost to Follow-up|0|||
44350282|NCT01252355|79354804|FG001|Overall Study|Lost to Follow-up|0|||
44350283|NCT01252355|79354805|FG002|Overall Study|Lost to Follow-up|1|||
44350284|NCT01252355|79354803|FG000|Overall Study|Poor Compliance to Protocol|1|||
44350285|NCT01252355|79354804|FG001|Overall Study|Poor Compliance to Protocol|1|||
44350286|NCT01252355|79354805|FG002|Overall Study|Poor Compliance to Protocol|1|||
44350287|NCT01252355|79354803|FG000|Overall Study|Progressive Disease|2|||
44350288|NCT01252355|79354804|FG001|Overall Study|Progressive Disease|0|||
44350289|NCT01252355|79354805|FG002|Overall Study|Progressive Disease|0|||
44350290|NCT01252355|79354803|FG000|Overall Study|Sponsor Early Termination of Study|149|||
44350291|NCT01252355|79354804|FG001|Overall Study|Sponsor Early Termination of Study|149|||
44350292|NCT01252355|79354805|FG002|Overall Study|Sponsor Early Termination of Study|146|||
44350293|NCT01252355|79354803|FG000|Overall Study|Randomized but not Treated|2|||
44350294|NCT01252355|79354804|FG001|Overall Study|Randomized but not Treated|0|||
44350295|NCT01252355|79354805|FG002|Overall Study|Randomized but not Treated|0|||
44350296|NCT01252355|79354803|FG000|Overall Study|Other Than Above|8|||
44350297|NCT01252355|79354804|FG001|Overall Study|Other Than Above|7|||
44350298|NCT01252355|79354805|FG002|Overall Study|Other Than Above|7|||
44350299|NCT01118325|79354816|FG000|Overall Study|Adverse Event|1|||
44350300|NCT01118325|79354817|FG001|Overall Study|Adverse Event|0|||
44350301|NCT01118325|79354818|FG002|Overall Study|Adverse Event|1|||
44350302|NCT01117857|79354839|FG000|Overall Study|Lost to Follow-up|4|||
44350303|NCT01117857|79354839|FG000|Overall Study|Withdrawal by Subject|4|||
44350304|NCT01117857|79354839|FG000|Overall Study|Physician Decision|1|||
44350305|NCT01251887|79354846|FG000|Overall Study|Scheduling conflict|1|||
44350306|NCT01251887|79354847|FG001|Overall Study|Scheduling conflict|2|||
44350307|NCT01251887|79354848|FG002|Overall Study|Scheduling conflict|2|||
44350308|NCT01251887|79354846|FG000|Overall Study|Physician Decision|0|||
44350309|NCT01251887|79354847|FG001|Overall Study|Physician Decision|1|||
44350310|NCT01251887|79354848|FG002|Overall Study|Physician Decision|0|||
44350311|NCT00991276|79354862|FG000|First Intervention Period|Adverse Event|0|||
44350312|NCT00991276|79354863|FG001|First Intervention Period|Adverse Event|1|||
44350313|NCT00991276|79354864|FG002|First Intervention Period|Adverse Event|0|||
44350314|NCT00991276|79354865|FG003|First Intervention Period|Adverse Event|1|||
44350315|NCT00991276|79354866|FG004|First Intervention Period|Adverse Event|0|||
44350316|NCT00991276|79354867|FG005|First Intervention Period|Adverse Event|0|||
44350317|NCT00991276|79354862|FG000|First Intervention Period|Protocol Violation|0|||
44350318|NCT00991276|79354863|FG001|First Intervention Period|Protocol Violation|0|||
44350319|NCT00991276|79354864|FG002|First Intervention Period|Protocol Violation|0|||
44350320|NCT00991276|79354865|FG003|First Intervention Period|Protocol Violation|0|||
44350321|NCT00991276|79354866|FG004|First Intervention Period|Protocol Violation|2|||
44350322|NCT00991276|79354867|FG005|First Intervention Period|Protocol Violation|0|||
44350323|NCT00991276|79354862|FG000|First Intervention Period|Insufficient clinical response|0|||
44447653|NCT04288115|79456019|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
44350324|NCT00991276|79354863|FG001|First Intervention Period|Insufficient clinical response|0|||
44350325|NCT00991276|79354864|FG002|First Intervention Period|Insufficient clinical response|0|||
44350326|NCT00991276|79354865|FG003|First Intervention Period|Insufficient clinical response|0|||
44350327|NCT00991276|79354866|FG004|First Intervention Period|Insufficient clinical response|1|||
44350328|NCT00991276|79354867|FG005|First Intervention Period|Insufficient clinical response|0|||
44350329|NCT00991276|79354862|FG000|First Intervention Period|Other|0|||
44350330|NCT00991276|79354863|FG001|First Intervention Period|Other|0|||
44350331|NCT00991276|79354864|FG002|First Intervention Period|Other|0|||
44350332|NCT00991276|79354865|FG003|First Intervention Period|Other|1|||
44350333|NCT00991276|79354866|FG004|First Intervention Period|Other|1|||
44350334|NCT00991276|79354867|FG005|First Intervention Period|Other|0|||
44350335|NCT00991276|79354862|FG000|First Intervention Period|Withdrawal by Subject|0|||
44350336|NCT00991276|79354863|FG001|First Intervention Period|Withdrawal by Subject|1|||
44350337|NCT00991276|79354864|FG002|First Intervention Period|Withdrawal by Subject|0|||
44350338|NCT00991276|79354865|FG003|First Intervention Period|Withdrawal by Subject|1|||
44350339|NCT00991276|79354866|FG004|First Intervention Period|Withdrawal by Subject|0|||
44350340|NCT00991276|79354867|FG005|First Intervention Period|Withdrawal by Subject|1|||
44350341|NCT00991276|79354862|FG000|First Intervention Period|Lost to Follow-up|0|||
44350342|NCT00991276|79354863|FG001|First Intervention Period|Lost to Follow-up|1|||
44350343|NCT00991276|79354864|FG002|First Intervention Period|Lost to Follow-up|0|||
44350344|NCT00991276|79354865|FG003|First Intervention Period|Lost to Follow-up|1|||
44350345|NCT00991276|79354866|FG004|First Intervention Period|Lost to Follow-up|0|||
44350346|NCT00991276|79354867|FG005|First Intervention Period|Lost to Follow-up|0|||
44350347|NCT00991276|79354862|FG000|Second Intervention Period|Adverse Event|0|||
44350348|NCT00991276|79354863|FG001|Second Intervention Period|Adverse Event|2|||
44350349|NCT00991276|79354864|FG002|Second Intervention Period|Adverse Event|0|||
44350350|NCT00991276|79354865|FG003|Second Intervention Period|Adverse Event|1|||
44350351|NCT00991276|79354866|FG004|Second Intervention Period|Adverse Event|1|||
44350352|NCT00991276|79354867|FG005|Second Intervention Period|Adverse Event|0|||
44350353|NCT00991276|79354862|FG000|Second Intervention Period|Protocol Violation|1|||
44350354|NCT00991276|79354863|FG001|Second Intervention Period|Protocol Violation|0|||
44350355|NCT00991276|79354864|FG002|Second Intervention Period|Protocol Violation|0|||
44350356|NCT00991276|79354865|FG003|Second Intervention Period|Protocol Violation|0|||
44350357|NCT00991276|79354866|FG004|Second Intervention Period|Protocol Violation|0|||
44350358|NCT00991276|79354867|FG005|Second Intervention Period|Protocol Violation|0|||
44350359|NCT00991276|79354862|FG000|Second Intervention Period|Other|0|||
44350360|NCT00991276|79354863|FG001|Second Intervention Period|Other|0|||
44350361|NCT00991276|79354864|FG002|Second Intervention Period|Other|0|||
44350362|NCT00991276|79354865|FG003|Second Intervention Period|Other|1|||
44350363|NCT00991276|79354866|FG004|Second Intervention Period|Other|0|||
44350364|NCT00991276|79354867|FG005|Second Intervention Period|Other|1|||
44350365|NCT00991276|79354862|FG000|Third Intervention Period|Protocol Violation|1|||
44350366|NCT00991276|79354863|FG001|Third Intervention Period|Protocol Violation|0|||
44350367|NCT00991276|79354864|FG002|Third Intervention Period|Protocol Violation|0|||
44350368|NCT00991276|79354865|FG003|Third Intervention Period|Protocol Violation|0|||
44350369|NCT00991276|79354866|FG004|Third Intervention Period|Protocol Violation|0|||
44350370|NCT00991276|79354867|FG005|Third Intervention Period|Protocol Violation|0|||
44350371|NCT00991276|79354862|FG000|Third Intervention Period|Other|0|||
44350372|NCT00991276|79354863|FG001|Third Intervention Period|Other|0|||
44350373|NCT00991276|79354864|FG002|Third Intervention Period|Other|0|||
44350374|NCT00991276|79354865|FG003|Third Intervention Period|Other|0|||
44350375|NCT00991276|79354866|FG004|Third Intervention Period|Other|0|||
44350376|NCT00991276|79354867|FG005|Third Intervention Period|Other|1|||
44350377|NCT00991276|79354862|FG000|Third Intervention Period|Adverse Event|0|||
44350378|NCT00991276|79354863|FG001|Third Intervention Period|Adverse Event|0|||
44350379|NCT00991276|79354864|FG002|Third Intervention Period|Adverse Event|1|||
44350380|NCT00991276|79354865|FG003|Third Intervention Period|Adverse Event|0|||
44350381|NCT00991276|79354866|FG004|Third Intervention Period|Adverse Event|0|||
44350382|NCT00991276|79354867|FG005|Third Intervention Period|Adverse Event|0|||
44350383|NCT00991276|79354862|FG000|Third Intervention Period|Withdrawal by Subject|0|||
44447654|NCT04288115|79456020|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
44350384|NCT00991276|79354863|FG001|Third Intervention Period|Withdrawal by Subject|0|||
44350385|NCT00991276|79354864|FG002|Third Intervention Period|Withdrawal by Subject|0|||
44350386|NCT00991276|79354865|FG003|Third Intervention Period|Withdrawal by Subject|1|||
44350387|NCT00991276|79354866|FG004|Third Intervention Period|Withdrawal by Subject|0|||
44350388|NCT00991276|79354867|FG005|Third Intervention Period|Withdrawal by Subject|0|||
44350389|NCT00990652|79354876|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
44350390|NCT00990652|79354876|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
44350391|NCT00990340|79354883|FG000|First 14-day Treatment|Not Compliant|2|||
44350392|NCT00990340|79354884|FG001|First 14-day Treatment|Not Compliant|1|||
44350393|NCT00990340|79354883|FG000|First 14-day Treatment|Lost to Follow-up|2|||
44350394|NCT00990340|79354884|FG001|First 14-day Treatment|Lost to Follow-up|1|||
44350395|NCT00990340|79354883|FG000|First 14-day Treatment|Protocol Violation|2|||
44350396|NCT00990340|79354884|FG001|First 14-day Treatment|Protocol Violation|2|||
44350397|NCT01207440|79354899|FG000|Overall Study|Adverse Event|46|||
44350398|NCT01207440|79354900|FG001|Overall Study|Adverse Event|11|||
44350399|NCT01207440|79354901|FG002|Overall Study|Adverse Event|7|||
44350400|NCT01207440|79354902|FG003|Overall Study|Adverse Event|2|||
44350401|NCT01207440|79354903|FG004|Overall Study|Adverse Event|6|||
44350402|NCT01207440|79354904|FG005|Overall Study|Adverse Event|6|||
44350403|NCT01207440|79354905|FG006|Overall Study|Adverse Event|2|||
44350404|NCT01207440|79354899|FG000|Overall Study|Death|6|||
44350405|NCT01207440|79354900|FG001|Overall Study|Death|3|||
44350406|NCT01207440|79354901|FG002|Overall Study|Death|2|||
44350407|NCT01207440|79354902|FG003|Overall Study|Death|2|||
44350408|NCT01207440|79354903|FG004|Overall Study|Death|7|||
44350409|NCT01207440|79354904|FG005|Overall Study|Death|5|||
44350410|NCT01207440|79354905|FG006|Overall Study|Death|1|||
44350411|NCT01207440|79354899|FG000|Overall Study|Lack of Efficacy|13|||
44350412|NCT01207440|79354900|FG001|Overall Study|Lack of Efficacy|2|||
44350413|NCT01207440|79354901|FG002|Overall Study|Lack of Efficacy|5|||
44350414|NCT01207440|79354902|FG003|Overall Study|Lack of Efficacy|1|||
44350415|NCT01207440|79354903|FG004|Overall Study|Lack of Efficacy|2|||
44350416|NCT01207440|79354904|FG005|Overall Study|Lack of Efficacy|3|||
44350417|NCT01207440|79354905|FG006|Overall Study|Lack of Efficacy|0|||
44350418|NCT01207440|79354899|FG000|Overall Study|Lost to Follow-up|0|||
44350419|NCT01207440|79354900|FG001|Overall Study|Lost to Follow-up|0|||
44350420|NCT01207440|79354901|FG002|Overall Study|Lost to Follow-up|2|||
44350421|NCT01207440|79354902|FG003|Overall Study|Lost to Follow-up|1|||
44350422|NCT01207440|79354903|FG004|Overall Study|Lost to Follow-up|0|||
44350423|NCT01207440|79354904|FG005|Overall Study|Lost to Follow-up|0|||
44350424|NCT01207440|79354905|FG006|Overall Study|Lost to Follow-up|0|||
44350425|NCT01207440|79354899|FG000|Overall Study|Non-compliance with Study Drug|3|||
44350426|NCT01207440|79354900|FG001|Overall Study|Non-compliance with Study Drug|0|||
44350427|NCT01207440|79354901|FG002|Overall Study|Non-compliance with Study Drug|1|||
44350428|NCT01207440|79354902|FG003|Overall Study|Non-compliance with Study Drug|0|||
44350429|NCT01207440|79354903|FG004|Overall Study|Non-compliance with Study Drug|0|||
44350430|NCT01207440|79354904|FG005|Overall Study|Non-compliance with Study Drug|0|||
44350431|NCT01207440|79354905|FG006|Overall Study|Non-compliance with Study Drug|0|||
44350432|NCT01207440|79354899|FG000|Overall Study|Physician Decision|6|||
44350433|NCT01207440|79354900|FG001|Overall Study|Physician Decision|5|||
44350434|NCT01207440|79354901|FG002|Overall Study|Physician Decision|5|||
44350435|NCT01207440|79354902|FG003|Overall Study|Physician Decision|0|||
44350436|NCT01207440|79354903|FG004|Overall Study|Physician Decision|1|||
44350437|NCT01207440|79354904|FG005|Overall Study|Physician Decision|0|||
44350438|NCT01207440|79354905|FG006|Overall Study|Physician Decision|0|||
44350439|NCT01207440|79354899|FG000|Overall Study|Progressive Disease|19|||
44350440|NCT01207440|79354900|FG001|Overall Study|Progressive Disease|10|||
44350441|NCT01207440|79354901|FG002|Overall Study|Progressive Disease|19|||
44350442|NCT01207440|79354902|FG003|Overall Study|Progressive Disease|7|||
44350443|NCT01207440|79354903|FG004|Overall Study|Progressive Disease|23|||
44350444|NCT01207440|79354904|FG005|Overall Study|Progressive Disease|27|||
44350445|NCT01207440|79354905|FG006|Overall Study|Progressive Disease|0|||
44350446|NCT01207440|79354899|FG000|Overall Study|Protocol Violation|2|||
44350447|NCT01207440|79354900|FG001|Overall Study|Protocol Violation|0|||
44350448|NCT01207440|79354901|FG002|Overall Study|Protocol Violation|0|||
44350449|NCT01207440|79354902|FG003|Overall Study|Protocol Violation|0|||
44350450|NCT01207440|79354903|FG004|Overall Study|Protocol Violation|0|||
44350451|NCT01207440|79354904|FG005|Overall Study|Protocol Violation|0|||
44350452|NCT01207440|79354905|FG006|Overall Study|Protocol Violation|0|||
44350453|NCT01207440|79354899|FG000|Overall Study|Site Terminated by Sponsor|69|||
44350454|NCT01207440|79354900|FG001|Overall Study|Site Terminated by Sponsor|19|||
44350455|NCT01207440|79354901|FG002|Overall Study|Site Terminated by Sponsor|12|||
44350456|NCT01207440|79354902|FG003|Overall Study|Site Terminated by Sponsor|2|||
44350457|NCT01207440|79354903|FG004|Overall Study|Site Terminated by Sponsor|3|||
44350458|NCT01207440|79354904|FG005|Overall Study|Site Terminated by Sponsor|0|||
44350459|NCT01207440|79354905|FG006|Overall Study|Site Terminated by Sponsor|2|||
44350460|NCT01207440|79354899|FG000|Overall Study|Withdrawal by Subject|29|||
44350461|NCT01207440|79354900|FG001|Overall Study|Withdrawal by Subject|4|||
44350462|NCT01207440|79354901|FG002|Overall Study|Withdrawal by Subject|5|||
44350463|NCT01207440|79354902|FG003|Overall Study|Withdrawal by Subject|3|||
44350464|NCT01207440|79354903|FG004|Overall Study|Withdrawal by Subject|2|||
44350465|NCT01207440|79354904|FG005|Overall Study|Withdrawal by Subject|2|||
44350466|NCT01207440|79354905|FG006|Overall Study|Withdrawal by Subject|0|||
44350467|NCT01207440|79354899|FG000|Overall Study|Reason Not Specified|10|||
44350468|NCT01207440|79354900|FG001|Overall Study|Reason Not Specified|10|||
44350469|NCT01207440|79354901|FG002|Overall Study|Reason Not Specified|7|||
44350470|NCT01207440|79354902|FG003|Overall Study|Reason Not Specified|0|||
44350471|NCT01207440|79354903|FG004|Overall Study|Reason Not Specified|4|||
44350472|NCT01207440|79354904|FG005|Overall Study|Reason Not Specified|3|||
44350473|NCT01207440|79354905|FG006|Overall Study|Reason Not Specified|0|||
44350474|NCT00990184|79354927|FG000|Overall Study|Physician Decision|1|||
44350475|NCT00986830|79354933|FG000|Overall Study|Death|1|||
44350476|NCT00986830|79354933|FG000|Overall Study|Lost to Follow-up|1|||
44350477|NCT00986830|79354933|FG000|Overall Study|Lack of Efficacy|1|||
44350478|NCT00986830|79354933|FG000|Overall Study|Unable to access sinus with device|5|||
44350479|NCT00990106|79354939|FG000|Overall Study|"too busy to continue"|1|||
44350480|NCT00990106|79354940|FG001|Overall Study|"too busy to continue"|2|||
44350481|NCT00990106|79354939|FG000|Overall Study|Lost to Follow-up|1|||
44350482|NCT00990106|79354940|FG001|Overall Study|Lost to Follow-up|3|||
44350483|NCT00990106|79354939|FG000|Overall Study|Withdrawal by Subject|2|||
44350484|NCT00990106|79354940|FG001|Overall Study|Withdrawal by Subject|1|||
44350485|NCT00990106|79354939|FG000|Overall Study|opted for open label prazosin|1|||
44350486|NCT00990106|79354940|FG001|Overall Study|opted for open label prazosin|1|||
44350487|NCT00990106|79354939|FG000|Overall Study|relocation/deployment|4|||
44350488|NCT00990106|79354940|FG001|Overall Study|relocation/deployment|1|||
44350489|NCT00990106|79354939|FG000|Overall Study|started exclusionary medication|0|||
44350490|NCT00990106|79354940|FG001|Overall Study|started exclusionary medication|1|||
44350491|NCT00990106|79354939|FG000|Overall Study|planned major surgery|0|||
44350492|NCT00990106|79354940|FG001|Overall Study|planned major surgery|1|||
44350493|NCT00990106|79354939|FG000|Overall Study|scheduling conflicts|0|||
44350494|NCT00990106|79354940|FG001|Overall Study|scheduling conflicts|2|||
44350495|NCT00983476|79354949|FG000|Overall Study|Did not receive intervention|17|||
44350496|NCT00983476|79354950|FG001|Overall Study|Did not receive intervention|22|||
44350497|NCT00983476|79354951|FG002|Overall Study|Did not receive intervention|0|||
44350498|NCT00982228|79354995|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
44350499|NCT00982228|79354996|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
44350500|NCT00982228|79354995|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
44350501|NCT00982228|79354996|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
44350502|NCT00982228|79354995|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
44350503|NCT00982228|79354996|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
44350504|NCT00982228|79354995|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
44350505|NCT00982228|79354996|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
44350506|NCT00982228|79354995|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
44350507|NCT00982228|79354996|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
44350508|NCT00982228|79354995|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
44350509|NCT00982228|79354996|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
44350510|NCT00982228|79354995|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
44350511|NCT00982228|79354996|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
44350512|NCT00982228|79354995|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
44350513|NCT00982228|79354996|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
44350514|NCT00982228|79354995|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
44350515|NCT00982228|79354996|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
44350516|NCT00982228|79354995|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
44350517|NCT00982228|79354996|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
44350518|NCT01260350|79355022|FG000|Overall Study|Lack of Efficacy|0|||
44350519|NCT01260350|79355023|FG001|Overall Study|Lack of Efficacy|0|||
44350520|NCT01260350|79355024|FG002|Overall Study|Lack of Efficacy|0|||
44350521|NCT01260350|79355025|FG003|Overall Study|Lack of Efficacy|0|||
44350522|NCT01260350|79355026|FG004|Overall Study|Lack of Efficacy|0|||
44350523|NCT01260350|79355027|FG005|Overall Study|Lack of Efficacy|0|||
44350524|NCT01260350|79355028|FG006|Overall Study|Lack of Efficacy|0|||
44350525|NCT01260350|79355029|FG007|Overall Study|Lack of Efficacy|0|||
44350526|NCT01260350|79355030|FG008|Overall Study|Lack of Efficacy|0|||
44350527|NCT01260350|79355031|FG009|Overall Study|Lack of Efficacy|0|||
44350528|NCT01260350|79355032|FG010|Overall Study|Lack of Efficacy|0|||
44350529|NCT01260350|79355033|FG011|Overall Study|Lack of Efficacy|0|||
44350530|NCT01260350|79355034|FG012|Overall Study|Lack of Efficacy|0|||
44350531|NCT01260350|79355035|FG013|Overall Study|Lack of Efficacy|0|||
44350532|NCT01260350|79355036|FG014|Overall Study|Lack of Efficacy|0|||
44350533|NCT01260350|79355037|FG015|Overall Study|Lack of Efficacy|0|||
44350534|NCT01260350|79355038|FG016|Overall Study|Lack of Efficacy|0|||
44350535|NCT01260350|79355039|FG017|Overall Study|Lack of Efficacy|1|||
44350536|NCT01260350|79355040|FG018|Overall Study|Lack of Efficacy|0|||
44350537|NCT01260350|79355041|FG019|Overall Study|Lack of Efficacy|0|||
44350538|NCT01260350|79355042|FG020|Overall Study|Lack of Efficacy|3|||
44350539|NCT01260350|79355043|FG021|Overall Study|Lack of Efficacy|0|||
44350540|NCT01260350|79355022|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350541|NCT01260350|79355023|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350542|NCT01260350|79355024|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350543|NCT01260350|79355025|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350544|NCT01260350|79355026|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350545|NCT01260350|79355027|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350546|NCT01260350|79355028|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350547|NCT01260350|79355029|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350548|NCT01260350|79355030|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
44350549|NCT01260350|79355031|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350550|NCT01260350|79355032|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350551|NCT01260350|79355033|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350552|NCT01260350|79355034|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350553|NCT01260350|79355035|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350554|NCT01260350|79355036|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350555|NCT01260350|79355037|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350556|NCT01260350|79355038|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350557|NCT01260350|79355039|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350558|NCT01260350|79355040|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350559|NCT01260350|79355041|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350560|NCT01260350|79355042|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350561|NCT01260350|79355043|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
44350562|NCT01260194|79355097|FG000|Overall Study|Withdrawal of Consent|1|||
44350563|NCT01259726|79355105|FG000|Overall Study|Death|1|||
44350564|NCT01259726|79355106|FG001|Overall Study|Death|0|||
44350565|NCT01259726|79355107|FG002|Overall Study|Death|0|||
44350566|NCT01259726|79355108|FG003|Overall Study|Death|0|||
44350567|NCT01259726|79355105|FG000|Overall Study|Physician Decision|2|||
44350568|NCT01259726|79355106|FG001|Overall Study|Physician Decision|0|||
44350569|NCT01259726|79355107|FG002|Overall Study|Physician Decision|1|||
44350570|NCT01259726|79355108|FG003|Overall Study|Physician Decision|1|||
44350571|NCT01259726|79355105|FG000|Overall Study|Withdrawal by Subject|1|||
44350572|NCT01259726|79355106|FG001|Overall Study|Withdrawal by Subject|3|||
44350573|NCT01259726|79355107|FG002|Overall Study|Withdrawal by Subject|2|||
44350574|NCT01259726|79355108|FG003|Overall Study|Withdrawal by Subject|1|||
44350575|NCT01259726|79355105|FG000|Overall Study|Lost to Follow-up|1|||
44350576|NCT01259726|79355106|FG001|Overall Study|Lost to Follow-up|1|||
44350577|NCT01259726|79355107|FG002|Overall Study|Lost to Follow-up|1|||
44350578|NCT01259726|79355108|FG003|Overall Study|Lost to Follow-up|3|||
44350579|NCT01259492|79355122|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
44350580|NCT01259492|79355123|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
44350581|NCT01259492|79355124|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
44350582|NCT01259492|79355125|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
44350583|NCT01259492|79355122|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
44350584|NCT01259492|79355123|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
44350585|NCT01259492|79355124|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
44350586|NCT01259492|79355125|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
44350587|NCT01259492|79355122|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
44350588|NCT01259492|79355123|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
44447655|NCT04287868|79456031|FG000|Overall Study|Screening fail|1|||
44260889|NCT00634010|79135907|FG001|Overall Study|Disease Progression|1|||
44260890|NCT00634010|79135906|FG000|Overall Study|Non-Compliant|1|||
44260891|NCT00634010|79135907|FG001|Overall Study|Non-Compliant|1|||
44260892|NCT00633932|79135920|FG000|Overall Study|Adverse Event|1|||
44260893|NCT00633932|79135921|FG001|Overall Study|Adverse Event|3|||
44260894|NCT00633932|79135922|FG002|Overall Study|Adverse Event|4|||
44260895|NCT00633932|79135920|FG000|Overall Study|Withdrawal by Subject|3|||
44260896|NCT00633932|79135921|FG001|Overall Study|Withdrawal by Subject|9|||
44260897|NCT00633932|79135922|FG002|Overall Study|Withdrawal by Subject|1|||
44260898|NCT00633932|79135920|FG000|Overall Study|Lost to Follow-up|1|||
44260899|NCT00633932|79135921|FG001|Overall Study|Lost to Follow-up|0|||
44260900|NCT00633932|79135922|FG002|Overall Study|Lost to Follow-up|2|||
44260901|NCT00633932|79135920|FG000|Overall Study|Protocol Violation|5|||
44260902|NCT00633932|79135921|FG001|Overall Study|Protocol Violation|2|||
44260903|NCT00633932|79135922|FG002|Overall Study|Protocol Violation|3|||
44260904|NCT00633932|79135920|FG000|Overall Study|Physician Decision|0|||
44260905|NCT00633932|79135921|FG001|Overall Study|Physician Decision|0|||
44260906|NCT00633932|79135922|FG002|Overall Study|Physician Decision|1|||
44260907|NCT00633932|79135920|FG000|Overall Study|Doctor's judgement|1|||
44260908|NCT00633932|79135921|FG001|Overall Study|Doctor's judgement|0|||
44260909|NCT00633932|79135922|FG002|Overall Study|Doctor's judgement|0|||
44260910|NCT00633932|79135920|FG000|Overall Study|Moved Away|1|||
44260911|NCT00633932|79135921|FG001|Overall Study|Moved Away|0|||
44350589|NCT01259492|79355124|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
44350590|NCT01259492|79355125|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
44350591|NCT01259492|79355122|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
44350592|NCT01259492|79355123|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
44350593|NCT01259492|79355124|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
44350594|NCT01259492|79355125|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
44350595|NCT01259492|79355122|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
44350596|NCT01259492|79355123|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
44350597|NCT01259492|79355124|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
44350598|NCT01259492|79355125|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
44350599|NCT01259492|79355122|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
44350600|NCT01259492|79355123|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
44350601|NCT01259492|79355124|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
44350602|NCT01259492|79355125|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
44350603|NCT01259492|79355122|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
44350604|NCT01259492|79355123|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
44350605|NCT01259492|79355124|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
44350606|NCT01259492|79355125|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
44350607|NCT01259492|79355122|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
44350608|NCT01259492|79355123|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
44350609|NCT01259492|79355124|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
44350610|NCT01259492|79355125|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
44350611|NCT01259492|79355122|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
44350612|NCT01259492|79355123|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
44350613|NCT01259492|79355124|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
44350614|NCT01259492|79355125|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
44350615|NCT01259492|79355122|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
44350616|NCT01259492|79355123|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
44350617|NCT01259492|79355124|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
44350618|NCT01259492|79355125|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
44350619|NCT01259492|79355122|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
44350620|NCT01259492|79355123|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
44350621|NCT01259492|79355124|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
44350622|NCT01259492|79355125|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
44350623|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
44350624|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
44350625|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
44350626|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
44350627|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
44350628|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
44350629|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
44350630|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
44350631|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
44350632|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
44350633|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
44350634|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
44350635|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
44350636|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
44350637|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
44350638|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
44350639|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
44350640|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
44350641|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
44350642|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
44350643|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
44350644|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
44350645|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
44350646|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
44350647|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
44350648|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
44350649|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
44350650|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
44350651|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
44350652|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
44166680|NCT02287233|78959736|FG002|Overall Study|Did Not Receive Treatment|2|||
44166681|NCT01646385|78959749|FG000|Overall Study|Death|202|||
44350653|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
44350654|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
44350655|NCT01259492|79355122|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
44350656|NCT01259492|79355123|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
44350657|NCT01259492|79355124|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
44350658|NCT01259492|79355125|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
44350659|NCT01117623|79355142|FG000|Overall Study|Adverse Event|0|||
44350660|NCT01117623|79355143|FG001|Overall Study|Adverse Event|2|||
44350661|NCT01117623|79355144|FG002|Overall Study|Adverse Event|4|||
44350662|NCT01117623|79355145|FG003|Overall Study|Adverse Event|0|||
44350663|NCT01117623|79355146|FG004|Overall Study|Adverse Event|2|||
44350664|NCT01117623|79355147|FG005|Overall Study|Adverse Event|0|||
44350665|NCT01117623|79355148|FG006|Overall Study|Adverse Event|0|||
44350666|NCT01117623|79355149|FG007|Overall Study|Adverse Event|2|||
44350667|NCT01117623|79355142|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
44350668|NCT01117623|79355143|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
44350669|NCT01117623|79355144|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
44350670|NCT01117623|79355145|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
44350671|NCT01117623|79355146|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
44350672|NCT01117623|79355147|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
44350673|NCT01117623|79355148|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
44350674|NCT01117623|79355149|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
44350675|NCT01117623|79355142|FG000|Overall Study|Withdrawal by Subject|0|||
44350676|NCT01117623|79355143|FG001|Overall Study|Withdrawal by Subject|0|||
44350677|NCT01117623|79355144|FG002|Overall Study|Withdrawal by Subject|2|||
44350678|NCT01117623|79355145|FG003|Overall Study|Withdrawal by Subject|0|||
44350679|NCT01117623|79355146|FG004|Overall Study|Withdrawal by Subject|0|||
44350680|NCT01117623|79355147|FG005|Overall Study|Withdrawal by Subject|1|||
44350681|NCT01117623|79355148|FG006|Overall Study|Withdrawal by Subject|1|||
44350682|NCT01117623|79355149|FG007|Overall Study|Withdrawal by Subject|1|||
44350683|NCT01117623|79355142|FG000|Overall Study|Non-compliance with study medication|0|||
44350684|NCT01117623|79355143|FG001|Overall Study|Non-compliance with study medication|0|||
44350685|NCT01117623|79355144|FG002|Overall Study|Non-compliance with study medication|0|||
44350686|NCT01117623|79355145|FG003|Overall Study|Non-compliance with study medication|0|||
44350687|NCT01117623|79355146|FG004|Overall Study|Non-compliance with study medication|0|||
44260912|NCT00633932|79135922|FG002|Overall Study|Moved Away|0|||
44260913|NCT00633464|79136052|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
44260914|NCT00633464|79136053|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
44260915|NCT00633464|79136052|FG000|Overall Study|Never Treated (Randomized in error)|0|||
44260916|NCT00633464|79136053|FG001|Overall Study|Never Treated (Randomized in error)|1|||
44260917|NCT00633152|79136094|FG000|Overall Study|Adverse Event|1|||
44260918|NCT00633152|79136095|FG001|Overall Study|Adverse Event|0|||
44260919|NCT00633152|79136094|FG000|Overall Study|Randomized, did not receive study drug|5|||
44260920|NCT00633152|79136095|FG001|Overall Study|Randomized, did not receive study drug|2|||
44260921|NCT00633152|79136094|FG000|Overall Study|Withdrawal by Subject|1|||
44260922|NCT00633152|79136095|FG001|Overall Study|Withdrawal by Subject|1|||
44260923|NCT00633152|79136094|FG000|Overall Study|Lost to Follow-up|4|||
44260924|NCT00633152|79136095|FG001|Overall Study|Lost to Follow-up|1|||
44260925|NCT00633152|79136094|FG000|Overall Study|Miscellaneous Other|3|||
44260926|NCT00633152|79136095|FG001|Overall Study|Miscellaneous Other|2|||
44260927|NCT00633074|79136114|FG000|Overall Study|Adverse Event|1|||
44260928|NCT00633074|79136115|FG001|Overall Study|Adverse Event|0|||
44260929|NCT00630344|79136302|FG000|Overall Study|Adverse Event|5|||
44260930|NCT00630344|79136302|FG000|Overall Study|Progressive Disease|19|||
44260931|NCT00630344|79136302|FG000|Overall Study|Physician Decision|9|||
44260932|NCT00630344|79136302|FG000|Overall Study|Withdrawal by Subject|1|||
44260933|NCT00630344|79136302|FG000|Overall Study|Intercurrent Illness|1|||
44260934|NCT00630344|79136302|FG000|Overall Study|Other|1|||
44260935|NCT02913261|79136328|FG000|Overall Study|Technical problems|0|||
44260936|NCT02913261|79136329|FG001|Overall Study|Technical problems|1|||
44260937|NCT02913261|79136328|FG000|Overall Study|Lack of Efficacy|32|||
44260938|NCT02913261|79136329|FG001|Overall Study|Lack of Efficacy|69|||
44260939|NCT02913261|79136328|FG000|Overall Study|Adverse Event|27|||
44260940|NCT02913261|79136329|FG001|Overall Study|Adverse Event|5|||
44260941|NCT02913261|79136328|FG000|Overall Study|Death|25|||
44260942|NCT02913261|79136329|FG001|Overall Study|Death|22|||
44260943|NCT02913261|79136328|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
44260944|NCT02913261|79136329|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
44350688|NCT01117623|79355147|FG005|Overall Study|Non-compliance with study medication|0|||
44350689|NCT01117623|79355148|FG006|Overall Study|Non-compliance with study medication|0|||
44350690|NCT01117623|79355149|FG007|Overall Study|Non-compliance with study medication|1|||
44350691|NCT01117623|79355142|FG000|Overall Study|Invest. text: completed all planned txs|0|||
44350692|NCT01117623|79355143|FG001|Overall Study|Invest. text: completed all planned txs|0|||
44350693|NCT01117623|79355144|FG002|Overall Study|Invest. text: completed all planned txs|0|||
44350694|NCT01117623|79355145|FG003|Overall Study|Invest. text: completed all planned txs|0|||
44350695|NCT01117623|79355146|FG004|Overall Study|Invest. text: completed all planned txs|0|||
44350696|NCT01117623|79355147|FG005|Overall Study|Invest. text: completed all planned txs|1|||
44350697|NCT01117623|79355148|FG006|Overall Study|Invest. text: completed all planned txs|0|||
44350698|NCT01117623|79355149|FG007|Overall Study|Invest. text: completed all planned txs|0|||
44350699|NCT01116687|79355169|FG000|Overall Study|Withdrawal by Subject|4|||
44350700|NCT01114737|79355175|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
44350701|NCT01114737|79355176|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
44350702|NCT01114737|79355175|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
44350703|NCT01114737|79355176|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
44350704|NCT01114737|79355175|FG000|Randomized Treatment Period|Pregnancy|1|||
44350705|NCT01114737|79355176|FG001|Randomized Treatment Period|Pregnancy|0|||
44350706|NCT01114737|79355175|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
44350707|NCT01114737|79355176|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
44350708|NCT01114737|79355175|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
44350709|NCT01114737|79355176|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
44350710|NCT01114737|79355175|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
44350711|NCT01114737|79355176|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
44350712|NCT01113879|79355199|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
44350713|NCT01113879|79355200|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
44350714|NCT00979576|79355211|FG000|Combination Treatment Phase|Progressive disease|3|||
44350715|NCT00979576|79355212|FG001|Combination Treatment Phase|Progressive disease|1|||
44350716|NCT00979576|79355213|FG002|Combination Treatment Phase|Progressive disease|5|||
44350717|NCT00979576|79355211|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
44350718|NCT00979576|79355212|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
44350719|NCT00979576|79355213|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
44350720|NCT00979576|79355211|FG000|Combination Treatment Phase|Adverse Event|0|||
44350721|NCT00979576|79355212|FG001|Combination Treatment Phase|Adverse Event|2|||
44350722|NCT00979576|79355213|FG002|Combination Treatment Phase|Adverse Event|2|||
44350723|NCT00979576|79355211|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
44350724|NCT00979576|79355212|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
44350725|NCT00979576|79355213|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
44350726|NCT00979420|79355226|FG000|Overall Study|Adverse Event|1|||
44350727|NCT00979420|79355227|FG001|Overall Study|Adverse Event|0|||
44350728|NCT00979420|79355228|FG002|Overall Study|Adverse Event|0|||
44350729|NCT00979420|79355229|FG003|Overall Study|Adverse Event|0|||
44350730|NCT00979420|79355226|FG000|Overall Study|Lack of Efficacy|3|||
44350731|NCT00979420|79355227|FG001|Overall Study|Lack of Efficacy|0|||
44350732|NCT00979420|79355228|FG002|Overall Study|Lack of Efficacy|1|||
44350733|NCT00979420|79355229|FG003|Overall Study|Lack of Efficacy|1|||
44350734|NCT00979420|79355226|FG000|Overall Study|Other reasons not related to Viramune|3|||
44350735|NCT00979420|79355227|FG001|Overall Study|Other reasons not related to Viramune|0|||
44350736|NCT00979420|79355228|FG002|Overall Study|Other reasons not related to Viramune|0|||
44350737|NCT00979420|79355229|FG003|Overall Study|Other reasons not related to Viramune|1|||
44350738|NCT02702180|79355240|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
44447656|NCT04287868|79456032|FG001|Overall Study|Screening fail|0|||
44447657|NCT04276935|79456043|FG000|Overall Study|Lost to Follow-up|3|||
44447658|NCT04191096|79456049|FG000|Overall Study|Death|102|||
44447659|NCT04191096|79456050|FG001|Overall Study|Death|89|||
44447660|NCT04191096|79456049|FG000|Overall Study|Lost to Follow-up|1|||
44447661|NCT04191096|79456050|FG001|Overall Study|Lost to Follow-up|1|||
44447662|NCT04191096|79456049|FG000|Overall Study|Withdrawal by Subject|5|||
44447663|NCT04191096|79456050|FG001|Overall Study|Withdrawal by Subject|5|||
44447664|NCT04191096|79456049|FG000|Overall Study|Participants Ongoing|518|||
44447665|NCT04191096|79456050|FG001|Overall Study|Participants Ongoing|530|||
44447666|NCT04145531|79456060|FG000|Part A|Adverse Event|2|||
44447667|NCT04145531|79456061|FG001|Part A|Adverse Event|12|||
44447668|NCT04145531|79456062|FG002|Part A|Adverse Event|6|||
44447669|NCT04145531|79456063|FG003|Part A|Adverse Event|0|||
44447670|NCT04145531|79456060|FG000|Part A|Death|1|||
44447671|NCT04145531|79456061|FG001|Part A|Death|2|||
44447672|NCT04145531|79456062|FG002|Part A|Death|0|||
44447673|NCT04145531|79456063|FG003|Part A|Death|0|||
44447674|NCT04145531|79456060|FG000|Part A|Physician Decision|2|||
44447675|NCT04145531|79456061|FG001|Part A|Physician Decision|5|||
44447676|NCT04145531|79456062|FG002|Part A|Physician Decision|2|||
44447677|NCT04145531|79456063|FG003|Part A|Physician Decision|0|||
44447678|NCT04145531|79456060|FG000|Part A|Progressive disease|0|||
44447679|NCT04145531|79456061|FG001|Part A|Progressive disease|2|||
44447680|NCT04145531|79456062|FG002|Part A|Progressive disease|1|||
44447681|NCT04145531|79456063|FG003|Part A|Progressive disease|0|||
44447682|NCT04145531|79456060|FG000|Part A|Protocol deviation|0|||
44447683|NCT04145531|79456061|FG001|Part A|Protocol deviation|0|||
44350739|NCT02702180|79355241|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
44350740|NCT02702180|79355242|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
44350741|NCT02702180|79355240|FG000|Double-blind Treatment Period|Adverse Event|0|||
44350742|NCT02702180|79355241|FG001|Double-blind Treatment Period|Adverse Event|0|||
44350743|NCT02702180|79355242|FG002|Double-blind Treatment Period|Adverse Event|1|||
44350744|NCT02702180|79355240|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
44350745|NCT02702180|79355241|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
44350746|NCT02702180|79355242|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
44350747|NCT02702180|79355240|FG000|Double-blind Treatment Period|Protocol Violation|0|||
44350748|NCT02702180|79355241|FG001|Double-blind Treatment Period|Protocol Violation|0|||
44350749|NCT02702180|79355242|FG002|Double-blind Treatment Period|Protocol Violation|2|||
44350750|NCT02702180|79355240|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
44350751|NCT02702180|79355241|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
44350752|NCT02702180|79355242|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
44350753|NCT02702180|79355240|FG000|Open-label Treatment Period|Withdrawn in error|0|||
44350754|NCT02702180|79355241|FG001|Open-label Treatment Period|Withdrawn in error|0|||
44350755|NCT02702180|79355242|FG002|Open-label Treatment Period|Withdrawn in error|1|||
44350756|NCT00980980|79355254|FG000|Overall Study|Withdrawal by Hospital|0|||
44350757|NCT00980980|79355255|FG001|Overall Study|Withdrawal by Hospital|1|||
44350758|NCT00980980|79355256|FG002|Overall Study|Withdrawal by Hospital|0|||
44350759|NCT00980200|79355267|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
44350760|NCT00980200|79355268|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
44350761|NCT00980200|79355269|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
44350762|NCT00980200|79355270|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
44350763|NCT00980200|79355271|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
44350764|NCT00980200|79355267|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
44350765|NCT00980200|79355268|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
44350766|NCT00980200|79355269|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
44350767|NCT00980200|79355270|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
44350768|NCT00980200|79355271|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
44350769|NCT00979654|79355283|FG000|Overall Study|Lost to Follow-up|1|||
44350770|NCT00979654|79355283|FG000|Overall Study|Withdrawal by Subject|22|||
44350771|NCT00979654|79355283|FG000|Overall Study|Death|1|||
44350772|NCT00979654|79355283|FG000|Overall Study|Lack of Efficacy|6|||
44350773|NCT00979654|79355283|FG000|Overall Study|Adverse Event|1|||
44350774|NCT00979654|79355283|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
44350775|NCT00979654|79355283|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
44350776|NCT00979654|79355283|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
44350777|NCT00979654|79355283|FG000|Overall Study|Serious Adverse Event|1|||
44350778|NCT00979654|79355283|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
44350779|NCT00978562|79355287|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
44350780|NCT02865460|79355295|FG000|Overall Study|Adverse Event|1|||
44350781|NCT02865460|79355296|FG001|Overall Study|Adverse Event|0|||
44350782|NCT02865460|79355295|FG000|Overall Study|Withdrawal by Subject|1|||
44350783|NCT02865460|79355296|FG001|Overall Study|Withdrawal by Subject|1|||
44350784|NCT02865460|79355295|FG000|Overall Study|Lost to Follow-up|7|||
44350785|NCT02865460|79355296|FG001|Overall Study|Lost to Follow-up|4|||
44350786|NCT02865460|79355295|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
44350787|NCT02865460|79355296|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
44350788|NCT01206816|79355309|FG000|Overall Study|Protocol Violation|0|||
44350789|NCT01206816|79355310|FG001|Overall Study|Protocol Violation|0|||
44350790|NCT01206816|79355311|FG002|Overall Study|Protocol Violation|1|||
44350791|NCT01206816|79355312|FG003|Overall Study|Protocol Violation|0|||
44350792|NCT01206816|79355313|FG004|Overall Study|Protocol Violation|0|||
44350793|NCT01206816|79355314|FG005|Overall Study|Protocol Violation|0|||
44350794|NCT01206816|79355315|FG006|Overall Study|Protocol Violation|0|||
44350795|NCT01206816|79355309|FG000|Overall Study|Withdrawal by Subject|0|||
44350796|NCT01206816|79355310|FG001|Overall Study|Withdrawal by Subject|0|||
44350797|NCT01206816|79355311|FG002|Overall Study|Withdrawal by Subject|1|||
44350798|NCT01206816|79355312|FG003|Overall Study|Withdrawal by Subject|0|||
44350799|NCT01206816|79355313|FG004|Overall Study|Withdrawal by Subject|0|||
44350800|NCT01206816|79355314|FG005|Overall Study|Withdrawal by Subject|0|||
44350801|NCT01206816|79355315|FG006|Overall Study|Withdrawal by Subject|0|||
44350802|NCT01206816|79355309|FG000|Overall Study|Progressive disease|3|||
44350803|NCT01206816|79355310|FG001|Overall Study|Progressive disease|3|||
44350804|NCT01206816|79355311|FG002|Overall Study|Progressive disease|13|||
44350805|NCT01206816|79355312|FG003|Overall Study|Progressive disease|3|||
44447684|NCT04145531|79456062|FG002|Part A|Protocol deviation|1|||
44350806|NCT01206816|79355313|FG004|Overall Study|Progressive disease|3|||
44350807|NCT01206816|79355314|FG005|Overall Study|Progressive disease|16|||
44350808|NCT01206816|79355315|FG006|Overall Study|Progressive disease|3|||
44447685|NCT04145531|79456063|FG003|Part A|Protocol deviation|0|||
44350809|NCT01206816|79355309|FG000|Overall Study|Other AE|0|||
44350810|NCT01206816|79355310|FG001|Overall Study|Other AE|0|||
44350811|NCT01206816|79355311|FG002|Overall Study|Other AE|4|||
44350812|NCT01206816|79355312|FG003|Overall Study|Other AE|0|||
44350813|NCT01206816|79355313|FG004|Overall Study|Other AE|0|||
44350814|NCT01206816|79355314|FG005|Overall Study|Other AE|3|||
44350815|NCT01206816|79355315|FG006|Overall Study|Other AE|2|||
44350816|NCT01206816|79355309|FG000|Overall Study|other than stated above|0|||
44350817|NCT01206816|79355310|FG001|Overall Study|other than stated above|0|||
44350818|NCT01206816|79355311|FG002|Overall Study|other than stated above|1|||
44350819|NCT01206816|79355312|FG003|Overall Study|other than stated above|0|||
44350820|NCT01206816|79355313|FG004|Overall Study|other than stated above|0|||
44350821|NCT01206816|79355314|FG005|Overall Study|other than stated above|0|||
44350822|NCT01206816|79355315|FG006|Overall Study|other than stated above|1|||
44350823|NCT01206582|79355337|FG000|Overall Study|Withdrew prior to study|1|||
44350824|NCT01206582|79355338|FG001|Overall Study|Withdrew prior to study|0|||
44350825|NCT01206582|79355337|FG000|Overall Study|Discontinued intervention before week 8|1|||
44350826|NCT01206582|79355338|FG001|Overall Study|Discontinued intervention before week 8|2|||
44350827|NCT01259102|79355349|FG000|Overall Study|Adverse Event|1|||
44350828|NCT01259102|79355350|FG001|Overall Study|Adverse Event|0|||
44350829|NCT01259102|79355351|FG002|Overall Study|Adverse Event|1|||
44350830|NCT01259102|79355352|FG003|Overall Study|Adverse Event|1|||
44350831|NCT01259102|79355353|FG004|Overall Study|Adverse Event|0|||
44350832|NCT01259102|79355349|FG000|Overall Study|Other|0|||
44350833|NCT01259102|79355350|FG001|Overall Study|Other|0|||
44350834|NCT01259102|79355351|FG002|Overall Study|Other|1|||
44350835|NCT01259102|79355352|FG003|Overall Study|Other|1|||
44350836|NCT01259102|79355353|FG004|Overall Study|Other|1|||
44350837|NCT00978250|79355369|FG000|Overall Study|Late determination of ineligibility|0|||
44350838|NCT00978250|79355370|FG001|Overall Study|Late determination of ineligibility|1|||
44350839|NCT00978250|79355371|FG002|Overall Study|Late determination of ineligibility|0|||
44350840|NCT00978250|79355372|FG003|Overall Study|Late determination of ineligibility|1|||
44350841|NCT01259024|79355384|FG000|Overall Study|Physician Decision|1|||
44350842|NCT01257698|79355390|FG000|Overall Study|Protocol Violation|4|||
44350843|NCT01257698|79355391|FG001|Overall Study|Protocol Violation|0|||
44350844|NCT01257542|79355399|FG000|Overall Study|Protocol Violation|3|||
44350845|NCT01257542|79355400|FG001|Overall Study|Protocol Violation|5|||
44350846|NCT01257542|79355399|FG000|Overall Study|Withdrawal by Subject|0|||
44350847|NCT01257542|79355400|FG001|Overall Study|Withdrawal by Subject|2|||
44350848|NCT01257230|79355409|FG000|Overall Study|Not Treated|0|||
44350849|NCT01257230|79355410|FG001|Overall Study|Not Treated|0|||
44350850|NCT01257230|79355411|FG002|Overall Study|Not Treated|1|||
44350851|NCT01257230|79355409|FG000|Overall Study|Adverse Event|2|||
44350852|NCT01257230|79355410|FG001|Overall Study|Adverse Event|0|||
44350853|NCT01257230|79355411|FG002|Overall Study|Adverse Event|0|||
44350854|NCT01257230|79355409|FG000|Overall Study|Lack of Efficacy|0|||
44350855|NCT01257230|79355410|FG001|Overall Study|Lack of Efficacy|1|||
44350856|NCT01257230|79355411|FG002|Overall Study|Lack of Efficacy|0|||
44350857|NCT01257230|79355409|FG000|Overall Study|Protocol Violation|3|||
44350858|NCT01257230|79355410|FG001|Overall Study|Protocol Violation|0|||
44350859|NCT01257230|79355411|FG002|Overall Study|Protocol Violation|1|||
44350860|NCT01257230|79355409|FG000|Overall Study|Withdrawal by Subject|0|||
44350861|NCT01257230|79355410|FG001|Overall Study|Withdrawal by Subject|4|||
44350862|NCT01257230|79355411|FG002|Overall Study|Withdrawal by Subject|1|||
44350863|NCT01257230|79355409|FG000|Overall Study|Other reason not defined above|1|||
44350864|NCT01257230|79355410|FG001|Overall Study|Other reason not defined above|5|||
44350865|NCT01257230|79355411|FG002|Overall Study|Other reason not defined above|3|||
44350866|NCT01113801|79355424|FG000|Overall Study|Adverse Event|4|||
44350867|NCT01113801|79355425|FG001|Overall Study|Adverse Event|0|||
44350868|NCT01113801|79355426|FG002|Overall Study|Adverse Event|2|||
44350869|NCT01113801|79355427|FG003|Overall Study|Adverse Event|6|||
44350870|NCT01113801|79355424|FG000|Overall Study|Death|4|||
44447686|NCT04145531|79456060|FG000|Part A|Withdrawal by parent or guardian|1|||
44447687|NCT04145531|79456061|FG001|Part A|Withdrawal by parent or guardian|0|||
44350871|NCT01113801|79355425|FG001|Overall Study|Death|5|||
44350872|NCT01113801|79355426|FG002|Overall Study|Death|3|||
44350873|NCT01113801|79355427|FG003|Overall Study|Death|4|||
44350874|NCT01113801|79355424|FG000|Overall Study|Protocol Violation|0|||
44350875|NCT01113801|79355425|FG001|Overall Study|Protocol Violation|1|||
44350876|NCT01113801|79355426|FG002|Overall Study|Protocol Violation|0|||
44350877|NCT01113801|79355427|FG003|Overall Study|Protocol Violation|0|||
44350878|NCT01113801|79355424|FG000|Overall Study|Withdrawal by Subject|9|||
44350879|NCT01113801|79355425|FG001|Overall Study|Withdrawal by Subject|7|||
44350880|NCT01113801|79355426|FG002|Overall Study|Withdrawal by Subject|7|||
44350881|NCT01113801|79355427|FG003|Overall Study|Withdrawal by Subject|8|||
44350882|NCT01113801|79355424|FG000|Overall Study|Physician Decision|2|||
44350883|NCT01113801|79355425|FG001|Overall Study|Physician Decision|2|||
44350884|NCT01113801|79355426|FG002|Overall Study|Physician Decision|3|||
44350885|NCT01113801|79355427|FG003|Overall Study|Physician Decision|3|||
44350886|NCT01113801|79355424|FG000|Overall Study|Sponsor Decision|15|||
44350887|NCT01113801|79355425|FG001|Overall Study|Sponsor Decision|21|||
44350888|NCT01113801|79355426|FG002|Overall Study|Sponsor Decision|20|||
44350889|NCT01113801|79355427|FG003|Overall Study|Sponsor Decision|15|||
44350890|NCT01113801|79355424|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
44350891|NCT01113801|79355425|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
44350892|NCT01113801|79355426|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
44350893|NCT01113801|79355427|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
44350894|NCT01256684|79355440|FG000|Overall Study|Adverse Event|1|||
44350895|NCT01256684|79355441|FG001|Overall Study|Adverse Event|4|||
44350896|NCT01256684|79355442|FG002|Overall Study|Adverse Event|2|||
44350897|NCT01256684|79355440|FG000|Overall Study|Withdrawal by Subject|4|||
44350898|NCT01256684|79355441|FG001|Overall Study|Withdrawal by Subject|0|||
44350899|NCT01256684|79355442|FG002|Overall Study|Withdrawal by Subject|2|||
44350900|NCT01256684|79355440|FG000|Overall Study|Physician Decision|0|||
44350901|NCT01256684|79355441|FG001|Overall Study|Physician Decision|1|||
44350902|NCT01256684|79355442|FG002|Overall Study|Physician Decision|0|||
44350903|NCT01256684|79355440|FG000|Overall Study|Lack of Efficacy|0|||
44350904|NCT01256684|79355441|FG001|Overall Study|Lack of Efficacy|1|||
44350905|NCT01256684|79355442|FG002|Overall Study|Lack of Efficacy|1|||
44350906|NCT01256684|79355440|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
44350907|NCT01256684|79355441|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
44350908|NCT01256684|79355442|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
44350909|NCT01204710|79355452|FG000|Randomization Treatment|Lost to Follow-up|1|||
44350910|NCT01204710|79355453|FG001|Randomization Treatment|Lost to Follow-up|0|||
44350911|NCT01204710|79355452|FG000|Randomization Treatment|Withdrawal by Subject|6|||
44350912|NCT01204710|79355453|FG001|Randomization Treatment|Withdrawal by Subject|5|||
44350913|NCT01204710|79355452|FG000|Randomization Treatment|Physician Decision|3|||
44350914|NCT01204710|79355453|FG001|Randomization Treatment|Physician Decision|2|||
44350915|NCT01204710|79355452|FG000|Randomization Treatment|Entry criteria not met|0|||
44350916|NCT01204710|79355453|FG001|Randomization Treatment|Entry criteria not met|1|||
44350917|NCT01204710|79355452|FG000|Randomization Treatment|Adverse Event|4|||
44350918|NCT01204710|79355453|FG001|Randomization Treatment|Adverse Event|2|||
44350919|NCT01204710|79355452|FG000|Randomization Treatment|Sponsor Decision|0|||
44350920|NCT01204710|79355453|FG001|Randomization Treatment|Sponsor Decision|1|||
44350921|NCT01204710|79355452|FG000|Randomization Treatment|Worsening of General condition|0|||
44350922|NCT01204710|79355453|FG001|Randomization Treatment|Worsening of General condition|1|||
44350923|NCT01204710|79355452|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
44350924|NCT01204710|79355453|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
44350925|NCT01204710|79355452|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
44350926|NCT01204710|79355453|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
44350927|NCT01204710|79355452|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
44350928|NCT01204710|79355453|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
44350929|NCT01204710|79355452|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
44350930|NCT01204710|79355453|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
44350931|NCT01256450|79355468|FG000|Open-label Titration|Adverse Event|39|||
44350932|NCT01256450|79355469|FG001|Open-label Titration|Adverse Event|0|||
44350933|NCT01256450|79355470|FG002|Open-label Titration|Adverse Event|0|||
44350934|NCT01256450|79355468|FG000|Open-label Titration|Lost to Follow-up|7|||
44350935|NCT01256450|79355469|FG001|Open-label Titration|Lost to Follow-up|0|||
44350936|NCT01256450|79355470|FG002|Open-label Titration|Lost to Follow-up|0|||
44350937|NCT01256450|79355468|FG000|Open-label Titration|Lack of analgesic effect|30|||
44350938|NCT01256450|79355469|FG001|Open-label Titration|Lack of analgesic effect|0|||
44350939|NCT01256450|79355470|FG002|Open-label Titration|Lack of analgesic effect|0|||
44350940|NCT01256450|79355468|FG000|Open-label Titration|Non-compliance|9|||
44350941|NCT01256450|79355469|FG001|Open-label Titration|Non-compliance|0|||
44447688|NCT04145531|79456062|FG002|Part A|Withdrawal by parent or guardian|0|||
44350942|NCT01256450|79355470|FG002|Open-label Titration|Non-compliance|0|||
44350943|NCT01256450|79355468|FG000|Open-label Titration|Screen failure|1|||
44350944|NCT01256450|79355469|FG001|Open-label Titration|Screen failure|0|||
44350945|NCT01256450|79355470|FG002|Open-label Titration|Screen failure|0|||
44350946|NCT01256450|79355468|FG000|Open-label Titration|Other|13|||
44350947|NCT01256450|79355469|FG001|Open-label Titration|Other|0|||
44350948|NCT01256450|79355470|FG002|Open-label Titration|Other|0|||
44350949|NCT01256450|79355468|FG000|Double-blind Treatment|Adverse Event|0|||
44350950|NCT01256450|79355469|FG001|Double-blind Treatment|Adverse Event|8|||
44350951|NCT01256450|79355470|FG002|Double-blind Treatment|Adverse Event|6|||
44350952|NCT01256450|79355468|FG000|Double-blind Treatment|Lost to Follow-up|0|||
44350953|NCT01256450|79355469|FG001|Double-blind Treatment|Lost to Follow-up|1|||
44350954|NCT01256450|79355470|FG002|Double-blind Treatment|Lost to Follow-up|7|||
44350955|NCT01256450|79355468|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
44350956|NCT01256450|79355469|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
44350957|NCT01256450|79355470|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
44350958|NCT01256450|79355468|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
44350959|NCT01256450|79355469|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
44350960|NCT01256450|79355470|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
44350961|NCT01256450|79355468|FG000|Double-blind Treatment|Non-compliance|0|||
44350962|NCT01256450|79355469|FG001|Double-blind Treatment|Non-compliance|5|||
44350963|NCT01256450|79355470|FG002|Double-blind Treatment|Non-compliance|4|||
44350964|NCT01256450|79355468|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
44350965|NCT01256450|79355469|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
44350966|NCT01256450|79355470|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
44350967|NCT01256450|79355468|FG000|Double-blind Treatment|Other|0|||
44350968|NCT01256450|79355469|FG001|Double-blind Treatment|Other|9|||
44350969|NCT01256450|79355470|FG002|Double-blind Treatment|Other|12|||
44350970|NCT01204398|79355477|FG000|Overall Study|Adverse Event|1|||
44350971|NCT01111851|79355483|FG000|Overall Study|All planned PET scans were not obtained.|2|||
44350972|NCT01111851|79355484|FG001|Overall Study|All planned PET scans were not obtained.|0|||
44350973|NCT01256294|79355490|FG000|Overall Study|Adverse Event|1|||
44350974|NCT01256294|79355491|FG001|Overall Study|Adverse Event|0|||
44350975|NCT01256294|79355490|FG000|Overall Study|Withdrawal by Subject|1|||
44350976|NCT01256294|79355491|FG001|Overall Study|Withdrawal by Subject|1|||
44350977|NCT01256294|79355490|FG000|Overall Study|Protocol deviation|2|||
44350978|NCT01256294|79355491|FG001|Overall Study|Protocol deviation|1|||
44350979|NCT01256060|79355497|FG000|Overall Study|Lost to Follow-up|0|||
44350980|NCT01256060|79355498|FG001|Overall Study|Lost to Follow-up|1|||
44350981|NCT01256060|79355499|FG002|Overall Study|Lost to Follow-up|0|||
44350982|NCT01256060|79355500|FG003|Overall Study|Lost to Follow-up|0|||
44350983|NCT01255904|79355508|FG000|Overall Study|Physician Decision|1|||
44350984|NCT01255904|79355509|FG001|Overall Study|Physician Decision|4|||
44350985|NCT01255670|79355517|FG000|Overall Study|Adverse Event|10|||
44350986|NCT01255670|79355518|FG001|Overall Study|Adverse Event|10|||
44350987|NCT01255670|79355517|FG000|Overall Study|Lost to Follow-up|16|||
44350988|NCT01255670|79355518|FG001|Overall Study|Lost to Follow-up|10|||
44350989|NCT01255592|79355526|FG000|Overall Study|Adverse Event|5|||
44350990|NCT01255592|79355527|FG001|Overall Study|Adverse Event|0|||
44350991|NCT01255592|79355526|FG000|Overall Study|Withdrawal by Subject|1|||
44350992|NCT01255592|79355527|FG001|Overall Study|Withdrawal by Subject|0|||
44350993|NCT01255592|79355526|FG000|Overall Study|Other|0|||
44350994|NCT01255592|79355527|FG001|Overall Study|Other|1|||
44350995|NCT01255436|79355536|FG000|Overall Study|Lost to Follow-up|178|||
44350996|NCT01255436|79355537|FG001|Overall Study|Lost to Follow-up|191|||
44350997|NCT01255436|79355536|FG000|Overall Study|Death, stroke, or MI|4|||
44350998|NCT01255436|79355537|FG001|Overall Study|Death, stroke, or MI|3|||
44350999|NCT01203930|79355545|FG000|Overall Study|Disease Progression|0|||
44351000|NCT01203930|79355546|FG001|Overall Study|Disease Progression|4|||
44351001|NCT01203930|79355545|FG000|Overall Study|Death|3|||
44351002|NCT01203930|79355546|FG001|Overall Study|Death|1|||
44351003|NCT01203930|79355545|FG000|Overall Study|Withdrew Consent|1|||
44351004|NCT01203930|79355546|FG001|Overall Study|Withdrew Consent|10|||
44351005|NCT01203930|79355545|FG000|Overall Study|Investigator Request|0|||
44351006|NCT01203930|79355546|FG001|Overall Study|Investigator Request|8|||
44351007|NCT01203930|79355545|FG000|Overall Study|Study Terminated by Sponsor|0|||
44351008|NCT01203930|79355546|FG001|Overall Study|Study Terminated by Sponsor|12|||
44351009|NCT01203930|79355545|FG000|Overall Study|Poor tolerance of study drug|0|||
44351010|NCT01203930|79355546|FG001|Overall Study|Poor tolerance of study drug|1|||
44351011|NCT01203930|79355545|FG000|Overall Study|Adverse Event|17|||
44351012|NCT01203930|79355546|FG001|Overall Study|Adverse Event|5|||
44351013|NCT01254890|79355556|FG000|Overall Study|Ineligible|0|||
44351014|NCT01254890|79355557|FG001|Overall Study|Ineligible|3|||
44351015|NCT01254890|79355556|FG000|Overall Study|Withdrawal by Subject|1|||
44351016|NCT01254890|79355557|FG001|Overall Study|Withdrawal by Subject|2|||
44351017|NCT01254890|79355556|FG000|Overall Study|Disease Progression|0|||
44351018|NCT01254890|79355557|FG001|Overall Study|Disease Progression|5|||
44351019|NCT01203852|79355562|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
44351020|NCT01203852|79355562|FG000|Washout 2 Weeks|Physician Decision|46|||
44351021|NCT01105533|79355569|FG000|Overall Study|Death|0|||
44351022|NCT01105533|79355570|FG001|Overall Study|Death|0|||
44351023|NCT01105533|79355571|FG002|Overall Study|Death|0|||
44351024|NCT01105533|79355572|FG003|Overall Study|Death|0|||
44447689|NCT04145531|79456063|FG003|Part A|Withdrawal by parent or guardian|0|||
44166682|NCT01646385|78959750|FG001|Overall Study|Death|222|||
44166683|NCT01646385|78959749|FG000|Overall Study|Switched to alternate biologic|636|||
44351025|NCT01105533|79355573|FG004|Overall Study|Death|1|||
44351026|NCT01105533|79355574|FG005|Overall Study|Death|0|||
44351027|NCT01105533|79355575|FG006|Overall Study|Death|0|||
44351028|NCT01105533|79355576|FG007|Overall Study|Death|0|||
44351029|NCT01105533|79355577|FG008|Overall Study|Death|0|||
44351030|NCT01105533|79355569|FG000|Overall Study|Lack of Efficacy|1|||
44351031|NCT01105533|79355570|FG001|Overall Study|Lack of Efficacy|1|||
44351032|NCT01105533|79355571|FG002|Overall Study|Lack of Efficacy|3|||
44351033|NCT01105533|79355572|FG003|Overall Study|Lack of Efficacy|3|||
44351034|NCT01105533|79355573|FG004|Overall Study|Lack of Efficacy|4|||
44351035|NCT01105533|79355574|FG005|Overall Study|Lack of Efficacy|5|||
44351036|NCT01105533|79355575|FG006|Overall Study|Lack of Efficacy|3|||
44351037|NCT01105533|79355576|FG007|Overall Study|Lack of Efficacy|2|||
44351038|NCT01105533|79355577|FG008|Overall Study|Lack of Efficacy|9|||
44351039|NCT01105533|79355569|FG000|Overall Study|Adverse Event|0|||
44351040|NCT01105533|79355570|FG001|Overall Study|Adverse Event|0|||
44351041|NCT01105533|79355571|FG002|Overall Study|Adverse Event|0|||
44351042|NCT01105533|79355572|FG003|Overall Study|Adverse Event|0|||
44351043|NCT01105533|79355573|FG004|Overall Study|Adverse Event|1|||
44351044|NCT01105533|79355574|FG005|Overall Study|Adverse Event|2|||
44351045|NCT01105533|79355575|FG006|Overall Study|Adverse Event|2|||
44351046|NCT01105533|79355576|FG007|Overall Study|Adverse Event|0|||
44351047|NCT01105533|79355577|FG008|Overall Study|Adverse Event|1|||
44351048|NCT01105533|79355569|FG000|Overall Study|Other|0|||
44351049|NCT01105533|79355570|FG001|Overall Study|Other|0|||
44351050|NCT01105533|79355571|FG002|Overall Study|Other|0|||
44351051|NCT01105533|79355572|FG003|Overall Study|Other|0|||
44351052|NCT01105533|79355573|FG004|Overall Study|Other|1|||
44351053|NCT01105533|79355574|FG005|Overall Study|Other|0|||
44351054|NCT01105533|79355575|FG006|Overall Study|Other|3|||
44351055|NCT01105533|79355576|FG007|Overall Study|Other|1|||
44351056|NCT01105533|79355577|FG008|Overall Study|Other|2|||
44351057|NCT01105533|79355569|FG000|Overall Study|Physician Decision|0|||
44351058|NCT01105533|79355570|FG001|Overall Study|Physician Decision|0|||
44351059|NCT01105533|79355571|FG002|Overall Study|Physician Decision|0|||
44351060|NCT01105533|79355572|FG003|Overall Study|Physician Decision|0|||
44351061|NCT01105533|79355573|FG004|Overall Study|Physician Decision|0|||
44351062|NCT01105533|79355574|FG005|Overall Study|Physician Decision|0|||
44351063|NCT01105533|79355575|FG006|Overall Study|Physician Decision|0|||
44351064|NCT01105533|79355576|FG007|Overall Study|Physician Decision|1|||
44351065|NCT01105533|79355577|FG008|Overall Study|Physician Decision|0|||
44351066|NCT01203072|79355595|FG000|Overall Study|Adverse Event|5|||
44351067|NCT01203072|79355596|FG001|Overall Study|Adverse Event|3|||
44351068|NCT01203072|79355597|FG002|Overall Study|Adverse Event|2|||
44351069|NCT01203072|79355598|FG003|Overall Study|Adverse Event|4|||
44351070|NCT01203072|79355599|FG004|Overall Study|Adverse Event|2|||
44351071|NCT01203072|79355595|FG000|Overall Study|Lack of Efficacy|1|||
44351072|NCT01203072|79355596|FG001|Overall Study|Lack of Efficacy|0|||
44351073|NCT01203072|79355597|FG002|Overall Study|Lack of Efficacy|0|||
44351074|NCT01203072|79355598|FG003|Overall Study|Lack of Efficacy|0|||
44351075|NCT01203072|79355599|FG004|Overall Study|Lack of Efficacy|0|||
44351076|NCT01203072|79355595|FG000|Overall Study|Lost to Follow-up|0|||
44351077|NCT01203072|79355596|FG001|Overall Study|Lost to Follow-up|1|||
44351078|NCT01203072|79355597|FG002|Overall Study|Lost to Follow-up|0|||
44351079|NCT01203072|79355598|FG003|Overall Study|Lost to Follow-up|0|||
44351080|NCT01203072|79355599|FG004|Overall Study|Lost to Follow-up|0|||
44351081|NCT01203072|79355595|FG000|Overall Study|Protocol Violation|2|||
44351082|NCT01203072|79355596|FG001|Overall Study|Protocol Violation|0|||
44351083|NCT01203072|79355597|FG002|Overall Study|Protocol Violation|0|||
44351084|NCT01203072|79355598|FG003|Overall Study|Protocol Violation|0|||
44351085|NCT01203072|79355599|FG004|Overall Study|Protocol Violation|1|||
44351086|NCT01203072|79355595|FG000|Overall Study|Withdrawal by Subject|2|||
44351087|NCT01203072|79355596|FG001|Overall Study|Withdrawal by Subject|2|||
44351088|NCT01203072|79355597|FG002|Overall Study|Withdrawal by Subject|1|||
44351089|NCT01203072|79355598|FG003|Overall Study|Withdrawal by Subject|2|||
44351090|NCT01203072|79355599|FG004|Overall Study|Withdrawal by Subject|3|||
44351091|NCT01105377|79355613|FG000|Overall Study|Withdrawal by Subject|0|||
44351092|NCT01105377|79355614|FG001|Overall Study|Withdrawal by Subject|1|||
44351093|NCT01105065|79355620|FG000|Overall Study|Adverse Event|5|||
44351094|NCT01105065|79355620|FG000|Overall Study|Technical Problems|1|||
44351095|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
44351096|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44351097|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44351098|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44351099|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
44351100|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
44351101|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44351102|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44351103|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44351104|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
44351105|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
44351106|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44351107|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44351108|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44351109|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
44351110|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
44351111|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
44351112|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
44351113|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
44351114|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
44351115|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
44351116|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
44351117|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
44351118|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
44351119|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
44351120|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
44351121|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44351122|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44351123|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44351124|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
44351125|NCT01111539|79355626|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
44351126|NCT01111539|79355627|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
44351127|NCT01111539|79355628|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
44351128|NCT01111539|79355629|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
44351129|NCT01111539|79355630|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
44351130|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44351131|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44351132|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
44351133|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
44351134|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
44351135|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44351136|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44351137|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
44351138|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
44351139|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
44351140|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
44351141|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
44351142|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
44351143|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
44351144|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
44351145|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
44351146|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
44351147|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
44351148|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
44351149|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
44351150|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
44351151|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
44351152|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
44351153|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
44351154|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
44351155|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
44351156|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
44351157|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
44351158|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
44351159|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
44351160|NCT01111539|79355626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44351161|NCT01111539|79355627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44351162|NCT01111539|79355628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44351163|NCT01111539|79355629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
44351164|NCT01111539|79355630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
44351165|NCT01111149|79355643|FG000|Overall Study|Protocol Violation|1|||
44351166|NCT01111149|79355644|FG001|Overall Study|Protocol Violation|1|||
44351167|NCT01111149|79355645|FG002|Overall Study|Protocol Violation|2|||
44351168|NCT01111149|79355643|FG000|Overall Study|Withdrawal by Subject|1|||
44351169|NCT01111149|79355644|FG001|Overall Study|Withdrawal by Subject|0|||
44351170|NCT01111149|79355645|FG002|Overall Study|Withdrawal by Subject|2|||
44351171|NCT01254656|79355656|FG000|Overall Study|Discontinued due to termination of study|40|||
44351172|NCT01254656|79355657|FG001|Overall Study|Discontinued due to termination of study|39|||
44351173|NCT01254656|79355658|FG002|Overall Study|Discontinued due to termination of study|13|||
44351174|NCT01254656|79355656|FG000|Overall Study|Lack of Efficacy|3|||
44351175|NCT01254656|79355657|FG001|Overall Study|Lack of Efficacy|0|||
44447690|NCT04145531|79456060|FG000|Part A|Withdrawal by participant|0|||
44447691|NCT04145531|79456061|FG001|Part A|Withdrawal by participant|0|||
44351176|NCT01254656|79355658|FG002|Overall Study|Lack of Efficacy|0|||
44351177|NCT01254656|79355656|FG000|Overall Study|Lost to Follow-up|1|||
44351178|NCT01254656|79355657|FG001|Overall Study|Lost to Follow-up|0|||
44351179|NCT01254656|79355658|FG002|Overall Study|Lost to Follow-up|2|||
44351180|NCT01254656|79355656|FG000|Overall Study|Withdrawal by Subject|2|||
44351181|NCT01254656|79355657|FG001|Overall Study|Withdrawal by Subject|2|||
44351182|NCT01254656|79355658|FG002|Overall Study|Withdrawal by Subject|1|||
44351183|NCT01254656|79355656|FG000|Overall Study|Pregnancy|0|||
44351184|NCT01254656|79355657|FG001|Overall Study|Pregnancy|0|||
44351185|NCT01254656|79355658|FG002|Overall Study|Pregnancy|2|||
44351186|NCT01254656|79355656|FG000|Overall Study|Adverse Event|1|||
44351187|NCT01254656|79355657|FG001|Overall Study|Adverse Event|1|||
44351188|NCT01254656|79355658|FG002|Overall Study|Adverse Event|0|||
44351189|NCT01254656|79355656|FG000|Overall Study|Death|0|||
44351190|NCT01254656|79355657|FG001|Overall Study|Death|1|||
44351191|NCT01254656|79355658|FG002|Overall Study|Death|0|||
44351192|NCT01110915|79355668|FG000|Overall Study|Death|2|||
44351193|NCT01110915|79355669|FG001|Overall Study|Death|1|||
44351194|NCT01110915|79355668|FG000|Overall Study|Lost to Follow-up|1|||
44351195|NCT01110915|79355669|FG001|Overall Study|Lost to Follow-up|0|||
44351196|NCT01110915|79355668|FG000|Overall Study|Withdrawal by Subject|7|||
44351197|NCT01110915|79355669|FG001|Overall Study|Withdrawal by Subject|1|||
44351198|NCT01254344|79355678|FG000|Overall Study|Adverse Event|2|||
44351199|NCT01254344|79355679|FG001|Overall Study|Adverse Event|5|||
44351200|NCT01254344|79355678|FG000|Overall Study|Physician Decision|7|||
44351201|NCT01254344|79355679|FG001|Overall Study|Physician Decision|4|||
44351202|NCT01254344|79355678|FG000|Overall Study|Protocol Violation|1|||
44351203|NCT01254344|79355679|FG001|Overall Study|Protocol Violation|4|||
44351204|NCT01254344|79355678|FG000|Overall Study|Withdrawal by Subject|3|||
44351205|NCT01254344|79355679|FG001|Overall Study|Withdrawal by Subject|6|||
44351206|NCT01102803|79355687|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
44351207|NCT01102803|79355688|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
44351208|NCT01102803|79355687|FG000|Post to Follow-Up|Lost to Follow-up|1|||
44351209|NCT01102803|79355688|FG001|Post to Follow-Up|Lost to Follow-up|3|||
44351210|NCT01254188|79355696|FG000|Overall Study|Disease Progression|6|||
44351211|NCT01254188|79355696|FG000|Overall Study|Protocol Violation|6|||
44351212|NCT01254188|79355696|FG000|Overall Study|Pregnancy|2|||
44351213|NCT01254188|79355696|FG000|Overall Study|Death|4|||
44351214|NCT01254188|79355696|FG000|Overall Study|Lost to Follow-up|5|||
44351215|NCT01254188|79355696|FG000|Overall Study|Withdrawal by Subject|7|||
44351216|NCT01254188|79355696|FG000|Overall Study|Adverse Event|43|||
44351217|NCT01254188|79355696|FG000|Overall Study|per investigator discretion|20|||
44351218|NCT01109979|79355702|FG000|Overall Study|Physician Decision|2|||
44351219|NCT01109979|79355703|FG001|Overall Study|Physician Decision|0|||
44351220|NCT01109979|79355702|FG000|Overall Study|Withdrawal by Subject|0|||
44351221|NCT01109979|79355703|FG001|Overall Study|Withdrawal by Subject|1|||
44351222|NCT01102491|79355711|FG000|Overall Study|Protocol Violation|11|||
44351223|NCT01102491|79355712|FG001|Overall Study|Protocol Violation|12|||
44351224|NCT01102257|79355720|FG000|Overall Study|Adverse Event|1|||
44351225|NCT01102257|79355721|FG001|Overall Study|Adverse Event|0|||
44351226|NCT01102257|79355720|FG000|Overall Study|Adverse Event|1|||
44351227|NCT01102257|79355721|FG001|Overall Study|Adverse Event|0|||
44351228|NCT01253564|79355727|FG000|Overall Study|Disease Progression|22|||
44351229|NCT01253564|79355727|FG000|Overall Study|Withdrawal by Subject|1|||
44351230|NCT01253564|79355727|FG000|Overall Study|Serious Adverse Event|1|||
44351231|NCT01108809|79355731|FG000|Overall Study|Adverse Event|3|||
44351232|NCT01108809|79355731|FG000|Overall Study|Lost to Follow-up|1|||
44351233|NCT01253408|79355739|FG000|Overall Study|Adverse Event|0|||
44351234|NCT01253408|79355740|FG001|Overall Study|Adverse Event|1|||
44351235|NCT01253408|79355741|FG002|Overall Study|Adverse Event|0|||
44351236|NCT01253174|79355749|FG000|Period 1|Randomized but not treated|0|||
44351237|NCT01253174|79355750|FG001|Period 1|Randomized but not treated|1|||
44351238|NCT01253174|79355751|FG002|Period 1|Randomized but not treated|1|||
44351239|NCT01253174|79355752|FG003|Period 1|Randomized but not treated|0|||
44351240|NCT01253174|79355753|FG004|Period 1|Randomized but not treated|1|||
44351241|NCT01253174|79355754|FG005|Period 1|Randomized but not treated|0|||
44351242|NCT01253174|79355749|FG000|Period 2|Adverse Event|0|||
44351243|NCT01253174|79355750|FG001|Period 2|Adverse Event|0|||
44351244|NCT01253174|79355751|FG002|Period 2|Adverse Event|1|||
44351245|NCT01253174|79355752|FG003|Period 2|Adverse Event|0|||
44166684|NCT01646385|78959750|FG001|Overall Study|Switched to alternate biologic|649|||
44351246|NCT01253174|79355753|FG004|Period 2|Adverse Event|0|||
44351247|NCT01253174|79355754|FG005|Period 2|Adverse Event|0|||
44351248|NCT01253174|79355749|FG000|Period 3|Withdrawal by Subject|0|||
44351249|NCT01253174|79355750|FG001|Period 3|Withdrawal by Subject|1|||
44351250|NCT01253174|79355751|FG002|Period 3|Withdrawal by Subject|0|||
44351251|NCT01253174|79355752|FG003|Period 3|Withdrawal by Subject|0|||
44351252|NCT01253174|79355753|FG004|Period 3|Withdrawal by Subject|1|||
44351253|NCT01253174|79355754|FG005|Period 3|Withdrawal by Subject|0|||
44351254|NCT01253174|79355749|FG000|Period 3|Pregnancy|0|||
44351255|NCT01253174|79355750|FG001|Period 3|Pregnancy|0|||
44351256|NCT01253174|79355751|FG002|Period 3|Pregnancy|1|||
44351257|NCT01253174|79355752|FG003|Period 3|Pregnancy|0|||
44351258|NCT01253174|79355753|FG004|Period 3|Pregnancy|0|||
44351259|NCT01253174|79355754|FG005|Period 3|Pregnancy|0|||
44351260|NCT01108731|79355765|FG000|Overall Study|Withdrawal by Subject|1|||
44351261|NCT01108731|79355766|FG001|Overall Study|Withdrawal by Subject|1|||
44351262|NCT01108731|79355765|FG000|Overall Study|Adverse Event|3|||
44351263|NCT01108731|79355766|FG001|Overall Study|Adverse Event|3|||
44351264|NCT01253018|79355774|FG000|Overall Study|Lost to Follow-up|1|||
44351265|NCT01253018|79355775|FG001|Overall Study|Lost to Follow-up|1|||
44351266|NCT01253018|79355774|FG000|Overall Study|Robot Repair Issues|2|||
44351267|NCT01253018|79355775|FG001|Overall Study|Robot Repair Issues|0|||
44351268|NCT01253018|79355774|FG000|Overall Study|Withdrawal by Subject|1|||
44351269|NCT01253018|79355775|FG001|Overall Study|Withdrawal by Subject|1|||
44351270|NCT01108341|79355782|FG000|Overall Study|Death|2|||
44351271|NCT01108341|79355782|FG000|Overall Study|Withdrawal by Subject|1|||
44351272|NCT01108341|79355782|FG000|Overall Study|Lost to Follow-up|1|||
44351273|NCT01108341|79355782|FG000|Overall Study|Other|1|||
44351274|NCT01108263|79355788|FG000|Overall Study|Adverse Event|0|||
44351275|NCT01108263|79355789|FG001|Overall Study|Adverse Event|1|||
44351276|NCT01108185|79355795|FG000|Overall Study|Non-compliance|15|||
44351277|NCT01108185|79355795|FG000|Overall Study|Lost to Follow-up|12|||
44351278|NCT01252940|79355801|FG000|Main Study Phase|Randomized but not treated|4|||
44351279|NCT01252940|79355802|FG001|Main Study Phase|Randomized but not treated|2|||
44351280|NCT01252940|79355801|FG000|Main Study Phase|Adverse Event|3|||
44351281|NCT01252940|79355802|FG001|Main Study Phase|Adverse Event|1|||
44351282|NCT01252940|79355801|FG000|Main Study Phase|Lack of Efficacy|1|||
44351283|NCT01252940|79355802|FG001|Main Study Phase|Lack of Efficacy|0|||
44351284|NCT01252940|79355801|FG000|Main Study Phase|Lost to Follow-up|6|||
44351285|NCT01252940|79355802|FG001|Main Study Phase|Lost to Follow-up|1|||
44351286|NCT01252940|79355801|FG000|Main Study Phase|Physician Decision|1|||
44351287|NCT01252940|79355802|FG001|Main Study Phase|Physician Decision|0|||
44351288|NCT01252940|79355801|FG000|Main Study Phase|Protocol Violation|4|||
44351289|NCT01252940|79355802|FG001|Main Study Phase|Protocol Violation|2|||
44351290|NCT01252940|79355801|FG000|Main Study Phase|Withdrawal by Subject|6|||
44351291|NCT01252940|79355802|FG001|Main Study Phase|Withdrawal by Subject|5|||
44351292|NCT01252940|79355801|FG000|Main Study Phase|Subject Non-compliance|1|||
44351293|NCT01252940|79355802|FG001|Main Study Phase|Subject Non-compliance|1|||
44351294|NCT01252940|79355801|FG000|Extension Phase|Adverse Event|2|||
44351295|NCT01252940|79355802|FG001|Extension Phase|Adverse Event|1|||
44351296|NCT01252940|79355801|FG000|Extension Phase|Lack of Efficacy|1|||
44351297|NCT01252940|79355802|FG001|Extension Phase|Lack of Efficacy|0|||
44351298|NCT01252940|79355801|FG000|Extension Phase|Lost to Follow-up|5|||
44351299|NCT01252940|79355802|FG001|Extension Phase|Lost to Follow-up|0|||
44351300|NCT01252940|79355801|FG000|Extension Phase|Physician Decision|0|||
44351301|NCT01252940|79355802|FG001|Extension Phase|Physician Decision|1|||
44351302|NCT01252940|79355801|FG000|Extension Phase|Subject Non-compliance|1|||
44351303|NCT01252940|79355802|FG001|Extension Phase|Subject Non-compliance|0|||
44351304|NCT01252940|79355801|FG000|Extension Phase|Withdrawal by Subject|1|||
44351305|NCT01252940|79355802|FG001|Extension Phase|Withdrawal by Subject|1|||
44351306|NCT01252238|79355812|FG000|Overall Study|Sponsor terminated study|4|||
44351307|NCT01252238|79355813|FG001|Overall Study|Sponsor terminated study|4|||
44351308|NCT01252238|79355814|FG002|Overall Study|Sponsor terminated study|4|||
44351309|NCT01101477|79355828|FG000|Overall Study|Protocol Violation|5|||
44351310|NCT01101477|79355829|FG001|Overall Study|Protocol Violation|3|||
44351311|NCT01101477|79355830|FG002|Overall Study|Protocol Violation|1|||
44351312|NCT01251770|79355840|FG000|Overall Study|Protocol Violation|13|||
44351313|NCT01251770|79355841|FG001|Overall Study|Protocol Violation|7|||
44351314|NCT01101321|79355847|FG000|Period 1|Withdrawal by Subject|1|||
44351315|NCT01101321|79355848|FG001|Period 1|Withdrawal by Subject|1|||
44351316|NCT01101321|79355847|FG000|Period 1|Adverse Event|3|||
44351317|NCT01101321|79355848|FG001|Period 1|Adverse Event|3|||
44351318|NCT01101165|79355854|FG000|Period 1|Adverse Event|1|||
44351319|NCT01101165|79355855|FG001|Period 1|Adverse Event|2|||
44351320|NCT01101165|79355854|FG000|Period 1|Withdrawal by Subject|0|||
44351321|NCT01101165|79355855|FG001|Period 1|Withdrawal by Subject|2|||
44351322|NCT01101165|79355854|FG000|Period 1|Positive Drug Screen|0|||
44351323|NCT01101165|79355855|FG001|Period 1|Positive Drug Screen|1|||
44351324|NCT01101165|79355854|FG000|Period 1|Lost to Follow-up|1|||
44351325|NCT01101165|79355855|FG001|Period 1|Lost to Follow-up|0|||
44351326|NCT01101165|79355854|FG000|Period 2|Withdrawal by Subject|3|||
44351327|NCT01101165|79355855|FG001|Period 2|Withdrawal by Subject|1|||
44351328|NCT01101165|79355854|FG000|Period 2|Adverse Event|1|||
44351329|NCT01101165|79355855|FG001|Period 2|Adverse Event|0|||
44351330|NCT01100853|79355863|FG000|Overall Study|Lost to Follow-up|11|||
44351331|NCT01100853|79355864|FG001|Overall Study|Lost to Follow-up|6|||
44351332|NCT01100853|79355863|FG000|Overall Study|Received <4 study injections|10|||
44351333|NCT01100853|79355864|FG001|Overall Study|Received <4 study injections|13|||
44447692|NCT04145531|79456062|FG002|Part A|Withdrawal by participant|1|||
44447693|NCT04145531|79456063|FG003|Part A|Withdrawal by participant|0|||
44447694|NCT04145531|79456060|FG000|Part A|Other|0|||
44447695|NCT04145531|79456061|FG001|Part A|Other|0|||
44447696|NCT04145531|79456062|FG002|Part A|Other|1|||
44447697|NCT04145531|79456063|FG003|Part A|Other|0|||
44447698|NCT04145531|79456060|FG000|Part B|Adverse Event|0|||
44447699|NCT04145531|79456061|FG001|Part B|Adverse Event|0|||
44447700|NCT04145531|79456062|FG002|Part B|Adverse Event|0|||
44447701|NCT04145531|79456063|FG003|Part B|Adverse Event|21|||
44447702|NCT04145531|79456060|FG000|Part B|Physician Decision|0|||
44447703|NCT04145531|79456061|FG001|Part B|Physician Decision|0|||
44447704|NCT04145531|79456062|FG002|Part B|Physician Decision|0|||
44447705|NCT04145531|79456063|FG003|Part B|Physician Decision|7|||
44447706|NCT04145531|79456060|FG000|Part B|Progressive disease|0|||
44447707|NCT04145531|79456061|FG001|Part B|Progressive disease|0|||
44447708|NCT04145531|79456062|FG002|Part B|Progressive disease|0|||
44447709|NCT04145531|79456063|FG003|Part B|Progressive disease|1|||
44447710|NCT04145531|79456060|FG000|Part B|Recurrent disease|0|||
44447711|NCT04145531|79456061|FG001|Part B|Recurrent disease|0|||
44447712|NCT04145531|79456062|FG002|Part B|Recurrent disease|0|||
44447713|NCT04145531|79456063|FG003|Part B|Recurrent disease|1|||
44447714|NCT04145531|79456060|FG000|Part B|Withdrawal by parent or guardian|0|||
44447715|NCT04145531|79456061|FG001|Part B|Withdrawal by parent or guardian|0|||
44447716|NCT04145531|79456062|FG002|Part B|Withdrawal by parent or guardian|0|||
44447717|NCT04145531|79456063|FG003|Part B|Withdrawal by parent or guardian|3|||
44447718|NCT04145531|79456060|FG000|Part B|Withdrawal by participant|0|||
44447719|NCT04145531|79456061|FG001|Part B|Withdrawal by participant|0|||
44447720|NCT04145531|79456062|FG002|Part B|Withdrawal by participant|0|||
44447721|NCT04145531|79456063|FG003|Part B|Withdrawal by participant|1|||
44447722|NCT04145531|79456060|FG000|Part B|Other|0|||
44447723|NCT04145531|79456061|FG001|Part B|Other|0|||
44447724|NCT04145531|79456062|FG002|Part B|Other|0|||
44447725|NCT04145531|79456063|FG003|Part B|Other|1|||
44447726|NCT04124692|79456075|FG000|Overall Study|Medical reason|0|||
44447727|NCT04124692|79456076|FG001|Overall Study|Medical reason|1|||
44447728|NCT04124692|79456075|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
44447729|NCT04124692|79456076|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
44447730|NCT04124692|79456075|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
44447731|NCT04124692|79456076|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
44447732|NCT04124692|79456075|FG000|Overall Study|Lost to Follow-up|2|||
44447733|NCT04124692|79456076|FG001|Overall Study|Lost to Follow-up|4|||
44447734|NCT04124692|79456075|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
44447735|NCT04124692|79456076|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
44447736|NCT04018066|79456098|FG000|Overall Study|participants started taking medications during the study period|3|||
44447737|NCT04018066|79456098|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
44447738|NCT03811249|79456103|FG000|Overall Study|Withdrawal by Subject|44|||
44447739|NCT03811249|79456103|FG000|Overall Study|Missed Visit|24|||
44447740|NCT03678688|79456117|FG000|Overall Study|Reason not Specified|0|||
44447741|NCT03678688|79456118|FG001|Overall Study|Reason not Specified|0|||
44447742|NCT03678688|79456119|FG002|Overall Study|Reason not Specified|3|||
44447743|NCT03678688|79456120|FG003|Overall Study|Reason not Specified|0|||
44447744|NCT03678688|79456121|FG004|Overall Study|Reason not Specified|1|||
44447745|NCT03678688|79456122|FG005|Overall Study|Reason not Specified|0|||
44447746|NCT03678688|79456123|FG006|Overall Study|Reason not Specified|0|||
44447747|NCT03678688|79456124|FG007|Overall Study|Reason not Specified|0|||
44447748|NCT03678688|79456125|FG008|Overall Study|Reason not Specified|0|||
44447749|NCT03678688|79456117|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
44447750|NCT03678688|79456118|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
44447751|NCT03678688|79456119|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
44447752|NCT03678688|79456120|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
44447753|NCT03678688|79456121|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
44447754|NCT03678688|79456122|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
44447755|NCT03678688|79456123|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
44447756|NCT03678688|79456124|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
44447757|NCT03678688|79456125|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
44447758|NCT03678688|79456117|FG000|Overall Study|Covid Related Adverse Event|0|||
44447759|NCT03678688|79456118|FG001|Overall Study|Covid Related Adverse Event|0|||
44447760|NCT03678688|79456119|FG002|Overall Study|Covid Related Adverse Event|0|||
44447761|NCT03678688|79456120|FG003|Overall Study|Covid Related Adverse Event|0|||
44447762|NCT03678688|79456121|FG004|Overall Study|Covid Related Adverse Event|0|||
44447763|NCT03678688|79456122|FG005|Overall Study|Covid Related Adverse Event|3|||
44447764|NCT03678688|79456123|FG006|Overall Study|Covid Related Adverse Event|1|||
44447765|NCT03678688|79456124|FG007|Overall Study|Covid Related Adverse Event|1|||
44447766|NCT03678688|79456125|FG008|Overall Study|Covid Related Adverse Event|0|||
44447767|NCT03678688|79456117|FG000|Overall Study|Physician Decision|0|||
44447768|NCT03678688|79456118|FG001|Overall Study|Physician Decision|0|||
44447769|NCT03678688|79456119|FG002|Overall Study|Physician Decision|0|||
44447770|NCT03678688|79456120|FG003|Overall Study|Physician Decision|0|||
44447771|NCT03678688|79456121|FG004|Overall Study|Physician Decision|0|||
44447772|NCT03678688|79456122|FG005|Overall Study|Physician Decision|1|||
44447773|NCT03678688|79456123|FG006|Overall Study|Physician Decision|0|||
44447774|NCT03678688|79456124|FG007|Overall Study|Physician Decision|0|||
44447775|NCT03678688|79456125|FG008|Overall Study|Physician Decision|0|||
44447776|NCT03678688|79456117|FG000|Overall Study|Withdrawal by Subject|0|||
44447777|NCT03678688|79456118|FG001|Overall Study|Withdrawal by Subject|0|||
44447778|NCT03678688|79456119|FG002|Overall Study|Withdrawal by Subject|0|||
44447779|NCT03678688|79456120|FG003|Overall Study|Withdrawal by Subject|0|||
44447780|NCT03678688|79456121|FG004|Overall Study|Withdrawal by Subject|0|||
44447781|NCT03678688|79456122|FG005|Overall Study|Withdrawal by Subject|0|||
44447782|NCT03678688|79456123|FG006|Overall Study|Withdrawal by Subject|2|||
44447783|NCT03678688|79456124|FG007|Overall Study|Withdrawal by Subject|1|||
44447784|NCT03678688|79456125|FG008|Overall Study|Withdrawal by Subject|0|||
44447785|NCT03624036|79456172|FG000|Overall Study|Death|2|||
44447786|NCT03624036|79456173|FG001|Overall Study|Death|3|||
44447787|NCT03624036|79456174|FG002|Overall Study|Death|0|||
44447788|NCT03624036|79456175|FG003|Overall Study|Death|1|||
44447789|NCT03624036|79456172|FG000|Overall Study|Withdrawal by Subject|1|||
44447790|NCT03624036|79456173|FG001|Overall Study|Withdrawal by Subject|0|||
44447791|NCT03624036|79456174|FG002|Overall Study|Withdrawal by Subject|1|||
44447792|NCT03624036|79456175|FG003|Overall Study|Withdrawal by Subject|0|||
44447793|NCT03624036|79456172|FG000|Overall Study|Enrolled but Never Treated|1|||
44447794|NCT03624036|79456173|FG001|Overall Study|Enrolled but Never Treated|0|||
44447795|NCT03624036|79456174|FG002|Overall Study|Enrolled but Never Treated|0|||
44447796|NCT03624036|79456175|FG003|Overall Study|Enrolled but Never Treated|0|||
44447797|NCT03624036|79456172|FG000|Overall Study|Reason not Specified|3|||
44447798|NCT03624036|79456173|FG001|Overall Study|Reason not Specified|0|||
44447799|NCT03624036|79456174|FG002|Overall Study|Reason not Specified|2|||
44447800|NCT03624036|79456175|FG003|Overall Study|Reason not Specified|2|||
44447801|NCT03442569|79456224|FG000|Overall Study|Subject was ineligible after enrollment|1|||
44447802|NCT03235544|79456232|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
44447803|NCT03235544|79456233|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
44447804|NCT03235544|79456234|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
44166685|NCT02286843|78959756|FG000|Overall Study|Not Treated|4|||
44351334|NCT01100853|79355863|FG000|Overall Study|Withdrawal by Subject|6|||
44351335|NCT01100853|79355864|FG001|Overall Study|Withdrawal by Subject|4|||
44351336|NCT01100307|79355872|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
44351337|NCT01100307|79355873|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
44351338|NCT01100307|79355872|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
44351339|NCT01100307|79355873|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
44351340|NCT01100307|79355872|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
44351341|NCT01100307|79355873|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
44351342|NCT01100307|79355872|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
44351343|NCT01100307|79355873|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
44351344|NCT01100307|79355872|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
44351345|NCT01100307|79355873|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
44351346|NCT01100307|79355872|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
44351347|NCT01100307|79355873|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
44351348|NCT01100073|79355881|FG000|Overall Study|Lack of Efficacy|4|||
44351349|NCT01100073|79355881|FG000|Overall Study|Insufficient Tolerability|21|||
44351350|NCT01100073|79355881|FG000|Overall Study|Withdrawal by Subject|13|||
44351351|NCT01100073|79355881|FG000|Overall Study|Lost to Follow-up|39|||
44351352|NCT01100073|79355881|FG000|Overall Study|Lack of effect + patient's wish|2|||
44351353|NCT01100073|79355881|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
44351354|NCT01100073|79355881|FG000|Overall Study|Other|8|||
44351355|NCT01100073|79355881|FG000|Overall Study|Missing|5|||
44351356|NCT01099917|79355885|FG000|Overall Study|Adverse Event|3|||
44351357|NCT01099917|79355885|FG000|Overall Study|Not Treated|24|||
44351358|NCT01099215|79355891|FG000|Overall Study|Withdrawal by Subject|1|||
44351359|NCT01099215|79355892|FG001|Overall Study|Withdrawal by Subject|0|||
44351360|NCT01099215|79355891|FG000|Overall Study|Adverse Event|0|||
44351361|NCT01099215|79355892|FG001|Overall Study|Adverse Event|1|||
44351362|NCT01097655|79355898|FG000|Overall Study|Withdrawal by Subject|1|||
44351363|NCT01097655|79355898|FG000|Overall Study|Subject Documented Twice|1|||
44447805|NCT03235544|79456235|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
44447806|NCT03235544|79456232|FG000|Overall Study|Death|11|||
44447807|NCT03235544|79456233|FG001|Overall Study|Death|23|||
44447808|NCT03235544|79456234|FG002|Overall Study|Death|11|||
44447809|NCT03235544|79456235|FG003|Overall Study|Death|20|||
44447810|NCT03235544|79456232|FG000|Overall Study|Lost to Follow-up|0|||
44447811|NCT03235544|79456233|FG001|Overall Study|Lost to Follow-up|1|||
44447812|NCT03235544|79456234|FG002|Overall Study|Lost to Follow-up|0|||
44351364|NCT01097655|79355898|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
44351365|NCT01107405|79355907|FG000|Overall Study|Adverse Event|1|||
44351366|NCT01107405|79355908|FG001|Overall Study|Adverse Event|1|||
44351367|NCT01107405|79355909|FG002|Overall Study|Adverse Event|0|||
44351368|NCT01107405|79355910|FG003|Overall Study|Adverse Event|0|||
44351369|NCT01107405|79355911|FG004|Overall Study|Adverse Event|2|||
44351370|NCT01107405|79355907|FG000|Overall Study|Withdrawal by Subject|1|||
44351371|NCT01107405|79355908|FG001|Overall Study|Withdrawal by Subject|0|||
44351372|NCT01107405|79355909|FG002|Overall Study|Withdrawal by Subject|1|||
44351373|NCT01107405|79355910|FG003|Overall Study|Withdrawal by Subject|2|||
44351374|NCT01107405|79355911|FG004|Overall Study|Withdrawal by Subject|1|||
44351375|NCT01107405|79355907|FG000|Overall Study|Protocol Violation|0|||
44351376|NCT01107405|79355908|FG001|Overall Study|Protocol Violation|0|||
44351377|NCT01107405|79355909|FG002|Overall Study|Protocol Violation|1|||
44351378|NCT01107405|79355910|FG003|Overall Study|Protocol Violation|1|||
44351379|NCT01107405|79355911|FG004|Overall Study|Protocol Violation|0|||
44351380|NCT01097577|79355925|FG000|Overall Study|Adverse Event|0|||
44351381|NCT01097577|79355926|FG001|Overall Study|Adverse Event|1|||
44351382|NCT01097421|79355932|FG000|Overall Study|Adverse Event|8|||
44351383|NCT01097421|79355932|FG000|Overall Study|Protocol Violation|2|||
44351384|NCT01097421|79355932|FG000|Overall Study|Lost to Follow-up|1|||
44351385|NCT01097421|79355932|FG000|Overall Study|Withdrawal by Subject|3|||
44351386|NCT01251614|79355939|FG000|Overall Study|Adverse Event|1|||
44351387|NCT01251614|79355940|FG001|Overall Study|Adverse Event|0|||
44351388|NCT01251614|79355941|FG002|Overall Study|Adverse Event|1|||
44351389|NCT01251614|79355939|FG000|Overall Study|Lack of Efficacy|1|||
44351390|NCT01251614|79355940|FG001|Overall Study|Lack of Efficacy|9|||
44351391|NCT01251614|79355941|FG002|Overall Study|Lack of Efficacy|4|||
44351392|NCT01251614|79355939|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
44351393|NCT01251614|79355940|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
44351394|NCT01251614|79355941|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
44351395|NCT01251614|79355939|FG000|Overall Study|Pregnancy|0|||
44351396|NCT01251614|79355940|FG001|Overall Study|Pregnancy|0|||
44351397|NCT01251614|79355941|FG002|Overall Study|Pregnancy|2|||
44351398|NCT01251614|79355939|FG000|Overall Study|Loss of Disease Control|0|||
44351399|NCT01251614|79355940|FG001|Overall Study|Loss of Disease Control|1|||
44351400|NCT01251614|79355941|FG002|Overall Study|Loss of Disease Control|0|||
44351401|NCT01251614|79355939|FG000|Overall Study|Withdrawal by Subject|0|||
44351402|NCT01251614|79355940|FG001|Overall Study|Withdrawal by Subject|2|||
44351403|NCT01251614|79355941|FG002|Overall Study|Withdrawal by Subject|1|||
44351404|NCT01251614|79355939|FG000|Overall Study|Lost to Follow-up|0|||
44351405|NCT01251614|79355940|FG001|Overall Study|Lost to Follow-up|1|||
44351406|NCT01251614|79355941|FG002|Overall Study|Lost to Follow-up|0|||
44351407|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
44351408|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
44351409|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
44351410|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
44351411|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
44351412|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
44351413|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
44351414|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
44351415|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
44351416|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
44351417|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
44351418|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
44351419|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
44351420|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
44351421|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
44351422|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
44351423|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
44351424|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
44351425|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
44351426|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
44351427|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
44351428|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
44351429|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
44351430|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
44351431|NCT01106625|79355962|FG000|Core Period: Baseline to Week 26|Other|8|||
44351432|NCT01106625|79355963|FG001|Core Period: Baseline to Week 26|Other|7|||
44351433|NCT01106625|79355964|FG002|Core Period: Baseline to Week 26|Other|4|||
44351434|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
44351435|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
44351436|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
44351437|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
44351438|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
44351439|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
44351440|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
44351441|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
44351442|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
44351443|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44351444|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
44351445|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
44351446|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
44351447|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44351448|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
44351449|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
44351450|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
44351451|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
44351452|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
44351453|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
44351454|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
44351455|NCT01106625|79355962|FG000|Extension Period: Week 26 to Week 52|Other|5|||
44351456|NCT01106625|79355963|FG001|Extension Period: Week 26 to Week 52|Other|5|||
44351457|NCT01106625|79355964|FG002|Extension Period: Week 26 to Week 52|Other|4|||
44351458|NCT01251380|79355975|FG000|Overall Study|Other (Not otherwise specified)|12|||
44351459|NCT01251380|79355975|FG000|Overall Study|Withdrawal by Subject|6|||
44351460|NCT01251380|79355975|FG000|Overall Study|Lack of Efficacy|1|||
44351461|NCT01251380|79355975|FG000|Overall Study|Adverse Event|1|||
44351462|NCT01251380|79355975|FG000|Overall Study|Lost to Follow-up|2|||
44351463|NCT01251146|79355986|FG000|Overall Study|Lost to Follow-up|3|||
44351464|NCT01251146|79355987|FG001|Overall Study|Lost to Follow-up|10|||
44351465|NCT01096017|79355993|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
44351466|NCT01096017|79355994|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
44351467|NCT01106157|79356002|FG000|Overall Study|Withdrawal by Subject|1|||
44351468|NCT01106157|79356003|FG001|Overall Study|Withdrawal by Subject|0|||
44351469|NCT01094301|79356009|FG000|Trial Stage|Withdrawal by Subject|1|||
44351470|NCT01094301|79356009|FG000|Implant Stage|Adverse Event|1|||
44351471|NCT01094301|79356009|FG000|Implant Stage|Protocol Violation|1|||
44351472|NCT01094301|79356009|FG000|Implant Stage|Withdrawal by Subject|2|||
44351473|NCT01094301|79356009|FG000|Implant Stage|No return of pain|4|||
44351474|NCT01093755|79356017|FG000|Overall Study|Withdrawal by Subject|3|||
44351475|NCT01093755|79356018|FG001|Overall Study|Withdrawal by Subject|4|||
44351476|NCT01093599|79356026|FG000|Overall Study|Lost to Follow-up|32|||
44351477|NCT01093599|79356027|FG001|Overall Study|Lost to Follow-up|46|||
44351478|NCT01092663|79356035|FG000|Overall Study|Withdrawal by Subject|3|||
44351479|NCT01092663|79356036|FG001|Overall Study|Withdrawal by Subject|2|||
44351480|NCT01092663|79356035|FG000|Overall Study|Glucose >300mg/dL|1|||
44351481|NCT01092663|79356036|FG001|Overall Study|Glucose >300mg/dL|0|||
44351482|NCT01092663|79356035|FG000|Overall Study|High fasting triglyceride|2|||
44351483|NCT01092663|79356036|FG001|Overall Study|High fasting triglyceride|0|||
44351484|NCT01092663|79356035|FG000|Overall Study|Adverse Event|1|||
44351485|NCT01092663|79356036|FG001|Overall Study|Adverse Event|1|||
44351486|NCT01092663|79356035|FG000|Overall Study|Protocol Violation|0|||
44351487|NCT01092663|79356036|FG001|Overall Study|Protocol Violation|1|||
44351488|NCT01078623|79356047|FG000|Treatment Period 1|Adverse Event|1|||
44351489|NCT01078623|79356048|FG001|Treatment Period 1|Adverse Event|1|||
44351490|NCT01078623|79356049|FG002|Treatment Period 1|Adverse Event|1|||
44351491|NCT01078623|79356050|FG003|Treatment Period 1|Adverse Event|0|||
44351492|NCT01078623|79356051|FG004|Treatment Period 1|Adverse Event|0|||
44351493|NCT01078623|79356052|FG005|Treatment Period 1|Adverse Event|0|||
44351494|NCT01078623|79356053|FG006|Treatment Period 1|Adverse Event|1|||
44351495|NCT01078623|79356054|FG007|Treatment Period 1|Adverse Event|0|||
44351496|NCT01078623|79356055|FG008|Treatment Period 1|Adverse Event|1|||
44351497|NCT01078623|79356056|FG009|Treatment Period 1|Adverse Event|1|||
44351498|NCT01078623|79356057|FG010|Treatment Period 1|Adverse Event|0|||
44351499|NCT01078623|79356058|FG011|Treatment Period 1|Adverse Event|0|||
44351500|NCT01078623|79356059|FG012|Treatment Period 1|Adverse Event|0|||
44351501|NCT01078623|79356060|FG013|Treatment Period 1|Adverse Event|0|||
44351502|NCT01078623|79356061|FG014|Treatment Period 1|Adverse Event|0|||
44351503|NCT01078623|79356062|FG015|Treatment Period 1|Adverse Event|0|||
44351504|NCT01078623|79356063|FG016|Treatment Period 1|Adverse Event|0|||
44351505|NCT01078623|79356064|FG017|Treatment Period 1|Adverse Event|0|||
44351506|NCT01078623|79356065|FG018|Treatment Period 1|Adverse Event|0|||
44351507|NCT01078623|79356066|FG019|Treatment Period 1|Adverse Event|0|||
44351508|NCT01078623|79356047|FG000|Treatment Period 1|Withdrawal by Subject|0|||
44351509|NCT01078623|79356048|FG001|Treatment Period 1|Withdrawal by Subject|0|||
44351510|NCT01078623|79356049|FG002|Treatment Period 1|Withdrawal by Subject|0|||
44351511|NCT01078623|79356050|FG003|Treatment Period 1|Withdrawal by Subject|0|||
44351512|NCT01078623|79356051|FG004|Treatment Period 1|Withdrawal by Subject|0|||
44351513|NCT01078623|79356052|FG005|Treatment Period 1|Withdrawal by Subject|0|||
44351514|NCT01078623|79356053|FG006|Treatment Period 1|Withdrawal by Subject|0|||
44351515|NCT01078623|79356054|FG007|Treatment Period 1|Withdrawal by Subject|1|||
44351516|NCT01078623|79356055|FG008|Treatment Period 1|Withdrawal by Subject|0|||
44351517|NCT01078623|79356056|FG009|Treatment Period 1|Withdrawal by Subject|0|||
44351518|NCT01078623|79356057|FG010|Treatment Period 1|Withdrawal by Subject|1|||
44351519|NCT01078623|79356058|FG011|Treatment Period 1|Withdrawal by Subject|0|||
44351520|NCT01078623|79356059|FG012|Treatment Period 1|Withdrawal by Subject|0|||
44351521|NCT01078623|79356060|FG013|Treatment Period 1|Withdrawal by Subject|0|||
44351522|NCT01078623|79356061|FG014|Treatment Period 1|Withdrawal by Subject|0|||
44351523|NCT01078623|79356062|FG015|Treatment Period 1|Withdrawal by Subject|0|||
44351524|NCT01078623|79356063|FG016|Treatment Period 1|Withdrawal by Subject|0|||
44351525|NCT01078623|79356064|FG017|Treatment Period 1|Withdrawal by Subject|0|||
44351526|NCT01078623|79356065|FG018|Treatment Period 1|Withdrawal by Subject|0|||
44351527|NCT01078623|79356066|FG019|Treatment Period 1|Withdrawal by Subject|0|||
44351528|NCT01078623|79356047|FG000|Treatment Period 1|Protocol Violation|0|||
44351529|NCT01078623|79356048|FG001|Treatment Period 1|Protocol Violation|0|||
44351530|NCT01078623|79356049|FG002|Treatment Period 1|Protocol Violation|0|||
44351531|NCT01078623|79356050|FG003|Treatment Period 1|Protocol Violation|0|||
44351532|NCT01078623|79356051|FG004|Treatment Period 1|Protocol Violation|0|||
44351533|NCT01078623|79356052|FG005|Treatment Period 1|Protocol Violation|1|||
44351534|NCT01078623|79356053|FG006|Treatment Period 1|Protocol Violation|0|||
44351535|NCT01078623|79356054|FG007|Treatment Period 1|Protocol Violation|0|||
44351536|NCT01078623|79356055|FG008|Treatment Period 1|Protocol Violation|0|||
44351537|NCT01078623|79356056|FG009|Treatment Period 1|Protocol Violation|0|||
44351538|NCT01078623|79356057|FG010|Treatment Period 1|Protocol Violation|0|||
44351539|NCT01078623|79356058|FG011|Treatment Period 1|Protocol Violation|0|||
44351540|NCT01078623|79356059|FG012|Treatment Period 1|Protocol Violation|0|||
44351541|NCT01078623|79356060|FG013|Treatment Period 1|Protocol Violation|0|||
44351542|NCT01078623|79356061|FG014|Treatment Period 1|Protocol Violation|0|||
44351543|NCT01078623|79356062|FG015|Treatment Period 1|Protocol Violation|0|||
44351544|NCT01078623|79356063|FG016|Treatment Period 1|Protocol Violation|0|||
44351545|NCT01078623|79356064|FG017|Treatment Period 1|Protocol Violation|0|||
44351546|NCT01078623|79356065|FG018|Treatment Period 1|Protocol Violation|0|||
44351547|NCT01078623|79356066|FG019|Treatment Period 1|Protocol Violation|0|||
44351548|NCT01078623|79356047|FG000|Treatment Period 2|Adverse Event|0|||
44351549|NCT01078623|79356048|FG001|Treatment Period 2|Adverse Event|0|||
44351550|NCT01078623|79356049|FG002|Treatment Period 2|Adverse Event|0|||
44351551|NCT01078623|79356050|FG003|Treatment Period 2|Adverse Event|0|||
44351552|NCT01078623|79356051|FG004|Treatment Period 2|Adverse Event|0|||
44351553|NCT01078623|79356052|FG005|Treatment Period 2|Adverse Event|0|||
44351554|NCT01078623|79356053|FG006|Treatment Period 2|Adverse Event|1|||
44351555|NCT01078623|79356054|FG007|Treatment Period 2|Adverse Event|0|||
44351556|NCT01078623|79356055|FG008|Treatment Period 2|Adverse Event|0|||
44351557|NCT01078623|79356056|FG009|Treatment Period 2|Adverse Event|0|||
44351558|NCT01078623|79356057|FG010|Treatment Period 2|Adverse Event|0|||
44351559|NCT01078623|79356058|FG011|Treatment Period 2|Adverse Event|0|||
44351560|NCT01078623|79356059|FG012|Treatment Period 2|Adverse Event|0|||
44351561|NCT01078623|79356060|FG013|Treatment Period 2|Adverse Event|0|||
44351562|NCT01078623|79356061|FG014|Treatment Period 2|Adverse Event|0|||
44351563|NCT01078623|79356062|FG015|Treatment Period 2|Adverse Event|0|||
44351564|NCT01078623|79356063|FG016|Treatment Period 2|Adverse Event|0|||
44351565|NCT01078623|79356064|FG017|Treatment Period 2|Adverse Event|0|||
44166686|NCT02286843|78959756|FG000|Overall Study|Protocol Violation|1|||
44351566|NCT01078623|79356065|FG018|Treatment Period 2|Adverse Event|1|||
44351567|NCT01078623|79356066|FG019|Treatment Period 2|Adverse Event|0|||
44351568|NCT01078623|79356047|FG000|Treatment Period 2|Withdrawal by Subject|0|||
44351569|NCT01078623|79356048|FG001|Treatment Period 2|Withdrawal by Subject|0|||
44351570|NCT01078623|79356049|FG002|Treatment Period 2|Withdrawal by Subject|0|||
44351571|NCT01078623|79356050|FG003|Treatment Period 2|Withdrawal by Subject|0|||
44351572|NCT01078623|79356051|FG004|Treatment Period 2|Withdrawal by Subject|0|||
44351573|NCT01078623|79356052|FG005|Treatment Period 2|Withdrawal by Subject|1|||
44351574|NCT01078623|79356053|FG006|Treatment Period 2|Withdrawal by Subject|0|||
44351575|NCT01078623|79356054|FG007|Treatment Period 2|Withdrawal by Subject|0|||
44351576|NCT01078623|79356055|FG008|Treatment Period 2|Withdrawal by Subject|0|||
44351577|NCT01078623|79356056|FG009|Treatment Period 2|Withdrawal by Subject|0|||
44351578|NCT01078623|79356057|FG010|Treatment Period 2|Withdrawal by Subject|0|||
44351579|NCT01078623|79356058|FG011|Treatment Period 2|Withdrawal by Subject|0|||
44351580|NCT01078623|79356059|FG012|Treatment Period 2|Withdrawal by Subject|0|||
44351581|NCT01078623|79356060|FG013|Treatment Period 2|Withdrawal by Subject|0|||
44351582|NCT01078623|79356061|FG014|Treatment Period 2|Withdrawal by Subject|0|||
44351583|NCT01078623|79356062|FG015|Treatment Period 2|Withdrawal by Subject|0|||
44351584|NCT01078623|79356063|FG016|Treatment Period 2|Withdrawal by Subject|0|||
44351585|NCT01078623|79356064|FG017|Treatment Period 2|Withdrawal by Subject|0|||
44351586|NCT01078623|79356065|FG018|Treatment Period 2|Withdrawal by Subject|0|||
44351587|NCT01078623|79356066|FG019|Treatment Period 2|Withdrawal by Subject|0|||
44351588|NCT01078623|79356047|FG000|Treatment Period 3|Adverse Event|0|||
44351589|NCT01078623|79356048|FG001|Treatment Period 3|Adverse Event|0|||
44351590|NCT01078623|79356049|FG002|Treatment Period 3|Adverse Event|0|||
44351591|NCT01078623|79356050|FG003|Treatment Period 3|Adverse Event|0|||
44351592|NCT01078623|79356051|FG004|Treatment Period 3|Adverse Event|1|||
44351593|NCT01078623|79356052|FG005|Treatment Period 3|Adverse Event|0|||
44351594|NCT01078623|79356053|FG006|Treatment Period 3|Adverse Event|0|||
44351595|NCT01078623|79356054|FG007|Treatment Period 3|Adverse Event|0|||
44351596|NCT01078623|79356055|FG008|Treatment Period 3|Adverse Event|0|||
44351597|NCT01078623|79356056|FG009|Treatment Period 3|Adverse Event|0|||
44351598|NCT01078623|79356057|FG010|Treatment Period 3|Adverse Event|0|||
44351599|NCT01078623|79356058|FG011|Treatment Period 3|Adverse Event|0|||
44351600|NCT01078623|79356059|FG012|Treatment Period 3|Adverse Event|0|||
44351601|NCT01078623|79356060|FG013|Treatment Period 3|Adverse Event|1|||
44351602|NCT01078623|79356061|FG014|Treatment Period 3|Adverse Event|0|||
44351603|NCT01078623|79356062|FG015|Treatment Period 3|Adverse Event|0|||
44351604|NCT01078623|79356063|FG016|Treatment Period 3|Adverse Event|0|||
44351605|NCT01078623|79356064|FG017|Treatment Period 3|Adverse Event|0|||
44351606|NCT01078623|79356065|FG018|Treatment Period 3|Adverse Event|0|||
44351607|NCT01078623|79356066|FG019|Treatment Period 3|Adverse Event|0|||
44351608|NCT01078623|79356047|FG000|Treatment Period 4|Adverse Event|0|||
44351609|NCT01078623|79356048|FG001|Treatment Period 4|Adverse Event|0|||
44351610|NCT01078623|79356049|FG002|Treatment Period 4|Adverse Event|1|||
44351611|NCT01078623|79356050|FG003|Treatment Period 4|Adverse Event|0|||
44351612|NCT01078623|79356051|FG004|Treatment Period 4|Adverse Event|0|||
44351613|NCT01078623|79356052|FG005|Treatment Period 4|Adverse Event|0|||
44351614|NCT01078623|79356053|FG006|Treatment Period 4|Adverse Event|0|||
44351615|NCT01078623|79356054|FG007|Treatment Period 4|Adverse Event|0|||
44351616|NCT01078623|79356055|FG008|Treatment Period 4|Adverse Event|0|||
44351617|NCT01078623|79356056|FG009|Treatment Period 4|Adverse Event|0|||
44351618|NCT01078623|79356057|FG010|Treatment Period 4|Adverse Event|0|||
44351619|NCT01078623|79356058|FG011|Treatment Period 4|Adverse Event|0|||
44351620|NCT01078623|79356059|FG012|Treatment Period 4|Adverse Event|0|||
44351621|NCT01078623|79356060|FG013|Treatment Period 4|Adverse Event|0|||
44351622|NCT01078623|79356061|FG014|Treatment Period 4|Adverse Event|0|||
44351623|NCT01078623|79356062|FG015|Treatment Period 4|Adverse Event|0|||
44351624|NCT01078623|79356063|FG016|Treatment Period 4|Adverse Event|0|||
44351625|NCT01078623|79356064|FG017|Treatment Period 4|Adverse Event|0|||
44351626|NCT01078623|79356065|FG018|Treatment Period 4|Adverse Event|0|||
44351627|NCT01078623|79356066|FG019|Treatment Period 4|Adverse Event|0|||
44351628|NCT01078623|79356047|FG000|Treatment Period 4|Withdrawal by Subject|0|||
44351629|NCT01078623|79356048|FG001|Treatment Period 4|Withdrawal by Subject|0|||
44351630|NCT01078623|79356049|FG002|Treatment Period 4|Withdrawal by Subject|0|||
44351631|NCT01078623|79356050|FG003|Treatment Period 4|Withdrawal by Subject|0|||
44351632|NCT01078623|79356051|FG004|Treatment Period 4|Withdrawal by Subject|0|||
44351633|NCT01078623|79356052|FG005|Treatment Period 4|Withdrawal by Subject|0|||
44351634|NCT01078623|79356053|FG006|Treatment Period 4|Withdrawal by Subject|0|||
44351635|NCT01078623|79356054|FG007|Treatment Period 4|Withdrawal by Subject|0|||
44351636|NCT01078623|79356055|FG008|Treatment Period 4|Withdrawal by Subject|0|||
44351637|NCT01078623|79356056|FG009|Treatment Period 4|Withdrawal by Subject|0|||
44351638|NCT01078623|79356057|FG010|Treatment Period 4|Withdrawal by Subject|0|||
44351639|NCT01078623|79356058|FG011|Treatment Period 4|Withdrawal by Subject|0|||
44351640|NCT01078623|79356059|FG012|Treatment Period 4|Withdrawal by Subject|0|||
44351641|NCT01078623|79356060|FG013|Treatment Period 4|Withdrawal by Subject|0|||
44351642|NCT01078623|79356061|FG014|Treatment Period 4|Withdrawal by Subject|0|||
44351643|NCT01078623|79356062|FG015|Treatment Period 4|Withdrawal by Subject|1|||
44351644|NCT01078623|79356063|FG016|Treatment Period 4|Withdrawal by Subject|0|||
44351645|NCT01078623|79356064|FG017|Treatment Period 4|Withdrawal by Subject|0|||
44351646|NCT01078623|79356065|FG018|Treatment Period 4|Withdrawal by Subject|0|||
44351647|NCT01078623|79356066|FG019|Treatment Period 4|Withdrawal by Subject|0|||
44351648|NCT01092507|79356080|FG000|Overall Study|Withdrawal by Subject|2|||
44351649|NCT01092507|79356081|FG001|Overall Study|Withdrawal by Subject|0|||
44351650|NCT01078545|79356087|FG000|Overall Study|Lost to Follow-up|13|||
44351651|NCT01078545|79356087|FG000|Overall Study|Physician Decision|6|||
44351652|NCT01078545|79356087|FG000|Overall Study|Withdrawal by Subject|3|||
44351653|NCT01078545|79356087|FG000|Overall Study|Death|3|||
44351654|NCT01078545|79356087|FG000|Overall Study|Participant moved to another physician|1|||
44351655|NCT01202760|79356094|FG000|Overall Study|Entry Criteria Not Met|0|||
44351656|NCT01202760|79356095|FG001|Overall Study|Entry Criteria Not Met|3|||
44351657|NCT01202760|79356096|FG002|Overall Study|Entry Criteria Not Met|1|||
44351658|NCT01202760|79356094|FG000|Overall Study|Adverse Event|11|||
44351659|NCT01202760|79356095|FG001|Overall Study|Adverse Event|9|||
44351660|NCT01202760|79356096|FG002|Overall Study|Adverse Event|10|||
44351661|NCT01202760|79356094|FG000|Overall Study|Death|2|||
44351662|NCT01202760|79356095|FG001|Overall Study|Death|1|||
44351663|NCT01202760|79356096|FG002|Overall Study|Death|0|||
44351664|NCT01202760|79356094|FG000|Overall Study|Lack of Efficacy|6|||
44351665|NCT01202760|79356095|FG001|Overall Study|Lack of Efficacy|8|||
44351666|NCT01202760|79356096|FG002|Overall Study|Lack of Efficacy|7|||
44351667|NCT01202760|79356094|FG000|Overall Study|Lost to Follow-up|0|||
44351668|NCT01202760|79356095|FG001|Overall Study|Lost to Follow-up|2|||
44351669|NCT01202760|79356096|FG002|Overall Study|Lost to Follow-up|1|||
44351670|NCT01202760|79356094|FG000|Overall Study|Parent / Caregiver Decision|0|||
44351671|NCT01202760|79356095|FG001|Overall Study|Parent / Caregiver Decision|1|||
44351672|NCT01202760|79356096|FG002|Overall Study|Parent / Caregiver Decision|0|||
44351673|NCT01202760|79356094|FG000|Overall Study|Withdrawal by Subject|17|||
44351674|NCT01202760|79356095|FG001|Overall Study|Withdrawal by Subject|18|||
44351675|NCT01202760|79356096|FG002|Overall Study|Withdrawal by Subject|14|||
44351676|NCT01202760|79356094|FG000|Overall Study|Physician Decision|0|||
44351677|NCT01202760|79356095|FG001|Overall Study|Physician Decision|1|||
44351678|NCT01202760|79356096|FG002|Overall Study|Physician Decision|0|||
44351679|NCT01202760|79356094|FG000|Overall Study|Protocol Violation|7|||
44351680|NCT01202760|79356095|FG001|Overall Study|Protocol Violation|5|||
44351681|NCT01202760|79356096|FG002|Overall Study|Protocol Violation|2|||
44351682|NCT01202760|79356094|FG000|Overall Study|Sponsor Decision|4|||
44351683|NCT01202760|79356095|FG001|Overall Study|Sponsor Decision|4|||
44351684|NCT01202760|79356096|FG002|Overall Study|Sponsor Decision|0|||
44351685|NCT01091259|79356116|FG000|Overall Study|Adverse Event|3|||
44351686|NCT01091259|79356116|FG000|Overall Study|Lack of Efficacy|2|||
44351687|NCT01091103|79356120|FG000|Overall Study|Adverse Event|1|||
44351688|NCT01091103|79356120|FG000|Overall Study|Progressive Disease|3|||
44351689|NCT01078389|79356128|FG000|Overall Study|Adverse Event|10|||
44351690|NCT01078389|79356129|FG001|Overall Study|Adverse Event|6|||
44351691|NCT01078389|79356128|FG000|Overall Study|Major Protocol Deviation|2|||
44351692|NCT01078389|79356129|FG001|Overall Study|Major Protocol Deviation|0|||
44351693|NCT01078389|79356128|FG000|Overall Study|Lost to Follow-up|23|||
44351694|NCT01078389|79356129|FG001|Overall Study|Lost to Follow-up|23|||
44351695|NCT01078389|79356128|FG000|Overall Study|Voluntary Withdrawal|20|||
44351696|NCT01078389|79356129|FG001|Overall Study|Voluntary Withdrawal|36|||
44351697|NCT01078389|79356128|FG000|Overall Study|Other|9|||
44351698|NCT01078389|79356129|FG001|Overall Study|Other|2|||
44351699|NCT01090323|79356137|FG000|Overall Study|Adverse Event|12|||
44351700|NCT01090323|79356138|FG001|Overall Study|Adverse Event|2|||
44351701|NCT01090323|79356137|FG000|Overall Study|Abnormal Lab Values|3|||
44351702|NCT01090323|79356138|FG001|Overall Study|Abnormal Lab Values|1|||
44351703|NCT01090323|79356137|FG000|Overall Study|Abnormal Test Procedure Results|2|||
44351704|NCT01090323|79356138|FG001|Overall Study|Abnormal Test Procedure Results|0|||
44351705|NCT01090323|79356137|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
44351706|NCT01090323|79356138|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
44351707|NCT01090323|79356137|FG000|Overall Study|Condition no longer requires drug|5|||
44351708|NCT01090323|79356138|FG001|Overall Study|Condition no longer requires drug|4|||
44351709|NCT01090323|79356137|FG000|Overall Study|Protocol Violation|2|||
44351710|NCT01090323|79356138|FG001|Overall Study|Protocol Violation|1|||
44351711|NCT01090323|79356137|FG000|Overall Study|Withdrew consent|33|||
44351712|NCT01090323|79356138|FG001|Overall Study|Withdrew consent|11|||
44351713|NCT01090323|79356137|FG000|Overall Study|Lost to Follow-up|11|||
44351714|NCT01090323|79356138|FG001|Overall Study|Lost to Follow-up|6|||
44351715|NCT01090323|79356137|FG000|Overall Study|Administrative problems|6|||
44351716|NCT01090323|79356138|FG001|Overall Study|Administrative problems|4|||
44351717|NCT01090323|79356137|FG000|Overall Study|Death|1|||
44351718|NCT01090323|79356138|FG001|Overall Study|Death|2|||
44351719|NCT01090323|79356137|FG000|Overall Study|Stopped end of core|7|||
44351720|NCT01090323|79356138|FG001|Overall Study|Stopped end of core|0|||
44351721|NCT01090323|79356137|FG000|Overall Study|Stopped end of extension 1#|3|||
44351722|NCT01090323|79356138|FG001|Overall Study|Stopped end of extension 1#|1|||
44351723|NCT01078155|79356144|FG000|Overall Study|Adverse Event|7|||
44351724|NCT01078155|79356144|FG000|Overall Study|Lack of Efficacy|16|||
44351725|NCT01078155|79356144|FG000|Overall Study|Participant's Decision|6|||
44351726|NCT01078155|79356144|FG000|Overall Study|Lost to Follow-up|15|||
44351727|NCT01201356|79356148|FG000|Overall Study|Adverse Event|170|||
44351728|NCT01201356|79356148|FG000|Overall Study|Abnormal laboratory value(s)|51|||
44351729|NCT01201356|79356148|FG000|Overall Study|Abnormal test procedure result(s)|3|||
44351730|NCT01201356|79356148|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
44351731|NCT01201356|79356148|FG000|Overall Study|Condition no longer requires study drug|12|||
44351732|NCT01201356|79356148|FG000|Overall Study|Withdrawal by Subject|144|||
44351733|NCT01201356|79356148|FG000|Overall Study|Lost to Follow-up|50|||
44351734|NCT01201356|79356148|FG000|Overall Study|administrative problems|74|||
44351735|NCT01201356|79356148|FG000|Overall Study|Death|16|||
44351736|NCT01201356|79356148|FG000|Overall Study|Protocol Violation|12|||
44351737|NCT01200810|79356154|FG000|Overall Study|Physician Decision|1|||
44447813|NCT03235544|79456235|FG003|Overall Study|Lost to Follow-up|1|||
44447814|NCT03235544|79456232|FG000|Overall Study|Withdrawal by Participant|0|||
44447815|NCT03235544|79456233|FG001|Overall Study|Withdrawal by Participant|0|||
44447816|NCT03235544|79456234|FG002|Overall Study|Withdrawal by Participant|1|||
44447817|NCT03235544|79456235|FG003|Overall Study|Withdrawal by Participant|0|||
44447818|NCT03235544|79456232|FG000|Overall Study|Reason not Specified|0|||
44447819|NCT03235544|79456233|FG001|Overall Study|Reason not Specified|4|||
44447820|NCT03235544|79456234|FG002|Overall Study|Reason not Specified|0|||
44447821|NCT03235544|79456235|FG003|Overall Study|Reason not Specified|1|||
44447822|NCT03187353|79456248|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
44447823|NCT03187353|79456249|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
44447824|NCT03187353|79456248|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
44447825|NCT03187353|79456249|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
44447826|NCT03187353|79456248|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
44447827|NCT03187353|79456249|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
44447828|NCT03187353|79456248|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
44447829|NCT03187353|79456249|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
44447830|NCT03187353|79456248|FG000|Washout (2 Weeks)|Adverse Event|2|||
44447831|NCT03187353|79456249|FG001|Washout (2 Weeks)|Adverse Event|0|||
44447832|NCT03187353|79456248|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
44351738|NCT01200810|79356155|FG001|Overall Study|Physician Decision|0|||
44351739|NCT01200810|79356154|FG000|Overall Study|Withdrawal by Subject|1|||
44351740|NCT01200810|79356155|FG001|Overall Study|Withdrawal by Subject|2|||
44351741|NCT01200810|79356154|FG000|Overall Study|Sponsor stopped making study drug|3|||
44351742|NCT01200810|79356155|FG001|Overall Study|Sponsor stopped making study drug|3|||
44351743|NCT01200342|79356161|FG000|Overall Study|Disease Progression|1|||
44351744|NCT01199016|79356165|FG000|Overall Study|No longer meets eligibility criteria|4|||
44351745|NCT01199016|79356165|FG000|Overall Study|Entrance criteria|5|||
44351746|NCT01199016|79356165|FG000|Overall Study|Protocol Violation|9|||
44447833|NCT03187353|79456249|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
44447834|NCT03056001|79456285|FG000|Overall Study|Death|24|||
44351747|NCT01199016|79356165|FG000|Overall Study|Other|13|||
44351748|NCT01199016|79356165|FG000|Overall Study|Withdrawal by Subject|21|||
44447835|NCT02998918|79456295|FG000|Overall Study|Withdrawal by Subject|1|||
44447836|NCT02998918|79456296|FG001|Overall Study|Withdrawal by Subject|0|||
44351749|NCT01199016|79356165|FG000|Overall Study|Lost to Follow-up|25|||
44351750|NCT01198548|79356169|FG000|Overall Study|Disease Progression|9|||
44351751|NCT01198548|79356169|FG000|Overall Study|Administrative Decision|1|||
44351752|NCT01198470|79356173|FG000|Overall Study|Adverse Event|2|||
44351753|NCT00977938|79356181|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
44351754|NCT00977938|79356182|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
44351755|NCT00977938|79356183|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
44351756|NCT00977938|79356184|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
44351757|NCT00977938|79356181|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
44351758|NCT00977938|79356182|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
44351759|NCT00977938|79356183|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
44351760|NCT00977938|79356184|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
44351761|NCT00977938|79356181|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
44260945|NCT02913261|79136328|FG000|Overall Study|Disease relapse|8|||
44260946|NCT02913261|79136329|FG001|Overall Study|Disease relapse|13|||
44260947|NCT02913261|79136328|FG000|Overall Study|Physician Decision|8|||
44260948|NCT02913261|79136329|FG001|Overall Study|Physician Decision|9|||
44260949|NCT02913261|79136328|FG000|Overall Study|Subject/guardian decision|4|||
44260950|NCT02913261|79136329|FG001|Overall Study|Subject/guardian decision|6|||
44260951|NCT02913261|79136328|FG000|Overall Study|Graft loss|2|||
44260952|NCT02913261|79136329|FG001|Overall Study|Graft loss|0|||
44260953|NCT00635882|79136393|FG000|Overall Study|Protocol Violation|1|||
44260954|NCT00635882|79136394|FG001|Overall Study|Protocol Violation|0|||
44166687|NCT02286843|78959756|FG000|Overall Study|Withdrawal by Subject|1|||
44166688|NCT02282163|78959760|FG000|Overall Study|Protocol Violation|1|||
44351762|NCT00977938|79356182|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
44351763|NCT00977938|79356183|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
44351764|NCT00977938|79356184|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
44447837|NCT02990338|79456304|FG000|Overall Study|Ongoing|30|||
44351765|NCT00977938|79356181|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
44351766|NCT00977938|79356182|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
44351767|NCT00977938|79356183|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
44351768|NCT00977938|79356184|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
44447838|NCT02990338|79456305|FG001|Overall Study|Ongoing|36|||
44351769|NCT00977938|79356181|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
44351770|NCT00977938|79356182|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
44351771|NCT00977938|79356183|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
44351772|NCT00977938|79356184|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
44351773|NCT00977938|79356181|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
44260955|NCT00635882|79136395|FG002|Overall Study|Protocol Violation|0|||
44260956|NCT00635882|79136396|FG003|Overall Study|Protocol Violation|0|||
44260957|NCT00635882|79136397|FG004|Overall Study|Protocol Violation|0|||
44260958|NCT00635882|79136398|FG005|Overall Study|Protocol Violation|0|||
44260959|NCT00986570|79136649|FG000|Overall Study|Lost to Follow-up|6|||
44260960|NCT00986570|79136649|FG000|Overall Study|Potential bias for objective assessment|1|||
44260961|NCT00986258|79136653|FG000|Observation Period|Not eligible to be dosed|11|||
44260962|NCT00986258|79136653|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
44351774|NCT00977938|79356182|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
44351775|NCT00977938|79356183|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
44351776|NCT00977938|79356184|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
44351777|NCT02716675|79356199|FG000|Overall Study|Death|2|||
44351778|NCT02716675|79356200|FG001|Overall Study|Death|3|||
44351779|NCT02716675|79356201|FG002|Overall Study|Death|0|||
44351780|NCT02716675|79356199|FG000|Overall Study|Physician Decision|2|||
44351781|NCT02716675|79356200|FG001|Overall Study|Physician Decision|1|||
44351782|NCT02716675|79356201|FG002|Overall Study|Physician Decision|1|||
44351783|NCT02716675|79356199|FG000|Overall Study|Lost to Follow-up|100|||
44351784|NCT02716675|79356200|FG001|Overall Study|Lost to Follow-up|87|||
44351785|NCT02716675|79356201|FG002|Overall Study|Lost to Follow-up|99|||
44351786|NCT02716675|79356199|FG000|Overall Study|Withdrawal by Subject|22|||
44351787|NCT02716675|79356200|FG001|Overall Study|Withdrawal by Subject|25|||
44351788|NCT02716675|79356201|FG002|Overall Study|Withdrawal by Subject|20|||
44351789|NCT02716675|79356199|FG000|Overall Study|Protocol Violation|0|||
44351790|NCT02716675|79356200|FG001|Overall Study|Protocol Violation|3|||
44351791|NCT02716675|79356201|FG002|Overall Study|Protocol Violation|1|||
44351792|NCT02716675|79356199|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
44351793|NCT02716675|79356200|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
44351794|NCT02716675|79356201|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
44351795|NCT02716675|79356199|FG000|Overall Study|Other|38|||
44351796|NCT02716675|79356200|FG001|Overall Study|Other|47|||
44351797|NCT02716675|79356201|FG002|Overall Study|Other|48|||
44351798|NCT00977548|79356214|FG000|Overall Study|Ineligible|4|||
44351799|NCT00977548|79356214|FG000|Overall Study|Adverse Event|8|||
44351800|NCT00977548|79356214|FG000|Overall Study|Withdrawal by Subject|1|||
44351801|NCT01090011|79356218|FG000|Overall Study|Progressive disease|128|||
44351802|NCT01090011|79356218|FG000|Overall Study|Adverse Event|32|||
44351803|NCT01090011|79356218|FG000|Overall Study|Protocol Violation|1|||
44351804|NCT01090011|79356218|FG000|Overall Study|Refusal to start/continue medication|5|||
44351805|NCT01090011|79356218|FG000|Overall Study|Other reason not defined above|5|||
44351806|NCT01251653|79356239|FG000|Overall Study|Progressive Disease|1|||
44351807|NCT01251653|79356240|FG001|Overall Study|Progressive Disease|7|||
44351808|NCT01251653|79356241|FG002|Overall Study|Progressive Disease|16|||
44351809|NCT01251653|79356242|FG003|Overall Study|Progressive Disease|4|||
44351810|NCT01251653|79356243|FG004|Overall Study|Progressive Disease|0|||
44351811|NCT01251653|79356244|FG005|Overall Study|Progressive Disease|17|||
44351812|NCT01251653|79356245|FG006|Overall Study|Progressive Disease|14|||
44351813|NCT01251653|79356246|FG007|Overall Study|Progressive Disease|7|||
44351814|NCT01251653|79356247|FG008|Overall Study|Progressive Disease|5|||
44351815|NCT01251653|79356239|FG000|Overall Study|Dose-limiting toxicity|0|||
44351816|NCT01251653|79356240|FG001|Overall Study|Dose-limiting toxicity|1|||
44351817|NCT01251653|79356241|FG002|Overall Study|Dose-limiting toxicity|1|||
44351818|NCT01251653|79356242|FG003|Overall Study|Dose-limiting toxicity|1|||
44351819|NCT01251653|79356243|FG004|Overall Study|Dose-limiting toxicity|0|||
44351820|NCT01251653|79356244|FG005|Overall Study|Dose-limiting toxicity|0|||
44351821|NCT01251653|79356245|FG006|Overall Study|Dose-limiting toxicity|2|||
44351822|NCT01251653|79356246|FG007|Overall Study|Dose-limiting toxicity|0|||
44351823|NCT01251653|79356247|FG008|Overall Study|Dose-limiting toxicity|0|||
44351824|NCT01251653|79356239|FG000|Overall Study|Adverse Event|1|||
44351825|NCT01251653|79356240|FG001|Overall Study|Adverse Event|0|||
44351826|NCT01251653|79356241|FG002|Overall Study|Adverse Event|2|||
44351827|NCT01251653|79356242|FG003|Overall Study|Adverse Event|1|||
44351828|NCT01251653|79356243|FG004|Overall Study|Adverse Event|1|||
44351829|NCT01251653|79356244|FG005|Overall Study|Adverse Event|0|||
44351830|NCT01251653|79356245|FG006|Overall Study|Adverse Event|2|||
44351831|NCT01251653|79356246|FG007|Overall Study|Adverse Event|2|||
44351832|NCT01251653|79356247|FG008|Overall Study|Adverse Event|1|||
44351833|NCT01251653|79356239|FG000|Overall Study|Withdrawal by Subject|1|||
44351834|NCT01251653|79356240|FG001|Overall Study|Withdrawal by Subject|0|||
44351835|NCT01251653|79356241|FG002|Overall Study|Withdrawal by Subject|1|||
44351836|NCT01251653|79356242|FG003|Overall Study|Withdrawal by Subject|0|||
44351837|NCT01251653|79356243|FG004|Overall Study|Withdrawal by Subject|1|||
44351838|NCT01251653|79356244|FG005|Overall Study|Withdrawal by Subject|1|||
44351839|NCT01251653|79356245|FG006|Overall Study|Withdrawal by Subject|0|||
44351840|NCT01251653|79356246|FG007|Overall Study|Withdrawal by Subject|1|||
44351841|NCT01251653|79356247|FG008|Overall Study|Withdrawal by Subject|0|||
44351842|NCT01251653|79356239|FG000|Overall Study|Other reason not mentioned above|0|||
44351843|NCT01251653|79356240|FG001|Overall Study|Other reason not mentioned above|0|||
44351844|NCT01251653|79356241|FG002|Overall Study|Other reason not mentioned above|0|||
44351845|NCT01251653|79356242|FG003|Overall Study|Other reason not mentioned above|0|||
44351846|NCT01251653|79356243|FG004|Overall Study|Other reason not mentioned above|0|||
44351847|NCT01251653|79356244|FG005|Overall Study|Other reason not mentioned above|0|||
44351848|NCT01251653|79356245|FG006|Overall Study|Other reason not mentioned above|0|||
44351849|NCT01251653|79356246|FG007|Overall Study|Other reason not mentioned above|2|||
44351850|NCT01251653|79356247|FG008|Overall Study|Other reason not mentioned above|0|||
44351851|NCT00910663|79356285|FG000|Period 1|Withdrawal by Subject|0|||
44351852|NCT00910663|79356286|FG001|Period 1|Withdrawal by Subject|1|||
44351853|NCT01077375|79356294|FG000|Overall Study|Adverse Event|2|||
44351854|NCT01077375|79356295|FG001|Overall Study|Adverse Event|15|||
44351855|NCT01077375|79356294|FG000|Overall Study|Lack of Efficacy|6|||
44351856|NCT01077375|79356295|FG001|Overall Study|Lack of Efficacy|8|||
44351857|NCT01077375|79356294|FG000|Overall Study|Withdrawal by Subject|0|||
44351858|NCT01077375|79356295|FG001|Overall Study|Withdrawal by Subject|6|||
44351859|NCT01077375|79356294|FG000|Overall Study|Lost to Follow-up|2|||
44351860|NCT01077375|79356295|FG001|Overall Study|Lost to Follow-up|5|||
44351861|NCT01077375|79356294|FG000|Overall Study|Other Reason|0|||
44351862|NCT01077375|79356295|FG001|Overall Study|Other Reason|1|||
44351863|NCT01250873|79356303|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
44351864|NCT01250873|79356303|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
44351865|NCT01250171|79356312|FG000|Overall Study|Administrative reasons|1|||
44351866|NCT01250171|79356313|FG001|Overall Study|Administrative reasons|0|||
44351867|NCT01250171|79356314|FG002|Overall Study|Administrative reasons|0|||
44351868|NCT01077063|79356324|FG000|Overall Study|Adverse Event|3|||
44351869|NCT01077063|79356325|FG001|Overall Study|Adverse Event|0|||
44351870|NCT01077063|79356324|FG000|Overall Study|Death|1|||
44351871|NCT01077063|79356325|FG001|Overall Study|Death|1|||
44351872|NCT01077063|79356324|FG000|Overall Study|Withdrawal by Subject|0|||
44351873|NCT01077063|79356325|FG001|Overall Study|Withdrawal by Subject|2|||
44351874|NCT01248065|79356333|FG000|Overall Study|Lost to Follow-up|3|||
44351875|NCT01248065|79356334|FG001|Overall Study|Lost to Follow-up|5|||
44351876|NCT01248065|79356333|FG000|Overall Study|Withdrawal by Subject|14|||
44351877|NCT01248065|79356334|FG001|Overall Study|Withdrawal by Subject|11|||
44351878|NCT01248065|79356333|FG000|Overall Study|Adverse Event|3|||
44351879|NCT01248065|79356334|FG001|Overall Study|Adverse Event|0|||
44351880|NCT01248065|79356333|FG000|Overall Study|Third treatment failure event|3|||
44351881|NCT01248065|79356334|FG001|Overall Study|Third treatment failure event|1|||
44351882|NCT01248065|79356333|FG000|Overall Study|Other|3|||
44351883|NCT01248065|79356334|FG001|Overall Study|Other|5|||
44351884|NCT01250756|79356342|FG000|Infant Series|Withdrawal by Subject|4|||
44351885|NCT01250756|79356343|FG001|Infant Series|Withdrawal by Subject|5|||
44351886|NCT01250756|79356342|FG000|Infant Series|Randomized, Not Vaccinated|2|||
44351887|NCT01250756|79356343|FG001|Infant Series|Randomized, Not Vaccinated|2|||
44351888|NCT01250756|79356342|FG000|Infant Series|Other|22|||
44351889|NCT01250756|79356343|FG001|Infant Series|Other|0|||
44351890|NCT01250756|79356342|FG000|After Infant Series|Adverse Event|5|||
44351891|NCT01250756|79356343|FG001|After Infant Series|Adverse Event|2|||
44351892|NCT01250756|79356342|FG000|After Infant Series|Withdrawal by Subject|4|||
44351893|NCT01250756|79356343|FG001|After Infant Series|Withdrawal by Subject|1|||
44351894|NCT01250756|79356342|FG000|After Infant Series|Other|2|||
44351895|NCT01250756|79356343|FG001|After Infant Series|Other|1|||
44351896|NCT01250756|79356342|FG000|Toddler Dose|Adverse Event|0|||
44351897|NCT01250756|79356343|FG001|Toddler Dose|Adverse Event|1|||
44351898|NCT01250756|79356342|FG000|After Toddler Dose|Adverse Event|0|||
44351899|NCT01250756|79356343|FG001|After Toddler Dose|Adverse Event|1|||
44351900|NCT01250054|79356355|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
44351901|NCT01250054|79356356|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
44351902|NCT00977470|79356364|FG000|Overall Study|Lack of Efficacy|32|||
44351903|NCT00977470|79356365|FG001|Overall Study|Lack of Efficacy|30|||
44351904|NCT00977470|79356364|FG000|Overall Study|Physician Decision|2|||
44351905|NCT00977470|79356365|FG001|Overall Study|Physician Decision|0|||
44351906|NCT00977470|79356364|FG000|Overall Study|Adverse Event|1|||
44351907|NCT00977470|79356365|FG001|Overall Study|Adverse Event|2|||
44351908|NCT00977470|79356364|FG000|Overall Study|Protocol Violation|1|||
44351909|NCT00977470|79356365|FG001|Overall Study|Protocol Violation|0|||
44351910|NCT00977470|79356364|FG000|Overall Study|Withdrawal by Subject|0|||
44351911|NCT00977470|79356365|FG001|Overall Study|Withdrawal by Subject|2|||
44351912|NCT00977470|79356364|FG000|Overall Study|Death|0|||
44351913|NCT00977470|79356365|FG001|Overall Study|Death|2|||
44351914|NCT00977470|79356364|FG000|Overall Study|clinical decline|0|||
44351915|NCT00977470|79356365|FG001|Overall Study|clinical decline|1|||
44351916|NCT00977470|79356364|FG000|Overall Study|prolonged recovery post-surgery|0|||
44351917|NCT00977470|79356365|FG001|Overall Study|prolonged recovery post-surgery|1|||
44351918|NCT00977470|79356364|FG000|Overall Study|Still on-study|2|||
44351919|NCT00977470|79356365|FG001|Overall Study|Still on-study|0|||
44351920|NCT01245374|79356371|FG000|Overall Study|Protocol Violation|1|||
44351921|NCT01245374|79356371|FG000|Overall Study|Withdrawal by Subject|3|||
44351922|NCT00977314|79356378|FG000|Overall Study|Withdrawal by Subject|1|||
44351923|NCT00977314|79356379|FG001|Overall Study|Withdrawal by Subject|0|||
44351924|NCT00977314|79356378|FG000|Overall Study|Physician Decision|1|||
44351925|NCT00977314|79356379|FG001|Overall Study|Physician Decision|0|||
44351926|NCT01087203|79356387|FG000|Overall Study|Lost to Follow-up|2|||
44351927|NCT01087203|79356388|FG001|Overall Study|Lost to Follow-up|0|||
44351928|NCT01087203|79356387|FG000|Overall Study|Withdrawal by Subject|2|||
44351929|NCT01087203|79356388|FG001|Overall Study|Withdrawal by Subject|6|||
44351930|NCT01087203|79356387|FG000|Overall Study|Lack of Efficacy|1|||
44351931|NCT01087203|79356388|FG001|Overall Study|Lack of Efficacy|2|||
44351932|NCT01087203|79356387|FG000|Overall Study|Study terminated by sponsor|27|||
44351933|NCT01087203|79356388|FG001|Overall Study|Study terminated by sponsor|27|||
44351934|NCT01246583|79356399|FG000|Overall Study|Lost to Follow-up|0|||
44351935|NCT01246583|79356400|FG001|Overall Study|Lost to Follow-up|0|||
44351936|NCT01246583|79356401|FG002|Overall Study|Lost to Follow-up|0|||
44351937|NCT01246583|79356402|FG003|Overall Study|Lost to Follow-up|1|||
44351938|NCT01246583|79356399|FG000|Overall Study|Protocol Violation|0|||
44351939|NCT01246583|79356400|FG001|Overall Study|Protocol Violation|0|||
44351940|NCT01246583|79356401|FG002|Overall Study|Protocol Violation|1|||
44351941|NCT01246583|79356402|FG003|Overall Study|Protocol Violation|0|||
44351942|NCT01246583|79356399|FG000|Overall Study|Withdrawal by Subject|1|||
44351943|NCT01246583|79356400|FG001|Overall Study|Withdrawal by Subject|0|||
44351944|NCT01246583|79356401|FG002|Overall Study|Withdrawal by Subject|0|||
44351945|NCT01246583|79356402|FG003|Overall Study|Withdrawal by Subject|0|||
44351946|NCT01084239|79356415|FG000|28-Day Follow-up|Lost to Follow-up|4|||
44351947|NCT01084239|79356416|FG001|28-Day Follow-up|Lost to Follow-up|9|||
44351948|NCT01244906|79356424|FG000|Overall Study|Death|2|||
44351949|NCT01244906|79356424|FG000|Overall Study|Progression of disease post treatment|6|||
44351950|NCT01080807|79356430|FG000|Overall Study|Adverse Event|9|||
44351951|NCT01080807|79356431|FG001|Overall Study|Adverse Event|1|||
44351952|NCT01080807|79356430|FG000|Overall Study|Lack of Efficacy|0|||
44351953|NCT01080807|79356431|FG001|Overall Study|Lack of Efficacy|1|||
44351954|NCT01080807|79356430|FG000|Overall Study|Withdrawal by Subject|7|||
44351955|NCT01080807|79356431|FG001|Overall Study|Withdrawal by Subject|2|||
44351956|NCT01080807|79356430|FG000|Overall Study|Protocol Violation|7|||
44351957|NCT01080807|79356431|FG001|Overall Study|Protocol Violation|6|||
44351958|NCT01080807|79356430|FG000|Overall Study|Lost to Follow-up|6|||
44351959|NCT01080807|79356431|FG001|Overall Study|Lost to Follow-up|4|||
44351960|NCT01080807|79356430|FG000|Overall Study|Noncompliance with drug administration|1|||
44351961|NCT01080807|79356431|FG001|Overall Study|Noncompliance with drug administration|1|||
44351962|NCT01080807|79356430|FG000|Overall Study|Noncompliance to study procedures|1|||
44351963|NCT01080807|79356431|FG001|Overall Study|Noncompliance to study procedures|1|||
44351964|NCT01080807|79356430|FG000|Overall Study|Began working day shift|0|||
44351965|NCT01080807|79356431|FG001|Overall Study|Began working day shift|2|||
44351966|NCT01080807|79356430|FG000|Overall Study|Laid off or terminated from job|1|||
44351967|NCT01080807|79356431|FG001|Overall Study|Laid off or terminated from job|2|||
44351968|NCT01080807|79356430|FG000|Overall Study|Stopped working consistent night shifts|0|||
44351969|NCT01080807|79356431|FG001|Overall Study|Stopped working consistent night shifts|1|||
44351970|NCT01080807|79356430|FG000|Overall Study|Work schedule changing|1|||
44351971|NCT01080807|79356431|FG001|Overall Study|Work schedule changing|1|||
44351972|NCT01080807|79356430|FG000|Overall Study|Work schedule and travel|0|||
44351973|NCT01080807|79356431|FG001|Overall Study|Work schedule and travel|1|||
44351974|NCT01080807|79356430|FG000|Overall Study|Switched to first shift|1|||
44351975|NCT01080807|79356431|FG001|Overall Study|Switched to first shift|0|||
44351976|NCT01080807|79356430|FG000|Overall Study|Moved away without notifying center|1|||
44351977|NCT01080807|79356431|FG001|Overall Study|Moved away without notifying center|0|||
44351978|NCT01076361|79356437|FG000|Overall Study|22 leads were excluded from analysis|21|||
44351979|NCT01079949|79356443|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
44351980|NCT01079949|79356444|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
44351981|NCT01079949|79356443|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
44351982|NCT01079949|79356444|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
44351983|NCT01079949|79356443|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
44351984|NCT01079949|79356444|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
44351985|NCT01079949|79356443|FG000|Overall Study|Randomized but not treated|1|||
44351986|NCT01079949|79356444|FG001|Overall Study|Randomized but not treated|0|||
44351987|NCT00909727|79356452|FG000|Overall Study|Adverse Event|1|||
44351988|NCT00909727|79356453|FG001|Overall Study|Adverse Event|0|||
44351989|NCT00909727|79356452|FG000|Overall Study|Wrong Genotype|1|||
44351990|NCT00909727|79356453|FG001|Overall Study|Wrong Genotype|0|||
44351991|NCT00909727|79356452|FG000|Overall Study|Withdrawal of Consent|1|||
44351992|NCT00909727|79356453|FG001|Overall Study|Withdrawal of Consent|0|||
44351993|NCT00909727|79356452|FG000|Overall Study|Prohibited Medication|1|||
44351994|NCT00909727|79356453|FG001|Overall Study|Prohibited Medication|0|||
44351995|NCT00977080|79356463|FG000|Overall Study|Adverse Event|2|||
44351996|NCT00977080|79356464|FG001|Overall Study|Adverse Event|7|||
44351997|NCT00977080|79356465|FG002|Overall Study|Adverse Event|7|||
44351998|NCT00977080|79356466|FG003|Overall Study|Adverse Event|7|||
44351999|NCT00977080|79356463|FG000|Overall Study|Withdrawal by Subject|1|||
44352000|NCT00977080|79356464|FG001|Overall Study|Withdrawal by Subject|5|||
44352001|NCT00977080|79356465|FG002|Overall Study|Withdrawal by Subject|1|||
44352002|NCT00977080|79356466|FG003|Overall Study|Withdrawal by Subject|5|||
44352003|NCT00977080|79356463|FG000|Overall Study|Protocol Violation|7|||
44352004|NCT00977080|79356464|FG001|Overall Study|Protocol Violation|3|||
44352005|NCT00977080|79356465|FG002|Overall Study|Protocol Violation|4|||
44352006|NCT00977080|79356466|FG003|Overall Study|Protocol Violation|3|||
44352007|NCT00977080|79356463|FG000|Overall Study|Noncompliance|0|||
44352008|NCT00977080|79356464|FG001|Overall Study|Noncompliance|2|||
44352009|NCT00977080|79356465|FG002|Overall Study|Noncompliance|1|||
44352010|NCT00977080|79356466|FG003|Overall Study|Noncompliance|0|||
44352011|NCT00977080|79356463|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
44352012|NCT00977080|79356464|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
44352013|NCT00977080|79356465|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
44352014|NCT00977080|79356466|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
44352015|NCT00977080|79356463|FG000|Overall Study|Required kidney transplantation|1|||
44352016|NCT00977080|79356464|FG001|Overall Study|Required kidney transplantation|3|||
44352017|NCT00977080|79356465|FG002|Overall Study|Required kidney transplantation|3|||
44352018|NCT00977080|79356466|FG003|Overall Study|Required kidney transplantation|1|||
44352019|NCT00977080|79356463|FG000|Overall Study|Travel for family reasons|1|||
44352020|NCT00977080|79356464|FG001|Overall Study|Travel for family reasons|0|||
44352021|NCT00977080|79356465|FG002|Overall Study|Travel for family reasons|0|||
44352022|NCT00977080|79356466|FG003|Overall Study|Travel for family reasons|0|||
44352023|NCT00975676|79356478|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
44352024|NCT00975676|79356479|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
44352025|NCT00975286|79356492|FG000|Overall Study|Adverse Event|9|||
44352026|NCT00975286|79356493|FG001|Overall Study|Adverse Event|19|||
44352027|NCT00975286|79356492|FG000|Overall Study|Protocol Violation|1|||
44352028|NCT00975286|79356493|FG001|Overall Study|Protocol Violation|2|||
44352029|NCT00975286|79356492|FG000|Overall Study|Withdrawal by Subject|0|||
44352030|NCT00975286|79356493|FG001|Overall Study|Withdrawal by Subject|2|||
44352031|NCT00975286|79356492|FG000|Overall Study|Familial and Personal Reasons|2|||
44352032|NCT00975286|79356493|FG001|Overall Study|Familial and Personal Reasons|2|||
44352033|NCT00975286|79356492|FG000|Overall Study|Poor Compliance to Protocol|0|||
44352034|NCT00975286|79356493|FG001|Overall Study|Poor Compliance to Protocol|2|||
44352035|NCT00975286|79356492|FG000|Overall Study|Sponsor Decision|0|||
44352036|NCT00975286|79356493|FG001|Overall Study|Sponsor Decision|2|||
44352037|NCT00907777|79356501|FG000|Overall Study|Withdrawal by Subject|0|||
44352038|NCT00907777|79356502|FG001|Overall Study|Withdrawal by Subject|1|||
44352039|NCT00908011|79356510|FG000|Overall Study|Withdrawal by Subject|2|||
44352040|NCT00908011|79356511|FG001|Overall Study|Withdrawal by Subject|2|||
44352041|NCT00976456|79356519|FG000|Overall Study|Adverse Event|17|||
44352042|NCT00976456|79356520|FG001|Overall Study|Adverse Event|22|||
44352043|NCT00976456|79356519|FG000|Overall Study|Death|7|||
44352044|NCT00976456|79356520|FG001|Overall Study|Death|9|||
44352045|NCT00976456|79356519|FG000|Overall Study|Lack of Efficacy|5|||
44352046|NCT00976456|79356520|FG001|Overall Study|Lack of Efficacy|2|||
44352047|NCT00976456|79356519|FG000|Overall Study|Withdrawal by Subject|3|||
44352048|NCT00976456|79356520|FG001|Overall Study|Withdrawal by Subject|1|||
44352049|NCT00976456|79356519|FG000|Overall Study|screening failure, unknown|11|||
44352050|NCT00976456|79356520|FG001|Overall Study|screening failure, unknown|4|||
44352051|NCT01243151|79356531|FG000|Overall Study|Adverse Event|0|||
44352052|NCT01243151|79356532|FG001|Overall Study|Adverse Event|1|||
44352053|NCT01243151|79356533|FG002|Overall Study|Adverse Event|0|||
44352054|NCT01243151|79356534|FG003|Overall Study|Adverse Event|0|||
44352055|NCT01243151|79356535|FG004|Overall Study|Adverse Event|0|||
44352056|NCT01243151|79356531|FG000|Overall Study|Protocol Violation|0|||
44352057|NCT01243151|79356532|FG001|Overall Study|Protocol Violation|0|||
44352058|NCT01243151|79356533|FG002|Overall Study|Protocol Violation|1|||
44352059|NCT01243151|79356534|FG003|Overall Study|Protocol Violation|0|||
44352060|NCT01243151|79356535|FG004|Overall Study|Protocol Violation|0|||
44352061|NCT01243151|79356531|FG000|Overall Study|Other|0|||
44352062|NCT01243151|79356532|FG001|Overall Study|Other|0|||
44352063|NCT01243151|79356533|FG002|Overall Study|Other|0|||
44352064|NCT01243151|79356534|FG003|Overall Study|Other|1|||
44352065|NCT01243151|79356535|FG004|Overall Study|Other|0|||
44352066|NCT01243151|79356531|FG000|Overall Study|Randomized but not treated|0|||
44352067|NCT01243151|79356532|FG001|Overall Study|Randomized but not treated|0|||
44352068|NCT01243151|79356533|FG002|Overall Study|Randomized but not treated|0|||
44352069|NCT01243151|79356534|FG003|Overall Study|Randomized but not treated|1|||
44352070|NCT01243151|79356535|FG004|Overall Study|Randomized but not treated|0|||
44352071|NCT00993148|79356559|FG000|Overall Study|Lost to Follow-up|2|||
44352072|NCT00993148|79356559|FG000|Overall Study|never initiated treatment|1|||
44352073|NCT00907621|79356565|FG000|Overall Study|Lost to Follow-up|6|||
44352074|NCT00907621|79356566|FG001|Overall Study|Lost to Follow-up|3|||
44352075|NCT00907621|79356565|FG000|Overall Study|intercurrent febrile illness|1|||
44352076|NCT00907621|79356566|FG001|Overall Study|intercurrent febrile illness|1|||
44352077|NCT03517111|79356586|FG000|Enrolled|Withdrawal by Subject|0|||
44352078|NCT03517111|79356587|FG001|Enrolled|Withdrawal by Subject|1|||
44352079|NCT03517111|79356588|FG002|Enrolled|Withdrawal by Subject|0|||
44352080|NCT03517111|79356586|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
44166689|NCT02281773|78959778|FG000|Overall Study|Adverse Event|6|||
44352081|NCT03517111|79356587|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
44447839|NCT02742246|79456326|FG000|Overall Study|Never initiated treatment|5|||
44166690|NCT02281773|78959779|FG001|Overall Study|Adverse Event|1|||
44166691|NCT02281773|78959780|FG002|Overall Study|Adverse Event|4|||
44166692|NCT02281773|78959781|FG003|Overall Study|Adverse Event|8|||
44166693|NCT02281773|78959782|FG004|Overall Study|Adverse Event|9|||
44166694|NCT02281773|78959778|FG000|Overall Study|Protocol Violation|1|||
44166695|NCT02281773|78959779|FG001|Overall Study|Protocol Violation|0|||
44166696|NCT02281773|78959780|FG002|Overall Study|Protocol Violation|0|||
44166697|NCT02281773|78959781|FG003|Overall Study|Protocol Violation|2|||
44166698|NCT02281773|78959782|FG004|Overall Study|Protocol Violation|2|||
44166699|NCT02281773|78959778|FG000|Overall Study|Lost to Follow-up|2|||
44166700|NCT02281773|78959779|FG001|Overall Study|Lost to Follow-up|2|||
44166701|NCT02281773|78959780|FG002|Overall Study|Lost to Follow-up|6|||
44166702|NCT02281773|78959781|FG003|Overall Study|Lost to Follow-up|2|||
44166703|NCT02281773|78959782|FG004|Overall Study|Lost to Follow-up|10|||
44166704|NCT02281773|78959778|FG000|Overall Study|Withdrawal by Subject|2|||
44166705|NCT02281773|78959779|FG001|Overall Study|Withdrawal by Subject|8|||
44166706|NCT02281773|78959780|FG002|Overall Study|Withdrawal by Subject|6|||
44166707|NCT02281773|78959781|FG003|Overall Study|Withdrawal by Subject|6|||
44166708|NCT02281773|78959782|FG004|Overall Study|Withdrawal by Subject|8|||
44166709|NCT02281773|78959778|FG000|Overall Study|Other Reason|0|||
44166710|NCT02281773|78959779|FG001|Overall Study|Other Reason|4|||
44166711|NCT02281773|78959780|FG002|Overall Study|Other Reason|2|||
44166712|NCT02281773|78959781|FG003|Overall Study|Other Reason|3|||
44166713|NCT02281773|78959782|FG004|Overall Study|Other Reason|1|||
44166714|NCT02285361|78959794|FG000|Overall Study|Protocol Violation|43|||
44166715|NCT02285361|78959794|FG000|Overall Study|Lost to Follow-up|5|||
44166716|NCT02285361|78959794|FG000|Overall Study|Not taken GIOTRIF|2|||
44166717|NCT02285361|78959794|FG000|Overall Study|Consented prior to the contract date|1|||
44166718|NCT02354235|78959800|FG000|Overall Study|Adverse Event|2|||
44166719|NCT02354235|78959801|FG001|Overall Study|Adverse Event|2|||
44166720|NCT02354235|78959800|FG000|Overall Study|Physician Decision|0|||
44166721|NCT02354235|78959801|FG001|Overall Study|Physician Decision|1|||
44166722|NCT02354235|78959800|FG000|Overall Study|Withdrawal by Subject|1|||
44166723|NCT02354235|78959801|FG001|Overall Study|Withdrawal by Subject|3|||
44166724|NCT02354235|78959800|FG000|Overall Study|Conflict with the stopping criteria|0|||
44166725|NCT02354235|78959801|FG001|Overall Study|Conflict with the stopping criteria|1|||
44166726|NCT02280291|78959811|FG000|Overall Study|Lost to Follow-up|2|||
44166727|NCT02280291|78959812|FG001|Overall Study|Lost to Follow-up|1|||
44166728|NCT02280291|78959813|FG002|Overall Study|Lost to Follow-up|3|||
44166729|NCT02280291|78959814|FG003|Overall Study|Lost to Follow-up|8|||
44166730|NCT02280291|78959811|FG000|Overall Study|Protocol Violation|1|||
44166731|NCT02280291|78959812|FG001|Overall Study|Protocol Violation|0|||
44166732|NCT02280291|78959813|FG002|Overall Study|Protocol Violation|0|||
44166733|NCT02280291|78959814|FG003|Overall Study|Protocol Violation|0|||
44166734|NCT02280291|78959811|FG000|Overall Study|Other|1|||
44166735|NCT02280291|78959812|FG001|Overall Study|Other|1|||
44166736|NCT02280291|78959813|FG002|Overall Study|Other|0|||
44166737|NCT02280291|78959814|FG003|Overall Study|Other|0|||
44166738|NCT02284893|78959828|FG000|26 Week (Short Term)|Adverse Event|1|||
44166739|NCT02284893|78959829|FG001|26 Week (Short Term)|Adverse Event|9|||
44166740|NCT02284893|78959828|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
44166741|NCT02284893|78959829|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
44166742|NCT02284893|78959828|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
44166743|NCT02284893|78959829|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
44166744|NCT02284893|78959828|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
44166745|NCT02284893|78959829|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
44166746|NCT02284893|78959828|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
44166747|NCT02284893|78959829|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
44166748|NCT02284893|78959828|FG000|26 Week (Short Term)|Other|1|||
44166749|NCT02284893|78959829|FG001|26 Week (Short Term)|Other|1|||
44166750|NCT02284893|78959828|FG000|52 Week (Long Term)|Adverse Event|3|||
44166751|NCT02284893|78959829|FG001|52 Week (Long Term)|Adverse Event|1|||
44166752|NCT02284893|78959828|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
44166753|NCT02284893|78959829|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
44166754|NCT02284893|78959828|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
44166755|NCT02284893|78959829|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
44166756|NCT02284893|78959828|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
44166757|NCT02284893|78959829|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
44166758|NCT02284893|78959828|FG000|52 Week (Long Term)|Non-Compliance|2|||
44166759|NCT02284893|78959829|FG001|52 Week (Long Term)|Non-Compliance|3|||
44166760|NCT02284347|78959835|FG000|Overall Study|Lost to Follow-up|2|||
44166761|NCT02284347|78959835|FG000|Overall Study|Withdrawn prior to treatment|1|||
44166762|NCT02279043|78959842|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
44166763|NCT02279043|78959843|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
44352082|NCT03517111|79356588|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
44352083|NCT03517111|79356586|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
44352084|NCT03517111|79356587|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
44352085|NCT03517111|79356588|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
44352086|NCT03517111|79356586|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
44352087|NCT03517111|79356587|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
44352088|NCT03517111|79356588|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
44352089|NCT03517111|79356586|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
44352090|NCT03517111|79356587|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
44352091|NCT03517111|79356588|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
44352092|NCT00907153|79356600|FG000|Overall Study|Lost to Follow-up|1|||
44352093|NCT00907153|79356601|FG001|Overall Study|Lost to Follow-up|1|||
44352094|NCT00907153|79356600|FG000|Overall Study|Withdrawal by Subject|1|||
44352095|NCT00907153|79356601|FG001|Overall Study|Withdrawal by Subject|3|||
44352096|NCT00904033|79356611|FG000|Overall Study|Withdrawal by Subject|1|||
44352097|NCT00904033|79356612|FG001|Overall Study|Withdrawal by Subject|1|||
44352098|NCT00904033|79356613|FG002|Overall Study|Withdrawal by Subject|0|||
44352099|NCT00904033|79356614|FG003|Overall Study|Withdrawal by Subject|0|||
44352100|NCT00904033|79356611|FG000|Overall Study|Physician Decision|0|||
44352101|NCT00904033|79356612|FG001|Overall Study|Physician Decision|0|||
44352102|NCT00904033|79356613|FG002|Overall Study|Physician Decision|1|||
44352103|NCT00904033|79356614|FG003|Overall Study|Physician Decision|0|||
44352104|NCT00904033|79356611|FG000|Overall Study|Unable to obtain final blood draw|0|||
44352105|NCT00904033|79356612|FG001|Overall Study|Unable to obtain final blood draw|0|||
44352106|NCT00904033|79356613|FG002|Overall Study|Unable to obtain final blood draw|0|||
44352107|NCT00904033|79356614|FG003|Overall Study|Unable to obtain final blood draw|2|||
44352108|NCT00903877|79356625|FG000|Overall Study|Did not meet study criteria|33|||
44352109|NCT00903877|79356625|FG000|Overall Study|Withdrawal by Subject|3|||
44352110|NCT00903877|79356625|FG000|Overall Study|Adverse Event|2|||
44352111|NCT00903877|79356625|FG000|Overall Study|Lost to Follow-up|1|||
44352112|NCT00903877|79356625|FG000|Overall Study|Participation put on hold|4|||
44352113|NCT01241591|79356633|FG000|Overall Study|Lack of Efficacy|5|||
44352114|NCT01241591|79356634|FG001|Overall Study|Lack of Efficacy|2|||
44352115|NCT01241591|79356635|FG002|Overall Study|Lack of Efficacy|2|||
44352116|NCT01241591|79356636|FG003|Overall Study|Lack of Efficacy|3|||
44352117|NCT01241591|79356633|FG000|Overall Study|Protocol Violation|5|||
44352118|NCT01241591|79356634|FG001|Overall Study|Protocol Violation|2|||
44352119|NCT01241591|79356635|FG002|Overall Study|Protocol Violation|3|||
44166764|NCT02279043|78959844|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
44166765|NCT02279043|78959842|FG000|Overall Study|Lost to Follow-up|46|||
44166766|NCT02279043|78959843|FG001|Overall Study|Lost to Follow-up|88|||
44166767|NCT02279043|78959844|FG002|Overall Study|Lost to Follow-up|0|||
44352120|NCT01241591|79356636|FG003|Overall Study|Protocol Violation|0|||
44352121|NCT01241591|79356633|FG000|Overall Study|Lost to Follow-up|1|||
44352122|NCT01241591|79356634|FG001|Overall Study|Lost to Follow-up|2|||
44352123|NCT01241591|79356635|FG002|Overall Study|Lost to Follow-up|2|||
44352124|NCT01241591|79356636|FG003|Overall Study|Lost to Follow-up|2|||
44352125|NCT01241591|79356633|FG000|Overall Study|Screen Failure|3|||
44352126|NCT01241591|79356634|FG001|Overall Study|Screen Failure|2|||
44352127|NCT01241591|79356635|FG002|Overall Study|Screen Failure|1|||
44352128|NCT01241591|79356636|FG003|Overall Study|Screen Failure|0|||
44352129|NCT01241591|79356633|FG000|Overall Study|Withdrawal by Subject|6|||
44352130|NCT01241591|79356634|FG001|Overall Study|Withdrawal by Subject|4|||
44352131|NCT01241591|79356635|FG002|Overall Study|Withdrawal by Subject|2|||
44352132|NCT01241591|79356636|FG003|Overall Study|Withdrawal by Subject|2|||
44352133|NCT01241591|79356633|FG000|Overall Study|Other|0|||
44352134|NCT01241591|79356634|FG001|Overall Study|Other|1|||
44352135|NCT01241591|79356635|FG002|Overall Study|Other|0|||
44352136|NCT01241591|79356636|FG003|Overall Study|Other|1|||
44352137|NCT01241591|79356633|FG000|Overall Study|Adverse Event|3|||
44352138|NCT01241591|79356634|FG001|Overall Study|Adverse Event|11|||
44352139|NCT01241591|79356635|FG002|Overall Study|Adverse Event|12|||
44352140|NCT01241591|79356636|FG003|Overall Study|Adverse Event|4|||
44352141|NCT00906373|79356648|FG000|Overall Study|Withdrawal by Subject|0|||
44352142|NCT00906373|79356649|FG001|Overall Study|Withdrawal by Subject|5|||
44352143|NCT00906373|79356648|FG000|Overall Study|Other|0|||
44352144|NCT00906373|79356649|FG001|Overall Study|Other|1|||
44352145|NCT00906373|79356648|FG000|Overall Study|Still on treatment at cutoff date|0|||
44352146|NCT00906373|79356649|FG001|Overall Study|Still on treatment at cutoff date|2|||
44352147|NCT00905437|79356662|FG000|Overall Study|Adverse Event|3|||
44352148|NCT00905437|79356663|FG001|Overall Study|Adverse Event|2|||
44352149|NCT00905437|79356662|FG000|Overall Study|Lost to Follow-up|0|||
44352150|NCT00905437|79356663|FG001|Overall Study|Lost to Follow-up|1|||
44352151|NCT00905437|79356662|FG000|Overall Study|Withdrawal by Subject|0|||
44352152|NCT00905437|79356663|FG001|Overall Study|Withdrawal by Subject|1|||
44352153|NCT00905437|79356662|FG000|Overall Study|Other|5|||
44352154|NCT00905437|79356663|FG001|Overall Study|Other|6|||
44352155|NCT01238861|79356675|FG000|Overall Study|Lost to Follow-up|4|||
44352156|NCT01238861|79356676|FG001|Overall Study|Lost to Follow-up|2|||
44352157|NCT01238861|79356677|FG002|Overall Study|Lost to Follow-up|3|||
44352158|NCT01238861|79356678|FG003|Overall Study|Lost to Follow-up|1|||
44352159|NCT01238861|79356679|FG004|Overall Study|Lost to Follow-up|1|||
44352160|NCT01238861|79356680|FG005|Overall Study|Lost to Follow-up|2|||
44352161|NCT01238861|79356675|FG000|Overall Study|Unplanned surgery|1|||
44352162|NCT01238861|79356676|FG001|Overall Study|Unplanned surgery|0|||
44352163|NCT01238861|79356677|FG002|Overall Study|Unplanned surgery|0|||
44352164|NCT01238861|79356678|FG003|Overall Study|Unplanned surgery|0|||
44352165|NCT01238861|79356679|FG004|Overall Study|Unplanned surgery|0|||
44352166|NCT01238861|79356680|FG005|Overall Study|Unplanned surgery|0|||
44352167|NCT01238861|79356675|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
44352168|NCT01238861|79356676|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
44352169|NCT01238861|79356677|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
44352170|NCT01238861|79356678|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
44352171|NCT01238861|79356679|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
44352172|NCT01238861|79356680|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
44352173|NCT01238861|79356675|FG000|Overall Study|Incorrect enrollment/randomization|0|||
44352174|NCT01238861|79356676|FG001|Overall Study|Incorrect enrollment/randomization|0|||
44352175|NCT01238861|79356677|FG002|Overall Study|Incorrect enrollment/randomization|1|||
44352176|NCT01238861|79356678|FG003|Overall Study|Incorrect enrollment/randomization|0|||
44352177|NCT01238861|79356679|FG004|Overall Study|Incorrect enrollment/randomization|1|||
44352178|NCT01238861|79356680|FG005|Overall Study|Incorrect enrollment/randomization|0|||
44352179|NCT01238861|79356675|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
44352180|NCT01238861|79356676|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
44352181|NCT01238861|79356677|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
44352182|NCT01238861|79356678|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
44352183|NCT01238861|79356679|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
44352184|NCT01238861|79356680|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
44352185|NCT01238861|79356675|FG000|Overall Study|Subject moved out of state/area|0|||
44352186|NCT01238861|79356676|FG001|Overall Study|Subject moved out of state/area|0|||
44352187|NCT01238861|79356677|FG002|Overall Study|Subject moved out of state/area|1|||
44352188|NCT01238861|79356678|FG003|Overall Study|Subject moved out of state/area|1|||
44352189|NCT01238861|79356679|FG004|Overall Study|Subject moved out of state/area|0|||
44352190|NCT01238861|79356680|FG005|Overall Study|Subject moved out of state/area|0|||
44352191|NCT01238861|79356675|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
44352192|NCT01238861|79356676|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
44352193|NCT01238861|79356677|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
44352194|NCT01238861|79356678|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
44352195|NCT01238861|79356679|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
44352196|NCT01238861|79356680|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
44352197|NCT01238861|79356675|FG000|Overall Study|Personal problems|0|||
44352198|NCT01238861|79356676|FG001|Overall Study|Personal problems|0|||
44352199|NCT01238861|79356677|FG002|Overall Study|Personal problems|0|||
44352200|NCT01238861|79356678|FG003|Overall Study|Personal problems|1|||
44352201|NCT01238861|79356679|FG004|Overall Study|Personal problems|0|||
44352202|NCT01238861|79356680|FG005|Overall Study|Personal problems|0|||
44352203|NCT01238861|79356675|FG000|Overall Study|Unable to continue visits|0|||
44352204|NCT01238861|79356676|FG001|Overall Study|Unable to continue visits|0|||
44352205|NCT01238861|79356677|FG002|Overall Study|Unable to continue visits|0|||
44352206|NCT01238861|79356678|FG003|Overall Study|Unable to continue visits|1|||
44352207|NCT01238861|79356679|FG004|Overall Study|Unable to continue visits|0|||
44352208|NCT01238861|79356680|FG005|Overall Study|Unable to continue visits|1|||
44352209|NCT01238861|79356675|FG000|Overall Study|Serious adverse event|0|||
44352210|NCT01238861|79356676|FG001|Overall Study|Serious adverse event|0|||
44352211|NCT01238861|79356677|FG002|Overall Study|Serious adverse event|0|||
44352212|NCT01238861|79356678|FG003|Overall Study|Serious adverse event|0|||
44352213|NCT01238861|79356679|FG004|Overall Study|Serious adverse event|0|||
44352214|NCT01238861|79356680|FG005|Overall Study|Serious adverse event|1|||
44352215|NCT01238861|79356675|FG000|Overall Study|Lack of compliance|0|||
44352216|NCT01238861|79356676|FG001|Overall Study|Lack of compliance|0|||
44352217|NCT01238861|79356677|FG002|Overall Study|Lack of compliance|0|||
44352218|NCT01238861|79356678|FG003|Overall Study|Lack of compliance|0|||
44352219|NCT01238861|79356679|FG004|Overall Study|Lack of compliance|0|||
44352220|NCT01238861|79356680|FG005|Overall Study|Lack of compliance|1|||
44352221|NCT01238861|79356675|FG000|Overall Study|Adverse Event|0|||
44352222|NCT01238861|79356676|FG001|Overall Study|Adverse Event|1|||
44352223|NCT01238861|79356677|FG002|Overall Study|Adverse Event|0|||
44352224|NCT01238861|79356678|FG003|Overall Study|Adverse Event|0|||
44352225|NCT01238861|79356679|FG004|Overall Study|Adverse Event|0|||
44352226|NCT01238861|79356680|FG005|Overall Study|Adverse Event|0|||
44352227|NCT01238861|79356675|FG000|Overall Study|Withdrawal by Subject|6|||
44352228|NCT01238861|79356676|FG001|Overall Study|Withdrawal by Subject|5|||
44352229|NCT01238861|79356677|FG002|Overall Study|Withdrawal by Subject|4|||
44352230|NCT01238861|79356678|FG003|Overall Study|Withdrawal by Subject|8|||
44352231|NCT01238861|79356679|FG004|Overall Study|Withdrawal by Subject|10|||
44352232|NCT01238861|79356680|FG005|Overall Study|Withdrawal by Subject|9|||
44352233|NCT00903409|79356703|FG000|Overall Study|Adverse Event|11|||
44352234|NCT00903409|79356704|FG001|Overall Study|Adverse Event|9|||
44352235|NCT00903409|79356703|FG000|Overall Study|Non-compliance with Protocol|1|||
44352236|NCT00903409|79356704|FG001|Overall Study|Non-compliance with Protocol|1|||
44352237|NCT00903409|79356703|FG000|Overall Study|Laboratory Abnormality|2|||
44352238|NCT00903409|79356704|FG001|Overall Study|Laboratory Abnormality|0|||
44352239|NCT00903409|79356703|FG000|Overall Study|Withdrawal by Subject|8|||
44352240|NCT00903409|79356704|FG001|Overall Study|Withdrawal by Subject|8|||
44352241|NCT00903409|79356703|FG000|Overall Study|Other|2|||
44352242|NCT00903409|79356704|FG001|Overall Study|Other|3|||
44352243|NCT00903409|79356703|FG000|Overall Study|Lost to Follow-up|2|||
44352244|NCT00903409|79356704|FG001|Overall Study|Lost to Follow-up|6|||
44352245|NCT01237223|79356718|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
44352246|NCT01237223|79356719|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
44352247|NCT01237223|79356720|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
44352248|NCT01237223|79356721|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
44352249|NCT01237223|79356722|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
44352250|NCT01237223|79356723|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
44352251|NCT01237223|79356718|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
44352252|NCT01237223|79356719|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
44352253|NCT01237223|79356720|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
44352254|NCT01237223|79356721|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
44352255|NCT01237223|79356722|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
44352256|NCT01237223|79356723|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
44352257|NCT01237223|79356718|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
44352258|NCT01237223|79356719|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
44352259|NCT01237223|79356720|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
44352260|NCT01237223|79356721|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
44352261|NCT01237223|79356722|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
44352262|NCT01237223|79356723|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
44352263|NCT01237223|79356718|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
44352264|NCT01237223|79356719|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
44352265|NCT01237223|79356720|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
44352266|NCT01237223|79356721|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
44352267|NCT01237223|79356722|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
44352268|NCT01237223|79356723|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
44352269|NCT01237223|79356718|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
44352270|NCT01237223|79356719|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
44352271|NCT01237223|79356720|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
44352272|NCT01237223|79356721|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
44352273|NCT01237223|79356722|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
44352274|NCT01237223|79356723|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
44352275|NCT01237223|79356718|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
44352276|NCT01237223|79356719|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
44352277|NCT01237223|79356720|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
44352278|NCT01237223|79356721|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
44352279|NCT01237223|79356722|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
44352280|NCT01237223|79356723|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
44352281|NCT01237223|79356718|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
44352282|NCT01237223|79356719|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
44352283|NCT01237223|79356720|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
44352284|NCT01237223|79356721|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
44352285|NCT01237223|79356722|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
44352286|NCT01237223|79356723|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
44352287|NCT01237223|79356718|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
44352288|NCT01237223|79356719|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
44352289|NCT01237223|79356720|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
44352290|NCT01237223|79356721|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
44352291|NCT01237223|79356722|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
44352292|NCT01237223|79356723|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
44352293|NCT01237223|79356718|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
44352294|NCT01237223|79356719|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
44352295|NCT01237223|79356720|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
44352296|NCT01237223|79356721|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
44352297|NCT01237223|79356722|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
44352298|NCT01237223|79356723|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
44352299|NCT01237223|79356718|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
44352300|NCT01237223|79356719|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
44352301|NCT01237223|79356720|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
44352302|NCT01237223|79356721|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
44352303|NCT01237223|79356722|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
44352304|NCT01237223|79356723|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
44352305|NCT01236755|79356739|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
44352306|NCT01236755|79356739|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
44352307|NCT01236755|79356739|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
44352308|NCT01236755|79356739|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
44352309|NCT01236365|79356746|FG000|Overall Study|Lost to Follow-up|0|||
44352310|NCT01236365|79356747|FG001|Overall Study|Lost to Follow-up|2|||
44352311|NCT01236365|79356746|FG000|Overall Study|Moved Out of State|1|||
44352312|NCT01236365|79356747|FG001|Overall Study|Moved Out of State|0|||
44352313|NCT01236365|79356746|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
44352314|NCT01236365|79356747|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
44352315|NCT01235975|79356767|FG000|Overall Study|Serious Adverse Event|0|||
44352316|NCT01235975|79356768|FG001|Overall Study|Serious Adverse Event|1|||
44352317|NCT01235975|79356767|FG000|Overall Study|Withdrawal by Subject|8|||
44352318|NCT01235975|79356768|FG001|Overall Study|Withdrawal by Subject|2|||
44352319|NCT01235975|79356767|FG000|Overall Study|Migrated/moved from study area|2|||
44352320|NCT01235975|79356768|FG001|Overall Study|Migrated/moved from study area|1|||
44352321|NCT01235975|79356767|FG000|Overall Study|Lost to Follow-up|7|||
44352322|NCT01235975|79356768|FG001|Overall Study|Lost to Follow-up|3|||
44352323|NCT00903331|79356776|FG000|Overall Study|Death|4|||
44352324|NCT00903331|79356777|FG001|Overall Study|Death|8|||
44352325|NCT00903331|79356776|FG000|Overall Study|Withdrawal of consent|1|||
44352326|NCT00903331|79356777|FG001|Overall Study|Withdrawal of consent|8|||
44352327|NCT00903331|79356776|FG000|Overall Study|Lung transplant|0|||
44352328|NCT00903331|79356777|FG001|Overall Study|Lung transplant|2|||
44352329|NCT01235741|79356786|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
44352330|NCT01235741|79356787|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
44447840|NCT02742246|79456327|FG001|Overall Study|Never initiated treatment|3|||
44447841|NCT02742246|79456328|FG002|Overall Study|Never initiated treatment|1|||
44447842|NCT02742246|79456326|FG000|Overall Study|dropped out during treatment|7|||
44447843|NCT02742246|79456327|FG001|Overall Study|dropped out during treatment|13|||
44447844|NCT02742246|79456328|FG002|Overall Study|dropped out during treatment|10|||
44447845|NCT02742246|79456326|FG000|Overall Study|Death|1|||
44447846|NCT02742246|79456327|FG001|Overall Study|Death|0|||
44447847|NCT02742246|79456328|FG002|Overall Study|Death|0|||
44447848|NCT02733042|79456355|FG000|Overall Study|Adverse Event|1|||
44447849|NCT02733042|79456356|FG001|Overall Study|Adverse Event|0|||
44447850|NCT02733042|79456357|FG002|Overall Study|Adverse Event|1|||
44447851|NCT02733042|79456358|FG003|Overall Study|Adverse Event|1|||
44447852|NCT02733042|79456359|FG004|Overall Study|Adverse Event|0|||
44447853|NCT02733042|79456360|FG005|Overall Study|Adverse Event|0|||
44447854|NCT02733042|79456361|FG006|Overall Study|Adverse Event|0|||
44447855|NCT02733042|79456362|FG007|Overall Study|Adverse Event|0|||
44447856|NCT02733042|79456363|FG008|Overall Study|Adverse Event|0|||
44447857|NCT02733042|79456364|FG009|Overall Study|Adverse Event|0|||
44447858|NCT02733042|79456365|FG010|Overall Study|Adverse Event|2|||
44447859|NCT02733042|79456366|FG011|Overall Study|Adverse Event|2|||
44447860|NCT02733042|79456367|FG012|Overall Study|Adverse Event|0|||
44447861|NCT02733042|79456368|FG013|Overall Study|Adverse Event|2|||
44447862|NCT02733042|79456369|FG014|Overall Study|Adverse Event|0|||
44447863|NCT02733042|79456370|FG015|Overall Study|Adverse Event|0|||
44447864|NCT02733042|79456371|FG016|Overall Study|Adverse Event|0|||
44447865|NCT02733042|79456372|FG017|Overall Study|Adverse Event|1|||
44447866|NCT02733042|79456373|FG018|Overall Study|Adverse Event|0|||
44447867|NCT02733042|79456355|FG000|Overall Study|Progressive Disease|2|||
44447868|NCT02733042|79456356|FG001|Overall Study|Progressive Disease|1|||
44447869|NCT02733042|79456357|FG002|Overall Study|Progressive Disease|3|||
44447870|NCT02733042|79456358|FG003|Overall Study|Progressive Disease|1|||
44447871|NCT02733042|79456359|FG004|Overall Study|Progressive Disease|2|||
44447872|NCT02733042|79456360|FG005|Overall Study|Progressive Disease|3|||
44447873|NCT02733042|79456361|FG006|Overall Study|Progressive Disease|0|||
44447874|NCT02733042|79456362|FG007|Overall Study|Progressive Disease|3|||
44447875|NCT02733042|79456363|FG008|Overall Study|Progressive Disease|3|||
44447876|NCT02733042|79456364|FG009|Overall Study|Progressive Disease|2|||
44447877|NCT02733042|79456365|FG010|Overall Study|Progressive Disease|2|||
44447878|NCT02733042|79456366|FG011|Overall Study|Progressive Disease|2|||
44447879|NCT02733042|79456367|FG012|Overall Study|Progressive Disease|8|||
44447880|NCT02733042|79456368|FG013|Overall Study|Progressive Disease|1|||
44447881|NCT02733042|79456369|FG014|Overall Study|Progressive Disease|4|||
44447882|NCT02733042|79456370|FG015|Overall Study|Progressive Disease|7|||
44447883|NCT02733042|79456371|FG016|Overall Study|Progressive Disease|2|||
44447884|NCT02733042|79456372|FG017|Overall Study|Progressive Disease|3|||
44447885|NCT02733042|79456373|FG018|Overall Study|Progressive Disease|4|||
44447886|NCT02733042|79456355|FG000|Overall Study|Withdrawal by Subject|0|||
44447887|NCT02733042|79456356|FG001|Overall Study|Withdrawal by Subject|1|||
44447888|NCT02733042|79456357|FG002|Overall Study|Withdrawal by Subject|2|||
44447889|NCT02733042|79456358|FG003|Overall Study|Withdrawal by Subject|1|||
44447890|NCT02733042|79456359|FG004|Overall Study|Withdrawal by Subject|1|||
44447891|NCT02733042|79456360|FG005|Overall Study|Withdrawal by Subject|0|||
44447892|NCT02733042|79456361|FG006|Overall Study|Withdrawal by Subject|0|||
44447893|NCT02733042|79456362|FG007|Overall Study|Withdrawal by Subject|0|||
44447894|NCT02733042|79456363|FG008|Overall Study|Withdrawal by Subject|1|||
44447895|NCT02733042|79456364|FG009|Overall Study|Withdrawal by Subject|1|||
44447896|NCT02733042|79456365|FG010|Overall Study|Withdrawal by Subject|0|||
44447897|NCT02733042|79456366|FG011|Overall Study|Withdrawal by Subject|2|||
44447898|NCT02733042|79456367|FG012|Overall Study|Withdrawal by Subject|1|||
44447899|NCT02733042|79456368|FG013|Overall Study|Withdrawal by Subject|1|||
44447900|NCT02733042|79456369|FG014|Overall Study|Withdrawal by Subject|0|||
44447901|NCT02733042|79456370|FG015|Overall Study|Withdrawal by Subject|0|||
44447902|NCT02733042|79456371|FG016|Overall Study|Withdrawal by Subject|0|||
44447903|NCT02733042|79456372|FG017|Overall Study|Withdrawal by Subject|0|||
44447904|NCT02733042|79456373|FG018|Overall Study|Withdrawal by Subject|0|||
44447905|NCT02733042|79456355|FG000|Overall Study|Other Reasons|0|||
44447906|NCT02733042|79456356|FG001|Overall Study|Other Reasons|0|||
44447907|NCT02733042|79456357|FG002|Overall Study|Other Reasons|1|||
44447908|NCT02733042|79456358|FG003|Overall Study|Other Reasons|0|||
44447909|NCT02733042|79456359|FG004|Overall Study|Other Reasons|0|||
44447910|NCT02733042|79456360|FG005|Overall Study|Other Reasons|0|||
44447911|NCT02733042|79456361|FG006|Overall Study|Other Reasons|0|||
44447912|NCT02733042|79456362|FG007|Overall Study|Other Reasons|0|||
44447913|NCT02733042|79456363|FG008|Overall Study|Other Reasons|0|||
44447914|NCT02733042|79456364|FG009|Overall Study|Other Reasons|1|||
44447915|NCT02733042|79456365|FG010|Overall Study|Other Reasons|1|||
44447916|NCT02733042|79456366|FG011|Overall Study|Other Reasons|0|||
44447917|NCT02733042|79456367|FG012|Overall Study|Other Reasons|0|||
44447918|NCT02733042|79456368|FG013|Overall Study|Other Reasons|0|||
44447919|NCT02733042|79456369|FG014|Overall Study|Other Reasons|0|||
44447920|NCT02733042|79456370|FG015|Overall Study|Other Reasons|1|||
44447921|NCT02733042|79456371|FG016|Overall Study|Other Reasons|0|||
44447922|NCT02733042|79456372|FG017|Overall Study|Other Reasons|1|||
44447923|NCT02733042|79456373|FG018|Overall Study|Other Reasons|0|||
44447924|NCT02733042|79456355|FG000|Overall Study|Death|0|||
44447925|NCT02733042|79456356|FG001|Overall Study|Death|0|||
44447926|NCT02733042|79456357|FG002|Overall Study|Death|0|||
44447927|NCT02733042|79456358|FG003|Overall Study|Death|0|||
44447928|NCT02733042|79456359|FG004|Overall Study|Death|0|||
44447929|NCT02733042|79456360|FG005|Overall Study|Death|0|||
44447930|NCT02733042|79456361|FG006|Overall Study|Death|1|||
44447931|NCT02733042|79456362|FG007|Overall Study|Death|0|||
44447932|NCT02733042|79456363|FG008|Overall Study|Death|1|||
44447933|NCT02733042|79456364|FG009|Overall Study|Death|0|||
44447934|NCT02733042|79456365|FG010|Overall Study|Death|1|||
44447935|NCT02733042|79456366|FG011|Overall Study|Death|0|||
44447936|NCT02733042|79456367|FG012|Overall Study|Death|0|||
44447937|NCT02733042|79456368|FG013|Overall Study|Death|0|||
44447938|NCT02733042|79456369|FG014|Overall Study|Death|1|||
44447939|NCT02733042|79456370|FG015|Overall Study|Death|2|||
44447940|NCT02733042|79456371|FG016|Overall Study|Death|0|||
44447941|NCT02733042|79456372|FG017|Overall Study|Death|0|||
44447942|NCT02733042|79456373|FG018|Overall Study|Death|0|||
44447943|NCT02614066|79456426|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
44447944|NCT02614066|79456427|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
44447945|NCT02614066|79456428|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
44447946|NCT02614066|79456429|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
44447947|NCT02614066|79456426|FG000|Overall Study|Full Consent Withdrawn|0|||
44447948|NCT02614066|79456427|FG001|Overall Study|Full Consent Withdrawn|1|||
44447949|NCT02614066|79456428|FG002|Overall Study|Full Consent Withdrawn|0|||
44447950|NCT02614066|79456429|FG003|Overall Study|Full Consent Withdrawn|3|||
44447951|NCT02614066|79456426|FG000|Overall Study|Lost to Follow-up|0|||
44447952|NCT02614066|79456427|FG001|Overall Study|Lost to Follow-up|1|||
44447953|NCT02614066|79456428|FG002|Overall Study|Lost to Follow-up|0|||
44447954|NCT02614066|79456429|FG003|Overall Study|Lost to Follow-up|0|||
44447955|NCT02614066|79456426|FG000|Overall Study|Still on-study|1|||
44447956|NCT02614066|79456427|FG001|Overall Study|Still on-study|9|||
44447957|NCT02614066|79456428|FG002|Overall Study|Still on-study|5|||
44447958|NCT02614066|79456429|FG003|Overall Study|Still on-study|32|||
44447959|NCT02614066|79456426|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
44447960|NCT02614066|79456427|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
44447961|NCT02614066|79456428|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
44447962|NCT02614066|79456429|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
44447963|NCT02504866|79456493|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
44447964|NCT02504866|79456494|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
44447965|NCT02504866|79456495|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
44447966|NCT02459769|79456507|FG000|Overall Study|Withdrawal by Subject|7|||
44447967|NCT02459769|79456508|FG001|Overall Study|Withdrawal by Subject|4|||
44447968|NCT02459769|79456509|FG002|Overall Study|Withdrawal by Subject|8|||
44447969|NCT02459769|79456510|FG003|Overall Study|Withdrawal by Subject|5|||
44447970|NCT02459769|79456507|FG000|Overall Study|Lost to Follow-up|1|||
44447971|NCT02459769|79456508|FG001|Overall Study|Lost to Follow-up|0|||
44447972|NCT02459769|79456509|FG002|Overall Study|Lost to Follow-up|1|||
44447973|NCT02459769|79456510|FG003|Overall Study|Lost to Follow-up|0|||
44447974|NCT02369016|79456522|FG000|Overall Study|AE associated with clinical disease progression|2|||
44447975|NCT02369016|79456523|FG001|Overall Study|AE associated with clinical disease progression|1|||
44447976|NCT02369016|79456522|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
44447977|NCT02369016|79456523|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
44447978|NCT02369016|79456522|FG000|Overall Study|Progressive disease - clinical progression|1|||
44447979|NCT02369016|79456523|FG001|Overall Study|Progressive disease - clinical progression|4|||
44447980|NCT02369016|79456522|FG000|Overall Study|withdrawal by patient|4|||
44447981|NCT02369016|79456523|FG001|Overall Study|withdrawal by patient|0|||
44447982|NCT02369016|79456522|FG000|Overall Study|Progressive disease - radiological progression|6|||
44447983|NCT02369016|79456523|FG001|Overall Study|Progressive disease - radiological progression|2|||
44447984|NCT02363959|79456536|FG000|Overall Study|Medical instability|1|||
44447985|NCT02363959|79456537|FG001|Overall Study|Medical instability|0|||
44447986|NCT01756040|79456560|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
44447987|NCT01756040|79456560|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
44447988|NCT01756040|79456560|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
44447989|NCT00567164|79456579|FG000|Overall Study|Withdrawal by Subject|171|||
44447990|NCT00567164|79456580|FG001|Overall Study|Withdrawal by Subject|21|||
44447991|NCT00567164|79456581|FG002|Overall Study|Withdrawal by Subject|17|||
44447992|NCT00567164|79456579|FG000|Overall Study|Protocol Violation|23|||
44447993|NCT00567164|79456580|FG001|Overall Study|Protocol Violation|4|||
44447994|NCT00567164|79456581|FG002|Overall Study|Protocol Violation|2|||
44447995|NCT00567164|79456579|FG000|Overall Study|Adverse Event|92|||
44447996|NCT00567164|79456580|FG001|Overall Study|Adverse Event|13|||
44447997|NCT00567164|79456581|FG002|Overall Study|Adverse Event|9|||
44447998|NCT00567164|79456579|FG000|Overall Study|Death|0|||
44447999|NCT00567164|79456580|FG001|Overall Study|Death|0|||
44448000|NCT00567164|79456581|FG002|Overall Study|Death|1|||
44448001|NCT00567164|79456579|FG000|Overall Study|Lost to Follow-up|202|||
44448002|NCT00567164|79456580|FG001|Overall Study|Lost to Follow-up|23|||
44448003|NCT00567164|79456581|FG002|Overall Study|Lost to Follow-up|21|||
44448004|NCT00567164|79456579|FG000|Overall Study|Pregnancy|20|||
44448005|NCT00567164|79456580|FG001|Overall Study|Pregnancy|4|||
44448006|NCT00567164|79456581|FG002|Overall Study|Pregnancy|6|||
44448007|NCT00567164|79456579|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
44448008|NCT00567164|79456580|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
44448009|NCT00567164|79456581|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
44448010|NCT00567164|79456579|FG000|Overall Study|Missing|1|||
44448011|NCT00567164|79456580|FG001|Overall Study|Missing|0|||
44448012|NCT00567164|79456581|FG002|Overall Study|Missing|0|||
44448013|NCT00713219|79456593|FG000|Overall Study|Death|1|||
44448014|NCT00713219|79456593|FG000|Overall Study|Protocol Violation|1|||
44448015|NCT00712985|79456597|FG000|Overall Study|1 withdrew prior to start of drug|1|||
44448016|NCT00712985|79456597|FG000|Overall Study|1 patient moved out of state|1|||
44448017|NCT00712985|79456597|FG000|Overall Study|Lack of Efficacy|3|||
44448018|NCT00700115|79456603|FG000|Overall Study|Withdrawal by Subject|1|||
44448019|NCT00700115|79456604|FG001|Overall Study|Withdrawal by Subject|0|||
44448020|NCT00700115|79456603|FG000|Overall Study|Lost to Follow-up|0|||
44448021|NCT00700115|79456604|FG001|Overall Study|Lost to Follow-up|1|||
44448022|NCT00566852|79456612|FG000|Overall Study|Protocol Violation|22|||
44448023|NCT00566852|79456613|FG001|Overall Study|Protocol Violation|24|||
44448024|NCT00566852|79456612|FG000|Overall Study|Death|95|||
44448025|NCT00566852|79456613|FG001|Overall Study|Death|78|||
44448026|NCT00566852|79456612|FG000|Overall Study|Withdrawal by Subject|30|||
44448027|NCT00566852|79456613|FG001|Overall Study|Withdrawal by Subject|25|||
44448028|NCT00566852|79456612|FG000|Overall Study|Patient refusal|37|||
44448029|NCT00566852|79456613|FG001|Overall Study|Patient refusal|37|||
44448030|NCT00566852|79456612|FG000|Overall Study|Not tested due to disability|6|||
44448031|NCT00566852|79456613|FG001|Overall Study|Not tested due to disability|12|||
44448032|NCT00566852|79456612|FG000|Overall Study|Missing reason not specified|1|||
44448033|NCT00566852|79456613|FG001|Overall Study|Missing reason not specified|2|||
44448034|NCT00566852|79456612|FG000|Overall Study|Missing reason not reported|16|||
44448035|NCT00566852|79456613|FG001|Overall Study|Missing reason not reported|20|||
44448036|NCT00442546|79456622|FG000|Overall Study|Adverse Event|11|||
44448037|NCT00442546|79456623|FG001|Overall Study|Adverse Event|17|||
44448038|NCT00442546|79456624|FG002|Overall Study|Adverse Event|13|||
44448039|NCT00442546|79456622|FG000|Overall Study|Lost to Follow-up|1|||
44448040|NCT00442546|79456623|FG001|Overall Study|Lost to Follow-up|2|||
44448041|NCT00442546|79456624|FG002|Overall Study|Lost to Follow-up|1|||
44448042|NCT00442546|79456622|FG000|Overall Study|Other|4|||
44448043|NCT00442546|79456623|FG001|Overall Study|Other|9|||
44448044|NCT00442546|79456624|FG002|Overall Study|Other|6|||
44448045|NCT00442546|79456622|FG000|Overall Study|Withdrawal by Subject|5|||
44448046|NCT00442546|79456623|FG001|Overall Study|Withdrawal by Subject|5|||
44448047|NCT00442546|79456624|FG002|Overall Study|Withdrawal by Subject|7|||
44448048|NCT00442546|79456622|FG000|Overall Study|Randomized But Not Treated|5|||
44448049|NCT00442546|79456623|FG001|Overall Study|Randomized But Not Treated|4|||
44448050|NCT00442546|79456624|FG002|Overall Study|Randomized But Not Treated|6|||
44448051|NCT00514683|79456639|FG000|Overall Study|Not treated|2|||
44448052|NCT00514683|79456640|FG001|Overall Study|Not treated|1|||
44448053|NCT00514683|79456641|FG002|Overall Study|Not treated|0|||
44448054|NCT00514683|79456642|FG003|Overall Study|Not treated|0|||
44448055|NCT00514683|79456643|FG004|Overall Study|Not treated|1|||
44448056|NCT00514683|79456639|FG000|Overall Study|Adverse Event|21|||
44448057|NCT00514683|79456640|FG001|Overall Study|Adverse Event|20|||
44448058|NCT00514683|79456641|FG002|Overall Study|Adverse Event|15|||
44448059|NCT00514683|79456642|FG003|Overall Study|Adverse Event|13|||
44448060|NCT00514683|79456643|FG004|Overall Study|Adverse Event|27|||
44448061|NCT00514683|79456639|FG000|Overall Study|Protocol Violation|1|||
44448062|NCT00514683|79456640|FG001|Overall Study|Protocol Violation|1|||
44448063|NCT00514683|79456641|FG002|Overall Study|Protocol Violation|0|||
44448064|NCT00514683|79456642|FG003|Overall Study|Protocol Violation|1|||
44448065|NCT00514683|79456643|FG004|Overall Study|Protocol Violation|0|||
44448066|NCT00514683|79456639|FG000|Overall Study|Withdrawal by Subject|2|||
44448067|NCT00514683|79456640|FG001|Overall Study|Withdrawal by Subject|2|||
44448068|NCT00514683|79456641|FG002|Overall Study|Withdrawal by Subject|1|||
44448069|NCT00514683|79456642|FG003|Overall Study|Withdrawal by Subject|0|||
44448070|NCT00514683|79456643|FG004|Overall Study|Withdrawal by Subject|4|||
44448071|NCT00514683|79456639|FG000|Overall Study|Reason other than listed above|0|||
44448072|NCT00514683|79456640|FG001|Overall Study|Reason other than listed above|1|||
44448073|NCT00514683|79456641|FG002|Overall Study|Reason other than listed above|2|||
44448074|NCT00514683|79456642|FG003|Overall Study|Reason other than listed above|0|||
44448075|NCT00514683|79456643|FG004|Overall Study|Reason other than listed above|1|||
44448076|NCT00566696|79456659|FG000|Overall Study|Met Exclusion Criteria|2|||
44448077|NCT00566696|79456659|FG000|Overall Study|Muromonab not available|1|||
44448078|NCT00566696|79456659|FG000|Overall Study|Health Status Change|1|||
44448079|NCT00566696|79456659|FG000|Overall Study|Physician Decision|1|||
44448080|NCT00566696|79456659|FG000|Overall Study|Non-Patient Donors|37|||
44448081|NCT00503841|79456663|FG000|Overall Study|All screen failures|44|||
44448082|NCT00442468|79456669|FG000|Overall Study|Adverse Event|4|||
44448083|NCT00442468|79456669|FG000|Overall Study|Withdrawal by Subject|91|||
44448084|NCT00442468|79456669|FG000|Overall Study|Did not complete all study procedures|88|||
44448085|NCT00506883|79456676|FG000|Overall Study|Lost to Follow-up|1|||
44448086|NCT00506883|79456677|FG001|Overall Study|Lost to Follow-up|1|||
44448087|NCT00506883|79456678|FG002|Overall Study|Lost to Follow-up|1|||
44448088|NCT00506883|79456676|FG000|Overall Study|Withdrawal by Subject|1|||
44448089|NCT00506883|79456677|FG001|Overall Study|Withdrawal by Subject|0|||
44448090|NCT00506883|79456678|FG002|Overall Study|Withdrawal by Subject|1|||
44448091|NCT00506883|79456676|FG000|Overall Study|Lack of Efficacy|0|||
44448092|NCT00506883|79456677|FG001|Overall Study|Lack of Efficacy|1|||
44448093|NCT00506883|79456678|FG002|Overall Study|Lack of Efficacy|1|||
44448094|NCT00506883|79456676|FG000|Overall Study|Other|5|||
44448095|NCT00506883|79456677|FG001|Overall Study|Other|1|||
44448096|NCT00506883|79456678|FG002|Overall Study|Other|1|||
44448097|NCT00503685|79456689|FG000|Overall Study|Adverse Event|0|||
44448098|NCT00503685|79456690|FG001|Overall Study|Adverse Event|0|||
44448099|NCT00503685|79456691|FG002|Overall Study|Adverse Event|2|||
44448100|NCT00503685|79456689|FG000|Overall Study|Withdrawal by Subject|0|||
44448101|NCT00503685|79456690|FG001|Overall Study|Withdrawal by Subject|1|||
44448102|NCT00503685|79456691|FG002|Overall Study|Withdrawal by Subject|0|||
44448103|NCT00503685|79456689|FG000|Overall Study|Protocol Violation|0|||
44448104|NCT00503685|79456690|FG001|Overall Study|Protocol Violation|1|||
44448105|NCT00503685|79456691|FG002|Overall Study|Protocol Violation|0|||
44448106|NCT00503685|79456689|FG000|Overall Study|Eligibility Criteria Not Met|0|||
44448107|NCT00503685|79456690|FG001|Overall Study|Eligibility Criteria Not Met|1|||
44448108|NCT00503685|79456691|FG002|Overall Study|Eligibility Criteria Not Met|0|||
44448109|NCT00712673|79456703|FG000|Overall Study|Adverse Event|3|||
44448110|NCT00712673|79456704|FG001|Overall Study|Adverse Event|3|||
44448111|NCT00712673|79456705|FG002|Overall Study|Adverse Event|21|||
44448112|NCT00712673|79456706|FG003|Overall Study|Adverse Event|26|||
44448113|NCT00712673|79456703|FG000|Overall Study|Lack of Efficacy|2|||
44448114|NCT00712673|79456704|FG001|Overall Study|Lack of Efficacy|8|||
44448115|NCT00712673|79456705|FG002|Overall Study|Lack of Efficacy|8|||
44448116|NCT00712673|79456706|FG003|Overall Study|Lack of Efficacy|6|||
44448117|NCT00712673|79456703|FG000|Overall Study|Poor Compliance to Protocol|3|||
44448118|NCT00712673|79456704|FG001|Overall Study|Poor Compliance to Protocol|3|||
44448119|NCT00712673|79456705|FG002|Overall Study|Poor Compliance to Protocol|4|||
44448120|NCT00712673|79456706|FG003|Overall Study|Poor Compliance to Protocol|16|||
44448121|NCT00712673|79456703|FG000|Overall Study|Lost to Follow-up|1|||
44448122|NCT00712673|79456704|FG001|Overall Study|Lost to Follow-up|0|||
44448123|NCT00712673|79456705|FG002|Overall Study|Lost to Follow-up|2|||
44448124|NCT00712673|79456706|FG003|Overall Study|Lost to Follow-up|0|||
44448125|NCT00712673|79456703|FG000|Overall Study|Withdrawal by Subject|6|||
44448126|NCT00712673|79456704|FG001|Overall Study|Withdrawal by Subject|7|||
44448127|NCT00712673|79456705|FG002|Overall Study|Withdrawal by Subject|15|||
44448128|NCT00712673|79456706|FG003|Overall Study|Withdrawal by Subject|20|||
44448129|NCT00712673|79456703|FG000|Overall Study|Familial and Personal Reasons|5|||
44448130|NCT00712673|79456704|FG001|Overall Study|Familial and Personal Reasons|0|||
44448131|NCT00712673|79456705|FG002|Overall Study|Familial and Personal Reasons|5|||
44448132|NCT00712673|79456706|FG003|Overall Study|Familial and Personal Reasons|2|||
44448133|NCT00712673|79456703|FG000|Overall Study|Investigator's Decision|1|||
44448134|NCT00712673|79456704|FG001|Overall Study|Investigator's Decision|0|||
44448135|NCT00712673|79456705|FG002|Overall Study|Investigator's Decision|0|||
44448136|NCT00712673|79456706|FG003|Overall Study|Investigator's Decision|0|||
44448137|NCT00712673|79456703|FG000|Overall Study|Protocol Violation|0|||
44448138|NCT00712673|79456704|FG001|Overall Study|Protocol Violation|0|||
44448139|NCT00712673|79456705|FG002|Overall Study|Protocol Violation|2|||
44448140|NCT00712673|79456706|FG003|Overall Study|Protocol Violation|0|||
44448141|NCT03976466|79456727|FG000|Overall Study|Lost to Follow-up|1|||
44448142|NCT03976466|79456728|FG001|Overall Study|Lost to Follow-up|3|||
44448143|NCT02536755|79456736|FG000|Overall Study|Adverse Event|4|||
44448144|NCT03303105|79456745|FG000|Overall Study|Adverse Event|0|||
44448145|NCT03303105|79456746|FG001|Overall Study|Adverse Event|2|||
44448146|NCT03303105|79456745|FG000|Overall Study|Lack of Efficacy|1|||
44448147|NCT03303105|79456746|FG001|Overall Study|Lack of Efficacy|0|||
44448148|NCT03303105|79456745|FG000|Overall Study|Protocol Violation|1|||
44448149|NCT03303105|79456746|FG001|Overall Study|Protocol Violation|0|||
44448150|NCT03303105|79456745|FG000|Overall Study|Withdrawal by Subject|0|||
44448151|NCT03303105|79456746|FG001|Overall Study|Withdrawal by Subject|2|||
44448152|NCT00447694|79456752|FG000|Overall Study|Adverse Event|2|||
44448153|NCT00447694|79456752|FG000|Overall Study|Abnormal laboratory value|1|||
44448154|NCT00447694|79456752|FG000|Overall Study|Abnormal test procedure result|1|||
44448155|NCT00447694|79456752|FG000|Overall Study|Withdrawal by Subject|2|||
44448156|NCT00564278|79456758|FG000|Overall Study|Lost to Follow-up|35|||
44448157|NCT00564278|79456759|FG001|Overall Study|Lost to Follow-up|33|||
44448158|NCT00564278|79456758|FG000|Overall Study|Physician Decision|1|||
44448159|NCT00564278|79456759|FG001|Overall Study|Physician Decision|2|||
44448160|NCT00564278|79456758|FG000|Overall Study|Withdrawal by Subject|11|||
44448161|NCT00564278|79456759|FG001|Overall Study|Withdrawal by Subject|7|||
44448162|NCT00565604|79456765|FG000|Overall Study|Failure to treat|2|||
44448163|NCT00565604|79456765|FG000|Overall Study|Lost to Follow-up|2|||
44448164|NCT00447226|79456769|FG000|12-Week Open-label Phase|Adverse Event|0|||
44448165|NCT00447226|79456770|FG001|12-Week Open-label Phase|Adverse Event|3|||
44448166|NCT00447226|79456769|FG000|12-Week Open-label Phase|Protocol Violation|0|||
44448167|NCT00447226|79456770|FG001|12-Week Open-label Phase|Protocol Violation|1|||
44448168|NCT00447226|79456769|FG000|12-Week Open-label Phase|Disease Progression|0|||
44448169|NCT00447226|79456770|FG001|12-Week Open-label Phase|Disease Progression|20|||
44448170|NCT00447226|79456769|FG000|12-Week Open-label Phase|Physician Decision|0|||
44448171|NCT00447226|79456770|FG001|12-Week Open-label Phase|Physician Decision|1|||
44448172|NCT00447226|79456769|FG000|Double-blind Phase|Disease Progression|4|||
44448173|NCT00447226|79456770|FG001|Double-blind Phase|Disease Progression|3|||
44448174|NCT00446992|79456785|FG000|Overall Study|Adverse Event|11|||
44448175|NCT00446992|79456785|FG000|Overall Study|Lost to Follow-up|5|||
44448176|NCT00503139|79456789|FG000|Overall Study|Case Report Forms were not collected|4|||
44448177|NCT00503139|79456789|FG000|Overall Study|Protocol Violation|4|||
44448178|NCT00577031|79456793|FG000|Overall Study|Adverse Event|52|||
44448179|NCT00577031|79456793|FG000|Overall Study|Progression of disease|93|||
44448180|NCT00577031|79456793|FG000|Overall Study|Protocol Violation|5|||
44448181|NCT00577031|79456793|FG000|Overall Study|Participant withdrew consent|13|||
44448182|NCT00577031|79456793|FG000|Overall Study|Participant non-compliance|5|||
44448183|NCT00577031|79456793|FG000|Overall Study|Need for surgery|17|||
44448184|NCT00577031|79456793|FG000|Overall Study|Medical decision|14|||
44448185|NCT00577031|79456793|FG000|Overall Study|Death|6|||
44448186|NCT00565448|79456802|FG000|Overall Study|Adverse Event|1|||
44448187|NCT00565448|79456803|FG001|Overall Study|Adverse Event|2|||
44448188|NCT00565448|79456802|FG000|Overall Study|Disease progression|1|||
44448189|NCT00565448|79456803|FG001|Overall Study|Disease progression|0|||
44448190|NCT00565448|79456802|FG000|Overall Study|Withdrawal by Subject|1|||
44448191|NCT00565448|79456803|FG001|Overall Study|Withdrawal by Subject|0|||
44448192|NCT00446446|79456812|FG000|Overall Study|Death|10|||
44448193|NCT00446446|79456812|FG000|Overall Study|Withdrawal by Subject|6|||
44448194|NCT00446446|79456812|FG000|Overall Study|Other|4|||
44448195|NCT00446446|79456812|FG000|Overall Study|Disease Progession|2|||
44448196|NCT00446446|79456812|FG000|Overall Study|Adverse Event|1|||
44448197|NCT00446446|79456812|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
44448198|NCT00514449|79456818|FG000|Overall Study|Withdrawal by Subject|1|||
44448199|NCT00514449|79456819|FG001|Overall Study|Withdrawal by Subject|2|||
44448200|NCT00514449|79456818|FG000|Overall Study|Protocol Violation|1|||
44448201|NCT00514449|79456819|FG001|Overall Study|Protocol Violation|2|||
44448202|NCT00514449|79456818|FG000|Overall Study|Lost to Follow-up|1|||
44448203|NCT00514449|79456819|FG001|Overall Study|Lost to Follow-up|0|||
44448204|NCT00565136|79456828|FG000|Overall Study|Lost to Follow-up|1|||
44448205|NCT00565136|79456828|FG000|Overall Study|Withdrawal by Subject|1|||
44448206|NCT00565136|79456828|FG000|Overall Study|Protocol Violation|1|||
44448207|NCT00492921|79456832|FG000|Overall Study|Death|1|||
44448208|NCT00492921|79456833|FG001|Overall Study|Death|0|||
44448209|NCT00492921|79456834|FG002|Overall Study|Death|1|||
44448210|NCT00502671|79456842|FG000|Overall Study|Disease Progression|13|||
44448211|NCT00502671|79456842|FG000|Overall Study|Personal Reasons|22|||
44448212|NCT00502671|79456842|FG000|Overall Study|Lost to Follow-up|7|||
44448213|NCT00502671|79456842|FG000|Overall Study|Protocol Violation|16|||
44448214|NCT00502671|79456842|FG000|Overall Study|Adverse Event|19|||
44448215|NCT00697463|79456846|FG000|Overall Study|Withdrawal by Subject|1|||
44448216|NCT00492531|79456852|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
44448217|NCT00492531|79456853|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
44448218|NCT00111475|79456869|FG000|Overall Study|Lost to Follow-up|0|||
44448219|NCT00111475|79456870|FG001|Overall Study|Lost to Follow-up|0|||
44448220|NCT00111475|79456871|FG002|Overall Study|Lost to Follow-up|0|||
44448221|NCT00111475|79456872|FG003|Overall Study|Lost to Follow-up|0|||
44448222|NCT00111475|79456873|FG004|Overall Study|Lost to Follow-up|0|||
44448223|NCT00111475|79456874|FG005|Overall Study|Lost to Follow-up|1|||
44448224|NCT00111475|79456875|FG006|Overall Study|Lost to Follow-up|0|||
44448225|NCT00111475|79456876|FG007|Overall Study|Lost to Follow-up|0|||
44448226|NCT00111475|79456877|FG008|Overall Study|Lost to Follow-up|0|||
44448227|NCT00111475|79456878|FG009|Overall Study|Lost to Follow-up|0|||
44448228|NCT00111241|79456907|FG000|Overall Study|Lost to Follow-up|1|||
44448229|NCT00111241|79456908|FG001|Overall Study|Lost to Follow-up|0|||
44448230|NCT00111241|79456907|FG000|Overall Study|Withdrawal by Subject|4|||
44448231|NCT00111241|79456908|FG001|Overall Study|Withdrawal by Subject|0|||
44448232|NCT00111241|79456907|FG000|Overall Study|Protocol Violation|9|||
44448233|NCT00111241|79456908|FG001|Overall Study|Protocol Violation|8|||
44448234|NCT00111241|79456907|FG000|Overall Study|Adverse Event|1|||
44448235|NCT00111241|79456908|FG001|Overall Study|Adverse Event|0|||
44448236|NCT00492297|79456916|FG000|Treatment|Death|2|||
44448237|NCT00492297|79456916|FG000|Treatment|Study terminated by sponsor|3|||
44448238|NCT00492297|79456916|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
44448239|NCT00492297|79456916|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
44448240|NCT00492297|79456916|FG000|Survival Only Follow-up|Death|46|||
44448241|NCT00492297|79456916|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
44448242|NCT00492297|79456916|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
44448243|NCT00565058|79456922|FG000|Overall Study|Adverse Event|1|||
44448244|NCT00565058|79456923|FG001|Overall Study|Adverse Event|0|||
44448245|NCT00564902|79456932|FG000|Overall Study|Withdrawal by Subject|0|||
44448246|NCT00564902|79456933|FG001|Overall Study|Withdrawal by Subject|3|||
44448247|NCT00564902|79456934|FG002|Overall Study|Withdrawal by Subject|4|||
44448248|NCT00564902|79456932|FG000|Overall Study|Death|1|||
44448249|NCT00564902|79456933|FG001|Overall Study|Death|1|||
44448250|NCT00564902|79456934|FG002|Overall Study|Death|0|||
44448251|NCT00446134|79456946|FG000|Overall Study|Adverse Event|7|||
44448252|NCT00446134|79456947|FG001|Overall Study|Adverse Event|17|||
44448253|NCT00446134|79456948|FG002|Overall Study|Adverse Event|13|||
44448254|NCT00446134|79456949|FG003|Overall Study|Adverse Event|18|||
44448255|NCT00446134|79456946|FG000|Overall Study|Lack of Efficacy|19|||
44448256|NCT00446134|79456947|FG001|Overall Study|Lack of Efficacy|19|||
44448257|NCT00446134|79456948|FG002|Overall Study|Lack of Efficacy|24|||
44448258|NCT00446134|79456949|FG003|Overall Study|Lack of Efficacy|19|||
44448259|NCT00446134|79456946|FG000|Overall Study|Protocol Violation|0|||
44448260|NCT00446134|79456947|FG001|Overall Study|Protocol Violation|2|||
44448261|NCT00446134|79456948|FG002|Overall Study|Protocol Violation|1|||
44448262|NCT00446134|79456949|FG003|Overall Study|Protocol Violation|0|||
44448263|NCT00446134|79456946|FG000|Overall Study|Lost to Follow-up|1|||
44448264|NCT00446134|79456947|FG001|Overall Study|Lost to Follow-up|3|||
44448265|NCT00446134|79456948|FG002|Overall Study|Lost to Follow-up|1|||
44448266|NCT00446134|79456949|FG003|Overall Study|Lost to Follow-up|1|||
44448267|NCT00446134|79456946|FG000|Overall Study|Withdrawal by Subject|3|||
44448268|NCT00446134|79456947|FG001|Overall Study|Withdrawal by Subject|3|||
44448269|NCT00446134|79456948|FG002|Overall Study|Withdrawal by Subject|1|||
44448270|NCT00446134|79456949|FG003|Overall Study|Withdrawal by Subject|3|||
44448271|NCT00446134|79456946|FG000|Overall Study|Physician Decision|0|||
44448272|NCT00446134|79456947|FG001|Overall Study|Physician Decision|0|||
44448273|NCT00446134|79456948|FG002|Overall Study|Physician Decision|0|||
44448274|NCT00446134|79456949|FG003|Overall Study|Physician Decision|2|||
44448275|NCT00446134|79456946|FG000|Overall Study|Adverse Event-Diarrhea|1|||
44448276|NCT00446134|79456947|FG001|Overall Study|Adverse Event-Diarrhea|1|||
44448277|NCT00446134|79456948|FG002|Overall Study|Adverse Event-Diarrhea|2|||
44448278|NCT00446134|79456949|FG003|Overall Study|Adverse Event-Diarrhea|0|||
44448279|NCT00446134|79456946|FG000|Overall Study|Reason Not Completed|3|||
44448280|NCT00446134|79456947|FG001|Overall Study|Reason Not Completed|0|||
44448281|NCT00446134|79456948|FG002|Overall Study|Reason Not Completed|1|||
44448282|NCT00446134|79456949|FG003|Overall Study|Reason Not Completed|2|||
44448283|NCT00563186|79456961|FG000|Overall Study|LOS<48 hours|97|||
44448284|NCT00563186|79456962|FG001|Overall Study|LOS<48 hours|74|||
44448285|NCT00563186|79456961|FG000|Overall Study|Incomplete data|1|||
44448286|NCT00563186|79456962|FG001|Overall Study|Incomplete data|1|||
44448287|NCT00699413|79456973|FG000|Overall Study|Withdrawal by Subject|0|||
44448288|NCT00699413|79456974|FG001|Overall Study|Withdrawal by Subject|2|||
44448289|NCT00699413|79456973|FG000|Overall Study|Study terminated by sponsor|4|||
44448290|NCT00699413|79456974|FG001|Overall Study|Study terminated by sponsor|2|||
44448291|NCT04808609|79456982|FG000|Overall Study|Lost to Follow-up|0|||
44448292|NCT04808609|79456983|FG001|Overall Study|Lost to Follow-up|2|||
44448293|NCT04808609|79456982|FG000|Overall Study|Administrative Withdrawal|0|||
44448294|NCT04808609|79456983|FG001|Overall Study|Administrative Withdrawal|1|||
44448295|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
44448296|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
44448297|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Death|5|||
44448298|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Death|2|||
44448299|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
44448300|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
44448301|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
44448302|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
44448303|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
44448304|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
44448305|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Relapse|1|||
44448306|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Relapse|0|||
44448307|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
44448308|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
44448309|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
44448310|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
44448311|NCT00111007|79456991|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
44448312|NCT00111007|79456992|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
44448313|NCT00111007|79456991|FG000|Active Follow-up|Adverse Event|1|||
44448314|NCT00111007|79456992|FG001|Active Follow-up|Adverse Event|0|||
44448315|NCT00111007|79456991|FG000|Active Follow-up|Death|2|||
44448316|NCT00111007|79456992|FG001|Active Follow-up|Death|0|||
44352331|NCT01235741|79356788|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
44352332|NCT01235741|79356786|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
44352333|NCT01235741|79356787|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
44352334|NCT01235741|79356788|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
44352335|NCT01235741|79356786|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
44352336|NCT01235741|79356787|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
44352337|NCT01235741|79356788|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
44352338|NCT01235741|79356786|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
44352339|NCT01235741|79356787|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
44352340|NCT01235741|79356788|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
44352341|NCT01235741|79356786|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
44352342|NCT01235741|79356787|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
44352343|NCT01235741|79356788|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
44352344|NCT01235741|79356786|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
44352345|NCT01235741|79356787|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
44352346|NCT01235741|79356788|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
44352347|NCT01235741|79356786|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
44352348|NCT01235741|79356787|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
44352349|NCT01235741|79356788|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
44352350|NCT01235741|79356786|FG000|Randomized to Treatment|Adverse Event|0|||
44352351|NCT01235741|79356787|FG001|Randomized to Treatment|Adverse Event|1|||
44352352|NCT01235741|79356788|FG002|Randomized to Treatment|Adverse Event|1|||
44352353|NCT01235741|79356786|FG000|Randomized to Treatment|Sponsor terminated study|0|||
44352354|NCT01235741|79356787|FG001|Randomized to Treatment|Sponsor terminated study|35|||
44352355|NCT01235741|79356788|FG002|Randomized to Treatment|Sponsor terminated study|34|||
44352356|NCT01235741|79356786|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
44352357|NCT01235741|79356787|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
44352358|NCT01235741|79356788|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
44352359|NCT01235741|79356786|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
44352360|NCT01235741|79356787|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
44352361|NCT01235741|79356788|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
44352362|NCT01235741|79356786|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
44352363|NCT01235741|79356787|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
44352364|NCT01235741|79356788|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
44352365|NCT01235507|79356800|FG000|Overall Study|Adverse Event|1|||
44352366|NCT01235507|79356800|FG000|Overall Study|Withdrawal by Subject|1|||
44352367|NCT01235351|79356806|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
44352368|NCT01235351|79356807|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
44352369|NCT01076205|79356817|FG000|Overall Study|Adverse Drug Reaction|299|||
44352370|NCT01076205|79356817|FG000|Overall Study|Lack of Effectiveness|1423|||
44352371|NCT01076205|79356817|FG000|Overall Study|Other Reason|1075|||
44352372|NCT01076205|79356817|FG000|Overall Study|Unknown Reason|71|||
44352373|NCT01076205|79356817|FG000|Overall Study|Lost to Follow-up|3151|||
44352374|NCT01234883|79356839|FG000|Overall Study|Early treatment release|8|||
44352375|NCT01234883|79356840|FG001|Overall Study|Early treatment release|10|||
44352376|NCT01234883|79356839|FG000|Overall Study|Parent/guardian withdrew consent|1|||
44352377|NCT01234883|79356840|FG001|Overall Study|Parent/guardian withdrew consent|2|||
44352378|NCT01234883|79356839|FG000|Overall Study|Technical difficulties with IV infusion|0|||
44352379|NCT01234883|79356840|FG001|Overall Study|Technical difficulties with IV infusion|1|||
44352380|NCT01234883|79356839|FG000|Overall Study|Inclusion/exclusion failure|1|||
44352381|NCT01234883|79356840|FG001|Overall Study|Inclusion/exclusion failure|0|||
44352382|NCT01234649|79356848|FG000|Overall Study|Withdrawal by Subject|32|||
44352383|NCT01234649|79356849|FG001|Overall Study|Withdrawal by Subject|26|||
44352384|NCT01234649|79356848|FG000|Overall Study|Pregnancy|6|||
44352385|NCT01234649|79356849|FG001|Overall Study|Pregnancy|6|||
44352386|NCT01234649|79356848|FG000|Overall Study|intolerant to side effects|4|||
44352387|NCT01234649|79356849|FG001|Overall Study|intolerant to side effects|3|||
44352388|NCT01234649|79356848|FG000|Overall Study|Allergic reaction|1|||
44352389|NCT01234649|79356849|FG001|Overall Study|Allergic reaction|0|||
44352390|NCT01234649|79356848|FG000|Overall Study|Lack of Efficacy|0|||
44352391|NCT01234649|79356849|FG001|Overall Study|Lack of Efficacy|3|||
44352392|NCT01075815|79356857|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
44352393|NCT01075815|79356858|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
44352394|NCT01075815|79356857|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
44352395|NCT01075815|79356858|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
44352396|NCT01075815|79356857|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
44352397|NCT01075815|79356858|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
44352398|NCT01075191|79356864|FG000|Overall Study|Death|1|||
44352399|NCT01075191|79356864|FG000|Overall Study|Intensification|3|||
44352400|NCT01075191|79356864|FG000|Overall Study|Co-morbidities|1|||
44352401|NCT01075191|79356864|FG000|Overall Study|Adverse Event|4|||
44352402|NCT01075191|79356864|FG000|Overall Study|Noncompliance|3|||
44448317|NCT00111007|79456991|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
44448318|NCT00111007|79456992|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
44352403|NCT01075191|79356864|FG000|Overall Study|Therapy Break|3|||
44352404|NCT01075191|79356864|FG000|Overall Study|Patient's Wish|2|||
44352405|NCT01075191|79356864|FG000|Overall Study|Unknown Reasons|1|||
44352406|NCT00905359|79356870|FG000|Overall Study|Lost to Follow-up|17|||
44352407|NCT00905359|79356871|FG001|Overall Study|Lost to Follow-up|10|||
44352408|NCT00905359|79356870|FG000|Overall Study|Death|2|||
44352409|NCT00905359|79356871|FG001|Overall Study|Death|0|||
44352410|NCT00905359|79356870|FG000|Overall Study|Withdrawal consent|5|||
44352411|NCT00905359|79356871|FG001|Overall Study|Withdrawal consent|6|||
44352412|NCT01072149|79356877|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352413|NCT01072149|79356878|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352414|NCT01072149|79356879|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
44352415|NCT01072149|79356880|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352416|NCT01072149|79356881|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352417|NCT01072149|79356882|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352418|NCT01072149|79356883|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352419|NCT01072149|79356884|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352420|NCT01072149|79356885|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352421|NCT01072149|79356886|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352422|NCT01072149|79356887|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352423|NCT01072149|79356888|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352424|NCT01072149|79356889|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352425|NCT01072149|79356890|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352426|NCT01072149|79356891|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352427|NCT01072149|79356892|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352428|NCT01072149|79356893|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352429|NCT01072149|79356894|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
44352430|NCT01072149|79356877|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352431|NCT01072149|79356878|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352432|NCT01072149|79356879|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352433|NCT01072149|79356880|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352434|NCT01072149|79356881|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352435|NCT01072149|79356882|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352436|NCT01072149|79356883|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352437|NCT01072149|79356884|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352438|NCT01072149|79356885|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352439|NCT01072149|79356886|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352440|NCT01072149|79356887|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352441|NCT01072149|79356888|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352442|NCT01072149|79356889|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352443|NCT01072149|79356890|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352444|NCT01072149|79356891|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352445|NCT01072149|79356892|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352446|NCT01072149|79356893|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
44352447|NCT01072149|79356894|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
44352448|NCT01072149|79356877|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352449|NCT01072149|79356878|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352450|NCT01072149|79356879|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352451|NCT01072149|79356880|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352452|NCT01072149|79356881|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352453|NCT01072149|79356882|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352454|NCT01072149|79356883|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352455|NCT01072149|79356884|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352456|NCT01072149|79356885|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352457|NCT01072149|79356886|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352458|NCT01072149|79356887|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
44352459|NCT01072149|79356888|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352460|NCT01072149|79356889|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352461|NCT01072149|79356890|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352462|NCT01072149|79356891|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352463|NCT01072149|79356892|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352464|NCT01072149|79356893|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352465|NCT01072149|79356894|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
44352466|NCT01072149|79356877|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352467|NCT01072149|79356878|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
44352468|NCT01072149|79356879|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352469|NCT01072149|79356880|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352470|NCT01072149|79356881|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352471|NCT01072149|79356882|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352472|NCT01072149|79356883|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352473|NCT01072149|79356884|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352474|NCT01072149|79356885|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352475|NCT01072149|79356886|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352476|NCT01072149|79356887|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352477|NCT01072149|79356888|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352478|NCT01072149|79356889|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352479|NCT01072149|79356890|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352480|NCT01072149|79356891|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352481|NCT01072149|79356892|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352482|NCT01072149|79356893|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352483|NCT01072149|79356894|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
44352484|NCT01072149|79356877|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352485|NCT01072149|79356878|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352486|NCT01072149|79356879|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
44352487|NCT01072149|79356880|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352488|NCT01072149|79356881|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352489|NCT01072149|79356882|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352490|NCT01072149|79356883|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352491|NCT01072149|79356884|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352492|NCT01072149|79356885|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352493|NCT01072149|79356886|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352494|NCT01072149|79356887|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352495|NCT01072149|79356888|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352496|NCT01072149|79356889|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352497|NCT01072149|79356890|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352498|NCT01072149|79356891|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352499|NCT01072149|79356892|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352500|NCT01072149|79356893|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352501|NCT01072149|79356894|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
44352502|NCT01072149|79356877|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352503|NCT01072149|79356878|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352504|NCT01072149|79356879|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352505|NCT01072149|79356880|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352506|NCT01072149|79356881|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352507|NCT01072149|79356882|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352508|NCT01072149|79356883|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352509|NCT01072149|79356884|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
44352510|NCT01072149|79356885|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352511|NCT01072149|79356886|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352512|NCT01072149|79356887|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352513|NCT01072149|79356888|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352514|NCT01072149|79356889|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352515|NCT01072149|79356890|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352516|NCT01072149|79356891|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352517|NCT01072149|79356892|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352518|NCT01072149|79356893|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352519|NCT01072149|79356894|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
44352520|NCT01072149|79356877|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
44352521|NCT01072149|79356878|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
44352522|NCT01072149|79356879|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
44352523|NCT01072149|79356880|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
44352524|NCT01072149|79356881|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
44352525|NCT01072149|79356882|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
44352526|NCT01072149|79356883|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
44352527|NCT01072149|79356884|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
44352528|NCT01072149|79356885|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
44352529|NCT01072149|79356886|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
44352530|NCT01072149|79356887|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
44352531|NCT01072149|79356888|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
44352532|NCT01072149|79356889|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
44352533|NCT01072149|79356890|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
44352534|NCT01072149|79356891|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
44352535|NCT01072149|79356892|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
44352536|NCT01072149|79356893|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
44352537|NCT01072149|79356894|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
44352538|NCT01072149|79356877|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352539|NCT01072149|79356878|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352540|NCT01072149|79356879|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352541|NCT01072149|79356880|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352542|NCT01072149|79356881|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352543|NCT01072149|79356882|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352544|NCT01072149|79356883|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352545|NCT01072149|79356884|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352546|NCT01072149|79356885|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352547|NCT01072149|79356886|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352548|NCT01072149|79356887|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352549|NCT01072149|79356888|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352550|NCT01072149|79356889|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352551|NCT01072149|79356890|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352552|NCT01072149|79356891|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352553|NCT01072149|79356892|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
44352554|NCT01072149|79356893|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352555|NCT01072149|79356894|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
44352556|NCT01072149|79356877|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
44352557|NCT01072149|79356878|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
44352558|NCT01072149|79356879|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
44352559|NCT01072149|79356880|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
44352560|NCT01072149|79356881|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
44352561|NCT01072149|79356882|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
44352562|NCT01072149|79356883|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
44352563|NCT01072149|79356884|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
44352564|NCT01072149|79356885|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
44352565|NCT01072149|79356886|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
44352566|NCT01072149|79356887|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
44352567|NCT01072149|79356888|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
44352568|NCT01072149|79356889|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
44352569|NCT01072149|79356890|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
44352570|NCT01072149|79356891|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
44352571|NCT01072149|79356892|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
44352572|NCT01072149|79356893|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
44352573|NCT01072149|79356894|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
44352574|NCT01072149|79356877|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352575|NCT01072149|79356878|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352576|NCT01072149|79356879|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352577|NCT01072149|79356880|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352578|NCT01072149|79356881|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352579|NCT01072149|79356882|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352580|NCT01072149|79356883|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352581|NCT01072149|79356884|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352582|NCT01072149|79356885|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352583|NCT01072149|79356886|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352584|NCT01072149|79356887|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352585|NCT01072149|79356888|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352586|NCT01072149|79356889|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
44352587|NCT01072149|79356890|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352588|NCT01072149|79356891|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352589|NCT01072149|79356892|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352590|NCT01072149|79356893|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352591|NCT01072149|79356894|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
44352592|NCT01072149|79356877|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352593|NCT01072149|79356878|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352594|NCT01072149|79356879|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
44352595|NCT01072149|79356880|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352596|NCT01072149|79356881|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352597|NCT01072149|79356882|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352598|NCT01072149|79356883|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352599|NCT01072149|79356884|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352600|NCT01072149|79356885|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352601|NCT01072149|79356886|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352602|NCT01072149|79356887|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352603|NCT01072149|79356888|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352604|NCT01072149|79356889|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352605|NCT01072149|79356890|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
44352606|NCT01072149|79356891|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352607|NCT01072149|79356892|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352608|NCT01072149|79356893|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352609|NCT01072149|79356894|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
44352610|NCT01071915|79356904|FG000|Overall Study|Adverse Event|3|||
44448319|NCT00111007|79456991|FG000|Long Term Follow-up|Death|34|||
44352611|NCT01071915|79356904|FG000|Overall Study|Physician Decision|2|||
44352612|NCT01071915|79356904|FG000|Overall Study|Withdrawal by Subject|2|||
44352613|NCT01071915|79356904|FG000|Overall Study|Miscellaneous Reasons|2|||
44352614|NCT00904969|79356908|FG000|Overall Study|Lost to Follow-up|4|||
44352615|NCT00904969|79356908|FG000|Overall Study|Withdrawal by Subject|3|||
44352616|NCT00904969|79356908|FG000|Overall Study|Additional Treatments|11|||
44352617|NCT00904969|79356908|FG000|Overall Study|Case Aborted; Subject Exited|1|||
44352618|NCT01070979|79356930|FG000|Overall Study|Adverse Event|2|||
44352619|NCT01070979|79356931|FG001|Overall Study|Adverse Event|3|||
44352620|NCT01070979|79356932|FG002|Overall Study|Adverse Event|3|||
44352621|NCT01070979|79356930|FG000|Overall Study|Lost to Follow-up|2|||
44352622|NCT01070979|79356931|FG001|Overall Study|Lost to Follow-up|1|||
44352623|NCT01070979|79356932|FG002|Overall Study|Lost to Follow-up|1|||
44352624|NCT01070979|79356930|FG000|Overall Study|Protocol Violation|0|||
44352625|NCT01070979|79356931|FG001|Overall Study|Protocol Violation|2|||
44352626|NCT01070979|79356932|FG002|Overall Study|Protocol Violation|6|||
44352627|NCT01070979|79356930|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
44352628|NCT01070979|79356931|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
44352629|NCT01070979|79356932|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
44352630|NCT01070979|79356930|FG000|Overall Study|Withdrawal by Subject|3|||
44352631|NCT01070979|79356931|FG001|Overall Study|Withdrawal by Subject|1|||
44352632|NCT01070979|79356932|FG002|Overall Study|Withdrawal by Subject|1|||
44352633|NCT01070979|79356930|FG000|Overall Study|No study drug taken|0|||
44352634|NCT01070979|79356931|FG001|Overall Study|No study drug taken|1|||
44352635|NCT01070979|79356932|FG002|Overall Study|No study drug taken|0|||
44352636|NCT01234337|79356942|FG000|Overall Study|Adverse Event|58|||
44352637|NCT01234337|79356943|FG001|Overall Study|Adverse Event|21|||
44352638|NCT01234337|79356942|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
44352639|NCT01234337|79356943|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
44352640|NCT01234337|79356942|FG000|Overall Study|Investi. decision not protocol driven|5|||
44352641|NCT01234337|79356943|FG001|Overall Study|Investi. decision not protocol driven|6|||
44352642|NCT01234337|79356942|FG000|Overall Study|Non-compliant with study medication|3|||
44352643|NCT01234337|79356943|FG001|Overall Study|Non-compliant with study medication|2|||
44352644|NCT01234337|79356942|FG000|Overall Study|Randomized but not treated|6|||
44352645|NCT01234337|79356943|FG001|Overall Study|Randomized but not treated|4|||
44352646|NCT01234337|79356942|FG000|Overall Study|Lost to Follow-up|0|||
44352647|NCT01234337|79356943|FG001|Overall Study|Lost to Follow-up|1|||
44352648|NCT01234337|79356942|FG000|Overall Study|Protocol Violation|2|||
44352649|NCT01234337|79356943|FG001|Overall Study|Protocol Violation|3|||
44352650|NCT01234337|79356942|FG000|Overall Study|Withdrawal by Subject|11|||
44352651|NCT01234337|79356943|FG001|Overall Study|Withdrawal by Subject|9|||
44352652|NCT01234337|79356942|FG000|Overall Study|Death|0|||
44352653|NCT01234337|79356943|FG001|Overall Study|Death|1|||
44352654|NCT01234337|79356942|FG000|Overall Study|Switch to commercial drug|0|||
44352655|NCT01234337|79356943|FG001|Overall Study|Switch to commercial drug|1|||
44352656|NCT01070043|79356951|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
44352657|NCT01070043|79356952|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
44352658|NCT01070043|79356953|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
44352659|NCT01070043|79356951|FG000|Double-Blind Treatment|Adverse Event|0|||
44352660|NCT01070043|79356952|FG001|Double-Blind Treatment|Adverse Event|0|||
44352661|NCT01070043|79356953|FG002|Double-Blind Treatment|Adverse Event|2|||
44352662|NCT01074255|79356959|FG000|Overall Study|Did not receive EMEND|2|||
44352663|NCT01073943|79356965|FG000|Overall Study|Withdrawal by Subject|8|||
44352664|NCT01073943|79356966|FG001|Overall Study|Withdrawal by Subject|2|||
44352665|NCT01073943|79356965|FG000|Overall Study|Protocol Violation|2|||
44352666|NCT01073943|79356966|FG001|Overall Study|Protocol Violation|1|||
44352667|NCT01073943|79356965|FG000|Overall Study|Adverse Event|1|||
44352668|NCT01073943|79356966|FG001|Overall Study|Adverse Event|1|||
44352669|NCT01073943|79356965|FG000|Overall Study|Lost to Follow-up|0|||
44352670|NCT01073943|79356966|FG001|Overall Study|Lost to Follow-up|2|||
44352671|NCT01073943|79356965|FG000|Overall Study|Power outage; colonoscopy not done|1|||
44352672|NCT01073943|79356966|FG001|Overall Study|Power outage; colonoscopy not done|0|||
44352673|NCT01073943|79356965|FG000|Overall Study|Subject forgot|0|||
44352674|NCT01073943|79356966|FG001|Overall Study|Subject forgot|1|||
44352675|NCT01073943|79356965|FG000|Overall Study|Unable to return for follow-up|0|||
44352676|NCT01073943|79356966|FG001|Overall Study|Unable to return for follow-up|1|||
44352677|NCT01073943|79356965|FG000|Overall Study|Could not tolerate prep|1|||
44352678|NCT01073943|79356966|FG001|Overall Study|Could not tolerate prep|0|||
44352679|NCT01073865|79356974|FG000|Overall Study|Reasons other than below|19|||
44352680|NCT01073865|79356975|FG001|Overall Study|Reasons other than below|31|||
44352681|NCT01073865|79356974|FG000|Overall Study|Lost to Follow-up|1|||
44352682|NCT01073865|79356975|FG001|Overall Study|Lost to Follow-up|1|||
44352683|NCT01073865|79356974|FG000|Overall Study|Death|3|||
44352684|NCT01073865|79356975|FG001|Overall Study|Death|2|||
44352685|NCT01073865|79356974|FG000|Overall Study|Withdrawal by Subject|5|||
44352686|NCT01073865|79356975|FG001|Overall Study|Withdrawal by Subject|5|||
44352687|NCT04862065|79356984|FG000|Screening|Protocol Violation|54|||
44352688|NCT04862065|79356985|FG001|Screening|Protocol Violation|0|||
44352689|NCT04862065|79356986|FG002|Screening|Protocol Violation|0|||
44352690|NCT04862065|79356984|FG000|Screening|Insufficient Sample|1|||
44352691|NCT04862065|79356985|FG001|Screening|Insufficient Sample|0|||
44352692|NCT04862065|79356986|FG002|Screening|Insufficient Sample|0|||
44352693|NCT04862065|79356984|FG000|Follow-Up|Lost to Follow-up|3|||
44352694|NCT04862065|79356985|FG001|Follow-Up|Lost to Follow-up|0|||
44352695|NCT04862065|79356986|FG002|Follow-Up|Lost to Follow-up|0|||
44352696|NCT01073631|79356992|FG000|Overall Study|Death|82|||
44352697|NCT01073631|79356992|FG000|Overall Study|Adverse Event|24|||
44352698|NCT01073631|79356992|FG000|Overall Study|Other|63|||
44352699|NCT01073163|79356996|FG000|Overall Study|Adverse Event|1|||
44352700|NCT01073163|79356996|FG000|Overall Study|Disease Progression|1|||
44352701|NCT01073163|79356996|FG000|Overall Study|Early termination|1|||
44352702|NCT01072929|79357007|FG000|Overall Study|Adverse Event|8|||
44352703|NCT01072929|79357008|FG001|Overall Study|Adverse Event|11|||
44352704|NCT01072929|79357009|FG002|Overall Study|Adverse Event|2|||
44352705|NCT01072929|79357007|FG000|Overall Study|Lack of Efficacy|7|||
44352706|NCT01072929|79357008|FG001|Overall Study|Lack of Efficacy|4|||
44352707|NCT01072929|79357009|FG002|Overall Study|Lack of Efficacy|0|||
44352708|NCT01072929|79357007|FG000|Overall Study|Withdrawal by Subject|7|||
44352709|NCT01072929|79357008|FG001|Overall Study|Withdrawal by Subject|15|||
44352710|NCT01072929|79357009|FG002|Overall Study|Withdrawal by Subject|3|||
44352711|NCT01072929|79357007|FG000|Overall Study|Protocol Violation|13|||
44352712|NCT01072929|79357008|FG001|Overall Study|Protocol Violation|11|||
44352713|NCT01072929|79357009|FG002|Overall Study|Protocol Violation|2|||
44352714|NCT01072929|79357007|FG000|Overall Study|Lost to Follow-up|8|||
44352715|NCT01072929|79357008|FG001|Overall Study|Lost to Follow-up|4|||
44352716|NCT01072929|79357009|FG002|Overall Study|Lost to Follow-up|1|||
44352717|NCT01072929|79357007|FG000|Overall Study|Noncompliance with study medication|0|||
44352718|NCT01072929|79357008|FG001|Overall Study|Noncompliance with study medication|3|||
44352719|NCT01072929|79357009|FG002|Overall Study|Noncompliance with study medication|0|||
44352720|NCT01072929|79357007|FG000|Overall Study|Noncompliance with study procedures|1|||
44352721|NCT01072929|79357008|FG001|Overall Study|Noncompliance with study procedures|0|||
44352722|NCT01072929|79357009|FG002|Overall Study|Noncompliance with study procedures|1|||
44352723|NCT01072929|79357007|FG000|Overall Study|Other|0|||
44352724|NCT01072929|79357008|FG001|Overall Study|Other|3|||
44352725|NCT01072929|79357009|FG002|Overall Study|Other|0|||
44352726|NCT01231607|79357023|FG000|Overall Study|Adverse Event|0|||
44352727|NCT01231607|79357024|FG001|Overall Study|Adverse Event|8|||
44352728|NCT01231607|79357025|FG002|Overall Study|Adverse Event|4|||
44352729|NCT01231607|79357026|FG003|Overall Study|Adverse Event|4|||
44352730|NCT01231607|79357027|FG004|Overall Study|Adverse Event|5|||
44352731|NCT01231607|79357023|FG000|Overall Study|Lost to Follow-up|13|||
44352732|NCT01231607|79357024|FG001|Overall Study|Lost to Follow-up|11|||
44352733|NCT01231607|79357025|FG002|Overall Study|Lost to Follow-up|10|||
44352734|NCT01231607|79357026|FG003|Overall Study|Lost to Follow-up|10|||
44352735|NCT01231607|79357027|FG004|Overall Study|Lost to Follow-up|4|||
44352736|NCT01231607|79357023|FG000|Overall Study|Physician Decision|4|||
44352737|NCT01231607|79357024|FG001|Overall Study|Physician Decision|4|||
44352738|NCT01231607|79357025|FG002|Overall Study|Physician Decision|3|||
44352739|NCT01231607|79357026|FG003|Overall Study|Physician Decision|5|||
44352740|NCT01231607|79357027|FG004|Overall Study|Physician Decision|4|||
44352741|NCT01231607|79357023|FG000|Overall Study|Protocol Violation|3|||
44352742|NCT01231607|79357024|FG001|Overall Study|Protocol Violation|2|||
44352743|NCT01231607|79357025|FG002|Overall Study|Protocol Violation|0|||
44352744|NCT01231607|79357026|FG003|Overall Study|Protocol Violation|2|||
44352745|NCT01231607|79357027|FG004|Overall Study|Protocol Violation|2|||
44352746|NCT01231607|79357023|FG000|Overall Study|Withdrawal by Subject|9|||
44352747|NCT01231607|79357024|FG001|Overall Study|Withdrawal by Subject|9|||
44352748|NCT01231607|79357025|FG002|Overall Study|Withdrawal by Subject|14|||
44352749|NCT01231607|79357026|FG003|Overall Study|Withdrawal by Subject|17|||
44352750|NCT01231607|79357027|FG004|Overall Study|Withdrawal by Subject|9|||
44352751|NCT01231373|79357046|FG000|Overall Study|Withdrew consent prior to randomization|2|||
44352752|NCT01231373|79357047|FG001|Overall Study|Withdrew consent prior to randomization|1|||
44352753|NCT01231373|79357048|FG002|Overall Study|Withdrew consent prior to randomization|0|||
44352754|NCT01231373|79357049|FG003|Overall Study|Withdrew consent prior to randomization|0|||
44352755|NCT01231373|79357046|FG000|Overall Study|Lost to Follow-up|0|||
44352756|NCT01231373|79357047|FG001|Overall Study|Lost to Follow-up|0|||
44352757|NCT01231373|79357048|FG002|Overall Study|Lost to Follow-up|0|||
44352758|NCT01231373|79357049|FG003|Overall Study|Lost to Follow-up|1|||
44352759|NCT01231373|79357046|FG000|Overall Study|Withdrew Consent|1|||
44352760|NCT01231373|79357047|FG001|Overall Study|Withdrew Consent|0|||
44352761|NCT01231373|79357048|FG002|Overall Study|Withdrew Consent|0|||
44352762|NCT01231373|79357049|FG003|Overall Study|Withdrew Consent|0|||
44352763|NCT00975130|79357061|FG000|Study Part 1|Adverse Event|150|||
44352764|NCT00975130|79357062|FG001|Study Part 1|Adverse Event|0|||
44352765|NCT00975130|79357063|FG002|Study Part 1|Adverse Event|0|||
44352766|NCT00975130|79357061|FG000|Study Part 1|Lost to Follow-up|19|||
44352767|NCT00975130|79357062|FG001|Study Part 1|Lost to Follow-up|0|||
44352768|NCT00975130|79357063|FG002|Study Part 1|Lost to Follow-up|0|||
44352769|NCT00975130|79357061|FG000|Study Part 1|Withdrawal by Subject|61|||
44352770|NCT00975130|79357062|FG001|Study Part 1|Withdrawal by Subject|0|||
44352771|NCT00975130|79357063|FG002|Study Part 1|Withdrawal by Subject|0|||
44352772|NCT00975130|79357061|FG000|Study Part 1|Protocol Violation|13|||
44352773|NCT00975130|79357062|FG001|Study Part 1|Protocol Violation|0|||
44352774|NCT00975130|79357063|FG002|Study Part 1|Protocol Violation|0|||
44352775|NCT00975130|79357061|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
44352776|NCT00975130|79357062|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
44352777|NCT00975130|79357063|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
44352778|NCT00975130|79357061|FG000|Study Part 1|Administrative|4|||
44352779|NCT00975130|79357062|FG001|Study Part 1|Administrative|0|||
44352780|NCT00975130|79357063|FG002|Study Part 1|Administrative|0|||
44352781|NCT00975130|79357061|FG000|Study Part 1|Withdrew Consent|24|||
44352782|NCT00975130|79357062|FG001|Study Part 1|Withdrew Consent|0|||
44352783|NCT00975130|79357063|FG002|Study Part 1|Withdrew Consent|0|||
44352784|NCT00975130|79357061|FG000|Study Part 2|Adverse Event|0|||
44352785|NCT00975130|79357062|FG001|Study Part 2|Adverse Event|14|||
44352786|NCT00975130|79357063|FG002|Study Part 2|Adverse Event|7|||
44352787|NCT00975130|79357061|FG000|Study Part 2|Lost to Follow-up|0|||
44352788|NCT00975130|79357062|FG001|Study Part 2|Lost to Follow-up|0|||
44352789|NCT00975130|79357063|FG002|Study Part 2|Lost to Follow-up|1|||
44352790|NCT00975130|79357061|FG000|Study Part 2|Withdrawal by Subject|0|||
44352791|NCT00975130|79357062|FG001|Study Part 2|Withdrawal by Subject|13|||
44352792|NCT00975130|79357063|FG002|Study Part 2|Withdrawal by Subject|5|||
44352793|NCT00975130|79357061|FG000|Study Part 2|Withdrew Consent|0|||
44352794|NCT00975130|79357062|FG001|Study Part 2|Withdrew Consent|6|||
44352795|NCT00975130|79357063|FG002|Study Part 2|Withdrew Consent|2|||
44352796|NCT00975130|79357061|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
44352797|NCT00975130|79357062|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
44352798|NCT00975130|79357063|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
44352799|NCT00975130|79357061|FG000|Study Part 2|Administrative|0|||
44352800|NCT00975130|79357062|FG001|Study Part 2|Administrative|1|||
44352801|NCT00975130|79357063|FG002|Study Part 2|Administrative|0|||
44352802|NCT00975130|79357061|FG000|Study Part 2|Protocol Violation|0|||
44352803|NCT00975130|79357062|FG001|Study Part 2|Protocol Violation|0|||
44352804|NCT00975130|79357063|FG002|Study Part 2|Protocol Violation|1|||
44352805|NCT01230827|79357080|FG000|Overall Study|Lost to Follow-up|0|||
44352806|NCT01230827|79357081|FG001|Overall Study|Lost to Follow-up|0|||
44352807|NCT01230827|79357082|FG002|Overall Study|Lost to Follow-up|1|||
44352808|NCT01230827|79357083|FG003|Overall Study|Lost to Follow-up|3|||
44352809|NCT01230827|79357080|FG000|Overall Study|Withdrawal by Subject|1|||
44352810|NCT01230827|79357081|FG001|Overall Study|Withdrawal by Subject|0|||
44352811|NCT01230827|79357082|FG002|Overall Study|Withdrawal by Subject|3|||
44352812|NCT01230827|79357083|FG003|Overall Study|Withdrawal by Subject|2|||
44352813|NCT01230827|79357080|FG000|Overall Study|Lack of Efficacy|14|||
44352814|NCT01230827|79357081|FG001|Overall Study|Lack of Efficacy|1|||
44260963|NCT00986258|79136653|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
44260964|NCT00986258|79136653|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
44260965|NCT00986258|79136653|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
44260966|NCT00986258|79136653|FG000|Titration and Optimal Dose Period|Other|1|||
44260967|NCT00986258|79136653|FG000|Maintenance Period|Adverse Event|5|||
44260968|NCT00986258|79136653|FG000|Maintenance Period|Lack of Efficacy|2|||
44260969|NCT00986258|79136653|FG000|Maintenance Period|Withdrawal by Subject|2|||
44260970|NCT00986180|79136669|FG000|Overall Study|Adverse Event|21|||
44260971|NCT00986180|79136670|FG001|Overall Study|Adverse Event|23|||
44260972|NCT00986180|79136669|FG000|Overall Study|Lack of Efficacy|4|||
44260973|NCT00986180|79136670|FG001|Overall Study|Lack of Efficacy|3|||
44260974|NCT00986180|79136669|FG000|Overall Study|Lost to Follow-up|5|||
44260975|NCT00986180|79136670|FG001|Overall Study|Lost to Follow-up|7|||
44260976|NCT00986180|79136669|FG000|Overall Study|Physician Decision|1|||
44260977|NCT00986180|79136670|FG001|Overall Study|Physician Decision|3|||
44260978|NCT00986180|79136669|FG000|Overall Study|Protocol Violation|2|||
44260979|NCT00986180|79136670|FG001|Overall Study|Protocol Violation|0|||
44260980|NCT00986180|79136669|FG000|Overall Study|Withdrawal by Subject|1|||
44260981|NCT00986180|79136670|FG001|Overall Study|Withdrawal by Subject|9|||
44260982|NCT00986180|79136669|FG000|Overall Study|Miscellanies|10|||
44260983|NCT00986180|79136670|FG001|Overall Study|Miscellanies|11|||
44260984|NCT00986102|79136852|FG000|Overall Study|Lost to Follow-up|0|||
44352815|NCT01230827|79357082|FG002|Overall Study|Lack of Efficacy|2|||
44352816|NCT01230827|79357083|FG003|Overall Study|Lack of Efficacy|3|||
44352817|NCT01230827|79357080|FG000|Overall Study|Adverse Event|4|||
44352818|NCT01230827|79357081|FG001|Overall Study|Adverse Event|2|||
44260985|NCT00986102|79136853|FG001|Overall Study|Lost to Follow-up|1|||
44166768|NCT02283411|78959850|FG000|Overall Study|Withdrawal by Subject|3|||
44166769|NCT02283411|78959850|FG000|Overall Study|Screen Failed|28|||
44166770|NCT02351817|78959854|FG000|Period 1|Adverse Event|1|||
44166771|NCT02351817|78959855|FG001|Period 1|Adverse Event|2|||
44166772|NCT02351817|78959854|FG000|Period 1|Lack of Efficacy|0|||
44166773|NCT02351817|78959855|FG001|Period 1|Lack of Efficacy|1|||
44166774|NCT02351817|78959854|FG000|Period 2|Adverse Event|0|||
44166775|NCT02351817|78959855|FG001|Period 2|Adverse Event|2|||
44166776|NCT02351817|78959854|FG000|Period 2|Protocol Violation|1|||
44166777|NCT02351817|78959855|FG001|Period 2|Protocol Violation|0|||
44166778|NCT02351349|78959864|FG000|Overall Study|Withdrawal by Subject|2|||
44166779|NCT02351349|78959865|FG001|Overall Study|Withdrawal by Subject|3|||
44166780|NCT02484547|78959879|FG000|Placebo-Controlled Period|Adverse Event|10|||
44166781|NCT02484547|78959880|FG001|Placebo-Controlled Period|Adverse Event|13|||
44166782|NCT02484547|78959881|FG002|Placebo-Controlled Period|Adverse Event|20|||
44166783|NCT02484547|78959882|FG003|Placebo-Controlled Period|Adverse Event|0|||
44166784|NCT02484547|78959883|FG004|Placebo-Controlled Period|Adverse Event|0|||
44166785|NCT02484547|78959884|FG005|Placebo-Controlled Period|Adverse Event|0|||
44166786|NCT02484547|78959885|FG006|Placebo-Controlled Period|Adverse Event|0|||
44166787|NCT02484547|78959879|FG000|Placebo-Controlled Period|Change of Treatment|0|||
44166788|NCT02484547|78959880|FG001|Placebo-Controlled Period|Change of Treatment|0|||
44166789|NCT02484547|78959881|FG002|Placebo-Controlled Period|Change of Treatment|1|||
44166790|NCT02484547|78959882|FG003|Placebo-Controlled Period|Change of Treatment|0|||
44166791|NCT02484547|78959883|FG004|Placebo-Controlled Period|Change of Treatment|0|||
44166792|NCT02484547|78959884|FG005|Placebo-Controlled Period|Change of Treatment|0|||
44166793|NCT02484547|78959885|FG006|Placebo-Controlled Period|Change of Treatment|0|||
44166794|NCT02484547|78959879|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
44166795|NCT02484547|78959880|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
44166796|NCT02484547|78959881|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
44166797|NCT02484547|78959882|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
44166798|NCT02484547|78959883|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
44166799|NCT02484547|78959884|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
44166800|NCT02484547|78959885|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
44166801|NCT02484547|78959879|FG000|Placebo-Controlled Period|Death|5|||
44166802|NCT02484547|78959880|FG001|Placebo-Controlled Period|Death|0|||
44166803|NCT02484547|78959881|FG002|Placebo-Controlled Period|Death|6|||
44166804|NCT02484547|78959882|FG003|Placebo-Controlled Period|Death|0|||
44166805|NCT02484547|78959883|FG004|Placebo-Controlled Period|Death|0|||
44166806|NCT02484547|78959884|FG005|Placebo-Controlled Period|Death|0|||
44166807|NCT02484547|78959885|FG006|Placebo-Controlled Period|Death|0|||
44166808|NCT02484547|78959879|FG000|Placebo-Controlled Period|Disease Progression|2|||
44166809|NCT02484547|78959880|FG001|Placebo-Controlled Period|Disease Progression|0|||
44166810|NCT02484547|78959881|FG002|Placebo-Controlled Period|Disease Progression|1|||
44166811|NCT02484547|78959882|FG003|Placebo-Controlled Period|Disease Progression|0|||
44166812|NCT02484547|78959883|FG004|Placebo-Controlled Period|Disease Progression|0|||
44166813|NCT02484547|78959884|FG005|Placebo-Controlled Period|Disease Progression|0|||
44166814|NCT02484547|78959885|FG006|Placebo-Controlled Period|Disease Progression|0|||
44166815|NCT02484547|78959879|FG000|Placebo-Controlled Period|Investigator Decision|2|||
44166816|NCT02484547|78959880|FG001|Placebo-Controlled Period|Investigator Decision|2|||
44166817|NCT02484547|78959881|FG002|Placebo-Controlled Period|Investigator Decision|5|||
44166818|NCT02484547|78959882|FG003|Placebo-Controlled Period|Investigator Decision|0|||
44166819|NCT02484547|78959883|FG004|Placebo-Controlled Period|Investigator Decision|0|||
44166820|NCT02484547|78959884|FG005|Placebo-Controlled Period|Investigator Decision|0|||
44166821|NCT02484547|78959885|FG006|Placebo-Controlled Period|Investigator Decision|0|||
44166822|NCT02484547|78959879|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
44166823|NCT02484547|78959880|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
44166824|NCT02484547|78959881|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
44166825|NCT02484547|78959882|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
44166826|NCT02484547|78959883|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
44166827|NCT02484547|78959884|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
44166828|NCT02484547|78959885|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
44166829|NCT02484547|78959879|FG000|Placebo-Controlled Period|Relocation|1|||
44166830|NCT02484547|78959880|FG001|Placebo-Controlled Period|Relocation|1|||
44166831|NCT02484547|78959881|FG002|Placebo-Controlled Period|Relocation|1|||
44166832|NCT02484547|78959882|FG003|Placebo-Controlled Period|Relocation|0|||
44166833|NCT02484547|78959883|FG004|Placebo-Controlled Period|Relocation|0|||
44166834|NCT02484547|78959884|FG005|Placebo-Controlled Period|Relocation|0|||
44166835|NCT02484547|78959885|FG006|Placebo-Controlled Period|Relocation|0|||
44166836|NCT02484547|78959879|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
44166837|NCT02484547|78959880|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
44166838|NCT02484547|78959881|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
44166839|NCT02484547|78959882|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
44166840|NCT02484547|78959883|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
44166841|NCT02484547|78959884|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
44166842|NCT02484547|78959885|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
44166843|NCT02484547|78959879|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
44166844|NCT02484547|78959880|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
44166845|NCT02484547|78959881|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
44166846|NCT02484547|78959882|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44166847|NCT02484547|78959883|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44166848|NCT02484547|78959884|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44166849|NCT02484547|78959885|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44166850|NCT02484547|78959879|FG000|Placebo-Controlled Period|Reason not Specified|216|||
44166851|NCT02484547|78959880|FG001|Placebo-Controlled Period|Reason not Specified|194|||
44166852|NCT02484547|78959881|FG002|Placebo-Controlled Period|Reason not Specified|183|||
44166853|NCT02484547|78959882|FG003|Placebo-Controlled Period|Reason not Specified|0|||
44166854|NCT02484547|78959883|FG004|Placebo-Controlled Period|Reason not Specified|0|||
44166855|NCT02484547|78959884|FG005|Placebo-Controlled Period|Reason not Specified|0|||
44166856|NCT02484547|78959885|FG006|Placebo-Controlled Period|Reason not Specified|0|||
44166857|NCT02484547|78959879|FG000|Long-Term Extension Period|Adverse Event|0|||
44166858|NCT02484547|78959880|FG001|Long-Term Extension Period|Adverse Event|0|||
44166859|NCT02484547|78959881|FG002|Long-Term Extension Period|Adverse Event|0|||
44166860|NCT02484547|78959882|FG003|Long-Term Extension Period|Adverse Event|0|||
44166861|NCT02484547|78959883|FG004|Long-Term Extension Period|Adverse Event|1|||
44166862|NCT02484547|78959884|FG005|Long-Term Extension Period|Adverse Event|3|||
44166863|NCT02484547|78959885|FG006|Long-Term Extension Period|Adverse Event|2|||
44166864|NCT02484547|78959879|FG000|Long-Term Extension Period|Death|0|||
44166865|NCT02484547|78959880|FG001|Long-Term Extension Period|Death|0|||
44166866|NCT02484547|78959881|FG002|Long-Term Extension Period|Death|0|||
44166867|NCT02484547|78959882|FG003|Long-Term Extension Period|Death|0|||
44166868|NCT02484547|78959883|FG004|Long-Term Extension Period|Death|0|||
44166869|NCT02484547|78959884|FG005|Long-Term Extension Period|Death|3|||
44166870|NCT02484547|78959885|FG006|Long-Term Extension Period|Death|0|||
44166871|NCT02484547|78959879|FG000|Long-Term Extension Period|Disease Progression|0|||
44166872|NCT02484547|78959880|FG001|Long-Term Extension Period|Disease Progression|0|||
44166873|NCT02484547|78959881|FG002|Long-Term Extension Period|Disease Progression|0|||
44166874|NCT02484547|78959882|FG003|Long-Term Extension Period|Disease Progression|0|||
44166875|NCT02484547|78959883|FG004|Long-Term Extension Period|Disease Progression|2|||
44166876|NCT02484547|78959884|FG005|Long-Term Extension Period|Disease Progression|4|||
44166877|NCT02484547|78959885|FG006|Long-Term Extension Period|Disease Progression|0|||
44166878|NCT02484547|78959879|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
44166879|NCT02484547|78959880|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
44166880|NCT02484547|78959881|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
44166881|NCT02484547|78959882|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
44166882|NCT02484547|78959883|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
44166883|NCT02484547|78959884|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
44166884|NCT02484547|78959885|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
44166885|NCT02484547|78959879|FG000|Long-Term Extension Period|Loss of Capacity|0|||
44166886|NCT02484547|78959880|FG001|Long-Term Extension Period|Loss of Capacity|0|||
44166887|NCT02484547|78959881|FG002|Long-Term Extension Period|Loss of Capacity|0|||
44166888|NCT02484547|78959882|FG003|Long-Term Extension Period|Loss of Capacity|0|||
44166889|NCT02484547|78959883|FG004|Long-Term Extension Period|Loss of Capacity|1|||
44166890|NCT02484547|78959884|FG005|Long-Term Extension Period|Loss of Capacity|0|||
44166891|NCT02484547|78959885|FG006|Long-Term Extension Period|Loss of Capacity|0|||
44166892|NCT02484547|78959879|FG000|Long-Term Extension Period|Change of Treatment|0|||
44166893|NCT02484547|78959880|FG001|Long-Term Extension Period|Change of Treatment|0|||
44166894|NCT02484547|78959881|FG002|Long-Term Extension Period|Change of Treatment|0|||
44166895|NCT02484547|78959882|FG003|Long-Term Extension Period|Change of Treatment|0|||
44166896|NCT02484547|78959883|FG004|Long-Term Extension Period|Change of Treatment|0|||
44166897|NCT02484547|78959884|FG005|Long-Term Extension Period|Change of Treatment|0|||
44166898|NCT02484547|78959885|FG006|Long-Term Extension Period|Change of Treatment|1|||
44166899|NCT02484547|78959879|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
44166900|NCT02484547|78959880|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
44166901|NCT02484547|78959881|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
44166902|NCT02484547|78959882|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
44166903|NCT02484547|78959883|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
44166904|NCT02484547|78959884|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
44166905|NCT02484547|78959885|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
44166906|NCT02484547|78959879|FG000|Long-Term Extension Period|Investigator Decision|0|||
44166907|NCT02484547|78959880|FG001|Long-Term Extension Period|Investigator Decision|0|||
44166908|NCT02484547|78959881|FG002|Long-Term Extension Period|Investigator Decision|0|||
44166909|NCT02484547|78959882|FG003|Long-Term Extension Period|Investigator Decision|2|||
44166910|NCT02484547|78959883|FG004|Long-Term Extension Period|Investigator Decision|1|||
44166911|NCT02484547|78959884|FG005|Long-Term Extension Period|Investigator Decision|0|||
44166912|NCT02484547|78959885|FG006|Long-Term Extension Period|Investigator Decision|1|||
44166913|NCT02484547|78959879|FG000|Long-Term Extension Period|Relocation|0|||
44166914|NCT02484547|78959880|FG001|Long-Term Extension Period|Relocation|0|||
44166915|NCT02484547|78959881|FG002|Long-Term Extension Period|Relocation|0|||
44166916|NCT02484547|78959882|FG003|Long-Term Extension Period|Relocation|1|||
44166917|NCT02484547|78959883|FG004|Long-Term Extension Period|Relocation|1|||
44166918|NCT02484547|78959884|FG005|Long-Term Extension Period|Relocation|0|||
44166919|NCT02484547|78959885|FG006|Long-Term Extension Period|Relocation|0|||
44166920|NCT02484547|78959879|FG000|Long-Term Extension Period|Study Visit Burden|0|||
44166921|NCT02484547|78959880|FG001|Long-Term Extension Period|Study Visit Burden|0|||
44166922|NCT02484547|78959881|FG002|Long-Term Extension Period|Study Visit Burden|0|||
44166923|NCT02484547|78959882|FG003|Long-Term Extension Period|Study Visit Burden|2|||
44166924|NCT02484547|78959883|FG004|Long-Term Extension Period|Study Visit Burden|0|||
44166925|NCT02484547|78959884|FG005|Long-Term Extension Period|Study Visit Burden|0|||
44166926|NCT02484547|78959885|FG006|Long-Term Extension Period|Study Visit Burden|3|||
44166927|NCT02484547|78959879|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
44166928|NCT02484547|78959880|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
44166929|NCT02484547|78959881|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
44166930|NCT02484547|78959882|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
44166931|NCT02484547|78959883|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
44166932|NCT02484547|78959884|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
44166933|NCT02484547|78959885|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
44166934|NCT02484547|78959879|FG000|Long-Term Extension Period|Reason not Specified|0|||
44166935|NCT02484547|78959880|FG001|Long-Term Extension Period|Reason not Specified|0|||
44166936|NCT02484547|78959881|FG002|Long-Term Extension Period|Reason not Specified|0|||
44166937|NCT02484547|78959882|FG003|Long-Term Extension Period|Reason not Specified|119|||
44166938|NCT02484547|78959883|FG004|Long-Term Extension Period|Reason not Specified|117|||
44166939|NCT02484547|78959884|FG005|Long-Term Extension Period|Reason not Specified|223|||
44166940|NCT02484547|78959885|FG006|Long-Term Extension Period|Reason not Specified|231|||
44166941|NCT02517541|78959897|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
44166942|NCT02517541|78959897|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
44166943|NCT02517541|78959897|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
44166944|NCT02517541|78959897|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
44166945|NCT02517541|78959897|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
44166946|NCT02517541|78959897|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
44166947|NCT02496091|78959903|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
44166948|NCT02483611|78959911|FG000|Overall Study|Protocol Violation|0|||
44166949|NCT02483611|78959912|FG001|Overall Study|Protocol Violation|0|||
44166950|NCT02483611|78959913|FG002|Overall Study|Protocol Violation|1|||
44166951|NCT02483533|78959923|FG000|Overall Study|Lack of Efficacy|50|||
44260986|NCT00986102|79136854|FG002|Overall Study|Lost to Follow-up|0|||
44260987|NCT00986102|79136855|FG003|Overall Study|Lost to Follow-up|1|||
44260988|NCT00986102|79136852|FG000|Overall Study|Withdrawal by Subject|1|||
44260989|NCT00986102|79136853|FG001|Overall Study|Withdrawal by Subject|1|||
44260990|NCT00986102|79136854|FG002|Overall Study|Withdrawal by Subject|0|||
44260991|NCT00986102|79136855|FG003|Overall Study|Withdrawal by Subject|0|||
44260992|NCT00985946|79136878|FG000|Overall Study|Lost to Follow-up|6|||
44260993|NCT00985946|79136878|FG000|Overall Study|Withdrawal by Subject|1|||
44260994|NCT00985790|79136893|FG000|Overall Study|Withdrawal by Subject|1|||
44260995|NCT00985790|79136894|FG001|Overall Study|Withdrawal by Subject|1|||
44260996|NCT00985790|79136893|FG000|Overall Study|Lost to Follow-up|6|||
44260997|NCT00985790|79136894|FG001|Overall Study|Lost to Follow-up|7|||
44260998|NCT00985712|79136921|FG000|Overall Study|Adverse Event|0|||
44260999|NCT00985712|79136922|FG001|Overall Study|Adverse Event|1|||
44261000|NCT00985712|79136921|FG000|Overall Study|Lost to Follow-up|2|||
44261001|NCT00985712|79136922|FG001|Overall Study|Lost to Follow-up|2|||
44261002|NCT00985712|79136921|FG000|Overall Study|Protocol Violation|0|||
44261003|NCT00985712|79136922|FG001|Overall Study|Protocol Violation|1|||
44261004|NCT00985712|79136921|FG000|Overall Study|Withdrawal by Subject|4|||
44261005|NCT00985712|79136922|FG001|Overall Study|Withdrawal by Subject|1|||
44261006|NCT00985712|79136921|FG000|Overall Study|Sponsor decision|0|||
44261007|NCT00985712|79136922|FG001|Overall Study|Sponsor decision|2|||
44261008|NCT00985166|79137029|FG000|Overall Study|Lost to Follow-up|3|||
44261009|NCT00985166|79137030|FG001|Overall Study|Lost to Follow-up|2|||
44261010|NCT00985166|79137031|FG002|Overall Study|Lost to Follow-up|2|||
44261011|NCT00985166|79137029|FG000|Overall Study|Withdrawal by Subject|3|||
44261012|NCT00985166|79137030|FG001|Overall Study|Withdrawal by Subject|2|||
44261013|NCT00985166|79137031|FG002|Overall Study|Withdrawal by Subject|0|||
44261014|NCT00985166|79137029|FG000|Overall Study|Test not done|2|||
44261015|NCT00985166|79137030|FG001|Overall Study|Test not done|0|||
44261016|NCT00985166|79137031|FG002|Overall Study|Test not done|4|||
44261017|NCT00985166|79137029|FG000|Overall Study|Other|1|||
44261018|NCT00985166|79137030|FG001|Overall Study|Other|0|||
44261019|NCT00985166|79137031|FG002|Overall Study|Other|1|||
44261020|NCT01341405|79137277|FG000|Overall Study|Adverse Event|0|||
44261021|NCT01341405|79137278|FG001|Overall Study|Adverse Event|1|||
44261022|NCT01341405|79137279|FG002|Overall Study|Adverse Event|1|||
44261023|NCT01341405|79137277|FG000|Overall Study|Withdrawal by Subject|3|||
44261024|NCT01341405|79137278|FG001|Overall Study|Withdrawal by Subject|2|||
44261025|NCT01341405|79137279|FG002|Overall Study|Withdrawal by Subject|1|||
44261026|NCT00633945|79138517|FG000|Overall Study|Physician Decision|2|||
44261027|NCT02574078|79138794|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261028|NCT02574078|79138795|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261029|NCT02574078|79138796|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261030|NCT02574078|79138797|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261031|NCT02574078|79138798|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261032|NCT02574078|79138799|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44261033|NCT02574078|79138800|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
44261034|NCT02574078|79138801|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261035|NCT02574078|79138802|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
44261036|NCT02574078|79138803|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261037|NCT02574078|79138804|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261038|NCT02574078|79138805|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261039|NCT02574078|79138806|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
44261040|NCT02574078|79138794|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
44261041|NCT02574078|79138795|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
44261042|NCT02574078|79138796|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
44261043|NCT02574078|79138797|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
44261044|NCT02574078|79138798|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
44261045|NCT02574078|79138799|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
44261046|NCT02574078|79138800|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
44261047|NCT02574078|79138801|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
44261048|NCT02574078|79138802|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
44261049|NCT02574078|79138803|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
44261050|NCT02574078|79138804|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
44261051|NCT02574078|79138805|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
44261052|NCT02574078|79138806|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
44261053|NCT02574078|79138794|FG000|Pre-Treatment Period|Other reasons|0|||
44261054|NCT02574078|79138795|FG001|Pre-Treatment Period|Other reasons|0|||
44261055|NCT02574078|79138796|FG002|Pre-Treatment Period|Other reasons|0|||
44261056|NCT02574078|79138797|FG003|Pre-Treatment Period|Other reasons|0|||
44261057|NCT02574078|79138798|FG004|Pre-Treatment Period|Other reasons|0|||
44261058|NCT02574078|79138799|FG005|Pre-Treatment Period|Other reasons|0|||
44261059|NCT02574078|79138800|FG006|Pre-Treatment Period|Other reasons|2|||
44261060|NCT02574078|79138801|FG007|Pre-Treatment Period|Other reasons|0|||
44261061|NCT02574078|79138802|FG008|Pre-Treatment Period|Other reasons|0|||
44261062|NCT02574078|79138803|FG009|Pre-Treatment Period|Other reasons|0|||
44261063|NCT02574078|79138804|FG010|Pre-Treatment Period|Other reasons|2|||
44261064|NCT02574078|79138805|FG011|Pre-Treatment Period|Other reasons|0|||
44261065|NCT02574078|79138806|FG012|Pre-Treatment Period|Other reasons|0|||
44261066|NCT02574078|79138794|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
44261067|NCT02574078|79138795|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
44261068|NCT02574078|79138796|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
44261069|NCT02574078|79138797|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
44261070|NCT02574078|79138798|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
44261071|NCT02574078|79138799|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
44261072|NCT02574078|79138800|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
44261073|NCT02574078|79138801|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
44261074|NCT02574078|79138802|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
44261075|NCT02574078|79138803|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
44261076|NCT02574078|79138804|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
44261077|NCT02574078|79138805|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
44261078|NCT02574078|79138806|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
44261079|NCT02574078|79138794|FG000|Treatment Period|Disease progression|6|||
44261080|NCT02574078|79138795|FG001|Treatment Period|Disease progression|4|||
44261081|NCT02574078|79138796|FG002|Treatment Period|Disease progression|7|||
44261082|NCT02574078|79138797|FG003|Treatment Period|Disease progression|18|||
44261083|NCT02574078|79138798|FG004|Treatment Period|Disease progression|16|||
44261084|NCT02574078|79138799|FG005|Treatment Period|Disease progression|26|||
44261085|NCT02574078|79138800|FG006|Treatment Period|Disease progression|5|||
44261086|NCT02574078|79138801|FG007|Treatment Period|Disease progression|9|||
44261087|NCT02574078|79138802|FG008|Treatment Period|Disease progression|8|||
44261088|NCT02574078|79138803|FG009|Treatment Period|Disease progression|5|||
44261089|NCT02574078|79138804|FG010|Treatment Period|Disease progression|20|||
44261090|NCT02574078|79138805|FG011|Treatment Period|Disease progression|29|||
44261091|NCT02574078|79138806|FG012|Treatment Period|Disease progression|2|||
44261092|NCT02574078|79138794|FG000|Treatment Period|Study drug toxicity|1|||
44261093|NCT02574078|79138795|FG001|Treatment Period|Study drug toxicity|1|||
44261094|NCT02574078|79138796|FG002|Treatment Period|Study drug toxicity|0|||
44261095|NCT02574078|79138797|FG003|Treatment Period|Study drug toxicity|5|||
44261096|NCT02574078|79138798|FG004|Treatment Period|Study drug toxicity|3|||
44261097|NCT02574078|79138799|FG005|Treatment Period|Study drug toxicity|1|||
44261098|NCT02574078|79138800|FG006|Treatment Period|Study drug toxicity|2|||
44261099|NCT02574078|79138801|FG007|Treatment Period|Study drug toxicity|0|||
44261100|NCT02574078|79138802|FG008|Treatment Period|Study drug toxicity|2|||
44261101|NCT02574078|79138803|FG009|Treatment Period|Study drug toxicity|1|||
44261102|NCT02574078|79138804|FG010|Treatment Period|Study drug toxicity|16|||
44261103|NCT02574078|79138805|FG011|Treatment Period|Study drug toxicity|2|||
44261104|NCT02574078|79138806|FG012|Treatment Period|Study drug toxicity|4|||
44261105|NCT02574078|79138794|FG000|Treatment Period|Death|2|||
44261106|NCT02574078|79138795|FG001|Treatment Period|Death|0|||
44261107|NCT02574078|79138796|FG002|Treatment Period|Death|0|||
44261108|NCT02574078|79138797|FG003|Treatment Period|Death|0|||
44261109|NCT02574078|79138798|FG004|Treatment Period|Death|1|||
44261110|NCT02574078|79138799|FG005|Treatment Period|Death|1|||
44261111|NCT02574078|79138800|FG006|Treatment Period|Death|1|||
44261112|NCT02574078|79138801|FG007|Treatment Period|Death|1|||
44261113|NCT02574078|79138802|FG008|Treatment Period|Death|7|||
44261114|NCT02574078|79138803|FG009|Treatment Period|Death|1|||
44261115|NCT02574078|79138804|FG010|Treatment Period|Death|0|||
44261116|NCT02574078|79138805|FG011|Treatment Period|Death|2|||
44261117|NCT02574078|79138806|FG012|Treatment Period|Death|1|||
44261118|NCT02574078|79138794|FG000|Treatment Period|Adverse event unrelated to drug|0|||
44261119|NCT02574078|79138795|FG001|Treatment Period|Adverse event unrelated to drug|0|||
44261120|NCT02574078|79138796|FG002|Treatment Period|Adverse event unrelated to drug|1|||
44261121|NCT02574078|79138797|FG003|Treatment Period|Adverse event unrelated to drug|0|||
44261122|NCT02574078|79138798|FG004|Treatment Period|Adverse event unrelated to drug|2|||
44261123|NCT02574078|79138799|FG005|Treatment Period|Adverse event unrelated to drug|3|||
44261124|NCT02574078|79138800|FG006|Treatment Period|Adverse event unrelated to drug|0|||
44261125|NCT02574078|79138801|FG007|Treatment Period|Adverse event unrelated to drug|0|||
44261126|NCT02574078|79138802|FG008|Treatment Period|Adverse event unrelated to drug|1|||
44261127|NCT02574078|79138803|FG009|Treatment Period|Adverse event unrelated to drug|2|||
44261128|NCT02574078|79138804|FG010|Treatment Period|Adverse event unrelated to drug|4|||
44261129|NCT02574078|79138805|FG011|Treatment Period|Adverse event unrelated to drug|1|||
44261130|NCT02574078|79138806|FG012|Treatment Period|Adverse event unrelated to drug|0|||
44261131|NCT02574078|79138794|FG000|Treatment Period|Administrative reason by Sponsor|0|||
44261132|NCT02574078|79138795|FG001|Treatment Period|Administrative reason by Sponsor|1|||
44261133|NCT02574078|79138796|FG002|Treatment Period|Administrative reason by Sponsor|0|||
44261134|NCT02574078|79138797|FG003|Treatment Period|Administrative reason by Sponsor|0|||
44261135|NCT02574078|79138798|FG004|Treatment Period|Administrative reason by Sponsor|0|||
44261136|NCT02574078|79138799|FG005|Treatment Period|Administrative reason by Sponsor|0|||
44261137|NCT02574078|79138800|FG006|Treatment Period|Administrative reason by Sponsor|1|||
44261138|NCT02574078|79138801|FG007|Treatment Period|Administrative reason by Sponsor|0|||
44261139|NCT02574078|79138802|FG008|Treatment Period|Administrative reason by Sponsor|0|||
44261140|NCT02574078|79138803|FG009|Treatment Period|Administrative reason by Sponsor|0|||
44261141|NCT02574078|79138804|FG010|Treatment Period|Administrative reason by Sponsor|0|||
44261142|NCT02574078|79138805|FG011|Treatment Period|Administrative reason by Sponsor|0|||
44261143|NCT02574078|79138806|FG012|Treatment Period|Administrative reason by Sponsor|3|||
44261144|NCT02574078|79138794|FG000|Treatment Period|Other reasons|1|||
44261145|NCT02574078|79138795|FG001|Treatment Period|Other reasons|0|||
44261146|NCT02574078|79138796|FG002|Treatment Period|Other reasons|1|||
44261147|NCT02574078|79138797|FG003|Treatment Period|Other reasons|3|||
44261148|NCT02574078|79138798|FG004|Treatment Period|Other reasons|3|||
44261149|NCT02574078|79138799|FG005|Treatment Period|Other reasons|1|||
44261150|NCT02574078|79138800|FG006|Treatment Period|Other reasons|2|||
44352819|NCT01230827|79357082|FG002|Overall Study|Adverse Event|3|||
44261151|NCT02574078|79138801|FG007|Treatment Period|Other reasons|1|||
44261152|NCT02574078|79138802|FG008|Treatment Period|Other reasons|3|||
44261153|NCT02574078|79138803|FG009|Treatment Period|Other reasons|1|||
44261154|NCT02574078|79138804|FG010|Treatment Period|Other reasons|1|||
44261155|NCT02574078|79138805|FG011|Treatment Period|Other reasons|3|||
44261156|NCT02574078|79138806|FG012|Treatment Period|Other reasons|1|||
44261157|NCT02574078|79138794|FG000|Treatment Period|Participant request to stop drug|0|||
44261158|NCT02574078|79138795|FG001|Treatment Period|Participant request to stop drug|0|||
44261159|NCT02574078|79138796|FG002|Treatment Period|Participant request to stop drug|0|||
44261160|NCT02574078|79138797|FG003|Treatment Period|Participant request to stop drug|2|||
44261161|NCT02574078|79138798|FG004|Treatment Period|Participant request to stop drug|4|||
44261162|NCT02574078|79138799|FG005|Treatment Period|Participant request to stop drug|0|||
44261163|NCT02574078|79138800|FG006|Treatment Period|Participant request to stop drug|1|||
44261164|NCT02574078|79138801|FG007|Treatment Period|Participant request to stop drug|0|||
44261165|NCT02574078|79138802|FG008|Treatment Period|Participant request to stop drug|3|||
44261166|NCT02574078|79138803|FG009|Treatment Period|Participant request to stop drug|2|||
44261167|NCT02574078|79138804|FG010|Treatment Period|Participant request to stop drug|2|||
44261168|NCT02574078|79138805|FG011|Treatment Period|Participant request to stop drug|4|||
44261169|NCT02574078|79138806|FG012|Treatment Period|Participant request to stop drug|1|||
44261170|NCT02574078|79138794|FG000|Treatment Period|Participant withdrew consent|0|||
44261171|NCT02574078|79138795|FG001|Treatment Period|Participant withdrew consent|0|||
44261172|NCT02574078|79138796|FG002|Treatment Period|Participant withdrew consent|0|||
44261173|NCT02574078|79138797|FG003|Treatment Period|Participant withdrew consent|0|||
44261174|NCT02574078|79138798|FG004|Treatment Period|Participant withdrew consent|1|||
44261175|NCT02574078|79138799|FG005|Treatment Period|Participant withdrew consent|1|||
44261176|NCT02574078|79138800|FG006|Treatment Period|Participant withdrew consent|0|||
44261177|NCT02574078|79138801|FG007|Treatment Period|Participant withdrew consent|1|||
44261178|NCT02574078|79138802|FG008|Treatment Period|Participant withdrew consent|0|||
44261179|NCT02574078|79138803|FG009|Treatment Period|Participant withdrew consent|2|||
44261180|NCT02574078|79138804|FG010|Treatment Period|Participant withdrew consent|1|||
44261181|NCT02574078|79138805|FG011|Treatment Period|Participant withdrew consent|4|||
44261182|NCT02574078|79138806|FG012|Treatment Period|Participant withdrew consent|1|||
44261183|NCT02574078|79138794|FG000|Treatment Period|Participant no longer meets criteria|0|||
44261184|NCT02574078|79138795|FG001|Treatment Period|Participant no longer meets criteria|0|||
44261185|NCT02574078|79138796|FG002|Treatment Period|Participant no longer meets criteria|0|||
44261186|NCT02574078|79138797|FG003|Treatment Period|Participant no longer meets criteria|0|||
44261187|NCT02574078|79138798|FG004|Treatment Period|Participant no longer meets criteria|1|||
44261188|NCT02574078|79138799|FG005|Treatment Period|Participant no longer meets criteria|0|||
44261189|NCT02574078|79138800|FG006|Treatment Period|Participant no longer meets criteria|0|||
44261190|NCT02574078|79138801|FG007|Treatment Period|Participant no longer meets criteria|0|||
44261191|NCT02574078|79138802|FG008|Treatment Period|Participant no longer meets criteria|0|||
44261192|NCT02574078|79138803|FG009|Treatment Period|Participant no longer meets criteria|1|||
44261193|NCT02574078|79138804|FG010|Treatment Period|Participant no longer meets criteria|1|||
44261194|NCT02574078|79138805|FG011|Treatment Period|Participant no longer meets criteria|1|||
44261195|NCT02574078|79138806|FG012|Treatment Period|Participant no longer meets criteria|0|||
44261196|NCT02574078|79138794|FG000|Treatment Period|Lost to Follow-up|0|||
44261197|NCT02574078|79138795|FG001|Treatment Period|Lost to Follow-up|0|||
44261198|NCT02574078|79138796|FG002|Treatment Period|Lost to Follow-up|0|||
44261199|NCT02574078|79138797|FG003|Treatment Period|Lost to Follow-up|0|||
44261200|NCT02574078|79138798|FG004|Treatment Period|Lost to Follow-up|0|||
44261201|NCT02574078|79138799|FG005|Treatment Period|Lost to Follow-up|0|||
44261202|NCT02574078|79138800|FG006|Treatment Period|Lost to Follow-up|0|||
44261203|NCT02574078|79138801|FG007|Treatment Period|Lost to Follow-up|0|||
44261204|NCT02574078|79138802|FG008|Treatment Period|Lost to Follow-up|0|||
44261205|NCT02574078|79138803|FG009|Treatment Period|Lost to Follow-up|1|||
44261206|NCT02574078|79138804|FG010|Treatment Period|Lost to Follow-up|0|||
44261207|NCT02574078|79138805|FG011|Treatment Period|Lost to Follow-up|1|||
44261208|NCT02574078|79138806|FG012|Treatment Period|Lost to Follow-up|0|||
44261209|NCT02574078|79138794|FG000|Treatment Period|Maximum clinical benefit|0|||
44261210|NCT02574078|79138795|FG001|Treatment Period|Maximum clinical benefit|0|||
44261211|NCT02574078|79138796|FG002|Treatment Period|Maximum clinical benefit|0|||
44261212|NCT02574078|79138797|FG003|Treatment Period|Maximum clinical benefit|0|||
44261213|NCT02574078|79138798|FG004|Treatment Period|Maximum clinical benefit|0|||
44261214|NCT02574078|79138799|FG005|Treatment Period|Maximum clinical benefit|0|||
44261215|NCT02574078|79138800|FG006|Treatment Period|Maximum clinical benefit|0|||
44261216|NCT02574078|79138801|FG007|Treatment Period|Maximum clinical benefit|0|||
44261217|NCT02574078|79138802|FG008|Treatment Period|Maximum clinical benefit|0|||
44261218|NCT02574078|79138803|FG009|Treatment Period|Maximum clinical benefit|1|||
44261219|NCT02574078|79138804|FG010|Treatment Period|Maximum clinical benefit|0|||
44261220|NCT02574078|79138805|FG011|Treatment Period|Maximum clinical benefit|0|||
44261221|NCT02574078|79138806|FG012|Treatment Period|Maximum clinical benefit|0|||
44261222|NCT02565810|79138924|FG000|Overall Study|Withdrawal by Subject|1|||
44261223|NCT02561832|79139089|FG000|Overall Study|Withdrawal by Subject|1|||
44352820|NCT01230827|79357083|FG003|Overall Study|Adverse Event|7|||
44352821|NCT01230827|79357080|FG000|Overall Study|Recovery|0|||
44352822|NCT01230827|79357081|FG001|Overall Study|Recovery|6|||
44352823|NCT01230827|79357082|FG002|Overall Study|Recovery|0|||
44352824|NCT01230827|79357083|FG003|Overall Study|Recovery|0|||
44352825|NCT01230827|79357080|FG000|Overall Study|Study terminated by Sponsor|0|||
44352826|NCT01230827|79357081|FG001|Overall Study|Study terminated by Sponsor|2|||
44352827|NCT01230827|79357082|FG002|Overall Study|Study terminated by Sponsor|56|||
44352828|NCT01230827|79357083|FG003|Overall Study|Study terminated by Sponsor|63|||
44352829|NCT01230749|79357095|FG000|Overall Study|Adverse Event|0|||
44352830|NCT01230749|79357096|FG001|Overall Study|Adverse Event|0|||
44352831|NCT01230749|79357097|FG002|Overall Study|Adverse Event|0|||
44352832|NCT01230749|79357098|FG003|Overall Study|Adverse Event|1|||
44352833|NCT01230749|79357095|FG000|Overall Study|Physician Decision|0|||
44352834|NCT01230749|79357096|FG001|Overall Study|Physician Decision|0|||
44352835|NCT01230749|79357097|FG002|Overall Study|Physician Decision|1|||
44352836|NCT01230749|79357098|FG003|Overall Study|Physician Decision|0|||
44352837|NCT01230749|79357095|FG000|Overall Study|Withdrawal by Subject|0|||
44352838|NCT01230749|79357096|FG001|Overall Study|Withdrawal by Subject|1|||
44352839|NCT01230749|79357097|FG002|Overall Study|Withdrawal by Subject|0|||
44352840|NCT01230749|79357098|FG003|Overall Study|Withdrawal by Subject|0|||
44352841|NCT01230749|79357095|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
44352842|NCT01230749|79357096|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
44352843|NCT01230749|79357097|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
44352844|NCT01230749|79357098|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
44352845|NCT00903175|79357113|FG000|Period 1 - First Line|Adverse Event|36|||
44352846|NCT00903175|79357114|FG001|Period 1 - First Line|Adverse Event|50|||
44352847|NCT00903175|79357113|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
44352848|NCT00903175|79357114|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
44352849|NCT00903175|79357113|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
44352850|NCT00903175|79357114|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
44352851|NCT00903175|79357113|FG000|Period 1 - First Line|Protocol Violation|3|||
44352852|NCT00903175|79357114|FG001|Period 1 - First Line|Protocol Violation|3|||
44352853|NCT00903175|79357113|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
44352854|NCT00903175|79357114|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
44352855|NCT00903175|79357113|FG000|Period 1 - First Line|Administrative problems|12|||
44352856|NCT00903175|79357114|FG001|Period 1 - First Line|Administrative problems|13|||
44352857|NCT00903175|79357113|FG000|Period 1 - First Line|Death|17|||
44352858|NCT00903175|79357114|FG001|Period 1 - First Line|Death|10|||
44352859|NCT00903175|79357113|FG000|Period 2 - Second Line|Missing|1|||
44352860|NCT00903175|79357114|FG001|Period 2 - Second Line|Missing|0|||
44352861|NCT00903175|79357113|FG000|Period 2 - Second Line|Adverse Event|16|||
44352862|NCT00903175|79357114|FG001|Period 2 - Second Line|Adverse Event|20|||
44352863|NCT00903175|79357113|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
44352864|NCT00903175|79357114|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
44352865|NCT00903175|79357113|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
44352866|NCT00903175|79357114|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
44352867|NCT00903175|79357113|FG000|Period 2 - Second Line|Administrative problems|19|||
44352868|NCT00903175|79357114|FG001|Period 2 - Second Line|Administrative problems|9|||
44352869|NCT00903175|79357113|FG000|Period 2 - Second Line|Death|5|||
44352870|NCT00903175|79357114|FG001|Period 2 - Second Line|Death|2|||
44352871|NCT01229735|79357122|FG000|Overall Study|Lack of Efficacy|8|||
44352872|NCT01229735|79357123|FG001|Overall Study|Lack of Efficacy|8|||
44352873|NCT01229735|79357122|FG000|Overall Study|Protocol Violation|13|||
44352874|NCT01229735|79357123|FG001|Overall Study|Protocol Violation|8|||
44352875|NCT01229735|79357122|FG000|Overall Study|Lost to Follow-up|0|||
44352876|NCT01229735|79357123|FG001|Overall Study|Lost to Follow-up|2|||
44352877|NCT01229735|79357122|FG000|Overall Study|Withdrawal by Subject|18|||
44352878|NCT01229735|79357123|FG001|Overall Study|Withdrawal by Subject|17|||
44352879|NCT01229735|79357122|FG000|Overall Study|Other Reason|13|||
44352880|NCT01229735|79357123|FG001|Overall Study|Other Reason|10|||
44352881|NCT01229735|79357122|FG000|Overall Study|SAE, non-fatal|0|||
44352882|NCT01229735|79357123|FG001|Overall Study|SAE, non-fatal|4|||
44352883|NCT01229735|79357122|FG000|Overall Study|AE, non-serious non-fatal|13|||
44352884|NCT01229735|79357123|FG001|Overall Study|AE, non-serious non-fatal|17|||
44352885|NCT01229735|79357122|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
44352886|NCT01229735|79357123|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
44352887|NCT00974974|79357142|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
44352888|NCT00974974|79357143|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
44352889|NCT00974974|79357142|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
44352890|NCT00974974|79357143|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
44352891|NCT00974974|79357142|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
44352892|NCT00974974|79357143|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
44352893|NCT00974974|79357142|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
44352894|NCT00974974|79357143|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
44352895|NCT00974974|79357142|FG000|IR CD-LD Dose Adjustment|Various|0|||
44352896|NCT00974974|79357143|FG001|IR CD-LD Dose Adjustment|Various|9|||
44448320|NCT00111007|79456992|FG001|Long Term Follow-up|Death|39|||
44352897|NCT00974974|79357142|FG000|IPX066 Dose Conversion|Adverse Event|23|||
44352898|NCT00974974|79357143|FG001|IPX066 Dose Conversion|Adverse Event|0|||
44352899|NCT00974974|79357142|FG000|IPX066 Dose Conversion|Death|2|||
44352900|NCT00974974|79357143|FG001|IPX066 Dose Conversion|Death|0|||
44352901|NCT00974974|79357142|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
44352902|NCT00974974|79357143|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
44352903|NCT00974974|79357142|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
44352904|NCT00974974|79357143|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
44352905|NCT00974974|79357142|FG000|IPX066 Dose Conversion|Various|3|||
44352906|NCT00974974|79357143|FG001|IPX066 Dose Conversion|Various|0|||
44352907|NCT00974974|79357142|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
44352908|NCT00974974|79357143|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
44352909|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
44352910|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
44352911|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
44352912|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
44352913|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
44352914|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
44352915|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
44352916|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
44352917|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
44352918|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
44352919|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
44352920|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
44352921|NCT00974974|79357142|FG000|Maintenance - Double Blind Treatment|Various|4|||
44352922|NCT00974974|79357143|FG001|Maintenance - Double Blind Treatment|Various|0|||
44352923|NCT01233869|79357153|FG000|Initial Treatment Period (24 Months)|Death|1|||
44352924|NCT01233869|79357154|FG001|Initial Treatment Period (24 Months)|Death|0|||
44352925|NCT01233869|79357155|FG002|Initial Treatment Period (24 Months)|Death|0|||
44352926|NCT01233869|79357156|FG003|Initial Treatment Period (24 Months)|Death|0|||
44352927|NCT01233869|79357153|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
44352928|NCT01233869|79357154|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
44352929|NCT01233869|79357155|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
44352930|NCT01233869|79357156|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
44352931|NCT01233869|79357153|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
44352932|NCT01233869|79357154|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
44352933|NCT01233869|79357155|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
44352934|NCT01233869|79357156|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
44352935|NCT01233869|79357153|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
44352936|NCT01233869|79357154|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
44352937|NCT01233869|79357155|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
44352938|NCT01233869|79357156|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
44352939|NCT01233869|79357153|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
44352940|NCT01233869|79357154|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
44352941|NCT01233869|79357155|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
44352942|NCT01233869|79357156|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
44352943|NCT01233869|79357153|FG000|Extended Treatment Period (46 Months)|Other|3|||
44352944|NCT01233869|79357154|FG001|Extended Treatment Period (46 Months)|Other|0|||
44352945|NCT01233869|79357155|FG002|Extended Treatment Period (46 Months)|Other|0|||
44352946|NCT01233869|79357156|FG003|Extended Treatment Period (46 Months)|Other|3|||
44352947|NCT01233869|79357153|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
44352948|NCT01233869|79357154|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
44352949|NCT01233869|79357155|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
44352950|NCT01233869|79357156|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
44352951|NCT00992992|79357166|FG000|Overall Study|Lost to Follow-up|3|||
44352952|NCT00992992|79357166|FG000|Overall Study|Death|16|||
44352953|NCT00992992|79357166|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
44352954|NCT00992992|79357166|FG000|Overall Study|Sponsor Closed the Study|4|||
44352955|NCT00992836|79357170|FG000|Overall Study|Lost to Follow-up|1|||
44352956|NCT00992836|79357170|FG000|Overall Study|Withdrawal by Subject|2|||
44352957|NCT00992836|79357170|FG000|Overall Study|Protocol Violation|2|||
44352958|NCT00992446|79357180|FG000|Overall Study|Disease Progression|1|||
44352959|NCT00992446|79357180|FG000|Overall Study|Withdrawal by Subject|2|||
44352960|NCT00992446|79357180|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
44352961|NCT04344301|79357186|FG000|Overall Study|Withdrawal by Subject|1|||
44352962|NCT04344301|79357187|FG001|Overall Study|Withdrawal by Subject|0|||
44352963|NCT04344301|79357186|FG000|Overall Study|Death|0|||
44352964|NCT04344301|79357187|FG001|Overall Study|Death|1|||
44352965|NCT00970294|79357194|FG000|Overall Study|Physician Decision|4|||
44352966|NCT00970294|79357194|FG000|Overall Study|Withdrawal by Subject|1|||
44352967|NCT00969436|79357201|FG000|Overall Study|Protocol Violation|1|||
44352968|NCT00969436|79357202|FG001|Overall Study|Protocol Violation|3|||
44352969|NCT00969436|79357203|FG002|Overall Study|Protocol Violation|0|||
44352970|NCT00969436|79357201|FG000|Overall Study|Migrated/moved from study area|12|||
44352971|NCT00969436|79357202|FG001|Overall Study|Migrated/moved from study area|10|||
44352972|NCT00969436|79357203|FG002|Overall Study|Migrated/moved from study area|2|||
44352973|NCT00969436|79357201|FG000|Overall Study|Father - serious health problem|0|||
44352974|NCT00969436|79357202|FG001|Overall Study|Father - serious health problem|0|||
44352975|NCT00969436|79357203|FG002|Overall Study|Father - serious health problem|1|||
44352976|NCT00969436|79357201|FG000|Overall Study|Parents personal problem|0|||
44352977|NCT00969436|79357202|FG001|Overall Study|Parents personal problem|0|||
44352978|NCT00969436|79357203|FG002|Overall Study|Parents personal problem|1|||
44352979|NCT00969436|79357201|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
44352980|NCT00969436|79357202|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
44352981|NCT00969436|79357203|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
44352982|NCT00969436|79357201|FG000|Overall Study|Withdrawal by Subject|3|||
44352983|NCT00969436|79357202|FG001|Overall Study|Withdrawal by Subject|0|||
44352984|NCT00969436|79357203|FG002|Overall Study|Withdrawal by Subject|2|||
44352985|NCT00969436|79357201|FG000|Overall Study|Lost to Follow-up|8|||
44352986|NCT00969436|79357202|FG001|Overall Study|Lost to Follow-up|8|||
44352987|NCT00969436|79357203|FG002|Overall Study|Lost to Follow-up|5|||
44352988|NCT00900757|79357211|FG000|Overall Study|screen failure|19|||
44352989|NCT00969280|79357217|FG000|Overall Study|Protocol Violation|2|||
44352990|NCT00969280|79357218|FG001|Overall Study|Protocol Violation|1|||
44352991|NCT00969280|79357217|FG000|Overall Study|Withdrawal by Subject|0|||
44352992|NCT00969280|79357218|FG001|Overall Study|Withdrawal by Subject|1|||
44352993|NCT00969280|79357217|FG000|Overall Study|infection of influenza A(H1N1)|0|||
44352994|NCT00969280|79357218|FG001|Overall Study|infection of influenza A(H1N1)|1|||
44352995|NCT00969124|79357224|FG000|Overall Study|Protocol Violation|2|||
44352996|NCT00969124|79357224|FG000|Overall Study|Inadequate bowel preparation|15|||
44352997|NCT00969124|79357224|FG000|Overall Study|Inability to reach cecum|9|||
44352998|NCT00969124|79357224|FG000|Overall Study|Previously unrecognized disease|3|||
44352999|NCT00969124|79357224|FG000|Overall Study|Technical error|1|||
44353000|NCT00900601|79357229|FG000|Overall Study|Physician Decision|1|||
44353001|NCT00901927|79357256|FG000|Overall Study|Lack of Efficacy|1|||
44353002|NCT00901927|79357256|FG000|Overall Study|Protocol Violation|3|||
44353003|NCT00901927|79357256|FG000|Overall Study|Withdrawal by Subject|2|||
44353004|NCT00968968|79357262|FG000|Overall Study|Study closed/terminated|10|||
44353005|NCT00968968|79357263|FG001|Overall Study|Study closed/terminated|10|||
44353006|NCT00968968|79357262|FG000|Overall Study|Protocol defined stopping criteria|3|||
44353007|NCT00968968|79357263|FG001|Overall Study|Protocol defined stopping criteria|1|||
44353008|NCT00968968|79357262|FG000|Overall Study|Withdrawal by Subject|2|||
44353009|NCT00968968|79357263|FG001|Overall Study|Withdrawal by Subject|0|||
44353010|NCT00968968|79357262|FG000|Overall Study|Physician Decision|1|||
44353011|NCT00968968|79357263|FG001|Overall Study|Physician Decision|2|||
44353012|NCT00968968|79357262|FG000|Overall Study|Lost to Follow-up|0|||
44353013|NCT00968968|79357263|FG001|Overall Study|Lost to Follow-up|1|||
44353014|NCT00973102|79357272|FG000|Overall Study|Protocol Violation|1|||
44353015|NCT00973102|79357273|FG001|Overall Study|Protocol Violation|0|||
44353016|NCT00973102|79357272|FG000|Overall Study|Prisoner|0|||
44353017|NCT00973102|79357273|FG001|Overall Study|Prisoner|1|||
44353018|NCT00901459|79357279|FG000|Overall Study|Withdrawal by Subject|6|||
44353019|NCT00896233|79357290|FG000|Overall Study|Claustrophobia during MRI|1|||
44353020|NCT00899431|79357315|FG000|Overall Study|Physician Decision|1|||
44353021|NCT00899431|79357316|FG001|Overall Study|Physician Decision|0|||
44353022|NCT00899431|79357317|FG002|Overall Study|Physician Decision|0|||
44353023|NCT00899353|79357328|FG000|Overall Study|Adverse Event|2|||
44353024|NCT00899353|79357328|FG000|Overall Study|Lost to Follow-up|1|||
44353025|NCT00899353|79357328|FG000|Overall Study|Withdrawal by Subject|2|||
44353026|NCT00898807|79357351|FG000|Overall Study|Withdrawal by Subject|5|||
44353027|NCT00898807|79357352|FG001|Overall Study|Withdrawal by Subject|3|||
44353028|NCT00898807|79357351|FG000|Overall Study|Family pressure to discontinue|2|||
44353029|NCT00898807|79357352|FG001|Overall Study|Family pressure to discontinue|2|||
44353030|NCT00898807|79357351|FG000|Overall Study|Lost to Follow-up|1|||
44353031|NCT00898807|79357352|FG001|Overall Study|Lost to Follow-up|3|||
44261224|NCT02561832|79139090|FG001|Overall Study|Withdrawal by Subject|1|||
44353032|NCT00898807|79357351|FG000|Overall Study|Death|0|||
44353033|NCT00898807|79357352|FG001|Overall Study|Death|1|||
44261225|NCT02561832|79139089|FG000|Overall Study|Adverse Event|3|||
44261226|NCT02561832|79139090|FG001|Overall Study|Adverse Event|0|||
44261227|NCT02561832|79139089|FG000|Overall Study|Disease progression|3|||
44261228|NCT02561832|79139090|FG001|Overall Study|Disease progression|3|||
44261229|NCT00985088|79140725|FG000|Overall Study|Serious Adverse Event|1|||
44261230|NCT00985088|79140726|FG001|Overall Study|Serious Adverse Event|1|||
44261231|NCT00985088|79140727|FG002|Overall Study|Serious Adverse Event|0|||
44261232|NCT00985088|79140728|FG003|Overall Study|Serious Adverse Event|0|||
44353034|NCT01229267|79357363|FG000|Overall Study|Adverse Event|4|||
44353035|NCT01229267|79357364|FG001|Overall Study|Adverse Event|6|||
44353036|NCT01229267|79357365|FG002|Overall Study|Adverse Event|3|||
44353037|NCT01229267|79357366|FG003|Overall Study|Adverse Event|2|||
44353038|NCT01229267|79357367|FG004|Overall Study|Adverse Event|10|||
44353039|NCT01229267|79357363|FG000|Overall Study|Death|40|||
44353040|NCT01229267|79357364|FG001|Overall Study|Death|37|||
44353041|NCT01229267|79357365|FG002|Overall Study|Death|35|||
44353042|NCT01229267|79357366|FG003|Overall Study|Death|13|||
44353043|NCT01229267|79357367|FG004|Overall Study|Death|103|||
44353044|NCT01229267|79357363|FG000|Overall Study|Withdrawal by Subject|23|||
44353045|NCT01229267|79357364|FG001|Overall Study|Withdrawal by Subject|22|||
44353046|NCT01229267|79357365|FG002|Overall Study|Withdrawal by Subject|32|||
44353047|NCT01229267|79357366|FG003|Overall Study|Withdrawal by Subject|14|||
44353048|NCT01229267|79357367|FG004|Overall Study|Withdrawal by Subject|59|||
44353049|NCT01229267|79357363|FG000|Overall Study|Protocol Violation|0|||
44353050|NCT01229267|79357364|FG001|Overall Study|Protocol Violation|1|||
44353051|NCT01229267|79357365|FG002|Overall Study|Protocol Violation|0|||
44353052|NCT01229267|79357366|FG003|Overall Study|Protocol Violation|0|||
44353053|NCT01229267|79357367|FG004|Overall Study|Protocol Violation|0|||
44353054|NCT01229267|79357363|FG000|Overall Study|Progressive disease|0|||
44353055|NCT01229267|79357364|FG001|Overall Study|Progressive disease|0|||
44353056|NCT01229267|79357365|FG002|Overall Study|Progressive disease|0|||
44353057|NCT01229267|79357366|FG003|Overall Study|Progressive disease|0|||
44353058|NCT01229267|79357367|FG004|Overall Study|Progressive disease|1|||
44353059|NCT01229267|79357363|FG000|Overall Study|Physician Decision|8|||
44448321|NCT00111007|79456991|FG000|Long Term Follow-up|Lost to Follow-up|1|||
44448322|NCT00111007|79456992|FG001|Long Term Follow-up|Lost to Follow-up|1|||
44448323|NCT00111007|79456991|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
44448324|NCT00111007|79456992|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
44448325|NCT00111007|79456991|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
44448326|NCT00111007|79456992|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
44448327|NCT00111007|79456991|FG000|Long Term Follow-up|Missing|10|||
44448328|NCT00111007|79456992|FG001|Long Term Follow-up|Missing|3|||
44448329|NCT03975920|79457000|FG000|Overall Study|Lost to Follow-up|1|||
44448330|NCT03975920|79457001|FG001|Overall Study|Lost to Follow-up|2|||
44448331|NCT03975920|79457000|FG000|Overall Study|Protocol Violation|1|||
44448332|NCT03975920|79457001|FG001|Overall Study|Protocol Violation|1|||
44448333|NCT03975920|79457000|FG000|Overall Study|Did not complete survey|2|||
44448334|NCT03975920|79457001|FG001|Overall Study|Did not complete survey|1|||
44448335|NCT00699335|79457007|FG000|Overall Study|Combination of multiple reasons|176|||
44448336|NCT00699335|79457007|FG000|Overall Study|Missing data|52|||
44448337|NCT00445978|79457014|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
44448338|NCT00445978|79457014|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
44448339|NCT00445978|79457014|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
44448340|NCT00445978|79457014|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
44448341|NCT00445978|79457014|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
44448342|NCT00445978|79457014|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
44448343|NCT00445978|79457014|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
44448344|NCT00445978|79457014|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
44448345|NCT00445978|79457014|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
44448346|NCT00566228|79457027|FG000|Overall Study|Withdrawal by Subject|1|||
44448347|NCT00566228|79457028|FG001|Overall Study|Withdrawal by Subject|0|||
44448348|NCT00566228|79457027|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
44448349|NCT00566228|79457028|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
44448350|NCT00566228|79457027|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
44448351|NCT00566228|79457028|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
44448352|NCT00566228|79457027|FG000|Overall Study|progressed before infusion could occur|0|||
44448353|NCT00566228|79457028|FG001|Overall Study|progressed before infusion could occur|1|||
44448354|NCT00698009|79457034|FG000|Overall Study|Withdrawal by Subject|1|||
44448355|NCT03968978|79457040|FG000|Overall Study|Adverse Event|1|||
44448356|NCT03968978|79457041|FG001|Overall Study|Adverse Event|0|||
44448357|NCT00562718|79457047|FG000|Overall Study|Death|1|||
44448358|NCT00562718|79457047|FG000|Overall Study|Withdrawal by Subject|3|||
44448359|NCT00562718|79457047|FG000|Overall Study|Adverse Event|4|||
44448360|NCT00562718|79457047|FG000|Overall Study|Lack of Efficacy|2|||
44448361|NCT00562718|79457047|FG000|Overall Study|not stated|1|||
44448362|NCT00697619|79457053|FG000|Overall Study|Lack of Efficacy|2|||
44448363|NCT00697619|79457054|FG001|Overall Study|Lack of Efficacy|2|||
44353060|NCT01229267|79357364|FG001|Overall Study|Physician Decision|11|||
44353061|NCT01229267|79357365|FG002|Overall Study|Physician Decision|8|||
44448364|NCT00697619|79457053|FG000|Overall Study|Adverse Event|4|||
44353062|NCT01229267|79357366|FG003|Overall Study|Physician Decision|3|||
44353063|NCT01229267|79357367|FG004|Overall Study|Physician Decision|25|||
44353064|NCT01229267|79357363|FG000|Overall Study|Lost to Follow-up|6|||
44353065|NCT01229267|79357364|FG001|Overall Study|Lost to Follow-up|5|||
44353066|NCT01229267|79357365|FG002|Overall Study|Lost to Follow-up|8|||
44448365|NCT00697619|79457054|FG001|Overall Study|Adverse Event|6|||
44448366|NCT00445432|79457063|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
44448367|NCT00445432|79457064|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
44448368|NCT00445432|79457065|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
44448369|NCT00445432|79457066|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
44448370|NCT00445432|79457063|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
44448371|NCT00445432|79457064|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
44448372|NCT00445432|79457065|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
44448373|NCT00445432|79457066|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
44448374|NCT00445432|79457063|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
44448375|NCT00445432|79457064|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
44448376|NCT00445432|79457065|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
44448377|NCT00445432|79457066|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
44448378|NCT00445432|79457063|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
44448379|NCT00445432|79457064|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
44448380|NCT00445432|79457065|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
44448381|NCT00445432|79457066|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
44448382|NCT00445432|79457063|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
44448383|NCT00445432|79457064|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
44448384|NCT00445432|79457065|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
44448385|NCT00445432|79457066|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
44448386|NCT00445432|79457063|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
44448387|NCT00445432|79457064|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
44448388|NCT00445432|79457065|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
44448389|NCT00445432|79457066|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
44448390|NCT00445432|79457063|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
44448391|NCT00445432|79457064|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
44353067|NCT01229267|79357366|FG003|Overall Study|Lost to Follow-up|3|||
44353068|NCT01229267|79357367|FG004|Overall Study|Lost to Follow-up|22|||
44353069|NCT00897715|79357376|FG000|Overall Study|Lost to Follow-up|0|||
44353070|NCT00897715|79357377|FG001|Overall Study|Lost to Follow-up|1|||
44353071|NCT00897715|79357376|FG000|Overall Study|Physician Decision|1|||
44353072|NCT00897715|79357377|FG001|Overall Study|Physician Decision|0|||
44353073|NCT00897715|79357376|FG000|Overall Study|increased risk of infection|1|||
44353074|NCT00897715|79357377|FG001|Overall Study|increased risk of infection|0|||
44353075|NCT01229111|79357383|FG000|Overall Study|Death|1|||
44353076|NCT00894361|79357389|FG000|Overall Study|deaths and less than 2 years followup|24|||
44353077|NCT00894361|79357390|FG001|Overall Study|deaths and less than 2 years followup|64|||
44353078|NCT01228175|79357400|FG000|Overall Study|Lost to Follow-up|64|||
44353079|NCT01228175|79357401|FG001|Overall Study|Lost to Follow-up|50|||
44353080|NCT01228175|79357400|FG000|Overall Study|Withdrawal by Subject|1|||
44353081|NCT01228175|79357401|FG001|Overall Study|Withdrawal by Subject|2|||
44353082|NCT01228175|79357400|FG000|Overall Study|Physician Decision|1|||
44353083|NCT01228175|79357401|FG001|Overall Study|Physician Decision|1|||
44353084|NCT01228019|79357407|FG000|Overall Study|Dose Violation|70|||
44353085|NCT01228019|79357407|FG000|Overall Study|Duplicate enrollment|1|||
44353086|NCT01228019|79357407|FG000|Overall Study|Missing pre-treatment data|72|||
44353087|NCT01228019|79357407|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
44353088|NCT01228019|79357407|FG000|Overall Study|Violation of Entry Criterion|9|||
44353089|NCT02987959|79357411|FG000|Overall Study|Grantor stopped supply of drugs|6|||
44353090|NCT01227707|79357415|FG000|Overall Study|Adverse Event|10|||
44353091|NCT01227707|79357415|FG000|Overall Study|Progression of disease|3|||
44353092|NCT01227707|79357415|FG000|Overall Study|Withdrawal by Subject|1|||
44353093|NCT01227707|79357415|FG000|Overall Study|Patient non-compliance|3|||
44261233|NCT00985088|79140729|FG004|Overall Study|Serious Adverse Event|0|||
44261234|NCT00985088|79140730|FG005|Overall Study|Serious Adverse Event|0|||
44261235|NCT00985088|79140731|FG006|Overall Study|Serious Adverse Event|0|||
44261236|NCT00985088|79140732|FG007|Overall Study|Serious Adverse Event|1|||
44261237|NCT00985088|79140725|FG000|Overall Study|Adverse Event|0|||
44261238|NCT00985088|79140726|FG001|Overall Study|Adverse Event|0|||
44261239|NCT00985088|79140727|FG002|Overall Study|Adverse Event|1|||
44261240|NCT00985088|79140728|FG003|Overall Study|Adverse Event|0|||
44261241|NCT00985088|79140729|FG004|Overall Study|Adverse Event|0|||
44261242|NCT00985088|79140730|FG005|Overall Study|Adverse Event|0|||
44261243|NCT00985088|79140731|FG006|Overall Study|Adverse Event|0|||
44261244|NCT00985088|79140732|FG007|Overall Study|Adverse Event|0|||
44261245|NCT00985088|79140725|FG000|Overall Study|Withdrawal by Subject|4|||
44261246|NCT00985088|79140726|FG001|Overall Study|Withdrawal by Subject|0|||
44261247|NCT00985088|79140727|FG002|Overall Study|Withdrawal by Subject|0|||
44261248|NCT00985088|79140728|FG003|Overall Study|Withdrawal by Subject|1|||
44261249|NCT00985088|79140729|FG004|Overall Study|Withdrawal by Subject|3|||
44261250|NCT00985088|79140730|FG005|Overall Study|Withdrawal by Subject|2|||
44261251|NCT00985088|79140731|FG006|Overall Study|Withdrawal by Subject|1|||
44261252|NCT00985088|79140732|FG007|Overall Study|Withdrawal by Subject|2|||
44261253|NCT00985088|79140725|FG000|Overall Study|Migrated/moved from study area|0|||
44261254|NCT00985088|79140726|FG001|Overall Study|Migrated/moved from study area|0|||
44261255|NCT00985088|79140727|FG002|Overall Study|Migrated/moved from study area|1|||
44261256|NCT00985088|79140728|FG003|Overall Study|Migrated/moved from study area|0|||
44261257|NCT00985088|79140729|FG004|Overall Study|Migrated/moved from study area|0|||
44261258|NCT00985088|79140730|FG005|Overall Study|Migrated/moved from study area|0|||
44261259|NCT00985088|79140731|FG006|Overall Study|Migrated/moved from study area|0|||
44261260|NCT00985088|79140732|FG007|Overall Study|Migrated/moved from study area|1|||
44261261|NCT00985088|79140725|FG000|Overall Study|Lost to Follow-up|6|||
44261262|NCT00985088|79140726|FG001|Overall Study|Lost to Follow-up|1|||
44261263|NCT00985088|79140727|FG002|Overall Study|Lost to Follow-up|2|||
44261264|NCT00985088|79140728|FG003|Overall Study|Lost to Follow-up|6|||
44261265|NCT00985088|79140729|FG004|Overall Study|Lost to Follow-up|6|||
44261266|NCT00985088|79140730|FG005|Overall Study|Lost to Follow-up|5|||
44261267|NCT00985088|79140731|FG006|Overall Study|Lost to Follow-up|3|||
44261268|NCT00985088|79140732|FG007|Overall Study|Lost to Follow-up|2|||
44261269|NCT00984542|79140778|FG000|Overall Study|disease progression|19|||
44261270|NCT00984542|79140778|FG000|Overall Study|toxicity|7|||
44261271|NCT00984542|79140778|FG000|Overall Study|Death|7|||
44261272|NCT00984542|79140778|FG000|Overall Study|complicating disease|3|||
44261273|NCT00984542|79140778|FG000|Overall Study|Withdrawal by Subject|3|||
44261274|NCT00984542|79140778|FG000|Overall Study|clinical deterioration|2|||
44261275|NCT00983918|79140787|FG000|Overall Study|conversion to open cholecystectomy|0|||
44261276|NCT00983918|79140788|FG001|Overall Study|conversion to open cholecystectomy|2|||
44261277|NCT00983918|79140789|FG002|Overall Study|conversion to open cholecystectomy|2|||
44261278|NCT00983918|79140790|FG003|Overall Study|conversion to open cholecystectomy|2|||
44261279|NCT00983528|79140800|FG000|Overall Study|Death|4|||
44261280|NCT00983528|79140800|FG000|Overall Study|Lost to Follow-up|1|||
44261281|NCT00983528|79140800|FG000|Overall Study|Study Terminated|1|||
44261282|NCT00983372|79140804|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
44261283|NCT00983372|79140804|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
44261284|NCT00983372|79140804|FG000|Diltiazem ER Alone|Adverse Event|1|||
44261285|NCT00983294|79140836|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
44261286|NCT00983294|79140836|FG000|Colchicine With Azithromycin|Adverse Event|1|||
44261287|NCT00982280|79140852|FG000|Observation Period|Not eligible to be dosed|19|||
44261288|NCT00982280|79140852|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
44261289|NCT00982280|79140852|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
44261290|NCT00982280|79140852|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
44261291|NCT00982280|79140852|FG000|Maintenance Period|Adverse Event|1|||
44261292|NCT00981578|79140870|FG000|Overall Study|Death|1|||
44261293|NCT00981578|79140870|FG000|Overall Study|Withdrawal by Subject|2|||
44261294|NCT00980798|79140893|FG000|Overall Study|Adverse Event|7|||
44261295|NCT00980798|79140894|FG001|Overall Study|Adverse Event|36|||
44261296|NCT00980798|79140893|FG000|Overall Study|Lack of Efficacy|16|||
44261297|NCT00980798|79140894|FG001|Overall Study|Lack of Efficacy|5|||
44261298|NCT00980798|79140893|FG000|Overall Study|Lost to Follow-up|0|||
44261299|NCT00980798|79140894|FG001|Overall Study|Lost to Follow-up|1|||
44261300|NCT00980798|79140893|FG000|Overall Study|Physician Decision|2|||
44261301|NCT00980798|79140894|FG001|Overall Study|Physician Decision|1|||
44261302|NCT00980798|79140893|FG000|Overall Study|Withdrawal by Subject|8|||
44261303|NCT00980798|79140894|FG001|Overall Study|Withdrawal by Subject|11|||
44261304|NCT00980798|79140893|FG000|Overall Study|Other|0|||
44261305|NCT00980798|79140894|FG001|Overall Study|Other|1|||
44261306|NCT00980330|79141039|FG000|Overall Study|Adverse Event|0|||
44261307|NCT00980330|79141040|FG001|Overall Study|Adverse Event|0|||
44261308|NCT00980330|79141041|FG002|Overall Study|Adverse Event|0|||
44261309|NCT00980330|79141042|FG003|Overall Study|Adverse Event|1|||
44261310|NCT00980330|79141043|FG004|Overall Study|Adverse Event|0|||
44261311|NCT00980330|79141044|FG005|Overall Study|Adverse Event|0|||
44261312|NCT00980330|79141045|FG006|Overall Study|Adverse Event|0|||
44261313|NCT00980330|79141039|FG000|Overall Study|Lost to Follow-up|1|||
44261314|NCT00980330|79141040|FG001|Overall Study|Lost to Follow-up|1|||
44261315|NCT00980330|79141041|FG002|Overall Study|Lost to Follow-up|4|||
44261316|NCT00980330|79141042|FG003|Overall Study|Lost to Follow-up|2|||
44261317|NCT00980330|79141043|FG004|Overall Study|Lost to Follow-up|1|||
44261318|NCT00980330|79141044|FG005|Overall Study|Lost to Follow-up|1|||
44261319|NCT00980330|79141045|FG006|Overall Study|Lost to Follow-up|2|||
44261320|NCT00980330|79141039|FG000|Overall Study|Withdrawal by Subject|2|||
44261321|NCT00980330|79141040|FG001|Overall Study|Withdrawal by Subject|4|||
44261322|NCT00980330|79141041|FG002|Overall Study|Withdrawal by Subject|4|||
44261323|NCT00980330|79141042|FG003|Overall Study|Withdrawal by Subject|1|||
44261324|NCT00980330|79141043|FG004|Overall Study|Withdrawal by Subject|3|||
44261325|NCT00980330|79141044|FG005|Overall Study|Withdrawal by Subject|2|||
44261326|NCT00980330|79141045|FG006|Overall Study|Withdrawal by Subject|5|||
44261327|NCT00980330|79141039|FG000|Overall Study|(not specified)|2|||
44261328|NCT00980330|79141040|FG001|Overall Study|(not specified)|0|||
44261329|NCT00980330|79141041|FG002|Overall Study|(not specified)|0|||
44261330|NCT00980330|79141042|FG003|Overall Study|(not specified)|1|||
44261331|NCT00980330|79141043|FG004|Overall Study|(not specified)|1|||
44261332|NCT00980330|79141044|FG005|Overall Study|(not specified)|1|||
44261333|NCT00980330|79141045|FG006|Overall Study|(not specified)|0|||
44261334|NCT00980174|79141089|FG000|Overall Study|Withdrawal by Subject|1|||
44261335|NCT00980174|79141090|FG001|Overall Study|Withdrawal by Subject|4|||
44261336|NCT00980174|79141089|FG000|Overall Study|Adverse Event|0|||
44261337|NCT00980174|79141090|FG001|Overall Study|Adverse Event|3|||
44261338|NCT00980174|79141089|FG000|Overall Study|Ineligibility determined|2|||
44261339|NCT00980174|79141090|FG001|Overall Study|Ineligibility determined|1|||
44261340|NCT00980174|79141089|FG000|Overall Study|Death|1|||
44261341|NCT00980174|79141090|FG001|Overall Study|Death|1|||
44261342|NCT00980174|79141089|FG000|Overall Study|Other|0|||
44261343|NCT00980174|79141090|FG001|Overall Study|Other|1|||
44261344|NCT00980018|79141118|FG000|Overall Study|Adverse Event|8|||
44261345|NCT00980018|79141118|FG000|Overall Study|Patient withdrew consent|3|||
44353094|NCT01227707|79357415|FG000|Overall Study|Medical decision|6|||
44261346|NCT00980018|79141118|FG000|Overall Study|Lost to Follow-up|1|||
44261347|NCT00988052|79141136|FG000|Overall Study|Missing|1|||
44261348|NCT00988052|79141137|FG001|Overall Study|Missing|0|||
44261349|NCT00988052|79141136|FG000|Overall Study|Teva requested subject withdrawal|3|||
44261350|NCT00988052|79141137|FG001|Overall Study|Teva requested subject withdrawal|1|||
44261351|NCT00988052|79141136|FG000|Overall Study|Death|1|||
44261352|NCT00988052|79141137|FG001|Overall Study|Death|3|||
44261353|NCT00988052|79141136|FG000|Overall Study|Protocol Violation|6|||
44261354|NCT00988052|79141137|FG001|Overall Study|Protocol Violation|5|||
44261355|NCT00988052|79141136|FG000|Overall Study|Pregnancy|6|||
44261356|NCT00988052|79141137|FG001|Overall Study|Pregnancy|6|||
44261357|NCT00988052|79141136|FG000|Overall Study|Lack of Efficacy|8|||
44261358|NCT00988052|79141137|FG001|Overall Study|Lack of Efficacy|7|||
44261359|NCT00988052|79141136|FG000|Overall Study|Lost to Follow-up|6|||
44261360|NCT00988052|79141137|FG001|Overall Study|Lost to Follow-up|11|||
44261361|NCT00988052|79141136|FG000|Overall Study|Physician Decision|27|||
44261362|NCT00988052|79141137|FG001|Overall Study|Physician Decision|28|||
44261363|NCT00988052|79141136|FG000|Overall Study|Adverse Event|35|||
44261364|NCT00988052|79141137|FG001|Overall Study|Adverse Event|28|||
44261365|NCT00988052|79141136|FG000|Overall Study|Withdrawal by Subject|90|||
44261366|NCT00988052|79141137|FG001|Overall Study|Withdrawal by Subject|91|||
44261367|NCT00988052|79141136|FG000|Overall Study|Study terminated by sponsor|240|||
44261368|NCT00988052|79141137|FG001|Overall Study|Study terminated by sponsor|236|||
44353095|NCT01227707|79357415|FG000|Overall Study|Death|1|||
44353096|NCT00895843|79357421|FG000|Overall Study|Protocol Violation|12|||
44353097|NCT00895843|79357422|FG001|Overall Study|Protocol Violation|12|||
44353098|NCT00895453|79357431|FG000|Overall Study|Lost to Follow-up|25|||
44353099|NCT00895453|79357432|FG001|Overall Study|Lost to Follow-up|25|||
44353100|NCT00895453|79357433|FG002|Overall Study|Lost to Follow-up|23|||
44353101|NCT00893971|79357441|FG000|Overall Study|Physician Decision|3|||
44353102|NCT00893737|79357454|FG000|Overall Study|Adverse Event|4|||
44353103|NCT00893737|79357454|FG000|Overall Study|Withdrawal by Subject|2|||
44353104|NCT00893737|79357454|FG000|Overall Study|Lost to Follow-up|6|||
44353105|NCT00893113|79357460|FG000|Overall Study|Lost to Follow-up|4|||
44353106|NCT00893113|79357461|FG001|Overall Study|Lost to Follow-up|8|||
44353107|NCT00893113|79357460|FG000|Overall Study|Early Termination|1|||
44353108|NCT00893113|79357461|FG001|Overall Study|Early Termination|1|||
44353109|NCT00893113|79357460|FG000|Overall Study|Withdrew Consent|8|||
44353110|NCT00893113|79357461|FG001|Overall Study|Withdrew Consent|7|||
44353111|NCT00892957|79357469|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
44353112|NCT00892957|79357470|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
44353113|NCT00892957|79357469|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
44353114|NCT00892957|79357470|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
44353115|NCT00968812|79357493|FG000|Overall Study|Adverse Event|30|||
44353116|NCT00968812|79357494|FG001|Overall Study|Adverse Event|46|||
44353117|NCT00968812|79357495|FG002|Overall Study|Adverse Event|33|||
44353118|NCT00968812|79357493|FG000|Overall Study|Death|2|||
44353119|NCT00968812|79357494|FG001|Overall Study|Death|2|||
44353120|NCT00968812|79357495|FG002|Overall Study|Death|1|||
44353121|NCT00968812|79357493|FG000|Overall Study|Lack of Efficacy|9|||
44353122|NCT00968812|79357494|FG001|Overall Study|Lack of Efficacy|7|||
44353123|NCT00968812|79357495|FG002|Overall Study|Lack of Efficacy|16|||
44353124|NCT00968812|79357493|FG000|Overall Study|Lost to Follow-up|17|||
44353125|NCT00968812|79357494|FG001|Overall Study|Lost to Follow-up|12|||
44353126|NCT00968812|79357495|FG002|Overall Study|Lost to Follow-up|11|||
44353127|NCT00968812|79357493|FG000|Overall Study|Physician Decision|8|||
44353128|NCT00968812|79357494|FG001|Overall Study|Physician Decision|5|||
44353129|NCT00968812|79357495|FG002|Overall Study|Physician Decision|9|||
44353130|NCT00968812|79357493|FG000|Overall Study|Protocol Violation|7|||
44353131|NCT00968812|79357494|FG001|Overall Study|Protocol Violation|4|||
44353132|NCT00968812|79357495|FG002|Overall Study|Protocol Violation|3|||
44353133|NCT00968812|79357493|FG000|Overall Study|Withdrawal by Subject|17|||
44353134|NCT00968812|79357494|FG001|Overall Study|Withdrawal by Subject|23|||
44353135|NCT00968812|79357495|FG002|Overall Study|Withdrawal by Subject|25|||
44353136|NCT00968812|79357493|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
44353137|NCT00968812|79357494|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
44353138|NCT00968812|79357495|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
44353139|NCT00968812|79357493|FG000|Overall Study|Noncompliance with study drug|4|||
44353140|NCT00968812|79357494|FG001|Overall Study|Noncompliance with study drug|1|||
44353141|NCT00968812|79357495|FG002|Overall Study|Noncompliance with study drug|6|||
44353142|NCT00968812|79357493|FG000|Overall Study|Unable to take rescue therapy|12|||
44353143|NCT00968812|79357494|FG001|Overall Study|Unable to take rescue therapy|12|||
44353144|NCT00968812|79357495|FG002|Overall Study|Unable to take rescue therapy|17|||
44353145|NCT00968812|79357493|FG000|Overall Study|Other|25|||
44353146|NCT00968812|79357494|FG001|Overall Study|Other|37|||
44353147|NCT00968812|79357495|FG002|Overall Study|Other|40|||
44353148|NCT00992056|79357508|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
44353149|NCT00992056|79357509|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
44353150|NCT00992056|79357508|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
44353151|NCT00992056|79357509|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
44353152|NCT00972322|79357517|FG000|Overall Study|Adverse Event|2|||
44353153|NCT00972322|79357518|FG001|Overall Study|Adverse Event|1|||
44353154|NCT00972322|79357517|FG000|Overall Study|Positive drug screen|0|||
44353155|NCT00972322|79357518|FG001|Overall Study|Positive drug screen|1|||
44353156|NCT00972322|79357517|FG000|Overall Study|Lost to Follow-up|0|||
44353157|NCT00972322|79357518|FG001|Overall Study|Lost to Follow-up|1|||
44353158|NCT00972322|79357517|FG000|Overall Study|Consistently high glucose values|1|||
44353159|NCT00972322|79357518|FG001|Overall Study|Consistently high glucose values|0|||
44353160|NCT00967798|79357526|FG000|Overall Study|Withdrawal by Subject|5|||
44353161|NCT00967798|79357527|FG001|Overall Study|Withdrawal by Subject|2|||
44353162|NCT00967798|79357526|FG000|Overall Study|Lost to Follow-up|4|||
44353163|NCT00967798|79357527|FG001|Overall Study|Lost to Follow-up|1|||
44353164|NCT00965458|79357535|FG000|Overall Study|Adverse Event|1|||
44353165|NCT00965458|79357536|FG001|Overall Study|Adverse Event|0|||
44353166|NCT00965458|79357535|FG000|Overall Study|Lost to Follow-up|1|||
44353167|NCT00965458|79357536|FG001|Overall Study|Lost to Follow-up|3|||
44353168|NCT00965458|79357535|FG000|Overall Study|Withdrawal by Subject|0|||
44353169|NCT00965458|79357536|FG001|Overall Study|Withdrawal by Subject|1|||
44353170|NCT00972244|79357549|FG000|Overall Study|Incorrect Enrolment|1|||
44353171|NCT00972244|79357550|FG001|Overall Study|Incorrect Enrolment|0|||
44353172|NCT00972244|79357551|FG002|Overall Study|Incorrect Enrolment|0|||
44353173|NCT00972244|79357552|FG003|Overall Study|Incorrect Enrolment|0|||
44353174|NCT00972244|79357553|FG004|Overall Study|Incorrect Enrolment|0|||
44353175|NCT00972244|79357549|FG000|Overall Study|Adverse Event|0|||
44353176|NCT00972244|79357550|FG001|Overall Study|Adverse Event|1|||
44353177|NCT00972244|79357551|FG002|Overall Study|Adverse Event|1|||
44353178|NCT00972244|79357552|FG003|Overall Study|Adverse Event|0|||
44353179|NCT00972244|79357553|FG004|Overall Study|Adverse Event|0|||
44353180|NCT00972244|79357549|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
44353181|NCT00972244|79357550|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
44353182|NCT00972244|79357551|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
44353183|NCT00972244|79357552|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
44353184|NCT00972244|79357553|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
44353185|NCT00972244|79357549|FG000|Overall Study|Withdrawal by Subject|1|||
44353186|NCT00972244|79357550|FG001|Overall Study|Withdrawal by Subject|2|||
44353187|NCT00972244|79357551|FG002|Overall Study|Withdrawal by Subject|1|||
44353188|NCT00972244|79357552|FG003|Overall Study|Withdrawal by Subject|0|||
44353189|NCT00972244|79357553|FG004|Overall Study|Withdrawal by Subject|1|||
44353190|NCT00972244|79357549|FG000|Overall Study|Safety|0|||
44353191|NCT00972244|79357550|FG001|Overall Study|Safety|0|||
44353192|NCT00972244|79357551|FG002|Overall Study|Safety|0|||
44353193|NCT00972244|79357552|FG003|Overall Study|Safety|0|||
44353194|NCT00972244|79357553|FG004|Overall Study|Safety|1|||
44353195|NCT00972244|79357549|FG000|Overall Study|Death|1|||
44353196|NCT00972244|79357550|FG001|Overall Study|Death|0|||
44353197|NCT00972244|79357551|FG002|Overall Study|Death|0|||
44353198|NCT00972244|79357552|FG003|Overall Study|Death|0|||
44353199|NCT00972244|79357553|FG004|Overall Study|Death|0|||
44353200|NCT00972244|79357549|FG000|Overall Study|Various|0|||
44353201|NCT00972244|79357550|FG001|Overall Study|Various|0|||
44353202|NCT00972244|79357551|FG002|Overall Study|Various|0|||
44353203|NCT00972244|79357552|FG003|Overall Study|Various|0|||
44353204|NCT00972244|79357553|FG004|Overall Study|Various|2|||
44353205|NCT00892723|79357568|FG000|Overall Study|Lost to Follow-up|1|||
44353206|NCT00892723|79357569|FG001|Overall Study|Lost to Follow-up|3|||
44353207|NCT00892723|79357570|FG002|Overall Study|Lost to Follow-up|1|||
44353208|NCT00892723|79357568|FG000|Overall Study|Withdrawal by Subject|1|||
44353209|NCT00892723|79357569|FG001|Overall Study|Withdrawal by Subject|1|||
44353210|NCT00892723|79357570|FG002|Overall Study|Withdrawal by Subject|1|||
44353211|NCT03811912|79357613|FG000|Overall Study|Withdrew Consent|4|||
44353212|NCT03811912|79357614|FG001|Overall Study|Withdrew Consent|2|||
44353213|NCT00971932|79357620|FG000|Overall Study|Withdrawal by Subject|1|||
44448392|NCT00445432|79457065|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
44448393|NCT00445432|79457066|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
44448394|NCT00696137|79457077|FG000|Overall Study|Withdrawal by Subject|2|||
44448395|NCT00441142|79457085|FG000|Overall Study|Adverse Event|2|||
44448396|NCT00441142|79457086|FG001|Overall Study|Adverse Event|3|||
44448397|NCT00441142|79457087|FG002|Overall Study|Adverse Event|3|||
44448398|NCT00441142|79457088|FG003|Overall Study|Adverse Event|22|||
44448399|NCT00441142|79457085|FG000|Overall Study|Lack of Efficacy|3|||
44448400|NCT00441142|79457086|FG001|Overall Study|Lack of Efficacy|3|||
44448401|NCT00441142|79457087|FG002|Overall Study|Lack of Efficacy|17|||
44448402|NCT00441142|79457088|FG003|Overall Study|Lack of Efficacy|32|||
44448403|NCT00441142|79457085|FG000|Overall Study|Withdrawal by Subject|0|||
44448404|NCT00441142|79457086|FG001|Overall Study|Withdrawal by Subject|0|||
44448405|NCT00441142|79457087|FG002|Overall Study|Withdrawal by Subject|2|||
44448406|NCT00441142|79457088|FG003|Overall Study|Withdrawal by Subject|10|||
44353214|NCT00971932|79357620|FG000|Overall Study|Investigator's decision|2|||
44448407|NCT00441142|79457085|FG000|Overall Study|Patient still receiving active study tx|1|||
44448408|NCT00441142|79457086|FG001|Overall Study|Patient still receiving active study tx|0|||
44448409|NCT00441142|79457087|FG002|Overall Study|Patient still receiving active study tx|0|||
44448410|NCT00441142|79457088|FG003|Overall Study|Patient still receiving active study tx|2|||
44448411|NCT00441142|79457085|FG000|Overall Study|Physician Decision|0|||
44448412|NCT00441142|79457086|FG001|Overall Study|Physician Decision|1|||
44353215|NCT00971932|79357620|FG000|Overall Study|Ongoing|4|||
44353216|NCT00970684|79357624|FG000|Overall Study|Lack of Efficacy|5|||
44353217|NCT00970684|79357624|FG000|Overall Study|Adverse Event|4|||
44353218|NCT00970684|79357624|FG000|Overall Study|Withdrawal by Subject|1|||
44353219|NCT00967330|79357630|FG000|Overall Study|Protocol Violation|3|||
44448413|NCT00441142|79457087|FG002|Overall Study|Physician Decision|0|||
44448414|NCT00441142|79457088|FG003|Overall Study|Physician Decision|1|||
44448415|NCT00441142|79457085|FG000|Overall Study|Death|0|||
44448416|NCT00441142|79457086|FG001|Overall Study|Death|0|||
44448417|NCT00441142|79457087|FG002|Overall Study|Death|0|||
44448418|NCT00441142|79457088|FG003|Overall Study|Death|1|||
44448419|NCT04025021|79457102|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
44448420|NCT04025021|79457103|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
44448421|NCT03848416|79457113|FG000|Overall Study|Withdrawal by Subject|1|||
44448422|NCT03848416|79457114|FG001|Overall Study|Withdrawal by Subject|0|||
44448423|NCT03848416|79457115|FG002|Overall Study|Withdrawal by Subject|0|||
44448424|NCT03848416|79457113|FG000|Overall Study|Death|0|||
44448425|NCT03848416|79457114|FG001|Overall Study|Death|0|||
44448426|NCT03848416|79457115|FG002|Overall Study|Death|1|||
44448427|NCT00458302|79457125|FG000|Overall Study|Adverse Event|4|||
44448428|NCT00458302|79457126|FG001|Overall Study|Adverse Event|14|||
44448429|NCT00458302|79457125|FG000|Overall Study|Pregnancy|2|||
44448430|NCT00458302|79457126|FG001|Overall Study|Pregnancy|1|||
44448431|NCT00458302|79457125|FG000|Overall Study|Protocol Violation|0|||
44448432|NCT00458302|79457126|FG001|Overall Study|Protocol Violation|2|||
44448433|NCT00458302|79457125|FG000|Overall Study|Withdrawal by Subject|6|||
44448434|NCT00458302|79457126|FG001|Overall Study|Withdrawal by Subject|4|||
44448435|NCT00458302|79457125|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
44448436|NCT00458302|79457126|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
44448437|NCT00458302|79457125|FG000|Overall Study|Study Termination By Sponsor|1|||
44448438|NCT00458302|79457126|FG001|Overall Study|Study Termination By Sponsor|0|||
44448439|NCT00458302|79457125|FG000|Overall Study|Lost to Follow-up|2|||
44448440|NCT00458302|79457126|FG001|Overall Study|Lost to Follow-up|0|||
44448441|NCT00458302|79457125|FG000|Overall Study|Other|4|||
44448442|NCT00458302|79457126|FG001|Overall Study|Other|2|||
44448443|NCT00444106|79457136|FG000|Overall Study|Lost to Follow-up|2|||
44448444|NCT00444106|79457137|FG001|Overall Study|Lost to Follow-up|1|||
44448445|NCT00444106|79457138|FG002|Overall Study|Lost to Follow-up|0|||
44448446|NCT00444106|79457136|FG000|Overall Study|Abnormal Test Procedure Results|0|||
44448447|NCT00444106|79457137|FG001|Overall Study|Abnormal Test Procedure Results|0|||
44448448|NCT00444106|79457138|FG002|Overall Study|Abnormal Test Procedure Results|1|||
44540856|NCT03311646|79552997|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
44540857|NCT01672892|79553004|FG000|Overall Study|Protocol Violation|7|||
44540858|NCT01672892|79553005|FG001|Overall Study|Protocol Violation|3|||
44540859|NCT03288987|79553016|FG000|Overall Study|Protocol Violation|10|||
44540860|NCT03288987|79553017|FG001|Overall Study|Protocol Violation|4|||
44540861|NCT02939781|79553023|FG000|Overall Study|Protocol Violation|8|||
44540862|NCT02939781|79553023|FG000|Overall Study|Withdrawal by Subject|1|||
44540863|NCT03083990|79553039|FG000|Overall Study|Adverse Event|1|||
44540864|NCT03083990|79553040|FG001|Overall Study|Adverse Event|0|||
44540865|NCT03252015|79553058|FG000|Overall Study|Withdrawal by Subject|0|||
44540866|NCT03252015|79553059|FG001|Overall Study|Withdrawal by Subject|1|||
44540867|NCT03252015|79553060|FG002|Overall Study|Withdrawal by Subject|1|||
44540868|NCT03252015|79553061|FG003|Overall Study|Withdrawal by Subject|0|||
44540869|NCT03252015|79553058|FG000|Overall Study|Adverse Event|1|||
44540870|NCT03252015|79553059|FG001|Overall Study|Adverse Event|0|||
44540871|NCT03252015|79553060|FG002|Overall Study|Adverse Event|0|||
44540872|NCT03252015|79553061|FG003|Overall Study|Adverse Event|1|||
44540873|NCT03083132|79553087|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
44540874|NCT03083132|79553088|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
44540875|NCT03083132|79553087|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
44540876|NCT03083132|79553088|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
44540877|NCT03083132|79553087|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
44540878|NCT03083132|79553088|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
44540879|NCT03683823|79553096|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
44540880|NCT03683823|79553097|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
44540881|NCT03683823|79553096|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
44540882|NCT03683823|79553097|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
44540883|NCT03683823|79553096|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
44540884|NCT03683823|79553097|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
44540885|NCT03285711|79553105|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
44540886|NCT03285711|79553106|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
44540887|NCT03285711|79553107|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
44540888|NCT03285711|79553108|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
44540889|NCT03285711|79553105|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
44540890|NCT03285711|79553106|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
44540891|NCT03285711|79553107|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
44540892|NCT03285711|79553108|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
44540893|NCT03285711|79553105|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
44540894|NCT03285711|79553106|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
44540895|NCT03285711|79553107|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
44540896|NCT03285711|79553108|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
44540897|NCT03285711|79553105|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
44540898|NCT03285711|79553106|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
44540899|NCT03285711|79553107|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
44540900|NCT03285711|79553108|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
44540901|NCT02927366|79553120|FG000|Overall Study|Adverse Event|1|||
44540902|NCT02927366|79553121|FG001|Overall Study|Adverse Event|0|||
44540903|NCT02927366|79553120|FG000|Overall Study|Patient schedule|1|||
44540904|NCT02927366|79553121|FG001|Overall Study|Patient schedule|0|||
44540905|NCT03249909|79553130|FG000|Overall Study|Withdrawal by Subject|3|||
44540906|NCT03249909|79553131|FG001|Overall Study|Withdrawal by Subject|0|||
44540907|NCT03249909|79553132|FG002|Overall Study|Withdrawal by Subject|0|||
44540908|NCT03249909|79553130|FG000|Overall Study|Adverse Event|3|||
44540909|NCT03249909|79553131|FG001|Overall Study|Adverse Event|0|||
44540910|NCT03249909|79553132|FG002|Overall Study|Adverse Event|0|||
44540911|NCT03249909|79553130|FG000|Overall Study|Lost to Follow-up|0|||
44540912|NCT03249909|79553131|FG001|Overall Study|Lost to Follow-up|1|||
44540913|NCT03249909|79553132|FG002|Overall Study|Lost to Follow-up|0|||
44540914|NCT03081884|79553143|FG000|Overall Study|deferred prostate cancer treatment|1|||
44540915|NCT03081884|79553143|FG000|Overall Study|metastasis managed with systemic therapy|3|||
44540916|NCT03077438|79553150|FG000|Overall Study|Protocol Violation|3|||
44540917|NCT03077438|79553151|FG001|Overall Study|Protocol Violation|5|||
44540918|NCT03077438|79553150|FG000|Overall Study|Withdrawal by Subject|3|||
44540919|NCT03077438|79553151|FG001|Overall Study|Withdrawal by Subject|6|||
44540920|NCT03077438|79553150|FG000|Overall Study|Lost to Follow-up|6|||
44540921|NCT03077438|79553151|FG001|Overall Study|Lost to Follow-up|3|||
44540922|NCT03076970|79553161|FG000|Washout Period 2|Adverse Event|0|||
44540923|NCT03076970|79553162|FG001|Washout Period 2|Adverse Event|0|||
44540924|NCT03076970|79553163|FG002|Washout Period 2|Adverse Event|0|||
44540925|NCT03076970|79553164|FG003|Washout Period 2|Adverse Event|0|||
44540926|NCT03076970|79553165|FG004|Washout Period 2|Adverse Event|1|||
44540927|NCT03076970|79553166|FG005|Washout Period 2|Adverse Event|0|||
44540928|NCT03076970|79553161|FG000|Period 3|Withdrawal by Subject|0|||
44540929|NCT03076970|79553162|FG001|Period 3|Withdrawal by Subject|0|||
44540930|NCT03076970|79553163|FG002|Period 3|Withdrawal by Subject|0|||
44540931|NCT03076970|79553164|FG003|Period 3|Withdrawal by Subject|0|||
44540932|NCT03076970|79553165|FG004|Period 3|Withdrawal by Subject|0|||
44540933|NCT03076970|79553166|FG005|Period 3|Withdrawal by Subject|1|||
44540934|NCT03076970|79553161|FG000|Period 3|Failure to meet I/E criteria|0|||
44540935|NCT03076970|79553162|FG001|Period 3|Failure to meet I/E criteria|0|||
44540936|NCT03076970|79553163|FG002|Period 3|Failure to meet I/E criteria|0|||
44540937|NCT03076970|79553164|FG003|Period 3|Failure to meet I/E criteria|0|||
44540938|NCT03076970|79553165|FG004|Period 3|Failure to meet I/E criteria|1|||
44540939|NCT03076970|79553166|FG005|Period 3|Failure to meet I/E criteria|0|||
44540940|NCT00726596|79553179|FG000|Overall Study|Adverse Event|2|||
44540941|NCT00726596|79553180|FG001|Overall Study|Adverse Event|1|||
44540942|NCT00726596|79553179|FG000|Overall Study|Withdrawal by Subject|3|||
44540943|NCT00726596|79553180|FG001|Overall Study|Withdrawal by Subject|3|||
44540944|NCT02890992|79553203|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540945|NCT02890992|79553204|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
44540946|NCT02890992|79553205|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540947|NCT02890992|79553206|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540948|NCT02890992|79553207|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540949|NCT02890992|79553208|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540950|NCT02890992|79553209|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540951|NCT02890992|79553210|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
44540952|NCT02890992|79553203|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
44540953|NCT02890992|79553204|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
44540954|NCT02890992|79553205|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
44540955|NCT02890992|79553206|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
44540956|NCT02890992|79553207|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
44540957|NCT02890992|79553208|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
44540958|NCT02890992|79553209|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
44540959|NCT02890992|79553210|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
44540960|NCT02890992|79553203|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540961|NCT02890992|79553204|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
44540962|NCT02890992|79553205|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540963|NCT02890992|79553206|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540964|NCT02890992|79553207|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540965|NCT02890992|79553208|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540966|NCT02890992|79553209|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540967|NCT02890992|79553210|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
44540968|NCT03076190|79553255|FG000|Overall Study|Lost to Follow-up|9|||
44540969|NCT03076190|79553256|FG001|Overall Study|Lost to Follow-up|34|||
44540970|NCT03076190|79553255|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
44540971|NCT03076190|79553256|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
44540972|NCT03328182|79553265|FG000|Overall Study|Withdrawal by Subject|1|||
44540973|NCT03328182|79553265|FG000|Overall Study|Protocol Violation|2|||
44540974|NCT03328182|79553265|FG000|Overall Study|No Product Evaluated|1|||
44540975|NCT03327402|79553269|FG000|Overall Study|Withdrawal by Subject|1|||
44540976|NCT03327402|79553269|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
44540977|NCT03075878|79553273|FG000|Overall Study|Physician Decision|1|||
44540978|NCT03326856|79553282|FG000|Overall Study|Lost to Follow-up|1|||
44540979|NCT03326856|79553283|FG001|Overall Study|Lost to Follow-up|1|||
44540980|NCT03326856|79553284|FG002|Overall Study|Lost to Follow-up|0|||
44540981|NCT03326856|79553285|FG003|Overall Study|Lost to Follow-up|0|||
44540982|NCT03326856|79553286|FG004|Overall Study|Lost to Follow-up|0|||
44540983|NCT03309696|79553300|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
44540984|NCT03309696|79553301|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
44540985|NCT03309696|79553302|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
44540986|NCT03309696|79553303|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
44540987|NCT03075644|79553317|FG000|Overall Study|Withdrawal by Subject|1|||
44540988|NCT03075644|79553318|FG001|Overall Study|Withdrawal by Subject|1|||
44540989|NCT03075410|79553334|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
44540990|NCT03075410|79553335|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540991|NCT03075410|79553336|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
44540992|NCT03075410|79553337|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540993|NCT03075410|79553338|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540994|NCT03075410|79553339|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540995|NCT03075410|79553340|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540996|NCT03075410|79553341|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540997|NCT03075410|79553342|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
44540998|NCT03075410|79553334|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
44540999|NCT03075410|79553335|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541000|NCT03075410|79553336|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541001|NCT03075410|79553337|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541002|NCT03075410|79553338|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541003|NCT03075410|79553339|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541004|NCT03075410|79553340|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541005|NCT03075410|79553341|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541006|NCT03075410|79553342|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
44541007|NCT03071276|79553384|FG000|Overall Study|Adverse Event|1|||
44541008|NCT03071276|79553384|FG000|Overall Study|Lack of Efficacy|14|||
44541009|NCT03074162|79553394|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
44541010|NCT03074162|79553395|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
44541011|NCT03074162|79553396|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
44541012|NCT03074162|79553397|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
44541013|NCT03074162|79553398|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
44541014|NCT03074162|79553399|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
44541015|NCT03074162|79553394|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
44541016|NCT03074162|79553395|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
44541017|NCT03074162|79553396|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
44541018|NCT03074162|79553397|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
44541019|NCT03074162|79553398|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
44541020|NCT03074162|79553399|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
44541021|NCT03074162|79553394|FG000|Period 3|Withdrawal by Subject|1|||
44541022|NCT03074162|79553395|FG001|Period 3|Withdrawal by Subject|0|||
44541023|NCT03074162|79553396|FG002|Period 3|Withdrawal by Subject|0|||
44541024|NCT03074162|79553397|FG003|Period 3|Withdrawal by Subject|0|||
44541025|NCT03074162|79553398|FG004|Period 3|Withdrawal by Subject|1|||
44541026|NCT03074162|79553399|FG005|Period 3|Withdrawal by Subject|0|||
44541027|NCT03070964|79553407|FG000|Overall Study|Progressive disease|8|||
44541028|NCT03070964|79553407|FG000|Overall Study|Treatment-unrelated adverse event|2|||
44541029|NCT03070964|79553407|FG000|Overall Study|Never treated|1|||
44541030|NCT03070964|79553407|FG000|Overall Study|Physician Decision|1|||
44541031|NCT03070964|79553407|FG000|Overall Study|Withdrawal by Subject|1|||
44541032|NCT03070964|79553407|FG000|Overall Study|Adverse Event|1|||
44541033|NCT02888106|79553417|FG000|Overall Study|Withdrawal by Subject|1|||
44541034|NCT02888106|79553418|FG001|Overall Study|Withdrawal by Subject|2|||
44541035|NCT02888106|79553419|FG002|Overall Study|Withdrawal by Subject|0|||
44541036|NCT02888106|79553420|FG003|Overall Study|Withdrawal by Subject|1|||
44541037|NCT02888106|79553421|FG004|Overall Study|Withdrawal by Subject|0|||
44541038|NCT02888106|79553422|FG005|Overall Study|Withdrawal by Subject|0|||
44541039|NCT02888106|79553417|FG000|Overall Study|Lost to Follow-up|1|||
44541040|NCT02888106|79553418|FG001|Overall Study|Lost to Follow-up|0|||
44541041|NCT02888106|79553419|FG002|Overall Study|Lost to Follow-up|0|||
44541042|NCT02888106|79553420|FG003|Overall Study|Lost to Follow-up|1|||
44541043|NCT02888106|79553421|FG004|Overall Study|Lost to Follow-up|0|||
44541044|NCT02888106|79553422|FG005|Overall Study|Lost to Follow-up|1|||
44541045|NCT02888106|79553417|FG000|Overall Study|Adverse Event|2|||
44541046|NCT02888106|79553418|FG001|Overall Study|Adverse Event|0|||
44541047|NCT02888106|79553419|FG002|Overall Study|Adverse Event|0|||
44541048|NCT02888106|79553420|FG003|Overall Study|Adverse Event|0|||
44541049|NCT02888106|79553421|FG004|Overall Study|Adverse Event|0|||
44541050|NCT02888106|79553422|FG005|Overall Study|Adverse Event|0|||
44541051|NCT02888106|79553417|FG000|Overall Study|Withdrawal of consent|0|||
44541052|NCT02888106|79553418|FG001|Overall Study|Withdrawal of consent|0|||
44541053|NCT02888106|79553419|FG002|Overall Study|Withdrawal of consent|0|||
44541054|NCT02888106|79553420|FG003|Overall Study|Withdrawal of consent|0|||
44541055|NCT02888106|79553421|FG004|Overall Study|Withdrawal of consent|1|||
44541056|NCT02888106|79553422|FG005|Overall Study|Withdrawal of consent|0|||
44541057|NCT02888106|79553417|FG000|Overall Study|Pregnancy|1|||
44541058|NCT02888106|79553418|FG001|Overall Study|Pregnancy|0|||
44541059|NCT02888106|79553419|FG002|Overall Study|Pregnancy|0|||
44541060|NCT02888106|79553420|FG003|Overall Study|Pregnancy|0|||
44541061|NCT02888106|79553421|FG004|Overall Study|Pregnancy|0|||
44541062|NCT02888106|79553422|FG005|Overall Study|Pregnancy|0|||
44541063|NCT03304626|79553444|FG000|Overall Study|Adverse Event|1|||
44541064|NCT03304626|79553445|FG001|Overall Study|Adverse Event|0|||
44541065|NCT03304626|79553444|FG000|Overall Study|Lack of Efficacy|1|||
44541066|NCT03304626|79553445|FG001|Overall Study|Lack of Efficacy|1|||
44541067|NCT03274986|79553454|FG000|Overall Study|Withdrawal by Subject|0|||
44541068|NCT03274986|79553455|FG001|Overall Study|Withdrawal by Subject|1|||
44541069|NCT03274986|79553454|FG000|Overall Study|Lost to Follow-up|0|||
44541070|NCT03274986|79553455|FG001|Overall Study|Lost to Follow-up|1|||
44541071|NCT02919306|79553470|FG000|Overall Study|Withdrawal by Subject|1|||
44541072|NCT02919306|79553471|FG001|Overall Study|Withdrawal by Subject|0|||
44541073|NCT02919306|79553470|FG000|Overall Study|Protocol Violation|1|||
44541074|NCT02919306|79553471|FG001|Overall Study|Protocol Violation|0|||
44541075|NCT03274440|79553477|FG000|Overall Study|Time commitment too great|1|||
44541076|NCT03274440|79553478|FG001|Overall Study|Time commitment too great|0|||
44541077|NCT03274440|79553479|FG002|Overall Study|Time commitment too great|0|||
44541078|NCT03274440|79553480|FG003|Overall Study|Time commitment too great|1|||
44541079|NCT03274440|79553481|FG004|Overall Study|Time commitment too great|0|||
44541080|NCT03274440|79553482|FG005|Overall Study|Time commitment too great|0|||
44541081|NCT03268746|79553490|FG000|Overall Study|Withdrawal by Subject|1|||
44541082|NCT03268590|79553501|FG000|Overall Study|Previously unknown exclusion criteria|1|||
44541083|NCT03267576|79553510|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
44541084|NCT03267576|79553511|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
44541085|NCT03267576|79553510|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
44541086|NCT03267576|79553511|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
44541087|NCT03267264|79553521|FG000|Overall Study|Withdrawal by Subject|1|||
44541088|NCT03267264|79553522|FG001|Overall Study|Withdrawal by Subject|0|||
44541089|NCT03267264|79553523|FG002|Overall Study|Withdrawal by Subject|2|||
44541090|NCT03267264|79553524|FG003|Overall Study|Withdrawal by Subject|4|||
44541091|NCT03244800|79553541|FG000|Overall Study|Adverse Event|0|||
44541092|NCT03244800|79553542|FG001|Overall Study|Adverse Event|1|||
44541093|NCT03244800|79553543|FG002|Overall Study|Adverse Event|0|||
44541094|NCT03244800|79553544|FG003|Overall Study|Adverse Event|1|||
44541095|NCT03244800|79553541|FG000|Overall Study|Withdrew treatment|0|||
44541096|NCT03244800|79553542|FG001|Overall Study|Withdrew treatment|0|||
44541097|NCT03244800|79553543|FG002|Overall Study|Withdrew treatment|0|||
44541098|NCT03244800|79553544|FG003|Overall Study|Withdrew treatment|1|||
44541099|NCT04516291|79553565|FG000|Treatment Period (24 Weeks)|Other|1|||
44541100|NCT04516291|79553566|FG001|Treatment Period (24 Weeks)|Other|0|||
44541101|NCT04516291|79553567|FG002|Treatment Period (24 Weeks)|Other|0|||
44541102|NCT04516291|79553568|FG003|Treatment Period (24 Weeks)|Other|2|||
44541103|NCT04516291|79553569|FG004|Treatment Period (24 Weeks)|Other|2|||
44541104|NCT04516291|79553570|FG005|Treatment Period (24 Weeks)|Other|4|||
44541105|NCT04516291|79553571|FG006|Treatment Period (24 Weeks)|Other|2|||
44541106|NCT04516291|79553572|FG007|Treatment Period (24 Weeks)|Other|0|||
44541107|NCT04516291|79553565|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44541108|NCT04516291|79553566|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
44541109|NCT04516291|79553567|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
44541110|NCT04516291|79553568|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44541111|NCT04516291|79553569|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
44541112|NCT04516291|79553570|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44541113|NCT04516291|79553571|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44541114|NCT04516291|79553572|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
44541115|NCT04516291|79553565|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541116|NCT04516291|79553566|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541117|NCT04516291|79553567|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541118|NCT04516291|79553568|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
44541119|NCT04516291|79553569|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541120|NCT04516291|79553570|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541121|NCT04516291|79553571|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541122|NCT04516291|79553572|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
44541123|NCT04516291|79553565|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541124|NCT04516291|79553566|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
44541125|NCT04516291|79553567|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541126|NCT04516291|79553568|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541127|NCT04516291|79553569|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541128|NCT04516291|79553570|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541129|NCT04516291|79553571|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541130|NCT04516291|79553572|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
44541131|NCT04516291|79553565|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
44541132|NCT04516291|79553566|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
44541133|NCT04516291|79553567|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
44541134|NCT04516291|79553568|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
44541135|NCT04516291|79553569|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
44541136|NCT04516291|79553570|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
44541137|NCT04516291|79553571|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
44541138|NCT04516291|79553572|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
44541139|NCT04516291|79553565|FG000|Follow-up Period (12 Weeks)|Other|0|||
44541140|NCT04516291|79553566|FG001|Follow-up Period (12 Weeks)|Other|1|||
44541141|NCT04516291|79553567|FG002|Follow-up Period (12 Weeks)|Other|0|||
44541142|NCT04516291|79553568|FG003|Follow-up Period (12 Weeks)|Other|2|||
44541143|NCT04516291|79553569|FG004|Follow-up Period (12 Weeks)|Other|0|||
44541144|NCT04516291|79553570|FG005|Follow-up Period (12 Weeks)|Other|0|||
44541145|NCT04516291|79553571|FG006|Follow-up Period (12 Weeks)|Other|0|||
44166952|NCT02483533|78959924|FG001|Overall Study|Lack of Efficacy|50|||
44353220|NCT00967330|79357631|FG001|Overall Study|Protocol Violation|4|||
44353221|NCT00967330|79357630|FG000|Overall Study|Regular|10|||
44353222|NCT00967330|79357631|FG001|Overall Study|Regular|3|||
44353223|NCT00967330|79357630|FG000|Overall Study|Withdrawal by Subject|6|||
44353224|NCT00967330|79357631|FG001|Overall Study|Withdrawal by Subject|0|||
44353225|NCT00967330|79357630|FG000|Overall Study|Lost to Follow-up|1|||
44353226|NCT00967330|79357631|FG001|Overall Study|Lost to Follow-up|1|||
44353227|NCT00967330|79357630|FG000|Overall Study|Death|102|||
44353228|NCT00967330|79357631|FG001|Overall Study|Death|51|||
44353229|NCT00967330|79357630|FG000|Overall Study|Severe protocol deviation|0|||
44353230|NCT00967330|79357631|FG001|Overall Study|Severe protocol deviation|1|||
44353231|NCT00967018|79357637|FG000|Overall Study|Adverse Event|2|||
44353232|NCT00967018|79357637|FG000|Overall Study|Physician Decision|7|||
44353233|NCT00967018|79357637|FG000|Overall Study|Lost to Follow-up|2|||
44353234|NCT00967018|79357637|FG000|Overall Study|Withdrawal by Subject|1|||
44353235|NCT00967018|79357637|FG000|Overall Study|Miscellaneous Reasons|9|||
44353236|NCT00965146|79357641|FG000|Overall Study|Death|7|||
44353237|NCT00965146|79357641|FG000|Overall Study|Lost to Follow-up|22|||
44353238|NCT00965146|79357641|FG000|Overall Study|Withdrawal by Subject|17|||
44541146|NCT04516291|79553572|FG007|Follow-up Period (12 Weeks)|Other|0|||
44541147|NCT04516291|79553565|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541148|NCT04516291|79553566|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541149|NCT04516291|79553567|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541150|NCT04516291|79553568|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541151|NCT04516291|79553569|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
44541152|NCT04516291|79553570|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541153|NCT04516291|79553571|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541154|NCT04516291|79553572|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
44541155|NCT04516291|79553565|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
44541156|NCT04516291|79553566|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
44541157|NCT04516291|79553567|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
44541158|NCT04516291|79553568|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
44541159|NCT04516291|79553569|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
44541160|NCT04516291|79553570|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
44541161|NCT04516291|79553571|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
44541162|NCT04516291|79553572|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
44541163|NCT03243630|79553590|FG000|Overall Study|Protocol Violation|1|||
44541164|NCT03243630|79553590|FG000|Overall Study|Physician Decision|1|||
44541165|NCT04450381|79553598|FG000|Overall Study|Protocol Violation|4|||
44541166|NCT04450381|79553598|FG000|Overall Study|Wrong device setting|2|||
44541167|NCT03068468|79553604|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
44541168|NCT03068468|79553605|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
44541169|NCT03068468|79553606|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
44541170|NCT03068468|79553607|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
44541171|NCT03068468|79553604|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
44541172|NCT03068468|79553605|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
44541173|NCT03068468|79553606|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
44541174|NCT03068468|79553607|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
44541175|NCT03068468|79553604|FG000|Placebo-Controlled Period|Adverse Event|16|||
44541176|NCT03068468|79553605|FG001|Placebo-Controlled Period|Adverse Event|21|||
44541177|NCT03068468|79553606|FG002|Placebo-Controlled Period|Adverse Event|0|||
44541178|NCT03068468|79553607|FG003|Placebo-Controlled Period|Adverse Event|0|||
44541179|NCT03068468|79553604|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
44541180|NCT03068468|79553605|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
44541181|NCT03068468|79553606|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
44541182|NCT03068468|79553607|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
44541183|NCT03068468|79553604|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
44541184|NCT03068468|79553605|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
44541185|NCT03068468|79553606|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44541186|NCT03068468|79553607|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
44541187|NCT03068468|79553604|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
44353239|NCT00965146|79357641|FG000|Overall Study|Unable to return|1|||
44353240|NCT00965146|79357641|FG000|Overall Study|Unwilling to return|11|||
44353241|NCT00965146|79357641|FG000|Overall Study|Intercurrent illness|1|||
44353242|NCT00965146|79357641|FG000|Overall Study|Revision / Removal of Study Implant|6|||
44353243|NCT00965146|79357641|FG000|Overall Study|Overall Study Termination|145|||
44353244|NCT00966940|79357647|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
44353245|NCT00966940|79357648|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
44353246|NCT00966940|79357647|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
44353247|NCT00966940|79357648|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
44353248|NCT00965848|79357654|FG000|Overall Study|Protocol Violation|3|||
44353249|NCT00965848|79357655|FG001|Overall Study|Protocol Violation|0|||
44353250|NCT00965848|79357656|FG002|Overall Study|Protocol Violation|1|||
44541188|NCT03068468|79553605|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
44541189|NCT03068468|79553606|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
44541190|NCT03068468|79553607|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
44541191|NCT03068468|79553604|FG000|Placebo-Controlled Period|Death|0|||
44541192|NCT03068468|79553605|FG001|Placebo-Controlled Period|Death|1|||
44541193|NCT03068468|79553606|FG002|Placebo-Controlled Period|Death|0|||
44541194|NCT03068468|79553607|FG003|Placebo-Controlled Period|Death|0|||
44541195|NCT03068468|79553604|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
44541196|NCT03068468|79553605|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
44541197|NCT03068468|79553606|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
44541198|NCT03068468|79553607|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
44541199|NCT03068468|79553604|FG000|Open-Label Extension Period|Adverse Event|0|||
44541200|NCT03068468|79553605|FG001|Open-Label Extension Period|Adverse Event|0|||
44541201|NCT03068468|79553606|FG002|Open-Label Extension Period|Adverse Event|13|||
44541202|NCT03068468|79553607|FG003|Open-Label Extension Period|Adverse Event|17|||
44541203|NCT03068468|79553604|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
44541204|NCT03068468|79553605|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
44541205|NCT03068468|79553606|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
44541206|NCT03068468|79553607|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
44541207|NCT03068468|79553604|FG000|Open-Label Extension Period|Death|0|||
44541208|NCT03068468|79553605|FG001|Open-Label Extension Period|Death|0|||
44541209|NCT03068468|79553606|FG002|Open-Label Extension Period|Death|0|||
44541210|NCT03068468|79553607|FG003|Open-Label Extension Period|Death|1|||
44541211|NCT03068468|79553604|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
44541212|NCT03068468|79553605|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
44541213|NCT03068468|79553606|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
44541214|NCT03068468|79553607|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
44541215|NCT03068468|79553604|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
44541216|NCT03068468|79553605|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
44541217|NCT03068468|79553606|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
44541218|NCT03068468|79553607|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
44541219|NCT03068468|79553604|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
44541220|NCT03068468|79553605|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
44541221|NCT03068468|79553606|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
44541222|NCT03068468|79553607|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
44541223|NCT03068468|79553604|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
44541224|NCT03068468|79553605|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
44541225|NCT03068468|79553606|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
44541226|NCT03068468|79553607|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
44541227|NCT03068468|79553604|FG000|Open-Label Extension Period|Reason not Specified|0|||
44541228|NCT03068468|79553605|FG001|Open-Label Extension Period|Reason not Specified|0|||
44541229|NCT03068468|79553606|FG002|Open-Label Extension Period|Reason not Specified|1|||
44541230|NCT03068468|79553607|FG003|Open-Label Extension Period|Reason not Specified|4|||
44541231|NCT04512001|79553617|FG000|Week 0 to Week 24|Adverse Event|14|||
44541232|NCT04512001|79553618|FG001|Week 0 to Week 24|Adverse Event|10|||
44541233|NCT04512001|79553619|FG002|Week 0 to Week 24|Adverse Event|0|||
44541234|NCT04512001|79553620|FG003|Week 0 to Week 24|Adverse Event|0|||
44541235|NCT04512001|79553621|FG004|Week 0 to Week 24|Adverse Event|0|||
44541236|NCT04512001|79553617|FG000|Week 0 to Week 24|Death|0|||
44541237|NCT04512001|79553618|FG001|Week 0 to Week 24|Death|2|||
44541238|NCT04512001|79553619|FG002|Week 0 to Week 24|Death|0|||
44541239|NCT04512001|79553620|FG003|Week 0 to Week 24|Death|0|||
44541240|NCT04512001|79553621|FG004|Week 0 to Week 24|Death|0|||
44541241|NCT04512001|79553617|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
44541242|NCT04512001|79553618|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
44353251|NCT00965848|79357654|FG000|Overall Study|Death|11|||
44353252|NCT00965848|79357655|FG001|Overall Study|Death|1|||
44353253|NCT00965848|79357656|FG002|Overall Study|Death|5|||
44353254|NCT00965848|79357654|FG000|Overall Study|Lost to Follow-up|0|||
44353255|NCT00965848|79357655|FG001|Overall Study|Lost to Follow-up|0|||
44353256|NCT00965848|79357656|FG002|Overall Study|Lost to Follow-up|1|||
44353257|NCT00965848|79357654|FG000|Overall Study|Withdrawal by Subject|1|||
44353258|NCT00965848|79357655|FG001|Overall Study|Withdrawal by Subject|0|||
44353259|NCT00965848|79357656|FG002|Overall Study|Withdrawal by Subject|0|||
44353260|NCT00965848|79357654|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
44353261|NCT00965848|79357655|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
44353262|NCT00965848|79357656|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
44353263|NCT00965848|79357654|FG000|Overall Study|Not Clinically Evaluable|7|||
44353264|NCT00965848|79357655|FG001|Overall Study|Not Clinically Evaluable|1|||
44353265|NCT00965848|79357656|FG002|Overall Study|Not Clinically Evaluable|1|||
44353266|NCT00965848|79357654|FG000|Overall Study|Other|5|||
44353267|NCT00965848|79357655|FG001|Overall Study|Other|0|||
44353268|NCT00965848|79357656|FG002|Overall Study|Other|1|||
44541243|NCT04512001|79553619|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
44541244|NCT04512001|79553620|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
44541245|NCT04512001|79553621|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
44541246|NCT04512001|79553617|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
44541247|NCT04512001|79553618|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
44541248|NCT04512001|79553619|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
44541249|NCT04512001|79553620|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
44541250|NCT04512001|79553621|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
44541251|NCT04512001|79553617|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
44541252|NCT04512001|79553618|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
44541253|NCT04512001|79553619|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
44541254|NCT04512001|79553620|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
44541255|NCT04512001|79553621|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
44541256|NCT04512001|79553617|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
44541257|NCT04512001|79553618|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
44541258|NCT04512001|79553619|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
44541259|NCT04512001|79553620|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
44541260|NCT04512001|79553621|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
44541261|NCT04512001|79553617|FG000|Week 24 to Week 63|Adverse Event|0|||
44541262|NCT04512001|79553618|FG001|Week 24 to Week 63|Adverse Event|0|||
44541263|NCT04512001|79553619|FG002|Week 24 to Week 63|Adverse Event|13|||
44541264|NCT04512001|79553620|FG003|Week 24 to Week 63|Adverse Event|8|||
44541265|NCT04512001|79553621|FG004|Week 24 to Week 63|Adverse Event|6|||
44541266|NCT04512001|79553617|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
44541267|NCT04512001|79553618|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
44541268|NCT04512001|79553619|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
44541269|NCT04512001|79553620|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
44541270|NCT04512001|79553621|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
44541271|NCT04512001|79553617|FG000|Week 24 to Week 63|Death|0|||
44541272|NCT04512001|79553618|FG001|Week 24 to Week 63|Death|0|||
44541273|NCT04512001|79553619|FG002|Week 24 to Week 63|Death|0|||
44541274|NCT04512001|79553620|FG003|Week 24 to Week 63|Death|1|||
44541275|NCT04512001|79553621|FG004|Week 24 to Week 63|Death|1|||
44541276|NCT04512001|79553617|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
44541277|NCT04512001|79553618|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
44541278|NCT04512001|79553619|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
44541279|NCT04512001|79553620|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
44541280|NCT04512001|79553621|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
44541281|NCT04512001|79553617|FG000|Week 24 to Week 63|Miscellaneous|0|||
44541282|NCT04512001|79553618|FG001|Week 24 to Week 63|Miscellaneous|0|||
44541283|NCT04512001|79553619|FG002|Week 24 to Week 63|Miscellaneous|3|||
44541284|NCT04512001|79553620|FG003|Week 24 to Week 63|Miscellaneous|2|||
44541285|NCT04512001|79553621|FG004|Week 24 to Week 63|Miscellaneous|1|||
44541286|NCT04447417|79553636|FG000|Overall Study|Withdrawal by Subject|1|||
44541287|NCT04447417|79553637|FG001|Overall Study|Withdrawal by Subject|0|||
44541288|NCT04447417|79553636|FG000|Overall Study|Failure to meet inclusion criteria|1|||
44541289|NCT04447417|79553637|FG001|Overall Study|Failure to meet inclusion criteria|0|||
44541290|NCT04447417|79553636|FG000|Overall Study|Lost to Follow-up|1|||
44541291|NCT04447417|79553637|FG001|Overall Study|Lost to Follow-up|0|||
44541292|NCT02787044|79553645|FG000|Overall Study|Lost to Follow-up|15|||
44541293|NCT02787044|79553646|FG001|Overall Study|Lost to Follow-up|19|||
44541294|NCT01345019|79553658|FG000|Blinded Treatment Phase|Death|147|||
44541295|NCT01345019|79553659|FG001|Blinded Treatment Phase|Death|137|||
44541296|NCT01345019|79553658|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
44541297|NCT01345019|79553659|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
44541298|NCT01345019|79553658|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
44541299|NCT01345019|79553659|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
44541300|NCT01345019|79553658|FG000|Blinded Treatment Phase|Disease Progression|12|||
44541301|NCT01345019|79553659|FG001|Blinded Treatment Phase|Disease Progression|10|||
44541302|NCT01345019|79553658|FG000|Blinded Treatment Phase|Adverse Event|6|||
44541303|NCT01345019|79553659|FG001|Blinded Treatment Phase|Adverse Event|13|||
44541304|NCT01345019|79553658|FG000|Blinded Treatment Phase|Administrative Decision|10|||
44541305|NCT01345019|79553659|FG001|Blinded Treatment Phase|Administrative Decision|8|||
44541306|NCT01345019|79553658|FG000|Blinded Treatment Phase|Noncompliance|5|||
44541307|NCT01345019|79553659|FG001|Blinded Treatment Phase|Noncompliance|3|||
44541308|NCT01345019|79553658|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
44541309|NCT01345019|79553659|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
44541310|NCT01345019|79553658|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
44541311|NCT01345019|79553659|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
44541312|NCT01345019|79553658|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
44541313|NCT01345019|79553659|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
44541314|NCT01345019|79553658|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
44541315|NCT01345019|79553659|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
44541316|NCT01345019|79553658|FG000|Open Label Treatment Phase|Death|49|||
44541317|NCT01345019|79553659|FG001|Open Label Treatment Phase|Death|48|||
44541318|NCT01345019|79553658|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
44541319|NCT01345019|79553659|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
44541320|NCT01345019|79553658|FG000|Open Label Treatment Phase|Adverse Event|30|||
44541321|NCT01345019|79553659|FG001|Open Label Treatment Phase|Adverse Event|51|||
44541322|NCT01345019|79553658|FG000|Open Label Treatment Phase|Administrative Decision|30|||
44541323|NCT01345019|79553659|FG001|Open Label Treatment Phase|Administrative Decision|15|||
44541324|NCT01345019|79553658|FG000|Open Label Treatment Phase|Disease Progression|17|||
44541325|NCT01345019|79553659|FG001|Open Label Treatment Phase|Disease Progression|18|||
44541326|NCT01345019|79553658|FG000|Open Label Treatment Phase|Noncompliance|5|||
44541327|NCT01345019|79553659|FG001|Open Label Treatment Phase|Noncompliance|4|||
44541328|NCT01345019|79553658|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
44541329|NCT01345019|79553659|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
44541330|NCT01345019|79553658|FG000|Open Label Treatment Phase|Pregnancy|1|||
44541331|NCT01345019|79553659|FG001|Open Label Treatment Phase|Pregnancy|0|||
44541332|NCT01345019|79553658|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
44541333|NCT01345019|79553659|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
44541334|NCT01345019|79553658|FG000|Open Label Treatment Phase|Protocol Violation|0|||
44541335|NCT01345019|79553659|FG001|Open Label Treatment Phase|Protocol Violation|1|||
44541336|NCT04507867|79553669|FG000|Overall Study|Death|7|||
44541337|NCT04507867|79553670|FG001|Overall Study|Death|1|||
44541338|NCT03069716|79553694|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
44541339|NCT03069716|79553695|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
44541340|NCT03069716|79553696|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
44541341|NCT03069716|79553694|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
44541342|NCT03069716|79553695|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
44541343|NCT03069716|79553696|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
44541344|NCT03069716|79553694|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
44541345|NCT03069716|79553695|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
44541346|NCT03069716|79553696|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
44541347|NCT03069716|79553694|FG000|Randomized Treatment|Withdrawal by Subject|0|||
44541348|NCT03069716|79553695|FG001|Randomized Treatment|Withdrawal by Subject|2|||
44541349|NCT03069716|79553696|FG002|Randomized Treatment|Withdrawal by Subject|0|||
44541350|NCT03693625|79553709|FG000|Overall Study|Adverse Event|2|||
44541351|NCT03693625|79553710|FG001|Overall Study|Adverse Event|0|||
44541352|NCT03693625|79553709|FG000|Overall Study|Study Terminated By Sponsor|20|||
44541353|NCT03693625|79553710|FG001|Overall Study|Study Terminated By Sponsor|7|||
44541354|NCT03693625|79553709|FG000|Overall Study|Withdrawal by Subject|1|||
44541355|NCT03693625|79553710|FG001|Overall Study|Withdrawal by Subject|1|||
44541356|NCT01265537|79553718|FG000|Overall Study|Adverse Event|2|||
44541357|NCT01265537|79553719|FG001|Overall Study|Adverse Event|1|||
44541358|NCT01265537|79553718|FG000|Overall Study|Physician Decision|0|||
44541359|NCT01265537|79553719|FG001|Overall Study|Physician Decision|1|||
44541360|NCT04396639|79553725|FG000|Overall Study|Withdrawal by Subject|1|||
44541361|NCT04396639|79553725|FG000|Overall Study|Other|1|||
44541362|NCT04432298|79553731|FG000|Overall Study|Other than specified|1|||
44541363|NCT04432298|79553732|FG001|Overall Study|Other than specified|0|||
44541364|NCT04432298|79553731|FG000|Overall Study|Lost to Follow-up|0|||
44541365|NCT04432298|79553732|FG001|Overall Study|Lost to Follow-up|1|||
44541366|NCT04432298|79553731|FG000|Overall Study|Death|3|||
44541367|NCT04432298|79553732|FG001|Overall Study|Death|2|||
44541368|NCT04432298|79553731|FG000|Overall Study|Withdrawal by Subject|2|||
44541369|NCT04432298|79553732|FG001|Overall Study|Withdrawal by Subject|0|||
44541370|NCT04167085|79553740|FG000|Baseline|Withdrawal by Subject|2|||
44541371|NCT04167085|79553741|FG001|Baseline|Withdrawal by Subject|1|||
44541372|NCT04167085|79553740|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
44541373|NCT04167085|79553741|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
44541374|NCT04162795|79553747|FG000|Overall Study|Other|16|||
44541375|NCT04162795|79553747|FG000|Overall Study|Screen failures|10|||
44541376|NCT03069482|79553753|FG000|Overall Study|Lost to Follow-up|0|||
44541377|NCT03069482|79553754|FG001|Overall Study|Lost to Follow-up|1|||
44541378|NCT03069482|79553753|FG000|Overall Study|Physician Decision|1|||
44541379|NCT03069482|79553754|FG001|Overall Study|Physician Decision|0|||
44541380|NCT03266172|79553766|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
44541381|NCT03266172|79553767|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
44541382|NCT03266172|79553768|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
44541383|NCT03266172|79553766|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
44541384|NCT03266172|79553767|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
44541385|NCT03266172|79553768|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
44541386|NCT03266172|79553766|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
44541387|NCT03266172|79553767|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
44541388|NCT03266172|79553768|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
44541389|NCT03266172|79553766|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
44541390|NCT03266172|79553767|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
44541391|NCT03266172|79553768|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
44541392|NCT03266172|79553766|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
44541393|NCT03266172|79553767|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
44541394|NCT03266172|79553768|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
44541395|NCT03266172|79553766|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
44541396|NCT03266172|79553767|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
44541397|NCT03266172|79553768|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
44541398|NCT04356937|79553820|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
44541399|NCT04356937|79553821|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
44541400|NCT03301740|79553833|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
44541401|NCT03301740|79553834|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
44541402|NCT03301740|79553833|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
44541403|NCT03301740|79553834|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
44541404|NCT04355767|79553842|FG000|Overall Study|Withdrawal by Subject|2|||
44541405|NCT04355767|79553843|FG001|Overall Study|Withdrawal by Subject|2|||
44541406|NCT04355767|79553842|FG000|Overall Study|Death|5|||
44541407|NCT04355767|79553843|FG001|Overall Study|Death|1|||
44541408|NCT00882050|79553852|FG000|Overall Study|Physician Decision|1|||
44541409|NCT00882050|79553853|FG001|Overall Study|Physician Decision|0|||
44541410|NCT00882050|79553854|FG002|Overall Study|Physician Decision|0|||
44541411|NCT03266094|79553862|FG000|Overall Study|Lost to Follow-up|1|||
44541412|NCT03266094|79553862|FG000|Overall Study|Withdrawal by Subject|1|||
44541413|NCT04161079|79553868|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
44541414|NCT03243084|79553878|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
44541415|NCT03243084|79553879|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
44541416|NCT04353817|79553888|FG000|Overall Study|Adverse Event|0|||
44541417|NCT04353817|79553889|FG001|Overall Study|Adverse Event|1|||
44541418|NCT00159588|79553898|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
44541419|NCT00159588|79553899|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
44541420|NCT00159588|79553900|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
44541421|NCT03265938|79553911|FG000|Overall Study|Withdrawal by Subject|1|||
44541422|NCT03265938|79553911|FG000|Overall Study|Physician Decision|1|||
44541423|NCT03265938|79553911|FG000|Overall Study|friable mass|6|||
44541424|NCT04353037|79553920|FG000|Overall Study|Lost to Follow-up|0|||
44541425|NCT04353037|79553921|FG001|Overall Study|Lost to Follow-up|1|||
44541426|NCT04353037|79553922|FG002|Overall Study|Lost to Follow-up|2|||
44541427|NCT04353037|79553923|FG003|Overall Study|Lost to Follow-up|3|||
44541428|NCT04353037|79553920|FG000|Overall Study|Withdrawal by Subject|0|||
44541429|NCT04353037|79553921|FG001|Overall Study|Withdrawal by Subject|2|||
44541430|NCT04353037|79553922|FG002|Overall Study|Withdrawal by Subject|3|||
44541431|NCT04353037|79553923|FG003|Overall Study|Withdrawal by Subject|5|||
44541432|NCT04353037|79553920|FG000|Overall Study|Adverse Event|0|||
44541433|NCT04353037|79553921|FG001|Overall Study|Adverse Event|0|||
44541434|NCT04353037|79553922|FG002|Overall Study|Adverse Event|2|||
44541435|NCT04353037|79553923|FG003|Overall Study|Adverse Event|0|||
44541436|NCT04353037|79553920|FG000|Overall Study|Exposure Change|0|||
44541437|NCT04353037|79553921|FG001|Overall Study|Exposure Change|0|||
44541438|NCT04353037|79553922|FG002|Overall Study|Exposure Change|0|||
44541439|NCT04353037|79553923|FG003|Overall Study|Exposure Change|2|||
44541440|NCT04349917|79553937|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
44541441|NCT04349917|79553938|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
44541442|NCT04349917|79553937|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
44541443|NCT04349917|79553938|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
44541444|NCT04156399|79553945|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
44541445|NCT04156399|79553945|FG000|Overall Study|study suspension due to COVID pandemic|3|||
44541446|NCT03300570|79553951|FG000|Overall Study|Adverse Event|0|||
44541447|NCT03300570|79553952|FG001|Overall Study|Adverse Event|1|||
44541448|NCT03300570|79553951|FG000|Overall Study|Withdrawal by Subject|1|||
44541449|NCT03300570|79553952|FG001|Overall Study|Withdrawal by Subject|0|||
44541450|NCT03300570|79553951|FG000|Overall Study|Inadequate bowel prep|1|||
44541451|NCT03300570|79553952|FG001|Overall Study|Inadequate bowel prep|0|||
44541452|NCT04154605|79553961|FG000|Overall Study|Procedure Canceled|1|||
44541453|NCT04154605|79553962|FG001|Overall Study|Procedure Canceled|1|||
44541454|NCT04154605|79553961|FG000|Overall Study|Missed follow up|1|||
44541455|NCT04154605|79553962|FG001|Overall Study|Missed follow up|1|||
44541456|NCT04154605|79553961|FG000|Overall Study|Withdrawal by Subject|1|||
44541457|NCT04154605|79553962|FG001|Overall Study|Withdrawal by Subject|0|||
44541458|NCT03264456|79553968|FG000|Overall Study|Withdrawal by Subject|3|||
44541459|NCT03264456|79553968|FG000|Overall Study|Lost to Follow-up|1|||
44541460|NCT03853694|79553975|FG000|Overall Study|Protocol Violation|3|||
44541461|NCT03853694|79553976|FG001|Overall Study|Protocol Violation|5|||
44541462|NCT03853694|79553977|FG002|Overall Study|Protocol Violation|3|||
44541463|NCT03853694|79553975|FG000|Overall Study|Delivered early|0|||
44541464|NCT03853694|79553976|FG001|Overall Study|Delivered early|1|||
44541465|NCT03853694|79553977|FG002|Overall Study|Delivered early|0|||
44541466|NCT03853694|79553975|FG000|Overall Study|not suitable to proceed|0|||
44541467|NCT03853694|79553976|FG001|Overall Study|not suitable to proceed|1|||
44541468|NCT03853694|79553977|FG002|Overall Study|not suitable to proceed|0|||
44541469|NCT03853694|79553975|FG000|Overall Study|difficult surgery|0|||
44541470|NCT03853694|79553976|FG001|Overall Study|difficult surgery|0|||
44541471|NCT03853694|79553977|FG002|Overall Study|difficult surgery|1|||
44541472|NCT03853694|79553975|FG000|Overall Study|Lost to Follow-up|0|||
44541473|NCT03853694|79553976|FG001|Overall Study|Lost to Follow-up|1|||
44541474|NCT03853694|79553977|FG002|Overall Study|Lost to Follow-up|0|||
44541475|NCT03853694|79553975|FG000|Overall Study|Withdrawal by Subject|0|||
44541476|NCT03853694|79553976|FG001|Overall Study|Withdrawal by Subject|1|||
44541477|NCT03853694|79553977|FG002|Overall Study|Withdrawal by Subject|0|||
44541478|NCT04154293|79553988|FG000|Overall Study|Withdrawal by Subject|2|||
44541479|NCT04154293|79553989|FG001|Overall Study|Withdrawal by Subject|3|||
44541480|NCT04154293|79553990|FG002|Overall Study|Withdrawal by Subject|1|||
44541481|NCT04154293|79553988|FG000|Overall Study|Physician Decision|0|||
44541482|NCT04154293|79553989|FG001|Overall Study|Physician Decision|0|||
44541483|NCT04154293|79553990|FG002|Overall Study|Physician Decision|1|||
44541484|NCT04342897|79554000|FG000|Overall Study|Death|7|||
44541485|NCT04342897|79554001|FG001|Overall Study|Death|4|||
44541486|NCT04342897|79554000|FG000|Overall Study|Lost to Follow-up|6|||
44541487|NCT04342897|79554001|FG001|Overall Study|Lost to Follow-up|6|||
44541488|NCT04342897|79554000|FG000|Overall Study|Withdrawal by Subject|1|||
44541489|NCT04342897|79554001|FG001|Overall Study|Withdrawal by Subject|2|||
44541490|NCT04340557|79554009|FG000|Overall Study|Transferred to ICU and/or death|1|||
44541491|NCT04340557|79554010|FG001|Overall Study|Transferred to ICU and/or death|2|||
44541492|NCT04382053|79554018|FG000|Overall Study|Death|6|||
44541493|NCT04382053|79554019|FG001|Overall Study|Death|8|||
44541494|NCT04382053|79554018|FG000|Overall Study|Lost to Follow-up|0|||
44541495|NCT04382053|79554019|FG001|Overall Study|Lost to Follow-up|2|||
44541496|NCT04382053|79554018|FG000|Overall Study|Protocol Deviation|1|||
44541497|NCT04382053|79554019|FG001|Overall Study|Protocol Deviation|2|||
44541498|NCT04382053|79554018|FG000|Overall Study|Withdrawal by Subject|2|||
44541499|NCT04382053|79554019|FG001|Overall Study|Withdrawal by Subject|1|||
44541500|NCT03066830|79554028|FG000|Overall Study|At the Participant's own Request|16|||
44541501|NCT03066830|79554029|FG001|Overall Study|At the Participant's own Request|17|||
44541502|NCT03066830|79554028|FG000|Overall Study|Other|3|||
44541503|NCT03066830|79554029|FG001|Overall Study|Other|0|||
44541504|NCT03066830|79554028|FG000|Overall Study|Poor Compliance to Protocol|1|||
44541505|NCT03066830|79554029|FG001|Overall Study|Poor Compliance to Protocol|0|||
44541506|NCT03066830|79554028|FG000|Overall Study|Adverse Event|2|||
44541507|NCT03066830|79554029|FG001|Overall Study|Adverse Event|2|||
44541508|NCT03066830|79554028|FG000|Overall Study|Lost to Follow-up|11|||
44541509|NCT03066830|79554029|FG001|Overall Study|Lost to Follow-up|3|||
44541510|NCT04380961|79554038|FG000|Overall Study|Lost to Follow-up|17|||
44541511|NCT04380961|79554039|FG001|Overall Study|Lost to Follow-up|11|||
44541512|NCT04380961|79554038|FG000|Overall Study|Withdrawal by Subject|3|||
44541513|NCT04380961|79554039|FG001|Overall Study|Withdrawal by Subject|0|||
44541514|NCT04380961|79554038|FG000|Overall Study|Death|22|||
44541515|NCT04380961|79554039|FG001|Overall Study|Death|16|||
44541516|NCT04380961|79554038|FG000|Overall Study|Other|1|||
44541517|NCT04380961|79554039|FG001|Overall Study|Other|0|||
44541518|NCT04380961|79554038|FG000|Overall Study|Randomized but Not Treated|1|||
44541519|NCT04380961|79554039|FG001|Overall Study|Randomized but Not Treated|2|||
44541520|NCT04331899|79554049|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
44541521|NCT04331899|79554050|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
44541522|NCT04328467|79554059|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
44541523|NCT04328467|79554060|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
44541524|NCT04328467|79554061|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
44541525|NCT04328077|79554073|FG000|Overall Study|Lost to Follow-up|0|||
44541526|NCT04328077|79554074|FG001|Overall Study|Lost to Follow-up|1|||
44541527|NCT04328077|79554075|FG002|Overall Study|Lost to Follow-up|0|||
44541528|NCT04328077|79554076|FG003|Overall Study|Lost to Follow-up|0|||
44541529|NCT04328077|79554073|FG000|Overall Study|Withdrawal by Subject|0|||
44541530|NCT04328077|79554074|FG001|Overall Study|Withdrawal by Subject|1|||
44541531|NCT04328077|79554075|FG002|Overall Study|Withdrawal by Subject|1|||
44541532|NCT04328077|79554076|FG003|Overall Study|Withdrawal by Subject|3|||
44541533|NCT03691831|79554094|FG000|Overall Study|Lost to Follow-up|16|||
44541534|NCT03691831|79554095|FG001|Overall Study|Lost to Follow-up|12|||
44541535|NCT03691831|79554094|FG000|Overall Study|Withdrawal by Subject|9|||
44541536|NCT03691831|79554095|FG001|Overall Study|Withdrawal by Subject|17|||
44541537|NCT03691831|79554094|FG000|Overall Study|Investigator Decision|2|||
44541538|NCT03691831|79554095|FG001|Overall Study|Investigator Decision|2|||
44541539|NCT04320745|79554112|FG000|Overall Study|Adverse Event|26|||
44541540|NCT04320745|79554112|FG000|Overall Study|Withdrawal by Subject|4|||
44541541|NCT04320745|79554112|FG000|Overall Study|Lost to Follow-up|12|||
44541542|NCT04320745|79554112|FG000|Overall Study|Protocol Deviation|2|||
44541543|NCT04320745|79554112|FG000|Overall Study|Non-compliance With Study Drug|2|||
44541544|NCT04320745|79554112|FG000|Overall Study|Reason Not Specified|1|||
44541545|NCT03063086|79554116|FG000|Overall Study|technical problems|1|||
44541546|NCT03063086|79554117|FG001|Overall Study|technical problems|0|||
44541547|NCT03063086|79554118|FG002|Overall Study|technical problems|0|||
44541548|NCT03063086|79554119|FG003|Overall Study|technical problems|0|||
44541549|NCT03063086|79554120|FG004|Overall Study|technical problems|0|||
44541550|NCT03063086|79554121|FG005|Overall Study|technical problems|0|||
44541551|NCT03063086|79554116|FG000|Overall Study|Adverse Event|1|||
44541552|NCT03063086|79554117|FG001|Overall Study|Adverse Event|1|||
44541553|NCT03063086|79554118|FG002|Overall Study|Adverse Event|1|||
44541554|NCT03063086|79554119|FG003|Overall Study|Adverse Event|1|||
44541555|NCT03063086|79554120|FG004|Overall Study|Adverse Event|0|||
44541556|NCT03063086|79554121|FG005|Overall Study|Adverse Event|0|||
44541557|NCT03063086|79554116|FG000|Overall Study|subject/guardian decision|1|||
44541558|NCT03063086|79554117|FG001|Overall Study|subject/guardian decision|0|||
44541559|NCT03063086|79554118|FG002|Overall Study|subject/guardian decision|0|||
44541560|NCT03063086|79554119|FG003|Overall Study|subject/guardian decision|0|||
44541561|NCT03063086|79554120|FG004|Overall Study|subject/guardian decision|0|||
44541562|NCT03063086|79554121|FG005|Overall Study|subject/guardian decision|0|||
44541563|NCT03063086|79554116|FG000|Overall Study|Non-compliance with study treatment|0|||
44541564|NCT03063086|79554117|FG001|Overall Study|Non-compliance with study treatment|0|||
44541565|NCT03063086|79554118|FG002|Overall Study|Non-compliance with study treatment|0|||
44541566|NCT03063086|79554119|FG003|Overall Study|Non-compliance with study treatment|1|||
44541567|NCT03063086|79554120|FG004|Overall Study|Non-compliance with study treatment|0|||
44541568|NCT03063086|79554121|FG005|Overall Study|Non-compliance with study treatment|1|||
44541569|NCT03063086|79554116|FG000|Overall Study|Physician Decision|0|||
44541570|NCT03063086|79554117|FG001|Overall Study|Physician Decision|0|||
44541571|NCT03063086|79554118|FG002|Overall Study|Physician Decision|0|||
44541572|NCT03063086|79554119|FG003|Overall Study|Physician Decision|1|||
44541573|NCT03063086|79554120|FG004|Overall Study|Physician Decision|0|||
44541574|NCT03063086|79554121|FG005|Overall Study|Physician Decision|0|||
44541575|NCT04128007|79554132|FG000|Overall Study|Withdrawal by Subject|9|||
44541576|NCT04128007|79554133|FG001|Overall Study|Withdrawal by Subject|6|||
44541577|NCT04128007|79554132|FG000|Overall Study|Protocol Violation|1|||
44541578|NCT04128007|79554133|FG001|Overall Study|Protocol Violation|0|||
44541579|NCT04128007|79554132|FG000|Overall Study|Lost to Follow-up|8|||
44541580|NCT04128007|79554133|FG001|Overall Study|Lost to Follow-up|7|||
44541581|NCT04128007|79554132|FG000|Overall Study|Adverse Event|5|||
44541582|NCT04128007|79554133|FG001|Overall Study|Adverse Event|2|||
44541583|NCT04128007|79554132|FG000|Overall Study|Not reported|0|||
44541584|NCT04128007|79554133|FG001|Overall Study|Not reported|2|||
44541585|NCT04318093|79554141|FG000|Overall Study|Adverse Event|2|||
44541586|NCT04318093|79554142|FG001|Overall Study|Adverse Event|2|||
44353269|NCT00961636|79357667|FG000|Overall Study|Adverse Event|35|||
44353270|NCT00961636|79357668|FG001|Overall Study|Adverse Event|54|||
44353271|NCT00961636|79357669|FG002|Overall Study|Adverse Event|13|||
44353272|NCT00961636|79357667|FG000|Overall Study|Flushing Symptoms|29|||
44353273|NCT00961636|79357668|FG001|Overall Study|Flushing Symptoms|46|||
44353274|NCT00961636|79357669|FG002|Overall Study|Flushing Symptoms|3|||
44353275|NCT00961636|79357667|FG000|Overall Study|Lost to Follow-up|2|||
44353276|NCT00961636|79357668|FG001|Overall Study|Lost to Follow-up|3|||
44353277|NCT00961636|79357669|FG002|Overall Study|Lost to Follow-up|1|||
44353278|NCT00961636|79357667|FG000|Overall Study|Physician Decision|3|||
44353279|NCT00961636|79357668|FG001|Overall Study|Physician Decision|1|||
44353280|NCT00961636|79357669|FG002|Overall Study|Physician Decision|1|||
44353281|NCT00961636|79357667|FG000|Overall Study|Protocol Violation|9|||
44353282|NCT00961636|79357668|FG001|Overall Study|Protocol Violation|5|||
44353283|NCT00961636|79357669|FG002|Overall Study|Protocol Violation|1|||
44353284|NCT00961636|79357667|FG000|Overall Study|Withdrawal by Subject|29|||
44353285|NCT00961636|79357668|FG001|Overall Study|Withdrawal by Subject|22|||
44353286|NCT00961636|79357669|FG002|Overall Study|Withdrawal by Subject|13|||
44353287|NCT00964678|79357677|FG000|Overall Study|Physician Decision|4|||
44353288|NCT00964366|79357684|FG000|Overall Study|Did not qualify at Day 1|1|||
44353289|NCT00964366|79357685|FG001|Overall Study|Did not qualify at Day 1|0|||
44353290|NCT00964366|79357684|FG000|Overall Study|Withdrawal by Subject|0|||
44353291|NCT00964366|79357685|FG001|Overall Study|Withdrawal by Subject|1|||
44353292|NCT00960154|79357693|FG000|Overall Study|Study termination|25|||
44353293|NCT00960154|79357694|FG001|Overall Study|Study termination|25|||
44353294|NCT00960076|79357702|FG000|Overall Study|Adverse Event|1|||
44353295|NCT00960076|79357703|FG001|Overall Study|Adverse Event|7|||
44353296|NCT00960076|79357702|FG000|Overall Study|No longer met study criteria|1|||
44353297|NCT00960076|79357703|FG001|Overall Study|No longer met study criteria|5|||
44353298|NCT00960076|79357702|FG000|Overall Study|Withdrawal by Subject|1|||
44353299|NCT00960076|79357703|FG001|Overall Study|Withdrawal by Subject|2|||
44353300|NCT00960076|79357702|FG000|Overall Study|Lost to Follow-up|3|||
44353301|NCT00960076|79357703|FG001|Overall Study|Lost to Follow-up|3|||
44353302|NCT00960076|79357702|FG000|Overall Study|Severe non-compliance to protocol|1|||
44353303|NCT00960076|79357703|FG001|Overall Study|Severe non-compliance to protocol|2|||
44353304|NCT00960076|79357702|FG000|Overall Study|Hyperglycemia|1|||
44353305|NCT00960076|79357703|FG001|Overall Study|Hyperglycemia|5|||
44353306|NCT00960076|79357702|FG000|Overall Study|Did not attend the termination visit|0|||
44353307|NCT00960076|79357703|FG001|Overall Study|Did not attend the termination visit|1|||
44353308|NCT01227629|79357719|FG000|Overall Study|Adverse Event|2|||
44353309|NCT01227629|79357720|FG001|Overall Study|Adverse Event|2|||
44353310|NCT01227629|79357721|FG002|Overall Study|Adverse Event|1|||
44353311|NCT01227629|79357722|FG003|Overall Study|Adverse Event|6|||
44353312|NCT01227629|79357723|FG004|Overall Study|Adverse Event|1|||
44353313|NCT01227629|79357724|FG005|Overall Study|Adverse Event|1|||
44353314|NCT01227629|79357725|FG006|Overall Study|Adverse Event|6|||
44353315|NCT01227629|79357726|FG007|Overall Study|Adverse Event|6|||
44353316|NCT01227629|79357727|FG008|Overall Study|Adverse Event|4|||
44353317|NCT01227629|79357728|FG009|Overall Study|Adverse Event|0|||
44353318|NCT01227629|79357719|FG000|Overall Study|Protocol Violation|0|||
44353319|NCT01227629|79357720|FG001|Overall Study|Protocol Violation|0|||
44353320|NCT01227629|79357721|FG002|Overall Study|Protocol Violation|0|||
44353321|NCT01227629|79357722|FG003|Overall Study|Protocol Violation|1|||
44353322|NCT01227629|79357723|FG004|Overall Study|Protocol Violation|0|||
44353323|NCT01227629|79357724|FG005|Overall Study|Protocol Violation|0|||
44353324|NCT01227629|79357725|FG006|Overall Study|Protocol Violation|0|||
44353325|NCT01227629|79357726|FG007|Overall Study|Protocol Violation|0|||
44353326|NCT01227629|79357727|FG008|Overall Study|Protocol Violation|0|||
44353327|NCT01227629|79357728|FG009|Overall Study|Protocol Violation|0|||
44353328|NCT01227629|79357719|FG000|Overall Study|Lost to Follow-up|0|||
44353329|NCT01227629|79357720|FG001|Overall Study|Lost to Follow-up|0|||
44353330|NCT01227629|79357721|FG002|Overall Study|Lost to Follow-up|0|||
44353331|NCT01227629|79357722|FG003|Overall Study|Lost to Follow-up|0|||
44353332|NCT01227629|79357723|FG004|Overall Study|Lost to Follow-up|1|||
44353333|NCT01227629|79357724|FG005|Overall Study|Lost to Follow-up|0|||
44353334|NCT01227629|79357725|FG006|Overall Study|Lost to Follow-up|0|||
44353335|NCT01227629|79357726|FG007|Overall Study|Lost to Follow-up|0|||
44353336|NCT01227629|79357727|FG008|Overall Study|Lost to Follow-up|0|||
44353337|NCT01227629|79357728|FG009|Overall Study|Lost to Follow-up|0|||
44353338|NCT01227629|79357719|FG000|Overall Study|Withdrawal by Subject|0|||
44353339|NCT01227629|79357720|FG001|Overall Study|Withdrawal by Subject|0|||
44353340|NCT01227629|79357721|FG002|Overall Study|Withdrawal by Subject|0|||
44353341|NCT01227629|79357722|FG003|Overall Study|Withdrawal by Subject|0|||
44353342|NCT01227629|79357723|FG004|Overall Study|Withdrawal by Subject|0|||
44353343|NCT01227629|79357724|FG005|Overall Study|Withdrawal by Subject|0|||
44353344|NCT01227629|79357725|FG006|Overall Study|Withdrawal by Subject|2|||
44353345|NCT01227629|79357726|FG007|Overall Study|Withdrawal by Subject|0|||
44353346|NCT01227629|79357727|FG008|Overall Study|Withdrawal by Subject|0|||
44353347|NCT01227629|79357728|FG009|Overall Study|Withdrawal by Subject|1|||
44353348|NCT01227629|79357719|FG000|Overall Study|Other|0|||
44353349|NCT01227629|79357720|FG001|Overall Study|Other|0|||
44353350|NCT01227629|79357721|FG002|Overall Study|Other|0|||
44353351|NCT01227629|79357722|FG003|Overall Study|Other|1|||
44353352|NCT01227629|79357723|FG004|Overall Study|Other|0|||
44353353|NCT01227629|79357724|FG005|Overall Study|Other|0|||
44353354|NCT01227629|79357725|FG006|Overall Study|Other|0|||
44353355|NCT01227629|79357726|FG007|Overall Study|Other|0|||
44353356|NCT01227629|79357727|FG008|Overall Study|Other|2|||
44353357|NCT01227629|79357728|FG009|Overall Study|Other|1|||
44353358|NCT00963820|79357774|FG000|Dose Escalation Phase|Progressive Disease|3|||
44353359|NCT00963820|79357775|FG001|Dose Escalation Phase|Progressive Disease|3|||
44353360|NCT00963820|79357776|FG002|Dose Escalation Phase|Progressive Disease|3|||
44353361|NCT00963820|79357777|FG003|Dose Escalation Phase|Progressive Disease|3|||
44353362|NCT00963820|79357778|FG004|Dose Escalation Phase|Progressive Disease|4|||
44353363|NCT00963820|79357779|FG005|Dose Escalation Phase|Progressive Disease|3|||
44353364|NCT00963820|79357780|FG006|Dose Escalation Phase|Progressive Disease|3|||
44353365|NCT00963820|79357781|FG007|Dose Escalation Phase|Progressive Disease|2|||
44353366|NCT00963820|79357782|FG008|Dose Escalation Phase|Progressive Disease|0|||
44353367|NCT00963820|79357783|FG009|Dose Escalation Phase|Progressive Disease|0|||
44353368|NCT00963820|79357784|FG010|Dose Escalation Phase|Progressive Disease|0|||
44353369|NCT00963820|79357785|FG011|Dose Escalation Phase|Progressive Disease|0|||
44353370|NCT00963820|79357774|FG000|Dose Escalation Phase|Adverse Event|0|||
44353371|NCT00963820|79357775|FG001|Dose Escalation Phase|Adverse Event|0|||
44353372|NCT00963820|79357776|FG002|Dose Escalation Phase|Adverse Event|0|||
44353373|NCT00963820|79357777|FG003|Dose Escalation Phase|Adverse Event|0|||
44353374|NCT00963820|79357778|FG004|Dose Escalation Phase|Adverse Event|0|||
44353375|NCT00963820|79357779|FG005|Dose Escalation Phase|Adverse Event|0|||
44353376|NCT00963820|79357780|FG006|Dose Escalation Phase|Adverse Event|3|||
44353377|NCT00963820|79357781|FG007|Dose Escalation Phase|Adverse Event|1|||
44353378|NCT00963820|79357782|FG008|Dose Escalation Phase|Adverse Event|0|||
44353379|NCT00963820|79357783|FG009|Dose Escalation Phase|Adverse Event|0|||
44353380|NCT00963820|79357784|FG010|Dose Escalation Phase|Adverse Event|0|||
44353381|NCT00963820|79357785|FG011|Dose Escalation Phase|Adverse Event|0|||
44353382|NCT00963820|79357774|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
44353383|NCT00963820|79357775|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
44353384|NCT00963820|79357776|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
44353385|NCT00963820|79357777|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
44353386|NCT00963820|79357778|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
44353387|NCT00963820|79357779|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
44353388|NCT00963820|79357780|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
44353389|NCT00963820|79357781|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
44353390|NCT00963820|79357782|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
44353391|NCT00963820|79357783|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
44353392|NCT00963820|79357784|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
44353393|NCT00963820|79357785|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
44353394|NCT00963820|79357774|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353395|NCT00963820|79357775|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353396|NCT00963820|79357776|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353397|NCT00963820|79357777|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353398|NCT00963820|79357778|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353399|NCT00963820|79357779|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353400|NCT00963820|79357780|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
44353401|NCT00963820|79357781|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353402|NCT00963820|79357782|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353403|NCT00963820|79357783|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353404|NCT00963820|79357784|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353405|NCT00963820|79357785|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
44353406|NCT00963820|79357774|FG000|Expansion Phase|Progressive Disease|0|||
44353407|NCT00963820|79357775|FG001|Expansion Phase|Progressive Disease|0|||
44353408|NCT00963820|79357776|FG002|Expansion Phase|Progressive Disease|0|||
44353409|NCT00963820|79357777|FG003|Expansion Phase|Progressive Disease|0|||
44353410|NCT00963820|79357778|FG004|Expansion Phase|Progressive Disease|0|||
44353411|NCT00963820|79357779|FG005|Expansion Phase|Progressive Disease|0|||
44353412|NCT00963820|79357780|FG006|Expansion Phase|Progressive Disease|0|||
44353413|NCT00963820|79357781|FG007|Expansion Phase|Progressive Disease|0|||
44353414|NCT00963820|79357782|FG008|Expansion Phase|Progressive Disease|8|||
44353415|NCT00963820|79357783|FG009|Expansion Phase|Progressive Disease|6|||
44353416|NCT00963820|79357784|FG010|Expansion Phase|Progressive Disease|4|||
44353417|NCT00963820|79357785|FG011|Expansion Phase|Progressive Disease|2|||
44353418|NCT00963820|79357774|FG000|Expansion Phase|Adverse Event|0|||
44353419|NCT00963820|79357775|FG001|Expansion Phase|Adverse Event|0|||
44353420|NCT00963820|79357776|FG002|Expansion Phase|Adverse Event|0|||
44353421|NCT00963820|79357777|FG003|Expansion Phase|Adverse Event|0|||
44353422|NCT00963820|79357778|FG004|Expansion Phase|Adverse Event|0|||
44353423|NCT00963820|79357779|FG005|Expansion Phase|Adverse Event|0|||
44353424|NCT00963820|79357780|FG006|Expansion Phase|Adverse Event|0|||
44353425|NCT00963820|79357781|FG007|Expansion Phase|Adverse Event|0|||
44353426|NCT00963820|79357782|FG008|Expansion Phase|Adverse Event|1|||
44353427|NCT00963820|79357783|FG009|Expansion Phase|Adverse Event|3|||
44353428|NCT00963820|79357784|FG010|Expansion Phase|Adverse Event|0|||
44353429|NCT00963820|79357785|FG011|Expansion Phase|Adverse Event|0|||
44353430|NCT00963820|79357774|FG000|Expansion Phase|Withdrawal by Subject|0|||
44353431|NCT00963820|79357775|FG001|Expansion Phase|Withdrawal by Subject|0|||
44353432|NCT00963820|79357776|FG002|Expansion Phase|Withdrawal by Subject|0|||
44353433|NCT00963820|79357777|FG003|Expansion Phase|Withdrawal by Subject|0|||
44353434|NCT00963820|79357778|FG004|Expansion Phase|Withdrawal by Subject|0|||
44353435|NCT00963820|79357779|FG005|Expansion Phase|Withdrawal by Subject|0|||
44353436|NCT00963820|79357780|FG006|Expansion Phase|Withdrawal by Subject|0|||
44353437|NCT00963820|79357781|FG007|Expansion Phase|Withdrawal by Subject|0|||
44353438|NCT00963820|79357782|FG008|Expansion Phase|Withdrawal by Subject|1|||
44353439|NCT00963820|79357783|FG009|Expansion Phase|Withdrawal by Subject|0|||
44353440|NCT00963820|79357784|FG010|Expansion Phase|Withdrawal by Subject|1|||
44353441|NCT00963820|79357785|FG011|Expansion Phase|Withdrawal by Subject|1|||
44353442|NCT00963820|79357774|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353443|NCT00963820|79357775|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353444|NCT00963820|79357776|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353445|NCT00963820|79357777|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353446|NCT00963820|79357778|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353447|NCT00963820|79357779|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353448|NCT00963820|79357780|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353449|NCT00963820|79357781|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353450|NCT00963820|79357782|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353451|NCT00963820|79357783|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353452|NCT00963820|79357784|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
44353453|NCT00963820|79357785|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
44353454|NCT01227395|79357804|FG000|Overall Study|Protocol Violation|0|||
44353455|NCT01227395|79357805|FG001|Overall Study|Protocol Violation|1|||
44353456|NCT01226459|79357832|FG000|Overall Study|Adverse Event|2|||
44353457|NCT01226459|79357833|FG001|Overall Study|Adverse Event|8|||
44353458|NCT01226459|79357832|FG000|Overall Study|Protocol Violation|4|||
44353459|NCT01226459|79357833|FG001|Overall Study|Protocol Violation|3|||
44353460|NCT01226459|79357832|FG000|Overall Study|Withdrawal by Subject|10|||
44353461|NCT01226459|79357833|FG001|Overall Study|Withdrawal by Subject|13|||
44353462|NCT01226459|79357832|FG000|Overall Study|Lost to Follow-up|4|||
44353463|NCT01226459|79357833|FG001|Overall Study|Lost to Follow-up|8|||
44353464|NCT01226459|79357832|FG000|Overall Study|Pregnancy|1|||
44353465|NCT01226459|79357833|FG001|Overall Study|Pregnancy|0|||
44353466|NCT01225991|79357839|FG000|Overall Study|Withdrawal by Subject|6|||
44353467|NCT00959374|79357843|FG000|Overall Study|Withdrawal by Subject|2|||
44353468|NCT00959374|79357843|FG000|Overall Study|Lost to Follow-up|14|||
44353469|NCT00959374|79357843|FG000|Overall Study|Death|1|||
44353470|NCT00959374|79357843|FG000|Overall Study|Protocol Violation|1|||
44353471|NCT00959374|79357843|FG000|Overall Study|Implant Removed/Not Replaced|4|||
44353472|NCT00959374|79357843|FG000|Overall Study|Physician Decision|1|||
44353473|NCT01225835|79357853|FG000|Overall Study|Completed protocol|2|||
44353474|NCT01225835|79357854|FG001|Overall Study|Completed protocol|1|||
44353475|NCT01225835|79357853|FG000|Overall Study|Did not meet hCG criterion|2|||
44353476|NCT01225835|79357854|FG001|Overall Study|Did not meet hCG criterion|0|||
44353477|NCT01225835|79357853|FG000|Overall Study|Adverse Event|2|||
44353478|NCT01225835|79357854|FG001|Overall Study|Adverse Event|1|||
44353479|NCT01225835|79357853|FG000|Overall Study|Other|1|||
44353480|NCT01225835|79357854|FG001|Overall Study|Other|1|||
44353481|NCT00962650|79357866|FG000|Overall Study|Transgastric DP was not completed|2|||
44353482|NCT00958828|79357874|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
44353483|NCT00958828|79357875|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
44353484|NCT00958828|79357874|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
44353485|NCT00958828|79357875|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
44353486|NCT00960934|79357887|FG000|Overall Study|Adverse Event|2|||
44353487|NCT00960934|79357888|FG001|Overall Study|Adverse Event|3|||
44353488|NCT00960934|79357889|FG002|Overall Study|Adverse Event|3|||
44353489|NCT00960934|79357890|FG003|Overall Study|Adverse Event|2|||
44353490|NCT00960934|79357891|FG004|Overall Study|Adverse Event|4|||
44353491|NCT00960934|79357892|FG005|Overall Study|Adverse Event|3|||
44353492|NCT00960934|79357887|FG000|Overall Study|Lack of Efficacy|1|||
44353493|NCT00960934|79357888|FG001|Overall Study|Lack of Efficacy|0|||
44353494|NCT00960934|79357889|FG002|Overall Study|Lack of Efficacy|0|||
44353495|NCT00960934|79357890|FG003|Overall Study|Lack of Efficacy|0|||
44353496|NCT00960934|79357891|FG004|Overall Study|Lack of Efficacy|0|||
44353497|NCT00960934|79357892|FG005|Overall Study|Lack of Efficacy|0|||
44353498|NCT00960934|79357887|FG000|Overall Study|Lost to Follow-up|0|||
44353499|NCT00960934|79357888|FG001|Overall Study|Lost to Follow-up|1|||
44353500|NCT00960934|79357889|FG002|Overall Study|Lost to Follow-up|0|||
44353501|NCT00960934|79357890|FG003|Overall Study|Lost to Follow-up|0|||
44353502|NCT00960934|79357891|FG004|Overall Study|Lost to Follow-up|0|||
44353503|NCT00960934|79357892|FG005|Overall Study|Lost to Follow-up|0|||
44353504|NCT00960934|79357887|FG000|Overall Study|Other|2|||
44353505|NCT00960934|79357888|FG001|Overall Study|Other|1|||
44353506|NCT00960934|79357889|FG002|Overall Study|Other|5|||
44353507|NCT00960934|79357890|FG003|Overall Study|Other|4|||
44353508|NCT00960934|79357891|FG004|Overall Study|Other|2|||
44353509|NCT00960934|79357892|FG005|Overall Study|Other|2|||
44353510|NCT00960934|79357887|FG000|Overall Study|Physician Decision|0|||
44353511|NCT00960934|79357888|FG001|Overall Study|Physician Decision|1|||
44353512|NCT00960934|79357889|FG002|Overall Study|Physician Decision|0|||
44353513|NCT00960934|79357890|FG003|Overall Study|Physician Decision|0|||
44353514|NCT00960934|79357891|FG004|Overall Study|Physician Decision|0|||
44353515|NCT00960934|79357892|FG005|Overall Study|Physician Decision|0|||
44353516|NCT00960934|79357887|FG000|Overall Study|Progressive Disease|1|||
44353517|NCT00960934|79357888|FG001|Overall Study|Progressive Disease|1|||
44353518|NCT00960934|79357889|FG002|Overall Study|Progressive Disease|0|||
44353519|NCT00960934|79357890|FG003|Overall Study|Progressive Disease|0|||
44353520|NCT00960934|79357891|FG004|Overall Study|Progressive Disease|1|||
44353521|NCT00960934|79357892|FG005|Overall Study|Progressive Disease|1|||
44353522|NCT00960934|79357887|FG000|Overall Study|Protocol Violation|3|||
44353523|NCT00960934|79357888|FG001|Overall Study|Protocol Violation|4|||
44353524|NCT00960934|79357889|FG002|Overall Study|Protocol Violation|0|||
44353525|NCT00960934|79357890|FG003|Overall Study|Protocol Violation|3|||
44353526|NCT00960934|79357891|FG004|Overall Study|Protocol Violation|3|||
44353527|NCT00960934|79357892|FG005|Overall Study|Protocol Violation|2|||
44353528|NCT00960934|79357887|FG000|Overall Study|Withdrawal by Subject|5|||
44353529|NCT00960934|79357888|FG001|Overall Study|Withdrawal by Subject|6|||
44353530|NCT00960934|79357889|FG002|Overall Study|Withdrawal by Subject|4|||
44353531|NCT00960934|79357890|FG003|Overall Study|Withdrawal by Subject|5|||
44353532|NCT00960934|79357891|FG004|Overall Study|Withdrawal by Subject|5|||
44353533|NCT00960934|79357892|FG005|Overall Study|Withdrawal by Subject|7|||
44353534|NCT00960934|79357887|FG000|Overall Study|Study Terminated by Sponsor|50|||
44353535|NCT00960934|79357888|FG001|Overall Study|Study Terminated by Sponsor|46|||
44353536|NCT00960934|79357889|FG002|Overall Study|Study Terminated by Sponsor|52|||
44353537|NCT00960934|79357890|FG003|Overall Study|Study Terminated by Sponsor|50|||
44353538|NCT00960934|79357891|FG004|Overall Study|Study Terminated by Sponsor|49|||
44353539|NCT00960934|79357892|FG005|Overall Study|Study Terminated by Sponsor|49|||
44353540|NCT00892177|79357909|FG000|Phase II|Ineligible|0|||
44353541|NCT00892177|79357910|FG001|Phase II|Ineligible|0|||
44353542|NCT00892177|79357911|FG002|Phase II|Ineligible|0|||
44353543|NCT00892177|79357912|FG003|Phase II|Ineligible|0|||
44353544|NCT00892177|79357913|FG004|Phase II|Ineligible|1|||
44353545|NCT00892177|79357914|FG005|Phase II|Ineligible|1|||
44353546|NCT00892177|79357909|FG000|Phase II|Withdrawal by Subject|0|||
44353547|NCT00892177|79357910|FG001|Phase II|Withdrawal by Subject|0|||
44353548|NCT00892177|79357911|FG002|Phase II|Withdrawal by Subject|0|||
44353549|NCT00892177|79357912|FG003|Phase II|Withdrawal by Subject|0|||
44353550|NCT00892177|79357913|FG004|Phase II|Withdrawal by Subject|4|||
44353551|NCT00892177|79357914|FG005|Phase II|Withdrawal by Subject|1|||
44353552|NCT00962104|79357931|FG000|Overall Study|Adverse Event|10|||
44353553|NCT00962104|79357932|FG001|Overall Study|Adverse Event|3|||
44353554|NCT00962104|79357931|FG000|Overall Study|Entry Criteria Not Met|1|||
44353555|NCT00962104|79357932|FG001|Overall Study|Entry Criteria Not Met|2|||
44353556|NCT00962104|79357931|FG000|Overall Study|Lack of Efficacy|0|||
44353557|NCT00962104|79357932|FG001|Overall Study|Lack of Efficacy|1|||
44353558|NCT00962104|79357931|FG000|Overall Study|Lost to Follow-up|10|||
44353559|NCT00962104|79357932|FG001|Overall Study|Lost to Follow-up|4|||
44353560|NCT00962104|79357931|FG000|Overall Study|Physician Decision|1|||
44353561|NCT00962104|79357932|FG001|Overall Study|Physician Decision|0|||
44353562|NCT00962104|79357931|FG000|Overall Study|Protocol Violation|6|||
44353563|NCT00962104|79357932|FG001|Overall Study|Protocol Violation|8|||
44353564|NCT00962104|79357931|FG000|Overall Study|Sponsor Decision|0|||
44353565|NCT00962104|79357932|FG001|Overall Study|Sponsor Decision|1|||
44353566|NCT00962104|79357931|FG000|Overall Study|Withdrawal by Subject|10|||
44353567|NCT00962104|79357932|FG001|Overall Study|Withdrawal by Subject|6|||
44353568|NCT00962104|79357931|FG000|Overall Study|Other|2|||
44353569|NCT00962104|79357932|FG001|Overall Study|Other|0|||
44353570|NCT02821000|79357938|FG000|Overall Study|Death|44|||
44353571|NCT02821000|79357938|FG000|Overall Study|Withdrawal by Subject|1|||
44353572|NCT02821000|79357938|FG000|Overall Study|Ongoing in Study|58|||
44353573|NCT00892099|79357945|FG000|Overall Study|Death|1|||
44353574|NCT00892099|79357946|FG001|Overall Study|Death|0|||
44353575|NCT00892099|79357947|FG002|Overall Study|Death|1|||
44353576|NCT00892099|79357945|FG000|Overall Study|Adverse Event|1|||
44353577|NCT00892099|79357946|FG001|Overall Study|Adverse Event|0|||
44353578|NCT00892099|79357947|FG002|Overall Study|Adverse Event|0|||
44353579|NCT00892099|79357945|FG000|Overall Study|replocated|1|||
44353580|NCT00892099|79357946|FG001|Overall Study|replocated|0|||
44353581|NCT00892099|79357947|FG002|Overall Study|replocated|2|||
44353582|NCT00892099|79357945|FG000|Overall Study|Prolonged hospitalization|1|||
44353583|NCT00892099|79357946|FG001|Overall Study|Prolonged hospitalization|0|||
44353584|NCT00892099|79357947|FG002|Overall Study|Prolonged hospitalization|1|||
44353585|NCT00892099|79357945|FG000|Overall Study|no further details|1|||
44353586|NCT00892099|79357946|FG001|Overall Study|no further details|0|||
44353587|NCT00892099|79357947|FG002|Overall Study|no further details|1|||
44353588|NCT00892099|79357945|FG000|Overall Study|kidney function recovered|0|||
44353589|NCT00892099|79357946|FG001|Overall Study|kidney function recovered|1|||
44353590|NCT00892099|79357947|FG002|Overall Study|kidney function recovered|0|||
44353591|NCT00892099|79357945|FG000|Overall Study|investigator decision|0|||
44353592|NCT00892099|79357946|FG001|Overall Study|investigator decision|0|||
44353593|NCT00892099|79357947|FG002|Overall Study|investigator decision|1|||
44353594|NCT00892099|79357945|FG000|Overall Study|Lost to Follow-up|0|||
44353595|NCT00892099|79357946|FG001|Overall Study|Lost to Follow-up|0|||
44353596|NCT00892099|79357947|FG002|Overall Study|Lost to Follow-up|1|||
44353597|NCT00960856|79357955|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
44353598|NCT00960856|79357956|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
44353599|NCT00960856|79357957|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
44353600|NCT00960856|79357958|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
44353601|NCT00960856|79357955|FG000|Washout Period of 7 Days|Adverse Event|0|||
44353602|NCT00960856|79357956|FG001|Washout Period of 7 Days|Adverse Event|0|||
44353603|NCT00960856|79357957|FG002|Washout Period of 7 Days|Adverse Event|1|||
44353604|NCT00960856|79357958|FG003|Washout Period of 7 Days|Adverse Event|0|||
44353605|NCT00958438|79357971|FG000|Overall Study|Protocol Violation|3|||
44353606|NCT00958438|79357972|FG001|Overall Study|Protocol Violation|2|||
44353607|NCT00958438|79357973|FG002|Overall Study|Protocol Violation|2|||
44353608|NCT00958438|79357971|FG000|Overall Study|Withdrawal by Subject|4|||
44353609|NCT00958438|79357972|FG001|Overall Study|Withdrawal by Subject|2|||
44353610|NCT00958438|79357973|FG002|Overall Study|Withdrawal by Subject|1|||
44353611|NCT00958438|79357971|FG000|Overall Study|Adverse Event|0|||
44353612|NCT00958438|79357972|FG001|Overall Study|Adverse Event|3|||
44353613|NCT00958438|79357973|FG002|Overall Study|Adverse Event|0|||
44353614|NCT00958438|79357971|FG000|Overall Study|Physician Decision|1|||
44353615|NCT00958438|79357972|FG001|Overall Study|Physician Decision|0|||
44353616|NCT00958438|79357973|FG002|Overall Study|Physician Decision|1|||
44353617|NCT00958438|79357971|FG000|Overall Study|Other than specified above|2|||
44353618|NCT00958438|79357972|FG001|Overall Study|Other than specified above|3|||
44353619|NCT00958438|79357973|FG002|Overall Study|Other than specified above|2|||
44353620|NCT00958360|79357983|FG000|Overall Study|Withdrawal by Subject|3|||
44353621|NCT00958360|79357984|FG001|Overall Study|Withdrawal by Subject|1|||
44353622|NCT00958360|79357983|FG000|Overall Study|Death|6|||
44353623|NCT00958360|79357984|FG001|Overall Study|Death|7|||
44353624|NCT00958360|79357983|FG000|Overall Study|Physician Decision|2|||
44353625|NCT00958360|79357984|FG001|Overall Study|Physician Decision|1|||
44353626|NCT00958360|79357983|FG000|Overall Study|Lost to Follow-up|0|||
44353627|NCT00958360|79357984|FG001|Overall Study|Lost to Follow-up|1|||
44353628|NCT00888433|79357992|FG000|Overall Study|Withdrawal by Subject|1|||
44353629|NCT00888433|79357993|FG001|Overall Study|Withdrawal by Subject|2|||
44353630|NCT00888433|79357992|FG000|Overall Study|Missed Visit|2|||
44353631|NCT00888433|79357993|FG001|Overall Study|Missed Visit|1|||
44353632|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
44354791|NCT01185366|79359201|FG000|First Line Therapy|Insurance Coverage Denied|1|||
44353633|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
44353634|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
44353635|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
44353636|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
44353637|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
44353638|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
44353639|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
44353640|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
44353641|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
44353642|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
44353643|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
44353644|NCT01243424|79358001|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
44353645|NCT01243424|79358002|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
44353646|NCT01243424|79358001|FG000|Discontinuation From Treatment|Not treated|5|||
44353647|NCT01243424|79358002|FG001|Discontinuation From Treatment|Not treated|4|||
44353648|NCT01243424|79358001|FG000|Discontinuation From Treatment|Adverse Event|457|||
44353649|NCT01243424|79358002|FG001|Discontinuation From Treatment|Adverse Event|523|||
44353650|NCT01243424|79358001|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
44353651|NCT01243424|79358002|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
44353652|NCT01243424|79358001|FG000|Discontinuation From Treatment|Protocol Violation|46|||
44353653|NCT01243424|79358002|FG001|Discontinuation From Treatment|Protocol Violation|47|||
44353654|NCT01243424|79358001|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
44353655|NCT01243424|79358002|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
44353656|NCT01243424|79358001|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
44353657|NCT01243424|79358002|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
44353658|NCT01243424|79358001|FG000|Discontinuation From Treatment|Other than listed above|230|||
44353659|NCT01243424|79358002|FG001|Discontinuation From Treatment|Other than listed above|211|||
44353660|NCT00887809|79358011|FG000|Overall Study|Patient Not Treated|3|||
44353661|NCT00887809|79358012|FG001|Overall Study|Patient Not Treated|0|||
44353662|NCT00887809|79358011|FG000|Overall Study|Death|1|||
44353663|NCT00887809|79358012|FG001|Overall Study|Death|0|||
44353664|NCT00958126|79358026|FG000|Overall Study|Serious Adverse Event|0|||
44353665|NCT00958126|79358027|FG001|Overall Study|Serious Adverse Event|2|||
44353666|NCT00958126|79358028|FG002|Overall Study|Serious Adverse Event|0|||
44353667|NCT00958126|79358029|FG003|Overall Study|Serious Adverse Event|0|||
44353668|NCT00958126|79358030|FG004|Overall Study|Serious Adverse Event|0|||
44353669|NCT00958126|79358031|FG005|Overall Study|Serious Adverse Event|0|||
44353670|NCT00958126|79358032|FG006|Overall Study|Serious Adverse Event|1|||
44353671|NCT00958126|79358033|FG007|Overall Study|Serious Adverse Event|0|||
44353672|NCT00958126|79358026|FG000|Overall Study|Withdrawal by Subject|0|||
44353673|NCT00958126|79358027|FG001|Overall Study|Withdrawal by Subject|2|||
44353674|NCT00958126|79358028|FG002|Overall Study|Withdrawal by Subject|0|||
44353675|NCT00958126|79358029|FG003|Overall Study|Withdrawal by Subject|0|||
44353676|NCT00958126|79358030|FG004|Overall Study|Withdrawal by Subject|0|||
44353677|NCT00958126|79358031|FG005|Overall Study|Withdrawal by Subject|0|||
44353678|NCT00958126|79358032|FG006|Overall Study|Withdrawal by Subject|0|||
44353679|NCT00958126|79358033|FG007|Overall Study|Withdrawal by Subject|0|||
44353680|NCT00958126|79358026|FG000|Overall Study|Moved away from study area|0|||
44353681|NCT00958126|79358027|FG001|Overall Study|Moved away from study area|0|||
44353682|NCT00958126|79358028|FG002|Overall Study|Moved away from study area|1|||
44353683|NCT00958126|79358029|FG003|Overall Study|Moved away from study area|1|||
44353684|NCT00958126|79358030|FG004|Overall Study|Moved away from study area|0|||
44353685|NCT00958126|79358031|FG005|Overall Study|Moved away from study area|0|||
44353686|NCT00958126|79358032|FG006|Overall Study|Moved away from study area|0|||
44353687|NCT00958126|79358033|FG007|Overall Study|Moved away from study area|0|||
44353688|NCT00958126|79358026|FG000|Overall Study|Lost to Follow-up|1|||
44353689|NCT00958126|79358027|FG001|Overall Study|Lost to Follow-up|5|||
44353690|NCT00958126|79358028|FG002|Overall Study|Lost to Follow-up|9|||
44353691|NCT00958126|79358029|FG003|Overall Study|Lost to Follow-up|8|||
44353692|NCT00958126|79358030|FG004|Overall Study|Lost to Follow-up|0|||
44353693|NCT00958126|79358031|FG005|Overall Study|Lost to Follow-up|0|||
44353694|NCT00958126|79358032|FG006|Overall Study|Lost to Follow-up|0|||
44353695|NCT00958126|79358033|FG007|Overall Study|Lost to Follow-up|0|||
44353696|NCT00958126|79358026|FG000|Overall Study|Sponsor/Investigator decision|0|||
44353697|NCT00958126|79358027|FG001|Overall Study|Sponsor/Investigator decision|0|||
44353698|NCT00958126|79358028|FG002|Overall Study|Sponsor/Investigator decision|0|||
44353699|NCT00958126|79358029|FG003|Overall Study|Sponsor/Investigator decision|1|||
44353700|NCT00958126|79358030|FG004|Overall Study|Sponsor/Investigator decision|0|||
44353701|NCT00958126|79358031|FG005|Overall Study|Sponsor/Investigator decision|0|||
44354868|NCT01035255|79359275|FG000|Overall Study|Lost to Follow-up|2|||
44353702|NCT00958126|79358032|FG006|Overall Study|Sponsor/Investigator decision|0|||
44353703|NCT00958126|79358033|FG007|Overall Study|Sponsor/Investigator decision|0|||
44353704|NCT00958126|79358026|FG000|Overall Study|Other Reason|0|||
44353705|NCT00958126|79358027|FG001|Overall Study|Other Reason|0|||
44353706|NCT00958126|79358028|FG002|Overall Study|Other Reason|0|||
44353707|NCT00958126|79358029|FG003|Overall Study|Other Reason|1|||
44353708|NCT00958126|79358030|FG004|Overall Study|Other Reason|0|||
44353709|NCT00958126|79358031|FG005|Overall Study|Other Reason|1|||
44353710|NCT00958126|79358032|FG006|Overall Study|Other Reason|0|||
44353711|NCT00958126|79358033|FG007|Overall Study|Other Reason|0|||
44353712|NCT00887341|79358057|FG000|Overall Study|Refused treatment|1|||
44353713|NCT00887341|79358058|FG001|Overall Study|Refused treatment|0|||
44353714|NCT00887341|79358057|FG000|Overall Study|Withdrawal by Subject|1|||
44353715|NCT00887341|79358058|FG001|Overall Study|Withdrawal by Subject|1|||
44353716|NCT00887341|79358057|FG000|Overall Study|Adverse Event|0|||
44353717|NCT00887341|79358058|FG001|Overall Study|Adverse Event|1|||
44353718|NCT00887341|79358057|FG000|Overall Study|Lost to Follow-up|0|||
44353719|NCT00887341|79358058|FG001|Overall Study|Lost to Follow-up|1|||
44353720|NCT00886795|79358064|FG000|Overall Study|Lack of Efficacy|1|||
44353721|NCT00889681|79358081|FG000|Overall Study|Not meeting qualification Criteria|2|||
44353722|NCT00889681|79358081|FG000|Overall Study|Insurance disapproval|1|||
44353723|NCT00957658|79358085|FG000|Overall Study|Death|1|||
44353724|NCT00957658|79358085|FG000|Overall Study|Lost to Follow-up|4|||
44353725|NCT00957658|79358085|FG000|Overall Study|Withdrawal by Subject|12|||
44353726|NCT00957658|79358085|FG000|Overall Study|Revision|1|||
44353727|NCT00957658|79358085|FG000|Overall Study|Incomplete 2 yr data|28|||
44353728|NCT00957658|79358085|FG000|Overall Study|Site termination|10|||
44353729|NCT00957658|79358085|FG000|Overall Study|unwilling/unable to return|2|||
44353730|NCT00957658|79358085|FG000|Overall Study|surgery cancelled|2|||
44353731|NCT00957658|79358085|FG000|Overall Study|Protocol Violation|5|||
44353732|NCT00953680|79358091|FG000|Period 1|Withdrawal by Subject|0|||
44353733|NCT00953680|79358092|FG001|Period 1|Withdrawal by Subject|1|||
44353734|NCT00890929|79358098|FG000|Overall Study|Death before treatment|2|||
44353735|NCT00890929|79358098|FG000|Overall Study|Withdrawal by Subject|3|||
44353736|NCT00890929|79358098|FG000|Overall Study|Physician Decision|1|||
44353737|NCT00886639|79358102|FG000|Overall Study|acute exacerbation|14|||
44353738|NCT00886639|79358102|FG000|Overall Study|non-compliance|2|||
44353739|NCT00889603|79358106|FG000|Overall Study|Adverse Event|7|||
44353740|NCT00889603|79358106|FG000|Overall Study|Death|3|||
44353741|NCT00889603|79358106|FG000|Overall Study|Lost to Follow-up|19|||
44353742|NCT00889603|79358106|FG000|Overall Study|No longer willing to participant in stud|4|||
44353743|NCT00889603|79358106|FG000|Overall Study|Other|4|||
44353744|NCT00886483|79358112|FG000|Overall Study|Lost to Follow-up|0|||
44353745|NCT00886483|79358113|FG001|Overall Study|Lost to Follow-up|1|||
44353746|NCT00886483|79358112|FG000|Overall Study|Pursue medications|1|||
44353747|NCT00886483|79358113|FG001|Overall Study|Pursue medications|2|||
44353748|NCT00886483|79358112|FG000|Overall Study|Distance to center, poor grades|1|||
44353749|NCT00886483|79358113|FG001|Overall Study|Distance to center, poor grades|0|||
44353750|NCT00886015|79358129|FG000|Overall Study|Death|0|||
44353751|NCT00886015|79358130|FG001|Overall Study|Death|2|||
44353752|NCT00890695|79358138|FG000|Overall Study|Protocol Violation|1|||
44353753|NCT00890695|79358139|FG001|Overall Study|Protocol Violation|0|||
44353754|NCT00957580|79358148|FG000|Overall Study|Ongoing at data cut-off|0|||
44353755|NCT00957580|79358149|FG001|Overall Study|Ongoing at data cut-off|1|||
44353756|NCT00957580|79358150|FG002|Overall Study|Ongoing at data cut-off|0|||
44353757|NCT00957580|79358148|FG000|Overall Study|Enrolled but not treated|0|||
44353758|NCT00957580|79358149|FG001|Overall Study|Enrolled but not treated|1|||
44353759|NCT00957580|79358150|FG002|Overall Study|Enrolled but not treated|0|||
44353760|NCT00957424|79358171|FG000|Overall Study|Lost to Follow-up|19|||
44353761|NCT00957424|79358171|FG000|Overall Study|Protocol Violation|3|||
44353762|NCT00957424|79358171|FG000|Overall Study|Withdrawal by Subject|1|||
44353763|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
44353764|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
44353765|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
44353766|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
44353767|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
44353768|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
44353769|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
44353770|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
44353771|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
44353772|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
44353773|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
44353774|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
44353775|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
44353776|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
44353777|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
44353778|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
44353779|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
44353780|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
44353781|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
44353782|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
44353783|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
44353784|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
44353785|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
44353786|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
44353787|NCT01061151|79358179|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
44353788|NCT01061151|79358180|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
44353789|NCT01061151|79358181|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
44353790|NCT01061151|79358182|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
44353791|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
44353792|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
44353793|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
44353794|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
44353795|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
44353796|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
44353797|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
44353798|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
44353799|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
44353800|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
44353801|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
44353802|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
44353803|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
44353804|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
44353805|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
44353806|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
44353807|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
44353808|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
44353809|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
44353810|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
44353811|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
44353812|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
44353813|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
44353814|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
44353815|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
44353816|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
44353817|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
44353818|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
44353819|NCT01061151|79358179|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
44353820|NCT01061151|79358180|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
44353821|NCT01061151|79358181|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
44353822|NCT01061151|79358182|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
44353823|NCT01241552|79358206|FG000|Overall Study|Lack of Efficacy|1|||
44353824|NCT01241552|79358207|FG001|Overall Study|Lack of Efficacy|0|||
44353825|NCT01241552|79358208|FG002|Overall Study|Lack of Efficacy|0|||
44353826|NCT01241552|79358209|FG003|Overall Study|Lack of Efficacy|0|||
44353827|NCT01241552|79358206|FG000|Overall Study|Death|26|||
44353828|NCT01241552|79358207|FG001|Overall Study|Death|30|||
44353829|NCT01241552|79358208|FG002|Overall Study|Death|20|||
44353830|NCT01241552|79358209|FG003|Overall Study|Death|25|||
44353831|NCT01241552|79358206|FG000|Overall Study|Adverse Event|1|||
44353832|NCT01241552|79358207|FG001|Overall Study|Adverse Event|1|||
44353833|NCT01241552|79358208|FG002|Overall Study|Adverse Event|0|||
44353834|NCT01241552|79358209|FG003|Overall Study|Adverse Event|0|||
44353835|NCT01241552|79358206|FG000|Overall Study|Technical Problems|2|||
44353836|NCT01241552|79358207|FG001|Overall Study|Technical Problems|0|||
44353837|NCT01241552|79358208|FG002|Overall Study|Technical Problems|2|||
44353838|NCT01241552|79358209|FG003|Overall Study|Technical Problems|2|||
44353839|NCT01241552|79358206|FG000|Overall Study|Progressive Disease|0|||
44353840|NCT01241552|79358207|FG001|Overall Study|Progressive Disease|0|||
44353841|NCT01241552|79358208|FG002|Overall Study|Progressive Disease|1|||
44353842|NCT01241552|79358209|FG003|Overall Study|Progressive Disease|2|||
44353843|NCT01241552|79358206|FG000|Overall Study|Protocol Violation|0|||
44353844|NCT01241552|79358207|FG001|Overall Study|Protocol Violation|2|||
44353845|NCT01241552|79358208|FG002|Overall Study|Protocol Violation|6|||
44353846|NCT01241552|79358209|FG003|Overall Study|Protocol Violation|1|||
44353847|NCT01241552|79358206|FG000|Overall Study|Withdrawal by Subject|7|||
44353848|NCT01241552|79358207|FG001|Overall Study|Withdrawal by Subject|15|||
44353849|NCT01241552|79358208|FG002|Overall Study|Withdrawal by Subject|14|||
44353850|NCT01241552|79358209|FG003|Overall Study|Withdrawal by Subject|15|||
44353851|NCT01241552|79358206|FG000|Overall Study|Physician Decision|2|||
44353852|NCT01241552|79358207|FG001|Overall Study|Physician Decision|4|||
44353853|NCT01241552|79358208|FG002|Overall Study|Physician Decision|2|||
44353854|NCT01241552|79358209|FG003|Overall Study|Physician Decision|3|||
44353855|NCT01241552|79358206|FG000|Overall Study|Lost to Follow-up|2|||
44353856|NCT01241552|79358207|FG001|Overall Study|Lost to Follow-up|11|||
44353857|NCT01241552|79358208|FG002|Overall Study|Lost to Follow-up|15|||
44353858|NCT01241552|79358209|FG003|Overall Study|Lost to Follow-up|16|||
44353859|NCT00948922|79358222|FG000|Overall Study|Did not start study treatment|2|||
44353860|NCT00948922|79358223|FG001|Overall Study|Did not start study treatment|5|||
44353861|NCT00948922|79358224|FG002|Overall Study|Did not start study treatment|0|||
44353862|NCT00948922|79358222|FG000|Overall Study|Withdrawal by Subject|0|||
44353863|NCT00948922|79358223|FG001|Overall Study|Withdrawal by Subject|2|||
44353864|NCT00948922|79358224|FG002|Overall Study|Withdrawal by Subject|1|||
44353865|NCT00948922|79358222|FG000|Overall Study|Death|3|||
44353866|NCT00948922|79358223|FG001|Overall Study|Death|0|||
44353867|NCT00948922|79358224|FG002|Overall Study|Death|0|||
44353868|NCT00948922|79358222|FG000|Overall Study|Disease progression|0|||
44353869|NCT00948922|79358223|FG001|Overall Study|Disease progression|1|||
44353870|NCT00948922|79358224|FG002|Overall Study|Disease progression|0|||
44353871|NCT00948922|79358222|FG000|Overall Study|Insurance issues|1|||
44353872|NCT00948922|79358223|FG001|Overall Study|Insurance issues|0|||
44353873|NCT00948922|79358224|FG002|Overall Study|Insurance issues|0|||
44353874|NCT00948922|79358222|FG000|Overall Study|Transplant eligibility issues|2|||
44353875|NCT00948922|79358223|FG001|Overall Study|Transplant eligibility issues|3|||
44353876|NCT00948922|79358224|FG002|Overall Study|Transplant eligibility issues|0|||
44353877|NCT00948922|79358222|FG000|Overall Study|Not evaluable at time of analysis|0|||
44353878|NCT00948922|79358223|FG001|Overall Study|Not evaluable at time of analysis|3|||
44353879|NCT00948922|79358224|FG002|Overall Study|Not evaluable at time of analysis|0|||
44353880|NCT01239992|79358236|FG000|Overall Study|Withdrawal by Subject|2|||
44353881|NCT01239680|79358242|FG000|Overall Study|Withdrawal by Subject|2|||
44353882|NCT01239680|79358243|FG001|Overall Study|Withdrawal by Subject|0|||
44353883|NCT01238900|79358249|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
44353884|NCT01238900|79358249|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
44353885|NCT01238822|79358254|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
44353886|NCT01238588|79358264|FG000|Overall Study|Withdrawal by Subject|1|||
44353887|NCT01238588|79358264|FG000|Overall Study|Physician Decision|2|||
44353888|NCT01047501|79358271|FG000|Overall Study|Adverse Event|7|||
44353889|NCT01047501|79358272|FG001|Overall Study|Adverse Event|8|||
44353890|NCT01047501|79358273|FG002|Overall Study|Adverse Event|5|||
44353891|NCT01047501|79358271|FG000|Overall Study|Withdrew Consent|6|||
44353892|NCT01047501|79358272|FG001|Overall Study|Withdrew Consent|2|||
44353893|NCT01047501|79358273|FG002|Overall Study|Withdrew Consent|4|||
44353894|NCT01047501|79358271|FG000|Overall Study|Lost to Follow-up|0|||
44353895|NCT01047501|79358272|FG001|Overall Study|Lost to Follow-up|1|||
44353896|NCT01047501|79358273|FG002|Overall Study|Lost to Follow-up|1|||
44353897|NCT01047501|79358271|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
44353898|NCT01047501|79358272|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
44353899|NCT01047501|79358273|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
44353900|NCT01047501|79358271|FG000|Overall Study|Death|1|||
44353901|NCT01047501|79358272|FG001|Overall Study|Death|0|||
44353902|NCT01047501|79358273|FG002|Overall Study|Death|0|||
44353903|NCT01047501|79358271|FG000|Overall Study|Other discontinuation|1|||
44353904|NCT01047501|79358272|FG001|Overall Study|Other discontinuation|0|||
44353905|NCT01047501|79358273|FG002|Overall Study|Other discontinuation|1|||
44353906|NCT01047501|79358271|FG000|Overall Study|Investigator judgement|0|||
44353907|NCT01047501|79358272|FG001|Overall Study|Investigator judgement|0|||
44353908|NCT01047501|79358273|FG002|Overall Study|Investigator judgement|1|||
44353909|NCT01238120|79358285|FG000|Overall Study|Withdrawal by Subject|4|||
44353910|NCT01238120|79358286|FG001|Overall Study|Withdrawal by Subject|1|||
44353911|NCT01238120|79358287|FG002|Overall Study|Withdrawal by Subject|2|||
44353912|NCT01238120|79358288|FG003|Overall Study|Withdrawal by Subject|5|||
44353913|NCT01238120|79358285|FG000|Overall Study|Lost to Follow-up|2|||
44353914|NCT01238120|79358286|FG001|Overall Study|Lost to Follow-up|0|||
44353915|NCT01238120|79358287|FG002|Overall Study|Lost to Follow-up|1|||
44353916|NCT01238120|79358288|FG003|Overall Study|Lost to Follow-up|1|||
44353917|NCT01238120|79358285|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
44353918|NCT01238120|79358286|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
44353919|NCT01238120|79358287|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
44353920|NCT01238120|79358288|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
44353921|NCT01237340|79358298|FG000|Overall Study|Adverse Event|3|||
44353922|NCT01237340|79358298|FG000|Overall Study|Withdrawal by Subject|1|||
44353923|NCT01237340|79358298|FG000|Overall Study|Early termination of the trial|36|||
44353924|NCT01045707|79358307|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
44353925|NCT01045707|79358308|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
44353926|NCT01045707|79358307|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
44353927|NCT01045707|79358308|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
44353928|NCT01045707|79358307|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
44353929|NCT01045707|79358308|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
44353930|NCT01045707|79358307|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
44353931|NCT01045707|79358308|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
44353932|NCT01045707|79358307|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
44353933|NCT01045707|79358308|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
44353934|NCT01045707|79358307|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
44353935|NCT01045707|79358308|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
44353936|NCT01045707|79358307|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
44353937|NCT01045707|79358308|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
44353938|NCT01045707|79358307|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
44353939|NCT01045707|79358308|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
44353940|NCT01045707|79358307|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
44353941|NCT01045707|79358308|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
44353942|NCT01054599|79358316|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
44353943|NCT01054599|79358317|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
44353944|NCT01054599|79358316|FG000|Overall Study|Protocol Violation|1|||
44353945|NCT01054599|79358317|FG001|Overall Study|Protocol Violation|0|||
44353946|NCT01054599|79358316|FG000|Overall Study|Spells/seizure-like episodes|1|||
44353947|NCT01054599|79358317|FG001|Overall Study|Spells/seizure-like episodes|1|||
44353948|NCT01054599|79358316|FG000|Overall Study|Timing/scheduling difficulties|1|||
44353949|NCT01054599|79358317|FG001|Overall Study|Timing/scheduling difficulties|1|||
44353950|NCT01054599|79358316|FG000|Overall Study|Visual impairment, WTAR <80|0|||
44353951|NCT01054599|79358317|FG001|Overall Study|Visual impairment, WTAR <80|1|||
44353952|NCT01054599|79358316|FG000|Overall Study|Lost to Follow-up|0|||
44353953|NCT01054599|79358317|FG001|Overall Study|Lost to Follow-up|2|||
44353954|NCT01054599|79358316|FG000|Overall Study|Adverse Event|0|||
44353955|NCT01054599|79358317|FG001|Overall Study|Adverse Event|1|||
44353956|NCT01054599|79358316|FG000|Overall Study|Withdrawal by Subject|0|||
44353957|NCT01054599|79358317|FG001|Overall Study|Withdrawal by Subject|1|||
44353958|NCT00948766|79358325|FG000|Core Study|Adverse Event|73|||
44353959|NCT00948766|79358326|FG001|Core Study|Adverse Event|51|||
44353960|NCT00948766|79358325|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
44353961|NCT00948766|79358326|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
44353962|NCT00948766|79358325|FG000|Core Study|Patient Withdrew Consent|27|||
44353963|NCT00948766|79358326|FG001|Core Study|Patient Withdrew Consent|46|||
44353964|NCT00948766|79358325|FG000|Core Study|Lost to Follow-up|3|||
44353965|NCT00948766|79358326|FG001|Core Study|Lost to Follow-up|2|||
44353966|NCT00948766|79358325|FG000|Core Study|Administrative Problems|2|||
44353967|NCT00948766|79358326|FG001|Core Study|Administrative Problems|2|||
44353968|NCT00948766|79358325|FG000|Core Study|Death|1|||
44353969|NCT00948766|79358326|FG001|Core Study|Death|1|||
44353970|NCT00948766|79358325|FG000|Core Study|Protocol Deviation|8|||
44353971|NCT00948766|79358326|FG001|Core Study|Protocol Deviation|10|||
44353972|NCT00948766|79358325|FG000|Extension Study|Adverse Event|43|||
44353973|NCT00948766|79358326|FG001|Extension Study|Adverse Event|0|||
44353974|NCT00948766|79358325|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
44353975|NCT00948766|79358326|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
44353976|NCT00948766|79358325|FG000|Extension Study|Study Drug No Longer Required|1|||
44353977|NCT00948766|79358326|FG001|Extension Study|Study Drug No Longer Required|0|||
44353978|NCT00948766|79358325|FG000|Extension Study|Patient Withdrew Consent|32|||
44353979|NCT00948766|79358326|FG001|Extension Study|Patient Withdrew Consent|0|||
44353980|NCT00948766|79358325|FG000|Extension Study|Lost to Follow-up|8|||
44353981|NCT00948766|79358326|FG001|Extension Study|Lost to Follow-up|0|||
44353982|NCT00948766|79358325|FG000|Extension Study|Administrative Problems|1|||
44353983|NCT00948766|79358326|FG001|Extension Study|Administrative Problems|0|||
44353984|NCT00948766|79358325|FG000|Extension Study|Death|4|||
44353985|NCT00948766|79358326|FG001|Extension Study|Death|0|||
44353986|NCT01053663|79358336|FG000|Overall Study|Death|2|||
44353987|NCT01053663|79358336|FG000|Overall Study|Lost to Follow-up|1|||
44353988|NCT01053663|79358336|FG000|Overall Study|Poor IV Access|1|||
44353989|NCT01053663|79358336|FG000|Overall Study|Transferred to Another Hospital|1|||
44353990|NCT01053663|79358336|FG000|Overall Study|Negative Influenza Diagnosis|1|||
44353991|NCT01235546|79358348|FG000|Overall Study|Staff error, medication not administered|1|||
44353992|NCT01235546|79358349|FG001|Overall Study|Staff error, medication not administered|0|||
44353993|NCT01235546|79358348|FG000|Overall Study|Protocol Violation|1|||
44353994|NCT01235546|79358349|FG001|Overall Study|Protocol Violation|1|||
44353995|NCT01053429|79358364|FG000|Overall Study|Adverse Event|64|||
44353996|NCT01053429|79358364|FG000|Overall Study|Other|309|||
44353997|NCT01233284|79358368|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
44353998|NCT01233284|79358369|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44353999|NCT01233284|79358370|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44354000|NCT01233284|79358371|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44354001|NCT01233284|79358372|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
44354002|NCT01233284|79358368|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44354003|NCT01233284|79358369|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
44354004|NCT01233284|79358370|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44354005|NCT01233284|79358371|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44354006|NCT01233284|79358372|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
44354007|NCT01233284|79358368|FG000|Period 1 (4 Weeks)|Other|0|||
44354008|NCT01233284|79358369|FG001|Period 1 (4 Weeks)|Other|0|||
44354009|NCT01233284|79358370|FG002|Period 1 (4 Weeks)|Other|1|||
44354010|NCT01233284|79358371|FG003|Period 1 (4 Weeks)|Other|0|||
44354011|NCT01233284|79358372|FG004|Period 1 (4 Weeks)|Other|0|||
44354012|NCT01233284|79358368|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44354013|NCT01233284|79358369|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44354014|NCT01233284|79358370|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
44354015|NCT01233284|79358371|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44354016|NCT01233284|79358372|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
44166953|NCT02482129|78959932|FG000|Overall Study|Adverse Event-prior to treatment|0|||
44166954|NCT02482129|78959933|FG001|Overall Study|Adverse Event-prior to treatment|1|||
44166955|NCT02482129|78959932|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
44166956|NCT02482129|78959933|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
44166957|NCT02482129|78959932|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
44166958|NCT02482129|78959933|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
44166959|NCT02482129|78959932|FG000|Overall Study|Criteria not met-prior to treatment|1|||
44166960|NCT02482129|78959933|FG001|Overall Study|Criteria not met-prior to treatment|0|||
44166961|NCT02482129|78959932|FG000|Overall Study|Adverse Event|1|||
44166962|NCT02482129|78959933|FG001|Overall Study|Adverse Event|0|||
44166963|NCT02482129|78959932|FG000|Overall Study|Withdrawal by Subject|2|||
44166964|NCT02482129|78959933|FG001|Overall Study|Withdrawal by Subject|0|||
44166965|NCT02482129|78959932|FG000|Overall Study|Criteria not met|1|||
44166966|NCT02482129|78959933|FG001|Overall Study|Criteria not met|0|||
44166967|NCT02495857|78959944|FG000|Overall Study|Adverse Event|5|||
44166968|NCT02495857|78959945|FG001|Overall Study|Adverse Event|0|||
44166969|NCT02495857|78959946|FG002|Overall Study|Adverse Event|1|||
44166970|NCT02495857|78959944|FG000|Overall Study|Withdrawal by Subject|9|||
44166971|NCT02495857|78959945|FG001|Overall Study|Withdrawal by Subject|6|||
44166972|NCT02495857|78959946|FG002|Overall Study|Withdrawal by Subject|10|||
44166973|NCT02495857|78959944|FG000|Overall Study|Physician Decision|0|||
44166974|NCT02495857|78959945|FG001|Overall Study|Physician Decision|1|||
44166975|NCT02495857|78959946|FG002|Overall Study|Physician Decision|0|||
44166976|NCT02495857|78959944|FG000|Overall Study|Protocol Violation|1|||
44166977|NCT02495857|78959945|FG001|Overall Study|Protocol Violation|1|||
44166978|NCT02495857|78959946|FG002|Overall Study|Protocol Violation|2|||
44166979|NCT02495857|78959944|FG000|Overall Study|Lost to Follow-up|4|||
44166980|NCT02495857|78959945|FG001|Overall Study|Lost to Follow-up|5|||
44166981|NCT02495857|78959946|FG002|Overall Study|Lost to Follow-up|3|||
44166982|NCT02495857|78959944|FG000|Overall Study|Other|3|||
44166983|NCT02495857|78959945|FG001|Overall Study|Other|3|||
44166984|NCT02495857|78959946|FG002|Overall Study|Other|2|||
44166985|NCT02495389|78959954|FG000|Overall Study|Withdrawal by Subject|40|||
44166986|NCT02495233|78959960|FG000|Overall Study|Miscellaneous|0|||
44166987|NCT02495233|78959961|FG001|Overall Study|Miscellaneous|1|||
44166988|NCT02495077|78959969|FG000|Overall Study|Adverse Event|0|||
44166989|NCT02495077|78959970|FG001|Overall Study|Adverse Event|1|||
44166990|NCT02495077|78959971|FG002|Overall Study|Adverse Event|1|||
44166991|NCT02495077|78959972|FG003|Overall Study|Adverse Event|0|||
44166992|NCT02495077|78959969|FG000|Overall Study|Death|3|||
44166993|NCT02495077|78959970|FG001|Overall Study|Death|5|||
44166994|NCT02495077|78959971|FG002|Overall Study|Death|0|||
44166995|NCT02495077|78959972|FG003|Overall Study|Death|0|||
44166996|NCT02495077|78959969|FG000|Overall Study|Lost to Follow-up|6|||
44166997|NCT02495077|78959970|FG001|Overall Study|Lost to Follow-up|4|||
44166998|NCT02495077|78959971|FG002|Overall Study|Lost to Follow-up|0|||
44166999|NCT02495077|78959972|FG003|Overall Study|Lost to Follow-up|0|||
44167000|NCT02495077|78959969|FG000|Overall Study|Physician Decision|2|||
44167001|NCT02495077|78959970|FG001|Overall Study|Physician Decision|1|||
44167002|NCT02495077|78959971|FG002|Overall Study|Physician Decision|4|||
44167003|NCT02495077|78959972|FG003|Overall Study|Physician Decision|0|||
44167004|NCT02495077|78959969|FG000|Overall Study|Protocol Violation|0|||
44167005|NCT02495077|78959970|FG001|Overall Study|Protocol Violation|1|||
44167006|NCT02495077|78959971|FG002|Overall Study|Protocol Violation|0|||
44167007|NCT02495077|78959972|FG003|Overall Study|Protocol Violation|0|||
44167008|NCT02495077|78959969|FG000|Overall Study|Screen Failure|0|||
44167009|NCT02495077|78959970|FG001|Overall Study|Screen Failure|0|||
44167010|NCT02495077|78959971|FG002|Overall Study|Screen Failure|0|||
44167011|NCT02495077|78959972|FG003|Overall Study|Screen Failure|48|||
44167012|NCT02495077|78959969|FG000|Overall Study|Withdrawal by Subject|7|||
44167013|NCT02495077|78959970|FG001|Overall Study|Withdrawal by Subject|7|||
44167014|NCT02495077|78959971|FG002|Overall Study|Withdrawal by Subject|7|||
44167015|NCT02495077|78959972|FG003|Overall Study|Withdrawal by Subject|0|||
44167016|NCT02495077|78959969|FG000|Overall Study|Covid-19 research restrictions|1|||
44167017|NCT02495077|78959970|FG001|Overall Study|Covid-19 research restrictions|0|||
44167018|NCT02495077|78959971|FG002|Overall Study|Covid-19 research restrictions|0|||
44167019|NCT02495077|78959972|FG003|Overall Study|Covid-19 research restrictions|0|||
44167020|NCT02495077|78959969|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
44167021|NCT02495077|78959970|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
44167022|NCT02495077|78959971|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
44167023|NCT02495077|78959972|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
44167024|NCT02495077|78959969|FG000|Overall Study|Incarcerated|0|||
44167025|NCT02495077|78959970|FG001|Overall Study|Incarcerated|1|||
44167026|NCT02495077|78959971|FG002|Overall Study|Incarcerated|0|||
44167027|NCT02495077|78959972|FG003|Overall Study|Incarcerated|0|||
44167028|NCT02495077|78959969|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
44167029|NCT02495077|78959970|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
44167030|NCT02495077|78959971|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
44167031|NCT02495077|78959972|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
44167032|NCT02495077|78959969|FG000|Overall Study|Timing of transplant and randomization|0|||
44167033|NCT02495077|78959970|FG001|Overall Study|Timing of transplant and randomization|0|||
44167034|NCT02495077|78959971|FG002|Overall Study|Timing of transplant and randomization|5|||
44167035|NCT02495077|78959972|FG003|Overall Study|Timing of transplant and randomization|0|||
44167036|NCT02278341|78959980|FG000|Overall Study|Randomized but never received study drug|1|||
44167037|NCT02278341|78959981|FG001|Overall Study|Randomized but never received study drug|1|||
44167038|NCT02278341|78959980|FG000|Overall Study|Adverse Event|3|||
44167039|NCT02278341|78959981|FG001|Overall Study|Adverse Event|0|||
44167040|NCT02278341|78959980|FG000|Overall Study|Death|68|||
44167041|NCT02278341|78959981|FG001|Overall Study|Death|56|||
44167042|NCT02278341|78959980|FG000|Overall Study|Withdrawal by Subject|30|||
44167043|NCT02278341|78959981|FG001|Overall Study|Withdrawal by Subject|19|||
44167044|NCT02278341|78959980|FG000|Overall Study|Lost to Follow-up|0|||
44167045|NCT02278341|78959981|FG001|Overall Study|Lost to Follow-up|1|||
44167046|NCT02278341|78959980|FG000|Overall Study|Physician Decision|1|||
44167047|NCT02278341|78959981|FG001|Overall Study|Physician Decision|1|||
44167048|NCT02278341|78959980|FG000|Overall Study|Miscellaneous|15|||
44167049|NCT02278341|78959981|FG001|Overall Study|Miscellaneous|14|||
44167050|NCT02282631|78959990|FG000|Overall Study|Lost to Follow-up|2|||
44167051|NCT02282631|78959991|FG001|Overall Study|Lost to Follow-up|0|||
44167052|NCT02278263|78960006|FG000|Overall Study|Protocol Violation|7|||
44167053|NCT02278263|78960007|FG001|Overall Study|Protocol Violation|0|||
44167054|NCT02278263|78960008|FG002|Overall Study|Protocol Violation|9|||
44167055|NCT02349789|78960019|FG000|Overall Study|Withdrawal by Subject|2|||
44167056|NCT02349711|78960025|FG000|Overall Study|Withdrawal by Subject|2|||
44167057|NCT02349711|78960026|FG001|Overall Study|Withdrawal by Subject|1|||
44167058|NCT02349711|78960025|FG000|Overall Study|Lost to Follow-up|1|||
44167059|NCT02349711|78960026|FG001|Overall Study|Lost to Follow-up|1|||
44167060|NCT02494921|78960037|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
44167061|NCT02494921|78960038|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
44167062|NCT02494921|78960039|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
44167063|NCT02494921|78960040|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
44167064|NCT02494921|78960041|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
44167065|NCT02494921|78960037|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
44167066|NCT02494921|78960038|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
44167067|NCT02494921|78960039|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
44167068|NCT02494921|78960040|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
44167069|NCT02494921|78960041|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
44167070|NCT02494921|78960037|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
44167071|NCT02494921|78960038|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
44167072|NCT02494921|78960039|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
44167073|NCT02494921|78960040|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
44167074|NCT02494921|78960041|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
44167075|NCT01653847|78960061|FG000|Overall Study|Withdrawal by Subject|1|||
44167076|NCT01653847|78960062|FG001|Overall Study|Withdrawal by Subject|0|||
44167077|NCT02493751|78960070|FG000|Overall Study|Withdrawal by Subject|2|||
44167078|NCT02493751|78960071|FG001|Overall Study|Withdrawal by Subject|8|||
44167079|NCT02493751|78960070|FG000|Overall Study|Death|6|||
44167080|NCT02493751|78960071|FG001|Overall Study|Death|13|||
44167081|NCT02493751|78960070|FG000|Overall Study|Lost to Follow-up|2|||
44167082|NCT02493751|78960071|FG001|Overall Study|Lost to Follow-up|3|||
44167083|NCT02493751|78960070|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
44167084|NCT02493751|78960071|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
44167085|NCT02493517|78960080|FG000|Overall Study|Protocol Violation|1|||
44167086|NCT02493517|78960081|FG001|Overall Study|Protocol Violation|2|||
44167087|NCT02493517|78960080|FG000|Overall Study|Withdrawal by Subject|1|||
44167088|NCT02493517|78960081|FG001|Overall Study|Withdrawal by Subject|2|||
44167089|NCT02493517|78960080|FG000|Overall Study|Adverse Event|0|||
44167090|NCT02493517|78960081|FG001|Overall Study|Adverse Event|2|||
44167091|NCT02493517|78960080|FG000|Overall Study|Missed study visit|0|||
44167092|NCT02493517|78960081|FG001|Overall Study|Missed study visit|1|||
44167093|NCT02493361|78960089|FG000|Overall Study|Withdrawal by Subject|3|||
44167094|NCT02493127|78960095|FG000|Overall Study|Lost to Follow-up|1|||
44167095|NCT02493127|78960096|FG001|Overall Study|Lost to Follow-up|1|||
44167096|NCT02478463|78960104|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
44167097|NCT02478463|78960104|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
44167098|NCT02478463|78960104|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
44167099|NCT02491411|78960110|FG000|Overall Study|Physician Decision|4|||
44167100|NCT02517463|78960116|FG000|Overall Study|Lost to Follow-up|5|||
44167101|NCT02517463|78960117|FG001|Overall Study|Lost to Follow-up|2|||
44167102|NCT02516605|78960128|FG000|Overall Study|Protocol Violation|0|||
44167103|NCT02516605|78960129|FG001|Overall Study|Protocol Violation|0|||
44167104|NCT02516605|78960130|FG002|Overall Study|Protocol Violation|0|||
44167105|NCT02516605|78960131|FG003|Overall Study|Protocol Violation|0|||
44167106|NCT02516605|78960132|FG004|Overall Study|Protocol Violation|1|||
44167107|NCT02516605|78960128|FG000|Overall Study|Withdrawal by Subject|0|||
44167108|NCT02516605|78960129|FG001|Overall Study|Withdrawal by Subject|0|||
44167109|NCT02516605|78960130|FG002|Overall Study|Withdrawal by Subject|0|||
44167110|NCT02516605|78960131|FG003|Overall Study|Withdrawal by Subject|1|||
44167111|NCT02516605|78960132|FG004|Overall Study|Withdrawal by Subject|0|||
44167112|NCT02490475|78960152|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
44167113|NCT02490475|78960153|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
44167114|NCT02490475|78960154|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
44167115|NCT02490475|78960155|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
44167116|NCT02490475|78960152|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
44167117|NCT02490475|78960153|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
44167118|NCT02490475|78960154|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
44167119|NCT02490475|78960155|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
44167120|NCT02490475|78960152|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
44167121|NCT02490475|78960153|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
44167122|NCT02490475|78960154|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
44167123|NCT02490475|78960155|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
44167124|NCT02490475|78960152|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
44167125|NCT02490475|78960153|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
44167126|NCT02490475|78960154|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
44167127|NCT02490475|78960155|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
44167128|NCT02490475|78960152|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
44167129|NCT02490475|78960153|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
44167130|NCT02490475|78960154|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
44167131|NCT02490475|78960155|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
44167132|NCT02490475|78960152|FG000|Period 2: Extension Phase|Refused Treatment|0|||
44167133|NCT02490475|78960153|FG001|Period 2: Extension Phase|Refused Treatment|0|||
44167134|NCT02490475|78960154|FG002|Period 2: Extension Phase|Refused Treatment|0|||
44167135|NCT02490475|78960155|FG003|Period 2: Extension Phase|Refused Treatment|1|||
44167136|NCT02490475|78960152|FG000|Period 2: Extension Phase|Adverse Event|0|||
44167137|NCT02490475|78960153|FG001|Period 2: Extension Phase|Adverse Event|0|||
44167138|NCT02490475|78960154|FG002|Period 2: Extension Phase|Adverse Event|1|||
44167139|NCT02490475|78960155|FG003|Period 2: Extension Phase|Adverse Event|0|||
44167140|NCT02477839|78960178|FG000|Overall Study|Adverse Event|0|||
44167141|NCT02477839|78960179|FG001|Overall Study|Adverse Event|1|||
44167142|NCT02477839|78960178|FG000|Overall Study|Protocol Violation|0|||
44167143|NCT02477839|78960179|FG001|Overall Study|Protocol Violation|2|||
44167144|NCT02477839|78960178|FG000|Overall Study|Withdrawal by Subject|3|||
44167145|NCT02477839|78960179|FG001|Overall Study|Withdrawal by Subject|3|||
44167146|NCT02477839|78960178|FG000|Overall Study|Participant had PGS during V6|0|||
44167147|NCT02477839|78960179|FG001|Overall Study|Participant had PGS during V6|1|||
44167148|NCT02477839|78960178|FG000|Overall Study|Parents decided to stop medication|0|||
44167149|NCT02477839|78960179|FG001|Overall Study|Parents decided to stop medication|1|||
44167150|NCT02477839|78960178|FG000|Overall Study|Lack of tolerability|0|||
44167151|NCT02477839|78960179|FG001|Overall Study|Lack of tolerability|1|||
44167152|NCT02477839|78960178|FG000|Overall Study|Exclusion criterion|0|||
44167153|NCT02477839|78960179|FG001|Overall Study|Exclusion criterion|1|||
44167154|NCT02489773|78960189|FG000|Overall Study|Lost to Follow-up|4|||
44167155|NCT02489773|78960190|FG001|Overall Study|Lost to Follow-up|1|||
44167156|NCT02489773|78960189|FG000|Overall Study|Physician Decision|1|||
44167157|NCT02489773|78960190|FG001|Overall Study|Physician Decision|0|||
44167158|NCT02489773|78960189|FG000|Overall Study|Withdrawal by Subject|1|||
44167159|NCT02489773|78960190|FG001|Overall Study|Withdrawal by Subject|0|||
44167160|NCT02489773|78960189|FG000|Overall Study|Leave the country or the state|1|||
44167161|NCT02489773|78960190|FG001|Overall Study|Leave the country or the state|1|||
44167162|NCT02488915|78960196|FG000|Overall Study|Death|21|||
44167163|NCT02488915|78960196|FG000|Overall Study|Lost to Follow-up|4|||
44167164|NCT02488915|78960196|FG000|Overall Study|Withdrawal by Subject|1|||
44167165|NCT02488681|78960200|FG000|Overall Study|Implant unsuccessful|7|||
44167166|NCT02477605|78960206|FG000|Overall Study|Discontinued prior to treatment|1|||
44167167|NCT02477605|78960207|FG001|Overall Study|Discontinued prior to treatment|0|||
44167168|NCT02477605|78960206|FG000|Overall Study|Lost to Follow-up|0|||
44167169|NCT02477605|78960207|FG001|Overall Study|Lost to Follow-up|2|||
44167170|NCT02477605|78960206|FG000|Overall Study|Withdrawal by Subject|0|||
44167171|NCT02477605|78960207|FG001|Overall Study|Withdrawal by Subject|1|||
44167172|NCT02477605|78960206|FG000|Overall Study|Administered gas during surgery|0|||
44167173|NCT02477605|78960207|FG001|Overall Study|Administered gas during surgery|1|||
44167174|NCT02477527|78960217|FG000|Overall Study|Lost to Follow-up|2|||
44167175|NCT02477527|78960217|FG000|Overall Study|Withdrawal by Subject|1|||
44167176|NCT02477527|78960217|FG000|Overall Study|Screen Failure|3|||
44167177|NCT02477215|78960225|FG000|Dose Escalation Phase|Physician Decision|1|||
44167178|NCT02477215|78960226|FG001|Dose Escalation Phase|Physician Decision|2|||
44167179|NCT02477215|78960227|FG002|Dose Escalation Phase|Physician Decision|0|||
44167180|NCT02477215|78960225|FG000|Fixed Dose Phase|Physician Decision|0|||
44167181|NCT02477215|78960226|FG001|Fixed Dose Phase|Physician Decision|7|||
44167182|NCT02477215|78960227|FG002|Fixed Dose Phase|Physician Decision|0|||
44167183|NCT02487199|78960240|FG000|Overall Study|Withdrew Consent|0|||
44167184|NCT02487199|78960241|FG001|Overall Study|Withdrew Consent|1|||
44167185|NCT02475733|78960249|FG000|Overall Study|Withdrawal by Subject|1|||
44167186|NCT02475733|78960250|FG001|Overall Study|Withdrawal by Subject|0|||
44167187|NCT02475733|78960249|FG000|Overall Study|Physician Decision|1|||
44167188|NCT02475733|78960250|FG001|Overall Study|Physician Decision|0|||
44167189|NCT02486653|78960258|FG000|Overall Study|Withdrawal by Subject|1|||
44167190|NCT02486653|78960259|FG001|Overall Study|Withdrawal by Subject|3|||
44167191|NCT02486653|78960258|FG000|Overall Study|Protocol Violation|1|||
44167192|NCT02486653|78960259|FG001|Overall Study|Protocol Violation|0|||
44167193|NCT02486653|78960258|FG000|Overall Study|surgery cancelled|4|||
44167194|NCT02486653|78960259|FG001|Overall Study|surgery cancelled|1|||
44167195|NCT02475655|78960267|FG000|Overall Study|Lost to Follow-up|0|||
44167196|NCT02475655|78960268|FG001|Overall Study|Lost to Follow-up|1|||
44167197|NCT02475265|78960274|FG000|Overall Study|Physician Decision|1|||
44167198|NCT02475265|78960274|FG000|Overall Study|Withdrawal by Subject|2|||
44167199|NCT02485717|78960281|FG000|Overall Study|Lost to Follow-up|6|||
44167200|NCT02485717|78960282|FG001|Overall Study|Lost to Follow-up|0|||
44167201|NCT02485717|78960283|FG002|Overall Study|Lost to Follow-up|0|||
44167202|NCT02485717|78960281|FG000|Overall Study|Withdrawal by Subject|0|||
44167203|NCT02485717|78960282|FG001|Overall Study|Withdrawal by Subject|0|||
44167204|NCT02485717|78960283|FG002|Overall Study|Withdrawal by Subject|1|||
44167205|NCT02485717|78960281|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
44167206|NCT02485717|78960282|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
44167207|NCT02485717|78960283|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
44167208|NCT02485717|78960281|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
44167209|NCT02485717|78960282|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
44167210|NCT02485717|78960283|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
44167211|NCT02451007|78960291|FG000|Overall Study|Withdrawal by Subject|4|||
44167212|NCT02451007|78960291|FG000|Overall Study|Adverse Event|1|||
44167213|NCT02451007|78960291|FG000|Overall Study|Disease Progression|2|||
44167214|NCT02485483|78960297|FG000|Overall Study|Depression at baseline|15|||
44167215|NCT02485483|78960298|FG001|Overall Study|Depression at baseline|0|||
44167216|NCT02485483|78960297|FG000|Overall Study|Discontinued after baseline|39|||
44167217|NCT02485483|78960298|FG001|Overall Study|Discontinued after baseline|0|||
44167218|NCT02473471|78960304|FG000|Overall Study|poor oral hygiene|2|||
44167219|NCT02473471|78960304|FG000|Overall Study|Lost to Follow-up|1|||
44167220|NCT02450539|78960316|FG000|Overall Study|Withdrawal by Subject|12|||
44167221|NCT02450539|78960317|FG001|Overall Study|Withdrawal by Subject|6|||
44167222|NCT02450539|78960316|FG000|Overall Study|Lost to Follow-up|4|||
44167223|NCT02450539|78960317|FG001|Overall Study|Lost to Follow-up|1|||
44167224|NCT02449915|78960328|FG000|Overall Study|Exclusion criteria - drug use|1|||
44167225|NCT02449915|78960329|FG001|Overall Study|Exclusion criteria - drug use|0|||
44167226|NCT02449915|78960328|FG000|Overall Study|Withdrawal by Subject|0|||
44167227|NCT02449915|78960329|FG001|Overall Study|Withdrawal by Subject|2|||
44167228|NCT02449915|78960328|FG000|Overall Study|Intraoperative surgical findings|1|||
44167229|NCT02449915|78960329|FG001|Overall Study|Intraoperative surgical findings|1|||
44167230|NCT02449915|78960328|FG000|Overall Study|Abnormal preop lab|0|||
44167231|NCT02449915|78960329|FG001|Overall Study|Abnormal preop lab|1|||
44167232|NCT02420119|78960335|FG000|Overall Study|insufficient laboratory data|5|||
44167233|NCT02473393|78960343|FG000|Overall Study|Adverse Event|0|||
44167234|NCT02473393|78960344|FG001|Overall Study|Adverse Event|0|||
44167235|NCT02473393|78960345|FG002|Overall Study|Adverse Event|1|||
44167236|NCT02473393|78960346|FG003|Overall Study|Adverse Event|0|||
44167237|NCT02473393|78960343|FG000|Overall Study|Withdrawal by Subject|0|||
44167238|NCT02473393|78960344|FG001|Overall Study|Withdrawal by Subject|0|||
44167239|NCT02473393|78960345|FG002|Overall Study|Withdrawal by Subject|1|||
44167240|NCT02473393|78960346|FG003|Overall Study|Withdrawal by Subject|1|||
44167241|NCT02419573|78960358|FG000|Overall Study|Lost to Follow-up|3|||
44167242|NCT02419573|78960359|FG001|Overall Study|Lost to Follow-up|0|||
44167243|NCT02419573|78960358|FG000|Overall Study|Withdrawal by Subject|1|||
44167244|NCT02419573|78960359|FG001|Overall Study|Withdrawal by Subject|0|||
44167245|NCT02472847|78960367|FG000|Overall Study|Withdrawal by Subject|1|||
44167246|NCT02472847|78960368|FG001|Overall Study|Withdrawal by Subject|5|||
44167247|NCT02472145|78960377|FG000|Overall Study|Death|10|||
44167248|NCT02472145|78960378|FG001|Overall Study|Death|101|||
44167249|NCT02472145|78960379|FG002|Overall Study|Death|99|||
44167250|NCT02472145|78960377|FG000|Overall Study|Lost to Follow-up|0|||
44167251|NCT02472145|78960378|FG001|Overall Study|Lost to Follow-up|1|||
44167252|NCT02472145|78960379|FG002|Overall Study|Lost to Follow-up|0|||
44167253|NCT02472145|78960377|FG000|Overall Study|Withdrawal by Subject|0|||
44167254|NCT02472145|78960378|FG001|Overall Study|Withdrawal by Subject|9|||
44167255|NCT02472145|78960379|FG002|Overall Study|Withdrawal by Subject|13|||
44167256|NCT02472145|78960377|FG000|Overall Study|Sponsor decision|0|||
44167257|NCT02472145|78960378|FG001|Overall Study|Sponsor decision|3|||
44167258|NCT02472145|78960379|FG002|Overall Study|Sponsor decision|2|||
44167259|NCT02472145|78960377|FG000|Overall Study|Other|0|||
44167260|NCT02472145|78960378|FG001|Overall Study|Other|45|||
44167261|NCT02472145|78960379|FG002|Overall Study|Other|43|||
44167262|NCT02448043|78960388|FG000|Overall Study|Withdrawal by Subject|2|||
44354017|NCT01233284|79358368|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44167263|NCT02448043|78960389|FG001|Overall Study|Withdrawal by Subject|2|||
44167264|NCT02448043|78960388|FG000|Overall Study|Protocol Violation|1|||
44167265|NCT02448043|78960389|FG001|Overall Study|Protocol Violation|2|||
44167266|NCT02447887|78960398|FG000|Overall Study|Study was terminated|3|||
44167267|NCT02471755|78960404|FG000|Overall Study|Withdrawal by Subject|1|||
44167268|NCT02471755|78960405|FG001|Overall Study|Withdrawal by Subject|0|||
44167269|NCT02471755|78960404|FG000|Overall Study|Lost to Follow-up|0|||
44167270|NCT02471755|78960405|FG001|Overall Study|Lost to Follow-up|1|||
44167271|NCT02470429|78960413|FG000|Overall Study|Adverse Event|1|||
44167272|NCT02470429|78960414|FG001|Overall Study|Adverse Event|0|||
44167273|NCT02470429|78960413|FG000|Overall Study|Withdrawal by Subject|1|||
44167274|NCT02470429|78960414|FG001|Overall Study|Withdrawal by Subject|0|||
44167275|NCT02447497|78960425|FG000|Overall Study|Did not meet treatment day baseline.|6|||
44167276|NCT02447497|78960426|FG001|Overall Study|Did not meet treatment day baseline.|5|||
44167277|NCT02447497|78960427|FG002|Overall Study|Did not meet treatment day baseline.|2|||
44167278|NCT02447497|78960428|FG003|Overall Study|Did not meet treatment day baseline.|2|||
44167279|NCT02447497|78960425|FG000|Overall Study|Dressing was compromised|0|||
44167280|NCT02447497|78960426|FG001|Overall Study|Dressing was compromised|1|||
44167281|NCT02447497|78960427|FG002|Overall Study|Dressing was compromised|0|||
44167282|NCT02447497|78960428|FG003|Overall Study|Dressing was compromised|0|||
44167283|NCT02417935|78960448|FG000|Treatment Period|Adverse Event|12|||
44167284|NCT02417935|78960449|FG001|Treatment Period|Adverse Event|10|||
44167285|NCT02417935|78960448|FG000|Treatment Period|Lost to Follow-up|1|||
44167286|NCT02417935|78960449|FG001|Treatment Period|Lost to Follow-up|0|||
44167287|NCT02417935|78960448|FG000|Treatment Period|Entry Criteria not met|0|||
44167288|NCT02417935|78960449|FG001|Treatment Period|Entry Criteria not met|1|||
44167289|NCT02417935|78960448|FG000|Treatment Period|Protocol Violation|2|||
44167290|NCT02417935|78960449|FG001|Treatment Period|Protocol Violation|1|||
44167291|NCT02417935|78960448|FG000|Treatment Period|Withdrawal by Subject|3|||
44167292|NCT02417935|78960449|FG001|Treatment Period|Withdrawal by Subject|3|||
44167293|NCT02417935|78960448|FG000|Treatment Period|Physician Decision|3|||
44167294|NCT02417935|78960449|FG001|Treatment Period|Physician Decision|1|||
44167295|NCT02417233|78960458|FG000|Overall Study|Death|4|||
44167296|NCT02417233|78960459|FG001|Overall Study|Death|10|||
44167297|NCT02417233|78960460|FG002|Overall Study|Death|14|||
44167298|NCT02417233|78960458|FG000|Overall Study|Lost to Follow-up|27|||
44167299|NCT02417233|78960459|FG001|Overall Study|Lost to Follow-up|39|||
44167300|NCT02417233|78960460|FG002|Overall Study|Lost to Follow-up|34|||
44167301|NCT02417233|78960458|FG000|Overall Study|Protocol Violation|2|||
44167302|NCT02417233|78960459|FG001|Overall Study|Protocol Violation|0|||
44167303|NCT02417233|78960460|FG002|Overall Study|Protocol Violation|2|||
44167304|NCT02417233|78960458|FG000|Overall Study|Withdrawal by Subject|2|||
44167305|NCT02417233|78960459|FG001|Overall Study|Withdrawal by Subject|1|||
44167306|NCT02417233|78960460|FG002|Overall Study|Withdrawal by Subject|8|||
44167307|NCT02417233|78960458|FG000|Overall Study|Relocation out of study area|1|||
44167308|NCT02417233|78960459|FG001|Overall Study|Relocation out of study area|0|||
44167309|NCT02417233|78960460|FG002|Overall Study|Relocation out of study area|1|||
44167310|NCT02417233|78960458|FG000|Overall Study|Mentally unstable|0|||
44167311|NCT02417233|78960459|FG001|Overall Study|Mentally unstable|1|||
44167312|NCT02417233|78960460|FG002|Overall Study|Mentally unstable|0|||
44167313|NCT02416453|78960480|FG000|Overall Study|Adverse Event|0|||
44167314|NCT02416453|78960481|FG001|Overall Study|Adverse Event|0|||
44167315|NCT02416453|78960482|FG002|Overall Study|Adverse Event|0|||
44167316|NCT02416453|78960483|FG003|Overall Study|Adverse Event|2|||
44167317|NCT02416453|78960484|FG004|Overall Study|Adverse Event|0|||
44167318|NCT02416453|78960485|FG005|Overall Study|Adverse Event|1|||
44167319|NCT02416453|78960486|FG006|Overall Study|Adverse Event|0|||
44167320|NCT02416453|78960487|FG007|Overall Study|Adverse Event|0|||
44167321|NCT02416453|78960488|FG008|Overall Study|Adverse Event|0|||
44167322|NCT02416453|78960489|FG009|Overall Study|Adverse Event|0|||
44167323|NCT02416453|78960490|FG010|Overall Study|Adverse Event|0|||
44167324|NCT02416453|78960480|FG000|Overall Study|Lost to Follow-up|1|||
44167325|NCT02416453|78960481|FG001|Overall Study|Lost to Follow-up|3|||
44167326|NCT02416453|78960482|FG002|Overall Study|Lost to Follow-up|0|||
44167327|NCT02416453|78960483|FG003|Overall Study|Lost to Follow-up|8|||
44167328|NCT02416453|78960484|FG004|Overall Study|Lost to Follow-up|0|||
44167329|NCT02416453|78960485|FG005|Overall Study|Lost to Follow-up|5|||
44167330|NCT02416453|78960486|FG006|Overall Study|Lost to Follow-up|1|||
44167331|NCT02416453|78960487|FG007|Overall Study|Lost to Follow-up|3|||
44167332|NCT02416453|78960488|FG008|Overall Study|Lost to Follow-up|1|||
44167333|NCT02416453|78960489|FG009|Overall Study|Lost to Follow-up|0|||
44167334|NCT02416453|78960490|FG010|Overall Study|Lost to Follow-up|0|||
44167335|NCT02416453|78960480|FG000|Overall Study|Physician Decision|0|||
44167336|NCT02416453|78960481|FG001|Overall Study|Physician Decision|0|||
44167337|NCT02416453|78960482|FG002|Overall Study|Physician Decision|0|||
44167338|NCT02416453|78960483|FG003|Overall Study|Physician Decision|0|||
44167339|NCT02416453|78960484|FG004|Overall Study|Physician Decision|0|||
44167340|NCT02416453|78960485|FG005|Overall Study|Physician Decision|1|||
44167341|NCT02416453|78960486|FG006|Overall Study|Physician Decision|1|||
44167342|NCT02416453|78960487|FG007|Overall Study|Physician Decision|1|||
44167343|NCT02416453|78960488|FG008|Overall Study|Physician Decision|0|||
44167344|NCT02416453|78960489|FG009|Overall Study|Physician Decision|0|||
44167345|NCT02416453|78960490|FG010|Overall Study|Physician Decision|0|||
44167346|NCT02416453|78960480|FG000|Overall Study|Withdrawal by Subject|2|||
44541587|NCT04318093|79554141|FG000|Overall Study|Participant withdrew consent|1|||
44167347|NCT02416453|78960481|FG001|Overall Study|Withdrawal by Subject|0|||
44167348|NCT02416453|78960482|FG002|Overall Study|Withdrawal by Subject|0|||
44167349|NCT02416453|78960483|FG003|Overall Study|Withdrawal by Subject|5|||
44167350|NCT02416453|78960484|FG004|Overall Study|Withdrawal by Subject|1|||
44167351|NCT02416453|78960485|FG005|Overall Study|Withdrawal by Subject|8|||
44167352|NCT02416453|78960486|FG006|Overall Study|Withdrawal by Subject|0|||
44167353|NCT02416453|78960487|FG007|Overall Study|Withdrawal by Subject|8|||
44167354|NCT02416453|78960488|FG008|Overall Study|Withdrawal by Subject|4|||
44167355|NCT02416453|78960489|FG009|Overall Study|Withdrawal by Subject|0|||
44167356|NCT02416453|78960490|FG010|Overall Study|Withdrawal by Subject|0|||
44167357|NCT02416453|78960480|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167358|NCT02416453|78960481|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167359|NCT02416453|78960482|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
44167360|NCT02416453|78960483|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167361|NCT02416453|78960484|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167362|NCT02416453|78960485|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167363|NCT02416453|78960486|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167364|NCT02416453|78960487|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167365|NCT02416453|78960488|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167366|NCT02416453|78960489|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167367|NCT02416453|78960490|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
44167368|NCT02416453|78960480|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167369|NCT02416453|78960481|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167370|NCT02416453|78960482|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167371|NCT02416453|78960483|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167372|NCT02416453|78960484|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167373|NCT02416453|78960485|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
44167374|NCT02416453|78960486|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167375|NCT02416453|78960487|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167376|NCT02416453|78960488|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167377|NCT02416453|78960489|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167378|NCT02416453|78960490|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
44167379|NCT02469961|78960522|FG000|Overall Study|Physician Decision|4|||
44167380|NCT02469961|78960523|FG001|Overall Study|Physician Decision|1|||
44167381|NCT02415595|78960538|FG000|Overall Study|Administrative reason by sponsor|39|||
44167382|NCT02415595|78960539|FG001|Overall Study|Administrative reason by sponsor|40|||
44167383|NCT02415595|78960540|FG002|Overall Study|Administrative reason by sponsor|41|||
44167384|NCT02415595|78960541|FG003|Overall Study|Administrative reason by sponsor|39|||
44167385|NCT02415595|78960538|FG000|Overall Study|Adverse Event|1|||
44167386|NCT02415595|78960539|FG001|Overall Study|Adverse Event|3|||
44167387|NCT02415595|78960540|FG002|Overall Study|Adverse Event|5|||
44167388|NCT02415595|78960541|FG003|Overall Study|Adverse Event|10|||
44167389|NCT02415595|78960538|FG000|Overall Study|Lack of Efficacy|4|||
44167390|NCT02415595|78960539|FG001|Overall Study|Lack of Efficacy|4|||
44167391|NCT02415595|78960540|FG002|Overall Study|Lack of Efficacy|0|||
44167392|NCT02415595|78960541|FG003|Overall Study|Lack of Efficacy|0|||
44167393|NCT02415595|78960538|FG000|Overall Study|Lost to Follow-up|1|||
44167394|NCT02415595|78960539|FG001|Overall Study|Lost to Follow-up|3|||
44167395|NCT02415595|78960540|FG002|Overall Study|Lost to Follow-up|1|||
44167396|NCT02415595|78960541|FG003|Overall Study|Lost to Follow-up|1|||
44167397|NCT02415595|78960538|FG000|Overall Study|Poor/Non-compliance|1|||
44167398|NCT02415595|78960539|FG001|Overall Study|Poor/Non-compliance|0|||
44167399|NCT02415595|78960540|FG002|Overall Study|Poor/Non-compliance|1|||
44167400|NCT02415595|78960541|FG003|Overall Study|Poor/Non-compliance|0|||
44167401|NCT02415595|78960538|FG000|Overall Study|Reached stopping criteria|0|||
44167402|NCT02415595|78960539|FG001|Overall Study|Reached stopping criteria|1|||
44167403|NCT02415595|78960540|FG002|Overall Study|Reached stopping criteria|1|||
44167404|NCT02415595|78960541|FG003|Overall Study|Reached stopping criteria|0|||
44167405|NCT02415595|78960538|FG000|Overall Study|Withdrawal by Subject|4|||
44167406|NCT02415595|78960539|FG001|Overall Study|Withdrawal by Subject|0|||
44167407|NCT02415595|78960540|FG002|Overall Study|Withdrawal by Subject|1|||
44167408|NCT02415595|78960541|FG003|Overall Study|Withdrawal by Subject|3|||
44167409|NCT02415595|78960538|FG000|Overall Study|Other|0|||
44167410|NCT02415595|78960539|FG001|Overall Study|Other|1|||
44167411|NCT02415595|78960540|FG002|Overall Study|Other|1|||
44167412|NCT02415595|78960541|FG003|Overall Study|Other|0|||
44167413|NCT02446717|78960557|FG000|Overall Study|Adverse Event|0|||
44167414|NCT02446717|78960558|FG001|Overall Study|Adverse Event|0|||
44167415|NCT02446717|78960559|FG002|Overall Study|Adverse Event|1|||
44167416|NCT02446717|78960560|FG003|Overall Study|Adverse Event|0|||
44167417|NCT02446717|78960561|FG004|Overall Study|Adverse Event|0|||
44167418|NCT02446717|78960557|FG000|Overall Study|Lost to Follow-up|0|||
44167419|NCT02446717|78960558|FG001|Overall Study|Lost to Follow-up|1|||
44167420|NCT02446717|78960559|FG002|Overall Study|Lost to Follow-up|1|||
44167421|NCT02446717|78960560|FG003|Overall Study|Lost to Follow-up|0|||
44167422|NCT02446717|78960561|FG004|Overall Study|Lost to Follow-up|1|||
44167423|NCT02446717|78960557|FG000|Overall Study|Withdrew consent|0|||
44167424|NCT02446717|78960558|FG001|Overall Study|Withdrew consent|0|||
44167425|NCT02446717|78960559|FG002|Overall Study|Withdrew consent|0|||
44167426|NCT02446717|78960560|FG003|Overall Study|Withdrew consent|1|||
44167427|NCT02446717|78960561|FG004|Overall Study|Withdrew consent|0|||
44167428|NCT02469415|78960573|FG000|Overall Study|Withdrawal by Subject|1|||
44167429|NCT02469415|78960573|FG000|Overall Study|Investigational agent placed on hold|2|||
44167430|NCT02446171|78960581|FG000|Overall Study|Withdrawal by Subject|0|||
44167431|NCT02446171|78960582|FG001|Overall Study|Withdrawal by Subject|0|||
44167432|NCT02446171|78960583|FG002|Overall Study|Withdrawal by Subject|2|||
44167433|NCT02446171|78960584|FG003|Overall Study|Withdrawal by Subject|0|||
44167434|NCT02446015|78960598|FG000|Overall Study|Adverse Event|0|||
44167435|NCT02446015|78960599|FG001|Overall Study|Adverse Event|1|||
44167436|NCT02446015|78960598|FG000|Overall Study|Withdrawal by Subject|1|||
44167437|NCT02446015|78960599|FG001|Overall Study|Withdrawal by Subject|0|||
44167438|NCT02415127|78960608|FG000|Overall Study|Adverse Event|1|||
44167439|NCT02415127|78960609|FG001|Overall Study|Adverse Event|0|||
44167440|NCT02468557|78960615|FG000|Overall Study|Adverse Event|1|||
44167441|NCT02468557|78960615|FG000|Overall Study|Death|1|||
44167442|NCT02468557|78960615|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
44167443|NCT02468557|78960615|FG000|Overall Study|All Enrolled but Never Dosed|4|||
44167444|NCT02413489|78960626|FG000|Overall Study|Death|11|||
44167445|NCT02413489|78960627|FG001|Overall Study|Death|3|||
44167446|NCT02413489|78960628|FG002|Overall Study|Death|4|||
44167447|NCT02413489|78960626|FG000|Overall Study|Withdrawal by Subject|2|||
44167448|NCT02413489|78960627|FG001|Overall Study|Withdrawal by Subject|0|||
44167449|NCT02413489|78960628|FG002|Overall Study|Withdrawal by Subject|0|||
44167450|NCT02413489|78960626|FG000|Overall Study|Study Terminated By Sponsor|2|||
44167451|NCT02413489|78960627|FG001|Overall Study|Study Terminated By Sponsor|13|||
44167452|NCT02413489|78960628|FG002|Overall Study|Study Terminated By Sponsor|1|||
44167453|NCT02413333|78960640|FG000|Period 1|Adverse Event|1|||
44167454|NCT02413333|78960641|FG001|Period 1|Adverse Event|0|||
44167455|NCT02413333|78960640|FG000|Period 1|Reason Not Specified|0|||
44167456|NCT02413333|78960641|FG001|Period 1|Reason Not Specified|1|||
44167457|NCT02413333|78960640|FG000|Period 2|Protocol Deviation|1|||
44167458|NCT02413333|78960641|FG001|Period 2|Protocol Deviation|0|||
44167459|NCT02413255|78960664|FG000|Overall Study|Voluntary Withdrawal|0|||
44167460|NCT02413255|78960665|FG001|Overall Study|Voluntary Withdrawal|0|||
44167461|NCT02413255|78960666|FG002|Overall Study|Voluntary Withdrawal|0|||
44167462|NCT02413255|78960667|FG003|Overall Study|Voluntary Withdrawal|0|||
44167463|NCT02413255|78960668|FG004|Overall Study|Voluntary Withdrawal|0|||
44167464|NCT02413255|78960669|FG005|Overall Study|Voluntary Withdrawal|0|||
44167465|NCT02413255|78960670|FG006|Overall Study|Voluntary Withdrawal|0|||
44167466|NCT02413255|78960671|FG007|Overall Study|Voluntary Withdrawal|0|||
44167467|NCT02413255|78960672|FG008|Overall Study|Voluntary Withdrawal|0|||
44167468|NCT02413255|78960673|FG009|Overall Study|Voluntary Withdrawal|0|||
44167469|NCT02413255|78960674|FG010|Overall Study|Voluntary Withdrawal|0|||
44167470|NCT02413255|78960675|FG011|Overall Study|Voluntary Withdrawal|0|||
44167471|NCT02413255|78960676|FG012|Overall Study|Voluntary Withdrawal|0|||
44167472|NCT02413255|78960677|FG013|Overall Study|Voluntary Withdrawal|0|||
44167473|NCT02413255|78960678|FG014|Overall Study|Voluntary Withdrawal|1|||
44167474|NCT02413255|78960679|FG015|Overall Study|Voluntary Withdrawal|0|||
44167475|NCT02413255|78960680|FG016|Overall Study|Voluntary Withdrawal|0|||
44167476|NCT02444533|78960733|FG000|Overall Study|Not able to complete forms|0|||
44167477|NCT02444533|78960734|FG001|Overall Study|Not able to complete forms|2|||
44167478|NCT02444533|78960733|FG000|Overall Study|Only gave post-procedure complications|2|||
44167479|NCT02444533|78960734|FG001|Overall Study|Only gave post-procedure complications|2|||
44167480|NCT01651039|78960740|FG000|Overall Study|Non-evaluables|5|||
44167481|NCT01651039|78960740|FG000|Overall Study|Physician Decision|2|||
44167482|NCT01651039|78960740|FG000|Overall Study|Withdrawal by Subject|1|||
44167483|NCT01651039|78960740|FG000|Overall Study|Progressive Disease|22|||
44354018|NCT01233284|79358369|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44354019|NCT01233284|79358370|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
44354020|NCT01233284|79358371|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44354021|NCT01233284|79358372|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
44354022|NCT01233284|79358368|FG000|Period 3 (4 Weeks)|Other|0|||
44354023|NCT01233284|79358369|FG001|Period 3 (4 Weeks)|Other|0|||
44354024|NCT01233284|79358370|FG002|Period 3 (4 Weeks)|Other|0|||
44354025|NCT01233284|79358371|FG003|Period 3 (4 Weeks)|Other|1|||
44354026|NCT01233284|79358372|FG004|Period 3 (4 Weeks)|Other|0|||
44354027|NCT01233284|79358368|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
44167484|NCT02349633|78960758|FG000|Overall Study|Death|0|||
44167485|NCT02349633|78960759|FG001|Overall Study|Death|1|||
44167486|NCT02349633|78960760|FG002|Overall Study|Death|0|||
44167487|NCT02349633|78960761|FG003|Overall Study|Death|0|||
44167488|NCT02349633|78960762|FG004|Overall Study|Death|0|||
44167489|NCT02349633|78960763|FG005|Overall Study|Death|1|||
44167490|NCT02349633|78960764|FG006|Overall Study|Death|1|||
44167491|NCT02349633|78960765|FG007|Overall Study|Death|1|||
44354028|NCT01233284|79358369|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
44354029|NCT01233284|79358370|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
44354030|NCT01233284|79358371|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
44354031|NCT01233284|79358372|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
44354032|NCT01233284|79358368|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
44354033|NCT01233284|79358369|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
44354034|NCT01233284|79358370|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
44354035|NCT01233284|79358371|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
44354036|NCT01233284|79358372|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
44354037|NCT00948688|79358382|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
44354038|NCT00948688|79358383|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
44354039|NCT00948688|79358382|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
44354040|NCT00948688|79358383|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
44354041|NCT00948688|79358382|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
44354042|NCT00948688|79358383|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
44354043|NCT01233050|79358392|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
44354044|NCT01233050|79358393|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
44354045|NCT01232894|79358401|FG000|Overall Study|Lost to Follow-up|0|||
44354046|NCT01232894|79358402|FG001|Overall Study|Lost to Follow-up|1|||
44354047|NCT01232894|79358401|FG000|Overall Study|Death|1|||
44354048|NCT01232894|79358402|FG001|Overall Study|Death|0|||
44354049|NCT01232894|79358401|FG000|Overall Study|Protocol Violation|1|||
44354050|NCT01232894|79358402|FG001|Overall Study|Protocol Violation|1|||
44354051|NCT01232894|79358401|FG000|Overall Study|Withdrawal by Subject|8|||
44354052|NCT01232894|79358402|FG001|Overall Study|Withdrawal by Subject|5|||
44354053|NCT01232894|79358401|FG000|Overall Study|Physician Decision|2|||
44354054|NCT01232894|79358402|FG001|Overall Study|Physician Decision|1|||
44354055|NCT01049217|79358410|FG000|Overall Study|Adverse Event|2|||
44354056|NCT01049217|79358411|FG001|Overall Study|Adverse Event|1|||
44354057|NCT01049217|79358410|FG000|Overall Study|Lack of Efficacy|1|||
44354058|NCT01049217|79358411|FG001|Overall Study|Lack of Efficacy|1|||
44354059|NCT01049217|79358410|FG000|Overall Study|Lost to Follow-up|3|||
44354060|NCT01049217|79358411|FG001|Overall Study|Lost to Follow-up|8|||
44354061|NCT01049217|79358410|FG000|Overall Study|Withdrawal by Subject|4|||
44354062|NCT01049217|79358411|FG001|Overall Study|Withdrawal by Subject|3|||
44354063|NCT01049217|79358410|FG000|Overall Study|Protocol Violation|1|||
44354064|NCT01049217|79358411|FG001|Overall Study|Protocol Violation|3|||
44354065|NCT01049217|79358410|FG000|Overall Study|Pregnancy|1|||
44354066|NCT01049217|79358411|FG001|Overall Study|Pregnancy|0|||
44354067|NCT01049217|79358410|FG000|Overall Study|Study Terminated by Sponsor|43|||
44354068|NCT01049217|79358411|FG001|Overall Study|Study Terminated by Sponsor|43|||
44354069|NCT01049217|79358410|FG000|Overall Study|Other|1|||
44354070|NCT01049217|79358411|FG001|Overall Study|Other|2|||
44354071|NCT01049217|79358410|FG000|Overall Study|Randomized but not Treated|0|||
44354072|NCT01049217|79358411|FG001|Overall Study|Randomized but not Treated|2|||
44354073|NCT01232738|79358417|FG000|Overall Study|Death|3|||
44354074|NCT01232738|79358417|FG000|Overall Study|Physician Decision|2|||
44354075|NCT01232738|79358417|FG000|Overall Study|Lost to Follow-up|1|||
44354076|NCT01232738|79358417|FG000|Overall Study|Withdrawal by Subject|2|||
44354077|NCT01232738|79358417|FG000|Overall Study|Adverse Event|5|||
44354078|NCT00957268|79358430|FG000|Overall Study|Voluntary Withdrawal|0|||
44354079|NCT00957268|79358431|FG001|Overall Study|Voluntary Withdrawal|0|||
44354080|NCT00957268|79358432|FG002|Overall Study|Voluntary Withdrawal|1|||
44354081|NCT00957268|79358433|FG003|Overall Study|Voluntary Withdrawal|0|||
44354082|NCT00957268|79358434|FG004|Overall Study|Voluntary Withdrawal|0|||
44354083|NCT01230788|79358446|FG000|Overall Study|Prescribed exclusion drug|1|||
44354084|NCT01230710|79358450|FG000|Overall Study|Disease Progression|41|||
44354085|NCT01230710|79358450|FG000|Overall Study|Lost to Follow-up|3|||
44354086|NCT01230710|79358450|FG000|Overall Study|Death|4|||
44354087|NCT01230710|79358450|FG000|Overall Study|Withdrawal of Consent|1|||
44354088|NCT01230554|79358454|FG000|Overall Study|Lost to Follow-up|2|||
44354089|NCT01230554|79358454|FG000|Overall Study|Inability to maintain visit schedule|1|||
44354090|NCT01040793|79358458|FG000|Overall Study|Adverse Event|5|||
44354091|NCT01040793|79358459|FG001|Overall Study|Adverse Event|3|||
44354092|NCT01040793|79358460|FG002|Overall Study|Adverse Event|0|||
44354093|NCT01040793|79358461|FG003|Overall Study|Adverse Event|2|||
44354094|NCT01040793|79358462|FG004|Overall Study|Adverse Event|2|||
44354095|NCT01040793|79358463|FG005|Overall Study|Adverse Event|1|||
44354096|NCT01040793|79358458|FG000|Overall Study|Protocol Violation|1|||
44354097|NCT01040793|79358459|FG001|Overall Study|Protocol Violation|1|||
44354098|NCT01040793|79358460|FG002|Overall Study|Protocol Violation|1|||
44354099|NCT01040793|79358461|FG003|Overall Study|Protocol Violation|0|||
44354100|NCT01040793|79358462|FG004|Overall Study|Protocol Violation|1|||
44354101|NCT01040793|79358463|FG005|Overall Study|Protocol Violation|0|||
44354102|NCT01040793|79358458|FG000|Overall Study|Lost to Follow-up|0|||
44354103|NCT01040793|79358459|FG001|Overall Study|Lost to Follow-up|1|||
44354104|NCT01040793|79358460|FG002|Overall Study|Lost to Follow-up|1|||
44354105|NCT01040793|79358461|FG003|Overall Study|Lost to Follow-up|0|||
44354106|NCT01040793|79358462|FG004|Overall Study|Lost to Follow-up|0|||
44354107|NCT01040793|79358463|FG005|Overall Study|Lost to Follow-up|0|||
44354108|NCT01040793|79358458|FG000|Overall Study|Withdrawal by Subject|0|||
44354109|NCT01040793|79358459|FG001|Overall Study|Withdrawal by Subject|0|||
44354110|NCT01040793|79358460|FG002|Overall Study|Withdrawal by Subject|0|||
44354111|NCT01040793|79358461|FG003|Overall Study|Withdrawal by Subject|2|||
44354112|NCT01040793|79358462|FG004|Overall Study|Withdrawal by Subject|0|||
44354113|NCT01040793|79358463|FG005|Overall Study|Withdrawal by Subject|0|||
44354114|NCT01040793|79358458|FG000|Overall Study|Other reasons not listed above|0|||
44354115|NCT01040793|79358459|FG001|Overall Study|Other reasons not listed above|0|||
44354116|NCT01040793|79358460|FG002|Overall Study|Other reasons not listed above|1|||
44354117|NCT01040793|79358461|FG003|Overall Study|Other reasons not listed above|0|||
44354118|NCT01040793|79358462|FG004|Overall Study|Other reasons not listed above|1|||
44354119|NCT01040793|79358463|FG005|Overall Study|Other reasons not listed above|0|||
44354120|NCT00948064|79358476|FG000|Phase I|No treatment received|1|||
44354121|NCT00948064|79358477|FG001|Phase I|No treatment received|0|||
44354122|NCT00948064|79358478|FG002|Phase I|No treatment received|0|||
44354123|NCT00948064|79358476|FG000|Phase II|Physician Decision|0|||
44354124|NCT00948064|79358477|FG001|Phase II|Physician Decision|0|||
44354125|NCT00948064|79358478|FG002|Phase II|Physician Decision|1|||
44354126|NCT00948064|79358476|FG000|Phase II|Withdrawal by Subject|0|||
44354127|NCT00948064|79358477|FG001|Phase II|Withdrawal by Subject|1|||
44354128|NCT00948064|79358478|FG002|Phase II|Withdrawal by Subject|0|||
44354129|NCT00953524|79358492|FG000|Overall Study|Adverse Event|2|||
44354130|NCT00953524|79358493|FG001|Overall Study|Adverse Event|0|||
44354131|NCT00953524|79358494|FG002|Overall Study|Adverse Event|1|||
44354132|NCT00953524|79358495|FG003|Overall Study|Adverse Event|2|||
44354133|NCT00953524|79358492|FG000|Overall Study|Protocol Violation|18|||
44354134|NCT00953524|79358493|FG001|Overall Study|Protocol Violation|10|||
44354135|NCT00953524|79358494|FG002|Overall Study|Protocol Violation|11|||
44354136|NCT00953524|79358495|FG003|Overall Study|Protocol Violation|6|||
44354137|NCT00953524|79358492|FG000|Overall Study|Lost to Follow-up|0|||
44354138|NCT00953524|79358493|FG001|Overall Study|Lost to Follow-up|1|||
44354139|NCT00953524|79358494|FG002|Overall Study|Lost to Follow-up|1|||
44354140|NCT00953524|79358495|FG003|Overall Study|Lost to Follow-up|0|||
44354141|NCT00953524|79358492|FG000|Overall Study|Withdrawal by Subject|2|||
44354142|NCT00953524|79358493|FG001|Overall Study|Withdrawal by Subject|4|||
44354143|NCT00953524|79358494|FG002|Overall Study|Withdrawal by Subject|1|||
44354144|NCT00953524|79358495|FG003|Overall Study|Withdrawal by Subject|0|||
44354145|NCT01040403|79358514|FG000|Overall Study|Adverse Event|10|||
44354146|NCT01040403|79358514|FG000|Overall Study|Protocol Violation|2|||
44354147|NCT01040403|79358514|FG000|Overall Study|Lost to Follow-up|1|||
44354148|NCT01040403|79358514|FG000|Overall Study|Not treated|1|||
44354149|NCT01040403|79358514|FG000|Overall Study|Other reason not defined above|6|||
44354150|NCT00957034|79358536|FG000|Overall Study|Adverse Event|0|||
44354151|NCT00957034|79358537|FG001|Overall Study|Adverse Event|1|||
44354152|NCT00957034|79358538|FG002|Overall Study|Adverse Event|1|||
44354153|NCT00957034|79358536|FG000|Overall Study|Sponsor Terminated Study|6|||
44354154|NCT00957034|79358537|FG001|Overall Study|Sponsor Terminated Study|1|||
44354155|NCT00957034|79358538|FG002|Overall Study|Sponsor Terminated Study|5|||
44354156|NCT00957034|79358536|FG000|Overall Study|Withdrawal by Subject|0|||
44354157|NCT00957034|79358537|FG001|Overall Study|Withdrawal by Subject|2|||
44354158|NCT00957034|79358538|FG002|Overall Study|Withdrawal by Subject|0|||
44354159|NCT00953056|79358552|FG000|Overall Study|Withdrew Consent|0|||
44354160|NCT00953056|79358553|FG001|Overall Study|Withdrew Consent|0|||
44354161|NCT00953056|79358554|FG002|Overall Study|Withdrew Consent|0|||
44354162|NCT00953056|79358555|FG003|Overall Study|Withdrew Consent|0|||
44354163|NCT00953056|79358556|FG004|Overall Study|Withdrew Consent|2|||
44354164|NCT00953056|79358557|FG005|Overall Study|Withdrew Consent|3|||
44354165|NCT00953056|79358552|FG000|Overall Study|Serious Adverse Event|0|||
44354166|NCT00953056|79358553|FG001|Overall Study|Serious Adverse Event|0|||
44354167|NCT00953056|79358554|FG002|Overall Study|Serious Adverse Event|0|||
44354168|NCT00953056|79358555|FG003|Overall Study|Serious Adverse Event|0|||
44354169|NCT00953056|79358556|FG004|Overall Study|Serious Adverse Event|0|||
44354170|NCT00953056|79358557|FG005|Overall Study|Serious Adverse Event|1|||
44354171|NCT00952822|79358582|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
44354172|NCT00952822|79358583|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
44354173|NCT00952822|79358584|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
44354174|NCT00952822|79358585|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
44354175|NCT00952822|79358582|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
44354176|NCT00952822|79358583|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
44354177|NCT00952822|79358584|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
44354178|NCT00952822|79358585|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
44354179|NCT01038297|79358599|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
44354180|NCT01038297|79358600|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
44354181|NCT01038297|79358601|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
44354182|NCT00955708|79358618|FG000|Overall Study|Death|269|||
44354183|NCT00955708|79358618|FG000|Overall Study|Lost to Follow-up|72|||
44354184|NCT00955708|79358618|FG000|Overall Study|Physician Decision|36|||
44354185|NCT00955708|79358618|FG000|Overall Study|Protocol Violation|134|||
44354186|NCT00955708|79358618|FG000|Overall Study|Registry Conclusion|186|||
44354187|NCT00955708|79358618|FG000|Overall Study|Product removed from service|94|||
44354188|NCT00955708|79358618|FG000|Overall Study|Patient Refused to participate further|116|||
44354189|NCT00955708|79358618|FG000|Overall Study|Closure of study location|60|||
44354190|NCT00955708|79358618|FG000|Overall Study|Patient changed care provider/moved|91|||
44354191|NCT01037985|79358622|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
44354192|NCT01037985|79358623|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
44354193|NCT01037985|79358622|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
44354194|NCT01037985|79358623|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
44354195|NCT01037985|79358622|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
44354196|NCT01037985|79358623|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
44354197|NCT01037985|79358622|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
44354198|NCT01037985|79358623|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
44354199|NCT00955474|79358635|FG000|Overall Study|Physician Decision|7|||
44354200|NCT00955474|79358636|FG001|Overall Study|Physician Decision|5|||
44354201|NCT01229150|79358648|FG000|Overall Study|Toxicity|2|||
44354202|NCT01229150|79358649|FG001|Overall Study|Toxicity|2|||
44354203|NCT01229150|79358650|FG002|Overall Study|Toxicity|0|||
44354204|NCT01229150|79358651|FG003|Overall Study|Toxicity|0|||
44354205|NCT00952588|79358667|FG000|Overall Study|Death|28|||
44354206|NCT00952588|79358668|FG001|Overall Study|Death|13|||
44354207|NCT00952588|79358667|FG000|Overall Study|Withdrawal by Subject|2|||
44354208|NCT00952588|79358668|FG001|Overall Study|Withdrawal by Subject|5|||
44354209|NCT00952588|79358667|FG000|Overall Study|Adverse Event|2|||
44354210|NCT00952588|79358668|FG001|Overall Study|Adverse Event|3|||
44354211|NCT00952588|79358667|FG000|Overall Study|Lost to Follow-up|2|||
44354212|NCT00952588|79358668|FG001|Overall Study|Lost to Follow-up|0|||
44354213|NCT00952588|79358667|FG000|Overall Study|Physician Decision|0|||
44354214|NCT00952588|79358668|FG001|Overall Study|Physician Decision|1|||
44354215|NCT00952588|79358667|FG000|Overall Study|Lack of Efficacy|2|||
44354216|NCT00952588|79358668|FG001|Overall Study|Lack of Efficacy|2|||
44354217|NCT01227902|79358678|FG000|Overall Study|Adverse Event|12|||
44354218|NCT01227902|79358679|FG001|Overall Study|Adverse Event|8|||
44354219|NCT01227902|79358680|FG002|Overall Study|Adverse Event|11|||
44354220|NCT01227902|79358681|FG003|Overall Study|Adverse Event|4|||
44354221|NCT01227902|79358678|FG000|Overall Study|Lack of Efficacy|1|||
44354222|NCT01227902|79358679|FG001|Overall Study|Lack of Efficacy|2|||
44354223|NCT01227902|79358680|FG002|Overall Study|Lack of Efficacy|2|||
44354224|NCT01227902|79358681|FG003|Overall Study|Lack of Efficacy|1|||
44354225|NCT01227902|79358678|FG000|Overall Study|Protocol Violation|1|||
44354226|NCT01227902|79358679|FG001|Overall Study|Protocol Violation|0|||
44354227|NCT01227902|79358680|FG002|Overall Study|Protocol Violation|0|||
44354228|NCT01227902|79358681|FG003|Overall Study|Protocol Violation|0|||
44354229|NCT01227902|79358678|FG000|Overall Study|Lost to Follow-up|0|||
44354230|NCT01227902|79358679|FG001|Overall Study|Lost to Follow-up|0|||
44354231|NCT01227902|79358680|FG002|Overall Study|Lost to Follow-up|1|||
44354232|NCT01227902|79358681|FG003|Overall Study|Lost to Follow-up|2|||
44354233|NCT01227902|79358678|FG000|Overall Study|Physician Decision|0|||
44354234|NCT01227902|79358679|FG001|Overall Study|Physician Decision|1|||
44354235|NCT01227902|79358680|FG002|Overall Study|Physician Decision|1|||
44354236|NCT01227902|79358681|FG003|Overall Study|Physician Decision|0|||
44354237|NCT01227902|79358678|FG000|Overall Study|Withdrawal by Subject|4|||
44354238|NCT01227902|79358679|FG001|Overall Study|Withdrawal by Subject|2|||
44354239|NCT01227902|79358680|FG002|Overall Study|Withdrawal by Subject|4|||
44354240|NCT01227902|79358681|FG003|Overall Study|Withdrawal by Subject|3|||
44354241|NCT00946192|79358695|FG000|Overall Study|Lost to Follow-up|6|||
44354242|NCT00946192|79358696|FG001|Overall Study|Lost to Follow-up|11|||
44354243|NCT00946192|79358697|FG002|Overall Study|Lost to Follow-up|9|||
44354244|NCT00946192|79358695|FG000|Overall Study|Withdrawal by Subject|10|||
44354245|NCT00946192|79358696|FG001|Overall Study|Withdrawal by Subject|7|||
44354246|NCT00946192|79358697|FG002|Overall Study|Withdrawal by Subject|3|||
44354247|NCT00946192|79358695|FG000|Overall Study|Did not start medication|2|||
44354248|NCT00946192|79358696|FG001|Overall Study|Did not start medication|0|||
44354249|NCT00946192|79358697|FG002|Overall Study|Did not start medication|0|||
44354250|NCT01037127|79358707|FG000|Overall Study|Lost to Follow-up|2|||
44354251|NCT01037127|79358708|FG001|Overall Study|Lost to Follow-up|4|||
44354252|NCT01037127|79358707|FG000|Overall Study|Physician Decision|1|||
44354253|NCT01037127|79358708|FG001|Overall Study|Physician Decision|0|||
44354254|NCT01037127|79358707|FG000|Overall Study|Study Closed Terminated|2|||
44354255|NCT01037127|79358708|FG001|Overall Study|Study Closed Terminated|17|||
44354256|NCT00946114|79358726|FG000|Overall Study|Death|5|||
44354257|NCT00946114|79358727|FG001|Overall Study|Death|2|||
44354258|NCT00946114|79358726|FG000|Overall Study|Other|1|||
44354259|NCT00946114|79358727|FG001|Overall Study|Other|0|||
44354260|NCT00946114|79358726|FG000|Overall Study|Withdrawal by Subject|2|||
44354261|NCT00946114|79358727|FG001|Overall Study|Withdrawal by Subject|0|||
44354262|NCT01038921|79358735|FG000|Overall Study|Withdrawal by Subject|1|||
44354263|NCT01038921|79358736|FG001|Overall Study|Withdrawal by Subject|0|||
44354264|NCT01038921|79358735|FG000|Overall Study|Physician Decision|1|||
44354265|NCT01038921|79358736|FG001|Overall Study|Physician Decision|0|||
44354266|NCT01038687|79358745|FG000|Overall Study|Adverse Event|0|||
44354267|NCT01038687|79358746|FG001|Overall Study|Adverse Event|2|||
44354268|NCT01038687|79358747|FG002|Overall Study|Adverse Event|1|||
44354269|NCT01081912|79358755|FG000|Conversion/Titration|Adverse Event|47|||
44354270|NCT01081912|79358756|FG001|Conversion/Titration|Adverse Event|0|||
44354271|NCT01081912|79358757|FG002|Conversion/Titration|Adverse Event|0|||
44354272|NCT01081912|79358755|FG000|Conversion/Titration|Lack of Efficacy|17|||
44354273|NCT01081912|79358756|FG001|Conversion/Titration|Lack of Efficacy|0|||
44354274|NCT01081912|79358757|FG002|Conversion/Titration|Lack of Efficacy|0|||
44354275|NCT01081912|79358755|FG000|Conversion/Titration|Lost to Follow-up|5|||
44354276|NCT01081912|79358756|FG001|Conversion/Titration|Lost to Follow-up|0|||
44354277|NCT01081912|79358757|FG002|Conversion/Titration|Lost to Follow-up|0|||
44354278|NCT01081912|79358755|FG000|Conversion/Titration|Physician Decision|2|||
44354279|NCT01081912|79358756|FG001|Conversion/Titration|Physician Decision|0|||
44354280|NCT01081912|79358757|FG002|Conversion/Titration|Physician Decision|0|||
44354281|NCT01081912|79358755|FG000|Conversion/Titration|Protocol Violation|67|||
44354282|NCT01081912|79358756|FG001|Conversion/Titration|Protocol Violation|0|||
44354283|NCT01081912|79358757|FG002|Conversion/Titration|Protocol Violation|0|||
44354284|NCT01081912|79358755|FG000|Conversion/Titration|Withdrawal by Subject|23|||
44354285|NCT01081912|79358756|FG001|Conversion/Titration|Withdrawal by Subject|0|||
44354286|NCT01081912|79358757|FG002|Conversion/Titration|Withdrawal by Subject|0|||
44354287|NCT01081912|79358755|FG000|Conversion/Titration|Non-Compliance|47|||
44354288|NCT01081912|79358756|FG001|Conversion/Titration|Non-Compliance|0|||
44354289|NCT01081912|79358757|FG002|Conversion/Titration|Non-Compliance|0|||
44354290|NCT01081912|79358755|FG000|Maintenance Treatment|Adverse Event|0|||
44354291|NCT01081912|79358756|FG001|Maintenance Treatment|Adverse Event|2|||
44354292|NCT01081912|79358757|FG002|Maintenance Treatment|Adverse Event|12|||
44354293|NCT01081912|79358755|FG000|Maintenance Treatment|Lack of Efficacy|0|||
44354294|NCT01081912|79358756|FG001|Maintenance Treatment|Lack of Efficacy|14|||
44354295|NCT01081912|79358757|FG002|Maintenance Treatment|Lack of Efficacy|64|||
44354296|NCT01081912|79358755|FG000|Maintenance Treatment|Lost to Follow-up|0|||
44354297|NCT01081912|79358756|FG001|Maintenance Treatment|Lost to Follow-up|1|||
44354298|NCT01081912|79358757|FG002|Maintenance Treatment|Lost to Follow-up|0|||
44354299|NCT01081912|79358755|FG000|Maintenance Treatment|Physician Decision|0|||
44354300|NCT01081912|79358756|FG001|Maintenance Treatment|Physician Decision|0|||
44354301|NCT01081912|79358757|FG002|Maintenance Treatment|Physician Decision|1|||
44354302|NCT01081912|79358755|FG000|Maintenance Treatment|Protocol Violation|0|||
44354303|NCT01081912|79358756|FG001|Maintenance Treatment|Protocol Violation|1|||
44354304|NCT01081912|79358757|FG002|Maintenance Treatment|Protocol Violation|2|||
44354305|NCT01081912|79358755|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
44354306|NCT01081912|79358756|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
44354307|NCT01081912|79358757|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
44354308|NCT01081912|79358755|FG000|Maintenance Treatment|Non-Compliance|0|||
44354309|NCT01081912|79358756|FG001|Maintenance Treatment|Non-Compliance|4|||
44354310|NCT01081912|79358757|FG002|Maintenance Treatment|Non-Compliance|7|||
44354311|NCT01081912|79358755|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
44354312|NCT01081912|79358756|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
44354313|NCT01081912|79358757|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
44354314|NCT01038609|79358769|FG000|Overall Study|Adverse Event|0|||
44354315|NCT01038609|79358770|FG001|Overall Study|Adverse Event|0|||
44354316|NCT01038609|79358771|FG002|Overall Study|Adverse Event|1|||
44354317|NCT01038609|79358772|FG003|Overall Study|Adverse Event|0|||
44354318|NCT01038609|79358773|FG004|Overall Study|Adverse Event|0|||
44354319|NCT01038609|79358769|FG000|Overall Study|Dosing Error|0|||
44354320|NCT01038609|79358770|FG001|Overall Study|Dosing Error|0|||
44354321|NCT01038609|79358771|FG002|Overall Study|Dosing Error|0|||
44354322|NCT01038609|79358772|FG003|Overall Study|Dosing Error|1|||
44354323|NCT01038609|79358773|FG004|Overall Study|Dosing Error|1|||
44354324|NCT01038609|79358769|FG000|Overall Study|Death in the Family|1|||
44354325|NCT01038609|79358770|FG001|Overall Study|Death in the Family|0|||
44354326|NCT01038609|79358771|FG002|Overall Study|Death in the Family|0|||
44354327|NCT01038609|79358772|FG003|Overall Study|Death in the Family|0|||
44354328|NCT01038609|79358773|FG004|Overall Study|Death in the Family|0|||
44354329|NCT01038609|79358769|FG000|Overall Study|Refusal of Blood Draws|0|||
44354330|NCT01038609|79358770|FG001|Overall Study|Refusal of Blood Draws|1|||
44354331|NCT01038609|79358771|FG002|Overall Study|Refusal of Blood Draws|0|||
44354332|NCT01038609|79358772|FG003|Overall Study|Refusal of Blood Draws|0|||
44354333|NCT01038609|79358773|FG004|Overall Study|Refusal of Blood Draws|0|||
44354334|NCT02357134|79358789|FG000|Overall Study|Lost to Follow-up|1|||
44354335|NCT02357134|79358790|FG001|Overall Study|Lost to Follow-up|0|||
44354336|NCT02357134|79358791|FG002|Overall Study|Lost to Follow-up|0|||
44354337|NCT02357134|79358792|FG003|Overall Study|Lost to Follow-up|0|||
44354338|NCT00745420|79358802|FG000|Overall Study|Ineligible|1|||
44354339|NCT02853370|79358806|FG000|Overall Study|Physician Decision|1|||
44354340|NCT02853370|79358806|FG000|Overall Study|Lack of Efficacy|2|||
44354341|NCT02853370|79358806|FG000|Overall Study|Death|1|||
44354342|NCT02853370|79358806|FG000|Overall Study|Adverse Event|4|||
44354343|NCT02853370|79358806|FG000|Overall Study|Withdrawal by Subject|3|||
44354344|NCT01879072|79358811|FG000|Overall Study|Withdrawal by Subject|121|||
44354345|NCT01879072|79358811|FG000|Overall Study|Not Transplanted|30|||
44354346|NCT00954538|79358817|FG000|Part III|Withdrawal by Subject|0|||
44541588|NCT04318093|79554142|FG001|Overall Study|Participant withdrew consent|0|||
44541589|NCT04318093|79554141|FG000|Overall Study|Other reasons|0|||
44541590|NCT04318093|79554142|FG001|Overall Study|Other reasons|1|||
44541591|NCT04123405|79554153|FG000|Overall Study|Adverse Event|1|||
44541592|NCT04123405|79554154|FG001|Overall Study|Adverse Event|2|||
44541593|NCT04123405|79554155|FG002|Overall Study|Adverse Event|3|||
44541594|NCT04123405|79554156|FG003|Overall Study|Adverse Event|3|||
44541595|NCT04123405|79554153|FG000|Overall Study|Exclusion criteria met|1|||
44541596|NCT04123405|79554154|FG001|Overall Study|Exclusion criteria met|2|||
44541597|NCT04123405|79554155|FG002|Overall Study|Exclusion criteria met|0|||
44541598|NCT04123405|79554156|FG003|Overall Study|Exclusion criteria met|2|||
44541599|NCT04123405|79554153|FG000|Overall Study|Withdrawal by Subject|1|||
44541600|NCT04123405|79554154|FG001|Overall Study|Withdrawal by Subject|3|||
44541601|NCT04123405|79554155|FG002|Overall Study|Withdrawal by Subject|0|||
44541602|NCT04123405|79554156|FG003|Overall Study|Withdrawal by Subject|2|||
44541603|NCT04123405|79554153|FG000|Overall Study|Contact to subject lost|0|||
44541604|NCT04123405|79554154|FG001|Overall Study|Contact to subject lost|0|||
44541605|NCT04123405|79554155|FG002|Overall Study|Contact to subject lost|0|||
44541606|NCT04123405|79554156|FG003|Overall Study|Contact to subject lost|1|||
44541607|NCT04123405|79554153|FG000|Overall Study|screening failure|1|||
44541608|NCT04123405|79554154|FG001|Overall Study|screening failure|0|||
44541609|NCT04123405|79554155|FG002|Overall Study|screening failure|0|||
44541610|NCT04123405|79554156|FG003|Overall Study|screening failure|0|||
44541611|NCT04314037|79554185|FG000|Treatment Period 2|Adverse Event|1|||
44541612|NCT04314037|79554186|FG001|Treatment Period 2|Adverse Event|0|||
44541613|NCT04314037|79554185|FG000|Treatment Period 3|Protocol Violation|1|||
44541614|NCT04314037|79554186|FG001|Treatment Period 3|Protocol Violation|0|||
44541615|NCT04314037|79554185|FG000|Treatment Period 3|Adverse Event|0|||
44541616|NCT04314037|79554186|FG001|Treatment Period 3|Adverse Event|1|||
44541617|NCT03056300|79554202|FG000|Overall Study|Surgical reason per study protocol|3|||
44541618|NCT03061214|79554209|FG000|Overall Study|Withdrawal by Subject|21|||
44541619|NCT03061214|79554210|FG001|Overall Study|Withdrawal by Subject|26|||
44541620|NCT03061214|79554211|FG002|Overall Study|Withdrawal by Subject|9|||
44541621|NCT03061214|79554209|FG000|Overall Study|Lost to Follow-up|3|||
44541622|NCT03061214|79554210|FG001|Overall Study|Lost to Follow-up|1|||
44541623|NCT03061214|79554211|FG002|Overall Study|Lost to Follow-up|1|||
44541624|NCT03061214|79554209|FG000|Overall Study|Death|1|||
44541625|NCT03061214|79554210|FG001|Overall Study|Death|1|||
44541626|NCT03061214|79554211|FG002|Overall Study|Death|0|||
44541627|NCT04115839|79554222|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
44541628|NCT04115839|79554223|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
44541629|NCT04115839|79554224|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
44541630|NCT04115839|79554225|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
44541631|NCT04115839|79554226|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
44541632|NCT04115839|79554227|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
44541633|NCT04115839|79554228|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
44541634|NCT04115839|79554222|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
44541635|NCT04115839|79554223|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
44541636|NCT04115839|79554224|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
44541637|NCT04115839|79554225|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
44541638|NCT04115839|79554226|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
44541639|NCT04115839|79554227|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
44541640|NCT04115839|79554228|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
44541641|NCT04115839|79554222|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
44541642|NCT04115839|79554223|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
44541643|NCT04115839|79554224|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
44541644|NCT04115839|79554225|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
44541645|NCT04115839|79554226|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
44541646|NCT04115839|79554227|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
44541647|NCT04115839|79554228|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
44541648|NCT04115839|79554222|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
44541649|NCT04115839|79554223|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
44541650|NCT04115839|79554224|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
44541651|NCT04115839|79554225|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
44354347|NCT00954538|79358818|FG001|Part III|Withdrawal by Subject|0|||
44541652|NCT04115839|79554226|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
44541653|NCT04115839|79554227|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
44541654|NCT04115839|79554228|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
44541655|NCT04115839|79554222|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
44541656|NCT04115839|79554223|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
44541657|NCT04115839|79554224|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
44541658|NCT04115839|79554225|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
44541659|NCT04115839|79554226|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
44541660|NCT04115839|79554227|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
44541661|NCT04115839|79554228|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
44541662|NCT04115839|79554222|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
44541663|NCT04115839|79554223|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
44541664|NCT04115839|79554224|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
44541665|NCT04115839|79554225|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
44541666|NCT04115839|79554226|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
44541667|NCT04115839|79554227|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
44541668|NCT04115839|79554228|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
44541669|NCT01561430|79554257|FG000|Overall Study|Adverse Event|0|||
44541670|NCT01561430|79554258|FG001|Overall Study|Adverse Event|0|||
44541671|NCT01561430|79554259|FG002|Overall Study|Adverse Event|3|||
44541672|NCT01561430|79554260|FG003|Overall Study|Adverse Event|1|||
44541673|NCT01561430|79554257|FG000|Overall Study|Withdrawal by Subject|0|||
44541674|NCT01561430|79554258|FG001|Overall Study|Withdrawal by Subject|0|||
44541675|NCT01561430|79554259|FG002|Overall Study|Withdrawal by Subject|1|||
44541676|NCT01561430|79554260|FG003|Overall Study|Withdrawal by Subject|0|||
44541677|NCT01561430|79554257|FG000|Overall Study|Physician Decision|0|||
44541678|NCT01561430|79554258|FG001|Overall Study|Physician Decision|1|||
44541679|NCT01561430|79554259|FG002|Overall Study|Physician Decision|0|||
44541680|NCT01561430|79554260|FG003|Overall Study|Physician Decision|0|||
44541681|NCT01561430|79554257|FG000|Overall Study|Sponsor Decision|1|||
44541682|NCT01561430|79554258|FG001|Overall Study|Sponsor Decision|14|||
44541683|NCT01561430|79554259|FG002|Overall Study|Sponsor Decision|13|||
44541684|NCT01561430|79554260|FG003|Overall Study|Sponsor Decision|12|||
44541685|NCT03060512|79554295|FG000|Overall Study|Adverse Event|4|||
44541686|NCT03060512|79554296|FG001|Overall Study|Adverse Event|6|||
44541687|NCT03060512|79554295|FG000|Overall Study|Lost to Follow-up|1|||
44541688|NCT03060512|79554296|FG001|Overall Study|Lost to Follow-up|1|||
44541689|NCT03060512|79554295|FG000|Overall Study|Withdrawal by Subject|1|||
44541690|NCT03060512|79554296|FG001|Overall Study|Withdrawal by Subject|0|||
44541691|NCT03060512|79554295|FG000|Overall Study|Non-compliance with study medication|1|||
44541692|NCT03060512|79554296|FG001|Overall Study|Non-compliance with study medication|2|||
44541693|NCT02539160|79554384|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
44541694|NCT02539160|79554385|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
44541695|NCT02539160|79554386|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
44541696|NCT02539160|79554387|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
44541697|NCT02539160|79554384|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
44541698|NCT02539160|79554385|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
44541699|NCT02539160|79554386|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
44541700|NCT02539160|79554387|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
44541701|NCT02539160|79554384|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
44541702|NCT02539160|79554385|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
44541703|NCT02539160|79554386|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
44541704|NCT02539160|79554387|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
44541705|NCT04292899|79554401|FG000|Overall Study|Death|21|||
44541706|NCT04292899|79554402|FG001|Overall Study|Death|28|||
44541707|NCT04292899|79554403|FG002|Overall Study|Death|188|||
44541708|NCT04292899|79554404|FG003|Overall Study|Death|371|||
44541709|NCT04292899|79554401|FG000|Overall Study|Lost to Follow-up|8|||
44541710|NCT04292899|79554402|FG001|Overall Study|Lost to Follow-up|4|||
44541711|NCT04292899|79554403|FG002|Overall Study|Lost to Follow-up|22|||
44541712|NCT04292899|79554404|FG003|Overall Study|Lost to Follow-up|235|||
44541713|NCT04292899|79554401|FG000|Overall Study|Withdrew consent|1|||
44541714|NCT04292899|79554402|FG001|Overall Study|Withdrew consent|0|||
44541715|NCT04292899|79554403|FG002|Overall Study|Withdrew consent|11|||
44541716|NCT04292899|79554404|FG003|Overall Study|Withdrew consent|32|||
44541717|NCT04292899|79554401|FG000|Overall Study|Adverse Event|2|||
44541718|NCT04292899|79554402|FG001|Overall Study|Adverse Event|1|||
44541719|NCT04292899|79554403|FG002|Overall Study|Adverse Event|2|||
44541720|NCT04292899|79554404|FG003|Overall Study|Adverse Event|2|||
44541721|NCT04292899|79554401|FG000|Overall Study|Investigator's Discretion|0|||
44541722|NCT04292899|79554402|FG001|Overall Study|Investigator's Discretion|0|||
44541723|NCT04292899|79554403|FG002|Overall Study|Investigator's Discretion|0|||
44541724|NCT04292899|79554404|FG003|Overall Study|Investigator's Discretion|3|||
44541725|NCT04292899|79554401|FG000|Overall Study|Non-compliance With Study Drug|0|||
44541726|NCT04292899|79554402|FG001|Overall Study|Non-compliance With Study Drug|0|||
44541727|NCT04292899|79554403|FG002|Overall Study|Non-compliance With Study Drug|0|||
44541728|NCT04292899|79554404|FG003|Overall Study|Non-compliance With Study Drug|1|||
44541729|NCT04292899|79554401|FG000|Overall Study|Protocol Violation|0|||
44541730|NCT04292899|79554402|FG001|Overall Study|Protocol Violation|0|||
44541731|NCT04292899|79554403|FG002|Overall Study|Protocol Violation|0|||
44541732|NCT04292899|79554404|FG003|Overall Study|Protocol Violation|1|||
44541733|NCT03241173|79554423|FG000|Overall Study|Death|3|||
44541734|NCT03241173|79554424|FG001|Overall Study|Death|2|||
44541735|NCT03241173|79554425|FG002|Overall Study|Death|4|||
44541736|NCT03241173|79554426|FG003|Overall Study|Death|4|||
44541737|NCT03241173|79554427|FG004|Overall Study|Death|2|||
44541738|NCT03241173|79554428|FG005|Overall Study|Death|2|||
44541739|NCT03241173|79554429|FG006|Overall Study|Death|3|||
44541740|NCT03241173|79554430|FG007|Overall Study|Death|1|||
44541741|NCT03241173|79554431|FG008|Overall Study|Death|0|||
44541742|NCT03241173|79554432|FG009|Overall Study|Death|5|||
44541743|NCT03241173|79554433|FG010|Overall Study|Death|4|||
44541744|NCT03241173|79554434|FG011|Overall Study|Death|3|||
44541745|NCT03241173|79554435|FG012|Overall Study|Death|0|||
44541746|NCT03241173|79554436|FG013|Overall Study|Death|0|||
44541747|NCT03241173|79554437|FG014|Overall Study|Death|0|||
44541748|NCT03241173|79554423|FG000|Overall Study|Withdrawal by Subject|0|||
44541749|NCT03241173|79554424|FG001|Overall Study|Withdrawal by Subject|0|||
44541750|NCT03241173|79554425|FG002|Overall Study|Withdrawal by Subject|1|||
44541751|NCT03241173|79554426|FG003|Overall Study|Withdrawal by Subject|0|||
44541752|NCT03241173|79554427|FG004|Overall Study|Withdrawal by Subject|0|||
44541753|NCT03241173|79554428|FG005|Overall Study|Withdrawal by Subject|1|||
44541754|NCT03241173|79554429|FG006|Overall Study|Withdrawal by Subject|0|||
44541755|NCT03241173|79554430|FG007|Overall Study|Withdrawal by Subject|0|||
44541756|NCT03241173|79554431|FG008|Overall Study|Withdrawal by Subject|0|||
44541757|NCT03241173|79554432|FG009|Overall Study|Withdrawal by Subject|0|||
44541758|NCT03241173|79554433|FG010|Overall Study|Withdrawal by Subject|0|||
44541759|NCT03241173|79554434|FG011|Overall Study|Withdrawal by Subject|0|||
44541760|NCT03241173|79554435|FG012|Overall Study|Withdrawal by Subject|0|||
44541761|NCT03241173|79554436|FG013|Overall Study|Withdrawal by Subject|0|||
44541762|NCT03241173|79554437|FG014|Overall Study|Withdrawal by Subject|0|||
44541763|NCT03241173|79554423|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
44541764|NCT03241173|79554424|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
44541765|NCT03241173|79554425|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
44541766|NCT03241173|79554426|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
44541767|NCT03241173|79554427|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
44541768|NCT03241173|79554428|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
44541769|NCT03241173|79554429|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
44541770|NCT03241173|79554430|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
44541771|NCT03241173|79554431|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
44541772|NCT03241173|79554432|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
44541773|NCT03241173|79554433|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
44541774|NCT03241173|79554434|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
44541775|NCT03241173|79554435|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
44541776|NCT03241173|79554436|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
44541777|NCT03241173|79554437|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
44541778|NCT03241173|79554423|FG000|Overall Study|Lost to Follow-up|0|||
44541779|NCT03241173|79554424|FG001|Overall Study|Lost to Follow-up|0|||
44541780|NCT03241173|79554425|FG002|Overall Study|Lost to Follow-up|0|||
44541781|NCT03241173|79554426|FG003|Overall Study|Lost to Follow-up|0|||
44541782|NCT03241173|79554427|FG004|Overall Study|Lost to Follow-up|1|||
44541783|NCT03241173|79554428|FG005|Overall Study|Lost to Follow-up|0|||
44541784|NCT03241173|79554429|FG006|Overall Study|Lost to Follow-up|0|||
44541785|NCT03241173|79554430|FG007|Overall Study|Lost to Follow-up|0|||
44541786|NCT03241173|79554431|FG008|Overall Study|Lost to Follow-up|0|||
44541787|NCT03241173|79554432|FG009|Overall Study|Lost to Follow-up|1|||
44541788|NCT03241173|79554433|FG010|Overall Study|Lost to Follow-up|0|||
44541789|NCT03241173|79554434|FG011|Overall Study|Lost to Follow-up|0|||
44541790|NCT03241173|79554435|FG012|Overall Study|Lost to Follow-up|0|||
44541791|NCT03241173|79554436|FG013|Overall Study|Lost to Follow-up|0|||
44541792|NCT03241173|79554437|FG014|Overall Study|Lost to Follow-up|0|||
44541793|NCT03264066|79554471|FG000|Overall Study|Adverse Event|1|||
44541794|NCT03264066|79554472|FG001|Overall Study|Adverse Event|1|||
44541795|NCT03264066|79554473|FG002|Overall Study|Adverse Event|0|||
44541796|NCT03264066|79554474|FG003|Overall Study|Adverse Event|0|||
44541797|NCT03264066|79554475|FG004|Overall Study|Adverse Event|0|||
44541798|NCT03264066|79554476|FG005|Overall Study|Adverse Event|0|||
44541799|NCT03264066|79554471|FG000|Overall Study|Death|12|||
44541800|NCT03264066|79554472|FG001|Overall Study|Death|12|||
44541801|NCT03264066|79554473|FG002|Overall Study|Death|8|||
44541802|NCT03264066|79554474|FG003|Overall Study|Death|10|||
44541803|NCT03264066|79554475|FG004|Overall Study|Death|6|||
44541804|NCT03264066|79554476|FG005|Overall Study|Death|1|||
44541805|NCT03264066|79554471|FG000|Overall Study|Lost to Follow-up|1|||
44541806|NCT03264066|79554472|FG001|Overall Study|Lost to Follow-up|0|||
44541807|NCT03264066|79554473|FG002|Overall Study|Lost to Follow-up|0|||
44541808|NCT03264066|79554474|FG003|Overall Study|Lost to Follow-up|0|||
44541809|NCT03264066|79554475|FG004|Overall Study|Lost to Follow-up|0|||
44541810|NCT03264066|79554476|FG005|Overall Study|Lost to Follow-up|0|||
44541811|NCT03264066|79554471|FG000|Overall Study|Progressive Disease|0|||
44541812|NCT03264066|79554472|FG001|Overall Study|Progressive Disease|2|||
44541813|NCT03264066|79554473|FG002|Overall Study|Progressive Disease|1|||
44541814|NCT03264066|79554474|FG003|Overall Study|Progressive Disease|0|||
44541815|NCT03264066|79554475|FG004|Overall Study|Progressive Disease|0|||
44541816|NCT03264066|79554476|FG005|Overall Study|Progressive Disease|0|||
44541817|NCT03264066|79554471|FG000|Overall Study|Study Terminated by Sponsor|5|||
44541818|NCT03264066|79554472|FG001|Overall Study|Study Terminated by Sponsor|5|||
44541819|NCT03264066|79554473|FG002|Overall Study|Study Terminated by Sponsor|8|||
44541820|NCT03264066|79554474|FG003|Overall Study|Study Terminated by Sponsor|5|||
44541821|NCT03264066|79554475|FG004|Overall Study|Study Terminated by Sponsor|1|||
44541822|NCT03264066|79554476|FG005|Overall Study|Study Terminated by Sponsor|2|||
44541823|NCT03264066|79554471|FG000|Overall Study|Withdrawal by Subject|1|||
44541824|NCT03264066|79554472|FG001|Overall Study|Withdrawal by Subject|0|||
44541825|NCT03264066|79554473|FG002|Overall Study|Withdrawal by Subject|0|||
44541826|NCT03264066|79554474|FG003|Overall Study|Withdrawal by Subject|5|||
44541827|NCT03264066|79554475|FG004|Overall Study|Withdrawal by Subject|0|||
44541828|NCT03264066|79554476|FG005|Overall Study|Withdrawal by Subject|0|||
44541829|NCT03759041|79554494|FG000|Overall Study|Withdrawal by Subject|4|||
44541830|NCT03759041|79554495|FG001|Overall Study|Withdrawal by Subject|10|||
44541831|NCT03759041|79554496|FG002|Overall Study|Withdrawal by Subject|10|||
44541832|NCT03759041|79554494|FG000|Overall Study|Adverse Event|1|||
44541833|NCT03759041|79554495|FG001|Overall Study|Adverse Event|3|||
44541834|NCT03759041|79554496|FG002|Overall Study|Adverse Event|4|||
44541835|NCT03759041|79554494|FG000|Overall Study|Lack of Efficacy|0|||
44541836|NCT03759041|79554495|FG001|Overall Study|Lack of Efficacy|0|||
44541837|NCT03759041|79554496|FG002|Overall Study|Lack of Efficacy|1|||
44541838|NCT03759041|79554494|FG000|Overall Study|Study Terminated by Sponsor|15|||
44541839|NCT03759041|79554495|FG001|Overall Study|Study Terminated by Sponsor|16|||
44541840|NCT03759041|79554496|FG002|Overall Study|Study Terminated by Sponsor|10|||
44541841|NCT03759041|79554494|FG000|Overall Study|Other reason for discontinuation|0|||
44541842|NCT03759041|79554495|FG001|Overall Study|Other reason for discontinuation|2|||
44541843|NCT03759041|79554496|FG002|Overall Study|Other reason for discontinuation|1|||
44541844|NCT03759041|79554494|FG000|Overall Study|Lost to Follow-up|7|||
44541845|NCT03759041|79554495|FG001|Overall Study|Lost to Follow-up|2|||
44541846|NCT03759041|79554496|FG002|Overall Study|Lost to Follow-up|2|||
44541847|NCT03759041|79554494|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
44541848|NCT03759041|79554495|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
44541849|NCT03759041|79554496|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
44541850|NCT04110145|79554509|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
44541851|NCT04110145|79554510|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
44541852|NCT04110145|79554511|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
44541853|NCT04110145|79554512|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
44541854|NCT04110145|79554513|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
44541855|NCT02477618|79554527|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
44541856|NCT02477618|79554528|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
44541857|NCT02477618|79554527|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
44541858|NCT02477618|79554528|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
44541859|NCT02477618|79554527|FG000|Overall Study|Adverse Event|1|||
44541860|NCT02477618|79554528|FG001|Overall Study|Adverse Event|1|||
44541861|NCT02477618|79554527|FG000|Overall Study|Transferred Away from Study Site|1|||
44541862|NCT02477618|79554528|FG001|Overall Study|Transferred Away from Study Site|0|||
44541863|NCT02477618|79554527|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
44541864|NCT02477618|79554528|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
44541865|NCT04102501|79554536|FG000|Overall Study|Withdrawal by Subject|7|||
44541866|NCT04102501|79554537|FG001|Overall Study|Withdrawal by Subject|9|||
44541867|NCT04102501|79554536|FG000|Overall Study|Adverse Event|1|||
44541868|NCT04102501|79554537|FG001|Overall Study|Adverse Event|3|||
44541869|NCT03285477|79554547|FG000|Treatment and Response Assessment Period|Death|1|||
44541870|NCT03285477|79554548|FG001|Treatment and Response Assessment Period|Death|0|||
44541871|NCT03285477|79554547|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
44541872|NCT03285477|79554548|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
44541873|NCT03285477|79554547|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
44541874|NCT03285477|79554548|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
44541875|NCT03285477|79554547|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
44541876|NCT03285477|79554548|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
44541877|NCT03285477|79554547|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
44541878|NCT03285477|79554548|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
44541879|NCT04289623|79554565|FG000|Wave 1 Emails|Email was not delivered|268|||
44541880|NCT04289623|79554566|FG001|Wave 1 Emails|Email was not delivered|257|||
44541881|NCT04289623|79554567|FG002|Wave 1 Emails|Email was not delivered|0|||
44541882|NCT04289623|79554568|FG003|Wave 1 Emails|Email was not delivered|0|||
44541883|NCT04289623|79554569|FG004|Wave 1 Emails|Email was not delivered|0|||
44541884|NCT04289623|79554570|FG005|Wave 1 Emails|Email was not delivered|0|||
44541885|NCT03248037|79554586|FG000|Overall Study|Withdrawal by Subject|6|||
44541886|NCT03248037|79554587|FG001|Overall Study|Withdrawal by Subject|9|||
44541887|NCT03248037|79554586|FG000|Overall Study|Adverse Event|15|||
44541888|NCT03248037|79554587|FG001|Overall Study|Adverse Event|0|||
44541889|NCT04287517|79554602|FG000|Overall Study|Withdrawal by Subject|1|||
44541890|NCT04287517|79554603|FG001|Overall Study|Withdrawal by Subject|1|||
44541891|NCT03284229|79554609|FG000|Overall Study|Lost to Follow-up|3|||
44541892|NCT03242928|79554616|FG000|Overall Study|Adverse Event|2|||
44541893|NCT03242928|79554617|FG001|Overall Study|Adverse Event|1|||
44541894|NCT03242928|79554616|FG000|Overall Study|Lost to Follow-up|2|||
44541895|NCT03242928|79554617|FG001|Overall Study|Lost to Follow-up|0|||
44541896|NCT03242928|79554616|FG000|Overall Study|Physician Decision|0|||
44541897|NCT03242928|79554617|FG001|Overall Study|Physician Decision|1|||
44541898|NCT03242928|79554616|FG000|Overall Study|Withdrawal by Subject|5|||
44541899|NCT03242928|79554617|FG001|Overall Study|Withdrawal by Subject|3|||
44541900|NCT03300024|79554625|FG000|Overall Study|Physician Decision|4|||
44541901|NCT03300024|79554626|FG001|Overall Study|Physician Decision|6|||
44541902|NCT04276207|79554634|FG000|Period 1|Withdrawal by Subject|0|||
44541903|NCT04276207|79554635|FG001|Period 1|Withdrawal by Subject|1|||
44167492|NCT02349633|78960766|FG008|Overall Study|Death|0|||
44167493|NCT02349633|78960767|FG009|Overall Study|Death|1|||
44167494|NCT02349633|78960768|FG010|Overall Study|Death|0|||
44167495|NCT02349633|78960769|FG011|Overall Study|Death|0|||
44167496|NCT02349633|78960770|FG012|Overall Study|Death|0|||
44167497|NCT02349633|78960771|FG013|Overall Study|Death|0|||
44167498|NCT02349633|78960758|FG000|Overall Study|Withdrawal by Subject|0|||
44167499|NCT02349633|78960759|FG001|Overall Study|Withdrawal by Subject|0|||
44167500|NCT02349633|78960760|FG002|Overall Study|Withdrawal by Subject|0|||
44167501|NCT02349633|78960761|FG003|Overall Study|Withdrawal by Subject|1|||
44167502|NCT02349633|78960762|FG004|Overall Study|Withdrawal by Subject|0|||
44167503|NCT02349633|78960763|FG005|Overall Study|Withdrawal by Subject|0|||
44167504|NCT02349633|78960764|FG006|Overall Study|Withdrawal by Subject|0|||
44167505|NCT02349633|78960765|FG007|Overall Study|Withdrawal by Subject|2|||
44167506|NCT02349633|78960766|FG008|Overall Study|Withdrawal by Subject|2|||
44167507|NCT02349633|78960767|FG009|Overall Study|Withdrawal by Subject|1|||
44167508|NCT02349633|78960768|FG010|Overall Study|Withdrawal by Subject|0|||
44167509|NCT02349633|78960769|FG011|Overall Study|Withdrawal by Subject|0|||
44167510|NCT02349633|78960770|FG012|Overall Study|Withdrawal by Subject|0|||
44167511|NCT02349633|78960771|FG013|Overall Study|Withdrawal by Subject|0|||
44167512|NCT02349633|78960758|FG000|Overall Study|Withdrawal of informed consent|0|||
44167513|NCT02349633|78960759|FG001|Overall Study|Withdrawal of informed consent|0|||
44167514|NCT02349633|78960760|FG002|Overall Study|Withdrawal of informed consent|0|||
44167515|NCT02349633|78960761|FG003|Overall Study|Withdrawal of informed consent|1|||
44167516|NCT02349633|78960762|FG004|Overall Study|Withdrawal of informed consent|1|||
44167517|NCT02349633|78960763|FG005|Overall Study|Withdrawal of informed consent|0|||
44167518|NCT02349633|78960764|FG006|Overall Study|Withdrawal of informed consent|0|||
44167519|NCT02349633|78960765|FG007|Overall Study|Withdrawal of informed consent|3|||
44167520|NCT02349633|78960766|FG008|Overall Study|Withdrawal of informed consent|0|||
44167521|NCT02349633|78960767|FG009|Overall Study|Withdrawal of informed consent|0|||
44167522|NCT02349633|78960768|FG010|Overall Study|Withdrawal of informed consent|0|||
44167523|NCT02349633|78960769|FG011|Overall Study|Withdrawal of informed consent|0|||
44167524|NCT02349633|78960770|FG012|Overall Study|Withdrawal of informed consent|0|||
44167525|NCT02349633|78960771|FG013|Overall Study|Withdrawal of informed consent|0|||
44167526|NCT02349633|78960758|FG000|Overall Study|Transition to compassionate use|0|||
44167527|NCT02349633|78960759|FG001|Overall Study|Transition to compassionate use|0|||
44167528|NCT02349633|78960760|FG002|Overall Study|Transition to compassionate use|0|||
44167529|NCT02349633|78960761|FG003|Overall Study|Transition to compassionate use|0|||
44167530|NCT02349633|78960762|FG004|Overall Study|Transition to compassionate use|1|||
44167531|NCT02349633|78960763|FG005|Overall Study|Transition to compassionate use|0|||
44167532|NCT02349633|78960764|FG006|Overall Study|Transition to compassionate use|0|||
44167533|NCT02349633|78960765|FG007|Overall Study|Transition to compassionate use|3|||
44167534|NCT02349633|78960766|FG008|Overall Study|Transition to compassionate use|0|||
44167535|NCT02349633|78960767|FG009|Overall Study|Transition to compassionate use|1|||
44167536|NCT02349633|78960768|FG010|Overall Study|Transition to compassionate use|0|||
44167537|NCT02349633|78960769|FG011|Overall Study|Transition to compassionate use|0|||
44167538|NCT02349633|78960770|FG012|Overall Study|Transition to compassionate use|0|||
44167539|NCT02349633|78960771|FG013|Overall Study|Transition to compassionate use|0|||
44167540|NCT02349633|78960758|FG000|Overall Study|Early termination of survival follow-up|0|||
44167541|NCT02349633|78960759|FG001|Overall Study|Early termination of survival follow-up|0|||
44167542|NCT02349633|78960760|FG002|Overall Study|Early termination of survival follow-up|0|||
44167543|NCT02349633|78960761|FG003|Overall Study|Early termination of survival follow-up|0|||
44167544|NCT02349633|78960762|FG004|Overall Study|Early termination of survival follow-up|0|||
44167545|NCT02349633|78960763|FG005|Overall Study|Early termination of survival follow-up|0|||
44167546|NCT02349633|78960764|FG006|Overall Study|Early termination of survival follow-up|0|||
44167547|NCT02349633|78960765|FG007|Overall Study|Early termination of survival follow-up|4|||
44167548|NCT02349633|78960766|FG008|Overall Study|Early termination of survival follow-up|0|||
44167549|NCT02349633|78960767|FG009|Overall Study|Early termination of survival follow-up|0|||
44167550|NCT02349633|78960768|FG010|Overall Study|Early termination of survival follow-up|0|||
44167551|NCT02349633|78960769|FG011|Overall Study|Early termination of survival follow-up|0|||
44167552|NCT02349633|78960770|FG012|Overall Study|Early termination of survival follow-up|0|||
44167553|NCT02349633|78960771|FG013|Overall Study|Early termination of survival follow-up|0|||
44167554|NCT02349633|78960758|FG000|Overall Study|Termination by sponsor|0|||
44167555|NCT02349633|78960759|FG001|Overall Study|Termination by sponsor|0|||
44167556|NCT02349633|78960760|FG002|Overall Study|Termination by sponsor|0|||
44167557|NCT02349633|78960761|FG003|Overall Study|Termination by sponsor|0|||
44167558|NCT02349633|78960762|FG004|Overall Study|Termination by sponsor|0|||
44167559|NCT02349633|78960763|FG005|Overall Study|Termination by sponsor|0|||
44167560|NCT02349633|78960764|FG006|Overall Study|Termination by sponsor|0|||
44167561|NCT02349633|78960765|FG007|Overall Study|Termination by sponsor|1|||
44167562|NCT02349633|78960766|FG008|Overall Study|Termination by sponsor|0|||
44167563|NCT02349633|78960767|FG009|Overall Study|Termination by sponsor|2|||
44167564|NCT02349633|78960768|FG010|Overall Study|Termination by sponsor|0|||
44167565|NCT02349633|78960769|FG011|Overall Study|Termination by sponsor|0|||
44167566|NCT02349633|78960770|FG012|Overall Study|Termination by sponsor|0|||
44167567|NCT02349633|78960771|FG013|Overall Study|Termination by sponsor|0|||
44167568|NCT02349633|78960758|FG000|Overall Study|Other|0|||
44167569|NCT02349633|78960759|FG001|Overall Study|Other|0|||
44167570|NCT02349633|78960760|FG002|Overall Study|Other|0|||
44167571|NCT02349633|78960761|FG003|Overall Study|Other|0|||
44167572|NCT02349633|78960762|FG004|Overall Study|Other|0|||
44167573|NCT02349633|78960763|FG005|Overall Study|Other|0|||
44167574|NCT02349633|78960764|FG006|Overall Study|Other|0|||
44167575|NCT02349633|78960765|FG007|Overall Study|Other|2|||
44167576|NCT02349633|78960766|FG008|Overall Study|Other|0|||
44167577|NCT02349633|78960767|FG009|Overall Study|Other|0|||
44167578|NCT02349633|78960768|FG010|Overall Study|Other|0|||
44167579|NCT02349633|78960769|FG011|Overall Study|Other|0|||
44167580|NCT02349633|78960770|FG012|Overall Study|Other|0|||
44167581|NCT02349633|78960771|FG013|Overall Study|Other|0|||
44167582|NCT02275611|78960836|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
44167583|NCT02275611|78960837|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
44167584|NCT02275611|78960838|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
44167585|NCT02275611|78960839|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
44167586|NCT02275065|78960856|FG000|Overall Study|Randomized but not treated|1|||
44167587|NCT02275065|78960857|FG001|Overall Study|Randomized but not treated|0|||
44167588|NCT02275065|78960858|FG002|Overall Study|Randomized but not treated|1|||
44167589|NCT02275065|78960859|FG003|Overall Study|Randomized but not treated|1|||
44167590|NCT02275065|78960860|FG004|Overall Study|Randomized but not treated|0|||
44167591|NCT02273973|78960874|FG000|Overall Study|Adverse Event|4|||
44167592|NCT02273973|78960875|FG001|Overall Study|Adverse Event|0|||
44167593|NCT02273973|78960874|FG000|Overall Study|Withdrawal by Subject|2|||
44167594|NCT02273973|78960875|FG001|Overall Study|Withdrawal by Subject|3|||
44167595|NCT02273973|78960874|FG000|Overall Study|Death|1|||
44167596|NCT02273973|78960875|FG001|Overall Study|Death|0|||
44167597|NCT02273973|78960874|FG000|Overall Study|Non-compliance|1|||
44167598|NCT02273973|78960875|FG001|Overall Study|Non-compliance|0|||
44167599|NCT02273973|78960874|FG000|Overall Study|Protocol Violation|1|||
44167600|NCT02273973|78960875|FG001|Overall Study|Protocol Violation|0|||
44167601|NCT02273973|78960874|FG000|Overall Study|Progression of disease|0|||
44167602|NCT02273973|78960875|FG001|Overall Study|Progression of disease|2|||
44167603|NCT02273973|78960874|FG000|Overall Study|Lost to Follow-up|0|||
44167604|NCT02273973|78960875|FG001|Overall Study|Lost to Follow-up|1|||
44167605|NCT02273973|78960874|FG000|Overall Study|Physician Decision|0|||
44167606|NCT02273973|78960875|FG001|Overall Study|Physician Decision|1|||
44167607|NCT02273973|78960874|FG000|Overall Study|Reason not specified|0|||
44167608|NCT02273973|78960875|FG001|Overall Study|Reason not specified|1|||
44167609|NCT02273739|78960885|FG000|Overall Study|Progression of Disease|3|||
44167610|NCT02273739|78960886|FG001|Overall Study|Progression of Disease|4|||
44167611|NCT02273739|78960887|FG002|Overall Study|Progression of Disease|5|||
44167612|NCT02273739|78960888|FG003|Overall Study|Progression of Disease|2|||
44167613|NCT02273739|78960885|FG000|Overall Study|Death|0|||
44167614|NCT02273739|78960886|FG001|Overall Study|Death|0|||
44167615|NCT02273739|78960887|FG002|Overall Study|Death|0|||
44167616|NCT02273739|78960888|FG003|Overall Study|Death|2|||
44167617|NCT02273739|78960885|FG000|Overall Study|Adverse Event|0|||
44167618|NCT02273739|78960886|FG001|Overall Study|Adverse Event|0|||
44167619|NCT02273739|78960887|FG002|Overall Study|Adverse Event|0|||
44167620|NCT02273739|78960888|FG003|Overall Study|Adverse Event|1|||
44167621|NCT02273739|78960885|FG000|Overall Study|Withdrawal by Subject|0|||
44167622|NCT02273739|78960886|FG001|Overall Study|Withdrawal by Subject|0|||
44167623|NCT02273739|78960887|FG002|Overall Study|Withdrawal by Subject|2|||
44167624|NCT02273739|78960888|FG003|Overall Study|Withdrawal by Subject|1|||
44167625|NCT02273739|78960885|FG000|Overall Study|Physician Decision|0|||
44167626|NCT02273739|78960886|FG001|Overall Study|Physician Decision|0|||
44167627|NCT02273739|78960887|FG002|Overall Study|Physician Decision|0|||
44167628|NCT02273739|78960888|FG003|Overall Study|Physician Decision|1|||
44167629|NCT02273037|78960905|FG000|Overall Study|Lost to Follow-up|1|||
44167630|NCT02273037|78960906|FG001|Overall Study|Lost to Follow-up|0|||
44167631|NCT02273037|78960905|FG000|Overall Study|Delivered before monitoring initiated|1|||
44167632|NCT02273037|78960906|FG001|Overall Study|Delivered before monitoring initiated|3|||
44167633|NCT02273037|78960905|FG000|Overall Study|Breech delivery|2|||
44167634|NCT02273037|78960906|FG001|Overall Study|Breech delivery|3|||
44167635|NCT02273037|78960905|FG000|Overall Study|Multiple delivery|2|||
44167636|NCT02273037|78960906|FG001|Overall Study|Multiple delivery|2|||
44167637|NCT02273037|78960905|FG000|Overall Study|Other complication|2|||
44167638|NCT02273037|78960906|FG001|Overall Study|Other complication|0|||
44167639|NCT02465515|78960916|FG000|Overall Study|Investigator site closed|4|||
44167640|NCT02465515|78960917|FG001|Overall Study|Investigator site closed|5|||
44167641|NCT02465515|78960916|FG000|Overall Study|Withdrawal by Subject|74|||
44167642|NCT02465515|78960917|FG001|Overall Study|Withdrawal by Subject|43|||
44167643|NCT02465515|78960916|FG000|Overall Study|Physician Decision|8|||
44167644|NCT02465515|78960917|FG001|Overall Study|Physician Decision|12|||
44167645|NCT02465515|78960916|FG000|Overall Study|Lost to Follow-up|68|||
44167646|NCT02465515|78960917|FG001|Overall Study|Lost to Follow-up|51|||
44167647|NCT02412631|78960925|FG000|Overall Study|Adverse Event|1|||
44167648|NCT02412631|78960926|FG001|Overall Study|Adverse Event|2|||
44167649|NCT02412631|78960925|FG000|Overall Study|Lost to Follow-up|5|||
44167650|NCT02412631|78960926|FG001|Overall Study|Lost to Follow-up|9|||
44167651|NCT02412631|78960925|FG000|Overall Study|Withdrawal by Subject|9|||
44167652|NCT02412631|78960926|FG001|Overall Study|Withdrawal by Subject|3|||
44167653|NCT02412631|78960925|FG000|Overall Study|Early stop by FDA|5|||
44167654|NCT02412631|78960926|FG001|Overall Study|Early stop by FDA|2|||
44167655|NCT02412631|78960925|FG000|Overall Study|Unspecified reason|6|||
44167656|NCT02412631|78960926|FG001|Overall Study|Unspecified reason|8|||
44167657|NCT02272803|78960934|FG000|Overall Study|Disease progression|16|||
44167658|NCT02272803|78960935|FG001|Overall Study|Disease progression|8|||
44167659|NCT02272803|78960934|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
44167660|NCT02272803|78960935|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
44167661|NCT02272803|78960934|FG000|Overall Study|Study drug toxicity|4|||
44167662|NCT02272803|78960935|FG001|Overall Study|Study drug toxicity|9|||
44167663|NCT02272803|78960934|FG000|Overall Study|Participant request to discontinue study treatment|3|||
44167664|NCT02272803|78960935|FG001|Overall Study|Participant request to discontinue study treatment|7|||
44167665|NCT02272803|78960934|FG000|Overall Study|Maximum clinical benefit|4|||
44167666|NCT02272803|78960935|FG001|Overall Study|Maximum clinical benefit|2|||
44167667|NCT02272803|78960934|FG000|Overall Study|Poor/non-compliance|2|||
44167668|NCT02272803|78960935|FG001|Overall Study|Poor/non-compliance|2|||
44167669|NCT02272803|78960934|FG000|Overall Study|Withdrawal by Subject|2|||
44167670|NCT02272803|78960935|FG001|Overall Study|Withdrawal by Subject|1|||
44167671|NCT02272803|78960934|FG000|Overall Study|Death|0|||
44167672|NCT02272803|78960935|FG001|Overall Study|Death|1|||
44167673|NCT02272803|78960934|FG000|Overall Study|Other reasons|1|||
44167674|NCT02272803|78960935|FG001|Overall Study|Other reasons|3|||
44167675|NCT02272803|78960934|FG000|Overall Study|Administrative reason by sponsor|5|||
44167676|NCT02272803|78960935|FG001|Overall Study|Administrative reason by sponsor|4|||
44167677|NCT02272725|78960943|FG000|Overall Study|equipment malfunction|2|||
44167678|NCT02272725|78960944|FG001|Overall Study|equipment malfunction|0|||
44167679|NCT01650805|78960952|FG000|Overall Study|Withdrawal by Subject|1|||
44167680|NCT01650805|78960953|FG001|Overall Study|Withdrawal by Subject|0|||
44167681|NCT02442349|78960959|FG000|Overall Study|Death|14|||
44167682|NCT02442349|78960959|FG000|Overall Study|Withdrawal by Subject|8|||
44167683|NCT02442349|78960959|FG000|Overall Study|On-going Study at Data Cut-off|149|||
44167684|NCT02411539|78960965|FG000|Overall Study|Lost to Follow-up|2|||
44167685|NCT02411539|78960966|FG001|Overall Study|Lost to Follow-up|0|||
44167686|NCT02411539|78960965|FG000|Overall Study|Confounding medical condition|0|||
44167687|NCT02411539|78960966|FG001|Overall Study|Confounding medical condition|1|||
44167688|NCT02465437|78960979|FG000|Overall Study|Physician Decision|0|||
44167689|NCT02465437|78960980|FG001|Overall Study|Physician Decision|0|||
44167690|NCT02465437|78960981|FG002|Overall Study|Physician Decision|1|||
44167691|NCT02465437|78960982|FG003|Overall Study|Physician Decision|0|||
44167692|NCT02465437|78960979|FG000|Overall Study|Withdrawal by Subject|1|||
44167693|NCT02465437|78960980|FG001|Overall Study|Withdrawal by Subject|0|||
44167694|NCT02465437|78960981|FG002|Overall Study|Withdrawal by Subject|0|||
44167695|NCT02465437|78960982|FG003|Overall Study|Withdrawal by Subject|1|||
44167696|NCT02465437|78960979|FG000|Overall Study|Adverse Event|0|||
44167697|NCT02465437|78960980|FG001|Overall Study|Adverse Event|1|||
44167698|NCT02465437|78960981|FG002|Overall Study|Adverse Event|0|||
44167699|NCT02465437|78960982|FG003|Overall Study|Adverse Event|0|||
44167700|NCT02442271|78960990|FG000|Overall Study|Adverse Event|1|||
44167701|NCT02442271|78960990|FG000|Overall Study|Withdrew Consent|1|||
44167702|NCT02442271|78960990|FG000|Overall Study|Lost to Follow-up|1|||
44167703|NCT02442271|78960990|FG000|Overall Study|Other|1|||
44167704|NCT02465203|78961011|FG000|Overall Study|Protocol Violation|1|||
44167705|NCT02465203|78961012|FG001|Overall Study|Protocol Violation|1|||
44167706|NCT02465203|78961013|FG002|Overall Study|Protocol Violation|1|||
44167707|NCT02465203|78961011|FG000|Overall Study|Study terminated by sponsor|50|||
44167708|NCT02465203|78961012|FG001|Overall Study|Study terminated by sponsor|34|||
44167709|NCT02465203|78961013|FG002|Overall Study|Study terminated by sponsor|11|||
44167710|NCT02465203|78961011|FG000|Overall Study|New therapy for study indication|4|||
44167711|NCT02465203|78961012|FG001|Overall Study|New therapy for study indication|0|||
44167712|NCT02465203|78961013|FG002|Overall Study|New therapy for study indication|0|||
44167713|NCT02465203|78961011|FG000|Overall Study|Patient/guardian decision|1|||
44167714|NCT02465203|78961012|FG001|Overall Study|Patient/guardian decision|1|||
44167715|NCT02465203|78961013|FG002|Overall Study|Patient/guardian decision|1|||
44167716|NCT02463409|78961020|FG000|Overall Study|Withdrawal by Subject|1|||
44167717|NCT02463409|78961020|FG000|Overall Study|Screen failure|1|||
44167718|NCT02528357|78961043|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167719|NCT02528357|78961044|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
44167720|NCT02528357|78961045|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167721|NCT02528357|78961046|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167722|NCT02528357|78961047|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167723|NCT02528357|78961048|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167724|NCT02528357|78961049|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167725|NCT02528357|78961050|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167726|NCT02528357|78961051|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167727|NCT02528357|78961052|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167728|NCT02528357|78961053|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167729|NCT02528357|78961054|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167730|NCT02528357|78961055|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167731|NCT02528357|78961056|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167732|NCT02528357|78961057|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167733|NCT02528357|78961058|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167734|NCT02528357|78961059|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167735|NCT02528357|78961060|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167736|NCT02528357|78961061|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
44167737|NCT02528357|78961043|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167738|NCT02528357|78961044|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167739|NCT02528357|78961045|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167740|NCT02528357|78961046|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
44167741|NCT02528357|78961047|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167742|NCT02528357|78961048|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
44167743|NCT02528357|78961049|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167744|NCT02528357|78961050|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
44167745|NCT02528357|78961051|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167746|NCT02528357|78961052|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167747|NCT02528357|78961053|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167748|NCT02528357|78961054|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167749|NCT02528357|78961055|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167750|NCT02528357|78961056|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167751|NCT02528357|78961057|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167752|NCT02528357|78961058|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167753|NCT02528357|78961059|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167754|NCT02528357|78961060|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167755|NCT02528357|78961061|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
44167756|NCT02528357|78961043|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167757|NCT02528357|78961044|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167758|NCT02528357|78961045|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
44167759|NCT02528357|78961046|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167760|NCT02528357|78961047|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
44167761|NCT02528357|78961048|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167762|NCT02528357|78961049|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
44167763|NCT02528357|78961050|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
44167764|NCT02528357|78961051|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167765|NCT02528357|78961052|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167766|NCT02528357|78961053|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167767|NCT02528357|78961054|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167768|NCT02528357|78961055|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167769|NCT02528357|78961056|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167770|NCT02528357|78961057|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167771|NCT02528357|78961058|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167772|NCT02528357|78961059|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167773|NCT02528357|78961060|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167774|NCT02528357|78961061|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
44167775|NCT02528357|78961043|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167776|NCT02528357|78961044|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167777|NCT02528357|78961045|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167778|NCT02528357|78961046|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167779|NCT02528357|78961047|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
44167780|NCT02528357|78961048|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167781|NCT02528357|78961049|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167782|NCT02528357|78961050|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167783|NCT02528357|78961051|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167784|NCT02528357|78961052|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167785|NCT02528357|78961053|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167786|NCT02528357|78961054|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167787|NCT02528357|78961055|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167788|NCT02528357|78961056|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167789|NCT02528357|78961057|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167790|NCT02528357|78961058|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167791|NCT02528357|78961059|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167792|NCT02528357|78961060|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167793|NCT02528357|78961061|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167794|NCT02528357|78961043|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167795|NCT02528357|78961044|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167796|NCT02528357|78961045|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167797|NCT02528357|78961046|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167798|NCT02528357|78961047|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167799|NCT02528357|78961048|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167800|NCT02528357|78961049|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167801|NCT02528357|78961050|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167802|NCT02528357|78961051|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167803|NCT02528357|78961052|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167804|NCT02528357|78961053|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167805|NCT02528357|78961054|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167806|NCT02528357|78961055|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167807|NCT02528357|78961056|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
44167808|NCT02528357|78961057|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
44167809|NCT02528357|78961058|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167810|NCT02528357|78961059|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167811|NCT02528357|78961060|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167812|NCT02528357|78961061|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
44167813|NCT02528357|78961043|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167814|NCT02528357|78961044|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167815|NCT02528357|78961045|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167816|NCT02528357|78961046|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167817|NCT02528357|78961047|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167818|NCT02528357|78961048|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167819|NCT02528357|78961049|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167820|NCT02528357|78961050|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167821|NCT02528357|78961051|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167822|NCT02528357|78961052|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167823|NCT02528357|78961053|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167824|NCT02528357|78961054|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167825|NCT02528357|78961055|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167826|NCT02528357|78961056|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
44167827|NCT02528357|78961057|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167828|NCT02528357|78961058|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167829|NCT02528357|78961059|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167830|NCT02528357|78961060|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167831|NCT02528357|78961061|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
44167832|NCT02528357|78961043|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167833|NCT02528357|78961044|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167834|NCT02528357|78961045|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167835|NCT02528357|78961046|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167836|NCT02528357|78961047|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167837|NCT02528357|78961048|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167838|NCT02528357|78961049|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44167839|NCT02528357|78961050|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
44354348|NCT00954538|79358819|FG002|Part III|Withdrawal by Subject|0|||
44354349|NCT00954538|79358820|FG003|Part III|Withdrawal by Subject|0|||
44354350|NCT00954538|79358821|FG004|Part III|Withdrawal by Subject|1|||
44354351|NCT00954538|79358822|FG005|Part III|Withdrawal by Subject|0|||
44354352|NCT00943852|79358831|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354353|NCT00943852|79358832|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354354|NCT00943852|79358833|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354355|NCT00943852|79358834|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
44354356|NCT00943852|79358835|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354357|NCT00943852|79358836|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354358|NCT00943852|79358837|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354359|NCT00943852|79358838|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354360|NCT00943852|79358839|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354361|NCT00943852|79358840|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
44354362|NCT00943852|79358831|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354363|NCT00943852|79358832|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354364|NCT00943852|79358833|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354365|NCT00943852|79358834|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354366|NCT00943852|79358835|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354367|NCT00943852|79358836|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
44354368|NCT00943852|79358837|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354369|NCT00943852|79358838|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354370|NCT00943852|79358839|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354371|NCT00943852|79358840|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
44354372|NCT00943852|79358831|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354373|NCT00943852|79358832|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354374|NCT00943852|79358833|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354375|NCT00943852|79358834|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354376|NCT00943852|79358835|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354377|NCT00943852|79358836|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354378|NCT00943852|79358837|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
44354379|NCT00943852|79358838|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354380|NCT00943852|79358839|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354381|NCT00943852|79358840|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
44354382|NCT00943852|79358831|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354383|NCT00943852|79358832|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354384|NCT00943852|79358833|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354385|NCT00943852|79358834|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354386|NCT00943852|79358835|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354387|NCT00943852|79358836|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354388|NCT00943852|79358837|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354389|NCT00943852|79358838|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
44354390|NCT00943852|79358839|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354391|NCT00943852|79358840|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
44354392|NCT00943852|79358831|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
44354393|NCT00943852|79358832|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
44354394|NCT00943852|79358833|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
44354395|NCT00943852|79358834|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
44354396|NCT00943852|79358835|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
44354397|NCT00943852|79358836|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
44354398|NCT00943852|79358837|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
44354399|NCT00943852|79358838|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
44354400|NCT00943852|79358839|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
44354401|NCT00943852|79358840|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
44354402|NCT00952276|79358855|FG000|Overall Study|Withdrawal by Subject|1|||
44354403|NCT00952276|79358856|FG001|Overall Study|Withdrawal by Subject|0|||
44354404|NCT00952276|79358857|FG002|Overall Study|Withdrawal by Subject|0|||
44354405|NCT00952276|79358858|FG003|Overall Study|Withdrawal by Subject|1|||
44354406|NCT00952276|79358859|FG004|Overall Study|Withdrawal by Subject|0|||
44354407|NCT00943384|79358871|FG000|Overall Study|Dispositioned prior to treatment|23|||
44354408|NCT00943384|79358871|FG000|Overall Study|Treated off protocol-protocol violation|5|||
44354409|NCT00943384|79358871|FG000|Overall Study|Lost to Follow-up|16|||
44354410|NCT00943384|79358871|FG000|Overall Study|Withdrawal by Subject|5|||
44354411|NCT00943306|79358875|FG000|Overall Study|Physician Decision|1|||
44354412|NCT00943306|79358875|FG000|Overall Study|Death|1|||
44354413|NCT00943306|79358875|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
44354414|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
44354415|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
44354416|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
44354417|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
44354418|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
44354419|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
44354420|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
44354421|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
44354422|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
44354423|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
44354424|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
44354425|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
44354426|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
44354427|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
44354428|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
44354429|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
44354430|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
44354431|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
44354432|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
44354433|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
44354434|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
44354435|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
44354436|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
44354437|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
44354438|NCT01198002|79358882|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
44354439|NCT01198002|79358883|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
44354440|NCT01198002|79358884|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
44354441|NCT01198002|79358882|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
44354442|NCT01198002|79358883|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
44354443|NCT01198002|79358884|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
44354444|NCT01198002|79358882|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
44354445|NCT01198002|79358883|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
44354446|NCT01198002|79358884|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
44354447|NCT01198002|79358882|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
44354448|NCT01198002|79358883|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
44354449|NCT01198002|79358884|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
44354450|NCT01198002|79358882|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
44354451|NCT01198002|79358883|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
44354452|NCT01198002|79358884|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
44354453|NCT01198002|79358882|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
44354454|NCT01198002|79358883|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
44354455|NCT01198002|79358884|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
44354456|NCT01198002|79358882|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
44354457|NCT01198002|79358883|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
44354458|NCT01198002|79358884|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
44354459|NCT01197534|79358917|FG000|Overall Study|Not reported|16|||
44354460|NCT01197534|79358918|FG001|Overall Study|Not reported|10|||
44354461|NCT01197534|79358919|FG002|Overall Study|Not reported|16|||
44354462|NCT01197534|79358917|FG000|Overall Study|Enrolment in long term extension|57|||
44354463|NCT01197534|79358918|FG001|Overall Study|Enrolment in long term extension|66|||
44354464|NCT01197534|79358919|FG002|Overall Study|Enrolment in long term extension|119|||
44354465|NCT01197534|79358917|FG000|Overall Study|Severe non-compliance to protocol|3|||
44354466|NCT01197534|79358918|FG001|Overall Study|Severe non-compliance to protocol|4|||
44354467|NCT01197534|79358919|FG002|Overall Study|Severe non-compliance to protocol|1|||
44354468|NCT01197534|79358917|FG000|Overall Study|Lack of therapeutic response|9|||
44354469|NCT01197534|79358918|FG001|Overall Study|Lack of therapeutic response|4|||
44354470|NCT01197534|79358919|FG002|Overall Study|Lack of therapeutic response|9|||
44354471|NCT01197534|79358917|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
44354472|NCT01197534|79358918|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
44354473|NCT01197534|79358919|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
44354474|NCT01197534|79358917|FG000|Overall Study|Lost to Follow-up|1|||
44354475|NCT01197534|79358918|FG001|Overall Study|Lost to Follow-up|4|||
44354476|NCT01197534|79358919|FG002|Overall Study|Lost to Follow-up|2|||
44354477|NCT01197534|79358917|FG000|Overall Study|Adverse Event|35|||
44354478|NCT01197534|79358918|FG001|Overall Study|Adverse Event|36|||
44354479|NCT01197534|79358919|FG002|Overall Study|Adverse Event|24|||
44354480|NCT01197378|79358930|FG000|Overall Study|Adverse Event|3|||
44354481|NCT01197378|79358930|FG000|Overall Study|Withdrawal by Subject|1|||
44354482|NCT01197378|79358930|FG000|Overall Study|Physician Decision|1|||
44354483|NCT01197378|79358930|FG000|Overall Study|Other|2|||
44354484|NCT01197300|79358936|FG000|Overall Study|Lost to Follow-up|0|||
44354485|NCT01197300|79358937|FG001|Overall Study|Lost to Follow-up|1|||
44354486|NCT01197300|79358936|FG000|Overall Study|Protocol Violation|0|||
44354487|NCT01197300|79358937|FG001|Overall Study|Protocol Violation|1|||
44354488|NCT01196988|79358952|FG000|Overall Study|Adverse Event|1|||
44354489|NCT01196988|79358953|FG001|Overall Study|Adverse Event|2|||
44354490|NCT01196988|79358954|FG002|Overall Study|Adverse Event|0|||
44354491|NCT01196988|79358955|FG003|Overall Study|Adverse Event|0|||
44354492|NCT01196988|79358952|FG000|Overall Study|Withdrawal by Subject|5|||
44354493|NCT01196988|79358953|FG001|Overall Study|Withdrawal by Subject|1|||
44354494|NCT01196988|79358954|FG002|Overall Study|Withdrawal by Subject|4|||
44354495|NCT01196988|79358955|FG003|Overall Study|Withdrawal by Subject|0|||
44354496|NCT01196988|79358952|FG000|Overall Study|Lost to Follow-up|16|||
44354497|NCT01196988|79358953|FG001|Overall Study|Lost to Follow-up|29|||
44354498|NCT01196988|79358954|FG002|Overall Study|Lost to Follow-up|21|||
44354499|NCT01196988|79358955|FG003|Overall Study|Lost to Follow-up|1|||
44354500|NCT01196988|79358952|FG000|Overall Study|Other|2|||
44354501|NCT01196988|79358953|FG001|Overall Study|Other|0|||
44354502|NCT01196988|79358954|FG002|Overall Study|Other|0|||
44354503|NCT01196988|79358955|FG003|Overall Study|Other|0|||
44354504|NCT01196052|79358966|FG000|Overall Study|Adverse Event|9|||
44354505|NCT01196052|79358966|FG000|Overall Study|Lost to Follow-up|1|||
44354506|NCT01196052|79358966|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
44354507|NCT01196052|79358966|FG000|Overall Study|Reason not Specified|5|||
44354508|NCT01196052|79358966|FG000|Overall Study|Withdrawal by Subject|6|||
44354509|NCT01195662|79358973|FG000|Double Blind Treatment Period|Adverse Event|4|||
44354510|NCT01195662|79358974|FG001|Double Blind Treatment Period|Adverse Event|1|||
44354511|NCT01195662|79358975|FG002|Double Blind Treatment Period|Adverse Event|2|||
44354512|NCT01195662|79358973|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
44354513|NCT01195662|79358974|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
44354514|NCT01195662|79358975|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
44354515|NCT01195662|79358973|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
44354516|NCT01195662|79358974|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
44354517|NCT01195662|79358975|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
44354518|NCT01195662|79358973|FG000|Double Blind Treatment Period|Administrative reason|2|||
44354519|NCT01195662|79358974|FG001|Double Blind Treatment Period|Administrative reason|1|||
44354520|NCT01195662|79358975|FG002|Double Blind Treatment Period|Administrative reason|1|||
44354521|NCT01195662|79358973|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
44354869|NCT01035255|79359276|FG001|Overall Study|Lost to Follow-up|5|||
44354522|NCT01195662|79358974|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
44354523|NCT01195662|79358975|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
44354524|NCT01195662|79358973|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
44354525|NCT01195662|79358974|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
44354870|NCT01035255|79359275|FG000|Overall Study|patient's request|15|||
44167888|NCT02528357|78961061|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
44167889|NCT02528357|78961043|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167890|NCT02528357|78961044|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167891|NCT02528357|78961045|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167892|NCT02528357|78961046|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167893|NCT02528357|78961047|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167894|NCT02528357|78961048|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167895|NCT02528357|78961049|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167896|NCT02528357|78961050|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167897|NCT02528357|78961051|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167898|NCT02528357|78961052|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167899|NCT02528357|78961053|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167900|NCT02528357|78961054|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167901|NCT02528357|78961055|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167902|NCT02528357|78961056|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167903|NCT02528357|78961057|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167904|NCT02528357|78961058|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
44167905|NCT02528357|78961059|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
44167906|NCT02528357|78961060|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
44167907|NCT02528357|78961061|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
44167908|NCT02463331|78961103|FG000|Overall Study|Adverse Event|4|||
44167909|NCT02463331|78961104|FG001|Overall Study|Adverse Event|2|||
44167910|NCT02463331|78961103|FG000|Overall Study|Lost to Follow-up|1|||
44167911|NCT02463331|78961104|FG001|Overall Study|Lost to Follow-up|1|||
44167912|NCT02463331|78961103|FG000|Overall Study|Pregnancy|2|||
44167913|NCT02463331|78961104|FG001|Overall Study|Pregnancy|3|||
44167914|NCT02463331|78961103|FG000|Overall Study|Lack of Efficacy|6|||
44167915|NCT02463331|78961104|FG001|Overall Study|Lack of Efficacy|0|||
44167916|NCT02463331|78961103|FG000|Overall Study|Physician Decision|3|||
44167917|NCT02463331|78961104|FG001|Overall Study|Physician Decision|0|||
44167918|NCT02410837|78961110|FG000|Overall Study|Death|387|||
44167919|NCT02410837|78961110|FG000|Overall Study|Lost to Follow-up|50|||
44167920|NCT02410837|78961110|FG000|Overall Study|Withdrawal by Subject|44|||
44167921|NCT02410837|78961110|FG000|Overall Study|Physician Decision|6|||
44167922|NCT02410837|78961110|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
44167923|NCT02314247|78961116|FG000|Overall Study|Adverse Event|2|||
44167924|NCT02314247|78961117|FG001|Overall Study|Adverse Event|1|||
44167925|NCT02314247|78961118|FG002|Overall Study|Adverse Event|0|||
44167926|NCT02314247|78961116|FG000|Overall Study|Withdrawal by Subject|1|||
44167927|NCT02314247|78961117|FG001|Overall Study|Withdrawal by Subject|3|||
44167928|NCT02314247|78961118|FG002|Overall Study|Withdrawal by Subject|1|||
44167929|NCT02314247|78961116|FG000|Overall Study|Progression of Disease|6|||
44167930|NCT02314247|78961117|FG001|Overall Study|Progression of Disease|2|||
44167931|NCT02314247|78961118|FG002|Overall Study|Progression of Disease|0|||
44167932|NCT02463097|78961128|FG000|Overall Study|Withdrawal by Subject|1|||
44167933|NCT02441179|78961134|FG000|Overall Study|Withdrawal by Subject|1|||
44167934|NCT02441179|78961135|FG001|Overall Study|Withdrawal by Subject|1|||
44167935|NCT02462473|78961142|FG000|Overall Study|Death|1|||
44167936|NCT02462473|78961142|FG000|Overall Study|Other|3|||
44354526|NCT01195662|79358975|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
44354527|NCT01195662|79358973|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
44354528|NCT01195662|79358974|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
44354529|NCT01195662|79358975|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
44354530|NCT01195662|79358973|FG000|Double Blind Treatment Period|Non-specified|3|||
44354531|NCT01195662|79358974|FG001|Double Blind Treatment Period|Non-specified|0|||
44354532|NCT01195662|79358975|FG002|Double Blind Treatment Period|Non-specified|0|||
44354533|NCT01195662|79358973|FG000|Double Blind Treatment Period|Missing disposition information|0|||
44354534|NCT01195662|79358974|FG001|Double Blind Treatment Period|Missing disposition information|1|||
44354535|NCT01195662|79358975|FG002|Double Blind Treatment Period|Missing disposition information|1|||
44354536|NCT01195662|79358973|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
44354537|NCT01195662|79358974|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
44354538|NCT01195662|79358975|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
44354539|NCT01195662|79358973|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
44354540|NCT01195662|79358974|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
44354792|NCT01185366|79359202|FG001|First Line Therapy|Insurance Coverage Denied|1|||
44354793|NCT01185366|79359201|FG000|First Line Therapy|Withdrawal by Subject|1|||
44354794|NCT01185366|79359202|FG001|First Line Therapy|Withdrawal by Subject|0|||
44354795|NCT01185366|79359201|FG000|First Line Therapy|Lack of Metastatic Site|1|||
44354796|NCT01185366|79359202|FG001|First Line Therapy|Lack of Metastatic Site|0|||
44354797|NCT01185366|79359201|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
44354798|NCT01185366|79359202|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
44354799|NCT01185366|79359201|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
44354800|NCT01185366|79359202|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
44354801|NCT01185366|79359201|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
44354802|NCT01185366|79359202|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
44354803|NCT01185366|79359201|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
44354804|NCT01185366|79359202|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
44354805|NCT01185288|79359212|FG000|Overall Study|Adverse Event|7|||
44354806|NCT01185288|79359213|FG001|Overall Study|Adverse Event|6|||
44354807|NCT01185288|79359212|FG000|Overall Study|Withdrawal by Subject|6|||
44354808|NCT01185288|79359213|FG001|Overall Study|Withdrawal by Subject|4|||
44354809|NCT01185288|79359212|FG000|Overall Study|Lost to Follow-up|2|||
44354810|NCT01185288|79359213|FG001|Overall Study|Lost to Follow-up|5|||
44354811|NCT01185288|79359212|FG000|Overall Study|Lack of Efficacy|2|||
44354812|NCT01185288|79359213|FG001|Overall Study|Lack of Efficacy|0|||
44354813|NCT01185288|79359212|FG000|Overall Study|Investigator discretion|1|||
44354814|NCT01185288|79359213|FG001|Overall Study|Investigator discretion|0|||
44354815|NCT01185288|79359212|FG000|Overall Study|Did not meet inclusion criteria|1|||
44354816|NCT01185288|79359213|FG001|Overall Study|Did not meet inclusion criteria|0|||
44354817|NCT01185288|79359212|FG000|Overall Study|Noncompliance|0|||
44354818|NCT01185288|79359213|FG001|Overall Study|Noncompliance|1|||
44354819|NCT01184508|79359221|FG000|Overall Study|Adverse Event|4|||
44354820|NCT01184508|79359222|FG001|Overall Study|Adverse Event|6|||
44354821|NCT01184508|79359221|FG000|Overall Study|Lack of Efficacy|1|||
44354822|NCT01184508|79359222|FG001|Overall Study|Lack of Efficacy|1|||
44354823|NCT01184508|79359221|FG000|Overall Study|Lost to Follow-up|1|||
44354824|NCT01184508|79359222|FG001|Overall Study|Lost to Follow-up|1|||
44354825|NCT01184508|79359221|FG000|Overall Study|Physician Decision|1|||
44354826|NCT01184508|79359222|FG001|Overall Study|Physician Decision|0|||
44354827|NCT01184508|79359221|FG000|Overall Study|Protocol Violation|3|||
44354828|NCT01184508|79359222|FG001|Overall Study|Protocol Violation|1|||
44354829|NCT01184508|79359221|FG000|Overall Study|Sponsor Decision|5|||
44354830|NCT01184508|79359222|FG001|Overall Study|Sponsor Decision|2|||
44354831|NCT01184508|79359221|FG000|Overall Study|Withdrawal by Subject|1|||
44354832|NCT01184508|79359222|FG001|Overall Study|Withdrawal by Subject|3|||
44354833|NCT01184508|79359221|FG000|Overall Study|Randomized, Not Treated|0|||
44354834|NCT01184508|79359222|FG001|Overall Study|Randomized, Not Treated|1|||
44354835|NCT01184118|79359229|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
44354836|NCT01184118|79359229|FG000|Overall Study|No physiologic confirmation of asthma|8|||
44354837|NCT01184118|79359229|FG000|Overall Study|FEV1 <60% predicted|2|||
44354838|NCT01184118|79359229|FG000|Overall Study|Exclusionary medical condition|2|||
44354839|NCT01184118|79359229|FG000|Overall Study|Withdrawal by Subject|5|||
44354840|NCT01183884|79359233|FG000|Overall Study|Progressive Disease|26|||
44354841|NCT01183884|79359233|FG000|Overall Study|Adverse Event|3|||
44354842|NCT01183884|79359233|FG000|Overall Study|Withdrawal by Subject|1|||
44354843|NCT01183884|79359233|FG000|Overall Study|Other Complicating Disease|3|||
44354844|NCT01183884|79359233|FG000|Overall Study|Not Treated|1|||
44354845|NCT01183884|79359233|FG000|Overall Study|Other|4|||
44354846|NCT01183260|79359239|FG000|Overall Study|Intraop screen failure|2|||
44354847|NCT01183260|79359240|FG001|Overall Study|Intraop screen failure|0|||
44354848|NCT01183260|79359239|FG000|Overall Study|Withdrawal by Subject|1|||
44354849|NCT01183260|79359240|FG001|Overall Study|Withdrawal by Subject|1|||
44354850|NCT01183260|79359239|FG000|Overall Study|Revised within 30 days|0|||
44354851|NCT01183260|79359240|FG001|Overall Study|Revised within 30 days|1|||
44354852|NCT01183260|79359239|FG000|Overall Study|Death|1|||
44354853|NCT01183260|79359240|FG001|Overall Study|Death|0|||
44354854|NCT01191762|79359248|FG000|Overall Study|Adverse Event|1|||
44354855|NCT01191762|79359249|FG001|Overall Study|Adverse Event|0|||
44354856|NCT01190514|79359255|FG000|First Intervention (Period 1)|Adverse Event|1|||
44354857|NCT01190514|79359256|FG001|First Intervention (Period 1)|Adverse Event|0|||
44354858|NCT01190514|79359257|FG002|First Intervention (Period 1)|Adverse Event|0|||
44354859|NCT01190514|79359258|FG003|First Intervention (Period 1)|Adverse Event|0|||
44354860|NCT01190514|79359255|FG000|Third Intervention (Period 3)|Adverse Event|1|||
44354861|NCT01190514|79359256|FG001|Third Intervention (Period 3)|Adverse Event|0|||
44354862|NCT01190514|79359257|FG002|Third Intervention (Period 3)|Adverse Event|0|||
44354863|NCT01190514|79359258|FG003|Third Intervention (Period 3)|Adverse Event|0|||
44354864|NCT01190436|79359268|FG000|Overall Study|Lost to Follow-up|35|||
44354865|NCT01190436|79359268|FG000|Overall Study|Other|4|||
44354866|NCT01035255|79359275|FG000|Overall Study|Death|724|||
44354867|NCT01035255|79359276|FG001|Overall Study|Death|844|||
44354896|NCT01189890|79359301|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
44354897|NCT01189812|79359309|FG000|Overall Study|Withdrawal by Subject|2|||
44354898|NCT01189812|79359310|FG001|Overall Study|Withdrawal by Subject|3|||
44354899|NCT01189812|79359309|FG000|Overall Study|Adverse Event|1|||
44354900|NCT01189812|79359310|FG001|Overall Study|Adverse Event|0|||
44354901|NCT01189812|79359309|FG000|Overall Study|Out of Window|4|||
44354902|NCT01189812|79359310|FG001|Overall Study|Out of Window|3|||
44354903|NCT01189812|79359309|FG000|Overall Study|Moved out of State|1|||
44354904|NCT01189812|79359310|FG001|Overall Study|Moved out of State|2|||
44354905|NCT00950950|79359318|FG000|Overall Study|Adverse Event|1|||
44354906|NCT00950950|79359319|FG001|Overall Study|Adverse Event|0|||
44354907|NCT00950950|79359318|FG000|Overall Study|Withdrawal by Subject|0|||
44354908|NCT00950950|79359319|FG001|Overall Study|Withdrawal by Subject|1|||
44354909|NCT00950872|79359326|FG000|Overall Study|Withdrawal by Subject|1|||
44354910|NCT00950872|79359326|FG000|Overall Study|Did not have surgery|2|||
44354911|NCT01189500|79359330|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
44354912|NCT01189500|79359330|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
